"","Collection","Gene_set","Size","NES_B_Cell","PValue_B_Cell","FDR_B_Cell","NES_T_Cell","PValue_T_Cell","FDR_T_Cell","NES_Monocyte","PValue_Monocyte","FDR_Monocyte"
"C7_Immunologic_signatures:C7_ALL_48_GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN","C7_Immunologic_signatures","C7_ALL_48_GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN",200,-3.2808,0,0,-1.2062,0.096,0.82,0.8933,0.76,1
"C7_Immunologic_signatures:C7_ALL_1282_GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN","C7_Immunologic_signatures","C7_ALL_1282_GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN",200,-3.2684,0,0,-1.2796,0.046,0.51,-0.8673,0.81,0.99
"C7_Immunologic_signatures:C7_ALL_1286_GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN","C7_Immunologic_signatures","C7_ALL_1286_GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN",200,-3.2638,0,0,-1.1312,0.15,1,-1.615,0,0.004
"C7_Immunologic_signatures:C7_ALL_42_GSE10325_BCELL_VS_MYELOID_DN","C7_Immunologic_signatures","C7_ALL_42_GSE10325_BCELL_VS_MYELOID_DN",198,-3.2374,0,0,-1.2865,0.035,0.51,-1.0951,0.23,0.51
"C7_Immunologic_signatures:C7_ALL_1270_GSE29618_BCELL_VS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1270_GSE29618_BCELL_VS_MONOCYTE_DN",200,-3.1681,0,0,-0.6744,1,1,-0.7957,0.96,1
"C7_Immunologic_signatures:C7_ALL_1274_GSE29618_BCELL_VS_MDC_DN","C7_Immunologic_signatures","C7_ALL_1274_GSE29618_BCELL_VS_MDC_DN",200,-3.1517,0,0,0.5847,1,1,-1.3913,0.0085,0.068
"C7_Immunologic_signatures:C7_ALL_46_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN","C7_Immunologic_signatures","C7_ALL_46_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN",200,-3.0641,0,0,-1.3557,0.014,0.35,-0.8613,0.87,1
"C4_Cancer_gene_neighborhoods:C4_CGN_324_GNF2_CASP1","C4_Cancer_gene_neighborhoods","C4_CGN_324_GNF2_CASP1",111,-3.0356,0,0,-0.8515,0.81,1,-1.1579,0.18,0.5
"C7_Immunologic_signatures:C7_ALL_1287_GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP","C7_Immunologic_signatures","C7_ALL_1287_GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP",200,-3.0355,0,0,-1.0826,0.25,1,-0.965,0.55,0.81
"C7_Immunologic_signatures:C7_ALL_984_GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_984_GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN",199,-3.0326,0,0,-0.8211,0.91,1,0.6411,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_356_GNF2_HCK","C4_Cancer_gene_neighborhoods","C4_CGN_356_GNF2_HCK",93,-3.0275,0,0,-0.7242,0.96,1,-1.1937,0.13,0.45
"C7_Immunologic_signatures:C7_ALL_1277_GSE29618_MONOCYTE_VS_MDC_UP","C7_Immunologic_signatures","C7_ALL_1277_GSE29618_MONOCYTE_VS_MDC_UP",199,-3.02,0,0,-1.0467,0.35,1,0.7172,1,1
"C7_Immunologic_signatures:C7_ALL_1275_GSE29618_MONOCYTE_VS_PDC_UP","C7_Immunologic_signatures","C7_ALL_1275_GSE29618_MONOCYTE_VS_PDC_UP",199,-3.0197,0,0,-0.8571,0.84,1,-0.8187,0.95,1
"C7_Immunologic_signatures:C7_ALL_1292_GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN","C7_Immunologic_signatures","C7_ALL_1292_GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN",200,-2.9646,0,0,-0.8254,0.92,1,-1.3197,0.025,0.12
"C7_Immunologic_signatures:C7_ALL_980_GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_980_GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN",198,-2.9478,0,0,0.8599,0.84,1,-1.0109,0.4,0.7
"C4_Cancer_gene_neighborhoods:C4_CGN_287_GNF2_CARD15","C4_Cancer_gene_neighborhoods","C4_CGN_287_GNF2_CARD15",69,-2.9444,0,0,-1.5063,0.0076,0.27,-1.3671,0.052,0.21
"C7_Immunologic_signatures:C7_ALL_990_GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_990_GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN",199,-2.9344,0,0,-1.0544,0.33,1,0.7487,0.99,1
"C7_Immunologic_signatures:C7_ALL_1886_GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1886_GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN",196,-2.9266,0,0,-2.1014,0,0,-2.2193,0,0
"C7_Immunologic_signatures:C7_ALL_978_GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_978_GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN",200,-2.923,0,0,-1.1719,0.12,0.95,-0.7138,0.99,1
"C7_Immunologic_signatures:C7_ALL_1289_GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP","C7_Immunologic_signatures","C7_ALL_1289_GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP",200,-2.9229,0,0,-0.7431,0.99,1,0.7685,0.98,1
"C7_Immunologic_signatures:C7_ALL_1280_GSE29618_PDC_VS_MDC_DN","C7_Immunologic_signatures","C7_ALL_1280_GSE29618_PDC_VS_MDC_DN",199,-2.9146,0,0,-0.6721,1,1,-1.3561,0.014,0.092
"C2_Chemical_and_genetic_perturbations:C2_CGP_1446_BROWN_MYELOID_CELL_DEVELOPMENT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1446_BROWN_MYELOID_CELL_DEVELOPMENT_UP",162,-2.8998,0,0,-0.8597,0.8,1,-0.7913,0.95,0.96
"C7_Immunologic_signatures:C7_ALL_996_GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_996_GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN",200,-2.8966,0,0,-0.9948,0.45,1,-0.8065,0.94,1
"C7_Immunologic_signatures:C7_ALL_1899_GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1899_GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP",192,-2.8879,0,0,-1.9496,0,0,-2.0358,0,0
"C4_Cancer_gene_neighborhoods:C4_CGN_419_GNF2_TNFRSF1B","C4_Cancer_gene_neighborhoods","C4_CGN_419_GNF2_TNFRSF1B",64,-2.8873,0,0,-0.7386,0.94,1,-1.1662,0.19,0.48
"C4_Cancer_gene_neighborhoods:C4_CGN_330_GNF2_CD33","C4_Cancer_gene_neighborhoods","C4_CGN_330_GNF2_CD33",51,-2.8853,0,0,-2.0468,0,0.0049,-1.4681,0.039,0.13
"C7_Immunologic_signatures:C7_ALL_73_GSE11057_PBMC_VS_MEM_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_73_GSE11057_PBMC_VS_MEM_CD4_TCELL_UP",193,-2.8696,0,0,-0.9716,0.55,1,-1.5515,0,0.011
"C7_Immunologic_signatures:C7_ALL_1746_GSE6269_HEALTHY_VS_STREP_AUREUS_INF_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1746_GSE6269_HEALTHY_VS_STREP_AUREUS_INF_PBMC_DN",167,-2.863,0,0,0.6097,1,1,1.1068,0.21,0.98
"C7_Immunologic_signatures:C7_ALL_1905_GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1905_GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP",192,-2.8612,0,0,-1.9707,0,0,-2.0163,0,0
"C7_Immunologic_signatures:C7_ALL_37_GSE10325_CD4_TCELL_VS_BCELL_UP","C7_Immunologic_signatures","C7_ALL_37_GSE10325_CD4_TCELL_VS_BCELL_UP",195,-2.8543,0,0,1.2236,0.051,0.19,-1.7271,0,0.00039
"C4_Cancer_gene_neighborhoods:C4_CGN_329_GNF2_CD1D","C4_Cancer_gene_neighborhoods","C4_CGN_329_GNF2_CD1D",44,-2.8498,0,0,-1.9237,0,0.0073,-1.5934,0.011,0.074
"C7_Immunologic_signatures:C7_ALL_1884_GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1884_GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN",197,-2.8366,0,0,-1.7935,0,0.00052,-2.2058,0,0
"C4_Cancer_gene_neighborhoods:C4_CGN_392_GNF2_PECAM1","C4_Cancer_gene_neighborhoods","C4_CGN_392_GNF2_PECAM1",56,-2.8354,0,0,-0.7885,0.84,1,-0.7594,0.91,1
"C7_Immunologic_signatures:C7_ALL_1888_GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1888_GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN",191,-2.8171,0,0,-2.0907,0,0,-2.307,0,0
"C7_Immunologic_signatures:C7_ALL_1062_GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN","C7_Immunologic_signatures","C7_ALL_1062_GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN",199,-2.8108,0,0,-0.9525,0.59,1,1.2794,0.045,0.42
"C7_Immunologic_signatures:C7_ALL_1903_GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1903_GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP",193,-2.8016,0,0,-2.0208,0,0,-2.0913,0,0
"C7_Immunologic_signatures:C7_ALL_70_GSE11057_CD4_CENT_MEM_VS_PBMC_DN","C7_Immunologic_signatures","C7_ALL_70_GSE11057_CD4_CENT_MEM_VS_PBMC_DN",191,-2.8004,0,0,-1.042,0.35,1,-1.5241,0.0041,0.016
"C7_Immunologic_signatures:C7_ALL_68_GSE11057_CD4_EFF_MEM_VS_PBMC_DN","C7_Immunologic_signatures","C7_ALL_68_GSE11057_CD4_EFF_MEM_VS_PBMC_DN",196,-2.7957,0,0,-0.9305,0.64,1,-1.5583,0,0.0096
"C7_Immunologic_signatures:C7_ALL_1897_GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1897_GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP",191,-2.7895,0,0,-1.853,0,7.6e-05,-1.9649,0,0
"C4_Cancer_gene_neighborhoods:C4_CGN_404_GNF2_S100A4","C4_Cancer_gene_neighborhoods","C4_CGN_404_GNF2_S100A4",47,-2.7652,0,0,-0.8093,0.79,1,-1.181,0.19,0.47
"C7_Immunologic_signatures:C7_ALL_1284_GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN","C7_Immunologic_signatures","C7_ALL_1284_GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN",199,-2.7441,0,0,-0.8712,0.81,1,-1.3956,0.0065,0.065
"C4_Cancer_gene_neighborhoods:C4_CGN_353_GNF2_FOS","C4_Cancer_gene_neighborhoods","C4_CGN_353_GNF2_FOS",41,-2.7107,0,0,-1.9897,0,0.0039,-1.4643,0.018,0.13
"C4_Cancer_gene_neighborhoods:C4_CGN_328_GNF2_CD14","C4_Cancer_gene_neighborhoods","C4_CGN_328_GNF2_CD14",34,-2.7103,0,0,-1.6445,0.0057,0.098,-1.5044,0.024,0.11
"C2_Chemical_and_genetic_perturbations:C2_CGP_3357_ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION","C2_Chemical_and_genetic_perturbations","C2_CGP_3357_ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION",127,-2.6846,0,0,-1.1916,0.13,0.81,-1.272,0.055,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_1522_VERHAAK_AML_WITH_NPM1_MUTATED_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1522_VERHAAK_AML_WITH_NPM1_MUTATED_UP",182,-2.6803,0,0,0.9557,0.58,0.86,-1.1285,0.16,0.59
"C4_Cancer_gene_neighborhoods:C4_CGN_376_GNF2_MCL1","C4_Cancer_gene_neighborhoods","C4_CGN_376_GNF2_MCL1",57,-2.6763,0,0,0.6816,0.98,1,-1.0858,0.3,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2547_RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2547_RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN",313,-2.6729,0,0,-0.8232,0.95,1,-1.2031,0.059,0.51
"C7_Immunologic_signatures:C7_ALL_43_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP","C7_Immunologic_signatures","C7_ALL_43_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP",195,-2.6647,0,0,1.1236,0.15,0.38,-1.5463,0,0.011
"C7_Immunologic_signatures:C7_ALL_1909_GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP","C7_Immunologic_signatures","C7_ALL_1909_GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP",190,-2.6559,0,0,-1.7713,0,7e-04,-1.4338,0.014,0.042
"C2_Chemical_and_genetic_perturbations:C2_CGP_321_JAATINEN_HEMATOPOIETIC_STEM_CELL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_321_JAATINEN_HEMATOPOIETIC_STEM_CELL_DN",223,-2.6502,0,0,1.769,0,0.054,-1.5824,0,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_1455_GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN","C2_Chemical_and_genetic_perturbations","C2_CGP_1455_GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN",85,-2.6482,0,0,-1.5701,0,0.44,-1.1201,0.22,0.61
"C7_Immunologic_signatures:C7_ALL_1907_GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP","C7_Immunologic_signatures","C7_ALL_1907_GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP",193,-2.6424,0,0,-1.8862,0,8.8e-05,-1.679,0,0.0012
"C7_Immunologic_signatures:C7_ALL_40_GSE10325_CD4_TCELL_VS_MYELOID_DN","C7_Immunologic_signatures","C7_ALL_40_GSE10325_CD4_TCELL_VS_MYELOID_DN",199,-2.6298,0,0,-1.0852,0.27,1,-1.286,0.034,0.15
"C2_Chemical_and_genetic_perturbations:C2_CGP_3035_KAMIKUBO_MYELOID_CEBPA_NETWORK","C2_Chemical_and_genetic_perturbations","C2_CGP_3035_KAMIKUBO_MYELOID_CEBPA_NETWORK",27,-2.6119,0,0,-0.5732,0.98,1,-0.8192,0.75,0.94
"C7_Immunologic_signatures:C7_ALL_1070_GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN","C7_Immunologic_signatures","C7_ALL_1070_GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN",200,-2.6084,0,0,-1.0335,0.35,1,-0.9992,0.44,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1554_HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1554_HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN",62,-2.6063,0,0,-1.0161,0.43,0.99,-1.4731,0.022,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_1493_HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1493_HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN",76,-2.6041,0,0,0.8666,0.76,0.96,1.14,0.24,0.83
"C7_Immunologic_signatures:C7_ALL_64_GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_64_GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN",197,-2.6037,0,0,0.548,1,1,-1.1314,0.16,0.41
"C7_Immunologic_signatures:C7_ALL_1748_GSE6269_HEALTHY_VS_STREP_PNEUMO_INF_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1748_GSE6269_HEALTHY_VS_STREP_PNEUMO_INF_PBMC_DN",169,-2.5953,0,0,-0.6937,1,1,0.7445,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3030_LI_INDUCED_T_TO_NATURAL_KILLER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3030_LI_INDUCED_T_TO_NATURAL_KILLER_UP",305,-2.5816,0,0,-0.6567,1,1,-0.866,0.88,0.91
"C0_Hallmark:H_ALL_1_HALLMARK_TNFA_SIGNALING_VIA_NFKB","C0_Hallmark","H_ALL_1_HALLMARK_TNFA_SIGNALING_VIA_NFKB",200,-2.5575,0,0,-1.7409,0,0.015,-1.2525,0.042,0.15
"C7_Immunologic_signatures:C7_ALL_1272_GSE29618_BCELL_VS_PDC_DN","C7_Immunologic_signatures","C7_ALL_1272_GSE29618_BCELL_VS_PDC_DN",197,-2.5557,0,0,0.7606,0.98,1,-1.349,0.012,0.097
"C4_Cancer_modules:C4_CM_156_MODULE_165","C4_Cancer_modules","C4_CM_156_MODULE_165",76,-2.5547,0,0,-0.9183,0.62,0.88,-1.6242,0.0039,0.11
"C2_Chemical_and_genetic_perturbations:C2_CGP_1984_MCLACHLAN_DENTAL_CARIES_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1984_MCLACHLAN_DENTAL_CARIES_UP",239,-2.5544,0,0,0.9099,0.75,0.91,-1.0171,0.4,0.73
"C7_Immunologic_signatures:C7_ALL_1064_GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN","C7_Immunologic_signatures","C7_ALL_1064_GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN",199,-2.5503,0,0,-0.6924,1,1,0.968,0.54,1
"C0_Hallmark:H_ALL_31_HALLMARK_INFLAMMATORY_RESPONSE","C0_Hallmark","H_ALL_31_HALLMARK_INFLAMMATORY_RESPONSE",196,-2.55,0,0,0.8484,0.9,1,1.0514,0.33,0.5
"C4_Cancer_gene_neighborhoods:C4_CGN_352_GNF2_FGR","C4_Cancer_gene_neighborhoods","C4_CGN_352_GNF2_FGR",32,-2.5392,0,0,-0.3997,1,1,-0.7511,0.87,1
"C7_Immunologic_signatures:C7_ALL_1631_GSE3982_DC_VS_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1631_GSE3982_DC_VS_BCELL_UP",196,-2.5256,0,0,0.7754,0.98,1,-1.244,0.057,0.2
"C7_Immunologic_signatures:C7_ALL_961_GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP","C7_Immunologic_signatures","C7_ALL_961_GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP",200,-2.5233,0,0,1.1998,0.086,0.23,-2.3505,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_160_GAL_LEUKEMIC_STEM_CELL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_160_GAL_LEUKEMIC_STEM_CELL_DN",234,-2.5231,0,0,-1.0513,0.31,0.97,-1.0374,0.34,0.7
"C7_Immunologic_signatures:C7_ALL_4_KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_4_KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN",198,-2.5211,0,0,0.938,0.64,0.94,-0.9356,0.65,0.88
"C4_Cancer_gene_neighborhoods:C4_CGN_420_GNF2_TNFSF10","C4_Cancer_gene_neighborhoods","C4_CGN_420_GNF2_TNFSF10",30,-2.5206,0,0,0.6218,0.97,1,-0.7281,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3056_VERHAAK_GLIOBLASTOMA_MESENCHYMAL","C2_Chemical_and_genetic_perturbations","C2_CGP_3056_VERHAAK_GLIOBLASTOMA_MESENCHYMAL",216,-2.5186,0,0,0.8439,0.9,0.97,1.3589,0.0038,0.56
"GO_BP:511686_GO_0050715_POSITIVE_REGULATION_OF_CYTOKINE_SECRETION","GO_BP","511686_GO_0050715_POSITIVE_REGULATION_OF_CYTOKINE_SECRETION",72,-2.513,0,0,-1.1769,0.2,0.9,-1.3269,0.067,0.62
"C4_Cancer_gene_neighborhoods:C4_CGN_366_GNF2_ITGB2","C4_Cancer_gene_neighborhoods","C4_CGN_366_GNF2_ITGB2",57,-2.5111,0,0,-0.4994,1,1,-0.9325,0.57,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_3375_GHANDHI_BYSTANDER_IRRADIATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3375_GHANDHI_BYSTANDER_IRRADIATION_UP",83,-2.5092,0,0,-1.6594,0.0018,0.38,-1.4411,0.021,0.33
"C7_Immunologic_signatures:C7_ALL_1090_GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1090_GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN",199,-2.5081,0,0,-0.8276,0.89,1,-1.3805,0.012,0.074
"C4_Cancer_modules:C4_CM_70_MODULE_75","C4_Cancer_modules","C4_CM_70_MODULE_75",381,-2.5031,0,0,1.1802,0.05,0.41,-0.982,0.5,0.73
"C7_Immunologic_signatures:C7_ALL_1114_GSE2706_UNSTIM_VS_2H_R848_DC_DN","C7_Immunologic_signatures","C7_ALL_1114_GSE2706_UNSTIM_VS_2H_R848_DC_DN",189,-2.4972,0,0,-1.6907,0,0.0031,-1.2839,0.03,0.15
"C2_Chemical_and_genetic_perturbations:C2_CGP_1510_LENAOUR_DENDRITIC_CELL_MATURATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1510_LENAOUR_DENDRITIC_CELL_MATURATION_DN",128,-2.4972,0,0,-0.8547,0.82,1,-0.8293,0.86,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_2550_RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2550_RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP",406,-2.4942,0,0,0.6886,1,1,0.8418,0.96,1
"C7_Immunologic_signatures:C7_ALL_941_GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP","C7_Immunologic_signatures","C7_ALL_941_GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP",198,-2.4925,0,0,1.0673,0.28,0.53,-1.5742,0,0.008
"C7_Immunologic_signatures:C7_ALL_992_GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_992_GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN",193,-2.4891,0,0,-0.8635,0.81,1,-1.0918,0.23,0.52
"C7_Immunologic_signatures:C7_ALL_16_GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_16_GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN",199,-2.4862,0,0,-0.7341,0.99,1,-1.1962,0.1,0.29
"C7_Immunologic_signatures:C7_ALL_1637_GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1637_GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP",199,-2.4857,0,0,-0.8296,0.92,1,-1.252,0.037,0.19
"C2_Chemical_and_genetic_perturbations:C2_CGP_1832_MCLACHLAN_DENTAL_CARIES_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1832_MCLACHLAN_DENTAL_CARIES_DN",234,-2.4851,0,0,0.9588,0.58,0.86,-1.0694,0.28,0.67
"C7_Immunologic_signatures:C7_ALL_1060_GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN","C7_Immunologic_signatures","C7_ALL_1060_GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN",197,-2.4828,0,0,-0.8194,0.91,1,1.0867,0.25,1
"C7_Immunologic_signatures:C7_ALL_986_GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_986_GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN",186,-2.4811,0,0,-0.8321,0.88,1,-1.0305,0.4,0.66
"C4_Cancer_modules:C4_CM_42_MODULE_46","C4_Cancer_modules","C4_CM_42_MODULE_46",374,-2.4701,0,0,1.1663,0.083,0.44,-1.0207,0.4,0.66
"GO_BP:516145_GO_0071219_CELLULAR_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN","GO_BP","516145_GO_0071219_CELLULAR_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN",120,-2.4697,0,0,-1.0506,0.35,0.97,-0.9181,0.63,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_2513_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2513_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP",130,-2.4679,0,0,1.0797,0.25,0.67,-0.8218,0.89,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_1491_NEMETH_INFLAMMATORY_RESPONSE_LPS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1491_NEMETH_INFLAMMATORY_RESPONSE_LPS_UP",88,-2.4663,0,0,-1.2303,0.14,0.77,-0.9369,0.6,0.84
"GO_BP:516148_GO_0071222_CELLULAR_RESPONSE_TO_LIPOPOLYSACCHARIDE","GO_BP","516148_GO_0071222_CELLULAR_RESPONSE_TO_LIPOPOLYSACCHARIDE",113,-2.4509,0,0,-0.9965,0.46,0.99,-0.9388,0.59,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_360_HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_360_HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP",62,-2.4508,0,0,-1.3845,0.054,0.61,-1.0725,0.3,0.67
"C7_Immunologic_signatures:C7_ALL_6_KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_6_KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN",198,-2.4481,0,0,0.7683,0.99,1,-1.0171,0.37,0.69
"GO_BP:501901_GO_0032675_REGULATION_OF_INTERLEUKIN_6_PRODUCTION","GO_BP","501901_GO_0032675_REGULATION_OF_INTERLEUKIN_6_PRODUCTION",87,-2.4407,0,0,-1.1039,0.26,0.94,-1.0352,0.36,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_219_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_219_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN",204,-2.4405,0,0,0.9367,0.68,0.88,1.2564,0.035,0.72
"WikiPathways:198912_WP98_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION","WikiPathways","198912_WP98_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION",30,-2.4397,0,0,-0.9298,0.55,1,0.9327,0.57,1
"GO_BP:516142_GO_0071216_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS","GO_BP","516142_GO_0071216_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS",139,-2.4392,0,0,-1.1246,0.2,0.94,-1.1076,0.22,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1284_ROSS_AML_WITH_CBFB_MYH11_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_1284_ROSS_AML_WITH_CBFB_MYH11_FUSION",51,-2.4371,0,0,-0.9599,0.52,1,-1.0905,0.3,0.64
"C7_Immunologic_signatures:C7_ALL_14_GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_14_GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN",198,-2.4332,0,0,1.0079,0.44,0.71,-1.6764,0,0.0014
"C7_Immunologic_signatures:C7_ALL_982_GSE22886_NAIVE_BCELL_VS_DC_DN","C7_Immunologic_signatures","C7_ALL_982_GSE22886_NAIVE_BCELL_VS_DC_DN",199,-2.4272,0,0,-0.5703,1,1,0.8842,0.8,1
"KEGG_pathway:HSA05134_LEGIONELLOSIS","KEGG_pathway","HSA05134_LEGIONELLOSIS",55,-2.4262,0,0,-1.397,0.048,0.38,-1.8937,0,0.034
"C4_Cancer_modules:C4_CM_5_MODULE_5","C4_Cancer_modules","C4_CM_5_MODULE_5",426,-2.4241,0,0,1.0123,0.4,0.71,1.0041,0.42,0.95
"C7_Immunologic_signatures:C7_ALL_976_GSE22886_NAIVE_TCELL_VS_DC_DN","C7_Immunologic_signatures","C7_ALL_976_GSE22886_NAIVE_TCELL_VS_DC_DN",200,-2.4224,0,0,-0.6838,1,1,0.9143,0.69,1
"C7_Immunologic_signatures:C7_ALL_1901_GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1901_GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP",195,-2.4217,0,0,-1.2809,0.048,0.51,-1.2554,0.038,0.19
"C4_Cancer_gene_neighborhoods:C4_CGN_394_GNF2_PTPN4","C4_Cancer_gene_neighborhoods","C4_CGN_394_GNF2_PTPN4",49,-2.4197,0,0,0.8396,0.75,0.94,-1.6259,0.0061,0.069
"C7_Immunologic_signatures:C7_ALL_1068_GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN","C7_Immunologic_signatures","C7_ALL_1068_GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN",200,-2.4176,0,0,-1.1837,0.12,0.88,1.0138,0.42,1
"C4_Cancer_gene_neighborhoods:C4_CGN_333_GNF2_CD7","C4_Cancer_gene_neighborhoods","C4_CGN_333_GNF2_CD7",38,-2.417,0,0,0.9625,0.51,0.67,-1.8415,0,0.01
"C7_Immunologic_signatures:C7_ALL_1078_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN","C7_Immunologic_signatures","C7_ALL_1078_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN",199,-2.4145,0,0,-0.6617,1,1,-1.1357,0.15,0.4
"C7_Immunologic_signatures:C7_ALL_334_GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_334_GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN",199,-2.4141,0,0,-1.7053,0,0.0028,-1.1585,0.13,0.35
"C7_Immunologic_signatures:C7_ALL_1056_GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN","C7_Immunologic_signatures","C7_ALL_1056_GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN",200,-2.4135,0,0,0.8463,0.89,1,-0.9302,0.67,0.89
"C7_Immunologic_signatures:C7_ALL_1647_GSE3982_MAC_VS_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1647_GSE3982_MAC_VS_BCELL_UP",197,-2.4062,0,0,-0.7665,0.98,1,-1.0494,0.31,0.61
"C7_Immunologic_signatures:C7_ALL_1577_GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1577_GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP",194,-2.405,0,0,0.9744,0.52,0.82,-1.167,0.12,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_2904_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2904_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP",71,-2.4044,0,0,-0.8186,0.81,1,-1.1077,0.26,0.62
"C7_Immunologic_signatures:C7_ALL_336_GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_336_GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN",198,-2.4016,0,0,-1.5881,0,0.02,-1.1653,0.12,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_1652_RAMALHO_STEMNESS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1652_RAMALHO_STEMNESS_DN",74,-2.4009,0,0,-1.1733,0.18,0.82,-1.2794,0.076,0.45
"C7_Immunologic_signatures:C7_ALL_1137_GSE2706_2H_VS_8H_R848_STIM_DC_UP","C7_Immunologic_signatures","C7_ALL_1137_GSE2706_2H_VS_8H_R848_STIM_DC_UP",193,-2.4009,0,0,-1.2584,0.065,0.59,-1.6735,0,0.0014
"C4_Cancer_gene_neighborhoods:C4_CGN_363_GNF2_IL2RB","C4_Cancer_gene_neighborhoods","C4_CGN_363_GNF2_IL2RB",45,-2.3994,0,0,0.8842,0.69,0.86,-1.4423,0.038,0.14
"C7_Immunologic_signatures:C7_ALL_1635_GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1635_GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP",199,-2.397,0,0,0.6528,1,1,-1.208,0.084,0.26
"REACTOME:106413_REACT_11152_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL","REACTOME","106413_REACT_11152_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL",67,-2.396,0,0,1.1322,0.23,0.54,-1.1193,0.23,0.68
"C7_Immunologic_signatures:C7_ALL_60_GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_60_GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN",195,-2.3959,0,0,-0.7093,1,1,-1.2912,0.033,0.15
"C7_Immunologic_signatures:C7_ALL_1025_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1025_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP",195,-2.3947,0,0,-1.021,0.4,1,-1.0087,0.42,0.7
"GO_BP:501981_GO_0032755_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION","GO_BP","501981_GO_0032755_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION",55,-2.3875,0,0,-1.1156,0.26,0.94,-0.8062,0.83,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1349_WIELAND_UP_BY_HBV_INFECTION","C2_Chemical_and_genetic_perturbations","C2_CGP_1349_WIELAND_UP_BY_HBV_INFECTION",100,-2.3861,0,0,0.9035,0.68,0.92,-1.4808,0.0059,0.31
"C7_Immunologic_signatures:C7_ALL_1073_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP","C7_Immunologic_signatures","C7_ALL_1073_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP",197,-2.3768,0,0,-0.8424,0.86,1,-1.1001,0.24,0.5
"C2_Chemical_and_genetic_perturbations:C2_CGP_2410_QI_PLASMACYTOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2410_QI_PLASMACYTOMA_UP",258,-2.3755,0,0,1.0259,0.37,0.76,-1.1377,0.13,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_334_GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_334_GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP",65,-2.3747,0,0,-1.0093,0.43,0.99,-1.5156,0.02,0.28
"C2_Chemical_and_genetic_perturbations:C2_CGP_1564_TAVOR_CEBPA_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1564_TAVOR_CEBPA_TARGETS_UP",48,-2.373,0,0,-0.6367,0.98,1,-1.3347,0.066,0.41
"C7_Immunologic_signatures:C7_ALL_1023_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1023_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP",196,-2.372,0,0,-0.7558,0.99,1,-0.9431,0.63,0.87
"C7_Immunologic_signatures:C7_ALL_1870_GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1870_GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN",198,-2.3713,0,0,1.2168,0.073,0.2,-1.0261,0.4,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_2528_PARK_APL_PATHOGENESIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2528_PARK_APL_PATHOGENESIS_DN",49,-2.3669,0,0,-0.6645,0.97,1,-1.0466,0.37,0.69
"C4_Cancer_modules:C4_CM_59_MODULE_63","C4_Cancer_modules","C4_CM_59_MODULE_63",207,-2.3618,0,0,-1.2681,0.041,0.57,1.2242,0.069,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_2515_LINDSTEDT_DENDRITIC_CELL_MATURATION_A","C2_Chemical_and_genetic_perturbations","C2_CGP_2515_LINDSTEDT_DENDRITIC_CELL_MATURATION_A",66,-2.3584,0,0,-1.036,0.4,0.97,-1.0688,0.33,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_1787_LIAN_LIPA_TARGETS_3M","C2_Chemical_and_genetic_perturbations","C2_CGP_1787_LIAN_LIPA_TARGETS_3M",59,-2.3497,0,0,1.0253,0.4,0.76,1.5146,0.019,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_1172_ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1172_ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP",219,-2.3455,0,0,-1.0107,0.43,0.99,-1.345,0.014,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_1341_FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1341_FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP",86,-2.3421,0,0,1.3679,0.027,0.32,-0.9236,0.64,0.85
"GO_BP:491964_GO_0007159_LEUKOCYTE_CELL_CELL_ADHESION","GO_BP","491964_GO_0007159_LEUKOCYTE_CELL_CELL_ADHESION",258,-2.3412,0,0,-0.7505,1,1,-1.3317,0.011,0.62
"KEGG_compound:C07645_ALDOPHOSPHAMIDE","KEGG_compound","C07645_ALDOPHOSPHAMIDE",27,-2.3376,0,0,-1.8616,0.0018,0.011,-1.9521,0,0.097
"C2_Chemical_and_genetic_perturbations:C2_CGP_214_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_214_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP",85,-2.3336,0,0,0.9382,0.6,0.88,-1.1689,0.16,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_423_MARKEY_RB1_ACUTE_LOF_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_423_MARKEY_RB1_ACUTE_LOF_UP",214,-2.3334,0,0,1.1222,0.17,0.6,-1.2095,0.088,0.51
"C7_Immunologic_signatures:C7_ALL_988_GSE22886_NAIVE_CD8_TCELL_VS_DC_DN","C7_Immunologic_signatures","C7_ALL_988_GSE22886_NAIVE_CD8_TCELL_VS_DC_DN",199,-2.3321,0,0,0.6525,1,1,0.7488,0.98,1
"C7_Immunologic_signatures:C7_ALL_1874_GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1874_GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN",199,-2.3318,0,0,0.8235,0.92,1,-1.0058,0.42,0.71
"GO_BP:511678_GO_0050707_REGULATION_OF_CYTOKINE_SECRETION","GO_BP","511678_GO_0050707_REGULATION_OF_CYTOKINE_SECRETION",112,-2.3303,0,0.00015,-0.8554,0.79,1,-1.0269,0.39,0.82
"C7_Immunologic_signatures:C7_ALL_994_GSE22886_NAIVE_CD4_TCELL_VS_DC_DN","C7_Immunologic_signatures","C7_ALL_994_GSE22886_NAIVE_CD4_TCELL_VS_DC_DN",200,-2.3268,0,0,0.9753,0.51,0.82,-0.9326,0.66,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_2174_WALLACE_PROSTATE_CANCER_RACE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2174_WALLACE_PROSTATE_CANCER_RACE_UP",285,-2.326,0,0,1.1873,0.076,0.51,-1.4852,0,0.31
"C7_Immunologic_signatures:C7_ALL_1122_GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN","C7_Immunologic_signatures","C7_ALL_1122_GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN",190,-2.3225,0,0,-1.262,0.056,0.58,-1.7058,0,0.00068
"C2_Chemical_and_genetic_perturbations:C2_CGP_508_DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_508_DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP",50,-2.3213,0,0,1.1436,0.25,0.56,-1.1421,0.25,0.58
"C7_Immunologic_signatures:C7_ALL_2_KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_2_KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN",200,-2.319,0,0,1.3848,0.012,0.043,-1.0212,0.39,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_1504_HALMOS_CEBPA_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1504_HALMOS_CEBPA_TARGETS_UP",51,-2.3189,0,0,-1.0589,0.35,0.97,-1.4575,0.024,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_1447_NADLER_OBESITY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1447_NADLER_OBESITY_UP",59,-2.315,0,0,0.8776,0.71,0.94,0.9605,0.53,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2472_BOYLAN_MULTIPLE_MYELOMA_C_D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2472_BOYLAN_MULTIPLE_MYELOMA_C_D_DN",249,-2.3128,0,0,1.0627,0.27,0.69,-0.9942,0.47,0.76
"C7_Immunologic_signatures:C7_ALL_1758_GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1758_GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN",162,-2.3122,0,0,0.8407,0.88,1,0.9449,0.59,1
"C7_Immunologic_signatures:C7_ALL_1118_GSE2706_UNSTIM_VS_2H_LPS_DC_DN","C7_Immunologic_signatures","C7_ALL_1118_GSE2706_UNSTIM_VS_2H_LPS_DC_DN",190,-2.31,0,0,-1.4021,0.016,0.23,-1.4469,0.0041,0.036
"C2_Chemical_and_genetic_perturbations:C2_CGP_221_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_221_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN",140,-2.3075,0,0,1.1283,0.2,0.59,1.4459,0.0099,0.54
"C7_Immunologic_signatures:C7_ALL_1088_GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1088_GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN",197,-2.3065,0,0,-0.8045,0.93,1,-1.3261,0.016,0.11
"C2_Chemical_and_genetic_perturbations:C2_CGP_2699_POOLA_INVASIVE_BREAST_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2699_POOLA_INVASIVE_BREAST_CANCER_UP",273,-2.3027,0,0,1.1008,0.19,0.63,-1.2075,0.065,0.51
"C4_Cancer_gene_neighborhoods:C4_CGN_334_GNF2_CD97","C4_Cancer_gene_neighborhoods","C4_CGN_334_GNF2_CD97",38,-2.2985,0,0,-0.6695,0.96,1,-1.4514,0.038,0.13
"C7_Immunologic_signatures:C7_ALL_1553_GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1553_GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP",196,-2.297,0,0,-0.9578,0.54,1,-2.0228,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_222_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_222_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP",171,-2.2963,0,0,1.3417,0.015,0.35,-1.5335,0,0.28
"C7_Immunologic_signatures:C7_ALL_1889_GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP","C7_Immunologic_signatures","C7_ALL_1889_GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP",198,-2.2959,0,0,-1.0349,0.35,1,1.3383,0.019,0.24
"KEGG_compound:C14786__1R_2S_NAPHTHALENE_1_2_OXIDE_1R_2S_NAPHTHALENE_EPOXIDE","KEGG_compound","C14786__1R_2S_NAPHTHALENE_1_2_OXIDE_1R_2S_NAPHTHALENE_EPOXIDE",25,-2.2953,0,0,-2.0603,0,0.012,-1.6737,0.013,0.093
"GO_BP:491808_GO_0006968_CELLULAR_DEFENSE_RESPONSE","GO_BP","491808_GO_0006968_CELLULAR_DEFENSE_RESPONSE",55,-2.295,0,0.00013,0.85,0.76,1,-0.7051,0.96,0.99
"GO_BP:515418_GO_0070486_LEUKOCYTE_AGGREGATION","GO_BP","515418_GO_0070486_LEUKOCYTE_AGGREGATION",225,-2.2897,0,0.00012,-0.7954,0.96,1,-1.3094,0.017,0.64
"C4_Cancer_modules:C4_CM_160_MODULE_170","C4_Cancer_modules","C4_CM_160_MODULE_170",98,-2.2889,0,0,1.2847,0.066,0.3,1.1256,0.2,0.75
"GO_BP:507785_GO_0045428_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS","GO_BP","507785_GO_0045428_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS",47,-2.2858,0,0.00011,-1.2547,0.14,0.91,-1.4813,0.025,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2510_GOLDRATH_ANTIGEN_RESPONSE","C2_Chemical_and_genetic_perturbations","C2_CGP_2510_GOLDRATH_ANTIGEN_RESPONSE",344,-2.2846,0,0,1.2193,0.034,0.47,-1.6199,0,0.24
"C7_Immunologic_signatures:C7_ALL_72_GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_72_GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN",197,-2.2823,0,0,0.6563,1,1,-1.3866,0.011,0.071
"GO_BP:491798_GO_0006954_INFLAMMATORY_RESPONSE","GO_BP","491798_GO_0006954_INFLAMMATORY_RESPONSE",413,-2.2823,0,1e-04,-1.1551,0.097,0.92,1.0369,0.32,0.82
"GO_BP:754528_GO_1901568_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS","GO_BP","754528_GO_1901568_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS",94,-2.2793,0,9.3e-05,-1.0232,0.39,0.97,-1.1537,0.17,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1521_GERY_CEBP_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1521_GERY_CEBP_TARGETS",125,-2.2789,0,0,-1.3678,0.022,0.64,-1.2089,0.11,0.51
"C7_Immunologic_signatures:C7_ALL_1895_GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1895_GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP",195,-2.277,0,0,-0.8982,0.75,1,-1.2968,0.044,0.14
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_6_BIOCARTA_GRANULOCYTES_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_6_BIOCARTA_GRANULOCYTES_PATHWAY",14,-2.2766,0,0,-1.2011,0.24,1,-1.9124,0.002,0.089
"GO_BP:499914_GO_0030593_NEUTROPHIL_CHEMOTAXIS","GO_BP","499914_GO_0030593_NEUTROPHIL_CHEMOTAXIS",42,-2.2763,0,8.6e-05,-1.0824,0.34,0.95,0.8235,0.77,1
"C7_Immunologic_signatures:C7_ALL_1822_GSE7852_LN_VS_FAT_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1822_GSE7852_LN_VS_FAT_TCONV_DN",200,-2.2758,0,0,-0.7704,0.96,1,-1.3653,0.01,0.084
"GO_BP:505284_GO_0042108_POSITIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS","GO_BP","505284_GO_0042108_POSITIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS",58,-2.2751,0,8.1e-05,-1.2102,0.15,0.88,-0.8691,0.71,0.95
"C4_Cancer_modules:C4_CM_71_MODULE_76","C4_Cancer_modules","C4_CM_71_MODULE_76",76,-2.2742,0,0,1.2035,0.14,0.39,1.4152,0.025,0.32
"KEGG_compound:C14802_1_NITRONAPHTHALENE_7_8_OXIDE","KEGG_compound","C14802_1_NITRONAPHTHALENE_7_8_OXIDE",19,-2.2734,0,0,-1.9333,0,0.0045,-1.8565,0.0076,0.063
"C7_Immunologic_signatures:C7_ALL_1676_GSE3982_BCELL_VS_BASOPHIL_DN","C7_Immunologic_signatures","C7_ALL_1676_GSE3982_BCELL_VS_BASOPHIL_DN",197,-2.2728,0,0,0.9517,0.6,0.89,-0.8935,0.78,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2549_RUTELLA_RESPONSE_TO_HGF_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2549_RUTELLA_RESPONSE_TO_HGF_DN",234,-2.2712,0,2.7e-05,-0.997,0.45,1,-1.4968,0.002,0.3
"C4_Cancer_gene_neighborhoods:C4_CGN_409_GNF2_SPI1","C4_Cancer_gene_neighborhoods","C4_CGN_409_GNF2_SPI1",34,-2.2706,0,0,0.6357,0.96,1,-1.2338,0.16,0.39
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_47_BIOCARTA_CTL_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_47_BIOCARTA_CTL_PATHWAY",13,-2.2706,0,0,1.3466,0.12,0.52,-1.54,0.04,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_2548_RUTELLA_RESPONSE_TO_HGF_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2548_RUTELLA_RESPONSE_TO_HGF_UP",413,-2.2701,0,2.6e-05,0.7779,1,1,1.0233,0.36,0.94
"C4_Cancer_gene_neighborhoods:C4_CGN_384_GNF2_MYD88","C4_Cancer_gene_neighborhoods","C4_CGN_384_GNF2_MYD88",60,-2.2689,0,0,1.1115,0.26,0.35,-0.8546,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_304_NAGASHIMA_EGF_SIGNALING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_304_NAGASHIMA_EGF_SIGNALING_UP",58,-2.2686,0,2.6e-05,-2.0267,0,0.075,-1.2412,0.14,0.48
"C7_Immunologic_signatures:C7_ALL_972_GSE22886_DC_VS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_972_GSE22886_DC_VS_MONOCYTE_DN",199,-2.2661,0,0,0.8456,0.89,1,-1.3124,0.025,0.13
"C2_Chemical_and_genetic_perturbations:C2_CGP_3063_WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3063_WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP",376,-2.2655,0,2.5e-05,-0.9387,0.65,1,-1.2478,0.013,0.48
"KEGG_pathway:HSA04640_HEMATOPOIETIC_CELL_LINEAGE","KEGG_pathway","HSA04640_HEMATOPOIETIC_CELL_LINEAGE",85,-2.2636,0,0,1.018,0.42,0.85,-1.0706,0.31,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1146_AMIT_SERUM_RESPONSE_40_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1146_AMIT_SERUM_RESPONSE_40_MCF10A",32,-2.2612,0,2.5e-05,-1.7411,0.008,0.35,-1.3617,0.086,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_2983_DAZARD_UV_RESPONSE_CLUSTER_G28","C2_Chemical_and_genetic_perturbations","C2_CGP_2983_DAZARD_UV_RESPONSE_CLUSTER_G28",20,-2.2612,0,2.4e-05,-1.9245,0.002,0.1,-1.8523,0.0021,0.085
"GO_BP:946597_GO_1990266_NEUTROPHIL_MIGRATION","GO_BP","946597_GO_1990266_NEUTROPHIL_MIGRATION",44,-2.2604,0,7.6e-05,-0.9868,0.47,1,0.8212,0.76,1
"C1_Positional:C1_ALL_235_CHR11Q11","C1_Positional","C1_ALL_235_CHR11Q11",46,-2.2592,0,0.00097,2.2543,0,0,2.5946,0,0
"REACTOME:1127556_REACT_264075_ATTENUATION_PHASE","REACTOME","1127556_REACT_264075_ATTENUATION_PHASE",14,-2.259,0,0,-2.0208,0,0.025,-2.2917,0,0.0013
"C7_Immunologic_signatures:C7_ALL_1267_GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP","C7_Immunologic_signatures","C7_ALL_1267_GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP",187,-2.2563,0,0,0.8872,0.81,1,-1.3481,0.01,0.098
"GO_BP:516517_GO_0071593_LYMPHOCYTE_AGGREGATION","GO_BP","516517_GO_0071593_LYMPHOCYTE_AGGREGATION",219,-2.2559,0,7.1e-05,-0.7694,0.99,1,-1.352,0.01,0.6
"GO_BP:489292_GO_0042026_PROTEIN_REFOLDING","GO_BP","489292_GO_0042026_PROTEIN_REFOLDING",22,-2.254,0,6.7e-05,-1.8117,0,0.43,-2.4666,0,0
"C7_Immunologic_signatures:C7_ALL_17_GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_17_GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP",200,-2.2529,0,0,0.9556,0.57,0.88,-1.7929,0,0.00015
"C2_Chemical_and_genetic_perturbations:C2_CGP_3269_HUANG_GATA2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3269_HUANG_GATA2_TARGETS_UP",147,-2.252,0,2.4e-05,0.9688,0.54,0.84,-1.0047,0.45,0.75
"C4_Cancer_modules:C4_CM_116_MODULE_121","C4_Cancer_modules","C4_CM_116_MODULE_121",93,-2.2505,0,0,-0.937,0.59,0.89,0.8716,0.76,1
"KEGG_compound:C06790_TRICHLOROETHENE_TRICHLOROETHYLENE_TCE","KEGG_compound","C06790_TRICHLOROETHENE_TRICHLOROETHYLENE_TCE",19,-2.2503,0,0,-1.9838,0.0019,0.0019,-1.8748,0.002,0.067
"GO_BP:503315_GO_0034109_HOMOTYPIC_CELL_CELL_ADHESION","GO_BP","503315_GO_0034109_HOMOTYPIC_CELL_CELL_ADHESION",275,-2.2489,0,6.4e-05,0.9337,0.69,1,-1.1693,0.092,0.73
"C7_Immunologic_signatures:C7_ALL_62_GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_62_GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN",198,-2.2487,0,0,-0.5612,1,1,-1.2543,0.045,0.19
"C2_Chemical_and_genetic_perturbations:C2_CGP_2518_LINDSTEDT_DENDRITIC_CELL_MATURATION_D","C2_Chemical_and_genetic_perturbations","C2_CGP_2518_LINDSTEDT_DENDRITIC_CELL_MATURATION_D",67,-2.2482,0,4.6e-05,0.8078,0.85,0.99,-0.7261,0.95,0.98
"KEGG_compound:C14787__1S_2R_NAPHTHALENE_1_2_OXIDE_1S_2R_NAPHTHALENE_EPOXIDE","KEGG_compound","C14787__1S_2R_NAPHTHALENE_1_2_OXIDE_1S_2R_NAPHTHALENE_EPOXIDE",24,-2.2467,0,0,-2.0279,0,0.0034,-1.6573,0.01,0.099
"C7_Immunologic_signatures:C7_ALL_944_GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN","C7_Immunologic_signatures","C7_ALL_944_GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN",195,-2.2427,0,0,0.7947,0.96,1,-1.0879,0.23,0.52
"GO_BP:505286_GO_0042110_T_CELL_ACTIVATION","GO_BP","505286_GO_0042110_T_CELL_ACTIVATION",217,-2.2424,0,0.00018,-0.7584,0.99,1,-1.339,0.017,0.61
"GO_BP:515421_GO_0070489_T_CELL_AGGREGATION","GO_BP","515421_GO_0070489_T_CELL_AGGREGATION",217,-2.2394,0,0.00017,-0.7625,0.98,1,-1.3384,0.022,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_357_HAHTOLA_SEZARY_SYNDROM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_357_HAHTOLA_SEZARY_SYNDROM_DN",39,-2.2384,0,4.5e-05,0.7448,0.89,1,-1.1518,0.23,0.58
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_192_BIOCARTA_THELPER_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_192_BIOCARTA_THELPER_PATHWAY",12,-2.2376,0,0,1.4928,0.064,0.37,-1.6676,0.012,0.37
"GO_BP:491578_GO_0006690_ICOSANOID_METABOLIC_PROCESS","GO_BP","491578_GO_0006690_ICOSANOID_METABOLIC_PROCESS",93,-2.2368,0,0.00016,-1.041,0.37,0.98,-1.1664,0.17,0.73
"C6_Oncogenic_signatures:C6_ALL_132_RPS14_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_132_RPS14_DN_V1_UP",186,-2.2323,0,0,0.9318,0.64,0.91,1.3274,0.023,0.18
"C7_Immunologic_signatures:C7_ALL_939_GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP","C7_Immunologic_signatures","C7_ALL_939_GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP",199,-2.2323,0,0,1.0582,0.29,0.56,-1.594,0,0.006
"REACTOME:105721_REACT_6959_PHASE_II_CONJUGATION","REACTOME","105721_REACT_6959_PHASE_II_CONJUGATION",89,-2.2302,0,0,-1.0309,0.39,0.97,-1.4256,0.018,0.4
"C7_Immunologic_signatures:C7_ALL_946_GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN","C7_Immunologic_signatures","C7_ALL_946_GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN",196,-2.2292,0,0,0.8678,0.83,1,-1.3165,0.015,0.12
"C6_Oncogenic_signatures:C6_ALL_70_RAF_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_70_RAF_UP_V1_UP",188,-2.228,0,0,-0.7488,0.99,1,-1.251,0.076,0.32
"C4_Cancer_modules:C4_CM_208_MODULE_223","C4_Cancer_modules","C4_CM_208_MODULE_223",136,-2.2274,0,0,0.9338,0.63,0.81,-0.749,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1657_LIAN_LIPA_TARGETS_6M","C2_Chemical_and_genetic_perturbations","C2_CGP_1657_LIAN_LIPA_TARGETS_6M",74,-2.2274,0,6.7e-05,1.0147,0.41,0.78,1.7943,0,0.2
"C7_Immunologic_signatures:C7_ALL_332_GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_332_GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN",199,-2.2274,0,0,-1.731,0,0.0018,-1.2968,0.031,0.14
"GO_BP:513882_GO_0060326_CELL_CHEMOTAXIS","GO_BP","513882_GO_0060326_CELL_CHEMOTAXIS",146,-2.2271,0,0.00026,1.0248,0.38,0.97,1.1514,0.15,0.73
"GO_BP:505226_GO_0042035_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS","GO_BP","505226_GO_0042035_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS",93,-2.2271,0,0.00025,-1.0257,0.41,0.97,-1.0279,0.39,0.83
"GO_BP:493740_GO_0009620_RESPONSE_TO_FUNGUS","GO_BP","493740_GO_0009620_RESPONSE_TO_FUNGUS",37,-2.2271,0,0.00024,1.3832,0.048,0.57,1.0469,0.35,0.81
"KEGG_pathway:HSA05162_MEASLES","KEGG_pathway","HSA05162_MEASLES",130,-2.2256,0,0,-0.8625,0.79,1,-1.849,0,0.024
"C2_Chemical_and_genetic_perturbations:C2_CGP_2681_VALK_AML_CLUSTER_5","C2_Chemical_and_genetic_perturbations","C2_CGP_2681_VALK_AML_CLUSTER_5",33,-2.2237,0,6.6e-05,-0.7412,0.86,1,0.857,0.66,1
"KEGG_compound:C14839_BROMOBENZENE_3_4_OXIDE_BROMOBENZENE_3_4_EPOXIDE","KEGG_compound","C14839_BROMOBENZENE_3_4_OXIDE_BROMOBENZENE_3_4_EPOXIDE",18,-2.2234,0,0,-1.8811,0,0.0087,-1.8494,0,0.045
"C4_Cancer_modules:C4_CM_123_MODULE_128","C4_Cancer_modules","C4_CM_123_MODULE_128",95,-2.2229,0,0,1.3117,0.056,0.26,1.1847,0.12,0.62
"C7_Immunologic_signatures:C7_ALL_937_GSE22886_TCELL_VS_BCELL_NAIVE_UP","C7_Immunologic_signatures","C7_ALL_937_GSE22886_TCELL_VS_BCELL_NAIVE_UP",198,-2.2211,0,0,1.3752,0.0096,0.048,-1.3074,0.036,0.13
"C0_Hallmark:H_ALL_23_HALLMARK_COMPLEMENT","C0_Hallmark","H_ALL_23_HALLMARK_COMPLEMENT",199,-2.2206,0,0,0.6704,1,0.99,0.892,0.76,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2847_HOSHIDA_LIVER_CANCER_SUBCLASS_S1","C2_Chemical_and_genetic_perturbations","C2_CGP_2847_HOSHIDA_LIVER_CANCER_SUBCLASS_S1",234,-2.2203,0,6.5e-05,0.9939,0.46,0.81,-0.8998,0.77,0.88
"C7_Immunologic_signatures:C7_ALL_1669_GSE3982_NEUTROPHIL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1669_GSE3982_NEUTROPHIL_VS_NKCELL_UP",199,-2.2201,0,0,0.8858,0.8,1,0.7866,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_263_PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_263_PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP",52,-2.2187,0,6.4e-05,0.8209,0.79,0.98,1.0951,0.28,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2223_WORSCHECH_TUMOR_REJECTION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2223_WORSCHECH_TUMOR_REJECTION_UP",53,-2.2181,0,8.3e-05,-1.0149,0.4,0.98,-1.2142,0.15,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_2500_SEKI_INFLAMMATORY_RESPONSE_LPS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2500_SEKI_INFLAMMATORY_RESPONSE_LPS_UP",77,-2.2178,0,8.2e-05,-1.2911,0.083,0.7,-0.8412,0.79,0.93
"KEGG_compound:C14870_2_BROMOACETALDEHYDE","KEGG_compound","C14870_2_BROMOACETALDEHYDE",17,-2.2171,0,0,-1.9519,0,0.0033,-1.85,0.0061,0.047
"GO_BP:511700_GO_0050729_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE","GO_BP","511700_GO_0050729_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE",88,-2.2146,0,0.00023,-0.9662,0.53,1,1.0581,0.34,0.8
"C7_Immunologic_signatures:C7_ALL_1756_GSE6269_E_COLI_VS_STREP_AUREUS_INF_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1756_GSE6269_E_COLI_VS_STREP_AUREUS_INF_PBMC_DN",172,-2.2138,0,0,-0.807,0.92,1,0.7276,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3328_BOSCO_TH1_CYTOTOXIC_MODULE","C2_Chemical_and_genetic_perturbations","C2_CGP_3328_BOSCO_TH1_CYTOTOXIC_MODULE",112,-2.2129,0,1e-04,0.9301,0.62,0.89,0.9783,0.52,0.97
"GO_BP:494734_GO_2000379_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS","GO_BP","494734_GO_2000379_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS",74,-2.2128,0,0.00022,-0.9402,0.58,1,-1.4901,0.025,0.54
"C7_Immunologic_signatures:C7_ALL_1891_GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP","C7_Immunologic_signatures","C7_ALL_1891_GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP",194,-2.2126,0,0,0.8912,0.79,1,1.6408,0,0.005
"GO_BP:751072_GO_0036152_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING","GO_BP","751072_GO_0036152_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING",22,-2.2111,0,0.00022,-0.9257,0.58,1,-0.9734,0.5,0.88
"GO_BP:501728_GO_0032496_RESPONSE_TO_LIPOPOLYSACCHARIDE","GO_BP","501728_GO_0032496_RESPONSE_TO_LIPOPOLYSACCHARIDE",250,-2.2107,0,0.00021,-0.8291,0.93,1,-1.1395,0.14,0.75
"GO_BP:502776_GO_0033559_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS","GO_BP","502776_GO_0033559_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS",105,-2.2101,0,2e-04,-1.0782,0.29,0.95,-1.3897,0.019,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_251_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_251_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN",183,-2.2092,0,9.9e-05,0.862,0.85,0.96,-1.3967,0.0063,0.36
"GO_MF:489730_GO_0004364_GLUTATHIONE_TRANSFERASE_ACTIVITY","GO_MF","489730_GO_0004364_GLUTATHIONE_TRANSFERASE_ACTIVITY",21,-2.2088,0,0.0023,-1.844,0.0038,0.15,-1.5948,0.016,0.37
"C2_Chemical_and_genetic_perturbations:C2_CGP_3304_GUILLAUMOND_KLF10_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3304_GUILLAUMOND_KLF10_TARGETS_DN",30,-2.2081,0,9.8e-05,-1.0169,0.43,0.99,-1.1058,0.3,0.62
"GO_BP:1047426_GO_1903426_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS","GO_BP","1047426_GO_1903426_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS",54,-2.2065,0,0.00019,-1.1911,0.19,0.9,-1.5414,0.012,0.53
"C7_Immunologic_signatures:C7_ALL_974_GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_974_GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN",193,-2.2044,0,0,0.959,0.57,0.87,1.2235,0.067,0.63
"GO_BP:516545_GO_0071621_GRANULOCYTE_CHEMOTAXIS","GO_BP","516545_GO_0071621_GRANULOCYTE_CHEMOTAXIS",49,-2.2043,0,0.00019,-0.7349,0.91,1,1.2846,0.11,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1979_DAZARD_UV_RESPONSE_CLUSTER_G2","C2_Chemical_and_genetic_perturbations","C2_CGP_1979_DAZARD_UV_RESPONSE_CLUSTER_G2",30,-2.2036,0,9.6e-05,-1.5571,0.023,0.43,-1.9276,0.0021,0.067
"GO_BP:487587_GO_0001676_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS","GO_BP","487587_GO_0001676_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS",96,-2.203,0,0.00018,-1.0385,0.37,0.98,-1.1544,0.19,0.74
"KEGG_compound:C14857_1_1_DICHLOROETHYLENE_EPOXIDE_2_2_DICHLOROOXIRANE","KEGG_compound","C14857_1_1_DICHLOROETHYLENE_EPOXIDE_2_2_DICHLOROOXIRANE",17,-2.2027,0,0,-2.0077,0.0018,0.0025,-1.8763,0.0039,0.088
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_191_BIOCARTA_TCYTOTOXIC_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_191_BIOCARTA_TCYTOTOXIC_PATHWAY",12,-2.2017,0,0,1.6755,0.01,0.26,-1.5921,0.029,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_302_NAGASHIMA_NRG1_SIGNALING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_302_NAGASHIMA_NRG1_SIGNALING_UP",174,-2.2011,0,9.5e-05,-1.7127,0,0.34,-1.0748,0.26,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_1833_BURTON_ADIPOGENESIS_PEAK_AT_2HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1833_BURTON_ADIPOGENESIS_PEAK_AT_2HR",51,-2.2009,0,9.3e-05,-1.578,0.011,0.46,-1.2986,0.09,0.43
"GO_BP:488111_GO_0002237_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN","GO_BP","488111_GO_0002237_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN",263,-2.1988,0,0.00018,-0.8595,0.89,1,-1.1052,0.18,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_2572_HINATA_NFKB_TARGETS_KERATINOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2572_HINATA_NFKB_TARGETS_KERATINOCYTE_UP",89,-2.1988,0,9.2e-05,-0.9678,0.52,1,-0.9776,0.5,0.79
"C7_Immunologic_signatures:C7_ALL_1555_GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1555_GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP",193,-2.198,0,0,-0.9319,0.63,1,-1.8925,0,0
"GO_BP:507786_GO_0045429_POSITIVE_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS","GO_BP","507786_GO_0045429_POSITIVE_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS",36,-2.1975,0,0.00017,-0.8271,0.76,1,-1.6711,0.0041,0.57
"KEGG_compound:C14858_2_2_DICHLOROACETALDEHYDE","KEGG_compound","C14858_2_2_DICHLOROACETALDEHYDE",17,-2.1964,0,0,-1.9844,0,0.002,-1.8559,0,0.058
"C2_Chemical_and_genetic_perturbations:C2_CGP_1520_THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1520_THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP",77,-2.1936,0,9.1e-05,0.8752,0.73,0.95,0.886,0.7,1
"KEGG_compound:C13645_HYDROBROMIC_ACID_HBR","KEGG_compound","C13645_HYDROBROMIC_ACID_HBR",17,-2.1932,0,0.00014,-1.9748,0,0.0024,-1.8886,0.0021,0.093
"C4_Cancer_modules:C4_CM_87_MODULE_92","C4_Cancer_modules","C4_CM_87_MODULE_92",138,-2.1928,0,0.00011,-1.3598,0.02,0.53,1.4284,0.014,0.3
"KEGG_pathway:HSA00980_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450","KEGG_pathway","HSA00980_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450",70,-2.1924,0,0,-1.3416,0.049,0.34,-1.2159,0.13,0.36
"C7_Immunologic_signatures:C7_ALL_1027_GSE24142_DN2_VS_DN3_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1027_GSE24142_DN2_VS_DN3_THYMOCYTE_UP",197,-2.1922,0,0,-0.7221,0.99,1,-1.4108,0.013,0.055
"KEGG_pathway:HSA04650_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY","KEGG_pathway","HSA04650_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",123,-2.1907,0,0,-0.7641,0.96,1,-1.2106,0.11,0.36
"C4_Cancer_modules:C4_CM_103_MODULE_108","C4_Cancer_modules","C4_CM_103_MODULE_108",49,-2.1883,0,2e-04,1.6302,0.0066,0.063,1.3753,0.054,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_3313_PHONG_TNF_RESPONSE_VIA_P38_PARTIAL","C2_Chemical_and_genetic_perturbations","C2_CGP_3313_PHONG_TNF_RESPONSE_VIA_P38_PARTIAL",160,-2.188,0,8.9e-05,-1.5104,0.0018,0.45,-1.2401,0.058,0.48
"GO_BP:911357_GO_0097530_GRANULOCYTE_MIGRATION","GO_BP","911357_GO_0097530_GRANULOCYTE_MIGRATION",53,-2.1876,0,0.00017,0.8487,0.76,1,1.365,0.063,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2805_KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS","C2_Chemical_and_genetic_perturbations","C2_CGP_2805_KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS",44,-2.1866,0,8.8e-05,1.2716,0.12,0.42,1.1646,0.2,0.81
"GO_BP:496376_GO_0016337_SINGLE_ORGANISMAL_CELL_CELL_ADHESION","GO_BP","496376_GO_0016337_SINGLE_ORGANISMAL_CELL_CELL_ADHESION",437,-2.1864,0,2e-04,-0.8683,0.91,1,-1.0874,0.17,0.78
"C0_Hallmark:H_ALL_10_HALLMARK_APOPTOSIS","C0_Hallmark","H_ALL_10_HALLMARK_APOPTOSIS",160,-2.1858,0,0,-1.0532,0.34,0.86,-1.3172,0.028,0.11
"KEGG_pathway:HSA05133_PERTUSSIS","KEGG_pathway","HSA05133_PERTUSSIS",73,-2.1849,0,0,-1.3821,0.044,0.34,-0.9203,0.6,0.83
"KEGG_compound:C14859_CHLOROACETYL_CHLORIDE","KEGG_compound","C14859_CHLOROACETYL_CHLORIDE",17,-2.184,0,0.00013,-2.0259,0,0.0028,-1.8538,0,0.051
"C4_Cancer_modules:C4_CM_162_MODULE_172","C4_Cancer_modules","C4_CM_162_MODULE_172",93,-2.1837,0,0.00018,1.0103,0.45,0.7,-1.3117,0.058,0.29
"GO_BP:511698_GO_0050727_REGULATION_OF_INFLAMMATORY_RESPONSE","GO_BP","511698_GO_0050727_REGULATION_OF_INFLAMMATORY_RESPONSE",251,-2.1837,0,0.00022,-0.8095,0.95,1,1.1147,0.19,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_519_MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_519_MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN",61,-2.1833,0,8.7e-05,1.0582,0.31,0.7,-1.0602,0.36,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_1339_YAGI_AML_RELAPSE_PROGNOSIS","C2_Chemical_and_genetic_perturbations","C2_CGP_1339_YAGI_AML_RELAPSE_PROGNOSIS",35,-2.1824,0,8.6e-05,-0.6402,0.95,1,-0.8506,0.69,0.92
"GO_BP:498212_GO_0019369_ARACHIDONIC_ACID_METABOLIC_PROCESS","GO_BP","498212_GO_0019369_ARACHIDONIC_ACID_METABOLIC_PROCESS",62,-2.1822,0,0.00022,-1.1249,0.24,0.94,-1.063,0.35,0.8
"KEGG_pathway:HSA05204_CHEMICAL_CARCINOGENESIS","KEGG_pathway","HSA05204_CHEMICAL_CARCINOGENESIS",77,-2.182,0,0,-1.2055,0.16,0.53,-1.3741,0.044,0.19
"GO_BP:754690_GO_1901739_REGULATION_OF_MYOBLAST_FUSION","GO_BP","754690_GO_1901739_REGULATION_OF_MYOBLAST_FUSION",17,-2.1819,0,0.00021,1.1493,0.26,0.84,-1.2317,0.18,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_97_FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_97_FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN",454,-2.1806,0,8.4e-05,-0.6357,1,1,-1.1789,0.054,0.54
"KEGG_compound:C14800_1_NITRONAPHTHALENE_5_6_OXIDE","KEGG_compound","C14800_1_NITRONAPHTHALENE_5_6_OXIDE",20,-2.1801,0,0.00012,-1.8882,0,0.008,-1.8058,0.0041,0.037
"C7_Immunologic_signatures:C7_ALL_389_GSE15767_MED_VS_SCS_MAC_LN_UP","C7_Immunologic_signatures","C7_ALL_389_GSE15767_MED_VS_SCS_MAC_LN_UP",200,-2.18,0,0,-0.9504,0.59,1,0.79,0.98,1
"GO_BP:982307_GO_0098602_SINGLE_ORGANISM_CELL_ADHESION","GO_BP","982307_GO_0098602_SINGLE_ORGANISM_CELL_ADHESION",486,-2.1794,0,0.00021,-0.9686,0.58,1,-1.038,0.31,0.82
"GO_BP:517936_GO_2000377_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS","GO_BP","517936_GO_2000377_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS",129,-2.1783,0,0.00026,-1.0632,0.35,0.96,-1.3581,0.031,0.6
"C4_Cancer_modules:C4_CM_256_MODULE_291","C4_Cancer_modules","C4_CM_256_MODULE_291",65,-2.1774,0,0.00017,1.0431,0.34,0.64,-0.9602,0.54,0.75
"GO_BP:501340_GO_0032103_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS","GO_BP","501340_GO_0032103_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS",221,-2.1773,0,0.00028,-0.9434,0.62,1,1.0561,0.27,0.8
"KEGG_compound:C11088_1_2_DIBROMOETHANE_ETHYLENE_DIBROMIDE","KEGG_compound","C11088_1_2_DIBROMOETHANE_ETHYLENE_DIBROMIDE",17,-2.1771,0,0.00011,-2.0382,0,0.011,-1.9127,0,0.12
"GO_BP:493739_GO_0009617_RESPONSE_TO_BACTERIUM","GO_BP","493739_GO_0009617_RESPONSE_TO_BACTERIUM",404,-2.1768,0,3e-04,0.9107,0.81,1,-0.9999,0.43,0.85
"KEGG_compound:C00162_FATTY_ACID","KEGG_compound","C00162_FATTY_ACID",49,-2.1751,0,1e-04,-0.9373,0.56,1,0.9912,0.45,0.7
"GO_BP:489314_GO_0042742_DEFENSE_RESPONSE_TO_BACTERIUM","GO_BP","489314_GO_0042742_DEFENSE_RESPONSE_TO_BACTERIUM",161,-2.1736,0,3e-04,1.0252,0.38,0.97,0.9596,0.54,0.9
"C7_Immunologic_signatures:C7_ALL_194_GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_194_GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN",200,-2.173,0,0,0.9944,0.48,0.76,-1.9253,0,0
"GO_BP:501948_GO_0032722_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION","GO_BP","501948_GO_0032722_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION",40,-2.1719,0,0.00029,-1.0063,0.45,0.98,0.9149,0.6,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_114_CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_114_CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP",173,-2.1698,0,8.3e-05,0.8379,0.89,0.98,-1.3765,0.011,0.38
"REACTOME:645317_REACT_121369_ACYL_CHAIN_REMODELLING_OF_PE","REACTOME","645317_REACT_121369_ACYL_CHAIN_REMODELLING_OF_PE",21,-2.1695,0,0.00025,-0.9143,0.58,1,-0.9833,0.47,0.87
"REACTOME:771578_REACT_160274_FCGR_ACTIVATION","REACTOME","771578_REACT_160274_FCGR_ACTIVATION",13,-2.1694,0,2e-04,-0.6234,0.93,1,-1.486,0.067,0.38
"C7_Immunologic_signatures:C7_ALL_1742_GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1742_GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN",160,-2.1683,0,0,0.6809,1,1,-1.1712,0.13,0.33
"GO_BP:987837_GO_1903036_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING","GO_BP","987837_GO_1903036_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING",134,-2.1682,0,0.00031,0.8501,0.84,1,1.155,0.16,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1351_GOLUB_ALL_VS_AML_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1351_GOLUB_ALL_VS_AML_DN",24,-2.1679,0,8.2e-05,-0.9896,0.45,1,-0.8843,0.63,0.9
"GO_BP:511837_GO_0050900_LEUKOCYTE_MIGRATION","GO_BP","511837_GO_0050900_LEUKOCYTE_MIGRATION",234,-2.1676,0,0.00033,0.995,0.45,0.98,1.026,0.38,0.83
"KEGG_reaction:R07084_7_8_DIHYDRO_7_HYDROXY_8_S_GLUTATHIONYL_BENZO_A_PYRENE_HYDROLASE_BENZO_A_PYRENE_7_8_DIOL_GLUTATHIONE_7_8_DIHYDRO_7_HYDROXY_8_S_GLUTATHIONYL_BENZO_A_PYRENE_H2O","KEGG_reaction","R07084_7_8_DIHYDRO_7_HYDROXY_8_S_GLUTATHIONYL_BENZO_A_PYRENE_HYDROLASE_BENZO_A_PYRENE_7_8_DIOL_GLUTATHIONE_7_8_DIHYDRO_7_HYDROXY_8_S_GLUTATHIONYL_BENZO_A_PYRENE_H2O",16,-2.1676,0,0,-2.0319,0.0019,0.0035,-1.8117,0.002,0.029
"GO_CC:507297_GO_0044291_CELL_CELL_CONTACT_ZONE","GO_CC","507297_GO_0044291_CELL_CELL_CONTACT_ZONE",59,-2.1673,0,0.00098,-1.2901,0.1,0.66,-1.0836,0.29,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_3373_GHANDHI_DIRECT_IRRADIATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3373_GHANDHI_DIRECT_IRRADIATION_UP",106,-2.1666,0,8.1e-05,-1.3192,0.04,0.7,-1.3327,0.039,0.4
"C7_Immunologic_signatures:C7_ALL_1058_GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN","C7_Immunologic_signatures","C7_ALL_1058_GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN",197,-2.1662,0,0,-0.7294,1,1,0.7818,0.98,1
"KEGG_compound:C14863_2_S_GLUTATHIONYL_ACETYL_GLUTATHIONE","KEGG_compound","C14863_2_S_GLUTATHIONYL_ACETYL_GLUTATHIONE",16,-2.1654,0,9.6e-05,-2.0129,0,0.0026,-1.8258,0.002,0.043
"C2_Chemical_and_genetic_perturbations:C2_CGP_532_KAN_RESPONSE_TO_ARSENIC_TRIOXIDE","C2_Chemical_and_genetic_perturbations","C2_CGP_532_KAN_RESPONSE_TO_ARSENIC_TRIOXIDE",117,-2.1652,0,9.6e-05,0.8822,0.75,0.94,1.1782,0.13,0.8
"C4_Cancer_modules:C4_CM_334_MODULE_399","C4_Cancer_modules","C4_CM_334_MODULE_399",51,-2.1649,0,0.00016,0.9315,0.59,0.81,-0.986,0.48,0.72
"KEGG_pathway:HSA04978_MINERAL_ABSORPTION","KEGG_pathway","HSA04978_MINERAL_ABSORPTION",49,-2.1646,0,0,-0.8268,0.79,1,-0.8981,0.64,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_1976_MAHAJAN_RESPONSE_TO_IL1A_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1976_MAHAJAN_RESPONSE_TO_IL1A_UP",77,-2.164,0,0.00011,-0.9918,0.48,1,0.8944,0.7,1
"C4_Cancer_modules:C4_CM_280_MODULE_321","C4_Cancer_modules","C4_CM_280_MODULE_321",111,-2.1637,0,0.00015,0.6772,0.99,1,-0.9025,0.69,0.85
"KEGG_compound:C14793__1R_GLUTATHIONYL_2R_HYDROXY_1_2_DIHYDRONAPHTHALENE","KEGG_compound","C14793__1R_GLUTATHIONYL_2R_HYDROXY_1_2_DIHYDRONAPHTHALENE",16,-2.1637,0,9e-05,-2.0002,0,0.0022,-1.7974,0.004,0.036
"C4_Cancer_gene_neighborhoods:C4_CGN_288_GNF2_CDC20","C4_Cancer_gene_neighborhoods","C4_CGN_288_GNF2_CDC20",56,-2.163,0,3.5e-05,-0.9816,0.49,0.87,-2.0246,0.002,0.0036
"GO_BP:1047428_GO_1903428_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS","GO_BP","1047428_GO_1903428_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS",38,-2.1622,0,0.00035,-0.8028,0.82,1,-1.6054,0.0041,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_232_PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_232_PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP",32,-2.1616,0,0.00011,-0.8661,0.69,1,-0.7341,0.89,0.98
"C4_Cancer_modules:C4_CM_364_MODULE_444","C4_Cancer_modules","C4_CM_364_MODULE_444",15,-2.1593,0,0.00014,0.774,0.77,0.98,0.9772,0.49,0.97
"C4_Cancer_modules:C4_CM_74_MODULE_79","C4_Cancer_modules","C4_CM_74_MODULE_79",97,-2.1573,0,0.00013,1.3492,0.051,0.23,1.2061,0.12,0.59
"GO_BP:511685_GO_0050714_POSITIVE_REGULATION_OF_PROTEIN_SECRETION","GO_BP","511685_GO_0050714_POSITIVE_REGULATION_OF_PROTEIN_SECRETION",162,-2.1552,0,0.00039,-0.8826,0.77,1,-1.3646,0.018,0.59
"C7_Immunologic_signatures:C7_ALL_1682_GSE3982_BCELL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1682_GSE3982_BCELL_VS_NKCELL_DN",193,-2.1534,0,0,-0.9209,0.65,1,-1.1686,0.13,0.34
"GO_CC:495152_GO_0014704_INTERCALATED_DISC","GO_CC","495152_GO_0014704_INTERCALATED_DISC",49,-2.1523,0,0.00049,-1.3735,0.048,0.62,-1.2227,0.16,0.75
"GO_BP:502880_GO_0044126_REGULATION_OF_GROWTH_OF_SYMBIONT_IN_HOST","GO_BP","502880_GO_0044126_REGULATION_OF_GROWTH_OF_SYMBIONT_IN_HOST",15,-2.1522,0,4e-04,-0.8022,0.72,1,-1.4241,0.067,0.57
"GO_BP:493583_GO_0009410_RESPONSE_TO_XENOBIOTIC_STIMULUS","GO_BP","493583_GO_0009410_RESPONSE_TO_XENOBIOTIC_STIMULUS",174,-2.1505,0,4e-04,-1.2979,0.023,0.89,-1.2132,0.081,0.72
"KEGG_compound:C14791__1R_HYDROXY_2R_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE","KEGG_compound","C14791__1R_HYDROXY_2R_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE",16,-2.1489,0,0.00025,-2.0075,0.0018,0.0024,-1.8172,0.006,0.038
"KEGG_compound:C14874_GLUTATHIONE_EPISULFONIUM_ION","KEGG_compound","C14874_GLUTATHIONE_EPISULFONIUM_ION",16,-2.1487,0,0.00024,-1.9887,0,0.0021,-1.814,0.002,0.037
"C2_Chemical_and_genetic_perturbations:C2_CGP_1780_ZHANG_PROLIFERATING_VS_QUIESCENT","C2_Chemical_and_genetic_perturbations","C2_CGP_1780_ZHANG_PROLIFERATING_VS_QUIESCENT",51,-2.1469,0,0.00012,-0.7498,0.89,1,-0.8867,0.67,0.89
"KEGG_compound:C11278_AFLATOXIN_B1EXO_8_9_EPOXIDE_GSH_8_9_DIHYDRO_8_S_GLUTATHIONYL_9_HYDROXYAFLATOXIN_B1","KEGG_compound","C11278_AFLATOXIN_B1EXO_8_9_EPOXIDE_GSH_8_9_DIHYDRO_8_S_GLUTATHIONYL_9_HYDROXYAFLATOXIN_B1",16,-2.146,0,0.00023,-2.0361,0,0.0044,-1.793,0.0021,0.036
"KEGG_compound:C14840_BROMOBENZENE_2_3_OXIDE_BROMOBENZENE_2_3_EPOXIDE","KEGG_compound","C14840_BROMOBENZENE_2_3_OXIDE_BROMOBENZENE_2_3_EPOXIDE",18,-2.1458,0,0.00021,-1.9057,0.0018,0.0065,-1.8657,0,0.067
"C7_Immunologic_signatures:C7_ALL_1667_GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1667_GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP",199,-2.1456,0,0,0.8197,0.92,1,-0.8709,0.83,0.99
"GO_BP:516390_GO_0071466_CELLULAR_RESPONSE_TO_XENOBIOTIC_STIMULUS","GO_BP","516390_GO_0071466_CELLULAR_RESPONSE_TO_XENOBIOTIC_STIMULUS",168,-2.1452,0,0.00041,-1.2867,0.047,0.89,-1.2664,0.041,0.67
"C4_Cancer_modules:C4_CM_26_MODULE_27","C4_Cancer_modules","C4_CM_26_MODULE_27",351,-2.1451,0,0.00013,0.9123,0.81,0.82,1.1914,0.071,0.61
"KEGG_compound:C14792__1S_HYDROXY_2S_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE","KEGG_compound","C14792__1S_HYDROXY_2S_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE",16,-2.1441,0,2e-04,-2.0072,0,0.0023,-1.8436,0.0019,0.045
"KEGG_reaction:R07026_1_NITRO_5_GLUTATHIONYL_6_HYDROXY_5_6_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_5_6_OXIDE_GLUTATHIONE_1_NITRO_5_GLUTATHIONYL_6_HYDROXY_5_6_DIHYDRONAPHTHALENE","KEGG_reaction","R07026_1_NITRO_5_GLUTATHIONYL_6_HYDROXY_5_6_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_5_6_OXIDE_GLUTATHIONE_1_NITRO_5_GLUTATHIONYL_6_HYDROXY_5_6_DIHYDRONAPHTHALENE",16,-2.1439,0,0,-2.0083,0,0.0019,-1.8311,0.004,0.039
"KEGG_compound:C14864_S_2_CHLOROACETYL_GLUTATHIONE","KEGG_compound","C14864_S_2_CHLOROACETYL_GLUTATHIONE",16,-2.1425,0,0.00019,-1.9957,0,0.0021,-1.8261,0.0085,0.045
"C2_Chemical_and_genetic_perturbations:C2_CGP_3372_SMIRNOV_RESPONSE_TO_IR_6HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3372_SMIRNOV_RESPONSE_TO_IR_6HR_DN",114,-2.1422,0,0.00012,-1.3218,0.047,0.69,-1.5024,0.0041,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_1385_SANA_TNF_SIGNALING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1385_SANA_TNF_SIGNALING_UP",81,-2.141,0,0.00012,0.7435,0.93,1,-1.2787,0.078,0.45
"KEGG_pathway:HSA00982_DRUG_METABOLISM","KEGG_pathway","HSA00982_DRUG_METABOLISM",64,-2.1391,0,0,-1.3374,0.055,0.34,1.3456,0.073,0.42
"C4_Cancer_gene_neighborhoods:C4_CGN_379_GNF2_MKI67","C4_Cancer_gene_neighborhoods","C4_CGN_379_GNF2_MKI67",28,-2.1388,0,6.6e-05,-0.9774,0.46,0.86,-1.9286,0,0.0072
"GO_CC:499715_GO_0030315_T_TUBULE","GO_CC","499715_GO_0030315_T_TUBULE",39,-2.1382,0,0.00064,-1.4085,0.069,0.65,-1.1887,0.18,0.81
"GO_BP:499915_GO_0030595_LEUKOCYTE_CHEMOTAXIS","GO_BP","499915_GO_0030595_LEUKOCYTE_CHEMOTAXIS",94,-2.138,0,0.00054,1.1634,0.17,0.82,1.1964,0.14,0.72
"C7_Immunologic_signatures:C7_ALL_1689_GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1689_GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP",198,-2.1368,0,0,0.9373,0.63,0.94,-0.918,0.72,0.92
"KEGG_reaction:R07025_1_NITRO_5_HYDROXY_6_GLUTATHIONYL_5_6_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_5_6_OXIDE_GLUTATHIONE_1_NITRO_5_HYDROXY_6_GLUTATHIONYL_5_6_DIHYDRONAPHTHALENE","KEGG_reaction","R07025_1_NITRO_5_HYDROXY_6_GLUTATHIONYL_5_6_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_5_6_OXIDE_GLUTATHIONE_1_NITRO_5_HYDROXY_6_GLUTATHIONYL_5_6_DIHYDRONAPHTHALENE",16,-2.1364,0,0,-1.9902,0.002,0.0016,-1.7907,0.0058,0.029
"KEGG_reaction:R07116_2_BROMOACETALDEHYDE_GLUTATHIONE_S_FORMYLMETHYL_TRANSFERASE_2_BROMOACETALDEHYDE_GLUTATHIONE_S_FORMYLMETHYL_GLUTATHIONE_HYDROBROMIC_ACID","KEGG_reaction","R07116_2_BROMOACETALDEHYDE_GLUTATHIONE_S_FORMYLMETHYL_TRANSFERASE_2_BROMOACETALDEHYDE_GLUTATHIONE_S_FORMYLMETHYL_GLUTATHIONE_HYDROBROMIC_ACID",16,-2.1354,0,0,-2.0022,0,0.0016,-1.8293,0,0.036
"C2_Chemical_and_genetic_perturbations:C2_CGP_1840_RODWELL_AGING_KIDNEY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1840_RODWELL_AGING_KIDNEY_UP",476,-2.1352,0,0.00012,1.2652,0.018,0.42,-1.0935,0.16,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2589_LEE_EARLY_T_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2589_LEE_EARLY_T_LYMPHOCYTE_UP",104,-2.135,0,0.00012,-0.787,0.9,1,-1.5908,0,0.25
"KEGG_reaction:R03522_RX_GLUTATHIONE_R_TRANSFERASE_RX_GLUTATHIONE_HALIDE_R_S_GLUTATHIONE","KEGG_reaction","R03522_RX_GLUTATHIONE_R_TRANSFERASE_RX_GLUTATHIONE_HALIDE_R_S_GLUTATHIONE",16,-2.1337,0,0,-2.0117,0,0.0021,-1.8016,0,0.029
"C7_Immunologic_signatures:C7_ALL_118_GSE12366_NAIVE_VS_MEMORY_BCELL_DN","C7_Immunologic_signatures","C7_ALL_118_GSE12366_NAIVE_VS_MEMORY_BCELL_DN",190,-2.1333,0,0,-0.9053,0.73,1,-1.0074,0.44,0.71
"GO_BP:507155_GO_0044146_NEGATIVE_REGULATION_OF_GROWTH_OF_SYMBIONT_INVOLVED_IN_INTERACTION_WITH_HOST","GO_BP","507155_GO_0044146_NEGATIVE_REGULATION_OF_GROWTH_OF_SYMBIONT_INVOLVED_IN_INTERACTION_WITH_HOST",15,-2.1331,0,0.00059,-0.7974,0.75,1,-1.4729,0.052,0.54
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_83_BIOCARTA_TCAPOPTOSIS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_83_BIOCARTA_TCAPOPTOSIS_PATHWAY",9,-2.1328,0,0.00056,1.6453,0.027,0.28,-0.8302,0.69,0.89
"KEGG_enzyme:2.5.1.18_GLUTATHIONE_TRANSFERASE_GLUTATHIONE_S_TRANSFERASE_GLUTATHIONE_S_ALKYLTRANSFERASE_GLUTATHIONE_S_ARYLTRANSFERASE_S_HYDROXYALKYL_GLUTATHIONE_LYASE_GLUTATHIONE_S_ARALKYLTRANSFERASE_GLUTATHIONE_S_ALKYL_TRANSFERASE_GST","KEGG_enzyme","2.5.1.18_GLUTATHIONE_TRANSFERASE_GLUTATHIONE_S_TRANSFERASE_GLUTATHIONE_S_ALKYLTRANSFERASE_GLUTATHIONE_S_ARYLTRANSFERASE_S_HYDROXYALKYL_GLUTATHIONE_LYASE_GLUTATHIONE_S_ARALKYLTRANSFERASE_GLUTATHIONE_S_ALKYL_TRANSFERASE_GST",16,-2.1324,0,0,-2.0309,0.0018,0.003,-1.8215,0.0019,0.055
"GO_BP:987835_GO_1903034_REGULATION_OF_RESPONSE_TO_WOUNDING","GO_BP","987835_GO_1903034_REGULATION_OF_RESPONSE_TO_WOUNDING",359,-2.1324,0,0.00058,0.8836,0.89,1,1.2219,0.04,0.71
"GO_CC:507512_GO_0045121_MEMBRANE_RAFT","GO_CC","507512_GO_0045121_MEMBRANE_RAFT",234,-2.1323,0,0.00048,-1.0391,0.36,0.84,-1.3159,0.011,0.63
"KEGG_pathway:HSA04060_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION","KEGG_pathway","HSA04060_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION",247,-2.1322,0,0,1.0012,0.44,0.89,1.2254,0.053,0.57
"C4_Cancer_gene_neighborhoods:C4_CGN_326_GNF2_CASP8","C4_Cancer_gene_neighborhoods","C4_CGN_326_GNF2_CASP8",27,-2.1318,0,6.3e-05,-0.8524,0.68,1,-2.165,0,0
"KEGG_compound:C01327_HYDROCHLORIC_ACID_HCL_HYDROGEN_CHLORIDE_HYDROCHLORIDE","KEGG_compound","C01327_HYDROCHLORIC_ACID_HCL_HYDROGEN_CHLORIDE_HYDROCHLORIDE",16,-2.1318,0,0.00024,-2.0261,0,0.0031,-1.812,0.006,0.036
"REACTOME:105698_REACT_13433_BIOLOGICAL_OXIDATIONS","REACTOME","105698_REACT_13433_BIOLOGICAL_OXIDATIONS",174,-2.1317,0,0.00099,-1.1782,0.13,0.86,-1.2709,0.043,0.55
"KEGG_compound:C14804_1_NITRO_7_GLUTATHIONYL_8_HYDROXY_7_8_DIHYDRONAPHTHALENE","KEGG_compound","C14804_1_NITRO_7_GLUTATHIONYL_8_HYDROXY_7_8_DIHYDRONAPHTHALENE",16,-2.1316,0,0.00023,-1.9989,0,0.0022,-1.8008,0.004,0.036
"GO_CC:487668_GO_0001772_IMMUNOLOGICAL_SYNAPSE","GO_CC","487668_GO_0001772_IMMUNOLOGICAL_SYNAPSE",30,-2.1311,0,0.00039,-0.6748,0.93,1,-1.2132,0.19,0.76
"C4_Cancer_modules:C4_CM_102_MODULE_107","C4_Cancer_modules","C4_CM_102_MODULE_107",77,-2.1305,0,0.00018,0.958,0.53,0.77,-1.2166,0.14,0.38
"KEGG_reaction:R07093_CHLOROACETYL_CHLORIDE_GLUTATHIONE_S_CHLOROACETYLTRANSFERASE_CHLOROACETYL_CHLORIDE_GLUTATHIONE_S_2_CHLOROACETYL_GLUTATHIONE_HYDROCHLORIC_ACID","KEGG_reaction","R07093_CHLOROACETYL_CHLORIDE_GLUTATHIONE_S_CHLOROACETYLTRANSFERASE_CHLOROACETYL_CHLORIDE_GLUTATHIONE_S_2_CHLOROACETYL_GLUTATHIONE_HYDROCHLORIC_ACID",16,-2.1302,0,0,-2.0058,0.002,0.0017,-1.7815,0.0099,0.027
"KEGG_compound:C14803_1_NITRO_7_HYDROXY_8_GLUTATHIONYL_7_8_DIHYDRONAPHTHALENE","KEGG_compound","C14803_1_NITRO_7_HYDROXY_8_GLUTATHIONYL_7_8_DIHYDRONAPHTHALENE",16,-2.1295,0,0.00023,-1.9691,0,0.0026,-1.8553,0,0.054
"C7_Immunologic_signatures:C7_ALL_1502_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN","C7_Immunologic_signatures","C7_ALL_1502_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN",194,-2.1295,0,0,-0.8885,0.78,1,-1.1152,0.18,0.46
"GO_CC:493991_GO_0009897_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE","GO_CC","493991_GO_0009897_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE",224,-2.1291,0,0.00032,0.9746,0.55,0.82,-0.9171,0.72,1
"KEGG_reaction:R09409_GLUTATHIONE_S_TRANSFERASE_AFLATOXIN_B1_EXO_8_9_EPOXIDE_GLUTATHIONE_AFLATOXIN_B1EXO_8_9_EPOXIDE_GSH","KEGG_reaction","R09409_GLUTATHIONE_S_TRANSFERASE_AFLATOXIN_B1_EXO_8_9_EPOXIDE_GLUTATHIONE_AFLATOXIN_B1EXO_8_9_EPOXIDE_GSH",16,-2.1285,0,0,-1.9803,0,0.0014,-1.8395,0.0019,0.04
"KEGG_compound:C14861_S_2_2_DICHLORO_1_HYDROXY_ETHYL_GLUTATHIONE","KEGG_compound","C14861_S_2_2_DICHLORO_1_HYDROXY_ETHYL_GLUTATHIONE",16,-2.1285,0,0.00022,-1.9552,0,0.003,-1.8205,0,0.041
"KEGG_reaction:R07100_TRICHLOROETHENE_GLUTATHIONE_S_1_2_DICHLOROVINYL_TRANSFERASE_TRICHLOROETHENE_GLUTATHIONE_S_1_2_DICHLOROVINYL_GLUTATHIONE_HYDROCHLORIC_ACID","KEGG_reaction","R07100_TRICHLOROETHENE_GLUTATHIONE_S_1_2_DICHLOROVINYL_TRANSFERASE_TRICHLOROETHENE_GLUTATHIONE_S_1_2_DICHLOROVINYL_GLUTATHIONE_HYDROCHLORIC_ACID",16,-2.1282,0,0,-2.041,0,0.012,-1.7855,0.0039,0.027
"C7_Immunologic_signatures:C7_ALL_237_GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP","C7_Immunologic_signatures","C7_ALL_237_GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP",193,-2.1278,0,0,0.829,0.91,1,-1.4336,0.0061,0.042
"KEGG_reaction:R07023_1_NITRO_7_HYDROXY_8_GLUTATHIONYL_7_8_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_7_8_OXIDE_GLUTATHIONE_1_NITRO_7_HYDROXY_8_GLUTATHIONYL_7_8_DIHYDRONAPHTHALENE","KEGG_reaction","R07023_1_NITRO_7_HYDROXY_8_GLUTATHIONYL_7_8_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_7_8_OXIDE_GLUTATHIONE_1_NITRO_7_HYDROXY_8_GLUTATHIONYL_7_8_DIHYDRONAPHTHALENE",16,-2.1274,0,0,-2.0236,0.0038,0.0022,-1.8531,0.0041,0.095
"GO_BP:492024_GO_0007229_INTEGRIN_MEDIATED_SIGNALING_PATHWAY","GO_BP","492024_GO_0007229_INTEGRIN_MEDIATED_SIGNALING_PATHWAY",79,-2.1271,0,0.00068,-1.0688,0.33,0.96,0.8029,0.87,1
"KEGG_compound:C14847_3_4_DIHYDRO_3_HYDROXY_4_S_GLUTATHIONYL_BROMOBENZENE","KEGG_compound","C14847_3_4_DIHYDRO_3_HYDROXY_4_S_GLUTATHIONYL_BROMOBENZENE",16,-2.1264,0,0.00021,-2.0375,0,0.0068,-1.7981,0.0081,0.037
"WikiPathways:198794_WP530_CYTOKINES_AND_INFLAMMATORY_RESPONSE","WikiPathways","198794_WP530_CYTOKINES_AND_INFLAMMATORY_RESPONSE",23,-2.1259,0,0,-1.4274,0.07,1,-1.2044,0.2,0.54
"KEGG_compound:C14851_BENZO_A_PYRENE_4_5_OXIDE_BENZO_A_PYRENE_4_5_EPOXIDE","KEGG_compound","C14851_BENZO_A_PYRENE_4_5_OXIDE_BENZO_A_PYRENE_4_5_EPOXIDE",20,-2.1257,0,2e-04,-2.0606,0,0.024,-1.7221,0.022,0.061
"C2_Chemical_and_genetic_perturbations:C2_CGP_1497_WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1497_WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP",31,-2.1243,0,0.00014,-0.7693,0.85,1,0.8265,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_207_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_207_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP",134,-2.1229,0,0.00014,-1.5047,0.0072,0.45,-1.886,0,0.079
"REACTOME:105727_REACT_6926_GLUTATHIONE_CONJUGATION","REACTOME","105727_REACT_6926_GLUTATHIONE_CONJUGATION",29,-2.1228,0,0.0013,-1.9468,0.0019,0.044,-1.8245,0.002,0.18
"GO_BP:491109_GO_0006749_GLUTATHIONE_METABOLIC_PROCESS","GO_BP","491109_GO_0006749_GLUTATHIONE_METABOLIC_PROCESS",43,-2.1223,0,0.00071,-1.3393,0.08,0.91,-1.935,0,0.44
"GO_MF:496916_GO_0030414_PEPTIDASE_INHIBITOR_ACTIVITY","GO_MF","496916_GO_0030414_PEPTIDASE_INHIBITOR_ACTIVITY",158,-2.1221,0,0.004,-1.0524,0.33,0.86,1.2162,0.087,0.71
"KEGG_reaction:R07004__1S_HYDROXY_2S_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1S_2R_NAPHTHALENE_1_2_OXIDE_GLUTATHIONE_1S_HYDROXY_2S_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE","KEGG_reaction","R07004__1S_HYDROXY_2S_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1S_2R_NAPHTHALENE_1_2_OXIDE_GLUTATHIONE_1S_HYDROXY_2S_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE",16,-2.1219,0,0.00011,-2.0336,0,0.0044,-1.8462,0.002,0.075
"C7_Immunologic_signatures:C7_ALL_1653_GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1653_GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP",199,-2.1212,0,0,0.814,0.94,1,-0.965,0.54,0.81
"C0_Hallmark:H_ALL_46_HALLMARK_ALLOGRAFT_REJECTION","C0_Hallmark","H_ALL_46_HALLMARK_ALLOGRAFT_REJECTION",195,-2.1212,0,0,1.6206,0.0024,0.011,-1.1163,0.19,0.29
"KEGG_reaction:R07003__1R_GLUTATHIONYL_2R_HYDROXY_1_2_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1S_2R_NAPHTHALENE_1_2_OXIDE_GLUTATHIONE_1R_GLUTATHIONYL_2R_HYDROXY_1_2_DIHYDRONAPHTHALENE","KEGG_reaction","R07003__1R_GLUTATHIONYL_2R_HYDROXY_1_2_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1S_2R_NAPHTHALENE_1_2_OXIDE_GLUTATHIONE_1R_GLUTATHIONYL_2R_HYDROXY_1_2_DIHYDRONAPHTHALENE",16,-2.1211,0,9.9e-05,-1.9785,0,0.0013,-1.8255,0.0019,0.034
"GO_BP:501958_GO_0032732_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION","GO_BP","501958_GO_0032732_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION",28,-2.1211,0,7e-04,-1.2345,0.16,0.9,-1.202,0.2,0.73
"KEGG_reaction:R07094_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_GLUTATHIONE_2_S_GLUTATHIONYL_ACETYLTRANSFERASE_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_GLUTATHIONE_2_S_GLUTATHIONYL_ACETYL_GLUTATHIONE_HYDROCHLORIC_ACID","KEGG_reaction","R07094_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_GLUTATHIONE_2_S_GLUTATHIONYL_ACETYLTRANSFERASE_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_GLUTATHIONE_2_S_GLUTATHIONYL_ACETYL_GLUTATHIONE_HYDROCHLORIC_ACID",16,-2.1209,0,9.1e-05,-1.9855,0.0019,0.0015,-1.8459,0.008,0.06
"KEGG_reaction:R07024_1_NITRO_7_GLUTATHIONYL_8_HYDROXY_7_8_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_7_8_OXIDE_GLUTATHIONE_1_NITRO_7_GLUTATHIONYL_8_HYDROXY_7_8_DIHYDRONAPHTHALENE","KEGG_reaction","R07024_1_NITRO_7_GLUTATHIONYL_8_HYDROXY_7_8_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1_NITRONAPHTHALENE_7_8_OXIDE_GLUTATHIONE_1_NITRO_7_GLUTATHIONYL_8_HYDROXY_7_8_DIHYDRONAPHTHALENE",16,-2.1208,0,8.4e-05,-1.9598,0,0.0017,-1.7974,0.0076,0.029
"KEGG_reaction:R07083_4_5_DIHYDRO_4_HYDROXY_5_S_GLUTATHIONYL_BENZO_A_PYRENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_BENZO_A_PYRENE_4_5_OXIDE_GLUTATHIONE_4_5_DIHYDRO_4_HYDROXY_5_S_GLUTATHIONYL_BENZO_A_PYRENE","KEGG_reaction","R07083_4_5_DIHYDRO_4_HYDROXY_5_S_GLUTATHIONYL_BENZO_A_PYRENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_BENZO_A_PYRENE_4_5_OXIDE_GLUTATHIONE_4_5_DIHYDRO_4_HYDROXY_5_S_GLUTATHIONYL_BENZO_A_PYRENE",16,-2.1205,0,7.8e-05,-2.0004,0,0.0016,-1.7864,0.006,0.029
"C2_Chemical_and_genetic_perturbations:C2_CGP_2685_VALK_AML_CLUSTER_9","C2_Chemical_and_genetic_perturbations","C2_CGP_2685_VALK_AML_CLUSTER_9",35,-2.1204,0,0.00016,-0.7239,0.9,1,0.6743,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1372_ROSS_AML_WITH_MLL_FUSIONS","C2_Chemical_and_genetic_perturbations","C2_CGP_1372_ROSS_AML_WITH_MLL_FUSIONS",78,-2.1203,0,0.00015,0.9983,0.47,0.8,-1.0192,0.44,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_3072_DEMAGALHAES_AGING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3072_DEMAGALHAES_AGING_UP",53,-2.1203,0,0.00015,1.1347,0.26,0.57,-0.9613,0.51,0.8
"C7_Immunologic_signatures:C7_ALL_1418_GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN","C7_Immunologic_signatures","C7_ALL_1418_GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN",196,-2.1199,0,0,0.8389,0.89,1,-0.7982,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1445_NAKAJIMA_EOSINOPHIL","C2_Chemical_and_genetic_perturbations","C2_CGP_1445_NAKAJIMA_EOSINOPHIL",30,-2.1197,0,0.00015,-0.6617,0.94,1,-0.9906,0.47,0.77
"C4_Cancer_modules:C4_CM_376_MODULE_462","C4_Cancer_modules","C4_CM_376_MODULE_462",15,-2.1197,0,0.00017,1.1817,0.24,0.42,-1.6934,0.014,0.083
"C2_Chemical_and_genetic_perturbations:C2_CGP_1142_AMIT_EGF_RESPONSE_120_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1142_AMIT_EGF_RESPONSE_120_MCF10A",43,-2.1196,0,0.00015,-1.1738,0.19,0.82,-0.9365,0.57,0.84
"KEGG_reaction:R08280_4_GLUTATHIONYL_CYCLOPHOSPHAMIDE_HYDROLASE_ALDOPHOSPHAMIDE_GLUTATHIONE_4_GLUTATHIONYL_CYCLOPHOSPHAMIDE_H2O","KEGG_reaction","R08280_4_GLUTATHIONYL_CYCLOPHOSPHAMIDE_HYDROLASE_ALDOPHOSPHAMIDE_GLUTATHIONE_4_GLUTATHIONYL_CYCLOPHOSPHAMIDE_H2O",16,-2.119,0,7.3e-05,-1.9843,0,0.0014,-1.8068,0.0041,0.029
"GO_BP:507677_GO_0045321_LEUKOCYTE_ACTIVATION","GO_BP","507677_GO_0045321_LEUKOCYTE_ACTIVATION",412,-2.1189,0,0.00072,-0.7659,1,1,-1.2989,0.0061,0.65
"KEGG_compound:C14805_1_NITRO_5_HYDROXY_6_GLUTATHIONYL_5_6_DIHYDRONAPHTHALENE","KEGG_compound","C14805_1_NITRO_5_HYDROXY_6_GLUTATHIONYL_5_6_DIHYDRONAPHTHALENE",16,-2.1184,0,0.00029,-1.9602,0,0.0028,-1.8357,0.002,0.042
"C2_Chemical_and_genetic_perturbations:C2_CGP_389_DELYS_THYROID_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_389_DELYS_THYROID_CANCER_UP",431,-2.1181,0,0.00016,-0.9652,0.57,1,1.1583,0.091,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_766_DIRMEIER_LMP1_RESPONSE_EARLY","C2_Chemical_and_genetic_perturbations","C2_CGP_766_DIRMEIER_LMP1_RESPONSE_EARLY",66,-2.1177,0,0.00016,-1.5039,0.014,0.45,-1.1302,0.21,0.59
"C7_Immunologic_signatures:C7_ALL_1639_GSE3982_DC_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1639_GSE3982_DC_VS_NKCELL_UP",198,-2.1164,0,0,-0.8741,0.81,1,0.9,0.75,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_100_ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_100_ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP",458,-2.1153,0,0.00016,-1.6643,0,0.4,-1.0981,0.16,0.63
"C7_Immunologic_signatures:C7_ALL_1613_GSE3982_MAST_CELL_VS_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1613_GSE3982_MAST_CELL_VS_BCELL_UP",200,-2.1151,0,0,1.2079,0.075,0.21,1.0166,0.42,1
"GO_BP:911356_GO_0097529_MYELOID_LEUKOCYTE_MIGRATION","GO_BP","911356_GO_0097529_MYELOID_LEUKOCYTE_MIGRATION",74,-2.1149,0,0.00081,0.9356,0.58,1,1.2998,0.082,0.67
"GO_BP:507987_GO_0045639_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION","GO_BP","507987_GO_0045639_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION",78,-2.1144,0,8e-04,-1.23,0.14,0.89,-1.4675,0.02,0.54
"KEGG_compound:C14855_4_5_DIHYDRO_4_HYDROXY_5_S_GLUTATHIONYL_BENZO_A_PYRENE","KEGG_compound","C14855_4_5_DIHYDRO_4_HYDROXY_5_S_GLUTATHIONYL_BENZO_A_PYRENE",16,-2.1142,0,0.00028,-2.0035,0,0.0023,-1.8505,0.0039,0.05
"GO_BP:491675_GO_0006805_XENOBIOTIC_METABOLIC_PROCESS","GO_BP","491675_GO_0006805_XENOBIOTIC_METABOLIC_PROCESS",167,-2.1137,0,8e-04,-1.3145,0.046,0.87,-1.2756,0.045,0.66
"GO_BP:1129383_GO_1903557_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION","GO_BP","1129383_GO_1903557_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION",46,-2.1131,0,0.00079,1.2026,0.18,0.78,-1.0266,0.4,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_483_MISSIAGLIA_REGULATED_BY_METHYLATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_483_MISSIAGLIA_REGULATED_BY_METHYLATION_UP",121,-2.1129,0,0.00016,0.8927,0.7,0.93,-1.3262,0.053,0.41
"C7_Immunologic_signatures:C7_ALL_1599_GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1599_GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP",197,-2.1129,0,0,0.8741,0.82,1,-0.8503,0.89,1
"GO_BP:501959_GO_0032733_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION","GO_BP","501959_GO_0032733_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION",24,-2.1126,0,8e-04,-1.5834,0.021,0.72,-1.3904,0.075,0.58
"KEGG_compound:C14852_BENZO_A_PYRENE_7_8_DIOL_BENZO_A_PYRENE_7_8_DIHYDRODIOL","KEGG_compound","C14852_BENZO_A_PYRENE_7_8_DIOL_BENZO_A_PYRENE_7_8_DIHYDRODIOL",21,-2.1121,0,0.00031,-1.9859,0,0.0021,-1.7508,0.0082,0.055
"KEGG_reaction:R07069_3_4_DIHYDRO_3_HYDROXY_4_S_GLUTATHIONYL_BROMOBENZENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_BROMOBENZENE_3_4_OXIDE_GLUTATHIONE_3_4_DIHYDRO_3_HYDROXY_4_S_GLUTATHIONYL_BROMOBENZENE","KEGG_reaction","R07069_3_4_DIHYDRO_3_HYDROXY_4_S_GLUTATHIONYL_BROMOBENZENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_BROMOBENZENE_3_4_OXIDE_GLUTATHIONE_3_4_DIHYDRO_3_HYDROXY_4_S_GLUTATHIONYL_BROMOBENZENE",16,-2.1116,0,6.8e-05,-2.0305,0,0.0025,-1.8412,0,0.052
"C4_Cancer_modules:C4_CM_220_MODULE_241","C4_Cancer_modules","C4_CM_220_MODULE_241",73,-2.1113,0,0.00016,1.0353,0.4,0.66,-1.1275,0.24,0.49
"KEGG_compound:C14856_7_8_DIHYDRO_7_HYDROXY_8_S_GLUTATHIONYL_BENZO_A_PYRENE","KEGG_compound","C14856_7_8_DIHYDRO_7_HYDROXY_8_S_GLUTATHIONYL_BENZO_A_PYRENE",16,-2.1113,0,3e-04,-2.0351,0.0019,0.0039,-1.8198,0.0079,0.04
"KEGG_compound:C14865_2_S_GLUTATHIONYL_ACETYL_CHLORIDE","KEGG_compound","C14865_2_S_GLUTATHIONYL_ACETYL_CHLORIDE",16,-2.1113,0,0.00029,-1.9683,0,0.0026,-1.821,0.0042,0.043
"KEGG_compound:C14871_S_FORMYLMETHYL_GLUTATHIONE","KEGG_compound","C14871_S_FORMYLMETHYL_GLUTATHIONE",16,-2.1099,0,0.00028,-2.0238,0,0.0028,-1.8125,0.0077,0.037
"C2_Chemical_and_genetic_perturbations:C2_CGP_3107_CHYLA_CBFA2T3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3107_CHYLA_CBFA2T3_TARGETS_UP",378,-2.1099,0,0.00017,-1.0519,0.31,0.97,-1.1117,0.15,0.61
"KEGG_compound:C14806_1_NITRO_5_GLUTATHIONYL_6_HYDROXY_5_6_DIHYDRONAPHTHALENE","KEGG_compound","C14806_1_NITRO_5_GLUTATHIONYL_6_HYDROXY_5_6_DIHYDRONAPHTHALENE",16,-2.1096,0.0015,0.00028,-2.0372,0,0.0057,-1.8409,0.002,0.044
"C4_Cancer_modules:C4_CM_382_MODULE_478","C4_Cancer_modules","C4_CM_382_MODULE_478",19,-2.1094,0,0.00016,-1.385,0.085,0.5,-0.7245,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1649_BROWNE_HCMV_INFECTION_16HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1649_BROWNE_HCMV_INFECTION_16HR_DN",84,-2.1064,0,0.00018,0.9129,0.62,0.91,1.0977,0.28,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_2952_NAKAMURA_ADIPOGENESIS_EARLY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2952_NAKAMURA_ADIPOGENESIS_EARLY_UP",64,-2.1064,0,0.00018,0.9318,0.57,0.89,-0.9337,0.59,0.84
"GO_BP:513511_GO_0055078_SODIUM_ION_HOMEOSTASIS","GO_BP","513511_GO_0055078_SODIUM_ION_HOMEOSTASIS",25,-2.1058,0,9e-04,-1.3865,0.077,1,-1.487,0.047,0.53
"KEGG_compound:C11583_4_GLUTATHIONYL_CYCLOPHOSPHAMIDE","KEGG_compound","C11583_4_GLUTATHIONYL_CYCLOPHOSPHAMIDE",16,-2.1056,0,0.00031,-2.0211,0,0.0027,-1.8164,0.0062,0.037
"C7_Immunologic_signatures:C7_ALL_192_GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_192_GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN",198,-2.1054,0,0,0.8851,0.79,1,-2.1723,0,0
"KEGG_reaction:R07091_S_2_2_DICHLORO_1_HYDROXY_ETHYL_GLUTATHIONE_2_2_DICHLOROACETALDEHYDE_LYASE_GLUTATHIONE_FORMING_2_2_DICHLOROACETALDEHYDE_GLUTATHIONE_S_2_2_DICHLORO_1_HYDROXY_ETHYL_GLUTATHIONE","KEGG_reaction","R07091_S_2_2_DICHLORO_1_HYDROXY_ETHYL_GLUTATHIONE_2_2_DICHLOROACETALDEHYDE_LYASE_GLUTATHIONE_FORMING_2_2_DICHLOROACETALDEHYDE_GLUTATHIONE_S_2_2_DICHLORO_1_HYDROXY_ETHYL_GLUTATHIONE",16,-2.105,0,6.4e-05,-2.0306,0.0019,0.003,-1.8408,0.0078,0.045
"C7_Immunologic_signatures:C7_ALL_1451_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP","C7_Immunologic_signatures","C7_ALL_1451_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP",196,-2.1047,0,0,0.7704,0.98,1,1.041,0.33,1
"KEGG_compound:C14848_2_3_DIHYDRO_2_S_GLUTATHIONYL_3_HYDROXY_BROMOBENZENE","KEGG_compound","C14848_2_3_DIHYDRO_2_S_GLUTATHIONYL_3_HYDROXY_BROMOBENZENE",16,-2.1042,0,3e-04,-2.0382,0,0.0085,-1.8113,0,0.035
"C7_Immunologic_signatures:C7_ALL_1641_GSE3982_DC_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_1641_GSE3982_DC_VS_TH1_UP",198,-2.1033,0,0,-0.7629,0.98,1,-0.9229,0.68,0.9
"KEGG_reaction:R07113_1_2_DIBROMOETHANE_GLUTATHIONE_ETHYLENETRANSFERASE_EPISULFONIUM_FORMING_1_2_DIBROMOETHANE_GLUTATHIONE_H_GLUTATHIONE_EPISULFONIUM_ION_2_HYDROBROMIC_ACID","KEGG_reaction","R07113_1_2_DIBROMOETHANE_GLUTATHIONE_ETHYLENETRANSFERASE_EPISULFONIUM_FORMING_1_2_DIBROMOETHANE_GLUTATHIONE_H_GLUTATHIONE_EPISULFONIUM_ION_2_HYDROBROMIC_ACID",16,-2.1031,0,6.1e-05,-2.0351,0,0.0058,-1.8246,0.0021,0.031
"GO_BP:491591_GO_0006704_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS","GO_BP","491591_GO_0006704_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS",10,-2.1022,0,9e-04,0.6679,0.88,1,-0.871,0.62,0.95
"KEGG_reaction:R07002__1R_HYDROXY_2R_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1R_2S_NAPHTHALENE_1_2_OXIDE_GLUTATHIONE_1R_HYDROXY_2R_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE","KEGG_reaction","R07002__1R_HYDROXY_2R_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_1R_2S_NAPHTHALENE_1_2_OXIDE_GLUTATHIONE_1R_HYDROXY_2R_GLUTATHIONYL_1_2_DIHYDRONAPHTHALENE",16,-2.1021,0,5.7e-05,-1.9887,0,0.0014,-1.8753,0,0.21
"C2_Chemical_and_genetic_perturbations:C2_CGP_3207_WINZEN_DEGRADED_VIA_KHSRP","C2_Chemical_and_genetic_perturbations","C2_CGP_3207_WINZEN_DEGRADED_VIA_KHSRP",100,-2.102,0,0.00017,-1.2548,0.1,0.74,1.1514,0.18,0.83
"KEGG_compound:C00462_HALIDE_HYDROGEN_HALIDE_HX_HALO_ACID","KEGG_compound","C00462_HALIDE_HYDROGEN_HALIDE_HX_HALO_ACID",16,-2.1011,0,0.00029,-2.0151,0,0.0027,-1.8229,0,0.043
"C2_Chemical_and_genetic_perturbations:C2_CGP_2511_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2511_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP",105,-2.1009,0,0.00018,1.3386,0.043,0.35,-1.3039,0.057,0.43
"GO_BP:518997_GO_2000351_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS","GO_BP","518997_GO_2000351_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS",37,-2.0991,0,9e-04,0.765,0.87,1,1.0742,0.36,0.78
"C4_Cancer_modules:C4_CM_155_MODULE_164","C4_Cancer_modules","C4_CM_155_MODULE_164",59,-2.0991,0,2e-04,1.1812,0.18,0.42,1.0741,0.33,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_1384_SANA_RESPONSE_TO_IFNG_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1384_SANA_RESPONSE_TO_IFNG_UP",74,-2.0988,0,0.00022,0.5789,1,1,-1.8783,0,0.082
"KEGG_compound:C14868_S_1_2_DICHLOROVINYL_GLUTATHIONE_DCVG","KEGG_compound","C14868_S_1_2_DICHLOROVINYL_GLUTATHIONE_DCVG",16,-2.0979,0,0.00032,-2.0343,0,0.0036,-1.8198,0.0019,0.038
"GO_BP:488576_GO_0002703_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY","GO_BP","488576_GO_0002703_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY",147,-2.097,0,0.00098,-1.1467,0.16,0.93,-1.3007,0.036,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_186_JAEGER_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_186_JAEGER_METASTASIS_DN",242,-2.0963,0,0.00024,-0.9646,0.56,1,1.2736,0.038,0.68
"GO_BP:502227_GO_0033005_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION","GO_BP","502227_GO_0033005_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION",15,-2.0959,0,0.001,-0.8434,0.68,1,-0.8892,0.61,0.93
"C4_Cancer_modules:C4_CM_237_MODULE_263","C4_Cancer_modules","C4_CM_237_MODULE_263",37,-2.0959,0,0.00019,1.7335,0.013,0.038,1.464,0.04,0.26
"C7_Immunologic_signatures:C7_ALL_1334_GSE30083_SP2_VS_SP4_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1334_GSE30083_SP2_VS_SP4_THYMOCYTE_DN",200,-2.0952,0,0,-0.9266,0.66,1,-1.575,0,0.008
"GO_BP:487712_GO_0001816_CYTOKINE_PRODUCTION","GO_BP","487712_GO_0001816_CYTOKINE_PRODUCTION",117,-2.0944,0,0.001,-0.8045,0.9,1,-0.975,0.5,0.88
"GO_BP:508897_GO_0046649_LYMPHOCYTE_ACTIVATION","GO_BP","508897_GO_0046649_LYMPHOCYTE_ACTIVATION",330,-2.0936,0,0.001,-0.823,0.96,1,-1.3921,0,0.58
"GO_BP:501986_GO_0032760_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_PRODUCTION","GO_BP","501986_GO_0032760_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_PRODUCTION",43,-2.0928,0,0.001,1.1898,0.18,0.79,-1.0354,0.38,0.82
"C7_Immunologic_signatures:C7_ALL_379_GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_379_GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP",191,-2.0926,0,0,-1.1324,0.17,1,1.0586,0.29,1
"KEGG_compound:C01322_RX_ORGANIC_HALIDE","KEGG_compound","C01322_RX_ORGANIC_HALIDE",16,-2.0921,0,0.00031,-2.0088,0,0.0026,-1.8367,0.0021,0.044
"C2_Chemical_and_genetic_perturbations:C2_CGP_182_SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_182_SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP",158,-2.0917,0,0.00026,1.2393,0.064,0.45,1.8127,0,0.21
"REACTOME:685553_REACT_147851_ARACHIDONIC_ACID_METABOLISM","REACTOME","685553_REACT_147851_ARACHIDONIC_ACID_METABOLISM",51,-2.0914,0,0.0019,-0.9481,0.55,1,-1.1936,0.18,0.61
"C7_Immunologic_signatures:C7_ALL_1130_GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN","C7_Immunologic_signatures","C7_ALL_1130_GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN",185,-2.0911,0,0,-1.0262,0.4,1,-1.762,0,0.00025
"GO_BP:488394_GO_0002521_LEUKOCYTE_DIFFERENTIATION","GO_BP","488394_GO_0002521_LEUKOCYTE_DIFFERENTIATION",284,-2.0908,0,0.0011,-1.0971,0.19,0.95,-1.2395,0.038,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_256_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_256_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP",157,-2.0908,0,0.00026,1.0014,0.43,0.8,1.0463,0.34,0.93
"GO_BP:754692_GO_1901741_POSITIVE_REGULATION_OF_MYOBLAST_FUSION","GO_BP","754692_GO_1901741_POSITIVE_REGULATION_OF_MYOBLAST_FUSION",14,-2.0908,0,0.001,1.546,0.041,0.35,-0.9759,0.49,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_371_KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_371_KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP",126,-2.0907,0,0.00026,0.7956,0.92,0.99,-1.3009,0.039,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_1033_CAFFAREL_RESPONSE_TO_THC_8HR_5_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1033_CAFFAREL_RESPONSE_TO_THC_8HR_5_DN",11,-2.0905,0,0.00027,-1.4484,0.078,0.53,-2.2524,0,0.0027
"GO_BP:507153_GO_0044144_MODULATION_OF_GROWTH_OF_SYMBIONT_INVOLVED_IN_INTERACTION_WITH_HOST","GO_BP","507153_GO_0044144_MODULATION_OF_GROWTH_OF_SYMBIONT_INVOLVED_IN_INTERACTION_WITH_HOST",15,-2.09,0,0.001,-0.8144,0.73,1,-1.4153,0.083,0.57
"C0_Hallmark:H_ALL_20_HALLMARK_APICAL_JUNCTION","C0_Hallmark","H_ALL_20_HALLMARK_APICAL_JUNCTION",198,-2.0897,0,0,-1.1158,0.19,0.86,-1.2367,0.056,0.14
"C7_Immunologic_signatures:C7_ALL_182_GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN","C7_Immunologic_signatures","C7_ALL_182_GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN",197,-2.0895,0,0,-0.6521,1,1,-1.426,0.0085,0.045
"KEGG_reaction:R07092_1_1_DICHLOROETHYLENE_EPOXIDE_GLUTATHIONE_S_CHLOROEPOXYETHYL_TRANSFERASE_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_FORMING_1_1_DICHLOROETHYLENE_EPOXIDE_GLUTATHIONE_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_HYDROCHLORIC_ACID","KEGG_reaction","R07092_1_1_DICHLOROETHYLENE_EPOXIDE_GLUTATHIONE_S_CHLOROEPOXYETHYL_TRANSFERASE_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_FORMING_1_1_DICHLOROETHYLENE_EPOXIDE_GLUTATHIONE_2_S_GLUTATHIONYL_ACETYL_CHLORIDE_HYDROCHLORIC_ACID",16,-2.0895,0,5.5e-05,-1.99,0,0.0015,-1.8175,0.002,0.029
"KEGG_reaction:R07070_2_3_DIHYDRO_2_S_GLUTATHIONYL_3_HYDROXY_BROMOBENZENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_BROMOBENZENE_2_3_OXIDE_GLUTATHIONE_2_3_DIHYDRO_2_S_GLUTATHIONYL_3_HYDROXY_BROMOBENZENE","KEGG_reaction","R07070_2_3_DIHYDRO_2_S_GLUTATHIONYL_3_HYDROXY_BROMOBENZENE_GLUTATHIONE_LYASE_EPOXIDE_FORMING_BROMOBENZENE_2_3_OXIDE_GLUTATHIONE_2_3_DIHYDRO_2_S_GLUTATHIONYL_3_HYDROXY_BROMOBENZENE",16,-2.0894,0,5.2e-05,-2.0177,0,0.002,-1.8182,0.0058,0.031
"C2_Chemical_and_genetic_perturbations:C2_CGP_1966_ZHU_CMV_8_HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1966_ZHU_CMV_8_HR_UP",47,-2.0887,0,0.00028,-0.9065,0.6,1,-1.7656,0.0041,0.14
"C2_Chemical_and_genetic_perturbations:C2_CGP_1473_ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1473_ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP",65,-2.0883,0,0.00027,-0.7722,0.89,1,-1.1889,0.16,0.53
"GO_BP:499534_GO_0030098_LYMPHOCYTE_DIFFERENTIATION","GO_BP","499534_GO_0030098_LYMPHOCYTE_DIFFERENTIATION",197,-2.0875,0,0.0011,-1.0496,0.35,0.97,-1.3855,0.0087,0.59
"GO_BP:499537_GO_0030101_NATURAL_KILLER_CELL_ACTIVATION","GO_BP","499537_GO_0030101_NATURAL_KILLER_CELL_ACTIVATION",48,-2.0873,0,0.0011,-0.9969,0.46,0.99,-0.9638,0.53,0.88
"REACTOME:366238_REACT_75925_AMYLOIDS","REACTOME","366238_REACT_75925_AMYLOIDS",79,-2.0868,0,0.0018,-1.808,0,0.079,-1.6162,0.0079,0.23
"GO_BP:501941_GO_0032715_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION","GO_BP","501941_GO_0032715_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION",31,-2.0868,0,0.0011,-1.4839,0.042,0.83,-1.1267,0.27,0.75
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_38_BIOCARTA_LAIR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_38_BIOCARTA_LAIR_PATHWAY",17,-2.0863,0,0.0012,-0.9971,0.46,1,-1.5649,0.026,0.32
"GO_MF:490167_GO_0004866_ENDOPEPTIDASE_INHIBITOR_ACTIVITY","GO_MF","490167_GO_0004866_ENDOPEPTIDASE_INHIBITOR_ACTIVITY",152,-2.0862,0,0.0042,-1.058,0.31,0.87,1.2942,0.041,0.64
"C7_Immunologic_signatures:C7_ALL_39_GSE10325_CD4_TCELL_VS_MYELOID_UP","C7_Immunologic_signatures","C7_ALL_39_GSE10325_CD4_TCELL_VS_MYELOID_UP",195,-2.0849,0,0,1.4807,0,0.016,-1.5501,0,0.011
"GO_BP:499627_GO_0030217_T_CELL_DIFFERENTIATION","GO_BP","499627_GO_0030217_T_CELL_DIFFERENTIATION",123,-2.0846,0,0.0011,-0.9626,0.53,1,-1.3106,0.04,0.64
"C0_Hallmark:H_ALL_26_HALLMARK_MTORC1_SIGNALING","C0_Hallmark","H_ALL_26_HALLMARK_MTORC1_SIGNALING",200,-2.0839,0,0,0.7496,1,1,-1.5286,0,0.021
"C4_Cancer_modules:C4_CM_196_MODULE_209","C4_Cancer_modules","C4_CM_196_MODULE_209",87,-2.0837,0,0.00023,0.8422,0.81,0.93,-1.199,0.14,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2530_PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_2530_PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION",30,-2.0816,0,0.00033,0.7355,0.88,1,1.1883,0.21,0.78
"GO_BP:1184559_GO_1904035_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS","GO_BP","1184559_GO_1904035_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS",50,-2.0816,0,0.0012,0.8855,0.69,1,1.2295,0.14,0.71
"C4_Cancer_gene_neighborhoods:C4_CGN_298_GNF2_H2AFX","C4_Cancer_gene_neighborhoods","C4_CGN_298_GNF2_H2AFX",31,-2.0805,0,0.00012,-1.1035,0.31,0.72,-1.8491,0,0.011
"C2_Chemical_and_genetic_perturbations:C2_CGP_2900_TIAN_TNF_SIGNALING_VIA_NFKB","C2_Chemical_and_genetic_perturbations","C2_CGP_2900_TIAN_TNF_SIGNALING_VIA_NFKB",28,-2.0805,0,0.00034,-1.9437,0,0.092,-1.6743,0.004,0.21
"C2_Chemical_and_genetic_perturbations:C2_CGP_1932_BURTON_ADIPOGENESIS_PEAK_AT_8HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1932_BURTON_ADIPOGENESIS_PEAK_AT_8HR",39,-2.0804,0,0.00033,-0.9027,0.63,1,-1.2432,0.16,0.48
"REACTOME:1127555_REACT_264164_HSF1_DEPENDENT_TRANSACTIVATION","REACTOME","1127555_REACT_264164_HSF1_DEPENDENT_TRANSACTIVATION",22,-2.0801,0,0.0017,-1.8349,0.0038,0.065,-2.0707,0,0.025
"C4_Cancer_modules:C4_CM_271_MODULE_310","C4_Cancer_modules","C4_CM_271_MODULE_310",20,-2.0778,0,0.00022,-1.6149,0.018,0.22,-1.7422,0.0098,0.07
"C4_Cancer_gene_neighborhoods:C4_CGN_367_GNF2_JAK1","C4_Cancer_gene_neighborhoods","C4_CGN_367_GNF2_JAK1",32,-2.0778,0,0.00012,0.9788,0.49,0.63,-1.5129,0.039,0.11
"C2_Chemical_and_genetic_perturbations:C2_CGP_1174_MORI_PRE_BI_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1174_MORI_PRE_BI_LYMPHOCYTE_UP",79,-2.0777,0,0.00033,0.8211,0.82,0.98,-1.8726,0,0.079
"C2_Chemical_and_genetic_perturbations:C2_CGP_2488_VILIMAS_NOTCH1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2488_VILIMAS_NOTCH1_TARGETS_UP",51,-2.0776,0,0.00033,-0.8256,0.77,1,-1.0682,0.36,0.67
"C4_Cancer_modules:C4_CM_40_MODULE_44","C4_Cancer_modules","C4_CM_40_MODULE_44",314,-2.0768,0,0.00021,1.2388,0.021,0.34,-1.0031,0.44,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1974_VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1974_VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN",14,-2.0762,0,0.00033,-1.1379,0.32,0.86,-1.9101,0,0.07
"C2_Chemical_and_genetic_perturbations:C2_CGP_2319_WILENSKY_RESPONSE_TO_DARAPLADIB","C2_Chemical_and_genetic_perturbations","C2_CGP_2319_WILENSKY_RESPONSE_TO_DARAPLADIB",29,-2.0756,0,0.00034,0.8371,0.72,0.98,1.1459,0.27,0.83
"C6_Oncogenic_signatures:C6_ALL_51_P53_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_51_P53_DN_V1_DN",183,-2.0753,0,0,-1.1668,0.12,0.48,-1.2866,0.05,0.29
"KEGG_compound:C02320_R_S_GLUTATHIONE","KEGG_compound","C02320_R_S_GLUTATHIONE",20,-2.0728,0,0.00041,-2.037,0,0.0049,-1.6502,0.0097,0.1
"GO_BP:512059_GO_0051149_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION","GO_BP","512059_GO_0051149_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION",71,-2.0725,0,0.0014,-0.8773,0.7,1,-1.1892,0.17,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_3130_JOHNSTONE_PARVB_TARGETS_3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3130_JOHNSTONE_PARVB_TARGETS_3_UP",426,-2.0723,0,0.00037,-0.5611,1,1,-0.8347,0.96,0.93
"C4_Cancer_gene_neighborhoods:C4_CGN_374_GNF2_MATK","C4_Cancer_gene_neighborhoods","C4_CGN_374_GNF2_MATK",24,-2.0722,0,0.00011,1.0522,0.37,0.46,-1.4525,0.053,0.14
"GO_BP:500608_GO_0031349_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE","GO_BP","500608_GO_0031349_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE",273,-2.0707,0,0.0014,-0.7238,1,1,-1.0509,0.3,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_121_DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_121_DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN",114,-2.0706,0,0.00037,1.4161,0.0092,0.28,-1.0616,0.33,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_2177_SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2177_SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN",146,-2.0702,0,0.00036,0.9275,0.65,0.9,-1.0749,0.29,0.66
"GO_BP:1129381_GO_1903555_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION","GO_BP","1129381_GO_1903555_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION",86,-2.0695,0,0.0014,0.9244,0.64,1,-0.9882,0.48,0.86
"C7_Immunologic_signatures:C7_ALL_1824_GSE7852_THYMUS_VS_FAT_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1824_GSE7852_THYMUS_VS_FAT_TCONV_DN",200,-2.069,0,0,-0.9082,0.69,1,-1.428,0.0063,0.045
"GO_MF:492393_GO_0008329_SIGNALING_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY","GO_MF","492393_GO_0008329_SIGNALING_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY",15,-2.069,0,0.0058,-0.8919,0.61,1,-0.8483,0.66,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1060_RICKMAN_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1060_RICKMAN_METASTASIS_DN",256,-2.0688,0,0.00037,-1.2892,0.028,0.7,-0.9395,0.64,0.83
"C7_Immunologic_signatures:C7_ALL_210_GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN","C7_Immunologic_signatures","C7_ALL_210_GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN",199,-2.0683,0,0,0.984,0.46,0.79,-2.3402,0,0
"GO_BP:501903_GO_0032677_REGULATION_OF_INTERLEUKIN_8_PRODUCTION","GO_BP","501903_GO_0032677_REGULATION_OF_INTERLEUKIN_8_PRODUCTION",49,-2.0669,0,0.0014,1.2063,0.16,0.78,0.8211,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2475_WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_2475_WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER",55,-2.0669,0,0.00037,-0.9173,0.61,1,-1.5229,0.014,0.29
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_91_BIOCARTA_IL17_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_91_BIOCARTA_IL17_PATHWAY",15,-2.0668,0,0.0018,1.625,0.034,0.25,-1.5082,0.05,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_1147_AMIT_SERUM_RESPONSE_60_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1147_AMIT_SERUM_RESPONSE_60_MCF10A",57,-2.0667,0,0.00037,-1.5734,0.011,0.43,-1.2971,0.11,0.43
"GO_BP:508891_GO_0046643_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION","GO_BP","508891_GO_0046643_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION",12,-2.0659,0,0.0014,-1.5172,0.054,0.8,-0.9217,0.56,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_396_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_396_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN",151,-2.0655,0,0.00039,-0.8602,0.8,1,-1.2038,0.088,0.51
"GO_BP:1026079_GO_1903307_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY","GO_BP","1026079_GO_1903307_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY",22,-2.0647,0,0.0015,0.9793,0.49,1,-0.9745,0.46,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_250_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_250_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP",182,-2.0643,0,0.00039,-0.9845,0.49,1,-1.1526,0.14,0.57
"C4_Cancer_modules:C4_CM_352_MODULE_424","C4_Cancer_modules","C4_CM_352_MODULE_424",18,-2.0643,0,0.00025,-1.3947,0.079,0.53,-0.6241,0.96,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_7_BIOCARTA_LYM_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_7_BIOCARTA_LYM_PATHWAY",11,-2.0641,0,0.0017,-0.8412,0.68,1,-1.559,0.041,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_2340_CHUNG_BLISTER_CYTOTOXICITY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2340_CHUNG_BLISTER_CYTOTOXICITY_DN",44,-2.0624,0,0.00041,0.8604,0.69,0.96,-1.6098,0.004,0.23
"REACTOME:645321_REACT_120829_ACYL_CHAIN_REMODELLING_OF_PC","REACTOME","645321_REACT_120829_ACYL_CHAIN_REMODELLING_OF_PC",23,-2.0624,0,0.0019,-0.8242,0.73,1,-1.0101,0.44,0.82
"C7_Immunologic_signatures:C7_ALL_421_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP","C7_Immunologic_signatures","C7_ALL_421_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP",198,-2.0621,0,0,1.1384,0.14,0.34,-1.1531,0.12,0.36
"C7_Immunologic_signatures:C7_ALL_239_GSE14000_4H_VS_16H_LPS_DC_UP","C7_Immunologic_signatures","C7_ALL_239_GSE14000_4H_VS_16H_LPS_DC_UP",192,-2.0619,0,0,1.1333,0.17,0.35,-1.4576,0.0063,0.033
"C2_Chemical_and_genetic_perturbations:C2_CGP_2383_PODAR_RESPONSE_TO_ADAPHOSTIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2383_PODAR_RESPONSE_TO_ADAPHOSTIN_UP",146,-2.0619,0,4e-04,-1.3141,0.054,0.69,-1.6315,0.0021,0.22
"GO_BP:508015_GO_0045667_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION","GO_BP","508015_GO_0045667_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION",105,-2.0616,0,0.0016,-0.9615,0.53,1,1.031,0.39,0.82
"GO_BP:754638_GO_1901687_GLUTATHIONE_DERIVATIVE_BIOSYNTHETIC_PROCESS","GO_BP","754638_GO_1901687_GLUTATHIONE_DERIVATIVE_BIOSYNTHETIC_PROCESS",24,-2.0612,0,0.0016,-1.8504,0,0.42,-1.8439,0.0019,0.52
"GO_BP:751071_GO_0036151_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING","GO_BP","751071_GO_0036151_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING",25,-2.0605,0,0.0016,-0.7181,0.9,1,-0.9675,0.49,0.88
"C4_Cancer_modules:C4_CM_225_MODULE_247","C4_Cancer_modules","C4_CM_225_MODULE_247",32,-2.0605,0,0.00028,-0.957,0.53,0.86,0.8209,0.77,1
"KEGG_pathway:HSA05132_SALMONELLA_INFECTION","KEGG_pathway","HSA05132_SALMONELLA_INFECTION",82,-2.0597,0,0,-0.9592,0.53,0.94,0.7468,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3310_PHONG_TNF_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3310_PHONG_TNF_TARGETS_UP",63,-2.0594,0,0.00044,-1.847,0,0.23,-1.0182,0.41,0.73
"GO_BP:488634_GO_0002761_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION","GO_BP","488634_GO_0002761_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION",107,-2.0589,0,0.0016,-0.9236,0.61,1,-1.0834,0.29,0.79
"REACTOME:105654_REACT_1503_LIGAND_DEPENDENT_CASPASE_ACTIVATION","REACTOME","105654_REACT_1503_LIGAND_DEPENDENT_CASPASE_ACTIVATION",17,-2.0588,0,0.0017,-0.5739,0.98,1,-0.9941,0.44,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_2095_FOSTER_TOLERANT_MACROPHAGE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2095_FOSTER_TOLERANT_MACROPHAGE_UP",156,-2.0585,0,0.00044,0.7948,0.93,0.99,1.0976,0.25,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_794_YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_794_YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN",84,-2.0579,0,0.00044,0.9431,0.55,0.87,-1.4975,0.0084,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_1392_SMITH_TERT_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1392_SMITH_TERT_TARGETS_DN",87,-2.0571,0,0.00044,-0.8324,0.81,1,-1.7698,0,0.14
"C3_TF_targets:C3_TFT_109_V_SRF_01","C3_TF_targets","C3_TFT_109_V_SRF_01",50,-2.0546,0,0,-1.4056,0.046,0.16,0.909,0.61,1
"GO_BP:518224_GO_0090084_NEGATIVE_REGULATION_OF_INCLUSION_BODY_ASSEMBLY","GO_BP","518224_GO_0090084_NEGATIVE_REGULATION_OF_INCLUSION_BODY_ASSEMBLY",10,-2.0545,0,0.0017,-1.8433,0.0077,0.43,-1.8791,0,0.56
"C2_Chemical_and_genetic_perturbations:C2_CGP_2349_BOQUEST_STEM_CELL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2349_BOQUEST_STEM_CELL_UP",252,-2.0542,0,0.00044,-1.2367,0.052,0.76,1.2062,0.048,0.77
"GO_BP:501878_GO_0032652_REGULATION_OF_INTERLEUKIN_1_PRODUCTION","GO_BP","501878_GO_0032652_REGULATION_OF_INTERLEUKIN_1_PRODUCTION",45,-2.0537,0,0.0017,-1.1968,0.18,0.9,-1.3413,0.076,0.61
"C7_Immunologic_signatures:C7_ALL_963_GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP","C7_Immunologic_signatures","C7_ALL_963_GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP",199,-2.0536,0,0,-1.1408,0.15,1,-1.6546,0,0.0018
"C7_Immunologic_signatures:C7_ALL_1809_GSE7852_TREG_VS_TCONV_THYMUS_UP","C7_Immunologic_signatures","C7_ALL_1809_GSE7852_TREG_VS_TCONV_THYMUS_UP",200,-2.0531,0,0,0.8403,0.89,1,-0.8432,0.89,1
"C7_Immunologic_signatures:C7_ALL_1039_GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP","C7_Immunologic_signatures","C7_ALL_1039_GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP",197,-2.0527,0,0,-0.8246,0.9,1,-1.3745,0.01,0.078
"C2_Chemical_and_genetic_perturbations:C2_CGP_2016_YANG_MUC2_TARGETS_DUODENUM_3MO_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2016_YANG_MUC2_TARGETS_DUODENUM_3MO_DN",21,-2.0524,0,0.00044,-1.5643,0.026,0.42,-2.051,0,0.031
"C4_Cancer_modules:C4_CM_286_MODULE_327","C4_Cancer_modules","C4_CM_286_MODULE_327",21,-2.0518,0,0.00035,0.8378,0.71,0.94,-1.4888,0.043,0.17
"C2_Chemical_and_genetic_perturbations:C2_CGP_1866_BURTON_ADIPOGENESIS_1","C2_Chemical_and_genetic_perturbations","C2_CGP_1866_BURTON_ADIPOGENESIS_1",33,-2.0511,0,0.00044,-1.1619,0.23,0.83,-1.2419,0.15,0.48
"GO_BP:515323_GO_0070391_RESPONSE_TO_LIPOTEICHOIC_ACID","GO_BP","515323_GO_0070391_RESPONSE_TO_LIPOTEICHOIC_ACID",8,-2.051,0,0.0017,-1.6376,0.025,0.69,-1.1596,0.29,0.73
"KEGG_pathway:HSA04261_ADRENERGIC_SIGNALING_IN_CARDIOMYOCYTES","KEGG_pathway","HSA04261_ADRENERGIC_SIGNALING_IN_CARDIOMYOCYTES",147,-2.051,0,0,-1.5277,0.0052,0.65,-1.2653,0.055,0.31
"GO_BP:488126_GO_0002253_ACTIVATION_OF_IMMUNE_RESPONSE","GO_BP","488126_GO_0002253_ACTIVATION_OF_IMMUNE_RESPONSE",347,-2.0509,0,0.0017,-0.69,1,1,-1.3122,0.0042,0.64
"GO_BP:506366_GO_0043306_POSITIVE_REGULATION_OF_MAST_CELL_DEGRANULATION","GO_BP","506366_GO_0043306_POSITIVE_REGULATION_OF_MAST_CELL_DEGRANULATION",13,-2.0506,0.0016,0.0017,-0.8898,0.6,1,-1.0702,0.37,0.8
"C4_Cancer_modules:C4_CM_140_MODULE_148","C4_Cancer_modules","C4_CM_140_MODULE_148",13,-2.0495,0,0.00037,1.4447,0.086,0.15,1.1196,0.32,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1953_SESTO_RESPONSE_TO_UV_C3","C2_Chemical_and_genetic_perturbations","C2_CGP_1953_SESTO_RESPONSE_TO_UV_C3",20,-2.0493,0,0.00047,-1.4261,0.069,0.55,-1.4801,0.052,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_1609_REN_ALVEOLAR_RHABDOMYOSARCOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1609_REN_ALVEOLAR_RHABDOMYOSARCOMA_DN",408,-2.0493,0,0.00047,1.0263,0.33,0.76,0.7895,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2574_HINATA_NFKB_TARGETS_FIBROBLAST_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2574_HINATA_NFKB_TARGETS_FIBROBLAST_UP",82,-2.0491,0,0.00046,-0.919,0.62,1,-0.8928,0.7,0.89
"GO_CC:490903_GO_0005901_CAVEOLA","GO_CC","490903_GO_0005901_CAVEOLA",69,-2.049,0,0.0025,0.8936,0.67,0.9,-1.3054,0.088,0.63
"KEGG_pathway:HSA04970_SALIVARY_SECRETION","KEGG_pathway","HSA04970_SALIVARY_SECRETION",83,-2.0489,0,0,-1.5175,0.014,0.57,-1.4588,0.019,0.15
"C2_Chemical_and_genetic_perturbations:C2_CGP_1871_KEEN_RESPONSE_TO_ROSIGLITAZONE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1871_KEEN_RESPONSE_TO_ROSIGLITAZONE_DN",104,-2.0487,0,0.00046,1.2237,0.1,0.46,-0.9046,0.66,0.87
"C7_Immunologic_signatures:C7_ALL_174_GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN","C7_Immunologic_signatures","C7_ALL_174_GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN",188,-2.0486,0,0,-1.0509,0.34,1,-1.1755,0.12,0.33
"C2_Chemical_and_genetic_perturbations:C2_CGP_2142_HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2142_HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP",442,-2.0483,0,0.00047,-1.4347,0.0017,0.54,-1.3177,0.0086,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1659_NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1659_NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN",20,-2.048,0,0.00046,-0.7198,0.87,1,1.143,0.27,0.83
"REACTOME:1127552_REACT_264249_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES","REACTOME","1127552_REACT_264249_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES",28,-2.0471,0,0.0021,-0.642,0.97,1,-1.171,0.21,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1556_LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS","C2_Chemical_and_genetic_perturbations","C2_CGP_1556_LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS",25,-2.0463,0,0.00048,1.5444,0.025,0.17,0.9045,0.61,1
"GO_BP:491579_GO_0006691_LEUKOTRIENE_METABOLIC_PROCESS","GO_BP","491579_GO_0006691_LEUKOTRIENE_METABOLIC_PROCESS",32,-2.046,0,0.0019,-0.6436,0.97,1,-0.7219,0.91,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2444_JIANG_TIP30_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2444_JIANG_TIP30_TARGETS_UP",45,-2.0459,0,0.00047,0.6221,0.98,1,-1.0716,0.33,0.67
"KEGG_compound:C19586_AFLATOXIN_B1_EXO_8_9_EPOXIDE_2_3_EPOXYAFLATOXIN_B1","KEGG_compound","C19586_AFLATOXIN_B1_EXO_8_9_EPOXIDE_2_3_EPOXYAFLATOXIN_B1",22,-2.0449,0,0.00049,-1.9389,0.0038,0.0041,-1.4019,0.058,0.29
"KEGG_pathway:HSA04971_GASTRIC_ACID_SECRETION","KEGG_pathway","HSA04971_GASTRIC_ACID_SECRETION",74,-2.0447,0,0,-1.4219,0.02,0.39,-1.553,0.0043,0.1
"GO_BP:508717_GO_0046456_ICOSANOID_BIOSYNTHETIC_PROCESS","GO_BP","508717_GO_0046456_ICOSANOID_BIOSYNTHETIC_PROCESS",45,-2.0442,0,0.0019,-0.9312,0.55,1,-1.4029,0.047,0.58
"GO_BP:488579_GO_0002706_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY","GO_BP","488579_GO_0002706_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY",110,-2.044,0,0.0019,-1.4416,0.017,0.91,-1.5598,0.004,0.51
"C7_Immunologic_signatures:C7_ALL_894_GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_894_GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN",197,-2.0437,0,0,-0.895,0.74,1,-1.0589,0.3,0.59
"GO_BP:502230_GO_0033008_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","502230_GO_0033008_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",13,-2.0436,0.0015,0.0019,-0.9035,0.59,1,-1.0574,0.39,0.81
"KEGG_pathway:HSA04380_OSTEOCLAST_DIFFERENTIATION","KEGG_pathway","HSA04380_OSTEOCLAST_DIFFERENTIATION",128,-2.0432,0,0,-1.0701,0.3,0.71,-0.9709,0.55,0.75
"GO_BP:501906_GO_0032680_REGULATION_OF_TUMOR_NECROSIS_FACTOR_PRODUCTION","GO_BP","501906_GO_0032680_REGULATION_OF_TUMOR_NECROSIS_FACTOR_PRODUCTION",82,-2.042,0,0.002,0.9594,0.57,1,-1.0076,0.43,0.84
"GO_BP:511687_GO_0050716_POSITIVE_REGULATION_OF_INTERLEUKIN_1_SECRETION","GO_BP","511687_GO_0050716_POSITIVE_REGULATION_OF_INTERLEUKIN_1_SECRETION",19,-2.0416,0,0.002,-1.0879,0.35,0.95,-1.1167,0.3,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2139_HELLER_SILENCED_BY_METHYLATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2139_HELLER_SILENCED_BY_METHYLATION_DN",102,-2.0412,0,0.00051,-1.1096,0.25,0.9,-1.6561,0,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_2590_LEE_EARLY_T_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2590_LEE_EARLY_T_LYMPHOCYTE_DN",56,-2.0411,0,0.00051,1.2512,0.13,0.43,-1.3692,0.064,0.38
"KEGG_compound:C00118_D_GLYCERALDEHYDE_3_PHOSPHATE_2R_2_HYDROXY_3_PHOSPHONOOXY_PROPANAL_GLYCERALDEHYDE_3_PHOSPHATE","KEGG_compound","C00118_D_GLYCERALDEHYDE_3_PHOSPHATE_2R_2_HYDROXY_3_PHOSPHONOOXY_PROPANAL_GLYCERALDEHYDE_3_PHOSPHATE",11,-2.0406,0.0016,0.00051,-1.1885,0.26,0.8,-1.1561,0.28,0.5
"C7_Immunologic_signatures:C7_ALL_1706_GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1706_GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN",195,-2.0406,0,0,0.9279,0.64,0.96,-1.4108,0.0061,0.055
"REACTOME:1183606_REACT_355336_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALIG_PATHWAY","REACTOME","1183606_REACT_355336_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALIG_PATHWAY",27,-2.0401,0,0.0023,-0.6507,0.94,1,-1.0249,0.4,0.8
"C7_Immunologic_signatures:C7_ALL_1665_GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1665_GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP",199,-2.04,0,0,0.7415,1,1,0.7439,0.98,1
"C7_Immunologic_signatures:C7_ALL_1643_GSE3982_DC_VS_TH2_UP","C7_Immunologic_signatures","C7_ALL_1643_GSE3982_DC_VS_TH2_UP",195,-2.0399,0,0,-0.9034,0.72,1,-1.0737,0.28,0.56
"GO_BP:506085_GO_0042993_POSITIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS","GO_BP","506085_GO_0042993_POSITIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS",43,-2.0399,0,0.002,-1.2832,0.13,0.89,-1.4704,0.031,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_216_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_216_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP",178,-2.0398,0,0.00052,1.0329,0.35,0.75,-1.7209,0,0.16
"WikiPathways:198899_WP692_SULFATION_BIOTRANSFORMATION_REACTION","WikiPathways","198899_WP692_SULFATION_BIOTRANSFORMATION_REACTION",16,-2.0397,0,0.0036,1.084,0.32,1,-1.2655,0.17,0.46
"C0_Hallmark:H_ALL_43_HALLMARK_IL2_STAT5_SIGNALING","C0_Hallmark","H_ALL_43_HALLMARK_IL2_STAT5_SIGNALING",199,-2.0393,0,0,0.7434,1,1,-0.9374,0.66,0.66
"GO_MF:490388_GO_0005125_CYTOKINE_ACTIVITY","GO_MF","490388_GO_0005125_CYTOKINE_ACTIVITY",197,-2.0385,0,0.01,1.1329,0.15,0.75,-1.0619,0.28,0.74
"C6_Oncogenic_signatures:C6_ALL_150_HOXA9_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_150_HOXA9_DN_V1_UP",192,-2.0377,0,0,0.8164,0.94,0.98,-1.1296,0.17,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_37_SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_37_SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP",343,-2.0374,0,0.00053,0.8526,0.95,0.97,1.1218,0.13,0.85
"C0_Hallmark:H_ALL_2_HALLMARK_HYPOXIA","C0_Hallmark","H_ALL_2_HALLMARK_HYPOXIA",197,-2.0371,0,0,-0.946,0.6,0.95,-1.175,0.12,0.21
"C0_Hallmark:H_ALL_3_HALLMARK_CHOLESTEROL_HOMEOSTASIS","C0_Hallmark","H_ALL_3_HALLMARK_CHOLESTEROL_HOMEOSTASIS",72,-2.037,0,0,-1.0407,0.37,0.82,1.0648,0.33,0.52
"C4_Cancer_gene_neighborhoods:C4_CGN_427_GNF2_ZAP70","C4_Cancer_gene_neighborhoods","C4_CGN_427_GNF2_ZAP70",26,-2.0369,0,0.00011,1.2704,0.15,0.15,-1.4988,0.042,0.11
"WikiPathways:198902_WP237_GLUCOCORTICOID_AMP_MINERALCORTICOID_METABOLISM","WikiPathways","198902_WP237_GLUCOCORTICOID_AMP_MINERALCORTICOID_METABOLISM",8,-2.0365,0,0.0027,0.8087,0.72,1,1.166,0.31,0.69
"GO_BP:754530_GO_1901570_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS","GO_BP","754530_GO_1901570_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS",45,-2.036,0,0.0021,-0.9319,0.57,1,-1.4215,0.046,0.57
"C7_Immunologic_signatures:C7_ALL_1076_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN","C7_Immunologic_signatures","C7_ALL_1076_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN",200,-2.0359,0,0,-0.9747,0.51,1,-0.9996,0.42,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1092_WU_CELL_MIGRATION","C2_Chemical_and_genetic_perturbations","C2_CGP_1092_WU_CELL_MIGRATION",178,-2.0359,0,0.00054,1.4047,0.0044,0.29,1.3847,0.011,0.54
"GO_BP:755342_GO_2001236_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","755342_GO_2001236_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",159,-2.0357,0,0.0021,-0.6643,1,1,-0.8726,0.8,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2868_UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN","C2_Chemical_and_genetic_perturbations","C2_CGP_2868_UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN",37,-2.0353,0,0.00055,-1.7779,0.0038,0.34,-1.517,0.029,0.29
"GO_CC:752590_GO_0090533_CATION_TRANSPORTING_ATPASE_COMPLEX","GO_CC","752590_GO_0090533_CATION_TRANSPORTING_ATPASE_COMPLEX",16,-2.0352,0,0.0023,-1.6563,0.013,0.31,-1.6795,0.016,0.5
"C2_Chemical_and_genetic_perturbations:C2_CGP_715_MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS","C2_Chemical_and_genetic_perturbations","C2_CGP_715_MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS",36,-2.0352,0,0.00054,-0.6773,0.96,1,-0.9712,0.48,0.79
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_54_BIOCARTA_DC_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_54_BIOCARTA_DC_PATHWAY",22,-2.0347,0,0.0025,0.7899,0.78,0.97,-1.3925,0.098,0.44
"GO_BP:488125_GO_0002252_IMMUNE_EFFECTOR_PROCESS","GO_BP","488125_GO_0002252_IMMUNE_EFFECTOR_PROCESS",430,-2.0345,0,0.0021,1.0512,0.27,0.95,-1.4681,0,0.54
"C7_Immunologic_signatures:C7_ALL_234_GSE14000_UNSTIM_VS_4H_LPS_DC_DN","C7_Immunologic_signatures","C7_ALL_234_GSE14000_UNSTIM_VS_4H_LPS_DC_DN",197,-2.0338,0,0,0.7634,0.99,1,-1.5606,0,0.0094
"C7_Immunologic_signatures:C7_ALL_1474_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN","C7_Immunologic_signatures","C7_ALL_1474_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN",197,-2.0335,0,0,0.8515,0.89,1,0.9036,0.73,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1449_ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN","C2_Chemical_and_genetic_perturbations","C2_CGP_1449_ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN",73,-2.0327,0,0.00055,1.0555,0.34,0.7,-0.9673,0.52,0.8
"GO_MF:494924_GO_0061135_ENDOPEPTIDASE_REGULATOR_ACTIVITY","GO_MF","494924_GO_0061135_ENDOPEPTIDASE_REGULATOR_ACTIVITY",161,-2.0327,0,0.0099,-0.9744,0.52,0.94,1.233,0.094,0.68
"GO_BP:515304_GO_0070372_REGULATION_OF_ERK1_AND_ERK2_CASCADE","GO_BP","515304_GO_0070372_REGULATION_OF_ERK1_AND_ERK2_CASCADE",166,-2.0322,0,0.0021,-0.9209,0.67,1,1.3507,0.028,0.65
"GO_MF:849756_GO_0038187_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY","GO_MF","849756_GO_0038187_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY",15,-2.0318,0,0.0089,-0.8556,0.64,1,-0.8753,0.64,0.9
"C7_Immunologic_signatures:C7_ALL_1242_GSE2826_WT_VS_BTK_KO_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1242_GSE2826_WT_VS_BTK_KO_BCELL_DN",194,-2.0305,0,0,0.7587,0.99,1,-0.9887,0.48,0.75
"C7_Immunologic_signatures:C7_ALL_773_GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_773_GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP",191,-2.0301,0,0,-0.993,0.48,1,-1.4691,0.0086,0.03
"WikiPathways:672459_WP2272_PATHOGENIC_ESCHERICHIA_COLI_INFECTION","WikiPathways","672459_WP2272_PATHOGENIC_ESCHERICHIA_COLI_INFECTION",55,-2.0296,0,0.0024,0.9895,0.45,1,-1.1127,0.25,0.58
"GO_BP:512175_GO_0051290_PROTEIN_HETEROTETRAMERIZATION","GO_BP","512175_GO_0051290_PROTEIN_HETEROTETRAMERIZATION",35,-2.0295,0,0.0023,-1.6905,0.0038,0.58,-1.6794,0.0083,0.59
"C7_Immunologic_signatures:C7_ALL_1035_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP","C7_Immunologic_signatures","C7_ALL_1035_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP",195,-2.0293,0,0,0.8792,0.82,1,-1.0976,0.24,0.5
"GO_BP:513700_GO_0060142_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION","GO_BP","513700_GO_0060142_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION",25,-2.0291,0,0.0022,1.1761,0.23,0.81,-1.6427,0.02,0.53
"GO_BP:508880_GO_0046632_ALPHA_BETA_T_CELL_DIFFERENTIATION","GO_BP","508880_GO_0046632_ALPHA_BETA_T_CELL_DIFFERENTIATION",45,-2.0285,0,0.0022,0.7267,0.92,1,0.873,0.7,0.96
"GO_BP:503309_GO_0034103_REGULATION_OF_TISSUE_REMODELING","GO_BP","503309_GO_0034103_REGULATION_OF_TISSUE_REMODELING",59,-2.0282,0,0.0022,-1.0334,0.38,0.98,-0.9349,0.57,0.9
"KEGG_pathway:HSA04915_ESTROGEN_SIGNALING_PATHWAY","KEGG_pathway","HSA04915_ESTROGEN_SIGNALING_PATHWAY",99,-2.0281,0,0.00015,-1.4766,0.0073,0.44,-1.8295,0,0.022
"C7_Immunologic_signatures:C7_ALL_230_GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN","C7_Immunologic_signatures","C7_ALL_230_GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN",193,-2.0279,0,0,-0.9342,0.65,1,-1.4579,0,0.033
"C2_Chemical_and_genetic_perturbations:C2_CGP_1791_DELLA_RESPONSE_TO_TSA_AND_BUTYRATE","C2_Chemical_and_genetic_perturbations","C2_CGP_1791_DELLA_RESPONSE_TO_TSA_AND_BUTYRATE",20,-2.0275,0,0.00059,-1.5451,0.037,0.43,-1.8599,0,0.084
"C6_Oncogenic_signatures:C6_ALL_102_ALK_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_102_ALK_DN_V1_UP",130,-2.0274,0,0,-0.8401,0.83,0.98,1.32,0.027,0.18
"GO_MF:498649_GO_0019865_IMMUNOGLOBULIN_BINDING","GO_MF","498649_GO_0019865_IMMUNOGLOBULIN_BINDING",22,-2.027,0,0.0081,-1.171,0.26,0.79,0.8828,0.63,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3033_NOUSHMEHR_GBM_GERMLINE_MUTATED","C2_Chemical_and_genetic_perturbations","C2_CGP_3033_NOUSHMEHR_GBM_GERMLINE_MUTATED",8,-2.0264,0,0.00061,-1.4511,0.097,0.52,1.2799,0.17,0.69
"GO_BP:508889_GO_0046641_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION","GO_BP","508889_GO_0046641_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION",18,-2.0259,0,0.0023,-0.6374,0.92,1,-0.7696,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1448_SANSOM_APC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1448_SANSOM_APC_TARGETS_DN",356,-2.0249,0,0.00064,-1.0635,0.25,0.96,-1.2685,0.019,0.45
"GO_BP:501875_GO_0032649_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION","GO_BP","501875_GO_0032649_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION",82,-2.0248,0,0.0023,-1.0208,0.43,0.97,-0.9302,0.61,0.9
"GO_BP:511735_GO_0050764_REGULATION_OF_PHAGOCYTOSIS","GO_BP","511735_GO_0050764_REGULATION_OF_PHAGOCYTOSIS",54,-2.0242,0,0.0023,-1.0297,0.4,0.97,0.9712,0.51,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_661_LINDGREN_BLADDER_CANCER_CLUSTER_2B","C2_Chemical_and_genetic_perturbations","C2_CGP_661_LINDGREN_BLADDER_CANCER_CLUSTER_2B",384,-2.0234,0,0.00064,0.8819,0.9,0.94,1.0597,0.29,0.9
"GO_BP:488159_GO_0002286_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488159_GO_0002286_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",50,-2.0228,0,0.0023,-0.8739,0.68,1,-1.2444,0.14,0.69
"GO_BP:501868_GO_0032642_REGULATION_OF_CHEMOKINE_PRODUCTION","GO_BP","501868_GO_0032642_REGULATION_OF_CHEMOKINE_PRODUCTION",55,-2.0224,0,0.0023,1.018,0.42,0.97,0.94,0.57,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_244_MULLIGHAN_MLL_SIGNATURE_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_244_MULLIGHAN_MLL_SIGNATURE_2_UP",417,-2.0223,0,0.00065,-0.6059,1,1,-1.0386,0.31,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_716_FARMER_BREAST_CANCER_CLUSTER_1","C2_Chemical_and_genetic_perturbations","C2_CGP_716_FARMER_BREAST_CANCER_CLUSTER_1",41,-2.0218,0,0.00066,2.0458,0,0.0037,-1.6688,0.01,0.21
"KEGG_pathway:HSA04913_OVARIAN_STEROIDOGENESIS","KEGG_pathway","HSA04913_OVARIAN_STEROIDOGENESIS",50,-2.021,0,0.00021,-0.8091,0.81,1,-1.1769,0.2,0.41
"C4_Cancer_modules:C4_CM_199_MODULE_212","C4_Cancer_modules","C4_CM_199_MODULE_212",321,-2.0209,0,4e-04,1.1262,0.13,0.49,-1.7716,0,0.055
"C7_Immunologic_signatures:C7_ALL_1851_GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1851_GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP",197,-2.0207,0,0,0.68,1,1,-0.8948,0.79,0.96
"GO_BP:489316_GO_0050832_DEFENSE_RESPONSE_TO_FUNGUS","GO_BP","489316_GO_0050832_DEFENSE_RESPONSE_TO_FUNGUS",24,-2.0205,0,0.0024,1.5919,0.019,0.3,1.4513,0.05,0.58
"KEGG_compound:C04438_1_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_L_2_LYSOPHOSPHATIDYLETHANOLAMINE","KEGG_compound","C04438_1_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_L_2_LYSOPHOSPHATIDYLETHANOLAMINE",25,-2.0205,0,0.00081,-0.8123,0.73,1,-0.7143,0.91,0.91
"GO_BP:1129359_GO_1903532_POSITIVE_REGULATION_OF_SECRETION_BY_CELL","GO_BP","1129359_GO_1903532_POSITIVE_REGULATION_OF_SECRETION_BY_CELL",268,-2.0204,0,0.0024,0.8544,0.92,1,-1.0591,0.27,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_325_GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_325_GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN",11,-2.0199,0.0017,0.00071,-0.6177,0.94,1,-1.4889,0.064,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_3276_PLASARI_TGFB1_TARGETS_10HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3276_PLASARI_TGFB1_TARGETS_10HR_UP",193,-2.0198,0,0.00071,-1.3914,0.014,0.59,1.1797,0.1,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2321_MATZUK_CUMULUS_EXPANSION","C2_Chemical_and_genetic_perturbations","C2_CGP_2321_MATZUK_CUMULUS_EXPANSION",9,-2.0197,0,0.00071,-1.4245,0.087,0.55,-1.0254,0.4,0.72
"C7_Immunologic_signatures:C7_ALL_1072_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN","C7_Immunologic_signatures","C7_ALL_1072_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN",199,-2.0192,0,0,0.9272,0.65,0.96,-1.5136,0.0022,0.018
"GO_CC:1025319_GO_0044853_PLASMA_MEMBRANE_RAFT","GO_CC","1025319_GO_0044853_PLASMA_MEMBRANE_RAFT",70,-2.0186,0,0.0025,-0.9001,0.64,0.96,-1.2353,0.13,0.74
"KEGG_pathway:HSA00591_LINOLEIC_ACID_METABOLISM","KEGG_pathway","HSA00591_LINOLEIC_ACID_METABOLISM",26,-2.0186,0,2e-04,-0.9191,0.56,0.96,1.0393,0.38,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1590_BRUNO_HEMATOPOIESIS","C2_Chemical_and_genetic_perturbations","C2_CGP_1590_BRUNO_HEMATOPOIESIS",64,-2.0183,0,0.00072,0.8399,0.8,0.98,-1.2528,0.095,0.47
"C4_Cancer_modules:C4_CM_34_MODULE_38","C4_Cancer_modules","C4_CM_34_MODULE_38",449,-2.0182,0,0.00042,-1.3408,0.0049,0.49,0.9959,0.47,0.95
"C7_Immunologic_signatures:C7_ALL_962_GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN","C7_Immunologic_signatures","C7_ALL_962_GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN",198,-2.0171,0,0,0.8638,0.84,1,1.3831,0.0061,0.16
"C2_Chemical_and_genetic_perturbations:C2_CGP_385_GESERICK_TERT_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_385_GESERICK_TERT_TARGETS_DN",21,-2.0168,0,0.00073,-1.7228,0.011,0.34,-1.2356,0.19,0.49
"C2_Chemical_and_genetic_perturbations:C2_CGP_1999_KRIGE_AMINO_ACID_DEPRIVATION","C2_Chemical_and_genetic_perturbations","C2_CGP_1999_KRIGE_AMINO_ACID_DEPRIVATION",28,-2.0158,0,0.00073,-1.5461,0.025,0.44,-1.4135,0.078,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_1619_SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A","C2_Chemical_and_genetic_perturbations","C2_CGP_1619_SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A",22,-2.0154,0,0.00073,-1.4323,0.085,0.54,-1.1137,0.3,0.61
"GO_BP:502884_GO_0044130_NEGATIVE_REGULATION_OF_GROWTH_OF_SYMBIONT_IN_HOST","GO_BP","502884_GO_0044130_NEGATIVE_REGULATION_OF_GROWTH_OF_SYMBIONT_IN_HOST",14,-2.0153,0,0.0026,-0.8067,0.74,1,-1.3753,0.091,0.59
"C7_Immunologic_signatures:C7_ALL_54_GSE10325_MYELOID_VS_LUPUS_MYELOID_DN","C7_Immunologic_signatures","C7_ALL_54_GSE10325_MYELOID_VS_LUPUS_MYELOID_DN",199,-2.0152,0,0,1.4891,0,0.014,-1.0447,0.34,0.62
"C7_Immunologic_signatures:C7_ALL_338_GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_338_GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN",198,-2.0149,0,0,-0.9938,0.46,1,-0.9008,0.75,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_3141_MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3141_MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP",254,-2.0148,0,0.00073,-1.1005,0.2,0.91,-1.1092,0.21,0.62
"C4_Cancer_modules:C4_CM_283_MODULE_324","C4_Cancer_modules","C4_CM_283_MODULE_324",130,-2.014,0,0.00048,0.8569,0.81,0.91,1.0524,0.33,0.86
"C7_Immunologic_signatures:C7_ALL_1551_GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1551_GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP",198,-2.0139,0,0,-0.911,0.7,1,-1.9242,0,0
"GO_BP:511689_GO_0050718_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_SECRETION","GO_BP","511689_GO_0050718_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_SECRETION",18,-2.0136,0,0.0026,-1.0833,0.34,0.96,-1.1195,0.3,0.76
"GO_BP:499536_GO_0030100_REGULATION_OF_ENDOCYTOSIS","GO_BP","499536_GO_0030100_REGULATION_OF_ENDOCYTOSIS",171,-2.0122,0,0.0027,-0.8056,0.92,1,0.9654,0.55,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_3385_ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF","C2_Chemical_and_genetic_perturbations","C2_CGP_3385_ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF",216,-2.0118,0,0.00075,-0.9392,0.62,1,-0.9415,0.65,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1342_LEE_LIVER_CANCER_ACOX1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1342_LEE_LIVER_CANCER_ACOX1_UP",63,-2.0118,0,0.00076,1.3701,0.057,0.32,0.9705,0.53,0.96
"GO_CC:505527_GO_0042383_SARCOLEMMA","GO_CC","505527_GO_0042383_SARCOLEMMA",99,-2.0117,0,0.0028,-1.2873,0.068,0.66,-1.3861,0.032,0.6
"C4_Cancer_modules:C4_CM_164_MODULE_174","C4_Cancer_modules","C4_CM_164_MODULE_174",95,-2.0116,0,5e-04,0.9857,0.49,0.72,-1.1638,0.18,0.44
"GO_BP:507985_GO_0045637_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION","GO_BP","507985_GO_0045637_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION",179,-2.0105,0,0.0027,-1.0443,0.35,0.97,-1.176,0.11,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2272_SMID_BREAST_CANCER_NORMAL_LIKE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2272_SMID_BREAST_CANCER_NORMAL_LIKE_UP",455,-2.0099,0,0.00079,0.9913,0.45,0.81,-1.4357,0,0.34
"C7_Immunologic_signatures:C7_ALL_1141_GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP","C7_Immunologic_signatures","C7_ALL_1141_GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP",197,-2.009,0,0,1.2436,0.073,0.16,-2.1483,0,0
"C7_Immunologic_signatures:C7_ALL_1092_GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1092_GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN",177,-2.0082,0,0,-0.9235,0.67,1,-1.0805,0.26,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1579_IGLESIAS_E2F_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1579_IGLESIAS_E2F_TARGETS_UP",149,-2.0081,0,0.00079,1.3064,0.042,0.39,-1.2254,0.092,0.5
"C7_Immunologic_signatures:C7_ALL_1787_GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1787_GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP",198,-2.0077,0,0,-0.6827,1,1,-0.8589,0.86,1
"GO_BP:494695_GO_0010631_EPITHELIAL_CELL_MIGRATION","GO_BP","494695_GO_0010631_EPITHELIAL_CELL_MIGRATION",69,-2.0073,0,0.0029,-1.063,0.34,0.96,-0.932,0.58,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1555_NAKAJIMA_MAST_CELL","C2_Chemical_and_genetic_perturbations","C2_CGP_1555_NAKAJIMA_MAST_CELL",46,-2.0067,0,0.00081,-0.8474,0.73,1,-0.9765,0.5,0.79
"WikiPathways:739007_WP2431_SPINAL_CORD_INJURY","WikiPathways","739007_WP2431_SPINAL_CORD_INJURY",109,-2.0066,0,0.0027,-1.2019,0.14,0.81,-1.3028,0.054,0.44
"C4_Cancer_modules:C4_CM_205_MODULE_220","C4_Cancer_modules","C4_CM_205_MODULE_220",317,-2.0064,0,0.00048,-1.0779,0.24,0.68,-1.3336,0,0.27
"GO_BP:488692_GO_0002819_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE","GO_BP","488692_GO_0002819_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE",120,-2.0064,0,0.003,-1.3314,0.044,0.9,-1.4543,0.0099,0.54
"GO_BP:751069_GO_0036149_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING","GO_BP","751069_GO_0036149_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING",14,-2.0062,0,0.003,0.7728,0.76,1,1.0279,0.42,0.82
"KEGG_pathway:HSA05140_LEISHMANIASIS","KEGG_pathway","HSA05140_LEISHMANIASIS",70,-2.0059,0,0.00019,-1.4353,0.02,0.38,-0.9785,0.48,0.73
"KEGG_compound:C00735_CORTISOL_HYDROCORTISONE_11BETA_17ALPHA_21_TRIHYDROXY_4_PREGNENE_3_20_DIONE_KENDALL_S_COMPOUND_F_REICHSTEIN_S_SUBSTANCE_M","KEGG_compound","C00735_CORTISOL_HYDROCORTISONE_11BETA_17ALPHA_21_TRIHYDROXY_4_PREGNENE_3_20_DIONE_KENDALL_S_COMPOUND_F_REICHSTEIN_S_SUBSTANCE_M",8,-2.0057,0,0.00094,0.5818,0.95,1,1.157,0.29,0.61
"GO_BP:511749_GO_0050778_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE","GO_BP","511749_GO_0050778_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE",481,-2.0052,0,0.003,-0.8057,0.99,1,-1.3672,0,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_1251_ROZANOV_MMP14_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1251_ROZANOV_MMP14_TARGETS_DN",35,-2.0049,0,0.00085,1.2782,0.12,0.42,1.1245,0.28,0.85
"KEGG_pathway:HSA04540_GAP_JUNCTION","KEGG_pathway","HSA04540_GAP_JUNCTION",88,-2.0047,0,0.00018,-0.852,0.75,1,-1.3901,0.041,0.18
"C4_Cancer_modules:C4_CM_14_MODULE_15","C4_Cancer_modules","C4_CM_14_MODULE_15",354,-2.0045,0,0.00047,1.104,0.19,0.54,-1.4586,0,0.18
"C6_Oncogenic_signatures:C6_ALL_156_STK33_SKM_UP","C6_Oncogenic_signatures","C6_ALL_156_STK33_SKM_UP",275,-2.0043,0,0.00019,-1.1018,0.21,0.57,1.2024,0.06,0.27
"C2_Chemical_and_genetic_perturbations:C2_CGP_1790_BURTON_ADIPOGENESIS_8","C2_Chemical_and_genetic_perturbations","C2_CGP_1790_BURTON_ADIPOGENESIS_8",86,-2.0041,0,0.00088,1.2265,0.13,0.46,0.7517,0.94,1
"GO_BP:488630_GO_0002757_IMMUNE_RESPONSE_ACTIVATING_SIGNAL_TRANSDUCTION","GO_BP","488630_GO_0002757_IMMUNE_RESPONSE_ACTIVATING_SIGNAL_TRANSDUCTION",300,-2.0041,0,0.003,-0.708,1,1,-1.3601,0,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_774_DAUER_STAT3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_774_DAUER_STAT3_TARGETS_UP",47,-2.004,0,0.00088,-0.8293,0.75,1,1.2813,0.13,0.7
"GO_BP:487572_GO_0001659_TEMPERATURE_HOMEOSTASIS","GO_BP","487572_GO_0001659_TEMPERATURE_HOMEOSTASIS",26,-2.0038,0,0.003,-1.2139,0.21,0.88,0.8722,0.65,0.96
"GO_BP:488123_GO_0002250_ADAPTIVE_IMMUNE_RESPONSE","GO_BP","488123_GO_0002250_ADAPTIVE_IMMUNE_RESPONSE",148,-2.0038,0,0.003,-0.7149,0.99,1,-1.1399,0.16,0.75
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_98_BIOCARTA_IL12_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_98_BIOCARTA_IL12_PATHWAY",21,-2.0037,0.0016,0.0031,-0.8099,0.75,1,-0.9729,0.49,0.78
"C4_Cancer_modules:C4_CM_230_MODULE_254","C4_Cancer_modules","C4_CM_230_MODULE_254",58,-2.0036,0,0.00052,1.0799,0.32,0.58,-1.2487,0.12,0.33
"GO_BP:515306_GO_0070374_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE","GO_BP","515306_GO_0070374_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE",117,-2.0035,0,0.003,-1.0814,0.31,0.95,1.4578,0.0081,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_307_KIM_WT1_TARGETS_8HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_307_KIM_WT1_TARGETS_8HR_UP",161,-2.0035,0,0.00088,-1.1921,0.12,0.81,-1.3599,0.02,0.39
"REACTOME:1183554_REACT_355442_DECTIN_2_FAMILY","REACTOME","1183554_REACT_355442_DECTIN_2_FAMILY",10,-2.0031,0,0.0048,-1.0009,0.48,0.99,-1.5081,0.065,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_979_GROSS_HYPOXIA_VIA_ELK3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_979_GROSS_HYPOXIA_VIA_ELK3_DN",156,-2.0031,0,0.00088,-0.8146,0.89,1,0.9615,0.55,0.98
"GO_BP:511699_GO_0050728_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE","GO_BP","511699_GO_0050728_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE",87,-2.0025,0,0.003,0.813,0.85,1,0.7698,0.93,1
"GO_MF:499638_GO_0030228_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY","GO_MF","499638_GO_0030228_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY",14,-2.0024,0,0.01,0.7396,0.84,1,1.0425,0.4,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_2664_CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2664_CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP",39,-2.0023,0,0.00088,-0.797,0.79,1,-1.1316,0.27,0.59
"GO_BP:754636_GO_1901685_GLUTATHIONE_DERIVATIVE_METABOLIC_PROCESS","GO_BP","754636_GO_1901685_GLUTATHIONE_DERIVATIVE_METABOLIC_PROCESS",24,-2.0022,0,0.003,-1.8708,0,0.43,-1.7822,0.012,0.58
"GO_MF:490289_GO_0005003_EPHRIN_RECEPTOR_ACTIVITY","GO_MF","490289_GO_0005003_EPHRIN_RECEPTOR_ACTIVITY",17,-2.002,0,0.0094,-1.2212,0.22,0.85,-1.4676,0.045,0.42
"GO_BP:808776_GO_1902105_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION","GO_BP","808776_GO_1902105_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION",223,-2.0019,0,0.003,-1.069,0.3,0.96,-1.0559,0.31,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_1375_LEE_LIVER_CANCER_MYC_E2F1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1375_LEE_LIVER_CANCER_MYC_E2F1_UP",53,-2.0011,0,0.00088,1.0565,0.37,0.7,-1.0895,0.29,0.64
"GO_BP:511972_GO_0051047_POSITIVE_REGULATION_OF_SECRETION","GO_BP","511972_GO_0051047_POSITIVE_REGULATION_OF_SECRETION",298,-2.0009,0,0.003,0.9192,0.76,1,-0.9654,0.56,0.88
"GO_BP:487464_GO_0001525_ANGIOGENESIS","GO_BP","487464_GO_0001525_ANGIOGENESIS",281,-2.0003,0,0.0031,-1.1336,0.18,0.93,1.2754,0.031,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1435_LEE_LIVER_CANCER_E2F1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1435_LEE_LIVER_CANCER_E2F1_UP",60,-2.0001,0,0.00091,1.2889,0.072,0.4,-1.3284,0.077,0.41
"C6_Oncogenic_signatures:C6_ALL_157_STK33_UP","C6_Oncogenic_signatures","C6_ALL_157_STK33_UP",280,-1.9999,0,0.00016,-0.9089,0.74,0.86,1.3985,0.0019,0.12
"C2_Chemical_and_genetic_perturbations:C2_CGP_2423_ALONSO_METASTASIS_EMT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2423_ALONSO_METASTASIS_EMT_UP",36,-1.9995,0,0.00092,1.1728,0.22,0.53,0.8952,0.62,1
"GO_BP:1184542_GO_1904018_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT","GO_BP","1184542_GO_1904018_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT",119,-1.999,0,0.0031,1.0922,0.28,0.91,1.2819,0.05,0.69
"C4_Cancer_modules:C4_CM_403_MODULE_516","C4_Cancer_modules","C4_CM_403_MODULE_516",14,-1.9979,0,0.00053,-0.5061,0.99,1,0.9673,0.49,0.97
"C4_Cancer_gene_neighborhoods:C4_CGN_294_GNF2_CCNB2","C4_Cancer_gene_neighborhoods","C4_CGN_294_GNF2_CCNB2",57,-1.9978,0,0.00029,-0.92,0.62,0.99,-1.9125,0,0.0071
"C7_Immunologic_signatures:C7_ALL_1818_GSE7852_THYMUS_VS_FAT_TREG_DN","C7_Immunologic_signatures","C7_ALL_1818_GSE7852_THYMUS_VS_FAT_TREG_DN",200,-1.9977,0,0,-1.2884,0.033,0.51,-1.1668,0.12,0.34
"C7_Immunologic_signatures:C7_ALL_892_GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN","C7_Immunologic_signatures","C7_ALL_892_GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN",195,-1.9976,0,0,-0.9515,0.6,1,-1.1745,0.1,0.33
"GO_BP:514551_GO_0060996_DENDRITIC_SPINE_DEVELOPMENT","GO_BP","514551_GO_0060996_DENDRITIC_SPINE_DEVELOPMENT",11,-1.9971,0,0.0033,-1.2029,0.25,0.89,-1.0305,0.42,0.82
"GO_BP:506362_GO_0043302_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION","GO_BP","506362_GO_0043302_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION",17,-1.9971,0,0.0032,0.9989,0.43,0.98,-0.9548,0.51,0.89
"KEGG_pathway:HSA05130_PATHOGENIC_ESCHERICHIA_COLI_INFECTION","KEGG_pathway","HSA05130_PATHOGENIC_ESCHERICHIA_COLI_INFECTION",55,-1.9968,0,0.00017,0.9893,0.45,0.91,-1.1263,0.25,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_3016_BROWNE_HCMV_INFECTION_2HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3016_BROWNE_HCMV_INFECTION_2HR_DN",47,-1.9964,0,0.00097,-1.2263,0.17,0.78,-0.947,0.55,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1389_CHEOK_RESPONSE_TO_HD_MTX_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1389_CHEOK_RESPONSE_TO_HD_MTX_UP",22,-1.9963,0,0.00097,0.7988,0.76,0.99,-0.7614,0.81,0.97
"GO_BP:1129532_GO_1903708_POSITIVE_REGULATION_OF_HEMOPOIESIS","GO_BP","1129532_GO_1903708_POSITIVE_REGULATION_OF_HEMOPOIESIS",153,-1.996,0,0.0032,-1.1713,0.15,0.91,-1.3084,0.056,0.64
"C7_Immunologic_signatures:C7_ALL_1686_GSE3982_BCELL_VS_TH2_DN","C7_Immunologic_signatures","C7_ALL_1686_GSE3982_BCELL_VS_TH2_DN",194,-1.9956,0,0,0.8948,0.78,1,-1.0662,0.29,0.58
"C7_Immunologic_signatures:C7_ALL_1037_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP","C7_Immunologic_signatures","C7_ALL_1037_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP",198,-1.9946,0,0,0.8195,0.95,1,-1.1446,0.14,0.38
"C7_Immunologic_signatures:C7_ALL_1661_GSE3982_NEUTROPHIL_VS_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1661_GSE3982_NEUTROPHIL_VS_BCELL_UP",191,-1.9942,0,0,1.2183,0.092,0.2,0.9703,0.54,1
"C4_Cancer_gene_neighborhoods:C4_CGN_383_GNF2_MSN","C4_Cancer_gene_neighborhoods","C4_CGN_383_GNF2_MSN",24,-1.9942,0,0.00028,0.7175,0.9,1,-0.5922,0.98,1
"GO_MF:490168_GO_0004867_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY","GO_MF","490168_GO_0004867_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY",88,-1.9936,0,0.011,-1.2558,0.096,0.84,1.4511,0.0099,0.5
"C2_Chemical_and_genetic_perturbations:C2_CGP_2356_LABBE_TGFB1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2356_LABBE_TGFB1_TARGETS_DN",98,-1.9933,0,0.001,-0.961,0.52,1,0.7967,0.9,1
"C4_Cancer_gene_neighborhoods:C4_CGN_399_GNF2_RAB7L1","C4_Cancer_gene_neighborhoods","C4_CGN_399_GNF2_RAB7L1",33,-1.9922,0,0.00027,0.9854,0.47,0.61,-1.5968,0.015,0.075
"C2_Chemical_and_genetic_perturbations:C2_CGP_1239_ONDER_CDH1_TARGETS_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1239_ONDER_CDH1_TARGETS_2_DN",452,-1.9914,0,0.001,-1.2289,0.03,0.77,1.2551,0.013,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_422_MARKEY_RB1_CHRONIC_LOF_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_422_MARKEY_RB1_CHRONIC_LOF_DN",116,-1.9914,0,0.001,-0.9256,0.63,1,-1.059,0.3,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_2062_GAVIN_FOXP3_TARGETS_CLUSTER_P4","C2_Chemical_and_genetic_perturbations","C2_CGP_2062_GAVIN_FOXP3_TARGETS_CLUSTER_P4",99,-1.9909,0,0.001,-0.4976,1,1,-1.0223,0.39,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_3249_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1","C2_Chemical_and_genetic_perturbations","C2_CGP_3249_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1",46,-1.9902,0,0.0011,-1.6973,0.011,0.33,1.0465,0.38,0.93
"GO_BP:511815_GO_0050873_BROWN_FAT_CELL_DIFFERENTIATION","GO_BP","511815_GO_0050873_BROWN_FAT_CELL_DIFFERENTIATION",32,-1.99,0,0.0037,-0.806,0.79,1,-1.1931,0.2,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_1462_ALCALAY_AML_BY_NPM1_LOCALIZATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1462_ALCALAY_AML_BY_NPM1_LOCALIZATION_UP",138,-1.9894,0,0.0011,0.9853,0.48,0.81,-1.0624,0.3,0.68
"KEGG_pathway:HSA05412_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_","KEGG_pathway","HSA05412_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC_",74,-1.9891,0,0.00027,-1.375,0.045,0.35,-0.8824,0.69,0.87
"KEGG_pathway:HSA00592_ALPHA_LINOLENIC_ACID_METABOLISM","KEGG_pathway","HSA00592_ALPHA_LINOLENIC_ACID_METABOLISM",22,-1.9891,0,0.00026,-0.8956,0.61,0.96,-1.4538,0.068,0.15
"GO_BP:911400_GO_0098542_DEFENSE_RESPONSE_TO_OTHER_ORGANISM","GO_BP","911400_GO_0098542_DEFENSE_RESPONSE_TO_OTHER_ORGANISM",307,-1.9887,0,0.0038,1.2866,0.0074,0.69,-1.2024,0.053,0.73
"C6_Oncogenic_signatures:C6_ALL_161_KRAS_DF_V1_UP","C6_Oncogenic_signatures","C6_ALL_161_KRAS_DF_V1_UP",188,-1.9887,0,0.00014,-1.1812,0.12,0.48,-1.4371,0.0084,0.16
"C2_Chemical_and_genetic_perturbations:C2_CGP_2843_BOYLAN_MULTIPLE_MYELOMA_PCA1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2843_BOYLAN_MULTIPLE_MYELOMA_PCA1_UP",98,-1.9882,0,0.0011,1.0659,0.32,0.68,-0.9616,0.54,0.8
"GO_CC:487622_GO_0005882_INTERMEDIATE_FILAMENT","GO_CC","487622_GO_0005882_INTERMEDIATE_FILAMENT",136,-1.9881,0,0.0046,1.265,0.063,0.45,1.8679,0,0.13
"REACTOME:160140_REACT_22232_SIGNALING_BY_INTERLEUKINS","REACTOME","160140_REACT_22232_SIGNALING_BY_INTERLEUKINS",111,-1.9876,0,0.0063,-0.632,0.99,1,-1.1053,0.24,0.7
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_57_BIOCARTA_MTA3_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_57_BIOCARTA_MTA3_PATHWAY",19,-1.9876,0,0.0038,-0.8741,0.62,1,-1.6147,0.029,0.34
"GO_BP:487715_GO_0001819_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION","GO_BP","487715_GO_0001819_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION",336,-1.9876,0,0.0038,-0.8145,0.95,1,-1.2481,0.025,0.68
"GO_BP:508018_GO_0045670_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION","GO_BP","508018_GO_0045670_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION",57,-1.9874,0,0.0038,-1.2763,0.12,0.89,1.0954,0.29,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_242_MULLIGHAN_MLL_SIGNATURE_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_242_MULLIGHAN_MLL_SIGNATURE_1_UP",380,-1.9874,0,0.0011,0.6634,1,1,-1.1315,0.094,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2707_BOYAULT_LIVER_CANCER_SUBCLASS_G2","C2_Chemical_and_genetic_perturbations","C2_CGP_2707_BOYAULT_LIVER_CANCER_SUBCLASS_G2",27,-1.9873,0,0.0011,-0.6454,0.95,1,-1.0983,0.31,0.63
"GO_BP:516149_GO_0071223_CELLULAR_RESPONSE_TO_LIPOTEICHOIC_ACID","GO_BP","516149_GO_0071223_CELLULAR_RESPONSE_TO_LIPOTEICHOIC_ACID",8,-1.9871,0,0.0038,-1.6326,0.025,0.7,-1.1757,0.25,0.73
"WikiPathways:920975_WP2447_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS_","WikiPathways","920975_WP2447_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS_",34,-1.9865,0.0014,0.0033,-0.8332,0.71,1,-1.3953,0.058,0.41
"GO_CC:490923_GO_0005924_CELL_SUBSTRATE_ADHERENS_JUNCTION","GO_CC","490923_GO_0005924_CELL_SUBSTRATE_ADHERENS_JUNCTION",388,-1.9862,0,0.0044,1.6639,0,0.081,-0.9061,0.83,1
"GO_BP:491744_GO_0006883_CELLULAR_SODIUM_ION_HOMEOSTASIS","GO_BP","491744_GO_0006883_CELLULAR_SODIUM_ION_HOMEOSTASIS",14,-1.9854,0,0.0039,-1.452,0.081,0.9,-1.7277,0.0059,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_132_CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_132_CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN",449,-1.9854,0,0.0011,0.9975,0.47,0.8,1.0431,0.31,0.92
"GO_BP:500540_GO_0031281_POSITIVE_REGULATION_OF_CYCLASE_ACTIVITY","GO_BP","500540_GO_0031281_POSITIVE_REGULATION_OF_CYCLASE_ACTIVITY",68,-1.985,0,0.0039,-0.9754,0.51,1,1.1327,0.24,0.74
"GO_CC:490892_GO_0005890_SODIUM_POTASSIUM_EXCHANGING_ATPASE_COMPLEX","GO_CC","490892_GO_0005890_SODIUM_POTASSIUM_EXCHANGING_ATPASE_COMPLEX",11,-1.9848,0,0.0043,-1.3965,0.1,0.63,-1.935,0,0.26
"WikiPathways:198770_WP127_IL_5_SIGNALING_PATHWAY","WikiPathways","198770_WP127_IL_5_SIGNALING_PATHWAY",69,-1.9847,0,0.0029,-0.56,1,1,-1.1613,0.2,0.58
"C7_Immunologic_signatures:C7_ALL_1892_GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN","C7_Immunologic_signatures","C7_ALL_1892_GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN",199,-1.9846,0,0,-0.946,0.61,1,-1.3117,0.015,0.13
"GO_BP:488635_GO_0002762_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION","GO_BP","488635_GO_0002762_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION",41,-1.9844,0,0.0039,-0.9161,0.56,1,1.284,0.13,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2406_HUANG_DASATINIB_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2406_HUANG_DASATINIB_RESISTANCE_UP",80,-1.9843,0,0.0011,1.0166,0.42,0.78,1.1905,0.14,0.78
"C7_Immunologic_signatures:C7_ALL_1601_GSE3982_EOSINOPHIL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1601_GSE3982_EOSINOPHIL_VS_NKCELL_UP",193,-1.9842,0,0,0.8378,0.89,1,-1.02,0.38,0.68
"GO_MF:490169_GO_0004869_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY","GO_MF","490169_GO_0004869_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY",47,-1.984,0,0.012,0.9777,0.47,0.9,0.9301,0.61,0.94
"GO_BP:487713_GO_0001817_REGULATION_OF_CYTOKINE_PRODUCTION","GO_BP","487713_GO_0001817_REGULATION_OF_CYTOKINE_PRODUCTION",498,-1.9836,0,0.0039,0.9049,0.87,1,-1.2684,0.0022,0.66
"KEGG_pathway:HSA05164_INFLUENZA_A","KEGG_pathway","HSA05164_INFLUENZA_A",167,-1.9836,0,0.00029,-1.133,0.18,0.65,-1.824,0,0.02
"GO_BP:507476_GO_0045076_REGULATION_OF_INTERLEUKIN_2_BIOSYNTHETIC_PROCESS","GO_BP","507476_GO_0045076_REGULATION_OF_INTERLEUKIN_2_BIOSYNTHETIC_PROCESS",18,-1.9835,0.0015,0.0039,-1.0122,0.47,0.98,-1.3223,0.13,0.63
"GO_BP:1129530_GO_1903706_REGULATION_OF_HEMOPOIESIS","GO_BP","1129530_GO_1903706_REGULATION_OF_HEMOPOIESIS",301,-1.9834,0,0.0039,-1.1184,0.18,0.94,-1.1111,0.17,0.76
"GO_BP:488329_GO_0002456_T_CELL_MEDIATED_IMMUNITY","GO_BP","488329_GO_0002456_T_CELL_MEDIATED_IMMUNITY",25,-1.9833,0,0.0038,-0.8617,0.65,1,-1.5034,0.033,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2785_MARSON_FOXP3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2785_MARSON_FOXP3_TARGETS_UP",66,-1.9827,0,0.0011,0.7464,0.95,1,-0.9529,0.56,0.82
"C4_Cancer_modules:C4_CM_23_MODULE_24","C4_Cancer_modules","C4_CM_23_MODULE_24",438,-1.9822,0,0.00067,-1.1606,0.095,0.63,-1.238,0.027,0.35
"GO_BP:514224_GO_0060669_EMBRYONIC_PLACENTA_MORPHOGENESIS","GO_BP","514224_GO_0060669_EMBRYONIC_PLACENTA_MORPHOGENESIS",24,-1.9822,0.0014,0.0039,-1.4842,0.035,0.83,-1.329,0.1,0.62
"C4_Cancer_modules:C4_CM_6_MODULE_6","C4_Cancer_modules","C4_CM_6_MODULE_6",397,-1.982,0,0.00065,-1.1512,0.097,0.63,-0.9809,0.51,0.72
"GO_BP:754304_GO_1901342_REGULATION_OF_VASCULATURE_DEVELOPMENT","GO_BP","754304_GO_1901342_REGULATION_OF_VASCULATURE_DEVELOPMENT",207,-1.9814,0,0.0039,0.9416,0.62,1,1.1528,0.13,0.73
"GO_BP:501661_GO_0032429_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY","GO_BP","501661_GO_0032429_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY",10,-1.9814,0,0.0039,-0.9803,0.49,1,-1.1769,0.26,0.74
"GO_BP:504902_GO_0035725_SODIUM_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","504902_GO_0035725_SODIUM_ION_TRANSMEMBRANE_TRANSPORT",83,-1.9801,0,0.004,-1.6176,0,0.7,-1.2875,0.071,0.65
"GO_CC:495323_GO_0031225_ANCHORED_COMPONENT_OF_MEMBRANE","GO_CC","495323_GO_0031225_ANCHORED_COMPONENT_OF_MEMBRANE",141,-1.9794,0,0.0044,1.2709,0.063,0.44,1.5353,0.002,0.54
"C6_Oncogenic_signatures:C6_ALL_6_EGFR_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_6_EGFR_UP_V1_UP",192,-1.9777,0,0.00013,-0.8592,0.83,0.95,1.1019,0.23,0.37
"C2_Chemical_and_genetic_perturbations:C2_CGP_1983_JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1983_JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP",31,-1.9777,0,0.0012,0.9915,0.47,0.81,-0.7824,0.81,0.96
"GO_BP:496142_GO_0016042_LIPID_CATABOLIC_PROCESS","GO_BP","496142_GO_0016042_LIPID_CATABOLIC_PROCESS",229,-1.9773,0,0.0041,0.9602,0.58,1,-1.0195,0.39,0.83
"GO_CC:490924_GO_0005925_FOCAL_ADHESION","GO_CC","490924_GO_0005925_FOCAL_ADHESION",384,-1.9773,0,0.0041,1.6646,0,0.082,-0.8905,0.87,1
"GO_BP:505489_GO_0042345_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS","GO_BP","505489_GO_0042345_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS",40,-1.9771,0,0.0041,-0.9818,0.48,1,-1.2885,0.12,0.65
"GO_BP:751341_GO_0038083_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION","GO_BP","751341_GO_0038083_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION",38,-1.9765,0,0.0041,-1.0473,0.38,0.97,-1.2491,0.13,0.68
"C7_Immunologic_signatures:C7_ALL_1449_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP","C7_Immunologic_signatures","C7_ALL_1449_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP",196,-1.9764,0,0,0.7923,0.96,1,-0.7943,0.97,1
"C7_Immunologic_signatures:C7_ALL_1029_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP","C7_Immunologic_signatures","C7_ALL_1029_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP",196,-1.9762,0,0,-0.6954,0.99,1,-1.0653,0.28,0.58
"REACTOME:1127695_REACT_264198_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS","REACTOME","1127695_REACT_264198_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS",48,-1.9754,0.0013,0.0071,-0.83,0.78,1,-1.5157,0.028,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_2662_CROONQUIST_NRAS_SIGNALING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2662_CROONQUIST_NRAS_SIGNALING_UP",40,-1.9751,0,0.0013,0.9889,0.47,0.81,1.012,0.43,0.96
"C7_Immunologic_signatures:C7_ALL_1816_GSE7852_LN_VS_FAT_TREG_DN","C7_Immunologic_signatures","C7_ALL_1816_GSE7852_LN_VS_FAT_TREG_DN",198,-1.9748,0,0,-1.1442,0.16,1,-1.0914,0.24,0.52
"C7_Immunologic_signatures:C7_ALL_1910_GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN","C7_Immunologic_signatures","C7_ALL_1910_GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN",199,-1.9746,0,0,-0.7395,0.99,1,-0.8033,0.95,1
"C4_Cancer_modules:C4_CM_36_MODULE_40","C4_Cancer_modules","C4_CM_36_MODULE_40",80,-1.9737,0,0.00088,0.9191,0.63,0.82,-1.6844,0,0.081
"GO_BP:488588_GO_0002715_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY","GO_BP","488588_GO_0002715_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY",29,-1.9734,0,0.0043,-0.721,0.88,1,-0.9264,0.56,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2857_CAIRO_LIVER_DEVELOPMENT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2857_CAIRO_LIVER_DEVELOPMENT_DN",214,-1.9727,0,0.0014,-1.0745,0.27,0.95,-1.3474,0.023,0.4
"GO_BP:503898_GO_0034698_RESPONSE_TO_GONADOTROPIN","GO_BP","503898_GO_0034698_RESPONSE_TO_GONADOTROPIN",27,-1.9725,0,0.0043,-1.3444,0.11,0.92,1.0554,0.34,0.8
"GO_BP:751849_GO_0044706_MULTI_MULTICELLULAR_ORGANISM_PROCESS","GO_BP","751849_GO_0044706_MULTI_MULTICELLULAR_ORGANISM_PROCESS",220,-1.9725,0,0.0043,-1.2755,0.049,0.89,-1.0322,0.33,0.82
"GO_BP:491581_GO_0006693_PROSTAGLANDIN_METABOLIC_PROCESS","GO_BP","491581_GO_0006693_PROSTAGLANDIN_METABOLIC_PROCESS",27,-1.9723,0,0.0043,-0.715,0.88,1,-0.9482,0.53,0.89
"C4_Cancer_modules:C4_CM_13_MODULE_14","C4_Cancer_modules","C4_CM_13_MODULE_14",12,-1.9719,0.0016,0.00086,-0.5178,0.99,1,0.8845,0.63,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2351_BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2351_BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP",420,-1.9718,0,0.0014,0.9906,0.49,0.81,1.014,0.38,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_328_GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_328_GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP",55,-1.9715,0,0.0014,-1.0396,0.38,0.97,-1.4847,0.028,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_367_LIU_CDX2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_367_LIU_CDX2_TARGETS_UP",35,-1.9712,0,0.0014,-1.1591,0.23,0.83,0.919,0.59,1
"C6_Oncogenic_signatures:C6_ALL_108_MEL18_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_108_MEL18_DN_V1_UP",139,-1.971,0,0.00011,-1.1913,0.14,0.47,1.3048,0.032,0.2
"C7_Immunologic_signatures:C7_ALL_1593_GSE3982_EOSINOPHIL_VS_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1593_GSE3982_EOSINOPHIL_VS_BCELL_UP",196,-1.9709,0,0,0.8199,0.9,1,-0.9415,0.62,0.87
"GO_BP:512752_GO_0051897_POSITIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING","GO_BP","512752_GO_0051897_POSITIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING",76,-1.9708,0,0.0044,-0.9719,0.5,1,0.855,0.76,0.98
"C4_Cancer_modules:C4_CM_312_MODULE_362","C4_Cancer_modules","C4_CM_312_MODULE_362",18,-1.9705,0,0.00087,0.5664,0.98,1,0.7093,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_73_DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_73_DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN",180,-1.9705,0,0.0014,-1.2404,0.088,0.75,1.1063,0.23,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1994_BILD_HRAS_ONCOGENIC_SIGNATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_1994_BILD_HRAS_ONCOGENIC_SIGNATURE",257,-1.9702,0,0.0014,-1.2781,0.028,0.71,1.1879,0.089,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2806_KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD","C2_Chemical_and_genetic_perturbations","C2_CGP_2806_KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD",20,-1.9701,0,0.0014,1.7476,0.0021,0.061,1.2946,0.12,0.69
"GO_BP:491764_GO_0006909_PHAGOCYTOSIS","GO_BP","491764_GO_0006909_PHAGOCYTOSIS",155,-1.9695,0,0.0044,0.699,0.99,1,-1.0618,0.3,0.8
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_176_BIOCARTA_TOB1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_176_BIOCARTA_TOB1_PATHWAY",19,-1.9692,0,0.0045,-0.7891,0.77,1,-1.5208,0.034,0.34
"REACTOME:645322_REACT_120977_HYDROLYSIS_OF_LPC","REACTOME","645322_REACT_120977_HYDROLYSIS_OF_LPC",8,-1.9691,0,0.0075,0.8974,0.59,0.91,1.2243,0.23,0.8
"KEGG_pathway:HSA00590_ARACHIDONIC_ACID_METABOLISM","KEGG_pathway","HSA00590_ARACHIDONIC_ACID_METABOLISM",58,-1.9688,0,0.00028,-0.8566,0.75,1,-1.1509,0.22,0.44
"C7_Immunologic_signatures:C7_ALL_1691_GSE3982_BASOPHIL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1691_GSE3982_BASOPHIL_VS_NKCELL_UP",192,-1.9685,0,0,1.3161,0.017,0.088,0.9748,0.53,1
"GO_BP:518270_GO_0090130_TISSUE_MIGRATION","GO_BP","518270_GO_0090130_TISSUE_MIGRATION",79,-1.9684,0,0.0045,-1.2304,0.13,0.89,-0.8973,0.66,0.93
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_128_BIOCARTA_NO2IL12_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_128_BIOCARTA_NO2IL12_PATHWAY",17,-1.9683,0,0.0042,0.9827,0.49,0.81,-1.0007,0.47,0.76
"C7_Immunologic_signatures:C7_ALL_1336_GSE30083_SP3_VS_SP4_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1336_GSE30083_SP3_VS_SP4_THYMOCYTE_DN",199,-1.9683,0,0,-0.573,1,1,0.9645,0.55,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1398_LEE_LIVER_CANCER_CIPROFIBRATE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1398_LEE_LIVER_CANCER_CIPROFIBRATE_UP",58,-1.9682,0,0.0014,0.9097,0.62,0.91,-1.0329,0.39,0.71
"C6_Oncogenic_signatures:C6_ALL_104_BMI1_DN_MEL18_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_104_BMI1_DN_MEL18_DN_V1_UP",143,-1.9681,0,1e-04,-1.1133,0.23,0.55,1.1121,0.22,0.35
"C7_Immunologic_signatures:C7_ALL_1020_GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1020_GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN",191,-1.968,0,0,-0.7812,0.97,1,-1.9296,0,0
"C4_Cancer_modules:C4_CM_1_MODULE_1","C4_Cancer_modules","C4_CM_1_MODULE_1",358,-1.9679,0,9e-04,-1.1959,0.065,0.61,1.0662,0.25,0.83
"GO_BP:508073_GO_0045730_RESPIRATORY_BURST","GO_BP","508073_GO_0045730_RESPIRATORY_BURST",14,-1.9676,0,0.0045,0.75,0.81,1,-1.0088,0.41,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_2867_HAHTOLA_CTCL_PATHOGENESIS","C2_Chemical_and_genetic_perturbations","C2_CGP_2867_HAHTOLA_CTCL_PATHOGENESIS",16,-1.9673,0.0032,0.0014,1.6749,0.023,0.097,0.5745,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1508_LENAOUR_DENDRITIC_CELL_MATURATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1508_LENAOUR_DENDRITIC_CELL_MATURATION_UP",110,-1.967,0,0.0014,-0.6974,0.99,1,-1.1132,0.23,0.61
"C4_Cancer_gene_neighborhoods:C4_CGN_290_GNF2_CENPE","C4_Cancer_gene_neighborhoods","C4_CGN_290_GNF2_CENPE",41,-1.9668,0,0.00038,-1.1273,0.28,0.7,-1.9129,0,0.0078
"GO_BP:518272_GO_0090132_EPITHELIUM_MIGRATION","GO_BP","518272_GO_0090132_EPITHELIUM_MIGRATION",71,-1.9664,0,0.0046,-1.1515,0.2,0.93,-0.977,0.49,0.87
"GO_CC:499503_GO_0030055_CELL_SUBSTRATE_JUNCTION","GO_CC","499503_GO_0030055_CELL_SUBSTRATE_JUNCTION",392,-1.9663,0,0.0046,1.6483,0,0.088,-0.9233,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1287_FERRANDO_TAL1_NEIGHBORS","C2_Chemical_and_genetic_perturbations","C2_CGP_1287_FERRANDO_TAL1_NEIGHBORS",20,-1.9662,0,0.0014,0.9328,0.55,0.89,0.9221,0.57,1
"GO_BP:512223_GO_0051339_REGULATION_OF_LYASE_ACTIVITY","GO_BP","512223_GO_0051339_REGULATION_OF_LYASE_ACTIVITY",141,-1.9661,0,0.0046,1.1095,0.2,0.89,1.1893,0.12,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2695_VALK_AML_WITH_CEBPA","C2_Chemical_and_genetic_perturbations","C2_CGP_2695_VALK_AML_WITH_CEBPA",35,-1.966,0,0.0014,0.9889,0.46,0.81,-0.8673,0.67,0.91
"GO_BP:491580_GO_0006692_PROSTANOID_METABOLIC_PROCESS","GO_BP","491580_GO_0006692_PROSTANOID_METABOLIC_PROCESS",27,-1.9655,0,0.0046,-0.7109,0.89,1,-0.9747,0.51,0.88
"C4_Cancer_gene_neighborhoods:C4_CGN_365_GNF2_ITGAL","C4_Cancer_gene_neighborhoods","C4_CGN_365_GNF2_ITGAL",55,-1.9652,0,0.00037,0.6756,0.97,1,-1.6521,0.0042,0.066
"C7_Immunologic_signatures:C7_ALL_1612_GSE3982_MAST_CELL_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1612_GSE3982_MAST_CELL_VS_NEUTROPHIL_DN",196,-1.9633,0,0,-0.695,1,1,-0.884,0.8,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2381_BRUECKNER_TARGETS_OF_MIRLET7A3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2381_BRUECKNER_TARGETS_OF_MIRLET7A3_UP",108,-1.9633,0,0.0015,-0.8452,0.82,1,-0.9008,0.71,0.88
"GO_MF:514681_GO_0061134_PEPTIDASE_REGULATOR_ACTIVITY","GO_MF","514681_GO_0061134_PEPTIDASE_REGULATOR_ACTIVITY",204,-1.9632,0,0.014,1.0076,0.42,0.87,1.0907,0.23,0.81
"WikiPathways:672454_WP2118_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY","WikiPathways","672454_WP2118_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY",74,-1.963,0,0.003,-1.3823,0.044,0.92,-0.8737,0.73,0.9
"GO_BP:488316_GO_0002443_LEUKOCYTE_MEDIATED_IMMUNITY","GO_BP","488316_GO_0002443_LEUKOCYTE_MEDIATED_IMMUNITY",164,-1.9621,0,0.0049,0.9421,0.62,1,-1.0237,0.36,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_2544_RUIZ_TNC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2544_RUIZ_TNC_TARGETS_UP",153,-1.9615,0,0.0015,0.9905,0.49,0.81,-1.1347,0.16,0.59
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_110_BIOCARTA_TCRA_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_110_BIOCARTA_TCRA_PATHWAY",11,-1.961,0,0.0047,1.1417,0.28,0.67,-1.7728,0.01,0.3
"KEGG_pathway:HSA05146_AMOEBIASIS","KEGG_pathway","HSA05146_AMOEBIASIS",108,-1.9609,0,0.00032,-1.2522,0.1,0.49,1.0006,0.46,1
"GO_BP:511702_GO_0050731_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION","GO_BP","511702_GO_0050731_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION",139,-1.9607,0,0.005,-1.2215,0.085,0.88,-1.3029,0.044,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1714_BROWNE_INTERFERON_RESPONSIVE_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_1714_BROWNE_INTERFERON_RESPONSIVE_GENES",68,-1.9606,0,0.0015,1.1979,0.16,0.49,-1.8659,0,0.081
"C2_Chemical_and_genetic_perturbations:C2_CGP_106_PRAMOONJAGO_SOX4_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_106_PRAMOONJAGO_SOX4_TARGETS_UP",52,-1.9594,0,0.0016,-0.9873,0.47,1,-0.9584,0.52,0.81
"KEGG_pathway:HSA05152_TUBERCULOSIS","KEGG_pathway","HSA05152_TUBERCULOSIS",169,-1.9594,0,0.00035,-1.1079,0.22,0.69,-0.8994,0.76,0.85
"REACTOME:105707_REACT_13645_EICOSANOIDS","REACTOME","105707_REACT_13645_EICOSANOIDS",12,-1.9593,0,0.008,-1.0594,0.38,0.93,1.1342,0.31,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_2569_SWEET_LUNG_CANCER_KRAS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2569_SWEET_LUNG_CANCER_KRAS_UP",483,-1.9591,0,0.0016,1.2632,0.012,0.42,-0.9202,0.78,0.85
"GO_BP:503320_GO_0034114_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION","GO_BP","503320_GO_0034114_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION",16,-1.9588,0,0.0052,-1.1886,0.22,0.9,0.7453,0.82,1
"C7_Immunologic_signatures:C7_ALL_1466_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN","C7_Immunologic_signatures","C7_ALL_1466_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN",198,-1.958,0,0,0.8223,0.92,1,-1.1648,0.12,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_3209_VANLOO_SP3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3209_VANLOO_SP3_TARGETS_DN",88,-1.9579,0,0.0016,-0.6963,0.99,1,-0.8807,0.73,0.9
"GO_BP:488695_GO_0002822_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS","GO_BP","488695_GO_0002822_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS",111,-1.9579,0,0.0053,-1.3695,0.029,0.98,-1.4121,0.016,0.58
"GO_BP:488399_GO_0002526_ACUTE_INFLAMMATORY_RESPONSE","GO_BP","488399_GO_0002526_ACUTE_INFLAMMATORY_RESPONSE",64,-1.9577,0,0.0053,-1.1807,0.18,0.91,0.8913,0.66,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1599_LIANG_SILENCED_BY_METHYLATION_2","C2_Chemical_and_genetic_perturbations","C2_CGP_1599_LIANG_SILENCED_BY_METHYLATION_2",51,-1.9577,0,0.0016,1.2171,0.15,0.47,-1.3753,0.048,0.38
"WikiPathways:198862_WP69_TCR_SIGNALING_PATHWAY","WikiPathways","198862_WP69_TCR_SIGNALING_PATHWAY",89,-1.9575,0,0.0033,-0.8447,0.78,1,-1.4202,0.025,0.43
"GO_BP:1026077_GO_1903305_REGULATION_OF_REGULATED_SECRETORY_PATHWAY","GO_BP","1026077_GO_1903305_REGULATION_OF_REGULATED_SECRETORY_PATHWAY",40,-1.957,0,0.0053,0.8501,0.72,1,-0.8566,0.69,0.96
"C7_Immunologic_signatures:C7_ALL_1592_GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1592_GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN",191,-1.9568,0,0,-0.6092,1,1,-1.0438,0.33,0.62
"KEGG_pathway:HSA00480_GLUTATHIONE_METABOLISM","KEGG_pathway","HSA00480_GLUTATHIONE_METABOLISM",46,-1.9562,0,0.00034,-1.4646,0.031,0.39,-1.512,0.031,0.13
"C0_Hallmark:H_ALL_32_HALLMARK_XENOBIOTIC_METABOLISM","C0_Hallmark","H_ALL_32_HALLMARK_XENOBIOTIC_METABOLISM",195,-1.9561,0,0,-0.9348,0.64,0.88,-1.139,0.17,0.25
"GO_BP:752430_GO_0086064_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION","GO_BP","752430_GO_0086064_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION",13,-1.956,0,0.0053,-1.2181,0.2,0.88,-0.8939,0.62,0.93
"REACTOME:645326_REACT_120722_ACYL_CHAIN_REMODELLING_OF_PI","REACTOME","645326_REACT_120722_ACYL_CHAIN_REMODELLING_OF_PI",14,-1.9558,0.0016,0.0082,0.7712,0.77,1,1.0227,0.41,0.99
"GO_BP:505490_GO_0042346_POSITIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS","GO_BP","505490_GO_0042346_POSITIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS",23,-1.9557,0,0.0053,-1.3543,0.11,0.96,-1.2631,0.14,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_984_GROSS_HYPOXIA_VIA_ELK3_ONLY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_984_GROSS_HYPOXIA_VIA_ELK3_ONLY_UP",33,-1.9555,0,0.0017,0.828,0.75,0.98,0.7253,0.89,1
"GO_BP:517581_GO_0072678_T_CELL_MIGRATION","GO_BP","517581_GO_0072678_T_CELL_MIGRATION",16,-1.9544,0,0.0054,1.1447,0.27,0.84,-0.8577,0.64,0.96
"WikiPathways:700638_WP2359_PARKIN_UBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY","WikiPathways","700638_WP2359_PARKIN_UBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY",75,-1.954,0,0.003,-1.1227,0.26,0.96,-1.74,0,0.3
"GO_BP:488567_GO_0002694_REGULATION_OF_LEUKOCYTE_ACTIVATION","GO_BP","488567_GO_0002694_REGULATION_OF_LEUKOCYTE_ACTIVATION",407,-1.9536,0,0.0054,0.9143,0.78,1,-0.9942,0.48,0.85
"C7_Immunologic_signatures:C7_ALL_1588_GSE3982_EOSINOPHIL_VS_DC_DN","C7_Immunologic_signatures","C7_ALL_1588_GSE3982_EOSINOPHIL_VS_DC_DN",199,-1.9536,0,0,1.1768,0.11,0.27,-1.2758,0.029,0.16
"GO_BP:511748_GO_0050777_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE","GO_BP","511748_GO_0050777_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE",105,-1.9536,0,0.0054,0.6914,0.99,1,0.7417,0.98,1
"GO_BP:488578_GO_0002705_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY","GO_BP","488578_GO_0002705_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY",94,-1.9532,0,0.0054,-1.3161,0.077,0.88,-1.3559,0.024,0.6
"GO_BP:505421_GO_0042269_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY","GO_BP","505421_GO_0042269_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",26,-1.9525,0,0.0054,-0.557,0.99,1,-0.9901,0.46,0.86
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_22_BIOCARTA_BLYMPHOCYTE_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_22_BIOCARTA_BLYMPHOCYTE_PATHWAY",11,-1.9521,0,0.0047,-1.3021,0.16,1,-1.4033,0.092,0.42
"GO_BP:503244_GO_0034035_PURINE_RIBONUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS","GO_BP","503244_GO_0034035_PURINE_RIBONUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS",18,-1.952,0,0.0054,0.7767,0.8,1,-1.3758,0.097,0.59
"GO_BP:502225_GO_0033003_REGULATION_OF_MAST_CELL_ACTIVATION","GO_BP","502225_GO_0033003_REGULATION_OF_MAST_CELL_ACTIVATION",36,-1.9518,0,0.0054,0.8477,0.71,1,1.2656,0.13,0.69
"GO_BP:488636_GO_0002763_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION","GO_BP","488636_GO_0002763_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION",49,-1.9517,0,0.0054,-1.2755,0.11,0.89,-1.5072,0.021,0.53
"GO_BP:506573_GO_0043542_ENDOTHELIAL_CELL_MIGRATION","GO_BP","506573_GO_0043542_ENDOTHELIAL_CELL_MIGRATION",54,-1.9517,0,0.0054,-1.1304,0.24,0.93,-1.1132,0.25,0.76
"C7_Immunologic_signatures:C7_ALL_1472_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN","C7_Immunologic_signatures","C7_ALL_1472_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN",198,-1.9511,0,0,1.1936,0.091,0.24,-0.782,0.97,1
"C7_Immunologic_signatures:C7_ALL_222_GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_222_GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN",192,-1.9509,0,0,-0.8091,0.95,1,-1.2527,0.039,0.19
"C2_Chemical_and_genetic_perturbations:C2_CGP_313_ELVIDGE_HYPOXIA_BY_DMOG_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_313_ELVIDGE_HYPOXIA_BY_DMOG_UP",131,-1.9507,0,0.0018,-0.7743,0.93,1,-1.0389,0.36,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_2324_MATZUK_IMPLANTATION_AND_UTERINE","C2_Chemical_and_genetic_perturbations","C2_CGP_2324_MATZUK_IMPLANTATION_AND_UTERINE",21,-1.9506,0,0.0018,-0.9019,0.59,1,1.0091,0.43,0.96
"GO_BP:508099_GO_0045762_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY","GO_BP","508099_GO_0045762_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY",56,-1.9503,0,0.0054,0.9099,0.61,1,1.216,0.16,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_373_KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_373_KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP",115,-1.9502,0,0.0018,-0.7535,0.96,1,-1.0345,0.35,0.71
"C4_Cancer_modules:C4_CM_15_MODULE_16","C4_Cancer_modules","C4_CM_15_MODULE_16",498,-1.9499,0,0.0013,1.1588,0.066,0.45,-1.1617,0.056,0.44
"KEGG_pathway:HSA04015_RAP1_SIGNALING_PATHWAY","KEGG_pathway","HSA04015_RAP1_SIGNALING_PATHWAY",199,-1.9498,0,0.00045,0.9681,0.52,0.96,1.0236,0.4,1
"KEGG_pathway:HSA04961_ENDOCRINE_AND_OTHER_FACTOR_REGULATED_CALCIUM_REABSORPTION","KEGG_pathway","HSA04961_ENDOCRINE_AND_OTHER_FACTOR_REGULATED_CALCIUM_REABSORPTION",48,-1.9492,0,0.00043,-1.0189,0.4,0.85,-1.8835,0,0.026
"C2_Chemical_and_genetic_perturbations:C2_CGP_2799_WINNEPENNINCKX_MELANOMA_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2799_WINNEPENNINCKX_MELANOMA_METASTASIS_DN",42,-1.9488,0,0.0018,-0.8875,0.64,1,-1.4643,0.031,0.31
"WikiPathways:198916_WP408_OXIDATIVE_STRESS","WikiPathways","198916_WP408_OXIDATIVE_STRESS",31,-1.9488,0,0.003,-1.2135,0.18,0.91,-1.3795,0.078,0.4
"C7_Immunologic_signatures:C7_ALL_1265_GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP","C7_Immunologic_signatures","C7_ALL_1265_GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP",187,-1.9484,0,0,-0.9531,0.56,1,-1.3547,0.02,0.092
"GO_BP:751070_GO_0036150_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING","GO_BP","751070_GO_0036150_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING",16,-1.9484,0,0.0056,-0.9426,0.53,1,0.957,0.55,0.9
"KEGG_pathway:HSA05414_DILATED_CARDIOMYOPATHY","KEGG_pathway","HSA05414_DILATED_CARDIOMYOPATHY",89,-1.9482,0,0.00042,-1.5755,0.0072,0.58,0.9699,0.52,1
"GO_BP:506364_GO_0043304_REGULATION_OF_MAST_CELL_DEGRANULATION","GO_BP","506364_GO_0043304_REGULATION_OF_MAST_CELL_DEGRANULATION",27,-1.9478,0,0.0056,0.8695,0.67,1,0.9012,0.61,0.94
"GO_BP:502360_GO_0033139_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN","GO_BP","502360_GO_0033139_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN",14,-1.9476,0,0.0056,-1.1103,0.34,0.94,-2.1855,0,0.013
"GO_BP:487800_GO_0001909_LEUKOCYTE_MEDIATED_CYTOTOXICITY","GO_BP","487800_GO_0001909_LEUKOCYTE_MEDIATED_CYTOTOXICITY",35,-1.9474,0,0.0056,0.9847,0.47,1,-1.1644,0.22,0.73
"GO_BP:507948_GO_0045600_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION","GO_BP","507948_GO_0045600_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION",40,-1.9473,0,0.0056,-1.0712,0.31,0.96,-0.9512,0.53,0.89
"REACTOME:730334_REACT_150420_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX_","REACTOME","730334_REACT_150420_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX_",22,-1.947,0.0015,0.0088,0.9131,0.6,0.89,0.9174,0.56,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1863_GEISS_RESPONSE_TO_DSRNA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1863_GEISS_RESPONSE_TO_DSRNA_UP",37,-1.9469,0,0.0019,-0.8595,0.7,1,-1.1332,0.25,0.59
"GO_BP:511411_GO_0050427_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_METABOLIC_PROCESS","GO_BP","511411_GO_0050427_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_METABOLIC_PROCESS",18,-1.9468,0,0.0056,0.7581,0.8,1,-1.3891,0.093,0.58
"GO_BP:519046_GO_2000406_POSITIVE_REGULATION_OF_T_CELL_MIGRATION","GO_BP","519046_GO_2000406_POSITIVE_REGULATION_OF_T_CELL_MIGRATION",19,-1.9461,0.0015,0.0056,-0.7081,0.89,1,0.8626,0.66,0.97
"WikiPathways:198915_WP206_FATTY_ACID_OMEGA_OXIDATION","WikiPathways","198915_WP206_FATTY_ACID_OMEGA_OXIDATION",15,-1.9454,0.0015,0.0028,-1.7988,0.0019,0.25,-1.1414,0.25,0.56
"C2_Chemical_and_genetic_perturbations:C2_CGP_2214_RIGGI_EWING_SARCOMA_PROGENITOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2214_RIGGI_EWING_SARCOMA_PROGENITOR_UP",422,-1.945,0,0.002,0.9288,0.75,0.89,-1.0518,0.27,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2315_ZHENG_IL22_SIGNALING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2315_ZHENG_IL22_SIGNALING_UP",55,-1.9449,0,0.002,0.8532,0.74,0.97,-1.0947,0.31,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_748_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_748_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",63,-1.9442,0,0.002,-0.9016,0.66,1,-0.8997,0.66,0.88
"REACTOME:187094_REACT_23837_INTERLEUKIN_3_5_AND_GM_CSF_SIGNALING","REACTOME","187094_REACT_23837_INTERLEUKIN_3_5_AND_GM_CSF_SIGNALING",44,-1.9438,0,0.0088,-0.7636,0.87,1,-1.386,0.049,0.44
"C4_Cancer_modules:C4_CM_49_MODULE_53","C4_Cancer_modules","C4_CM_49_MODULE_53",394,-1.9433,0,0.0014,0.9553,0.63,0.77,-1.4087,0,0.21
"GO_BP:501871_GO_0032645_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION","GO_BP","501871_GO_0032645_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION",12,-1.943,0,0.0057,-1.9503,0.0019,0.37,-1.2866,0.17,0.65
"GO_BP:518223_GO_0090083_REGULATION_OF_INCLUSION_BODY_ASSEMBLY","GO_BP","518223_GO_0090083_REGULATION_OF_INCLUSION_BODY_ASSEMBLY",16,-1.9429,0,0.0057,-1.6156,0.017,0.7,-1.8948,0.002,0.54
"GO_BP:506360_GO_0043300_REGULATION_OF_LEUKOCYTE_DEGRANULATION","GO_BP","506360_GO_0043300_REGULATION_OF_LEUKOCYTE_DEGRANULATION",35,-1.9425,0,0.0058,0.9153,0.59,1,0.7182,0.93,1
"GO_BP:511856_GO_0050921_POSITIVE_REGULATION_OF_CHEMOTAXIS","GO_BP","511856_GO_0050921_POSITIVE_REGULATION_OF_CHEMOTAXIS",103,-1.9422,0,0.0058,1.0478,0.34,0.95,1.1442,0.18,0.73
"GO_BP:511701_GO_0050730_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION","GO_BP","511701_GO_0050730_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION",190,-1.9417,0,0.0058,-1.0556,0.33,0.97,-1.0916,0.25,0.78
"GO_BP:494536_GO_0010466_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY","GO_BP","494536_GO_0010466_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY",217,-1.9416,0,0.0057,0.9879,0.47,0.99,0.9751,0.5,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2464_DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2464_DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN",28,-1.9413,0,0.0021,1.6339,0.013,0.12,0.7762,0.83,1
"GO_BP:519043_GO_2000403_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION","GO_BP","519043_GO_2000403_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION",25,-1.9412,0,0.0057,0.983,0.47,1,1.2477,0.18,0.7
"C7_Immunologic_signatures:C7_ALL_1545_GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1545_GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP",191,-1.9409,0,0,1.1814,0.12,0.26,-1.9033,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_1794_VERRECCHIA_EARLY_RESPONSE_TO_TGFB1","C2_Chemical_and_genetic_perturbations","C2_CGP_1794_VERRECCHIA_EARLY_RESPONSE_TO_TGFB1",58,-1.9408,0,0.0021,-0.7844,0.87,1,1.1974,0.15,0.78
"GO_BP:508102_GO_0045765_REGULATION_OF_ANGIOGENESIS","GO_BP","508102_GO_0045765_REGULATION_OF_ANGIOGENESIS",190,-1.9407,0,0.0058,0.9365,0.66,1,1.0507,0.32,0.8
"C6_Oncogenic_signatures:C6_ALL_128_CAHOY_ASTROGLIAL","C6_Oncogenic_signatures","C6_ALL_128_CAHOY_ASTROGLIAL",98,-1.9402,0,9.4e-05,-0.9372,0.56,0.84,-1.0478,0.34,0.59
"GO_BP:508103_GO_0045766_POSITIVE_REGULATION_OF_ANGIOGENESIS","GO_BP","508103_GO_0045766_POSITIVE_REGULATION_OF_ANGIOGENESIS",110,-1.9397,0.0012,0.0059,1.1005,0.24,0.9,1.2279,0.099,0.71
"GO_BP:514268_GO_0060713_LABYRINTHINE_LAYER_MORPHOGENESIS","GO_BP","514268_GO_0060713_LABYRINTHINE_LAYER_MORPHOGENESIS",21,-1.9395,0,0.0059,-1.4937,0.041,0.82,-1.077,0.35,0.8
"GO_BP:508888_GO_0046640_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION","GO_BP","508888_GO_0046640_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION",25,-1.9394,0,0.0058,0.6573,0.94,1,-0.7624,0.85,1
"GO_BP:516320_GO_0071396_CELLULAR_RESPONSE_TO_LIPID","GO_BP","516320_GO_0071396_CELLULAR_RESPONSE_TO_LIPID",320,-1.9392,0,0.0059,-1.0279,0.37,0.97,0.9762,0.51,0.88
"GO_BP:488147_GO_0002274_MYELOID_LEUKOCYTE_ACTIVATION","GO_BP","488147_GO_0002274_MYELOID_LEUKOCYTE_ACTIVATION",103,-1.9382,0,0.0059,0.9752,0.51,1,0.8017,0.9,1
"GO_BP:495016_GO_0010951_NEGATIVE_REGULATION_OF_ENDOPEPTIDASE_ACTIVITY","GO_BP","495016_GO_0010951_NEGATIVE_REGULATION_OF_ENDOPEPTIDASE_ACTIVITY",210,-1.9381,0,0.0059,0.99,0.48,0.99,1.002,0.45,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_871_SIMBULAN_UV_RESPONSE_NORMAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_871_SIMBULAN_UV_RESPONSE_NORMAL_UP",9,-1.9378,0,0.0021,-1.613,0.026,0.4,-1.7382,0.011,0.16
"C2_Chemical_and_genetic_perturbations:C2_CGP_2140_HELLER_HDAC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2140_HELLER_HDAC_TARGETS_UP",310,-1.9378,0,0.0021,-1.6337,0,0.37,-1.5145,0,0.29
"C7_Immunologic_signatures:C7_ALL_965_GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP","C7_Immunologic_signatures","C7_ALL_965_GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP",200,-1.9378,0,0,-1.002,0.43,1,0.8379,0.89,1
"WikiPathways:198918_WP619_TYPE_II_INTERFERON_SIGNALING_IFNG_","WikiPathways","198918_WP619_TYPE_II_INTERFERON_SIGNALING_IFNG_",48,-1.9374,0,0.003,-1.2083,0.17,0.89,-1.7517,0,0.53
"C7_Immunologic_signatures:C7_ALL_137_GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP","C7_Immunologic_signatures","C7_ALL_137_GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP",194,-1.9373,0,0,-0.769,0.97,1,-1.2358,0.053,0.22
"GO_BP:512642_GO_0051770_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS","GO_BP","512642_GO_0051770_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS",15,-1.9371,0,0.0059,-0.8072,0.75,1,-1.0511,0.39,0.81
"GO_BP:491526_GO_0006636_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS","GO_BP","491526_GO_0006636_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS",54,-1.9368,0,0.0059,-0.9981,0.47,0.99,-1.5213,0.016,0.54
"GO_CC:490911_GO_0005912_ADHERENS_JUNCTION","GO_CC","490911_GO_0005912_ADHERENS_JUNCTION",452,-1.9367,0,0.0071,1.5419,0,0.16,-0.9019,0.87,1
"GO_BP:508161_GO_0045840_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION","GO_BP","508161_GO_0045840_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION",39,-1.9367,0,0.0059,-1.1559,0.25,0.92,-1.2004,0.19,0.73
"GO_BP:507486_GO_0045086_POSITIVE_REGULATION_OF_INTERLEUKIN_2_BIOSYNTHETIC_PROCESS","GO_BP","507486_GO_0045086_POSITIVE_REGULATION_OF_INTERLEUKIN_2_BIOSYNTHETIC_PROCESS",13,-1.9361,0,0.0059,-0.8434,0.67,1,-1.3843,0.11,0.59
"GO_BP:503800_GO_0034599_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS","GO_BP","503800_GO_0034599_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS",153,-1.9361,0,0.0059,-0.8714,0.81,1,-1.5644,0,0.52
"GO_BP:492390_GO_0008015_BLOOD_CIRCULATION","GO_BP","492390_GO_0008015_BLOOD_CIRCULATION",286,-1.9359,0,0.0059,-1.1678,0.11,0.91,1.1563,0.12,0.73
"GO_BP:505564_GO_0042423_CATECHOLAMINE_BIOSYNTHETIC_PROCESS","GO_BP","505564_GO_0042423_CATECHOLAMINE_BIOSYNTHETIC_PROCESS",18,-1.9356,0.0015,0.0059,-0.998,0.44,0.99,-1.5463,0.029,0.52
"GO_BP:501886_GO_0032660_REGULATION_OF_INTERLEUKIN_17_PRODUCTION","GO_BP","501886_GO_0032660_REGULATION_OF_INTERLEUKIN_17_PRODUCTION",21,-1.9353,0.0015,0.0059,-1.5721,0.03,0.72,-1.1863,0.2,0.73
"C7_Immunologic_signatures:C7_ALL_1404_GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1404_GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN",200,-1.9351,0,0,1.5609,0,0.0053,-1.1629,0.13,0.34
"C7_Immunologic_signatures:C7_ALL_1341_GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1341_GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP",200,-1.9348,0,0,-1.0338,0.39,1,-1.5252,0,0.016
"C2_Chemical_and_genetic_perturbations:C2_CGP_220_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_220_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP",190,-1.9348,0,0.0022,1.3433,0.023,0.35,-1.1679,0.1,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_2901_TIAN_TNF_SIGNALING_NOT_VIA_NFKB","C2_Chemical_and_genetic_perturbations","C2_CGP_2901_TIAN_TNF_SIGNALING_NOT_VIA_NFKB",22,-1.9346,0,0.0022,-1.9598,0.0019,0.094,-1.4318,0.063,0.34
"C4_Cancer_modules:C4_CM_96_MODULE_101","C4_Cancer_modules","C4_CM_96_MODULE_101",9,-1.9338,0,0.0016,-1.442,0.08,0.48,-1.4822,0.061,0.17
"GO_BP:507946_GO_0045598_REGULATION_OF_FAT_CELL_DIFFERENTIATION","GO_BP","507946_GO_0045598_REGULATION_OF_FAT_CELL_DIFFERENTIATION",93,-1.9338,0,0.0059,-1.1225,0.24,0.94,0.9713,0.51,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_822_WEINMANN_ADAPTATION_TO_HYPOXIA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_822_WEINMANN_ADAPTATION_TO_HYPOXIA_DN",40,-1.9336,0,0.0022,-0.9371,0.55,1,-1.2579,0.14,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_1569_APPEL_IMATINIB_RESPONSE","C2_Chemical_and_genetic_perturbations","C2_CGP_1569_APPEL_IMATINIB_RESPONSE",33,-1.9336,0,0.0022,0.6894,0.94,1,1.3974,0.06,0.54
"WikiPathways:198898_WP697_ESTROGEN_METABOLISM","WikiPathways","198898_WP697_ESTROGEN_METABOLISM",16,-1.9336,0.0015,0.0028,-1.0977,0.32,0.94,-1.4361,0.074,0.44
"REACTOME:1183588_REACT_355391_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3","REACTOME","1183588_REACT_355391_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3",63,-1.9332,0,0.0099,-1.8895,0.0018,0.062,-1.8633,0,0.15
"C2_Chemical_and_genetic_perturbations:C2_CGP_1597_KIM_HYPOXIA","C2_Chemical_and_genetic_perturbations","C2_CGP_1597_KIM_HYPOXIA",25,-1.9327,0,0.0022,-1.2441,0.16,0.75,-1.0552,0.37,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_1697_BROWNE_HCMV_INFECTION_24HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1697_BROWNE_HCMV_INFECTION_24HR_DN",146,-1.9316,0,0.0022,0.8478,0.86,0.97,-1.2505,0.067,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_1054_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1054_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN",373,-1.9315,0,0.0022,-1.028,0.35,0.98,1.4081,0,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_319_ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_319_ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN",104,-1.9315,0,0.0022,-0.9044,0.65,1,-1.1281,0.23,0.59
"GO_BP:488581_GO_0002708_POSITIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY","GO_BP","488581_GO_0002708_POSITIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY",79,-1.9311,0,0.0062,-1.4876,0.013,0.83,-1.5984,0.002,0.51
"GO_BP:510613_GO_0048545_RESPONSE_TO_STEROID_HORMONE","GO_BP","510613_GO_0048545_RESPONSE_TO_STEROID_HORMONE",358,-1.9309,0,0.0062,-0.9973,0.46,0.99,1.1662,0.086,0.73
"C4_Cancer_modules:C4_CM_168_MODULE_178","C4_Cancer_modules","C4_CM_168_MODULE_178",14,-1.9308,0,0.0017,0.4985,0.99,1,0.7857,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1266_ZUCCHI_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1266_ZUCCHI_METASTASIS_DN",43,-1.9308,0,0.0022,-1.1009,0.28,0.91,-1.2292,0.15,0.49
"GO_BP:508874_GO_0046626_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","508874_GO_0046626_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY",40,-1.9305,0,0.0062,-0.991,0.48,1,-0.7965,0.79,0.99
"C7_Immunologic_signatures:C7_ALL_1619_GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1619_GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP",199,-1.9301,0,0,0.7523,0.99,1,-1.0269,0.39,0.66
"GO_BP:488239_GO_0002366_LEUKOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488239_GO_0002366_LEUKOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",119,-1.9301,0,0.0062,-0.6096,1,1,-1.1174,0.23,0.76
"C6_Oncogenic_signatures:C6_ALL_57_MYC_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_57_MYC_UP_V1_DN",160,-1.9291,0,8.7e-05,-1.3446,0.04,0.44,-0.9495,0.58,0.71
"GO_BP:508898_GO_0046651_LYMPHOCYTE_PROLIFERATION","GO_BP","508898_GO_0046651_LYMPHOCYTE_PROLIFERATION",81,-1.9284,0,0.0064,0.6648,1,1,-1.0209,0.4,0.83
"GO_BP:491990_GO_0007190_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY","GO_BP","491990_GO_0007190_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY",35,-1.9281,0,0.0064,0.9455,0.54,1,1.1579,0.22,0.73
"GO_MF:752611_GO_0097110_SCAFFOLD_PROTEIN_BINDING","GO_MF","752611_GO_0097110_SCAFFOLD_PROTEIN_BINDING",38,-1.928,0,0.021,-0.9169,0.6,0.97,0.8852,0.64,0.97
"GO_MF:506579_GO_0043548_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING","GO_MF","506579_GO_0043548_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING",27,-1.928,0,0.02,-0.7152,0.9,1,-1.4122,0.064,0.48
"GO_BP:488546_GO_0002673_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE","GO_BP","488546_GO_0002673_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE",65,-1.9277,0,0.0064,-1.3332,0.068,0.91,1.359,0.065,0.64
"GO_BP:494640_GO_0010575_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION","GO_BP","494640_GO_0010575_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION",25,-1.9274,0.0029,0.0064,-1.1511,0.26,0.93,-0.9587,0.49,0.88
"C4_Cancer_modules:C4_CM_273_MODULE_312","C4_Cancer_modules","C4_CM_273_MODULE_312",46,-1.927,0.0014,0.0017,1.0613,0.34,0.61,-1.2729,0.091,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_781_WANG_METHYLATED_IN_BREAST_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_781_WANG_METHYLATED_IN_BREAST_CANCER",35,-1.927,0,0.0024,-1.002,0.44,1,0.851,0.69,1
"C6_Oncogenic_signatures:C6_ALL_62_SNF5_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_62_SNF5_DN_V1_UP",149,-1.9268,0,8.1e-05,1.0414,0.35,0.72,-0.9608,0.57,0.7
"GO_BP:501877_GO_0032651_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION","GO_BP","501877_GO_0032651_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION",37,-1.9268,0.0014,0.0065,-0.9048,0.6,1,-1.4312,0.041,0.56
"GO_MF:490159_GO_0004857_ENZYME_INHIBITOR_ACTIVITY","GO_MF","490159_GO_0004857_ENZYME_INHIBITOR_ACTIVITY",323,-1.9267,0,0.019,-0.8646,0.89,1,-1.0017,0.42,0.79
"C4_Cancer_modules:C4_CM_108_MODULE_113","C4_Cancer_modules","C4_CM_108_MODULE_113",100,-1.9264,0,0.0017,-1.0799,0.29,0.68,-1.2848,0.071,0.32
"GO_BP:488570_GO_0002697_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS","GO_BP","488570_GO_0002697_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS",290,-1.9262,0,0.0065,-0.8038,0.97,1,-1.3718,0.0021,0.59
"C7_Immunologic_signatures:C7_ALL_1597_GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1597_GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP",198,-1.9262,0,0,0.8696,0.87,1,0.8115,0.92,1
"GO_BP:488759_GO_0002886_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY","GO_BP","488759_GO_0002886_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY",36,-1.9261,0,0.0065,0.7034,0.94,1,0.7737,0.85,1
"GO_BP:506197_GO_0043123_POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING","GO_BP","506197_GO_0043123_POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING",177,-1.9259,0,0.0065,-0.7752,0.96,1,-1.2618,0.048,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_505_MCBRYAN_PUBERTAL_BREAST_6_7WK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_505_MCBRYAN_PUBERTAL_BREAST_6_7WK_DN",77,-1.9258,0,0.0024,1.0979,0.29,0.64,-0.9013,0.65,0.88
"GO_CC:501145_GO_0031904_ENDOSOME_LUMEN","GO_CC","501145_GO_0031904_ENDOSOME_LUMEN",13,-1.9257,0,0.0077,-0.5798,0.96,1,0.9822,0.48,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2138_HELLER_SILENCED_BY_METHYLATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2138_HELLER_SILENCED_BY_METHYLATION_UP",267,-1.9256,0,0.0024,-0.9681,0.54,1,-1.4922,0,0.3
"C6_Oncogenic_signatures:C6_ALL_107_MEL18_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_107_MEL18_DN_V1_DN",144,-1.9255,0,7.6e-05,0.8886,0.76,0.96,-1.2292,0.077,0.33
"KEGG_pathway:HSA05014_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS_","KEGG_pathway","HSA05014_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS_",51,-1.9255,0,0.00055,-0.8225,0.8,1,-1.3128,0.087,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_2660_CROONQUIST_STROMAL_STIMULATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2660_CROONQUIST_STROMAL_STIMULATION_UP",58,-1.9255,0,0.0024,-1.2428,0.13,0.75,-0.8694,0.71,0.91
"KEGG_compound:C00157_PHOSPHATIDYLCHOLINE_LECITHIN_PHOSPHATIDYL_N_TRIMETHYLETHANOLAMINE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_CHOLINE_PHOSPHATIDE_3_SN_PHOSPHATIDYLCHOLINE","KEGG_compound","C00157_PHOSPHATIDYLCHOLINE_LECITHIN_PHOSPHATIDYL_N_TRIMETHYLETHANOLAMINE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_CHOLINE_PHOSPHATIDE_3_SN_PHOSPHATIDYLCHOLINE",34,-1.9254,0.0014,0.0032,-0.6424,0.97,1,-0.8945,0.64,0.77
"GO_BP:500118_GO_0030819_POSITIVE_REGULATION_OF_CAMP_BIOSYNTHETIC_PROCESS","GO_BP","500118_GO_0030819_POSITIVE_REGULATION_OF_CAMP_BIOSYNTHETIC_PROCESS",82,-1.9253,0,0.0065,-0.9577,0.53,1,1.241,0.13,0.71
"C7_Immunologic_signatures:C7_ALL_1768_GSE7460_TCONV_VS_TREG_THYMUS_DN","C7_Immunologic_signatures","C7_ALL_1768_GSE7460_TCONV_VS_TREG_THYMUS_DN",200,-1.9251,0,0,0.6961,1,1,-1.0062,0.45,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_324_GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_324_GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP",22,-1.9249,0,0.0024,-1.3373,0.1,0.69,-1.1648,0.23,0.56
"C2_Chemical_and_genetic_perturbations:C2_CGP_1518_ABBUD_LIF_SIGNALING_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1518_ABBUD_LIF_SIGNALING_1_UP",43,-1.9249,0,0.0024,1.3042,0.096,0.39,1.3639,0.064,0.55
"GO_BP:507514_GO_0045123_CELLULAR_EXTRAVASATION","GO_BP","507514_GO_0045123_CELLULAR_EXTRAVASATION",26,-1.9248,0,0.0065,-0.8707,0.67,1,-0.7558,0.86,1
"GO_BP:489009_GO_0003215_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS","GO_BP","489009_GO_0003215_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS",16,-1.9247,0,0.0065,-0.9766,0.48,1,0.8437,0.7,0.99
"GO_BP:511807_GO_0050865_REGULATION_OF_CELL_ACTIVATION","GO_BP","511807_GO_0050865_REGULATION_OF_CELL_ACTIVATION",437,-1.9243,0,0.0065,0.9238,0.8,1,-0.9959,0.49,0.85
"C4_Cancer_modules:C4_CM_91_MODULE_96","C4_Cancer_modules","C4_CM_91_MODULE_96",35,-1.9241,0,0.0017,-1.2478,0.15,0.58,-1.0791,0.33,0.56
"C4_Cancer_modules:C4_CM_342_MODULE_410","C4_Cancer_modules","C4_CM_342_MODULE_410",34,-1.924,0,0.0016,-1.1669,0.21,0.63,-1.0502,0.35,0.61
"C7_Immunologic_signatures:C7_ALL_989_GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_989_GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP",198,-1.924,0,0,0.8862,0.81,1,-1.9396,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_155_NEWMAN_ERCC6_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_155_NEWMAN_ERCC6_TARGETS_UP",26,-1.9232,0,0.0024,0.9545,0.53,0.86,-0.8859,0.62,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_2352_BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2352_BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN",30,-1.9227,0,0.0024,-1.1606,0.25,0.83,-0.9715,0.51,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2725_CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2725_CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP",24,-1.9224,0,0.0025,0.7264,0.87,1,1.0252,0.43,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1321_SANA_TNF_SIGNALING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1321_SANA_TNF_SIGNALING_DN",89,-1.9223,0,0.0024,1.0486,0.35,0.71,-0.8518,0.81,0.92
"GO_BP:488811_GO_0003013_CIRCULATORY_SYSTEM_PROCESS","GO_BP","488811_GO_0003013_CIRCULATORY_SYSTEM_PROCESS",307,-1.9218,0,0.0067,-1.1322,0.15,0.93,1.1776,0.086,0.72
"GO_BP:501915_GO_0032689_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION","GO_BP","501915_GO_0032689_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION",27,-1.9218,0,0.0067,-0.9492,0.53,1,0.6159,0.97,1
"GO_BP:751866_GO_0044724_SINGLE_ORGANISM_CARBOHYDRATE_CATABOLIC_PROCESS","GO_BP","751866_GO_0044724_SINGLE_ORGANISM_CARBOHYDRATE_CATABOLIC_PROCESS",118,-1.9211,0,0.0067,-0.816,0.88,1,-1.5649,0.002,0.52
"GO_CC:921100_GO_0098552_SIDE_OF_MEMBRANE","GO_CC","921100_GO_0098552_SIDE_OF_MEMBRANE",315,-1.921,0,0.0077,0.9723,0.58,0.82,-0.8557,0.93,1
"C7_Immunologic_signatures:C7_ALL_905_GSE20715_0H_VS_24H_OZONE_LUNG_UP","C7_Immunologic_signatures","C7_ALL_905_GSE20715_0H_VS_24H_OZONE_LUNG_UP",198,-1.9208,0,0,0.8238,0.93,1,-1.5561,0,0.0098
"GO_BP:508879_GO_0046631_ALPHA_BETA_T_CELL_ACTIVATION","GO_BP","508879_GO_0046631_ALPHA_BETA_T_CELL_ACTIVATION",52,-1.9207,0,0.0068,-0.7721,0.85,1,0.7744,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3092_WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG","C2_Chemical_and_genetic_perturbations","C2_CGP_3092_WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG",25,-1.9207,0,0.0025,-0.9932,0.47,1,-1.457,0.037,0.32
"C4_Cancer_gene_neighborhoods:C4_CGN_408_GNF2_SNRK","C4_Cancer_gene_neighborhoods","C4_CGN_408_GNF2_SNRK",28,-1.92,0,0.00058,0.5179,1,1,-2.0581,0,0.0022
"GO_CC:490373_GO_0046658_ANCHORED_COMPONENT_OF_PLASMA_MEMBRANE","GO_CC","490373_GO_0046658_ANCHORED_COMPONENT_OF_PLASMA_MEMBRANE",37,-1.9196,0,0.0074,1.2641,0.12,0.45,0.9359,0.55,1
"REACTOME:1183540_REACT_355210_MYD88_DEFICIENCY_TLR2_4_","REACTOME","1183540_REACT_355210_MYD88_DEFICIENCY_TLR2_4_",10,-1.9195,0,0.012,-0.8262,0.68,1,-0.9375,0.55,0.92
"GO_BP:505458_GO_0042312_REGULATION_OF_VASODILATION","GO_BP","505458_GO_0042312_REGULATION_OF_VASODILATION",40,-1.9195,0,0.0069,1.2551,0.14,0.73,1.496,0.03,0.56
"C7_Immunologic_signatures:C7_ALL_302_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_302_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN",198,-1.9191,0,0,0.6491,1,1,-1.2935,0.039,0.14
"GO_BP:508017_GO_0045669_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION","GO_BP","508017_GO_0045669_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION",58,-1.9189,0,0.0069,-0.8115,0.81,1,1.3637,0.066,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_1488_LEI_MYB_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1488_LEI_MYB_TARGETS",313,-1.9185,0,0.0026,0.8966,0.83,0.93,-1.0269,0.37,0.71
"C7_Immunologic_signatures:C7_ALL_1332_GSE30083_SP2_VS_SP3_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1332_GSE30083_SP2_VS_SP3_THYMOCYTE_DN",196,-1.9185,0,0,-1.1506,0.14,1,-1.1561,0.13,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_2906_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2906_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP",83,-1.9185,0,0.0025,0.8449,0.81,0.97,-1.3345,0.068,0.41
"C1_Positional:C1_ALL_102_CHR1Q23","C1_Positional","C1_ALL_102_CHR1Q23",92,-1.9181,0,0.021,1.0592,0.31,0.66,-1.0248,0.4,0.86
"GO_BP:501957_GO_0032731_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION","GO_BP","501957_GO_0032731_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION",24,-1.9177,0,0.007,-1.0926,0.33,0.95,-1.189,0.21,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2609_ZHANG_TLX_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2609_ZHANG_TLX_TARGETS_DN",108,-1.9174,0,0.0026,-0.9576,0.56,1,0.9353,0.6,1
"WikiPathways:198792_WP1433_NOD_PATHWAY","WikiPathways","198792_WP1433_NOD_PATHWAY",38,-1.9162,0,0.0033,-0.8925,0.63,1,-1.0786,0.32,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2166_FINETTI_BREAST_CANCER_KINOME_GREEN","C2_Chemical_and_genetic_perturbations","C2_CGP_2166_FINETTI_BREAST_CANCER_KINOME_GREEN",16,-1.9157,0,0.0026,-0.9497,0.5,1,-1.6069,0.031,0.24
"GO_BP:507488_GO_0045088_REGULATION_OF_INNATE_IMMUNE_RESPONSE","GO_BP","507488_GO_0045088_REGULATION_OF_INNATE_IMMUNE_RESPONSE",255,-1.9155,0,0.0071,0.624,1,1,-1.1031,0.2,0.77
"REACTOME:161021_REACT_21264_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS","REACTOME","161021_REACT_21264_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS",8,-1.9151,0,0.012,0.909,0.54,0.9,1.2928,0.19,0.74
"KEGG_compound:C00051_GLUTATHIONE_5_L_GLUTAMYL_L_CYSTEINYLGLYCINE_N_N_GAMMA_L_GLUTAMYL_L_CYSTEINYL_GLYCINE_GAMMA_L_GLUTAMYL_L_CYSTEINYL_GLYCINE_GSH_REDUCED_GLUTATHIONE","KEGG_compound","C00051_GLUTATHIONE_5_L_GLUTAMYL_L_CYSTEINYLGLYCINE_N_N_GAMMA_L_GLUTAMYL_L_CYSTEINYL_GLYCINE_GAMMA_L_GLUTAMYL_L_CYSTEINYL_GLYCINE_GSH_REDUCED_GLUTATHIONE",35,-1.9151,0,0.004,-1.5728,0.015,0.18,-1.4582,0.053,0.24
"GO_BP:496151_GO_0016052_CARBOHYDRATE_CATABOLIC_PROCESS","GO_BP","496151_GO_0016052_CARBOHYDRATE_CATABOLIC_PROCESS",125,-1.9143,0,0.0073,0.8221,0.88,1,-1.4885,0.0042,0.53
"KEGG_pathway:HSA05150_STAPHYLOCOCCUS_AUREUS_INFECTION","KEGG_pathway","HSA05150_STAPHYLOCOCCUS_AUREUS_INFECTION",52,-1.9141,0,0.00075,-0.906,0.63,0.97,0.6506,0.98,1
"GO_BP:500538_GO_0031279_REGULATION_OF_CYCLASE_ACTIVITY","GO_BP","500538_GO_0031279_REGULATION_OF_CYCLASE_ACTIVITY",115,-1.9136,0,0.0073,0.9549,0.57,1,1.3027,0.049,0.67
"C7_Immunologic_signatures:C7_ALL_1801_GSE7764_NKCELL_VS_SPLENOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1801_GSE7764_NKCELL_VS_SPLENOCYTE_UP",199,-1.9132,0,0,-0.726,0.99,1,-0.9035,0.75,0.94
"C7_Immunologic_signatures:C7_ALL_160_GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_160_GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN",197,-1.9124,0,0,-1.0248,0.38,1,-1.5586,0.0042,0.0096
"C7_Immunologic_signatures:C7_ALL_290_GSE14350_IL2RB_KO_VS_WT_TREG_DN","C7_Immunologic_signatures","C7_ALL_290_GSE14350_IL2RB_KO_VS_WT_TREG_DN",199,-1.9123,0,0,-0.8897,0.75,1,-1.11,0.17,0.47
"C7_Immunologic_signatures:C7_ALL_1026_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1026_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN",200,-1.9122,0,0,0.9266,0.68,0.96,-1.2529,0.065,0.19
"GO_MF:498648_GO_0019864_IGG_BINDING","GO_MF","498648_GO_0019864_IGG_BINDING",12,-1.9122,0,0.023,-1.0731,0.35,0.85,0.907,0.58,0.95
"C7_Immunologic_signatures:C7_ALL_1764_GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1764_GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN",191,-1.9121,0,0,1.211,0.085,0.21,1.0701,0.27,1
"GO_BP:487714_GO_0001818_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION","GO_BP","487714_GO_0001818_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION",189,-1.9119,0,0.0075,0.957,0.57,1,-1.1689,0.11,0.73
"C7_Immunologic_signatures:C7_ALL_1680_GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1680_GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN",191,-1.9118,0,0,-1.0455,0.33,1,-1.0286,0.37,0.66
"GO_MF:487838_GO_0001948_GLYCOPROTEIN_BINDING","GO_MF","487838_GO_0001948_GLYCOPROTEIN_BINDING",77,-1.9113,0,0.022,-0.9886,0.48,0.92,1.018,0.42,0.85
"C4_Cancer_modules:C4_CM_117_MODULE_122","C4_Cancer_modules","C4_CM_117_MODULE_122",132,-1.9107,0,0.0019,1.0544,0.32,0.62,-0.9466,0.6,0.78
"GO_BP:502165_GO_0032943_MONONUCLEAR_CELL_PROLIFERATION","GO_BP","502165_GO_0032943_MONONUCLEAR_CELL_PROLIFERATION",83,-1.9106,0,0.0076,0.6197,1,1,-1.0181,0.42,0.83
"GO_BP:487801_GO_0001910_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY","GO_BP","487801_GO_0001910_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY",51,-1.9105,0,0.0076,-0.7699,0.87,1,-0.8747,0.7,0.94
"C4_Cancer_modules:C4_CM_327_MODULE_387","C4_Cancer_modules","C4_CM_327_MODULE_387",49,-1.9105,0,0.0019,-1.1854,0.18,0.61,-1.2697,0.12,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_141_DOANE_BREAST_CANCER_ESR1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_141_DOANE_BREAST_CANCER_ESR1_UP",111,-1.9103,0,0.0028,-1.2184,0.11,0.79,-1.4113,0.016,0.35
"REACTOME:730333_REACT_150149_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX_","REACTOME","730333_REACT_150149_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX_",14,-1.9102,0,0.013,-0.8269,0.7,1,-1.0335,0.4,0.8
"GO_CC:983697_GO_0098636_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION","GO_CC","983697_GO_0098636_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION",30,-1.9099,0.0015,0.0081,-0.8833,0.65,0.96,0.7883,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2086_RIGGINS_TAMOXIFEN_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2086_RIGGINS_TAMOXIFEN_RESISTANCE_UP",64,-1.9099,0,0.0028,1.0509,0.36,0.71,-0.7239,0.96,0.98
"C3_TF_targets:C3_TFT_457_V_AP1_Q6_01","C3_TF_targets","C3_TFT_457_V_AP1_Q6_01",255,-1.9097,0,0.0033,-1.0932,0.23,0.56,-1.2496,0.035,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_2877_CHIARETTI_T_ALL_RELAPSE_PROGNOSIS","C2_Chemical_and_genetic_perturbations","C2_CGP_2877_CHIARETTI_T_ALL_RELAPSE_PROGNOSIS",19,-1.9095,0,0.0028,0.872,0.66,0.95,-1.1865,0.21,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_122_CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_122_CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP",39,-1.9093,0,0.0028,-0.7156,0.91,1,-1.0908,0.31,0.64
"KEGG_pathway:HSA04972_PANCREATIC_SECRETION","KEGG_pathway","HSA04972_PANCREATIC_SECRETION",89,-1.9092,0,0.00087,-1.23,0.12,0.53,-1.5201,0.0039,0.13
"C2_Chemical_and_genetic_perturbations:C2_CGP_3117_ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3117_ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN",115,-1.9091,0,0.0028,0.7982,0.93,0.99,-1.0443,0.34,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_1067_SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1067_SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN",55,-1.9089,0,0.0028,-1.1803,0.21,0.82,1.1838,0.17,0.79
"C7_Immunologic_signatures:C7_ALL_1487_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP","C7_Immunologic_signatures","C7_ALL_1487_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP",195,-1.9089,0,0,-1.0678,0.26,1,0.9718,0.51,1
"GO_BP:753073_GO_1900077_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS","GO_BP","753073_GO_1900077_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS",32,-1.9089,0,0.0077,-1.2363,0.18,0.9,-1.0732,0.33,0.8
"C7_Immunologic_signatures:C7_ALL_1410_GSE360_CTRL_VS_L_MAJOR_DC_DN","C7_Immunologic_signatures","C7_ALL_1410_GSE360_CTRL_VS_L_MAJOR_DC_DN",198,-1.9084,0,0,-0.9064,0.69,1,-0.8944,0.77,0.96
"GO_BP:502228_GO_0033006_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","502228_GO_0033006_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",28,-1.9083,0,0.0077,0.8464,0.7,1,0.9728,0.51,0.88
"C7_Immunologic_signatures:C7_ALL_1036_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN","C7_Immunologic_signatures","C7_ALL_1036_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN",193,-1.908,0,0,-1.2168,0.08,0.8,-1.4433,0.0046,0.037
"C2_Chemical_and_genetic_perturbations:C2_CGP_3179_DELPUECH_FOXO3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3179_DELPUECH_FOXO3_TARGETS_UP",67,-1.9077,0,0.0028,-0.7569,0.91,1,1.0062,0.43,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2181_MARZEC_IL2_SIGNALING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2181_MARZEC_IL2_SIGNALING_UP",114,-1.9074,0,0.0028,-0.7802,0.92,1,0.9929,0.45,0.96
"GO_BP:494639_GO_0010574_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION","GO_BP","494639_GO_0010574_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION",29,-1.9072,0.0015,0.0078,-1.1029,0.31,0.94,-0.8377,0.72,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2990_NIELSEN_SYNOVIAL_SARCOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2990_NIELSEN_SYNOVIAL_SARCOMA_DN",20,-1.907,0,0.0028,0.865,0.66,0.96,-1.6529,0.014,0.22
"GO_BP:498214_GO_0019371_CYCLOOXYGENASE_PATHWAY","GO_BP","498214_GO_0019371_CYCLOOXYGENASE_PATHWAY",14,-1.9069,0,0.0078,0.781,0.76,1,-1.1138,0.32,0.76
"GO_BP:508228_GO_0045921_POSITIVE_REGULATION_OF_EXOCYTOSIS","GO_BP","508228_GO_0045921_POSITIVE_REGULATION_OF_EXOCYTOSIS",66,-1.9068,0,0.0078,0.9969,0.43,0.98,-0.8578,0.76,0.96
"GO_BP:507994_GO_0045646_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION","GO_BP","507994_GO_0045646_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION",35,-1.9063,0,0.0078,-0.9726,0.48,1,-1.0737,0.35,0.8
"GO_BP:488761_GO_0002888_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY","GO_BP","488761_GO_0002888_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY",17,-1.9061,0,0.0078,-0.7529,0.83,1,-0.9508,0.53,0.89
"GO_BP:491471_GO_0006575_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS","GO_BP","491471_GO_0006575_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS",195,-1.9061,0,0.0078,-1.1365,0.16,0.93,-1.6937,0,0.62
"GO_BP:487507_GO_0001569_PATTERNING_OF_BLOOD_VESSELS","GO_BP","487507_GO_0001569_PATTERNING_OF_BLOOD_VESSELS",36,-1.9057,0,0.0078,-0.8055,0.78,1,-0.9616,0.49,0.88
"C7_Immunologic_signatures:C7_ALL_1204_GSE27786_CD8_TCELL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1204_GSE27786_CD8_TCELL_VS_NKCELL_DN",200,-1.9056,0,0,0.8223,0.95,1,-0.8175,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_723_ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER","C2_Chemical_and_genetic_perturbations","C2_CGP_723_ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER",140,-1.9051,0,0.0029,0.625,1,1,-2.224,0,0.0027
"C2_Chemical_and_genetic_perturbations:C2_CGP_2679_VALK_AML_CLUSTER_3","C2_Chemical_and_genetic_perturbations","C2_CGP_2679_VALK_AML_CLUSTER_3",32,-1.9049,0.0014,0.0029,1.308,0.11,0.39,-1.0533,0.37,0.69
"GO_BP:501951_GO_0032725_POSITIVE_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION","GO_BP","501951_GO_0032725_POSITIVE_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION",12,-1.9047,0,0.0078,-1.9138,0,0.31,-1.2949,0.15,0.64
"C7_Immunologic_signatures:C7_ALL_1357_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1357_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP",194,-1.9046,0,0,-1.2147,0.083,0.81,-1.4657,0,0.031
"C2_Chemical_and_genetic_perturbations:C2_CGP_2150_AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G","C2_Chemical_and_genetic_perturbations","C2_CGP_2150_AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G",95,-1.9044,0,0.0029,0.8177,0.87,0.98,0.8197,0.85,1
"GO_BP:488302_GO_0002429_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","488302_GO_0002429_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY",186,-1.9042,0,0.0079,-0.6312,1,1,-1.4373,0.004,0.56
"GO_MF:489324_GO_0003823_ANTIGEN_BINDING","GO_MF","489324_GO_0003823_ANTIGEN_BINDING",74,-1.9041,0,0.023,-1.045,0.36,0.86,-1.4841,0.015,0.43
"KEGG_pathway:HSA04666_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS","KEGG_pathway","HSA04666_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS",91,-1.9036,0,0.00095,-0.8338,0.81,1,-0.9596,0.54,0.77
"GO_BP:494895_GO_0010831_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION","GO_BP","494895_GO_0010831_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION",23,-1.9035,0.0015,0.008,1.4246,0.074,0.52,-1.1952,0.22,0.74
"GO_BP:508629_GO_0046365_MONOSACCHARIDE_CATABOLIC_PROCESS","GO_BP","508629_GO_0046365_MONOSACCHARIDE_CATABOLIC_PROCESS",84,-1.9034,0,0.0079,-0.8259,0.81,1,-1.5072,0.0084,0.54
"GO_BP:502414_GO_0033194_RESPONSE_TO_HYDROPEROXIDE","GO_BP","502414_GO_0033194_RESPONSE_TO_HYDROPEROXIDE",15,-1.9032,0,0.008,-1.1896,0.23,0.9,-1.5587,0.029,0.51
"C7_Immunologic_signatures:C7_ALL_789_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_789_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP",192,-1.9025,0,0,-0.9226,0.68,1,-1.6885,0,0.00098
"C2_Chemical_and_genetic_perturbations:C2_CGP_2693_VALK_AML_WITH_11Q23_REARRANGED","C2_Chemical_and_genetic_perturbations","C2_CGP_2693_VALK_AML_WITH_11Q23_REARRANGED",22,-1.9025,0,0.003,0.981,0.48,0.81,-1.2014,0.2,0.52
"GO_MF:490191_GO_0030246_CARBOHYDRATE_BINDING","GO_MF","490191_GO_0030246_CARBOHYDRATE_BINDING",266,-1.9017,0,0.023,-1.1558,0.12,0.81,-1.3996,0.0045,0.5
"REACTOME:105688_REACT_18266_AXON_GUIDANCE","REACTOME","105688_REACT_18266_AXON_GUIDANCE",325,-1.901,0,0.014,-1.1738,0.083,0.86,-1.1951,0.056,0.61
"GO_BP:513701_GO_0060143_POSITIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION","GO_BP","513701_GO_0060143_POSITIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION",20,-1.9007,0.0015,0.0082,1.5361,0.044,0.36,-1.3715,0.09,0.58
"KEGG_pathway:HSA04612_ANTIGEN_PROCESSING_AND_PRESENTATION","KEGG_pathway","HSA04612_ANTIGEN_PROCESSING_AND_PRESENTATION",69,-1.9007,0,0.00095,-1.0925,0.3,0.7,-1.5721,0.0059,0.11
"GO_MF:498054_GO_0019199_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY","GO_MF","498054_GO_0019199_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY",80,-1.9007,0,0.022,-1.1345,0.24,0.81,-1.0483,0.34,0.75
"C7_Immunologic_signatures:C7_ALL_450_GSE17721_CTRL_VS_LPS_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_450_GSE17721_CTRL_VS_LPS_1H_BMDM_DN",194,-1.9001,0,0,-1.2731,0.044,0.53,-1.1925,0.096,0.29
"GO_BP:500549_GO_0031290_RETINAL_GANGLION_CELL_AXON_GUIDANCE","GO_BP","500549_GO_0031290_RETINAL_GANGLION_CELL_AXON_GUIDANCE",18,-1.9,0,0.0083,-1.0057,0.44,0.98,-0.8986,0.6,0.93
"GO_CC:500511_GO_0031252_CELL_LEADING_EDGE","GO_CC","500511_GO_0031252_CELL_LEADING_EDGE",326,-1.8998,0,0.0092,-0.9648,0.58,0.89,-0.8416,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_118_HUTTMANN_B_CLL_POOR_SURVIVAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_118_HUTTMANN_B_CLL_POOR_SURVIVAL_UP",270,-1.8998,0,0.0031,-1.1068,0.21,0.92,-0.9383,0.65,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_848_WOOD_EBV_EBNA1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_848_WOOD_EBV_EBNA1_TARGETS_UP",110,-1.8998,0,0.0031,0.7925,0.93,0.99,-1.2642,0.082,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_201_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_201_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP",28,-1.8997,0,0.0031,-1.5643,0.015,0.43,-1.4749,0.052,0.31
"REACTOME:576262_REACT_118779_EXTRACELLULAR_MATRIX_ORGANIZATION","REACTOME","576262_REACT_118779_EXTRACELLULAR_MATRIX_ORGANIZATION",262,-1.8996,0,0.014,-0.9468,0.63,1,1.5265,0,0.48
"GO_BP:488706_GO_0002833_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS","GO_BP","488706_GO_0002833_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS",27,-1.8995,0,0.0083,0.555,0.98,1,-1.0532,0.36,0.81
"GO_BP:488637_GO_0002764_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY","GO_BP","488637_GO_0002764_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY",402,-1.8994,0,0.0083,-0.8184,0.97,1,-1.3471,0.0022,0.61
"KEGG_pathway:HSA04071_SPHINGOLIPID_SIGNALING_PATHWAY","KEGG_pathway","HSA04071_SPHINGOLIPID_SIGNALING_PATHWAY",120,-1.8993,0,0.00096,-1.0879,0.26,0.7,-1.4083,0.019,0.17
"GO_BP:499462_GO_0071260_CELLULAR_RESPONSE_TO_MECHANICAL_STIMULUS","GO_BP","499462_GO_0071260_CELLULAR_RESPONSE_TO_MECHANICAL_STIMULUS",69,-1.8988,0,0.0083,-0.7207,0.95,1,-1.039,0.37,0.82
"KEGG_compound:C04230_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ACYL_SN_GLYCEROL_3_PHOSPHOCHOLINE_ALPHA_ACYLGLYCEROPHOSPHOCHOLINE_2_LYSOLECITHIN_2_LYSOPHOSPHATIDYLCHOLINE_1_ACYLGLYCEROPHOSPHOCHOLINE","KEGG_compound","C04230_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ACYL_SN_GLYCEROL_3_PHOSPHOCHOLINE_ALPHA_ACYLGLYCEROPHOSPHOCHOLINE_2_LYSOLECITHIN_2_LYSOPHOSPHATIDYLCHOLINE_1_ACYLGLYCEROPHOSPHOCHOLINE",27,-1.8988,0,0.0047,-1.003,0.44,1,-0.7658,0.84,0.87
"C7_Immunologic_signatures:C7_ALL_1131_GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP","C7_Immunologic_signatures","C7_ALL_1131_GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP",183,-1.8986,0,0,-0.7035,0.99,1,-1.0799,0.26,0.54
"GO_BP:512066_GO_0051156_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS","GO_BP","512066_GO_0051156_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS",22,-1.8986,0,0.0083,-0.8612,0.64,1,-1.4745,0.054,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1868_MOREIRA_RESPONSE_TO_TSA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1868_MOREIRA_RESPONSE_TO_TSA_DN",18,-1.8985,0,0.0031,0.9143,0.59,0.91,-0.9185,0.56,0.85
"GO_BP:488136_GO_0002263_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488136_GO_0002263_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",120,-1.8981,0,0.0083,-0.6414,1,1,-1.0896,0.25,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_229_BILBAN_B_CLL_LPL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_229_BILBAN_B_CLL_LPL_DN",42,-1.8978,0.0014,0.0031,-1.3187,0.11,0.7,-1.9383,0,0.063
"C2_Chemical_and_genetic_perturbations:C2_CGP_2270_SMID_BREAST_CANCER_ERBB2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2270_SMID_BREAST_CANCER_ERBB2_UP",133,-1.8978,0,0.0031,-0.7908,0.92,1,-0.8541,0.81,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_639_HUMMERICH_SKIN_CANCER_PROGRESSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_639_HUMMERICH_SKIN_CANCER_PROGRESSION_UP",85,-1.8976,0,0.0031,0.9203,0.64,0.9,0.8848,0.72,1
"REACTOME:366167_REACT_75808_THE_NLRP3_INFLAMMASOME","REACTOME","366167_REACT_75808_THE_NLRP3_INFLAMMASOME",12,-1.8969,0,0.014,-0.9582,0.5,1,-1.5017,0.072,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_2672_ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2672_ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP",32,-1.8968,0.0015,0.0032,0.9567,0.51,0.86,0.6938,0.92,1
"C7_Immunologic_signatures:C7_ALL_651_GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_651_GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDM_UP",195,-1.8968,0,0,1.5186,0.0023,0.0094,-1.1774,0.11,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_544_DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_544_DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP",141,-1.8961,0,0.0032,1.0588,0.35,0.7,-0.9268,0.66,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1454_MA_MYELOID_DIFFERENTIATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1454_MA_MYELOID_DIFFERENTIATION_DN",44,-1.8959,0,0.0032,-0.8484,0.71,1,-0.7889,0.87,0.96
"C7_Immunologic_signatures:C7_ALL_860_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN","C7_Immunologic_signatures","C7_ALL_860_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN",191,-1.8958,0,0,-0.7947,0.94,1,-1.9789,0,0
"WikiPathways:198864_WP364_IL_6_SIGNALING_PATHWAY","WikiPathways","198864_WP364_IL_6_SIGNALING_PATHWAY",98,-1.8955,0,0.0042,-1.0268,0.38,0.98,-1.5796,0.0041,0.28
"C2_Chemical_and_genetic_perturbations:C2_CGP_2855_CAIRO_HEPATOBLASTOMA_CLASSES_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2855_CAIRO_HEPATOBLASTOMA_CLASSES_DN",206,-1.8954,0,0.0032,-0.8761,0.8,1,-1.2252,0.062,0.5
"KEGG_pathway:HSA05020_PRION_DISEASES","KEGG_pathway","HSA05020_PRION_DISEASES",36,-1.895,0,0.00099,-0.9777,0.49,0.9,-1.4726,0.03,0.15
"C2_Chemical_and_genetic_perturbations:C2_CGP_1927_KAAB_FAILED_HEART_VENTRICLE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1927_KAAB_FAILED_HEART_VENTRICLE_DN",41,-1.8946,0,0.0032,0.9344,0.58,0.88,-1.1302,0.25,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2415_HUPER_BREAST_BASAL_VS_LUMINAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2415_HUPER_BREAST_BASAL_VS_LUMINAL_UP",53,-1.8945,0.0014,0.0032,1.1643,0.19,0.53,1.4531,0.02,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_3327_BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE","C2_Chemical_and_genetic_perturbations","C2_CGP_3327_BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE",150,-1.8945,0,0.0032,1.5854,0,0.15,0.8624,0.8,1
"GO_BP:512233_GO_0051349_POSITIVE_REGULATION_OF_LYASE_ACTIVITY","GO_BP","512233_GO_0051349_POSITIVE_REGULATION_OF_LYASE_ACTIVITY",68,-1.8944,0,0.0088,-0.9194,0.62,1,1.16,0.2,0.73
"C4_Cancer_modules:C4_CM_69_MODULE_73","C4_Cancer_modules","C4_CM_69_MODULE_73",23,-1.8942,0,0.0024,1.6137,0.014,0.071,1.7284,0.0074,0.096
"C2_Chemical_and_genetic_perturbations:C2_CGP_2571_SWEET_KRAS_ONCOGENIC_SIGNATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_2571_SWEET_KRAS_ONCOGENIC_SIGNATURE",89,-1.8942,0,0.0032,1.5669,0.0089,0.16,-0.6748,0.99,0.99
"C4_Cancer_modules:C4_CM_226_MODULE_248","C4_Cancer_modules","C4_CM_226_MODULE_248",129,-1.8941,0,0.0023,-1.1735,0.16,0.62,-1.0061,0.45,0.68
"GO_BP:510586_GO_0048514_BLOOD_VESSEL_MORPHOGENESIS","GO_BP","510586_GO_0048514_BLOOD_VESSEL_MORPHOGENESIS",359,-1.8941,0,0.0088,-1.0744,0.25,0.96,1.3352,0.017,0.65
"REACTOME:160967_REACT_20649_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS","REACTOME","160967_REACT_20649_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS",17,-1.8939,0,0.014,-0.9951,0.47,0.99,-0.9216,0.55,0.93
"C7_Immunologic_signatures:C7_ALL_1406_GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1406_GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN",195,-1.8936,0,0,1.0158,0.38,0.69,-1.079,0.26,0.54
"GO_BP:1184560_GO_1904036_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS","GO_BP","1184560_GO_1904036_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS",32,-1.8933,0,0.0089,0.9542,0.5,1,1.3181,0.087,0.66
"GO_BP:513296_GO_0052548_REGULATION_OF_ENDOPEPTIDASE_ACTIVITY","GO_BP","513296_GO_0052548_REGULATION_OF_ENDOPEPTIDASE_ACTIVITY",352,-1.893,0,0.0089,0.99,0.5,0.99,-1.1092,0.15,0.77
"KEGG_pathway:HSA04810_REGULATION_OF_ACTIN_CYTOSKELETON","KEGG_pathway","HSA04810_REGULATION_OF_ACTIN_CYTOSKELETON",202,-1.8928,0,0.0011,-0.9425,0.6,0.97,0.7927,0.95,1
"GO_BP:501983_GO_0032757_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION","GO_BP","501983_GO_0032757_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION",34,-1.8926,0.0015,0.0089,1.2389,0.13,0.75,0.8302,0.75,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2723_CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2723_CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP",176,-1.8925,0,0.0033,-0.9397,0.61,1,-1.2409,0.063,0.48
"GO_BP:488869_GO_0003071_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE","GO_BP","488869_GO_0003071_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE",23,-1.8924,0,0.0089,1.4615,0.045,0.48,1.1915,0.22,0.72
"GO_BP:487930_GO_0002040_SPROUTING_ANGIOGENESIS","GO_BP","487930_GO_0002040_SPROUTING_ANGIOGENESIS",42,-1.892,0,0.0089,-1.4214,0.042,0.94,-1.4389,0.04,0.56
"KEGG_pathway:HSA04664_FC_EPSILON_RI_SIGNALING_PATHWAY","KEGG_pathway","HSA04664_FC_EPSILON_RI_SIGNALING_PATHWAY",70,-1.8919,0,0.001,-1.2767,0.079,0.46,-1.4239,0.03,0.17
"C4_Cancer_modules:C4_CM_396_MODULE_501","C4_Cancer_modules","C4_CM_396_MODULE_501",15,-1.8916,0.0016,0.0024,-1.5621,0.034,0.3,-1.2805,0.17,0.31
"GO_BP:488558_GO_0002685_REGULATION_OF_LEUKOCYTE_MIGRATION","GO_BP","488558_GO_0002685_REGULATION_OF_LEUKOCYTE_MIGRATION",126,-1.8909,0,0.009,1.0045,0.47,0.98,1.2388,0.1,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_1243_ONDER_CDH1_TARGETS_3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1243_ONDER_CDH1_TARGETS_3_DN",53,-1.8909,0,0.0034,-1.0792,0.34,0.95,1.4182,0.032,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_2454_VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2454_VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP",160,-1.8908,0,0.0034,0.9809,0.52,0.81,1.1327,0.19,0.84
"GO_BP:512065_GO_0051155_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION","GO_BP","512065_GO_0051155_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION",41,-1.8908,0,0.009,1.1493,0.22,0.84,0.8975,0.65,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2182_MARZEC_IL2_SIGNALING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2182_MARZEC_IL2_SIGNALING_DN",36,-1.8907,0,0.0033,-0.7937,0.82,1,-1.55,0.027,0.27
"C4_Cancer_modules:C4_CM_288_MODULE_329","C4_Cancer_modules","C4_CM_288_MODULE_329",51,-1.8907,0,0.0024,-1.0337,0.4,0.76,-1.2126,0.16,0.39
"GO_BP:488577_GO_0002704_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY","GO_BP","488577_GO_0002704_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY",37,-1.8904,0,0.0091,-0.6165,0.98,1,-0.7021,0.92,0.99
"KEGG_compound:C04635_1_1_ALKENYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_1_ALKENYLGLYCEROPHOSPHOETHANOLAMINE","KEGG_compound","C04635_1_1_ALKENYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_1_ALKENYLGLYCEROPHOSPHOETHANOLAMINE",22,-1.8901,0,0.0053,-0.8815,0.61,1,-0.8639,0.68,0.8
"C4_Cancer_gene_neighborhoods:C4_CGN_293_GNF2_CCNA2","C4_Cancer_gene_neighborhoods","C4_CGN_293_GNF2_CCNA2",68,-1.8895,0,0.00091,0.9036,0.67,0.83,-2.1518,0,0
"GO_BP:502362_GO_0033141_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN","GO_BP","502362_GO_0033141_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN",14,-1.8887,0.0015,0.0093,-1.1441,0.28,0.93,-2.1941,0,0.016
"C2_Chemical_and_genetic_perturbations:C2_CGP_2551_RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2551_RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN",241,-1.8885,0,0.0034,-0.9125,0.71,1,-1.2452,0.045,0.48
"GO_CC:490685_GO_0008305_INTEGRIN_COMPLEX","GO_CC","490685_GO_0008305_INTEGRIN_COMPLEX",30,-1.8885,0.0014,0.01,-0.8992,0.6,0.96,0.7894,0.83,1
"C3_TF_targets:C3_TFT_316_V_AP1_01","C3_TF_targets","C3_TFT_316_V_AP1_01",261,-1.8884,0,0.0033,-1.2574,0.035,0.27,-1.1469,0.11,0.47
"C7_Immunologic_signatures:C7_ALL_1744_GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1744_GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN",161,-1.888,0,0,1.0428,0.35,0.61,0.8773,0.78,1
"GO_BP:505454_GO_0042307_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","505454_GO_0042307_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS",85,-1.8879,0,0.0094,-1.1237,0.25,0.94,-1.483,0.01,0.53
"GO_BP:506082_GO_0042990_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS","GO_BP","506082_GO_0042990_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS",82,-1.8878,0,0.0094,-0.9782,0.49,1,-1.5814,0,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2065_GAVIN_PDE3B_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2065_GAVIN_PDE3B_TARGETS",22,-1.8878,0.0015,0.0035,-0.6799,0.92,1,-1.2732,0.15,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_438_CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_438_CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",171,-1.8878,0,0.0034,-0.9245,0.66,1,-1.5429,0,0.27
"GO_BP:489005_GO_0003211_CARDIAC_VENTRICLE_FORMATION","GO_BP","489005_GO_0003211_CARDIAC_VENTRICLE_FORMATION",10,-1.8876,0.0016,0.0094,-1.1,0.35,0.94,1.306,0.18,0.67
"C7_Immunologic_signatures:C7_ALL_1030_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN","C7_Immunologic_signatures","C7_ALL_1030_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN",195,-1.8874,0,0,-0.749,0.98,1,-1.5769,0,0.0078
"GO_BP:519041_GO_2000401_REGULATION_OF_LYMPHOCYTE_MIGRATION","GO_BP","519041_GO_2000401_REGULATION_OF_LYMPHOCYTE_MIGRATION",36,-1.8874,0,0.0094,1.1472,0.25,0.84,1.2375,0.16,0.7
"GO_CC:506270_GO_0043202_LYSOSOMAL_LUMEN","GO_CC","506270_GO_0043202_LYSOSOMAL_LUMEN",71,-1.8867,0,0.01,-0.9475,0.55,0.89,1.231,0.13,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_2750_YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2750_YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP",10,-1.8866,0.0017,0.0035,-1.5556,0.03,0.43,-1.1555,0.28,0.57
"REACTOME:645324_REACT_121384_ACYL_CHAIN_REMODELLING_OF_PS","REACTOME","645324_REACT_121384_ACYL_CHAIN_REMODELLING_OF_PS",15,-1.8865,0,0.015,-0.9145,0.56,1,0.9228,0.56,1
"C7_Immunologic_signatures:C7_ALL_1031_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP","C7_Immunologic_signatures","C7_ALL_1031_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP",195,-1.8865,0,0,-0.7349,0.98,1,-1.136,0.14,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_1022_SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1022_SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP",11,-1.8862,0,0.0035,-0.8497,0.66,1,-1.4722,0.067,0.31
"GO_BP:500912_GO_0031663_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY","GO_BP","500912_GO_0031663_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY",27,-1.8862,0.003,0.0095,-1.054,0.37,0.97,-1.0265,0.39,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_495_ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_495_ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN",26,-1.8861,0,0.0035,-0.9352,0.57,1,-1.0089,0.44,0.74
"GO_BP:488568_GO_0002695_NEGATIVE_REGULATION_OF_LEUKOCYTE_ACTIVATION","GO_BP","488568_GO_0002695_NEGATIVE_REGULATION_OF_LEUKOCYTE_ACTIVATION",121,-1.8858,0,0.0095,-0.791,0.91,1,1.0177,0.44,0.84
"C7_Immunologic_signatures:C7_ALL_310_GSE1460_DP_VS_CD4_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_310_GSE1460_DP_VS_CD4_THYMOCYTE_DN",200,-1.8858,0,0,1.2786,0.034,0.12,-1.0662,0.29,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_193_OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_193_OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP",232,-1.8857,0,0.0035,-1.0872,0.23,0.94,-1.4129,0.0082,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_2697_JISON_SICKLE_CELL_DISEASE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2697_JISON_SICKLE_CELL_DISEASE_UP",180,-1.8856,0,0.0035,1.3784,0.012,0.31,-1.2081,0.081,0.51
"GO_BP:512140_GO_0051249_REGULATION_OF_LYMPHOCYTE_ACTIVATION","GO_BP","512140_GO_0051249_REGULATION_OF_LYMPHOCYTE_ACTIVATION",351,-1.8856,0,0.0095,0.7758,0.99,1,-1.1798,0.056,0.74
"GO_BP:507925_GO_0045577_REGULATION_OF_B_CELL_DIFFERENTIATION","GO_BP","507925_GO_0045577_REGULATION_OF_B_CELL_DIFFERENTIATION",23,-1.8856,0,0.0095,-0.8383,0.69,1,-1.0451,0.4,0.81
"GO_BP:514552_GO_0060997_DENDRITIC_SPINE_MORPHOGENESIS","GO_BP","514552_GO_0060997_DENDRITIC_SPINE_MORPHOGENESIS",8,-1.8852,0,0.0095,-1.3731,0.13,0.98,-1.2242,0.23,0.71
"C3_TF_targets:C3_TFT_117_ARGGGTTAA_UNKNOWN","C3_TF_targets","C3_TFT_117_ARGGGTTAA_UNKNOWN",119,-1.8852,0,0.0025,-1.1967,0.12,0.35,-1.1007,0.24,0.54
"GO_BP:491051_GO_0006066_ALCOHOL_METABOLIC_PROCESS","GO_BP","491051_GO_0006066_ALCOHOL_METABOLIC_PROCESS",341,-1.8846,0,0.0095,-1.0007,0.47,0.99,0.94,0.66,0.91
"C7_Immunologic_signatures:C7_ALL_1616_GSE3982_MAST_CELL_VS_BASOPHIL_DN","C7_Immunologic_signatures","C7_ALL_1616_GSE3982_MAST_CELL_VS_BASOPHIL_DN",197,-1.8846,0,0,1.0075,0.43,0.71,-1.1019,0.19,0.49
"C2_Chemical_and_genetic_perturbations:C2_CGP_2297_BASSO_HAIRY_CELL_LEUKEMIA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2297_BASSO_HAIRY_CELL_LEUKEMIA_DN",80,-1.8844,0.0013,0.0035,0.7513,0.94,1,1.015,0.42,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2607_ZHANG_TLX_TARGETS_60HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2607_ZHANG_TLX_TARGETS_60HR_UP",292,-1.8844,0,0.0035,-0.8696,0.85,1,-1.0017,0.44,0.75
"GO_BP:501590_GO_0032355_RESPONSE_TO_ESTRADIOL","GO_BP","501590_GO_0032355_RESPONSE_TO_ESTRADIOL",95,-1.8841,0,0.0096,-0.9991,0.45,0.99,0.9278,0.62,0.92
"C4_Cancer_modules:C4_CM_30_MODULE_33","C4_Cancer_modules","C4_CM_30_MODULE_33",370,-1.8838,0,0.0025,-0.981,0.54,0.83,-1.1342,0.11,0.48
"C3_MicroRNA_targets:C3_MIR_134_TCTCTCC_MIR_185","C3_MicroRNA_targets","C3_MIR_134_TCTCTCC_MIR_185",123,-1.8837,0,0.024,-1.0881,0.27,1,1.1387,0.18,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_118_BIOCARTA_MONOCYTE_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_118_BIOCARTA_MONOCYTE_PATHWAY",11,-1.8834,0,0.012,-0.5484,0.97,1,-1.2997,0.15,0.51
"GO_BP:488590_GO_0002717_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY","GO_BP","488590_GO_0002717_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY",19,-1.8833,0.0016,0.0097,-0.4308,1,1,-1.1903,0.22,0.74
"GO_BP:808778_GO_1902107_POSITIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION","GO_BP","808778_GO_1902107_POSITIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION",121,-1.8833,0,0.0096,-1.1786,0.13,0.91,-1.2535,0.078,0.68
"GO_BP:487506_GO_0001568_BLOOD_VESSEL_DEVELOPMENT","GO_BP","487506_GO_0001568_BLOOD_VESSEL_DEVELOPMENT",428,-1.8832,0,0.0096,-1.0441,0.32,0.97,1.2951,0.0058,0.67
"GO_BP:488160_GO_0002287_ALPHA_BETA_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488160_GO_0002287_ALPHA_BETA_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",23,-1.8829,0.0015,0.0096,-1.0893,0.31,0.95,-0.8653,0.69,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2064_GAVIN_FOXP3_TARGETS_CLUSTER_P7","C2_Chemical_and_genetic_perturbations","C2_CGP_2064_GAVIN_FOXP3_TARGETS_CLUSTER_P7",89,-1.8827,0,0.0036,-0.5603,1,1,-0.9973,0.45,0.76
"REACTOME:205110_REACT_27283_INTERLEUKIN_2_SIGNALING","REACTOME","205110_REACT_27283_INTERLEUKIN_2_SIGNALING",49,-1.8826,0,0.015,-0.7366,0.92,1,-1.1335,0.22,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_293_ZHOU_INFLAMMATORY_RESPONSE_LPS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_293_ZHOU_INFLAMMATORY_RESPONSE_LPS_UP",402,-1.8825,0,0.0036,-1.1822,0.069,0.82,-1.0812,0.2,0.65
"GO_BP:506448_GO_0043410_POSITIVE_REGULATION_OF_MAPK_CASCADE","GO_BP","506448_GO_0043410_POSITIVE_REGULATION_OF_MAPK_CASCADE",404,-1.8821,0,0.0098,-0.9721,0.54,1,1.0733,0.24,0.78
"KEGG_compound:C01595_LINOLEATE_LINOLEIC_ACID_9Z_12Z_OCTADECADIENOIC_ACID_9_CIS_12_CIS_OCTADECADIENOATE_9_CIS_12_CIS_OCTADECADIENOIC_ACID","KEGG_compound","C01595_LINOLEATE_LINOLEIC_ACID_9Z_12Z_OCTADECADIENOIC_ACID_9_CIS_12_CIS_OCTADECADIENOATE_9_CIS_12_CIS_OCTADECADIENOIC_ACID",30,-1.8816,0.0014,0.0058,-0.8957,0.65,1,1.1924,0.2,0.56
"C2_Chemical_and_genetic_perturbations:C2_CGP_3244_SERVITJA_LIVER_HNF1A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3244_SERVITJA_LIVER_HNF1A_TARGETS_UP",130,-1.8815,0,0.0036,-0.7464,0.97,1,-0.9669,0.53,0.8
"GO_BP:497083_GO_0018108_PEPTIDYL_TYROSINE_PHOSPHORYLATION","GO_BP","497083_GO_0018108_PEPTIDYL_TYROSINE_PHOSPHORYLATION",149,-1.8815,0,0.0098,-1.2505,0.068,0.91,-1.2478,0.053,0.68
"GO_CC:499487_GO_0030027_LAMELLIPODIUM","GO_CC","499487_GO_0030027_LAMELLIPODIUM",155,-1.8815,0,0.011,-0.8825,0.76,0.95,0.7745,0.97,1
"GO_BP:808777_GO_1902106_NEGATIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION","GO_BP","808777_GO_1902106_NEGATIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION",74,-1.8814,0,0.0098,-1.079,0.31,0.95,1.1728,0.17,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_223_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_223_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN",139,-1.8813,0,0.0036,1.4205,0.016,0.28,1.3307,0.029,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_1827_GEORGANTAS_HSC_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_1827_GEORGANTAS_HSC_MARKERS",70,-1.8812,0,0.0036,0.89,0.69,0.94,-1.2122,0.14,0.51
"GO_BP:505665_GO_0042534_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS","GO_BP","505665_GO_0042534_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS",15,-1.881,0,0.0098,-0.7263,0.84,1,-0.9481,0.52,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_642_KLEIN_TARGETS_OF_BCR_ABL1_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_642_KLEIN_TARGETS_OF_BCR_ABL1_FUSION",45,-1.8809,0,0.0036,-1.092,0.32,0.93,-1.5633,0.0065,0.27
"C7_Immunologic_signatures:C7_ALL_885_GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP","C7_Immunologic_signatures","C7_ALL_885_GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP",196,-1.8809,0,0,-0.9206,0.68,1,-1.0128,0.44,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_906_HOWLIN_PUBERTAL_MAMMARY_GLAND","C2_Chemical_and_genetic_perturbations","C2_CGP_906_HOWLIN_PUBERTAL_MAMMARY_GLAND",63,-1.8804,0,0.0036,0.8953,0.67,0.93,0.9686,0.51,0.97
"GO_BP:492564_GO_0050830_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM","GO_BP","492564_GO_0050830_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM",62,-1.8802,0,0.0099,0.8656,0.71,1,-0.9321,0.57,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2600_SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4","C2_Chemical_and_genetic_perturbations","C2_CGP_2600_SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4",193,-1.88,0,0.0037,-1.3888,0.0089,0.6,-1.4826,0,0.31
"GO_MF:515779_GO_0070851_GROWTH_FACTOR_RECEPTOR_BINDING","GO_MF","515779_GO_0070851_GROWTH_FACTOR_RECEPTOR_BINDING",112,-1.8798,0,0.029,-1.021,0.42,0.89,0.7948,0.89,1
"GO_BP:489312_GO_0006953_ACUTE_PHASE_RESPONSE","GO_BP","489312_GO_0006953_ACUTE_PHASE_RESPONSE",36,-1.8794,0,0.0099,-1.1621,0.22,0.92,1.1431,0.25,0.73
"KEGG_pathway:HSA04260_CARDIAC_MUSCLE_CONTRACTION","KEGG_pathway","HSA04260_CARDIAC_MUSCLE_CONTRACTION",70,-1.8792,0,0.0011,1.0228,0.4,0.87,0.6978,0.97,1
"KEGG_pathway:HSA04064_NF_KAPPA_B_SIGNALING_PATHWAY","KEGG_pathway","HSA04064_NF_KAPPA_B_SIGNALING_PATHWAY",87,-1.8792,0,0.0011,-1.08,0.34,0.7,-1.1176,0.24,0.49
"C7_Immunologic_signatures:C7_ALL_9_KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_9_KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP",199,-1.8789,0,0,1.6456,0,0.0012,-1.306,0.026,0.13
"GO_BP:753175_GO_1900182_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS","GO_BP","753175_GO_1900182_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS",92,-1.8787,0,0.01,-1.013,0.4,0.98,-1.6087,0.0044,0.52
"REACTOME:106062_REACT_12051_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL","REACTOME","106062_REACT_12051_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL",99,-1.8785,0,0.015,0.8451,0.82,0.96,-0.9541,0.57,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2031_SINGH_NFE2L2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2031_SINGH_NFE2L2_TARGETS",15,-1.8784,0,0.0037,-1.4631,0.07,0.52,-1.3294,0.14,0.41
"GO_BP:511855_GO_0050920_REGULATION_OF_CHEMOTAXIS","GO_BP","511855_GO_0050920_REGULATION_OF_CHEMOTAXIS",138,-1.8783,0,0.01,0.8571,0.84,1,1.2612,0.069,0.69
"GO_BP:514882_GO_0061337_CARDIAC_CONDUCTION","GO_BP","514882_GO_0061337_CARDIAC_CONDUCTION",50,-1.8781,0,0.01,-1.4433,0.036,0.91,1.0823,0.32,0.77
"GO_CC:515098_GO_0070161_ANCHORING_JUNCTION","GO_CC","515098_GO_0070161_ANCHORING_JUNCTION",490,-1.8781,0,0.011,1.5082,0,0.19,-0.9308,0.75,1
"GO_BP:488166_GO_0002293_ALPHA_BETA_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488166_GO_0002293_ALPHA_BETA_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE",23,-1.878,0,0.01,-1.1193,0.3,0.94,-0.8777,0.64,0.94
"GO_BP:508875_GO_0046627_NEGATIVE_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","508875_GO_0046627_NEGATIVE_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY",28,-1.8779,0.0015,0.01,-1.1239,0.29,0.94,-0.8856,0.64,0.94
"GO_BP:511795_GO_0050850_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING","GO_BP","511795_GO_0050850_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING",27,-1.8778,0.0031,0.0099,-0.8695,0.67,1,-0.8311,0.74,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_863_GRUETZMANN_PANCREATIC_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_863_GRUETZMANN_PANCREATIC_CANCER_UP",357,-1.8778,0,0.0037,1.1757,0.058,0.52,-1.0873,0.17,0.65
"GO_BP:752806_GO_0097305_RESPONSE_TO_ALCOHOL","GO_BP","752806_GO_0097305_RESPONSE_TO_ALCOHOL",275,-1.8773,0,0.01,0.9562,0.61,1,1.0985,0.19,0.76
"GO_BP:505171_GO_0040013_NEGATIVE_REGULATION_OF_LOCOMOTION","GO_BP","505171_GO_0040013_NEGATIVE_REGULATION_OF_LOCOMOTION",220,-1.8771,0,0.01,-0.771,0.97,1,1.0257,0.37,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1422_KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1422_KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP",51,-1.8771,0.0013,0.0037,0.8148,0.81,0.98,-1.2115,0.16,0.51
"C4_Cancer_modules:C4_CM_424_MODULE_562","C4_Cancer_modules","C4_CM_424_MODULE_562",21,-1.8771,0,0.0028,-0.8622,0.66,0.94,-1.1652,0.23,0.45
"GO_BP:516360_GO_0071436_SODIUM_ION_EXPORT","GO_BP","516360_GO_0071436_SODIUM_ION_EXPORT",9,-1.8769,0,0.01,-1.6944,0.018,0.59,-1.7867,0.0057,0.58
"GO_BP:506196_GO_0043122_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING","GO_BP","506196_GO_0043122_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING",225,-1.8766,0,0.01,-0.8133,0.92,1,-1.374,0.004,0.59
"GO_CC:496363_GO_0016323_BASOLATERAL_PLASMA_MEMBRANE","GO_CC","496363_GO_0016323_BASOLATERAL_PLASMA_MEMBRANE",188,-1.8764,0,0.011,-1.2129,0.067,0.67,-1.2917,0.03,0.66
"REACTOME:106359_REACT_15344_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES","REACTOME","106359_REACT_15344_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES",50,-1.8764,0,0.015,1.7255,0.0043,0.039,1.6677,0.0018,0.41
"GO_BP:487834_GO_0001944_VASCULATURE_DEVELOPMENT","GO_BP","487834_GO_0001944_VASCULATURE_DEVELOPMENT",449,-1.8756,0,0.01,-1.0786,0.21,0.95,1.2806,0.013,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_3162_PASINI_SUZ12_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3162_PASINI_SUZ12_TARGETS_DN",313,-1.8756,0,0.0038,-0.8779,0.86,1,1.1487,0.12,0.83
"REACTOME:105924_REACT_18405_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION","REACTOME","105924_REACT_18405_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION",10,-1.8755,0,0.015,-1.4636,0.064,0.46,-1.014,0.44,0.82
"C7_Immunologic_signatures:C7_ALL_874_GSE20366_TREG_VS_TCONV_DN","C7_Immunologic_signatures","C7_ALL_874_GSE20366_TREG_VS_TCONV_DN",198,-1.8754,0,0,-0.9397,0.62,1,-0.886,0.79,0.97
"GO_BP:512141_GO_0051250_NEGATIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION","GO_BP","512141_GO_0051250_NEGATIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION",104,-1.8752,0,0.01,-0.8192,0.86,1,0.9465,0.53,0.91
"GO_BP:512641_GO_0051769_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS","GO_BP","512641_GO_0051769_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS",19,-1.875,0,0.01,0.6969,0.89,1,0.9293,0.55,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1585_HANSON_HRAS_SIGNALING_VIA_NFKB","C2_Chemical_and_genetic_perturbations","C2_CGP_1585_HANSON_HRAS_SIGNALING_VIA_NFKB",21,-1.8749,0,0.0038,-0.9429,0.53,1,-0.9392,0.54,0.83
"C7_Immunologic_signatures:C7_ALL_1071_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP","C7_Immunologic_signatures","C7_ALL_1071_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP",198,-1.8749,0,0,-0.8534,0.86,1,1.0227,0.4,1
"C0_Hallmark:H_ALL_38_HALLMARK_UV_RESPONSE_UP","C0_Hallmark","H_ALL_38_HALLMARK_UV_RESPONSE_UP",158,-1.8746,0,0.00019,-1.4887,0.0053,0.073,-1.6317,0,0.019
"C2_Chemical_and_genetic_perturbations:C2_CGP_333_GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_333_GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN",93,-1.8744,0,0.0039,0.8935,0.71,0.93,-0.9783,0.48,0.78
"C4_Cancer_modules:C4_CM_206_MODULE_221","C4_Cancer_modules","C4_CM_206_MODULE_221",30,-1.8744,0,0.0028,0.7148,0.9,1,-1.7092,0.0077,0.085
"REACTOME:1183538_REACT_355462_IRAK4_DEFICIENCY_TLR2_4_","REACTOME","1183538_REACT_355462_IRAK4_DEFICIENCY_TLR2_4_",10,-1.8743,0.0034,0.015,-0.829,0.68,1,-0.9403,0.53,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_2012_ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM","C2_Chemical_and_genetic_perturbations","C2_CGP_2012_ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM",63,-1.8742,0,0.0039,1.2771,0.086,0.42,0.6829,0.99,1
"WikiPathways:672448_WP2059_ALZHEIMERS_DISEASE","WikiPathways","672448_WP2059_ALZHEIMERS_DISEASE",77,-1.8742,0,0.0054,-0.7947,0.86,1,-1.1485,0.19,0.56
"C4_Cancer_modules:C4_CM_336_MODULE_401","C4_Cancer_modules","C4_CM_336_MODULE_401",13,-1.8736,0,0.0028,-0.7009,0.88,1,1.0512,0.38,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_311_ELVIDGE_HYPOXIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_311_ELVIDGE_HYPOXIA_UP",171,-1.8736,0,0.0039,-0.8828,0.77,1,-0.9323,0.62,0.84
"GO_MF:490244_GO_0004953_ICOSANOID_RECEPTOR_ACTIVITY","GO_MF","490244_GO_0004953_ICOSANOID_RECEPTOR_ACTIVITY",16,-1.8732,0.0031,0.031,1.349,0.13,0.53,0.745,0.82,1
"C7_Immunologic_signatures:C7_ALL_1479_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP","C7_Immunologic_signatures","C7_ALL_1479_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP",196,-1.8732,0,0,0.8084,0.96,1,0.8112,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1582_ZHAN_MULTIPLE_MYELOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1582_ZHAN_MULTIPLE_MYELOMA_DN",41,-1.8731,0,0.0039,1.2802,0.12,0.41,0.9942,0.47,0.97
"GO_BP:488591_GO_0002718_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488591_GO_0002718_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE",50,-1.8723,0,0.011,-1.1523,0.24,0.92,-0.964,0.52,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2303_MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2303_MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN",22,-1.8722,0,0.0039,-1.0768,0.34,0.95,-1.6735,0.022,0.21
"GO_BP:503310_GO_0034104_NEGATIVE_REGULATION_OF_TISSUE_REMODELING","GO_BP","503310_GO_0034104_NEGATIVE_REGULATION_OF_TISSUE_REMODELING",15,-1.8722,0,0.011,0.7929,0.73,1,1.149,0.29,0.73
"GO_BP:500601_GO_0031342_NEGATIVE_REGULATION_OF_CELL_KILLING","GO_BP","500601_GO_0031342_NEGATIVE_REGULATION_OF_CELL_KILLING",13,-1.8721,0.0016,0.01,-0.5608,0.98,1,-0.7613,0.77,1
"C7_Immunologic_signatures:C7_ALL_1523_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP","C7_Immunologic_signatures","C7_ALL_1523_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP",196,-1.8717,0,0,-0.8137,0.92,1,-1.4571,0,0.033
"C7_Immunologic_signatures:C7_ALL_1043_GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1043_GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP",196,-1.8716,0,0,-0.9992,0.47,1,-1.4584,0.0021,0.033
"GO_BP:488165_GO_0002292_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488165_GO_0002292_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE",23,-1.8715,0,0.011,-1.1081,0.28,0.94,-0.8753,0.64,0.95
"WikiPathways:198880_WP558_COMPLEMENT_AND_COAGULATION_CASCADES","WikiPathways","198880_WP558_COMPLEMENT_AND_COAGULATION_CASCADES",51,-1.8714,0,0.0052,0.9695,0.52,1,0.846,0.75,1
"C6_Oncogenic_signatures:C6_ALL_154_STK33_NOMO_UP","C6_Oncogenic_signatures","C6_ALL_154_STK33_NOMO_UP",284,-1.8713,0,0.00035,0.7961,0.99,0.98,1.6529,0,0.07
"C7_Immunologic_signatures:C7_ALL_1687_GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1687_GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP",200,-1.8712,0,0,1.2737,0.041,0.13,-0.8347,0.92,1
"GO_BP:488561_GO_0002688_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS","GO_BP","488561_GO_0002688_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS",82,-1.8708,0,0.011,1.1024,0.26,0.9,1.3606,0.036,0.64
"KEGG_compound:C01176_17ALPHA_HYDROXYPROGESTERONE_17ALPHA_HYDROXY_4_PREGNENE_3_20_DIONE_PREGN_4_ENE_3_20_DIONE_17_OL_17ALPHA_HYDROXY_PROGESTERONE","KEGG_compound","C01176_17ALPHA_HYDROXYPROGESTERONE_17ALPHA_HYDROXY_4_PREGNENE_3_20_DIONE_PREGN_4_ENE_3_20_DIONE_17_OL_17ALPHA_HYDROXY_PROGESTERONE",6,-1.8708,0.0034,0.0066,1.275,0.2,0.79,1.4978,0.061,0.17
"C2_Chemical_and_genetic_perturbations:C2_CGP_2628_SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE","C2_Chemical_and_genetic_perturbations","C2_CGP_2628_SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE",101,-1.8707,0,0.004,0.6419,1,1,-1.512,0.002,0.29
"C7_Immunologic_signatures:C7_ALL_1340_GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1340_GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN",196,-1.8707,0,0,-1.2842,0.034,0.5,-0.9961,0.46,0.73
"GO_MF:490372_GO_0046875_EPHRIN_RECEPTOR_BINDING","GO_MF","490372_GO_0046875_EPHRIN_RECEPTOR_BINDING",29,-1.8703,0,0.03,-1.2851,0.13,0.81,-1.2399,0.16,0.59
"C7_Immunologic_signatures:C7_ALL_637_GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_637_GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDM_UP",192,-1.8695,0,0,-1.1977,0.091,0.82,-1.1777,0.094,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_3111_WIERENGA_STAT5A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3111_WIERENGA_STAT5A_TARGETS_UP",216,-1.8693,0,0.0041,-1.0344,0.38,0.97,-1.1271,0.19,0.59
"GO_BP:487515_GO_0007157_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES","GO_BP","487515_GO_0007157_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES",32,-1.8692,0,0.011,-0.9211,0.57,1,-0.8601,0.66,0.96
"GO_CC:499432_GO_0042101_T_CELL_RECEPTOR_COMPLEX","GO_CC","499432_GO_0042101_T_CELL_RECEPTOR_COMPLEX",14,-1.8689,0.003,0.012,1.4064,0.07,0.29,-1.4626,0.066,0.51
"KEGG_pathway:HSA04145_PHAGOSOME","KEGG_pathway","HSA04145_PHAGOSOME",146,-1.8688,0,0.0013,0.7662,0.95,1,0.9208,0.64,1
"C4_Cancer_modules:C4_CM_417_MODULE_543","C4_Cancer_modules","C4_CM_417_MODULE_543",14,-1.8688,0.0031,0.003,-0.9324,0.55,0.88,0.7565,0.81,1
"WikiPathways:198795_WP306_FOCAL_ADHESION","WikiPathways","198795_WP306_FOCAL_ADHESION",181,-1.8687,0,0.0051,0.7486,0.99,1,0.9182,0.68,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_1442_ZHAN_MULTIPLE_MYELOMA_CD1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1442_ZHAN_MULTIPLE_MYELOMA_CD1_UP",45,-1.8685,0,0.0041,-0.9644,0.51,1,-1.4583,0.025,0.32
"C4_Cancer_modules:C4_CM_264_MODULE_300","C4_Cancer_modules","C4_CM_264_MODULE_300",33,-1.8682,0,0.0029,-0.6491,0.95,1,-1.0354,0.41,0.63
"GO_BP:488322_GO_0002449_LYMPHOCYTE_MEDIATED_IMMUNITY","GO_BP","488322_GO_0002449_LYMPHOCYTE_MEDIATED_IMMUNITY",120,-1.8677,0,0.011,0.6908,1,1,-1.0994,0.26,0.78
"GO_BP:512159_GO_0051271_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_MOVEMENT","GO_BP","512159_GO_0051271_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_MOVEMENT",199,-1.8677,0,0.011,-0.8401,0.89,1,1.0729,0.27,0.78
"GO_BP:508019_GO_0045671_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION","GO_BP","508019_GO_0045671_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION",21,-1.8675,0.0016,0.011,-0.8362,0.71,1,1.3405,0.1,0.65
"GO_BP:488572_GO_0002699_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS","GO_BP","488572_GO_0002699_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS",152,-1.867,0,0.011,-1.043,0.35,0.98,-1.1418,0.18,0.75
"GO_BP:500607_GO_0031348_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE","GO_BP","500607_GO_0031348_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE",124,-1.8669,0,0.011,0.7886,0.95,1,0.6655,1,1
"GO_BP:488694_GO_0002821_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE","GO_BP","488694_GO_0002821_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE",81,-1.8668,0,0.011,-1.4638,0.016,0.87,-1.4555,0.029,0.54
"REACTOME:106036_REACT_1695_GPVI_MEDIATED_ACTIVATION_CASCADE","REACTOME","106036_REACT_1695_GPVI_MEDIATED_ACTIVATION_CASCADE",49,-1.8668,0.0014,0.016,-0.6574,0.97,1,-1.1034,0.29,0.7
"GO_BP:501835_GO_0032609_INTERFERON_GAMMA_PRODUCTION","GO_BP","501835_GO_0032609_INTERFERON_GAMMA_PRODUCTION",18,-1.8666,0,0.011,-0.9439,0.54,1,-1.0214,0.41,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_488_WANG_BARRETTS_ESOPHAGUS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_488_WANG_BARRETTS_ESOPHAGUS_DN",22,-1.8663,0,0.0042,0.729,0.86,1,1.0013,0.46,0.96
"REACTOME:106503_REACT_11051_RHO_GTPASE_CYCLE","REACTOME","106503_REACT_11051_RHO_GTPASE_CYCLE",123,-1.8663,0,0.015,-1.1608,0.19,0.84,-1.1412,0.18,0.67
"C7_Immunologic_signatures:C7_ALL_1840_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN","C7_Immunologic_signatures","C7_ALL_1840_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN",189,-1.8662,0,0,0.9937,0.47,0.76,1.3912,0.025,0.15
"C2_Chemical_and_genetic_perturbations:C2_CGP_480_WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_480_WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN",34,-1.8661,0,0.0042,-1.3935,0.058,0.59,-0.8748,0.66,0.9
"GO_BP:501889_GO_0032663_REGULATION_OF_INTERLEUKIN_2_PRODUCTION","GO_BP","501889_GO_0032663_REGULATION_OF_INTERLEUKIN_2_PRODUCTION",46,-1.8656,0,0.011,-0.9607,0.51,1,-1.0113,0.44,0.84
"REACTOME:106153_REACT_11047_MINERALOCORTICOID_BIOSYNTHESIS","REACTOME","106153_REACT_11047_MINERALOCORTICOID_BIOSYNTHESIS",6,-1.8652,0.0017,0.015,0.9309,0.54,0.86,1.3185,0.18,0.77
"REACTOME:730312_REACT_150361_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH","REACTOME","730312_REACT_150361_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH",10,-1.865,0,0.015,-0.568,0.96,1,0.6146,0.92,1
"C7_Immunologic_signatures:C7_ALL_1377_GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP","C7_Immunologic_signatures","C7_ALL_1377_GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP",197,-1.8644,0,0,-0.8549,0.85,1,-0.9581,0.57,0.83
"C7_Immunologic_signatures:C7_ALL_175_GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP","C7_Immunologic_signatures","C7_ALL_175_GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP",191,-1.8641,0,0,-1.1696,0.11,0.93,-1.2975,0.028,0.14
"GO_BP:516724_GO_0071801_REGULATION_OF_PODOSOME_ASSEMBLY","GO_BP","516724_GO_0071801_REGULATION_OF_PODOSOME_ASSEMBLY",10,-1.864,0.0033,0.011,-1.0792,0.35,0.95,-1.0126,0.43,0.84
"C6_Oncogenic_signatures:C6_ALL_63_CAMP_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_63_CAMP_UP_V1_DN",199,-1.8638,0,4e-04,-0.9048,0.74,0.87,-1.2431,0.061,0.33
"GO_BP:507765_GO_0045408_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS","GO_BP","507765_GO_0045408_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS",14,-1.8631,0.0016,0.012,-1.5682,0.029,0.72,-0.9392,0.56,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1415_SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1415_SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP",45,-1.8631,0,0.0044,0.4651,1,1,-1.5234,0.011,0.29
"GO_BP:506657_GO_0043627_RESPONSE_TO_ESTROGEN","GO_BP","506657_GO_0043627_RESPONSE_TO_ESTROGEN",157,-1.8629,0,0.012,-0.9425,0.6,1,1.1668,0.12,0.73
"KEGG_compound:C00060_CARBOXYLATE_R_COOH_MONOCARBOXYLATE_CARBOXYLIC_ACID","KEGG_compound","C00060_CARBOXYLATE_R_COOH_MONOCARBOXYLATE_CARBOXYLIC_ACID",18,-1.8628,0,0.0072,0.8154,0.74,1,0.9947,0.47,0.7
"REACTOME:106061_REACT_641_DISSOLUTION_OF_FIBRIN_CLOT","REACTOME","106061_REACT_641_DISSOLUTION_OF_FIBRIN_CLOT",13,-1.8627,0.0015,0.015,0.6966,0.88,1,1.3035,0.15,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_3114_WIERENGA_STAT5A_TARGETS_GROUP2","C2_Chemical_and_genetic_perturbations","C2_CGP_3114_WIERENGA_STAT5A_TARGETS_GROUP2",60,-1.8626,0,0.0044,-0.7381,0.92,1,-0.7854,0.88,0.96
"GO_MF:487469_GO_0001530_LIPOPOLYSACCHARIDE_BINDING","GO_MF","487469_GO_0001530_LIPOPOLYSACCHARIDE_BINDING",16,-1.8616,0,0.033,-0.8067,0.72,1,-1.1758,0.25,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_401_CASTELLANO_NRAS_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_401_CASTELLANO_NRAS_TARGETS_UP",65,-1.8616,0,0.0045,-0.9351,0.58,1,-1.4653,0.016,0.31
"GO_MF:490030_GO_0004714_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY","GO_MF","490030_GO_0004714_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY",64,-1.8614,0,0.031,-1.2178,0.15,0.83,-1.0904,0.3,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_518_MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_518_MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP",168,-1.8613,0,0.0045,-0.8248,0.89,1,1.0008,0.45,0.96
"C7_Immunologic_signatures:C7_ALL_1580_GSE3982_DC_VS_MAC_LPS_STIM_DN","C7_Immunologic_signatures","C7_ALL_1580_GSE3982_DC_VS_MAC_LPS_STIM_DN",197,-1.8611,0,0,-0.8825,0.76,1,-1.3953,0.0081,0.065
"C2_Chemical_and_genetic_perturbations:C2_CGP_897_WANG_RESPONSE_TO_BEXAROTENE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_897_WANG_RESPONSE_TO_BEXAROTENE_DN",29,-1.8611,0.0014,0.0045,0.9834,0.44,0.81,-1.2255,0.21,0.5
"GO_BP:518998_GO_2000352_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS","GO_BP","518998_GO_2000352_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS",25,-1.8611,0,0.012,0.6802,0.91,1,1.1768,0.22,0.72
"C7_Immunologic_signatures:C7_ALL_1139_GSE2706_2H_VS_8H_LPS_STIM_DC_UP","C7_Immunologic_signatures","C7_ALL_1139_GSE2706_2H_VS_8H_LPS_STIM_DC_UP",194,-1.8611,0,0,-1.0301,0.38,1,-2.0895,0,0
"REACTOME:105724_REACT_6913_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES","REACTOME","105724_REACT_6913_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES",19,-1.8607,0,0.015,0.9839,0.47,0.78,-1.0275,0.42,0.8
"C1_Positional:C1_ALL_197_CHR13Q21","C1_Positional","C1_ALL_197_CHR13Q21",9,-1.8605,0,0.035,0.6138,0.94,1,-0.8886,0.62,0.97
"REACTOME:1127692_REACT_264548_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE","REACTOME","1127692_REACT_264548_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE",34,-1.8604,0,0.015,0.9448,0.54,0.84,-1.1609,0.23,0.64
"GO_BP:491989_GO_0007189_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY","GO_BP","491989_GO_0007189_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",69,-1.8601,0,0.012,0.8997,0.67,1,-0.9732,0.51,0.88
"GO_BP:500386_GO_0031099_REGENERATION","GO_BP","500386_GO_0031099_REGENERATION",110,-1.86,0,0.012,-0.978,0.5,1,-0.8966,0.7,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_2853_CAIRO_HEPATOBLASTOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2853_CAIRO_HEPATOBLASTOMA_DN",259,-1.8599,0,0.0045,-0.8945,0.79,1,-1.1825,0.073,0.53
"GO_BP:502066_GO_0032844_REGULATION_OF_HOMEOSTATIC_PROCESS","GO_BP","502066_GO_0032844_REGULATION_OF_HOMEOSTATIC_PROCESS",337,-1.8599,0,0.012,0.9248,0.73,1,-0.9631,0.58,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1155_LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT","C2_Chemical_and_genetic_perturbations","C2_CGP_1155_LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT",101,-1.8595,0,0.0045,0.808,0.9,0.99,-0.9792,0.51,0.78
"C3_TF_targets:C3_TFT_456_V_AP1_Q2_01","C3_TF_targets","C3_TFT_456_V_AP1_Q2_01",270,-1.8595,0,0.004,-1.5085,0,0.13,-1.231,0.049,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_1708_YAMAZAKI_TCEB3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1708_YAMAZAKI_TCEB3_TARGETS_UP",174,-1.8594,0,0.0045,-0.8587,0.84,1,-0.9132,0.7,0.86
"GO_BP:487444_GO_0001505_REGULATION_OF_NEUROTRANSMITTER_LEVELS","GO_BP","487444_GO_0001505_REGULATION_OF_NEUROTRANSMITTER_LEVELS",151,-1.8593,0,0.012,-1.0948,0.25,0.95,-1.4555,0.0083,0.54
"C6_Oncogenic_signatures:C6_ALL_15_HINATA_NFKB_IMMU_INF","C6_Oncogenic_signatures","C6_ALL_15_HINATA_NFKB_IMMU_INF",14,-1.8593,0.0016,0.00043,-1.2697,0.17,0.35,-1.1196,0.31,0.48
"GO_BP:507489_GO_0045089_POSITIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE","GO_BP","507489_GO_0045089_POSITIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE",189,-1.8593,0,0.012,0.616,1,1,-1.169,0.11,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1481_HSIAO_LIVER_SPECIFIC_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_1481_HSIAO_LIVER_SPECIFIC_GENES",236,-1.8592,0,0.0045,-1.1491,0.14,0.85,-1.1692,0.11,0.55
"GO_BP:500115_GO_0030816_POSITIVE_REGULATION_OF_CAMP_METABOLIC_PROCESS","GO_BP","500115_GO_0030816_POSITIVE_REGULATION_OF_CAMP_METABOLIC_PROCESS",90,-1.8588,0,0.012,0.9985,0.46,0.98,1.0533,0.32,0.8
"C4_Cancer_modules:C4_CM_127_MODULE_132","C4_Cancer_modules","C4_CM_127_MODULE_132",13,-1.8588,0,0.0033,-1.3171,0.14,0.52,-1.3624,0.11,0.24
"C4_Cancer_modules:C4_CM_359_MODULE_433","C4_Cancer_modules","C4_CM_359_MODULE_433",58,-1.8588,0,0.0033,-1.1799,0.18,0.62,0.9842,0.5,0.97
"GO_BP:752381_GO_0086009_MEMBRANE_REPOLARIZATION","GO_BP","752381_GO_0086009_MEMBRANE_REPOLARIZATION",15,-1.8585,0,0.012,-1.4907,0.067,0.82,-1.3704,0.11,0.59
"GO_MF:496892_GO_0031072_HEAT_SHOCK_PROTEIN_BINDING","GO_MF","496892_GO_0031072_HEAT_SHOCK_PROTEIN_BINDING",69,-1.8584,0.0013,0.032,-0.9764,0.5,0.94,-2.17,0,0.013
"GO_BP:488556_GO_0002683_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS","GO_BP","488556_GO_0002683_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS",332,-1.858,0,0.012,0.8567,0.93,1,0.9878,0.5,0.87
"GO_BP:509070_GO_0046850_REGULATION_OF_BONE_REMODELING","GO_BP","509070_GO_0046850_REGULATION_OF_BONE_REMODELING",38,-1.8576,0,0.012,-0.5825,0.99,1,0.972,0.51,0.89
"C7_Immunologic_signatures:C7_ALL_1328_GSE30083_SP1_VS_SP3_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1328_GSE30083_SP1_VS_SP3_THYMOCYTE_DN",196,-1.8575,0,0,-0.813,0.92,1,-1.3755,0.0041,0.077
"C6_Oncogenic_signatures:C6_ALL_3_E2F1_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_3_E2F1_UP_V1_DN",190,-1.8575,0,0.00047,-1.2498,0.064,0.38,-1.0944,0.22,0.5
"GO_BP:501969_GO_0032743_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION","GO_BP","501969_GO_0032743_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION",31,-1.8572,0.0014,0.012,-0.7724,0.8,1,-0.7828,0.83,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1929_ZAMORA_NOS2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1929_ZAMORA_NOS2_TARGETS_DN",92,-1.8571,0,0.0046,0.9538,0.53,0.86,-1.1287,0.23,0.59
"C4_Cancer_gene_neighborhoods:C4_CGN_313_GNF2_RRM2","C4_Cancer_gene_neighborhoods","C4_CGN_313_GNF2_RRM2",40,-1.8569,0,0.0014,-0.769,0.85,1,-1.8448,0,0.011
"GO_BP:487864_GO_0001974_BLOOD_VESSEL_REMODELING","GO_BP","487864_GO_0001974_BLOOD_VESSEL_REMODELING",32,-1.8569,0,0.012,0.8093,0.8,1,0.7666,0.83,1
"C7_Immunologic_signatures:C7_ALL_1452_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN","C7_Immunologic_signatures","C7_ALL_1452_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN",200,-1.8568,0,4.6e-06,-0.8348,0.89,1,-1.319,0.03,0.12
"C4_Cancer_gene_neighborhoods:C4_CGN_295_GNF2_ESPL1","C4_Cancer_gene_neighborhoods","C4_CGN_295_GNF2_ESPL1",35,-1.8565,0.0015,0.0014,0.8279,0.76,0.96,-1.638,0.01,0.071
"WikiPathways:755436_WP2100_AHR_PATHWAY","WikiPathways","755436_WP2100_AHR_PATHWAY",26,-1.8564,0,0.0055,-1.2892,0.13,1,-1.1984,0.19,0.54
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_40_BIOCARTA_TID_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_40_BIOCARTA_TID_PATHWAY",19,-1.8562,0.0031,0.014,-1.0749,0.36,1,-1.6326,0.02,0.37
"GO_BP:511766_GO_0050798_ACTIVATED_T_CELL_PROLIFERATION","GO_BP","511766_GO_0050798_ACTIVATED_T_CELL_PROLIFERATION",10,-1.8561,0.0017,0.012,0.5455,0.96,1,-0.8175,0.7,0.98
"REACTOME:1183587_REACT_355542_RHO_GTPASES_ACTIVATE_PKNS","REACTOME","1183587_REACT_355542_RHO_GTPASES_ACTIVATE_PKNS",89,-1.8558,0,0.015,-1.5311,0.0071,0.41,-1.5733,0.006,0.28
"GO_BP:491546_GO_0006658_PHOSPHATIDYLSERINE_METABOLIC_PROCESS","GO_BP","491546_GO_0006658_PHOSPHATIDYLSERINE_METABOLIC_PROCESS",26,-1.8558,0.0015,0.012,0.9321,0.56,1,1.0171,0.45,0.84
"GO_BP:492325_GO_0042267_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY","GO_BP","492325_GO_0042267_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",24,-1.8555,0.0045,0.012,-0.5849,0.97,1,-0.9812,0.49,0.87
"C7_Immunologic_signatures:C7_ALL_1608_GSE3982_MAST_CELL_VS_DC_DN","C7_Immunologic_signatures","C7_ALL_1608_GSE3982_MAST_CELL_VS_DC_DN",198,-1.8555,0,4.6e-06,-1.0522,0.33,1,-1.2786,0.033,0.16
"GO_BP:500116_GO_0030817_REGULATION_OF_CAMP_BIOSYNTHETIC_PROCESS","GO_BP","500116_GO_0030817_REGULATION_OF_CAMP_BIOSYNTHETIC_PROCESS",112,-1.8552,0,0.012,-0.9449,0.55,1,1.5096,0.014,0.54
"REACTOME:771577_REACT_160123_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS","REACTOME","771577_REACT_160123_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS",84,-1.855,0,0.015,-0.6678,0.99,1,-1.2848,0.094,0.54
"GO_BP:755343_GO_2001237_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","755343_GO_2001237_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",93,-1.8549,0,0.012,-0.8201,0.83,1,0.7904,0.89,1
"C4_Cancer_gene_neighborhoods:C4_CGN_401_GNF2_RAP1B","C4_Cancer_gene_neighborhoods","C4_CGN_401_GNF2_RAP1B",36,-1.8549,0.0014,0.0014,0.7329,0.91,1,-1.3158,0.1,0.27
"KEGG_pathway:HSA05144_MALARIA","KEGG_pathway","HSA05144_MALARIA",48,-1.8548,0,0.0015,1.2398,0.15,0.48,-1.2414,0.13,0.33
"GO_CC:490805_GO_0005775_VACUOLAR_LUMEN","GO_CC","490805_GO_0005775_VACUOLAR_LUMEN",76,-1.8547,0,0.014,-0.8757,0.75,0.95,1.2826,0.076,0.73
"GO_BP:518794_GO_2000146_NEGATIVE_REGULATION_OF_CELL_MOTILITY","GO_BP","518794_GO_2000146_NEGATIVE_REGULATION_OF_CELL_MOTILITY",186,-1.8541,0,0.012,-0.8133,0.91,1,1.0048,0.45,0.85
"C6_Oncogenic_signatures:C6_ALL_8_ERB2_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_8_ERB2_UP_V1_UP",190,-1.8536,0,5e-04,0.9488,0.61,0.95,-0.8568,0.88,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_260_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_260_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP",44,-1.8535,0,0.0048,-0.7367,0.9,1,-0.7055,0.95,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_498_MCBRYAN_PUBERTAL_BREAST_3_4WK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_498_MCBRYAN_PUBERTAL_BREAST_3_4WK_UP",206,-1.8534,0,0.0048,0.8373,0.91,0.98,-1.0134,0.4,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1136_AMIT_EGF_RESPONSE_120_HELA","C2_Chemical_and_genetic_perturbations","C2_CGP_1136_AMIT_EGF_RESPONSE_120_HELA",69,-1.8528,0,0.0048,-1.2106,0.16,0.79,-1.2011,0.17,0.52
"GO_BP:507773_GO_0045416_POSITIVE_REGULATION_OF_INTERLEUKIN_8_BIOSYNTHETIC_PROCESS","GO_BP","507773_GO_0045416_POSITIVE_REGULATION_OF_INTERLEUKIN_8_BIOSYNTHETIC_PROCESS",8,-1.8528,0.0033,0.012,-0.8393,0.67,1,-0.9788,0.45,0.87
"GO_BP:516173_GO_0071248_CELLULAR_RESPONSE_TO_METAL_ION","GO_BP","516173_GO_0071248_CELLULAR_RESPONSE_TO_METAL_ION",101,-1.8523,0,0.013,1.1204,0.23,0.88,0.9051,0.66,0.94
"GO_BP:513749_GO_0060193_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY","GO_BP","513749_GO_0060193_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY",93,-1.8522,0,0.012,-1.0646,0.33,0.96,-1.3911,0.036,0.58
"GO_BP:516548_GO_0071624_POSITIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS","GO_BP","516548_GO_0071624_POSITIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS",20,-1.852,0,0.012,-0.8651,0.66,1,-0.9283,0.56,0.9
"C7_Immunologic_signatures:C7_ALL_281_GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP","C7_Immunologic_signatures","C7_ALL_281_GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP",199,-1.8518,0,4.5e-06,1.0253,0.41,0.66,1.6932,0,0.0021
"C2_Chemical_and_genetic_perturbations:C2_CGP_986_GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_986_GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP",140,-1.8517,0,0.0049,-1.0277,0.38,0.98,0.8267,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2527_PARK_APL_PATHOGENESIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2527_PARK_APL_PATHOGENESIS_UP",14,-1.8517,0.0031,0.0049,1.1736,0.24,0.53,-1.447,0.071,0.32
"GO_MF:490417_GO_0005154_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING","GO_MF","490417_GO_0005154_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING",28,-1.8516,0.0015,0.034,-0.6212,0.96,1,0.6125,0.97,1
"WikiPathways:198785_WP716_VITAMIN_A_AND_CAROTENOID_METABOLISM","WikiPathways","198785_WP716_VITAMIN_A_AND_CAROTENOID_METABOLISM",39,-1.8512,0,0.0059,-1.4969,0.027,0.87,-1.0483,0.37,0.66
"GO_BP:488560_GO_0002687_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION","GO_BP","488560_GO_0002687_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION",90,-1.851,0,0.013,1.1763,0.16,0.81,1.1621,0.15,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2422_WINTER_HYPOXIA_METAGENE","C2_Chemical_and_genetic_perturbations","C2_CGP_2422_WINTER_HYPOXIA_METAGENE",235,-1.8504,0,0.0049,-0.9717,0.54,1,-1.3263,0.01,0.41
"GO_BP:497183_GO_0018212_PEPTIDYL_TYROSINE_MODIFICATION","GO_BP","497183_GO_0018212_PEPTIDYL_TYROSINE_MODIFICATION",171,-1.8504,0,0.013,-1.2379,0.07,0.91,-1.1687,0.12,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_56_SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_56_SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP",151,-1.8504,0,0.0049,1.0641,0.28,0.69,-1.7664,0,0.14
"C4_Cancer_gene_neighborhoods:C4_CGN_358_GNF2_HMMR","C4_Cancer_gene_neighborhoods","C4_CGN_358_GNF2_HMMR",47,-1.8502,0,0.0014,-0.6791,0.94,1,-1.8835,0,0.0078
"GO_BP:492048_GO_0007269_NEUROTRANSMITTER_SECRETION","GO_BP","492048_GO_0007269_NEUROTRANSMITTER_SECRETION",119,-1.8493,0,0.013,-1.0869,0.3,0.95,-1.4277,0.014,0.57
"KEGG_pathway:HSA05142_CHAGAS_DISEASE_AMERICAN_TRYPANOSOMIASIS_","KEGG_pathway","HSA05142_CHAGAS_DISEASE_AMERICAN_TRYPANOSOMIASIS_",103,-1.8492,0,0.0015,-0.9066,0.69,0.97,-1.0547,0.29,0.59
"GO_MF:490029_GO_0004713_PROTEIN_TYROSINE_KINASE_ACTIVITY","GO_MF","490029_GO_0004713_PROTEIN_TYROSINE_KINASE_ACTIVITY",141,-1.8492,0,0.035,-1.4181,0.012,0.66,-1.212,0.092,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1602_MARTINEZ_RESPONSE_TO_TRABECTEDIN","C2_Chemical_and_genetic_perturbations","C2_CGP_1602_MARTINEZ_RESPONSE_TO_TRABECTEDIN",50,-1.8488,0,0.005,-1.2142,0.17,0.8,-1.688,0.0022,0.19
"GO_BP:491592_GO_0006705_MINERALOCORTICOID_BIOSYNTHETIC_PROCESS","GO_BP","491592_GO_0006705_MINERALOCORTICOID_BIOSYNTHETIC_PROCESS",6,-1.8486,0,0.013,0.7715,0.75,1,1.1559,0.28,0.73
"KEGG_pathway:HSA04610_COMPLEMENT_AND_COAGULATION_CASCADES","KEGG_pathway","HSA04610_COMPLEMENT_AND_COAGULATION_CASCADES",68,-1.8486,0,0.0015,-0.8806,0.71,0.99,1.2268,0.15,0.59
"C4_Cancer_modules:C4_CM_113_MODULE_118","C4_Cancer_modules","C4_CM_113_MODULE_118",399,-1.8485,0,0.0036,1.0286,0.35,0.68,1.0087,0.41,0.94
"REACTOME:105715_REACT_34_ETHANOL_OXIDATION","REACTOME","105715_REACT_34_ETHANOL_OXIDATION",10,-1.8481,0,0.016,-1.8726,0.0036,0.061,-1.6034,0.023,0.25
"GO_BP:511771_GO_0050805_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION","GO_BP","511771_GO_0050805_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION",46,-1.8479,0,0.013,-1.2818,0.1,0.89,1.2627,0.12,0.69
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_178_BIOCARTA_NKT_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_178_BIOCARTA_NKT_PATHWAY",29,-1.8478,0.0044,0.016,0.9186,0.57,0.9,1.3604,0.097,1
"GO_CC:490888_GO_0005883_NEUROFILAMENT","GO_CC","490888_GO_0005883_NEUROFILAMENT",9,-1.8478,0,0.015,0.7578,0.77,0.98,-0.9742,0.48,1
"C7_Immunologic_signatures:C7_ALL_1440_GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN","C7_Immunologic_signatures","C7_ALL_1440_GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN",199,-1.8477,0,4.5e-06,0.8651,0.86,1,-1.2027,0.083,0.27
"KEGG_pathway:HSA04142_LYSOSOME","KEGG_pathway","HSA04142_LYSOSOME",123,-1.8475,0,0.0015,-0.5549,1,1,0.9066,0.66,1
"GO_BP:492025_GO_0019722_CALCIUM_MEDIATED_SIGNALING","GO_BP","492025_GO_0019722_CALCIUM_MEDIATED_SIGNALING",81,-1.8472,0,0.013,-1.0285,0.39,0.97,-1.124,0.25,0.75
"GO_BP:511778_GO_0050818_REGULATION_OF_COAGULATION","GO_BP","511778_GO_0050818_REGULATION_OF_COAGULATION",84,-1.8472,0,0.013,1.1482,0.18,0.84,1.1351,0.21,0.74
"GO_BP:500898_GO_0031649_HEAT_GENERATION","GO_BP","500898_GO_0031649_HEAT_GENERATION",7,-1.8471,0.0016,0.013,-1.7361,0.0057,0.63,-1.257,0.21,0.67
"GO_BP:510591_GO_0048520_POSITIVE_REGULATION_OF_BEHAVIOR","GO_BP","510591_GO_0048520_POSITIVE_REGULATION_OF_BEHAVIOR",120,-1.847,0,0.013,1.1693,0.14,0.81,1.2662,0.055,0.69
"C7_Immunologic_signatures:C7_ALL_1054_GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN","C7_Immunologic_signatures","C7_ALL_1054_GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN",200,-1.8469,0,4.5e-06,1.0756,0.28,0.51,-1.2086,0.06,0.26
"GO_BP:491529_GO_0006639_ACYLGLYCEROL_METABOLIC_PROCESS","GO_BP","491529_GO_0006639_ACYLGLYCEROL_METABOLIC_PROCESS",95,-1.8469,0,0.013,-0.7771,0.92,1,-0.9933,0.46,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_636_DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS","C2_Chemical_and_genetic_perturbations","C2_CGP_636_DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS",22,-1.8468,0,0.0051,-1.6502,0.014,0.37,-1.4516,0.071,0.32
"GO_BP:495140_GO_0014068_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING","GO_BP","495140_GO_0014068_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING",55,-1.8464,0,0.013,0.8568,0.76,1,-0.9762,0.49,0.88
"KEGG_reaction:R07064_PHOSPHATIDYLCHOLINE_2_ACYLHYDROLASE_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_LINOLEATE","KEGG_reaction","R07064_PHOSPHATIDYLCHOLINE_2_ACYLHYDROLASE_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_LINOLEATE",18,-1.8463,0.0015,0.0063,0.8227,0.72,1,1.026,0.4,0.61
"C0_Hallmark:H_ALL_48_HALLMARK_KRAS_SIGNALING_UP","C0_Hallmark","H_ALL_48_HALLMARK_KRAS_SIGNALING_UP",198,-1.8461,0,0.00026,-0.872,0.81,0.98,-1.0357,0.35,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_600_PEREZ_TP63_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_600_PEREZ_TP63_TARGETS",344,-1.846,0,0.0052,-1.693,0,0.33,-1.3327,0.0061,0.41
"GO_BP:507934_GO_0045586_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION","GO_BP","507934_GO_0045586_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION",8,-1.8457,0,0.013,-1.419,0.096,0.94,-0.7788,0.75,1
"C0_Hallmark:H_ALL_21_HALLMARK_APICAL_SURFACE","C0_Hallmark","H_ALL_21_HALLMARK_APICAL_SURFACE",43,-1.8456,0,0.00024,0.8331,0.76,1,-1.3006,0.091,0.11
"C7_Immunologic_signatures:C7_ALL_661_GSE17721_LPS_VS_CPG_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_661_GSE17721_LPS_VS_CPG_6H_BMDM_UP",196,-1.8456,0,8.9e-06,0.8318,0.92,1,-1.2817,0.035,0.16
"GO_BP:753357_GO_1900373_POSITIVE_REGULATION_OF_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","753357_GO_1900373_POSITIVE_REGULATION_OF_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",102,-1.845,0,0.013,-1.0969,0.27,0.94,1.1993,0.14,0.72
"GO_BP:501881_GO_0032655_REGULATION_OF_INTERLEUKIN_12_PRODUCTION","GO_BP","501881_GO_0032655_REGULATION_OF_INTERLEUKIN_12_PRODUCTION",45,-1.845,0,0.013,-1.2163,0.19,0.88,-1.6061,0.012,0.52
"GO_BP:508136_GO_0045807_POSITIVE_REGULATION_OF_ENDOCYTOSIS","GO_BP","508136_GO_0045807_POSITIVE_REGULATION_OF_ENDOCYTOSIS",91,-1.845,0,0.013,-1.1396,0.21,0.93,0.9985,0.43,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_1304_JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1304_JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP",71,-1.8449,0,0.0053,1.4308,0.03,0.27,1.2811,0.084,0.7
"GO_BP:488582_GO_0002709_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY","GO_BP","488582_GO_0002709_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY",53,-1.8448,0,0.013,-1.1989,0.17,0.9,-1.5204,0.011,0.53
"GO_MF:490245_GO_0004954_PROSTANOID_RECEPTOR_ACTIVITY","GO_MF","490245_GO_0004954_PROSTANOID_RECEPTOR_ACTIVITY",12,-1.8444,0,0.036,1.3965,0.091,0.49,0.9821,0.47,0.88
"GO_BP:513295_GO_0052547_REGULATION_OF_PEPTIDASE_ACTIVITY","GO_BP","513295_GO_0052547_REGULATION_OF_PEPTIDASE_ACTIVITY",369,-1.8444,0,0.013,0.9744,0.55,1,-1.1047,0.2,0.77
"GO_BP:488571_GO_0002698_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS","GO_BP","488571_GO_0002698_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS",83,-1.8444,0,0.013,0.8481,0.79,1,0.7206,0.98,1
"GO_BP:496324_GO_0016264_GAP_JUNCTION_ASSEMBLY","GO_BP","496324_GO_0016264_GAP_JUNCTION_ASSEMBLY",8,-1.8441,0.0049,0.013,-0.9694,0.49,1,-0.8028,0.72,0.99
"C4_Cancer_modules:C4_CM_39_MODULE_43","C4_Cancer_modules","C4_CM_39_MODULE_43",98,-1.8441,0,0.0038,1.4192,0.022,0.17,-1.8798,0,0.025
"KEGG_pathway:HSA05145_TOXOPLASMOSIS","KEGG_pathway","HSA05145_TOXOPLASMOSIS",116,-1.8438,0,0.0015,-1.2914,0.057,0.42,-1.2342,0.089,0.34
"C7_Immunologic_signatures:C7_ALL_1900_GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1900_GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN",200,-1.8438,0,8.9e-06,-0.6469,1,1,-0.88,0.83,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_3198_DALESSIO_TSA_RESPONSE","C2_Chemical_and_genetic_perturbations","C2_CGP_3198_DALESSIO_TSA_RESPONSE",21,-1.8434,0.0029,0.0054,-1.7599,0.0056,0.34,-1.8378,0.004,0.096
"GO_BP:513308_GO_0052564_RESPONSE_TO_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513308_GO_0052564_RESPONSE_TO_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",13,-1.8433,0,0.013,1.0949,0.34,0.91,-0.7276,0.84,0.99
"GO_BP:508101_GO_0045764_POSITIVE_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS","GO_BP","508101_GO_0045764_POSITIVE_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS",234,-1.8432,0,0.013,-1.0294,0.38,0.97,-1.1446,0.14,0.75
"GO_BP:494586_GO_0010517_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY","GO_BP","494586_GO_0010517_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY",93,-1.8432,0,0.013,-1.0146,0.42,0.98,-1.4305,0.014,0.56
"GO_BP:500600_GO_0031341_REGULATION_OF_CELL_KILLING","GO_BP","500600_GO_0031341_REGULATION_OF_CELL_KILLING",66,-1.8429,0,0.013,-1.0064,0.44,0.98,-0.9881,0.48,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_275_SENESE_HDAC1_AND_HDAC2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_275_SENESE_HDAC1_AND_HDAC2_TARGETS_UP",229,-1.8428,0,0.0054,-0.838,0.92,1,-0.9574,0.59,0.81
"GO_BP:487788_GO_0001892_EMBRYONIC_PLACENTA_DEVELOPMENT","GO_BP","487788_GO_0001892_EMBRYONIC_PLACENTA_DEVELOPMENT",89,-1.8425,0,0.013,-1.4178,0.037,0.94,-1.2701,0.072,0.66
"GO_BP:504542_GO_0035358_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY","GO_BP","504542_GO_0035358_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY",11,-1.8424,0,0.013,-1.0695,0.38,0.96,-1.6831,0.021,0.61
"KEGG_compound:C04317_1_ORGANYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_1_RADYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ALKYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE","KEGG_compound","C04317_1_ORGANYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_1_RADYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ALKYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE",26,-1.8423,0,0.0094,0.5374,0.99,1,0.851,0.71,0.87
"C4_Cancer_gene_neighborhoods:C4_CGN_405_GNF2_SELL","C4_Cancer_gene_neighborhoods","C4_CGN_405_GNF2_SELL",47,-1.8419,0,0.0016,1.2361,0.14,0.18,-0.8346,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1048_FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1048_FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN",8,-1.8418,0,0.0054,-1.2106,0.24,0.8,-1.3662,0.13,0.39
"GO_BP:518183_GO_0090036_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING","GO_BP","518183_GO_0090036_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING",15,-1.8408,0,0.014,-0.9637,0.51,1,-1.1704,0.26,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1545_PETROVA_PROX1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1545_PETROVA_PROX1_TARGETS_DN",64,-1.8407,0,0.0055,1.1544,0.2,0.55,0.8888,0.66,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2096_FOSTER_TOLERANT_MACROPHAGE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2096_FOSTER_TOLERANT_MACROPHAGE_DN",409,-1.8405,0,0.0055,-0.8389,0.94,1,-1.0054,0.42,0.75
"GO_BP:503532_GO_0034329_CELL_JUNCTION_ASSEMBLY","GO_BP","503532_GO_0034329_CELL_JUNCTION_ASSEMBLY",157,-1.8401,0,0.014,-1.2252,0.083,0.88,1.1032,0.24,0.76
"C7_Immunologic_signatures:C7_ALL_1775_GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP","C7_Immunologic_signatures","C7_ALL_1775_GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP",198,-1.84,0,8.8e-06,-0.8518,0.85,1,-1.2407,0.043,0.21
"C2_Chemical_and_genetic_perturbations:C2_CGP_1786_DAZARD_RESPONSE_TO_UV_NHEK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1786_DAZARD_RESPONSE_TO_UV_NHEK_UP",240,-1.84,0,0.0055,1.0924,0.22,0.64,-1.3745,0.002,0.38
"C3_TF_targets:C3_TFT_143_V_AP1_C","C3_TF_targets","C3_TFT_143_V_AP1_C",268,-1.8399,0,0.0041,-1.3543,0.013,0.19,-1.1578,0.11,0.44
"C7_Immunologic_signatures:C7_ALL_1116_GSE2706_UNSTIM_VS_8H_R848_DC_DN","C7_Immunologic_signatures","C7_ALL_1116_GSE2706_UNSTIM_VS_8H_R848_DC_DN",196,-1.8399,0,8.8e-06,0.8431,0.88,1,-1.2484,0.051,0.2
"GO_BP:511809_GO_0050867_POSITIVE_REGULATION_OF_CELL_ACTIVATION","GO_BP","511809_GO_0050867_POSITIVE_REGULATION_OF_CELL_ACTIVATION",280,-1.8398,0,0.014,0.8129,0.96,1,-1.254,0.029,0.68
"C4_Cancer_modules:C4_CM_285_MODULE_326","C4_Cancer_modules","C4_CM_285_MODULE_326",13,-1.8397,0,0.0039,1.3927,0.089,0.2,-1.0261,0.42,0.65
"C6_Oncogenic_signatures:C6_ALL_105_BMI1_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_105_BMI1_DN_V1_DN",137,-1.8395,0,0.00059,1.1723,0.16,0.39,-1.3093,0.052,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_2503_HUNSBERGER_EXERCISE_REGULATED_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_2503_HUNSBERGER_EXERCISE_REGULATED_GENES",31,-1.8394,0.0044,0.0055,-0.8142,0.75,1,1.0014,0.45,0.96
"GO_BP:515593_GO_0070663_REGULATION_OF_LEUKOCYTE_PROLIFERATION","GO_BP","515593_GO_0070663_REGULATION_OF_LEUKOCYTE_PROLIFERATION",183,-1.8388,0,0.014,-0.7769,0.96,1,-1.0188,0.42,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_2470_BOYLAN_MULTIPLE_MYELOMA_D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2470_BOYLAN_MULTIPLE_MYELOMA_D_DN",78,-1.8386,0,0.0056,-0.827,0.81,1,-1.2056,0.12,0.51
"REACTOME:119536_REACT_19375_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION","REACTOME","119536_REACT_19375_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION",8,-1.8386,0.0017,0.018,-1.4862,0.063,0.45,-1.0406,0.42,0.79
"GO_BP:754839_GO_1901888_REGULATION_OF_CELL_JUNCTION_ASSEMBLY","GO_BP","754839_GO_1901888_REGULATION_OF_CELL_JUNCTION_ASSEMBLY",57,-1.8385,0,0.014,-1.2278,0.13,0.88,0.9525,0.53,0.9
"KEGG_compound:C05345_BETA_D_FRUCTOSE_6_PHOSPHATE","KEGG_compound","C05345_BETA_D_FRUCTOSE_6_PHOSPHATE",17,-1.8385,0.0031,0.0097,0.5511,0.97,1,-0.8354,0.69,0.82
"GO_MF:489953_GO_0004622_LYSOPHOSPHOLIPASE_ACTIVITY","GO_MF","489953_GO_0004622_LYSOPHOSPHOLIPASE_ACTIVITY",16,-1.8383,0,0.038,-0.7003,0.88,1,-0.8336,0.72,0.94
"C7_Immunologic_signatures:C7_ALL_1684_GSE3982_BCELL_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_1684_GSE3982_BCELL_VS_TH1_DN",196,-1.8383,0,8.7e-06,0.8556,0.87,1,-1.0931,0.25,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_515_OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_515_OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN",32,-1.8381,0,0.0056,-0.7744,0.81,1,-1.026,0.41,0.72
"GO_BP:502178_GO_0032956_REGULATION_OF_ACTIN_CYTOSKELETON_ORGANIZATION","GO_BP","502178_GO_0032956_REGULATION_OF_ACTIN_CYTOSKELETON_ORGANIZATION",251,-1.8378,0,0.014,-1.0653,0.29,0.96,-1.1583,0.11,0.74
"GO_BP:753015_GO_1900017_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE","GO_BP","753015_GO_1900017_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE",7,-1.8378,0,0.014,-1.5143,0.047,0.81,-1.0427,0.41,0.82
"GO_BP:488333_GO_0002460_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS","GO_BP","488333_GO_0002460_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS",117,-1.8374,0,0.014,-0.7041,0.99,1,-1.1046,0.25,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1594_KUMAR_TARGETS_OF_MLL_AF9_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_1594_KUMAR_TARGETS_OF_MLL_AF9_FUSION",399,-1.8373,0,0.0057,1.2038,0.053,0.48,-1.407,0.004,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_394_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_394_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN",141,-1.8373,0,0.0056,0.8572,0.84,0.96,-1.041,0.34,0.7
"C7_Immunologic_signatures:C7_ALL_769_GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_769_GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP",198,-1.8368,0,8.7e-06,-1.1047,0.23,1,-1.9341,0,0
"GO_MF:486561_GO_0015036_DISULFIDE_OXIDOREDUCTASE_ACTIVITY","GO_MF","486561_GO_0015036_DISULFIDE_OXIDOREDUCTASE_ACTIVITY",30,-1.8368,0,0.037,-0.6995,0.91,1,-1.2816,0.1,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_2993_DASU_IL6_SIGNALING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2993_DASU_IL6_SIGNALING_UP",59,-1.8366,0,0.0057,-1.1193,0.26,0.9,-0.8679,0.71,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1715_MCCLUNG_DELTA_FOSB_TARGETS_2WK","C2_Chemical_and_genetic_perturbations","C2_CGP_1715_MCCLUNG_DELTA_FOSB_TARGETS_2WK",47,-1.8366,0,0.0057,-1.1853,0.19,0.81,-1.1194,0.24,0.61
"KEGG_pathway:HSA00380_TRYPTOPHAN_METABOLISM","KEGG_pathway","HSA00380_TRYPTOPHAN_METABOLISM",40,-1.8364,0,0.0018,-1.1639,0.22,0.59,-1.5705,0.0096,0.11
"WikiPathways:198850_WP465_TRYPTOPHAN_METABOLISM","WikiPathways","198850_WP465_TRYPTOPHAN_METABOLISM",46,-1.8363,0,0.0069,0.7673,0.89,1,-1.3268,0.066,0.41
"C7_Immunologic_signatures:C7_ALL_1398_GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN","C7_Immunologic_signatures","C7_ALL_1398_GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN",198,-1.8363,0,8.7e-06,-0.8875,0.78,1,-0.8249,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2011_ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE","C2_Chemical_and_genetic_perturbations","C2_CGP_2011_ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE",75,-1.8358,0,0.0057,1.2009,0.13,0.49,-0.6932,0.98,0.99
"GO_BP:501955_GO_0032729_POSITIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION","GO_BP","501955_GO_0032729_POSITIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION",55,-1.8357,0,0.014,-0.9823,0.47,1,-0.9234,0.59,0.91
"GO_BP:507249_GO_0044242_CELLULAR_LIPID_CATABOLIC_PROCESS","GO_BP","507249_GO_0044242_CELLULAR_LIPID_CATABOLIC_PROCESS",136,-1.8357,0,0.014,0.9648,0.57,1,-1.0553,0.33,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_467_LANDIS_ERBB2_BREAST_TUMORS_324_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_467_LANDIS_ERBB2_BREAST_TUMORS_324_UP",148,-1.8357,0,0.0057,0.7428,0.98,1,-0.846,0.89,0.93
"KEGG_compound:C00053_3_PHOSPHOADENYLYL_SULFATE_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_3_PHOSPHO_5_ADENYLYL_SULFATE_PAPS","KEGG_compound","C00053_3_PHOSPHOADENYLYL_SULFATE_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_3_PHOSPHO_5_ADENYLYL_SULFATE_PAPS",20,-1.8354,0.0015,0.0098,0.7973,0.74,1,-1.2519,0.17,0.41
"GO_MF:498635_GO_0019855_CALCIUM_CHANNEL_INHIBITOR_ACTIVITY","GO_MF","498635_GO_0019855_CALCIUM_CHANNEL_INHIBITOR_ACTIVITY",10,-1.8354,0,0.036,-0.9135,0.58,0.97,0.9659,0.51,0.9
"C4_Cancer_modules:C4_CM_88_MODULE_93","C4_Cancer_modules","C4_CM_88_MODULE_93",181,-1.8353,0,0.0041,1.3912,0.007,0.2,-1.6003,0,0.12
"GO_BP:511793_GO_0050848_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING","GO_BP","511793_GO_0050848_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING",44,-1.835,0,0.014,-0.8518,0.73,1,-0.8879,0.65,0.93
"GO_BP:491066_GO_0006081_CELLULAR_ALDEHYDE_METABOLIC_PROCESS","GO_BP","491066_GO_0006081_CELLULAR_ALDEHYDE_METABOLIC_PROCESS",55,-1.835,0,0.014,0.9193,0.61,1,-1.2293,0.14,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_231_HOEBEKE_LYMPHOID_STEM_CELL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_231_HOEBEKE_LYMPHOID_STEM_CELL_DN",86,-1.8349,0,0.0058,1.4434,0.0065,0.26,-1.3518,0.036,0.39
"C4_Cancer_gene_neighborhoods:C4_CGN_289_GNF2_CDC2","C4_Cancer_gene_neighborhoods","C4_CGN_289_GNF2_CDC2",62,-1.8349,0,0.0017,0.8172,0.83,0.98,-2.0738,0,0.0026
"GO_BP:494708_GO_0010644_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING","GO_BP","494708_GO_0010644_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING",15,-1.8347,0,0.014,-1.1876,0.26,0.9,-0.9868,0.47,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_903_HASINA_NOL7_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_903_HASINA_NOL7_TARGETS_UP",13,-1.8345,0,0.0058,-0.7304,0.85,1,0.8582,0.61,1
"GO_BP:515485_GO_0070555_RESPONSE_TO_INTERLEUKIN_1","GO_BP","515485_GO_0070555_RESPONSE_TO_INTERLEUKIN_1",72,-1.8344,0.0013,0.014,1.3209,0.069,0.64,1.1267,0.25,0.74
"C3_TF_targets:C3_TFT_302_V_BACH1_01","C3_TF_targets","C3_TFT_302_V_BACH1_01",259,-1.8344,0,0.0036,-1.4347,0.0017,0.15,-1.3667,0.0042,0.29
"C4_Cancer_modules:C4_CM_166_MODULE_176","C4_Cancer_modules","C4_CM_166_MODULE_176",220,-1.8342,0,0.0041,-1.2181,0.078,0.62,-1.1567,0.13,0.44
"KEGG_reaction:R02053_PHOSPHATIDYLETHANOLAMINE_2_ACYLHYDROLASE_PHOSPHATIDYLETHANOLAMINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_FATTY_ACID","KEGG_reaction","R02053_PHOSPHATIDYLETHANOLAMINE_2_ACYLHYDROLASE_PHOSPHATIDYLETHANOLAMINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_FATTY_ACID",18,-1.8341,0.0015,0.0076,0.8059,0.74,1,1.0084,0.43,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_3277_PLASARI_TGFB1_TARGETS_10HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3277_PLASARI_TGFB1_TARGETS_10HR_DN",241,-1.8336,0,0.0058,1.2235,0.062,0.46,1.0051,0.45,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_410_LINDGREN_BLADDER_CANCER_CLUSTER_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_410_LINDGREN_BLADDER_CANCER_CLUSTER_1_DN",375,-1.8331,0,0.0059,-1.0196,0.39,0.98,-1.2731,0.0081,0.45
"C4_Cancer_modules:C4_CM_320_MODULE_375","C4_Cancer_modules","C4_CM_320_MODULE_375",85,-1.833,0,0.0041,1.1063,0.26,0.53,1.646,0,0.14
"GO_BP:501384_GO_0032148_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY","GO_BP","501384_GO_0032148_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY",20,-1.8327,0.0015,0.015,-0.9371,0.56,1,-0.8921,0.61,0.93
"KEGG_reaction:R07379_PLASMENYLETHANOLAMINE_2_ACYLHYDROLASE_O_1_ALK_1_ENYL_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_H2O_1_1_ALKENYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_CARBOXYLATE","KEGG_reaction","R07379_PLASMENYLETHANOLAMINE_2_ACYLHYDROLASE_O_1_ALK_1_ENYL_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_H2O_1_1_ALKENYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_CARBOXYLATE",18,-1.8324,0,0.0074,0.8168,0.72,1,1.024,0.42,0.6
"C7_Immunologic_signatures:C7_ALL_1330_GSE30083_SP1_VS_SP4_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1330_GSE30083_SP1_VS_SP4_THYMOCYTE_DN",200,-1.8323,0,1.3e-05,0.7922,0.97,1,-1.4845,0.0042,0.026
"C4_Cancer_modules:C4_CM_347_MODULE_416","C4_Cancer_modules","C4_CM_347_MODULE_416",22,-1.8323,0.003,0.0041,-0.9049,0.58,0.88,0.8577,0.67,1
"GO_BP:488196_GO_0002323_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488196_GO_0002323_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",19,-1.8322,0.0016,0.015,0.8789,0.66,1,-1.2859,0.15,0.65
"REACTOME:530759_REACT_115897_BETA_DEFENSINS","REACTOME","530759_REACT_115897_BETA_DEFENSINS",14,-1.8319,0,0.019,-1.3402,0.13,0.6,1.8545,0.0019,0.2
"REACTOME:187093_REACT_23950_INTERLEUKIN_1_PROCESSING","REACTOME","187093_REACT_23950_INTERLEUKIN_1_PROCESSING",7,-1.8317,0.0017,0.018,-1.4716,0.077,0.46,-1.401,0.11,0.42
"GO_MF:511756_GO_0050786_RAGE_RECEPTOR_BINDING","GO_MF","511756_GO_0050786_RAGE_RECEPTOR_BINDING",11,-1.8316,0,0.037,1.473,0.065,0.4,0.6329,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_41_FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_41_FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP",21,-1.8316,0.0045,0.0059,-1.051,0.38,0.97,-0.8786,0.63,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2540_WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2540_WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP",57,-1.8316,0,0.0059,0.7673,0.89,1,-1.4493,0.035,0.32
"GO_BP:511823_GO_0050885_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE","GO_BP","511823_GO_0050885_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE",55,-1.8315,0,0.015,-0.9729,0.52,1,-0.6444,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2954_NAKAMURA_ADIPOGENESIS_LATE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2954_NAKAMURA_ADIPOGENESIS_LATE_UP",102,-1.8314,0,0.0059,0.8772,0.77,0.95,-1.0086,0.43,0.74
"KEGG_pathway:HSA04062_CHEMOKINE_SIGNALING_PATHWAY","KEGG_pathway","HSA04062_CHEMOKINE_SIGNALING_PATHWAY",178,-1.8312,0,0.0018,1.055,0.3,0.83,-1.0503,0.31,0.6
"GO_BP:488096_GO_0002221_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY","GO_BP","488096_GO_0002221_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY",140,-1.8312,0,0.015,-0.6283,1,1,-1.058,0.31,0.81
"GO_BP:492315_GO_0007565_FEMALE_PREGNANCY","GO_BP","492315_GO_0007565_FEMALE_PREGNANCY",163,-1.831,0,0.015,-1.2403,0.062,0.91,-0.985,0.48,0.86
"C6_Oncogenic_signatures:C6_ALL_66_LTE2_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_66_LTE2_UP_V1_UP",184,-1.831,0,0.00071,-0.7059,1,0.99,-0.8994,0.75,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2539_CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL","C2_Chemical_and_genetic_perturbations","C2_CGP_2539_CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL",12,-1.8309,0.0015,0.0059,-0.6669,0.88,1,-1.6519,0.013,0.22
"GO_BP:501876_GO_0032650_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION","GO_BP","501876_GO_0032650_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION",6,-1.8308,0,0.015,-1.182,0.3,0.91,-0.9514,0.51,0.89
"GO_BP:498167_GO_0019322_PENTOSE_BIOSYNTHETIC_PROCESS","GO_BP","498167_GO_0019322_PENTOSE_BIOSYNTHETIC_PROCESS",6,-1.8305,0,0.015,-0.7254,0.8,1,-1.4153,0.1,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1465_XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1465_XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP",17,-1.8301,0.0031,0.006,0.863,0.65,0.96,-1.0588,0.35,0.68
"C7_Immunologic_signatures:C7_ALL_1473_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP","C7_Immunologic_signatures","C7_ALL_1473_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP",199,-1.8296,0,1.3e-05,1.3553,0.02,0.059,-0.9757,0.51,0.78
"KEGG_reaction:R01317_PHOSPHATIDYLCHOLINE_2_ACYLHYDROLASE_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_ARACHIDONATE","KEGG_reaction","R01317_PHOSPHATIDYLCHOLINE_2_ACYLHYDROLASE_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_ARACHIDONATE",18,-1.8296,0,0.0073,0.8092,0.74,1,0.9923,0.46,0.58
"GO_BP:493461_GO_0009268_RESPONSE_TO_PH","GO_BP","493461_GO_0009268_RESPONSE_TO_PH",31,-1.8292,0.0044,0.015,-1.3235,0.1,0.89,-0.9953,0.45,0.85
"GO_BP:505288_GO_0042116_MACROPHAGE_ACTIVATION","GO_BP","505288_GO_0042116_MACROPHAGE_ACTIVATION",27,-1.8292,0,0.015,0.7489,0.86,1,-0.8644,0.65,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1788_ZHU_CMV_ALL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1788_ZHU_CMV_ALL_UP",120,-1.8284,0,0.0061,-0.9049,0.69,1,-1.5915,0,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_234_AKL_HTLV1_INFECTION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_234_AKL_HTLV1_INFECTION_UP",27,-1.8283,0.0014,0.0061,0.5239,1,1,-1.0913,0.31,0.64
"C4_Cancer_gene_neighborhoods:C4_CGN_360_GNF2_ICAM3","C4_Cancer_gene_neighborhoods","C4_CGN_360_GNF2_ICAM3",39,-1.8282,0.0014,0.0018,1.0607,0.34,0.44,0.6661,0.97,1
"GO_BP:501956_GO_0032730_POSITIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION","GO_BP","501956_GO_0032730_POSITIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION",6,-1.8279,0,0.015,-1.1877,0.29,0.9,-0.9903,0.45,0.86
"GO_BP:505339_GO_0042178_XENOBIOTIC_CATABOLIC_PROCESS","GO_BP","505339_GO_0042178_XENOBIOTIC_CATABOLIC_PROCESS",10,-1.8279,0.0017,0.015,-1.9749,0,0.35,-1.7537,0.0019,0.64
"GO_BP:488631_GO_0002758_INNATE_IMMUNE_RESPONSE_ACTIVATING_SIGNAL_TRANSDUCTION","GO_BP","488631_GO_0002758_INNATE_IMMUNE_RESPONSE_ACTIVATING_SIGNAL_TRANSDUCTION",145,-1.8278,0,0.015,-0.7228,0.98,1,-1.1072,0.22,0.77
"GO_BP:508098_GO_0045761_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY","GO_BP","508098_GO_0045761_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY",78,-1.8272,0,0.015,0.9488,0.56,1,1.5277,0.0077,0.53
"C7_Immunologic_signatures:C7_ALL_1655_GSE3982_MAC_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1655_GSE3982_MAC_VS_NKCELL_UP",200,-1.8272,0,1.7e-05,0.9325,0.64,0.95,0.9607,0.55,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2152_COATES_MACROPHAGE_M1_VS_M2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2152_COATES_MACROPHAGE_M1_VS_M2_UP",81,-1.8269,0,0.0062,-1.1502,0.24,0.85,-1.0356,0.37,0.71
"GO_CC:490910_GO_0005911_CELL_CELL_JUNCTION","GO_CC","490910_GO_0005911_CELL_CELL_JUNCTION",360,-1.8268,0,0.019,-1.2451,0.024,0.64,-1.0904,0.2,0.93
"KEGG_pathway:HSA04750_INFLAMMATORY_MEDIATOR_REGULATION_OF_TRP_CHANNELS","KEGG_pathway","HSA04750_INFLAMMATORY_MEDIATOR_REGULATION_OF_TRP_CHANNELS",97,-1.8267,0,0.0019,-1.2609,0.088,0.48,-1.1237,0.22,0.48
"GO_MF:513558_GO_0055131_C3HC4_TYPE_RING_FINGER_DOMAIN_BINDING","GO_MF","513558_GO_0055131_C3HC4_TYPE_RING_FINGER_DOMAIN_BINDING",6,-1.8266,0.0017,0.039,-1.8361,0,0.15,-2.0299,0.0021,0.088
"C2_Chemical_and_genetic_perturbations:C2_CGP_2656_LIU_VAV3_PROSTATE_CARCINOGENESIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2656_LIU_VAV3_PROSTATE_CARCINOGENESIS_UP",86,-1.8266,0,0.0062,1.0501,0.35,0.71,1.321,0.048,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_3364_LIM_MAMMARY_LUMINAL_PROGENITOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3364_LIM_MAMMARY_LUMINAL_PROGENITOR_DN",13,-1.8261,0.0016,0.0063,-0.8258,0.7,1,-1.0697,0.35,0.67
"GO_BP:513302_GO_0052555_POSITIVE_REGULATION_BY_ORGANISM_OF_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513302_GO_0052555_POSITIVE_REGULATION_BY_ORGANISM_OF_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",7,-1.8258,0,0.015,0.7972,0.73,1,-0.8493,0.66,0.96
"C3_TF_targets:C3_TFT_20_V_NFE2_01","C3_TF_targets","C3_TFT_20_V_NFE2_01",262,-1.8258,0,0.0035,-1.1509,0.13,0.45,-1.1217,0.17,0.49
"C3_TF_targets:C3_TFT_396_V_ELF1_Q6","C3_TF_targets","C3_TFT_396_V_ELF1_Q6",243,-1.8255,0,0.0031,-0.9838,0.5,0.8,-1.3009,0.013,0.24
"GO_BP:508755_GO_0046496_NICOTINAMIDE_NUCLEOTIDE_METABOLIC_PROCESS","GO_BP","508755_GO_0046496_NICOTINAMIDE_NUCLEOTIDE_METABOLIC_PROCESS",91,-1.8254,0,0.016,-0.7607,0.94,1,-1.5677,0.0042,0.52
"GO_MF:487546_GO_0001618_VIRUS_RECEPTOR_ACTIVITY","GO_MF","487546_GO_0001618_VIRUS_RECEPTOR_ACTIVITY",33,-1.8253,0.0027,0.038,-1.1275,0.27,0.81,-1.3155,0.097,0.56
"C7_Immunologic_signatures:C7_ALL_1700_GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1700_GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN",196,-1.8252,0,1.7e-05,-0.7194,0.99,1,-0.8675,0.84,0.99
"GO_BP:494927_GO_0010863_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY","GO_BP","494927_GO_0010863_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY",69,-1.8252,0,0.016,-0.8589,0.71,1,-1.3912,0.06,0.58
"WikiPathways:198781_WP334_GPCRS_CLASS_B_SECRETIN_LIKE","WikiPathways","198781_WP334_GPCRS_CLASS_B_SECRETIN_LIKE",23,-1.8251,0,0.0076,1.0234,0.42,1,1.0346,0.4,0.88
"GO_MF:489499_GO_0004030_ALDEHYDE_DEHYDROGENASE_NAD_P_ACTIVITY","GO_MF","489499_GO_0004030_ALDEHYDE_DEHYDROGENASE_NAD_P_ACTIVITY",7,-1.8249,0.0033,0.037,-1.1314,0.31,0.81,-1.2318,0.25,0.58
"C7_Immunologic_signatures:C7_ALL_1610_GSE3982_MAST_CELL_VS_MAC_DN","C7_Immunologic_signatures","C7_ALL_1610_GSE3982_MAST_CELL_VS_MAC_DN",195,-1.8247,0,1.7e-05,-0.9832,0.47,1,0.7985,0.95,1
"GO_BP:494882_GO_0010818_T_CELL_CHEMOTAXIS","GO_BP","494882_GO_0010818_T_CELL_CHEMOTAXIS",9,-1.8247,0,0.016,0.9826,0.47,1,-1.0357,0.41,0.82
"C7_Immunologic_signatures:C7_ALL_1124_GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN","C7_Immunologic_signatures","C7_ALL_1124_GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN",193,-1.8246,0,1.7e-05,0.8558,0.88,1,-1.2789,0.045,0.16
"KEGG_reaction:R01315_PHOSPHATIDYLCHOLINE_2_ACYLHYDROLASE_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_FATTY_ACID","KEGG_reaction","R01315_PHOSPHATIDYLCHOLINE_2_ACYLHYDROLASE_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_FATTY_ACID",18,-1.8245,0.0016,0.0072,0.8054,0.75,1,1.0116,0.43,0.6
"GO_CC:506302_GO_0043235_RECEPTOR_COMPLEX","GO_CC","506302_GO_0043235_RECEPTOR_COMPLEX",293,-1.8245,0,0.019,-1.2205,0.06,0.66,1.183,0.084,0.82
"GO_BP:755345_GO_2001239_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND","GO_BP","755345_GO_2001239_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND",58,-1.8241,0.0013,0.016,-1.114,0.27,0.94,-1.5055,0.014,0.53
"C4_Cancer_modules:C4_CM_197_MODULE_210","C4_Cancer_modules","C4_CM_197_MODULE_210",27,-1.8239,0.0015,0.0045,-1.316,0.12,0.51,-1.3101,0.12,0.29
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_52_BIOCARTA_INFLAM_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_52_BIOCARTA_INFLAM_PATHWAY",29,-1.8239,0.003,0.019,-1.5165,0.034,1,-1.3605,0.087,0.47
"GO_BP:516161_GO_0071236_CELLULAR_RESPONSE_TO_ANTIBIOTIC","GO_BP","516161_GO_0071236_CELLULAR_RESPONSE_TO_ANTIBIOTIC",14,-1.8236,0.0016,0.016,-1.0731,0.35,0.96,0.9262,0.55,0.92
"WikiPathways:198816_WP185_INTEGRIN_MEDIATED_CELL_ADHESION","WikiPathways","198816_WP185_INTEGRIN_MEDIATED_CELL_ADHESION",98,-1.8235,0,0.0074,-0.881,0.72,1,-1.0491,0.34,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_1685_CUI_TCF21_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1685_CUI_TCF21_TARGETS_UP",35,-1.8233,0.0014,0.0064,0.8697,0.67,0.95,1.0841,0.32,0.87
"GO_BP:507497_GO_0045104_INTERMEDIATE_FILAMENT_CYTOSKELETON_ORGANIZATION","GO_BP","507497_GO_0045104_INTERMEDIATE_FILAMENT_CYTOSKELETON_ORGANIZATION",35,-1.8232,0,0.016,1.0047,0.43,0.98,0.8149,0.79,1
"GO_BP:488094_GO_0002218_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE","GO_BP","488094_GO_0002218_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE",152,-1.8231,0,0.016,-0.7279,0.99,1,-1.17,0.14,0.73
"GO_BP:507967_GO_0045619_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION","GO_BP","507967_GO_0045619_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION",127,-1.8229,0,0.016,-1.2392,0.1,0.91,-1.0098,0.42,0.84
"KEGG_pathway:HSA05410_HYPERTROPHIC_CARDIOMYOPATHY_HCM_","KEGG_pathway","HSA05410_HYPERTROPHIC_CARDIOMYOPATHY_HCM_",82,-1.8228,0,0.002,-1.4801,0.013,0.54,1.2482,0.11,0.57
"GO_CC:911391_GO_0098533_ATPASE_DEPENDENT_TRANSMEMBRANE_TRANSPORT_COMPLEX","GO_CC","911391_GO_0098533_ATPASE_DEPENDENT_TRANSMEMBRANE_TRANSPORT_COMPLEX",24,-1.8227,0.0014,0.019,-1.8282,0.002,0.35,-1.6939,0.0098,0.49
"GO_BP:753258_GO_1900274_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY","GO_BP","753258_GO_1900274_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY",71,-1.8223,0,0.016,-0.941,0.55,1,-1.4199,0.026,0.57
"C7_Immunologic_signatures:C7_ALL_1849_GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1849_GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP",198,-1.8223,0,1.7e-05,0.8144,0.94,1,0.7236,1,1
"C3_TF_targets:C3_TFT_594_TGASTMAGC_V_NFE2_01","C3_TF_targets","C3_TFT_594_TGASTMAGC_V_NFE2_01",192,-1.8223,0,0.003,-1.0153,0.41,0.73,-1.1063,0.21,0.52
"GO_BP:488697_GO_0002824_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS","GO_BP","488697_GO_0002824_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS",78,-1.8222,0,0.016,-1.4854,0.0092,0.84,-1.3803,0.038,0.59
"C6_Oncogenic_signatures:C6_ALL_68_MEK_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_68_MEK_UP_V1_UP",194,-1.822,0,0.00068,0.8596,0.86,0.99,1.1169,0.19,0.36
"C3_TF_targets:C3_TFT_421_V_HNF1_Q6","C3_TF_targets","C3_TFT_421_V_HNF1_Q6",245,-1.822,0,0.0027,-0.8825,0.8,0.99,1.2543,0.054,0.61
"KEGG_reaction:R07859_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_9Z_12Z_15Z_OCTADECATRIENOIC_ACID","KEGG_reaction","R07859_PHOSPHATIDYLCHOLINE_H2O_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_9Z_12Z_15Z_OCTADECATRIENOIC_ACID",18,-1.8217,0.0016,0.0071,0.8252,0.74,1,1.0084,0.41,0.59
"GO_BP:513385_GO_0052646_ALDITOL_PHOSPHATE_METABOLIC_PROCESS","GO_BP","513385_GO_0052646_ALDITOL_PHOSPHATE_METABOLIC_PROCESS",33,-1.8217,0,0.016,1.0592,0.36,0.94,0.7294,0.87,1
"C4_Cancer_modules:C4_CM_107_MODULE_112","C4_Cancer_modules","C4_CM_107_MODULE_112",250,-1.8216,0,0.0045,-1.2483,0.042,0.6,-1.1771,0.095,0.44
"C7_Immunologic_signatures:C7_ALL_438_GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN","C7_Immunologic_signatures","C7_ALL_438_GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN",196,-1.8214,0,1.7e-05,1.088,0.23,0.48,-1.2384,0.057,0.21
"C7_Immunologic_signatures:C7_ALL_1835_GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1835_GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP",200,-1.8212,0,1.7e-05,-0.9505,0.59,1,-0.9931,0.46,0.74
"KEGG_pathway:HSA04360_AXON_GUIDANCE","KEGG_pathway","HSA04360_AXON_GUIDANCE",124,-1.821,0.0012,0.002,-1.2436,0.09,0.51,-0.8506,0.82,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2279_ITO_PTTG1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2279_ITO_PTTG1_TARGETS_DN",9,-1.8209,0.0017,0.0066,-0.6147,0.92,1,-0.7765,0.74,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2355_LABBE_TGFB1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2355_LABBE_TGFB1_TARGETS_UP",100,-1.8204,0,0.0066,-0.8562,0.76,1,-0.9537,0.56,0.82
"C7_Immunologic_signatures:C7_ALL_1630_GSE3982_DC_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1630_GSE3982_DC_VS_NEUTROPHIL_DN",196,-1.8203,0,1.7e-05,0.8176,0.94,1,-1.0272,0.4,0.67
"C7_Immunologic_signatures:C7_ALL_1896_GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1896_GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN",195,-1.8202,0,1.6e-05,-0.8291,0.88,1,1.6903,0,0.0022
"C7_Immunologic_signatures:C7_ALL_1877_GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1877_GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP",198,-1.8198,0,1.6e-05,1.4629,0.0047,0.019,-1.2292,0.063,0.23
"GO_BP:502254_GO_0033032_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS","GO_BP","502254_GO_0033032_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS",24,-1.8197,0,0.016,0.8564,0.68,1,-0.9879,0.47,0.86
"GO_MF:490322_GO_0005041_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY","GO_MF","490322_GO_0005041_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY",10,-1.8196,0,0.039,0.8329,0.68,1,1.2666,0.18,0.65
"GO_BP:494893_GO_0010829_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSPORT","GO_BP","494893_GO_0010829_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSPORT",15,-1.8195,0.0016,0.016,-1.3111,0.13,0.87,-1.4877,0.069,0.53
"GO_BP:946750_GO_1990267_RESPONSE_TO_TRANSITION_METAL_NANOPARTICLE","GO_BP","946750_GO_1990267_RESPONSE_TO_TRANSITION_METAL_NANOPARTICLE",112,-1.8195,0,0.016,1.174,0.14,0.81,-0.9675,0.52,0.88
"C7_Immunologic_signatures:C7_ALL_1678_GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1678_GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN",185,-1.819,0,1.6e-05,-1.0667,0.28,1,-1.1395,0.15,0.39
"GO_BP:503319_GO_0034113_HETEROTYPIC_CELL_CELL_ADHESION","GO_BP","503319_GO_0034113_HETEROTYPIC_CELL_CELL_ADHESION",27,-1.8189,0.0015,0.016,0.8642,0.7,1,0.65,0.95,1
"C7_Immunologic_signatures:C7_ALL_787_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_787_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP",190,-1.8188,0,1.6e-05,-1.1089,0.21,1,-1.8584,0,1e-04
"GO_BP:492415_GO_0008037_CELL_RECOGNITION","GO_BP","492415_GO_0008037_CELL_RECOGNITION",107,-1.8186,0,0.016,-1.1802,0.15,0.91,-1.2363,0.099,0.69
"GO_BP:513098_GO_0052255_MODULATION_BY_ORGANISM_OF_DEFENSE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513098_GO_0052255_MODULATION_BY_ORGANISM_OF_DEFENSE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",9,-1.8185,0,0.016,0.6257,0.93,1,-0.8402,0.66,0.96
"GO_BP:507427_GO_0045019_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS","GO_BP","507427_GO_0045019_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS",11,-1.8179,0.0047,0.016,-1.5711,0.037,0.71,-1.1388,0.3,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1570_YAGI_AML_FAB_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_1570_YAGI_AML_FAB_MARKERS",190,-1.8179,0,0.0068,0.9644,0.56,0.84,-1.2883,0.024,0.44
"KEGG_reaction:R07000_NAPHTHALENE_NADPH_OXYGEN_OXIDOREDUCTASE_RH_HYDROXYLATING_OR_EPOXIDIZING_NAPHTHALENE_NADPH_OXYGEN_H_1R_2S_NAPHTHALENE_1_2_OXIDE_NADP_H2O","KEGG_reaction","R07000_NAPHTHALENE_NADPH_OXYGEN_OXIDOREDUCTASE_RH_HYDROXYLATING_OR_EPOXIDIZING_NAPHTHALENE_NADPH_OXYGEN_H_1R_2S_NAPHTHALENE_1_2_OXIDE_NADP_H2O",8,-1.8177,0.0016,0.007,-1.4207,0.079,0.26,-0.8543,0.61,0.81
"GO_BP:488587_GO_0002714_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY","GO_BP","488587_GO_0002714_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY",28,-1.8176,0,0.017,-1.751,0.0078,0.6,-1.2304,0.16,0.7
"GO_BP:753355_GO_1900371_REGULATION_OF_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","753355_GO_1900371_REGULATION_OF_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",139,-1.8176,0,0.016,-0.9483,0.56,1,1.6367,0.002,0.4
"GO_BP:506406_GO_0043367_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION","GO_BP","506406_GO_0043367_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION",29,-1.8172,0.0043,0.017,-0.9608,0.52,1,0.844,0.7,0.99
"KEGG_compound:C05138_17ALPHA_HYDROXYPREGNENOLONE","KEGG_compound","C05138_17ALPHA_HYDROXYPREGNENOLONE",5,-1.8171,0.0018,0.013,1.0762,0.37,1,1.569,0.036,0.12
"KEGG_module:HSA_M00109_C21_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_CORTISOL_CORTISONE","KEGG_module","HSA_M00109_C21_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_CORTISOL_CORTISONE",6,-1.8171,0,0.15,0.9411,0.52,0.88,-1.1982,0.27,0.51
"GO_BP:502166_GO_0032944_REGULATION_OF_MONONUCLEAR_CELL_PROLIFERATION","GO_BP","502166_GO_0032944_REGULATION_OF_MONONUCLEAR_CELL_PROLIFERATION",177,-1.817,0,0.017,-0.815,0.9,1,-1.017,0.41,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_3026_KARLSSON_TGFB1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3026_KARLSSON_TGFB1_TARGETS_DN",207,-1.8168,0,0.0069,-0.7737,0.97,1,-1.1519,0.13,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_253_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_253_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN",17,-1.8167,0.0048,0.0069,-1.224,0.19,0.78,-0.993,0.46,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_635_DUTTA_APOPTOSIS_VIA_NFKB","C2_Chemical_and_genetic_perturbations","C2_CGP_635_DUTTA_APOPTOSIS_VIA_NFKB",33,-1.8166,0.0028,0.0069,-0.9596,0.47,1,-0.9744,0.49,0.79
"GO_BP:987836_GO_1903035_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING","GO_BP","987836_GO_1903035_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING",141,-1.8165,0,0.017,0.8378,0.85,1,1.1622,0.16,0.73
"GO_BP:487675_GO_0001779_NATURAL_KILLER_CELL_DIFFERENTIATION","GO_BP","487675_GO_0001779_NATURAL_KILLER_CELL_DIFFERENTIATION",13,-1.8164,0.0031,0.017,-0.92,0.57,1,-0.7246,0.86,0.99
"GO_BP:503533_GO_0034330_CELL_JUNCTION_ORGANIZATION","GO_BP","503533_GO_0034330_CELL_JUNCTION_ORGANIZATION",188,-1.816,0,0.017,-1.3333,0.0089,0.91,1.1223,0.17,0.74
"REACTOME:106552_REACT_2232_RNA_POLYMERASE_I_PROMOTER_OPENING","REACTOME","106552_REACT_2232_RNA_POLYMERASE_I_PROMOTER_OPENING",59,-1.8153,0.0014,0.023,-1.9591,0,0.045,-1.8238,0,0.15
"C7_Immunologic_signatures:C7_ALL_1657_GSE3982_MAC_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_1657_GSE3982_MAC_VS_TH1_UP",197,-1.815,0,1.6e-05,0.7538,0.99,1,-0.8708,0.85,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_356_HAHTOLA_SEZARY_SYNDROM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_356_HAHTOLA_SEZARY_SYNDROM_UP",97,-1.8149,0,0.007,1.6996,0,0.083,-1.0767,0.29,0.66
"KEGG_pathway:HSA04911_INSULIN_SECRETION","KEGG_pathway","HSA04911_INSULIN_SECRETION",83,-1.8147,0,0.0021,-1.2978,0.068,0.42,-1.2215,0.12,0.35
"GO_BP:512006_GO_0051092_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY","GO_BP","512006_GO_0051092_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY",128,-1.8146,0,0.017,0.8725,0.78,1,-1.3347,0.036,0.62
"C7_Immunologic_signatures:C7_ALL_771_GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_771_GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP",186,-1.8146,0,1.6e-05,-0.9908,0.46,1,-1.5074,0.0041,0.02
"GO_BP:492172_GO_0007411_AXON_GUIDANCE","GO_BP","492172_GO_0007411_AXON_GUIDANCE",399,-1.8145,0,0.017,-1.2512,0.029,0.91,-1.2509,0.012,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_1583_BASSO_CD40_SIGNALING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1583_BASSO_CD40_SIGNALING_UP",100,-1.8142,0,0.007,-1.152,0.2,0.85,-0.8286,0.87,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_1813_DAZARD_UV_RESPONSE_CLUSTER_G4","C2_Chemical_and_genetic_perturbations","C2_CGP_1813_DAZARD_UV_RESPONSE_CLUSTER_G4",20,-1.8142,0.0031,0.007,-1.4048,0.092,0.58,-1.5917,0.017,0.25
"GO_BP:517429_GO_0072524_PYRIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","517429_GO_0072524_PYRIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",105,-1.8142,0,0.017,-0.7198,0.98,1,-1.6209,0,0.52
"C4_Cancer_modules:C4_CM_174_MODULE_184","C4_Cancer_modules","C4_CM_174_MODULE_184",29,-1.8141,0.0014,0.0051,0.6792,0.94,1,-1.9934,0,0.011
"REACTOME:105701_REACT_13812_ENDOGENOUS_STEROLS","REACTOME","105701_REACT_13812_ENDOGENOUS_STEROLS",22,-1.8139,0.003,0.023,1.1205,0.3,0.56,0.7668,0.82,1
"GO_CC:486839_GO_0000323_LYTIC_VACUOLE","GO_CC","486839_GO_0000323_LYTIC_VACUOLE",473,-1.8139,0,0.021,0.8902,0.91,0.91,-0.8921,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1044_SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1044_SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP",18,-1.8139,0.0015,0.007,-1.4074,0.07,0.58,0.8425,0.7,1
"WikiPathways:920957_WP2355_CORTICOTROPIN_RELEASING_HORMONE","WikiPathways","920957_WP2355_CORTICOTROPIN_RELEASING_HORMONE",89,-1.8138,0.0013,0.0083,-1.2875,0.065,1,-1.5447,0.0021,0.27
"GO_BP:488102_GO_0002228_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY","GO_BP","488102_GO_0002228_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY",26,-1.8138,0.0016,0.017,-0.7361,0.85,1,-1.0678,0.36,0.8
"C7_Immunologic_signatures:C7_ALL_1085_GSE25087_TREG_VS_TCONV_ADULT_UP","C7_Immunologic_signatures","C7_ALL_1085_GSE25087_TREG_VS_TCONV_ADULT_UP",198,-1.8138,0,1.6e-05,-0.7299,0.99,1,-1.2096,0.075,0.26
"GO_BP:1022094_GO_0098657_IMPORT_INTO_CELL","GO_BP","1022094_GO_0098657_IMPORT_INTO_CELL",18,-1.8131,0,0.017,-1.3586,0.1,0.96,-0.9859,0.45,0.86
"GO_BP:507705_GO_0045348_POSITIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS","GO_BP","507705_GO_0045348_POSITIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS",8,-1.813,0.0017,0.017,-1.3261,0.15,0.89,-0.7912,0.71,0.99
"GO_BP:503348_GO_0034142_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY","GO_BP","503348_GO_0034142_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY",99,-1.8128,0,0.017,-0.8238,0.87,1,-1.1018,0.27,0.77
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_18_BIOCARTA_SPPA_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_18_BIOCARTA_SPPA_PATHWAY",21,-1.8123,0.0015,0.021,-0.8479,0.66,1,-0.8353,0.71,0.89
"GO_BP:511675_GO_0050704_REGULATION_OF_INTERLEUKIN_1_SECRETION","GO_BP","511675_GO_0050704_REGULATION_OF_INTERLEUKIN_1_SECRETION",23,-1.812,0.0015,0.017,-1.095,0.32,0.95,-1.1439,0.27,0.75
"C7_Immunologic_signatures:C7_ALL_120_GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN","C7_Immunologic_signatures","C7_ALL_120_GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN",188,-1.812,0,1.6e-05,1.6222,0.0023,0.0021,-0.9322,0.69,0.89
"GO_BP:505283_GO_0042107_CYTOKINE_METABOLIC_PROCESS","GO_BP","505283_GO_0042107_CYTOKINE_METABOLIC_PROCESS",21,-1.8119,0.0046,0.017,-0.9683,0.48,1,0.996,0.46,0.86
"WikiPathways:198888_WP167_EICOSANOID_SYNTHESIS","WikiPathways","198888_WP167_EICOSANOID_SYNTHESIS",20,-1.8118,0.0016,0.0081,1.0842,0.34,1,-1.151,0.26,0.56
"GO_CC:489651_GO_0005764_LYSOSOME","GO_CC","489651_GO_0005764_LYSOSOME",473,-1.8117,0,0.021,0.8853,0.9,0.91,-0.8808,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1915_SEMENZA_HIF1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1915_SEMENZA_HIF1_TARGETS",35,-1.8117,0.0014,0.0072,-1.0732,0.33,0.95,-0.9281,0.56,0.84
"GO_BP:505276_GO_0042098_T_CELL_PROLIFERATION","GO_BP","505276_GO_0042098_T_CELL_PROLIFERATION",44,-1.8117,0,0.017,0.7828,0.82,1,-0.7078,0.93,0.99
"GO_BP:502298_GO_0033077_T_CELL_DIFFERENTIATION_IN_THYMUS","GO_BP","502298_GO_0033077_T_CELL_DIFFERENTIATION_IN_THYMUS",51,-1.8116,0,0.017,-1.0319,0.4,0.98,-1.3289,0.072,0.62
"GO_BP:516518_GO_0071594_THYMOCYTE_AGGREGATION","GO_BP","516518_GO_0071594_THYMOCYTE_AGGREGATION",51,-1.8116,0,0.017,-1.0144,0.44,0.98,-1.3456,0.068,0.61
"GO_MF:490031_GO_0004715_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY","GO_MF","490031_GO_0004715_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY",45,-1.8113,0.0014,0.043,-1.2207,0.15,0.84,-1.1863,0.2,0.59
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_162_BIOCARTA_RHO_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_162_BIOCARTA_RHO_PATHWAY",31,-1.8112,0.0015,0.02,0.909,0.58,0.91,-0.8117,0.79,0.88
"GO_BP:513508_GO_0055075_POTASSIUM_ION_HOMEOSTASIS","GO_BP","513508_GO_0055075_POTASSIUM_ION_HOMEOSTASIS",16,-1.811,0.0032,0.017,-1.3327,0.14,0.91,-1.5914,0.037,0.51
"GO_BP:507947_GO_0045599_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION","GO_BP","507947_GO_0045599_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION",40,-1.8109,0.0028,0.017,-0.8095,0.8,1,0.8365,0.73,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1088_RICKMAN_HEAD_AND_NECK_CANCER_C","C2_Chemical_and_genetic_perturbations","C2_CGP_1088_RICKMAN_HEAD_AND_NECK_CANCER_C",99,-1.8107,0,0.0073,1.0361,0.38,0.74,1.2769,0.066,0.68
"C7_Immunologic_signatures:C7_ALL_220_GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_220_GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN",198,-1.8105,0,1.6e-05,0.799,0.95,1,-1.1041,0.19,0.49
"C7_Immunologic_signatures:C7_ALL_1718_GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1718_GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN",197,-1.8105,0,1.6e-05,0.9461,0.62,0.91,-0.8308,0.91,1
"C7_Immunologic_signatures:C7_ALL_1468_GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN","C7_Immunologic_signatures","C7_ALL_1468_GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN",195,-1.8103,0,1.6e-05,1.0933,0.22,0.46,-1.1494,0.14,0.37
"WikiPathways:198837_WP702_METAPATHWAY_BIOTRANSFORMATION","WikiPathways","198837_WP702_METAPATHWAY_BIOTRANSFORMATION",175,-1.8103,0,0.0079,1.0187,0.4,1,1.3837,0.017,0.46
"GO_BP:487456_GO_0001516_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS","GO_BP","487456_GO_0001516_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS",21,-1.81,0.003,0.017,-0.7379,0.88,1,-1.1232,0.28,0.76
"C3_TF_targets:C3_TFT_153_V_SRF_C","C3_TF_targets","C3_TFT_153_V_SRF_C",207,-1.81,0,0.0031,-1.2618,0.045,0.26,0.8616,0.82,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_3_BIOCARTA_CSK_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_3_BIOCARTA_CSK_PATHWAY",21,-1.8099,0.0059,0.019,1.367,0.082,0.54,-1.7414,0.0061,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_354_GOZGIT_ESR1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_354_GOZGIT_ESR1_TARGETS_UP",144,-1.8098,0,0.0074,-1.3014,0.055,0.69,-0.9023,0.67,0.88
"C4_Cancer_modules:C4_CM_18_MODULE_19","C4_Cancer_modules","C4_CM_18_MODULE_19",306,-1.8098,0,0.0052,-0.9031,0.75,0.88,-1.3256,0.0085,0.28
"GO_BP:488348_GO_0002475_ANTIGEN_PROCESSING_AND_PRESENTATION_VIA_MHC_CLASS_IB","GO_BP","488348_GO_0002475_ANTIGEN_PROCESSING_AND_PRESENTATION_VIA_MHC_CLASS_IB",11,-1.8092,0.0063,0.018,-1.0035,0.44,0.99,-1.4925,0.072,0.54
"C7_Immunologic_signatures:C7_ALL_1621_GSE3982_MAST_CELL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1621_GSE3982_MAST_CELL_VS_NKCELL_UP",199,-1.8092,0,1.6e-05,1.2004,0.093,0.23,-1.0156,0.43,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_3338_GENTLES_LEUKEMIC_STEM_CELL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3338_GENTLES_LEUKEMIC_STEM_CELL_DN",19,-1.8091,0.003,0.0074,1.2407,0.18,0.45,0.6298,0.94,1
"GO_BP:502068_GO_0032846_POSITIVE_REGULATION_OF_HOMEOSTATIC_PROCESS","GO_BP","502068_GO_0032846_POSITIVE_REGULATION_OF_HOMEOSTATIC_PROCESS",147,-1.809,0,0.018,-0.9348,0.61,1,-1.0929,0.26,0.78
"GO_BP:507496_GO_0045103_INTERMEDIATE_FILAMENT_BASED_PROCESS","GO_BP","507496_GO_0045103_INTERMEDIATE_FILAMENT_BASED_PROCESS",36,-1.809,0.0014,0.018,0.9272,0.57,1,0.7708,0.85,1
"GO_BP:509047_GO_0046824_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT","GO_BP","509047_GO_0046824_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT",100,-1.8088,0,0.018,-1.0569,0.33,0.96,-1.427,0.024,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1102_DEN_INTERACT_WITH_LCA5","C2_Chemical_and_genetic_perturbations","C2_CGP_1102_DEN_INTERACT_WITH_LCA5",26,-1.8088,0.0015,0.0074,1.0873,0.32,0.65,-1.4115,0.082,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_134_CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_134_CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN",458,-1.8087,0,0.0074,1.0673,0.19,0.68,0.9766,0.53,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1181_MORI_IMMATURE_B_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1181_MORI_IMMATURE_B_LYMPHOCYTE_DN",90,-1.8086,0,0.0074,0.7415,0.94,1,-2.0229,0,0.033
"REACTOME:1127693_REACT_263952_EPHB_MEDIATED_FORWARD_SIGNALING","REACTOME","1127693_REACT_263952_EPHB_MEDIATED_FORWARD_SIGNALING",41,-1.8086,0,0.024,0.7394,0.91,1,-0.8147,0.81,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1347_CHEN_LUNG_CANCER_SURVIVAL","C2_Chemical_and_genetic_perturbations","C2_CGP_1347_CHEN_LUNG_CANCER_SURVIVAL",26,-1.8085,0,0.0074,-0.9196,0.58,1,-0.5671,0.99,0.99
"GO_BP:499232_GO_0021953_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION","GO_BP","499232_GO_0021953_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION",163,-1.8085,0,0.018,-1.1968,0.12,0.9,1.0949,0.25,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1742_RUAN_RESPONSE_TO_TNF_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1742_RUAN_RESPONSE_TO_TNF_DN",82,-1.8084,0,0.0073,0.8749,0.71,0.95,-1.3246,0.069,0.41
"GO_MF:504223_GO_0035035_HISTONE_ACETYLTRANSFERASE_BINDING","GO_MF","504223_GO_0035035_HISTONE_ACETYLTRANSFERASE_BINDING",21,-1.8082,0.003,0.043,-0.944,0.53,0.95,-0.7486,0.85,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_3008_SASSON_RESPONSE_TO_FORSKOLIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3008_SASSON_RESPONSE_TO_FORSKOLIN_DN",88,-1.8078,0,0.0074,0.6197,1,1,-1.1213,0.25,0.6
"GO_BP:492437_GO_0008064_REGULATION_OF_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION","GO_BP","492437_GO_0008064_REGULATION_OF_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION",129,-1.8074,0,0.018,-0.8029,0.9,1,-1.332,0.015,0.62
"GO_BP:502192_GO_0032970_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS","GO_BP","502192_GO_0032970_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS",298,-1.8072,0,0.018,-0.9942,0.47,1,-1.0659,0.25,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2063_GAVIN_FOXP3_TARGETS_CLUSTER_P6","C2_Chemical_and_genetic_perturbations","C2_CGP_2063_GAVIN_FOXP3_TARGETS_CLUSTER_P6",91,-1.8071,0,0.0074,0.6987,0.98,1,-1.5917,0.004,0.25
"GO_BP:508746_GO_0046486_GLYCEROLIPID_METABOLIC_PROCESS","GO_BP","508746_GO_0046486_GLYCEROLIPID_METABOLIC_PROCESS",297,-1.8069,0,0.018,-0.8336,0.94,1,-0.9482,0.63,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_528_STREICHER_LSM1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_528_STREICHER_LSM1_TARGETS_UP",44,-1.8069,0,0.0074,-1.0235,0.41,0.98,-1.3456,0.068,0.4
"KEGG_pathway:HSA04611_PLATELET_ACTIVATION","KEGG_pathway","HSA04611_PLATELET_ACTIVATION",131,-1.8069,0,0.0024,1.2167,0.1,0.53,-1.3475,0.03,0.21
"GO_BP:500107_GO_0030808_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","500107_GO_0030808_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",141,-1.8067,0,0.018,-0.9456,0.6,1,1.6544,0.002,0.39
"C2_Chemical_and_genetic_perturbations:C2_CGP_1803_SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_1803_SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER",45,-1.8062,0,0.0075,-0.8484,0.72,1,-1.3956,0.049,0.36
"GO_BP:516546_GO_0071622_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS","GO_BP","516546_GO_0071622_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS",31,-1.806,0,0.018,1.0029,0.45,0.98,1.1357,0.26,0.74
"GO_BP:486819_GO_0000302_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES","GO_BP","486819_GO_0000302_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES",156,-1.8059,0,0.018,-0.8192,0.89,1,-1.1919,0.1,0.74
"REACTOME:119537_REACT_19193_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION","REACTOME","119537_REACT_19193_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION",8,-1.8058,0.0034,0.024,-1.4812,0.058,0.46,-1.0408,0.42,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_3093_WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1","C2_Chemical_and_genetic_perturbations","C2_CGP_3093_WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1",27,-1.8056,0.003,0.0075,-1.1186,0.28,0.89,-1.4312,0.044,0.34
"GO_BP:491054_GO_0006069_ETHANOL_OXIDATION","GO_BP","491054_GO_0006069_ETHANOL_OXIDATION",11,-1.8056,0.0048,0.018,-1.3461,0.13,0.92,-1.5049,0.066,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_164_NOJIMA_SFRP2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_164_NOJIMA_SFRP2_TARGETS_UP",31,-1.8055,0.003,0.0075,-1.3304,0.1,0.69,-1.517,0.034,0.29
"GO_BP:498206_GO_0019362_PYRIDINE_NUCLEOTIDE_METABOLIC_PROCESS","GO_BP","498206_GO_0019362_PYRIDINE_NUCLEOTIDE_METABOLIC_PROCESS",97,-1.8054,0,0.018,-0.7116,0.97,1,-1.6252,0.0021,0.51
"GO_BP:508016_GO_0045668_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION","GO_BP","508016_GO_0045668_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION",37,-1.8052,0,0.018,-1.2245,0.15,0.88,-0.8383,0.71,0.96
"KEGG_pathway:HSA04930_TYPE_II_DIABETES_MELLITUS","KEGG_pathway","HSA04930_TYPE_II_DIABETES_MELLITUS",47,-1.8052,0,0.0024,-1.3848,0.056,0.35,-1.2247,0.15,0.35
"GO_BP:491528_GO_0006638_NEUTRAL_LIPID_METABOLIC_PROCESS","GO_BP","491528_GO_0006638_NEUTRAL_LIPID_METABOLIC_PROCESS",96,-1.8051,0,0.018,-0.7151,0.97,1,-1.0213,0.41,0.83
"GO_MF:492830_GO_0008556_POTASSIUM_TRANSPORTING_ATPASE_ACTIVITY","GO_MF","492830_GO_0008556_POTASSIUM_TRANSPORTING_ATPASE_ACTIVITY",11,-1.8049,0.0017,0.044,-1.3896,0.11,0.65,-1.4912,0.045,0.42
"GO_BP:506202_GO_0043129_SURFACTANT_HOMEOSTASIS","GO_BP","506202_GO_0043129_SURFACTANT_HOMEOSTASIS",10,-1.8049,0,0.018,0.6487,0.92,1,-0.7251,0.82,0.99
"GO_BP:515591_GO_0070661_LEUKOCYTE_PROLIFERATION","GO_BP","515591_GO_0070661_LEUKOCYTE_PROLIFERATION",89,-1.8048,0,0.018,0.7416,0.96,1,-0.8588,0.76,0.96
"GO_BP:517579_GO_0072676_LYMPHOCYTE_MIGRATION","GO_BP","517579_GO_0072676_LYMPHOCYTE_MIGRATION",28,-1.8048,0.0015,0.018,0.8623,0.66,1,-0.8527,0.71,0.96
"C7_Immunologic_signatures:C7_ALL_884_GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN","C7_Immunologic_signatures","C7_ALL_884_GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN",199,-1.8045,0,2e-05,-0.7834,0.97,1,-1.4246,0.004,0.046
"GO_BP:491758_GO_0006897_ENDOCYTOSIS","GO_BP","491758_GO_0006897_ENDOCYTOSIS",482,-1.8039,0,0.018,-0.8626,0.93,1,-0.9982,0.45,0.85
"GO_BP:752431_GO_0086065_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION","GO_BP","752431_GO_0086065_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION",36,-1.8039,0,0.018,-1.2744,0.13,0.89,-0.895,0.62,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1471_FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1471_FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP",86,-1.8038,0.0013,0.0077,0.9694,0.51,0.84,-1.4167,0.022,0.34
"GO_BP:491702_GO_0006837_SEROTONIN_TRANSPORT","GO_BP","491702_GO_0006837_SEROTONIN_TRANSPORT",7,-1.8038,0,0.018,-1.3114,0.16,0.87,-1.1773,0.27,0.74
"GO_BP:492553_GO_0008212_MINERALOCORTICOID_METABOLIC_PROCESS","GO_BP","492553_GO_0008212_MINERALOCORTICOID_METABOLIC_PROCESS",6,-1.8037,0.0017,0.018,0.7599,0.76,1,1.1544,0.3,0.73
"C7_Immunologic_signatures:C7_ALL_795_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_795_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP",193,-1.8036,0,2e-05,-0.8434,0.88,1,-1.1943,0.08,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_2546_RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2546_RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP",334,-1.8033,0,0.0077,0.7454,1,1,0.8833,0.86,1
"GO_BP:519044_GO_2000404_REGULATION_OF_T_CELL_MIGRATION","GO_BP","519044_GO_2000404_REGULATION_OF_T_CELL_MIGRATION",22,-1.8033,0.0015,0.018,-0.8987,0.63,1,0.8061,0.76,1
"GO_BP:510176_GO_0048008_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","510176_GO_0048008_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",34,-1.8031,0,0.018,0.536,0.99,1,-0.9493,0.54,0.89
"GO_BP:492171_GO_0007409_AXONOGENESIS","GO_BP","492171_GO_0007409_AXONOGENESIS",486,-1.8028,0,0.018,-1.2159,0.04,0.88,-1.2249,0.039,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_21_KORKOLA_CHORIOCARCINOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_21_KORKOLA_CHORIOCARCINOMA_UP",6,-1.8027,0.0035,0.0077,-0.7753,0.73,1,0.6448,0.88,1
"REACTOME:1127677_REACT_268237_DNA_METHYLATION","REACTOME","1127677_REACT_268237_DNA_METHYLATION",61,-1.8026,0,0.025,-2.0866,0,0.042,-1.7656,0,0.21
"C2_Chemical_and_genetic_perturbations:C2_CGP_1746_LEONARD_HYPOXIA","C2_Chemical_and_genetic_perturbations","C2_CGP_1746_LEONARD_HYPOXIA",47,-1.8026,0.0014,0.0077,-1.1521,0.21,0.85,-0.9303,0.59,0.84
"GO_BP:511679_GO_0050708_REGULATION_OF_PROTEIN_SECRETION","GO_BP","511679_GO_0050708_REGULATION_OF_PROTEIN_SECRETION",333,-1.8025,0,0.018,0.8212,0.98,1,-1.0899,0.2,0.78
"C7_Immunologic_signatures:C7_ALL_613_GSE17721_LPS_VS_PAM3CSK4_16H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_613_GSE17721_LPS_VS_PAM3CSK4_16H_BMDM_UP",198,-1.8025,0,2e-05,0.8647,0.86,1,-0.7379,0.99,1
"GO_MF:496634_GO_0016713_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_IRON_SULFUR_PROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN","GO_MF","496634_GO_0016713_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_IRON_SULFUR_PROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN",8,-1.8025,0.0048,0.045,0.7004,0.83,1,1.7257,0.014,0.16
"C2_Chemical_and_genetic_perturbations:C2_CGP_1699_CHIBA_RESPONSE_TO_TSA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1699_CHIBA_RESPONSE_TO_TSA_UP",49,-1.8025,0.0027,0.0077,-0.9107,0.6,1,-1.0566,0.35,0.68
"GO_BP:508893_GO_0046645_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION","GO_BP","508893_GO_0046645_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION",8,-1.8023,0.0017,0.018,-1.0811,0.34,0.95,-0.8816,0.62,0.94
"GO_BP:491988_GO_0007188_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY","GO_BP","491988_GO_0007188_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",138,-1.8022,0,0.018,-1.0003,0.44,0.99,-1.0698,0.27,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1727_NATSUME_RESPONSE_TO_INTERFERON_BETA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1727_NATSUME_RESPONSE_TO_INTERFERON_BETA_DN",52,-1.802,0,0.0078,1.6026,0.0065,0.14,-0.6512,0.99,0.99
"KEGG_reaction:R07387_PLASMANYLCHOLINE_2_ACYLHYDROLASE_1_RADYL_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_H2O_1_ORGANYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_CARBOXYLATE","KEGG_reaction","R07387_PLASMANYLCHOLINE_2_ACYLHYDROLASE_1_RADYL_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_H2O_1_ORGANYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_CARBOXYLATE",18,-1.8019,0,0.0086,0.8091,0.74,1,0.9967,0.46,0.58
"GO_BP:503814_GO_0034614_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES","GO_BP","503814_GO_0034614_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES",82,-1.8017,0,0.018,0.6037,1,1,-1.5579,0.002,0.51
"GO_BP:499586_GO_0030168_PLATELET_ACTIVATION","GO_BP","499586_GO_0030168_PLATELET_ACTIVATION",229,-1.8016,0,0.018,1.2635,0.033,0.72,-0.9312,0.68,0.9
"GO_BP:511764_GO_0050795_REGULATION_OF_BEHAVIOR","GO_BP","511764_GO_0050795_REGULATION_OF_BEHAVIOR",186,-1.8015,0,0.018,0.9621,0.57,1,1.4523,0.0037,0.59
"C4_Cancer_gene_neighborhoods:C4_CGN_396_GNF2_PTPRC","C4_Cancer_gene_neighborhoods","C4_CGN_396_GNF2_PTPRC",68,-1.8015,0.0013,0.0028,0.6338,1,1,-1.3896,0.03,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_1261_TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1261_TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP",76,-1.8013,0.0013,0.0078,1.0728,0.32,0.67,-0.9353,0.59,0.84
"GO_BP:508011_GO_0045663_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION","GO_BP","508011_GO_0045663_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION",16,-1.8012,0.003,0.018,0.67,0.9,1,-1.6773,0.016,0.59
"C7_Immunologic_signatures:C7_ALL_278_GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN","C7_Immunologic_signatures","C7_ALL_278_GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN",199,-1.8012,0,1.9e-05,1.0053,0.45,0.72,-1.8592,0,1e-04
"GO_BP:494874_GO_0010810_REGULATION_OF_CELL_SUBSTRATE_ADHESION","GO_BP","494874_GO_0010810_REGULATION_OF_CELL_SUBSTRATE_ADHESION",155,-1.8011,0,0.018,-1.0236,0.41,0.97,1.1379,0.2,0.73
"GO_MF:489754_GO_0050839_CELL_ADHESION_MOLECULE_BINDING","GO_MF","489754_GO_0050839_CELL_ADHESION_MOLECULE_BINDING",171,-1.801,0,0.045,0.7528,0.98,1,1.108,0.21,0.81
"C7_Immunologic_signatures:C7_ALL_1291_GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP","C7_Immunologic_signatures","C7_ALL_1291_GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP",196,-1.801,0,1.9e-05,0.7166,1,1,-1.4652,0.0021,0.031
"GO_MF:492411_GO_0071723_LIPOPEPTIDE_BINDING","GO_MF","492411_GO_0071723_LIPOPEPTIDE_BINDING",7,-1.8009,0.0017,0.044,-1.1323,0.32,0.81,-0.86,0.63,0.91
"GO_BP:488569_GO_0002696_POSITIVE_REGULATION_OF_LEUKOCYTE_ACTIVATION","GO_BP","488569_GO_0002696_POSITIVE_REGULATION_OF_LEUKOCYTE_ACTIVATION",269,-1.8008,0,0.018,0.8274,0.94,1,-1.1856,0.099,0.73
"GO_BP:488563_GO_0002690_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS","GO_BP","488563_GO_0002690_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS",67,-1.8006,0.0013,0.018,1.2557,0.11,0.72,1.2547,0.098,0.69
"GO_BP:753115_GO_1900120_REGULATION_OF_RECEPTOR_BINDING","GO_BP","753115_GO_1900120_REGULATION_OF_RECEPTOR_BINDING",15,-1.8005,0.0016,0.018,1.1512,0.26,0.83,1.0256,0.42,0.83
"C7_Immunologic_signatures:C7_ALL_89_GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP","C7_Immunologic_signatures","C7_ALL_89_GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP",199,-1.8005,0,1.9e-05,-0.6845,1,1,-1.8436,0,8.9e-05
"GO_CC:487625_GO_0001726_RUFFLE","GO_CC","487625_GO_0001726_RUFFLE",154,-1.8005,0,0.023,-0.6693,0.99,1,0.8376,0.87,1
"KEGG_module:HSA_M00353_SPLICEOSOME_PRP19_CDC5L_COMPLEX","KEGG_module","HSA_M00353_SPLICEOSOME_PRP19_CDC5L_COMPLEX",14,-1.7997,0.0047,0.09,-1.6627,0.024,0.35,-1.9025,0.0039,0.042
"GO_BP:510733_GO_0048678_RESPONSE_TO_AXON_INJURY","GO_BP","510733_GO_0048678_RESPONSE_TO_AXON_INJURY",40,-1.7996,0.0041,0.018,-1.3399,0.087,0.91,-0.9644,0.5,0.88
"GO_BP:1129382_GO_1903556_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION","GO_BP","1129382_GO_1903556_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION",38,-1.7996,0.003,0.018,-0.9451,0.54,1,-0.8185,0.79,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_326_GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_326_GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP",86,-1.7996,0,0.008,1.2094,0.15,0.48,-1.6048,0.0042,0.24
"GO_MF:490389_GO_0005126_CYTOKINE_RECEPTOR_BINDING","GO_MF","490389_GO_0005126_CYTOKINE_RECEPTOR_BINDING",237,-1.7993,0,0.044,-0.9898,0.47,0.92,-0.9999,0.45,0.78
"C7_Immunologic_signatures:C7_ALL_1697_GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1697_GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP",192,-1.7993,0,1.9e-05,-0.8636,0.82,1,-1.386,0.012,0.071
"KEGG_pathway:HSA04620_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY","KEGG_pathway","HSA04620_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",99,-1.7989,0,0.0026,-0.9435,0.58,0.97,-1.1361,0.19,0.46
"GO_BP:488167_GO_0002294_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488167_GO_0002294_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE",21,-1.7987,0.003,0.019,-1.0836,0.33,0.96,-0.7052,0.88,0.99
"GO_BP:491052_GO_0006067_ETHANOL_METABOLIC_PROCESS","GO_BP","491052_GO_0006067_ETHANOL_METABOLIC_PROCESS",14,-1.7987,0.003,0.019,-1.212,0.24,0.88,-1.6209,0.021,0.51
"GO_BP:493825_GO_0009713_CATECHOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","493825_GO_0009713_CATECHOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",20,-1.7982,0.0016,0.019,-1.0576,0.39,0.96,-1.261,0.16,0.67
"KEGG_pathway:HSA04921_OXYTOCIN_SIGNALING_PATHWAY","KEGG_pathway","HSA04921_OXYTOCIN_SIGNALING_PATHWAY",157,-1.7982,0,0.0026,-1.1799,0.14,0.55,-1.1716,0.13,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2732_COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2732_COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN",134,-1.798,0,0.0082,-0.9877,0.48,1,-1.0613,0.29,0.68
"C7_Immunologic_signatures:C7_ALL_925_GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP","C7_Immunologic_signatures","C7_ALL_925_GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP",195,-1.7977,0,2.3e-05,1.0866,0.25,0.48,-1.4896,0.0022,0.025
"C2_Chemical_and_genetic_perturbations:C2_CGP_1971_BURTON_ADIPOGENESIS_9","C2_Chemical_and_genetic_perturbations","C2_CGP_1971_BURTON_ADIPOGENESIS_9",91,-1.7977,0,0.0082,-0.8306,0.83,1,-0.9649,0.53,0.8
"GO_BP:488449_GO_0002576_PLATELET_DEGRANULATION","GO_BP","488449_GO_0002576_PLATELET_DEGRANULATION",85,-1.7977,0.0013,0.019,1.5049,0.014,0.4,0.8643,0.77,0.97
"GO_BP:506565_GO_0043534_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION","GO_BP","506565_GO_0043534_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION",25,-1.7975,0.0045,0.019,-1.3884,0.06,1,0.7982,0.8,1
"KEGG_compound:C00350_PHOSPHATIDYLETHANOLAMINE_3_PHOSPHATIDYL_ETHANOLAMINE_3_PHOSPHATIDYL_ETHANOLAMINE_CEPHALIN_O_1_BETA_ACYL_2_ACYL_SN_GLYCERO_3_PHOSPHO_ETHANOLAMINE_1_ACYL_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_L_1_PHOSPHATIDYLETHANOLAMINE","KEGG_compound","C00350_PHOSPHATIDYLETHANOLAMINE_3_PHOSPHATIDYL_ETHANOLAMINE_3_PHOSPHATIDYL_ETHANOLAMINE_CEPHALIN_O_1_BETA_ACYL_2_ACYL_SN_GLYCERO_3_PHOSPHO_ETHANOLAMINE_1_ACYL_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_L_1_PHOSPHATIDYLETHANOLAMINE",35,-1.7973,0,0.017,-0.7982,0.79,1,-0.7532,0.86,0.88
"C7_Immunologic_signatures:C7_ALL_184_GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN","C7_Immunologic_signatures","C7_ALL_184_GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN",197,-1.7972,0,2.3e-05,-0.9474,0.61,1,-1.2565,0.056,0.19
"C4_Cancer_gene_neighborhoods:C4_CGN_291_GNF2_CENPF","C4_Cancer_gene_neighborhoods","C4_CGN_291_GNF2_CENPF",62,-1.7966,0.0014,0.003,0.9417,0.55,0.73,-1.9787,0,0.0037
"GO_BP:508773_GO_0046514_CERAMIDE_CATABOLIC_PROCESS","GO_BP","508773_GO_0046514_CERAMIDE_CATABOLIC_PROCESS",12,-1.7965,0.0031,0.019,-0.9132,0.57,1,-0.7212,0.84,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1738_KUNINGER_IGF1_VS_PDGFB_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1738_KUNINGER_IGF1_VS_PDGFB_TARGETS_DN",45,-1.7965,0.0014,0.0083,0.9513,0.52,0.86,1.1485,0.24,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1899_DAZARD_RESPONSE_TO_UV_SCC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1899_DAZARD_RESPONSE_TO_UV_SCC_UP",122,-1.7963,0,0.0083,1.3978,0.028,0.29,-1.4255,0.019,0.33
"C2_Chemical_and_genetic_perturbations:C2_CGP_2596_LEE_DIFFERENTIATING_T_LYMPHOCYTE","C2_Chemical_and_genetic_perturbations","C2_CGP_2596_LEE_DIFFERENTIATING_T_LYMPHOCYTE",197,-1.7962,0,0.0082,0.9211,0.72,0.9,-1.3915,0.02,0.36
"C4_Cancer_modules:C4_CM_2_MODULE_2","C4_Cancer_modules","C4_CM_2_MODULE_2",370,-1.7962,0,0.006,1.0067,0.43,0.7,-1.1074,0.16,0.52
"GO_BP:500101_GO_0030802_REGULATION_OF_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","500101_GO_0030802_REGULATION_OF_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",137,-1.7961,0,0.019,-0.9194,0.65,1,1.5991,0,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_2665_CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2665_CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN",98,-1.796,0,0.0082,-1.425,0.029,0.55,-1.5984,0.0022,0.24
"GO_BP:511677_GO_0050706_REGULATION_OF_INTERLEUKIN_1_BETA_SECRETION","GO_BP","511677_GO_0050706_REGULATION_OF_INTERLEUKIN_1_BETA_SECRETION",21,-1.7959,0.0017,0.019,-0.9531,0.52,1,-1.1458,0.27,0.74
"C4_Cancer_modules:C4_CM_306_MODULE_355","C4_Cancer_modules","C4_CM_306_MODULE_355",29,-1.7959,0.0028,0.006,-1.4262,0.056,0.46,-2.2942,0,0
"REACTOME:106248_REACT_16967_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY","REACTOME","106248_REACT_16967_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY",19,-1.7958,0.0015,0.027,-1.0296,0.41,0.97,-1.6338,0.018,0.23
"GO_BP:499736_GO_0030336_NEGATIVE_REGULATION_OF_CELL_MIGRATION","GO_BP","499736_GO_0030336_NEGATIVE_REGULATION_OF_CELL_MIGRATION",179,-1.7956,0,0.019,-0.8682,0.82,1,1.0116,0.43,0.84
"C7_Immunologic_signatures:C7_ALL_548_GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_548_GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDM_DN",197,-1.7955,0,2.3e-05,-0.8225,0.92,1,0.8481,0.9,1
"GO_BP:512781_GO_0051931_REGULATION_OF_SENSORY_PERCEPTION","GO_BP","512781_GO_0051931_REGULATION_OF_SENSORY_PERCEPTION",30,-1.7955,0.0015,0.019,1.1387,0.26,0.85,0.8217,0.77,1
"GO_BP:503585_GO_0034383_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE","GO_BP","503585_GO_0034383_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE",10,-1.7953,0.0032,0.019,-1.1284,0.33,0.93,0.7831,0.75,1
"GO_BP:492874_GO_0008625_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS","GO_BP","492874_GO_0008625_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS",35,-1.7951,0.0014,0.019,0.617,0.98,1,-0.7962,0.82,0.99
"C7_Immunologic_signatures:C7_ALL_1828_GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN","C7_Immunologic_signatures","C7_ALL_1828_GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN",197,-1.7951,0,2.3e-05,-1.0679,0.29,1,-0.9019,0.75,0.95
"C6_Oncogenic_signatures:C6_ALL_181_KRAS_KIDNEY_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_181_KRAS_KIDNEY_UP_V1_UP",136,-1.7951,0,0.00084,1.0283,0.4,0.74,1.1132,0.23,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_1278_HOUSTIS_ROS","C2_Chemical_and_genetic_perturbations","C2_CGP_1278_HOUSTIS_ROS",36,-1.795,0,0.0083,1.0557,0.37,0.7,-0.8861,0.66,0.89
"GO_BP:752383_GO_0086011_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL","GO_BP","752383_GO_0086011_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL",11,-1.7949,0.0033,0.019,-0.9537,0.5,1,-1.3428,0.11,0.61
"GO_BP:500109_GO_0030810_POSITIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","500109_GO_0030810_POSITIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",103,-1.7946,0,0.019,-1.0729,0.33,0.96,1.1894,0.16,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1567_VERHAAK_AML_WITH_NPM1_MUTATED_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1567_VERHAAK_AML_WITH_NPM1_MUTATED_DN",242,-1.7942,0,0.0084,1.1448,0.13,0.56,-1.1562,0.11,0.57
"GO_MF:490192_GO_0004896_CYTOKINE_RECEPTOR_ACTIVITY","GO_MF","490192_GO_0004896_CYTOKINE_RECEPTOR_ACTIVITY",87,-1.7941,0,0.046,1.0322,0.37,0.84,1.5763,0.006,0.36
"GO_BP:511999_GO_0051084_DE_NOVO_POSTTRANSLATIONAL_PROTEIN_FOLDING","GO_BP","511999_GO_0051084_DE_NOVO_POSTTRANSLATIONAL_PROTEIN_FOLDING",49,-1.7941,0.0013,0.019,1.0541,0.35,0.94,-1.6624,0.004,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2788_ONO_AML1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2788_ONO_AML1_TARGETS_DN",40,-1.7935,0,0.0084,0.9545,0.54,0.86,0.9317,0.59,1
"C7_Immunologic_signatures:C7_ALL_1028_GSE24142_DN2_VS_DN3_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1028_GSE24142_DN2_VS_DN3_THYMOCYTE_DN",200,-1.7935,0,2.3e-05,-0.6501,1,1,-1.2023,0.065,0.28
"GO_BP:506148_GO_0043062_EXTRACELLULAR_STRUCTURE_ORGANIZATION","GO_BP","506148_GO_0043062_EXTRACELLULAR_STRUCTURE_ORGANIZATION",369,-1.7934,0,0.019,-1.1131,0.17,0.94,1.3666,0.0038,0.65
"C7_Immunologic_signatures:C7_ALL_793_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_793_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP",190,-1.7931,0,2.3e-05,-1.0576,0.32,1,-1.4899,0,0.025
"GO_MF:489530_GO_0004062_ARYL_SULFOTRANSFERASE_ACTIVITY","GO_MF","489530_GO_0004062_ARYL_SULFOTRANSFERASE_ACTIVITY",6,-1.7928,0,0.045,-1.0876,0.38,0.85,-1.1965,0.25,0.6
"GO_BP:511737_GO_0050766_POSITIVE_REGULATION_OF_PHAGOCYTOSIS","GO_BP","511737_GO_0050766_POSITIVE_REGULATION_OF_PHAGOCYTOSIS",36,-1.7926,0.0028,0.019,-1.3335,0.094,0.92,1.0651,0.37,0.79
"REACTOME:106363_REACT_16983_AMINE_LIGAND_BINDING_RECEPTORS","REACTOME","106363_REACT_16983_AMINE_LIGAND_BINDING_RECEPTORS",40,-1.7926,0.0014,0.027,1.0171,0.43,0.72,1.7365,0.0019,0.41
"GO_MF:491980_GO_0050431_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING","GO_MF","491980_GO_0050431_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING",16,-1.7925,0.0062,0.045,0.8926,0.61,0.98,-0.6858,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1526_PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1526_PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN",160,-1.7925,0,0.0086,-0.7987,0.92,1,1.0303,0.39,0.93
"REACTOME:106506_REACT_12529_SIGNALING_BY_VEGF","REACTOME","106506_REACT_12529_SIGNALING_BY_VEGF",116,-1.7921,0,0.027,-0.7114,0.98,1,-1.2675,0.064,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1515_NGUYEN_NOTCH1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1515_NGUYEN_NOTCH1_TARGETS_UP",29,-1.7918,0.0014,0.0086,-0.996,0.45,1,-1.2634,0.13,0.45
"GO_BP:501966_GO_0032740_POSITIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION","GO_BP","501966_GO_0032740_POSITIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION",11,-1.7917,0.0031,0.02,-1.564,0.034,0.72,-1.4513,0.085,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_332_GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_332_GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP",180,-1.7915,0,0.0086,1.4184,0.0072,0.28,-1.7329,0,0.15
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_53_BIOCARTA_D4GDI_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_53_BIOCARTA_D4GDI_PATHWAY",13,-1.7912,0.0065,0.024,-0.6064,0.95,1,-0.9209,0.6,0.85
"C4_Cancer_modules:C4_CM_94_MODULE_99","C4_Cancer_modules","C4_CM_94_MODULE_99",341,-1.7905,0,0.0062,-1.3116,0.01,0.5,1.0017,0.45,0.93
"GO_BP:514182_GO_0060627_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT","GO_BP","514182_GO_0060627_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT",373,-1.7903,0,0.02,0.9812,0.55,1,1.0115,0.42,0.84
"C4_Cancer_gene_neighborhoods:C4_CGN_370_GNF2_LCAT","C4_Cancer_gene_neighborhoods","C4_CGN_370_GNF2_LCAT",121,-1.7902,0,0.0032,-1.1653,0.15,0.65,1.3768,0.028,0.24
"GO_BP:487670_GO_0001774_MICROGLIAL_CELL_ACTIVATION","GO_BP","487670_GO_0001774_MICROGLIAL_CELL_ACTIVATION",12,-1.7901,0.0046,0.02,1.1283,0.29,0.87,-1.1924,0.25,0.74
"REACTOME:576263_REACT_118572_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX","REACTOME","576263_REACT_118572_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX",87,-1.79,0,0.027,-0.8479,0.79,1,1.5625,0.0062,0.43
"KEGG_pathway:HSA04960_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION","KEGG_pathway","HSA04960_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION",38,-1.79,0.0015,0.0028,-1.3546,0.083,0.32,-1.1536,0.24,0.43
"GO_BP:499325_GO_0022407_REGULATION_OF_CELL_CELL_ADHESION","GO_BP","499325_GO_0022407_REGULATION_OF_CELL_CELL_ADHESION",340,-1.7899,0,0.02,0.9361,0.66,1,-0.9098,0.78,0.92
"GO_BP:501961_GO_0032735_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION","GO_BP","501961_GO_0032735_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION",29,-1.7896,0.0015,0.02,-1.486,0.038,0.84,-1.747,0.002,0.66
"GO_BP:511635_GO_0050663_CYTOKINE_SECRETION","GO_BP","511635_GO_0050663_CYTOKINE_SECRETION",32,-1.7896,0.0029,0.02,0.9556,0.54,1,0.7538,0.86,1
"GO_BP:512118_GO_0051222_POSITIVE_REGULATION_OF_PROTEIN_TRANSPORT","GO_BP","512118_GO_0051222_POSITIVE_REGULATION_OF_PROTEIN_TRANSPORT",358,-1.7894,0,0.02,0.8263,0.99,1,-1.2993,0.0063,0.65
"GO_BP:491674_GO_0006801_SUPEROXIDE_METABOLIC_PROCESS","GO_BP","491674_GO_0006801_SUPEROXIDE_METABOLIC_PROCESS",31,-1.7892,0.0043,0.02,-1.1584,0.25,0.92,-0.998,0.45,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_1665_HENDRICKS_SMARCA4_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1665_HENDRICKS_SMARCA4_TARGETS_UP",54,-1.7892,0.0014,0.0088,0.8552,0.73,0.97,1.3025,0.082,0.69
"GO_MF:496348_GO_0016298_LIPASE_ACTIVITY","GO_MF","496348_GO_0016298_LIPASE_ACTIVITY",105,-1.7891,0.0012,0.046,0.8003,0.91,1,1.309,0.046,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_1978_KYNG_RESPONSE_TO_H2O2","C2_Chemical_and_genetic_perturbations","C2_CGP_1978_KYNG_RESPONSE_TO_H2O2",71,-1.789,0,0.0088,1.4446,0.031,0.26,-0.955,0.53,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_1427_LEE_LIVER_CANCER_DENA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1427_LEE_LIVER_CANCER_DENA_UP",58,-1.7888,0,0.0088,1.3515,0.048,0.34,1.0837,0.29,0.87
"C6_Oncogenic_signatures:C6_ALL_85_PKCA_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_85_PKCA_DN_V1_DN",141,-1.7882,0,0.00085,-1.0511,0.34,0.57,0.9159,0.67,0.74
"KEGG_pathway:HSA04668_TNF_SIGNALING_PATHWAY","KEGG_pathway","HSA04668_TNF_SIGNALING_PATHWAY",109,-1.7879,0,0.0028,-1.1505,0.2,0.61,-1.1011,0.26,0.51
"GO_BP:511805_GO_0050863_REGULATION_OF_T_CELL_ACTIVATION","GO_BP","511805_GO_0050863_REGULATION_OF_T_CELL_ACTIVATION",258,-1.7877,0,0.02,0.8477,0.93,1,-1.0195,0.38,0.83
"GO_BP:487916_GO_0002026_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION","GO_BP","487916_GO_0002026_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION",27,-1.7876,0.0015,0.02,-1.3139,0.13,0.87,-1.0694,0.38,0.8
"GO_BP:849823_GO_0097485_NEURON_PROJECTION_GUIDANCE","GO_BP","849823_GO_0097485_NEURON_PROJECTION_GUIDANCE",413,-1.7876,0,0.02,-1.2312,0.029,0.9,-1.2345,0.022,0.7
"KEGG_pathway:HSA04514_CELL_ADHESION_MOLECULES_CAMS_","KEGG_pathway","HSA04514_CELL_ADHESION_MOLECULES_CAMS_",137,-1.7873,0,0.0028,-0.909,0.66,0.98,0.7764,0.95,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_199_BIOCARTA_CTLA4_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_199_BIOCARTA_CTLA4_PATHWAY",19,-1.7872,0.0015,0.024,1.5702,0.019,0.3,-0.7054,0.89,0.99
"GO_MF:487680_GO_0001784_PHOSPHOTYROSINE_BINDING","GO_MF","487680_GO_0001784_PHOSPHOTYROSINE_BINDING",13,-1.7871,0.0016,0.046,-0.72,0.82,1,0.6552,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1973_TRACEY_RESISTANCE_TO_IFNA2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1973_TRACEY_RESISTANCE_TO_IFNA2_DN",31,-1.787,0.0015,0.009,0.7242,0.89,1,0.7766,0.84,1
"GO_BP:496384_GO_0016358_DENDRITE_DEVELOPMENT","GO_BP","496384_GO_0016358_DENDRITE_DEVELOPMENT",76,-1.7866,0,0.02,-1.0386,0.38,0.98,-0.8518,0.78,0.96
"KEGG_pathway:HSA05321_INFLAMMATORY_BOWEL_DISEASE_IBD_","KEGG_pathway","HSA05321_INFLAMMATORY_BOWEL_DISEASE_IBD_",62,-1.7866,0.0013,0.0028,-1.4048,0.042,0.39,-1.0139,0.41,0.66
"C4_Cancer_modules:C4_CM_183_MODULE_196","C4_Cancer_modules","C4_CM_183_MODULE_196",23,-1.7863,0.0015,0.0064,-1.1441,0.26,0.61,-1.4873,0.048,0.17
"REACTOME:106050_REACT_318_PLATELET_DEGRANULATION","REACTOME","106050_REACT_318_PLATELET_DEGRANULATION",79,-1.7863,0,0.028,1.5104,0,0.14,0.9051,0.68,1
"KEGG_pathway:HSA04510_FOCAL_ADHESION","KEGG_pathway","HSA04510_FOCAL_ADHESION",202,-1.7862,0,0.0028,-0.8618,0.83,1,0.9344,0.66,1
"GO_BP:498817_GO_0021533_CELL_DIFFERENTIATION_IN_HINDBRAIN","GO_BP","498817_GO_0021533_CELL_DIFFERENTIATION_IN_HINDBRAIN",24,-1.7862,0.0029,0.021,-0.8403,0.72,1,0.5045,1,1
"GO_BP:492001_GO_0007202_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY","GO_BP","492001_GO_0007202_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY",61,-1.7861,0,0.021,-0.9379,0.58,1,-1.3984,0.047,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_2036_HARRIS_BRAIN_CANCER_PROGENITORS","C2_Chemical_and_genetic_perturbations","C2_CGP_2036_HARRIS_BRAIN_CANCER_PROGENITORS",43,-1.786,0,0.0091,0.9533,0.51,0.86,1.3892,0.056,0.55
"GO_BP:508120_GO_0045785_POSITIVE_REGULATION_OF_CELL_ADHESION","GO_BP","508120_GO_0045785_POSITIVE_REGULATION_OF_CELL_ADHESION",338,-1.7858,0,0.021,0.91,0.78,1,0.9925,0.47,0.86
"GO_BP:510716_GO_0048661_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION","GO_BP","510716_GO_0048661_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION",49,-1.7853,0.0028,0.021,-0.9405,0.57,1,1.3442,0.093,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_601_PEREZ_TP53_AND_TP63_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_601_PEREZ_TP53_AND_TP63_TARGETS",200,-1.785,0,0.0092,-1.7062,0,0.34,-1.2066,0.084,0.51
"GO_BP:1047427_GO_1903427_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS","GO_BP","1047427_GO_1903427_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS",14,-1.785,0.0016,0.021,-1.5627,0.04,0.72,-1.2123,0.2,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1720_BROWNE_HCMV_INFECTION_8HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1720_BROWNE_HCMV_INFECTION_8HR_UP",102,-1.7849,0,0.0092,-1.6455,0,0.36,-1.9628,0,0.067
"C2_Chemical_and_genetic_perturbations:C2_CGP_2395_CADWELL_ATG16L1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2395_CADWELL_ATG16L1_TARGETS_UP",88,-1.7846,0,0.0092,-0.9062,0.68,1,1.152,0.2,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_217_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_217_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN",31,-1.7844,0,0.0092,1.0376,0.39,0.74,1.1701,0.25,0.8
"GO_BP:513500_GO_0055067_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS","GO_BP","513500_GO_0055067_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS",95,-1.7843,0,0.021,-1.0068,0.44,0.98,-1.0093,0.41,0.84
"GO_BP:502460_GO_0033240_POSITIVE_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS","GO_BP","502460_GO_0033240_POSITIVE_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS",242,-1.7843,0,0.021,-1.01,0.42,0.98,-1.1474,0.15,0.74
"GO_CC:500513_GO_0031254_CELL_TRAILING_EDGE","GO_CC","500513_GO_0031254_CELL_TRAILING_EDGE",9,-1.7841,0.0048,0.028,-1.0432,0.4,0.84,-1.5495,0.048,0.5
"C7_Immunologic_signatures:C7_ALL_1673_GSE3982_NEUTROPHIL_VS_TH2_UP","C7_Immunologic_signatures","C7_ALL_1673_GSE3982_NEUTROPHIL_VS_TH2_UP",197,-1.784,0,3e-05,-0.6919,1,1,-0.8621,0.86,1
"GO_BP:493575_GO_0009636_RESPONSE_TO_TOXIC_SUBSTANCE","GO_BP","493575_GO_0009636_RESPONSE_TO_TOXIC_SUBSTANCE",150,-1.7839,0,0.021,-1.1363,0.17,0.93,-1.3469,0.015,0.61
"GO_MF:500176_GO_0030881_BETA_2_MICROGLOBULIN_BINDING","GO_MF","500176_GO_0030881_BETA_2_MICROGLOBULIN_BINDING",11,-1.7839,0.0032,0.047,-1.1992,0.23,0.81,-1.5525,0.044,0.4
"GO_BP:1041581_GO_1903409_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS","GO_BP","1041581_GO_1903409_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS",25,-1.7838,0.0045,0.021,-1.0619,0.37,0.96,-1.0009,0.46,0.85
"GO_BP:503966_GO_0034767_POSITIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","503966_GO_0034767_POSITIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORT",78,-1.7838,0.0013,0.021,-1.1709,0.19,0.91,1.022,0.41,0.83
"GO_BP:488549_GO_0002676_REGULATION_OF_CHRONIC_INFLAMMATORY_RESPONSE","GO_BP","488549_GO_0002676_REGULATION_OF_CHRONIC_INFLAMMATORY_RESPONSE",9,-1.7836,0.0048,0.021,-1.1158,0.33,0.94,-1.0785,0.36,0.8
"REACTOME:106034_REACT_798_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION","REACTOME","106034_REACT_798_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION",220,-1.7836,0,0.029,1.0921,0.22,0.59,-1.1252,0.17,0.68
"GO_MF:506432_GO_0043394_PROTEOGLYCAN_BINDING","GO_MF","506432_GO_0043394_PROTEOGLYCAN_BINDING",26,-1.7836,0.0015,0.046,-1.1085,0.32,0.83,0.9922,0.45,0.88
"GO_BP:496036_GO_0015914_PHOSPHOLIPID_TRANSPORT","GO_BP","496036_GO_0015914_PHOSPHOLIPID_TRANSPORT",51,-1.7835,0,0.021,-1.1822,0.18,0.91,-0.8025,0.84,0.99
"C7_Immunologic_signatures:C7_ALL_1522_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN","C7_Immunologic_signatures","C7_ALL_1522_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN",200,-1.7834,0,3e-05,0.8295,0.92,1,-1.4179,0.01,0.05
"C7_Immunologic_signatures:C7_ALL_1128_GSE2706_R848_VS_LPS_8H_STIM_DC_DN","C7_Immunologic_signatures","C7_ALL_1128_GSE2706_R848_VS_LPS_8H_STIM_DC_DN",185,-1.7833,0,3e-05,-0.7231,1,1,-1.1291,0.17,0.42
"REACTOME:106357_REACT_14828_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS_","REACTOME","106357_REACT_14828_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS_",295,-1.7831,0,0.028,1.4951,0,0.15,1.6467,0,0.35
"GO_BP:513273_GO_0052510_POSITIVE_REGULATION_BY_ORGANISM_OF_DEFENSE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513273_GO_0052510_POSITIVE_REGULATION_BY_ORGANISM_OF_DEFENSE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",9,-1.7831,0.0032,0.021,0.6308,0.94,1,-0.8217,0.69,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2137_STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2137_STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN",60,-1.7829,0,0.0093,0.9042,0.64,0.92,0.7773,0.88,1
"GO_BP:491701_GO_0006836_NEUROTRANSMITTER_TRANSPORT","GO_BP","491701_GO_0006836_NEUROTRANSMITTER_TRANSPORT",158,-1.7828,0,0.021,-1.0328,0.37,0.98,-1.3525,0.023,0.6
"REACTOME:106370_REACT_18352_EICOSANOID_LIGAND_BINDING_RECEPTORS","REACTOME","106370_REACT_18352_EICOSANOID_LIGAND_BINDING_RECEPTORS",15,-1.7828,0.0094,0.028,-1.0254,0.42,0.97,-1.2051,0.22,0.6
"GO_BP:505562_GO_0042421_NOREPINEPHRINE_BIOSYNTHETIC_PROCESS","GO_BP","505562_GO_0042421_NOREPINEPHRINE_BIOSYNTHETIC_PROCESS",6,-1.7827,0.0018,0.021,-0.6195,0.93,1,-1.4573,0.074,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1160_JEON_SMAD6_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1160_JEON_SMAD6_TARGETS_DN",19,-1.7826,0.0016,0.0094,-1.3286,0.11,0.69,-1.5546,0.031,0.27
"KEGG_compound:C01953_PREGNENOLONE_5_PREGNEN_3BETA_OL_20_ONE_3BETA_HYDROXYPREGN_5_EN_20_ONE","KEGG_compound","C01953_PREGNENOLONE_5_PREGNEN_3BETA_OL_20_ONE_3BETA_HYDROXYPREGN_5_EN_20_ONE",8,-1.7825,0.0033,0.02,1.3443,0.14,0.64,1.3905,0.12,0.29
"C0_Hallmark:H_ALL_14_HALLMARK_ESTROGEN_RESPONSE_LATE","C0_Hallmark","H_ALL_14_HALLMARK_ESTROGEN_RESPONSE_LATE",194,-1.7824,0,0.00075,-1.1185,0.21,1,-0.9918,0.45,0.53
"GO_BP:494587_GO_0010518_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY","GO_BP","494587_GO_0010518_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY",82,-1.7822,0.0013,0.021,-0.9561,0.55,1,-1.3704,0.035,0.59
"GO_BP:487789_GO_0001893_MATERNAL_PLACENTA_DEVELOPMENT","GO_BP","487789_GO_0001893_MATERNAL_PLACENTA_DEVELOPMENT",27,-1.782,0.0015,0.021,-1.074,0.36,0.95,-1.1271,0.28,0.75
"GO_BP:491365_GO_0006458_DE_NOVO_PROTEIN_FOLDING","GO_BP","491365_GO_0006458_DE_NOVO_PROTEIN_FOLDING",54,-1.7817,0.0027,0.021,1.0023,0.47,0.98,-1.741,0,0.65
"GO_BP:511642_GO_0050670_REGULATION_OF_LYMPHOCYTE_PROLIFERATION","GO_BP","511642_GO_0050670_REGULATION_OF_LYMPHOCYTE_PROLIFERATION",172,-1.7816,0,0.021,-0.871,0.79,1,-0.9957,0.46,0.85
"GO_BP:515601_GO_0070671_RESPONSE_TO_INTERLEUKIN_12","GO_BP","515601_GO_0070671_RESPONSE_TO_INTERLEUKIN_12",6,-1.7815,0.0034,0.021,-1.3215,0.16,0.89,-1.4542,0.062,0.54
"C7_Immunologic_signatures:C7_ALL_1557_GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1557_GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP",198,-1.7815,0,3e-05,0.833,0.91,1,-1.277,0.041,0.16
"GO_MF:490567_GO_0005391_SODIUM_POTASSIUM_EXCHANGING_ATPASE_ACTIVITY","GO_MF","490567_GO_0005391_SODIUM_POTASSIUM_EXCHANGING_ATPASE_ACTIVITY",10,-1.7812,0.012,0.047,-1.4005,0.093,0.62,-1.4251,0.093,0.45
"REACTOME:106148_REACT_11048_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL","REACTOME","106148_REACT_11048_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL",15,-1.781,0.0044,0.028,-0.7773,0.8,1,0.7752,0.72,1
"GO_BP:489301_GO_0051017_ACTIN_FILAMENT_BUNDLE_ASSEMBLY","GO_BP","489301_GO_0051017_ACTIN_FILAMENT_BUNDLE_ASSEMBLY",42,-1.7809,0,0.021,-1.0703,0.35,0.96,0.9568,0.47,0.9
"GO_BP:752692_GO_0097191_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","752692_GO_0097191_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",95,-1.7807,0,0.021,-1.0485,0.37,0.97,-0.9734,0.5,0.88
"C7_Immunologic_signatures:C7_ALL_1033_GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP","C7_Immunologic_signatures","C7_ALL_1033_GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP",196,-1.7804,0,3e-05,-1.1327,0.19,1,-1.1814,0.11,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_2849_HOSHIDA_LIVER_CANCER_SUBCLASS_S3","C2_Chemical_and_genetic_perturbations","C2_CGP_2849_HOSHIDA_LIVER_CANCER_SUBCLASS_S3",261,-1.7804,0,0.0096,1.1022,0.16,0.63,-1.0849,0.22,0.65
"C4_Cancer_modules:C4_CM_159_MODULE_169","C4_Cancer_modules","C4_CM_159_MODULE_169",96,-1.7801,0,0.0069,0.9673,0.54,0.76,-0.7929,0.91,0.99
"C7_Immunologic_signatures:C7_ALL_797_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_797_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP",186,-1.7801,0,2.9e-05,0.7425,0.99,1,-0.9333,0.62,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_615_MAHADEVAN_RESPONSE_TO_MP470_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_615_MAHADEVAN_RESPONSE_TO_MP470_UP",19,-1.78,0.0046,0.0096,0.749,0.81,1,-1.7423,0.016,0.16
"REACTOME:1127512_REACT_264464_VEGFA_VEGFR2_PATHWAY","REACTOME","1127512_REACT_264464_VEGFA_VEGFR2_PATHWAY",109,-1.7799,0,0.028,0.7301,0.97,1,-1.2254,0.086,0.58
"REACTOME:106048_REACT_1280_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_","REACTOME","106048_REACT_1280_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_",84,-1.7798,0,0.028,1.5017,0.011,0.15,0.8556,0.78,1
"GO_BP:487798_GO_0001906_CELL_KILLING","GO_BP","487798_GO_0001906_CELL_KILLING",51,-1.7798,0,0.021,1.2102,0.17,0.78,0.8636,0.72,0.97
"GO_BP:498983_GO_0021700_DEVELOPMENTAL_MATURATION","GO_BP","498983_GO_0021700_DEVELOPMENTAL_MATURATION",205,-1.7798,0,0.021,-1.3032,0.044,0.89,-0.9377,0.65,0.9
"GO_BP:495963_GO_0015837_AMINE_TRANSPORT","GO_BP","495963_GO_0015837_AMINE_TRANSPORT",6,-1.7797,0.0018,0.021,0.646,0.89,1,-0.6959,0.83,0.99
"GO_MF:489497_GO_0004028_3_CHLOROALLYL_ALDEHYDE_DEHYDROGENASE_ACTIVITY","GO_MF","489497_GO_0004028_3_CHLOROALLYL_ALDEHYDE_DEHYDROGENASE_ACTIVITY",7,-1.7797,0.0017,0.047,1.0438,0.39,0.83,-0.8488,0.63,0.93
"GO_BP:494896_GO_0010832_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION","GO_BP","494896_GO_0010832_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION",15,-1.7795,0.0031,0.021,-1.171,0.26,0.91,-1.0446,0.38,0.81
"C4_Cancer_gene_neighborhoods:C4_CGN_297_GNF2_GSTM1","C4_Cancer_gene_neighborhoods","C4_CGN_297_GNF2_GSTM1",108,-1.7794,0,0.0036,-1.1158,0.24,0.72,1.2678,0.078,0.35
"GO_MF:492495_GO_0008142_OXYSTEROL_BINDING","GO_MF","492495_GO_0008142_OXYSTEROL_BINDING",5,-1.7794,0.0017,0.046,-0.5762,0.94,1,-1.3561,0.13,0.53
"GO_CC:487822_GO_0001931_UROPOD","GO_CC","487822_GO_0001931_UROPOD",9,-1.7792,0.0031,0.029,-1.0458,0.41,0.84,-1.5312,0.048,0.46
"GO_BP:755346_GO_2001240_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND","GO_BP","755346_GO_2001240_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND",34,-1.7789,0,0.021,-1.3497,0.071,0.93,-1.5946,0.0096,0.51
"GO_BP:506634_GO_0043603_CELLULAR_AMIDE_METABOLIC_PROCESS","GO_BP","506634_GO_0043603_CELLULAR_AMIDE_METABOLIC_PROCESS",259,-1.7785,0,0.022,-0.81,0.94,1,-1.3817,0.0062,0.59
"GO_BP:1184561_GO_1904037_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS","GO_BP","1184561_GO_1904037_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS",18,-1.7785,0,0.021,0.7462,0.85,1,0.6366,0.95,1
"GO_BP:507771_GO_0045414_REGULATION_OF_INTERLEUKIN_8_BIOSYNTHETIC_PROCESS","GO_BP","507771_GO_0045414_REGULATION_OF_INTERLEUKIN_8_BIOSYNTHETIC_PROCESS",11,-1.7782,0.0016,0.022,-0.8503,0.65,1,-1.1569,0.28,0.74
"GO_BP:516820_GO_0071900_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY","GO_BP","516820_GO_0071900_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",449,-1.7781,0,0.022,0.7548,1,1,1.0458,0.31,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_3037_MARTENS_BOUND_BY_PML_RARA_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_3037_MARTENS_BOUND_BY_PML_RARA_FUSION",449,-1.7779,0,0.0099,-0.9675,0.61,1,0.8549,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_365_PROVENZANI_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_365_PROVENZANI_METASTASIS_DN",132,-1.7778,0,0.0099,1.6248,0,0.12,-0.8064,0.91,0.95
"C4_Cancer_modules:C4_CM_56_MODULE_60","C4_Cancer_modules","C4_CM_56_MODULE_60",412,-1.7776,0,0.007,-1.0531,0.29,0.72,-1.0098,0.42,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_2845_BOYLAN_MULTIPLE_MYELOMA_PCA3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2845_BOYLAN_MULTIPLE_MYELOMA_PCA3_UP",79,-1.7776,0,0.0099,-0.9716,0.51,1,1.0241,0.42,0.95
"GO_BP:489310_GO_0030832_REGULATION_OF_ACTIN_FILAMENT_LENGTH","GO_BP","489310_GO_0030832_REGULATION_OF_ACTIN_FILAMENT_LENGTH",130,-1.7773,0,0.022,-0.8045,0.9,1,-1.319,0.043,0.63
"REACTOME:1127547_REACT_264303_CONDENSATION_OF_PROPHASE_CHROMOSOMES","REACTOME","1127547_REACT_264303_CONDENSATION_OF_PROPHASE_CHROMOSOMES",70,-1.7771,0.0013,0.028,-1.9232,0,0.047,-1.8608,0,0.14
"GO_BP:511991_GO_0051262_PROTEIN_TETRAMERIZATION","GO_BP","511991_GO_0051262_PROTEIN_TETRAMERIZATION",115,-1.7768,0.0013,0.022,-1.1819,0.15,0.91,-1.5707,0.0021,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_112_THUM_SYSTOLIC_HEART_FAILURE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_112_THUM_SYSTOLIC_HEART_FAILURE_UP",412,-1.7768,0,0.01,1.2751,0.017,0.42,-0.9064,0.84,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1926_SESTO_RESPONSE_TO_UV_C7","C2_Chemical_and_genetic_perturbations","C2_CGP_1926_SESTO_RESPONSE_TO_UV_C7",67,-1.7765,0,0.01,1.0608,0.33,0.69,-1.634,0.0085,0.22
"GO_BP:487579_GO_0001667_AMEBOIDAL_TYPE_CELL_MIGRATION","GO_BP","487579_GO_0001667_AMEBOIDAL_TYPE_CELL_MIGRATION",132,-1.7764,0,0.022,-0.8263,0.87,1,1.1194,0.23,0.75
"GO_BP:500103_GO_0030804_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","500103_GO_0030804_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",100,-1.7763,0,0.022,-1.0532,0.34,0.97,1.166,0.17,0.73
"KEGG_compound:C00080_H_HYDRON","KEGG_compound","C00080_H_HYDRON",260,-1.7763,0,0.021,-1.0695,0.28,0.98,-1.7278,0,0.06
"GO_MF:489299_GO_0030674_PROTEIN_BINDING_BRIDGING","GO_MF","489299_GO_0030674_PROTEIN_BINDING_BRIDGING",138,-1.7763,0,0.047,1.0664,0.28,0.82,0.979,0.5,0.89
"GO_BP:491792_GO_0009612_RESPONSE_TO_MECHANICAL_STIMULUS","GO_BP","491792_GO_0009612_RESPONSE_TO_MECHANICAL_STIMULUS",182,-1.7761,0,0.022,-1.0627,0.28,0.96,0.9079,0.71,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_920_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1","C2_Chemical_and_genetic_perturbations","C2_CGP_920_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1",224,-1.7759,0,0.01,0.7877,0.98,1,-0.8553,0.9,0.92
"GO_BP:499608_GO_0030198_EXTRACELLULAR_MATRIX_ORGANIZATION","GO_BP","499608_GO_0030198_EXTRACELLULAR_MATRIX_ORGANIZATION",363,-1.7757,0,0.022,-1.0544,0.3,0.97,1.3591,0.0037,0.64
"GO_CC:506110_GO_0043020_NADPH_OXIDASE_COMPLEX","GO_CC","506110_GO_0043020_NADPH_OXIDASE_COMPLEX",9,-1.7752,0.005,0.029,-1.328,0.14,0.64,-0.824,0.67,1
"C3_TF_targets:C3_TFT_78_V_CEBPB_02","C3_TF_targets","C3_TFT_78_V_CEBPB_02",254,-1.7752,0,0.0051,-1.0241,0.38,0.71,-1.3891,0.0081,0.28
"C2_Chemical_and_genetic_perturbations:C2_CGP_489_WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_489_WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP",119,-1.7752,0,0.01,0.7963,0.94,0.99,-1.2792,0.064,0.45
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_95_BIOCARTA_IL5_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_95_BIOCARTA_IL5_PATHWAY",9,-1.775,0.0067,0.026,-1.1885,0.27,1,-0.9136,0.56,0.85
"C7_Immunologic_signatures:C7_ALL_1434_GSE360_DC_VS_MAC_L_DONOVANI_DN","C7_Immunologic_signatures","C7_ALL_1434_GSE360_DC_VS_MAC_L_DONOVANI_DN",200,-1.7748,0,3.3e-05,1.1597,0.11,0.3,-1.0638,0.29,0.58
"C7_Immunologic_signatures:C7_ALL_1651_GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1651_GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP",199,-1.7748,0,3.3e-05,1.2837,0.031,0.12,0.6062,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2931_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5","C2_Chemical_and_genetic_perturbations","C2_CGP_2931_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5",26,-1.7747,0,0.01,0.8732,0.67,0.95,-0.8897,0.65,0.89
"GO_BP:487733_GO_0001837_EPITHELIAL_TO_MESENCHYMAL_TRANSITION","GO_BP","487733_GO_0001837_EPITHELIAL_TO_MESENCHYMAL_TRANSITION",53,-1.7746,0.0013,0.022,-1.1104,0.28,0.94,1.2227,0.14,0.71
"GO_BP:518905_GO_2000258_NEGATIVE_REGULATION_OF_PROTEIN_ACTIVATION_CASCADE","GO_BP","518905_GO_2000258_NEGATIVE_REGULATION_OF_PROTEIN_ACTIVATION_CASCADE",11,-1.7746,0.0064,0.022,0.7611,0.77,1,1.1346,0.29,0.74
"GO_BP:488583_GO_0002710_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY","GO_BP","488583_GO_0002710_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY",11,-1.7745,0.0017,0.022,-0.5959,0.95,1,-1.5149,0.048,0.54
"GO_BP:510822_GO_0048771_TISSUE_REMODELING","GO_BP","510822_GO_0048771_TISSUE_REMODELING",89,-1.7745,0,0.022,-1.2213,0.12,0.88,1.0121,0.42,0.84
"GO_BP:512230_GO_0051346_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY","GO_BP","512230_GO_0051346_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY",351,-1.7745,0,0.022,-1.0113,0.42,0.98,0.9871,0.49,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_491_WANG_ESOPHAGUS_CANCER_PROGRESSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_491_WANG_ESOPHAGUS_CANCER_PROGRESSION_UP",8,-1.7743,0,0.01,-1.5748,0.033,0.45,-1.4299,0.089,0.33
"C2_Chemical_and_genetic_perturbations:C2_CGP_2888_DANG_REGULATED_BY_MYC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2888_DANG_REGULATED_BY_MYC_DN",252,-1.7743,0,0.01,0.9424,0.66,0.88,-0.8576,0.88,0.92
"GO_BP:507473_GO_0045073_REGULATION_OF_CHEMOKINE_BIOSYNTHETIC_PROCESS","GO_BP","507473_GO_0045073_REGULATION_OF_CHEMOKINE_BIOSYNTHETIC_PROCESS",13,-1.774,0,0.022,-1.1511,0.29,0.93,1.0034,0.43,0.85
"GO_BP:987838_GO_1903037_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION","GO_BP","987838_GO_1903037_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION",263,-1.7738,0,0.022,0.8701,0.88,1,-0.9849,0.5,0.86
"C4_Cancer_modules:C4_CM_261_MODULE_297","C4_Cancer_modules","C4_CM_261_MODULE_297",73,-1.7736,0,0.0072,-1.0421,0.39,0.74,1.7186,0.0019,0.091
"GO_BP:508945_GO_0046717_ACID_SECRETION","GO_BP","508945_GO_0046717_ACID_SECRETION",55,-1.7734,0.0027,0.022,-1.0855,0.33,0.95,-0.7552,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3236_KATSANOU_ELAVL1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3236_KATSANOU_ELAVL1_TARGETS_UP",167,-1.7734,0,0.01,-1.0848,0.25,0.94,0.8512,0.85,1
"C3_TF_targets:C3_TFT_459_V_AP1_Q4_01","C3_TF_targets","C3_TFT_459_V_AP1_Q4_01",259,-1.7734,0,0.005,-1.2845,0.022,0.25,-1.3016,0.0084,0.24
"GO_BP:512881_GO_0052031_MODULATION_BY_SYMBIONT_OF_HOST_DEFENSE_RESPONSE","GO_BP","512881_GO_0052031_MODULATION_BY_SYMBIONT_OF_HOST_DEFENSE_RESPONSE",9,-1.7732,0.0033,0.022,0.6428,0.91,1,-0.8217,0.7,0.97
"C4_Cancer_modules:C4_CM_370_MODULE_454","C4_Cancer_modules","C4_CM_370_MODULE_454",10,-1.773,0.0097,0.0072,0.6626,0.91,1,-0.772,0.79,1
"GO_BP:499603_GO_0030193_REGULATION_OF_BLOOD_COAGULATION","GO_BP","499603_GO_0030193_REGULATION_OF_BLOOD_COAGULATION",77,-1.7729,0,0.022,1.1836,0.17,0.8,1.1838,0.16,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2668_ZHAN_LATE_DIFFERENTIATION_GENES_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2668_ZHAN_LATE_DIFFERENTIATION_GENES_UP",33,-1.7729,0,0.01,0.8998,0.63,0.93,-0.6713,0.95,0.99
"C7_Immunologic_signatures:C7_ALL_1766_GSE7460_TCONV_VS_TREG_LN_DN","C7_Immunologic_signatures","C7_ALL_1766_GSE7460_TCONV_VS_TREG_LN_DN",199,-1.7728,0,3.6e-05,-0.8426,0.84,1,-1.2571,0.037,0.19
"REACTOME:1183596_REACT_355141_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES","REACTOME","1183596_REACT_355141_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES",10,-1.7728,0.0047,0.029,-1.1197,0.33,0.87,-0.7255,0.82,1
"GO_BP:494894_GO_0010830_REGULATION_OF_MYOTUBE_DIFFERENTIATION","GO_BP","494894_GO_0010830_REGULATION_OF_MYOTUBE_DIFFERENTIATION",46,-1.7725,0.0014,0.022,1.1707,0.19,0.81,-1.4508,0.029,0.54
"REACTOME:106518_REACT_13723_NEUROTRANSMITTER_RELEASE_CYCLE","REACTOME","106518_REACT_13723_NEUROTRANSMITTER_RELEASE_CYCLE",48,-1.7722,0.0014,0.029,-1.3725,0.067,0.57,-1.7345,0.002,0.2
"GO_BP:506968_GO_0043950_POSITIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING","GO_BP","506968_GO_0043950_POSITIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING",12,-1.7722,0.0045,0.022,0.7901,0.76,1,-1.8132,0.01,0.53
"C3_TF_targets:C3_TFT_610_CCAWWNAAGG_V_SRF_Q4","C3_TF_targets","C3_TFT_610_CCAWWNAAGG_V_SRF_Q4",82,-1.7719,0,0.0047,-1.2846,0.095,0.25,-0.8597,0.76,0.97
"C0_Hallmark:H_ALL_7_HALLMARK_IL6_JAK_STAT3_SIGNALING","C0_Hallmark","H_ALL_7_HALLMARK_IL6_JAK_STAT3_SIGNALING",85,-1.7719,0,0.00084,1.1175,0.23,0.34,1.4474,0.015,0.058
"C2_Chemical_and_genetic_perturbations:C2_CGP_1247_CERVERA_SDHB_TARGETS_2","C2_Chemical_and_genetic_perturbations","C2_CGP_1247_CERVERA_SDHB_TARGETS_2",109,-1.7719,0,0.01,-0.8657,0.8,1,1.231,0.097,0.74
"KEGG_pathway:HSA04976_BILE_SECRETION","KEGG_pathway","HSA04976_BILE_SECRETION",72,-1.7716,0,0.0033,-1.2149,0.15,0.51,-1.2227,0.16,0.35
"C7_Immunologic_signatures:C7_ALL_777_GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_777_GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP",193,-1.7712,0,3.6e-05,-1.1005,0.23,1,-1.3557,0.015,0.092
"C2_Chemical_and_genetic_perturbations:C2_CGP_30_LIU_PROSTATE_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_30_LIU_PROSTATE_CANCER_DN",466,-1.7711,0,0.01,-0.9567,0.61,1,-1.151,0.064,0.58
"GO_BP:518904_GO_2000257_REGULATION_OF_PROTEIN_ACTIVATION_CASCADE","GO_BP","518904_GO_2000257_REGULATION_OF_PROTEIN_ACTIVATION_CASCADE",30,-1.7711,0.0028,0.023,0.996,0.44,0.98,1.2852,0.12,0.69
"GO_BP:488764_GO_0002891_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE","GO_BP","488764_GO_0002891_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE",26,-1.7707,0,0.023,-1.708,0.0097,0.71,-1.2871,0.13,0.65
"C7_Immunologic_signatures:C7_ALL_418_GSE15930_STIM_VS_STIM_AND_IL_12_48H_CD8_T_CELL_DN","C7_Immunologic_signatures","C7_ALL_418_GSE15930_STIM_VS_STIM_AND_IL_12_48H_CD8_T_CELL_DN",198,-1.7707,0,3.6e-05,1.1785,0.1,0.26,-0.8733,0.82,0.99
"GO_BP:515594_GO_0070664_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION","GO_BP","515594_GO_0070664_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION",58,-1.7706,0.004,0.023,-0.6118,0.99,1,0.7992,0.83,1
"KEGG_pathway:HSA04520_ADHERENS_JUNCTION","KEGG_pathway","HSA04520_ADHERENS_JUNCTION",73,-1.7704,0,0.0033,1.2476,0.13,0.47,0.9028,0.66,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_849_WOOD_EBV_EBNA1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_849_WOOD_EBV_EBNA1_TARGETS_DN",47,-1.7704,0.0014,0.01,0.9461,0.56,0.87,-0.7539,0.88,0.97
"GO_BP:503963_GO_0034764_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT","GO_BP","503963_GO_0034764_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT",84,-1.7703,0,0.023,-1.0522,0.34,0.97,0.9383,0.52,0.91
"GO_BP:488793_GO_0002920_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE","GO_BP","488793_GO_0002920_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE",42,-1.7702,0.0015,0.023,-1.2466,0.13,0.91,-0.7774,0.87,1
"GO_BP:508590_GO_0046325_NEGATIVE_REGULATION_OF_GLUCOSE_IMPORT","GO_BP","508590_GO_0046325_NEGATIVE_REGULATION_OF_GLUCOSE_IMPORT",12,-1.7701,0.0031,0.023,-1.2308,0.21,0.89,-1.4001,0.086,0.58
"C7_Immunologic_signatures:C7_ALL_11_KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_11_KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP",195,-1.7699,0,3.6e-05,0.8927,0.78,1,-0.9055,0.74,0.94
"GO_MF:495364_GO_0015081_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495364_GO_0015081_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",130,-1.7698,0,0.05,-1.7467,0,0.25,-1.4631,0.0042,0.42
"GO_BP:504456_GO_0035272_EXOCRINE_SYSTEM_DEVELOPMENT","GO_BP","504456_GO_0035272_EXOCRINE_SYSTEM_DEVELOPMENT",42,-1.7697,0,0.023,-1.1731,0.21,0.91,0.9663,0.51,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_3369_SMIRNOV_RESPONSE_TO_IR_2HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3369_SMIRNOV_RESPONSE_TO_IR_2HR_UP",52,-1.7696,0,0.011,-1.3176,0.086,0.69,-1.3754,0.057,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_1244_ONDER_CDH1_SIGNALING_VIA_CTNNB1","C2_Chemical_and_genetic_perturbations","C2_CGP_1244_ONDER_CDH1_SIGNALING_VIA_CTNNB1",79,-1.7695,0,0.011,0.8829,0.7,0.94,-0.9665,0.52,0.8
"GO_BP:488573_GO_0002700_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE","GO_BP","488573_GO_0002700_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE",84,-1.7695,0.0013,0.023,-1.1429,0.22,0.93,-1.2327,0.14,0.7
"GO_BP:488734_GO_0002861_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS","GO_BP","488734_GO_0002861_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",22,-1.7694,0.0047,0.023,-0.9647,0.5,1,-0.7596,0.81,1
"C1_Positional:C1_ALL_299_CHR12P13","C1_Positional","C1_ALL_299_CHR12P13",195,-1.7694,0,0.084,-1.232,0.067,1,-1.358,0.025,0.48
"GO_BP:858521_GO_0061572_ACTIN_FILAMENT_BUNDLE_ORGANIZATION","GO_BP","858521_GO_0061572_ACTIN_FILAMENT_BUNDLE_ORGANIZATION",42,-1.7694,0.0014,0.023,-1.0813,0.32,0.95,0.9496,0.55,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1910_BROWNE_HCMV_INFECTION_6HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1910_BROWNE_HCMV_INFECTION_6HR_UP",69,-1.7693,0.0013,0.011,-0.8637,0.75,1,-1.5616,0.0058,0.27
"C2_Chemical_and_genetic_perturbations:C2_CGP_1721_MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1721_MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP",69,-1.7692,0.0013,0.011,1.7429,0,0.063,-0.6547,0.99,0.99
"GO_BP:488158_GO_0002285_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488158_GO_0002285_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",84,-1.7692,0,0.023,0.5689,1,1,-1.139,0.19,0.75
"GO_BP:511808_GO_0050866_NEGATIVE_REGULATION_OF_CELL_ACTIVATION","GO_BP","511808_GO_0050866_NEGATIVE_REGULATION_OF_CELL_ACTIVATION",140,-1.769,0,0.023,-0.8137,0.9,1,1.1624,0.15,0.73
"GO_BP:495040_GO_0010975_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT","GO_BP","495040_GO_0010975_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT",291,-1.7688,0,0.023,-1.2827,0.037,0.89,0.9505,0.64,0.9
"KEGG_compound:C00410_PROGESTERONE_4_PREGNENE_3_20_DIONE","KEGG_compound","C00410_PROGESTERONE_4_PREGNENE_3_20_DIONE",10,-1.7688,0.005,0.023,1.2018,0.24,0.86,1.2954,0.16,0.42
"GO_BP:754002_GO_1901032_NEGATIVE_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES","GO_BP","754002_GO_1901032_NEGATIVE_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES",13,-1.7686,0.0049,0.023,1.4873,0.061,0.43,0.9617,0.49,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2862_GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2862_GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN",9,-1.7684,0.0087,0.011,-1.3734,0.12,0.63,-1.4718,0.057,0.31
"GO_BP:514255_GO_0060700_REGULATION_OF_RIBONUCLEASE_ACTIVITY","GO_BP","514255_GO_0060700_REGULATION_OF_RIBONUCLEASE_ACTIVITY",6,-1.7684,0.0033,0.023,-1.4015,0.094,0.98,-1.6386,0.023,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1463_FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1463_FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP",48,-1.7681,0,0.011,-1.2298,0.15,0.77,-1.3764,0.054,0.38
"GO_BP:1184586_GO_1904062_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT","GO_BP","1184586_GO_1904062_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT",139,-1.7681,0,0.023,-1.3158,0.029,0.88,-1.1692,0.14,0.73
"GO_BP:499467_GO_0023061_SIGNAL_RELEASE","GO_BP","499467_GO_0023061_SIGNAL_RELEASE",191,-1.768,0,0.023,0.8822,0.8,1,-1.1482,0.15,0.74
"GO_BP:515543_GO_0070613_REGULATION_OF_PROTEIN_PROCESSING","GO_BP","515543_GO_0070613_REGULATION_OF_PROTEIN_PROCESSING",346,-1.768,0,0.023,0.8933,0.86,1,-0.9156,0.75,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1334_RADAEVA_RESPONSE_TO_IFNA1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1334_RADAEVA_RESPONSE_TO_IFNA1_UP",52,-1.7679,0,0.011,1.1304,0.23,0.58,-1.9216,0.002,0.067
"GO_MF:490606_GO_0005496_STEROID_BINDING","GO_MF","490606_GO_0005496_STEROID_BINDING",80,-1.7676,0,0.051,-1.0633,0.32,0.86,0.8847,0.71,0.97
"WikiPathways:198886_WP455_GPCRS_CLASS_A_RHODOPSIN_LIKE","WikiPathways","198886_WP455_GPCRS_CLASS_A_RHODOPSIN_LIKE",244,-1.7676,0,0.014,1.4316,0.0025,0.43,1.7839,0,0.099
"GO_BP:510924_GO_0048875_CHEMICAL_HOMEOSTASIS_WITHIN_A_TISSUE","GO_BP","510924_GO_0048875_CHEMICAL_HOMEOSTASIS_WITHIN_A_TISSUE",12,-1.7675,0.0049,0.023,-1.3943,0.095,1,0.911,0.56,0.93
"C7_Immunologic_signatures:C7_ALL_204_GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_204_GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN",193,-1.7675,0,3.6e-05,1.2432,0.055,0.16,-1.4949,0,0.024
"C2_Chemical_and_genetic_perturbations:C2_CGP_1603_WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2","C2_Chemical_and_genetic_perturbations","C2_CGP_1603_WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2",36,-1.7675,0.0014,0.011,0.6349,0.97,1,-1.1509,0.24,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_2306_GAURNIER_PSMD4_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2306_GAURNIER_PSMD4_TARGETS",69,-1.7675,0.0013,0.011,0.8831,0.71,0.94,1.0812,0.3,0.87
"C7_Immunologic_signatures:C7_ALL_1804_GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN","C7_Immunologic_signatures","C7_ALL_1804_GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN",194,-1.767,0,3.6e-05,-0.8052,0.94,1,-1.3392,0.012,0.1
"GO_BP:754832_GO_1901881_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION","GO_BP","754832_GO_1901881_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION",14,-1.767,0.0046,0.023,-0.5929,0.96,1,1.0873,0.33,0.77
"C7_Immunologic_signatures:C7_ALL_629_GSE17721_POLYIC_VS_CPG_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_629_GSE17721_POLYIC_VS_CPG_12H_BMDM_UP",197,-1.767,0,3.6e-05,0.8541,0.83,1,-0.9648,0.56,0.81
"C7_Immunologic_signatures:C7_ALL_1454_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN","C7_Immunologic_signatures","C7_ALL_1454_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN",199,-1.7669,0,3.6e-05,1.0558,0.32,0.57,-1.1165,0.19,0.45
"C7_Immunologic_signatures:C7_ALL_94_GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN","C7_Immunologic_signatures","C7_ALL_94_GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN",191,-1.7668,0,3.5e-05,-0.7667,0.96,1,-1.5703,0,0.0083
"REACTOME:187194_REACT_25149_ION_TRANSPORT_BY_P_TYPE_ATPASES","REACTOME","187194_REACT_25149_ION_TRANSPORT_BY_P_TYPE_ATPASES",47,-1.7667,0,0.031,-1.4551,0.04,0.48,-1.3759,0.057,0.46
"GO_BP:500913_GO_0031664_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY","GO_BP","500913_GO_0031664_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY",19,-1.7663,0.003,0.023,-1.1566,0.27,0.92,-1.1124,0.31,0.76
"C6_Oncogenic_signatures:C6_ALL_48_P53_DN_V2_UP","C6_Oncogenic_signatures","C6_ALL_48_P53_DN_V2_UP",141,-1.7661,0,0.00099,-1.1636,0.14,0.48,1.2664,0.062,0.2
"KEGG_pathway:HSA04621_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY","KEGG_pathway","HSA04621_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY",57,-1.7659,0.0026,0.0035,-1.2242,0.14,0.52,-1.4616,0.033,0.15
"C2_Chemical_and_genetic_perturbations:C2_CGP_640_HUMMERICH_SKIN_CANCER_PROGRESSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_640_HUMMERICH_SKIN_CANCER_PROGRESSION_DN",100,-1.7659,0,0.011,-0.8574,0.8,1,-0.9657,0.54,0.8
"GO_BP:512657_GO_0051785_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION","GO_BP","512657_GO_0051785_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION",52,-1.7659,0.0013,0.023,-1.1354,0.26,0.93,-1.2528,0.13,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_2534_WU_ALZHEIMER_DISEASE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2534_WU_ALZHEIMER_DISEASE_DN",18,-1.7658,0.0015,0.011,-1.0159,0.43,0.99,-1.7986,0.0019,0.13
"C7_Immunologic_signatures:C7_ALL_172_GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN","C7_Immunologic_signatures","C7_ALL_172_GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN",191,-1.7657,0,3.9e-05,-1.0603,0.3,1,-1.0933,0.23,0.52
"GO_MF:490395_GO_0005132_TYPE_I_INTERFERON_RECEPTOR_BINDING","GO_MF","490395_GO_0005132_TYPE_I_INTERFERON_RECEPTOR_BINDING",12,-1.7656,0.0016,0.052,-0.8288,0.71,1,-1.5439,0.038,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_847_LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_847_LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN",110,-1.7655,0.0012,0.011,-1.1375,0.19,0.86,-1.4796,0.01,0.3
"KEGG_pathway:HSA04670_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION","KEGG_pathway","HSA04670_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION",113,-1.7654,0,0.0035,0.8092,0.89,1,-0.8884,0.72,0.86
"REACTOME:160998_REACT_21402_CDO_IN_MYOGENESIS","REACTOME","160998_REACT_21402_CDO_IN_MYOGENESIS",30,-1.7653,0.0045,0.031,-1.1831,0.22,0.85,-1.7438,0.002,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_476_BERENJENO_TRANSFORMED_BY_RHOA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_476_BERENJENO_TRANSFORMED_BY_RHOA_DN",390,-1.7651,0,0.011,0.887,0.9,0.94,-1.2011,0.052,0.52
"GO_BP:511806_GO_0050864_REGULATION_OF_B_CELL_ACTIVATION","GO_BP","511806_GO_0050864_REGULATION_OF_B_CELL_ACTIVATION",101,-1.7651,0,0.023,-0.7721,0.92,1,-1.2146,0.12,0.72
"WikiPathways:198855_WP75_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY","WikiPathways","198855_WP75_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",98,-1.765,0.0012,0.014,-0.9383,0.62,1,-1.1318,0.2,0.57
"GO_BP:508718_GO_0046457_PROSTANOID_BIOSYNTHETIC_PROCESS","GO_BP","508718_GO_0046457_PROSTANOID_BIOSYNTHETIC_PROCESS",21,-1.7649,0,0.023,-0.7233,0.85,1,-1.1641,0.24,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_430_VANHARANTA_UTERINE_FIBROID_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_430_VANHARANTA_UTERINE_FIBROID_DN",67,-1.7648,0.004,0.011,-1.4152,0.036,0.57,-1.3707,0.044,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_2485_BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2485_BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN",40,-1.7648,0.0044,0.011,-0.5847,0.99,1,-1.6432,0.01,0.22
"C7_Immunologic_signatures:C7_ALL_1520_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN","C7_Immunologic_signatures","C7_ALL_1520_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN",199,-1.7646,0,3.9e-05,0.8626,0.82,1,-1.3678,0.0062,0.083
"GO_BP:498215_GO_0019372_LIPOXYGENASE_PATHWAY","GO_BP","498215_GO_0019372_LIPOXYGENASE_PATHWAY",13,-1.7643,0.0048,0.024,0.8738,0.64,1,0.9359,0.54,0.91
"C4_Cancer_modules:C4_CM_47_MODULE_51","C4_Cancer_modules","C4_CM_47_MODULE_51",36,-1.7642,0.0014,0.0078,-0.8415,0.72,0.96,-1.3787,0.078,0.23
"C2_Chemical_and_genetic_perturbations:C2_CGP_2743_BUDHU_LIVER_CANCER_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2743_BUDHU_LIVER_CANCER_METASTASIS_UP",10,-1.764,0.0082,0.011,0.5394,0.97,1,0.9328,0.53,1
"C7_Immunologic_signatures:C7_ALL_912_GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN","C7_Immunologic_signatures","C7_ALL_912_GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN",196,-1.7637,0,3.9e-05,-0.7062,1,1,0.9801,0.49,1
"REACTOME:1127691_REACT_264068_EPH_EPHRIN_SIGNALING","REACTOME","1127691_REACT_264068_EPH_EPHRIN_SIGNALING",94,-1.7634,0.0012,0.031,0.9254,0.63,0.87,-0.9992,0.45,0.84
"GO_BP:513272_GO_0052509_POSITIVE_REGULATION_BY_SYMBIONT_OF_HOST_DEFENSE_RESPONSE","GO_BP","513272_GO_0052509_POSITIVE_REGULATION_BY_SYMBIONT_OF_HOST_DEFENSE_RESPONSE",9,-1.7632,0.0049,0.024,0.6238,0.92,1,-0.8157,0.69,0.98
"REACTOME:187196_REACT_24970_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION","REACTOME","187196_REACT_24970_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION",131,-1.7631,0,0.031,-0.8823,0.75,1,-1.4982,0.013,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_1668_CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1668_CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN",42,-1.7631,0.0014,0.011,1.0659,0.33,0.69,1.136,0.24,0.84
"GO_BP:491372_GO_0006469_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY","GO_BP","491372_GO_0006469_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY",199,-1.763,0,0.024,-0.7033,1,1,-1.0694,0.28,0.8
"C7_Immunologic_signatures:C7_ALL_908_GSE20715_0H_VS_48H_OZONE_LUNG_DN","C7_Immunologic_signatures","C7_ALL_908_GSE20715_0H_VS_48H_OZONE_LUNG_DN",200,-1.763,0,3.8e-05,-1.025,0.39,1,-1.6907,0,0.00093
"GO_BP:491766_GO_0006911_PHAGOCYTOSIS_ENGULFMENT","GO_BP","491766_GO_0006911_PHAGOCYTOSIS_ENGULFMENT",15,-1.7628,0.0081,0.024,1.1438,0.27,0.84,-0.8295,0.69,0.97
"C6_Oncogenic_signatures:C6_ALL_36_BCAT_GDS748_UP","C6_Oncogenic_signatures","C6_ALL_36_BCAT_GDS748_UP",47,-1.7628,0.0027,0.001,-1.0522,0.35,0.59,-1.3407,0.078,0.32
"WikiPathways:198881_WP286_IL_3_SIGNALING_PATHWAY","WikiPathways","198881_WP286_IL_3_SIGNALING_PATHWAY",100,-1.7627,0,0.014,0.8069,0.89,1,-1.1406,0.19,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_1345_UEDA_PERIFERAL_CLOCK","C2_Chemical_and_genetic_perturbations","C2_CGP_1345_UEDA_PERIFERAL_CLOCK",168,-1.7625,0,0.011,-0.9227,0.65,1,-1.4459,0.0064,0.32
"GO_BP:487466_GO_0006790_SULFUR_COMPOUND_METABOLIC_PROCESS","GO_BP","487466_GO_0006790_SULFUR_COMPOUND_METABOLIC_PROCESS",322,-1.7624,0,0.024,-1.0244,0.4,0.97,-1.5874,0,0.52
"GO_BP:513747_GO_0060191_REGULATION_OF_LIPASE_ACTIVITY","GO_BP","513747_GO_0060191_REGULATION_OF_LIPASE_ACTIVITY",173,-1.7622,0,0.024,1.1719,0.097,0.81,1.0145,0.41,0.84
"C7_Immunologic_signatures:C7_ALL_188_GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN","C7_Immunologic_signatures","C7_ALL_188_GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN",197,-1.7621,0,3.8e-05,1.2521,0.051,0.15,-1.442,0.006,0.038
"KEGG_pathway:HSA04974_PROTEIN_DIGESTION_AND_ABSORPTION","KEGG_pathway","HSA04974_PROTEIN_DIGESTION_AND_ABSORPTION",85,-1.762,0,0.0036,-1.586,0.0018,0.8,-1.1554,0.2,0.43
"GO_BP:491684_GO_0006814_SODIUM_ION_TRANSPORT","GO_BP","491684_GO_0006814_SODIUM_ION_TRANSPORT",139,-1.762,0,0.024,-1.7528,0,0.61,-1.2832,0.054,0.65
"C7_Immunologic_signatures:C7_ALL_895_GSE20715_WT_VS_TLR4_KO_LUNG_UP","C7_Immunologic_signatures","C7_ALL_895_GSE20715_WT_VS_TLR4_KO_LUNG_UP",196,-1.7616,0,3.8e-05,1.4805,0.0023,0.016,0.957,0.57,1
"C4_Cancer_modules:C4_CM_146_MODULE_154","C4_Cancer_modules","C4_CM_146_MODULE_154",69,-1.7613,0,0.008,-1.1458,0.22,0.63,1.6046,0.0095,0.18
"GO_BP:508687_GO_0046425_REGULATION_OF_JAK_STAT_CASCADE","GO_BP","508687_GO_0046425_REGULATION_OF_JAK_STAT_CASCADE",94,-1.761,0,0.024,-1.3614,0.044,0.97,-1.3048,0.06,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2669_ZHAN_LATE_DIFFERENTIATION_GENES_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2669_ZHAN_LATE_DIFFERENTIATION_GENES_DN",16,-1.761,0.0032,0.011,-1.0885,0.33,0.93,-0.9103,0.58,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1671_MCDOWELL_ACUTE_LUNG_INJURY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1671_MCDOWELL_ACUTE_LUNG_INJURY_UP",44,-1.7608,0.0041,0.011,1.1633,0.22,0.53,1.5598,0.012,0.43
"KEGG_module:HSA_M00042_CATECHOLAMINE_BIOSYNTHESIS_TYROSINE_DOPAMINE_NORADRENALINE_ADRENALINE","KEGG_module","HSA_M00042_CATECHOLAMINE_BIOSYNTHESIS_TYROSINE_DOPAMINE_NORADRENALINE_ADRENALINE",5,-1.7607,0,0.099,0.8074,0.69,0.94,-1.9717,0,0.041
"GO_BP:512160_GO_0051272_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_MOVEMENT","GO_BP","512160_GO_0051272_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_MOVEMENT",326,-1.7605,0,0.024,1.0674,0.25,0.93,1.0602,0.3,0.79
"GO_BP:518522_GO_0090382_PHAGOSOME_MATURATION","GO_BP","518522_GO_0090382_PHAGOSOME_MATURATION",49,-1.7604,0.0014,0.024,-0.6827,0.96,1,0.8739,0.7,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1548_XU_RESPONSE_TO_TRETINOIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1548_XU_RESPONSE_TO_TRETINOIN_UP",16,-1.7604,0.0047,0.011,-1.0058,0.45,1,-0.6967,0.92,0.99
"GO_MF:496555_GO_0016614_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS","GO_MF","496555_GO_0016614_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS",129,-1.7604,0,0.054,0.9425,0.6,0.94,-1.1866,0.12,0.59
"GO_MF:487576_GO_0001664_G_PROTEIN_COUPLED_RECEPTOR_BINDING","GO_MF","487576_GO_0001664_G_PROTEIN_COUPLED_RECEPTOR_BINDING",223,-1.7604,0,0.053,-1.234,0.068,0.84,-1.0889,0.24,0.7
"GO_BP:513300_GO_0052552_MODULATION_BY_ORGANISM_OF_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513300_GO_0052552_MODULATION_BY_ORGANISM_OF_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",9,-1.7602,0.0048,0.024,0.6329,0.92,1,-0.8171,0.69,0.98
"C4_Cancer_modules:C4_CM_308_MODULE_357","C4_Cancer_modules","C4_CM_308_MODULE_357",72,-1.7598,0,0.008,-0.9815,0.49,0.83,1.7408,0,0.1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1459_ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1459_ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN",51,-1.7598,0,0.011,1.0788,0.31,0.67,0.8482,0.75,1
"GO_MF:505523_GO_0042379_CHEMOKINE_RECEPTOR_BINDING","GO_MF","505523_GO_0042379_CHEMOKINE_RECEPTOR_BINDING",49,-1.7598,0,0.053,1.4035,0.054,0.48,1.0638,0.33,0.83
"C4_Cancer_gene_neighborhoods:C4_CGN_285_GNF2_BUB1","C4_Cancer_gene_neighborhoods","C4_CGN_285_GNF2_BUB1",26,-1.7597,0.003,0.0045,-0.529,0.99,1,-1.4445,0.056,0.14
"C2_Chemical_and_genetic_perturbations:C2_CGP_1090_RICKMAN_HEAD_AND_NECK_CANCER_E","C2_Chemical_and_genetic_perturbations","C2_CGP_1090_RICKMAN_HEAD_AND_NECK_CANCER_E",84,-1.7597,0,0.011,1.109,0.27,0.62,1.5688,0.0075,0.43
"GO_BP:505453_GO_0042306_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","505453_GO_0042306_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS",150,-1.7595,0,0.024,-1.1038,0.23,0.94,-1.6749,0,0.57
"GO_BP:754068_GO_1901099_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND","GO_BP","754068_GO_1901099_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND",34,-1.7595,0.0045,0.024,-1.3419,0.099,0.91,-1.5637,0.018,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_1683_HU_GENOTOXIC_DAMAGE_24HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1683_HU_GENOTOXIC_DAMAGE_24HR",35,-1.7595,0.0057,0.011,1.224,0.15,0.47,-1.3186,0.096,0.41
"C7_Immunologic_signatures:C7_ALL_1552_GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1552_GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN",196,-1.7592,0,4.5e-05,-0.9355,0.64,1,-0.7725,0.99,1
"C7_Immunologic_signatures:C7_ALL_934_GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_934_GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN",198,-1.7592,0,4.5e-05,0.5943,1,1,0.9717,0.55,1
"KEGG_pathway:HSA00562_INOSITOL_PHOSPHATE_METABOLISM","KEGG_pathway","HSA00562_INOSITOL_PHOSPHATE_METABOLISM",63,-1.7591,0,0.0036,-1.5167,0.01,0.48,-0.7286,0.95,0.98
"REACTOME:106199_REACT_723_GLUCOSE_METABOLISM","REACTOME","106199_REACT_723_GLUCOSE_METABOLISM",76,-1.7591,0,0.032,0.7347,0.93,1,-1.7391,0.0019,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_2541_WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2541_WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN",11,-1.759,0,0.011,-1.0749,0.36,0.95,-1.2875,0.17,0.44
"KEGG_pathway:HSA00340_HISTIDINE_METABOLISM","KEGG_pathway","HSA00340_HISTIDINE_METABOLISM",23,-1.7589,0.0046,0.0036,0.9337,0.56,1,-1.0376,0.41,0.62
"GO_MF:507654_GO_0045295_GAMMA_CATENIN_BINDING","GO_MF","507654_GO_0045295_GAMMA_CATENIN_BINDING",12,-1.7586,0.0096,0.052,0.9066,0.59,0.98,-1.5083,0.065,0.42
"GO_BP:498270_GO_0019430_REMOVAL_OF_SUPEROXIDE_RADICALS","GO_BP","498270_GO_0019430_REMOVAL_OF_SUPEROXIDE_RADICALS",12,-1.7586,0.0032,0.025,0.5827,0.96,1,-1.3233,0.14,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2143_HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2143_HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN",276,-1.7583,0,0.011,0.7408,1,1,-1.3622,0.0021,0.39
"GO_MF:490638_GO_0005543_PHOSPHOLIPID_BINDING","GO_MF","490638_GO_0005543_PHOSPHOLIPID_BINDING",325,-1.7582,0,0.052,-0.9919,0.48,0.92,-1.2126,0.042,0.58
"KEGG_compound:C00219_ARACHIDONATE_ARACHIDONIC_ACID_5Z_8Z_11Z_14Z_ICOSATETRAENOIC_ACID_CIS_5_8_11_14_EICOSATETRAENOIC_ACID","KEGG_compound","C00219_ARACHIDONATE_ARACHIDONIC_ACID_5Z_8Z_11Z_14Z_ICOSATETRAENOIC_ACID_CIS_5_8_11_14_EICOSATETRAENOIC_ACID",39,-1.7581,0.0014,0.025,0.9148,0.58,1,1.1295,0.26,0.64
"GO_BP:505666_GO_0042535_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS","GO_BP","505666_GO_0042535_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS",9,-1.7579,0.0032,0.025,0.732,0.81,1,0.7632,0.79,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1876_DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1876_DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN",287,-1.7572,0,0.012,-1.7361,0,0.34,-1.5993,0,0.24
"C4_Cancer_gene_neighborhoods:C4_CGN_348_GNF2_EGFR","C4_Cancer_gene_neighborhoods","C4_CGN_348_GNF2_EGFR",27,-1.7572,0.0015,0.0045,1.2369,0.14,0.18,1.4689,0.036,0.19
"REACTOME:106388_REACT_6966_TOLL_LIKE_RECEPTORS_CASCADES","REACTOME","106388_REACT_6966_TOLL_LIKE_RECEPTORS_CASCADES",141,-1.7571,0,0.032,-0.7765,0.95,1,-1.1383,0.19,0.67
"C3_TF_targets:C3_TFT_121_V_AP1_Q6","C3_TF_targets","C3_TFT_121_V_AP1_Q6",255,-1.7571,0,0.0054,-1.2568,0.03,0.27,-1.1357,0.15,0.47
"GO_BP:502162_GO_0032940_SECRETION_BY_CELL","GO_BP","502162_GO_0032940_SECRETION_BY_CELL",478,-1.757,0,0.025,1.1214,0.12,0.88,-1.0583,0.26,0.81
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_116_BIOCARTA_PPARA_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_116_BIOCARTA_PPARA_PATHWAY",55,-1.757,0,0.03,-0.882,0.69,1,-1.1244,0.25,0.65
"C0_Hallmark:H_ALL_42_HALLMARK_COAGULATION","C0_Hallmark","H_ALL_42_HALLMARK_COAGULATION",135,-1.7567,0,0.00092,1.0348,0.37,0.55,1.2187,0.1,0.25
"GO_CC:490798_GO_0005766_PRIMARY_LYSOSOME","GO_CC","490798_GO_0005766_PRIMARY_LYSOSOME",14,-1.7565,0.0016,0.037,0.9486,0.51,0.84,-0.5312,0.99,1
"REACTOME:187209_REACT_23916_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS","REACTOME","187209_REACT_23916_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS",13,-1.7565,0.0049,0.032,-0.5175,0.99,1,-1.1228,0.35,0.68
"C7_Immunologic_signatures:C7_ALL_85_GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP","C7_Immunologic_signatures","C7_ALL_85_GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP",195,-1.7563,0,4.8e-05,-1.0476,0.34,1,-1.76,0,0.00024
"REACTOME:1127694_REACT_264047_EPHRIN_SIGNALING","REACTOME","1127694_REACT_264047_EPHRIN_SIGNALING",19,-1.7562,0.0063,0.031,-1.0659,0.36,0.91,-1.7458,0.012,0.23
"GO_BP:498213_GO_0019370_LEUKOTRIENE_BIOSYNTHETIC_PROCESS","GO_BP","498213_GO_0019370_LEUKOTRIENE_BIOSYNTHETIC_PROCESS",20,-1.756,0.0062,0.025,-0.7761,0.8,1,-0.7462,0.85,1
"WikiPathways:198832_WP236_ADIPOGENESIS","WikiPathways","198832_WP236_ADIPOGENESIS",129,-1.756,0,0.014,-0.7361,0.96,1,0.8842,0.76,1
"GO_BP:489308_GO_0030036_ACTIN_CYTOSKELETON_ORGANIZATION","GO_BP","489308_GO_0030036_ACTIN_CYTOSKELETON_ORGANIZATION",375,-1.7558,0,0.025,-1.1055,0.18,0.94,-1.0853,0.2,0.79
"GO_BP:751039_GO_0036119_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR","GO_BP","751039_GO_0036119_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR",10,-1.7557,0.0081,0.025,1.3319,0.14,0.63,1.0035,0.42,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_2128_LEE_LIVER_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_2128_LEE_LIVER_CANCER",48,-1.7556,0,0.012,-0.957,0.52,1,1.3819,0.064,0.54
"C4_Cancer_gene_neighborhoods:C4_CGN_299_GNF2_HPX","C4_Cancer_gene_neighborhoods","C4_CGN_299_GNF2_HPX",132,-1.7554,0,0.0045,-1.2195,0.1,0.67,1.4975,0.0039,0.19
"KEGG_compound:C05488_11_DEOXYCORTISOL_CORTODOXONE","KEGG_compound","C05488_11_DEOXYCORTISOL_CORTODOXONE",5,-1.7549,0.0018,0.026,1.0936,0.34,1,1.4754,0.07,0.19
"GO_BP:753042_GO_1900046_REGULATION_OF_HEMOSTASIS","GO_BP","753042_GO_1900046_REGULATION_OF_HEMOSTASIS",77,-1.7549,0,0.025,1.1736,0.19,0.81,1.1809,0.17,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2358_LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2358_LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN",102,-1.7547,0,0.012,-1.0731,0.3,0.95,-1.2608,0.086,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_2061_GAVIN_FOXP3_TARGETS_CLUSTER_P3","C2_Chemical_and_genetic_perturbations","C2_CGP_2061_GAVIN_FOXP3_TARGETS_CLUSTER_P3",159,-1.7543,0,0.012,-1.2555,0.063,0.74,-1.1545,0.13,0.57
"GO_CC:505709_GO_0042582_AZUROPHIL_GRANULE","GO_CC","505709_GO_0042582_AZUROPHIL_GRANULE",14,-1.7543,0.0063,0.037,0.9358,0.55,0.86,-0.5256,0.98,1
"C7_Immunologic_signatures:C7_ALL_1032_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN","C7_Immunologic_signatures","C7_ALL_1032_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN",198,-1.7542,0,5.1e-05,0.9799,0.53,0.8,-1.5508,0,0.011
"REACTOME:160997_REACT_21303_MYOGENESIS","REACTOME","160997_REACT_21303_MYOGENESIS",30,-1.754,0.0042,0.032,-1.1933,0.21,0.84,-1.7377,0,0.21
"GO_BP:500593_GO_0031334_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY","GO_BP","500593_GO_0031334_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY",141,-1.7537,0,0.026,-0.7779,0.93,1,-1.4047,0.012,0.57
"WikiPathways:198825_WP15_SELENIUM_PATHWAY","WikiPathways","198825_WP15_SELENIUM_PATHWAY",83,-1.7536,0.0026,0.014,1.155,0.2,0.89,-1.1271,0.24,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1547_BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS","C2_Chemical_and_genetic_perturbations","C2_CGP_1547_BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS",31,-1.7535,0.0015,0.012,1.61,0.019,0.13,-1.3286,0.067,0.41
"C4_Cancer_modules:C4_CM_297_MODULE_341","C4_Cancer_modules","C4_CM_297_MODULE_341",82,-1.7534,0.0013,0.0085,-1.2038,0.14,0.64,0.7628,0.92,1
"C4_Cancer_modules:C4_CM_11_MODULE_12","C4_Cancer_modules","C4_CM_11_MODULE_12",348,-1.7533,0,0.0084,-1.0077,0.4,0.8,-1.0903,0.2,0.55
"C7_Immunologic_signatures:C7_ALL_1695_GSE3982_BASOPHIL_VS_TH2_UP","C7_Immunologic_signatures","C7_ALL_1695_GSE3982_BASOPHIL_VS_TH2_UP",197,-1.7533,0,5.1e-05,0.7343,1,1,-0.8956,0.76,0.96
"C4_Cancer_gene_neighborhoods:C4_CGN_338_GNF2_CDKN1C","C4_Cancer_gene_neighborhoods","C4_CGN_338_GNF2_CDKN1C",22,-1.7533,0.0015,0.0045,1.0399,0.38,0.48,-0.9188,0.56,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_269_ODONNELL_TFRC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_269_ODONNELL_TFRC_TARGETS_UP",417,-1.7533,0,0.012,-1.0434,0.33,0.98,-0.9299,0.74,0.84
"GO_BP:494517_GO_0010447_RESPONSE_TO_ACIDIC_PH","GO_BP","494517_GO_0010447_RESPONSE_TO_ACIDIC_PH",13,-1.7531,0.0098,0.026,-1.3423,0.13,0.92,0.6561,0.9,1
"GO_BP:505662_GO_0042531_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN","GO_BP","505662_GO_0042531_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN",49,-1.7531,0.0084,0.026,-1.6026,0.0073,0.69,-1.4358,0.039,0.56
"C7_Immunologic_signatures:C7_ALL_1115_GSE2706_UNSTIM_VS_8H_R848_DC_UP","C7_Immunologic_signatures","C7_ALL_1115_GSE2706_UNSTIM_VS_8H_R848_DC_UP",189,-1.7527,0,5.1e-05,-0.9252,0.66,1,-1.4379,0.004,0.04
"C2_Chemical_and_genetic_perturbations:C2_CGP_2354_LABBE_WNT3A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2354_LABBE_WNT3A_TARGETS_DN",93,-1.7526,0,0.012,1.4486,0.021,0.26,1.0827,0.3,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2696_VALK_AML_WITH_FLT3_ITD","C2_Chemical_and_genetic_perturbations","C2_CGP_2696_VALK_AML_WITH_FLT3_ITD",40,-1.7525,0,0.012,1.175,0.21,0.52,-1.0169,0.43,0.73
"GO_BP:500098_GO_0030799_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS","GO_BP","500098_GO_0030799_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS",200,-1.7518,0,0.026,1.1899,0.081,0.79,1.3411,0.016,0.65
"C7_Immunologic_signatures:C7_ALL_1716_GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1716_GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN",199,-1.7517,0,5.4e-05,-0.7446,0.98,1,-1.0015,0.45,0.72
"GO_BP:515600_GO_0070670_RESPONSE_TO_INTERLEUKIN_4","GO_BP","515600_GO_0070670_RESPONSE_TO_INTERLEUKIN_4",30,-1.7517,0.0044,0.026,0.927,0.58,1,-1.6592,0.0082,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1031_CAFFAREL_RESPONSE_TO_THC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1031_CAFFAREL_RESPONSE_TO_THC_DN",31,-1.7516,0.0029,0.012,1.0507,0.39,0.71,-1.7852,0,0.13
"C1_Positional:C1_ALL_207_CHRXQ25","C1_Positional","C1_ALL_207_CHRXQ25",20,-1.7515,0.0045,0.086,-1.1282,0.3,1,-0.7284,0.87,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2135_STEARMAN_TUMOR_FIELD_EFFECT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2135_STEARMAN_TUMOR_FIELD_EFFECT_UP",36,-1.7515,0.0029,0.012,1.2321,0.17,0.46,1.2467,0.15,0.74
"C7_Immunologic_signatures:C7_ALL_1582_GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN","C7_Immunologic_signatures","C7_ALL_1582_GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN",191,-1.7515,0,5.4e-05,-0.8404,0.85,1,-0.9517,0.56,0.85
"C7_Immunologic_signatures:C7_ALL_1261_GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP","C7_Immunologic_signatures","C7_ALL_1261_GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP",184,-1.7513,0,5.4e-05,-1.3996,0.0081,0.23,-1.0127,0.44,0.7
"C3_TF_targets:C3_TFT_498_KRCTCNNNNMANAGC_UNKNOWN","C3_TF_targets","C3_TFT_498_KRCTCNNNNMANAGC_UNKNOWN",64,-1.7508,0.0013,0.0056,-1.7545,0,0.1,-1.289,0.087,0.25
"GO_BP:503511_GO_0034308_PRIMARY_ALCOHOL_METABOLIC_PROCESS","GO_BP","503511_GO_0034308_PRIMARY_ALCOHOL_METABOLIC_PROCESS",41,-1.7508,0.0014,0.027,1.2852,0.11,0.7,-1.0516,0.36,0.81
"GO_BP:494946_GO_0010882_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING","GO_BP","494946_GO_0010882_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING",23,-1.7508,0.0061,0.026,-1.2139,0.19,0.88,0.8574,0.7,0.97
"C1_Positional:C1_ALL_261_CHR12Q","C1_Positional","C1_ALL_261_CHR12Q",16,-1.7508,0.0016,0.073,-0.81,0.72,0.96,-1.3788,0.092,0.51
"KEGG_compound:C04637_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_5_BISPHOSPHATE_PHOSPHATIDYL_MYO_INOSITOL_4_5_BISPHOSPHATE_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_4_5_BISPHOSPHATE_","KEGG_compound","C04637_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_5_BISPHOSPHATE_PHOSPHATIDYL_MYO_INOSITOL_4_5_BISPHOSPHATE_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_4_5_BISPHOSPHATE_",36,-1.7507,0.0058,0.027,-1.4718,0.042,0.34,-1.086,0.32,0.55
"GO_BP:511811_GO_0050869_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION","GO_BP","511811_GO_0050869_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION",32,-1.7503,0.0058,0.027,0.8824,0.66,1,-0.8231,0.77,0.97
"C7_Immunologic_signatures:C7_ALL_1279_GSE29618_PDC_VS_MDC_UP","C7_Immunologic_signatures","C7_ALL_1279_GSE29618_PDC_VS_MDC_UP",195,-1.7501,0,5.7e-05,-0.8511,0.87,1,-1.4339,0,0.042
"GO_MF:496567_GO_0016903_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS","GO_MF","496567_GO_0016903_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS",41,-1.7501,0.0043,0.056,0.9799,0.43,0.9,-1.6828,0.002,0.3
"REACTOME:477123_REACT_111174_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES_","REACTOME","477123_REACT_111174_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES_",8,-1.75,0.0048,0.033,-1.0006,0.45,0.98,-1.0745,0.36,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_931_TOMLINS_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_931_TOMLINS_METASTASIS_DN",20,-1.75,0.003,0.012,-1.168,0.23,0.83,-1.1353,0.26,0.59
"C7_Immunologic_signatures:C7_ALL_1571_GSE3982_CTRL_VS_LPS_48H_DC_UP","C7_Immunologic_signatures","C7_ALL_1571_GSE3982_CTRL_VS_LPS_48H_DC_UP",198,-1.7498,0,5.7e-05,0.7717,0.98,1,-1.4743,0.002,0.029
"GO_BP:488641_GO_0002768_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","488641_GO_0002768_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY",301,-1.7497,0,0.027,-0.7772,0.98,1,-1.4267,0.002,0.57
"KEGG_pathway:HSA05143_AFRICAN_TRYPANOSOMIASIS","KEGG_pathway","HSA05143_AFRICAN_TRYPANOSOMIASIS",34,-1.7497,0.0014,0.0041,-1.3637,0.074,0.32,-1.7676,0.0021,0.029
"GO_BP:507502_GO_0045109_INTERMEDIATE_FILAMENT_ORGANIZATION","GO_BP","507502_GO_0045109_INTERMEDIATE_FILAMENT_ORGANIZATION",16,-1.7495,0.0079,0.027,1.0576,0.37,0.94,-1.0181,0.43,0.83
"REACTOME:477121_REACT_111225_REGULATION_OF_KIT_SIGNALING","REACTOME","477121_REACT_111225_REGULATION_OF_KIT_SIGNALING",16,-1.7493,0.0015,0.033,0.4891,0.99,1,-1.3084,0.11,0.55
"GO_MF:493634_GO_0015038_GLUTATHIONE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY","GO_MF","493634_GO_0015038_GLUTATHIONE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY",5,-1.7492,0.0054,0.056,-1.2328,0.26,0.84,-1.378,0.12,0.51
"GO_BP:510623_GO_0048557_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS","GO_BP","510623_GO_0048557_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS",18,-1.7491,0.0047,0.027,1.1129,0.31,0.89,1.5676,0.027,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_258_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_258_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP",21,-1.749,0,0.012,1.1619,0.24,0.54,0.9217,0.57,1
"C7_Immunologic_signatures:C7_ALL_1765_GSE7460_TCONV_VS_TREG_LN_UP","C7_Immunologic_signatures","C7_ALL_1765_GSE7460_TCONV_VS_TREG_LN_UP",199,-1.749,0,5.7e-05,-0.7907,0.95,1,-0.9799,0.5,0.77
"GO_BP:516166_GO_0071241_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE","GO_BP","516166_GO_0071241_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE",114,-1.7489,0,0.027,1.1476,0.19,0.84,1.0235,0.4,0.83
"GO_BP:488417_GO_0002544_CHRONIC_INFLAMMATORY_RESPONSE","GO_BP","488417_GO_0002544_CHRONIC_INFLAMMATORY_RESPONSE",13,-1.7489,0,0.027,0.801,0.72,1,1.0521,0.36,0.8
"GO_BP:511812_GO_0050870_POSITIVE_REGULATION_OF_T_CELL_ACTIVATION","GO_BP","511812_GO_0050870_POSITIVE_REGULATION_OF_T_CELL_ACTIVATION",183,-1.7487,0,0.027,0.8677,0.83,1,-1.1114,0.2,0.76
"GO_BP:518999_GO_2000353_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS","GO_BP","518999_GO_2000353_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS",12,-1.7486,0.0016,0.027,0.7182,0.86,1,0.7267,0.84,1
"C0_Hallmark:H_ALL_19_HALLMARK_INTERFERON_GAMMA_RESPONSE","C0_Hallmark","H_ALL_19_HALLMARK_INTERFERON_GAMMA_RESPONSE",200,-1.7485,0,0.00087,1.4296,0.0023,0.046,-1.6899,0,0.01
"C3_TF_targets:C3_TFT_214_V_ETS2_B","C3_TF_targets","C3_TFT_214_V_ETS2_B",273,-1.7484,0,0.0053,-0.9089,0.74,0.95,-1.1507,0.13,0.46
"GO_BP:500100_GO_0030801_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS","GO_BP","500100_GO_0030801_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS",110,-1.7482,0,0.027,0.9739,0.48,1,1.0175,0.4,0.84
"GO_BP:507700_GO_0045343_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS","GO_BP","507700_GO_0045343_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS",18,-1.7478,0.0092,0.027,0.9502,0.51,1,-1.6982,0.0061,0.6
"GO_BP:518249_GO_0090109_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ASSEMBLY","GO_BP","518249_GO_0090109_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ASSEMBLY",40,-1.7477,0.0043,0.027,-1.3561,0.072,0.97,0.8597,0.7,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_650_RASHI_RESPONSE_TO_IONIZING_RADIATION_6","C2_Chemical_and_genetic_perturbations","C2_CGP_650_RASHI_RESPONSE_TO_IONIZING_RADIATION_6",82,-1.7476,0,0.013,1.4231,0.017,0.28,0.8588,0.77,1
"GO_BP:488304_GO_0002431_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY","GO_BP","488304_GO_0002431_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY",72,-1.7475,0.0013,0.027,0.6149,0.99,1,-1.1897,0.15,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_2153_COATES_MACROPHAGE_M1_VS_M2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2153_COATES_MACROPHAGE_M1_VS_M2_DN",76,-1.7474,0,0.013,-1.0224,0.4,0.98,-1.1337,0.22,0.59
"C7_Immunologic_signatures:C7_ALL_1438_GSE360_DC_VS_MAC_T_GONDII_DN","C7_Immunologic_signatures","C7_ALL_1438_GSE360_DC_VS_MAC_T_GONDII_DN",198,-1.7473,0,6.3e-05,-1.0562,0.3,1,0.9505,0.59,1
"GO_BP:499819_GO_0030449_REGULATION_OF_COMPLEMENT_ACTIVATION","GO_BP","499819_GO_0030449_REGULATION_OF_COMPLEMENT_ACTIVATION",28,-1.7472,0.0015,0.027,0.8774,0.65,1,1.1123,0.27,0.75
"C7_Immunologic_signatures:C7_ALL_1811_GSE7852_TREG_VS_TCONV_FAT_UP","C7_Immunologic_signatures","C7_ALL_1811_GSE7852_TREG_VS_TCONV_FAT_UP",199,-1.747,0,6.3e-05,-0.8193,0.92,1,-1.0097,0.41,0.7
"C7_Immunologic_signatures:C7_ALL_1559_GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1559_GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP",199,-1.7469,0,6.6e-05,0.5679,1,1,-0.7343,1,1
"GO_MF:489663_GO_0008236_SERINE_TYPE_PEPTIDASE_ACTIVITY","GO_MF","489663_GO_0008236_SERINE_TYPE_PEPTIDASE_ACTIVITY",165,-1.7469,0,0.056,1.107,0.21,0.78,-1.0013,0.44,0.79
"GO_BP:503316_GO_0034110_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION","GO_BP","503316_GO_0034110_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION",273,-1.7468,0,0.027,0.9054,0.79,1,-1.0154,0.4,0.84
"REACTOME:106157_REACT_6841_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT","REACTOME","106157_REACT_6841_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT",17,-1.7468,0.0094,0.033,-1.3368,0.12,0.59,-0.8784,0.62,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1577_SCHURINGA_STAT5A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1577_SCHURINGA_STAT5A_TARGETS_DN",16,-1.7466,0.0015,0.013,1.152,0.29,0.55,-0.4921,0.99,1
"GO_BP:510864_GO_0048813_DENDRITE_MORPHOGENESIS","GO_BP","510864_GO_0048813_DENDRITE_MORPHOGENESIS",43,-1.7465,0,0.027,-0.5718,1,1,-0.7234,0.92,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2476_FERRARI_RESPONSE_TO_FENRETINIDE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2476_FERRARI_RESPONSE_TO_FENRETINIDE_UP",22,-1.7463,0.0015,0.013,-1.5097,0.034,0.45,-0.8592,0.69,0.92
"C3_TF_targets:C3_TFT_140_V_NFKB_Q6","C3_TF_targets","C3_TFT_140_V_NFKB_Q6",251,-1.7462,0,0.0051,-1.4031,0.0052,0.16,-1.3058,0.013,0.24
"GO_BP:753391_GO_1900407_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS","GO_BP","753391_GO_1900407_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS",45,-1.7461,0.0013,0.027,1.0529,0.36,0.95,-1.0642,0.36,0.8
"GO_BP:516331_GO_0071407_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND","GO_BP","516331_GO_0071407_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND",318,-1.7459,0,0.027,-0.8653,0.86,1,0.967,0.59,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1646_MARCHINI_TRABECTEDIN_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1646_MARCHINI_TRABECTEDIN_RESISTANCE_UP",21,-1.7459,0.003,0.013,1.1726,0.22,0.53,0.751,0.84,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1783_GERHOLD_ADIPOGENESIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1783_GERHOLD_ADIPOGENESIS_DN",64,-1.7459,0.0026,0.013,0.6949,0.95,1,1.1016,0.28,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_3075_DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3075_DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN",91,-1.7459,0.0013,0.013,-0.9927,0.47,1,-1.1169,0.27,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_1371_JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1371_JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN",65,-1.7458,0.0013,0.013,-1.5693,0.0037,0.43,-0.9827,0.5,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_3006_SASSON_RESPONSE_TO_GONADOTROPHINS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3006_SASSON_RESPONSE_TO_GONADOTROPHINS_DN",87,-1.7458,0.0013,0.013,-0.657,1,1,-1.1542,0.18,0.57
"GO_MF:505929_GO_0042834_PEPTIDOGLYCAN_BINDING","GO_MF","505929_GO_0042834_PEPTIDOGLYCAN_BINDING",9,-1.7457,0.0088,0.056,-1.0822,0.36,0.85,-0.9151,0.57,0.86
"GO_MF:495329_GO_0015037_PEPTIDE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY","GO_MF","495329_GO_0015037_PEPTIDE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY",6,-1.7456,0.0052,0.056,-1.1111,0.35,0.83,-1.3725,0.12,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_3251_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4","C2_Chemical_and_genetic_perturbations","C2_CGP_3251_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4",108,-1.7455,0,0.013,-1.1467,0.19,0.85,-0.968,0.53,0.8
"GO_BP:752691_GO_0097190_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","752691_GO_0097190_APOPTOTIC_SIGNALING_PATHWAY",347,-1.7455,0,0.027,-0.7977,0.98,1,-1.3534,0.013,0.6
"GO_BP:512325_GO_0051447_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE","GO_BP","512325_GO_0051447_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE",16,-1.7454,0.0065,0.027,-1.2704,0.2,0.89,-1.8075,0.0061,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_2333_MATZUK_MALE_REPRODUCTION_SERTOLI","C2_Chemical_and_genetic_perturbations","C2_CGP_2333_MATZUK_MALE_REPRODUCTION_SERTOLI",28,-1.7452,0.0029,0.013,0.8621,0.7,0.96,-0.8646,0.65,0.91
"C7_Immunologic_signatures:C7_ALL_446_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN","C7_Immunologic_signatures","C7_ALL_446_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN",197,-1.7449,0,6.9e-05,1.488,0.0024,0.014,-0.941,0.62,0.87
"GO_BP:509071_GO_0046851_NEGATIVE_REGULATION_OF_BONE_REMODELING","GO_BP","509071_GO_0046851_NEGATIVE_REGULATION_OF_BONE_REMODELING",10,-1.7447,0.0016,0.028,-0.6529,0.9,1,1.1702,0.25,0.72
"GO_BP:499735_GO_0030335_POSITIVE_REGULATION_OF_CELL_MIGRATION","GO_BP","499735_GO_0030335_POSITIVE_REGULATION_OF_CELL_MIGRATION",310,-1.7447,0,0.027,1.08,0.2,0.92,1.1138,0.15,0.75
"GO_BP:508256_GO_0045954_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY","GO_BP","508256_GO_0045954_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",17,-1.7446,0.0096,0.027,-0.4809,0.99,1,-1.1161,0.31,0.76
"KEGG_compound:C05582_HOMOVANILLATE_HOMOVANILLIC_ACID_3_METHOXY_4_HYDROXYPHENYLACETATE","KEGG_compound","C05582_HOMOVANILLATE_HOMOVANILLIC_ACID_3_METHOXY_4_HYDROXYPHENYLACETATE",5,-1.7446,0.0036,0.028,0.7846,0.73,1,-1.3476,0.13,0.33
"GO_BP:491415_GO_0006518_PEPTIDE_METABOLIC_PROCESS","GO_BP","491415_GO_0006518_PEPTIDE_METABOLIC_PROCESS",109,-1.7444,0,0.027,0.8564,0.8,1,-1.4964,0.0061,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1959_ABE_VEGFA_TARGETS_30MIN","C2_Chemical_and_genetic_perturbations","C2_CGP_1959_ABE_VEGFA_TARGETS_30MIN",29,-1.7443,0.0029,0.013,-1.3788,0.076,0.62,-1.1216,0.28,0.6
"C7_Immunologic_signatures:C7_ALL_1004_GSE22886_CTRL_VS_LPS_24H_DC_DN","C7_Immunologic_signatures","C7_ALL_1004_GSE22886_CTRL_VS_LPS_24H_DC_DN",199,-1.7442,0,6.9e-05,1.0782,0.25,0.51,-1.7217,0,0.00047
"GO_BP:1129349_GO_1903522_REGULATION_OF_BLOOD_CIRCULATION","GO_BP","1129349_GO_1903522_REGULATION_OF_BLOOD_CIRCULATION",217,-1.7442,0,0.028,-1.1582,0.13,0.92,1.2647,0.036,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_3017_BROWNE_HCMV_INFECTION_4HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3017_BROWNE_HCMV_INFECTION_4HR_UP",54,-1.7441,0,0.013,-1.2924,0.096,0.7,-1.4103,0.036,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_3_WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3_WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP",21,-1.7441,0.0087,0.013,-0.7509,0.82,1,-1.6409,0.014,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_2361_NAKAMURA_METASTASIS_MODEL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2361_NAKAMURA_METASTASIS_MODEL_DN",42,-1.7438,0.0056,0.013,0.9487,0.54,0.87,1.58,0.0098,0.42
"C7_Immunologic_signatures:C7_ALL_1572_GSE3982_CTRL_VS_LPS_48H_DC_DN","C7_Immunologic_signatures","C7_ALL_1572_GSE3982_CTRL_VS_LPS_48H_DC_DN",196,-1.7438,0,6.9e-05,1.0013,0.45,0.73,-1.2951,0.028,0.14
"C2_Chemical_and_genetic_perturbations:C2_CGP_1618_ABE_VEGFA_TARGETS_2HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1618_ABE_VEGFA_TARGETS_2HR",34,-1.7437,0.0073,0.013,-0.7823,0.82,1,-0.8822,0.67,0.9
"GO_BP:491531_GO_0006641_TRIGLYCERIDE_METABOLIC_PROCESS","GO_BP","491531_GO_0006641_TRIGLYCERIDE_METABOLIC_PROCESS",86,-1.7436,0.0013,0.028,-0.6387,1,1,-1.1774,0.16,0.74
"GO_MF:495324_GO_0015026_CORECEPTOR_ACTIVITY","GO_MF","495324_GO_0015026_CORECEPTOR_ACTIVITY",27,-1.7435,0.0043,0.056,1.6721,0.0022,0.18,0.8905,0.64,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1812_ZHENG_RESPONSE_TO_ARSENITE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1812_ZHENG_RESPONSE_TO_ARSENITE_UP",17,-1.7434,0.0046,0.013,0.8822,0.66,0.94,1.0313,0.41,0.93
"KEGG_compound:C00829_NAPHTHALENE","KEGG_compound","C00829_NAPHTHALENE",8,-1.7433,0.0033,0.028,-1.4146,0.086,0.41,-0.8506,0.64,0.8
"GO_BP:510920_GO_0048871_MULTICELLULAR_ORGANISMAL_HOMEOSTASIS","GO_BP","510920_GO_0048871_MULTICELLULAR_ORGANISMAL_HOMEOSTASIS",196,-1.7432,0,0.028,-1.0833,0.26,0.96,1.1045,0.2,0.76
"GO_BP:494123_GO_0010043_RESPONSE_TO_ZINC_ION","GO_BP","494123_GO_0010043_RESPONSE_TO_ZINC_ION",38,-1.7431,0,0.028,1.2815,0.1,0.7,0.8719,0.66,0.96
"C6_Oncogenic_signatures:C6_ALL_103_BMI1_DN_MEL18_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_103_BMI1_DN_MEL18_DN_V1_DN",144,-1.7431,0,0.0014,1.0913,0.23,0.57,-1.1097,0.22,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_1180_MORI_IMMATURE_B_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1180_MORI_IMMATURE_B_LYMPHOCYTE_UP",52,-1.743,0.0013,0.013,-0.6934,0.95,1,-0.846,0.75,0.93
"C0_Hallmark:H_ALL_15_HALLMARK_ANDROGEN_RESPONSE","C0_Hallmark","H_ALL_15_HALLMARK_ANDROGEN_RESPONSE",100,-1.743,0.0025,0.00082,0.9949,0.49,0.66,1.0029,0.45,0.61
"C0_Hallmark:H_ALL_33_HALLMARK_FATTY_ACID_METABOLISM","C0_Hallmark","H_ALL_33_HALLMARK_FATTY_ACID_METABOLISM",155,-1.7429,0,0.00078,1.2186,0.084,0.2,-1.7029,0,0.014
"GO_BP:516599_GO_0071675_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION","GO_BP","516599_GO_0071675_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION",13,-1.7427,0.0077,0.028,-0.8208,0.69,1,1.1311,0.3,0.74
"REACTOME:106259_REACT_11213_NICOTINAMIDE_SALVAGING","REACTOME","106259_REACT_11213_NICOTINAMIDE_SALVAGING",5,-1.7425,0,0.035,-1.4344,0.06,0.5,-1.3445,0.15,0.51
"GO_BP:505267_GO_0042088_T_HELPER_1_TYPE_IMMUNE_RESPONSE","GO_BP","505267_GO_0042088_T_HELPER_1_TYPE_IMMUNE_RESPONSE",16,-1.7424,0.006,0.028,-1.1222,0.3,0.93,0.8543,0.67,0.98
"KEGG_pathway:HSA04210_APOPTOSIS","KEGG_pathway","HSA04210_APOPTOSIS",86,-1.7424,0.0025,0.0045,-0.8489,0.78,0.99,-1.0392,0.35,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_2058_GAVIN_FOXP3_TARGETS_CLUSTER_T4","C2_Chemical_and_genetic_perturbations","C2_CGP_2058_GAVIN_FOXP3_TARGETS_CLUSTER_T4",94,-1.7423,0,0.013,1.41,0.018,0.29,0.8519,0.79,1
"C7_Immunologic_signatures:C7_ALL_906_GSE20715_0H_VS_24H_OZONE_LUNG_DN","C7_Immunologic_signatures","C7_ALL_906_GSE20715_0H_VS_24H_OZONE_LUNG_DN",199,-1.7421,0,7.2e-05,-1.106,0.23,1,-0.8918,0.82,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2049_LEIN_ASTROCYTE_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_2049_LEIN_ASTROCYTE_MARKERS",42,-1.7419,0.0014,0.013,1.2906,0.12,0.4,1.1228,0.27,0.85
"C3_TF_targets:C3_TFT_72_V_CEBPB_01","C3_TF_targets","C3_TFT_72_V_CEBPB_01",255,-1.7418,0,0.0054,-1.0599,0.29,0.63,-0.9354,0.69,0.88
"REACTOME:187095_REACT_23891_INTERLEUKIN_RECEPTOR_SHC_SIGNALING","REACTOME","187095_REACT_23891_INTERLEUKIN_RECEPTOR_SHC_SIGNALING",28,-1.7418,0.0014,0.035,-0.8823,0.64,1,-1.2604,0.14,0.54
"GO_BP:812220_GO_0036376_SODIUM_ION_EXPORT_FROM_CELL","GO_BP","812220_GO_0036376_SODIUM_ION_EXPORT_FROM_CELL",7,-1.7417,0.0017,0.028,-1.5842,0.024,0.72,-1.6675,0.016,0.56
"GO_BP:507996_GO_0045648_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION","GO_BP","507996_GO_0045648_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION",21,-1.7417,0.0029,0.028,-1.1181,0.3,0.94,-1.1872,0.22,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2899_DORN_ADENOVIRUS_INFECTION_48HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2899_DORN_ADENOVIRUS_INFECTION_48HR_DN",37,-1.7416,0.0043,0.013,-1.4399,0.043,0.53,0.8245,0.77,1
"GO_BP:495138_GO_0014066_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING","GO_BP","495138_GO_0014066_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING",72,-1.7416,0.0026,0.028,0.7603,0.95,1,-0.8806,0.72,0.94
"WikiPathways:920955_WP1449_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY","WikiPathways","920955_WP1449_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",97,-1.7415,0.0013,0.016,-0.9486,0.56,1,-1.184,0.14,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1850_GENTILE_UV_HIGH_DOSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1850_GENTILE_UV_HIGH_DOSE_UP",25,-1.7414,0.0015,0.013,-1.028,0.44,0.98,-1.529,0.023,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_977_GROSS_ELK3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_977_GROSS_ELK3_TARGETS_DN",31,-1.7413,0.0045,0.013,1.2294,0.17,0.46,-0.9995,0.45,0.76
"KEGG_pathway:HSA04740_OLFACTORY_TRANSDUCTION","KEGG_pathway","HSA04740_OLFACTORY_TRANSDUCTION",336,-1.7411,0,0.0045,2.4514,0,0,3.4727,0,0
"C7_Immunologic_signatures:C7_ALL_1646_GSE3982_MAC_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1646_GSE3982_MAC_VS_NEUTROPHIL_DN",186,-1.741,0,7.8e-05,0.5955,1,1,-0.9273,0.68,0.9
"GO_BP:751352_GO_0038094_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY","GO_BP","751352_GO_0038094_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY",72,-1.741,0,0.028,0.5805,1,1,-1.1704,0.19,0.73
"C6_Oncogenic_signatures:C6_ALL_134_IL15_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_134_IL15_UP_V1_UP",182,-1.7408,0,0.0014,-1.0477,0.35,0.57,1.2771,0.043,0.19
"C3_TF_targets:C3_TFT_221_V_PAX4_02","C3_TF_targets","C3_TFT_221_V_PAX4_02",229,-1.7407,0,0.0051,-1.1296,0.18,0.48,-0.9765,0.49,0.81
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_51_BIOCARTA_CYTOKINE_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_51_BIOCARTA_CYTOKINE_PATHWAY",21,-1.7407,0.003,0.035,-1.5202,0.054,1,-1.6538,0.0022,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_753_XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_753_XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN",20,-1.7407,0.006,0.013,-1.2201,0.2,0.79,-1.3503,0.089,0.39
"KEGG_pathway:HSA00500_STARCH_AND_SUCROSE_METABOLISM","KEGG_pathway","HSA00500_STARCH_AND_SUCROSE_METABOLISM",54,-1.7405,0.0027,0.0045,0.7733,0.88,1,-1.3869,0.05,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_2722_CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2722_CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN",165,-1.7405,0,0.013,0.8686,0.81,0.96,1.157,0.15,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1793_BURTON_ADIPOGENESIS_2","C2_Chemical_and_genetic_perturbations","C2_CGP_1793_BURTON_ADIPOGENESIS_2",71,-1.7403,0.0027,0.013,-0.8414,0.8,1,-1.1095,0.25,0.62
"GO_BP:488735_GO_0002862_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS","GO_BP","488735_GO_0002862_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",10,-1.7403,0.0017,0.028,-1.0028,0.46,0.99,0.7169,0.84,1
"GO_BP:505272_GO_0042093_T_HELPER_CELL_DIFFERENTIATION","GO_BP","505272_GO_0042093_T_HELPER_CELL_DIFFERENTIATION",20,-1.7403,0.0015,0.028,-0.8455,0.71,1,0.7152,0.88,1
"KEGG_pathway:HSA04010_MAPK_SIGNALING_PATHWAY","KEGG_pathway","HSA04010_MAPK_SIGNALING_PATHWAY",248,-1.7399,0,0.0044,-1.5945,0,1,-1.2952,0.026,0.27
"C7_Immunologic_signatures:C7_ALL_1194_GSE27786_CD4_TCELL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1194_GSE27786_CD4_TCELL_VS_NKCELL_DN",200,-1.7396,0,7.8e-05,0.9215,0.69,0.97,-0.9343,0.65,0.88
"REACTOME:119519_REACT_19271_SEMAPHORIN_INTERACTIONS","REACTOME","119519_REACT_19271_SEMAPHORIN_INTERACTIONS",66,-1.7395,0,0.035,-0.8296,0.84,1,-1.3092,0.073,0.55
"GO_BP:754571_GO_1901615_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS","GO_BP","754571_GO_1901615_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS",491,-1.7395,0,0.028,-0.9487,0.64,1,0.9954,0.47,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_309_KIM_WT1_TARGETS_12HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_309_KIM_WT1_TARGETS_12HR_UP",159,-1.7391,0,0.013,-1.1021,0.25,0.91,-1.4081,0.018,0.35
"GO_MF:496869_GO_0017048_RHO_GTPASE_BINDING","GO_MF","496869_GO_0017048_RHO_GTPASE_BINDING",71,-1.7389,0.0013,0.059,-1.5923,0.0056,0.46,-1.026,0.39,0.77
"GO_MF:504443_GO_0035259_GLUCOCORTICOID_RECEPTOR_BINDING","GO_MF","504443_GO_0035259_GLUCOCORTICOID_RECEPTOR_BINDING",10,-1.7388,0.0016,0.058,-0.9902,0.45,0.92,-1.0006,0.45,0.79
"GO_BP:505585_GO_0042445_HORMONE_METABOLIC_PROCESS","GO_BP","505585_GO_0042445_HORMONE_METABOLIC_PROCESS",161,-1.7388,0,0.029,0.9513,0.61,1,-1.0375,0.37,0.82
"KEGG_pathway:HSA04923_REGULATION_OF_LIPOLYSIS_IN_ADIPOCYTES","KEGG_pathway","HSA04923_REGULATION_OF_LIPOLYSIS_IN_ADIPOCYTES",55,-1.7387,0,0.0045,-0.9825,0.49,0.9,-1.1742,0.18,0.41
"KEGG_compound:C02140_CORTICOSTERONE_11BETA_21_DIHYDROXY_4_PREGNENE_3_20_DIONE_KENDALL_S_COMPOUND_B_REICHSTEIN_S_SUBSTANCE_H","KEGG_compound","C02140_CORTICOSTERONE_11BETA_21_DIHYDROXY_4_PREGNENE_3_20_DIONE_KENDALL_S_COMPOUND_B_REICHSTEIN_S_SUBSTANCE_H",5,-1.7386,0,0.029,0.6985,0.82,1,-1.3163,0.17,0.35
"GO_BP:503805_GO_0034605_CELLULAR_RESPONSE_TO_HEAT","GO_BP","503805_GO_0034605_CELLULAR_RESPONSE_TO_HEAT",64,-1.7385,0,0.029,-1.183,0.18,0.91,-1.8174,0,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_218_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_218_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP",153,-1.7384,0,0.013,1.591,0,0.14,-1.3274,0.038,0.41
"GO_BP:487716_GO_0001820_SEROTONIN_SECRETION","GO_BP","487716_GO_0001820_SEROTONIN_SECRETION",5,-1.7383,0.0035,0.029,-1.2557,0.21,0.91,-1.0933,0.38,0.78
"GO_BP:753072_GO_1900076_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS","GO_BP","753072_GO_1900076_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS",52,-1.7382,0,0.029,-1.0167,0.43,0.98,-1.1002,0.29,0.77
"GO_BP:502010_GO_0032787_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS","GO_BP","502010_GO_0032787_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS",477,-1.7381,0,0.029,0.9871,0.48,0.99,-1.2997,0.0022,0.65
"REACTOME:905994_REACT_169185_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE","REACTOME","905994_REACT_169185_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE",76,-1.7381,0.0013,0.035,-1.4335,0.022,0.49,-1.5648,0.015,0.28
"GO_MF:490246_GO_0004955_PROSTAGLANDIN_RECEPTOR_ACTIVITY","GO_MF","490246_GO_0004955_PROSTAGLANDIN_RECEPTOR_ACTIVITY",9,-1.738,0.0016,0.058,1.5024,0.056,0.38,1.313,0.16,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_486_TANG_SENESCENCE_TP53_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_486_TANG_SENESCENCE_TP53_TARGETS_DN",57,-1.7379,0.0013,0.013,0.8057,0.83,0.99,-1.7676,0.0019,0.14
"GO_BP:505278_GO_0042102_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION","GO_BP","505278_GO_0042102_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION",84,-1.7378,0,0.029,-0.7277,0.94,1,-1.1911,0.16,0.74
"GO_MF:500177_GO_0030882_LIPID_ANTIGEN_BINDING","GO_MF","500177_GO_0030882_LIPID_ANTIGEN_BINDING",5,-1.7378,0.0051,0.057,-1.4098,0.094,0.66,-1.2602,0.23,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2357_LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2357_LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP",108,-1.7378,0,0.013,-1.0514,0.35,0.97,-0.9644,0.54,0.8
"GO_BP:751354_GO_0038096_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS","GO_BP","751354_GO_0038096_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS",71,-1.7375,0,0.029,0.605,1,1,-1.1784,0.19,0.74
"C7_Immunologic_signatures:C7_ALL_1244_GSE2826_XID_VS_BTK_KO_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1244_GSE2826_XID_VS_BTK_KO_BCELL_DN",197,-1.7375,0,7.8e-05,1.1885,0.095,0.25,-1.0156,0.39,0.7
"GO_MF:507666_GO_0045309_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING","GO_MF","507666_GO_0045309_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING",19,-1.7373,0.0075,0.057,0.6914,0.9,1,-0.6182,0.94,1
"REACTOME:106019_REACT_6835_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS","REACTOME","106019_REACT_6835_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS",28,-1.737,0.0087,0.035,1.038,0.38,0.69,-1.7195,0.0041,0.21
"REACTOME:106548_REACT_7963_PACKAGING_OF_TELOMERE_ENDS","REACTOME","106548_REACT_7963_PACKAGING_OF_TELOMERE_ENDS",49,-1.7369,0.0041,0.035,-1.707,0.0018,0.16,-1.6616,0,0.22
"C1_Positional:C1_ALL_176_CHR2Q23","C1_Positional","C1_ALL_176_CHR2Q23",20,-1.7368,0.0047,0.077,-1.3324,0.12,0.97,-1.3577,0.1,0.46
"GO_BP:507480_GO_0045080_POSITIVE_REGULATION_OF_CHEMOKINE_BIOSYNTHETIC_PROCESS","GO_BP","507480_GO_0045080_POSITIVE_REGULATION_OF_CHEMOKINE_BIOSYNTHETIC_PROCESS",9,-1.7365,0.0064,0.029,-1.2111,0.22,0.88,1.0389,0.4,0.82
"GO_BP:508762_GO_0046503_GLYCEROLIPID_CATABOLIC_PROCESS","GO_BP","508762_GO_0046503_GLYCEROLIPID_CATABOLIC_PROCESS",31,-1.7364,0.0029,0.029,1.0227,0.41,0.97,0.7618,0.83,1
"GO_BP:488628_GO_0002755_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","488628_GO_0002755_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",82,-1.7364,0,0.029,-0.6931,0.98,1,-1.2547,0.093,0.68
"C7_Immunologic_signatures:C7_ALL_1516_GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN","C7_Immunologic_signatures","C7_ALL_1516_GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN",193,-1.7364,0,8.1e-05,0.925,0.66,0.96,1.176,0.11,0.78
"C7_Immunologic_signatures:C7_ALL_620_GSE17721_POLYIC_VS_CPG_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_620_GSE17721_POLYIC_VS_CPG_1H_BMDM_DN",196,-1.7364,0,8e-05,-1.4251,0.0081,0.18,-1.2448,0.05,0.2
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_189_BIOCARTA_HSP27_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_189_BIOCARTA_HSP27_PATHWAY",15,-1.7364,0.0094,0.035,-1.3178,0.13,1,-1.4875,0.055,0.33
"GO_BP:491765_GO_0006910_PHAGOCYTOSIS_RECOGNITION","GO_BP","491765_GO_0006910_PHAGOCYTOSIS_RECOGNITION",11,-1.7363,0.0033,0.029,1.0241,0.42,0.97,-1.291,0.17,0.65
"GO_BP:946741_GO_1902622_REGULATION_OF_NEUTROPHIL_MIGRATION","GO_BP","946741_GO_1902622_REGULATION_OF_NEUTROPHIL_MIGRATION",24,-1.7363,0.0044,0.029,0.6719,0.93,1,-0.8613,0.66,0.96
"GO_BP:516307_GO_0071383_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS","GO_BP","516307_GO_0071383_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS",125,-1.7363,0,0.029,-1.1206,0.21,0.94,0.9873,0.48,0.87
"GO_CC:503904_GO_0034704_CALCIUM_CHANNEL_COMPLEX","GO_CC","503904_GO_0034704_CALCIUM_CHANNEL_COMPLEX",63,-1.7362,0.0013,0.044,-1.3158,0.081,0.63,-0.9131,0.61,1
"GO_BP:491076_GO_0006096_GLYCOLYTIC_PROCESS","GO_BP","491076_GO_0006096_GLYCOLYTIC_PROCESS",40,-1.7361,0.0057,0.029,-0.9465,0.56,1,-1.4557,0.027,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_2478_HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS","C2_Chemical_and_genetic_perturbations","C2_CGP_2478_HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS",79,-1.7361,0,0.014,-1.2356,0.14,0.76,0.8699,0.74,1
"KEGG_pathway:HSA03320_PPAR_SIGNALING_PATHWAY","KEGG_pathway","HSA03320_PPAR_SIGNALING_PATHWAY",67,-1.7359,0,0.0046,-0.7192,0.94,1,0.915,0.63,1
"GO_BP:491846_GO_0007015_ACTIN_FILAMENT_ORGANIZATION","GO_BP","491846_GO_0007015_ACTIN_FILAMENT_ORGANIZATION",163,-1.7358,0,0.029,-1.0772,0.3,0.95,-1.1296,0.18,0.75
"C7_Immunologic_signatures:C7_ALL_1381_GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP","C7_Immunologic_signatures","C7_ALL_1381_GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP",191,-1.7357,0,8e-05,-0.9501,0.56,1,0.9855,0.49,1
"GO_MF:505438_GO_0042287_MHC_PROTEIN_BINDING","GO_MF","505438_GO_0042287_MHC_PROTEIN_BINDING",22,-1.7356,0.0062,0.057,1.1784,0.25,0.73,-1.2802,0.14,0.59
"C7_Immunologic_signatures:C7_ALL_1659_GSE3982_MAC_VS_TH2_UP","C7_Immunologic_signatures","C7_ALL_1659_GSE3982_MAC_VS_TH2_UP",199,-1.7351,0,8e-05,0.8033,0.97,1,-0.7745,0.98,1
"GO_MF:495539_GO_0015295_SOLUTE_PROTON_SYMPORTER_ACTIVITY","GO_MF","495539_GO_0015295_SOLUTE_PROTON_SYMPORTER_ACTIVITY",17,-1.7347,0.0031,0.057,-1.0345,0.41,0.87,-1.1263,0.29,0.68
"WikiPathways:198819_WP26_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR","WikiPathways","198819_WP26_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR",24,-1.7347,0.006,0.016,-1.0512,0.38,0.98,-1.3792,0.069,0.38
"GO_BP:987840_GO_1903039_POSITIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION","GO_BP","987840_GO_1903039_POSITIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION",185,-1.7347,0,0.029,0.9039,0.73,1,-1.0851,0.24,0.79
"GO_BP:507997_GO_0045649_REGULATION_OF_MACROPHAGE_DIFFERENTIATION","GO_BP","507997_GO_0045649_REGULATION_OF_MACROPHAGE_DIFFERENTIATION",20,-1.7346,0.0044,0.029,-0.6105,0.96,1,-0.9407,0.54,0.89
"C3_TF_targets:C3_TFT_300_V_STAT5A_03","C3_TF_targets","C3_TFT_300_V_STAT5A_03",250,-1.7345,0,0.0052,-1.0062,0.42,0.75,-1.0861,0.22,0.58
"GO_BP:499327_GO_0022409_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION","GO_BP","499327_GO_0022409_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION",217,-1.7344,0,0.029,1.0194,0.4,0.97,-0.9999,0.45,0.85
"GO_BP:516150_GO_0071224_CELLULAR_RESPONSE_TO_PEPTIDOGLYCAN","GO_BP","516150_GO_0071224_CELLULAR_RESPONSE_TO_PEPTIDOGLYCAN",5,-1.7344,0.0036,0.029,-0.8888,0.6,1,-0.4839,0.98,1
"GO_BP:753356_GO_1900372_NEGATIVE_REGULATION_OF_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","753356_GO_1900372_NEGATIVE_REGULATION_OF_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",40,-1.7343,0.0056,0.029,0.9277,0.6,1,1.5909,0.012,0.44
"WikiPathways:198765_WP117_GPCRS_OTHER","WikiPathways","198765_WP117_GPCRS_OTHER",88,-1.734,0,0.016,1.3711,0.04,0.54,1.554,0,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_3205_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3205_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP",269,-1.734,0.0011,0.014,-1.1762,0.098,0.82,-1.0342,0.35,0.71
"GO_BP:502418_GO_0033198_RESPONSE_TO_ATP","GO_BP","502418_GO_0033198_RESPONSE_TO_ATP",25,-1.7339,0.0015,0.029,-0.7086,0.9,1,-0.9448,0.53,0.89
"C7_Immunologic_signatures:C7_ALL_1182_GSE27786_BCELL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1182_GSE27786_BCELL_VS_NKCELL_DN",198,-1.7339,0,9.2e-05,0.6509,1,1,-1.259,0.046,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_3242_SERVITJA_ISLET_HNF1A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3242_SERVITJA_ISLET_HNF1A_TARGETS_UP",153,-1.7337,0,0.014,1.2035,0.12,0.48,1.2744,0.057,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_2798_SEIKE_LUNG_CANCER_POOR_SURVIVAL","C2_Chemical_and_genetic_perturbations","C2_CGP_2798_SEIKE_LUNG_CANCER_POOR_SURVIVAL",10,-1.7337,0.0048,0.014,-1.4605,0.089,0.52,-1.1563,0.28,0.57
"REACTOME:106065_REACT_12560_BASIGIN_INTERACTIONS","REACTOME","106065_REACT_12560_BASIGIN_INTERACTIONS",25,-1.7337,0.0046,0.036,-1.4643,0.042,0.47,0.8317,0.72,1
"GO_MF:500179_GO_0030884_EXOGENOUS_LIPID_ANTIGEN_BINDING","GO_MF","500179_GO_0030884_EXOGENOUS_LIPID_ANTIGEN_BINDING",5,-1.7336,0.0018,0.057,-1.4285,0.078,0.65,-1.297,0.17,0.58
"REACTOME:106152_REACT_11036_GLUCOCORTICOID_BIOSYNTHESIS","REACTOME","106152_REACT_11036_GLUCOCORTICOID_BIOSYNTHESIS",8,-1.7336,0.014,0.036,0.8022,0.73,0.99,0.9135,0.56,1
"KEGG_pathway:HSA04144_ENDOCYTOSIS","KEGG_pathway","HSA04144_ENDOCYTOSIS",213,-1.7335,0,0.0046,-0.9629,0.54,0.93,-1.0865,0.25,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1884_BURTON_ADIPOGENESIS_PEAK_AT_0HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1884_BURTON_ADIPOGENESIS_PEAK_AT_0HR",62,-1.7335,0.0013,0.014,-0.7405,0.92,1,-1.3261,0.062,0.41
"C4_Cancer_modules:C4_CM_405_MODULE_521","C4_Cancer_modules","C4_CM_405_MODULE_521",35,-1.7333,0.0015,0.01,-1.0812,0.33,0.69,-0.7695,0.83,0.99
"GO_BP:499618_GO_0030208_DERMATAN_SULFATE_BIOSYNTHETIC_PROCESS","GO_BP","499618_GO_0030208_DERMATAN_SULFATE_BIOSYNTHETIC_PROCESS",11,-1.7332,0.0097,0.03,-1.2053,0.24,0.89,0.5706,0.97,1
"C3_TF_targets:C3_TFT_603_RGAGGAARY_V_PU1_Q6","C3_TF_targets","C3_TFT_603_RGAGGAARY_V_PU1_Q6",497,-1.7332,0,0.0051,-0.9954,0.48,0.76,-0.9499,0.65,0.85
"C6_Oncogenic_signatures:C6_ALL_28_AKT_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_28_AKT_UP_V1_UP",154,-1.7332,0,0.0016,-0.9249,0.65,0.84,-1.0882,0.22,0.5
"GO_BP:1129450_GO_1903624_REGULATION_OF_DNA_CATABOLIC_PROCESS","GO_BP","1129450_GO_1903624_REGULATION_OF_DNA_CATABOLIC_PROCESS",11,-1.733,0.0068,0.03,0.8398,0.69,1,-1.6199,0.028,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_2268_SMID_BREAST_CANCER_LUMINAL_A_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2268_SMID_BREAST_CANCER_LUMINAL_A_UP",82,-1.7328,0.0013,0.014,0.936,0.59,0.89,-1.1345,0.22,0.59
"GO_BP:750851_GO_0035924_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS","GO_BP","750851_GO_0035924_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS",27,-1.7326,0.003,0.03,-1.3642,0.083,0.98,-1.214,0.21,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_3284_WANG_MLL_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3284_WANG_MLL_TARGETS",279,-1.7323,0,0.014,0.9751,0.52,0.83,1.2011,0.057,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_211_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_211_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP",18,-1.7322,0.0044,0.014,-1.1376,0.29,0.86,-0.7379,0.83,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2144_CLAUS_PGR_POSITIVE_MENINGIOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2144_CLAUS_PGR_POSITIVE_MENINGIOMA_UP",10,-1.7319,0.0065,0.014,1.3547,0.12,0.34,-0.7041,0.86,0.99
"GO_BP:495830_GO_0015695_ORGANIC_CATION_TRANSPORT","GO_BP","495830_GO_0015695_ORGANIC_CATION_TRANSPORT",15,-1.7317,0.0094,0.03,-1.2155,0.25,0.88,-1.6039,0.016,0.51
"GO_BP:491987_GO_0007187_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER","GO_BP","491987_GO_0007187_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER",164,-1.7314,0,0.03,1.2091,0.083,0.78,1.2275,0.077,0.71
"C1_Positional:C1_ALL_276_CHR6P22","C1_Positional","C1_ALL_276_CHR6P22",105,-1.7314,0,0.074,-1.6311,0.0018,0.55,-1.4237,0.019,0.72
"REACTOME:1127684_REACT_263923_HDACS_DEACETYLATE_HISTONES","REACTOME","1127684_REACT_263923_HDACS_DEACETYLATE_HISTONES",91,-1.7313,0.0013,0.036,-2.0256,0,0.033,-1.2952,0.072,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_2203_POS_RESPONSE_TO_HISTAMINE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2203_POS_RESPONSE_TO_HISTAMINE_UP",13,-1.7311,0.012,0.014,-1.0482,0.37,0.97,0.8523,0.69,1
"GO_BP:499434_GO_0050852_T_CELL_RECEPTOR_SIGNALING_PATHWAY","GO_BP","499434_GO_0050852_T_CELL_RECEPTOR_SIGNALING_PATHWAY",93,-1.731,0,0.03,0.8955,0.73,1,-1.4566,0.015,0.54
"GO_BP:512748_GO_0051893_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY","GO_BP","512748_GO_0051893_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY",40,-1.731,0.0014,0.03,-1.3645,0.081,0.98,0.8679,0.66,0.97
"GO_BP:512751_GO_0051896_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING","GO_BP","512751_GO_0051896_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING",116,-1.731,0,0.03,-0.7638,0.94,1,0.8895,0.74,0.95
"C4_Cancer_modules:C4_CM_357_MODULE_431","C4_Cancer_modules","C4_CM_357_MODULE_431",14,-1.731,0.011,0.011,-0.9353,0.55,0.89,-1.6276,0.013,0.11
"REACTOME:106398_REACT_6894_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE","REACTOME","106398_REACT_6894_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE",122,-1.7309,0,0.036,-0.6786,0.99,1,-1.1708,0.14,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1170_SHIN_B_CELL_LYMPHOMA_CLUSTER_8","C2_Chemical_and_genetic_perturbations","C2_CGP_1170_SHIN_B_CELL_LYMPHOMA_CLUSTER_8",35,-1.7308,0.0043,0.014,-0.7724,0.82,1,-0.9236,0.58,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_522_LUCAS_HNF4A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_522_LUCAS_HNF4A_TARGETS_UP",57,-1.7304,0.0014,0.014,-0.8225,0.79,1,-0.9698,0.49,0.8
"REACTOME:161003_REACT_22205_L1CAM_INTERACTIONS","REACTOME","161003_REACT_22205_L1CAM_INTERACTIONS",97,-1.7302,0,0.036,-1.1274,0.22,0.89,-1.043,0.35,0.79
"KEGG_pathway:HSA04918_THYROID_HORMONE_SYNTHESIS","KEGG_pathway","HSA04918_THYROID_HORMONE_SYNTHESIS",71,-1.7301,0.0013,0.0047,-1.3688,0.05,0.34,-1.359,0.048,0.2
"GO_BP:492558_GO_0008217_REGULATION_OF_BLOOD_PRESSURE","GO_BP","492558_GO_0008217_REGULATION_OF_BLOOD_PRESSURE",159,-1.7301,0,0.03,-1.0314,0.36,0.98,1.1311,0.18,0.74
"KEGG_compound:C16453_4_N_NITROSOMETHYLAMINO_1_3_PYRIDYL_1_BUTANONE_NNK","KEGG_compound","C16453_4_N_NITROSOMETHYLAMINO_1_3_PYRIDYL_1_BUTANONE_NNK",12,-1.7298,0.0048,0.032,-1.3319,0.13,0.58,-1.1898,0.26,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_3361_LIM_MAMMARY_STEM_CELL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3361_LIM_MAMMARY_STEM_CELL_UP",481,-1.7296,0,0.014,-1.0849,0.2,0.94,1.1033,0.14,0.88
"C4_Cancer_modules:C4_CM_89_MODULE_94","C4_Cancer_modules","C4_CM_89_MODULE_94",358,-1.7296,0,0.011,-1.0605,0.27,0.72,-1.259,0.022,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_2141_HELLER_HDAC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2141_HELLER_HDAC_TARGETS_DN",284,-1.7295,0,0.014,0.795,0.99,0.99,-1.3178,0.013,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1733_BROWNE_HCMV_INFECTION_20HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1733_BROWNE_HCMV_INFECTION_20HR_DN",99,-1.7293,0,0.014,-0.8864,0.71,1,-1.2493,0.091,0.47
"GO_BP:500108_GO_0030809_NEGATIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","500108_GO_0030809_NEGATIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",40,-1.7293,0.0014,0.03,0.9189,0.57,1,1.613,0.006,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1474_MATSUDA_NATURAL_KILLER_DIFFERENTIATION","C2_Chemical_and_genetic_perturbations","C2_CGP_1474_MATSUDA_NATURAL_KILLER_DIFFERENTIATION",471,-1.7293,0,0.014,1.0804,0.2,0.66,-0.8166,0.99,0.94
"GO_BP:508689_GO_0046427_POSITIVE_REGULATION_OF_JAK_STAT_CASCADE","GO_BP","508689_GO_0046427_POSITIVE_REGULATION_OF_JAK_STAT_CASCADE",63,-1.7292,0.0026,0.03,-1.5422,0.0055,0.74,-1.3427,0.05,0.61
"C7_Immunologic_signatures:C7_ALL_1509_GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP","C7_Immunologic_signatures","C7_ALL_1509_GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP",199,-1.7291,0,9.5e-05,-0.9313,0.67,1,-1.1595,0.14,0.35
"GO_BP:519122_GO_2000482_REGULATION_OF_INTERLEUKIN_8_SECRETION","GO_BP","519122_GO_2000482_REGULATION_OF_INTERLEUKIN_8_SECRETION",13,-1.729,0.0062,0.03,1.3152,0.15,0.65,1.3495,0.1,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_593_MUELLER_METHYLATED_IN_GLIOBLASTOMA","C2_Chemical_and_genetic_perturbations","C2_CGP_593_MUELLER_METHYLATED_IN_GLIOBLASTOMA",36,-1.7289,0,0.014,1.009,0.41,0.78,-1.4522,0.032,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_1772_RHODES_UNDIFFERENTIATED_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_1772_RHODES_UNDIFFERENTIATED_CANCER",69,-1.7289,0,0.014,1.5713,0,0.16,-1.6687,0.002,0.21
"C7_Immunologic_signatures:C7_ALL_1484_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN","C7_Immunologic_signatures","C7_ALL_1484_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN",197,-1.7288,0,9.8e-05,0.827,0.91,1,-1.0419,0.35,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_3314_PHONG_TNF_RESPONSE_NOT_VIA_P38","C2_Chemical_and_genetic_perturbations","C2_CGP_3314_PHONG_TNF_RESPONSE_NOT_VIA_P38",336,-1.7288,0,0.014,-1.0032,0.45,1,-0.9991,0.47,0.76
"WikiPathways:198851_WP727_MONOAMINE_TRANSPORT","WikiPathways","198851_WP727_MONOAMINE_TRANSPORT",32,-1.7285,0.0045,0.017,-0.8268,0.78,1,1.1423,0.26,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_490_WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_490_WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN",101,-1.7285,0,0.014,0.9475,0.57,0.87,-0.9351,0.6,0.84
"C4_Cancer_modules:C4_CM_381_MODULE_474","C4_Cancer_modules","C4_CM_381_MODULE_474",16,-1.7285,0.0015,0.011,1.1003,0.31,0.54,0.9764,0.48,0.97
"GO_BP:751040_GO_0036120_CELLULAR_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR_STIMULUS","GO_BP","751040_GO_0036120_CELLULAR_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR_STIMULUS",9,-1.7285,0.0016,0.031,1.4317,0.1,0.52,1.0292,0.41,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_167_WIKMAN_ASBESTOS_LUNG_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_167_WIKMAN_ASBESTOS_LUNG_CANCER_DN",27,-1.7285,0,0.014,0.6804,0.94,1,-1.2191,0.19,0.5
"C2_Chemical_and_genetic_perturbations:C2_CGP_1912_LY_AGING_OLD_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1912_LY_AGING_OLD_DN",56,-1.7284,0.0027,0.014,1.342,0.063,0.35,-1.3842,0.054,0.37
"C7_Immunologic_signatures:C7_ALL_1337_GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1337_GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP",197,-1.7284,0,9.8e-05,0.7875,0.97,1,-1.8441,0,9.2e-05
"C2_Chemical_and_genetic_perturbations:C2_CGP_1056_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1056_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN",101,-1.7283,0.0012,0.014,-1.1192,0.24,0.89,1.2991,0.068,0.69
"GO_MF:490271_GO_0004984_OLFACTORY_RECEPTOR_ACTIVITY","GO_MF","490271_GO_0004984_OLFACTORY_RECEPTOR_ACTIVITY",311,-1.7278,0,0.061,2.4604,0,0.00036,3.6837,0,0
"C7_Immunologic_signatures:C7_ALL_1083_GSE25087_TREG_VS_TCONV_FETUS_UP","C7_Immunologic_signatures","C7_ALL_1083_GSE25087_TREG_VS_TCONV_FETUS_UP",197,-1.7276,0,9.8e-05,0.7781,0.98,1,-1.071,0.28,0.57
"GO_BP:508012_GO_0045664_REGULATION_OF_NEURON_DIFFERENTIATION","GO_BP","508012_GO_0045664_REGULATION_OF_NEURON_DIFFERENTIATION",420,-1.7275,0,0.031,-1.1849,0.065,0.91,1.0192,0.39,0.84
"C4_Cancer_modules:C4_CM_391_MODULE_492","C4_Cancer_modules","C4_CM_391_MODULE_492",16,-1.7274,0.0079,0.011,-0.6461,0.93,1,-1.0737,0.35,0.57
"REACTOME:119559_REACT_19397_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES","REACTOME","119559_REACT_19397_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES",95,-1.7274,0,0.037,-1.0909,0.3,0.91,-1.1107,0.25,0.69
"C6_Oncogenic_signatures:C6_ALL_106_BMI1_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_106_BMI1_DN_V1_UP",144,-1.7269,0,0.0018,-1.3246,0.037,0.4,1.5779,0,0.041
"C6_Oncogenic_signatures:C6_ALL_97_ESC_V6_5_UP_EARLY_V1_DN","C6_Oncogenic_signatures","C6_ALL_97_ESC_V6_5_UP_EARLY_V1_DN",150,-1.7267,0,0.0017,-1.0098,0.43,0.66,1.1383,0.18,0.35
"GO_BP:491968_GO_0007163_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY","GO_BP","491968_GO_0007163_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY",128,-1.7266,0,0.031,-0.9461,0.59,1,-1.5941,0.0021,0.51
"WikiPathways:198845_WP481_INSULIN_SIGNALING","WikiPathways","198845_WP481_INSULIN_SIGNALING",162,-1.7265,0,0.016,-1.0441,0.36,0.96,-1.2848,0.043,0.44
"C2_Chemical_and_genetic_perturbations:C2_CGP_2385_LU_TUMOR_ENDOTHELIAL_MARKERS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2385_LU_TUMOR_ENDOTHELIAL_MARKERS_UP",22,-1.7265,0.0015,0.014,1.3103,0.12,0.38,0.8558,0.65,1
"GO_MF:500178_GO_0030883_ENDOGENOUS_LIPID_ANTIGEN_BINDING","GO_MF","500178_GO_0030883_ENDOGENOUS_LIPID_ANTIGEN_BINDING",5,-1.7263,0.0034,0.061,-1.4099,0.11,0.66,-1.2804,0.19,0.6
"GO_BP:1022134_GO_0099587_INORGANIC_ION_IMPORT_INTO_CELL","GO_BP","1022134_GO_0099587_INORGANIC_ION_IMPORT_INTO_CELL",12,-1.7262,0.0081,0.031,-1.2249,0.2,0.88,-0.843,0.67,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1443_ABBUD_LIF_SIGNALING_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1443_ABBUD_LIF_SIGNALING_1_DN",26,-1.7261,0.0044,0.015,-0.9872,0.47,1,-1.3364,0.12,0.41
"C4_Cancer_modules:C4_CM_343_MODULE_411","C4_Cancer_modules","C4_CM_343_MODULE_411",78,-1.7261,0,0.011,-1.1457,0.22,0.62,0.7632,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_126_LIU_CMYB_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_126_LIU_CMYB_TARGETS_UP",163,-1.7259,0,0.015,-0.7162,0.99,1,-1.1276,0.2,0.6
"GO_BP:512149_GO_0051258_PROTEIN_POLYMERIZATION","GO_BP","512149_GO_0051258_PROTEIN_POLYMERIZATION",84,-1.7258,0,0.031,0.8353,0.83,1,-1.5301,0.008,0.53
"GO_CC:507495_GO_0045095_KERATIN_FILAMENT","GO_CC","507495_GO_0045095_KERATIN_FILAMENT",56,-1.7258,0.0013,0.049,0.9682,0.52,0.82,1.7372,0,0.24
"GO_BP:755339_GO_2001233_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","755339_GO_2001233_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY",369,-1.7257,0,0.031,0.8635,0.92,1,-1.0051,0.42,0.84
"GO_BP:498798_GO_0021514_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION","GO_BP","498798_GO_0021514_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION",15,-1.7252,0.0077,0.031,-1.6011,0.029,0.7,0.9332,0.55,0.92
"GO_BP:518795_GO_2000147_POSITIVE_REGULATION_OF_CELL_MOTILITY","GO_BP","518795_GO_2000147_POSITIVE_REGULATION_OF_CELL_MOTILITY",317,-1.7251,0,0.031,1.0653,0.23,0.93,1.0908,0.2,0.77
"C4_Cancer_modules:C4_CM_75_MODULE_80","C4_Cancer_modules","C4_CM_75_MODULE_80",32,-1.725,0.0028,0.011,-0.8397,0.7,0.96,-1.4647,0.039,0.18
"GO_BP:501893_GO_0032667_REGULATION_OF_INTERLEUKIN_23_PRODUCTION","GO_BP","501893_GO_0032667_REGULATION_OF_INTERLEUKIN_23_PRODUCTION",7,-1.725,0.007,0.031,-1.0807,0.36,0.95,-1.1896,0.28,0.74
"GO_BP:500113_GO_0030814_REGULATION_OF_CAMP_METABOLIC_PROCESS","GO_BP","500113_GO_0030814_REGULATION_OF_CAMP_METABOLIC_PROCESS",128,-1.7249,0,0.031,0.9512,0.56,1,1.3144,0.042,0.66
"GO_BP:498220_GO_0019377_GLYCOLIPID_CATABOLIC_PROCESS","GO_BP","498220_GO_0019377_GLYCOLIPID_CATABOLIC_PROCESS",11,-1.7248,0.0033,0.031,-0.9103,0.58,1,-0.8131,0.72,0.98
"GO_BP:518578_GO_0097028_DENDRITIC_CELL_DIFFERENTIATION","GO_BP","518578_GO_0097028_DENDRITIC_CELL_DIFFERENTIATION",32,-1.7247,0,0.031,-1.4813,0.041,0.84,-1.0829,0.31,0.79
"C0_Hallmark:H_ALL_16_HALLMARK_MYOGENESIS","C0_Hallmark","H_ALL_16_HALLMARK_MYOGENESIS",197,-1.7247,0,0.00097,-1.6186,0,0.028,-1.557,0,0.02
"C2_Chemical_and_genetic_perturbations:C2_CGP_646_RASHI_RESPONSE_TO_IONIZING_RADIATION_2","C2_Chemical_and_genetic_perturbations","C2_CGP_646_RASHI_RESPONSE_TO_IONIZING_RADIATION_2",125,-1.7246,0,0.015,-0.9917,0.44,1,0.7782,0.95,1
"REACTOME:477132_REACT_111155_CELL_CELL_COMMUNICATION","REACTOME","477132_REACT_111155_CELL_CELL_COMMUNICATION",129,-1.7246,0,0.038,-1.0924,0.26,0.91,-1.1492,0.14,0.66
"GO_BP:511662_GO_0050690_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_VIRUS","GO_BP","511662_GO_0050690_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_VIRUS",29,-1.7241,0.0088,0.032,1.1393,0.27,0.85,-1.6567,0.011,0.53
"C7_Immunologic_signatures:C7_ALL_775_GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_775_GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP",194,-1.7241,0,1e-04,-0.9135,0.72,1,-1.2368,0.066,0.21
"REACTOME:106371_REACT_18425_PROSTANOID_LIGAND_RECEPTORS","REACTOME","106371_REACT_18425_PROSTANOID_LIGAND_RECEPTORS",9,-1.724,0.0068,0.037,-0.9849,0.46,1,-1.304,0.15,0.55
"C7_Immunologic_signatures:C7_ALL_1419_GSE360_CTRL_VS_L_DONOVANI_MAC_UP","C7_Immunologic_signatures","C7_ALL_1419_GSE360_CTRL_VS_L_DONOVANI_MAC_UP",199,-1.7238,0,0.00011,0.7839,0.96,1,-0.9422,0.6,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_2649_ZHAN_EARLY_DIFFERENTIATION_GENES_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2649_ZHAN_EARLY_DIFFERENTIATION_GENES_UP",7,-1.7236,0.0069,0.015,0.9192,0.55,0.9,-0.7395,0.78,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_1980_VERRECCHIA_RESPONSE_TO_TGFB1_C3","C2_Chemical_and_genetic_perturbations","C2_CGP_1980_VERRECCHIA_RESPONSE_TO_TGFB1_C3",14,-1.7235,0.0063,0.015,0.7385,0.81,1,1.801,0,0.2
"GO_BP:491817_GO_0006979_RESPONSE_TO_OXIDATIVE_STRESS","GO_BP","491817_GO_0006979_RESPONSE_TO_OXIDATIVE_STRESS",312,-1.7234,0,0.032,-0.9034,0.76,1,-1.4686,0.0021,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_255_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_255_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN",54,-1.7232,0.0013,0.015,1.0065,0.46,0.79,-1.1167,0.25,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_846_LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_846_LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP",81,-1.7231,0,0.015,0.6105,1,1,1.5471,0.013,0.45
"GO_BP:491480_GO_0006584_CATECHOLAMINE_METABOLIC_PROCESS","GO_BP","491480_GO_0006584_CATECHOLAMINE_METABOLIC_PROCESS",42,-1.7229,0.0028,0.032,-0.9457,0.55,1,-1.5742,0.0059,0.53
"GO_BP:508739_GO_0046479_GLYCOSPHINGOLIPID_CATABOLIC_PROCESS","GO_BP","508739_GO_0046479_GLYCOSPHINGOLIPID_CATABOLIC_PROCESS",11,-1.7229,0.0098,0.032,-0.8787,0.59,1,-0.8198,0.69,0.97
"GO_BP:500839_GO_0031589_CELL_SUBSTRATE_ADHESION","GO_BP","500839_GO_0031589_CELL_SUBSTRATE_ADHESION",158,-1.7228,0,0.032,-1.0304,0.38,0.98,1.1296,0.17,0.74
"REACTOME:105911_REACT_1383_GLYCOLYSIS","REACTOME","105911_REACT_1383_GLYCOLYSIS",31,-1.7228,0.0029,0.038,-1.0571,0.38,0.93,-1.3087,0.11,0.55
"GO_BP:499488_GO_0030029_ACTIN_FILAMENT_BASED_PROCESS","GO_BP","499488_GO_0030029_ACTIN_FILAMENT_BASED_PROCESS",417,-1.7228,0,0.032,-1.0941,0.18,0.95,-1.0968,0.18,0.78
"GO_MF:489956_GO_0047498_CALCIUM_DEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY","GO_MF","489956_GO_0047498_CALCIUM_DEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY",8,-1.7226,0.01,0.062,-1.081,0.35,0.85,-1.0639,0.37,0.74
"C7_Immunologic_signatures:C7_ALL_836_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN","C7_Immunologic_signatures","C7_ALL_836_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN",175,-1.7225,0,0.00011,-1.3182,0.037,0.42,-0.9367,0.64,0.88
"GO_BP:518889_GO_2000242_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS","GO_BP","518889_GO_2000242_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS",95,-1.7223,0.0013,0.032,1.2671,0.075,0.71,-1.4023,0.032,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_2201_BIERIE_INFLAMMATORY_RESPONSE_TGFB1","C2_Chemical_and_genetic_perturbations","C2_CGP_2201_BIERIE_INFLAMMATORY_RESPONSE_TGFB1",5,-1.7223,0.0018,0.015,-1.1977,0.27,0.8,0.7442,0.76,1
"REACTOME:160966_REACT_20676_CELL_JUNCTION_ORGANIZATION","REACTOME","160966_REACT_20676_CELL_JUNCTION_ORGANIZATION",84,-1.722,0.0013,0.038,-1.0446,0.36,0.95,1.2985,0.08,0.75
"C3_TF_targets:C3_TFT_4_V_E47_01","C3_TF_targets","C3_TFT_4_V_E47_01",249,-1.7218,0,0.0061,-1.6287,0,0.15,-1.3053,0.019,0.24
"C7_Immunologic_signatures:C7_ALL_1807_GSE7852_TREG_VS_TCONV_LN_UP","C7_Immunologic_signatures","C7_ALL_1807_GSE7852_TREG_VS_TCONV_LN_UP",200,-1.7218,0,0.00011,-0.9227,0.69,1,-1.1703,0.13,0.34
"GO_BP:500136_GO_0030838_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION","GO_BP","500136_GO_0030838_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION",63,-1.7218,0.0013,0.032,-0.7944,0.84,1,-1.2319,0.14,0.7
"GO_BP:1129311_GO_0098754_DETOXIFICATION","GO_BP","1129311_GO_0098754_DETOXIFICATION",12,-1.7215,0.011,0.032,-1.0499,0.39,0.97,-1.572,0.044,0.53
"GO_CC:498675_GO_0019897_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE","GO_CC","498675_GO_0019897_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE",130,-1.7215,0,0.05,-1.1982,0.11,0.7,-1.1159,0.22,0.89
"GO_BP:516277_GO_0071353_CELLULAR_RESPONSE_TO_INTERLEUKIN_4","GO_BP","516277_GO_0071353_CELLULAR_RESPONSE_TO_INTERLEUKIN_4",26,-1.7214,0.0044,0.032,0.9521,0.56,1,-1.6488,0.016,0.52
"C4_Cancer_modules:C4_CM_239_MODULE_265","C4_Cancer_modules","C4_CM_239_MODULE_265",29,-1.7214,0.012,0.011,1.3818,0.075,0.2,1.5895,0.02,0.18
"C7_Immunologic_signatures:C7_ALL_956_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN","C7_Immunologic_signatures","C7_ALL_956_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN",187,-1.7214,0,0.00012,-0.7411,0.98,1,-0.9789,0.52,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1534_THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1534_THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN",225,-1.7213,0,0.015,0.8399,0.94,0.98,-1.4326,0.0062,0.34
"GO_BP:494687_GO_0010623_DEVELOPMENTAL_PROGRAMMED_CELL_DEATH","GO_BP","494687_GO_0010623_DEVELOPMENTAL_PROGRAMMED_CELL_DEATH",28,-1.7212,0.0072,0.032,-1.4075,0.053,0.97,-1.3494,0.11,0.6
"C0_Hallmark:H_ALL_36_HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY","C0_Hallmark","H_ALL_36_HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY",49,-1.721,0.0014,0.00097,0.8031,0.8,1,-1.3689,0.058,0.078
"C7_Immunologic_signatures:C7_ALL_1833_GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP","C7_Immunologic_signatures","C7_ALL_1833_GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP",198,-1.7209,0,0.00012,-0.9975,0.45,1,-0.9557,0.56,0.83
"GO_MF:492384_GO_0008009_CHEMOKINE_ACTIVITY","GO_MF","492384_GO_0008009_CHEMOKINE_ACTIVITY",39,-1.7209,0.0028,0.063,1.5587,0.0067,0.33,1.1991,0.19,0.72
"GO_BP:501837_GO_0032611_INTERLEUKIN_1_BETA_PRODUCTION","GO_BP","501837_GO_0032611_INTERLEUKIN_1_BETA_PRODUCTION",11,-1.7208,0.013,0.032,-0.6814,0.86,1,-0.6236,0.93,1
"GO_CC:501813_GO_0032587_RUFFLE_MEMBRANE","GO_CC","501813_GO_0032587_RUFFLE_MEMBRANE",76,-1.7207,0,0.049,0.6211,1,1,0.7729,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2520_MARSHALL_VIRAL_INFECTION_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2520_MARSHALL_VIRAL_INFECTION_RESPONSE_DN",29,-1.7206,0.0015,0.015,0.7219,0.89,1,-1.3067,0.12,0.42
"GO_BP:491553_GO_0006665_SPHINGOLIPID_METABOLIC_PROCESS","GO_BP","491553_GO_0006665_SPHINGOLIPID_METABOLIC_PROCESS",125,-1.7206,0,0.032,-0.8079,0.89,1,0.9234,0.63,0.92
"GO_BP:504544_GO_0035360_POSITIVE_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY","GO_BP","504544_GO_0035360_POSITIVE_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY",6,-1.7205,0.0034,0.032,-1.5042,0.06,0.82,-1.6242,0.029,0.51
"GO_BP:507279_GO_0044272_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","507279_GO_0044272_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS",166,-1.7204,0,0.032,-0.9786,0.51,1,-1.4638,0.0061,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1162_SUNG_METASTASIS_STROMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1162_SUNG_METASTASIS_STROMA_UP",108,-1.7204,0,0.015,-1.2571,0.086,0.74,-1.0715,0.3,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_614_MAHADEVAN_RESPONSE_TO_MP470_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_614_MAHADEVAN_RESPONSE_TO_MP470_DN",19,-1.7204,0.011,0.015,-1.4032,0.085,0.58,-1.3894,0.081,0.36
"GO_BP:755344_GO_2001238_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","755344_GO_2001238_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",57,-1.7203,0.0014,0.032,0.6521,0.99,1,-0.7344,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1785_BURTON_ADIPOGENESIS_3","C2_Chemical_and_genetic_perturbations","C2_CGP_1785_BURTON_ADIPOGENESIS_3",100,-1.7202,0,0.015,0.7716,0.93,1,-1.6936,0,0.19
"C2_Chemical_and_genetic_perturbations:C2_CGP_2516_LINDSTEDT_DENDRITIC_CELL_MATURATION_B","C2_Chemical_and_genetic_perturbations","C2_CGP_2516_LINDSTEDT_DENDRITIC_CELL_MATURATION_B",53,-1.7201,0.0014,0.015,-0.6454,0.96,1,-0.7009,0.96,0.99
"GO_BP:511847_GO_0050911_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SMELL","GO_BP","511847_GO_0050911_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SMELL",311,-1.72,0,0.032,2.4734,0,0,3.7082,0,0
"GO_BP:492273_GO_0007520_MYOBLAST_FUSION","GO_BP","492273_GO_0007520_MYOBLAST_FUSION",18,-1.7198,0.011,0.032,-1.6302,0.014,0.7,-1.4199,0.083,0.57
"GO_BP:500153_GO_0030855_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","500153_GO_0030855_EPITHELIAL_CELL_DIFFERENTIATION",481,-1.7198,0,0.032,0.9952,0.48,0.98,1.019,0.38,0.83
"KEGG_pathway:HSA05202_TRANSCRIPTIONAL_MISREGULATION_IN_CANCER","KEGG_pathway","HSA05202_TRANSCRIPTIONAL_MISREGULATION_IN_CANCER",174,-1.7197,0,0.0054,-0.9137,0.68,0.97,-1.093,0.24,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2846_BOYLAN_MULTIPLE_MYELOMA_PCA3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2846_BOYLAN_MULTIPLE_MYELOMA_PCA3_DN",69,-1.7196,0,0.015,0.9183,0.59,0.9,-1.0107,0.43,0.74
"GO_BP:508725_GO_0046464_ACYLGLYCEROL_CATABOLIC_PROCESS","GO_BP","508725_GO_0046464_ACYLGLYCEROL_CATABOLIC_PROCESS",24,-1.7194,0.0063,0.032,1.1294,0.29,0.87,0.7447,0.85,1
"GO_BP:494881_GO_0010817_REGULATION_OF_HORMONE_LEVELS","GO_BP","494881_GO_0010817_REGULATION_OF_HORMONE_LEVELS",237,-1.719,0,0.033,1.0514,0.31,0.95,1.0891,0.23,0.77
"C4_Cancer_gene_neighborhoods:C4_CGN_415_GNF2_STAT6","C4_Cancer_gene_neighborhoods","C4_CGN_415_GNF2_STAT6",79,-1.7189,0.0026,0.0067,1.6484,0.0022,0.0099,-0.8533,0.81,1
"GO_BP:488693_GO_0002820_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE","GO_BP","488693_GO_0002820_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE",30,-1.7188,0.0058,0.033,-0.7745,0.83,1,-0.8951,0.63,0.93
"GO_BP:501383_GO_0032147_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY","GO_BP","501383_GO_0032147_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY",260,-1.7188,0,0.032,0.8222,0.95,1,0.9182,0.74,0.93
"KEGG_module:HSA_M00087_BETA_OXIDATION","KEGG_module","HSA_M00087_BETA_OXIDATION",12,-1.7186,0.0065,0.12,0.5872,0.95,1,-1.6204,0.024,0.22
"GO_BP:505668_GO_0042537_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","505668_GO_0042537_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS",26,-1.7185,0.0058,0.033,-1.4775,0.038,0.84,-1.5471,0.04,0.52
"GO_BP:518170_GO_0090023_POSITIVE_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS","GO_BP","518170_GO_0090023_POSITIVE_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS",17,-1.7183,0.0091,0.033,0.8102,0.77,1,-1.0997,0.32,0.78
"C7_Immunologic_signatures:C7_ALL_32_GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_32_GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN",198,-1.7181,0,0.00012,0.8193,0.94,1,-1.116,0.19,0.46
"GO_BP:507515_GO_0045124_REGULATION_OF_BONE_RESORPTION","GO_BP","507515_GO_0045124_REGULATION_OF_BONE_RESORPTION",31,-1.7178,0.0015,0.033,0.6628,0.95,1,-0.8664,0.66,0.95
"C7_Immunologic_signatures:C7_ALL_406_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_406_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN",199,-1.7177,0,0.00012,1.2879,0.029,0.11,-1.0478,0.32,0.61
"C7_Immunologic_signatures:C7_ALL_65_GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_65_GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP",195,-1.7174,0,0.00012,-1.2509,0.05,0.62,0.9146,0.68,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_437_CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_437_CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",235,-1.7174,0,0.016,-1.1066,0.21,0.91,-1.2139,0.063,0.51
"C3_TF_targets:C3_TFT_91_V_HNF3B_01","C3_TF_targets","C3_TFT_91_V_HNF3B_01",208,-1.7171,0,0.006,-1.2456,0.053,0.29,-1.0824,0.24,0.58
"GO_BP:494883_GO_0010819_REGULATION_OF_T_CELL_CHEMOTAXIS","GO_BP","494883_GO_0010819_REGULATION_OF_T_CELL_CHEMOTAXIS",11,-1.7171,0.0064,0.033,0.7889,0.77,1,-0.8903,0.59,0.93
"GO_BP:488446_GO_0002573_MYELOID_LEUKOCYTE_DIFFERENTIATION","GO_BP","488446_GO_0002573_MYELOID_LEUKOCYTE_DIFFERENTIATION",98,-1.7171,0,0.033,-0.8541,0.8,1,1.0357,0.37,0.82
"GO_BP:488871_GO_0003073_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE","GO_BP","488871_GO_0003073_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE",85,-1.7168,0.0013,0.033,-1.1185,0.25,0.94,-0.8878,0.7,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1467_YU_MYC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1467_YU_MYC_TARGETS_UP",42,-1.7168,0.0029,0.016,0.9728,0.5,0.83,-1.8778,0,0.078
"GO_BP:507358_GO_0044406_ADHESION_OF_SYMBIONT_TO_HOST","GO_BP","507358_GO_0044406_ADHESION_OF_SYMBIONT_TO_HOST",11,-1.7167,0,0.033,-0.6623,0.9,1,-1.1726,0.27,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_2618_MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2618_MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP",26,-1.7163,0.0059,0.016,-0.6309,0.96,1,1.0461,0.37,0.92
"KEGG_compound:C05487_17ALPHA_21_DIHYDROXYPREGNENOLONE","KEGG_compound","C05487_17ALPHA_21_DIHYDROXYPREGNENOLONE",5,-1.7163,0.0055,0.037,1.1417,0.32,0.97,1.4702,0.072,0.19
"C2_Chemical_and_genetic_perturbations:C2_CGP_2280_LE_SKI_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2280_LE_SKI_TARGETS_UP",16,-1.7162,0.0031,0.016,0.7508,0.83,1,-0.6934,0.9,0.99
"C7_Immunologic_signatures:C7_ALL_1526_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN","C7_Immunologic_signatures","C7_ALL_1526_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN",200,-1.7162,0.0011,0.00012,1.0767,0.25,0.51,-1.6491,0,0.0019
"GO_BP:982451_GO_1902883_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS","GO_BP","982451_GO_1902883_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS",28,-1.7161,0.0075,0.033,1.2756,0.14,0.7,-0.9488,0.55,0.89
"C6_Oncogenic_signatures:C6_ALL_177_KRAS_600_LUNG_BREAST_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_177_KRAS_600_LUNG_BREAST_UP_V1_UP",262,-1.7161,0,0.0019,-0.9235,0.7,0.84,1.2887,0.028,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_2691_VALK_AML_CLUSTER_16","C2_Chemical_and_genetic_perturbations","C2_CGP_2691_VALK_AML_CLUSTER_16",26,-1.716,0.0075,0.016,0.5853,0.97,1,-1.6328,0.016,0.22
"C7_Immunologic_signatures:C7_ALL_1107_GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1107_GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP",185,-1.716,0,0.00012,-0.9928,0.48,1,-0.8336,0.91,1
"GO_BP:516635_GO_0071711_BASEMENT_MEMBRANE_ORGANIZATION","GO_BP","516635_GO_0071711_BASEMENT_MEMBRANE_ORGANIZATION",10,-1.7158,0.0049,0.033,-1.2082,0.25,0.88,-1.1217,0.32,0.76
"GO_BP:503648_GO_0034446_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING","GO_BP","503648_GO_0034446_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING",39,-1.7158,0.0028,0.033,-1.1424,0.25,0.93,0.9983,0.44,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_1942_WENG_POR_TARGETS_LIVER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1942_WENG_POR_TARGETS_LIVER_UP",39,-1.7156,0.0014,0.016,-1.1833,0.21,0.82,-0.951,0.53,0.82
"GO_MF:496961_GO_0017171_SERINE_HYDROLASE_ACTIVITY","GO_MF","496961_GO_0017171_SERINE_HYDROLASE_ACTIVITY",167,-1.7156,0,0.066,1.093,0.23,0.8,-1.0047,0.44,0.79
"C4_Cancer_modules:C4_CM_341_MODULE_408","C4_Cancer_modules","C4_CM_341_MODULE_408",18,-1.7154,0.0093,0.012,-0.5701,0.97,1,1.0349,0.39,0.88
"GO_BP:512142_GO_0051251_POSITIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION","GO_BP","512142_GO_0051251_POSITIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION",241,-1.7153,0,0.033,0.662,1,1,-1.2823,0.017,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_1796_ZHU_CMV_8_HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1796_ZHU_CMV_8_HR_DN",53,-1.7153,0.0014,0.016,-0.6573,0.97,1,1.3438,0.071,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_1614_MODY_HIPPOCAMPUS_POSTNATAL","C2_Chemical_and_genetic_perturbations","C2_CGP_1614_MODY_HIPPOCAMPUS_POSTNATAL",62,-1.715,0.0013,0.016,1.013,0.4,0.78,-0.9172,0.64,0.86
"GO_BP:751382_GO_0038124_TOLL_LIKE_RECEPTOR_TLR6_TLR2_SIGNALING_PATHWAY","GO_BP","751382_GO_0038124_TOLL_LIKE_RECEPTOR_TLR6_TLR2_SIGNALING_PATHWAY",72,-1.715,0,0.033,-0.6754,0.98,1,-1.1501,0.22,0.74
"GO_BP:510562_GO_0048488_SYNAPTIC_VESICLE_ENDOCYTOSIS","GO_BP","510562_GO_0048488_SYNAPTIC_VESICLE_ENDOCYTOSIS",28,-1.7148,0.0029,0.033,-1.2911,0.11,0.88,-1.5593,0.018,0.51
"GO_BP:513546_GO_0055117_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION","GO_BP","513546_GO_0055117_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION",77,-1.7146,0.0026,0.033,-1.196,0.14,0.89,1.2108,0.14,0.71
"KEGG_compound:C00084_ACETALDEHYDE_ETHANAL","KEGG_compound","C00084_ACETALDEHYDE_ETHANAL",19,-1.7146,0.011,0.037,1.2167,0.18,0.86,-1.2935,0.14,0.36
"GO_BP:487867_GO_0001977_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_BLOOD_VOLUME","GO_BP","487867_GO_0001977_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_BLOOD_VOLUME",17,-1.7145,0.013,0.033,1.5617,0.043,0.34,1.3539,0.12,0.64
"GO_BP:506431_GO_0043393_REGULATION_OF_PROTEIN_BINDING","GO_BP","506431_GO_0043393_REGULATION_OF_PROTEIN_BINDING",141,-1.7145,0,0.033,-0.6749,1,1,-1.1503,0.18,0.74
"GO_BP:498705_GO_0019932_SECOND_MESSENGER_MEDIATED_SIGNALING","GO_BP","498705_GO_0019932_SECOND_MESSENGER_MEDIATED_SIGNALING",137,-1.7144,0,0.033,-0.7755,0.94,1,1.0821,0.28,0.77
"REACTOME:530757_REACT_115846_DEFENSINS","REACTOME","530757_REACT_115846_DEFENSINS",23,-1.7142,0.0045,0.041,1.0396,0.4,0.68,1.9569,0,0.12
"C3_TF_targets:C3_TFT_352_V_PU1_Q6","C3_TF_targets","C3_TFT_352_V_PU1_Q6",226,-1.7142,0,0.0061,0.8958,0.79,1,0.6794,1,1
"KEGG_module:HSA_M00004_PENTOSE_PHOSPHATE_PATHWAY_PENTOSE_PHOSPHATE_CYCLE_","KEGG_module","HSA_M00004_PENTOSE_PHOSPHATE_PATHWAY_PENTOSE_PHOSPHATE_CYCLE_",12,-1.7142,0.0063,0.098,0.5606,0.99,0.98,-0.9063,0.59,0.87
"GO_BP:505640_GO_0042509_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN","GO_BP","505640_GO_0042509_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN",57,-1.714,0.004,0.033,-1.5729,0.016,0.73,-1.3029,0.073,0.65
"GO_BP:508731_GO_0046470_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS","GO_BP","508731_GO_0046470_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS",61,-1.7139,0.004,0.033,-1.089,0.32,0.95,0.7752,0.9,1
"REACTOME:106383_REACT_15488_OLFACTORY_SIGNALING_PATHWAY","REACTOME","106383_REACT_15488_OLFACTORY_SIGNALING_PATHWAY",313,-1.7138,0,0.041,2.4373,0,0,3.6785,0,0
"KEGG_pathway:HSA04370_VEGF_SIGNALING_PATHWAY","KEGG_pathway","HSA04370_VEGF_SIGNALING_PATHWAY",61,-1.7138,0.0013,0.0057,-0.9423,0.55,0.96,-0.8357,0.77,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2864_GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2","C2_Chemical_and_genetic_perturbations","C2_CGP_2864_GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2",13,-1.7134,0.011,0.016,0.578,0.96,1,-0.8752,0.66,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2612_MELLMAN_TUT1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2612_MELLMAN_TUT1_TARGETS_DN",46,-1.7134,0.0028,0.016,-0.7981,0.83,1,-1.2569,0.11,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_1364_BROCKE_APOPTOSIS_REVERSED_BY_IL6","C2_Chemical_and_genetic_perturbations","C2_CGP_1364_BROCKE_APOPTOSIS_REVERSED_BY_IL6",144,-1.7131,0,0.016,0.9833,0.49,0.81,-0.832,0.9,0.93
"GO_BP:510178_GO_0048010_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","510178_GO_0048010_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",108,-1.7131,0,0.034,0.7967,0.91,1,-1.0608,0.32,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1361_NELSON_RESPONSE_TO_ANDROGEN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1361_NELSON_RESPONSE_TO_ANDROGEN_UP",85,-1.7131,0.0026,0.016,0.7798,0.87,1,0.9771,0.49,0.96
"GO_MF:496557_GO_0016616_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR","GO_MF","496557_GO_0016616_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR",114,-1.7128,0,0.066,1.025,0.41,0.86,-1.2339,0.093,0.58
"C7_Immunologic_signatures:C7_ALL_1411_GSE360_CTRL_VS_T_GONDII_DC_UP","C7_Immunologic_signatures","C7_ALL_1411_GSE360_CTRL_VS_T_GONDII_DC_UP",198,-1.7127,0,0.00014,1.2176,0.064,0.2,-0.8886,0.77,0.96
"C7_Immunologic_signatures:C7_ALL_779_GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_779_GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP",192,-1.7125,0,0.00014,-0.7041,1,1,-1.0877,0.23,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_2129_ZHANG_GATA6_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2129_ZHANG_GATA6_TARGETS_UP",15,-1.7125,0.012,0.016,1.1856,0.24,0.51,-1.4229,0.077,0.34
"GO_BP:499604_GO_0030194_POSITIVE_REGULATION_OF_BLOOD_COAGULATION","GO_BP","499604_GO_0030194_POSITIVE_REGULATION_OF_BLOOD_COAGULATION",25,-1.7125,0.0076,0.034,1.0391,0.41,0.96,0.8935,0.62,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1797_ZHU_CMV_24_HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1797_ZHU_CMV_24_HR_DN",89,-1.7123,0.0013,0.016,0.9888,0.5,0.81,1.0235,0.4,0.94
"GO_BP:501838_GO_0032612_INTERLEUKIN_1_PRODUCTION","GO_BP","501838_GO_0032612_INTERLEUKIN_1_PRODUCTION",12,-1.7123,0.0096,0.034,-0.6788,0.87,1,-0.6107,0.96,1
"GO_BP:494830_GO_0010765_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT","GO_BP","494830_GO_0010765_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT",31,-1.7119,0.0043,0.034,-1.608,0.016,0.71,-1.1265,0.27,0.75
"C7_Immunologic_signatures:C7_ALL_747_GSE17721_0_5H_VS_24H_CPG_BMDM_UP","C7_Immunologic_signatures","C7_ALL_747_GSE17721_0_5H_VS_24H_CPG_BMDM_UP",199,-1.7118,0,0.00014,1.2048,0.1,0.22,-1.0588,0.3,0.59
"GO_MF:499642_GO_0030235_NITRIC_OXIDE_SYNTHASE_REGULATOR_ACTIVITY","GO_MF","499642_GO_0030235_NITRIC_OXIDE_SYNTHASE_REGULATOR_ACTIVITY",10,-1.7118,0,0.066,0.6821,0.88,1,-1.4882,0.06,0.42
"GO_BP:751381_GO_0038123_TOLL_LIKE_RECEPTOR_TLR1_TLR2_SIGNALING_PATHWAY","GO_BP","751381_GO_0038123_TOLL_LIKE_RECEPTOR_TLR1_TLR2_SIGNALING_PATHWAY",72,-1.7118,0.0026,0.034,-0.6752,0.99,1,-1.1843,0.19,0.73
"GO_BP:501200_GO_0031960_RESPONSE_TO_CORTICOSTEROID","GO_BP","501200_GO_0031960_RESPONSE_TO_CORTICOSTEROID",139,-1.7116,0,0.034,0.821,0.89,1,1.0453,0.34,0.81
"GO_BP:507969_GO_0045621_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION","GO_BP","507969_GO_0045621_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION",75,-1.7113,0,0.034,-1.0848,0.29,0.96,-1.0638,0.32,0.8
"GO_BP:505301_GO_0042129_REGULATION_OF_T_CELL_PROLIFERATION","GO_BP","505301_GO_0042129_REGULATION_OF_T_CELL_PROLIFERATION",129,-1.7112,0,0.034,-0.7456,0.96,1,-0.8839,0.76,0.94
"KEGG_compound:C02336_BETA_D_FRUCTOSE_BETA_FRUIT_SUGAR_BETA_D_ARABINO_HEXULOSE_BETA_LEVULOSE_FRUCTOSE","KEGG_compound","C02336_BETA_D_FRUCTOSE_BETA_FRUIT_SUGAR_BETA_D_ARABINO_HEXULOSE_BETA_LEVULOSE_FRUCTOSE",8,-1.7109,0.0081,0.038,-1.1401,0.29,0.86,-1.1406,0.3,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_3360_ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_3360_ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE",61,-1.7108,0,0.016,0.9262,0.61,0.89,-1.1209,0.24,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_1046_WOTTON_RUNX_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1046_WOTTON_RUNX_TARGETS_DN",28,-1.7107,0.0074,0.016,-1.0473,0.39,0.97,-1.2115,0.18,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_1310_LEE_LIVER_CANCER_MYC_TGFA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1310_LEE_LIVER_CANCER_MYC_TGFA_UP",58,-1.7106,0.0027,0.016,0.9375,0.58,0.88,0.8908,0.64,1
"C4_Cancer_modules:C4_CM_255_MODULE_289","C4_Cancer_modules","C4_CM_255_MODULE_289",119,-1.7106,0,0.012,1.1576,0.18,0.45,1.5267,0.0019,0.2
"GO_BP:488580_GO_0002707_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY","GO_BP","488580_GO_0002707_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY",28,-1.7103,0.0028,0.034,-0.6512,0.94,1,-0.8286,0.74,0.97
"GO_BP:1039945_GO_1903391_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION","GO_BP","1039945_GO_1903391_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION",41,-1.7103,0.0042,0.034,-1.3209,0.088,0.89,0.8537,0.74,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_1525_ZHAN_MULTIPLE_MYELOMA_MF_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1525_ZHAN_MULTIPLE_MYELOMA_MF_UP",44,-1.7103,0.0014,0.016,-0.7551,0.89,1,-0.7355,0.89,0.98
"GO_BP:495020_GO_0010955_NEGATIVE_REGULATION_OF_PROTEIN_PROCESSING","GO_BP","495020_GO_0010955_NEGATIVE_REGULATION_OF_PROTEIN_PROCESSING",310,-1.7103,0,0.034,0.9431,0.67,1,-0.9145,0.76,0.92
"REACTOME:106417_REACT_12623_GENERATION_OF_SECOND_MESSENGER_MOLECULES","REACTOME","106417_REACT_12623_GENERATION_OF_SECOND_MESSENGER_MOLECULES",30,-1.7102,0.0014,0.042,1.0051,0.44,0.75,-1.588,0.017,0.26
"GO_BP:500604_GO_0031345_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION","GO_BP","500604_GO_0031345_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION",110,-1.7102,0,0.034,-0.9433,0.58,1,0.9404,0.6,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_74_DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_74_DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP",254,-1.7101,0,0.016,1.0635,0.28,0.69,1.137,0.12,0.84
"GO_CC:492527_GO_0008180_COP9_SIGNALOSOME","GO_CC","492527_GO_0008180_COP9_SIGNALOSOME",36,-1.7099,0.0029,0.054,-1.109,0.29,0.76,-1.497,0.029,0.48
"GO_BP:498163_GO_0019318_HEXOSE_METABOLIC_PROCESS","GO_BP","498163_GO_0019318_HEXOSE_METABOLIC_PROCESS",176,-1.7099,0,0.034,-0.8698,0.8,1,-1.6638,0,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1183_MORI_MATURE_B_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1183_MORI_MATURE_B_LYMPHOCYTE_DN",75,-1.7096,0,0.016,1.4656,0.015,0.24,-1.1232,0.22,0.6
"GO_BP:488952_GO_0003158_ENDOTHELIUM_DEVELOPMENT","GO_BP","488952_GO_0003158_ENDOTHELIUM_DEVELOPMENT",85,-1.7095,0.0013,0.034,0.819,0.86,1,1.1539,0.19,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1141_AMIT_EGF_RESPONSE_60_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1141_AMIT_EGF_RESPONSE_60_MCF10A",39,-1.7094,0.0043,0.016,-1.4599,0.044,0.52,-0.8478,0.73,0.93
"REACTOME:366166_REACT_75900_INFLAMMASOMES","REACTOME","366166_REACT_75900_INFLAMMASOMES",17,-1.7094,0.011,0.042,-0.7707,0.79,1,-1.1411,0.28,0.66
"GO_BP:498166_GO_0019321_PENTOSE_METABOLIC_PROCESS","GO_BP","498166_GO_0019321_PENTOSE_METABOLIC_PROCESS",14,-1.7094,0.0047,0.034,0.6653,0.93,1,-1.1372,0.3,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_537_NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_537_NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN",13,-1.7091,0.013,0.016,-1.581,0.039,0.46,-1.9087,0,0.068
"GO_BP:503340_GO_0034134_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY","GO_BP","503340_GO_0034134_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY",74,-1.7088,0,0.035,-0.6088,1,1,-1.193,0.14,0.74
"GO_BP:501918_GO_0032692_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION","GO_BP","501918_GO_0032692_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION",11,-1.7087,0.0048,0.035,-1.5255,0.043,0.77,-1.0067,0.46,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_2559_ROSS_LEUKEMIA_WITH_MLL_FUSIONS","C2_Chemical_and_genetic_perturbations","C2_CGP_2559_ROSS_LEUKEMIA_WITH_MLL_FUSIONS",78,-1.7085,0.0013,0.017,1.2746,0.09,0.42,0.7416,0.94,1
"GO_MF:496677_GO_0016765_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS","GO_MF","496677_GO_0016765_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS",51,-1.7085,0.0013,0.068,-1.1414,0.24,0.81,-1.2208,0.14,0.57
"GO_BP:515457_GO_0070527_PLATELET_AGGREGATION","GO_BP","515457_GO_0070527_PLATELET_AGGREGATION",39,-1.7082,0.0042,0.035,1.5943,0.013,0.3,-0.5829,0.99,1
"GO_BP:517431_GO_0072526_PYRIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS","GO_BP","517431_GO_0072526_PYRIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",46,-1.7082,0.0041,0.035,-0.8818,0.65,1,-1.6262,0.0039,0.52
"C4_Cancer_gene_neighborhoods:C4_CGN_317_GNF2_TST","C4_Cancer_gene_neighborhoods","C4_CGN_317_GNF2_TST",102,-1.708,0,0.0075,-1.1906,0.14,0.69,1.1585,0.18,0.51
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_156_BIOCARTA_STEM_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_156_BIOCARTA_STEM_PATHWAY",15,-1.708,0.008,0.047,-1.2979,0.14,1,-1.0556,0.37,0.67
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_78_BIOCARTA_GATA3_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_78_BIOCARTA_GATA3_PATHWAY",16,-1.7079,0.0094,0.046,0.8113,0.71,0.97,-1.3703,0.085,0.46
"C7_Immunologic_signatures:C7_ALL_791_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_791_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP",192,-1.7079,0,0.00017,-0.7675,0.97,1,-1.1537,0.12,0.36
"C7_Immunologic_signatures:C7_ALL_276_GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN","C7_Immunologic_signatures","C7_ALL_276_GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN",200,-1.7078,0,0.00017,1.2237,0.055,0.19,-1.3824,0.011,0.074
"GO_MF:506250_GO_0043178_ALCOHOL_BINDING","GO_MF","506250_GO_0043178_ALCOHOL_BINDING",94,-1.7077,0.0012,0.068,-1.298,0.068,0.78,-0.958,0.53,0.82
"C7_Immunologic_signatures:C7_ALL_844_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN","C7_Immunologic_signatures","C7_ALL_844_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN",198,-1.7073,0,0.00017,0.8382,0.9,1,-1.5212,0,0.016
"GO_BP:511796_GO_0050851_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY","GO_BP","511796_GO_0050851_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY",119,-1.7073,0,0.035,0.8255,0.88,1,-1.4965,0.004,0.54
"REACTOME:906029_REACT_169262_LAMININ_INTERACTIONS","REACTOME","906029_REACT_169262_LAMININ_INTERACTIONS",23,-1.7073,0.0042,0.042,-0.4618,1,1,1.0921,0.32,0.97
"C3_TF_targets:C3_TFT_417_V_SREBP_Q3","C3_TF_targets","C3_TFT_417_V_SREBP_Q3",252,-1.7071,0,0.0062,-1.1932,0.11,0.36,-0.9261,0.68,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1412_DORSAM_HOXA9_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1412_DORSAM_HOXA9_TARGETS_DN",32,-1.7071,0.0059,0.017,-0.9253,0.6,1,-0.7604,0.86,0.97
"GO_MF:498070_GO_0019215_INTERMEDIATE_FILAMENT_BINDING","GO_MF","498070_GO_0019215_INTERMEDIATE_FILAMENT_BINDING",10,-1.7071,0.0062,0.067,-0.5628,0.97,1,0.6175,0.93,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_15_BIOCARTA_ASBCELL_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_15_BIOCARTA_ASBCELL_PATHWAY",12,-1.7071,0.0049,0.045,0.6762,0.89,1,-0.5413,0.98,0.99
"GO_BP:488306_GO_0002433_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS","GO_BP","488306_GO_0002433_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS",71,-1.7071,0.0013,0.035,0.6027,1,1,-1.2016,0.15,0.73
"KEGG_pathway:HSA05323_RHEUMATOID_ARTHRITIS","KEGG_pathway","HSA05323_RHEUMATOID_ARTHRITIS",85,-1.7068,0,0.0063,-1.1122,0.25,0.68,-0.8331,0.83,0.89
"C7_Immunologic_signatures:C7_ALL_1506_GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN","C7_Immunologic_signatures","C7_ALL_1506_GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN",198,-1.7068,0,0.00018,-0.9337,0.65,1,-1.1707,0.12,0.34
"GO_BP:500603_GO_0031344_REGULATION_OF_CELL_PROJECTION_ORGANIZATION","GO_BP","500603_GO_0031344_REGULATION_OF_CELL_PROJECTION_ORGANIZATION",419,-1.7068,0,0.035,-1.1929,0.056,0.9,-1.0262,0.36,0.83
"GO_BP:512057_GO_0051147_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION","GO_BP","512057_GO_0051147_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION",135,-1.7066,0,0.035,-0.9969,0.47,0.99,-1.3966,0.017,0.58
"GO_BP:510715_GO_0048660_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION","GO_BP","510715_GO_0048660_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION",80,-1.7065,0,0.035,-0.9773,0.5,1,1.2552,0.11,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1529_PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1529_PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP",129,-1.7065,0,0.017,0.9414,0.58,0.88,-1.2833,0.055,0.45
"GO_MF:490364_GO_0005096_GTPASE_ACTIVATOR_ACTIVITY","GO_MF","490364_GO_0005096_GTPASE_ACTIVATOR_ACTIVITY",240,-1.7065,0,0.067,-1.4091,0.0034,0.65,-1.5876,0,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_2605_ZHANG_TLX_TARGETS_36HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2605_ZHANG_TLX_TARGETS_36HR_UP",221,-1.7062,0,0.017,-0.897,0.75,1,0.7727,0.99,1
"C7_Immunologic_signatures:C7_ALL_1350_GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1350_GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN",198,-1.706,0,0.00018,-1.3419,0.014,0.37,-1.3078,0.026,0.13
"WikiPathways:198900_WP129_MATRIX_METALLOPROTEINASES","WikiPathways","198900_WP129_MATRIX_METALLOPROTEINASES",29,-1.7057,0.0029,0.02,-0.9496,0.54,1,-1.0614,0.37,0.65
"GO_BP:511779_GO_0050820_POSITIVE_REGULATION_OF_COAGULATION","GO_BP","511779_GO_0050820_POSITIVE_REGULATION_OF_COAGULATION",27,-1.7056,0.0029,0.035,1.0007,0.44,0.98,0.8899,0.65,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2309_ZHENG_GLIOBLASTOMA_PLASTICITY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2309_ZHENG_GLIOBLASTOMA_PLASTICITY_UP",249,-1.7055,0,0.017,0.8825,0.83,0.94,-1.0494,0.29,0.69
"KEGG_compound:C00159_D_MANNOSE_MANNOSE_SEMINOSE_CARUBINOSE","KEGG_compound","C00159_D_MANNOSE_MANNOSE_SEMINOSE_CARUBINOSE",13,-1.7054,0.0092,0.04,-1.2846,0.17,0.65,-1.4753,0.069,0.24
"GO_BP:506334_GO_0043268_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT","GO_BP","506334_GO_0043268_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT",28,-1.7054,0.0044,0.035,-1.6657,0.0058,0.64,-1.1552,0.24,0.74
"GO_BP:495137_GO_0014065_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING","GO_BP","495137_GO_0014065_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING",25,-1.7053,0.0091,0.035,-1.1601,0.25,0.92,1.2537,0.16,0.69
"KEGG_compound:C06427__9Z_12Z_15Z_OCTADECATRIENOIC_ACID_ALPHA_LINOLENIC_ACID_9_12_15_OCTADECATRIENOIC_ACID_LINOLENATE_ALPHA_LINOLENATE","KEGG_compound","C06427__9Z_12Z_15Z_OCTADECATRIENOIC_ACID_ALPHA_LINOLENIC_ACID_9_12_15_OCTADECATRIENOIC_ACID_LINOLENATE_ALPHA_LINOLENATE",23,-1.7053,0.0029,0.039,-0.7382,0.84,1,-0.8923,0.63,0.77
"GO_BP:515235_GO_0070302_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE","GO_BP","515235_GO_0070302_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE",176,-1.7048,0,0.036,-1.1498,0.15,0.93,-1.1224,0.18,0.76
"GO_BP:502722_GO_0033504_FLOOR_PLATE_DEVELOPMENT","GO_BP","502722_GO_0033504_FLOOR_PLATE_DEVELOPMENT",7,-1.7048,0.0085,0.036,1.1485,0.29,0.84,-0.9598,0.51,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2897_DORN_ADENOVIRUS_INFECTION_32HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2897_DORN_ADENOVIRUS_INFECTION_32HR_DN",36,-1.7047,0.0029,0.017,-1.5188,0.019,0.44,0.8285,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2577_HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2577_HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP",162,-1.7044,0,0.017,0.8336,0.88,0.98,-1.9552,0,0.061
"C2_Chemical_and_genetic_perturbations:C2_CGP_1610_TRAYNOR_RETT_SYNDROM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1610_TRAYNOR_RETT_SYNDROM_UP",42,-1.7043,0.0026,0.017,-0.9862,0.48,1,-1.1993,0.18,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_542_DARWICHE_PAPILLOMA_RISK_HIGH_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_542_DARWICHE_PAPILLOMA_RISK_HIGH_UP",139,-1.7043,0,0.017,1.1733,0.15,0.53,-0.8299,0.86,0.94
"GO_BP:514625_GO_0061077_CHAPERONE_MEDIATED_PROTEIN_FOLDING","GO_BP","514625_GO_0061077_CHAPERONE_MEDIATED_PROTEIN_FOLDING",46,-1.7042,0.0027,0.036,0.8045,0.79,1,-1.6795,0.01,0.6
"GO_BP:516822_GO_0071902_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY","GO_BP","516822_GO_0071902_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",270,-1.7041,0,0.036,0.7435,1,1,1.0607,0.28,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_2007_DURCHDEWALD_SKIN_CARCINOGENESIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2007_DURCHDEWALD_SKIN_CARCINOGENESIS_DN",258,-1.7039,0,0.017,0.7296,1,1,0.8308,0.93,1
"KEGG_compound:C05580_3_4_DIHYDROXYMANDELATE_3_4_DIHYDROXYMANDELIC_ACID_DIHYDROXYMANDELIC_ACID","KEGG_compound","C05580_3_4_DIHYDROXYMANDELATE_3_4_DIHYDROXYMANDELIC_ACID_DIHYDROXYMANDELIC_ACID",5,-1.7038,0.0035,0.04,0.7882,0.72,1,-1.3472,0.12,0.33
"GO_BP:490998_GO_0006012_GALACTOSE_METABOLIC_PROCESS","GO_BP","490998_GO_0006012_GALACTOSE_METABOLIC_PROCESS",14,-1.7038,0.0094,0.036,-1.4536,0.065,0.9,-1.052,0.38,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_1691_VARELA_ZMPSTE24_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1691_VARELA_ZMPSTE24_TARGETS_DN",37,-1.7032,0.0057,0.017,-0.8573,0.7,1,-0.8759,0.68,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1530_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1530_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP",179,-1.7031,0,0.017,1.2041,0.1,0.49,0.8416,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1939_LY_AGING_MIDDLE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1939_LY_AGING_MIDDLE_DN",16,-1.7029,0.0082,0.017,-1.2097,0.19,0.79,-1.4029,0.074,0.35
"GO_BP:508180_GO_0045861_NEGATIVE_REGULATION_OF_PROTEOLYSIS","GO_BP","508180_GO_0045861_NEGATIVE_REGULATION_OF_PROTEOLYSIS",295,-1.7028,0,0.036,0.937,0.68,1,-0.9427,0.64,0.89
"REACTOME:905996_REACT_169168_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP_","REACTOME","905996_REACT_169168_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP_",104,-1.7026,0,0.044,-1.4224,0.016,0.5,-1.6782,0.002,0.23
"GO_BP:505470_GO_0042326_NEGATIVE_REGULATION_OF_PHOSPHORYLATION","GO_BP","505470_GO_0042326_NEGATIVE_REGULATION_OF_PHOSPHORYLATION",353,-1.7026,0,0.036,0.9287,0.73,1,-1.039,0.32,0.82
"KEGG_pathway:HSA04070_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM","KEGG_pathway","HSA04070_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM",81,-1.7025,0,0.0064,-1.4784,0.015,0.48,-0.8782,0.74,0.87
"GO_BP:495942_GO_0015812_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT","GO_BP","495942_GO_0015812_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT",8,-1.7023,0.01,0.036,-0.9108,0.58,1,-1.7236,0.012,0.63
"GO_MF:490470_GO_0005229_INTRACELLULAR_CALCIUM_ACTIVATED_CHLORIDE_CHANNEL_ACTIVITY","GO_MF","490470_GO_0005229_INTRACELLULAR_CALCIUM_ACTIVATED_CHLORIDE_CHANNEL_ACTIVITY",14,-1.7019,0.016,0.069,1.3198,0.14,0.57,1.3158,0.14,0.67
"GO_BP:508233_GO_0045926_NEGATIVE_REGULATION_OF_GROWTH","GO_BP","508233_GO_0045926_NEGATIVE_REGULATION_OF_GROWTH",216,-1.7017,0,0.037,-1.3257,0.019,0.89,-1.1105,0.2,0.76
"C4_Cancer_gene_neighborhoods:C4_CGN_359_GNF2_HPN","C4_Cancer_gene_neighborhoods","C4_CGN_359_GNF2_HPN",129,-1.7016,0,0.0082,-1.169,0.15,0.68,1.4201,0.014,0.24
"GO_BP:488099_GO_0002224_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","488099_GO_0002224_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",123,-1.7016,0,0.036,-0.7007,0.99,1,-1.0221,0.42,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_2468_BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2468_BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN",40,-1.7016,0.0028,0.018,-0.7207,0.91,1,-0.702,0.92,0.99
"GO_BP:508722_GO_0046461_NEUTRAL_LIPID_CATABOLIC_PROCESS","GO_BP","508722_GO_0046461_NEUTRAL_LIPID_CATABOLIC_PROCESS",24,-1.7016,0.0093,0.036,1.1212,0.28,0.88,0.7683,0.83,1
"GO_BP:491560_GO_0006672_CERAMIDE_METABOLIC_PROCESS","GO_BP","491560_GO_0006672_CERAMIDE_METABOLIC_PROCESS",61,-1.7015,0.0026,0.036,-0.811,0.83,1,-0.8849,0.67,0.94
"GO_BP:502379_GO_0033158_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION","GO_BP","502379_GO_0033158_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION",17,-1.7015,0.0078,0.036,-0.9776,0.5,1,-1.1552,0.27,0.74
"GO_BP:488794_GO_0002921_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE","GO_BP","488794_GO_0002921_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE",12,-1.7015,0.0093,0.036,-0.8534,0.64,1,0.7074,0.85,1
"WikiPathways:672458_WP2261_SIGNALING_PATHWAYS_IN_GLIOBLASTOMA","WikiPathways","672458_WP2261_SIGNALING_PATHWAYS_IN_GLIOBLASTOMA",80,-1.7014,0.0013,0.02,-1.1443,0.23,0.93,-1.0191,0.41,0.66
"GO_BP:517292_GO_0072376_PROTEIN_ACTIVATION_CASCADE","GO_BP","517292_GO_0072376_PROTEIN_ACTIVATION_CASCADE",64,-1.7014,0.0013,0.036,1.0871,0.29,0.92,1.1348,0.25,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_281_LEE_NEURAL_CREST_STEM_CELL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_281_LEE_NEURAL_CREST_STEM_CELL_UP",142,-1.7013,0,0.018,0.955,0.56,0.86,1.1779,0.14,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_197_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_197_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP",78,-1.7011,0.0026,0.018,-0.725,0.96,1,1.2807,0.1,0.7
"GO_BP:489002_GO_0003208_CARDIAC_VENTRICLE_MORPHOGENESIS","GO_BP","489002_GO_0003208_CARDIAC_VENTRICLE_MORPHOGENESIS",62,-1.701,0.0013,0.036,0.8552,0.75,1,1.2583,0.11,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2629_SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE","C2_Chemical_and_genetic_perturbations","C2_CGP_2629_SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE",67,-1.7009,0,0.018,-0.7043,0.95,1,-1.1693,0.2,0.55
"C7_Immunologic_signatures:C7_ALL_277_GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP","C7_Immunologic_signatures","C7_ALL_277_GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP",199,-1.7008,0,0.00021,-0.8297,0.9,1,1.1196,0.18,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_3250_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3","C2_Chemical_and_genetic_perturbations","C2_CGP_3250_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3",19,-1.7008,0.0044,0.018,-1.3111,0.15,0.68,0.9716,0.49,0.96
"GO_BP:492863_GO_0008610_LIPID_BIOSYNTHETIC_PROCESS","GO_BP","492863_GO_0008610_LIPID_BIOSYNTHETIC_PROCESS",491,-1.7007,0,0.037,-0.7818,1,1,-1.1837,0.036,0.73
"GO_CC:911483_GO_1902495_TRANSMEMBRANE_TRANSPORTER_COMPLEX","GO_CC","911483_GO_1902495_TRANSMEMBRANE_TRANSPORTER_COMPLEX",301,-1.7007,0,0.058,-1.5937,0,0.45,1.3333,0.0057,0.7
"GO_BP:1184588_GO_1904064_POSITIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT","GO_BP","1184588_GO_1904064_POSITIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT",55,-1.7006,0.0055,0.037,-1.2303,0.15,0.89,0.8049,0.83,1
"GO_BP:507589_GO_0045216_CELL_CELL_JUNCTION_ORGANIZATION","GO_BP","507589_GO_0045216_CELL_CELL_JUNCTION_ORGANIZATION",162,-1.7004,0,0.037,-1.3016,0.046,0.89,1.1117,0.21,0.75
"C3_MicroRNA_targets:C3_MIR_116_ATGAAGG_MIR_205","C3_MicroRNA_targets","C3_MIR_116_ATGAAGG_MIR_205",157,-1.7004,0,0.13,-0.9831,0.49,1,-1.0248,0.39,1
"GO_BP:508927_GO_0046697_DECIDUALIZATION","GO_BP","508927_GO_0046697_DECIDUALIZATION",17,-1.7004,0.015,0.037,-1.692,0.017,0.59,-1.0616,0.34,0.8
"C4_Cancer_modules:C4_CM_229_MODULE_253","C4_Cancer_modules","C4_CM_229_MODULE_253",21,-1.7003,0.0016,0.013,-1.1544,0.27,0.64,-1.4225,0.07,0.21
"KEGG_compound:C05584_3_METHOXY_4_HYDROXYMANDELATE_VANILLYLMANDELIC_ACID","KEGG_compound","C05584_3_METHOXY_4_HYDROXYMANDELATE_VANILLYLMANDELIC_ACID",5,-1.7,0,0.041,0.7891,0.73,1,-1.3402,0.12,0.34
"GO_BP:505579_GO_0042439_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","505579_GO_0042439_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",80,-1.6999,0,0.037,-0.9614,0.54,1,0.9068,0.68,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_151_ROY_WOUND_BLOOD_VESSEL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_151_ROY_WOUND_BLOOD_VESSEL_UP",49,-1.6997,0.0028,0.018,0.9705,0.5,0.83,-0.9367,0.57,0.84
"GO_BP:508238_GO_0045931_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE","GO_BP","508238_GO_0045931_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE",106,-1.6996,0,0.037,-0.7868,0.89,1,-1.3803,0.012,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_3274_PLASARI_TGFB1_TARGETS_1HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3274_PLASARI_TGFB1_TARGETS_1HR_UP",34,-1.6996,0,0.018,-2.2407,0,0.0054,-0.9746,0.48,0.79
"REACTOME:160135_REACT_21308_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE","REACTOME","160135_REACT_21308_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE",56,-1.6995,0.0039,0.045,-1.0308,0.38,0.97,-1.1001,0.27,0.71
"GO_BP:487786_GO_0001890_PLACENTA_DEVELOPMENT","GO_BP","487786_GO_0001890_PLACENTA_DEVELOPMENT",144,-1.6994,0,0.037,-1.1182,0.2,0.94,-1.1818,0.12,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2299_IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2299_IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP",125,-1.6994,0,0.018,0.8001,0.92,0.99,1.092,0.26,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_3202_FARDIN_HYPOXIA_11","C2_Chemical_and_genetic_perturbations","C2_CGP_3202_FARDIN_HYPOXIA_11",32,-1.6992,0.0028,0.018,0.6418,0.95,1,-1.3225,0.097,0.41
"GO_BP:498216_GO_0019373_EPOXYGENASE_P450_PATHWAY","GO_BP","498216_GO_0019373_EPOXYGENASE_P450_PATHWAY",19,-1.6987,0.009,0.037,-1.7141,0.011,0.74,1.1867,0.23,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1848_ZHU_CMV_ALL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1848_ZHU_CMV_ALL_DN",126,-1.6986,0,0.018,0.8147,0.9,0.98,1.2548,0.066,0.71
"C3_TF_targets:C3_TFT_443_V_NRF2_Q4","C3_TF_targets","C3_TFT_443_V_NRF2_Q4",249,-1.6986,0,0.0067,-1.1708,0.12,0.41,-1.1246,0.17,0.49
"KEGG_pathway:HSA04919_THYROID_HORMONE_SIGNALING_PATHWAY","KEGG_pathway","HSA04919_THYROID_HORMONE_SIGNALING_PATHWAY",118,-1.6985,0,0.0067,-1.4036,0.021,0.38,-0.9435,0.59,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_792_SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_792_SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP",68,-1.6984,0.0025,0.018,1.6302,0.0065,0.12,-1.2971,0.06,0.43
"REACTOME:771579_REACT_160086_REGULATION_OF_ACTIN_DYNAMICS_FOR_PHAGOCYTIC_CUP_FORMATION","REACTOME","771579_REACT_160086_REGULATION_OF_ACTIN_DYNAMICS_FOR_PHAGOCYTIC_CUP_FORMATION",59,-1.6983,0.0013,0.045,0.6347,0.99,1,-1.0893,0.28,0.72
"C7_Immunologic_signatures:C7_ALL_419_GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP","C7_Immunologic_signatures","C7_ALL_419_GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP",198,-1.6977,0,0.00022,1.6423,0,0.0014,-1.0695,0.3,0.57
"GO_MF:496561_GO_0016620_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR","GO_MF","496561_GO_0016620_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR",29,-1.6975,0.0044,0.072,-0.9082,0.63,0.98,-1.5061,0.032,0.42
"GO_BP:507798_GO_0045444_FAT_CELL_DIFFERENTIATION","GO_BP","507798_GO_0045444_FAT_CELL_DIFFERENTIATION",93,-1.6972,0.0013,0.038,-0.899,0.68,1,-1.3253,0.044,0.63
"OMIM_gene:OMIM188370_THYMOCYTE_ANTIGEN_CD1A_CD1A","OMIM_gene","OMIM188370_THYMOCYTE_ANTIGEN_CD1A_CD1A",5,-1.697,0.0018,0.33,-1.4344,0.082,0.66,-1.2901,0.17,1
"C6_Oncogenic_signatures:C6_ALL_183_KRAS_LUNG_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_183_KRAS_LUNG_UP_V1_UP",130,-1.6968,0.0012,0.0024,-1.0668,0.33,0.6,-1.0142,0.41,0.63
"GO_CC:505607_GO_0042470_MELANOSOME","GO_CC","505607_GO_0042470_MELANOSOME",103,-1.6968,0,0.059,0.9636,0.53,0.82,-1.0722,0.29,0.95
"GO_BP:499475_GO_0030007_CELLULAR_POTASSIUM_ION_HOMEOSTASIS","GO_BP","499475_GO_0030007_CELLULAR_POTASSIUM_ION_HOMEOSTASIS",9,-1.6967,0.0081,0.038,-1.4585,0.079,0.88,-1.4394,0.079,0.56
"REACTOME:645336_REACT_121025_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE","REACTOME","645336_REACT_121025_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE",33,-1.6967,0.0058,0.045,-0.8331,0.69,1,-0.899,0.65,0.95
"KEGG_compound:C01161_3_4_DIHYDROXYPHENYLACETATE_3_4_DIHYDROXYPHENYLACETIC_ACID_HOMOPROTOCATECHUATE","KEGG_compound","C01161_3_4_DIHYDROXYPHENYLACETATE_3_4_DIHYDROXYPHENYLACETIC_ACID_HOMOPROTOCATECHUATE",5,-1.6966,0.0018,0.042,0.7822,0.74,1,-1.3699,0.13,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_2220_HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2220_HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN",47,-1.6966,0.0043,0.018,-0.9411,0.56,1,-1.1049,0.28,0.62
"GO_BP:495154_GO_0014706_STRIATED_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","495154_GO_0014706_STRIATED_MUSCLE_TISSUE_DEVELOPMENT",254,-1.6965,0,0.038,-1.036,0.35,0.98,0.9685,0.57,0.89
"GO_BP:489321_GO_0006956_COMPLEMENT_ACTIVATION","GO_BP","489321_GO_0006956_COMPLEMENT_ACTIVATION",43,-1.6964,0.0028,0.038,1.0669,0.36,0.94,1.0528,0.32,0.8
"GO_BP:753044_GO_1900048_POSITIVE_REGULATION_OF_HEMOSTASIS","GO_BP","753044_GO_1900048_POSITIVE_REGULATION_OF_HEMOSTASIS",25,-1.6963,0.01,0.038,1.0599,0.35,0.94,0.9012,0.6,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_1711_MACLACHLAN_BRCA1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1711_MACLACHLAN_BRCA1_TARGETS_DN",16,-1.6961,0.0078,0.018,-0.985,0.44,1,0.61,0.96,1
"KEGG_module:HSA_M00001_GLYCOLYSIS_EMBDEN_MEYERHOF_PATHWAY_GLUCOSE_PYRUVATE","KEGG_module","HSA_M00001_GLYCOLYSIS_EMBDEN_MEYERHOF_PATHWAY_GLUCOSE_PYRUVATE",25,-1.6961,0.0061,0.094,-1.2243,0.21,1,-1.3636,0.09,0.5
"GO_BP:754343_GO_1901381_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","754343_GO_1901381_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT",20,-1.6961,0.0079,0.038,-1.6585,0.019,0.67,-0.9055,0.57,0.92
"REACTOME:1183536_REACT_355047_DISEASES_OF_IMMUNE_SYSTEM","REACTOME","1183536_REACT_355047_DISEASES_OF_IMMUNE_SYSTEM",23,-1.696,0.0061,0.045,-0.4777,1,1,-0.7906,0.81,1
"GO_BP:500131_GO_0030833_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION","GO_BP","500131_GO_0030833_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION",112,-1.6957,0.0012,0.038,-0.8153,0.86,1,-1.4111,0.02,0.58
"C3_MicroRNA_targets:C3_MIR_59_CTAGGAA_MIR_384","C3_MicroRNA_targets","C3_MIR_59_CTAGGAA_MIR_384",62,-1.6956,0.0013,0.087,-0.9725,0.5,1,0.7483,0.92,1
"GO_BP:502890_GO_0033673_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY","GO_BP","502890_GO_0033673_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY",213,-1.6955,0,0.038,-0.7371,1,1,-1.1569,0.11,0.74
"REACTOME:105699_REACT_13705_PHASE_1_FUNCTIONALIZATION_OF_COMPOUNDS","REACTOME","105699_REACT_13705_PHASE_1_FUNCTIONALIZATION_OF_COMPOUNDS",78,-1.6955,0.0013,0.045,-1.236,0.12,0.78,1.1809,0.16,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_826_MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_826_MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP",172,-1.6955,0,0.018,1.1133,0.2,0.61,-0.9439,0.59,0.83
"GO_BP:752703_GO_0097202_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_BP","752703_GO_0097202_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",96,-1.6955,0,0.038,0.8043,0.9,1,-1.4855,0.0063,0.53
"GO_BP:514111_GO_0060556_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS","GO_BP","514111_GO_0060556_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS",9,-1.6954,0.018,0.038,-1.6244,0.024,0.69,-1.5471,0.043,0.52
"GO_BP:499158_GO_0021879_FOREBRAIN_NEURON_DIFFERENTIATION","GO_BP","499158_GO_0021879_FOREBRAIN_NEURON_DIFFERENTIATION",52,-1.6953,0.0027,0.038,-1.3506,0.069,0.93,1.145,0.21,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2350_BOQUEST_STEM_CELL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2350_BOQUEST_STEM_CELL_DN",215,-1.6952,0,0.018,-1.042,0.37,0.98,1.1493,0.14,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_2384_PODAR_RESPONSE_TO_ADAPHOSTIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2384_PODAR_RESPONSE_TO_ADAPHOSTIN_DN",18,-1.6952,0.011,0.018,0.9845,0.45,0.81,-1.3235,0.13,0.41
"GO_BP:517721_GO_0075136_RESPONSE_TO_HOST","GO_BP","517721_GO_0075136_RESPONSE_TO_HOST",14,-1.6951,0.0031,0.038,1.0598,0.39,0.94,-0.7004,0.87,0.99
"GO_BP:501508_GO_0032273_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION","GO_BP","501508_GO_0032273_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION",76,-1.695,0,0.038,-0.74,0.94,1,-1.3016,0.08,0.65
"C3_TF_targets:C3_TFT_178_V_CHOP_01","C3_TF_targets","C3_TFT_178_V_CHOP_01",230,-1.695,0,0.0067,-0.9215,0.69,0.93,-1.1259,0.17,0.48
"REACTOME:105650_REACT_1619_DEATH_RECEPTOR_SIGNALLING","REACTOME","105650_REACT_1619_DEATH_RECEPTOR_SIGNALLING",21,-1.695,0.01,0.045,-0.9364,0.53,1,-1.0631,0.34,0.75
"GO_BP:501887_GO_0032661_REGULATION_OF_INTERLEUKIN_18_PRODUCTION","GO_BP","501887_GO_0032661_REGULATION_OF_INTERLEUKIN_18_PRODUCTION",5,-1.6948,0,0.038,-1.5637,0.024,0.72,-1.2629,0.2,0.67
"GO_BP:504887_GO_0035710_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION","GO_BP","504887_GO_0035710_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",31,-1.6948,0.009,0.038,-0.8686,0.67,1,0.8206,0.75,0.99
"GO_MF:490412_GO_0005149_INTERLEUKIN_1_RECEPTOR_BINDING","GO_MF","490412_GO_0005149_INTERLEUKIN_1_RECEPTOR_BINDING",16,-1.6947,0.011,0.074,-1.5255,0.038,0.53,0.8792,0.63,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_745_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_745_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",37,-1.6946,0.0056,0.018,-0.9134,0.59,1,-1.1057,0.31,0.62
"KEGG_reaction:R07001_NAPHTHALENE_NADPH_OXYGEN_OXIDOREDUCTASE_RH_HYDROXYLATING_OR_EPOXIDIZING_NAPHTHALENE_NADPH_OXYGEN_H_1S_2R_NAPHTHALENE_1_2_OXIDE_NADP_H2O","KEGG_reaction","R07001_NAPHTHALENE_NADPH_OXYGEN_OXIDOREDUCTASE_RH_HYDROXYLATING_OR_EPOXIDIZING_NAPHTHALENE_NADPH_OXYGEN_H_1S_2R_NAPHTHALENE_1_2_OXIDE_NADP_H2O",7,-1.6945,0.0069,0.032,-1.3523,0.15,0.34,-0.8211,0.68,0.83
"C3_TF_targets:C3_TFT_131_V_SRF_Q6","C3_TF_targets","C3_TFT_131_V_SRF_Q6",234,-1.6944,0,0.0065,-0.8941,0.77,0.97,1.2678,0.042,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_832_BORLAK_LIVER_CANCER_EGF_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_832_BORLAK_LIVER_CANCER_EGF_UP",54,-1.6944,0.0013,0.018,-0.8534,0.74,1,-1.1271,0.24,0.6
"GO_BP:489317_GO_0009615_RESPONSE_TO_VIRUS","GO_BP","489317_GO_0009615_RESPONSE_TO_VIRUS",225,-1.6943,0,0.038,1.4041,0.0067,0.55,-1.3882,0.0019,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_3094_PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3094_PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP",131,-1.6943,0,0.018,0.964,0.53,0.85,0.8461,0.83,1
"GO_BP:500899_GO_0031650_REGULATION_OF_HEAT_GENERATION","GO_BP","500899_GO_0031650_REGULATION_OF_HEAT_GENERATION",13,-1.6941,0.013,0.038,-1.0423,0.39,0.98,1.2985,0.16,0.67
"GO_BP:488700_GO_0002827_POSITIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE","GO_BP","488700_GO_0002827_POSITIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE",12,-1.6941,0.014,0.038,-1.4022,0.096,0.99,-0.9029,0.58,0.92
"GO_BP:488548_GO_0002675_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE","GO_BP","488548_GO_0002675_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE",25,-1.6938,0.013,0.038,-1.4339,0.06,0.92,0.7396,0.85,1
"C7_Immunologic_signatures:C7_ALL_1528_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN","C7_Immunologic_signatures","C7_ALL_1528_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN",200,-1.6938,0,0.00024,0.935,0.64,0.94,-1.7102,0,0.00059
"GO_MF:496396_GO_0016408_C_ACYLTRANSFERASE_ACTIVITY","GO_MF","496396_GO_0016408_C_ACYLTRANSFERASE_ACTIVITY",14,-1.6937,0.0063,0.074,-0.7588,0.82,1,-1.475,0.063,0.43
"GO_BP:491870_GO_0007043_CELL_CELL_JUNCTION_ASSEMBLY","GO_BP","491870_GO_0007043_CELL_CELL_JUNCTION_ASSEMBLY",75,-1.6937,0,0.038,-1.2255,0.12,0.88,-0.9785,0.49,0.87
"GO_MF:487582_GO_0001671_ATPASE_ACTIVATOR_ACTIVITY","GO_MF","487582_GO_0001671_ATPASE_ACTIVATOR_ACTIVITY",14,-1.6936,0.0066,0.073,-1.2397,0.2,0.84,-1.4739,0.065,0.42
"GO_BP:491472_GO_0006576_CELLULAR_BIOGENIC_AMINE_METABOLIC_PROCESS","GO_BP","491472_GO_0006576_CELLULAR_BIOGENIC_AMINE_METABOLIC_PROCESS",142,-1.6936,0,0.038,-1.0901,0.27,0.95,-1.2654,0.049,0.67
"GO_MF:495439_GO_0015166_POLYOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495439_GO_0015166_POLYOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",11,-1.6936,0.008,0.072,-1.2102,0.24,0.81,-1.0035,0.45,0.79
"GO_BP:994747_GO_0036465_SYNAPTIC_VESICLE_RECYCLING","GO_BP","994747_GO_0036465_SYNAPTIC_VESICLE_RECYCLING",30,-1.6935,0.0042,0.038,-1.2855,0.12,0.89,-1.3985,0.071,0.58
"C3_TF_targets:C3_TFT_580_TTCNRGNNNNTTC_V_HSF_Q6","C3_TF_targets","C3_TFT_580_TTCNRGNNNNTTC_V_HSF_Q6",148,-1.6934,0.0012,0.0065,-1.0054,0.44,0.74,-1.3574,0.022,0.27
"C7_Immunologic_signatures:C7_ALL_876_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN","C7_Immunologic_signatures","C7_ALL_876_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN",199,-1.6934,0,0.00025,0.809,0.93,1,-1.3399,0.011,0.1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1892_ZHU_CMV_24_HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1892_ZHU_CMV_24_HR_UP",93,-1.6934,0,0.018,0.9328,0.61,0.89,-1.3749,0.044,0.38
"GO_CC:516361_GO_0071437_INVADOPODIUM","GO_CC","516361_GO_0071437_INVADOPODIUM",10,-1.6932,0.0065,0.06,-1.1391,0.3,0.72,0.8714,0.64,1
"GO_BP:518169_GO_0090022_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS","GO_BP","518169_GO_0090022_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS",22,-1.6931,0.0074,0.038,0.7145,0.88,1,-0.9212,0.58,0.91
"GO_BP:514266_GO_0060711_LABYRINTHINE_LAYER_DEVELOPMENT","GO_BP","514266_GO_0060711_LABYRINTHINE_LAYER_DEVELOPMENT",48,-1.6931,0.0014,0.038,-1.2124,0.18,0.88,-0.9994,0.46,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_2772_MIKKELSEN_MEF_LCP_WITH_H3K4ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2772_MIKKELSEN_MEF_LCP_WITH_H3K4ME3",127,-1.693,0,0.019,-0.944,0.61,1,-0.9375,0.61,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1265_ROSS_AML_WITH_PML_RARA_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_1265_ROSS_AML_WITH_PML_RARA_FUSION",76,-1.693,0.0013,0.018,-1.0259,0.39,0.98,-1.2272,0.13,0.5
"C7_Immunologic_signatures:C7_ALL_1355_GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1355_GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP",199,-1.693,0,0.00025,-0.6472,1,1,-1.3053,0.03,0.13
"GO_MF:513648_GO_0060090_BINDING_BRIDGING","GO_MF","513648_GO_0060090_BINDING_BRIDGING",153,-1.6929,0,0.072,0.9903,0.48,0.88,0.9141,0.7,0.94
"GO_CC:510821_GO_0048770_PIGMENT_GRANULE","GO_CC","510821_GO_0048770_PIGMENT_GRANULE",104,-1.6929,0.0013,0.059,0.9903,0.5,0.8,-1.0267,0.38,1
"GO_BP:512653_GO_0051781_POSITIVE_REGULATION_OF_CELL_DIVISION","GO_BP","512653_GO_0051781_POSITIVE_REGULATION_OF_CELL_DIVISION",116,-1.6928,0.0024,0.038,0.8954,0.67,1,-1.3098,0.044,0.64
"GO_BP:508462_GO_0046164_ALCOHOL_CATABOLIC_PROCESS","GO_BP","508462_GO_0046164_ALCOHOL_CATABOLIC_PROCESS",52,-1.6927,0,0.038,-0.7169,0.93,1,1.0339,0.38,0.82
"GO_BP:509004_GO_0046777_PROTEIN_AUTOPHOSPHORYLATION","GO_BP","509004_GO_0046777_PROTEIN_AUTOPHOSPHORYLATION",187,-1.6927,0,0.038,-1.3513,0.024,0.94,-1.5553,0.0021,0.51
"GO_BP:511797_GO_0050853_B_CELL_RECEPTOR_SIGNALING_PATHWAY","GO_BP","511797_GO_0050853_B_CELL_RECEPTOR_SIGNALING_PATHWAY",34,-1.6925,0.0014,0.038,-0.9338,0.58,1,-1.4231,0.049,0.57
"GO_BP:1022096_GO_0098659_INORGANIC_CATION_IMPORT_INTO_CELL","GO_BP","1022096_GO_0098659_INORGANIC_CATION_IMPORT_INTO_CELL",12,-1.6924,0.0051,0.038,-1.2281,0.21,0.88,-0.8581,0.63,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_3174_WANG_NFKB_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3174_WANG_NFKB_TARGETS",25,-1.6924,0.0015,0.019,-1.0235,0.42,0.98,0.9965,0.45,0.97
"GO_BP:510173_GO_0048003_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_LIPID_ANTIGEN_VIA_MHC_CLASS_IB","GO_BP","510173_GO_0048003_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_LIPID_ANTIGEN_VIA_MHC_CLASS_IB",7,-1.6923,0.017,0.038,-1.3304,0.15,0.9,-1.3582,0.15,0.6
"GO_BP:752201_GO_0061458_REPRODUCTIVE_SYSTEM_DEVELOPMENT","GO_BP","752201_GO_0061458_REPRODUCTIVE_SYSTEM_DEVELOPMENT",395,-1.6922,0,0.038,-0.9201,0.73,1,-1.0213,0.37,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1767_VERRECCHIA_RESPONSE_TO_TGFB1_C2","C2_Chemical_and_genetic_perturbations","C2_CGP_1767_VERRECCHIA_RESPONSE_TO_TGFB1_C2",25,-1.6922,0.0045,0.019,-1.0714,0.35,0.95,1.3245,0.089,0.62
"C7_Immunologic_signatures:C7_ALL_744_GSE17721_0_5H_VS_4H_CPG_BMDM_DN","C7_Immunologic_signatures","C7_ALL_744_GSE17721_0_5H_VS_4H_CPG_BMDM_DN",200,-1.6918,0,0.00025,0.8152,0.94,1,-0.8636,0.84,1
"GO_BP:492272_GO_0007519_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","492272_GO_0007519_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT",114,-1.6917,0.0024,0.038,-1.1098,0.25,0.94,-1.1365,0.17,0.75
"C7_Immunologic_signatures:C7_ALL_1786_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1786_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN",198,-1.6915,0,0.00025,-0.7605,0.98,1,-0.9897,0.48,0.75
"C6_Oncogenic_signatures:C6_ALL_174_KRAS_600_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_174_KRAS_600_UP_V1_DN",260,-1.6914,0,0.0025,-1.3983,0,0.38,-1.0585,0.27,0.59
"GO_BP:508223_GO_0045916_NEGATIVE_REGULATION_OF_COMPLEMENT_ACTIVATION","GO_BP","508223_GO_0045916_NEGATIVE_REGULATION_OF_COMPLEMENT_ACTIVATION",10,-1.6913,0.011,0.039,0.5098,0.99,1,0.9315,0.51,0.92
"GO_BP:491967_GO_0007162_NEGATIVE_REGULATION_OF_CELL_ADHESION","GO_BP","491967_GO_0007162_NEGATIVE_REGULATION_OF_CELL_ADHESION",189,-1.6912,0,0.038,-1.0486,0.36,0.97,0.7676,0.98,1
"GO_BP:510631_GO_0048566_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT","GO_BP","510631_GO_0048566_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT",34,-1.6911,0.0043,0.038,1.0157,0.46,0.97,1.3494,0.091,0.65
"KEGG_pathway:HSA04014_RAS_SIGNALING_PATHWAY","KEGG_pathway","HSA04014_RAS_SIGNALING_PATHWAY",212,-1.6909,0,0.0073,-0.877,0.81,0.99,0.9289,0.66,1
"GO_BP:513043_GO_0052200_RESPONSE_TO_HOST_DEFENSES","GO_BP","513043_GO_0052200_RESPONSE_TO_HOST_DEFENSES",14,-1.6907,0.014,0.039,1.0764,0.35,0.93,-0.6867,0.89,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2766_MIKKELSEN_MCV6_ICP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2766_MIKKELSEN_MCV6_ICP_WITH_H3K27ME3",70,-1.6907,0,0.019,-1.4462,0.023,0.53,-1.2316,0.13,0.49
"GO_BP:508594_GO_0046330_POSITIVE_REGULATION_OF_JNK_CASCADE","GO_BP","508594_GO_0046330_POSITIVE_REGULATION_OF_JNK_CASCADE",104,-1.6905,0.0013,0.039,-1.4498,0.017,0.9,-1.2238,0.11,0.71
"GO_BP:752385_GO_0086013_MEMBRANE_REPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL","GO_BP","752385_GO_0086013_MEMBRANE_REPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",9,-1.6905,0.012,0.039,-1.1676,0.27,0.91,-1.5204,0.055,0.53
"REACTOME:106516_REACT_13477_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES","REACTOME","106516_REACT_13477_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES",206,-1.6903,0,0.047,-1.5995,0,0.34,-1.4682,0.0021,0.38
"GO_BP:514261_GO_0060706_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT","GO_BP","514261_GO_0060706_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT",23,-1.6903,0.0031,0.039,-1.2726,0.17,0.89,-1.3965,0.08,0.58
"GO_BP:754916_GO_2000810_REGULATION_OF_TIGHT_JUNCTION_ASSEMBLY","GO_BP","754916_GO_2000810_REGULATION_OF_TIGHT_JUNCTION_ASSEMBLY",9,-1.6903,0.0099,0.039,-1.1114,0.32,0.94,-0.6472,0.89,1
"GO_BP:753173_GO_1900180_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS","GO_BP","753173_GO_1900180_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS",166,-1.6902,0,0.039,-1.0364,0.37,0.98,-1.6769,0,0.58
"GO_BP:504753_GO_0035574_HISTONE_H4_K20_DEMETHYLATION","GO_BP","504753_GO_0035574_HISTONE_H4_K20_DEMETHYLATION",15,-1.6902,0.013,0.039,-1.6059,0.031,0.71,-0.9547,0.52,0.89
"GO_BP:495024_GO_0010959_REGULATION_OF_METAL_ION_TRANSPORT","GO_BP","495024_GO_0010959_REGULATION_OF_METAL_ION_TRANSPORT",277,-1.6902,0,0.039,-1.2305,0.052,0.89,-1.0903,0.21,0.78
"C3_TF_targets:C3_TFT_442_V_SRF_Q4","C3_TF_targets","C3_TFT_442_V_SRF_Q4",216,-1.6901,0,0.0065,-1.0078,0.43,0.75,1.121,0.17,0.89
"C7_Immunologic_signatures:C7_ALL_566_GSE17721_PAM3CSK4_VS_CPG_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_566_GSE17721_PAM3CSK4_VS_CPG_1H_BMDM_DN",195,-1.6901,0,0.00026,-1.0624,0.32,1,-1.03,0.34,0.66
"KEGG_pathway:HSA05161_HEPATITIS_B","KEGG_pathway","HSA05161_HEPATITIS_B",142,-1.6897,0,0.0072,-0.8998,0.71,0.97,-1.5171,0.002,0.13
"C2_Chemical_and_genetic_perturbations:C2_CGP_1660_HARRIS_HYPOXIA","C2_Chemical_and_genetic_perturbations","C2_CGP_1660_HARRIS_HYPOXIA",79,-1.6895,0.0025,0.019,-0.9952,0.44,1,-0.9818,0.49,0.78
"WikiPathways:920993_WP585_INTERFERON_TYPE_I","WikiPathways","920993_WP585_INTERFERON_TYPE_I",49,-1.6895,0.0042,0.023,0.6454,0.99,1,-1.3512,0.06,0.39
"C7_Immunologic_signatures:C7_ALL_715_GSE17721_12H_VS_24H_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_715_GSE17721_12H_VS_24H_LPS_BMDM_UP",199,-1.6893,0,0.00026,-0.6219,1,1,-0.6945,1,1
"REACTOME:161070_REACT_20506_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS","REACTOME","161070_REACT_20506_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS",18,-1.6892,0.0089,0.047,-1.0863,0.33,0.9,-2.2472,0,0.00063
"C7_Immunologic_signatures:C7_ALL_1120_GSE2706_UNSTIM_VS_8H_LPS_DC_DN","C7_Immunologic_signatures","C7_ALL_1120_GSE2706_UNSTIM_VS_8H_LPS_DC_DN",196,-1.6892,0,0.00026,-0.7347,0.99,1,-1.106,0.23,0.48
"GO_BP:488613_GO_0002740_NEGATIVE_REGULATION_OF_CYTOKINE_SECRETION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488613_GO_0002740_NEGATIVE_REGULATION_OF_CYTOKINE_SECRETION_INVOLVED_IN_IMMUNE_RESPONSE",6,-1.6891,0,0.039,-1.1028,0.33,0.94,-1.0791,0.37,0.8
"WikiPathways:198824_WP100_GLUTATHIONE_METABOLISM","WikiPathways","198824_WP100_GLUTATHIONE_METABOLISM",19,-1.689,0.0095,0.022,-1.0141,0.44,1,-1.2977,0.11,0.44
"REACTOME:645310_REACT_120800_DERMATAN_SULFATE_BIOSYNTHESIS","REACTOME","645310_REACT_120800_DERMATAN_SULFATE_BIOSYNTHESIS",10,-1.6889,0.018,0.046,-1.2387,0.2,0.78,0.6689,0.91,1
"GO_CC:506263_GO_0043195_TERMINAL_BOUTON","GO_CC","506263_GO_0043195_TERMINAL_BOUTON",41,-1.6888,0.0043,0.061,-0.968,0.49,0.89,0.9743,0.51,1
"KEGG_pathway:HSA04320_DORSO_VENTRAL_AXIS_FORMATION","KEGG_pathway","HSA04320_DORSO_VENTRAL_AXIS_FORMATION",26,-1.6888,0.0029,0.0072,-1.1322,0.27,0.64,-0.7863,0.81,0.95
"GO_BP:508135_GO_0045806_NEGATIVE_REGULATION_OF_ENDOCYTOSIS","GO_BP","508135_GO_0045806_NEGATIVE_REGULATION_OF_ENDOCYTOSIS",38,-1.6886,0.0042,0.039,0.7435,0.88,1,0.7951,0.81,1
"GO_BP:492043_GO_0007264_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION","GO_BP","492043_GO_0007264_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION",425,-1.6885,0,0.039,-0.9923,0.48,1,-1.1485,0.091,0.74
"GO_BP:512366_GO_0051488_ACTIVATION_OF_ANAPHASE_PROMOTING_COMPLEX_ACTIVITY","GO_BP","512366_GO_0051488_ACTIVATION_OF_ANAPHASE_PROMOTING_COMPLEX_ACTIVITY",7,-1.6884,0.0086,0.039,-1.5043,0.06,0.82,-1.3998,0.11,0.58
"GO_CC:506271_GO_0043203_AXON_HILLOCK","GO_CC","506271_GO_0043203_AXON_HILLOCK",7,-1.6883,0.0082,0.06,-1.3017,0.18,0.65,-1.2342,0.24,0.73
"GO_BP:516371_GO_0071447_CELLULAR_RESPONSE_TO_HYDROPEROXIDE","GO_BP","516371_GO_0071447_CELLULAR_RESPONSE_TO_HYDROPEROXIDE",6,-1.6883,0.009,0.039,-1.0827,0.37,0.96,-1.5831,0.044,0.52
"GO_BP:505175_GO_0040017_POSITIVE_REGULATION_OF_LOCOMOTION","GO_BP","505175_GO_0040017_POSITIVE_REGULATION_OF_LOCOMOTION",334,-1.6881,0,0.039,1.1148,0.16,0.88,1.0818,0.21,0.77
"KEGG_compound:C01172_BETA_D_GLUCOSE_6_PHOSPHATE","KEGG_compound","C01172_BETA_D_GLUCOSE_6_PHOSPHATE",9,-1.6881,0.0099,0.045,-1.1053,0.34,0.93,-1.3377,0.13,0.34
"GO_BP:494731_GO_0010668_ECTODERMAL_CELL_DIFFERENTIATION","GO_BP","494731_GO_0010668_ECTODERMAL_CELL_DIFFERENTIATION",5,-1.6881,0.0053,0.039,-1.3084,0.16,0.88,0.7241,0.79,1
"C7_Immunologic_signatures:C7_ALL_915_GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP","C7_Immunologic_signatures","C7_ALL_915_GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP",199,-1.688,0,0.00026,0.9514,0.61,0.89,-1.0698,0.28,0.57
"GO_BP:487802_GO_0001911_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY","GO_BP","487802_GO_0001911_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY",11,-1.6878,0.013,0.039,0.7658,0.78,1,-0.7426,0.81,1
"GO_MF:506303_GO_0043236_LAMININ_BINDING","GO_MF","506303_GO_0043236_LAMININ_BINDING",27,-1.6878,0.0044,0.076,0.7329,0.88,1,1.0776,0.35,0.8
"GO_BP:518755_GO_2000106_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS","GO_BP","518755_GO_2000106_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS",81,-1.6876,0,0.039,0.726,0.97,1,-1.0414,0.36,0.82
"GO_BP:496218_GO_0016125_STEROL_METABOLIC_PROCESS","GO_BP","496218_GO_0016125_STEROL_METABOLIC_PROCESS",119,-1.6874,0,0.039,-0.7203,0.98,1,1.0846,0.28,0.77
"GO_BP:505029_GO_0035860_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","505029_GO_0035860_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY",5,-1.6874,0.01,0.039,-1.5805,0.029,0.72,-1.4236,0.094,0.57
"KEGG_pathway:HSA00140_STEROID_HORMONE_BIOSYNTHESIS","KEGG_pathway","HSA00140_STEROID_HORMONE_BIOSYNTHESIS",57,-1.6874,0.0053,0.0072,1.6647,0.0043,0.038,1.3223,0.092,0.46
"GO_BP:491618_GO_0006733_OXIDOREDUCTION_COENZYME_METABOLIC_PROCESS","GO_BP","491618_GO_0006733_OXIDOREDUCTION_COENZYME_METABOLIC_PROCESS",109,-1.6873,0,0.039,0.8093,0.9,1,-1.4531,0.017,0.54
"GO_BP:512773_GO_0051923_SULFATION","GO_BP","512773_GO_0051923_SULFATION",15,-1.6873,0.0063,0.039,1.0293,0.4,0.97,-0.9716,0.51,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1069_SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1069_SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN",414,-1.6872,0,0.019,-1.1997,0.054,0.79,1.2366,0.034,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_1061_FRIDMAN_SENESCENCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1061_FRIDMAN_SENESCENCE_UP",76,-1.6871,0.0013,0.019,-0.8666,0.73,1,-1.032,0.41,0.71
"GO_BP:499635_GO_0030225_MACROPHAGE_DIFFERENTIATION","GO_BP","499635_GO_0030225_MACROPHAGE_DIFFERENTIATION",17,-1.687,0.0078,0.039,-0.7397,0.83,1,1.3738,0.095,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_3156_ISSAEVA_MLL2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3156_ISSAEVA_MLL2_TARGETS",59,-1.687,0.0027,0.019,0.7245,0.93,1,1.2074,0.16,0.77
"GO_BP:487804_GO_0001913_T_CELL_MEDIATED_CYTOTOXICITY","GO_BP","487804_GO_0001913_T_CELL_MEDIATED_CYTOTOXICITY",9,-1.687,0.0035,0.039,-0.6346,0.93,1,-1.4005,0.091,0.58
"GO_BP:503513_GO_0034310_PRIMARY_ALCOHOL_CATABOLIC_PROCESS","GO_BP","503513_GO_0034310_PRIMARY_ALCOHOL_CATABOLIC_PROCESS",9,-1.687,0.0097,0.039,1.2679,0.19,0.71,-1.1156,0.34,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_1568_RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1568_RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN",28,-1.6868,0.0015,0.019,-1.6022,0.02,0.41,1.1004,0.32,0.88
"GO_BP:488810_GO_0003012_MUSCLE_SYSTEM_PROCESS","GO_BP","488810_GO_0003012_MUSCLE_SYSTEM_PROCESS",253,-1.6862,0,0.039,-1.3389,0.007,0.9,-1.1906,0.074,0.74
"KEGG_compound:C03205_11_DEOXYCORTICOSTERONE_DEOXYCORTICOSTERONE_CORTEXONE_21_HYDROXY_4_PREGNENE_3_20_DIONE_DESOXYCORTONE_DOC","KEGG_compound","C03205_11_DEOXYCORTICOSTERONE_DEOXYCORTICOSTERONE_CORTEXONE_21_HYDROXY_4_PREGNENE_3_20_DIONE_DESOXYCORTONE_DOC",8,-1.6861,0.0066,0.045,0.9143,0.56,1,1.0893,0.34,0.65
"GO_BP:510667_GO_0048608_REPRODUCTIVE_STRUCTURE_DEVELOPMENT","GO_BP","510667_GO_0048608_REPRODUCTIVE_STRUCTURE_DEVELOPMENT",391,-1.6861,0,0.039,-0.891,0.82,1,-0.9988,0.47,0.85
"C4_Cancer_gene_neighborhoods:C4_CGN_373_GNF2_MAPT","C4_Cancer_gene_neighborhoods","C4_CGN_373_GNF2_MAPT",40,-1.686,0.007,0.0095,-1.3507,0.085,0.51,1.0219,0.41,0.76
"GO_BP:508155_GO_0045834_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS","GO_BP","508155_GO_0045834_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS",104,-1.686,0,0.039,-0.9853,0.48,1,-0.9716,0.53,0.88
"GO_BP:505648_GO_0042517_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN","GO_BP","505648_GO_0042517_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN",29,-1.6859,0.0087,0.039,-1.6888,0.0075,0.58,-1.3156,0.11,0.64
"KEGG_pathway:HSA04630_JAK_STAT_SIGNALING_PATHWAY","KEGG_pathway","HSA04630_JAK_STAT_SIGNALING_PATHWAY",148,-1.6857,0,0.0072,-1.3119,0.026,0.39,-0.9296,0.64,0.81
"REACTOME:106146_REACT_11041_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL","REACTOME","106146_REACT_11041_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL",24,-1.6857,0.011,0.047,1.1547,0.25,0.5,-0.8631,0.69,0.97
"GO_BP:493824_GO_0009712_CATECHOL_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","493824_GO_0009712_CATECHOL_CONTAINING_COMPOUND_METABOLIC_PROCESS",44,-1.6856,0.0028,0.039,-0.953,0.53,1,-1.3822,0.055,0.59
"GO_BP:516201_GO_0071277_CELLULAR_RESPONSE_TO_CALCIUM_ION","GO_BP","516201_GO_0071277_CELLULAR_RESPONSE_TO_CALCIUM_ION",37,-1.6856,0.0042,0.039,-0.7186,0.91,1,-1.0032,0.42,0.85
"REACTOME:106415_REACT_12582_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS","REACTOME","106415_REACT_12582_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS",18,-1.6855,0.0095,0.047,1.1422,0.26,0.52,-1.3995,0.092,0.42
"WikiPathways:198847_WP399_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY","WikiPathways","198847_WP399_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY",101,-1.6854,0.0012,0.023,-1.2077,0.13,0.86,-1.019,0.39,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_2073_MARSON_FOXP3_TARGETS_STIMULATED_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2073_MARSON_FOXP3_TARGETS_STIMULATED_DN",10,-1.6851,0.011,0.02,-1.47,0.069,0.51,-1.388,0.1,0.36
"GO_BP:488585_GO_0002712_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY","GO_BP","488585_GO_0002712_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY",43,-1.6851,0.0041,0.04,-1.5764,0.014,0.74,-1.1472,0.25,0.74
"C7_Immunologic_signatures:C7_ALL_681_GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_681_GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDM_UP",195,-1.6851,0,0.00027,-0.7635,0.98,1,-1.1804,0.1,0.32
"C6_Oncogenic_signatures:C6_ALL_171_KRAS_300_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_171_KRAS_300_UP_V1_UP",133,-1.6851,0,0.0025,-0.863,0.77,0.96,1.3523,0.03,0.17
"GO_MF:510193_GO_0048029_MONOSACCHARIDE_BINDING","GO_MF","510193_GO_0048029_MONOSACCHARIDE_BINDING",64,-1.685,0.004,0.077,-0.832,0.77,1,-1.2646,0.11,0.58
"GO_MF:490178_GO_0004879_LIGAND_ACTIVATED_SEQUENCE_SPECIFIC_DNA_BINDING_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_ACTIVITY","GO_MF","490178_GO_0004879_LIGAND_ACTIVATED_SEQUENCE_SPECIFIC_DNA_BINDING_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_ACTIVITY",48,-1.6849,0.0027,0.076,-1.056,0.35,0.87,-0.9797,0.47,0.8
"GO_BP:495015_GO_0010950_POSITIVE_REGULATION_OF_ENDOPEPTIDASE_ACTIVITY","GO_BP","495015_GO_0010950_POSITIVE_REGULATION_OF_ENDOPEPTIDASE_ACTIVITY",139,-1.6849,0,0.04,0.9313,0.66,1,-1.4034,0.0082,0.58
"C4_Cancer_modules:C4_CM_276_MODULE_316","C4_Cancer_modules","C4_CM_276_MODULE_316",69,-1.6849,0.0013,0.015,-1.5148,0.0076,0.35,1.4447,0.018,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_2752_MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2752_MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP",12,-1.6848,0.0083,0.02,-0.5996,0.95,1,-1.6483,0.016,0.22
"GO_BP:499961_GO_0030656_REGULATION_OF_VITAMIN_METABOLIC_PROCESS","GO_BP","499961_GO_0030656_REGULATION_OF_VITAMIN_METABOLIC_PROCESS",11,-1.6848,0.0066,0.04,-1.6006,0.025,0.69,-1.5739,0.039,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_3384_ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF","C2_Chemical_and_genetic_perturbations","C2_CGP_3384_ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF",46,-1.6847,0.0055,0.02,-1.5077,0.015,0.45,-1.0532,0.34,0.68
"GO_BP:500102_GO_0030803_NEGATIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","500102_GO_0030803_NEGATIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",38,-1.6846,0,0.04,0.9885,0.47,0.99,1.6498,0.01,0.39
"REACTOME:730332_REACT_150352_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL","REACTOME","730332_REACT_150352_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL",11,-1.6845,0.013,0.047,-1.4399,0.072,0.51,0.547,0.98,1
"C7_Immunologic_signatures:C7_ALL_1494_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN","C7_Immunologic_signatures","C7_ALL_1494_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN",197,-1.6844,0,0.00027,-1.2245,0.067,0.75,-1.3325,0.018,0.11
"C2_Chemical_and_genetic_perturbations:C2_CGP_316_ELVIDGE_HIF1A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_316_ELVIDGE_HIF1A_TARGETS_DN",91,-1.6842,0.0012,0.02,-0.7966,0.9,1,-1.2114,0.13,0.51
"WikiPathways:198826_WP304_KIT_RECEPTOR_SIGNALING_PATHWAY","WikiPathways","198826_WP304_KIT_RECEPTOR_SIGNALING_PATHWAY",66,-1.6841,0.0013,0.022,-0.8033,0.84,1,-0.8972,0.67,0.86
"C4_Cancer_gene_neighborhoods:C4_CGN_411_GNF2_SPRR1B","C4_Cancer_gene_neighborhoods","C4_CGN_411_GNF2_SPRR1B",17,-1.6839,0.0078,0.0097,-1.0424,0.39,0.82,1.2885,0.16,0.31
"REACTOME:106401_REACT_6809_MYD88_INDEPENDENT_TLR3_TLR4_CASCADE","REACTOME","106401_REACT_6809_MYD88_INDEPENDENT_TLR3_TLR4_CASCADE",100,-1.6839,0.0013,0.047,-0.7586,0.93,1,-1.0484,0.34,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2553_SCHRAETS_MLL_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2553_SCHRAETS_MLL_TARGETS_DN",33,-1.6838,0.0099,0.02,1.547,0.032,0.17,0.989,0.47,0.97
"GO_BP:499472_GO_0030004_CELLULAR_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS","GO_BP","499472_GO_0030004_CELLULAR_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS",63,-1.6836,0.0013,0.04,-1.3409,0.06,0.91,-1.2382,0.12,0.69
"C7_Immunologic_signatures:C7_ALL_852_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN","C7_Immunologic_signatures","C7_ALL_852_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN",188,-1.6834,0,0.00027,-1.314,0.026,0.43,-1.6147,0,0.004
"GO_CC:517467_GO_0072562_BLOOD_MICROPARTICLE","GO_CC","517467_GO_0072562_BLOOD_MICROPARTICLE",111,-1.6833,0.0013,0.062,1.1861,0.14,0.54,-1.1512,0.17,0.86
"GO_BP:490984_GO_0005996_MONOSACCHARIDE_METABOLIC_PROCESS","GO_BP","490984_GO_0005996_MONOSACCHARIDE_METABOLIC_PROCESS",242,-1.6831,0,0.04,0.7842,0.99,1,-1.333,0.017,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_576_WONG_ENDOMETRIAL_CANCER_LATE","C2_Chemical_and_genetic_perturbations","C2_CGP_576_WONG_ENDOMETRIAL_CANCER_LATE",9,-1.6831,0.01,0.02,-0.9615,0.51,1,-1.369,0.11,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_3358_ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3358_ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP",280,-1.6831,0,0.02,1.0057,0.47,0.79,-1.0473,0.31,0.69
"GO_MF:517257_GO_0072341_MODIFIED_AMINO_ACID_BINDING","GO_MF","517257_GO_0072341_MODIFIED_AMINO_ACID_BINDING",51,-1.683,0.0053,0.077,-1.2186,0.16,0.84,-1.313,0.095,0.56
"GO_BP:501879_GO_0032653_REGULATION_OF_INTERLEUKIN_10_PRODUCTION","GO_BP","501879_GO_0032653_REGULATION_OF_INTERLEUKIN_10_PRODUCTION",39,-1.683,0.01,0.04,-1.2072,0.18,0.88,-1.1333,0.27,0.75
"C7_Immunologic_signatures:C7_ALL_1761_GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1761_GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP",177,-1.6829,0,0.00027,1.0978,0.22,0.45,-1.3092,0.035,0.13
"C7_Immunologic_signatures:C7_ALL_1393_GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP","C7_Immunologic_signatures","C7_ALL_1393_GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP",197,-1.6829,0,0.00027,1.3285,0.017,0.078,0.7938,0.96,1
"C3_TF_targets:C3_TFT_455_V_SRF_Q5_01","C3_TF_targets","C3_TFT_455_V_SRF_Q5_01",217,-1.6828,0,0.0072,-0.8775,0.8,0.99,1.0994,0.22,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2050_LEIN_OLIGODENDROCYTE_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_2050_LEIN_OLIGODENDROCYTE_MARKERS",71,-1.6827,0.0013,0.02,-1.0681,0.33,0.96,0.9609,0.53,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2927_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1","C2_Chemical_and_genetic_perturbations","C2_CGP_2927_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1",68,-1.6826,0.0027,0.02,-0.9077,0.64,1,-0.9848,0.49,0.78
"GO_BP:511745_GO_0050774_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS","GO_BP","511745_GO_0050774_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS",9,-1.6825,0.0081,0.04,-0.7562,0.79,1,-0.6921,0.86,0.99
"GO_BP:508592_GO_0046328_REGULATION_OF_JNK_CASCADE","GO_BP","508592_GO_0046328_REGULATION_OF_JNK_CASCADE",146,-1.6824,0,0.04,-1.3017,0.043,0.89,-1.1898,0.11,0.74
"GO_BP:496230_GO_0016137_GLYCOSIDE_METABOLIC_PROCESS","GO_BP","496230_GO_0016137_GLYCOSIDE_METABOLIC_PROCESS",16,-1.6822,0.011,0.04,-0.9962,0.46,0.99,-0.7601,0.8,1
"REACTOME:106390_REACT_6788_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE","REACTOME","106390_REACT_6788_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE",95,-1.6817,0,0.048,-0.6291,1,1,-1.1293,0.22,0.68
"C0_Hallmark:H_ALL_44_HALLMARK_BILE_ACID_METABOLISM","C0_Hallmark","H_ALL_44_HALLMARK_BILE_ACID_METABOLISM",109,-1.6817,0,0.0017,-0.9414,0.6,0.91,-1.5858,0.0083,0.018
"REACTOME:106400_REACT_6890_ACTIVATED_TLR4_SIGNALLING","REACTOME","106400_REACT_6890_ACTIVATED_TLR4_SIGNALLING",114,-1.6817,0.0012,0.047,-0.702,0.98,1,-1.1319,0.23,0.67
"C7_Immunologic_signatures:C7_ALL_656_GSE17721_LPS_VS_CPG_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_656_GSE17721_LPS_VS_CPG_1H_BMDM_DN",197,-1.6817,0.0011,0.00027,-1.5748,0,0.024,-1.4508,0,0.034
"C2_Chemical_and_genetic_perturbations:C2_CGP_2595_LEE_NAIVE_T_LYMPHOCYTE","C2_Chemical_and_genetic_perturbations","C2_CGP_2595_LEE_NAIVE_T_LYMPHOCYTE",19,-1.6817,0.011,0.02,-0.7558,0.83,1,1.0004,0.45,0.96
"C7_Immunologic_signatures:C7_ALL_150_GSE13306_TREG_VS_TCONV_SPLEEN_DN","C7_Immunologic_signatures","C7_ALL_150_GSE13306_TREG_VS_TCONV_SPLEEN_DN",196,-1.6816,0,0.00027,0.8581,0.87,1,-0.9971,0.43,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2709_BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2709_BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN",50,-1.6814,0.004,0.02,0.8852,0.68,0.94,-1.2252,0.17,0.5
"C4_Cancer_modules:C4_CM_80_MODULE_85","C4_Cancer_modules","C4_CM_80_MODULE_85",51,-1.6814,0.0054,0.016,-0.8677,0.7,0.93,-0.8954,0.67,0.85
"KEGG_pathway:HSA04730_LONG_TERM_DEPRESSION","KEGG_pathway","HSA04730_LONG_TERM_DEPRESSION",60,-1.6813,0,0.0075,-0.7887,0.87,1,-0.9663,0.51,0.76
"C4_Cancer_gene_neighborhoods:C4_CGN_339_GNF2_CEBPA","C4_Cancer_gene_neighborhoods","C4_CGN_339_GNF2_CEBPA",64,-1.6813,0.0038,0.0098,-1.1601,0.19,0.65,1.2998,0.079,0.3
"GO_BP:491679_GO_0006809_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS","GO_BP","491679_GO_0006809_NITRIC_OXIDE_BIOSYNTHETIC_PROCESS",14,-1.6813,0.02,0.041,-1.3118,0.14,0.87,0.6669,0.91,1
"REACTOME:106402_REACT_7980_TOLL_LIKE_RECEPTOR_2_TLR2_CASCADE","REACTOME","106402_REACT_7980_TOLL_LIKE_RECEPTOR_2_TLR2_CASCADE",95,-1.6812,0,0.047,-0.6375,0.99,1,-1.1233,0.23,0.68
"GO_BP:517246_GO_0072330_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS","GO_BP","517246_GO_0072330_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS",166,-1.681,0,0.041,1.0526,0.31,0.95,-1.3583,0.013,0.6
"C4_Cancer_modules:C4_CM_161_MODULE_171","C4_Cancer_modules","C4_CM_161_MODULE_171",133,-1.6809,0,0.016,1.6363,0.0023,0.065,-1.194,0.13,0.4
"GO_BP:518765_GO_2000116_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_BP","518765_GO_2000116_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",216,-1.6807,0,0.041,0.9336,0.66,1,-1.3343,0.0063,0.62
"GO_BP:513011_GO_0052166_POSITIVE_REGULATION_BY_SYMBIONT_OF_HOST_INNATE_IMMUNE_RESPONSE","GO_BP","513011_GO_0052166_POSITIVE_REGULATION_BY_SYMBIONT_OF_HOST_INNATE_IMMUNE_RESPONSE",6,-1.6807,0.0052,0.041,0.7939,0.73,1,-0.8633,0.64,0.95
"GO_BP:510559_GO_0048485_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT","GO_BP","510559_GO_0048485_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT",22,-1.6807,0.0077,0.041,-1.1419,0.29,0.93,0.9299,0.54,0.92
"GO_BP:513151_GO_0052308_PATHOGEN_ASSOCIATED_MOLECULAR_PATTERN_DEPENDENT_MODULATION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513151_GO_0052308_PATHOGEN_ASSOCIATED_MOLECULAR_PATTERN_DEPENDENT_MODULATION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",6,-1.6807,0.012,0.041,0.7961,0.72,1,-0.8803,0.61,0.94
"GO_BP:488156_GO_0002283_NEUTROPHIL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488156_GO_0002283_NEUTROPHIL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",11,-1.6806,0.0063,0.041,1.1622,0.27,0.82,-0.5983,0.96,1
"C7_Immunologic_signatures:C7_ALL_1543_GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1543_GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP",197,-1.6806,0,0.00027,1.0164,0.39,0.69,-1.8146,0,0.00012
"GO_BP:516726_GO_0071803_POSITIVE_REGULATION_OF_PODOSOME_ASSEMBLY","GO_BP","516726_GO_0071803_POSITIVE_REGULATION_OF_PODOSOME_ASSEMBLY",7,-1.6804,0.012,0.041,-1.1784,0.27,0.91,-0.8496,0.66,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2614_HAN_SATB1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2614_HAN_SATB1_TARGETS_DN",440,-1.68,0,0.021,0.8632,0.95,0.96,0.9022,0.85,1
"C7_Immunologic_signatures:C7_ALL_903_GSE20715_0H_VS_6H_OZONE_LUNG_UP","C7_Immunologic_signatures","C7_ALL_903_GSE20715_0H_VS_6H_OZONE_LUNG_UP",200,-1.68,0,0.00027,0.7712,0.98,1,-1.2576,0.062,0.19
"GO_BP:510181_GO_0048013_EPHRIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","510181_GO_0048013_EPHRIN_RECEPTOR_SIGNALING_PATHWAY",91,-1.68,0,0.041,0.9389,0.59,1,-0.9834,0.47,0.87
"GO_BP:516821_GO_0071901_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY","GO_BP","516821_GO_0071901_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",124,-1.6799,0,0.041,-0.6634,1,1,0.8403,0.85,0.99
"GO_BP:510175_GO_0048007_ANTIGEN_PROCESSING_AND_PRESENTATION_EXOGENOUS_LIPID_ANTIGEN_VIA_MHC_CLASS_IB","GO_BP","510175_GO_0048007_ANTIGEN_PROCESSING_AND_PRESENTATION_EXOGENOUS_LIPID_ANTIGEN_VIA_MHC_CLASS_IB",7,-1.6799,0.01,0.041,-1.3655,0.14,0.99,-1.3358,0.15,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_1952_WANG_SMARCE1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1952_WANG_SMARCE1_TARGETS_UP",277,-1.6799,0,0.021,1.2666,0.032,0.42,1.2678,0.029,0.7
"C4_Cancer_modules:C4_CM_268_MODULE_306","C4_Cancer_modules","C4_CM_268_MODULE_306",26,-1.6799,0.0045,0.016,1.2545,0.14,0.32,-1.9087,0,0.024
"C2_Chemical_and_genetic_perturbations:C2_CGP_1986_WENG_POR_TARGETS_LIVER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1986_WENG_POR_TARGETS_LIVER_DN",19,-1.6799,0.0093,0.021,-0.8884,0.61,1,-1.2866,0.13,0.44
"GO_BP:752000_GO_0052803_IMIDAZOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","752000_GO_0052803_IMIDAZOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS",9,-1.6799,0.0098,0.041,0.5491,0.99,1,-0.8063,0.73,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_513_HAMAI_APOPTOSIS_VIA_TRAIL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_513_HAMAI_APOPTOSIS_VIA_TRAIL_DN",175,-1.6797,0,0.021,-1.0124,0.42,0.99,0.9683,0.55,0.97
"GO_BP:492544_GO_0008203_CHOLESTEROL_METABOLIC_PROCESS","GO_BP","492544_GO_0008203_CHOLESTEROL_METABOLIC_PROCESS",106,-1.6796,0,0.041,-0.8768,0.74,1,1.007,0.41,0.85
"GO_BP:754572_GO_1901616_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS","GO_BP","754572_GO_1901616_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS",66,-1.6794,0.0013,0.041,0.9005,0.67,1,1.1459,0.2,0.73
"KEGG_compound:C00029_UDP_GLUCOSE_UDPGLUCOSE_UDP_D_GLUCOSE_URIDINE_DIPHOSPHATE_GLUCOSE_UDP_ALPHA_D_GLUCOSE","KEGG_compound","C00029_UDP_GLUCOSE_UDPGLUCOSE_UDP_D_GLUCOSE_URIDINE_DIPHOSPHATE_GLUCOSE_UDP_ALPHA_D_GLUCOSE",11,-1.6794,0.013,0.048,-1.0439,0.4,0.99,-1.543,0.035,0.2
"C4_Cancer_modules:C4_CM_121_MODULE_126","C4_Cancer_modules","C4_CM_121_MODULE_126",181,-1.6794,0,0.016,0.7234,1,1,-1.2346,0.071,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_2895_DORN_ADENOVIRUS_INFECTION_24HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2895_DORN_ADENOVIRUS_INFECTION_24HR_DN",41,-1.6793,0.0014,0.021,-1.1884,0.19,0.81,0.7555,0.88,1
"GO_BP:488405_GO_0002532_PRODUCTION_OF_MOLECULAR_MEDIATOR_INVOLVED_IN_INFLAMMATORY_RESPONSE","GO_BP","488405_GO_0002532_PRODUCTION_OF_MOLECULAR_MEDIATOR_INVOLVED_IN_INFLAMMATORY_RESPONSE",19,-1.6792,0.012,0.041,1.0281,0.41,0.97,-0.9708,0.48,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_384_LANDIS_BREAST_CANCER_PROGRESSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_384_LANDIS_BREAST_CANCER_PROGRESSION_DN",70,-1.6791,0.0039,0.021,0.89,0.69,0.94,-1.1111,0.25,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_13_PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_13_PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP",203,-1.6791,0,0.021,1.0678,0.29,0.68,1.5014,0.0038,0.48
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_49_BIOCARTA_CELLCYCLE_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_49_BIOCARTA_CELLCYCLE_PATHWAY",23,-1.6791,0.0029,0.058,-0.5662,0.98,1,-1.304,0.12,0.52
"GO_BP:508882_GO_0046634_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION","GO_BP","508882_GO_0046634_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION",69,-1.679,0.0013,0.041,-0.8499,0.75,1,-0.9281,0.6,0.9
"GO_BP:513149_GO_0052306_MODULATION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513149_GO_0052306_MODULATION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",6,-1.6789,0.0053,0.041,0.8018,0.71,1,-0.8642,0.65,0.95
"GO_MF:504754_GO_0035575_HISTONE_DEMETHYLASE_ACTIVITY_H4_K20_SPECIFIC_","GO_MF","504754_GO_0035575_HISTONE_DEMETHYLASE_ACTIVITY_H4_K20_SPECIFIC_",15,-1.6788,0.017,0.079,-1.5842,0.039,0.47,-0.9721,0.48,0.8
"GO_BP:501722_GO_0032490_DETECTION_OF_MOLECULE_OF_BACTERIAL_ORIGIN","GO_BP","501722_GO_0032490_DETECTION_OF_MOLECULE_OF_BACTERIAL_ORIGIN",10,-1.6787,0.011,0.041,-1.1228,0.31,0.94,0.8537,0.65,0.98
"GO_BP:512483_GO_0051607_DEFENSE_RESPONSE_TO_VIRUS","GO_BP","512483_GO_0051607_DEFENSE_RESPONSE_TO_VIRUS",148,-1.6787,0,0.041,1.2345,0.074,0.75,-1.825,0,0.6
"REACTOME:106391_REACT_6783_TOLL_LIKE_RECEPTOR_3_TLR3_CASCADE","REACTOME","106391_REACT_6783_TOLL_LIKE_RECEPTOR_3_TLR3_CASCADE",100,-1.6787,0,0.048,-0.7671,0.91,1,-1.0421,0.36,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_3144_KIM_GLIS2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3144_KIM_GLIS2_TARGETS_UP",82,-1.6787,0.0026,0.021,0.9837,0.49,0.81,0.9217,0.61,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2950_MOOTHA_GLYCOLYSIS","C2_Chemical_and_genetic_perturbations","C2_CGP_2950_MOOTHA_GLYCOLYSIS",21,-1.6786,0.0076,0.021,-0.9799,0.47,1,-1.1107,0.33,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_874_CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_874_CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP",21,-1.6786,0.012,0.021,-0.8805,0.62,1,-1.4652,0.049,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_2985_NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2985_NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN",20,-1.6785,0.009,0.021,-1.1915,0.22,0.8,-1.409,0.088,0.35
"GO_BP:498794_GO_0021510_SPINAL_CORD_DEVELOPMENT","GO_BP","498794_GO_0021510_SPINAL_CORD_DEVELOPMENT",86,-1.6785,0.0013,0.041,-1.2933,0.067,0.88,1.0661,0.33,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_1049_FUJIWARA_PARK2_IN_LIVER_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1049_FUJIWARA_PARK2_IN_LIVER_CANCER_UP",8,-1.6783,0.0087,0.021,-1.783,0.0059,0.36,-0.8026,0.72,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2507_CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2507_CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN",100,-1.6782,0,0.021,1.6584,0,0.11,-1.3469,0.039,0.4
"KEGG_compound:C00427_PROSTAGLANDIN_H2_5Z_13E_15S_9ALPHA_11ALPHA_EPIDIOXY_15_HYDROXYPROSTA_5_13_DIENOATE_5Z_13E_15S_9ALPHA_11ALPHA_EPIDIOXY_15_HYDROXYPROSTA_5_13_DIENOATE_PGH2_5Z_9ALPHA_11ALPHA_13E_15S_9_11_EPIDIOXY_15_HYDROXY_PROSTA_5_13_DIENOATE","KEGG_compound","C00427_PROSTAGLANDIN_H2_5Z_13E_15S_9ALPHA_11ALPHA_EPIDIOXY_15_HYDROXYPROSTA_5_13_DIENOATE_5Z_13E_15S_9ALPHA_11ALPHA_EPIDIOXY_15_HYDROXYPROSTA_5_13_DIENOATE_PGH2_5Z_9ALPHA_11ALPHA_13E_15S_9_11_EPIDIOXY_15_HYDROXY_PROSTA_5_13_DIENOATE",10,-1.6781,0.0033,0.048,-0.9863,0.47,1,-1.1384,0.28,0.51
"GO_BP:491771_GO_0006919_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_BP","491771_GO_0006919_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",90,-1.678,0.0013,0.041,0.7734,0.92,1,-1.4425,0.029,0.56
"C2_Chemical_and_genetic_perturbations:C2_CGP_2884_ZHAN_MULTIPLE_MYELOMA_MF_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2884_ZHAN_MULTIPLE_MYELOMA_MF_DN",40,-1.6778,0.01,0.021,0.8374,0.76,0.98,-1.2087,0.18,0.51
"GO_BP:511644_GO_0050672_NEGATIVE_REGULATION_OF_LYMPHOCYTE_PROLIFERATION","GO_BP","511644_GO_0050672_NEGATIVE_REGULATION_OF_LYMPHOCYTE_PROLIFERATION",55,-1.6777,0.0041,0.041,-0.6376,0.99,1,0.7384,0.93,1
"GO_MF:514145_GO_0060590_ATPASE_REGULATOR_ACTIVITY","GO_MF","514145_GO_0060590_ATPASE_REGULATOR_ACTIVITY",20,-1.6777,0.0059,0.08,-1.1855,0.22,0.79,-1.1385,0.28,0.66
"C3_TF_targets:C3_TFT_541_YATTNATC_UNKNOWN","C3_TF_targets","C3_TFT_541_YATTNATC_UNKNOWN",363,-1.6777,0,0.0073,-1.2263,0.048,0.3,-1.1896,0.033,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_273_SENESE_HDAC1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_273_SENESE_HDAC1_TARGETS_UP",447,-1.6777,0,0.021,0.9269,0.8,0.89,-0.9036,0.84,0.88
"C7_Immunologic_signatures:C7_ALL_1303_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1303_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP",189,-1.6776,0,0.00029,-1.263,0.044,0.58,1.0003,0.43,1
"KEGG_pathway:HSA00062_FATTY_ACID_ELONGATION","KEGG_pathway","HSA00062_FATTY_ACID_ELONGATION",25,-1.6775,0.0029,0.0077,0.4765,0.99,1,-1.588,0.025,0.099
"GO_BP:507243_GO_0044236_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS","GO_BP","507243_GO_0044236_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS",94,-1.6773,0.0025,0.041,-1.1486,0.2,0.93,1.3908,0.04,0.63
"C7_Immunologic_signatures:C7_ALL_846_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN","C7_Immunologic_signatures","C7_ALL_846_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN",193,-1.6772,0,0.00029,-0.8319,0.91,1,-1.6215,0,0.0034
"GO_BP:502059_GO_0032836_GLOMERULAR_BASEMENT_MEMBRANE_DEVELOPMENT","GO_BP","502059_GO_0032836_GLOMERULAR_BASEMENT_MEMBRANE_DEVELOPMENT",10,-1.6772,0.0098,0.041,-0.7897,0.74,1,-1.0125,0.45,0.84
"GO_BP:505291_GO_0042119_NEUTROPHIL_ACTIVATION","GO_BP","505291_GO_0042119_NEUTROPHIL_ACTIVATION",21,-1.6772,0.012,0.041,1.3757,0.083,0.58,0.9881,0.47,0.87
"GO_BP:503318_GO_0034112_POSITIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION","GO_BP","503318_GO_0034112_POSITIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION",187,-1.6771,0,0.041,0.9372,0.64,1,-1.092,0.23,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_1025_GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1025_GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN",26,-1.6771,0.003,0.021,0.6095,0.97,1,1.3898,0.089,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_1784_LU_AGING_BRAIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1784_LU_AGING_BRAIN_UP",256,-1.6769,0,0.021,1.0098,0.39,0.78,-1.1272,0.18,0.6
"GO_MF:496569_GO_0016628_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR","GO_MF","496569_GO_0016628_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR",23,-1.6767,0.0072,0.08,-0.7131,0.89,1,-1.3429,0.096,0.54
"GO_BP:489296_GO_0006936_MUSCLE_CONTRACTION","GO_BP","489296_GO_0006936_MUSCLE_CONTRACTION",208,-1.6764,0,0.042,-1.3685,0.0086,0.99,-1.3598,0.0082,0.6
"GO_BP:508116_GO_0045779_NEGATIVE_REGULATION_OF_BONE_RESORPTION","GO_BP","508116_GO_0045779_NEGATIVE_REGULATION_OF_BONE_RESORPTION",8,-1.6763,0.0053,0.042,0.666,0.87,1,-0.8887,0.57,0.93
"GO_BP:487824_GO_0001933_NEGATIVE_REGULATION_OF_PROTEIN_PHOSPHORYLATION","GO_BP","487824_GO_0001933_NEGATIVE_REGULATION_OF_PROTEIN_PHOSPHORYLATION",285,-1.6762,0,0.042,0.8374,0.94,1,-1.0201,0.36,0.83
"KEGG_module:HSA_M00002_GLYCOLYSIS_CORE_MODULE_INVOLVING_THREE_CARBON_COMPOUNDS","KEGG_module","HSA_M00002_GLYCOLYSIS_CORE_MODULE_INVOLVING_THREE_CARBON_COMPOUNDS",12,-1.6762,0.0063,0.098,-1.1212,0.33,1,-1.2481,0.16,0.46
"GO_MF:490451_GO_0005200_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON","GO_MF","490451_GO_0005200_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON",97,-1.6761,0.0038,0.079,1.2076,0.12,0.7,-1.3041,0.07,0.57
"KEGG_pathway:HSA04022_CGMP_PKG_SIGNALING_PATHWAY","KEGG_pathway","HSA04022_CGMP_PKG_SIGNALING_PATHWAY",164,-1.6761,0,0.0078,-1.1611,0.14,0.59,-1.1079,0.24,0.5
"C7_Immunologic_signatures:C7_ALL_930_GSE22886_NAIVE_TCELL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_930_GSE22886_NAIVE_TCELL_VS_NKCELL_DN",198,-1.676,0,3e-04,-0.6551,1,1,1.0458,0.33,1
"GO_MF:499583_GO_0030165_PDZ_DOMAIN_BINDING","GO_MF","499583_GO_0030165_PDZ_DOMAIN_BINDING",86,-1.676,0.0013,0.079,-0.8688,0.74,1,-0.9467,0.57,0.84
"GO_BP:491802_GO_0006959_HUMORAL_IMMUNE_RESPONSE","GO_BP","491802_GO_0006959_HUMORAL_IMMUNE_RESPONSE",135,-1.676,0,0.042,1.1113,0.22,0.89,1.0288,0.38,0.82
"C0_Hallmark:H_ALL_25_HALLMARK_PI3K_AKT_MTOR_SIGNALING","C0_Hallmark","H_ALL_25_HALLMARK_PI3K_AKT_MTOR_SIGNALING",102,-1.6758,0.0013,0.0018,-0.8458,0.78,1,-1.2377,0.11,0.15
"REACTOME:106403_REACT_8005_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE","REACTOME","106403_REACT_8005_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE",95,-1.6758,0,0.049,-0.6349,0.99,1,-1.1203,0.22,0.68
"GO_MF:911389_GO_0098531_DIRECT_LIGAND_REGULATED_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY","GO_MF","911389_GO_0098531_DIRECT_LIGAND_REGULATED_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",48,-1.6758,0.0068,0.078,-1.0419,0.36,0.87,-0.9612,0.52,0.82
"GO_BP:989119_GO_1903054_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION","GO_BP","989119_GO_1903054_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION",5,-1.6758,0.0035,0.042,-0.9975,0.47,0.99,-1.5493,0.03,0.52
"GO_BP:516167_GO_0071242_CELLULAR_RESPONSE_TO_AMMONIUM_ION","GO_BP","516167_GO_0071242_CELLULAR_RESPONSE_TO_AMMONIUM_ION",19,-1.6757,0.0045,0.042,-1.0969,0.33,0.94,0.9431,0.52,0.91
"GO_MF:490259_GO_0004969_HISTAMINE_RECEPTOR_ACTIVITY","GO_MF","490259_GO_0004969_HISTAMINE_RECEPTOR_ACTIVITY",6,-1.6757,0.0034,0.077,-1.3663,0.14,0.68,-0.9014,0.56,0.87
"GO_BP:502094_GO_0032872_REGULATION_OF_STRESS_ACTIVATED_MAPK_CASCADE","GO_BP","502094_GO_0032872_REGULATION_OF_STRESS_ACTIVATED_MAPK_CASCADE",172,-1.6757,0,0.042,-1.128,0.2,0.93,-1.099,0.23,0.77
"GO_BP:511681_GO_0050710_NEGATIVE_REGULATION_OF_CYTOKINE_SECRETION","GO_BP","511681_GO_0050710_NEGATIVE_REGULATION_OF_CYTOKINE_SECRETION",34,-1.6756,0,0.042,-0.5346,1,1,0.9217,0.61,0.92
"GO_BP:488712_GO_0002839_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE_TO_TUMOR_CELL","GO_BP","488712_GO_0002839_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE_TO_TUMOR_CELL",9,-1.6756,0.013,0.042,0.71,0.86,1,0.7432,0.78,1
"GO_MF:492790_GO_0008510_SODIUM_BICARBONATE_SYMPORTER_ACTIVITY","GO_MF","492790_GO_0008510_SODIUM_BICARBONATE_SYMPORTER_ACTIVITY",6,-1.6756,0.0034,0.077,-1.5818,0.055,0.46,-0.9652,0.48,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_2767_MIKKELSEN_MCV6_LCP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2767_MIKKELSEN_MCV6_LCP_WITH_H3K27ME3",25,-1.6753,0.011,0.021,-1.0745,0.35,0.95,-1.5258,0.029,0.29
"GO_BP:505647_GO_0042516_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN","GO_BP","505647_GO_0042516_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN",35,-1.6752,0.0028,0.042,-1.6785,0.0059,0.59,-1.3395,0.087,0.61
"C4_Cancer_modules:C4_CM_48_MODULE_52","C4_Cancer_modules","C4_CM_48_MODULE_52",422,-1.6752,0,0.016,1.0953,0.18,0.54,0.9542,0.6,0.94
"GO_BP:489001_GO_0003207_CARDIAC_CHAMBER_FORMATION","GO_BP","489001_GO_0003207_CARDIAC_CHAMBER_FORMATION",11,-1.6748,0.017,0.042,-1.2164,0.23,0.88,1.2138,0.22,0.71
"C4_Cancer_modules:C4_CM_191_MODULE_204","C4_Cancer_modules","C4_CM_191_MODULE_204",84,-1.6747,0.0013,0.016,-1.0841,0.3,0.7,-1.4641,0.013,0.17
"GO_MF:753721_GO_1900750_OLIGOPEPTIDE_BINDING","GO_MF","753721_GO_1900750_OLIGOPEPTIDE_BINDING",11,-1.6746,0.011,0.077,-1.5335,0.04,0.55,-1.3483,0.12,0.53
"C6_Oncogenic_signatures:C6_ALL_26_AKT_UP_MTOR_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_26_AKT_UP_MTOR_DN_V1_UP",163,-1.6744,0.0012,0.0028,-0.8403,0.86,0.98,-0.9699,0.51,0.7
"GO_MF:489951_GO_0004620_PHOSPHOLIPASE_ACTIVITY","GO_MF","489951_GO_0004620_PHOSPHOLIPASE_ACTIVITY",87,-1.6744,0.0013,0.076,0.9419,0.58,0.93,1.2277,0.12,0.7
"GO_BP:755162_GO_2001056_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_BP","755162_GO_2001056_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",129,-1.6744,0,0.042,0.8743,0.8,1,-1.4641,0.004,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_659_LI_LUNG_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_659_LI_LUNG_CANCER",40,-1.6744,0.011,0.021,0.8398,0.74,0.98,-1.5494,0.015,0.27
"C7_Immunologic_signatures:C7_ALL_1457_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP","C7_Immunologic_signatures","C7_ALL_1457_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP",195,-1.6744,0.0011,3e-04,0.6519,1,1,0.831,0.89,1
"GO_BP:513012_GO_0052167_MODULATION_BY_SYMBIONT_OF_HOST_INNATE_IMMUNE_RESPONSE","GO_BP","513012_GO_0052167_MODULATION_BY_SYMBIONT_OF_HOST_INNATE_IMMUNE_RESPONSE",6,-1.6743,0.0066,0.042,0.8377,0.68,1,-0.8878,0.61,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_3123_BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3123_BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN",88,-1.6743,0.0013,0.021,-1.1508,0.2,0.85,-1.2111,0.14,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_729_OHASHI_AURKB_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_729_OHASHI_AURKB_TARGETS",9,-1.6741,0.01,0.021,0.4771,1,1,-0.6417,0.9,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_935_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_935_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN",32,-1.6741,0.0043,0.021,-0.8478,0.69,1,-0.9871,0.48,0.77
"GO_BP:488762_GO_0002889_REGULATION_OF_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE","GO_BP","488762_GO_0002889_REGULATION_OF_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE",42,-1.6738,0.0081,0.042,-1.5435,0.0074,0.75,-1.0749,0.33,0.8
"C3_TF_targets:C3_TFT_409_V_AML_Q6","C3_TF_targets","C3_TFT_409_V_AML_Q6",262,-1.6738,0,0.0075,-1.2861,0.029,0.25,-0.8929,0.78,0.93
"GO_BP:511643_GO_0050671_POSITIVE_REGULATION_OF_LYMPHOCYTE_PROLIFERATION","GO_BP","511643_GO_0050671_POSITIVE_REGULATION_OF_LYMPHOCYTE_PROLIFERATION",115,-1.6737,0,0.042,-0.7847,0.9,1,-1.2219,0.083,0.71
"GO_CC:502486_GO_0033267_AXON_PART","GO_CC","502486_GO_0033267_AXON_PART",152,-1.6736,0,0.067,-1.1273,0.19,0.73,-1.2704,0.056,0.69
"REACTOME:106110_REACT_13552_INTEGRIN_CELL_SURFACE_INTERACTIONS","REACTOME","106110_REACT_13552_INTEGRIN_CELL_SURFACE_INTERACTIONS",66,-1.6736,0.004,0.05,0.7785,0.9,1,1.0188,0.4,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2259_SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2259_SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN",286,-1.6736,0,0.021,1.0202,0.39,0.77,-1.1856,0.087,0.53
"GO_BP:514589_GO_0061041_REGULATION_OF_WOUND_HEALING","GO_BP","514589_GO_0061041_REGULATION_OF_WOUND_HEALING",109,-1.6735,0,0.042,1.06,0.31,0.94,1.1896,0.14,0.72
"C7_Immunologic_signatures:C7_ALL_1338_GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1338_GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN",194,-1.6734,0,3e-04,-0.9632,0.56,1,-1.462,0.013,0.033
"C7_Immunologic_signatures:C7_ALL_1459_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP","C7_Immunologic_signatures","C7_ALL_1459_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP",196,-1.6732,0,3e-04,-0.7039,0.99,1,-0.9791,0.54,0.77
"GO_BP:784765_GO_1902041_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS","GO_BP","784765_GO_1902041_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS",45,-1.6732,0.0028,0.042,0.9248,0.6,1,1.1702,0.2,0.72
"C7_Immunologic_signatures:C7_ALL_911_GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP","C7_Immunologic_signatures","C7_ALL_911_GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP",195,-1.6728,0,3e-04,0.9772,0.5,0.82,-1.3803,0.006,0.074
"GO_BP:498799_GO_0021515_CELL_DIFFERENTIATION_IN_SPINAL_CORD","GO_BP","498799_GO_0021515_CELL_DIFFERENTIATION_IN_SPINAL_CORD",51,-1.6728,0.0027,0.042,-1.3103,0.087,0.87,-0.9864,0.48,0.86
"GO_BP:510177_GO_0048009_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","510177_GO_0048009_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",14,-1.6728,0.011,0.042,-0.7265,0.86,1,0.8777,0.64,0.96
"GO_BP:510683_GO_0048625_MYOBLAST_FATE_COMMITMENT","GO_BP","510683_GO_0048625_MYOBLAST_FATE_COMMITMENT",5,-1.6727,0.01,0.042,-1.4999,0.048,0.82,0.9177,0.58,0.93
"WikiPathways:920995_WP2436_DOPAMINE_METABOLISM","WikiPathways","920995_WP2436_DOPAMINE_METABOLISM",13,-1.6726,0.013,0.025,0.8127,0.73,1,-1.6224,0.03,0.29
"REACTOME:106496_REACT_15426_PLC_BETA_MEDIATED_EVENTS","REACTOME","106496_REACT_15426_PLC_BETA_MEDIATED_EVENTS",46,-1.6726,0.0041,0.05,-1.3022,0.12,0.66,-1.6696,0.0042,0.23
"GO_BP:502167_GO_0032945_NEGATIVE_REGULATION_OF_MONONUCLEAR_CELL_PROLIFERATION","GO_BP","502167_GO_0032945_NEGATIVE_REGULATION_OF_MONONUCLEAR_CELL_PROLIFERATION",55,-1.6725,0.0042,0.042,-0.6413,0.98,1,0.7389,0.91,1
"C3_TF_targets:C3_TFT_297_V_BACH2_01","C3_TF_targets","C3_TFT_297_V_BACH2_01",264,-1.6722,0,0.0075,-1.2394,0.047,0.29,-1.0603,0.27,0.62
"C3_TF_targets:C3_TFT_462_V_OCT1_Q5_01","C3_TF_targets","C3_TFT_462_V_OCT1_Q5_01",257,-1.6721,0,0.0073,-1.1779,0.12,0.4,-1.2211,0.052,0.31
"C7_Immunologic_signatures:C7_ALL_1407_GSE360_CTRL_VS_L_DONOVANI_DC_UP","C7_Immunologic_signatures","C7_ALL_1407_GSE360_CTRL_VS_L_DONOVANI_DC_UP",198,-1.672,0,3e-04,1.1078,0.21,0.42,-1.2627,0.059,0.18
"GO_CC:517464_GO_0072559_NLRP3_INFLAMMASOME_COMPLEX","GO_CC","517464_GO_0072559_NLRP3_INFLAMMASOME_COMPLEX",7,-1.6719,0.007,0.068,-1.2526,0.19,0.66,-0.9274,0.53,1
"C7_Immunologic_signatures:C7_ALL_1024_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1024_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN",198,-1.6718,0,3e-04,0.8173,0.95,1,-1.5064,0.0042,0.02
"GO_BP:983729_GO_1903010_REGULATION_OF_BONE_DEVELOPMENT","GO_BP","983729_GO_1903010_REGULATION_OF_BONE_DEVELOPMENT",11,-1.6717,0.0096,0.043,-0.8326,0.69,1,1.0137,0.4,0.84
"GO_MF:490241_GO_0004950_CHEMOKINE_RECEPTOR_ACTIVITY","GO_MF","490241_GO_0004950_CHEMOKINE_RECEPTOR_ACTIVITY",25,-1.6716,0.0076,0.078,1.6561,0.011,0.2,1.655,0.002,0.25
"C7_Immunologic_signatures:C7_ALL_811_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_811_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP",194,-1.6716,0,3e-04,0.6137,1,1,0.8073,0.95,1
"GO_BP:501917_GO_0032691_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION","GO_BP","501917_GO_0032691_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION",9,-1.6715,0.011,0.043,-1.3305,0.15,0.9,-1.0909,0.35,0.78
"C7_Immunologic_signatures:C7_ALL_232_GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN","C7_Immunologic_signatures","C7_ALL_232_GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN",194,-1.6714,0,3e-04,0.831,0.9,1,-1.6091,0,0.0046
"C7_Immunologic_signatures:C7_ALL_1860_GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN","C7_Immunologic_signatures","C7_ALL_1860_GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN",194,-1.6714,0,3e-04,-0.9148,0.68,1,-0.9273,0.66,0.9
"GO_BP:499615_GO_0030205_DERMATAN_SULFATE_METABOLIC_PROCESS","GO_BP","499615_GO_0030205_DERMATAN_SULFATE_METABOLIC_PROCESS",12,-1.6711,0.013,0.043,-1.2837,0.15,0.9,0.5373,0.97,1
"C6_Oncogenic_signatures:C6_ALL_90_PTEN_DN_V2_UP","C6_Oncogenic_signatures","C6_ALL_90_PTEN_DN_V2_UP",135,-1.6711,0,0.003,-1.056,0.33,0.59,1.4877,0.0057,0.069
"GO_BP:494116_GO_0010035_RESPONSE_TO_INORGANIC_SUBSTANCE","GO_BP","494116_GO_0010035_RESPONSE_TO_INORGANIC_SUBSTANCE",372,-1.6711,0,0.043,0.9599,0.62,1,-1.2193,0.036,0.71
"GO_BP:496951_GO_0017157_REGULATION_OF_EXOCYTOSIS","GO_BP","496951_GO_0017157_REGULATION_OF_EXOCYTOSIS",167,-1.671,0,0.043,1.155,0.14,0.83,0.9901,0.47,0.87
"GO_BP:493490_GO_0009306_PROTEIN_SECRETION","GO_BP","493490_GO_0009306_PROTEIN_SECRETION",125,-1.6709,0.0012,0.043,1.1892,0.12,0.79,-0.7261,0.99,0.99
"GO_BP:499231_GO_0021952_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS","GO_BP","499231_GO_0021952_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS",22,-1.6708,0.011,0.043,-1.0478,0.38,0.97,-1.6089,0.0062,0.53
"C7_Immunologic_signatures:C7_ALL_1380_GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN","C7_Immunologic_signatures","C7_ALL_1380_GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN",195,-1.6708,0,0.00031,-0.6671,1,1,-0.9253,0.67,0.9
"GO_BP:507689_GO_0045332_PHOSPHOLIPID_TRANSLOCATION","GO_BP","507689_GO_0045332_PHOSPHOLIPID_TRANSLOCATION",19,-1.6707,0.009,0.043,-1.2636,0.17,0.9,-1.0966,0.32,0.78
"GO_MF:492421_GO_0008046_AXON_GUIDANCE_RECEPTOR_ACTIVITY","GO_MF","492421_GO_0008046_AXON_GUIDANCE_RECEPTOR_ACTIVITY",8,-1.6705,0.021,0.078,-1.0162,0.44,0.89,-1.8904,0.0021,0.17
"GO_BP:510805_GO_0048754_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE","GO_BP","510805_GO_0048754_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE",148,-1.6704,0,0.043,1.2844,0.048,0.7,1.2706,0.049,0.69
"GO_BP:754181_GO_1901214_REGULATION_OF_NEURON_DEATH","GO_BP","754181_GO_1901214_REGULATION_OF_NEURON_DEATH",226,-1.6703,0,0.043,-1.0742,0.27,0.95,-1.0979,0.24,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_3112_WIERENGA_STAT5A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3112_WIERENGA_STAT5A_TARGETS_DN",212,-1.6702,0,0.022,0.9833,0.49,0.81,-1.6163,0,0.23
"GO_BP:513716_GO_0060158_PHOSPHOLIPASE_C_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","513716_GO_0060158_PHOSPHOLIPASE_C_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY",9,-1.6701,0.012,0.043,-0.8882,0.59,1,0.8487,0.64,0.98
"GO_BP:502168_GO_0032946_POSITIVE_REGULATION_OF_MONONUCLEAR_CELL_PROLIFERATION","GO_BP","502168_GO_0032946_POSITIVE_REGULATION_OF_MONONUCLEAR_CELL_PROLIFERATION",116,-1.6699,0,0.043,-0.7686,0.94,1,-1.148,0.18,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_983_GROSS_HYPOXIA_VIA_HIF1A_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_983_GROSS_HYPOXIA_VIA_HIF1A_DN",109,-1.6696,0,0.022,-1.0597,0.33,0.97,-0.8042,0.9,0.95
"C3_TF_targets:C3_TFT_427_V_OCT_Q6","C3_TF_targets","C3_TFT_427_V_OCT_Q6",251,-1.6694,0,0.0075,-1.2535,0.039,0.27,-1.3236,0.012,0.24
"C2_Chemical_and_genetic_perturbations:C2_CGP_1401_LU_IL4_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_1401_LU_IL4_SIGNALING",94,-1.6693,0,0.022,1.277,0.077,0.42,-0.9456,0.57,0.83
"REACTOME:106404_REACT_8006_TOLL_LIKE_RECEPTOR_TLR6_TLR2_CASCADE","REACTOME","106404_REACT_8006_TOLL_LIKE_RECEPTOR_TLR6_TLR2_CASCADE",95,-1.6693,0,0.052,-0.6411,1,1,-1.129,0.2,0.67
"GO_BP:504843_GO_0035666_TRIF_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","504843_GO_0035666_TRIF_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",78,-1.6691,0.0038,0.043,-0.8057,0.86,1,-1.0507,0.34,0.81
"C7_Immunologic_signatures:C7_ALL_1464_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN","C7_Immunologic_signatures","C7_ALL_1464_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN",198,-1.669,0,0.00031,1.0177,0.41,0.69,-0.9303,0.65,0.89
"GO_BP:507463_GO_0045063_T_HELPER_1_CELL_DIFFERENTIATION","GO_BP","507463_GO_0045063_T_HELPER_1_CELL_DIFFERENTIATION",6,-1.6688,0.0085,0.043,-1.1445,0.3,0.93,0.7413,0.78,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1101_AMIT_DELAYED_EARLY_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_1101_AMIT_DELAYED_EARLY_GENES",18,-1.6686,0.0076,0.022,-1.3778,0.11,0.62,-0.6655,0.91,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2555_CHANG_CORE_SERUM_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2555_CHANG_CORE_SERUM_RESPONSE_DN",209,-1.6685,0,0.022,-0.9769,0.51,1,-1.0394,0.3,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_770_NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF","C2_Chemical_and_genetic_perturbations","C2_CGP_770_NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF",8,-1.6685,0.0017,0.022,1.4567,0.094,0.25,1.3506,0.13,0.57
"C4_Cancer_modules:C4_CM_300_MODULE_345","C4_Cancer_modules","C4_CM_300_MODULE_345",122,-1.6685,0,0.017,1.327,0.031,0.25,-1.2807,0.049,0.32
"GO_BP:755150_GO_2001044_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY","GO_BP","755150_GO_2001044_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY",12,-1.6684,0.011,0.044,0.9531,0.52,1,0.811,0.73,1
"C1_Positional:C1_ALL_104_CHR11Q14","C1_Positional","C1_ALL_104_CHR11Q14",41,-1.6683,0.0028,0.13,-1.1078,0.29,1,-1.1099,0.27,0.79
"GO_CC:507692_GO_0045335_PHAGOCYTIC_VESICLE","GO_CC","507692_GO_0045335_PHAGOCYTIC_VESICLE",80,-1.6679,0.0026,0.069,0.9282,0.6,0.86,0.8642,0.75,1
"GO_MF:490424_GO_0005159_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING","GO_MF","490424_GO_0005159_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING",14,-1.6678,0.013,0.08,0.6385,0.93,1,1.0032,0.46,0.87
"GO_BP:1026090_GO_1903318_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION","GO_BP","1026090_GO_1903318_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION",299,-1.6677,0,0.044,0.94,0.65,1,-0.8807,0.84,0.94
"C4_Cancer_modules:C4_CM_372_MODULE_456","C4_Cancer_modules","C4_CM_372_MODULE_456",111,-1.6677,0,0.017,-0.9319,0.61,0.88,-1.043,0.35,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_2314_AUJLA_IL22_AND_IL17A_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_2314_AUJLA_IL22_AND_IL17A_SIGNALING",10,-1.6676,0.0033,0.022,-0.7941,0.73,1,-0.6718,0.88,0.99
"REACTOME:119543_REACT_19323_SPHINGOLIPID_METABOLISM","REACTOME","119543_REACT_19323_SPHINGOLIPID_METABOLISM",72,-1.6675,0.004,0.052,-0.9136,0.62,1,-0.86,0.79,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2005_GHO_ATF5_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2005_GHO_ATF5_TARGETS_DN",16,-1.6675,0.016,0.022,0.6213,0.95,1,0.6726,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2170_MASSARWEH_TAMOXIFEN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2170_MASSARWEH_TAMOXIFEN_RESISTANCE_DN",244,-1.6673,0,0.022,-0.942,0.6,1,-0.9616,0.56,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1179_MORI_SMALL_PRE_BII_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1179_MORI_SMALL_PRE_BII_LYMPHOCYTE_DN",76,-1.6672,0.0026,0.022,0.9046,0.66,0.92,-1.7497,0,0.15
"GO_BP:513303_GO_0052556_POSITIVE_REGULATION_BY_SYMBIONT_OF_HOST_IMMUNE_RESPONSE","GO_BP","513303_GO_0052556_POSITIVE_REGULATION_BY_SYMBIONT_OF_HOST_IMMUNE_RESPONSE",6,-1.667,0.0087,0.044,0.8382,0.64,1,-0.8937,0.56,0.93
"GO_MF:492413_GO_0008035_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING","GO_MF","492413_GO_0008035_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING",8,-1.6669,0.0099,0.08,-0.7976,0.73,1,-0.6966,0.83,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2783_OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2783_OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP",24,-1.6668,0.012,0.022,1.0348,0.39,0.74,0.6593,0.96,1
"C7_Immunologic_signatures:C7_ALL_1067_GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP","C7_Immunologic_signatures","C7_ALL_1067_GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP",200,-1.6666,0,0.00033,1.2187,0.057,0.2,-1.5198,0,0.017
"C6_Oncogenic_signatures:C6_ALL_30_MTOR_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_30_MTOR_UP_V1_UP",154,-1.6665,0,0.0032,-1.0559,0.31,0.58,-1.2602,0.04,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_3309_PEDRIOLI_MIR31_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3309_PEDRIOLI_MIR31_TARGETS_DN",401,-1.6664,0,0.022,-1.0049,0.44,1,-1.2861,0.0042,0.44
"REACTOME:187096_REACT_23787_REGULATION_OF_SIGNALING_BY_CBL","REACTOME","187096_REACT_23787_REGULATION_OF_SIGNALING_BY_CBL",18,-1.6664,0.011,0.052,-0.8003,0.75,1,-1.2968,0.14,0.54
"C7_Immunologic_signatures:C7_ALL_296_GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_296_GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN",196,-1.6664,0,0.00033,0.9492,0.62,0.9,-1.2502,0.035,0.2
"C2_Chemical_and_genetic_perturbations:C2_CGP_391_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_391_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP",57,-1.6663,0.0054,0.022,1.3541,0.077,0.34,1.276,0.1,0.68
"GO_MF:496709_GO_0016810_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS","GO_MF","496709_GO_0016810_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS",119,-1.6663,0,0.079,-1.0103,0.42,0.89,-1.5669,0.002,0.39
"REACTOME:105653_REACT_402_TRAIL_SIGNALING","REACTOME","105653_REACT_402_TRAIL_SIGNALING",7,-1.6662,0.017,0.052,-0.9812,0.48,1,-1.2367,0.23,0.57
"C3_TF_targets:C3_TFT_3_V_MYOD_01","C3_TF_targets","C3_TFT_3_V_MYOD_01",261,-1.6661,0,0.0077,-1.344,0.013,0.2,-1.042,0.3,0.64
"C7_Immunologic_signatures:C7_ALL_1202_GSE27786_CD4_TCELL_VS_MONO_MAC_DN","C7_Immunologic_signatures","C7_ALL_1202_GSE27786_CD4_TCELL_VS_MONO_MAC_DN",197,-1.6661,0,0.00033,-1.0182,0.4,1,-1.3431,0.015,0.1
"C7_Immunologic_signatures:C7_ALL_824_GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_824_GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN",198,-1.6658,0,0.00033,0.7215,1,1,-1.9539,0,0
"GO_BP:491791_GO_0006942_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION","GO_BP","491791_GO_0006942_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION",87,-1.6657,0,0.045,-1.1982,0.15,0.9,1.2314,0.12,0.71
"C7_Immunologic_signatures:C7_ALL_1343_GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1343_GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP",198,-1.6656,0,0.00033,-0.8246,0.9,1,-1.7066,0,7e-04
"REACTOME:106495_REACT_15526_G_PROTEIN_MEDIATED_EVENTS","REACTOME","106495_REACT_15526_G_PROTEIN_MEDIATED_EVENTS",47,-1.6656,0,0.052,-1.2852,0.1,0.67,-1.6933,0.004,0.22
"GO_BP:496362_GO_0016322_NEURON_REMODELING","GO_BP","496362_GO_0016322_NEURON_REMODELING",9,-1.6656,0.014,0.045,-1.5875,0.031,0.71,-0.8881,0.6,0.93
"GO_BP:505865_GO_0042759_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS","GO_BP","505865_GO_0042759_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS",10,-1.6655,0.0095,0.045,-0.5466,0.96,1,-1.6147,0.017,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_1134_AMIT_EGF_RESPONSE_40_HELA","C2_Chemical_and_genetic_perturbations","C2_CGP_1134_AMIT_EGF_RESPONSE_40_HELA",42,-1.6655,0.011,0.022,-1.5755,0.0077,0.46,-1.1219,0.28,0.6
"REACTOME:187089_REACT_25281_TRIF_MEDIATED_TLR3_TLR4_SIGNALING","REACTOME","187089_REACT_25281_TRIF_MEDIATED_TLR3_TLR4_SIGNALING",100,-1.6655,0.0012,0.052,-0.759,0.94,1,-1.0664,0.31,0.75
"C7_Immunologic_signatures:C7_ALL_1038_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN","C7_Immunologic_signatures","C7_ALL_1038_GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN",198,-1.6652,0,0.00033,-0.8799,0.78,1,-1.2623,0.05,0.18
"GO_BP:516721_GO_0071798_RESPONSE_TO_PROSTAGLANDIN_D","GO_BP","516721_GO_0071798_RESPONSE_TO_PROSTAGLANDIN_D",5,-1.6652,0.0054,0.045,1.0086,0.47,0.98,0.5186,0.97,1
"GO_BP:514092_GO_0060537_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","514092_GO_0060537_MUSCLE_TISSUE_DEVELOPMENT",269,-1.6652,0,0.045,-1.0833,0.24,0.95,-0.9823,0.52,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_2907_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2907_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN",77,-1.6649,0,0.023,1.078,0.29,0.67,1.257,0.08,0.72
"GO_BP:507926_GO_0045578_NEGATIVE_REGULATION_OF_B_CELL_DIFFERENTIATION","GO_BP","507926_GO_0045578_NEGATIVE_REGULATION_OF_B_CELL_DIFFERENTIATION",6,-1.6649,0.011,0.045,-0.9593,0.51,1,1.0302,0.4,0.82
"GO_BP:506422_GO_0043383_NEGATIVE_T_CELL_SELECTION","GO_BP","506422_GO_0043383_NEGATIVE_T_CELL_SELECTION",11,-1.6648,0.0064,0.045,0.6879,0.88,1,-1.2359,0.23,0.69
"GO_BP:487826_GO_0001935_ENDOTHELIAL_CELL_PROLIFERATION","GO_BP","487826_GO_0001935_ENDOTHELIAL_CELL_PROLIFERATION",21,-1.6648,0.014,0.045,-1.1538,0.26,0.92,-1.2757,0.15,0.66
"KEGG_compound:C11150_TRICHLOROACETATE_TRICHLOROACETIC_ACID_TCA","KEGG_compound","C11150_TRICHLOROACETATE_TRICHLOROACETIC_ACID_TCA",5,-1.6648,0.0054,0.055,0.7674,0.73,1,-1.325,0.16,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_3015_BROWNE_HCMV_INFECTION_2HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3015_BROWNE_HCMV_INFECTION_2HR_UP",39,-1.6647,0.012,0.023,-1.7648,0,0.35,-1.7972,0,0.13
"GO_BP:501921_GO_0032695_NEGATIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION","GO_BP","501921_GO_0032695_NEGATIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION",15,-1.6643,0.012,0.045,0.7001,0.88,1,-0.6856,0.9,0.99
"C7_Immunologic_signatures:C7_ALL_830_GSE17974_2_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_830_GSE17974_2_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN",195,-1.6642,0,0.00034,0.7534,0.99,1,-1.4916,0.002,0.024
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_115_BIOCARTA_MCALPAIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_115_BIOCARTA_MCALPAIN_PATHWAY",24,-1.6642,0.0028,0.066,0.9627,0.51,0.84,-1.2511,0.14,0.56
"GO_BP:493585_GO_0010038_RESPONSE_TO_METAL_ION","GO_BP","493585_GO_0010038_RESPONSE_TO_METAL_ION",262,-1.664,0,0.045,1.1132,0.16,0.89,-1.0079,0.4,0.84
"GO_BP:503311_GO_0034105_POSITIVE_REGULATION_OF_TISSUE_REMODELING","GO_BP","503311_GO_0034105_POSITIVE_REGULATION_OF_TISSUE_REMODELING",26,-1.6638,0.0043,0.045,-1.2971,0.13,0.88,-0.8436,0.71,0.96
"GO_BP:518770_GO_2000121_REGULATION_OF_REMOVAL_OF_SUPEROXIDE_RADICALS","GO_BP","518770_GO_2000121_REGULATION_OF_REMOVAL_OF_SUPEROXIDE_RADICALS",6,-1.6636,0.0052,0.045,0.9434,0.51,1,-0.8817,0.64,0.94
"C7_Immunologic_signatures:C7_ALL_1387_GSE339_CD8POS_VS_CD4CD8DN_DC_UP","C7_Immunologic_signatures","C7_ALL_1387_GSE339_CD8POS_VS_CD4CD8DN_DC_UP",197,-1.6635,0,0.00034,1.3128,0.018,0.091,-1.2667,0.05,0.18
"GO_MF:750963_GO_0036041_LONG_CHAIN_FATTY_ACID_BINDING","GO_MF","750963_GO_0036041_LONG_CHAIN_FATTY_ACID_BINDING",10,-1.6633,0.015,0.081,1.2216,0.2,0.71,1.075,0.39,0.81
"GO_BP:488101_GO_0002227_INNATE_IMMUNE_RESPONSE_IN_MUCOSA","GO_BP","488101_GO_0002227_INNATE_IMMUNE_RESPONSE_IN_MUCOSA",25,-1.6633,0.006,0.045,1.1752,0.23,0.81,1.0394,0.39,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_2956_RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2956_RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN",10,-1.6632,0.0095,0.023,0.5369,0.97,1,0.6229,0.92,1
"REACTOME:161004_REACT_22365_RECYCLING_PATHWAY_OF_L1","REACTOME","161004_REACT_22365_RECYCLING_PATHWAY_OF_L1",28,-1.663,0.014,0.053,-0.5393,0.99,1,-1.4616,0.044,0.37
"GO_BP:488148_GO_0002275_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488148_GO_0002275_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",37,-1.663,0.0085,0.045,0.9072,0.63,1,-1.1198,0.29,0.76
"GO_CC:490838_GO_0005811_LIPID_PARTICLE","GO_CC","490838_GO_0005811_LIPID_PARTICLE",55,-1.663,0.004,0.072,0.7311,0.93,0.99,-0.7776,0.9,1
"GO_MF:506356_GO_0043295_GLUTATHIONE_BINDING","GO_MF","506356_GO_0043295_GLUTATHIONE_BINDING",11,-1.6629,0.0098,0.081,-1.5242,0.043,0.53,-1.3858,0.11,0.51
"GO_MF:496705_GO_0016801_HYDROLASE_ACTIVITY_ACTING_ON_ETHER_BONDS","GO_MF","496705_GO_0016801_HYDROLASE_ACTIVITY_ACTING_ON_ETHER_BONDS",11,-1.6627,0.013,0.081,-1.6144,0.02,0.45,-1.4855,0.08,0.43
"GO_MF:492388_GO_0008013_BETA_CATENIN_BINDING","GO_MF","492388_GO_0008013_BETA_CATENIN_BINDING",64,-1.6627,0.004,0.08,-1.1967,0.16,0.8,-1.0947,0.29,0.7
"GO_MF:492422_GO_0008047_ENZYME_ACTIVATOR_ACTIVITY","GO_MF","492422_GO_0008047_ENZYME_ACTIVATOR_ACTIVITY",424,-1.6626,0,0.079,-1.0177,0.4,0.89,-1.3904,0.0021,0.5
"GO_CC:982594_GO_1990351_TRANSPORTER_COMPLEX","GO_CC","982594_GO_1990351_TRANSPORTER_COMPLEX",310,-1.6625,0,0.071,-1.5297,0,0.61,1.337,0.0075,0.71
"GO_BP:505247_GO_0042063_GLIOGENESIS","GO_BP","505247_GO_0042063_GLIOGENESIS",168,-1.6623,0,0.045,0.9833,0.5,1,0.8758,0.79,0.96
"GO_BP:503322_GO_0034116_POSITIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION","GO_BP","503322_GO_0034116_POSITIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION",9,-1.6623,0.0095,0.045,-1.0146,0.44,0.98,0.7997,0.72,1
"GO_BP:492350_GO_0007608_SENSORY_PERCEPTION_OF_SMELL","GO_BP","492350_GO_0007608_SENSORY_PERCEPTION_OF_SMELL",338,-1.6623,0,0.045,2.3531,0,6.8e-05,3.5127,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_337_BIDUS_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_337_BIDUS_METASTASIS_DN",155,-1.6623,0,0.023,-0.6767,0.99,1,-1.1381,0.17,0.59
"C7_Immunologic_signatures:C7_ALL_1781_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1781_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP",195,-1.6622,0,0.00034,1.0075,0.45,0.71,-1.2281,0.063,0.23
"C2_Chemical_and_genetic_perturbations:C2_CGP_1781_GAJATE_RESPONSE_TO_TRABECTEDIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1781_GAJATE_RESPONSE_TO_TRABECTEDIN_UP",66,-1.662,0.0066,0.023,1.2894,0.089,0.4,-0.9477,0.54,0.83
"GO_BP:494876_GO_0010812_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION","GO_BP","494876_GO_0010812_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION",43,-1.662,0.0042,0.045,-0.9461,0.51,1,0.8179,0.79,1
"GO_MF:490643_GO_0005548_PHOSPHOLIPID_TRANSPORTER_ACTIVITY","GO_MF","490643_GO_0005548_PHOSPHOLIPID_TRANSPORTER_ACTIVITY",44,-1.662,0.0042,0.079,-1.043,0.36,0.87,-0.7964,0.84,0.97
"C7_Immunologic_signatures:C7_ALL_869_GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_869_GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP",192,-1.662,0,0.00034,-1.1767,0.12,0.92,1.2451,0.064,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1167_SHIN_B_CELL_LYMPHOMA_CLUSTER_5","C2_Chemical_and_genetic_perturbations","C2_CGP_1167_SHIN_B_CELL_LYMPHOMA_CLUSTER_5",16,-1.6619,0.0089,0.023,-1.1488,0.28,0.85,-1.2654,0.17,0.46
"C7_Immunologic_signatures:C7_ALL_156_GSE13306_RA_VS_UNTREATED_TREG_DN","C7_Immunologic_signatures","C7_ALL_156_GSE13306_RA_VS_UNTREATED_TREG_DN",194,-1.6619,0.0011,0.00034,-0.9555,0.57,1,-1.0776,0.26,0.55
"GO_MF:489318_GO_0004252_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_MF","489318_GO_0004252_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY",144,-1.6618,0,0.078,1.2646,0.056,0.65,-1.0485,0.34,0.75
"WikiPathways:198901_WP706_SIDS_SUSCEPTIBILITY_PATHWAYS","WikiPathways","198901_WP706_SIDS_SUSCEPTIBILITY_PATHWAYS",156,-1.6617,0,0.027,-1.1366,0.18,0.93,1.2585,0.063,0.58
"C6_Oncogenic_signatures:C6_ALL_61_SNF5_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_61_SNF5_DN_V1_DN",133,-1.6616,0,0.0034,-1.0594,0.34,0.59,1.2881,0.059,0.18
"C7_Immunologic_signatures:C7_ALL_1767_GSE7460_TCONV_VS_TREG_THYMUS_UP","C7_Immunologic_signatures","C7_ALL_1767_GSE7460_TCONV_VS_TREG_THYMUS_UP",198,-1.6616,0,0.00034,-0.8601,0.85,1,-1.1178,0.19,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_2744_BUDHU_LIVER_CANCER_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2744_BUDHU_LIVER_CANCER_METASTASIS_DN",7,-1.6615,0.013,0.023,-1.7165,0.0098,0.34,-1.4346,0.1,0.34
"C3_TF_targets:C3_TFT_466_V_NFAT_Q4_01","C3_TF_targets","C3_TFT_466_V_NFAT_Q4_01",258,-1.6613,0.0011,0.0078,-0.8497,0.88,1,-1.09,0.22,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1917_WANG_CISPLATIN_RESPONSE_AND_XPC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1917_WANG_CISPLATIN_RESPONSE_AND_XPC_UP",195,-1.6613,0.0012,0.023,-0.9032,0.72,1,-1.3015,0.024,0.43
"GO_MF:487744_GO_0001848_COMPLEMENT_BINDING","GO_MF","487744_GO_0001848_COMPLEMENT_BINDING",17,-1.6612,0.0092,0.078,-1.2534,0.17,0.84,1.2221,0.23,0.7
"GO_BP:753031_GO_1900034_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT","GO_BP","753031_GO_1900034_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT",35,-1.6612,0.0086,0.046,-1.3394,0.084,0.91,-2.0623,0,0.084
"KEGG_pathway:HSA00010_GLYCOLYSIS_GLUCONEOGENESIS","KEGG_pathway","HSA00010_GLYCOLYSIS_GLUCONEOGENESIS",67,-1.6611,0.0026,0.0093,0.9981,0.44,0.89,-1.5945,0.0041,0.098
"C4_Cancer_modules:C4_CM_414_MODULE_537","C4_Cancer_modules","C4_CM_414_MODULE_537",17,-1.6611,0.011,0.018,-0.9254,0.55,0.88,-1.4653,0.067,0.18
"GO_BP:508883_GO_0046635_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION","GO_BP","508883_GO_0046635_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION",46,-1.6611,0.0054,0.046,-0.6337,0.99,1,-1.0546,0.36,0.81
"C4_Cancer_modules:C4_CM_348_MODULE_417","C4_Cancer_modules","C4_CM_348_MODULE_417",20,-1.661,0.01,0.018,1.4769,0.051,0.13,0.9646,0.52,0.97
"GO_BP:1129531_GO_1903707_NEGATIVE_REGULATION_OF_HEMOPOIESIS","GO_BP","1129531_GO_1903707_NEGATIVE_REGULATION_OF_HEMOPOIESIS",119,-1.6609,0,0.046,-1.1785,0.13,0.91,0.8165,0.86,1
"C4_Cancer_modules:C4_CM_301_MODULE_346","C4_Cancer_modules","C4_CM_301_MODULE_346",17,-1.6608,0.011,0.017,-0.5626,0.98,1,1.2438,0.2,0.54
"REACTOME:106159_REACT_6934_LDL_MEDIATED_LIPID_TRANSPORT","REACTOME","106159_REACT_6934_LDL_MEDIATED_LIPID_TRANSPORT",6,-1.6607,0.0086,0.053,-0.631,0.91,1,0.925,0.52,1
"C7_Immunologic_signatures:C7_ALL_952_GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN","C7_Immunologic_signatures","C7_ALL_952_GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN",195,-1.6607,0,0.00035,0.7078,1,1,-0.942,0.62,0.87
"C1_Positional:C1_ALL_163_CHR16Q12","C1_Positional","C1_ALL_163_CHR16Q12",42,-1.6607,0.0041,0.13,-0.7986,0.81,0.96,-1.1729,0.19,0.69
"GO_BP:506346_GO_0043281_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_BP","506346_GO_0043281_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",202,-1.6606,0,0.046,0.8963,0.76,1,-1.2946,0.035,0.64
"GO_BP:498690_GO_0019915_LIPID_STORAGE","GO_BP","498690_GO_0019915_LIPID_STORAGE",25,-1.6605,0.016,0.046,-1.2298,0.18,0.89,-0.8784,0.64,0.94
"C7_Immunologic_signatures:C7_ALL_360_GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_360_GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN",187,-1.6605,0,0.00035,0.8661,0.83,1,-0.8317,0.93,1
"C6_Oncogenic_signatures:C6_ALL_189_LEF1_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_189_LEF1_UP_V1_UP",183,-1.6604,0,0.0033,-0.9929,0.47,0.68,1.181,0.12,0.3
"GO_BP:501946_GO_0032720_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_PRODUCTION","GO_BP","501946_GO_0032720_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_PRODUCTION",36,-1.6603,0.011,0.046,-1.039,0.41,0.98,-0.8526,0.71,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2576_HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2576_HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN",73,-1.6602,0.0013,0.023,0.8013,0.87,0.99,0.7833,0.89,1
"GO_BP:511651_GO_0050679_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION","GO_BP","511651_GO_0050679_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION",142,-1.6601,0,0.046,-0.9845,0.5,1,1.431,0.0058,0.61
"GO_BP:513848_GO_0060292_LONG_TERM_SYNAPTIC_DEPRESSION","GO_BP","513848_GO_0060292_LONG_TERM_SYNAPTIC_DEPRESSION",15,-1.6599,0.0064,0.046,-0.9776,0.48,1,1.5026,0.053,0.56
"REACTOME:161020_REACT_21340_GPCR_LIGAND_BINDING","REACTOME","161020_REACT_21340_GPCR_LIGAND_BINDING",412,-1.6599,0,0.054,1.3061,0.0077,0.32,1.6844,0,0.46
"C7_Immunologic_signatures:C7_ALL_22_GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_22_GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN",191,-1.6599,0.0011,0.00036,1.3875,0.0095,0.041,-0.9306,0.66,0.89
"GO_BP:493723_GO_0009595_DETECTION_OF_BIOTIC_STIMULUS","GO_BP","493723_GO_0009595_DETECTION_OF_BIOTIC_STIMULUS",24,-1.6598,0.0077,0.046,-0.614,0.97,1,0.8302,0.73,0.99
"GO_MF:489298_GO_0003779_ACTIN_BINDING","GO_MF","489298_GO_0003779_ACTIN_BINDING",381,-1.6597,0,0.079,-1.0419,0.31,0.86,-1.1467,0.11,0.65
"GO_BP:752384_GO_0086012_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL","GO_BP","752384_GO_0086012_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",10,-1.6596,0.018,0.046,-1.3797,0.12,0.99,0.6957,0.84,1
"C7_Immunologic_signatures:C7_ALL_1596_GSE3982_EOSINOPHIL_VS_BASOPHIL_DN","C7_Immunologic_signatures","C7_ALL_1596_GSE3982_EOSINOPHIL_VS_BASOPHIL_DN",195,-1.6596,0,0.00036,1.6398,0,0.0014,-1.639,0,0.0024
"C2_Chemical_and_genetic_perturbations:C2_CGP_1218_NIKOLSKY_BREAST_CANCER_19Q13_4_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1218_NIKOLSKY_BREAST_CANCER_19Q13_4_AMPLICON",7,-1.6595,0.0098,0.023,-0.8922,0.6,1,-1.0082,0.44,0.74
"GO_MF:507895_GO_0045545_SYNDECAN_BINDING","GO_MF","507895_GO_0045545_SYNDECAN_BINDING",5,-1.6595,0.0035,0.078,0.9012,0.57,0.98,-0.4354,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2244_ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2244_ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP",267,-1.6595,0,0.023,1.3899,0.0071,0.3,1.2959,0.019,0.69
"C4_Cancer_gene_neighborhoods:C4_CGN_368_GNF2_KISS1","C4_Cancer_gene_neighborhoods","C4_CGN_368_GNF2_KISS1",42,-1.6592,0.0014,0.012,0.9318,0.56,0.75,1.156,0.22,0.51
"GO_BP:499721_GO_0030320_CELLULAR_MONOVALENT_INORGANIC_ANION_HOMEOSTASIS","GO_BP","499721_GO_0030320_CELLULAR_MONOVALENT_INORGANIC_ANION_HOMEOSTASIS",13,-1.6592,0.014,0.046,-0.7939,0.75,1,-0.9725,0.49,0.88
"GO_BP:507503_GO_0045110_INTERMEDIATE_FILAMENT_BUNDLE_ASSEMBLY","GO_BP","507503_GO_0045110_INTERMEDIATE_FILAMENT_BUNDLE_ASSEMBLY",5,-1.6591,0.0088,0.046,-0.4742,0.99,1,-1.0129,0.43,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1312_DORSAM_HOXA9_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1312_DORSAM_HOXA9_TARGETS_UP",35,-1.659,0.01,0.024,-0.9391,0.54,1,-1.3331,0.074,0.41
"GO_BP:487568_GO_0001655_UROGENITAL_SYSTEM_DEVELOPMENT","GO_BP","487568_GO_0001655_UROGENITAL_SYSTEM_DEVELOPMENT",295,-1.6589,0,0.046,-1.0664,0.28,0.96,1.2387,0.043,0.71
"GO_BP:499810_GO_0030432_PERISTALSIS","GO_BP","499810_GO_0030432_PERISTALSIS",9,-1.6588,0.0087,0.046,-1.1936,0.25,0.9,-1.6083,0.038,0.52
"C7_Immunologic_signatures:C7_ALL_1000_GSE22886_TH1_VS_TH2_48H_ACT_DN","C7_Immunologic_signatures","C7_ALL_1000_GSE22886_TH1_VS_TH2_48H_ACT_DN",199,-1.6587,0,0.00037,0.9424,0.61,0.92,-0.989,0.5,0.75
"C7_Immunologic_signatures:C7_ALL_815_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_815_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP",185,-1.6586,0,0.00037,0.999,0.45,0.74,-1.0015,0.46,0.72
"GO_BP:502344_GO_0033123_POSITIVE_REGULATION_OF_PURINE_NUCLEOTIDE_CATABOLIC_PROCESS","GO_BP","502344_GO_0033123_POSITIVE_REGULATION_OF_PURINE_NUCLEOTIDE_CATABOLIC_PROCESS",497,-1.6586,0,0.046,-1.3876,0,1,-1.3198,0.002,0.63
"C3_TF_targets:C3_TFT_539_YAATNANRNNNCAG_UNKNOWN","C3_TF_targets","C3_TFT_539_YAATNANRNNNCAG_UNKNOWN",65,-1.6585,0.0051,0.008,-1.0951,0.3,0.56,-0.7837,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_15_LU_TUMOR_VASCULATURE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_15_LU_TUMOR_VASCULATURE_UP",29,-1.6584,0.012,0.024,1.1993,0.2,0.49,0.9721,0.48,0.97
"C0_Hallmark:H_ALL_12_HALLMARK_ADIPOGENESIS","C0_Hallmark","H_ALL_12_HALLMARK_ADIPOGENESIS",199,-1.6584,0,0.0021,1.4017,0.012,0.053,-1.1873,0.1,0.2
"C2_Chemical_and_genetic_perturbations:C2_CGP_1158_SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1158_SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",33,-1.6584,0.0058,0.024,-0.9586,0.53,1,-1.618,0.013,0.23
"C2_Chemical_and_genetic_perturbations:C2_CGP_3206_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3206_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN",318,-1.6583,0,0.024,-0.8205,0.96,1,-1.4313,0,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_1693_ZHANG_RESPONSE_TO_CANTHARIDIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1693_ZHANG_RESPONSE_TO_CANTHARIDIN_UP",19,-1.6582,0.012,0.024,0.8502,0.71,0.97,-0.9147,0.58,0.86
"GO_BP:492896_GO_0030041_ACTIN_FILAMENT_POLYMERIZATION","GO_BP","492896_GO_0030041_ACTIN_FILAMENT_POLYMERIZATION",26,-1.658,0.012,0.046,1.0422,0.38,0.96,-1.6984,0.0082,0.61
"GO_BP:499470_GO_0030002_CELLULAR_ANION_HOMEOSTASIS","GO_BP","499470_GO_0030002_CELLULAR_ANION_HOMEOSTASIS",13,-1.658,0.016,0.046,-0.8027,0.69,1,-0.9741,0.47,0.88
"REACTOME:106414_REACT_12526_TCR_SIGNALING","REACTOME","106414_REACT_12526_TCR_SIGNALING",58,-1.6576,0.0013,0.054,0.9393,0.57,0.85,-1.3143,0.078,0.56
"GO_BP:755340_GO_2001234_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","755340_GO_2001234_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY",195,-1.6575,0,0.047,0.9394,0.65,1,0.8398,0.88,0.99
"GO_BP:516236_GO_0071312_CELLULAR_RESPONSE_TO_ALKALOID","GO_BP","516236_GO_0071312_CELLULAR_RESPONSE_TO_ALKALOID",32,-1.6574,0.0029,0.047,-1.3641,0.08,0.98,0.9266,0.58,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_340_WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_340_WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP",136,-1.6574,0,0.024,-0.8224,0.9,1,-0.8329,0.88,0.93
"GO_BP:502256_GO_0033034_POSITIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS","GO_BP","502256_GO_0033034_POSITIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS",6,-1.6573,0.0054,0.047,-0.6567,0.89,1,-1.0664,0.39,0.8
"C0_Hallmark:H_ALL_30_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","C0_Hallmark","H_ALL_30_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION",198,-1.6572,0,0.0021,0.9636,0.52,0.73,1.3112,0.013,0.13
"C2_Chemical_and_genetic_perturbations:C2_CGP_2522_MARTINELLI_IMMATURE_NEUTROPHIL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2522_MARTINELLI_IMMATURE_NEUTROPHIL_DN",13,-1.6572,0.014,0.024,1.3148,0.16,0.38,1.4067,0.11,0.54
"GO_MF:489300_GO_0051015_ACTIN_FILAMENT_BINDING","GO_MF","489300_GO_0051015_ACTIN_FILAMENT_BINDING",114,-1.657,0,0.08,-1.1144,0.22,0.83,-1.2375,0.08,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_406_BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_406_BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN",48,-1.657,0.0043,0.024,-0.8012,0.81,1,-0.946,0.56,0.83
"GO_CC:507397_GO_0044449_CONTRACTILE_FIBER_PART","GO_CC","507397_GO_0044449_CONTRACTILE_FIBER_PART",197,-1.657,0,0.074,-0.9765,0.5,0.88,-1.1898,0.091,0.82
"REACTOME:106245_REACT_16956_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC","REACTOME","106245_REACT_16956_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC",21,-1.6569,0.017,0.054,0.7938,0.75,1,-1.6255,0.014,0.23
"C7_Immunologic_signatures:C7_ALL_1517_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP","C7_Immunologic_signatures","C7_ALL_1517_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP",198,-1.6568,0,0.00039,1.1456,0.13,0.33,-1.7296,0,0.00037
"C7_Immunologic_signatures:C7_ALL_763_GSE17721_12H_VS_24H_GARDIQUIMOD_BMDM_UP","C7_Immunologic_signatures","C7_ALL_763_GSE17721_12H_VS_24H_GARDIQUIMOD_BMDM_UP",198,-1.6567,0,0.00039,1.0765,0.25,0.51,0.8648,0.88,1
"REACTOME:106111_REACT_602_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT","REACTOME","106111_REACT_602_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT",53,-1.6566,0.0027,0.054,-1.2941,0.097,0.66,1.2301,0.11,0.8
"GO_BP:489102_GO_0003310_PANCREATIC_A_CELL_DIFFERENTIATION","GO_BP","489102_GO_0003310_PANCREATIC_A_CELL_DIFFERENTIATION",6,-1.6566,0.01,0.047,-0.6718,0.85,1,1.5021,0.058,0.56
"KEGG_compound:C00068_THIAMIN_DIPHOSPHATE_THIAMINE_DIPHOSPHATE_THIAMIN_PYROPHOSPHATE_TPP_THPP","KEGG_compound","C00068_THIAMIN_DIPHOSPHATE_THIAMINE_DIPHOSPHATE_THIAMIN_PYROPHOSPHATE_TPP_THPP",10,-1.6566,0.017,0.059,0.8761,0.62,1,-1.7503,0.0041,0.054
"GO_MF:505439_GO_0042288_MHC_CLASS_I_PROTEIN_BINDING","GO_MF","505439_GO_0042288_MHC_CLASS_I_PROTEIN_BINDING",13,-1.6564,0.0093,0.08,1.1065,0.33,0.78,-0.9804,0.48,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_598_EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_598_EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP",199,-1.6562,0,0.024,-1.4281,0.0017,0.55,-1.0427,0.34,0.7
"GO_BP:515036_GO_0070098_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY","GO_BP","515036_GO_0070098_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY",45,-1.6561,0.0041,0.047,1.7319,0.0089,0.16,1.491,0.036,0.57
"GO_BP:489281_GO_0006457_PROTEIN_FOLDING","GO_BP","489281_GO_0006457_PROTEIN_FOLDING",220,-1.656,0,0.047,0.9709,0.55,1,-1.736,0,0.65
"GO_BP:494948_GO_0010884_POSITIVE_REGULATION_OF_LIPID_STORAGE","GO_BP","494948_GO_0010884_POSITIVE_REGULATION_OF_LIPID_STORAGE",20,-1.656,0.0063,0.047,-1.0133,0.44,0.98,-1.0516,0.38,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_2784_OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2784_OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN",6,-1.6559,0.012,0.024,-0.9587,0.5,1,-0.9435,0.53,0.83
"GO_BP:488704_GO_0002831_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS","GO_BP","488704_GO_0002831_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS",117,-1.6557,0,0.047,0.6802,1,1,-1.5887,0.0022,0.52
"KEGG_pathway:HSA04151_PI3K_AKT_SIGNALING_PATHWAY","KEGG_pathway","HSA04151_PI3K_AKT_SIGNALING_PATHWAY",329,-1.6556,0,0.0097,-0.8943,0.79,0.96,-0.9569,0.61,0.77
"GO_BP:507986_GO_0045638_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION","GO_BP","507986_GO_0045638_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION",82,-1.6555,0.0013,0.047,-1.0592,0.33,0.96,0.8372,0.84,0.99
"GO_BP:495042_GO_0010977_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT","GO_BP","495042_GO_0010977_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT",91,-1.6554,0.0025,0.047,-1.0264,0.41,0.98,-0.9751,0.5,0.88
"GO_BP:487803_GO_0001912_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY","GO_BP","487803_GO_0001912_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY",39,-1.6554,0.0041,0.047,0.6546,0.96,1,-1.0621,0.34,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1255_LE_EGR2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1255_LE_EGR2_TARGETS_DN",106,-1.6554,0,0.024,-1.1021,0.27,0.92,-1.295,0.059,0.43
"GO_BP:850008_GO_1902307_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","850008_GO_1902307_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT",15,-1.6554,0.016,0.047,-1.1962,0.23,0.89,-1.1707,0.26,0.73
"KEGG_compound:C00116_GLYCEROL_GLYCERIN_1_2_3_TRIHYDROXYPROPANE_1_2_3_PROPANETRIOL","KEGG_compound","C00116_GLYCEROL_GLYCERIN_1_2_3_TRIHYDROXYPROPANE_1_2_3_PROPANETRIOL",11,-1.6553,0.0098,0.059,-0.7709,0.75,1,0.9664,0.5,0.72
"GO_BP:513035_GO_0052192_MOVEMENT_IN_ENVIRONMENT_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513035_GO_0052192_MOVEMENT_IN_ENVIRONMENT_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",56,-1.6552,0.0027,0.047,-1.0369,0.39,0.98,-0.919,0.61,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1900_KAYO_CALORIE_RESTRICTION_MUSCLE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1900_KAYO_CALORIE_RESTRICTION_MUSCLE_UP",92,-1.655,0.0012,0.024,0.8307,0.8,0.98,-0.866,0.77,0.91
"C7_Immunologic_signatures:C7_ALL_1715_GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1715_GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP",197,-1.655,0,4e-04,0.9935,0.45,0.76,-1.351,0.025,0.095
"C2_Chemical_and_genetic_perturbations:C2_CGP_2859_GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2859_GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP",12,-1.655,0.0081,0.024,-0.736,0.8,1,-1.5795,0.032,0.25
"GO_BP:492316_GO_0007566_EMBRYO_IMPLANTATION","GO_BP","492316_GO_0007566_EMBRYO_IMPLANTATION",39,-1.6549,0.0028,0.047,-0.882,0.67,1,-0.758,0.89,1
"C4_Cancer_gene_neighborhoods:C4_CGN_403_GNF2_RTN1","C4_Cancer_gene_neighborhoods","C4_CGN_403_GNF2_RTN1",50,-1.6549,0.004,0.013,-1.6693,0,0.092,-0.9868,0.47,0.88
"C7_Immunologic_signatures:C7_ALL_536_GSE17721_LPS_VS_POLYIC_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_536_GSE17721_LPS_VS_POLYIC_6H_BMDM_DN",198,-1.6549,0,4e-04,0.9249,0.7,0.96,-1.1062,0.23,0.48
"GO_BP:488547_GO_0002674_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE","GO_BP","488547_GO_0002674_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE",11,-1.6547,0.016,0.047,-1.1406,0.28,0.93,1.2396,0.19,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_2111_KYNG_DNA_DAMAGE_BY_4NQO_OR_UV","C2_Chemical_and_genetic_perturbations","C2_CGP_2111_KYNG_DNA_DAMAGE_BY_4NQO_OR_UV",61,-1.6546,0.0013,0.024,0.862,0.72,0.96,0.9578,0.53,0.98
"GO_BP:512268_GO_0051384_RESPONSE_TO_GLUCOCORTICOID","GO_BP","512268_GO_0051384_RESPONSE_TO_GLUCOCORTICOID",127,-1.6546,0.0012,0.047,0.8907,0.76,1,-1.0466,0.35,0.82
"C7_Immunologic_signatures:C7_ALL_299_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_299_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP",197,-1.6545,0,4e-04,1.1711,0.098,0.28,-1.2423,0.047,0.21
"GO_BP:510563_GO_0048489_SYNAPTIC_VESICLE_TRANSPORT","GO_BP","510563_GO_0048489_SYNAPTIC_VESICLE_TRANSPORT",113,-1.6543,0.0012,0.047,0.8309,0.87,1,-1.1942,0.13,0.74
"GO_BP:504944_GO_0035767_ENDOTHELIAL_CELL_CHEMOTAXIS","GO_BP","504944_GO_0035767_ENDOTHELIAL_CELL_CHEMOTAXIS",8,-1.6543,0.014,0.047,-1.2145,0.25,0.88,-1.0876,0.36,0.78
"GO_BP:507928_GO_0045580_REGULATION_OF_T_CELL_DIFFERENTIATION","GO_BP","507928_GO_0045580_REGULATION_OF_T_CELL_DIFFERENTIATION",100,-1.6541,0,0.047,-1.3606,0.045,0.97,-1.0352,0.38,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_814_AMUNDSON_RESPONSE_TO_ARSENITE","C2_Chemical_and_genetic_perturbations","C2_CGP_814_AMUNDSON_RESPONSE_TO_ARSENITE",214,-1.6541,0,0.024,0.7181,1,1,-1.2768,0.031,0.45
"C7_Immunologic_signatures:C7_ALL_57_GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP","C7_Immunologic_signatures","C7_ALL_57_GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP",188,-1.6541,0,4e-04,-1.1006,0.23,1,-1.3402,0.012,0.1
"GO_BP:751150_GO_0036230_GRANULOCYTE_ACTIVATION","GO_BP","751150_GO_0036230_GRANULOCYTE_ACTIVATION",24,-1.654,0.011,0.047,1.4586,0.053,0.48,1.0223,0.42,0.83
"GO_MF:500671_GO_0031420_ALKALI_METAL_ION_BINDING","GO_MF","500671_GO_0031420_ALKALI_METAL_ION_BINDING",12,-1.654,0.012,0.081,-1.6413,0.011,0.41,-1.5366,0.04,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_2768_MIKKELSEN_MCV6_LCP_WITH_H3K4ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2768_MIKKELSEN_MCV6_LCP_WITH_H3K4ME3",156,-1.6539,0,0.024,-1.4413,0.0052,0.53,-1.2196,0.093,0.5
"GO_BP:494940_GO_0010876_LIPID_LOCALIZATION","GO_BP","494940_GO_0010876_LIPID_LOCALIZATION",244,-1.6539,0,0.047,-1.037,0.37,0.98,1.2194,0.058,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_500_MCBRYAN_PUBERTAL_BREAST_4_5WK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_500_MCBRYAN_PUBERTAL_BREAST_4_5WK_UP",261,-1.6539,0,0.024,0.9767,0.51,0.82,1.167,0.1,0.8
"KEGG_reaction:R00904_3_AMINOPROPANAL_NAD_OXIDOREDUCTASE_3_AMINOPROPANAL_NAD_H2O_BETA_ALANINE_NADH_H_","KEGG_reaction","R00904_3_AMINOPROPANAL_NAD_OXIDOREDUCTASE_3_AMINOPROPANAL_NAD_H2O_BETA_ALANINE_NADH_H_",9,-1.6538,0.015,0.049,0.8307,0.67,1,-1.3785,0.12,0.38
"KEGG_compound:C00106_URACIL","KEGG_compound","C00106_URACIL",6,-1.6538,0.013,0.059,-0.8456,0.62,1,-0.6704,0.87,0.92
"C3_TF_targets:C3_TFT_581_RGAANNTTC_V_HSF1_01","C3_TF_targets","C3_TFT_581_RGAANNTTC_V_HSF1_01",436,-1.6536,0,0.0086,-1.4113,0.0034,0.16,-1.2893,0.0043,0.26
"C7_Immunologic_signatures:C7_ALL_1375_GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP","C7_Immunologic_signatures","C7_ALL_1375_GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP",195,-1.6536,0,4e-04,-0.6655,1,1,-0.9464,0.6,0.86
"REACTOME:771580_REACT_160158_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS","REACTOME","771580_REACT_160158_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS",26,-1.6535,0.0073,0.055,-0.9658,0.52,1,-1.2413,0.16,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1524_BASSO_CD40_SIGNALING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1524_BASSO_CD40_SIGNALING_DN",66,-1.6535,0.0027,0.024,-0.5856,1,1,-1.4709,0.03,0.31
"C4_Cancer_modules:C4_CM_195_MODULE_208","C4_Cancer_modules","C4_CM_195_MODULE_208",119,-1.6534,0,0.019,1.634,0,0.065,-1.0689,0.3,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_305_KIM_WT1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_305_KIM_WT1_TARGETS_UP",211,-1.6534,0,0.024,-1.0369,0.39,0.98,1.1354,0.18,0.83
"GO_MF:490639_GO_0005544_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING","GO_MF","490639_GO_0005544_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING",54,-1.6534,0.0041,0.081,0.9632,0.52,0.91,-1.5101,0.012,0.42
"WikiPathways:672462_WP2037_PROLACTIN_SIGNALING_PATHWAY","WikiPathways","672462_WP2037_PROLACTIN_SIGNALING_PATHWAY",74,-1.6533,0.0026,0.029,-0.6474,0.99,1,-0.7797,0.9,0.96
"GO_BP:500887_GO_0031638_ZYMOGEN_ACTIVATION","GO_BP","500887_GO_0031638_ZYMOGEN_ACTIVATION",110,-1.6533,0,0.048,-0.6851,0.98,1,-1.5796,0.006,0.53
"GO_BP:512289_GO_0051410_DETOXIFICATION_OF_NITROGEN_COMPOUND","GO_BP","512289_GO_0051410_DETOXIFICATION_OF_NITROGEN_COMPOUND",5,-1.6532,0.012,0.048,-1.4607,0.057,0.88,-1.609,0.018,0.53
"GO_BP:508009_GO_0045661_REGULATION_OF_MYOBLAST_DIFFERENTIATION","GO_BP","508009_GO_0045661_REGULATION_OF_MYOBLAST_DIFFERENTIATION",40,-1.6532,0.0071,0.047,-1.2581,0.13,0.91,-1.4814,0.018,0.53
"C6_Oncogenic_signatures:C6_ALL_163_TBK1_DF_UP","C6_Oncogenic_signatures","C6_ALL_163_TBK1_DF_UP",288,-1.6531,0,0.0035,-0.7262,1,1,-0.8809,0.86,0.84
"C7_Immunologic_signatures:C7_ALL_1568_GSE3982_CTRL_VS_LPS_4H_MAC_DN","C7_Immunologic_signatures","C7_ALL_1568_GSE3982_CTRL_VS_LPS_4H_MAC_DN",198,-1.6531,0.0011,4e-04,1.1387,0.15,0.34,-1.3114,0.015,0.13
"GO_BP:518962_GO_2000316_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE","GO_BP","518962_GO_2000316_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE",7,-1.653,0.0052,0.047,-1.5123,0.065,0.81,-1.1772,0.26,0.74
"GO_BP:514683_GO_0061138_MORPHOGENESIS_OF_A_BRANCHING_EPITHELIUM","GO_BP","514683_GO_0061138_MORPHOGENESIS_OF_A_BRANCHING_EPITHELIUM",179,-1.6529,0,0.048,1.0836,0.23,0.92,1.4043,0.012,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1320_CHANG_POU5F1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1320_CHANG_POU5F1_TARGETS_DN",8,-1.6527,0.011,0.024,-1.0373,0.4,0.98,0.6061,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1941_SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1","C2_Chemical_and_genetic_perturbations","C2_CGP_1941_SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1",392,-1.6526,0,0.024,-1.0955,0.21,0.92,-0.9932,0.5,0.77
"GO_BP:488592_GO_0002719_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488592_GO_0002719_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE",18,-1.6526,0.013,0.048,-1.0804,0.35,0.95,-1.061,0.37,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_6_WINTER_HYPOXIA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_6_WINTER_HYPOXIA_DN",50,-1.6525,0.0041,0.024,0.6685,0.96,1,-1.797,0,0.13
"C2_Chemical_and_genetic_perturbations:C2_CGP_3057_HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3057_HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP",242,-1.6525,0,0.024,1.2041,0.068,0.48,1.0864,0.23,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1482_GILDEA_METASTASIS","C2_Chemical_and_genetic_perturbations","C2_CGP_1482_GILDEA_METASTASIS",29,-1.6524,0.01,0.024,1.2372,0.16,0.45,-1.4833,0.046,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_3279_PLASARI_NFIC_TARGETS_BASAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3279_PLASARI_NFIC_TARGETS_BASAL_DN",18,-1.6522,0.014,0.024,0.7134,0.84,1,0.9437,0.52,1
"GO_BP:511896_GO_0050962_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION","GO_BP","511896_GO_0050962_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION",16,-1.6522,0.015,0.048,-1.6848,0.014,0.59,1.1201,0.32,0.75
"GO_BP:513610_GO_0060052_NEUROFILAMENT_CYTOSKELETON_ORGANIZATION","GO_BP","513610_GO_0060052_NEUROFILAMENT_CYTOSKELETON_ORGANIZATION",10,-1.6522,0.019,0.048,0.5697,0.96,1,-0.5793,0.96,1
"WikiPathways:198779_WP382_MAPK_SIGNALING_PATHWAY","WikiPathways","198779_WP382_MAPK_SIGNALING_PATHWAY",164,-1.6521,0,0.029,-1.2611,0.071,0.88,-1.1822,0.14,0.56
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_93_BIOCARTA_IL3_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_93_BIOCARTA_IL3_PATHWAY",15,-1.652,0.014,0.071,-1.2093,0.22,1,-1.2425,0.19,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_3065_QI_HYPOXIA","C2_Chemical_and_genetic_perturbations","C2_CGP_3065_QI_HYPOXIA",138,-1.652,0,0.024,-1.0312,0.37,0.98,-1.1391,0.17,0.59
"GO_BP:500389_GO_0031102_NEURON_PROJECTION_REGENERATION","GO_BP","500389_GO_0031102_NEURON_PROJECTION_REGENERATION",25,-1.6519,0.017,0.048,-1.4996,0.044,0.82,-1.022,0.43,0.83
"GO_BP:499181_GO_0021902_COMMITMENT_OF_NEURONAL_CELL_TO_SPECIFIC_NEURON_TYPE_IN_FOREBRAIN","GO_BP","499181_GO_0021902_COMMITMENT_OF_NEURONAL_CELL_TO_SPECIFIC_NEURON_TYPE_IN_FOREBRAIN",6,-1.6516,0.01,0.048,-1.7077,0.006,0.7,-1.5475,0.051,0.52
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_75_BIOCARTA_FMLP_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_75_BIOCARTA_FMLP_PATHWAY",35,-1.6516,0.01,0.07,0.5574,1,1,-1.1764,0.21,0.58
"GO_BP:1129485_GO_1903659_REGULATION_OF_COMPLEMENT_DEPENDENT_CYTOTOXICITY","GO_BP","1129485_GO_1903659_REGULATION_OF_COMPLEMENT_DEPENDENT_CYTOTOXICITY",5,-1.6515,0.007,0.048,-1.3749,0.11,0.99,-1.1616,0.32,0.73
"GO_BP:514896_GO_0061351_NEURAL_PRECURSOR_CELL_PROLIFERATION","GO_BP","514896_GO_0061351_NEURAL_PRECURSOR_CELL_PROLIFERATION",64,-1.6515,0.0066,0.048,-0.8754,0.68,1,0.797,0.83,1
"GO_BP:512973_GO_0052126_MOVEMENT_IN_HOST_ENVIRONMENT","GO_BP","512973_GO_0052126_MOVEMENT_IN_HOST_ENVIRONMENT",56,-1.6514,0.0027,0.048,-1.0309,0.4,0.98,-0.936,0.59,0.9
"GO_BP:508113_GO_0045776_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE","GO_BP","508113_GO_0045776_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE",41,-1.6514,0.0072,0.048,-1.3007,0.11,0.89,-1.2651,0.13,0.67
"GO_BP:507799_GO_0045445_MYOBLAST_DIFFERENTIATION","GO_BP","507799_GO_0045445_MYOBLAST_DIFFERENTIATION",33,-1.6512,0.0042,0.048,-0.822,0.75,1,1.2059,0.19,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_295_KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_295_KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN",322,-1.6511,0,0.025,-0.9184,0.72,1,-0.8702,0.9,0.91
"GO_BP:511845_GO_0050908_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_VISUAL_PERCEPTION","GO_BP","511845_GO_0050908_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_VISUAL_PERCEPTION",16,-1.6511,0.0093,0.048,-1.7026,0.006,0.69,1.1142,0.31,0.75
"GO_BP:501973_GO_0032747_POSITIVE_REGULATION_OF_INTERLEUKIN_23_PRODUCTION","GO_BP","501973_GO_0032747_POSITIVE_REGULATION_OF_INTERLEUKIN_23_PRODUCTION",5,-1.651,0.007,0.048,-1.3283,0.14,0.89,-1.3921,0.11,0.58
"GO_MF:490348_GO_0051019_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING","GO_MF","490348_GO_0051019_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING",21,-1.6509,0.006,0.082,-0.6736,0.91,1,-1.0445,0.39,0.75
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_67_BIOCARTA_ERYTH_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_67_BIOCARTA_ERYTH_PATHWAY",15,-1.6508,0.016,0.068,-1.5139,0.054,1,-1.4327,0.061,0.41
"GO_BP:516295_GO_0071371_CELLULAR_RESPONSE_TO_GONADOTROPIN_STIMULUS","GO_BP","516295_GO_0071371_CELLULAR_RESPONSE_TO_GONADOTROPIN_STIMULUS",18,-1.6507,0.013,0.048,-1.0069,0.44,0.98,1.3805,0.085,0.64
"C7_Immunologic_signatures:C7_ALL_1808_GSE7852_TREG_VS_TCONV_LN_DN","C7_Immunologic_signatures","C7_ALL_1808_GSE7852_TREG_VS_TCONV_LN_DN",199,-1.6505,0,0.00042,-0.791,0.95,1,-1.0757,0.27,0.56
"GO_BP:513148_GO_0052305_POSITIVE_REGULATION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513148_GO_0052305_POSITIVE_REGULATION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",6,-1.6503,0.012,0.048,0.8203,0.67,1,-0.8784,0.62,0.94
"KEGG_module:HSA_M00684_JAK_STAT_SIGNALING","KEGG_module","HSA_M00684_JAK_STAT_SIGNALING",19,-1.6502,0.016,0.11,-0.9,0.57,1,-1.3313,0.11,0.52
"C3_TF_targets:C3_TFT_472_V_CP2_02","C3_TF_targets","C3_TFT_472_V_CP2_02",243,-1.6502,0,0.0088,-1.2703,0.034,0.26,-1.146,0.13,0.46
"GO_BP:505305_GO_0042133_NEUROTRANSMITTER_METABOLIC_PROCESS","GO_BP","505305_GO_0042133_NEUROTRANSMITTER_METABOLIC_PROCESS",24,-1.65,0.015,0.048,-0.8527,0.66,1,-1.2877,0.12,0.65
"GO_BP:488629_GO_0002756_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","488629_GO_0002756_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",81,-1.6497,0,0.048,-0.9062,0.62,1,-1.1299,0.2,0.75
"GO_MF:490291_GO_0005005_TRANSMEMBRANE_EPHRIN_RECEPTOR_ACTIVITY","GO_MF","490291_GO_0005005_TRANSMEMBRANE_EPHRIN_RECEPTOR_ACTIVITY",9,-1.6496,0.013,0.083,-1.2821,0.19,0.81,-1.5876,0.031,0.37
"C2_Chemical_and_genetic_perturbations:C2_CGP_2197_OSADA_ASCL1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2197_OSADA_ASCL1_TARGETS_DN",24,-1.6495,0.011,0.025,-0.7381,0.84,1,1.5397,0.019,0.46
"REACTOME:106461_REACT_12033_SIGNALLING_TO_RAS","REACTOME","106461_REACT_12033_SIGNALLING_TO_RAS",34,-1.6492,0.0045,0.057,-0.5291,1,1,-0.7975,0.8,1
"GO_BP:506345_GO_0043280_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_BP","506345_GO_0043280_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",120,-1.6488,0.0012,0.049,0.8505,0.83,1,-1.4133,0.0083,0.57
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_177_BIOCARTA_BARRESTIN_SRC_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_177_BIOCARTA_BARRESTIN_SRC_PATHWAY",14,-1.6487,0.013,0.068,-1.0998,0.32,1,-1.2192,0.21,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2965_MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1","C2_Chemical_and_genetic_perturbations","C2_CGP_2965_MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1",9,-1.6486,0.013,0.025,0.8331,0.67,0.97,0.6324,0.92,1
"GO_BP:487589_GO_0001678_CELLULAR_GLUCOSE_HOMEOSTASIS","GO_BP","487589_GO_0001678_CELLULAR_GLUCOSE_HOMEOSTASIS",61,-1.6485,0.0013,0.049,0.8143,0.82,1,0.8385,0.8,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1076_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1076_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP",11,-1.6484,0.016,0.025,-1.2135,0.23,0.79,1.0389,0.4,0.92
"GO_BP:921131_GO_1902532_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION","GO_BP","921131_GO_1902532_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION",376,-1.6483,0,0.049,0.7209,1,1,-0.8715,0.9,0.95
"GO_MF:490442_GO_0005178_INTEGRIN_BINDING","GO_MF","490442_GO_0005178_INTEGRIN_BINDING",103,-1.6483,0.0012,0.083,-0.7263,0.96,1,1.1712,0.15,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_1176_MORI_LARGE_PRE_BII_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1176_MORI_LARGE_PRE_BII_LYMPHOCYTE_UP",86,-1.648,0.0038,0.025,0.8846,0.74,0.94,-2.1703,0,0.0079
"GO_MF:490428_GO_0005164_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING","GO_MF","490428_GO_0005164_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING",31,-1.648,0.015,0.083,-1.0496,0.36,0.86,-1.543,0.018,0.4
"GO_MF:489645_GO_0004180_CARBOXYPEPTIDASE_ACTIVITY","GO_MF","489645_GO_0004180_CARBOXYPEPTIDASE_ACTIVITY",37,-1.6479,0.0099,0.082,-0.5442,0.99,1,-1.4989,0.028,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_3370_SMIRNOV_RESPONSE_TO_IR_2HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3370_SMIRNOV_RESPONSE_TO_IR_2HR_DN",55,-1.6479,0.0039,0.025,-1.2929,0.11,0.71,-1.63,0.0019,0.22
"REACTOME:685549_REACT_147694_DAP12_INTERACTIONS","REACTOME","685549_REACT_147694_DAP12_INTERACTIONS",172,-1.6476,0,0.058,-1.0505,0.34,0.94,-1.1289,0.17,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_3048_KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3048_KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN",80,-1.6476,0.0026,0.025,-0.8753,0.72,1,1.2241,0.11,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_3070_HOELZEL_NF1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3070_HOELZEL_NF1_TARGETS_UP",135,-1.6474,0.0012,0.025,1.1936,0.1,0.5,1.4447,0.0057,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2060_GAVIN_FOXP3_TARGETS_CLUSTER_P2","C2_Chemical_and_genetic_perturbations","C2_CGP_2060_GAVIN_FOXP3_TARGETS_CLUSTER_P2",78,-1.6474,0.0038,0.025,0.9581,0.54,0.86,1.2053,0.13,0.77
"GO_BP:500307_GO_0031017_EXOCRINE_PANCREAS_DEVELOPMENT","GO_BP","500307_GO_0031017_EXOCRINE_PANCREAS_DEVELOPMENT",8,-1.6474,0.017,0.049,1.0075,0.47,0.98,-1.1174,0.36,0.76
"GO_BP:507425_GO_0045017_GLYCEROLIPID_BIOSYNTHETIC_PROCESS","GO_BP","507425_GO_0045017_GLYCEROLIPID_BIOSYNTHETIC_PROCESS",209,-1.6469,0,0.049,-0.6786,0.99,1,-1.0223,0.41,0.83
"GO_BP:506443_GO_0043405_REGULATION_OF_MAP_KINASE_ACTIVITY","GO_BP","506443_GO_0043405_REGULATION_OF_MAP_KINASE_ACTIVITY",283,-1.6469,0,0.049,-0.6909,1,1,1.1428,0.14,0.73
"C4_Cancer_gene_neighborhoods:C4_CGN_323_GNF2_BUB1B","C4_Cancer_gene_neighborhoods","C4_CGN_323_GNF2_BUB1B",49,-1.6469,0.0068,0.014,-0.6937,0.95,1,-1.5078,0.028,0.11
"C3_TF_targets:C3_TFT_151_V_OCT_C","C3_TF_targets","C3_TFT_151_V_OCT_C",250,-1.6467,0,0.0089,-1.4689,0.0035,0.13,-1.3534,0.0043,0.28
"GO_BP:513017_GO_0052173_RESPONSE_TO_DEFENSES_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513017_GO_0052173_RESPONSE_TO_DEFENSES_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",14,-1.6467,0.016,0.049,1.064,0.35,0.94,-0.6764,0.9,1
"GO_BP:518462_GO_0090322_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS","GO_BP","518462_GO_0090322_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS",18,-1.6467,0.0078,0.049,0.7969,0.78,1,-0.5431,0.99,1
"GO_CC:850015_GO_1990104_DNA_BENDING_COMPLEX","GO_CC","850015_GO_1990104_DNA_BENDING_COMPLEX",93,-1.6466,0,0.08,-1.7534,0,0.18,-1.5232,0.0083,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_1543_MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1543_MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP",401,-1.6465,0,0.026,-1.3423,0.0065,0.7,-0.9743,0.54,0.79
"GO_BP:487578_GO_0001666_RESPONSE_TO_HYPOXIA","GO_BP","487578_GO_0001666_RESPONSE_TO_HYPOXIA",243,-1.6464,0,0.049,0.8318,0.94,1,0.9714,0.55,0.89
"GO_CC:506272_GO_0043204_PERIKARYON","GO_CC","506272_GO_0043204_PERIKARYON",64,-1.6464,0.0027,0.079,-0.9655,0.52,0.89,1.176,0.19,0.81
"GO_BP:514910_GO_0061365_POSITIVE_REGULATION_OF_TRIGLYCERIDE_LIPASE_ACTIVITY","GO_BP","514910_GO_0061365_POSITIVE_REGULATION_OF_TRIGLYCERIDE_LIPASE_ACTIVITY",11,-1.6464,0.016,0.049,-1.4086,0.1,0.97,-1.3832,0.1,0.59
"GO_BP:513312_GO_0052572_RESPONSE_TO_HOST_IMMUNE_RESPONSE","GO_BP","513312_GO_0052572_RESPONSE_TO_HOST_IMMUNE_RESPONSE",12,-1.6464,0.0096,0.049,1.1084,0.32,0.89,-0.7821,0.78,1
"GO_BP:488552_GO_0002679_RESPIRATORY_BURST_INVOLVED_IN_DEFENSE_RESPONSE","GO_BP","488552_GO_0002679_RESPIRATORY_BURST_INVOLVED_IN_DEFENSE_RESPONSE",5,-1.6462,0.0086,0.049,-0.5461,0.96,1,-1.0422,0.42,0.82
"GO_BP:513014_GO_0052169_PATHOGEN_ASSOCIATED_MOLECULAR_PATTERN_DEPENDENT_MODULATION_BY_SYMBIONT_OF_HOST_INNATE_IMMUNE_RESPONSE","GO_BP","513014_GO_0052169_PATHOGEN_ASSOCIATED_MOLECULAR_PATTERN_DEPENDENT_MODULATION_BY_SYMBIONT_OF_HOST_INNATE_IMMUNE_RESPONSE",6,-1.6461,0.012,0.049,0.799,0.71,1,-0.8627,0.65,0.95
"C7_Immunologic_signatures:C7_ALL_1017_GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP","C7_Immunologic_signatures","C7_ALL_1017_GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP",197,-1.646,0,0.00048,1.7164,0,0.00044,0.8729,0.82,1
"GO_BP:518836_GO_2000188_REGULATION_OF_CHOLESTEROL_HOMEOSTASIS","GO_BP","518836_GO_2000188_REGULATION_OF_CHOLESTEROL_HOMEOSTASIS",11,-1.6459,0.021,0.049,-1.2362,0.21,0.9,-0.8218,0.68,0.97
"GO_BP:513100_GO_0052257_PATHOGEN_ASSOCIATED_MOLECULAR_PATTERN_DEPENDENT_INDUCTION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513100_GO_0052257_PATHOGEN_ASSOCIATED_MOLECULAR_PATTERN_DEPENDENT_INDUCTION_BY_ORGANISM_OF_INNATE_IMMUNE_RESPONSE_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",6,-1.6458,0.0085,0.049,0.8109,0.71,1,-0.8749,0.61,0.94
"GO_BP:519154_GO_2000514_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION","GO_BP","519154_GO_2000514_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",33,-1.6458,0.013,0.049,-1.5212,0.028,0.79,-0.9997,0.44,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_390_DELYS_THYROID_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_390_DELYS_THYROID_CANCER_DN",224,-1.6457,0,0.026,-0.9848,0.51,1,-1.2777,0.034,0.45
"GO_BP:500197_GO_0030902_HINDBRAIN_DEVELOPMENT","GO_BP","500197_GO_0030902_HINDBRAIN_DEVELOPMENT",128,-1.6457,0.0012,0.049,-1.1042,0.24,0.94,-0.963,0.54,0.88
"GO_BP:504643_GO_0035459_CARGO_LOADING_INTO_VESICLE","GO_BP","504643_GO_0035459_CARGO_LOADING_INTO_VESICLE",6,-1.6457,0.0069,0.049,1.2188,0.26,0.76,-0.5128,0.97,1
"KEGG_compound:C00279_D_ERYTHROSE_4_PHOSPHATE","KEGG_compound","C00279_D_ERYTHROSE_4_PHOSPHATE",7,-1.6455,0.0051,0.064,-0.7808,0.77,1,-0.9531,0.53,0.71
"GO_BP:753392_GO_1900408_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS","GO_BP","753392_GO_1900408_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS",27,-1.6454,0.0042,0.049,1.2724,0.13,0.71,-1.0012,0.44,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_3295_TIAN_BHLHA15_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3295_TIAN_BHLHA15_TARGETS",16,-1.6453,0.014,0.026,-1.1273,0.31,0.89,-0.8887,0.62,0.9
"C3_TF_targets:C3_TFT_563_TTGCWCAAY_V_CEBPB_02","C3_TF_targets","C3_TFT_563_TTGCWCAAY_V_CEBPB_02",63,-1.6453,0.0079,0.0088,-0.756,0.92,1,-0.9752,0.5,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_412_LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_412_LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN",140,-1.6452,0,0.026,1.1488,0.15,0.56,0.9017,0.71,1
"GO_MF:490634_GO_0005536_GLUCOSE_BINDING","GO_MF","490634_GO_0005536_GLUCOSE_BINDING",8,-1.6452,0.0067,0.084,-1.3245,0.16,0.73,-1.6945,0.01,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_2067_GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2067_GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN",5,-1.6451,0.012,0.026,-0.8071,0.72,1,-0.9808,0.49,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2941_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15","C2_Chemical_and_genetic_perturbations","C2_CGP_2941_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15",34,-1.645,0.0044,0.026,0.8391,0.73,0.98,-1.6605,0.0063,0.21
"GO_BP:499623_GO_0030213_HYALURONAN_BIOSYNTHETIC_PROCESS","GO_BP","499623_GO_0030213_HYALURONAN_BIOSYNTHETIC_PROCESS",6,-1.6449,0.012,0.05,-0.88,0.62,1,-0.662,0.87,1
"REACTOME:1183537_REACT_355585_DISEASES_ASSOCIATED_WITH_THE_TLR_SIGNALING_CASCADE","REACTOME","1183537_REACT_355585_DISEASES_ASSOCIATED_WITH_THE_TLR_SIGNALING_CASCADE",23,-1.6449,0.013,0.059,-0.4802,1,1,-0.7872,0.79,1
"GO_BP:504618_GO_0035434_COPPER_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","504618_GO_0035434_COPPER_ION_TRANSMEMBRANE_TRANSPORT",7,-1.6448,0.0066,0.05,-0.8903,0.57,1,0.6195,0.91,1
"GO_MF:490310_GO_0005021_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY","GO_MF","490310_GO_0005021_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",7,-1.6448,0.0035,0.084,0.584,0.94,1,-1.1518,0.28,0.64
"GO_BP:516722_GO_0071799_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_D_STIMULUS","GO_BP","516722_GO_0071799_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_D_STIMULUS",5,-1.6447,0.013,0.05,0.9876,0.48,0.99,0.5346,0.97,1
"GO_BP:752738_GO_0097237_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE","GO_BP","752738_GO_0097237_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE",19,-1.6446,0.011,0.05,-0.9,0.57,1,-0.9146,0.59,0.92
"GO_BP:1022187_GO_1903201_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH","GO_BP","1022187_GO_1903201_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH",39,-1.6445,0.013,0.05,1.0058,0.45,0.98,-0.9525,0.52,0.89
"GO_BP:1053346_GO_0098739_IMPORT_ACROSS_PLASMA_MEMBRANE","GO_BP","1053346_GO_0098739_IMPORT_ACROSS_PLASMA_MEMBRANE",6,-1.6442,0.0098,0.05,-1.6848,0.025,0.58,-1.3516,0.14,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_1985_GERHOLD_ADIPOGENESIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1985_GERHOLD_ADIPOGENESIS_UP",49,-1.6441,0.0067,0.026,1.2995,0.093,0.39,1.2433,0.11,0.75
"GO_BP:498627_GO_0046686_RESPONSE_TO_CADMIUM_ION","GO_BP","498627_GO_0046686_RESPONSE_TO_CADMIUM_ION",38,-1.6439,0.0073,0.05,0.815,0.79,1,1.0957,0.29,0.76
"GO_BP:518896_GO_2000249_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION","GO_BP","518896_GO_2000249_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION",26,-1.6439,0.015,0.05,-1.2017,0.22,0.89,-1.1187,0.3,0.76
"C6_Oncogenic_signatures:C6_ALL_101_ALK_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_101_ALK_DN_V1_DN",134,-1.6439,0,0.0038,-0.9998,0.45,0.68,1.2201,0.11,0.25
"C6_Oncogenic_signatures:C6_ALL_180_KRAS_KIDNEY_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_180_KRAS_KIDNEY_UP_V1_DN",126,-1.6438,0.0025,0.0037,-1.2814,0.056,0.34,-1.0529,0.34,0.59
"GO_BP:505634_GO_0042503_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN","GO_BP","505634_GO_0042503_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN",6,-1.6437,0.012,0.05,-1.2939,0.18,0.88,-1.4173,0.093,0.57
"GO_BP:488816_GO_0003018_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM","GO_BP","488816_GO_0003018_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM",99,-1.6437,0.0025,0.05,1.2119,0.12,0.77,1.0842,0.28,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1506_NUMATA_CSF3_SIGNALING_VIA_STAT3","C2_Chemical_and_genetic_perturbations","C2_CGP_1506_NUMATA_CSF3_SIGNALING_VIA_STAT3",22,-1.6436,0.0077,0.026,-1.0436,0.38,0.98,-1.1702,0.25,0.55
"GO_MF:502036_GO_0032813_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING","GO_MF","502036_GO_0032813_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING",44,-1.6436,0.0028,0.084,-0.8525,0.72,1,-1.2238,0.14,0.58
"GO_BP:498208_GO_0019364_PYRIDINE_NUCLEOTIDE_CATABOLIC_PROCESS","GO_BP","498208_GO_0019364_PYRIDINE_NUCLEOTIDE_CATABOLIC_PROCESS",42,-1.6435,0.01,0.05,-1.0321,0.41,0.98,-1.5667,0.016,0.52
"C6_Oncogenic_signatures:C6_ALL_42_ATF2_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_42_ATF2_UP_V1_UP",178,-1.6435,0,0.0037,-1.0596,0.31,0.6,0.9345,0.65,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_2013_ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST","C2_Chemical_and_genetic_perturbations","C2_CGP_2013_ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST",128,-1.6434,0.0024,0.026,1.4537,0.0094,0.25,-0.6672,1,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2018_YANG_MUC2_TARGETS_DUODENUM_6MO_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2018_YANG_MUC2_TARGETS_DUODENUM_6MO_DN",19,-1.6434,0.012,0.026,-1.5593,0.051,0.43,-1.7281,0.0075,0.16
"C6_Oncogenic_signatures:C6_ALL_50_RELA_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_50_RELA_DN_V1_UP",146,-1.6433,0.0012,0.0036,-1.4662,0.015,0.28,-0.9028,0.72,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_130_LIU_TARGETS_OF_VMYB_VS_CMYB_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_130_LIU_TARGETS_OF_VMYB_VS_CMYB_DN",43,-1.6427,0.0057,0.026,0.8282,0.79,0.98,-1.0483,0.38,0.69
"KEGG_pathway:HSA00071_FATTY_ACID_DEGRADATION","KEGG_pathway","HSA00071_FATTY_ACID_DEGRADATION",44,-1.6426,0.0096,0.011,0.5509,1,1,-1.487,0.025,0.15
"GO_BP:516316_GO_0071392_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS","GO_BP","516316_GO_0071392_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS",21,-1.6426,0.021,0.05,-1.0963,0.31,0.94,-1.181,0.22,0.73
"GO_BP:514609_GO_0061061_MUSCLE_STRUCTURE_DEVELOPMENT","GO_BP","514609_GO_0061061_MUSCLE_STRUCTURE_DEVELOPMENT",434,-1.6425,0,0.05,-1.1248,0.13,0.94,-1.2153,0.045,0.72
"C7_Immunologic_signatures:C7_ALL_1806_GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1806_GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN",199,-1.6425,0,0.00053,0.7338,1,1,-1.2311,0.065,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_1729_LINDVALL_IMMORTALIZED_BY_TERT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1729_LINDVALL_IMMORTALIZED_BY_TERT_UP",75,-1.6424,0.0039,0.026,-0.9709,0.5,1,0.9021,0.67,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_974_WILLIAMS_ESR2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_974_WILLIAMS_ESR2_TARGETS_UP",27,-1.6424,0.014,0.026,-1.2832,0.13,0.69,-0.995,0.43,0.76
"GO_BP:753518_GO_1900543_NEGATIVE_REGULATION_OF_PURINE_NUCLEOTIDE_METABOLIC_PROCESS","GO_BP","753518_GO_1900543_NEGATIVE_REGULATION_OF_PURINE_NUCLEOTIDE_METABOLIC_PROCESS",88,-1.6424,0.0012,0.05,1.1175,0.23,0.88,1.4774,0.0059,0.58
"GO_BP:502096_GO_0032874_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_MAPK_CASCADE","GO_BP","502096_GO_0032874_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_MAPK_CASCADE",118,-1.6424,0,0.05,-1.3791,0.02,0.98,-1.176,0.14,0.73
"GO_MF:487771_GO_0001875_LIPOPOLYSACCHARIDE_RECEPTOR_ACTIVITY","GO_MF","487771_GO_0001875_LIPOPOLYSACCHARIDE_RECEPTOR_ACTIVITY",5,-1.6423,0.009,0.085,-0.8195,0.67,1,0.702,0.82,1
"C3_TF_targets:C3_TFT_356_V_TEF_Q6","C3_TF_targets","C3_TFT_356_V_TEF_Q6",246,-1.6421,0,0.0089,-1.0563,0.31,0.64,0.9686,0.54,1
"GO_BP:501506_GO_0032271_REGULATION_OF_PROTEIN_POLYMERIZATION","GO_BP","501506_GO_0032271_REGULATION_OF_PROTEIN_POLYMERIZATION",137,-1.642,0.0012,0.05,-0.8957,0.7,1,-1.5057,0,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_569_OLSSON_E2F3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_569_OLSSON_E2F3_TARGETS_DN",47,-1.642,0.0055,0.026,1.0405,0.36,0.73,-1.1176,0.28,0.61
"GO_MF:490644_GO_0005549_ODORANT_BINDING","GO_MF","490644_GO_0005549_ODORANT_BINDING",62,-1.6419,0.0026,0.084,1.8602,0,0.043,3.1026,0,0
"C6_Oncogenic_signatures:C6_ALL_41_ATF2_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_41_ATF2_UP_V1_DN",176,-1.6417,0,0.0036,-1.1789,0.11,0.47,1.0877,0.23,0.38
"GO_CC:500494_GO_0031233_INTRINSIC_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE","GO_CC","500494_GO_0031233_INTRINSIC_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE",23,-1.6417,0.015,0.081,1.1812,0.22,0.55,0.9215,0.58,1
"C6_Oncogenic_signatures:C6_ALL_75_PRC2_EZH2_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_75_PRC2_EZH2_UP_V1_DN",187,-1.6416,0,0.0036,-1.063,0.29,0.61,0.9273,0.65,0.71
"C6_Oncogenic_signatures:C6_ALL_17_CYCLIN_D1_KE_V1_DN","C6_Oncogenic_signatures","C6_ALL_17_CYCLIN_D1_KE_V1_DN",183,-1.6412,0,0.0035,1.3397,0.016,0.32,-1.3196,0.023,0.33
"GO_CC:500495_GO_0031234_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE","GO_CC","500495_GO_0031234_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE",95,-1.6411,0.0038,0.08,-0.9567,0.55,0.9,-1.1241,0.23,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_3252_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5","C2_Chemical_and_genetic_perturbations","C2_CGP_3252_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5",11,-1.641,0.019,0.027,-1.531,0.045,0.45,-1.3403,0.14,0.4
"GO_BP:507800_GO_0045446_ENDOTHELIAL_CELL_DIFFERENTIATION","GO_BP","507800_GO_0045446_ENDOTHELIAL_CELL_DIFFERENTIATION",72,-1.6407,0.0026,0.051,0.7496,0.93,1,1.1336,0.23,0.74
"GO_BP:507458_GO_0045058_T_CELL_SELECTION","GO_BP","507458_GO_0045058_T_CELL_SELECTION",33,-1.6406,0.0074,0.051,-0.7828,0.81,1,-0.9175,0.58,0.91
"GO_BP:500390_GO_0031103_AXON_REGENERATION","GO_BP","500390_GO_0031103_AXON_REGENERATION",18,-1.6405,0.018,0.051,-1.1757,0.26,0.9,-0.9494,0.54,0.89
"GO_BP:1129337_GO_1903510_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS","GO_BP","1129337_GO_1903510_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS",120,-1.6404,0,0.051,-0.776,0.95,1,1.009,0.38,0.85
"KEGG_compound:C05382_SEDOHEPTULOSE_7_PHOSPHATE_D_SEDOHEPTULOSE_7_PHOSPHATE_D_ALTRO_HEPTULOSE_7_PHOSPHATE_ALTRO_HEPTULOSE_7_PHOSPHATE","KEGG_compound","C05382_SEDOHEPTULOSE_7_PHOSPHATE_D_SEDOHEPTULOSE_7_PHOSPHATE_D_ALTRO_HEPTULOSE_7_PHOSPHATE_ALTRO_HEPTULOSE_7_PHOSPHATE",5,-1.6404,0.013,0.066,-0.5355,0.97,1,-0.5887,0.94,0.97
"KEGG_module:HSA_M00131_INOSITOL_PHOSPHATE_METABOLISM_INS_1_3_4_5_P4_INS_1_3_4_P3_MYO_INOSITOL","KEGG_module","HSA_M00131_INOSITOL_PHOSPHATE_METABOLISM_INS_1_3_4_5_P4_INS_1_3_4_P3_MYO_INOSITOL",9,-1.6404,0.015,0.11,-0.9161,0.57,1,-0.4504,1,1
"GO_BP:487918_GO_0002028_REGULATION_OF_SODIUM_ION_TRANSPORT","GO_BP","487918_GO_0002028_REGULATION_OF_SODIUM_ION_TRANSPORT",67,-1.6403,0.0026,0.051,-1.6093,0.0038,0.71,-1.7218,0,0.63
"GO_BP:507930_GO_0045582_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION","GO_BP","507930_GO_0045582_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION",63,-1.6402,0.0026,0.051,-1.0105,0.45,0.98,-0.9024,0.66,0.92
"C3_TF_targets:C3_TFT_244_V_FOXJ2_01","C3_TF_targets","C3_TFT_244_V_FOXJ2_01",178,-1.6402,0,0.009,-1.0187,0.41,0.72,-1.2789,0.047,0.26
"KEGG_pathway:HSA04066_HIF_1_SIGNALING_PATHWAY","KEGG_pathway","HSA04066_HIF_1_SIGNALING_PATHWAY",101,-1.6401,0.0024,0.011,-0.8303,0.84,1,-1.1365,0.21,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_1843_WELCSH_BRCA1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1843_WELCSH_BRCA1_TARGETS_UP",197,-1.64,0,0.027,1.5399,0,0.18,-1.1111,0.2,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_2918_MIKKELSEN_NPC_HCP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2918_MIKKELSEN_NPC_HCP_WITH_H3K27ME3",314,-1.6399,0,0.027,-1.1706,0.092,0.82,1.5911,0,0.4
"C6_Oncogenic_signatures:C6_ALL_111_NOTCH_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_111_NOTCH_DN_V1_DN",173,-1.6398,0,0.0035,-1.0824,0.28,0.58,-1.0039,0.43,0.64
"GO_MF:499587_GO_0030169_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING","GO_MF","499587_GO_0030169_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING",15,-1.6398,0.017,0.086,0.8934,0.58,0.99,0.9572,0.51,0.9
"C3_TF_targets:C3_TFT_350_V_PEA3_Q6","C3_TF_targets","C3_TFT_350_V_PEA3_Q6",256,-1.6396,0,0.0088,0.8469,0.93,1,-1.171,0.097,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1836_LEE_AGING_CEREBELLUM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1836_LEE_AGING_CEREBELLUM_UP",82,-1.6395,0.0013,0.027,-0.8234,0.82,1,-1.1022,0.25,0.62
"GO_BP:518227_GO_0090087_REGULATION_OF_PEPTIDE_TRANSPORT","GO_BP","518227_GO_0090087_REGULATION_OF_PEPTIDE_TRANSPORT",242,-1.6394,0,0.051,-0.8933,0.79,1,-1.0087,0.41,0.84
"GO_MF:495521_GO_0015267_CHANNEL_ACTIVITY","GO_MF","495521_GO_0015267_CHANNEL_ACTIVITY",425,-1.6393,0,0.085,-1.5309,0,0.54,1.2841,0.0074,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1294_GNATENKO_PLATELET_SIGNATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_1294_GNATENKO_PLATELET_SIGNATURE",47,-1.6391,0.0042,0.027,1.8722,0,0.025,-1.1543,0.22,0.57
"GO_BP:753116_GO_1900121_NEGATIVE_REGULATION_OF_RECEPTOR_BINDING","GO_BP","753116_GO_1900121_NEGATIVE_REGULATION_OF_RECEPTOR_BINDING",10,-1.639,0.012,0.051,1.0163,0.42,0.97,1.3869,0.11,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2804_UROSEVIC_RESPONSE_TO_IMIQUIMOD","C2_Chemical_and_genetic_perturbations","C2_CGP_2804_UROSEVIC_RESPONSE_TO_IMIQUIMOD",23,-1.6389,0.01,0.027,1.4326,0.07,0.27,-1.6194,0.029,0.24
"C2_Chemical_and_genetic_perturbations:C2_CGP_788_TERAMOTO_OPN_TARGETS_CLUSTER_7","C2_Chemical_and_genetic_perturbations","C2_CGP_788_TERAMOTO_OPN_TARGETS_CLUSTER_7",19,-1.6389,0.014,0.027,-1.4988,0.045,0.46,-1.0171,0.42,0.73
"KEGG_pathway:HSA01212_FATTY_ACID_METABOLISM","KEGG_pathway","HSA01212_FATTY_ACID_METABOLISM",49,-1.6388,0.0041,0.012,-0.8073,0.81,0.99,-1.7922,0,0.024
"C2_Chemical_and_genetic_perturbations:C2_CGP_3302_REICHERT_MITOSIS_LIN9_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3302_REICHERT_MITOSIS_LIN9_TARGETS",28,-1.6387,0.0072,0.027,-0.8655,0.67,1,-1.5299,0.026,0.29
"REACTOME:187221_REACT_25210_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI","REACTOME","187221_REACT_25210_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI",5,-1.6386,0.0069,0.063,-0.567,0.95,1,-1.2337,0.24,0.58
"GO_BP:488666_GO_0002793_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION","GO_BP","488666_GO_0002793_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION",68,-1.6385,0.0052,0.052,0.7369,0.94,1,-0.7478,0.95,1
"GO_BP:512677_GO_0051806_ENTRY_INTO_CELL_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","512677_GO_0051806_ENTRY_INTO_CELL_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",56,-1.6384,0.0041,0.052,-1.0312,0.39,0.98,-0.9267,0.6,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_298_SABATES_COLORECTAL_ADENOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_298_SABATES_COLORECTAL_ADENOMA_UP",128,-1.6384,0,0.027,-0.9882,0.47,1,-1.1796,0.14,0.54
"GO_BP:782511_GO_0038179_NEUROTROPHIN_SIGNALING_PATHWAY","GO_BP","782511_GO_0038179_NEUROTROPHIN_SIGNALING_PATHWAY",272,-1.6383,0,0.052,-0.9333,0.67,1,-1.0828,0.21,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_1792_RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1792_RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP",17,-1.6382,0.011,0.027,0.8429,0.68,0.97,1.0235,0.43,0.95
"REACTOME:685555_REACT_147707_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS","REACTOME","685555_REACT_147707_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS",15,-1.6382,0.021,0.063,1.5323,0.039,0.13,-0.9493,0.51,0.91
"GO_BP:499598_GO_0030183_B_CELL_DIFFERENTIATION","GO_BP","499598_GO_0030183_B_CELL_DIFFERENTIATION",85,-1.6382,0.0026,0.052,-1.0859,0.3,0.96,-1.6659,0,0.55
"KEGG_module:HSA_M00549_NUCLEOTIDE_SUGAR_BIOSYNTHESIS_GLUCOSE_UDP_GLUCOSE","KEGG_module","HSA_M00549_NUCLEOTIDE_SUGAR_BIOSYNTHESIS_GLUCOSE_UDP_GLUCOSE",7,-1.6381,0.01,0.1,-0.9262,0.53,1,-1.5555,0.043,0.29
"GO_BP:516200_GO_0071276_CELLULAR_RESPONSE_TO_CADMIUM_ION","GO_BP","516200_GO_0071276_CELLULAR_RESPONSE_TO_CADMIUM_ION",15,-1.638,0.015,0.052,1.1632,0.25,0.82,1.5099,0.045,0.54
"C7_Immunologic_signatures:C7_ALL_842_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN","C7_Immunologic_signatures","C7_ALL_842_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN",193,-1.6379,0,0.00059,0.9514,0.58,0.89,-1.7882,0,0.00019
"C4_Cancer_modules:C4_CM_124_MODULE_129","C4_Cancer_modules","C4_CM_124_MODULE_129",216,-1.6379,0,0.022,-1.0827,0.25,0.69,1.1586,0.13,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_2474_BOYLAN_MULTIPLE_MYELOMA_C_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2474_BOYLAN_MULTIPLE_MYELOMA_C_DN",56,-1.6378,0.0066,0.027,-0.8194,0.81,1,-0.783,0.88,0.96
"GO_BP:503961_GO_0034762_REGULATION_OF_TRANSMEMBRANE_TRANSPORT","GO_BP","503961_GO_0034762_REGULATION_OF_TRANSMEMBRANE_TRANSPORT",350,-1.6378,0,0.052,-1.3131,0.013,0.87,1.0527,0.28,0.8
"GO_BP:492551_GO_0008210_ESTROGEN_METABOLIC_PROCESS","GO_BP","492551_GO_0008210_ESTROGEN_METABOLIC_PROCESS",20,-1.6376,0.017,0.052,0.9127,0.6,1,-1.0966,0.32,0.78
"GO_BP:512698_GO_0051828_ENTRY_INTO_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","512698_GO_0051828_ENTRY_INTO_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",56,-1.6376,0.0054,0.052,-1.0321,0.39,0.98,-0.9137,0.6,0.92
"GO_BP:492391_GO_0008016_REGULATION_OF_HEART_CONTRACTION","GO_BP","492391_GO_0008016_REGULATION_OF_HEART_CONTRACTION",155,-1.6376,0.0012,0.052,-1.2317,0.094,0.9,1.1621,0.14,0.73
"GO_BP:505271_GO_0042092_TYPE_2_IMMUNE_RESPONSE","GO_BP","505271_GO_0042092_TYPE_2_IMMUNE_RESPONSE",8,-1.6375,0.018,0.052,-1.5571,0.04,0.72,0.4338,1,1
"GO_BP:512371_GO_0051493_REGULATION_OF_CYTOSKELETON_ORGANIZATION","GO_BP","512371_GO_0051493_REGULATION_OF_CYTOSKELETON_ORGANIZATION",378,-1.6374,0,0.052,-1.0362,0.35,0.98,-1.2431,0.019,0.69
"GO_BP:519040_GO_2000400_POSITIVE_REGULATION_OF_THYMOCYTE_AGGREGATION","GO_BP","519040_GO_2000400_POSITIVE_REGULATION_OF_THYMOCYTE_AGGREGATION",11,-1.6373,0.015,0.052,0.6668,0.9,1,-0.733,0.83,0.99
"GO_CC:503903_GO_0034703_CATION_CHANNEL_COMPLEX","GO_CC","503903_GO_0034703_CATION_CHANNEL_COMPLEX",161,-1.6372,0.0023,0.082,-1.4568,0.0068,0.62,1.0298,0.38,1
"GO_BP:505535_GO_0042391_REGULATION_OF_MEMBRANE_POTENTIAL","GO_BP","505535_GO_0042391_REGULATION_OF_MEMBRANE_POTENTIAL",281,-1.637,0,0.052,-1.3788,0.0052,0.98,-1.1476,0.11,0.74
"C3_TF_targets:C3_TFT_120_V_AP1_Q2","C3_TF_targets","C3_TFT_120_V_AP1_Q2",256,-1.637,0,0.0089,-1.2022,0.087,0.35,-0.9148,0.71,0.89
"GO_BP:503410_GO_0034204_LIPID_TRANSLOCATION","GO_BP","503410_GO_0034204_LIPID_TRANSLOCATION",20,-1.6369,0.018,0.052,-1.1323,0.28,0.93,-1.1213,0.28,0.76
"KEGG_compound:C04756_O_1_ALK_1_ENYL_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_PHOSPHATIDALETHANOLAMINE_PLASMENYLETHANOLAMINE_ETHANOLAMINEPLASMALOGEN_2_ACYL_1_1_ALKENYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_1_ALKENYL_2_ACYLGLYCEROPHOSPHOETHANOLAMINE","KEGG_compound","C04756_O_1_ALK_1_ENYL_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_PHOSPHATIDALETHANOLAMINE_PLASMENYLETHANOLAMINE_ETHANOLAMINEPLASMALOGEN_2_ACYL_1_1_ALKENYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_1_ALKENYL_2_ACYLGLYCEROPHOSPHOETHANOLAMINE",25,-1.6369,0.014,0.068,0.6713,0.92,1,0.8089,0.78,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_31_LIU_SOX4_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_31_LIU_SOX4_TARGETS_UP",136,-1.6369,0,0.027,0.8128,0.9,0.98,-0.9997,0.43,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_898_STANHILL_HRAS_TRANSFROMATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_898_STANHILL_HRAS_TRANSFROMATION_UP",8,-1.6369,0.012,0.027,-1.6034,0.021,0.42,-1.3986,0.098,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_645_RASHI_RESPONSE_TO_IONIZING_RADIATION_1","C2_Chemical_and_genetic_perturbations","C2_CGP_645_RASHI_RESPONSE_TO_IONIZING_RADIATION_1",43,-1.6366,0.013,0.027,-1.1444,0.25,0.85,-0.8191,0.79,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_327_GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_327_GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN",46,-1.6366,0.015,0.027,0.959,0.51,0.86,0.7757,0.88,1
"KEGG_pathway:HSA04270_VASCULAR_SMOOTH_MUSCLE_CONTRACTION","KEGG_pathway","HSA04270_VASCULAR_SMOOTH_MUSCLE_CONTRACTION",116,-1.6363,0.0012,0.012,-1.0443,0.34,0.77,-1.4566,0.0085,0.15
"C3_TF_targets:C3_TFT_133_V_AP1_Q4","C3_TF_targets","C3_TFT_133_V_AP1_Q4",266,-1.6363,0,0.0088,-1.243,0.064,0.29,-1.0095,0.4,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_3142_MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3142_MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN",221,-1.6362,0.0011,0.027,0.955,0.61,0.86,1.3443,0.017,0.58
"GO_BP:511810_GO_0050868_NEGATIVE_REGULATION_OF_T_CELL_ACTIVATION","GO_BP","511810_GO_0050868_NEGATIVE_REGULATION_OF_T_CELL_ACTIVATION",74,-1.6361,0,0.052,-0.8525,0.78,1,0.7558,0.95,1
"WikiPathways:198869_WP80_NUCLEOTIDE_GPCRS","WikiPathways","198869_WP80_NUCLEOTIDE_GPCRS",11,-1.6361,0.019,0.034,1.1798,0.24,0.97,1.2625,0.18,0.6
"GO_MF:495362_GO_0015079_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495362_GO_0015079_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",137,-1.6361,0,0.088,-1.1863,0.15,0.79,1.2704,0.059,0.65
"C7_Immunologic_signatures:C7_ALL_1713_GSE3982_NKCELL_VS_TH2_UP","C7_Immunologic_signatures","C7_ALL_1713_GSE3982_NKCELL_VS_TH2_UP",192,-1.636,0.0022,0.00063,-0.9677,0.54,1,-1.2948,0.033,0.14
"C7_Immunologic_signatures:C7_ALL_1773_GSE7460_CD8_TCELL_VS_TREG_ACT_UP","C7_Immunologic_signatures","C7_ALL_1773_GSE7460_CD8_TCELL_VS_TREG_ACT_UP",194,-1.6359,0,0.00063,-0.8855,0.75,1,-1.3009,0.028,0.14
"C2_Chemical_and_genetic_perturbations:C2_CGP_235_AKL_HTLV1_INFECTION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_235_AKL_HTLV1_INFECTION_DN",67,-1.6359,0.0026,0.027,1.2503,0.12,0.44,-0.7788,0.88,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2084_SANSOM_WNT_PATHWAY_REQUIRE_MYC","C2_Chemical_and_genetic_perturbations","C2_CGP_2084_SANSOM_WNT_PATHWAY_REQUIRE_MYC",57,-1.6359,0.004,0.027,-1.3042,0.075,0.69,-1.3627,0.052,0.39
"C4_Cancer_modules:C4_CM_200_MODULE_213","C4_Cancer_modules","C4_CM_200_MODULE_213",79,-1.6356,0.0038,0.022,1.0034,0.45,0.7,-1.0009,0.44,0.69
"GO_BP:499682_GO_0030278_REGULATION_OF_OSSIFICATION","GO_BP","499682_GO_0030278_REGULATION_OF_OSSIFICATION",170,-1.6356,0.0023,0.052,-1.0988,0.24,0.95,1.1145,0.22,0.75
"GO_BP:751211_GO_0036293_RESPONSE_TO_DECREASED_OXYGEN_LEVELS","GO_BP","751211_GO_0036293_RESPONSE_TO_DECREASED_OXYGEN_LEVELS",260,-1.6354,0,0.052,-0.8028,0.96,1,0.9585,0.59,0.9
"WikiPathways:198873_WP357_FATTY_ACID_BIOSYNTHESIS","WikiPathways","198873_WP357_FATTY_ACID_BIOSYNTHESIS",22,-1.6353,0.013,0.033,0.6469,0.95,1,-1.1721,0.24,0.57
"GO_BP:505268_GO_0042089_CYTOKINE_BIOSYNTHETIC_PROCESS","GO_BP","505268_GO_0042089_CYTOKINE_BIOSYNTHETIC_PROCESS",17,-1.6353,0.022,0.052,-0.9293,0.55,1,0.5363,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_395_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_395_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP",118,-1.6353,0,0.027,1.1834,0.13,0.51,0.9821,0.47,0.96
"GO_BP:515595_GO_0070665_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION","GO_BP","515595_GO_0070665_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION",120,-1.6352,0,0.052,-0.7161,0.98,1,-1.1618,0.16,0.73
"REACTOME:187223_REACT_25208_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI","REACTOME","187223_REACT_25208_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI",20,-1.6348,0.013,0.064,-0.6042,0.97,1,-1.1848,0.21,0.62
"C7_Immunologic_signatures:C7_ALL_1401_GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1401_GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP",192,-1.634,0.0011,0.00065,1.6416,0,0.0014,-1.217,0.076,0.25
"GO_BP:500029_GO_0030728_OVULATION","GO_BP","500029_GO_0030728_OVULATION",18,-1.634,0.011,0.053,1.1034,0.33,0.9,1.055,0.39,0.8
"GO_BP:512058_GO_0051148_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION","GO_BP","512058_GO_0051148_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION",49,-1.6338,0.007,0.053,-1.211,0.15,0.88,-1.3815,0.048,0.59
"GO_BP:511800_GO_0050857_POSITIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY","GO_BP","511800_GO_0050857_POSITIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY",13,-1.6338,0.016,0.053,0.5055,0.99,1,-1.0964,0.34,0.78
"GO_MF:498721_GO_0019955_CYTOKINE_BINDING","GO_MF","498721_GO_0019955_CYTOKINE_BINDING",83,-1.6338,0.0025,0.089,1.3959,0.038,0.48,1.7612,0,0.15
"GO_MF:487910_GO_0002020_PROTEASE_BINDING","GO_MF","487910_GO_0002020_PROTEASE_BINDING",90,-1.6338,0.0013,0.089,0.9504,0.59,0.93,0.6977,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2489_VILIMAS_NOTCH1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2489_VILIMAS_NOTCH1_TARGETS_DN",19,-1.6337,0.016,0.028,0.8402,0.69,0.98,0.7981,0.79,1
"GO_MF:486557_GO_0051082_UNFOLDED_PROTEIN_BINDING","GO_MF","486557_GO_0051082_UNFOLDED_PROTEIN_BINDING",94,-1.6336,0.0013,0.088,-1.0069,0.4,0.89,-1.7883,0,0.23
"REACTOME:106513_REACT_13685_NEURONAL_SYSTEM","REACTOME","106513_REACT_13685_NEURONAL_SYSTEM",284,-1.6335,0,0.065,-1.5692,0,0.36,-1.3247,0.011,0.53
"C7_Immunologic_signatures:C7_ALL_727_GSE17721_12H_VS_24H_POLYIC_BMDM_UP","C7_Immunologic_signatures","C7_ALL_727_GSE17721_12H_VS_24H_POLYIC_BMDM_UP",199,-1.6335,0,0.00065,0.8609,0.88,1,-0.8545,0.85,1
"GO_BP:946743_GO_1902624_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION","GO_BP","946743_GO_1902624_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION",18,-1.6334,0.016,0.053,0.7731,0.8,1,-1.0264,0.42,0.82
"GO_BP:493281_GO_0009080_PYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS","GO_BP","493281_GO_0009080_PYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS",5,-1.6333,0.007,0.053,-1.3661,0.12,0.99,1.4036,0.088,0.62
"GO_BP:751794_GO_0044650_ADHESION_OF_SYMBIONT_TO_HOST_CELL","GO_BP","751794_GO_0044650_ADHESION_OF_SYMBIONT_TO_HOST_CELL",9,-1.6331,0.019,0.053,-0.7635,0.76,1,-1.2036,0.24,0.73
"REACTOME:105709_REACT_13425_MISCELLANEOUS_SUBSTRATES","REACTOME","105709_REACT_13425_MISCELLANEOUS_SUBSTRATES",12,-1.633,0.014,0.065,-1.1646,0.26,0.85,-0.7776,0.75,1
"C7_Immunologic_signatures:C7_ALL_1396_GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN","C7_Immunologic_signatures","C7_ALL_1396_GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN",200,-1.6329,0,0.00067,1.106,0.22,0.43,0.8824,0.78,1
"GO_MF:490563_GO_0005375_COPPER_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490563_GO_0005375_COPPER_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",7,-1.6328,0.017,0.088,-0.8966,0.57,0.99,0.612,0.91,1
"GO_BP:509045_GO_0046822_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT","GO_BP","509045_GO_0046822_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT",188,-1.6328,0,0.053,-0.9877,0.47,1,-1.6036,0,0.51
"C7_Immunologic_signatures:C7_ALL_507_GSE17721_CTRL_VS_CPG_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_507_GSE17721_CTRL_VS_CPG_12H_BMDM_UP",197,-1.6327,0,0.00068,1.1054,0.22,0.43,-1.3631,0.013,0.085
"GO_BP:495248_GO_0014854_RESPONSE_TO_INACTIVITY","GO_BP","495248_GO_0014854_RESPONSE_TO_INACTIVITY",8,-1.6326,0.0099,0.053,-1.1842,0.27,0.91,-1.4743,0.072,0.54
"WikiPathways:712094_WP2406_CARDIAC_PROGENITOR_DIFFERENTIATION","WikiPathways","712094_WP2406_CARDIAC_PROGENITOR_DIFFERENTIATION",51,-1.6326,0.0054,0.033,-1.2552,0.13,0.86,1.6339,0.0043,0.2
"GO_MF:492826_GO_0015662_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS_PHOSPHORYLATIVE_MECHANISM","GO_MF","492826_GO_0015662_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS_PHOSPHORYLATIVE_MECHANISM",31,-1.6326,0.013,0.088,-1.1451,0.25,0.81,-1.2738,0.13,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_804_DACOSTA_UV_RESPONSE_VIA_ERCC3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_804_DACOSTA_UV_RESPONSE_VIA_ERCC3_UP",307,-1.6324,0,0.028,-1.2259,0.054,0.77,-1.7367,0,0.16
"C2_Chemical_and_genetic_perturbations:C2_CGP_2748_WOO_LIVER_CANCER_RECURRENCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2748_WOO_LIVER_CANCER_RECURRENCE_UP",105,-1.6322,0,0.028,-0.7487,0.97,1,1.041,0.39,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_2581_HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2581_HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP",42,-1.6322,0.0057,0.028,0.849,0.72,0.97,-1.1685,0.21,0.55
"C7_Immunologic_signatures:C7_ALL_1789_GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1789_GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP",198,-1.6321,0,0.00069,1.1369,0.15,0.35,-0.7948,0.96,1
"REACTOME:106481_REACT_12433_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION_","REACTOME","106481_REACT_12433_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION_",24,-1.632,0.0088,0.065,-0.9319,0.57,1,-0.7908,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1301_LEE_LIVER_CANCER_MYC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1301_LEE_LIVER_CANCER_MYC_UP",53,-1.6319,0.007,0.028,1.6357,0.0022,0.12,-0.8993,0.66,0.88
"GO_MF:495511_GO_0015250_WATER_CHANNEL_ACTIVITY","GO_MF","495511_GO_0015250_WATER_CHANNEL_ACTIVITY",11,-1.6318,0.011,0.088,-0.6045,0.95,1,-0.7767,0.75,0.98
"GO_MF:505331_GO_0042169_SH2_DOMAIN_BINDING","GO_MF","505331_GO_0042169_SH2_DOMAIN_BINDING",30,-1.6318,0.0043,0.087,-0.8156,0.76,1,-1.3431,0.094,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_2231_MCCABE_HOXC6_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2231_MCCABE_HOXC6_TARGETS_DN",21,-1.6317,0.018,0.028,-0.8876,0.62,1,0.7791,0.81,1
"GO_BP:501719_GO_0032487_REGULATION_OF_RAP_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","501719_GO_0032487_REGULATION_OF_RAP_PROTEIN_SIGNAL_TRANSDUCTION",480,-1.6316,0,0.054,-1.3401,0.0016,0.91,-1.3027,0.0067,0.65
"GO_BP:849817_GO_0097479_SYNAPTIC_VESICLE_LOCALIZATION","GO_BP","849817_GO_0097479_SYNAPTIC_VESICLE_LOCALIZATION",118,-1.6315,0,0.054,0.8479,0.84,1,-1.1166,0.21,0.76
"GO_BP:500149_GO_0030851_GRANULOCYTE_DIFFERENTIATION","GO_BP","500149_GO_0030851_GRANULOCYTE_DIFFERENTIATION",16,-1.6315,0.026,0.054,0.7634,0.78,1,-1.2902,0.13,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_2428_CROMER_TUMORIGENESIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2428_CROMER_TUMORIGENESIS_UP",59,-1.6315,0.004,0.028,1.1766,0.17,0.52,1.2045,0.14,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1920_SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_1920_SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER",41,-1.6311,0.0084,0.028,-1.3588,0.067,0.66,0.9341,0.56,1
"GO_CC:911320_GO_0044815_DNA_PACKAGING_COMPLEX","GO_CC","911320_GO_0044815_DNA_PACKAGING_COMPLEX",99,-1.6311,0.0026,0.086,-1.7298,0,0.19,-1.5312,0.01,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_393_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_393_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP",125,-1.631,0,0.028,1.1101,0.25,0.61,-0.9952,0.47,0.76
"REACTOME:106154_REACT_11059_ANDROGEN_BIOSYNTHESIS","REACTOME","106154_REACT_11059_ANDROGEN_BIOSYNTHESIS",11,-1.6309,0.022,0.065,0.7236,0.81,1,-0.896,0.6,0.96
"GO_BP:494719_GO_0010656_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","494719_GO_0010656_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS",23,-1.6309,0.012,0.054,0.7596,0.8,1,1.2683,0.15,0.69
"GO_BP:753999_GO_1901029_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","753999_GO_1901029_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",7,-1.6307,0.022,0.054,-1.5,0.064,0.83,-1.2174,0.24,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_1587_GREENBAUM_E2A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1587_GREENBAUM_E2A_TARGETS_UP",33,-1.6305,0.0043,0.028,1.0866,0.33,0.65,-1.2173,0.18,0.5
"C2_Chemical_and_genetic_perturbations:C2_CGP_2914_MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2914_MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3",129,-1.6303,0,0.028,-1.0084,0.46,0.99,-1.0285,0.37,0.71
"C6_Oncogenic_signatures:C6_ALL_136_IL2_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_136_IL2_UP_V1_UP",182,-1.6303,0,0.0039,-0.9971,0.46,0.68,1.0235,0.37,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_1822_BURTON_ADIPOGENESIS_PEAK_AT_24HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1822_BURTON_ADIPOGENESIS_PEAK_AT_24HR",42,-1.6301,0.0041,0.028,-0.9578,0.51,1,-1.7262,0.0086,0.16
"C7_Immunologic_signatures:C7_ALL_280_GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN","C7_Immunologic_signatures","C7_ALL_280_GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN",200,-1.63,0,0.00071,1.2367,0.051,0.17,-1.36,0.0064,0.087
"REACTOME:106243_REACT_17029_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING","REACTOME","106243_REACT_17029_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING",28,-1.63,0.022,0.065,1.1779,0.21,0.47,-1.4719,0.059,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_1408_COLLER_MYC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1408_COLLER_MYC_TARGETS_UP",25,-1.6298,0.012,0.028,0.6992,0.91,1,-1.2106,0.16,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_461_BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_461_BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP",19,-1.6298,0.011,0.028,1.0065,0.45,0.79,0.9658,0.49,0.97
"GO_BP:501249_GO_0032012_REGULATION_OF_ARF_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","501249_GO_0032012_REGULATION_OF_ARF_PROTEIN_SIGNAL_TRANSDUCTION",477,-1.6298,0,0.055,-1.3243,0.0067,0.89,-1.2969,0.0066,0.64
"REACTOME:530751_REACT_116105_GLYCOSPHINGOLIPID_METABOLISM","REACTOME","530751_REACT_116105_GLYCOSPHINGOLIPID_METABOLISM",39,-1.6297,0.009,0.065,-0.9059,0.6,1,0.5972,0.99,1
"WikiPathways:198877_WP384_APOPTOSIS_MODULATION_BY_HSP70","WikiPathways","198877_WP384_APOPTOSIS_MODULATION_BY_HSP70",19,-1.6297,0.013,0.034,-1.0379,0.41,0.96,-1.3734,0.099,0.37
"GO_BP:494084_GO_0010001_GLIAL_CELL_DIFFERENTIATION","GO_BP","494084_GO_0010001_GLIAL_CELL_DIFFERENTIATION",137,-1.6295,0.0023,0.055,1.048,0.33,0.95,-0.8516,0.84,0.96
"GO_CC:500515_GO_0031256_LEADING_EDGE_MEMBRANE","GO_CC","500515_GO_0031256_LEADING_EDGE_MEMBRANE",124,-1.6291,0.0012,0.086,-0.8438,0.82,0.98,0.7376,0.98,1
"C4_Cancer_modules:C4_CM_360_MODULE_436","C4_Cancer_modules","C4_CM_360_MODULE_436",132,-1.629,0,0.023,1.2933,0.054,0.29,-1.2946,0.066,0.31
"GO_BP:506554_GO_0043523_REGULATION_OF_NEURON_APOPTOTIC_PROCESS","GO_BP","506554_GO_0043523_REGULATION_OF_NEURON_APOPTOTIC_PROCESS",185,-1.6289,0,0.055,-1.1535,0.16,0.92,-0.9169,0.72,0.91
"GO_BP:513606_GO_0060048_CARDIAC_MUSCLE_CONTRACTION","GO_BP","513606_GO_0060048_CARDIAC_MUSCLE_CONTRACTION",43,-1.6289,0.0085,0.055,-1.3332,0.077,0.91,0.8965,0.64,0.95
"GO_BP:504520_GO_0035336_LONG_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS","GO_BP","504520_GO_0035336_LONG_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS",23,-1.6288,0.011,0.055,-1.2257,0.16,0.88,-1.7705,0.006,0.63
"GO_BP:492326_GO_0007584_RESPONSE_TO_NUTRIENT","GO_BP","492326_GO_0007584_RESPONSE_TO_NUTRIENT",180,-1.6288,0,0.055,-0.823,0.91,1,1.219,0.077,0.71
"C6_Oncogenic_signatures:C6_ALL_153_STK33_NOMO_DN","C6_Oncogenic_signatures","C6_ALL_153_STK33_NOMO_DN",271,-1.6288,0,0.0039,0.8346,0.94,1,-1.3709,0.0042,0.26
"GO_MF:751693_GO_0044548_S100_PROTEIN_BINDING","GO_MF","751693_GO_0044548_S100_PROTEIN_BINDING",10,-1.6287,0.02,0.089,-1.0349,0.4,0.88,-0.626,0.93,1
"GO_BP:499211_GO_0021932_HINDBRAIN_RADIAL_GLIA_GUIDED_CELL_MIGRATION","GO_BP","499211_GO_0021932_HINDBRAIN_RADIAL_GLIA_GUIDED_CELL_MIGRATION",9,-1.6285,0.018,0.055,0.6447,0.91,1,-1.4889,0.062,0.53
"GO_MF:495441_GO_0015168_GLYCEROL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495441_GO_0015168_GLYCEROL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",10,-1.6284,0.017,0.089,-0.7672,0.78,1,-0.8115,0.74,0.96
"GO_BP:497941_GO_0019062_VIRION_ATTACHMENT_TO_HOST_CELL","GO_BP","497941_GO_0019062_VIRION_ATTACHMENT_TO_HOST_CELL",9,-1.6283,0.02,0.055,-0.7636,0.79,1,-1.1711,0.28,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_405_BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_405_BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP",27,-1.6282,0.015,0.029,0.9857,0.47,0.81,-0.8602,0.66,0.92
"GO_BP:500183_GO_0030888_REGULATION_OF_B_CELL_PROLIFERATION","GO_BP","500183_GO_0030888_REGULATION_OF_B_CELL_PROLIFERATION",57,-1.6282,0.0081,0.055,-0.6935,0.96,1,-1.0654,0.36,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1647_GENTILE_UV_LOW_DOSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1647_GENTILE_UV_LOW_DOSE_UP",27,-1.628,0.016,0.029,-1.1015,0.31,0.91,-1.2466,0.15,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_117_CORRE_MULTIPLE_MYELOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_117_CORRE_MULTIPLE_MYELOMA_DN",59,-1.628,0.0054,0.029,0.7717,0.9,1,1.0145,0.41,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_176_VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_176_VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP",171,-1.6279,0,0.029,0.9741,0.53,0.83,1.097,0.22,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1913_WENG_POR_DOSAGE","C2_Chemical_and_genetic_perturbations","C2_CGP_1913_WENG_POR_DOSAGE",19,-1.6278,0.017,0.029,-1.3115,0.13,0.69,-0.805,0.77,0.95
"GO_BP:513301_GO_0052553_MODULATION_BY_SYMBIONT_OF_HOST_IMMUNE_RESPONSE","GO_BP","513301_GO_0052553_MODULATION_BY_SYMBIONT_OF_HOST_IMMUNE_RESPONSE",8,-1.6277,0.023,0.055,0.6327,0.92,1,-0.8432,0.68,0.96
"REACTOME:205111_REACT_27307_INTERLEUKIN_6_SIGNALING","REACTOME","205111_REACT_27307_INTERLEUKIN_6_SIGNALING",11,-1.6276,0.015,0.066,-0.7327,0.83,1,-1.1717,0.25,0.63
"GO_BP:502113_GO_0032891_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT","GO_BP","502113_GO_0032891_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT",19,-1.6275,0.022,0.055,-1.1252,0.28,0.94,-0.939,0.54,0.9
"REACTOME:530735_REACT_115993_SHC1_EVENTS_IN_ERBB2_SIGNALING","REACTOME","530735_REACT_115993_SHC1_EVENTS_IN_ERBB2_SIGNALING",32,-1.6273,0.0072,0.066,-0.8176,0.75,1,-0.7441,0.87,1
"GO_BP:495147_GO_0014075_RESPONSE_TO_AMINE","GO_BP","495147_GO_0014075_RESPONSE_TO_AMINE",41,-1.6272,0.0043,0.055,0.7087,0.92,1,-1.0902,0.3,0.78
"GO_BP:491844_GO_0007009_PLASMA_MEMBRANE_ORGANIZATION","GO_BP","491844_GO_0007009_PLASMA_MEMBRANE_ORGANIZATION",179,-1.6272,0,0.055,0.8486,0.87,1,-0.8233,0.9,0.97
"C7_Immunologic_signatures:C7_ALL_1819_GSE7852_LN_VS_THYMUS_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1819_GSE7852_LN_VS_THYMUS_TCONV_UP",197,-1.6271,0,0.00076,0.8289,0.93,1,-0.9728,0.54,0.79
"C6_Oncogenic_signatures:C6_ALL_188_LEF1_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_188_LEF1_UP_V1_DN",186,-1.6271,0.0023,0.0039,0.8208,0.94,0.99,-1.5293,0,0.18
"WikiPathways:198814_WP534_GLYCOLYSIS_AND_GLUCONEOGENESIS","WikiPathways","198814_WP534_GLYCOLYSIS_AND_GLUCONEOGENESIS",49,-1.627,0.0013,0.034,0.9013,0.65,1,-1.4709,0.02,0.39
"GO_BP:514723_GO_0061178_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS","GO_BP","514723_GO_0061178_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS",37,-1.6269,0.013,0.055,0.9423,0.55,1,-1.154,0.24,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2737_KAPOSI_LIVER_CANCER_MET_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2737_KAPOSI_LIVER_CANCER_MET_UP",18,-1.6268,0.018,0.029,-1.2458,0.19,0.75,-0.8793,0.65,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2621_MIKKELSEN_PLURIPOTENT_STATE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2621_MIKKELSEN_PLURIPOTENT_STATE_DN",8,-1.6268,0.018,0.029,-0.8505,0.67,1,-1.1634,0.3,0.56
"GO_BP:508727_GO_0046466_MEMBRANE_LIPID_CATABOLIC_PROCESS","GO_BP","508727_GO_0046466_MEMBRANE_LIPID_CATABOLIC_PROCESS",23,-1.6267,0.02,0.055,-0.6612,0.93,1,1.1832,0.23,0.72
"REACTOME:905993_REACT_169436_OXIDATIVE_STRESS_INDUCED_SENESCENCE","REACTOME","905993_REACT_169436_OXIDATIVE_STRESS_INDUCED_SENESCENCE",118,-1.6266,0.0024,0.065,-1.547,0.0035,0.39,-1.6876,0.002,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_2074_MARSON_FOXP3_CORE_DIRECT_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2074_MARSON_FOXP3_CORE_DIRECT_TARGETS",19,-1.6266,0.012,0.029,0.9295,0.55,0.89,-1.0582,0.35,0.68
"GO_BP:752665_GO_0097164_AMMONIUM_ION_METABOLIC_PROCESS","GO_BP","752665_GO_0097164_AMMONIUM_ION_METABOLIC_PROCESS",159,-1.6264,0,0.056,-1.0581,0.32,0.96,-1.128,0.17,0.76
"REACTOME:645297_REACT_121315_GLYCOSAMINOGLYCAN_METABOLISM","REACTOME","645297_REACT_121315_GLYCOSAMINOGLYCAN_METABOLISM",119,-1.6263,0,0.065,0.9695,0.53,0.8,1.2049,0.11,0.82
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_97_BIOCARTA_IL10_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_97_BIOCARTA_IL10_PATHWAY",17,-1.6263,0.012,0.079,-1.119,0.31,1,-1.0201,0.43,0.73
"GO_BP:504497_GO_0035313_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS","GO_BP","504497_GO_0035313_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS",11,-1.6262,0.016,0.056,-1.2304,0.21,0.89,-0.7573,0.8,1
"C3_TF_targets:C3_TFT_377_V_COREBINDINGFACTOR_Q6","C3_TF_targets","C3_TFT_377_V_COREBINDINGFACTOR_Q6",269,-1.6261,0,0.0094,0.7828,0.99,1,-0.7929,0.98,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_107_BIOCARTA_INTEGRIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_107_BIOCARTA_INTEGRIN_PATHWAY",38,-1.626,0.013,0.077,-0.8094,0.78,1,-0.8459,0.71,0.91
"C3_TF_targets:C3_TFT_351_V_PTF1BETA_Q6","C3_TF_targets","C3_TFT_351_V_PTF1BETA_Q6",238,-1.626,0,0.0093,-1.2791,0.043,0.25,0.8718,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1560_CROMER_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1560_CROMER_METASTASIS_DN",79,-1.6259,0.0025,0.029,-0.9354,0.59,1,-1.0955,0.31,0.63
"GO_BP:494303_GO_0010226_RESPONSE_TO_LITHIUM_ION","GO_BP","494303_GO_0010226_RESPONSE_TO_LITHIUM_ION",25,-1.6258,0.018,0.056,-0.9084,0.6,1,-1.4384,0.062,0.56
"GO_BP:506336_GO_0043270_POSITIVE_REGULATION_OF_ION_TRANSPORT","GO_BP","506336_GO_0043270_POSITIVE_REGULATION_OF_ION_TRANSPORT",201,-1.6258,0,0.056,-1.0986,0.23,0.95,0.9623,0.56,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2573_HINATA_NFKB_TARGETS_KERATINOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2573_HINATA_NFKB_TARGETS_KERATINOCYTE_DN",20,-1.6257,0.014,0.029,1.1437,0.28,0.56,1.1372,0.28,0.84
"C7_Immunologic_signatures:C7_ALL_1795_GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1795_GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP",199,-1.6257,0.0011,0.00078,-0.9024,0.73,1,-1.3096,0.019,0.13
"C2_Chemical_and_genetic_perturbations:C2_CGP_2149_AMUNDSON_GAMMA_RADIATION_RESPONSE","C2_Chemical_and_genetic_perturbations","C2_CGP_2149_AMUNDSON_GAMMA_RADIATION_RESPONSE",40,-1.6256,0.0098,0.029,-0.9363,0.57,1,-1.7221,0.0043,0.16
"GO_BP:491733_GO_0006869_LIPID_TRANSPORT","GO_BP","491733_GO_0006869_LIPID_TRANSPORT",224,-1.6256,0,0.056,-0.9792,0.5,1,1.2599,0.046,0.69
"REACTOME:106145_REACT_11054_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS","REACTOME","106145_REACT_11054_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS",26,-1.6255,0.015,0.065,1.2008,0.19,0.44,-0.7992,0.76,1
"GO_BP:487659_GO_0001763_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE","GO_BP","487659_GO_0001763_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE",187,-1.6255,0,0.056,1.0157,0.39,0.97,1.4436,0.006,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_902_SHANK_TAL1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_902_SHANK_TAL1_TARGETS_DN",10,-1.6255,0.017,0.029,0.9518,0.51,0.86,0.7051,0.86,1
"REACTOME:119526_REACT_19200_OTHER_SEMAPHORIN_INTERACTIONS","REACTOME","119526_REACT_19200_OTHER_SEMAPHORIN_INTERACTIONS",19,-1.6255,0.014,0.065,-0.8564,0.65,1,-0.7643,0.81,1
"GO_BP:508281_GO_0045980_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS","GO_BP","508281_GO_0045980_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS",91,-1.6255,0.0013,0.056,1.1118,0.23,0.89,1.4743,0.014,0.58
"C7_Immunologic_signatures:C7_ALL_529_GSE17721_LPS_VS_POLYIC_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_529_GSE17721_LPS_VS_POLYIC_1H_BMDM_UP",197,-1.6253,0,0.00078,0.9569,0.6,0.88,-0.9253,0.68,0.9
"GO_BP:516375_GO_0071451_CELLULAR_RESPONSE_TO_SUPEROXIDE","GO_BP","516375_GO_0071451_CELLULAR_RESPONSE_TO_SUPEROXIDE",14,-1.6253,0.019,0.056,0.641,0.92,1,-1.3746,0.11,0.59
"GO_BP:506444_GO_0043406_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY","GO_BP","506444_GO_0043406_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY",205,-1.6253,0,0.056,-0.6773,1,1,1.0176,0.42,0.84
"C7_Immunologic_signatures:C7_ALL_1906_GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1906_GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN",200,-1.6252,0,0.00078,0.9074,0.74,1,0.8085,0.94,1
"C3_TF_targets:C3_TFT_461_V_MYOD_Q6_01","C3_TF_targets","C3_TFT_461_V_MYOD_Q6_01",251,-1.6252,0,0.0091,-1.5712,0,0.12,-1.3335,0.0066,0.25
"GO_CC:487079_GO_0000786_NUCLEOSOME","GO_CC","487079_GO_0000786_NUCLEOSOME",93,-1.6251,0.0013,0.088,-1.7745,0.0018,0.18,-1.5294,0.013,0.44
"C2_Chemical_and_genetic_perturbations:C2_CGP_747_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_747_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",24,-1.625,0.015,0.029,-1.0564,0.37,0.96,-1.4382,0.066,0.33
"REACTOME:105728_REACT_6960_GLUTATHIONE_SYNTHESIS_AND_RECYCLING","REACTOME","105728_REACT_6960_GLUTATHIONE_SYNTHESIS_AND_RECYCLING",12,-1.625,0.013,0.065,0.4013,1,1,-1.4534,0.08,0.38
"GO_BP:491787_GO_0006937_REGULATION_OF_MUSCLE_CONTRACTION","GO_BP","491787_GO_0006937_REGULATION_OF_MUSCLE_CONTRACTION",147,-1.6248,0,0.056,-1.1683,0.15,0.91,1.0692,0.3,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_1368_TENEDINI_MEGAKARYOCYTE_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_1368_TENEDINI_MEGAKARYOCYTE_MARKERS",66,-1.6248,0.0052,0.029,0.9489,0.53,0.87,-1.3161,0.053,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1931_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1931_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN",157,-1.6246,0,0.029,-1.3382,0.033,0.7,-0.8973,0.71,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2637_MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2637_MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3",138,-1.6245,0.0024,0.029,-1.3695,0.02,0.63,0.9906,0.49,0.96
"GO_BP:506578_GO_0043547_POSITIVE_REGULATION_OF_GTPASE_ACTIVITY","GO_BP","506578_GO_0043547_POSITIVE_REGULATION_OF_GTPASE_ACTIVITY",447,-1.6243,0,0.056,-1.3892,0,1,-1.2519,0.017,0.68
"GO_MF:490341_GO_0005070_SH3_SH2_ADAPTOR_ACTIVITY","GO_MF","490341_GO_0005070_SH3_SH2_ADAPTOR_ACTIVITY",52,-1.6242,0.0053,0.092,0.9013,0.67,0.98,-1.0213,0.4,0.77
"C7_Immunologic_signatures:C7_ALL_166_GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN","C7_Immunologic_signatures","C7_ALL_166_GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN",191,-1.6242,0,8e-04,-1.093,0.25,1,-1.2029,0.093,0.28
"KEGG_pathway:HSA00040_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS","KEGG_pathway","HSA00040_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS",36,-1.6241,0.0088,0.013,1.5078,0.029,0.097,1.4144,0.061,0.37
"GO_BP:507104_GO_0044089_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS","GO_BP","507104_GO_0044089_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS",277,-1.6241,0.0011,0.056,-0.912,0.74,1,-1.1183,0.16,0.76
"GO_CC:505755_GO_0042641_ACTOMYOSIN","GO_CC","505755_GO_0042641_ACTOMYOSIN",67,-1.624,0.0026,0.088,-0.9183,0.64,0.94,-0.9364,0.6,1
"GO_BP:510362_GO_0048247_LYMPHOCYTE_CHEMOTAXIS","GO_BP","510362_GO_0048247_LYMPHOCYTE_CHEMOTAXIS",16,-1.6239,0.016,0.056,1.0359,0.39,0.96,0.9386,0.53,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_921_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2","C2_Chemical_and_genetic_perturbations","C2_CGP_921_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2",150,-1.6239,0.0012,0.03,0.9157,0.67,0.9,0.8864,0.77,1
"GO_BP:511769_GO_0050803_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY","GO_BP","511769_GO_0050803_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY",63,-1.6235,0.0027,0.056,-1.4139,0.056,0.95,-0.9377,0.57,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2790_ONO_FOXP3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2790_ONO_FOXP3_TARGETS_DN",41,-1.6234,0.0014,0.03,1.2058,0.16,0.48,-0.8514,0.74,0.92
"KEGG_compound:C05212_1_RADYL_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ORGANYL_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_2_ACYL_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE","KEGG_compound","C05212_1_RADYL_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_1_ORGANYL_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_2_ACYL_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE",22,-1.6233,0.024,0.078,0.6965,0.87,1,0.8143,0.73,0.89
"GO_BP:506921_GO_0043901_NEGATIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS","GO_BP","506921_GO_0043901_NEGATIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS",141,-1.6233,0.0012,0.057,1.1596,0.16,0.83,-1.4317,0.01,0.56
"GO_BP:492543_GO_0008202_STEROID_METABOLIC_PROCESS","GO_BP","492543_GO_0008202_STEROID_METABOLIC_PROCESS",234,-1.6231,0.0011,0.057,0.8269,0.95,1,1.0777,0.28,0.78
"GO_BP:751214_GO_0036296_RESPONSE_TO_INCREASED_OXYGEN_LEVELS","GO_BP","751214_GO_0036296_RESPONSE_TO_INCREASED_OXYGEN_LEVELS",23,-1.623,0.015,0.057,-0.7688,0.81,1,-0.8568,0.7,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1250_ROZANOV_MMP14_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1250_ROZANOV_MMP14_TARGETS_UP",264,-1.623,0,0.03,1.1786,0.077,0.52,-0.9268,0.7,0.84
"GO_BP:491418_GO_0006522_ALANINE_METABOLIC_PROCESS","GO_BP","491418_GO_0006522_ALANINE_METABOLIC_PROCESS",5,-1.623,0.016,0.057,-1.3815,0.11,1,1.4105,0.087,0.63
"C3_TF_targets:C3_TFT_177_V_OCT1_07","C3_TF_targets","C3_TFT_177_V_OCT1_07",154,-1.6229,0,0.0092,-1.2268,0.086,0.31,-1.3827,0.03,0.27
"GO_CC:490893_GO_0005891_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX","GO_CC","490893_GO_0005891_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX",41,-1.6228,0.0057,0.088,-1.7816,0.0055,0.2,-0.9026,0.63,1
"GO_BP:504418_GO_0035234_ECTOPIC_GERM_CELL_PROGRAMMED_CELL_DEATH","GO_BP","504418_GO_0035234_ECTOPIC_GERM_CELL_PROGRAMMED_CELL_DEATH",8,-1.6228,0.013,0.057,-0.9097,0.57,1,-1.4116,0.096,0.57
"GO_BP:849818_GO_0097480_ESTABLISHMENT_OF_SYNAPTIC_VESICLE_LOCALIZATION","GO_BP","849818_GO_0097480_ESTABLISHMENT_OF_SYNAPTIC_VESICLE_LOCALIZATION",116,-1.6227,0,0.057,0.8163,0.89,1,-1.1703,0.18,0.73
"GO_BP:516209_GO_0071285_CELLULAR_RESPONSE_TO_LITHIUM_ION","GO_BP","516209_GO_0071285_CELLULAR_RESPONSE_TO_LITHIUM_ION",15,-1.6227,0.017,0.057,0.9796,0.46,1,-1.2784,0.16,0.66
"C7_Immunologic_signatures:C7_ALL_737_GSE17721_ALL_VS_24H_PAM3CSK4_BMDM_UP","C7_Immunologic_signatures","C7_ALL_737_GSE17721_ALL_VS_24H_PAM3CSK4_BMDM_UP",198,-1.6227,0.0011,0.00084,0.8711,0.83,1,0.8232,0.92,1
"REACTOME:106439_REACT_11061_SIGNALLING_BY_NGF","REACTOME","106439_REACT_11061_SIGNALLING_BY_NGF",281,-1.6227,0,0.066,-0.9437,0.63,1,-1.1183,0.14,0.68
"GO_BP:501721_GO_0032489_REGULATION_OF_CDC42_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","501721_GO_0032489_REGULATION_OF_CDC42_PROTEIN_SIGNAL_TRANSDUCTION",481,-1.6226,0,0.057,-1.3247,0.0048,0.89,-1.2802,0.01,0.65
"GO_BP:502310_GO_0033089_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS","GO_BP","502310_GO_0033089_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS",11,-1.6226,0.011,0.056,0.6766,0.88,1,-0.7329,0.84,0.99
"GO_BP:501717_GO_0032485_REGULATION_OF_RAL_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","501717_GO_0032485_REGULATION_OF_RAL_PROTEIN_SIGNAL_TRANSDUCTION",478,-1.6226,0,0.056,-1.3145,0.0093,0.87,-1.2944,0.0086,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_795_YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_795_YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP",25,-1.6224,0.015,0.03,-1.0202,0.42,0.98,-1.1355,0.27,0.59
"GO_MF:499383_GO_0022838_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY","GO_MF","499383_GO_0022838_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY",406,-1.6223,0,0.093,-1.5481,0,0.52,1.2562,0.015,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_594_RIZ_ERYTHROID_DIFFERENTIATION_HEMGN","C2_Chemical_and_genetic_perturbations","C2_CGP_594_RIZ_ERYTHROID_DIFFERENTIATION_HEMGN",30,-1.6222,0.018,0.03,-0.9028,0.62,1,-1.6156,0.01,0.23
"GO_BP:488317_GO_0002444_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY","GO_BP","488317_GO_0002444_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY",48,-1.6222,0.0042,0.057,1.2562,0.11,0.73,-0.8338,0.76,0.97
"C3_TF_targets:C3_TFT_89_V_HFH1_01","C3_TF_targets","C3_TFT_89_V_HFH1_01",237,-1.6218,0,0.0092,-0.7628,0.99,1,-1.0647,0.28,0.62
"GO_BP:502841_GO_0033625_POSITIVE_REGULATION_OF_INTEGRIN_ACTIVATION","GO_BP","502841_GO_0033625_POSITIVE_REGULATION_OF_INTEGRIN_ACTIVATION",5,-1.6218,0.011,0.057,-0.827,0.67,1,-0.7665,0.76,1
"GO_CC:505281_GO_0042105_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX","GO_CC","505281_GO_0042105_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX",5,-1.6218,0.01,0.087,1.4858,0.058,0.21,-1.2026,0.27,0.8
"GO_BP:488380_GO_0002507_TOLERANCE_INDUCTION","GO_BP","488380_GO_0002507_TOLERANCE_INDUCTION",8,-1.6217,0.022,0.057,-1.1046,0.35,0.94,-1.2959,0.16,0.64
"GO_BP:500164_GO_0030866_CORTICAL_ACTIN_CYTOSKELETON_ORGANIZATION","GO_BP","500164_GO_0030866_CORTICAL_ACTIN_CYTOSKELETON_ORGANIZATION",20,-1.6216,0.016,0.057,-1.0649,0.35,0.96,-1.2036,0.2,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1882_BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1882_BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN",46,-1.6215,0.0028,0.03,1.425,0.036,0.28,-1.3226,0.095,0.41
"C7_Immunologic_signatures:C7_ALL_1447_GSE360_L_DONOVANI_VS_T_GONDII_DC_UP","C7_Immunologic_signatures","C7_ALL_1447_GSE360_L_DONOVANI_VS_T_GONDII_DC_UP",197,-1.6215,0.0012,0.00086,-0.9735,0.56,1,0.8272,0.89,1
"GO_MF:490561_GO_0005372_WATER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490561_GO_0005372_WATER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",12,-1.6215,0.018,0.093,-0.6586,0.91,1,-0.8884,0.62,0.88
"KEGG_compound:C03024_REDUCED_FLAVOPROTEIN","KEGG_compound","C03024_REDUCED_FLAVOPROTEIN",9,-1.6212,0.02,0.078,-1.2121,0.23,0.75,0.8168,0.7,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_2764_MIKKELSEN_MCV6_HCP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2764_MIKKELSEN_MCV6_HCP_WITH_H3K27ME3",400,-1.6212,0,0.03,-1.5453,0,0.43,1.178,0.054,0.79
"GO_BP:492352_GO_0007611_LEARNING_OR_MEMORY","GO_BP","492352_GO_0007611_LEARNING_OR_MEMORY",195,-1.6212,0.0011,0.057,-1.2361,0.057,0.9,1.2102,0.073,0.71
"GO_BP:512005_GO_0051091_POSITIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY","GO_BP","512005_GO_0051091_POSITIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",215,-1.6209,0.0011,0.057,0.8562,0.9,1,-1.1069,0.18,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_374_KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_374_KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN",75,-1.6208,0.0039,0.03,-0.8155,0.83,1,-1.3354,0.045,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1452_SCHURINGA_STAT5A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1452_SCHURINGA_STAT5A_TARGETS_UP",21,-1.6208,0.018,0.03,-0.6933,0.9,1,-1.4449,0.051,0.32
"GO_BP:781987_GO_1901998_TOXIN_TRANSPORT","GO_BP","781987_GO_1901998_TOXIN_TRANSPORT",33,-1.6207,0.019,0.057,-0.7328,0.88,1,-1.2881,0.12,0.65
"GO_BP:501339_GO_0032102_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS","GO_BP","501339_GO_0032102_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS",233,-1.6207,0,0.057,1.0524,0.3,0.95,1.2984,0.023,0.67
"GO_BP:494736_GO_2000378_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS","GO_BP","494736_GO_2000378_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS",32,-1.6205,0.01,0.057,-1.2389,0.16,0.91,-1.0764,0.34,0.8
"C7_Immunologic_signatures:C7_ALL_886_GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN","C7_Immunologic_signatures","C7_ALL_886_GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN",196,-1.6205,0,0.00087,0.9853,0.48,0.79,-0.8622,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2999_WHITFIELD_CELL_CYCLE_LITERATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_2999_WHITFIELD_CELL_CYCLE_LITERATURE",44,-1.6204,0.0098,0.03,-0.9478,0.55,1,-1.8552,0,0.085
"GO_BP:510718_GO_0048663_NEURON_FATE_COMMITMENT","GO_BP","510718_GO_0048663_NEURON_FATE_COMMITMENT",66,-1.6204,0.0025,0.057,-1.2131,0.15,0.88,1.1654,0.2,0.73
"GO_BP:508179_GO_0045860_POSITIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY","GO_BP","508179_GO_0045860_POSITIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY",477,-1.6203,0,0.057,0.8551,0.96,1,-0.9791,0.55,0.87
"REACTOME:106204_REACT_1520_GLUCONEOGENESIS","REACTOME","106204_REACT_1520_GLUCONEOGENESIS",31,-1.6203,0.013,0.067,0.8966,0.61,0.91,-1.335,0.089,0.52
"GO_BP:507927_GO_0045579_POSITIVE_REGULATION_OF_B_CELL_DIFFERENTIATION","GO_BP","507927_GO_0045579_POSITIVE_REGULATION_OF_B_CELL_DIFFERENTIATION",12,-1.6203,0.026,0.057,-0.5628,0.97,1,-1.2047,0.22,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1081_SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1081_SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN",45,-1.6199,0.0098,0.03,1.5574,0.013,0.17,-0.7103,0.94,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_1947_GENTILE_UV_LOW_DOSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1947_GENTILE_UV_LOW_DOSE_DN",67,-1.6198,0.0026,0.03,-1.0282,0.37,0.98,-1.2927,0.099,0.43
"GO_BP:501715_GO_0032483_REGULATION_OF_RAB_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","501715_GO_0032483_REGULATION_OF_RAB_PROTEIN_SIGNAL_TRANSDUCTION",477,-1.6198,0,0.057,-1.3276,0.0016,0.89,-1.2988,0.0042,0.65
"GO_BP:777642_GO_1901985_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION","GO_BP","777642_GO_1901985_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION",26,-1.6198,0.015,0.057,-1.1157,0.3,0.94,-1.595,0.012,0.51
"GO_BP:494785_GO_0010720_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT","GO_BP","494785_GO_0010720_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT",385,-1.6195,0,0.058,-1.0433,0.3,0.98,-0.9721,0.54,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_3317_ABDELMOHSEN_ELAVL4_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3317_ABDELMOHSEN_ELAVL4_TARGETS",16,-1.6192,0.017,0.03,-0.635,0.94,1,-1.1457,0.27,0.58
"REACTOME:187091_REACT_25351_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX","REACTOME","187091_REACT_25351_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX",16,-1.6192,0.018,0.067,1.2021,0.2,0.44,-0.8261,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2341_WHITEFORD_PEDIATRIC_CANCER_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_2341_WHITEFORD_PEDIATRIC_CANCER_MARKERS",116,-1.6192,0.0012,0.03,-0.8933,0.73,1,-1.9168,0,0.067
"GO_BP:494187_GO_0010107_POTASSIUM_ION_IMPORT","GO_BP","494187_GO_0010107_POTASSIUM_ION_IMPORT",25,-1.6191,0.015,0.058,-1.1537,0.24,0.92,-0.9039,0.63,0.92
"GO_BP:490994_GO_0006006_GLUCOSE_METABOLIC_PROCESS","GO_BP","490994_GO_0006006_GLUCOSE_METABOLIC_PROCESS",138,-1.6191,0,0.058,-0.8087,0.91,1,-1.7086,0,0.63
"C3_TF_targets:C3_TFT_444_V_CEBP_Q2_01","C3_TF_targets","C3_TFT_444_V_CEBP_Q2_01",264,-1.6191,0,0.0093,-1.0509,0.3,0.64,-1.2468,0.026,0.29
"GO_MF:496710_GO_0016811_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES","GO_MF","496710_GO_0016811_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES",59,-1.619,0.0066,0.095,-0.8963,0.64,0.99,-1.7974,0,0.22
"GO_BP:510276_GO_0048146_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION","GO_BP","510276_GO_0048146_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION",48,-1.6188,0.007,0.058,1.3862,0.064,0.57,1.2269,0.14,0.71
"C7_Immunologic_signatures:C7_ALL_544_GSE17721_LPS_VS_POLYIC_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_544_GSE17721_LPS_VS_POLYIC_24H_BMDM_DN",198,-1.6186,0,0.00091,1.165,0.11,0.29,0.7331,1,1
"GO_BP:515237_GO_0070304_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE","GO_BP","515237_GO_0070304_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE",119,-1.6185,0,0.058,-1.3736,0.024,0.98,-1.1587,0.17,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_48_KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_48_KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP",121,-1.6185,0,0.031,-0.9077,0.69,1,-1.1147,0.23,0.61
"GO_BP:491420_GO_0006524_ALANINE_CATABOLIC_PROCESS","GO_BP","491420_GO_0006524_ALANINE_CATABOLIC_PROCESS",5,-1.6183,0.011,0.058,-1.3937,0.11,1,1.4056,0.089,0.63
"KEGG_compound:C00059_SULFATE_SULFURIC_ACID","KEGG_compound","C00059_SULFATE_SULFURIC_ACID",13,-1.6183,0.022,0.079,-1.3235,0.15,0.59,-1.3193,0.15,0.35
"C7_Immunologic_signatures:C7_ALL_881_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_881_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP",198,-1.6183,0,0.00092,0.7708,0.98,1,-1.0566,0.29,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_548_TOMIDA_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_548_TOMIDA_METASTASIS_UP",26,-1.618,0.011,0.031,1.0757,0.34,0.67,-1.0534,0.35,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2265_SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2265_SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN",25,-1.6179,0.015,0.031,-0.7653,0.83,1,1.0474,0.37,0.93
"C3_TF_targets:C3_TFT_159_V_STAT_01","C3_TF_targets","C3_TFT_159_V_STAT_01",247,-1.6179,0,0.0092,-0.9392,0.61,0.89,-0.9956,0.45,0.78
"GO_MF:487767_GO_0001871_PATTERN_BINDING","GO_MF","487767_GO_0001871_PATTERN_BINDING",168,-1.6179,0.0012,0.095,-1.0389,0.35,0.87,1.5096,0.0059,0.43
"GO_BP:491078_GO_0006098_PENTOSE_PHOSPHATE_SHUNT","GO_BP","491078_GO_0006098_PENTOSE_PHOSPHATE_SHUNT",13,-1.6179,0.023,0.058,-0.8714,0.63,1,-1.0117,0.45,0.84
"C6_Oncogenic_signatures:C6_ALL_112_NOTCH_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_112_NOTCH_DN_V1_UP",177,-1.6178,0.0023,0.0045,0.948,0.6,0.93,-1.0495,0.33,0.59
"REACTOME:106405_REACT_6932_COMPLEMENT_CASCADE","REACTOME","106405_REACT_6932_COMPLEMENT_CASCADE",36,-1.6178,0.013,0.067,1.157,0.23,0.5,0.8217,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2039_BAFNA_MUC4_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2039_BAFNA_MUC4_TARGETS_UP",6,-1.6178,0.014,0.031,-1.1034,0.35,0.91,0.8877,0.62,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3058_HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3058_HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN",103,-1.6177,0,0.031,0.8473,0.83,0.97,-1.1403,0.21,0.59
"C6_Oncogenic_signatures:C6_ALL_166_NFE2L2_V2","C6_Oncogenic_signatures","C6_ALL_166_NFE2L2_V2",425,-1.6176,0,0.0044,0.9396,0.67,0.92,1.3011,0.0057,0.19
"C2_Chemical_and_genetic_perturbations:C2_CGP_3106_PHESSE_TARGETS_OF_APC_AND_MBD2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3106_PHESSE_TARGETS_OF_APC_AND_MBD2_DN",12,-1.6173,0.029,0.031,-0.9043,0.59,1,-1.5186,0.055,0.29
"C7_Immunologic_signatures:C7_ALL_502_GSE17721_CTRL_VS_CPG_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_502_GSE17721_CTRL_VS_CPG_4H_BMDM_DN",194,-1.6173,0,0.00093,0.8367,0.9,1,0.8492,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_474_BARIS_THYROID_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_474_BARIS_THYROID_CANCER_DN",58,-1.6173,0.01,0.031,0.9275,0.6,0.9,-1.2964,0.076,0.43
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_65_BIOCARTA_ECM_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_65_BIOCARTA_ECM_PATHWAY",23,-1.6173,0.016,0.081,1.0596,0.35,0.77,0.8282,0.73,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2015_CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2015_CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN",35,-1.6172,0.0044,0.031,0.8019,0.78,0.99,0.7566,0.88,1
"C6_Oncogenic_signatures:C6_ALL_40_ATF2_S_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_40_ATF2_S_UP_V1_UP",187,-1.6172,0.0011,0.0043,-0.9974,0.45,0.68,-1.1024,0.22,0.5
"KEGG_pathway:HSA05200_PATHWAYS_IN_CANCER","KEGG_pathway","HSA05200_PATHWAYS_IN_CANCER",387,-1.6172,0,0.014,-0.8517,0.93,0.99,0.965,0.59,1
"GO_BP:499138_GO_0021859_PYRAMIDAL_NEURON_DIFFERENTIATION","GO_BP","499138_GO_0021859_PYRAMIDAL_NEURON_DIFFERENTIATION",7,-1.6172,0.013,0.058,-1.0622,0.4,0.96,-0.6475,0.9,1
"GO_CC:487472_GO_0001533_CORNIFIED_ENVELOPE","GO_CC","487472_GO_0001533_CORNIFIED_ENVELOPE",16,-1.6172,0.015,0.09,1.0855,0.37,0.67,1.517,0.053,0.56
"GO_BP:506310_GO_0043243_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY","GO_BP","506310_GO_0043243_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY",21,-1.6168,0.023,0.059,-0.8281,0.71,1,0.879,0.67,0.95
"C4_Cancer_gene_neighborhoods:C4_CGN_276_CAR_HPX","C4_Cancer_gene_neighborhoods","C4_CGN_276_CAR_HPX",69,-1.6167,0.0065,0.019,1.5564,0.01,0.021,1.9162,0,0.033
"GO_BP:519366_GO_2000727_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION","GO_BP","519366_GO_2000727_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION",10,-1.6166,0.023,0.059,-0.9888,0.45,1,1.1405,0.29,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2521_MARTINELLI_IMMATURE_NEUTROPHIL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2521_MARTINELLI_IMMATURE_NEUTROPHIL_UP",11,-1.6166,0.015,0.031,1.6845,0.018,0.092,0.9275,0.53,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1066_SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1066_SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP",112,-1.6165,0.0025,0.031,-1.1044,0.24,0.91,-1.3161,0.043,0.41
"GO_MF:502156_GO_0032934_STEROL_BINDING","GO_MF","502156_GO_0032934_STEROL_BINDING",41,-1.6165,0.0069,0.096,-1.2131,0.17,0.82,1.0212,0.41,0.86
"C7_Immunologic_signatures:C7_ALL_1872_GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1872_GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN",200,-1.6165,0,0.00094,0.8731,0.8,1,-0.8837,0.8,0.97
"GO_BP:494696_GO_0010632_REGULATION_OF_EPITHELIAL_CELL_MIGRATION","GO_BP","494696_GO_0010632_REGULATION_OF_EPITHELIAL_CELL_MIGRATION",143,-1.6165,0.0023,0.059,-1.0297,0.4,0.97,1.0306,0.37,0.82
"GO_BP:487842_GO_0001952_REGULATION_OF_CELL_MATRIX_ADHESION","GO_BP","487842_GO_0001952_REGULATION_OF_CELL_MATRIX_ADHESION",80,-1.6164,0.0025,0.059,-1.2995,0.064,0.89,1.0093,0.43,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_815_FUNG_IL2_SIGNALING_2","C2_Chemical_and_genetic_perturbations","C2_CGP_815_FUNG_IL2_SIGNALING_2",12,-1.6163,0.022,0.031,0.9251,0.54,0.89,0.8039,0.72,1
"GO_BP:501252_GO_0032015_REGULATION_OF_RAN_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","501252_GO_0032015_REGULATION_OF_RAN_PROTEIN_SIGNAL_TRANSDUCTION",477,-1.6163,0,0.059,-1.316,0.0063,0.88,-1.2882,0.013,0.65
"GO_BP:755304_GO_2001198_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION","GO_BP","755304_GO_2001198_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION",7,-1.6162,0.012,0.059,-0.5125,0.98,1,-0.943,0.52,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_858_JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_858_JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN",45,-1.6162,0.014,0.031,1.116,0.25,0.61,-1.2688,0.11,0.45
"C0_Hallmark:H_ALL_37_HALLMARK_P53_PATHWAY","C0_Hallmark","H_ALL_37_HALLMARK_P53_PATHWAY",199,-1.6162,0,0.0033,-0.8811,0.77,1,-1.0833,0.24,0.32
"GO_MF:495680_GO_0015491_CATION_CATION_ANTIPORTER_ACTIVITY","GO_MF","495680_GO_0015491_CATION_CATION_ANTIPORTER_ACTIVITY",22,-1.6161,0.015,0.096,-0.8136,0.74,1,0.9886,0.44,0.88
"C7_Immunologic_signatures:C7_ALL_550_GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_550_GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDM_DN",196,-1.616,0,0.00094,-1.0114,0.44,1,-0.8986,0.77,0.95
"GO_BP:487610_GO_0001707_MESODERM_FORMATION","GO_BP","487610_GO_0001707_MESODERM_FORMATION",62,-1.616,0.0069,0.059,-1.3562,0.054,0.97,0.8103,0.83,1
"GO_BP:752457_GO_0086091_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION","GO_BP","752457_GO_0086091_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION",26,-1.6159,0.017,0.059,-0.954,0.51,1,1.0287,0.41,0.82
"GO_MF:496599_GO_0016667_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS","GO_MF","496599_GO_0016667_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS",49,-1.6159,0.0054,0.095,1.0153,0.43,0.87,-1.4414,0.035,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_335_GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_335_GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN",86,-1.6158,0.005,0.031,1.4023,0.021,0.29,-1.7742,0,0.14
"C7_Immunologic_signatures:C7_ALL_1135_GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP","C7_Immunologic_signatures","C7_ALL_1135_GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP",197,-1.6156,0,0.00095,0.9199,0.7,0.98,-1.2739,0.039,0.17
"GO_BP:502058_GO_0032835_GLOMERULUS_DEVELOPMENT","GO_BP","502058_GO_0032835_GLOMERULUS_DEVELOPMENT",48,-1.6156,0.0098,0.059,-1.3062,0.1,0.88,-0.6843,0.97,1
"GO_CC:499480_GO_0030016_MYOFIBRIL","GO_CC","499480_GO_0030016_MYOFIBRIL",201,-1.6156,0,0.09,-0.9171,0.7,0.94,-1.0869,0.22,0.93
"GO_BP:487496_GO_0016049_CELL_GROWTH","GO_BP","487496_GO_0016049_CELL_GROWTH",120,-1.6156,0.0037,0.059,-1.148,0.17,0.93,-1.2479,0.079,0.68
"KEGG_pathway:HSA04020_CALCIUM_SIGNALING_PATHWAY","KEGG_pathway","HSA04020_CALCIUM_SIGNALING_PATHWAY",178,-1.6155,0.0011,0.014,-1.3663,0.02,0.33,1.0253,0.37,1
"GO_BP:503964_GO_0034765_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","503964_GO_0034765_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORT",334,-1.6155,0,0.059,-1.3657,0.0068,0.99,1.1024,0.18,0.76
"C6_Oncogenic_signatures:C6_ALL_185_KRAS_LUNG_BREAST_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_185_KRAS_LUNG_BREAST_UP_V1_UP",127,-1.6153,0,0.0044,0.9621,0.56,0.94,1.1419,0.2,0.35
"GO_MF:510618_GO_0048551_METALLOENZYME_INHIBITOR_ACTIVITY","GO_MF","510618_GO_0048551_METALLOENZYME_INHIBITOR_ACTIVITY",14,-1.6152,0.022,0.095,-1.3244,0.12,0.72,1.1146,0.33,0.81
"GO_BP:500148_GO_0030850_PROSTATE_GLAND_DEVELOPMENT","GO_BP","500148_GO_0030850_PROSTATE_GLAND_DEVELOPMENT",40,-1.6152,0.0083,0.059,0.9836,0.46,1,1.3423,0.078,0.65
"GO_BP:514629_GO_0061081_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","514629_GO_0061081_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE",11,-1.6151,0.023,0.059,0.7787,0.75,1,0.7885,0.75,1
"GO_CC:506265_GO_0043197_DENDRITIC_SPINE","GO_CC","506265_GO_0043197_DENDRITIC_SPINE",97,-1.6151,0,0.089,-1.3774,0.028,0.63,-1.168,0.16,0.86
"GO_MF:490248_GO_0004957_PROSTAGLANDIN_E_RECEPTOR_ACTIVITY","GO_MF","490248_GO_0004957_PROSTAGLANDIN_E_RECEPTOR_ACTIVITY",5,-1.615,0.021,0.095,0.8508,0.63,1,1.1538,0.31,0.77
"REACTOME:106406_REACT_8024_INITIAL_TRIGGERING_OF_COMPLEMENT","REACTOME","106406_REACT_8024_INITIAL_TRIGGERING_OF_COMPLEMENT",18,-1.615,0.021,0.069,-0.8635,0.64,1,-0.8104,0.72,1
"GO_BP:518443_GO_0090303_POSITIVE_REGULATION_OF_WOUND_HEALING","GO_BP","518443_GO_0090303_POSITIVE_REGULATION_OF_WOUND_HEALING",44,-1.6148,0.011,0.059,1.1001,0.3,0.9,1.0527,0.36,0.8
"KEGG_compound:C00022_PYRUVATE_PYRUVIC_ACID_2_OXOPROPANOATE_2_OXOPROPANOIC_ACID_PYRORACEMIC_ACID","KEGG_compound","C00022_PYRUVATE_PYRUVIC_ACID_2_OXOPROPANOATE_2_OXOPROPANOIC_ACID_PYRORACEMIC_ACID",29,-1.6147,0.0061,0.082,0.734,0.87,1,0.7285,0.89,0.95
"GO_BP:754110_GO_1901142_INSULIN_METABOLIC_PROCESS","GO_BP","754110_GO_1901142_INSULIN_METABOLIC_PROCESS",7,-1.6147,0.012,0.059,-1.9371,0.0019,0.3,-1.4608,0.076,0.54
"GO_BP:513605_GO_0060047_HEART_CONTRACTION","GO_BP","513605_GO_0060047_HEART_CONTRACTION",53,-1.6146,0.0056,0.059,-1.2948,0.093,0.88,-0.8983,0.66,0.93
"GO_BP:489000_GO_0003206_CARDIAC_CHAMBER_MORPHOGENESIS","GO_BP","489000_GO_0003206_CARDIAC_CHAMBER_MORPHOGENESIS",104,-1.6146,0.0025,0.059,-0.8993,0.68,1,1.3361,0.048,0.65
"GO_BP:495066_GO_0012502_INDUCTION_OF_PROGRAMMED_CELL_DEATH","GO_BP","495066_GO_0012502_INDUCTION_OF_PROGRAMMED_CELL_DEATH",141,-1.6145,0,0.059,-0.647,1,1,-1.3998,0.02,0.58
"C3_TF_targets:C3_TFT_492_GTGGGTGK_UNKNOWN","C3_TF_targets","C3_TFT_492_GTGGGTGK_UNKNOWN",285,-1.6144,0,0.0094,-1.164,0.11,0.41,-0.9079,0.77,0.91
"GO_BP:508115_GO_0045778_POSITIVE_REGULATION_OF_OSSIFICATION","GO_BP","508115_GO_0045778_POSITIVE_REGULATION_OF_OSSIFICATION",82,-1.6144,0.0026,0.059,-1.1138,0.26,0.94,1.0663,0.3,0.79
"GO_MF:492691_GO_0008391_ARACHIDONIC_ACID_MONOOXYGENASE_ACTIVITY","GO_MF","492691_GO_0008391_ARACHIDONIC_ACID_MONOOXYGENASE_ACTIVITY",16,-1.6144,0.033,0.095,-1.9428,0,0.11,1.5457,0.035,0.36
"GO_BP:509069_GO_0046849_BONE_REMODELING","GO_BP","509069_GO_0046849_BONE_REMODELING",41,-1.6144,0.0042,0.059,-1.5481,0.039,0.74,0.8382,0.76,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1682_KAAB_HEART_ATRIUM_VS_VENTRICLE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1682_KAAB_HEART_ATRIUM_VS_VENTRICLE_UP",245,-1.6144,0,0.031,1.0478,0.3,0.72,-1.1484,0.13,0.58
"REACTOME:106156_REACT_6823_LIPOPROTEIN_METABOLISM","REACTOME","106156_REACT_6823_LIPOPROTEIN_METABOLISM",30,-1.614,0.012,0.069,-1.4521,0.05,0.48,0.9617,0.5,1
"GO_BP:495103_GO_0014031_MESENCHYMAL_CELL_DEVELOPMENT","GO_BP","495103_GO_0014031_MESENCHYMAL_CELL_DEVELOPMENT",101,-1.6138,0,0.059,0.9461,0.57,1,1.4921,0.0057,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1149_AMIT_SERUM_RESPONSE_240_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1149_AMIT_SERUM_RESPONSE_240_MCF10A",57,-1.6138,0.0069,0.031,1.1314,0.23,0.58,1.6405,0.0057,0.33
"C4_Cancer_modules:C4_CM_85_MODULE_90","C4_Cancer_modules","C4_CM_85_MODULE_90",17,-1.6137,0.027,0.027,-1.1951,0.23,0.6,-1.3543,0.1,0.25
"GO_MF:751289_GO_0038024_CARGO_RECEPTOR_ACTIVITY","GO_MF","751289_GO_0038024_CARGO_RECEPTOR_ACTIVITY",63,-1.6134,0.0066,0.095,-1.4372,0.033,0.63,1.3289,0.076,0.67
"GO_BP:506167_GO_0043087_REGULATION_OF_GTPASE_ACTIVITY","GO_BP","506167_GO_0043087_REGULATION_OF_GTPASE_ACTIVITY",477,-1.6134,0,0.059,-1.3252,0.0033,0.89,-1.3009,0.0061,0.65
"GO_CC:496301_GO_0016234_INCLUSION_BODY","GO_CC","496301_GO_0016234_INCLUSION_BODY",60,-1.6133,0.0027,0.089,-0.9672,0.51,0.89,-1.6158,0.0081,0.37
"GO_BP:495879_GO_0015748_ORGANOPHOSPHATE_ESTER_TRANSPORT","GO_BP","495879_GO_0015748_ORGANOPHOSPHATE_ESTER_TRANSPORT",76,-1.6133,0.0026,0.059,-1.1049,0.26,0.94,-1.0246,0.39,0.83
"C7_Immunologic_signatures:C7_ALL_1376_GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN","C7_Immunologic_signatures","C7_ALL_1376_GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN",199,-1.6133,0,0.001,1.0964,0.22,0.45,-1.1988,0.093,0.28
"GO_BP:510179_GO_0048011_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY","GO_BP","510179_GO_0048011_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY",268,-1.6132,0,0.059,-0.9205,0.7,1,-1.0678,0.27,0.8
"GO_CC:503902_GO_0034702_ION_CHANNEL_COMPLEX","GO_CC","503902_GO_0034702_ION_CHANNEL_COMPLEX",270,-1.6132,0,0.088,-1.4793,0.0017,0.64,1.4364,0.0037,0.67
"GO_BP:501544_GO_0032309_ICOSANOID_SECRETION","GO_BP","501544_GO_0032309_ICOSANOID_SECRETION",13,-1.6131,0.019,0.059,-0.6456,0.93,1,0.9582,0.52,0.9
"GO_BP:500893_GO_0031644_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS","GO_BP","500893_GO_0031644_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS",109,-1.6131,0.0013,0.059,-1.0449,0.34,0.97,-1.0562,0.3,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_778_KORKOLA_TERATOMA","C2_Chemical_and_genetic_perturbations","C2_CGP_778_KORKOLA_TERATOMA",39,-1.6131,0.013,0.032,-1.2198,0.15,0.78,-1.215,0.18,0.5
"C7_Immunologic_signatures:C7_ALL_131_GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP","C7_Immunologic_signatures","C7_ALL_131_GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP",189,-1.613,0,0.001,0.7686,0.99,1,-1.4591,0,0.033
"KEGG_compound:C02700_L_FORMYLKYNURENINE_N_FORMYL_L_KYNURENINE_N_FORMYLKYNURENINE","KEGG_compound","C02700_L_FORMYLKYNURENINE_N_FORMYL_L_KYNURENINE_N_FORMYLKYNURENINE",5,-1.6128,0.0052,0.082,-1.4258,0.099,0.41,-1.3361,0.15,0.34
"WikiPathways:198913_WP1545_MIRNAS_INVOLVED_IN_DDR","WikiPathways","198913_WP1545_MIRNAS_INVOLVED_IN_DDR",23,-1.6127,0.009,0.039,-1.4215,0.081,0.96,-1.4771,0.048,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2731_COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2731_COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP",107,-1.6127,0.0012,0.032,0.8428,0.82,0.97,0.9281,0.63,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3288_DELACROIX_RAR_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3288_DELACROIX_RAR_TARGETS_UP",47,-1.6126,0.018,0.032,-1.1125,0.28,0.9,0.8461,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_868_JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_868_JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN",65,-1.6126,0.004,0.032,-0.6626,0.98,1,-1.2447,0.12,0.48
"GO_BP:493499_GO_0042493_RESPONSE_TO_DRUG","GO_BP","493499_GO_0042493_RESPONSE_TO_DRUG",390,-1.6125,0,0.06,-1.1379,0.12,0.93,-1.0247,0.39,0.83
"GO_BP:514262_GO_0060707_TROPHOBLAST_GIANT_CELL_DIFFERENTIATION","GO_BP","514262_GO_0060707_TROPHOBLAST_GIANT_CELL_DIFFERENTIATION",13,-1.6124,0.023,0.06,-1.3013,0.16,0.89,-1.507,0.047,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_20_KORKOLA_YOLK_SAC_TUMOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_20_KORKOLA_YOLK_SAC_TUMOR_UP",20,-1.6123,0.014,0.032,0.7727,0.79,1,-0.4663,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1844_JACKSON_DNMT1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1844_JACKSON_DNMT1_TARGETS_UP",77,-1.6122,0.0013,0.032,1.1148,0.24,0.61,1.0015,0.45,0.96
"C7_Immunologic_signatures:C7_ALL_1432_GSE360_DC_VS_MAC_DN","C7_Immunologic_signatures","C7_ALL_1432_GSE360_DC_VS_MAC_DN",193,-1.6122,0,0.001,-0.7161,0.99,1,-0.9419,0.64,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1138_AMIT_EGF_RESPONSE_480_HELA","C2_Chemical_and_genetic_perturbations","C2_CGP_1138_AMIT_EGF_RESPONSE_480_HELA",161,-1.6122,0.0012,0.032,0.6878,1,1,1.3766,0.018,0.53
"GO_BP:512174_GO_0051289_PROTEIN_HOMOTETRAMERIZATION","GO_BP","512174_GO_0051289_PROTEIN_HOMOTETRAMERIZATION",55,-1.6119,0.012,0.06,-0.7821,0.85,1,-1.4619,0.017,0.54
"GO_MF:504765_GO_0035586_PURINERGIC_RECEPTOR_ACTIVITY","GO_MF","504765_GO_0035586_PURINERGIC_RECEPTOR_ACTIVITY",38,-1.6117,0.0085,0.096,1.2855,0.11,0.63,0.854,0.73,0.98
"WikiPathways:198894_WP314_FAS_PATHWAY_AND_STRESS_INDUCTION_OF_HSP_REGULATION","WikiPathways","198894_WP314_FAS_PATHWAY_AND_STRESS_INDUCTION_OF_HSP_REGULATION",38,-1.6117,0.014,0.038,-1.0549,0.36,0.99,-1.449,0.034,0.43
"C4_Cancer_modules:C4_CM_353_MODULE_426","C4_Cancer_modules","C4_CM_353_MODULE_426",85,-1.6117,0.0025,0.027,-0.958,0.54,0.87,-0.9029,0.68,0.86
"GO_BP:1039947_GO_1903393_POSITIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION","GO_BP","1039947_GO_1903393_POSITIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION",20,-1.6116,0.02,0.06,-1.1456,0.26,0.93,1.3325,0.12,0.64
"GO_MF:511515_GO_0050542_ICOSANOID_BINDING","GO_MF","511515_GO_0050542_ICOSANOID_BINDING",6,-1.6115,0.015,0.096,1.492,0.07,0.39,1.4957,0.067,0.43
"GO_BP:501644_GO_0032412_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","501644_GO_0032412_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",154,-1.611,0.0023,0.06,-1.4808,0.0069,0.83,-1.1588,0.14,0.74
"GO_BP:494950_GO_0010886_POSITIVE_REGULATION_OF_CHOLESTEROL_STORAGE","GO_BP","494950_GO_0010886_POSITIVE_REGULATION_OF_CHOLESTEROL_STORAGE",7,-1.611,0.018,0.06,-0.7063,0.85,1,1.0482,0.41,0.81
"C7_Immunologic_signatures:C7_ALL_1276_GSE29618_MONOCYTE_VS_PDC_DN","C7_Immunologic_signatures","C7_ALL_1276_GSE29618_MONOCYTE_VS_PDC_DN",194,-1.611,0,0.0011,-0.7223,0.99,1,-1.3686,0.0044,0.082
"GO_BP:516246_GO_0071322_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS","GO_BP","516246_GO_0071322_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS",63,-1.6108,0.011,0.06,-0.6972,0.97,1,-0.8291,0.81,0.97
"GO_CC:489297_GO_0043292_CONTRACTILE_FIBER","GO_CC","489297_GO_0043292_CONTRACTILE_FIBER",214,-1.6107,0,0.089,-0.8745,0.79,0.95,-1.1239,0.18,0.91
"GO_MF:750773_GO_0001221_TRANSCRIPTION_COFACTOR_BINDING","GO_MF","750773_GO_0001221_TRANSCRIPTION_COFACTOR_BINDING",16,-1.6106,0.016,0.096,-0.9001,0.61,0.99,-1.1334,0.29,0.66
"C7_Immunologic_signatures:C7_ALL_570_GSE17721_PAM3CSK4_VS_CPG_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_570_GSE17721_PAM3CSK4_VS_CPG_4H_BMDM_DN",198,-1.6106,0.0034,0.0011,0.8699,0.85,1,-1.1592,0.13,0.35
"GO_BP:510373_GO_0048259_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS","GO_BP","510373_GO_0048259_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS",62,-1.6105,0.0039,0.06,-0.6913,0.96,1,1.0336,0.37,0.82
"REACTOME:106220_REACT_1859_PENTOSE_PHOSPHATE_PATHWAY_HEXOSE_MONOPHOSPHATE_SHUNT_","REACTOME","106220_REACT_1859_PENTOSE_PHOSPHATE_PATHWAY_HEXOSE_MONOPHOSPHATE_SHUNT_",7,-1.6105,0.0098,0.071,-0.7334,0.79,1,-1.0942,0.35,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_38_SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_38_SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN",82,-1.6105,0.0026,0.032,-0.7937,0.87,1,-0.9286,0.62,0.84
"GO_BP:494884_GO_0010820_POSITIVE_REGULATION_OF_T_CELL_CHEMOTAXIS","GO_BP","494884_GO_0010820_POSITIVE_REGULATION_OF_T_CELL_CHEMOTAXIS",10,-1.6105,0.024,0.06,0.89,0.58,1,0.9863,0.46,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_526_ZIRN_TRETINOIN_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_526_ZIRN_TRETINOIN_RESPONSE_UP",21,-1.6105,0.019,0.032,-1.4748,0.052,0.51,1.1868,0.25,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_407_BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_407_BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP",8,-1.6104,0.034,0.032,1.3038,0.16,0.39,0.9346,0.51,1
"GO_BP:511843_GO_0050906_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION","GO_BP","511843_GO_0050906_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION",397,-1.6104,0,0.06,2.0789,0,0.0047,2.9295,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_746_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_746_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",81,-1.6101,0,0.032,0.8185,0.85,0.98,0.9679,0.52,0.97
"REACTOME:1127675_REACT_264541_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION","REACTOME","1127675_REACT_264541_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION",64,-1.61,0.0052,0.071,-1.8557,0,0.059,-1.6108,0.0042,0.24
"C2_Chemical_and_genetic_perturbations:C2_CGP_2556_CHANG_CYCLING_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_2556_CHANG_CYCLING_GENES",148,-1.6099,0,0.032,1.0192,0.37,0.77,-1.7391,0,0.16
"REACTOME:106502_REACT_11044_SIGNALING_BY_RHO_GTPASES","REACTOME","106502_REACT_11044_SIGNALING_BY_RHO_GTPASES",395,-1.6099,0,0.07,-0.9829,0.5,1,-1.4261,0,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_162_BASAKI_YBX1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_162_BASAKI_YBX1_TARGETS_UP",287,-1.6098,0,0.032,1.0509,0.31,0.71,-1.0322,0.35,0.71
"REACTOME:1127514_REACT_264273_VEGFR2_MEDIATED_CELL_PROLIFERATION","REACTOME","1127514_REACT_264273_VEGFR2_MEDIATED_CELL_PROLIFERATION",35,-1.6097,0.015,0.07,-0.8938,0.64,1,-1.3108,0.099,0.55
"REACTOME:833815_REACT_163679_SCAVENGING_BY_CLASS_B_RECEPTORS","REACTOME","833815_REACT_163679_SCAVENGING_BY_CLASS_B_RECEPTORS",5,-1.6097,0.012,0.07,-1.2058,0.27,0.83,-1.0346,0.43,0.8
"GO_BP:494957_GO_0010893_POSITIVE_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS","GO_BP","494957_GO_0010893_POSITIVE_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS",13,-1.6096,0.027,0.061,-1.402,0.082,0.98,-0.8043,0.71,0.99
"REACTOME:530742_REACT_116005_SHC1_EVENTS_IN_ERBB4_SIGNALING","REACTOME","530742_REACT_116005_SHC1_EVENTS_IN_ERBB4_SIGNALING",28,-1.6095,0.017,0.069,-0.5869,0.98,1,-0.7794,0.81,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_434_LANDIS_ERBB2_BREAST_TUMORS_65_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_434_LANDIS_ERBB2_BREAST_TUMORS_65_DN",35,-1.6095,0.0055,0.032,1.1549,0.27,0.55,-1.0333,0.41,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_171_RODRIGUES_NTN1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_171_RODRIGUES_NTN1_TARGETS_DN",155,-1.6094,0.0012,0.032,-1.0933,0.27,0.93,-0.9076,0.72,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_993_INGRAM_SHH_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_993_INGRAM_SHH_TARGETS_DN",60,-1.6093,0.011,0.032,-1.1258,0.27,0.89,-1.056,0.35,0.68
"C0_Hallmark:H_ALL_13_HALLMARK_ESTROGEN_RESPONSE_EARLY","C0_Hallmark","H_ALL_13_HALLMARK_ESTROGEN_RESPONSE_EARLY",195,-1.6093,0,0.0035,-1.1791,0.12,0.83,0.9586,0.56,0.65
"GO_BP:492351_GO_0007610_BEHAVIOR","GO_BP","492351_GO_0007610_BEHAVIOR",470,-1.6092,0,0.061,-1.2312,0.034,0.9,1.2563,0.011,0.69
"GO_MF:499996_GO_0030695_GTPASE_REGULATOR_ACTIVITY","GO_MF","499996_GO_0030695_GTPASE_REGULATOR_ACTIVITY",268,-1.6091,0,0.097,-1.4027,0,0.63,-1.5814,0,0.35
"GO_BP:500872_GO_0031622_POSITIVE_REGULATION_OF_FEVER_GENERATION","GO_BP","500872_GO_0031622_POSITIVE_REGULATION_OF_FEVER_GENERATION",7,-1.6091,0.017,0.061,-1.2578,0.19,0.91,1.0166,0.42,0.84
"C4_Cancer_modules:C4_CM_3_MODULE_3","C4_Cancer_modules","C4_CM_3_MODULE_3",383,-1.609,0,0.027,1.4991,0,0.12,0.7915,0.99,1
"GO_BP:499468_GO_0045056_TRANSCYTOSIS","GO_BP","499468_GO_0045056_TRANSCYTOSIS",11,-1.6089,0.026,0.061,-1.0892,0.34,0.95,-1.0656,0.38,0.8
"GO_BP:498506_GO_0019682_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS","GO_BP","498506_GO_0019682_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS",13,-1.6088,0.025,0.061,-0.8577,0.67,1,-1.0284,0.44,0.83
"C7_Immunologic_signatures:C7_ALL_1184_GSE27786_BCELL_VS_NKTCELL_DN","C7_Immunologic_signatures","C7_ALL_1184_GSE27786_BCELL_VS_NKTCELL_DN",199,-1.6087,0.0023,0.0011,-0.9555,0.56,1,-1.0466,0.31,0.62
"GO_MF:496565_GO_0016624_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR","GO_MF","496565_GO_0016624_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR",8,-1.6087,0.027,0.097,1.0185,0.43,0.87,-1.7084,0.0079,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_2563_VANTVEER_BREAST_CANCER_ESR1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2563_VANTVEER_BREAST_CANCER_ESR1_DN",238,-1.6086,0,0.032,0.9728,0.54,0.83,-0.9365,0.66,0.84
"GO_BP:510592_GO_0048521_NEGATIVE_REGULATION_OF_BEHAVIOR","GO_BP","510592_GO_0048521_NEGATIVE_REGULATION_OF_BEHAVIOR",44,-1.6086,0.01,0.061,0.8782,0.68,1,1.6212,0.0056,0.4
"GO_BP:488813_GO_0003015_HEART_PROCESS","GO_BP","488813_GO_0003015_HEART_PROCESS",60,-1.6083,0.0068,0.061,-1.3292,0.063,0.9,0.8914,0.68,0.95
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_149_BIOCARTA_NKCELLS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_149_BIOCARTA_NKCELLS_PATHWAY",20,-1.6082,0.016,0.085,-0.6994,0.88,1,-0.7003,0.88,0.98
"GO_CC:495775_GO_0015629_ACTIN_CYTOSKELETON","GO_CC","495775_GO_0015629_ACTIN_CYTOSKELETON",429,-1.6082,0,0.09,-0.9432,0.65,0.89,-1.2634,0.013,0.68
"GO_BP:507714_GO_0045357_REGULATION_OF_INTERFERON_BETA_BIOSYNTHETIC_PROCESS","GO_BP","507714_GO_0045357_REGULATION_OF_INTERFERON_BETA_BIOSYNTHETIC_PROCESS",8,-1.6082,0.021,0.061,-0.6651,0.91,1,-1.2737,0.19,0.66
"GO_BP:518323_GO_0090183_REGULATION_OF_KIDNEY_DEVELOPMENT","GO_BP","518323_GO_0090183_REGULATION_OF_KIDNEY_DEVELOPMENT",59,-1.6082,0.0039,0.061,-0.8702,0.71,1,1.1232,0.25,0.74
"GO_MF:496461_GO_0016493_C_C_CHEMOKINE_RECEPTOR_ACTIVITY","GO_MF","496461_GO_0016493_C_C_CHEMOKINE_RECEPTOR_ACTIVITY",12,-1.6082,0.011,0.096,1.2819,0.16,0.63,1.4067,0.076,0.52
"GO_MF:492573_GO_0008242_OMEGA_PEPTIDASE_ACTIVITY","GO_MF","492573_GO_0008242_OMEGA_PEPTIDASE_ACTIVITY",19,-1.6081,0.013,0.096,-0.7621,0.83,1,-1.4407,0.067,0.43
"C7_Immunologic_signatures:C7_ALL_1365_GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1365_GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP",198,-1.6081,0,0.0011,0.8773,0.83,1,-1.1165,0.19,0.46
"C3_TF_targets:C3_TFT_122_V_AP4_Q5","C3_TF_targets","C3_TFT_122_V_AP4_Q5",268,-1.6081,0,0.01,-1.3012,0.027,0.24,-1.2767,0.023,0.26
"WikiPathways:198874_WP51_REGULATION_OF_ACTIN_CYTOSKELETON","WikiPathways","198874_WP51_REGULATION_OF_ACTIN_CYTOSKELETON",137,-1.608,0,0.039,-1.0467,0.35,0.97,-0.8032,0.91,0.98
"GO_BP:488696_GO_0002823_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS","GO_BP","488696_GO_0002823_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS",27,-1.6079,0.013,0.061,-0.8472,0.68,1,-0.8622,0.72,0.95
"GO_BP:512000_GO_0051085_CHAPERONE_MEDIATED_PROTEIN_FOLDING_REQUIRING_COFACTOR","GO_BP","512000_GO_0051085_CHAPERONE_MEDIATED_PROTEIN_FOLDING_REQUIRING_COFACTOR",11,-1.6079,0.026,0.061,-0.6454,0.92,1,-1.6341,0.019,0.52
"GO_BP:493459_GO_0009266_RESPONSE_TO_TEMPERATURE_STIMULUS","GO_BP","493459_GO_0009266_RESPONSE_TO_TEMPERATURE_STIMULUS",157,-1.6078,0,0.061,-0.9858,0.48,1,-1.4515,0.0081,0.54
"GO_MF:492533_GO_0008191_METALLOENDOPEPTIDASE_INHIBITOR_ACTIVITY","GO_MF","492533_GO_0008191_METALLOENDOPEPTIDASE_INHIBITOR_ACTIVITY",14,-1.6078,0.029,0.096,-1.3611,0.13,0.69,1.1046,0.33,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_1943_HU_GENOTOXIC_DAMAGE_4HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1943_HU_GENOTOXIC_DAMAGE_4HR",35,-1.6078,0.0086,0.033,-1.1187,0.29,0.89,-1.6715,0.01,0.21
"GO_BP:514251_GO_0060696_REGULATION_OF_PHOSPHOLIPID_CATABOLIC_PROCESS","GO_BP","514251_GO_0060696_REGULATION_OF_PHOSPHOLIPID_CATABOLIC_PROCESS",5,-1.6078,0.007,0.061,-0.6376,0.9,1,0.9298,0.56,0.92
"C7_Immunologic_signatures:C7_ALL_159_GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_159_GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP",198,-1.6077,0,0.0011,0.6276,1,1,-1.1308,0.16,0.42
"WikiPathways:711361_WP2374_ONCOSTATIN_M_SIGNALING_PATHWAY","WikiPathways","711361_WP2374_ONCOSTATIN_M_SIGNALING_PATHWAY",63,-1.6076,0.0078,0.038,-0.6944,0.97,1,-0.8674,0.71,0.91
"GO_BP:515414_GO_0070482_RESPONSE_TO_OXYGEN_LEVELS","GO_BP","515414_GO_0070482_RESPONSE_TO_OXYGEN_LEVELS",278,-1.6076,0,0.061,0.8155,0.97,1,0.9597,0.61,0.9
"GO_BP:501467_GO_0032232_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY","GO_BP","501467_GO_0032232_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY",13,-1.6075,0.022,0.061,0.5886,0.96,1,-0.6383,0.92,1
"GO_BP:503583_GO_0034381_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE","GO_BP","503583_GO_0034381_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE",21,-1.6074,0.017,0.061,0.646,0.95,1,1.3436,0.12,0.65
"GO_BP:493279_GO_0009078_PYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS","GO_BP","493279_GO_0009078_PYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS",5,-1.6074,0.0088,0.061,-1.3915,0.11,1,1.4577,0.076,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2588_HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2588_HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN",21,-1.6071,0.018,0.033,0.944,0.55,0.87,0.7038,0.88,1
"C3_TF_targets:C3_TFT_63_V_PBX1_01","C3_TF_targets","C3_TFT_63_V_PBX1_01",239,-1.607,0,0.01,-1.0323,0.37,0.69,-1.373,0,0.29
"KEGG_pathway:HSA01200_CARBON_METABOLISM","KEGG_pathway","HSA01200_CARBON_METABOLISM",113,-1.607,0.0025,0.015,1.0886,0.25,0.81,-1.5627,0.002,0.1
"GO_BP:510606_GO_0048537_MUCOSAL_ASSOCIATED_LYMPHOID_TISSUE_DEVELOPMENT","GO_BP","510606_GO_0048537_MUCOSAL_ASSOCIATED_LYMPHOID_TISSUE_DEVELOPMENT",12,-1.6069,0.021,0.061,-0.8552,0.63,1,-1.265,0.17,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_887_KIM_MYCL1_AMPLIFICATION_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_887_KIM_MYCL1_AMPLIFICATION_TARGETS_UP",12,-1.6068,0.023,0.033,-1.3377,0.15,0.7,-1.0588,0.38,0.68
"GO_BP:499535_GO_0030099_MYELOID_CELL_DIFFERENTIATION","GO_BP","499535_GO_0030099_MYELOID_CELL_DIFFERENTIATION",198,-1.6068,0,0.062,1.0293,0.36,0.97,-1.126,0.19,0.75
"GO_BP:505684_GO_0042554_SUPEROXIDE_ANION_GENERATION","GO_BP","505684_GO_0042554_SUPEROXIDE_ANION_GENERATION",13,-1.6068,0.016,0.061,-1.1706,0.27,0.91,-0.8739,0.63,0.95
"REACTOME:833827_REACT_163834_FCERI_MEDIATED_CA_2_MOBILIZATION","REACTOME","833827_REACT_163834_FCERI_MEDIATED_CA_2_MOBILIZATION",29,-1.6067,0.0086,0.071,-0.7416,0.85,1,-1.6681,0.015,0.22
"GO_MF:507653_GO_0045294_ALPHA_CATENIN_BINDING","GO_MF","507653_GO_0045294_ALPHA_CATENIN_BINDING",10,-1.6066,0.016,0.096,-1.6404,0.027,0.4,-1.2767,0.18,0.58
"GO_MF:750780_GO_0001228_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION","GO_MF","750780_GO_0001228_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION",246,-1.6064,0,0.096,-0.9324,0.67,0.97,-0.9451,0.62,0.84
"GO_BP:502492_GO_0033273_RESPONSE_TO_VITAMIN","GO_BP","502492_GO_0033273_RESPONSE_TO_VITAMIN",97,-1.6064,0,0.062,-0.8319,0.83,1,1.4058,0.036,0.63
"KEGG_compound:C00003_NAD_NAD_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_DPN_DIPHOSPHOPYRIDINE_NUCLEOTIDE_NADIDE_BETA_NAD_","KEGG_compound","C00003_NAD_NAD_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_DPN_DIPHOSPHOPYRIDINE_NUCLEOTIDE_NADIDE_BETA_NAD_",118,-1.6063,0.0012,0.086,0.9561,0.54,1,-1.7121,0,0.066
"C2_Chemical_and_genetic_perturbations:C2_CGP_435_LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_435_LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP",20,-1.6063,0.022,0.033,0.9515,0.55,0.86,1.1897,0.23,0.78
"GO_BP:486718_GO_0000187_ACTIVATION_OF_MAPK_ACTIVITY","GO_BP","486718_GO_0000187_ACTIVATION_OF_MAPK_ACTIVITY",139,-1.6062,0.0012,0.062,-0.6509,1,1,0.8882,0.74,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2570_SWEET_LUNG_CANCER_KRAS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2570_SWEET_LUNG_CANCER_KRAS_DN",426,-1.606,0,0.033,1.0252,0.33,0.76,-1.1772,0.05,0.54
"KEGG_compound:C00092_D_GLUCOSE_6_PHOSPHATE_GLUCOSE_6_PHOSPHATE_ROBISON_ESTER","KEGG_compound","C00092_D_GLUCOSE_6_PHOSPHATE_GLUCOSE_6_PHOSPHATE_ROBISON_ESTER",9,-1.606,0.027,0.085,-1.0965,0.36,0.94,-1.3536,0.14,0.33
"C2_Chemical_and_genetic_perturbations:C2_CGP_436_LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_436_LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN",55,-1.606,0.0081,0.033,0.8391,0.78,0.98,-1.1075,0.26,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_2926_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0","C2_Chemical_and_genetic_perturbations","C2_CGP_2926_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0",74,-1.6059,0.0051,0.033,0.8906,0.64,0.94,-1.104,0.27,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_502_MCBRYAN_PUBERTAL_BREAST_5_6WK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_502_MCBRYAN_PUBERTAL_BREAST_5_6WK_UP",113,-1.6059,0.0025,0.033,0.969,0.53,0.84,-1.0744,0.3,0.66
"WikiPathways:198782_WP437_EGFR1_SIGNALING_PATHWAY","WikiPathways","198782_WP437_EGFR1_SIGNALING_PATHWAY",177,-1.6058,0,0.038,-0.8007,0.93,1,-0.9293,0.64,0.81
"C7_Immunologic_signatures:C7_ALL_1540_GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1540_GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN",188,-1.6058,0,0.0012,-1.3468,0.022,0.36,-1.4613,0.0042,0.033
"GO_BP:491575_GO_0006687_GLYCOSPHINGOLIPID_METABOLIC_PROCESS","GO_BP","491575_GO_0006687_GLYCOSPHINGOLIPID_METABOLIC_PROCESS",59,-1.6058,0.0052,0.062,-0.6599,0.97,1,0.7953,0.84,1
"C1_Positional:C1_ALL_282_CHR4Q23","C1_Positional","C1_ALL_282_CHR4Q23",21,-1.6055,0.024,0.2,-1.3282,0.12,0.77,-1.3573,0.11,0.44
"C3_TF_targets:C3_TFT_484_V_PXR_Q2","C3_TF_targets","C3_TFT_484_V_PXR_Q2",251,-1.6055,0,0.01,-1.3455,0.012,0.2,-1.2511,0.043,0.29
"C7_Immunologic_signatures:C7_ALL_1561_GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1561_GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP",197,-1.6055,0,0.0012,0.9143,0.7,0.99,0.854,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2912_MIKKELSEN_ES_ICP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2912_MIKKELSEN_ES_ICP_WITH_H3K27ME3",41,-1.6054,0.015,0.033,-1.5464,0.028,0.44,-1.3926,0.044,0.36
"GO_MF:489236_GO_0005521_LAMIN_BINDING","GO_MF","489236_GO_0005521_LAMIN_BINDING",12,-1.6053,0.018,0.096,-1.1913,0.25,0.79,-1.6349,0.028,0.35
"GO_BP:505654_GO_0042523_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN","GO_BP","505654_GO_0042523_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN",17,-1.6049,0.025,0.062,-1.6047,0.021,0.7,-1.1918,0.21,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_468_LANDIS_ERBB2_BREAST_TUMORS_324_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_468_LANDIS_ERBB2_BREAST_TUMORS_324_DN",145,-1.6049,0,0.033,1.1065,0.21,0.62,-1.2541,0.07,0.47
"GO_BP:510651_GO_0048588_DEVELOPMENTAL_CELL_GROWTH","GO_BP","510651_GO_0048588_DEVELOPMENTAL_CELL_GROWTH",62,-1.6048,0.0052,0.062,-1.0075,0.46,0.98,-1.1572,0.2,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_2745_LEE_LIVER_CANCER_HEPATOBLAST","C2_Chemical_and_genetic_perturbations","C2_CGP_2745_LEE_LIVER_CANCER_HEPATOBLAST",15,-1.6048,0.016,0.033,-1.2135,0.21,0.8,-0.9939,0.43,0.76
"C3_MicroRNA_targets:C3_MIR_212_GTAAACC_MIR_299_5P","C3_MicroRNA_targets","C3_MIR_212_GTAAACC_MIR_299_5P",48,-1.6048,0.0069,0.19,-1.2133,0.18,1,-0.8991,0.64,1
"C7_Immunologic_signatures:C7_ALL_531_GSE17721_LPS_VS_POLYIC_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_531_GSE17721_LPS_VS_POLYIC_2H_BMDM_UP",195,-1.6047,0,0.0012,0.8998,0.76,1,-0.8257,0.92,1
"GO_BP:492550_GO_0008209_ANDROGEN_METABOLIC_PROCESS","GO_BP","492550_GO_0008209_ANDROGEN_METABOLIC_PROCESS",30,-1.6046,0.014,0.062,0.9109,0.6,1,-1.038,0.38,0.82
"GO_BP:501328_GO_0032091_NEGATIVE_REGULATION_OF_PROTEIN_BINDING","GO_BP","501328_GO_0032091_NEGATIVE_REGULATION_OF_PROTEIN_BINDING",61,-1.6044,0.0066,0.062,0.8766,0.72,1,0.9288,0.56,0.92
"WikiPathways:198882_WP581_EPO_RECEPTOR_SIGNALING","WikiPathways","198882_WP581_EPO_RECEPTOR_SIGNALING",26,-1.6043,0.017,0.038,-0.9011,0.63,1,-1.0692,0.35,0.64
"GO_BP:1184361_GO_0090630_ACTIVATION_OF_GTPASE_ACTIVITY","GO_BP","1184361_GO_0090630_ACTIVATION_OF_GTPASE_ACTIVITY",27,-1.6043,0.012,0.063,-1.2484,0.15,0.91,-1.129,0.3,0.75
"GO_CC:501664_GO_0032432_ACTIN_FILAMENT_BUNDLE","GO_CC","501664_GO_0032432_ACTIN_FILAMENT_BUNDLE",59,-1.6042,0.011,0.092,-0.8183,0.78,1,-0.9503,0.55,1
"REACTOME:106459_REACT_12056_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE","REACTOME","106459_REACT_12056_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE",199,-1.6042,0,0.072,-0.947,0.58,1,-1.1352,0.14,0.67
"GO_BP:518585_GO_0097035_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION","GO_BP","518585_GO_0097035_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION",33,-1.604,0.013,0.063,-0.9219,0.58,1,-0.9649,0.52,0.88
"GO_BP:487061_GO_0000768_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION","GO_BP","487061_GO_0000768_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION",22,-1.6039,0.0077,0.063,-1.3518,0.096,0.95,-1.5469,0.031,0.52
"GO_CC:490879_GO_0005871_KINESIN_COMPLEX","GO_CC","490879_GO_0005871_KINESIN_COMPLEX",51,-1.6039,0.017,0.091,-0.979,0.5,0.87,-1.2692,0.12,0.68
"GO_BP:508730_GO_0046469_PLATELET_ACTIVATING_FACTOR_METABOLIC_PROCESS","GO_BP","508730_GO_0046469_PLATELET_ACTIVATING_FACTOR_METABOLIC_PROCESS",5,-1.6039,0.0073,0.063,-0.9385,0.55,1,-0.9292,0.53,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2826_WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2826_WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP",28,-1.6038,0.0088,0.033,-0.7854,0.8,1,-1.0544,0.37,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_1550_MENSE_HYPOXIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1550_MENSE_HYPOXIA_UP",98,-1.6038,0.0062,0.033,-1.023,0.4,0.98,-1.5778,0.0022,0.25
"GO_BP:513862_GO_0060306_REGULATION_OF_MEMBRANE_REPOLARIZATION","GO_BP","513862_GO_0060306_REGULATION_OF_MEMBRANE_REPOLARIZATION",27,-1.6037,0.015,0.063,-0.8496,0.72,1,0.8899,0.65,0.95
"REACTOME:161046_REACT_21346_ACTIVATION_OF_CA_PERMEABLE_KAINATE_RECEPTOR","REACTOME","161046_REACT_21346_ACTIVATION_OF_CA_PERMEABLE_KAINATE_RECEPTOR",12,-1.6037,0.022,0.072,-0.8455,0.66,1,-0.8143,0.71,1
"GO_MF:490641_GO_0005546_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING","GO_MF","490641_GO_0005546_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING",45,-1.6036,0.0085,0.097,-0.9521,0.52,0.95,-1.2306,0.15,0.57
"GO_BP:498980_GO_0021697_CEREBELLAR_CORTEX_FORMATION","GO_BP","498980_GO_0021697_CEREBELLAR_CORTEX_FORMATION",21,-1.6036,0.015,0.063,0.8364,0.72,1,-0.7381,0.84,1
"GO_BP:513623_GO_0060065_UTERUS_DEVELOPMENT","GO_BP","513623_GO_0060065_UTERUS_DEVELOPMENT",18,-1.6036,0.024,0.063,-0.7639,0.82,1,0.9198,0.61,0.93
"GO_BP:498073_GO_0019218_REGULATION_OF_STEROID_METABOLIC_PROCESS","GO_BP","498073_GO_0019218_REGULATION_OF_STEROID_METABOLIC_PROCESS",75,-1.6035,0.0039,0.063,0.8208,0.82,1,-0.792,0.89,0.99
"GO_BP:507460_GO_0045060_NEGATIVE_THYMIC_T_CELL_SELECTION","GO_BP","507460_GO_0045060_NEGATIVE_THYMIC_T_CELL_SELECTION",10,-1.6035,0.024,0.063,0.8193,0.69,1,-0.9763,0.49,0.88
"GO_BP:510544_GO_0048469_CELL_MATURATION","GO_BP","510544_GO_0048469_CELL_MATURATION",130,-1.6034,0,0.063,-1.3632,0.023,0.97,-1.0285,0.4,0.83
"GO_BP:753716_GO_1900745_POSITIVE_REGULATION_OF_P38MAPK_CASCADE","GO_BP","753716_GO_1900745_POSITIVE_REGULATION_OF_P38MAPK_CASCADE",9,-1.6033,0.024,0.063,-1.1316,0.31,0.93,-1.2316,0.23,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_1538_ALCALAY_AML_BY_NPM1_LOCALIZATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1538_ALCALAY_AML_BY_NPM1_LOCALIZATION_DN",184,-1.6033,0,0.033,1.0432,0.33,0.73,-1.4276,0.011,0.33
"GO_MF:490162_GO_0004860_PROTEIN_KINASE_INHIBITOR_ACTIVITY","GO_MF","490162_GO_0004860_PROTEIN_KINASE_INHIBITOR_ACTIVITY",61,-1.6033,0.0093,0.097,0.7768,0.9,1,-1.0959,0.29,0.7
"C4_Cancer_modules:C4_CM_367_MODULE_448","C4_Cancer_modules","C4_CM_367_MODULE_448",45,-1.6032,0.0042,0.029,0.7662,0.89,0.99,0.9779,0.48,0.98
"C7_Immunologic_signatures:C7_ALL_387_GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_387_GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP",199,-1.6032,0.0011,0.0012,1.0437,0.35,0.61,-1.7606,0,0.00024
"C2_Chemical_and_genetic_perturbations:C2_CGP_827_MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_827_MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN",161,-1.6031,0,0.033,0.9153,0.7,0.9,-1.2243,0.077,0.5
"C7_Immunologic_signatures:C7_ALL_231_GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP","C7_Immunologic_signatures","C7_ALL_231_GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP",195,-1.603,0,0.0012,0.7428,1,1,-1.7639,0,0.00025
"GO_BP:508082_GO_0045742_POSITIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","508082_GO_0045742_POSITIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",22,-1.603,0.015,0.063,-0.804,0.76,1,-1.0358,0.43,0.82
"C7_Immunologic_signatures:C7_ALL_609_GSE17721_LPS_VS_PAM3CSK4_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_609_GSE17721_LPS_VS_PAM3CSK4_8H_BMDM_UP",199,-1.603,0,0.0012,0.9571,0.56,0.88,-0.9458,0.63,0.86
"C7_Immunologic_signatures:C7_ALL_748_GSE17721_0_5H_VS_24H_CPG_BMDM_DN","C7_Immunologic_signatures","C7_ALL_748_GSE17721_0_5H_VS_24H_CPG_BMDM_DN",199,-1.603,0,0.0012,0.8776,0.79,1,-1.0519,0.31,0.61
"C7_Immunologic_signatures:C7_ALL_347_GSE15215_CD2_POS_VS_NEG_PDC_UP","C7_Immunologic_signatures","C7_ALL_347_GSE15215_CD2_POS_VS_NEG_PDC_UP",193,-1.603,0,0.0012,-1.3358,0.014,0.37,-1.454,0.0021,0.033
"KEGG_pathway:HSA04024_CAMP_SIGNALING_PATHWAY","KEGG_pathway","HSA04024_CAMP_SIGNALING_PATHWAY",198,-1.6029,0,0.016,-1.0926,0.23,0.71,-1.2241,0.068,0.35
"GO_MF:752654_GO_0097153_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_MF","752654_GO_0097153_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",15,-1.6029,0.023,0.096,-1.0235,0.42,0.89,-0.9248,0.57,0.85
"C7_Immunologic_signatures:C7_ALL_710_GSE17721_0_5H_VS_4H_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_710_GSE17721_0_5H_VS_4H_LPS_BMDM_DN",194,-1.6029,0.0011,0.0012,-0.8643,0.83,1,-0.9245,0.66,0.9
"C3_TF_targets:C3_TFT_344_V_MAF_Q6","C3_TF_targets","C3_TFT_344_V_MAF_Q6",251,-1.6028,0,0.01,-1.0386,0.35,0.67,-0.8481,0.93,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_3100_OHGUCHI_LIVER_HNF4A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3100_OHGUCHI_LIVER_HNF4A_TARGETS_UP",40,-1.6028,0.013,0.034,-1.3137,0.11,0.69,0.8471,0.75,1
"GO_BP:753013_GO_1900015_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE","GO_BP","753013_GO_1900015_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE",11,-1.6026,0.019,0.063,-1.6959,0.02,0.61,-1.2729,0.17,0.66
"GO_BP:512812_GO_0051962_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT","GO_BP","512812_GO_0051962_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT",331,-1.6024,0,0.063,-1.0463,0.29,0.97,0.996,0.44,0.86
"KEGG_compound:C03161_OXIDIZED_FLAVOPROTEIN","KEGG_compound","C03161_OXIDIZED_FLAVOPROTEIN",9,-1.6021,0.017,0.087,-1.2212,0.25,0.77,0.8158,0.74,0.89
"C7_Immunologic_signatures:C7_ALL_1176_GSE27786_LIN_NEG_VS_MONO_MAC_DN","C7_Immunologic_signatures","C7_ALL_1176_GSE27786_LIN_NEG_VS_MONO_MAC_DN",199,-1.602,0.0011,0.0012,-1.2111,0.071,0.79,-0.9087,0.74,0.93
"C3_TF_targets:C3_TFT_204_V_HFH8_01","C3_TF_targets","C3_TFT_204_V_HFH8_01",196,-1.6019,0,0.01,0.7888,0.96,1,-0.9717,0.56,0.81
"GO_BP:512749_GO_0051894_POSITIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY","GO_BP","512749_GO_0051894_POSITIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY",19,-1.6019,0.022,0.063,-1.1622,0.25,0.92,1.2961,0.13,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_128_LIU_VMYB_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_128_LIU_VMYB_TARGETS_UP",126,-1.6019,0.0036,0.034,0.6653,1,1,-1.4215,0.015,0.34
"KEGG_pathway:HSA05100_BACTERIAL_INVASION_OF_EPITHELIAL_CELLS","KEGG_pathway","HSA05100_BACTERIAL_INVASION_OF_EPITHELIAL_CELLS",78,-1.6019,0.005,0.016,0.9555,0.58,0.97,0.7929,0.87,1
"REACTOME:187105_REACT_25216_REGULATION_OF_IFNA_SIGNALING","REACTOME","187105_REACT_25216_REGULATION_OF_IFNA_SIGNALING",22,-1.6018,0.026,0.072,-0.6513,0.94,1,-1.671,0.01,0.23
"GO_BP:498833_GO_0021549_CEREBELLUM_DEVELOPMENT","GO_BP","498833_GO_0021549_CEREBELLUM_DEVELOPMENT",84,-1.6018,0.0026,0.063,-1.1646,0.19,0.92,-1.0528,0.37,0.81
"GO_BP:495075_GO_0014002_ASTROCYTE_DEVELOPMENT","GO_BP","495075_GO_0014002_ASTROCYTE_DEVELOPMENT",14,-1.6018,0.014,0.063,-0.9255,0.55,1,1.1687,0.26,0.72
"C7_Immunologic_signatures:C7_ALL_1702_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_1702_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN",200,-1.6016,0.0011,0.0012,1.1691,0.11,0.28,-0.9594,0.57,0.82
"GO_BP:487954_GO_0002064_EPITHELIAL_CELL_DEVELOPMENT","GO_BP","487954_GO_0002064_EPITHELIAL_CELL_DEVELOPMENT",188,-1.6015,0.0011,0.063,-0.9845,0.49,1,0.9288,0.63,0.92
"GO_MF:495515_GO_0015254_GLYCEROL_CHANNEL_ACTIVITY","GO_MF","495515_GO_0015254_GLYCEROL_CHANNEL_ACTIVITY",10,-1.6015,0.013,0.097,-0.7595,0.79,1,-0.8157,0.71,0.96
"GO_BP:751014_GO_0036092_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","751014_GO_0036092_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS",15,-1.6014,0.022,0.063,-1.1565,0.26,0.92,-1.2282,0.19,0.7
"KEGG_pathway:HSA04916_MELANOGENESIS","KEGG_pathway","HSA04916_MELANOGENESIS",100,-1.6012,0.0037,0.016,-1.0832,0.3,0.69,-0.9521,0.55,0.77
"REACTOME:106144_REACT_11040_BILE_ACID_AND_BILE_SALT_METABOLISM","REACTOME","106144_REACT_11040_BILE_ACID_AND_BILE_SALT_METABOLISM",34,-1.6012,0.013,0.072,0.8902,0.65,0.91,-1.0141,0.42,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_2490_SPIRA_SMOKERS_LUNG_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2490_SPIRA_SMOKERS_LUNG_CANCER_UP",37,-1.6011,0.013,0.034,1.8141,0.0022,0.039,-1.2795,0.13,0.45
"C7_Immunologic_signatures:C7_ALL_1902_GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1902_GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN",196,-1.601,0,0.0012,1.0605,0.28,0.56,2.0375,0,9e-05
"GO_BP:508246_GO_0045940_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS","GO_BP","508246_GO_0045940_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS",23,-1.6008,0.025,0.064,-1.2416,0.16,0.91,-0.8525,0.69,0.96
"C3_TF_targets:C3_TFT_217_V_OCT1_B","C3_TF_targets","C3_TFT_217_V_OCT1_B",252,-1.6008,0,0.01,-1.1527,0.15,0.45,-1.3473,0.015,0.25
"REACTOME:645311_REACT_120888_CS_DS_DEGRADATION","REACTOME","645311_REACT_120888_CS_DS_DEGRADATION",13,-1.6008,0.013,0.072,-0.9444,0.54,1,0.6703,0.89,1
"GO_CC:499802_GO_0030424_AXON","GO_CC","499802_GO_0030424_AXON",323,-1.6007,0,0.093,-0.9717,0.53,0.88,-1.1181,0.14,0.9
"GO_BP:518899_GO_2000252_NEGATIVE_REGULATION_OF_FEEDING_BEHAVIOR","GO_BP","518899_GO_2000252_NEGATIVE_REGULATION_OF_FEEDING_BEHAVIOR",6,-1.6006,0.021,0.064,0.8495,0.64,1,-1.1166,0.33,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2176_SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2176_SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP",179,-1.6004,0,0.034,0.768,0.98,1,-1.6461,0,0.22
"GO_BP:496184_GO_0046889_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS","GO_BP","496184_GO_0046889_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS",53,-1.6003,0.0067,0.064,-1.1737,0.2,0.91,-0.8491,0.73,0.96
"GO_BP:499861_GO_0030522_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","499861_GO_0030522_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY",191,-1.6003,0,0.064,-0.6724,1,1,-1.1413,0.14,0.75
"REACTOME:106186_REACT_1249_HISTIDINE_CATABOLISM","REACTOME","106186_REACT_1249_HISTIDINE_CATABOLISM",5,-1.6002,0.024,0.072,-0.6111,0.91,1,0.8222,0.67,1
"GO_BP:499151_GO_0021872_FOREBRAIN_GENERATION_OF_NEURONS","GO_BP","499151_GO_0021872_FOREBRAIN_GENERATION_OF_NEURONS",64,-1.6,0.0079,0.064,-1.247,0.11,0.91,1.3318,0.063,0.64
"GO_MF:487554_GO_0001637_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY","GO_MF","487554_GO_0001637_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY",26,-1.6,0.017,0.098,1.7431,0,0.11,1.5891,0.035,0.36
"GO_BP:492192_GO_0007431_SALIVARY_GLAND_DEVELOPMENT","GO_BP","492192_GO_0007431_SALIVARY_GLAND_DEVELOPMENT",31,-1.5999,0.0099,0.064,-1.1335,0.29,0.93,1.0397,0.38,0.82
"KEGG_pathway:HSA04080_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION","KEGG_pathway","HSA04080_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION",266,-1.5996,0,0.016,1.3145,0.014,0.34,1.8366,0,0.026
"GO_BP:513868_GO_0060312_REGULATION_OF_BLOOD_VESSEL_REMODELING","GO_BP","513868_GO_0060312_REGULATION_OF_BLOOD_VESSEL_REMODELING",5,-1.5996,0.023,0.064,-0.7333,0.77,1,-0.7931,0.7,0.99
"GO_MF:499363_GO_0022803_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","499363_GO_0022803_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",462,-1.5996,0,0.098,-1.5038,0,0.55,1.3106,0.0058,0.66
"GO_MF:489954_GO_0004623_PHOSPHOLIPASE_A2_ACTIVITY","GO_MF","489954_GO_0004623_PHOSPHOLIPASE_A2_ACTIVITY",27,-1.5995,0.016,0.097,1.0387,0.39,0.83,1.0385,0.37,0.85
"GO_BP:511623_GO_0050651_DERMATAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS","GO_BP","511623_GO_0050651_DERMATAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS",14,-1.5995,0.034,0.064,-1.0448,0.41,0.97,0.472,0.99,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_89_BIOCARTA_HIF_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_89_BIOCARTA_HIF_PATHWAY",15,-1.5994,0.022,0.09,-0.6317,0.93,1,-0.643,0.94,0.99
"GO_BP:751208_GO_0036289_PEPTIDYL_SERINE_AUTOPHOSPHORYLATION","GO_BP","751208_GO_0036289_PEPTIDYL_SERINE_AUTOPHOSPHORYLATION",6,-1.5994,0.01,0.064,-0.722,0.81,1,-1.0597,0.39,0.8
"GO_BP:491279_GO_0006335_DNA_REPLICATION_DEPENDENT_NUCLEOSOME_ASSEMBLY","GO_BP","491279_GO_0006335_DNA_REPLICATION_DEPENDENT_NUCLEOSOME_ASSEMBLY",31,-1.5994,0.013,0.064,-1.8179,0.0095,0.42,-1.6337,0.0061,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_3268_GUO_TARGETS_OF_IRS1_AND_IRS2","C2_Chemical_and_genetic_perturbations","C2_CGP_3268_GUO_TARGETS_OF_IRS1_AND_IRS2",97,-1.5993,0.0025,0.035,-0.7902,0.89,1,-1.281,0.079,0.45
"GO_BP:492504_GO_0008154_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION","GO_BP","492504_GO_0008154_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION",42,-1.5992,0.0083,0.064,-0.9416,0.58,1,-1.506,0.026,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1805_BROWNE_HCMV_INFECTION_18HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1805_BROWNE_HCMV_INFECTION_18HR_DN",173,-1.5992,0.0012,0.035,-0.9798,0.52,1,-1.2813,0.037,0.45
"C3_TF_targets:C3_TFT_96_V_OCT1_01","C3_TF_targets","C3_TFT_96_V_OCT1_01",249,-1.5992,0,0.01,-1.225,0.051,0.3,-1.0626,0.27,0.63
"GO_BP:492042_GO_0007263_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION","GO_BP","492042_GO_0007263_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION",18,-1.5988,0.018,0.064,0.7404,0.83,1,-0.7112,0.84,0.99
"C7_Immunologic_signatures:C7_ALL_1493_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP","C7_Immunologic_signatures","C7_ALL_1493_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP",196,-1.5987,0,0.0013,0.7642,0.99,1,-1.2432,0.054,0.21
"GO_BP:502772_GO_0033555_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS","GO_BP","502772_GO_0033555_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS",66,-1.5987,0.012,0.064,-1.3888,0.04,1,-1.0295,0.4,0.83
"GO_MF:502438_GO_0033218_AMIDE_BINDING","GO_MF","502438_GO_0033218_AMIDE_BINDING",225,-1.5987,0,0.097,0.8666,0.85,1,-1.0219,0.39,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1869_WENG_POR_TARGETS_GLOBAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1869_WENG_POR_TARGETS_GLOBAL_DN",22,-1.5987,0.012,0.035,0.6599,0.95,1,-1.4806,0.066,0.31
"GO_MF:487235_GO_0001012_RNA_POLYMERASE_II_REGULATORY_REGION_DNA_BINDING","GO_MF","487235_GO_0001012_RNA_POLYMERASE_II_REGULATORY_REGION_DNA_BINDING",375,-1.5986,0,0.097,-1.1971,0.057,0.8,-1.3724,0.0022,0.52
"GO_BP:492002_GO_0007204_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION","GO_BP","492002_GO_0007204_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION",154,-1.5984,0.0012,0.064,1.1522,0.16,0.84,1.2909,0.044,0.68
"GO_BP:751351_GO_0038093_FC_RECEPTOR_SIGNALING_PATHWAY","GO_BP","751351_GO_0038093_FC_RECEPTOR_SIGNALING_PATHWAY",215,-1.5984,0,0.064,-0.7539,0.99,1,-1.2971,0.03,0.64
"REACTOME:905991_REACT_169274_CELLULAR_SENESCENCE","REACTOME","905991_REACT_169274_CELLULAR_SENESCENCE",185,-1.5983,0,0.073,-1.2503,0.052,0.75,-1.5694,0,0.28
"GO_MF:499388_GO_0022843_VOLTAGE_GATED_CATION_CHANNEL_ACTIVITY","GO_MF","499388_GO_0022843_VOLTAGE_GATED_CATION_CHANNEL_ACTIVITY",147,-1.5983,0,0.097,-1.5495,0.0018,0.54,1.5494,0.0061,0.37
"GO_BP:488575_GO_0002702_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE","GO_BP","488575_GO_0002702_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE",57,-1.5983,0.0094,0.064,-1.245,0.13,0.91,-0.9586,0.49,0.88
"GO_BP:491734_GO_0006873_CELLULAR_ION_HOMEOSTASIS","GO_BP","491734_GO_0006873_CELLULAR_ION_HOMEOSTASIS",447,-1.5982,0,0.064,1.0891,0.19,0.92,1.2313,0.027,0.71
"C7_Immunologic_signatures:C7_ALL_1213_GSE27786_NKCELL_VS_NKTCELL_UP","C7_Immunologic_signatures","C7_ALL_1213_GSE27786_NKCELL_VS_NKTCELL_UP",199,-1.5981,0,0.0013,0.8506,0.89,1,-1.1275,0.18,0.42
"KEGG_pathway:HSA05203_VIRAL_CARCINOGENESIS","KEGG_pathway","HSA05203_VIRAL_CARCINOGENESIS",202,-1.598,0,0.016,-0.8759,0.81,0.99,-1.3427,0.024,0.22
"C7_Immunologic_signatures:C7_ALL_1402_GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1402_GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN",198,-1.5979,0,0.0013,1.6844,0,0.00081,-1.01,0.42,0.7
"C7_Immunologic_signatures:C7_ALL_1109_GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1109_GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP",185,-1.5978,0.0012,0.0013,-0.9356,0.64,1,-0.8979,0.74,0.95
"KEGG_pathway:HSA04660_T_CELL_RECEPTOR_SIGNALING_PATHWAY","KEGG_pathway","HSA04660_T_CELL_RECEPTOR_SIGNALING_PATHWAY",102,-1.5977,0.007,0.016,0.7405,0.97,1,-1.3262,0.051,0.24
"C2_Chemical_and_genetic_perturbations:C2_CGP_957_KHETCHOUMIAN_TRIM24_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_957_KHETCHOUMIAN_TRIM24_TARGETS_UP",46,-1.5977,0.013,0.035,0.7818,0.85,1,1.0455,0.38,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_2455_VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2455_VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN",134,-1.5977,0.0012,0.035,-0.9249,0.65,1,1.2338,0.078,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_1707_DELASERNA_MYOD_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1707_DELASERNA_MYOD_TARGETS_DN",55,-1.5976,0.0069,0.035,0.7681,0.9,1,0.9351,0.58,1
"GO_BP:504210_GO_0035020_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","504210_GO_0035020_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION",483,-1.5976,0,0.065,-1.2968,0.011,0.88,-1.2777,0.0086,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1935_WU_HBX_TARGETS_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1935_WU_HBX_TARGETS_2_UP",23,-1.5975,0.015,0.035,0.8984,0.62,0.93,-0.9846,0.46,0.78
"GO_BP:499584_GO_0030166_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS","GO_BP","499584_GO_0030166_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS",53,-1.5975,0.0053,0.065,0.7771,0.86,1,1.1188,0.27,0.75
"GO_BP:507250_GO_0044243_MULTICELLULAR_ORGANISMAL_CATABOLIC_PROCESS","GO_BP","507250_GO_0044243_MULTICELLULAR_ORGANISMAL_CATABOLIC_PROCESS",80,-1.5973,0.0013,0.065,-1.0564,0.34,0.97,1.3902,0.044,0.63
"GO_MF:495417_GO_0015144_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495417_GO_0015144_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",32,-1.5972,0.017,0.097,-1.1195,0.27,0.82,-1.0372,0.38,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_3127_JOHNSTONE_PARVB_TARGETS_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3127_JOHNSTONE_PARVB_TARGETS_1_DN",61,-1.5972,0.0027,0.035,-0.7003,0.95,1,1.0915,0.29,0.88
"GO_BP:516344_GO_0071420_CELLULAR_RESPONSE_TO_HISTAMINE","GO_BP","516344_GO_0071420_CELLULAR_RESPONSE_TO_HISTAMINE",8,-1.5972,0.018,0.065,0.7965,0.72,1,1.5434,0.037,0.52
"GO_BP:496191_GO_0016098_MONOTERPENOID_METABOLIC_PROCESS","GO_BP","496191_GO_0016098_MONOTERPENOID_METABOLIC_PROCESS",6,-1.5972,0.018,0.065,-0.9275,0.57,1,1.1973,0.27,0.72
"GO_BP:510610_GO_0048541_PEYER_S_PATCH_DEVELOPMENT","GO_BP","510610_GO_0048541_PEYER_S_PATCH_DEVELOPMENT",12,-1.597,0.025,0.065,-0.8598,0.64,1,-1.2715,0.18,0.66
"C7_Immunologic_signatures:C7_ALL_1617_GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1617_GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP",199,-1.597,0.0011,0.0013,1.305,0.017,0.097,-0.7554,0.99,1
"GO_BP:488795_GO_0002922_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE","GO_BP","488795_GO_0002922_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE",10,-1.5967,0.034,0.065,-1.3162,0.13,0.89,-1.5765,0.035,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_3022_WHITFIELD_CELL_CYCLE_G2_M","C2_Chemical_and_genetic_perturbations","C2_CGP_3022_WHITFIELD_CELL_CYCLE_G2_M",215,-1.5964,0,0.035,-1.0361,0.34,0.98,-1.3077,0.016,0.42
"GO_BP:511937_GO_0051004_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY","GO_BP","511937_GO_0051004_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY",35,-1.5964,0.013,0.065,0.8944,0.6,1,0.8328,0.73,0.99
"GO_BP:506522_GO_0043491_PROTEIN_KINASE_B_SIGNALING","GO_BP","506522_GO_0043491_PROTEIN_KINASE_B_SIGNALING",33,-1.5962,0.012,0.065,-0.8588,0.7,1,1.1845,0.22,0.72
"GO_BP:510787_GO_0048732_GLAND_DEVELOPMENT","GO_BP","510787_GO_0048732_GLAND_DEVELOPMENT",373,-1.5962,0,0.065,-0.8172,0.97,1,1.1133,0.17,0.75
"GO_BP:512004_GO_0051090_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY","GO_BP","512004_GO_0051090_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",342,-1.5962,0,0.065,-0.8083,0.97,1,-1.1691,0.063,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_965_GROSS_HYPOXIA_VIA_HIF1A_ONLY","C2_Chemical_and_genetic_perturbations","C2_CGP_965_GROSS_HYPOXIA_VIA_HIF1A_ONLY",8,-1.596,0.027,0.035,-1.0124,0.46,0.99,-0.8082,0.68,0.95
"GO_BP:503953_GO_0034754_CELLULAR_HORMONE_METABOLIC_PROCESS","GO_BP","503953_GO_0034754_CELLULAR_HORMONE_METABOLIC_PROCESS",103,-1.5959,0.005,0.065,-1.0387,0.37,0.98,-1.1821,0.13,0.73
"GO_BP:513958_GO_0060402_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL","GO_BP","513958_GO_0060402_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL",44,-1.5959,0.014,0.065,-0.8025,0.82,1,-1.0035,0.43,0.85
"GO_BP:500901_GO_0031652_POSITIVE_REGULATION_OF_HEAT_GENERATION","GO_BP","500901_GO_0031652_POSITIVE_REGULATION_OF_HEAT_GENERATION",8,-1.5959,0.032,0.065,-1.2129,0.23,0.88,0.9921,0.47,0.86
"C7_Immunologic_signatures:C7_ALL_207_GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_207_GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP",198,-1.5959,0,0.0013,0.8774,0.82,1,-1.4113,0.0085,0.055
"C6_Oncogenic_signatures:C6_ALL_176_KRAS_600_LUNG_BREAST_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_176_KRAS_600_LUNG_BREAST_UP_V1_DN",268,-1.5958,0,0.0052,-1.1327,0.15,0.52,-1.3085,0.018,0.3
"GO_BP:752807_GO_0097306_CELLULAR_RESPONSE_TO_ALCOHOL","GO_BP","752807_GO_0097306_CELLULAR_RESPONSE_TO_ALCOHOL",77,-1.5956,0.0064,0.065,0.8497,0.79,1,0.8003,0.86,1
"GO_BP:499233_GO_0021954_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT","GO_BP","499233_GO_0021954_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT",68,-1.5956,0.01,0.065,-1.3412,0.067,0.92,1.1766,0.17,0.72
"GO_BP:512093_GO_0051187_COFACTOR_CATABOLIC_PROCESS","GO_BP","512093_GO_0051187_COFACTOR_CATABOLIC_PROCESS",81,-1.5956,0.0054,0.065,1.0021,0.43,0.98,-1.5314,0.0083,0.53
"C7_Immunologic_signatures:C7_ALL_1513_GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP","C7_Immunologic_signatures","C7_ALL_1513_GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP",197,-1.5955,0,0.0013,-1.1371,0.16,1,-0.9141,0.69,0.92
"C4_Cancer_modules:C4_CM_262_MODULE_298","C4_Cancer_modules","C4_CM_262_MODULE_298",21,-1.5954,0.012,0.03,0.9507,0.51,0.78,-1.1577,0.25,0.44
"GO_BP:491790_GO_0006941_STRIATED_MUSCLE_CONTRACTION","GO_BP","491790_GO_0006941_STRIATED_MUSCLE_CONTRACTION",73,-1.5953,0.0039,0.065,-1.5346,0.015,0.77,-0.962,0.53,0.88
"C7_Immunologic_signatures:C7_ALL_1708_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_1708_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN",199,-1.5953,0,0.0013,1.103,0.21,0.44,-1.3946,0.0063,0.066
"GO_BP:486645_GO_0000103_SULFATE_ASSIMILATION","GO_BP","486645_GO_0000103_SULFATE_ASSIMILATION",8,-1.5952,0.027,0.065,-0.5683,0.96,1,-0.8475,0.66,0.96
"GO_BP:500163_GO_0030865_CORTICAL_CYTOSKELETON_ORGANIZATION","GO_BP","500163_GO_0030865_CORTICAL_CYTOSKELETON_ORGANIZATION",23,-1.5951,0.013,0.065,-0.8626,0.66,1,-0.8179,0.75,0.98
"KEGG_pathway:HSA05230_CENTRAL_CARBON_METABOLISM_IN_CANCER","KEGG_pathway","HSA05230_CENTRAL_CARBON_METABOLISM_IN_CANCER",67,-1.5951,0.0065,0.017,-1.0921,0.3,0.69,-0.8473,0.78,0.9
"GO_BP:503329_GO_0034123_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","503329_GO_0034123_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",14,-1.595,0.023,0.065,1.2072,0.22,0.78,0.86,0.63,0.97
"GO_BP:499569_GO_0030149_SPHINGOLIPID_CATABOLIC_PROCESS","GO_BP","499569_GO_0030149_SPHINGOLIPID_CATABOLIC_PROCESS",22,-1.5949,0.022,0.065,0.6853,0.92,1,1.2036,0.21,0.72
"C4_Cancer_modules:C4_CM_129_MODULE_134","C4_Cancer_modules","C4_CM_129_MODULE_134",29,-1.5947,0.015,0.03,1.665,0.0063,0.056,1.9296,0.002,0.022
"C2_Chemical_and_genetic_perturbations:C2_CGP_1317_SHEPARD_BMYB_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1317_SHEPARD_BMYB_TARGETS",71,-1.5946,0.0052,0.036,-0.9337,0.6,1,-1.2636,0.097,0.46
"GO_BP:505019_GO_0035850_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT","GO_BP","505019_GO_0035850_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",23,-1.5945,0.024,0.065,-0.8768,0.66,1,-0.8442,0.69,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1325_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1","C2_Chemical_and_genetic_perturbations","C2_CGP_1325_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1",9,-1.5944,0.012,0.036,1.1502,0.3,0.56,-1.0444,0.39,0.7
"WikiPathways:198812_WP474_ENDOCHONDRAL_OSSIFICATION","WikiPathways","198812_WP474_ENDOCHONDRAL_OSSIFICATION",64,-1.5942,0.0079,0.041,-1.246,0.12,0.85,0.9298,0.59,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_855_MURATA_VIRULENCE_OF_H_PILORI","C2_Chemical_and_genetic_perturbations","C2_CGP_855_MURATA_VIRULENCE_OF_H_PILORI",23,-1.5942,0.017,0.036,-1.1178,0.29,0.89,-1.3774,0.085,0.38
"C3_TF_targets:C3_TFT_340_V_HSF_Q6","C3_TF_targets","C3_TFT_340_V_HSF_Q6",199,-1.5942,0.0011,0.011,-1.2086,0.085,0.34,-1.519,0,1
"GO_BP:508020_GO_0045672_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION","GO_BP","508020_GO_0045672_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION",22,-1.5941,0.024,0.066,-1.7108,0.0038,0.72,-1.184,0.23,0.73
"KEGG_pathway:HSA04912_GNRH_SIGNALING_PATHWAY","KEGG_pathway","HSA04912_GNRH_SIGNALING_PATHWAY",91,-1.5941,0.0026,0.017,-1.018,0.4,0.84,-1.1142,0.27,0.49
"GO_BP:514093_GO_0060538_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT","GO_BP","514093_GO_0060538_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT",122,-1.594,0.0024,0.066,-1.0542,0.32,0.97,-1.0648,0.29,0.8
"GO_BP:499426_GO_0022898_REGULATION_OF_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","499426_GO_0022898_REGULATION_OF_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",157,-1.5939,0.0012,0.066,-1.4408,0.0069,0.91,-1.183,0.13,0.73
"GO_CC:490837_GO_0030139_ENDOCYTIC_VESICLE","GO_CC","490837_GO_0030139_ENDOCYTIC_VESICLE",223,-1.5939,0,0.098,1.0146,0.44,0.76,0.8177,0.93,1
"KEGG_compound:C05665_3_AMINOPROPANAL_BETA_AMINOPROPION_ALDEHYDE","KEGG_compound","C05665_3_AMINOPROPANAL_BETA_AMINOPROPION_ALDEHYDE",12,-1.5939,0.018,0.093,-0.9626,0.5,1,-1.1059,0.33,0.54
"REACTOME:366164_REACT_75913_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS","REACTOME","366164_REACT_75913_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS",48,-1.5938,0.0096,0.076,-0.79,0.82,1,-1.0553,0.34,0.77
"GO_BP:494836_GO_0010771_NEGATIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION","GO_BP","494836_GO_0010771_NEGATIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION",89,-1.5936,0.0049,0.066,-1.1359,0.23,0.93,-1.0239,0.4,0.83
"GO_BP:505801_GO_0042692_MUSCLE_CELL_DIFFERENTIATION","GO_BP","505801_GO_0042692_MUSCLE_CELL_DIFFERENTIATION",250,-1.5935,0,0.066,-1.1067,0.21,0.94,-1.0906,0.21,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2047_DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2047_DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP",77,-1.5934,0.0039,0.036,-1.7271,0,0.35,-1.7883,0,0.14
"C4_Cancer_modules:C4_CM_170_MODULE_180","C4_Cancer_modules","C4_CM_170_MODULE_180",114,-1.5934,0.0024,0.03,-1.3423,0.054,0.51,-1.3317,0.04,0.27
"GO_BP:849963_GO_1902262_APOPTOTIC_PROCESS_INVOLVED_IN_PATTERNING_OF_BLOOD_VESSELS","GO_BP","849963_GO_1902262_APOPTOTIC_PROCESS_INVOLVED_IN_PATTERNING_OF_BLOOD_VESSELS",6,-1.5933,0.031,0.066,0.9066,0.58,1,-0.583,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1502_RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1502_RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP",30,-1.5932,0.025,0.036,0.7235,0.89,1,-0.9825,0.49,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_88_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_88_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP",66,-1.593,0.0013,0.036,0.9392,0.56,0.88,-1.0066,0.41,0.74
"KEGG_pathway:HSA00052_GALACTOSE_METABOLISM","KEGG_pathway","HSA00052_GALACTOSE_METABOLISM",29,-1.5927,0.022,0.017,-1.3623,0.082,0.31,-1.7107,0.0039,0.041
"GO_BP:754153_GO_1901186_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY","GO_BP","754153_GO_1901186_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY",23,-1.5926,0.022,0.066,-0.7727,0.8,1,-0.9731,0.5,0.88
"GO_BP:495017_GO_0010952_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY","GO_BP","495017_GO_0010952_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY",150,-1.5926,0,0.066,0.9225,0.64,1,-1.3284,0.034,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_79_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_79_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN",153,-1.5925,0.0034,0.036,-1.1896,0.13,0.81,1.2323,0.079,0.74
"GO_CC:505708_GO_0042581_SPECIFIC_GRANULE","GO_CC","505708_GO_0042581_SPECIFIC_GRANULE",14,-1.5925,0.031,0.098,1.1243,0.31,0.61,0.812,0.73,1
"GO_MF:499378_GO_0022832_VOLTAGE_GATED_CHANNEL_ACTIVITY","GO_MF","499378_GO_0022832_VOLTAGE_GATED_CHANNEL_ACTIVITY",185,-1.5925,0.0012,0.1,-1.4465,0.0035,0.63,1.2665,0.055,0.65
"GO_BP:751848_GO_0044705_MULTI_ORGANISM_REPRODUCTIVE_BEHAVIOR","GO_BP","751848_GO_0044705_MULTI_ORGANISM_REPRODUCTIVE_BEHAVIOR",31,-1.5923,0.0087,0.066,0.7731,0.82,1,-0.9976,0.46,0.85
"C7_Immunologic_signatures:C7_ALL_642_GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_642_GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDM_DN",199,-1.5919,0,0.0014,0.8847,0.78,1,-0.9326,0.65,0.89
"C7_Immunologic_signatures:C7_ALL_66_GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_66_GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN",187,-1.5919,0,0.0014,-0.9443,0.61,1,-1.1793,0.096,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_169_RODRIGUES_DCC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_169_RODRIGUES_DCC_TARGETS_DN",121,-1.5919,0.0024,0.036,0.776,0.94,1,-1.3098,0.038,0.42
"GO_BP:507290_GO_0044283_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS","GO_BP","507290_GO_0044283_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS",410,-1.5918,0,0.066,-0.7982,0.98,1,-1.3794,0.0022,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_1879_ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1879_ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN",51,-1.5917,0.0055,0.036,-0.8946,0.67,1,-0.8372,0.77,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1360_CHESLER_BRAIN_D6MIT150_QTL_TRANS","C2_Chemical_and_genetic_perturbations","C2_CGP_1360_CHESLER_BRAIN_D6MIT150_QTL_TRANS",8,-1.5917,0.03,0.036,-1.1449,0.31,0.85,-1.3569,0.14,0.39
"GO_MF:490478_GO_0005244_VOLTAGE_GATED_ION_CHANNEL_ACTIVITY","GO_MF","490478_GO_0005244_VOLTAGE_GATED_ION_CHANNEL_ACTIVITY",185,-1.5917,0,0.1,-1.4349,0.0068,0.64,1.2737,0.046,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1544_CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70","C2_Chemical_and_genetic_perturbations","C2_CGP_1544_CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70",67,-1.5916,0.012,0.036,-1.1946,0.16,0.8,-0.9341,0.61,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_75_DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_75_DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN",68,-1.5914,0.0065,0.036,-0.8657,0.73,1,-0.9431,0.57,0.83
"GO_BP:512806_GO_0051956_NEGATIVE_REGULATION_OF_AMINO_ACID_TRANSPORT","GO_BP","512806_GO_0051956_NEGATIVE_REGULATION_OF_AMINO_ACID_TRANSPORT",9,-1.5914,0.02,0.067,-1.3552,0.12,0.96,-0.9213,0.55,0.91
"GO_CC:500923_GO_0031674_I_BAND","GO_CC","500923_GO_0031674_I_BAND",122,-1.5914,0,0.098,-1.0196,0.4,0.84,1.0105,0.44,0.99
"GO_CC:499970_GO_0030666_ENDOCYTIC_VESICLE_MEMBRANE","GO_CC","499970_GO_0030666_ENDOCYTIC_VESICLE_MEMBRANE",128,-1.5913,0,0.096,0.8747,0.78,0.91,1.1518,0.16,0.84
"GO_BP:512061_GO_0051151_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION","GO_BP","512061_GO_0051151_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION",6,-1.5913,0.016,0.067,-1.0941,0.36,0.95,-1.3218,0.2,0.63
"C3_TF_targets:C3_TFT_30_V_NFKAPPAB_01","C3_TF_targets","C3_TFT_30_V_NFKAPPAB_01",247,-1.591,0,0.011,-1.1943,0.1,0.36,-1.3433,0.013,0.26
"C2_Chemical_and_genetic_perturbations:C2_CGP_3266_VERNOCHET_ADIPOGENESIS","C2_Chemical_and_genetic_perturbations","C2_CGP_3266_VERNOCHET_ADIPOGENESIS",18,-1.5909,0.019,0.036,1.3876,0.09,0.3,-1.148,0.26,0.58
"C3_TF_targets:C3_TFT_512_RYTAAWNNNTGAY_UNKNOWN","C3_TF_targets","C3_TFT_512_RYTAAWNNNTGAY_UNKNOWN",60,-1.5908,0.0053,0.011,-1.3328,0.065,0.19,1.3066,0.082,0.64
"GO_BP:516420_GO_0071496_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS","GO_BP","516420_GO_0071496_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS",285,-1.5907,0,0.067,-0.7654,0.99,1,-0.8451,0.92,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1829_HAN_JNK_SINGALING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1829_HAN_JNK_SINGALING_UP",35,-1.5905,0.013,0.036,1.0133,0.4,0.78,-0.9817,0.48,0.78
"C7_Immunologic_signatures:C7_ALL_81_GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP","C7_Immunologic_signatures","C7_ALL_81_GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP",196,-1.5905,0.0011,0.0015,1.0098,0.42,0.72,-1.8554,0,9.7e-05
"C2_Chemical_and_genetic_perturbations:C2_CGP_1023_SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1023_SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN",29,-1.5904,0.019,0.036,-0.9869,0.48,1,-0.6912,0.93,0.99
"GO_BP:1184489_GO_1903963_ARACHIDONATE_TRANSPORT","GO_BP","1184489_GO_1903963_ARACHIDONATE_TRANSPORT",13,-1.5904,0.027,0.067,-0.6311,0.94,1,0.9565,0.53,0.9
"C6_Oncogenic_signatures:C6_ALL_47_P53_DN_V2_DN","C6_Oncogenic_signatures","C6_ALL_47_P53_DN_V2_DN",139,-1.5902,0.0023,0.0055,-0.9353,0.61,0.84,1.034,0.37,0.49
"REACTOME:119523_REACT_19279_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION","REACTOME","119523_REACT_19279_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION",14,-1.59,0.028,0.078,-1.2325,0.2,0.79,-0.8829,0.62,0.97
"KEGG_pathway:HSA04724_GLUTAMATERGIC_SYNAPSE","KEGG_pathway","HSA04724_GLUTAMATERGIC_SYNAPSE",115,-1.5897,0.0024,0.017,-1.227,0.1,0.52,1.0243,0.38,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_694_FARMER_BREAST_CANCER_BASAL_VS_LULMINAL","C2_Chemical_and_genetic_perturbations","C2_CGP_694_FARMER_BREAST_CANCER_BASAL_VS_LULMINAL",327,-1.5897,0,0.037,0.78,1,1,-1.4682,0.0021,0.31
"GO_MF:506117_GO_0043028_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_MF","506117_GO_0043028_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",44,-1.5897,0.0096,0.1,0.8073,0.82,1,-1.5115,0.019,0.42
"C7_Immunologic_signatures:C7_ALL_663_GSE17721_LPS_VS_CPG_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_663_GSE17721_LPS_VS_CPG_8H_BMDM_UP",196,-1.5896,0,0.0015,-0.7447,0.99,1,-1.2288,0.06,0.23
"C4_Cancer_modules:C4_CM_400_MODULE_511","C4_Cancer_modules","C4_CM_400_MODULE_511",38,-1.5895,0.015,0.031,-1.0538,0.38,0.72,-0.8684,0.69,0.89
"GO_MF:490458_GO_0005216_ION_CHANNEL_ACTIVITY","GO_MF","490458_GO_0005216_ION_CHANNEL_ACTIVITY",388,-1.5895,0,0.1,-1.572,0,0.48,1.2856,0.015,0.65
"GO_BP:505083_GO_0035914_SKELETAL_MUSCLE_CELL_DIFFERENTIATION","GO_BP","505083_GO_0035914_SKELETAL_MUSCLE_CELL_DIFFERENTIATION",50,-1.5895,0.012,0.068,-1.0937,0.31,0.95,-0.9378,0.56,0.9
"GO_MF:504770_GO_0035591_SIGNALING_ADAPTOR_ACTIVITY","GO_MF","504770_GO_0035591_SIGNALING_ADAPTOR_ACTIVITY",72,-1.5895,0.0064,0.1,1.0582,0.37,0.83,-0.9929,0.46,0.79
"GO_BP:512234_GO_0051350_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY","GO_BP","512234_GO_0051350_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY",27,-1.5889,0.0089,0.068,0.756,0.88,1,1.139,0.28,0.73
"C4_Cancer_modules:C4_CM_362_MODULE_439","C4_Cancer_modules","C4_CM_362_MODULE_439",21,-1.5888,0.011,0.031,1.2149,0.2,0.38,-1.5753,0.031,0.12
"GO_BP:491688_GO_0006820_ANION_TRANSPORT","GO_BP","491688_GO_0006820_ANION_TRANSPORT",484,-1.5888,0,0.068,-1.2808,0.013,0.89,-1.1924,0.048,0.74
"GO_BP:500117_GO_0030818_NEGATIVE_REGULATION_OF_CAMP_BIOSYNTHETIC_PROCESS","GO_BP","500117_GO_0030818_NEGATIVE_REGULATION_OF_CAMP_BIOSYNTHETIC_PROCESS",33,-1.5886,0.01,0.068,-0.7843,0.81,1,1.395,0.057,0.63
"WikiPathways:755439_WP2038_REGULATION_OF_MICROTUBULE_CYTOSKELETON","WikiPathways","755439_WP2038_REGULATION_OF_MICROTUBULE_CYTOSKELETON",44,-1.5885,0.013,0.043,-0.6265,0.97,1,-1.3593,0.068,0.39
"GO_BP:502498_GO_0033280_RESPONSE_TO_VITAMIN_D","GO_BP","502498_GO_0033280_RESPONSE_TO_VITAMIN_D",21,-1.5885,0.024,0.068,-0.7552,0.83,1,1.2708,0.15,0.69
"C7_Immunologic_signatures:C7_ALL_919_GSE22045_TREG_VS_TCONV_UP","C7_Immunologic_signatures","C7_ALL_919_GSE22045_TREG_VS_TCONV_UP",180,-1.5885,0.0023,0.0015,-0.9424,0.61,1,0.9023,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3148_STEGER_ADIPOGENESIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3148_STEGER_ADIPOGENESIS_UP",20,-1.5882,0.017,0.037,0.9504,0.52,0.86,-1.031,0.43,0.71
"C3_TF_targets:C3_TFT_141_V_OCT1_Q6","C3_TF_targets","C3_TFT_141_V_OCT1_Q6",256,-1.5881,0,0.011,-1.0793,0.25,0.6,-1.0423,0.31,0.65
"C7_Immunologic_signatures:C7_ALL_588_GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_588_GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_DN",198,-1.5881,0.0011,0.0016,-0.8101,0.92,1,-0.8538,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2823_GYORFFY_DOXORUBICIN_RESISTANCE","C2_Chemical_and_genetic_perturbations","C2_CGP_2823_GYORFFY_DOXORUBICIN_RESISTANCE",52,-1.588,0.0081,0.037,-1.2122,0.15,0.8,1.1561,0.22,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_736_BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX","C2_Chemical_and_genetic_perturbations","C2_CGP_736_BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX",17,-1.588,0.022,0.037,1.6379,0.023,0.12,-1.3614,0.1,0.38
"GO_BP:500533_GO_0031274_POSITIVE_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY","GO_BP","500533_GO_0031274_POSITIVE_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY",12,-1.5878,0.024,0.068,-1.0059,0.43,0.98,-1.3618,0.11,0.6
"GO_CC:496364_GO_0016324_APICAL_PLASMA_MEMBRANE","GO_CC","496364_GO_0016324_APICAL_PLASMA_MEMBRANE",255,-1.5877,0,0.099,-1.1588,0.11,0.68,1.1006,0.2,0.89
"REACTOME:160969_REACT_20580_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS","REACTOME","160969_REACT_20580_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS",9,-1.5877,0.025,0.079,-0.4545,1,1,0.6554,0.9,1
"C7_Immunologic_signatures:C7_ALL_52_GSE10325_BCELL_VS_LUPUS_BCELL_DN","C7_Immunologic_signatures","C7_ALL_52_GSE10325_BCELL_VS_LUPUS_BCELL_DN",199,-1.5876,0.0011,0.0016,1.7784,0,0.00022,-0.9784,0.49,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_851_MOHANKUMAR_TLX1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_851_MOHANKUMAR_TLX1_TARGETS_DN",185,-1.5873,0.0012,0.037,0.9909,0.48,0.81,1.4703,0.0019,0.53
"GO_MF:487205_GO_0000981_SEQUENCE_SPECIFIC_DNA_BINDING_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_ACTIVITY","GO_MF","487205_GO_0000981_SEQUENCE_SPECIFIC_DNA_BINDING_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_ACTIVITY",496,-1.5872,0,0.1,-1.128,0.13,0.81,-1.0501,0.27,0.75
"GO_BP:511461_GO_0050482_ARACHIDONIC_ACID_SECRETION","GO_BP","511461_GO_0050482_ARACHIDONIC_ACID_SECRETION",13,-1.5871,0.027,0.069,-0.6478,0.91,1,0.932,0.55,0.92
"GO_MF:496861_GO_0017040_CERAMIDASE_ACTIVITY","GO_MF","496861_GO_0017040_CERAMIDASE_ACTIVITY",5,-1.5871,0.022,0.1,-0.7681,0.75,1,-1.2222,0.23,0.57
"C3_TF_targets:C3_TFT_284_V_FOXO1_01","C3_TF_targets","C3_TFT_284_V_FOXO1_01",241,-1.587,0,0.011,-0.902,0.75,0.96,-1.0801,0.24,0.58
"WikiPathways:198789_WP428_WNT_SIGNALING_PATHWAY","WikiPathways","198789_WP428_WNT_SIGNALING_PATHWAY",60,-1.5869,0.0067,0.042,-1.2071,0.17,0.82,-0.9429,0.56,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_1469_ABBUD_LIF_SIGNALING_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1469_ABBUD_LIF_SIGNALING_2_UP",13,-1.5869,0.027,0.037,-0.882,0.61,1,-1.1479,0.28,0.58
"GO_MF:499384_GO_0022839_ION_GATED_CHANNEL_ACTIVITY","GO_MF","499384_GO_0022839_ION_GATED_CHANNEL_ACTIVITY",41,-1.5868,0.019,0.1,1.1685,0.21,0.73,1.22,0.17,0.7
"C7_Immunologic_signatures:C7_ALL_966_GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN","C7_Immunologic_signatures","C7_ALL_966_GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN",200,-1.5868,0,0.0016,1.7055,0,6e-04,-1.5803,0,0.0073
"REACTOME:366171_REACT_75790_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM","REACTOME","366171_REACT_75790_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM",301,-1.5868,0,0.079,1.1115,0.14,0.56,-1.3094,0.023,0.55
"GO_BP:499234_GO_0021955_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS","GO_BP","499234_GO_0021955_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS",29,-1.5866,0.015,0.069,-0.9102,0.6,1,-1.4482,0.051,0.55
"REACTOME:645258_REACT_120956_CELLULAR_RESPONSES_TO_STRESS","REACTOME","645258_REACT_120956_CELLULAR_RESPONSES_TO_STRESS",312,-1.5866,0,0.079,-0.9947,0.45,0.98,-1.6843,0,0.22
"GO_BP:488193_GO_0002320_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION","GO_BP","488193_GO_0002320_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION",11,-1.5864,0.031,0.069,-1.0612,0.38,0.96,-1.0046,0.41,0.84
"GO_BP:491522_GO_0006631_FATTY_ACID_METABOLIC_PROCESS","GO_BP","491522_GO_0006631_FATTY_ACID_METABOLIC_PROCESS",284,-1.5863,0,0.069,0.9226,0.72,1,-1.3701,0.002,0.59
"C4_Cancer_modules:C4_CM_187_MODULE_200","C4_Cancer_modules","C4_CM_187_MODULE_200",27,-1.5863,0.016,0.031,-0.8565,0.71,0.94,-0.9195,0.59,0.83
"GO_BP:511744_GO_0050773_REGULATION_OF_DENDRITE_DEVELOPMENT","GO_BP","511744_GO_0050773_REGULATION_OF_DENDRITE_DEVELOPMENT",88,-1.5862,0.0025,0.069,-1.4576,0.0073,0.88,-1.1944,0.14,0.74
"GO_BP:506517_GO_0043485_ENDOSOME_TO_PIGMENT_GRANULE_TRANSPORT","GO_BP","506517_GO_0043485_ENDOSOME_TO_PIGMENT_GRANULE_TRANSPORT",9,-1.5862,0.021,0.069,0.5208,0.98,1,0.7654,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1460_GUO_HEX_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1460_GUO_HEX_TARGETS_UP",81,-1.5859,0.0091,0.038,-0.885,0.69,1,-0.7726,0.92,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_50_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_50_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP",294,-1.5858,0,0.038,1.112,0.16,0.61,-1.5136,0,0.28
"C2_Chemical_and_genetic_perturbations:C2_CGP_224_LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_224_LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP",14,-1.5853,0.03,0.038,-1.0658,0.37,0.96,-0.9674,0.5,0.8
"WikiPathways:198813_WP410_DIURNALLY_REGULATED_GENES_WITH_CIRCADIAN_ORTHOLOGS","WikiPathways","198813_WP410_DIURNALLY_REGULATED_GENES_WITH_CIRCADIAN_ORTHOLOGS",50,-1.5852,0.0083,0.042,0.7047,0.96,1,-1.2414,0.15,0.48
"GO_MF:490426_GO_0005161_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BINDING","GO_MF","490426_GO_0005161_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BINDING",14,-1.5849,0.03,0.1,1.3725,0.11,0.49,1.0211,0.44,0.86
"REACTOME:119571_REACT_19305_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS","REACTOME","119571_REACT_19305_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS",96,-1.5847,0.0038,0.08,-1.5324,0.0072,0.42,-1.6768,0.0021,0.22
"GO_MF:752380_GO_0086008_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION","GO_MF","752380_GO_0086008_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION",7,-1.5846,0.028,0.1,0.721,0.82,1,-1.0599,0.4,0.74
"GO_BP:515502_GO_0070572_POSITIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION","GO_BP","515502_GO_0070572_POSITIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION",5,-1.5845,0.016,0.07,-0.8654,0.6,1,0.5204,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_458_GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_458_GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN",31,-1.5844,0.016,0.038,0.8916,0.66,0.93,0.9725,0.49,0.97
"GO_BP:504214_GO_0035024_NEGATIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","504214_GO_0035024_NEGATIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION",15,-1.5844,0.034,0.07,-1.0297,0.4,0.97,-0.863,0.64,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_807_DIRMEIER_LMP1_RESPONSE_LATE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_807_DIRMEIER_LMP1_RESPONSE_LATE_UP",57,-1.5844,0.0056,0.038,-0.588,0.99,1,0.7479,0.93,1
"C7_Immunologic_signatures:C7_ALL_1881_GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1881_GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP",195,-1.5842,0,0.0016,-0.8367,0.88,1,-1.1674,0.13,0.34
"C4_Cancer_gene_neighborhoods:C4_CGN_390_GNF2_PAK2","C4_Cancer_gene_neighborhoods","C4_CGN_390_GNF2_PAK2",28,-1.5842,0.021,0.026,1.1795,0.25,0.24,-1.186,0.22,0.46
"GO_BP:494122_GO_0010042_RESPONSE_TO_MANGANESE_ION","GO_BP","494122_GO_0010042_RESPONSE_TO_MANGANESE_ION",12,-1.5842,0.024,0.07,-0.8769,0.62,1,1.0445,0.43,0.81
"GO_BP:504823_GO_0035646_ENDOSOME_TO_MELANOSOME_TRANSPORT","GO_BP","504823_GO_0035646_ENDOSOME_TO_MELANOSOME_TRANSPORT",9,-1.5842,0.022,0.07,0.5398,0.98,1,0.7613,0.79,1
"C7_Immunologic_signatures:C7_ALL_850_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN","C7_Immunologic_signatures","C7_ALL_850_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN",193,-1.5841,0,0.0016,-1.0683,0.3,1,-1.831,0,0.00013
"C2_Chemical_and_genetic_perturbations:C2_CGP_2034_LOPES_METHYLATED_IN_COLON_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2034_LOPES_METHYLATED_IN_COLON_CANCER_UP",27,-1.5841,0.015,0.038,0.893,0.6,0.93,-1.5794,0.018,0.25
"GO_BP:987839_GO_1903038_NEGATIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION","GO_BP","987839_GO_1903038_NEGATIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION",78,-1.584,0.0052,0.07,-0.8405,0.81,1,0.8145,0.85,1
"GO_BP:508287_GO_0045986_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION","GO_BP","508287_GO_0045986_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION",14,-1.584,0.021,0.07,-0.675,0.89,1,-1.1387,0.28,0.75
"GO_BP:500553_GO_0031294_LYMPHOCYTE_COSTIMULATION","GO_BP","500553_GO_0031294_LYMPHOCYTE_COSTIMULATION",77,-1.584,0.0026,0.07,0.9623,0.54,1,-1.0723,0.32,0.8
"GO_MF:492451_GO_0008083_GROWTH_FACTOR_ACTIVITY","GO_MF","492451_GO_0008083_GROWTH_FACTOR_ACTIVITY",147,-1.584,0.0011,0.1,1.0098,0.44,0.87,1.2982,0.043,0.65
"GO_CC:499973_GO_0030670_PHAGOCYTIC_VESICLE_MEMBRANE","GO_CC","499973_GO_0030670_PHAGOCYTIC_VESICLE_MEMBRANE",53,-1.5839,0.0095,0.1,1.1063,0.26,0.64,0.9752,0.5,1
"C6_Oncogenic_signatures:C6_ALL_141_PDGF_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_141_PDGF_UP_V1_DN",125,-1.5839,0.0012,0.0059,1.0177,0.41,0.76,-1.0982,0.26,0.49
"GO_BP:850006_GO_1902305_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","850006_GO_1902305_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT",45,-1.5839,0.015,0.07,-1.3518,0.07,0.95,-1.7353,0.002,0.63
"GO_BP:494612_GO_0010543_REGULATION_OF_PLATELET_ACTIVATION","GO_BP","494612_GO_0010543_REGULATION_OF_PLATELET_ACTIVATION",27,-1.5838,0.023,0.07,1.2502,0.17,0.73,0.9864,0.48,0.87
"GO_BP:501538_GO_0032303_REGULATION_OF_ICOSANOID_SECRETION","GO_BP","501538_GO_0032303_REGULATION_OF_ICOSANOID_SECRETION",18,-1.5838,0.029,0.07,0.7537,0.8,1,1.018,0.42,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_462_BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_462_BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN",31,-1.5838,0.02,0.038,1.0327,0.4,0.75,1.0212,0.41,0.94
"KEGG_compound:C00103_D_GLUCOSE_1_PHOSPHATE_ALPHA_D_GLUCOSE_1_PHOSPHATE_CORI_ESTER_D_GLUCOSE_ALPHA_1_PHOSPHATE","KEGG_compound","C00103_D_GLUCOSE_1_PHOSPHATE_ALPHA_D_GLUCOSE_1_PHOSPHATE_CORI_ESTER_D_GLUCOSE_ALPHA_1_PHOSPHATE",10,-1.5835,0.021,0.1,-1.2241,0.2,0.78,-1.9556,0.0041,0.19
"C7_Immunologic_signatures:C7_ALL_330_GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_330_GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN",196,-1.5832,0.0011,0.0017,-1.1308,0.19,1,-1.0114,0.41,0.7
"GO_BP:488812_GO_0003014_RENAL_SYSTEM_PROCESS","GO_BP","488812_GO_0003014_RENAL_SYSTEM_PROCESS",99,-1.5831,0.0013,0.07,1.2336,0.077,0.75,1.0789,0.31,0.77
"GO_BP:784766_GO_1902042_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS","GO_BP","784766_GO_1902042_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS",25,-1.5831,0.027,0.07,0.9513,0.54,1,1.0011,0.44,0.86
"GO_BP:499326_GO_0022408_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION","GO_BP","499326_GO_0022408_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION",117,-1.5831,0.0025,0.07,-0.8065,0.86,1,0.8838,0.72,0.95
"GO_MF:489477_GO_0046873_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","489477_GO_0046873_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",398,-1.583,0,0.1,-1.5929,0,0.47,-1.091,0.21,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_1005_ROPERO_HDAC2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1005_ROPERO_HDAC2_TARGETS",107,-1.5829,0.0037,0.039,0.778,0.93,1,-0.8335,0.83,0.93
"GO_BP:499617_GO_0030207_CHONDROITIN_SULFATE_CATABOLIC_PROCESS","GO_BP","499617_GO_0030207_CHONDROITIN_SULFATE_CATABOLIC_PROCESS",13,-1.5828,0.025,0.07,-0.9319,0.56,1,0.8221,0.72,1
"GO_BP:507289_GO_0044282_SMALL_MOLECULE_CATABOLIC_PROCESS","GO_BP","507289_GO_0044282_SMALL_MOLECULE_CATABOLIC_PROCESS",271,-1.5827,0,0.07,0.9917,0.45,0.99,-1.2907,0.017,0.65
"C7_Immunologic_signatures:C7_ALL_1784_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1784_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN",199,-1.5827,0.0011,0.0017,-0.8657,0.83,1,-0.9248,0.66,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2948_MOOTHA_GLUCONEOGENESIS","C2_Chemical_and_genetic_perturbations","C2_CGP_2948_MOOTHA_GLUCONEOGENESIS",32,-1.5826,0.013,0.039,-0.8735,0.69,1,-0.8795,0.63,0.9
"C7_Immunologic_signatures:C7_ALL_1511_GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP","C7_Immunologic_signatures","C7_ALL_1511_GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP",191,-1.5825,0,0.0017,-1.2049,0.1,0.81,1.1381,0.17,0.92
"GO_BP:514396_GO_0060841_VENOUS_BLOOD_VESSEL_DEVELOPMENT","GO_BP","514396_GO_0060841_VENOUS_BLOOD_VESSEL_DEVELOPMENT",15,-1.5825,0.023,0.071,-0.8791,0.65,1,1.0955,0.33,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_1230_JI_METASTASIS_REPRESSED_BY_STK11","C2_Chemical_and_genetic_perturbations","C2_CGP_1230_JI_METASTASIS_REPRESSED_BY_STK11",27,-1.5825,0.025,0.039,1.1696,0.24,0.53,0.9943,0.44,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1441_YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1441_YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP",78,-1.5825,0.0052,0.039,-0.9999,0.44,1,-1.3166,0.07,0.41
"C7_Immunologic_signatures:C7_ALL_200_GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_200_GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN",198,-1.5824,0,0.0017,1.6725,0.0023,0.00096,-1.3068,0.028,0.13
"C6_Oncogenic_signatures:C6_ALL_184_KRAS_LUNG_BREAST_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_184_KRAS_LUNG_BREAST_UP_V1_DN",134,-1.5824,0.0024,0.006,-1.3156,0.043,0.37,-1.4756,0.0041,0.15
"C7_Immunologic_signatures:C7_ALL_1240_GSE2826_WT_VS_XID_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1240_GSE2826_WT_VS_XID_BCELL_DN",196,-1.5823,0,0.0017,0.9889,0.49,0.77,-0.9668,0.54,0.8
"GO_BP:516374_GO_0071450_CELLULAR_RESPONSE_TO_OXYGEN_RADICAL","GO_BP","516374_GO_0071450_CELLULAR_RESPONSE_TO_OXYGEN_RADICAL",14,-1.5823,0.02,0.071,0.6372,0.93,1,-1.3788,0.099,0.58
"C7_Immunologic_signatures:C7_ALL_1485_GSE360_L_MAJOR_VS_T_GONDII_MAC_UP","C7_Immunologic_signatures","C7_ALL_1485_GSE360_L_MAJOR_VS_T_GONDII_MAC_UP",187,-1.5821,0.0011,0.0017,-0.7698,0.97,1,0.8966,0.73,1
"C7_Immunologic_signatures:C7_ALL_1564_GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN","C7_Immunologic_signatures","C7_ALL_1564_GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN",189,-1.582,0,0.0017,-1.0673,0.29,1,-1.1903,0.11,0.3
"GO_BP:518333_GO_0090193_POSITIVE_REGULATION_OF_GLOMERULUS_DEVELOPMENT","GO_BP","518333_GO_0090193_POSITIVE_REGULATION_OF_GLOMERULUS_DEVELOPMENT",8,-1.5819,0.025,0.071,0.8411,0.66,1,1.4046,0.088,0.63
"REACTOME:685550_REACT_147814_DAP12_SIGNALING","REACTOME","685550_REACT_147814_DAP12_SIGNALING",158,-1.5819,0,0.082,-1.1701,0.13,0.86,-1.3038,0.046,0.55
"GO_BP:507548_GO_0045165_CELL_FATE_COMMITMENT","GO_BP","507548_GO_0045165_CELL_FATE_COMMITMENT",223,-1.5818,0,0.071,-1.032,0.36,0.98,1.2311,0.062,0.71
"GO_MF:489481_GO_0004012_PHOSPHOLIPID_TRANSLOCATING_ATPASE_ACTIVITY","GO_MF","489481_GO_0004012_PHOSPHOLIPID_TRANSLOCATING_ATPASE_ACTIVITY",15,-1.5818,0.025,0.1,-1.5201,0.055,0.54,-1.326,0.14,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_1293_LAMB_CCND1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1293_LAMB_CCND1_TARGETS",19,-1.5818,0.018,0.039,-1.1607,0.26,0.83,-1.6125,0.017,0.23
"C7_Immunologic_signatures:C7_ALL_783_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0_5H_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_783_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0_5H_CD4_TCELL_UP",173,-1.5816,0,0.0017,-1.6916,0,0.0033,0.9599,0.58,1
"GO_BP:948741_GO_1902713_REGULATION_OF_INTERFERON_GAMMA_SECRETION","GO_BP","948741_GO_1902713_REGULATION_OF_INTERFERON_GAMMA_SECRETION",5,-1.5816,0.016,0.071,1.0756,0.37,0.93,0.6239,0.89,1
"GO_BP:850044_GO_1990138_NEURON_PROJECTION_EXTENSION","GO_BP","850044_GO_1990138_NEURON_PROJECTION_EXTENSION",44,-1.5816,0.0098,0.071,-1.2425,0.14,0.91,-1.1618,0.22,0.73
"KEGG_pathway:HSA04973_CARBOHYDRATE_DIGESTION_AND_ABSORPTION","KEGG_pathway","HSA04973_CARBOHYDRATE_DIGESTION_AND_ABSORPTION",44,-1.5813,0.011,0.018,-1.2388,0.14,0.51,-1.5023,0.016,0.13
"C2_Chemical_and_genetic_perturbations:C2_CGP_1909_BAELDE_DIABETIC_NEPHROPATHY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1909_BAELDE_DIABETIC_NEPHROPATHY_DN",431,-1.5812,0,0.039,1.2858,0.01,0.4,-0.8891,0.88,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_55_KOBAYASHI_EGFR_SIGNALING_6HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_55_KOBAYASHI_EGFR_SIGNALING_6HR_DN",17,-1.5811,0.02,0.039,-1.6115,0.024,0.4,1.2394,0.19,0.75
"C7_Immunologic_signatures:C7_ALL_1754_GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1754_GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN",170,-1.5811,0.0012,0.0017,1.3488,0.02,0.063,-0.9367,0.63,0.88
"REACTOME:161044_REACT_21322_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS","REACTOME","161044_REACT_21322_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS",12,-1.5809,0.029,0.082,-0.8374,0.68,1,-0.8202,0.7,1
"GO_BP:495813_GO_0015677_COPPER_ION_IMPORT","GO_BP","495813_GO_0015677_COPPER_ION_IMPORT",9,-1.5808,0.021,0.071,0.5869,0.95,1,1.0329,0.41,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1557_ZHAN_MULTIPLE_MYELOMA_MS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1557_ZHAN_MULTIPLE_MYELOMA_MS_UP",46,-1.5808,0.0097,0.039,-0.8071,0.8,1,-1.1325,0.25,0.59
"C7_Immunologic_signatures:C7_ALL_542_GSE17721_LPS_VS_POLYIC_16H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_542_GSE17721_LPS_VS_POLYIC_16H_BMDM_DN",199,-1.5808,0,0.0017,0.9396,0.62,0.93,-0.888,0.8,0.97
"C7_Immunologic_signatures:C7_ALL_124_GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN","C7_Immunologic_signatures","C7_ALL_124_GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN",200,-1.5807,0.0011,0.0017,0.795,0.97,1,-1.3564,0.024,0.092
"KEGG_pathway:HSA00600_SPHINGOLIPID_METABOLISM","KEGG_pathway","HSA00600_SPHINGOLIPID_METABOLISM",47,-1.5806,0.019,0.018,-0.9288,0.59,0.97,-0.9562,0.55,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_3021_WHITFIELD_CELL_CYCLE_G2","C2_Chemical_and_genetic_perturbations","C2_CGP_3021_WHITFIELD_CELL_CYCLE_G2",180,-1.5806,0,0.039,-0.9321,0.65,1,-1.2423,0.077,0.48
"REACTOME:1127575_REACT_268571_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN","REACTOME","1127575_REACT_268571_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN",6,-1.5805,0.019,0.082,0.8793,0.61,0.92,-1.4256,0.09,0.4
"GO_MF:487654_GO_0001758_RETINAL_DEHYDROGENASE_ACTIVITY","GO_MF","487654_GO_0001758_RETINAL_DEHYDROGENASE_ACTIVITY",7,-1.5805,0.025,0.11,-1.0202,0.44,0.89,0.7914,0.75,1
"GO_BP:505041_GO_0035872_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY","GO_BP","505041_GO_0035872_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY",47,-1.5804,0.013,0.072,0.6729,0.98,1,-1.105,0.29,0.77
"C0_Hallmark:H_ALL_35_HALLMARK_GLYCOLYSIS","C0_Hallmark","H_ALL_35_HALLMARK_GLYCOLYSIS",199,-1.5803,0.0012,0.0046,-0.745,0.99,1,-1.1935,0.11,0.2
"REACTOME:119533_REACT_19195_ADHERENS_JUNCTIONS_INTERACTIONS","REACTOME","119533_REACT_19195_ADHERENS_JUNCTIONS_INTERACTIONS",29,-1.5803,0.019,0.082,0.8999,0.62,0.91,1.2555,0.16,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_672_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27","C2_Chemical_and_genetic_perturbations","C2_CGP_672_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27",10,-1.5803,0.031,0.039,0.7609,0.77,1,-1.1734,0.24,0.55
"GO_BP:982450_GO_1902882_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS","GO_BP","982450_GO_1902882_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS",49,-1.5802,0.016,0.072,1.3049,0.11,0.66,-0.9688,0.52,0.88
"GO_BP:499613_GO_0030203_GLYCOSAMINOGLYCAN_METABOLIC_PROCESS","GO_BP","499613_GO_0030203_GLYCOSAMINOGLYCAN_METABOLIC_PROCESS",160,-1.58,0.0012,0.072,-0.7303,0.99,1,1.1224,0.2,0.75
"GO_BP:488709_GO_0002836_POSITIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL","GO_BP","488709_GO_0002836_POSITIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL",11,-1.58,0.021,0.072,0.7931,0.74,1,0.6782,0.88,1
"C4_Cancer_modules:C4_CM_214_MODULE_235","C4_Cancer_modules","C4_CM_214_MODULE_235",79,-1.5799,0.0025,0.033,-1.1028,0.26,0.69,-1.1255,0.23,0.49
"GO_MF:487201_GO_0000977_RNA_POLYMERASE_II_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING","GO_MF","487201_GO_0000977_RNA_POLYMERASE_II_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING",371,-1.5799,0,0.11,-1.2301,0.036,0.84,-1.3918,0.0022,0.51
"C7_Immunologic_signatures:C7_ALL_1172_GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN","C7_Immunologic_signatures","C7_ALL_1172_GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN",193,-1.5799,0,0.0018,-1.3276,0.017,0.4,-1.1965,0.088,0.29
"C7_Immunologic_signatures:C7_ALL_611_GSE17721_LPS_VS_PAM3CSK4_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_611_GSE17721_LPS_VS_PAM3CSK4_12H_BMDM_UP",197,-1.5797,0,0.0018,-0.9703,0.55,1,-1.0114,0.43,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_1632_WEIGEL_OXIDATIVE_STRESS_RESPONSE","C2_Chemical_and_genetic_perturbations","C2_CGP_1632_WEIGEL_OXIDATIVE_STRESS_RESPONSE",35,-1.5797,0.019,0.039,-1.239,0.16,0.75,-1.1389,0.25,0.59
"GO_BP:494786_GO_0010721_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT","GO_BP","494786_GO_0010721_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT",240,-1.5797,0,0.072,-1.0821,0.23,0.95,1.1067,0.19,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2841_KOBAYASHI_EGFR_SIGNALING_24HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2841_KOBAYASHI_EGFR_SIGNALING_24HR_DN",250,-1.5795,0,0.039,1.01,0.41,0.78,-1.2101,0.068,0.51
"GO_BP:492183_GO_0007422_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT","GO_BP","492183_GO_0007422_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT",70,-1.5795,0.0039,0.072,-1.1238,0.24,0.94,-0.9961,0.44,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_1988_BURTON_ADIPOGENESIS_6","C2_Chemical_and_genetic_perturbations","C2_CGP_1988_BURTON_ADIPOGENESIS_6",188,-1.5794,0.0011,0.039,1.3696,0.0043,0.32,-1.364,0.017,0.39
"C7_Immunologic_signatures:C7_ALL_1663_GSE3982_NEUTROPHIL_VS_BASOPHIL_UP","C7_Immunologic_signatures","C7_ALL_1663_GSE3982_NEUTROPHIL_VS_BASOPHIL_UP",190,-1.5791,0.0011,0.0018,-0.9549,0.59,1,-0.8938,0.78,0.96
"C0_Hallmark:H_ALL_4_HALLMARK_MITOTIC_SPINDLE","C0_Hallmark","H_ALL_4_HALLMARK_MITOTIC_SPINDLE",200,-1.579,0,0.0045,-0.752,0.97,1,-1.2807,0.037,0.12
"C7_Immunologic_signatures:C7_ALL_579_GSE17721_PAM3CSK4_VS_CPG_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_579_GSE17721_PAM3CSK4_VS_CPG_24H_BMDM_UP",198,-1.579,0,0.0018,1.4884,0,0.014,-0.8578,0.88,1
"C3_TF_targets:C3_TFT_604_CTAWWWATA_V_RSRFC4_Q2","C3_TF_targets","C3_TFT_604_CTAWWWATA_V_RSRFC4_Q2",347,-1.5789,0,0.012,-1.3583,0.0016,0.19,-1.5144,0,0.81
"GO_BP:491683_GO_0006813_POTASSIUM_ION_TRANSPORT","GO_BP","491683_GO_0006813_POTASSIUM_ION_TRANSPORT",150,-1.5789,0.0024,0.072,-1.1263,0.18,0.94,1.2044,0.11,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_724_SCHEIDEREIT_IKK_INTERACTING_PROTEINS","C2_Chemical_and_genetic_perturbations","C2_CGP_724_SCHEIDEREIT_IKK_INTERACTING_PROTEINS",58,-1.5788,0.0068,0.039,-0.9996,0.43,1,-0.9308,0.61,0.84
"GO_MF:502169_GO_0032947_PROTEIN_COMPLEX_SCAFFOLD","GO_MF","502169_GO_0032947_PROTEIN_COMPLEX_SCAFFOLD",63,-1.5788,0.015,0.11,-0.9577,0.55,0.95,-0.9943,0.45,0.79
"GO_BP:512576_GO_0051701_INTERACTION_WITH_HOST","GO_BP","512576_GO_0051701_INTERACTION_WITH_HOST",126,-1.5786,0.0047,0.072,0.81,0.92,1,0.7819,0.94,1
"GO_BP:518420_GO_0090280_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT","GO_BP","518420_GO_0090280_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT",14,-1.5786,0.023,0.072,0.8011,0.73,1,1.335,0.14,0.65
"GO_MF:754527_GO_1901567_FATTY_ACID_DERIVATIVE_BINDING","GO_MF","754527_GO_1901567_FATTY_ACID_DERIVATIVE_BINDING",6,-1.5786,0.023,0.11,1.5464,0.048,0.34,1.469,0.077,0.48
"C7_Immunologic_signatures:C7_ALL_924_GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN","C7_Immunologic_signatures","C7_ALL_924_GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN",199,-1.5785,0.0011,0.0018,1.2799,0.039,0.12,-1.1958,0.087,0.29
"GO_BP:513972_GO_0060416_RESPONSE_TO_GROWTH_HORMONE","GO_BP","513972_GO_0060416_RESPONSE_TO_GROWTH_HORMONE",36,-1.5784,0.018,0.072,-0.824,0.76,1,-0.9097,0.61,0.92
"GO_BP:499471_GO_0030003_CELLULAR_CATION_HOMEOSTASIS","GO_BP","499471_GO_0030003_CELLULAR_CATION_HOMEOSTASIS",435,-1.5784,0,0.072,1.0974,0.18,0.9,1.2309,0.031,0.71
"GO_BP:491759_GO_0006898_RECEPTOR_MEDIATED_ENDOCYTOSIS","GO_BP","491759_GO_0006898_RECEPTOR_MEDIATED_ENDOCYTOSIS",192,-1.5784,0.0011,0.072,-0.8384,0.87,1,0.9315,0.66,0.92
"C7_Immunologic_signatures:C7_ALL_1550_GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1550_GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN",195,-1.5784,0.0011,0.0018,-0.7159,0.99,1,-0.9452,0.59,0.86
"GO_BP:498811_GO_0021527_SPINAL_CORD_ASSOCIATION_NEURON_DIFFERENTIATION","GO_BP","498811_GO_0021527_SPINAL_CORD_ASSOCIATION_NEURON_DIFFERENTIATION",13,-1.5784,0.022,0.072,0.9267,0.56,1,0.8796,0.64,0.95
"GO_BP:511828_GO_0050890_COGNITION","GO_BP","511828_GO_0050890_COGNITION",223,-1.5783,0,0.072,-1.1777,0.11,0.9,1.2169,0.062,0.71
"GO_BP:513952_GO_0060396_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","513952_GO_0060396_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY",26,-1.5781,0.018,0.072,0.5052,1,1,-0.6797,0.91,1
"C7_Immunologic_signatures:C7_ALL_605_GSE17721_LPS_VS_PAM3CSK4_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_605_GSE17721_LPS_VS_PAM3CSK4_4H_BMDM_UP",198,-1.578,0,0.0018,-0.6446,1,1,-1.1673,0.13,0.34
"GO_MF:777638_GO_1901981_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING","GO_MF","777638_GO_1901981_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING",99,-1.578,0.0074,0.11,-0.7429,0.95,1,-1.0805,0.28,0.71
"KEGG_compound:C00040_ACYL_COA_ACYL_COENZYME_A","KEGG_compound","C00040_ACYL_COA_ACYL_COENZYME_A",43,-1.578,0.011,0.11,-1.0476,0.35,0.99,-1.5101,0.02,0.22
"GO_BP:511740_GO_0050769_POSITIVE_REGULATION_OF_NEUROGENESIS","GO_BP","511740_GO_0050769_POSITIVE_REGULATION_OF_NEUROGENESIS",299,-1.578,0,0.072,-0.9928,0.46,1,1.0249,0.35,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1514_GREENBAUM_E2A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1514_GREENBAUM_E2A_TARGETS_DN",21,-1.5779,0.026,0.04,1.4979,0.042,0.21,-0.7706,0.81,0.97
"GO_MF:490479_GO_0005245_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY","GO_MF","490479_GO_0005245_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY",44,-1.5778,0.0042,0.11,-1.7853,0.0056,0.2,1.028,0.4,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_2982_DAZARD_UV_RESPONSE_CLUSTER_G24","C2_Chemical_and_genetic_perturbations","C2_CGP_2982_DAZARD_UV_RESPONSE_CLUSTER_G24",28,-1.5777,0.018,0.04,-1.411,0.058,0.58,-0.8409,0.73,0.93
"GO_CC:507303_GO_0044297_CELL_BODY","GO_CC","507303_GO_0044297_CELL_BODY",389,-1.5776,0,0.11,-1.2184,0.038,0.66,-0.9019,0.84,1
"GO_BP:510813_GO_0048762_MESENCHYMAL_CELL_DIFFERENTIATION","GO_BP","510813_GO_0048762_MESENCHYMAL_CELL_DIFFERENTIATION",114,-1.5776,0.0024,0.072,-0.9019,0.7,1,1.5797,0.0019,0.45
"GO_BP:754341_GO_1901379_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","754341_GO_1901379_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT",46,-1.5775,0.0098,0.073,-1.1416,0.24,0.93,-0.8254,0.78,0.97
"GO_BP:488589_GO_0002716_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY","GO_BP","488589_GO_0002716_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY",9,-1.5774,0.021,0.072,0.5566,0.97,1,0.5152,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_775_DAUER_STAT3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_775_DAUER_STAT3_TARGETS_DN",50,-1.5774,0.015,0.04,1.4931,0.021,0.21,-2.0509,0,0.027
"GO_BP:501758_GO_0032528_MICROVILLUS_ORGANIZATION","GO_BP","501758_GO_0032528_MICROVILLUS_ORGANIZATION",18,-1.5774,0.028,0.072,0.701,0.88,1,-1.3287,0.11,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_1140_AMIT_EGF_RESPONSE_40_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1140_AMIT_EGF_RESPONSE_40_MCF10A",19,-1.5773,0.028,0.04,-1.3432,0.13,0.7,-0.9191,0.57,0.85
"GO_MF:489934_GO_0004602_GLUTATHIONE_PEROXIDASE_ACTIVITY","GO_MF","489934_GO_0004602_GLUTATHIONE_PEROXIDASE_ACTIVITY",16,-1.5773,0.032,0.11,-0.7979,0.74,1,1.0143,0.43,0.85
"GO_MF:494641_GO_0010576_METALLOENZYME_REGULATOR_ACTIVITY","GO_MF","494641_GO_0010576_METALLOENZYME_REGULATOR_ACTIVITY",15,-1.5772,0.025,0.1,-1.3605,0.12,0.69,1.0164,0.42,0.85
"KEGG_compound:C00095_D_FRUCTOSE_LEVULOSE_FRUIT_SUGAR_D_ARABINO_HEXULOSE","KEGG_compound","C00095_D_FRUCTOSE_LEVULOSE_FRUIT_SUGAR_D_ARABINO_HEXULOSE",10,-1.5772,0.02,0.11,-1.1547,0.27,0.84,-1.2726,0.18,0.39
"C2_Chemical_and_genetic_perturbations:C2_CGP_249_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_249_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN",7,-1.5772,0.024,0.04,-0.8068,0.69,1,1.1434,0.29,0.83
"REACTOME:530736_REACT_115854_GRB2_EVENTS_IN_ERBB2_SIGNALING","REACTOME","530736_REACT_115854_GRB2_EVENTS_IN_ERBB2_SIGNALING",30,-1.5771,0.02,0.083,0.6386,0.96,1,-0.696,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1878_SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1878_SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN",18,-1.577,0.032,0.04,-0.5623,0.97,1,-1.7853,0,0.13
"GO_BP:754182_GO_1901215_NEGATIVE_REGULATION_OF_NEURON_DEATH","GO_BP","754182_GO_1901215_NEGATIVE_REGULATION_OF_NEURON_DEATH",153,-1.577,0.0012,0.073,-1.0258,0.38,0.98,-0.9417,0.62,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_2331_MATZUK_LUTEAL_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_2331_MATZUK_LUTEAL_GENES",8,-1.577,0.027,0.04,0.6068,0.93,1,-0.8523,0.64,0.92
"GO_BP:494875_GO_0010811_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION","GO_BP","494875_GO_0010811_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION",95,-1.5769,0.0051,0.073,0.8926,0.7,1,1.2775,0.073,0.69
"GO_MF:492692_GO_0008392_ARACHIDONIC_ACID_EPOXYGENASE_ACTIVITY","GO_MF","492692_GO_0008392_ARACHIDONIC_ACID_EPOXYGENASE_ACTIVITY",16,-1.5769,0.022,0.1,-1.9439,0,0.14,1.5517,0.037,0.38
"C3_TF_targets:C3_TFT_327_V_CEBPDELTA_Q6","C3_TF_targets","C3_TFT_327_V_CEBPDELTA_Q6",234,-1.5768,0.0011,0.012,-1.0547,0.31,0.64,-1.2218,0.062,0.31
"GO_BP:508014_GO_0045666_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION","GO_BP","508014_GO_0045666_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION",234,-1.5768,0,0.073,-1.0448,0.34,0.97,1.0461,0.32,0.81
"C7_Immunologic_signatures:C7_ALL_1813_GSE7852_LN_VS_THYMUS_TREG_UP","C7_Immunologic_signatures","C7_ALL_1813_GSE7852_LN_VS_THYMUS_TREG_UP",199,-1.5768,0.0023,0.0018,-0.882,0.8,1,-1.4737,0.0046,0.028
"C7_Immunologic_signatures:C7_ALL_1126_GSE2706_R848_VS_LPS_2H_STIM_DC_DN","C7_Immunologic_signatures","C7_ALL_1126_GSE2706_R848_VS_LPS_2H_STIM_DC_DN",179,-1.5767,0,0.0018,-1.1936,0.1,0.84,-1.5787,0.0021,0.0076
"C7_Immunologic_signatures:C7_ALL_766_GSE17974_0H_VS_0_5H_IN_VITRO_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_766_GSE17974_0H_VS_0_5H_IN_VITRO_ACT_CD4_TCELL_DN",183,-1.5767,0,0.0018,-1.4587,0.0037,0.12,-0.9514,0.6,0.85
"GO_CC:506115_GO_0043025_NEURONAL_CELL_BODY","GO_CC","506115_GO_0043025_NEURONAL_CELL_BODY",341,-1.5767,0,0.11,-1.3465,0.01,0.63,0.925,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1987_SU_PLACENTA","C2_Chemical_and_genetic_perturbations","C2_CGP_1987_SU_PLACENTA",26,-1.5766,0.018,0.04,-0.8163,0.76,1,-0.8759,0.66,0.9
"C3_TF_targets:C3_TFT_135_V_CEBP_Q2","C3_TF_targets","C3_TFT_135_V_CEBP_Q2",226,-1.5765,0,0.012,-1.2678,0.039,0.26,-1.2951,0.026,0.25
"REACTOME:106358_REACT_14819_PEPTIDE_LIGAND_BINDING_RECEPTORS","REACTOME","106358_REACT_14819_PEPTIDE_LIGAND_BINDING_RECEPTORS",175,-1.5765,0.0012,0.083,1.6685,0,0.061,1.7879,0,0.34
"GO_BP:488710_GO_0002837_REGULATION_OF_IMMUNE_RESPONSE_TO_TUMOR_CELL","GO_BP","488710_GO_0002837_REGULATION_OF_IMMUNE_RESPONSE_TO_TUMOR_CELL",11,-1.5764,0.036,0.073,0.8122,0.72,1,0.6937,0.86,1
"GO_MF:490300_GO_0019838_GROWTH_FACTOR_BINDING","GO_MF","490300_GO_0019838_GROWTH_FACTOR_BINDING",121,-1.5763,0.0036,0.1,-0.8005,0.9,1,1.1777,0.13,0.75
"GO_BP:498080_GO_0019228_NEURONAL_ACTION_POTENTIAL","GO_BP","498080_GO_0019228_NEURONAL_ACTION_POTENTIAL",29,-1.5762,0.022,0.073,-1.0491,0.38,0.97,1.0023,0.44,0.85
"C3_TF_targets:C3_TFT_288_V_CDC5_01","C3_TF_targets","C3_TFT_288_V_CDC5_01",243,-1.5761,0,0.012,1.0065,0.41,1,-0.9764,0.54,0.81
"GO_MF:498574_GO_0019763_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY","GO_MF","498574_GO_0019763_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY",7,-1.5761,0.024,0.1,-1.5318,0.05,0.54,-1.4713,0.088,0.42
"C1_Positional:C1_ALL_63_CHR4Q21","C1_Positional","C1_ALL_63_CHR4Q21",82,-1.5761,0.0089,0.25,1.1595,0.18,0.63,-1.1532,0.2,0.69
"GO_BP:518991_GO_2000345_REGULATION_OF_HEPATOCYTE_PROLIFERATION","GO_BP","518991_GO_2000345_REGULATION_OF_HEPATOCYTE_PROLIFERATION",8,-1.5761,0.032,0.073,-0.741,0.81,1,-1.6298,0.025,0.52
"GO_BP:488319_GO_0002446_NEUTROPHIL_MEDIATED_IMMUNITY","GO_BP","488319_GO_0002446_NEUTROPHIL_MEDIATED_IMMUNITY",23,-1.576,0.018,0.073,1.6175,0.015,0.28,-0.6813,0.92,1
"C1_Positional:C1_ALL_9_CHR1P13","C1_Positional","C1_ALL_9_CHR1P13",104,-1.576,0.0038,0.23,-1.1393,0.19,1,0.843,0.81,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_3319_FOSTER_KDM1A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3319_FOSTER_KDM1A_TARGETS_UP",252,-1.5759,0,0.04,1.0767,0.24,0.67,-1.2627,0.052,0.45
"C3_MicroRNA_targets:C3_MIR_164_CCCAGAG_MIR_326","C3_MicroRNA_targets","C3_MIR_164_CCCAGAG_MIR_326",152,-1.5758,0.0023,0.22,-1.2566,0.073,1,-1.164,0.12,1
"GO_BP:492328_GO_0007586_DIGESTION","GO_BP","492328_GO_0007586_DIGESTION",112,-1.5757,0.0062,0.073,-1.0393,0.38,0.98,1.148,0.17,0.73
"GO_BP:492669_GO_0008360_REGULATION_OF_CELL_SHAPE","GO_BP","492669_GO_0008360_REGULATION_OF_CELL_SHAPE",124,-1.5757,0.0024,0.073,1.0981,0.25,0.91,-0.8424,0.86,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2619_MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2619_MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN",65,-1.5756,0.0093,0.04,-1.1262,0.23,0.89,-1.0813,0.31,0.65
"GO_MF:492567_GO_0008227_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY","GO_MF","492567_GO_0008227_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY",49,-1.5754,0.011,0.1,-1.1042,0.31,0.84,1.5634,0.02,0.39
"C3_TF_targets:C3_TFT_483_V_T3R_Q6","C3_TF_targets","C3_TFT_483_V_T3R_Q6",240,-1.5753,0,0.012,-1.1316,0.17,0.48,-1.1642,0.11,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_2575_HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2575_HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP",35,-1.5753,0.012,0.04,-0.9533,0.51,1,-1.5933,0.018,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_534_MCBRYAN_TERMINAL_END_BUD_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_534_MCBRYAN_TERMINAL_END_BUD_UP",11,-1.5752,0.027,0.04,-1.0682,0.38,0.96,0.9196,0.57,1
"GO_MF:505429_GO_0042277_PEPTIDE_BINDING","GO_MF","505429_GO_0042277_PEPTIDE_BINDING",204,-1.5751,0,0.1,0.9508,0.62,0.93,-0.9326,0.69,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_550_SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_550_SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN",12,-1.5751,0.026,0.04,0.8751,0.6,0.95,1.5358,0.047,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_1168_SHIN_B_CELL_LYMPHOMA_CLUSTER_6","C2_Chemical_and_genetic_perturbations","C2_CGP_1168_SHIN_B_CELL_LYMPHOMA_CLUSTER_6",11,-1.575,0.017,0.04,-0.9399,0.55,1,-1.4041,0.088,0.35
"C4_Cancer_modules:C4_CM_407_MODULE_524","C4_Cancer_modules","C4_CM_407_MODULE_524",30,-1.575,0.018,0.034,0.9278,0.58,0.8,0.8485,0.73,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2932_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6","C2_Chemical_and_genetic_perturbations","C2_CGP_2932_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6",73,-1.575,0.0038,0.04,1.3378,0.058,0.35,-1.0604,0.36,0.68
"GO_BP:494539_GO_0010469_REGULATION_OF_RECEPTOR_ACTIVITY","GO_BP","494539_GO_0010469_REGULATION_OF_RECEPTOR_ACTIVITY",88,-1.575,0.0064,0.073,-1.2704,0.097,0.89,-0.9452,0.59,0.89
"GO_BP:506494_GO_0043462_REGULATION_OF_ATPASE_ACTIVITY","GO_BP","506494_GO_0043462_REGULATION_OF_ATPASE_ACTIVITY",44,-1.5748,0.0099,0.073,-1.2162,0.17,0.88,-1.0284,0.4,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_928_TOMLINS_PROSTATE_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_928_TOMLINS_PROSTATE_CANCER_UP",40,-1.5748,0.017,0.04,1.4144,0.055,0.28,-0.9391,0.57,0.83
"GO_BP:510808_GO_0048757_PIGMENT_GRANULE_MATURATION","GO_BP","510808_GO_0048757_PIGMENT_GRANULE_MATURATION",9,-1.5745,0.035,0.074,0.5481,0.96,1,0.7611,0.79,1
"GO_BP:1129477_GO_1903651_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT","GO_BP","1129477_GO_1903651_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT",218,-1.5745,0,0.074,0.9644,0.57,1,-1.233,0.065,0.7
"C7_Immunologic_signatures:C7_ALL_1040_GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN","C7_Immunologic_signatures","C7_ALL_1040_GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN",199,-1.5744,0.0023,0.0019,0.6432,1,1,-1.318,0.017,0.12
"GO_BP:500554_GO_0031295_T_CELL_COSTIMULATION","GO_BP","500554_GO_0031295_T_CELL_COSTIMULATION",69,-1.5744,0.0013,0.074,1.1835,0.14,0.8,-0.9491,0.55,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_308_KIM_WT1_TARGETS_8HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_308_KIM_WT1_TARGETS_8HR_DN",126,-1.5744,0.0024,0.04,-0.8495,0.86,1,0.9101,0.67,1
"GO_BP:492358_GO_0007617_MATING_BEHAVIOR","GO_BP","492358_GO_0007617_MATING_BEHAVIOR",22,-1.5743,0.016,0.074,0.9124,0.57,1,0.9459,0.53,0.91
"GO_BP:497101_GO_0018126_PROTEIN_HYDROXYLATION","GO_BP","497101_GO_0018126_PROTEIN_HYDROXYLATION",16,-1.5743,0.027,0.074,-1.0981,0.33,0.95,-1.1372,0.3,0.75
"GO_BP:510891_GO_0048841_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE","GO_BP","510891_GO_0048841_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE",15,-1.5742,0.031,0.073,-0.9769,0.48,1,1.0762,0.36,0.78
"GO_MF:490628_GO_0005527_MACROLIDE_BINDING","GO_MF","490628_GO_0005527_MACROLIDE_BINDING",16,-1.5741,0.031,0.1,-0.9166,0.59,0.97,-1.0994,0.34,0.7
"GO_MF:513534_GO_0055102_LIPASE_INHIBITOR_ACTIVITY","GO_MF","513534_GO_0055102_LIPASE_INHIBITOR_ACTIVITY",17,-1.574,0.024,0.1,1.0682,0.35,0.82,1.4511,0.075,0.51
"C4_Cancer_modules:C4_CM_181_MODULE_194","C4_Cancer_modules","C4_CM_181_MODULE_194",15,-1.5736,0.033,0.034,0.8737,0.64,0.89,-1.0972,0.33,0.54
"GO_BP:511650_GO_0050678_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION","GO_BP","511650_GO_0050678_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION",264,-1.5735,0.0011,0.074,-0.9932,0.47,1,1.1728,0.077,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2749_WOO_LIVER_CANCER_RECURRENCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2749_WOO_LIVER_CANCER_RECURRENCE_DN",80,-1.5732,0.0038,0.041,-1.0207,0.4,0.98,-1.2517,0.1,0.47
"KEGG_pathway:HSA05205_PROTEOGLYCANS_IN_CANCER","KEGG_pathway","HSA05205_PROTEOGLYCANS_IN_CANCER",201,-1.5729,0.0034,0.019,1.1535,0.15,0.65,1.1049,0.2,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1296_SHEPARD_BMYB_MORPHOLINO_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1296_SHEPARD_BMYB_MORPHOLINO_DN",195,-1.5729,0.0023,0.041,-0.9624,0.58,1,-1.4805,0.0042,0.31
"GO_BP:491730_GO_0006865_AMINO_ACID_TRANSPORT","GO_BP","491730_GO_0006865_AMINO_ACID_TRANSPORT",120,-1.5728,0.005,0.074,-1.2043,0.1,0.89,-1.0499,0.36,0.81
"GO_CC:490707_GO_0005641_NUCLEAR_ENVELOPE_LUMEN","GO_CC","490707_GO_0005641_NUCLEAR_ENVELOPE_LUMEN",9,-1.5728,0.018,0.11,0.9646,0.51,0.83,-0.9349,0.54,1
"C7_Immunologic_signatures:C7_ALL_596_GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_596_GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDM_DN",195,-1.5727,0.0011,0.002,0.9258,0.67,0.96,-0.7995,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1311_FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1311_FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN",41,-1.5726,0.0055,0.041,-0.5118,1,1,-0.5626,0.99,0.99
"C6_Oncogenic_signatures:C6_ALL_170_KRAS_300_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_170_KRAS_300_UP_V1_DN",131,-1.5726,0,0.0065,-1.0952,0.27,0.57,1.2313,0.09,0.23
"C2_Chemical_and_genetic_perturbations:C2_CGP_2973_ZEMBUTSU_SENSITIVITY_TO_CISPLATIN","C2_Chemical_and_genetic_perturbations","C2_CGP_2973_ZEMBUTSU_SENSITIVITY_TO_CISPLATIN",20,-1.5725,0.013,0.041,0.6301,0.95,1,1.2927,0.13,0.69
"KEGG_pathway:HSA00410_BETA_ALANINE_METABOLISM","KEGG_pathway","HSA00410_BETA_ALANINE_METABOLISM",30,-1.5724,0.025,0.019,-0.862,0.71,1,-1.4655,0.028,0.15
"WikiPathways:198911_WP696_BENZO_A_PYRENE_METABOLISM","WikiPathways","198911_WP696_BENZO_A_PYRENE_METABOLISM",9,-1.5724,0.036,0.046,-1.098,0.35,0.97,-1.1473,0.3,0.56
"WikiPathways:198865_WP143_FATTY_ACID_BETA_OXIDATION","WikiPathways","198865_WP143_FATTY_ACID_BETA_OXIDATION",34,-1.5722,0.014,0.046,0.5648,0.98,1,-0.9677,0.53,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2916_MIKKELSEN_ES_LCP_WITH_H3K4ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2916_MIKKELSEN_ES_LCP_WITH_H3K4ME3",135,-1.5722,0.0012,0.041,-1.4082,0.013,0.58,-0.9614,0.54,0.8
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_4_BIOCARTA_SRCRPTP_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_4_BIOCARTA_SRCRPTP_PATHWAY",11,-1.5722,0.034,0.11,-0.7233,0.82,1,-1.2558,0.19,0.56
"GO_BP:511853_GO_0050918_POSITIVE_CHEMOTAXIS","GO_BP","511853_GO_0050918_POSITIVE_CHEMOTAXIS",31,-1.572,0.026,0.075,1.4012,0.062,0.55,1.1472,0.25,0.73
"GO_CC:507559_GO_0045177_APICAL_PART_OF_CELL","GO_CC","507559_GO_0045177_APICAL_PART_OF_CELL",332,-1.572,0,0.11,-1.1483,0.13,0.7,1.1112,0.17,0.9
"GO_BP:512373_GO_0051495_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION","GO_BP","512373_GO_0051495_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION",153,-1.572,0,0.075,-1.0414,0.34,0.98,-0.9029,0.71,0.92
"GO_BP:495041_GO_0010976_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT","GO_BP","495041_GO_0010976_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT",161,-1.5718,0,0.075,-1.0477,0.31,0.97,0.9693,0.53,0.89
"REACTOME:105678_REACT_107_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS","REACTOME","105678_REACT_107_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS",38,-1.5716,0.01,0.087,-0.6322,0.96,1,0.7975,0.8,1
"GO_BP:912527_GO_0044818_MITOTIC_G2_M_TRANSITION_CHECKPOINT","GO_BP","912527_GO_0044818_MITOTIC_G2_M_TRANSITION_CHECKPOINT",20,-1.5715,0.028,0.075,0.7174,0.87,1,-0.9237,0.57,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1677_MCCLUNG_CREB1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1677_MCCLUNG_CREB1_TARGETS_DN",55,-1.5715,0.0069,0.041,-0.8415,0.75,1,-0.9012,0.63,0.88
"GO_BP:496938_GO_0046685_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE","GO_BP","496938_GO_0046685_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE",23,-1.5715,0.016,0.075,-1.0082,0.47,0.98,-1.1992,0.21,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1835_MCCLUNG_CREB1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1835_MCCLUNG_CREB1_TARGETS_UP",98,-1.5715,0.005,0.041,-0.8857,0.7,1,0.9717,0.49,0.96
"C4_Cancer_modules:C4_CM_275_MODULE_315","C4_Cancer_modules","C4_CM_275_MODULE_315",16,-1.5714,0.029,0.035,0.7961,0.75,0.97,-1.3827,0.1,0.23
"C2_Chemical_and_genetic_perturbations:C2_CGP_2579_HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2579_HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP",67,-1.5712,0.0093,0.041,-0.5225,1,1,-0.7839,0.87,0.96
"KEGG_compound:C00100_PROPANOYL_COA_PROPIONYL_COA_PROPIONYL_COENZYME_A","KEGG_compound","C00100_PROPANOYL_COA_PROPIONYL_COA_PROPIONYL_COENZYME_A",12,-1.5711,0.025,0.11,-0.6265,0.93,1,-1.5688,0.034,0.18
"GO_BP:754579_GO_1901623_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS","GO_BP","754579_GO_1901623_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS",20,-1.5711,0.015,0.075,1.1727,0.24,0.81,1.4164,0.07,0.62
"GO_BP:487607_GO_0001704_FORMATION_OF_PRIMARY_GERM_LAYER","GO_BP","487607_GO_0001704_FORMATION_OF_PRIMARY_GERM_LAYER",108,-1.571,0.0049,0.075,-1.097,0.26,0.94,1.1165,0.22,0.75
"C7_Immunologic_signatures:C7_ALL_1220_GSE27786_NKCELL_VS_MONO_MAC_DN","C7_Immunologic_signatures","C7_ALL_1220_GSE27786_NKCELL_VS_MONO_MAC_DN",196,-1.571,0,0.002,0.8277,0.93,1,-1.0899,0.23,0.52
"GO_CC:487787_GO_0001891_PHAGOCYTIC_CUP","GO_CC","487787_GO_0001891_PHAGOCYTIC_CUP",17,-1.5709,0.031,0.11,1.0469,0.39,0.72,-1.6227,0.021,0.39
"GO_BP:516341_GO_0071417_CELLULAR_RESPONSE_TO_ORGANONITROGEN_COMPOUND","GO_BP","516341_GO_0071417_CELLULAR_RESPONSE_TO_ORGANONITROGEN_COMPOUND",438,-1.5709,0,0.075,-0.8396,0.95,1,-1.0222,0.37,0.83
"GO_BP:501585_GO_0032350_REGULATION_OF_HORMONE_METABOLIC_PROCESS","GO_BP","501585_GO_0032350_REGULATION_OF_HORMONE_METABOLIC_PROCESS",30,-1.5708,0.013,0.075,-0.89,0.62,1,0.8613,0.68,0.97
"GO_BP:493721_GO_0009593_DETECTION_OF_CHEMICAL_STIMULUS","GO_BP","493721_GO_0009593_DETECTION_OF_CHEMICAL_STIMULUS",388,-1.5708,0,0.075,2.1565,0,0.0014,3.1004,0,0
"GO_BP:487432_GO_0044409_ENTRY_INTO_HOST","GO_BP","487432_GO_0044409_ENTRY_INTO_HOST",54,-1.5708,0.0066,0.075,-1.0374,0.38,0.98,-0.9362,0.58,0.9
"GO_MF:499382_GO_0022836_GATED_CHANNEL_ACTIVITY","GO_MF","499382_GO_0022836_GATED_CHANNEL_ACTIVITY",323,-1.5708,0,0.11,-1.461,0.0017,0.61,1.4399,0.0038,0.51
"GO_BP:513548_GO_0055119_RELAXATION_OF_CARDIAC_MUSCLE","GO_BP","513548_GO_0055119_RELAXATION_OF_CARDIAC_MUSCLE",12,-1.5707,0.027,0.075,-1.5024,0.048,0.82,-1.1473,0.28,0.74
"GO_BP:755318_GO_2001212_REGULATION_OF_VASCULOGENESIS","GO_BP","755318_GO_2001212_REGULATION_OF_VASCULOGENESIS",12,-1.5707,0.021,0.075,1.4405,0.078,0.51,1.184,0.23,0.72
"KEGG_pathway:HSA00640_PROPANOATE_METABOLISM","KEGG_pathway","HSA00640_PROPANOATE_METABOLISM",28,-1.5707,0.023,0.02,-0.837,0.71,1,-1.8507,0,0.028
"REACTOME:1183610_REACT_355311_CASP8_ACTIVITY_IS_INHIBITED","REACTOME","1183610_REACT_355311_CASP8_ACTIVITY_IS_INHIBITED",11,-1.5704,0.039,0.087,0.5728,0.95,1,-1.1023,0.34,0.7
"C7_Immunologic_signatures:C7_ALL_1322_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN","C7_Immunologic_signatures","C7_ALL_1322_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN",196,-1.5703,0,0.0021,-0.9744,0.52,1,-0.7516,0.99,1
"GO_BP:510973_GO_0048925_LATERAL_LINE_SYSTEM_DEVELOPMENT","GO_BP","510973_GO_0048925_LATERAL_LINE_SYSTEM_DEVELOPMENT",10,-1.5703,0.027,0.075,-1.3591,0.12,0.96,-1.1358,0.29,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1450_ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_1450_ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION",86,-1.5701,0.0062,0.041,-0.7488,0.93,1,-0.9102,0.65,0.87
"C4_Cancer_gene_neighborhoods:C4_CGN_256_GCM_PTPRD","C4_Cancer_gene_neighborhoods","C4_CGN_256_GCM_PTPRD",56,-1.5701,0.012,0.03,-1.1742,0.21,0.68,-1.5471,0.014,0.089
"C7_Immunologic_signatures:C7_ALL_749_GSE17721_4_VS_24H_CPG_BMDM_UP","C7_Immunologic_signatures","C7_ALL_749_GSE17721_4_VS_24H_CPG_BMDM_UP",199,-1.5701,0.0011,0.0021,-0.8385,0.87,1,-0.949,0.62,0.85
"KEGG_module:HSA_M00678_HEDGEHOG_SIGNALING","KEGG_module","HSA_M00678_HEDGEHOG_SIGNALING",10,-1.5701,0.028,0.17,-1.1349,0.33,1,-1.1568,0.26,0.56
"REACTOME:187088_REACT_25148_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON","REACTOME","187088_REACT_25148_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON",18,-1.5701,0.034,0.087,1.11,0.32,0.56,-1.3367,0.11,0.52
"GO_CC:507404_GO_0044456_SYNAPSE_PART","GO_CC","507404_GO_0044456_SYNAPSE_PART",432,-1.57,0,0.11,-1.1983,0.064,0.71,1.2613,0.016,0.76
"GO_BP:508851_GO_0046597_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL","GO_BP","508851_GO_0046597_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL",18,-1.5698,0.021,0.075,1.284,0.16,0.7,-1.2299,0.2,0.7
"C3_TF_targets:C3_TFT_199_V_HFH3_01","C3_TF_targets","C3_TFT_199_V_HFH3_01",185,-1.5697,0.0023,0.013,-0.9867,0.51,0.79,-0.9652,0.52,0.81
"GO_BP:849937_GO_1902236_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","849937_GO_1902236_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",17,-1.5697,0.024,0.076,-1.1789,0.23,0.91,-1.3898,0.1,0.58
"GO_BP:511645_GO_0050673_EPITHELIAL_CELL_PROLIFERATION","GO_BP","511645_GO_0050673_EPITHELIAL_CELL_PROLIFERATION",79,-1.5696,0.0076,0.075,-0.9359,0.59,1,0.8997,0.67,0.94
"GO_MF:495537_GO_0015293_SYMPORTER_ACTIVITY","GO_MF","495537_GO_0015293_SYMPORTER_ACTIVITY",134,-1.5695,0,0.11,-1.6598,0.0018,0.41,-1.2122,0.11,0.57
"GO_MF:487203_GO_0000979_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING","GO_MF","487203_GO_0000979_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING",49,-1.5694,0.012,0.11,-1.0083,0.46,0.89,-1.0955,0.28,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_392_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_392_CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN",50,-1.5693,0.0069,0.042,1.1037,0.29,0.62,-1.0704,0.34,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_2273_SMID_BREAST_CANCER_NORMAL_LIKE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2273_SMID_BREAST_CANCER_NORMAL_LIKE_DN",6,-1.5692,0.023,0.042,0.7531,0.78,1,-0.6423,0.89,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1249_ROZANOV_MMP14_CORRELATED","C2_Chemical_and_genetic_perturbations","C2_CGP_1249_ROZANOV_MMP14_CORRELATED",11,-1.5692,0.038,0.042,1.0762,0.34,0.67,-0.6133,0.94,0.99
"C3_TF_targets:C3_TFT_148_V_NFKB_C","C3_TF_targets","C3_TFT_148_V_NFKB_C",260,-1.5691,0.0011,0.013,-1.1356,0.15,0.47,-1.1282,0.13,0.48
"GO_BP:519397_GO_2000758_POSITIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION","GO_BP","519397_GO_2000758_POSITIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION",21,-1.5691,0.015,0.076,-1.1943,0.21,0.9,-1.6058,0.0097,0.52
"GO_BP:513953_GO_0060397_JAK_STAT_CASCADE_INVOLVED_IN_GROWTH_HORMONE_SIGNALING_PATHWAY","GO_BP","513953_GO_0060397_JAK_STAT_CASCADE_INVOLVED_IN_GROWTH_HORMONE_SIGNALING_PATHWAY",23,-1.5691,0.02,0.076,-0.6443,0.95,1,-0.8656,0.67,0.95
"C4_Cancer_modules:C4_CM_339_MODULE_404","C4_Cancer_modules","C4_CM_339_MODULE_404",22,-1.569,0.03,0.035,-1.5549,0.031,0.29,-1.271,0.16,0.31
"KEGG_compound:C00031_D_GLUCOSE_GRAPE_SUGAR_DEXTROSE_GLUCOSE_D_GLUCOPYRANOSE","KEGG_compound","C00031_D_GLUCOSE_GRAPE_SUGAR_DEXTROSE_GLUCOSE_D_GLUCOPYRANOSE",20,-1.569,0.03,0.11,-1.174,0.24,0.81,-1.395,0.079,0.29
"GO_BP:493581_GO_0009408_RESPONSE_TO_HEAT","GO_BP","493581_GO_0009408_RESPONSE_TO_HEAT",106,-1.569,0.0051,0.076,-1.0744,0.32,0.96,-1.7009,0,0.62
"C7_Immunologic_signatures:C7_ALL_1785_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1785_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP",196,-1.5689,0.0012,0.0021,0.7604,0.97,1,0.6375,1,1
"GO_BP:501641_GO_0032409_REGULATION_OF_TRANSPORTER_ACTIVITY","GO_BP","501641_GO_0032409_REGULATION_OF_TRANSPORTER_ACTIVITY",190,-1.5689,0,0.076,-1.2529,0.056,0.91,-1.1033,0.21,0.77
"GO_BP:511622_GO_0050650_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS","GO_BP","511622_GO_0050650_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS",27,-1.5689,0.026,0.076,-0.5612,0.99,1,0.9582,0.53,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_3263_YANG_BCL3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3263_YANG_BCL3_TARGETS_UP",357,-1.5688,0,0.042,0.9199,0.78,0.9,-1.1488,0.098,0.58
"GO_MF:490617_GO_0046870_CADMIUM_ION_BINDING","GO_MF","490617_GO_0046870_CADMIUM_ION_BINDING",6,-1.5686,0.03,0.11,-1.7114,0.0098,0.32,0.7093,0.83,1
"KEGG_compound:C00153_NICOTINAMIDE_NICOTINIC_ACID_AMIDE_NIACINAMIDE_VITAMIN_PP","KEGG_compound","C00153_NICOTINAMIDE_NICOTINIC_ACID_AMIDE_NIACINAMIDE_VITAMIN_PP",5,-1.5685,0.011,0.11,0.3923,1,1,-0.7985,0.68,0.85
"GO_MF:490161_GO_0004859_PHOSPHOLIPASE_INHIBITOR_ACTIVITY","GO_MF","490161_GO_0004859_PHOSPHOLIPASE_INHIBITOR_ACTIVITY",12,-1.5684,0.021,0.11,0.9543,0.52,0.92,1.2346,0.2,0.69
"REACTOME:477136_REACT_111176_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION","REACTOME","477136_REACT_111176_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION",12,-1.5684,0.028,0.088,0.9745,0.45,0.79,-1.1789,0.23,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_575_WONG_ENDMETRIUM_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_575_WONG_ENDMETRIUM_CANCER_DN",80,-1.5684,0.0078,0.042,1.1581,0.18,0.54,1.468,0.015,0.53
"GO_BP:491443_GO_0006547_HISTIDINE_METABOLIC_PROCESS","GO_BP","491443_GO_0006547_HISTIDINE_METABOLIC_PROCESS",7,-1.5683,0.028,0.076,-0.6228,0.91,1,-0.905,0.58,0.92
"GO_BP:496152_GO_0016053_ORGANIC_ACID_BIOSYNTHETIC_PROCESS","GO_BP","496152_GO_0016053_ORGANIC_ACID_BIOSYNTHETIC_PROCESS",284,-1.5683,0,0.076,0.8996,0.81,1,-1.5098,0,0.53
"C3_TF_targets:C3_TFT_92_V_HNF1_01","C3_TF_targets","C3_TFT_92_V_HNF1_01",236,-1.5681,0,0.013,-0.9965,0.48,0.76,1.302,0.013,0.6
"GO_BP:1022188_GO_1903202_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH","GO_BP","1022188_GO_1903202_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH",26,-1.5681,0.026,0.076,1.2393,0.16,0.75,-0.9508,0.53,0.89
"GO_BP:501192_GO_0031952_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION","GO_BP","501192_GO_0031952_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION",32,-1.5681,0.02,0.076,0.9417,0.54,1,1.0427,0.39,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_237_RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_237_RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN",361,-1.5681,0,0.042,1.7483,0,0.061,-2.0368,0,0.031
"C2_Chemical_and_genetic_perturbations:C2_CGP_890_YANG_BREAST_CANCER_ESR1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_890_YANG_BREAST_CANCER_ESR1_UP",36,-1.5679,0.013,0.042,-1.4951,0.048,0.46,-1.4269,0.054,0.33
"GO_BP:492347_GO_0007606_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS","GO_BP","492347_GO_0007606_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS",416,-1.5678,0,0.076,2.0179,0,0.01,3.0059,0,0
"GO_BP:500605_GO_0031346_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION","GO_BP","500605_GO_0031346_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION",215,-1.5678,0,0.076,-1.0081,0.41,0.98,-0.8965,0.77,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1591_MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1591_MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP",89,-1.5677,0.0063,0.042,-1.7998,0,0.33,-1.2281,0.12,0.5
"C7_Immunologic_signatures:C7_ALL_304_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN","C7_Immunologic_signatures","C7_ALL_304_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN",193,-1.5676,0,0.0022,-0.6668,1,1,-1.3741,0.0067,0.078
"C2_Chemical_and_genetic_perturbations:C2_CGP_3272_LE_NEURONAL_DIFFERENTIATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3272_LE_NEURONAL_DIFFERENTIATION_DN",19,-1.5675,0.027,0.042,-1.1422,0.28,0.86,-1.5841,0.021,0.25
"GO_BP:499626_GO_0030216_KERATINOCYTE_DIFFERENTIATION","GO_BP","499626_GO_0030216_KERATINOCYTE_DIFFERENTIATION",82,-1.5673,0.0078,0.076,1.1929,0.14,0.79,1.1606,0.19,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1580_MUNSHI_MULTIPLE_MYELOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1580_MUNSHI_MULTIPLE_MYELOMA_UP",80,-1.5672,0.0013,0.042,1.139,0.2,0.57,-0.7157,0.97,0.98
"C7_Immunologic_signatures:C7_ALL_50_GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_50_GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN",195,-1.567,0,0.0022,1.5485,0,0.0063,-1.2706,0.032,0.17
"C7_Immunologic_signatures:C7_ALL_1395_GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP","C7_Immunologic_signatures","C7_ALL_1395_GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP",198,-1.567,0,0.0022,0.8177,0.93,1,-1.6992,0,0.00082
"GO_BP:500099_GO_0030800_NEGATIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS","GO_BP","500099_GO_0030800_NEGATIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS",48,-1.5669,0.018,0.077,1.263,0.12,0.72,1.6938,0.002,0.42
"REACTOME:576264_REACT_118682_ACTIVATION_OF_MATRIX_METALLOPROTEINASES","REACTOME","576264_REACT_118682_ACTIVATION_OF_MATRIX_METALLOPROTEINASES",31,-1.5668,0.012,0.088,0.9806,0.45,0.78,-1.1245,0.28,0.68
"GO_BP:505307_GO_0042135_NEUROTRANSMITTER_CATABOLIC_PROCESS","GO_BP","505307_GO_0042135_NEUROTRANSMITTER_CATABOLIC_PROCESS",8,-1.5667,0.033,0.077,-1.1538,0.28,0.93,-1.3473,0.14,0.61
"GO_BP:499340_GO_0022604_REGULATION_OF_CELL_MORPHOGENESIS","GO_BP","499340_GO_0022604_REGULATION_OF_CELL_MORPHOGENESIS",437,-1.5667,0,0.077,-1.1343,0.13,0.93,-1.0086,0.44,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1148_AMIT_SERUM_RESPONSE_120_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1148_AMIT_SERUM_RESPONSE_120_MCF10A",65,-1.5667,0.01,0.042,-0.9647,0.5,1,0.8635,0.7,1
"GO_BP:491444_GO_0006548_HISTIDINE_CATABOLIC_PROCESS","GO_BP","491444_GO_0006548_HISTIDINE_CATABOLIC_PROCESS",5,-1.5665,0.028,0.077,-0.6222,0.91,1,0.8198,0.69,0.99
"REACTOME:833813_REACT_164011_REGULATION_BY_C_FLIP","REACTOME","833813_REACT_164011_REGULATION_BY_C_FLIP",11,-1.5664,0.036,0.088,0.5741,0.95,1,-1.0873,0.37,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_533_LANG_MYB_FAMILY_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_533_LANG_MYB_FAMILY_TARGETS",29,-1.5664,0.023,0.042,0.6173,0.97,1,-0.8896,0.63,0.89
"C7_Immunologic_signatures:C7_ALL_1132_GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN","C7_Immunologic_signatures","C7_ALL_1132_GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN",190,-1.5663,0.0011,0.0022,-0.9814,0.5,1,-0.9151,0.7,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_2119_KYNG_DNA_DAMAGE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2119_KYNG_DNA_DAMAGE_DN",192,-1.5663,0.0012,0.042,0.9878,0.49,0.81,-0.9633,0.56,0.8
"GO_BP:501623_GO_0032388_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT","GO_BP","501623_GO_0032388_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT",297,-1.5662,0,0.077,0.9381,0.69,1,-1.2395,0.031,0.69
"GO_BP:983731_GO_1903012_POSITIVE_REGULATION_OF_BONE_DEVELOPMENT","GO_BP","983731_GO_1903012_POSITIVE_REGULATION_OF_BONE_DEVELOPMENT",5,-1.5661,0.019,0.077,-1.0214,0.47,0.97,0.9077,0.58,0.93
"C3_TF_targets:C3_TFT_415_V_NFKB_Q6_01","C3_TF_targets","C3_TFT_415_V_NFKB_Q6_01",228,-1.5658,0,0.013,-1.4374,0.005,0.15,-1.5005,0,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_70_ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_70_ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP",178,-1.5658,0,0.042,-1.1647,0.14,0.83,0.8758,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_448_GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_448_GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN",89,-1.5658,0.0063,0.042,-1.349,0.039,0.68,-0.9402,0.57,0.83
"REACTOME:161001_REACT_22384_NETRIN_MEDIATED_REPULSION_SIGNALS","REACTOME","161001_REACT_22384_NETRIN_MEDIATED_REPULSION_SIGNALS",10,-1.5658,0.033,0.088,0.6553,0.89,1,0.8326,0.69,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_146_TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_146_TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN",16,-1.5658,0.028,0.042,-0.5974,0.96,1,-1.2288,0.2,0.49
"GO_BP:509146_GO_0046949_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS","GO_BP","509146_GO_0046949_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS",19,-1.5657,0.02,0.077,-0.9391,0.51,1,-1.6353,0.024,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_3083_FIGUEROA_AML_METHYLATION_CLUSTER_3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3083_FIGUEROA_AML_METHYLATION_CLUSTER_3_DN",39,-1.5657,0.011,0.042,-0.7771,0.83,1,-0.92,0.6,0.85
"GO_BP:518337_GO_0090197_POSITIVE_REGULATION_OF_CHEMOKINE_SECRETION","GO_BP","518337_GO_0090197_POSITIVE_REGULATION_OF_CHEMOKINE_SECRETION",8,-1.5656,0.028,0.077,-0.7149,0.82,1,-1.1051,0.34,0.77
"GO_BP:947899_GO_0098581_DETECTION_OF_EXTERNAL_BIOTIC_STIMULUS","GO_BP","947899_GO_0098581_DETECTION_OF_EXTERNAL_BIOTIC_STIMULUS",21,-1.5654,0.017,0.077,-0.7126,0.88,1,0.8927,0.61,0.95
"GO_BP:512754_GO_0051899_MEMBRANE_DEPOLARIZATION","GO_BP","512754_GO_0051899_MEMBRANE_DEPOLARIZATION",107,-1.5651,0.0074,0.077,-1.3619,0.028,0.97,1.1201,0.23,0.75
"C6_Oncogenic_signatures:C6_ALL_18_CYCLIN_D1_KE_V1_UP","C6_Oncogenic_signatures","C6_ALL_18_CYCLIN_D1_KE_V1_UP",184,-1.5651,0,0.007,-0.8705,0.8,0.96,-0.9469,0.6,0.68
"GO_MF:516736_GO_0071814_PROTEIN_LIPID_COMPLEX_BINDING","GO_MF","516736_GO_0071814_PROTEIN_LIPID_COMPLEX_BINDING",24,-1.565,0.021,0.11,1.0118,0.45,0.87,1.0974,0.32,0.81
"C3_TF_targets:C3_TFT_242_V_MEIS1AHOXA9_01","C3_TF_targets","C3_TFT_242_V_MEIS1AHOXA9_01",106,-1.5647,0.0037,0.013,-1.0227,0.43,0.71,0.9333,0.62,1
"GO_BP:507266_GO_0044259_MULTICELLULAR_ORGANISMAL_MACROMOLECULE_METABOLIC_PROCESS","GO_BP","507266_GO_0044259_MULTICELLULAR_ORGANISMAL_MACROMOLECULE_METABOLIC_PROCESS",89,-1.5645,0.0038,0.078,-1.133,0.19,0.93,1.3808,0.028,0.64
"WikiPathways:198856_WP500_GLYCOGEN_METABOLISM","WikiPathways","198856_WP500_GLYCOGEN_METABOLISM",37,-1.5645,0.013,0.048,-0.8461,0.73,1,-1.651,0.004,0.35
"GO_BP:502037_GO_0032814_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION","GO_BP","502037_GO_0032814_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION",26,-1.5644,0.016,0.078,-1.2179,0.17,0.88,-1.0254,0.4,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1774_YAMAZAKI_TCEB3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1774_YAMAZAKI_TCEB3_TARGETS_DN",212,-1.5644,0.0022,0.043,0.9443,0.62,0.87,-1.3342,0.035,0.41
"GO_CC:499482_GO_0030018_Z_DISC","GO_CC","499482_GO_0030018_Z_DISC",108,-1.5643,0.0072,0.11,-1.0067,0.43,0.85,1.0192,0.41,0.98
"GO_BP:508156_GO_0045835_NEGATIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION","GO_BP","508156_GO_0045835_NEGATIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION",10,-1.5642,0.041,0.078,-1.2185,0.23,0.88,-1.7095,0.011,0.66
"GO_BP:491523_GO_0006633_FATTY_ACID_BIOSYNTHETIC_PROCESS","GO_BP","491523_GO_0006633_FATTY_ACID_BIOSYNTHETIC_PROCESS",113,-1.5641,0,0.078,0.8561,0.84,1,-1.4217,0.014,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1764_CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1764_CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP",102,-1.5641,0.0064,0.043,-0.8511,0.77,1,-0.9109,0.66,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1115_BENPORATH_MYC_TARGETS_WITH_EBOX","C2_Chemical_and_genetic_perturbations","C2_CGP_1115_BENPORATH_MYC_TARGETS_WITH_EBOX",225,-1.5641,0,0.043,1,0.46,0.8,-1.4723,0,0.31
"REACTOME:119561_REACT_19320_SODIUM_CALCIUM_EXCHANGERS","REACTOME","119561_REACT_19320_SODIUM_CALCIUM_EXCHANGERS",9,-1.564,0.018,0.089,-0.6831,0.88,1,-0.8489,0.67,0.99
"GO_BP:516561_GO_0071637_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION","GO_BP","516561_GO_0071637_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION",6,-1.564,0.031,0.078,-1.0078,0.45,0.98,-0.8504,0.65,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1405_FERRANDO_LYL1_NEIGHBORS","C2_Chemical_and_genetic_perturbations","C2_CGP_1405_FERRANDO_LYL1_NEIGHBORS",15,-1.5639,0.032,0.043,0.6117,0.96,1,0.5544,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3280_PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3280_PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP",33,-1.5639,0.017,0.043,0.9134,0.61,0.91,-0.7223,0.94,0.98
"C7_Immunologic_signatures:C7_ALL_812_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_812_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN",184,-1.5639,0,0.0024,1.0252,0.37,0.66,1.1567,0.13,0.83
"C7_Immunologic_signatures:C7_ALL_1477_GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP","C7_Immunologic_signatures","C7_ALL_1477_GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP",192,-1.5638,0.0011,0.0024,1.1387,0.16,0.34,1.1293,0.16,0.93
"C7_Immunologic_signatures:C7_ALL_742_GSE17721_0_5H_VS_12H_CPG_BMDM_DN","C7_Immunologic_signatures","C7_ALL_742_GSE17721_0_5H_VS_12H_CPG_BMDM_DN",200,-1.5636,0.0011,0.0024,-0.9172,0.69,1,-1.3821,0.014,0.073
"C2_Chemical_and_genetic_perturbations:C2_CGP_1818_VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1","C2_Chemical_and_genetic_perturbations","C2_CGP_1818_VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1",38,-1.5635,0.017,0.043,1.2082,0.17,0.48,1.0462,0.38,0.92
"GO_CC:507315_GO_0044309_NEURON_SPINE","GO_CC","507315_GO_0044309_NEURON_SPINE",99,-1.5633,0.0026,0.11,-1.3176,0.053,0.65,-1.1654,0.16,0.85
"C7_Immunologic_signatures:C7_ALL_1443_GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP","C7_Immunologic_signatures","C7_ALL_1443_GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP",192,-1.5633,0,0.0024,0.8453,0.85,1,0.9321,0.63,1
"GO_CC:508926_GO_0046696_LIPOPOLYSACCHARIDE_RECEPTOR_COMPLEX","GO_CC","508926_GO_0046696_LIPOPOLYSACCHARIDE_RECEPTOR_COMPLEX",5,-1.5633,0.013,0.11,0.8502,0.66,0.92,-1.1327,0.36,0.9
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_140_BIOCARTA_MYOSIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_140_BIOCARTA_MYOSIN_PATHWAY",29,-1.5632,0.026,0.12,-0.8921,0.64,1,-1.0762,0.34,0.67
"GO_BP:508657_GO_0046394_CARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS","GO_BP","508657_GO_0046394_CARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS",284,-1.5632,0,0.078,0.8938,0.8,1,-1.511,0,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2584_HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2584_HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN",28,-1.5631,0.015,0.043,-0.5577,0.99,1,0.9395,0.57,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2795_NGO_MALIGNANT_GLIOMA_1P_LOH","C2_Chemical_and_genetic_perturbations","C2_CGP_2795_NGO_MALIGNANT_GLIOMA_1P_LOH",16,-1.5631,0.021,0.043,1.3209,0.14,0.37,-1.1182,0.33,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_3166_VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3166_VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP",14,-1.563,0.038,0.043,-0.5882,0.97,1,0.9708,0.48,0.96
"KEGG_reaction:R01786_ATP_ALPHA_D_GLUCOSE_6_PHOSPHOTRANSFERASE_ATP_ALPHA_D_GLUCOSE_ADP_ALPHA_D_GLUCOSE_6_PHOSPHATE","KEGG_reaction","R01786_ATP_ALPHA_D_GLUCOSE_6_PHOSPHOTRANSFERASE_ATP_ALPHA_D_GLUCOSE_ADP_ALPHA_D_GLUCOSE_6_PHOSPHATE",5,-1.5629,0.018,0.11,-1.1927,0.28,0.54,-1.2628,0.21,0.46
"GO_BP:752382_GO_0086010_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL","GO_BP","752382_GO_0086010_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL",38,-1.5628,0.0086,0.078,-1.3514,0.072,0.94,1.1004,0.31,0.76
"GO_BP:502031_GO_0032808_LACRIMAL_GLAND_DEVELOPMENT","GO_BP","502031_GO_0032808_LACRIMAL_GLAND_DEVELOPMENT",5,-1.5628,0.023,0.078,-1.3801,0.12,1,0.5046,0.98,1
"REACTOME:105700_REACT_13567_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE","REACTOME","105700_REACT_13567_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE",60,-1.5627,0.011,0.089,-1.1186,0.27,0.87,1.1149,0.27,0.95
"GO_BP:504766_GO_0035587_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY","GO_BP","504766_GO_0035587_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY",28,-1.5627,0.021,0.078,1.4203,0.05,0.53,1.0331,0.39,0.82
"GO_CC:517462_GO_0072557_IPAF_INFLAMMASOME_COMPLEX","GO_CC","517462_GO_0072557_IPAF_INFLAMMASOME_COMPLEX",5,-1.5626,0.021,0.11,-0.4178,1,1,0.8436,0.64,1
"GO_MF:498065_GO_0019210_KINASE_INHIBITOR_ACTIVITY","GO_MF","498065_GO_0019210_KINASE_INHIBITOR_ACTIVITY",63,-1.5625,0.0054,0.11,0.7586,0.9,1,-1.1003,0.27,0.7
"GO_BP:512756_GO_0051901_POSITIVE_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION","GO_BP","512756_GO_0051901_POSITIVE_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION",8,-1.5625,0.035,0.078,-1.0242,0.45,0.97,-0.9011,0.56,0.92
"C3_TF_targets:C3_TFT_301_V_STAT6_01","C3_TF_targets","C3_TFT_301_V_STAT6_01",250,-1.5623,0.0011,0.013,-1.0149,0.39,0.73,-1.0864,0.21,0.58
"GO_MF:982504_GO_1902936_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING","GO_MF","982504_GO_1902936_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING",64,-1.5623,0.012,0.11,-0.7646,0.88,1,-1.1874,0.16,0.59
"C7_Immunologic_signatures:C7_ALL_907_GSE20715_0H_VS_48H_OZONE_LUNG_UP","C7_Immunologic_signatures","C7_ALL_907_GSE20715_0H_VS_48H_OZONE_LUNG_UP",199,-1.5623,0,0.0024,0.8775,0.81,1,-1.3102,0.032,0.13
"GO_BP:499850_GO_0030511_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY","GO_BP","499850_GO_0030511_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY",23,-1.5623,0.022,0.079,0.5248,0.99,1,0.8997,0.58,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_2394_LIN_NPAS4_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2394_LIN_NPAS4_TARGETS_DN",67,-1.5622,0.008,0.043,-1.5219,0.028,0.44,1.0066,0.43,0.96
"C7_Immunologic_signatures:C7_ALL_1046_GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1046_GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN",197,-1.5621,0,0.0024,-0.7767,0.98,1,-1.0023,0.45,0.72
"GO_BP:506447_GO_0043409_NEGATIVE_REGULATION_OF_MAPK_CASCADE","GO_BP","506447_GO_0043409_NEGATIVE_REGULATION_OF_MAPK_CASCADE",133,-1.5621,0.0024,0.079,0.7756,0.95,1,1.0861,0.25,0.77
"GO_BP:513632_GO_0060074_SYNAPSE_MATURATION","GO_BP","513632_GO_0060074_SYNAPSE_MATURATION",6,-1.5621,0.02,0.079,-0.9491,0.49,1,-1.2105,0.24,0.72
"C7_Immunologic_signatures:C7_ALL_1890_GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN","C7_Immunologic_signatures","C7_ALL_1890_GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN",200,-1.5621,0.0011,0.0024,-0.5325,1,1,-1.1636,0.13,0.34
"GO_BP:512375_GO_0051497_NEGATIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY","GO_BP","512375_GO_0051497_NEGATIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY",10,-1.5619,0.036,0.079,0.6697,0.89,1,-0.6954,0.86,0.99
"GO_MF:512720_GO_0051861_GLYCOLIPID_BINDING","GO_MF","512720_GO_0051861_GLYCOLIPID_BINDING",24,-1.5618,0.016,0.11,-1.0279,0.39,0.88,-1.5669,0.028,0.38
"GO_MF:487206_GO_0000982_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY","GO_MF","487206_GO_0000982_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",267,-1.5617,0,0.11,-0.9714,0.5,0.94,-0.9793,0.52,0.8
"GO_CC:500844_GO_0031594_NEUROMUSCULAR_JUNCTION","GO_CC","500844_GO_0031594_NEUROMUSCULAR_JUNCTION",50,-1.5617,0.021,0.11,-1.3492,0.076,0.63,-1.1607,0.22,0.84
"REACTOME:645312_REACT_120870_PHOSPHOLIPID_METABOLISM","REACTOME","645312_REACT_120870_PHOSPHOLIPID_METABOLISM",140,-1.5616,0,0.09,0.6251,1,1,-0.8117,0.92,1
"GO_BP:513927_GO_0060371_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION","GO_BP","513927_GO_0060371_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION",8,-1.5616,0.025,0.079,-0.8261,0.68,1,1.3133,0.16,0.66
"C7_Immunologic_signatures:C7_ALL_1605_GSE3982_EOSINOPHIL_VS_TH2_UP","C7_Immunologic_signatures","C7_ALL_1605_GSE3982_EOSINOPHIL_VS_TH2_UP",192,-1.5615,0.0012,0.0025,-0.8493,0.86,1,0.8995,0.73,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2433_YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2433_YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP",144,-1.5613,0.0046,0.043,0.9346,0.63,0.88,-1.1015,0.22,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_2911_MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED","C2_Chemical_and_genetic_perturbations","C2_CGP_2911_MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED",57,-1.5612,0.011,0.043,-1.1341,0.25,0.87,1.3684,0.054,0.55
"GO_MF:490629_GO_0005528_FK506_BINDING","GO_MF","490629_GO_0005528_FK506_BINDING",16,-1.561,0.035,0.11,-0.9253,0.53,0.97,-1.0919,0.34,0.7
"C7_Immunologic_signatures:C7_ALL_1546_GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1546_GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN",199,-1.5609,0,0.0025,-0.7244,0.99,1,-0.7688,0.99,1
"GO_BP:512169_GO_0051283_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION","GO_BP","512169_GO_0051283_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION",32,-1.5608,0.02,0.079,-0.6238,0.96,1,-0.9072,0.58,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_3256_WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR","C2_Chemical_and_genetic_perturbations","C2_CGP_3256_WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR",152,-1.5608,0.0024,0.044,-0.749,0.98,1,-1.2312,0.085,0.49
"GO_BP:493606_GO_0009435_NAD_BIOSYNTHETIC_PROCESS","GO_BP","493606_GO_0009435_NAD_BIOSYNTHETIC_PROCESS",15,-1.5607,0.031,0.079,-1.0921,0.34,0.95,-1.5687,0.025,0.52
"GO_BP:488202_GO_0002329_PRE_B_CELL_DIFFERENTIATION","GO_BP","488202_GO_0002329_PRE_B_CELL_DIFFERENTIATION",6,-1.5607,0.015,0.079,-0.9062,0.56,1,-0.7816,0.73,1
"GO_BP:512151_GO_0051261_PROTEIN_DEPOLYMERIZATION","GO_BP","512151_GO_0051261_PROTEIN_DEPOLYMERIZATION",26,-1.5607,0.013,0.079,-0.9527,0.53,1,-1.6225,0.016,0.52
"GO_BP:495974_GO_0015849_ORGANIC_ACID_TRANSPORT","GO_BP","495974_GO_0015849_ORGANIC_ACID_TRANSPORT",233,-1.5607,0.0022,0.079,-1.2275,0.051,0.88,1.0024,0.44,0.85
"GO_CC:751048_GO_0036128_CATSPER_COMPLEX","GO_CC","751048_GO_0036128_CATSPER_COMPLEX",9,-1.5606,0.029,0.11,-1.7604,0.002,0.19,-1.0859,0.34,0.93
"GO_BP:755291_GO_2001185_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION","GO_BP","755291_GO_2001185_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",7,-1.5606,0.032,0.079,-1.315,0.17,0.88,-1.0013,0.47,0.85
"GO_BP:499665_GO_0030260_ENTRY_INTO_HOST_CELL","GO_BP","499665_GO_0030260_ENTRY_INTO_HOST_CELL",54,-1.5604,0.019,0.079,-1.022,0.4,0.97,-0.9512,0.54,0.89
"GO_MF:490487_GO_0005253_ANION_CHANNEL_ACTIVITY","GO_MF","490487_GO_0005253_ANION_CHANNEL_ACTIVITY",77,-1.5604,0.013,0.11,1.0427,0.36,0.84,1.0916,0.28,0.81
"GO_BP:752435_GO_0086069_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_COMMUNICATION","GO_BP","752435_GO_0086069_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_COMMUNICATION",12,-1.5604,0.033,0.079,1.1174,0.31,0.88,1.0423,0.39,0.81
"GO_BP:515260_GO_0070328_TRIGLYCERIDE_HOMEOSTASIS","GO_BP","515260_GO_0070328_TRIGLYCERIDE_HOMEOSTASIS",29,-1.5601,0.015,0.079,0.6477,0.96,1,1.4227,0.054,0.61
"GO_BP:513748_GO_0060192_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY","GO_BP","513748_GO_0060192_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY",16,-1.5601,0.026,0.079,-0.7686,0.8,1,1.1558,0.26,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1495_NADLER_OBESITY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1495_NADLER_OBESITY_DN",48,-1.56,0.016,0.044,1.2664,0.12,0.42,-1.019,0.43,0.73
"GO_CC:490676_GO_0005604_BASEMENT_MEMBRANE","GO_CC","490676_GO_0005604_BASEMENT_MEMBRANE",95,-1.56,0.0062,0.11,-0.9982,0.43,0.86,1.2246,0.1,0.82
"GO_BP:491533_GO_0006643_MEMBRANE_LIPID_METABOLIC_PROCESS","GO_BP","491533_GO_0006643_MEMBRANE_LIPID_METABOLIC_PROCESS",166,-1.56,0,0.079,-0.7738,0.95,1,0.8798,0.81,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1409_MANALO_HYPOXIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1409_MANALO_HYPOXIA_UP",204,-1.5599,0.0023,0.044,-0.862,0.85,1,-0.9461,0.56,0.83
"GO_MF:490281_GO_0004994_SOMATOSTATIN_RECEPTOR_ACTIVITY","GO_MF","490281_GO_0004994_SOMATOSTATIN_RECEPTOR_ACTIVITY",5,-1.5599,0.026,0.11,0.6941,0.85,1,-1.476,0.056,0.43
"GO_BP:512811_GO_0051961_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT","GO_BP","512811_GO_0051961_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT",213,-1.5598,0.0011,0.079,-1.0706,0.29,0.96,1.1426,0.15,0.73
"GO_BP:502458_GO_0033238_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS","GO_BP","502458_GO_0033238_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS",406,-1.5598,0,0.079,1.0661,0.25,0.93,-0.9495,0.67,0.89
"C1_Positional:C1_ALL_228_CHR7Q36","C1_Positional","C1_ALL_228_CHR7Q36",73,-1.5598,0.0052,0.24,-1.034,0.38,1,-1.6996,0,0.43
"GO_MF:490015_GO_0004697_PROTEIN_KINASE_C_ACTIVITY","GO_MF","490015_GO_0004697_PROTEIN_KINASE_C_ACTIVITY",16,-1.5597,0.032,0.11,-1.456,0.058,0.61,-1.2677,0.16,0.58
"KEGG_pathway:HSA00053_ASCORBATE_AND_ALDARATE_METABOLISM","KEGG_pathway","HSA00053_ASCORBATE_AND_ALDARATE_METABOLISM",27,-1.5597,0.022,0.022,1.5306,0.037,0.097,1.7538,0.004,0.045
"C2_Chemical_and_genetic_perturbations:C2_CGP_2770_MIKKELSEN_MEF_ICP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2770_MIKKELSEN_MEF_ICP_WITH_H3K27ME3",193,-1.5595,0,0.044,-1.5744,0,0.44,-1.5167,0,0.28
"REACTOME:105689_REACT_18334_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH","REACTOME","105689_REACT_18334_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH",70,-1.5595,0.004,0.091,-1.3529,0.053,0.59,-0.9829,0.47,0.87
"GO_BP:488756_GO_0002883_REGULATION_OF_HYPERSENSITIVITY","GO_BP","488756_GO_0002883_REGULATION_OF_HYPERSENSITIVITY",8,-1.5594,0.029,0.079,-1.1417,0.31,0.93,-1.2587,0.18,0.67
"C4_Cancer_modules:C4_CM_350_MODULE_419","C4_Cancer_modules","C4_CM_350_MODULE_419",34,-1.5593,0.02,0.038,1.0264,0.4,0.68,0.8268,0.76,1
"GO_BP:499473_GO_0072503_CELLULAR_DIVALENT_INORGANIC_CATION_HOMEOSTASIS","GO_BP","499473_GO_0072503_CELLULAR_DIVALENT_INORGANIC_CATION_HOMEOSTASIS",306,-1.5593,0.0011,0.079,1.1439,0.11,0.84,1.3617,0.0057,0.64
"GO_BP:1022192_GO_1903206_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_INDUCED_CELL_DEATH","GO_BP","1022192_GO_1903206_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_INDUCED_CELL_DEATH",11,-1.5591,0.026,0.08,1.4944,0.06,0.42,1.0864,0.36,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_2506_CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2506_CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP",49,-1.5591,0.011,0.044,-1.2926,0.096,0.7,-1.3922,0.056,0.36
"GO_BP:511973_GO_0051048_NEGATIVE_REGULATION_OF_SECRETION","GO_BP","511973_GO_0051048_NEGATIVE_REGULATION_OF_SECRETION",161,-1.5589,0.0012,0.08,0.9187,0.67,1,-1.0379,0.35,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1676_SESTO_RESPONSE_TO_UV_C6","C2_Chemical_and_genetic_perturbations","C2_CGP_1676_SESTO_RESPONSE_TO_UV_C6",39,-1.5589,0.01,0.044,0.8665,0.68,0.96,-1.438,0.051,0.33
"GO_BP:515305_GO_0070373_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE","GO_BP","515305_GO_0070373_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE",38,-1.5589,0.024,0.08,0.8229,0.74,1,1.1151,0.31,0.75
"KEGG_module:HSA_M00003_GLUCONEOGENESIS_OXALOACETATE_FRUCTOSE_6P","KEGG_module","HSA_M00003_GLUCONEOGENESIS_OXALOACETATE_FRUCTOSE_6P",17,-1.5589,0.017,0.17,-1.1545,0.26,1,-0.8456,0.7,0.91
"KEGG_pathway:HSA04115_P53_SIGNALING_PATHWAY","KEGG_pathway","HSA04115_P53_SIGNALING_PATHWAY",68,-1.5588,0.0092,0.022,-0.733,0.95,1,-1.1338,0.22,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_3170_VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3170_VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN",15,-1.5585,0.028,0.044,0.791,0.76,0.99,0.9459,0.54,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1893_NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1893_NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP",20,-1.5585,0.028,0.044,-0.9753,0.5,1,1.1192,0.32,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_741_LI_CISPLATIN_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_741_LI_CISPLATIN_RESISTANCE_UP",27,-1.5584,0.012,0.044,-1.0346,0.4,0.97,0.9548,0.51,0.99
"C1_Positional:C1_ALL_142_CHR7P12","C1_Positional","C1_ALL_142_CHR7P12",19,-1.5582,0.031,0.23,1.1924,0.23,0.61,1.198,0.22,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_603_RODRIGUES_NTN1_AND_DCC_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_603_RODRIGUES_NTN1_AND_DCC_TARGETS",34,-1.5581,0.02,0.044,-1.1728,0.22,0.82,-0.818,0.76,0.94
"GO_CC:498676_GO_0019898_EXTRINSIC_COMPONENT_OF_MEMBRANE","GO_CC","498676_GO_0019898_EXTRINSIC_COMPONENT_OF_MEMBRANE",243,-1.5579,0,0.11,-0.9964,0.46,0.86,-1.0987,0.22,0.92
"GO_BP:512176_GO_0051291_PROTEIN_HETEROOLIGOMERIZATION","GO_BP","512176_GO_0051291_PROTEIN_HETEROOLIGOMERIZATION",109,-1.5579,0.0049,0.08,-1.3312,0.068,0.9,-1.2964,0.052,0.64
"GO_MF:492412_GO_0071813_LIPOPROTEIN_PARTICLE_BINDING","GO_MF","492412_GO_0071813_LIPOPROTEIN_PARTICLE_BINDING",24,-1.5579,0.021,0.11,1.0108,0.45,0.87,1.0961,0.32,0.81
"C7_Immunologic_signatures:C7_ALL_904_GSE20715_0H_VS_6H_OZONE_LUNG_DN","C7_Immunologic_signatures","C7_ALL_904_GSE20715_0H_VS_6H_OZONE_LUNG_DN",195,-1.5578,0,0.0026,-0.8028,0.92,1,0.845,0.88,1
"GO_BP:501926_GO_0032700_NEGATIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION","GO_BP","501926_GO_0032700_NEGATIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION",11,-1.5576,0.027,0.08,-1.0201,0.44,0.97,-0.7119,0.82,0.99
"GO_MF:750779_GO_0001227_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION","GO_MF","750779_GO_0001227_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION",120,-1.5575,0.0061,0.11,-1.2847,0.057,0.81,-1.4662,0.0062,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_2883_ZHAN_MULTIPLE_MYELOMA_HP_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2883_ZHAN_MULTIPLE_MYELOMA_HP_DN",45,-1.5574,0.021,0.044,0.8283,0.78,0.98,-0.6989,0.94,0.99
"GO_BP:491008_GO_0006022_AMINOGLYCAN_METABOLIC_PROCESS","GO_BP","491008_GO_0006022_AMINOGLYCAN_METABOLIC_PROCESS",169,-1.5572,0.0012,0.081,0.9185,0.68,1,1.1687,0.12,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1565_YAGI_AML_SURVIVAL","C2_Chemical_and_genetic_perturbations","C2_CGP_1565_YAGI_AML_SURVIVAL",128,-1.5572,0,0.045,-0.825,0.85,1,-1.078,0.29,0.66
"GO_CC:487624_GO_0001725_STRESS_FIBER","GO_CC","487624_GO_0001725_STRESS_FIBER",57,-1.5572,0.011,0.11,-0.8338,0.78,0.99,-0.8244,0.79,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_859_WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_859_WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP",8,-1.5572,0.015,0.044,-0.7823,0.72,1,-1.1914,0.28,0.53
"WikiPathways:198817_WP368_MITOCHONDRIAL_LC_FATTY_ACID_BETA_OXIDATION","WikiPathways","198817_WP368_MITOCHONDRIAL_LC_FATTY_ACID_BETA_OXIDATION",16,-1.5571,0.025,0.05,1.0231,0.42,1,-1.0383,0.4,0.63
"GO_BP:754674_GO_1901723_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT","GO_BP","754674_GO_1901723_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",5,-1.5571,0.026,0.081,-0.7632,0.74,1,1.2904,0.17,0.68
"REACTOME:105680_REACT_13579_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS","REACTOME","105680_REACT_13579_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS",11,-1.5571,0.03,0.092,1.2792,0.17,0.35,1.1744,0.25,0.86
"GO_BP:504521_GO_0035337_FATTY_ACYL_COA_METABOLIC_PROCESS","GO_BP","504521_GO_0035337_FATTY_ACYL_COA_METABOLIC_PROCESS",31,-1.557,0.023,0.081,-0.9655,0.52,1,-1.8151,0.0041,0.55
"GO_BP:496456_GO_0016486_PEPTIDE_HORMONE_PROCESSING","GO_BP","496456_GO_0016486_PEPTIDE_HORMONE_PROCESSING",34,-1.5569,0.011,0.081,1.1222,0.25,0.88,0.9843,0.49,0.87
"WikiPathways:198822_WP1772_APOPTOSIS_MODULATION_AND_SIGNALING","WikiPathways","198822_WP1772_APOPTOSIS_MODULATION_AND_SIGNALING",79,-1.5568,0.0026,0.05,-0.859,0.75,1,-0.9371,0.6,0.79
"C4_Cancer_modules:C4_CM_430_MODULE_575","C4_Cancer_modules","C4_CM_430_MODULE_575",12,-1.5568,0.036,0.039,1.7139,0.019,0.043,-0.9425,0.54,0.78
"GO_BP:505702_GO_0042574_RETINAL_METABOLIC_PROCESS","GO_BP","505702_GO_0042574_RETINAL_METABOLIC_PROCESS",13,-1.5566,0.032,0.081,-1.4446,0.068,0.91,0.7467,0.83,1
"C7_Immunologic_signatures:C7_ALL_1326_GSE30083_SP1_VS_SP2_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1326_GSE30083_SP1_VS_SP2_THYMOCYTE_DN",195,-1.5563,0.0011,0.0027,-0.9333,0.62,1,-1.2023,0.079,0.28
"C2_Chemical_and_genetic_perturbations:C2_CGP_1369_TARTE_PLASMA_CELL_VS_PLASMABLAST_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1369_TARTE_PLASMA_CELL_VS_PLASMABLAST_DN",307,-1.5561,0,0.045,1.7916,0,0.045,-1.343,0.013,0.4
"GO_BP:508588_GO_0046323_GLUCOSE_IMPORT","GO_BP","508588_GO_0046323_GLUCOSE_IMPORT",8,-1.556,0.033,0.081,-1.5193,0.058,0.79,0.8047,0.71,1
"GO_BP:513957_GO_0060401_CYTOSOLIC_CALCIUM_ION_TRANSPORT","GO_BP","513957_GO_0060401_CYTOSOLIC_CALCIUM_ION_TRANSPORT",45,-1.5559,0.0044,0.081,-0.787,0.84,1,-0.9182,0.57,0.91
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_112_BIOCARTA_PYK2_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_112_BIOCARTA_PYK2_PATHWAY",28,-1.5559,0.022,0.12,-0.8522,0.68,1,-1.1784,0.22,0.58
"GO_BP:510275_GO_0048145_REGULATION_OF_FIBROBLAST_PROLIFERATION","GO_BP","510275_GO_0048145_REGULATION_OF_FIBROBLAST_PROLIFERATION",76,-1.5557,0.012,0.081,1.3317,0.073,0.63,1.1403,0.21,0.73
"REACTOME:106482_REACT_12599_ERK_MAPK_TARGETS","REACTOME","106482_REACT_12599_ERK_MAPK_TARGETS",21,-1.5557,0.02,0.093,-0.87,0.63,1,-0.6752,0.93,1
"GO_BP:751425_GO_0038169_SOMATOSTATIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","751425_GO_0038169_SOMATOSTATIN_RECEPTOR_SIGNALING_PATHWAY",5,-1.5556,0.026,0.081,0.6991,0.83,1,-1.4668,0.054,0.54
"C7_Immunologic_signatures:C7_ALL_404_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_404_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN",199,-1.5555,0.0011,0.0027,1.4335,0.0074,0.027,-1.3638,0.014,0.085
"C2_Chemical_and_genetic_perturbations:C2_CGP_3203_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3203_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP",20,-1.5554,0.033,0.045,-0.711,0.85,1,0.5521,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2977_ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN","C2_Chemical_and_genetic_perturbations","C2_CGP_2977_ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN",18,-1.5553,0.043,0.045,0.8792,0.61,0.94,1.1186,0.31,0.85
"GO_BP:500387_GO_0031100_ORGAN_REGENERATION","GO_BP","500387_GO_0031100_ORGAN_REGENERATION",54,-1.5553,0.0071,0.081,-0.7355,0.92,1,-0.8051,0.82,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2734_HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2734_HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN",68,-1.5553,0.0053,0.045,-0.7677,0.89,1,-0.837,0.81,0.93
"GO_BP:512105_GO_0051209_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL","GO_BP","512105_GO_0051209_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL",32,-1.5551,0.021,0.081,-0.6444,0.97,1,-0.9185,0.6,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_3299_ALFANO_MYC_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3299_ALFANO_MYC_TARGETS",235,-1.555,0,0.045,1.1433,0.14,0.56,0.9645,0.55,0.97
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_62_BIOCARTA_NDKDYNAMIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_62_BIOCARTA_NDKDYNAMIN_PATHWAY",18,-1.5549,0.023,0.12,0.7249,0.86,1,-0.8985,0.61,0.84
"GO_BP:753098_GO_1900103_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE","GO_BP","753098_GO_1900103_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE",11,-1.5547,0.036,0.082,-1.116,0.32,0.94,-1.326,0.14,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2934_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8","C2_Chemical_and_genetic_perturbations","C2_CGP_2934_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8",49,-1.5547,0.0097,0.045,-0.7205,0.94,1,0.9174,0.62,1
"GO_BP:513919_GO_0060363_CRANIAL_SUTURE_MORPHOGENESIS","GO_BP","513919_GO_0060363_CRANIAL_SUTURE_MORPHOGENESIS",10,-1.5546,0.035,0.082,-1.0993,0.36,0.95,0.5938,0.95,1
"C7_Immunologic_signatures:C7_ALL_1465_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP","C7_Immunologic_signatures","C7_ALL_1465_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP",189,-1.5546,0,0.0027,-0.8415,0.87,1,-1.2649,0.047,0.18
"WikiPathways:198821_WP698_GLUCURONIDATION","WikiPathways","198821_WP698_GLUCURONIDATION",26,-1.5546,0.025,0.05,1.749,0.01,0.081,1.5607,0.022,0.3
"REACTOME:187174_REACT_23947_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION","REACTOME","187174_REACT_23947_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION",17,-1.5546,0.028,0.094,-1.0959,0.34,0.91,-1.6245,0.021,0.23
"C7_Immunologic_signatures:C7_ALL_1481_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP","C7_Immunologic_signatures","C7_ALL_1481_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP",198,-1.5544,0,0.0027,1.2574,0.034,0.15,0.7478,0.98,1
"GO_BP:516218_GO_0071294_CELLULAR_RESPONSE_TO_ZINC_ION","GO_BP","516218_GO_0071294_CELLULAR_RESPONSE_TO_ZINC_ION",12,-1.5543,0.044,0.082,1.4479,0.06,0.5,-0.8129,0.71,0.98
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_31_BIOCARTA_CBL_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_31_BIOCARTA_CBL_PATHWAY",13,-1.5543,0.026,0.12,0.9024,0.61,0.9,0.9153,0.57,1
"C7_Immunologic_signatures:C7_ALL_1507_GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP","C7_Immunologic_signatures","C7_ALL_1507_GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP",197,-1.5543,0.0023,0.0027,1.2964,0.022,0.11,1.4635,0.0038,0.067
"GO_MF:490018_GO_0004702_RECEPTOR_SIGNALING_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY","GO_MF","490018_GO_0004702_RECEPTOR_SIGNALING_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",83,-1.5542,0.0078,0.11,-1.3332,0.059,0.72,-1.1898,0.16,0.59
"GO_BP:753021_GO_1900024_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING","GO_BP","753021_GO_1900024_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING",33,-1.5542,0.017,0.082,1.1405,0.26,0.85,1.1475,0.25,0.73
"C6_Oncogenic_signatures:C6_ALL_100_ESC_V6_5_UP_LATE_V1_UP","C6_Oncogenic_signatures","C6_ALL_100_ESC_V6_5_UP_LATE_V1_UP",173,-1.5542,0.0011,0.0081,-0.825,0.88,0.95,-0.989,0.46,0.66
"GO_BP:488303_GO_0002430_COMPLEMENT_RECEPTOR_MEDIATED_SIGNALING_PATHWAY","GO_BP","488303_GO_0002430_COMPLEMENT_RECEPTOR_MEDIATED_SIGNALING_PATHWAY",5,-1.5542,0.018,0.082,-0.6985,0.85,1,0.5646,0.94,1
"REACTOME:645309_REACT_120989_CHONDROITIN_SULFATE_BIOSYNTHESIS","REACTOME","645309_REACT_120989_CHONDROITIN_SULFATE_BIOSYNTHESIS",19,-1.554,0.023,0.094,-0.5865,0.98,1,1.0804,0.34,0.93
"GO_BP:1184427_GO_1903901_NEGATIVE_REGULATION_OF_VIRAL_LIFE_CYCLE","GO_BP","1184427_GO_1903901_NEGATIVE_REGULATION_OF_VIRAL_LIFE_CYCLE",83,-1.5539,0.01,0.082,1.3856,0.03,0.57,-1.4809,0.015,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_199_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_199_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP",17,-1.5539,0.032,0.045,0.4945,0.99,1,0.6067,0.95,1
"GO_MF:487742_GO_0001846_OPSONIN_BINDING","GO_MF","487742_GO_0001846_OPSONIN_BINDING",12,-1.5539,0.038,0.11,-1.2771,0.16,0.82,1.0758,0.35,0.81
"GO_BP:499041_GO_0021761_LIMBIC_SYSTEM_DEVELOPMENT","GO_BP","499041_GO_0021761_LIMBIC_SYSTEM_DEVELOPMENT",81,-1.5539,0,0.082,-1.0358,0.39,0.98,-1.0017,0.44,0.85
"C7_Immunologic_signatures:C7_ALL_890_GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN","C7_Immunologic_signatures","C7_ALL_890_GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN",197,-1.5538,0,0.0028,-0.9037,0.74,1,-1.1803,0.092,0.32
"REACTOME:106170_REACT_13796_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE","REACTOME","106170_REACT_13796_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE",31,-1.5537,0.024,0.093,-1.0843,0.32,0.91,-1.0546,0.34,0.77
"GO_BP:487805_GO_0001914_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY","GO_BP","487805_GO_0001914_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY",27,-1.5537,0.025,0.082,-0.6619,0.95,1,-0.91,0.57,0.92
"GO_BP:508306_GO_0046006_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION","GO_BP","508306_GO_0046006_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION",35,-1.5537,0.026,0.082,-1.0249,0.4,0.97,-0.8873,0.65,0.93
"GO_BP:1184553_GO_1904029_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY","GO_BP","1184553_GO_1904029_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY",90,-1.5533,0.0089,0.082,-0.8268,0.81,1,-0.7901,0.92,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2644_TAVAZOIE_METASTASIS","C2_Chemical_and_genetic_perturbations","C2_CGP_2644_TAVAZOIE_METASTASIS",101,-1.5533,0.0075,0.046,-1.3554,0.034,0.66,-0.9829,0.5,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2613_HAN_SATB1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2613_HAN_SATB1_TARGETS_UP",393,-1.5532,0,0.046,0.8675,0.92,0.96,-0.9444,0.66,0.83
"C6_Oncogenic_signatures:C6_ALL_31_PIGF_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_31_PIGF_UP_V1_DN",183,-1.5531,0.0012,0.008,-1.2426,0.058,0.36,1.0908,0.26,0.38
"C7_Immunologic_signatures:C7_ALL_1791_GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1791_GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP",192,-1.5528,0,0.0028,0.7837,0.98,1,0.871,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2742_YAMASHITA_LIVER_CANCER_STEM_CELL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2742_YAMASHITA_LIVER_CANCER_STEM_CELL_DN",75,-1.5528,0.005,0.046,-1.0159,0.44,0.99,1.6257,0.0077,0.35
"GO_BP:502039_GO_0032816_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION","GO_BP","502039_GO_0032816_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION",20,-1.5527,0.03,0.083,-1.4742,0.065,0.85,-1.3845,0.083,0.59
"C6_Oncogenic_signatures:C6_ALL_167_CORDENONSI_YAP_CONSERVED_SIGNATURE","C6_Oncogenic_signatures","C6_ALL_167_CORDENONSI_YAP_CONSERVED_SIGNATURE",57,-1.5526,0.01,0.0079,-1.4432,0.027,0.29,0.968,0.51,0.63
"REACTOME:106526_REACT_13583_NEUROTRANSMITTER_CLEARANCE_IN_THE_SYNAPTIC_CLEFT","REACTOME","106526_REACT_13583_NEUROTRANSMITTER_CLEARANCE_IN_THE_SYNAPTIC_CLEFT",8,-1.5525,0.024,0.094,-0.9322,0.53,1,-1.6254,0.016,0.23
"GO_BP:911401_GO_0098543_DETECTION_OF_OTHER_ORGANISM","GO_BP","911401_GO_0098543_DETECTION_OF_OTHER_ORGANISM",17,-1.5524,0.036,0.083,0.8787,0.63,1,1.0126,0.43,0.84
"GO_BP:1144984_GO_1903846_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS","GO_BP","1144984_GO_1903846_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS",23,-1.5522,0.033,0.083,0.5346,1,1,0.8892,0.6,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1864_ABE_VEGFA_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1864_ABE_VEGFA_TARGETS",20,-1.5522,0.024,0.046,0.9198,0.54,0.9,0.8439,0.69,1
"GO_BP:513507_GO_0055074_CALCIUM_ION_HOMEOSTASIS","GO_BP","513507_GO_0055074_CALCIUM_ION_HOMEOSTASIS",284,-1.5521,0,0.083,1.2053,0.057,0.78,1.3804,0.0074,0.63
"GO_BP:512358_GO_0051480_CYTOSOLIC_CALCIUM_ION_HOMEOSTASIS","GO_BP","512358_GO_0051480_CYTOSOLIC_CALCIUM_ION_HOMEOSTASIS",181,-1.552,0.0012,0.083,1.1791,0.11,0.8,1.3598,0.012,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_570_MARKS_HDAC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_570_MARKS_HDAC_TARGETS_UP",23,-1.552,0.028,0.046,0.7265,0.88,1,-1.3947,0.087,0.36
"GO_MF:490570_GO_0005402_CATION_SUGAR_SYMPORTER_ACTIVITY","GO_MF","490570_GO_0005402_CATION_SUGAR_SYMPORTER_ACTIVITY",8,-1.552,0.035,0.12,-0.7829,0.73,1,-1.2958,0.16,0.58
"GO_BP:504522_GO_0035338_LONG_CHAIN_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS","GO_BP","504522_GO_0035338_LONG_CHAIN_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS",17,-1.5519,0.023,0.083,-0.7459,0.82,1,-1.5056,0.043,0.53
"C7_Immunologic_signatures:C7_ALL_1471_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP","C7_Immunologic_signatures","C7_ALL_1471_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP",199,-1.5518,0,0.0029,1.2497,0.064,0.15,-1.0503,0.33,0.61
"GO_BP:513498_GO_0072507_DIVALENT_INORGANIC_CATION_HOMEOSTASIS","GO_BP","513498_GO_0072507_DIVALENT_INORGANIC_CATION_HOMEOSTASIS",328,-1.5517,0,0.083,1.101,0.18,0.9,1.3719,0.002,0.64
"GO_BP:752002_GO_0052805_IMIDAZOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS","GO_BP","752002_GO_0052805_IMIDAZOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",5,-1.5516,0.019,0.083,-0.6006,0.94,1,0.8333,0.65,0.99
"GO_MF:506116_GO_0043027_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_MF","506116_GO_0043027_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",25,-1.5515,0.02,0.12,-0.7085,0.87,1,-1.4789,0.045,0.43
"GO_BP:514000_GO_0060445_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS","GO_BP","514000_GO_0060445_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS",16,-1.5513,0.038,0.083,-0.9067,0.58,1,1.4149,0.058,0.62
"GO_BP:1129406_GO_1903580_POSITIVE_REGULATION_OF_ATP_METABOLIC_PROCESS","GO_BP","1129406_GO_1903580_POSITIVE_REGULATION_OF_ATP_METABOLIC_PROCESS",33,-1.5512,0.022,0.083,-1.0001,0.46,0.99,-0.9113,0.59,0.92
"GO_BP:491748_GO_0006887_EXOCYTOSIS","GO_BP","491748_GO_0006887_EXOCYTOSIS",304,-1.5511,0.0011,0.083,1.3031,0.0097,0.66,-1.0313,0.37,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_320_JAATINEN_HEMATOPOIETIC_STEM_CELL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_320_JAATINEN_HEMATOPOIETIC_STEM_CELL_UP",310,-1.551,0,0.046,-0.7745,0.99,1,-1.1421,0.12,0.58
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_73_BIOCARTA_FEEDER_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_73_BIOCARTA_FEEDER_PATHWAY",9,-1.5509,0.023,0.12,-1.3542,0.13,1,-1.5616,0.055,0.31
"GO_CC:505841_GO_0042734_PRESYNAPTIC_MEMBRANE","GO_CC","505841_GO_0042734_PRESYNAPTIC_MEMBRANE",55,-1.5508,0.012,0.11,-1.2857,0.1,0.66,1.0448,0.4,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2377_RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2377_RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP",100,-1.5508,0.0074,0.046,-0.9783,0.51,1,0.8278,0.82,1
"GO_BP:506514_GO_0043482_CELLULAR_PIGMENT_ACCUMULATION","GO_BP","506514_GO_0043482_CELLULAR_PIGMENT_ACCUMULATION",11,-1.5508,0.028,0.083,-0.6334,0.91,1,0.6676,0.91,1
"GO_BP:494986_GO_0010922_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY","GO_BP","494986_GO_0010922_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY",23,-1.5507,0.028,0.083,0.6501,0.95,1,-0.9067,0.59,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_2601_BRUNEAU_SEPTATION_ATRIAL","C2_Chemical_and_genetic_perturbations","C2_CGP_2601_BRUNEAU_SEPTATION_ATRIAL",5,-1.5506,0.016,0.046,-0.9975,0.45,1,1.4147,0.11,0.55
"C7_Immunologic_signatures:C7_ALL_1383_GSE339_CD4POS_VS_CD8POS_DC_UP","C7_Immunologic_signatures","C7_ALL_1383_GSE339_CD4POS_VS_CD8POS_DC_UP",198,-1.5505,0,0.003,0.8548,0.88,1,0.8601,0.85,1
"GO_BP:517430_GO_0072525_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","517430_GO_0072525_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",22,-1.5504,0.025,0.083,-1.0139,0.45,0.98,-1.5653,0.017,0.52
"GO_MF:490468_GO_0005227_CALCIUM_ACTIVATED_CATION_CHANNEL_ACTIVITY","GO_MF","490468_GO_0005227_CALCIUM_ACTIVATED_CATION_CHANNEL_ACTIVITY",30,-1.5504,0.019,0.12,-0.9569,0.52,0.95,-1.107,0.28,0.7
"GO_MF:492572_GO_0008238_EXOPEPTIDASE_ACTIVITY","GO_MF","492572_GO_0008238_EXOPEPTIDASE_ACTIVITY",106,-1.5503,0.0088,0.12,0.677,1,1,-1.4982,0.004,0.41
"GO_MF:496264_GO_0016175_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVITY","GO_MF","496264_GO_0016175_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVITY",9,-1.5503,0.049,0.12,-0.8997,0.59,0.99,-0.8898,0.62,0.88
"REACTOME:106196_REACT_474_METABOLISM_OF_CARBOHYDRATES","REACTOME","106196_REACT_474_METABOLISM_OF_CARBOHYDRATES",262,-1.5503,0,0.095,0.8944,0.81,0.91,-0.9531,0.62,0.9
"C3_TF_targets:C3_TFT_208_V_PAX3_B","C3_TF_targets","C3_TFT_208_V_PAX3_B",87,-1.5502,0.0038,0.015,0.7217,0.96,1,-1.3661,0.037,0.28
"C2_Chemical_and_genetic_perturbations:C2_CGP_882_SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION","C2_Chemical_and_genetic_perturbations","C2_CGP_882_SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION",49,-1.5501,0.014,0.046,0.8857,0.65,0.94,1.086,0.32,0.87
"C3_TF_targets:C3_TFT_329_V_CRX_Q4","C3_TF_targets","C3_TFT_329_V_CRX_Q4",262,-1.5499,0,0.015,-1.0461,0.33,0.65,1.1677,0.12,0.77
"GO_MF:493089_GO_0008865_FRUCTOKINASE_ACTIVITY","GO_MF","493089_GO_0008865_FRUCTOKINASE_ACTIVITY",5,-1.5499,0.028,0.12,-1.2122,0.27,0.82,-1.2426,0.23,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_64_CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_64_CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP",145,-1.5498,0.0059,0.047,0.6978,1,1,-1.7095,0,0.17
"GO_BP:517562_GO_0072659_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE","GO_BP","517562_GO_0072659_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",126,-1.5498,0,0.084,0.836,0.86,1,0.7745,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_540_DARWICHE_PAPILLOMA_RISK_LOW_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_540_DARWICHE_PAPILLOMA_RISK_LOW_UP",154,-1.5497,0,0.047,1.1537,0.14,0.55,-0.9714,0.5,0.79
"C6_Oncogenic_signatures:C6_ALL_23_CSR_LATE_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_23_CSR_LATE_UP_V1_DN",141,-1.5497,0.0012,0.0081,0.9493,0.57,0.97,1.0355,0.37,0.5
"GO_BP:507998_GO_0045650_NEGATIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION","GO_BP","507998_GO_0045650_NEGATIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION",8,-1.5497,0.035,0.084,-0.7572,0.79,1,-0.749,0.77,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_30_BIOCARTA_CASPASE_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_30_BIOCARTA_CASPASE_PATHWAY",23,-1.5496,0.018,0.12,-0.6984,0.9,1,-0.8769,0.64,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_850_MOHANKUMAR_TLX1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_850_MOHANKUMAR_TLX1_TARGETS_UP",409,-1.5496,0,0.047,0.9603,0.61,0.85,-1.514,0,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_2353_LABBE_WNT3A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2353_LABBE_WNT3A_TARGETS_UP",111,-1.5496,0.0025,0.047,-0.8542,0.81,1,-1.2967,0.052,0.43
"GO_CC:752843_GO_0097342_RIPOPTOSOME","GO_CC","752843_GO_0097342_RIPOPTOSOME",7,-1.5495,0.02,0.11,-1.0224,0.43,0.84,-0.5747,0.96,1
"GO_BP:502185_GO_0032963_COLLAGEN_METABOLIC_PROCESS","GO_BP","502185_GO_0032963_COLLAGEN_METABOLIC_PROCESS",83,-1.5495,0.0065,0.084,-1.1712,0.18,0.91,1.3945,0.032,0.63
"GO_BP:487448_GO_0001508_ACTION_POTENTIAL","GO_BP","487448_GO_0001508_ACTION_POTENTIAL",88,-1.5494,0.0085,0.084,-1.3318,0.05,0.9,-1.0111,0.43,0.84
"GO_BP:753986_GO_1901016_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","753986_GO_1901016_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",31,-1.5493,0.024,0.084,-1.1158,0.3,0.94,0.7889,0.81,1
"GO_BP:518766_GO_2000117_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_BP","518766_GO_2000117_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",78,-1.5493,0.011,0.084,0.906,0.67,1,-1.0455,0.35,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1275_UEDA_CENTRAL_CLOCK","C2_Chemical_and_genetic_perturbations","C2_CGP_1275_UEDA_CENTRAL_CLOCK",88,-1.5492,0.0026,0.047,-0.9329,0.59,1,-1.3627,0.049,0.39
"GO_BP:486620_GO_0000079_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY","GO_BP","486620_GO_0000079_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",90,-1.5492,0.0063,0.084,-0.839,0.82,1,-0.788,0.9,0.99
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_169_BIOCARTA_MEF2D_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_169_BIOCARTA_MEF2D_PATHWAY",18,-1.5492,0.027,0.11,-0.607,0.95,1,-1.4299,0.07,0.4
"GO_BP:513458_GO_0055025_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","513458_GO_0055025_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",26,-1.5491,0.018,0.084,-0.7749,0.82,1,1.3125,0.13,0.66
"GO_CC:499481_GO_0030017_SARCOMERE","GO_CC","499481_GO_0030017_SARCOMERE",178,-1.549,0,0.11,-0.9883,0.49,0.85,-1.1644,0.14,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_1539_KANG_IMMORTALIZED_BY_TERT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1539_KANG_IMMORTALIZED_BY_TERT_DN",100,-1.549,0.0025,0.047,0.8825,0.73,0.94,1.4983,0.0097,0.48
"GO_BP:511939_GO_0051006_POSITIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY","GO_BP","511939_GO_0051006_POSITIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY",10,-1.5489,0.022,0.084,-1.4189,0.099,0.94,-1.3357,0.14,0.62
"KEGG_pathway:HSA04614_RENIN_ANGIOTENSIN_SYSTEM","KEGG_pathway","HSA04614_RENIN_ANGIOTENSIN_SYSTEM",17,-1.5488,0.031,0.024,1.5297,0.027,0.094,0.8815,0.65,1
"C4_Cancer_modules:C4_CM_377_MODULE_464","C4_Cancer_modules","C4_CM_377_MODULE_464",14,-1.5488,0.04,0.041,0.8368,0.7,0.93,-1.0811,0.36,0.56
"GO_BP:505719_GO_0042593_GLUCOSE_HOMEOSTASIS","GO_BP","505719_GO_0042593_GLUCOSE_HOMEOSTASIS",153,-1.5487,0.0036,0.084,0.9926,0.44,0.99,1.0573,0.31,0.8
"GO_MF:507655_GO_0045296_CADHERIN_BINDING","GO_MF","507655_GO_0045296_CADHERIN_BINDING",27,-1.5487,0.023,0.12,-0.7551,0.85,1,-1.0031,0.44,0.79
"GO_BP:499139_GO_0021860_PYRAMIDAL_NEURON_DEVELOPMENT","GO_BP","499139_GO_0021860_PYRAMIDAL_NEURON_DEVELOPMENT",6,-1.5486,0.018,0.084,-1.2297,0.24,0.89,-0.9558,0.52,0.88
"GO_MF:489788_GO_0016308_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_ACTIVITY","GO_MF","489788_GO_0016308_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_ACTIVITY",7,-1.5486,0.041,0.12,-1.2411,0.23,0.85,-1.2254,0.23,0.58
"GO_BP:751426_GO_0038170_SOMATOSTATIN_SIGNALING_PATHWAY","GO_BP","751426_GO_0038170_SOMATOSTATIN_SIGNALING_PATHWAY",5,-1.5485,0.02,0.084,0.6942,0.82,1,-1.4917,0.052,0.54
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_125_BIOCARTA_NTHI_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_125_BIOCARTA_NTHI_PATHWAY",24,-1.5484,0.034,0.11,-0.685,0.92,1,0.5922,0.98,1
"GO_BP:518324_GO_0090184_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT","GO_BP","518324_GO_0090184_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT",38,-1.5484,0.02,0.084,0.986,0.48,1,1.1701,0.22,0.72
"GO_BP:500134_GO_0030836_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION","GO_BP","500134_GO_0030836_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION",8,-1.5483,0.04,0.084,-0.6462,0.89,1,-1.1893,0.26,0.74
"GO_CC:750942_GO_0036019_ENDOLYSOSOME","GO_CC","750942_GO_0036019_ENDOLYSOSOME",9,-1.5482,0.031,0.11,0.8534,0.62,0.91,1.0508,0.39,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_538_DARWICHE_SKIN_TUMOR_PROMOTER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_538_DARWICHE_SKIN_TUMOR_PROMOTER_UP",137,-1.5482,0.0012,0.047,0.8933,0.76,0.93,0.844,0.85,1
"GO_BP:511842_GO_0050905_NEUROMUSCULAR_PROCESS","GO_BP","511842_GO_0050905_NEUROMUSCULAR_PROCESS",101,-1.5478,0.0037,0.084,-0.9442,0.58,1,-0.7351,0.95,1
"GO_BP:492070_GO_0007292_FEMALE_GAMETE_GENERATION","GO_BP","492070_GO_0007292_FEMALE_GAMETE_GENERATION",89,-1.5478,0.01,0.084,-1.209,0.16,0.88,-1.0724,0.3,0.8
"REACTOME:106507_REACT_12380_VEGF_LIGAND_RECEPTOR_INTERACTIONS","REACTOME","106507_REACT_12380_VEGF_LIGAND_RECEPTOR_INTERACTIONS",7,-1.5478,0.039,0.097,0.5196,0.98,1,-1.425,0.11,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_2733_HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2733_HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP",62,-1.5477,0.0093,0.047,1.074,0.32,0.67,-1.5084,0.024,0.29
"KEGG_pathway:HSA00920_SULFUR_METABOLISM","KEGG_pathway","HSA00920_SULFUR_METABOLISM",10,-1.5477,0.033,0.024,-0.4444,0.99,1,-1.4398,0.09,0.15
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_213_BIOCARTA_UCALPAIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_213_BIOCARTA_UCALPAIN_PATHWAY",18,-1.5474,0.043,0.11,-0.7821,0.8,1,-1.0777,0.35,0.68
"GO_BP:494076_GO_0009991_RESPONSE_TO_EXTRACELLULAR_STIMULUS","GO_BP","494076_GO_0009991_RESPONSE_TO_EXTRACELLULAR_STIMULUS",418,-1.5474,0,0.085,-0.928,0.73,1,-0.941,0.69,0.89
"C7_Immunologic_signatures:C7_ALL_180_GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN","C7_Immunologic_signatures","C7_ALL_180_GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN",199,-1.5472,0,0.0031,0.8072,0.95,1,0.7458,1,1
"GO_MF:489958_GO_0047499_CALCIUM_INDEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY","GO_MF","489958_GO_0047499_CALCIUM_INDEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY",5,-1.547,0.019,0.12,-0.5862,0.91,1,0.5604,0.95,1
"C3_TF_targets:C3_TFT_435_V_E2A_Q2","C3_TF_targets","C3_TFT_435_V_E2A_Q2",237,-1.5468,0,0.016,-1.5728,0,0.14,-1.1527,0.12,0.46
"KEGG_module:HSA_M00014_GLUCURONATE_PATHWAY_URONATE_PATHWAY_","KEGG_module","HSA_M00014_GLUCURONATE_PATHWAY_URONATE_PATHWAY_",27,-1.5467,0.029,0.18,1.6115,0.0067,0.12,1.6381,0.0061,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_2199_DE_YY1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2199_DE_YY1_TARGETS_UP",20,-1.5463,0.03,0.048,0.7288,0.88,1,-1.3191,0.12,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1322_TARTE_PLASMA_CELL_VS_PLASMABLAST_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1322_TARTE_PLASMA_CELL_VS_PLASMABLAST_UP",374,-1.5463,0.0011,0.048,1.5699,0,0.16,0.9853,0.52,0.97
"KEGG_pathway:HSA00524_BUTIROSIN_AND_NEOMYCIN_BIOSYNTHESIS","KEGG_pathway","HSA00524_BUTIROSIN_AND_NEOMYCIN_BIOSYNTHESIS",5,-1.5462,0.03,0.024,-1.1977,0.29,0.52,-1.2652,0.2,0.31
"C7_Immunologic_signatures:C7_ALL_729_GSE17721_0_5H_VS_12H_PAM3CSK4_BMDM_UP","C7_Immunologic_signatures","C7_ALL_729_GSE17721_0_5H_VS_12H_PAM3CSK4_BMDM_UP",197,-1.5461,0,0.0032,1.2851,0.026,0.12,-1.1549,0.13,0.36
"GO_MF:495514_GO_0051119_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495514_GO_0051119_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",22,-1.546,0.035,0.12,-1.0983,0.3,0.84,-1.1513,0.27,0.64
"GO_BP:512203_GO_0051319_G2_PHASE","GO_BP","512203_GO_0051319_G2_PHASE",9,-1.5456,0.027,0.086,-0.91,0.6,1,-0.9381,0.53,0.9
"GO_MF:490163_GO_0004861_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY","GO_MF","490163_GO_0004861_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY",12,-1.5456,0.041,0.12,-1.222,0.22,0.85,-1.6884,0.023,0.3
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_103_BIOCARTA_DEATH_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_103_BIOCARTA_DEATH_PATHWAY",33,-1.5456,0.019,0.11,-1.0439,0.39,1,-0.9333,0.58,0.84
"C7_Immunologic_signatures:C7_ALL_162_GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN","C7_Immunologic_signatures","C7_ALL_162_GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN",193,-1.5453,0.0034,0.0033,1.2811,0.031,0.12,-1.0975,0.23,0.5
"GO_MF:487531_GO_0001594_TRACE_AMINE_RECEPTOR_ACTIVITY","GO_MF","487531_GO_0001594_TRACE_AMINE_RECEPTOR_ACTIVITY",6,-1.5453,0.037,0.12,0.8724,0.61,1,1.8106,0.0038,0.11
"C2_Chemical_and_genetic_perturbations:C2_CGP_3312_PHONG_TNF_RESPONSE_VIA_P38_COMPLETE","C2_Chemical_and_genetic_perturbations","C2_CGP_3312_PHONG_TNF_RESPONSE_VIA_P38_COMPLETE",226,-1.5453,0,0.048,-1.0636,0.29,0.96,-0.9326,0.68,0.84
"C3_TF_targets:C3_TFT_166_V_AHRARNT_01","C3_TF_targets","C3_TFT_166_V_AHRARNT_01",140,-1.5453,0,0.016,-1.0757,0.28,0.61,-1.0584,0.3,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1701_MODY_HIPPOCAMPUS_NEONATAL","C2_Chemical_and_genetic_perturbations","C2_CGP_1701_MODY_HIPPOCAMPUS_NEONATAL",35,-1.5453,0.019,0.048,1.2471,0.15,0.44,0.9074,0.61,1
"GO_BP:500111_GO_0030812_NEGATIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS","GO_BP","500111_GO_0030812_NEGATIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS",38,-1.5451,0.02,0.086,-0.8515,0.74,1,0.7908,0.84,1
"C7_Immunologic_signatures:C7_ALL_809_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_809_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP",178,-1.5451,0,0.0033,-0.8448,0.88,1,1.1701,0.11,0.8
"GO_BP:513497_GO_0055065_METAL_ION_HOMEOSTASIS","GO_BP","513497_GO_0055065_METAL_ION_HOMEOSTASIS",442,-1.545,0,0.086,1.2236,0.026,0.76,1.3094,0.0019,0.67
"GO_BP:512012_GO_0051098_REGULATION_OF_BINDING","GO_BP","512012_GO_0051098_REGULATION_OF_BINDING",233,-1.545,0,0.086,0.9333,0.66,1,-0.9762,0.53,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2592_LEE_DOUBLE_POLAR_THYMOCYTE","C2_Chemical_and_genetic_perturbations","C2_CGP_2592_LEE_DOUBLE_POLAR_THYMOCYTE",25,-1.545,0.02,0.048,-1.0263,0.42,0.98,-1.7645,0.0059,0.13
"WikiPathways:198784_WP1544_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY","WikiPathways","198784_WP1544_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY",84,-1.5448,0.005,0.054,-0.7679,0.93,1,-1.1811,0.16,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_1177_MORI_LARGE_PRE_BII_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1177_MORI_LARGE_PRE_BII_LYMPHOCYTE_DN",58,-1.5447,0.018,0.048,-0.771,0.89,1,-1.25,0.12,0.47
"C6_Oncogenic_signatures:C6_ALL_121_RB_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_121_RB_DN_V1_DN",114,-1.5447,0.0024,0.0085,1.2243,0.095,0.38,0.9821,0.48,0.62
"GO_BP:1129358_GO_1903531_NEGATIVE_REGULATION_OF_SECRETION_BY_CELL","GO_BP","1129358_GO_1903531_NEGATIVE_REGULATION_OF_SECRETION_BY_CELL",144,-1.5446,0.0036,0.087,0.9298,0.63,1,-0.935,0.61,0.9
"C7_Immunologic_signatures:C7_ALL_1480_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN","C7_Immunologic_signatures","C7_ALL_1480_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN",199,-1.5444,0.0023,0.0033,-0.8297,0.88,1,-1.4563,0.006,0.033
"GO_BP:511844_GO_0050907_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION","GO_BP","511844_GO_0050907_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION",350,-1.5443,0,0.087,2.2908,0,0.00013,3.3428,0,0
"C7_Immunologic_signatures:C7_ALL_805_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_805_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP",183,-1.5443,0.0034,0.0033,0.961,0.58,0.86,0.7392,0.98,1
"GO_BP:494834_GO_0010769_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION","GO_BP","494834_GO_0010769_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION",266,-1.5443,0,0.087,-1.2424,0.059,0.91,0.8935,0.79,0.95
"GO_MF:495328_GO_0015035_PROTEIN_DISULFIDE_OXIDOREDUCTASE_ACTIVITY","GO_MF","495328_GO_0015035_PROTEIN_DISULFIDE_OXIDOREDUCTASE_ACTIVITY",24,-1.5442,0.033,0.12,0.8301,0.72,1,-1.359,0.087,0.53
"C3_TF_targets:C3_TFT_557_RACCACAR_V_AML_Q6","C3_TF_targets","C3_TFT_557_RACCACAR_V_AML_Q6",258,-1.5442,0,0.016,-0.8004,0.97,1,0.9312,0.66,1
"GO_BP:494172_GO_0010092_SPECIFICATION_OF_ORGAN_IDENTITY","GO_BP","494172_GO_0010092_SPECIFICATION_OF_ORGAN_IDENTITY",14,-1.5441,0.04,0.087,-1.0204,0.41,0.97,1.2018,0.23,0.72
"GO_BP:752373_GO_0086001_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL","GO_BP","752373_GO_0086001_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",33,-1.544,0.013,0.087,-1.0032,0.45,0.99,-1.0643,0.37,0.8
"GO_BP:513873_GO_0060317_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION","GO_BP","513873_GO_0060317_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION",21,-1.5438,0.043,0.087,0.7975,0.77,1,0.85,0.7,0.98
"GO_BP:506508_GO_0043476_PIGMENT_ACCUMULATION","GO_BP","506508_GO_0043476_PIGMENT_ACCUMULATION",11,-1.5438,0.022,0.087,-0.6473,0.91,1,0.6519,0.92,1
"C7_Immunologic_signatures:C7_ALL_1102_GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1102_GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN",188,-1.5437,0.0023,0.0033,0.7482,0.99,1,0.8875,0.77,1
"C7_Immunologic_signatures:C7_ALL_1453_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP","C7_Immunologic_signatures","C7_ALL_1453_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP",196,-1.5436,0.0045,0.0033,1.088,0.23,0.47,-1.243,0.048,0.2
"C2_Chemical_and_genetic_perturbations:C2_CGP_2688_VALK_AML_CLUSTER_12","C2_Chemical_and_genetic_perturbations","C2_CGP_2688_VALK_AML_CLUSTER_12",29,-1.5436,0.016,0.048,0.9073,0.61,0.91,-1.3153,0.12,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1238_ONDER_CDH1_TARGETS_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1238_ONDER_CDH1_TARGETS_2_UP",252,-1.5435,0,0.048,1.2974,0.021,0.39,1.2396,0.045,0.75
"C3_TF_targets:C3_TFT_257_V_CHX10_01","C3_TF_targets","C3_TFT_257_V_CHX10_01",212,-1.5435,0,0.016,-1.0824,0.25,0.59,1.0708,0.27,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1453_HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1453_HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP",77,-1.5433,0.0078,0.048,-0.885,0.71,1,-1.1893,0.15,0.53
"GO_BP:499352_GO_0022617_EXTRACELLULAR_MATRIX_DISASSEMBLY","GO_BP","499352_GO_0022617_EXTRACELLULAR_MATRIX_DISASSEMBLY",119,-1.5433,0.0025,0.087,-0.8358,0.84,1,1.5559,0,0.5
"GO_BP:488893_GO_0003097_RENAL_WATER_TRANSPORT","GO_BP","488893_GO_0003097_RENAL_WATER_TRANSPORT",6,-1.5432,0.042,0.087,-0.7501,0.76,1,0.9313,0.54,0.92
"GO_CC:500380_GO_0031093_PLATELET_ALPHA_GRANULE_LUMEN","GO_CC","500380_GO_0031093_PLATELET_ALPHA_GRANULE_LUMEN",47,-1.543,0.02,0.12,1.6345,0.0043,0.094,1.122,0.27,0.88
"REACTOME:477128_REACT_111133_GROWTH_HORMONE_RECEPTOR_SIGNALING","REACTOME","477128_REACT_111133_GROWTH_HORMONE_RECEPTOR_SIGNALING",23,-1.5426,0.025,0.1,-0.679,0.92,1,-0.8013,0.76,1
"REACTOME:730320_REACT_150154_INOSITOL_PHOSPHATE_METABOLISM","REACTOME","730320_REACT_150154_INOSITOL_PHOSPHATE_METABOLISM",46,-1.5426,0.011,0.1,-1.1574,0.19,0.85,-0.6577,0.99,1
"C0_Hallmark:H_ALL_22_HALLMARK_HEDGEHOG_SIGNALING","C0_Hallmark","H_ALL_22_HALLMARK_HEDGEHOG_SIGNALING",33,-1.5426,0.013,0.0065,-0.7743,0.83,1,1.3308,0.09,0.14
"GO_BP:511627_GO_0050655_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS","GO_BP","511627_GO_0050655_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS",15,-1.5425,0.037,0.088,-1.1765,0.26,0.9,-0.5066,1,1
"GO_BP:754673_GO_1901722_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT","GO_BP","754673_GO_1901722_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",11,-1.5423,0.033,0.088,-0.8631,0.61,1,1.2969,0.16,0.67
"GO_BP:512013_GO_0051099_POSITIVE_REGULATION_OF_BINDING","GO_BP","512013_GO_0051099_POSITIVE_REGULATION_OF_BINDING",99,-1.5422,0.0065,0.088,-0.5994,1,1,-1.421,0.021,0.57
"GO_MF:498023_GO_0019158_MANNOKINASE_ACTIVITY","GO_MF","498023_GO_0019158_MANNOKINASE_ACTIVITY",5,-1.542,0.019,0.12,-1.216,0.26,0.82,-1.2744,0.18,0.58
"GO_BP:516146_GO_0071220_CELLULAR_RESPONSE_TO_BACTERIAL_LIPOPROTEIN","GO_BP","516146_GO_0071220_CELLULAR_RESPONSE_TO_BACTERIAL_LIPOPROTEIN",5,-1.542,0.029,0.088,0.8171,0.67,1,0.9583,0.52,0.9
"GO_BP:516929_GO_0072010_GLOMERULAR_EPITHELIUM_DEVELOPMENT","GO_BP","516929_GO_0072010_GLOMERULAR_EPITHELIUM_DEVELOPMENT",19,-1.5419,0.031,0.088,-0.9626,0.5,1,-1.002,0.45,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_3128_JOHNSTONE_PARVB_TARGETS_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3128_JOHNSTONE_PARVB_TARGETS_2_UP",135,-1.5419,0.0059,0.049,1.1051,0.23,0.62,-0.778,0.95,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2466_BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2466_BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN",32,-1.5418,0.029,0.049,0.8288,0.72,0.98,-0.8501,0.71,0.92
"GO_BP:948898_GO_1902743_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION","GO_BP","948898_GO_1902743_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION",31,-1.5417,0.017,0.088,0.839,0.74,1,-0.8546,0.72,0.96
"GO_BP:494234_GO_0010155_REGULATION_OF_PROTON_TRANSPORT","GO_BP","494234_GO_0010155_REGULATION_OF_PROTON_TRANSPORT",14,-1.5416,0.028,0.088,1.2386,0.2,0.75,-0.6288,0.92,1
"KEGG_compound:C18040_5ALPHA_DIHYDRODEOXYCORTICOSTERONE_5ALPHA_PREGNAN_21_OL_3_20_DIONE_ALLOPREGNANE_21_OL_3_20_DIONE","KEGG_compound","C18040_5ALPHA_DIHYDRODEOXYCORTICOSTERONE_5ALPHA_PREGNAN_21_OL_3_20_DIONE_ALLOPREGNANE_21_OL_3_20_DIONE",7,-1.5416,0.026,0.14,-0.6942,0.83,1,-0.7975,0.7,0.85
"GO_BP:507936_GO_0045588_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION","GO_BP","507936_GO_0045588_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION",5,-1.5416,0.039,0.088,-0.7101,0.82,1,-1.1627,0.32,0.73
"GO_BP:493578_GO_0009405_PATHOGENESIS","GO_BP","493578_GO_0009405_PATHOGENESIS",264,-1.5416,0,0.088,0.8956,0.81,1,-0.7985,0.98,0.99
"GO_BP:491735_GO_0006874_CELLULAR_CALCIUM_ION_HOMEOSTASIS","GO_BP","491735_GO_0006874_CELLULAR_CALCIUM_ION_HOMEOSTASIS",271,-1.5414,0,0.088,1.2319,0.049,0.75,1.3925,0,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_3158_CHENG_TAF7L_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3158_CHENG_TAF7L_TARGETS",6,-1.5413,0.034,0.049,-1.3309,0.15,0.69,-1.4074,0.098,0.35
"GO_BP:509139_GO_0046942_CARBOXYLIC_ACID_TRANSPORT","GO_BP","509139_GO_0046942_CARBOXYLIC_ACID_TRANSPORT",231,-1.541,0,0.088,-1.2278,0.06,0.88,1.0154,0.4,0.84
"GO_MF:489959_GO_0004629_PHOSPHOLIPASE_C_ACTIVITY","GO_MF","489959_GO_0004629_PHOSPHOLIPASE_C_ACTIVITY",30,-1.541,0.019,0.12,-1.0552,0.36,0.87,1.052,0.38,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_2480_GU_PDEF_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2480_GU_PDEF_TARGETS_UP",71,-1.5409,0.0065,0.049,0.9831,0.49,0.81,1.5352,0.0095,0.45
"GO_MF:496630_GO_0016709_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN","GO_MF","496630_GO_0016709_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN",37,-1.5409,0.018,0.12,-0.6738,0.94,1,1.3232,0.08,0.67
"GO_BP:502046_GO_0032823_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION","GO_BP","502046_GO_0032823_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION",11,-1.5409,0.037,0.088,-1.3023,0.15,0.89,-0.8622,0.64,0.95
"GO_MF:490542_GO_0005351_SUGAR_PROTON_SYMPORTER_ACTIVITY","GO_MF","490542_GO_0005351_SUGAR_PROTON_SYMPORTER_ACTIVITY",8,-1.5407,0.039,0.12,-0.809,0.72,1,-1.3259,0.14,0.55
"GO_CC:503973_GO_0034774_SECRETORY_GRANULE_LUMEN","GO_CC","503973_GO_0034774_SECRETORY_GRANULE_LUMEN",58,-1.5407,0.008,0.12,1.5201,0.016,0.18,1.1739,0.19,0.81
"GO_BP:514219_GO_0060664_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS","GO_BP","514219_GO_0060664_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS",5,-1.5407,0.022,0.088,-0.8125,0.7,1,0.9291,0.53,0.92
"GO_BP:501621_GO_0032386_REGULATION_OF_INTRACELLULAR_TRANSPORT","GO_BP","501621_GO_0032386_REGULATION_OF_INTRACELLULAR_TRANSPORT",495,-1.5406,0,0.088,0.9002,0.87,1,-1.1828,0.05,0.73
"KEGG_pathway:HSA04390_HIPPO_SIGNALING_PATHWAY","KEGG_pathway","HSA04390_HIPPO_SIGNALING_PATHWAY",150,-1.5405,0.0012,0.025,-0.8962,0.74,0.97,0.8706,0.8,1
"GO_BP:494658_GO_0010594_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION","GO_BP","494658_GO_0010594_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION",99,-1.5403,0.0051,0.088,-0.9607,0.56,1,1.0568,0.31,0.8
"C7_Immunologic_signatures:C7_ALL_691_GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_691_GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDM_UP",195,-1.5402,0,0.0035,-1.01,0.42,1,-1.3235,0.026,0.12
"KEGG_reaction:R01600_ATP_BETA_D_GLUCOSE_6_PHOSPHOTRANSFERASE_ATP_BETA_D_GLUCOSE_ADP_BETA_D_GLUCOSE_6_PHOSPHATE","KEGG_reaction","R01600_ATP_BETA_D_GLUCOSE_6_PHOSPHOTRANSFERASE_ATP_BETA_D_GLUCOSE_ADP_BETA_D_GLUCOSE_6_PHOSPHATE",5,-1.54,0.029,0.13,-1.1971,0.27,0.55,-1.2472,0.24,0.44
"C4_Cancer_modules:C4_CM_425_MODULE_563","C4_Cancer_modules","C4_CM_425_MODULE_563",14,-1.5399,0.038,0.044,1.0108,0.44,0.71,1.1026,0.32,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_669_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24","C2_Chemical_and_genetic_perturbations","C2_CGP_669_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24",13,-1.5399,0.045,0.05,-1.2731,0.17,0.71,-1.1561,0.29,0.57
"C1_Positional:C1_ALL_179_CHR9Q13","C1_Positional","C1_ALL_179_CHR9Q13",17,-1.5395,0.037,0.26,-0.886,0.63,1,-1.7663,0.01,0.43
"GO_BP:503317_GO_0034111_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION","GO_BP","503317_GO_0034111_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION",84,-1.5395,0.012,0.089,-0.8654,0.72,1,0.751,0.95,1
"GO_BP:750893_GO_0035966_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN","GO_BP","750893_GO_0035966_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN",158,-1.5395,0.0012,0.089,-0.8859,0.76,1,-1.7106,0,0.67
"KEGG_compound:C00004_NADH_DPNH_REDUCED_NICOTINAMIDE_ADENINE_DINUCLEOTIDE","KEGG_compound","C00004_NADH_DPNH_REDUCED_NICOTINAMIDE_ADENINE_DINUCLEOTIDE",106,-1.5393,0.0086,0.14,0.9941,0.46,1,-1.5559,0,0.19
"GO_BP:518397_GO_0090257_REGULATION_OF_MUSCLE_SYSTEM_PROCESS","GO_BP","518397_GO_0090257_REGULATION_OF_MUSCLE_SYSTEM_PROCESS",190,-1.5393,0.0012,0.089,-1.046,0.34,0.97,-1.0888,0.24,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_1191_LEE_TARGETS_OF_PTCH1_AND_SUFU_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1191_LEE_TARGETS_OF_PTCH1_AND_SUFU_UP",53,-1.5392,0.018,0.05,1.0076,0.42,0.79,-0.8751,0.68,0.9
"GO_BP:753096_GO_1900101_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE","GO_BP","753096_GO_1900101_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE",18,-1.5392,0.049,0.089,-1.1717,0.26,0.91,-1.481,0.048,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_236_RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_236_RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP",77,-1.539,0.0038,0.05,1.2261,0.11,0.46,-0.76,0.91,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2793_SCHOEN_NFKB_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_2793_SCHOEN_NFKB_SIGNALING",34,-1.539,0.013,0.05,-1.4284,0.04,0.55,0.9843,0.48,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1535_AFFAR_YY1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1535_AFFAR_YY1_TARGETS_DN",230,-1.539,0.0011,0.05,1.1495,0.15,0.56,-1.1015,0.2,0.62
"GO_BP:511813_GO_0050871_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION","GO_BP","511813_GO_0050871_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION",63,-1.5389,0.0082,0.089,-0.9259,0.58,1,-1.3965,0.036,0.57
"GO_BP:518826_GO_2000178_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION","GO_BP","518826_GO_2000178_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION",20,-1.5388,0.028,0.089,-1.4692,0.04,0.86,-1.1211,0.3,0.76
"GO_BP:500915_GO_0031666_POSITIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY","GO_BP","500915_GO_0031666_POSITIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY",7,-1.5387,0.031,0.089,-0.7354,0.79,1,-0.8811,0.59,0.94
"KEGG_pathway:HSA04723_RETROGRADE_ENDOCANNABINOID_SIGNALING","KEGG_pathway","HSA04723_RETROGRADE_ENDOCANNABINOID_SIGNALING",100,-1.5386,0.0038,0.025,-1.095,0.29,0.71,1.1919,0.15,0.66
"GO_BP:507248_GO_0044241_LIPID_DIGESTION","GO_BP","507248_GO_0044241_LIPID_DIGESTION",12,-1.5384,0.035,0.089,-1.6976,0.0084,0.61,1.2892,0.16,0.68
"C3_MicroRNA_targets:C3_MIR_105_GAGCCTG_MIR_484","C3_MicroRNA_targets","C3_MIR_105_GAGCCTG_MIR_484",104,-1.5384,0.0063,0.27,-1.2791,0.082,1,-1.1554,0.2,1
"GO_BP:508834_GO_0046580_NEGATIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","508834_GO_0046580_NEGATIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION",41,-1.5384,0.022,0.089,-0.8878,0.64,1,0.7035,0.93,1
"C6_Oncogenic_signatures:C6_ALL_155_STK33_SKM_DN","C6_Oncogenic_signatures","C6_ALL_155_STK33_SKM_DN",265,-1.5382,0.0011,0.0092,1.0371,0.34,0.72,-1.1485,0.1,0.46
"REACTOME:187104_REACT_25162_INTERFERON_ALPHA_BETA_SIGNALING","REACTOME","187104_REACT_25162_INTERFERON_ALPHA_BETA_SIGNALING",64,-1.5381,0.016,0.1,1.2298,0.12,0.42,-1.7136,0.0021,0.2
"C7_Immunologic_signatures:C7_ALL_679_GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_679_GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDM_UP",200,-1.5381,0.0023,0.0037,0.9062,0.73,1,-0.9,0.75,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1641_JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1641_JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN",63,-1.538,0.019,0.05,-0.945,0.54,1,-1.3691,0.053,0.38
"C7_Immunologic_signatures:C7_ALL_15_GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_15_GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP",200,-1.5378,0.0011,0.0037,0.7333,0.99,1,-1.3521,0.0081,0.095
"C2_Chemical_and_genetic_perturbations:C2_CGP_2687_VALK_AML_CLUSTER_11","C2_Chemical_and_genetic_perturbations","C2_CGP_2687_VALK_AML_CLUSTER_11",36,-1.5377,0.013,0.05,0.7113,0.92,1,-0.8694,0.69,0.91
"GO_BP:503344_GO_0034138_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY","GO_BP","503344_GO_0034138_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY",82,-1.5376,0.0078,0.09,-0.7534,0.94,1,-1.0876,0.29,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_1732_MURAKAMI_UV_RESPONSE_6HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1732_MURAKAMI_UV_RESPONSE_6HR_UP",36,-1.5376,0.025,0.05,0.8113,0.79,0.98,0.9346,0.57,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3307_BRIDEAU_IMPRINTED_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_3307_BRIDEAU_IMPRINTED_GENES",60,-1.5376,0.014,0.05,-1.0387,0.39,0.97,-0.9277,0.59,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1377_LE_EGR2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1377_LE_EGR2_TARGETS_UP",108,-1.5375,0.0062,0.05,1.1396,0.19,0.57,-1.2339,0.094,0.49
"GO_MF:502767_GO_0033549_MAP_KINASE_PHOSPHATASE_ACTIVITY","GO_MF","502767_GO_0033549_MAP_KINASE_PHOSPHATASE_ACTIVITY",13,-1.5374,0.033,0.12,-0.7114,0.83,1,1.2961,0.16,0.65
"C3_TF_targets:C3_TFT_599_CCCNNGGGAR_V_OLF1_01","C3_TF_targets","C3_TFT_599_CCCNNGGGAR_V_OLF1_01",315,-1.5374,0,0.017,-1.3729,0.0085,0.18,-1.23,0.052,0.29
"C7_Immunologic_signatures:C7_ALL_1482_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN","C7_Immunologic_signatures","C7_ALL_1482_GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN",197,-1.5373,0,0.0037,0.931,0.68,0.95,-1.0475,0.32,0.61
"GO_BP:488537_GO_0002664_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION","GO_BP","488537_GO_0002664_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION",11,-1.5373,0.048,0.09,0.7828,0.76,1,-1.0024,0.46,0.85
"C7_Immunologic_signatures:C7_ALL_432_GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_432_GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN",197,-1.5371,0.0023,0.0037,0.8327,0.9,1,-1.3254,0.011,0.11
"GO_BP:510940_GO_0048892_LATERAL_LINE_NERVE_DEVELOPMENT","GO_BP","510940_GO_0048892_LATERAL_LINE_NERVE_DEVELOPMENT",10,-1.5371,0.031,0.09,-1.3394,0.15,0.91,-1.1399,0.29,0.75
"C7_Immunologic_signatures:C7_ALL_294_GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_294_GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN",196,-1.5371,0.0011,0.0037,1.093,0.22,0.46,-0.9836,0.5,0.76
"GO_BP:488881_GO_0003085_NEGATIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE","GO_BP","488881_GO_0003085_NEGATIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE",15,-1.5371,0.034,0.09,-1.2026,0.23,0.89,-1.2497,0.19,0.68
"GO_BP:505541_GO_0042398_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS","GO_BP","505541_GO_0042398_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS",50,-1.537,0.012,0.09,-0.7572,0.87,1,-1.7028,0.002,0.63
"GO_MF:505448_GO_0042301_PHOSPHATE_ION_BINDING","GO_MF","505448_GO_0042301_PHOSPHATE_ION_BINDING",12,-1.5368,0.039,0.12,0.6145,0.95,1,-0.8003,0.76,0.97
"GO_MF:504441_GO_0035257_NUCLEAR_HORMONE_RECEPTOR_BINDING","GO_MF","504441_GO_0035257_NUCLEAR_HORMONE_RECEPTOR_BINDING",127,-1.5368,0.0048,0.12,0.7878,0.93,1,-0.7754,0.95,0.97
"GO_BP:499438_GO_0023014_SIGNAL_TRANSDUCTION_BY_PHOSPHORYLATION","GO_BP","499438_GO_0023014_SIGNAL_TRANSDUCTION_BY_PHOSPHORYLATION",238,-1.5368,0.0011,0.09,-0.7871,0.96,1,-0.8938,0.8,0.93
"GO_BP:507076_GO_0044060_REGULATION_OF_ENDOCRINE_PROCESS","GO_BP","507076_GO_0044060_REGULATION_OF_ENDOCRINE_PROCESS",41,-1.5368,0.016,0.09,1.0212,0.41,0.97,-1.3092,0.096,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_662_LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE","C2_Chemical_and_genetic_perturbations","C2_CGP_662_LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE",49,-1.5367,0.0096,0.051,0.8502,0.74,0.97,-1.0856,0.3,0.65
"WikiPathways:698753_WP2332_INTERLEUKIN_11_SIGNALING_PATHWAY","WikiPathways","698753_WP2332_INTERLEUKIN_11_SIGNALING_PATHWAY",40,-1.5367,0.02,0.057,0.7077,0.94,1,-1.2963,0.09,0.43
"GO_BP:754840_GO_1901889_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY","GO_BP","754840_GO_1901889_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY",13,-1.5366,0.034,0.09,0.9432,0.52,1,-0.6911,0.87,0.99
"REACTOME:105776_REACT_683_G1_S_SPECIFIC_TRANSCRIPTION","REACTOME","105776_REACT_683_G1_S_SPECIFIC_TRANSCRIPTION",17,-1.5365,0.036,0.1,-0.6317,0.92,1,-1.0681,0.39,0.75
"C4_Cancer_modules:C4_CM_189_MODULE_202","C4_Cancer_modules","C4_CM_189_MODULE_202",28,-1.5365,0.028,0.045,-1.0051,0.44,0.8,0.9216,0.58,0.95
"GO_BP:513516_GO_0055083_MONOVALENT_INORGANIC_ANION_HOMEOSTASIS","GO_BP","513516_GO_0055083_MONOVALENT_INORGANIC_ANION_HOMEOSTASIS",19,-1.5364,0.037,0.09,-1.2917,0.15,0.88,-1.333,0.12,0.62
"GO_MF:496472_GO_0016505_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_MF","496472_GO_0016505_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",21,-1.5362,0.037,0.12,1.1801,0.21,0.73,-1.2541,0.17,0.59
"GO_BP:488707_GO_0002834_REGULATION_OF_RESPONSE_TO_TUMOR_CELL","GO_BP","488707_GO_0002834_REGULATION_OF_RESPONSE_TO_TUMOR_CELL",11,-1.5361,0.042,0.09,0.7957,0.71,1,0.7013,0.87,1
"KEGG_pathway:HSA04964_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION","KEGG_pathway","HSA04964_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION",23,-1.536,0.022,0.026,-1.2032,0.22,0.52,-1.554,0.04,0.1
"GO_BP:510928_GO_0048880_SENSORY_SYSTEM_DEVELOPMENT","GO_BP","510928_GO_0048880_SENSORY_SYSTEM_DEVELOPMENT",13,-1.5359,0.04,0.09,-1.1872,0.26,0.9,0.7603,0.77,1
"GO_BP:503327_GO_0034121_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","503327_GO_0034121_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",36,-1.5358,0.03,0.09,-0.7624,0.85,1,0.7572,0.85,1
"C7_Immunologic_signatures:C7_ALL_300_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_300_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN",190,-1.5358,0.0023,0.0038,-1.2965,0.037,0.49,-1.1513,0.14,0.37
"GO_BP:499046_GO_0021766_HIPPOCAMPUS_DEVELOPMENT","GO_BP","499046_GO_0021766_HIPPOCAMPUS_DEVELOPMENT",55,-1.5357,0.015,0.09,-0.8076,0.84,1,-0.9726,0.52,0.88
"GO_BP:507716_GO_0045359_POSITIVE_REGULATION_OF_INTERFERON_BETA_BIOSYNTHETIC_PROCESS","GO_BP","507716_GO_0045359_POSITIVE_REGULATION_OF_INTERFERON_BETA_BIOSYNTHETIC_PROCESS",7,-1.5357,0.03,0.09,-0.7148,0.83,1,-1.193,0.26,0.74
"C7_Immunologic_signatures:C7_ALL_1883_GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1883_GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP",199,-1.5356,0,0.0038,1.376,0.017,0.047,2.1565,0,0
"GO_BP:488516_GO_0002643_REGULATION_OF_TOLERANCE_INDUCTION","GO_BP","488516_GO_0002643_REGULATION_OF_TOLERANCE_INDUCTION",13,-1.5355,0.025,0.09,-0.7739,0.75,1,-1.1313,0.32,0.75
"GO_CC:490677_GO_0005605_BASAL_LAMINA","GO_CC","490677_GO_0005605_BASAL_LAMINA",23,-1.5354,0.038,0.12,-0.6747,0.92,1,1.2129,0.21,0.82
"C3_TF_targets:C3_TFT_577_AAAYWAACM_V_HFH4_01","C3_TF_targets","C3_TFT_577_AAAYWAACM_V_HFH4_01",248,-1.5354,0.0011,0.017,-0.9121,0.72,0.95,-0.9966,0.45,0.78
"GO_CC:490915_GO_0005916_FASCIA_ADHERENS","GO_CC","490915_GO_0005916_FASCIA_ADHERENS",13,-1.5353,0.032,0.12,-1.0501,0.37,0.83,1.0817,0.33,0.94
"GO_CC:752670_GO_0097169_AIM2_INFLAMMASOME_COMPLEX","GO_CC","752670_GO_0097169_AIM2_INFLAMMASOME_COMPLEX",6,-1.5351,0.036,0.12,-0.9367,0.55,0.91,-1.1162,0.34,0.89
"REACTOME:106508_REACT_12583_VEGF_BINDS_TO_VEGFR_LEADING_TO_RECEPTOR_DIMERIZATION","REACTOME","106508_REACT_12583_VEGF_BINDS_TO_VEGFR_LEADING_TO_RECEPTOR_DIMERIZATION",7,-1.5351,0.048,0.1,0.5235,0.98,1,-1.4499,0.077,0.38
"GO_BP:501765_GO_0032535_REGULATION_OF_CELLULAR_COMPONENT_SIZE","GO_BP","501765_GO_0032535_REGULATION_OF_CELLULAR_COMPONENT_SIZE",242,-1.535,0,0.091,-0.9446,0.63,1,-1.1246,0.16,0.76
"GO_BP:505406_GO_0042246_TISSUE_REGENERATION","GO_BP","505406_GO_0042246_TISSUE_REGENERATION",37,-1.5349,0.027,0.091,-1.1087,0.3,0.94,0.7349,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3031_LI_INDUCED_T_TO_NATURAL_KILLER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3031_LI_INDUCED_T_TO_NATURAL_KILLER_DN",110,-1.5348,0.0072,0.051,-1.0363,0.39,0.98,-1.2682,0.071,0.45
"C4_Cancer_modules:C4_CM_43_MODULE_47","C4_Cancer_modules","C4_CM_43_MODULE_47",219,-1.5348,0.0023,0.045,1.2521,0.048,0.32,1.2449,0.042,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_2836_LOPEZ_MESOTHELIOMA_SURVIVAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2836_LOPEZ_MESOTHELIOMA_SURVIVAL_DN",12,-1.5347,0.037,0.051,-1.2581,0.18,0.74,-1.3609,0.11,0.38
"GO_MF:490635_GO_0005539_GLYCOSAMINOGLYCAN_BINDING","GO_MF","490635_GO_0005539_GLYCOSAMINOGLYCAN_BINDING",181,-1.5345,0,0.12,1.1198,0.17,0.77,1.5458,0.0021,0.37
"C7_Immunologic_signatures:C7_ALL_540_GSE17721_LPS_VS_POLYIC_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_540_GSE17721_LPS_VS_POLYIC_12H_BMDM_DN",197,-1.5344,0.0011,0.0039,0.7875,0.98,1,-1.0126,0.43,0.7
"WikiPathways:198793_WP550_BIOGENIC_AMINE_SYNTHESIS","WikiPathways","198793_WP550_BIOGENIC_AMINE_SYNTHESIS",14,-1.5344,0.039,0.057,0.8073,0.74,1,1.2411,0.22,0.6
"C6_Oncogenic_signatures:C6_ALL_144_TGFB_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_144_TGFB_UP_V1_UP",186,-1.5343,0,0.0095,-1.3394,0.017,0.42,0.974,0.51,0.62
"WikiPathways:198829_WP134_PENTOSE_PHOSPHATE_PATHWAY","WikiPathways","198829_WP134_PENTOSE_PHOSPHATE_PATHWAY",8,-1.5343,0.027,0.057,0.7361,0.8,1,-0.7248,0.83,0.97
"C7_Immunologic_signatures:C7_ALL_1810_GSE7852_TREG_VS_TCONV_THYMUS_DN","C7_Immunologic_signatures","C7_ALL_1810_GSE7852_TREG_VS_TCONV_THYMUS_DN",198,-1.5343,0.0034,0.0039,-0.8743,0.8,1,0.9677,0.54,1
"KEGG_compound:C00024_ACETYL_COA_ACETYL_COENZYME_A","KEGG_compound","C00024_ACETYL_COA_ACETYL_COENZYME_A",35,-1.5342,0.022,0.14,0.5165,1,1,-1.3308,0.068,0.34
"GO_BP:492196_GO_0007435_SALIVARY_GLAND_MORPHOGENESIS","GO_BP","492196_GO_0007435_SALIVARY_GLAND_MORPHOGENESIS",28,-1.534,0.025,0.091,-1.1223,0.28,0.93,1.0524,0.36,0.8
"GO_BP:751253_GO_0036336_DENDRITIC_CELL_MIGRATION","GO_BP","751253_GO_0036336_DENDRITIC_CELL_MIGRATION",19,-1.5339,0.032,0.091,1.4714,0.049,0.46,1.4283,0.074,0.61
"KEGG_pathway:HSA00983_DRUG_METABOLISM","KEGG_pathway","HSA00983_DRUG_METABOLISM",46,-1.5339,0.014,0.026,1.1095,0.27,0.78,1.6935,0.0079,0.064
"GO_CC:490799_GO_0005767_SECONDARY_LYSOSOME","GO_CC","490799_GO_0005767_SECONDARY_LYSOSOME",7,-1.5339,0.03,0.12,0.9645,0.49,0.82,0.5454,0.97,1
"GO_BP:506445_GO_0043407_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY","GO_BP","506445_GO_0043407_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY",73,-1.5338,0.013,0.091,-0.8558,0.75,1,1.179,0.17,0.72
"GO_CC:507386_GO_0044437_VACUOLAR_PART","GO_CC","507386_GO_0044437_VACUOLAR_PART",369,-1.5337,0.001,0.12,0.8626,0.92,0.91,0.806,0.99,1
"GO_BP:513523_GO_0055090_ACYLGLYCEROL_HOMEOSTASIS","GO_BP","513523_GO_0055090_ACYLGLYCEROL_HOMEOSTASIS",29,-1.5336,0.025,0.092,0.6451,0.96,1,1.435,0.05,0.6
"GO_BP:491780_GO_0006929_SUBSTRATE_DEPENDENT_CELL_MIGRATION","GO_BP","491780_GO_0006929_SUBSTRATE_DEPENDENT_CELL_MIGRATION",26,-1.5335,0.022,0.092,-0.6172,0.97,1,-1.276,0.15,0.66
"WikiPathways:920963_WP2328_ALLOGRAFT_REJECTION","WikiPathways","920963_WP2328_ALLOGRAFT_REJECTION",36,-1.5334,0.026,0.056,-0.7412,0.88,1,-0.7473,0.89,0.95
"C3_MicroRNA_targets:C3_MIR_150_AACTGAC_MIR_223","C3_MicroRNA_targets","C3_MIR_150_AACTGAC_MIR_223",96,-1.5334,0.0076,0.24,-0.8896,0.68,1,-0.9657,0.51,1
"C7_Immunologic_signatures:C7_ALL_500_GSE17721_CTRL_VS_CPG_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_500_GSE17721_CTRL_VS_CPG_2H_BMDM_DN",196,-1.5333,0,0.0039,-0.8117,0.92,1,1.03,0.36,1
"C7_Immunologic_signatures:C7_ALL_308_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN","C7_Immunologic_signatures","C7_ALL_308_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN",198,-1.5333,0.0011,0.0039,0.9366,0.64,0.94,1.1612,0.15,0.83
"GO_BP:515271_GO_0070339_RESPONSE_TO_BACTERIAL_LIPOPEPTIDE","GO_BP","515271_GO_0070339_RESPONSE_TO_BACTERIAL_LIPOPEPTIDE",5,-1.5333,0.043,0.092,0.8218,0.68,1,0.9742,0.49,0.88
"C3_TF_targets:C3_TFT_324_V_AFP1_Q6","C3_TF_targets","C3_TFT_324_V_AFP1_Q6",258,-1.5333,0,0.017,1.0055,0.44,1,-1.1268,0.15,0.48
"C4_Cancer_gene_neighborhoods:C4_CGN_417_GNF2_TIMP2","C4_Cancer_gene_neighborhoods","C4_CGN_417_GNF2_TIMP2",39,-1.5332,0.02,0.043,0.9868,0.46,0.61,1.2297,0.17,0.39
"GO_BP:498247_GO_0019405_ALDITOL_CATABOLIC_PROCESS","GO_BP","498247_GO_0019405_ALDITOL_CATABOLIC_PROCESS",5,-1.5331,0.031,0.092,0.8539,0.63,1,-0.7737,0.74,1
"C6_Oncogenic_signatures:C6_ALL_27_AKT_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_27_AKT_UP_V1_DN",173,-1.5329,0.0023,0.0095,-0.9582,0.57,0.79,1.0594,0.31,0.44
"GO_BP:502839_GO_0033623_REGULATION_OF_INTEGRIN_ACTIVATION","GO_BP","502839_GO_0033623_REGULATION_OF_INTEGRIN_ACTIVATION",10,-1.5327,0.04,0.092,-0.7682,0.77,1,-1.0116,0.42,0.84
"GO_BP:514225_GO_0060670_BRANCHING_INVOLVED_IN_LABYRINTHINE_LAYER_MORPHOGENESIS","GO_BP","514225_GO_0060670_BRANCHING_INVOLVED_IN_LABYRINTHINE_LAYER_MORPHOGENESIS",9,-1.5327,0.035,0.092,-1.1097,0.34,0.94,0.7035,0.85,1
"GO_CC:499505_GO_0030057_DESMOSOME","GO_CC","499505_GO_0030057_DESMOSOME",23,-1.5327,0.035,0.12,1.0279,0.42,0.74,0.7289,0.87,1
"C3_TF_targets:C3_TFT_90_V_FOXD3_01","C3_TF_targets","C3_TFT_90_V_FOXD3_01",189,-1.5325,0.0023,0.017,-0.9714,0.53,0.82,-1.0573,0.3,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2542_RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2542_RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP",15,-1.5325,0.047,0.052,-1.196,0.23,0.8,-1.0175,0.45,0.73
"GO_BP:488593_GO_0002720_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488593_GO_0002720_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE",27,-1.5325,0.024,0.092,-0.73,0.9,1,-0.6001,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_797_KANG_GIST_WITH_PDGFRA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_797_KANG_GIST_WITH_PDGFRA_DN",5,-1.5325,0.014,0.052,0.5339,0.96,1,-0.816,0.68,0.94
"GO_BP:511976_GO_0051051_NEGATIVE_REGULATION_OF_TRANSPORT","GO_BP","511976_GO_0051051_NEGATIVE_REGULATION_OF_TRANSPORT",397,-1.5325,0,0.092,0.8873,0.87,1,-1.2062,0.036,0.73
"GO_BP:754001_GO_1901031_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES","GO_BP","754001_GO_1901031_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES",24,-1.5325,0.03,0.092,1.7299,0.0066,0.16,0.6122,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1399_IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1399_IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP",24,-1.5324,0.019,0.052,1.0683,0.38,0.68,1.0555,0.36,0.91
"GO_BP:496148_GO_0016048_DETECTION_OF_TEMPERATURE_STIMULUS","GO_BP","496148_GO_0016048_DETECTION_OF_TEMPERATURE_STIMULUS",14,-1.5324,0.028,0.092,-0.7697,0.79,1,-1.0543,0.42,0.81
"C4_Cancer_modules:C4_CM_190_MODULE_203","C4_Cancer_modules","C4_CM_190_MODULE_203",16,-1.5324,0.033,0.046,-1.1305,0.28,0.64,-1.2009,0.24,0.41
"C6_Oncogenic_signatures:C6_ALL_110_PTEN_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_110_PTEN_DN_V1_UP",172,-1.5323,0.0023,0.0095,-0.9455,0.59,0.83,-0.9642,0.54,0.71
"GO_BP:491739_GO_0006878_CELLULAR_COPPER_ION_HOMEOSTASIS","GO_BP","491739_GO_0006878_CELLULAR_COPPER_ION_HOMEOSTASIS",14,-1.5323,0.042,0.092,0.6605,0.91,1,0.7822,0.78,1
"GO_BP:495846_GO_0015711_ORGANIC_ANION_TRANSPORT","GO_BP","495846_GO_0015711_ORGANIC_ANION_TRANSPORT",340,-1.5323,0,0.092,-1.3034,0.012,0.89,-1.1062,0.16,0.77
"KEGG_reaction:R00299_ATP_D_GLUCOSE_6_PHOSPHOTRANSFERASE_ATP_D_GLUCOSE_ADP_D_GLUCOSE_6_PHOSPHATE","KEGG_reaction","R00299_ATP_D_GLUCOSE_6_PHOSPHOTRANSFERASE_ATP_D_GLUCOSE_ADP_D_GLUCOSE_6_PHOSPHATE",5,-1.5323,0.026,0.13,-1.2116,0.26,0.53,-1.2552,0.21,0.44
"REACTOME:105655_REACT_832_DIMERIZATION_OF_PROCASPASE_8","REACTOME","105655_REACT_832_DIMERIZATION_OF_PROCASPASE_8",11,-1.5322,0.036,0.11,0.5599,0.97,1,-1.0888,0.34,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2483_TOOKER_GEMCITABINE_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2483_TOOKER_GEMCITABINE_RESISTANCE_DN",122,-1.5322,0.0012,0.052,1.093,0.25,0.64,-0.8644,0.77,0.91
"C7_Immunologic_signatures:C7_ALL_971_GSE22886_DC_VS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_971_GSE22886_DC_VS_MONOCYTE_UP",198,-1.5321,0.0012,0.004,0.899,0.76,1,-0.8666,0.84,0.99
"GO_BP:506227_GO_0043154_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_BP","506227_GO_0043154_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",76,-1.5321,0.0079,0.092,0.9404,0.57,1,-1.0632,0.3,0.8
"C7_Immunologic_signatures:C7_ALL_578_GSE17721_PAM3CSK4_VS_CPG_16H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_578_GSE17721_PAM3CSK4_VS_CPG_16H_BMDM_DN",197,-1.5321,0.0023,0.004,1.2827,0.038,0.12,0.948,0.57,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2813_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL","C2_Chemical_and_genetic_perturbations","C2_CGP_2813_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL",17,-1.5319,0.044,0.052,-0.7259,0.84,1,-1.4173,0.072,0.34
"GO_BP:514646_GO_0061098_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY","GO_BP","514646_GO_0061098_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY",35,-1.5319,0.027,0.092,-0.9373,0.56,1,-0.8651,0.71,0.95
"GO_MF:489759_GO_0004396_HEXOKINASE_ACTIVITY","GO_MF","489759_GO_0004396_HEXOKINASE_ACTIVITY",5,-1.5318,0.024,0.12,-1.1942,0.29,0.8,-1.2347,0.24,0.58
"GO_BP:515441_GO_0070509_CALCIUM_ION_IMPORT","GO_BP","515441_GO_0070509_CALCIUM_ION_IMPORT",33,-1.5317,0.033,0.092,-1.2589,0.16,0.91,-1.101,0.34,0.77
"C7_Immunologic_signatures:C7_ALL_848_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN","C7_Immunologic_signatures","C7_ALL_848_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN",184,-1.5316,0,0.004,-1.1884,0.12,0.85,-1.9318,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_2838_KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2838_KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP",22,-1.5316,0.035,0.052,1.0909,0.3,0.64,1.1419,0.28,0.83
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_37_BIOCARTA_CELL2CELL_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_37_BIOCARTA_CELL2CELL_PATHWAY",14,-1.5314,0.034,0.12,-0.72,0.84,1,-0.839,0.68,0.89
"OMIM_gene:OMIM603335_DYNEIN_AXONEMAL_HEAVY_CHAIN_5_DNAH5","OMIM_gene","OMIM603335_DYNEIN_AXONEMAL_HEAVY_CHAIN_5_DNAH5",5,-1.5312,0.028,0.95,-0.744,0.78,0.98,1.2597,0.22,1
"GO_MF:487328_GO_0001105_RNA_POLYMERASE_II_TRANSCRIPTION_COACTIVATOR_ACTIVITY","GO_MF","487328_GO_0001105_RNA_POLYMERASE_II_TRANSCRIPTION_COACTIVATOR_ACTIVITY",24,-1.5312,0.029,0.12,-0.9765,0.49,0.94,-0.9133,0.59,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_3091_FIGUEROA_AML_METHYLATION_CLUSTER_7_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3091_FIGUEROA_AML_METHYLATION_CLUSTER_7_DN",5,-1.531,0.027,0.053,-0.8585,0.65,1,0.8642,0.62,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_154_GRABARCZYK_BCL11B_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_154_GRABARCZYK_BCL11B_TARGETS_DN",55,-1.5308,0.025,0.053,0.8673,0.75,0.96,-1.3058,0.099,0.42
"C7_Immunologic_signatures:C7_ALL_354_GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_354_GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN",193,-1.5307,0,0.0041,-1.5903,0,0.02,-1.2602,0.04,0.18
"C4_Cancer_modules:C4_CM_64_MODULE_68","C4_Cancer_modules","C4_CM_64_MODULE_68",21,-1.5307,0.038,0.046,0.9658,0.48,0.76,0.9435,0.55,0.95
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_76_BIOCARTA_FREE_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_76_BIOCARTA_FREE_PATHWAY",10,-1.5307,0.046,0.12,-1.2344,0.23,1,-1.2383,0.21,0.57
"GO_BP:487932_GO_0002042_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS","GO_BP","487932_GO_0002042_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS",15,-1.5306,0.04,0.093,-1.4674,0.069,0.87,-0.9815,0.48,0.87
"C7_Immunologic_signatures:C7_ALL_1827_GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP","C7_Immunologic_signatures","C7_ALL_1827_GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP",198,-1.5305,0.0034,0.0041,0.8736,0.83,1,-1.3371,0.016,0.1
"GO_BP:514155_GO_0060600_DICHOTOMOUS_SUBDIVISION_OF_AN_EPITHELIAL_TERMINAL_UNIT","GO_BP","514155_GO_0060600_DICHOTOMOUS_SUBDIVISION_OF_AN_EPITHELIAL_TERMINAL_UNIT",17,-1.5304,0.033,0.093,-1.1625,0.26,0.92,0.7913,0.75,1
"GO_BP:512817_GO_0051967_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC","GO_BP","512817_GO_0051967_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC",10,-1.5304,0.038,0.093,-0.9836,0.48,1,1.4154,0.11,0.62
"GO_BP:496455_GO_0016485_PROTEIN_PROCESSING","GO_BP","496455_GO_0016485_PROTEIN_PROCESSING",213,-1.5304,0,0.093,0.9487,0.61,1,-1.3739,0.015,0.59
"C6_Oncogenic_signatures:C6_ALL_173_KRAS_50_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_173_KRAS_50_UP_V1_UP",48,-1.5304,0.0097,0.0095,0.7487,0.89,0.99,1.406,0.044,0.13
"C2_Chemical_and_genetic_perturbations:C2_CGP_722_FARMER_BREAST_CANCER_CLUSTER_2","C2_Chemical_and_genetic_perturbations","C2_CGP_722_FARMER_BREAST_CANCER_CLUSTER_2",33,-1.5304,0.021,0.053,1.2184,0.18,0.47,-1.2142,0.19,0.51
"REACTOME:477134_REACT_75792_MEIOTIC_SYNAPSIS","REACTOME","477134_REACT_75792_MEIOTIC_SYNAPSIS",75,-1.5304,0.01,0.11,-1.6197,0.0037,0.32,-1.4345,0.022,0.39
"C2_Chemical_and_genetic_perturbations:C2_CGP_2729_CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2729_CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP",85,-1.5301,0.017,0.053,-1.2878,0.093,0.69,-1.2493,0.11,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_2779_MIKKELSEN_IPS_LCP_WITH_H3K4ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2779_MIKKELSEN_IPS_LCP_WITH_H3K4ME3",166,-1.5301,0.0023,0.053,-1.4544,0.0089,0.53,-1.2646,0.047,0.45
"GO_BP:506333_GO_0043266_REGULATION_OF_POTASSIUM_ION_TRANSPORT","GO_BP","506333_GO_0043266_REGULATION_OF_POTASSIUM_ION_TRANSPORT",62,-1.53,0.015,0.093,-1.324,0.062,0.89,-0.8701,0.69,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_905_KONDO_HYPOXIA","C2_Chemical_and_genetic_perturbations","C2_CGP_905_KONDO_HYPOXIA",8,-1.5298,0.04,0.053,-0.5785,0.95,1,0.7763,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2810_FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2810_FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN",26,-1.5298,0.019,0.053,1.2541,0.15,0.43,-0.9301,0.55,0.84
"GO_MF:499540_GO_0032393_MHC_CLASS_I_RECEPTOR_ACTIVITY","GO_MF","499540_GO_0032393_MHC_CLASS_I_RECEPTOR_ACTIVITY",7,-1.5297,0.046,0.13,-0.5253,0.98,1,-0.7881,0.73,0.97
"C3_TF_targets:C3_TFT_426_V_TTF1_Q6","C3_TF_targets","C3_TFT_426_V_TTF1_Q6",253,-1.5296,0,0.018,-1.4757,0,0.14,-1.1104,0.18,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_3125_BHAT_ESR1_TARGETS_VIA_AKT1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3125_BHAT_ESR1_TARGETS_VIA_AKT1_DN",82,-1.5296,0.0087,0.053,-0.8814,0.72,1,1.0232,0.39,0.94
"GO_BP:750939_GO_0036016_CELLULAR_RESPONSE_TO_INTERLEUKIN_3","GO_BP","750939_GO_0036016_CELLULAR_RESPONSE_TO_INTERLEUKIN_3",5,-1.5295,0.027,0.093,0.6421,0.91,1,0.8625,0.6,0.97
"REACTOME:106449_REACT_13415_P75NTR_RECRUITS_SIGNALLING_COMPLEXES","REACTOME","106449_REACT_13415_P75NTR_RECRUITS_SIGNALLING_COMPLEXES",13,-1.5294,0.027,0.11,1.1734,0.24,0.47,0.6674,0.91,1
"C7_Immunologic_signatures:C7_ALL_1081_GSE25087_FETAL_VS_ADULT_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1081_GSE25087_FETAL_VS_ADULT_TCONV_UP",199,-1.5293,0.0011,0.0041,0.8861,0.81,1,-1.4016,0.01,0.061
"C2_Chemical_and_genetic_perturbations:C2_CGP_179_VECCHI_GASTRIC_CANCER_EARLY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_179_VECCHI_GASTRIC_CANCER_EARLY_DN",344,-1.5292,0,0.053,1.3522,0,0.34,-1.1308,0.13,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_487_WANG_BARRETTS_ESOPHAGUS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_487_WANG_BARRETTS_ESOPHAGUS_UP",47,-1.5292,0.028,0.053,-0.9381,0.54,1,-0.9095,0.59,0.87
"C7_Immunologic_signatures:C7_ALL_817_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_817_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP",176,-1.5292,0.0023,0.0042,1.0654,0.3,0.54,0.9423,0.62,1
"GO_MF:497601_GO_0018685_ALKANE_1_MONOOXYGENASE_ACTIVITY","GO_MF","497601_GO_0018685_ALKANE_1_MONOOXYGENASE_ACTIVITY",5,-1.5291,0.032,0.13,-1.2362,0.23,0.85,1.7284,0.012,0.17
"GO_BP:491539_GO_0006650_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS","GO_BP","491539_GO_0006650_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS",231,-1.5291,0,0.094,-0.7746,0.98,1,-0.9287,0.67,0.9
"C3_TF_targets:C3_TFT_555_YWATTWNNRGCT_UNKNOWN","C3_TF_targets","C3_TFT_555_YWATTWNNRGCT_UNKNOWN",65,-1.5291,0.017,0.018,-1.5217,0.016,0.13,-1.0466,0.39,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_3011_BROWNE_HCMV_INFECTION_30MIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3011_BROWNE_HCMV_INFECTION_30MIN_UP",51,-1.5289,0.028,0.053,-1.2844,0.1,0.7,-1.09,0.27,0.64
"GO_BP:495122_GO_0014050_NEGATIVE_REGULATION_OF_GLUTAMATE_SECRETION","GO_BP","495122_GO_0014050_NEGATIVE_REGULATION_OF_GLUTAMATE_SECRETION",7,-1.5289,0.024,0.094,1.4457,0.093,0.5,0.8256,0.68,1
"C7_Immunologic_signatures:C7_ALL_880_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_880_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN",192,-1.5288,0.0033,0.0042,1.0903,0.24,0.47,-1.1126,0.21,0.46
"GO_CC:507369_GO_0044420_EXTRACELLULAR_MATRIX_COMPONENT","GO_CC","507369_GO_0044420_EXTRACELLULAR_MATRIX_COMPONENT",132,-1.5288,0.0037,0.12,-1.0616,0.33,0.81,1.168,0.14,0.81
"GO_BP:518670_GO_2000021_REGULATION_OF_ION_HOMEOSTASIS","GO_BP","518670_GO_2000021_REGULATION_OF_ION_HOMEOSTASIS",167,-1.5287,0,0.094,0.9702,0.49,1,0.9649,0.53,0.89
"C7_Immunologic_signatures:C7_ALL_967_GSE22886_NEUTROPHIL_VS_DC_UP","C7_Immunologic_signatures","C7_ALL_967_GSE22886_NEUTROPHIL_VS_DC_UP",189,-1.5287,0.0011,0.0042,1.3466,0.017,0.065,1.2205,0.099,0.63
"GO_BP:516281_GO_0071357_CELLULAR_RESPONSE_TO_TYPE_I_INTERFERON","GO_BP","516281_GO_0071357_CELLULAR_RESPONSE_TO_TYPE_I_INTERFERON",65,-1.5286,0.0052,0.094,1.1989,0.15,0.78,-1.6807,0,0.61
"C7_Immunologic_signatures:C7_ALL_482_GSE17721_CTRL_VS_PAM3CSK4_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_482_GSE17721_CTRL_VS_PAM3CSK4_1H_BMDM_DN",193,-1.5286,0.0035,0.0042,-1.2033,0.1,0.81,-1.0144,0.41,0.69
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_28_BIOCARTA_CDMAC_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_28_BIOCARTA_CDMAC_PATHWAY",16,-1.5285,0.049,0.12,-1.3393,0.12,1,-1.0679,0.37,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_3113_WIERENGA_STAT5A_TARGETS_GROUP1","C2_Chemical_and_genetic_perturbations","C2_CGP_3113_WIERENGA_STAT5A_TARGETS_GROUP1",135,-1.5283,0.0037,0.053,-1.2029,0.11,0.8,-1.3338,0.017,0.41
"GO_BP:514528_GO_0060973_CELL_MIGRATION_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","514528_GO_0060973_CELL_MIGRATION_INVOLVED_IN_HEART_DEVELOPMENT",9,-1.5283,0.043,0.094,0.902,0.57,1,-0.8325,0.68,0.97
"C1_Positional:C1_ALL_272_CHR6Q24","C1_Positional","C1_ALL_272_CHR6Q24",41,-1.5282,0.019,0.27,0.9379,0.58,0.84,-0.9296,0.58,1
"C3_TF_targets:C3_TFT_398_V_SREBP1_Q6","C3_TF_targets","C3_TFT_398_V_SREBP1_Q6",238,-1.5281,0.0034,0.018,-1.5324,0.0017,0.14,-1.3257,0.01,0.25
"REACTOME:187193_REACT_25300_ION_CHANNEL_TRANSPORT","REACTOME","187193_REACT_25300_ION_CHANNEL_TRANSPORT",191,-1.5281,0.0023,0.11,-1.2863,0.045,0.67,-1.114,0.2,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1098_GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1098_GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN",202,-1.528,0.0011,0.053,1.401,0.01,0.29,-1.1467,0.16,0.58
"C7_Immunologic_signatures:C7_ALL_914_GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN","C7_Immunologic_signatures","C7_ALL_914_GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN",198,-1.528,0.0011,0.0042,1.1727,0.089,0.27,-1.0458,0.32,0.62
"KEGG_compound:C00319_SPHINGOSINE_SPHINGENINE_SPHINGOID_SPHING_4_ENINE","KEGG_compound","C00319_SPHINGOSINE_SPHINGENINE_SPHINGOID_SPHING_4_ENINE",15,-1.5279,0.043,0.15,-0.8445,0.68,1,-1.0475,0.4,0.6
"GO_BP:518336_GO_0090196_REGULATION_OF_CHEMOKINE_SECRETION","GO_BP","518336_GO_0090196_REGULATION_OF_CHEMOKINE_SECRETION",9,-1.5279,0.037,0.094,0.5936,0.94,1,-1.07,0.37,0.8
"C7_Immunologic_signatures:C7_ALL_484_GSE17721_CTRL_VS_PAM3CSK4_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_484_GSE17721_CTRL_VS_PAM3CSK4_2H_BMDM_DN",196,-1.5278,0,0.0042,-1.0304,0.39,1,1.0542,0.3,1
"KEGG_pathway:HSA00565_ETHER_LIPID_METABOLISM","KEGG_pathway","HSA00565_ETHER_LIPID_METABOLISM",42,-1.5277,0.023,0.027,0.7133,0.95,1,1.1408,0.23,0.78
"GO_BP:491736_GO_0006875_CELLULAR_METAL_ION_HOMEOSTASIS","GO_BP","491736_GO_0006875_CELLULAR_METAL_ION_HOMEOSTASIS",377,-1.5277,0,0.094,1.2364,0.031,0.75,1.3364,0.006,0.65
"C3_TF_targets:C3_TFT_176_V_EGR2_01","C3_TF_targets","C3_TFT_176_V_EGR2_01",196,-1.5276,0.0011,0.018,-1.129,0.18,0.48,0.8691,0.82,1
"GO_CC:501247_GO_0032010_PHAGOLYSOSOME","GO_CC","501247_GO_0032010_PHAGOLYSOSOME",6,-1.5276,0.048,0.12,1.1632,0.28,0.57,0.6061,0.9,1
"C7_Immunologic_signatures:C7_ALL_1693_GSE3982_BASOPHIL_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_1693_GSE3982_BASOPHIL_VS_TH1_UP",196,-1.5276,0.0023,0.0042,1.2807,0.039,0.12,-0.9421,0.64,0.87
"C7_Immunologic_signatures:C7_ALL_158_GSE13306_RA_VS_UNTREATED_TCONV_DN","C7_Immunologic_signatures","C7_ALL_158_GSE13306_RA_VS_UNTREATED_TCONV_DN",196,-1.5274,0.0023,0.0042,1.1507,0.15,0.32,0.9228,0.7,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1262_BYSTROEM_CORRELATED_WITH_IL5_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1262_BYSTROEM_CORRELATED_WITH_IL5_DN",64,-1.5273,0.019,0.054,0.8575,0.77,0.96,-1.0594,0.35,0.68
"GO_BP:512755_GO_0051900_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION","GO_BP","512755_GO_0051900_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION",16,-1.5272,0.039,0.095,-0.9362,0.55,1,-0.9071,0.59,0.92
"GO_BP:511857_GO_0050922_NEGATIVE_REGULATION_OF_CHEMOTAXIS","GO_BP","511857_GO_0050922_NEGATIVE_REGULATION_OF_CHEMOTAXIS",31,-1.5272,0.032,0.095,0.9563,0.52,1,1.8447,0,0.23
"C2_Chemical_and_genetic_perturbations:C2_CGP_2390_CHEN_HOXA5_TARGETS_6HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2390_CHEN_HOXA5_TARGETS_6HR_DN",6,-1.527,0.041,0.054,-0.5374,0.98,1,-1.025,0.44,0.72
"GO_BP:507269_GO_0044262_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS","GO_BP","507269_GO_0044262_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS",170,-1.527,0.0011,0.095,0.8661,0.85,1,-1.2446,0.074,0.69
"GO_BP:752377_GO_0086005_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL","GO_BP","752377_GO_0086005_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",15,-1.527,0.034,0.095,0.6086,0.96,1,-0.9163,0.56,0.91
"C6_Oncogenic_signatures:C6_ALL_179_KRAS_BREAST_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_179_KRAS_BREAST_UP_V1_UP",122,-1.5267,0.0049,0.0099,1.2857,0.047,0.41,1.5351,0.004,0.056
"C6_Oncogenic_signatures:C6_ALL_45_ATM_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_45_ATM_DN_V1_DN",141,-1.5267,0.0059,0.0098,-1.3836,0.019,0.34,-1.1608,0.14,0.45
"GO_BP:497076_GO_0018101_PROTEIN_CITRULLINATION","GO_BP","497076_GO_0018101_PROTEIN_CITRULLINATION",5,-1.5267,0.021,0.095,-1.2902,0.17,0.88,1.1514,0.33,0.73
"GO_BP:492620_GO_0008299_ISOPRENOID_BIOSYNTHETIC_PROCESS","GO_BP","492620_GO_0008299_ISOPRENOID_BIOSYNTHETIC_PROCESS",25,-1.5265,0.038,0.095,-1.0955,0.31,0.95,-1.0923,0.3,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_299_SABATES_COLORECTAL_ADENOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_299_SABATES_COLORECTAL_ADENOMA_DN",266,-1.5265,0,0.054,1.3276,0.0077,0.36,1.4142,0.0039,0.54
"GO_BP:514040_GO_0060485_MESENCHYME_DEVELOPMENT","GO_BP","514040_GO_0060485_MESENCHYME_DEVELOPMENT",160,-1.5265,0,0.095,-0.9387,0.61,1,1.4811,0,0.58
"GO_BP:492013_GO_0007215_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","492013_GO_0007215_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY",39,-1.5264,0.016,0.095,-1.2811,0.13,0.89,1.8258,0.002,0.26
"GO_BP:518348_GO_0090208_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS","GO_BP","518348_GO_0090208_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS",18,-1.5263,0.047,0.095,-0.8939,0.6,1,-0.8508,0.65,0.96
"GO_BP:948899_GO_1902744_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION","GO_BP","948899_GO_1902744_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION",5,-1.5263,0.031,0.095,0.8071,0.7,1,0.6434,0.89,1
"GO_BP:509094_GO_0046883_REGULATION_OF_HORMONE_SECRETION","GO_BP","509094_GO_0046883_REGULATION_OF_HORMONE_SECRETION",237,-1.5261,0.0011,0.095,0.9333,0.69,1,0.9134,0.71,0.93
"GO_MF:490537_GO_0005342_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490537_GO_0005342_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",118,-1.5261,0.0037,0.13,-1.1852,0.13,0.78,-0.9109,0.68,0.87
"C6_Oncogenic_signatures:C6_ALL_88_MTOR_UP_N4_V1_UP","C6_Oncogenic_signatures","C6_ALL_88_MTOR_UP_N4_V1_UP",194,-1.526,0.0011,0.0097,-0.7112,0.99,1,-1.0655,0.31,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1842_ZHOU_TNF_SIGNALING_30MIN","C2_Chemical_and_genetic_perturbations","C2_CGP_1842_ZHOU_TNF_SIGNALING_30MIN",53,-1.526,0.015,0.054,0.8545,0.73,0.97,-0.9317,0.59,0.84
"C7_Immunologic_signatures:C7_ALL_1041_GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP","C7_Immunologic_signatures","C7_ALL_1041_GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP",198,-1.5259,0.0011,0.0043,-1.1466,0.15,1,-1.3479,0.014,0.098
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_32_BIOCARTA_CCR3_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_32_BIOCARTA_CCR3_PATHWAY",20,-1.5258,0.033,0.12,-1.0182,0.43,1,-0.821,0.74,0.89
"GO_MF:489706_GO_0004340_GLUCOKINASE_ACTIVITY","GO_MF","489706_GO_0004340_GLUCOKINASE_ACTIVITY",5,-1.5258,0.03,0.13,-1.1936,0.27,0.8,-1.2342,0.25,0.58
"C7_Immunologic_signatures:C7_ALL_442_GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN","C7_Immunologic_signatures","C7_ALL_442_GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN",199,-1.5257,0,0.0043,0.8164,0.94,1,-1.2943,0.029,0.14
"GO_BP:511739_GO_0050768_NEGATIVE_REGULATION_OF_NEUROGENESIS","GO_BP","511739_GO_0050768_NEGATIVE_REGULATION_OF_NEUROGENESIS",191,-1.5257,0,0.095,-1.0726,0.29,0.96,1.153,0.13,0.73
"C7_Immunologic_signatures:C7_ALL_901_GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP","C7_Immunologic_signatures","C7_ALL_901_GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP",197,-1.5253,0.0011,0.0044,0.8133,0.95,1,-1.3011,0.024,0.14
"C2_Chemical_and_genetic_perturbations:C2_CGP_1119_PETRETTO_CARDIAC_HYPERTROPHY","C2_Chemical_and_genetic_perturbations","C2_CGP_1119_PETRETTO_CARDIAC_HYPERTROPHY",34,-1.5252,0.031,0.054,-0.6864,0.94,1,-1.1373,0.25,0.59
"WikiPathways:198790_WP262_EBV_LMP1_SIGNALING","WikiPathways","198790_WP262_EBV_LMP1_SIGNALING",22,-1.5251,0.032,0.06,-0.8986,0.62,1,-1.1532,0.27,0.58
"GO_BP:491914_GO_0007095_MITOTIC_G2_DNA_DAMAGE_CHECKPOINT","GO_BP","491914_GO_0007095_MITOTIC_G2_DNA_DAMAGE_CHECKPOINT",15,-1.525,0.038,0.096,-0.794,0.76,1,-1.1665,0.25,0.73
"GO_BP:495294_GO_0014902_MYOTUBE_DIFFERENTIATION","GO_BP","495294_GO_0014902_MYOTUBE_DIFFERENTIATION",49,-1.525,0.018,0.096,-1.2347,0.15,0.9,-1.4899,0.018,0.53
"GO_MF:489533_GO_0004065_ARYLSULFATASE_ACTIVITY","GO_MF","489533_GO_0004065_ARYLSULFATASE_ACTIVITY",12,-1.525,0.046,0.13,-0.9708,0.49,0.94,-1.2249,0.22,0.58
"GO_BP:505341_GO_0042180_CELLULAR_KETONE_METABOLIC_PROCESS","GO_BP","505341_GO_0042180_CELLULAR_KETONE_METABOLIC_PROCESS",64,-1.525,0.019,0.096,-0.7645,0.87,1,-1.2189,0.13,0.71
"GO_BP:487445_GO_0042136_NEUROTRANSMITTER_BIOSYNTHETIC_PROCESS","GO_BP","487445_GO_0042136_NEUROTRANSMITTER_BIOSYNTHETIC_PROCESS",16,-1.5249,0.033,0.096,-0.8096,0.72,1,-1.3136,0.13,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_5_WINTER_HYPOXIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_5_WINTER_HYPOXIA_UP",92,-1.5248,0.0051,0.055,-0.9695,0.53,1,-1.0568,0.33,0.68
"GO_BP:500184_GO_0030889_NEGATIVE_REGULATION_OF_B_CELL_PROLIFERATION","GO_BP","500184_GO_0030889_NEGATIVE_REGULATION_OF_B_CELL_PROLIFERATION",15,-1.5247,0.049,0.096,1.0286,0.43,0.97,0.7195,0.85,1
"C6_Oncogenic_signatures:C6_ALL_96_ESC_J1_UP_LATE_V1_UP","C6_Oncogenic_signatures","C6_ALL_96_ESC_J1_UP_LATE_V1_UP",176,-1.5247,0.0023,0.0098,-1.2737,0.059,0.35,-1.2415,0.058,0.32
"GO_BP:517546_GO_0072643_INTERFERON_GAMMA_SECRETION","GO_BP","517546_GO_0072643_INTERFERON_GAMMA_SECRETION",8,-1.5247,0.051,0.096,-0.7875,0.71,1,-0.9666,0.5,0.88
"C7_Immunologic_signatures:C7_ALL_12_KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_12_KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN",199,-1.5246,0.0011,0.0044,1.418,0.0049,0.032,-1.2924,0.022,0.15
"REACTOME:1127530_REACT_263890_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4","REACTOME","1127530_REACT_263890_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4",15,-1.5244,0.032,0.11,0.7116,0.88,1,1.0662,0.38,0.95
"GO_BP:516727_GO_0071804_CELLULAR_POTASSIUM_ION_TRANSPORT","GO_BP","516727_GO_0071804_CELLULAR_POTASSIUM_ION_TRANSPORT",129,-1.5244,0.0036,0.096,-1.2259,0.11,0.88,1.272,0.063,0.69
"GO_BP:500870_GO_0031620_REGULATION_OF_FEVER_GENERATION","GO_BP","500870_GO_0031620_REGULATION_OF_FEVER_GENERATION",8,-1.5242,0.046,0.096,-1.0559,0.39,0.97,1.3499,0.14,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_2221_ENGELMANN_CANCER_PROGENITORS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2221_ENGELMANN_CANCER_PROGENITORS_UP",46,-1.524,0.014,0.055,-0.8441,0.73,1,-1.2742,0.13,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_3151_ZHU_SKIL_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3151_ZHU_SKIL_TARGETS_DN",9,-1.524,0.031,0.055,0.8325,0.67,0.97,-1.0601,0.39,0.68
"C4_Cancer_modules:C4_CM_257_MODULE_292","C4_Cancer_modules","C4_CM_257_MODULE_292",132,-1.5238,0.0061,0.048,1.5517,0.007,0.094,-0.9879,0.47,0.72
"REACTOME:1183607_REACT_355027_REGULATED_NECROSIS","REACTOME","1183607_REACT_355027_REGULATED_NECROSIS",16,-1.5237,0.028,0.11,0.4936,1,1,-0.7939,0.78,1
"GO_BP:492891_GO_0045909_POSITIVE_REGULATION_OF_VASODILATION","GO_BP","492891_GO_0045909_POSITIVE_REGULATION_OF_VASODILATION",26,-1.5236,0.041,0.096,1.3294,0.12,0.63,1.404,0.064,0.62
"GO_BP:518215_GO_0090075_RELAXATION_OF_MUSCLE","GO_BP","518215_GO_0090075_RELAXATION_OF_MUSCLE",20,-1.5236,0.047,0.096,-1.0825,0.33,0.95,-1.0325,0.38,0.82
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_102_BIOCARTA_GSK3_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_102_BIOCARTA_GSK3_PATHWAY",26,-1.5235,0.031,0.12,0.9052,0.6,0.91,0.8077,0.79,1
"KEGG_pathway:HSA05131_SHIGELLOSIS","KEGG_pathway","HSA05131_SHIGELLOSIS",64,-1.5235,0.017,0.028,0.9738,0.5,0.96,-0.7894,0.87,0.95
"GO_MF:490488_GO_0005254_CHLORIDE_CHANNEL_ACTIVITY","GO_MF","490488_GO_0005254_CHLORIDE_CHANNEL_ACTIVITY",68,-1.5235,0.012,0.13,-0.9582,0.53,0.95,1.1663,0.17,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2040_BAFNA_MUC4_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2040_BAFNA_MUC4_TARGETS_DN",5,-1.5234,0.024,0.055,-1.2014,0.28,0.8,0.5798,0.93,1
"C3_MicroRNA_targets:C3_MIR_83_GTGACTT_MIR_224","C3_MicroRNA_targets","C3_MIR_83_GTGACTT_MIR_224",156,-1.5234,0.0024,0.24,-0.9983,0.46,1,-1.1244,0.19,1
"KEGG_compound:C00114_CHOLINE_BILINEURINE","KEGG_compound","C00114_CHOLINE_BILINEURINE",12,-1.5234,0.048,0.15,-0.6319,0.92,1,0.8064,0.77,0.87
"C3_MicroRNA_targets:C3_MIR_219_AGTGCGT_MIR_521","C3_MicroRNA_targets","C3_MIR_219_AGTGCGT_MIR_521",6,-1.5234,0.03,0.21,-1.3742,0.12,0.66,-0.8097,0.72,1
"GO_MF:499364_GO_0022804_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","499364_GO_0022804_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",328,-1.5233,0,0.13,-1.1885,0.076,0.79,-1.1085,0.17,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_3363_LIM_MAMMARY_LUMINAL_PROGENITOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3363_LIM_MAMMARY_LUMINAL_PROGENITOR_UP",54,-1.5233,0.013,0.055,-0.8792,0.69,1,-0.8674,0.73,0.91
"GO_MF:490356_GO_0005088_RAS_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY","GO_MF","490356_GO_0005088_RAS_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",127,-1.5233,0.0036,0.13,-1.4675,0.0089,0.59,-0.9489,0.6,0.83
"GO_BP:911354_GO_0097527_NECROPTOTIC_SIGNALING_PATHWAY","GO_BP","911354_GO_0097527_NECROPTOTIC_SIGNALING_PATHWAY",6,-1.5233,0.046,0.096,0.7802,0.73,1,-0.6387,0.91,1
"C6_Oncogenic_signatures:C6_ALL_159_KRAS_AMP_LUNG_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_159_KRAS_AMP_LUNG_UP_V1_UP",128,-1.5232,0.0035,0.01,-1.096,0.26,0.57,1.1592,0.16,0.33
"GO_MF:504276_GO_0035091_PHOSPHATIDYLINOSITOL_BINDING","GO_MF","504276_GO_0035091_PHOSPHATIDYLINOSITOL_BINDING",184,-1.523,0.0023,0.13,-0.8464,0.87,1,-1.1994,0.098,0.59
"KEGG_compound:C00054_ADENOSINE_3_5_BISPHOSPHATE_PAP_3_PHOSPHOADENYLATE_PHOSPHOADENOSINE_PHOSPHATE","KEGG_compound","C00054_ADENOSINE_3_5_BISPHOSPHATE_PAP_3_PHOSPHOADENYLATE_PHOSPHOADENOSINE_PHOSPHATE",18,-1.523,0.04,0.15,1.3039,0.12,0.73,-1.1446,0.26,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_889_TSAI_RESPONSE_TO_IONIZING_RADIATION","C2_Chemical_and_genetic_perturbations","C2_CGP_889_TSAI_RESPONSE_TO_IONIZING_RADIATION",145,-1.5229,0.0023,0.055,0.8993,0.71,0.93,-1.0416,0.37,0.7
"C7_Immunologic_signatures:C7_ALL_178_GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN","C7_Immunologic_signatures","C7_ALL_178_GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN",197,-1.5227,0.0023,0.0046,1.1505,0.13,0.32,1.0293,0.37,1
"GO_MF:507608_GO_0045236_CXCR_CHEMOKINE_RECEPTOR_BINDING","GO_MF","507608_GO_0045236_CXCR_CHEMOKINE_RECEPTOR_BINDING",16,-1.5226,0.039,0.13,1.232,0.18,0.7,-1.2517,0.19,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_590_CHASSOT_SKIN_WOUND","C2_Chemical_and_genetic_perturbations","C2_CGP_590_CHASSOT_SKIN_WOUND",10,-1.5225,0.044,0.055,-1.5276,0.04,0.45,-0.654,0.89,0.99
"KEGG_compound:C00535_TESTOSTERONE_17BETA_HYDROXY_4_ANDROSTEN_3_ONE","KEGG_compound","C00535_TESTOSTERONE_17BETA_HYDROXY_4_ANDROSTEN_3_ONE",31,-1.5225,0.023,0.15,1.7619,0,0.049,1.8903,0,0.0057
"C3_TF_targets:C3_TFT_341_V_LBP1_Q6","C3_TF_targets","C3_TFT_341_V_LBP1_Q6",219,-1.5224,0,0.019,-1.1123,0.19,0.51,-1.2377,0.052,0.3
"C7_Immunologic_signatures:C7_ALL_807_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_807_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP",191,-1.5222,0.0011,0.0046,-1.051,0.31,1,-1.0895,0.24,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_3230_IKEDA_MIR30_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3230_IKEDA_MIR30_TARGETS_UP",116,-1.5221,0.0087,0.055,0.7892,0.94,1,-0.7627,0.94,0.97
"GO_BP:750856_GO_0035929_STEROID_HORMONE_SECRETION","GO_BP","750856_GO_0035929_STEROID_HORMONE_SECRETION",5,-1.5221,0.026,0.097,0.8087,0.68,1,1.1644,0.3,0.73
"C3_TF_targets:C3_TFT_175_V_EGR3_01","C3_TF_targets","C3_TFT_175_V_EGR3_01",85,-1.5219,0.0099,0.019,-1.0702,0.32,0.61,-0.797,0.9,1
"C7_Immunologic_signatures:C7_ALL_384_GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_384_GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN",183,-1.5219,0.0011,0.0046,-1.5031,0.0051,0.065,-1.0904,0.23,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_3289_DELACROIX_RAR_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3289_DELACROIX_RAR_TARGETS_DN",24,-1.5218,0.045,0.056,-0.921,0.59,1,1.3523,0.093,0.56
"GO_BP:511899_GO_0050965_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN","GO_BP","511899_GO_0050965_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN",10,-1.5217,0.052,0.097,-1.1022,0.32,0.94,-1.2236,0.21,0.71
"C3_TF_targets:C3_TFT_77_V_CEBPA_01","C3_TF_targets","C3_TFT_77_V_CEBPA_01",240,-1.5217,0.0011,0.018,-1.0126,0.43,0.73,-1.0903,0.22,0.57
"GO_BP:503535_GO_0034332_ADHERENS_JUNCTION_ORGANIZATION","GO_BP","503535_GO_0034332_ADHERENS_JUNCTION_ORGANIZATION",70,-1.5216,0.012,0.097,-0.9031,0.65,1,1.0921,0.29,0.77
"C7_Immunologic_signatures:C7_ALL_1190_GSE27786_BCELL_VS_MONO_MAC_DN","C7_Immunologic_signatures","C7_ALL_1190_GSE27786_BCELL_VS_MONO_MAC_DN",196,-1.5216,0.0011,0.0046,-1.025,0.4,1,-1.2063,0.074,0.27
"GO_BP:498076_GO_0019221_CYTOKINE_MEDIATED_SIGNALING_PATHWAY","GO_BP","498076_GO_0019221_CYTOKINE_MEDIATED_SIGNALING_PATHWAY",372,-1.5215,0,0.098,1.2183,0.041,0.76,-1.0094,0.42,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_44_FOURNIER_ACINAR_DEVELOPMENT_LATE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_44_FOURNIER_ACINAR_DEVELOPMENT_LATE_DN",21,-1.5215,0.04,0.056,1.069,0.37,0.68,-0.7543,0.84,0.97
"GO_BP:503923_GO_0034723_DNA_REPLICATION_DEPENDENT_NUCLEOSOME_ORGANIZATION","GO_BP","503923_GO_0034723_DNA_REPLICATION_DEPENDENT_NUCLEOSOME_ORGANIZATION",32,-1.5215,0.023,0.098,-1.8271,0.0038,0.4,-1.595,0.017,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_2824_GYORFFY_MITOXANTRONE_RESISTANCE","C2_Chemical_and_genetic_perturbations","C2_CGP_2824_GYORFFY_MITOXANTRONE_RESISTANCE",54,-1.5213,0.019,0.056,0.7778,0.87,1,0.9662,0.53,0.97
"C3_TF_targets:C3_TFT_200_V_FREAC2_01","C3_TF_targets","C3_TFT_200_V_FREAC2_01",248,-1.5212,0,0.018,-0.797,0.95,1,-1.0052,0.45,0.75
"GO_CC:499504_GO_0030056_HEMIDESMOSOME","GO_CC","499504_GO_0030056_HEMIDESMOSOME",9,-1.5211,0.052,0.13,-1.0208,0.43,0.84,-0.9561,0.52,1
"GO_MF:496495_GO_0016538_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY","GO_MF","496495_GO_0016538_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY",20,-1.5211,0.027,0.13,-1.3843,0.086,0.65,-1.4423,0.058,0.43
"GO_BP:755305_GO_2001199_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION","GO_BP","755305_GO_2001199_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION",5,-1.5208,0.023,0.098,-0.9059,0.57,1,-1.1271,0.35,0.75
"KEGG_pathway:HSA00030_PENTOSE_PHOSPHATE_PATHWAY","KEGG_pathway","HSA00030_PENTOSE_PHOSPHATE_PATHWAY",29,-1.5208,0.04,0.029,0.9062,0.61,1,-0.8432,0.7,0.9
"GO_MF:490337_GO_0005057_RECEPTOR_SIGNALING_PROTEIN_ACTIVITY","GO_MF","490337_GO_0005057_RECEPTOR_SIGNALING_PROTEIN_ACTIVITY",149,-1.5208,0.0048,0.13,-1.0485,0.33,0.86,-0.9697,0.51,0.8
"C3_TF_targets:C3_TFT_613_TGANNYRGCA_V_TCF11MAFG_01","C3_TF_targets","C3_TFT_613_TGANNYRGCA_V_TCF11MAFG_01",294,-1.5207,0,0.018,-0.969,0.54,0.82,-1.1629,0.076,0.43
"GO_BP:511814_GO_0050872_WHITE_FAT_CELL_DIFFERENTIATION","GO_BP","511814_GO_0050872_WHITE_FAT_CELL_DIFFERENTIATION",12,-1.5206,0.045,0.098,0.9443,0.53,1,-0.795,0.73,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1333_KIM_GERMINAL_CENTER_T_HELPER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1333_KIM_GERMINAL_CENTER_T_HELPER_DN",24,-1.5205,0.024,0.056,0.7039,0.9,1,0.7644,0.81,1
"GO_BP:511983_GO_0051058_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION","GO_BP","511983_GO_0051058_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION",42,-1.5205,0.021,0.098,-0.8851,0.66,1,-0.7037,0.94,0.99
"KEGG_pathway:HSA05322_SYSTEMIC_LUPUS_ERYTHEMATOSUS","KEGG_pathway","HSA05322_SYSTEMIC_LUPUS_ERYTHEMATOSUS",125,-1.5205,0.0036,0.029,-1.4093,0.019,0.41,-1.3505,0.023,0.21
"GO_MF:500248_GO_0030955_POTASSIUM_ION_BINDING","GO_MF","500248_GO_0030955_POTASSIUM_ION_BINDING",8,-1.5203,0.039,0.13,-1.4687,0.056,0.6,-1.4102,0.094,0.48
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_159_BIOCARTA_PML_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_159_BIOCARTA_PML_PATHWAY",17,-1.5202,0.055,0.12,-0.5996,0.96,1,-1.223,0.21,0.59
"C7_Immunologic_signatures:C7_ALL_1390_GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN","C7_Immunologic_signatures","C7_ALL_1390_GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN",197,-1.5201,0.0011,0.0048,1.326,0.024,0.08,-0.7992,0.96,1
"C7_Immunologic_signatures:C7_ALL_922_GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN","C7_Immunologic_signatures","C7_ALL_922_GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN",193,-1.5201,0.0023,0.0048,-1.1656,0.12,0.94,-1.1385,0.16,0.39
"GO_CC:490889_GO_0005884_ACTIN_FILAMENT","GO_CC","490889_GO_0005884_ACTIN_FILAMENT",77,-1.5199,0.01,0.13,-0.7878,0.87,1,-0.921,0.62,1
"C7_Immunologic_signatures:C7_ALL_498_GSE17721_CTRL_VS_CPG_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_498_GSE17721_CTRL_VS_CPG_1H_BMDM_DN",197,-1.5199,0.0011,0.0048,-1.1358,0.18,1,-1.0271,0.37,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_62_GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_62_GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP",39,-1.5197,0.026,0.056,0.8422,0.74,0.97,-0.6677,0.97,0.99
"GO_BP:491689_GO_0006821_CHLORIDE_TRANSPORT","GO_BP","491689_GO_0006821_CHLORIDE_TRANSPORT",89,-1.5197,0.009,0.099,-1.0146,0.4,0.98,-1.2018,0.14,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2151_AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G","C2_Chemical_and_genetic_perturbations","C2_CGP_2151_AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G",171,-1.5196,0.0023,0.056,0.9726,0.56,0.83,-0.888,0.79,0.9
"GO_MF:490002_GO_0004675_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY","GO_MF","490002_GO_0004675_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",16,-1.5195,0.057,0.13,-0.6385,0.93,1,0.9046,0.58,0.95
"GO_BP:496153_GO_0016054_ORGANIC_ACID_CATABOLIC_PROCESS","GO_BP","496153_GO_0016054_ORGANIC_ACID_CATABOLIC_PROCESS",196,-1.5193,0,0.099,0.9035,0.75,1,-1.3531,0.019,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_3368_DURAND_STROMA_NS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3368_DURAND_STROMA_NS_UP",161,-1.5193,0.0048,0.056,-1.0257,0.37,0.98,-1.2715,0.043,0.46
"GO_BP:513566_GO_0060008_SERTOLI_CELL_DIFFERENTIATION","GO_BP","513566_GO_0060008_SERTOLI_CELL_DIFFERENTIATION",21,-1.5192,0.037,0.099,-1.9331,0.0019,0.27,-1.5336,0.036,0.54
"C7_Immunologic_signatures:C7_ALL_576_GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_576_GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_DN",197,-1.5191,0,0.0048,-0.9697,0.52,1,-1.0071,0.44,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_3007_SASSON_RESPONSE_TO_FORSKOLIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3007_SASSON_RESPONSE_TO_FORSKOLIN_UP",90,-1.5191,0.013,0.056,0.9775,0.49,0.82,-0.976,0.5,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_2215_RIGGI_EWING_SARCOMA_PROGENITOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2215_RIGGI_EWING_SARCOMA_PROGENITOR_DN",185,-1.5191,0.0035,0.056,1.1996,0.096,0.49,1.5749,0,0.42
"KEGG_compound:C03681_5ALPHA_PREGNANE_3_20_DIONE_5ALPHA_DIHYDROPROGESTERONE","KEGG_compound","C03681_5ALPHA_PREGNANE_3_20_DIONE_5ALPHA_DIHYDROPROGESTERONE",7,-1.519,0.027,0.15,-0.7048,0.82,1,-0.7875,0.74,0.85
"C4_Cancer_modules:C4_CM_138_MODULE_146","C4_Cancer_modules","C4_CM_138_MODULE_146",100,-1.519,0.0073,0.05,1.1485,0.2,0.46,1.5453,0.002,0.19
"C2_Chemical_and_genetic_perturbations:C2_CGP_271_ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_271_ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP",82,-1.519,0.0078,0.056,1.0157,0.41,0.78,-0.9793,0.49,0.78
"C7_Immunologic_signatures:C7_ALL_1178_GSE27786_BCELL_VS_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1178_GSE27786_BCELL_VS_CD4_TCELL_DN",194,-1.5189,0.0035,0.0048,0.8697,0.83,1,-1.013,0.41,0.7
"C3_TF_targets:C3_TFT_123_V_AP4_Q6","C3_TF_targets","C3_TFT_123_V_AP4_Q6",219,-1.5187,0,0.019,-1.4386,0.0074,0.15,-1.2867,0.043,0.26
"GO_MF:498750_GO_0019992_DIACYLGLYCEROL_BINDING","GO_MF","498750_GO_0019992_DIACYLGLYCEROL_BINDING",10,-1.5187,0.042,0.13,0.8632,0.62,1,0.7686,0.79,1
"C7_Immunologic_signatures:C7_ALL_659_GSE17721_LPS_VS_CPG_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_659_GSE17721_LPS_VS_CPG_4H_BMDM_UP",196,-1.5186,0.0022,0.0049,0.8946,0.77,1,-1.0481,0.33,0.61
"GO_BP:516147_GO_0071221_CELLULAR_RESPONSE_TO_BACTERIAL_LIPOPEPTIDE","GO_BP","516147_GO_0071221_CELLULAR_RESPONSE_TO_BACTERIAL_LIPOPEPTIDE",5,-1.5185,0.027,0.099,0.8111,0.69,1,0.9697,0.52,0.89
"GO_BP:751342_GO_0038084_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY","GO_BP","751342_GO_0038084_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY",14,-1.5185,0.049,0.099,-0.8937,0.58,1,-1.2486,0.18,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_1573_ABBUD_LIF_SIGNALING_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1573_ABBUD_LIF_SIGNALING_2_DN",7,-1.5184,0.049,0.056,1.2766,0.19,0.42,-1.1881,0.28,0.53
"GO_MF:494614_GO_0051879_HSP90_PROTEIN_BINDING","GO_MF","494614_GO_0051879_HSP90_PROTEIN_BINDING",19,-1.5184,0.052,0.13,0.8117,0.73,1,-1.4353,0.076,0.44
"GO_BP:494659_GO_0010595_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION","GO_BP","494659_GO_0010595_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION",59,-1.5183,0.021,0.099,-0.915,0.62,1,0.9928,0.44,0.86
"GO_MF:490490_GO_0005261_CATION_CHANNEL_ACTIVITY","GO_MF","490490_GO_0005261_CATION_CHANNEL_ACTIVITY",287,-1.5183,0,0.13,-1.5817,0,0.45,1.1559,0.12,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_821_WEINMANN_ADAPTATION_TO_HYPOXIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_821_WEINMANN_ADAPTATION_TO_HYPOXIA_UP",28,-1.5182,0.034,0.057,-0.8215,0.77,1,-0.897,0.58,0.88
"GO_BP:498819_GO_0021535_CELL_MIGRATION_IN_HINDBRAIN","GO_BP","498819_GO_0021535_CELL_MIGRATION_IN_HINDBRAIN",13,-1.5182,0.05,0.099,0.5374,0.98,1,-1.3499,0.13,0.61
"GO_MF:754436_GO_1901476_CARBOHYDRATE_TRANSPORTER_ACTIVITY","GO_MF","754436_GO_1901476_CARBOHYDRATE_TRANSPORTER_ACTIVITY",33,-1.5182,0.03,0.13,-1.0668,0.34,0.86,-0.9998,0.48,0.78
"C7_Immunologic_signatures:C7_ALL_401_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_401_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP",193,-1.5182,0.0011,0.0049,-1.0067,0.42,1,-1.2115,0.074,0.26
"GO_BP:512774_GO_0051924_REGULATION_OF_CALCIUM_ION_TRANSPORT","GO_BP","512774_GO_0051924_REGULATION_OF_CALCIUM_ION_TRANSPORT",183,-1.5181,0.0011,0.1,-1.1286,0.19,0.93,1.173,0.12,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_3255_PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2","C2_Chemical_and_genetic_perturbations","C2_CGP_3255_PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2",76,-1.518,0.011,0.057,0.691,0.99,1,1.3922,0.042,0.55
"C7_Immunologic_signatures:C7_ALL_1633_GSE3982_DC_VS_BASOPHIL_UP","C7_Immunologic_signatures","C7_ALL_1633_GSE3982_DC_VS_BASOPHIL_UP",196,-1.518,0.0024,0.0049,-0.7662,0.97,1,0.9867,0.48,1
"GO_BP:492281_GO_0007528_NEUROMUSCULAR_JUNCTION_DEVELOPMENT","GO_BP","492281_GO_0007528_NEUROMUSCULAR_JUNCTION_DEVELOPMENT",42,-1.5178,0.028,0.1,-1.0238,0.4,0.97,-0.7872,0.81,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2646_FERRANDO_HOX11_NEIGHBORS","C2_Chemical_and_genetic_perturbations","C2_CGP_2646_FERRANDO_HOX11_NEIGHBORS",23,-1.5178,0.036,0.057,0.7994,0.77,0.99,-1.1631,0.27,0.56
"GO_BP:515563_GO_0070633_TRANSEPITHELIAL_TRANSPORT","GO_BP","515563_GO_0070633_TRANSEPITHELIAL_TRANSPORT",13,-1.5177,0.035,0.1,-0.7744,0.78,1,0.7843,0.76,1
"GO_BP:518417_GO_0090277_POSITIVE_REGULATION_OF_PEPTIDE_HORMONE_SECRETION","GO_BP","518417_GO_0090277_POSITIVE_REGULATION_OF_PEPTIDE_HORMONE_SECRETION",64,-1.5176,0.017,0.1,0.7461,0.92,1,-0.8213,0.8,0.97
"GO_BP:495833_GO_0015698_INORGANIC_ANION_TRANSPORT","GO_BP","495833_GO_0015698_INORGANIC_ANION_TRANSPORT",171,-1.5176,0.0023,0.1,-1.0244,0.38,0.97,-1.13,0.18,0.75
"GO_BP:500531_GO_0031272_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY","GO_BP","500531_GO_0031272_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY",13,-1.5176,0.051,0.1,-1.0867,0.38,0.95,-1.1714,0.29,0.73
"C4_Cancer_modules:C4_CM_163_MODULE_173","C4_Cancer_modules","C4_CM_163_MODULE_173",16,-1.5175,0.042,0.05,0.7889,0.74,0.98,0.9688,0.51,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_869_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_869_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP",29,-1.5174,0.033,0.057,0.9902,0.5,0.81,-1.5527,0.024,0.27
"GO_BP:500829_GO_0031579_MEMBRANE_RAFT_ORGANIZATION","GO_BP","500829_GO_0031579_MEMBRANE_RAFT_ORGANIZATION",15,-1.5173,0.047,0.1,0.9838,0.49,1,1.1249,0.28,0.74
"GO_MF:489789_GO_0004435_PHOSPHATIDYLINOSITOL_PHOSPHOLIPASE_C_ACTIVITY","GO_MF","489789_GO_0004435_PHOSPHATIDYLINOSITOL_PHOSPHOLIPASE_C_ACTIVITY",28,-1.5172,0.029,0.13,-1.0875,0.34,0.85,0.9886,0.48,0.88
"KEGG_pathway:HSA04068_FOXO_SIGNALING_PATHWAY","KEGG_pathway","HSA04068_FOXO_SIGNALING_PATHWAY",132,-1.5172,0.0086,0.029,-0.8145,0.87,1,-1.0716,0.28,0.57
"C1_Positional:C1_ALL_103_CHR6Q23","C1_Positional","C1_ALL_103_CHR6Q23",51,-1.5171,0.015,0.28,1.0873,0.32,0.63,-1.1584,0.21,0.68
"GO_BP:491800_GO_0006957_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY","GO_BP","491800_GO_0006957_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY",13,-1.5171,0.027,0.1,-1.0371,0.4,0.98,1.1556,0.28,0.73
"REACTOME:106396_REACT_9020_TOLL_LIKE_RECEPTOR_7_8_TLR7_8_CASCADE","REACTOME","106396_REACT_9020_TOLL_LIKE_RECEPTOR_7_8_TLR7_8_CASCADE",89,-1.517,0.0076,0.12,-0.5606,1,1,-1.2116,0.13,0.59
"REACTOME:645332_REACT_121175_PI_METABOLISM","REACTOME","645332_REACT_121175_PI_METABOLISM",51,-1.517,0.018,0.12,-0.7999,0.84,1,-0.9317,0.56,0.93
"GO_BP:514462_GO_0060907_POSITIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION","GO_BP","514462_GO_0060907_POSITIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION",8,-1.517,0.029,0.1,0.993,0.45,0.99,0.8718,0.6,0.96
"C7_Immunologic_signatures:C7_ALL_1880_GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1880_GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN",199,-1.5169,0.0011,0.005,1.5542,0,0.0058,-1.1451,0.17,0.38
"GO_BP:513612_GO_0060054_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_WOUND_HEALING","GO_BP","513612_GO_0060054_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_WOUND_HEALING",5,-1.5168,0.028,0.1,-1.6069,0.014,0.71,-1.7613,0.0058,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_3329_BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE","C2_Chemical_and_genetic_perturbations","C2_CGP_3329_BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE",78,-1.5167,0.016,0.057,1.3583,0.036,0.33,-1.9588,0,0.063
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_55_BIOCARTA_P35ALZHEIMERS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_55_BIOCARTA_P35ALZHEIMERS_PATHWAY",11,-1.5167,0.048,0.12,-1.0868,0.35,1,-1.3524,0.12,0.47
"C3_TF_targets:C3_TFT_514_SMTTTTGT_UNKNOWN","C3_TF_targets","C3_TFT_514_SMTTTTGT_UNKNOWN",394,-1.5166,0,0.019,-1.1155,0.16,0.5,-1.1188,0.12,0.49
"C4_Cancer_modules:C4_CM_259_MODULE_294","C4_Cancer_modules","C4_CM_259_MODULE_294",18,-1.5165,0.036,0.05,-0.4326,1,1,-1.79,0.01,0.05
"C7_Immunologic_signatures:C7_ALL_1361_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP","C7_Immunologic_signatures","C7_ALL_1361_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP",185,-1.5164,0.0058,0.005,-1.1292,0.19,1,-1.2429,0.045,0.2
"GO_MF:490311_GO_0005024_TRANSFORMING_GROWTH_FACTOR_BETA_ACTIVATED_RECEPTOR_ACTIVITY","GO_MF","490311_GO_0005024_TRANSFORMING_GROWTH_FACTOR_BETA_ACTIVATED_RECEPTOR_ACTIVITY",16,-1.5164,0.041,0.13,-0.6461,0.92,1,0.9293,0.54,0.94
"C6_Oncogenic_signatures:C6_ALL_20_CYCLIN_D1_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_20_CYCLIN_D1_UP_V1_UP",184,-1.5164,0.0057,0.011,-1.0727,0.28,0.6,-0.8577,0.84,0.88
"C3_TF_targets:C3_TFT_268_V_STAT5A_01","C3_TF_targets","C3_TFT_268_V_STAT5A_01",246,-1.5164,0,0.019,-0.8869,0.78,0.98,-0.9659,0.57,0.81
"GO_BP:492900_GO_0008654_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS","GO_BP","492900_GO_0008654_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS",213,-1.5163,0.0011,0.1,-0.6968,1,1,-1.0008,0.43,0.85
"C3_TF_targets:C3_TFT_105_V_HSF1_01","C3_TF_targets","C3_TFT_105_V_HSF1_01",260,-1.5163,0,0.019,-1.3943,0.0066,0.17,-1.3147,0.019,0.26
"GO_BP:514859_GO_0061314_NOTCH_SIGNALING_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","514859_GO_0061314_NOTCH_SIGNALING_INVOLVED_IN_HEART_DEVELOPMENT",9,-1.5163,0.046,0.1,-1.2421,0.2,0.91,-0.9021,0.58,0.92
"KEGG_compound:C06002__S_METHYLMALONATE_SEMIALDEHYDE","KEGG_compound","C06002__S_METHYLMALONATE_SEMIALDEHYDE",11,-1.5161,0.047,0.15,0.6509,0.92,1,-1.3055,0.16,0.36
"GO_BP:755310_GO_2001204_REGULATION_OF_OSTEOCLAST_DEVELOPMENT","GO_BP","755310_GO_2001204_REGULATION_OF_OSTEOCLAST_DEVELOPMENT",7,-1.5161,0.033,0.1,-0.7123,0.84,1,0.7539,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_266_DITTMER_PTHLH_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_266_DITTMER_PTHLH_TARGETS_DN",72,-1.5161,0.012,0.057,1.2214,0.13,0.47,-0.8558,0.76,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_955_GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS","C2_Chemical_and_genetic_perturbations","C2_CGP_955_GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS",12,-1.516,0.051,0.057,1.1649,0.26,0.54,-1.0666,0.37,0.67
"C7_Immunologic_signatures:C7_ALL_1408_GSE360_CTRL_VS_L_DONOVANI_DC_DN","C7_Immunologic_signatures","C7_ALL_1408_GSE360_CTRL_VS_L_DONOVANI_DC_DN",195,-1.516,0,0.0051,0.8411,0.88,1,1.1843,0.097,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1816_KAAB_HEART_ATRIUM_VS_VENTRICLE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1816_KAAB_HEART_ATRIUM_VS_VENTRICLE_DN",257,-1.516,0.0011,0.057,1.4155,0.005,0.28,-1.1405,0.13,0.59
"GO_MF:503440_GO_0034235_GPI_ANCHOR_BINDING","GO_MF","503440_GO_0034235_GPI_ANCHOR_BINDING",8,-1.5159,0.031,0.13,-0.6109,0.94,1,-1.3812,0.11,0.52
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_135_BIOCARTA_CCR5_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_135_BIOCARTA_CCR5_PATHWAY",17,-1.5158,0.023,0.12,0.7117,0.85,1,1.1438,0.28,1
"GO_BP:505287_GO_0042113_B_CELL_ACTIVATION","GO_BP","505287_GO_0042113_B_CELL_ACTIVATION",132,-1.5157,0.0037,0.1,-0.7689,0.95,1,-1.6002,0.0021,0.51
"GO_BP:503349_GO_0034143_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY","GO_BP","503349_GO_0034143_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY",14,-1.5156,0.046,0.1,-0.9835,0.45,1,0.7637,0.79,1
"GO_BP:506555_GO_0043524_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS","GO_BP","506555_GO_0043524_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS",129,-1.5156,0.007,0.1,-1.0983,0.26,0.95,0.9571,0.53,0.9
"GO_MF:492768_GO_0008484_SULFURIC_ESTER_HYDROLASE_ACTIVITY","GO_MF","492768_GO_0008484_SULFURIC_ESTER_HYDROLASE_ACTIVITY",17,-1.5155,0.041,0.13,-1.0881,0.34,0.85,-1.0949,0.33,0.7
"GO_CC:487081_GO_0000788_NUCLEAR_NUCLEOSOME","GO_CC","487081_GO_0000788_NUCLEAR_NUCLEOSOME",37,-1.5155,0.034,0.13,-1.8062,0,0.22,-1.6551,0.0041,0.46
"GO_MF:490562_GO_0015291_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490562_GO_0015291_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",191,-1.5155,0.0023,0.13,-1.4828,0.0051,0.59,-1.0964,0.22,0.7
"REACTOME:905992_REACT_169325_ONCOGENE_INDUCED_SENESCENCE","REACTOME","905992_REACT_169325_ONCOGENE_INDUCED_SENESCENCE",30,-1.5154,0.032,0.12,0.6841,0.94,1,-1.4796,0.029,0.38
"GO_BP:491631_GO_0006750_GLUTATHIONE_BIOSYNTHETIC_PROCESS","GO_BP","491631_GO_0006750_GLUTATHIONE_BIOSYNTHETIC_PROCESS",16,-1.5153,0.041,0.1,0.5121,0.99,1,-1.5029,0.053,0.53
"GO_BP:489025_GO_0003231_CARDIAC_VENTRICLE_DEVELOPMENT","GO_BP","489025_GO_0003231_CARDIAC_VENTRICLE_DEVELOPMENT",93,-1.5152,0.0074,0.1,0.9031,0.7,1,1.3201,0.045,0.66
"GO_BP:750938_GO_0036015_RESPONSE_TO_INTERLEUKIN_3","GO_BP","750938_GO_0036015_RESPONSE_TO_INTERLEUKIN_3",5,-1.5151,0.022,0.1,0.6348,0.89,1,0.8488,0.61,0.98
"C7_Immunologic_signatures:C7_ALL_1790_GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1790_GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN",198,-1.5151,0.0022,0.0051,-0.5914,1,1,-1.3366,0.016,0.11
"GO_BP:493923_GO_0009820_ALKALOID_METABOLIC_PROCESS","GO_BP","493923_GO_0009820_ALKALOID_METABOLIC_PROCESS",11,-1.515,0.039,0.1,-1.1935,0.24,0.9,-1.4051,0.12,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_779_KORKOLA_YOLK_SAC_TUMOR","C2_Chemical_and_genetic_perturbations","C2_CGP_779_KORKOLA_YOLK_SAC_TUMOR",61,-1.515,0.018,0.058,-0.9659,0.51,1,-1.0818,0.31,0.65
"C0_Hallmark:H_ALL_39_HALLMARK_UV_RESPONSE_DN","C0_Hallmark","H_ALL_39_HALLMARK_UV_RESPONSE_DN",144,-1.515,0.0036,0.0088,1.245,0.075,0.17,1.1901,0.1,0.27
"GO_BP:511798_GO_0050854_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY","GO_BP","511798_GO_0050854_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY",35,-1.5149,0.032,0.1,0.7853,0.83,1,-0.9317,0.56,0.9
"GO_MF:490525_GO_0005319_LIPID_TRANSPORTER_ACTIVITY","GO_MF","490525_GO_0005319_LIPID_TRANSPORTER_ACTIVITY",91,-1.5149,0.014,0.13,-1.2602,0.11,0.84,1.2506,0.11,0.66
"GO_BP:499492_GO_0030033_MICROVILLUS_ASSEMBLY","GO_BP","499492_GO_0030033_MICROVILLUS_ASSEMBLY",17,-1.5149,0.043,0.1,0.7034,0.88,1,-1.2407,0.17,0.69
"GO_BP:754650_GO_1901699_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND","GO_BP","754650_GO_1901699_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND",493,-1.5148,0,0.1,-0.8063,1,1,-1.0846,0.18,0.79
"GO_BP:491606_GO_0006720_ISOPRENOID_METABOLIC_PROCESS","GO_BP","491606_GO_0006720_ISOPRENOID_METABOLIC_PROCESS",117,-1.5148,0.0061,0.1,-1.1151,0.24,0.94,-1.0738,0.31,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2811_FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2811_FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP",62,-1.5146,0.017,0.058,0.7492,0.92,1,-1.303,0.091,0.43
"GO_BP:512323_GO_0051445_REGULATION_OF_MEIOTIC_CELL_CYCLE","GO_BP","512323_GO_0051445_REGULATION_OF_MEIOTIC_CELL_CYCLE",36,-1.5145,0.027,0.1,-1.2288,0.17,0.89,-1.5699,0.011,0.52
"GO_BP:492270_GO_0007517_MUSCLE_ORGAN_DEVELOPMENT","GO_BP","492270_GO_0007517_MUSCLE_ORGAN_DEVELOPMENT",262,-1.5145,0.0011,0.1,-1.0978,0.2,0.95,-1.2186,0.061,0.71
"C4_Cancer_gene_neighborhoods:C4_CGN_422_GNF2_TTK","C4_Cancer_gene_neighborhoods","C4_CGN_422_GNF2_TTK",39,-1.5145,0.022,0.052,0.8131,0.78,0.98,-1.5909,0.012,0.072
"C2_Chemical_and_genetic_perturbations:C2_CGP_3316_KINNEY_DNMT1_METHYLATION_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3316_KINNEY_DNMT1_METHYLATION_TARGETS",13,-1.5144,0.05,0.058,-0.8354,0.69,1,-0.9339,0.56,0.84
"GO_BP:512165_GO_0051279_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL","GO_BP","512165_GO_0051279_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL",62,-1.5144,0.02,0.1,1.1191,0.26,0.88,0.8458,0.76,0.98
"GO_BP:508658_GO_0046395_CARBOXYLIC_ACID_CATABOLIC_PROCESS","GO_BP","508658_GO_0046395_CARBOXYLIC_ACID_CATABOLIC_PROCESS",196,-1.5143,0.0011,0.1,0.8878,0.76,1,-1.3458,0.0099,0.61
"GO_BP:499134_GO_0021854_HYPOTHALAMUS_DEVELOPMENT","GO_BP","499134_GO_0021854_HYPOTHALAMUS_DEVELOPMENT",24,-1.5141,0.044,0.1,0.774,0.82,1,-0.8062,0.76,0.99
"GO_BP:502067_GO_0032845_NEGATIVE_REGULATION_OF_HOMEOSTATIC_PROCESS","GO_BP","502067_GO_0032845_NEGATIVE_REGULATION_OF_HOMEOSTATIC_PROCESS",90,-1.514,0.01,0.1,0.9172,0.66,1,-0.8257,0.82,0.97
"GO_MF:504358_GO_0035173_HISTONE_KINASE_ACTIVITY","GO_MF","504358_GO_0035173_HISTONE_KINASE_ACTIVITY",20,-1.5139,0.037,0.13,-0.8032,0.77,1,-1.4725,0.049,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_447_GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_447_GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP",186,-1.5139,0.0011,0.058,0.7241,1,1,0.8938,0.75,1
"C7_Immunologic_signatures:C7_ALL_818_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_818_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN",196,-1.5138,0,0.0053,0.7809,0.98,1,-1.3807,0.014,0.074
"GO_BP:1184555_GO_1904031_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY","GO_BP","1184555_GO_1904031_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY",20,-1.5135,0.04,0.1,-0.9587,0.52,1,-0.8725,0.64,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_574_WONG_ENDMETRIUM_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_574_WONG_ENDMETRIUM_CANCER_UP",25,-1.5135,0.026,0.058,-1.0851,0.31,0.94,1.0292,0.44,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1169_SHIN_B_CELL_LYMPHOMA_CLUSTER_7","C2_Chemical_and_genetic_perturbations","C2_CGP_1169_SHIN_B_CELL_LYMPHOMA_CLUSTER_7",27,-1.5134,0.032,0.058,-1.7019,0.0074,0.34,-1.4036,0.061,0.35
"C4_Cancer_modules:C4_CM_158_MODULE_168","C4_Cancer_modules","C4_CM_158_MODULE_168",22,-1.5133,0.037,0.051,-0.8324,0.72,0.97,-1.1961,0.2,0.41
"GO_BP:491700_GO_0006835_DICARBOXYLIC_ACID_TRANSPORT","GO_BP","491700_GO_0006835_DICARBOXYLIC_ACID_TRANSPORT",63,-1.5133,0.016,0.1,-1.1881,0.19,0.9,-1.1039,0.28,0.77
"GO_MF:500653_GO_0031402_SODIUM_ION_BINDING","GO_MF","500653_GO_0031402_SODIUM_ION_BINDING",6,-1.5132,0.037,0.13,-1.5092,0.052,0.55,-1.356,0.13,0.52
"C7_Immunologic_signatures:C7_ALL_1075_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP","C7_Immunologic_signatures","C7_ALL_1075_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP",195,-1.513,0,0.0053,0.9488,0.61,0.9,-1.184,0.094,0.31
"GO_BP:513893_GO_0060337_TYPE_I_INTERFERON_SIGNALING_PATHWAY","GO_BP","513893_GO_0060337_TYPE_I_INTERFERON_SIGNALING_PATHWAY",65,-1.513,0.0093,0.1,1.1939,0.16,0.79,-1.6762,0.004,0.58
"C7_Immunologic_signatures:C7_ALL_800_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_800_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN",200,-1.5129,0,0.0053,0.695,1,1,-1.3922,0.0061,0.067
"GO_BP:506359_GO_0043299_LEUKOCYTE_DEGRANULATION","GO_BP","506359_GO_0043299_LEUKOCYTE_DEGRANULATION",31,-1.5129,0.022,0.1,0.9779,0.49,1,-1.0929,0.33,0.78
"GO_BP:518898_GO_2000251_POSITIVE_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION","GO_BP","518898_GO_2000251_POSITIVE_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION",12,-1.5128,0.039,0.1,-1.0692,0.38,0.96,-1.5626,0.043,0.52
"C7_Immunologic_signatures:C7_ALL_1826_GSE7852_TREG_VS_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1826_GSE7852_TREG_VS_TCONV_DN",200,-1.5128,0,0.0053,0.7298,1,1,-0.8471,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2659_CROONQUIST_IL6_DEPRIVATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2659_CROONQUIST_IL6_DEPRIVATION_DN",98,-1.5128,0.009,0.058,-0.762,0.93,1,-1.887,0,0.082
"C7_Immunologic_signatures:C7_ALL_1288_GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN","C7_Immunologic_signatures","C7_ALL_1288_GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN",197,-1.5127,0,0.0053,0.9323,0.7,0.95,-1.5431,0,0.012
"GO_BP:502007_GO_0032781_POSITIVE_REGULATION_OF_ATPASE_ACTIVITY","GO_BP","502007_GO_0032781_POSITIVE_REGULATION_OF_ATPASE_ACTIVITY",29,-1.5127,0.036,0.1,-1.1366,0.25,0.93,-1.0655,0.36,0.8
"GO_BP:512184_GO_0051299_CENTROSOME_SEPARATION","GO_BP","512184_GO_0051299_CENTROSOME_SEPARATION",7,-1.5127,0.049,0.1,-1.0528,0.4,0.97,-1.3112,0.16,0.64
"GO_MF:495592_GO_0015368_CALCIUM_CATION_ANTIPORTER_ACTIVITY","GO_MF","495592_GO_0015368_CALCIUM_CATION_ANTIPORTER_ACTIVITY",10,-1.5126,0.027,0.13,-0.6667,0.86,1,-0.941,0.53,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_140_DOANE_RESPONSE_TO_ANDROGEN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_140_DOANE_RESPONSE_TO_ANDROGEN_DN",237,-1.5126,0.0022,0.058,-0.7735,0.98,1,-1.2694,0.034,0.46
"GO_BP:500602_GO_0031343_POSITIVE_REGULATION_OF_CELL_KILLING","GO_BP","500602_GO_0031343_POSITIVE_REGULATION_OF_CELL_KILLING",50,-1.5125,0.026,0.1,-0.8114,0.77,1,-1.0452,0.39,0.81
"GO_BP:488612_GO_0002739_REGULATION_OF_CYTOKINE_SECRETION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488612_GO_0002739_REGULATION_OF_CYTOKINE_SECRETION_INVOLVED_IN_IMMUNE_RESPONSE",11,-1.5124,0.036,0.1,-0.731,0.81,1,0.8103,0.7,1
"GO_BP:491534_GO_0006644_PHOSPHOLIPID_METABOLIC_PROCESS","GO_BP","491534_GO_0006644_PHOSPHOLIPID_METABOLIC_PROCESS",288,-1.5123,0.0011,0.1,-0.8231,0.94,1,-0.9114,0.75,0.92
"WikiPathways:198827_WP710_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT_","WikiPathways","198827_WP710_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT_",91,-1.5122,0.012,0.066,-0.9116,0.64,1,-1.1216,0.23,0.57
"C4_Cancer_modules:C4_CM_55_MODULE_59","C4_Cancer_modules","C4_CM_55_MODULE_59",26,-1.5121,0.037,0.051,-1.3514,0.095,0.5,-1.0572,0.36,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_637_ROVERSI_GLIOMA_COPY_NUMBER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_637_ROVERSI_GLIOMA_COPY_NUMBER_DN",51,-1.5121,0.018,0.059,0.8753,0.69,0.95,-0.7951,0.86,0.96
"GO_BP:513693_GO_0060135_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY","GO_BP","513693_GO_0060135_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY",52,-1.512,0.02,0.1,-0.971,0.52,1,0.9254,0.57,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1801_PAL_PRMT5_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1801_PAL_PRMT5_TARGETS_DN",28,-1.512,0.017,0.059,-1.2053,0.19,0.8,-1.4107,0.064,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_1306_KANNAN_TP53_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1306_KANNAN_TP53_TARGETS_UP",58,-1.512,0.015,0.058,0.7714,0.91,1,-0.8195,0.8,0.94
"C7_Immunologic_signatures:C7_ALL_34_GSE10239_NAIVE_VS_DAY4_5_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_34_GSE10239_NAIVE_VS_DAY4_5_EFF_CD8_TCELL_DN",199,-1.5118,0.0023,0.0054,1.2697,0.038,0.13,-1.2941,0.03,0.14
"GO_BP:500539_GO_0031280_NEGATIVE_REGULATION_OF_CYCLASE_ACTIVITY","GO_BP","500539_GO_0031280_NEGATIVE_REGULATION_OF_CYCLASE_ACTIVITY",26,-1.5118,0.03,0.1,0.7379,0.86,1,1.1793,0.24,0.72
"GO_MF:495360_GO_0015077_MONOVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495360_GO_0015077_MONOVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",342,-1.5116,0.0011,0.13,-1.0512,0.3,0.86,0.8789,0.89,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_962_ALCALA_APOPTOSIS","C2_Chemical_and_genetic_perturbations","C2_CGP_962_ALCALA_APOPTOSIS",87,-1.5115,0.01,0.059,1.4979,0.017,0.21,-1.1877,0.14,0.53
"WikiPathways:672455_WP2035_FSH_SIGNALING_PATHWAY","WikiPathways","672455_WP2035_FSH_SIGNALING_PATHWAY",27,-1.5115,0.03,0.066,1.0538,0.37,1,0.4869,1,1
"REACTOME:645301_REACT_121288_KERATAN_SULFATE_KERATIN_METABOLISM","REACTOME","645301_REACT_121288_KERATAN_SULFATE_KERATIN_METABOLISM",33,-1.5115,0.029,0.12,0.5917,0.98,1,0.9869,0.47,1
"C3_TF_targets:C3_TFT_546_YGTCCTTGR_UNKNOWN","C3_TF_targets","C3_TFT_546_YGTCCTTGR_UNKNOWN",94,-1.5115,0.012,0.019,-1.3086,0.064,0.23,-0.8437,0.79,0.98
"GO_BP:517132_GO_0072216_POSITIVE_REGULATION_OF_METANEPHROS_DEVELOPMENT","GO_BP","517132_GO_0072216_POSITIVE_REGULATION_OF_METANEPHROS_DEVELOPMENT",14,-1.5115,0.039,0.1,1.057,0.38,0.94,1.1445,0.27,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1270_ASTON_MAJOR_DEPRESSIVE_DISORDER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1270_ASTON_MAJOR_DEPRESSIVE_DISORDER_DN",157,-1.5114,0.0024,0.059,-1.0708,0.29,0.95,-0.8484,0.85,0.93
"C3_MicroRNA_targets:C3_MIR_194_GTACAGG_MIR_486","C3_MicroRNA_targets","C3_MIR_194_GTACAGG_MIR_486",58,-1.5112,0.029,0.21,-0.8873,0.67,1,-1.0008,0.44,1
"C3_TF_targets:C3_TFT_262_V_ZIC1_01","C3_TF_targets","C3_TFT_262_V_ZIC1_01",255,-1.5111,0.0011,0.019,-1.3669,0.0088,0.19,-0.9508,0.61,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_997_MANTOVANI_VIRAL_GPCR_SIGNALING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_997_MANTOVANI_VIRAL_GPCR_SIGNALING_DN",49,-1.5111,0.02,0.059,-0.7963,0.82,1,-0.9437,0.58,0.83
"C7_Immunologic_signatures:C7_ALL_1236_GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1236_GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN",198,-1.5111,0.0034,0.0055,0.8703,0.84,1,-1.3052,0.025,0.13
"C2_Chemical_and_genetic_perturbations:C2_CGP_1737_IVANOVA_HEMATOPOIESIS_STEM_CELL","C2_Chemical_and_genetic_perturbations","C2_CGP_1737_IVANOVA_HEMATOPOIESIS_STEM_CELL",245,-1.5111,0.0011,0.059,-1.2893,0.026,0.71,-1.4306,0.0066,0.34
"KEGG_pathway:HSA05416_VIRAL_MYOCARDITIS","KEGG_pathway","HSA05416_VIRAL_MYOCARDITIS",56,-1.511,0.015,0.031,0.6297,0.99,1,-0.9045,0.64,0.85
"GO_BP:518841_GO_2000194_REGULATION_OF_FEMALE_GONAD_DEVELOPMENT","GO_BP","518841_GO_2000194_REGULATION_OF_FEMALE_GONAD_DEVELOPMENT",10,-1.5106,0.05,0.1,-0.9103,0.56,1,0.8969,0.59,0.95
"GO_BP:491692_GO_0006825_COPPER_ION_TRANSPORT","GO_BP","491692_GO_0006825_COPPER_ION_TRANSPORT",20,-1.5106,0.036,0.1,0.5632,0.97,1,0.6559,0.92,1
"GO_BP:491743_GO_0006882_CELLULAR_ZINC_ION_HOMEOSTASIS","GO_BP","491743_GO_0006882_CELLULAR_ZINC_ION_HOMEOSTASIS",14,-1.5106,0.059,0.1,-0.8955,0.63,1,-0.7671,0.8,1
"GO_MF:512305_GO_0051427_HORMONE_RECEPTOR_BINDING","GO_MF","512305_GO_0051427_HORMONE_RECEPTOR_BINDING",150,-1.5105,0.0036,0.13,-0.669,1,1,-0.9008,0.72,0.87
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_217_BIOCARTA_ACTINY_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_217_BIOCARTA_ACTINY_PATHWAY",20,-1.5104,0.052,0.12,1.24,0.19,0.66,-0.7744,0.81,0.93
"GO_BP:508085_GO_0045746_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY","GO_BP","508085_GO_0045746_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY",22,-1.5104,0.043,0.1,-1.5615,0.015,0.71,-1.2687,0.16,0.66
"C3_MicroRNA_targets:C3_MIR_106_GTAAGAT_MIR_200A","C3_MicroRNA_targets","C3_MIR_106_GTAAGAT_MIR_200A",54,-1.5102,0.025,0.2,1.1069,0.27,1,0.7873,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1839_RODWELL_AGING_KIDNEY_NO_BLOOD_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1839_RODWELL_AGING_KIDNEY_NO_BLOOD_UP",217,-1.5102,0.0011,0.059,1.153,0.13,0.55,0.9537,0.62,0.99
"KEGG_compound:C12126_DIHYDROCERAMIDE_N_ACYLSPHINGANINE","KEGG_compound","C12126_DIHYDROCERAMIDE_N_ACYLSPHINGANINE",11,-1.5101,0.047,0.16,-1.1438,0.28,0.85,-1.5357,0.034,0.21
"C3_TF_targets:C3_TFT_116_V_OCT1_05","C3_TF_targets","C3_TFT_116_V_OCT1_05",239,-1.5101,0.0022,0.019,-1.3335,0.016,0.2,0.8492,0.89,1
"GO_BP:516728_GO_0071805_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","516728_GO_0071805_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT",129,-1.51,0.0024,0.1,-1.2321,0.089,0.9,1.2803,0.055,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1760_BROWNE_HCMV_INFECTION_48HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1760_BROWNE_HCMV_INFECTION_48HR_UP",177,-1.5095,0,0.059,-0.9214,0.66,1,-1.4702,0.0041,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_2054_LEIN_MEDULLA_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_2054_LEIN_MEDULLA_MARKERS",80,-1.5095,0.0078,0.059,-0.7206,0.96,1,-0.937,0.6,0.84
"GO_BP:508078_GO_0045737_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY","GO_BP","508078_GO_0045737_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",20,-1.5093,0.039,0.1,-0.9562,0.51,1,-0.8716,0.66,0.95
"GO_BP:491073_GO_0006090_PYRUVATE_METABOLIC_PROCESS","GO_BP","491073_GO_0006090_PYRUVATE_METABOLIC_PROCESS",69,-1.5091,0.012,0.1,0.8164,0.84,1,-1.1971,0.17,0.73
"GO_BP:516271_GO_0071347_CELLULAR_RESPONSE_TO_INTERLEUKIN_1","GO_BP","516271_GO_0071347_CELLULAR_RESPONSE_TO_INTERLEUKIN_1",47,-1.5089,0.026,0.1,1.0108,0.43,0.98,1.1065,0.3,0.76
"GO_BP:505342_GO_0042181_KETONE_BIOSYNTHETIC_PROCESS","GO_BP","505342_GO_0042181_KETONE_BIOSYNTHETIC_PROCESS",28,-1.5089,0.047,0.1,-0.6538,0.95,1,0.8444,0.69,0.99
"GO_BP:502112_GO_0032890_REGULATION_OF_ORGANIC_ACID_TRANSPORT","GO_BP","502112_GO_0032890_REGULATION_OF_ORGANIC_ACID_TRANSPORT",52,-1.5088,0.018,0.1,-0.7202,0.93,1,-0.9592,0.53,0.88
"WikiPathways:198777_WP3_KEAP1_NRF2_PATHWAY","WikiPathways","198777_WP3_KEAP1_NRF2_PATHWAY",13,-1.5088,0.063,0.066,-0.5832,0.96,1,0.7343,0.82,1
"C7_Immunologic_signatures:C7_ALL_1622_GSE3982_MAST_CELL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1622_GSE3982_MAST_CELL_VS_NKCELL_DN",195,-1.5086,0.0068,0.0057,-0.8914,0.77,1,-1.1734,0.09,0.33
"GO_BP:491776_GO_0006925_INFLAMMATORY_CELL_APOPTOTIC_PROCESS","GO_BP","491776_GO_0006925_INFLAMMATORY_CELL_APOPTOTIC_PROCESS",7,-1.5084,0.053,0.1,0.7144,0.82,1,-1.0566,0.42,0.81
"KEGG_reaction:R03435_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_5_BISPHOSPHATE_INOSITOLTRISPHOSPHOHYDROLASE_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_H2O_D_MYO_INOSITOL_1_4_5_TRISPHOSPHATE_1_2_DIACYL_SN_GLYCEROL","KEGG_reaction","R03435_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_5_BISPHOSPHATE_INOSITOLTRISPHOSPHOHYDROLASE_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_H2O_D_MYO_INOSITOL_1_4_5_TRISPHOSPHATE_1_2_DIACYL_SN_GLYCEROL",13,-1.5084,0.044,0.16,-1.6693,0.021,0.048,-0.7973,0.75,0.84
"C7_Immunologic_signatures:C7_ALL_1061_GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP","C7_Immunologic_signatures","C7_ALL_1061_GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP",199,-1.5083,0,0.0057,1.1137,0.18,0.41,-1.4558,0.0041,0.033
"C7_Immunologic_signatures:C7_ALL_441_GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP","C7_Immunologic_signatures","C7_ALL_441_GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP",198,-1.5083,0,0.0057,0.7295,1,1,-0.9479,0.63,0.86
"GO_BP:508013_GO_0045665_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION","GO_BP","508013_GO_0045665_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION",146,-1.5081,0.0024,0.1,-0.9907,0.47,1,1.1047,0.23,0.76
"GO_CC:513761_GO_0060205_CYTOPLASMIC_MEMBRANE_BOUNDED_VESICLE_LUMEN","GO_CC","513761_GO_0060205_CYTOPLASMIC_MEMBRANE_BOUNDED_VESICLE_LUMEN",75,-1.508,0.012,0.14,1.741,0.0023,0.044,0.9215,0.63,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2109_KYNG_DNA_DAMAGE_BY_UV","C2_Chemical_and_genetic_perturbations","C2_CGP_2109_KYNG_DNA_DAMAGE_BY_UV",61,-1.5079,0.012,0.06,-0.6698,0.98,1,-0.8794,0.71,0.9
"GO_BP:519103_GO_2000463_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL","GO_BP","519103_GO_2000463_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL",19,-1.5079,0.038,0.1,-0.9826,0.46,1,1.3557,0.096,0.64
"C7_Immunologic_signatures:C7_ALL_810_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_810_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN",191,-1.5078,0,0.0057,1.1545,0.13,0.31,-0.9729,0.55,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_1608_REN_ALVEOLAR_RHABDOMYOSARCOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1608_REN_ALVEOLAR_RHABDOMYOSARCOMA_UP",96,-1.5078,0.005,0.06,-0.9532,0.57,1,-1.0926,0.28,0.64
"GO_BP:501726_GO_0032494_RESPONSE_TO_PEPTIDOGLYCAN","GO_BP","501726_GO_0032494_RESPONSE_TO_PEPTIDOGLYCAN",11,-1.5075,0.042,0.1,-0.6964,0.84,1,0.7088,0.85,1
"C3_TF_targets:C3_TFT_129_V_MYOD_Q6","C3_TF_targets","C3_TFT_129_V_MYOD_Q6",239,-1.5075,0,0.02,-1.6085,0,0.11,-1.5037,0,0.45
"GO_MF:492859_GO_0019887_PROTEIN_KINASE_REGULATOR_ACTIVITY","GO_MF","492859_GO_0019887_PROTEIN_KINASE_REGULATOR_ACTIVITY",128,-1.5073,0.0071,0.14,0.7547,0.97,1,-1.2005,0.11,0.59
"C7_Immunologic_signatures:C7_ALL_1195_GSE27786_CD4_TCELL_VS_NKTCELL_UP","C7_Immunologic_signatures","C7_ALL_1195_GSE27786_CD4_TCELL_VS_NKTCELL_UP",198,-1.5073,0.0023,0.0058,-0.9895,0.5,1,-1.5857,0,0.0068
"GO_BP:516925_GO_0072006_NEPHRON_DEVELOPMENT","GO_BP","516925_GO_0072006_NEPHRON_DEVELOPMENT",115,-1.5073,0.0085,0.1,-1.1102,0.25,0.94,0.9652,0.54,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1886_JACKSON_DNMT1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1886_JACKSON_DNMT1_TARGETS_DN",23,-1.5073,0.031,0.06,-1.6329,0.016,0.36,-0.9611,0.5,0.8
"GO_BP:514576_GO_0061028_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER","GO_BP","514576_GO_0061028_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER",29,-1.5072,0.025,0.1,0.9846,0.49,1,1.1599,0.24,0.73
"C7_Immunologic_signatures:C7_ALL_899_GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP","C7_Immunologic_signatures","C7_ALL_899_GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP",198,-1.5072,0,0.0058,0.9108,0.7,1,-0.8417,0.91,1
"GO_BP:754675_GO_1901724_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT","GO_BP","754675_GO_1901724_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",5,-1.5072,0.047,0.1,-0.9366,0.53,1,0.6994,0.82,1
"GO_BP:499164_GO_0021885_FOREBRAIN_CELL_MIGRATION","GO_BP","499164_GO_0021885_FOREBRAIN_CELL_MIGRATION",57,-1.5071,0.015,0.1,-1.3794,0.055,0.99,1.1542,0.21,0.73
"GO_BP:512168_GO_0051282_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION","GO_BP","512168_GO_0051282_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION",34,-1.5071,0.034,0.1,-0.6034,0.97,1,-0.9436,0.56,0.89
"GO_BP:508239_GO_0045932_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION","GO_BP","508239_GO_0045932_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION",20,-1.507,0.043,0.1,0.8839,0.63,1,-1.0764,0.35,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2775_MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2775_MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3",115,-1.507,0.0061,0.06,-1.0666,0.31,0.96,-1.0498,0.35,0.69
"C7_Immunologic_signatures:C7_ALL_806_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_806_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN",173,-1.5069,0.0047,0.0058,-1.0557,0.32,1,1.2928,0.027,0.4
"GO_BP:505807_GO_0042698_OVULATION_CYCLE","GO_BP","505807_GO_0042698_OVULATION_CYCLE",81,-1.5068,0.0093,0.1,0.7928,0.89,1,1.3068,0.059,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_3175_WANG_TNF_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3175_WANG_TNF_TARGETS",22,-1.5068,0.025,0.06,-1.4225,0.073,0.55,-0.6634,0.94,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_157_HORIUCHI_WTAP_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_157_HORIUCHI_WTAP_TARGETS_UP",300,-1.5065,0.0011,0.06,1.1376,0.12,0.57,1.0183,0.4,0.95
"GO_BP:493855_GO_0009743_RESPONSE_TO_CARBOHYDRATE","GO_BP","493855_GO_0009743_RESPONSE_TO_CARBOHYDRATE",154,-1.5064,0.0023,0.11,0.8178,0.91,1,0.8395,0.87,0.99
"C3_TF_targets:C3_TFT_286_V_FOXO4_02","C3_TF_targets","C3_TFT_286_V_FOXO4_02",249,-1.5064,0.0011,0.02,-1.0552,0.3,0.64,-0.9922,0.46,0.78
"C7_Immunologic_signatures:C7_ALL_513_GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_513_GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDM_UP",198,-1.5064,0.0023,0.0058,-0.8728,0.82,1,-1.1643,0.11,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_2222_ENGELMANN_CANCER_PROGENITORS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2222_ENGELMANN_CANCER_PROGENITORS_DN",63,-1.5063,0.017,0.06,-1.3229,0.084,0.7,-1.124,0.25,0.6
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_81_BIOCARTA_GH_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_81_BIOCARTA_GH_PATHWAY",27,-1.5063,0.038,0.12,-0.8437,0.73,1,-0.8441,0.7,0.9
"KEGG_compound:C00555_4_AMINOBUTYRALDEHYDE_4_AMINOBUTANAL","KEGG_compound","C00555_4_AMINOBUTYRALDEHYDE_4_AMINOBUTANAL",6,-1.5063,0.043,0.16,0.75,0.76,1,-0.9339,0.54,0.73
"GO_MF:515609_GO_0070679_INOSITOL_1_4_5_TRISPHOSPHATE_BINDING","GO_MF","515609_GO_0070679_INOSITOL_1_4_5_TRISPHOSPHATE_BINDING",10,-1.5063,0.037,0.14,-1.5695,0.053,0.48,-1.4599,0.072,0.42
"C4_Cancer_modules:C4_CM_344_MODULE_412","C4_Cancer_modules","C4_CM_344_MODULE_412",13,-1.5063,0.048,0.054,0.524,0.98,1,1.0437,0.4,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_1703_KAYO_AGING_MUSCLE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1703_KAYO_AGING_MUSCLE_UP",236,-1.5061,0,0.061,1.1451,0.13,0.56,-1.1046,0.22,0.62
"GO_MF:495563_GO_0015321_SODIUM_DEPENDENT_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495563_GO_0015321_SODIUM_DEPENDENT_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-1.506,0.028,0.14,-0.7782,0.72,1,-0.9251,0.57,0.85
"KEGG_compound:C00016_FAD_FLAVIN_ADENINE_DINUCLEOTIDE","KEGG_compound","C00016_FAD_FLAVIN_ADENINE_DINUCLEOTIDE",17,-1.5058,0.031,0.16,-0.5304,0.99,1,-1.5172,0.042,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_1601_LY_AGING_PREMATURE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1601_LY_AGING_PREMATURE_DN",30,-1.5058,0.025,0.061,0.8333,0.73,0.98,-1.305,0.093,0.42
"GO_CC:501221_GO_0031983_VESICLE_LUMEN","GO_CC","501221_GO_0031983_VESICLE_LUMEN",76,-1.5057,0.014,0.14,1.7228,0,0.052,0.9562,0.54,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_279_SENESE_HDAC3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_279_SENESE_HDAC3_TARGETS_UP",492,-1.5057,0,0.061,1.0092,0.43,0.78,-0.9171,0.78,0.86
"GO_BP:509057_GO_0046834_LIPID_PHOSPHORYLATION","GO_BP","509057_GO_0046834_LIPID_PHOSPHORYLATION",40,-1.5056,0.016,0.11,-0.8122,0.79,1,-0.7134,0.93,0.99
"GO_MF:487301_GO_0001078_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION","GO_MF","487301_GO_0001078_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION",88,-1.5055,0.01,0.14,-1.3417,0.041,0.7,-1.2313,0.1,0.58
"GO_BP:503542_GO_0034340_RESPONSE_TO_TYPE_I_INTERFERON","GO_BP","503542_GO_0034340_RESPONSE_TO_TYPE_I_INTERFERON",66,-1.5055,0.017,0.11,1.2405,0.12,0.75,-1.6404,0.0022,0.53
"GO_BP:488201_GO_0002328_PRO_B_CELL_DIFFERENTIATION","GO_BP","488201_GO_0002328_PRO_B_CELL_DIFFERENTIATION",5,-1.5055,0.042,0.11,-1.1829,0.28,0.91,-1.1184,0.34,0.76
"GO_MF:487300_GO_0001077_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION","GO_MF","487300_GO_0001077_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION",187,-1.5054,0.0035,0.14,0.905,0.75,0.98,0.9235,0.69,0.94
"REACTOME:1127511_REACT_264461_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION","REACTOME","1127511_REACT_264461_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION",21,-1.5054,0.037,0.13,-0.7517,0.84,1,-1.2006,0.2,0.6
"GO_BP:511838_GO_0050901_LEUKOCYTE_TETHERING_OR_ROLLING","GO_BP","511838_GO_0050901_LEUKOCYTE_TETHERING_OR_ROLLING",15,-1.5053,0.041,0.11,-0.7573,0.81,1,-1.0649,0.36,0.8
"GO_CC:499839_GO_0030496_MIDBODY","GO_CC","499839_GO_0030496_MIDBODY",123,-1.5051,0.0061,0.14,0.842,0.84,0.92,-1.1873,0.14,0.81
"GO_BP:513567_GO_0060009_SERTOLI_CELL_DEVELOPMENT","GO_BP","513567_GO_0060009_SERTOLI_CELL_DEVELOPMENT",15,-1.5049,0.045,0.11,-1.9038,0,0.31,-1.5378,0.035,0.54
"C7_Immunologic_signatures:C7_ALL_1875_GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1875_GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP",197,-1.5048,0.0012,0.006,1.2249,0.075,0.19,-0.9157,0.71,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_23_KORKOLA_SEMINOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_23_KORKOLA_SEMINOMA_UP",44,-1.5048,0.027,0.061,-1.1742,0.22,0.82,0.7574,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1934_SAFFORD_T_LYMPHOCYTE_ANERGY","C2_Chemical_and_genetic_perturbations","C2_CGP_1934_SAFFORD_T_LYMPHOCYTE_ANERGY",87,-1.5047,0.0051,0.061,0.8938,0.7,0.93,-0.9628,0.51,0.8
"GO_BP:506342_GO_0043277_APOPTOTIC_CELL_CLEARANCE","GO_BP","506342_GO_0043277_APOPTOTIC_CELL_CLEARANCE",25,-1.5047,0.037,0.11,0.7306,0.86,1,-0.8354,0.72,0.97
"REACTOME:730321_REACT_150312_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL","REACTOME","730321_REACT_150312_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL",27,-1.5046,0.04,0.13,-1.2192,0.18,0.79,-0.7405,0.85,1
"C7_Immunologic_signatures:C7_ALL_1417_GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP","C7_Immunologic_signatures","C7_ALL_1417_GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP",199,-1.5045,0.0023,0.006,1.2119,0.083,0.21,-1.4715,0.0065,0.029
"C7_Immunologic_signatures:C7_ALL_1868_GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN","C7_Immunologic_signatures","C7_ALL_1868_GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN",197,-1.5045,0.0034,0.006,0.971,0.54,0.83,-1.147,0.15,0.37
"C6_Oncogenic_signatures:C6_ALL_39_ATF2_S_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_39_ATF2_S_UP_V1_DN",178,-1.5045,0.0023,0.012,-0.8601,0.83,0.95,1.4769,0.0036,0.067
"C2_Chemical_and_genetic_perturbations:C2_CGP_1804_CHEN_ETV5_TARGETS_SERTOLI","C2_Chemical_and_genetic_perturbations","C2_CGP_1804_CHEN_ETV5_TARGETS_SERTOLI",19,-1.5045,0.037,0.061,0.8515,0.67,0.97,1.3843,0.1,0.54
"GO_BP:516303_GO_0071379_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS","GO_BP","516303_GO_0071379_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS",15,-1.5044,0.046,0.11,1.1204,0.3,0.88,1.335,0.13,0.64
"GO_BP:488518_GO_0002645_POSITIVE_REGULATION_OF_TOLERANCE_INDUCTION","GO_BP","488518_GO_0002645_POSITIVE_REGULATION_OF_TOLERANCE_INDUCTION",10,-1.5044,0.058,0.11,0.7552,0.76,1,-1.1361,0.29,0.75
"GO_BP:497131_GO_0018158_PROTEIN_OXIDATION","GO_BP","497131_GO_0018158_PROTEIN_OXIDATION",7,-1.5044,0.053,0.11,0.8467,0.66,1,-1.2366,0.21,0.69
"C4_Cancer_modules:C4_CM_331_MODULE_395","C4_Cancer_modules","C4_CM_331_MODULE_395",14,-1.5043,0.051,0.054,0.605,0.96,1,-1.1665,0.27,0.46
"GO_BP:495124_GO_0014052_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION","GO_BP","495124_GO_0014052_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION",6,-1.5043,0.064,0.11,-1.139,0.3,0.93,-1.2419,0.22,0.69
"GO_BP:506120_GO_0043031_NEGATIVE_REGULATION_OF_MACROPHAGE_ACTIVATION","GO_BP","506120_GO_0043031_NEGATIVE_REGULATION_OF_MACROPHAGE_ACTIVATION",5,-1.5043,0.025,0.11,-0.9725,0.5,1,0.7154,0.81,1
"KEGG_compound:C05130_IMIDAZOLE_4_ACETALDEHYDE_IMIDAZOLE_ACETALDEHYDE","KEGG_compound","C05130_IMIDAZOLE_4_ACETALDEHYDE_IMIDAZOLE_ACETALDEHYDE",6,-1.5043,0.037,0.16,0.7522,0.77,1,-0.9389,0.56,0.72
"C3_TF_targets:C3_TFT_234_V_AREB6_01","C3_TF_targets","C3_TFT_234_V_AREB6_01",262,-1.5041,0.0011,0.02,-1.393,0.0034,0.16,0.9136,0.71,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_187_OSMAN_BLADDER_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_187_OSMAN_BLADDER_CANCER_UP",403,-1.5041,0,0.061,1.3725,0.0024,0.32,-0.8797,0.86,0.9
"GO_BP:514113_GO_0060558_REGULATION_OF_CALCIDIOL_1_MONOOXYGENASE_ACTIVITY","GO_BP","514113_GO_0060558_REGULATION_OF_CALCIDIOL_1_MONOOXYGENASE_ACTIVITY",7,-1.504,0.051,0.11,-1.6266,0.028,0.7,-1.3417,0.14,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_433_LANDIS_ERBB2_BREAST_TUMORS_65_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_433_LANDIS_ERBB2_BREAST_TUMORS_65_UP",22,-1.5038,0.041,0.061,0.8838,0.64,0.94,-0.7343,0.87,0.98
"C7_Immunologic_signatures:C7_ALL_1727_GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1727_GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP",198,-1.5036,0.0011,0.0061,-1.0021,0.46,1,-1.0504,0.32,0.61
"C4_Cancer_modules:C4_CM_207_MODULE_222","C4_Cancer_modules","C4_CM_207_MODULE_222",22,-1.5035,0.034,0.054,-0.7837,0.77,0.99,-1.2842,0.13,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_1431_MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1431_MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP",41,-1.5035,0.039,0.061,-1.1658,0.21,0.83,-1.1901,0.18,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_558_BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_558_BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN",45,-1.5034,0.02,0.061,-1.473,0.025,0.5,1.2855,0.1,0.7
"GO_BP:508159_GO_0045838_POSITIVE_REGULATION_OF_MEMBRANE_POTENTIAL","GO_BP","508159_GO_0045838_POSITIVE_REGULATION_OF_MEMBRANE_POTENTIAL",25,-1.5034,0.032,0.11,-1.2575,0.16,0.91,1.1928,0.22,0.72
"C7_Immunologic_signatures:C7_ALL_1498_GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN","C7_Immunologic_signatures","C7_ALL_1498_GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN",191,-1.5034,0.0011,0.0061,0.8724,0.8,1,1.0435,0.32,1
"GO_BP:498499_GO_0019674_NAD_METABOLIC_PROCESS","GO_BP","498499_GO_0019674_NAD_METABOLIC_PROCESS",30,-1.5032,0.033,0.11,-0.863,0.71,1,-1.87,0,0.5
"GO_BP:508123_GO_0045792_NEGATIVE_REGULATION_OF_CELL_SIZE","GO_BP","508123_GO_0045792_NEGATIVE_REGULATION_OF_CELL_SIZE",10,-1.5031,0.044,0.11,-1.3007,0.17,0.89,-1.4732,0.05,0.54
"GO_BP:495809_GO_0015672_MONOVALENT_INORGANIC_CATION_TRANSPORT","GO_BP","495809_GO_0015672_MONOVALENT_INORGANIC_CATION_TRANSPORT",411,-1.503,0,0.11,-1.0426,0.33,0.98,-0.9081,0.8,0.92
"C3_TF_targets:C3_TFT_119_V_AP1FJ_Q2","C3_TF_targets","C3_TFT_119_V_AP1FJ_Q2",260,-1.5029,0,0.02,-1.1352,0.16,0.47,0.8945,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1885_JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1885_JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP",49,-1.5029,0.029,0.062,-0.7282,0.93,1,-0.9835,0.5,0.78
"C4_Cancer_gene_neighborhoods:C4_CGN_255_GCM_PTK2","C4_Cancer_gene_neighborhoods","C4_CGN_255_GCM_PTK2",143,-1.5029,0.0072,0.057,-0.9634,0.52,0.88,-1.2681,0.048,0.34
"GO_MF:489997_GO_0004668_PROTEIN_ARGININE_DEIMINASE_ACTIVITY","GO_MF","489997_GO_0004668_PROTEIN_ARGININE_DEIMINASE_ACTIVITY",5,-1.5028,0.03,0.14,-1.3068,0.17,0.76,1.1162,0.38,0.82
"C3_TF_targets:C3_TFT_383_V_CDX2_Q5","C3_TF_targets","C3_TFT_383_V_CDX2_Q5",241,-1.5027,0.0011,0.02,-0.8819,0.8,0.98,-1.323,0.02,0.24
"GO_BP:491495_GO_0006600_CREATINE_METABOLIC_PROCESS","GO_BP","491495_GO_0006600_CREATINE_METABOLIC_PROCESS",11,-1.5025,0.059,0.11,-1.1956,0.25,0.89,-1.0396,0.39,0.82
"C7_Immunologic_signatures:C7_ALL_425_GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP","C7_Immunologic_signatures","C7_ALL_425_GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP",192,-1.5024,0.0023,0.0062,-0.9764,0.51,1,-1.2241,0.069,0.23
"GO_BP:516315_GO_0071391_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS","GO_BP","516315_GO_0071391_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS",29,-1.5024,0.032,0.11,-1.0093,0.45,0.98,-1.3569,0.097,0.6
"GO_CC:499563_GO_0030136_CLATHRIN_COATED_VESICLE","GO_CC","499563_GO_0030136_CLATHRIN_COATED_VESICLE",132,-1.5023,0.006,0.14,1.1312,0.18,0.6,0.8061,0.93,1
"GO_MF:496603_GO_0016671_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR","GO_MF","496603_GO_0016671_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR",13,-1.5023,0.063,0.14,-0.6345,0.94,1,-1.282,0.13,0.6
"GO_CC:517589_GO_0072686_MITOTIC_SPINDLE","GO_CC","517589_GO_0072686_MITOTIC_SPINDLE",41,-1.5022,0.023,0.14,-1.1141,0.27,0.75,-1.4995,0.025,0.49
"C7_Immunologic_signatures:C7_ALL_1711_GSE3982_NKCELL_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_1711_GSE3982_NKCELL_VS_TH1_UP",190,-1.5021,0.0011,0.0062,-1.0691,0.28,1,-0.8784,0.83,0.98
"GO_BP:496232_GO_0016139_GLYCOSIDE_CATABOLIC_PROCESS","GO_BP","496232_GO_0016139_GLYCOSIDE_CATABOLIC_PROCESS",6,-1.5018,0.037,0.11,-0.9288,0.56,1,-1.1546,0.3,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_1037_CAFFAREL_RESPONSE_TO_THC_24HR_3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1037_CAFFAREL_RESPONSE_TO_THC_24HR_3_DN",13,-1.5018,0.033,0.062,0.9835,0.47,0.81,-0.693,0.87,0.99
"C7_Immunologic_signatures:C7_ALL_1097_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP","C7_Immunologic_signatures","C7_ALL_1097_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP",198,-1.5018,0.0023,0.0062,0.7923,0.96,1,-1.0562,0.32,0.6
"REACTOME:106192_REACT_813_CREATINE_METABOLISM","REACTOME","106192_REACT_813_CREATINE_METABOLISM",11,-1.5017,0.041,0.13,-1.3985,0.11,0.53,-1.6569,0.016,0.22
"REACTOME:477120_REACT_111040_SIGNALING_BY_SCF_KIT","REACTOME","477120_REACT_111040_SIGNALING_BY_SCF_KIT",134,-1.5017,0.0048,0.13,-1.0108,0.41,0.99,-1.018,0.42,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_1795_XU_GH1_EXOGENOUS_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1795_XU_GH1_EXOGENOUS_TARGETS_UP",82,-1.5016,0.01,0.062,0.9816,0.49,0.81,-0.9953,0.46,0.76
"C7_Immunologic_signatures:C7_ALL_1623_GSE3982_MAST_CELL_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_1623_GSE3982_MAST_CELL_VS_TH1_UP",196,-1.5016,0.0011,0.0063,0.8862,0.8,1,-0.7316,1,1
"REACTOME:119550_REACT_19231_G_ALPHA_I_SIGNALLING_EVENTS","REACTOME","119550_REACT_19231_G_ALPHA_I_SIGNALLING_EVENTS",221,-1.5016,0.0011,0.13,1.3985,0.0024,0.23,1.3341,0.011,0.73
"GO_BP:507347_GO_0044341_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT","GO_BP","507347_GO_0044341_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT",5,-1.5015,0.034,0.11,-0.7671,0.75,1,-0.9228,0.56,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_2787_ONO_AML1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2787_ONO_AML1_TARGETS_UP",24,-1.5015,0.043,0.062,-0.914,0.59,1,-0.8171,0.74,0.94
"GO_CC:500302_GO_0031012_EXTRACELLULAR_MATRIX","GO_CC","500302_GO_0031012_EXTRACELLULAR_MATRIX",403,-1.5015,0,0.14,-1.1941,0.054,0.69,1.6463,0,0.35
"GO_BP:501929_GO_0032703_NEGATIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION","GO_BP","501929_GO_0032703_NEGATIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION",15,-1.5014,0.033,0.11,-0.9409,0.54,1,-0.7765,0.77,1
"GO_MF:500936_GO_0031690_ADRENERGIC_RECEPTOR_BINDING","GO_MF","500936_GO_0031690_ADRENERGIC_RECEPTOR_BINDING",17,-1.5013,0.039,0.14,-0.5792,0.97,1,-1.0816,0.35,0.71
"C4_Cancer_gene_neighborhoods:C4_CGN_377_GNF2_MCM4","C4_Cancer_gene_neighborhoods","C4_CGN_377_GNF2_MCM4",53,-1.5013,0.026,0.056,1.0949,0.3,0.38,-1.6256,0.004,0.066
"GO_BP:488154_GO_0002281_MACROPHAGE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488154_GO_0002281_MACROPHAGE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",7,-1.5011,0.033,0.11,0.6692,0.86,1,-1.1761,0.27,0.74
"GO_BP:488220_GO_0002347_RESPONSE_TO_TUMOR_CELL","GO_BP","488220_GO_0002347_RESPONSE_TO_TUMOR_CELL",6,-1.501,0.052,0.11,1.0602,0.4,0.94,-0.8602,0.63,0.96
"GO_BP:754531_GO_1901571_FATTY_ACID_DERIVATIVE_TRANSPORT","GO_BP","754531_GO_1901571_FATTY_ACID_DERIVATIVE_TRANSPORT",16,-1.501,0.035,0.11,-0.804,0.73,1,1.2322,0.21,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_3228_IKEDA_MIR133_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3228_IKEDA_MIR133_TARGETS_UP",43,-1.5009,0.035,0.062,-0.5109,1,1,-0.8977,0.65,0.88
"GO_BP:491417_GO_0006521_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS","GO_BP","491417_GO_0006521_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS",351,-1.5009,0.0011,0.11,1.0171,0.37,0.97,-0.9499,0.64,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_2840_KOBAYASHI_EGFR_SIGNALING_24HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2840_KOBAYASHI_EGFR_SIGNALING_24HR_UP",96,-1.5009,0.0077,0.062,-0.8675,0.76,1,-1.1962,0.13,0.52
"C7_Immunologic_signatures:C7_ALL_612_GSE17721_LPS_VS_PAM3CSK4_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_612_GSE17721_LPS_VS_PAM3CSK4_12H_BMDM_DN",197,-1.5008,0,0.0063,1.3585,0.0025,0.057,-1.126,0.17,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_2359_NAKAMURA_METASTASIS","C2_Chemical_and_genetic_perturbations","C2_CGP_2359_NAKAMURA_METASTASIS",46,-1.5007,0.025,0.062,0.6519,0.98,1,1.2555,0.13,0.72
"KEGG_compound:C19574_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_NNAL","KEGG_compound","C19574_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_NNAL",27,-1.5007,0.03,0.17,1.4346,0.051,0.42,1.8054,0.0042,0.015
"GO_BP:494704_GO_0010640_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","494704_GO_0010640_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",14,-1.5006,0.053,0.11,-1.2235,0.2,0.88,-1.2032,0.24,0.73
"GO_BP:499616_GO_0030206_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS","GO_BP","499616_GO_0030206_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS",23,-1.5006,0.034,0.11,-0.54,0.99,1,1.0241,0.42,0.83
"GO_BP:502718_GO_0033500_CARBOHYDRATE_HOMEOSTASIS","GO_BP","502718_GO_0033500_CARBOHYDRATE_HOMEOSTASIS",157,-1.5006,0.0012,0.11,0.975,0.53,1,1.0039,0.42,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_1612_BRACHAT_RESPONSE_TO_METHOTREXATE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1612_BRACHAT_RESPONSE_TO_METHOTREXATE_DN",27,-1.5005,0.035,0.062,1.0587,0.36,0.7,-1.048,0.4,0.69
"GO_BP:508603_GO_0046339_DIACYLGLYCEROL_METABOLIC_PROCESS","GO_BP","508603_GO_0046339_DIACYLGLYCEROL_METABOLIC_PROCESS",13,-1.5004,0.058,0.11,-1.4309,0.08,0.92,-0.76,0.78,1
"GO_BP:488584_GO_0002711_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY","GO_BP","488584_GO_0002711_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY",37,-1.5003,0.023,0.11,-1.0982,0.3,0.95,-1.1891,0.19,0.73
"GO_BP:498203_GO_0019359_NICOTINAMIDE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","498203_GO_0019359_NICOTINAMIDE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",18,-1.5002,0.043,0.11,-1.0015,0.46,0.99,-1.5838,0.041,0.53
"GO_BP:516257_GO_0071333_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS","GO_BP","516257_GO_0071333_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS",45,-1.5,0.029,0.11,0.786,0.85,1,-0.7245,0.92,0.99
"KEGG_pathway:HSA04917_PROLACTIN_SIGNALING_PATHWAY","KEGG_pathway","HSA04917_PROLACTIN_SIGNALING_PATHWAY",70,-1.5,0.01,0.034,-0.9246,0.6,0.97,-1.0502,0.36,0.6
"GO_MF:498678_GO_0019901_PROTEIN_KINASE_BINDING","GO_MF","498678_GO_0019901_PROTEIN_KINASE_BINDING",448,-1.4996,0,0.14,0.7515,1,1,-1.2371,0.012,0.59
"REACTOME:1127672_REACT_264352_PRC2_METHYLATES_HISTONES_AND_DNA","REACTOME","1127672_REACT_264352_PRC2_METHYLATES_HISTONES_AND_DNA",69,-1.4996,0.01,0.13,-2.0464,0,0.037,-1.6573,0,0.23
"C3_TF_targets:C3_TFT_107_V_HSF2_01","C3_TF_targets","C3_TFT_107_V_HSF2_01",243,-1.4995,0,0.021,-1.3513,0.017,0.19,-1.2259,0.054,0.3
"C7_Immunologic_signatures:C7_ALL_395_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_395_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP",198,-1.4995,0.0011,0.0065,-1.0207,0.41,1,-1.1157,0.19,0.46
"REACTOME:187220_REACT_25046_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION","REACTOME","187220_REACT_25046_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION",36,-1.4994,0.027,0.13,0.6149,0.99,1,-1.2361,0.15,0.57
"GO_BP:498975_GO_0021692_CEREBELLAR_PURKINJE_CELL_LAYER_MORPHOGENESIS","GO_BP","498975_GO_0021692_CEREBELLAR_PURKINJE_CELL_LAYER_MORPHOGENESIS",13,-1.4993,0.046,0.11,-1.3402,0.13,0.91,-1.1631,0.25,0.73
"GO_BP:496865_GO_0046887_POSITIVE_REGULATION_OF_HORMONE_SECRETION","GO_BP","496865_GO_0046887_POSITIVE_REGULATION_OF_HORMONE_SECRETION",92,-1.4993,0.014,0.11,1.229,0.1,0.76,0.9009,0.65,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_3366_LIM_MAMMARY_LUMINAL_MATURE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3366_LIM_MAMMARY_LUMINAL_MATURE_DN",96,-1.4993,0.014,0.063,1.164,0.17,0.53,1.3325,0.048,0.61
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_190_BIOCARTA_TCR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_190_BIOCARTA_TCR_PATHWAY",44,-1.4992,0.016,0.13,0.8634,0.72,0.9,-1.2775,0.11,0.53
"GO_BP:494077_GO_0009992_CELLULAR_WATER_HOMEOSTASIS","GO_BP","494077_GO_0009992_CELLULAR_WATER_HOMEOSTASIS",12,-1.4991,0.053,0.11,-0.6987,0.88,1,-1.1334,0.29,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_2765_MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2765_MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3",33,-1.4991,0.034,0.063,-1.1853,0.2,0.81,1.5241,0.018,0.48
"GO_BP:488728_GO_0002855_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL","GO_BP","488728_GO_0002855_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL",6,-1.4991,0.054,0.11,-0.5007,0.99,1,0.7657,0.74,1
"C4_Cancer_modules:C4_CM_298_MODULE_342","C4_Cancer_modules","C4_CM_298_MODULE_342",205,-1.4987,0,0.056,-1.1207,0.2,0.67,1.0983,0.22,0.77
"GO_BP:512359_GO_0051481_NEGATIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION","GO_BP","512359_GO_0051481_NEGATIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION",8,-1.4986,0.036,0.11,1.004,0.45,0.98,-1.6336,0.021,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_147_LAIHO_COLORECTAL_CANCER_SERRATED_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_147_LAIHO_COLORECTAL_CANCER_SERRATED_UP",111,-1.4986,0.011,0.063,1.7577,0,0.058,-0.7237,0.99,0.98
"GO_MF:754632_GO_1901681_SULFUR_COMPOUND_BINDING","GO_MF","754632_GO_1901681_SULFUR_COMPOUND_BINDING",204,-1.4985,0.0023,0.14,-1.0552,0.3,0.87,1.1486,0.13,0.78
"C4_Cancer_gene_neighborhoods:C4_CGN_332_GNF2_CD53","C4_Cancer_gene_neighborhoods","C4_CGN_332_GNF2_CD53",58,-1.4985,0.015,0.057,1.2204,0.16,0.19,-1.4287,0.032,0.15
"GO_BP:503543_GO_0034341_RESPONSE_TO_INTERFERON_GAMMA","GO_BP","503543_GO_0034341_RESPONSE_TO_INTERFERON_GAMMA",121,-1.4984,0.0082,0.11,1.077,0.31,0.93,-0.9083,0.7,0.92
"C4_Cancer_modules:C4_CM_263_MODULE_299","C4_Cancer_modules","C4_CM_263_MODULE_299",35,-1.4984,0.037,0.056,-1.0654,0.35,0.71,-2.0572,0,0.0079
"GO_BP:494947_GO_0010883_REGULATION_OF_LIPID_STORAGE","GO_BP","494947_GO_0010883_REGULATION_OF_LIPID_STORAGE",39,-1.4984,0.022,0.11,-0.8807,0.67,1,-1.1434,0.23,0.74
"GO_BP:496150_GO_0016051_CARBOHYDRATE_BIOSYNTHETIC_PROCESS","GO_BP","496150_GO_0016051_CARBOHYDRATE_BIOSYNTHETIC_PROCESS",135,-1.4983,0.0047,0.11,1.0667,0.29,0.93,-1.2902,0.042,0.65
"WikiPathways:672449_WP2012_MIRS_IN_MUSCLE_CELL_DIFFERENTIATION","WikiPathways","672449_WP2012_MIRS_IN_MUSCLE_CELL_DIFFERENTIATION",32,-1.4982,0.037,0.072,-1.0791,0.32,0.97,-1.3889,0.06,0.41
"C7_Immunologic_signatures:C7_ALL_1710_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN","C7_Immunologic_signatures","C7_ALL_1710_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN",198,-1.4981,0.0023,0.0066,1.3379,0.019,0.071,-1.1795,0.12,0.32
"GO_MF:504791_GO_0035612_AP_2_ADAPTOR_COMPLEX_BINDING","GO_MF","504791_GO_0035612_AP_2_ADAPTOR_COMPLEX_BINDING",8,-1.4978,0.038,0.14,-0.6584,0.89,1,-1.1723,0.29,0.61
"GO_BP:494931_GO_0010867_POSITIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS","GO_BP","494931_GO_0010867_POSITIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS",11,-1.4978,0.035,0.11,0.9305,0.55,1,-0.5419,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_46_FRASOR_TAMOXIFEN_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_46_FRASOR_TAMOXIFEN_RESPONSE_UP",50,-1.4977,0.013,0.064,-0.6727,0.96,1,-0.9642,0.5,0.8
"GO_BP:755406_GO_2001300_LIPOXIN_METABOLIC_PROCESS","GO_BP","755406_GO_2001300_LIPOXIN_METABOLIC_PROCESS",7,-1.4976,0.038,0.11,1.1126,0.34,0.89,1.2209,0.22,0.71
"C3_TF_targets:C3_TFT_25_V_E4BP4_01","C3_TF_targets","C3_TFT_25_V_E4BP4_01",221,-1.4975,0.0068,0.021,-1.1931,0.11,0.36,-1.3482,0.016,0.27
"GO_BP:504767_GO_0035588_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY","GO_BP","504767_GO_0035588_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY",21,-1.4975,0.049,0.11,1.64,0.014,0.25,1.0901,0.31,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_516_HUMMERICH_BENIGN_SKIN_TUMOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_516_HUMMERICH_BENIGN_SKIN_TUMOR_UP",16,-1.4975,0.048,0.064,1.2521,0.18,0.44,1.2806,0.16,0.7
"C3_TF_targets:C3_TFT_394_V_POU1F1_Q6","C3_TF_targets","C3_TFT_394_V_POU1F1_Q6",225,-1.4975,0.0044,0.021,-1.0437,0.35,0.66,-0.881,0.8,0.95
"C4_Cancer_modules:C4_CM_130_MODULE_135","C4_Cancer_modules","C4_CM_130_MODULE_135",25,-1.4972,0.041,0.056,-1.3258,0.12,0.52,-0.7578,0.85,0.99
"GO_BP:496272_GO_0016198_AXON_CHOICE_POINT_RECOGNITION","GO_BP","496272_GO_0016198_AXON_CHOICE_POINT_RECOGNITION",6,-1.4972,0.054,0.11,-1.1361,0.31,0.93,-1.5556,0.032,0.51
"GO_BP:500114_GO_0030815_NEGATIVE_REGULATION_OF_CAMP_METABOLIC_PROCESS","GO_BP","500114_GO_0030815_NEGATIVE_REGULATION_OF_CAMP_METABOLIC_PROCESS",37,-1.497,0.027,0.11,0.8281,0.75,1,1.3799,0.07,0.64
"C3_TF_targets:C3_TFT_232_V_SOX9_B1","C3_TF_targets","C3_TFT_232_V_SOX9_B1",230,-1.4969,0.0011,0.021,0.8736,0.86,1,-1.2757,0.038,0.25
"GO_BP:487835_GO_0001945_LYMPH_VESSEL_DEVELOPMENT","GO_BP","487835_GO_0001945_LYMPH_VESSEL_DEVELOPMENT",19,-1.4967,0.039,0.11,-0.9976,0.47,0.99,-1.0289,0.38,0.83
"GO_BP:488731_GO_0002858_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY_DIRECTED_AGAINST_TUMOR_CELL_TARGET","GO_BP","488731_GO_0002858_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY_DIRECTED_AGAINST_TUMOR_CELL_TARGET",6,-1.4966,0.054,0.11,-0.5121,0.97,1,0.7778,0.73,1
"C7_Immunologic_signatures:C7_ALL_997_GSE22886_TH1_VS_TH2_12H_ACT_UP","C7_Immunologic_signatures","C7_ALL_997_GSE22886_TH1_VS_TH2_12H_ACT_UP",196,-1.4966,0,0.0068,-1.0406,0.35,1,-1.0892,0.23,0.52
"C7_Immunologic_signatures:C7_ALL_555_GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_555_GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDM_UP",199,-1.4965,0.0034,0.0068,0.9578,0.56,0.88,-1.1313,0.16,0.41
"GO_BP:501859_GO_0032633_INTERLEUKIN_4_PRODUCTION","GO_BP","501859_GO_0032633_INTERLEUKIN_4_PRODUCTION",7,-1.4965,0.052,0.11,-0.6204,0.9,1,-0.7826,0.74,1
"GO_BP:1053349_GO_0098742_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES","GO_BP","1053349_GO_0098742_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES",187,-1.4964,0.0023,0.11,1.3766,0.0098,0.58,2.1495,0,0.0055
"GO_BP:514560_GO_0061005_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT","GO_BP","514560_GO_0061005_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",35,-1.4964,0.038,0.11,-1.1105,0.3,0.94,0.6555,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3005_SASSON_RESPONSE_TO_GONADOTROPHINS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3005_SASSON_RESPONSE_TO_GONADOTROPHINS_UP",91,-1.4962,0.011,0.064,0.9944,0.47,0.81,-0.8682,0.77,0.91
"C3_TF_targets:C3_TFT_412_V_IRF_Q6","C3_TF_targets","C3_TFT_412_V_IRF_Q6",236,-1.4962,0,0.021,0.8094,0.96,1,-1.0747,0.29,0.6
"GO_BP:1022081_GO_0036473_CELL_DEATH_IN_RESPONSE_TO_OXIDATIVE_STRESS","GO_BP","1022081_GO_0036473_CELL_DEATH_IN_RESPONSE_TO_OXIDATIVE_STRESS",19,-1.4962,0.044,0.11,-0.8662,0.64,1,-1.282,0.13,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1851_SU_LIVER","C2_Chemical_and_genetic_perturbations","C2_CGP_1851_SU_LIVER",54,-1.4961,0.025,0.064,0.7112,0.94,1,1.0624,0.32,0.9
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_109_BIOCARTA_KERATINOCYTE_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_109_BIOCARTA_KERATINOCYTE_PATHWAY",46,-1.4961,0.017,0.13,-0.8532,0.74,1,-0.9493,0.57,0.81
"GO_BP:508628_GO_0046364_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS","GO_BP","508628_GO_0046364_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS",59,-1.496,0.011,0.11,0.8872,0.69,1,-1.2332,0.12,0.7
"C7_Immunologic_signatures:C7_ALL_1728_GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1728_GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN",196,-1.496,0.0023,0.0068,-0.8143,0.93,1,-1.366,0.015,0.084
"KEGG_compound:C05269_3_OXOHEXANOYL_COA_3_KETOHEXANOYL_COA","KEGG_compound","C05269_3_OXOHEXANOYL_COA_3_KETOHEXANOYL_COA",8,-1.496,0.047,0.17,0.5544,0.96,1,-1.4259,0.1,0.26
"C3_MicroRNA_targets:C3_MIR_43_CTCTGGA_MIR_520A_MIR_525","C3_MicroRNA_targets","C3_MIR_43_CTCTGGA_MIR_520A_MIR_525",155,-1.4959,0.0047,0.2,-1.1047,0.22,1,-0.9552,0.58,1
"GO_BP:911402_GO_1902414_PROTEIN_LOCALIZATION_TO_CELL_JUNCTION","GO_BP","911402_GO_1902414_PROTEIN_LOCALIZATION_TO_CELL_JUNCTION",6,-1.4959,0.048,0.11,0.5495,0.96,1,0.8557,0.65,0.98
"REACTOME:1183608_REACT_355409_RIPK1_MEDIATED_REGULATED_NECROSIS","REACTOME","1183608_REACT_355409_RIPK1_MEDIATED_REGULATED_NECROSIS",16,-1.4958,0.036,0.13,0.4905,0.99,1,-0.7856,0.78,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3330_BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE","C2_Chemical_and_genetic_perturbations","C2_CGP_3330_BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE",58,-1.4958,0.024,0.064,1.3991,0.031,0.3,1.2567,0.11,0.72
"GO_BP:508255_GO_0045953_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY","GO_BP","508255_GO_0045953_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",7,-1.4958,0.052,0.11,0.6701,0.86,1,0.6709,0.89,1
"C7_Immunologic_signatures:C7_ALL_814_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_814_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN",191,-1.4958,0.0023,0.0068,-0.8808,0.79,1,-1.4528,0.0021,0.033
"C2_Chemical_and_genetic_perturbations:C2_CGP_1182_MORI_MATURE_B_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1182_MORI_MATURE_B_LYMPHOCYTE_UP",89,-1.4958,0.013,0.064,0.7195,0.98,1,-1.3885,0.029,0.36
"GO_BP:496173_GO_0016079_SYNAPTIC_VESICLE_EXOCYTOSIS","GO_BP","496173_GO_0016079_SYNAPTIC_VESICLE_EXOCYTOSIS",72,-1.4957,0.016,0.11,0.956,0.53,1,-1.1614,0.19,0.73
"GO_BP:512150_GO_0051259_PROTEIN_OLIGOMERIZATION","GO_BP","512150_GO_0051259_PROTEIN_OLIGOMERIZATION",400,-1.4957,0,0.11,-1.0265,0.33,0.98,-1.0512,0.27,0.81
"GO_BP:948112_GO_1902669_POSITIVE_REGULATION_OF_AXON_GUIDANCE","GO_BP","948112_GO_1902669_POSITIVE_REGULATION_OF_AXON_GUIDANCE",7,-1.4956,0.062,0.11,0.6147,0.92,1,-0.8198,0.71,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_170_RODRIGUES_NTN1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_170_RODRIGUES_NTN1_TARGETS_UP",17,-1.4956,0.042,0.064,1.2358,0.17,0.45,-0.9919,0.45,0.76
"C7_Immunologic_signatures:C7_ALL_236_GSE14000_UNSTIM_VS_16H_LPS_DC_DN","C7_Immunologic_signatures","C7_ALL_236_GSE14000_UNSTIM_VS_16H_LPS_DC_DN",197,-1.4956,0.0034,0.0068,-0.7149,0.99,1,-1.1945,0.11,0.29
"GO_BP:982314_GO_0098609_CELL_CELL_ADHESION","GO_BP","982314_GO_0098609_CELL_CELL_ADHESION",188,-1.4955,0.0023,0.11,1.3599,0.011,0.6,2.1495,0,0.0061
"GO_MF:490357_GO_0005089_RHO_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY","GO_MF","490357_GO_0005089_RHO_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",77,-1.4951,0.012,0.14,-1.59,0.0071,0.46,-0.8685,0.73,0.9
"C7_Immunologic_signatures:C7_ALL_1488_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN","C7_Immunologic_signatures","C7_ALL_1488_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN",193,-1.4951,0.0023,0.0069,-0.9063,0.73,1,-1.4843,0.0064,0.026
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_66_BIOCARTA_ERK_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_66_BIOCARTA_ERK_PATHWAY",27,-1.495,0.042,0.13,-0.7588,0.82,1,0.7377,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1021_SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1021_SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN",22,-1.4949,0.042,0.065,-1.0664,0.35,0.96,-1.1478,0.27,0.58
"GO_CC:500921_GO_0031672_A_BAND","GO_CC","500921_GO_0031672_A_BAND",29,-1.4948,0.037,0.15,-1.4114,0.073,0.68,-0.8659,0.68,1
"REACTOME:645298_REACT_121083_HYALURONAN_METABOLISM","REACTOME","645298_REACT_121083_HYALURONAN_METABOLISM",16,-1.4948,0.054,0.13,-1.0202,0.43,0.98,0.6886,0.89,1
"C3_TF_targets:C3_TFT_385_V_SMAD4_Q6","C3_TF_targets","C3_TFT_385_V_SMAD4_Q6",237,-1.4947,0.0011,0.021,-1.1188,0.18,0.5,-0.8769,0.86,0.96
"REACTOME:187226_REACT_25085_N_GLYCAN_ANTENNAE_ELONGATION","REACTOME","187226_REACT_25085_N_GLYCAN_ANTENNAE_ELONGATION",15,-1.4946,0.05,0.13,0.6211,0.95,1,-0.7741,0.8,1
"C7_Immunologic_signatures:C7_ALL_995_GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_995_GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP",195,-1.4946,0.0022,0.0069,1.0149,0.39,0.7,-1.598,0,0.0056
"C2_Chemical_and_genetic_perturbations:C2_CGP_2876_CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY","C2_Chemical_and_genetic_perturbations","C2_CGP_2876_CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY",29,-1.4945,0.025,0.065,0.6459,0.96,1,-1.0021,0.46,0.75
"REACTOME:205242_REACT_27271_MEIOTIC_RECOMBINATION","REACTOME","205242_REACT_27271_MEIOTIC_RECOMBINATION",82,-1.4945,0.011,0.13,-1.5803,0.0054,0.35,-1.533,0.013,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_3359_ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3359_ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN",297,-1.4945,0,0.065,-1.0282,0.35,0.98,1.2076,0.058,0.78
"GO_BP:510793_GO_0048738_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","510793_GO_0048738_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",146,-1.4945,0.0047,0.11,0.8663,0.8,1,1.2087,0.095,0.71
"WikiPathways:198807_WP244_ALPHA6_BETA4_INTEGRIN_SIGNALING_PATHWAY","WikiPathways","198807_WP244_ALPHA6_BETA4_INTEGRIN_SIGNALING_PATHWAY",69,-1.4944,0.031,0.073,1.0663,0.32,1,1.2313,0.12,0.6
"GO_BP:493495_GO_0009311_OLIGOSACCHARIDE_METABOLIC_PROCESS","GO_BP","493495_GO_0009311_OLIGOSACCHARIDE_METABOLIC_PROCESS",44,-1.4944,0.025,0.11,-0.8225,0.77,1,0.7734,0.88,1
"GO_MF:495366_GO_0015085_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495366_GO_0015085_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",126,-1.4944,0.0024,0.14,-1.6235,0.0018,0.44,-0.9521,0.59,0.83
"GO_BP:511895_GO_0050961_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION","GO_BP","511895_GO_0050961_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION",10,-1.4943,0.056,0.11,-1.1028,0.34,0.94,-1.2376,0.2,0.69
"GO_BP:491763_GO_0006907_PINOCYTOSIS","GO_BP","491763_GO_0006907_PINOCYTOSIS",10,-1.4943,0.055,0.11,-0.781,0.76,1,-0.5896,0.94,1
"GO_BP:494809_GO_0010744_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION","GO_BP","494809_GO_0010744_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION",14,-1.4942,0.046,0.11,1.2256,0.21,0.76,1.1922,0.24,0.72
"C7_Immunologic_signatures:C7_ALL_1386_GSE339_CD4POS_VS_CD4CD8DN_DC_DN","C7_Immunologic_signatures","C7_ALL_1386_GSE339_CD4POS_VS_CD4CD8DN_DC_DN",198,-1.4939,0.0045,0.007,0.8181,0.93,1,1.0025,0.45,1
"REACTOME:106058_REACT_1573_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION","REACTOME","106058_REACT_1573_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION",5,-1.4938,0.045,0.13,-0.9297,0.54,1,-0.8619,0.63,0.97
"GO_MF:501289_GO_0032052_BILE_ACID_BINDING","GO_MF","501289_GO_0032052_BILE_ACID_BINDING",7,-1.4938,0.048,0.14,-0.7492,0.77,1,-1.0209,0.43,0.77
"C3_TF_targets:C3_TFT_338_V_HNF6_Q6","C3_TF_targets","C3_TFT_338_V_HNF6_Q6",226,-1.4938,0.0022,0.021,0.9252,0.74,1,-0.9133,0.71,0.9
"GO_BP:492339_GO_0007598_BLOOD_COAGULATION_EXTRINSIC_PATHWAY","GO_BP","492339_GO_0007598_BLOOD_COAGULATION_EXTRINSIC_PATHWAY",5,-1.4937,0.042,0.11,-0.9077,0.58,1,-0.8573,0.64,0.96
"GO_BP:517027_GO_0072111_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT","GO_BP","517027_GO_0072111_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",10,-1.4937,0.047,0.11,-1.022,0.45,0.97,-0.5984,0.94,1
"GO_BP:754606_GO_1901654_RESPONSE_TO_KETONE","GO_BP","754606_GO_1901654_RESPONSE_TO_KETONE",118,-1.4937,0.0073,0.11,0.9294,0.64,1,1.2441,0.071,0.7
"C7_Immunologic_signatures:C7_ALL_461_GSE17721_CTRL_VS_LPS_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_461_GSE17721_CTRL_VS_LPS_24H_BMDM_UP",198,-1.4937,0.0045,0.007,1.044,0.34,0.61,-0.8699,0.85,0.99
"C6_Oncogenic_signatures:C6_ALL_73_PRC2_EDD_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_73_PRC2_EDD_UP_V1_DN",182,-1.4936,0.0023,0.014,-0.9935,0.48,0.68,-0.9914,0.49,0.66
"GO_CC:501391_GO_0032155_CELL_DIVISION_SITE_PART","GO_CC","501391_GO_0032155_CELL_DIVISION_SITE_PART",48,-1.4936,0.027,0.15,0.8599,0.7,0.91,0.6839,0.96,1
"GO_BP:490997_GO_0006011_UDP_GLUCOSE_METABOLIC_PROCESS","GO_BP","490997_GO_0006011_UDP_GLUCOSE_METABOLIC_PROCESS",5,-1.4935,0.035,0.11,-0.7425,0.78,1,-1.4656,0.062,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1439_DER_IFN_GAMMA_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1439_DER_IFN_GAMMA_RESPONSE_UP",71,-1.4934,0.014,0.065,1.3526,0.03,0.34,-1.2097,0.13,0.51
"C7_Immunologic_signatures:C7_ALL_1168_GSE27786_LIN_NEG_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1168_GSE27786_LIN_NEG_VS_NKCELL_DN",200,-1.4934,0,0.0071,-0.8694,0.83,1,-1.0642,0.27,0.58
"GO_MF:495342_GO_0016918_RETINAL_BINDING","GO_MF","495342_GO_0016918_RETINAL_BINDING",13,-1.4934,0.051,0.14,0.9428,0.51,0.94,1.1586,0.27,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_728_OHASHI_AURKA_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_728_OHASHI_AURKA_TARGETS",6,-1.4933,0.052,0.065,-1.452,0.093,0.52,-1.5209,0.039,0.29
"C7_Immunologic_signatures:C7_ALL_1525_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP","C7_Immunologic_signatures","C7_ALL_1525_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP",195,-1.4932,0.0022,0.0071,0.7846,0.98,1,-1.1569,0.15,0.36
"GO_BP:752363_GO_0080184_RESPONSE_TO_PHENYLPROPANOID","GO_BP","752363_GO_0080184_RESPONSE_TO_PHENYLPROPANOID",8,-1.4932,0.051,0.11,-1.0249,0.42,0.97,0.8052,0.72,1
"C3_TF_targets:C3_TFT_370_GCCNNNWTAAR_UNKNOWN","C3_TF_targets","C3_TFT_370_GCCNNNWTAAR_UNKNOWN",145,-1.4932,0.0095,0.021,-1.2755,0.059,0.25,-1.0716,0.24,0.6
"C7_Immunologic_signatures:C7_ALL_623_GSE17721_POLYIC_VS_CPG_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_623_GSE17721_POLYIC_VS_CPG_4H_BMDM_UP",199,-1.493,0.0034,0.0071,1.3487,0.017,0.063,-1.0065,0.45,0.71
"C6_Oncogenic_signatures:C6_ALL_49_RELA_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_49_RELA_DN_V1_DN",133,-1.493,0.006,0.014,-1.1947,0.13,0.47,-1.0089,0.43,0.63
"C7_Immunologic_signatures:C7_ALL_1740_GSE5960_TH1_VS_ANERGIC_TH1_DN","C7_Immunologic_signatures","C7_ALL_1740_GSE5960_TH1_VS_ANERGIC_TH1_DN",196,-1.493,0.0034,0.0071,0.684,1,1,-1.0074,0.43,0.71
"GO_BP:492852_GO_0008593_REGULATION_OF_NOTCH_SIGNALING_PATHWAY","GO_BP","492852_GO_0008593_REGULATION_OF_NOTCH_SIGNALING_PATHWAY",53,-1.493,0.02,0.11,-0.8654,0.72,1,-1.1567,0.2,0.74
"C7_Immunologic_signatures:C7_ALL_1191_GSE27786_CD4_VS_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1191_GSE27786_CD4_VS_CD8_TCELL_UP",199,-1.4929,0.0011,0.0071,-0.753,0.98,1,0.6961,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3180_DELPUECH_FOXO3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3180_DELPUECH_FOXO3_TARGETS_DN",41,-1.4929,0.032,0.065,-0.7395,0.9,1,-1.4109,0.048,0.35
"GO_BP:499052_GO_0021772_OLFACTORY_BULB_DEVELOPMENT","GO_BP","499052_GO_0021772_OLFACTORY_BULB_DEVELOPMENT",36,-1.4927,0.032,0.11,-1.3843,0.064,0.99,1.0585,0.38,0.8
"KEGG_pathway:HSA05332_GRAFT_VERSUS_HOST_DISEASE","KEGG_pathway","HSA05332_GRAFT_VERSUS_HOST_DISEASE",37,-1.4926,0.034,0.036,-0.7244,0.89,1,-0.9452,0.55,0.78
"GO_BP:1129351_GO_1903524_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION","GO_BP","1129351_GO_1903524_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION",74,-1.4925,0.01,0.11,1.0908,0.28,0.91,1.3462,0.052,0.65
"REACTOME:161007_REACT_22292_CHL1_INTERACTIONS","REACTOME","161007_REACT_22292_CHL1_INTERACTIONS",9,-1.4925,0.05,0.13,-1.1684,0.28,0.85,-1.441,0.1,0.39
"GO_BP:486820_GO_0000303_RESPONSE_TO_SUPEROXIDE","GO_BP","486820_GO_0000303_RESPONSE_TO_SUPEROXIDE",17,-1.4924,0.057,0.11,-0.5724,0.97,1,-1.2882,0.14,0.65
"C6_Oncogenic_signatures:C6_ALL_86_PKCA_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_86_PKCA_DN_V1_UP",144,-1.4924,0.0048,0.014,-1.3325,0.042,0.41,-1.0421,0.34,0.59
"C7_Immunologic_signatures:C7_ALL_816_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_816_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN",187,-1.4924,0.0011,0.0071,0.9387,0.63,0.93,0.9228,0.66,1
"GO_BP:498230_GO_0019388_GALACTOSE_CATABOLIC_PROCESS","GO_BP","498230_GO_0019388_GALACTOSE_CATABOLIC_PROCESS",8,-1.4924,0.055,0.11,-1.1289,0.3,0.93,-1.4085,0.11,0.58
"GO_BP:518956_GO_2000310_REGULATION_OF_N_METHYL_D_ASPARTATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY","GO_BP","518956_GO_2000310_REGULATION_OF_N_METHYL_D_ASPARTATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY",15,-1.4924,0.056,0.11,-1.2317,0.19,0.9,-0.6802,0.9,1
"C7_Immunologic_signatures:C7_ALL_292_GSE14350_IL2RB_KO_VS_WT_TEFF_DN","C7_Immunologic_signatures","C7_ALL_292_GSE14350_IL2RB_KO_VS_WT_TEFF_DN",198,-1.4922,0.0035,0.0071,1.0201,0.38,0.68,-0.8261,0.92,1
"GO_BP:1022191_GO_1903205_REGULATION_OF_HYDROGEN_PEROXIDE_INDUCED_CELL_DEATH","GO_BP","1022191_GO_1903205_REGULATION_OF_HYDROGEN_PEROXIDE_INDUCED_CELL_DEATH",13,-1.492,0.055,0.11,1.4578,0.093,0.48,0.9519,0.52,0.9
"GO_BP:499717_GO_0030317_SPERM_MOTILITY","GO_BP","499717_GO_0030317_SPERM_MOTILITY",41,-1.492,0.038,0.11,-1.3458,0.079,0.92,-1.2675,0.13,0.67
"C6_Oncogenic_signatures:C6_ALL_83_CTIP_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_83_CTIP_DN_V1_DN",129,-1.492,0.0084,0.014,-1.1314,0.22,0.52,1.2328,0.1,0.24
"C2_Chemical_and_genetic_perturbations:C2_CGP_2893_DORN_ADENOVIRUS_INFECTION_12HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2893_DORN_ADENOVIRUS_INFECTION_12HR_DN",33,-1.4918,0.045,0.066,-1.3343,0.092,0.69,0.6768,0.96,1
"KEGG_compound:C00074_PHOSPHOENOLPYRUVATE_PHOSPHOENOLPYRUVIC_ACID_PEP","KEGG_compound","C00074_PHOSPHOENOLPYRUVATE_PHOSPHOENOLPYRUVIC_ACID_PEP",8,-1.4918,0.05,0.18,-0.7384,0.82,1,-1.4286,0.065,0.26
"GO_BP:508748_GO_0046488_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS","GO_BP","508748_GO_0046488_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS",130,-1.4917,0.0061,0.11,-0.8076,0.87,1,-1.0072,0.42,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_2778_MIKKELSEN_IPS_LCP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2778_MIKKELSEN_IPS_LCP_WITH_H3K27ME3",10,-1.4916,0.049,0.066,-0.9403,0.52,1,1.0637,0.38,0.9
"GO_MF:489647_GO_0004185_SERINE_TYPE_CARBOXYPEPTIDASE_ACTIVITY","GO_MF","489647_GO_0004185_SERINE_TYPE_CARBOXYPEPTIDASE_ACTIVITY",5,-1.4916,0.051,0.15,0.5947,0.92,1,-0.5698,0.95,1
"GO_BP:502002_GO_0032776_DNA_METHYLATION_ON_CYTOSINE","GO_BP","502002_GO_0032776_DNA_METHYLATION_ON_CYTOSINE",35,-1.4915,0.026,0.11,-2.1128,0,0.11,-1.3687,0.077,0.59
"C7_Immunologic_signatures:C7_ALL_474_GSE17721_CTRL_VS_POLYIC_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_474_GSE17721_CTRL_VS_POLYIC_8H_BMDM_DN",197,-1.4915,0.0033,0.0072,-0.948,0.58,1,-1.0418,0.33,0.63
"GO_BP:496520_GO_0016572_HISTONE_PHOSPHORYLATION","GO_BP","496520_GO_0016572_HISTONE_PHOSPHORYLATION",25,-1.4915,0.037,0.11,-0.9416,0.55,1,-1.2881,0.13,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_2103_JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2103_JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN",17,-1.4914,0.045,0.066,1.0904,0.33,0.64,0.9839,0.48,0.96
"GO_BP:506583_GO_0043552_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY","GO_BP","506583_GO_0043552_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY",26,-1.4914,0.043,0.11,-0.8906,0.61,1,-0.9073,0.61,0.92
"GO_BP:489302_GO_0051016_BARBED_END_ACTIN_FILAMENT_CAPPING","GO_BP","489302_GO_0051016_BARBED_END_ACTIN_FILAMENT_CAPPING",11,-1.4913,0.044,0.11,0.8044,0.74,1,-0.7965,0.72,0.99
"GO_BP:513580_GO_0060022_HARD_PALATE_DEVELOPMENT","GO_BP","513580_GO_0060022_HARD_PALATE_DEVELOPMENT",6,-1.4912,0.036,0.11,-0.7761,0.75,1,-1.0017,0.46,0.85
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_153_BIOCARTA_CK1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_153_BIOCARTA_CK1_PATHWAY",17,-1.491,0.053,0.13,0.9775,0.49,0.81,-1.2936,0.14,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_2266_SMID_BREAST_CANCER_LUMINAL_B_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2266_SMID_BREAST_CANCER_LUMINAL_B_UP",170,-1.491,0.0024,0.066,-1.3035,0.03,0.69,-1.2964,0.032,0.43
"GO_BP:519212_GO_2000573_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS","GO_BP","519212_GO_2000573_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS",18,-1.4909,0.054,0.11,-0.9256,0.55,1,0.9964,0.47,0.86
"C7_Immunologic_signatures:C7_ALL_954_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN","C7_Immunologic_signatures","C7_ALL_954_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN",196,-1.4908,0.0012,0.0073,0.7064,1,1,-1.0019,0.44,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1175_MORI_PRE_BI_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1175_MORI_PRE_BI_LYMPHOCYTE_DN",77,-1.4908,0.013,0.066,0.8329,0.83,0.97,-0.8278,0.84,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_3285_SANDERSON_PPARA_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3285_SANDERSON_PPARA_TARGETS",14,-1.4906,0.052,0.066,-0.6487,0.92,1,-1.2691,0.17,0.45
"GO_BP:751851_GO_0044708_SINGLE_ORGANISM_BEHAVIOR","GO_BP","751851_GO_0044708_SINGLE_ORGANISM_BEHAVIOR",352,-1.4906,0,0.11,-1.2796,0.02,0.89,1.2502,0.024,0.69
"C7_Immunologic_signatures:C7_ALL_1152_GSE27786_LSK_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1152_GSE27786_LSK_VS_NKCELL_DN",200,-1.4906,0.0012,0.0073,0.7363,1,1,-1.0464,0.34,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_36_BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_36_BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN",165,-1.4906,0.0047,0.066,-1.024,0.39,0.98,-1.1779,0.11,0.54
"GO_BP:506321_GO_0043254_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY","GO_BP","506321_GO_0043254_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY",283,-1.4905,0.0011,0.11,0.7732,0.99,1,-1.3302,0.015,0.62
"GO_MF:1053355_GO_0098748_ENDOCYTIC_ADAPTOR_ACTIVITY","GO_MF","1053355_GO_0098748_ENDOCYTIC_ADAPTOR_ACTIVITY",9,-1.4905,0.058,0.15,0.8383,0.65,1,-0.9961,0.45,0.79
"C7_Immunologic_signatures:C7_ALL_1476_GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN","C7_Immunologic_signatures","C7_ALL_1476_GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN",197,-1.4905,0.0011,0.0073,-1.0989,0.25,1,-1.0515,0.31,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_1873_LIU_SMARCA4_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1873_LIU_SMARCA4_TARGETS",61,-1.4905,0.018,0.066,-1.1121,0.25,0.9,1.0596,0.38,0.9
"REACTOME:187081_REACT_25222_MYD88_DEPENDENT_CASCADE_INITIATED_ON_ENDOSOME","REACTOME","187081_REACT_25222_MYD88_DEPENDENT_CASCADE_INITIATED_ON_ENDOSOME",89,-1.4903,0.0078,0.14,-0.572,1,1,-1.2148,0.11,0.59
"REACTOME:106021_REACT_11149_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS","REACTOME","106021_REACT_11149_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS",21,-1.4903,0.038,0.13,1.1833,0.23,0.46,-1.3674,0.11,0.47
"GO_BP:507968_GO_0045620_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION","GO_BP","507968_GO_0045620_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION",35,-1.4902,0.032,0.11,-1.2488,0.15,0.91,0.9605,0.5,0.9
"C1_Positional:C1_ALL_95_CHR1Q21","C1_Positional","C1_ALL_95_CHR1Q21",246,-1.4901,0.0011,0.33,-1.2688,0.038,1,-1.2155,0.07,0.64
"GO_BP:519319_GO_2000680_REGULATION_OF_RUBIDIUM_ION_TRANSPORT","GO_BP","519319_GO_2000680_REGULATION_OF_RUBIDIUM_ION_TRANSPORT",5,-1.49,0.035,0.11,-0.534,0.98,1,-0.8471,0.66,0.96
"GO_BP:503368_GO_0034162_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY","GO_BP","503368_GO_0034162_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY",73,-1.4899,0.015,0.11,-0.599,0.99,1,-1.2934,0.07,0.64
"GO_BP:488411_GO_0002538_ARACHIDONIC_ACID_METABOLITE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE","GO_BP","488411_GO_0002538_ARACHIDONIC_ACID_METABOLITE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE",5,-1.4899,0.034,0.11,0.6709,0.86,1,0.9256,0.56,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_2068_ZHENG_BOUND_BY_FOXP3","C2_Chemical_and_genetic_perturbations","C2_CGP_2068_ZHENG_BOUND_BY_FOXP3",483,-1.4899,0,0.066,1.2122,0.03,0.48,-1.2123,0.026,0.51
"C7_Immunologic_signatures:C7_ALL_616_GSE17721_LPS_VS_PAM3CSK4_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_616_GSE17721_LPS_VS_PAM3CSK4_24H_BMDM_DN",198,-1.4898,0.0035,0.0073,1.1611,0.12,0.3,-0.9647,0.59,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_3287_DELACROIX_RARG_BOUND_MEF","C2_Chemical_and_genetic_perturbations","C2_CGP_3287_DELACROIX_RARG_BOUND_MEF",361,-1.4898,0,0.066,-1.1047,0.19,0.92,0.8207,0.98,1
"C7_Immunologic_signatures:C7_ALL_1752_GSE6269_FLU_VS_STREP_AUREUS_INF_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1752_GSE6269_FLU_VS_STREP_AUREUS_INF_PBMC_DN",170,-1.4897,0.0034,0.0074,1.0462,0.31,0.6,0.727,0.99,1
"GO_BP:494702_GO_0010638_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION","GO_BP","494702_GO_0010638_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION",439,-1.4896,0,0.11,0.7445,1,1,-1.1463,0.088,0.74
"C7_Immunologic_signatures:C7_ALL_115_GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP","C7_Immunologic_signatures","C7_ALL_115_GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP",186,-1.4895,0.0045,0.0074,0.7636,0.99,1,-0.9694,0.5,0.8
"GO_BP:507259_GO_0044252_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS","GO_BP","507259_GO_0044252_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS",8,-1.4894,0.048,0.11,0.8132,0.7,1,1.5102,0.051,0.54
"GO_BP:488730_GO_0002857_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL","GO_BP","488730_GO_0002857_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL",6,-1.4893,0.039,0.11,-0.4995,0.96,1,0.7693,0.76,1
"GO_MF:496312_GO_0016248_CHANNEL_INHIBITOR_ACTIVITY","GO_MF","496312_GO_0016248_CHANNEL_INHIBITOR_ACTIVITY",37,-1.4891,0.038,0.15,0.6991,0.95,1,0.959,0.52,0.9
"C7_Immunologic_signatures:C7_ALL_121_GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP","C7_Immunologic_signatures","C7_ALL_121_GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP",193,-1.489,0.0034,0.0074,0.7213,1,1,-1.2735,0.041,0.17
"C3_TF_targets:C3_TFT_241_V_MEIS1_01","C3_TF_targets","C3_TFT_241_V_MEIS1_01",236,-1.489,0.0022,0.022,-0.9683,0.54,0.82,-0.982,0.51,0.8
"WikiPathways:198804_WP691_TAMOXIFEN_METABOLISM","WikiPathways","198804_WP691_TAMOXIFEN_METABOLISM",18,-1.4889,0.045,0.075,0.8765,0.62,1,1.3815,0.075,0.43
"GO_BP:491919_GO_0007100_MITOTIC_CENTROSOME_SEPARATION","GO_BP","491919_GO_0007100_MITOTIC_CENTROSOME_SEPARATION",5,-1.4889,0.037,0.11,-0.9267,0.54,1,-0.9093,0.57,0.92
"GO_BP:501943_GO_0032717_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION","GO_BP","501943_GO_0032717_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION",13,-1.4888,0.051,0.11,1.0258,0.4,0.97,-1.3665,0.12,0.59
"C3_TF_targets:C3_TFT_411_V_ETS_Q4","C3_TF_targets","C3_TFT_411_V_ETS_Q4",248,-1.4887,0.0022,0.022,-0.9258,0.69,0.92,-0.9935,0.47,0.78
"GO_BP:488733_GO_0002860_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY_DIRECTED_AGAINST_TUMOR_CELL_TARGET","GO_BP","488733_GO_0002860_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY_DIRECTED_AGAINST_TUMOR_CELL_TARGET",6,-1.4887,0.05,0.11,-0.5175,0.98,1,0.7732,0.74,1
"REACTOME:105694_REACT_1482_ERK_ACTIVATION","REACTOME","105694_REACT_1482_ERK_ACTIVATION",12,-1.4887,0.053,0.14,-0.8641,0.64,1,-1.1899,0.22,0.61
"GO_BP:512063_GO_0051153_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION","GO_BP","512063_GO_0051153_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION",75,-1.4886,0.014,0.11,1.1726,0.18,0.81,-1.0785,0.31,0.79
"GO_BP:492552_GO_0008211_GLUCOCORTICOID_METABOLIC_PROCESS","GO_BP","492552_GO_0008211_GLUCOCORTICOID_METABOLIC_PROCESS",16,-1.4886,0.044,0.11,-1.0517,0.37,0.97,0.8838,0.62,0.95
"REACTOME:106020_REACT_11068_NEF_AND_SIGNAL_TRANSDUCTION","REACTOME","106020_REACT_11068_NEF_AND_SIGNAL_TRANSDUCTION",8,-1.4885,0.057,0.14,-0.6187,0.92,1,-1.5226,0.048,0.34
"GO_BP:1129399_GO_1903573_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS","GO_BP","1129399_GO_1903573_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS",26,-1.4884,0.038,0.11,-1.0056,0.43,0.98,-1.4631,0.062,0.54
"KEGG_compound:C00027_HYDROGEN_PEROXIDE_H2O2_OXYDOL","KEGG_compound","C00027_HYDROGEN_PEROXIDE_H2O2_OXYDOL",28,-1.4882,0.034,0.18,-1.396,0.073,0.45,1.2991,0.13,0.42
"C3_TF_targets:C3_TFT_440_V_PAX_Q6","C3_TF_targets","C3_TFT_440_V_PAX_Q6",251,-1.4882,0.0011,0.022,-1.3043,0.02,0.23,-1.2321,0.058,0.3
"KEGG_compound:C00577_D_GLYCERALDEHYDE","KEGG_compound","C00577_D_GLYCERALDEHYDE",11,-1.4882,0.05,0.18,-0.7105,0.85,1,-1.4593,0.069,0.25
"GO_BP:492318_GO_0007568_AGING","GO_BP","492318_GO_0007568_AGING",210,-1.488,0.0033,0.11,0.8975,0.81,1,-0.9931,0.45,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_923_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4","C2_Chemical_and_genetic_perturbations","C2_CGP_923_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4",256,-1.4879,0.0011,0.067,-1.0483,0.33,0.97,-1.1126,0.17,0.61
"GO_BP:501507_GO_0032272_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION","GO_BP","501507_GO_0032272_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION",56,-1.4879,0.027,0.11,-0.982,0.51,1,-1.4707,0.014,0.54
"GO_BP:489303_GO_0051014_ACTIN_FILAMENT_SEVERING","GO_BP","489303_GO_0051014_ACTIN_FILAMENT_SEVERING",7,-1.4879,0.065,0.11,-0.4947,0.97,1,-1.0637,0.39,0.8
"C7_Immunologic_signatures:C7_ALL_1770_GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1770_GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN",199,-1.4878,0.0045,0.0076,0.7701,0.99,1,-1.3624,0.019,0.085
"WikiPathways:198861_WP58_MONOAMINE_GPCRS","WikiPathways","198861_WP58_MONOAMINE_GPCRS",33,-1.4877,0.034,0.075,0.9941,0.45,1,1.5593,0.021,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_1269_LEE_LIVER_CANCER_CIPROFIBRATE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1269_LEE_LIVER_CANCER_CIPROFIBRATE_DN",61,-1.4877,0.016,0.067,-1.2661,0.11,0.72,-1.5088,0.01,0.29
"GO_BP:506619_GO_0043588_SKIN_DEVELOPMENT","GO_BP","506619_GO_0043588_SKIN_DEVELOPMENT",190,-1.4877,0.0022,0.11,0.972,0.53,1,1.2143,0.09,0.71
"GO_BP:510380_GO_0048266_BEHAVIORAL_RESPONSE_TO_PAIN","GO_BP","510380_GO_0048266_BEHAVIORAL_RESPONSE_TO_PAIN",15,-1.4876,0.054,0.11,-1.5321,0.053,0.77,-0.6796,0.91,1
"GO_BP:510892_GO_0048842_POSITIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE","GO_BP","510892_GO_0048842_POSITIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE",7,-1.4876,0.06,0.11,0.6153,0.94,1,-0.838,0.68,0.96
"C7_Immunologic_signatures:C7_ALL_625_GSE17721_POLYIC_VS_CPG_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_625_GSE17721_POLYIC_VS_CPG_6H_BMDM_UP",197,-1.4876,0.0023,0.0076,0.7241,0.99,1,-0.9296,0.69,0.89
"GO_BP:511773_GO_0050807_REGULATION_OF_SYNAPSE_ORGANIZATION","GO_BP","511773_GO_0050807_REGULATION_OF_SYNAPSE_ORGANIZATION",60,-1.4876,0.022,0.11,-1.3707,0.052,0.98,-0.8345,0.78,0.97
"GO_BP:499945_GO_0030638_POLYKETIDE_METABOLIC_PROCESS","GO_BP","499945_GO_0030638_POLYKETIDE_METABOLIC_PROCESS",9,-1.4876,0.048,0.11,-0.7089,0.83,1,0.7992,0.72,1
"GO_BP:498711_GO_0048017_INOSITOL_LIPID_MEDIATED_SIGNALING","GO_BP","498711_GO_0048017_INOSITOL_LIPID_MEDIATED_SIGNALING",129,-1.4875,0.0097,0.11,-1.1154,0.23,0.94,1.0334,0.37,0.82
"GO_MF:754574_GO_1901618_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","754574_GO_1901618_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",43,-1.4875,0.027,0.15,-1.8916,0,0.17,-0.9192,0.61,0.86
"REACTOME:1127591_REACT_267917_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE","REACTOME","1127591_REACT_267917_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE",6,-1.4874,0.048,0.14,-0.8616,0.63,1,1.1018,0.37,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_19_KORKOLA_TERATOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_19_KORKOLA_TERATOMA_UP",16,-1.4872,0.054,0.068,0.9911,0.43,0.81,0.6675,0.93,1
"GO_CC:496302_GO_0016235_AGGRESOME","GO_CC","496302_GO_0016235_AGGRESOME",28,-1.4872,0.035,0.15,-0.9024,0.6,0.96,-1.5427,0.014,0.49
"C7_Immunologic_signatures:C7_ALL_1812_GSE7852_TREG_VS_TCONV_FAT_DN","C7_Immunologic_signatures","C7_ALL_1812_GSE7852_TREG_VS_TCONV_FAT_DN",200,-1.4872,0.0035,0.0076,0.8453,0.92,1,-1.4151,0.0021,0.053
"GO_BP:518332_GO_0090192_REGULATION_OF_GLOMERULUS_DEVELOPMENT","GO_BP","518332_GO_0090192_REGULATION_OF_GLOMERULUS_DEVELOPMENT",12,-1.4871,0.058,0.11,1.0765,0.34,0.93,1.7952,0.0081,0.3
"GO_BP:494821_GO_0010756_POSITIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION","GO_BP","494821_GO_0010756_POSITIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION",5,-1.4871,0.048,0.11,-0.8749,0.62,1,-1.1164,0.36,0.76
"GO_BP:499347_GO_0022612_GLAND_MORPHOGENESIS","GO_BP","499347_GO_0022612_GLAND_MORPHOGENESIS",101,-1.4871,0.017,0.11,-0.8805,0.72,1,1.3076,0.046,0.67
"GO_MF:489502_GO_0004033_ALDO_KETO_REDUCTASE_NADP_ACTIVITY","GO_MF","489502_GO_0004033_ALDO_KETO_REDUCTASE_NADP_ACTIVITY",20,-1.4871,0.037,0.15,-0.8206,0.74,1,-0.7335,0.85,0.99
"GO_BP:503321_GO_0034115_NEGATIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION","GO_BP","503321_GO_0034115_NEGATIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION",7,-1.4871,0.054,0.11,-1.363,0.15,0.97,-0.4862,0.99,1
"GO_BP:498829_GO_0021545_CRANIAL_NERVE_DEVELOPMENT","GO_BP","498829_GO_0021545_CRANIAL_NERVE_DEVELOPMENT",51,-1.4871,0.014,0.11,-1.0855,0.31,0.96,1.2973,0.11,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_3009_BAE_BRCA1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3009_BAE_BRCA1_TARGETS_UP",74,-1.4869,0.0051,0.068,1.2898,0.075,0.4,0.7023,0.98,1
"C7_Immunologic_signatures:C7_ALL_463_GSE17721_CTRL_VS_POLYIC_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_463_GSE17721_CTRL_VS_POLYIC_0_5H_BMDM_UP",196,-1.4868,0.0045,0.0077,1.0218,0.4,0.68,0.762,0.98,1
"REACTOME:105697_REACT_18312_NCAM1_INTERACTIONS","REACTOME","105697_REACT_18312_NCAM1_INTERACTIONS",37,-1.4868,0.036,0.14,-1.4872,0.028,0.47,0.6599,0.97,1
"C3_TF_targets:C3_TFT_438_V_NF1_Q6_01","C3_TF_targets","C3_TFT_438_V_NF1_Q6_01",262,-1.4867,0,0.022,-0.9052,0.75,0.95,-1.1476,0.14,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_178_VECCHI_GASTRIC_CANCER_EARLY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_178_VECCHI_GASTRIC_CANCER_EARLY_UP",415,-1.4866,0.001,0.068,1.0125,0.41,0.78,-1.2691,0.0083,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_86_TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_86_TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP",20,-1.4865,0.051,0.068,-1.0793,0.35,0.95,-1.3687,0.1,0.38
"WikiPathways:198772_WP1539_ANGIOGENESIS","WikiPathways","198772_WP1539_ANGIOGENESIS",23,-1.4865,0.038,0.075,0.64,0.94,1,-0.7943,0.8,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_3342_HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3342_HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN",12,-1.4865,0.049,0.068,-0.9327,0.56,1,-0.9438,0.55,0.83
"C3_TF_targets:C3_TFT_45_V_CP2_01","C3_TF_targets","C3_TFT_45_V_CP2_01",256,-1.4865,0.0022,0.022,-1.3487,0.0069,0.19,0.8368,0.92,1
"GO_BP:516168_GO_0071243_CELLULAR_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE","GO_BP","516168_GO_0071243_CELLULAR_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE",11,-1.4865,0.044,0.11,-1.2536,0.2,0.91,-0.8107,0.72,0.98
"C4_Cancer_modules:C4_CM_234_MODULE_259","C4_Cancer_modules","C4_CM_234_MODULE_259",46,-1.4863,0.018,0.06,-0.9417,0.56,0.89,-0.9076,0.63,0.85
"GO_BP:493862_GO_0009750_RESPONSE_TO_FRUCTOSE","GO_BP","493862_GO_0009750_RESPONSE_TO_FRUCTOSE",6,-1.4862,0.062,0.12,-0.9622,0.48,1,-0.8557,0.66,0.96
"GO_BP:494965_GO_0010901_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING","GO_BP","494965_GO_0010901_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING",5,-1.4861,0.052,0.12,-1.4668,0.08,0.87,-1.2625,0.21,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_2108_KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2108_KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION",77,-1.4861,0.016,0.068,-0.6431,0.99,1,-1.0309,0.37,0.71
"C4_Cancer_gene_neighborhoods:C4_CGN_325_GNF2_CASP4","C4_Cancer_gene_neighborhoods","C4_CGN_325_GNF2_CASP4",24,-1.486,0.034,0.063,1.3924,0.08,0.064,-0.6488,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1937_LI_ADIPOGENESIS_BY_ACTIVATED_PPARG","C2_Chemical_and_genetic_perturbations","C2_CGP_1937_LI_ADIPOGENESIS_BY_ACTIVATED_PPARG",17,-1.4859,0.053,0.068,0.8209,0.74,0.98,-0.9532,0.53,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_153_GRABARCZYK_BCL11B_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_153_GRABARCZYK_BCL11B_TARGETS_UP",80,-1.4858,0.02,0.068,1.2094,0.13,0.48,-0.8291,0.81,0.94
"GO_BP:515229_GO_0070296_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT","GO_BP","515229_GO_0070296_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT",10,-1.4857,0.079,0.12,0.4523,1,1,1.3903,0.1,0.63
"GO_BP:499709_GO_0030309_POLY_N_ACETYLLACTOSAMINE_METABOLIC_PROCESS","GO_BP","499709_GO_0030309_POLY_N_ACETYLLACTOSAMINE_METABOLIC_PROCESS",6,-1.4856,0.055,0.12,0.5135,0.97,1,0.7511,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_98_GARY_CD5_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_98_GARY_CD5_TARGETS_UP",470,-1.4856,0,0.068,-0.696,1,1,-1.4456,0,0.32
"GO_CC:495068_GO_0012506_VESICLE_MEMBRANE","GO_CC","495068_GO_0012506_VESICLE_MEMBRANE",453,-1.4854,0,0.15,1.1406,0.07,0.6,0.8864,0.88,1
"KEGG_pathway:HSA01040_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS","KEGG_pathway","HSA01040_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS",23,-1.4853,0.037,0.038,-0.8563,0.7,1,-1.7117,0.0042,0.043
"C4_Cancer_modules:C4_CM_118_MODULE_123","C4_Cancer_modules","C4_CM_118_MODULE_123",242,-1.4853,0,0.061,-1.1524,0.14,0.64,-0.9965,0.48,0.7
"GO_MF:509140_GO_0046943_CARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","509140_GO_0046943_CARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",111,-1.4852,0.0087,0.15,-1.2229,0.13,0.85,0.8811,0.76,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_767_EINAV_INTERFERON_SIGNATURE_IN_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_767_EINAV_INTERFERON_SIGNATURE_IN_CANCER",27,-1.4851,0.031,0.068,1.502,0.038,0.21,-1.6554,0.01,0.22
"GO_BP:508734_GO_0046474_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS","GO_BP","508734_GO_0046474_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS",184,-1.4849,0.0023,0.12,0.6878,1,1,-0.9196,0.7,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_2653_MILI_PSEUDOPODIA_CHEMOTAXIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2653_MILI_PSEUDOPODIA_CHEMOTAXIS_DN",456,-1.4848,0,0.068,-0.9879,0.52,1,-0.8023,1,0.95
"GO_BP:1022099_GO_0098662_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORT","GO_BP","1022099_GO_0098662_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORT",446,-1.4847,0,0.12,-1.1388,0.11,0.93,1.0475,0.29,0.81
"GO_BP:492353_GO_0007612_LEARNING","GO_BP","492353_GO_0007612_LEARNING",116,-1.4847,0.0097,0.12,-1.1963,0.14,0.9,1.0391,0.38,0.82
"C6_Oncogenic_signatures:C6_ALL_19_CYCLIN_D1_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_19_CYCLIN_D1_UP_V1_DN",185,-1.4845,0.0023,0.015,0.8583,0.85,0.98,-1.1948,0.088,0.37
"C7_Immunologic_signatures:C7_ALL_1861_GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP","C7_Immunologic_signatures","C7_ALL_1861_GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP",196,-1.4844,0.0023,0.008,0.6061,1,1,-0.8459,0.88,1
"GO_BP:501798_GO_0032570_RESPONSE_TO_PROGESTERONE","GO_BP","501798_GO_0032570_RESPONSE_TO_PROGESTERONE",34,-1.4844,0.04,0.12,-0.7795,0.84,1,0.854,0.73,0.98
"GO_BP:492010_GO_0007212_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","492010_GO_0007212_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY",26,-1.4844,0.032,0.12,0.7165,0.89,1,0.7441,0.87,1
"GO_BP:492000_GO_0007200_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY","GO_BP","492000_GO_0007200_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",65,-1.4841,0.027,0.12,1.3325,0.055,0.63,2.0513,0,0.025
"GO_MF:495528_GO_0015277_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY","GO_MF","495528_GO_0015277_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY",5,-1.4841,0.052,0.15,-1.1851,0.3,0.78,1.3064,0.18,0.66
"C7_Immunologic_signatures:C7_ALL_1649_GSE3982_MAC_VS_BASOPHIL_UP","C7_Immunologic_signatures","C7_ALL_1649_GSE3982_MAC_VS_BASOPHIL_UP",200,-1.484,0.0023,0.008,-1.0224,0.38,1,-0.9759,0.52,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2758_MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2758_MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3",319,-1.484,0,0.069,-1.3279,0.023,0.68,1.5072,0,0.48
"C3_TF_targets:C3_TFT_190_V_LMO2COM_01","C3_TF_targets","C3_TFT_190_V_LMO2COM_01",258,-1.4839,0.0011,0.023,-1.6633,0,0.14,-1.1341,0.15,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_667_GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION","C2_Chemical_and_genetic_perturbations","C2_CGP_667_GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION",22,-1.4839,0.036,0.069,-0.8435,0.71,1,-0.8022,0.8,0.95
"C6_Oncogenic_signatures:C6_ALL_143_TGFB_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_143_TGFB_UP_V1_DN",186,-1.4838,0.0034,0.015,-1.1703,0.14,0.48,-1.105,0.21,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_3013_BROWNE_HCMV_INFECTION_1HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3013_BROWNE_HCMV_INFECTION_1HR_UP",58,-1.4838,0.024,0.069,-0.9646,0.5,1,-1.1934,0.18,0.53
"GO_MF:495403_GO_0015129_LACTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495403_GO_0015129_LACTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-1.4838,0.051,0.15,-1.3518,0.13,0.69,-1.024,0.43,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_83_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_83_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN",189,-1.4837,0.0023,0.069,-1.2537,0.056,0.74,-1.0553,0.32,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_514_OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_514_OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP",67,-1.4836,0.016,0.069,1.0926,0.3,0.64,-1.1963,0.14,0.52
"GO_BP:512372_GO_0051494_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION","GO_BP","512372_GO_0051494_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION",111,-1.4836,0.014,0.12,-0.9183,0.65,1,-1.376,0.019,0.59
"WikiPathways:198908_WP195_IL_1_SIGNALING_PATHWAY","WikiPathways","198908_WP195_IL_1_SIGNALING_PATHWAY",12,-1.4835,0.057,0.076,0.944,0.5,1,1.4604,0.075,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_66_ZERBINI_RESPONSE_TO_SULINDAC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_66_ZERBINI_RESPONSE_TO_SULINDAC_UP",9,-1.4835,0.054,0.069,-0.5532,0.95,1,-1.3648,0.13,0.39
"WikiPathways:198830_WP694_ARYLAMINE_METABOLISM","WikiPathways","198830_WP694_ARYLAMINE_METABOLISM",7,-1.4834,0.05,0.075,0.5844,0.95,1,1.1531,0.29,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_1219_NIKOLSKY_BREAST_CANCER_20P13_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1219_NIKOLSKY_BREAST_CANCER_20P13_AMPLICON",8,-1.4832,0.057,0.069,-0.8803,0.61,1,-1.4086,0.1,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_2536_MIZUKAMI_HYPOXIA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2536_MIZUKAMI_HYPOXIA_DN",6,-1.4832,0.049,0.069,0.7874,0.73,1,-0.7591,0.75,0.97
"GO_BP:487865_GO_0001975_RESPONSE_TO_AMPHETAMINE","GO_BP","487865_GO_0001975_RESPONSE_TO_AMPHETAMINE",29,-1.4831,0.044,0.12,-0.7785,0.79,1,-0.9021,0.62,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_3395_HECKER_IFNB1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3395_HECKER_IFNB1_TARGETS",91,-1.4829,0.016,0.069,2.0388,0,0.004,-1.4215,0.026,0.34
"WikiPathways:760636_WP1422_SPHINGOLIPID_METABOLISM","WikiPathways","760636_WP1422_SPHINGOLIPID_METABOLISM",21,-1.4829,0.058,0.075,-0.7747,0.8,1,-1.0462,0.4,0.64
"GO_MF:496353_GO_0016307_PHOSPHATIDYLINOSITOL_PHOSPHATE_KINASE_ACTIVITY","GO_MF","496353_GO_0016307_PHOSPHATIDYLINOSITOL_PHOSPHATE_KINASE_ACTIVITY",16,-1.4829,0.057,0.15,-0.9059,0.57,0.98,-0.6023,0.95,1
"GO_BP:506684_GO_0043654_RECOGNITION_OF_APOPTOTIC_CELL","GO_BP","506684_GO_0043654_RECOGNITION_OF_APOPTOTIC_CELL",7,-1.4826,0.057,0.12,1.0869,0.37,0.92,-1.6295,0.029,0.51
"GO_BP:515458_GO_0070528_PROTEIN_KINASE_C_SIGNALING","GO_BP","515458_GO_0070528_PROTEIN_KINASE_C_SIGNALING",12,-1.4824,0.044,0.12,-0.8703,0.62,1,-0.8852,0.61,0.94
"GO_BP:510596_GO_0048525_NEGATIVE_REGULATION_OF_VIRAL_PROCESS","GO_BP","510596_GO_0048525_NEGATIVE_REGULATION_OF_VIRAL_PROCESS",84,-1.4823,0.01,0.12,1.3668,0.035,0.59,-1.5213,0.01,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2680_VALK_AML_CLUSTER_4","C2_Chemical_and_genetic_perturbations","C2_CGP_2680_VALK_AML_CLUSTER_4",30,-1.4822,0.036,0.069,0.7799,0.83,1,0.6319,0.98,1
"C1_Positional:C1_ALL_319_CHR1Q12","C1_Positional","C1_ALL_319_CHR1Q12",14,-1.4822,0.065,0.33,-1.3542,0.12,0.95,1.2544,0.16,0.55
"GO_BP:505483_GO_0042339_KERATAN_SULFATE_METABOLIC_PROCESS","GO_BP","505483_GO_0042339_KERATAN_SULFATE_METABOLIC_PROCESS",33,-1.4822,0.037,0.12,0.6516,0.96,1,0.9732,0.47,0.88
"GO_BP:501193_GO_0031953_NEGATIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION","GO_BP","501193_GO_0031953_NEGATIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION",10,-1.4822,0.07,0.12,-1.245,0.22,0.91,0.8082,0.71,1
"GO_CC:507396_GO_0044448_CELL_CORTEX_PART","GO_CC","507396_GO_0044448_CELL_CORTEX_PART",119,-1.482,0.011,0.16,-0.8718,0.76,0.94,-0.9187,0.64,1
"GO_BP:507526_GO_0045137_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS","GO_BP","507526_GO_0045137_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS",193,-1.4818,0.0057,0.12,-0.9044,0.71,1,1.0142,0.43,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_2225_HUANG_FOXA2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2225_HUANG_FOXA2_TARGETS_UP",45,-1.4816,0.026,0.069,-0.9323,0.59,1,0.9938,0.46,0.97
"C3_TF_targets:C3_TFT_267_V_FAC1_01","C3_TF_targets","C3_TFT_267_V_FAC1_01",214,-1.4816,0.0011,0.023,-0.9451,0.63,0.88,0.9184,0.7,1
"GO_BP:755341_GO_2001235_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","755341_GO_2001235_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY",174,-1.4815,0.0045,0.12,0.8351,0.9,1,-1.2111,0.091,0.72
"GO_BP:488539_GO_0002666_POSITIVE_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION","GO_BP","488539_GO_0002666_POSITIVE_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION",8,-1.4815,0.053,0.12,1.1114,0.33,0.89,-0.9857,0.48,0.86
"GO_BP:494723_GO_0010660_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","494723_GO_0010660_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS",39,-1.4814,0.032,0.12,0.8051,0.78,1,1.1789,0.22,0.72
"GO_BP:491965_GO_0007160_CELL_MATRIX_ADHESION","GO_BP","491965_GO_0007160_CELL_MATRIX_ADHESION",116,-1.4814,0.0098,0.12,0.8814,0.73,1,1.198,0.11,0.72
"GO_BP:518419_GO_0090279_REGULATION_OF_CALCIUM_ION_IMPORT","GO_BP","518419_GO_0090279_REGULATION_OF_CALCIUM_ION_IMPORT",24,-1.4814,0.037,0.12,0.9575,0.51,1,1.7189,0.014,0.42
"GO_BP:499719_GO_0072501_CELLULAR_DIVALENT_INORGANIC_ANION_HOMEOSTASIS","GO_BP","499719_GO_0072501_CELLULAR_DIVALENT_INORGANIC_ANION_HOMEOSTASIS",7,-1.4814,0.056,0.12,0.5144,0.98,1,-0.812,0.68,0.98
"GO_BP:516308_GO_0071384_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS","GO_BP","516308_GO_0071384_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS",39,-1.4813,0.029,0.12,0.9098,0.64,1,1.1143,0.29,0.75
"REACTOME:187082_REACT_25024_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION","REACTOME","187082_REACT_25024_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION",87,-1.4813,0.021,0.14,0.5807,1,1,-1.1952,0.16,0.61
"GO_CC:501390_GO_0032154_CLEAVAGE_FURROW","GO_CC","501390_GO_0032154_CLEAVAGE_FURROW",45,-1.4812,0.029,0.16,0.8625,0.73,0.91,0.6816,0.95,1
"GO_MF:489846_GO_0004497_MONOOXYGENASE_ACTIVITY","GO_MF","489846_GO_0004497_MONOOXYGENASE_ACTIVITY",95,-1.4809,0.02,0.15,-1.0149,0.44,0.89,1.282,0.064,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_2578_HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2578_HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN",71,-1.4809,0.023,0.07,-0.9245,0.6,1,-1.1643,0.19,0.56
"GO_MF:506249_GO_0043177_ORGANIC_ACID_BINDING","GO_MF","506249_GO_0043177_ORGANIC_ACID_BINDING",219,-1.4808,0.0011,0.15,0.9643,0.58,0.91,-1.1775,0.097,0.6
"C4_Cancer_modules:C4_CM_84_MODULE_89","C4_Cancer_modules","C4_CM_84_MODULE_89",14,-1.4808,0.052,0.063,-1.0009,0.45,0.79,-1.254,0.18,0.33
"GO_BP:510717_GO_0048662_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION","GO_BP","510717_GO_0048662_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION",28,-1.4807,0.039,0.12,-0.8889,0.64,1,1.0516,0.39,0.8
"C6_Oncogenic_signatures:C6_ALL_127_CAHOY_ASTROCYTIC","C6_Oncogenic_signatures","C6_ALL_127_CAHOY_ASTROCYTIC",95,-1.4806,0.01,0.015,-1.1624,0.16,0.47,1.1335,0.19,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_329_GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_329_GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN",11,-1.4806,0.06,0.07,0.7547,0.8,1,-1.0121,0.47,0.74
"C7_Immunologic_signatures:C7_ALL_1587_GSE3982_EOSINOPHIL_VS_DC_UP","C7_Immunologic_signatures","C7_ALL_1587_GSE3982_EOSINOPHIL_VS_DC_UP",195,-1.4805,0,0.0085,0.7298,0.99,1,-1.0191,0.4,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2484_BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2484_BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP",47,-1.4804,0.027,0.07,1.1851,0.18,0.51,-0.7927,0.82,0.96
"C3_TF_targets:C3_TFT_362_V_E12_Q6","C3_TF_targets","C3_TFT_362_V_E12_Q6",259,-1.4804,0,0.023,-1.426,0.0017,0.16,-1.3263,0.01,0.26
"C6_Oncogenic_signatures:C6_ALL_135_IL2_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_135_IL2_UP_V1_DN",184,-1.4803,0.0023,0.015,0.9909,0.46,0.85,-1.1037,0.21,0.5
"GO_BP:512480_GO_0051602_RESPONSE_TO_ELECTRICAL_STIMULUS","GO_BP","512480_GO_0051602_RESPONSE_TO_ELECTRICAL_STIMULUS",38,-1.4803,0.043,0.12,-0.9246,0.6,1,0.825,0.75,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2666_IRITANI_MAD1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2666_IRITANI_MAD1_TARGETS_UP",13,-1.4803,0.049,0.07,1.0837,0.35,0.66,-0.9804,0.47,0.78
"C3_TF_targets:C3_TFT_86_V_GATA1_02","C3_TF_targets","C3_TFT_86_V_GATA1_02",236,-1.4803,0.0011,0.023,-1.0307,0.36,0.69,1.0735,0.26,1
"GO_BP:751029_GO_0036109_ALPHA_LINOLENIC_ACID_METABOLIC_PROCESS","GO_BP","751029_GO_0036109_ALPHA_LINOLENIC_ACID_METABOLIC_PROCESS",11,-1.4802,0.053,0.12,-1.0396,0.39,0.98,-1.7936,0.0019,0.57
"C3_TF_targets:C3_TFT_1_AAANWWTGC_UNKNOWN","C3_TF_targets","C3_TFT_1_AAANWWTGC_UNKNOWN",185,-1.4801,0,0.023,-0.8029,0.94,1,0.7959,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1820_LEE_AGING_NEOCORTEX_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1820_LEE_AGING_NEOCORTEX_UP",88,-1.48,0.015,0.07,-0.7389,0.94,1,-1.1906,0.15,0.53
"GO_BP:498709_GO_0048015_PHOSPHATIDYLINOSITOL_MEDIATED_SIGNALING","GO_BP","498709_GO_0048015_PHOSPHATIDYLINOSITOL_MEDIATED_SIGNALING",129,-1.4798,0.0049,0.12,-1.1234,0.22,0.94,1.0404,0.36,0.82
"C7_Immunologic_signatures:C7_ALL_704_GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_704_GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDM_DN",198,-1.4798,0.0034,0.0086,1.4519,0.0025,0.022,0.7649,0.99,1
"GO_MF:492541_GO_0008200_ION_CHANNEL_INHIBITOR_ACTIVITY","GO_MF","492541_GO_0008200_ION_CHANNEL_INHIBITOR_ACTIVITY",36,-1.4797,0.043,0.15,0.7379,0.9,1,0.9993,0.45,0.88
"GO_BP:490964_GO_0005976_POLYSACCHARIDE_METABOLIC_PROCESS","GO_BP","490964_GO_0005976_POLYSACCHARIDE_METABOLIC_PROCESS",90,-1.4795,0.02,0.12,1.1286,0.21,0.87,-0.9497,0.56,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_2133_KANG_CISPLATIN_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2133_KANG_CISPLATIN_RESISTANCE_UP",19,-1.4795,0.055,0.07,-0.9078,0.57,1,-0.74,0.84,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_185_JAEGER_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_185_JAEGER_METASTASIS_UP",39,-1.4794,0.051,0.07,-0.7857,0.83,1,1.1263,0.27,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1954_HAN_JNK_SINGALING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1954_HAN_JNK_SINGALING_DN",37,-1.4794,0.028,0.07,1.3221,0.09,0.37,0.9254,0.58,1
"GO_BP:505830_GO_0042723_THIAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","505830_GO_0042723_THIAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",6,-1.4793,0.053,0.12,-1.0751,0.39,0.96,-1.1837,0.26,0.73
"C7_Immunologic_signatures:C7_ALL_1574_GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_1574_GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN",199,-1.4792,0.0022,0.0087,1.1718,0.11,0.28,-1.3264,0.017,0.11
"C2_Chemical_and_genetic_perturbations:C2_CGP_353_RODRIGUES_THYROID_CARCINOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_353_RODRIGUES_THYROID_CARCINOMA_DN",77,-1.4792,0.025,0.07,0.7456,0.94,1,0.9843,0.48,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1639_WHITESIDE_CISPLATIN_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1639_WHITESIDE_CISPLATIN_RESISTANCE_UP",11,-1.4792,0.068,0.07,0.9359,0.56,0.89,-0.7393,0.81,0.98
"GO_BP:1129549_GO_1903725_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS","GO_BP","1129549_GO_1903725_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS",54,-1.4791,0.026,0.12,-0.715,0.93,1,1.1299,0.27,0.74
"GO_BP:518556_GO_0097006_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS","GO_BP","518556_GO_0097006_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS",43,-1.479,0.033,0.12,-0.7618,0.86,1,1.4408,0.033,0.59
"C6_Oncogenic_signatures:C6_ALL_172_KRAS_50_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_172_KRAS_50_UP_V1_DN",43,-1.4789,0.034,0.015,0.9341,0.58,0.92,1.6459,0.002,0.037
"WikiPathways:198909_WP23_B_CELL_RECEPTOR_SIGNALING_PATHWAY","WikiPathways","198909_WP23_B_CELL_RECEPTOR_SIGNALING_PATHWAY",157,-1.4787,0.0081,0.076,0.7481,0.98,1,-1.3827,0.013,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1933_SIMBULAN_PARP1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1933_SIMBULAN_PARP1_TARGETS_DN",16,-1.4787,0.059,0.07,-1.1213,0.29,0.89,-1.6244,0.023,0.23
"C3_TF_targets:C3_TFT_245_V_FOXJ2_02","C3_TF_targets","C3_TFT_245_V_FOXJ2_02",230,-1.4787,0.0023,0.023,-0.8865,0.79,0.98,-1.191,0.068,0.37
"WikiPathways:198808_WP699_AFLATOXIN_B1_METABOLISM","WikiPathways","198808_WP699_AFLATOXIN_B1_METABOLISM",7,-1.4786,0.044,0.075,-1.1055,0.34,1,-0.9698,0.48,0.76
"GO_BP:506358_GO_0043297_APICAL_JUNCTION_ASSEMBLY","GO_BP","506358_GO_0043297_APICAL_JUNCTION_ASSEMBLY",45,-1.4786,0.03,0.12,-1.112,0.28,0.94,-1.0934,0.28,0.78
"C7_Immunologic_signatures:C7_ALL_858_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN","C7_Immunologic_signatures","C7_ALL_858_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN",196,-1.4785,0.0034,0.0087,0.7878,0.98,1,-1.8737,0,5.4e-05
"GO_MF:752701_GO_0097200_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS","GO_MF","752701_GO_0097200_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS",7,-1.4785,0.054,0.15,-0.5434,0.97,1,0.8609,0.63,0.98
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_17_BIOCARTA_CHEMICAL_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_17_BIOCARTA_CHEMICAL_PATHWAY",22,-1.4782,0.042,0.14,-0.7887,0.76,1,-1.1217,0.28,0.63
"GO_BP:502907_GO_0033690_POSITIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION","GO_BP","502907_GO_0033690_POSITIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION",10,-1.4782,0.049,0.12,-0.7039,0.85,1,1.1207,0.31,0.75
"GO_MF:492839_GO_0008574_ATP_DEPENDENT_MICROTUBULE_MOTOR_ACTIVITY_PLUS_END_DIRECTED","GO_MF","492839_GO_0008574_ATP_DEPENDENT_MICROTUBULE_MOTOR_ACTIVITY_PLUS_END_DIRECTED",18,-1.4782,0.064,0.15,-1.3834,0.11,0.65,-1.2554,0.18,0.59
"GO_BP:487899_GO_0002009_MORPHOGENESIS_OF_AN_EPITHELIUM","GO_BP","487899_GO_0002009_MORPHOGENESIS_OF_AN_EPITHELIUM",428,-1.4781,0.0011,0.12,-0.8337,0.97,1,1.0643,0.25,0.79
"GO_BP:502237_GO_0033015_TETRAPYRROLE_CATABOLIC_PROCESS","GO_BP","502237_GO_0033015_TETRAPYRROLE_CATABOLIC_PROCESS",7,-1.4781,0.06,0.12,-0.6439,0.9,1,1.0257,0.42,0.83
"C7_Immunologic_signatures:C7_ALL_1830_GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN","C7_Immunologic_signatures","C7_ALL_1830_GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN",192,-1.4779,0.0012,0.0088,-1.0171,0.4,1,-1.1461,0.16,0.38
"REACTOME:105753_REACT_1846_G2_M_DNA_REPLICATION_CHECKPOINT","REACTOME","105753_REACT_1846_G2_M_DNA_REPLICATION_CHECKPOINT",5,-1.4778,0.04,0.14,-0.6631,0.86,1,-1.142,0.32,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_803_DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_803_DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN",9,-1.4778,0.068,0.071,-0.502,0.99,1,-0.7413,0.83,0.98
"GO_BP:505457_GO_0042311_VASODILATION","GO_BP","505457_GO_0042311_VASODILATION",29,-1.4777,0.041,0.12,1.4465,0.043,0.5,0.9804,0.48,0.88
"GO_BP:505673_GO_0042542_RESPONSE_TO_HYDROGEN_PEROXIDE","GO_BP","505673_GO_0042542_RESPONSE_TO_HYDROGEN_PEROXIDE",87,-1.4777,0.015,0.12,-0.7642,0.91,1,-1.3701,0.044,0.59
"GO_BP:493712_GO_0009581_DETECTION_OF_EXTERNAL_STIMULUS","GO_BP","493712_GO_0009581_DETECTION_OF_EXTERNAL_STIMULUS",177,-1.4775,0.0035,0.12,-1.2808,0.028,0.89,-1.1763,0.1,0.74
"GO_BP:501261_GO_0032024_POSITIVE_REGULATION_OF_INSULIN_SECRETION","GO_BP","501261_GO_0032024_POSITIVE_REGULATION_OF_INSULIN_SECRETION",51,-1.4775,0.026,0.12,0.6954,0.96,1,-1.1115,0.27,0.76
"C4_Cancer_modules:C4_CM_167_MODULE_177","C4_Cancer_modules","C4_CM_167_MODULE_177",100,-1.4775,0.014,0.064,1.3651,0.033,0.21,-0.9728,0.51,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_2038_TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2038_TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN",15,-1.4774,0.06,0.071,-1.0231,0.44,0.98,-0.939,0.55,0.83
"C7_Immunologic_signatures:C7_ALL_1003_GSE22886_CTRL_VS_LPS_24H_DC_UP","C7_Immunologic_signatures","C7_ALL_1003_GSE22886_CTRL_VS_LPS_24H_DC_UP",200,-1.4774,0.0034,0.0089,2.1009,0,0,-1.4366,0,0.04
"GO_BP:512014_GO_0051100_NEGATIVE_REGULATION_OF_BINDING","GO_BP","512014_GO_0051100_NEGATIVE_REGULATION_OF_BINDING",108,-1.4773,0.0061,0.12,1.0615,0.32,0.94,1.0927,0.27,0.77
"GO_BP:507420_GO_0045010_ACTIN_NUCLEATION","GO_BP","507420_GO_0045010_ACTIN_NUCLEATION",24,-1.4772,0.048,0.12,0.8434,0.72,1,-0.7978,0.79,0.99
"REACTOME:106147_REACT_11053_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL","REACTOME","106147_REACT_11053_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL",13,-1.4772,0.066,0.14,0.9025,0.58,0.9,1.1047,0.34,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2277_KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2277_KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN",10,-1.4769,0.067,0.071,-1.163,0.26,0.83,-1.3305,0.16,0.41
"GO_BP:518616_GO_0097066_RESPONSE_TO_THYROID_HORMONE","GO_BP","518616_GO_0097066_RESPONSE_TO_THYROID_HORMONE",15,-1.4767,0.047,0.12,0.5974,0.97,1,0.8419,0.68,0.99
"REACTOME:1127590_REACT_267648_DEFECTIVE_CHST3_CAUSES_SEDCJD","REACTOME","1127590_REACT_267648_DEFECTIVE_CHST3_CAUSES_SEDCJD",6,-1.4767,0.063,0.14,-0.8617,0.63,1,1.1271,0.33,0.91
"GO_MF:490394_GO_0005131_GROWTH_HORMONE_RECEPTOR_BINDING","GO_MF","490394_GO_0005131_GROWTH_HORMONE_RECEPTOR_BINDING",5,-1.4767,0.051,0.16,-0.9248,0.55,0.96,-1.0224,0.44,0.77
"GO_MF:496047_GO_0015925_GALACTOSIDASE_ACTIVITY","GO_MF","496047_GO_0015925_GALACTOSIDASE_ACTIVITY",6,-1.4766,0.048,0.16,-1.4079,0.1,0.64,-1.2231,0.25,0.58
"C7_Immunologic_signatures:C7_ALL_932_GSE22886_NAIVE_VS_MEMORY_TCELL_DN","C7_Immunologic_signatures","C7_ALL_932_GSE22886_NAIVE_VS_MEMORY_TCELL_DN",199,-1.4765,0.0034,0.009,1.4063,0.0069,0.035,-1.1332,0.18,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_17_KORKOLA_EMBRYONAL_CARCINOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_17_KORKOLA_EMBRYONAL_CARCINOMA_UP",41,-1.4764,0.042,0.072,1.1231,0.26,0.6,1.1046,0.27,0.88
"GO_BP:488104_GO_0002230_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST","GO_BP","488104_GO_0002230_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST",19,-1.4763,0.037,0.12,-1.4258,0.077,0.93,-1.7263,0.0077,0.65
"GO_BP:502359_GO_0033138_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION","GO_BP","502359_GO_0033138_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION",83,-1.4763,0.012,0.12,-0.7394,0.95,1,-0.8179,0.86,0.98
"REACTOME:1127589_REACT_268113_DEFECTIVE_CHSY1_CAUSES_TPBS","REACTOME","1127589_REACT_268113_DEFECTIVE_CHSY1_CAUSES_TPBS",6,-1.4763,0.065,0.14,-0.8618,0.61,1,1.1523,0.32,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_457_GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_457_GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP",182,-1.4762,0.0083,0.072,0.9976,0.44,0.8,1.0391,0.36,0.92
"GO_BP:510943_GO_0048895_LATERAL_LINE_NERVE_GLIAL_CELL_DIFFERENTIATION","GO_BP","510943_GO_0048895_LATERAL_LINE_NERVE_GLIAL_CELL_DIFFERENTIATION",9,-1.4762,0.057,0.12,-1.3182,0.15,0.89,-1.0891,0.34,0.78
"GO_BP:492011_GO_0007213_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","492011_GO_0007213_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY",12,-1.476,0.05,0.12,-0.9166,0.57,1,-0.6825,0.87,1
"KEGG_pathway:HSA04977_VITAMIN_DIGESTION_AND_ABSORPTION","KEGG_pathway","HSA04977_VITAMIN_DIGESTION_AND_ABSORPTION",23,-1.476,0.045,0.041,-1.2214,0.19,0.5,-0.8921,0.6,0.85
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_145_BIOCARTA_PTEN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_145_BIOCARTA_PTEN_PATHWAY",18,-1.476,0.055,0.14,0.6864,0.9,1,-1.216,0.2,0.56
"GO_BP:495263_GO_0014870_RESPONSE_TO_MUSCLE_INACTIVITY","GO_BP","495263_GO_0014870_RESPONSE_TO_MUSCLE_INACTIVITY",6,-1.4759,0.052,0.12,-1.0293,0.41,0.97,-1.5482,0.042,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_2320_MATZUK_OVULATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2320_MATZUK_OVULATION",13,-1.4759,0.052,0.072,0.6422,0.91,1,-1.1481,0.28,0.58
"GO_BP:501587_GO_0032352_POSITIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS","GO_BP","501587_GO_0032352_POSITIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS",13,-1.4758,0.052,0.12,0.8837,0.6,1,0.745,0.83,1
"GO_BP:489291_GO_0006986_RESPONSE_TO_UNFOLDED_PROTEIN","GO_BP","489291_GO_0006986_RESPONSE_TO_UNFOLDED_PROTEIN",146,-1.4757,0.0093,0.12,-0.9745,0.51,1,-1.6802,0,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_419_NADERI_BREAST_CANCER_PROGNOSIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_419_NADERI_BREAST_CANCER_PROGNOSIS_UP",49,-1.4756,0.023,0.072,-0.7352,0.9,1,-1.1919,0.18,0.53
"GO_MF:499485_GO_0050840_EXTRACELLULAR_MATRIX_BINDING","GO_MF","499485_GO_0050840_EXTRACELLULAR_MATRIX_BINDING",47,-1.4756,0.031,0.16,0.9749,0.52,0.9,1.148,0.24,0.78
"C7_Immunologic_signatures:C7_ALL_477_GSE17721_CTRL_VS_POLYIC_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_477_GSE17721_CTRL_VS_POLYIC_24H_BMDM_UP",198,-1.4755,0.0046,0.0092,1.4469,0.0023,0.023,-1.0035,0.44,0.72
"GO_MF:514949_GO_0070008_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY","GO_MF","514949_GO_0070008_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY",11,-1.4755,0.055,0.16,-1.084,0.36,0.85,-0.9387,0.52,0.85
"GO_BP:488564_GO_0002691_REGULATION_OF_CELLULAR_EXTRAVASATION","GO_BP","488564_GO_0002691_REGULATION_OF_CELLULAR_EXTRAVASATION",13,-1.4754,0.062,0.12,0.7216,0.86,1,0.89,0.61,0.95
"GO_BP:494778_GO_0010713_NEGATIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS","GO_BP","494778_GO_0010713_NEGATIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS",7,-1.4754,0.061,0.12,0.8442,0.68,1,1.3656,0.13,0.64
"GO_CC:499964_GO_0030659_CYTOPLASMIC_VESICLE_MEMBRANE","GO_CC","499964_GO_0030659_CYTOPLASMIC_VESICLE_MEMBRANE",439,-1.4753,0.001,0.16,1.1585,0.05,0.57,0.9098,0.79,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_549_TOMIDA_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_549_TOMIDA_METASTASIS_DN",18,-1.4753,0.043,0.072,0.8014,0.74,0.99,-1.013,0.45,0.73
"GO_BP:495203_GO_0014807_REGULATION_OF_SOMITOGENESIS","GO_BP","495203_GO_0014807_REGULATION_OF_SOMITOGENESIS",8,-1.4752,0.06,0.12,-1.5824,0.036,0.71,-0.9487,0.53,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_2557_MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2557_MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP",14,-1.4752,0.053,0.072,-0.7933,0.76,1,-1.4823,0.069,0.31
"C7_Immunologic_signatures:C7_ALL_1862_GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN","C7_Immunologic_signatures","C7_ALL_1862_GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN",199,-1.4752,0.0023,0.0092,0.7753,0.98,1,-1.0352,0.37,0.65
"KEGG_compound:C00836_SPHINGANINE_DIHYDROSPHINGOSINE_2_AMINO_1_3_DIHYDROXYOCTADECANE","KEGG_compound","C00836_SPHINGANINE_DIHYDROSPHINGOSINE_2_AMINO_1_3_DIHYDROXYOCTADECANE",17,-1.4752,0.059,0.19,-0.9556,0.5,1,-1.0755,0.34,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_2834_LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2834_LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN",16,-1.4751,0.057,0.072,-1.1346,0.29,0.87,1.2414,0.17,0.76
"GO_MF:490493_GO_0005272_SODIUM_CHANNEL_ACTIVITY","GO_MF","490493_GO_0005272_SODIUM_CHANNEL_ACTIVITY",34,-1.4749,0.039,0.16,-1.386,0.066,0.65,-0.8922,0.64,0.88
"REACTOME:106244_REACT_16936_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC","REACTOME","106244_REACT_16936_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC",27,-1.4748,0.043,0.15,1.2226,0.19,0.42,-1.3772,0.085,0.46
"GO_BP:493916_GO_0009812_FLAVONOID_METABOLIC_PROCESS","GO_BP","493916_GO_0009812_FLAVONOID_METABOLIC_PROCESS",28,-1.4747,0.04,0.12,1.5151,0.045,0.39,1.7526,0.0041,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_2502_RAY_ALZHEIMERS_DISEASE","C2_Chemical_and_genetic_perturbations","C2_CGP_2502_RAY_ALZHEIMERS_DISEASE",12,-1.4747,0.052,0.072,1.0374,0.39,0.74,-1.0182,0.42,0.73
"GO_BP:511637_GO_0050665_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS","GO_BP","511637_GO_0050665_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS",9,-1.4747,0.04,0.12,0.7678,0.78,1,-1.3011,0.15,0.65
"GO_MF:492468_GO_0008106_ALCOHOL_DEHYDROGENASE_NADP_ACTIVITY","GO_MF","492468_GO_0008106_ALCOHOL_DEHYDROGENASE_NADP_ACTIVITY",12,-1.4746,0.046,0.16,0.8229,0.72,1,0.6493,0.9,1
"GO_MF:498062_GO_0019207_KINASE_REGULATOR_ACTIVITY","GO_MF","498062_GO_0019207_KINASE_REGULATOR_ACTIVITY",146,-1.4746,0.0072,0.15,0.7797,0.97,1,-1.1887,0.12,0.59
"GO_CC:501389_GO_0032153_CELL_DIVISION_SITE","GO_CC","501389_GO_0032153_CELL_DIVISION_SITE",48,-1.4746,0.03,0.16,0.8679,0.73,0.91,0.6651,0.96,1
"GO_BP:948110_GO_1902667_REGULATION_OF_AXON_GUIDANCE","GO_BP","948110_GO_1902667_REGULATION_OF_AXON_GUIDANCE",17,-1.4745,0.048,0.12,-0.9505,0.54,1,1.0004,0.46,0.86
"C7_Immunologic_signatures:C7_ALL_1384_GSE339_CD4POS_VS_CD8POS_DC_DN","C7_Immunologic_signatures","C7_ALL_1384_GSE339_CD4POS_VS_CD8POS_DC_DN",198,-1.4744,0.0034,0.0093,1.1406,0.15,0.34,-0.6712,1,1
"GO_BP:492300_GO_0007548_SEX_DIFFERENTIATION","GO_BP","492300_GO_0007548_SEX_DIFFERENTIATION",247,-1.4743,0,0.12,-0.8916,0.76,1,1.1299,0.14,0.74
"C4_Cancer_modules:C4_CM_244_MODULE_275","C4_Cancer_modules","C4_CM_244_MODULE_275",16,-1.4742,0.055,0.065,-1.0566,0.37,0.72,0.6973,0.88,1
"GO_MF:499870_GO_0030544_HSP70_PROTEIN_BINDING","GO_MF","499870_GO_0030544_HSP70_PROTEIN_BINDING",24,-1.4741,0.069,0.15,-0.8208,0.74,1,-1.861,0.0041,0.16
"C2_Chemical_and_genetic_perturbations:C2_CGP_261_LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_261_LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP",14,-1.4741,0.064,0.072,-1.3605,0.12,0.66,1.1494,0.26,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_2378_RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2378_RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN",155,-1.4741,0.0059,0.072,-0.8434,0.85,1,-1.1769,0.11,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_125_DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_125_DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN",312,-1.4739,0.0021,0.072,1.5656,0,0.16,-0.8451,0.94,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_3389_ZWANG_EGF_INTERVAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3389_ZWANG_EGF_INTERVAL_UP",91,-1.4738,0.016,0.072,-1.1743,0.17,0.83,0.8629,0.78,1
"C3_TF_targets:C3_TFT_58_V_IK1_01","C3_TF_targets","C3_TFT_58_V_IK1_01",269,-1.4737,0,0.025,-1.4249,0.005,0.15,-1.0834,0.26,0.58
"GO_BP:503837_GO_0034637_CELLULAR_CARBOHYDRATE_BIOSYNTHETIC_PROCESS","GO_BP","503837_GO_0034637_CELLULAR_CARBOHYDRATE_BIOSYNTHETIC_PROCESS",58,-1.4737,0.025,0.12,0.9871,0.47,0.99,-1.1736,0.2,0.73
"GO_BP:518358_GO_0090218_POSITIVE_REGULATION_OF_LIPID_KINASE_ACTIVITY","GO_BP","518358_GO_0090218_POSITIVE_REGULATION_OF_LIPID_KINASE_ACTIVITY",28,-1.4737,0.047,0.12,-0.6882,0.93,1,-0.8231,0.75,0.97
"REACTOME:1127519_REACT_264242_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX","REACTOME","1127519_REACT_264242_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX",86,-1.4735,0.021,0.15,-1.689,0.0019,0.18,-1.4233,0.037,0.4
"REACTOME:530734_REACT_115755_SIGNALING_BY_ERBB2","REACTOME","530734_REACT_115755_SIGNALING_BY_ERBB2",157,-1.4735,0.0012,0.15,-1.0078,0.42,0.99,-1.2772,0.044,0.54
"GO_BP:518965_GO_2000319_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION","GO_BP","518965_GO_2000319_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION",6,-1.4735,0.055,0.12,-1.5386,0.051,0.76,-0.9463,0.52,0.89
"GO_BP:488452_GO_0002579_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION","GO_BP","488452_GO_0002579_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION",10,-1.4735,0.054,0.12,-0.9774,0.5,1,-1.1756,0.26,0.73
"GO_MF:501784_GO_0032554_PURINE_DEOXYRIBONUCLEOTIDE_BINDING","GO_MF","501784_GO_0032554_PURINE_DEOXYRIBONUCLEOTIDE_BINDING",7,-1.4734,0.047,0.16,1.343,0.15,0.53,-1.6583,0.016,0.32
"C0_Hallmark:H_ALL_40_HALLMARK_ANGIOGENESIS","C0_Hallmark","H_ALL_40_HALLMARK_ANGIOGENESIS",36,-1.4733,0.032,0.015,1.5673,0.011,0.013,1.617,0.0039,0.03
"C7_Immunologic_signatures:C7_ALL_440_GSE17580_TREG_VS_TEFF_DN","C7_Immunologic_signatures","C7_ALL_440_GSE17580_TREG_VS_TEFF_DN",197,-1.4732,0.0045,0.0095,0.8033,0.96,1,-1.2153,0.064,0.25
"C3_TF_targets:C3_TFT_164_V_MEF2_03","C3_TF_targets","C3_TFT_164_V_MEF2_03",231,-1.4732,0.0022,0.025,-1.4999,0,0.13,-1.4806,0.0021,0.23
"C2_Chemical_and_genetic_perturbations:C2_CGP_441_GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_441_GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP",205,-1.4732,0.0023,0.073,1.3914,0.012,0.3,-1.0841,0.25,0.65
"GO_MF:487381_GO_0001159_CORE_PROMOTER_PROXIMAL_REGION_DNA_BINDING","GO_MF","487381_GO_0001159_CORE_PROMOTER_PROXIMAL_REGION_DNA_BINDING",253,-1.4731,0,0.16,-0.9293,0.65,0.97,-1.1127,0.16,0.7
"C7_Immunologic_signatures:C7_ALL_454_GSE17721_CTRL_VS_LPS_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_454_GSE17721_CTRL_VS_LPS_4H_BMDM_DN",195,-1.4728,0.0046,0.0096,-0.9322,0.63,1,0.899,0.75,1
"KEGG_compound:C00486_BILIRUBIN","KEGG_compound","C00486_BILIRUBIN",21,-1.4727,0.052,0.2,1.739,0.0062,0.06,1.9141,0,0.0042
"C3_TF_targets:C3_TFT_283_V_FOXO4_01","C3_TF_targets","C3_TFT_283_V_FOXO4_01",238,-1.4726,0,0.025,-0.8678,0.83,0.99,-0.924,0.73,0.88
"C3_TF_targets:C3_TFT_202_V_FREAC4_01","C3_TF_targets","C3_TFT_202_V_FREAC4_01",146,-1.4726,0.007,0.025,-0.8188,0.9,1,0.9351,0.65,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2246_ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2246_ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP",124,-1.4726,0.0074,0.073,0.8993,0.71,0.93,1.0676,0.32,0.89
"C7_Immunologic_signatures:C7_ALL_649_GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_649_GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDM_UP",193,-1.4726,0.0034,0.0096,1.4093,0.007,0.035,-0.9887,0.49,0.75
"C7_Immunologic_signatures:C7_ALL_665_GSE17721_LPS_VS_CPG_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_665_GSE17721_LPS_VS_CPG_12H_BMDM_UP",196,-1.4725,0.0023,0.0096,1.5665,0,0.005,-0.9438,0.61,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_616_APPIERTO_RESPONSE_TO_FENRETINIDE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_616_APPIERTO_RESPONSE_TO_FENRETINIDE_UP",37,-1.4725,0.028,0.073,-0.9318,0.57,1,-0.8668,0.68,0.91
"C7_Immunologic_signatures:C7_ALL_415_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP","C7_Immunologic_signatures","C7_ALL_415_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP",192,-1.4724,0.0033,0.0096,1.0938,0.21,0.46,1.0078,0.42,1
"GO_BP:750799_GO_0002934_DESMOSOME_ORGANIZATION","GO_BP","750799_GO_0002934_DESMOSOME_ORGANIZATION",9,-1.4723,0.049,0.12,0.6096,0.94,1,-0.9695,0.49,0.88
"GO_BP:515517_GO_0070587_REGULATION_OF_CELL_CELL_ADHESION_INVOLVED_IN_GASTRULATION","GO_BP","515517_GO_0070587_REGULATION_OF_CELL_CELL_ADHESION_INVOLVED_IN_GASTRULATION",7,-1.4723,0.071,0.12,-1.3649,0.13,0.98,-0.5001,0.97,1
"KEGG_reaction:R07055_LINOLEATE_OXYGEN_NADPH_H_9_10_EPOME_NADP_H2O","KEGG_reaction","R07055_LINOLEATE_OXYGEN_NADPH_H_9_10_EPOME_NADP_H2O",7,-1.4723,0.061,0.2,-0.9562,0.51,0.83,1.0849,0.34,0.62
"GO_BP:502278_GO_0033057_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_BEHAVIOR","GO_BP","502278_GO_0033057_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_BEHAVIOR",23,-1.4723,0.042,0.12,0.5044,1,1,-1.1781,0.2,0.74
"C3_TF_targets:C3_TFT_365_V_HEB_Q6","C3_TF_targets","C3_TFT_365_V_HEB_Q6",261,-1.4723,0.0011,0.024,-1.2221,0.057,0.31,-0.9272,0.72,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_3229_IKEDA_MIR133_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3229_IKEDA_MIR133_TARGETS_DN",8,-1.4723,0.066,0.073,1.0018,0.44,0.8,1.0797,0.35,0.87
"GO_CC:490653_GO_0005578_PROTEINACEOUS_EXTRACELLULAR_MATRIX","GO_CC","490653_GO_0005578_PROTEINACEOUS_EXTRACELLULAR_MATRIX",331,-1.4723,0,0.16,-1.1779,0.078,0.68,1.7389,0,0.26
"GO_BP:499663_GO_0030258_LIPID_MODIFICATION","GO_BP","499663_GO_0030258_LIPID_MODIFICATION",136,-1.4723,0.0084,0.12,0.7094,0.99,1,-1.0344,0.37,0.82
"GO_CC:507561_GO_0045179_APICAL_CORTEX","GO_CC","507561_GO_0045179_APICAL_CORTEX",6,-1.4722,0.073,0.16,-0.876,0.63,0.96,1.1455,0.31,0.85
"C3_TF_targets:C3_TFT_436_GGARNTKYCCA_UNKNOWN","C3_TF_targets","C3_TFT_436_GGARNTKYCCA_UNKNOWN",74,-1.4721,0.016,0.024,-0.8822,0.7,0.98,-0.9256,0.61,0.89
"KEGG_compound:C05827_METHYLIMIDAZOLE_ACETALDEHYDE_1_METHYLIMIDAZOLE_4_ACETALDEHYDE_METHYLIMIDAZOLEACETALDEHYDE","KEGG_compound","C05827_METHYLIMIDAZOLE_ACETALDEHYDE_1_METHYLIMIDAZOLE_4_ACETALDEHYDE_METHYLIMIDAZOLEACETALDEHYDE",7,-1.4721,0.048,0.2,0.9407,0.52,1,-0.9029,0.59,0.76
"GO_BP:500916_GO_0031667_RESPONSE_TO_NUTRIENT_LEVELS","GO_BP","500916_GO_0031667_RESPONSE_TO_NUTRIENT_LEVELS",390,-1.4721,0,0.12,-0.8643,0.9,1,0.8605,0.93,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_485_TANG_SENESCENCE_TP53_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_485_TANG_SENESCENCE_TP53_TARGETS_UP",32,-1.472,0.047,0.073,0.9581,0.52,0.86,-1.2986,0.1,0.43
"GO_BP:498207_GO_0019363_PYRIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","498207_GO_0019363_PYRIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",18,-1.4719,0.048,0.12,-1.026,0.41,0.98,-1.5867,0.016,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_1438_OSAWA_TNF_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1438_OSAWA_TNF_TARGETS",10,-1.4719,0.071,0.073,-1.2868,0.18,0.69,-1.1046,0.33,0.62
"GO_BP:492880_GO_0008631_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS","GO_BP","492880_GO_0008631_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS",19,-1.4718,0.062,0.12,-0.8519,0.68,1,-1.2574,0.19,0.67
"GO_BP:514229_GO_0060674_PLACENTA_BLOOD_VESSEL_DEVELOPMENT","GO_BP","514229_GO_0060674_PLACENTA_BLOOD_VESSEL_DEVELOPMENT",31,-1.4718,0.041,0.12,-1.1346,0.26,0.93,-0.7807,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_641_CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN","C2_Chemical_and_genetic_perturbations","C2_CGP_641_CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN",29,-1.4717,0.039,0.073,1.5435,0.021,0.17,1.091,0.32,0.88
"GO_BP:487781_GO_0001885_ENDOTHELIAL_CELL_DEVELOPMENT","GO_BP","487781_GO_0001885_ENDOTHELIAL_CELL_DEVELOPMENT",46,-1.4717,0.033,0.12,0.6858,0.95,1,1.1874,0.19,0.72
"C7_Immunologic_signatures:C7_ALL_1500_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN","C7_Immunologic_signatures","C7_ALL_1500_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN",200,-1.4717,0.0022,0.0097,-0.7502,0.98,1,-0.8308,0.92,1
"GO_BP:754604_GO_1901652_RESPONSE_TO_PEPTIDE","GO_BP","754604_GO_1901652_RESPONSE_TO_PEPTIDE",416,-1.4717,0,0.12,-0.7796,0.99,1,-1.0626,0.26,0.8
"GO_BP:498564_GO_0019751_POLYOL_METABOLIC_PROCESS","GO_BP","498564_GO_0019751_POLYOL_METABOLIC_PROCESS",100,-1.4716,0.016,0.12,-1.1533,0.21,0.92,-1.117,0.23,0.76
"C6_Oncogenic_signatures:C6_ALL_52_P53_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_52_P53_DN_V1_UP",183,-1.4716,0.007,0.016,0.9001,0.76,0.96,1.2948,0.024,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_2519_MARSHALL_VIRAL_INFECTION_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2519_MARSHALL_VIRAL_INFECTION_RESPONSE_UP",7,-1.4716,0.061,0.073,0.9912,0.46,0.81,1.0817,0.38,0.87
"GO_BP:493264_GO_0009063_CELLULAR_AMINO_ACID_CATABOLIC_PROCESS","GO_BP","493264_GO_0009063_CELLULAR_AMINO_ACID_CATABOLIC_PROCESS",111,-1.4713,0.0086,0.12,-0.7817,0.9,1,-1.3038,0.057,0.65
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_42_BIOCARTA_COMP_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_42_BIOCARTA_COMP_PATHWAY",18,-1.4712,0.047,0.14,-0.9618,0.5,1,-0.912,0.58,0.84
"GO_BP:499316_GO_0022037_METENCEPHALON_DEVELOPMENT","GO_BP","499316_GO_0022037_METENCEPHALON_DEVELOPMENT",96,-1.4711,0.01,0.12,-1.233,0.12,0.9,-0.9923,0.47,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_285_TIEN_INTESTINE_PROBIOTICS_2HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_285_TIEN_INTESTINE_PROBIOTICS_2HR_UP",27,-1.4711,0.034,0.073,1.6654,0.013,0.1,-1.0378,0.38,0.7
"GO_BP:487571_GO_0001658_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS","GO_BP","487571_GO_0001658_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS",45,-1.4711,0.033,0.12,0.8537,0.75,1,1.0968,0.29,0.76
"GO_BP:498518_GO_0019695_CHOLINE_METABOLIC_PROCESS","GO_BP","498518_GO_0019695_CHOLINE_METABOLIC_PROCESS",6,-1.4711,0.061,0.12,-1.2494,0.2,0.91,-1.5663,0.049,0.52
"GO_MF:487200_GO_0000976_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING","GO_MF","487200_GO_0000976_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING",439,-1.471,0,0.16,-1.1927,0.051,0.79,-1.2211,0.033,0.57
"C7_Immunologic_signatures:C7_ALL_1290_GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN","C7_Immunologic_signatures","C7_ALL_1290_GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN",198,-1.471,0.0011,0.0098,1.9032,0,0,-1.2675,0.044,0.18
"GO_BP:493308_GO_0009109_COENZYME_CATABOLIC_PROCESS","GO_BP","493308_GO_0009109_COENZYME_CATABOLIC_PROCESS",73,-1.4709,0.021,0.12,1.0914,0.28,0.92,-1.6149,0.0021,0.52
"GO_BP:514230_GO_0060675_URETERIC_BUD_MORPHOGENESIS","GO_BP","514230_GO_0060675_URETERIC_BUD_MORPHOGENESIS",52,-1.4708,0.03,0.12,0.7615,0.87,1,1.2269,0.14,0.71
"GO_BP:492168_GO_0007405_NEUROBLAST_PROLIFERATION","GO_BP","492168_GO_0007405_NEUROBLAST_PROLIFERATION",27,-1.4707,0.058,0.12,-0.8071,0.77,1,-0.8672,0.68,0.95
"GO_BP:486790_GO_0000271_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS","GO_BP","486790_GO_0000271_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS",52,-1.4705,0.029,0.12,1.0837,0.31,0.92,-1.1175,0.27,0.76
"OMIM_gene:OMIM602940_MARCKS_LIKE_PROTEIN_1_MARCKSL1","OMIM_gene","OMIM602940_MARCKS_LIKE_PROTEIN_1_MARCKSL1",5,-1.4705,0.056,1,-1.4066,0.11,0.66,0.842,0.65,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2880_ZHAN_MULTIPLE_MYELOMA_CD1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2880_ZHAN_MULTIPLE_MYELOMA_CD1_DN",44,-1.4705,0.045,0.074,-1.0569,0.37,0.97,-0.9484,0.57,0.83
"REACTOME:160138_REACT_21328_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES","REACTOME","160138_REACT_21328_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES",30,-1.4704,0.035,0.15,-1.1695,0.23,0.85,-0.8801,0.65,0.97
"KEGG_compound:C00006_NADP_NADP_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_PHOSPHATE_BETA_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_PHOSPHATE_TPN_TRIPHOSPHOPYRIDINE_NUCLEOTIDE_BETA_NADP_","KEGG_compound","C00006_NADP_NADP_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_PHOSPHATE_BETA_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_PHOSPHATE_TPN_TRIPHOSPHOPYRIDINE_NUCLEOTIDE_BETA_NADP_",145,-1.4704,0.0082,0.2,-0.7079,0.99,1,-1.6337,0,0.12
"C2_Chemical_and_genetic_perturbations:C2_CGP_1028_GOUYER_TATI_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1028_GOUYER_TATI_TARGETS_UP",10,-1.4704,0.07,0.074,0.763,0.82,1,0.8799,0.61,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2757_YAGI_AML_WITH_11Q23_REARRANGED","C2_Chemical_and_genetic_perturbations","C2_CGP_2757_YAGI_AML_WITH_11Q23_REARRANGED",347,-1.4704,0.0011,0.074,0.8162,0.98,0.98,-1.2704,0.015,0.45
"REACTOME:160978_REACT_380_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS","REACTOME","160978_REACT_380_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS",19,-1.4704,0.056,0.15,0.6523,0.94,1,-1.2868,0.15,0.54
"C3_TF_targets:C3_TFT_99_V_OCT1_04","C3_TF_targets","C3_TFT_99_V_OCT1_04",227,-1.4703,0.0011,0.025,-1.0737,0.29,0.61,-1.06,0.28,0.62
"GO_BP:518547_GO_0090407_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","518547_GO_0090407_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS",456,-1.4703,0,0.12,-0.7833,1,1,-1.3219,0.0021,0.63
"C7_Immunologic_signatures:C7_ALL_466_GSE17721_CTRL_VS_POLYIC_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_466_GSE17721_CTRL_VS_POLYIC_1H_BMDM_DN",195,-1.4703,0.0023,0.0099,-1.1011,0.23,1,-1.029,0.38,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_2171_MASSARWEH_RESPONSE_TO_ESTRADIOL","C2_Chemical_and_genetic_perturbations","C2_CGP_2171_MASSARWEH_RESPONSE_TO_ESTRADIOL",61,-1.4703,0.023,0.073,-0.8519,0.76,1,1.1277,0.24,0.85
"GO_BP:504251_GO_0035066_POSITIVE_REGULATION_OF_HISTONE_ACETYLATION","GO_BP","504251_GO_0035066_POSITIVE_REGULATION_OF_HISTONE_ACETYLATION",19,-1.4703,0.042,0.12,-1.2021,0.22,0.89,-1.4367,0.068,0.56
"C3_MicroRNA_targets:C3_MIR_118_GGCAGCT_MIR_22","C3_MicroRNA_targets","C3_MIR_118_GGCAGCT_MIR_22",231,-1.4702,0.0044,0.24,-1.2264,0.073,1,-1.1538,0.11,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3197_DUAN_PRDM5_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3197_DUAN_PRDM5_TARGETS",78,-1.47,0.027,0.074,-1.4117,0.031,0.58,-1.0447,0.36,0.7
"REACTOME:730336_REACT_150422_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES","REACTOME","730336_REACT_150422_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES",6,-1.47,0.053,0.15,-0.7029,0.83,1,-1.2646,0.21,0.54
"C7_Immunologic_signatures:C7_ALL_1879_GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1879_GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP",198,-1.47,0.0045,0.0099,0.8776,0.82,1,0.8169,0.93,1
"REACTOME:1183556_REACT_355289_SIGNALING_BY_FGFR1","REACTOME","1183556_REACT_355289_SIGNALING_BY_FGFR1",157,-1.4699,0.0036,0.15,-0.9397,0.62,1,-1.2522,0.074,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_2264_SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2264_SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP",6,-1.4698,0.047,0.074,1.4748,0.065,0.23,-0.8691,0.62,0.91
"C4_Cancer_modules:C4_CM_390_MODULE_491","C4_Cancer_modules","C4_CM_390_MODULE_491",78,-1.4698,0.024,0.067,-0.769,0.92,1,0.5325,1,1
"GO_BP:498549_GO_0019730_ANTIMICROBIAL_HUMORAL_RESPONSE","GO_BP","498549_GO_0019730_ANTIMICROBIAL_HUMORAL_RESPONSE",33,-1.4697,0.038,0.12,1.6232,0.013,0.27,1.0894,0.32,0.77
"GO_BP:508885_GO_0046637_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION","GO_BP","508885_GO_0046637_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION",42,-1.4697,0.029,0.12,-1.1979,0.19,0.9,-0.7297,0.92,0.99
"GO_BP:753998_GO_1901028_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","753998_GO_1901028_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",42,-1.4696,0.032,0.12,-0.7548,0.87,1,-0.9315,0.56,0.9
"GO_BP:812240_GO_1902117_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY","GO_BP","812240_GO_1902117_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY",29,-1.4695,0.048,0.12,-0.5889,0.98,1,-0.6697,0.94,1
"GO_CC:506709_GO_0043679_AXON_TERMINUS","GO_CC","506709_GO_0043679_AXON_TERMINUS",76,-1.4694,0.022,0.17,1.0881,0.3,0.67,1.0201,0.4,0.98
"GO_BP:516302_GO_0071378_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS","GO_BP","516302_GO_0071378_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS",27,-1.4694,0.041,0.12,-0.4385,1,1,0.7739,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_987_GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_987_GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN",103,-1.4693,0.01,0.074,-0.8556,0.79,1,0.6696,0.99,1
"GO_BP:505329_GO_0042167_HEME_CATABOLIC_PROCESS","GO_BP","505329_GO_0042167_HEME_CATABOLIC_PROCESS",7,-1.4692,0.062,0.12,-0.6512,0.91,1,1.0362,0.4,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_2670_ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2670_ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP",15,-1.4692,0.056,0.074,0.9666,0.48,0.84,-0.9682,0.48,0.8
"GO_MF:511517_GO_0050544_ARACHIDONIC_ACID_BINDING","GO_MF","511517_GO_0050544_ARACHIDONIC_ACID_BINDING",5,-1.4692,0.05,0.16,1.5859,0.027,0.3,1.5609,0.045,0.37
"C2_Chemical_and_genetic_perturbations:C2_CGP_306_KIM_WT1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_306_KIM_WT1_TARGETS_DN",457,-1.4692,0,0.074,0.8759,0.93,0.95,-1.4967,0,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_107_PRAMOONJAGO_SOX4_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_107_PRAMOONJAGO_SOX4_TARGETS_DN",51,-1.469,0.023,0.074,1.2239,0.15,0.46,-1.3062,0.089,0.42
"GO_MF:509171_GO_0046982_PROTEIN_HETERODIMERIZATION_ACTIVITY","GO_MF","509171_GO_0046982_PROTEIN_HETERODIMERIZATION_ACTIVITY",437,-1.469,0,0.16,-0.9736,0.54,0.94,-1.3182,0.0044,0.56
"GO_BP:518757_GO_2000108_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS","GO_BP","518757_GO_2000108_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS",28,-1.469,0.04,0.12,-0.6896,0.93,1,-1.0622,0.36,0.8
"GO_BP:488698_GO_0002825_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE","GO_BP","488698_GO_0002825_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE",20,-1.4689,0.048,0.12,-1.1251,0.28,0.94,-0.7463,0.84,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1799_SU_KIDNEY","C2_Chemical_and_genetic_perturbations","C2_CGP_1799_SU_KIDNEY",15,-1.4689,0.056,0.074,-1.3531,0.091,0.67,-0.9186,0.57,0.85
"GO_BP:513636_GO_0060078_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL","GO_BP","513636_GO_0060078_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL",58,-1.4688,0.028,0.12,-1.1619,0.19,0.91,0.8898,0.67,0.95
"GO_BP:487718_GO_0001822_KIDNEY_DEVELOPMENT","GO_BP","487718_GO_0001822_KIDNEY_DEVELOPMENT",243,-1.4688,0.0022,0.12,-1.1096,0.18,0.94,1.2389,0.048,0.71
"REACTOME:105695_REACT_1391_ERK1_ACTIVATION","REACTOME","105695_REACT_1391_ERK1_ACTIVATION",10,-1.4688,0.061,0.15,-0.9432,0.54,1,-1.1554,0.28,0.65
"GO_BP:752693_GO_0097192_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND","GO_BP","752693_GO_0097192_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND",37,-1.4686,0.04,0.12,-0.8584,0.68,1,-0.7164,0.93,0.99
"GO_BP:518059_GO_0080135_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS","GO_BP","518059_GO_0080135_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS",473,-1.4686,0,0.12,0.8704,0.95,1,-1.2067,0.029,0.73
"C4_Cancer_modules:C4_CM_404_MODULE_519","C4_Cancer_modules","C4_CM_404_MODULE_519",15,-1.4686,0.064,0.067,-0.6571,0.91,1,-1.5648,0.024,0.12
"C2_Chemical_and_genetic_perturbations:C2_CGP_994_MANTOVANI_NFKB_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_994_MANTOVANI_NFKB_TARGETS_UP",43,-1.4685,0.036,0.074,0.7773,0.84,1,1.1738,0.22,0.79
"GO_BP:488124_GO_0002251_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE","GO_BP","488124_GO_0002251_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE",37,-1.4684,0.022,0.13,0.9502,0.52,1,-0.8577,0.69,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_27_HOLLMANN_APOPTOSIS_VIA_CD40_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_27_HOLLMANN_APOPTOSIS_VIA_CD40_UP",199,-1.4684,0.0034,0.074,1.2915,0.03,0.4,-1.1876,0.082,0.53
"C7_Immunologic_signatures:C7_ALL_283_GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP","C7_Immunologic_signatures","C7_ALL_283_GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP",200,-1.4684,0.0011,0.01,1.1414,0.15,0.34,1.1435,0.16,0.9
"GO_BP:508077_GO_0045736_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY","GO_BP","508077_GO_0045736_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",27,-1.4684,0.048,0.13,-0.6019,0.98,1,-1.1592,0.23,0.73
"GO_BP:518377_GO_0090237_REGULATION_OF_ARACHIDONIC_ACID_SECRETION","GO_BP","518377_GO_0090237_REGULATION_OF_ARACHIDONIC_ACID_SECRETION",5,-1.4682,0.052,0.13,-0.6752,0.84,1,-0.8341,0.64,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2830_STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA","C2_Chemical_and_genetic_perturbations","C2_CGP_2830_STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA",18,-1.4682,0.055,0.074,0.6937,0.88,1,-1.3654,0.1,0.39
"GO_BP:518925_GO_2000278_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS","GO_BP","518925_GO_2000278_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS",39,-1.4682,0.037,0.13,0.548,1,1,1.0661,0.36,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_692_FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL","C2_Chemical_and_genetic_perturbations","C2_CGP_692_FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL",324,-1.4681,0,0.074,1.0234,0.38,0.77,-1.2565,0.03,0.47
"C7_Immunologic_signatures:C7_ALL_670_GSE17721_LPS_VS_CPG_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_670_GSE17721_LPS_VS_CPG_24H_BMDM_DN",200,-1.4681,0.0023,0.01,1.6513,0,0.0012,-1.0149,0.41,0.69
"KEGG_compound:C11554_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_4_BISPHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_3_4_BISPHOSPHATE_","KEGG_compound","C11554_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_4_BISPHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_3_4_BISPHOSPHATE_",12,-1.468,0.066,0.2,-0.9912,0.46,1,-1.1437,0.29,0.51
"KEGG_pathway:HSA05310_ASTHMA","KEGG_pathway","HSA05310_ASTHMA",27,-1.4679,0.033,0.044,-1.1322,0.29,0.65,-1.1874,0.23,0.39
"GO_BP:492162_GO_0007398_ECTODERM_DEVELOPMENT","GO_BP","492162_GO_0007398_ECTODERM_DEVELOPMENT",20,-1.4679,0.064,0.13,-1.4267,0.067,0.93,0.7685,0.79,1
"C6_Oncogenic_signatures:C6_ALL_9_GCNP_SHH_UP_EARLY_V1_DN","C6_Oncogenic_signatures","C6_ALL_9_GCNP_SHH_UP_EARLY_V1_DN",157,-1.4678,0.0058,0.017,-1.039,0.35,0.58,0.9549,0.56,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_60_GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_60_GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP",30,-1.4677,0.044,0.074,-0.606,0.99,1,-0.8046,0.77,0.95
"GO_BP:492367_GO_0007626_LOCOMOTORY_BEHAVIOR","GO_BP","492367_GO_0007626_LOCOMOTORY_BEHAVIOR",173,-1.4676,0.0058,0.13,-1.0275,0.38,0.97,-0.945,0.6,0.89
"C3_MicroRNA_targets:C3_MIR_132_GGCAGTG_MIR_324_3P","C3_MicroRNA_targets","C3_MIR_132_GGCAGTG_MIR_324_3P",96,-1.4676,0.013,0.23,-0.9437,0.58,1,-1.104,0.25,1
"C3_TF_targets:C3_TFT_10_V_SP1_01","C3_TF_targets","C3_TFT_10_V_SP1_01",231,-1.4676,0.0022,0.025,-1.5232,0.0016,0.14,-1.3479,0.011,0.26
"KEGG_reaction:R09420_CARBONYL_REDUCTASE_4_N_NITROSOMETHYLAMINO_1_3_PYRIDYL_1_BUTANONE_NADPH_H_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_NADP_","KEGG_reaction","R09420_CARBONYL_REDUCTASE_4_N_NITROSOMETHYLAMINO_1_3_PYRIDYL_1_BUTANONE_NADPH_H_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_NADP_",6,-1.4675,0.058,0.2,-0.5553,0.96,1,-1.1151,0.34,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_756_XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_756_XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP",10,-1.4674,0.068,0.074,0.8545,0.63,0.97,1.7873,0.0021,0.19
"C3_TF_targets:C3_TFT_50_V_EVI1_02","C3_TF_targets","C3_TFT_50_V_EVI1_02",128,-1.4673,0.0024,0.025,-1.0024,0.45,0.75,0.8755,0.78,1
"GO_BP:512186_GO_0051302_REGULATION_OF_CELL_DIVISION","GO_BP","512186_GO_0051302_REGULATION_OF_CELL_DIVISION",248,-1.4672,0,0.13,0.8483,0.92,1,-1.267,0.033,0.67
"C7_Immunologic_signatures:C7_ALL_987_GSE22886_NAIVE_CD8_TCELL_VS_DC_UP","C7_Immunologic_signatures","C7_ALL_987_GSE22886_NAIVE_CD8_TCELL_VS_DC_UP",198,-1.4671,0.0023,0.01,1.7624,0,0.00026,-1.9144,0,0
"GO_BP:754482_GO_1901522_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_CELLULAR_RESPONSE_TO_CHEMICAL_STIMULUS","GO_BP","754482_GO_1901522_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_CELLULAR_RESPONSE_TO_CHEMICAL_STIMULUS",23,-1.467,0.049,0.13,0.951,0.53,1,1.063,0.36,0.79
"REACTOME:106523_REACT_15293_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE","REACTOME","106523_REACT_15293_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE",23,-1.467,0.047,0.15,-1.1135,0.28,0.88,-0.9354,0.54,0.92
"C3_TF_targets:C3_TFT_191_V_LMO2COM_02","C3_TF_targets","C3_TFT_191_V_LMO2COM_02",235,-1.4669,0.0022,0.025,-1.0589,0.31,0.64,-0.9505,0.62,0.85
"GO_BP:506441_GO_0043403_SKELETAL_MUSCLE_TISSUE_REGENERATION","GO_BP","506441_GO_0043403_SKELETAL_MUSCLE_TISSUE_REGENERATION",22,-1.4667,0.052,0.13,-0.9891,0.47,1,0.8521,0.68,0.98
"GO_CC:513754_GO_0060198_CLATHRIN_SCULPTED_VESICLE","GO_CC","513754_GO_0060198_CLATHRIN_SCULPTED_VESICLE",11,-1.4666,0.066,0.17,-0.7646,0.76,1,-1.6526,0.023,0.44
"KEGG_compound:C00137_MYO_INOSITOL_D_MYO_INOSITOL_1D_MYO_INOSITOL_L_MYO_INOSITOL_1L_MYO_INOSITOL_MESO_INOSITOL_INOSITOL_DAMBOSE_CYCLOHEXITOL_MEAT_SUGAR_BIOS_I","KEGG_compound","C00137_MYO_INOSITOL_D_MYO_INOSITOL_1D_MYO_INOSITOL_L_MYO_INOSITOL_1L_MYO_INOSITOL_MESO_INOSITOL_INOSITOL_DAMBOSE_CYCLOHEXITOL_MEAT_SUGAR_BIOS_I",6,-1.4665,0.048,0.2,-1.2582,0.22,0.7,-1.3107,0.15,0.36
"C7_Immunologic_signatures:C7_ALL_385_GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_385_GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP",200,-1.4664,0.0045,0.01,1.2503,0.045,0.15,-1.6026,0,0.005
"GO_BP:506949_GO_0043931_OSSIFICATION_INVOLVED_IN_BONE_MATURATION","GO_BP","506949_GO_0043931_OSSIFICATION_INVOLVED_IN_BONE_MATURATION",12,-1.4663,0.059,0.13,-0.661,0.89,1,-0.9687,0.5,0.88
"GO_BP:505048_GO_0035879_PLASMA_MEMBRANE_LACTATE_TRANSPORT","GO_BP","505048_GO_0035879_PLASMA_MEMBRANE_LACTATE_TRANSPORT",7,-1.4663,0.055,0.13,-1.0545,0.38,0.97,-0.9093,0.57,0.92
"GO_BP:503593_GO_0034391_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","503593_GO_0034391_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS",12,-1.4662,0.064,0.13,-0.7566,0.8,1,-0.6205,0.95,1
"GO_BP:508447_GO_0046149_PIGMENT_CATABOLIC_PROCESS","GO_BP","508447_GO_0046149_PIGMENT_CATABOLIC_PROCESS",7,-1.4661,0.045,0.13,-0.6267,0.91,1,0.9937,0.46,0.86
"GO_BP:491796_GO_0006949_SYNCYTIUM_FORMATION","GO_BP","491796_GO_0006949_SYNCYTIUM_FORMATION",26,-1.4659,0.05,0.13,-1.2317,0.17,0.9,-1.4966,0.035,0.54
"GO_BP:499683_GO_0030279_NEGATIVE_REGULATION_OF_OSSIFICATION","GO_BP","499683_GO_0030279_NEGATIVE_REGULATION_OF_OSSIFICATION",63,-1.4656,0.025,0.13,-1.0401,0.38,0.98,0.8684,0.74,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3371_SMIRNOV_RESPONSE_TO_IR_6HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3371_SMIRNOV_RESPONSE_TO_IR_6HR_UP",165,-1.4656,0.0046,0.075,0.7426,0.98,1,-1.0919,0.26,0.64
"GO_MF:487211_GO_0000987_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING","GO_MF","487211_GO_0000987_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING",252,-1.4655,0.0011,0.16,-0.9276,0.67,0.97,-1.1235,0.15,0.68
"GO_BP:511792_GO_0050847_PROGESTERONE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","511792_GO_0050847_PROGESTERONE_RECEPTOR_SIGNALING_PATHWAY",6,-1.4655,0.06,0.13,0.7364,0.77,1,-1.205,0.23,0.73
"C3_TF_targets:C3_TFT_486_V_DR3_Q4","C3_TF_targets","C3_TFT_486_V_DR3_Q4",143,-1.4654,0.0085,0.025,-1.3845,0.022,0.17,-1.1145,0.22,0.51
"GO_BP:494591_GO_0010522_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL","GO_BP","494591_GO_0010522_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL",78,-1.4654,0.021,0.13,0.9501,0.59,1,0.9037,0.66,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_421_MARKEY_RB1_CHRONIC_LOF_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_421_MARKEY_RB1_CHRONIC_LOF_UP",111,-1.4653,0.0099,0.075,0.7701,0.94,1,-1.1372,0.2,0.59
"GO_MF:487270_GO_0001047_CORE_PROMOTER_BINDING","GO_MF","487270_GO_0001047_CORE_PROMOTER_BINDING",130,-1.4653,0.0083,0.16,-0.766,0.95,1,-1.041,0.36,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1806_MOREIRA_RESPONSE_TO_TSA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1806_MOREIRA_RESPONSE_TO_TSA_UP",28,-1.4652,0.053,0.075,0.8687,0.68,0.96,-1.5365,0.024,0.28
"GO_CC:487593_GO_0005858_AXONEMAL_DYNEIN_COMPLEX","GO_CC","487593_GO_0005858_AXONEMAL_DYNEIN_COMPLEX",12,-1.4651,0.055,0.17,-1.7461,0.0057,0.17,-0.6736,0.91,1
"GO_BP:496543_GO_0016601_RAC_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","496543_GO_0016601_RAC_PROTEIN_SIGNAL_TRANSDUCTION",18,-1.4649,0.061,0.13,0.7294,0.85,1,-0.6551,0.94,1
"GO_CC:490912_GO_0005913_CELL_CELL_ADHERENS_JUNCTION","GO_CC","490912_GO_0005913_CELL_CELL_ADHERENS_JUNCTION",46,-1.4649,0.046,0.17,-0.9557,0.53,0.89,1.0014,0.46,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1870_BURTON_ADIPOGENESIS_7","C2_Chemical_and_genetic_perturbations","C2_CGP_1870_BURTON_ADIPOGENESIS_7",51,-1.4648,0.028,0.076,1.1987,0.15,0.49,0.8459,0.74,1
"GO_MF:496265_GO_0016176_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVATOR_ACTIVITY","GO_MF","496265_GO_0016176_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVATOR_ACTIVITY",5,-1.4647,0.04,0.16,0.7721,0.73,1,-1.394,0.13,0.51
"GO_BP:755163_GO_2001057_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS","GO_BP","755163_GO_2001057_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS",34,-1.4647,0.042,0.13,-0.7128,0.92,1,-0.7176,0.91,0.99
"GO_BP:501646_GO_0032414_POSITIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","501646_GO_0032414_POSITIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",52,-1.4645,0.037,0.13,-1.1321,0.24,0.93,0.9962,0.47,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_2429_CROMER_TUMORIGENESIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2429_CROMER_TUMORIGENESIS_DN",44,-1.4644,0.034,0.076,1.1139,0.27,0.61,1.2855,0.098,0.7
"GO_BP:491801_GO_0006958_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY","GO_BP","491801_GO_0006958_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY",30,-1.4644,0.043,0.13,1.0258,0.4,0.97,0.8968,0.61,0.95
"GO_BP:512655_GO_0051783_REGULATION_OF_NUCLEAR_DIVISION","GO_BP","512655_GO_0051783_REGULATION_OF_NUCLEAR_DIVISION",150,-1.4644,0.0048,0.13,-0.8982,0.72,1,-1.1771,0.14,0.74
"GO_BP:491660_GO_0006787_PORPHYRIN_CONTAINING_COMPOUND_CATABOLIC_PROCESS","GO_BP","491660_GO_0006787_PORPHYRIN_CONTAINING_COMPOUND_CATABOLIC_PROCESS",7,-1.4644,0.057,0.13,-0.6337,0.91,1,1.0472,0.4,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_3283_PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3283_PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN",30,-1.4644,0.041,0.076,0.716,0.92,1,1.016,0.43,0.95
"KEGG_compound:C00637_INDOLE_3_ACETALDEHYDE_2_INDOL_3_YL_ACETALDEHYDE_INDOLEACETALDEHYDE","KEGG_compound","C00637_INDOLE_3_ACETALDEHYDE_2_INDOL_3_YL_ACETALDEHYDE_INDOLEACETALDEHYDE",8,-1.4644,0.06,0.2,0.8144,0.69,1,-1.1196,0.33,0.53
"C7_Immunologic_signatures:C7_ALL_1585_GSE3982_EOSINOPHIL_VS_MAST_CELL_UP","C7_Immunologic_signatures","C7_ALL_1585_GSE3982_EOSINOPHIL_VS_MAST_CELL_UP",196,-1.4643,0.0045,0.011,0.7195,1,1,-0.813,0.95,1
"KEGG_pathway:HSA01130_BIOSYNTHESIS_OF_ANTIBIOTICS","KEGG_pathway","HSA01130_BIOSYNTHESIS_OF_ANTIBIOTICS",208,-1.464,0.0011,0.045,1.0587,0.3,0.85,-1.404,0.0082,0.17
"GO_BP:506651_GO_0043620_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS","GO_BP","506651_GO_0043620_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS",57,-1.464,0.017,0.13,0.7046,0.95,1,-0.7114,0.96,0.99
"GO_BP:511927_GO_0050994_REGULATION_OF_LIPID_CATABOLIC_PROCESS","GO_BP","511927_GO_0050994_REGULATION_OF_LIPID_CATABOLIC_PROCESS",42,-1.4638,0.025,0.13,-1.2382,0.18,0.91,-1.0723,0.34,0.8
"GO_MF:490203_GO_0004908_INTERLEUKIN_1_RECEPTOR_ACTIVITY","GO_MF","490203_GO_0004908_INTERLEUKIN_1_RECEPTOR_ACTIVITY",7,-1.4635,0.048,0.16,1.4721,0.067,0.4,1.7272,0.01,0.17
"GO_BP:514844_GO_0061299_RETINA_VASCULATURE_MORPHOGENESIS_IN_CAMERA_TYPE_EYE","GO_BP","514844_GO_0061299_RETINA_VASCULATURE_MORPHOGENESIS_IN_CAMERA_TYPE_EYE",11,-1.4635,0.082,0.13,0.8191,0.7,1,1.1803,0.25,0.72
"GO_BP:507767_GO_0045410_POSITIVE_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS","GO_BP","507767_GO_0045410_POSITIVE_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS",7,-1.4634,0.047,0.13,-1.135,0.32,0.93,0.9541,0.5,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1414_YE_METASTATIC_LIVER_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_1414_YE_METASTATIC_LIVER_CANCER",26,-1.4634,0.05,0.076,0.6009,0.99,1,-0.8217,0.72,0.94
"GO_MF:496470_GO_0016502_NUCLEOTIDE_RECEPTOR_ACTIVITY","GO_MF","496470_GO_0016502_NUCLEOTIDE_RECEPTOR_ACTIVITY",33,-1.4633,0.035,0.16,1.2807,0.14,0.63,0.7703,0.85,1
"WikiPathways:198823_WP545_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY","WikiPathways","198823_WP545_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY",17,-1.4632,0.057,0.084,0.8649,0.66,1,-0.9388,0.53,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_873_SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_873_SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN",31,-1.4632,0.045,0.076,1.1193,0.29,0.6,1.4451,0.05,0.54
"KEGG_pathway:HSA00603_GLYCOSPHINGOLIPID_BIOSYNTHESIS","KEGG_pathway","HSA00603_GLYCOSPHINGOLIPID_BIOSYNTHESIS",14,-1.4632,0.063,0.045,-0.7767,0.76,1,0.7864,0.76,1
"C7_Immunologic_signatures:C7_ALL_1138_GSE2706_2H_VS_8H_R848_STIM_DC_DN","C7_Immunologic_signatures","C7_ALL_1138_GSE2706_2H_VS_8H_R848_STIM_DC_DN",189,-1.4631,0.0023,0.011,1.1617,0.1,0.3,-1.0116,0.43,0.7
"C4_Cancer_modules:C4_CM_319_MODULE_373","C4_Cancer_modules","C4_CM_319_MODULE_373",22,-1.463,0.058,0.069,-1.3866,0.095,0.52,-0.8158,0.71,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_496_JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_496_JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP",57,-1.463,0.027,0.076,1.4549,0.02,0.25,0.8547,0.74,1
"C3_TF_targets:C3_TFT_48_V_GATA3_01","C3_TF_targets","C3_TFT_48_V_GATA3_01",234,-1.463,0.0022,0.026,-0.9978,0.48,0.76,1.0661,0.29,1
"GO_BP:752785_GO_0097284_HEPATOCYTE_APOPTOTIC_PROCESS","GO_BP","752785_GO_0097284_HEPATOCYTE_APOPTOTIC_PROCESS",13,-1.463,0.062,0.13,0.8943,0.59,1,0.8028,0.75,1
"GO_BP:494602_GO_0010533_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY","GO_BP","494602_GO_0010533_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY",8,-1.4629,0.085,0.13,-1.1187,0.34,0.94,-0.838,0.68,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2404_THUM_MIR21_TARGETS_HEART_DISEASE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2404_THUM_MIR21_TARGETS_HEART_DISEASE_DN",8,-1.4628,0.065,0.076,-1.091,0.37,0.93,-0.7641,0.78,0.97
"GO_BP:754605_GO_1901653_CELLULAR_RESPONSE_TO_PEPTIDE","GO_BP","754605_GO_1901653_CELLULAR_RESPONSE_TO_PEPTIDE",296,-1.4628,0.0022,0.13,-0.7546,0.99,1,-1.0566,0.26,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_2477_FERRARI_RESPONSE_TO_FENRETINIDE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2477_FERRARI_RESPONSE_TO_FENRETINIDE_DN",5,-1.4626,0.06,0.076,-1.5554,0.029,0.42,-1.6464,0.013,0.22
"GO_BP:491582_GO_0006694_STEROID_BIOSYNTHETIC_PROCESS","GO_BP","491582_GO_0006694_STEROID_BIOSYNTHETIC_PROCESS",109,-1.4626,0.015,0.13,0.9312,0.61,1,-0.7984,0.91,0.99
"GO_BP:495146_GO_0014074_RESPONSE_TO_PURINE_CONTAINING_COMPOUND","GO_BP","495146_GO_0014074_RESPONSE_TO_PURINE_CONTAINING_COMPOUND",141,-1.4625,0.0083,0.13,1.0811,0.27,0.92,1.066,0.28,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_567_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_567_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN",8,-1.4624,0.075,0.077,-1.1867,0.24,0.81,-1.1439,0.3,0.58
"C7_Immunologic_signatures:C7_ALL_693_GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_693_GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDM_UP",195,-1.4624,0.0035,0.011,0.8751,0.8,1,-0.8481,0.88,1
"C3_TF_targets:C3_TFT_186_V_HLF_01","C3_TF_targets","C3_TFT_186_V_HLF_01",246,-1.4624,0.0033,0.026,-1.3007,0.029,0.23,-1.232,0.051,0.3
"C3_MicroRNA_targets:C3_MIR_158_ACAACCT_MIR_453","C3_MicroRNA_targets","C3_MIR_158_ACAACCT_MIR_453",42,-1.4623,0.039,0.22,-0.9132,0.63,1,-1.4288,0.043,1
"GO_BP:498366_GO_0019532_OXALATE_TRANSPORT","GO_BP","498366_GO_0019532_OXALATE_TRANSPORT",5,-1.4621,0.043,0.13,0.7553,0.77,1,0.7289,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3081_FIGUEROA_AML_METHYLATION_CLUSTER_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3081_FIGUEROA_AML_METHYLATION_CLUSTER_2_DN",9,-1.462,0.075,0.077,1.4639,0.064,0.24,-0.695,0.85,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_660_LI_AMPLIFIED_IN_LUNG_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_660_LI_AMPLIFIED_IN_LUNG_CANCER",175,-1.4619,0.008,0.077,2.1551,0,0.0011,-0.9365,0.63,0.84
"GO_CC:507304_GO_0044298_CELL_BODY_MEMBRANE","GO_CC","507304_GO_0044298_CELL_BODY_MEMBRANE",11,-1.4619,0.079,0.17,-1.4767,0.07,0.63,1.2002,0.22,0.84
"GO_BP:513492_GO_0072505_DIVALENT_INORGANIC_ANION_HOMEOSTASIS","GO_BP","513492_GO_0072505_DIVALENT_INORGANIC_ANION_HOMEOSTASIS",12,-1.4619,0.074,0.13,-0.7593,0.8,1,-1.0827,0.37,0.79
"C4_Cancer_modules:C4_CM_209_MODULE_226","C4_Cancer_modules","C4_CM_209_MODULE_226",27,-1.4617,0.055,0.069,1.0991,0.31,0.54,1.2461,0.17,0.56
"C7_Immunologic_signatures:C7_ALL_147_GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP","C7_Immunologic_signatures","C7_ALL_147_GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP",197,-1.4617,0.0034,0.011,-0.8026,0.94,1,0.9022,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2586_HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2586_HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN",20,-1.4616,0.048,0.077,-0.9295,0.54,1,-0.8946,0.6,0.89
"GO_BP:509067_GO_0046847_FILOPODIUM_ASSEMBLY","GO_BP","509067_GO_0046847_FILOPODIUM_ASSEMBLY",17,-1.4615,0.055,0.13,-0.6896,0.9,1,0.7789,0.79,1
"C6_Oncogenic_signatures:C6_ALL_14_RAPA_EARLY_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_14_RAPA_EARLY_UP_V1_UP",163,-1.4615,0.0035,0.018,-1.5627,0,0.13,-1.2635,0.048,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_1766_APRELIKOVA_BRCA1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1766_APRELIKOVA_BRCA1_TARGETS",49,-1.4615,0.038,0.077,1.0238,0.41,0.77,-1.3312,0.079,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2789_ONO_FOXP3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2789_ONO_FOXP3_TARGETS_UP",23,-1.4615,0.046,0.077,-0.9919,0.44,1,0.5713,0.99,1
"GO_BP:503514_GO_0034311_DIOL_METABOLIC_PROCESS","GO_BP","503514_GO_0034311_DIOL_METABOLIC_PROCESS",11,-1.4614,0.059,0.13,-0.5921,0.94,1,-1.4951,0.058,0.54
"C7_Immunologic_signatures:C7_ALL_1717_GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1717_GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP",196,-1.4614,0.0058,0.011,1.1748,0.14,0.27,-1.2477,0.06,0.2
"GO_BP:513637_GO_0060079_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL","GO_BP","513637_GO_0060079_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL",51,-1.4613,0.016,0.13,-1.0775,0.32,0.95,0.8705,0.71,0.96
"WikiPathways:198871_WP53_ID_SIGNALING_PATHWAY","WikiPathways","198871_WP53_ID_SIGNALING_PATHWAY",52,-1.4612,0.04,0.084,0.9065,0.61,1,-0.8035,0.83,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_342_MAYBURD_RESPONSE_TO_L663536_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_342_MAYBURD_RESPONSE_TO_L663536_UP",28,-1.4609,0.065,0.077,0.6643,0.95,1,-1.178,0.22,0.54
"GO_BP:505588_GO_0042448_PROGESTERONE_METABOLIC_PROCESS","GO_BP","505588_GO_0042448_PROGESTERONE_METABOLIC_PROCESS",14,-1.4608,0.056,0.13,0.8862,0.61,1,1.1803,0.23,0.72
"REACTOME:730347_REACT_150139_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R","REACTOME","730347_REACT_150139_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R",25,-1.4608,0.049,0.16,0.5567,0.99,1,-1.0185,0.41,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_881_WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_881_WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN",54,-1.4607,0.028,0.077,-1.3305,0.069,0.69,-1.135,0.25,0.59
"C4_Cancer_modules:C4_CM_427_MODULE_568","C4_Cancer_modules","C4_CM_427_MODULE_568",72,-1.4606,0.018,0.069,-0.8229,0.79,0.96,0.55,1,1
"GO_BP:487501_GO_0001562_RESPONSE_TO_PROTOZOAN","GO_BP","487501_GO_0001562_RESPONSE_TO_PROTOZOAN",20,-1.4605,0.057,0.13,-1.1818,0.23,0.91,-0.8438,0.69,0.96
"GO_BP:754573_GO_1901617_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","754573_GO_1901617_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS",172,-1.4604,0.0093,0.13,-0.8357,0.86,1,-1.0084,0.44,0.84
"REACTOME:105706_REACT_13814_FATTY_ACIDS","REACTOME","105706_REACT_13814_FATTY_ACIDS",15,-1.4603,0.055,0.16,-1.5668,0.03,0.35,1.6548,0.011,0.37
"C2_Chemical_and_genetic_perturbations:C2_CGP_678_EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_678_EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN",48,-1.4602,0.033,0.077,-0.9169,0.6,1,-0.7907,0.85,0.96
"GO_BP:494757_GO_0010692_REGULATION_OF_ALKALINE_PHOSPHATASE_ACTIVITY","GO_BP","494757_GO_0010692_REGULATION_OF_ALKALINE_PHOSPHATASE_ACTIVITY",10,-1.4602,0.066,0.13,-1.3558,0.11,0.97,-1.4707,0.067,0.54
"C6_Oncogenic_signatures:C6_ALL_175_KRAS_600_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_175_KRAS_600_UP_V1_UP",260,-1.4601,0,0.018,1.1826,0.08,0.43,1.6377,0,0.028
"C3_TF_targets:C3_TFT_118_V_OCT1_06","C3_TF_targets","C3_TFT_118_V_OCT1_06",247,-1.46,0.0011,0.026,-1.0016,0.46,0.75,-1.0426,0.34,0.65
"GO_BP:507456_GO_0045055_REGULATED_SECRETORY_PATHWAY","GO_BP","507456_GO_0045055_REGULATED_SECRETORY_PATHWAY",45,-1.46,0.04,0.13,1.1386,0.25,0.85,-0.815,0.8,0.98
"KEGG_pathway:HSA05215_PROSTATE_CANCER","KEGG_pathway","HSA05215_PROSTATE_CANCER",88,-1.46,0.017,0.046,0.5955,1,1,-0.9285,0.65,0.81
"GO_BP:512477_GO_0051599_RESPONSE_TO_HYDROSTATIC_PRESSURE","GO_BP","512477_GO_0051599_RESPONSE_TO_HYDROSTATIC_PRESSURE",7,-1.4599,0.071,0.13,-1.3794,0.12,0.98,-1.2495,0.23,0.68
"GO_BP:502144_GO_0032922_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION","GO_BP","502144_GO_0032922_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION",58,-1.4598,0.029,0.13,-1.0516,0.38,0.97,-0.955,0.53,0.89
"GO_MF:487202_GO_0000978_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING","GO_MF","487202_GO_0000978_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_DNA_BINDING",237,-1.4598,0.0022,0.17,-0.9582,0.57,0.95,-1.1687,0.11,0.61
"KEGG_compound:C05299_2_METHOXYESTRONE","KEGG_compound","C05299_2_METHOXYESTRONE",20,-1.4598,0.049,0.2,1.8652,0.0021,0.018,2.2093,0,6.4e-05
"C7_Immunologic_signatures:C7_ALL_468_GSE17721_CTRL_VS_POLYIC_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_468_GSE17721_CTRL_VS_POLYIC_2H_BMDM_DN",199,-1.4597,0.0011,0.012,-1.2506,0.057,0.61,-0.8923,0.77,0.96
"GO_MF:499447_GO_0023026_MHC_CLASS_II_PROTEIN_COMPLEX_BINDING","GO_MF","499447_GO_0023026_MHC_CLASS_II_PROTEIN_COMPLEX_BINDING",16,-1.4595,0.066,0.17,-1.1526,0.29,0.81,-1.8768,0.0059,0.17
"GO_MF:502511_GO_0033293_MONOCARBOXYLIC_ACID_BINDING","GO_MF","502511_GO_0033293_MONOCARBOXYLIC_ACID_BINDING",56,-1.4594,0.027,0.17,1.2106,0.13,0.7,1.409,0.037,0.52
"REACTOME:119549_REACT_19327_G_ALPHA_S_SIGNALLING_EVENTS","REACTOME","119549_REACT_19327_G_ALPHA_S_SIGNALLING_EVENTS",119,-1.4594,0.0097,0.16,-1.2244,0.11,0.79,-1.2709,0.065,0.55
"GO_BP:512225_GO_0051341_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY","GO_BP","512225_GO_0051341_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY",81,-1.4593,0.022,0.13,0.8695,0.75,1,-0.8905,0.7,0.93
"GO_BP:492044_GO_0007265_RAS_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","492044_GO_0007265_RAS_PROTEIN_SIGNAL_TRANSDUCTION",217,-1.4592,0.0022,0.13,1.006,0.43,0.98,-0.9535,0.58,0.89
"REACTOME:187090_REACT_25374_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1","REACTOME","187090_REACT_25374_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1",25,-1.4591,0.041,0.16,0.9948,0.45,0.76,0.5504,0.98,1
"GO_BP:499349_GO_0022614_MEMBRANE_TO_MEMBRANE_DOCKING","GO_BP","499349_GO_0022614_MEMBRANE_TO_MEMBRANE_DOCKING",5,-1.459,0.048,0.13,-0.609,0.92,1,-0.9313,0.55,0.9
"GO_MF:510308_GO_0048185_ACTIVIN_BINDING","GO_MF","510308_GO_0048185_ACTIVIN_BINDING",12,-1.4588,0.071,0.17,-0.8086,0.72,1,-0.6012,0.93,1
"GO_BP:491993_GO_0007193_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY","GO_BP","491993_GO_0007193_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",63,-1.4588,0.028,0.13,-0.9019,0.66,1,-1.118,0.24,0.76
"GO_MF:492693_GO_0008395_STEROID_HYDROXYLASE_ACTIVITY","GO_MF","492693_GO_0008395_STEROID_HYDROXYLASE_ACTIVITY",29,-1.4587,0.026,0.17,-1.1782,0.22,0.78,1.2673,0.15,0.65
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_131_BIOCARTA_ARENRF2_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_131_BIOCARTA_ARENRF2_PATHWAY",13,-1.4587,0.066,0.15,-1.6033,0.035,1,-1.2039,0.23,0.58
"KEGG_pathway:HSA05031_AMPHETAMINE_ADDICTION","KEGG_pathway","HSA05031_AMPHETAMINE_ADDICTION",67,-1.4586,0.034,0.047,-0.9209,0.61,0.96,-0.9202,0.6,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_742_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_742_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",21,-1.4586,0.053,0.078,1.2397,0.2,0.45,0.9008,0.6,1
"GO_BP:488240_GO_0002367_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488240_GO_0002367_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE",13,-1.4585,0.06,0.13,-0.8679,0.67,1,-1.3647,0.11,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_1335_PEART_HDAC_PROLIFERATION_CLUSTER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1335_PEART_HDAC_PROLIFERATION_CLUSTER_UP",57,-1.4585,0.032,0.078,-0.8125,0.82,1,-1.0157,0.43,0.73
"GO_BP:491962_GO_0007156_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES","GO_BP","491962_GO_0007156_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES",140,-1.4585,0.0084,0.13,1.5048,0.0023,0.4,2.4155,0,0.00025
"GO_BP:499267_GO_0021988_OLFACTORY_LOBE_DEVELOPMENT","GO_BP","499267_GO_0021988_OLFACTORY_LOBE_DEVELOPMENT",38,-1.4584,0.04,0.13,-1.3726,0.078,0.98,0.9923,0.47,0.86
"GO_MF:490631_GO_0005534_GALACTOSE_BINDING","GO_MF","490631_GO_0005534_GALACTOSE_BINDING",5,-1.4584,0.048,0.17,-0.8882,0.61,1,-1.0709,0.4,0.73
"GO_BP:487917_GO_0002027_REGULATION_OF_HEART_RATE","GO_BP","487917_GO_0002027_REGULATION_OF_HEART_RATE",81,-1.4584,0.021,0.13,1.1203,0.25,0.88,1.3586,0.039,0.64
"GO_BP:507703_GO_0045346_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS","GO_BP","507703_GO_0045346_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS",14,-1.4583,0.058,0.13,0.9755,0.5,1,-0.592,0.96,1
"GO_BP:513863_GO_0060307_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION","GO_BP","513863_GO_0060307_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION",15,-1.4582,0.058,0.13,-0.8691,0.63,1,0.9845,0.5,0.87
"C7_Immunologic_signatures:C7_ALL_923_GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP","C7_Immunologic_signatures","C7_ALL_923_GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP",195,-1.4581,0.0023,0.012,-0.6947,1,1,-1.3287,0.021,0.11
"GO_BP:751297_GO_0038034_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND","GO_BP","751297_GO_0038034_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND",37,-1.4581,0.038,0.13,-0.867,0.69,1,-0.7239,0.91,0.99
"C7_Immunologic_signatures:C7_ALL_74_GSE11057_PBMC_VS_MEM_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_74_GSE11057_PBMC_VS_MEM_CD4_TCELL_DN",196,-1.4579,0.0011,0.012,1.2882,0.036,0.11,-1.4097,0.011,0.055
"GO_BP:518825_GO_2000177_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION","GO_BP","518825_GO_2000177_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION",70,-1.4579,0.032,0.13,-0.8791,0.71,1,0.9162,0.62,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_2234_MCCABE_HOXC6_TARGETS_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2234_MCCABE_HOXC6_TARGETS_CANCER_UP",31,-1.4578,0.046,0.079,-1.0145,0.44,0.98,-0.6398,0.96,0.99
"GO_BP:488574_GO_0002701_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE","GO_BP","488574_GO_0002701_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE",21,-1.4578,0.055,0.13,-0.8771,0.64,1,-1.0933,0.28,0.78
"C7_Immunologic_signatures:C7_ALL_666_GSE17721_LPS_VS_CPG_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_666_GSE17721_LPS_VS_CPG_12H_BMDM_DN",198,-1.4578,0.0023,0.012,1.3025,0.024,0.1,1.0808,0.26,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_870_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_870_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN",50,-1.4578,0.025,0.079,1.572,0.014,0.16,1.2776,0.11,0.68
"GO_BP:495270_GO_0014877_RESPONSE_TO_MUSCLE_INACTIVITY_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION","GO_BP","495270_GO_0014877_RESPONSE_TO_MUSCLE_INACTIVITY_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION",6,-1.4577,0.065,0.13,-1.0332,0.43,0.98,-1.5607,0.038,0.51
"GO_BP:492565_GO_0050829_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM","GO_BP","492565_GO_0050829_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM",32,-1.4577,0.057,0.13,-0.9417,0.54,1,-0.7247,0.9,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2754_YAGI_AML_WITH_T_8_21_TRANSLOCATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2754_YAGI_AML_WITH_T_8_21_TRANSLOCATION",362,-1.4575,0,0.079,1.0766,0.2,0.67,-0.8838,0.87,0.9
"C3_MicroRNA_targets:C3_MIR_87_TCGATGG_MIR_213","C3_MicroRNA_targets","C3_MIR_87_TCGATGG_MIR_213",6,-1.4574,0.063,0.22,-0.9307,0.54,1,-0.851,0.62,1
"GO_BP:921109_GO_1902510_REGULATION_OF_APOPTOTIC_DNA_FRAGMENTATION","GO_BP","921109_GO_1902510_REGULATION_OF_APOPTOTIC_DNA_FRAGMENTATION",7,-1.4574,0.087,0.13,0.4536,0.99,1,-1.3097,0.16,0.64
"GO_BP:488664_GO_0002791_REGULATION_OF_PEPTIDE_SECRETION","GO_BP","488664_GO_0002791_REGULATION_OF_PEPTIDE_SECRETION",197,-1.4573,0.007,0.13,-0.8192,0.93,1,0.9177,0.69,0.93
"GO_BP:488736_GO_0002863_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS","GO_BP","488736_GO_0002863_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",11,-1.4573,0.068,0.13,-0.9733,0.48,1,-0.9835,0.49,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_2247_ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2247_ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN",115,-1.4572,0.013,0.079,-1.4061,0.016,0.58,-0.9501,0.55,0.82
"KEGG_compound:C00899_11_CIS_RETINOL","KEGG_compound","C00899_11_CIS_RETINOL",5,-1.4571,0.05,0.21,-1.219,0.24,0.75,-1.0358,0.43,0.61
"GO_MF:487455_GO_0001515_OPIOID_PEPTIDE_ACTIVITY","GO_MF","487455_GO_0001515_OPIOID_PEPTIDE_ACTIVITY",5,-1.4568,0.057,0.17,-1.1461,0.33,0.82,-1.3055,0.17,0.57
"GO_BP:510375_GO_0048261_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS","GO_BP","510375_GO_0048261_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS",15,-1.4567,0.062,0.13,0.6417,0.94,1,0.942,0.51,0.91
"GO_BP:514265_GO_0060710_CHORIO_ALLANTOIC_FUSION","GO_BP","514265_GO_0060710_CHORIO_ALLANTOIC_FUSION",7,-1.4567,0.076,0.13,-1.4118,0.1,0.95,-1.1162,0.33,0.76
"C3_TF_targets:C3_TFT_203_V_FREAC7_01","C3_TF_targets","C3_TFT_203_V_FREAC7_01",188,-1.4567,0.0067,0.027,0.9673,0.55,1,-0.9604,0.55,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_924_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5","C2_Chemical_and_genetic_perturbations","C2_CGP_924_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5",89,-1.4566,0.018,0.079,1.0909,0.27,0.64,0.9906,0.47,0.97
"REACTOME:905997_REACT_169118_SIGNALING_BY_LEPTIN","REACTOME","905997_REACT_169118_SIGNALING_BY_LEPTIN",26,-1.4565,0.064,0.16,0.5523,0.98,1,-1.0629,0.36,0.75
"GO_BP:517227_GO_0072311_GLOMERULAR_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","517227_GO_0072311_GLOMERULAR_EPITHELIAL_CELL_DIFFERENTIATION",16,-1.4565,0.049,0.13,-1.0059,0.44,0.98,-0.991,0.47,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_158_HORIUCHI_WTAP_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_158_HORIUCHI_WTAP_TARGETS_DN",308,-1.4563,0,0.079,1.3003,0.012,0.39,-1.4709,0.0043,0.31
"REACTOME:106460_REACT_12058_SIGNALLING_TO_ERKS","REACTOME","106460_REACT_12058_SIGNALLING_TO_ERKS",43,-1.4562,0.036,0.16,0.7047,0.96,1,-0.7562,0.88,1
"C4_Cancer_modules:C4_CM_401_MODULE_512","C4_Cancer_modules","C4_CM_401_MODULE_512",37,-1.4561,0.028,0.072,-1.2167,0.18,0.61,-1.4119,0.059,0.21
"KEGG_module:HSA_M00135_GABA_BIOSYNTHESIS_EUKARYOTES_PUTRESCINE_GABA","KEGG_module","HSA_M00135_GABA_BIOSYNTHESIS_EUKARYOTES_PUTRESCINE_GABA",9,-1.4561,0.064,0.33,-0.7058,0.83,1,-1.2883,0.19,0.48
"GO_BP:492626_GO_0008306_ASSOCIATIVE_LEARNING","GO_BP","492626_GO_0008306_ASSOCIATIVE_LEARNING",66,-1.4561,0.02,0.13,-1.1872,0.18,0.9,1.0079,0.42,0.85
"GO_BP:498801_GO_0021517_VENTRAL_SPINAL_CORD_DEVELOPMENT","GO_BP","498801_GO_0021517_VENTRAL_SPINAL_CORD_DEVELOPMENT",43,-1.4561,0.023,0.13,-1.4513,0.032,0.9,-0.9738,0.5,0.88
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_188_BIOCARTA_STATHMIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_188_BIOCARTA_STATHMIN_PATHWAY",19,-1.4558,0.047,0.15,1.9093,0.0043,0.082,-1.4181,0.092,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_1607_LEE_AGING_NEOCORTEX_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1607_LEE_AGING_NEOCORTEX_DN",75,-1.4558,0.016,0.079,-0.9458,0.58,1,-0.9716,0.54,0.8
"C7_Immunologic_signatures:C7_ALL_1876_GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1876_GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN",197,-1.4558,0.0023,0.012,-0.7374,0.99,1,1.0646,0.3,1
"GO_CC:993476_GO_0097610_CELL_SURFACE_FURROW","GO_CC","993476_GO_0097610_CELL_SURFACE_FURROW",45,-1.4558,0.031,0.18,0.8637,0.7,0.91,0.6987,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2582_HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2582_HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN",50,-1.4557,0.031,0.079,0.727,0.94,1,-1.3353,0.065,0.41
"GO_BP:503241_GO_0034032_PURINE_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS","GO_BP","503241_GO_0034032_PURINE_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS",36,-1.4557,0.029,0.13,0.8485,0.71,1,-1.2449,0.13,0.69
"REACTOME:1183577_REACT_355408_SIGNALING_BY_FGFR4","REACTOME","1183577_REACT_355408_SIGNALING_BY_FGFR4",156,-1.4557,0.0058,0.16,-0.952,0.58,1,-1.2185,0.086,0.59
"GO_BP:491075_GO_0006094_GLUCONEOGENESIS","GO_BP","491075_GO_0006094_GLUCONEOGENESIS",45,-1.4557,0.03,0.13,0.9378,0.56,1,-1.0993,0.3,0.77
"REACTOME:105651_REACT_900_FASL_CD95L_SIGNALING","REACTOME","105651_REACT_900_FASL_CD95L_SIGNALING",5,-1.4555,0.049,0.16,-0.7568,0.76,1,0.4516,1,1
"REACTOME:1127687_REACT_264545_RMTS_METHYLATE_HISTONE_ARGININES","REACTOME","1127687_REACT_264545_RMTS_METHYLATE_HISTONE_ARGININES",71,-1.4555,0.02,0.16,-1.9396,0,0.042,-1.4572,0.016,0.38
"GO_BP:495286_GO_0014894_RESPONSE_TO_DENERVATION_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION","GO_BP","495286_GO_0014894_RESPONSE_TO_DENERVATION_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION",6,-1.4554,0.055,0.13,-1.0529,0.39,0.97,-1.5557,0.04,0.51
"GO_BP:491994_GO_0007194_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY","GO_BP","491994_GO_0007194_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY",25,-1.4554,0.042,0.13,-0.6832,0.94,1,1.2842,0.13,0.69
"GO_BP:518758_GO_2000109_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS","GO_BP","518758_GO_2000109_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS",8,-1.4551,0.067,0.13,0.778,0.73,1,-1.4853,0.06,0.53
"C3_TF_targets:C3_TFT_256_V_IPF1_Q4","C3_TF_targets","C3_TFT_256_V_IPF1_Q4",243,-1.455,0.0022,0.028,-0.8775,0.83,0.99,-0.8174,0.96,1
"GO_BP:487741_GO_0001845_PHAGOLYSOSOME_ASSEMBLY","GO_BP","487741_GO_0001845_PHAGOLYSOSOME_ASSEMBLY",11,-1.455,0.069,0.13,0.5262,0.98,1,-0.9606,0.51,0.88
"GO_MF:489294_GO_0003777_MICROTUBULE_MOTOR_ACTIVITY","GO_MF","489294_GO_0003777_MICROTUBULE_MOTOR_ACTIVITY",75,-1.4549,0.028,0.17,-1.1503,0.21,0.81,-1.0348,0.39,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_1195_NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1195_NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON",38,-1.4549,0.055,0.08,-1.3386,0.095,0.71,-1.7338,0.0042,0.16
"GO_BP:498914_GO_0021631_OPTIC_NERVE_MORPHOGENESIS","GO_BP","498914_GO_0021631_OPTIC_NERVE_MORPHOGENESIS",6,-1.4548,0.059,0.13,-0.9564,0.5,1,-0.9145,0.53,0.92
"C3_TF_targets:C3_TFT_287_V_FOXO3_01","C3_TF_targets","C3_TFT_287_V_FOXO3_01",240,-1.4548,0.0033,0.027,-0.9433,0.64,0.89,-1.0124,0.41,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1628_RUAN_RESPONSE_TO_TROGLITAZONE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1628_RUAN_RESPONSE_TO_TROGLITAZONE_UP",24,-1.4547,0.053,0.08,-1.0567,0.38,0.97,1.0073,0.45,0.96
"GO_BP:500195_GO_0030900_FOREBRAIN_DEVELOPMENT","GO_BP","500195_GO_0030900_FOREBRAIN_DEVELOPMENT",331,-1.4547,0.0021,0.13,-1.1189,0.16,0.94,-0.9933,0.47,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_1828_HENDRICKS_SMARCA4_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1828_HENDRICKS_SMARCA4_TARGETS_DN",49,-1.4547,0.026,0.08,-0.9006,0.63,1,1.3578,0.072,0.56
"GO_BP:506566_GO_0043535_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION","GO_BP","506566_GO_0043535_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION",46,-1.4547,0.035,0.13,-1.0094,0.44,0.98,-1.1906,0.17,0.74
"GO_BP:519417_GO_2000778_POSITIVE_REGULATION_OF_INTERLEUKIN_6_SECRETION","GO_BP","519417_GO_2000778_POSITIVE_REGULATION_OF_INTERLEUKIN_6_SECRETION",7,-1.4547,0.064,0.13,1.0174,0.44,0.97,-1.2086,0.24,0.73
"C7_Immunologic_signatures:C7_ALL_577_GSE17721_PAM3CSK4_VS_CPG_16H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_577_GSE17721_PAM3CSK4_VS_CPG_16H_BMDM_UP",192,-1.4546,0.0067,0.012,0.8385,0.92,1,-0.8627,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3238_WANG_THOC1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3238_WANG_THOC1_TARGETS_UP",5,-1.4545,0.059,0.08,-0.7379,0.78,1,1.155,0.29,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1378_FERNANDEZ_BOUND_BY_MYC","C2_Chemical_and_genetic_perturbations","C2_CGP_1378_FERNANDEZ_BOUND_BY_MYC",177,-1.4544,0.008,0.08,1.0082,0.43,0.78,-1.2467,0.065,0.48
"REACTOME:119547_REACT_19287_LYSOSOME_VESICLE_BIOGENESIS","REACTOME","119547_REACT_19287_LYSOSOME_VESICLE_BIOGENESIS",35,-1.4544,0.038,0.16,0.9244,0.56,0.87,-1.0468,0.37,0.78
"GO_BP:492400_GO_0050796_REGULATION_OF_INSULIN_SECRETION","GO_BP","492400_GO_0050796_REGULATION_OF_INSULIN_SECRETION",168,-1.4543,0.0081,0.13,-0.8639,0.82,1,-1.0303,0.38,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1241_ONDER_CDH1_TARGETS_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1241_ONDER_CDH1_TARGETS_1_DN",161,-1.4543,0.0035,0.08,1.023,0.36,0.77,0.9708,0.52,0.96
"GO_BP:492702_GO_0008406_GONAD_DEVELOPMENT","GO_BP","492702_GO_0008406_GONAD_DEVELOPMENT",185,-1.4542,0.0068,0.13,-0.9113,0.69,1,1.0177,0.41,0.84
"GO_BP:504335_GO_0035150_REGULATION_OF_TUBE_SIZE","GO_BP","504335_GO_0035150_REGULATION_OF_TUBE_SIZE",70,-1.454,0.02,0.13,1.2732,0.093,0.71,1.1947,0.15,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_439_ODONNELL_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_439_ODONNELL_METASTASIS_UP",77,-1.4539,0.02,0.08,-1.0854,0.3,0.94,0.8122,0.85,1
"C4_Cancer_modules:C4_CM_361_MODULE_438","C4_Cancer_modules","C4_CM_361_MODULE_438",65,-1.4539,0.029,0.072,-1.0934,0.31,0.68,-1.2269,0.14,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_3296_LIU_IL13_MEMORY_MODEL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3296_LIU_IL13_MEMORY_MODEL_UP",17,-1.4538,0.067,0.08,-0.7742,0.8,1,0.7441,0.83,1
"GO_BP:494937_GO_0010873_POSITIVE_REGULATION_OF_CHOLESTEROL_ESTERIFICATION","GO_BP","494937_GO_0010873_POSITIVE_REGULATION_OF_CHOLESTEROL_ESTERIFICATION",8,-1.4537,0.068,0.13,0.6236,0.91,1,1.054,0.4,0.8
"GO_BP:492354_GO_0007613_MEMORY","GO_BP","492354_GO_0007613_MEMORY",89,-1.4537,0.013,0.13,-0.9815,0.51,1,1.3725,0.037,0.64
"GO_BP:502847_GO_0033631_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN","GO_BP","502847_GO_0033631_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN",5,-1.4535,0.047,0.13,0.6407,0.9,1,1.4072,0.1,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2724_CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2724_CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN",177,-1.4534,0.0012,0.08,-0.8982,0.72,1,-1.2962,0.023,0.43
"GO_BP:491464_GO_0006568_TRYPTOPHAN_METABOLIC_PROCESS","GO_BP","491464_GO_0006568_TRYPTOPHAN_METABOLIC_PROCESS",13,-1.4533,0.057,0.13,-1.2765,0.16,0.89,-1.7634,0.0039,0.65
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_70_BIOCARTA_EXTRINSIC_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_70_BIOCARTA_EXTRINSIC_PATHWAY",13,-1.4532,0.068,0.16,1.6239,0.033,0.23,1.285,0.16,1
"C7_Immunologic_signatures:C7_ALL_964_GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN","C7_Immunologic_signatures","C7_ALL_964_GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN",200,-1.4532,0.0045,0.013,1.2551,0.052,0.15,-0.8175,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1741_MAHAJAN_RESPONSE_TO_IL1A_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1741_MAHAJAN_RESPONSE_TO_IL1A_DN",76,-1.4532,0.024,0.08,-0.6906,0.98,1,-1.324,0.076,0.41
"C3_TF_targets:C3_TFT_196_V_TCF11MAFG_01","C3_TF_targets","C3_TFT_196_V_TCF11MAFG_01",205,-1.4532,0.0033,0.028,-0.784,0.97,1,1.0581,0.31,1
"WikiPathways:698754_WP2324_AGE_RAGE_PATHWAY","WikiPathways","698754_WP2324_AGE_RAGE_PATHWAY",65,-1.4531,0.042,0.089,0.9207,0.61,1,-0.836,0.78,0.94
"KEGG_compound:C00005_NADPH_TPNH_REDUCED_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_PHOSPHATE","KEGG_compound","C00005_NADPH_TPNH_REDUCED_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_PHOSPHATE",141,-1.4531,0.013,0.21,-0.7097,0.99,1,-1.5813,0.004,0.16
"GO_BP:812223_GO_0038180_NERVE_GROWTH_FACTOR_SIGNALING_PATHWAY","GO_BP","812223_GO_0038180_NERVE_GROWTH_FACTOR_SIGNALING_PATHWAY",9,-1.4531,0.076,0.13,-0.657,0.9,1,-0.8942,0.59,0.93
"GO_MF:490500_GO_0015171_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490500_GO_0015171_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",69,-1.4531,0.026,0.17,-1.0641,0.34,0.86,-1.0975,0.3,0.7
"C7_Immunologic_signatures:C7_ALL_431_GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_431_GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP",200,-1.453,0.0045,0.013,1.0506,0.32,0.59,-0.8544,0.86,1
"KEGG_pathway:HSA05330_ALLOGRAFT_REJECTION","KEGG_pathway","HSA05330_ALLOGRAFT_REJECTION",35,-1.4528,0.038,0.049,-0.5708,0.99,1,-0.8212,0.78,0.91
"REACTOME:106416_REACT_12596_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE","REACTOME","106416_REACT_12596_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE",16,-1.4528,0.066,0.16,1.1631,0.24,0.49,-1.2682,0.17,0.54
"C3_TF_targets:C3_TFT_235_V_AREB6_02","C3_TF_targets","C3_TFT_235_V_AREB6_02",251,-1.4527,0.0022,0.028,-1.2399,0.048,0.29,-1.1325,0.14,0.47
"GO_BP:508503_GO_0046209_NITRIC_OXIDE_METABOLIC_PROCESS","GO_BP","508503_GO_0046209_NITRIC_OXIDE_METABOLIC_PROCESS",31,-1.4526,0.05,0.13,-0.7201,0.9,1,0.7712,0.84,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2561_VANASSE_BCL2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2561_VANASSE_BCL2_TARGETS_DN",74,-1.4525,0.033,0.081,0.674,0.99,1,0.9939,0.46,0.97
"GO_BP:1184554_GO_1904030_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY","GO_BP","1184554_GO_1904030_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY",27,-1.4525,0.047,0.13,-0.5966,0.98,1,-1.1495,0.24,0.74
"KEGG_pathway:HSA05340_PRIMARY_IMMUNODEFICIENCY","KEGG_pathway","HSA05340_PRIMARY_IMMUNODEFICIENCY",36,-1.4524,0.039,0.048,0.9143,0.61,1,-1.4671,0.054,0.15
"C7_Immunologic_signatures:C7_ALL_1504_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN","C7_Immunologic_signatures","C7_ALL_1504_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN",194,-1.4524,0.0046,0.013,1.3962,0.0098,0.038,-0.9676,0.5,0.8
"WikiPathways:198791_WP1584_TYPE_II_DIABETES_MELLITUS","WikiPathways","198791_WP1584_TYPE_II_DIABETES_MELLITUS",21,-1.4524,0.062,0.089,-1.5254,0.035,0.93,-0.8008,0.78,0.98
"KEGG_pathway:HSA05034_ALCOHOLISM","KEGG_pathway","HSA05034_ALCOHOLISM",171,-1.4524,0.013,0.048,-1.4641,0.0071,0.36,-1.3243,0.03,0.24
"C7_Immunologic_signatures:C7_ALL_674_GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_674_GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDM_DN",197,-1.4523,0.0089,0.013,1.2284,0.067,0.18,0.7988,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_418_CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_418_CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN",23,-1.4522,0.058,0.081,-0.6671,0.92,1,-0.6277,0.96,0.99
"C7_Immunologic_signatures:C7_ALL_1441_GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP","C7_Immunologic_signatures","C7_ALL_1441_GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP",195,-1.4522,0.0056,0.013,1.2178,0.063,0.2,-0.6916,1,1
"GO_BP:512815_GO_0051965_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY","GO_BP","512815_GO_0051965_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY",23,-1.4522,0.046,0.13,-0.9602,0.5,1,-0.7123,0.89,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_39_DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_39_DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP",57,-1.4521,0.027,0.081,1.1705,0.21,0.53,-0.9405,0.56,0.83
"GO_MF:503795_GO_0034594_PHOSPHATIDYLINOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY","GO_MF","503795_GO_0034594_PHOSPHATIDYLINOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY",5,-1.452,0.047,0.17,-1.1747,0.3,0.78,-1.2721,0.22,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_737_BOWIE_RESPONSE_TO_TAMOXIFEN","C2_Chemical_and_genetic_perturbations","C2_CGP_737_BOWIE_RESPONSE_TO_TAMOXIFEN",18,-1.452,0.048,0.081,1.4737,0.039,0.23,-1.362,0.11,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_1423_SASAKI_ADULT_T_CELL_LEUKEMIA","C2_Chemical_and_genetic_perturbations","C2_CGP_1423_SASAKI_ADULT_T_CELL_LEUKEMIA",175,-1.4519,0.0081,0.081,1.2659,0.043,0.42,-1.5548,0,0.27
"GO_BP:506471_GO_0043434_RESPONSE_TO_PEPTIDE_HORMONE","GO_BP","506471_GO_0043434_RESPONSE_TO_PEPTIDE_HORMONE",387,-1.4519,0.0011,0.13,-0.7884,1,1,-1.0272,0.34,0.82
"KEGG_compound:C05576_3_4_DIHYDROXYPHENYLETHYLENEGLYCOL","KEGG_compound","C05576_3_4_DIHYDROXYPHENYLETHYLENEGLYCOL",8,-1.4518,0.07,0.21,0.9806,0.44,1,-1.0129,0.46,0.64
"GO_BP:516639_GO_0071715_ICOSANOID_TRANSPORT","GO_BP","516639_GO_0071715_ICOSANOID_TRANSPORT",16,-1.4518,0.052,0.13,-0.8121,0.71,1,1.2166,0.2,0.71
"GO_BP:755285_GO_2001179_REGULATION_OF_INTERLEUKIN_10_SECRETION","GO_BP","755285_GO_2001179_REGULATION_OF_INTERLEUKIN_10_SECRETION",8,-1.4516,0.079,0.13,-1.0079,0.45,0.98,0.8381,0.65,0.99
"C7_Immunologic_signatures:C7_ALL_1140_GSE2706_2H_VS_8H_LPS_STIM_DC_DN","C7_Immunologic_signatures","C7_ALL_1140_GSE2706_2H_VS_8H_LPS_STIM_DC_DN",189,-1.4515,0.0057,0.013,1.0583,0.29,0.56,-0.9572,0.57,0.83
"C7_Immunologic_signatures:C7_ALL_602_GSE17721_LPS_VS_PAM3CSK4_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_602_GSE17721_LPS_VS_PAM3CSK4_1H_BMDM_DN",198,-1.4515,0.0056,0.013,-0.9034,0.72,1,-1.0816,0.25,0.54
"GO_BP:512778_GO_0051928_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT","GO_BP","512778_GO_0051928_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT",94,-1.4515,0.014,0.14,-0.9283,0.61,1,1.2808,0.08,0.69
"C7_Immunologic_signatures:C7_ALL_627_GSE17721_POLYIC_VS_CPG_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_627_GSE17721_POLYIC_VS_CPG_8H_BMDM_UP",197,-1.4514,0.0022,0.013,-0.8285,0.91,1,-1.0851,0.26,0.53
"REACTOME:106385_REACT_17025_DOWNSTREAM_SIGNAL_TRANSDUCTION","REACTOME","106385_REACT_17025_DOWNSTREAM_SIGNAL_TRANSDUCTION",155,-1.4513,0.0058,0.16,-1.0913,0.24,0.91,-1.2968,0.039,0.54
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_45_BIOCARTA_GCR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_45_BIOCARTA_GCR_PATHWAY",18,-1.4511,0.056,0.16,0.8734,0.63,0.92,-0.9858,0.47,0.79
"C7_Immunologic_signatures:C7_ALL_49_GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_49_GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP",195,-1.4509,0.0034,0.013,1.2968,0.03,0.11,-1.2266,0.049,0.23
"KEGG_compound:C14826_12_13_EPOME_12R_13S_9Z_12_13_EPOXYOCTADECENOIC_ACID","KEGG_compound","C14826_12_13_EPOME_12R_13S_9Z_12_13_EPOXYOCTADECENOIC_ACID",7,-1.4509,0.064,0.21,-0.9797,0.51,1,1.079,0.36,0.62
"GO_MF:498633_GO_0019842_VITAMIN_BINDING","GO_MF","498633_GO_0019842_VITAMIN_BINDING",76,-1.4508,0.02,0.17,-0.9821,0.47,0.93,-1.432,0.018,0.44
"GO_CC:490833_GO_0030141_SECRETORY_GRANULE","GO_CC","490833_GO_0030141_SECRETORY_GRANULE",297,-1.4507,0.0011,0.18,1.3658,0.005,0.33,0.9606,0.6,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_942_THEODOROU_MAMMARY_TUMORIGENESIS","C2_Chemical_and_genetic_perturbations","C2_CGP_942_THEODOROU_MAMMARY_TUMORIGENESIS",27,-1.4506,0.047,0.082,-1.3071,0.13,0.69,1.0921,0.32,0.88
"GO_BP:849877_GO_1902175_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","849877_GO_1902175_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",26,-1.4506,0.048,0.14,0.7664,0.85,1,-1.1581,0.23,0.74
"GO_CC:496379_GO_0016342_CATENIN_COMPLEX","GO_CC","496379_GO_0016342_CATENIN_COMPLEX",9,-1.4506,0.075,0.18,-1.2698,0.2,0.66,-1.2004,0.25,0.79
"GO_BP:510180_GO_0048012_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","510180_GO_0048012_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",6,-1.4505,0.072,0.14,0.7633,0.77,1,0.9572,0.5,0.9
"C6_Oncogenic_signatures:C6_ALL_46_ATM_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_46_ATM_DN_V1_UP",139,-1.4504,0.0083,0.02,-1.2204,0.1,0.41,-1.2651,0.056,0.33
"C2_Chemical_and_genetic_perturbations:C2_CGP_1496_FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1496_FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN",87,-1.4504,0.014,0.082,1.6208,0.0022,0.13,-1.1443,0.21,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_1891_VERRECCHIA_RESPONSE_TO_TGFB1_C4","C2_Chemical_and_genetic_perturbations","C2_CGP_1891_VERRECCHIA_RESPONSE_TO_TGFB1_C4",13,-1.4504,0.061,0.082,-0.7254,0.85,1,-0.7922,0.74,0.96
"C7_Immunologic_signatures:C7_ALL_79_GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP","C7_Immunologic_signatures","C7_ALL_79_GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP",197,-1.4503,0.0045,0.013,0.8095,0.95,1,-1.3522,0.019,0.095
"GO_BP:493619_GO_0009448_GAMMA_AMINOBUTYRIC_ACID_METABOLIC_PROCESS","GO_BP","493619_GO_0009448_GAMMA_AMINOBUTYRIC_ACID_METABOLIC_PROCESS",5,-1.4503,0.073,0.14,0.879,0.59,1,-1.0642,0.4,0.8
"GO_MF:495674_GO_0015485_CHOLESTEROL_BINDING","GO_MF","495674_GO_0015485_CHOLESTEROL_BINDING",37,-1.4503,0.038,0.17,-1.2054,0.19,0.81,1.0988,0.3,0.81
"GO_BP:505042_GO_0035873_LACTATE_TRANSMEMBRANE_TRANSPORT","GO_BP","505042_GO_0035873_LACTATE_TRANSMEMBRANE_TRANSPORT",7,-1.4502,0.059,0.14,-1.0407,0.41,0.98,-0.9394,0.52,0.9
"GO_BP:487844_GO_0001954_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION","GO_BP","487844_GO_0001954_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION",38,-1.4502,0.037,0.14,-1.0618,0.35,0.96,0.952,0.51,0.9
"GO_BP:755152_GO_2001046_POSITIVE_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY","GO_BP","755152_GO_2001046_POSITIVE_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY",7,-1.4502,0.06,0.14,1.1923,0.23,0.79,0.9101,0.58,0.93
"GO_MF:487269_GO_0001046_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING","GO_MF","487269_GO_0001046_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING",84,-1.4501,0.021,0.17,-0.9234,0.62,0.96,-0.8685,0.74,0.91
"KEGG_compound:C02737_PHOSPHATIDYLSERINE_PHOSPHATIDYL_L_SERINE_1_2_DIACYL_SN_GLYCEROL_3_PHOSPHO_L_SERINE_3_O_SN_PHOSPHATIDYL_L_SERINE_O3_PHOSPHATIDYL_L_SERINE_L_1_PHOSPHATIDYLSERINE","KEGG_compound","C02737_PHOSPHATIDYLSERINE_PHOSPHATIDYL_L_SERINE_1_2_DIACYL_SN_GLYCEROL_3_PHOSPHO_L_SERINE_3_O_SN_PHOSPHATIDYL_L_SERINE_O3_PHOSPHATIDYL_L_SERINE_L_1_PHOSPHATIDYLSERINE",8,-1.4499,0.084,0.21,-0.7124,0.83,1,-0.5633,0.96,0.97
"GO_BP:516995_GO_0072078_NEPHRON_TUBULE_MORPHOGENESIS","GO_BP","516995_GO_0072078_NEPHRON_TUBULE_MORPHOGENESIS",62,-1.4498,0.029,0.14,-1.0136,0.4,0.98,1.1,0.27,0.76
"GO_BP:488943_GO_0003149_MEMBRANOUS_SEPTUM_MORPHOGENESIS","GO_BP","488943_GO_0003149_MEMBRANOUS_SEPTUM_MORPHOGENESIS",6,-1.4498,0.063,0.14,-0.9278,0.56,1,-1.189,0.26,0.73
"C3_TF_targets:C3_TFT_55_V_MZF1_01","C3_TF_targets","C3_TFT_55_V_MZF1_01",233,-1.4498,0.0034,0.029,-1.2552,0.065,0.27,0.8607,0.87,1
"C6_Oncogenic_signatures:C6_ALL_139_PDGF_ERK_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_139_PDGF_ERK_DN_V1_DN",146,-1.4496,0.0096,0.02,-1.2955,0.042,0.35,-1.2909,0.045,0.3
"WikiPathways:198885_WP49_IL_2_SIGNALING_PATHWAY","WikiPathways","198885_WP49_IL_2_SIGNALING_PATHWAY",42,-1.4496,0.031,0.09,0.834,0.75,1,-0.7513,0.88,0.95
"GO_BP:503074_GO_0033865_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS","GO_BP","503074_GO_0033865_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS",36,-1.4496,0.044,0.14,0.8542,0.7,1,-1.2176,0.16,0.71
"REACTOME:1127565_REACT_264041_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS","REACTOME","1127565_REACT_264041_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS",29,-1.4496,0.046,0.16,0.804,0.77,1,0.8595,0.69,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1302_MENSSEN_MYC_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1302_MENSSEN_MYC_TARGETS",53,-1.4494,0.033,0.082,1.3939,0.048,0.3,-2.0757,0,0.026
"C2_Chemical_and_genetic_perturbations:C2_CGP_322_MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_322_MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP",20,-1.4492,0.06,0.082,-1.1693,0.24,0.82,-1.0617,0.36,0.68
"C7_Immunologic_signatures:C7_ALL_553_GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_553_GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDM_UP",197,-1.4492,0.0023,0.014,0.7909,0.96,1,-0.9924,0.47,0.74
"GO_BP:508122_GO_0045787_POSITIVE_REGULATION_OF_CELL_CYCLE","GO_BP","508122_GO_0045787_POSITIVE_REGULATION_OF_CELL_CYCLE",289,-1.4491,0,0.14,1.0223,0.37,0.97,-1.4107,0,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1330_IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1330_IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP",12,-1.4491,0.081,0.082,1.378,0.11,0.31,-0.9954,0.49,0.76
"GO_BP:1134004_GO_1903829_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION","GO_BP","1134004_GO_1903829_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION",268,-1.449,0.0033,0.14,0.8201,0.95,1,-1.1692,0.1,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_813_AMUNDSON_GENOTOXIC_SIGNATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_813_AMUNDSON_GENOTOXIC_SIGNATURE",103,-1.4489,0.011,0.082,-1.2448,0.093,0.75,-0.8026,0.89,0.95
"GO_BP:1129551_GO_1903727_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS","GO_BP","1129551_GO_1903727_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS",37,-1.4489,0.042,0.14,-0.6897,0.93,1,1.1051,0.29,0.76
"GO_BP:501543_GO_0032308_POSITIVE_REGULATION_OF_PROSTAGLANDIN_SECRETION","GO_BP","501543_GO_0032308_POSITIVE_REGULATION_OF_PROSTAGLANDIN_SECRETION",11,-1.4489,0.083,0.14,0.643,0.92,1,0.9475,0.53,0.91
"GO_BP:752694_GO_0097193_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","752694_GO_0097193_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",172,-1.4488,0.01,0.14,0.599,1,1,-1.3797,0.012,0.58
"C7_Immunologic_signatures:C7_ALL_603_GSE17721_LPS_VS_PAM3CSK4_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_603_GSE17721_LPS_VS_PAM3CSK4_2H_BMDM_UP",197,-1.4488,0.0067,0.014,1.05,0.32,0.59,-1.056,0.31,0.6
"C4_Cancer_gene_neighborhoods:C4_CGN_99_MORF_ETV3","C4_Cancer_gene_neighborhoods","C4_CGN_99_MORF_ETV3",62,-1.4488,0.025,0.088,-1.3874,0.053,0.47,-0.9237,0.59,1
"C7_Immunologic_signatures:C7_ALL_1226_GSE27786_NKTCELL_VS_MONO_MAC_DN","C7_Immunologic_signatures","C7_ALL_1226_GSE27786_NKTCELL_VS_MONO_MAC_DN",199,-1.4487,0.014,0.014,0.9808,0.52,0.8,-0.886,0.78,0.97
"REACTOME:1183564_REACT_355265_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2","REACTOME","1183564_REACT_355265_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2",143,-1.4486,0.0083,0.16,-1.0792,0.27,0.91,-1.2934,0.048,0.53
"GO_BP:513967_GO_0060411_CARDIAC_SEPTUM_MORPHOGENESIS","GO_BP","513967_GO_0060411_CARDIAC_SEPTUM_MORPHOGENESIS",49,-1.4486,0.051,0.14,-1.0115,0.42,0.98,1.2757,0.11,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2827_WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2827_WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN",14,-1.4482,0.061,0.083,0.6374,0.94,1,1.0388,0.39,0.92
"C4_Cancer_modules:C4_CM_419_MODULE_545","C4_Cancer_modules","C4_CM_419_MODULE_545",18,-1.4481,0.068,0.075,1.1678,0.25,0.44,1.9787,0,0.023
"KEGG_compound:C01352_FADH2","KEGG_compound","C01352_FADH2",14,-1.4481,0.071,0.21,-0.6381,0.94,1,-1.3874,0.095,0.3
"GO_BP:752376_GO_0086004_REGULATION_OF_CARDIAC_MUSCLE_CELL_CONTRACTION","GO_BP","752376_GO_0086004_REGULATION_OF_CARDIAC_MUSCLE_CELL_CONTRACTION",41,-1.4481,0.038,0.14,-0.9536,0.53,1,1.132,0.23,0.74
"C3_TF_targets:C3_TFT_395_V_LEF1_Q6","C3_TF_targets","C3_TFT_395_V_LEF1_Q6",252,-1.4481,0.0022,0.029,-1.0948,0.24,0.56,-1.0565,0.29,0.62
"C7_Immunologic_signatures:C7_ALL_1671_GSE3982_NEUTROPHIL_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_1671_GSE3982_NEUTROPHIL_VS_TH1_UP",193,-1.4481,0.01,0.014,0.6522,1,1,1.1148,0.18,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_888_KIM_MYCL1_AMPLIFICATION_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_888_KIM_MYCL1_AMPLIFICATION_TARGETS_DN",20,-1.448,0.063,0.083,-1.5369,0.035,0.44,-1.1616,0.25,0.56
"GO_BP:511680_GO_0050709_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION","GO_BP","511680_GO_0050709_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION",81,-1.4479,0.027,0.14,0.7532,0.93,1,-0.9168,0.64,0.91
"REACTOME:1183593_REACT_355372_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES","REACTOME","1183593_REACT_355372_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES",34,-1.4479,0.041,0.16,0.8621,0.66,0.94,-0.6056,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1638_RUAN_RESPONSE_TO_TNF_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1638_RUAN_RESPONSE_TO_TNF_UP",12,-1.4478,0.062,0.083,0.6604,0.9,1,1.0338,0.39,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_3237_KATSANOU_ELAVL1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3237_KATSANOU_ELAVL1_TARGETS_DN",144,-1.4478,0.011,0.083,-1.0205,0.41,0.98,-1.0625,0.31,0.68
"GO_BP:498307_GO_0019471_4_HYDROXYPROLINE_METABOLIC_PROCESS","GO_BP","498307_GO_0019471_4_HYDROXYPROLINE_METABOLIC_PROCESS",12,-1.4478,0.072,0.14,-0.7466,0.81,1,-1.3354,0.12,0.62
"C3_TF_targets:C3_TFT_213_V_ETS1_B","C3_TF_targets","C3_TFT_213_V_ETS1_B",260,-1.4478,0.0044,0.029,-1.0959,0.21,0.56,-1.1116,0.17,0.51
"GO_BP:508292_GO_0045992_NEGATIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT","GO_BP","508292_GO_0045992_NEGATIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT",26,-1.4476,0.04,0.14,-1.3261,0.11,0.89,-1.3762,0.09,0.59
"GO_BP:518964_GO_2000318_POSITIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE","GO_BP","518964_GO_2000318_POSITIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE",5,-1.4476,0.06,0.14,-1.3581,0.16,0.96,-1.462,0.09,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_3260_WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK","C2_Chemical_and_genetic_perturbations","C2_CGP_3260_WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK",145,-1.4474,0.0058,0.083,0.7666,0.97,1,-1.294,0.054,0.43
"GO_BP:518611_GO_0097061_DENDRITIC_SPINE_ORGANIZATION","GO_BP","518611_GO_0097061_DENDRITIC_SPINE_ORGANIZATION",16,-1.4474,0.062,0.14,-0.9884,0.46,1,-0.7653,0.79,1
"C0_Hallmark:H_ALL_11_HALLMARK_NOTCH_SIGNALING","C0_Hallmark","H_ALL_11_HALLMARK_NOTCH_SIGNALING",32,-1.4473,0.043,0.019,-1.0903,0.34,0.88,0.9665,0.5,0.67
"REACTOME:106373_REACT_18342_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS","REACTOME","106373_REACT_18342_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS",16,-1.4473,0.074,0.16,1.8233,0.006,0.018,1.0042,0.47,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1831_SESTO_RESPONSE_TO_UV_C0","C2_Chemical_and_genetic_perturbations","C2_CGP_1831_SESTO_RESPONSE_TO_UV_C0",105,-1.4472,0.025,0.083,1.2233,0.11,0.46,-0.9334,0.63,0.84
"C7_Immunologic_signatures:C7_ALL_785_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_785_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP",190,-1.4472,0.0068,0.014,-1.0036,0.43,1,-1.1012,0.22,0.5
"GO_BP:512098_GO_0051195_NEGATIVE_REGULATION_OF_COFACTOR_METABOLIC_PROCESS","GO_BP","512098_GO_0051195_NEGATIVE_REGULATION_OF_COFACTOR_METABOLIC_PROCESS",7,-1.4471,0.055,0.14,-0.725,0.81,1,0.7511,0.76,1
"C7_Immunologic_signatures:C7_ALL_494_GSE17721_CTRL_VS_PAM3CSK4_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_494_GSE17721_CTRL_VS_PAM3CSK4_24H_BMDM_DN",195,-1.4468,0.0023,0.014,1.1886,0.093,0.25,-0.9026,0.73,0.95
"GO_BP:491053_GO_0006068_ETHANOL_CATABOLIC_PROCESS","GO_BP","491053_GO_0006068_ETHANOL_CATABOLIC_PROCESS",6,-1.4468,0.078,0.14,1.2675,0.21,0.71,-1.2918,0.17,0.65
"GO_BP:507924_GO_0045576_MAST_CELL_ACTIVATION","GO_BP","507924_GO_0045576_MAST_CELL_ACTIVATION",22,-1.4468,0.053,0.14,-0.7608,0.81,1,-0.902,0.6,0.92
"GO_BP:492003_GO_0007205_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY","GO_BP","492003_GO_0007205_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",37,-1.4467,0.049,0.14,-1.393,0.056,1,-0.7378,0.9,1
"GO_MF:490624_GO_0005522_PROFILIN_BINDING","GO_MF","490624_GO_0005522_PROFILIN_BINDING",8,-1.4467,0.065,0.18,-0.8645,0.63,1,0.6559,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3185_KASLER_HDAC7_TARGETS_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3185_KASLER_HDAC7_TARGETS_2_DN",32,-1.4467,0.052,0.083,-0.8499,0.68,1,-0.7823,0.82,0.96
"GO_BP:503352_GO_0034146_TOLL_LIKE_RECEPTOR_5_SIGNALING_PATHWAY","GO_BP","503352_GO_0034146_TOLL_LIKE_RECEPTOR_5_SIGNALING_PATHWAY",66,-1.4467,0.026,0.14,-0.6128,0.99,1,-1.0506,0.34,0.81
"GO_BP:501325_GO_0032088_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY","GO_BP","501325_GO_0032088_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY",66,-1.4467,0.024,0.14,-0.8669,0.71,1,-1.0108,0.44,0.84
"GO_BP:495000_GO_0010935_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION","GO_BP","495000_GO_0010935_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION",12,-1.4466,0.077,0.14,-0.7883,0.75,1,0.7118,0.83,1
"C3_TF_targets:C3_TFT_138_V_NF1_Q6","C3_TF_targets","C3_TFT_138_V_NF1_Q6",256,-1.4466,0.0011,0.029,-1.177,0.11,0.39,-1.1891,0.079,0.36
"GO_MF:495378_GO_0015103_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495378_GO_0015103_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",132,-1.4464,0.013,0.18,-1.1016,0.26,0.83,1.0305,0.37,0.86
"REACTOME:119560_REACT_19298_BICARBONATE_TRANSPORTERS","REACTOME","119560_REACT_19298_BICARBONATE_TRANSPORTERS",9,-1.4463,0.078,0.16,-1.1853,0.27,0.86,-1.2152,0.23,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2938_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12","C2_Chemical_and_genetic_perturbations","C2_CGP_2938_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12",77,-1.4462,0.027,0.083,1.2039,0.14,0.48,-1.522,0.0039,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_102_SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_102_SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP",8,-1.4462,0.07,0.083,0.8494,0.66,0.97,1.2027,0.25,0.77
"C3_TF_targets:C3_TFT_108_V_SRY_01","C3_TF_targets","C3_TFT_108_V_SRY_01",220,-1.4461,0.0078,0.029,0.9649,0.57,1,-1.0621,0.26,0.62
"REACTOME:530762_REACT_115529_INTERLEUKIN_7_SIGNALING","REACTOME","530762_REACT_115529_INTERLEUKIN_7_SIGNALING",11,-1.4461,0.085,0.16,0.6244,0.92,1,-1.1108,0.33,0.7
"GO_BP:503084_GO_0033875_RIBONUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS","GO_BP","503084_GO_0033875_RIBONUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS",36,-1.446,0.039,0.14,0.8609,0.73,1,-1.2313,0.16,0.7
"KEGG_enzyme:2.7.1.68_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_DIPHOSPHOINOSITIDE_KINASE_PIP_KINASE_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_KINASE_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_TYPE_I_PIP_KINASE","KEGG_enzyme","2.7.1.68_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_DIPHOSPHOINOSITIDE_KINASE_PIP_KINASE_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_KINASE_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_TYPE_I_PIP_KINASE",5,-1.4459,0.078,0.56,-1.139,0.32,0.57,-1.2854,0.2,0.53
"C6_Oncogenic_signatures:C6_ALL_152_STK33_DN","C6_Oncogenic_signatures","C6_ALL_152_STK33_DN",271,-1.4458,0.0011,0.021,0.91,0.73,0.96,-1.5211,0.0041,0.14
"GO_BP:751068_GO_0036148_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING","GO_BP","751068_GO_0036148_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING",16,-1.4457,0.078,0.14,-0.9723,0.5,1,-1.0631,0.38,0.8
"GO_BP:500132_GO_0030834_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION","GO_BP","500132_GO_0030834_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION",45,-1.4457,0.039,0.14,-1.0772,0.33,0.95,-1.2984,0.085,0.65
"GO_MF:500473_GO_0031210_PHOSPHATIDYLCHOLINE_BINDING","GO_MF","500473_GO_0031210_PHOSPHATIDYLCHOLINE_BINDING",17,-1.4457,0.069,0.18,-1.221,0.21,0.84,-0.7028,0.85,1
"GO_BP:487790_GO_0001894_TISSUE_HOMEOSTASIS","GO_BP","487790_GO_0001894_TISSUE_HOMEOSTASIS",154,-1.4456,0.0083,0.14,-0.9877,0.48,1,1.1224,0.19,0.75
"GO_BP:503534_GO_0034331_CELL_JUNCTION_MAINTENANCE","GO_BP","503534_GO_0034331_CELL_JUNCTION_MAINTENANCE",11,-1.4454,0.068,0.14,-1.7504,0.0038,0.56,1.039,0.4,0.82
"REACTOME:1183570_REACT_252852_SIGNALING_BY_FGFR3","REACTOME","1183570_REACT_252852_SIGNALING_BY_FGFR3",156,-1.4454,0.0058,0.16,-0.9513,0.58,1,-1.2162,0.091,0.59
"C6_Oncogenic_signatures:C6_ALL_29_MTOR_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_29_MTOR_UP_V1_DN",168,-1.4454,0.0035,0.021,-1.0603,0.31,0.61,-1.0368,0.35,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_2_NAKAMURA_CANCER_MICROENVIRONMENT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2_NAKAMURA_CANCER_MICROENVIRONMENT_DN",46,-1.4453,0.038,0.084,-0.9663,0.52,1,-0.8388,0.76,0.93
"REACTOME:576253_REACT_118632_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR","REACTOME","576253_REACT_118632_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR",13,-1.4453,0.074,0.16,-0.8903,0.6,1,0.9422,0.51,1
"GO_BP:506607_GO_0043576_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE","GO_BP","506607_GO_0043576_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE",21,-1.4451,0.061,0.14,-1.5429,0.026,0.74,-1.505,0.025,0.53
"C4_Cancer_modules:C4_CM_101_MODULE_106","C4_Cancer_modules","C4_CM_101_MODULE_106",14,-1.4451,0.068,0.076,-1.4305,0.09,0.48,-0.885,0.59,0.87
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_166_BIOCARTA_HER2_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_166_BIOCARTA_HER2_PATHWAY",22,-1.445,0.056,0.16,-0.8696,0.63,1,0.5762,0.97,0.99
"GO_BP:505749_GO_0042635_POSITIVE_REGULATION_OF_HAIR_CYCLE","GO_BP","505749_GO_0042635_POSITIVE_REGULATION_OF_HAIR_CYCLE",9,-1.4449,0.088,0.14,-1.2208,0.21,0.88,-0.7119,0.86,0.99
"GO_BP:518837_GO_2000189_POSITIVE_REGULATION_OF_CHOLESTEROL_HOMEOSTASIS","GO_BP","518837_GO_2000189_POSITIVE_REGULATION_OF_CHOLESTEROL_HOMEOSTASIS",6,-1.4449,0.08,0.14,-1.4226,0.093,0.94,0.9085,0.57,0.93
"GO_BP:501589_GO_0032354_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE","GO_BP","501589_GO_0032354_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE",11,-1.4449,0.078,0.14,-1.3616,0.12,0.97,0.8021,0.74,1
"C4_Cancer_modules:C4_CM_388_MODULE_488","C4_Cancer_modules","C4_CM_388_MODULE_488",29,-1.4448,0.06,0.076,0.672,0.95,1,0.7622,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2417_MALONEY_RESPONSE_TO_17AAG_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2417_MALONEY_RESPONSE_TO_17AAG_UP",40,-1.4448,0.047,0.084,-1.2148,0.18,0.8,-1.5513,0.013,0.27
"C3_TF_targets:C3_TFT_170_V_NKX25_02","C3_TF_targets","C3_TFT_170_V_NKX25_02",247,-1.4447,0.0033,0.029,-0.9702,0.54,0.82,-1.4031,0.0039,0.3
"C4_Cancer_modules:C4_CM_165_MODULE_175","C4_Cancer_modules","C4_CM_165_MODULE_175",53,-1.4447,0.036,0.076,0.9339,0.59,0.81,-0.8989,0.65,0.84
"C7_Immunologic_signatures:C7_ALL_913_GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP","C7_Immunologic_signatures","C7_ALL_913_GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP",194,-1.4446,0.0034,0.014,0.9641,0.54,0.85,-0.9412,0.61,0.87
"C7_Immunologic_signatures:C7_ALL_585_GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_585_GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDM_UP",193,-1.4446,0.008,0.014,-1.142,0.18,1,-1.311,0.035,0.13
"GO_BP:503607_GO_0034405_RESPONSE_TO_FLUID_SHEAR_STRESS","GO_BP","503607_GO_0034405_RESPONSE_TO_FLUID_SHEAR_STRESS",31,-1.4443,0.052,0.14,-0.5209,0.99,1,0.8349,0.74,0.99
"C7_Immunologic_signatures:C7_ALL_1724_GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1724_GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN",199,-1.4443,0.008,0.014,0.7642,0.98,1,-1.0999,0.23,0.5
"C6_Oncogenic_signatures:C6_ALL_113_EIF4E_DN","C6_Oncogenic_signatures","C6_ALL_113_EIF4E_DN",99,-1.4443,0.022,0.021,-0.828,0.84,0.96,-1.019,0.43,0.62
"C4_Cancer_modules:C4_CM_340_MODULE_407","C4_Cancer_modules","C4_CM_340_MODULE_407",13,-1.4441,0.076,0.076,0.7861,0.77,0.98,1.1064,0.33,0.77
"KEGG_pathway:HSA04146_PEROXISOME","KEGG_pathway","HSA04146_PEROXISOME",82,-1.4441,0.028,0.051,1.2012,0.14,0.56,-1.4477,0.027,0.15
"REACTOME:1183578_REACT_252869_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4","REACTOME","1183578_REACT_252869_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4",143,-1.444,0.014,0.16,-1.0731,0.31,0.9,-1.3024,0.048,0.55
"GO_MF:492526_GO_0008179_ADENYLATE_CYCLASE_BINDING","GO_MF","492526_GO_0008179_ADENYLATE_CYCLASE_BINDING",10,-1.444,0.083,0.18,-0.7183,0.83,1,-1.0295,0.42,0.76
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_200_BIOCARTA_LONGEVITY_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_200_BIOCARTA_LONGEVITY_PATHWAY",15,-1.444,0.071,0.16,1.5398,0.038,0.34,0.9082,0.58,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_872_SIMBULAN_UV_RESPONSE_NORMAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_872_SIMBULAN_UV_RESPONSE_NORMAL_DN",33,-1.444,0.054,0.084,-1.0096,0.44,0.99,1.3774,0.085,0.53
"GO_CC:490909_GO_0030122_AP_2_ADAPTOR_COMPLEX","GO_CC","490909_GO_0030122_AP_2_ADAPTOR_COMPLEX",11,-1.4438,0.087,0.19,0.94,0.53,0.85,0.6704,0.88,1
"GO_BP:516380_GO_0071456_CELLULAR_RESPONSE_TO_HYPOXIA","GO_BP","516380_GO_0071456_CELLULAR_RESPONSE_TO_HYPOXIA",107,-1.4437,0.014,0.14,-0.748,0.96,1,1.0854,0.3,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_341_WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_341_WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN",65,-1.4437,0.021,0.085,1.5033,0.025,0.21,-1.0955,0.29,0.63
"KEGG_compound:C00089_SUCROSE_CANE_SUGAR_SACCHAROSE_1_ALPHA_D_GLUCOPYRANOSYL_2_BETA_D_FRUCTOFURANOSIDE","KEGG_compound","C00089_SUCROSE_CANE_SUGAR_SACCHAROSE_1_ALPHA_D_GLUCOPYRANOSYL_2_BETA_D_FRUCTOFURANOSIDE",5,-1.4436,0.062,0.22,-1.3322,0.15,0.6,-1.0356,0.43,0.61
"GO_BP:508193_GO_0045879_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY","GO_BP","508193_GO_0045879_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY",29,-1.4436,0.065,0.14,-1.0801,0.33,0.95,-1.3036,0.11,0.65
"C4_Cancer_gene_neighborhoods:C4_CGN_406_GNF2_SERPINB5","C4_Cancer_gene_neighborhoods","C4_CGN_406_GNF2_SERPINB5",27,-1.4435,0.06,0.09,0.8077,0.77,0.98,1.5172,0.028,0.19
"C3_TF_targets:C3_TFT_334_V_GATA4_Q3","C3_TF_targets","C3_TFT_334_V_GATA4_Q3",242,-1.4434,0.0011,0.03,-0.8682,0.85,0.99,-0.8834,0.83,0.95
"C3_TF_targets:C3_TFT_375_V_CACBINDINGPROTEIN_Q6","C3_TF_targets","C3_TFT_375_V_CACBINDINGPROTEIN_Q6",236,-1.4434,0.0056,0.029,-1.0527,0.32,0.64,-0.6728,1,1
"GO_BP:911464_GO_1902476_CHLORIDE_TRANSMEMBRANE_TRANSPORT","GO_BP","911464_GO_1902476_CHLORIDE_TRANSMEMBRANE_TRANSPORT",81,-1.4433,0.011,0.14,-0.98,0.5,1,-1.1552,0.21,0.74
"GO_BP:487957_GO_0002067_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","487957_GO_0002067_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION",34,-1.4433,0.047,0.14,-1.0247,0.41,0.97,1.3149,0.1,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_3001_WU_APOPTOSIS_BY_CDKN1A_VIA_TP53","C2_Chemical_and_genetic_perturbations","C2_CGP_3001_WU_APOPTOSIS_BY_CDKN1A_VIA_TP53",55,-1.4432,0.031,0.085,0.7774,0.88,1,-1.5431,0.011,0.27
"GO_BP:500306_GO_0031016_PANCREAS_DEVELOPMENT","GO_BP","500306_GO_0031016_PANCREAS_DEVELOPMENT",73,-1.443,0.03,0.14,0.978,0.48,1,1.3885,0.047,0.63
"C7_Immunologic_signatures:C7_ALL_340_GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_340_GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN",198,-1.443,0.0035,0.015,-0.7227,0.99,1,-1.0796,0.26,0.54
"GO_BP:510439_GO_0048332_MESODERM_MORPHOGENESIS","GO_BP","510439_GO_0048332_MESODERM_MORPHOGENESIS",66,-1.443,0.031,0.14,-1.338,0.064,0.91,-0.875,0.7,0.94
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_187_BIOCARTA_BARRESTIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_187_BIOCARTA_BARRESTIN_PATHWAY",9,-1.4429,0.087,0.16,-1.2667,0.19,1,-1.4763,0.063,0.34
"GO_CC:500162_GO_0030864_CORTICAL_ACTIN_CYTOSKELETON","GO_CC","500162_GO_0030864_CORTICAL_ACTIN_CYTOSKELETON",50,-1.4429,0.032,0.19,-1.0356,0.4,0.84,-1.1282,0.26,0.91
"GO_BP:486719_GO_0000188_INACTIVATION_OF_MAPK_ACTIVITY","GO_BP","486719_GO_0000188_INACTIVATION_OF_MAPK_ACTIVITY",28,-1.4428,0.061,0.14,0.6143,0.98,1,1.1261,0.25,0.74
"GO_MF:499680_GO_0030276_CLATHRIN_BINDING","GO_MF","499680_GO_0030276_CLATHRIN_BINDING",58,-1.4426,0.028,0.18,0.7745,0.9,1,-1.3,0.086,0.57
"GO_CC:492395_GO_0008021_SYNAPTIC_VESICLE","GO_CC","492395_GO_0008021_SYNAPTIC_VESICLE",125,-1.4426,0.011,0.19,1.0788,0.29,0.68,1.0436,0.33,0.96
"GO_BP:515276_GO_0070344_REGULATION_OF_FAT_CELL_PROLIFERATION","GO_BP","515276_GO_0070344_REGULATION_OF_FAT_CELL_PROLIFERATION",7,-1.4425,0.064,0.14,-1.1834,0.26,0.91,-0.7541,0.76,1
"GO_BP:499622_GO_0030212_HYALURONAN_METABOLIC_PROCESS","GO_BP","499622_GO_0030212_HYALURONAN_METABOLIC_PROCESS",29,-1.4425,0.043,0.14,-1.3447,0.097,0.92,0.7233,0.91,1
"C7_Immunologic_signatures:C7_ALL_1278_GSE29618_MONOCYTE_VS_MDC_DN","C7_Immunologic_signatures","C7_ALL_1278_GSE29618_MONOCYTE_VS_MDC_DN",198,-1.4423,0.0069,0.015,1.5937,0,0.0034,-1.2895,0.023,0.15
"REACTOME:1183584_REACT_355474_RHO_GTPASE_EFFECTORS","REACTOME","1183584_REACT_355474_RHO_GTPASE_EFFECTORS",281,-1.4421,0.0011,0.17,-0.8696,0.85,1,-1.4017,0,0.42
"C3_TF_targets:C3_TFT_495_GTTRYCATRR_UNKNOWN","C3_TF_targets","C3_TFT_495_GTTRYCATRR_UNKNOWN",169,-1.4419,0.0057,0.03,-1.2031,0.095,0.35,-1.2543,0.085,0.29
"C3_TF_targets:C3_TFT_59_V_IK2_01","C3_TF_targets","C3_TFT_59_V_IK2_01",262,-1.4415,0.0011,0.03,-1.1454,0.15,0.45,1.0099,0.42,1
"GO_BP:517025_GO_0072109_GLOMERULAR_MESANGIUM_DEVELOPMENT","GO_BP","517025_GO_0072109_GLOMERULAR_MESANGIUM_DEVELOPMENT",7,-1.4413,0.076,0.14,-0.7068,0.83,1,0.509,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_383_LANDIS_BREAST_CANCER_PROGRESSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_383_LANDIS_BREAST_CANCER_PROGRESSION_UP",42,-1.4413,0.041,0.086,1.3589,0.072,0.33,0.6066,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1358_BYSTROEM_CORRELATED_WITH_IL5_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1358_BYSTROEM_CORRELATED_WITH_IL5_UP",51,-1.4411,0.037,0.086,1.0751,0.32,0.67,-0.8732,0.69,0.91
"GO_BP:516322_GO_0071398_CELLULAR_RESPONSE_TO_FATTY_ACID","GO_BP","516322_GO_0071398_CELLULAR_RESPONSE_TO_FATTY_ACID",33,-1.4411,0.048,0.14,0.722,0.92,1,0.9477,0.53,0.91
"C3_TF_targets:C3_TFT_47_V_GATA2_01","C3_TF_targets","C3_TFT_47_V_GATA2_01",103,-1.4409,0.022,0.03,-0.7263,0.97,1,0.9315,0.62,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2923_MIKKELSEN_NPC_LCP_WITH_H3K4ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2923_MIKKELSEN_NPC_LCP_WITH_H3K4ME3",56,-1.4409,0.029,0.086,-0.9454,0.51,1,-0.8797,0.68,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2531_PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_2531_PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION",22,-1.4408,0.059,0.086,1.0932,0.32,0.64,1.496,0.038,0.48
"REACTOME:106448_REACT_13537_P75NTR_SIGNALS_VIA_NF_KB","REACTOME","106448_REACT_13537_P75NTR_SIGNALS_VIA_NF_KB",16,-1.4404,0.066,0.17,1.0773,0.35,0.62,-0.7048,0.86,1
"GO_BP:503069_GO_0033860_REGULATION_OF_NAD_P_H_OXIDASE_ACTIVITY","GO_BP","503069_GO_0033860_REGULATION_OF_NAD_P_H_OXIDASE_ACTIVITY",6,-1.4403,0.07,0.14,0.9062,0.58,1,-0.7076,0.8,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2700_POOLA_INVASIVE_BREAST_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2700_POOLA_INVASIVE_BREAST_CANCER_DN",130,-1.4403,0.0097,0.086,-0.9965,0.46,1,0.9726,0.51,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_783_TERAMOTO_OPN_TARGETS_CLUSTER_1","C2_Chemical_and_genetic_perturbations","C2_CGP_783_TERAMOTO_OPN_TARGETS_CLUSTER_1",12,-1.4403,0.073,0.086,-1.2032,0.24,0.8,-0.618,0.95,0.99
"REACTOME:106395_REACT_9061_TOLL_LIKE_RECEPTOR_5_TLR5_CASCADE","REACTOME","106395_REACT_9061_TOLL_LIKE_RECEPTOR_5_TLR5_CASCADE",86,-1.4403,0.025,0.17,0.6004,1,1,-1.0293,0.38,0.8
"GO_CC:502032_GO_0032809_NEURONAL_CELL_BODY_MEMBRANE","GO_CC","502032_GO_0032809_NEURONAL_CELL_BODY_MEMBRANE",11,-1.4403,0.067,0.19,-1.5024,0.05,0.6,1.2228,0.21,0.82
"GO_BP:508946_GO_0046718_VIRAL_ENTRY_INTO_HOST_CELL","GO_BP","508946_GO_0046718_VIRAL_ENTRY_INTO_HOST_CELL",51,-1.4402,0.035,0.14,-1.0688,0.34,0.96,-1.0335,0.37,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1178_MORI_SMALL_PRE_BII_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1178_MORI_SMALL_PRE_BII_LYMPHOCYTE_UP",86,-1.4401,0.038,0.086,-0.5957,1,1,-1.1338,0.21,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_1624_SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1624_SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP",39,-1.4401,0.034,0.086,0.927,0.58,0.89,1.0211,0.41,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_1039_CAFFAREL_RESPONSE_TO_THC_24HR_5_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1039_CAFFAREL_RESPONSE_TO_THC_24HR_5_DN",59,-1.4401,0.033,0.086,1.1437,0.21,0.56,-0.9239,0.61,0.85
"GO_CC:500378_GO_0031091_PLATELET_ALPHA_GRANULE","GO_CC","500378_GO_0031091_PLATELET_ALPHA_GRANULE",62,-1.44,0.027,0.19,1.8728,0,0.013,1.0265,0.42,1
"GO_BP:492260_GO_0007507_HEART_DEVELOPMENT","GO_BP","492260_GO_0007507_HEART_DEVELOPMENT",423,-1.44,0.001,0.14,-1.0982,0.19,0.95,0.999,0.44,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_1758_KANG_DOXORUBICIN_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1758_KANG_DOXORUBICIN_RESISTANCE_UP",54,-1.4399,0.037,0.086,-1.0117,0.43,0.99,-1.6989,0.002,0.19
"C2_Chemical_and_genetic_perturbations:C2_CGP_26_WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_26_WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN",91,-1.4395,0.022,0.086,0.7657,0.93,1,-1.2246,0.11,0.5
"C2_Chemical_and_genetic_perturbations:C2_CGP_2409_MATTHEWS_AP1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2409_MATTHEWS_AP1_TARGETS",17,-1.4395,0.075,0.086,-1.4638,0.061,0.52,-1.3334,0.14,0.41
"GO_BP:516920_GO_0072001_RENAL_SYSTEM_DEVELOPMENT","GO_BP","516920_GO_0072001_RENAL_SYSTEM_DEVELOPMENT",260,-1.4395,0.0011,0.14,-1.1051,0.22,0.94,1.308,0.021,0.67
"GO_BP:1022093_GO_0098656_ANION_TRANSMEMBRANE_TRANSPORT","GO_BP","1022093_GO_0098656_ANION_TRANSMEMBRANE_TRANSPORT",210,-1.4395,0.0023,0.14,-1.221,0.068,0.88,-1.1207,0.18,0.76
"GO_BP:515500_GO_0070570_REGULATION_OF_NEURON_PROJECTION_REGENERATION","GO_BP","515500_GO_0070570_REGULATION_OF_NEURON_PROJECTION_REGENERATION",10,-1.4393,0.053,0.14,-1.3183,0.15,0.89,1.0238,0.4,0.83
"GO_BP:494824_GO_0010759_POSITIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS","GO_BP","494824_GO_0010759_POSITIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS",7,-1.4392,0.066,0.14,1.3392,0.15,0.62,1.235,0.22,0.7
"GO_BP:503372_GO_0034166_TOLL_LIKE_RECEPTOR_10_SIGNALING_PATHWAY","GO_BP","503372_GO_0034166_TOLL_LIKE_RECEPTOR_10_SIGNALING_PATHWAY",66,-1.4391,0.032,0.14,-0.6048,1,1,-1.0788,0.3,0.8
"GO_BP:499952_GO_0030647_AMINOGLYCOSIDE_ANTIBIOTIC_METABOLIC_PROCESS","GO_BP","499952_GO_0030647_AMINOGLYCOSIDE_ANTIBIOTIC_METABOLIC_PROCESS",9,-1.4391,0.076,0.14,-0.8648,0.64,1,0.8007,0.69,1
"REACTOME:1183557_REACT_355063_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1","REACTOME","1183557_REACT_355063_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1",143,-1.439,0.013,0.17,-1.0766,0.27,0.9,-1.2998,0.053,0.55
"GO_BP:493263_GO_0009062_FATTY_ACID_CATABOLIC_PROCESS","GO_BP","493263_GO_0009062_FATTY_ACID_CATABOLIC_PROCESS",66,-1.439,0.031,0.14,1.0305,0.4,0.97,-1.3321,0.063,0.62
"C3_TF_targets:C3_TFT_479_V_PR_Q2","C3_TF_targets","C3_TFT_479_V_PR_Q2",254,-1.4387,0.0022,0.03,-1.241,0.051,0.29,1.053,0.29,1
"GO_BP:489149_GO_0003357_NORADRENERGIC_NEURON_DIFFERENTIATION","GO_BP","489149_GO_0003357_NORADRENERGIC_NEURON_DIFFERENTIATION",7,-1.4387,0.063,0.14,-1.2606,0.2,0.91,-1.1904,0.25,0.74
"C7_Immunologic_signatures:C7_ALL_1497_GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP","C7_Immunologic_signatures","C7_ALL_1497_GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP",196,-1.4387,0.0092,0.016,-0.8366,0.89,1,-0.9958,0.45,0.73
"REACTOME:106343_REACT_9470_SIGNALING_BY_FGFR","REACTOME","106343_REACT_9470_SIGNALING_BY_FGFR",160,-1.4387,0.0081,0.17,-0.8947,0.72,1,-1.2707,0.058,0.55
"C7_Immunologic_signatures:C7_ALL_1433_GSE360_DC_VS_MAC_L_DONOVANI_UP","C7_Immunologic_signatures","C7_ALL_1433_GSE360_DC_VS_MAC_L_DONOVANI_UP",197,-1.4386,0.0045,0.016,1.1266,0.18,0.37,0.7868,0.97,1
"REACTOME:1183609_REACT_355361_REGULATION_OF_NECROPTOTIC_CELL_DEATH","REACTOME","1183609_REACT_355361_REGULATION_OF_NECROPTOTIC_CELL_DEATH",14,-1.4385,0.072,0.17,-0.3979,1,1,-0.864,0.66,0.97
"REACTOME:187208_REACT_24968_RETINOID_METABOLISM_AND_TRANSPORT","REACTOME","187208_REACT_24968_RETINOID_METABOLISM_AND_TRANSPORT",42,-1.4385,0.05,0.17,0.8482,0.73,0.96,1.0398,0.39,0.97
"C7_Immunologic_signatures:C7_ALL_364_GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN","C7_Immunologic_signatures","C7_ALL_364_GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN",189,-1.4384,0.0056,0.016,-0.8033,0.93,1,0.8244,0.93,1
"GO_BP:754830_GO_1901879_REGULATION_OF_PROTEIN_DEPOLYMERIZATION","GO_BP","754830_GO_1901879_REGULATION_OF_PROTEIN_DEPOLYMERIZATION",73,-1.4383,0.028,0.14,-0.9127,0.64,1,-1.1975,0.17,0.73
"C7_Immunologic_signatures:C7_ALL_104_GSE11924_TH1_VS_TH17_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_104_GSE11924_TH1_VS_TH17_CD4_TCELL_DN",197,-1.4382,0.0056,0.016,-0.8171,0.91,1,-0.7262,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2219_HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2219_HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP",34,-1.4382,0.044,0.087,1.4052,0.056,0.29,0.8706,0.67,1
"GO_BP:494887_GO_0010823_NEGATIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION","GO_BP","494887_GO_0010823_NEGATIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION",38,-1.4382,0.038,0.14,0.7484,0.89,1,1.0067,0.44,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_2243_ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2243_ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN",268,-1.4382,0.0044,0.087,-0.9116,0.73,1,-1.0215,0.39,0.72
"C7_Immunologic_signatures:C7_ALL_587_GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_587_GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_UP",198,-1.438,0.0011,0.016,1.041,0.33,0.61,-1.0037,0.43,0.72
"GO_BP:502843_GO_0033627_CELL_ADHESION_MEDIATED_BY_INTEGRIN","GO_BP","502843_GO_0033627_CELL_ADHESION_MEDIATED_BY_INTEGRIN",12,-1.438,0.083,0.14,-0.6619,0.89,1,0.8776,0.64,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2090_STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2090_STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN",41,-1.438,0.036,0.087,1.1618,0.22,0.54,-0.9439,0.57,0.83
"GO_BP:507253_GO_0044246_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS","GO_BP","507253_GO_0044246_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS",45,-1.438,0.053,0.14,-0.8928,0.66,1,1.1909,0.21,0.72
"C6_Oncogenic_signatures:C6_ALL_182_KRAS_LUNG_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_182_KRAS_LUNG_UP_V1_DN",124,-1.4379,0.012,0.022,-1.2147,0.13,0.41,1.095,0.24,0.37
"GO_BP:491589_GO_0006702_ANDROGEN_BIOSYNTHETIC_PROCESS","GO_BP","491589_GO_0006702_ANDROGEN_BIOSYNTHETIC_PROCESS",15,-1.4378,0.062,0.14,0.6617,0.92,1,0.9373,0.54,0.91
"GO_CC:507585_GO_0045211_POSTSYNAPTIC_MEMBRANE","GO_CC","507585_GO_0045211_POSTSYNAPTIC_MEMBRANE",195,-1.4377,0.0046,0.19,-1.3686,0.021,0.62,1.3486,0.017,0.73
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_86_BIOCARTA_MPR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_86_BIOCARTA_MPR_PATHWAY",33,-1.4377,0.051,0.16,1.276,0.11,0.63,-0.9495,0.54,0.82
"GO_BP:518456_GO_0090316_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT","GO_BP","518456_GO_0090316_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT",205,-1.4377,0.0068,0.14,0.8773,0.83,1,-1.1974,0.084,0.73
"C4_Cancer_gene_neighborhoods:C4_CGN_319_GNF2_AF1Q","C4_Cancer_gene_neighborhoods","C4_CGN_319_GNF2_AF1Q",24,-1.4377,0.066,0.093,-1.4369,0.05,0.38,-1.2022,0.18,0.45
"GO_BP:498280_GO_0019441_TRYPTOPHAN_CATABOLIC_PROCESS_TO_KYNURENINE","GO_BP","498280_GO_0019441_TRYPTOPHAN_CATABOLIC_PROCESS_TO_KYNURENINE",7,-1.4373,0.096,0.14,-1.6729,0.017,0.61,-1.529,0.047,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_1728_BAELDE_DIABETIC_NEPHROPATHY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1728_BAELDE_DIABETIC_NEPHROPATHY_UP",85,-1.4373,0.02,0.088,-0.8537,0.75,1,1.0566,0.31,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_268_UDAYAKUMAR_MED1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_268_UDAYAKUMAR_MED1_TARGETS_DN",237,-1.4372,0,0.088,-0.9525,0.59,1,-1.028,0.38,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_1348_POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1348_POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP",61,-1.4372,0.038,0.088,-0.8271,0.79,1,-1.2664,0.095,0.46
"GO_BP:487511_GO_0001573_GANGLIOSIDE_METABOLIC_PROCESS","GO_BP","487511_GO_0001573_GANGLIOSIDE_METABOLIC_PROCESS",14,-1.4372,0.076,0.14,0.8611,0.67,1,1.2212,0.2,0.71
"C7_Immunologic_signatures:C7_ALL_493_GSE17721_CTRL_VS_PAM3CSK4_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_493_GSE17721_CTRL_VS_PAM3CSK4_24H_BMDM_UP",199,-1.4372,0.0045,0.016,1.5504,0,0.0061,-0.8855,0.8,0.97
"KEGG_reaction:R07056_LINOLEATE_OXYGEN_NADPH_H_12_13_EPOME_NADP_H2O","KEGG_reaction","R07056_LINOLEATE_OXYGEN_NADPH_H_12_13_EPOME_NADP_H2O",7,-1.4372,0.068,0.24,-1.0086,0.44,0.8,1.0967,0.34,0.61
"GO_MF:492794_GO_0008514_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","492794_GO_0008514_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",143,-1.4371,0.012,0.18,-1.1311,0.21,0.81,-1.1175,0.2,0.69
"C7_Immunologic_signatures:C7_ALL_767_GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_767_GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP",190,-1.437,0.0099,0.016,-1.1643,0.14,0.94,-1.2836,0.041,0.15
"GO_BP:499840_GO_0030497_FATTY_ACID_ELONGATION","GO_BP","499840_GO_0030497_FATTY_ACID_ELONGATION",12,-1.437,0.084,0.14,-0.6378,0.92,1,-1.6032,0.032,0.51
"GO_BP:494820_GO_0010755_REGULATION_OF_PLASMINOGEN_ACTIVATION","GO_BP","494820_GO_0010755_REGULATION_OF_PLASMINOGEN_ACTIVATION",10,-1.4369,0.065,0.14,-0.9135,0.58,1,0.8395,0.65,0.99
"REACTOME:106484_REACT_12524_CREB_PHOSPHORYLATION","REACTOME","106484_REACT_12524_CREB_PHOSPHORYLATION",7,-1.4369,0.065,0.17,-1.1459,0.3,0.87,-1.3692,0.12,0.47
"GO_BP:494706_GO_0010642_NEGATIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","494706_GO_0010642_NEGATIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",10,-1.4368,0.066,0.14,-1.2734,0.19,0.89,-1.09,0.32,0.78
"C7_Immunologic_signatures:C7_ALL_1325_GSE30083_SP1_VS_SP2_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1325_GSE30083_SP1_VS_SP2_THYMOCYTE_UP",197,-1.4368,0.0056,0.016,-0.8688,0.82,1,0.9189,0.68,1
"C3_TF_targets:C3_TFT_44_V_E47_02","C3_TF_targets","C3_TFT_44_V_E47_02",244,-1.4366,0.0022,0.031,-1.3224,0.024,0.21,-0.9416,0.65,0.86
"REACTOME:106258_REACT_11088_NICOTINATE_METABOLISM","REACTOME","106258_REACT_11088_NICOTINATE_METABOLISM",11,-1.4366,0.076,0.17,-0.7649,0.8,1,-1.6479,0.018,0.23
"GO_BP:508147_GO_0045824_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE","GO_BP","508147_GO_0045824_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE",32,-1.4366,0.059,0.15,0.787,0.8,1,0.637,0.97,1
"GO_CC:506264_GO_0043196_VARICOSITY","GO_CC","506264_GO_0043196_VARICOSITY",7,-1.4365,0.066,0.19,0.6537,0.87,0.99,0.6598,0.89,1
"WikiPathways:198896_WP1742_TP53_NETWORK","WikiPathways","198896_WP1742_TP53_NETWORK",19,-1.4365,0.079,0.097,-0.5686,0.98,1,-1.1258,0.29,0.57
"KEGG_compound:C03758_DOPAMINE_4_2_AMINOETHYL_1_2_BENZENEDIOL_4_2_AMINOETHYL_BENZENE_1_2_DIOL_3_4_DIHYDROXYPHENETHYLAMINE_2_3_4_DIHYDROXYPHENYL_ETHYLAMINE","KEGG_compound","C03758_DOPAMINE_4_2_AMINOETHYL_1_2_BENZENEDIOL_4_2_AMINOETHYL_BENZENE_1_2_DIOL_3_4_DIHYDROXYPHENETHYLAMINE_2_3_4_DIHYDROXYPHENYL_ETHYLAMINE",8,-1.4364,0.078,0.22,-1.1319,0.34,0.87,-1.724,0.0059,0.061
"C2_Chemical_and_genetic_perturbations:C2_CGP_680_SCHAVOLT_TARGETS_OF_TP53_AND_TP63","C2_Chemical_and_genetic_perturbations","C2_CGP_680_SCHAVOLT_TARGETS_OF_TP53_AND_TP63",16,-1.4364,0.06,0.088,-1.2725,0.17,0.71,-1.0715,0.37,0.67
"GO_BP:491009_GO_0006023_AMINOGLYCAN_BIOSYNTHETIC_PROCESS","GO_BP","491009_GO_0006023_AMINOGLYCAN_BIOSYNTHETIC_PROCESS",102,-1.4364,0.018,0.15,1.0935,0.27,0.91,1.1943,0.14,0.72
"GO_CC:490816_GO_0005788_ENDOPLASMIC_RETICULUM_LUMEN","GO_CC","490816_GO_0005788_ENDOPLASMIC_RETICULUM_LUMEN",187,-1.4363,0.011,0.19,-0.905,0.71,0.96,-1.0248,0.4,1
"GO_BP:1129475_GO_1903649_REGULATION_OF_CYTOPLASMIC_TRANSPORT","GO_BP","1129475_GO_1903649_REGULATION_OF_CYTOPLASMIC_TRANSPORT",374,-1.4361,0.0011,0.15,0.9131,0.8,1,-1.2138,0.043,0.72
"GO_CC:490804_GO_0005774_VACUOLAR_MEMBRANE","GO_CC","490804_GO_0005774_VACUOLAR_MEMBRANE",290,-1.436,0.0022,0.19,0.7498,1,0.98,-0.8245,0.97,1
"GO_BP:993490_GO_1903115_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT","GO_BP","993490_GO_1903115_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT",44,-1.436,0.04,0.15,-0.9128,0.64,1,1.2082,0.18,0.71
"GO_MF:513785_GO_0060229_LIPASE_ACTIVATOR_ACTIVITY","GO_MF","513785_GO_0060229_LIPASE_ACTIVATOR_ACTIVITY",12,-1.4359,0.056,0.19,1.0218,0.46,0.87,-0.7179,0.84,0.99
"GO_BP:507964_GO_0045616_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION","GO_BP","507964_GO_0045616_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION",27,-1.4359,0.067,0.15,-1.1671,0.23,0.91,0.7935,0.8,1
"KEGG_compound:C04006_1D_MYO_INOSITOL_3_PHOSPHATE_D_MYO_INOSITOL_3_PHOSPHATE_MYO_INOSITOL_3_PHOSPHATE_INOSITOL_3_PHOSPHATE_1D_MYO_INOSITOL_3_MONOPHOSPHATE_D_MYO_INOSITOL_3_MONOPHOSPHATE_MYO_INOSITOL_3_MONOPHOSPHATE_INOSITOL_3_MONOPHOSPHATE_1L_MYO_INOSITOL_1_PHOSPHATE_L_MYO_INOSITOL_1_PHOSPHATE","KEGG_compound","C04006_1D_MYO_INOSITOL_3_PHOSPHATE_D_MYO_INOSITOL_3_PHOSPHATE_MYO_INOSITOL_3_PHOSPHATE_INOSITOL_3_PHOSPHATE_1D_MYO_INOSITOL_3_MONOPHOSPHATE_D_MYO_INOSITOL_3_MONOPHOSPHATE_MYO_INOSITOL_3_MONOPHOSPHATE_INOSITOL_3_MONOPHOSPHATE_1L_MYO_INOSITOL_1_PHOSPHATE_L_MYO_INOSITOL_1_PHOSPHATE",6,-1.4359,0.077,0.22,-1.0536,0.42,0.99,-0.848,0.65,0.8
"GO_MF:496707_GO_0016803_ETHER_HYDROLASE_ACTIVITY","GO_MF","496707_GO_0016803_ETHER_HYDROLASE_ACTIVITY",8,-1.4359,0.076,0.19,-1.3329,0.15,0.71,-1.2371,0.21,0.59
"GO_BP:519124_GO_2000484_POSITIVE_REGULATION_OF_INTERLEUKIN_8_SECRETION","GO_BP","519124_GO_2000484_POSITIVE_REGULATION_OF_INTERLEUKIN_8_SECRETION",8,-1.4358,0.077,0.15,1.301,0.18,0.67,1.303,0.17,0.67
"GO_BP:499156_GO_0021877_FOREBRAIN_NEURON_FATE_COMMITMENT","GO_BP","499156_GO_0021877_FOREBRAIN_NEURON_FATE_COMMITMENT",14,-1.4358,0.069,0.15,-1.6426,0.018,0.69,-1.3775,0.11,0.58
"C3_TF_targets:C3_TFT_34_V_HEN1_02","C3_TF_targets","C3_TFT_34_V_HEN1_02",193,-1.4358,0.01,0.031,-1.0254,0.41,0.71,-1.0563,0.3,0.62
"KEGG_compound:C00547_L_NORADRENALINE_NORADRENALINE_NOREPINEPHRINE_ARTERENOL_4_1R_2_AMINO_1_HYDROXYETHYL_1_2_BENZENEDIOL","KEGG_compound","C00547_L_NORADRENALINE_NORADRENALINE_NOREPINEPHRINE_ARTERENOL_4_1R_2_AMINO_1_HYDROXYETHYL_1_2_BENZENEDIOL",5,-1.4357,0.073,0.22,0.5412,0.97,1,-1.4859,0.067,0.23
"GO_BP:512232_GO_0051348_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY","GO_BP","512232_GO_0051348_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY",303,-1.4356,0.0022,0.15,1.2068,0.052,0.78,-0.939,0.65,0.9
"GO_BP:925912_GO_1902563_REGULATION_OF_NEUTROPHIL_ACTIVATION","GO_BP","925912_GO_1902563_REGULATION_OF_NEUTROPHIL_ACTIVATION",5,-1.4356,0.078,0.15,-1.265,0.19,0.9,-1.0912,0.37,0.78
"C3_TF_targets:C3_TFT_94_V_HNF4_01","C3_TF_targets","C3_TFT_94_V_HNF4_01",263,-1.4355,0.0011,0.031,-1.2682,0.034,0.26,-1.3596,0.012,0.28
"GO_BP:500643_GO_0031392_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS","GO_BP","500643_GO_0031392_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS",6,-1.4354,0.068,0.15,-0.6506,0.88,1,-1.5337,0.043,0.54
"WikiPathways:198906_WP536_CALCIUM_REGULATION_IN_THE_CARDIAC_CELL","WikiPathways","198906_WP536_CALCIUM_REGULATION_IN_THE_CARDIAC_CELL",147,-1.4353,0.011,0.097,-0.9247,0.64,1,-1.0449,0.32,0.63
"C3_TF_targets:C3_TFT_410_V_CEBP_Q3","C3_TF_targets","C3_TFT_410_V_CEBP_Q3",246,-1.4353,0.0055,0.031,-0.9976,0.43,0.76,-0.8711,0.84,0.97
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_157_BIOCARTA_P27_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_157_BIOCARTA_P27_PATHWAY",13,-1.4352,0.085,0.16,-0.559,0.96,1,-1.614,0.021,0.31
"GO_MF:490320_GO_0005123_DEATH_RECEPTOR_BINDING","GO_MF","490320_GO_0005123_DEATH_RECEPTOR_BINDING",16,-1.4352,0.058,0.19,0.8135,0.74,1,0.7499,0.8,1
"GO_BP:517416_GO_0072511_DIVALENT_INORGANIC_CATION_TRANSPORT","GO_BP","517416_GO_0072511_DIVALENT_INORGANIC_CATION_TRANSPORT",257,-1.435,0.0032,0.15,-1.2148,0.072,0.88,1.1192,0.17,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_2627_SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM","C2_Chemical_and_genetic_perturbations","C2_CGP_2627_SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM",36,-1.4349,0.054,0.089,-0.9806,0.49,1,-1.0789,0.33,0.66
"GO_BP:509074_GO_0046854_PHOSPHATIDYLINOSITOL_PHOSPHORYLATION","GO_BP","509074_GO_0046854_PHOSPHATIDYLINOSITOL_PHOSPHORYLATION",35,-1.4348,0.062,0.15,-0.7629,0.85,1,-0.6991,0.93,0.99
"GO_BP:488842_GO_0003044_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL","GO_BP","488842_GO_0003044_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL",46,-1.4347,0.039,0.15,-1.0431,0.41,0.98,-1.1666,0.21,0.73
"GO_BP:487651_GO_0001755_NEURAL_CREST_CELL_MIGRATION","GO_BP","487651_GO_0001755_NEURAL_CREST_CELL_MIGRATION",33,-1.4346,0.048,0.15,1.4574,0.037,0.48,1.4832,0.035,0.58
"KEGG_pathway:HSA05217_BASAL_CELL_CARCINOMA","KEGG_pathway","HSA05217_BASAL_CELL_CARCINOMA",54,-1.4346,0.047,0.056,-1.4386,0.056,0.4,0.9759,0.52,1
"GO_BP:507280_GO_0044273_SULFUR_COMPOUND_CATABOLIC_PROCESS","GO_BP","507280_GO_0044273_SULFUR_COMPOUND_CATABOLIC_PROCESS",42,-1.4345,0.061,0.15,0.687,0.96,1,-0.758,0.87,1
"GO_MF:496283_GO_0016209_ANTIOXIDANT_ACTIVITY","GO_MF","496283_GO_0016209_ANTIOXIDANT_ACTIVITY",66,-1.4345,0.018,0.19,1.2077,0.16,0.7,-1.0254,0.4,0.77
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_50_BIOCARTA_CFTR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_50_BIOCARTA_CFTR_PATHWAY",12,-1.4344,0.08,0.16,1.0817,0.34,0.74,-1.2273,0.19,0.59
"REACTOME:833825_REACT_163936_FC_EPSILON_RECEPTOR_FCERI_SIGNALING","REACTOME","833825_REACT_163936_FC_EPSILON_RECEPTOR_FCERI_SIGNALING",171,-1.4343,0.01,0.17,-1.0985,0.24,0.9,-1.3128,0.033,0.55
"KEGG_pathway:HSA00280_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION","KEGG_pathway","HSA00280_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION",47,-1.4343,0.042,0.055,1.0522,0.36,0.81,-1.8352,0,0.024
"C2_Chemical_and_genetic_perturbations:C2_CGP_1240_ONDER_CDH1_TARGETS_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1240_ONDER_CDH1_TARGETS_1_UP",139,-1.4343,0.012,0.089,-0.7383,0.97,1,-0.9233,0.65,0.85
"WikiPathways:198797_WP254_APOPTOSIS","WikiPathways","198797_WP254_APOPTOSIS",83,-1.4342,0.022,0.097,-0.6929,0.98,1,-1.029,0.37,0.64
"C7_Immunologic_signatures:C7_ALL_1045_GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1045_GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP",197,-1.4342,0.0023,0.017,0.7613,0.98,1,-1.2043,0.081,0.27
"KEGG_compound:C05302_2_METHOXY_17BETA_ESTRADIOL_2_METHOXYESTRADIOL_17BETA","KEGG_compound","C05302_2_METHOXY_17BETA_ESTRADIOL_2_METHOXYESTRADIOL_17BETA",20,-1.4341,0.053,0.22,1.8759,0.002,0.017,2.2029,0.002,6.1e-05
"C2_Chemical_and_genetic_perturbations:C2_CGP_3167_VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3167_VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP",87,-1.4341,0.023,0.089,-0.9984,0.46,1,0.8488,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2312_BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2312_BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN",24,-1.434,0.056,0.089,1.0712,0.35,0.68,0.7833,0.78,1
"REACTOME:119557_REACT_19324_PD_1_SIGNALING","REACTOME","119557_REACT_19324_PD_1_SIGNALING",21,-1.4339,0.063,0.17,1.2299,0.19,0.42,-0.9732,0.47,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2741_YAMASHITA_LIVER_CANCER_STEM_CELL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2741_YAMASHITA_LIVER_CANCER_STEM_CELL_UP",47,-1.4339,0.031,0.089,-0.6901,0.94,1,1.0333,0.4,0.93
"GO_BP:488999_GO_0003205_CARDIAC_CHAMBER_DEVELOPMENT","GO_BP","488999_GO_0003205_CARDIAC_CHAMBER_DEVELOPMENT",123,-1.4339,0.014,0.15,-0.9719,0.5,1,1.4683,0.0078,0.58
"GO_BP:500914_GO_0031665_NEGATIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY","GO_BP","500914_GO_0031665_NEGATIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY",9,-1.4338,0.073,0.15,-1.2329,0.21,0.9,-0.6369,0.91,1
"GO_BP:501540_GO_0032305_POSITIVE_REGULATION_OF_ICOSANOID_SECRETION","GO_BP","501540_GO_0032305_POSITIVE_REGULATION_OF_ICOSANOID_SECRETION",15,-1.4338,0.064,0.15,-0.7593,0.82,1,0.9274,0.55,0.92
"GO_BP:517235_GO_0072319_VESICLE_UNCOATING","GO_BP","517235_GO_0072319_VESICLE_UNCOATING",5,-1.4337,0.079,0.15,-0.8054,0.7,1,-1.0736,0.41,0.8
"GO_BP:510865_GO_0048814_REGULATION_OF_DENDRITE_MORPHOGENESIS","GO_BP","510865_GO_0048814_REGULATION_OF_DENDRITE_MORPHOGENESIS",57,-1.4337,0.03,0.15,-1.4731,0.025,0.85,-1.2617,0.12,0.67
"GO_MF:492789_GO_0008509_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","492789_GO_0008509_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",263,-1.4336,0.0044,0.19,-1.1855,0.092,0.79,-1.2042,0.066,0.58
"GO_BP:515228_GO_0070295_RENAL_WATER_ABSORPTION","GO_BP","515228_GO_0070295_RENAL_WATER_ABSORPTION",5,-1.4335,0.072,0.15,0.7226,0.8,1,0.8811,0.59,0.95
"GO_BP:1039946_GO_1903392_NEGATIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION","GO_BP","1039946_GO_1903392_NEGATIVE_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION",12,-1.4333,0.07,0.15,0.9803,0.46,1,-0.7729,0.77,1
"GO_BP:488328_GO_0002455_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN","GO_BP","488328_GO_0002455_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN",36,-1.433,0.053,0.15,0.8626,0.71,1,0.8084,0.79,1
"GO_BP:753715_GO_1900744_REGULATION_OF_P38MAPK_CASCADE","GO_BP","753715_GO_1900744_REGULATION_OF_P38MAPK_CASCADE",13,-1.433,0.067,0.15,-1.2173,0.22,0.88,-1.2198,0.23,0.71
"C3_TF_targets:C3_TFT_595_GGGNNTTTCC_V_NFKB_Q6_01","C3_TF_targets","C3_TFT_595_GGGNNTTTCC_V_NFKB_Q6_01",130,-1.433,0.017,0.032,-1.0263,0.41,0.7,-1.2692,0.059,0.26
"GO_BP:514117_GO_0060562_EPITHELIAL_TUBE_MORPHOGENESIS","GO_BP","514117_GO_0060562_EPITHELIAL_TUBE_MORPHOGENESIS",299,-1.4329,0.0022,0.15,0.95,0.65,1,1.1088,0.17,0.76
"C6_Oncogenic_signatures:C6_ALL_56_E2F3_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_56_E2F3_UP_V1_UP",188,-1.4329,0.0058,0.023,-1.049,0.31,0.57,-1.3018,0.033,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_504_MCBRYAN_PUBERTAL_BREAST_6_7WK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_504_MCBRYAN_PUBERTAL_BREAST_6_7WK_UP",192,-1.4329,0.0035,0.09,0.7526,0.99,1,-0.8479,0.88,0.93
"GO_BP:498078_GO_0019226_TRANSMISSION_OF_NERVE_IMPULSE","GO_BP","498078_GO_0019226_TRANSMISSION_OF_NERVE_IMPULSE",52,-1.4329,0.036,0.15,-1.2306,0.15,0.89,1.2416,0.13,0.71
"GO_BP:505700_GO_0042572_RETINOL_METABOLIC_PROCESS","GO_BP","505700_GO_0042572_RETINOL_METABOLIC_PROCESS",23,-1.4329,0.059,0.15,1.047,0.39,0.95,0.9288,0.56,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_3226_IKEDA_MIR1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3226_IKEDA_MIR1_TARGETS_UP",53,-1.4329,0.033,0.09,0.7868,0.88,1,-0.8205,0.79,0.94
"C3_TF_targets:C3_TFT_434_V_E2F_Q2","C3_TF_targets","C3_TFT_434_V_E2F_Q2",173,-1.4328,0.0093,0.032,1.0869,0.25,1,-1.3524,0.023,0.26
"GO_MF:515223_GO_0070290_N_ACYLPHOSPHATIDYLETHANOLAMINE_SPECIFIC_PHOSPHOLIPASE_D_ACTIVITY","GO_MF","515223_GO_0070290_N_ACYLPHOSPHATIDYLETHANOLAMINE_SPECIFIC_PHOSPHOLIPASE_D_ACTIVITY",5,-1.4327,0.067,0.19,-0.8328,0.66,1,-0.564,0.95,1
"GO_BP:849878_GO_1902176_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","849878_GO_1902176_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",17,-1.4327,0.072,0.15,0.933,0.55,1,-1.2031,0.24,0.73
"GO_BP:515126_GO_0070189_KYNURENINE_METABOLIC_PROCESS","GO_BP","515126_GO_0070189_KYNURENINE_METABOLIC_PROCESS",10,-1.4325,0.087,0.15,-1.3223,0.15,0.89,-1.7439,0.0057,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_1143_AMIT_EGF_RESPONSE_240_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1143_AMIT_EGF_RESPONSE_240_MCF10A",20,-1.4325,0.076,0.09,1.0168,0.42,0.78,1.7059,0.013,0.27
"C3_MicroRNA_targets:C3_MIR_28_CAGTGTT_MIR_141_MIR_200A","C3_MicroRNA_targets","C3_MIR_28_CAGTGTT_MIR_141_MIR_200A",309,-1.4324,0.0011,0.26,-1.2069,0.06,1,-0.9727,0.55,1
"C3_TF_targets:C3_TFT_13_V_HOX13_01","C3_TF_targets","C3_TFT_13_V_HOX13_01",44,-1.4324,0.041,0.032,0.8537,0.73,1,-1.0107,0.43,0.73
"GO_MF:495542_GO_0015298_SOLUTE_CATION_ANTIPORTER_ACTIVITY","GO_MF","495542_GO_0015298_SOLUTE_CATION_ANTIPORTER_ACTIVITY",27,-1.4323,0.048,0.19,-0.9394,0.55,0.95,0.9201,0.59,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_3052_KIM_ALL_DISORDERS_DURATION_CORR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3052_KIM_ALL_DISORDERS_DURATION_CORR_DN",142,-1.4323,0.012,0.09,1.5425,0,0.17,-1.321,0.035,0.41
"KEGG_compound:C04549_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_3_PHOSPHATE_","KEGG_compound","C04549_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_3_PHOSPHATE_",9,-1.4321,0.084,0.22,-1.096,0.34,0.93,-0.9023,0.58,0.76
"C7_Immunologic_signatures:C7_ALL_594_GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_594_GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_DN",199,-1.4321,0.0058,0.017,0.8604,0.86,1,-1.2705,0.051,0.17
"C1_Positional:C1_ALL_156_CHR9Q32","C1_Positional","C1_ALL_156_CHR9Q32",33,-1.432,0.045,0.46,1.0719,0.33,0.67,-0.9018,0.62,0.96
"GO_BP:1026078_GO_1903306_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY","GO_BP","1026078_GO_1903306_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY",7,-1.432,0.073,0.15,-0.8914,0.6,1,1.2161,0.24,0.71
"GO_BP:499895_GO_0030574_COLLAGEN_CATABOLIC_PROCESS","GO_BP","499895_GO_0030574_COLLAGEN_CATABOLIC_PROCESS",73,-1.432,0.029,0.15,-1.0103,0.45,0.98,1.4111,0.033,0.63
"GO_BP:513657_GO_0060099_REGULATION_OF_PHAGOCYTOSIS_ENGULFMENT","GO_BP","513657_GO_0060099_REGULATION_OF_PHAGOCYTOSIS_ENGULFMENT",8,-1.4318,0.089,0.15,-0.6093,0.94,1,-0.7636,0.78,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_916_FURUKAWA_DUSP6_TARGETS_PCI35_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_916_FURUKAWA_DUSP6_TARGETS_PCI35_DN",73,-1.4318,0.031,0.09,0.8503,0.78,0.97,-1.5095,0.015,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_1068_SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1068_SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP",473,-1.4317,0.001,0.09,1.0163,0.4,0.78,-1.0085,0.41,0.74
"GO_MF:504848_GO_0035671_ENONE_REDUCTASE_ACTIVITY","GO_MF","504848_GO_0035671_ENONE_REDUCTASE_ACTIVITY",5,-1.4317,0.066,0.19,-0.7554,0.76,1,0.718,0.81,1
"GO_BP:507999_GO_0045651_POSITIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION","GO_BP","507999_GO_0045651_POSITIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION",12,-1.4316,0.056,0.15,0.4995,0.99,1,-0.9137,0.59,0.92
"GO_BP:495970_GO_0015844_MONOAMINE_TRANSPORT","GO_BP","495970_GO_0015844_MONOAMINE_TRANSPORT",23,-1.4316,0.051,0.15,-0.8517,0.7,1,-1.5365,0.022,0.53
"GO_CC:518610_GO_0097060_SYNAPTIC_MEMBRANE","GO_CC","518610_GO_0097060_SYNAPTIC_MEMBRANE",239,-1.4316,0.0022,0.19,-1.3644,0.016,0.6,1.3323,0.016,0.69
"REACTOME:1127680_REACT_264269_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS","REACTOME","1127680_REACT_264269_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS",39,-1.4315,0.042,0.17,-1.0076,0.45,0.99,1.2001,0.19,0.83
"GO_CC:507560_GO_0045178_BASAL_PART_OF_CELL","GO_CC","507560_GO_0045178_BASAL_PART_OF_CELL",42,-1.4315,0.043,0.19,-1.4727,0.022,0.6,-1.0352,0.37,0.98
"C7_Immunologic_signatures:C7_ALL_1111_GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1111_GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP",180,-1.4314,0.0092,0.017,1.1058,0.22,0.43,-0.8123,0.95,1
"C4_Cancer_modules:C4_CM_252_MODULE_286","C4_Cancer_modules","C4_CM_252_MODULE_286",37,-1.4313,0.055,0.083,0.6727,0.95,1,-1.6916,0.0021,0.081
"C7_Immunologic_signatures:C7_ALL_1143_GSE27786_LSK_VS_LIN_NEG_CELL_UP","C7_Immunologic_signatures","C7_ALL_1143_GSE27786_LSK_VS_LIN_NEG_CELL_UP",200,-1.4313,0.0068,0.017,-0.7441,0.98,1,-1.3475,0.015,0.098
"C2_Chemical_and_genetic_perturbations:C2_CGP_996_MANTOVANI_VIRAL_GPCR_SIGNALING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_996_MANTOVANI_VIRAL_GPCR_SIGNALING_UP",83,-1.4313,0.026,0.09,-0.8122,0.84,1,1.1756,0.17,0.79
"C7_Immunologic_signatures:C7_ALL_706_GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_706_GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDM_DN",198,-1.4312,0.0068,0.017,1.13,0.17,0.36,-0.7205,1,1
"GO_BP:492875_GO_0008626_GRANZYME_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","492875_GO_0008626_GRANZYME_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY",5,-1.4311,0.084,0.15,1.1888,0.29,0.79,-0.9655,0.5,0.88
"GO_CC:499969_GO_0030665_CLATHRIN_COATED_VESICLE_MEMBRANE","GO_CC","499969_GO_0030665_CLATHRIN_COATED_VESICLE_MEMBRANE",73,-1.4311,0.028,0.19,0.8622,0.76,0.91,-0.999,0.43,1
"GO_BP:516140_GO_0071214_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS","GO_BP","516140_GO_0071214_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS",242,-1.431,0.011,0.15,-0.7197,1,1,-1.2256,0.055,0.71
"REACTOME:106115_REACT_1319_FATTY_ACYL_COA_BIOSYNTHESIS","REACTOME","106115_REACT_1319_FATTY_ACYL_COA_BIOSYNTHESIS",24,-1.4309,0.054,0.17,0.4697,1,1,-1.4448,0.06,0.38
"GO_BP:518416_GO_0090276_REGULATION_OF_PEPTIDE_HORMONE_SECRETION","GO_BP","518416_GO_0090276_REGULATION_OF_PEPTIDE_HORMONE_SECRETION",188,-1.4309,0.0059,0.15,-0.8636,0.84,1,0.8898,0.78,0.95
"REACTOME:1183571_REACT_97307_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3","REACTOME","1183571_REACT_97307_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3",143,-1.4308,0.012,0.17,-1.072,0.32,0.9,-1.2945,0.033,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_135_CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_135_CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP",118,-1.4307,0.02,0.091,0.879,0.74,0.94,-1.0134,0.41,0.73
"GO_BP:752801_GO_0097300_PROGRAMMED_NECROTIC_CELL_DEATH","GO_BP","752801_GO_0097300_PROGRAMMED_NECROTIC_CELL_DEATH",25,-1.4306,0.061,0.15,-0.6898,0.9,1,-1.3,0.13,0.65
"C7_Immunologic_signatures:C7_ALL_1496_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN","C7_Immunologic_signatures","C7_ALL_1496_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN",199,-1.4305,0.012,0.018,-0.6751,1,1,-0.9833,0.5,0.76
"REACTOME:106389_REACT_9027_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE","REACTOME","106389_REACT_9027_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE",86,-1.4304,0.024,0.17,0.6128,1,1,-1.0237,0.39,0.8
"GO_BP:487933_GO_0002043_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS","GO_BP","487933_GO_0002043_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS",6,-1.4304,0.073,0.15,-1.0472,0.43,0.97,-0.8556,0.64,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2717_BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2717_BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP",11,-1.4303,0.083,0.091,-0.5493,0.97,1,-1.5186,0.043,0.29
"GO_CC:503560_GO_0034358_PLASMA_LIPOPROTEIN_PARTICLE","GO_CC","503560_GO_0034358_PLASMA_LIPOPROTEIN_PARTICLE",37,-1.4301,0.052,0.19,1.1252,0.29,0.61,1.4578,0.034,0.66
"GO_CC:495141_GO_0014069_POSTSYNAPTIC_DENSITY","GO_CC","495141_GO_0014069_POSTSYNAPTIC_DENSITY",129,-1.4299,0.0083,0.19,-1.0796,0.28,0.81,1.0251,0.4,0.98
"GO_BP:511818_GO_0050880_REGULATION_OF_BLOOD_VESSEL_SIZE","GO_BP","511818_GO_0050880_REGULATION_OF_BLOOD_VESSEL_SIZE",69,-1.4298,0.026,0.15,1.2521,0.1,0.73,1.1404,0.2,0.73
"GO_MF:498647_GO_0019863_IGE_BINDING","GO_MF","498647_GO_0019863_IGE_BINDING",5,-1.4298,0.066,0.19,-1.4581,0.075,0.61,-1.0632,0.41,0.74
"C3_TF_targets:C3_TFT_275_V_POU6F1_01","C3_TF_targets","C3_TFT_275_V_POU6F1_01",226,-1.4298,0.0057,0.032,0.9646,0.57,1,1.0413,0.33,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3181_WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2","C2_Chemical_and_genetic_perturbations","C2_CGP_3181_WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2",55,-1.4298,0.035,0.091,-1.0325,0.41,0.98,0.8099,0.81,1
"GO_BP:491010_GO_0006024_GLYCOSAMINOGLYCAN_BIOSYNTHETIC_PROCESS","GO_BP","491010_GO_0006024_GLYCOSAMINOGLYCAN_BIOSYNTHETIC_PROCESS",101,-1.4298,0.016,0.15,1.078,0.29,0.93,1.1646,0.16,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1340_SHIPP_DLBCL_CURED_VS_FATAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1340_SHIPP_DLBCL_CURED_VS_FATAL_UP",39,-1.4298,0.053,0.091,-0.9443,0.55,1,-1.1835,0.2,0.53
"C7_Immunologic_signatures:C7_ALL_882_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_882_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN",191,-1.4297,0.008,0.018,-1.073,0.28,1,-0.9396,0.62,0.88
"GO_BP:508850_GO_0046596_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL","GO_BP","508850_GO_0046596_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL",24,-1.4296,0.088,0.15,1.4251,0.058,0.52,-0.8672,0.67,0.95
"GO_BP:507711_GO_0045354_REGULATION_OF_INTERFERON_ALPHA_BIOSYNTHETIC_PROCESS","GO_BP","507711_GO_0045354_REGULATION_OF_INTERFERON_ALPHA_BIOSYNTHETIC_PROCESS",5,-1.4296,0.065,0.15,-0.6555,0.87,1,-1.0109,0.46,0.84
"GO_BP:509096_GO_0046885_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS","GO_BP","509096_GO_0046885_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS",21,-1.4296,0.059,0.15,0.7445,0.84,1,0.8274,0.71,1
"C3_TF_targets:C3_TFT_188_V_AML1_01","C3_TF_targets","C3_TFT_188_V_AML1_01",261,-1.4295,0.0044,0.032,-1.1348,0.15,0.47,0.8627,0.91,1
"GO_BP:494823_GO_0010758_REGULATION_OF_MACROPHAGE_CHEMOTAXIS","GO_BP","494823_GO_0010758_REGULATION_OF_MACROPHAGE_CHEMOTAXIS",11,-1.4294,0.071,0.15,1.1503,0.27,0.84,1.5061,0.058,0.55
"KEGG_compound:C00154_PALMITOYL_COA_HEXADECANOYL_COA","KEGG_compound","C00154_PALMITOYL_COA_HEXADECANOYL_COA",30,-1.4294,0.055,0.23,-0.7117,0.89,1,0.926,0.57,0.77
"C4_Cancer_modules:C4_CM_186_MODULE_199","C4_Cancer_modules","C4_CM_186_MODULE_199",57,-1.4294,0.028,0.083,-0.9053,0.63,0.89,-1.0879,0.3,0.55
"GO_BP:491907_GO_0007088_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION","GO_BP","491907_GO_0007088_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION",125,-1.4294,0.0085,0.15,-0.9416,0.59,1,-0.9429,0.57,0.89
"C4_Cancer_modules:C4_CM_399_MODULE_509","C4_Cancer_modules","C4_CM_399_MODULE_509",14,-1.4293,0.075,0.083,0.6116,0.94,1,-1.1106,0.3,0.52
"C7_Immunologic_signatures:C7_ALL_832_GSE18148_CBFB_KO_VS_WT_TREG_DN","C7_Immunologic_signatures","C7_ALL_832_GSE18148_CBFB_KO_VS_WT_TREG_DN",195,-1.4292,0.0068,0.018,0.7988,0.96,1,-0.9443,0.6,0.87
"GO_BP:518149_GO_0090002_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE","GO_BP","518149_GO_0090002_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",67,-1.4291,0.028,0.15,-0.7664,0.9,1,-0.6777,0.98,1
"C7_Immunologic_signatures:C7_ALL_1249_GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1249_GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP",166,-1.4287,0.012,0.018,-1.0965,0.24,1,-1.0868,0.25,0.53
"REACTOME:106397_REACT_9047_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE","REACTOME","106397_REACT_9047_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE",93,-1.4287,0.019,0.17,-0.5369,1,1,-1.1741,0.17,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1662_SU_SALIVARY_GLAND","C2_Chemical_and_genetic_perturbations","C2_CGP_1662_SU_SALIVARY_GLAND",15,-1.4286,0.059,0.092,-0.8346,0.7,1,-1.7279,0.0097,0.16
"GO_BP:501980_GO_0032754_POSITIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION","GO_BP","501980_GO_0032754_POSITIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION",7,-1.4285,0.083,0.15,-1.0613,0.39,0.96,-1.1355,0.33,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1135_AMIT_EGF_RESPONSE_60_HELA","C2_Chemical_and_genetic_perturbations","C2_CGP_1135_AMIT_EGF_RESPONSE_60_HELA",45,-1.4285,0.041,0.092,-0.9113,0.62,1,-1.0916,0.31,0.64
"GO_BP:753433_GO_1900449_REGULATION_OF_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","753433_GO_1900449_REGULATION_OF_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY",29,-1.4285,0.057,0.15,-1.5338,0.036,0.77,-0.9186,0.58,0.91
"GO_BP:751564_GO_0044351_MACROPINOCYTOSIS","GO_BP","751564_GO_0044351_MACROPINOCYTOSIS",6,-1.4284,0.083,0.15,-1.3062,0.17,0.88,-0.9362,0.52,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2949_MOOTHA_GLYCOGEN_METABOLISM","C2_Chemical_and_genetic_perturbations","C2_CGP_2949_MOOTHA_GLYCOGEN_METABOLISM",21,-1.4284,0.067,0.092,1.0009,0.41,0.8,-1.0446,0.38,0.7
"C3_TF_targets:C3_TFT_400_V_AML1_Q6","C3_TF_targets","C3_TFT_400_V_AML1_Q6",261,-1.4284,0.0033,0.033,-1.1403,0.14,0.45,0.8656,0.88,1
"REACTOME:119569_REACT_19372_ORGANIC_ANION_TRANSPORTERS","REACTOME","119569_REACT_19372_ORGANIC_ANION_TRANSPORTERS",8,-1.4283,0.086,0.17,0.9658,0.52,0.8,-1.3069,0.15,0.55
"GO_BP:510696_GO_0048640_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH","GO_BP","510696_GO_0048640_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH",71,-1.4282,0.029,0.15,-1.3372,0.06,0.9,1.1461,0.23,0.73
"GO_BP:752561_GO_0090504_EPIBOLY","GO_BP","752561_GO_0090504_EPIBOLY",20,-1.4282,0.067,0.15,-0.7478,0.83,1,-0.9125,0.59,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_95_WILCOX_RESPONSE_TO_PROGESTERONE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_95_WILCOX_RESPONSE_TO_PROGESTERONE_DN",64,-1.4281,0.035,0.092,-1.1494,0.2,0.85,1.2305,0.14,0.73
"GO_BP:498821_GO_0021537_TELENCEPHALON_DEVELOPMENT","GO_BP","498821_GO_0021537_TELENCEPHALON_DEVELOPMENT",200,-1.4281,0.0079,0.15,-1.1413,0.16,0.93,1.1694,0.11,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_408_BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_408_BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN",29,-1.4279,0.056,0.092,-1.0559,0.37,0.96,-0.8608,0.71,0.92
"C7_Immunologic_signatures:C7_ALL_705_GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_705_GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDM_UP",198,-1.4279,0.0034,0.018,-0.7612,0.98,1,-0.9613,0.55,0.82
"GO_BP:488702_GO_0002829_NEGATIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE","GO_BP","488702_GO_0002829_NEGATIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE",9,-1.4278,0.086,0.15,1.0676,0.38,0.93,-1.3627,0.13,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_2251_HOQUE_METHYLATED_IN_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_2251_HOQUE_METHYLATED_IN_CANCER",55,-1.4278,0.039,0.092,1.1693,0.19,0.53,-0.911,0.62,0.87
"REACTOME:576254_REACT_118707_REGULATION_OF_COMPLEMENT_CASCADE","REACTOME","576254_REACT_118707_REGULATION_OF_COMPLEMENT_CASCADE",23,-1.4277,0.07,0.17,-0.835,0.71,1,1.2584,0.17,0.78
"GO_BP:495860_GO_0015727_LACTATE_TRANSPORT","GO_BP","495860_GO_0015727_LACTATE_TRANSPORT",7,-1.4277,0.069,0.15,-1.032,0.43,0.98,-0.9177,0.55,0.91
"C4_Cancer_gene_neighborhoods:C4_CGN_307_GNF2_PCNA","C4_Cancer_gene_neighborhoods","C4_CGN_307_GNF2_PCNA",68,-1.4276,0.039,0.1,1.2214,0.13,0.19,-1.9827,0,0.0043
"GO_BP:506967_GO_0043949_REGULATION_OF_CAMP_MEDIATED_SIGNALING","GO_BP","506967_GO_0043949_REGULATION_OF_CAMP_MEDIATED_SIGNALING",22,-1.4276,0.067,0.15,-0.7479,0.84,1,-1.6935,0.0083,0.61
"GO_BP:489048_GO_0003254_REGULATION_OF_MEMBRANE_DEPOLARIZATION","GO_BP","489048_GO_0003254_REGULATION_OF_MEMBRANE_DEPOLARIZATION",36,-1.4276,0.052,0.15,-0.9748,0.49,1,-0.7186,0.91,0.99
"GO_MF:495383_GO_0015108_CHLORIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495383_GO_0015108_CHLORIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",82,-1.4274,0.033,0.19,-0.9734,0.51,0.94,1.0685,0.31,0.82
"GO_BP:511660_GO_0050688_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS","GO_BP","511660_GO_0050688_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS",83,-1.4274,0.02,0.15,0.7629,0.94,1,-1.707,0,0.63
"REACTOME:205107_REACT_27215_MYD88_CASCADE_INITIATED_ON_PLASMA_MEMBRANE","REACTOME","205107_REACT_27215_MYD88_CASCADE_INITIATED_ON_PLASMA_MEMBRANE",86,-1.4273,0.03,0.17,0.6062,1,1,-1.007,0.44,0.82
"GO_MF:505729_GO_0042609_CD4_RECEPTOR_BINDING","GO_MF","505729_GO_0042609_CD4_RECEPTOR_BINDING",5,-1.4273,0.066,0.19,-0.5793,0.94,1,-1.2897,0.19,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2919_MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2919_MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3",202,-1.4272,0.0079,0.092,-1.3142,0.029,0.7,0.9999,0.47,0.96
"GO_BP:516400_GO_0071476_CELLULAR_HYPOTONIC_RESPONSE","GO_BP","516400_GO_0071476_CELLULAR_HYPOTONIC_RESPONSE",7,-1.4272,0.075,0.15,0.485,0.99,1,-1.0209,0.45,0.83
"REACTOME:106276_REACT_2086_PURINE_CATABOLISM","REACTOME","106276_REACT_2086_PURINE_CATABOLISM",10,-1.4272,0.078,0.17,-0.9621,0.49,1,-0.694,0.87,1
"GO_BP:492548_GO_0008207_C21_STEROID_HORMONE_METABOLIC_PROCESS","GO_BP","492548_GO_0008207_C21_STEROID_HORMONE_METABOLIC_PROCESS",25,-1.4272,0.056,0.15,-0.8211,0.74,1,1.1043,0.32,0.76
"C3_TF_targets:C3_TFT_531_TTTNNANAGCYR_UNKNOWN","C3_TF_targets","C3_TFT_531_TTTNNANAGCYR_UNKNOWN",132,-1.4271,0.0098,0.033,-1.2073,0.13,0.34,-1.3272,0.045,0.26
"C2_Chemical_and_genetic_perturbations:C2_CGP_853_DAIRKEE_TERT_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_853_DAIRKEE_TERT_TARGETS_DN",122,-1.427,0.016,0.093,0.9185,0.67,0.9,-1.0101,0.42,0.74
"GO_MF:492498_GO_0008146_SULFOTRANSFERASE_ACTIVITY","GO_MF","492498_GO_0008146_SULFOTRANSFERASE_ACTIVITY",48,-1.427,0.039,0.19,2.0062,0,0.013,1.6521,0.0082,0.25
"GO_BP:501725_GO_0032493_RESPONSE_TO_BACTERIAL_LIPOPROTEIN","GO_BP","501725_GO_0032493_RESPONSE_TO_BACTERIAL_LIPOPROTEIN",6,-1.4268,0.084,0.15,0.7148,0.81,1,0.8709,0.63,0.97
"GO_BP:508438_GO_0051198_NEGATIVE_REGULATION_OF_COENZYME_METABOLIC_PROCESS","GO_BP","508438_GO_0051198_NEGATIVE_REGULATION_OF_COENZYME_METABOLIC_PROCESS",7,-1.4267,0.068,0.15,-0.7278,0.83,1,0.7397,0.79,1
"C4_Cancer_gene_neighborhoods:C4_CGN_27_MORF_NF1","C4_Cancer_gene_neighborhoods","C4_CGN_27_MORF_NF1",162,-1.4267,0.016,0.1,-1.2661,0.051,0.55,-1.2483,0.058,0.37
"KEGG_pathway:HSA05320_AUTOIMMUNE_THYROID_DISEASE","KEGG_pathway","HSA05320_AUTOIMMUNE_THYROID_DISEASE",46,-1.4266,0.05,0.059,-0.6316,0.97,1,0.6418,0.97,1
"C3_TF_targets:C3_TFT_306_V_STAT4_01","C3_TF_targets","C3_TFT_306_V_STAT4_01",255,-1.4265,0.0044,0.033,0.832,0.95,1,0.9883,0.52,1
"GO_BP:506198_GO_0043124_NEGATIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING","GO_BP","506198_GO_0043124_NEGATIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING",47,-1.4265,0.048,0.15,-0.538,1,1,-0.7566,0.9,1
"GO_BP:487807_GO_0001916_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY","GO_BP","487807_GO_0001916_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY",22,-1.4265,0.06,0.15,-0.752,0.85,1,-0.9066,0.58,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_3239_WANG_THOC1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3239_WANG_THOC1_TARGETS_DN",20,-1.4265,0.069,0.093,1.335,0.11,0.36,0.9844,0.47,0.97
"REACTOME:106337_REACT_9417_SIGNALING_BY_EGFR","REACTOME","106337_REACT_9417_SIGNALING_BY_EGFR",173,-1.4265,0.015,0.17,-0.9486,0.61,1,-1.1501,0.16,0.66
"KEGG_compound:C13747_1_7_DIMETHYLXANTHINE_PARAXANTHINE","KEGG_compound","C13747_1_7_DIMETHYLXANTHINE_PARAXANTHINE",5,-1.4264,0.08,0.23,-0.708,0.82,1,1.2739,0.21,0.45
"GO_BP:487485_GO_0001547_ANTRAL_OVARIAN_FOLLICLE_GROWTH","GO_BP","487485_GO_0001547_ANTRAL_OVARIAN_FOLLICLE_GROWTH",5,-1.4263,0.072,0.15,-1.3421,0.14,0.92,-0.7906,0.71,0.99
"OMIM_gene:OMIM606945_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_LDLR","OMIM_gene","OMIM606945_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_LDLR",5,-1.4263,0.078,1,-0.7454,0.79,1,-0.8164,0.68,0.95
"GO_BP:518644_GO_0097094_CRANIOFACIAL_SUTURE_MORPHOGENESIS","GO_BP","518644_GO_0097094_CRANIOFACIAL_SUTURE_MORPHOGENESIS",15,-1.4262,0.062,0.15,-1.022,0.44,0.97,-0.8895,0.59,0.93
"C7_Immunologic_signatures:C7_ALL_1100_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN","C7_Immunologic_signatures","C7_ALL_1100_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN",199,-1.4261,0.012,0.019,0.7609,1,1,-1.2996,0.021,0.14
"C2_Chemical_and_genetic_perturbations:C2_CGP_730_KOBAYASHI_RESPONSE_TO_ROMIDEPSIN","C2_Chemical_and_genetic_perturbations","C2_CGP_730_KOBAYASHI_RESPONSE_TO_ROMIDEPSIN",19,-1.4261,0.073,0.093,-1.5226,0.031,0.45,-1.724,0.01,0.16
"GO_BP:516309_GO_0071385_CELLULAR_RESPONSE_TO_GLUCOCORTICOID_STIMULUS","GO_BP","516309_GO_0071385_CELLULAR_RESPONSE_TO_GLUCOCORTICOID_STIMULUS",37,-1.426,0.058,0.15,0.9289,0.57,1,1.1412,0.26,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2419_CUI_GLUCOSE_DEPRIVATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2419_CUI_GLUCOSE_DEPRIVATION",60,-1.426,0.041,0.093,0.7495,0.92,1,-1.109,0.25,0.62
"C7_Immunologic_signatures:C7_ALL_519_GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_519_GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDM_UP",196,-1.4257,0.0046,0.019,1.1556,0.13,0.31,-1.0349,0.35,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1716_CUI_TCF21_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1716_CUI_TCF21_TARGETS_DN",31,-1.4257,0.056,0.093,-1.2519,0.16,0.74,-1.3443,0.088,0.4
"GO_BP:514645_GO_0061097_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY","GO_BP","514645_GO_0061097_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY",58,-1.4255,0.043,0.15,-0.7247,0.94,1,0.8569,0.73,0.97
"GO_BP:518172_GO_0090025_REGULATION_OF_MONOCYTE_CHEMOTAXIS","GO_BP","518172_GO_0090025_REGULATION_OF_MONOCYTE_CHEMOTAXIS",17,-1.4254,0.062,0.15,1.3505,0.11,0.61,1.8098,0.01,0.27
"GO_BP:487893_GO_0002003_ANGIOTENSIN_MATURATION","GO_BP","487893_GO_0002003_ANGIOTENSIN_MATURATION",12,-1.4254,0.083,0.15,1.4827,0.063,0.44,0.783,0.75,1
"C3_TF_targets:C3_TFT_401_V_P53_DECAMER_Q2","C3_TF_targets","C3_TFT_401_V_P53_DECAMER_Q2",254,-1.4253,0.0033,0.033,-1.1229,0.18,0.49,-1.0162,0.39,0.72
"KEGG_compound:C14825_9_10_EPOME_9R_10S_12Z_9_10_EPOXYOCTADECENOIC_ACID","KEGG_compound","C14825_9_10_EPOME_9R_10S_12Z_9_10_EPOXYOCTADECENOIC_ACID",7,-1.4253,0.079,0.23,-0.9821,0.48,1,1.0744,0.37,0.61
"C7_Immunologic_signatures:C7_ALL_1558_GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1558_GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN",194,-1.4252,0.0069,0.019,-0.758,0.99,1,-0.9105,0.73,0.93
"C7_Immunologic_signatures:C7_ALL_391_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_391_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP",197,-1.4252,0.008,0.019,-1.0344,0.37,1,-1.0625,0.31,0.59
"GO_BP:508483_GO_0046185_ALDEHYDE_CATABOLIC_PROCESS","GO_BP","508483_GO_0046185_ALDEHYDE_CATABOLIC_PROCESS",10,-1.4251,0.073,0.15,1.6734,0.02,0.22,-1.1601,0.29,0.73
"REACTOME:106555_REACT_2204_RNA_POLYMERASE_I_CHAIN_ELONGATION","REACTOME","106555_REACT_2204_RNA_POLYMERASE_I_CHAIN_ELONGATION",86,-1.425,0.031,0.17,-1.4778,0.0092,0.45,-1.4178,0.025,0.39
"C2_Chemical_and_genetic_perturbations:C2_CGP_2706_BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2706_BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN",40,-1.4249,0.056,0.094,1.358,0.079,0.33,-1.0577,0.36,0.68
"GO_BP:493713_GO_0009582_DETECTION_OF_ABIOTIC_STIMULUS","GO_BP","493713_GO_0009582_DETECTION_OF_ABIOTIC_STIMULUS",180,-1.4248,0.011,0.15,-1.2527,0.072,0.91,-1.1691,0.12,0.73
"KEGG_compound:C00071_ALDEHYDE_RCHO","KEGG_compound","C00071_ALDEHYDE_RCHO",13,-1.4247,0.075,0.23,-0.9083,0.58,1,-1.0884,0.32,0.55
"GO_BP:504347_GO_0035162_EMBRYONIC_HEMOPOIESIS","GO_BP","504347_GO_0035162_EMBRYONIC_HEMOPOIESIS",25,-1.4246,0.065,0.15,1.1817,0.22,0.8,-0.6881,0.92,0.99
"KEGG_compound:C00221_BETA_D_GLUCOSE","KEGG_compound","C00221_BETA_D_GLUCOSE",7,-1.4244,0.088,0.23,-0.9395,0.53,1,-1.0752,0.38,0.55
"GO_BP:1134002_GO_1903827_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION","GO_BP","1134002_GO_1903827_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION",422,-1.4244,0.001,0.15,0.765,1,1,-1.2808,0.0062,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_205_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_205_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP",23,-1.4243,0.06,0.094,-0.7234,0.89,1,-0.9713,0.51,0.79
"GO_BP:512776_GO_0051926_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT","GO_BP","512776_GO_0051926_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT",40,-1.4243,0.047,0.15,-0.7468,0.87,1,0.8651,0.7,0.97
"C7_Immunologic_signatures:C7_ALL_1087_GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1087_GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP",193,-1.4243,0.0093,0.019,0.7161,1,1,-1.0544,0.3,0.6
"GO_BP:503812_GO_0034612_RESPONSE_TO_TUMOR_NECROSIS_FACTOR","GO_BP","503812_GO_0034612_RESPONSE_TO_TUMOR_NECROSIS_FACTOR",117,-1.4242,0.012,0.15,0.9639,0.55,1,1.2983,0.052,0.67
"REACTOME:645343_REACT_121284_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM","REACTOME","645343_REACT_121284_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM",13,-1.424,0.093,0.17,-1.2262,0.23,0.79,-1.9211,0,0.12
"GO_BP:491593_GO_0006706_STEROID_CATABOLIC_PROCESS","GO_BP","491593_GO_0006706_STEROID_CATABOLIC_PROCESS",23,-1.424,0.062,0.15,1.0652,0.35,0.93,1.1373,0.28,0.73
"C1_Positional:C1_ALL_80_CHR16Q13","C1_Positional","C1_ALL_80_CHR16Q13",40,-1.4239,0.041,0.47,1.5124,0.02,0.28,1.3466,0.088,0.4
"GO_BP:751212_GO_0036294_CELLULAR_RESPONSE_TO_DECREASED_OXYGEN_LEVELS","GO_BP","751212_GO_0036294_CELLULAR_RESPONSE_TO_DECREASED_OXYGEN_LEVELS",109,-1.4239,0.019,0.15,-0.7299,0.97,1,1.1329,0.18,0.74
"GO_CC:487198_GO_0000974_PRP19_COMPLEX","GO_CC","487198_GO_0000974_PRP19_COMPLEX",6,-1.4239,0.09,0.2,-1.193,0.28,0.68,-1.0362,0.43,0.98
"GO_BP:502042_GO_0032819_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION","GO_BP","502042_GO_0032819_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION",6,-1.4238,0.095,0.15,-1.4924,0.056,0.82,-0.9933,0.48,0.85
"GO_MF:505908_GO_0042805_ACTININ_BINDING","GO_MF","505908_GO_0042805_ACTININ_BINDING",27,-1.4238,0.065,0.2,1.074,0.36,0.83,1.434,0.065,0.52
"GO_BP:499716_GO_0030316_OSTEOCLAST_DIFFERENTIATION","GO_BP","499716_GO_0030316_OSTEOCLAST_DIFFERENTIATION",34,-1.4237,0.061,0.15,0.7898,0.81,1,1.1112,0.29,0.75
"GO_BP:488968_GO_0003174_MITRAL_VALVE_DEVELOPMENT","GO_BP","488968_GO_0003174_MITRAL_VALVE_DEVELOPMENT",7,-1.4237,0.097,0.15,0.7945,0.74,1,0.7195,0.82,1
"C3_TF_targets:C3_TFT_70_V_CDPCR3HD_01","C3_TF_targets","C3_TFT_70_V_CDPCR3HD_01",230,-1.4236,0.0056,0.034,-1.2895,0.034,0.25,-1.0319,0.37,0.67
"GO_BP:508143_GO_0045820_NEGATIVE_REGULATION_OF_GLYCOLYTIC_PROCESS","GO_BP","508143_GO_0045820_NEGATIVE_REGULATION_OF_GLYCOLYTIC_PROCESS",7,-1.4236,0.078,0.15,-0.7169,0.83,1,0.7394,0.79,1
"C7_Immunologic_signatures:C7_ALL_803_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_803_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP",170,-1.4236,0.018,0.019,-1.1893,0.11,0.86,0.7572,0.98,1
"GO_BP:1129404_GO_1903578_REGULATION_OF_ATP_METABOLIC_PROCESS","GO_BP","1129404_GO_1903578_REGULATION_OF_ATP_METABOLIC_PROCESS",48,-1.4235,0.056,0.15,-0.7312,0.9,1,-0.8045,0.83,0.99
"KEGG_pathway:HSA04713_CIRCADIAN_ENTRAINMENT","KEGG_pathway","HSA04713_CIRCADIAN_ENTRAINMENT",95,-1.4235,0.024,0.06,-1.0081,0.44,0.87,-0.9992,0.47,0.68
"GO_BP:494630_GO_0010565_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS","GO_BP","494630_GO_0010565_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS",455,-1.4235,0.001,0.15,1.0338,0.32,0.96,-1.0099,0.41,0.84
"REACTOME:119558_REACT_19118_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT","REACTOME","119558_REACT_19118_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT",257,-1.4235,0.0066,0.17,-1.1761,0.089,0.87,-1.2672,0.025,0.54
"GO_BP:502250_GO_0033028_MYELOID_CELL_APOPTOTIC_PROCESS","GO_BP","502250_GO_0033028_MYELOID_CELL_APOPTOTIC_PROCESS",6,-1.4233,0.079,0.15,-0.6103,0.92,1,-0.9061,0.58,0.92
"GO_MF:490303_GO_0048406_NERVE_GROWTH_FACTOR_BINDING","GO_MF","490303_GO_0048406_NERVE_GROWTH_FACTOR_BINDING",6,-1.4233,0.072,0.2,0.6619,0.87,1,-1.0349,0.43,0.76
"GO_BP:505173_GO_0040015_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH","GO_BP","505173_GO_0040015_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH",13,-1.4233,0.067,0.15,-1.1103,0.33,0.94,-0.9163,0.57,0.91
"GO_MF:504442_GO_0035258_STEROID_HORMONE_RECEPTOR_BINDING","GO_MF","504442_GO_0035258_STEROID_HORMONE_RECEPTOR_BINDING",71,-1.4231,0.032,0.2,0.8034,0.85,1,0.8066,0.83,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_209_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_209_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP",35,-1.4229,0.062,0.095,-1.2754,0.14,0.72,-1.2776,0.14,0.45
"C3_TF_targets:C3_TFT_104_V_BRN2_01","C3_TF_targets","C3_TFT_104_V_BRN2_01",229,-1.4228,0.0034,0.034,-0.9103,0.73,0.95,-1.0141,0.42,0.73
"GO_BP:518888_GO_2000241_REGULATION_OF_REPRODUCTIVE_PROCESS","GO_BP","518888_GO_2000241_REGULATION_OF_REPRODUCTIVE_PROCESS",240,-1.4228,0.0034,0.15,1.3014,0.012,0.67,-1.1186,0.16,0.76
"GO_BP:491594_GO_0006707_CHOLESTEROL_CATABOLIC_PROCESS","GO_BP","491594_GO_0006707_CHOLESTEROL_CATABOLIC_PROCESS",10,-1.4226,0.093,0.15,-1.3176,0.16,0.89,0.8542,0.67,0.98
"C3_MicroRNA_targets:C3_MIR_142_ATGCAGT_MIR_217","C3_MicroRNA_targets","C3_MIR_142_ATGCAGT_MIR_217",115,-1.4225,0.019,0.27,0.6782,1,1,0.7303,0.97,1
"GO_BP:513639_GO_0060081_MEMBRANE_HYPERPOLARIZATION","GO_BP","513639_GO_0060081_MEMBRANE_HYPERPOLARIZATION",24,-1.4224,0.049,0.15,-1.1778,0.23,0.91,-0.8283,0.72,0.97
"GO_BP:506101_GO_0043010_CAMERA_TYPE_EYE_DEVELOPMENT","GO_BP","506101_GO_0043010_CAMERA_TYPE_EYE_DEVELOPMENT",278,-1.4224,0.0044,0.15,-1.149,0.13,0.93,1.196,0.064,0.72
"C3_TF_targets:C3_TFT_39_V_TAL1ALPHAE47_01","C3_TF_targets","C3_TFT_39_V_TAL1ALPHAE47_01",243,-1.4223,0.0033,0.034,-1.1514,0.15,0.45,-1.077,0.26,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_1675_TRAYNOR_RETT_SYNDROM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1675_TRAYNOR_RETT_SYNDROM_DN",18,-1.4223,0.084,0.095,1.0079,0.45,0.79,1.0702,0.36,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_3394_HORTON_SREBF_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3394_HORTON_SREBF_TARGETS",25,-1.4222,0.07,0.095,-1.027,0.44,0.98,-1.3367,0.11,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2028_CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5","C2_Chemical_and_genetic_perturbations","C2_CGP_2028_CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5",473,-1.4222,0.0031,0.095,0.9082,0.83,0.91,-0.8577,0.96,0.92
"C3_TF_targets:C3_TFT_93_V_TST1_01","C3_TF_targets","C3_TFT_93_V_TST1_01",244,-1.4221,0.0055,0.034,-0.8726,0.82,0.99,-0.9703,0.56,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_893_YANG_BREAST_CANCER_ESR1_LASER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_893_YANG_BREAST_CANCER_ESR1_LASER_DN",49,-1.4221,0.055,0.095,0.8588,0.75,0.96,-0.6246,0.99,0.99
"GO_BP:518763_GO_2000114_REGULATION_OF_ESTABLISHMENT_OF_CELL_POLARITY","GO_BP","518763_GO_2000114_REGULATION_OF_ESTABLISHMENT_OF_CELL_POLARITY",16,-1.422,0.083,0.15,0.6276,0.93,1,-0.9436,0.54,0.89
"GO_BP:506439_GO_0043401_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY","GO_BP","506439_GO_0043401_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY",55,-1.4219,0.043,0.15,-1.0867,0.3,0.95,0.9132,0.64,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_613_MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH","C2_Chemical_and_genetic_perturbations","C2_CGP_613_MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH",15,-1.4218,0.086,0.095,0.991,0.45,0.81,1.5053,0.046,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_3298_LIU_IL13_PRIMING_MODEL","C2_Chemical_and_genetic_perturbations","C2_CGP_3298_LIU_IL13_PRIMING_MODEL",15,-1.4217,0.057,0.095,-1.5429,0.042,0.43,1.1916,0.23,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_1038_CAFFAREL_RESPONSE_TO_THC_24HR_5_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1038_CAFFAREL_RESPONSE_TO_THC_24HR_5_UP",34,-1.4217,0.053,0.095,1.2157,0.17,0.47,-0.7271,0.89,0.98
"GO_BP:498550_GO_0019731_ANTIBACTERIAL_HUMORAL_RESPONSE","GO_BP","498550_GO_0019731_ANTIBACTERIAL_HUMORAL_RESPONSE",31,-1.4216,0.056,0.15,1.5763,0.018,0.32,1.0281,0.37,0.82
"C7_Immunologic_signatures:C7_ALL_1066_GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN","C7_Immunologic_signatures","C7_ALL_1066_GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN",195,-1.4216,0.0068,0.02,0.824,0.93,1,-1.2257,0.071,0.23
"C3_TF_targets:C3_TFT_598_YATGNWAAT_V_OCT_C","C3_TF_targets","C3_TFT_598_YATGNWAAT_V_OCT_C",348,-1.4215,0,0.034,-1.409,0.0034,0.16,-0.9439,0.67,0.86
"GO_BP:492819_GO_0008544_EPIDERMIS_DEVELOPMENT","GO_BP","492819_GO_0008544_EPIDERMIS_DEVELOPMENT",236,-1.4215,0.0066,0.15,0.8561,0.9,1,1.4004,0.002,0.63
"C7_Immunologic_signatures:C7_ALL_1259_GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1259_GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP",183,-1.4214,0.012,0.02,1.3716,0.018,0.05,1.5697,0,0.014
"GO_BP:505277_GO_0042100_B_CELL_PROLIFERATION","GO_BP","505277_GO_0042100_B_CELL_PROLIFERATION",33,-1.4213,0.061,0.15,0.5052,1,1,-1.3499,0.072,0.6
"GO_BP:516250_GO_0071326_CELLULAR_RESPONSE_TO_MONOSACCHARIDE_STIMULUS","GO_BP","516250_GO_0071326_CELLULAR_RESPONSE_TO_MONOSACCHARIDE_STIMULUS",54,-1.4213,0.047,0.15,-0.6651,0.97,1,-0.7444,0.91,1
"GO_BP:493497_GO_0009313_OLIGOSACCHARIDE_CATABOLIC_PROCESS","GO_BP","493497_GO_0009313_OLIGOSACCHARIDE_CATABOLIC_PROCESS",8,-1.4211,0.096,0.15,1.0223,0.45,0.97,0.6667,0.87,1
"C4_Cancer_modules:C4_CM_147_MODULE_155","C4_Cancer_modules","C4_CM_147_MODULE_155",25,-1.421,0.048,0.087,0.9767,0.48,0.74,-2.0856,0,0.0063
"GO_BP:512092_GO_0051186_COFACTOR_METABOLIC_PROCESS","GO_BP","512092_GO_0051186_COFACTOR_METABOLIC_PROCESS",319,-1.4208,0.0021,0.15,0.9783,0.52,1,-1.6864,0,0.62
"C7_Immunologic_signatures:C7_ALL_1825_GSE7852_TREG_VS_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1825_GSE7852_TREG_VS_TCONV_UP",198,-1.4208,0.017,0.02,0.7183,1,1,-0.8841,0.81,0.97
"GO_BP:500831_GO_0031581_HEMIDESMOSOME_ASSEMBLY","GO_BP","500831_GO_0031581_HEMIDESMOSOME_ASSEMBLY",11,-1.4208,0.072,0.15,-0.9707,0.48,1,1.1447,0.27,0.73
"GO_BP:510763_GO_0048708_ASTROCYTE_DIFFERENTIATION","GO_BP","510763_GO_0048708_ASTROCYTE_DIFFERENTIATION",29,-1.4207,0.065,0.15,1.2282,0.17,0.76,1.1032,0.3,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_499_MCBRYAN_PUBERTAL_BREAST_3_4WK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_499_MCBRYAN_PUBERTAL_BREAST_3_4WK_DN",36,-1.4206,0.045,0.096,1.1484,0.23,0.56,-1.1229,0.26,0.6
"GO_BP:499720_GO_0072502_CELLULAR_TRIVALENT_INORGANIC_ANION_HOMEOSTASIS","GO_BP","499720_GO_0072502_CELLULAR_TRIVALENT_INORGANIC_ANION_HOMEOSTASIS",6,-1.4204,0.087,0.15,0.4826,0.99,1,-0.783,0.74,1
"GO_BP:512669_GO_0051798_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT","GO_BP","512669_GO_0051798_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT",9,-1.4203,0.092,0.15,-1.2474,0.21,0.91,-0.7146,0.81,0.99
"KEGG_pathway:HSA04310_WNT_SIGNALING_PATHWAY","KEGG_pathway","HSA04310_WNT_SIGNALING_PATHWAY",137,-1.4202,0.016,0.061,-0.9915,0.47,0.9,-1.233,0.099,0.34
"REACTOME:106123_REACT_1541_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS","REACTOME","106123_REACT_1541_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS",8,-1.4202,0.089,0.18,0.9424,0.53,0.84,-1.5938,0.041,0.26
"GO_MF:490301_GO_0043121_NEUROTROPHIN_BINDING","GO_MF","490301_GO_0043121_NEUROTROPHIN_BINDING",9,-1.4201,0.066,0.2,0.8091,0.71,1,-0.7927,0.72,0.97
"C3_TF_targets:C3_TFT_197_V_TCF11_01","C3_TF_targets","C3_TFT_197_V_TCF11_01",247,-1.42,0.0011,0.035,-0.8284,0.92,1,0.8632,0.85,1
"C3_TF_targets:C3_TFT_185_V_ISRE_01","C3_TF_targets","C3_TFT_185_V_ISRE_01",241,-1.42,0.0077,0.034,1.127,0.15,0.97,-0.896,0.77,0.92
"C4_Cancer_modules:C4_CM_238_MODULE_264","C4_Cancer_modules","C4_CM_238_MODULE_264",11,-1.4199,0.1,0.088,0.9811,0.47,0.73,-0.7066,0.86,1
"GO_BP:486822_GO_0000305_RESPONSE_TO_OXYGEN_RADICAL","GO_BP","486822_GO_0000305_RESPONSE_TO_OXYGEN_RADICAL",18,-1.4195,0.086,0.16,-0.554,0.98,1,-1.2787,0.16,0.66
"GO_CC:518575_GO_0097025_MPP7_DLG1_LIN7_COMPLEX","GO_CC","518575_GO_0097025_MPP7_DLG1_LIN7_COMPLEX",5,-1.4195,0.08,0.2,0.9824,0.45,0.81,-1.5022,0.05,0.49
"GO_BP:488760_GO_0002887_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY","GO_BP","488760_GO_0002887_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY",7,-1.4193,0.08,0.16,-0.8862,0.6,1,1.1893,0.25,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2616_COLINA_TARGETS_OF_4EBP1_AND_4EBP2","C2_Chemical_and_genetic_perturbations","C2_CGP_2616_COLINA_TARGETS_OF_4EBP1_AND_4EBP2",351,-1.4193,0.0032,0.097,1.3807,0.0078,0.31,-1.0383,0.32,0.7
"GO_BP:512037_GO_0051126_NEGATIVE_REGULATION_OF_ACTIN_NUCLEATION","GO_BP","512037_GO_0051126_NEGATIVE_REGULATION_OF_ACTIN_NUCLEATION",6,-1.4193,0.079,0.16,0.7283,0.81,1,-0.7596,0.74,1
"C6_Oncogenic_signatures:C6_ALL_44_WNT_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_44_WNT_UP_V1_UP",158,-1.4192,0.013,0.027,-0.913,0.67,0.87,1.2048,0.11,0.27
"GO_BP:489077_GO_0003284_SEPTUM_PRIMUM_DEVELOPMENT","GO_BP","489077_GO_0003284_SEPTUM_PRIMUM_DEVELOPMENT",5,-1.4191,0.063,0.16,0.745,0.78,1,-0.9087,0.59,0.92
"C7_Immunologic_signatures:C7_ALL_140_GSE13229_IMM_VS_MATURE_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_140_GSE13229_IMM_VS_MATURE_NKCELL_DN",198,-1.4191,0.0092,0.02,-0.7243,1,1,-1.0876,0.23,0.52
"GO_BP:511824_GO_0050886_ENDOCRINE_PROCESS","GO_BP","511824_GO_0050886_ENDOCRINE_PROCESS",48,-1.419,0.048,0.16,-0.9331,0.57,1,-1.0712,0.33,0.8
"KEGG_pathway:HSA00561_GLYCEROLIPID_METABOLISM","KEGG_pathway","HSA00561_GLYCEROLIPID_METABOLISM",56,-1.419,0.04,0.062,-0.983,0.49,0.91,-0.8944,0.64,0.85
"GO_BP:752562_GO_0090505_EPIBOLY_INVOLVED_IN_WOUND_HEALING","GO_BP","752562_GO_0090505_EPIBOLY_INVOLVED_IN_WOUND_HEALING",19,-1.419,0.083,0.16,-0.6518,0.9,1,-0.9758,0.49,0.88
"C3_TF_targets:C3_TFT_147_V_HNF1_C","C3_TF_targets","C3_TFT_147_V_HNF1_C",233,-1.419,0.0056,0.035,-0.9835,0.5,0.8,-1.2033,0.085,0.35
"KEGG_pathway:HSA00520_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM","KEGG_pathway","HSA00520_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM",48,-1.419,0.054,0.061,-0.6111,1,1,-1.4147,0.028,0.17
"REACTOME:645328_REACT_121324_ACYL_CHAIN_REMODELLING_OF_PG","REACTOME","645328_REACT_121324_ACYL_CHAIN_REMODELLING_OF_PG",15,-1.4188,0.089,0.18,-0.9538,0.51,1,-1.0329,0.4,0.8
"C7_Immunologic_signatures:C7_ALL_1324_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN","C7_Immunologic_signatures","C7_ALL_1324_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN",192,-1.4188,0.008,0.021,-0.8518,0.84,1,-0.8719,0.83,0.99
"GO_BP:518920_GO_2000273_POSITIVE_REGULATION_OF_RECEPTOR_ACTIVITY","GO_BP","518920_GO_2000273_POSITIVE_REGULATION_OF_RECEPTOR_ACTIVITY",31,-1.4188,0.065,0.16,-1.077,0.33,0.95,-1.1186,0.29,0.76
"GO_BP:513903_GO_0060347_HEART_TRABECULA_FORMATION","GO_BP","513903_GO_0060347_HEART_TRABECULA_FORMATION",15,-1.4187,0.085,0.16,-1.38,0.087,1,1.0847,0.34,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_2437_FIRESTEIN_PROLIFERATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2437_FIRESTEIN_PROLIFERATION",173,-1.4187,0.0046,0.097,-0.7836,0.96,1,-1.2202,0.081,0.5
"REACTOME:1183563_REACT_355200_SIGNALING_BY_FGFR2","REACTOME","1183563_REACT_355200_SIGNALING_BY_FGFR2",159,-1.4186,0.015,0.18,-0.9049,0.73,1,-1.2635,0.049,0.54
"C3_TF_targets:C3_TFT_393_V_HFH4_01","C3_TF_targets","C3_TFT_393_V_HFH4_01",189,-1.4186,0.011,0.034,1.0707,0.26,1,0.7986,0.95,1
"GO_BP:487674_GO_0001778_PLASMA_MEMBRANE_REPAIR","GO_BP","487674_GO_0001778_PLASMA_MEMBRANE_REPAIR",8,-1.4185,0.089,0.16,-1.6212,0.023,0.69,-1.0454,0.4,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_527_ZIRN_TRETINOIN_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_527_ZIRN_TRETINOIN_RESPONSE_DN",6,-1.4183,0.088,0.097,0.6383,0.9,1,1.4491,0.075,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1519_ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1519_ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP",26,-1.4183,0.07,0.097,-0.8075,0.77,1,1.3013,0.11,0.68
"GO_BP:492402_GO_0050810_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS","GO_BP","492402_GO_0050810_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS",50,-1.4183,0.05,0.16,-0.9821,0.45,1,-0.729,0.92,0.99
"KEGG_pathway:HSA00564_GLYCEROPHOSPHOLIPID_METABOLISM","KEGG_pathway","HSA00564_GLYCEROPHOSPHOLIPID_METABOLISM",91,-1.4182,0.022,0.061,-0.6071,1,1,0.7621,0.94,1
"C1_Positional:C1_ALL_286_CHR12Q13","C1_Positional","C1_ALL_286_CHR12Q13",236,-1.4182,0.013,0.47,-1.3292,0.025,0.83,-0.9651,0.58,0.95
"GO_BP:516270_GO_0071346_CELLULAR_RESPONSE_TO_INTERFERON_GAMMA","GO_BP","516270_GO_0071346_CELLULAR_RESPONSE_TO_INTERFERON_GAMMA",101,-1.4181,0.017,0.16,0.8802,0.74,1,0.8184,0.88,1
"GO_MF:496296_GO_0016229_STEROID_DEHYDROGENASE_ACTIVITY","GO_MF","496296_GO_0016229_STEROID_DEHYDROGENASE_ACTIVITY",26,-1.4181,0.062,0.2,1.4118,0.078,0.48,-1.2351,0.17,0.58
"GO_BP:487849_GO_0001959_REGULATION_OF_CYTOKINE_MEDIATED_SIGNALING_PATHWAY","GO_BP","487849_GO_0001959_REGULATION_OF_CYTOKINE_MEDIATED_SIGNALING_PATHWAY",98,-1.4181,0.025,0.16,0.7539,0.96,1,-0.8385,0.82,0.96
"KEGG_pathway:HSA00232_CAFFEINE_METABOLISM","KEGG_pathway","HSA00232_CAFFEINE_METABOLISM",5,-1.4179,0.077,0.061,-0.6978,0.81,1,1.2775,0.19,0.54
"GO_BP:492818_GO_0008543_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","492818_GO_0008543_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",159,-1.4179,0.018,0.16,-0.8923,0.73,1,-1.1311,0.18,0.75
"C7_Immunologic_signatures:C7_ALL_853_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP","C7_Immunologic_signatures","C7_ALL_853_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP",166,-1.4179,0.0093,0.021,-1.0701,0.3,1,1.2075,0.1,0.68
"GO_BP:492355_GO_0007614_SHORT_TERM_MEMORY","GO_BP","492355_GO_0007614_SHORT_TERM_MEMORY",8,-1.4178,0.078,0.16,0.9425,0.52,1,0.8821,0.61,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2583_HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2583_HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP",22,-1.4178,0.074,0.098,-1.1742,0.24,0.82,-1.3722,0.088,0.38
"C7_Immunologic_signatures:C7_ALL_802_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0_5H_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_802_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0_5H_ACT_CD4_TCELL_DN",171,-1.4178,0.017,0.021,-1.2862,0.048,0.5,1.4375,0.0058,0.092
"GO_BP:495104_GO_0014032_NEURAL_CREST_CELL_DEVELOPMENT","GO_BP","495104_GO_0014032_NEURAL_CREST_CELL_DEVELOPMENT",50,-1.4178,0.04,0.16,1.4273,0.033,0.52,1.6425,0.0041,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1026_SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1026_SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP",13,-1.4177,0.074,0.098,-1.3555,0.13,0.67,0.7926,0.74,1
"C7_Immunologic_signatures:C7_ALL_1084_GSE25087_TREG_VS_TCONV_FETUS_DN","C7_Immunologic_signatures","C7_ALL_1084_GSE25087_TREG_VS_TCONV_FETUS_DN",191,-1.4177,0.011,0.021,1.0399,0.37,0.62,-1.2001,0.11,0.28
"C7_Immunologic_signatures:C7_ALL_408_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_408_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN",200,-1.4177,0.0069,0.021,1.6373,0,0.0015,-1.2467,0.052,0.2
"GO_BP:494945_GO_0010881_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION","GO_BP","494945_GO_0010881_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION",19,-1.4176,0.072,0.16,1.0317,0.41,0.96,1.1975,0.22,0.72
"KEGG_pathway:HSA04914_PROGESTERONE_MEDIATED_OOCYTE_MATURATION","KEGG_pathway","HSA04914_PROGESTERONE_MEDIATED_OOCYTE_MATURATION",87,-1.4174,0.029,0.061,0.9112,0.65,1,-1.3604,0.024,0.21
"GO_BP:755385_GO_2001279_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS","GO_BP","755385_GO_2001279_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS",6,-1.4173,0.069,0.16,-0.6515,0.88,1,-1.5305,0.045,0.53
"C7_Immunologic_signatures:C7_ALL_20_GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_20_GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN",187,-1.4173,0.0069,0.021,0.8843,0.78,1,-1.0025,0.46,0.72
"GO_BP:751383_GO_0038127_ERBB_SIGNALING_PATHWAY","GO_BP","751383_GO_0038127_ERBB_SIGNALING_PATHWAY",195,-1.4173,0.0068,0.16,-1.0523,0.32,0.97,-1.0753,0.29,0.8
"C3_TF_targets:C3_TFT_24_V_SOX5_01","C3_TF_targets","C3_TFT_24_V_SOX5_01",260,-1.4173,0.0033,0.035,-0.8538,0.87,1,-1.3132,0.013,0.24
"KEGG_compound:C02232_3_OXOADIPYL_COA_BETA_KETOADIPYL_COA","KEGG_compound","C02232_3_OXOADIPYL_COA_BETA_KETOADIPYL_COA",5,-1.4172,0.087,0.24,0.5708,0.94,1,-1.2045,0.24,0.44
"GO_MF:499745_GO_0030346_PROTEIN_PHOSPHATASE_2B_BINDING","GO_MF","499745_GO_0030346_PROTEIN_PHOSPHATASE_2B_BINDING",6,-1.4172,0.072,0.2,-1.1973,0.29,0.81,-1.4729,0.065,0.42
"GO_BP:500152_GO_0030854_POSITIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION","GO_BP","500152_GO_0030854_POSITIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION",9,-1.4171,0.072,0.16,0.832,0.67,1,-1.2141,0.23,0.72
"C7_Immunologic_signatures:C7_ALL_314_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN","C7_Immunologic_signatures","C7_ALL_314_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN",194,-1.4171,0.013,0.021,1.5769,0,0.0043,-1.0278,0.38,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_2966_MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2","C2_Chemical_and_genetic_perturbations","C2_CGP_2966_MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2",8,-1.417,0.09,0.098,-1.296,0.17,0.7,0.5647,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1380_ROSS_AML_OF_FAB_M7_TYPE","C2_Chemical_and_genetic_perturbations","C2_CGP_1380_ROSS_AML_OF_FAB_M7_TYPE",68,-1.4169,0.037,0.098,1.7969,0,0.044,-1.1903,0.17,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_929_TOMLINS_PROSTATE_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_929_TOMLINS_PROSTATE_CANCER_DN",39,-1.4169,0.051,0.098,0.7281,0.92,1,1.0223,0.41,0.94
"GO_BP:492416_GO_0008038_NEURON_RECOGNITION","GO_BP","492416_GO_0008038_NEURON_RECOGNITION",33,-1.4168,0.055,0.16,-1.5009,0.038,0.83,-1.2346,0.17,0.7
"C7_Immunologic_signatures:C7_ALL_1628_GSE3982_DC_VS_MAC_DN","C7_Immunologic_signatures","C7_ALL_1628_GSE3982_DC_VS_MAC_DN",199,-1.4168,0.008,0.021,1.1443,0.13,0.33,1.0095,0.42,1
"GO_BP:506361_GO_0043301_NEGATIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION","GO_BP","506361_GO_0043301_NEGATIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION",7,-1.4168,0.073,0.16,-0.89,0.62,1,1.2468,0.22,0.7
"GO_BP:506647_GO_0043616_KERATINOCYTE_PROLIFERATION","GO_BP","506647_GO_0043616_KERATINOCYTE_PROLIFERATION",11,-1.4167,0.082,0.16,-1.064,0.39,0.96,0.806,0.71,1
"C7_Immunologic_signatures:C7_ALL_320_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN","C7_Immunologic_signatures","C7_ALL_320_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN",199,-1.4165,0.0069,0.021,1.3144,0.021,0.09,-1.2561,0.047,0.19
"C7_Immunologic_signatures:C7_ALL_1820_GSE7852_LN_VS_THYMUS_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1820_GSE7852_LN_VS_THYMUS_TCONV_DN",200,-1.4165,0.0046,0.021,-0.6418,1,1,-1.3399,0.012,0.1
"GO_MF:487745_GO_0001849_COMPLEMENT_COMPONENT_C1Q_BINDING","GO_MF","487745_GO_0001849_COMPLEMENT_COMPONENT_C1Q_BINDING",8,-1.4165,0.092,0.2,-1.3627,0.14,0.69,1.3168,0.16,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_3231_IKEDA_MIR30_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3231_IKEDA_MIR30_TARGETS_DN",27,-1.4164,0.069,0.098,1.423,0.06,0.28,-0.7894,0.81,0.96
"C3_TF_targets:C3_TFT_552_YTAAYNGCT_UNKNOWN","C3_TF_targets","C3_TFT_552_YTAAYNGCT_UNKNOWN",144,-1.4164,0.011,0.035,1.0057,0.44,1,1.2537,0.072,0.57
"C0_Hallmark:H_ALL_45_HALLMARK_PEROXISOME","C0_Hallmark","H_ALL_45_HALLMARK_PEROXISOME",103,-1.4163,0.024,0.025,-0.9524,0.55,1,-1.5375,0.0021,0.022
"GO_MF:499695_GO_0030291_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY","GO_MF","499695_GO_0030291_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY",28,-1.4162,0.06,0.2,-0.6148,0.97,1,-1.0264,0.43,0.77
"GO_MF:499444_GO_0023023_MHC_PROTEIN_COMPLEX_BINDING","GO_MF","499444_GO_0023023_MHC_PROTEIN_COMPLEX_BINDING",19,-1.4162,0.071,0.2,-1.1048,0.32,0.84,-1.8635,0.0021,0.18
"REACTOME:119539_REACT_19388_G_PROTEIN_BETA_GAMMA_SIGNALLING","REACTOME","119539_REACT_19388_G_PROTEIN_BETA_GAMMA_SIGNALLING",50,-1.416,0.03,0.18,-0.7774,0.86,1,-0.9789,0.48,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_2104_JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2104_JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP",12,-1.4159,0.065,0.098,1.0142,0.41,0.78,-0.8943,0.62,0.89
"GO_BP:506191_GO_0043113_RECEPTOR_CLUSTERING","GO_BP","506191_GO_0043113_RECEPTOR_CLUSTERING",40,-1.4159,0.063,0.16,-1.0346,0.4,0.98,-1.0912,0.29,0.78
"GO_BP:516299_GO_0071375_CELLULAR_RESPONSE_TO_PEPTIDE_HORMONE_STIMULUS","GO_BP","516299_GO_0071375_CELLULAR_RESPONSE_TO_PEPTIDE_HORMONE_STIMULUS",285,-1.4158,0.0043,0.16,-0.768,0.98,1,-1.0675,0.28,0.8
"REACTOME:161011_REACT_22128_LIGAND_INDEPENDENT_CASPASE_ACTIVATION_VIA_DCC","REACTOME","161011_REACT_22128_LIGAND_INDEPENDENT_CASPASE_ACTIVATION_VIA_DCC",10,-1.4158,0.082,0.18,-0.6197,0.92,1,-0.6292,0.92,1
"GO_BP:502100_GO_0032878_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY","GO_BP","502100_GO_0032878_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY",19,-1.4157,0.07,0.16,0.6794,0.91,1,-0.8474,0.7,0.96
"GO_BP:491558_GO_0006670_SPHINGOSINE_METABOLIC_PROCESS","GO_BP","491558_GO_0006670_SPHINGOSINE_METABOLIC_PROCESS",10,-1.4156,0.11,0.16,-0.6176,0.94,1,-1.4188,0.097,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_2828_STEIN_ESR1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2828_STEIN_ESR1_TARGETS",85,-1.4156,0.028,0.099,1.1013,0.26,0.63,-1.4524,0.014,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_1298_LEE_LIVER_CANCER_ACOX1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1298_LEE_LIVER_CANCER_ACOX1_DN",63,-1.4156,0.034,0.099,-0.9186,0.6,1,-1.0244,0.41,0.72
"GO_BP:500135_GO_0030837_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION","GO_BP","500135_GO_0030837_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION",46,-1.4156,0.043,0.16,-0.7962,0.82,1,-1.3543,0.053,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_2598_FINAK_BREAST_CANCER_SDPP_SIGNATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_2598_FINAK_BREAST_CANCER_SDPP_SIGNATURE",25,-1.4156,0.061,0.099,1.3761,0.077,0.31,-0.774,0.79,0.97
"GO_MF:504195_GO_0035004_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY","GO_MF","504195_GO_0035004_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY",12,-1.4155,0.083,0.2,-0.9248,0.58,0.96,-1.0338,0.38,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2640_MEISSNER_BRAIN_HCP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2640_MEISSNER_BRAIN_HCP_WITH_H3K27ME3",245,-1.4155,0.0033,0.098,-1.208,0.084,0.8,1.706,0,0.28
"GO_BP:507325_GO_0044319_WOUND_HEALING_SPREADING_OF_CELLS","GO_BP","507325_GO_0044319_WOUND_HEALING_SPREADING_OF_CELLS",19,-1.4155,0.071,0.16,-0.6625,0.94,1,-0.9719,0.49,0.88
"KEGG_pathway:HSA00051_FRUCTOSE_AND_MANNOSE_METABOLISM","KEGG_pathway","HSA00051_FRUCTOSE_AND_MANNOSE_METABOLISM",32,-1.4154,0.051,0.061,-0.5944,0.98,1,-0.8808,0.66,0.87
"C3_TF_targets:C3_TFT_209_V_PAX8_B","C3_TF_targets","C3_TFT_209_V_PAX8_B",101,-1.4154,0.019,0.035,-0.9505,0.57,0.88,-1.0637,0.32,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_124_DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_124_DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP",359,-1.4153,0.0053,0.099,-0.9608,0.61,1,-1.5028,0,0.3
"GO_MF:506017_GO_0042923_NEUROPEPTIDE_BINDING","GO_MF","506017_GO_0042923_NEUROPEPTIDE_BINDING",20,-1.4153,0.088,0.2,1.153,0.25,0.74,-1.0551,0.38,0.74
"C7_Immunologic_signatures:C7_ALL_1777_GSE7460_TREG_VS_TCONV_ACT_UP","C7_Immunologic_signatures","C7_ALL_1777_GSE7460_TREG_VS_TCONV_ACT_UP",196,-1.4152,0.0068,0.021,0.6977,1,1,-0.8911,0.79,0.96
"GO_BP:510652_GO_0048589_DEVELOPMENTAL_GROWTH","GO_BP","510652_GO_0048589_DEVELOPMENTAL_GROWTH",214,-1.4152,0.008,0.16,-1.0743,0.28,0.95,-0.8235,0.93,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_465_OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_465_OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP",117,-1.4151,0.014,0.099,1.9993,0,0.0063,-0.8623,0.81,0.91
"GO_BP:510895_GO_0048845_VENOUS_BLOOD_VESSEL_MORPHOGENESIS","GO_BP","510895_GO_0048845_VENOUS_BLOOD_VESSEL_MORPHOGENESIS",9,-1.4151,0.076,0.16,-0.4603,1,1,0.879,0.65,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1253_CERVERA_SDHB_TARGETS_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1253_CERVERA_SDHB_TARGETS_1_UP",113,-1.4151,0.012,0.099,1.0207,0.43,0.77,-1.0401,0.37,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_1623_DAZARD_UV_RESPONSE_CLUSTER_G3","C2_Chemical_and_genetic_perturbations","C2_CGP_1623_DAZARD_UV_RESPONSE_CLUSTER_G3",15,-1.4149,0.078,0.099,-0.9747,0.48,1,0.795,0.74,1
"GO_BP:506192_GO_0043114_REGULATION_OF_VASCULAR_PERMEABILITY","GO_BP","506192_GO_0043114_REGULATION_OF_VASCULAR_PERMEABILITY",26,-1.4149,0.07,0.16,-0.6725,0.94,1,0.9522,0.55,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2173_WALLACE_PROSTATE_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2173_WALLACE_PROSTATE_CANCER_DN",6,-1.4147,0.088,0.099,-0.9186,0.55,1,1.722,0.0096,0.3
"GO_CC:505741_GO_0042627_CHYLOMICRON","GO_CC","505741_GO_0042627_CHYLOMICRON",13,-1.4147,0.087,0.21,-1.1097,0.31,0.76,1.2951,0.16,0.72
"C3_TF_targets:C3_TFT_399_V_HMGIY_Q6","C3_TF_targets","C3_TFT_399_V_HMGIY_Q6",241,-1.4147,0.0055,0.035,-1.2755,0.04,0.25,-1.2317,0.043,0.29
"C7_Immunologic_signatures:C7_ALL_1344_GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1344_GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN",198,-1.4146,0.01,0.022,1.156,0.13,0.31,-0.8835,0.82,0.97
"C3_TF_targets:C3_TFT_179_V_GFI1_01","C3_TF_targets","C3_TFT_179_V_GFI1_01",255,-1.4146,0.0033,0.035,-1.1745,0.11,0.4,-1.1421,0.12,0.46
"C7_Immunologic_signatures:C7_ALL_738_GSE17721_ALL_VS_24H_PAM3CSK4_BMDM_DN","C7_Immunologic_signatures","C7_ALL_738_GSE17721_ALL_VS_24H_PAM3CSK4_BMDM_DN",199,-1.4144,0.011,0.022,1.1595,0.13,0.3,-1.1235,0.17,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_52_WATANABE_COLON_CANCER_MSI_VS_MSS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_52_WATANABE_COLON_CANCER_MSI_VS_MSS_UP",29,-1.4144,0.069,0.099,1.0273,0.42,0.76,1.0347,0.39,0.93
"GO_BP:514314_GO_0060759_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS","GO_BP","514314_GO_0060759_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS",105,-1.4143,0.034,0.16,0.8482,0.84,1,-0.8204,0.87,0.97
"GO_BP:500754_GO_0031503_PROTEIN_COMPLEX_LOCALIZATION","GO_BP","500754_GO_0031503_PROTEIN_COMPLEX_LOCALIZATION",20,-1.4143,0.072,0.16,-0.9712,0.5,1,-0.9487,0.53,0.89
"REACTOME:771603_REACT_160078_PEPTIDE_HORMONE_METABOLISM","REACTOME","771603_REACT_160078_PEPTIDE_HORMONE_METABOLISM",80,-1.4143,0.033,0.18,1.1817,0.15,0.46,-1.0367,0.37,0.8
"GO_BP:491616_GO_0006732_COENZYME_METABOLIC_PROCESS","GO_BP","491616_GO_0006732_COENZYME_METABOLIC_PROCESS",256,-1.4143,0.0033,0.16,0.9517,0.63,1,-1.6633,0,0.54
"C7_Immunologic_signatures:C7_ALL_491_GSE17721_CTRL_VS_PAM3CSK4_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_491_GSE17721_CTRL_VS_PAM3CSK4_12H_BMDM_UP",199,-1.4142,0.0069,0.022,1.159,0.11,0.3,-1.0476,0.34,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_3383_ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF","C2_Chemical_and_genetic_perturbations","C2_CGP_3383_ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF",495,-1.4141,0,0.099,-1.0896,0.22,0.93,1.1868,0.033,0.78
"GO_BP:751231_GO_0036314_RESPONSE_TO_STEROL","GO_BP","751231_GO_0036314_RESPONSE_TO_STEROL",23,-1.414,0.079,0.16,-0.6281,0.96,1,-0.7084,0.89,0.99
"GO_BP:755328_GO_2001222_REGULATION_OF_NEURON_MIGRATION","GO_BP","755328_GO_2001222_REGULATION_OF_NEURON_MIGRATION",25,-1.4139,0.065,0.16,-0.7502,0.83,1,0.8206,0.78,0.99
"GO_MF:510413_GO_0048306_CALCIUM_DEPENDENT_PROTEIN_BINDING","GO_MF","510413_GO_0048306_CALCIUM_DEPENDENT_PROTEIN_BINDING",57,-1.4139,0.046,0.2,1.1188,0.25,0.77,1.0541,0.37,0.84
"GO_BP:495853_GO_0015718_MONOCARBOXYLIC_ACID_TRANSPORT","GO_BP","495853_GO_0015718_MONOCARBOXYLIC_ACID_TRANSPORT",106,-1.4138,0.02,0.16,-1.0824,0.28,0.95,1.0962,0.26,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_944_SCHLESINGER_METHYLATED_IN_COLON_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_944_SCHLESINGER_METHYLATED_IN_COLON_CANCER",10,-1.4137,0.08,0.099,1.1453,0.3,0.56,-0.8551,0.64,0.92
"GO_BP:487881_GO_0001991_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CIRCULATORY_RENIN_ANGIOTENSIN","GO_BP","487881_GO_0001991_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CIRCULATORY_RENIN_ANGIOTENSIN",16,-1.4137,0.078,0.16,1.6342,0.016,0.25,0.8812,0.63,0.96
"GO_BP:486717_GO_0000186_ACTIVATION_OF_MAPKK_ACTIVITY","GO_BP","486717_GO_0000186_ACTIVATION_OF_MAPKK_ACTIVITY",63,-1.4135,0.054,0.16,-0.8166,0.83,1,-0.8856,0.7,0.94
"GO_CC:499829_GO_0030485_SMOOTH_MUSCLE_CONTRACTILE_FIBER","GO_CC","499829_GO_0030485_SMOOTH_MUSCLE_CONTRACTILE_FIBER",5,-1.4135,0.089,0.21,-0.7804,0.72,1,-1.5458,0.032,0.49
"C7_Immunologic_signatures:C7_ALL_83_GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP","C7_Immunologic_signatures","C7_ALL_83_GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP",193,-1.4134,0.011,0.022,-0.9343,0.63,1,0.9584,0.56,1
"GO_BP:491931_GO_0030010_ESTABLISHMENT_OF_CELL_POLARITY","GO_BP","491931_GO_0030010_ESTABLISHMENT_OF_CELL_POLARITY",72,-1.4133,0.049,0.16,-0.8931,0.65,1,-1.2737,0.097,0.66
"WikiPathways:198914_WP1600_NICOTINE_METABOLISM","WikiPathways","198914_WP1600_NICOTINE_METABOLISM",6,-1.4133,0.083,0.11,-1.2954,0.19,1,1.9604,0,0.023
"GO_BP:499065_GO_0021785_BRANCHIOMOTOR_NEURON_AXON_GUIDANCE","GO_BP","499065_GO_0021785_BRANCHIOMOTOR_NEURON_AXON_GUIDANCE",6,-1.4132,0.081,0.16,-1.3374,0.14,0.9,-1.0005,0.48,0.85
"GO_BP:501900_GO_0032674_REGULATION_OF_INTERLEUKIN_5_PRODUCTION","GO_BP","501900_GO_0032674_REGULATION_OF_INTERLEUKIN_5_PRODUCTION",14,-1.4132,0.09,0.16,-0.8686,0.66,1,1.0106,0.44,0.84
"GO_BP:491676_GO_0017085_RESPONSE_TO_INSECTICIDE","GO_BP","491676_GO_0017085_RESPONSE_TO_INSECTICIDE",12,-1.4132,0.076,0.16,-0.9047,0.59,1,-1.4979,0.06,0.54
"GO_BP:517131_GO_0072215_REGULATION_OF_METANEPHROS_DEVELOPMENT","GO_BP","517131_GO_0072215_REGULATION_OF_METANEPHROS_DEVELOPMENT",23,-1.4132,0.07,0.16,0.9812,0.47,1,1.0571,0.38,0.8
"C7_Immunologic_signatures:C7_ALL_1423_GSE360_CTRL_VS_T_GONDII_MAC_UP","C7_Immunologic_signatures","C7_ALL_1423_GSE360_CTRL_VS_T_GONDII_MAC_UP",199,-1.4131,0.013,0.022,1.1924,0.09,0.24,-0.9089,0.7,0.93
"KEGG_compound:C00010_COA_COENZYME_A_COA_SH","KEGG_compound","C00010_COA_COENZYME_A_COA_SH",120,-1.4131,0.026,0.24,-0.828,0.87,1,-1.274,0.067,0.39
"GO_BP:505280_GO_0042104_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION","GO_BP","505280_GO_0042104_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION",24,-1.413,0.058,0.16,-1.088,0.35,0.95,-0.7605,0.82,1
"C3_MicroRNA_targets:C3_MIR_15_TGCACTT_MIR_519C_MIR_519B_MIR_519A","C3_MicroRNA_targets","C3_MIR_15_TGCACTT_MIR_519C_MIR_519B_MIR_519A",444,-1.4129,0,0.28,-0.7983,0.99,1,-0.9142,0.83,1
"GO_BP:505322_GO_0042159_LIPOPROTEIN_CATABOLIC_PROCESS","GO_BP","505322_GO_0042159_LIPOPROTEIN_CATABOLIC_PROCESS",7,-1.4128,0.093,0.16,-0.7326,0.81,1,-1.046,0.4,0.82
"GO_BP:498417_GO_0019585_GLUCURONATE_METABOLIC_PROCESS","GO_BP","498417_GO_0019585_GLUCURONATE_METABOLIC_PROCESS",25,-1.4128,0.072,0.16,1.5578,0.013,0.34,1.7064,0.0083,0.42
"GO_BP:753988_GO_1901018_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","753988_GO_1901018_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-1.4126,0.082,0.16,-1.3797,0.085,1,0.7665,0.79,1
"REACTOME:645344_REACT_121147_ALPHA_LINOLENIC_ACID_ALA_METABOLISM","REACTOME","645344_REACT_121147_ALPHA_LINOLENIC_ACID_ALA_METABOLISM",13,-1.4125,0.09,0.18,-1.2081,0.24,0.83,-1.9257,0.002,0.13
"C3_TF_targets:C3_TFT_134_V_AP2_Q6","C3_TF_targets","C3_TFT_134_V_AP2_Q6",255,-1.4124,0.0044,0.036,-1.2503,0.045,0.28,0.7687,0.98,1
"GO_BP:492513_GO_0046683_RESPONSE_TO_ORGANOPHOSPHORUS","GO_BP","492513_GO_0046683_RESPONSE_TO_ORGANOPHOSPHORUS",124,-1.4123,0.012,0.16,1.0218,0.4,0.97,1.0241,0.37,0.83
"REACTOME:645300_REACT_120996_HYALURONAN_UPTAKE_AND_DEGRADATION","REACTOME","645300_REACT_120996_HYALURONAN_UPTAKE_AND_DEGRADATION",12,-1.4123,0.068,0.18,-1.2683,0.2,0.7,0.644,0.91,1
"GO_BP:502184_GO_0032962_POSITIVE_REGULATION_OF_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","502184_GO_0032962_POSITIVE_REGULATION_OF_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS",5,-1.4123,0.064,0.16,0.9365,0.55,1,1.6323,0.012,0.4
"KEGG_pathway:HSA04726_SEROTONERGIC_SYNAPSE","KEGG_pathway","HSA04726_SEROTONERGIC_SYNAPSE",113,-1.4122,0.028,0.063,-1.0192,0.39,0.86,-0.8623,0.8,0.89
"GO_MF:496870_GO_0017049_GTP_RHO_BINDING","GO_MF","496870_GO_0017049_GTP_RHO_BINDING",13,-1.4121,0.099,0.2,-1.1427,0.31,0.82,-1.0749,0.34,0.72
"GO_BP:499436_GO_0050856_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY","GO_BP","499436_GO_0050856_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY",25,-1.4121,0.073,0.16,1.0142,0.41,0.97,-0.4695,1,1
"GO_BP:498071_GO_0019216_REGULATION_OF_LIPID_METABOLIC_PROCESS","GO_BP","498071_GO_0019216_REGULATION_OF_LIPID_METABOLIC_PROCESS",254,-1.4121,0.0056,0.16,0.8149,0.97,1,0.9372,0.65,0.91
"GO_BP:516603_GO_0071679_COMMISSURAL_NEURON_AXON_GUIDANCE","GO_BP","516603_GO_0071679_COMMISSURAL_NEURON_AXON_GUIDANCE",7,-1.412,0.082,0.16,-0.7596,0.77,1,-0.9451,0.54,0.89
"C3_TF_targets:C3_TFT_471_V_MEF2_Q6_01","C3_TF_targets","C3_TFT_471_V_MEF2_Q6_01",238,-1.4119,0.0078,0.036,-1.3598,0.0066,0.19,-1.2805,0.023,0.26
"GO_BP:506243_GO_0043171_PEPTIDE_CATABOLIC_PROCESS","GO_BP","506243_GO_0043171_PEPTIDE_CATABOLIC_PROCESS",13,-1.4119,0.087,0.16,0.4371,1,1,-0.855,0.63,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2185_IWANAGA_CARCINOGENESIS_BY_KRAS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2185_IWANAGA_CARCINOGENESIS_BY_KRAS_UP",168,-1.4118,0.013,0.1,0.9203,0.69,0.9,0.8783,0.78,1
"KEGG_pathway:HSA04910_INSULIN_SIGNALING_PATHWAY","KEGG_pathway","HSA04910_INSULIN_SIGNALING_PATHWAY",138,-1.4118,0.015,0.063,0.7298,0.98,1,-1.1577,0.16,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_937_SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_937_SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN",20,-1.4118,0.081,0.1,1.0097,0.43,0.78,-1.0183,0.41,0.73
"KEGG_pathway:HSA04512_ECM_RECEPTOR_INTERACTION","KEGG_pathway","HSA04512_ECM_RECEPTOR_INTERACTION",86,-1.4118,0.025,0.062,-1.0854,0.3,0.7,1.2943,0.073,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_1404_MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1404_MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN",23,-1.4117,0.076,0.1,0.8529,0.68,0.97,-1.4338,0.072,0.34
"WikiPathways:672446_WP2032_TSH_SIGNALING_PATHWAY","WikiPathways","672446_WP2032_TSH_SIGNALING_PATHWAY",63,-1.4116,0.042,0.11,1.0273,0.39,1,-1.3368,0.049,0.41
"GO_BP:505302_GO_0042130_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION","GO_BP","505302_GO_0042130_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION",45,-1.4115,0.051,0.16,0.7467,0.9,1,0.7825,0.85,1
"C7_Immunologic_signatures:C7_ALL_1319_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1319_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP",191,-1.4115,0.0068,0.022,0.9311,0.67,0.95,-1.2966,0.024,0.14
"GO_BP:502048_GO_0032825_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION","GO_BP","502048_GO_0032825_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION",8,-1.4114,0.098,0.16,-1.6318,0.024,0.7,-1.3807,0.11,0.59
"GO_MF:511516_GO_0050543_ICOSATETRAENOIC_ACID_BINDING","GO_MF","511516_GO_0050543_ICOSATETRAENOIC_ACID_BINDING",6,-1.4114,0.074,0.2,1.5141,0.053,0.36,1.5595,0.037,0.37
"GO_BP:497336_GO_0018401_PEPTIDYL_PROLINE_HYDROXYLATION_TO_4_HYDROXY_L_PROLINE","GO_BP","497336_GO_0018401_PEPTIDYL_PROLINE_HYDROXYLATION_TO_4_HYDROXY_L_PROLINE",6,-1.4111,0.078,0.16,-0.8395,0.68,1,-1.5332,0.034,0.53
"C4_Cancer_modules:C4_CM_50_MODULE_54","C4_Cancer_modules","C4_CM_50_MODULE_54",261,-1.411,0.0076,0.093,1.3347,0.014,0.24,-1.6434,0,0.11
"GO_CC:490882_GO_0005874_MICROTUBULE","GO_CC","490882_GO_0005874_MICROTUBULE",378,-1.4109,0.0032,0.21,-0.9756,0.54,0.88,-1.4419,0.002,0.51
"GO_MF:499846_GO_0030506_ANKYRIN_BINDING","GO_MF","499846_GO_0030506_ANKYRIN_BINDING",20,-1.4107,0.073,0.21,-1.0887,0.36,0.85,0.6244,0.96,1
"C7_Immunologic_signatures:C7_ALL_1460_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN","C7_Immunologic_signatures","C7_ALL_1460_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN",194,-1.4107,0.014,0.023,0.7603,0.98,1,-1.217,0.06,0.25
"GO_BP:514843_GO_0061298_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE","GO_BP","514843_GO_0061298_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE",18,-1.4106,0.084,0.16,0.9331,0.55,1,1.2826,0.15,0.69
"REACTOME:106483_REACT_12436_ERKS_ARE_INACTIVATED","REACTOME","106483_REACT_12436_ERKS_ARE_INACTIVATED",12,-1.4106,0.092,0.18,-0.5253,0.98,1,0.5617,0.97,1
"GO_BP:516229_GO_0071305_CELLULAR_RESPONSE_TO_VITAMIN_D","GO_BP","516229_GO_0071305_CELLULAR_RESPONSE_TO_VITAMIN_D",8,-1.4106,0.11,0.16,0.8224,0.68,1,1.6769,0.016,0.41
"C7_Immunologic_signatures:C7_ALL_1542_GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1542_GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN",188,-1.4106,0.016,0.023,-1.0075,0.43,1,-1.0304,0.36,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_1391_OKUMURA_INFLAMMATORY_RESPONSE_LPS","C2_Chemical_and_genetic_perturbations","C2_CGP_1391_OKUMURA_INFLAMMATORY_RESPONSE_LPS",182,-1.4104,0.0048,0.1,0.8974,0.75,0.93,0.8627,0.85,1
"GO_BP:519288_GO_2000649_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","519288_GO_2000649_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",37,-1.4103,0.059,0.16,-1.0169,0.41,0.98,-1.6015,0.02,0.51
"GO_BP:516463_GO_0071539_PROTEIN_LOCALIZATION_TO_CENTROSOME","GO_BP","516463_GO_0071539_PROTEIN_LOCALIZATION_TO_CENTROSOME",8,-1.4103,0.097,0.16,-1.3145,0.15,0.88,-1.2861,0.19,0.65
"GO_BP:508737_GO_0046477_GLYCOSYLCERAMIDE_CATABOLIC_PROCESS","GO_BP","508737_GO_0046477_GLYCOSYLCERAMIDE_CATABOLIC_PROCESS",5,-1.4102,0.078,0.16,-1.2811,0.23,0.89,-1.3396,0.13,0.61
"REACTOME:161073_REACT_22357_ORGANIC_CATION_TRANSPORT","REACTOME","161073_REACT_22357_ORGANIC_CATION_TRANSPORT",9,-1.41,0.093,0.18,-0.9947,0.47,0.99,-0.5818,0.96,1
"GO_MF:498055_GO_0019200_CARBOHYDRATE_KINASE_ACTIVITY","GO_MF","498055_GO_0019200_CARBOHYDRATE_KINASE_ACTIVITY",20,-1.4098,0.081,0.21,-0.8497,0.69,1,-0.8825,0.63,0.89
"GO_BP:515363_GO_0070431_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY","GO_BP","515363_GO_0070431_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY",5,-1.4097,0.083,0.16,-0.7441,0.77,1,-0.5032,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1906_SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1906_SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP",19,-1.4097,0.078,0.1,0.9217,0.58,0.9,0.837,0.7,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_241_MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_241_MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN",75,-1.4096,0.041,0.1,1.499,0.02,0.21,-0.526,1,1
"GO_BP:487785_GO_0001889_LIVER_DEVELOPMENT","GO_BP","487785_GO_0001889_LIVER_DEVELOPMENT",105,-1.4096,0.028,0.16,-0.5567,1,1,-0.9495,0.56,0.89
"GO_MF:499578_GO_0030159_RECEPTOR_SIGNALING_COMPLEX_SCAFFOLD_ACTIVITY","GO_MF","499578_GO_0030159_RECEPTOR_SIGNALING_COMPLEX_SCAFFOLD_ACTIVITY",23,-1.4096,0.069,0.21,-0.8785,0.65,1,0.6843,0.91,1
"GO_MF:492597_GO_0008273_CALCIUM_POTASSIUM_SODIUM_ANTIPORTER_ACTIVITY","GO_MF","492597_GO_0008273_CALCIUM_POTASSIUM_SODIUM_ANTIPORTER_ACTIVITY",5,-1.4096,0.066,0.21,0.5665,0.96,1,-0.7897,0.71,0.97
"C1_Positional:C1_ALL_253_CHR9P22","C1_Positional","C1_ALL_253_CHR9P22",32,-1.4094,0.06,0.48,1.0886,0.33,0.64,1.145,0.25,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_817_FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1","C2_Chemical_and_genetic_perturbations","C2_CGP_817_FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1",9,-1.4094,0.082,0.1,1.0936,0.35,0.64,1.0136,0.44,0.95
"C7_Immunologic_signatures:C7_ALL_622_GSE17721_POLYIC_VS_CPG_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_622_GSE17721_POLYIC_VS_CPG_2H_BMDM_DN",195,-1.4093,0.015,0.023,0.9201,0.68,0.98,1.0511,0.32,1
"GO_CC:499561_GO_0030132_CLATHRIN_COAT_OF_COATED_PIT","GO_CC","499561_GO_0030132_CLATHRIN_COAT_OF_COATED_PIT",16,-1.4093,0.075,0.21,0.884,0.62,0.91,0.5967,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_674_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29","C2_Chemical_and_genetic_perturbations","C2_CGP_674_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29",7,-1.4093,0.09,0.1,0.8822,0.61,0.94,-1.1172,0.31,0.61
"C6_Oncogenic_signatures:C6_ALL_142_PDGF_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_142_PDGF_UP_V1_UP",141,-1.4092,0.018,0.03,-1.052,0.33,0.58,-0.7498,0.98,0.99
"GO_BP:498085_GO_0019233_SENSORY_PERCEPTION_OF_PAIN","GO_BP","498085_GO_0019233_SENSORY_PERCEPTION_OF_PAIN",66,-1.4092,0.042,0.16,-1.0329,0.41,0.98,1.2165,0.16,0.71
"GO_BP:516280_GO_0071356_CELLULAR_RESPONSE_TO_TUMOR_NECROSIS_FACTOR","GO_BP","516280_GO_0071356_CELLULAR_RESPONSE_TO_TUMOR_NECROSIS_FACTOR",94,-1.4092,0.032,0.16,0.96,0.52,1,1.4209,0.021,0.62
"GO_BP:498843_GO_0021559_TRIGEMINAL_NERVE_DEVELOPMENT","GO_BP","498843_GO_0021559_TRIGEMINAL_NERVE_DEVELOPMENT",9,-1.4091,0.11,0.16,-1.0306,0.42,0.98,1.0553,0.38,0.8
"GO_BP:487667_GO_0001771_IMMUNOLOGICAL_SYNAPSE_FORMATION","GO_BP","487667_GO_0001771_IMMUNOLOGICAL_SYNAPSE_FORMATION",6,-1.4091,0.091,0.16,-0.9923,0.48,1,-1.6541,0.018,0.52
"REACTOME:119525_REACT_19199_CRMPS_IN_SEMA3A_SIGNALING","REACTOME","119525_REACT_19199_CRMPS_IN_SEMA3A_SIGNALING",15,-1.4091,0.091,0.18,-0.8244,0.69,1,-1.2394,0.2,0.57
"GO_BP:494727_GO_0010664_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","494727_GO_0010664_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS",12,-1.4089,0.089,0.16,0.6745,0.89,1,-1.1271,0.3,0.75
"GO_BP:502229_GO_0033007_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","502229_GO_0033007_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",5,-1.4089,0.074,0.16,-0.5569,0.94,1,1.3539,0.15,0.64
"GO_BP:515766_GO_0070838_DIVALENT_METAL_ION_TRANSPORT","GO_BP","515766_GO_0070838_DIVALENT_METAL_ION_TRANSPORT",254,-1.4088,0.0022,0.16,-1.2295,0.05,0.89,1.0997,0.2,0.76
"GO_BP:755320_GO_2001214_POSITIVE_REGULATION_OF_VASCULOGENESIS","GO_BP","755320_GO_2001214_POSITIVE_REGULATION_OF_VASCULOGENESIS",8,-1.4088,0.084,0.16,1.0571,0.39,0.94,0.982,0.48,0.87
"C7_Immunologic_signatures:C7_ALL_1188_GSE27786_BCELL_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1188_GSE27786_BCELL_VS_NEUTROPHIL_DN",193,-1.4088,0.0056,0.023,0.8703,0.85,1,-0.9133,0.72,0.92
"REACTOME:530739_REACT_115896_GRB7_EVENTS_IN_ERBB2_SIGNALING","REACTOME","530739_REACT_115896_GRB7_EVENTS_IN_ERBB2_SIGNALING",5,-1.4088,0.099,0.18,-1.4357,0.086,0.5,0.7493,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_588_RIZ_ERYTHROID_DIFFERENTIATION_CCNE1","C2_Chemical_and_genetic_perturbations","C2_CGP_588_RIZ_ERYTHROID_DIFFERENTIATION_CCNE1",40,-1.4087,0.059,0.1,0.6778,0.95,1,-1.2434,0.14,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_1002_NAKAYAMA_FRA2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1002_NAKAYAMA_FRA2_TARGETS",42,-1.4087,0.045,0.1,1.0742,0.33,0.67,0.9854,0.5,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1093_TAGHAVI_NEOPLASTIC_TRANSFORMATION","C2_Chemical_and_genetic_perturbations","C2_CGP_1093_TAGHAVI_NEOPLASTIC_TRANSFORMATION",12,-1.4086,0.089,0.1,-1.4521,0.065,0.53,-1.3334,0.14,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2323_MATZUK_MATERNAL_EFFECT","C2_Chemical_and_genetic_perturbations","C2_CGP_2323_MATZUK_MATERNAL_EFFECT",9,-1.4086,0.091,0.1,-0.665,0.88,1,1.0297,0.41,0.93
"GO_BP:498977_GO_0021694_CEREBELLAR_PURKINJE_CELL_LAYER_FORMATION","GO_BP","498977_GO_0021694_CEREBELLAR_PURKINJE_CELL_LAYER_FORMATION",11,-1.4086,0.082,0.16,-0.9752,0.48,1,-0.7822,0.77,1
"GO_BP:488559_GO_0002686_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION","GO_BP","488559_GO_0002686_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION",27,-1.4082,0.071,0.16,-0.8407,0.72,1,1.5302,0.022,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1403_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1","C2_Chemical_and_genetic_perturbations","C2_CGP_1403_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1",9,-1.4082,0.087,0.1,-0.9403,0.53,1,-1.2555,0.17,0.47
"GO_MF:490491_GO_0005262_CALCIUM_CHANNEL_ACTIVITY","GO_MF","490491_GO_0005262_CALCIUM_CHANNEL_ACTIVITY",107,-1.4082,0.026,0.21,-1.6754,0.0054,0.37,-1.0073,0.45,0.78
"GO_BP:497854_GO_0018958_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","497854_GO_0018958_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS",81,-1.4082,0.045,0.16,-0.9131,0.63,1,-0.925,0.62,0.91
"REACTOME:833816_REACT_163813_SCAVENGING_BY_CLASS_F_RECEPTORS","REACTOME","833816_REACT_163813_SCAVENGING_BY_CLASS_F_RECEPTORS",6,-1.4082,0.083,0.18,0.4979,0.98,1,-1.399,0.12,0.41
"C4_Cancer_gene_neighborhoods:C4_CGN_98_MORF_ESR1","C4_Cancer_gene_neighborhoods","C4_CGN_98_MORF_ESR1",165,-1.4081,0.0095,0.12,-1.0674,0.29,0.75,-1.1153,0.19,0.6
"GO_MF:495422_GO_0015149_HEXOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495422_GO_0015149_HEXOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-1.4081,0.081,0.21,-1.0906,0.34,0.85,-0.9849,0.48,0.79
"GO_BP:982378_GO_1902808_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION","GO_BP","982378_GO_1902808_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION",22,-1.408,0.062,0.16,-0.8667,0.66,1,-1.3558,0.088,0.6
"C3_TF_targets:C3_TFT_366_V_ICSBP_Q6","C3_TF_targets","C3_TFT_366_V_ICSBP_Q6",241,-1.4079,0.0089,0.038,0.864,0.85,1,-1.042,0.33,0.64
"GO_BP:491810_GO_0006971_HYPOTONIC_RESPONSE","GO_BP","491810_GO_0006971_HYPOTONIC_RESPONSE",8,-1.4078,0.1,0.16,-0.4349,1,1,-0.9476,0.53,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1645_ZHOU_TNF_SIGNALING_4HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1645_ZHOU_TNF_SIGNALING_4HR",54,-1.4077,0.059,0.1,1.6053,0.011,0.14,-0.8982,0.66,0.88
"GO_BP:508117_GO_0045780_POSITIVE_REGULATION_OF_BONE_RESORPTION","GO_BP","508117_GO_0045780_POSITIVE_REGULATION_OF_BONE_RESORPTION",14,-1.4077,0.09,0.16,-0.8319,0.68,1,-0.8326,0.7,0.97
"C6_Oncogenic_signatures:C6_ALL_72_PRC1_BMI_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_72_PRC1_BMI_UP_V1_UP",186,-1.4076,0.0046,0.03,-1.155,0.13,0.49,-1.2036,0.094,0.36
"REACTOME:106384_REACT_16888_SIGNALING_BY_PDGF","REACTOME","106384_REACT_16888_SIGNALING_BY_PDGF",178,-1.4076,0.012,0.18,-1.033,0.38,0.97,-1.2085,0.08,0.59
"GO_BP:499308_GO_0022029_TELENCEPHALON_CELL_MIGRATION","GO_BP","499308_GO_0022029_TELENCEPHALON_CELL_MIGRATION",54,-1.4076,0.048,0.16,-1.33,0.078,0.9,1.1929,0.18,0.72
"GO_BP:491685_GO_0006816_CALCIUM_ION_TRANSPORT","GO_BP","491685_GO_0006816_CALCIUM_ION_TRANSPORT",212,-1.4076,0.01,0.16,-1.2595,0.043,0.91,1.1654,0.12,0.73
"C6_Oncogenic_signatures:C6_ALL_99_ESC_V6_5_UP_LATE_V1_DN","C6_Oncogenic_signatures","C6_ALL_99_ESC_V6_5_UP_LATE_V1_DN",164,-1.4075,0.015,0.03,-0.8653,0.82,0.97,-0.9025,0.73,0.8
"C3_TF_targets:C3_TFT_372_V_MYOGENIN_Q6","C3_TF_targets","C3_TFT_372_V_MYOGENIN_Q6",248,-1.4075,0.0099,0.038,-1.2836,0.034,0.25,-1.1244,0.17,0.48
"GO_BP:490419_GO_0045741_POSITIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY","GO_BP","490419_GO_0045741_POSITIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",11,-1.4074,0.086,0.16,-0.9597,0.48,1,-0.7518,0.79,1
"C3_MicroRNA_targets:C3_MIR_46_GCACCTT_MIR_18A_MIR_18B","C3_MicroRNA_targets","C3_MIR_46_GCACCTT_MIR_18A_MIR_18B",117,-1.4072,0.026,0.28,-1.0219,0.4,1,-1.0088,0.41,1
"GO_BP:491089_GO_0006110_REGULATION_OF_GLYCOLYTIC_PROCESS","GO_BP","491089_GO_0006110_REGULATION_OF_GLYCOLYTIC_PROCESS",26,-1.4072,0.073,0.16,0.9295,0.57,1,1.6793,0.0096,0.42
"C7_Immunologic_signatures:C7_ALL_1044_GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1044_GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN",197,-1.4071,0.008,0.024,1.132,0.19,0.36,1.0041,0.44,1
"C3_TF_targets:C3_TFT_611_TTCYNRGAA_V_STAT5B_01","C3_TF_targets","C3_TFT_611_TTCYNRGAA_V_STAT5B_01",328,-1.407,0.0021,0.038,0.8929,0.84,1,-0.9212,0.73,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_765_NEBEN_AML_WITH_FLT3_OR_NRAS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_765_NEBEN_AML_WITH_FLT3_OR_NRAS_DN",12,-1.4069,0.095,0.1,1.4633,0.087,0.24,-0.8734,0.61,0.91
"GO_BP:505499_GO_0042355_L_FUCOSE_CATABOLIC_PROCESS","GO_BP","505499_GO_0042355_L_FUCOSE_CATABOLIC_PROCESS",9,-1.4069,0.088,0.16,0.684,0.86,1,-1.0668,0.4,0.8
"GO_BP:491976_GO_0007173_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","491976_GO_0007173_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",192,-1.4069,0.008,0.16,-1.0337,0.36,0.98,-1.0731,0.27,0.8
"KEGG_module:HSA_M00099_SPHINGOSINE_BIOSYNTHESIS","KEGG_module","HSA_M00099_SPHINGOSINE_BIOSYNTHESIS",16,-1.4067,0.09,0.42,-1.145,0.3,1,-1.4176,0.055,0.48
"GO_BP:501297_GO_0032060_BLEB_ASSEMBLY","GO_BP","501297_GO_0032060_BLEB_ASSEMBLY",9,-1.4066,0.088,0.16,1.2968,0.18,0.67,1.3453,0.12,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_492_SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_492_SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP",15,-1.4066,0.096,0.1,-0.7033,0.86,1,1.0825,0.36,0.88
"GO_CC:500621_GO_0031362_ANCHORED_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE","GO_CC","500621_GO_0031362_ANCHORED_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE",18,-1.4066,0.079,0.21,1.384,0.08,0.3,0.9707,0.49,1
"GO_BP:517119_GO_0072203_CELL_PROLIFERATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT","GO_BP","517119_GO_0072203_CELL_PROLIFERATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT",7,-1.4064,0.1,0.16,0.6115,0.92,1,-1.3589,0.14,0.6
"C3_TF_targets:C3_TFT_62_ACAWYAAAG_UNKNOWN","C3_TF_targets","C3_TFT_62_ACAWYAAAG_UNKNOWN",96,-1.4064,0.03,0.038,0.9967,0.48,1,1.1998,0.13,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2674_ISHIDA_E2F_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2674_ISHIDA_E2F_TARGETS",52,-1.4063,0.056,0.1,0.8191,0.77,0.98,-1.9487,0,0.06
"C1_Positional:C1_ALL_227_CHR10P12","C1_Positional","C1_ALL_227_CHR10P12",44,-1.4063,0.047,0.47,0.9728,0.5,0.79,-0.8895,0.66,0.98
"GO_MF:501782_GO_0032552_DEOXYRIBONUCLEOTIDE_BINDING","GO_MF","501782_GO_0032552_DEOXYRIBONUCLEOTIDE_BINDING",9,-1.4063,0.086,0.21,1.489,0.07,0.39,-1.5881,0.032,0.38
"C4_Cancer_modules:C4_CM_188_MODULE_201","C4_Cancer_modules","C4_CM_188_MODULE_201",50,-1.4063,0.044,0.096,-1.1735,0.19,0.63,-0.9458,0.57,0.78
"KEGG_reaction:R01274_PALMITOYL_COA_HYDROLASE_PALMITOYL_COA_H2O_COA_HEXADECANOIC_ACID","KEGG_reaction","R01274_PALMITOYL_COA_HYDROLASE_PALMITOYL_COA_H2O_COA_HEXADECANOIC_ACID",6,-1.4062,0.1,0.29,-0.6529,0.9,0.98,0.6439,0.9,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1299_PENG_GLUCOSE_DEPRIVATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1299_PENG_GLUCOSE_DEPRIVATION_UP",46,-1.4059,0.059,0.1,-0.8413,0.75,1,-1.5767,0.014,0.25
"GO_BP:502152_GO_0032930_POSITIVE_REGULATION_OF_SUPEROXIDE_ANION_GENERATION","GO_BP","502152_GO_0032930_POSITIVE_REGULATION_OF_SUPEROXIDE_ANION_GENERATION",8,-1.4059,0.095,0.16,1.1301,0.31,0.87,0.8501,0.67,0.98
"GO_CC:500524_GO_0031265_CD95_DEATH_INDUCING_SIGNALING_COMPLEX","GO_CC","500524_GO_0031265_CD95_DEATH_INDUCING_SIGNALING_COMPLEX",6,-1.4057,0.088,0.21,-0.8987,0.58,0.95,-0.9709,0.51,1
"GO_MF:511636_GO_0050664_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_OXYGEN_AS_ACCEPTOR","GO_MF","511636_GO_0050664_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_OXYGEN_AS_ACCEPTOR",14,-1.4057,0.09,0.21,-0.9398,0.54,0.95,-0.8936,0.62,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2735_HOSHIDA_LIVER_CANCER_SURVIVAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2735_HOSHIDA_LIVER_CANCER_SURVIVAL_UP",72,-1.4057,0.041,0.1,0.8984,0.65,0.93,0.8263,0.83,1
"GO_BP:508067_GO_0045723_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS","GO_BP","508067_GO_0045723_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS",14,-1.4056,0.091,0.16,0.9516,0.49,1,-1.0365,0.4,0.82
"GO_CC:507312_GO_0044306_NEURON_PROJECTION_TERMINUS","GO_CC","507312_GO_0044306_NEURON_PROJECTION_TERMINUS",86,-1.4055,0.036,0.21,1.0448,0.37,0.72,1.1036,0.25,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2721_CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2721_CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP",170,-1.4054,0.014,0.1,-0.8276,0.89,1,-1.2184,0.08,0.5
"GO_BP:514221_GO_0060666_DICHOTOMOUS_SUBDIVISION_OF_TERMINAL_UNITS_INVOLVED_IN_SALIVARY_GLAND_BRANCHING","GO_BP","514221_GO_0060666_DICHOTOMOUS_SUBDIVISION_OF_TERMINAL_UNITS_INVOLVED_IN_SALIVARY_GLAND_BRANCHING",5,-1.4054,0.075,0.16,-0.954,0.51,1,0.8427,0.64,0.99
"C7_Immunologic_signatures:C7_ALL_213_GSE13493_DP_VS_CD8POS_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_213_GSE13493_DP_VS_CD8POS_THYMOCYTE_UP",196,-1.4053,0.0091,0.024,-0.9263,0.64,1,-1.1907,0.11,0.3
"C3_TF_targets:C3_TFT_270_V_STAT5A_02","C3_TF_targets","C3_TFT_270_V_STAT5A_02",135,-1.4053,0.013,0.038,-0.7284,0.98,1,-0.9489,0.59,0.85
"C3_TF_targets:C3_TFT_272_V_GATA6_01","C3_TF_targets","C3_TFT_272_V_GATA6_01",254,-1.4052,0.0087,0.038,-0.9543,0.58,0.86,1.2404,0.045,0.58
"GO_BP:487955_GO_0002065_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","487955_GO_0002065_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION",118,-1.4052,0.023,0.16,1.0838,0.28,0.92,1.3138,0.051,0.66
"REACTOME:1127553_REACT_263897_CELLULAR_RESPONSE_TO_HEAT_STRESS","REACTOME","1127553_REACT_263897_CELLULAR_RESPONSE_TO_HEAT_STRESS",86,-1.4051,0.036,0.19,0.8477,0.81,0.96,-1.7476,0,0.24
"C2_Chemical_and_genetic_perturbations:C2_CGP_2833_LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2833_LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP",7,-1.405,0.11,0.1,-1.0983,0.35,0.92,-1.6363,0.0065,0.22
"GO_BP:498273_GO_0019433_TRIGLYCERIDE_CATABOLIC_PROCESS","GO_BP","498273_GO_0019433_TRIGLYCERIDE_CATABOLIC_PROCESS",20,-1.405,0.082,0.16,1.21,0.2,0.78,-0.9632,0.49,0.88
"GO_MF:489476_GO_0019829_CATION_TRANSPORTING_ATPASE_ACTIVITY","GO_MF","489476_GO_0019829_CATION_TRANSPORTING_ATPASE_ACTIVITY",52,-1.405,0.046,0.21,0.9439,0.52,0.94,-0.812,0.79,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_3308_PEDRIOLI_MIR31_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3308_PEDRIOLI_MIR31_TARGETS_UP",210,-1.4049,0.0089,0.1,-0.8964,0.74,1,-0.9824,0.51,0.78
"C4_Cancer_gene_neighborhoods:C4_CGN_386_GNF2_MYL3","C4_Cancer_gene_neighborhoods","C4_CGN_386_GNF2_MYL3",30,-1.4049,0.078,0.12,-1.4533,0.034,0.38,1.1271,0.28,0.58
"GO_BP:491673_GO_0072593_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS","GO_BP","491673_GO_0072593_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS",114,-1.4048,0.024,0.16,0.8981,0.73,1,-0.8106,0.9,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_54_KOBAYASHI_EGFR_SIGNALING_6HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_54_KOBAYASHI_EGFR_SIGNALING_6HR_UP",7,-1.4048,0.089,0.1,0.7973,0.72,0.99,-1.3214,0.16,0.41
"REACTOME:106219_REACT_532_GALACTOSE_CATABOLISM","REACTOME","106219_REACT_532_GALACTOSE_CATABOLISM",5,-1.4048,0.08,0.19,-1.1526,0.31,0.85,-1.4149,0.1,0.4
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_194_BIOCARTA_TEL_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_194_BIOCARTA_TEL_PATHWAY",18,-1.4048,0.091,0.19,0.5587,0.98,1,-1.1616,0.25,0.58
"GO_BP:514243_GO_0060688_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE","GO_BP","514243_GO_0060688_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE",51,-1.4047,0.043,0.16,1.3996,0.036,0.55,1.7216,0.0019,0.43
"GO_BP:519290_GO_2000651_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","519290_GO_2000651_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",11,-1.4045,0.087,0.17,-0.9678,0.51,1,-1.0506,0.39,0.81
"GO_BP:506649_GO_0043618_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS","GO_BP","506649_GO_0043618_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS",53,-1.4045,0.038,0.17,0.813,0.82,1,0.7389,0.92,1
"C7_Immunologic_signatures:C7_ALL_301_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_301_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP",198,-1.4044,0.0078,0.025,1.3672,0.013,0.052,-1.4773,0.0022,0.027
"GO_BP:505052_GO_0035883_ENTEROENDOCRINE_CELL_DIFFERENTIATION","GO_BP","505052_GO_0035883_ENTEROENDOCRINE_CELL_DIFFERENTIATION",16,-1.4043,0.082,0.17,1.042,0.4,0.96,1.269,0.16,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1419_BECKER_TAMOXIFEN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1419_BECKER_TAMOXIFEN_RESISTANCE_DN",52,-1.4043,0.052,0.1,1.3733,0.035,0.32,1.2036,0.17,0.77
"GO_BP:511830_GO_0050892_INTESTINAL_ABSORPTION","GO_BP","511830_GO_0050892_INTESTINAL_ABSORPTION",18,-1.4042,0.08,0.17,-1.2308,0.21,0.9,0.9702,0.49,0.89
"C4_Cancer_gene_neighborhoods:C4_CGN_395_GNF2_PTPN6","C4_Cancer_gene_neighborhoods","C4_CGN_395_GNF2_PTPN6",47,-1.4039,0.046,0.12,1.4008,0.062,0.061,-1.0714,0.36,0.67
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_2_BIOCARTA_NO1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_2_BIOCARTA_NO1_PATHWAY",30,-1.4037,0.071,0.19,1.4933,0.042,0.4,-1.2168,0.18,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_111_PIEPOLI_LGI1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_111_PIEPOLI_LGI1_TARGETS_DN",14,-1.4037,0.095,0.1,-0.8368,0.66,1,-1.3134,0.14,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_844_OXFORD_RALA_OR_RALB_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_844_OXFORD_RALA_OR_RALB_TARGETS_UP",48,-1.4037,0.044,0.1,-0.9363,0.55,1,-1.1017,0.27,0.62
"GO_BP:488889_GO_0003093_REGULATION_OF_GLOMERULAR_FILTRATION","GO_BP","488889_GO_0003093_REGULATION_OF_GLOMERULAR_FILTRATION",12,-1.4037,0.097,0.17,1.6119,0.019,0.28,1.1575,0.25,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2382_BRUECKNER_TARGETS_OF_MIRLET7A3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2382_BRUECKNER_TARGETS_OF_MIRLET7A3_DN",75,-1.4035,0.029,0.1,1.1558,0.2,0.55,1.398,0.042,0.54
"GO_MF:490620_GO_0005516_CALMODULIN_BINDING","GO_MF","490620_GO_0005516_CALMODULIN_BINDING",173,-1.4035,0.011,0.21,-1.3518,0.019,0.69,-1.2653,0.048,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_2800_TSAI_DNAJB4_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2800_TSAI_DNAJB4_TARGETS_UP",13,-1.4032,0.088,0.1,1.5931,0.016,0.14,-1.0303,0.4,0.71
"C7_Immunologic_signatures:C7_ALL_888_GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN","C7_Immunologic_signatures","C7_ALL_888_GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN",197,-1.4032,0.01,0.025,-1.0526,0.33,1,0.8519,0.88,1
"GO_BP:489023_GO_0003229_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","489023_GO_0003229_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",46,-1.4031,0.059,0.17,0.8562,0.73,1,1.084,0.3,0.77
"GO_BP:506193_GO_0043116_NEGATIVE_REGULATION_OF_VASCULAR_PERMEABILITY","GO_BP","506193_GO_0043116_NEGATIVE_REGULATION_OF_VASCULAR_PERMEABILITY",9,-1.4029,0.1,0.17,0.9244,0.57,1,-1.1282,0.32,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_3168_VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3168_VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN",35,-1.4028,0.078,0.11,-1.1259,0.3,0.89,-0.8981,0.63,0.88
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_77_BIOCARTA_GABA_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_77_BIOCARTA_GABA_PATHWAY",9,-1.4028,0.087,0.19,-0.6974,0.86,1,0.9777,0.46,1
"GO_BP:498985_GO_0021702_CEREBELLAR_PURKINJE_CELL_DIFFERENTIATION","GO_BP","498985_GO_0021702_CEREBELLAR_PURKINJE_CELL_DIFFERENTIATION",11,-1.4027,0.095,0.17,-0.9476,0.51,1,-0.7965,0.74,0.99
"C7_Immunologic_signatures:C7_ALL_1547_GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1547_GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP",187,-1.4026,0.0094,0.025,1.4156,0.0048,0.033,-1.4866,0.0021,0.025
"C7_Immunologic_signatures:C7_ALL_492_GSE17721_CTRL_VS_PAM3CSK4_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_492_GSE17721_CTRL_VS_PAM3CSK4_12H_BMDM_DN",192,-1.4025,0.016,0.025,0.7716,0.97,1,-0.8849,0.82,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2226_HUANG_FOXA2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2226_HUANG_FOXA2_TARGETS_DN",35,-1.4024,0.062,0.11,0.8055,0.8,0.99,1.0458,0.38,0.92
"KEGG_compound:C03344_2_METHYLACETOACETYL_COA_2_METHYL_3_ACETOACETYL_COA","KEGG_compound","C03344_2_METHYLACETOACETYL_COA_2_METHYL_3_ACETOACETYL_COA",6,-1.4024,0.092,0.26,0.7931,0.72,1,-1.261,0.21,0.41
"GO_BP:506470_GO_0043433_NEGATIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY","GO_BP","506470_GO_0043433_NEGATIVE_REGULATION_OF_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",128,-1.4024,0.018,0.17,-0.9779,0.5,1,-1.1711,0.14,0.73
"GO_MF:505740_GO_0042625_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS","GO_MF","505740_GO_0042625_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS",55,-1.4024,0.066,0.21,0.9808,0.5,0.9,-0.9126,0.64,0.87
"C7_Immunologic_signatures:C7_ALL_935_GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_935_GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP",192,-1.4024,0.013,0.025,1.0388,0.32,0.62,-1.4112,0.0082,0.055
"REACTOME:160975_REACT_508_SIGNAL_ATTENUATION","REACTOME","160975_REACT_508_SIGNAL_ATTENUATION",13,-1.4024,0.088,0.19,-0.7943,0.73,1,-1.1735,0.27,0.63
"GO_BP:516560_GO_0071636_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION","GO_BP","516560_GO_0071636_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION",12,-1.4024,0.089,0.17,-0.9529,0.52,1,-0.8279,0.67,0.97
"GO_BP:754561_GO_1901605_ALPHA_AMINO_ACID_METABOLIC_PROCESS","GO_BP","754561_GO_1901605_ALPHA_AMINO_ACID_METABOLIC_PROCESS",245,-1.4023,0.0022,0.17,-1.0077,0.42,0.98,-1.3965,0.004,0.57
"C7_Immunologic_signatures:C7_ALL_75_GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP","C7_Immunologic_signatures","C7_ALL_75_GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP",194,-1.4022,0.011,0.025,1.2189,0.087,0.2,-0.8919,0.76,0.96
"C3_MicroRNA_targets:C3_MIR_6_GTGCAAT_MIR_25_MIR_32_MIR_92_MIR_363_MIR_367","C3_MicroRNA_targets","C3_MIR_6_GTGCAAT_MIR_25_MIR_32_MIR_92_MIR_363_MIR_367",307,-1.4021,0.0022,0.28,-0.8995,0.81,1,-1.1449,0.13,1
"C4_Cancer_gene_neighborhoods:C4_CGN_407_GNF2_SERPINI2","C4_Cancer_gene_neighborhoods","C4_CGN_407_GNF2_SERPINI2",20,-1.4021,0.095,0.12,1.29,0.15,0.13,-1.0409,0.4,0.75
"GO_BP:512750_GO_0051895_NEGATIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY","GO_BP","512750_GO_0051895_NEGATIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY",12,-1.402,0.093,0.17,0.9584,0.5,1,-0.7852,0.74,1
"GO_BP:502040_GO_0032817_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION","GO_BP","502040_GO_0032817_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION",7,-1.4018,0.097,0.17,-1.3192,0.14,0.89,-0.9761,0.51,0.88
"GO_MF:499625_GO_0030215_SEMAPHORIN_RECEPTOR_BINDING","GO_MF","499625_GO_0030215_SEMAPHORIN_RECEPTOR_BINDING",10,-1.4017,0.087,0.21,0.8147,0.7,1,0.8129,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1406_PENG_GLUCOSE_DEPRIVATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1406_PENG_GLUCOSE_DEPRIVATION_DN",165,-1.4017,0.014,0.11,1.101,0.22,0.63,-1.1349,0.17,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_904_HASINA_NOL7_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_904_HASINA_NOL7_TARGETS_DN",13,-1.4016,0.084,0.11,1.6074,0.023,0.13,1.3566,0.11,0.56
"GO_BP:751911_GO_0052695_CELLULAR_GLUCURONIDATION","GO_BP","751911_GO_0052695_CELLULAR_GLUCURONIDATION",24,-1.4016,0.076,0.17,1.609,0.02,0.28,1.7745,0.0078,0.33
"GO_BP:507982_GO_0045634_REGULATION_OF_MELANOCYTE_DIFFERENTIATION","GO_BP","507982_GO_0045634_REGULATION_OF_MELANOCYTE_DIFFERENTIATION",7,-1.4016,0.095,0.17,1.0503,0.38,0.95,-1.0796,0.37,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_28_HOLLMANN_APOPTOSIS_VIA_CD40_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_28_HOLLMANN_APOPTOSIS_VIA_CD40_DN",262,-1.4015,0.0088,0.11,1.2567,0.03,0.43,-1.3747,0.011,0.38
"GO_BP:508905_GO_0046661_MALE_SEX_DIFFERENTIATION","GO_BP","508905_GO_0046661_MALE_SEX_DIFFERENTIATION",144,-1.4015,0.015,0.17,-0.943,0.6,1,1.0411,0.35,0.82
"C7_Immunologic_signatures:C7_ALL_1584_GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN","C7_Immunologic_signatures","C7_ALL_1584_GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN",193,-1.4015,0.011,0.026,-1.0032,0.44,1,1.1127,0.2,0.96
"GO_BP:514699_GO_0061154_ENDOTHELIAL_TUBE_MORPHOGENESIS","GO_BP","514699_GO_0061154_ENDOTHELIAL_TUBE_MORPHOGENESIS",8,-1.4014,0.089,0.17,-1.0483,0.4,0.97,0.9762,0.5,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1749_NIELSEN_LIPOSARCOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1749_NIELSEN_LIPOSARCOMA_UP",18,-1.4014,0.083,0.11,-1.2562,0.18,0.74,1.4434,0.08,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_755_XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_755_XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN",27,-1.4013,0.073,0.11,-0.7084,0.91,1,-0.7642,0.84,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2591_LEE_INTRATHYMIC_T_PROGENITOR","C2_Chemical_and_genetic_perturbations","C2_CGP_2591_LEE_INTRATHYMIC_T_PROGENITOR",21,-1.4013,0.088,0.11,-0.6105,0.96,1,-1.1546,0.25,0.57
"GO_BP:486696_GO_0000165_MAPK_CASCADE","GO_BP","486696_GO_0000165_MAPK_CASCADE",196,-1.4012,0.011,0.17,-0.7209,0.99,1,-0.8582,0.88,0.96
"GO_MF:490492_GO_0005267_POTASSIUM_CHANNEL_ACTIVITY","GO_MF","490492_GO_0005267_POTASSIUM_CHANNEL_ACTIVITY",117,-1.4011,0.024,0.21,-1.1293,0.19,0.82,1.4144,0.016,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_1100_HE_PTEN_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1100_HE_PTEN_TARGETS_DN",6,-1.4011,0.1,0.11,-1.2745,0.19,0.71,0.8298,0.67,1
"GO_BP:513493_GO_0072506_TRIVALENT_INORGANIC_ANION_HOMEOSTASIS","GO_BP","513493_GO_0072506_TRIVALENT_INORGANIC_ANION_HOMEOSTASIS",11,-1.401,0.082,0.17,-0.9599,0.51,1,-1.0694,0.36,0.8
"GO_BP:501828_GO_0032602_CHEMOKINE_PRODUCTION","GO_BP","501828_GO_0032602_CHEMOKINE_PRODUCTION",9,-1.401,0.11,0.17,0.7258,0.83,1,-1.0071,0.46,0.84
"GO_BP:499437_GO_0050862_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY","GO_BP","499437_GO_0050862_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY",7,-1.4009,0.1,0.17,0.7083,0.81,1,-0.8471,0.63,0.96
"C7_Immunologic_signatures:C7_ALL_1544_GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1544_GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN",197,-1.4008,0.0057,0.026,-0.9538,0.56,1,-0.8641,0.85,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_48_BIOCARTA_CXCR4_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_48_BIOCARTA_CXCR4_PATHWAY",23,-1.4008,0.072,0.19,0.5412,0.99,1,1.0111,0.44,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_520_HUMMERICH_MALIGNANT_SKIN_TUMOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_520_HUMMERICH_MALIGNANT_SKIN_TUMOR_UP",15,-1.4007,0.099,0.11,1.2701,0.15,0.42,1.834,0.0021,0.23
"GO_MF:492805_GO_0008526_PHOSPHATIDYLINOSITOL_TRANSPORTER_ACTIVITY","GO_MF","492805_GO_0008526_PHOSPHATIDYLINOSITOL_TRANSPORTER_ACTIVITY",5,-1.4007,0.097,0.21,-1.1574,0.3,0.81,0.8353,0.65,1
"C7_Immunologic_signatures:C7_ALL_1394_GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN","C7_Immunologic_signatures","C7_ALL_1394_GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN",200,-1.4007,0.014,0.026,0.8958,0.76,1,-1.2233,0.066,0.24
"C3_TF_targets:C3_TFT_198_V_NFY_01","C3_TF_targets","C3_TFT_198_V_NFY_01",250,-1.4007,0.0078,0.04,-1.1423,0.14,0.45,-1.4844,0,0.25
"GO_BP:516423_GO_0071499_CELLULAR_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS","GO_BP","516423_GO_0071499_CELLULAR_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS",8,-1.4004,0.095,0.17,-0.5933,0.93,1,-1.1212,0.33,0.76
"REACTOME:645313_REACT_121401_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS","REACTOME","645313_REACT_121401_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS",90,-1.4004,0.026,0.19,0.8007,0.9,0.99,-0.7526,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2594_LEE_RECENT_THYMIC_EMIGRANT","C2_Chemical_and_genetic_perturbations","C2_CGP_2594_LEE_RECENT_THYMIC_EMIGRANT",223,-1.4003,0.009,0.11,1.1455,0.14,0.56,-1.249,0.057,0.47
"C3_TF_targets:C3_TFT_614_WGGAATGY_V_TEF1_Q6","C3_TF_targets","C3_TFT_614_WGGAATGY_V_TEF1_Q6",367,-1.4003,0.0032,0.04,-1.376,0.0066,0.18,-0.9294,0.72,0.89
"GO_MF:487532_GO_0001595_ANGIOTENSIN_RECEPTOR_ACTIVITY","GO_MF","487532_GO_0001595_ANGIOTENSIN_RECEPTOR_ACTIVITY",5,-1.4002,0.1,0.21,0.7801,0.73,1,0.7078,0.79,1
"C3_MicroRNA_targets:C3_MIR_123_AAGCACA_MIR_218","C3_MicroRNA_targets","C3_MIR_123_AAGCACA_MIR_218",396,-1.4002,0.001,0.27,1.0428,0.32,1,0.854,0.93,1
"GO_BP:506311_GO_0043244_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY","GO_BP","506311_GO_0043244_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY",87,-1.4001,0.027,0.17,-0.9531,0.55,1,-1.2023,0.12,0.73
"KEGG_pathway:HSA05231_CHOLINE_METABOLISM_IN_CANCER","KEGG_pathway","HSA05231_CHOLINE_METABOLISM_IN_CANCER",101,-1.4,0.035,0.068,-0.922,0.63,0.97,-0.8197,0.88,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1642_IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM","C2_Chemical_and_genetic_perturbations","C2_CGP_1642_IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM",294,-1.3997,0.0076,0.11,-0.9981,0.45,1,-1.0011,0.44,0.75
"KEGG_compound:C00099_BETA_ALANINE_3_AMINOPROPIONIC_ACID_3_AMINOPROPANOATE","KEGG_compound","C00099_BETA_ALANINE_3_AMINOPROPIONIC_ACID_3_AMINOPROPANOATE",16,-1.3996,0.086,0.26,0.713,0.88,1,-1.2451,0.16,0.42
"GO_BP:514017_GO_0060462_LUNG_LOBE_DEVELOPMENT","GO_BP","514017_GO_0060462_LUNG_LOBE_DEVELOPMENT",8,-1.3996,0.096,0.17,0.879,0.65,1,1.036,0.4,0.82
"C3_TF_targets:C3_TFT_298_V_MAZR_01","C3_TF_targets","C3_TFT_298_V_MAZR_01",217,-1.3996,0.0068,0.04,-1.6205,0,0.12,-1.0331,0.35,0.66
"KEGG_compound:C00672_2_DEOXY_D_RIBOSE_1_PHOSPHATE_2_DEOXY_ALPHA_D_RIBOSE_1_PHOSPHATE","KEGG_compound","C00672_2_DEOXY_D_RIBOSE_1_PHOSPHATE_2_DEOXY_ALPHA_D_RIBOSE_1_PHOSPHATE",5,-1.3996,0.098,0.26,-0.7036,0.83,1,0.7421,0.78,0.94
"REACTOME:160137_REACT_21399_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION","REACTOME","160137_REACT_21399_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION",17,-1.3995,0.075,0.19,-0.6421,0.93,1,-0.8465,0.67,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2346_GRADE_COLON_AND_RECTAL_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2346_GRADE_COLON_AND_RECTAL_CANCER_DN",99,-1.3995,0.034,0.11,0.8438,0.84,0.97,0.9318,0.58,1
"C7_Immunologic_signatures:C7_ALL_183_GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP","C7_Immunologic_signatures","C7_ALL_183_GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP",199,-1.3995,0.015,0.026,1.3824,0.012,0.044,-1.2415,0.056,0.21
"GO_MF:489501_GO_0004032_ALDITOL_NADP_1_OXIDOREDUCTASE_ACTIVITY","GO_MF","489501_GO_0004032_ALDITOL_NADP_1_OXIDOREDUCTASE_ACTIVITY",7,-1.3995,0.088,0.21,-0.8669,0.61,1,-0.6142,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2447_WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC","C2_Chemical_and_genetic_perturbations","C2_CGP_2447_WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC",20,-1.3994,0.07,0.11,-1.0531,0.36,0.97,-1.1766,0.24,0.54
"GO_BP:499075_GO_0021795_CEREBRAL_CORTEX_CELL_MIGRATION","GO_BP","499075_GO_0021795_CEREBRAL_CORTEX_CELL_MIGRATION",42,-1.3994,0.052,0.17,-0.7799,0.83,1,0.9554,0.53,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1696_CHANG_IMMORTALIZED_BY_HPV31_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1696_CHANG_IMMORTALIZED_BY_HPV31_DN",61,-1.3993,0.04,0.11,1.3146,0.084,0.38,-1.1997,0.17,0.52
"GO_BP:488200_GO_0002327_IMMATURE_B_CELL_DIFFERENTIATION","GO_BP","488200_GO_0002327_IMMATURE_B_CELL_DIFFERENTIATION",9,-1.3993,0.085,0.17,-0.747,0.77,1,-0.8903,0.6,0.93
"C4_Cancer_gene_neighborhoods:C4_CGN_312_GNF2_RRM1","C4_Cancer_gene_neighborhoods","C4_CGN_312_GNF2_RRM1",88,-1.3992,0.036,0.12,1.4553,0.016,0.042,-1.8399,0,0.01
"GO_BP:514147_GO_0060592_MAMMARY_GLAND_FORMATION","GO_BP","514147_GO_0060592_MAMMARY_GLAND_FORMATION",8,-1.3991,0.093,0.17,-0.9953,0.49,0.99,-0.872,0.63,0.95
"C7_Immunologic_signatures:C7_ALL_505_GSE17721_CTRL_VS_CPG_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_505_GSE17721_CTRL_VS_CPG_8H_BMDM_UP",199,-1.3989,0.018,0.026,0.7938,0.98,1,-1.3911,0.0021,0.067
"C2_Chemical_and_genetic_perturbations:C2_CGP_1692_SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2","C2_Chemical_and_genetic_perturbations","C2_CGP_1692_SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2",43,-1.3989,0.06,0.11,-1.3046,0.11,0.69,-0.8588,0.71,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_14_PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_14_PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN",134,-1.3986,0.021,0.11,-0.7627,0.95,1,-1.5554,0.0039,0.28
"C2_Chemical_and_genetic_perturbations:C2_CGP_2462_MOOTHA_ROS","C2_Chemical_and_genetic_perturbations","C2_CGP_2462_MOOTHA_ROS",7,-1.3985,0.09,0.11,0.761,0.77,1,-1.0353,0.4,0.71
"REACTOME:730338_REACT_150320_SYNTHESIS_OF_LIPOXINS_LX_","REACTOME","730338_REACT_150320_SYNTHESIS_OF_LIPOXINS_LX_",6,-1.3985,0.094,0.19,1.0725,0.39,0.63,1.4899,0.063,0.55
"C7_Immunologic_signatures:C7_ALL_434_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_434_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN",200,-1.3985,0.011,0.027,1.2258,0.048,0.19,-1.2322,0.051,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_2305_BERNARD_PPAPDC1B_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2305_BERNARD_PPAPDC1B_TARGETS_DN",55,-1.3984,0.033,0.11,-1.0722,0.34,0.95,-1.0355,0.38,0.71
"GO_BP:517087_GO_0072171_MESONEPHRIC_TUBULE_MORPHOGENESIS","GO_BP","517087_GO_0072171_MESONEPHRIC_TUBULE_MORPHOGENESIS",53,-1.3984,0.05,0.17,0.7411,0.9,1,1.1999,0.15,0.72
"GO_BP:491120_GO_0006144_PURINE_NUCLEOBASE_METABOLIC_PROCESS","GO_BP","491120_GO_0006144_PURINE_NUCLEOBASE_METABOLIC_PROCESS",41,-1.3984,0.063,0.17,0.5192,1,1,-1.1561,0.22,0.74
"GO_BP:491474_GO_0006578_AMINO_ACID_BETAINE_BIOSYNTHETIC_PROCESS","GO_BP","491474_GO_0006578_AMINO_ACID_BETAINE_BIOSYNTHETIC_PROCESS",7,-1.3984,0.11,0.17,-0.6577,0.89,1,-1.7404,0.002,0.64
"GO_BP:509037_GO_0046813_RECEPTOR_MEDIATED_VIRION_ATTACHMENT_TO_HOST_CELL","GO_BP","509037_GO_0046813_RECEPTOR_MEDIATED_VIRION_ATTACHMENT_TO_HOST_CELL",5,-1.3983,0.09,0.17,-0.8488,0.66,1,-1.1211,0.36,0.76
"GO_BP:502909_GO_0033692_CELLULAR_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS","GO_BP","502909_GO_0033692_CELLULAR_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS",50,-1.3983,0.042,0.17,1.13,0.24,0.87,-1.13,0.23,0.75
"GO_MF:495538_GO_0015294_SOLUTE_CATION_SYMPORTER_ACTIVITY","GO_MF","495538_GO_0015294_SOLUTE_CATION_SYMPORTER_ACTIVITY",89,-1.3983,0.023,0.21,-1.6003,0.0035,0.49,-1.4444,0.012,0.44
"GO_CC:490935_GO_0005938_CELL_CORTEX","GO_CC","490935_GO_0005938_CELL_CORTEX",222,-1.3981,0.009,0.22,-0.6911,1,1,1.0529,0.32,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_359_HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_359_HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN",25,-1.3981,0.077,0.11,0.9594,0.52,0.86,-0.7032,0.91,0.99
"GO_BP:515602_GO_0070672_RESPONSE_TO_INTERLEUKIN_15","GO_BP","515602_GO_0070672_RESPONSE_TO_INTERLEUKIN_15",13,-1.3981,0.083,0.17,1.2759,0.17,0.7,0.9474,0.53,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1658_WU_HBX_TARGETS_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1658_WU_HBX_TARGETS_1_DN",22,-1.3981,0.079,0.11,-0.9594,0.53,1,-0.8077,0.77,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_535_MCBRYAN_TERMINAL_END_BUD_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_535_MCBRYAN_TERMINAL_END_BUD_DN",6,-1.398,0.087,0.11,0.9114,0.55,0.91,-0.7437,0.78,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2808_FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2808_FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN",65,-1.3979,0.037,0.11,0.9989,0.45,0.8,-0.6313,1,0.99
"GO_BP:508027_GO_0045682_REGULATION_OF_EPIDERMIS_DEVELOPMENT","GO_BP","508027_GO_0045682_REGULATION_OF_EPIDERMIS_DEVELOPMENT",58,-1.3979,0.04,0.17,-1.3102,0.071,0.87,-0.7502,0.93,1
"C3_TF_targets:C3_TFT_454_V_GR_Q6_01","C3_TF_targets","C3_TFT_454_V_GR_Q6_01",268,-1.3979,0.0055,0.041,-1.0568,0.3,0.64,-0.8533,0.91,0.97
"GO_BP:1129336_GO_1903509_LIPOSACCHARIDE_METABOLIC_PROCESS","GO_BP","1129336_GO_1903509_LIPOSACCHARIDE_METABOLIC_PROCESS",99,-1.3978,0.025,0.17,0.717,0.98,1,0.7091,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3224_GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION","C2_Chemical_and_genetic_perturbations","C2_CGP_3224_GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION",39,-1.3977,0.063,0.11,-0.9385,0.54,1,-1.0172,0.44,0.73
"GO_CC:496366_GO_0016327_APICOLATERAL_PLASMA_MEMBRANE","GO_CC","496366_GO_0016327_APICOLATERAL_PLASMA_MEMBRANE",12,-1.3977,0.11,0.22,0.8083,0.71,0.95,-1.5827,0.036,0.44
"GO_MF:509370_GO_0047184_1_ACYLGLYCEROPHOSPHOCHOLINE_O_ACYLTRANSFERASE_ACTIVITY","GO_MF","509370_GO_0047184_1_ACYLGLYCEROPHOSPHOCHOLINE_O_ACYLTRANSFERASE_ACTIVITY",5,-1.3977,0.089,0.21,-1.0351,0.45,0.88,-0.9635,0.49,0.82
"GO_CC:490797_GO_0005765_LYSOSOMAL_MEMBRANE","GO_CC","490797_GO_0005765_LYSOSOMAL_MEMBRANE",246,-1.3976,0.0033,0.22,0.8291,0.95,0.94,-0.7853,0.98,1
"C7_Immunologic_signatures:C7_ALL_927_GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP","C7_Immunologic_signatures","C7_ALL_927_GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP",192,-1.3976,0.01,0.027,-1.1167,0.21,1,-1.115,0.18,0.46
"C3_TF_targets:C3_TFT_423_V_SMAD_Q6","C3_TF_targets","C3_TFT_423_V_SMAD_Q6",250,-1.3976,0.0065,0.041,0.9086,0.78,1,-1.2354,0.044,0.29
"C6_Oncogenic_signatures:C6_ALL_130_CAHOY_OLIGODENDROCUTIC","C6_Oncogenic_signatures","C6_ALL_130_CAHOY_OLIGODENDROCUTIC",97,-1.3974,0.04,0.033,-0.7725,0.92,1,-0.952,0.57,0.72
"GO_BP:508463_GO_0046165_ALCOHOL_BIOSYNTHETIC_PROCESS","GO_BP","508463_GO_0046165_ALCOHOL_BIOSYNTHETIC_PROCESS",107,-1.3973,0.023,0.17,-0.771,0.94,1,0.7552,0.96,1
"GO_BP:493867_GO_0009755_HORMONE_MEDIATED_SIGNALING_PATHWAY","GO_BP","493867_GO_0009755_HORMONE_MEDIATED_SIGNALING_PATHWAY",92,-1.3973,0.035,0.17,-1.0328,0.37,0.98,-1.0186,0.42,0.83
"GO_BP:487829_GO_0001938_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION","GO_BP","487829_GO_0001938_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION",64,-1.3972,0.045,0.17,1.122,0.24,0.88,1.3883,0.04,0.63
"C4_Cancer_modules:C4_CM_349_MODULE_418","C4_Cancer_modules","C4_CM_349_MODULE_418",57,-1.3972,0.043,0.1,-1.0081,0.45,0.81,0.6873,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3254_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7","C2_Chemical_and_genetic_perturbations","C2_CGP_3254_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7",393,-1.3971,0.0011,0.11,-0.84,0.95,1,-1.0563,0.26,0.68
"GO_BP:514018_GO_0060463_LUNG_LOBE_MORPHOGENESIS","GO_BP","514018_GO_0060463_LUNG_LOBE_MORPHOGENESIS",8,-1.397,0.096,0.17,0.8834,0.61,1,1.031,0.42,0.82
"GO_BP:518523_GO_0090383_PHAGOSOME_ACIDIFICATION","GO_BP","518523_GO_0090383_PHAGOSOME_ACIDIFICATION",5,-1.3969,0.086,0.17,-0.8673,0.62,1,-0.6787,0.82,1
"C3_TF_targets:C3_TFT_114_V_CEBP_01","C3_TF_targets","C3_TFT_114_V_CEBP_01",262,-1.3969,0.0089,0.041,0.9727,0.53,1,1.033,0.33,1
"C3_TF_targets:C3_TFT_369_V_TFIII_Q6","C3_TF_targets","C3_TFT_369_V_TFIII_Q6",201,-1.3969,0.013,0.04,-1.3433,0.012,0.19,-1.0305,0.37,0.67
"KEGG_compound:C05634_5_HYDROXYINDOLEACETALDEHYDE","KEGG_compound","C05634_5_HYDROXYINDOLEACETALDEHYDE",8,-1.3968,0.084,0.26,0.8124,0.68,1,-0.9281,0.54,0.73
"GO_BP:488942_GO_0003148_OUTFLOW_TRACT_SEPTUM_MORPHOGENESIS","GO_BP","488942_GO_0003148_OUTFLOW_TRACT_SEPTUM_MORPHOGENESIS",14,-1.3968,0.11,0.17,-1.1227,0.31,0.94,1.1778,0.25,0.72
"GO_BP:506681_GO_0043651_LINOLEIC_ACID_METABOLIC_PROCESS","GO_BP","506681_GO_0043651_LINOLEIC_ACID_METABOLIC_PROCESS",12,-1.3968,0.091,0.17,-1.1328,0.3,0.93,-1.8187,0.0059,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_801_DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_801_DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN",34,-1.3968,0.065,0.11,-1.0023,0.44,1,1.4269,0.063,0.55
"GO_BP:511412_GO_0050428_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BIOSYNTHETIC_PROCESS","GO_BP","511412_GO_0050428_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BIOSYNTHETIC_PROCESS",6,-1.3967,0.077,0.17,-0.926,0.52,1,-0.7339,0.8,1
"KEGG_compound:C00831_PANTETHEINE_R_PANTETHEINE","KEGG_compound","C00831_PANTETHEINE_R_PANTETHEINE",6,-1.3966,0.12,0.26,-1.1704,0.28,0.81,-1.2299,0.23,0.42
"C7_Immunologic_signatures:C7_ALL_1399_GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP","C7_Immunologic_signatures","C7_ALL_1399_GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP",200,-1.3965,0.014,0.027,0.9957,0.46,0.75,-1.3716,0.012,0.08
"C2_Chemical_and_genetic_perturbations:C2_CGP_2087_RIGGINS_TAMOXIFEN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2087_RIGGINS_TAMOXIFEN_RESISTANCE_DN",220,-1.3965,0.0089,0.11,0.9662,0.55,0.84,-0.9913,0.48,0.77
"KEGG_pathway:HSA04940_TYPE_I_DIABETES_MELLITUS","KEGG_pathway","HSA04940_TYPE_I_DIABETES_MELLITUS",39,-1.3965,0.064,0.069,0.6433,0.98,1,-1.0369,0.41,0.62
"OMIM_gene:OMIM614216_ACTIVATING_SIGNAL_COINTEGRATOR_1_COMPLEX_SUBUNIT_2_ASCC2","OMIM_gene","OMIM614216_ACTIVATING_SIGNAL_COINTEGRATOR_1_COMPLEX_SUBUNIT_2_ASCC2",6,-1.3965,0.097,1,0.5706,0.95,1,-1.2698,0.22,1
"C7_Immunologic_signatures:C7_ALL_977_GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_977_GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP",197,-1.3964,0.011,0.027,0.9185,0.7,0.98,-1.6088,0,0.0045
"KEGG_reaction:R01279_PALMITOYL_COA_ELECTRON_TRANSFER_FLAVOPROTEIN_2_3_OXIDOREDUCTASE_PALMITOYL_COA_FAD_TRANS_HEXADEC_2_ENOYL_COA_FADH2","KEGG_reaction","R01279_PALMITOYL_COA_ELECTRON_TRANSFER_FLAVOPROTEIN_2_3_OXIDOREDUCTASE_PALMITOYL_COA_FAD_TRANS_HEXADEC_2_ENOYL_COA_FADH2",5,-1.3962,0.082,0.3,-0.6331,0.9,0.99,-1.377,0.1,0.37
"C4_Cancer_modules:C4_CM_111_MODULE_116","C4_Cancer_modules","C4_CM_111_MODULE_116",29,-1.3962,0.083,0.1,1.9415,0.0041,0.0058,0.6468,0.96,1
"KEGG_compound:C05272_TRANS_HEXADEC_2_ENOYL_COA_TRANS_2_HEXADECENOYL_COA_2E_HEXADECENOYL_COA","KEGG_compound","C05272_TRANS_HEXADEC_2_ENOYL_COA_TRANS_2_HEXADECENOYL_COA_2E_HEXADECENOYL_COA",9,-1.3961,0.11,0.26,0.5406,0.96,1,-1.4831,0.062,0.24
"GO_BP:498827_GO_0021543_PALLIUM_DEVELOPMENT","GO_BP","498827_GO_0021543_PALLIUM_DEVELOPMENT",127,-1.3961,0.023,0.17,-0.7177,0.98,1,1.0904,0.26,0.77
"GO_BP:498830_GO_0021546_RHOMBOMERE_DEVELOPMENT","GO_BP","498830_GO_0021546_RHOMBOMERE_DEVELOPMENT",8,-1.396,0.1,0.17,-0.7341,0.81,1,0.8439,0.64,0.99
"GO_BP:496939_GO_0046677_RESPONSE_TO_ANTIBIOTIC","GO_BP","496939_GO_0046677_RESPONSE_TO_ANTIBIOTIC",47,-1.396,0.044,0.17,0.899,0.62,1,0.7924,0.84,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3291_KRIEG_HYPOXIA_VIA_KDM3A","C2_Chemical_and_genetic_perturbations","C2_CGP_3291_KRIEG_HYPOXIA_VIA_KDM3A",53,-1.3957,0.033,0.11,0.8622,0.7,0.96,1.6977,0.0021,0.27
"GO_BP:514167_GO_0060612_ADIPOSE_TISSUE_DEVELOPMENT","GO_BP","514167_GO_0060612_ADIPOSE_TISSUE_DEVELOPMENT",29,-1.3957,0.071,0.17,-1.0455,0.36,0.97,-0.83,0.74,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2714_BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2714_BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN",15,-1.3957,0.081,0.11,0.7324,0.83,1,-0.7468,0.82,0.97
"GO_BP:1129360_GO_1903533_REGULATION_OF_PROTEIN_TARGETING","GO_BP","1129360_GO_1903533_REGULATION_OF_PROTEIN_TARGETING",247,-1.3956,0.011,0.17,0.9349,0.67,1,-1.4346,0.002,0.56
"GO_BP:1129341_GO_1903514_CALCIUM_ION_TRANSPORT_FROM_ENDOPLASMIC_RETICULUM_TO_CYTOSOL","GO_BP","1129341_GO_1903514_CALCIUM_ION_TRANSPORT_FROM_ENDOPLASMIC_RETICULUM_TO_CYTOSOL",7,-1.3956,0.085,0.17,0.6249,0.92,1,0.9044,0.58,0.94
"GO_BP:513731_GO_0060174_LIMB_BUD_FORMATION","GO_BP","513731_GO_0060174_LIMB_BUD_FORMATION",8,-1.3955,0.099,0.17,-0.8207,0.68,1,-0.7543,0.78,1
"GO_BP:491978_GO_0007176_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY","GO_BP","491978_GO_0007176_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",24,-1.3955,0.071,0.17,-0.8395,0.7,1,0.6377,0.96,1
"C7_Immunologic_signatures:C7_ALL_1802_GSE7764_NKCELL_VS_SPLENOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1802_GSE7764_NKCELL_VS_SPLENOCYTE_DN",199,-1.3955,0.0067,0.027,1.0636,0.27,0.55,-1.0066,0.43,0.71
"GO_BP:501643_GO_0032411_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY","GO_BP","501643_GO_0032411_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY",58,-1.3954,0.037,0.17,-1.0133,0.44,0.98,0.8894,0.7,0.95
"REACTOME:161010_REACT_6840_TRANSPORT_AND_SYNTHESIS_OF_PAPS","REACTOME","161010_REACT_6840_TRANSPORT_AND_SYNTHESIS_OF_PAPS",6,-1.3954,0.1,0.2,-0.9192,0.57,1,-0.7247,0.82,1
"GO_CC:507691_GO_0045334_CLATHRIN_COATED_ENDOCYTIC_VESICLE","GO_CC","507691_GO_0045334_CLATHRIN_COATED_ENDOCYTIC_VESICLE",44,-1.3953,0.076,0.22,0.6814,0.94,0.98,1.1059,0.3,0.9
"GO_BP:752652_GO_0097151_POSITIVE_REGULATION_OF_INHIBITORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL","GO_BP","752652_GO_0097151_POSITIVE_REGULATION_OF_INHIBITORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL",5,-1.3952,0.097,0.17,-1.0186,0.44,0.98,-0.7624,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_94_WILCOX_RESPONSE_TO_PROGESTERONE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_94_WILCOX_RESPONSE_TO_PROGESTERONE_UP",151,-1.3952,0.013,0.11,0.9887,0.49,0.81,-1.1138,0.2,0.61
"GO_BP:516945_GO_0072028_NEPHRON_MORPHOGENESIS","GO_BP","516945_GO_0072028_NEPHRON_MORPHOGENESIS",65,-1.3952,0.045,0.17,-0.868,0.72,1,1.1214,0.26,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_2611_MELLMAN_TUT1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2611_MELLMAN_TUT1_TARGETS_UP",19,-1.3952,0.076,0.11,1.256,0.15,0.43,0.6451,0.95,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_99_BIOCARTA_IL2RB_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_99_BIOCARTA_IL2RB_PATHWAY",38,-1.3952,0.049,0.19,0.9862,0.48,0.82,-0.8192,0.78,0.88
"GO_BP:508010_GO_0045662_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION","GO_BP","508010_GO_0045662_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION",22,-1.3952,0.086,0.17,-1.5761,0.025,0.73,-1.2419,0.19,0.69
"GO_BP:491850_GO_0007019_MICROTUBULE_DEPOLYMERIZATION","GO_BP","491850_GO_0007019_MICROTUBULE_DEPOLYMERIZATION",12,-1.395,0.089,0.17,-0.7739,0.76,1,-1.8694,0.0041,0.42
"KEGG_compound:C00620_ALPHA_D_RIBOSE_1_PHOSPHATE_RIBOSE_1_PHOSPHATE_D_RIBOSE_1_PHOSPHATE","KEGG_compound","C00620_ALPHA_D_RIBOSE_1_PHOSPHATE_RIBOSE_1_PHOSPHATE_D_RIBOSE_1_PHOSPHATE",5,-1.3949,0.073,0.26,0.761,0.74,1,-0.7211,0.81,0.9
"GO_BP:499079_GO_0021799_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION","GO_BP","499079_GO_0021799_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION",27,-1.3949,0.074,0.17,-1.175,0.21,0.9,1.2582,0.17,0.69
"C4_Cancer_modules:C4_CM_224_MODULE_245","C4_Cancer_modules","C4_CM_224_MODULE_245",26,-1.3948,0.066,0.1,0.9222,0.57,0.81,-2.0034,0,0.011
"C3_MicroRNA_targets:C3_MIR_29_AGTTCTC_MIR_146A_MIR_146B","C3_MicroRNA_targets","C3_MIR_29_AGTTCTC_MIR_146A_MIR_146B",58,-1.3948,0.057,0.27,-1.2458,0.13,1,-1.0854,0.31,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2387_LU_TUMOR_ANGIOGENESIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2387_LU_TUMOR_ANGIOGENESIS_UP",25,-1.3948,0.073,0.11,-0.962,0.51,1,1.2016,0.18,0.77
"GO_BP:508295_GO_0045995_REGULATION_OF_EMBRYONIC_DEVELOPMENT","GO_BP","508295_GO_0045995_REGULATION_OF_EMBRYONIC_DEVELOPMENT",103,-1.3947,0.029,0.17,-1.2279,0.12,0.88,-1.3663,0.036,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_735_PATTERSON_DOCETAXEL_RESISTANCE","C2_Chemical_and_genetic_perturbations","C2_CGP_735_PATTERSON_DOCETAXEL_RESISTANCE",28,-1.3947,0.07,0.11,-1.18,0.22,0.82,-1.7779,0.0039,0.14
"GO_BP:510557_GO_0048483_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT","GO_BP","510557_GO_0048483_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT",42,-1.3947,0.059,0.17,0.9631,0.51,1,1.2662,0.13,0.69
"GO_BP:514878_GO_0061333_RENAL_TUBULE_MORPHOGENESIS","GO_BP","514878_GO_0061333_RENAL_TUBULE_MORPHOGENESIS",65,-1.3946,0.041,0.17,-0.9281,0.6,1,1.0197,0.44,0.84
"C7_Immunologic_signatures:C7_ALL_221_GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_221_GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP",197,-1.3946,0.017,0.028,0.9083,0.74,1,-0.9044,0.75,0.94
"GO_BP:491691_GO_0006824_COBALT_ION_TRANSPORT","GO_BP","491691_GO_0006824_COBALT_ION_TRANSPORT",5,-1.3945,0.097,0.17,0.927,0.54,1,1.2099,0.27,0.71
"C7_Immunologic_signatures:C7_ALL_1435_GSE360_DC_VS_MAC_L_MAJOR_UP","C7_Immunologic_signatures","C7_ALL_1435_GSE360_DC_VS_MAC_L_MAJOR_UP",196,-1.3945,0.009,0.028,1.1478,0.15,0.32,0.8226,0.92,1
"GO_BP:513509_GO_0055076_TRANSITION_METAL_ION_HOMEOSTASIS","GO_BP","513509_GO_0055076_TRANSITION_METAL_ION_HOMEOSTASIS",129,-1.3945,0.028,0.17,1.268,0.06,0.71,0.9371,0.61,0.91
"C7_Immunologic_signatures:C7_ALL_862_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN","C7_Immunologic_signatures","C7_ALL_862_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN",181,-1.3945,0.011,0.028,-0.9097,0.72,1,-1.6224,0,0.0035
"C2_Chemical_and_genetic_perturbations:C2_CGP_2255_SAGIV_CD24_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2255_SAGIV_CD24_TARGETS_DN",45,-1.3945,0.054,0.11,0.9415,0.56,0.88,-0.8222,0.79,0.94
"REACTOME:119574_REACT_19165_NA_DEPENDENT_GLUCOSE_TRANSPORTERS","REACTOME","119574_REACT_19165_NA_DEPENDENT_GLUCOSE_TRANSPORTERS",6,-1.3944,0.1,0.2,-1.1653,0.3,0.85,-1.3304,0.17,0.52
"GO_BP:501329_GO_0032092_POSITIVE_REGULATION_OF_PROTEIN_BINDING","GO_BP","501329_GO_0032092_POSITIVE_REGULATION_OF_PROTEIN_BINDING",57,-1.3944,0.049,0.17,-0.9421,0.56,1,-1.5052,0.01,0.53
"GO_BP:754305_GO_1901343_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT","GO_BP","754305_GO_1901343_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT",69,-1.3944,0.044,0.17,-1.0273,0.4,0.97,-1.3501,0.052,0.61
"C7_Immunologic_signatures:C7_ALL_960_GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN","C7_Immunologic_signatures","C7_ALL_960_GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN",195,-1.3944,0.007,0.028,-0.7725,0.98,1,-1.0974,0.23,0.5
"C2_Chemical_and_genetic_perturbations:C2_CGP_239_MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_239_MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN",124,-1.3942,0.04,0.11,1.262,0.062,0.43,-0.7492,0.96,0.97
"GO_MF:489876_GO_0004528_PHOSPHODIESTERASE_I_ACTIVITY","GO_MF","489876_GO_0004528_PHOSPHODIESTERASE_I_ACTIVITY",5,-1.3941,0.094,0.22,-0.7914,0.72,1,-1.3541,0.14,0.52
"GO_BP:989118_GO_1903053_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION","GO_BP","989118_GO_1903053_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION",22,-1.3941,0.094,0.17,0.8491,0.69,1,-1.2275,0.18,0.7
"GO_BP:516928_GO_0072009_NEPHRON_EPITHELIUM_DEVELOPMENT","GO_BP","516928_GO_0072009_NEPHRON_EPITHELIUM_DEVELOPMENT",94,-1.394,0.025,0.17,-0.8751,0.71,1,0.8217,0.85,1
"C7_Immunologic_signatures:C7_ALL_1640_GSE3982_DC_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1640_GSE3982_DC_VS_NKCELL_DN",191,-1.394,0.012,0.028,0.8973,0.77,1,-0.9692,0.53,0.8
"GO_BP:494656_GO_0010592_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY","GO_BP","494656_GO_0010592_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY",12,-1.3939,0.076,0.17,1.1164,0.3,0.88,0.5701,0.96,1
"GO_BP:499949_GO_0030643_CELLULAR_PHOSPHATE_ION_HOMEOSTASIS","GO_BP","499949_GO_0030643_CELLULAR_PHOSPHATE_ION_HOMEOSTASIS",6,-1.3939,0.099,0.17,0.4765,0.99,1,-0.7747,0.75,1
"GO_BP:486587_GO_0000038_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS","GO_BP","486587_GO_0000038_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS",29,-1.3938,0.072,0.17,0.7114,0.91,1,-1.4402,0.051,0.56
"GO_BP:516182_GO_0071257_CELLULAR_RESPONSE_TO_ELECTRICAL_STIMULUS","GO_BP","516182_GO_0071257_CELLULAR_RESPONSE_TO_ELECTRICAL_STIMULUS",11,-1.3937,0.094,0.17,-1.0225,0.39,0.97,-0.6399,0.92,1
"KEGG_compound:C00189_ETHANOLAMINE_AMINOETHANOL_2_HYDROXYETHYLAMINE","KEGG_compound","C00189_ETHANOLAMINE_AMINOETHANOL_2_HYDROXYETHYLAMINE",12,-1.3937,0.093,0.26,-0.5611,0.97,1,1.0091,0.43,0.68
"C1_Positional:C1_ALL_53_CHRXQ28","C1_Positional","C1_ALL_53_CHRXQ28",88,-1.3937,0.033,0.5,0.9849,0.48,0.79,-0.8157,0.86,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_1166_SHIN_B_CELL_LYMPHOMA_CLUSTER_3","C2_Chemical_and_genetic_perturbations","C2_CGP_1166_SHIN_B_CELL_LYMPHOMA_CLUSTER_3",28,-1.3936,0.064,0.11,-0.6602,0.94,1,0.9161,0.59,1
"GO_CC:495072_GO_0012510_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE_MEMBRANE","GO_CC","495072_GO_0012510_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE_MEMBRANE",12,-1.3935,0.11,0.22,-0.5659,0.96,1,-1.1943,0.23,0.81
"GO_CC:499972_GO_0030669_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE","GO_CC","499972_GO_0030669_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE",38,-1.3935,0.077,0.22,0.7908,0.81,0.96,1.1881,0.18,0.82
"GO_BP:503487_GO_0034284_RESPONSE_TO_MONOSACCHARIDE","GO_BP","503487_GO_0034284_RESPONSE_TO_MONOSACCHARIDE",132,-1.3935,0.02,0.17,0.8256,0.9,1,0.9566,0.56,0.9
"GO_BP:511742_GO_0050771_NEGATIVE_REGULATION_OF_AXONOGENESIS","GO_BP","511742_GO_0050771_NEGATIVE_REGULATION_OF_AXONOGENESIS",49,-1.3934,0.056,0.17,-1.1364,0.24,0.93,-1.0092,0.43,0.84
"C7_Immunologic_signatures:C7_ALL_1437_GSE360_DC_VS_MAC_T_GONDII_UP","C7_Immunologic_signatures","C7_ALL_1437_GSE360_DC_VS_MAC_T_GONDII_UP",192,-1.3933,0.012,0.028,0.7646,0.99,1,-1.0884,0.25,0.52
"C4_Cancer_modules:C4_CM_321_MODULE_377","C4_Cancer_modules","C4_CM_321_MODULE_377",10,-1.3932,0.1,0.1,-1.0998,0.35,0.69,-1.4203,0.098,0.21
"C2_Chemical_and_genetic_perturbations:C2_CGP_583_CROSBY_E2F4_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_583_CROSBY_E2F4_TARGETS",6,-1.3932,0.09,0.11,0.6285,0.91,1,-0.7907,0.73,0.96
"GO_BP:516274_GO_0071350_CELLULAR_RESPONSE_TO_INTERLEUKIN_15","GO_BP","516274_GO_0071350_CELLULAR_RESPONSE_TO_INTERLEUKIN_15",10,-1.3932,0.11,0.17,1.0979,0.34,0.9,1.1383,0.29,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2909_CHANDRAN_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2909_CHANDRAN_METASTASIS_DN",298,-1.393,0.0043,0.11,-1.0805,0.25,0.95,-1.0132,0.42,0.73
"GO_BP:509136_GO_0046939_NUCLEOTIDE_PHOSPHORYLATION","GO_BP","509136_GO_0046939_NUCLEOTIDE_PHOSPHORYLATION",34,-1.393,0.062,0.17,-1.2407,0.15,0.91,-1.2782,0.13,0.65
"GO_BP:502381_GO_0033160_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION","GO_BP","502381_GO_0033160_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION",10,-1.393,0.11,0.17,0.5337,0.98,1,-1.282,0.17,0.65
"GO_BP:496220_GO_0016127_STEROL_CATABOLIC_PROCESS","GO_BP","496220_GO_0016127_STEROL_CATABOLIC_PROCESS",10,-1.3929,0.099,0.17,-1.2934,0.18,0.88,0.845,0.67,0.99
"C7_Immunologic_signatures:C7_ALL_1293_GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1293_GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP",189,-1.3928,0.0057,0.028,-1.1718,0.14,0.93,0.9711,0.53,1
"C4_Cancer_gene_neighborhoods:C4_CGN_381_GNF2_MMP1","C4_Cancer_gene_neighborhoods","C4_CGN_381_GNF2_MMP1",32,-1.3927,0.067,0.12,-1.0388,0.36,0.79,1.2523,0.15,0.36
"WikiPathways:198780_WP615_SENESCENCE_AND_AUTOPHAGY","WikiPathways","198780_WP615_SENESCENCE_AND_AUTOPHAGY",105,-1.3927,0.025,0.13,0.6534,1,1,-1.2479,0.098,0.48
"GO_BP:517028_GO_0072112_GLOMERULAR_VISCERAL_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","517028_GO_0072112_GLOMERULAR_VISCERAL_EPITHELIAL_CELL_DIFFERENTIATION",15,-1.3927,0.087,0.17,0.7164,0.85,1,-0.6171,0.94,1
"KEGG_compound:C02170_METHYLMALONATE_METHYLMALONIC_ACID","KEGG_compound","C02170_METHYLMALONATE_METHYLMALONIC_ACID",7,-1.3926,0.1,0.26,-0.7323,0.8,1,-0.8174,0.7,0.83
"GO_BP:512484_GO_0051608_HISTAMINE_TRANSPORT","GO_BP","512484_GO_0051608_HISTAMINE_TRANSPORT",11,-1.3926,0.12,0.17,0.8124,0.71,1,-1.0418,0.38,0.82
"GO_BP:492039_GO_0007260_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN","GO_BP","492039_GO_0007260_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN",10,-1.3925,0.082,0.17,-0.5675,0.96,1,-1.4683,0.062,0.54
"GO_BP:499724_GO_0030323_RESPIRATORY_TUBE_DEVELOPMENT","GO_BP","499724_GO_0030323_RESPIRATORY_TUBE_DEVELOPMENT",181,-1.3924,0.014,0.17,0.8956,0.74,1,1.2428,0.06,0.71
"KEGG_compound:C20876_VERY_LONG_CHAIN_ACYL_COA","KEGG_compound","C20876_VERY_LONG_CHAIN_ACYL_COA",8,-1.3922,0.098,0.26,-0.9482,0.5,1,-1.3541,0.16,0.33
"GO_BP:754577_GO_1901621_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING","GO_BP","754577_GO_1901621_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING",6,-1.3921,0.087,0.17,-0.8234,0.68,1,-1.5154,0.036,0.54
"GO_MF:490353_GO_0005085_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY","GO_MF","490353_GO_0005085_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",193,-1.3917,0.027,0.22,-1.2477,0.065,0.84,0.9487,0.6,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1718_KANG_FLUOROURACIL_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1718_KANG_FLUOROURACIL_RESISTANCE_DN",16,-1.3916,0.095,0.11,-1.2765,0.16,0.72,0.8723,0.64,1
"C7_Immunologic_signatures:C7_ALL_113_GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP","C7_Immunologic_signatures","C7_ALL_113_GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP",189,-1.3915,0.019,0.029,0.7693,0.97,1,-1.0882,0.27,0.52
"C7_Immunologic_signatures:C7_ALL_1483_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP","C7_Immunologic_signatures","C7_ALL_1483_GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP",198,-1.3915,0.01,0.029,1.0091,0.42,0.71,1.119,0.18,0.95
"KEGG_compound:C06174_CODEINE_5ALPHA_6ALPHA_7_8_DIDEHYDRO_4_5_EPOXY_3_METHOXY_17_METHYLMORPHINAN_6_OL","KEGG_compound","C06174_CODEINE_5ALPHA_6ALPHA_7_8_DIDEHYDRO_4_5_EPOXY_3_METHOXY_17_METHYLMORPHINAN_6_OL",21,-1.3914,0.08,0.26,1.6642,0.01,0.1,2.4038,0,0
"KEGG_compound:C00401_CHONDROITIN_CHONDROITIN_D_GLUCURONATE","KEGG_compound","C00401_CHONDROITIN_CHONDROITIN_D_GLUCURONATE",6,-1.3914,0.093,0.26,0.7305,0.79,1,-0.7468,0.77,0.89
"GO_MF:505692_GO_0042562_HORMONE_BINDING","GO_MF","505692_GO_0042562_HORMONE_BINDING",66,-1.3912,0.039,0.22,1.1106,0.26,0.77,1.0786,0.32,0.81
"C7_Immunologic_signatures:C7_ALL_452_GSE17721_CTRL_VS_LPS_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_452_GSE17721_CTRL_VS_LPS_2H_BMDM_DN",193,-1.3911,0.013,0.029,-0.8609,0.83,1,-0.897,0.76,0.95
"GO_BP:514136_GO_0060581_CELL_FATE_COMMITMENT_INVOLVED_IN_PATTERN_SPECIFICATION","GO_BP","514136_GO_0060581_CELL_FATE_COMMITMENT_INVOLVED_IN_PATTERN_SPECIFICATION",13,-1.3908,0.098,0.17,-1.5061,0.042,0.82,1.0304,0.41,0.82
"WikiPathways:198841_WP521_AMINO_ACID_CONJUGATION_OF_BENZOIC_ACID","WikiPathways","198841_WP521_AMINO_ACID_CONJUGATION_OF_BENZOIC_ACID",5,-1.3907,0.11,0.13,-1.6001,0.025,0.78,0.8114,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1503_ZHAN_MULTIPLE_MYELOMA_PR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1503_ZHAN_MULTIPLE_MYELOMA_PR_UP",42,-1.3907,0.056,0.11,0.9135,0.6,0.91,-1.5975,0.016,0.24
"C2_Chemical_and_genetic_perturbations:C2_CGP_1552_ZHAN_V2_LATE_DIFFERENTIATION_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_1552_ZHAN_V2_LATE_DIFFERENTIATION_GENES",44,-1.3906,0.056,0.11,0.7899,0.85,1,-1.0187,0.41,0.73
"GO_BP:503245_GO_0034036_PURINE_RIBONUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","503245_GO_0034036_PURINE_RIBONUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS",6,-1.3906,0.097,0.17,-0.9217,0.55,1,-0.7411,0.79,1
"C7_Immunologic_signatures:C7_ALL_1521_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP","C7_Immunologic_signatures","C7_ALL_1521_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP",198,-1.3906,0.018,0.029,1.0172,0.41,0.69,-1.3392,0.02,0.1
"GO_BP:753360_GO_1900376_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS","GO_BP","753360_GO_1900376_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS",5,-1.3905,0.099,0.17,1.0347,0.42,0.96,1.1551,0.31,0.73
"C3_TF_targets:C3_TFT_524_TGGNNNNNNKCCAR_UNKNOWN","C3_TF_targets","C3_TFT_524_TGGNNNNNNKCCAR_UNKNOWN",414,-1.3902,0.0052,0.044,-1.1259,0.14,0.49,-1.2382,0.021,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_2072_MARSON_FOXP3_TARGETS_STIMULATED_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2072_MARSON_FOXP3_TARGETS_STIMULATED_UP",29,-1.3901,0.06,0.11,1.4393,0.045,0.26,-1.2443,0.13,0.48
"GO_BP:515518_GO_0070588_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","515518_GO_0070588_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT",127,-1.3901,0.037,0.18,-1.5757,0,0.73,1.0033,0.44,0.85
"KEGG_compound:C00280_ANDROSTENEDIONE_ANDROST_4_ENE_3_17_DIONE_4_ANDROSTENE_3_17_DIONE","KEGG_compound","C00280_ANDROSTENEDIONE_ANDROST_4_ENE_3_17_DIONE_4_ANDROSTENE_3_17_DIONE",15,-1.3898,0.085,0.26,1.1581,0.25,0.95,-0.7795,0.8,0.86
"GO_BP:491000_GO_0006014_D_RIBOSE_METABOLIC_PROCESS","GO_BP","491000_GO_0006014_D_RIBOSE_METABOLIC_PROCESS",6,-1.3898,0.087,0.18,0.8505,0.64,1,-0.9783,0.48,0.87
"OMIM_gene:OMIM601985_COILED_COIL_DOMAIN_CONTAINING_PROTEIN_6_CCDC6","OMIM_gene","OMIM601985_COILED_COIL_DOMAIN_CONTAINING_PROTEIN_6_CCDC6",8,-1.3898,0.094,0.94,-1.0657,0.37,0.84,-0.9402,0.53,1
"KEGG_compound:C00864_PANTOTHENATE_PANTOTHENIC_ACID_R_PANTOTHENATE","KEGG_compound","C00864_PANTOTHENATE_PANTOTHENIC_ACID_R_PANTOTHENATE",6,-1.3898,0.09,0.26,-1.1217,0.34,0.89,-1.2198,0.25,0.43
"GO_BP:508005_GO_0045657_POSITIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION","GO_BP","508005_GO_0045657_POSITIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION",6,-1.3895,0.096,0.18,-1.0434,0.4,0.98,0.952,0.51,0.9
"GO_BP:491699_GO_0006833_WATER_TRANSPORT","GO_BP","491699_GO_0006833_WATER_TRANSPORT",40,-1.3895,0.065,0.18,0.9493,0.55,1,-0.9326,0.59,0.9
"GO_BP:515199_GO_0070266_NECROPTOTIC_PROCESS","GO_BP","515199_GO_0070266_NECROPTOTIC_PROCESS",18,-1.3895,0.088,0.18,0.5743,0.98,1,-1.1064,0.33,0.77
"GO_BP:518184_GO_0090037_POSITIVE_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING","GO_BP","518184_GO_0090037_POSITIVE_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING",8,-1.3894,0.11,0.18,-0.6729,0.91,1,-1.0765,0.35,0.8
"GO_BP:512805_GO_0051955_REGULATION_OF_AMINO_ACID_TRANSPORT","GO_BP","512805_GO_0051955_REGULATION_OF_AMINO_ACID_TRANSPORT",22,-1.3893,0.084,0.18,-0.8877,0.62,1,-1.1079,0.3,0.77
"C4_Cancer_modules:C4_CM_379_MODULE_470","C4_Cancer_modules","C4_CM_379_MODULE_470",16,-1.3892,0.088,0.1,-1.0039,0.46,0.79,-1.1966,0.22,0.41
"C7_Immunologic_signatures:C7_ALL_1309_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP","C7_Immunologic_signatures","C7_ALL_1309_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP",186,-1.3892,0.016,0.03,-1.2,0.11,0.82,1.0534,0.33,1
"C3_TF_targets:C3_TFT_110_V_ARP1_01","C3_TF_targets","C3_TFT_110_V_ARP1_01",160,-1.3892,0.016,0.044,-1.1526,0.17,0.45,-0.8134,0.92,1
"GO_BP:494007_GO_0009913_EPIDERMAL_CELL_DIFFERENTIATION","GO_BP","494007_GO_0009913_EPIDERMAL_CELL_DIFFERENTIATION",124,-1.3891,0.026,0.18,1.0216,0.41,0.97,1.2722,0.074,0.69
"C3_MicroRNA_targets:C3_MIR_173_AACTGGA_MIR_145","C3_MicroRNA_targets","C3_MIR_173_AACTGGA_MIR_145",228,-1.3891,0.0078,0.27,-0.7243,1,1,0.9145,0.72,1
"REACTOME:187204_REACT_23879_PLATELET_SENSITIZATION_BY_LDL","REACTOME","187204_REACT_23879_PLATELET_SENSITIZATION_BY_LDL",17,-1.3889,0.088,0.2,0.5686,0.97,1,-1.0345,0.4,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2971_VISALA_AGING_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2971_VISALA_AGING_LYMPHOCYTE_UP",10,-1.3889,0.099,0.11,-0.6495,0.91,1,-1.1844,0.27,0.53
"KEGG_module:HSA_M00689_MAPK_P38_SIGNALING","KEGG_module","HSA_M00689_MAPK_P38_SIGNALING",22,-1.3887,0.089,0.44,-1.6186,0.024,0.34,-1.5839,0.026,0.26
"C7_Immunologic_signatures:C7_ALL_689_GSE17721_LPS_VS_GARDIQUIMOD_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_689_GSE17721_LPS_VS_GARDIQUIMOD_0_5H_BMDM_UP",192,-1.3886,0.0092,0.03,1.109,0.18,0.42,-0.7388,0.99,1
"GO_BP:498162_GO_0019317_FUCOSE_CATABOLIC_PROCESS","GO_BP","498162_GO_0019317_FUCOSE_CATABOLIC_PROCESS",9,-1.3886,0.1,0.18,0.6986,0.83,1,-1.0819,0.36,0.79
"GO_BP:517040_GO_0072124_REGULATION_OF_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION","GO_BP","517040_GO_0072124_REGULATION_OF_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION",7,-1.3885,0.098,0.18,-0.872,0.62,1,1.3076,0.17,0.67
"GO_BP:487567_GO_0001654_EYE_DEVELOPMENT","GO_BP","487567_GO_0001654_EYE_DEVELOPMENT",316,-1.3885,0.0032,0.18,-1.1448,0.14,0.93,1.1377,0.13,0.73
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_59_BIOCARTA_CALCINEURIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_59_BIOCARTA_CALCINEURIN_PATHWAY",18,-1.3882,0.092,0.2,-0.4146,1,1,-1.4238,0.078,0.4
"GO_BP:511982_GO_0051057_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION","GO_BP","511982_GO_0051057_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION",35,-1.3881,0.068,0.18,-0.806,0.77,1,0.8029,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2124_KONDO_PROSTATE_CANCER_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2124_KONDO_PROSTATE_CANCER_WITH_H3K27ME3",180,-1.3881,0.019,0.11,1.2612,0.053,0.43,1.8504,0,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_284_HUMMEL_BURKITTS_LYMPHOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_284_HUMMEL_BURKITTS_LYMPHOMA_DN",15,-1.388,0.1,0.11,-1.0573,0.38,0.97,-1.0525,0.37,0.69
"GO_MF:487478_GO_0001540_BETA_AMYLOID_BINDING","GO_MF","487478_GO_0001540_BETA_AMYLOID_BINDING",32,-1.388,0.072,0.23,-0.8856,0.67,1,-1.2393,0.16,0.59
"REACTOME:105827_REACT_6875_PHOSPHORYLATION_OF_EMI1","REACTOME","105827_REACT_6875_PHOSPHORYLATION_OF_EMI1",6,-1.3879,0.094,0.2,-1.1871,0.25,0.86,-1.4728,0.081,0.38
"GO_MF:490480_GO_0005246_CALCIUM_CHANNEL_REGULATOR_ACTIVITY","GO_MF","490480_GO_0005246_CALCIUM_CHANNEL_REGULATOR_ACTIVITY",34,-1.3879,0.063,0.23,-1.0508,0.39,0.86,1.2853,0.12,0.65
"C7_Immunologic_signatures:C7_ALL_572_GSE17721_PAM3CSK4_VS_CPG_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_572_GSE17721_PAM3CSK4_VS_CPG_6H_BMDM_DN",196,-1.3878,0.018,0.03,0.7598,0.99,1,-0.8137,0.94,1
"REACTOME:106418_REACT_12555_DOWNSTREAM_TCR_SIGNALING","REACTOME","106418_REACT_12555_DOWNSTREAM_TCR_SIGNALING",40,-1.3878,0.06,0.2,1.0713,0.34,0.63,-0.8764,0.69,0.96
"GO_BP:507271_GO_0044264_CELLULAR_POLYSACCHARIDE_METABOLIC_PROCESS","GO_BP","507271_GO_0044264_CELLULAR_POLYSACCHARIDE_METABOLIC_PROCESS",84,-1.3878,0.044,0.18,1.072,0.31,0.93,-0.9487,0.57,0.89
"GO_BP:499152_GO_0021873_FOREBRAIN_NEUROBLAST_DIVISION","GO_BP","499152_GO_0021873_FOREBRAIN_NEUROBLAST_DIVISION",9,-1.3878,0.11,0.18,-0.7332,0.79,1,0.8585,0.66,0.97
"GO_BP:514863_GO_0061318_RENAL_FILTRATION_CELL_DIFFERENTIATION","GO_BP","514863_GO_0061318_RENAL_FILTRATION_CELL_DIFFERENTIATION",15,-1.3877,0.087,0.18,0.7299,0.84,1,-0.6211,0.94,1
"GO_BP:487604_GO_0001701_IN_UTERO_EMBRYONIC_DEVELOPMENT","GO_BP","487604_GO_0001701_IN_UTERO_EMBRYONIC_DEVELOPMENT",363,-1.3877,0,0.18,-0.7194,1,1,-1.0804,0.2,0.79
"GO_MF:487855_GO_0001965_G_PROTEIN_ALPHA_SUBUNIT_BINDING","GO_MF","487855_GO_0001965_G_PROTEIN_ALPHA_SUBUNIT_BINDING",15,-1.3877,0.1,0.22,0.6506,0.94,1,1.0865,0.34,0.81
"REACTOME:771599_REACT_160300_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS","REACTOME","771599_REACT_160300_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS",40,-1.3877,0.059,0.2,1.351,0.059,0.26,-1.2776,0.12,0.55
"C7_Immunologic_signatures:C7_ALL_1590_GSE3982_EOSINOPHIL_VS_MAC_DN","C7_Immunologic_signatures","C7_ALL_1590_GSE3982_EOSINOPHIL_VS_MAC_DN",195,-1.3877,0.014,0.03,1.5304,0.0023,0.0083,-1.1686,0.13,0.34
"REACTOME:160971_REACT_22297_HEME_DEGRADATION","REACTOME","160971_REACT_22297_HEME_DEGRADATION",6,-1.3876,0.096,0.2,-0.6025,0.93,1,0.9715,0.5,1
"REACTOME:187100_REACT_24938_TRAF6_MEDIATED_IRF7_ACTIVATION","REACTOME","187100_REACT_24938_TRAF6_MEDIATED_IRF7_ACTIVATION",29,-1.3876,0.081,0.2,-0.7353,0.87,1,-1.7101,0.006,0.2
"C2_Chemical_and_genetic_perturbations:C2_CGP_246_MULLIGHAN_NPM1_SIGNATURE_3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_246_MULLIGHAN_NPM1_SIGNATURE_3_UP",334,-1.3875,0.0032,0.11,1.0926,0.19,0.64,-1.0403,0.32,0.7
"GO_BP:500308_GO_0031018_ENDOCRINE_PANCREAS_DEVELOPMENT","GO_BP","500308_GO_0031018_ENDOCRINE_PANCREAS_DEVELOPMENT",43,-1.3875,0.061,0.18,1.0454,0.39,0.95,1.3433,0.079,0.65
"GO_BP:496194_GO_0016101_DITERPENOID_METABOLIC_PROCESS","GO_BP","496194_GO_0016101_DITERPENOID_METABOLIC_PROCESS",87,-1.3875,0.034,0.18,-1.0685,0.32,0.96,-1.1327,0.22,0.75
"C3_TF_targets:C3_TFT_296_V_NKX62_Q2","C3_TF_targets","C3_TFT_296_V_NKX62_Q2",231,-1.3875,0.012,0.045,0.9977,0.45,1,-1.0691,0.26,0.61
"GO_BP:503328_GO_0034122_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","503328_GO_0034122_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",22,-1.3874,0.085,0.18,-1.1594,0.27,0.92,0.6536,0.94,1
"C7_Immunologic_signatures:C7_ALL_1519_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP","C7_Immunologic_signatures","C7_ALL_1519_GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP",196,-1.3873,0.023,0.03,1.1323,0.17,0.36,-1.3261,0.021,0.11
"GO_BP:495975_GO_0015850_ORGANIC_HYDROXY_COMPOUND_TRANSPORT","GO_BP","495975_GO_0015850_ORGANIC_HYDROXY_COMPOUND_TRANSPORT",138,-1.3873,0.022,0.18,-1.2771,0.066,0.89,1.2297,0.083,0.71
"GO_MF:495447_GO_0015175_NEUTRAL_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495447_GO_0015175_NEUTRAL_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",26,-1.3872,0.083,0.22,0.8411,0.72,1,-0.9472,0.54,0.84
"C3_TF_targets:C3_TFT_346_V_MTF1_Q4","C3_TF_targets","C3_TFT_346_V_MTF1_Q4",247,-1.3872,0.01,0.044,-1.0886,0.23,0.58,-0.9927,0.49,0.78
"C7_Immunologic_signatures:C7_ALL_92_GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN","C7_Immunologic_signatures","C7_ALL_92_GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN",187,-1.3872,0.013,0.03,-0.6808,1,1,1.1543,0.15,0.84
"REACTOME:105767_REACT_821_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1","REACTOME","105767_REACT_821_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1",38,-1.3871,0.07,0.2,1.0108,0.45,0.73,-1.2613,0.13,0.54
"GO_BP:491693_GO_0006826_IRON_ION_TRANSPORT","GO_BP","491693_GO_0006826_IRON_ION_TRANSPORT",56,-1.387,0.059,0.18,0.9967,0.47,0.98,1.1529,0.22,0.73
"GO_BP:754576_GO_1901620_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING","GO_BP","754576_GO_1901620_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING",6,-1.387,0.11,0.18,-0.8427,0.68,1,-1.5295,0.06,0.52
"C7_Immunologic_signatures:C7_ALL_91_GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP","C7_Immunologic_signatures","C7_ALL_91_GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP",197,-1.3869,0.0081,0.03,1.0189,0.38,0.68,-2.1396,0,0
"C7_Immunologic_signatures:C7_ALL_722_GSE17721_0_5H_VS_8H_POLYIC_BMDM_DN","C7_Immunologic_signatures","C7_ALL_722_GSE17721_0_5H_VS_8H_POLYIC_BMDM_DN",198,-1.3869,0.015,0.03,0.9551,0.59,0.88,-1.1058,0.2,0.48
"GO_BP:503894_GO_0034694_RESPONSE_TO_PROSTAGLANDIN","GO_BP","503894_GO_0034694_RESPONSE_TO_PROSTAGLANDIN",23,-1.3869,0.076,0.18,1.062,0.35,0.94,1.1569,0.24,0.73
"GO_MF:509552_GO_0047372_ACYLGLYCEROL_LIPASE_ACTIVITY","GO_MF","509552_GO_0047372_ACYLGLYCEROL_LIPASE_ACTIVITY",5,-1.3868,0.094,0.23,-0.6013,0.93,1,1.4976,0.065,0.43
"C7_Immunologic_signatures:C7_ALL_322_GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN","C7_Immunologic_signatures","C7_ALL_322_GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN",199,-1.3867,0.015,0.03,-0.7747,0.98,1,0.8466,0.9,1
"GO_MF:512281_GO_0051400_BH_DOMAIN_BINDING","GO_MF","512281_GO_0051400_BH_DOMAIN_BINDING",10,-1.3867,0.11,0.22,-0.7051,0.86,1,1.1036,0.35,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_2239_ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2239_ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN",346,-1.3866,0.0043,0.11,0.9811,0.54,0.81,-1.0462,0.31,0.69
"GO_BP:500780_GO_0031529_RUFFLE_ORGANIZATION","GO_BP","500780_GO_0031529_RUFFLE_ORGANIZATION",23,-1.3866,0.089,0.18,-1.0069,0.43,0.98,-0.9286,0.55,0.9
"REACTOME:645302_REACT_121120_KERATAN_SULFATE_BIOSYNTHESIS","REACTOME","645302_REACT_121120_KERATAN_SULFATE_BIOSYNTHESIS",28,-1.3866,0.074,0.2,0.7498,0.85,1,1.1117,0.31,0.95
"C7_Immunologic_signatures:C7_ALL_87_GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP","C7_Immunologic_signatures","C7_ALL_87_GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP",193,-1.3865,0.011,0.03,-0.8834,0.79,1,-1.9514,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_2964_GERHOLD_RESPONSE_TO_TZD_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2964_GERHOLD_RESPONSE_TO_TZD_DN",13,-1.3864,0.074,0.11,1.2404,0.19,0.45,1.5353,0.026,0.46
"GO_BP:498806_GO_0021522_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION","GO_BP","498806_GO_0021522_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION",31,-1.3862,0.079,0.18,-1.1022,0.33,0.94,-0.9138,0.58,0.92
"GO_MF:490621_GO_0005518_COLLAGEN_BINDING","GO_MF","490621_GO_0005518_COLLAGEN_BINDING",61,-1.3861,0.053,0.22,-0.818,0.8,1,1.1253,0.25,0.81
"GO_MF:503794_GO_0034593_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_PHOSPHATASE_ACTIVITY","GO_MF","503794_GO_0034593_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_PHOSPHATASE_ACTIVITY",16,-1.3861,0.086,0.22,-0.7376,0.82,1,-0.7098,0.86,1
"GO_MF:492902_GO_0008656_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_MF","492902_GO_0008656_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",18,-1.386,0.086,0.22,0.8088,0.76,1,-1.178,0.23,0.6
"GO_MF:495584_GO_0015355_SECONDARY_ACTIVE_MONOCARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495584_GO_0015355_SECONDARY_ACTIVE_MONOCARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-1.3859,0.089,0.22,-1.0742,0.39,0.86,-1.0534,0.39,0.74
"C7_Immunologic_signatures:C7_ALL_1174_GSE27786_LIN_NEG_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1174_GSE27786_LIN_NEG_VS_NEUTROPHIL_DN",199,-1.3859,0.015,0.031,-1.1217,0.22,1,-0.7022,1,1
"GO_BP:513503_GO_0055070_COPPER_ION_HOMEOSTASIS","GO_BP","513503_GO_0055070_COPPER_ION_HOMEOSTASIS",17,-1.3859,0.098,0.18,0.7691,0.79,1,0.8794,0.63,0.95
"GO_BP:499711_GO_0030311_POLY_N_ACETYLLACTOSAMINE_BIOSYNTHETIC_PROCESS","GO_BP","499711_GO_0030311_POLY_N_ACETYLLACTOSAMINE_BIOSYNTHETIC_PROCESS",5,-1.3859,0.093,0.18,0.4796,0.99,1,0.6269,0.92,1
"C4_Cancer_gene_neighborhoods:C4_CGN_123_MORF_LMO1","C4_Cancer_gene_neighborhoods","C4_CGN_123_MORF_LMO1",47,-1.3859,0.069,0.13,-1.5781,0.0057,0.16,-1.1495,0.22,0.53
"GO_BP:510734_GO_0048679_REGULATION_OF_AXON_REGENERATION","GO_BP","510734_GO_0048679_REGULATION_OF_AXON_REGENERATION",9,-1.3858,0.13,0.18,-1.2397,0.21,0.91,1.0844,0.36,0.77
"GO_BP:487843_GO_0001953_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION","GO_BP","487843_GO_0001953_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION",26,-1.3858,0.09,0.18,0.9453,0.52,1,-0.6489,0.95,1
"REACTOME:187182_REACT_25282_INHIBITION_OF_ADENYLATE_CYCLASE_PATHWAY","REACTOME","187182_REACT_25282_INHIBITION_OF_ADENYLATE_CYCLASE_PATHWAY",14,-1.3857,0.095,0.2,-1.0937,0.35,0.91,-1.0032,0.44,0.83
"GO_BP:509072_GO_0046852_POSITIVE_REGULATION_OF_BONE_REMODELING","GO_BP","509072_GO_0046852_POSITIVE_REGULATION_OF_BONE_REMODELING",14,-1.3856,0.095,0.18,-0.835,0.68,1,-0.8254,0.7,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3183_KASLER_HDAC7_TARGETS_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3183_KASLER_HDAC7_TARGETS_1_DN",17,-1.3856,0.11,0.11,-0.6717,0.91,1,0.8806,0.6,1
"C4_Cancer_modules:C4_CM_125_MODULE_130","C4_Cancer_modules","C4_CM_125_MODULE_130",23,-1.3856,0.074,0.11,-1.016,0.44,0.8,0.7867,0.81,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_108_PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_108_PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP",81,-1.3856,0.048,0.11,0.933,0.62,0.89,-0.9767,0.47,0.79
"C3_MicroRNA_targets:C3_MIR_78_GGGCATT_MIR_365","C3_MicroRNA_targets","C3_MIR_78_GGGCATT_MIR_365",108,-1.3855,0.027,0.27,-1.0755,0.29,1,0.7503,0.96,1
"WikiPathways:920992_WP1981_THYROXINE_THYROID_HORMONE_PRODUCTION","WikiPathways","920992_WP1981_THYROXINE_THYROID_HORMONE_PRODUCTION",6,-1.3855,0.11,0.13,0.8845,0.58,1,-0.8228,0.68,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1357_LEE_LIVER_CANCER_MYC_E2F1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1357_LEE_LIVER_CANCER_MYC_E2F1_DN",62,-1.3854,0.049,0.11,-0.9711,0.5,1,-1.0624,0.36,0.68
"KEGG_pathway:HSA00760_NICOTINATE_AND_NICOTINAMIDE_METABOLISM","KEGG_pathway","HSA00760_NICOTINATE_AND_NICOTINAMIDE_METABOLISM",29,-1.3853,0.074,0.075,0.7623,0.81,1,-1.7398,0.0061,0.036
"REACTOME:477125_REACT_111168_ENDOSOMAL_VACUOLAR_PATHWAY","REACTOME","477125_REACT_111168_ENDOSOMAL_VACUOLAR_PATHWAY",11,-1.3851,0.11,0.2,0.8303,0.68,0.97,0.664,0.9,1
"GO_BP:519156_GO_2000516_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION","GO_BP","519156_GO_2000516_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",22,-1.385,0.096,0.18,-1.3157,0.12,0.88,-1.0253,0.43,0.83
"C7_Immunologic_signatures:C7_ALL_1814_GSE7852_LN_VS_THYMUS_TREG_DN","C7_Immunologic_signatures","C7_ALL_1814_GSE7852_LN_VS_THYMUS_TREG_DN",200,-1.385,0.013,0.031,1.2137,0.087,0.2,-1.1753,0.11,0.33
"GO_MF:515335_GO_0070403_NAD_BINDING","GO_MF","515335_GO_0070403_NAD_BINDING",13,-1.385,0.077,0.22,-0.7733,0.76,1,-1.0539,0.39,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_2718_BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2718_BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN",17,-1.3849,0.093,0.12,0.683,0.89,1,0.7947,0.78,1
"GO_BP:508279_GO_0045978_NEGATIVE_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS","GO_BP","508279_GO_0045978_NEGATIVE_REGULATION_OF_NUCLEOSIDE_METABOLIC_PROCESS",40,-1.3847,0.064,0.18,0.9177,0.62,1,0.9814,0.5,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1362_LIN_APC_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1362_LIN_APC_TARGETS",77,-1.3847,0.047,0.12,-0.7436,0.95,1,-1.1999,0.13,0.52
"C3_TF_targets:C3_TFT_269_V_STAT5B_01","C3_TF_targets","C3_TFT_269_V_STAT5B_01",243,-1.3847,0.0045,0.046,0.9669,0.58,1,-0.975,0.54,0.8
"C7_Immunologic_signatures:C7_ALL_1698_GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1698_GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN",191,-1.3847,0.019,0.031,-0.7327,0.99,1,-1.0662,0.29,0.58
"GO_BP:511968_GO_0051043_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS","GO_BP","511968_GO_0051043_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS",21,-1.3846,0.088,0.18,-0.9697,0.5,1,-0.6311,0.95,1
"GO_BP:493858_GO_0009746_RESPONSE_TO_HEXOSE","GO_BP","493858_GO_0009746_RESPONSE_TO_HEXOSE",127,-1.3846,0.028,0.18,0.7933,0.93,1,0.9597,0.57,0.9
"C3_TF_targets:C3_TFT_239_V_CART1_01","C3_TF_targets","C3_TFT_239_V_CART1_01",216,-1.3844,0.012,0.046,-1.0062,0.42,0.74,-1.0065,0.44,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_497_JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_497_JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN",21,-1.3843,0.098,0.12,-1.3108,0.15,0.68,-1.2663,0.15,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_565_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_565_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN",8,-1.3843,0.089,0.12,0.6801,0.86,1,-1.0864,0.36,0.64
"GO_BP:754841_GO_1901890_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY","GO_BP","754841_GO_1901890_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY",22,-1.3841,0.089,0.18,-0.9076,0.61,1,1.4908,0.047,0.57
"GO_BP:514563_GO_0061008_HEPATICOBILIARY_SYSTEM_DEVELOPMENT","GO_BP","514563_GO_0061008_HEPATICOBILIARY_SYSTEM_DEVELOPMENT",107,-1.3841,0.039,0.18,-0.6089,1,1,-0.9396,0.6,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_3390_ZWANG_EGF_INTERVAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3390_ZWANG_EGF_INTERVAL_DN",205,-1.3841,0.0088,0.12,-0.8779,0.78,1,-1.0051,0.46,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1702_MCCLUNG_COCAINE_REWARD_5D","C2_Chemical_and_genetic_perturbations","C2_CGP_1702_MCCLUNG_COCAINE_REWARD_5D",78,-1.384,0.048,0.12,-0.9201,0.62,1,-0.7936,0.9,0.96
"GO_BP:512036_GO_0051125_REGULATION_OF_ACTIN_NUCLEATION","GO_BP","512036_GO_0051125_REGULATION_OF_ACTIN_NUCLEATION",21,-1.3839,0.097,0.18,-0.5138,0.99,1,-0.9267,0.56,0.9
"C3_MicroRNA_targets:C3_MIR_88_GTCTTCC_MIR_7","C3_MicroRNA_targets","C3_MIR_88_GTCTTCC_MIR_7",168,-1.3839,0.015,0.26,-1.02,0.41,1,-0.7554,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1260_NELSON_RESPONSE_TO_ANDROGEN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1260_NELSON_RESPONSE_TO_ANDROGEN_DN",19,-1.3838,0.096,0.12,-0.8717,0.66,1,1.1338,0.28,0.84
"GO_BP:497119_GO_0018146_KERATAN_SULFATE_BIOSYNTHETIC_PROCESS","GO_BP","497119_GO_0018146_KERATAN_SULFATE_BIOSYNTHETIC_PROCESS",28,-1.3836,0.082,0.18,0.7557,0.86,1,1.1231,0.27,0.74
"GO_BP:491746_GO_0006885_REGULATION_OF_PH","GO_BP","491746_GO_0006885_REGULATION_OF_PH",64,-1.3836,0.058,0.18,-0.892,0.67,1,0.856,0.75,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_3176_AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3176_AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP",121,-1.3835,0.033,0.12,1.3078,0.047,0.39,0.9471,0.56,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_270_ODONNELL_TFRC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_270_ODONNELL_TFRC_TARGETS_DN",129,-1.3835,0.029,0.12,0.7673,0.96,1,-1.1411,0.18,0.59
"C3_TF_targets:C3_TFT_158_V_HAND1E47_01","C3_TF_targets","C3_TFT_158_V_HAND1E47_01",267,-1.3834,0.0086,0.046,-1.2339,0.053,0.29,-1.1705,0.11,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_330_GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_330_GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP",13,-1.3834,0.1,0.12,1.6183,0.026,0.13,-1.1193,0.32,0.61
"KEGG_compound:C01181_4_TRIMETHYLAMMONIOBUTANOATE_BUTYRO_BETAINE_GAMMA_BUTYROBETAINE","KEGG_compound","C01181_4_TRIMETHYLAMMONIOBUTANOATE_BUTYRO_BETAINE_GAMMA_BUTYROBETAINE",6,-1.3834,0.092,0.26,0.9588,0.52,1,-1.3174,0.16,0.35
"GO_BP:495126_GO_0014054_POSITIVE_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION","GO_BP","495126_GO_0014054_POSITIVE_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION",5,-1.3833,0.1,0.18,-1.0675,0.4,0.96,-1.1512,0.32,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_247_MULLIGHAN_NPM1_SIGNATURE_3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_247_MULLIGHAN_NPM1_SIGNATURE_3_DN",160,-1.3833,0.023,0.12,1.2936,0.034,0.4,-0.8334,0.91,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_2630_SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE","C2_Chemical_and_genetic_perturbations","C2_CGP_2630_SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE",81,-1.383,0.048,0.12,1.2594,0.088,0.43,-0.9192,0.63,0.85
"GO_BP:507020_GO_0044003_MODIFICATION_BY_SYMBIONT_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY","GO_BP","507020_GO_0044003_MODIFICATION_BY_SYMBIONT_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY",34,-1.383,0.074,0.18,0.8067,0.79,1,0.8148,0.8,1
"GO_BP:499539_GO_0030104_WATER_HOMEOSTASIS","GO_BP","499539_GO_0030104_WATER_HOMEOSTASIS",68,-1.3829,0.049,0.18,1.5125,0.021,0.39,0.9615,0.54,0.9
"GO_MF:495456_GO_0015187_GLYCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495456_GO_0015187_GLYCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",7,-1.3828,0.097,0.23,-0.8565,0.64,1,-1.5451,0.04,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_568_OLSSON_E2F3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_568_OLSSON_E2F3_TARGETS_UP",28,-1.3828,0.077,0.12,-1.1297,0.29,0.89,0.8502,0.7,1
"GO_BP:515472_GO_0070542_RESPONSE_TO_FATTY_ACID","GO_BP","515472_GO_0070542_RESPONSE_TO_FATTY_ACID",56,-1.3828,0.058,0.18,0.6766,0.97,1,0.9153,0.6,0.93
"GO_BP:505641_GO_0042510_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT1_PROTEIN","GO_BP","505641_GO_0042510_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT1_PROTEIN",13,-1.3827,0.11,0.18,-1.6455,0.028,0.71,-1.5576,0.029,0.51
"C7_Immunologic_signatures:C7_ALL_1382_GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN","C7_Immunologic_signatures","C7_ALL_1382_GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN",194,-1.3827,0.014,0.032,-0.7368,0.99,1,-1.1693,0.12,0.34
"C4_Cancer_gene_neighborhoods:C4_CGN_63_MORF_ARL3","C4_Cancer_gene_neighborhoods","C4_CGN_63_MORF_ARL3",298,-1.3827,0.0066,0.13,-1.2708,0.019,0.56,0.9208,0.7,0.99
"WikiPathways:198910_WP1425_BMP_SIGNALLING_AND_REGULATION","WikiPathways","198910_WP1425_BMP_SIGNALLING_AND_REGULATION",12,-1.3825,0.12,0.13,-1.1687,0.27,0.88,0.9308,0.54,1
"GO_BP:510256_GO_0048103_SOMATIC_STEM_CELL_DIVISION","GO_BP","510256_GO_0048103_SOMATIC_STEM_CELL_DIVISION",23,-1.3825,0.08,0.18,0.6569,0.95,1,-1.1891,0.22,0.73
"GO_CC:499803_GO_0030425_DENDRITE","GO_CC","499803_GO_0030425_DENDRITE",373,-1.3824,0.0032,0.24,-1.0744,0.24,0.81,0.8714,0.89,1
"C7_Immunologic_signatures:C7_ALL_1224_GSE27786_NKTCELL_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1224_GSE27786_NKTCELL_VS_NEUTROPHIL_DN",195,-1.3824,0.0069,0.032,0.8666,0.85,1,-0.7509,0.99,1
"C0_Hallmark:H_ALL_49_HALLMARK_KRAS_SIGNALING_DN","C0_Hallmark","H_ALL_49_HALLMARK_KRAS_SIGNALING_DN",182,-1.3824,0.027,0.034,-1.0337,0.38,0.78,1.0707,0.28,0.56
"C7_Immunologic_signatures:C7_ALL_834_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN","C7_Immunologic_signatures","C7_ALL_834_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN",177,-1.3822,0.02,0.032,-1.2054,0.11,0.82,-1.3945,0.0041,0.065
"REACTOME:106534_REACT_15370_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL","REACTOME","106534_REACT_15370_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL",140,-1.3822,0.026,0.21,-1.4219,0.015,0.49,-1.0119,0.43,0.82
"C3_MicroRNA_targets:C3_MIR_218_TTCCGTT_MIR_191","C3_MicroRNA_targets","C3_MIR_218_TTCCGTT_MIR_191",29,-1.3821,0.074,0.26,-0.9385,0.56,1,-1.0129,0.43,1
"GO_BP:493275_GO_0009074_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS","GO_BP","493275_GO_0009074_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS",19,-1.3821,0.078,0.18,-1.1939,0.22,0.9,-1.4468,0.065,0.55
"GO_BP:515106_GO_0070169_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT","GO_BP","515106_GO_0070169_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT",36,-1.3819,0.083,0.18,-1.6568,0.0037,0.67,1.1744,0.22,0.72
"KEGG_module:HSA_M00013_MALONATE_SEMIALDEHYDE_PATHWAY_PROPANOYL_COA_ACETYL_COA","KEGG_module","HSA_M00013_MALONATE_SEMIALDEHYDE_PATHWAY_PROPANOYL_COA_ACETYL_COA",6,-1.3818,0.1,0.43,-0.5875,0.94,1,-1.3142,0.18,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_455_GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_455_GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP",96,-1.3818,0.043,0.12,0.9864,0.47,0.81,-0.9677,0.51,0.8
"GO_BP:511703_GO_0050732_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION","GO_BP","511703_GO_0050732_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION",36,-1.3817,0.073,0.18,-0.7723,0.86,1,0.9596,0.54,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_3134_BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C","C2_Chemical_and_genetic_perturbations","C2_CGP_3134_BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C",89,-1.3817,0.033,0.12,1.0085,0.41,0.79,-1.1842,0.16,0.53
"GO_CC:487580_GO_0001669_ACROSOMAL_VESICLE","GO_CC","487580_GO_0001669_ACROSOMAL_VESICLE",87,-1.3816,0.032,0.24,-0.936,0.6,0.9,-0.9466,0.58,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_13_BIOCARTA_AT1R_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_13_BIOCARTA_AT1R_PATHWAY",33,-1.3813,0.076,0.2,-0.509,1,1,-0.736,0.89,0.97
"REACTOME:645295_REACT_120966_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK","REACTOME","645295_REACT_120966_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK",209,-1.3813,0.014,0.21,1.0178,0.4,0.72,1.103,0.21,0.96
"REACTOME:105722_REACT_6784_GLUCURONIDATION","REACTOME","105722_REACT_6784_GLUCURONIDATION",20,-1.3811,0.094,0.21,1.7475,0.0042,0.033,1.6397,0.012,0.33
"GO_BP:494960_GO_0010896_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS","GO_BP","494960_GO_0010896_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS",11,-1.3811,0.088,0.18,-1.1023,0.32,0.94,-0.8552,0.64,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2443_WANG_TUMOR_INVASIVENESS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2443_WANG_TUMOR_INVASIVENESS_DN",209,-1.3811,0.01,0.12,1.1145,0.19,0.61,-1.0352,0.34,0.7
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_79_BIOCARTA_GLYCOLYSIS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_79_BIOCARTA_GLYCOLYSIS_PATHWAY",10,-1.3811,0.096,0.2,-0.8715,0.62,1,-1.2176,0.23,0.58
"GO_BP:509092_GO_0046879_HORMONE_SECRETION","GO_BP","509092_GO_0046879_HORMONE_SECRETION",74,-1.381,0.052,0.18,1.1363,0.25,0.85,1.0725,0.31,0.78
"KEGG_pathway:HSA05166_HTLV_I_INFECTION","KEGG_pathway","HSA05166_HTLV_I_INFECTION",256,-1.3808,0.015,0.077,0.6836,1,1,-0.9699,0.54,0.75
"C3_TF_targets:C3_TFT_285_V_FOXO1_02","C3_TF_targets","C3_TFT_285_V_FOXO1_02",235,-1.3807,0.01,0.047,0.8178,0.97,1,-0.9705,0.56,0.81
"C3_TF_targets:C3_TFT_266_V_IRF7_01","C3_TF_targets","C3_TFT_266_V_IRF7_01",243,-1.3806,0.0099,0.047,0.8734,0.87,1,-1.144,0.15,0.46
"C3_MicroRNA_targets:C3_MIR_131_ATACCTC_MIR_202","C3_MicroRNA_targets","C3_MIR_131_ATACCTC_MIR_202",178,-1.3805,0.013,0.25,-0.9551,0.57,1,-0.8032,0.93,1
"C7_Immunologic_signatures:C7_ALL_1299_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP","C7_Immunologic_signatures","C7_ALL_1299_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP",188,-1.3805,0.015,0.033,-0.7465,0.99,1,-1.113,0.21,0.46
"GO_BP:508802_GO_0046546_DEVELOPMENT_OF_PRIMARY_MALE_SEXUAL_CHARACTERISTICS","GO_BP","508802_GO_0046546_DEVELOPMENT_OF_PRIMARY_MALE_SEXUAL_CHARACTERISTICS",120,-1.3803,0.022,0.18,-0.9015,0.68,1,-0.9202,0.64,0.91
"KEGG_compound:C00275_D_MANNOSE_6_PHOSPHATE","KEGG_compound","C00275_D_MANNOSE_6_PHOSPHATE",7,-1.3803,0.11,0.27,0.5449,0.96,1,-1.1045,0.35,0.53
"GO_BP:510551_GO_0048477_OOGENESIS","GO_BP","510551_GO_0048477_OOGENESIS",58,-1.3802,0.044,0.18,-1.1452,0.23,0.93,-0.923,0.59,0.91
"GO_BP:518829_GO_2000181_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_MORPHOGENESIS","GO_BP","518829_GO_2000181_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_MORPHOGENESIS",65,-1.3801,0.063,0.18,-1.0124,0.42,0.98,-1.34,0.057,0.61
"REACTOME:771601_REACT_160131_FIBRONECTIN_MATRIX_FORMATION","REACTOME","771601_REACT_160131_FIBRONECTIN_MATRIX_FORMATION",6,-1.38,0.1,0.21,1.0523,0.42,0.66,1.6594,0.019,0.38
"C3_TF_targets:C3_TFT_437_V_LEF1_Q2","C3_TF_targets","C3_TFT_437_V_LEF1_Q2",216,-1.38,0.017,0.047,-0.9599,0.54,0.85,-0.9253,0.71,0.89
"C3_TF_targets:C3_TFT_67_V_CDP_02","C3_TF_targets","C3_TFT_67_V_CDP_02",101,-1.3799,0.037,0.047,-1.3391,0.043,0.19,-1.139,0.2,0.46
"C3_TF_targets:C3_TFT_439_V_EGR_Q6","C3_TF_targets","C3_TFT_439_V_EGR_Q6",267,-1.3799,0.011,0.047,-1.2217,0.059,0.3,-0.861,0.9,0.96
"GO_BP:493588_GO_0009415_RESPONSE_TO_WATER","GO_BP","493588_GO_0009415_RESPONSE_TO_WATER",12,-1.3798,0.087,0.18,-0.9716,0.49,1,-1.2889,0.17,0.65
"GO_CC:502216_GO_0032994_PROTEIN_LIPID_COMPLEX","GO_CC","502216_GO_0032994_PROTEIN_LIPID_COMPLEX",39,-1.3798,0.062,0.24,1.1233,0.26,0.61,1.3844,0.067,0.75
"GO_BP:510558_GO_0048484_ENTERIC_NERVOUS_SYSTEM_DEVELOPMENT","GO_BP","510558_GO_0048484_ENTERIC_NERVOUS_SYSTEM_DEVELOPMENT",12,-1.3797,0.094,0.18,1.703,0.018,0.19,1.3899,0.1,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1695_JIANG_AGING_HYPOTHALAMUS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1695_JIANG_AGING_HYPOTHALAMUS_DN",40,-1.3796,0.07,0.12,0.9094,0.6,0.91,-1.411,0.051,0.35
"GO_BP:510185_GO_0048021_REGULATION_OF_MELANIN_BIOSYNTHETIC_PROCESS","GO_BP","510185_GO_0048021_REGULATION_OF_MELANIN_BIOSYNTHETIC_PROCESS",5,-1.3794,0.083,0.18,1.0312,0.41,0.97,1.1945,0.29,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_509_DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_509_DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN",19,-1.3794,0.09,0.12,0.5619,0.98,1,1.7014,0.0062,0.27
"C2_Chemical_and_genetic_perturbations:C2_CGP_1295_KIM_GERMINAL_CENTER_T_HELPER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1295_KIM_GERMINAL_CENTER_T_HELPER_UP",66,-1.3793,0.057,0.12,0.7714,0.89,1,-0.8282,0.82,0.94
"GO_BP:511772_GO_0050806_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION","GO_BP","511772_GO_0050806_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION",86,-1.3792,0.039,0.18,-1.4211,0.035,0.94,0.906,0.67,0.94
"GO_BP:1129377_GO_1903551_REGULATION_OF_EXTRACELLULAR_EXOSOME_ASSEMBLY","GO_BP","1129377_GO_1903551_REGULATION_OF_EXTRACELLULAR_EXOSOME_ASSEMBLY",6,-1.3791,0.11,0.18,1.025,0.44,0.97,1.1055,0.35,0.76
"C7_Immunologic_signatures:C7_ALL_517_GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_517_GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDM_UP",199,-1.3791,0.01,0.033,-0.894,0.74,1,-1.6525,0,0.0018
"KEGG_compound:C05577_3_4_DIHYDROXYMANDELALDEHYDE_3_4_DIHYDROXYPHENYLGLYCOLALDEHYDE","KEGG_compound","C05577_3_4_DIHYDROXYMANDELALDEHYDE_3_4_DIHYDROXYPHENYLGLYCOLALDEHYDE",13,-1.3791,0.11,0.27,1.172,0.24,0.92,-1.1093,0.3,0.54
"KEGG_compound:C00264_3_OXOACYL_COA","KEGG_compound","C00264_3_OXOACYL_COA",11,-1.379,0.094,0.27,-0.7162,0.84,1,-1.4729,0.06,0.24
"C2_Chemical_and_genetic_perturbations:C2_CGP_1777_VERRECCHIA_RESPONSE_TO_TGFB1_C1","C2_Chemical_and_genetic_perturbations","C2_CGP_1777_VERRECCHIA_RESPONSE_TO_TGFB1_C1",19,-1.3789,0.092,0.12,0.8269,0.72,0.98,-1.1756,0.23,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_843_OXFORD_RALA_AND_RALB_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_843_OXFORD_RALA_AND_RALB_TARGETS_DN",9,-1.3788,0.11,0.12,1.0394,0.38,0.74,-1.2765,0.16,0.45
"GO_BP:516255_GO_0071331_CELLULAR_RESPONSE_TO_HEXOSE_STIMULUS","GO_BP","516255_GO_0071331_CELLULAR_RESPONSE_TO_HEXOSE_STIMULUS",53,-1.3788,0.056,0.18,0.69,0.98,1,-0.695,0.96,0.99
"KEGG_pathway:HSA05030_COCAINE_ADDICTION","KEGG_pathway","HSA05030_COCAINE_ADDICTION",50,-1.3788,0.053,0.078,-1.1361,0.24,0.65,-1.2531,0.14,0.33
"GO_BP:505227_GO_0042036_NEGATIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS","GO_BP","505227_GO_0042036_NEGATIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS",27,-1.3788,0.083,0.18,-0.7249,0.89,1,-0.9323,0.54,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1773_BROWNE_HCMV_INFECTION_14HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1773_BROWNE_HCMV_INFECTION_14HR_UP",156,-1.3787,0.022,0.12,-1.2884,0.053,0.7,-1.3236,0.027,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2661_CROONQUIST_STROMAL_STIMULATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2661_CROONQUIST_STROMAL_STIMULATION_DN",12,-1.3786,0.087,0.12,-0.6793,0.88,1,0.9803,0.49,0.97
"C4_Cancer_modules:C4_CM_106_MODULE_111","C4_Cancer_modules","C4_CM_106_MODULE_111",147,-1.3784,0.022,0.11,-1.1472,0.18,0.63,-0.9473,0.61,0.78
"GO_BP:514555_GO_0061000_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT","GO_BP","514555_GO_0061000_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT",6,-1.3784,0.11,0.18,-1.3761,0.13,0.99,0.9122,0.57,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_978_GROSS_HYPOXIA_VIA_ELK3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_978_GROSS_HYPOXIA_VIA_ELK3_UP",206,-1.3782,0.012,0.12,-0.904,0.72,1,-0.8412,0.9,0.93
"GO_MF:489341_GO_0003840_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY","GO_MF","489341_GO_0003840_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY",7,-1.3782,0.1,0.23,0.6514,0.89,1,-1.0449,0.41,0.75
"REACTOME:530741_REACT_115596_SIGNALING_BY_ERBB4","REACTOME","530741_REACT_115596_SIGNALING_BY_ERBB4",143,-1.3782,0.02,0.21,-0.7876,0.93,1,-1.1346,0.2,0.67
"KEGG_compound:C00195_N_ACYLSPHINGOSINE_CERAMIDE","KEGG_compound","C00195_N_ACYLSPHINGOSINE_CERAMIDE",28,-1.3782,0.082,0.26,-0.7412,0.87,1,-0.8321,0.73,0.82
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_175_BIOCARTA_BARR_MAPK_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_175_BIOCARTA_BARR_MAPK_PATHWAY",11,-1.3782,0.096,0.2,-1.1083,0.33,1,-1.1567,0.29,0.58
"REACTOME:106251_REACT_11202_VITAMIN_C_ASCORBATE_METABOLISM","REACTOME","106251_REACT_11202_VITAMIN_C_ASCORBATE_METABOLISM",8,-1.3781,0.11,0.21,-1.4012,0.11,0.53,0.6205,0.91,1
"GO_BP:502090_GO_0032868_RESPONSE_TO_INSULIN","GO_BP","502090_GO_0032868_RESPONSE_TO_INSULIN",244,-1.3781,0.013,0.18,-0.8418,0.9,1,-0.962,0.57,0.88
"GO_BP:488805_GO_0003007_HEART_MORPHOGENESIS","GO_BP","488805_GO_0003007_HEART_MORPHOGENESIS",206,-1.3781,0.011,0.18,-0.9463,0.59,1,1.3397,0.022,0.65
"GO_BP:515142_GO_0070207_PROTEIN_HOMOTRIMERIZATION","GO_BP","515142_GO_0070207_PROTEIN_HOMOTRIMERIZATION",18,-1.378,0.1,0.18,1.2683,0.16,0.71,0.9929,0.45,0.86
"GO_BP:513591_GO_0060033_ANATOMICAL_STRUCTURE_REGRESSION","GO_BP","513591_GO_0060033_ANATOMICAL_STRUCTURE_REGRESSION",13,-1.3779,0.097,0.18,-1.1878,0.25,0.9,1.1001,0.31,0.76
"GO_BP:514790_GO_0061245_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY","GO_BP","514790_GO_0061245_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY",32,-1.3779,0.075,0.18,0.9537,0.55,1,-1.8694,0.0019,0.46
"GO_BP:509098_GO_0046890_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS","GO_BP","509098_GO_0046890_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS",116,-1.3778,0.036,0.18,-0.7534,0.96,1,0.9548,0.56,0.9
"REACTOME:1183553_REACT_355550_CLEC7A_INFLAMMASOME_PATHWAY","REACTOME","1183553_REACT_355550_CLEC7A_INFLAMMASOME_PATHWAY",6,-1.3778,0.11,0.21,-0.52,0.97,1,-0.7425,0.8,1
"GO_MF:504794_GO_0035615_CLATHRIN_ADAPTOR_ACTIVITY","GO_MF","504794_GO_0035615_CLATHRIN_ADAPTOR_ACTIVITY",8,-1.3777,0.11,0.23,0.9584,0.49,0.92,-0.8803,0.64,0.89
"GO_BP:511770_GO_0050804_REGULATION_OF_SYNAPTIC_TRANSMISSION","GO_BP","511770_GO_0050804_REGULATION_OF_SYNAPTIC_TRANSMISSION",245,-1.3775,0.0078,0.18,-1.2475,0.047,0.91,1.1975,0.082,0.72
"C7_Immunologic_signatures:C7_ALL_1501_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP","C7_Immunologic_signatures","C7_ALL_1501_GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP",197,-1.3775,0.013,0.034,0.841,0.89,1,-0.8123,0.95,1
"C3_MicroRNA_targets:C3_MIR_117_CTCAAGA_MIR_526B","C3_MicroRNA_targets","C3_MIR_117_CTCAAGA_MIR_526B",68,-1.3774,0.06,0.25,-0.7075,0.96,1,-1.0666,0.34,1
"GO_BP:507590_GO_0045217_CELL_CELL_JUNCTION_MAINTENANCE","GO_BP","507590_GO_0045217_CELL_CELL_JUNCTION_MAINTENANCE",9,-1.3773,0.1,0.19,-1.8338,0.0038,0.42,1.0685,0.36,0.78
"GO_BP:502348_GO_0033127_REGULATION_OF_HISTONE_PHOSPHORYLATION","GO_BP","502348_GO_0033127_REGULATION_OF_HISTONE_PHOSPHORYLATION",9,-1.3773,0.092,0.19,-0.6147,0.91,1,-0.9455,0.53,0.89
"GO_BP:498164_GO_0019319_HEXOSE_BIOSYNTHETIC_PROCESS","GO_BP","498164_GO_0019319_HEXOSE_BIOSYNTHETIC_PROCESS",51,-1.3773,0.081,0.18,0.9001,0.63,1,-1.0552,0.36,0.81
"GO_BP:514405_GO_0060850_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_CELL_FATE_COMMITMENT","GO_BP","514405_GO_0060850_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_CELL_FATE_COMMITMENT",17,-1.3772,0.088,0.18,-1.1032,0.32,0.94,-0.7834,0.78,1
"GO_BP:512064_GO_0051154_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION","GO_BP","512064_GO_0051154_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION",24,-1.3771,0.09,0.18,-0.7706,0.8,1,-1.0387,0.4,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1192_LEE_TARGETS_OF_PTCH1_AND_SUFU_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1192_LEE_TARGETS_OF_PTCH1_AND_SUFU_DN",79,-1.3771,0.036,0.12,-1.0411,0.36,0.97,-1.3823,0.025,0.37
"KEGG_module:HSA_M00677_WNT_SIGNALING","KEGG_module","HSA_M00677_WNT_SIGNALING",37,-1.377,0.084,0.42,-1.1196,0.28,1,1.1784,0.21,0.79
"GO_BP:488758_GO_0002885_POSITIVE_REGULATION_OF_HYPERSENSITIVITY","GO_BP","488758_GO_0002885_POSITIVE_REGULATION_OF_HYPERSENSITIVITY",6,-1.3768,0.12,0.19,-0.9116,0.57,1,-1.1824,0.29,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_215_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_215_TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN",41,-1.3767,0.081,0.12,-0.8536,0.72,1,1.2853,0.1,0.69
"GO_MF:853109_GO_0097493_STRUCTURAL_MOLECULE_ACTIVITY_CONFERRING_ELASTICITY","GO_MF","853109_GO_0097493_STRUCTURAL_MOLECULE_ACTIVITY_CONFERRING_ELASTICITY",6,-1.3766,0.11,0.23,-1.1144,0.35,0.83,-1.0269,0.43,0.77
"GO_BP:510366_GO_0048251_ELASTIC_FIBER_ASSEMBLY","GO_BP","510366_GO_0048251_ELASTIC_FIBER_ASSEMBLY",7,-1.3765,0.11,0.19,-1.2002,0.29,0.9,-0.6206,0.92,1
"GO_BP:515226_GO_0070293_RENAL_ABSORPTION","GO_BP","515226_GO_0070293_RENAL_ABSORPTION",14,-1.3764,0.098,0.19,-0.7165,0.84,1,-0.7195,0.84,0.99
"GO_BP:495301_GO_0014911_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION","GO_BP","495301_GO_0014911_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION",19,-1.3762,0.1,0.19,1.2161,0.19,0.76,0.6897,0.88,1
"GO_BP:504640_GO_0035456_RESPONSE_TO_INTERFERON_BETA","GO_BP","504640_GO_0035456_RESPONSE_TO_INTERFERON_BETA",19,-1.3762,0.11,0.19,1.2443,0.18,0.74,-1.5748,0.034,0.53
"GO_BP:512284_GO_0051403_STRESS_ACTIVATED_MAPK_CASCADE","GO_BP","512284_GO_0051403_STRESS_ACTIVATED_MAPK_CASCADE",117,-1.376,0.026,0.19,-0.7511,0.95,1,-1.1829,0.12,0.73
"C7_Immunologic_signatures:C7_ALL_1541_GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1541_GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP",197,-1.376,0.011,0.035,0.9188,0.69,0.98,-1.3144,0.015,0.12
"C3_TF_targets:C3_TFT_206_V_NFAT_Q6","C3_TF_targets","C3_TFT_206_V_NFAT_Q6",234,-1.3757,0.0077,0.049,-0.9896,0.46,0.78,-0.9885,0.47,0.78
"C3_MicroRNA_targets:C3_MIR_31_ATGTAGC_MIR_221_MIR_222","C3_MicroRNA_targets","C3_MIR_31_ATGTAGC_MIR_221_MIR_222",139,-1.3757,0.022,0.25,0.9721,0.48,1,1.1455,0.18,1
"GO_BP:511736_GO_0050765_NEGATIVE_REGULATION_OF_PHAGOCYTOSIS","GO_BP","511736_GO_0050765_NEGATIVE_REGULATION_OF_PHAGOCYTOSIS",10,-1.3756,0.12,0.19,1.0709,0.38,0.93,0.6074,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2078_ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2078_ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN",37,-1.3755,0.071,0.12,-0.7992,0.79,1,-1.4226,0.053,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_1350_SHEPARD_BMYB_MORPHOLINO_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1350_SHEPARD_BMYB_MORPHOLINO_UP",202,-1.3755,0.017,0.12,1.0937,0.22,0.64,-1.1269,0.17,0.59
"GO_BP:498964_GO_0021681_CEREBELLAR_GRANULAR_LAYER_DEVELOPMENT","GO_BP","498964_GO_0021681_CEREBELLAR_GRANULAR_LAYER_DEVELOPMENT",15,-1.3754,0.1,0.19,1.0217,0.41,0.97,0.7398,0.85,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_133_BIOCARTA_P53_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_133_BIOCARTA_P53_PATHWAY",16,-1.3754,0.081,0.21,-1.3386,0.14,1,-1.5969,0.022,0.32
"C3_TF_targets:C3_TFT_342_V_LFA1_Q6","C3_TF_targets","C3_TFT_342_V_LFA1_Q6",243,-1.3754,0.015,0.049,-1.4569,0,0.13,-1.0425,0.34,0.65
"C4_Cancer_modules:C4_CM_289_MODULE_330","C4_Cancer_modules","C4_CM_289_MODULE_330",28,-1.3753,0.089,0.11,1.2154,0.2,0.38,1.1194,0.3,0.74
"C7_Immunologic_signatures:C7_ALL_56_GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN","C7_Immunologic_signatures","C7_ALL_56_GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN",176,-1.3752,0.016,0.035,-1.3134,0.033,0.42,-1.3091,0.032,0.13
"KEGG_module:HSA_M00049_ADENINE_RIBONUCLEOTIDE_BIOSYNTHESIS_IMP_ADP_ATP","KEGG_module","HSA_M00049_ADENINE_RIBONUCLEOTIDE_BIOSYNTHESIS_IMP_ADP_ATP",21,-1.3752,0.086,0.4,-0.9423,0.55,1,-1.0144,0.42,0.78
"GO_BP:488280_GO_0002407_DENDRITIC_CELL_CHEMOTAXIS","GO_BP","488280_GO_0002407_DENDRITIC_CELL_CHEMOTAXIS",15,-1.3752,0.11,0.19,1.5392,0.045,0.36,1.5908,0.032,0.43
"KEGG_compound:C00007_OXYGEN_O2","KEGG_compound","C00007_OXYGEN_O2",128,-1.3751,0.031,0.27,-1.2003,0.12,0.77,1.1414,0.19,0.62
"C7_Immunologic_signatures:C7_ALL_1206_GSE27786_CD8_TCELL_VS_NKTCELL_DN","C7_Immunologic_signatures","C7_ALL_1206_GSE27786_CD8_TCELL_VS_NKTCELL_DN",198,-1.3751,0.011,0.035,0.8981,0.76,1,1.0635,0.3,1
"C7_Immunologic_signatures:C7_ALL_1149_GSE27786_LSK_VS_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1149_GSE27786_LSK_VS_CD8_TCELL_UP",199,-1.3751,0.016,0.035,-0.8797,0.79,1,-1.3888,0.0021,0.069
"C7_Immunologic_signatures:C7_ALL_1136_GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN","C7_Immunologic_signatures","C7_ALL_1136_GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN",186,-1.375,0.015,0.035,-1.1565,0.16,0.96,-0.9415,0.66,0.87
"C3_MicroRNA_targets:C3_MIR_155_ACTTTAT_MIR_142_5P","C3_MicroRNA_targets","C3_MIR_155_ACTTTAT_MIR_142_5P",282,-1.375,0.0055,0.24,-0.8332,0.92,1,-0.9005,0.79,1
"GO_BP:496175_GO_0016082_SYNAPTIC_VESICLE_PRIMING","GO_BP","496175_GO_0016082_SYNAPTIC_VESICLE_PRIMING",8,-1.375,0.11,0.19,0.9125,0.56,1,-0.9894,0.45,0.86
"GO_BP:491574_GO_0006686_SPHINGOMYELIN_BIOSYNTHETIC_PROCESS","GO_BP","491574_GO_0006686_SPHINGOMYELIN_BIOSYNTHETIC_PROCESS",5,-1.3749,0.1,0.19,-0.7267,0.81,1,-0.7337,0.78,1
"GO_BP:499194_GO_0021915_NEURAL_TUBE_DEVELOPMENT","GO_BP","499194_GO_0021915_NEURAL_TUBE_DEVELOPMENT",153,-1.3748,0.019,0.19,-0.7885,0.93,1,0.8849,0.78,0.95
"C7_Immunologic_signatures:C7_ALL_804_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_804_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN",170,-1.3748,0.024,0.035,-0.9987,0.46,1,-1.0898,0.21,0.52
"C3_TF_targets:C3_TFT_111_V_RORA1_01","C3_TF_targets","C3_TFT_111_V_RORA1_01",234,-1.3746,0.015,0.049,-0.9333,0.65,0.9,-1.134,0.12,0.47
"C3_TF_targets:C3_TFT_475_V_GR_01","C3_TF_targets","C3_TFT_475_V_GR_01",193,-1.3746,0.011,0.049,0.7689,0.99,1,0.6782,1,1
"GO_BP:518840_GO_2000193_POSITIVE_REGULATION_OF_FATTY_ACID_TRANSPORT","GO_BP","518840_GO_2000193_POSITIVE_REGULATION_OF_FATTY_ACID_TRANSPORT",17,-1.3746,0.1,0.19,-0.664,0.91,1,0.8038,0.75,1
"GO_BP:505981_GO_0042886_AMIDE_TRANSPORT","GO_BP","505981_GO_0042886_AMIDE_TRANSPORT",96,-1.3746,0.042,0.19,0.6583,0.99,1,0.8448,0.81,0.99
"C4_Cancer_gene_neighborhoods:C4_CGN_126_MORF_MAGEA9","C4_Cancer_gene_neighborhoods","C4_CGN_126_MORF_MAGEA9",409,-1.3745,0,0.14,-1.0735,0.23,0.77,1.0932,0.2,0.63
"KEGG_compound:C00167_UDP_GLUCURONATE_UDPGLUCURONATE_UDP_D_GLUCURONATE_UDP_ALPHA_D_GLUCURONATE","KEGG_compound","C00167_UDP_GLUCURONATE_UDPGLUCURONATE_UDP_D_GLUCURONATE_UDP_ALPHA_D_GLUCURONATE",25,-1.3744,0.081,0.27,1.7049,0.013,0.075,1.9336,0,0.0035
"GO_BP:505498_GO_0042354_L_FUCOSE_METABOLIC_PROCESS","GO_BP","505498_GO_0042354_L_FUCOSE_METABOLIC_PROCESS",11,-1.3743,0.093,0.19,-0.8095,0.69,1,-1.0133,0.42,0.84
"C3_TF_targets:C3_TFT_88_V_GATA1_04","C3_TF_targets","C3_TFT_88_V_GATA1_04",230,-1.3743,0.012,0.049,-0.9637,0.55,0.84,1.1802,0.087,0.75
"KEGG_reaction:R10825_VERY_LONG_CHAIN_ACYL_COA_MALONYL_COA_C_ACYLTRANSFERASE_DECARBOXYLATING_VERY_LONG_CHAIN_ACYL_COA_MALONYL_COA_VERY_LONG_CHAIN_3_OXOACYL_COA_CO2_COA","KEGG_reaction","R10825_VERY_LONG_CHAIN_ACYL_COA_MALONYL_COA_C_ACYLTRANSFERASE_DECARBOXYLATING_VERY_LONG_CHAIN_ACYL_COA_MALONYL_COA_VERY_LONG_CHAIN_3_OXOACYL_COA_CO2_COA",7,-1.3743,0.11,0.33,-1.1157,0.33,0.66,-1.4343,0.086,0.33
"GO_BP:508876_GO_0046628_POSITIVE_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","508876_GO_0046628_POSITIVE_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY",10,-1.3743,0.1,0.19,-0.6776,0.84,1,-0.7878,0.77,0.99
"GO_BP:499163_GO_0021884_FOREBRAIN_NEURON_DEVELOPMENT","GO_BP","499163_GO_0021884_FOREBRAIN_NEURON_DEVELOPMENT",28,-1.3743,0.086,0.19,-1.3469,0.11,0.93,1.0997,0.33,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2425_ALONSO_METASTASIS_NEURAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2425_ALONSO_METASTASIS_NEURAL_UP",17,-1.374,0.087,0.12,1.1088,0.3,0.61,1.2258,0.19,0.74
"GO_MF:500657_GO_0031406_CARBOXYLIC_ACID_BINDING","GO_MF","500657_GO_0031406_CARBOXYLIC_ACID_BINDING",180,-1.374,0.017,0.24,1.0919,0.23,0.8,-1.0558,0.3,0.74
"C7_Immunologic_signatures:C7_ALL_900_GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN","C7_Immunologic_signatures","C7_ALL_900_GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN",200,-1.3738,0.014,0.035,-1.0031,0.43,1,-1.0269,0.38,0.66
"GO_BP:492052_GO_0007274_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION","GO_BP","492052_GO_0007274_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION",21,-1.3738,0.097,0.19,-1.5681,0.032,0.72,0.7411,0.83,1
"REACTOME:645267_REACT_121237_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS","REACTOME","645267_REACT_121237_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS",33,-1.3738,0.082,0.21,0.8353,0.76,0.97,1.1842,0.21,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_1596_SESTO_RESPONSE_TO_UV_C8","C2_Chemical_and_genetic_perturbations","C2_CGP_1596_SESTO_RESPONSE_TO_UV_C8",72,-1.3737,0.043,0.12,1.2688,0.11,0.42,0.7851,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_557_BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_557_BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP",60,-1.3736,0.06,0.12,0.8863,0.69,0.94,-0.9476,0.56,0.83
"GO_BP:504990_GO_0035821_MODIFICATION_OF_MORPHOLOGY_OR_PHYSIOLOGY_OF_OTHER_ORGANISM","GO_BP","504990_GO_0035821_MODIFICATION_OF_MORPHOLOGY_OR_PHYSIOLOGY_OF_OTHER_ORGANISM",406,-1.3736,0.0021,0.19,1.2494,0.019,0.73,-1.1226,0.12,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_378_CHOW_RASSF1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_378_CHOW_RASSF1_TARGETS_DN",29,-1.3736,0.1,0.12,1.6101,0.013,0.13,-1.1124,0.29,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_1950_GENTILE_UV_RESPONSE_CLUSTER_D8","C2_Chemical_and_genetic_perturbations","C2_CGP_1950_GENTILE_UV_RESPONSE_CLUSTER_D8",40,-1.3736,0.073,0.12,0.6712,0.95,1,-0.7782,0.84,0.97
"GO_MF:499733_GO_0030332_CYCLIN_BINDING","GO_MF","499733_GO_0030332_CYCLIN_BINDING",20,-1.3736,0.11,0.24,-1.3568,0.11,0.69,-1.5976,0.022,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_2252_NADELLA_PRKAR1A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2252_NADELLA_PRKAR1A_TARGETS_UP",9,-1.3735,0.11,0.12,0.8437,0.69,0.97,-1.5177,0.038,0.29
"C7_Immunologic_signatures:C7_ALL_910_GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN","C7_Immunologic_signatures","C7_ALL_910_GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN",197,-1.3733,0.015,0.036,-0.7073,0.99,1,-1.145,0.15,0.38
"GO_BP:508904_GO_0046660_FEMALE_SEX_DIFFERENTIATION","GO_BP","508904_GO_0046660_FEMALE_SEX_DIFFERENTIATION",102,-1.3732,0.031,0.19,-0.8642,0.75,1,1.2397,0.097,0.71
"GO_MF:489486_GO_0004017_ADENYLATE_KINASE_ACTIVITY","GO_MF","489486_GO_0004017_ADENYLATE_KINASE_ACTIVITY",8,-1.3732,0.12,0.24,-1.0489,0.42,0.86,0.5146,0.98,1
"KEGG_compound:C00641_1_2_DIACYL_SN_GLYCEROL_1_2_DIACYLGLYCEROL_L_1_2_DIACYLGLYCEROL","KEGG_compound","C00641_1_2_DIACYL_SN_GLYCEROL_1_2_DIACYLGLYCEROL_L_1_2_DIACYLGLYCEROL",46,-1.3731,0.062,0.27,-1.5679,0.013,0.19,-0.8492,0.71,0.8
"GO_BP:506344_GO_0043279_RESPONSE_TO_ALKALOID","GO_BP","506344_GO_0043279_RESPONSE_TO_ALKALOID",115,-1.373,0.02,0.19,-1.0704,0.31,0.96,1.3643,0.018,0.64
"GO_CC:499593_GO_0030175_FILOPODIUM","GO_CC","499593_GO_0030175_FILOPODIUM",78,-1.3729,0.054,0.25,-1.1243,0.24,0.73,1.0687,0.33,0.95
"GO_MF:510363_GO_0048248_CXCR3_CHEMOKINE_RECEPTOR_BINDING","GO_MF","510363_GO_0048248_CXCR3_CHEMOKINE_RECEPTOR_BINDING",5,-1.3729,0.12,0.24,1.4159,0.11,0.48,-1.5589,0.051,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_1274_GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3","C2_Chemical_and_genetic_perturbations","C2_CGP_1274_GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3",14,-1.3728,0.093,0.12,0.7241,0.86,1,-1.5587,0.045,0.27
"C2_Chemical_and_genetic_perturbations:C2_CGP_1042_BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1042_BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP",24,-1.3728,0.085,0.12,0.9198,0.59,0.9,-1.2252,0.19,0.5
"REACTOME:106341_REACT_12578_GAB1_SIGNALOSOME","REACTOME","106341_REACT_12578_GAB1_SIGNALOSOME",95,-1.3728,0.025,0.21,-1.0808,0.28,0.92,-0.8823,0.73,0.97
"GO_BP:512518_GO_0051642_CENTROSOME_LOCALIZATION","GO_BP","512518_GO_0051642_CENTROSOME_LOCALIZATION",16,-1.3727,0.1,0.19,-0.8489,0.68,1,-1.1678,0.29,0.73
"GO_BP:501605_GO_0032370_POSITIVE_REGULATION_OF_LIPID_TRANSPORT","GO_BP","501605_GO_0032370_POSITIVE_REGULATION_OF_LIPID_TRANSPORT",49,-1.3726,0.069,0.19,1.0074,0.44,0.98,1.0853,0.34,0.77
"GO_BP:518173_GO_0090026_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS","GO_BP","518173_GO_0090026_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS",12,-1.3726,0.12,0.19,1.2626,0.18,0.72,1.73,0.02,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_3147_MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3147_MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN",6,-1.3725,0.11,0.12,0.8658,0.6,0.96,-0.9418,0.53,0.83
"GO_BP:507804_GO_0045453_BONE_RESORPTION","GO_BP","507804_GO_0045453_BONE_RESORPTION",21,-1.3725,0.082,0.19,-0.9396,0.52,1,0.8926,0.61,0.95
"GO_BP:500242_GO_0030949_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","500242_GO_0030949_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",15,-1.3725,0.11,0.19,-0.8581,0.66,1,0.7451,0.85,1
"GO_BP:493444_GO_0009251_GLUCAN_CATABOLIC_PROCESS","GO_BP","493444_GO_0009251_GLUCAN_CATABOLIC_PROCESS",21,-1.3724,0.077,0.19,-0.9595,0.48,1,-1.5783,0.03,0.53
"C3_TF_targets:C3_TFT_433_V_PIT1_Q6","C3_TF_targets","C3_TFT_433_V_PIT1_Q6",223,-1.3723,0.015,0.05,-1.067,0.29,0.62,-0.9723,0.53,0.81
"GO_BP:494698_GO_0010634_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION","GO_BP","494698_GO_0010634_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION",87,-1.3723,0.042,0.19,-1.0032,0.44,0.99,0.9376,0.59,0.91
"REACTOME:1127557_REACT_264487_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE","REACTOME","1127557_REACT_264487_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE",68,-1.3723,0.056,0.21,0.8811,0.72,0.92,-1.6897,0.0021,0.22
"REACTOME:106024_REACT_11166_NEF_MEDIATED_CD4_DOWN_REGULATION","REACTOME","106024_REACT_11166_NEF_MEDIATED_CD4_DOWN_REGULATION",9,-1.3723,0.11,0.21,0.7767,0.77,1,-1.0523,0.41,0.77
"REACTOME:106497_REACT_15307_CA_DEPENDENT_EVENTS","REACTOME","106497_REACT_15307_CA_DEPENDENT_EVENTS",30,-1.3722,0.074,0.21,0.7429,0.87,1,-1.3138,0.12,0.56
"C7_Immunologic_signatures:C7_ALL_253_GSE14308_TH1_VS_TH17_UP","C7_Immunologic_signatures","C7_ALL_253_GSE14308_TH1_VS_TH17_UP",197,-1.3722,0.014,0.036,0.9978,0.44,0.74,-0.9361,0.64,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1823_SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1823_SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP",34,-1.3721,0.073,0.12,1.1871,0.2,0.51,1.7644,0.0019,0.23
"GO_BP:494523_GO_0010453_REGULATION_OF_CELL_FATE_COMMITMENT","GO_BP","494523_GO_0010453_REGULATION_OF_CELL_FATE_COMMITMENT",31,-1.3721,0.078,0.19,-1.5741,0.021,0.73,1.0151,0.43,0.84
"GO_BP:508777_GO_0046519_SPHINGOID_METABOLIC_PROCESS","GO_BP","508777_GO_0046519_SPHINGOID_METABOLIC_PROCESS",13,-1.3721,0.1,0.19,-0.6436,0.92,1,-1.4269,0.079,0.57
"GO_BP:751743_GO_0044598_DOXORUBICIN_METABOLIC_PROCESS","GO_BP","751743_GO_0044598_DOXORUBICIN_METABOLIC_PROCESS",8,-1.3721,0.12,0.19,-0.7398,0.78,1,0.4932,0.99,1
"KEGG_enzyme:2.7.4.3_ADENYLATE_KINASE_MYOKINASE_5_AMP_KINASE_ADENYLIC_KINASE_ADENYLOKINASE","KEGG_enzyme","2.7.4.3_ADENYLATE_KINASE_MYOKINASE_5_AMP_KINASE_ADENYLIC_KINASE_ADENYLOKINASE",8,-1.372,0.12,0.63,-1.2683,0.2,0.64,0.5563,0.97,0.97
"C7_Immunologic_signatures:C7_ALL_375_GSE15659_RESTING_VS_ACTIVATED_TREG_UP","C7_Immunologic_signatures","C7_ALL_375_GSE15659_RESTING_VS_ACTIVATED_TREG_UP",182,-1.372,0.019,0.036,0.9507,0.59,0.89,-1.2819,0.031,0.16
"C7_Immunologic_signatures:C7_ALL_319_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP","C7_Immunologic_signatures","C7_ALL_319_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP",198,-1.372,0.017,0.036,1.2232,0.084,0.19,-0.8779,0.8,0.98
"KEGG_compound:C07490_TRICHLOROETHANOL_2_2_2_TRICHLOROETHANOL","KEGG_compound","C07490_TRICHLOROETHANOL_2_2_2_TRICHLOROETHANOL",27,-1.372,0.079,0.27,1.8409,0,0.024,2.2683,0,0
"C7_Immunologic_signatures:C7_ALL_1364_GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1364_GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN",190,-1.372,0.016,0.036,0.928,0.67,0.96,0.953,0.59,1
"GO_BP:506102_GO_0043011_MYELOID_DENDRITIC_CELL_DIFFERENTIATION","GO_BP","506102_GO_0043011_MYELOID_DENDRITIC_CELL_DIFFERENTIATION",20,-1.3719,0.1,0.19,-0.9191,0.58,1,-0.8973,0.58,0.93
"GO_BP:513808_GO_0060252_POSITIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION","GO_BP","513808_GO_0060252_POSITIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION",8,-1.3719,0.12,0.19,-1.0797,0.34,0.95,-0.8477,0.67,0.96
"GO_BP:517245_GO_0072329_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS","GO_BP","517245_GO_0072329_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS",84,-1.3719,0.04,0.19,1.0437,0.36,0.95,-1.2368,0.1,0.69
"C3_TF_targets:C3_TFT_97_V_OCT1_02","C3_TF_targets","C3_TFT_97_V_OCT1_02",202,-1.3719,0.017,0.05,0.9519,0.57,1,-1.1139,0.19,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_956_GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS","C2_Chemical_and_genetic_perturbations","C2_CGP_956_GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS",14,-1.3718,0.091,0.12,-0.6724,0.88,1,-1.351,0.14,0.39
"C4_Cancer_gene_neighborhoods:C4_CGN_278_CAR_MLANA","C4_Cancer_gene_neighborhoods","C4_CGN_278_CAR_MLANA",42,-1.3718,0.084,0.14,-1.4143,0.048,0.42,0.9303,0.57,0.97
"KEGG_compound:C05274_DECANOYL_COA","KEGG_compound","C05274_DECANOYL_COA",8,-1.3716,0.1,0.27,-0.5723,0.94,1,-1.4998,0.057,0.22
"GO_BP:514394_GO_0060839_ENDOTHELIAL_CELL_FATE_COMMITMENT","GO_BP","514394_GO_0060839_ENDOTHELIAL_CELL_FATE_COMMITMENT",5,-1.3716,0.098,0.19,0.9256,0.53,1,1.2068,0.27,0.71
"GO_BP:503350_GO_0034144_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY","GO_BP","503350_GO_0034144_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY",9,-1.3715,0.1,0.19,-1.4497,0.081,0.9,-0.624,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1429_PENG_RAPAMYCIN_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1429_PENG_RAPAMYCIN_RESPONSE_UP",194,-1.3715,0.022,0.12,0.8452,0.9,0.97,-1.2025,0.08,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_1630_ZAMORA_NOS2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1630_ZAMORA_NOS2_TARGETS_UP",68,-1.3715,0.044,0.12,1.39,0.046,0.3,-1.0471,0.37,0.69
"GO_BP:491640_GO_0006766_VITAMIN_METABOLIC_PROCESS","GO_BP","491640_GO_0006766_VITAMIN_METABOLIC_PROCESS",144,-1.3715,0.03,0.19,-0.9885,0.49,1,-1.0677,0.31,0.8
"GO_BP:488540_GO_0002667_REGULATION_OF_T_CELL_ANERGY","GO_BP","488540_GO_0002667_REGULATION_OF_T_CELL_ANERGY",7,-1.3715,0.095,0.19,0.6706,0.86,1,-0.7093,0.81,0.99
"C7_Immunologic_signatures:C7_ALL_24_GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_24_GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN",200,-1.3714,0.013,0.036,1.2899,0.028,0.11,-1.0307,0.38,0.66
"C3_TF_targets:C3_TFT_309_V_LHX3_01","C3_TF_targets","C3_TFT_309_V_LHX3_01",212,-1.3714,0.013,0.05,-1.1201,0.2,0.5,-1.1615,0.12,0.43
"C3_TF_targets:C3_TFT_308_V_STAT6_02","C3_TF_targets","C3_TFT_308_V_STAT6_02",252,-1.3714,0.0099,0.049,-0.9724,0.55,0.82,-1.0568,0.3,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1593_HOEGERKORP_CD44_TARGETS_DIRECT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1593_HOEGERKORP_CD44_TARGETS_DIRECT_UP",27,-1.3713,0.093,0.12,-0.6973,0.9,1,-1.5823,0.021,0.25
"GO_BP:491565_GO_0006677_GLYCOSYLCERAMIDE_METABOLIC_PROCESS","GO_BP","491565_GO_0006677_GLYCOSYLCERAMIDE_METABOLIC_PROCESS",12,-1.3712,0.12,0.19,-1.0084,0.45,0.98,-1.4381,0.083,0.56
"GO_BP:501699_GO_0032467_POSITIVE_REGULATION_OF_CYTOKINESIS","GO_BP","501699_GO_0032467_POSITIVE_REGULATION_OF_CYTOKINESIS",35,-1.3711,0.071,0.19,0.8116,0.77,1,-1.2823,0.14,0.65
"GO_BP:491960_GO_0040007_GROWTH","GO_BP","491960_GO_0040007_GROWTH",381,-1.3711,0.0032,0.19,-1.075,0.25,0.96,-1.04,0.29,0.82
"C3_TF_targets:C3_TFT_115_V_SRY_02","C3_TF_targets","C3_TFT_115_V_SRY_02",244,-1.371,0.0067,0.05,-0.8671,0.82,0.99,-0.8931,0.79,0.93
"C3_TF_targets:C3_TFT_295_V_PAX2_02","C3_TF_targets","C3_TFT_295_V_PAX2_02",251,-1.371,0.0077,0.049,0.8856,0.84,1,1.1237,0.17,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_793_SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_793_SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN",30,-1.371,0.091,0.12,-1.1184,0.29,0.89,-0.9655,0.51,0.8
"C7_Immunologic_signatures:C7_ALL_657_GSE17721_LPS_VS_CPG_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_657_GSE17721_LPS_VS_CPG_2H_BMDM_UP",198,-1.3708,0.021,0.037,0.8891,0.76,1,-1.0478,0.32,0.61
"GO_MF:489644_GO_0008235_METALLOEXOPEPTIDASE_ACTIVITY","GO_MF","489644_GO_0008235_METALLOEXOPEPTIDASE_ACTIVITY",38,-1.3707,0.057,0.24,0.867,0.68,1,-1.5468,0.018,0.42
"GO_BP:752180_GO_0061437_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT","GO_BP","752180_GO_0061437_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT",20,-1.3707,0.09,0.19,-1.1568,0.26,0.92,1.3318,0.12,0.64
"REACTOME:106421_REACT_999_SHC_RELATED_EVENTS","REACTOME","106421_REACT_999_SHC_RELATED_EVENTS",24,-1.3707,0.086,0.21,-0.5927,0.98,1,-1.1945,0.19,0.61
"GO_CC:510837_GO_0048786_PRESYNAPTIC_ACTIVE_ZONE","GO_CC","510837_GO_0048786_PRESYNAPTIC_ACTIVE_ZONE",24,-1.3706,0.1,0.25,0.7168,0.89,0.99,1.7432,0.0082,0.29
"C1_Positional:C1_ALL_70_CHR10P13","C1_Positional","C1_ALL_70_CHR10P13",24,-1.3706,0.086,0.56,-0.8438,0.69,0.97,0.8254,0.74,0.92
"GO_BP:504175_GO_0034983_PEPTIDYL_LYSINE_DEACETYLATION","GO_BP","504175_GO_0034983_PEPTIDYL_LYSINE_DEACETYLATION",7,-1.3705,0.13,0.19,-1.4161,0.089,0.95,-1.6065,0.031,0.52
"GO_BP:513494_GO_0055062_PHOSPHATE_ION_HOMEOSTASIS","GO_BP","513494_GO_0055062_PHOSPHATE_ION_HOMEOSTASIS",11,-1.3704,0.11,0.19,-0.9469,0.53,1,-1.0309,0.42,0.82
"GO_BP:511979_GO_0051054_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS","GO_BP","511979_GO_0051054_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS",126,-1.3703,0.034,0.19,-0.8412,0.82,1,-1.1339,0.19,0.75
"GO_BP:753114_GO_1900119_POSITIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS","GO_BP","753114_GO_1900119_POSITIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS",7,-1.3702,0.1,0.19,-0.4563,1,1,-0.8425,0.63,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2408_MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN","C2_Chemical_and_genetic_perturbations","C2_CGP_2408_MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN",17,-1.3702,0.1,0.12,0.7109,0.86,1,1.719,0.021,0.29
"C3_TF_targets:C3_TFT_530_TTCYRGAA_UNKNOWN","C3_TF_targets","C3_TFT_530_TTCYRGAA_UNKNOWN",324,-1.3702,0.0075,0.05,-1.2019,0.077,0.34,-1.3829,0.0021,0.29
"GO_BP:510785_GO_0048730_EPIDERMIS_MORPHOGENESIS","GO_BP","510785_GO_0048730_EPIDERMIS_MORPHOGENESIS",34,-1.3702,0.083,0.19,-1.2406,0.16,0.91,0.7537,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_163_BASAKI_YBX1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_163_BASAKI_YBX1_TARGETS_DN",375,-1.3701,0.0042,0.12,1.1461,0.1,0.56,0.9756,0.55,0.96
"C6_Oncogenic_signatures:C6_ALL_133_IL15_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_133_IL15_UP_V1_DN",172,-1.3701,0.022,0.045,-1.1186,0.21,0.54,1.2343,0.08,0.24
"C4_Cancer_modules:C4_CM_310_MODULE_360","C4_Cancer_modules","C4_CM_310_MODULE_360",14,-1.3701,0.1,0.12,1.5973,0.027,0.075,0.9372,0.54,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_501_MCBRYAN_PUBERTAL_BREAST_4_5WK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_501_MCBRYAN_PUBERTAL_BREAST_4_5WK_DN",193,-1.3701,0.019,0.12,0.9951,0.47,0.81,-0.9048,0.76,0.87
"C7_Immunologic_signatures:C7_ALL_1719_GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1719_GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP",197,-1.37,0.018,0.037,1.2989,0.029,0.1,-1.1253,0.2,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_138_DOANE_BREAST_CANCER_CLASSES_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_138_DOANE_BREAST_CANCER_CLASSES_DN",34,-1.37,0.081,0.12,-0.7443,0.87,1,-1.2327,0.16,0.49
"GO_BP:498920_GO_0021637_TRIGEMINAL_NERVE_STRUCTURAL_ORGANIZATION","GO_BP","498920_GO_0021637_TRIGEMINAL_NERVE_STRUCTURAL_ORGANIZATION",5,-1.3699,0.11,0.19,-1.1896,0.29,0.9,-0.7384,0.76,1
"GO_CC:512127_GO_0051233_SPINDLE_MIDZONE","GO_CC","512127_GO_0051233_SPINDLE_MIDZONE",25,-1.3699,0.09,0.25,0.6354,0.96,1,-1.3579,0.098,0.62
"KEGG_pathway:HSA04720_LONG_TERM_POTENTIATION","KEGG_pathway","HSA04720_LONG_TERM_POTENTIATION",66,-1.3697,0.038,0.083,1.1125,0.26,0.79,-1.0165,0.44,0.67
"C7_Immunologic_signatures:C7_ALL_353_GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_353_GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP",195,-1.3697,0.016,0.037,-1.1214,0.23,1,-0.975,0.54,0.78
"GO_MF:506523_GO_0043492_ATPASE_ACTIVITY_COUPLED_TO_MOVEMENT_OF_SUBSTANCES","GO_MF","506523_GO_0043492_ATPASE_ACTIVITY_COUPLED_TO_MOVEMENT_OF_SUBSTANCES",116,-1.3697,0.043,0.24,-0.817,0.87,1,-1.1218,0.22,0.69
"GO_BP:491607_GO_0006721_TERPENOID_METABOLIC_PROCESS","GO_BP","491607_GO_0006721_TERPENOID_METABOLIC_PROCESS",99,-1.3697,0.055,0.19,-1.0173,0.43,0.98,-1.0198,0.4,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_344_WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_344_WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP",18,-1.3697,0.087,0.12,0.9995,0.47,0.8,-1.2591,0.17,0.46
"GO_BP:750889_GO_0035962_RESPONSE_TO_INTERLEUKIN_13","GO_BP","750889_GO_0035962_RESPONSE_TO_INTERLEUKIN_13",6,-1.3697,0.13,0.19,-1.2575,0.21,0.91,-1.5243,0.043,0.53
"GO_BP:510379_GO_0048265_RESPONSE_TO_PAIN","GO_BP","510379_GO_0048265_RESPONSE_TO_PAIN",30,-1.3696,0.083,0.19,-1.6981,0.0059,0.63,-0.9564,0.52,0.88
"GO_BP:911329_GO_0090557_ESTABLISHMENT_OF_ENDOTHELIAL_INTESTINAL_BARRIER","GO_BP","911329_GO_0090557_ESTABLISHMENT_OF_ENDOTHELIAL_INTESTINAL_BARRIER",10,-1.3696,0.12,0.19,1.036,0.39,0.96,0.6496,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1765_BROWNE_HCMV_INFECTION_8HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1765_BROWNE_HCMV_INFECTION_8HR_DN",45,-1.3696,0.068,0.12,1.0136,0.45,0.78,0.9317,0.58,1
"GO_BP:752787_GO_0097286_IRON_ION_IMPORT","GO_BP","752787_GO_0097286_IRON_ION_IMPORT",10,-1.3695,0.12,0.19,-0.759,0.77,1,1.1279,0.31,0.74
"C3_TF_targets:C3_TFT_222_V_PAX4_03","C3_TF_targets","C3_TFT_222_V_PAX4_03",247,-1.3695,0.011,0.05,-1.4799,0.0035,0.14,-1.1407,0.12,0.46
"GO_BP:514248_GO_0060693_REGULATION_OF_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS","GO_BP","514248_GO_0060693_REGULATION_OF_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS",10,-1.3694,0.13,0.19,1.0102,0.42,0.98,1.7023,0.019,0.41
"GO_BP:492467_GO_0008105_ASYMMETRIC_PROTEIN_LOCALIZATION","GO_BP","492467_GO_0008105_ASYMMETRIC_PROTEIN_LOCALIZATION",22,-1.3694,0.099,0.19,1.2831,0.15,0.7,-0.5507,0.99,1
"KEGG_reaction:R01177_BUTANOYL_COA_ACETYL_COA_C_BUTANOYLTRANSFERASE_ACETYL_COA_BUTANOYL_COA_COA_3_OXOHEXANOYL_COA","KEGG_reaction","R01177_BUTANOYL_COA_ACETYL_COA_C_BUTANOYLTRANSFERASE_ACETYL_COA_BUTANOYL_COA_COA_3_OXOHEXANOYL_COA",5,-1.3694,0.1,0.33,-0.4839,0.99,0.99,-1.277,0.19,0.49
"GO_BP:504423_GO_0035239_TUBE_MORPHOGENESIS","GO_BP","504423_GO_0035239_TUBE_MORPHOGENESIS",339,-1.3691,0.0074,0.19,1.0074,0.44,0.98,1.1993,0.068,0.72
"C7_Immunologic_signatures:C7_ALL_312_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN","C7_Immunologic_signatures","C7_ALL_312_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN",190,-1.3688,0.019,0.037,0.9917,0.49,0.76,-0.9418,0.63,0.87
"GO_MF:489313_GO_0003796_LYSOZYME_ACTIVITY","GO_MF","489313_GO_0003796_LYSOZYME_ACTIVITY",8,-1.3688,0.12,0.24,-1.3421,0.15,0.71,-1.5866,0.046,0.36
"C4_Cancer_modules:C4_CM_35_MODULE_39","C4_Cancer_modules","C4_CM_35_MODULE_39",10,-1.3687,0.12,0.12,0.9968,0.46,0.71,-0.6712,0.9,1
"GO_BP:494605_GO_0010536_POSITIVE_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY","GO_BP","494605_GO_0010536_POSITIVE_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY",7,-1.3687,0.11,0.19,-1.0926,0.35,0.95,-0.8973,0.56,0.93
"GO_BP:754257_GO_1901293_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","754257_GO_1901293_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS",218,-1.3686,0.015,0.19,0.8466,0.91,1,-1.3826,0.01,0.59
"C7_Immunologic_signatures:C7_ALL_1705_GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1705_GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP",195,-1.3686,0.016,0.037,1.2546,0.036,0.15,-1.0494,0.35,0.61
"C7_Immunologic_signatures:C7_ALL_306_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN","C7_Immunologic_signatures","C7_ALL_306_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN",195,-1.3684,0.022,0.037,0.6653,1,1,-1.1693,0.12,0.34
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_44_BIOCARTA_HDAC_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_44_BIOCARTA_HDAC_PATHWAY",28,-1.3682,0.082,0.21,1.0291,0.41,0.84,-0.9062,0.59,0.84
"GO_MF:492496_GO_0008144_DRUG_BINDING","GO_MF","492496_GO_0008144_DRUG_BINDING",94,-1.3682,0.047,0.24,0.8567,0.78,1,1.1581,0.18,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1862_WU_HBX_TARGETS_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1862_WU_HBX_TARGETS_1_UP",15,-1.368,0.1,0.13,1.2463,0.18,0.44,-1.0256,0.42,0.72
"GO_CC:500523_GO_0031264_DEATH_INDUCING_SIGNALING_COMPLEX","GO_CC","500523_GO_0031264_DEATH_INDUCING_SIGNALING_COMPLEX",8,-1.3679,0.11,0.25,-0.8,0.72,1,-1.0045,0.46,1
"GO_BP:503351_GO_0034145_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY","GO_BP","503351_GO_0034145_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY",7,-1.3678,0.13,0.19,1.0603,0.39,0.94,0.9859,0.45,0.87
"GO_MF:487542_GO_0001608_G_PROTEIN_COUPLED_NUCLEOTIDE_RECEPTOR_ACTIVITY","GO_MF","487542_GO_0001608_G_PROTEIN_COUPLED_NUCLEOTIDE_RECEPTOR_ACTIVITY",26,-1.3678,0.094,0.24,1.526,0.033,0.36,-0.7672,0.84,0.98
"GO_MF:490482_GO_0005248_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY","GO_MF","490482_GO_0005248_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY",19,-1.3678,0.1,0.24,-1.0133,0.43,0.89,1.0557,0.36,0.83
"GO_BP:498165_GO_0019320_HEXOSE_CATABOLIC_PROCESS","GO_BP","498165_GO_0019320_HEXOSE_CATABOLIC_PROCESS",23,-1.3678,0.088,0.19,-0.9531,0.53,1,-1.1537,0.26,0.73
"GO_BP:502781_GO_0033564_ANTERIOR_POSTERIOR_AXON_GUIDANCE","GO_BP","502781_GO_0033564_ANTERIOR_POSTERIOR_AXON_GUIDANCE",5,-1.3676,0.092,0.19,-0.6752,0.85,1,0.9108,0.56,0.93
"C7_Immunologic_signatures:C7_ALL_1625_GSE3982_MAST_CELL_VS_TH2_UP","C7_Immunologic_signatures","C7_ALL_1625_GSE3982_MAST_CELL_VS_TH2_UP",196,-1.3674,0.015,0.038,0.7748,0.97,1,1.0179,0.4,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2538_YOSHIMURA_MAPK8_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2538_YOSHIMURA_MAPK8_TARGETS_DN",359,-1.3674,0.0021,0.13,1.3028,0.0078,0.39,-1.1078,0.15,0.62
"KEGG_compound:C05445_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTAN_26_AL","KEGG_compound","C05445_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTAN_26_AL",6,-1.3674,0.13,0.27,0.6209,0.91,1,-1.234,0.23,0.42
"C7_Immunologic_signatures:C7_ALL_1699_GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1699_GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP",190,-1.3673,0.012,0.038,1.4233,0,0.031,-1.1071,0.19,0.48
"GO_BP:516618_GO_0071694_MAINTENANCE_OF_PROTEIN_LOCATION_IN_EXTRACELLULAR_REGION","GO_BP","516618_GO_0071694_MAINTENANCE_OF_PROTEIN_LOCATION_IN_EXTRACELLULAR_REGION",5,-1.3673,0.13,0.19,1.2237,0.24,0.76,-1.3728,0.13,0.59
"GO_BP:514856_GO_0061311_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","514856_GO_0061311_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",21,-1.3673,0.1,0.19,-0.8855,0.59,1,1.073,0.35,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2051_LEIN_CHOROID_PLEXUS_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_2051_LEIN_CHOROID_PLEXUS_MARKERS",99,-1.3673,0.035,0.13,0.7429,0.96,1,-0.9829,0.5,0.78
"GO_BP:493457_GO_0009264_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS","GO_BP","493457_GO_0009264_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS",19,-1.3672,0.096,0.19,1.3528,0.12,0.61,-1.4419,0.067,0.56
"GO_BP:498919_GO_0021636_TRIGEMINAL_NERVE_MORPHOGENESIS","GO_BP","498919_GO_0021636_TRIGEMINAL_NERVE_MORPHOGENESIS",5,-1.3672,0.096,0.19,-1.1676,0.29,0.91,-0.7291,0.8,0.99
"C4_Cancer_modules:C4_CM_114_MODULE_119","C4_Cancer_modules","C4_CM_114_MODULE_119",140,-1.367,0.025,0.12,0.8588,0.84,0.91,-1.0668,0.28,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_203_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_203_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP",11,-1.367,0.11,0.13,-0.6574,0.9,1,-0.9608,0.52,0.8
"REACTOME:106441_REACT_13776_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING","REACTOME","106441_REACT_13776_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING",84,-1.367,0.041,0.22,-0.815,0.85,1,-0.7746,0.94,1
"GO_BP:1129340_GO_1903513_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT","GO_BP","1129340_GO_1903513_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT",7,-1.3669,0.12,0.19,0.6003,0.93,1,0.9177,0.56,0.93
"GO_BP:512056_GO_0051146_STRIATED_MUSCLE_CELL_DIFFERENTIATION","GO_BP","512056_GO_0051146_STRIATED_MUSCLE_CELL_DIFFERENTIATION",177,-1.3669,0.028,0.19,-1.1396,0.18,0.93,-1.2068,0.084,0.73
"GO_MF:489253_GO_0003707_STEROID_HORMONE_RECEPTOR_ACTIVITY","GO_MF","489253_GO_0003707_STEROID_HORMONE_RECEPTOR_ACTIVITY",53,-1.3669,0.074,0.24,-1.0316,0.39,0.88,-0.9042,0.63,0.87
"KEGG_reaction:R00127_ATP_AMP_PHOSPHOTRANSFERASE_ATP_AMP_2_ADP","KEGG_reaction","R00127_ATP_AMP_PHOSPHOTRANSFERASE_ATP_AMP_2_ADP",8,-1.3667,0.11,0.33,-1.2657,0.19,0.44,0.5544,0.95,0.98
"GO_BP:499708_GO_0030308_NEGATIVE_REGULATION_OF_CELL_GROWTH","GO_BP","499708_GO_0030308_NEGATIVE_REGULATION_OF_CELL_GROWTH",149,-1.3667,0.029,0.19,-1.3439,0.033,0.92,-1.0344,0.38,0.82
"GO_BP:752182_GO_0061439_KIDNEY_VASCULATURE_MORPHOGENESIS","GO_BP","752182_GO_0061439_KIDNEY_VASCULATURE_MORPHOGENESIS",7,-1.3666,0.13,0.19,-1.2283,0.23,0.89,1.6228,0.022,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1775_LEE_CALORIE_RESTRICTION_MUSCLE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1775_LEE_CALORIE_RESTRICTION_MUSCLE_UP",41,-1.3666,0.072,0.13,1.5316,0.023,0.18,1.1906,0.18,0.78
"C7_Immunologic_signatures:C7_ALL_291_GSE14350_IL2RB_KO_VS_WT_TEFF_UP","C7_Immunologic_signatures","C7_ALL_291_GSE14350_IL2RB_KO_VS_WT_TEFF_UP",198,-1.3666,0.019,0.038,-0.7524,0.98,1,-1.5817,0,0.0072
"GO_BP:510633_GO_0048568_EMBRYONIC_ORGAN_DEVELOPMENT","GO_BP","510633_GO_0048568_EMBRYONIC_ORGAN_DEVELOPMENT",412,-1.3665,0.0031,0.19,-1.1168,0.15,0.94,1.0623,0.24,0.79
"REACTOME:106122_REACT_1473_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION","REACTOME","106122_REACT_1473_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION",15,-1.3663,0.096,0.22,1.0374,0.41,0.68,-1.719,0.0082,0.2
"C2_Chemical_and_genetic_perturbations:C2_CGP_3201_FARDIN_HYPOXIA_9","C2_Chemical_and_genetic_perturbations","C2_CGP_3201_FARDIN_HYPOXIA_9",7,-1.3663,0.096,0.13,0.8297,0.68,0.98,0.6162,0.93,1
"GO_BP:498260_GO_0019418_SULFIDE_OXIDATION","GO_BP","498260_GO_0019418_SULFIDE_OXIDATION",5,-1.3663,0.11,0.19,-0.6354,0.88,1,-1.1423,0.35,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_3003_ONGUSAHA_BRCA1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3003_ONGUSAHA_BRCA1_TARGETS_UP",12,-1.3663,0.092,0.13,1.036,0.4,0.74,1.1057,0.32,0.88
"GO_BP:505556_GO_0042415_NOREPINEPHRINE_METABOLIC_PROCESS","GO_BP","505556_GO_0042415_NOREPINEPHRINE_METABOLIC_PROCESS",12,-1.3662,0.11,0.19,-0.4702,0.99,1,-1.1602,0.27,0.73
"GO_BP:517004_GO_0072088_NEPHRON_EPITHELIUM_MORPHOGENESIS","GO_BP","517004_GO_0072088_NEPHRON_EPITHELIUM_MORPHOGENESIS",64,-1.3662,0.063,0.19,-0.8828,0.68,1,1.1396,0.22,0.73
"C3_MicroRNA_targets:C3_MIR_136_GCAAAAA_MIR_129","C3_MicroRNA_targets","C3_MIR_136_GCAAAAA_MIR_129",183,-1.3661,0.021,0.25,-1.1623,0.13,1,-1.2484,0.053,1
"REACTOME:106412_REACT_7972_ACTIVATION_OF_C3_AND_C5","REACTOME","106412_REACT_7972_ACTIVATION_OF_C3_AND_C5",6,-1.366,0.12,0.22,-1.5955,0.025,0.34,0.7426,0.78,1
"GO_BP:489168_GO_0003376_SPHINGOSINE_1_PHOSPHATE_SIGNALING_PATHWAY","GO_BP","489168_GO_0003376_SPHINGOSINE_1_PHOSPHATE_SIGNALING_PATHWAY",8,-1.366,0.12,0.19,0.9065,0.59,1,-1.1373,0.32,0.75
"REACTOME:106519_REACT_15418_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE","REACTOME","106519_REACT_15418_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE",18,-1.366,0.1,0.22,-1.2616,0.17,0.72,0.9325,0.55,1
"GO_BP:513871_GO_0060315_NEGATIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY","GO_BP","513871_GO_0060315_NEGATIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY",12,-1.3659,0.11,0.19,1.2531,0.19,0.73,0.7834,0.73,1
"GO_BP:514242_GO_0060687_REGULATION_OF_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS","GO_BP","514242_GO_0060687_REGULATION_OF_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS",7,-1.3659,0.11,0.19,-1.1933,0.25,0.9,1.0977,0.36,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_3378_WARTERS_IR_RESPONSE_5GY","C2_Chemical_and_genetic_perturbations","C2_CGP_3378_WARTERS_IR_RESPONSE_5GY",46,-1.3659,0.068,0.13,0.9827,0.48,0.81,-1.1628,0.2,0.56
"GO_BP:1133968_GO_1903793_POSITIVE_REGULATION_OF_ANION_TRANSPORT","GO_BP","1133968_GO_1903793_POSITIVE_REGULATION_OF_ANION_TRANSPORT",49,-1.3658,0.065,0.19,-0.759,0.86,1,0.7254,0.91,1
"C3_MicroRNA_targets:C3_MIR_186_ACCAATC_MIR_509","C3_MicroRNA_targets","C3_MIR_186_ACCAATC_MIR_509",48,-1.3658,0.064,0.24,1.457,0.03,0.57,1.8555,0,0.026
"GO_MF:490483_GO_0005249_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY","GO_MF","490483_GO_0005249_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY",86,-1.3658,0.051,0.24,-1.1988,0.14,0.81,1.5991,0,0.34
"C7_Immunologic_signatures:C7_ALL_1430_GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN","C7_Immunologic_signatures","C7_ALL_1430_GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN",195,-1.3655,0.01,0.039,-0.9065,0.69,1,-0.9869,0.49,0.75
"C7_Immunologic_signatures:C7_ALL_105_GSE11924_TH2_VS_TH17_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_105_GSE11924_TH2_VS_TH17_CD4_TCELL_UP",197,-1.3655,0.017,0.039,-0.988,0.47,1,-0.9015,0.72,0.94
"GO_BP:492317_GO_0007567_PARTURITION","GO_BP","492317_GO_0007567_PARTURITION",18,-1.3653,0.1,0.19,1.4542,0.062,0.49,0.9291,0.53,0.92
"C3_MicroRNA_targets:C3_MIR_95_TTGCCAA_MIR_182","C3_MicroRNA_targets","C3_MIR_95_TTGCCAA_MIR_182",323,-1.3653,0.0075,0.24,-0.7052,1,1,-0.9206,0.75,1
"C3_TF_targets:C3_TFT_333_V_FXR_Q3","C3_TF_targets","C3_TFT_333_V_FXR_Q3",111,-1.3651,0.042,0.052,-0.7581,0.95,1,0.7139,0.99,1
"C3_TF_targets:C3_TFT_487_V_HNF4_Q6","C3_TF_targets","C3_TFT_487_V_HNF4_Q6",257,-1.3651,0.016,0.052,-1.0723,0.26,0.61,-1.1386,0.13,0.46
"GO_BP:487440_GO_0001501_SKELETAL_SYSTEM_DEVELOPMENT","GO_BP","487440_GO_0001501_SKELETAL_SYSTEM_DEVELOPMENT",452,-1.3651,0.001,0.19,-1.1675,0.082,0.91,1.0865,0.19,0.77
"GO_BP:506489_GO_0043455_REGULATION_OF_SECONDARY_METABOLIC_PROCESS","GO_BP","506489_GO_0043455_REGULATION_OF_SECONDARY_METABOLIC_PROCESS",6,-1.3651,0.13,0.19,1.1754,0.29,0.81,1.1774,0.28,0.72
"C4_Cancer_modules:C4_CM_368_MODULE_451","C4_Cancer_modules","C4_CM_368_MODULE_451",33,-1.3651,0.088,0.12,0.7208,0.9,1,-1.8533,0,0.031
"C4_Cancer_modules:C4_CM_17_MODULE_18","C4_Cancer_modules","C4_CM_17_MODULE_18",444,-1.3649,0.0021,0.12,1.1832,0.045,0.42,-1.037,0.32,0.63
"GO_BP:514134_GO_0060579_VENTRAL_SPINAL_CORD_INTERNEURON_FATE_COMMITMENT","GO_BP","514134_GO_0060579_VENTRAL_SPINAL_CORD_INTERNEURON_FATE_COMMITMENT",13,-1.3649,0.11,0.19,-1.5226,0.044,0.79,1.0421,0.38,0.81
"GO_BP:510730_GO_0048675_AXON_EXTENSION","GO_BP","510730_GO_0048675_AXON_EXTENSION",28,-1.3648,0.097,0.19,-0.7168,0.89,1,0.8824,0.67,0.95
"C0_Hallmark:H_ALL_18_HALLMARK_INTERFERON_ALPHA_RESPONSE","C0_Hallmark","H_ALL_18_HALLMARK_INTERFERON_ALPHA_RESPONSE",97,-1.3648,0.03,0.04,1.6761,0,0.0052,-1.6285,0.0062,0.016
"GO_BP:488310_GO_0002437_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS","GO_BP","488310_GO_0002437_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",22,-1.3647,0.085,0.19,-0.9777,0.48,1,0.6168,0.97,1
"C3_TF_targets:C3_TFT_585_YTAATTAA_V_LHX3_01","C3_TF_targets","C3_TFT_585_YTAATTAA_V_LHX3_01",178,-1.3646,0.014,0.052,-1.0326,0.37,0.69,-1.1461,0.15,0.47
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_146_BIOCARTA_RAB_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_146_BIOCARTA_RAB_PATHWAY",12,-1.3646,0.11,0.21,0.994,0.46,0.84,-1.3192,0.12,0.5
"C3_MicroRNA_targets:C3_MIR_200_ACCGAGC_MIR_423","C3_MicroRNA_targets","C3_MIR_200_ACCGAGC_MIR_423",8,-1.3645,0.12,0.23,-1.16,0.27,1,-0.7699,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_668_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17","C2_Chemical_and_genetic_perturbations","C2_CGP_668_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17",19,-1.3644,0.11,0.13,-1.1282,0.29,0.89,-0.8382,0.7,0.93
"REACTOME:161072_REACT_22345_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT","REACTOME","161072_REACT_22345_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT",14,-1.3643,0.11,0.22,-0.875,0.64,1,-0.9554,0.5,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1991_MARCHINI_TRABECTEDIN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1991_MARCHINI_TRABECTEDIN_RESISTANCE_DN",49,-1.3642,0.066,0.13,0.9857,0.47,0.81,1.2958,0.096,0.69
"REACTOME:105766_REACT_1590_G1_PHASE","REACTOME","105766_REACT_1590_G1_PHASE",38,-1.3641,0.075,0.22,0.9829,0.49,0.78,-1.258,0.14,0.54
"GO_BP:510411_GO_0048304_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES","GO_BP","510411_GO_0048304_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES",6,-1.3641,0.13,0.19,-1.333,0.15,0.91,-1.1246,0.31,0.75
"GO_MF:511633_GO_0050661_NADP_BINDING","GO_MF","511633_GO_0050661_NADP_BINDING",46,-1.364,0.064,0.25,-1.0516,0.39,0.86,-1.2553,0.12,0.59
"GO_BP:500185_GO_0030890_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION","GO_BP","500185_GO_0030890_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION",39,-1.364,0.079,0.19,-0.7087,0.92,1,-1.0467,0.39,0.82
"GO_MF:490613_GO_0005504_FATTY_ACID_BINDING","GO_MF","490613_GO_0005504_FATTY_ACID_BINDING",23,-1.364,0.1,0.24,1.6842,0.015,0.17,1.3183,0.12,0.67
"C7_Immunologic_signatures:C7_ALL_998_GSE22886_TH1_VS_TH2_12H_ACT_DN","C7_Immunologic_signatures","C7_ALL_998_GSE22886_TH1_VS_TH2_12H_ACT_DN",187,-1.3639,0.026,0.039,-0.8499,0.84,1,-0.9825,0.51,0.76
"C4_Cancer_modules:C4_CM_169_MODULE_179","C4_Cancer_modules","C4_CM_169_MODULE_179",456,-1.3639,0.0041,0.12,0.9886,0.53,0.72,0.9039,0.81,0.98
"REACTOME:106500_REACT_15333_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY","REACTOME","106500_REACT_15333_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY",14,-1.3638,0.1,0.22,-1.0988,0.35,0.91,-1.0314,0.4,0.8
"KEGG_module:HSA_M00355_SPLICEOSOME_35S_U5_SNRNP","KEGG_module","HSA_M00355_SPLICEOSOME_35S_U5_SNRNP",37,-1.3638,0.08,0.41,1.4212,0.045,0.26,-1.4326,0.061,0.48
"GO_BP:516697_GO_0071774_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR","GO_BP","516697_GO_0071774_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR",184,-1.3636,0.023,0.19,-0.947,0.6,1,-1.0344,0.34,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1154_SHEN_SMARCA2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1154_SHEN_SMARCA2_TARGETS_DN",332,-1.3635,0.0075,0.13,-1.2334,0.046,0.76,1.2972,0.0077,0.69
"GO_BP:516377_GO_0071453_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS","GO_BP","516377_GO_0071453_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS",120,-1.3635,0.043,0.19,-0.7037,0.99,1,1.2531,0.087,0.7
"C7_Immunologic_signatures:C7_ALL_897_GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP","C7_Immunologic_signatures","C7_ALL_897_GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP",197,-1.3635,0.014,0.04,1.0271,0.39,0.66,-1.1964,0.067,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_1165_SHIN_B_CELL_LYMPHOMA_CLUSTER_2","C2_Chemical_and_genetic_perturbations","C2_CGP_1165_SHIN_B_CELL_LYMPHOMA_CLUSTER_2",29,-1.3634,0.078,0.13,0.6215,0.98,1,-0.8916,0.64,0.89
"C6_Oncogenic_signatures:C6_ALL_34_VEGF_A_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_34_VEGF_A_UP_V1_UP",190,-1.3633,0.017,0.048,-1.069,0.28,0.61,-1.0343,0.37,0.6
"GO_BP:500651_GO_0031400_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS","GO_BP","500651_GO_0031400_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS",439,-1.3633,0.0031,0.19,1.1463,0.081,0.84,-1.0483,0.3,0.81
"KEGG_pathway:HSA05206_MICRORNAS_IN_CANCER","KEGG_pathway","HSA05206_MICRORNAS_IN_CANCER",166,-1.3632,0.02,0.087,-0.9326,0.64,0.96,0.9872,0.51,1
"GO_BP:753023_GO_1900026_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING","GO_BP","753023_GO_1900026_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING",26,-1.3631,0.099,0.2,1.3684,0.072,0.59,1.4079,0.068,0.63
"C7_Immunologic_signatures:C7_ALL_1210_GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1210_GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN",198,-1.3631,0.018,0.04,0.7795,0.99,1,0.8335,0.88,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_117_BIOCARTA_ETS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_117_BIOCARTA_ETS_PATHWAY",18,-1.363,0.094,0.21,-0.8945,0.61,1,-1.077,0.34,0.68
"C3_MicroRNA_targets:C3_MIR_85_CAGGGTC_MIR_504","C3_MicroRNA_targets","C3_MIR_85_CAGGGTC_MIR_504",82,-1.363,0.049,0.23,0.6424,1,1,-0.7709,0.92,1
"C7_Immunologic_signatures:C7_ALL_10_KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_10_KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN",199,-1.3629,0.017,0.04,0.993,0.46,0.76,-1.0554,0.3,0.6
"WikiPathways:198810_WP560_TGF_BETA_SIGNALING_PATHWAY","WikiPathways","198810_WP560_TGF_BETA_SIGNALING_PATHWAY",54,-1.3628,0.066,0.15,-0.8299,0.79,1,1.0959,0.28,0.73
"C6_Oncogenic_signatures:C6_ALL_11_GCNP_SHH_UP_LATE_V1_DN","C6_Oncogenic_signatures","C6_ALL_11_GCNP_SHH_UP_LATE_V1_DN",159,-1.3628,0.026,0.048,0.7629,0.99,0.99,-0.9486,0.62,0.71
"GO_BP:498895_GO_0021612_FACIAL_NERVE_STRUCTURAL_ORGANIZATION","GO_BP","498895_GO_0021612_FACIAL_NERVE_STRUCTURAL_ORGANIZATION",10,-1.3627,0.13,0.2,-0.8613,0.63,1,0.9362,0.55,0.91
"C3_MicroRNA_targets:C3_MIR_196_GTCAGGA_MIR_378","C3_MicroRNA_targets","C3_MIR_196_GTCAGGA_MIR_378",59,-1.3627,0.071,0.22,0.9033,0.64,1,0.7569,0.93,1
"KEGG_compound:C05259_3_OXOPALMITOYL_COA_3_KETOPALMITOYL_COA_3_OXOHEXADECANOYL_COA","KEGG_compound","C05259_3_OXOPALMITOYL_COA_3_KETOPALMITOYL_COA_3_OXOHEXADECANOYL_COA",6,-1.3627,0.12,0.28,0.8206,0.67,1,-1.18,0.27,0.47
"GO_BP:488953_GO_0003159_MORPHOGENESIS_OF_AN_ENDOTHELIUM","GO_BP","488953_GO_0003159_MORPHOGENESIS_OF_AN_ENDOTHELIUM",8,-1.3627,0.14,0.2,-1.0754,0.37,0.96,1.0264,0.42,0.83
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_206_BIOCARTA_TOLL_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_206_BIOCARTA_TOLL_PATHWAY",37,-1.3626,0.068,0.21,-0.5619,1,1,-0.7423,0.91,0.97
"C4_Cancer_modules:C4_CM_277_MODULE_317","C4_Cancer_modules","C4_CM_277_MODULE_317",431,-1.3626,0.0032,0.12,0.9347,0.72,0.81,0.8882,0.88,1
"C6_Oncogenic_signatures:C6_ALL_125_RB_P130_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_125_RB_P130_DN_V1_DN",121,-1.3626,0.036,0.047,1.26,0.061,0.41,-0.8618,0.77,0.89
"GO_BP:487737_GO_0001841_NEURAL_TUBE_FORMATION","GO_BP","487737_GO_0001841_NEURAL_TUBE_FORMATION",99,-1.3624,0.038,0.2,-0.6847,0.98,1,-0.8157,0.87,0.98
"GO_BP:518659_GO_2000010_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE","GO_BP","518659_GO_2000010_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE",8,-1.3624,0.13,0.2,-1.0846,0.36,0.96,-1.417,0.1,0.57
"GO_BP:510850_GO_0048799_ORGAN_MATURATION","GO_BP","510850_GO_0048799_ORGAN_MATURATION",18,-1.3623,0.11,0.2,0.8424,0.69,1,0.9495,0.52,0.9
"GO_BP:754562_GO_1901606_ALPHA_AMINO_ACID_CATABOLIC_PROCESS","GO_BP","754562_GO_1901606_ALPHA_AMINO_ACID_CATABOLIC_PROCESS",91,-1.3623,0.046,0.2,-0.895,0.7,1,-1.0904,0.28,0.78
"GO_CC:504925_GO_0035748_MYELIN_SHEATH_ABAXONAL_REGION","GO_CC","504925_GO_0035748_MYELIN_SHEATH_ABAXONAL_REGION",7,-1.3622,0.13,0.26,-1.4352,0.12,0.64,-1.4035,0.12,0.6
"GO_BP:507282_GO_0044275_CELLULAR_CARBOHYDRATE_CATABOLIC_PROCESS","GO_BP","507282_GO_0044275_CELLULAR_CARBOHYDRATE_CATABOLIC_PROCESS",32,-1.3622,0.082,0.2,-0.7849,0.79,1,-1.2731,0.11,0.66
"C7_Immunologic_signatures:C7_ALL_1455_GSE360_L_MAJOR_VS_T_GONDII_DC_UP","C7_Immunologic_signatures","C7_ALL_1455_GSE360_L_MAJOR_VS_T_GONDII_DC_UP",193,-1.3621,0.021,0.04,-1.2129,0.11,0.79,1.0759,0.27,1
"C7_Immunologic_signatures:C7_ALL_447_GSE17721_CTRL_VS_LPS_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_447_GSE17721_CTRL_VS_LPS_0_5H_BMDM_UP",198,-1.3621,0.018,0.04,1.1506,0.13,0.32,0.7744,0.98,1
"GO_BP:755348_GO_2001242_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","755348_GO_2001242_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",142,-1.362,0.029,0.2,0.8061,0.91,1,-1.0163,0.42,0.83
"KEGG_reaction:R01547_ATP_DAMP_PHOSPHOTRANSFERASE_ATP_DAMP_ADP_DADP","KEGG_reaction","R01547_ATP_DAMP_PHOSPHOTRANSFERASE_ATP_DAMP_ADP_DADP",8,-1.362,0.12,0.33,-1.2736,0.2,0.44,0.5622,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1981_WESTON_VEGFA_TARGETS_3HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1981_WESTON_VEGFA_TARGETS_3HR",70,-1.3619,0.062,0.13,1.1969,0.15,0.49,-0.9791,0.48,0.78
"C3_TF_targets:C3_TFT_548_YNGTTNNNATT_UNKNOWN","C3_TF_targets","C3_TFT_548_YNGTTNNNATT_UNKNOWN",356,-1.3618,0.0053,0.053,0.9474,0.66,1,-1.0374,0.32,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1103_PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1103_PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP",283,-1.3617,0.012,0.13,0.8209,0.97,0.98,-1.2421,0.028,0.48
"GO_MF:499376_GO_0022829_WIDE_PORE_CHANNEL_ACTIVITY","GO_MF","499376_GO_0022829_WIDE_PORE_CHANNEL_ACTIVITY",21,-1.3617,0.1,0.25,0.9445,0.53,0.94,-0.9993,0.46,0.78
"C7_Immunologic_signatures:C7_ALL_470_GSE17721_CTRL_VS_POLYIC_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_470_GSE17721_CTRL_VS_POLYIC_4H_BMDM_DN",198,-1.3617,0.016,0.04,-0.85,0.87,1,0.9392,0.6,1
"GO_CC:500512_GO_0031253_CELL_PROJECTION_MEMBRANE","GO_CC","500512_GO_0031253_CELL_PROJECTION_MEMBRANE",265,-1.3617,0.018,0.26,-1.0304,0.38,0.84,1.0446,0.32,0.97
"C3_TF_targets:C3_TFT_465_V_SP1_Q2_01","C3_TF_targets","C3_TFT_465_V_SP1_Q2_01",241,-1.3616,0.0098,0.053,-1.5085,0,0.14,-0.9705,0.53,0.81
"C4_Cancer_gene_neighborhoods:C4_CGN_204_GCM_SIRT2","C4_Cancer_gene_neighborhoods","C4_CGN_204_GCM_SIRT2",43,-1.3614,0.07,0.15,-0.7933,0.82,1,-1.1099,0.28,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_1420_PEART_HDAC_PROLIFERATION_CLUSTER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1420_PEART_HDAC_PROLIFERATION_CLUSTER_DN",76,-1.3613,0.045,0.13,1.2367,0.13,0.45,-1.0609,0.35,0.68
"REACTOME:119524_REACT_19236_SEMA3A_PAK_DEPENDENT_AXON_REPULSION","REACTOME","119524_REACT_19236_SEMA3A_PAK_DEPENDENT_AXON_REPULSION",16,-1.3612,0.1,0.22,-0.7193,0.85,1,-1.6169,0.019,0.24
"GO_BP:507766_GO_0045409_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS","GO_BP","507766_GO_0045409_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_BIOSYNTHETIC_PROCESS",5,-1.3612,0.1,0.2,-1.5527,0.026,0.73,-1.2245,0.23,0.71
"GO_BP:519056_GO_2000416_REGULATION_OF_EOSINOPHIL_MIGRATION","GO_BP","519056_GO_2000416_REGULATION_OF_EOSINOPHIL_MIGRATION",5,-1.3611,0.11,0.2,-1.082,0.39,0.95,0.9511,0.52,0.9
"GO_BP:516616_GO_0071692_PROTEIN_LOCALIZATION_TO_EXTRACELLULAR_REGION","GO_BP","516616_GO_0071692_PROTEIN_LOCALIZATION_TO_EXTRACELLULAR_REGION",5,-1.3611,0.12,0.2,1.2023,0.26,0.78,-1.3782,0.14,0.58
"KEGG_compound:C02946_4_ACETAMIDOBUTANOATE_N4_ACETYLAMINOBUTANOATE","KEGG_compound","C02946_4_ACETAMIDOBUTANOATE_N4_ACETYLAMINOBUTANOATE",5,-1.3611,0.15,0.28,0.7038,0.83,1,-1.2354,0.24,0.42
"GO_BP:751742_GO_0044597_DAUNORUBICIN_METABOLIC_PROCESS","GO_BP","751742_GO_0044597_DAUNORUBICIN_METABOLIC_PROCESS",8,-1.3611,0.1,0.2,-0.7509,0.78,1,0.5047,0.99,1
"GO_BP:506582_GO_0043551_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY","GO_BP","506582_GO_0043551_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY",36,-1.3611,0.078,0.2,-0.7972,0.79,1,-0.8567,0.71,0.96
"GO_BP:500150_GO_0030852_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION","GO_BP","500150_GO_0030852_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION",17,-1.3609,0.11,0.2,1.073,0.34,0.93,-1.364,0.11,0.59
"GO_MF:489290_GO_0051087_CHAPERONE_BINDING","GO_MF","489290_GO_0051087_CHAPERONE_BINDING",71,-1.3608,0.066,0.25,0.726,0.93,1,-1.4746,0.048,0.42
"GO_BP:487570_GO_0001657_URETERIC_BUD_DEVELOPMENT","GO_BP","487570_GO_0001657_URETERIC_BUD_DEVELOPMENT",86,-1.3608,0.061,0.2,-0.8736,0.72,1,1.3986,0.036,0.63
"GO_MF:516759_GO_0071837_HMG_BOX_DOMAIN_BINDING","GO_MF","516759_GO_0071837_HMG_BOX_DOMAIN_BINDING",17,-1.3608,0.091,0.25,-0.7404,0.85,1,-0.6538,0.93,1
"KEGG_reaction:R00710_ACETALDEHYDE_NAD_OXIDOREDUCTASE_ACETALDEHYDE_NAD_H2O_ACETATE_NADH_H_","KEGG_reaction","R00710_ACETALDEHYDE_NAD_OXIDOREDUCTASE_ACETALDEHYDE_NAD_H2O_ACETATE_NADH_H_",5,-1.3608,0.12,0.33,0.6934,0.86,1,-1.247,0.24,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_2113_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD","C2_Chemical_and_genetic_perturbations","C2_CGP_2113_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD",13,-1.3607,0.11,0.13,0.7486,0.81,1,-0.7536,0.79,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2796_YANAGISAWA_LUNG_CANCER_RECURRENCE","C2_Chemical_and_genetic_perturbations","C2_CGP_2796_YANAGISAWA_LUNG_CANCER_RECURRENCE",8,-1.3606,0.096,0.13,1.4278,0.097,0.28,0.7091,0.84,1
"GO_BP:492658_GO_0008347_GLIAL_CELL_MIGRATION","GO_BP","492658_GO_0008347_GLIAL_CELL_MIGRATION",31,-1.3606,0.077,0.2,0.6237,0.98,1,1.3489,0.079,0.65
"KEGG_module:HSA_M00388_ECS_COMPLEX","KEGG_module","HSA_M00388_ECS_COMPLEX",12,-1.3606,0.12,0.39,0.7809,0.74,0.92,0.7939,0.75,1
"GO_BP:494742_GO_0010677_NEGATIVE_REGULATION_OF_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS","GO_BP","494742_GO_0010677_NEGATIVE_REGULATION_OF_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS",42,-1.3605,0.084,0.2,0.5199,1,1,1.0292,0.4,0.82
"REACTOME:106096_REACT_1505_INTEGRATION_OF_ENERGY_METABOLISM","REACTOME","106096_REACT_1505_INTEGRATION_OF_ENERGY_METABOLISM",103,-1.3604,0.04,0.22,-0.9795,0.52,1,-0.9975,0.45,0.84
"KEGG_compound:C00187_CHOLESTEROL_CHOLEST_5_EN_3BETA_OL","KEGG_compound","C00187_CHOLESTEROL_CHOLEST_5_EN_3BETA_OL",13,-1.3604,0.11,0.28,-1.0618,0.36,1,0.7232,0.85,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1755_CHIBA_RESPONSE_TO_TSA","C2_Chemical_and_genetic_perturbations","C2_CGP_1755_CHIBA_RESPONSE_TO_TSA",49,-1.3604,0.075,0.13,-0.7604,0.87,1,-0.9206,0.61,0.85
"GO_CC:501819_GO_0032593_INSULIN_RESPONSIVE_COMPARTMENT","GO_CC","501819_GO_0032593_INSULIN_RESPONSIVE_COMPARTMENT",8,-1.3604,0.13,0.26,-1.081,0.35,0.81,1.0244,0.44,0.97
"KEGG_enzyme:2.3.1.199_VERY_LONG_CHAIN_3_OXOACYL_COA_SYNTHASE_VERY_LONG_CHAIN_3_KETOACYL_COA_SYNTHASE_VERY_LONG_CHAIN_BETA_KETOACYL_COA_SYNTHASE_CONDENSING_ENZYME_CUT1_GENE_NAME_CER6_GENE_NAME_FAE1_GENE_NAME_KCS_GENE_NAME_ELO_GENE_NAME_","KEGG_enzyme","2.3.1.199_VERY_LONG_CHAIN_3_OXOACYL_COA_SYNTHASE_VERY_LONG_CHAIN_3_KETOACYL_COA_SYNTHASE_VERY_LONG_CHAIN_BETA_KETOACYL_COA_SYNTHASE_CONDENSING_ENZYME_CUT1_GENE_NAME_CER6_GENE_NAME_FAE1_GENE_NAME_KCS_GENE_NAME_ELO_GENE_NAME_",7,-1.3603,0.12,0.51,-1.1426,0.31,0.64,-1.4304,0.075,0.76
"GO_BP:500873_GO_0031623_RECEPTOR_INTERNALIZATION","GO_BP","500873_GO_0031623_RECEPTOR_INTERNALIZATION",44,-1.3601,0.078,0.2,0.9985,0.44,0.98,1.4995,0.016,0.55
"GO_BP:492030_GO_0007249_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING","GO_BP","492030_GO_0007249_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING",58,-1.36,0.063,0.2,0.6308,1,1,-1.1331,0.26,0.75
"C7_Immunologic_signatures:C7_ALL_522_GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_522_GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDM_DN",197,-1.36,0.017,0.041,-0.6751,1,1,-1.0908,0.27,0.52
"GO_BP:518756_GO_2000107_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS","GO_BP","518756_GO_2000107_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS",45,-1.3599,0.06,0.2,1.015,0.45,0.97,0.9595,0.5,0.9
"WikiPathways:198892_WP247_SMALL_LIGAND_GPCRS","WikiPathways","198892_WP247_SMALL_LIGAND_GPCRS",19,-1.3599,0.11,0.15,0.7914,0.77,1,0.8478,0.7,1
"C7_Immunologic_signatures:C7_ALL_646_GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_646_GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDM_DN",199,-1.3598,0.017,0.041,1.052,0.31,0.58,0.7733,0.98,1
"GO_CC:516362_GO_0071438_INVADOPODIUM_MEMBRANE","GO_CC","516362_GO_0071438_INVADOPODIUM_MEMBRANE",6,-1.3597,0.11,0.26,-0.8664,0.64,0.95,-0.8501,0.62,1
"GO_BP:507471_GO_0045071_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION","GO_BP","507471_GO_0045071_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION",45,-1.3597,0.074,0.2,1.6093,0.0084,0.28,-1.4483,0.03,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_2663_CROONQUIST_NRAS_SIGNALING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2663_CROONQUIST_NRAS_SIGNALING_DN",72,-1.3597,0.058,0.13,-0.8709,0.72,1,-1.6686,0.0065,0.2
"GO_BP:514115_GO_0060560_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS","GO_BP","514115_GO_0060560_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS",106,-1.3597,0.056,0.2,-1.1986,0.13,0.9,-0.9826,0.49,0.87
"GO_CC:503907_GO_0034707_CHLORIDE_CHANNEL_COMPLEX","GO_CC","503907_GO_0034707_CHLORIDE_CHANNEL_COMPLEX",47,-1.3595,0.082,0.26,-1.1641,0.23,0.68,1.1275,0.25,0.88
"GO_BP:513928_GO_0060372_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION","GO_BP","513928_GO_0060372_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION",6,-1.3594,0.12,0.2,-0.9114,0.58,1,-1.2585,0.21,0.67
"C3_TF_targets:C3_TFT_315_CTGYNNCTYTAA_UNKNOWN","C3_TF_targets","C3_TFT_315_CTGYNNCTYTAA_UNKNOWN",85,-1.3594,0.058,0.054,-0.9881,0.45,0.79,-0.823,0.83,1
"GO_MF:490236_GO_0004945_ANGIOTENSIN_TYPE_II_RECEPTOR_ACTIVITY","GO_MF","490236_GO_0004945_ANGIOTENSIN_TYPE_II_RECEPTOR_ACTIVITY",5,-1.3594,0.12,0.25,0.807,0.7,1,0.7058,0.83,1
"GO_MF:500940_GO_0031694_ALPHA_2A_ADRENERGIC_RECEPTOR_BINDING","GO_MF","500940_GO_0031694_ALPHA_2A_ADRENERGIC_RECEPTOR_BINDING",5,-1.3593,0.13,0.25,-0.7907,0.74,1,-0.8849,0.61,0.89
"GO_MF:489293_GO_0003774_MOTOR_ACTIVITY","GO_MF","489293_GO_0003774_MOTOR_ACTIVITY",128,-1.3593,0.033,0.25,-1.1393,0.19,0.81,-0.9331,0.63,0.85
"GO_BP:501466_GO_0032231_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY","GO_BP","501466_GO_0032231_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY",63,-1.3593,0.062,0.2,-1.2347,0.13,0.9,-0.7366,0.96,1
"GO_BP:1129308_GO_0098751_BONE_CELL_DEVELOPMENT","GO_BP","1129308_GO_0098751_BONE_CELL_DEVELOPMENT",21,-1.3592,0.11,0.2,0.9686,0.49,1,-0.7852,0.79,0.99
"GO_BP:512780_GO_0051930_REGULATION_OF_SENSORY_PERCEPTION_OF_PAIN","GO_BP","512780_GO_0051930_REGULATION_OF_SENSORY_PERCEPTION_OF_PAIN",25,-1.3592,0.097,0.2,1.4989,0.035,0.41,1.0813,0.35,0.77
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_126_BIOCARTA_NFKB_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_126_BIOCARTA_NFKB_PATHWAY",23,-1.3592,0.095,0.21,-0.8628,0.67,1,0.9951,0.45,1
"GO_BP:754494_GO_1901534_POSITIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION","GO_BP","754494_GO_1901534_POSITIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION",11,-1.3591,0.12,0.2,-1.0112,0.44,0.98,-1.1377,0.31,0.75
"REACTOME:645268_REACT_121256_PHAGOSOMAL_MATURATION_EARLY_ENDOSOMAL_STAGE_","REACTOME","645268_REACT_121256_PHAGOSOMAL_MATURATION_EARLY_ENDOSOMAL_STAGE_",33,-1.3591,0.084,0.22,0.8453,0.76,0.96,1.1853,0.21,0.86
"GO_BP:488977_GO_0003183_MITRAL_VALVE_MORPHOGENESIS","GO_BP","488977_GO_0003183_MITRAL_VALVE_MORPHOGENESIS",6,-1.3591,0.13,0.2,-0.858,0.64,1,0.6876,0.84,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1605_TAKAO_RESPONSE_TO_UVB_RADIATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1605_TAKAO_RESPONSE_TO_UVB_RADIATION_UP",86,-1.359,0.056,0.13,1.9284,0,0.014,-0.8115,0.86,0.95
"GO_BP:491552_GO_0006664_GLYCOLIPID_METABOLIC_PROCESS","GO_BP","491552_GO_0006664_GLYCOLIPID_METABOLIC_PROCESS",97,-1.359,0.047,0.2,0.6227,1,1,0.731,0.96,1
"C7_Immunologic_signatures:C7_ALL_574_GSE17721_PAM3CSK4_VS_CPG_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_574_GSE17721_PAM3CSK4_VS_CPG_8H_BMDM_DN",199,-1.3589,0.014,0.042,0.9562,0.57,0.88,-0.9195,0.69,0.92
"GO_BP:498805_GO_0021521_VENTRAL_SPINAL_CORD_INTERNEURON_SPECIFICATION","GO_BP","498805_GO_0021521_VENTRAL_SPINAL_CORD_INTERNEURON_SPECIFICATION",9,-1.3588,0.099,0.2,-0.9477,0.52,1,0.9212,0.55,0.92
"GO_CC:504555_GO_0035371_MICROTUBULE_PLUS_END","GO_CC","504555_GO_0035371_MICROTUBULE_PLUS_END",15,-1.3587,0.1,0.26,0.6078,0.96,0.99,-0.6312,0.93,1
"GO_BP:496941_GO_0017144_DRUG_METABOLIC_PROCESS","GO_BP","496941_GO_0017144_DRUG_METABOLIC_PROCESS",48,-1.3587,0.064,0.2,-1.2707,0.12,0.89,1.5998,0.016,0.43
"GO_BP:487569_GO_0001656_METANEPHROS_DEVELOPMENT","GO_BP","487569_GO_0001656_METANEPHROS_DEVELOPMENT",83,-1.3586,0.053,0.2,-1.0159,0.41,0.98,1.4638,0.021,0.59
"GO_MF:489607_GO_0004143_DIACYLGLYCEROL_KINASE_ACTIVITY","GO_MF","489607_GO_0004143_DIACYLGLYCEROL_KINASE_ACTIVITY",15,-1.3585,0.11,0.25,-1.6472,0.018,0.42,-1.0802,0.35,0.71
"GO_BP:490972_GO_0005984_DISACCHARIDE_METABOLIC_PROCESS","GO_BP","490972_GO_0005984_DISACCHARIDE_METABOLIC_PROCESS",6,-1.3585,0.15,0.2,-0.9688,0.48,1,-1.28,0.2,0.65
"GO_MF:496685_GO_0016775_PHOSPHOTRANSFERASE_ACTIVITY_NITROGENOUS_GROUP_AS_ACCEPTOR","GO_MF","496685_GO_0016775_PHOSPHOTRANSFERASE_ACTIVITY_NITROGENOUS_GROUP_AS_ACCEPTOR",16,-1.3585,0.11,0.25,-0.8554,0.66,1,-0.7371,0.82,0.99
"GO_BP:494902_GO_0010838_POSITIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION","GO_BP","494902_GO_0010838_POSITIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION",6,-1.3584,0.12,0.2,-1.2614,0.21,0.91,0.7745,0.73,1
"C4_Cancer_modules:C4_CM_231_MODULE_255","C4_Cancer_modules","C4_CM_231_MODULE_255",441,-1.3583,0.0042,0.12,0.9985,0.47,0.71,0.883,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2022_MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2022_MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP",10,-1.3582,0.13,0.13,0.5717,0.96,1,0.9963,0.46,0.97
"GO_BP:502008_GO_0032782_BILE_ACID_SECRETION","GO_BP","502008_GO_0032782_BILE_ACID_SECRETION",6,-1.358,0.12,0.2,-0.8077,0.72,1,-0.5394,0.97,1
"C3_MicroRNA_targets:C3_MIR_209_AAGGGAT_MIR_188","C3_MicroRNA_targets","C3_MIR_209_AAGGGAT_MIR_188",75,-1.358,0.066,0.23,0.5584,1,1,-1.1708,0.19,1
"GO_BP:515156_GO_0070221_SULFIDE_OXIDATION_USING_SULFIDE_QUINONE_OXIDOREDUCTASE","GO_BP","515156_GO_0070221_SULFIDE_OXIDATION_USING_SULFIDE_QUINONE_OXIDOREDUCTASE",5,-1.358,0.12,0.2,-0.6451,0.88,1,-1.1629,0.33,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2253_NADELLA_PRKAR1A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2253_NADELLA_PRKAR1A_TARGETS_DN",8,-1.3577,0.12,0.13,1.0857,0.37,0.65,-1.2533,0.2,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_2925_MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED","C2_Chemical_and_genetic_perturbations","C2_CGP_2925_MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED",212,-1.3577,0.018,0.13,-1.0579,0.3,0.97,-1.0949,0.22,0.63
"C1_Positional:C1_ALL_315_CHR4Q13","C1_Positional","C1_ALL_315_CHR4Q13",50,-1.3577,0.07,0.59,1.7351,0.0021,0.13,1.2709,0.11,0.54
"GO_BP:516619_GO_0071695_ANATOMICAL_STRUCTURE_MATURATION","GO_BP","516619_GO_0071695_ANATOMICAL_STRUCTURE_MATURATION",51,-1.3577,0.076,0.2,-0.8061,0.81,1,0.9688,0.5,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1798_WU_HBX_TARGETS_3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1798_WU_HBX_TARGETS_3_DN",13,-1.3576,0.11,0.13,-1.2071,0.23,0.8,-1.6889,0.018,0.19
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_202_BIOCARTA_PAR1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_202_BIOCARTA_PAR1_PATHWAY",36,-1.3576,0.085,0.21,-0.7771,0.84,1,0.8964,0.64,1
"C3_TF_targets:C3_TFT_106_AGCYRWTTC_UNKNOWN","C3_TF_targets","C3_TFT_106_AGCYRWTTC_UNKNOWN",117,-1.3576,0.044,0.055,-1.0705,0.31,0.61,-0.7668,0.97,1
"KEGG_reaction:R09381_ACYL_ACP_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_2_O_ACYLTRANSFERASE_ACYL_ACYL_CARRIER_PROTEIN_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_ACYL_CARRIER_PROTEIN_PHOSPHATIDATE","KEGG_reaction","R09381_ACYL_ACP_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_2_O_ACYLTRANSFERASE_ACYL_ACYL_CARRIER_PROTEIN_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_ACYL_CARRIER_PROTEIN_PHOSPHATIDATE",8,-1.3574,0.14,0.33,-1.1267,0.32,0.65,-1.319,0.16,0.48
"GO_BP:508409_GO_0046113_NUCLEOBASE_CATABOLIC_PROCESS","GO_BP","508409_GO_0046113_NUCLEOBASE_CATABOLIC_PROCESS",9,-1.3574,0.13,0.2,1.0486,0.4,0.95,-0.9794,0.49,0.87
"GO_BP:509121_GO_0046916_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS","GO_BP","509121_GO_0046916_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS",96,-1.3573,0.035,0.2,1.1363,0.18,0.85,1.0282,0.41,0.83
"GO_BP:504273_GO_0035088_ESTABLISHMENT_OR_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY","GO_BP","504273_GO_0035088_ESTABLISHMENT_OR_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY",32,-1.3572,0.077,0.2,0.9553,0.54,1,-1.87,0,0.56
"GO_CC:507301_GO_0044295_AXONAL_GROWTH_CONE","GO_CC","507301_GO_0044295_AXONAL_GROWTH_CONE",13,-1.3572,0.095,0.26,-1.0965,0.33,0.79,-1.532,0.056,0.47
"GO_BP:498665_GO_0019882_ANTIGEN_PROCESSING_AND_PRESENTATION","GO_BP","498665_GO_0019882_ANTIGEN_PROCESSING_AND_PRESENTATION",221,-1.3571,0.018,0.2,1.5001,0,0.41,-0.7154,1,0.99
"GO_BP:491877_GO_0007052_MITOTIC_SPINDLE_ORGANIZATION","GO_BP","491877_GO_0007052_MITOTIC_SPINDLE_ORGANIZATION",51,-1.3571,0.055,0.2,-0.9628,0.52,1,-1.49,0.024,0.53
"GO_BP:502343_GO_0033122_NEGATIVE_REGULATION_OF_PURINE_NUCLEOTIDE_CATABOLIC_PROCESS","GO_BP","502343_GO_0033122_NEGATIVE_REGULATION_OF_PURINE_NUCLEOTIDE_CATABOLIC_PROCESS",30,-1.357,0.074,0.2,-0.7938,0.77,1,0.6439,0.97,1
"C3_TF_targets:C3_TFT_258_V_VDR_Q3","C3_TF_targets","C3_TFT_258_V_VDR_Q3",216,-1.357,0.014,0.055,-1.3186,0.021,0.21,-1.0153,0.43,0.73
"GO_BP:506372_GO_0043312_NEUTROPHIL_DEGRANULATION","GO_BP","506372_GO_0043312_NEUTROPHIL_DEGRANULATION",8,-1.3569,0.14,0.2,1.3097,0.18,0.66,-0.7022,0.84,0.99
"GO_MF:510472_GO_0048365_RAC_GTPASE_BINDING","GO_MF","510472_GO_0048365_RAC_GTPASE_BINDING",33,-1.3569,0.082,0.25,-1.4194,0.071,0.67,-0.6101,0.97,1
"GO_BP:505907_GO_0051260_PROTEIN_HOMOOLIGOMERIZATION","GO_BP","505907_GO_0051260_PROTEIN_HOMOOLIGOMERIZATION",233,-1.3566,0.017,0.2,-1.0301,0.36,0.98,0.9594,0.58,0.9
"GO_BP:501766_GO_0032536_REGULATION_OF_CELL_PROJECTION_SIZE","GO_BP","501766_GO_0032536_REGULATION_OF_CELL_PROJECTION_SIZE",8,-1.3566,0.13,0.2,-0.7824,0.76,1,-0.9701,0.47,0.87
"GO_BP:499725_GO_0030324_LUNG_DEVELOPMENT","GO_BP","499725_GO_0030324_LUNG_DEVELOPMENT",177,-1.3565,0.017,0.2,0.8937,0.73,1,1.291,0.03,0.68
"GO_MF:492784_GO_0008503_BENZODIAZEPINE_RECEPTOR_ACTIVITY","GO_MF","492784_GO_0008503_BENZODIAZEPINE_RECEPTOR_ACTIVITY",5,-1.3564,0.12,0.25,-0.9424,0.56,0.96,1.418,0.12,0.52
"C7_Immunologic_signatures:C7_ALL_77_GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP","C7_Immunologic_signatures","C7_ALL_77_GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP",193,-1.3563,0.017,0.043,1.2896,0.046,0.11,-0.8722,0.83,0.99
"GO_BP:508003_GO_0045655_REGULATION_OF_MONOCYTE_DIFFERENTIATION","GO_BP","508003_GO_0045655_REGULATION_OF_MONOCYTE_DIFFERENTIATION",13,-1.3563,0.13,0.2,-1.0885,0.36,0.95,1.0472,0.38,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_2881_ZHAN_MULTIPLE_MYELOMA_CD2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2881_ZHAN_MULTIPLE_MYELOMA_CD2_DN",46,-1.3561,0.067,0.13,0.8073,0.8,0.99,-1.1367,0.23,0.59
"GO_BP:487462_GO_0001523_RETINOID_METABOLIC_PROCESS","GO_BP","487462_GO_0001523_RETINOID_METABOLIC_PROCESS",81,-1.356,0.064,0.2,-1.0451,0.34,0.97,-1.0649,0.31,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2286_GALI_TP53_TARGETS_APOPTOTIC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2286_GALI_TP53_TARGETS_APOPTOTIC_UP",8,-1.3559,0.13,0.13,-0.9514,0.5,1,-1.1879,0.25,0.53
"C6_Oncogenic_signatures:C6_ALL_80_JNK_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_80_JNK_DN_V1_UP",181,-1.3559,0.027,0.051,-1.284,0.054,0.35,-1.099,0.23,0.5
"GO_BP:514548_GO_0060993_KIDNEY_MORPHOGENESIS","GO_BP","514548_GO_0060993_KIDNEY_MORPHOGENESIS",81,-1.3559,0.057,0.2,0.7878,0.91,1,1.0217,0.39,0.83
"KEGG_compound:C05985_2_PROPYNAL_2_PROPYN_1_AL_PROPIOLALDEHYDE","KEGG_compound","C05985_2_PROPYNAL_2_PROPYN_1_AL_PROPIOLALDEHYDE",5,-1.3558,0.12,0.28,0.7004,0.81,1,-1.2557,0.22,0.41
"KEGG_module:HSA_M00415_FATTY_ACID_BIOSYNTHESIS_ELONGATION_ENDOPLASMIC_RETICULUM","KEGG_module","HSA_M00415_FATTY_ACID_BIOSYNTHESIS_ELONGATION_ENDOPLASMIC_RETICULUM",13,-1.3556,0.12,0.39,-0.6109,0.95,1,-1.6877,0.0098,0.17
"GO_BP:512269_GO_0051385_RESPONSE_TO_MINERALOCORTICOID","GO_BP","512269_GO_0051385_RESPONSE_TO_MINERALOCORTICOID",30,-1.3555,0.085,0.2,-0.8693,0.66,1,-0.8463,0.7,0.96
"C7_Immunologic_signatures:C7_ALL_393_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_393_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP",196,-1.3555,0.017,0.044,-1.0095,0.44,1,-0.9914,0.48,0.74
"GO_BP:849988_GO_1902287_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY_INVOLVED_IN_AXON_GUIDANCE","GO_BP","849988_GO_1902287_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY_INVOLVED_IN_AXON_GUIDANCE",5,-1.3555,0.12,0.2,-1.1927,0.27,0.9,-0.7419,0.77,1
"C7_Immunologic_signatures:C7_ALL_279_GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP","C7_Immunologic_signatures","C7_ALL_279_GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP",197,-1.3554,0.022,0.044,0.8944,0.74,1,-1.0479,0.31,0.61
"C7_Immunologic_signatures:C7_ALL_516_GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_516_GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDM_DN",198,-1.3553,0.02,0.044,-0.8167,0.93,1,-0.7172,1,1
"GO_MF:496114_GO_0016004_PHOSPHOLIPASE_ACTIVATOR_ACTIVITY","GO_MF","496114_GO_0016004_PHOSPHOLIPASE_ACTIVATOR_ACTIVITY",10,-1.3551,0.14,0.25,1.2176,0.22,0.7,0.4019,1,1
"GO_BP:506920_GO_0043900_REGULATION_OF_MULTI_ORGANISM_PROCESS","GO_BP","506920_GO_0043900_REGULATION_OF_MULTI_ORGANISM_PROCESS",345,-1.355,0.0022,0.2,1.322,0.0025,0.64,-1.2711,0.019,0.66
"GO_BP:499336_GO_0022600_DIGESTIVE_SYSTEM_PROCESS","GO_BP","499336_GO_0022600_DIGESTIVE_SYSTEM_PROCESS",55,-1.355,0.063,0.2,-0.9259,0.57,1,1.2526,0.13,0.69
"GO_BP:488798_GO_0002925_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN","GO_BP","488798_GO_0002925_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN",5,-1.3549,0.12,0.2,-1.3516,0.15,0.94,-1.172,0.3,0.74
"GO_BP:911272_GO_0036445_NEURONAL_STEM_CELL_DIVISION","GO_BP","911272_GO_0036445_NEURONAL_STEM_CELL_DIVISION",12,-1.3548,0.12,0.2,-0.5359,0.98,1,0.7143,0.84,1
"GO_BP:499477_GO_0030011_MAINTENANCE_OF_CELL_POLARITY","GO_BP","499477_GO_0030011_MAINTENANCE_OF_CELL_POLARITY",12,-1.3548,0.12,0.2,-1.0335,0.43,0.98,-1.4704,0.063,0.54
"WikiPathways:198778_WP1601_FLUOROPYRIMIDINE_ACTIVITY","WikiPathways","198778_WP1601_FLUOROPYRIMIDINE_ACTIVITY",33,-1.3548,0.086,0.15,-0.9433,0.56,1,-1.0645,0.34,0.65
"REACTOME:685535_REACT_147727_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER","REACTOME","685535_REACT_147727_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER",54,-1.3547,0.053,0.23,-1.0148,0.43,0.99,0.9836,0.47,1
"GO_BP:514553_GO_0060998_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT","GO_BP","514553_GO_0060998_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT",37,-1.3546,0.085,0.2,-1.2579,0.15,0.91,-0.7839,0.83,1
"GO_BP:799419_GO_0061515_MYELOID_CELL_DEVELOPMENT","GO_BP","799419_GO_0061515_MYELOID_CELL_DEVELOPMENT",47,-1.3546,0.072,0.2,1.2483,0.15,0.73,-1.0085,0.44,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1356_MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1356_MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN",24,-1.3546,0.088,0.13,1.5529,0.037,0.17,-0.6386,0.95,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1872_BROWNE_HCMV_INFECTION_10HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1872_BROWNE_HCMV_INFECTION_10HR_UP",100,-1.3545,0.039,0.13,-1.5689,0.0037,0.42,-1.2763,0.057,0.45
"GO_BP:514391_GO_0060836_LYMPHATIC_ENDOTHELIAL_CELL_DIFFERENTIATION","GO_BP","514391_GO_0060836_LYMPHATIC_ENDOTHELIAL_CELL_DIFFERENTIATION",6,-1.3544,0.13,0.2,0.7294,0.79,1,0.5432,0.97,1
"C4_Cancer_modules:C4_CM_337_MODULE_402","C4_Cancer_modules","C4_CM_337_MODULE_402",11,-1.3544,0.13,0.12,1.0772,0.37,0.58,-0.8016,0.73,0.99
"KEGG_module:HSA_M00692_CELL_CYCLE","KEGG_module","HSA_M00692_CELL_CYCLE",13,-1.3542,0.11,0.37,-0.9617,0.5,1,-0.8546,0.66,0.92
"KEGG_compound:C01944_OCTANOYL_COA","KEGG_compound","C01944_OCTANOYL_COA",8,-1.3541,0.12,0.29,-0.5675,0.95,1,-1.4434,0.088,0.25
"GO_BP:751913_GO_0052697_XENOBIOTIC_GLUCURONIDATION","GO_BP","751913_GO_0052697_XENOBIOTIC_GLUCURONIDATION",9,-1.3541,0.11,0.2,1.1549,0.28,0.83,2.122,0,0.0087
"GO_BP:515240_GO_0070307_LENS_FIBER_CELL_DEVELOPMENT","GO_BP","515240_GO_0070307_LENS_FIBER_CELL_DEVELOPMENT",14,-1.3541,0.13,0.2,0.7608,0.79,1,-1.0182,0.45,0.83
"GO_BP:752183_GO_0061440_KIDNEY_VASCULATURE_DEVELOPMENT","GO_BP","752183_GO_0061440_KIDNEY_VASCULATURE_DEVELOPMENT",19,-1.3541,0.11,0.2,-1.0562,0.4,0.97,1.307,0.12,0.67
"C4_Cancer_gene_neighborhoods:C4_CGN_277_CAR_IGFBP1","C4_Cancer_gene_neighborhoods","C4_CGN_277_CAR_IGFBP1",53,-1.3539,0.058,0.16,1.1913,0.15,0.23,1.6027,0.0059,0.099
"GO_BP:505837_GO_0042730_FIBRINOLYSIS","GO_BP","505837_GO_0042730_FIBRINOLYSIS",18,-1.3538,0.11,0.2,0.9399,0.55,1,1.1679,0.25,0.72
"GO_BP:501697_GO_0032465_REGULATION_OF_CYTOKINESIS","GO_BP","501697_GO_0032465_REGULATION_OF_CYTOKINESIS",58,-1.3537,0.069,0.2,0.6316,1,1,-1.414,0.031,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_985_GROSS_HYPOXIA_VIA_ELK3_ONLY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_985_GROSS_HYPOXIA_VIA_ELK3_ONLY_DN",43,-1.3537,0.081,0.14,-1.0977,0.31,0.91,-0.869,0.69,0.91
"KEGG_compound:C05263_3_OXODODECANOYL_COA","KEGG_compound","C05263_3_OXODODECANOYL_COA",6,-1.3536,0.13,0.29,0.8321,0.67,1,-1.1913,0.28,0.46
"GO_BP:784767_GO_1902043_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS","GO_BP","784767_GO_1902043_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS",16,-1.3534,0.13,0.2,0.6338,0.95,1,0.9519,0.52,0.9
"C1_Positional:C1_ALL_225_CHR17Q25","C1_Positional","C1_ALL_225_CHR17Q25",176,-1.3534,0.022,0.59,-0.9861,0.48,1,-1.2385,0.064,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_1280_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS","C2_Chemical_and_genetic_perturbations","C2_CGP_1280_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS",126,-1.3532,0.031,0.14,1.5249,0.0045,0.19,-0.7574,0.96,0.97
"REACTOME:106452_REACT_13620_P75NTR_REGULATES_AXONOGENESIS","REACTOME","106452_REACT_13620_P75NTR_REGULATES_AXONOGENESIS",11,-1.3532,0.12,0.23,-1.0119,0.42,0.99,0.9318,0.54,1
"GO_BP:503341_GO_0034135_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY","GO_BP","503341_GO_0034135_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY",6,-1.3532,0.13,0.2,-1.0867,0.37,0.95,-1.1339,0.33,0.75
"C7_Immunologic_signatures:C7_ALL_708_GSE17721_0_5H_VS_12H_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_708_GSE17721_0_5H_VS_12H_LPS_BMDM_DN",198,-1.3531,0.025,0.045,0.917,0.66,0.98,-0.8812,0.8,0.97
"GO_BP:498543_GO_0019724_B_CELL_MEDIATED_IMMUNITY","GO_BP","498543_GO_0019724_B_CELL_MEDIATED_IMMUNITY",70,-1.3531,0.068,0.2,0.7915,0.87,1,-0.9126,0.66,0.91
"GO_BP:500597_GO_0031338_REGULATION_OF_VESICLE_FUSION","GO_BP","500597_GO_0031338_REGULATION_OF_VESICLE_FUSION",22,-1.353,0.1,0.2,0.8216,0.75,1,-1.132,0.29,0.75
"GO_BP:755349_GO_2001243_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","755349_GO_2001243_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",87,-1.3528,0.046,0.2,0.7557,0.94,1,-1.0645,0.33,0.8
"GO_BP:505178_GO_0040020_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION","GO_BP","505178_GO_0040020_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION",30,-1.3528,0.082,0.2,-1.0256,0.41,0.97,-1.5357,0.021,0.53
"GO_MF:490000_GO_0004673_PROTEIN_HISTIDINE_KINASE_ACTIVITY","GO_MF","490000_GO_0004673_PROTEIN_HISTIDINE_KINASE_ACTIVITY",10,-1.3527,0.11,0.26,-0.7106,0.83,1,-1.1498,0.3,0.64
"GO_BP:488095_GO_0002220_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","488095_GO_0002220_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY",6,-1.3527,0.11,0.2,-1.269,0.21,0.89,-0.8537,0.64,0.96
"C3_TF_targets:C3_TFT_343_V_LXR_Q3","C3_TF_targets","C3_TFT_343_V_LXR_Q3",75,-1.3527,0.063,0.058,-1.0882,0.28,0.57,1.2611,0.1,0.62
"C7_Immunologic_signatures:C7_ALL_444_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN","C7_Immunologic_signatures","C7_ALL_444_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN",196,-1.3526,0.021,0.045,1.4095,0.014,0.035,0.9574,0.58,1
"GO_CC:490826_GO_0005798_GOLGI_ASSOCIATED_VESICLE","GO_CC","490826_GO_0005798_GOLGI_ASSOCIATED_VESICLE",72,-1.3525,0.058,0.27,1.1053,0.28,0.64,-1.0194,0.41,1
"GO_MF:983692_GO_0098631_PROTEIN_BINDING_INVOLVED_IN_CELL_ADHESION","GO_MF","983692_GO_0098631_PROTEIN_BINDING_INVOLVED_IN_CELL_ADHESION",16,-1.3524,0.13,0.26,-1.0013,0.46,0.9,-0.9737,0.5,0.8
"C4_Cancer_gene_neighborhoods:C4_CGN_37_MORF_RAD51L3","C4_Cancer_gene_neighborhoods","C4_CGN_37_MORF_RAD51L3",375,-1.3524,0.0043,0.16,-1.0308,0.35,0.81,1.1003,0.18,0.62
"GO_MF:495377_GO_0015101_ORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495377_GO_0015101_ORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",29,-1.3522,0.098,0.25,-1.1458,0.27,0.82,-1.4457,0.04,0.44
"GO_BP:507821_GO_0045471_RESPONSE_TO_ETHANOL","GO_BP","507821_GO_0045471_RESPONSE_TO_ETHANOL",106,-1.3522,0.047,0.2,0.9587,0.57,1,1.0294,0.37,0.83
"GO_CC:752709_GO_0097208_ALVEOLAR_LAMELLAR_BODY","GO_CC","752709_GO_0097208_ALVEOLAR_LAMELLAR_BODY",7,-1.3522,0.13,0.27,-0.7953,0.71,1,-1.631,0.028,0.4
"GO_BP:494949_GO_0010885_REGULATION_OF_CHOLESTEROL_STORAGE","GO_BP","494949_GO_0010885_REGULATION_OF_CHOLESTEROL_STORAGE",13,-1.3521,0.12,0.2,1.1109,0.31,0.89,1.1946,0.22,0.72
"C7_Immunologic_signatures:C7_ALL_186_GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN","C7_Immunologic_signatures","C7_ALL_186_GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN",199,-1.3521,0.023,0.045,1.6017,0,0.003,0.6864,1,1
"GO_BP:487892_GO_0002002_REGULATION_OF_ANGIOTENSIN_LEVELS_IN_BLOOD","GO_BP","487892_GO_0002002_REGULATION_OF_ANGIOTENSIN_LEVELS_IN_BLOOD",13,-1.352,0.13,0.2,1.5405,0.046,0.36,0.922,0.58,0.92
"C3_TF_targets:C3_TFT_582_STTTCRNTTT_V_IRF_Q6","C3_TF_targets","C3_TFT_582_STTTCRNTTT_V_IRF_Q6",183,-1.352,0.024,0.058,1.0193,0.41,1,-1.2017,0.065,0.34
"GO_BP:501832_GO_0032606_TYPE_I_INTERFERON_PRODUCTION","GO_BP","501832_GO_0032606_TYPE_I_INTERFERON_PRODUCTION",9,-1.352,0.15,0.2,-0.5745,0.95,1,-1.0027,0.46,0.85
"KEGG_compound:C00818_D_GLUCARATE_D_GLUCARIC_ACID_L_GULARIC_ACID_D_SACCHARIC_ACID_D_GLUCOSACCHARIC_ACID_GLUCARIC_ACID_GLUCARATE","KEGG_compound","C00818_D_GLUCARATE_D_GLUCARIC_ACID_L_GULARIC_ACID_D_SACCHARIC_ACID_D_GLUCOSACCHARIC_ACID_GLUCARIC_ACID_GLUCARATE",5,-1.3519,0.12,0.29,0.6972,0.85,1,-1.2173,0.26,0.43
"C3_TF_targets:C3_TFT_335_V_GCM_Q2","C3_TF_targets","C3_TFT_335_V_GCM_Q2",231,-1.3519,0.015,0.058,-1.4805,0.0052,0.15,0.8962,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1902_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1902_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN",32,-1.3518,0.085,0.14,-0.7256,0.91,1,0.981,0.46,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_740_LI_CISPLATIN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_740_LI_CISPLATIN_RESISTANCE_DN",34,-1.3518,0.076,0.14,-0.7952,0.8,1,1.0754,0.36,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_481_KERLEY_RESPONSE_TO_CISPLATIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_481_KERLEY_RESPONSE_TO_CISPLATIN_UP",44,-1.3518,0.086,0.14,-0.9263,0.57,1,-0.7041,0.95,0.99
"GO_CC:503563_GO_0034361_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE","GO_CC","503563_GO_0034361_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE",20,-1.3518,0.12,0.27,0.7724,0.8,0.97,1.1549,0.26,0.84
"GO_BP:506567_GO_0043536_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION","GO_BP","506567_GO_0043536_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION",23,-1.3518,0.1,0.2,-1.1299,0.27,0.94,-1.4851,0.036,0.53
"REACTOME:477139_REACT_111214_G0_AND_EARLY_G1","REACTOME","477139_REACT_111214_G0_AND_EARLY_G1",25,-1.3518,0.092,0.23,-0.6413,0.97,1,-1.4189,0.065,0.39
"GO_MF:497890_GO_0019001_GUANYL_NUCLEOTIDE_BINDING","GO_MF","497890_GO_0019001_GUANYL_NUCLEOTIDE_BINDING",381,-1.3518,0.0074,0.25,0.9354,0.72,0.94,-1.338,0.0041,0.54
"GO_BP:753097_GO_1900102_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE","GO_BP","753097_GO_1900102_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE",9,-1.3518,0.13,0.2,-0.7759,0.75,1,-1.0991,0.32,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_85_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_85_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN",64,-1.3517,0.077,0.14,-1.4983,0.017,0.45,-1.5345,0.012,0.28
"C7_Immunologic_signatures:C7_ALL_1450_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN","C7_Immunologic_signatures","C7_ALL_1450_GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN",199,-1.3517,0.022,0.046,0.9535,0.6,0.89,-1.15,0.13,0.37
"C3_TF_targets:C3_TFT_305_V_STAT3_02","C3_TF_targets","C3_TFT_305_V_STAT3_02",143,-1.3517,0.027,0.058,-1.4713,0.0052,0.14,-0.8508,0.87,0.97
"C1_Positional:C1_ALL_147_CHR1Q32","C1_Positional","C1_ALL_147_CHR1Q32",145,-1.3517,0.037,0.58,-1.2104,0.1,1,0.8783,0.79,0.87
"GO_BP:1025448_GO_1990440_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS","GO_BP","1025448_GO_1990440_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS",10,-1.3517,0.13,0.2,-0.6845,0.87,1,0.6875,0.88,1
"C7_Immunologic_signatures:C7_ALL_768_GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_768_GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN",196,-1.3517,0.023,0.045,-1.1598,0.14,0.97,1.4183,0.0055,0.12
"GO_BP:518819_GO_2000171_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT","GO_BP","518819_GO_2000171_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT",16,-1.3515,0.12,0.2,-1.3112,0.16,0.87,-0.7655,0.78,1
"C3_TF_targets:C3_TFT_460_V_AP4_Q6_01","C3_TF_targets","C3_TFT_460_V_AP4_Q6_01",255,-1.3515,0.0089,0.058,-1.2013,0.077,0.34,0.8746,0.85,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_20_BIOCARTA_AGPCR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_20_BIOCARTA_AGPCR_PATHWAY",12,-1.3512,0.12,0.22,1.0614,0.39,0.78,-1.2032,0.23,0.57
"C3_TF_targets:C3_TFT_575_GATAAGR_V_GATA_C","C3_TF_targets","C3_TFT_575_GATAAGR_V_GATA_C",287,-1.3511,0.0022,0.058,-1.0198,0.41,0.72,1.2036,0.062,0.73
"GO_BP:488421_GO_0002548_MONOCYTE_CHEMOTAXIS","GO_BP","488421_GO_0002548_MONOCYTE_CHEMOTAXIS",17,-1.3511,0.1,0.2,1.5377,0.041,0.36,1.3595,0.12,0.64
"GO_BP:510374_GO_0048260_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS","GO_BP","510374_GO_0048260_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS",37,-1.3508,0.079,0.2,0.7119,0.9,1,1.0959,0.31,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_966_FALVELLA_SMOKERS_WITH_LUNG_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_966_FALVELLA_SMOKERS_WITH_LUNG_CANCER",78,-1.3508,0.049,0.14,0.8349,0.85,0.98,0.919,0.64,1
"GO_CC:501516_GO_0032281_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLEPROPIONIC_ACID_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX","GO_CC","501516_GO_0032281_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLEPROPIONIC_ACID_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX",27,-1.3507,0.12,0.27,-1.131,0.27,0.72,1.6721,0.0041,0.33
"GO_BP:500895_GO_0031646_POSITIVE_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS","GO_BP","500895_GO_0031646_POSITIVE_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS",71,-1.3506,0.063,0.2,-1.2272,0.15,0.88,-0.9461,0.57,0.89
"KEGG_reaction:R00631_ALDEHYDE_NAD_OXIDOREDUCTASE_ALDEHYDE_NAD_H2O_FATTY_ACID_NADH_H_","KEGG_reaction","R00631_ALDEHYDE_NAD_OXIDOREDUCTASE_ALDEHYDE_NAD_H2O_FATTY_ACID_NADH_H_",5,-1.3505,0.12,0.33,0.6987,0.84,1,-1.2209,0.23,0.42
"GO_BP:508487_GO_0046189_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","508487_GO_0046189_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",35,-1.3504,0.095,0.2,-1.0315,0.4,0.98,-1.2216,0.18,0.71
"KEGG_compound:C05270_HEXANOYL_COA","KEGG_compound","C05270_HEXANOYL_COA",10,-1.3503,0.12,0.29,-0.6155,0.9,1,-1.7317,0.0098,0.059
"GO_MF:489269_GO_0003725_DOUBLE_STRANDED_RNA_BINDING","GO_MF","489269_GO_0003725_DOUBLE_STRANDED_RNA_BINDING",59,-1.3503,0.067,0.26,0.8338,0.78,1,-1.7046,0.002,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_2809_FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2809_FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP",35,-1.3503,0.087,0.14,0.9888,0.47,0.81,-1.0916,0.32,0.64
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_10_BIOCARTA_AKAP95_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_10_BIOCARTA_AKAP95_PATHWAY",12,-1.3502,0.12,0.22,0.9965,0.43,0.84,-0.9568,0.5,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_856_WANG_HCP_PROSTATE_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_856_WANG_HCP_PROSTATE_CANCER",109,-1.3502,0.036,0.14,0.842,0.85,0.97,-0.9187,0.65,0.85
"KEGG_reaction:R01752_D_GLYCERALDEHYDE_NAD_OXIDOREDUCTASE_D_GLYCERALDEHYDE_NAD_H2O_D_GLYCERATE_NADH_H_","KEGG_reaction","R01752_D_GLYCERALDEHYDE_NAD_OXIDOREDUCTASE_D_GLYCERALDEHYDE_NAD_H2O_D_GLYCERATE_NADH_H_",5,-1.3501,0.11,0.33,0.7084,0.82,1,-1.2354,0.24,0.44
"REACTOME:645330_REACT_121006_ACYL_CHAIN_REMODELING_OF_CL","REACTOME","645330_REACT_121006_ACYL_CHAIN_REMODELING_OF_CL",6,-1.3501,0.12,0.23,-0.5707,0.95,1,-1.3673,0.13,0.47
"GO_BP:507528_GO_0046688_RESPONSE_TO_COPPER_ION","GO_BP","507528_GO_0046688_RESPONSE_TO_COPPER_ION",21,-1.3501,0.1,0.2,0.7171,0.88,1,-1.1621,0.23,0.73
"GO_BP:512411_GO_0051533_POSITIVE_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","512411_GO_0051533_POSITIVE_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS",7,-1.3501,0.13,0.2,-1.6476,0.016,0.71,-1.3969,0.097,0.58
"GO_BP:495204_GO_0014808_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM","GO_BP","495204_GO_0014808_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM",7,-1.3501,0.12,0.2,0.6067,0.93,1,0.9257,0.54,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_553_HWANG_PROSTATE_CANCER_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_553_HWANG_PROSTATE_CANCER_MARKERS",27,-1.3495,0.096,0.14,1.109,0.3,0.62,-0.8128,0.77,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2258_SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2258_SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP",93,-1.3495,0.034,0.14,-1.5251,0.011,0.45,-1.1166,0.24,0.61
"C7_Immunologic_signatures:C7_ALL_148_GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN","C7_Immunologic_signatures","C7_ALL_148_GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN",198,-1.3495,0.021,0.047,-0.8422,0.85,1,-1.0643,0.29,0.58
"GO_CC:507504_GO_0045111_INTERMEDIATE_FILAMENT_CYTOSKELETON","GO_CC","507504_GO_0045111_INTERMEDIATE_FILAMENT_CYTOSKELETON",187,-1.3495,0.016,0.27,1.211,0.076,0.51,1.4381,0,0.68
"GO_BP:492844_GO_0008584_MALE_GONAD_DEVELOPMENT","GO_BP","492844_GO_0008584_MALE_GONAD_DEVELOPMENT",120,-1.3494,0.033,0.21,-0.9052,0.68,1,-0.9306,0.64,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1782_VERRECCHIA_RESPONSE_TO_TGFB1_C5","C2_Chemical_and_genetic_perturbations","C2_CGP_1782_VERRECCHIA_RESPONSE_TO_TGFB1_C5",20,-1.3494,0.11,0.14,1.5696,0.041,0.16,1.2944,0.15,0.68
"GO_BP:508801_GO_0046545_DEVELOPMENT_OF_PRIMARY_FEMALE_SEXUAL_CHARACTERISTICS","GO_BP","508801_GO_0046545_DEVELOPMENT_OF_PRIMARY_FEMALE_SEXUAL_CHARACTERISTICS",85,-1.3494,0.055,0.21,-0.8849,0.72,1,1.2049,0.14,0.71
"GO_BP:849936_GO_1902235_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","849936_GO_1902235_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",25,-1.3493,0.095,0.21,-0.8831,0.65,1,-1.4194,0.053,0.57
"GO_MF:492542_GO_0008201_HEPARIN_BINDING","GO_MF","492542_GO_0008201_HEPARIN_BINDING",137,-1.3492,0.04,0.26,1.1367,0.19,0.75,1.5501,0.0059,0.38
"GO_BP:506222_GO_0043149_STRESS_FIBER_ASSEMBLY","GO_BP","506222_GO_0043149_STRESS_FIBER_ASSEMBLY",14,-1.3492,0.12,0.21,-0.773,0.79,1,1.4026,0.081,0.63
"GO_MF:496957_GO_0017166_VINCULIN_BINDING","GO_MF","496957_GO_0017166_VINCULIN_BINDING",10,-1.3492,0.12,0.26,0.6313,0.91,1,-0.7372,0.8,0.99
"GO_MF:517414_GO_0072509_DIVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","517414_GO_0072509_DIVALENT_INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",162,-1.3491,0.027,0.26,-1.5994,0,0.48,-0.9377,0.62,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1190_TOMIDA_LUNG_CANCER_POOR_SURVIVAL","C2_Chemical_and_genetic_perturbations","C2_CGP_1190_TOMIDA_LUNG_CANCER_POOR_SURVIVAL",5,-1.3491,0.13,0.14,0.6893,0.84,1,-1.4275,0.081,0.33
"KEGG_reaction:R04065_IMIDAZOLE_ACETALDEHYDE_NAD_OXIDOREDUCTASE_IMIDAZOLE_4_ACETALDEHYDE_NAD_H2O_IMIDAZOLE_4_ACETATE_NADH_H_","KEGG_reaction","R04065_IMIDAZOLE_ACETALDEHYDE_NAD_OXIDOREDUCTASE_IMIDAZOLE_4_ACETALDEHYDE_NAD_H2O_IMIDAZOLE_4_ACETATE_NADH_H_",5,-1.3489,0.12,0.32,0.6924,0.83,1,-1.2192,0.23,0.41
"GO_BP:511928_GO_0050995_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS","GO_BP","511928_GO_0050995_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS",18,-1.3487,0.11,0.21,-0.932,0.55,1,0.8891,0.64,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2517_LINDSTEDT_DENDRITIC_CELL_MATURATION_C","C2_Chemical_and_genetic_perturbations","C2_CGP_2517_LINDSTEDT_DENDRITIC_CELL_MATURATION_C",67,-1.3486,0.058,0.14,1.3984,0.045,0.29,-0.7644,0.92,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2397_BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2397_BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP",60,-1.3486,0.066,0.14,0.6155,0.99,1,-1.1833,0.19,0.53
"C3_TF_targets:C3_TFT_237_V_AREB6_04","C3_TF_targets","C3_TFT_237_V_AREB6_04",246,-1.3485,0.016,0.059,-1.1444,0.13,0.45,-0.8907,0.81,0.93
"REACTOME:106232_REACT_1132_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS","REACTOME","106232_REACT_1132_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS",11,-1.3484,0.13,0.24,-0.9737,0.48,1,-1.0026,0.45,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_2747_WANG_RECURRENT_LIVER_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2747_WANG_RECURRENT_LIVER_CANCER_DN",16,-1.3483,0.12,0.14,1.3338,0.13,0.35,1.46,0.06,0.54
"GO_BP:488877_GO_0035814_NEGATIVE_REGULATION_OF_RENAL_SODIUM_EXCRETION","GO_BP","488877_GO_0035814_NEGATIVE_REGULATION_OF_RENAL_SODIUM_EXCRETION",6,-1.3483,0.13,0.21,0.9966,0.47,0.98,-0.996,0.47,0.85
"GO_BP:500890_GO_0031641_REGULATION_OF_MYELINATION","GO_BP","500890_GO_0031641_REGULATION_OF_MYELINATION",28,-1.3483,0.09,0.21,-0.9152,0.61,1,-0.9879,0.47,0.86
"C3_TF_targets:C3_TFT_249_CCTNTMAGA_UNKNOWN","C3_TF_targets","C3_TFT_249_CCTNTMAGA_UNKNOWN",125,-1.3483,0.04,0.059,-0.9003,0.71,0.95,-1.1394,0.21,0.46
"C7_Immunologic_signatures:C7_ALL_397_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_397_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP",196,-1.3482,0.015,0.048,-1.0055,0.44,1,-1.2071,0.076,0.27
"C3_TF_targets:C3_TFT_478_V_ER_Q6_02","C3_TF_targets","C3_TFT_478_V_ER_Q6_02",248,-1.3481,0.014,0.059,-0.9473,0.62,0.88,1.0114,0.42,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1616_JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1616_JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN",41,-1.3481,0.076,0.14,0.7478,0.88,1,-0.9109,0.6,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_195_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_195_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP",32,-1.348,0.095,0.14,0.4553,1,1,0.6838,0.97,1
"C3_TF_targets:C3_TFT_259_V_SPZ1_01","C3_TF_targets","C3_TFT_259_V_SPZ1_01",226,-1.348,0.024,0.059,-1.2971,0.021,0.24,-0.9975,0.48,0.77
"GO_CC:492644_GO_0008328_IONOTROPIC_GLUTAMATE_RECEPTOR_COMPLEX","GO_CC","492644_GO_0008328_IONOTROPIC_GLUTAMATE_RECEPTOR_COMPLEX",50,-1.348,0.087,0.27,-0.9641,0.52,0.89,2.0523,0,0.042
"GO_BP:518347_GO_0090207_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS","GO_BP","518347_GO_0090207_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS",29,-1.3479,0.11,0.21,-0.6279,0.96,1,-1.0721,0.34,0.8
"KEGG_compound:C02670_D_GLUCURONOLACTONE_GLUCURONE_D_GLUCURONO_3_6_LACTONE_D_GLUCURONE","KEGG_compound","C02670_D_GLUCURONOLACTONE_GLUCURONE_D_GLUCURONO_3_6_LACTONE_D_GLUCURONE",5,-1.3479,0.14,0.29,0.6934,0.82,1,-1.2311,0.23,0.42
"GO_BP:491048_GO_0006063_URONIC_ACID_METABOLIC_PROCESS","GO_BP","491048_GO_0006063_URONIC_ACID_METABOLIC_PROCESS",26,-1.3479,0.096,0.21,1.5544,0.027,0.34,1.6399,0.008,0.4
"GO_MF:496834_GO_0017002_ACTIVIN_ACTIVATED_RECEPTOR_ACTIVITY","GO_MF","496834_GO_0017002_ACTIVIN_ACTIVATED_RECEPTOR_ACTIVITY",7,-1.3478,0.11,0.26,-0.7432,0.79,1,0.7309,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_551_OZANNE_AP1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_551_OZANNE_AP1_TARGETS_UP",17,-1.3478,0.11,0.14,0.9411,0.55,0.88,0.8389,0.7,1
"C7_Immunologic_signatures:C7_ALL_376_GSE15659_RESTING_VS_ACTIVATED_TREG_DN","C7_Immunologic_signatures","C7_ALL_376_GSE15659_RESTING_VS_ACTIVATED_TREG_DN",195,-1.3477,0.024,0.048,1.095,0.23,0.46,-0.7197,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3177_AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3177_AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN",16,-1.3477,0.13,0.14,-0.9368,0.55,1,1.101,0.32,0.88
"GO_BP:512129_GO_0051235_MAINTENANCE_OF_LOCATION","GO_BP","512129_GO_0051235_MAINTENANCE_OF_LOCATION",163,-1.3477,0.035,0.21,-0.66,1,1,-0.958,0.53,0.88
"C3_MicroRNA_targets:C3_MIR_100_AAACCAC_MIR_140","C3_MicroRNA_targets","C3_MIR_100_AAACCAC_MIR_140",109,-1.3477,0.043,0.24,-0.8505,0.81,1,-1.0288,0.38,1
"C7_Immunologic_signatures:C7_ALL_509_GSE17721_CTRL_VS_CPG_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_509_GSE17721_CTRL_VS_CPG_24H_BMDM_UP",195,-1.3476,0.019,0.048,-0.8277,0.87,1,-1.2203,0.067,0.24
"KEGG_compound:C05981_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_4_5_TRISPHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_3_4_5_BISPHOSPHATE_","KEGG_compound","C05981_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_4_5_TRISPHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_3_4_5_BISPHOSPHATE_",11,-1.3476,0.13,0.29,-0.7402,0.8,1,-0.8542,0.66,0.8
"GO_BP:493697_GO_0009566_FERTILIZATION","GO_BP","493697_GO_0009566_FERTILIZATION",134,-1.3475,0.028,0.21,-0.8344,0.86,1,-0.9741,0.53,0.88
"C3_TF_targets:C3_TFT_18_AACWWCAANK_UNKNOWN","C3_TF_targets","C3_TFT_18_AACWWCAANK_UNKNOWN",139,-1.3475,0.034,0.059,-0.8186,0.88,1,-1.2834,0.041,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_1012_FREDERICK_PRKCI_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1012_FREDERICK_PRKCI_TARGETS",9,-1.3475,0.11,0.14,-0.8279,0.69,1,-0.9352,0.52,0.84
"WikiPathways:198760_WP395_IL_4_SIGNALING_PATHWAY","WikiPathways","198760_WP395_IL_4_SIGNALING_PATHWAY",62,-1.3474,0.068,0.16,-0.8329,0.77,1,-1.0955,0.29,0.61
"GO_BP:514128_GO_0060573_CELL_FATE_SPECIFICATION_INVOLVED_IN_PATTERN_SPECIFICATION","GO_BP","514128_GO_0060573_CELL_FATE_SPECIFICATION_INVOLVED_IN_PATTERN_SPECIFICATION",9,-1.3474,0.14,0.21,-0.9612,0.5,1,0.9318,0.55,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_2120_KYNG_DNA_DAMAGE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2120_KYNG_DNA_DAMAGE_UP",219,-1.3474,0.016,0.14,-0.7844,0.96,1,-0.8205,0.94,0.94
"C1_Positional:C1_ALL_300_CHR7P15","C1_Positional","C1_ALL_300_CHR7P15",75,-1.3474,0.059,0.57,1.2345,0.12,0.59,-0.8018,0.86,0.99
"GO_BP:488135_GO_0002262_MYELOID_CELL_HOMEOSTASIS","GO_BP","488135_GO_0002262_MYELOID_CELL_HOMEOSTASIS",96,-1.3473,0.056,0.21,1.3523,0.046,0.61,-1.2208,0.12,0.71
"GO_BP:513488_GO_0055057_NEUROBLAST_DIVISION","GO_BP","513488_GO_0055057_NEUROBLAST_DIVISION",12,-1.3473,0.12,0.21,-0.5462,0.96,1,0.7152,0.85,1
"GO_CC:490883_GO_0005875_MICROTUBULE_ASSOCIATED_COMPLEX","GO_CC","490883_GO_0005875_MICROTUBULE_ASSOCIATED_COMPLEX",134,-1.3472,0.045,0.27,-1.0093,0.41,0.85,-1.0519,0.33,0.98
"GO_BP:501622_GO_0032387_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT","GO_BP","501622_GO_0032387_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT",108,-1.3472,0.042,0.21,-0.8548,0.81,1,-1.1015,0.25,0.77
"GO_BP:493361_GO_0009165_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","493361_GO_0009165_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",216,-1.3472,0.017,0.21,0.8614,0.9,1,-1.388,0.0045,0.58
"WikiPathways:198800_WP524_G13_SIGNALING_PATHWAY","WikiPathways","198800_WP524_G13_SIGNALING_PATHWAY",38,-1.347,0.086,0.16,0.9415,0.56,1,-0.773,0.85,0.95
"GO_BP:504610_GO_0035426_EXTRACELLULAR_MATRIX_CELL_SIGNALING","GO_BP","504610_GO_0035426_EXTRACELLULAR_MATRIX_CELL_SIGNALING",5,-1.347,0.12,0.21,-0.8206,0.7,1,1.4855,0.069,0.58
"C4_Cancer_gene_neighborhoods:C4_CGN_340_GNF2_CKS1B","C4_Cancer_gene_neighborhoods","C4_CGN_340_GNF2_CKS1B",37,-1.3468,0.094,0.16,1.5418,0.019,0.023,-1.365,0.072,0.21
"C7_Immunologic_signatures:C7_ALL_1688_GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1688_GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN",193,-1.3468,0.022,0.048,-0.6616,1,1,-1.1488,0.13,0.37
"C7_Immunologic_signatures:C7_ALL_683_GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_683_GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDM_UP",197,-1.3466,0.019,0.048,-0.9,0.7,1,-0.9063,0.75,0.94
"GO_BP:514141_GO_0060586_MULTICELLULAR_ORGANISMAL_IRON_ION_HOMEOSTASIS","GO_BP","514141_GO_0060586_MULTICELLULAR_ORGANISMAL_IRON_ION_HOMEOSTASIS",7,-1.3466,0.13,0.21,0.8242,0.68,1,-1.1713,0.28,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_411_LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_411_LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP",8,-1.3465,0.12,0.14,1.4078,0.12,0.29,-1.0031,0.44,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_3282_PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3282_PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP",54,-1.3464,0.086,0.14,0.8903,0.68,0.94,0.9746,0.5,0.96
"GO_BP:489101_GO_0003309_TYPE_B_PANCREATIC_CELL_DIFFERENTIATION","GO_BP","489101_GO_0003309_TYPE_B_PANCREATIC_CELL_DIFFERENTIATION",15,-1.3462,0.14,0.21,0.9237,0.56,1,1.2153,0.2,0.71
"GO_BP:513734_GO_0060177_REGULATION_OF_ANGIOTENSIN_METABOLIC_PROCESS","GO_BP","513734_GO_0060177_REGULATION_OF_ANGIOTENSIN_METABOLIC_PROCESS",13,-1.346,0.11,0.21,1.53,0.055,0.37,0.9068,0.58,0.93
"KEGG_reaction:R01986_4_AMINOBUTYRALDEHYDE_NAD_OXIDOREDUCTASE_4_AMINOBUTYRALDEHYDE_NADP_H2O_4_AMINOBUTANOATE_NADPH_H_","KEGG_reaction","R01986_4_AMINOBUTYRALDEHYDE_NAD_OXIDOREDUCTASE_4_AMINOBUTYRALDEHYDE_NADP_H2O_4_AMINOBUTANOATE_NADPH_H_",5,-1.3459,0.14,0.32,0.6899,0.84,1,-1.2421,0.22,0.43
"GO_BP:518934_GO_2000288_POSITIVE_REGULATION_OF_MYOBLAST_PROLIFERATION","GO_BP","518934_GO_2000288_POSITIVE_REGULATION_OF_MYOBLAST_PROLIFERATION",6,-1.3458,0.12,0.21,0.8131,0.7,1,0.9428,0.51,0.91
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_196_BIOCARTA_TH1TH2_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_196_BIOCARTA_TH1TH2_PATHWAY",19,-1.3458,0.093,0.22,0.7621,0.81,1,0.9783,0.48,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2262_SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2262_SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP",6,-1.3456,0.12,0.14,1.0791,0.37,0.67,-0.7979,0.75,0.95
"C7_Immunologic_signatures:C7_ALL_282_GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN","C7_Immunologic_signatures","C7_ALL_282_GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN",200,-1.3456,0.025,0.049,1.1037,0.21,0.43,-1.9002,0,0
"KEGG_pathway:HSA04975_FAT_DIGESTION_AND_ABSORPTION","KEGG_pathway","HSA04975_FAT_DIGESTION_AND_ABSORPTION",34,-1.3455,0.088,0.099,-1.2216,0.17,0.52,1.2276,0.16,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_2010_KIM_LRRC3B_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2010_KIM_LRRC3B_TARGETS",30,-1.3455,0.093,0.14,1.6592,0.013,0.11,-1.1244,0.28,0.6
"GO_CC:515618_GO_0070688_MLL5_L_COMPLEX","GO_CC","515618_GO_0070688_MLL5_L_COMPLEX",8,-1.3455,0.15,0.27,1.0756,0.37,0.68,-0.9871,0.48,1
"GO_BP:502350_GO_0033129_POSITIVE_REGULATION_OF_HISTONE_PHOSPHORYLATION","GO_BP","502350_GO_0033129_POSITIVE_REGULATION_OF_HISTONE_PHOSPHORYLATION",6,-1.3454,0.13,0.21,-1.3289,0.14,0.9,-1.0144,0.44,0.84
"GO_BP:501541_GO_0032306_REGULATION_OF_PROSTAGLANDIN_SECRETION","GO_BP","501541_GO_0032306_REGULATION_OF_PROSTAGLANDIN_SECRETION",12,-1.3453,0.13,0.21,0.7653,0.81,1,1.0595,0.37,0.8
"GO_BP:502006_GO_0032780_NEGATIVE_REGULATION_OF_ATPASE_ACTIVITY","GO_BP","502006_GO_0032780_NEGATIVE_REGULATION_OF_ATPASE_ACTIVITY",11,-1.3452,0.13,0.21,-1.2907,0.17,0.88,-0.6738,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1187_MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1187_MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN",17,-1.3449,0.11,0.14,-0.6951,0.87,1,0.9959,0.45,0.97
"KEGG_reaction:R03869__S_METHYLMALONATE_SEMIALDEHYDE_NAD_OXIDOREDUCTASE_S_METHYLMALONATE_SEMIALDEHYDE_NAD_H2O_METHYLMALONATE_NADH_H_","KEGG_reaction","R03869__S_METHYLMALONATE_SEMIALDEHYDE_NAD_OXIDOREDUCTASE_S_METHYLMALONATE_SEMIALDEHYDE_NAD_H2O_METHYLMALONATE_NADH_H_",5,-1.3449,0.12,0.32,0.6917,0.84,1,-1.2292,0.24,0.43
"GO_BP:488784_GO_0002911_REGULATION_OF_LYMPHOCYTE_ANERGY","GO_BP","488784_GO_0002911_REGULATION_OF_LYMPHOCYTE_ANERGY",7,-1.3448,0.14,0.21,0.6869,0.87,1,-0.6965,0.87,0.99
"GO_BP:506390_GO_0043330_RESPONSE_TO_EXOGENOUS_DSRNA","GO_BP","506390_GO_0043330_RESPONSE_TO_EXOGENOUS_DSRNA",37,-1.3447,0.082,0.21,1.1501,0.22,0.84,-1.104,0.28,0.77
"GO_BP:505653_GO_0042522_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN","GO_BP","505653_GO_0042522_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT5_PROTEIN",21,-1.3446,0.097,0.21,-1.4376,0.083,0.92,0.9234,0.56,0.92
"C6_Oncogenic_signatures:C6_ALL_117_CRX_NRL_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_117_CRX_NRL_DN_V1_DN",112,-1.3446,0.036,0.056,-1.0916,0.3,0.55,-0.9402,0.57,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1487_HASLINGER_B_CLL_WITH_11Q23_DELETION","C2_Chemical_and_genetic_perturbations","C2_CGP_1487_HASLINGER_B_CLL_WITH_11Q23_DELETION",23,-1.3445,0.097,0.14,-1.0618,0.34,0.97,0.8337,0.72,1
"GO_BP:507823_GO_0048149_BEHAVIORAL_RESPONSE_TO_ETHANOL","GO_BP","507823_GO_0048149_BEHAVIORAL_RESPONSE_TO_ETHANOL",9,-1.3444,0.13,0.21,-1.1372,0.3,0.93,-0.5485,0.97,1
"GO_BP:500385_GO_0031098_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE","GO_BP","500385_GO_0031098_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE",119,-1.3444,0.05,0.21,-0.7438,0.96,1,-1.2438,0.083,0.69
"GO_BP:493400_GO_0009204_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS","GO_BP","493400_GO_0009204_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS",7,-1.3443,0.13,0.21,0.7525,0.77,1,-1.3284,0.16,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_1256_ROSS_ACUTE_MYELOID_LEUKEMIA_CBF","C2_Chemical_and_genetic_perturbations","C2_CGP_1256_ROSS_ACUTE_MYELOID_LEUKEMIA_CBF",82,-1.3443,0.058,0.14,-0.9495,0.55,1,-1.1896,0.16,0.53
"WikiPathways:198766_WP453_INFLAMMATORY_RESPONSE_PATHWAY","WikiPathways","198766_WP453_INFLAMMATORY_RESPONSE_PATHWAY",30,-1.3443,0.1,0.16,0.9063,0.61,1,1.1427,0.26,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_3253_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6","C2_Chemical_and_genetic_perturbations","C2_CGP_3253_PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6",29,-1.3442,0.095,0.14,1.1423,0.26,0.56,-1.0472,0.38,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2416_HUPER_BREAST_BASAL_VS_LUMINAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2416_HUPER_BREAST_BASAL_VS_LUMINAL_DN",57,-1.3442,0.065,0.14,0.8993,0.65,0.93,0.9236,0.61,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1706_BROWNE_HCMV_INFECTION_14HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1706_BROWNE_HCMV_INFECTION_14HR_DN",294,-1.3442,0.0088,0.14,0.9532,0.62,0.86,1.0266,0.39,0.94
"GO_BP:499609_GO_0030199_COLLAGEN_FIBRIL_ORGANIZATION","GO_BP","499609_GO_0030199_COLLAGEN_FIBRIL_ORGANIZATION",41,-1.344,0.093,0.21,-1.5465,0.02,0.74,0.9102,0.62,0.93
"C3_TF_targets:C3_TFT_28_V_CREL_01","C3_TF_targets","C3_TFT_28_V_CREL_01",251,-1.344,0.02,0.061,-1.2801,0.028,0.25,-1.4648,0.0043,0.24
"GO_BP:494677_GO_0010613_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_HYPERTROPHY","GO_BP","494677_GO_0010613_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_HYPERTROPHY",15,-1.3437,0.13,0.21,-0.6286,0.92,1,-1.2793,0.14,0.66
"GO_MF:750852_GO_0035925_MRNA_3_UTR_AU_RICH_REGION_BINDING","GO_MF","750852_GO_0035925_MRNA_3_UTR_AU_RICH_REGION_BINDING",6,-1.3437,0.11,0.26,-1.1219,0.34,0.81,-1.4563,0.089,0.43
"GO_CC:490453_GO_0005581_COLLAGEN_TRIMER","GO_CC","490453_GO_0005581_COLLAGEN_TRIMER",86,-1.3437,0.057,0.27,-1.1741,0.18,0.69,1.1891,0.14,0.83
"GO_MF:486556_GO_0044183_PROTEIN_BINDING_INVOLVED_IN_PROTEIN_FOLDING","GO_MF","486556_GO_0044183_PROTEIN_BINDING_INVOLVED_IN_PROTEIN_FOLDING",11,-1.3437,0.14,0.26,-1.139,0.29,0.8,-1.2493,0.19,0.59
"GO_BP:494603_GO_0010534_REGULATION_OF_ACTIVATION_OF_JAK2_KINASE_ACTIVITY","GO_BP","494603_GO_0010534_REGULATION_OF_ACTIVATION_OF_JAK2_KINASE_ACTIVITY",7,-1.3436,0.12,0.21,-1.1015,0.33,0.94,-0.9818,0.49,0.87
"C7_Immunologic_signatures:C7_ALL_1439_GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP","C7_Immunologic_signatures","C7_ALL_1439_GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP",197,-1.3436,0.028,0.05,1.3271,0.012,0.079,0.9803,0.52,1
"GO_BP:502378_GO_0033157_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT","GO_BP","502378_GO_0033157_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT",303,-1.3436,0.0087,0.21,0.8674,0.9,1,-1.3067,0.015,0.64
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_152_BIOCARTA_BAD_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_152_BIOCARTA_BAD_PATHWAY",26,-1.3435,0.12,0.22,1.3519,0.1,0.53,0.6806,0.93,1
"GO_BP:508181_GO_0045862_POSITIVE_REGULATION_OF_PROTEOLYSIS","GO_BP","508181_GO_0045862_POSITIVE_REGULATION_OF_PROTEOLYSIS",315,-1.3435,0.0095,0.21,1.2106,0.057,0.78,-1.3452,0.015,0.61
"C3_TF_targets:C3_TFT_291_V_ATF6_01","C3_TF_targets","C3_TFT_291_V_ATF6_01",121,-1.3435,0.042,0.061,-0.9141,0.65,0.94,-0.808,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3159_CHANGOLKAR_H2AFY_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3159_CHANGOLKAR_H2AFY_TARGETS_UP",48,-1.3434,0.073,0.14,1.315,0.099,0.38,0.8019,0.83,1
"REACTOME:771568_REACT_160189_STIMULI_SENSING_CHANNELS","REACTOME","771568_REACT_160189_STIMULI_SENSING_CHANNELS",97,-1.3434,0.047,0.24,-1.1717,0.18,0.86,-0.9434,0.57,0.91
"GO_BP:511801_GO_0050858_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY","GO_BP","511801_GO_0050858_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY",17,-1.3433,0.12,0.21,0.5646,0.99,1,-0.6812,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1606_URS_ADIPOCYTE_DIFFERENTIATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1606_URS_ADIPOCYTE_DIFFERENTIATION_UP",73,-1.3433,0.078,0.14,1.1355,0.21,0.57,1.2667,0.1,0.69
"GO_BP:488512_GO_0002639_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION","GO_BP","488512_GO_0002639_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION",30,-1.3432,0.093,0.21,-1.3212,0.085,0.89,-1.0422,0.38,0.82
"GO_BP:498963_GO_0021680_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT","GO_BP","498963_GO_0021680_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT",23,-1.3432,0.11,0.21,-1.2164,0.19,0.88,-0.9757,0.48,0.88
"KEGG_reaction:R02940_2_PROPYN_1_AL_NAD_OXIDOREDUCTASE_2_PROPYNAL_NAD_H2O_PROPYNOATE_NADH_H_","KEGG_reaction","R02940_2_PROPYN_1_AL_NAD_OXIDOREDUCTASE_2_PROPYNAL_NAD_H2O_PROPYNOATE_NADH_H_",5,-1.3431,0.13,0.31,0.6866,0.84,1,-1.229,0.26,0.42
"C7_Immunologic_signatures:C7_ALL_700_GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_700_GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDM_DN",199,-1.3431,0.025,0.05,0.9344,0.67,0.94,-0.936,0.63,0.88
"C3_TF_targets:C3_TFT_43_V_TAL1BETAITF2_01","C3_TF_targets","C3_TFT_43_V_TAL1BETAITF2_01",246,-1.343,0.012,0.061,-1.2864,0.034,0.26,-1.0525,0.29,0.63
"C3_TF_targets:C3_TFT_481_V_VDR_Q6","C3_TF_targets","C3_TFT_481_V_VDR_Q6",258,-1.3429,0.0098,0.061,-1.2767,0.034,0.25,-0.8999,0.8,0.92
"C7_Immunologic_signatures:C7_ALL_1757_GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1757_GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP",166,-1.3428,0.027,0.05,1.0436,0.37,0.61,-0.9958,0.49,0.73
"C7_Immunologic_signatures:C7_ALL_349_GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_349_GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP",196,-1.3428,0.028,0.05,-1.1673,0.14,0.94,-1.0837,0.24,0.54
"KEGG_reaction:R09419_ACYL_COA_MALONYL_COA_C_ACYLTRANSFERASE_DECARBOXYLATING_MALONYL_COA_ACYL_COA_3_OXOACYL_COA_COA_CO2","KEGG_reaction","R09419_ACYL_COA_MALONYL_COA_C_ACYLTRANSFERASE_DECARBOXYLATING_MALONYL_COA_ACYL_COA_3_OXOACYL_COA_COA_CO2",7,-1.3427,0.13,0.31,-1.1275,0.31,0.66,-1.4716,0.046,0.31
"C7_Immunologic_signatures:C7_ALL_464_GSE17721_CTRL_VS_POLYIC_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_464_GSE17721_CTRL_VS_POLYIC_0_5H_BMDM_DN",191,-1.3427,0.033,0.05,-0.8848,0.77,1,-1.2624,0.035,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_838_OXFORD_RALA_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_838_OXFORD_RALA_TARGETS_UP",9,-1.3427,0.14,0.14,-0.6423,0.93,1,-1.1435,0.3,0.58
"GO_BP:514158_GO_0060603_MAMMARY_GLAND_DUCT_MORPHOGENESIS","GO_BP","514158_GO_0060603_MAMMARY_GLAND_DUCT_MORPHOGENESIS",34,-1.3427,0.088,0.21,-0.9319,0.55,1,-0.8352,0.73,0.97
"GO_BP:499842_GO_0030501_POSITIVE_REGULATION_OF_BONE_MINERALIZATION","GO_BP","499842_GO_0030501_POSITIVE_REGULATION_OF_BONE_MINERALIZATION",33,-1.3427,0.083,0.21,-1.6054,0.016,0.7,1.1572,0.24,0.73
"GO_BP:496370_GO_0016331_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM","GO_BP","496370_GO_0016331_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM",141,-1.3426,0.044,0.21,-0.7761,0.95,1,0.8468,0.82,0.98
"KEGG_reaction:R00086_ATP_PHOSPHOHYDROLASE_ATP_H2O_ADP_ORTHOPHOSPHATE","KEGG_reaction","R00086_ATP_PHOSPHOHYDROLASE_ATP_H2O_ADP_ORTHOPHOSPHATE",6,-1.3426,0.12,0.3,0.5209,0.96,0.98,-1.4252,0.094,0.32
"C3_TF_targets:C3_TFT_386_V_CIZ_01","C3_TF_targets","C3_TFT_386_V_CIZ_01",233,-1.3426,0.016,0.061,-0.7691,0.98,1,-0.9154,0.76,0.89
"KEGG_pathway:HSA05110_VIBRIO_CHOLERAE_INFECTION","KEGG_pathway","HSA05110_VIBRIO_CHOLERAE_INFECTION",53,-1.3426,0.079,0.1,1.034,0.38,0.84,0.7342,0.93,1
"GO_MF:490637_GO_0005542_FOLIC_ACID_BINDING","GO_MF","490637_GO_0005542_FOLIC_ACID_BINDING",11,-1.3423,0.11,0.26,0.6779,0.85,1,-1.1951,0.24,0.59
"GO_BP:518427_GO_0090287_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS","GO_BP","518427_GO_0090287_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS",173,-1.3423,0.039,0.21,1.0598,0.31,0.94,1.0637,0.29,0.79
"GO_BP:983737_GO_1903018_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS","GO_BP","983737_GO_1903018_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS",34,-1.3421,0.089,0.21,-0.772,0.83,1,-0.728,0.9,0.99
"GO_MF:507542_GO_0045159_MYOSIN_II_BINDING","GO_MF","507542_GO_0045159_MYOSIN_II_BINDING",5,-1.342,0.14,0.26,1.3213,0.17,0.58,-1.0226,0.44,0.77
"C1_Positional:C1_ALL_110_CHR1Q25","C1_Positional","C1_ALL_110_CHR1Q25",73,-1.342,0.062,0.58,-0.8536,0.76,0.97,0.7357,0.94,0.94
"KEGG_reaction:R02678_INDOLE_3_ACETALDEHYDE_NAD_OXIDOREDUCTASE_INDOLE_3_ACETALDEHYDE_NAD_H2O_INDOLE_3_ACETATE_NADH_H_","KEGG_reaction","R02678_INDOLE_3_ACETALDEHYDE_NAD_OXIDOREDUCTASE_INDOLE_3_ACETALDEHYDE_NAD_H2O_INDOLE_3_ACETATE_NADH_H_",5,-1.3419,0.13,0.3,0.6976,0.82,1,-1.2662,0.2,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_693_FARMER_BREAST_CANCER_APOCRINE_VS_BASAL","C2_Chemical_and_genetic_perturbations","C2_CGP_693_FARMER_BREAST_CANCER_APOCRINE_VS_BASAL",326,-1.3418,0.011,0.14,1.2503,0.036,0.44,-1.0434,0.31,0.7
"GO_BP:495922_GO_0015791_POLYOL_TRANSPORT","GO_BP","495922_GO_0015791_POLYOL_TRANSPORT",14,-1.3418,0.13,0.21,-1.076,0.34,0.95,-0.7912,0.76,0.99
"GO_BP:500592_GO_0031333_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY","GO_BP","500592_GO_0031333_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY",100,-1.3418,0.063,0.21,-0.7312,0.95,1,-1.3856,0.013,0.59
"GO_BP:507275_GO_0044268_MULTICELLULAR_ORGANISMAL_PROTEIN_METABOLIC_PROCESS","GO_BP","507275_GO_0044268_MULTICELLULAR_ORGANISMAL_PROTEIN_METABOLIC_PROCESS",5,-1.3418,0.1,0.21,0.5778,0.94,1,-1.1573,0.29,0.74
"C7_Immunologic_signatures:C7_ALL_456_GSE17721_CTRL_VS_LPS_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_456_GSE17721_CTRL_VS_LPS_6H_BMDM_DN",195,-1.3417,0.026,0.051,0.6993,1,1,1.0056,0.41,1
"C7_Immunologic_signatures:C7_ALL_1603_GSE3982_EOSINOPHIL_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_1603_GSE3982_EOSINOPHIL_VS_TH1_UP",194,-1.3416,0.023,0.051,0.9242,0.7,0.96,-1.0486,0.31,0.61
"GO_BP:508886_GO_0046638_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION","GO_BP","508886_GO_0046638_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION",32,-1.3416,0.099,0.21,-0.8666,0.67,1,-0.718,0.93,0.99
"GO_BP:505618_GO_0042482_POSITIVE_REGULATION_OF_ODONTOGENESIS","GO_BP","505618_GO_0042482_POSITIVE_REGULATION_OF_ODONTOGENESIS",10,-1.3415,0.13,0.21,0.718,0.84,1,1.4227,0.091,0.61
"GO_BP:488186_GO_0002313_MATURE_B_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488186_GO_0002313_MATURE_B_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE",9,-1.3415,0.14,0.21,-0.7148,0.81,1,0.7983,0.71,1
"C7_Immunologic_signatures:C7_ALL_1712_GSE3982_NKCELL_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_1712_GSE3982_NKCELL_VS_TH1_DN",197,-1.3415,0.025,0.051,1.0041,0.43,0.72,-1.3424,0.015,0.1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1860_LY_AGING_MIDDLE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1860_LY_AGING_MIDDLE_UP",13,-1.3415,0.13,0.14,1.0473,0.39,0.72,-0.8277,0.68,0.94
"GO_BP:499950_GO_0030644_CELLULAR_CHLORIDE_ION_HOMEOSTASIS","GO_BP","499950_GO_0030644_CELLULAR_CHLORIDE_ION_HOMEOSTASIS",5,-1.3414,0.12,0.21,-1.0243,0.43,0.97,-0.9942,0.46,0.85
"KEGG_enzyme:1.2.1.3_ALDEHYDE_DEHYDROGENASE_NAD_COA_INDEPENDENT_ALDEHYDE_DEHYDROGENASE_M_METHYLBENZALDEHYDE_DEHYDROGENASE_NAD_ALDEHYDE_DEHYDROGENASE_NAD_DEPENDENT_4_HYDROXYNONENAL_DEHYDROGENASE_NAD_DEPENDENT_ALDEHYDE_DEHYDROGENASE_NAD_LINKED_ALDEHYDE_DEHYDROGENASE_PROPIONALDEHYDE_DEHYDROGENASE_ALDEHYDE_DEHYDROGENASE_NAD_","KEGG_enzyme","1.2.1.3_ALDEHYDE_DEHYDROGENASE_NAD_COA_INDEPENDENT_ALDEHYDE_DEHYDROGENASE_M_METHYLBENZALDEHYDE_DEHYDROGENASE_NAD_ALDEHYDE_DEHYDROGENASE_NAD_DEPENDENT_4_HYDROXYNONENAL_DEHYDROGENASE_NAD_DEPENDENT_ALDEHYDE_DEHYDROGENASE_NAD_LINKED_ALDEHYDE_DEHYDROGENASE_PROPIONALDEHYDE_DEHYDROGENASE_ALDEHYDE_DEHYDROGENASE_NAD_",5,-1.3414,0.12,0.45,0.6817,0.87,0.93,-1.2494,0.23,0.41
"GO_BP:496013_GO_0015889_COBALAMIN_TRANSPORT","GO_BP","496013_GO_0015889_COBALAMIN_TRANSPORT",5,-1.3413,0.14,0.21,-1.1687,0.3,0.91,0.9108,0.58,0.93
"C3_TF_targets:C3_TFT_8_V_MEF2_01","C3_TF_targets","C3_TFT_8_V_MEF2_01",138,-1.3413,0.033,0.061,0.941,0.6,1,1.4503,0.0079,0.56
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_24_BIOCARTA_BIOPEPTIDES_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_24_BIOCARTA_BIOPEPTIDES_PATHWAY",41,-1.3413,0.08,0.22,0.881,0.67,0.92,-1.387,0.07,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_8_PARENT_MTOR_SIGNALING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_8_PARENT_MTOR_SIGNALING_DN",45,-1.3413,0.084,0.14,-0.9057,0.62,1,-0.982,0.48,0.78
"GO_MF:490632_GO_0005537_MANNOSE_BINDING","GO_MF","490632_GO_0005537_MANNOSE_BINDING",16,-1.3412,0.11,0.27,1.3108,0.14,0.59,1.4271,0.07,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_1643_WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2","C2_Chemical_and_genetic_perturbations","C2_CGP_1643_WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2",39,-1.341,0.075,0.14,0.9314,0.56,0.89,1.0272,0.4,0.94
"GO_BP:512580_GO_0051705_MULTI_ORGANISM_BEHAVIOR","GO_BP","512580_GO_0051705_MULTI_ORGANISM_BEHAVIOR",79,-1.341,0.069,0.21,-0.8055,0.86,1,-0.8422,0.8,0.96
"GO_BP:494953_GO_0010889_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE","GO_BP","494953_GO_0010889_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE",12,-1.341,0.13,0.21,0.7635,0.78,1,-0.9003,0.61,0.92
"REACTOME:106365_REACT_16927_ADRENOCEPTORS","REACTOME","106365_REACT_16927_ADRENOCEPTORS",9,-1.3409,0.15,0.25,-1.3485,0.14,0.59,-0.9871,0.46,0.86
"GO_BP:488945_GO_0003151_OUTFLOW_TRACT_MORPHOGENESIS","GO_BP","488945_GO_0003151_OUTFLOW_TRACT_MORPHOGENESIS",56,-1.3409,0.067,0.21,-0.8968,0.64,1,1.393,0.052,0.63
"GO_BP:518240_GO_0090100_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY","GO_BP","518240_GO_0090100_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY",101,-1.3408,0.041,0.21,-0.8765,0.74,1,1.0356,0.39,0.82
"GO_BP:512688_GO_0051817_MODIFICATION_OF_MORPHOLOGY_OR_PHYSIOLOGY_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","512688_GO_0051817_MODIFICATION_OF_MORPHOLOGY_OR_PHYSIOLOGY_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",395,-1.3408,0.0095,0.21,1.2033,0.026,0.78,-1.1761,0.047,0.74
"REACTOME:106466_REACT_12002_ARMS_MEDIATED_ACTIVATION","REACTOME","106466_REACT_12002_ARMS_MEDIATED_ACTIVATION",23,-1.3407,0.11,0.25,0.6491,0.94,1,-0.9634,0.5,0.88
"C1_Positional:C1_ALL_243_CHRXQ27","C1_Positional","C1_ALL_243_CHRXQ27",18,-1.3406,0.12,0.56,1.1904,0.23,0.61,1.0853,0.34,0.7
"GO_BP:505894_GO_0042789_MRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER","GO_BP","505894_GO_0042789_MRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER",13,-1.3406,0.13,0.21,-1.1291,0.29,0.93,0.8126,0.71,1
"REACTOME:1183591_REACT_355469_RHO_GTPASES_ACTIVATE_IQGAPS","REACTOME","1183591_REACT_355469_RHO_GTPASES_ACTIVATE_IQGAPS",13,-1.3406,0.11,0.24,1.1855,0.25,0.46,0.7414,0.82,1
"GO_BP:501873_GO_0032647_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION","GO_BP","501873_GO_0032647_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION",16,-1.3403,0.12,0.21,0.7941,0.75,1,-1.5331,0.04,0.53
"GO_BP:753082_GO_1900087_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","753082_GO_1900087_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",20,-1.3403,0.13,0.21,-0.7877,0.76,1,-1.4178,0.073,0.57
"REACTOME:105804_REACT_2101_CYCLIN_B2_MEDIATED_EVENTS","REACTOME","105804_REACT_2101_CYCLIN_B2_MEDIATED_EVENTS",5,-1.3403,0.14,0.24,-0.5552,0.97,1,-1.3351,0.16,0.52
"REACTOME:187197_REACT_25201_KINESINS","REACTOME","187197_REACT_25201_KINESINS",26,-1.3403,0.1,0.24,0.8756,0.63,0.93,-1.146,0.26,0.66
"C6_Oncogenic_signatures:C6_ALL_79_JNK_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_79_JNK_DN_V1_DN",180,-1.3401,0.032,0.059,-1.1777,0.13,0.46,-1.0366,0.35,0.6
"C3_MicroRNA_targets:C3_MIR_148_TTTGTAG_MIR_520D","C3_MicroRNA_targets","C3_MIR_148_TTTGTAG_MIR_520D",329,-1.3401,0.0053,0.25,-0.7468,1,1,0.7472,1,1
"C7_Immunologic_signatures:C7_ALL_305_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP","C7_Immunologic_signatures","C7_ALL_305_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP",199,-1.3401,0.024,0.052,1.0106,0.44,0.71,-1.8239,0,0.00013
"C7_Immunologic_signatures:C7_ALL_557_GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_557_GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDM_UP",198,-1.34,0.028,0.052,0.655,1,1,-0.848,0.9,1
"C7_Immunologic_signatures:C7_ALL_863_GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_863_GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP",190,-1.34,0.033,0.052,1.2312,0.062,0.18,1.4065,0,0.13
"GO_MF:489809_GO_0004457_LACTATE_DEHYDROGENASE_ACTIVITY","GO_MF","489809_GO_0004457_LACTATE_DEHYDROGENASE_ACTIVITY",6,-1.3399,0.14,0.27,-1.082,0.36,0.85,-0.9263,0.53,0.85
"GO_BP:518134_GO_0085029_EXTRACELLULAR_MATRIX_ASSEMBLY","GO_BP","518134_GO_0085029_EXTRACELLULAR_MATRIX_ASSEMBLY",16,-1.3399,0.14,0.21,-1.566,0.023,0.72,0.7879,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_110_PIEPOLI_LGI1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_110_PIEPOLI_LGI1_TARGETS_UP",15,-1.3398,0.12,0.15,1.6088,0.014,0.13,0.7755,0.78,1
"GO_BP:513552_GO_0055123_DIGESTIVE_SYSTEM_DEVELOPMENT","GO_BP","513552_GO_0055123_DIGESTIVE_SYSTEM_DEVELOPMENT",138,-1.3398,0.035,0.21,-1.0286,0.4,0.97,1.1815,0.13,0.72
"GO_BP:499319_GO_0022401_NEGATIVE_ADAPTATION_OF_SIGNALING_PATHWAY","GO_BP","499319_GO_0022401_NEGATIVE_ADAPTATION_OF_SIGNALING_PATHWAY",18,-1.3397,0.11,0.21,-1.2879,0.15,0.88,1.2257,0.19,0.71
"C7_Immunologic_signatures:C7_ALL_1059_GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP","C7_Immunologic_signatures","C7_ALL_1059_GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP",196,-1.3396,0.029,0.052,0.8037,0.95,1,-1.326,0.021,0.11
"C2_Chemical_and_genetic_perturbations:C2_CGP_510_LUI_THYROID_CANCER_PAX8_PPARG_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_510_LUI_THYROID_CANCER_PAX8_PPARG_UP",44,-1.3395,0.087,0.15,-1.3145,0.1,0.7,-0.9972,0.44,0.76
"GO_BP:506581_GO_0043550_REGULATION_OF_LIPID_KINASE_ACTIVITY","GO_BP","506581_GO_0043550_REGULATION_OF_LIPID_KINASE_ACTIVITY",43,-1.3394,0.085,0.21,-0.5861,0.99,1,-0.9936,0.47,0.85
"GO_BP:506677_GO_0043647_INOSITOL_PHOSPHATE_METABOLIC_PROCESS","GO_BP","506677_GO_0043647_INOSITOL_PHOSPHATE_METABOLIC_PROCESS",55,-1.3394,0.086,0.21,-0.9848,0.48,1,-0.634,0.99,1
"GO_BP:495105_GO_0014033_NEURAL_CREST_CELL_DIFFERENTIATION","GO_BP","495105_GO_0014033_NEURAL_CREST_CELL_DIFFERENTIATION",59,-1.3393,0.08,0.21,1.2592,0.12,0.72,1.6641,0.0058,0.39
"GO_BP:515236_GO_0070303_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE","GO_BP","515236_GO_0070303_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE",40,-1.3393,0.094,0.21,1.0054,0.44,0.98,0.9168,0.57,0.93
"KEGG_reaction:R04506_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTAN_26_AL_NAD_OXIDOREDUCTASE_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTAN_26_AL_NAD_H2O_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTANATE_NADH_H_","KEGG_reaction","R04506_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTAN_26_AL_NAD_OXIDOREDUCTASE_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTAN_26_AL_NAD_H2O_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTANATE_NADH_H_",5,-1.3392,0.12,0.3,0.6784,0.86,1,-1.2528,0.23,0.43
"GO_BP:487863_GO_0001973_ADENOSINE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","487863_GO_0001973_ADENOSINE_RECEPTOR_SIGNALING_PATHWAY",9,-1.3392,0.13,0.21,1.3955,0.11,0.56,0.9666,0.48,0.89
"REACTOME:1183589_REACT_355303_RHO_GTPASES_ACTIVATE_CIT","REACTOME","1183589_REACT_355303_RHO_GTPASES_ACTIVATE_CIT",16,-1.3391,0.11,0.25,0.8186,0.73,0.99,-1.5519,0.042,0.3
"GO_MF:750774_GO_0001222_TRANSCRIPTION_COREPRESSOR_BINDING","GO_MF","750774_GO_0001222_TRANSCRIPTION_COREPRESSOR_BINDING",8,-1.3389,0.12,0.27,-1.0808,0.33,0.85,-0.8584,0.64,0.91
"C7_Immunologic_signatures:C7_ALL_631_GSE17721_POLYIC_VS_CPG_16H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_631_GSE17721_POLYIC_VS_CPG_16H_BMDM_UP",197,-1.3387,0.017,0.053,-0.6467,1,1,-0.9103,0.72,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_414_LINDGREN_BLADDER_CANCER_CLUSTER_3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_414_LINDGREN_BLADDER_CANCER_CLUSTER_3_DN",224,-1.3386,0.025,0.15,0.8127,0.96,0.98,-0.8905,0.83,0.89
"KEGG_compound:C14869_TRICHLOROETHANOL_GLUCURONIDE_UROCHLORALIC_ACID_2_2_2_TRICHLOROETHYL_BETA_D_GLUCOPYRANOSIDURONIC_ACID","KEGG_compound","C14869_TRICHLOROETHANOL_GLUCURONIDE_UROCHLORALIC_ACID_2_2_2_TRICHLOROETHYL_BETA_D_GLUCOPYRANOSIDURONIC_ACID",19,-1.3386,0.14,0.3,1.9686,0.002,0.059,2.394,0,0
"KEGG_compound:C05261_3_OXOTETRADECANOYL_COA","KEGG_compound","C05261_3_OXOTETRADECANOYL_COA",6,-1.3386,0.13,0.3,0.8103,0.7,1,-1.1992,0.22,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_2310_ZHENG_GLIOBLASTOMA_PLASTICITY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2310_ZHENG_GLIOBLASTOMA_PLASTICITY_DN",57,-1.3386,0.084,0.15,0.8333,0.79,0.98,-0.8176,0.82,0.94
"GO_BP:501603_GO_0032368_REGULATION_OF_LIPID_TRANSPORT","GO_BP","501603_GO_0032368_REGULATION_OF_LIPID_TRANSPORT",87,-1.3384,0.06,0.21,1.0517,0.34,0.95,1.0508,0.35,0.81
"GO_MF:505705_GO_0042578_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY","GO_MF","505705_GO_0042578_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY",349,-1.3383,0.013,0.27,0.8911,0.89,0.98,-0.9072,0.79,0.87
"GO_BP:491566_GO_0006678_GLUCOSYLCERAMIDE_METABOLIC_PROCESS","GO_BP","491566_GO_0006678_GLUCOSYLCERAMIDE_METABOLIC_PROCESS",5,-1.3383,0.13,0.21,-0.4575,0.99,1,-0.9822,0.5,0.87
"KEGG_compound:C04554_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTANATE_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTANOATE","KEGG_compound","C04554_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTANATE_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLESTANOATE",7,-1.3383,0.14,0.3,0.7358,0.82,1,-0.9091,0.58,0.75
"GO_BP:515100_GO_0070163_REGULATION_OF_ADIPONECTIN_SECRETION","GO_BP","515100_GO_0070163_REGULATION_OF_ADIPONECTIN_SECRETION",6,-1.3381,0.14,0.21,-1.3637,0.13,0.97,-1.6124,0.028,0.52
"REACTOME:645288_REACT_120729_COLLAGEN_FORMATION","REACTOME","645288_REACT_120729_COLLAGEN_FORMATION",86,-1.3381,0.069,0.25,-1.4376,0.024,0.51,1.3498,0.034,0.71
"GO_BP:503975_GO_0034776_RESPONSE_TO_HISTAMINE","GO_BP","503975_GO_0034776_RESPONSE_TO_HISTAMINE",11,-1.3381,0.13,0.21,0.9101,0.57,1,1.5911,0.038,0.44
"REACTOME:530750_REACT_115810_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS","REACTOME","530750_REACT_115810_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS",33,-1.338,0.11,0.25,-0.7509,0.85,1,-0.9306,0.57,0.93
"KEGG_reaction:R02549_4_AMINOBUTANAL_NAD_1_OXIDOREDUCTASE_4_AMINOBUTYRALDEHYDE_NAD_OXIDOREDUCTASE_4_AMINOBUTYRALDEHYDE_NAD_H2O_4_AMINOBUTANOATE_NADH_H_","KEGG_reaction","R02549_4_AMINOBUTANAL_NAD_1_OXIDOREDUCTASE_4_AMINOBUTYRALDEHYDE_NAD_OXIDOREDUCTASE_4_AMINOBUTYRALDEHYDE_NAD_H2O_4_AMINOBUTANOATE_NADH_H_",5,-1.338,0.12,0.29,0.7095,0.82,1,-1.2242,0.26,0.42
"GO_BP:499722_GO_0030321_TRANSEPITHELIAL_CHLORIDE_TRANSPORT","GO_BP","499722_GO_0030321_TRANSEPITHELIAL_CHLORIDE_TRANSPORT",6,-1.338,0.14,0.21,1.034,0.44,0.96,0.9116,0.57,0.93
"KEGG_module:HSA_M00007_PENTOSE_PHOSPHATE_PATHWAY_NON_OXIDATIVE_PHASE_FRUCTOSE_6P_RIBOSE_5P","KEGG_module","HSA_M00007_PENTOSE_PHOSPHATE_PATHWAY_NON_OXIDATIVE_PHASE_FRUCTOSE_6P_RIBOSE_5P",7,-1.3378,0.14,0.39,0.9499,0.52,0.94,0.4354,1,1
"GO_BP:488321_GO_0002448_MAST_CELL_MEDIATED_IMMUNITY","GO_BP","488321_GO_0002448_MAST_CELL_MEDIATED_IMMUNITY",19,-1.3377,0.13,0.21,-0.9206,0.56,1,-1.0316,0.39,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_2677_VALK_AML_CLUSTER_1","C2_Chemical_and_genetic_perturbations","C2_CGP_2677_VALK_AML_CLUSTER_1",27,-1.3375,0.11,0.15,0.8169,0.74,0.98,-1.5843,0.017,0.25
"GO_BP:488887_GO_0003091_RENAL_WATER_HOMEOSTASIS","GO_BP","488887_GO_0003091_RENAL_WATER_HOMEOSTASIS",34,-1.3374,0.1,0.21,0.904,0.63,1,-0.942,0.54,0.89
"KEGG_pathway:HSA04725_CHOLINERGIC_SYNAPSE","KEGG_pathway","HSA04725_CHOLINERGIC_SYNAPSE",112,-1.3373,0.042,0.1,-1.3695,0.033,0.35,-1.1961,0.12,0.38
"GO_BP:752577_GO_0090520_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY","GO_BP","752577_GO_0090520_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY",8,-1.3372,0.12,0.21,0.9204,0.55,1,-1.1636,0.3,0.73
"C7_Immunologic_signatures:C7_ALL_108_GSE12366_GC_BCELL_VS_PLASMA_CELL_DN","C7_Immunologic_signatures","C7_ALL_108_GSE12366_GC_BCELL_VS_PLASMA_CELL_DN",188,-1.3372,0.035,0.054,0.7748,0.98,1,-1.2228,0.071,0.24
"GO_BP:513968_GO_0060412_VENTRICULAR_SEPTUM_MORPHOGENESIS","GO_BP","513968_GO_0060412_VENTRICULAR_SEPTUM_MORPHOGENESIS",28,-1.3372,0.1,0.21,-0.8425,0.7,1,1.067,0.36,0.79
"C7_Immunologic_signatures:C7_ALL_1864_GSE9037_WT_VS_IRAK4_KO_BMDM_DN","C7_Immunologic_signatures","C7_ALL_1864_GSE9037_WT_VS_IRAK4_KO_BMDM_DN",194,-1.3371,0.032,0.054,1.0491,0.34,0.59,-1.1912,0.11,0.3
"GO_BP:486640_GO_0000098_SULFUR_AMINO_ACID_CATABOLIC_PROCESS","GO_BP","486640_GO_0000098_SULFUR_AMINO_ACID_CATABOLIC_PROCESS",12,-1.3371,0.13,0.21,0.7869,0.76,1,-1.4836,0.078,0.53
"GO_BP:752181_GO_0061438_RENAL_SYSTEM_VASCULATURE_MORPHOGENESIS","GO_BP","752181_GO_0061438_RENAL_SYSTEM_VASCULATURE_MORPHOGENESIS",7,-1.3371,0.13,0.21,-1.224,0.21,0.88,1.607,0.034,0.41
"GO_MF:490226_GO_0004935_ADRENERGIC_RECEPTOR_ACTIVITY","GO_MF","490226_GO_0004935_ADRENERGIC_RECEPTOR_ACTIVITY",9,-1.337,0.13,0.27,-1.3561,0.12,0.68,-1.0021,0.43,0.79
"GO_BP:493483_GO_0009299_MRNA_TRANSCRIPTION","GO_BP","493483_GO_0009299_MRNA_TRANSCRIPTION",19,-1.337,0.1,0.21,-1.0043,0.44,0.99,0.6577,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1859_SESTO_RESPONSE_TO_UV_C1","C2_Chemical_and_genetic_perturbations","C2_CGP_1859_SESTO_RESPONSE_TO_UV_C1",70,-1.3368,0.071,0.15,1.2726,0.083,0.42,0.9074,0.65,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_252_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_252_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP",55,-1.3368,0.075,0.15,0.8607,0.74,0.96,-1.413,0.035,0.35
"GO_CC:499564_GO_0030140_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE","GO_CC","499564_GO_0030140_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE",26,-1.3367,0.089,0.28,1.1794,0.22,0.55,-0.9359,0.53,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1666_ZHENG_RESPONSE_TO_ARSENITE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1666_ZHENG_RESPONSE_TO_ARSENITE_DN",17,-1.3367,0.12,0.15,0.7972,0.74,0.99,1.0059,0.44,0.96
"GO_BP:516339_GO_0071415_CELLULAR_RESPONSE_TO_PURINE_CONTAINING_COMPOUND","GO_BP","516339_GO_0071415_CELLULAR_RESPONSE_TO_PURINE_CONTAINING_COMPOUND",7,-1.3366,0.14,0.22,0.7722,0.74,1,-0.8474,0.68,0.96
"GO_BP:494637_GO_0010572_POSITIVE_REGULATION_OF_PLATELET_ACTIVATION","GO_BP","494637_GO_0010572_POSITIVE_REGULATION_OF_PLATELET_ACTIVATION",6,-1.3366,0.14,0.22,1.3526,0.14,0.61,-1.0625,0.41,0.8
"KEGG_compound:C00668_ALPHA_D_GLUCOSE_6_PHOSPHATE","KEGG_compound","C00668_ALPHA_D_GLUCOSE_6_PHOSPHATE",12,-1.3365,0.12,0.3,-0.6566,0.89,1,-1.5181,0.063,0.22
"GO_BP:491465_GO_0006569_TRYPTOPHAN_CATABOLIC_PROCESS","GO_BP","491465_GO_0006569_TRYPTOPHAN_CATABOLIC_PROCESS",11,-1.3365,0.13,0.22,-1.315,0.14,0.88,-1.6547,0.015,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_3367_DURAND_STROMA_S_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3367_DURAND_STROMA_S_UP",290,-1.3365,0.016,0.15,1.3137,0.023,0.38,1.5159,0,0.49
"GO_BP:513993_GO_0060438_TRACHEA_DEVELOPMENT","GO_BP","513993_GO_0060438_TRACHEA_DEVELOPMENT",14,-1.3365,0.12,0.22,-0.9088,0.59,1,1.2118,0.21,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_366_PACHER_TARGETS_OF_IGF1_AND_IGF2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_366_PACHER_TARGETS_OF_IGF1_AND_IGF2_UP",34,-1.3364,0.11,0.15,-0.7851,0.82,1,1.008,0.44,0.96
"REACTOME:106493_REACT_15295_OPIOID_SIGNALLING","REACTOME","106493_REACT_15295_OPIOID_SIGNALLING",83,-1.3363,0.06,0.25,-1.2013,0.14,0.83,-1.5848,0.002,0.27
"GO_BP:518919_GO_2000272_NEGATIVE_REGULATION_OF_RECEPTOR_ACTIVITY","GO_BP","518919_GO_2000272_NEGATIVE_REGULATION_OF_RECEPTOR_ACTIVITY",14,-1.3362,0.13,0.22,-1.2653,0.2,0.9,0.7205,0.86,1
"GO_BP:498859_GO_0021575_HINDBRAIN_MORPHOGENESIS","GO_BP","498859_GO_0021575_HINDBRAIN_MORPHOGENESIS",43,-1.3362,0.072,0.22,-1.02,0.42,0.97,-0.6639,0.98,1
"KEGG_compound:C05936_N4_ACETYLAMINOBUTANAL_4_ACETAMIDOBUTANAL","KEGG_compound","C05936_N4_ACETYLAMINOBUTANAL_4_ACETAMIDOBUTANAL",7,-1.3359,0.14,0.3,0.8072,0.71,1,-1.4325,0.1,0.26
"GO_BP:499947_GO_0030641_REGULATION_OF_CELLULAR_PH","GO_BP","499947_GO_0030641_REGULATION_OF_CELLULAR_PH",46,-1.3359,0.084,0.22,-1.0902,0.31,0.95,-0.9542,0.54,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1578_HOEGERKORP_CD44_TARGETS_TEMPORAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1578_HOEGERKORP_CD44_TARGETS_TEMPORAL_DN",24,-1.3359,0.11,0.15,0.8219,0.72,0.98,-1.2977,0.12,0.43
"GO_BP:487660_GO_0001764_NEURON_MIGRATION","GO_BP","487660_GO_0001764_NEURON_MIGRATION",111,-1.3357,0.04,0.22,-1.3556,0.024,0.96,1.1436,0.18,0.73
"GO_BP:513502_GO_0055069_ZINC_ION_HOMEOSTASIS","GO_BP","513502_GO_0055069_ZINC_ION_HOMEOSTASIS",17,-1.3356,0.15,0.22,-0.9435,0.52,1,-0.91,0.59,0.92
"GO_MF:496729_GO_0016832_ALDEHYDE_LYASE_ACTIVITY","GO_MF","496729_GO_0016832_ALDEHYDE_LYASE_ACTIVITY",9,-1.3356,0.12,0.27,0.64,0.9,1,-0.7079,0.85,1
"GO_CC:500161_GO_0030863_CORTICAL_CYTOSKELETON","GO_CC","500161_GO_0030863_CORTICAL_CYTOSKELETON",76,-1.3356,0.066,0.28,1.033,0.4,0.74,-0.9055,0.66,1
"KEGG_compound:C05267_3_OXOOCTANOYL_COA","KEGG_compound","C05267_3_OXOOCTANOYL_COA",6,-1.3355,0.14,0.3,0.8223,0.68,1,-1.1788,0.3,0.47
"KEGG_reaction:R02957_D_GLUCURONOLACTONE_NAD_OXIDOREDUCTASE_D_GLUCURONOLACTONE_NAD_2_H2O_D_GLUCARATE_NADH_H_","KEGG_reaction","R02957_D_GLUCURONOLACTONE_NAD_OXIDOREDUCTASE_D_GLUCURONOLACTONE_NAD_2_H2O_D_GLUCARATE_NADH_H_",5,-1.3355,0.14,0.29,0.6896,0.84,1,-1.2272,0.25,0.42
"GO_BP:506419_GO_0043380_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION","GO_BP","506419_GO_0043380_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION",8,-1.3353,0.13,0.22,-1.2642,0.2,0.9,-1.0691,0.36,0.8
"GO_MF:500975_GO_0031730_CCR5_CHEMOKINE_RECEPTOR_BINDING","GO_MF","500975_GO_0031730_CCR5_CHEMOKINE_RECEPTOR_BINDING",8,-1.3353,0.14,0.27,0.7943,0.75,1,-0.3678,1,1
"GO_CC:500866_GO_0031616_SPINDLE_POLE_CENTROSOME","GO_CC","500866_GO_0031616_SPINDLE_POLE_CENTROSOME",11,-1.3353,0.15,0.28,-0.6291,0.92,1,-1.4638,0.067,0.52
"GO_BP:510292_GO_0048167_REGULATION_OF_SYNAPTIC_PLASTICITY","GO_BP","510292_GO_0048167_REGULATION_OF_SYNAPTIC_PLASTICITY",122,-1.3352,0.043,0.22,-1.2496,0.068,0.91,0.8705,0.79,0.97
"C4_Cancer_modules:C4_CM_53_MODULE_57","C4_Cancer_modules","C4_CM_53_MODULE_57",56,-1.3352,0.064,0.14,0.7437,0.92,1,-1.642,0.0042,0.11
"C7_Immunologic_signatures:C7_ALL_1554_GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1554_GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN",198,-1.3351,0.026,0.055,0.6047,1,1,0.8257,0.92,1
"GO_BP:517434_GO_0072529_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS","GO_BP","517434_GO_0072529_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",35,-1.335,0.1,0.22,1.1023,0.29,0.9,-1.2688,0.14,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_3374_GHANDHI_DIRECT_IRRADIATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3374_GHANDHI_DIRECT_IRRADIATION_DN",33,-1.3348,0.12,0.15,-1.2435,0.16,0.75,-1.0524,0.36,0.69
"KEGG_compound:C02593_TETRADECANOYL_COA_MYRISTOYL_COA","KEGG_compound","C02593_TETRADECANOYL_COA_MYRISTOYL_COA",8,-1.3348,0.13,0.3,-0.5635,0.95,1,-1.4642,0.085,0.25
"C7_Immunologic_signatures:C7_ALL_1086_GSE25087_TREG_VS_TCONV_ADULT_DN","C7_Immunologic_signatures","C7_ALL_1086_GSE25087_TREG_VS_TCONV_ADULT_DN",193,-1.3348,0.033,0.055,1.1831,0.12,0.25,-1.1648,0.1,0.34
"GO_BP:488353_GO_0002480_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I_TAP_INDEPENDENT","GO_BP","488353_GO_0002480_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I_TAP_INDEPENDENT",9,-1.3348,0.14,0.22,1.0039,0.45,0.98,-0.8577,0.65,0.96
"KEGG_compound:C01832_LAUROYL_COA_LAUROYL_COENZYME_A_DODECANOYL_COA","KEGG_compound","C01832_LAUROYL_COA_LAUROYL_COENZYME_A_DODECANOYL_COA",8,-1.3348,0.12,0.3,-0.5577,0.97,1,-1.4452,0.08,0.25
"GO_BP:487732_GO_0001836_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA","GO_BP","487732_GO_0001836_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA",24,-1.3347,0.11,0.22,0.5686,0.99,1,-0.7654,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2308_EHLERS_ANEUPLOIDY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2308_EHLERS_ANEUPLOIDY_DN",12,-1.3347,0.13,0.15,0.7839,0.73,1,1.0916,0.33,0.88
"C7_Immunologic_signatures:C7_ALL_1123_GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP","C7_Immunologic_signatures","C7_ALL_1123_GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP",196,-1.3346,0.022,0.055,0.7735,0.98,1,-1.8549,0,9.5e-05
"C3_TF_targets:C3_TFT_2_AAAYRNCTG_UNKNOWN","C3_TF_targets","C3_TFT_2_AAAYRNCTG_UNKNOWN",362,-1.3346,0.0095,0.066,1.0264,0.37,1,0.9568,0.61,1
"GO_BP:505451_GO_0042304_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS","GO_BP","505451_GO_0042304_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS",30,-1.3346,0.1,0.22,0.769,0.84,1,0.9764,0.49,0.88
"C7_Immunologic_signatures:C7_ALL_1368_GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1368_GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN",198,-1.3346,0.023,0.055,1.017,0.37,0.69,-0.873,0.85,0.99
"GO_MF:754300_GO_1901338_CATECHOLAMINE_BINDING","GO_MF","754300_GO_1901338_CATECHOLAMINE_BINDING",15,-1.3345,0.13,0.27,-0.9818,0.48,0.93,-1.0356,0.4,0.76
"GO_BP:514046_GO_0060491_REGULATION_OF_CELL_PROJECTION_ASSEMBLY","GO_BP","514046_GO_0060491_REGULATION_OF_CELL_PROJECTION_ASSEMBLY",128,-1.3345,0.045,0.22,-0.7484,0.96,1,-0.9669,0.51,0.88
"GO_MF:489668_GO_0004301_EPOXIDE_HYDROLASE_ACTIVITY","GO_MF","489668_GO_0004301_EPOXIDE_HYDROLASE_ACTIVITY",5,-1.3344,0.14,0.27,-0.987,0.5,0.92,-1.2536,0.23,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_150_BORCZUK_MALIGNANT_MESOTHELIOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_150_BORCZUK_MALIGNANT_MESOTHELIOMA_DN",97,-1.3343,0.05,0.15,-1.4841,0.011,0.48,-1.4015,0.031,0.35
"GO_BP:490968_GO_0005980_GLYCOGEN_CATABOLIC_PROCESS","GO_BP","490968_GO_0005980_GLYCOGEN_CATABOLIC_PROCESS",20,-1.3342,0.093,0.22,-0.989,0.47,1,-1.6705,0.015,0.56
"GO_CC:490802_GO_0005770_LATE_ENDOSOME","GO_CC","490802_GO_0005770_LATE_ENDOSOME",197,-1.3341,0.029,0.28,1.2458,0.057,0.47,-0.7867,0.97,1
"GO_BP:1051071_GO_1903431_POSITIVE_REGULATION_OF_CELL_MATURATION","GO_BP","1051071_GO_1903431_POSITIVE_REGULATION_OF_CELL_MATURATION",5,-1.334,0.14,0.22,-1.1999,0.29,0.9,0.6498,0.89,1
"C6_Oncogenic_signatures:C6_ALL_1_GLI1_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_1_GLI1_UP_V1_DN",28,-1.334,0.11,0.062,0.8617,0.69,1,-1.1546,0.24,0.46
"KEGG_pathway:HSA05222_SMALL_CELL_LUNG_CANCER","KEGG_pathway","HSA05222_SMALL_CELL_LUNG_CANCER",86,-1.3338,0.06,0.11,-0.8069,0.84,0.99,1.0387,0.39,1
"GO_MF:496924_GO_0017124_SH3_DOMAIN_BINDING","GO_MF","496924_GO_0017124_SH3_DOMAIN_BINDING",113,-1.3338,0.056,0.27,-0.7742,0.95,1,-0.8994,0.67,0.87
"GO_MF:487682_GO_0001786_PHOSPHATIDYLSERINE_BINDING","GO_MF","487682_GO_0001786_PHOSPHATIDYLSERINE_BINDING",22,-1.3337,0.1,0.27,-0.8847,0.65,1,0.7061,0.88,1
"C4_Cancer_gene_neighborhoods:C4_CGN_337_GNF2_CDH3","C4_Cancer_gene_neighborhoods","C4_CGN_337_GNF2_CDH3",26,-1.3337,0.11,0.18,0.8547,0.68,0.93,1.7048,0.0097,0.089
"C2_Chemical_and_genetic_perturbations:C2_CGP_773_SILIGAN_BOUND_BY_EWS_FLT1_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_773_SILIGAN_BOUND_BY_EWS_FLT1_FUSION",46,-1.3337,0.11,0.15,0.6922,0.95,1,-1.1832,0.2,0.53
"KEGG_pathway:HSA00770_PANTOTHENATE_AND_COA_BIOSYNTHESIS","KEGG_pathway","HSA00770_PANTOTHENATE_AND_COA_BIOSYNTHESIS",18,-1.3336,0.13,0.11,-0.9784,0.5,0.91,-1.1041,0.34,0.51
"GO_BP:492364_GO_0007623_CIRCADIAN_RHYTHM","GO_BP","492364_GO_0007623_CIRCADIAN_RHYTHM",140,-1.3336,0.04,0.22,-1.041,0.35,0.98,-0.8048,0.92,0.99
"KEGG_compound:C01277_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_4_PHOSPHATE_","KEGG_compound","C01277_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_4_PHOSPHATE_",21,-1.3336,0.1,0.3,-1.0564,0.39,0.99,-0.8488,0.69,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1466_STOSSI_RESPONSE_TO_ESTRADIOL","C2_Chemical_and_genetic_perturbations","C2_CGP_1466_STOSSI_RESPONSE_TO_ESTRADIOL",47,-1.3336,0.077,0.15,-0.9692,0.47,1,1.0967,0.27,0.88
"C3_TF_targets:C3_TFT_504_RNCTGNYNRNCTGNY_UNKNOWN","C3_TF_targets","C3_TFT_504_RNCTGNYNRNCTGNY_UNKNOWN",79,-1.3335,0.08,0.067,-1.1416,0.23,0.45,-1.0837,0.31,0.59
"C3_MicroRNA_targets:C3_MIR_54_CATTTCA_MIR_203","C3_MicroRNA_targets","C3_MIR_54_CATTTCA_MIR_203",282,-1.3335,0.014,0.26,-0.7184,1,1,-1.0907,0.21,1
"GO_BP:493413_GO_0009217_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS","GO_BP","493413_GO_0009217_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS",5,-1.3335,0.15,0.22,0.6059,0.91,1,-1.4052,0.096,0.58
"REACTOME:106131_REACT_160_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS","REACTOME","106131_REACT_160_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS",6,-1.3335,0.12,0.25,1.1221,0.34,0.55,-1.4743,0.078,0.38
"GO_CC:501817_GO_0032591_DENDRITIC_SPINE_MEMBRANE","GO_CC","501817_GO_0032591_DENDRITIC_SPINE_MEMBRANE",7,-1.3334,0.14,0.28,-1.0257,0.44,0.84,1.3505,0.13,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1461_WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1461_WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN",24,-1.3333,0.11,0.15,1.0499,0.37,0.71,1.1946,0.22,0.78
"C3_TF_targets:C3_TFT_16_V_RSRFC4_01","C3_TF_targets","C3_TFT_16_V_RSRFC4_01",240,-1.333,0.014,0.067,-1.239,0.059,0.29,-1.4923,0,0.25
"GO_BP:516237_GO_0071313_CELLULAR_RESPONSE_TO_CAFFEINE","GO_BP","516237_GO_0071313_CELLULAR_RESPONSE_TO_CAFFEINE",7,-1.333,0.14,0.22,0.7685,0.74,1,-0.834,0.67,0.97
"C3_MicroRNA_targets:C3_MIR_126_CCTGCTG_MIR_214","C3_MicroRNA_targets","C3_MIR_126_CCTGCTG_MIR_214",239,-1.333,0.019,0.25,-0.9169,0.7,1,-1.1613,0.09,1
"GO_BP:510412_GO_0048305_IMMUNOGLOBULIN_SECRETION","GO_BP","510412_GO_0048305_IMMUNOGLOBULIN_SECRETION",5,-1.3328,0.13,0.22,0.9653,0.5,1,-1.3102,0.16,0.64
"REACTOME:576268_REACT_118798_PRE_NOTCH_PROCESSING_IN_GOLGI","REACTOME","576268_REACT_118798_PRE_NOTCH_PROCESSING_IN_GOLGI",18,-1.3327,0.11,0.25,-0.9061,0.63,1,0.9359,0.55,1
"WikiPathways:920962_WP1455_SEROTONIN_TRANSPORTER_ACTIVITY","WikiPathways","920962_WP1455_SEROTONIN_TRANSPORTER_ACTIVITY",10,-1.3326,0.13,0.17,-0.975,0.48,1,1.158,0.27,0.68
"C7_Immunologic_signatures:C7_ALL_1238_GSE28237_EARLY_VS_LATE_GC_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1238_GSE28237_EARLY_VS_LATE_GC_BCELL_DN",197,-1.3326,0.02,0.056,0.8674,0.81,1,-1.0879,0.24,0.52
"GO_CC:507388_GO_0044440_ENDOSOMAL_PART","GO_CC","507388_GO_0044440_ENDOSOMAL_PART",388,-1.3325,0.0095,0.28,1.0803,0.17,0.67,0.8327,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_825_MAINA_HYPOXIA_VHL_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_825_MAINA_HYPOXIA_VHL_TARGETS_UP",6,-1.3324,0.15,0.15,-0.9542,0.53,1,0.9428,0.51,1
"C3_TF_targets:C3_TFT_567_TTAYRTAA_V_E4BP4_01","C3_TF_targets","C3_TFT_567_TTAYRTAA_V_E4BP4_01",260,-1.3322,0.021,0.067,-1.3011,0.0087,0.24,-0.9823,0.5,0.8
"C7_Immunologic_signatures:C7_ALL_909_GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP","C7_Immunologic_signatures","C7_ALL_909_GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP",195,-1.3322,0.025,0.057,0.8624,0.86,1,-1.3421,0.014,0.1
"GO_MF:496311_GO_0016247_CHANNEL_REGULATOR_ACTIVITY","GO_MF","496311_GO_0016247_CHANNEL_REGULATOR_ACTIVITY",119,-1.3322,0.049,0.27,-1.1378,0.19,0.8,-1.0604,0.3,0.74
"KEGG_pathway:HSA04150_MTOR_SIGNALING_PATHWAY","KEGG_pathway","HSA04150_MTOR_SIGNALING_PATHWAY",59,-1.3322,0.067,0.11,0.804,0.82,1,-0.8381,0.78,0.9
"GO_BP:492038_GO_0007259_JAK_STAT_CASCADE","GO_BP","492038_GO_0007259_JAK_STAT_CASCADE",53,-1.3322,0.078,0.22,0.7241,0.93,1,0.7243,0.93,1
"GO_BP:487734_GO_0001838_EMBRYONIC_EPITHELIAL_TUBE_FORMATION","GO_BP","487734_GO_0001838_EMBRYONIC_EPITHELIAL_TUBE_FORMATION",117,-1.3322,0.043,0.22,-0.7388,0.97,1,0.9267,0.61,0.92
"C7_Immunologic_signatures:C7_ALL_993_GSE22886_NAIVE_CD4_TCELL_VS_DC_UP","C7_Immunologic_signatures","C7_ALL_993_GSE22886_NAIVE_CD4_TCELL_VS_DC_UP",196,-1.3321,0.036,0.057,1.3248,0.021,0.081,-1.815,0,0.00012
"GO_BP:514096_GO_0060541_RESPIRATORY_SYSTEM_DEVELOPMENT","GO_BP","514096_GO_0060541_RESPIRATORY_SYSTEM_DEVELOPMENT",206,-1.332,0.034,0.22,-0.8484,0.88,1,1.313,0.013,0.66
"GO_MF:489641_GO_0004175_ENDOPEPTIDASE_ACTIVITY","GO_MF","489641_GO_0004175_ENDOPEPTIDASE_ACTIVITY",395,-1.3319,0.011,0.27,0.9031,0.84,0.98,0.9175,0.76,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_2465_BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2465_BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP",38,-1.3319,0.1,0.15,0.773,0.85,1,0.5944,0.99,1
"GO_BP:507575_GO_0045197_ESTABLISHMENT_OR_MAINTENANCE_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY","GO_BP","507575_GO_0045197_ESTABLISHMENT_OR_MAINTENANCE_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY",25,-1.3319,0.11,0.22,1.1574,0.24,0.83,-1.6541,0.008,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_2728_CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2728_CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN",24,-1.3317,0.12,0.15,-1.1789,0.21,0.82,-1.0542,0.36,0.68
"KEGG_compound:C00954_INDOLE_3_ACETATE_INDOLE_3_ACETIC_ACID_INDOL_3_YL_ACETATE_INDOLEACETATE_INDOLEACETIC_ACID_IAA","KEGG_compound","C00954_INDOLE_3_ACETATE_INDOLE_3_ACETIC_ACID_INDOL_3_YL_ACETATE_INDOLEACETATE_INDOLEACETIC_ACID_IAA",5,-1.3317,0.14,0.3,0.7121,0.84,1,-1.2144,0.28,0.43
"C7_Immunologic_signatures:C7_ALL_1388_GSE339_CD8POS_VS_CD4CD8DN_DC_DN","C7_Immunologic_signatures","C7_ALL_1388_GSE339_CD8POS_VS_CD4CD8DN_DC_DN",198,-1.3315,0.018,0.057,0.6536,1,1,1.1588,0.14,0.83
"KEGG_compound:C00877_CROTONOYL_COA_CROTONYL_COA_2_BUTENOYL_COA_TRANS_BUT_2_ENOYL_COA_BUT_2_ENOYL_COA_E_BUT_2_ENOYL_COA","KEGG_compound","C00877_CROTONOYL_COA_CROTONYL_COA_2_BUTENOYL_COA_TRANS_BUT_2_ENOYL_COA_BUT_2_ENOYL_COA_E_BUT_2_ENOYL_COA",9,-1.3313,0.15,0.3,0.5261,0.99,1,-1.7455,0.0079,0.055
"GO_MF:490184_GO_0004887_THYROID_HORMONE_RECEPTOR_ACTIVITY","GO_MF","490184_GO_0004887_THYROID_HORMONE_RECEPTOR_ACTIVITY",7,-1.3312,0.14,0.27,-1.0856,0.37,0.85,-1.274,0.21,0.58
"GO_BP:487883_GO_0001993_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_NOREPINEPHRINE_EPINEPHRINE","GO_BP","487883_GO_0001993_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_NOREPINEPHRINE_EPINEPHRINE",9,-1.3312,0.15,0.22,0.893,0.59,1,-0.7324,0.79,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2369_BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2369_BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP",119,-1.3312,0.043,0.15,-0.8123,0.89,1,-0.9085,0.65,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_912_CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_912_CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN",5,-1.3311,0.16,0.15,-0.8156,0.68,1,0.6924,0.82,1
"GO_BP:755329_GO_2001223_NEGATIVE_REGULATION_OF_NEURON_MIGRATION","GO_BP","755329_GO_2001223_NEGATIVE_REGULATION_OF_NEURON_MIGRATION",7,-1.3311,0.13,0.22,-1.0599,0.38,0.96,-0.6334,0.91,1
"GO_BP:507702_GO_0045345_POSITIVE_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS","GO_BP","507702_GO_0045345_POSITIVE_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS",5,-1.331,0.16,0.22,1.0634,0.4,0.94,-1.3532,0.15,0.6
"KEGG_compound:C05581_3_METHOXY_4_HYDROXYPHENYLACETALDEHYDE_4_HYDROXY_3_METHOXYPHENYL_ACETALDEHYDE_HOMOVANILLIN","KEGG_compound","C05581_3_METHOXY_4_HYDROXYPHENYLACETALDEHYDE_4_HYDROXY_3_METHOXYPHENYL_ACETALDEHYDE_HOMOVANILLIN",6,-1.331,0.14,0.3,0.911,0.56,1,-1.1911,0.28,0.46
"GO_MF:510201_GO_0048037_COFACTOR_BINDING","GO_MF","510201_GO_0048037_COFACTOR_BINDING",255,-1.331,0.021,0.27,-0.7883,0.97,1,-1.4748,0.0022,0.43
"GO_CC:502062_GO_0032839_DENDRITE_CYTOPLASM","GO_CC","502062_GO_0032839_DENDRITE_CYTOPLASM",16,-1.331,0.12,0.28,0.974,0.49,0.82,-0.9545,0.53,1
"GO_CC:487149_GO_0000922_SPINDLE_POLE","GO_CC","487149_GO_0000922_SPINDLE_POLE",118,-1.331,0.058,0.28,0.7244,0.99,0.99,-1.6388,0,0.4
"GO_CC:500430_GO_0031143_PSEUDOPODIUM","GO_CC","500430_GO_0031143_PSEUDOPODIUM",16,-1.331,0.13,0.28,0.963,0.51,0.82,0.6435,0.95,1
"GO_MF:489498_GO_0004029_ALDEHYDE_DEHYDROGENASE_NAD_ACTIVITY","GO_MF","489498_GO_0004029_ALDEHYDE_DEHYDROGENASE_NAD_ACTIVITY",18,-1.331,0.12,0.27,0.9108,0.58,0.98,-1.1431,0.25,0.65
"WikiPathways:198836_WP313_SIGNALING_OF_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR","WikiPathways","198836_WP313_SIGNALING_OF_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR",33,-1.331,0.1,0.17,0.6522,0.96,1,-0.6098,0.98,0.99
"GO_BP:501747_GO_0032516_POSITIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY","GO_BP","501747_GO_0032516_POSITIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY",13,-1.3309,0.15,0.22,0.8544,0.65,1,-1.0055,0.45,0.84
"C4_Cancer_gene_neighborhoods:C4_CGN_382_GNF2_MMP11","C4_Cancer_gene_neighborhoods","C4_CGN_382_GNF2_MMP11",35,-1.3308,0.091,0.18,1.1253,0.26,0.33,1.3505,0.081,0.28
"C7_Immunologic_signatures:C7_ALL_533_GSE17721_LPS_VS_POLYIC_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_533_GSE17721_LPS_VS_POLYIC_4H_BMDM_UP",198,-1.3307,0.019,0.057,1.4539,0,0.021,0.7315,1,1
"REACTOME:576260_REACT_118659_RORA_ACTIVATES_GENE_EXPRESSION","REACTOME","576260_REACT_118659_RORA_ACTIVATES_GENE_EXPRESSION",27,-1.3307,0.1,0.25,-0.9611,0.52,1,-0.946,0.53,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_2643_MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED","C2_Chemical_and_genetic_perturbations","C2_CGP_2643_MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED",34,-1.3307,0.11,0.15,0.8899,0.62,0.94,-1.2433,0.14,0.48
"C6_Oncogenic_signatures:C6_ALL_109_PTEN_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_109_PTEN_DN_V1_DN",178,-1.3306,0.035,0.064,1.2587,0.045,0.38,1.0955,0.21,0.38
"C7_Immunologic_signatures:C7_ALL_1534_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN","C7_Immunologic_signatures","C7_ALL_1534_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN",199,-1.3306,0.019,0.057,0.8686,0.85,1,-0.9367,0.65,0.88
"GO_BP:517018_GO_0072102_GLOMERULUS_MORPHOGENESIS","GO_BP","517018_GO_0072102_GLOMERULUS_MORPHOGENESIS",8,-1.3304,0.14,0.22,-1.2369,0.19,0.9,1.5154,0.064,0.55
"C7_Immunologic_signatures:C7_ALL_487_GSE17721_CTRL_VS_PAM3CSK4_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_487_GSE17721_CTRL_VS_PAM3CSK4_6H_BMDM_UP",198,-1.3304,0.028,0.058,1.3893,0,0.041,-1.1546,0.13,0.36
"C1_Positional:C1_ALL_222_CHR21Q11","C1_Positional","C1_ALL_222_CHR21Q11",15,-1.3303,0.12,0.59,0.9833,0.47,0.78,1.4751,0.064,0.31
"C7_Immunologic_signatures:C7_ALL_486_GSE17721_CTRL_VS_PAM3CSK4_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_486_GSE17721_CTRL_VS_PAM3CSK4_4H_BMDM_DN",196,-1.3303,0.036,0.058,-0.9093,0.71,1,-0.6898,1,1
"GO_BP:754749_GO_1901798_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR","GO_BP","754749_GO_1901798_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",19,-1.3301,0.15,0.22,-0.6875,0.9,1,-1.3146,0.13,0.64
"C1_Positional:C1_ALL_162_CHR2P13","C1_Positional","C1_ALL_162_CHR2P13",73,-1.33,0.072,0.57,-1.1106,0.26,1,-1.1781,0.17,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_586_TAKAYAMA_BOUND_BY_AR","C2_Chemical_and_genetic_perturbations","C2_CGP_586_TAKAYAMA_BOUND_BY_AR",10,-1.3299,0.14,0.15,0.9757,0.48,0.82,-0.7628,0.78,0.97
"REACTOME:106407_REACT_8012_CREATION_OF_C4_AND_C2_ACTIVATORS","REACTOME","106407_REACT_8012_CREATION_OF_C4_AND_C2_ACTIVATORS",11,-1.3299,0.15,0.25,1.3738,0.14,0.25,-0.9218,0.58,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1533_AFFAR_YY1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1533_AFFAR_YY1_TARGETS_UP",209,-1.3299,0.025,0.15,1.0796,0.27,0.66,-0.946,0.63,0.83
"C7_Immunologic_signatures:C7_ALL_535_GSE17721_LPS_VS_POLYIC_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_535_GSE17721_LPS_VS_POLYIC_6H_BMDM_UP",198,-1.3298,0.031,0.058,1.32,0.026,0.085,0.8105,0.94,1
"GO_BP:507350_GO_0044344_CELLULAR_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR_STIMULUS","GO_BP","507350_GO_0044344_CELLULAR_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR_STIMULUS",181,-1.3298,0.024,0.22,-0.9489,0.61,1,-1.0373,0.35,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_2632_HSIAO_HOUSEKEEPING_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_2632_HSIAO_HOUSEKEEPING_GENES",389,-1.3295,0.0074,0.15,3.0159,0,0,-0.6077,1,0.99
"GO_BP:493861_GO_0009749_RESPONSE_TO_GLUCOSE","GO_BP","493861_GO_0009749_RESPONSE_TO_GLUCOSE",107,-1.3295,0.053,0.22,0.8964,0.71,1,1.0408,0.34,0.82
"GO_BP:487774_GO_0001878_RESPONSE_TO_YEAST","GO_BP","487774_GO_0001878_RESPONSE_TO_YEAST",5,-1.3294,0.14,0.22,0.8427,0.66,1,-0.8839,0.61,0.94
"C6_Oncogenic_signatures:C6_ALL_84_CTIP_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_84_CTIP_DN_V1_UP",122,-1.3293,0.042,0.064,-1.1516,0.2,0.48,-1.308,0.053,0.29
"GO_BP:505612_GO_0042475_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH","GO_BP","505612_GO_0042475_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH",72,-1.3292,0.074,0.22,-1.007,0.46,0.98,1.1757,0.19,0.72
"C7_Immunologic_signatures:C7_ALL_784_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0_5H_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_784_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0_5H_CD4_TCELL_DN",188,-1.329,0.029,0.058,-0.9343,0.64,1,-0.922,0.66,0.91
"GO_MF:489960_GO_0004630_PHOSPHOLIPASE_D_ACTIVITY","GO_MF","489960_GO_0004630_PHOSPHOLIPASE_D_ACTIVITY",6,-1.3289,0.16,0.28,-0.4786,0.99,1,1.089,0.35,0.81
"C4_Cancer_modules:C4_CM_375_MODULE_459","C4_Cancer_modules","C4_CM_375_MODULE_459",422,-1.3288,0.0063,0.15,0.9656,0.6,0.76,0.9361,0.7,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1043_BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1043_BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN",46,-1.3287,0.09,0.15,1.0224,0.41,0.77,0.9364,0.56,1
"GO_BP:518658_GO_2000009_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE","GO_BP","518658_GO_2000009_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE",9,-1.3287,0.16,0.22,-1.3331,0.14,0.91,-1.5306,0.045,0.53
"GO_BP:508869_GO_0046621_NEGATIVE_REGULATION_OF_ORGAN_GROWTH","GO_BP","508869_GO_0046621_NEGATIVE_REGULATION_OF_ORGAN_GROWTH",23,-1.3287,0.1,0.22,-0.788,0.81,1,0.8798,0.66,0.95
"GO_BP:495019_GO_0010954_POSITIVE_REGULATION_OF_PROTEIN_PROCESSING","GO_BP","495019_GO_0010954_POSITIVE_REGULATION_OF_PROTEIN_PROCESSING",17,-1.3286,0.13,0.22,-1.4109,0.073,0.96,-0.9315,0.54,0.9
"GO_BP:508029_GO_0045684_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT","GO_BP","508029_GO_0045684_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT",29,-1.3286,0.1,0.22,-1.2496,0.16,0.91,-0.6633,0.94,1
"C4_Cancer_modules:C4_CM_406_MODULE_522","C4_Cancer_modules","C4_CM_406_MODULE_522",33,-1.3286,0.097,0.15,-0.7837,0.83,0.98,-0.6189,0.98,1
"C1_Positional:C1_ALL_124_CHR12Q12","C1_Positional","C1_ALL_124_CHR12Q12",58,-1.3285,0.075,0.56,-0.9524,0.53,1,0.9211,0.59,0.83
"KEGG_compound:C05265_3_OXODECANOYL_COA","KEGG_compound","C05265_3_OXODECANOYL_COA",6,-1.3285,0.15,0.3,0.82,0.66,1,-1.1884,0.26,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_1196_NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1196_NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON",13,-1.3284,0.14,0.15,-0.9984,0.46,1,-1.3267,0.12,0.41
"GO_BP:496145_GO_0016045_DETECTION_OF_BACTERIUM","GO_BP","496145_GO_0016045_DETECTION_OF_BACTERIUM",15,-1.3282,0.13,0.22,0.9233,0.56,1,1.0377,0.41,0.82
"GO_MF:498056_GO_0019201_NUCLEOTIDE_KINASE_ACTIVITY","GO_MF","498056_GO_0019201_NUCLEOTIDE_KINASE_ACTIVITY",24,-1.3281,0.12,0.28,-1.1563,0.24,0.81,-1.1081,0.3,0.7
"GO_MF:752378_GO_0086006_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL","GO_MF","752378_GO_0086006_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",5,-1.3281,0.13,0.28,-1.4825,0.063,0.59,-0.7499,0.77,0.99
"C3_TF_targets:C3_TFT_38_V_TAL1BETAE47_01","C3_TF_targets","C3_TFT_38_V_TAL1BETAE47_01",241,-1.328,0.021,0.07,-1.2266,0.053,0.3,-0.9232,0.71,0.88
"GO_CC:503587_GO_0034385_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE","GO_CC","503587_GO_0034385_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE",20,-1.328,0.12,0.28,0.7956,0.78,0.96,1.1697,0.24,0.81
"GO_MF:502975_GO_0033764_STEROID_DEHYDROGENASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR","GO_MF","502975_GO_0033764_STEROID_DEHYDROGENASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR",23,-1.3279,0.11,0.28,1.4521,0.059,0.43,-1.1806,0.25,0.6
"GO_BP:498346_GO_0019511_PEPTIDYL_PROLINE_HYDROXYLATION","GO_BP","498346_GO_0019511_PEPTIDYL_PROLINE_HYDROXYLATION",13,-1.3279,0.15,0.22,-0.9828,0.47,1,-1.3854,0.11,0.59
"GO_BP:499491_GO_0030032_LAMELLIPODIUM_ASSEMBLY","GO_BP","499491_GO_0030032_LAMELLIPODIUM_ASSEMBLY",33,-1.3278,0.1,0.22,0.8264,0.75,1,-0.5335,1,1
"GO_BP:486733_GO_0000212_MEIOTIC_SPINDLE_ORGANIZATION","GO_BP","486733_GO_0000212_MEIOTIC_SPINDLE_ORGANIZATION",7,-1.3278,0.12,0.22,-0.9787,0.47,1,-1.3933,0.11,0.58
"GO_CC:490906_GO_0005905_COATED_PIT","GO_CC","490906_GO_0005905_COATED_PIT",64,-1.3278,0.074,0.28,0.7153,0.95,0.99,0.7248,0.94,1
"GO_CC:506122_GO_0043034_COSTAMERE","GO_CC","506122_GO_0043034_COSTAMERE",19,-1.3276,0.12,0.28,-1.3402,0.12,0.62,-1.0585,0.38,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1553_DORSEY_GAB2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1553_DORSEY_GAB2_TARGETS",30,-1.3276,0.12,0.15,1.0728,0.35,0.67,1.2083,0.2,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_1661_RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1661_RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN",40,-1.3275,0.097,0.15,1.14,0.25,0.57,-1.1478,0.25,0.58
"KEGG_compound:C00206_DADP_2_DEOXYADENOSINE_5_DIPHOSPHATE","KEGG_compound","C00206_DADP_2_DEOXYADENOSINE_5_DIPHOSPHATE",23,-1.3274,0.11,0.3,-0.7992,0.78,1,-1.14,0.25,0.51
"GO_BP:502429_GO_0033209_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY","GO_BP","502429_GO_0033209_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY",29,-1.3274,0.12,0.22,-0.5774,0.99,1,-0.9477,0.53,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_759_XU_AKT1_TARGETS_48HR","C2_Chemical_and_genetic_perturbations","C2_CGP_759_XU_AKT1_TARGETS_48HR",9,-1.3274,0.14,0.15,0.5812,0.94,1,0.8036,0.71,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2288_MOSERLE_IFNA_RESPONSE","C2_Chemical_and_genetic_perturbations","C2_CGP_2288_MOSERLE_IFNA_RESPONSE",31,-1.3273,0.12,0.15,2.1962,0,0.00059,-1.8015,0,0.13
"REACTOME:106474_REACT_12464_PI3K_AKT_ACTIVATION","REACTOME","106474_REACT_12464_PI3K_AKT_ACTIVATION",94,-1.3273,0.06,0.26,-1.1548,0.19,0.85,-0.9285,0.63,0.93
"C7_Immunologic_signatures:C7_ALL_718_GSE17721_0_5H_VS_12H_POLYIC_BMDM_DN","C7_Immunologic_signatures","C7_ALL_718_GSE17721_0_5H_VS_12H_POLYIC_BMDM_DN",199,-1.3271,0.019,0.06,-0.9165,0.69,1,-1.2441,0.052,0.2
"C2_Chemical_and_genetic_perturbations:C2_CGP_649_RASHI_RESPONSE_TO_IONIZING_RADIATION_5","C2_Chemical_and_genetic_perturbations","C2_CGP_649_RASHI_RESPONSE_TO_IONIZING_RADIATION_5",146,-1.3271,0.039,0.15,0.7812,0.97,1,-0.9325,0.64,0.84
"C3_MicroRNA_targets:C3_MIR_204_CTTTGCA_MIR_527","C3_MicroRNA_targets","C3_MIR_204_CTTTGCA_MIR_527",231,-1.327,0.02,0.26,-1.1152,0.19,1,-1.1779,0.12,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2042_HOWLIN_CITED1_TARGETS_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2042_HOWLIN_CITED1_TARGETS_1_DN",37,-1.327,0.096,0.15,1.2757,0.12,0.42,-0.6957,0.93,0.99
"C7_Immunologic_signatures:C7_ALL_1463_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP","C7_Immunologic_signatures","C7_ALL_1463_GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP",193,-1.3269,0.03,0.06,-0.6515,1,1,-1.4264,0.0021,0.045
"C3_MicroRNA_targets:C3_MIR_25_TACTTGA_MIR_26A_MIR_26B","C3_MicroRNA_targets","C3_MIR_25_TACTTGA_MIR_26A_MIR_26B",299,-1.3268,0.014,0.25,0.8287,0.95,1,0.883,0.86,1
"C7_Immunologic_signatures:C7_ALL_1446_GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN","C7_Immunologic_signatures","C7_ALL_1446_GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN",193,-1.3264,0.031,0.06,-1.0901,0.26,1,-0.9265,0.68,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2235_MCCABE_HOXC6_TARGETS_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2235_MCCABE_HOXC6_TARGETS_CANCER_DN",20,-1.3264,0.1,0.16,-0.7884,0.78,1,-1.3337,0.1,0.41
"C4_Cancer_modules:C4_CM_322_MODULE_378","C4_Cancer_modules","C4_CM_322_MODULE_378",426,-1.3264,0.011,0.15,0.9632,0.58,0.76,0.9306,0.72,0.95
"C6_Oncogenic_signatures:C6_ALL_25_AKT_UP_MTOR_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_25_AKT_UP_MTOR_DN_V1_DN",174,-1.3263,0.033,0.065,0.9027,0.77,0.97,0.974,0.52,0.63
"GO_BP:494835_GO_0010770_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION","GO_BP","494835_GO_0010770_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION",136,-1.3263,0.054,0.23,-1.0821,0.28,0.95,0.877,0.77,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_3087_FIGUEROA_AML_METHYLATION_CLUSTER_5_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3087_FIGUEROA_AML_METHYLATION_CLUSTER_5_DN",48,-1.3262,0.085,0.16,1.3612,0.058,0.33,-0.9685,0.5,0.8
"GO_BP:508721_GO_0046460_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS","GO_BP","508721_GO_0046460_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS",45,-1.3262,0.077,0.23,-0.5779,0.99,1,-1.3096,0.11,0.64
"GO_MF:490187_GO_0004890_GABA_A_RECEPTOR_ACTIVITY","GO_MF","490187_GO_0004890_GABA_A_RECEPTOR_ACTIVITY",17,-1.3261,0.13,0.28,-1.2184,0.21,0.83,1.9338,0,0.037
"KEGG_compound:C11132_2_METHOXYESTRONE_3_GLUCURONIDE","KEGG_compound","C11132_2_METHOXYESTRONE_3_GLUCURONIDE",19,-1.3261,0.13,0.3,1.929,0,0.018,2.4031,0,0
"GO_BP:500359_GO_0031069_HAIR_FOLLICLE_MORPHOGENESIS","GO_BP","500359_GO_0031069_HAIR_FOLLICLE_MORPHOGENESIS",29,-1.3261,0.1,0.23,-1.1441,0.26,0.93,0.7001,0.92,1
"GO_BP:517080_GO_0072164_MESONEPHRIC_TUBULE_DEVELOPMENT","GO_BP","517080_GO_0072164_MESONEPHRIC_TUBULE_DEVELOPMENT",87,-1.326,0.064,0.23,-0.8954,0.7,1,1.387,0.036,0.63
"GO_MF:511634_GO_0050662_COENZYME_BINDING","GO_MF","511634_GO_0050662_COENZYME_BINDING",180,-1.326,0.026,0.28,0.7269,1,1,-1.5821,0.0021,0.36
"C7_Immunologic_signatures:C7_ALL_1885_GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1885_GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP",198,-1.326,0.025,0.06,1.4762,0.0048,0.016,2.3686,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_960_OHM_EMBRYONIC_CARCINOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_960_OHM_EMBRYONIC_CARCINOMA_UP",6,-1.326,0.15,0.16,-0.6029,0.92,1,0.6232,0.9,1
"GO_MF:499652_GO_0030247_POLYSACCHARIDE_BINDING","GO_MF","499652_GO_0030247_POLYSACCHARIDE_BINDING",19,-1.3259,0.11,0.28,-0.9493,0.5,0.94,-1.2543,0.16,0.59
"KEGG_pathway:HSA00601_GLYCOSPHINGOLIPID_BIOSYNTHESIS","KEGG_pathway","HSA00601_GLYCOSPHINGOLIPID_BIOSYNTHESIS",26,-1.3259,0.11,0.11,0.7464,0.87,1,0.6932,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1024_GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1024_GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP",21,-1.3258,0.14,0.16,1.2133,0.18,0.48,1.8204,0.0059,0.24
"WikiPathways:198897_WP24_PEPTIDE_GPCRS","WikiPathways","198897_WP24_PEPTIDE_GPCRS",72,-1.3258,0.084,0.17,1.3176,0.051,0.65,1.6997,0.0039,0.15
"C2_Chemical_and_genetic_perturbations:C2_CGP_459_GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_459_GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP",227,-1.3258,0.039,0.16,-1.0139,0.41,0.98,-1.0014,0.43,0.75
"GO_BP:490965_GO_0005977_GLYCOGEN_METABOLIC_PROCESS","GO_BP","490965_GO_0005977_GLYCOGEN_METABOLIC_PROCESS",58,-1.3258,0.085,0.23,0.8715,0.71,1,-1.1789,0.18,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_2762_MEISSNER_NPC_HCP_WITH_H3K4ME2","C2_Chemical_and_genetic_perturbations","C2_CGP_2762_MEISSNER_NPC_HCP_WITH_H3K4ME2",473,-1.3257,0.0073,0.16,-1.2565,0.015,0.74,1.1544,0.076,0.83
"C4_Cancer_gene_neighborhoods:C4_CGN_210_GCM_AQP4","C4_Cancer_gene_neighborhoods","C4_CGN_210_GCM_AQP4",44,-1.3254,0.09,0.19,-0.8383,0.74,1,-1.1667,0.23,0.49
"GO_BP:513521_GO_0055088_LIPID_HOMEOSTASIS","GO_BP","513521_GO_0055088_LIPID_HOMEOSTASIS",99,-1.3253,0.075,0.23,-0.7166,0.98,1,1.2979,0.055,0.67
"REACTOME:187191_REACT_25060_IRON_UPTAKE_AND_TRANSPORT","REACTOME","187191_REACT_25060_IRON_UPTAKE_AND_TRANSPORT",42,-1.3253,0.096,0.26,0.862,0.69,0.94,1.0436,0.36,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2658_CROONQUIST_IL6_DEPRIVATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2658_CROONQUIST_IL6_DEPRIVATION_UP",20,-1.3252,0.12,0.16,1.0855,0.33,0.65,-1.0289,0.4,0.71
"KEGG_compound:C15972_ENZYME_N6_LIPOYL_LYSINE_LIPOAMIDE_E","KEGG_compound","C15972_ENZYME_N6_LIPOYL_LYSINE_LIPOAMIDE_E",8,-1.3252,0.15,0.3,1.316,0.17,0.71,-1.4591,0.071,0.25
"C4_Cancer_gene_neighborhoods:C4_CGN_103_MORF_FOSL1","C4_Cancer_gene_neighborhoods","C4_CGN_103_MORF_FOSL1",395,-1.3251,0.0094,0.18,-1.1547,0.11,0.66,0.9506,0.64,0.94
"C3_MicroRNA_targets:C3_MIR_61_AGGGCAG_MIR_18A","C3_MicroRNA_targets","C3_MIR_61_AGGGCAG_MIR_18A",135,-1.3249,0.041,0.25,-1.0267,0.39,1,1.2666,0.07,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_2736_HOSHIDA_LIVER_CANCER_SURVIVAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2736_HOSHIDA_LIVER_CANCER_SURVIVAL_DN",113,-1.3248,0.05,0.16,1.1502,0.16,0.56,-1.0379,0.38,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_35_BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_35_BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP",201,-1.3248,0.025,0.16,0.8309,0.93,0.98,-1.3056,0.025,0.42
"C3_TF_targets:C3_TFT_281_V_TBP_01","C3_TF_targets","C3_TFT_281_V_TBP_01",229,-1.3246,0.023,0.073,-1.0191,0.38,0.72,-0.967,0.56,0.81
"GO_BP:492363_GO_0007622_RHYTHMIC_BEHAVIOR","GO_BP","492363_GO_0007622_RHYTHMIC_BEHAVIOR",17,-1.3245,0.13,0.23,-0.9913,0.45,1,-0.784,0.78,1
"C3_MicroRNA_targets:C3_MIR_60_CTATGCA_MIR_153","C3_MicroRNA_targets","C3_MIR_60_CTATGCA_MIR_153",215,-1.3245,0.03,0.25,-0.9459,0.6,1,-0.9879,0.48,1
"C3_MicroRNA_targets:C3_MIR_51_ACAACTT_MIR_382","C3_MicroRNA_targets","C3_MIR_51_ACAACTT_MIR_382",71,-1.3245,0.077,0.24,-0.6243,1,1,-0.9697,0.49,1
"KEGG_reaction:R05050_N4_ACETYLAMINOBUTANAL_NAD_OXIDOREDUCTASE_N4_ACETYLAMINOBUTANAL_NAD_H2O_4_ACETAMIDOBUTANOATE_NADH_H_","KEGG_reaction","R05050_N4_ACETYLAMINOBUTANAL_NAD_OXIDOREDUCTASE_N4_ACETYLAMINOBUTANAL_NAD_H2O_4_ACETAMIDOBUTANOATE_NADH_H_",5,-1.3244,0.14,0.3,0.7031,0.84,1,-1.264,0.22,0.47
"C7_Immunologic_signatures:C7_ALL_685_GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_685_GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDM_UP",198,-1.3243,0.021,0.062,0.9068,0.76,1,0.9445,0.62,1
"WikiPathways:198788_WP707_DNA_DAMAGE_RESPONSE","WikiPathways","198788_WP707_DNA_DAMAGE_RESPONSE",67,-1.3242,0.072,0.17,-0.8621,0.73,1,-1.5857,0.006,0.3
"C3_TF_targets:C3_TFT_319_V_NERF_Q2","C3_TF_targets","C3_TFT_319_V_NERF_Q2",247,-1.3241,0.021,0.073,-0.9997,0.44,0.76,0.7954,0.99,1
"GO_BP:491622_GO_0006739_NADP_METABOLIC_PROCESS","GO_BP","491622_GO_0006739_NADP_METABOLIC_PROCESS",29,-1.3241,0.093,0.23,-0.9619,0.5,1,-1.0314,0.4,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_226_BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_226_BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP",30,-1.324,0.11,0.16,-1.0324,0.37,0.97,0.5844,0.99,1
"GO_BP:495295_GO_0014904_MYOTUBE_CELL_DEVELOPMENT","GO_BP","495295_GO_0014904_MYOTUBE_CELL_DEVELOPMENT",21,-1.324,0.13,0.23,-1.2523,0.18,0.91,-1.4211,0.066,0.57
"C3_MicroRNA_targets:C3_MIR_197_ACACTAC_MIR_142_3P","C3_MicroRNA_targets","C3_MIR_197_ACACTAC_MIR_142_3P",130,-1.324,0.05,0.24,-0.7758,0.95,1,0.6564,1,1
"GO_BP:504490_GO_0035306_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION","GO_BP","504490_GO_0035306_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION",40,-1.3239,0.09,0.23,0.7458,0.89,1,-0.6915,0.93,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_282_LEE_NEURAL_CREST_STEM_CELL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_282_LEE_NEURAL_CREST_STEM_CELL_DN",114,-1.3237,0.067,0.16,-1.0361,0.37,0.98,1.001,0.45,0.96
"GO_BP:512736_GO_0051881_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL","GO_BP","512736_GO_0051881_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL",35,-1.3237,0.1,0.23,1.0555,0.34,0.94,-1.3089,0.095,0.64
"REACTOME:106139_REACT_17062_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS","REACTOME","106139_REACT_17062_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS",6,-1.3236,0.15,0.26,0.4703,0.99,1,-1.4667,0.076,0.37
"C2_Chemical_and_genetic_perturbations:C2_CGP_2407_HUANG_DASATINIB_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2407_HUANG_DASATINIB_RESISTANCE_DN",67,-1.3236,0.078,0.16,-0.6719,0.98,1,-0.8723,0.74,0.91
"GO_MF:501791_GO_0032561_GUANYL_RIBONUCLEOTIDE_BINDING","GO_MF","501791_GO_0032561_GUANYL_RIBONUCLEOTIDE_BINDING",380,-1.3236,0.012,0.28,0.9372,0.75,0.94,-1.3038,0.013,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1248_ROZANOV_MMP14_TARGETS_SUBSET","C2_Chemical_and_genetic_perturbations","C2_CGP_1248_ROZANOV_MMP14_TARGETS_SUBSET",33,-1.3236,0.085,0.16,0.7472,0.89,1,0.9074,0.64,1
"GO_MF:490642_GO_0005547_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING","GO_MF","490642_GO_0005547_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING",34,-1.3235,0.099,0.28,-0.95,0.54,0.95,-1.0851,0.31,0.7
"KEGG_module:HSA_M00695_CAMP_SIGNALING","KEGG_module","HSA_M00695_CAMP_SIGNALING",14,-1.3233,0.14,0.41,-0.598,0.98,1,-1.2715,0.18,0.48
"C3_TF_targets:C3_TFT_500_MCAATNNNNNGCG_UNKNOWN","C3_TF_targets","C3_TFT_500_MCAATNNNNNGCG_UNKNOWN",82,-1.3233,0.067,0.073,-0.8368,0.79,1,-0.8217,0.84,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1908_XU_GH1_EXOGENOUS_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1908_XU_GH1_EXOGENOUS_TARGETS_DN",113,-1.3232,0.058,0.16,1.1717,0.16,0.53,-1.4288,0.019,0.33
"GO_BP:499701_GO_0030299_INTESTINAL_CHOLESTEROL_ABSORPTION","GO_BP","499701_GO_0030299_INTESTINAL_CHOLESTEROL_ABSORPTION",8,-1.3232,0.13,0.23,-1.8271,0.004,0.42,1.2936,0.18,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_2882_ZHAN_MULTIPLE_MYELOMA_LB_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2882_ZHAN_MULTIPLE_MYELOMA_LB_DN",41,-1.3231,0.091,0.16,0.8103,0.8,0.98,-1.1632,0.22,0.56
"C7_Immunologic_signatures:C7_ALL_1352_GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1352_GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN",200,-1.3231,0.03,0.062,0.8316,0.93,1,-1.325,0.018,0.11
"REACTOME:106242_REACT_17004_CHAPERONIN_MEDIATED_PROTEIN_FOLDING","REACTOME","106242_REACT_17004_CHAPERONIN_MEDIATED_PROTEIN_FOLDING",49,-1.323,0.098,0.26,1.115,0.25,0.56,-1.1655,0.19,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1592_PETROVA_PROX1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1592_PETROVA_PROX1_TARGETS_UP",28,-1.323,0.11,0.16,-0.7755,0.82,1,-1.3193,0.11,0.41
"GO_BP:508219_GO_0045912_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS","GO_BP","508219_GO_0045912_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS",49,-1.3226,0.083,0.23,-0.5548,1,1,0.9385,0.58,0.91
"OMIM_gene:OMIM609916_5_AZACYTIDINE_INDUCED_GENE_2_MOUSE_HOMOLOG_OF_AZI2","OMIM_gene","OMIM609916_5_AZACYTIDINE_INDUCED_GENE_2_MOUSE_HOMOLOG_OF_AZI2",10,-1.3226,0.13,1,-0.6922,0.86,0.94,-1.1828,0.27,1
"GO_BP:516990_GO_0072073_KIDNEY_EPITHELIUM_DEVELOPMENT","GO_BP","516990_GO_0072073_KIDNEY_EPITHELIUM_DEVELOPMENT",125,-1.3224,0.047,0.23,-0.9298,0.61,1,1.1524,0.18,0.73
"C7_Immunologic_signatures:C7_ALL_412_GSE15930_STIM_VS_STIM_AND_IL_12_24H_CD8_T_CELL_DN","C7_Immunologic_signatures","C7_ALL_412_GSE15930_STIM_VS_STIM_AND_IL_12_24H_CD8_T_CELL_DN",193,-1.3224,0.037,0.063,1.0175,0.4,0.69,0.9,0.73,1
"GO_BP:750930_GO_0036005_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR","GO_BP","750930_GO_0036005_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR",7,-1.3223,0.14,0.23,0.8481,0.65,1,1.1457,0.31,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_3076_DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3076_DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP",319,-1.3223,0.02,0.16,-0.6841,1,1,-1.8327,0,0.097
"C7_Immunologic_signatures:C7_ALL_7_KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_7_KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP",199,-1.3223,0.044,0.063,2.2816,0,0,-1.1407,0.16,0.39
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_100_BIOCARTA_IL22BP_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_100_BIOCARTA_IL22BP_PATHWAY",16,-1.3222,0.13,0.24,-0.8007,0.74,1,-1.1865,0.25,0.57
"GO_BP:511969_GO_0051044_POSITIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS","GO_BP","511969_GO_0051044_POSITIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS",15,-1.3222,0.14,0.23,-1.0491,0.4,0.97,-0.819,0.73,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_546_MAHADEVAN_IMATINIB_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_546_MAHADEVAN_IMATINIB_RESISTANCE_UP",19,-1.3221,0.13,0.16,-1.2007,0.22,0.8,-0.8212,0.71,0.94
"C7_Immunologic_signatures:C7_ALL_1180_GSE27786_BCELL_VS_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1180_GSE27786_BCELL_VS_CD8_TCELL_DN",195,-1.322,0.026,0.063,0.8674,0.85,1,-1.1512,0.13,0.37
"GO_BP:508084_GO_0045745_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY","GO_BP","508084_GO_0045745_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY",18,-1.3219,0.13,0.23,-1.0308,0.42,0.98,-0.919,0.59,0.91
"REACTOME:105705_REACT_13797_CYP2E1_REACTIONS","REACTOME","105705_REACT_13797_CYP2E1_REACTIONS",11,-1.3218,0.14,0.26,-1.8731,0.0019,0.067,1.4507,0.072,0.61
"C7_Immunologic_signatures:C7_ALL_758_GSE17721_0_5H_VS_8H_GARDIQUIMOD_BMDM_DN","C7_Immunologic_signatures","C7_ALL_758_GSE17721_0_5H_VS_8H_GARDIQUIMOD_BMDM_DN",198,-1.3218,0.03,0.063,1.076,0.26,0.51,0.8879,0.77,1
"C7_Immunologic_signatures:C7_ALL_1726_GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1726_GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN",197,-1.3218,0.039,0.063,0.7816,0.98,1,-1.3779,0.01,0.075
"REACTOME:530756_REACT_116010_SULFIDE_OXIDATION_TO_SULFATE","REACTOME","530756_REACT_116010_SULFIDE_OXIDATION_TO_SULFATE",5,-1.3218,0.15,0.26,-0.6369,0.9,1,-1.1508,0.32,0.66
"GO_MF:492406_GO_0008028_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","492406_GO_0008028_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",34,-1.3218,0.1,0.28,-1.5039,0.032,0.56,1.0369,0.41,0.86
"GO_BP:495831_GO_0015696_AMMONIUM_TRANSPORT","GO_BP","495831_GO_0015696_AMMONIUM_TRANSPORT",54,-1.3216,0.089,0.23,-0.7596,0.9,1,-0.9306,0.59,0.9
"KEGG_compound:C02835_IMIDAZOLE_4_ACETATE_IMIDAZOLEACETIC_ACID_4_IMIDAZOLEACETATE","KEGG_compound","C02835_IMIDAZOLE_4_ACETATE_IMIDAZOLEACETIC_ACID_4_IMIDAZOLEACETATE",5,-1.3216,0.13,0.3,0.6847,0.82,1,-1.2429,0.23,0.42
"C7_Immunologic_signatures:C7_ALL_1491_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP","C7_Immunologic_signatures","C7_ALL_1491_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP",189,-1.3216,0.038,0.063,0.8601,0.88,1,0.8589,0.88,1
"GO_BP:494394_GO_0010324_MEMBRANE_INVAGINATION","GO_BP","494394_GO_0010324_MEMBRANE_INVAGINATION",36,-1.3215,0.1,0.23,1.1883,0.22,0.79,0.8068,0.81,1
"GO_CC:502205_GO_0032983_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX","GO_CC","502205_GO_0032983_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX",7,-1.3215,0.16,0.29,-1.071,0.36,0.8,1.4019,0.11,0.75
"C7_Immunologic_signatures:C7_ALL_270_GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN","C7_Immunologic_signatures","C7_ALL_270_GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN",200,-1.3214,0.04,0.063,0.8453,0.91,1,-1.5706,0,0.0083
"C7_Immunologic_signatures:C7_ALL_672_GSE17721_POLYIC_VS_GARDIQUIMOD_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_672_GSE17721_POLYIC_VS_GARDIQUIMOD_0_5H_BMDM_DN",197,-1.3213,0.033,0.063,0.9516,0.58,0.89,-0.9161,0.68,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_29_LIU_PROSTATE_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_29_LIU_PROSTATE_CANCER_UP",94,-1.3213,0.063,0.16,-0.9372,0.58,1,-1.1597,0.16,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_2774_MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED","C2_Chemical_and_genetic_perturbations","C2_CGP_2774_MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED",73,-1.3213,0.077,0.16,0.9026,0.64,0.92,1.8177,0,0.22
"GO_BP:495190_GO_0014742_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY","GO_BP","495190_GO_0014742_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY",16,-1.3212,0.14,0.23,-0.6395,0.95,1,-1.273,0.16,0.66
"REACTOME:161043_REACT_21312_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING","REACTOME","161043_REACT_21312_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING",31,-1.3211,0.12,0.26,-0.9689,0.47,1,-0.845,0.75,0.99
"GO_BP:513929_GO_0060373_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION","GO_BP","513929_GO_0060373_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION",7,-1.3211,0.14,0.23,0.798,0.71,1,-0.8314,0.66,0.97
"KEGG_compound:C00191_D_GLUCURONATE_GLUCURONIC_ACID_GLUCURONATE","KEGG_compound","C00191_D_GLUCURONATE_GLUCURONIC_ACID_GLUCURONATE",23,-1.3211,0.12,0.3,1.6225,0.01,0.14,2.2674,0,0
"GO_MF:487858_GO_0001968_FIBRONECTIN_BINDING","GO_MF","487858_GO_0001968_FIBRONECTIN_BINDING",24,-1.321,0.13,0.28,1.0739,0.36,0.82,0.8167,0.74,1
"GO_BP:510912_GO_0048863_STEM_CELL_DIFFERENTIATION","GO_BP","510912_GO_0048863_STEM_CELL_DIFFERENTIATION",277,-1.3209,0.023,0.23,-0.9518,0.59,1,1.0729,0.27,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_403_CHEBOTAEV_GR_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_403_CHEBOTAEV_GR_TARGETS_UP",77,-1.3209,0.07,0.16,1.0217,0.4,0.77,1.0618,0.32,0.9
"GO_BP:508884_GO_0046636_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION","GO_BP","508884_GO_0046636_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION",19,-1.3208,0.14,0.23,0.7359,0.88,1,0.9212,0.59,0.92
"REACTOME:833812_REACT_163906_ECM_PROTEOGLYCANS","REACTOME","833812_REACT_163906_ECM_PROTEOGLYCANS",54,-1.3208,0.085,0.26,1.0568,0.36,0.65,1.1483,0.21,0.89
"GO_BP:495004_GO_0010939_REGULATION_OF_NECROTIC_CELL_DEATH","GO_BP","495004_GO_0010939_REGULATION_OF_NECROTIC_CELL_DEATH",18,-1.3207,0.12,0.23,-0.8704,0.64,1,0.6359,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2165_FINETTI_BREAST_CANCER_KINOME_RED","C2_Chemical_and_genetic_perturbations","C2_CGP_2165_FINETTI_BREAST_CANCER_KINOME_RED",16,-1.3205,0.13,0.16,0.8887,0.61,0.94,-1.6627,0.006,0.21
"C2_Chemical_and_genetic_perturbations:C2_CGP_2249_MITSIADES_RESPONSE_TO_APLIDIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2249_MITSIADES_RESPONSE_TO_APLIDIN_UP",433,-1.3205,0.0073,0.16,-0.9063,0.81,1,-0.8038,1,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_379_ENK_UV_RESPONSE_EPIDERMIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_379_ENK_UV_RESPONSE_EPIDERMIS_UP",290,-1.3204,0.022,0.16,0.9143,0.78,0.91,-0.883,0.86,0.9
"C3_TF_targets:C3_TFT_379_V_HP1SITEFACTOR_Q6","C3_TF_targets","C3_TFT_379_V_HP1SITEFACTOR_Q6",222,-1.3204,0.024,0.075,-0.7819,0.97,1,0.9305,0.67,1
"GO_BP:517091_GO_0072175_EPITHELIAL_TUBE_FORMATION","GO_BP","517091_GO_0072175_EPITHELIAL_TUBE_FORMATION",118,-1.3204,0.05,0.23,-0.7656,0.95,1,0.917,0.64,0.93
"C3_TF_targets:C3_TFT_518_TAAYNRNNTCC_UNKNOWN","C3_TF_targets","C3_TFT_518_TAAYNRNNTCC_UNKNOWN",165,-1.3204,0.04,0.075,-1.2187,0.096,0.31,1.1242,0.19,0.96
"GO_BP:508511_GO_0046218_INDOLALKYLAMINE_CATABOLIC_PROCESS","GO_BP","508511_GO_0046218_INDOLALKYLAMINE_CATABOLIC_PROCESS",11,-1.3204,0.15,0.23,-1.3183,0.13,0.89,-1.629,0.019,0.51
"GO_BP:755386_GO_2001280_POSITIVE_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS","GO_BP","755386_GO_2001280_POSITIVE_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS",5,-1.3203,0.14,0.23,-0.767,0.76,1,-1.5028,0.058,0.53
"GO_BP:510448_GO_0048341_PARAXIAL_MESODERM_FORMATION","GO_BP","510448_GO_0048341_PARAXIAL_MESODERM_FORMATION",5,-1.3203,0.13,0.23,1.0875,0.38,0.92,0.7235,0.78,1
"C7_Immunologic_signatures:C7_ALL_1788_GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1788_GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN",198,-1.3202,0.03,0.064,-0.729,0.99,1,-1.0745,0.29,0.56
"KEGG_pathway:HSA00830_RETINOL_METABOLISM","KEGG_pathway","HSA00830_RETINOL_METABOLISM",65,-1.3202,0.084,0.12,1.5716,0.016,0.079,1.6114,0.002,0.11
"GO_MF:495541_GO_0015297_ANTIPORTER_ACTIVITY","GO_MF","495541_GO_0015297_ANTIPORTER_ACTIVITY",61,-1.3201,0.072,0.28,-0.9907,0.46,0.92,0.8318,0.78,1
"C7_Immunologic_signatures:C7_ALL_399_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_399_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP",197,-1.32,0.035,0.064,0.9935,0.43,0.76,-1.3987,0.002,0.063
"GO_BP:510913_GO_0048864_STEM_CELL_DEVELOPMENT","GO_BP","510913_GO_0048864_STEM_CELL_DEVELOPMENT",223,-1.3199,0.031,0.23,-0.8352,0.89,1,0.9973,0.45,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_3150_ZHU_SKIL_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3150_ZHU_SKIL_TARGETS_UP",19,-1.3199,0.13,0.16,-1.0507,0.4,0.97,1.0137,0.43,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_69_IGARASHI_ATF4_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_69_IGARASHI_ATF4_TARGETS_DN",89,-1.3199,0.079,0.16,0.8642,0.76,0.96,0.8406,0.79,1
"KEGG_reaction:R03283_4_TRIMETHYLAMMONIOBUTANAL_NAD_1_OXIDOREDUCTASE_4_TRIMETHYLAMMONIOBUTANAL_NAD_OXIDOREDUCTASE_4_TRIMETHYLAMMONIOBUTANAL_NAD_H2O_4_TRIMETHYLAMMONIOBUTANOATE_NADH_H_","KEGG_reaction","R03283_4_TRIMETHYLAMMONIOBUTANAL_NAD_1_OXIDOREDUCTASE_4_TRIMETHYLAMMONIOBUTANAL_NAD_OXIDOREDUCTASE_4_TRIMETHYLAMMONIOBUTANAL_NAD_H2O_4_TRIMETHYLAMMONIOBUTANOATE_NADH_H_",5,-1.3199,0.13,0.31,0.694,0.83,1,-1.2109,0.24,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_651_RASHI_NFKB1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_651_RASHI_NFKB1_TARGETS",19,-1.3199,0.12,0.16,-0.6927,0.91,1,0.9859,0.45,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1332_SHEPARD_CRUSH_AND_BURN_MUTANT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1332_SHEPARD_CRUSH_AND_BURN_MUTANT_DN",178,-1.3199,0.039,0.16,-0.7529,0.97,1,-1.0692,0.3,0.67
"GO_BP:750931_GO_0036006_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS","GO_BP","750931_GO_0036006_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS",7,-1.3197,0.15,0.23,0.8632,0.59,1,1.1572,0.28,0.73
"GO_MF:496849_GO_0017017_MAP_KINASE_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY","GO_MF","496849_GO_0017017_MAP_KINASE_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY",12,-1.3197,0.16,0.28,-0.6298,0.93,1,1.3464,0.14,0.64
"KEGG_compound:C11173_SN_38","KEGG_compound","C11173_SN_38",22,-1.3197,0.13,0.3,1.8772,0,0.018,2.3336,0,0
"GO_CC:487096_GO_0000805_X_CHROMOSOME","GO_CC","487096_GO_0000805_X_CHROMOSOME",6,-1.3196,0.16,0.29,-1.0876,0.35,0.81,-1.1628,0.3,0.84
"C3_TF_targets:C3_TFT_228_V_AMEF2_Q6","C3_TF_targets","C3_TFT_228_V_AMEF2_Q6",251,-1.3196,0.02,0.075,-1.0412,0.34,0.67,-1.0419,0.31,0.64
"C3_MicroRNA_targets:C3_MIR_146_AAGCAAT_MIR_137","C3_MicroRNA_targets","C3_MIR_146_AAGCAAT_MIR_137",218,-1.3196,0.031,0.24,-0.9631,0.54,1,-0.8927,0.81,1
"C7_Immunologic_signatures:C7_ALL_865_GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_865_GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP",188,-1.3195,0.035,0.064,-1.1208,0.19,1,-1.0623,0.31,0.59
"GO_BP:514849_GO_0061304_RETINAL_BLOOD_VESSEL_MORPHOGENESIS","GO_BP","514849_GO_0061304_RETINAL_BLOOD_VESSEL_MORPHOGENESIS",5,-1.3195,0.15,0.23,0.9833,0.5,1,1.0418,0.44,0.81
"KEGG_compound:C01419_CYS_GLY_L_CYSTEINYLGLYCINE","KEGG_compound","C01419_CYS_GLY_L_CYSTEINYLGLYCINE",6,-1.3194,0.13,0.3,-0.7582,0.74,1,-0.7229,0.8,0.91
"GO_BP:506190_GO_0043112_RECEPTOR_METABOLIC_PROCESS","GO_BP","506190_GO_0043112_RECEPTOR_METABOLIC_PROCESS",71,-1.3194,0.088,0.23,0.6964,0.96,1,1.2093,0.12,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_3337_GENTLES_LEUKEMIC_STEM_CELL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3337_GENTLES_LEUKEMIC_STEM_CELL_UP",29,-1.3193,0.11,0.16,-0.6783,0.95,1,-1.6546,0.0042,0.22
"GO_BP:515234_GO_0070301_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE","GO_BP","515234_GO_0070301_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE",44,-1.3192,0.11,0.23,-0.6284,0.99,1,-1.4346,0.03,0.56
"GO_BP:497179_GO_0018208_PEPTIDYL_PROLINE_MODIFICATION","GO_BP","497179_GO_0018208_PEPTIDYL_PROLINE_MODIFICATION",55,-1.3192,0.091,0.23,1.0655,0.32,0.93,-1.1202,0.27,0.76
"C3_TF_targets:C3_TFT_502_RAAGNYNNCTTY_UNKNOWN","C3_TF_targets","C3_TFT_502_RAAGNYNNCTTY_UNKNOWN",141,-1.3192,0.053,0.075,-0.7694,0.96,1,-1.0625,0.3,0.63
"GO_BP:512189_GO_0051305_CHROMOSOME_MOVEMENT_TOWARDS_SPINDLE_POLE","GO_BP","512189_GO_0051305_CHROMOSOME_MOVEMENT_TOWARDS_SPINDLE_POLE",6,-1.3191,0.17,0.23,0.8573,0.65,1,-1.0697,0.39,0.8
"C4_Cancer_modules:C4_CM_243_MODULE_274","C4_Cancer_modules","C4_CM_243_MODULE_274",80,-1.3191,0.081,0.15,-1.3519,0.055,0.53,1.044,0.41,0.87
"C7_Immunologic_signatures:C7_ALL_582_GSE17721_CPG_VS_GARDIQUIMOD_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_582_GSE17721_CPG_VS_GARDIQUIMOD_0_5H_BMDM_DN",197,-1.3191,0.026,0.065,0.6617,1,1,-0.8042,0.96,1
"REACTOME:119572_REACT_19343_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS","REACTOME","119572_REACT_19343_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS",12,-1.319,0.13,0.26,-1.2897,0.17,0.66,-1.2934,0.17,0.53
"REACTOME:106378_REACT_18372_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS_","REACTOME","106378_REACT_18372_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS_",81,-1.319,0.063,0.26,-1.0871,0.29,0.91,1.0986,0.3,0.95
"C7_Immunologic_signatures:C7_ALL_1104_GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1104_GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN",189,-1.319,0.046,0.065,0.7795,0.97,1,-0.7565,0.98,1
"C7_Immunologic_signatures:C7_ALL_1731_GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1731_GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP",197,-1.319,0.027,0.065,-0.7893,0.95,1,-0.8878,0.8,0.97
"GO_BP:508433_GO_0046137_NEGATIVE_REGULATION_OF_VITAMIN_METABOLIC_PROCESS","GO_BP","508433_GO_0046137_NEGATIVE_REGULATION_OF_VITAMIN_METABOLIC_PROCESS",6,-1.3189,0.15,0.23,-1.1633,0.31,0.91,-1.11,0.34,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2740_YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2740_YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN",15,-1.3187,0.15,0.16,1.6878,0.015,0.09,1.496,0.06,0.48
"GO_MF:750815_GO_0052742_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY","GO_MF","750815_GO_0052742_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY",15,-1.3186,0.13,0.28,-1.0624,0.38,0.86,-0.9312,0.53,0.84
"GO_BP:500541_GO_0031282_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY","GO_BP","500541_GO_0031282_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY",11,-1.3185,0.16,0.23,-1.191,0.24,0.9,-0.9129,0.55,0.92
"KEGG_compound:C00804_PROPYNOATE_PROPIOLIC_ACID_ACETYLENECARBOXYLIC_ACID_ACETYLENEMONOCARBOXYLATE","KEGG_compound","C00804_PROPYNOATE_PROPIOLIC_ACID_ACETYLENECARBOXYLIC_ACID_ACETYLENEMONOCARBOXYLATE",5,-1.3185,0.15,0.3,0.7303,0.78,1,-1.2536,0.23,0.41
"GO_BP:488796_GO_0002923_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN","GO_BP","488796_GO_0002923_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN",11,-1.3185,0.14,0.23,-1.2476,0.21,0.91,-0.6842,0.9,1
"GO_BP:494643_GO_0010578_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY_INVOLVED_IN_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY","GO_BP","494643_GO_0010578_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY_INVOLVED_IN_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",24,-1.3185,0.11,0.23,-0.9724,0.5,1,1.3478,0.089,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_3042_STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3042_STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN",49,-1.3185,0.099,0.16,1.2676,0.1,0.42,-1.7661,0,0.14
"REACTOME:1127543_REACT_268573_LIGAND_RECEPTOR_INTERACTIONS","REACTOME","1127543_REACT_268573_LIGAND_RECEPTOR_INTERACTIONS",7,-1.3184,0.17,0.26,-1.5691,0.026,0.35,-1.1166,0.33,0.68
"GO_BP:751221_GO_0036303_LYMPH_VESSEL_MORPHOGENESIS","GO_BP","751221_GO_0036303_LYMPH_VESSEL_MORPHOGENESIS",11,-1.3184,0.15,0.23,-0.7683,0.79,1,1.0552,0.36,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1388_SWEET_KRAS_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1388_SWEET_KRAS_TARGETS_UP",82,-1.3182,0.078,0.16,0.9253,0.64,0.89,-0.9233,0.6,0.85
"KEGG_compound:C11131_2_METHOXY_ESTRADIOL_17BETA_3_GLUCURONIDE","KEGG_compound","C11131_2_METHOXY_ESTRADIOL_17BETA_3_GLUCURONIDE",19,-1.3181,0.12,0.3,1.9235,0,0.017,2.3467,0,0
"GO_BP:494777_GO_0010712_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS","GO_BP","494777_GO_0010712_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS",36,-1.3181,0.12,0.23,0.9079,0.58,1,1.3993,0.053,0.63
"GO_MF:495418_GO_0015145_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495418_GO_0015145_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",15,-1.318,0.14,0.28,-1.1784,0.24,0.79,-0.9565,0.5,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1004_LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED","C2_Chemical_and_genetic_perturbations","C2_CGP_1004_LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED",16,-1.318,0.14,0.16,0.9443,0.52,0.87,-1.0363,0.41,0.7
"GO_MF:752058_GO_0052866_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY","GO_MF","752058_GO_0052866_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY",21,-1.3177,0.12,0.28,-0.777,0.78,1,-0.9519,0.51,0.83
"KEGG_compound:C01149_4_TRIMETHYLAMMONIOBUTANAL","KEGG_compound","C01149_4_TRIMETHYLAMMONIOBUTANAL",5,-1.3177,0.14,0.3,0.6904,0.85,1,-1.2072,0.3,0.44
"GO_MF:486689_GO_0000155_PHOSPHORELAY_SENSOR_KINASE_ACTIVITY","GO_MF","486689_GO_0000155_PHOSPHORELAY_SENSOR_KINASE_ACTIVITY",8,-1.3176,0.14,0.28,-0.7388,0.79,1,-1.0422,0.41,0.75
"GO_BP:486591_GO_0000041_TRANSITION_METAL_ION_TRANSPORT","GO_BP","486591_GO_0000041_TRANSITION_METAL_ION_TRANSPORT",105,-1.3174,0.059,0.23,0.9428,0.6,1,0.7403,0.96,1
"GO_BP:515904_GO_0070977_BONE_MATURATION","GO_BP","515904_GO_0070977_BONE_MATURATION",14,-1.3174,0.13,0.23,-0.8255,0.67,1,-0.9371,0.54,0.9
"GO_MF:495354_GO_0016303_1_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY","GO_MF","495354_GO_0016303_1_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY",11,-1.3173,0.13,0.28,-0.9543,0.52,0.95,-1.0635,0.37,0.74
"GO_CC:506277_GO_0043209_MYELIN_SHEATH","GO_CC","506277_GO_0043209_MYELIN_SHEATH",42,-1.3173,0.11,0.29,-1.5704,0.0097,0.5,-0.8568,0.68,1
"GO_MF:500929_GO_0031683_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING","GO_MF","500929_GO_0031683_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING",22,-1.3172,0.12,0.28,-0.8023,0.78,1,-1.0137,0.42,0.78
"GO_BP:496486_GO_0016525_NEGATIVE_REGULATION_OF_ANGIOGENESIS","GO_BP","496486_GO_0016525_NEGATIVE_REGULATION_OF_ANGIOGENESIS",63,-1.3171,0.083,0.23,-0.9257,0.59,1,-1.3719,0.051,0.59
"GO_BP:506119_GO_0043030_REGULATION_OF_MACROPHAGE_ACTIVATION","GO_BP","506119_GO_0043030_REGULATION_OF_MACROPHAGE_ACTIVATION",22,-1.3171,0.12,0.23,1.534,0.036,0.36,1.1613,0.25,0.73
"GO_MF:512403_GO_0051525_NFAT_PROTEIN_BINDING","GO_MF","512403_GO_0051525_NFAT_PROTEIN_BINDING",5,-1.317,0.14,0.28,0.4427,1,1,-1.2816,0.2,0.6
"GO_BP:502544_GO_0033326_CEREBROSPINAL_FLUID_SECRETION","GO_BP","502544_GO_0033326_CEREBROSPINAL_FLUID_SECRETION",5,-1.317,0.15,0.23,-1.3205,0.17,0.89,0.9823,0.46,0.87
"C7_Immunologic_signatures:C7_ALL_1077_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP","C7_Immunologic_signatures","C7_ALL_1077_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP",193,-1.3169,0.05,0.066,1.2537,0.054,0.15,-1.3854,0.0043,0.071
"GO_MF:487543_GO_0001609_G_PROTEIN_COUPLED_ADENOSINE_RECEPTOR_ACTIVITY","GO_MF","487543_GO_0001609_G_PROTEIN_COUPLED_ADENOSINE_RECEPTOR_ACTIVITY",7,-1.3169,0.15,0.28,1.4888,0.076,0.39,1.0234,0.43,0.87
"GO_BP:487953_GO_0002063_CHONDROCYTE_DEVELOPMENT","GO_BP","487953_GO_0002063_CHONDROCYTE_DEVELOPMENT",23,-1.3168,0.13,0.23,-1.4309,0.07,0.93,-0.9499,0.54,0.89
"GO_CC:505743_GO_0042629_MAST_CELL_GRANULE","GO_CC","505743_GO_0042629_MAST_CELL_GRANULE",21,-1.3168,0.15,0.29,0.8424,0.69,0.93,-0.8302,0.73,1
"GO_BP:752695_GO_0097194_EXECUTION_PHASE_OF_APOPTOSIS","GO_BP","752695_GO_0097194_EXECUTION_PHASE_OF_APOPTOSIS",84,-1.3167,0.066,0.23,-0.6291,0.99,1,-0.959,0.53,0.88
"REACTOME:106064_REACT_12519_PECAM1_INTERACTIONS","REACTOME","106064_REACT_12519_PECAM1_INTERACTIONS",12,-1.3167,0.14,0.27,0.5908,0.96,1,-1.2314,0.19,0.58
"C3_TF_targets:C3_TFT_61_V_CDP_01","C3_TF_targets","C3_TFT_61_V_CDP_01",85,-1.3167,0.073,0.077,-1.4152,0.031,0.16,-0.8448,0.81,0.98
"GO_MF:495619_GO_0015405_P_P_BOND_HYDROLYSIS_DRIVEN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495619_GO_0015405_P_P_BOND_HYDROLYSIS_DRIVEN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",130,-1.3166,0.052,0.28,0.8396,0.87,1,-0.9882,0.47,0.79
"KEGG_reaction:R07106_UDP_GLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_TRICHLOROETHANOL_UDP_GLUCURONATE_TRICHLOROETHANOL_GLUCURONIDE_UDP","KEGG_reaction","R07106_UDP_GLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_TRICHLOROETHANOL_UDP_GLUCURONATE_TRICHLOROETHANOL_GLUCURONIDE_UDP",19,-1.3166,0.12,0.31,1.8971,0.0044,0.008,2.3622,0,0
"GO_BP:498958_GO_0021675_NERVE_DEVELOPMENT","GO_BP","498958_GO_0021675_NERVE_DEVELOPMENT",76,-1.3165,0.085,0.23,-1.1232,0.26,0.94,1.1487,0.21,0.73
"KEGG_compound:C01190_BETA_D_GLUCOSYL_1_1_CERAMIDE_GLUCOSYLCERAMIDE_GLUCOCEREBROSIDE_D_GLUCOSYL_N_ACYLSPHINGOSINE","KEGG_compound","C01190_BETA_D_GLUCOSYL_1_1_CERAMIDE_GLUCOSYLCERAMIDE_GLUCOCEREBROSIDE_D_GLUCOSYL_N_ACYLSPHINGOSINE",5,-1.3164,0.15,0.3,-0.4609,1,1,-0.9606,0.52,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_3184_KASLER_HDAC7_TARGETS_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3184_KASLER_HDAC7_TARGETS_2_UP",6,-1.3164,0.16,0.16,1.2371,0.23,0.45,-0.9659,0.5,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_144_WANG_RESPONSE_TO_FORSKOLIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_144_WANG_RESPONSE_TO_FORSKOLIN_UP",23,-1.3164,0.13,0.16,1.0493,0.38,0.71,0.8881,0.63,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_992_INGRAM_SHH_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_992_INGRAM_SHH_TARGETS_UP",125,-1.3164,0.051,0.16,-0.6968,0.99,1,0.9905,0.46,0.96
"GO_BP:493494_GO_0009310_AMINE_CATABOLIC_PROCESS","GO_BP","493494_GO_0009310_AMINE_CATABOLIC_PROCESS",16,-1.3164,0.14,0.23,-1.4649,0.068,0.87,-1.4292,0.085,0.57
"GO_BP:500240_GO_0030947_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","500240_GO_0030947_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",26,-1.3164,0.12,0.23,-0.8977,0.59,1,0.6926,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_230_HOEBEKE_LYMPHOID_STEM_CELL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_230_HOEBEKE_LYMPHOID_STEM_CELL_UP",92,-1.3161,0.063,0.16,-1.0416,0.35,0.98,-1.0364,0.4,0.71
"GO_BP:490420_GO_0007175_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY","GO_BP","490420_GO_0007175_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",8,-1.3161,0.14,0.23,-0.7586,0.77,1,0.9725,0.5,0.88
"GO_BP:491233_GO_0006269_DNA_REPLICATION_SYNTHESIS_OF_RNA_PRIMER","GO_BP","491233_GO_0006269_DNA_REPLICATION_SYNTHESIS_OF_RNA_PRIMER",5,-1.3161,0.15,0.23,-0.452,0.99,1,-1.5126,0.032,0.53
"KEGG_reaction:R04903_5_HYDROXYINDOLEACETALDEHYDE_NAD_OXIDOREDUCTASE_5_HYDROXYINDOLEACETALDEHYDE_NAD_H2O_5_HYDROXYINDOLEACETATE_H_NADH","KEGG_reaction","R04903_5_HYDROXYINDOLEACETALDEHYDE_NAD_OXIDOREDUCTASE_5_HYDROXYINDOLEACETALDEHYDE_NAD_H2O_5_HYDROXYINDOLEACETATE_H_NADH",5,-1.316,0.14,0.3,0.7139,0.8,1,-1.2304,0.26,0.44
"C7_Immunologic_signatures:C7_ALL_676_GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_676_GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDM_DN",199,-1.316,0.021,0.067,0.9764,0.51,0.82,0.7181,1,1
"REACTOME:477133_REACT_111183_MEIOSIS","REACTOME","477133_REACT_111183_MEIOSIS",113,-1.3158,0.065,0.27,-1.4661,0.0092,0.47,-1.4284,0.014,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_277_SENESE_HDAC2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_277_SENESE_HDAC2_TARGETS_UP",113,-1.3158,0.064,0.16,1.3168,0.027,0.38,0.725,0.98,1
"KEGG_compound:C19645_ACCEPTOR_AGLYCON","KEGG_compound","C19645_ACCEPTOR_AGLYCON",19,-1.3158,0.13,0.3,1.9948,0.0021,0.078,2.3999,0,0
"GO_BP:508218_GO_0045911_POSITIVE_REGULATION_OF_DNA_RECOMBINATION","GO_BP","508218_GO_0045911_POSITIVE_REGULATION_OF_DNA_RECOMBINATION",17,-1.3157,0.13,0.24,-1.3131,0.13,0.87,-1.0769,0.34,0.8
"REACTOME:530755_REACT_115654_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE","REACTOME","530755_REACT_115654_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE",8,-1.3157,0.16,0.27,0.7488,0.79,1,-1.2001,0.25,0.6
"REACTOME:106551_REACT_1974_RNA_POLYMERASE_I_PROMOTER_CLEARANCE","REACTOME","106551_REACT_1974_RNA_POLYMERASE_I_PROMOTER_CLEARANCE",105,-1.3157,0.062,0.27,-1.5127,0.012,0.43,-1.3407,0.037,0.51
"GO_BP:487919_GO_0002029_DESENSITIZATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY","GO_BP","487919_GO_0002029_DESENSITIZATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY",18,-1.3155,0.15,0.24,-1.2676,0.19,0.89,1.2146,0.22,0.71
"KEGG_reaction:R04352_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ETIOCHOLANOLONE_UDP_GLUCURONATE_ETIOCHOLAN_3ALPHA_OL_17_ONE_3_GLUCURONIDE_UDP","KEGG_reaction","R04352_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ETIOCHOLANOLONE_UDP_GLUCURONATE_ETIOCHOLAN_3ALPHA_OL_17_ONE_3_GLUCURONIDE_UDP",19,-1.315,0.12,0.3,1.9307,0.0021,0.0074,2.3652,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_413_LINDGREN_BLADDER_CANCER_CLUSTER_3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_413_LINDGREN_BLADDER_CANCER_CLUSTER_3_UP",325,-1.315,0.015,0.16,1.2388,0.034,0.45,-1.4534,0,0.32
"GO_BP:516794_GO_0071873_RESPONSE_TO_NOREPINEPHRINE","GO_BP","516794_GO_0071873_RESPONSE_TO_NOREPINEPHRINE",6,-1.315,0.14,0.24,-1.342,0.15,0.92,-0.8785,0.62,0.94
"GO_BP:502814_GO_0033598_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION","GO_BP","502814_GO_0033598_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION",14,-1.3149,0.14,0.24,0.6699,0.91,1,1.3328,0.14,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2981_DAZARD_UV_RESPONSE_CLUSTER_G5","C2_Chemical_and_genetic_perturbations","C2_CGP_2981_DAZARD_UV_RESPONSE_CLUSTER_G5",11,-1.3147,0.17,0.16,0.9679,0.51,0.84,-1.0794,0.38,0.65
"C4_Cancer_gene_neighborhoods:C4_CGN_115_MORF_IL4","C4_Cancer_gene_neighborhoods","C4_CGN_115_MORF_IL4",185,-1.3145,0.029,0.2,-0.9461,0.58,0.91,1.1441,0.17,0.54
"GO_BP:498272_GO_0019432_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS","GO_BP","498272_GO_0019432_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS",42,-1.3145,0.1,0.24,0.5721,0.99,1,-1.4159,0.046,0.57
"GO_BP:504568_GO_0035384_THIOESTER_BIOSYNTHETIC_PROCESS","GO_BP","504568_GO_0035384_THIOESTER_BIOSYNTHETIC_PROCESS",27,-1.3145,0.12,0.24,0.637,0.96,1,-1.5685,0.028,0.52
"WikiPathways:198848_WP170_NUCLEAR_RECEPTORS","WikiPathways","198848_WP170_NUCLEAR_RECEPTORS",38,-1.3144,0.1,0.18,-1.2768,0.12,1,-1.2387,0.14,0.48
"KEGG_compound:C05729_R_S_CYSTEINYLGLYCINE","KEGG_compound","C05729_R_S_CYSTEINYLGLYCINE",6,-1.3144,0.15,0.3,-0.7457,0.79,1,-0.7034,0.85,0.91
"C3_MicroRNA_targets:C3_MIR_161_GAGCTGG_MIR_337","C3_MicroRNA_targets","C3_MIR_161_GAGCTGG_MIR_337",157,-1.3144,0.038,0.25,-1.804,0,0.077,-1.1221,0.2,1
"KEGG_compound:C11134_TESTOSTERONE_GLUCURONIDE_TESTOSTERONE_17BETA_BETA_D_GLUCURONIDE_","KEGG_compound","C11134_TESTOSTERONE_GLUCURONIDE_TESTOSTERONE_17BETA_BETA_D_GLUCURONIDE_",19,-1.3144,0.14,0.3,1.9269,0,0.018,2.4302,0,0
"KEGG_compound:C00231_D_XYLULOSE_5_PHOSPHATE","KEGG_compound","C00231_D_XYLULOSE_5_PHOSPHATE",6,-1.3143,0.14,0.3,0.8144,0.72,1,0.572,0.95,1
"C3_TF_targets:C3_TFT_180_V_XBP1_01","C3_TF_targets","C3_TFT_180_V_XBP1_01",130,-1.3143,0.054,0.079,0.932,0.6,1,-0.7647,0.96,1
"KEGG_pathway:HSA04530_TIGHT_JUNCTION","KEGG_pathway","HSA04530_TIGHT_JUNCTION",134,-1.3142,0.048,0.12,-0.7921,0.93,1,-0.9319,0.63,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_276_SENESE_HDAC1_AND_HDAC2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_276_SENESE_HDAC1_AND_HDAC2_TARGETS_DN",222,-1.3142,0.029,0.16,1.0844,0.22,0.66,1.0897,0.22,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_656_MARTIN_INTERACT_WITH_HDAC","C2_Chemical_and_genetic_perturbations","C2_CGP_656_MARTIN_INTERACT_WITH_HDAC",44,-1.3142,0.1,0.16,0.7608,0.88,1,-0.6862,0.95,0.99
"GO_BP:508650_GO_0046386_DEOXYRIBOSE_PHOSPHATE_CATABOLIC_PROCESS","GO_BP","508650_GO_0046386_DEOXYRIBOSE_PHOSPHATE_CATABOLIC_PROCESS",20,-1.3142,0.13,0.24,1.3528,0.087,0.61,-1.5044,0.036,0.53
"C7_Immunologic_signatures:C7_ALL_1772_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN","C7_Immunologic_signatures","C7_ALL_1772_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN",195,-1.3141,0.037,0.068,-0.773,0.98,1,-0.8893,0.78,0.96
"GO_BP:1134000_GO_1903825_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT","GO_BP","1134000_GO_1903825_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT",84,-1.314,0.062,0.24,-1.0179,0.43,0.98,-1.065,0.33,0.8
"GO_CC:490801_GO_0005769_EARLY_ENDOSOME","GO_CC","490801_GO_0005769_EARLY_ENDOSOME",266,-1.314,0.024,0.3,0.998,0.45,0.79,-0.9235,0.71,1
"GO_BP:516540_GO_0071616_ACYL_COA_BIOSYNTHETIC_PROCESS","GO_BP","516540_GO_0071616_ACYL_COA_BIOSYNTHETIC_PROCESS",27,-1.3139,0.11,0.24,0.6554,0.96,1,-1.5608,0.027,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_3053_VERHAAK_GLIOBLASTOMA_PRONEURAL","C2_Chemical_and_genetic_perturbations","C2_CGP_3053_VERHAAK_GLIOBLASTOMA_PRONEURAL",173,-1.3139,0.037,0.16,-0.8068,0.92,1,1.0814,0.26,0.87
"C7_Immunologic_signatures:C7_ALL_828_GSE17974_1_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_828_GSE17974_1_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN",199,-1.3139,0.034,0.068,-0.7865,0.95,1,-1.4556,0.01,0.033
"KEGG_compound:C07649_5_FU_FLUOROURACIL_5_FLUOROURACIL","KEGG_compound","C07649_5_FU_FLUOROURACIL_5_FLUOROURACIL",6,-1.3138,0.15,0.3,-1.0577,0.4,0.99,1.2287,0.24,0.51
"GO_MF:512173_GO_0051287_NAD_BINDING","GO_MF","512173_GO_0051287_NAD_BINDING",49,-1.3137,0.089,0.29,1.0545,0.37,0.83,-1.5423,0.0064,0.4
"GO_BP:505071_GO_0035902_RESPONSE_TO_IMMOBILIZATION_STRESS","GO_BP","505071_GO_0035902_RESPONSE_TO_IMMOBILIZATION_STRESS",16,-1.3137,0.13,0.24,0.8844,0.61,1,1.1761,0.24,0.72
"GO_MF:490032_GO_0004716_RECEPTOR_SIGNALING_PROTEIN_TYROSINE_KINASE_ACTIVITY","GO_MF","490032_GO_0004716_RECEPTOR_SIGNALING_PROTEIN_TYROSINE_KINASE_ACTIVITY",9,-1.3136,0.14,0.29,0.4318,0.99,1,-0.8136,0.68,0.96
"C3_TF_targets:C3_TFT_6_V_AP4_01","C3_TF_targets","C3_TFT_6_V_AP4_01",255,-1.3136,0.028,0.079,-0.9747,0.53,0.82,-0.9664,0.55,0.81
"GO_BP:502459_GO_0033239_NEGATIVE_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS","GO_BP","502459_GO_0033239_NEGATIVE_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS",82,-1.3135,0.074,0.24,1.0891,0.28,0.92,0.882,0.71,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_539_DARWICHE_SKIN_TUMOR_PROMOTER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_539_DARWICHE_SKIN_TUMOR_PROMOTER_DN",174,-1.3135,0.056,0.16,-0.7867,0.94,1,-1.0635,0.29,0.68
"GO_BP:508678_GO_0046415_URATE_METABOLIC_PROCESS","GO_BP","508678_GO_0046415_URATE_METABOLIC_PROCESS",13,-1.3134,0.12,0.24,0.8239,0.71,1,-0.8941,0.6,0.93
"WikiPathways:698757_WP2291_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER","WikiPathways","698757_WP2291_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER",16,-1.3134,0.13,0.18,0.8848,0.62,1,-1.152,0.26,0.57
"GO_BP:505576_GO_0042436_INDOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS","GO_BP","505576_GO_0042436_INDOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",11,-1.3133,0.16,0.24,-1.3159,0.12,0.88,-1.6899,0.018,0.61
"GO_MF:495540_GO_0015296_ANION_CATION_SYMPORTER_ACTIVITY","GO_MF","495540_GO_0015296_ANION_CATION_SYMPORTER_ACTIVITY",49,-1.3133,0.092,0.29,-1.8827,0,0.15,-1.3417,0.073,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1198_NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1198_NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON",21,-1.3132,0.12,0.16,0.5502,0.99,1,-1.1311,0.28,0.59
"GO_BP:488477_GO_0002604_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION","GO_BP","488477_GO_0002604_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION",7,-1.3132,0.15,0.24,0.8777,0.62,1,0.783,0.73,1
"GO_BP:752374_GO_0086002_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_CONTRACTION","GO_BP","752374_GO_0086002_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_CONTRACTION",24,-1.3131,0.13,0.24,-1.0539,0.39,0.97,-0.9982,0.45,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_2532_ZHANG_INTERFERON_RESPONSE","C2_Chemical_and_genetic_perturbations","C2_CGP_2532_ZHANG_INTERFERON_RESPONSE",23,-1.3131,0.13,0.16,1.4621,0.044,0.24,-1.5814,0.025,0.25
"C3_MicroRNA_targets:C3_MIR_65_TATTATA_MIR_374","C3_MicroRNA_targets","C3_MIR_65_TATTATA_MIR_374",280,-1.3131,0.016,0.24,0.7618,0.99,1,-0.8655,0.88,1
"GO_BP:507952_GO_0045604_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION","GO_BP","507952_GO_0045604_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION",40,-1.313,0.1,0.24,-1.1896,0.2,0.9,0.7417,0.9,1
"GO_BP:501908_GO_0032682_NEGATIVE_REGULATION_OF_CHEMOKINE_PRODUCTION","GO_BP","501908_GO_0032682_NEGATIVE_REGULATION_OF_CHEMOKINE_PRODUCTION",13,-1.313,0.13,0.24,-0.8842,0.6,1,-0.7954,0.72,0.99
"GO_BP:503816_GO_0034616_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS","GO_BP","503816_GO_0034616_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS",16,-1.3129,0.13,0.24,-0.4954,1,1,-0.6337,0.93,1
"GO_BP:751353_GO_0038095_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY","GO_BP","751353_GO_0038095_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY",161,-1.3129,0.041,0.24,-0.8896,0.74,1,-1.2879,0.047,0.65
"GO_MF:490627_GO_0005525_GTP_BINDING","GO_MF","490627_GO_0005525_GTP_BINDING",360,-1.3128,0.02,0.29,0.9068,0.83,0.98,-1.3684,0.0021,0.51
"GO_BP:511877_GO_0050942_POSITIVE_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION","GO_BP","511877_GO_0050942_POSITIVE_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION",7,-1.3126,0.15,0.24,1.1001,0.33,0.9,0.5664,0.95,1
"GO_BP:494962_GO_0010898_POSITIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS","GO_BP","494962_GO_0010898_POSITIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS",7,-1.3126,0.16,0.24,-1.6355,0.016,0.7,-1.1103,0.35,0.76
"GO_BP:507121_GO_0044106_CELLULAR_AMINE_METABOLIC_PROCESS","GO_BP","507121_GO_0044106_CELLULAR_AMINE_METABOLIC_PROCESS",457,-1.3126,0.014,0.24,-0.8515,0.94,1,-1.4183,0,0.57
"C7_Immunologic_signatures:C7_ALL_167_GSE13411_NAIVE_VS_MEMORY_BCELL_UP","C7_Immunologic_signatures","C7_ALL_167_GSE13411_NAIVE_VS_MEMORY_BCELL_UP",181,-1.3125,0.036,0.07,1.0831,0.26,0.49,1.1397,0.16,0.92
"GO_BP:1022156_GO_1903169_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","1022156_GO_1903169_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT",56,-1.3124,0.088,0.24,-1.2363,0.15,0.9,-0.7743,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_626_SANCHEZ_MDM2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_626_SANCHEZ_MDM2_TARGETS",15,-1.3124,0.14,0.17,-0.7514,0.8,1,0.7453,0.85,1
"GO_BP:495088_GO_0014015_POSITIVE_REGULATION_OF_GLIOGENESIS","GO_BP","495088_GO_0014015_POSITIVE_REGULATION_OF_GLIOGENESIS",35,-1.3124,0.11,0.24,0.8253,0.76,1,0.7752,0.85,1
"C7_Immunologic_signatures:C7_ALL_1421_GSE360_CTRL_VS_L_MAJOR_MAC_UP","C7_Immunologic_signatures","C7_ALL_1421_GSE360_CTRL_VS_L_MAJOR_MAC_UP",198,-1.3124,0.027,0.07,1.0516,0.31,0.58,-1.1362,0.16,0.4
"C3_MicroRNA_targets:C3_MIR_135_AGCATTA_MIR_155","C3_MicroRNA_targets","C3_MIR_135_AGCATTA_MIR_155",133,-1.3123,0.048,0.24,0.8035,0.92,1,-0.8476,0.85,1
"GO_BP:493492_GO_0009308_AMINE_METABOLIC_PROCESS","GO_BP","493492_GO_0009308_AMINE_METABOLIC_PROCESS",463,-1.3123,0.0073,0.24,-0.8665,0.94,1,-1.4149,0,0.57
"GO_BP:513439_GO_0055006_CARDIAC_CELL_DEVELOPMENT","GO_BP","513439_GO_0055006_CARDIAC_CELL_DEVELOPMENT",51,-1.3121,0.098,0.24,-1.2643,0.12,0.9,0.9316,0.57,0.92
"GO_BP:512816_GO_0051966_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC","GO_BP","512816_GO_0051966_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC",46,-1.312,0.1,0.24,-0.9283,0.58,1,1.6998,0,0.41
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_201_BIOCARTA_SARS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_201_BIOCARTA_SARS_PATHWAY",10,-1.3119,0.14,0.26,1.2376,0.21,0.65,-0.8407,0.68,0.9
"GO_BP:500322_GO_0031032_ACTOMYOSIN_STRUCTURE_ORGANIZATION","GO_BP","500322_GO_0031032_ACTOMYOSIN_STRUCTURE_ORGANIZATION",76,-1.3119,0.078,0.24,-1.2894,0.095,0.88,-0.8479,0.77,0.96
"KEGG_compound:C05583_3_METHOXY_4_HYDROXYPHENYLGLYCOLALDEHYDE","KEGG_compound","C05583_3_METHOXY_4_HYDROXYPHENYLGLYCOLALDEHYDE",6,-1.3118,0.14,0.3,0.8874,0.61,1,-1.2385,0.23,0.42
"GO_MF:496686_GO_0016776_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR","GO_MF","496686_GO_0016776_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR",40,-1.3117,0.11,0.29,-1.1945,0.18,0.8,-1.3341,0.081,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_2363_WEST_ADRENOCORTICAL_TUMOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2363_WEST_ADRENOCORTICAL_TUMOR_UP",293,-1.3116,0.016,0.17,1.4207,0,0.28,-1.0779,0.25,0.66
"KEGG_reaction:R02502_17BETA_HYDROXYSTEROID_UDP_GLUCURONOSYLTRANSFERASE_TESTOSTERONE_UDP_GLUCURONATE_TESTOSTERONE_GLUCURONIDE_UDP","KEGG_reaction","R02502_17BETA_HYDROXYSTEROID_UDP_GLUCURONOSYLTRANSFERASE_TESTOSTERONE_UDP_GLUCURONATE_TESTOSTERONE_GLUCURONIDE_UDP",19,-1.3116,0.13,0.3,1.9269,0.004,0.0072,2.3996,0,0
"GO_BP:488441_GO_0002568_SOMATIC_DIVERSIFICATION_OF_T_CELL_RECEPTOR_GENES","GO_BP","488441_GO_0002568_SOMATIC_DIVERSIFICATION_OF_T_CELL_RECEPTOR_GENES",5,-1.3115,0.15,0.24,0.6732,0.83,1,-0.9678,0.52,0.88
"GO_MF:495356_GO_0046934_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_3_KINASE_ACTIVITY","GO_MF","495356_GO_0046934_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_3_KINASE_ACTIVITY",5,-1.3115,0.15,0.29,0.718,0.81,1,0.9198,0.56,0.94
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_139_BIOCARTA_CDK5_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_139_BIOCARTA_CDK5_PATHWAY",11,-1.3114,0.14,0.25,-1.1288,0.3,1,-0.7124,0.85,0.99
"KEGG_reaction:R08615_UDP_GLUCURONATE_GLUCURONOHYDROLASE_UDP_GLUCURONATE_H2O_UDP_D_GLUCURONATE","KEGG_reaction","R08615_UDP_GLUCURONATE_GLUCURONOHYDROLASE_UDP_GLUCURONATE_H2O_UDP_D_GLUCURONATE",19,-1.3112,0.14,0.3,1.9251,0,0.0069,2.4127,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_1370_SMITH_LIVER_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_1370_SMITH_LIVER_CANCER",45,-1.3112,0.11,0.17,1.0716,0.32,0.68,-1.3066,0.094,0.42
"GO_BP:501962_GO_0032736_POSITIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION","GO_BP","501962_GO_0032736_POSITIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION",9,-1.3112,0.16,0.24,-1.3526,0.15,0.95,-0.9616,0.49,0.88
"KEGG_reaction:R08262_MORPHINE_UDP_GLUCURONATE_MORPHINE_3_GLUCURONIDE_UDP","KEGG_reaction","R08262_MORPHINE_UDP_GLUCURONATE_MORPHINE_3_GLUCURONIDE_UDP",19,-1.311,0.13,0.29,1.9333,0,0.0081,2.3755,0,0
"KEGG_reaction:R02478_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ANDROSTERONE_UDP_GLUCURONATE_ANDROSTERONE_GLUCURONIDE_UDP","KEGG_reaction","R02478_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ANDROSTERONE_UDP_GLUCURONATE_ANDROSTERONE_GLUCURONIDE_UDP",19,-1.3109,0.14,0.29,1.9372,0.002,0.012,2.4229,0,0
"REACTOME:160141_REACT_22442_INTERLEUKIN_1_SIGNALING","REACTOME","160141_REACT_22442_INTERLEUKIN_1_SIGNALING",41,-1.3109,0.097,0.27,0.8632,0.71,0.94,0.7055,0.94,1
"GO_MF:498679_GO_0019902_PHOSPHATASE_BINDING","GO_MF","498679_GO_0019902_PHOSPHATASE_BINDING",141,-1.3109,0.065,0.29,-0.8972,0.73,0.99,-1.37,0.028,0.51
"C7_Immunologic_signatures:C7_ALL_71_GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_71_GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP",191,-1.3107,0.036,0.071,0.6655,1,1,-1.0695,0.29,0.57
"C3_MicroRNA_targets:C3_MIR_156_TTTGCAG_MIR_518A_2","C3_MicroRNA_targets","C3_MIR_156_TTTGCAG_MIR_518A_2",208,-1.3107,0.03,0.24,0.6889,1,1,-0.8244,0.93,1
"GO_BP:513998_GO_0060443_MAMMARY_GLAND_MORPHOGENESIS","GO_BP","513998_GO_0060443_MAMMARY_GLAND_MORPHOGENESIS",45,-1.3107,0.11,0.24,-0.8495,0.71,1,1.009,0.43,0.84
"C7_Immunologic_signatures:C7_ALL_635_GSE17721_PAM3CSK4_VS_GADIQUIMOD_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_635_GSE17721_PAM3CSK4_VS_GADIQUIMOD_0_5H_BMDM_UP",196,-1.3107,0.036,0.071,0.8996,0.78,1,0.944,0.64,1
"C3_TF_targets:C3_TFT_19_V_P300_01","C3_TF_targets","C3_TFT_19_V_P300_01",241,-1.3107,0.023,0.082,-1.1492,0.15,0.45,0.823,0.95,1
"GO_MF:495615_GO_0015399_PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495615_GO_0015399_PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",130,-1.3106,0.057,0.29,0.8545,0.83,1,-0.9868,0.47,0.79
"GO_BP:752433_GO_0086067_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_COMMUNICATION","GO_BP","752433_GO_0086067_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_COMMUNICATION",5,-1.3105,0.14,0.24,-1.2285,0.27,0.89,1.474,0.052,0.58
"GO_BP:488737_GO_0002864_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS","GO_BP","488737_GO_0002864_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",11,-1.3105,0.15,0.24,-0.8498,0.66,1,0.724,0.83,1
"C3_TF_targets:C3_TFT_201_V_FREAC3_01","C3_TF_targets","C3_TFT_201_V_FREAC3_01",236,-1.3105,0.033,0.081,-0.7872,0.97,1,-1.3146,0.012,0.25
"KEGG_compound:C19646_ACCEPTOR_BETA_D_GLUCURONOSIDE","KEGG_compound","C19646_ACCEPTOR_BETA_D_GLUCURONOSIDE",19,-1.3105,0.098,0.3,1.9514,0.002,0.031,2.3383,0,0
"GO_BP:491430_GO_0006534_CYSTEINE_METABOLIC_PROCESS","GO_BP","491430_GO_0006534_CYSTEINE_METABOLIC_PROCESS",7,-1.3105,0.16,0.24,0.9023,0.59,1,-1.4326,0.074,0.56
"GO_BP:491916_GO_0007097_NUCLEAR_MIGRATION","GO_BP","491916_GO_0007097_NUCLEAR_MIGRATION",8,-1.3104,0.16,0.24,-1.0213,0.44,0.97,-1.0909,0.36,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2370_BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2370_BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN",126,-1.3104,0.038,0.17,1.7391,0,0.063,-0.8438,0.84,0.93
"GO_BP:487663_GO_0001767_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY","GO_BP","487663_GO_0001767_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY",5,-1.3104,0.17,0.24,-0.7316,0.78,1,-1.354,0.15,0.6
"GO_BP:487324_GO_0001101_RESPONSE_TO_ACID_CHEMICAL","GO_BP","487324_GO_0001101_RESPONSE_TO_ACID_CHEMICAL",267,-1.3104,0.03,0.24,0.9235,0.72,1,1.1651,0.12,0.73
"GO_BP:495959_GO_0015833_PEPTIDE_TRANSPORT","GO_BP","495959_GO_0015833_PEPTIDE_TRANSPORT",74,-1.3103,0.077,0.24,0.7553,0.93,1,1.1057,0.26,0.76
"C3_TF_targets:C3_TFT_33_V_COMP1_01","C3_TF_targets","C3_TFT_33_V_COMP1_01",110,-1.3103,0.066,0.081,-1.1485,0.18,0.45,-1.1889,0.14,0.36
"C1_Positional:C1_ALL_216_CHR22Q12","C1_Positional","C1_ALL_216_CHR22Q12",106,-1.3102,0.066,0.61,-0.7726,0.92,0.96,-1.1302,0.19,0.73
"C7_Immunologic_signatures:C7_ALL_808_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_808_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN",168,-1.3102,0.036,0.071,-1.0144,0.42,1,1.1294,0.2,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_596_RIZ_ERYTHROID_DIFFERENTIATION_6HR","C2_Chemical_and_genetic_perturbations","C2_CGP_596_RIZ_ERYTHROID_DIFFERENTIATION_6HR",36,-1.3102,0.1,0.17,0.6145,0.98,1,-1.113,0.29,0.61
"GO_BP:489131_GO_0003339_REGULATION_OF_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS","GO_BP","489131_GO_0003339_REGULATION_OF_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS",8,-1.3102,0.15,0.24,-1.2949,0.18,0.88,-1.2056,0.23,0.73
"KEGG_compound:C16578_MORPHINE_6_GLUCURONIDE","KEGG_compound","C16578_MORPHINE_6_GLUCURONIDE",19,-1.3102,0.15,0.3,1.9305,0,0.022,2.4161,0,0
"KEGG_compound:C16577_CODEINE_6_GLUCURONIDE","KEGG_compound","C16577_CODEINE_6_GLUCURONIDE",19,-1.3101,0.14,0.3,1.9361,0,0.022,2.4108,0,0
"GO_BP:507461_GO_0045061_THYMIC_T_CELL_SELECTION","GO_BP","507461_GO_0045061_THYMIC_T_CELL_SELECTION",18,-1.3101,0.12,0.24,0.7163,0.88,1,-0.8669,0.62,0.95
"GO_BP:501994_GO_0032768_REGULATION_OF_MONOOXYGENASE_ACTIVITY","GO_BP","501994_GO_0032768_REGULATION_OF_MONOOXYGENASE_ACTIVITY",53,-1.3101,0.088,0.24,0.8827,0.69,1,-0.8297,0.78,0.97
"GO_BP:506556_GO_0043525_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS","GO_BP","506556_GO_0043525_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS",48,-1.3098,0.1,0.24,-1.1645,0.21,0.91,-0.9475,0.54,0.89
"KEGG_reaction:R08259_SN_38_UDP_GLUCURONATE_SN38_GLUCURONIDE_UDP","KEGG_reaction","R08259_SN_38_UDP_GLUCURONATE_SN38_GLUCURONIDE_UDP",19,-1.3098,0.13,0.28,1.9822,0,0.028,2.3089,0,0
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_124_BIOCARTA_NFAT_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_124_BIOCARTA_NFAT_PATHWAY",53,-1.3098,0.089,0.25,0.987,0.47,0.83,-0.9126,0.62,0.84
"KEGG_compound:C05273_TRANS_TETRADEC_2_ENOYL_COA_2E_TETRADECENOYL_COA","KEGG_compound","C05273_TRANS_TETRADEC_2_ENOYL_COA_2E_TETRADECENOYL_COA",8,-1.3098,0.17,0.3,0.6127,0.92,1,-1.4613,0.08,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_2690_VALK_AML_CLUSTER_15","C2_Chemical_and_genetic_perturbations","C2_CGP_2690_VALK_AML_CLUSTER_15",30,-1.3097,0.14,0.17,0.9912,0.5,0.81,-1.0466,0.37,0.69
"KEGG_compound:C01335_ROH","KEGG_compound","C01335_ROH",19,-1.3097,0.14,0.3,1.9204,0,0.016,2.3848,0,0
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_179_BIOCARTA_IL1R_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_179_BIOCARTA_IL1R_PATHWAY",33,-1.3095,0.12,0.25,-0.9388,0.55,1,-0.8279,0.76,0.89
"GO_BP:487669_GO_0001773_MYELOID_DENDRITIC_CELL_ACTIVATION","GO_BP","487669_GO_0001773_MYELOID_DENDRITIC_CELL_ACTIVATION",23,-1.3094,0.14,0.24,-0.8482,0.69,1,-0.9628,0.51,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1118_BENPORATH_PROLIFERATION","C2_Chemical_and_genetic_perturbations","C2_CGP_1118_BENPORATH_PROLIFERATION",147,-1.3094,0.06,0.17,1.2528,0.062,0.43,-1.4278,0.01,0.34
"GO_BP:505243_GO_0042058_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","505243_GO_0042058_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",73,-1.3094,0.071,0.24,0.922,0.61,1,0.7059,0.97,1
"GO_BP:488450_GO_0002577_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION","GO_BP","488450_GO_0002577_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION",18,-1.3093,0.16,0.24,-0.8922,0.61,1,-0.9665,0.53,0.88
"KEGG_reaction:R09426_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_UDP_GLUCURONATE_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_GLUCURONIDE_UDP","KEGG_reaction","R09426_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_UDP_GLUCURONATE_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_GLUCURONIDE_UDP",19,-1.3093,0.13,0.28,1.977,0.0021,0.021,2.4557,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_3163_BAKKER_FOXO3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3163_BAKKER_FOXO3_TARGETS_UP",61,-1.3093,0.091,0.17,1.1137,0.25,0.61,0.8838,0.71,1
"GO_BP:508772_GO_0046513_CERAMIDE_BIOSYNTHETIC_PROCESS","GO_BP","508772_GO_0046513_CERAMIDE_BIOSYNTHETIC_PROCESS",30,-1.3091,0.13,0.24,-0.5851,0.99,1,-0.7905,0.8,0.99
"KEGG_compound:C00416_PHOSPHATIDATE_PHOSPHATIDIC_ACID_1_2_DIACYL_SN_GLYCEROL_3_PHOSPHATE_3_SN_PHOSPHATIDATE","KEGG_compound","C00416_PHOSPHATIDATE_PHOSPHATIDIC_ACID_1_2_DIACYL_SN_GLYCEROL_3_PHOSPHATE_3_SN_PHOSPHATIDATE",32,-1.3089,0.11,0.3,-1.1784,0.2,0.82,-0.8234,0.77,0.83
"GO_BP:505545_GO_0042402_CELLULAR_BIOGENIC_AMINE_CATABOLIC_PROCESS","GO_BP","505545_GO_0042402_CELLULAR_BIOGENIC_AMINE_CATABOLIC_PROCESS",16,-1.3089,0.14,0.24,-1.4342,0.068,0.93,-1.4586,0.063,0.54
"GO_MF:489646_GO_0004181_METALLOCARBOXYPEPTIDASE_ACTIVITY","GO_MF","489646_GO_0004181_METALLOCARBOXYPEPTIDASE_ACTIVITY",23,-1.3089,0.14,0.29,-0.6504,0.94,1,-1.556,0.02,0.4
"GO_BP:496976_GO_0017187_PEPTIDYL_GLUTAMIC_ACID_CARBOXYLATION","GO_BP","496976_GO_0017187_PEPTIDYL_GLUTAMIC_ACID_CARBOXYLATION",12,-1.3089,0.16,0.24,-0.9278,0.56,1,-0.9532,0.52,0.89
"GO_BP:493307_GO_0009108_COENZYME_BIOSYNTHETIC_PROCESS","GO_BP","493307_GO_0009108_COENZYME_BIOSYNTHETIC_PROCESS",100,-1.3088,0.063,0.24,0.8863,0.74,1,-1.4901,0.0063,0.54
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_180_BIOCARTA_MET_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_180_BIOCARTA_MET_PATHWAY",37,-1.3087,0.11,0.25,1.0019,0.44,0.84,0.769,0.86,1
"C3_MicroRNA_targets:C3_MIR_178_AGGTGCA_MIR_500","C3_MicroRNA_targets","C3_MIR_178_AGGTGCA_MIR_500",96,-1.3087,0.074,0.24,0.7036,0.99,1,-0.7415,0.96,1
"GO_BP:510409_GO_0048302_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES","GO_BP","510409_GO_0048302_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES",9,-1.3087,0.16,0.24,-0.7508,0.79,1,-1.2209,0.22,0.71
"GO_BP:487976_GO_0002087_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE_BY_NEUROLOGICAL_SYSTEM_PROCESS","GO_BP","487976_GO_0002087_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE_BY_NEUROLOGICAL_SYSTEM_PROCESS",13,-1.3087,0.14,0.24,-1.3128,0.14,0.87,-1.2881,0.16,0.65
"GO_BP:508145_GO_0045822_NEGATIVE_REGULATION_OF_HEART_CONTRACTION","GO_BP","508145_GO_0045822_NEGATIVE_REGULATION_OF_HEART_CONTRACTION",21,-1.3086,0.13,0.24,0.9566,0.49,1,0.8986,0.61,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2545_RUIZ_TNC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2545_RUIZ_TNC_TARGETS_DN",141,-1.3085,0.058,0.17,1.2732,0.038,0.42,-0.8933,0.73,0.89
"C3_TF_targets:C3_TFT_441_V_FOX_Q2","C3_TF_targets","C3_TFT_441_V_FOX_Q2",206,-1.3084,0.033,0.083,-0.9351,0.62,0.9,-1.0726,0.28,0.6
"GO_CC:502859_GO_0033643_HOST_CELL_PART","GO_CC","502859_GO_0033643_HOST_CELL_PART",8,-1.3084,0.16,0.31,-1.2349,0.22,0.63,-0.7047,0.86,1
"KEGG_compound:C00043_UDP_N_ACETYL_ALPHA_D_GLUCOSAMINE_UDP_N_ACETYL_D_GLUCOSAMINE_UDP_N_ACETYLGLUCOSAMINE","KEGG_compound","C00043_UDP_N_ACETYL_ALPHA_D_GLUCOSAMINE_UDP_N_ACETYL_D_GLUCOSAMINE_UDP_N_ACETYLGLUCOSAMINE",6,-1.3084,0.19,0.3,-1.0214,0.45,1,-0.5897,0.93,0.97
"REACTOME:1127598_REACT_264366_SIALIC_ACID_METABOLISM","REACTOME","1127598_REACT_264366_SIALIC_ACID_METABOLISM",33,-1.3082,0.11,0.28,0.8073,0.76,0.99,0.8466,0.71,1
"C3_TF_targets:C3_TFT_360_V_AP3_Q6","C3_TF_targets","C3_TFT_360_V_AP3_Q6",237,-1.308,0.029,0.083,0.8865,0.81,1,1.0006,0.45,1
"GO_BP:505682_GO_0042551_NEURON_MATURATION","GO_BP","505682_GO_0042551_NEURON_MATURATION",30,-1.308,0.11,0.24,-1.6999,0.0056,0.63,-1.128,0.27,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_1640_LEE_CALORIE_RESTRICTION_NEOCORTEX_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1640_LEE_CALORIE_RESTRICTION_NEOCORTEX_UP",83,-1.3079,0.081,0.17,-0.6437,1,1,-1.0842,0.32,0.65
"C4_Cancer_modules:C4_CM_429_MODULE_573","C4_Cancer_modules","C4_CM_429_MODULE_573",25,-1.3078,0.13,0.16,1.3165,0.12,0.26,0.8571,0.68,1
"GO_BP:508724_GO_0046463_ACYLGLYCEROL_BIOSYNTHETIC_PROCESS","GO_BP","508724_GO_0046463_ACYLGLYCEROL_BIOSYNTHETIC_PROCESS",45,-1.3078,0.099,0.24,-0.5645,1,1,-1.3124,0.1,0.64
"KEGG_compound:C00523_ANDROSTERONE_3ALPHA_HYDROXY_5ALPHA_ANDROSTAN_17_ONE","KEGG_compound","C00523_ANDROSTERONE_3ALPHA_HYDROXY_5ALPHA_ANDROSTAN_17_ONE",20,-1.3078,0.14,0.3,1.9304,0.0042,0.02,2.1846,0,9.9e-05
"GO_BP:518669_GO_2000020_POSITIVE_REGULATION_OF_MALE_GONAD_DEVELOPMENT","GO_BP","518669_GO_2000020_POSITIVE_REGULATION_OF_MALE_GONAD_DEVELOPMENT",8,-1.3077,0.16,0.24,-1.0553,0.39,0.97,1.493,0.058,0.57
"GO_BP:812249_GO_1990089_RESPONSE_TO_NERVE_GROWTH_FACTOR","GO_BP","812249_GO_1990089_RESPONSE_TO_NERVE_GROWTH_FACTOR",18,-1.3077,0.13,0.24,0.5635,0.98,1,1.0216,0.42,0.83
"GO_BP:499568_GO_0030148_SPHINGOLIPID_BIOSYNTHETIC_PROCESS","GO_BP","499568_GO_0030148_SPHINGOLIPID_BIOSYNTHETIC_PROCESS",63,-1.3076,0.092,0.24,-0.7491,0.92,1,-0.9329,0.58,0.9
"KEGG_pathway:HSA04623_CYTOSOLIC_DNA_SENSING_PATHWAY","KEGG_pathway","HSA04623_CYTOSOLIC_DNA_SENSING_PATHWAY",58,-1.3076,0.092,0.12,-0.6132,0.99,1,-1.4848,0.033,0.14
"C2_Chemical_and_genetic_perturbations:C2_CGP_580_KONG_E2F3_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_580_KONG_E2F3_TARGETS",97,-1.3075,0.065,0.17,1.116,0.23,0.6,-1.6518,0,0.22
"GO_BP:511867_GO_0050932_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION","GO_BP","511867_GO_0050932_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION",9,-1.3075,0.18,0.24,0.9941,0.45,0.98,-1.0764,0.37,0.8
"GO_MF:496568_GO_0016627_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS","GO_MF","496568_GO_0016627_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS",54,-1.3074,0.11,0.29,0.8356,0.77,1,-1.8158,0,0.2
"GO_BP:514762_GO_0061217_REGULATION_OF_MESONEPHROS_DEVELOPMENT","GO_BP","514762_GO_0061217_REGULATION_OF_MESONEPHROS_DEVELOPMENT",26,-1.3074,0.14,0.24,1.2729,0.14,0.7,1.0935,0.31,0.77
"C7_Immunologic_signatures:C7_ALL_1333_GSE30083_SP2_VS_SP4_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1333_GSE30083_SP2_VS_SP4_THYMOCYTE_UP",192,-1.3074,0.045,0.073,-0.9658,0.52,1,-1.2921,0.027,0.15
"GO_CC:501246_GO_0032009_EARLY_PHAGOSOME","GO_CC","501246_GO_0032009_EARLY_PHAGOSOME",5,-1.3073,0.16,0.31,-0.8028,0.7,1,-1.3994,0.1,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_1444_SANSOM_APC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1444_SANSOM_APC_TARGETS_UP",124,-1.3073,0.053,0.17,-0.8577,0.78,1,-1.4747,0.0083,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_1094_COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1094_COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP",34,-1.3072,0.1,0.17,0.8659,0.7,0.96,-1.0359,0.4,0.71
"KEGG_reaction:R09427_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_UDP_GLUCURONATE_NNAL_N_GLUCURONIDE_UDP","KEGG_reaction","R09427_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_UDP_GLUCURONATE_NNAL_N_GLUCURONIDE_UDP",19,-1.3071,0.13,0.28,1.9359,0,0.0096,2.4017,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_2777_MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2777_MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3",5,-1.307,0.16,0.17,-1.0577,0.41,0.97,-0.9101,0.56,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_3028_WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3028_WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN",29,-1.307,0.11,0.17,-0.7705,0.79,1,-0.8931,0.64,0.89
"KEGG_compound:C00398_TRYPTAMINE_3_2_AMINOETHYL_INDOLE","KEGG_compound","C00398_TRYPTAMINE_3_2_AMINOETHYL_INDOLE",5,-1.3069,0.17,0.3,0.9519,0.52,1,1.1234,0.34,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2041_HOWLIN_CITED1_TARGETS_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2041_HOWLIN_CITED1_TARGETS_1_UP",35,-1.3066,0.12,0.17,1.2907,0.1,0.4,-0.9492,0.55,0.82
"GO_BP:500180_GO_0030885_REGULATION_OF_MYELOID_DENDRITIC_CELL_ACTIVATION","GO_BP","500180_GO_0030885_REGULATION_OF_MYELOID_DENDRITIC_CELL_ACTIVATION",5,-1.3066,0.12,0.24,1.3824,0.11,0.57,-1.0577,0.42,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_3193_BILANGES_SERUM_SENSITIVE_VIA_TSC1","C2_Chemical_and_genetic_perturbations","C2_CGP_3193_BILANGES_SERUM_SENSITIVE_VIA_TSC1",23,-1.3066,0.15,0.17,1.0178,0.39,0.78,1.0064,0.45,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_265_DITTMER_PTHLH_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_265_DITTMER_PTHLH_TARGETS_UP",111,-1.3065,0.058,0.17,1.2107,0.12,0.48,0.7225,0.98,1
"KEGG_compound:C00777_RETINOATE_RETINOIC_ACID_VITAMIN_A_ACID_ALL_TRANS_RETINOATE_ACIDE_RETINOIQUE_FRENCH_DSL_TRETINOINE_FRENCH_EINECS_3_7_DIMETHYL_9_2_6_6_TRIMETHYL_1_CYCLOHEXENE_1_YL_2_4_6_8_NONATETRAENOIC_ACID_ECL_ALL_E_3_7_DIMETHYL_9_2_6_6_TRIMETHYL_1_CYCLOHEXEN_1_YL_2_4_6_8_NONATETRAENOIC_ACID_BETA_RETINOIC_ACID_AGN_100335_ALL_E_RETINOIC_ACID_ALL_TRANS_BETA_RETINOIC_ACID_ALL_TRANS_RETINOIC_ACID_ALL_TRANS_TRETINOIN_ALL_TRANS_VITAMIN_A_ACID_RO_1_5488_TRANS_RETINOIC_ACID_TRETIN_M_ALL_TRANS_VITAMIN_A1_ACID","KEGG_compound","C00777_RETINOATE_RETINOIC_ACID_VITAMIN_A_ACID_ALL_TRANS_RETINOATE_ACIDE_RETINOIQUE_FRENCH_DSL_TRETINOINE_FRENCH_EINECS_3_7_DIMETHYL_9_2_6_6_TRIMETHYL_1_CYCLOHEXENE_1_YL_2_4_6_8_NONATETRAENOIC_ACID_ECL_ALL_E_3_7_DIMETHYL_9_2_6_6_TRIMETHYL_1_CYCLOHEXEN_1_YL_2_4_6_8_NONATETRAENOIC_ACID_BETA_RETINOIC_ACID_AGN_100335_ALL_E_RETINOIC_ACID_ALL_TRANS_BETA_RETINOIC_ACID_ALL_TRANS_RETINOIC_ACID_ALL_TRANS_TRETINOIN_ALL_TRANS_VITAMIN_A_ACID_RO_1_5488_TRANS_RETINOIC_ACID_TRETIN_M_ALL_TRANS_VITAMIN_A1_ACID",38,-1.3065,0.096,0.3,1.4659,0.052,0.38,1.9861,0,0.0016
"KEGG_pathway:HSA04727_GABAERGIC_SYNAPSE","KEGG_pathway","HSA04727_GABAERGIC_SYNAPSE",85,-1.3065,0.069,0.12,-0.9668,0.55,0.93,-1.39,0.025,0.18
"C6_Oncogenic_signatures:C6_ALL_65_LTE2_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_65_LTE2_UP_V1_DN",194,-1.3063,0.028,0.08,1.1437,0.12,0.43,-1.0685,0.27,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_3043_STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3043_STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP",81,-1.3062,0.07,0.17,0.8657,0.76,0.96,-0.882,0.73,0.9
"KEGG_reaction:R03091_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ESTRADIOL_17BETA_UDP_GLUCURONATE_ESTRADIOL_17BETA_3_GLUCURONIDE_UDP","KEGG_reaction","R03091_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ESTRADIOL_17BETA_UDP_GLUCURONATE_ESTRADIOL_17BETA_3_GLUCURONIDE_UDP",19,-1.3061,0.15,0.28,1.922,0.0021,0.0064,2.3874,0,0
"GO_BP:512055_GO_0051145_SMOOTH_MUSCLE_CELL_DIFFERENTIATION","GO_BP","512055_GO_0051145_SMOOTH_MUSCLE_CELL_DIFFERENTIATION",35,-1.3061,0.12,0.24,0.804,0.77,1,1.671,0.012,0.4
"GO_BP:501464_GO_0032229_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC","GO_BP","501464_GO_0032229_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC",7,-1.306,0.17,0.24,-1.5107,0.04,0.82,1.4021,0.13,0.63
"GO_CC:497888_GO_0018995_HOST","GO_CC","497888_GO_0018995_HOST",8,-1.306,0.15,0.31,-1.2198,0.23,0.66,-0.7125,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3232_KUWANO_RNA_STABILIZED_BY_NO","C2_Chemical_and_genetic_perturbations","C2_CGP_3232_KUWANO_RNA_STABILIZED_BY_NO",7,-1.3059,0.18,0.17,-1.3319,0.13,0.69,0.7367,0.8,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_41_BIOCARTA_CLASSIC_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_41_BIOCARTA_CLASSIC_PATHWAY",14,-1.3059,0.15,0.25,-0.8983,0.6,1,-0.9789,0.47,0.77
"C4_Cancer_gene_neighborhoods:C4_CGN_342_GNF2_CYP2B6","C4_Cancer_gene_neighborhoods","C4_CGN_342_GNF2_CYP2B6",49,-1.3057,0.12,0.21,-1.1205,0.26,0.72,1.6813,0,0.091
"C2_Chemical_and_genetic_perturbations:C2_CGP_541_DARWICHE_PAPILLOMA_RISK_LOW_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_541_DARWICHE_PAPILLOMA_RISK_LOW_DN",157,-1.3057,0.052,0.17,-1.0228,0.37,0.98,-0.9075,0.71,0.87
"GO_BP:506537_GO_0043506_REGULATION_OF_JUN_KINASE_ACTIVITY","GO_BP","506537_GO_0043506_REGULATION_OF_JUN_KINASE_ACTIVITY",75,-1.3056,0.09,0.24,-0.9933,0.45,1,-0.9416,0.58,0.89
"GO_MF:812218_GO_0036374_GLUTATHIONE_HYDROLASE_ACTIVITY","GO_MF","812218_GO_0036374_GLUTATHIONE_HYDROLASE_ACTIVITY",6,-1.3056,0.16,0.29,-1.0535,0.41,0.86,-1.1013,0.36,0.71
"GO_BP:505667_GO_0042536_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS","GO_BP","505667_GO_0042536_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_BIOSYNTHETIC_PROCESS",5,-1.3054,0.16,0.24,-1.1774,0.31,0.9,-1.1433,0.33,0.74
"GO_BP:487465_GO_0006029_PROTEOGLYCAN_METABOLIC_PROCESS","GO_BP","487465_GO_0006029_PROTEOGLYCAN_METABOLIC_PROCESS",93,-1.3054,0.074,0.24,0.8461,0.81,1,1.117,0.23,0.75
"GO_BP:487717_GO_0001821_HISTAMINE_SECRETION","GO_BP","487717_GO_0001821_HISTAMINE_SECRETION",9,-1.3053,0.17,0.24,0.9749,0.46,1,-0.9821,0.46,0.87
"WikiPathways:672456_WP2034_LEPTIN_SIGNALING_PATHWAY","WikiPathways","672456_WP2034_LEPTIN_SIGNALING_PATHWAY",60,-1.3052,0.081,0.19,0.6772,0.99,1,-0.9091,0.64,0.84
"GO_BP:502844_GO_0033628_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN","GO_BP","502844_GO_0033628_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN",41,-1.3052,0.1,0.24,1.1011,0.29,0.9,0.9689,0.49,0.89
"GO_CC:501816_GO_0032590_DENDRITE_MEMBRANE","GO_CC","501816_GO_0032590_DENDRITE_MEMBRANE",15,-1.3052,0.17,0.31,1.0546,0.38,0.71,1.387,0.088,0.78
"KEGG_reaction:R09428_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_UDP_GLUCURONATE_ACCEPTOR_UDP_ACCEPTOR_BETA_D_GLUCURONOSIDE","KEGG_reaction","R09428_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_UDP_GLUCURONATE_ACCEPTOR_UDP_ACCEPTOR_BETA_D_GLUCURONOSIDE",19,-1.3052,0.11,0.27,1.9353,0.002,0.0088,2.4038,0,0
"C3_TF_targets:C3_TFT_64_V_PAX6_01","C3_TF_targets","C3_TFT_64_V_PAX6_01",98,-1.3051,0.078,0.085,-0.9822,0.48,0.8,-1.2352,0.1,0.29
"GO_BP:517079_GO_0072163_MESONEPHRIC_EPITHELIUM_DEVELOPMENT","GO_BP","517079_GO_0072163_MESONEPHRIC_EPITHELIUM_DEVELOPMENT",87,-1.3051,0.062,0.24,-0.8875,0.69,1,1.3931,0.026,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1955_KRASNOSELSKAYA_ILF3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1955_KRASNOSELSKAYA_ILF3_TARGETS_DN",46,-1.3049,0.1,0.17,-1.0989,0.3,0.92,-0.8539,0.74,0.92
"GO_CC:487458_GO_0001518_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX","GO_CC","487458_GO_0001518_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX",14,-1.3048,0.18,0.31,-1.007,0.44,0.85,0.9345,0.54,1
"GO_BP:513526_GO_0055093_RESPONSE_TO_HYPEROXIA","GO_BP","513526_GO_0055093_RESPONSE_TO_HYPEROXIA",20,-1.3048,0.14,0.24,-0.6703,0.93,1,-0.8966,0.59,0.93
"GO_BP:517488_GO_0072583_CLATHRIN_MEDIATED_ENDOCYTOSIS","GO_BP","517488_GO_0072583_CLATHRIN_MEDIATED_ENDOCYTOSIS",16,-1.3048,0.14,0.24,0.4363,0.99,1,-1.1245,0.29,0.75
"C7_Immunologic_signatures:C7_ALL_170_GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN","C7_Immunologic_signatures","C7_ALL_170_GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN",197,-1.3047,0.042,0.076,1.0327,0.35,0.64,-0.9289,0.66,0.89
"GO_BP:505380_GO_0042219_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS","GO_BP","505380_GO_0042219_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS",15,-1.3047,0.14,0.24,0.7751,0.77,1,-0.921,0.56,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1763_WESTON_VEGFA_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1763_WESTON_VEGFA_TARGETS",104,-1.3046,0.07,0.17,1.2338,0.11,0.45,1.0156,0.42,0.95
"KEGG_reaction:R08263_MORPHINE_UDP_GLUCURONATE_MORPHINE_6_GLUCURONIDE_UDP","KEGG_reaction","R08263_MORPHINE_UDP_GLUCURONATE_MORPHINE_6_GLUCURONIDE_UDP",19,-1.3044,0.14,0.27,1.9435,0,0.015,2.4346,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_2098_TESAR_ALK_TARGETS_EPISC_4D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2098_TESAR_ALK_TARGETS_EPISC_4D_UP",6,-1.3044,0.15,0.17,-0.8181,0.69,1,-0.9495,0.52,0.82
"REACTOME:106261_REACT_17044_MUSCLE_CONTRACTION","REACTOME","106261_REACT_17044_MUSCLE_CONTRACTION",60,-1.3042,0.1,0.28,1.2199,0.14,0.42,-0.872,0.71,0.96
"C3_TF_targets:C3_TFT_368_V_TEF1_Q6","C3_TF_targets","C3_TFT_368_V_TEF1_Q6",218,-1.3042,0.036,0.086,-1.2631,0.044,0.26,-0.9255,0.7,0.89
"GO_BP:512033_GO_0051122_HEPOXILIN_BIOSYNTHETIC_PROCESS","GO_BP","512033_GO_0051122_HEPOXILIN_BIOSYNTHETIC_PROCESS",5,-1.3041,0.15,0.25,0.9296,0.53,1,-1.5226,0.038,0.53
"C7_Immunologic_signatures:C7_ALL_658_GSE17721_LPS_VS_CPG_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_658_GSE17721_LPS_VS_CPG_2H_BMDM_DN",195,-1.304,0.035,0.076,1.3222,0.024,0.083,0.7818,0.96,1
"GO_BP:491809_GO_0006970_RESPONSE_TO_OSMOTIC_STRESS","GO_BP","491809_GO_0006970_RESPONSE_TO_OSMOTIC_STRESS",67,-1.3039,0.083,0.25,-0.9541,0.51,1,-1.0492,0.34,0.81
"GO_BP:518268_GO_0090128_REGULATION_OF_SYNAPSE_MATURATION","GO_BP","518268_GO_0090128_REGULATION_OF_SYNAPSE_MATURATION",12,-1.3039,0.17,0.25,-1.3193,0.14,0.89,-1.1544,0.28,0.74
"KEGG_reaction:R04354_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_2_METHOXY_17BETA_ESTRADIOL_UDP_GLUCURONATE_2_METHOXY_ESTRADIOL_17BETA_3_GLUCURONIDE_UDP","KEGG_reaction","R04354_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_2_METHOXY_17BETA_ESTRADIOL_UDP_GLUCURONATE_2_METHOXY_ESTRADIOL_17BETA_3_GLUCURONIDE_UDP",19,-1.3039,0.13,0.27,1.9839,0.0021,0.055,2.3328,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_1337_KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1337_KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN",41,-1.3038,0.12,0.17,1.223,0.18,0.46,-1.0054,0.43,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_3339_ROESSLER_LIVER_CANCER_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3339_ROESSLER_LIVER_CANCER_METASTASIS_UP",105,-1.3037,0.059,0.17,0.8883,0.71,0.93,-1.1513,0.17,0.58
"GO_BP:508833_GO_0046579_POSITIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","508833_GO_0046579_POSITIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION",30,-1.3037,0.11,0.25,-0.799,0.81,1,0.8665,0.69,0.97
"C7_Immunologic_signatures:C7_ALL_152_GSE13306_TREG_RA_VS_TCONV_RA_DN","C7_Immunologic_signatures","C7_ALL_152_GSE13306_TREG_RA_VS_TCONV_RA_DN",196,-1.3037,0.04,0.077,-1.4839,0,0.084,-0.8493,0.87,1
"GO_BP:502023_GO_0032800_RECEPTOR_BIOSYNTHETIC_PROCESS","GO_BP","502023_GO_0032800_RECEPTOR_BIOSYNTHETIC_PROCESS",5,-1.3036,0.15,0.25,-0.7873,0.73,1,0.8628,0.63,0.97
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_9_BIOCARTA_AGR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_9_BIOCARTA_AGR_PATHWAY",35,-1.3036,0.15,0.25,0.8817,0.67,0.93,-0.9181,0.57,0.85
"C7_Immunologic_signatures:C7_ALL_598_GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_598_GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDM_DN",198,-1.3035,0.041,0.077,1.4132,0.011,0.034,-0.757,0.97,1
"REACTOME:685534_REACT_147723_PI3K_AKT_SIGNALING_IN_CANCER","REACTOME","685534_REACT_147723_PI3K_AKT_SIGNALING_IN_CANCER",78,-1.3034,0.084,0.28,-1.1028,0.28,0.9,-0.8039,0.88,1
"REACTOME:106190_REACT_916_TRYPTOPHAN_CATABOLISM","REACTOME","106190_REACT_916_TRYPTOPHAN_CATABOLISM",11,-1.3034,0.16,0.28,-1.2945,0.16,0.67,-1.6296,0.022,0.23
"KEGG_compound:C05504_16_GLUCURONIDE_ESTRIOL_16ALPHA_17BETA_ESTRIOL_16_BETA_D_GLUCURONIDE_","KEGG_compound","C05504_16_GLUCURONIDE_ESTRIOL_16ALPHA_17BETA_ESTRIOL_16_BETA_D_GLUCURONIDE_",19,-1.3034,0.14,0.3,1.9523,0,0.039,2.4357,0,0
"GO_BP:509097_GO_0046888_NEGATIVE_REGULATION_OF_HORMONE_SECRETION","GO_BP","509097_GO_0046888_NEGATIVE_REGULATION_OF_HORMONE_SECRETION",60,-1.3032,0.081,0.25,-1.3939,0.041,1,-1.2922,0.075,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_981_GROSS_HIF1A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_981_GROSS_HIF1A_TARGETS_DN",24,-1.3032,0.14,0.17,1.2715,0.13,0.42,-0.6842,0.92,0.99
"GO_BP:498210_GO_0019367_FATTY_ACID_ELONGATION_SATURATED_FATTY_ACID","GO_BP","498210_GO_0019367_FATTY_ACID_ELONGATION_SATURATED_FATTY_ACID",5,-1.3032,0.16,0.25,-0.8029,0.71,1,-1.4049,0.1,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1072_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1072_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP",6,-1.3032,0.17,0.17,-1.226,0.24,0.78,0.8392,0.66,1
"GO_BP:493582_GO_0009409_RESPONSE_TO_COLD","GO_BP","493582_GO_0009409_RESPONSE_TO_COLD",37,-1.3031,0.11,0.25,1.1857,0.21,0.8,0.8942,0.65,0.95
"GO_MF:486783_GO_0003924_GTPASE_ACTIVITY","GO_MF","486783_GO_0003924_GTPASE_ACTIVITY",240,-1.3031,0.032,0.3,1.039,0.34,0.83,-1.1345,0.15,0.66
"C3_TF_targets:C3_TFT_66_V_S8_01","C3_TF_targets","C3_TFT_66_V_S8_01",233,-1.3031,0.027,0.086,-0.9171,0.69,0.93,1.0426,0.34,1
"GO_MF:492678_GO_0008375_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY","GO_MF","492678_GO_0008375_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY",44,-1.3031,0.1,0.3,0.7102,0.95,1,-1.0595,0.35,0.74
"REACTOME:105814_REACT_1100_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION","REACTOME","105814_REACT_1100_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION",14,-1.3031,0.14,0.28,0.7482,0.81,1,-0.8391,0.7,1
"GO_BP:505181_GO_0040023_ESTABLISHMENT_OF_NUCLEUS_LOCALIZATION","GO_BP","505181_GO_0040023_ESTABLISHMENT_OF_NUCLEUS_LOCALIZATION",12,-1.303,0.15,0.25,-1.2964,0.15,0.88,-1.3204,0.12,0.63
"C7_Immunologic_signatures:C7_ALL_26_GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_26_GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN",198,-1.303,0.037,0.077,1.3644,0.014,0.054,-0.9993,0.43,0.72
"GO_BP:511862_GO_0050927_POSITIVE_REGULATION_OF_POSITIVE_CHEMOTAXIS","GO_BP","511862_GO_0050927_POSITIVE_REGULATION_OF_POSITIVE_CHEMOTAXIS",23,-1.303,0.13,0.25,0.814,0.76,1,-0.8037,0.75,0.99
"KEGG_compound:C05635_5_HYDROXYINDOLEACETATE","KEGG_compound","C05635_5_HYDROXYINDOLEACETATE",7,-1.303,0.14,0.3,0.7556,0.8,1,0.8409,0.63,0.88
"C3_MicroRNA_targets:C3_MIR_110_AGGAAGC_MIR_516_3P","C3_MicroRNA_targets","C3_MIR_110_AGGAAGC_MIR_516_3P",120,-1.3029,0.074,0.25,-0.8483,0.81,1,-0.9988,0.49,1
"C3_MicroRNA_targets:C3_MIR_14_TTGCACT_MIR_130A_MIR_301_MIR_130B","C3_MicroRNA_targets","C3_MIR_14_TTGCACT_MIR_130A_MIR_301_MIR_130B",400,-1.3029,0.0084,0.24,-0.8344,0.96,1,-1.1396,0.098,1
"GO_BP:517226_GO_0072310_GLOMERULAR_EPITHELIAL_CELL_DEVELOPMENT","GO_BP","517226_GO_0072310_GLOMERULAR_EPITHELIAL_CELL_DEVELOPMENT",9,-1.3029,0.17,0.25,-1.1094,0.34,0.94,-1.188,0.24,0.73
"GO_BP:494703_GO_0010639_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION","GO_BP","494703_GO_0010639_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION",274,-1.3029,0.023,0.25,0.8356,0.95,1,-1.0852,0.21,0.79
"KEGG_compound:C11136_ETIOCHOLAN_3ALPHA_OL_17_ONE_3_GLUCURONIDE","KEGG_compound","C11136_ETIOCHOLAN_3ALPHA_OL_17_ONE_3_GLUCURONIDE",19,-1.3028,0.14,0.3,1.9151,0.0061,0.015,2.4069,0,0
"GO_BP:511891_GO_0050957_EQUILIBRIOCEPTION","GO_BP","511891_GO_0050957_EQUILIBRIOCEPTION",8,-1.3028,0.16,0.25,1.3759,0.14,0.58,1.6694,0.022,0.4
"C4_Cancer_modules:C4_CM_126_MODULE_131","C4_Cancer_modules","C4_CM_126_MODULE_131",32,-1.3027,0.11,0.17,1.1294,0.25,0.49,1.0771,0.34,0.83
"REACTOME:833832_REACT_163710_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING","REACTOME","833832_REACT_163710_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING",26,-1.3027,0.12,0.28,0.8997,0.61,0.9,1.0183,0.45,1
"C7_Immunologic_signatures:C7_ALL_1153_GSE27786_LSK_VS_NKTCELL_UP","C7_Immunologic_signatures","C7_ALL_1153_GSE27786_LSK_VS_NKTCELL_UP",199,-1.3026,0.034,0.077,-0.9012,0.73,1,-1.3906,0.0083,0.068
"KEGG_compound:C11135_ANDROSTERONE_GLUCURONIDE_ANDROSTERONE_3_GLUCURONIDE","KEGG_compound","C11135_ANDROSTERONE_GLUCURONIDE_ANDROSTERONE_3_GLUCURONIDE",19,-1.3026,0.16,0.3,1.9177,0.0043,0.015,2.4217,0,0
"C7_Immunologic_signatures:C7_ALL_163_GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP","C7_Immunologic_signatures","C7_ALL_163_GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP",187,-1.3025,0.053,0.077,-1.3249,0.015,0.4,-1.2516,0.06,0.19
"REACTOME:106454_REACT_13815_AXONAL_GROWTH_INHIBITION_RHOA_ACTIVATION_","REACTOME","106454_REACT_13815_AXONAL_GROWTH_INHIBITION_RHOA_ACTIVATION_",10,-1.3025,0.15,0.28,-0.9656,0.51,1,0.6773,0.86,1
"GO_BP:491392_GO_0006491_N_GLYCAN_PROCESSING","GO_BP","491392_GO_0006491_N_GLYCAN_PROCESSING",10,-1.3024,0.16,0.25,0.716,0.84,1,-0.7603,0.78,1
"C7_Immunologic_signatures:C7_ALL_1142_GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN","C7_Immunologic_signatures","C7_ALL_1142_GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN",196,-1.3024,0.044,0.077,1.223,0.067,0.19,1.0412,0.32,1
"C7_Immunologic_signatures:C7_ALL_437_GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP","C7_Immunologic_signatures","C7_ALL_437_GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP",198,-1.3024,0.053,0.077,-0.6268,1,1,-0.9866,0.48,0.76
"KEGG_reaction:R04353_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_2_METHOXYESTRONE_UDP_GLUCURONATE_2_METHOXYESTRONE_3_GLUCURONIDE_UDP","KEGG_reaction","R04353_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_2_METHOXYESTRONE_UDP_GLUCURONATE_2_METHOXYESTRONE_3_GLUCURONIDE_UDP",19,-1.3023,0.16,0.27,1.9382,0,0.013,2.4323,0,0
"C2_Chemical_and_genetic_perturbations:C2_CGP_90_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_90_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP",90,-1.3023,0.083,0.17,1.1901,0.16,0.5,-0.9752,0.51,0.79
"GO_BP:505722_GO_0042596_FEAR_RESPONSE","GO_BP","505722_GO_0042596_FEAR_RESPONSE",31,-1.3023,0.13,0.25,1.021,0.42,0.97,1.5877,0.017,0.44
"GO_BP:505558_GO_0042417_DOPAMINE_METABOLIC_PROCESS","GO_BP","505558_GO_0042417_DOPAMINE_METABOLIC_PROCESS",26,-1.3023,0.13,0.25,-0.8606,0.67,1,-1.6855,0.012,0.62
"GO_BP:499628_GO_0030218_ERYTHROCYTE_DIFFERENTIATION","GO_BP","499628_GO_0030218_ERYTHROCYTE_DIFFERENTIATION",75,-1.3023,0.093,0.25,1.2881,0.086,0.69,-1.1696,0.17,0.73
"GO_BP:491180_GO_0006208_PYRIMIDINE_NUCLEOBASE_CATABOLIC_PROCESS","GO_BP","491180_GO_0006208_PYRIMIDINE_NUCLEOBASE_CATABOLIC_PROCESS",7,-1.3022,0.17,0.25,1.1792,0.27,0.8,-1.082,0.37,0.79
"GO_CC:501815_GO_0032589_NEURON_PROJECTION_MEMBRANE","GO_CC","501815_GO_0032589_NEURON_PROJECTION_MEMBRANE",31,-1.3022,0.13,0.31,-0.8829,0.65,0.96,1.0795,0.34,0.93
"C4_Cancer_gene_neighborhoods:C4_CGN_105_MORF_FSHR","C4_Cancer_gene_neighborhoods","C4_CGN_105_MORF_FSHR",269,-1.3022,0.028,0.21,-1.1418,0.16,0.68,1.0714,0.24,0.65
"GO_BP:502374_GO_0033153_T_CELL_RECEPTOR_V_D_J_RECOMBINATION","GO_BP","502374_GO_0033153_T_CELL_RECEPTOR_V_D_J_RECOMBINATION",5,-1.3022,0.15,0.25,0.6828,0.84,1,-0.9689,0.52,0.88
"GO_BP:492817_GO_0008542_VISUAL_LEARNING","GO_BP","492817_GO_0008542_VISUAL_LEARNING",47,-1.3022,0.096,0.25,-1.1419,0.24,0.93,0.9243,0.58,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_503_MCBRYAN_PUBERTAL_BREAST_5_6WK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_503_MCBRYAN_PUBERTAL_BREAST_5_6WK_DN",135,-1.3021,0.057,0.17,0.7243,0.98,1,0.7236,1,1
"REACTOME:833829_REACT_163769_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION","REACTOME","833829_REACT_163769_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION",97,-1.302,0.063,0.28,-1.1123,0.25,0.88,-0.8937,0.7,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2088_NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_2088_NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER",22,-1.302,0.14,0.17,-1.2114,0.18,0.8,-1.177,0.23,0.54
"GO_BP:488258_GO_0002385_MUCOSAL_IMMUNE_RESPONSE","GO_BP","488258_GO_0002385_MUCOSAL_IMMUNE_RESPONSE",34,-1.302,0.13,0.25,0.9691,0.49,1,-0.9096,0.59,0.92
"C3_TF_targets:C3_TFT_274_V_POU3F2_02","C3_TF_targets","C3_TFT_274_V_POU3F2_02",252,-1.3019,0.03,0.087,-1.0095,0.44,0.74,1.1534,0.12,0.84
"C4_Cancer_gene_neighborhoods:C4_CGN_282_GNF2_ATM","C4_Cancer_gene_neighborhoods","C4_CGN_282_GNF2_ATM",30,-1.3019,0.12,0.21,0.8059,0.77,0.98,-1.198,0.22,0.45
"KEGG_reaction:R02358_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ESTRONE_UDP_GLUCURONATE_ESTRONE_GLUCURONIDE_UDP","KEGG_reaction","R02358_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_ESTRONE_UDP_GLUCURONATE_ESTRONE_GLUCURONIDE_UDP",19,-1.3018,0.15,0.26,1.9367,0.0019,0.01,2.3904,0,0
"WikiPathways:198828_WP516_HYPERTROPHY_MODEL","WikiPathways","198828_WP516_HYPERTROPHY_MODEL",20,-1.3018,0.14,0.19,-1.0799,0.35,0.99,1.0213,0.43,0.88
"GO_MF:499732_GO_0030331_ESTROGEN_RECEPTOR_BINDING","GO_MF","499732_GO_0030331_ESTROGEN_RECEPTOR_BINDING",30,-1.3018,0.12,0.3,1.0275,0.42,0.85,1.0246,0.41,0.87
"GO_BP:504763_GO_0035584_CALCIUM_MEDIATED_SIGNALING_USING_INTRACELLULAR_CALCIUM_SOURCE","GO_BP","504763_GO_0035584_CALCIUM_MEDIATED_SIGNALING_USING_INTRACELLULAR_CALCIUM_SOURCE",13,-1.3017,0.15,0.25,0.8573,0.64,1,1.1925,0.22,0.72
"KEGG_reaction:R08261_UDP_GLUCURONATE_CODEINE_UDP_CODEINE_6_GLUCURONIDE","KEGG_reaction","R08261_UDP_GLUCURONATE_CODEINE_UDP_CODEINE_6_GLUCURONIDE",19,-1.3016,0.13,0.26,1.9749,0.0041,0.017,2.4728,0,0
"GO_MF:495522_GO_0015269_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY","GO_MF","495522_GO_0015269_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY",17,-1.3016,0.14,0.3,1.4803,0.061,0.39,1.1796,0.25,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1343_IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1343_IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN",9,-1.3016,0.17,0.17,0.6748,0.88,1,-0.9755,0.48,0.79
"C4_Cancer_gene_neighborhoods:C4_CGN_136_MORF_NOS2A","C4_Cancer_gene_neighborhoods","C4_CGN_136_MORF_NOS2A",281,-1.3016,0.021,0.21,-1.2925,0.015,0.57,1.0242,0.4,0.76
"C4_Cancer_modules:C4_CM_411_MODULE_532","C4_Cancer_modules","C4_CM_411_MODULE_532",399,-1.3015,0.015,0.17,0.9281,0.74,0.8,0.921,0.77,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_1127_PETRETTO_BLOOD_PRESSURE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1127_PETRETTO_BLOOD_PRESSURE_UP",12,-1.3014,0.15,0.17,-0.9569,0.52,1,-1.1927,0.23,0.53
"GO_MF:512277_GO_0051393_ALPHA_ACTININ_BINDING","GO_MF","512277_GO_0051393_ALPHA_ACTININ_BINDING",23,-1.3012,0.12,0.3,1.2406,0.16,0.69,1.4282,0.067,0.52
"OMIM_gene:OMIM613170_TETRASPANIN_1_TSPAN1","OMIM_gene","OMIM613170_TETRASPANIN_1_TSPAN1",5,-1.3012,0.18,1,-0.8039,0.7,0.98,-1.2373,0.24,1
"GO_BP:502114_GO_0032892_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT","GO_BP","502114_GO_0032892_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT",26,-1.3012,0.14,0.25,-0.7015,0.89,1,-1.1263,0.28,0.75
"GO_BP:488554_GO_0002681_SOMATIC_RECOMBINATION_OF_T_CELL_RECEPTOR_GENE_SEGMENTS","GO_BP","488554_GO_0002681_SOMATIC_RECOMBINATION_OF_T_CELL_RECEPTOR_GENE_SEGMENTS",5,-1.3012,0.17,0.25,0.676,0.85,1,-0.9797,0.5,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1213_NIKOLSKY_BREAST_CANCER_17P11_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1213_NIKOLSKY_BREAST_CANCER_17P11_AMPLICON",10,-1.3012,0.15,0.17,0.5688,0.95,1,-0.8782,0.63,0.9
"C6_Oncogenic_signatures:C6_ALL_119_NRL_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_119_NRL_DN_V1_DN",125,-1.3012,0.071,0.083,-0.9295,0.59,0.85,-1.127,0.2,0.46
"GO_BP:515163_GO_0070228_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS","GO_BP","515163_GO_0070228_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS",56,-1.3012,0.079,0.25,0.7131,0.96,1,-1.0313,0.38,0.82
"KEGG_compound:C19606_NNAL_N_GLUCURONIDE","KEGG_compound","C19606_NNAL_N_GLUCURONIDE",19,-1.3009,0.15,0.3,1.938,0,0.028,2.409,0,0
"GO_BP:494588_GO_0010519_NEGATIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY","GO_BP","494588_GO_0010519_NEGATIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY",8,-1.3009,0.19,0.25,-1.2985,0.17,0.89,-1.0332,0.41,0.82
"C7_Immunologic_signatures:C7_ALL_648_GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_648_GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDM_DN",199,-1.3009,0.049,0.079,-0.6794,1,1,-1.0283,0.39,0.66
"GO_BP:504433_GO_0035249_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC","GO_BP","504433_GO_0035249_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC",35,-1.3008,0.12,0.25,-1.1235,0.27,0.94,1.3843,0.07,0.63
"C7_Immunologic_signatures:C7_ALL_1127_GSE2706_R848_VS_LPS_8H_STIM_DC_UP","C7_Immunologic_signatures","C7_ALL_1127_GSE2706_R848_VS_LPS_8H_STIM_DC_UP",169,-1.3008,0.037,0.079,-0.9169,0.68,1,1.1378,0.19,0.91
"GO_BP:503829_GO_0034629_CELLULAR_PROTEIN_COMPLEX_LOCALIZATION","GO_BP","503829_GO_0034629_CELLULAR_PROTEIN_COMPLEX_LOCALIZATION",16,-1.3007,0.13,0.25,-0.771,0.8,1,0.5738,0.97,1
"C3_TF_targets:C3_TFT_607_CATTGTYY_V_SOX9_B1","C3_TF_targets","C3_TFT_607_CATTGTYY_V_SOX9_B1",350,-1.3004,0.012,0.088,0.8927,0.84,1,-1.3061,0.012,0.25
"REACTOME:106444_REACT_13638_NRAGE_SIGNALS_DEATH_THROUGH_JNK","REACTOME","106444_REACT_13638_NRAGE_SIGNALS_DEATH_THROUGH_JNK",45,-1.3004,0.11,0.28,-1.2722,0.13,0.7,-0.9512,0.53,0.9
"KEGG_compound:C16643_MORPHINE_3_GLUCURONIDE","KEGG_compound","C16643_MORPHINE_3_GLUCURONIDE",19,-1.3003,0.15,0.3,1.9369,0,0.025,2.3763,0,0
"GO_BP:515277_GO_0070345_NEGATIVE_REGULATION_OF_FAT_CELL_PROLIFERATION","GO_BP","515277_GO_0070345_NEGATIVE_REGULATION_OF_FAT_CELL_PROLIFERATION",5,-1.3003,0.16,0.25,-1.0976,0.37,0.95,0.9614,0.5,0.9
"GO_BP:508778_GO_0046520_SPHINGOID_BIOSYNTHETIC_PROCESS","GO_BP","508778_GO_0046520_SPHINGOID_BIOSYNTHETIC_PROCESS",7,-1.3002,0.16,0.25,0.6541,0.9,1,-1.0912,0.35,0.78
"C3_MicroRNA_targets:C3_MIR_10_TGCACTG_MIR_148A_MIR_152_MIR_148B","C3_MicroRNA_targets","C3_MIR_10_TGCACTG_MIR_148A_MIR_152_MIR_148B",304,-1.3001,0.019,0.24,-0.7898,0.98,1,-1.0442,0.32,1
"GO_BP:518657_GO_2000008_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE","GO_BP","518657_GO_2000008_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE",24,-1.3001,0.15,0.25,-0.8857,0.65,1,-1.2394,0.17,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_854_DAWSON_METHYLATED_IN_LYMPHOMA_TCL1","C2_Chemical_and_genetic_perturbations","C2_CGP_854_DAWSON_METHYLATED_IN_LYMPHOMA_TCL1",56,-1.3001,0.091,0.18,1.3322,0.073,0.36,1.0986,0.29,0.89
"KEGG_pathway:HSA04922_GLUCAGON_SIGNALING_PATHWAY","KEGG_pathway","HSA04922_GLUCAGON_SIGNALING_PATHWAY",100,-1.2999,0.066,0.13,-1.1144,0.29,0.69,-1.3965,0.026,0.18
"GO_BP:507477_GO_0045077_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS","GO_BP","507477_GO_0045077_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS",5,-1.2998,0.16,0.25,0.5187,0.98,1,0.8824,0.61,0.96
"GO_BP:754151_GO_1901184_REGULATION_OF_ERBB_SIGNALING_PATHWAY","GO_BP","754151_GO_1901184_REGULATION_OF_ERBB_SIGNALING_PATHWAY",76,-1.2997,0.08,0.25,0.8966,0.7,1,0.7855,0.89,1
"GO_BP:487612_GO_0001709_CELL_FATE_DETERMINATION","GO_BP","487612_GO_0001709_CELL_FATE_DETERMINATION",39,-1.2996,0.11,0.25,-1.3817,0.077,1,0.9652,0.5,0.89
"C3_TF_targets:C3_TFT_446_V_ER_Q6_01","C3_TF_targets","C3_TFT_446_V_ER_Q6_01",265,-1.2994,0.025,0.089,-1.0001,0.44,0.76,-1.0451,0.32,0.64
"C1_Positional:C1_ALL_81_CHR1P22","C1_Positional","C1_ALL_81_CHR1P22",80,-1.2989,0.079,0.64,0.8182,0.85,0.93,0.8239,0.81,0.91
"C3_TF_targets:C3_TFT_174_V_NGFIC_01","C3_TF_targets","C3_TFT_174_V_NGFIC_01",249,-1.2988,0.032,0.089,-1.0875,0.23,0.57,-0.7295,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2769_MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2769_MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3",35,-1.2984,0.13,0.18,1.2225,0.16,0.46,0.9236,0.57,1
"C1_Positional:C1_ALL_265_CHR17Q24","C1_Positional","C1_ALL_265_CHR17Q24",41,-1.2984,0.12,0.63,-1.2068,0.19,1,-0.9193,0.59,0.96
"GO_BP:501564_GO_0032329_SERINE_TRANSPORT","GO_BP","501564_GO_0032329_SERINE_TRANSPORT",9,-1.2984,0.16,0.25,0.8175,0.71,1,-0.6368,0.91,1
"GO_BP:508081_GO_0045740_POSITIVE_REGULATION_OF_DNA_REPLICATION","GO_BP","508081_GO_0045740_POSITIVE_REGULATION_OF_DNA_REPLICATION",59,-1.2981,0.082,0.25,-0.7512,0.9,1,-0.9943,0.45,0.85
"GO_MF:506570_GO_0043539_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY","GO_MF","506570_GO_0043539_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY",17,-1.2979,0.16,0.3,0.6262,0.93,1,0.7991,0.75,1
"C7_Immunologic_signatures:C7_ALL_508_GSE17721_CTRL_VS_CPG_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_508_GSE17721_CTRL_VS_CPG_12H_BMDM_DN",196,-1.2978,0.049,0.081,-0.8612,0.84,1,0.8466,0.9,1
"GO_MF:492450_GO_0008081_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY","GO_MF","492450_GO_0008081_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY",87,-1.2978,0.073,0.3,-0.8684,0.73,1,0.9038,0.68,0.95
"GO_MF:489358_GO_0003857_3_HYDROXYACYL_COA_DEHYDROGENASE_ACTIVITY","GO_MF","489358_GO_0003857_3_HYDROXYACYL_COA_DEHYDROGENASE_ACTIVITY",8,-1.2976,0.18,0.3,0.9173,0.56,0.96,-1.3708,0.13,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_3099_SUBTIL_PROGESTIN_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3099_SUBTIL_PROGESTIN_TARGETS",36,-1.2976,0.11,0.18,-1.1654,0.21,0.83,-1.1237,0.28,0.6
"C3_MicroRNA_targets:C3_MIR_176_GTGTCAA_MIR_514","C3_MicroRNA_targets","C3_MIR_176_GTGTCAA_MIR_514",61,-1.2976,0.1,0.24,0.859,0.77,1,-1.031,0.38,1
"C4_Cancer_modules:C4_CM_267_MODULE_305","C4_Cancer_modules","C4_CM_267_MODULE_305",19,-1.2974,0.15,0.17,1.0692,0.36,0.59,-1.9332,0,0.021
"KEGG_module:HSA_M00361_NUCLEOTIDE_SUGAR_BIOSYNTHESIS_EUKARYOTES","KEGG_module","HSA_M00361_NUCLEOTIDE_SUGAR_BIOSYNTHESIS_EUKARYOTES",8,-1.2973,0.17,0.44,-0.8941,0.58,1,-1.1275,0.33,0.61
"GO_BP:487914_GO_0002024_DIET_INDUCED_THERMOGENESIS","GO_BP","487914_GO_0002024_DIET_INDUCED_THERMOGENESIS",7,-1.2973,0.17,0.25,-0.8226,0.7,1,-1.3429,0.12,0.61
"GO_BP:493273_GO_0009072_AROMATIC_AMINO_ACID_FAMILY_METABOLIC_PROCESS","GO_BP","493273_GO_0009072_AROMATIC_AMINO_ACID_FAMILY_METABOLIC_PROCESS",28,-1.2973,0.13,0.25,-1.1054,0.31,0.94,-1.6504,0.01,0.53
"GO_BP:498979_GO_0021696_CEREBELLAR_CORTEX_MORPHOGENESIS","GO_BP","498979_GO_0021696_CEREBELLAR_CORTEX_MORPHOGENESIS",31,-1.2973,0.14,0.25,-1.1711,0.25,0.91,-0.8567,0.69,0.96
"GO_CC:506323_GO_0043256_LAMININ_COMPLEX","GO_CC","506323_GO_0043256_LAMININ_COMPLEX",10,-1.2972,0.16,0.32,1.2625,0.16,0.45,1.4351,0.087,0.65
"KEGG_compound:C04373_ETIOCHOLANOLONE_3ALPHA_HYDROXY_5BETA_ANDROSTAN_17_ONE_ETIOCHOLAN_3ALPHA_OL_17_ONE_3ALPHA_HYDROXYETIOCHOLAN_17_ONE","KEGG_compound","C04373_ETIOCHOLANOLONE_3ALPHA_HYDROXY_5BETA_ANDROSTAN_17_ONE_ETIOCHOLAN_3ALPHA_OL_17_ONE_3ALPHA_HYDROXYETIOCHOLAN_17_ONE",20,-1.2971,0.15,0.3,1.9237,0,0.018,2.2365,0,6.6e-05
"C2_Chemical_and_genetic_perturbations:C2_CGP_2285_BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING","C2_Chemical_and_genetic_perturbations","C2_CGP_2285_BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING",497,-1.2969,0.0072,0.18,-0.8003,1,1,-0.9716,0.56,0.8
"GO_BP:510893_GO_0048843_NEGATIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE","GO_BP","510893_GO_0048843_NEGATIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE",9,-1.2969,0.17,0.25,-1.0018,0.46,0.99,1.2675,0.18,0.69
"GO_BP:518525_GO_0090385_PHAGOSOME_LYSOSOME_FUSION","GO_BP","518525_GO_0090385_PHAGOSOME_LYSOSOME_FUSION",6,-1.2969,0.16,0.25,0.5677,0.96,1,-0.5832,0.94,1
"C3_TF_targets:C3_TFT_98_V_OCT1_03","C3_TF_targets","C3_TFT_98_V_OCT1_03",220,-1.2968,0.04,0.091,0.9791,0.51,1,-1.0445,0.32,0.64
"WikiPathways:198759_WP289_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS","WikiPathways","198759_WP289_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS",151,-1.2968,0.062,0.2,0.9217,0.68,1,-1.0794,0.27,0.63
"GO_BP:508002_GO_0045654_POSITIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION","GO_BP","508002_GO_0045654_POSITIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION",9,-1.2967,0.18,0.25,-0.7643,0.73,1,-0.7697,0.75,1
"C3_MicroRNA_targets:C3_MIR_71_GTGTTGA_MIR_505","C3_MicroRNA_targets","C3_MIR_71_GTGTTGA_MIR_505",104,-1.2963,0.077,0.24,-1.1465,0.18,1,-1.2803,0.066,1
"GO_BP:513456_GO_0055023_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH","GO_BP","513456_GO_0055023_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH",21,-1.2962,0.13,0.25,-0.5915,0.96,1,1.2382,0.18,0.71
"GO_BP:511774_GO_0050808_SYNAPSE_ORGANIZATION","GO_BP","511774_GO_0050808_SYNAPSE_ORGANIZATION",124,-1.2961,0.064,0.25,-1.1173,0.22,0.94,1.3021,0.048,0.67
"GO_BP:494644_GO_0010579_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY_INVOLVED_IN_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY","GO_BP","494644_GO_0010579_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY_INVOLVED_IN_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",24,-1.2961,0.12,0.25,-0.986,0.47,1,1.3689,0.094,0.65
"KEGG_reaction:R02902_RETINOATE_UDP_GLUCURONATE_ALL_TRANS_RETINOYL_BETA_GLUCURONIDE_UDP","KEGG_reaction","R02902_RETINOATE_UDP_GLUCURONATE_ALL_TRANS_RETINOYL_BETA_GLUCURONIDE_UDP",19,-1.296,0.14,0.27,1.9564,0,0.017,2.3884,0,0
"REACTOME:106550_REACT_1309_RNA_POLYMERASE_I_TRANSCRIPTION","REACTOME","106550_REACT_1309_RNA_POLYMERASE_I_TRANSCRIPTION",107,-1.2959,0.073,0.29,-1.5286,0.0054,0.41,-1.2654,0.064,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1838_TSENG_IRS1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1838_TSENG_IRS1_TARGETS_DN",131,-1.2958,0.059,0.18,1.4855,0.0068,0.22,0.9392,0.61,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3350_HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3350_HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN",11,-1.2958,0.16,0.18,-0.7534,0.78,1,0.8941,0.58,1
"GO_MF:496752_GO_0016860_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY","GO_MF","496752_GO_0016860_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY",54,-1.2956,0.099,0.31,-0.6855,0.98,1,-1.2695,0.12,0.58
"GO_CC:500517_GO_0031258_LAMELLIPODIUM_MEMBRANE","GO_CC","500517_GO_0031258_LAMELLIPODIUM_MEMBRANE",18,-1.2956,0.16,0.32,-0.6716,0.9,1,-0.6915,0.88,1
"GO_BP:496162_GO_0016064_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE","GO_BP","496162_GO_0016064_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE",67,-1.2956,0.1,0.25,0.638,0.99,1,-0.9169,0.64,0.91
"GO_BP:487901_GO_0002011_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET","GO_BP","487901_GO_0002011_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET",43,-1.2956,0.11,0.25,0.8675,0.7,1,0.8915,0.66,0.95
"GO_BP:513924_GO_0060368_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY","GO_BP","513924_GO_0060368_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY",5,-1.2955,0.15,0.25,0.5448,0.95,1,0.8125,0.7,1
"GO_BP:752702_GO_0097201_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS","GO_BP","752702_GO_0097201_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS",6,-1.2954,0.18,0.25,-1.1612,0.3,0.92,0.5408,0.97,1
"C7_Immunologic_signatures:C7_ALL_1714_GSE3982_NKCELL_VS_TH2_DN","C7_Immunologic_signatures","C7_ALL_1714_GSE3982_NKCELL_VS_TH2_DN",199,-1.2953,0.044,0.084,1.5762,0,0.0044,-1.2186,0.067,0.24
"C4_Cancer_gene_neighborhoods:C4_CGN_140_MORF_PAX7","C4_Cancer_gene_neighborhoods","C4_CGN_140_MORF_PAX7",260,-1.2953,0.029,0.22,-1.2805,0.029,0.54,0.9357,0.63,0.96
"C7_Immunologic_signatures:C7_ALL_1462_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN","C7_Immunologic_signatures","C7_ALL_1462_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN",193,-1.2952,0.044,0.084,1.0425,0.32,0.61,-1.0076,0.44,0.71
"GO_BP:504951_GO_0035774_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS","GO_BP","504951_GO_0035774_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS",17,-1.2951,0.15,0.25,1.0368,0.38,0.96,-0.9371,0.54,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_2560_VANASSE_BCL2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2560_VANASSE_BCL2_TARGETS_UP",38,-1.2948,0.13,0.18,1.0502,0.38,0.71,0.9261,0.57,1
"REACTOME:106057_REACT_2051_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE_","REACTOME","106057_REACT_2051_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE_",39,-1.2946,0.13,0.29,1.4946,0.01,0.15,1.1395,0.26,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_2756_YAGI_AML_WITH_T_9_11_TRANSLOCATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2756_YAGI_AML_WITH_T_9_11_TRANSLOCATION",129,-1.2946,0.055,0.18,-0.7105,0.99,1,-1.2983,0.041,0.43
"GO_BP:496008_GO_0015884_FOLIC_ACID_TRANSPORT","GO_BP","496008_GO_0015884_FOLIC_ACID_TRANSPORT",8,-1.2946,0.15,0.25,-0.974,0.48,1,-1.2629,0.19,0.67
"C7_Immunologic_signatures:C7_ALL_1863_GSE9037_WT_VS_IRAK4_KO_BMDM_UP","C7_Immunologic_signatures","C7_ALL_1863_GSE9037_WT_VS_IRAK4_KO_BMDM_UP",198,-1.2945,0.049,0.084,1.1219,0.16,0.38,0.8719,0.84,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1653_ONGUSAHA_TP53_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1653_ONGUSAHA_TP53_TARGETS",36,-1.2945,0.14,0.18,-1.2467,0.16,0.75,-1.1923,0.2,0.53
"REACTOME:106467_REACT_12079_PLC_GAMMA1_SIGNALLING","REACTOME","106467_REACT_12079_PLC_GAMMA1_SIGNALLING",36,-1.2944,0.12,0.29,-1.1105,0.28,0.88,-1.4484,0.032,0.38
"C7_Immunologic_signatures:C7_ALL_109_GSE12366_GC_VS_NAIVE_BCELL_UP","C7_Immunologic_signatures","C7_ALL_109_GSE12366_GC_VS_NAIVE_BCELL_UP",198,-1.2943,0.042,0.084,1.2138,0.069,0.2,-1.4612,0.0043,0.032
"GO_MF:509016_GO_0046790_VIRION_BINDING","GO_MF","509016_GO_0046790_VIRION_BINDING",10,-1.2942,0.16,0.31,0.8698,0.62,1,1.1711,0.27,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_2318_HONMA_DOCETAXEL_RESISTANCE","C2_Chemical_and_genetic_perturbations","C2_CGP_2318_HONMA_DOCETAXEL_RESISTANCE",34,-1.294,0.14,0.18,1.6318,0.0087,0.12,-0.6049,0.99,0.99
"GO_BP:500645_GO_0031394_POSITIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS","GO_BP","500645_GO_0031394_POSITIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS",5,-1.294,0.15,0.26,-0.7606,0.77,1,-1.4758,0.076,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_2338_BONCI_TARGETS_OF_MIR15A_AND_MIR16_1","C2_Chemical_and_genetic_perturbations","C2_CGP_2338_BONCI_TARGETS_OF_MIR15A_AND_MIR16_1",91,-1.2939,0.093,0.18,-1.0061,0.44,1,0.7551,0.93,1
"C7_Immunologic_signatures:C7_ALL_169_GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP","C7_Immunologic_signatures","C7_ALL_169_GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP",185,-1.2939,0.056,0.085,1.0203,0.39,0.68,1.1763,0.11,0.79
"GO_BP:508482_GO_0046184_ALDEHYDE_BIOSYNTHETIC_PROCESS","GO_BP","508482_GO_0046184_ALDEHYDE_BIOSYNTHETIC_PROCESS",5,-1.2939,0.17,0.26,-0.9896,0.46,1,-0.7744,0.74,1
"GO_CC:499562_GO_0030135_COATED_VESICLE","GO_CC","499562_GO_0030135_COATED_VESICLE",236,-1.2939,0.05,0.32,1.147,0.15,0.59,0.9394,0.65,1
"C7_Immunologic_signatures:C7_ALL_185_GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP","C7_Immunologic_signatures","C7_ALL_185_GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP",197,-1.2937,0.041,0.085,0.9953,0.46,0.75,-1.1832,0.13,0.31
"GO_BP:504274_GO_0035089_ESTABLISHMENT_OF_APICAL_BASAL_CELL_POLARITY","GO_BP","504274_GO_0035089_ESTABLISHMENT_OF_APICAL_BASAL_CELL_POLARITY",9,-1.2937,0.16,0.26,-0.7267,0.83,1,-1.033,0.4,0.82
"REACTOME:119552_REACT_19344_COSTIMULATION_BY_THE_CD28_FAMILY","REACTOME","119552_REACT_19344_COSTIMULATION_BY_THE_CD28_FAMILY",67,-1.2936,0.096,0.29,1.0956,0.27,0.59,-1.005,0.42,0.83
"GO_BP:1129350_GO_1903523_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION","GO_BP","1129350_GO_1903523_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION",28,-1.2936,0.13,0.26,0.8845,0.63,1,0.9532,0.53,0.9
"GO_BP:514541_GO_0060986_ENDOCRINE_HORMONE_SECRETION","GO_BP","514541_GO_0060986_ENDOCRINE_HORMONE_SECRETION",12,-1.2936,0.16,0.26,0.7551,0.81,1,0.7719,0.79,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_67_ZERBINI_RESPONSE_TO_SULINDAC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_67_ZERBINI_RESPONSE_TO_SULINDAC_DN",6,-1.2936,0.19,0.18,-0.6509,0.89,1,-1.4646,0.072,0.31
"C7_Immunologic_signatures:C7_ALL_29_GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_29_GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP",194,-1.2936,0.048,0.085,-0.9995,0.45,1,-0.923,0.71,0.9
"GO_BP:505544_GO_0042401_CELLULAR_BIOGENIC_AMINE_BIOSYNTHETIC_PROCESS","GO_BP","505544_GO_0042401_CELLULAR_BIOGENIC_AMINE_BIOSYNTHETIC_PROCESS",38,-1.2935,0.11,0.26,-0.8341,0.74,1,-1.044,0.38,0.82
"GO_CC:515865_GO_0070938_CONTRACTILE_RING","GO_CC","515865_GO_0070938_CONTRACTILE_RING",9,-1.2935,0.16,0.32,-1.1089,0.34,0.75,-1.263,0.19,0.67
"REACTOME:105939_REACT_14835_NOTCH_HLH_TRANSCRIPTION_PATHWAY","REACTOME","105939_REACT_14835_NOTCH_HLH_TRANSCRIPTION_PATHWAY",13,-1.2935,0.14,0.29,-1.1986,0.23,0.83,1.0353,0.38,0.98
"GO_BP:983738_GO_1903019_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS","GO_BP","983738_GO_1903019_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS",13,-1.2935,0.17,0.26,-0.9505,0.51,1,-0.7124,0.87,0.99
"GO_MF:489933_GO_0004601_PEROXIDASE_ACTIVITY","GO_MF","489933_GO_0004601_PEROXIDASE_ACTIVITY",39,-1.2934,0.12,0.31,1.1422,0.24,0.76,-0.9741,0.52,0.8
"GO_BP:755132_GO_2001026_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS","GO_BP","755132_GO_2001026_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS",13,-1.2934,0.16,0.26,-0.7154,0.82,1,1.2654,0.18,0.69
"GO_BP:513736_GO_0060179_MALE_MATING_BEHAVIOR","GO_BP","513736_GO_0060179_MALE_MATING_BEHAVIOR",6,-1.2933,0.17,0.26,0.9114,0.57,1,0.9541,0.51,0.9
"GO_MF:489890_GO_0004553_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS","GO_MF","489890_GO_0004553_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS",94,-1.2932,0.082,0.31,-0.9177,0.64,0.97,-1.0192,0.37,0.77
"GO_BP:517427_GO_0072522_PURINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","517427_GO_0072522_PURINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",161,-1.2932,0.07,0.26,0.9176,0.68,1,-1.3621,0.027,0.6
"KEGG_compound:C19605_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_GLUCURONIDE_NNAL_O_GLUCURONIDE","KEGG_compound","C19605_4_METHYLNITROSAMINO_1_3_PYRIDYL_1_BUTANOL_GLUCURONIDE_NNAL_O_GLUCURONIDE",19,-1.2932,0.13,0.31,1.9027,0,0.014,2.3826,0,0
"GO_BP:514291_GO_0060736_PROSTATE_GLAND_GROWTH","GO_BP","514291_GO_0060736_PROSTATE_GLAND_GROWTH",10,-1.2932,0.16,0.26,1.2771,0.16,0.7,0.9607,0.49,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1373_GRANDVAUX_IRF3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1373_GRANDVAUX_IRF3_TARGETS_UP",15,-1.2931,0.15,0.18,1.954,0,0.011,-1.0602,0.37,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_1735_ULE_SPLICING_VIA_NOVA2","C2_Chemical_and_genetic_perturbations","C2_CGP_1735_ULE_SPLICING_VIA_NOVA2",43,-1.2931,0.12,0.18,0.8104,0.82,0.98,0.8547,0.72,1
"GO_CC:499559_GO_0030130_CLATHRIN_COAT_OF_TRANS_GOLGI_NETWORK_VESICLE","GO_CC","499559_GO_0030130_CLATHRIN_COAT_OF_TRANS_GOLGI_NETWORK_VESICLE",11,-1.293,0.17,0.32,-0.7381,0.82,1,-1.3166,0.14,0.64
"GO_BP:754037_GO_1901068_GUANOSINE_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","754037_GO_1901068_GUANOSINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",286,-1.293,0.024,0.26,0.9958,0.48,0.98,-1.1636,0.078,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1055_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1055_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP",107,-1.2929,0.061,0.18,-1.0922,0.27,0.93,-1.4949,0.0062,0.3
"GO_BP:513434_GO_0055001_MUSCLE_CELL_DEVELOPMENT","GO_BP","513434_GO_0055001_MUSCLE_CELL_DEVELOPMENT",123,-1.2926,0.059,0.26,-1.2377,0.11,0.9,-1.1015,0.23,0.77
"GO_BP:495192_GO_0014744_POSITIVE_REGULATION_OF_MUSCLE_ADAPTATION","GO_BP","495192_GO_0014744_POSITIVE_REGULATION_OF_MUSCLE_ADAPTATION",5,-1.2925,0.17,0.26,0.9266,0.56,1,-1.5614,0.019,0.52
"GO_BP:751593_GO_0044380_PROTEIN_LOCALIZATION_TO_CYTOSKELETON","GO_BP","751593_GO_0044380_PROTEIN_LOCALIZATION_TO_CYTOSKELETON",18,-1.2925,0.16,0.26,-1.1159,0.31,0.94,-0.8654,0.65,0.95
"GO_BP:506337_GO_0043271_NEGATIVE_REGULATION_OF_ION_TRANSPORT","GO_BP","506337_GO_0043271_NEGATIVE_REGULATION_OF_ION_TRANSPORT",101,-1.2925,0.076,0.26,0.9687,0.53,1,-0.9372,0.58,0.9
"GO_BP:511799_GO_0050855_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY","GO_BP","511799_GO_0050855_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY",12,-1.2924,0.17,0.26,0.7897,0.74,1,-0.9387,0.55,0.9
"GO_BP:753025_GO_1900028_NEGATIVE_REGULATION_OF_RUFFLE_ASSEMBLY","GO_BP","753025_GO_1900028_NEGATIVE_REGULATION_OF_RUFFLE_ASSEMBLY",5,-1.2923,0.17,0.26,-0.9518,0.54,1,-0.9381,0.52,0.9
"GO_BP:513899_GO_0060343_TRABECULA_FORMATION","GO_BP","513899_GO_0060343_TRABECULA_FORMATION",24,-1.2923,0.16,0.26,-1.1103,0.31,0.94,0.9719,0.48,0.88
"C7_Immunologic_signatures:C7_ALL_255_GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_255_GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP",198,-1.2922,0.047,0.086,1.1767,0.1,0.27,-1.1081,0.2,0.48
"C7_Immunologic_signatures:C7_ALL_1492_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN","C7_Immunologic_signatures","C7_ALL_1492_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN",191,-1.2922,0.041,0.086,-0.8779,0.79,1,-1.1317,0.17,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_375_PASTURAL_RIZ1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_375_PASTURAL_RIZ1_TARGETS_UP",10,-1.292,0.16,0.18,1.3402,0.14,0.35,-1.4657,0.067,0.31
"KEGG_pathway:HSA04141_PROTEIN_PROCESSING_IN_ENDOPLASMIC_RETICULUM","KEGG_pathway","HSA04141_PROTEIN_PROCESSING_IN_ENDOPLASMIC_RETICULUM",167,-1.292,0.055,0.14,0.93,0.66,1,-1.4747,0.0042,0.15
"WikiPathways:920958_WP2525_TRANS_SULFURATION_AND_ONE_CARBON_METABOLISM","WikiPathways","920958_WP2525_TRANS_SULFURATION_AND_ONE_CARBON_METABOLISM",30,-1.2919,0.13,0.2,-1.3462,0.099,1,-1.2386,0.18,0.47
"GO_CC:487585_GO_0001674_FEMALE_GERM_CELL_NUCLEUS","GO_CC","487585_GO_0001674_FEMALE_GERM_CELL_NUCLEUS",5,-1.2919,0.16,0.32,-1.0234,0.45,0.85,-1.121,0.36,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1382_FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1382_FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN",50,-1.2919,0.1,0.18,1.3526,0.074,0.34,-1.1762,0.19,0.54
"GO_CC:504926_GO_0035749_MYELIN_SHEATH_ADAXONAL_REGION","GO_CC","504926_GO_0035749_MYELIN_SHEATH_ADAXONAL_REGION",5,-1.2918,0.14,0.32,-0.9094,0.57,0.96,0.5116,0.96,1
"GO_BP:516605_GO_0071681_CELLULAR_RESPONSE_TO_INDOLE_3_METHANOL","GO_BP","516605_GO_0071681_CELLULAR_RESPONSE_TO_INDOLE_3_METHANOL",5,-1.2918,0.16,0.26,-0.6505,0.85,1,-0.8982,0.61,0.93
"C7_Immunologic_signatures:C7_ALL_538_GSE17721_LPS_VS_POLYIC_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_538_GSE17721_LPS_VS_POLYIC_8H_BMDM_DN",198,-1.2918,0.055,0.086,1.1318,0.17,0.36,-0.9935,0.47,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_2803_LI_PROSTATE_CANCER_EPIGENETIC","C2_Chemical_and_genetic_perturbations","C2_CGP_2803_LI_PROSTATE_CANCER_EPIGENETIC",30,-1.2918,0.15,0.18,0.7508,0.88,1,1.2393,0.17,0.75
"GO_BP:512291_GO_0051412_RESPONSE_TO_CORTICOSTERONE","GO_BP","512291_GO_0051412_RESPONSE_TO_CORTICOSTERONE",23,-1.2916,0.14,0.26,-0.8872,0.63,1,-1.0211,0.41,0.83
"GO_BP:500156_GO_0030858_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","500156_GO_0030858_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION",53,-1.2916,0.1,0.26,-1.0171,0.4,0.98,0.8444,0.73,0.99
"GO_BP:493714_GO_0009583_DETECTION_OF_LIGHT_STIMULUS","GO_BP","493714_GO_0009583_DETECTION_OF_LIGHT_STIMULUS",123,-1.2916,0.072,0.26,-1.0697,0.3,0.96,-0.9705,0.5,0.87
"C7_Immunologic_signatures:C7_ALL_740_GSE17721_12H_VS_24H_PAM3CSK4_BMDM_DN","C7_Immunologic_signatures","C7_ALL_740_GSE17721_12H_VS_24H_PAM3CSK4_BMDM_DN",198,-1.2913,0.052,0.087,1.1277,0.16,0.37,-1.1534,0.14,0.36
"GO_BP:754038_GO_1901069_GUANOSINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS","GO_BP","754038_GO_1901069_GUANOSINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",261,-1.2913,0.04,0.26,1.0002,0.48,0.98,-1.1331,0.13,0.75
"KEGG_reaction:R02389_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_2_UDP_GLUCURONATE_BILIRUBIN_2_UDP_BILIRUBIN_BETA_DIGLUCURONIDE","KEGG_reaction","R02389_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_2_UDP_GLUCURONATE_BILIRUBIN_2_UDP_BILIRUBIN_BETA_DIGLUCURONIDE",19,-1.2912,0.14,0.27,1.9344,0.0021,0.0083,2.4041,0,0
"KEGG_enzyme:2.4.1.17_GLUCURONOSYLTRANSFERASE_1_NAPHTHOL_GLUCURONYLTRANSFERASE_1_NAPHTHOL_UDP_GLUCURONOSYLTRANSFERASE_17BETA_HYDROXYSTEROID_UDP_GLUCURONOSYLTRANSFERASE_3ALPHA_HYDROXYSTEROID_UDP_GLUCURONOSYLTRANSFERASE_4_HYDROXYBIPHENYL_UDP_GLUCURONOSYLTRANSFERASE_4_METHYLUMBELLIFERONE_UDP_GLUCURONOSYLTRANSFERASE_4_NITROPHENOL_UDP_GLUCURONYLTRANSFERASE_4_NITROPHENOL_UDPGT_17_OH_STEROID_UDPGT_3_OH_ANDROGENIC_UDPGT_BILIRUBIN_URIDINE_DIPHOSPHOGLUCURONYLTRANSFERASE_BILIRUBIN_UDP_GLUCURONOSYLTRANSFERASE_BILIRUBIN_MONOGLUCURONIDE_GLUCURONYLTRANSFERASE_BILIRUBIN_UDPGT_BILIRUBIN_GLUCURONYLTRANSFERASE_CIRAMADOL_UDP_GLUCURONYLTRANSFERASE_ESTRIOL_UDP_GLUCURONOSYLTRANSFERASE_ESTRONE_UDP_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_BILIRUBIN_GLUCURONOSIDE_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_BILIRUBIN_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_ESTRIOL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_ESTRADIOL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_4_HYDROXYBIPHENYL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_1_2_DIACYLGLYCEROL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_ESTRIOL_16ALPHA_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONOSYLTRANSFERASE_GT_MORPHINE_GLUCURONYLTRANSFERASE_P_HYDROXYBIPHENYL_UDP_GLUCURONYLTRANSFERASE_P_NITROPHENOL_UDP_GLUCURONOSYLTRANSFERASE_P_NITROPHENOL_UDP_GLUCURONYLTRANSFERASE_P_NITROPHENYLGLUCURONOSYLTRANSFERASE_P_PHENYLPHENOL_GLUCURONYLTRANSFERASE_PHENYL_UDP_GLUCURONOSYLTRANSFERASE_PNP_UDPGT_UDP_GLUCURONATE_ESTRADIOL_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONATE_ESTRIOL_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONIC_ACID_TRANSFERASE_UDP_GLUCURONYLTRANSFERASE_UDP_GLUCURONATE_4_HYDROXYBIPHENYL_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONATE_BILIRUBIN_GLUCURONYLTRANSFERASE_UDP_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONYLTRANSFERASE_UDPGA_TRANSFERASE_UDPGA_GLUCURONYLTRANSFERASE_UDPGT_URIDINE_DIPHOSPHOGLUCURONYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_BILIRUBIN_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHATE_GLUCURONYLTRANSFERASE_URIDINE_5_DIPHOSPHOGLUCURONYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONOSYLTRANSFERASE","KEGG_enzyme","2.4.1.17_GLUCURONOSYLTRANSFERASE_1_NAPHTHOL_GLUCURONYLTRANSFERASE_1_NAPHTHOL_UDP_GLUCURONOSYLTRANSFERASE_17BETA_HYDROXYSTEROID_UDP_GLUCURONOSYLTRANSFERASE_3ALPHA_HYDROXYSTEROID_UDP_GLUCURONOSYLTRANSFERASE_4_HYDROXYBIPHENYL_UDP_GLUCURONOSYLTRANSFERASE_4_METHYLUMBELLIFERONE_UDP_GLUCURONOSYLTRANSFERASE_4_NITROPHENOL_UDP_GLUCURONYLTRANSFERASE_4_NITROPHENOL_UDPGT_17_OH_STEROID_UDPGT_3_OH_ANDROGENIC_UDPGT_BILIRUBIN_URIDINE_DIPHOSPHOGLUCURONYLTRANSFERASE_BILIRUBIN_UDP_GLUCURONOSYLTRANSFERASE_BILIRUBIN_MONOGLUCURONIDE_GLUCURONYLTRANSFERASE_BILIRUBIN_UDPGT_BILIRUBIN_GLUCURONYLTRANSFERASE_CIRAMADOL_UDP_GLUCURONYLTRANSFERASE_ESTRIOL_UDP_GLUCURONOSYLTRANSFERASE_ESTRONE_UDP_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_BILIRUBIN_GLUCURONOSIDE_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_BILIRUBIN_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_ESTRIOL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_ESTRADIOL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_4_HYDROXYBIPHENYL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_1_2_DIACYLGLYCEROL_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_ESTRIOL_16ALPHA_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONOSYLTRANSFERASE_GT_MORPHINE_GLUCURONYLTRANSFERASE_P_HYDROXYBIPHENYL_UDP_GLUCURONYLTRANSFERASE_P_NITROPHENOL_UDP_GLUCURONOSYLTRANSFERASE_P_NITROPHENOL_UDP_GLUCURONYLTRANSFERASE_P_NITROPHENYLGLUCURONOSYLTRANSFERASE_P_PHENYLPHENOL_GLUCURONYLTRANSFERASE_PHENYL_UDP_GLUCURONOSYLTRANSFERASE_PNP_UDPGT_UDP_GLUCURONATE_ESTRADIOL_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONATE_ESTRIOL_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONIC_ACID_TRANSFERASE_UDP_GLUCURONYLTRANSFERASE_UDP_GLUCURONATE_4_HYDROXYBIPHENYL_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONATE_BILIRUBIN_GLUCURONYLTRANSFERASE_UDP_GLUCURONOSYLTRANSFERASE_UDP_GLUCURONYLTRANSFERASE_UDPGA_TRANSFERASE_UDPGA_GLUCURONYLTRANSFERASE_UDPGT_URIDINE_DIPHOSPHOGLUCURONYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONATE_BILIRUBIN_GLUCURONOSYLTRANSFERASE_URIDINE_DIPHOSPHATE_GLUCURONYLTRANSFERASE_URIDINE_5_DIPHOSPHOGLUCURONYLTRANSFERASE_URIDINE_DIPHOSPHOGLUCURONOSYLTRANSFERASE",19,-1.2912,0.15,0.49,1.9313,0,0.015,2.3822,0,0
"C7_Immunologic_signatures:C7_ALL_430_GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_430_GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN",194,-1.2912,0.046,0.087,-1.123,0.18,1,0.9454,0.59,1
"REACTOME:645308_REACT_121206_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM","REACTOME","645308_REACT_121206_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM",49,-1.2911,0.12,0.29,0.9841,0.49,0.78,0.8828,0.7,1
"GO_BP:750892_GO_0035965_CARDIOLIPIN_ACYL_CHAIN_REMODELING","GO_BP","750892_GO_0035965_CARDIOLIPIN_ACYL_CHAIN_REMODELING",7,-1.291,0.16,0.26,-0.9242,0.55,1,-1.5076,0.052,0.54
"C7_Immunologic_signatures:C7_ALL_153_GSE13306_TREG_VS_TCONV_UP","C7_Immunologic_signatures","C7_ALL_153_GSE13306_TREG_VS_TCONV_UP",195,-1.291,0.045,0.087,-1.0334,0.36,1,-1.0755,0.27,0.56
"GO_BP:753989_GO_1901019_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","753989_GO_1901019_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",56,-1.291,0.1,0.26,-1.228,0.16,0.88,-0.7707,0.88,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_160_BIOCARTA_DREAM_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_160_BIOCARTA_DREAM_PATHWAY",13,-1.291,0.16,0.27,-0.8807,0.64,1,-1.0761,0.33,0.66
"C7_Immunologic_signatures:C7_ALL_1378_GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN","C7_Immunologic_signatures","C7_ALL_1378_GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN",199,-1.291,0.055,0.087,0.7032,1,1,-1.1403,0.16,0.39
"C2_Chemical_and_genetic_perturbations:C2_CGP_3182_KASLER_HDAC7_TARGETS_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3182_KASLER_HDAC7_TARGETS_1_UP",192,-1.2907,0.028,0.18,0.738,0.99,1,-0.9281,0.69,0.84
"GO_CC:490904_GO_0005902_MICROVILLUS","GO_CC","490904_GO_0005902_MICROVILLUS",85,-1.2907,0.098,0.32,-1.031,0.4,0.84,1.0273,0.4,1
"GO_CC:487991_GO_0002102_PODOSOME","GO_CC","487991_GO_0002102_PODOSOME",22,-1.2907,0.14,0.32,0.8694,0.67,0.91,-0.67,0.93,1
"GO_MF:490476_GO_0005242_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY","GO_MF","490476_GO_0005242_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",22,-1.2907,0.14,0.31,-0.8022,0.74,1,1.4217,0.066,0.52
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_25_BIOCARTA_NEUROTRANSMITTERS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_25_BIOCARTA_NEUROTRANSMITTERS_PATHWAY",6,-1.2906,0.16,0.26,1.1659,0.29,0.7,0.8787,0.62,1
"GO_MF:516541_GO_0071617_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY","GO_MF","516541_GO_0071617_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY",13,-1.2906,0.15,0.31,0.5848,0.95,1,-1.1401,0.29,0.65
"REACTOME:106212_REACT_1008_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS_","REACTOME","106212_REACT_1008_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS_",17,-1.2906,0.15,0.29,-1.124,0.29,0.89,-1.6412,0.029,0.23
"C7_Immunologic_signatures:C7_ALL_1530_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1530_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN",190,-1.2906,0.047,0.087,-1.0327,0.37,1,-1.3644,0.0062,0.085
"C7_Immunologic_signatures:C7_ALL_1359_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP","C7_Immunologic_signatures","C7_ALL_1359_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP",192,-1.2906,0.043,0.087,-0.8033,0.93,1,-1.2978,0.034,0.14
"GO_BP:514301_GO_0060746_PARENTAL_BEHAVIOR","GO_BP","514301_GO_0060746_PARENTAL_BEHAVIOR",13,-1.2905,0.16,0.26,0.7266,0.85,1,-1.3802,0.092,0.58
"C1_Positional:C1_ALL_5_CHR7P21","C1_Positional","C1_ALL_5_CHR7P21",34,-1.2904,0.13,0.64,-0.869,0.66,0.99,-1.2967,0.11,0.49
"REACTOME:187107_REACT_24980_REGULATION_OF_IFNG_SIGNALING","REACTOME","187107_REACT_24980_REGULATION_OF_IFNG_SIGNALING",14,-1.2904,0.15,0.29,0.7178,0.84,1,-1.0907,0.34,0.72
"C3_TF_targets:C3_TFT_549_YNTTTNNNANGCARM_UNKNOWN","C3_TF_targets","C3_TFT_549_YNTTTNNNANGCARM_UNKNOWN",62,-1.2903,0.086,0.097,-0.7379,0.91,1,0.8998,0.67,1
"GO_CC:500779_GO_0031528_MICROVILLUS_MEMBRANE","GO_CC","500779_GO_0031528_MICROVILLUS_MEMBRANE",22,-1.2903,0.15,0.32,-0.8229,0.74,1,-1.0707,0.36,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_415_KOINUMA_COLON_CANCER_MSI_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_415_KOINUMA_COLON_CANCER_MSI_UP",16,-1.2903,0.16,0.18,0.8672,0.67,0.96,-1.4287,0.086,0.33
"KEGG_compound:C18126_1_ACYL_SN_GLYCERO_3_PHOSPHOGLYCEROL","KEGG_compound","C18126_1_ACYL_SN_GLYCERO_3_PHOSPHOGLYCEROL",5,-1.2903,0.17,0.31,-0.5433,0.95,1,-1.1032,0.36,0.53
"C4_Cancer_gene_neighborhoods:C4_CGN_341_GNF2_CKS2","C4_Cancer_gene_neighborhoods","C4_CGN_341_GNF2_CKS2",50,-1.2902,0.11,0.22,1.5099,0.022,0.029,-1.6298,0.0062,0.074
"C2_Chemical_and_genetic_perturbations:C2_CGP_3186_DORMOY_ELAVL1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3186_DORMOY_ELAVL1_TARGETS",17,-1.2902,0.14,0.18,0.6339,0.94,1,-0.6797,0.89,0.99
"KEGG_compound:C03221_2_TRANS_DODECENOYL_COA_2E_DODEC_2_ENOYL_COA_2E_DODECENOYL_COA","KEGG_compound","C03221_2_TRANS_DODECENOYL_COA_2E_DODEC_2_ENOYL_COA_2E_DODECENOYL_COA",8,-1.2901,0.17,0.31,0.6075,0.92,1,-1.4471,0.07,0.26
"C2_Chemical_and_genetic_perturbations:C2_CGP_1437_BHATTACHARYA_EMBRYONIC_STEM_CELL","C2_Chemical_and_genetic_perturbations","C2_CGP_1437_BHATTACHARYA_EMBRYONIC_STEM_CELL",88,-1.2901,0.075,0.18,1.5003,0.0045,0.21,-1.0669,0.29,0.67
"KEGG_pathway:HSA04114_OOCYTE_MEIOSIS","KEGG_pathway","HSA04114_OOCYTE_MEIOSIS",111,-1.29,0.083,0.14,0.8712,0.77,1,-1.3889,0.024,0.18
"GO_BP:512032_GO_0051121_HEPOXILIN_METABOLIC_PROCESS","GO_BP","512032_GO_0051121_HEPOXILIN_METABOLIC_PROCESS",5,-1.2898,0.16,0.26,0.9135,0.55,1,-1.5375,0.033,0.53
"C4_Cancer_modules:C4_CM_104_MODULE_109","C4_Cancer_modules","C4_CM_104_MODULE_109",37,-1.2897,0.14,0.18,1.0016,0.43,0.71,-1.5731,0.021,0.12
"GO_BP:511741_GO_0050770_REGULATION_OF_AXONOGENESIS","GO_BP","511741_GO_0050770_REGULATION_OF_AXONOGENESIS",124,-1.2897,0.063,0.26,-1.1755,0.16,0.9,0.8928,0.73,0.95
"C3_MicroRNA_targets:C3_MIR_84_GAGACTG_MIR_452","C3_MicroRNA_targets","C3_MIR_84_GAGACTG_MIR_452",92,-1.2893,0.068,0.25,0.6194,1,1,-1.1963,0.13,1
"REACTOME:366239_REACT_75829_PIP3_ACTIVATES_AKT_SIGNALING","REACTOME","366239_REACT_75829_PIP3_ACTIVATES_AKT_SIGNALING",91,-1.2892,0.09,0.29,-1.1237,0.24,0.89,-0.9356,0.6,0.92
"GO_MF:490640_GO_0005545_1_PHOSPHATIDYLINOSITOL_BINDING","GO_MF","490640_GO_0005545_1_PHOSPHATIDYLINOSITOL_BINDING",20,-1.2892,0.16,0.31,-0.6778,0.9,1,1.0824,0.32,0.8
"C7_Immunologic_signatures:C7_ALL_1642_GSE3982_DC_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_1642_GSE3982_DC_VS_TH1_DN",196,-1.2892,0.048,0.088,1.028,0.38,0.65,-1.483,0,0.026
"GO_BP:750957_GO_0036035_OSTEOCLAST_DEVELOPMENT","GO_BP","750957_GO_0036035_OSTEOCLAST_DEVELOPMENT",6,-1.2891,0.18,0.26,0.7616,0.77,1,0.8904,0.57,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2689_VALK_AML_CLUSTER_13","C2_Chemical_and_genetic_perturbations","C2_CGP_2689_VALK_AML_CLUSTER_13",30,-1.289,0.13,0.19,-0.6202,0.97,1,0.9632,0.52,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2837_KORKOLA_CORRELATED_WITH_POU5F1","C2_Chemical_and_genetic_perturbations","C2_CGP_2837_KORKOLA_CORRELATED_WITH_POU5F1",33,-1.2889,0.13,0.19,-1.3222,0.11,0.69,0.7223,0.92,1
"C3_MicroRNA_targets:C3_MIR_20_AAAGGGA_MIR_204_MIR_211","C3_MicroRNA_targets","C3_MIR_20_AAAGGGA_MIR_204_MIR_211",222,-1.2889,0.039,0.25,-0.7557,0.98,1,-1.0613,0.28,1
"KEGG_compound:C05503_ESTRADIOL_17BETA_3_GLUCURONIDE_17BETA_ESTRADIOL_3_BETA_D_GLUCURONIDE_","KEGG_compound","C05503_ESTRADIOL_17BETA_3_GLUCURONIDE_17BETA_ESTRADIOL_3_BETA_D_GLUCURONIDE_",19,-1.2889,0.16,0.31,1.9559,0,0.049,2.3904,0,0
"WikiPathways:198811_WP179_CELL_CYCLE","WikiPathways","198811_WP179_CELL_CYCLE",101,-1.2888,0.08,0.21,0.8294,0.86,1,-1.5749,0.002,0.26
"C3_MicroRNA_targets:C3_MIR_1_AGCACTT_MIR_93_MIR_302A_MIR_302B_MIR_302C_MIR_302D_MIR_372_MIR_373_MIR_520E_MIR_520A_MIR_526B_MIR_520B_MIR_520C_MIR_520D","C3_MicroRNA_targets","C3_MIR_1_AGCACTT_MIR_93_MIR_302A_MIR_302B_MIR_302C_MIR_302D_MIR_372_MIR_373_MIR_520E_MIR_520A_MIR_526B_MIR_520B_MIR_520C_MIR_520D",339,-1.2888,0.021,0.24,-0.6936,1,1,-0.9935,0.5,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2075_ZHENG_FOXP3_TARGETS_IN_THYMUS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2075_ZHENG_FOXP3_TARGETS_IN_THYMUS_UP",194,-1.2887,0.057,0.19,1.1089,0.2,0.61,-0.8665,0.85,0.91
"KEGG_compound:C05276_TRANS_OCT_2_ENOYL_COA_2E_OCTENOYL_COA","KEGG_compound","C05276_TRANS_OCT_2_ENOYL_COA_2E_OCTENOYL_COA",8,-1.2886,0.15,0.31,0.6001,0.93,1,-1.4293,0.094,0.26
"GO_MF:495533_GO_0015288_PORIN_ACTIVITY","GO_MF","495533_GO_0015288_PORIN_ACTIVITY",7,-1.2886,0.17,0.31,1.4601,0.085,0.41,-1.4954,0.057,0.42
"GO_BP:494008_GO_0009914_HORMONE_TRANSPORT","GO_BP","494008_GO_0009914_HORMONE_TRANSPORT",81,-1.2885,0.095,0.26,1.1698,0.15,0.81,1.201,0.14,0.72
"GO_BP:518325_GO_0090185_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT","GO_BP","518325_GO_0090185_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT",16,-1.2885,0.17,0.26,-0.7576,0.8,1,0.9661,0.49,0.89
"GO_BP:516558_GO_0071634_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION","GO_BP","516558_GO_0071634_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION",21,-1.2885,0.15,0.26,0.8357,0.72,1,1.1023,0.31,0.76
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_35_BIOCARTA_G1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_35_BIOCARTA_G1_PATHWAY",28,-1.2884,0.14,0.26,-0.8862,0.64,1,-1.7284,0.008,0.27
"C4_Cancer_gene_neighborhoods:C4_CGN_315_GNF2_SMC2L1","C4_Cancer_gene_neighborhoods","C4_CGN_315_GNF2_SMC2L1",33,-1.2884,0.14,0.22,1.0899,0.33,0.39,-1.6113,0.016,0.069
"GO_BP:513941_GO_0060385_AXONOGENESIS_INVOLVED_IN_INNERVATION","GO_BP","513941_GO_0060385_AXONOGENESIS_INVOLVED_IN_INNERVATION",5,-1.2884,0.18,0.26,-1.4237,0.085,0.94,-0.8384,0.64,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1541_YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1541_YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN",17,-1.2884,0.15,0.19,1.5245,0.054,0.19,1.0322,0.42,0.93
"C7_Immunologic_signatures:C7_ALL_782_GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_782_GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN",200,-1.2884,0.054,0.089,0.8686,0.85,1,-1.5402,0,0.012
"REACTOME:161006_REACT_22272_SIGNAL_TRANSDUCTION_BY_L1","REACTOME","161006_REACT_22272_SIGNAL_TRANSDUCTION_BY_L1",21,-1.2883,0.13,0.3,1.1502,0.25,0.51,0.8486,0.67,1
"C7_Immunologic_signatures:C7_ALL_8_KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_8_KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN",195,-1.2883,0.04,0.089,0.9281,0.69,0.96,-0.9496,0.59,0.85
"KEGG_compound:C04043_3_4_DIHYDROXYPHENYLACETALDEHYDE_PROTOCATECHUATEALDEHYDE","KEGG_compound","C04043_3_4_DIHYDROXYPHENYLACETALDEHYDE_PROTOCATECHUATEALDEHYDE",8,-1.2882,0.18,0.31,-0.9901,0.5,1,-1.5087,0.045,0.22
"GO_BP:488311_GO_0002438_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS","GO_BP","488311_GO_0002438_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",7,-1.288,0.17,0.26,1.1082,0.33,0.89,0.8631,0.62,0.97
"GO_BP:501306_GO_0032069_REGULATION_OF_NUCLEASE_ACTIVITY","GO_BP","501306_GO_0032069_REGULATION_OF_NUCLEASE_ACTIVITY",81,-1.288,0.098,0.26,-0.6379,0.99,1,-1.3547,0.045,0.6
"KEGG_compound:C01516_MORPHINE","KEGG_compound","C01516_MORPHINE",20,-1.288,0.17,0.31,1.7378,0.0083,0.059,2.2912,0,0
"GO_BP:503307_GO_0034101_ERYTHROCYTE_HOMEOSTASIS","GO_BP","503307_GO_0034101_ERYTHROCYTE_HOMEOSTASIS",82,-1.2879,0.094,0.26,1.4661,0.0044,0.47,-1.0453,0.34,0.81
"GO_CC:513469_GO_0055038_RECYCLING_ENDOSOME_MEMBRANE","GO_CC","513469_GO_0055038_RECYCLING_ENDOSOME_MEMBRANE",40,-1.2877,0.11,0.32,0.6931,0.94,0.99,0.7025,0.93,1
"GO_BP:516604_GO_0071680_RESPONSE_TO_INDOLE_3_METHANOL","GO_BP","516604_GO_0071680_RESPONSE_TO_INDOLE_3_METHANOL",5,-1.2876,0.19,0.26,-0.6535,0.88,1,-0.9413,0.54,0.89
"C3_MicroRNA_targets:C3_MIR_68_GGGGCCC_MIR_296","C3_MicroRNA_targets","C3_MIR_68_GGGGCCC_MIR_296",69,-1.2876,0.11,0.24,-1.7097,0.0035,0.11,-1.1027,0.28,1
"KEGG_module:HSA_M00047_CREATINE_PATHWAY","KEGG_module","HSA_M00047_CREATINE_PATHWAY",7,-1.2874,0.17,0.45,-1.264,0.22,1,-0.9357,0.53,0.88
"C1_Positional:C1_ALL_111_CHRXQ11","C1_Positional","C1_ALL_111_CHRXQ11",10,-1.2873,0.17,0.64,-0.9594,0.49,1,-0.9653,0.5,0.96
"C7_Immunologic_signatures:C7_ALL_1397_GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP","C7_Immunologic_signatures","C7_ALL_1397_GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP",200,-1.2872,0.053,0.09,1.0125,0.43,0.71,-1.4818,0.0044,0.026
"GO_BP:495119_GO_0014047_GLUTAMATE_SECRETION","GO_BP","495119_GO_0014047_GLUTAMATE_SECRETION",24,-1.2871,0.15,0.26,-1.3595,0.11,0.97,-0.8998,0.61,0.92
"GO_BP:511916_GO_0050982_DETECTION_OF_MECHANICAL_STIMULUS","GO_BP","511916_GO_0050982_DETECTION_OF_MECHANICAL_STIMULUS",40,-1.2871,0.12,0.26,-1.5049,0.022,0.82,-1.4651,0.032,0.54
"C3_TF_targets:C3_TFT_476_V_AR_03","C3_TF_targets","C3_TFT_476_V_AR_03",56,-1.2869,0.1,0.1,-1.12,0.28,0.5,-0.9494,0.54,0.85
"REACTOME:160970_REACT_20537_TYPE_I_HEMIDESMOSOME_ASSEMBLY","REACTOME","160970_REACT_20537_TYPE_I_HEMIDESMOSOME_ASSEMBLY",9,-1.2869,0.16,0.3,-0.9672,0.5,1,1.2788,0.19,0.78
"C7_Immunologic_signatures:C7_ALL_786_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_786_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN",192,-1.2869,0.044,0.09,-1.2947,0.044,0.49,1.3691,0.011,0.17
"C2_Chemical_and_genetic_perturbations:C2_CGP_1395_SANA_RESPONSE_TO_IFNG_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1395_SANA_RESPONSE_TO_IFNG_DN",85,-1.2869,0.095,0.19,1.6073,0.0046,0.13,-0.824,0.85,0.94
"REACTOME:1127510_REACT_268456_PROGRAMMED_CELL_DEATH","REACTOME","1127510_REACT_268456_PROGRAMMED_CELL_DEATH",163,-1.2868,0.059,0.3,1.4761,0.0048,0.16,-0.7542,0.97,1
"GO_MF:489431_GO_0003951_NAD_KINASE_ACTIVITY","GO_MF","489431_GO_0003951_NAD_KINASE_ACTIVITY",17,-1.2868,0.14,0.32,-1.5442,0.037,0.53,-1.3021,0.14,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_3218_PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3218_PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP",85,-1.2866,0.079,0.19,1.5466,0.012,0.17,-0.9247,0.64,0.85
"GO_BP:504419_GO_0035235_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","504419_GO_0035235_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY",24,-1.2866,0.16,0.26,-0.9879,0.48,1,1.8671,0.0059,0.19
"GO_BP:504513_GO_0035329_HIPPO_SIGNALING","GO_BP","504513_GO_0035329_HIPPO_SIGNALING",26,-1.2866,0.14,0.26,0.5786,0.98,1,-0.9326,0.56,0.9
"GO_BP:507995_GO_0045647_NEGATIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION","GO_BP","507995_GO_0045647_NEGATIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION",8,-1.2866,0.18,0.26,1.1753,0.26,0.81,0.6847,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1390_MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1390_MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP",20,-1.2866,0.16,0.19,-1.1746,0.23,0.83,0.7056,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2130_ZHANG_GATA6_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2130_ZHANG_GATA6_TARGETS_DN",63,-1.2866,0.097,0.19,0.7176,0.94,1,-0.7835,0.89,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2080_ZHENG_FOXP3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2080_ZHENG_FOXP3_TARGETS_DN",5,-1.2865,0.19,0.19,1.1679,0.29,0.53,-0.778,0.74,0.97
"C3_TF_targets:C3_TFT_330_V_DBP_Q6","C3_TF_targets","C3_TFT_330_V_DBP_Q6",244,-1.2865,0.041,0.1,-0.9208,0.7,0.93,-0.8403,0.93,0.98
"GO_BP:500400_GO_0031113_REGULATION_OF_MICROTUBULE_POLYMERIZATION","GO_BP","500400_GO_0031113_REGULATION_OF_MICROTUBULE_POLYMERIZATION",22,-1.2863,0.14,0.26,-1.1127,0.29,0.94,-1.3213,0.11,0.63
"C7_Immunologic_signatures:C7_ALL_274_GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN","C7_Immunologic_signatures","C7_ALL_274_GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN",195,-1.2863,0.046,0.091,1.1618,0.15,0.3,-0.9336,0.65,0.89
"KEGG_compound:C00136_BUTANOYL_COA_BUTYRYL_COA","KEGG_compound","C00136_BUTANOYL_COA_BUTYRYL_COA",16,-1.2863,0.17,0.31,-0.582,0.97,1,-1.8603,0.004,0.066
"GO_BP:491974_GO_0007171_ACTIVATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY","GO_BP","491974_GO_0007171_ACTIVATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY",11,-1.2863,0.19,0.26,-0.9334,0.58,1,-1.0124,0.46,0.84
"GO_BP:516927_GO_0072008_GLOMERULAR_MESANGIAL_CELL_DIFFERENTIATION","GO_BP","516927_GO_0072008_GLOMERULAR_MESANGIAL_CELL_DIFFERENTIATION",5,-1.2862,0.18,0.26,0.5012,0.97,1,0.5732,0.95,1
"GO_CC:506687_GO_0043657_HOST_CELL","GO_CC","506687_GO_0043657_HOST_CELL",8,-1.2862,0.17,0.32,-1.2427,0.22,0.63,-0.7016,0.86,1
"GO_BP:511652_GO_0050680_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION","GO_BP","511652_GO_0050680_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION",111,-1.2861,0.077,0.26,-1.0145,0.43,0.98,-1.0103,0.44,0.84
"GO_MF:507849_GO_0045499_CHEMOREPELLENT_ACTIVITY","GO_MF","507849_GO_0045499_CHEMOREPELLENT_ACTIVITY",8,-1.286,0.16,0.32,1.4074,0.11,0.48,1.3803,0.12,0.56
"C2_Chemical_and_genetic_perturbations:C2_CGP_2389_CHEN_HOXA5_TARGETS_6HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2389_CHEN_HOXA5_TARGETS_6HR_UP",9,-1.286,0.18,0.19,-1.2054,0.23,0.8,0.8605,0.63,1
"GO_BP:501953_GO_0032727_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION","GO_BP","501953_GO_0032727_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION",15,-1.2859,0.15,0.26,0.8138,0.71,1,-1.636,0.021,0.53
"GO_BP:753112_GO_1900117_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS","GO_BP","753112_GO_1900117_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS",20,-1.2859,0.14,0.26,0.9841,0.49,1,-0.7429,0.83,1
"GO_BP:487827_GO_0001936_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION","GO_BP","487827_GO_0001936_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION",91,-1.2857,0.076,0.26,1.2186,0.11,0.76,1.5383,0.0081,0.53
"C7_Immunologic_signatures:C7_ALL_366_GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN","C7_Immunologic_signatures","C7_ALL_366_GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN",192,-1.2857,0.055,0.091,0.8747,0.85,1,0.8839,0.78,1
"KEGG_compound:C11133_ESTRONE_GLUCURONIDE_ESTRONE_3_GLUCURONIDE_ESTRONE_BETA_D_GLUCURONIDE","KEGG_compound","C11133_ESTRONE_GLUCURONIDE_ESTRONE_3_GLUCURONIDE_ESTRONE_BETA_D_GLUCURONIDE",19,-1.2855,0.15,0.31,1.9465,0.0043,0.028,2.4027,0,0
"C7_Immunologic_signatures:C7_ALL_139_GSE13229_IMM_VS_MATURE_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_139_GSE13229_IMM_VS_MATURE_NKCELL_UP",196,-1.2853,0.045,0.091,0.8574,0.86,1,0.9762,0.5,1
"GO_BP:510635_GO_0048570_NOTOCHORD_MORPHOGENESIS","GO_BP","510635_GO_0048570_NOTOCHORD_MORPHOGENESIS",9,-1.2851,0.18,0.26,-1.2329,0.22,0.9,0.6923,0.84,1
"GO_BP:494784_GO_0010719_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION","GO_BP","494784_GO_0010719_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION",22,-1.2849,0.13,0.26,-0.981,0.48,1,-0.8226,0.74,0.97
"C7_Immunologic_signatures:C7_ALL_1119_GSE2706_UNSTIM_VS_8H_LPS_DC_UP","C7_Immunologic_signatures","C7_ALL_1119_GSE2706_UNSTIM_VS_8H_LPS_DC_UP",195,-1.2848,0.045,0.092,1.3429,0.0094,0.067,-1.9216,0,0
"GO_MF:490092_GO_0004784_SUPEROXIDE_DISMUTASE_ACTIVITY","GO_MF","490092_GO_0004784_SUPEROXIDE_DISMUTASE_ACTIVITY",5,-1.2847,0.17,0.32,-0.619,0.92,1,-1.3138,0.18,0.56
"OMIM_gene:OMIM603850_DYNAMIN_1_LIKE_DNM1L","OMIM_gene","OMIM603850_DYNAMIN_1_LIKE_DNM1L",5,-1.2847,0.17,1,0.8082,0.71,1,-0.9163,0.58,1
"GO_BP:498885_GO_0021602_CRANIAL_NERVE_MORPHOGENESIS","GO_BP","498885_GO_0021602_CRANIAL_NERVE_MORPHOGENESIS",24,-1.2847,0.14,0.26,-0.6754,0.93,1,1.0007,0.47,0.86
"C3_MicroRNA_targets:C3_MIR_24_CTCAGGG_MIR_125B_MIR_125A","C3_MicroRNA_targets","C3_MIR_24_CTCAGGG_MIR_125B_MIR_125A",327,-1.2847,0.028,0.24,-1.0696,0.25,1,-0.8257,0.96,1
"C3_MicroRNA_targets:C3_MIR_99_TTGGGAG_MIR_150","C3_MicroRNA_targets","C3_MIR_99_TTGGGAG_MIR_150",90,-1.2846,0.093,0.24,-0.7658,0.93,1,0.8015,0.88,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_72_BIOCARTA_FCER1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_72_BIOCARTA_FCER1_PATHWAY",38,-1.2846,0.14,0.27,0.6002,0.99,1,-1.3436,0.069,0.48
"GO_BP:508653_GO_0046390_RIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","508653_GO_0046390_RIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS",155,-1.2846,0.051,0.26,0.8621,0.82,1,-1.2982,0.044,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1940_BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1940_BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP",25,-1.2845,0.15,0.19,0.9812,0.45,0.81,-0.9207,0.57,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_2525_NUTT_GBM_VS_AO_GLIOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2525_NUTT_GBM_VS_AO_GLIOMA_UP",46,-1.2843,0.12,0.19,1.4878,0.016,0.22,-1.1934,0.18,0.53
"GO_BP:507342_GO_0044336_CANONICAL_WNT_SIGNALING_PATHWAY_INVOLVED_IN_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS","GO_BP","507342_GO_0044336_CANONICAL_WNT_SIGNALING_PATHWAY_INVOLVED_IN_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS",5,-1.2843,0.17,0.26,-0.6674,0.87,1,-0.7426,0.8,1
"GO_BP:486714_GO_0000183_CHROMATIN_SILENCING_AT_RDNA","GO_BP","486714_GO_0000183_CHROMATIN_SILENCING_AT_RDNA",38,-1.2843,0.16,0.26,-1.6283,0.0072,0.7,-1.1203,0.27,0.76
"GO_BP:519119_GO_2000479_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY","GO_BP","519119_GO_2000479_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY",13,-1.2842,0.16,0.26,1.037,0.37,0.96,-0.6803,0.88,1
"REACTOME:187186_REACT_23988_TRANSPORT_OF_ORGANIC_ANIONS","REACTOME","187186_REACT_23988_TRANSPORT_OF_ORGANIC_ANIONS",11,-1.2842,0.17,0.3,-1.1295,0.31,0.9,1.5754,0.039,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_750_XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR","C2_Chemical_and_genetic_perturbations","C2_CGP_750_XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR",26,-1.2842,0.14,0.19,0.908,0.62,0.91,1.706,0.0058,0.3
"C7_Immunologic_signatures:C7_ALL_1634_GSE3982_DC_VS_BASOPHIL_DN","C7_Immunologic_signatures","C7_ALL_1634_GSE3982_DC_VS_BASOPHIL_DN",199,-1.2841,0.056,0.093,1.1819,0.092,0.26,-1.0689,0.26,0.57
"C7_Immunologic_signatures:C7_ALL_1412_GSE360_CTRL_VS_T_GONDII_DC_DN","C7_Immunologic_signatures","C7_ALL_1412_GSE360_CTRL_VS_T_GONDII_DC_DN",192,-1.284,0.057,0.093,0.8479,0.9,1,-1.2132,0.094,0.25
"KEGG_compound:C01211_PROCOLLAGEN_5_HYDROXY_L_LYSINE_PROCOLLAGEN_L_ERYTHRO_5_HYDROXYLYSINE","KEGG_compound","C01211_PROCOLLAGEN_5_HYDROXY_L_LYSINE_PROCOLLAGEN_L_ERYTHRO_5_HYDROXYLYSINE",5,-1.2837,0.16,0.31,-1.032,0.43,1,-0.7078,0.84,0.91
"KEGG_compound:C11061_ALL_TRANS_RETINOYL_BETA_GLUCURONIDE_RETINOYL_GLUCURONIDE","KEGG_compound","C11061_ALL_TRANS_RETINOYL_BETA_GLUCURONIDE_RETINOYL_GLUCURONIDE",19,-1.2837,0.16,0.31,1.9076,0,0.015,2.3975,0,0
"C4_Cancer_modules:C4_CM_393_MODULE_495","C4_Cancer_modules","C4_CM_393_MODULE_495",15,-1.2837,0.15,0.19,0.6421,0.95,1,0.4834,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1769_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1769_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN",30,-1.2836,0.13,0.19,-0.9102,0.58,1,-0.8271,0.74,0.94
"REACTOME:106128_REACT_1697_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA","REACTOME","106128_REACT_1697_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA",5,-1.2836,0.18,0.3,0.9932,0.49,0.76,-1.4731,0.062,0.38
"C3_MicroRNA_targets:C3_MIR_220_CAATGCA_MIR_33","C3_MicroRNA_targets","C3_MIR_220_CAATGCA_MIR_33",91,-1.2835,0.084,0.24,-0.9755,0.52,1,-0.856,0.78,1
"GO_CC:499713_GO_0030313_CELL_ENVELOPE","GO_CC","499713_GO_0030313_CELL_ENVELOPE",6,-1.2834,0.17,0.33,0.9321,0.52,0.85,1.313,0.17,0.72
"GO_CC:752724_GO_0097223_SPERM_PART","GO_CC","752724_GO_0097223_SPERM_PART",119,-1.2834,0.078,0.32,-1.1811,0.14,0.68,-0.9368,0.62,1
"GO_BP:812250_GO_1990090_CELLULAR_RESPONSE_TO_NERVE_GROWTH_FACTOR_STIMULUS","GO_BP","812250_GO_1990090_CELLULAR_RESPONSE_TO_NERVE_GROWTH_FACTOR_STIMULUS",18,-1.2833,0.16,0.27,0.5827,0.98,1,1.01,0.44,0.84
"C3_TF_targets:C3_TFT_229_V_MMEF2_Q6","C3_TF_targets","C3_TFT_229_V_MMEF2_Q6",261,-1.2831,0.035,0.1,-0.942,0.63,0.88,-0.9577,0.61,0.83
"KEGG_compound:C00601_PHENYLACETALDEHYDE_ALPHA_TOLUALDEHYDE","KEGG_compound","C00601_PHENYLACETALDEHYDE_ALPHA_TOLUALDEHYDE",8,-1.2831,0.18,0.31,-0.9994,0.45,1,-1.4922,0.054,0.23
"C7_Immunologic_signatures:C7_ALL_1134_GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN","C7_Immunologic_signatures","C7_ALL_1134_GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN",170,-1.283,0.062,0.094,-1.241,0.088,0.66,1.0925,0.25,1
"C3_MicroRNA_targets:C3_MIR_181_TGCTTTG_MIR_330","C3_MicroRNA_targets","C3_MIR_181_TGCTTTG_MIR_330",325,-1.2829,0.017,0.24,0.9545,0.6,1,-0.9239,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2430_KRISHNAN_FURIN_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2430_KRISHNAN_FURIN_TARGETS_UP",11,-1.2829,0.16,0.19,-1.4856,0.069,0.48,-1.2372,0.21,0.49
"C3_MicroRNA_targets:C3_MIR_157_AACATTC_MIR_409_3P","C3_MicroRNA_targets","C3_MIR_157_AACATTC_MIR_409_3P",141,-1.2829,0.067,0.23,1.0076,0.41,1,-1.0169,0.41,1
"KEGG_compound:C05275_TRANS_DEC_2_ENOYL_COA_2E_DECENOYL_COA","KEGG_compound","C05275_TRANS_DEC_2_ENOYL_COA_2E_DECENOYL_COA",8,-1.2828,0.18,0.31,0.6114,0.93,1,-1.4283,0.095,0.26
"REACTOME:106136_REACT_16957_PEROXISOMAL_LIPID_METABOLISM","REACTOME","106136_REACT_16957_PEROXISOMAL_LIPID_METABOLISM",21,-1.2827,0.14,0.3,1.2983,0.12,0.32,-1.5172,0.04,0.34
"KEGG_reaction:R01383_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_UDP_GLUCURONATE_ROH_UDP_BETA_D_GLUCURONOSIDE","KEGG_reaction","R01383_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_UDP_GLUCURONATE_ROH_UDP_BETA_D_GLUCURONOSIDE",19,-1.2826,0.17,0.28,1.9313,0.0022,0.0079,2.4392,0,0
"REACTOME:105778_REACT_471_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION","REACTOME","105778_REACT_471_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION",33,-1.2826,0.13,0.3,0.6921,0.93,1,-1.2972,0.12,0.55
"C7_Immunologic_signatures:C7_ALL_413_GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP","C7_Immunologic_signatures","C7_ALL_413_GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP",196,-1.2826,0.057,0.094,1.4227,0.0045,0.031,-0.8988,0.74,0.95
"C7_Immunologic_signatures:C7_ALL_59_GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_59_GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP",197,-1.2826,0.042,0.094,-0.6943,0.99,1,-1.0838,0.25,0.54
"REACTOME:119534_REACT_19268_NECTIN_NECL_TRANS_HETERODIMERIZATION","REACTOME","119534_REACT_19268_NECTIN_NECL_TRANS_HETERODIMERIZATION",6,-1.2825,0.17,0.3,0.9566,0.5,0.82,1.0009,0.45,1
"GO_MF:495545_GO_0015301_ANION_ANION_ANTIPORTER_ACTIVITY","GO_MF","495545_GO_0015301_ANION_ANION_ANTIPORTER_ACTIVITY",24,-1.2825,0.16,0.32,-0.8734,0.67,1,-0.9676,0.52,0.81
"GO_BP:510764_GO_0048709_OLIGODENDROCYTE_DIFFERENTIATION","GO_BP","510764_GO_0048709_OLIGODENDROCYTE_DIFFERENTIATION",57,-1.2825,0.11,0.27,1.0149,0.43,0.97,0.917,0.62,0.93
"C7_Immunologic_signatures:C7_ALL_1736_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1736_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN",192,-1.2824,0.05,0.094,0.8066,0.94,1,-0.9994,0.44,0.72
"GO_BP:508688_GO_0046426_NEGATIVE_REGULATION_OF_JAK_STAT_CASCADE","GO_BP","508688_GO_0046426_NEGATIVE_REGULATION_OF_JAK_STAT_CASCADE",20,-1.2824,0.16,0.27,0.4939,0.99,1,-0.943,0.53,0.89
"KEGG_compound:C07108_TAMOXIFEN","KEGG_compound","C07108_TAMOXIFEN",8,-1.2823,0.19,0.31,-0.6707,0.88,1,1.0778,0.36,0.62
"GO_MF:496711_GO_0016812_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDES","GO_MF","496711_GO_0016812_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDES",9,-1.2823,0.18,0.32,1.1155,0.33,0.77,-1.0057,0.48,0.79
"C3_MicroRNA_targets:C3_MIR_7_TGAATGT_MIR_181A_MIR_181B_MIR_181C_MIR_181D","C3_MicroRNA_targets","C3_MIR_7_TGAATGT_MIR_181A_MIR_181B_MIR_181C_MIR_181D",476,-1.2822,0.015,0.23,-0.7667,1,1,-0.8143,0.99,1
"C7_Immunologic_signatures:C7_ALL_1313_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP","C7_Immunologic_signatures","C7_ALL_1313_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP",194,-1.2821,0.053,0.094,-0.679,1,1,0.8501,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3050_KIM_ALL_DISORDERS_CALB1_CORR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3050_KIM_ALL_DISORDERS_CALB1_CORR_DN",33,-1.2819,0.14,0.19,0.9267,0.59,0.89,1.0629,0.35,0.9
"GO_MF:500206_GO_0030911_TPR_DOMAIN_BINDING","GO_MF","500206_GO_0030911_TPR_DOMAIN_BINDING",5,-1.2819,0.17,0.32,0.6518,0.9,1,-1.143,0.33,0.65
"C3_TF_targets:C3_TFT_56_V_MZF1_02","C3_TF_targets","C3_TFT_56_V_MZF1_02",226,-1.2818,0.05,0.1,-1.2647,0.058,0.26,-1.1419,0.14,0.46
"KEGG_reaction:R01881_ATP_CREATINE_N_PHOSPHOTRANSFERASE_ATP_CREATINE_ADP_PHOSPHOCREATINE","KEGG_reaction","R01881_ATP_CREATINE_N_PHOSPHOTRANSFERASE_ATP_CREATINE_ADP_PHOSPHOCREATINE",5,-1.2817,0.16,0.27,-1.083,0.37,0.69,1.1123,0.35,0.62
"C3_TF_targets:C3_TFT_144_V_CEBP_C","C3_TF_targets","C3_TFT_144_V_CEBP_C",198,-1.2815,0.034,0.1,0.9631,0.55,1,-0.9115,0.7,0.9
"GO_BP:495219_GO_0014823_RESPONSE_TO_ACTIVITY","GO_BP","495219_GO_0014823_RESPONSE_TO_ACTIVITY",46,-1.2815,0.12,0.27,-0.7719,0.87,1,1.324,0.086,0.65
"C7_Immunologic_signatures:C7_ALL_1549_GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1549_GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP",197,-1.2815,0.056,0.095,0.8503,0.86,1,-1.7236,0,0.00048
"REACTOME:1183575_REACT_355160_PI_3K_CASCADE_FGFR3","REACTOME","1183575_REACT_355160_PI_3K_CASCADE_FGFR3",91,-1.2814,0.091,0.3,-1.1347,0.22,0.9,-0.9284,0.62,0.92
"GO_BP:499062_GO_0021782_GLIAL_CELL_DEVELOPMENT","GO_BP","499062_GO_0021782_GLIAL_CELL_DEVELOPMENT",69,-1.2813,0.092,0.27,0.8076,0.84,1,-1.0289,0.4,0.82
"GO_BP:492845_GO_0008585_FEMALE_GONAD_DEVELOPMENT","GO_BP","492845_GO_0008585_FEMALE_GONAD_DEVELOPMENT",81,-1.2813,0.08,0.27,-0.9017,0.66,1,1.1815,0.18,0.72
"REACTOME:106437_REACT_524_SOS_MEDIATED_SIGNALLING","REACTOME","106437_REACT_524_SOS_MEDIATED_SIGNALLING",21,-1.2813,0.16,0.3,0.5178,0.99,1,-0.8561,0.67,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_679_EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_679_EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION",49,-1.2813,0.12,0.19,1.0455,0.37,0.72,-0.8583,0.74,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1622_IVANOVA_HEMATOPOIESIS_MATURE_CELL","C2_Chemical_and_genetic_perturbations","C2_CGP_1622_IVANOVA_HEMATOPOIESIS_MATURE_CELL",293,-1.2812,0.024,0.19,1.4601,0.0026,0.25,-0.9257,0.74,0.85
"GO_BP:508472_GO_0046174_POLYOL_CATABOLIC_PROCESS","GO_BP","508472_GO_0046174_POLYOL_CATABOLIC_PROCESS",19,-1.2812,0.15,0.27,0.5775,0.96,1,-0.7355,0.86,1
"GO_BP:512813_GO_0051963_REGULATION_OF_SYNAPSE_ASSEMBLY","GO_BP","512813_GO_0051963_REGULATION_OF_SYNAPSE_ASSEMBLY",38,-1.2812,0.14,0.27,-1.1112,0.28,0.94,0.6614,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3064_WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3064_WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN",362,-1.2811,0.029,0.19,1.2022,0.035,0.48,-1.1291,0.13,0.59
"GO_MF:490010_GO_0004690_CYCLIC_NUCLEOTIDE_DEPENDENT_PROTEIN_KINASE_ACTIVITY","GO_MF","490010_GO_0004690_CYCLIC_NUCLEOTIDE_DEPENDENT_PROTEIN_KINASE_ACTIVITY",9,-1.2811,0.17,0.32,1.3539,0.13,0.52,-0.8088,0.71,0.96
"C6_Oncogenic_signatures:C6_ALL_92_DCA_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_92_DCA_UP_V1_UP",171,-1.2811,0.053,0.1,-1.1908,0.11,0.46,0.9032,0.72,0.76
"GO_BP:512745_GO_0051890_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION","GO_BP","512745_GO_0051890_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION",9,-1.2811,0.17,0.27,-0.9896,0.47,1,1.3666,0.12,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_3324_RAO_BOUND_BY_SALL4","C2_Chemical_and_genetic_perturbations","C2_CGP_3324_RAO_BOUND_BY_SALL4",224,-1.2811,0.046,0.19,-0.8484,0.88,1,1.0169,0.41,0.95
"GO_BP:497185_GO_0018214_PROTEIN_CARBOXYLATION","GO_BP","497185_GO_0018214_PROTEIN_CARBOXYLATION",12,-1.281,0.17,0.27,-0.9143,0.59,1,-0.9566,0.52,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1944_MCDOWELL_ACUTE_LUNG_INJURY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1944_MCDOWELL_ACUTE_LUNG_INJURY_DN",46,-1.281,0.12,0.19,0.7974,0.85,0.99,0.859,0.7,1
"GO_BP:491788_GO_0006939_SMOOTH_MUSCLE_CONTRACTION","GO_BP","491788_GO_0006939_SMOOTH_MUSCLE_CONTRACTION",47,-1.281,0.12,0.27,0.8039,0.83,1,-1.0693,0.32,0.8
"GO_BP:982376_GO_1902806_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION","GO_BP","982376_GO_1902806_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION",139,-1.281,0.081,0.27,1.2595,0.082,0.72,-1.4294,0.0065,0.57
"KEGG_compound:C00028_ACCEPTOR_HYDROGEN_ACCEPTOR_A_OXIDIZED_DONOR","KEGG_compound","C00028_ACCEPTOR_HYDROGEN_ACCEPTOR_A_OXIDIZED_DONOR",21,-1.281,0.15,0.31,1.1913,0.22,0.87,-1.1896,0.23,0.46
"GO_BP:925920_GO_1902571_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY","GO_BP","925920_GO_1902571_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY",7,-1.2808,0.2,0.27,1.2904,0.17,0.69,-0.7795,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2509_FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2509_FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN",50,-1.2807,0.12,0.19,-1.0565,0.37,0.96,-1.7871,0.0041,0.13
"KEGG_compound:C00300_CREATINE_ALPHA_METHYLGUANIDINO_ACETIC_ACID_METHYLGLYCOCYAMINE","KEGG_compound","C00300_CREATINE_ALPHA_METHYLGUANIDINO_ACETIC_ACID_METHYLGLYCOCYAMINE",6,-1.2807,0.17,0.3,-0.9815,0.5,1,-0.9884,0.46,0.66
"C3_TF_targets:C3_TFT_145_V_GATA_C","C3_TF_targets","C3_TFT_145_V_GATA_C",258,-1.2806,0.041,0.11,-0.9266,0.68,0.92,1.0468,0.31,1
"C7_Immunologic_signatures:C7_ALL_840_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN","C7_Immunologic_signatures","C7_ALL_840_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN",198,-1.2806,0.05,0.096,0.9848,0.49,0.79,-1.5675,0,0.0084
"C2_Chemical_and_genetic_perturbations:C2_CGP_1752_DASU_IL6_SIGNALING_SCAR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1752_DASU_IL6_SIGNALING_SCAR_UP",30,-1.2806,0.15,0.19,-0.6737,0.94,1,-0.9439,0.55,0.83
"GO_CC:490652_GO_0005577_FIBRINOGEN_COMPLEX","GO_CC","490652_GO_0005577_FIBRINOGEN_COMPLEX",7,-1.2805,0.18,0.33,0.9318,0.52,0.85,1.2594,0.2,0.76
"GO_CC:490821_GO_0005793_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT","GO_CC","490821_GO_0005793_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT",78,-1.2805,0.095,0.33,0.9427,0.57,0.85,-0.8252,0.83,1
"GO_BP:492563_GO_0070265_NECROTIC_CELL_DEATH","GO_BP","492563_GO_0070265_NECROTIC_CELL_DEATH",27,-1.2804,0.16,0.27,-0.6339,0.96,1,-1.2614,0.13,0.67
"C4_Cancer_gene_neighborhoods:C4_CGN_113_MORF_IL13","C4_Cancer_gene_neighborhoods","C4_CGN_113_MORF_IL13",225,-1.2804,0.04,0.23,-1.2032,0.083,0.65,-1.1355,0.16,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_2892_DORN_ADENOVIRUS_INFECTION_12HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2892_DORN_ADENOVIRUS_INFECTION_12HR_UP",26,-1.2802,0.14,0.19,0.885,0.66,0.94,1.3569,0.092,0.56
"GO_BP:510982_GO_0048934_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION","GO_BP","510982_GO_0048934_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION",12,-1.2801,0.17,0.27,0.9548,0.48,1,1.0657,0.38,0.79
"GO_BP:516394_GO_0071470_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS","GO_BP","516394_GO_0071470_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS",22,-1.28,0.16,0.27,-0.608,0.98,1,-1.2194,0.2,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_1407_VANTVEER_BREAST_CANCER_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1407_VANTVEER_BREAST_CANCER_METASTASIS_UP",55,-1.28,0.12,0.19,-1.1401,0.25,0.86,-1.3264,0.078,0.41
"KEGG_pathway:HSA01230_BIOSYNTHESIS_OF_AMINO_ACIDS","KEGG_pathway","HSA01230_BIOSYNTHESIS_OF_AMINO_ACIDS",72,-1.28,0.096,0.15,0.8936,0.68,0.99,-1.0329,0.39,0.62
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_68_BIOCARTA_EPONFKB_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_68_BIOCARTA_EPONFKB_PATHWAY",11,-1.28,0.18,0.27,-0.8957,0.58,1,-0.9118,0.59,0.83
"GO_BP:499664_GO_0030259_LIPID_GLYCOSYLATION","GO_BP","499664_GO_0030259_LIPID_GLYCOSYLATION",5,-1.2797,0.18,0.27,-1.2304,0.23,0.89,0.9969,0.48,0.86
"GO_BP:501468_GO_0032233_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY","GO_BP","501468_GO_0032233_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY",44,-1.2796,0.12,0.27,-1.2552,0.12,0.91,0.7828,0.86,1
"C7_Immunologic_signatures:C7_ALL_433_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_433_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP",197,-1.2796,0.052,0.096,-1.0388,0.34,1,0.8387,0.9,1
"GO_BP:499527_GO_0030091_PROTEIN_REPAIR","GO_BP","499527_GO_0030091_PROTEIN_REPAIR",5,-1.2795,0.19,0.27,0.8541,0.65,1,-1.1435,0.33,0.74
"REACTOME:366231_REACT_75897_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS","REACTOME","366231_REACT_75897_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS",12,-1.2795,0.18,0.3,1.2056,0.22,0.44,0.6527,0.92,1
"GO_CC:500472_GO_0031209_SCAR_COMPLEX","GO_CC","500472_GO_0031209_SCAR_COMPLEX",8,-1.2794,0.18,0.33,-0.6911,0.86,1,-0.7298,0.8,1
"C7_Immunologic_signatures:C7_ALL_1052_GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN","C7_Immunologic_signatures","C7_ALL_1052_GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN",200,-1.2793,0.055,0.097,1.1852,0.097,0.25,-1.1286,0.14,0.42
"C7_Immunologic_signatures:C7_ALL_723_GSE17721_0_5H_VS_24H_POLYIC_BMDM_UP","C7_Immunologic_signatures","C7_ALL_723_GSE17721_0_5H_VS_24H_POLYIC_BMDM_UP",194,-1.2793,0.059,0.096,1.645,0,0.0013,0.8186,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1946_MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6","C2_Chemical_and_genetic_perturbations","C2_CGP_1946_MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6",51,-1.2793,0.12,0.19,-0.6971,0.94,1,-1.5709,0.016,0.26
"C3_TF_targets:C3_TFT_65_V_PAX2_01","C3_TF_targets","C3_TFT_65_V_PAX2_01",57,-1.2793,0.11,0.11,-1.2238,0.14,0.3,-1.435,0.031,0.28
"C7_Immunologic_signatures:C7_ALL_746_GSE17721_0_5H_VS_8H_CPG_BMDM_DN","C7_Immunologic_signatures","C7_ALL_746_GSE17721_0_5H_VS_8H_CPG_BMDM_DN",200,-1.2792,0.048,0.096,1.0086,0.45,0.71,-0.8202,0.95,1
"GO_MF:489653_GO_0008239_DIPEPTIDYL_PEPTIDASE_ACTIVITY","GO_MF","489653_GO_0008239_DIPEPTIDYL_PEPTIDASE_ACTIVITY",11,-1.2792,0.19,0.32,0.723,0.84,1,-1.3178,0.16,0.56
"C7_Immunologic_signatures:C7_ALL_1532_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN","C7_Immunologic_signatures","C7_ALL_1532_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN",191,-1.2792,0.057,0.096,0.7888,0.96,1,-1.1679,0.12,0.34
"GO_CC:492446_GO_0008076_VOLTAGE_GATED_POTASSIUM_CHANNEL_COMPLEX","GO_CC","492446_GO_0008076_VOLTAGE_GATED_POTASSIUM_CHANNEL_COMPLEX",78,-1.2791,0.09,0.33,-1.2465,0.11,0.64,1.0531,0.35,0.99
"C7_Immunologic_signatures:C7_ALL_1709_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP","C7_Immunologic_signatures","C7_ALL_1709_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP",194,-1.279,0.059,0.096,-0.7882,0.96,1,-1.2859,0.036,0.15
"C2_Chemical_and_genetic_perturbations:C2_CGP_2307_EHLERS_ANEUPLOIDY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2307_EHLERS_ANEUPLOIDY_UP",40,-1.279,0.12,0.19,1.7664,0.0021,0.055,-0.811,0.76,0.95
"GO_BP:511803_GO_0050860_NEGATIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY","GO_BP","511803_GO_0050860_NEGATIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY",13,-1.2789,0.17,0.27,0.9476,0.51,1,0.6129,0.96,1
"GO_BP:516296_GO_0071372_CELLULAR_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE_STIMULUS","GO_BP","516296_GO_0071372_CELLULAR_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE_STIMULUS",8,-1.2788,0.17,0.27,-1.2566,0.19,0.91,1.2253,0.22,0.71
"GO_BP:510355_GO_0048240_SPERM_CAPACITATION","GO_BP","510355_GO_0048240_SPERM_CAPACITATION",13,-1.2788,0.17,0.27,-1.2379,0.19,0.91,0.5813,0.97,1
"C7_Immunologic_signatures:C7_ALL_298_GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_298_GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN",198,-1.2786,0.065,0.097,0.8086,0.94,1,-1.2444,0.053,0.2
"C2_Chemical_and_genetic_perturbations:C2_CGP_507_VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_507_VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",14,-1.2786,0.16,0.19,1.175,0.24,0.53,-1.4471,0.065,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_1318_KANNAN_TP53_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1318_KANNAN_TP53_TARGETS_DN",21,-1.2785,0.15,0.19,-0.6047,0.97,1,0.8753,0.65,1
"C3_MicroRNA_targets:C3_MIR_17_CAGTATT_MIR_200B_MIR_200C_MIR_429","C3_MicroRNA_targets","C3_MIR_17_CAGTATT_MIR_200B_MIR_200C_MIR_429",466,-1.2785,0.017,0.23,1.0228,0.37,1,0.885,0.9,1
"C7_Immunologic_signatures:C7_ALL_205_GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_205_GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP",198,-1.2783,0.046,0.097,-0.5605,1,1,-0.8167,0.93,1
"C7_Immunologic_signatures:C7_ALL_590_GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_590_GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDM_DN",198,-1.2783,0.053,0.097,0.9353,0.65,0.94,-0.9454,0.59,0.86
"GO_BP:492601_GO_0008277_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY","GO_BP","492601_GO_0008277_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY",144,-1.2782,0.058,0.27,-1.0649,0.31,0.96,-1.1724,0.12,0.74
"GO_BP:518208_GO_0090068_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS","GO_BP","518208_GO_0090068_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS",227,-1.2782,0.043,0.27,1.1712,0.1,0.81,-1.4108,0.0041,0.57
"KEGG_reaction:R04683_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_UDP_GLUCURONATE_ESTRIOL_UDP_16_GLUCURONIDE_ESTRIOL","KEGG_reaction","R04683_UDPGLUCURONATE_BETA_D_GLUCURONOSYLTRANSFERASE_ACCEPTOR_UNSPECIFIC_UDP_GLUCURONATE_ESTRIOL_UDP_16_GLUCURONIDE_ESTRIOL",19,-1.2781,0.14,0.28,1.9237,0,0.0066,2.3978,0,0
"C7_Immunologic_signatures:C7_ALL_1524_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN","C7_Immunologic_signatures","C7_ALL_1524_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN",199,-1.2781,0.053,0.097,1.0756,0.28,0.51,-0.769,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_248_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_248_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP",15,-1.278,0.16,0.2,-1.1555,0.28,0.84,-1.583,0.031,0.25
"C3_TF_targets:C3_TFT_101_V_LYF1_01","C3_TF_targets","C3_TFT_101_V_LYF1_01",254,-1.2779,0.039,0.11,-1.1668,0.12,0.41,-1.036,0.36,0.65
"C7_Immunologic_signatures:C7_ALL_750_GSE17721_4_VS_24H_CPG_BMDM_DN","C7_Immunologic_signatures","C7_ALL_750_GSE17721_4_VS_24H_CPG_BMDM_DN",198,-1.2778,0.056,0.097,-0.7467,0.99,1,-0.8807,0.85,0.98
"GO_BP:513496_GO_0055064_CHLORIDE_ION_HOMEOSTASIS","GO_BP","513496_GO_0055064_CHLORIDE_ION_HOMEOSTASIS",6,-1.2778,0.18,0.27,-1.2956,0.18,0.88,-1.2973,0.18,0.64
"GO_BP:498045_GO_0019184_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS","GO_BP","498045_GO_0019184_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS",17,-1.2778,0.14,0.27,0.7978,0.77,1,-1.5157,0.045,0.54
"GO_BP:495302_GO_0014912_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION","GO_BP","495302_GO_0014912_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION",13,-1.2777,0.17,0.27,0.7145,0.85,1,0.89,0.63,0.95
"KEGG_compound:C00052_UDP_ALPHA_D_GALACTOSE_UDP_D_GALACTOSE_UDP_GALACTOSE_UDP_D_GALACTOPYRANOSE_UDP_ALPHA_D_GALACTOPYRANOSE","KEGG_compound","C00052_UDP_ALPHA_D_GALACTOSE_UDP_D_GALACTOSE_UDP_GALACTOSE_UDP_D_GALACTOPYRANOSE_UDP_ALPHA_D_GALACTOPYRANOSE",10,-1.2777,0.19,0.31,-0.9962,0.49,1,-0.681,0.87,0.92
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_85_BIOCARTA_SALMONELLA_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_85_BIOCARTA_SALMONELLA_PATHWAY",13,-1.2777,0.17,0.27,1.1611,0.26,0.66,-0.5404,0.99,0.99
"GO_BP:513435_GO_0055002_STRIATED_MUSCLE_CELL_DEVELOPMENT","GO_BP","513435_GO_0055002_STRIATED_MUSCLE_CELL_DEVELOPMENT",112,-1.2776,0.083,0.27,-1.2834,0.078,0.89,-1.0943,0.28,0.78
"GO_MF:509120_GO_0046915_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","509120_GO_0046915_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",28,-1.2776,0.16,0.33,-0.6466,0.95,1,-0.8772,0.65,0.9
"GO_BP:493386_GO_0009190_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","493386_GO_0009190_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",33,-1.2776,0.13,0.27,-1.2341,0.16,0.9,-1.6205,0.015,0.51
"GO_BP:514556_GO_0061001_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS","GO_BP","514556_GO_0061001_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS",23,-1.2775,0.15,0.27,-1.2374,0.2,0.9,-0.7511,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1397_LEE_LIVER_CANCER_MYC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1397_LEE_LIVER_CANCER_MYC_DN",61,-1.2774,0.1,0.2,0.9896,0.46,0.81,1.2779,0.093,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_243_MULLIGHAN_MLL_SIGNATURE_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_243_MULLIGHAN_MLL_SIGNATURE_1_DN",238,-1.2772,0.048,0.2,1.0067,0.45,0.79,-1.1462,0.14,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_2781_KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2781_KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP",12,-1.2772,0.17,0.2,-0.8916,0.58,1,-1.2228,0.24,0.5
"C4_Cancer_gene_neighborhoods:C4_CGN_3_MORF_BCL2","C4_Cancer_gene_neighborhoods","C4_CGN_3_MORF_BCL2",215,-1.277,0.048,0.24,-1.1669,0.13,0.66,-1.1769,0.1,0.47
"GO_BP:487480_GO_0001542_OVULATION_FROM_OVARIAN_FOLLICLE","GO_BP","487480_GO_0001542_OVULATION_FROM_OVARIAN_FOLLICLE",10,-1.277,0.16,0.27,1.0542,0.39,0.94,1.0622,0.38,0.79
"GO_BP:510394_GO_0048286_LUNG_ALVEOLUS_DEVELOPMENT","GO_BP","510394_GO_0048286_LUNG_ALVEOLUS_DEVELOPMENT",44,-1.2769,0.098,0.27,-1.125,0.27,0.94,1.0025,0.44,0.85
"C3_TF_targets:C3_TFT_292_V_NCX_01","C3_TF_targets","C3_TFT_292_V_NCX_01",166,-1.2768,0.05,0.11,-0.944,0.62,0.89,0.9224,0.65,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2580_HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2580_HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN",49,-1.2766,0.12,0.2,-0.6133,0.98,1,-1.2746,0.1,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_2457_MOOTHA_PGC","C2_Chemical_and_genetic_perturbations","C2_CGP_2457_MOOTHA_PGC",416,-1.2766,0.017,0.2,1.7419,0,0.063,-1.1385,0.087,0.59
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_181_BIOCARTA_GPCR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_181_BIOCARTA_GPCR_PATHWAY",33,-1.2765,0.13,0.27,0.7002,0.94,1,-1.466,0.04,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_2505_PIONTEK_PKD1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2505_PIONTEK_PKD1_TARGETS_DN",17,-1.2765,0.16,0.2,1.0129,0.45,0.78,-0.9589,0.52,0.81
"REACTOME:106517_REACT_13606_DEPOLARIZATION_OF_THE_PRESYNAPTIC_TERMINAL_TRIGGERS_THE_OPENING_OF_CALCIUM_CHANNELS","REACTOME","106517_REACT_13606_DEPOLARIZATION_OF_THE_PRESYNAPTIC_TERMINAL_TRIGGERS_THE_OPENING_OF_CALCIUM_CHANNELS",13,-1.2763,0.18,0.31,-1.6148,0.025,0.32,-0.7675,0.8,1
"GO_BP:514267_GO_0060712_SPONGIOTROPHOBLAST_LAYER_DEVELOPMENT","GO_BP","514267_GO_0060712_SPONGIOTROPHOBLAST_LAYER_DEVELOPMENT",13,-1.2763,0.15,0.27,-1.3601,0.12,0.97,-0.9546,0.51,0.89
"GO_BP:750928_GO_0036003_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS","GO_BP","750928_GO_0036003_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS",19,-1.2761,0.16,0.27,-0.6035,0.96,1,1.2533,0.15,0.7
"OMIM_gene:OMIM602462_COLLAPSIN_RESPONSE_MEDIATOR_PROTEIN_1_CRMP1","OMIM_gene","OMIM602462_COLLAPSIN_RESPONSE_MEDIATOR_PROTEIN_1_CRMP1",5,-1.2761,0.14,1,0.8205,0.66,1,-0.9051,0.59,0.95
"REACTOME:106233_REACT_1050_GAMMA_CARBOXYLATION_OF_PROTEIN_PRECURSORS","REACTOME","106233_REACT_1050_GAMMA_CARBOXYLATION_OF_PROTEIN_PRECURSORS",9,-1.2759,0.18,0.31,-1.2021,0.23,0.83,-1.255,0.21,0.55
"GO_BP:752191_GO_0061448_CONNECTIVE_TISSUE_DEVELOPMENT","GO_BP","752191_GO_0061448_CONNECTIVE_TISSUE_DEVELOPMENT",196,-1.2758,0.059,0.27,-1.1437,0.14,0.93,1.0731,0.29,0.78
"REACTOME:187170_REACT_23974_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION","REACTOME","187170_REACT_23974_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION",21,-1.2758,0.15,0.31,1.2978,0.14,0.32,-0.8176,0.73,1
"GO_BP:499338_GO_0022602_OVULATION_CYCLE_PROCESS","GO_BP","499338_GO_0022602_OVULATION_CYCLE_PROCESS",72,-1.2757,0.12,0.27,0.9273,0.6,1,1.3175,0.067,0.66
"GO_BP:498978_GO_0021695_CEREBELLAR_CORTEX_DEVELOPMENT","GO_BP","498978_GO_0021695_CEREBELLAR_CORTEX_DEVELOPMENT",47,-1.2757,0.12,0.27,-1.0672,0.36,0.96,-0.7239,0.93,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2053_LEIN_PONS_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_2053_LEIN_PONS_MARKERS",89,-1.2756,0.096,0.2,1.3981,0.026,0.29,1.0858,0.3,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1907_XU_GH1_AUTOCRINE_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1907_XU_GH1_AUTOCRINE_TARGETS_UP",255,-1.2756,0.033,0.2,1.069,0.27,0.68,1.0595,0.28,0.9
"GO_MF:490474_GO_0005234_EXTRACELLULAR_GLUTAMATE_GATED_ION_CHANNEL_ACTIVITY","GO_MF","490474_GO_0005234_EXTRACELLULAR_GLUTAMATE_GATED_ION_CHANNEL_ACTIVITY",18,-1.2755,0.14,0.33,1.0002,0.44,0.87,2.0263,0,0.015
"C3_TF_targets:C3_TFT_358_V_ALPHACP1_01","C3_TF_targets","C3_TFT_358_V_ALPHACP1_01",256,-1.2755,0.038,0.11,-1.0649,0.29,0.63,-1.2852,0.02,0.25
"C6_Oncogenic_signatures:C6_ALL_115_CRX_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_115_CRX_DN_V1_DN",129,-1.2755,0.067,0.11,-1.0579,0.3,0.59,1.0171,0.41,0.53
"GO_BP:515669_GO_0070741_RESPONSE_TO_INTERLEUKIN_6","GO_BP","515669_GO_0070741_RESPONSE_TO_INTERLEUKIN_6",24,-1.2755,0.15,0.27,1.209,0.21,0.78,1.0786,0.33,0.78
"C7_Immunologic_signatures:C7_ALL_1231_GSE27786_NEUTROPHIL_VS_MONO_MAC_UP","C7_Immunologic_signatures","C7_ALL_1231_GSE27786_NEUTROPHIL_VS_MONO_MAC_UP",197,-1.2754,0.055,0.1,0.8957,0.76,1,-0.8231,0.93,1
"GO_MF:496613_GO_0016684_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR","GO_MF","496613_GO_0016684_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR",40,-1.2754,0.12,0.33,1.2787,0.12,0.63,-0.9586,0.52,0.82
"C7_Immunologic_signatures:C7_ALL_1415_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP","C7_Immunologic_signatures","C7_ALL_1415_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP",192,-1.2754,0.051,0.1,0.9983,0.46,0.74,-0.8096,0.95,1
"GO_BP:491745_GO_0006884_CELL_VOLUME_HOMEOSTASIS","GO_BP","491745_GO_0006884_CELL_VOLUME_HOMEOSTASIS",26,-1.2753,0.13,0.27,-0.882,0.62,1,-1.146,0.27,0.74
"REACTOME:105679_REACT_13541_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS","REACTOME","105679_REACT_13541_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS",12,-1.2753,0.18,0.31,-1.1209,0.3,0.87,-0.964,0.51,0.88
"GO_BP:496185_GO_0016090_PRENOL_METABOLIC_PROCESS","GO_BP","496185_GO_0016090_PRENOL_METABOLIC_PROCESS",6,-1.2752,0.2,0.27,-0.7924,0.7,1,-0.5623,0.96,1
"C7_Immunologic_signatures:C7_ALL_1444_GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN","C7_Immunologic_signatures","C7_ALL_1444_GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN",199,-1.2752,0.054,0.1,1.3081,0.031,0.095,-0.836,0.91,1
"C7_Immunologic_signatures:C7_ALL_1427_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP","C7_Immunologic_signatures","C7_ALL_1427_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP",196,-1.2751,0.053,0.1,0.9727,0.55,0.83,0.6698,1,1
"GO_BP:513441_GO_0055008_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS","GO_BP","513441_GO_0055008_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS",53,-1.2751,0.11,0.27,1.083,0.33,0.92,1.6279,0.0081,0.4
"KEGG_compound:C11376_SN38_GLUCURONIDE_SN_38G","KEGG_compound","C11376_SN38_GLUCURONIDE_SN_38G",20,-1.2751,0.16,0.31,1.9178,0.0022,0.016,2.456,0,0
"GO_CC:487071_GO_0000778_CONDENSED_NUCLEAR_CHROMOSOME_KINETOCHORE","GO_CC","487071_GO_0000778_CONDENSED_NUCLEAR_CHROMOSOME_KINETOCHORE",8,-1.2751,0.19,0.33,0.4702,1,1,-1.1411,0.28,0.87
"GO_BP:516278_GO_0071354_CELLULAR_RESPONSE_TO_INTERLEUKIN_6","GO_BP","516278_GO_0071354_CELLULAR_RESPONSE_TO_INTERLEUKIN_6",20,-1.2751,0.16,0.27,0.9028,0.58,1,0.7069,0.88,1
"GO_CC:486691_GO_0000159_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX","GO_CC","486691_GO_0000159_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX",20,-1.275,0.16,0.33,-0.6514,0.94,1,-1.2276,0.19,0.74
"GO_BP:487609_GO_0001706_ENDODERM_FORMATION","GO_BP","487609_GO_0001706_ENDODERM_FORMATION",52,-1.275,0.11,0.27,0.7541,0.91,1,1.4884,0.035,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_76_DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_76_DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP",62,-1.2749,0.11,0.2,1.1363,0.23,0.57,0.7951,0.85,1
"C7_Immunologic_signatures:C7_ALL_583_GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_583_GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDM_UP",197,-1.2749,0.054,0.1,-1.3033,0.033,0.46,-1.1163,0.2,0.45
"C3_MicroRNA_targets:C3_MIR_75_TCCCCAC_MIR_491","C3_MicroRNA_targets","C3_MIR_75_TCCCCAC_MIR_491",57,-1.2747,0.1,0.24,-1.0167,0.41,1,0.9497,0.54,1
"REACTOME:1183582_REACT_355304_PI_3K_CASCADE_FGFR4","REACTOME","1183582_REACT_355304_PI_3K_CASCADE_FGFR4",91,-1.2746,0.087,0.31,-1.1286,0.22,0.9,-0.9198,0.6,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1810_ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1810_ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP",29,-1.2746,0.15,0.2,1.2367,0.16,0.45,-1.0895,0.29,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2786_MARSON_FOXP3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2786_MARSON_FOXP3_TARGETS_DN",53,-1.2746,0.13,0.2,1.1426,0.21,0.56,0.8286,0.77,1
"OMIM_gene:OMIM128240_UTROPHIN_UTRN","OMIM_gene","OMIM128240_UTROPHIN_UTRN",5,-1.2745,0.19,1,0.7982,0.7,1,-0.923,0.57,1
"C7_Immunologic_signatures:C7_ALL_614_GSE17721_LPS_VS_PAM3CSK4_16H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_614_GSE17721_LPS_VS_PAM3CSK4_16H_BMDM_DN",198,-1.2743,0.05,0.1,1.2923,0.026,0.11,-1.0015,0.44,0.72
"C7_Immunologic_signatures:C7_ALL_45_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP","C7_Immunologic_signatures","C7_ALL_45_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP",195,-1.2743,0.056,0.1,1.4538,0.0025,0.021,-1.6966,0,0.00086
"GO_BP:511866_GO_0050931_PIGMENT_CELL_DIFFERENTIATION","GO_BP","511866_GO_0050931_PIGMENT_CELL_DIFFERENTIATION",30,-1.2742,0.16,0.27,1.1721,0.23,0.81,1.2118,0.21,0.71
"C7_Immunologic_signatures:C7_ALL_1112_GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1112_GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN",184,-1.2741,0.062,0.1,-1.171,0.13,0.93,-1.226,0.076,0.23
"REACTOME:1183561_REACT_355552_PI_3K_CASCADE_FGFR1","REACTOME","1183561_REACT_355552_PI_3K_CASCADE_FGFR1",91,-1.274,0.082,0.31,-1.1212,0.26,0.88,-0.9342,0.61,0.92
"C6_Oncogenic_signatures:C6_ALL_77_PRC2_SUZ12_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_77_PRC2_SUZ12_UP_V1_DN",173,-1.2739,0.064,0.11,-0.8305,0.89,0.97,-0.9477,0.61,0.7
"GO_BP:493493_GO_0009309_AMINE_BIOSYNTHETIC_PROCESS","GO_BP","493493_GO_0009309_AMINE_BIOSYNTHETIC_PROCESS",39,-1.2738,0.13,0.28,-0.8885,0.64,1,-1.003,0.43,0.85
"GO_BP:498800_GO_0021516_DORSAL_SPINAL_CORD_DEVELOPMENT","GO_BP","498800_GO_0021516_DORSAL_SPINAL_CORD_DEVELOPMENT",19,-1.2736,0.17,0.28,1.1198,0.3,0.88,1.0935,0.32,0.77
"GO_BP:491917_GO_0007098_CENTROSOME_CYCLE","GO_BP","491917_GO_0007098_CENTROSOME_CYCLE",36,-1.2735,0.14,0.28,-0.7131,0.91,1,-1.4711,0.037,0.54
"REACTOME:105677_REACT_995_APOPTOTIC_EXECUTION_PHASE","REACTOME","105677_REACT_995_APOPTOTIC_EXECUTION_PHASE",52,-1.2734,0.14,0.31,0.9848,0.48,0.78,0.8402,0.78,1
"REACTOME:530743_REACT_115961_PI3K_EVENTS_IN_ERBB4_SIGNALING","REACTOME","530743_REACT_115961_PI3K_EVENTS_IN_ERBB4_SIGNALING",91,-1.2733,0.11,0.31,-1.1216,0.23,0.88,-0.9099,0.64,0.95
"KEGG_enzyme:2.7.3.2_CREATINE_KINASE_ATP_CREATINE_PHOSPHOTRANSFERASE_CK_MM_CK_MB_CK_BB_CK_CREATINE_PHOSPHOKINASE_CREATINE_PHOSPHOTRANSFERASE_PHOSPHOCREATINE_KINASE_ADENOSINE_TRIPHOSPHATE_CREATINE_TRANSPHOSPHORYLASE_MI_CK_CK_BB_CK_MM_CK_MB_CKMIMI_MIMI_CK","KEGG_enzyme","2.7.3.2_CREATINE_KINASE_ATP_CREATINE_PHOSPHOTRANSFERASE_CK_MM_CK_MB_CK_BB_CK_CREATINE_PHOSPHOKINASE_CREATINE_PHOSPHOTRANSFERASE_PHOSPHOCREATINE_KINASE_ADENOSINE_TRIPHOSPHATE_CREATINE_TRANSPHOSPHORYLASE_MI_CK_CK_BB_CK_MM_CK_MB_CKMIMI_MIMI_CK",5,-1.2732,0.18,0.46,-1.0388,0.45,0.7,1.1064,0.37,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2878_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA","C2_Chemical_and_genetic_perturbations","C2_CGP_2878_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA",8,-1.2732,0.19,0.2,-0.6464,0.9,1,-0.9022,0.57,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_3243_SERVITJA_ISLET_HNF1A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3243_SERVITJA_ISLET_HNF1A_TARGETS_DN",103,-1.2731,0.099,0.2,-1.1385,0.22,0.86,-1.2972,0.054,0.43
"C7_Immunologic_signatures:C7_ALL_1769_GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1769_GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP",197,-1.2731,0.063,0.1,1.1364,0.18,0.35,-0.9193,0.7,0.92
"GO_BP:492251_GO_0007498_MESODERM_DEVELOPMENT","GO_BP","492251_GO_0007498_MESODERM_DEVELOPMENT",108,-1.2731,0.084,0.28,-1.2195,0.11,0.88,-1.0256,0.37,0.83
"C4_Cancer_gene_neighborhoods:C4_CGN_153_MORF_PRKACA","C4_Cancer_gene_neighborhoods","C4_CGN_153_MORF_PRKACA",109,-1.273,0.089,0.24,-1.1103,0.25,0.73,-1.4947,0.0062,0.12
"GO_BP:510983_GO_0048935_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT","GO_BP","510983_GO_0048935_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT",12,-1.2729,0.18,0.28,0.9529,0.53,1,1.1071,0.33,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_860_WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_860_WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN",5,-1.2728,0.19,0.2,-0.7668,0.74,1,0.6758,0.84,1
"C3_TF_targets:C3_TFT_68_V_CDPCR1_01","C3_TF_targets","C3_TFT_68_V_CDPCR1_01",125,-1.2728,0.093,0.11,-1.1786,0.13,0.4,-0.9991,0.46,0.77
"C7_Immunologic_signatures:C7_ALL_5_KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_5_KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP",198,-1.2727,0.056,0.1,0.7748,0.98,1,-0.8945,0.76,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_3270_HUANG_GATA2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3270_HUANG_GATA2_TARGETS_DN",71,-1.2727,0.12,0.2,0.87,0.73,0.95,-1.0997,0.27,0.63
"GO_BP:512121_GO_0051225_SPINDLE_ASSEMBLY","GO_BP","512121_GO_0051225_SPINDLE_ASSEMBLY",59,-1.2726,0.12,0.28,-1.0009,0.45,0.99,-1.4921,0.022,0.54
"GO_BP:514056_GO_0060501_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS","GO_BP","514056_GO_0060501_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS",5,-1.2726,0.21,0.28,-1.0069,0.46,0.98,1.3149,0.17,0.66
"GO_BP:488974_GO_0003180_AORTIC_VALVE_MORPHOGENESIS","GO_BP","488974_GO_0003180_AORTIC_VALVE_MORPHOGENESIS",5,-1.2726,0.17,0.28,-0.8235,0.69,1,-0.5257,0.96,1
"GO_BP:508215_GO_0045907_POSITIVE_REGULATION_OF_VASOCONSTRICTION","GO_BP","508215_GO_0045907_POSITIVE_REGULATION_OF_VASOCONSTRICTION",29,-1.2726,0.14,0.28,1.3401,0.1,0.62,1.1737,0.2,0.72
"GO_CC:500763_GO_0031512_MOTILE_PRIMARY_CILIUM","GO_CC","500763_GO_0031512_MOTILE_PRIMARY_CILIUM",8,-1.2725,0.18,0.33,0.5176,0.99,1,0.87,0.63,1
"GO_BP:487719_GO_0001823_MESONEPHROS_DEVELOPMENT","GO_BP","487719_GO_0001823_MESONEPHROS_DEVELOPMENT",90,-1.2725,0.11,0.28,-0.9183,0.63,1,1.3382,0.051,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_2869_VANTVEER_BREAST_CANCER_POOR_PROGNOSIS","C2_Chemical_and_genetic_perturbations","C2_CGP_2869_VANTVEER_BREAST_CANCER_POOR_PROGNOSIS",53,-1.2724,0.14,0.2,-0.7952,0.83,1,-1.7072,0.011,0.17
"GO_BP:491577_GO_0006689_GANGLIOSIDE_CATABOLIC_PROCESS","GO_BP","491577_GO_0006689_GANGLIOSIDE_CATABOLIC_PROCESS",5,-1.2724,0.17,0.28,1.0431,0.4,0.96,1.1093,0.35,0.76
"C7_Immunologic_signatures:C7_ALL_472_GSE17721_CTRL_VS_POLYIC_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_472_GSE17721_CTRL_VS_POLYIC_6H_BMDM_DN",196,-1.2724,0.058,0.1,0.8302,0.93,1,0.7124,1,1
"KEGG_reaction:R09036_ACYL_COA_1_ACYL_SN_GLYCERO_3_PHOSPHOGLYCEROL_O_ACYLTRANSFERASE_ACYL_COA_1_ACYL_SN_GLYCERO_3_PHOSPHOGLYCEROL_COA_PHOSPHATIDYLGLYCEROL","KEGG_reaction","R09036_ACYL_COA_1_ACYL_SN_GLYCERO_3_PHOSPHOGLYCEROL_O_ACYLTRANSFERASE_ACYL_COA_1_ACYL_SN_GLYCERO_3_PHOSPHOGLYCEROL_COA_PHOSPHATIDYLGLYCEROL",5,-1.2724,0.16,0.28,-0.5507,0.95,0.99,-1.102,0.37,0.47
"GO_BP:516931_GO_0072012_GLOMERULUS_VASCULATURE_DEVELOPMENT","GO_BP","516931_GO_0072012_GLOMERULUS_VASCULATURE_DEVELOPMENT",17,-1.2723,0.17,0.28,-1.1585,0.26,0.92,1.2817,0.16,0.69
"GO_BP:512370_GO_0051492_REGULATION_OF_STRESS_FIBER_ASSEMBLY","GO_BP","512370_GO_0051492_REGULATION_OF_STRESS_FIBER_ASSEMBLY",57,-1.2722,0.13,0.28,-1.2644,0.11,0.9,-0.6835,0.97,1
"C1_Positional:C1_ALL_198_CHR15Q23","C1_Positional","C1_ALL_198_CHR15Q23",32,-1.2721,0.15,0.69,-0.8125,0.75,0.98,-1.089,0.31,0.81
"REACTOME:530737_REACT_116008_PI3K_EVENTS_IN_ERBB2_SIGNALING","REACTOME","530737_REACT_116008_PI3K_EVENTS_IN_ERBB2_SIGNALING",91,-1.2721,0.099,0.31,-1.1221,0.26,0.89,-0.9104,0.64,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1936_SESTO_RESPONSE_TO_UV_C5","C2_Chemical_and_genetic_perturbations","C2_CGP_1936_SESTO_RESPONSE_TO_UV_C5",46,-1.2721,0.13,0.2,-0.5076,1,1,-0.7151,0.93,0.98
"GO_MF:750816_GO_0052813_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_KINASE_ACTIVITY","GO_MF","750816_GO_0052813_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_KINASE_ACTIVITY",5,-1.272,0.17,0.33,0.7435,0.78,1,0.9114,0.58,0.94
"GO_MF:511063_GO_0050072_M7G_5_PPPN_DIPHOSPHATASE_ACTIVITY","GO_MF","511063_GO_0050072_M7G_5_PPPN_DIPHOSPHATASE_ACTIVITY",8,-1.272,0.18,0.33,1.1411,0.28,0.75,-1.4104,0.085,0.48
"GO_BP:491615_GO_0006730_ONE_CARBON_METABOLIC_PROCESS","GO_BP","491615_GO_0006730_ONE_CARBON_METABOLIC_PROCESS",32,-1.2719,0.13,0.28,-1.0118,0.42,0.98,-1.3973,0.082,0.58
"GO_BP:500420_GO_0031133_REGULATION_OF_AXON_DIAMETER","GO_BP","500420_GO_0031133_REGULATION_OF_AXON_DIAMETER",6,-1.2719,0.18,0.28,-0.7825,0.72,1,-0.9702,0.5,0.88
"KEGG_compound:C03765_4_HYDROXYPHENYLACETALDEHYDE_2_4_HYDROXYPHENYL_ACETALDEHYDE","KEGG_compound","C03765_4_HYDROXYPHENYLACETALDEHYDE_2_4_HYDROXYPHENYL_ACETALDEHYDE",8,-1.2718,0.19,0.31,-0.9686,0.5,1,-1.5245,0.041,0.22
"GO_BP:503579_GO_0034377_PLASMA_LIPOPROTEIN_PARTICLE_ASSEMBLY","GO_BP","503579_GO_0034377_PLASMA_LIPOPROTEIN_PARTICLE_ASSEMBLY",17,-1.2718,0.16,0.28,-1.1538,0.28,0.92,1.0997,0.31,0.76
"GO_BP:510297_GO_0048172_REGULATION_OF_SHORT_TERM_NEURONAL_SYNAPTIC_PLASTICITY","GO_BP","510297_GO_0048172_REGULATION_OF_SHORT_TERM_NEURONAL_SYNAPTIC_PLASTICITY",10,-1.2716,0.19,0.28,0.7094,0.81,1,1.1425,0.29,0.73
"GO_BP:502255_GO_0033033_NEGATIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS","GO_BP","502255_GO_0033033_NEGATIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS",14,-1.2716,0.17,0.28,1.2185,0.21,0.76,0.7711,0.77,1
"KEGG_compound:C04233_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_2_ACYLGLYCERO_3_PHOSPHOCHOLINE_1_LYSOPHOSPHATIDYLCHOLINE_1_LYSOLECITHIN_3_LYSOLECITHIN","KEGG_compound","C04233_2_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_2_ACYLGLYCERO_3_PHOSPHOCHOLINE_1_LYSOPHOSPHATIDYLCHOLINE_1_LYSOLECITHIN_3_LYSOLECITHIN",6,-1.2716,0.18,0.31,-0.8062,0.73,1,-0.5783,0.94,0.97
"REACTOME:1183568_REACT_355450_PI_3K_CASCADE_FGFR2","REACTOME","1183568_REACT_355450_PI_3K_CASCADE_FGFR2",91,-1.2714,0.1,0.31,-1.1142,0.26,0.88,-0.9101,0.67,0.95
"C3_TF_targets:C3_TFT_230_V_HMEF2_Q6","C3_TF_targets","C3_TFT_230_V_HMEF2_Q6",129,-1.2714,0.079,0.11,0.9803,0.51,1,1.2039,0.1,0.77
"REACTOME:106121_REACT_494_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS","REACTOME","106121_REACT_494_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS",17,-1.2713,0.15,0.31,1.1595,0.26,0.5,0.9252,0.57,1
"GO_BP:516796_GO_0071875_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY","GO_BP","516796_GO_0071875_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY",14,-1.2713,0.18,0.28,-1.1972,0.24,0.9,-0.8726,0.62,0.95
"OMIM_gene:OMIM601896_TNF_RECEPTOR_ASSOCIATED_FACTOR_3_TRAF3","OMIM_gene","OMIM601896_TNF_RECEPTOR_ASSOCIATED_FACTOR_3_TRAF3",6,-1.2712,0.21,0.93,-0.9485,0.5,0.85,-0.956,0.52,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1272_CHESLER_BRAIN_D6MIT150_QTL_CIS","C2_Chemical_and_genetic_perturbations","C2_CGP_1272_CHESLER_BRAIN_D6MIT150_QTL_CIS",7,-1.2712,0.19,0.2,-1.65,0.014,0.36,-1.4736,0.063,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_133_CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_133_CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP",442,-1.2712,0.024,0.2,-1.1002,0.18,0.91,-1.1995,0.034,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_43_FOURNIER_ACINAR_DEVELOPMENT_LATE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_43_FOURNIER_ACINAR_DEVELOPMENT_LATE_UP",11,-1.271,0.18,0.2,-0.6681,0.89,1,1.1787,0.26,0.8
"KEGG_pathway:HSA00350_TYROSINE_METABOLISM","KEGG_pathway","HSA00350_TYROSINE_METABOLISM",35,-1.2709,0.15,0.16,-0.9015,0.62,0.97,0.9798,0.48,1
"GO_BP:507466_GO_0045066_REGULATORY_T_CELL_DIFFERENTIATION","GO_BP","507466_GO_0045066_REGULATORY_T_CELL_DIFFERENTIATION",5,-1.2708,0.19,0.28,-1.3165,0.13,0.89,-1.0676,0.43,0.8
"GO_MF:499380_GO_0022834_LIGAND_GATED_CHANNEL_ACTIVITY","GO_MF","499380_GO_0022834_LIGAND_GATED_CHANNEL_ACTIVITY",146,-1.2708,0.078,0.34,-1.2431,0.075,0.84,1.6947,0,0.2
"C7_Immunologic_signatures:C7_ALL_1837_GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP","C7_Immunologic_signatures","C7_ALL_1837_GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP",199,-1.2708,0.055,0.1,-0.6098,1,1,-1.0815,0.24,0.54
"GO_BP:493898_GO_0009791_POST_EMBRYONIC_DEVELOPMENT","GO_BP","493898_GO_0009791_POST_EMBRYONIC_DEVELOPMENT",98,-1.2706,0.087,0.28,0.7328,0.98,1,-1.0851,0.3,0.79
"GO_MF:509609_GO_0047429_NUCLEOSIDE_TRIPHOSPHATE_DIPHOSPHATASE_ACTIVITY","GO_MF","509609_GO_0047429_NUCLEOSIDE_TRIPHOSPHATE_DIPHOSPHATASE_ACTIVITY",8,-1.2706,0.19,0.33,0.6168,0.93,1,-1.4085,0.093,0.48
"GO_BP:492555_GO_0008214_PROTEIN_DEALKYLATION","GO_BP","492555_GO_0008214_PROTEIN_DEALKYLATION",39,-1.2705,0.13,0.28,-1.5382,0.027,0.75,-0.9611,0.53,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1925_XU_GH1_AUTOCRINE_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1925_XU_GH1_AUTOCRINE_TARGETS_DN",137,-1.2705,0.067,0.2,-0.7468,0.96,1,-1.1591,0.17,0.57
"C4_Cancer_gene_neighborhoods:C4_CGN_156_MORF_PRKCA","C4_Cancer_gene_neighborhoods","C4_CGN_156_MORF_PRKCA",172,-1.2704,0.057,0.24,-1.0771,0.28,0.77,1.1684,0.12,0.49
"WikiPathways:712093_WP2380_BDNF_SIGNALING_PATHWAY","WikiPathways","712093_WP2380_BDNF_SIGNALING_PATHWAY",142,-1.2704,0.075,0.23,1.0664,0.29,1,0.9342,0.62,1
"C7_Immunologic_signatures:C7_ALL_626_GSE17721_POLYIC_VS_CPG_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_626_GSE17721_POLYIC_VS_CPG_6H_BMDM_DN",199,-1.2703,0.07,0.1,1.0048,0.44,0.72,0.8424,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1921_CHENG_RESPONSE_TO_NICKEL_ACETATE","C2_Chemical_and_genetic_perturbations","C2_CGP_1921_CHENG_RESPONSE_TO_NICKEL_ACETATE",44,-1.2703,0.13,0.2,0.9712,0.5,0.83,-1.2116,0.17,0.51
"REACTOME:119527_REACT_19351_SIGNALING_BY_ROBO_RECEPTOR","REACTOME","119527_REACT_19351_SIGNALING_BY_ROBO_RECEPTOR",31,-1.2702,0.16,0.31,-0.7071,0.92,1,-0.7639,0.84,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1546_HOEGERKORP_CD44_TARGETS_DIRECT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1546_HOEGERKORP_CD44_TARGETS_DIRECT_DN",14,-1.2701,0.16,0.2,0.7612,0.79,1,-0.7135,0.85,0.98
"GO_BP:499431_GO_0071230_CELLULAR_RESPONSE_TO_AMINO_ACID_STIMULUS","GO_BP","499431_GO_0071230_CELLULAR_RESPONSE_TO_AMINO_ACID_STIMULUS",46,-1.2701,0.14,0.28,1.1638,0.22,0.82,0.7634,0.89,1
"GO_BP:513446_GO_0055013_CARDIAC_MUSCLE_CELL_DEVELOPMENT","GO_BP","513446_GO_0055013_CARDIAC_MUSCLE_CELL_DEVELOPMENT",49,-1.2701,0.12,0.28,-1.2817,0.11,0.89,0.9189,0.62,0.93
"KEGG_pathway:HSA00460_CYANOAMINO_ACID_METABOLISM","KEGG_pathway","HSA00460_CYANOAMINO_ACID_METABOLISM",6,-1.27,0.17,0.16,-0.9375,0.52,0.95,-1.0601,0.36,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_571_MARKS_HDAC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_571_MARKS_HDAC_TARGETS_DN",15,-1.27,0.16,0.2,-0.9064,0.58,1,1.1513,0.27,0.83
"GO_BP:513771_GO_0060215_PRIMITIVE_HEMOPOIESIS","GO_BP","513771_GO_0060215_PRIMITIVE_HEMOPOIESIS",6,-1.2698,0.19,0.28,-0.6006,0.92,1,-0.672,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_895_YANG_BREAST_CANCER_ESR1_BULK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_895_YANG_BREAST_CANCER_ESR1_BULK_DN",23,-1.2698,0.15,0.2,0.6461,0.96,1,-0.6398,0.96,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_3247_KOHOUTEK_CCNT1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3247_KOHOUTEK_CCNT1_TARGETS",49,-1.2696,0.11,0.2,-0.7026,0.93,1,0.7747,0.86,1
"GO_CC:505706_GO_0042579_MICROBODY","GO_CC","505706_GO_0042579_MICROBODY",130,-1.2696,0.091,0.34,0.8724,0.78,0.91,-1.3553,0.026,0.6
"GO_BP:516838_GO_0071918_UREA_TRANSMEMBRANE_TRANSPORT","GO_BP","516838_GO_0071918_UREA_TRANSMEMBRANE_TRANSPORT",5,-1.2695,0.18,0.28,-0.553,0.96,1,-1.2651,0.23,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_3154_ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS","C2_Chemical_and_genetic_perturbations","C2_CGP_3154_ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS",6,-1.2695,0.2,0.2,0.6879,0.83,1,-0.6504,0.9,0.99
"GO_MF:503911_GO_0034711_INHIBIN_BINDING","GO_MF","503911_GO_0034711_INHIBIN_BINDING",5,-1.2694,0.18,0.34,0.6697,0.86,1,1.3014,0.19,0.66
"GO_MF:490001_GO_0004674_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY","GO_MF","490001_GO_0004674_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",438,-1.2694,0.016,0.34,-1.1842,0.064,0.78,-1.3596,0.0041,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2448_TSAI_RESPONSE_TO_RADIATION_THERAPY","C2_Chemical_and_genetic_perturbations","C2_CGP_2448_TSAI_RESPONSE_TO_RADIATION_THERAPY",32,-1.2694,0.16,0.2,1.0114,0.43,0.78,-0.996,0.44,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2366_WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2366_WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN",24,-1.2693,0.16,0.2,0.8692,0.64,0.96,-0.9395,0.58,0.83
"GO_BP:513391_GO_0052652_CYCLIC_PURINE_NUCLEOTIDE_METABOLIC_PROCESS","GO_BP","513391_GO_0052652_CYCLIC_PURINE_NUCLEOTIDE_METABOLIC_PROCESS",32,-1.2693,0.16,0.28,-1.1638,0.21,0.91,-1.5267,0.022,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_301_SCIBETTA_KDM5B_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_301_SCIBETTA_KDM5B_TARGETS_DN",79,-1.2692,0.087,0.2,1.205,0.12,0.48,-0.9284,0.63,0.84
"C3_TF_targets:C3_TFT_136_V_ER_Q6","C3_TF_targets","C3_TFT_136_V_ER_Q6",267,-1.2691,0.042,0.12,-1.1694,0.11,0.41,1.0151,0.39,1
"KEGG_module:HSA_M00059_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_BACKBONE","KEGG_module","HSA_M00059_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE_BACKBONE",10,-1.2691,0.19,0.47,-0.9017,0.58,1,-1.3171,0.14,0.5
"C3_MicroRNA_targets:C3_MIR_73_TGTATGA_MIR_485_3P","C3_MicroRNA_targets","C3_MIR_73_TGTATGA_MIR_485_3P",149,-1.269,0.079,0.24,1.0361,0.38,1,-0.6812,1,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1509_TAVOR_CEBPA_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1509_TAVOR_CEBPA_TARGETS_DN",30,-1.269,0.16,0.2,-1.0551,0.37,0.96,-0.863,0.67,0.91
"C7_Immunologic_signatures:C7_ALL_870_GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_870_GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN",200,-1.2688,0.069,0.11,1.2949,0.033,0.11,-0.9603,0.55,0.82
"GO_BP:517564_GO_0072661_PROTEIN_TARGETING_TO_PLASMA_MEMBRANE","GO_BP","517564_GO_0072661_PROTEIN_TARGETING_TO_PLASMA_MEMBRANE",20,-1.2688,0.17,0.28,-0.6951,0.87,1,-0.7652,0.81,1
"GO_BP:506421_GO_0043382_POSITIVE_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION","GO_BP","506421_GO_0043382_POSITIVE_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION",6,-1.2687,0.2,0.28,-1.2852,0.18,0.89,-1.0896,0.34,0.78
"GO_BP:513889_GO_0060333_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY","GO_BP","513889_GO_0060333_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY",75,-1.2687,0.11,0.28,0.6701,0.99,1,-1.0291,0.4,0.83
"REACTOME:106189_REACT_1786_PHENYLALANINE_AND_TYROSINE_CATABOLISM","REACTOME","106189_REACT_1786_PHENYLALANINE_AND_TYROSINE_CATABOLISM",10,-1.2687,0.19,0.31,-1.0504,0.4,0.94,0.7343,0.81,1
"GO_BP:511794_GO_0050849_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING","GO_BP","511794_GO_0050849_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING",7,-1.2686,0.2,0.28,0.6033,0.93,1,-1.1208,0.36,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2344_GRADE_COLON_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2344_GRADE_COLON_CANCER_DN",33,-1.2686,0.13,0.2,-0.6397,0.97,1,-1.5867,0.026,0.25
"GO_BP:514526_GO_0060971_EMBRYONIC_HEART_TUBE_LEFT_RIGHT_PATTERN_FORMATION","GO_BP","514526_GO_0060971_EMBRYONIC_HEART_TUBE_LEFT_RIGHT_PATTERN_FORMATION",5,-1.2683,0.19,0.28,-1.4597,0.079,0.88,-0.9293,0.55,0.9
"KEGG_compound:C00332_ACETOACETYL_COA_ACETOACETYL_COENZYME_A_3_ACETOACETYL_COA","KEGG_compound","C00332_ACETOACETYL_COA_ACETOACETYL_COENZYME_A_3_ACETOACETYL_COA",9,-1.2683,0.18,0.32,-0.7536,0.8,1,-1.6603,0.023,0.098
"GO_BP:516749_GO_0071827_PLASMA_LIPOPROTEIN_PARTICLE_ORGANIZATION","GO_BP","516749_GO_0071827_PLASMA_LIPOPROTEIN_PARTICLE_ORGANIZATION",31,-1.2683,0.15,0.28,-0.8462,0.71,1,1.3244,0.081,0.65
"REACTOME:106522_REACT_12591_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE","REACTOME","106522_REACT_12591_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE",24,-1.2683,0.18,0.31,-1.3389,0.12,0.6,-1.1749,0.22,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2615_SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12","C2_Chemical_and_genetic_perturbations","C2_CGP_2615_SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12",285,-1.2682,0.048,0.2,-0.8919,0.77,1,-0.9355,0.7,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1315_NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1315_NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN",119,-1.2681,0.092,0.2,1.5056,0.0048,0.21,-0.6921,0.99,0.99
"C7_Immunologic_signatures:C7_ALL_1832_GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN","C7_Immunologic_signatures","C7_ALL_1832_GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN",179,-1.268,0.065,0.11,-1.0147,0.42,1,-1.0393,0.34,0.63
"KEGG_compound:C05787_BILIRUBIN_BETA_DIGLUCURONIDE_BILIRUBIN_BISGLUCURONOSIDE","KEGG_compound","C05787_BILIRUBIN_BETA_DIGLUCURONIDE_BILIRUBIN_BISGLUCURONOSIDE",20,-1.268,0.18,0.32,1.9075,0.0021,0.014,2.4471,0,0
"C0_Hallmark:H_ALL_17_HALLMARK_PROTEIN_SECRETION","C0_Hallmark","H_ALL_17_HALLMARK_PROTEIN_SECRETION",96,-1.268,0.096,0.097,1.3807,0.029,0.06,-0.8846,0.71,0.76
"GO_BP:491058_GO_0006073_CELLULAR_GLUCAN_METABOLIC_PROCESS","GO_BP","491058_GO_0006073_CELLULAR_GLUCAN_METABOLIC_PROCESS",59,-1.268,0.14,0.28,0.907,0.64,1,-1.1442,0.24,0.75
"C7_Immunologic_signatures:C7_ALL_420_GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN","C7_Immunologic_signatures","C7_ALL_420_GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN",199,-1.268,0.049,0.11,1.1833,0.11,0.25,-0.9628,0.55,0.81
"GO_MF:490035_GO_0004721_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY","GO_MF","490035_GO_0004721_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY",167,-1.2679,0.08,0.34,1.0483,0.34,0.83,-0.9049,0.71,0.87
"C3_TF_targets:C3_TFT_137_V_GR_Q6","C3_TF_targets","C3_TFT_137_V_GR_Q6",255,-1.2679,0.051,0.12,-0.8355,0.92,1,1.0918,0.22,1
"GO_BP:495120_GO_0014048_REGULATION_OF_GLUTAMATE_SECRETION","GO_BP","495120_GO_0014048_REGULATION_OF_GLUTAMATE_SECRETION",13,-1.2679,0.18,0.28,0.8988,0.59,1,-1.1987,0.23,0.73
"C7_Immunologic_signatures:C7_ALL_1251_GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1251_GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP",161,-1.2679,0.078,0.11,1.3436,0.035,0.067,1.6199,0,0.0068
"GO_BP:498966_GO_0021683_CEREBELLAR_GRANULAR_LAYER_MORPHOGENESIS","GO_BP","498966_GO_0021683_CEREBELLAR_GRANULAR_LAYER_MORPHOGENESIS",12,-1.2679,0.18,0.28,1.0364,0.39,0.96,-0.6302,0.91,1
"C7_Immunologic_signatures:C7_ALL_551_GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_551_GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDM_UP",199,-1.2678,0.043,0.11,1.2024,0.083,0.22,-0.9017,0.75,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_1854_BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1854_BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN",164,-1.2677,0.068,0.2,1.307,0.041,0.39,-1.0061,0.46,0.74
"C3_TF_targets:C3_TFT_27_V_NFKAPPAB65_01","C3_TF_targets","C3_TFT_27_V_NFKAPPAB65_01",232,-1.2677,0.054,0.12,-1.2978,0.034,0.24,-1.5026,0,0.37
"GO_BP:507058_GO_0044042_GLUCAN_METABOLIC_PROCESS","GO_BP","507058_GO_0044042_GLUCAN_METABOLIC_PROCESS",59,-1.2676,0.13,0.28,0.8914,0.68,1,-1.1715,0.17,0.73
"GO_BP:500122_GO_0030823_REGULATION_OF_CGMP_METABOLIC_PROCESS","GO_BP","500122_GO_0030823_REGULATION_OF_CGMP_METABOLIC_PROCESS",26,-1.2676,0.18,0.28,0.8694,0.68,1,1.3456,0.1,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_116_CORRE_MULTIPLE_MYELOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_116_CORRE_MULTIPLE_MYELOMA_UP",70,-1.2676,0.11,0.2,0.8885,0.69,0.93,1.069,0.32,0.89
"GO_BP:489073_GO_0003279_CARDIAC_SEPTUM_DEVELOPMENT","GO_BP","489073_GO_0003279_CARDIAC_SEPTUM_DEVELOPMENT",66,-1.2675,0.13,0.28,-1.128,0.24,0.93,1.4501,0.031,0.58
"C7_Immunologic_signatures:C7_ALL_458_GSE17721_CTRL_VS_LPS_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_458_GSE17721_CTRL_VS_LPS_8H_BMDM_DN",195,-1.2674,0.064,0.11,-0.9378,0.62,1,0.9461,0.58,1
"GO_BP:503447_GO_0034242_NEGATIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION","GO_BP","503447_GO_0034242_NEGATIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION",6,-1.2674,0.2,0.28,-1.2836,0.19,0.89,-1.4912,0.054,0.54
"GO_MF:492807_GO_0008528_G_PROTEIN_COUPLED_PEPTIDE_RECEPTOR_ACTIVITY","GO_MF","492807_GO_0008528_G_PROTEIN_COUPLED_PEPTIDE_RECEPTOR_ACTIVITY",120,-1.2673,0.098,0.34,1.6837,0,0.17,2.1113,0,0.0055
"C7_Immunologic_signatures:C7_ALL_799_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_799_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP",194,-1.2672,0.053,0.11,0.8041,0.95,1,-0.9702,0.53,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2375_SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2375_SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN",6,-1.2672,0.19,0.2,0.7047,0.83,1,-0.676,0.85,0.99
"GO_MF:511671_GO_0050700_CARD_DOMAIN_BINDING","GO_MF","511671_GO_0050700_CARD_DOMAIN_BINDING",8,-1.2672,0.2,0.34,-0.8518,0.66,1,-1.3495,0.14,0.53
"GO_BP:502356_GO_0033135_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION","GO_BP","502356_GO_0033135_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION",106,-1.2671,0.11,0.28,0.9276,0.61,1,0.7624,0.95,1
"C7_Immunologic_signatures:C7_ALL_1679_GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1679_GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP",193,-1.2671,0.068,0.11,0.7902,0.96,1,-1.312,0.028,0.13
"C3_TF_targets:C3_TFT_130_V_NFY_Q6","C3_TF_targets","C3_TFT_130_V_NFY_Q6",255,-1.267,0.053,0.12,-0.8481,0.88,1,-1.0819,0.24,0.58
"C7_Immunologic_signatures:C7_ALL_1331_GSE30083_SP2_VS_SP3_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1331_GSE30083_SP2_VS_SP3_THYMOCYTE_UP",192,-1.267,0.071,0.11,-1.0218,0.39,1,-1.0123,0.4,0.7
"C4_Cancer_gene_neighborhoods:C4_CGN_102_MORF_FLT1","C4_Cancer_gene_neighborhoods","C4_CGN_102_MORF_FLT1",120,-1.2668,0.069,0.25,-1.3619,0.039,0.5,-1.1954,0.12,0.45
"KEGG_module:HSA_M00035_METHIONINE_DEGRADATION","KEGG_module","HSA_M00035_METHIONINE_DEGRADATION",9,-1.2666,0.19,0.46,-1.4787,0.063,0.55,-0.9845,0.47,0.81
"REACTOME:106149_REACT_11042_RECYCLING_OF_BILE_ACIDS_AND_SALTS","REACTOME","106149_REACT_11042_RECYCLING_OF_BILE_ACIDS_AND_SALTS",15,-1.2666,0.17,0.31,-0.88,0.62,1,-1.1701,0.24,0.63
"REACTOME:106423_REACT_661_SHC_MEDIATED_SIGNALLING","REACTOME","106423_REACT_661_SHC_MEDIATED_SIGNALLING",22,-1.2666,0.17,0.31,-0.5078,1,1,-1.0885,0.34,0.72
"KEGG_compound:C00008_ADP_ADENOSINE_5_DIPHOSPHATE","KEGG_compound","C00008_ADP_ADENOSINE_5_DIPHOSPHATE",173,-1.2665,0.079,0.32,-0.7209,0.99,1,-1.3707,0.008,0.31
"GO_BP:515130_GO_0070193_SYNAPTONEMAL_COMPLEX_ORGANIZATION","GO_BP","515130_GO_0070193_SYNAPTONEMAL_COMPLEX_ORGANIZATION",19,-1.2664,0.16,0.28,-0.9135,0.57,1,-0.9491,0.53,0.89
"GO_BP:488510_GO_0002637_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION","GO_BP","488510_GO_0002637_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION",42,-1.2662,0.12,0.28,-1.2236,0.18,0.88,-1.0797,0.33,0.79
"GO_MF:499484_GO_0030021_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_COMPRESSION_RESISTANCE","GO_MF","499484_GO_0030021_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_COMPRESSION_RESISTANCE",5,-1.2662,0.2,0.34,-1.3665,0.13,0.69,1.0035,0.45,0.88
"C7_Immunologic_signatures:C7_ALL_518_GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_518_GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDM_DN",195,-1.2662,0.062,0.11,0.9693,0.53,0.84,1.2844,0.049,0.42
"REACTOME:106469_REACT_9000_CALMODULIN_INDUCED_EVENTS","REACTOME","106469_REACT_9000_CALMODULIN_INDUCED_EVENTS",28,-1.2662,0.14,0.31,0.8104,0.78,0.99,-1.2104,0.21,0.59
"GO_MF:490325_GO_0005044_SCAVENGER_RECEPTOR_ACTIVITY","GO_MF","490325_GO_0005044_SCAVENGER_RECEPTOR_ACTIVITY",46,-1.2661,0.13,0.34,-1.1979,0.17,0.81,1.4138,0.06,0.52
"C7_Immunologic_signatures:C7_ALL_61_GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_61_GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP",192,-1.2661,0.067,0.11,-0.7356,0.99,1,-1.1414,0.16,0.39
"KEGG_compound:C05966_15_S_HPETE_5Z_8Z_11Z_13E_15S_15_HYDROPEROXYICOSA_5_8_11_13_TETRAENOIC_ACID_15_HYDROPEROXYEICOSATETRAENOATE_15_HYDROPEROXYICOSATETRAENOATE_15_HYDROPEROXYEICOSATETRAENOIC_ACID_15_HYDROPEROXYICOSATETRAENOIC_ACID_5Z_8Z_11Z_13E_15S_15_HYDROPEROXYICOSA_5_8_11_13_TETRAENOATE","KEGG_compound","C05966_15_S_HPETE_5Z_8Z_11Z_13E_15S_15_HYDROPEROXYICOSA_5_8_11_13_TETRAENOIC_ACID_15_HYDROPEROXYEICOSATETRAENOATE_15_HYDROPEROXYICOSATETRAENOATE_15_HYDROPEROXYEICOSATETRAENOIC_ACID_15_HYDROPEROXYICOSATETRAENOIC_ACID_5Z_8Z_11Z_13E_15S_15_HYDROPEROXYICOSA_5_8_11_13_TETRAENOATE",10,-1.2661,0.19,0.32,-0.8125,0.72,1,1.0799,0.36,0.63
"GO_BP:753024_GO_1900027_REGULATION_OF_RUFFLE_ASSEMBLY","GO_BP","753024_GO_1900027_REGULATION_OF_RUFFLE_ASSEMBLY",16,-1.2661,0.17,0.28,-0.449,1,1,-1.3355,0.11,0.62
"OMIM_gene:OMIM162151_PROPROTEIN_CONVERTASE_SUBTILISIN_KEXIN_TYPE_2_PCSK2","OMIM_gene","OMIM162151_PROPROTEIN_CONVERTASE_SUBTILISIN_KEXIN_TYPE_2_PCSK2",5,-1.266,0.18,0.88,0.5855,0.94,1,-0.8874,0.61,0.93
"GO_BP:491469_GO_0006573_VALINE_METABOLIC_PROCESS","GO_BP","491469_GO_0006573_VALINE_METABOLIC_PROCESS",8,-1.266,0.2,0.28,0.6948,0.85,1,-1.1321,0.33,0.75
"GO_MF:490290_GO_0005004_GPI_LINKED_EPHRIN_RECEPTOR_ACTIVITY","GO_MF","490290_GO_0005004_GPI_LINKED_EPHRIN_RECEPTOR_ACTIVITY",5,-1.2659,0.17,0.34,0.7407,0.78,1,0.9713,0.54,0.89
"C7_Immunologic_signatures:C7_ALL_781_GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_781_GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP",191,-1.2659,0.062,0.11,0.9564,0.61,0.88,-0.931,0.63,0.89
"GO_BP:518475_GO_0090335_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION","GO_BP","518475_GO_0090335_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION",5,-1.2658,0.18,0.28,-1.1476,0.34,0.93,0.8094,0.68,1
"GO_BP:507081_GO_0044065_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS","GO_BP","507081_GO_0044065_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS",16,-1.2658,0.16,0.28,-1.2171,0.2,0.88,-1.2975,0.15,0.64
"C3_TF_targets:C3_TFT_318_V_GNCF_01","C3_TF_targets","C3_TFT_318_V_GNCF_01",74,-1.2656,0.11,0.12,0.9536,0.55,1,0.9002,0.66,1
"C7_Immunologic_signatures:C7_ALL_235_GSE14000_UNSTIM_VS_16H_LPS_DC_UP","C7_Immunologic_signatures","C7_ALL_235_GSE14000_UNSTIM_VS_16H_LPS_DC_UP",195,-1.2656,0.062,0.11,1.5286,0.0023,0.0084,-1.5091,0,0.019
"GO_MF:495469_GO_0015204_UREA_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495469_GO_0015204_UREA_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-1.2655,0.19,0.34,-0.5661,0.97,1,-1.2213,0.28,0.57
"GO_BP:491525_GO_0006635_FATTY_ACID_BETA_OXIDATION","GO_BP","491525_GO_0006635_FATTY_ACID_BETA_OXIDATION",47,-1.2655,0.15,0.28,1.2185,0.15,0.76,-1.4093,0.032,0.57
"C1_Positional:C1_ALL_144_CHRXQ21","C1_Positional","C1_ALL_144_CHRXQ21",38,-1.2654,0.15,0.7,1.1411,0.27,0.63,-1.2333,0.14,0.59
"GO_BP:514392_GO_0060837_BLOOD_VESSEL_ENDOTHELIAL_CELL_DIFFERENTIATION","GO_BP","514392_GO_0060837_BLOOD_VESSEL_ENDOTHELIAL_CELL_DIFFERENTIATION",7,-1.2652,0.2,0.28,1.1458,0.32,0.84,1.065,0.38,0.79
"C7_Immunologic_signatures:C7_ALL_1854_GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN","C7_Immunologic_signatures","C7_ALL_1854_GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN",200,-1.2651,0.05,0.11,1.365,0.014,0.053,-1.4645,0.0021,0.032
"C3_TF_targets:C3_TFT_233_V_HNF4_01_B","C3_TF_targets","C3_TFT_233_V_HNF4_01_B",245,-1.2651,0.055,0.12,-1.144,0.15,0.45,-1.3138,0.018,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_714_MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS","C2_Chemical_and_genetic_perturbations","C2_CGP_714_MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS",11,-1.2649,0.18,0.21,1.1203,0.29,0.6,-1.3417,0.14,0.4
"GO_BP:491454_GO_0006558_L_PHENYLALANINE_METABOLIC_PROCESS","GO_BP","491454_GO_0006558_L_PHENYLALANINE_METABOLIC_PROCESS",10,-1.2648,0.19,0.28,-0.8569,0.65,1,-0.8713,0.63,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1654_GENTILE_UV_RESPONSE_CLUSTER_D4","C2_Chemical_and_genetic_perturbations","C2_CGP_1654_GENTILE_UV_RESPONSE_CLUSTER_D4",55,-1.2646,0.13,0.21,-0.8777,0.67,1,0.81,0.84,1
"C7_Immunologic_signatures:C7_ALL_1436_GSE360_DC_VS_MAC_L_MAJOR_DN","C7_Immunologic_signatures","C7_ALL_1436_GSE360_DC_VS_MAC_L_MAJOR_DN",196,-1.2646,0.069,0.11,-0.8257,0.91,1,-0.8711,0.83,0.99
"GO_BP:517214_GO_0072298_REGULATION_OF_METANEPHRIC_GLOMERULUS_DEVELOPMENT","GO_BP","517214_GO_0072298_REGULATION_OF_METANEPHRIC_GLOMERULUS_DEVELOPMENT",6,-1.2646,0.2,0.29,0.9665,0.48,1,1.6598,0.018,0.39
"REACTOME:105802_REACT_1857_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION","REACTOME","105802_REACT_1857_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION",22,-1.2645,0.17,0.31,0.5901,0.97,1,-0.8188,0.75,1
"C7_Immunologic_signatures:C7_ALL_525_GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_525_GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDM_UP",199,-1.2645,0.068,0.11,0.8493,0.88,1,-1.0036,0.44,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2194_FUJII_YBX1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2194_FUJII_YBX1_TARGETS_UP",43,-1.2643,0.14,0.21,-0.7496,0.91,1,-1.0456,0.36,0.7
"GO_MF:498064_GO_0019209_KINASE_ACTIVATOR_ACTIVITY","GO_MF","498064_GO_0019209_KINASE_ACTIVATOR_ACTIVITY",58,-1.2643,0.12,0.34,0.8212,0.82,1,-0.865,0.7,0.91
"C7_Immunologic_signatures:C7_ALL_1366_GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1366_GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN",196,-1.2642,0.065,0.11,0.7793,0.98,1,-1.0338,0.36,0.65
"GO_CC:499975_GO_0030672_SYNAPTIC_VESICLE_MEMBRANE","GO_CC","499975_GO_0030672_SYNAPTIC_VESICLE_MEMBRANE",57,-1.2642,0.13,0.35,-1.1947,0.19,0.7,1.1161,0.27,0.89
"REACTOME:1127544_REACT_267753_ACTIVATION_OF_SMO","REACTOME","1127544_REACT_267753_ACTIVATION_OF_SMO",17,-1.2642,0.17,0.31,-0.9316,0.54,1,0.6585,0.92,1
"GO_BP:510701_GO_0048645_ORGAN_FORMATION","GO_BP","510701_GO_0048645_ORGAN_FORMATION",28,-1.2642,0.17,0.29,-0.9517,0.53,1,1.4476,0.056,0.58
"GO_BP:502426_GO_0033206_MEIOTIC_CYTOKINESIS","GO_BP","502426_GO_0033206_MEIOTIC_CYTOKINESIS",6,-1.2642,0.2,0.29,1.2221,0.26,0.76,1.0983,0.35,0.76
"GO_BP:500917_GO_0031668_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS","GO_BP","500917_GO_0031668_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS",217,-1.2642,0.047,0.29,-0.7221,1,1,0.8901,0.78,0.95
"C4_Cancer_gene_neighborhoods:C4_CGN_64_MORF_ATF2","C4_Cancer_gene_neighborhoods","C4_CGN_64_MORF_ATF2",318,-1.2641,0.038,0.25,-1.0966,0.2,0.73,1.1876,0.051,0.46
"REACTOME:106127_REACT_1708_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA","REACTOME","106127_REACT_1708_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA",5,-1.2639,0.19,0.31,0.9989,0.46,0.76,-1.421,0.075,0.4
"GO_BP:504540_GO_0035356_CELLULAR_TRIGLYCERIDE_HOMEOSTASIS","GO_BP","504540_GO_0035356_CELLULAR_TRIGLYCERIDE_HOMEOSTASIS",6,-1.2638,0.2,0.29,-0.5864,0.92,1,-1.0314,0.41,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_2107_KYNG_DNA_DAMAGE_BY_4NQO","C2_Chemical_and_genetic_perturbations","C2_CGP_2107_KYNG_DNA_DAMAGE_BY_4NQO",38,-1.2637,0.14,0.21,0.9926,0.46,0.81,0.8565,0.71,1
"GO_MF:498089_GO_0019238_CYCLOHYDROLASE_ACTIVITY","GO_MF","498089_GO_0019238_CYCLOHYDROLASE_ACTIVITY",7,-1.2635,0.18,0.34,-0.8101,0.7,1,-1.172,0.29,0.6
"GO_BP:506502_GO_0043470_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS","GO_BP","506502_GO_0043470_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS",34,-1.2634,0.13,0.29,1.0097,0.42,0.98,1.6173,0.018,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_900_SEMBA_FHIT_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_900_SEMBA_FHIT_TARGETS_UP",11,-1.2634,0.18,0.21,-1.1251,0.31,0.89,-1.4458,0.083,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_941_DIERICK_SEROTONIN_FUNCTION_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_941_DIERICK_SEROTONIN_FUNCTION_GENES",6,-1.2634,0.19,0.21,-1.3127,0.16,0.69,0.7903,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_559_DARWICHE_PAPILLOMA_PROGRESSION_RISK","C2_Chemical_and_genetic_perturbations","C2_CGP_559_DARWICHE_PAPILLOMA_PROGRESSION_RISK",69,-1.2632,0.12,0.21,-1.0118,0.42,0.99,-1.2336,0.12,0.49
"C7_Immunologic_signatures:C7_ALL_1391_GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP","C7_Immunologic_signatures","C7_ALL_1391_GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP",198,-1.2631,0.06,0.11,1.0047,0.45,0.72,0.9814,0.5,1
"C3_MicroRNA_targets:C3_MIR_55_TCCAGAT_MIR_516_5P","C3_MicroRNA_targets","C3_MIR_55_TCCAGAT_MIR_516_5P",109,-1.2631,0.095,0.25,-1.0945,0.27,1,-1.1194,0.22,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1363_VANTVEER_BREAST_CANCER_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1363_VANTVEER_BREAST_CANCER_METASTASIS_DN",119,-1.2631,0.095,0.21,0.9103,0.68,0.91,-1.2999,0.048,0.43
"GO_BP:495085_GO_0014012_PERIPHERAL_NERVOUS_SYSTEM_AXON_REGENERATION","GO_BP","495085_GO_0014012_PERIPHERAL_NERVOUS_SYSTEM_AXON_REGENERATION",6,-1.263,0.19,0.29,-0.967,0.51,1,-0.7933,0.72,0.99
"GO_MF:508872_GO_0046624_SPHINGOLIPID_TRANSPORTER_ACTIVITY","GO_MF","508872_GO_0046624_SPHINGOLIPID_TRANSPORTER_ACTIVITY",5,-1.2628,0.19,0.34,0.8135,0.69,1,-0.4974,0.99,1
"GO_BP:500125_GO_0030826_REGULATION_OF_CGMP_BIOSYNTHETIC_PROCESS","GO_BP","500125_GO_0030826_REGULATION_OF_CGMP_BIOSYNTHETIC_PROCESS",19,-1.2628,0.18,0.29,-0.9602,0.55,1,-1.0923,0.34,0.78
"GO_BP:494577_GO_0010508_POSITIVE_REGULATION_OF_AUTOPHAGY","GO_BP","494577_GO_0010508_POSITIVE_REGULATION_OF_AUTOPHAGY",43,-1.2628,0.15,0.29,1.0012,0.42,0.98,-0.6078,0.99,1
"GO_BP:488562_GO_0002689_NEGATIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS","GO_BP","488562_GO_0002689_NEGATIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS",11,-1.2627,0.17,0.29,0.8086,0.74,1,1.5876,0.03,0.43
"GO_BP:499514_GO_0030072_PEPTIDE_HORMONE_SECRETION","GO_BP","499514_GO_0030072_PEPTIDE_HORMONE_SECRETION",57,-1.2627,0.12,0.29,0.9154,0.63,1,1.1985,0.16,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1901_JIANG_HYPOXIA_NORMAL","C2_Chemical_and_genetic_perturbations","C2_CGP_1901_JIANG_HYPOXIA_NORMAL",306,-1.2626,0.041,0.21,1.4968,0,0.21,0.8977,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2529_PARK_TRETINOIN_RESPONSE","C2_Chemical_and_genetic_perturbations","C2_CGP_2529_PARK_TRETINOIN_RESPONSE",12,-1.2626,0.18,0.21,1.4809,0.067,0.23,1.8046,0,0.21
"GO_BP:508000_GO_0045652_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION","GO_BP","508000_GO_0045652_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION",28,-1.2625,0.15,0.29,-1.2048,0.19,0.89,-1.0538,0.37,0.81
"GO_BP:508887_GO_0046639_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION","GO_BP","508887_GO_0046639_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION",11,-1.2625,0.21,0.29,-0.9952,0.46,0.99,0.8295,0.68,0.99
"GO_BP:506635_GO_0043604_AMIDE_BIOSYNTHETIC_PROCESS","GO_BP","506635_GO_0043604_AMIDE_BIOSYNTHETIC_PROCESS",88,-1.2624,0.095,0.29,0.6448,0.99,1,-1.1395,0.2,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1222_NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1222_NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON",16,-1.262,0.18,0.21,-0.8122,0.72,1,-0.636,0.92,0.99
"GO_BP:505864_GO_0042758_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS","GO_BP","505864_GO_0042758_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS",7,-1.262,0.19,0.29,1.131,0.31,0.87,1.6043,0.036,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_1214_NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1214_NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON",125,-1.2619,0.089,0.21,-1.1054,0.25,0.91,-1.07,0.3,0.67
"KEGG_pathway:HSA04728_DOPAMINERGIC_SYNAPSE","KEGG_pathway","HSA04728_DOPAMINERGIC_SYNAPSE",129,-1.2619,0.092,0.16,-0.8335,0.86,1,-1.1845,0.14,0.4
"GO_BP:508230_GO_0045923_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS","GO_BP","508230_GO_0045923_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS",28,-1.2614,0.16,0.29,1.115,0.28,0.88,0.954,0.52,0.9
"C3_TF_targets:C3_TFT_304_CTGRYYYNATT_UNKNOWN","C3_TF_targets","C3_TFT_304_CTGRYYYNATT_UNKNOWN",68,-1.2614,0.12,0.12,-1.0105,0.45,0.74,-1.0816,0.29,0.58
"KEGG_compound:C00030_REDUCED_ACCEPTOR_AH2_HYDROGEN_DONOR_DONOR","KEGG_compound","C00030_REDUCED_ACCEPTOR_AH2_HYDROGEN_DONOR_DONOR",21,-1.2613,0.16,0.32,1.2082,0.21,0.87,-1.2118,0.22,0.43
"GO_BP:491847_GO_0007016_CYTOSKELETAL_ANCHORING_AT_PLASMA_MEMBRANE","GO_BP","491847_GO_0007016_CYTOSKELETAL_ANCHORING_AT_PLASMA_MEMBRANE",12,-1.2613,0.19,0.29,-0.9258,0.55,1,1.5315,0.034,0.53
"C3_TF_targets:C3_TFT_155_V_USF_C","C3_TF_targets","C3_TFT_155_V_USF_C",275,-1.2613,0.052,0.12,0.8884,0.83,1,-0.8973,0.83,0.92
"GO_MF:504510_GO_0035326_ENHANCER_BINDING","GO_MF","504510_GO_0035326_ENHANCER_BINDING",86,-1.2612,0.12,0.34,-1.2163,0.14,0.83,-1.5179,0.004,0.41
"REACTOME:161057_REACT_21330_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES","REACTOME","161057_REACT_21330_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES",19,-1.2611,0.17,0.32,0.8904,0.64,0.91,-1.5116,0.046,0.34
"GO_BP:503453_GO_0034248_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS","GO_BP","503453_GO_0034248_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS",18,-1.261,0.16,0.29,0.8458,0.67,1,-0.7562,0.81,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1305_DER_IFN_ALPHA_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1305_DER_IFN_ALPHA_RESPONSE_UP",74,-1.2609,0.11,0.21,1.4701,0.022,0.24,-1.4501,0.026,0.32
"GO_BP:506454_GO_0043416_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION","GO_BP","506454_GO_0043416_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION",6,-1.2609,0.19,0.29,-0.9039,0.56,1,-1.3144,0.16,0.64
"GO_BP:498081_GO_0019229_REGULATION_OF_VASOCONSTRICTION","GO_BP","498081_GO_0019229_REGULATION_OF_VASOCONSTRICTION",54,-1.2609,0.14,0.29,1.0156,0.41,0.97,-1.057,0.37,0.81
"REACTOME:106241_REACT_16952_PROTEIN_FOLDING","REACTOME","106241_REACT_16952_PROTEIN_FOLDING",55,-1.2609,0.15,0.32,0.998,0.46,0.76,-1.2019,0.16,0.61
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_96_BIOCARTA_IL6_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_96_BIOCARTA_IL6_PATHWAY",22,-1.2608,0.17,0.29,-0.7536,0.86,1,-0.6599,0.92,0.99
"C3_TF_targets:C3_TFT_246_V_NKX61_01","C3_TF_targets","C3_TFT_246_V_NKX61_01",224,-1.2606,0.062,0.12,-0.9186,0.69,0.93,1.0379,0.35,1
"GO_BP:500896_GO_0031647_REGULATION_OF_PROTEIN_STABILITY","GO_BP","500896_GO_0031647_REGULATION_OF_PROTEIN_STABILITY",156,-1.2606,0.073,0.29,0.8645,0.82,1,-1.0526,0.31,0.81
"C3_TF_targets:C3_TFT_231_V_RSRFC4_Q2","C3_TF_targets","C3_TFT_231_V_RSRFC4_Q2",207,-1.2605,0.067,0.12,-1.1218,0.19,0.49,-1.3059,0.027,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_143_WANG_RESPONSE_TO_ANDROGEN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_143_WANG_RESPONSE_TO_ANDROGEN_UP",29,-1.2605,0.15,0.21,0.8813,0.63,0.94,0.8254,0.73,1
"REACTOME:645338_REACT_120756_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE","REACTOME","645338_REACT_120756_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE",13,-1.2605,0.17,0.32,-0.6745,0.86,1,-1.0774,0.36,0.74
"GO_MF:515258_GO_0070325_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING","GO_MF","515258_GO_0070325_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING",20,-1.2604,0.15,0.34,-1.3168,0.12,0.74,-1.1045,0.3,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_3381_ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR","C2_Chemical_and_genetic_perturbations","C2_CGP_3381_ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR",128,-1.2602,0.091,0.21,0.904,0.73,0.92,-1.5547,0.0021,0.27
"C2_Chemical_and_genetic_perturbations:C2_CGP_2093_WANG_LSD1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2093_WANG_LSD1_TARGETS_UP",24,-1.2601,0.15,0.21,-1.3383,0.097,0.7,-0.9948,0.47,0.76
"C7_Immunologic_signatures:C7_ALL_501_GSE17721_CTRL_VS_CPG_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_501_GSE17721_CTRL_VS_CPG_4H_BMDM_UP",200,-1.2601,0.059,0.11,1.4281,0,0.029,-1.0583,0.31,0.6
"KEGG_pathway:HSA05219_BLADDER_CANCER","KEGG_pathway","HSA05219_BLADDER_CANCER",38,-1.2597,0.16,0.16,0.7326,0.9,1,-0.9033,0.62,0.84
"GO_MF:487566_GO_0001653_PEPTIDE_RECEPTOR_ACTIVITY","GO_MF","487566_GO_0001653_PEPTIDE_RECEPTOR_ACTIVITY",122,-1.2596,0.11,0.35,1.6305,0,0.23,2.0957,0,0.0057
"C7_Immunologic_signatures:C7_ALL_1595_GSE3982_EOSINOPHIL_VS_BASOPHIL_UP","C7_Immunologic_signatures","C7_ALL_1595_GSE3982_EOSINOPHIL_VS_BASOPHIL_UP",190,-1.2595,0.076,0.11,-0.73,0.99,1,0.8318,0.91,1
"C4_Cancer_modules:C4_CM_198_MODULE_211","C4_Cancer_modules","C4_CM_198_MODULE_211",11,-1.2595,0.18,0.22,1.5757,0.024,0.082,-1.5882,0.032,0.13
"C7_Immunologic_signatures:C7_ALL_917_GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP","C7_Immunologic_signatures","C7_ALL_917_GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP",197,-1.2594,0.058,0.11,0.8194,0.94,1,0.647,1,1
"C7_Immunologic_signatures:C7_ALL_1607_GSE3982_MAST_CELL_VS_DC_UP","C7_Immunologic_signatures","C7_ALL_1607_GSE3982_MAST_CELL_VS_DC_UP",199,-1.2594,0.065,0.11,1.1202,0.16,0.39,0.8113,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3054_VERHAAK_GLIOBLASTOMA_NEURAL","C2_Chemical_and_genetic_perturbations","C2_CGP_3054_VERHAAK_GLIOBLASTOMA_NEURAL",125,-1.2594,0.075,0.21,1.8149,0,0.039,-0.7392,0.98,0.98
"GO_BP:492389_GO_0016339_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES","GO_BP","492389_GO_0016339_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES",28,-1.2593,0.14,0.29,1.211,0.2,0.77,1.7466,0.0078,0.37
"GO_BP:491091_GO_0006112_ENERGY_RESERVE_METABOLIC_PROCESS","GO_BP","491091_GO_0006112_ENERGY_RESERVE_METABOLIC_PROCESS",152,-1.2592,0.07,0.29,-0.734,0.99,1,-1.0958,0.23,0.78
"REACTOME:645290_REACT_121399_MHC_CLASS_II_ANTIGEN_PRESENTATION","REACTOME","645290_REACT_121399_MHC_CLASS_II_ANTIGEN_PRESENTATION",100,-1.2591,0.11,0.32,1.0511,0.34,0.66,-0.8625,0.77,0.97
"GO_BP:514186_GO_0060631_REGULATION_OF_MEIOSIS_I","GO_BP","514186_GO_0060631_REGULATION_OF_MEIOSIS_I",8,-1.2591,0.19,0.29,0.8703,0.64,1,-0.7928,0.73,0.99
"GO_BP:494944_GO_0010880_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM","GO_BP","494944_GO_0010880_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM",25,-1.259,0.18,0.29,1.1676,0.25,0.82,1.0921,0.33,0.77
"GO_MF:499698_GO_0030295_PROTEIN_KINASE_ACTIVATOR_ACTIVITY","GO_MF","499698_GO_0030295_PROTEIN_KINASE_ACTIVATOR_ACTIVITY",52,-1.259,0.16,0.35,0.9069,0.65,0.98,0.8263,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_973_WILLIAMS_ESR1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_973_WILLIAMS_ESR1_TARGETS_DN",6,-1.259,0.19,0.21,-1.2663,0.2,0.72,-1.5426,0.042,0.27
"GO_BP:502848_GO_0033632_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN","GO_BP","502848_GO_0033632_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN",11,-1.2589,0.18,0.29,0.9628,0.51,1,-0.8423,0.67,0.96
"KEGG_compound:C02686_GALACTOSYLCERAMIDE_GALACTOCEREBROSIDE_D_GALACTOSYL_N_ACYLSPHINGOSINE_CEREBROSIDE_D_GALACTOSYLCERAMIDE","KEGG_compound","C02686_GALACTOSYLCERAMIDE_GALACTOCEREBROSIDE_D_GALACTOSYL_N_ACYLSPHINGOSINE_CEREBROSIDE_D_GALACTOSYLCERAMIDE",9,-1.2589,0.19,0.32,-1.1576,0.26,0.84,-0.8776,0.62,0.78
"KEGG_module:HSA_M00071_GLYCOSPHINGOLIPID_BIOSYNTHESIS_NEOLACTO_SERIES_LACCER_NLC4CER","KEGG_module","HSA_M00071_GLYCOSPHINGOLIPID_BIOSYNTHESIS_NEOLACTO_SERIES_LACCER_NLC4CER",5,-1.2589,0.19,0.46,0.79,0.74,0.93,0.9801,0.51,1
"WikiPathways:198872_WP734_SEROTONIN_RECEPTOR_4_6_7_AND_NR3C_SIGNALING","WikiPathways","198872_WP734_SEROTONIN_RECEPTOR_4_6_7_AND_NR3C_SIGNALING",19,-1.2589,0.17,0.24,-0.9869,0.47,1,-0.7173,0.86,0.97
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_138_BIOCARTA_EDG1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_138_BIOCARTA_EDG1_PATHWAY",26,-1.2589,0.16,0.29,1.0108,0.44,0.83,1.0191,0.42,1
"GO_BP:486746_GO_0000226_MICROTUBULE_CYTOSKELETON_ORGANIZATION","GO_BP","486746_GO_0000226_MICROTUBULE_CYTOSKELETON_ORGANIZATION",306,-1.2587,0.045,0.29,-0.8414,0.95,1,-1.3223,0.0065,0.63
"GO_BP:506503_GO_0043471_REGULATION_OF_CELLULAR_CARBOHYDRATE_CATABOLIC_PROCESS","GO_BP","506503_GO_0043471_REGULATION_OF_CELLULAR_CARBOHYDRATE_CATABOLIC_PROCESS",34,-1.2587,0.14,0.29,1.0612,0.36,0.94,1.6554,0.016,0.39
"C3_TF_targets:C3_TFT_236_V_AREB6_03","C3_TF_targets","C3_TFT_236_V_AREB6_03",253,-1.2587,0.05,0.12,-1.459,0,0.13,0.8474,0.89,1
"C7_Immunologic_signatures:C7_ALL_1793_GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1793_GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP",197,-1.2587,0.068,0.12,-1.1358,0.17,1,-1.0074,0.42,0.71
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_58_BIOCARTA_SKP2E2F_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_58_BIOCARTA_SKP2E2F_PATHWAY",10,-1.2586,0.18,0.29,-0.7652,0.78,1,-1.3034,0.16,0.51
"GO_MF:492540_GO_0008199_FERRIC_IRON_BINDING","GO_MF","492540_GO_0008199_FERRIC_IRON_BINDING",10,-1.2586,0.18,0.35,0.9918,0.44,0.89,1.6051,0.024,0.33
"GO_BP:513505_GO_0055072_IRON_ION_HOMEOSTASIS","GO_BP","513505_GO_0055072_IRON_ION_HOMEOSTASIS",91,-1.2585,0.099,0.29,1.4051,0.026,0.55,1.0361,0.4,0.82
"GO_BP:493715_GO_0009584_DETECTION_OF_VISIBLE_LIGHT","GO_BP","493715_GO_0009584_DETECTION_OF_VISIBLE_LIGHT",110,-1.2585,0.1,0.29,-1.0703,0.3,0.96,0.9519,0.53,0.9
"GO_BP:516559_GO_0071635_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION","GO_BP","516559_GO_0071635_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION",6,-1.2583,0.2,0.29,1.3829,0.12,0.57,1.1166,0.32,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_303_NAGASHIMA_NRG1_SIGNALING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_303_NAGASHIMA_NRG1_SIGNALING_DN",55,-1.2582,0.14,0.21,0.8102,0.81,0.98,0.7711,0.89,1
"C7_Immunologic_signatures:C7_ALL_355_GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_355_GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP",199,-1.2582,0.075,0.12,0.8176,0.94,1,-1.3447,0.0042,0.1
"C7_Immunologic_signatures:C7_ALL_489_GSE17721_CTRL_VS_PAM3CSK4_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_489_GSE17721_CTRL_VS_PAM3CSK4_8H_BMDM_UP",200,-1.2582,0.058,0.12,1.2906,0.039,0.11,-0.9131,0.72,0.92
"GO_BP:493311_GO_0009112_NUCLEOBASE_METABOLIC_PROCESS","GO_BP","493311_GO_0009112_NUCLEOBASE_METABOLIC_PROCESS",69,-1.2582,0.12,0.29,0.8981,0.67,1,-1.1165,0.24,0.76
"REACTOME:105780_REACT_329_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1","REACTOME","105780_REACT_329_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1",12,-1.2581,0.19,0.32,0.6052,0.95,1,-1.6297,0.034,0.23
"C2_Chemical_and_genetic_perturbations:C2_CGP_3204_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3204_TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN",18,-1.2581,0.18,0.21,0.6981,0.9,1,-0.7557,0.82,0.97
"GO_BP:488991_GO_0003197_ENDOCARDIAL_CUSHION_DEVELOPMENT","GO_BP","488991_GO_0003197_ENDOCARDIAL_CUSHION_DEVELOPMENT",27,-1.258,0.17,0.29,-1.1466,0.25,0.93,1.2911,0.13,0.68
"GO_BP:505867_GO_0042761_VERY_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS","GO_BP","505867_GO_0042761_VERY_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS",11,-1.258,0.17,0.29,0.593,0.96,1,-1.6555,0.02,0.53
"GO_CC:490331_GO_0005777_PEROXISOME","GO_CC","490331_GO_0005777_PEROXISOME",128,-1.2579,0.087,0.36,0.8846,0.73,0.91,-1.3092,0.051,0.63
"GO_BP:498990_GO_0021707_CEREBELLAR_GRANULE_CELL_DIFFERENTIATION","GO_BP","498990_GO_0021707_CEREBELLAR_GRANULE_CELL_DIFFERENTIATION",10,-1.2579,0.17,0.29,1.2358,0.2,0.75,0.6452,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2873_KYNG_NORMAL_AGING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2873_KYNG_NORMAL_AGING_DN",30,-1.2579,0.16,0.21,-0.6884,0.93,1,-0.8943,0.64,0.89
"KEGG_compound:C00173_ACYL_ACYL_CARRIER_PROTEIN_","KEGG_compound","C00173_ACYL_ACYL_CARRIER_PROTEIN_",13,-1.2579,0.19,0.33,-0.659,0.92,1,-1.0141,0.43,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_643_ROVERSI_GLIOMA_LOH_REGIONS","C2_Chemical_and_genetic_perturbations","C2_CGP_643_ROVERSI_GLIOMA_LOH_REGIONS",43,-1.2578,0.14,0.21,0.9496,0.54,0.87,-0.8688,0.7,0.91
"GO_BP:518698_GO_2000049_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN","GO_BP","518698_GO_2000049_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN",6,-1.2578,0.21,0.29,1.1939,0.25,0.79,1.443,0.082,0.59
"C6_Oncogenic_signatures:C6_ALL_137_IL21_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_137_IL21_UP_V1_DN",168,-1.2577,0.088,0.12,1.1777,0.1,0.41,1.1658,0.15,0.32
"REACTOME:160999_REACT_22237_NETRIN_1_SIGNALING","REACTOME","160999_REACT_22237_NETRIN_1_SIGNALING",42,-1.2577,0.17,0.32,-1.2218,0.16,0.8,-1.2705,0.11,0.55
"GO_BP:750934_GO_0036010_PROTEIN_LOCALIZATION_TO_ENDOSOME","GO_BP","750934_GO_0036010_PROTEIN_LOCALIZATION_TO_ENDOSOME",8,-1.2577,0.2,0.29,0.7327,0.78,1,1.0295,0.41,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_103_SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_103_SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN",62,-1.2576,0.12,0.21,1.2782,0.094,0.42,-0.8055,0.86,0.95
"C6_Oncogenic_signatures:C6_ALL_22_CSR_EARLY_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_22_CSR_EARLY_UP_V1_UP",146,-1.2576,0.08,0.12,0.8269,0.89,0.99,0.8269,0.88,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_768_AMUNDSON_DNA_DAMAGE_RESPONSE_TP53","C2_Chemical_and_genetic_perturbations","C2_CGP_768_AMUNDSON_DNA_DAMAGE_RESPONSE_TP53",16,-1.2576,0.19,0.21,-0.6552,0.92,1,-0.8457,0.7,0.93
"GO_BP:492049_GO_0007270_NEURON_NEURON_SYNAPTIC_TRANSMISSION","GO_BP","492049_GO_0007270_NEURON_NEURON_SYNAPTIC_TRANSMISSION",59,-1.2574,0.12,0.29,1.0358,0.38,0.96,1.2693,0.087,0.7
"GO_MF:492994_GO_0008762_UDP_N_ACETYLMURAMATE_DEHYDROGENASE_ACTIVITY","GO_MF","492994_GO_0008762_UDP_N_ACETYLMURAMATE_DEHYDROGENASE_ACTIVITY",6,-1.2573,0.21,0.35,-1.0928,0.36,0.85,0.878,0.61,0.96
"GO_MF:496703_GO_0016798_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS","GO_MF","496703_GO_0016798_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS",120,-1.2573,0.092,0.35,0.7676,0.97,1,-0.8955,0.72,0.87
"GO_MF:490351_GO_0005080_PROTEIN_KINASE_C_BINDING","GO_MF","490351_GO_0005080_PROTEIN_KINASE_C_BINDING",47,-1.2572,0.14,0.35,1.0837,0.33,0.81,-0.8058,0.8,0.96
"GO_BP:498871_GO_0021587_CEREBELLUM_MORPHOGENESIS","GO_BP","498871_GO_0021587_CEREBELLUM_MORPHOGENESIS",40,-1.2572,0.15,0.29,-1.0895,0.3,0.95,-0.6502,0.98,1
"GO_BP:510583_GO_0048511_RHYTHMIC_PROCESS","GO_BP","510583_GO_0048511_RHYTHMIC_PROCESS",270,-1.2572,0.042,0.29,-0.8606,0.89,1,0.8921,0.82,0.95
"GO_MF:498680_GO_0019903_PROTEIN_PHOSPHATASE_BINDING","GO_MF","498680_GO_0019903_PROTEIN_PHOSPHATASE_BINDING",99,-1.2571,0.096,0.35,0.8291,0.83,1,-1.3979,0.021,0.5
"GO_MF:492392_GO_0008017_MICROTUBULE_BINDING","GO_MF","492392_GO_0008017_MICROTUBULE_BINDING",177,-1.2571,0.064,0.35,-0.7016,1,1,-1.1138,0.21,0.69
"C7_Immunologic_signatures:C7_ALL_55_GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP","C7_Immunologic_signatures","C7_ALL_55_GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP",187,-1.2571,0.072,0.12,0.851,0.86,1,-1.1296,0.18,0.42
"KEGG_pathway:HSA05169_EPSTEIN_BARR_VIRUS_INFECTION","KEGG_pathway","HSA05169_EPSTEIN_BARR_VIRUS_INFECTION",197,-1.257,0.061,0.17,0.8939,0.78,1,-1.2444,0.047,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_2497_PALOMERO_GSI_SENSITIVITY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2497_PALOMERO_GSI_SENSITIVITY_UP",7,-1.2568,0.22,0.21,-1.2424,0.21,0.75,-1.0679,0.35,0.67
"REACTOME:1127670_REACT_267790_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS","REACTOME","1127670_REACT_267790_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS",28,-1.2565,0.16,0.32,1.1095,0.3,0.56,0.8001,0.81,1
"GO_BP:486772_GO_0000255_ALLANTOIN_METABOLIC_PROCESS","GO_BP","486772_GO_0000255_ALLANTOIN_METABOLIC_PROCESS",5,-1.2564,0.19,0.29,1.2305,0.24,0.75,-0.6146,0.91,1
"GO_BP:506969_GO_0043951_NEGATIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING","GO_BP","506969_GO_0043951_NEGATIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING",8,-1.2563,0.18,0.29,0.5475,0.96,1,-1.3538,0.14,0.6
"C6_Oncogenic_signatures:C6_ALL_138_IL21_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_138_IL21_UP_V1_UP",178,-1.2563,0.07,0.12,-1.1206,0.22,0.54,1.0124,0.4,0.53
"GO_BP:516450_GO_0071526_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY","GO_BP","516450_GO_0071526_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY",20,-1.2562,0.17,0.29,-0.8748,0.67,1,1.0854,0.34,0.77
"GO_MF:490517_GO_0005310_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490517_GO_0005310_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",24,-1.2561,0.16,0.35,0.7553,0.81,1,-0.9558,0.52,0.82
"C7_Immunologic_signatures:C7_ALL_149_GSE13306_TREG_VS_TCONV_SPLEEN_UP","C7_Immunologic_signatures","C7_ALL_149_GSE13306_TREG_VS_TCONV_SPLEEN_UP",194,-1.2561,0.06,0.12,-0.829,0.9,1,0.8687,0.83,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2558_MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2558_MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN",31,-1.2561,0.16,0.22,-0.9387,0.54,1,-0.8333,0.74,0.93
"C3_TF_targets:C3_TFT_538_WYAAANNRNNNGCG_UNKNOWN","C3_TF_targets","C3_TFT_538_WYAAANNRNNNGCG_UNKNOWN",65,-1.256,0.15,0.13,-1.1089,0.28,0.52,1.1742,0.18,0.76
"GO_MF:506073_GO_0042979_ORNITHINE_DECARBOXYLASE_REGULATOR_ACTIVITY","GO_MF","506073_GO_0042979_ORNITHINE_DECARBOXYLASE_REGULATOR_ACTIVITY",6,-1.2557,0.18,0.35,0.6804,0.87,1,-0.7477,0.78,0.99
"GO_BP:491614_GO_0006729_TETRAHYDROBIOPTERIN_BIOSYNTHETIC_PROCESS","GO_BP","491614_GO_0006729_TETRAHYDROBIOPTERIN_BIOSYNTHETIC_PROCESS",6,-1.2557,0.19,0.29,0.8556,0.66,1,-1.0378,0.42,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_995_MANTOVANI_NFKB_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_995_MANTOVANI_NFKB_TARGETS_DN",11,-1.2557,0.18,0.22,-0.9169,0.56,1,-1.1085,0.33,0.62
"GO_BP:750912_GO_0035987_ENDODERMAL_CELL_DIFFERENTIATION","GO_BP","750912_GO_0035987_ENDODERMAL_CELL_DIFFERENTIATION",40,-1.2553,0.15,0.3,-0.6376,0.97,1,1.4176,0.048,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_1574_XU_CREBBP_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1574_XU_CREBBP_TARGETS_DN",42,-1.2553,0.14,0.22,0.7379,0.9,1,-0.969,0.48,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1215_NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1215_NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON",330,-1.2553,0.047,0.22,-0.9201,0.7,1,-1.2745,0.015,0.45
"C7_Immunologic_signatures:C7_ALL_1099_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP","C7_Immunologic_signatures","C7_ALL_1099_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP",200,-1.2553,0.073,0.12,0.7997,0.96,1,-1.1759,0.1,0.33
"GO_BP:499081_GO_0021801_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION","GO_BP","499081_GO_0021801_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION",17,-1.2552,0.18,0.3,-0.5962,0.96,1,1.2302,0.19,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_2460_LEE_LIVER_CANCER_SURVIVAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2460_LEE_LIVER_CANCER_SURVIVAL_UP",177,-1.2552,0.07,0.22,-0.8179,0.91,1,-1.2099,0.092,0.51
"GO_BP:491814_GO_0006975_DNA_DAMAGE_INDUCED_PROTEIN_PHOSPHORYLATION","GO_BP","491814_GO_0006975_DNA_DAMAGE_INDUCED_PROTEIN_PHOSPHORYLATION",8,-1.2552,0.19,0.3,-1.2986,0.18,0.89,-1.4607,0.11,0.54
"GO_MF:499420_GO_0022889_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","499420_GO_0022889_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-1.2551,0.2,0.35,0.9721,0.49,0.9,0.673,0.87,1
"GO_BP:494593_GO_0010524_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL","GO_BP","494593_GO_0010524_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL",39,-1.2551,0.15,0.3,0.993,0.46,0.99,-1.0165,0.41,0.83
"C4_Cancer_modules:C4_CM_313_MODULE_363","C4_Cancer_modules","C4_CM_313_MODULE_363",49,-1.2551,0.15,0.22,1.9127,0,0.0074,-0.6753,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2218_AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53","C2_Chemical_and_genetic_perturbations","C2_CGP_2218_AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53",109,-1.255,0.089,0.22,-1.18,0.17,0.82,-1.3139,0.046,0.42
"GO_BP:512237_GO_0051353_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY","GO_BP","512237_GO_0051353_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY",42,-1.255,0.15,0.3,0.8977,0.63,1,-0.7479,0.9,1
"C7_Immunologic_signatures:C7_ALL_356_GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_356_GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN",193,-1.2549,0.091,0.12,0.8774,0.84,1,1.0711,0.28,1
"C7_Immunologic_signatures:C7_ALL_595_GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_595_GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDM_UP",197,-1.2549,0.073,0.12,-0.8848,0.77,1,-1.0632,0.29,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_2599_SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6","C2_Chemical_and_genetic_perturbations","C2_CGP_2599_SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6",453,-1.2549,0.026,0.22,1.3771,0,0.31,-1.3217,0.0021,0.41
"C3_TF_targets:C3_TFT_336_V_HNF4ALPHA_Q6","C3_TF_targets","C3_TFT_336_V_HNF4ALPHA_Q6",264,-1.2549,0.054,0.13,-0.973,0.53,0.82,-1.0694,0.27,0.61
"GO_BP:486692_GO_0000160_PHOSPHORELAY_SIGNAL_TRANSDUCTION_SYSTEM","GO_BP","486692_GO_0000160_PHOSPHORELAY_SIGNAL_TRANSDUCTION_SYSTEM",11,-1.2548,0.19,0.3,-0.81,0.71,1,-1.2784,0.16,0.66
"WikiPathways:198852_WP430_STATIN_PATHWAY","WikiPathways","198852_WP430_STATIN_PATHWAY",30,-1.2547,0.16,0.24,-1.1551,0.23,0.91,1.0317,0.39,0.87
"C7_Immunologic_signatures:C7_ALL_589_GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_589_GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDM_UP",198,-1.2547,0.072,0.12,1.1111,0.2,0.41,0.9573,0.56,1
"GO_BP:513443_GO_0055010_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS","GO_BP","513443_GO_0055010_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS",39,-1.2547,0.14,0.3,1.0453,0.38,0.95,1.226,0.15,0.71
"GO_BP:510693_GO_0048636_POSITIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT","GO_BP","510693_GO_0048636_POSITIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT",44,-1.2547,0.15,0.3,0.7898,0.85,1,1.1557,0.23,0.73
"GO_BP:491423_GO_0006527_ARGININE_CATABOLIC_PROCESS","GO_BP","491423_GO_0006527_ARGININE_CATABOLIC_PROCESS",8,-1.2546,0.2,0.3,-1.3246,0.16,0.89,1.0215,0.45,0.83
"GO_MF:490580_GO_0005452_INORGANIC_ANION_EXCHANGER_ACTIVITY","GO_MF","490580_GO_0005452_INORGANIC_ANION_EXCHANGER_ACTIVITY",13,-1.2546,0.18,0.35,-1.2038,0.23,0.81,-1.2856,0.17,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_780_KORKOLA_CHORIOCARCINOMA","C2_Chemical_and_genetic_perturbations","C2_CGP_780_KORKOLA_CHORIOCARCINOMA",5,-1.2546,0.2,0.22,0.975,0.48,0.82,1.0863,0.37,0.87
"GO_BP:488965_GO_0003171_ATRIOVENTRICULAR_VALVE_DEVELOPMENT","GO_BP","488965_GO_0003171_ATRIOVENTRICULAR_VALVE_DEVELOPMENT",18,-1.2545,0.18,0.3,-0.8444,0.68,1,1.0196,0.42,0.84
"C7_Immunologic_signatures:C7_ALL_559_GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_559_GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDM_UP",198,-1.2544,0.081,0.12,0.9694,0.53,0.84,1.0268,0.36,1
"GO_BP:487836_GO_0001946_LYMPHANGIOGENESIS","GO_BP","487836_GO_0001946_LYMPHANGIOGENESIS",10,-1.2544,0.18,0.3,-0.823,0.67,1,0.998,0.46,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_1047_FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1047_FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP",9,-1.2543,0.19,0.22,-1.622,0.023,0.39,-0.9638,0.51,0.8
"GO_MF:500875_GO_0031625_UBIQUITIN_PROTEIN_LIGASE_BINDING","GO_MF","500875_GO_0031625_UBIQUITIN_PROTEIN_LIGASE_BINDING",216,-1.2543,0.071,0.35,0.8183,0.95,1,-0.9063,0.76,0.87
"REACTOME:106043_REACT_18283_G_ALPHA_Q_SIGNALLING_EVENTS","REACTOME","106043_REACT_18283_G_ALPHA_Q_SIGNALLING_EVENTS",181,-1.2543,0.076,0.33,1.0987,0.23,0.58,1.2943,0.039,0.74
"GO_BP:501606_GO_0032371_REGULATION_OF_STEROL_TRANSPORT","GO_BP","501606_GO_0032371_REGULATION_OF_STEROL_TRANSPORT",34,-1.2543,0.15,0.3,0.9805,0.5,1,1.0548,0.36,0.8
"WikiPathways:672457_WP2267_SYNAPTIC_VESICLE_PATHWAY","WikiPathways","672457_WP2267_SYNAPTIC_VESICLE_PATHWAY",51,-1.2542,0.14,0.24,-0.6984,0.95,1,-0.908,0.62,0.84
"GO_BP:505194_GO_0040036_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","505194_GO_0040036_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",29,-1.2542,0.17,0.3,0.991,0.47,0.99,1.5115,0.03,0.54
"C6_Oncogenic_signatures:C6_ALL_178_KRAS_BREAST_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_178_KRAS_BREAST_UP_V1_DN",139,-1.2541,0.092,0.12,-1.2439,0.078,0.37,-1.034,0.37,0.59
"REACTOME:105648_REACT_578_APOPTOSIS","REACTOME","105648_REACT_578_APOPTOSIS",160,-1.2541,0.071,0.33,1.5202,0.0048,0.14,-0.7606,0.98,1
"GO_BP:494804_GO_0010739_POSITIVE_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING","GO_BP","494804_GO_0010739_POSITIVE_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING",5,-1.254,0.21,0.3,-0.7195,0.81,1,0.9506,0.53,0.9
"C7_Immunologic_signatures:C7_ALL_739_GSE17721_12H_VS_24H_PAM3CSK4_BMDM_UP","C7_Immunologic_signatures","C7_ALL_739_GSE17721_12H_VS_24H_PAM3CSK4_BMDM_UP",198,-1.2538,0.065,0.12,1.1767,0.11,0.27,0.7914,0.97,1
"GO_BP:508240_GO_0045933_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION","GO_BP","508240_GO_0045933_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION",34,-1.2538,0.14,0.3,-0.8601,0.68,1,-0.934,0.55,0.9
"GO_MF:512263_GO_0051379_EPINEPHRINE_BINDING","GO_MF","512263_GO_0051379_EPINEPHRINE_BINDING",5,-1.2538,0.2,0.35,-1.0689,0.38,0.86,-0.6866,0.83,1
"GO_BP:517505_GO_0072602_INTERLEUKIN_4_SECRETION","GO_BP","517505_GO_0072602_INTERLEUKIN_4_SECRETION",5,-1.2538,0.19,0.3,-1.0664,0.39,0.96,-0.5403,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2281_LE_SKI_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2281_LE_SKI_TARGETS_DN",8,-1.2538,0.21,0.22,0.9672,0.48,0.84,-0.6588,0.9,0.99
"C7_Immunologic_signatures:C7_ALL_1300_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN","C7_Immunologic_signatures","C7_ALL_1300_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN",195,-1.2537,0.072,0.12,-1.0614,0.29,1,-1.1295,0.15,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_254_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_254_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP",202,-1.2536,0.071,0.22,1.3087,0.035,0.39,0.9798,0.5,0.97
"GO_MF:500526_GO_0031267_SMALL_GTPASE_BINDING","GO_MF","500526_GO_0031267_SMALL_GTPASE_BINDING",226,-1.2535,0.074,0.35,-1.1536,0.14,0.81,-0.9038,0.74,0.87
"GO_BP:495093_GO_0014020_PRIMARY_NEURAL_TUBE_FORMATION","GO_BP","495093_GO_0014020_PRIMARY_NEURAL_TUBE_FORMATION",87,-1.2535,0.11,0.3,-0.7203,0.97,1,-0.8355,0.82,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3036_KAMIKUBO_MYELOID_MN1_NETWORK","C2_Chemical_and_genetic_perturbations","C2_CGP_3036_KAMIKUBO_MYELOID_MN1_NETWORK",19,-1.2534,0.19,0.22,1.5381,0.029,0.18,-0.7294,0.86,0.98
"GO_BP:504333_GO_0035148_TUBE_FORMATION","GO_BP","504333_GO_0035148_TUBE_FORMATION",130,-1.2534,0.093,0.3,0.7363,0.98,1,0.894,0.74,0.95
"GO_BP:517140_GO_0072224_METANEPHRIC_GLOMERULUS_DEVELOPMENT","GO_BP","517140_GO_0072224_METANEPHRIC_GLOMERULUS_DEVELOPMENT",11,-1.2534,0.18,0.3,0.421,1,1,1.0898,0.36,0.77
"GO_BP:501194_GO_0031954_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION","GO_BP","501194_GO_0031954_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION",19,-1.2533,0.2,0.3,1.4194,0.08,0.53,1.008,0.45,0.85
"C3_MicroRNA_targets:C3_MIR_195_GTTATAT_MIR_410","C3_MicroRNA_targets","C3_MIR_195_GTTATAT_MIR_410",91,-1.2533,0.11,0.27,-1.0407,0.36,1,0.6745,0.99,1
"WikiPathways:198889_WP259_NIFEDIPINE_ACTIVITY","WikiPathways","198889_WP259_NIFEDIPINE_ACTIVITY",5,-1.2531,0.19,0.24,-1.1938,0.29,0.81,0.6518,0.87,1
"GO_BP:513440_GO_0055007_CARDIAC_MUSCLE_CELL_DIFFERENTIATION","GO_BP","513440_GO_0055007_CARDIAC_MUSCLE_CELL_DIFFERENTIATION",78,-1.2528,0.11,0.3,-1.126,0.25,0.94,0.8781,0.74,0.96
"C3_TF_targets:C3_TFT_36_V_IRF1_01","C3_TF_targets","C3_TFT_36_V_IRF1_01",241,-1.2528,0.054,0.13,0.9227,0.72,1,-1.1298,0.14,0.48
"GO_BP:500365_GO_0031077_POST_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT","GO_BP","500365_GO_0031077_POST_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT",7,-1.2527,0.21,0.3,-0.8968,0.58,1,-0.7244,0.82,0.99
"GO_CC:752885_GO_0097386_GLIAL_CELL_PROJECTION","GO_CC","752885_GO_0097386_GLIAL_CELL_PROJECTION",10,-1.2527,0.2,0.37,-0.6877,0.87,1,0.9014,0.59,1
"GO_CC:513468_GO_0055037_RECYCLING_ENDOSOME","GO_CC","513468_GO_0055037_RECYCLING_ENDOSOME",122,-1.2526,0.1,0.36,0.8788,0.79,0.91,0.9938,0.46,1
"KEGG_compound:C00249_HEXADECANOIC_ACID_HEXADECANOATE_HEXADECYLIC_ACID_PALMITIC_ACID_PALMITATE_CETYLIC_ACID","KEGG_compound","C00249_HEXADECANOIC_ACID_HEXADECANOATE_HEXADECYLIC_ACID_PALMITIC_ACID_PALMITATE_CETYLIC_ACID",15,-1.2526,0.18,0.33,0.4591,1,1,0.7431,0.85,0.95
"C7_Immunologic_signatures:C7_ALL_1720_GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1720_GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN",199,-1.2526,0.078,0.12,1.0919,0.24,0.47,0.8822,0.81,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_579_KONG_E2F1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_579_KONG_E2F1_TARGETS",10,-1.2525,0.2,0.22,-1.371,0.093,0.63,-1.1356,0.28,0.59
"WikiPathways:711360_WP2377_INTEGRATED_PANCREATIC_CANCER_PATHWAY","WikiPathways","711360_WP2377_INTEGRATED_PANCREATIC_CANCER_PATHWAY",191,-1.2524,0.086,0.24,-0.7487,0.98,1,-1.0855,0.26,0.63
"GO_BP:493352_GO_0009155_PURINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS","GO_BP","493352_GO_0009155_PURINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS",9,-1.2524,0.19,0.3,0.6947,0.85,1,-1.2868,0.17,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_2792_SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2792_SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN",19,-1.2523,0.17,0.22,-0.9253,0.59,1,-1.1339,0.27,0.59
"GO_MF:496626_GO_0016705_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN","GO_MF","496626_GO_0016705_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN",157,-1.2523,0.09,0.35,-0.9649,0.53,0.95,0.928,0.66,0.94
"GO_BP:492184_GO_0007423_SENSORY_ORGAN_DEVELOPMENT","GO_BP","492184_GO_0007423_SENSORY_ORGAN_DEVELOPMENT",484,-1.2523,0.022,0.3,-0.9007,0.82,1,1.2998,0.0054,0.67
"GO_BP:491876_GO_0007051_SPINDLE_ORGANIZATION","GO_BP","491876_GO_0007051_SPINDLE_ORGANIZATION",95,-1.2522,0.12,0.3,-0.9961,0.46,0.99,-1.6406,0,0.54
"GO_CC:490905_GO_0005903_BRUSH_BORDER","GO_CC","490905_GO_0005903_BRUSH_BORDER",70,-1.2522,0.14,0.36,-1.1736,0.17,0.68,1.0248,0.41,0.98
"GO_BP:495267_GO_0014874_RESPONSE_TO_STIMULUS_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION","GO_BP","495267_GO_0014874_RESPONSE_TO_STIMULUS_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION",9,-1.2521,0.21,0.3,-0.7262,0.81,1,-1.5112,0.059,0.53
"GO_BP:494525_GO_0010455_POSITIVE_REGULATION_OF_CELL_FATE_COMMITMENT","GO_BP","494525_GO_0010455_POSITIVE_REGULATION_OF_CELL_FATE_COMMITMENT",12,-1.252,0.2,0.3,-1.1638,0.27,0.91,0.6798,0.86,1
"C6_Oncogenic_signatures:C6_ALL_12_GCNP_SHH_UP_LATE_V1_UP","C6_Oncogenic_signatures","C6_ALL_12_GCNP_SHH_UP_LATE_V1_UP",170,-1.252,0.075,0.12,-0.7062,1,1,-0.8572,0.86,0.87
"C7_Immunologic_signatures:C7_ALL_1160_GSE27786_LSK_VS_MONO_MAC_DN","C7_Immunologic_signatures","C7_ALL_1160_GSE27786_LSK_VS_MONO_MAC_DN",198,-1.2518,0.076,0.12,-0.896,0.74,1,-0.8118,0.96,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_84_BIOCARTA_HIVNEF_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_84_BIOCARTA_HIVNEF_PATHWAY",58,-1.2518,0.14,0.29,-0.4968,1,1,-0.8197,0.81,0.89
"GO_MF:490610_GO_0005501_RETINOID_BINDING","GO_MF","490610_GO_0005501_RETINOID_BINDING",37,-1.2518,0.13,0.35,1.2409,0.14,0.69,1.6263,0.006,0.3
"GO_BP:499317_GO_0022038_CORPUS_CALLOSUM_DEVELOPMENT","GO_BP","499317_GO_0022038_CORPUS_CALLOSUM_DEVELOPMENT",12,-1.2517,0.19,0.3,-1.1027,0.31,0.94,-0.905,0.56,0.92
"GO_BP:925921_GO_1902572_NEGATIVE_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY","GO_BP","925921_GO_1902572_NEGATIVE_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY",7,-1.2516,0.2,0.3,1.2487,0.21,0.73,-0.8188,0.7,0.98
"REACTOME:833826_REACT_163701_FCERI_MEDIATED_MAPK_ACTIVATION","REACTOME","833826_REACT_163701_FCERI_MEDIATED_MAPK_ACTIVATION",42,-1.2516,0.16,0.33,-0.8191,0.78,1,-1.3255,0.069,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1626_KAAB_FAILED_HEART_ATRIUM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1626_KAAB_FAILED_HEART_ATRIUM_DN",141,-1.2515,0.096,0.22,1.4838,0.007,0.23,-0.8013,0.92,0.95
"C7_Immunologic_signatures:C7_ALL_1576_GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN","C7_Immunologic_signatures","C7_ALL_1576_GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN",199,-1.2514,0.08,0.12,1.3877,0.005,0.042,-1.3402,0.012,0.1
"GO_BP:516797_GO_0071877_REGULATION_OF_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY","GO_BP","516797_GO_0071877_REGULATION_OF_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY",6,-1.2514,0.2,0.3,-1.0422,0.41,0.98,-0.7692,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_131_CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_131_CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP",372,-1.2513,0.032,0.22,-1.517,0,0.44,-1.2919,0.0089,0.43
"GO_BP:849922_GO_1902221_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS","GO_BP","849922_GO_1902221_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS",10,-1.2512,0.21,0.3,-0.856,0.65,1,-0.8672,0.63,0.95
"C7_Immunologic_signatures:C7_ALL_197_GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_197_GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP",170,-1.2512,0.086,0.12,-1.2139,0.081,0.8,2.0022,0,7.5e-05
"GO_BP:506176_GO_0043096_PURINE_NUCLEOBASE_SALVAGE","GO_BP","506176_GO_0043096_PURINE_NUCLEOBASE_SALVAGE",6,-1.2511,0.21,0.3,0.8347,0.64,1,-1.1858,0.26,0.73
"GO_MF:502351_GO_0033130_ACETYLCHOLINE_RECEPTOR_BINDING","GO_MF","502351_GO_0033130_ACETYLCHOLINE_RECEPTOR_BINDING",8,-1.2511,0.18,0.35,-0.9855,0.46,0.92,-1.1339,0.31,0.66
"KEGG_compound:C16587_3_CARBAMOYL_2_PHENYLPROPIONALDEHYDE","KEGG_compound","C16587_3_CARBAMOYL_2_PHENYLPROPIONALDEHYDE",11,-1.2511,0.2,0.33,1.2193,0.23,0.86,-1.1206,0.3,0.53
"GO_MF:496641_GO_0016721_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SUPEROXIDE_RADICALS_AS_ACCEPTOR","GO_MF","496641_GO_0016721_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SUPEROXIDE_RADICALS_AS_ACCEPTOR",5,-1.251,0.19,0.35,-0.6214,0.91,1,-1.3052,0.15,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_460_GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_460_GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN",34,-1.251,0.18,0.22,-1.1115,0.31,0.9,-0.9922,0.48,0.76
"GO_BP:505620_GO_0042487_REGULATION_OF_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH","GO_BP","505620_GO_0042487_REGULATION_OF_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH",12,-1.2509,0.19,0.3,0.7668,0.78,1,1.4316,0.089,0.61
"GO_BP:488970_GO_0003176_AORTIC_VALVE_DEVELOPMENT","GO_BP","488970_GO_0003176_AORTIC_VALVE_DEVELOPMENT",5,-1.2508,0.19,0.3,-0.8298,0.67,1,-0.5314,0.94,1
"GO_MF:490401_GO_0005138_INTERLEUKIN_6_RECEPTOR_BINDING","GO_MF","490401_GO_0005138_INTERLEUKIN_6_RECEPTOR_BINDING",6,-1.2507,0.19,0.35,-0.8685,0.62,1,-1.0874,0.39,0.7
"C3_MicroRNA_targets:C3_MIR_103_GTACTGT_MIR_101","C3_MicroRNA_targets","C3_MIR_103_GTACTGT_MIR_101",257,-1.2505,0.055,0.27,-1.0355,0.36,1,-0.9946,0.45,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_589_RIZ_ERYTHROID_DIFFERENTIATION_HBZ","C2_Chemical_and_genetic_perturbations","C2_CGP_589_RIZ_ERYTHROID_DIFFERENTIATION_HBZ",40,-1.2505,0.15,0.22,0.9949,0.46,0.81,-1.3443,0.067,0.4
"GO_BP:488597_GO_0002724_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION","GO_BP","488597_GO_0002724_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION",15,-1.2504,0.19,0.3,-0.9904,0.44,1,-1.1083,0.31,0.77
"WikiPathways:198838_WP678_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE","WikiPathways","198838_WP678_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE",7,-1.2503,0.21,0.24,-0.5901,0.93,1,-0.6175,0.92,0.99
"GO_BP:754814_GO_1901863_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","754814_GO_1901863_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT",45,-1.2503,0.15,0.3,0.8334,0.76,1,1.2518,0.13,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2890_DANG_MYC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2890_DANG_MYC_TARGETS_DN",31,-1.2502,0.17,0.22,1.1555,0.25,0.55,0.877,0.68,1
"C4_Cancer_gene_neighborhoods:C4_CGN_180_MORF_SUPT3H","C4_Cancer_gene_neighborhoods","C4_CGN_180_MORF_SUPT3H",316,-1.2502,0.049,0.27,-1.0727,0.28,0.76,1.2585,0.018,0.36
"C4_Cancer_modules:C4_CM_351_MODULE_421","C4_Cancer_modules","C4_CM_351_MODULE_421",28,-1.2502,0.14,0.23,-0.6454,0.96,1,-1.4016,0.075,0.22
"GO_MF:495802_GO_0015665_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495802_GO_0015665_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",17,-1.2502,0.17,0.35,-1.4521,0.062,0.62,-0.8459,0.71,0.93
"GO_BP:494528_GO_0010458_EXIT_FROM_MITOSIS","GO_BP","494528_GO_0010458_EXIT_FROM_MITOSIS",7,-1.2501,0.19,0.3,-1.1065,0.35,0.94,-1.3722,0.13,0.59
"GO_BP:502819_GO_0033603_POSITIVE_REGULATION_OF_DOPAMINE_SECRETION","GO_BP","502819_GO_0033603_POSITIVE_REGULATION_OF_DOPAMINE_SECRETION",6,-1.2501,0.23,0.3,0.7178,0.82,1,0.7892,0.71,1
"GO_BP:514386_GO_0060831_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING","GO_BP","514386_GO_0060831_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING",7,-1.2501,0.22,0.3,-0.7212,0.8,1,0.74,0.79,1
"GO_CC:494090_GO_0010008_ENDOSOME_MEMBRANE","GO_CC","494090_GO_0010008_ENDOSOME_MEMBRANE",369,-1.25,0.04,0.37,1.0695,0.26,0.69,0.8306,0.96,1
"GO_BP:515141_GO_0070206_PROTEIN_TRIMERIZATION","GO_BP","515141_GO_0070206_PROTEIN_TRIMERIZATION",36,-1.2499,0.16,0.3,1.0997,0.28,0.9,1.0253,0.4,0.83
"GO_BP:751422_GO_0038166_ANGIOTENSIN_ACTIVATED_SIGNALING_PATHWAY","GO_BP","751422_GO_0038166_ANGIOTENSIN_ACTIVATED_SIGNALING_PATHWAY",9,-1.2497,0.18,0.3,0.8216,0.69,1,0.9463,0.52,0.91
"GO_MF:496697_GO_0016791_PHOSPHATASE_ACTIVITY","GO_MF","496697_GO_0016791_PHOSPHATASE_ACTIVITY",258,-1.2497,0.057,0.35,0.9242,0.7,0.95,-0.8701,0.86,0.9
"GO_MF:489667_GO_0004300_ENOYL_COA_HYDRATASE_ACTIVITY","GO_MF","489667_GO_0004300_ENOYL_COA_HYDRATASE_ACTIVITY",5,-1.2496,0.2,0.35,0.7973,0.74,1,-1.24,0.25,0.6
"C7_Immunologic_signatures:C7_ALL_1069_GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP","C7_Immunologic_signatures","C7_ALL_1069_GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP",199,-1.2495,0.063,0.13,1.1024,0.21,0.44,-1.2737,0.039,0.17
"GO_MF:489576_GO_0004111_CREATINE_KINASE_ACTIVITY","GO_MF","489576_GO_0004111_CREATINE_KINASE_ACTIVITY",6,-1.2495,0.21,0.35,-1.1023,0.34,0.83,1.401,0.11,0.52
"GO_BP:512753_GO_0051898_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING","GO_BP","512753_GO_0051898_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING",32,-1.2494,0.2,0.3,0.6565,0.96,1,0.7546,0.87,1
"GO_BP:499576_GO_0030157_PANCREATIC_JUICE_SECRETION","GO_BP","499576_GO_0030157_PANCREATIC_JUICE_SECRETION",7,-1.2493,0.2,0.3,-1.4748,0.084,0.85,1.2766,0.18,0.69
"REACTOME:106468_REACT_9053_CAM_PATHWAY","REACTOME","106468_REACT_9053_CAM_PATHWAY",28,-1.2493,0.17,0.33,0.8132,0.78,0.99,-1.1978,0.2,0.61
"C4_Cancer_gene_neighborhoods:C4_CGN_125_MORF_MAGEA8","C4_Cancer_gene_neighborhoods","C4_CGN_125_MORF_MAGEA8",249,-1.2493,0.066,0.27,-0.9934,0.47,0.87,1.1186,0.18,0.6
"GO_BP:513983_GO_0060428_LUNG_EPITHELIUM_DEVELOPMENT","GO_BP","513983_GO_0060428_LUNG_EPITHELIUM_DEVELOPMENT",35,-1.2492,0.18,0.3,-1.1061,0.3,0.94,-0.8633,0.66,0.95
"GO_BP:518723_GO_2000074_REGULATION_OF_TYPE_B_PANCREATIC_CELL_DEVELOPMENT","GO_BP","518723_GO_2000074_REGULATION_OF_TYPE_B_PANCREATIC_CELL_DEVELOPMENT",7,-1.2492,0.21,0.3,-1.3829,0.12,1,-0.7128,0.83,0.99
"GO_BP:505586_GO_0042446_HORMONE_BIOSYNTHETIC_PROCESS","GO_BP","505586_GO_0042446_HORMONE_BIOSYNTHETIC_PROCESS",44,-1.2492,0.15,0.3,0.9219,0.6,1,0.9934,0.47,0.86
"C7_Immunologic_signatures:C7_ALL_514_GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_514_GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDM_DN",196,-1.249,0.076,0.13,1.1796,0.096,0.26,-1.021,0.38,0.68
"C4_Cancer_gene_neighborhoods:C4_CGN_183_MORF_TNFRSF25","C4_Cancer_gene_neighborhoods","C4_CGN_183_MORF_TNFRSF25",254,-1.249,0.06,0.27,-1.2904,0.026,0.55,-1.0146,0.42,0.82
"C4_Cancer_modules:C4_CM_269_MODULE_307","C4_Cancer_modules","C4_CM_269_MODULE_307",25,-1.2489,0.17,0.23,1.7566,0.0043,0.034,0.9677,0.51,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_3066_QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2","C2_Chemical_and_genetic_perturbations","C2_CGP_3066_QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2",37,-1.2489,0.17,0.22,-0.587,0.99,1,1.1888,0.19,0.78
"GO_BP:514411_GO_0060856_ESTABLISHMENT_OF_BLOOD_BRAIN_BARRIER","GO_BP","514411_GO_0060856_ESTABLISHMENT_OF_BLOOD_BRAIN_BARRIER",6,-1.2488,0.21,0.3,-1.2418,0.22,0.91,0.8582,0.62,0.97
"GO_BP:500402_GO_0031115_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION","GO_BP","500402_GO_0031115_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION",10,-1.2488,0.21,0.3,-1.1498,0.28,0.93,-1.2543,0.2,0.68
"KEGG_compound:C02166_LEUKOTRIENE_C4_LTC4","KEGG_compound","C02166_LEUKOTRIENE_C4_LTC4",5,-1.2488,0.21,0.34,-1.2857,0.18,0.66,0.4518,0.99,1
"GO_BP:502905_GO_0033688_REGULATION_OF_OSTEOBLAST_PROLIFERATION","GO_BP","502905_GO_0033688_REGULATION_OF_OSTEOBLAST_PROLIFERATION",21,-1.2487,0.19,0.3,-0.9234,0.57,1,1.2446,0.19,0.7
"C3_MicroRNA_targets:C3_MIR_104_CAGGTCC_MIR_492","C3_MicroRNA_targets","C3_MIR_104_CAGGTCC_MIR_492",62,-1.2487,0.14,0.27,-1.4418,0.042,0.54,-1.0164,0.4,1
"REACTOME:106443_REACT_13720_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE","REACTOME","106443_REACT_13720_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE",61,-1.2486,0.12,0.33,-0.8122,0.8,1,-0.9286,0.6,0.93
"C7_Immunologic_signatures:C7_ALL_1470_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN","C7_Immunologic_signatures","C7_ALL_1470_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN",196,-1.2486,0.068,0.13,0.9683,0.57,0.84,0.908,0.74,1
"GO_BP:500598_GO_0031339_NEGATIVE_REGULATION_OF_VESICLE_FUSION","GO_BP","500598_GO_0031339_NEGATIVE_REGULATION_OF_VESICLE_FUSION",5,-1.2486,0.21,0.3,-0.8018,0.68,1,-0.8761,0.61,0.94
"C7_Immunologic_signatures:C7_ALL_1264_GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN","C7_Immunologic_signatures","C7_ALL_1264_GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN",199,-1.2484,0.07,0.13,2.0289,0,0,-1.4741,0.0042,0.028
"GO_BP:502182_GO_0032960_REGULATION_OF_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","502182_GO_0032960_REGULATION_OF_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS",6,-1.2483,0.21,0.3,0.7384,0.79,1,1.7045,0.018,0.41
"REACTOME:730309_REACT_150401_COLLAGEN_DEGRADATION","REACTOME","730309_REACT_150401_COLLAGEN_DEGRADATION",38,-1.2483,0.16,0.33,1.1268,0.27,0.55,1.3163,0.092,0.76
"C7_Immunologic_signatures:C7_ALL_111_GSE12366_GC_VS_MEMORY_BCELL_UP","C7_Immunologic_signatures","C7_ALL_111_GSE12366_GC_VS_MEMORY_BCELL_UP",199,-1.2481,0.073,0.13,1.1595,0.14,0.3,-1.0415,0.34,0.63
"GO_BP:514067_GO_0060512_PROSTATE_GLAND_MORPHOGENESIS","GO_BP","514067_GO_0060512_PROSTATE_GLAND_MORPHOGENESIS",25,-1.2481,0.16,0.3,0.988,0.45,0.99,1.5168,0.034,0.55
"GO_BP:948863_GO_0097581_LAMELLIPODIUM_ORGANIZATION","GO_BP","948863_GO_0097581_LAMELLIPODIUM_ORGANIZATION",38,-1.2481,0.15,0.3,0.9593,0.49,1,-0.5295,1,1
"REACTOME:1127676_REACT_263965_NORC_NEGATIVELY_REGULATES_RRNA_EXPRESSION","REACTOME","1127676_REACT_263965_NORC_NEGATIVELY_REGULATES_RRNA_EXPRESSION",102,-1.2481,0.1,0.33,-1.4121,0.03,0.5,-1.3582,0.044,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_1386_POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1386_POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP",46,-1.2481,0.16,0.22,-0.9357,0.57,1,-1.0408,0.38,0.7
"GO_BP:499611_GO_0030201_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS","GO_BP","499611_GO_0030201_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS",25,-1.2481,0.17,0.3,0.7162,0.88,1,-0.8772,0.66,0.94
"GO_BP:513807_GO_0060251_REGULATION_OF_GLIAL_CELL_PROLIFERATION","GO_BP","513807_GO_0060251_REGULATION_OF_GLIAL_CELL_PROLIFERATION",17,-1.248,0.18,0.3,-0.7955,0.78,1,0.6839,0.89,1
"GO_BP:487965_GO_0002076_OSTEOBLAST_DEVELOPMENT","GO_BP","487965_GO_0002076_OSTEOBLAST_DEVELOPMENT",18,-1.248,0.18,0.3,0.5558,0.98,1,-0.9617,0.5,0.88
"C4_Cancer_modules:C4_CM_395_MODULE_500","C4_Cancer_modules","C4_CM_395_MODULE_500",27,-1.248,0.16,0.23,-0.5392,0.99,1,-0.9296,0.56,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_370_COLDREN_GEFITINIB_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_370_COLDREN_GEFITINIB_RESISTANCE_DN",225,-1.2479,0.058,0.22,0.9509,0.61,0.86,-1.0337,0.35,0.71
"GO_BP:489143_GO_0003351_EPITHELIAL_CILIUM_MOVEMENT","GO_BP","489143_GO_0003351_EPITHELIAL_CILIUM_MOVEMENT",18,-1.2477,0.19,0.3,-1.702,0.013,0.66,-1.2255,0.2,0.71
"C7_Immunologic_signatures:C7_ALL_1778_GSE7460_TREG_VS_TCONV_ACT_DN","C7_Immunologic_signatures","C7_ALL_1778_GSE7460_TREG_VS_TCONV_ACT_DN",193,-1.2477,0.077,0.13,0.8469,0.88,1,-0.9893,0.47,0.75
"GO_BP:517152_GO_0072236_METANEPHRIC_LOOP_OF_HENLE_DEVELOPMENT","GO_BP","517152_GO_0072236_METANEPHRIC_LOOP_OF_HENLE_DEVELOPMENT",5,-1.2477,0.2,0.3,-1.2541,0.19,0.91,0.6569,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1558_MA_MYELOID_DIFFERENTIATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1558_MA_MYELOID_DIFFERENTIATION_UP",38,-1.2476,0.17,0.22,0.6269,0.99,1,-1.0643,0.33,0.67
"KEGG_reaction:R01496_ACYL_COA_SPHINGOSINE_N_ACYLTRANSFERASE_ACYL_COA_SPHINGOSINE_COA_N_ACYLSPHINGOSINE","KEGG_reaction","R01496_ACYL_COA_SPHINGOSINE_N_ACYLTRANSFERASE_ACYL_COA_SPHINGOSINE_COA_N_ACYLSPHINGOSINE",6,-1.2475,0.22,0.31,-1.3428,0.14,0.34,-1.3183,0.16,0.47
"C7_Immunologic_signatures:C7_ALL_664_GSE17721_LPS_VS_CPG_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_664_GSE17721_LPS_VS_CPG_8H_BMDM_DN",199,-1.2475,0.079,0.13,1.2565,0.054,0.15,-1.1114,0.19,0.47
"C7_Immunologic_signatures:C7_ALL_1843_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP","C7_Immunologic_signatures","C7_ALL_1843_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP",200,-1.2475,0.072,0.13,1.5818,0,0.0041,-0.8854,0.8,0.97
"GO_CC:499967_GO_0030662_COATED_VESICLE_MEMBRANE","GO_CC","499967_GO_0030662_COATED_VESICLE_MEMBRANE",164,-1.2475,0.093,0.37,0.9279,0.66,0.86,0.9365,0.6,1
"GO_BP:509675_GO_0047496_VESICLE_TRANSPORT_ALONG_MICROTUBULE","GO_BP","509675_GO_0047496_VESICLE_TRANSPORT_ALONG_MICROTUBULE",17,-1.2474,0.19,0.3,0.7617,0.82,1,-0.6667,0.91,1
"C6_Oncogenic_signatures:C6_ALL_38_BCAT_100_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_38_BCAT_100_UP_V1_UP",45,-1.2474,0.13,0.13,-0.8356,0.77,0.98,1.5069,0.012,0.064
"GO_MF:489543_GO_0004075_BIOTIN_CARBOXYLASE_ACTIVITY","GO_MF","489543_GO_0004075_BIOTIN_CARBOXYLASE_ACTIVITY",6,-1.2473,0.19,0.35,-1.4924,0.057,0.57,-1.3829,0.12,0.52
"C3_TF_targets:C3_TFT_146_V_GRE_C","C3_TF_targets","C3_TFT_146_V_GRE_C",121,-1.2472,0.12,0.14,0.8742,0.76,1,-0.9287,0.65,0.89
"GO_BP:515168_GO_0070233_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS","GO_BP","515168_GO_0070233_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS",17,-1.2472,0.18,0.3,1.2022,0.2,0.78,-0.947,0.52,0.89
"GO_MF:489887_GO_0004550_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY","GO_MF","489887_GO_0004550_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY",18,-1.2471,0.17,0.35,-0.8315,0.66,1,-0.923,0.55,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_2316_ZHENG_IL22_SIGNALING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2316_ZHENG_IL22_SIGNALING_DN",37,-1.2469,0.16,0.22,-0.6316,0.98,1,-0.8054,0.79,0.95
"GO_BP:515165_GO_0070230_POSITIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS","GO_BP","515165_GO_0070230_POSITIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS",19,-1.2469,0.18,0.3,-0.6185,0.95,1,-0.8805,0.64,0.94
"GO_BP:499335_GO_0022417_PROTEIN_MATURATION_BY_PROTEIN_FOLDING","GO_BP","499335_GO_0022417_PROTEIN_MATURATION_BY_PROTEIN_FOLDING",9,-1.2468,0.21,0.3,-0.7005,0.85,1,-0.854,0.65,0.96
"GO_CC:486673_GO_0000137_GOLGI_CIS_CISTERNA","GO_CC","486673_GO_0000137_GOLGI_CIS_CISTERNA",6,-1.2468,0.2,0.37,0.684,0.86,0.98,-1.3564,0.16,0.61
"C7_Immunologic_signatures:C7_ALL_929_GSE22886_NAIVE_TCELL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_929_GSE22886_NAIVE_TCELL_VS_NKCELL_UP",195,-1.2467,0.08,0.13,2.0404,0,0,-1.3905,0.008,0.067
"GO_BP:497082_GO_0018107_PEPTIDYL_THREONINE_PHOSPHORYLATION","GO_BP","497082_GO_0018107_PEPTIDYL_THREONINE_PHOSPHORYLATION",42,-1.2466,0.16,0.3,-0.8244,0.77,1,-1.1175,0.28,0.76
"C7_Immunologic_signatures:C7_ALL_1560_GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1560_GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN",196,-1.2466,0.084,0.13,0.8642,0.86,1,-0.78,0.98,1
"GO_BP:513626_GO_0060068_VAGINA_DEVELOPMENT","GO_BP","513626_GO_0060068_VAGINA_DEVELOPMENT",11,-1.2466,0.19,0.3,-0.7564,0.81,1,1.1758,0.24,0.72
"GO_MF:489469_GO_0003997_ACYL_COA_OXIDASE_ACTIVITY","GO_MF","489469_GO_0003997_ACYL_COA_OXIDASE_ACTIVITY",6,-1.2465,0.21,0.35,0.9165,0.58,0.97,-1.4444,0.087,0.44
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_88_BIOCARTA_P53HYPOXIA_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_88_BIOCARTA_P53HYPOXIA_PATHWAY",22,-1.2465,0.18,0.3,-0.8677,0.64,1,-1.1965,0.2,0.57
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_121_BIOCARTA_PITX2_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_121_BIOCARTA_PITX2_PATHWAY",15,-1.2464,0.19,0.3,-0.7027,0.88,1,-0.9142,0.58,0.85
"GO_BP:515758_GO_0070830_TIGHT_JUNCTION_ASSEMBLY","GO_BP","515758_GO_0070830_TIGHT_JUNCTION_ASSEMBLY",37,-1.2462,0.16,0.3,-1.2082,0.18,0.88,-0.7165,0.9,0.99
"GO_BP:492102_GO_0007338_SINGLE_FERTILIZATION","GO_BP","492102_GO_0007338_SINGLE_FERTILIZATION",99,-1.2461,0.12,0.3,-0.9471,0.58,1,-0.966,0.52,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1523_KANG_IMMORTALIZED_BY_TERT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1523_KANG_IMMORTALIZED_BY_TERT_UP",86,-1.2461,0.13,0.23,-0.7229,0.94,1,1.0021,0.45,0.96
"C3_TF_targets:C3_TFT_163_V_MEF2_02","C3_TF_targets","C3_TFT_163_V_MEF2_02",223,-1.2459,0.074,0.14,-1.5459,0,0.14,-1.4022,0.0063,0.28
"REACTOME:530758_REACT_115574_ALPHA_DEFENSINS","REACTOME","530758_REACT_115574_ALPHA_DEFENSINS",9,-1.2459,0.2,0.34,1.503,0.055,0.15,1.6682,0.029,0.44
"GO_MF:499879_GO_0030553_CGMP_BINDING","GO_MF","499879_GO_0030553_CGMP_BINDING",17,-1.2457,0.17,0.35,0.9111,0.57,0.98,1.7507,0.002,0.16
"GO_BP:488701_GO_0002828_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE","GO_BP","488701_GO_0002828_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE",22,-1.2457,0.18,0.3,1.1838,0.24,0.8,-1.2817,0.14,0.65
"C3_TF_targets:C3_TFT_218_V_GATA1_05","C3_TF_targets","C3_TFT_218_V_GATA1_05",269,-1.2456,0.051,0.14,0.945,0.64,1,0.9258,0.69,1
"GO_BP:506941_GO_0043921_MODULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION","GO_BP","506941_GO_0043921_MODULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION",22,-1.2456,0.18,0.3,0.8544,0.68,1,-1.0096,0.44,0.84
"C3_TF_targets:C3_TFT_75_V_TAXCREB_01","C3_TF_targets","C3_TFT_75_V_TAXCREB_01",136,-1.2456,0.11,0.14,0.7442,0.97,1,-0.6993,0.99,1
"C7_Immunologic_signatures:C7_ALL_1461_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP","C7_Immunologic_signatures","C7_ALL_1461_GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP",194,-1.2455,0.077,0.13,0.9436,0.6,0.92,-0.801,0.97,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_185_BIOCARTA_PTC1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_185_BIOCARTA_PTC1_PATHWAY",10,-1.2455,0.2,0.3,-0.5666,0.97,1,-0.9286,0.54,0.84
"REACTOME:771571_REACT_160122_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7","REACTOME","771571_REACT_160122_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7",7,-1.2454,0.22,0.34,-1.0772,0.37,0.9,-1.1753,0.25,0.63
"C7_Immunologic_signatures:C7_ALL_757_GSE17721_0_5H_VS_8H_GARDIQUIMOD_BMDM_UP","C7_Immunologic_signatures","C7_ALL_757_GSE17721_0_5H_VS_8H_GARDIQUIMOD_BMDM_UP",200,-1.2453,0.071,0.13,1.3207,0.029,0.084,-1.2647,0.055,0.18
"C4_Cancer_gene_neighborhoods:C4_CGN_426_GNF2_VAV1","C4_Cancer_gene_neighborhoods","C4_CGN_426_GNF2_VAV1",36,-1.2453,0.16,0.28,1.0831,0.31,0.4,-1.2405,0.16,0.38
"GO_BP:512524_GO_0051648_VESICLE_LOCALIZATION","GO_BP","512524_GO_0051648_VESICLE_LOCALIZATION",197,-1.2453,0.064,0.3,1.1601,0.12,0.83,-0.9387,0.65,0.9
"GO_BP:492106_GO_0007342_FUSION_OF_SPERM_TO_EGG_PLASMA_MEMBRANE","GO_BP","492106_GO_0007342_FUSION_OF_SPERM_TO_EGG_PLASMA_MEMBRANE",10,-1.2452,0.19,0.3,0.9661,0.49,1,-1.3208,0.14,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1394_LEE_LIVER_CANCER_DENA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1394_LEE_LIVER_CANCER_DENA_DN",70,-1.2451,0.12,0.23,-0.8171,0.8,1,-1.1556,0.2,0.57
"GO_BP:755347_GO_2001241_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND","GO_BP","755347_GO_2001241_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND",15,-1.2451,0.18,0.3,-0.851,0.69,1,-1.1533,0.26,0.73
"KEGG_compound:C00328_L_KYNURENINE_3_ANTHRANILOYL_L_ALANINE","KEGG_compound","C00328_L_KYNURENINE_3_ANTHRANILOYL_L_ALANINE",6,-1.2451,0.24,0.34,-1.4692,0.069,0.34,-1.4864,0.066,0.24
"C7_Immunologic_signatures:C7_ALL_1780_GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN","C7_Immunologic_signatures","C7_ALL_1780_GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN",191,-1.2451,0.086,0.13,1.0526,0.31,0.58,-1.0265,0.39,0.67
"GO_BP:514871_GO_0061326_RENAL_TUBULE_DEVELOPMENT","GO_BP","514871_GO_0061326_RENAL_TUBULE_DEVELOPMENT",78,-1.245,0.13,0.3,-1.0081,0.48,0.98,0.9251,0.6,0.92
"GO_BP:498826_GO_0021542_DENTATE_GYRUS_DEVELOPMENT","GO_BP","498826_GO_0021542_DENTATE_GYRUS_DEVELOPMENT",13,-1.245,0.18,0.3,-0.6771,0.9,1,-0.9643,0.51,0.88
"C4_Cancer_gene_neighborhoods:C4_CGN_114_MORF_IL16","C4_Cancer_gene_neighborhoods","C4_CGN_114_MORF_IL16",232,-1.245,0.066,0.27,-1.0671,0.31,0.74,-0.805,0.97,1
"GO_MF:491973_GO_0030971_RECEPTOR_TYROSINE_KINASE_BINDING","GO_MF","491973_GO_0030971_RECEPTOR_TYROSINE_KINASE_BINDING",44,-1.2449,0.15,0.35,-0.9903,0.46,0.92,-1.2403,0.14,0.6
"C3_MicroRNA_targets:C3_MIR_125_ATGTCAC_MIR_489","C3_MicroRNA_targets","C3_MIR_125_ATGTCAC_MIR_489",87,-1.2447,0.12,0.28,-1.0001,0.45,1,-0.843,0.8,1
"GO_BP:506678_GO_0043648_DICARBOXYLIC_ACID_METABOLIC_PROCESS","GO_BP","506678_GO_0043648_DICARBOXYLIC_ACID_METABOLIC_PROCESS",86,-1.2447,0.12,0.31,1.1159,0.22,0.88,-1.1919,0.14,0.74
"GO_BP:505233_GO_0042044_FLUID_TRANSPORT","GO_BP","505233_GO_0042044_FLUID_TRANSPORT",45,-1.2447,0.15,0.31,1.004,0.45,0.98,0.7926,0.84,1
"REACTOME:106512_REACT_11065_BETA_CATENIN_PHOSPHORYLATION_CASCADE","REACTOME","106512_REACT_11065_BETA_CATENIN_PHOSPHORYLATION_CASCADE",17,-1.2447,0.17,0.34,0.6891,0.89,1,-1.1469,0.29,0.66
"KEGG_compound:C06205_1_2_DIHYDRONAPHTHALENE_1_2_DIOL","KEGG_compound","C06205_1_2_DIHYDRONAPHTHALENE_1_2_DIOL",5,-1.2446,0.19,0.34,-0.7732,0.75,1,-0.8295,0.66,0.82
"GO_BP:513798_GO_0060242_CONTACT_INHIBITION","GO_BP","513798_GO_0060242_CONTACT_INHIBITION",8,-1.2445,0.21,0.31,0.6924,0.87,1,-1.304,0.18,0.65
"C7_Immunologic_signatures:C7_ALL_35_GSE10239_MEMORY_VS_DAY4_5_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_35_GSE10239_MEMORY_VS_DAY4_5_EFF_CD8_TCELL_UP",197,-1.2445,0.077,0.13,-0.7975,0.94,1,-0.8795,0.8,0.98
"GO_BP:754957_GO_2000851_POSITIVE_REGULATION_OF_GLUCOCORTICOID_SECRETION","GO_BP","754957_GO_2000851_POSITIVE_REGULATION_OF_GLUCOCORTICOID_SECRETION",5,-1.2445,0.2,0.31,1.3027,0.19,0.66,-0.7737,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_718_FARMER_BREAST_CANCER_CLUSTER_7","C2_Chemical_and_genetic_perturbations","C2_CGP_718_FARMER_BREAST_CANCER_CLUSTER_7",20,-1.2444,0.19,0.23,-1.0823,0.35,0.94,-0.6384,0.95,0.99
"GO_BP:519395_GO_2000756_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION","GO_BP","519395_GO_2000756_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION",46,-1.2443,0.16,0.31,-0.7812,0.84,1,-1.5507,0.02,0.52
"C3_TF_targets:C3_TFT_225_V_HOXA3_01","C3_TF_targets","C3_TFT_225_V_HOXA3_01",13,-1.2442,0.19,0.14,-0.8242,0.69,1,0.5991,0.94,1
"GO_BP:512577_GO_0051702_INTERACTION_WITH_SYMBIONT","GO_BP","512577_GO_0051702_INTERACTION_WITH_SYMBIONT",44,-1.2442,0.17,0.31,1.1767,0.2,0.81,-0.7769,0.85,1
"C6_Oncogenic_signatures:C6_ALL_149_HOXA9_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_149_HOXA9_DN_V1_DN",188,-1.2441,0.082,0.13,0.7428,0.98,0.97,-1.1482,0.16,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_2021_MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2021_MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN",370,-1.2441,0.047,0.23,0.9184,0.79,0.9,-1.0989,0.16,0.63
"REACTOME:119532_REACT_19331_CELL_CELL_JUNCTION_ORGANIZATION","REACTOME","119532_REACT_19331_CELL_CELL_JUNCTION_ORGANIZATION",58,-1.2441,0.16,0.34,-0.9726,0.51,1,1.3136,0.075,0.76
"GO_BP:501609_GO_0032374_REGULATION_OF_CHOLESTEROL_TRANSPORT","GO_BP","501609_GO_0032374_REGULATION_OF_CHOLESTEROL_TRANSPORT",34,-1.244,0.16,0.31,0.9823,0.46,1,1.0561,0.36,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_3101_OHGUCHI_LIVER_HNF4A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3101_OHGUCHI_LIVER_HNF4A_TARGETS_DN",145,-1.244,0.096,0.23,-1.285,0.061,0.7,-1.1295,0.19,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2237_MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2237_MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN",58,-1.244,0.13,0.23,0.7453,0.92,1,-1.1802,0.2,0.54
"REACTOME:645289_REACT_121139_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES","REACTOME","645289_REACT_121139_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES",64,-1.244,0.13,0.34,-1.391,0.05,0.54,1.1284,0.23,0.91
"GO_BP:496525_GO_0016577_HISTONE_DEMETHYLATION","GO_BP","496525_GO_0016577_HISTONE_DEMETHYLATION",35,-1.2439,0.15,0.31,-1.598,0.013,0.69,-0.9004,0.61,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_2091_STEIN_ESRRA_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2091_STEIN_ESRRA_TARGETS_UP",387,-1.2439,0.044,0.23,1.2123,0.026,0.48,-1.1688,0.07,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_751_XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR","C2_Chemical_and_genetic_perturbations","C2_CGP_751_XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR",19,-1.2437,0.18,0.23,-1.0834,0.35,0.94,-1.0866,0.34,0.65
"GO_BP:492283_GO_0007530_SEX_DETERMINATION","GO_BP","492283_GO_0007530_SEX_DETERMINATION",22,-1.2436,0.19,0.31,-1.7006,0.0075,0.66,-1.2464,0.18,0.68
"GO_BP:510791_GO_0048736_APPENDAGE_DEVELOPMENT","GO_BP","510791_GO_0048736_APPENDAGE_DEVELOPMENT",168,-1.2436,0.087,0.31,-1.0298,0.38,0.97,1.1623,0.13,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2997_HOFFMAN_CLOCK_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2997_HOFFMAN_CLOCK_TARGETS_UP",11,-1.2434,0.19,0.23,0.781,0.76,1,-0.8622,0.65,0.91
"KEGG_pathway:HSA05010_ALZHEIMER_S_DISEASE","KEGG_pathway","HSA05010_ALZHEIMER_S_DISEASE",158,-1.2433,0.1,0.18,2.0308,0,0.0013,0.6349,1,1
"OMIM_gene:OMIM148069_KERATIN_17_KRT17","OMIM_gene","OMIM148069_KERATIN_17_KRT17",5,-1.2432,0.21,0.91,0.563,0.94,1,-0.8795,0.62,0.92
"GO_BP:510615_GO_0048548_REGULATION_OF_PINOCYTOSIS","GO_BP","510615_GO_0048548_REGULATION_OF_PINOCYTOSIS",8,-1.243,0.22,0.31,-0.6093,0.93,1,0.955,0.53,0.9
"GO_BP:517020_GO_0072104_GLOMERULAR_CAPILLARY_FORMATION","GO_BP","517020_GO_0072104_GLOMERULAR_CAPILLARY_FORMATION",5,-1.243,0.2,0.31,-1.2973,0.18,0.89,1.5232,0.027,0.54
"C1_Positional:C1_ALL_304_CHR12Q11","C1_Positional","C1_ALL_304_CHR12Q11",8,-1.243,0.22,0.77,1.0946,0.36,0.64,-0.5998,0.93,1
"KEGG_compound:C02305_PHOSPHOCREATINE_N_PHOSPHOCREATINE_CREATINE_PHOSPHATE","KEGG_compound","C02305_PHOSPHOCREATINE_N_PHOSPHOCREATINE_CREATINE_PHOSPHATE",5,-1.243,0.22,0.34,-1.0219,0.47,1,1.143,0.32,0.63
"REACTOME:105726_REACT_6946_METHYLATION","REACTOME","105726_REACT_6946_METHYLATION",10,-1.2429,0.2,0.34,0.7902,0.74,1,-1.043,0.4,0.79
"REACTOME:106340_REACT_12579_SHC1_EVENTS_IN_EGFR_SIGNALING","REACTOME","106340_REACT_12579_SHC1_EVENTS_IN_EGFR_SIGNALING",22,-1.2429,0.16,0.34,0.7042,0.93,1,-0.9069,0.57,0.95
"C4_Cancer_gene_neighborhoods:C4_CGN_410_GNF2_SPINK1","C4_Cancer_gene_neighborhoods","C4_CGN_410_GNF2_SPINK1",21,-1.2429,0.18,0.28,1.5518,0.042,0.022,1.5073,0.042,0.19
"GO_BP:510222_GO_0048066_DEVELOPMENTAL_PIGMENTATION","GO_BP","510222_GO_0048066_DEVELOPMENTAL_PIGMENTATION",41,-1.2428,0.18,0.31,1.1617,0.2,0.82,0.9721,0.49,0.89
"GO_BP:488830_GO_0003032_DETECTION_OF_OXYGEN","GO_BP","488830_GO_0003032_DETECTION_OF_OXYGEN",5,-1.2428,0.21,0.31,-0.5831,0.93,1,0.627,0.9,1
"C7_Immunologic_signatures:C7_ALL_1255_GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1255_GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP",177,-1.2428,0.073,0.13,1.4942,0,0.014,1.4799,0,0.056
"C7_Immunologic_signatures:C7_ALL_1091_GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1091_GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP",181,-1.2428,0.086,0.13,-1.0167,0.4,1,-1.3789,0.018,0.074
"GO_BP:505819_GO_0042711_MATERNAL_BEHAVIOR","GO_BP","505819_GO_0042711_MATERNAL_BEHAVIOR",13,-1.2428,0.21,0.31,0.7319,0.8,1,-1.3178,0.13,0.63
"C7_Immunologic_signatures:C7_ALL_745_GSE17721_0_5H_VS_8H_CPG_BMDM_UP","C7_Immunologic_signatures","C7_ALL_745_GSE17721_0_5H_VS_8H_CPG_BMDM_UP",200,-1.2427,0.087,0.13,1.0986,0.22,0.45,-1.0855,0.26,0.53
"C3_TF_targets:C3_TFT_355_V_TCF4_Q5","C3_TF_targets","C3_TFT_355_V_TCF4_Q5",231,-1.2426,0.05,0.14,0.9582,0.59,1,0.9712,0.53,1
"KEGG_compound:C00267_ALPHA_D_GLUCOSE","KEGG_compound","C00267_ALPHA_D_GLUCOSE",19,-1.2426,0.18,0.34,-0.9624,0.51,1,-1.2846,0.15,0.37
"WikiPathways:198801_WP34_OVARIAN_INFERTILITY_GENES","WikiPathways","198801_WP34_OVARIAN_INFERTILITY_GENES",32,-1.2424,0.16,0.25,-0.8693,0.68,1,1.2038,0.19,0.65
"KEGG_compound:C06899_CHLORAL_HYDRATE","KEGG_compound","C06899_CHLORAL_HYDRATE",11,-1.2423,0.2,0.34,1.2245,0.21,0.86,-1.1088,0.31,0.53
"C7_Immunologic_signatures:C7_ALL_650_GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_650_GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDM_DN",198,-1.2423,0.083,0.13,1.5445,0,0.0066,-0.9044,0.75,0.94
"C7_Immunologic_signatures:C7_ALL_639_GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_639_GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDM_UP",193,-1.2423,0.07,0.13,-0.993,0.48,1,0.9276,0.69,1
"C7_Immunologic_signatures:C7_ALL_1755_GSE6269_E_COLI_VS_STREP_AUREUS_INF_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1755_GSE6269_E_COLI_VS_STREP_AUREUS_INF_PBMC_UP",157,-1.2423,0.076,0.13,0.9294,0.68,0.96,-1.5153,0,0.018
"C2_Chemical_and_genetic_perturbations:C2_CGP_1719_NIELSEN_LIPOSARCOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1719_NIELSEN_LIPOSARCOMA_DN",19,-1.2422,0.2,0.23,-1.1788,0.23,0.82,-0.9808,0.51,0.78
"C4_Cancer_modules:C4_CM_299_MODULE_343","C4_Cancer_modules","C4_CM_299_MODULE_343",24,-1.242,0.19,0.23,1.1407,0.28,0.47,-1.4297,0.068,0.21
"C4_Cancer_modules:C4_CM_266_MODULE_303","C4_Cancer_modules","C4_CM_266_MODULE_303",28,-1.242,0.19,0.23,-0.6504,0.93,1,-1.5561,0.023,0.12
"C2_Chemical_and_genetic_perturbations:C2_CGP_1776_MACLACHLAN_BRCA1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1776_MACLACHLAN_BRCA1_TARGETS_UP",21,-1.2419,0.19,0.23,1.2073,0.21,0.48,1.051,0.38,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_81_TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_81_TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN",7,-1.2419,0.22,0.23,-0.8674,0.63,1,-1.0093,0.46,0.74
"REACTOME:105733_REACT_6812_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE","REACTOME","105733_REACT_6812_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE",8,-1.2419,0.21,0.34,-1.3708,0.11,0.56,0.9719,0.49,1
"GO_BP:500133_GO_0030835_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION","GO_BP","500133_GO_0030835_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION",35,-1.2418,0.17,0.31,-1.0963,0.3,0.95,-1.37,0.072,0.58
"C7_Immunologic_signatures:C7_ALL_1379_GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP","C7_Immunologic_signatures","C7_ALL_1379_GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP",199,-1.2416,0.081,0.13,1.4189,0.0094,0.032,-0.9172,0.71,0.92
"GO_BP:753022_GO_1900025_NEGATIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING","GO_BP","753022_GO_1900025_NEGATIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING",7,-1.2416,0.22,0.31,-0.6515,0.89,1,-0.5739,0.96,1
"GO_CC:505725_GO_0042599_LAMELLAR_BODY","GO_CC","505725_GO_0042599_LAMELLAR_BODY",11,-1.2415,0.21,0.38,0.8196,0.69,0.94,-1.0966,0.33,0.92
"GO_BP:508100_GO_0045763_NEGATIVE_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS","GO_BP","508100_GO_0045763_NEGATIVE_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS",79,-1.2414,0.13,0.31,1.0419,0.4,0.96,0.791,0.88,1
"GO_BP:508757_GO_0046498_S_ADENOSYLHOMOCYSTEINE_METABOLIC_PROCESS","GO_BP","508757_GO_0046498_S_ADENOSYLHOMOCYSTEINE_METABOLIC_PROCESS",9,-1.2414,0.19,0.31,-1.348,0.15,0.92,-1.2115,0.22,0.72
"GO_MF:498782_GO_0020037_HEME_BINDING","GO_MF","498782_GO_0020037_HEME_BINDING",130,-1.2413,0.12,0.36,1.2011,0.13,0.7,-1.1961,0.12,0.6
"C7_Immunologic_signatures:C7_ALL_733_GSE17721_0_5H_VS_8H_PAM3CSK4_BMDM_UP","C7_Immunologic_signatures","C7_ALL_733_GSE17721_0_5H_VS_8H_PAM3CSK4_BMDM_UP",198,-1.2413,0.084,0.13,1.4205,0.0049,0.031,-1.1545,0.14,0.36
"GO_BP:513977_GO_0060421_POSITIVE_REGULATION_OF_HEART_GROWTH","GO_BP","513977_GO_0060421_POSITIVE_REGULATION_OF_HEART_GROWTH",25,-1.2413,0.17,0.31,0.6955,0.92,1,1.0565,0.37,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2974_ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE","C2_Chemical_and_genetic_perturbations","C2_CGP_2974_ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE",17,-1.2413,0.19,0.23,-1.27,0.18,0.71,-1.4667,0.074,0.31
"REACTOME:105979_REACT_15525_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY","REACTOME","105979_REACT_15525_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY",50,-1.2413,0.15,0.34,-1.124,0.27,0.9,-0.9013,0.64,0.95
"C7_Immunologic_signatures:C7_ALL_1602_GSE3982_EOSINOPHIL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1602_GSE3982_EOSINOPHIL_VS_NKCELL_DN",196,-1.2412,0.08,0.13,1.3806,0.0066,0.045,-1.3663,0.0084,0.084
"C2_Chemical_and_genetic_perturbations:C2_CGP_1464_HEDVAT_ELF4_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1464_HEDVAT_ELF4_TARGETS_UP",12,-1.2412,0.21,0.23,-0.4471,0.99,1,-1.3125,0.15,0.42
"GO_BP:509090_GO_0046874_QUINOLINATE_METABOLIC_PROCESS","GO_BP","509090_GO_0046874_QUINOLINATE_METABOLIC_PROCESS",6,-1.2411,0.23,0.31,1.0669,0.4,0.93,-0.8348,0.68,0.97
"OMIM_gene:OMIM605126_FOUR_AND_A_HALF_LIM_DOMAINS_5_FHL5","OMIM_gene","OMIM605126_FOUR_AND_A_HALF_LIM_DOMAINS_5_FHL5",8,-1.241,0.21,0.85,1.3121,0.15,0.79,1.043,0.38,0.95
"GO_MF:495462_GO_0015194_L_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495462_GO_0015194_L_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-1.241,0.2,0.36,0.9905,0.46,0.88,0.6669,0.86,1
"GO_BP:496030_GO_0015908_FATTY_ACID_TRANSPORT","GO_BP","496030_GO_0015908_FATTY_ACID_TRANSPORT",48,-1.2409,0.14,0.31,0.7257,0.93,1,1.1971,0.18,0.72
"REACTOME:187217_REACT_23878_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE","REACTOME","187217_REACT_23878_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE",13,-1.2409,0.2,0.34,0.6105,0.94,1,-1.1408,0.29,0.66
"GO_BP:511804_GO_0050861_POSITIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY","GO_BP","511804_GO_0050861_POSITIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY",5,-1.2408,0.2,0.31,-0.8226,0.68,1,-0.74,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1748_KAAB_FAILED_HEART_ATRIUM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1748_KAAB_FAILED_HEART_ATRIUM_UP",38,-1.2408,0.16,0.23,-0.9097,0.59,1,1.0844,0.32,0.88
"GO_CC:502337_GO_0033116_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE","GO_CC","502337_GO_0033116_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE",37,-1.2407,0.17,0.38,1.2422,0.15,0.47,-1.1,0.31,0.93
"WikiPathways:198891_WP268_NOTCH_SIGNALING_PATHWAY","WikiPathways","198891_WP268_NOTCH_SIGNALING_PATHWAY",46,-1.2407,0.15,0.25,-1.263,0.12,0.93,-0.6369,0.99,0.99
"REACTOME:1127537_REACT_264256_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL","REACTOME","1127537_REACT_264256_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL",7,-1.2407,0.21,0.34,-1.0501,0.38,0.94,-1.2977,0.16,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_2780_GLINSKY_CANCER_DEATH_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2780_GLINSKY_CANCER_DEATH_UP",6,-1.2407,0.22,0.23,-0.4198,1,1,-0.976,0.5,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_1918_VARELA_ZMPSTE24_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1918_VARELA_ZMPSTE24_TARGETS_UP",40,-1.2406,0.18,0.23,-1.0254,0.42,0.98,0.7542,0.87,1
"REACTOME:106126_REACT_735_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA","REACTOME","106126_REACT_735_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA",5,-1.2405,0.2,0.34,0.9564,0.52,0.82,-1.2873,0.16,0.54
"C4_Cancer_modules:C4_CM_272_MODULE_311","C4_Cancer_modules","C4_CM_272_MODULE_311",18,-1.2404,0.18,0.23,1.9164,0.0041,0.0074,1.3344,0.1,0.4
"GO_BP:504454_GO_0035270_ENDOCRINE_SYSTEM_DEVELOPMENT","GO_BP","504454_GO_0035270_ENDOCRINE_SYSTEM_DEVELOPMENT",122,-1.2404,0.11,0.31,1.098,0.25,0.9,1.46,0.012,0.59
"C7_Immunologic_signatures:C7_ALL_374_GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN","C7_Immunologic_signatures","C7_ALL_374_GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN",194,-1.2403,0.073,0.13,1.2381,0.047,0.17,0.9652,0.56,1
"C4_Cancer_gene_neighborhoods:C4_CGN_68_MORF_CAMK4","C4_Cancer_gene_neighborhoods","C4_CGN_68_MORF_CAMK4",281,-1.2402,0.061,0.28,-0.9573,0.59,0.9,1.2936,0.014,0.3
"GO_CC:504184_GO_0034993_LINC_COMPLEX","GO_CC","504184_GO_0034993_LINC_COMPLEX",7,-1.2402,0.2,0.38,-0.9439,0.53,0.9,-1.3737,0.13,0.61
"GO_BP:513981_GO_0060426_LUNG_VASCULATURE_DEVELOPMENT","GO_BP","513981_GO_0060426_LUNG_VASCULATURE_DEVELOPMENT",8,-1.2401,0.2,0.31,-1.2724,0.18,0.89,1.3117,0.16,0.66
"GO_BP:510620_GO_0048553_NEGATIVE_REGULATION_OF_METALLOENZYME_ACTIVITY","GO_BP","510620_GO_0048553_NEGATIVE_REGULATION_OF_METALLOENZYME_ACTIVITY",6,-1.2401,0.21,0.31,-0.6437,0.88,1,0.7195,0.81,1
"GO_BP:754183_GO_1901216_POSITIVE_REGULATION_OF_NEURON_DEATH","GO_BP","754183_GO_1901216_POSITIVE_REGULATION_OF_NEURON_DEATH",58,-1.24,0.15,0.31,-0.976,0.48,1,-0.9636,0.51,0.88
"C7_Immunologic_signatures:C7_ALL_1469_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP","C7_Immunologic_signatures","C7_ALL_1469_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP",195,-1.2399,0.078,0.13,0.9069,0.74,1,-0.905,0.72,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_1282_LEI_HOXC8_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1282_LEI_HOXC8_TARGETS_DN",16,-1.2399,0.2,0.23,-0.7943,0.75,1,-1.4602,0.055,0.31
"GO_BP:516790_GO_0071869_RESPONSE_TO_CATECHOLAMINE","GO_BP","516790_GO_0071869_RESPONSE_TO_CATECHOLAMINE",26,-1.2397,0.19,0.31,-0.799,0.79,1,0.8827,0.64,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2426_ALONSO_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2426_ALONSO_METASTASIS_UP",196,-1.2397,0.084,0.23,2.1399,0,0.0013,0.9758,0.53,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2066_GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2066_GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP",19,-1.2397,0.2,0.23,0.5585,0.98,1,-0.7608,0.8,0.97
"GO_BP:499859_GO_0030520_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","499859_GO_0030520_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY",22,-1.2397,0.19,0.31,-0.7462,0.84,1,-0.7875,0.79,0.99
"GO_BP:502758_GO_0033540_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_OXIDASE","GO_BP","502758_GO_0033540_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_OXIDASE",11,-1.2396,0.19,0.31,1.0325,0.39,0.96,-1.5313,0.055,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_835_YAN_ESCAPE_FROM_ANOIKIS","C2_Chemical_and_genetic_perturbations","C2_CGP_835_YAN_ESCAPE_FROM_ANOIKIS",23,-1.2394,0.18,0.23,0.9656,0.51,0.84,-1.1557,0.25,0.57
"GO_BP:496307_GO_0016241_REGULATION_OF_MACROAUTOPHAGY","GO_BP","496307_GO_0016241_REGULATION_OF_MACROAUTOPHAGY",39,-1.2394,0.17,0.31,0.6626,0.97,1,-0.7321,0.88,0.99
"C7_Immunologic_signatures:C7_ALL_460_GSE17721_CTRL_VS_LPS_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_460_GSE17721_CTRL_VS_LPS_12H_BMDM_DN",197,-1.2394,0.082,0.14,1.0753,0.26,0.51,0.796,0.95,1
"GO_BP:516422_GO_0071498_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS","GO_BP","516422_GO_0071498_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS",14,-1.2393,0.22,0.31,0.3678,1,1,-0.774,0.8,1
"KEGG_compound:C14850_BENZO_A_PYRENE_7_8_OXIDE_BENZO_A_PYRENE_7_8_EPOXIDE","KEGG_compound","C14850_BENZO_A_PYRENE_7_8_OXIDE_BENZO_A_PYRENE_7_8_EPOXIDE",5,-1.2393,0.22,0.34,-1.4937,0.046,0.3,-0.8731,0.6,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2421_BLUM_RESPONSE_TO_SALIRASIB_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2421_BLUM_RESPONSE_TO_SALIRASIB_DN",341,-1.2393,0.041,0.23,0.9233,0.74,0.9,-1.7376,0,0.16
"REACTOME:906028_REACT_169333_TRP_CHANNELS","REACTOME","906028_REACT_169333_TRP_CHANNELS",25,-1.2393,0.17,0.34,-1.5181,0.026,0.43,-1.0361,0.4,0.8
"C4_Cancer_gene_neighborhoods:C4_CGN_96_MORF_ERCC4","C4_Cancer_gene_neighborhoods","C4_CGN_96_MORF_ERCC4",312,-1.2392,0.05,0.28,-1.0392,0.35,0.8,1.0486,0.31,0.68
"GO_BP:504905_GO_0035728_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR","GO_BP","504905_GO_0035728_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR",7,-1.2391,0.22,0.31,-0.5965,0.92,1,-1.0857,0.36,0.79
"GO_BP:517019_GO_0072103_GLOMERULUS_VASCULATURE_MORPHOGENESIS","GO_BP","517019_GO_0072103_GLOMERULUS_VASCULATURE_MORPHOGENESIS",5,-1.2391,0.22,0.31,-1.3266,0.16,0.9,1.5726,0.028,0.47
"GO_MF:498631_GO_0019840_ISOPRENOID_BINDING","GO_MF","498631_GO_0019840_ISOPRENOID_BINDING",40,-1.2391,0.16,0.36,1.2671,0.12,0.64,1.8307,0,0.098
"C2_Chemical_and_genetic_perturbations:C2_CGP_907_KREPPEL_CD99_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_907_KREPPEL_CD99_TARGETS_UP",5,-1.2391,0.22,0.23,0.544,0.98,1,-1.1398,0.34,0.59
"REACTOME:1127674_REACT_264000_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION","REACTOME","1127674_REACT_264000_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION",105,-1.239,0.11,0.34,-1.3906,0.033,0.53,-1.3621,0.026,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_2947_MOOTHA_FFA_OXYDATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2947_MOOTHA_FFA_OXYDATION",22,-1.2389,0.18,0.23,1.1183,0.31,0.6,-1.3761,0.081,0.38
"GO_BP:510630_GO_0048565_DIGESTIVE_TRACT_DEVELOPMENT","GO_BP","510630_GO_0048565_DIGESTIVE_TRACT_DEVELOPMENT",127,-1.2388,0.099,0.31,-1.0515,0.34,0.97,1.2392,0.087,0.71
"C7_Immunologic_signatures:C7_ALL_1012_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN","C7_Immunologic_signatures","C7_ALL_1012_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN",198,-1.2387,0.079,0.14,1.5506,0,0.0061,-1.0527,0.31,0.61
"C7_Immunologic_signatures:C7_ALL_1620_GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1620_GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN",190,-1.2387,0.085,0.14,-0.9487,0.59,1,-1.2388,0.056,0.21
"OMIM_gene:OMIM603079_CHROMOBOX_HOMOLOG_4_DROSOPHILA_POLYCOMB_CLASS_CBX4","OMIM_gene","OMIM603079_CHROMOBOX_HOMOLOG_4_DROSOPHILA_POLYCOMB_CLASS_CBX4",5,-1.2386,0.23,0.81,0.5712,0.95,1,-0.8937,0.6,0.94
"C1_Positional:C1_ALL_8_CHR10Q21","C1_Positional","C1_ALL_8_CHR10Q21",42,-1.2385,0.16,0.77,0.9332,0.57,0.82,1.1753,0.19,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_1470_PARK_HSC_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_1470_PARK_HSC_MARKERS",44,-1.2385,0.16,0.23,0.8251,0.8,0.98,-1.2276,0.15,0.5
"GO_BP:513915_GO_0060359_RESPONSE_TO_AMMONIUM_ION","GO_BP","513915_GO_0060359_RESPONSE_TO_AMMONIUM_ION",67,-1.2384,0.14,0.31,-1.0696,0.34,0.96,1.0941,0.29,0.77
"C7_Immunologic_signatures:C7_ALL_568_GSE17721_PAM3CSK4_VS_CPG_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_568_GSE17721_PAM3CSK4_VS_CPG_2H_BMDM_DN",194,-1.2384,0.087,0.14,0.9271,0.69,0.96,-0.9797,0.52,0.77
"GO_BP:504642_GO_0035458_CELLULAR_RESPONSE_TO_INTERFERON_BETA","GO_BP","504642_GO_0035458_CELLULAR_RESPONSE_TO_INTERFERON_BETA",13,-1.2384,0.2,0.31,-0.9134,0.58,1,-1.4151,0.069,0.57
"GO_BP:510795_GO_0048741_SKELETAL_MUSCLE_FIBER_DEVELOPMENT","GO_BP","510795_GO_0048741_SKELETAL_MUSCLE_FIBER_DEVELOPMENT",19,-1.2383,0.18,0.31,-1.3513,0.11,0.94,-1.6179,0.025,0.51
"C3_TF_targets:C3_TFT_278_V_AP2REP_01","C3_TF_targets","C3_TFT_278_V_AP2REP_01",176,-1.2383,0.091,0.15,-1.0991,0.26,0.55,-0.8561,0.85,0.97
"GO_BP:508431_GO_0046135_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS","GO_BP","508431_GO_0046135_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS",22,-1.238,0.18,0.31,-0.4267,1,1,-1.2479,0.17,0.68
"KEGG_compound:C00124_D_GALACTOSE_D_GALACTOPYRANOSE","KEGG_compound","C00124_D_GALACTOSE_D_GALACTOPYRANOSE",7,-1.238,0.2,0.34,-1.5893,0.024,0.17,-1.1544,0.29,0.5
"GO_MF:506577_GO_0043546_MOLYBDOPTERIN_COFACTOR_BINDING","GO_MF","506577_GO_0043546_MOLYBDOPTERIN_COFACTOR_BINDING",5,-1.238,0.22,0.36,-1.1729,0.28,0.78,-0.8404,0.65,0.93
"GO_BP:492105_GO_0007341_PENETRATION_OF_ZONA_PELLUCIDA","GO_BP","492105_GO_0007341_PENETRATION_OF_ZONA_PELLUCIDA",5,-1.2379,0.2,0.31,-0.5986,0.93,1,-1.1736,0.28,0.73
"GO_BP:498667_GO_0019884_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_ANTIGEN","GO_BP","498667_GO_0019884_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_ANTIGEN",175,-1.2379,0.085,0.31,1.5766,0.0023,0.32,-0.721,0.99,0.99
"GO_BP:504769_GO_0035590_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","504769_GO_0035590_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY",21,-1.2378,0.18,0.31,1.4609,0.051,0.48,1.0424,0.39,0.81
"KEGG_compound:C00151_L_AMINO_ACID_L_2_AMINO_ACID","KEGG_compound","C00151_L_AMINO_ACID_L_2_AMINO_ACID",5,-1.2378,0.22,0.34,-0.673,0.88,1,-0.7757,0.71,0.86
"GO_BP:487497_GO_0001558_REGULATION_OF_CELL_GROWTH","GO_BP","487497_GO_0001558_REGULATION_OF_CELL_GROWTH",328,-1.2378,0.053,0.31,-0.9719,0.55,1,0.9804,0.51,0.88
"GO_BP:518521_GO_0090381_REGULATION_OF_HEART_INDUCTION","GO_BP","518521_GO_0090381_REGULATION_OF_HEART_INDUCTION",6,-1.2377,0.22,0.31,0.9033,0.6,1,0.9751,0.5,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_771_WHITE_NEUROBLASTOMA_WITH_1P36_3_DELETION","C2_Chemical_and_genetic_perturbations","C2_CGP_771_WHITE_NEUROBLASTOMA_WITH_1P36_3_DELETION",21,-1.2376,0.19,0.23,-0.975,0.48,1,-1.4816,0.038,0.31
"GO_BP:491641_GO_0006767_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS","GO_BP","491641_GO_0006767_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS",90,-1.2376,0.13,0.31,-0.7375,0.95,1,-1.4887,0.0084,0.53
"GO_BP:496355_GO_0016311_DEPHOSPHORYLATION","GO_BP","496355_GO_0016311_DEPHOSPHORYLATION",270,-1.2376,0.062,0.31,0.8774,0.84,1,-0.9118,0.78,0.92
"GO_BP:492344_GO_0007603_PHOTOTRANSDUCTION_VISIBLE_LIGHT","GO_BP","492344_GO_0007603_PHOTOTRANSDUCTION_VISIBLE_LIGHT",95,-1.2375,0.13,0.31,-0.9016,0.69,1,-0.9865,0.49,0.86
"GO_CC:499555_GO_0030125_CLATHRIN_VESICLE_COAT","GO_CC","499555_GO_0030125_CLATHRIN_VESICLE_COAT",23,-1.2375,0.18,0.38,0.7123,0.88,0.99,-1.0521,0.36,0.98
"C4_Cancer_modules:C4_CM_81_MODULE_86","C4_Cancer_modules","C4_CM_81_MODULE_86",43,-1.2374,0.16,0.24,1.6797,0.0021,0.051,0.6566,0.97,1
"REACTOME:105811_REACT_15364_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES","REACTOME","105811_REACT_15364_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES",62,-1.2374,0.14,0.34,-0.8557,0.73,1,-1.8094,0,0.17
"GO_BP:777640_GO_1901983_REGULATION_OF_PROTEIN_ACETYLATION","GO_BP","777640_GO_1901983_REGULATION_OF_PROTEIN_ACETYLATION",52,-1.2374,0.14,0.31,0.8849,0.69,1,-1.4701,0.03,0.53
"GO_BP:507074_GO_0044058_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS","GO_BP","507074_GO_0044058_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS",26,-1.2374,0.17,0.31,-1.2418,0.17,0.91,-1.22,0.18,0.71
"GO_BP:488878_GO_0003081_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN","GO_BP","488878_GO_0003081_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN",23,-1.2374,0.18,0.31,1.0613,0.34,0.94,0.8335,0.73,0.99
"GO_BP:514395_GO_0060840_ARTERY_DEVELOPMENT","GO_BP","514395_GO_0060840_ARTERY_DEVELOPMENT",56,-1.2374,0.14,0.31,-0.653,0.98,1,1.7025,0,0.41
"C7_Immunologic_signatures:C7_ALL_218_GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_218_GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN",200,-1.2371,0.079,0.14,1.369,0.012,0.051,1.1983,0.089,0.72
"GO_BP:498566_GO_0019755_ONE_CARBON_COMPOUND_TRANSPORT","GO_BP","498566_GO_0019755_ONE_CARBON_COMPOUND_TRANSPORT",12,-1.2371,0.21,0.31,0.5896,0.96,1,-0.9965,0.46,0.85
"C7_Immunologic_signatures:C7_ALL_1389_GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP","C7_Immunologic_signatures","C7_ALL_1389_GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP",199,-1.237,0.079,0.14,1.4671,0,0.018,-1.0928,0.24,0.52
"GO_BP:492359_GO_0007618_MATING","GO_BP","492359_GO_0007618_MATING",38,-1.237,0.18,0.31,1.0051,0.46,0.98,1.2284,0.14,0.71
"C7_Immunologic_signatures:C7_ALL_1799_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP","C7_Immunologic_signatures","C7_ALL_1799_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP",192,-1.2369,0.09,0.14,0.7966,0.97,1,-1.1843,0.099,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_2535_MIZUKAMI_HYPOXIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2535_MIZUKAMI_HYPOXIA_UP",12,-1.2368,0.2,0.24,0.707,0.83,1,1.5237,0.057,0.48
"C6_Oncogenic_signatures:C6_ALL_122_RB_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_122_RB_DN_V1_UP",127,-1.2368,0.12,0.14,-1.2308,0.092,0.39,-1.1337,0.18,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_2368_CHO_NR4A1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2368_CHO_NR4A1_TARGETS",31,-1.2368,0.18,0.24,-1.0251,0.42,0.98,-0.8413,0.72,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_362_HAHTOLA_MYCOSIS_FUNGOIDES_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_362_HAHTOLA_MYCOSIS_FUNGOIDES_UP",18,-1.2367,0.21,0.24,0.8351,0.7,0.98,-0.7236,0.88,0.98
"GO_BP:494901_GO_0010837_REGULATION_OF_KERATINOCYTE_PROLIFERATION","GO_BP","494901_GO_0010837_REGULATION_OF_KERATINOCYTE_PROLIFERATION",23,-1.2366,0.19,0.31,-1.1767,0.22,0.9,-1.1678,0.24,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_819_SASAKI_TARGETS_OF_TP73_AND_TP63","C2_Chemical_and_genetic_perturbations","C2_CGP_819_SASAKI_TARGETS_OF_TP73_AND_TP63",11,-1.2366,0.18,0.24,0.7999,0.71,0.99,1.067,0.37,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_954_SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_954_SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER",86,-1.2365,0.13,0.24,-1.1728,0.17,0.82,1.0074,0.43,0.96
"KEGG_module:HSA_M00130_INOSITOL_PHOSPHATE_METABOLISM_PI_PIP2_INS_1_4_5_P3_INS_1_3_4_5_P4","KEGG_module","HSA_M00130_INOSITOL_PHOSPHATE_METABOLISM_PI_PIP2_INS_1_4_5_P3_INS_1_3_4_5_P4",22,-1.2365,0.17,0.49,-1.734,0,0.38,-0.7565,0.83,0.98
"GO_BP:512469_GO_0051591_RESPONSE_TO_CAMP","GO_BP","512469_GO_0051591_RESPONSE_TO_CAMP",94,-1.2364,0.12,0.31,1.084,0.3,0.92,0.8972,0.71,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1246_ZEILSTRA_CD44_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1246_ZEILSTRA_CD44_TARGETS_DN",7,-1.2364,0.23,0.24,-1.2709,0.19,0.71,-1.0363,0.41,0.71
"GO_BP:489307_GO_0042989_SEQUESTERING_OF_ACTIN_MONOMERS","GO_BP","489307_GO_0042989_SEQUESTERING_OF_ACTIN_MONOMERS",9,-1.2364,0.18,0.31,1.4754,0.064,0.45,0.6082,0.96,1
"GO_BP:515923_GO_0070997_NEURON_DEATH","GO_BP","515923_GO_0070997_NEURON_DEATH",46,-1.2363,0.16,0.31,0.9323,0.57,1,1.226,0.16,0.71
"C7_Immunologic_signatures:C7_ALL_1847_GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1847_GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP",198,-1.2363,0.079,0.14,1.0504,0.31,0.59,-0.9028,0.73,0.95
"GO_BP:491549_GO_0006661_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS","GO_BP","491549_GO_0006661_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS",90,-1.2362,0.13,0.31,0.5837,1,1,-1.0277,0.39,0.82
"GO_BP:487880_GO_0001990_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE","GO_BP","487880_GO_0001990_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE",36,-1.2362,0.18,0.31,-1.0141,0.43,0.98,-1.0457,0.37,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1133_AMIT_EGF_RESPONSE_20_HELA","C2_Chemical_and_genetic_perturbations","C2_CGP_1133_AMIT_EGF_RESPONSE_20_HELA",11,-1.2361,0.2,0.24,-1.2034,0.23,0.8,-0.805,0.7,0.95
"GO_BP:488479_GO_0002606_POSITIVE_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION","GO_BP","488479_GO_0002606_POSITIVE_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION",6,-1.2361,0.23,0.31,0.5402,0.97,1,-1.0057,0.45,0.84
"GO_MF:489460_GO_0003988_ACETYL_COA_C_ACYLTRANSFERASE_ACTIVITY","GO_MF","489460_GO_0003988_ACETYL_COA_C_ACYLTRANSFERASE_ACTIVITY",6,-1.236,0.21,0.37,0.5675,0.95,1,-1.2815,0.2,0.6
"GO_BP:494530_GO_0010460_POSITIVE_REGULATION_OF_HEART_RATE","GO_BP","494530_GO_0010460_POSITIVE_REGULATION_OF_HEART_RATE",20,-1.236,0.21,0.31,0.944,0.53,1,0.7909,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_581_TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA","C2_Chemical_and_genetic_perturbations","C2_CGP_581_TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA",98,-1.236,0.12,0.24,0.9008,0.69,0.92,0.9854,0.45,0.97
"GO_BP:513787_GO_0060231_MESENCHYMAL_TO_EPITHELIAL_TRANSITION","GO_BP","513787_GO_0060231_MESENCHYMAL_TO_EPITHELIAL_TRANSITION",15,-1.2359,0.21,0.31,-1.2218,0.19,0.88,1.2226,0.21,0.71
"GO_MF:751602_GO_0044389_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING","GO_MF","751602_GO_0044389_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING",218,-1.2359,0.079,0.37,0.8267,0.93,1,-0.9168,0.69,0.86
"C1_Positional:C1_ALL_24_CHR10Q25","C1_Positional","C1_ALL_24_CHR10Q25",44,-1.2357,0.16,0.77,1.1341,0.25,0.65,-1.3749,0.055,0.49
"GO_BP:503515_GO_0034312_DIOL_BIOSYNTHETIC_PROCESS","GO_BP","503515_GO_0034312_DIOL_BIOSYNTHETIC_PROCESS",6,-1.2356,0.21,0.31,0.7216,0.8,1,-1.4005,0.1,0.58
"KEGG_enzyme:2.3.1.24_SPHINGOSINE_N_ACYLTRANSFERASE_CERAMIDE_SYNTHETASE_SPHINGOSINE_ACYLTRANSFERASE","KEGG_enzyme","2.3.1.24_SPHINGOSINE_N_ACYLTRANSFERASE_CERAMIDE_SYNTHETASE_SPHINGOSINE_ACYLTRANSFERASE",6,-1.2355,0.21,0.48,-1.4,0.12,0.42,-1.3028,0.17,0.58
"GO_MF:487544_GO_0001614_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY","GO_MF","487544_GO_0001614_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY",21,-1.2354,0.18,0.37,1.4149,0.075,0.48,1.0467,0.36,0.85
"C1_Positional:C1_ALL_152_CHR17P13","C1_Positional","C1_ALL_152_CHR17P13",233,-1.2353,0.077,0.76,-1.5717,0,0.6,-0.8978,0.8,0.96
"GO_BP:506680_GO_0043650_DICARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS","GO_BP","506680_GO_0043650_DICARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS",11,-1.2353,0.2,0.31,-0.9426,0.52,1,-1.1088,0.33,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_290_TIEN_INTESTINE_PROBIOTICS_24HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_290_TIEN_INTESTINE_PROBIOTICS_24HR_DN",213,-1.2353,0.082,0.24,2.0307,0,0.0044,-0.8607,0.87,0.92
"GO_MF:496848_GO_0017016_RAS_GTPASE_BINDING","GO_MF","496848_GO_0017016_RAS_GTPASE_BINDING",209,-1.2352,0.078,0.37,-1.1703,0.13,0.79,-0.923,0.68,0.85
"C7_Immunologic_signatures:C7_ALL_480_GSE17721_CTRL_VS_PAM3CSK4_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_480_GSE17721_CTRL_VS_PAM3CSK4_0_5H_BMDM_DN",194,-1.2351,0.082,0.14,0.7534,0.99,1,-0.7537,0.99,1
"GO_BP:495134_GO_0014062_REGULATION_OF_SEROTONIN_SECRETION","GO_BP","495134_GO_0014062_REGULATION_OF_SEROTONIN_SECRETION",6,-1.2351,0.22,0.31,1.2474,0.22,0.73,0.7595,0.76,1
"C7_Immunologic_signatures:C7_ALL_102_GSE11924_TH1_VS_TH2_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_102_GSE11924_TH1_VS_TH2_CD4_TCELL_DN",199,-1.2351,0.1,0.14,1.2669,0.037,0.13,1.0574,0.3,1
"GO_BP:512526_GO_0051650_ESTABLISHMENT_OF_VESICLE_LOCALIZATION","GO_BP","512526_GO_0051650_ESTABLISHMENT_OF_VESICLE_LOCALIZATION",188,-1.2351,0.091,0.31,1.0973,0.19,0.9,-0.9666,0.53,0.88
"C7_Immunologic_signatures:C7_ALL_597_GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_597_GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDM_UP",197,-1.2351,0.072,0.14,0.7454,0.99,1,-0.882,0.79,0.97
"C7_Immunologic_signatures:C7_ALL_593_GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_593_GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_UP",194,-1.2351,0.089,0.14,0.9283,0.67,0.96,0.8359,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2048_LEIN_NEURON_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_2048_LEIN_NEURON_MARKERS",68,-1.235,0.15,0.24,0.9837,0.48,0.81,0.9389,0.57,1
"GO_BP:500396_GO_0031109_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION","GO_BP","500396_GO_0031109_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION",34,-1.235,0.19,0.31,-0.5833,0.99,1,-1.4445,0.046,0.55
"GO_BP:515321_GO_0070389_CHAPERONE_COFACTOR_DEPENDENT_PROTEIN_REFOLDING","GO_BP","515321_GO_0070389_CHAPERONE_COFACTOR_DEPENDENT_PROTEIN_REFOLDING",5,-1.2349,0.22,0.31,0.9682,0.53,1,-1.3315,0.16,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_2565_VANTVEER_BREAST_CANCER_BRCA1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2565_VANTVEER_BREAST_CANCER_BRCA1_DN",43,-1.2349,0.15,0.24,-1.0541,0.38,0.96,-0.8679,0.71,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_2101_TESAR_JAK_TARGETS_MOUSE_ES_D3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2101_TESAR_JAK_TARGETS_MOUSE_ES_D3_UP",6,-1.2347,0.23,0.24,-1.1013,0.34,0.91,-1.6187,0.01,0.23
"GO_MF:490111_GO_0004806_TRIGLYCERIDE_LIPASE_ACTIVITY","GO_MF","490111_GO_0004806_TRIGLYCERIDE_LIPASE_ACTIVITY",14,-1.2346,0.19,0.37,-0.998,0.46,0.91,0.9821,0.45,0.88
"C7_Immunologic_signatures:C7_ALL_1535_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP","C7_Immunologic_signatures","C7_ALL_1535_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP",190,-1.2345,0.086,0.14,-0.9846,0.51,1,0.9664,0.56,1
"GO_MF:750818_GO_0052745_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY","GO_MF","750818_GO_0052745_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY",16,-1.2345,0.2,0.37,-0.6838,0.88,1,0.6365,0.94,1
"C7_Immunologic_signatures:C7_ALL_1873_GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1873_GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP",198,-1.2344,0.074,0.14,0.7954,0.97,1,-0.9205,0.69,0.91
"GO_BP:753039_GO_1900042_POSITIVE_REGULATION_OF_INTERLEUKIN_2_SECRETION","GO_BP","753039_GO_1900042_POSITIVE_REGULATION_OF_INTERLEUKIN_2_SECRETION",5,-1.2344,0.21,0.32,-1.3167,0.16,0.89,1.0233,0.44,0.83
"REACTOME:105810_REACT_15451_LOSS_OF_PROTEINS_REQUIRED_FOR_INTERPHASE_MICROTUBULE_ORGANIZATIONFROM_THE_CENTROSOME","REACTOME","105810_REACT_15451_LOSS_OF_PROTEINS_REQUIRED_FOR_INTERPHASE_MICROTUBULE_ORGANIZATIONFROM_THE_CENTROSOME",62,-1.2343,0.14,0.34,-0.855,0.76,1,-1.7949,0,0.18
"GO_BP:487442_GO_0001503_OSSIFICATION","GO_BP","487442_GO_0001503_OSSIFICATION",245,-1.2342,0.076,0.32,1.1086,0.18,0.89,0.884,0.84,0.95
"C7_Immunologic_signatures:C7_ALL_1794_GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1794_GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN",195,-1.2342,0.094,0.14,1.3173,0.012,0.087,-1.0038,0.45,0.72
"C3_TF_targets:C3_TFT_290_V_PITX2_Q2","C3_TF_targets","C3_TFT_290_V_PITX2_Q2",244,-1.2341,0.072,0.15,-0.9463,0.65,0.88,0.9271,0.7,1
"REACTOME:106025_REACT_11200_NEF_MEDIATED_CD8_DOWN_REGULATION","REACTOME","106025_REACT_11200_NEF_MEDIATED_CD8_DOWN_REGULATION",7,-1.2341,0.23,0.34,0.7654,0.75,1,-0.9476,0.51,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_2692_VALK_AML_WITH_T_8_21_TRANSLOCATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2692_VALK_AML_WITH_T_8_21_TRANSLOCATION",5,-1.2341,0.21,0.24,-0.659,0.88,1,-1.4956,0.063,0.3
"C7_Immunologic_signatures:C7_ALL_151_GSE13306_TREG_RA_VS_TCONV_RA_UP","C7_Immunologic_signatures","C7_ALL_151_GSE13306_TREG_RA_VS_TCONV_RA_UP",198,-1.234,0.092,0.14,-0.7626,0.97,1,-1.1021,0.22,0.49
"GO_BP:518838_GO_2000191_REGULATION_OF_FATTY_ACID_TRANSPORT","GO_BP","518838_GO_2000191_REGULATION_OF_FATTY_ACID_TRANSPORT",26,-1.234,0.18,0.32,0.822,0.76,1,0.8934,0.64,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_338_WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_338_WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP",262,-1.2339,0.064,0.24,0.7827,0.99,1,-0.9798,0.52,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_376_PASTURAL_RIZ1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_376_PASTURAL_RIZ1_TARGETS_DN",5,-1.2339,0.23,0.24,1.0971,0.37,0.64,0.9802,0.47,0.97
"GO_BP:502091_GO_0032869_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS","GO_BP","502091_GO_0032869_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS",195,-1.2339,0.085,0.32,-0.8558,0.86,1,-0.9774,0.5,0.87
"GO_MF:490577_GO_0005432_CALCIUM_SODIUM_ANTIPORTER_ACTIVITY","GO_MF","490577_GO_0005432_CALCIUM_SODIUM_ANTIPORTER_ACTIVITY",5,-1.2338,0.22,0.37,-1.0007,0.48,0.9,-0.7523,0.76,0.99
"C4_Cancer_gene_neighborhoods:C4_CGN_385_GNF2_MYL2","C4_Cancer_gene_neighborhoods","C4_CGN_385_GNF2_MYL2",30,-1.2338,0.18,0.28,-1.7136,0.0038,0.074,0.9199,0.61,0.98
"C3_TF_targets:C3_TFT_320_V_RP58_01","C3_TF_targets","C3_TFT_320_V_RP58_01",197,-1.2338,0.081,0.15,-0.9427,0.6,0.88,0.9043,0.73,1
"KEGG_enzyme:1.11.1.15_PEROXIREDOXIN_THIOREDOXIN_PEROXIDASE_TRYPAREDOXIN_PEROXIDASE_ALKYL_HYDROPEROXIDE_REDUCTASE_C22_AHPC_TRXPX_TXNPX_PRX_PRDX","KEGG_enzyme","1.11.1.15_PEROXIREDOXIN_THIOREDOXIN_PEROXIDASE_TRYPAREDOXIN_PEROXIDASE_ALKYL_HYDROPEROXIDE_REDUCTASE_C22_AHPC_TRXPX_TXNPX_PRX_PRDX",6,-1.2333,0.23,0.43,1.3116,0.18,0.5,-1.3631,0.12,0.54
"GO_BP:493266_GO_0009065_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS","GO_BP","493266_GO_0009065_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS",21,-1.2332,0.17,0.32,-1.0359,0.41,0.98,-0.8712,0.68,0.95
"GO_BP:513613_GO_0060055_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING","GO_BP","513613_GO_0060055_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING",9,-1.2332,0.22,0.32,0.9824,0.48,1,0.5812,0.96,1
"REACTOME:119555_REACT_19238_CD28_DEPENDENT_VAV1_PATHWAY","REACTOME","119555_REACT_19238_CD28_DEPENDENT_VAV1_PATHWAY",12,-1.2331,0.21,0.35,0.5981,0.95,1,-1.2298,0.22,0.57
"GO_BP:513730_GO_0060173_LIMB_DEVELOPMENT","GO_BP","513730_GO_0060173_LIMB_DEVELOPMENT",162,-1.2331,0.092,0.32,-1.0375,0.35,0.98,1.2075,0.098,0.71
"GO_BP:500151_GO_0030853_NEGATIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION","GO_BP","500151_GO_0030853_NEGATIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION",7,-1.233,0.21,0.32,0.6861,0.88,1,-0.8272,0.67,0.97
"GO_BP:508165_GO_0045844_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","508165_GO_0045844_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT",44,-1.233,0.17,0.32,0.7782,0.86,1,1.176,0.2,0.72
"GO_BP:495998_GO_0051180_VITAMIN_TRANSPORT","GO_BP","495998_GO_0051180_VITAMIN_TRANSPORT",28,-1.2329,0.17,0.32,-1.5515,0.024,0.73,-0.802,0.8,0.99
"GO_MF:495777_GO_0015631_TUBULIN_BINDING","GO_MF","495777_GO_0015631_TUBULIN_BINDING",246,-1.2329,0.075,0.37,-0.7136,1,1,-1.1787,0.11,0.6
"GO_BP:493402_GO_0009206_PURINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493402_GO_0009206_PURINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",64,-1.2329,0.15,0.32,1.2651,0.097,0.71,-0.9335,0.59,0.9
"C3_MicroRNA_targets:C3_MIR_97_TAGCTTT_MIR_9","C3_MicroRNA_targets","C3_MIR_97_TAGCTTT_MIR_9",233,-1.2329,0.07,0.3,-0.7583,0.99,1,0.7917,0.98,1
"GO_MF:509113_GO_0046906_TETRAPYRROLE_BINDING","GO_MF","509113_GO_0046906_TETRAPYRROLE_BINDING",139,-1.2328,0.095,0.37,1.1732,0.14,0.73,-1.1607,0.15,0.63
"GO_MF:496575_GO_0016634_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR","GO_MF","496575_GO_0016634_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR",11,-1.2327,0.19,0.37,0.529,0.98,1,-1.6113,0.03,0.37
"C2_Chemical_and_genetic_perturbations:C2_CGP_701_LUI_THYROID_CANCER_CLUSTER_5","C2_Chemical_and_genetic_perturbations","C2_CGP_701_LUI_THYROID_CANCER_CLUSTER_5",12,-1.2327,0.21,0.24,-0.5538,0.97,1,-1.0261,0.43,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1366_FRASOR_RESPONSE_TO_ESTRADIOL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1366_FRASOR_RESPONSE_TO_ESTRADIOL_DN",82,-1.2326,0.14,0.24,-0.9292,0.59,1,0.8862,0.72,1
"WikiPathways:198849_WP35_G_PROTEIN_SIGNALING_PATHWAYS","WikiPathways","198849_WP35_G_PROTEIN_SIGNALING_PATHWAYS",94,-1.2326,0.13,0.26,-1.098,0.28,1,-1.4153,0.014,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_2322_MATZUK_FERTILIZATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2322_MATZUK_FERTILIZATION",8,-1.2325,0.21,0.24,0.9192,0.58,0.9,-0.8588,0.64,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_3010_BAE_BRCA1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3010_BAE_BRCA1_TARGETS_DN",32,-1.2325,0.18,0.24,1.0897,0.31,0.65,0.7383,0.87,1
"C3_TF_targets:C3_TFT_240_V_TGIF_01","C3_TF_targets","C3_TFT_240_V_TGIF_01",240,-1.2324,0.071,0.15,0.977,0.51,1,-1.0969,0.21,0.55
"GO_MF:499872_GO_0030546_RECEPTOR_ACTIVATOR_ACTIVITY","GO_MF","499872_GO_0030546_RECEPTOR_ACTIVATOR_ACTIVITY",29,-1.2324,0.18,0.37,-0.7284,0.88,1,-0.8232,0.76,0.95
"C3_TF_targets:C3_TFT_416_V_NFY_Q6_01","C3_TF_targets","C3_TFT_416_V_NFY_Q6_01",256,-1.2324,0.081,0.15,-1.0809,0.25,0.59,-1.3413,0.014,0.25
"KEGG_compound:C00111_GLYCERONE_PHOSPHATE_DIHYDROXYACETONE_PHOSPHATE_3_HYDROXY_2_OXOPROPYL_PHOSPHATE","KEGG_compound","C00111_GLYCERONE_PHOSPHATE_DIHYDROXYACETONE_PHOSPHATE_3_HYDROXY_2_OXOPROPYL_PHOSPHATE",9,-1.2324,0.23,0.35,-1.1451,0.29,0.86,-1.4285,0.089,0.26
"GO_BP:982481_GO_1902913_POSITIVE_REGULATION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION","GO_BP","982481_GO_1902913_POSITIVE_REGULATION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION",6,-1.2322,0.22,0.32,1.1828,0.27,0.8,0.6971,0.83,1
"GO_BP:515812_GO_0070884_REGULATION_OF_CALCINEURIN_NFAT_SIGNALING_CASCADE","GO_BP","515812_GO_0070884_REGULATION_OF_CALCINEURIN_NFAT_SIGNALING_CASCADE",13,-1.232,0.2,0.32,0.6603,0.9,1,-0.9136,0.56,0.91
"GO_BP:517300_GO_0072384_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE","GO_BP","517300_GO_0072384_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE",35,-1.232,0.17,0.32,0.811,0.76,1,-0.7881,0.82,0.99
"C4_Cancer_modules:C4_CM_33_MODULE_37","C4_Cancer_modules","C4_CM_33_MODULE_37",464,-1.232,0.033,0.24,0.8024,0.99,0.97,0.8345,0.97,1
"C4_Cancer_gene_neighborhoods:C4_CGN_118_MORF_JAG1","C4_Cancer_gene_neighborhoods","C4_CGN_118_MORF_JAG1",91,-1.2319,0.12,0.29,-0.8557,0.81,1,-0.9538,0.53,0.95
"REACTOME:106288_REACT_1023_PYRIMIDINE_CATABOLISM","REACTOME","106288_REACT_1023_PYRIMIDINE_CATABOLISM",12,-1.2319,0.21,0.35,-0.6135,0.94,1,-1.1344,0.3,0.67
"GO_BP:501882_GO_0032656_REGULATION_OF_INTERLEUKIN_13_PRODUCTION","GO_BP","501882_GO_0032656_REGULATION_OF_INTERLEUKIN_13_PRODUCTION",13,-1.2317,0.19,0.32,-0.8293,0.69,1,0.8664,0.64,0.97
"GO_BP:494655_GO_0010591_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY","GO_BP","494655_GO_0010591_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY",23,-1.2317,0.2,0.32,1.2836,0.13,0.7,0.6844,0.93,1
"GO_BP:487956_GO_0002066_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT","GO_BP","487956_GO_0002066_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT",47,-1.2315,0.14,0.32,-0.8431,0.72,1,1.2097,0.15,0.71
"GO_BP:488396_GO_0002523_LEUKOCYTE_MIGRATION_INVOLVED_IN_INFLAMMATORY_RESPONSE","GO_BP","488396_GO_0002523_LEUKOCYTE_MIGRATION_INVOLVED_IN_INFLAMMATORY_RESPONSE",11,-1.2314,0.21,0.32,1.2226,0.21,0.76,1.0377,0.4,0.82
"GO_MF:508931_GO_0046703_NATURAL_KILLER_CELL_LECTIN_LIKE_RECEPTOR_BINDING","GO_MF","508931_GO_0046703_NATURAL_KILLER_CELL_LECTIN_LIKE_RECEPTOR_BINDING",8,-1.2313,0.21,0.37,0.6777,0.88,1,1.0218,0.42,0.87
"C3_MicroRNA_targets:C3_MIR_205_GGTGTGT_MIR_329","C3_MicroRNA_targets","C3_MIR_205_GGTGTGT_MIR_329",113,-1.2312,0.11,0.3,1.0452,0.33,1,1.3798,0.038,1
"GO_BP:494675_GO_0010611_REGULATION_OF_CARDIAC_MUSCLE_HYPERTROPHY","GO_BP","494675_GO_0010611_REGULATION_OF_CARDIAC_MUSCLE_HYPERTROPHY",27,-1.2311,0.19,0.32,-0.5524,0.99,1,-1.2497,0.16,0.68
"GO_BP:499309_GO_0022030_TELENCEPHALON_GLIAL_CELL_MIGRATION","GO_BP","499309_GO_0022030_TELENCEPHALON_GLIAL_CELL_MIGRATION",17,-1.2311,0.19,0.32,-0.5956,0.96,1,1.2201,0.2,0.71
"GO_BP:508444_GO_0046146_TETRAHYDROBIOPTERIN_METABOLIC_PROCESS","GO_BP","508444_GO_0046146_TETRAHYDROBIOPTERIN_METABOLIC_PROCESS",6,-1.2311,0.22,0.32,0.85,0.65,1,-1.0187,0.45,0.83
"C7_Immunologic_signatures:C7_ALL_813_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_813_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP",172,-1.2311,0.1,0.15,1.1955,0.11,0.23,1.1006,0.22,0.99
"C3_TF_targets:C3_TFT_600_CGTSACG_V_PAX3_B","C3_TF_targets","C3_TFT_600_CGTSACG_V_PAX3_B",147,-1.231,0.1,0.16,-1.0485,0.33,0.65,-1.2523,0.093,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_2514_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2514_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN",48,-1.2309,0.16,0.24,0.8473,0.74,0.97,-1.0062,0.43,0.74
"GO_CC:507298_GO_0044292_DENDRITE_TERMINUS","GO_CC","507298_GO_0044292_DENDRITE_TERMINUS",10,-1.2308,0.21,0.39,0.8431,0.66,0.93,-1.5601,0.031,0.48
"GO_BP:493765_GO_0009650_UV_PROTECTION","GO_BP","493765_GO_0009650_UV_PROTECTION",12,-1.2308,0.22,0.32,0.6124,0.93,1,-1.1491,0.29,0.74
"C3_TF_targets:C3_TFT_367_V_SMAD3_Q6","C3_TF_targets","C3_TFT_367_V_SMAD3_Q6",233,-1.2307,0.083,0.16,-1.4123,0.0035,0.16,-1.1214,0.18,0.49
"C7_Immunologic_signatures:C7_ALL_662_GSE17721_LPS_VS_CPG_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_662_GSE17721_LPS_VS_CPG_6H_BMDM_DN",197,-1.2306,0.089,0.15,1.2325,0.054,0.18,-1.0185,0.39,0.69
"GO_BP:515239_GO_0070306_LENS_FIBER_CELL_DIFFERENTIATION","GO_BP","515239_GO_0070306_LENS_FIBER_CELL_DIFFERENTIATION",25,-1.2306,0.18,0.32,-0.4806,0.99,1,-0.6176,0.96,1
"GO_BP:514297_GO_0060742_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT","GO_BP","514297_GO_0060742_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT",12,-1.2306,0.21,0.32,-0.5355,0.97,1,1.1276,0.31,0.74
"GO_BP:508004_GO_0045656_NEGATIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION","GO_BP","508004_GO_0045656_NEGATIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION",5,-1.2305,0.22,0.32,-1.191,0.3,0.9,1.0888,0.39,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1472_HOFMANN_CELL_LYMPHOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1472_HOFMANN_CELL_LYMPHOMA_DN",38,-1.2305,0.18,0.24,0.9517,0.54,0.86,0.845,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2635_MEISSNER_NPC_HCP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2635_MEISSNER_NPC_HCP_WITH_H3K27ME3",73,-1.2305,0.14,0.24,1.4467,0.023,0.26,1.3819,0.042,0.53
"GO_BP:752389_GO_0086018_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_SIGNALLING","GO_BP","752389_GO_0086018_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_SIGNALLING",7,-1.2303,0.24,0.32,0.8542,0.62,1,1.1753,0.29,0.72
"GO_MF:489657_GO_0016805_DIPEPTIDASE_ACTIVITY","GO_MF","489657_GO_0016805_DIPEPTIDASE_ACTIVITY",14,-1.2303,0.19,0.37,-0.6861,0.9,1,-1.5333,0.055,0.39
"GO_BP:755136_GO_2001030_NEGATIVE_REGULATION_OF_CELLULAR_GLUCURONIDATION","GO_BP","755136_GO_2001030_NEGATIVE_REGULATION_OF_CELLULAR_GLUCURONIDATION",8,-1.2303,0.21,0.32,0.8647,0.61,1,2.0343,0,0.03
"GO_BP:511822_GO_0050884_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE","GO_BP","511822_GO_0050884_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE",13,-1.2303,0.21,0.32,-1.5106,0.061,0.81,-0.8704,0.62,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1289_PENG_LEUCINE_DEPRIVATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1289_PENG_LEUCINE_DEPRIVATION_UP",138,-1.2303,0.11,0.24,0.9777,0.52,0.82,-0.8696,0.81,0.91
"C4_Cancer_modules:C4_CM_171_MODULE_181","C4_Cancer_modules","C4_CM_171_MODULE_181",293,-1.2302,0.058,0.25,-1.2863,0.028,0.54,1.3387,0.0091,0.42
"GO_BP:499341_GO_0022605_OOGENESIS_STAGE","GO_BP","499341_GO_0022605_OOGENESIS_STAGE",5,-1.2302,0.23,0.32,0.8386,0.67,1,-0.7226,0.8,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1969_JIANG_AGING_CEREBRAL_CORTEX_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1969_JIANG_AGING_CEREBRAL_CORTEX_DN",54,-1.2302,0.15,0.24,1.4383,0.036,0.26,-1.0739,0.33,0.66
"GO_BP:502226_GO_0033004_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION","GO_BP","502226_GO_0033004_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION",8,-1.2301,0.2,0.32,0.6944,0.84,1,1.625,0.029,0.4
"KEGG_reaction:R06517_ACYL_COA_SPHINGOSINE_N_ACYLTRANSFERASE_ACYL_COA_SPHINGANINE_COA_DIHYDROCERAMIDE","KEGG_reaction","R06517_ACYL_COA_SPHINGOSINE_N_ACYLTRANSFERASE_ACYL_COA_SPHINGANINE_COA_DIHYDROCERAMIDE",6,-1.23,0.22,0.33,-1.3531,0.15,0.35,-1.2899,0.19,0.49
"GO_BP:499140_GO_0021861_FOREBRAIN_RADIAL_GLIAL_CELL_DIFFERENTIATION","GO_BP","499140_GO_0021861_FOREBRAIN_RADIAL_GLIAL_CELL_DIFFERENTIATION",5,-1.2299,0.22,0.32,-0.7805,0.73,1,0.8299,0.68,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_152_ROY_WOUND_BLOOD_VESSEL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_152_ROY_WOUND_BLOOD_VESSEL_DN",21,-1.2299,0.2,0.24,-1.2006,0.22,0.79,1.5085,0.029,0.49
"C1_Positional:C1_ALL_113_CHR4Q28","C1_Positional","C1_ALL_113_CHR4Q28",32,-1.2299,0.16,0.76,1.2388,0.16,0.58,0.8699,0.68,0.87
"GO_BP:512038_GO_0051127_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION","GO_BP","512038_GO_0051127_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION",10,-1.2299,0.22,0.32,-0.7254,0.81,1,-0.6369,0.91,1
"C7_Immunologic_signatures:C7_ALL_734_GSE17721_0_5H_VS_8H_PAM3CSK4_BMDM_DN","C7_Immunologic_signatures","C7_ALL_734_GSE17721_0_5H_VS_8H_PAM3CSK4_BMDM_DN",199,-1.2299,0.084,0.15,1.3132,0.021,0.091,0.787,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2148_AMUNDSON_GAMMA_RADIATION_RESISTANCE","C2_Chemical_and_genetic_perturbations","C2_CGP_2148_AMUNDSON_GAMMA_RADIATION_RESISTANCE",20,-1.2298,0.22,0.24,1.2286,0.16,0.46,-1.3333,0.11,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_3118_KANG_AR_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3118_KANG_AR_TARGETS_UP",16,-1.2298,0.19,0.24,-0.9644,0.53,1,-0.763,0.8,0.97
"C3_MicroRNA_targets:C3_MIR_201_TGTGTGA_MIR_377","C3_MicroRNA_targets","C3_MIR_201_TGTGTGA_MIR_377",197,-1.2298,0.1,0.3,-0.9277,0.66,1,-1.0111,0.42,1
"REACTOME:530744_REACT_116022_NUCLEAR_SIGNALING_BY_ERBB4","REACTOME","530744_REACT_116022_NUCLEAR_SIGNALING_BY_ERBB4",37,-1.2297,0.18,0.35,0.8929,0.64,0.91,-0.8413,0.74,0.99
"C7_Immunologic_signatures:C7_ALL_707_GSE17721_0_5H_VS_12H_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_707_GSE17721_0_5H_VS_12H_LPS_BMDM_UP",195,-1.2297,0.088,0.15,1.3977,0.012,0.038,-1.1739,0.1,0.33
"C7_Immunologic_signatures:C7_ALL_459_GSE17721_CTRL_VS_LPS_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_459_GSE17721_CTRL_VS_LPS_12H_BMDM_UP",198,-1.2296,0.099,0.15,1.1983,0.087,0.23,-1.0661,0.29,0.58
"GO_MF:492724_GO_0008429_PHOSPHATIDYLETHANOLAMINE_BINDING","GO_MF","492724_GO_0008429_PHOSPHATIDYLETHANOLAMINE_BINDING",7,-1.2295,0.22,0.37,0.9763,0.49,0.9,0.4608,0.99,1
"GO_CC:500681_GO_0031430_M_BAND","GO_CC","500681_GO_0031430_M_BAND",18,-1.2295,0.21,0.4,-1.403,0.085,0.64,0.6582,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_959_OHM_METHYLATED_IN_ADULT_CANCERS","C2_Chemical_and_genetic_perturbations","C2_CGP_959_OHM_METHYLATED_IN_ADULT_CANCERS",27,-1.2294,0.2,0.24,0.9013,0.62,0.92,-1.0287,0.38,0.71
"C1_Positional:C1_ALL_123_CHR13Q32","C1_Positional","C1_ALL_123_CHR13Q32",26,-1.2293,0.2,0.75,0.8617,0.69,0.89,-0.7556,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2228_MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2228_MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN",19,-1.2292,0.18,0.24,1.0139,0.43,0.78,0.8161,0.7,1
"REACTOME:771569_REACT_160315_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION","REACTOME","771569_REACT_160315_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION",80,-1.2292,0.13,0.35,-0.7186,0.97,1,-1.8834,0,0.16
"REACTOME:576270_REACT_118614_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS","REACTOME","576270_REACT_118614_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS",31,-1.2292,0.18,0.35,-0.7605,0.83,1,-1.3513,0.085,0.49
"C2_Chemical_and_genetic_perturbations:C2_CGP_963_OKAWA_NEUROBLASTOMA_1P36_31_DELETION","C2_Chemical_and_genetic_perturbations","C2_CGP_963_OKAWA_NEUROBLASTOMA_1P36_31_DELETION",21,-1.2291,0.18,0.24,-0.9685,0.48,1,-1.4115,0.076,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_2245_ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2245_ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN",205,-1.2291,0.077,0.24,0.8893,0.8,0.94,1.0899,0.23,0.87
"GO_BP:513577_GO_0060019_RADIAL_GLIAL_CELL_DIFFERENTIATION","GO_BP","513577_GO_0060019_RADIAL_GLIAL_CELL_DIFFERENTIATION",6,-1.2291,0.24,0.32,0.487,0.99,1,0.9394,0.53,0.91
"C3_TF_targets:C3_TFT_187_V_OLF1_01","C3_TF_targets","C3_TFT_187_V_OLF1_01",266,-1.2291,0.061,0.16,-1.3231,0.02,0.21,-0.9528,0.61,0.85
"GO_BP:504293_GO_0035108_LIMB_MORPHOGENESIS","GO_BP","504293_GO_0035108_LIMB_MORPHOGENESIS",144,-1.229,0.11,0.32,-0.9397,0.6,1,1.2879,0.059,0.68
"C7_Immunologic_signatures:C7_ALL_1373_GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1373_GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP",193,-1.2289,0.091,0.15,-0.9203,0.7,1,1.24,0.076,0.56
"C7_Immunologic_signatures:C7_ALL_318_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN","C7_Immunologic_signatures","C7_ALL_318_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN",186,-1.2289,0.067,0.15,1.2904,0.037,0.11,-0.9829,0.5,0.76
"GO_BP:494985_GO_0010921_REGULATION_OF_PHOSPHATASE_ACTIVITY","GO_BP","494985_GO_0010921_REGULATION_OF_PHOSPHATASE_ACTIVITY",99,-1.2289,0.13,0.32,-0.8226,0.86,1,0.9339,0.61,0.92
"KEGG_compound:C01598_MELATONIN_N_ACETYL_5_METHOXYTRYPTAMINE","KEGG_compound","C01598_MELATONIN_N_ACETYL_5_METHOXYTRYPTAMINE",6,-1.2288,0.24,0.35,-0.9798,0.48,1,-1.016,0.45,0.64
"GO_BP:498845_GO_0021561_FACIAL_NERVE_DEVELOPMENT","GO_BP","498845_GO_0021561_FACIAL_NERVE_DEVELOPMENT",11,-1.2287,0.19,0.32,-0.8705,0.64,1,0.976,0.47,0.88
"GO_BP:494073_GO_0009988_CELL_CELL_RECOGNITION","GO_BP","494073_GO_0009988_CELL_CELL_RECOGNITION",53,-1.2286,0.15,0.32,-1.067,0.36,0.96,-0.9389,0.55,0.9
"GO_BP:751912_GO_0052696_FLAVONOID_GLUCURONIDATION","GO_BP","751912_GO_0052696_FLAVONOID_GLUCURONIDATION",21,-1.2286,0.2,0.32,1.8046,0.002,0.097,2.286,0,0.00089
"GO_BP:517216_GO_0072300_POSITIVE_REGULATION_OF_METANEPHRIC_GLOMERULUS_DEVELOPMENT","GO_BP","517216_GO_0072300_POSITIVE_REGULATION_OF_METANEPHRIC_GLOMERULUS_DEVELOPMENT",5,-1.2286,0.23,0.32,-0.8128,0.69,1,1.5371,0.025,0.52
"C7_Immunologic_signatures:C7_ALL_141_GSE13229_IMM_VS_INTMATURE_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_141_GSE13229_IMM_VS_INTMATURE_NKCELL_UP",193,-1.2285,0.11,0.15,-1.0077,0.41,1,-0.9834,0.5,0.76
"GO_BP:502571_GO_0033353_S_ADENOSYLMETHIONINE_CYCLE","GO_BP","502571_GO_0033353_S_ADENOSYLMETHIONINE_CYCLE",5,-1.2285,0.21,0.32,-0.9435,0.54,1,-1.434,0.083,0.56
"GO_BP:492568_GO_0008228_OPSONIZATION","GO_BP","492568_GO_0008228_OPSONIZATION",6,-1.2285,0.23,0.32,-1.1795,0.28,0.91,-0.5221,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_857_JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_857_JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP",7,-1.2284,0.22,0.24,-0.8605,0.64,1,0.7736,0.76,1
"GO_MF:499759_GO_0030368_INTERLEUKIN_17_RECEPTOR_ACTIVITY","GO_MF","499759_GO_0030368_INTERLEUKIN_17_RECEPTOR_ACTIVITY",7,-1.2284,0.23,0.37,-0.9495,0.52,0.95,-0.9749,0.48,0.8
"C7_Immunologic_signatures:C7_ALL_1074_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN","C7_Immunologic_signatures","C7_ALL_1074_GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN",196,-1.2281,0.1,0.15,1.5557,0,0.0057,-1.0491,0.33,0.61
"C7_Immunologic_signatures:C7_ALL_873_GSE20366_TREG_VS_TCONV_UP","C7_Immunologic_signatures","C7_ALL_873_GSE20366_TREG_VS_TCONV_UP",189,-1.228,0.1,0.15,-0.9083,0.71,1,0.904,0.73,1
"GO_MF:490518_GO_0005343_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY","GO_MF","490518_GO_0005343_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY",31,-1.228,0.17,0.37,-1.8358,0.0058,0.13,-1.3477,0.094,0.53
"GO_BP:512713_GO_0051851_MODIFICATION_BY_HOST_OF_SYMBIONT_MORPHOLOGY_OR_PHYSIOLOGY","GO_BP","512713_GO_0051851_MODIFICATION_BY_HOST_OF_SYMBIONT_MORPHOLOGY_OR_PHYSIOLOGY",41,-1.2278,0.17,0.32,1.1973,0.19,0.78,-0.7204,0.9,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_867_JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_867_JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP",106,-1.2278,0.13,0.24,0.9136,0.66,0.91,0.739,0.97,1
"GO_BP:516997_GO_0072080_NEPHRON_TUBULE_DEVELOPMENT","GO_BP","516997_GO_0072080_NEPHRON_TUBULE_DEVELOPMENT",75,-1.2276,0.15,0.32,-0.9979,0.46,0.99,0.9834,0.48,0.87
"GO_BP:755134_GO_2001028_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS","GO_BP","755134_GO_2001028_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS",8,-1.2276,0.21,0.32,-0.7516,0.8,1,0.8273,0.68,1
"C7_Immunologic_signatures:C7_ALL_125_GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP","C7_Immunologic_signatures","C7_ALL_125_GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP",191,-1.2276,0.095,0.15,0.9317,0.65,0.95,-1.3824,0.013,0.073
"GO_BP:503596_GO_0034394_PROTEIN_LOCALIZATION_TO_CELL_SURFACE","GO_BP","503596_GO_0034394_PROTEIN_LOCALIZATION_TO_CELL_SURFACE",19,-1.2275,0.21,0.32,-0.7323,0.89,1,1.2303,0.2,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_1303_IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1303_IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN",21,-1.2275,0.2,0.24,1.6518,0.017,0.11,-0.6862,0.89,0.99
"GO_BP:850035_GO_1990126_RETROGRADE_TRANSPORT_ENDOSOME_TO_PLASMA_MEMBRANE","GO_BP","850035_GO_1990126_RETROGRADE_TRANSPORT_ENDOSOME_TO_PLASMA_MEMBRANE",11,-1.2273,0.22,0.32,0.6709,0.88,1,-1.0339,0.39,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_653_AIGNER_ZEB1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_653_AIGNER_ZEB1_TARGETS",34,-1.2272,0.17,0.24,-0.9912,0.46,1,-1.0475,0.39,0.69
"C7_Immunologic_signatures:C7_ALL_1053_GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP","C7_Immunologic_signatures","C7_ALL_1053_GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP",192,-1.2272,0.082,0.15,1.1057,0.23,0.43,-0.9278,0.64,0.9
"GO_BP:501727_GO_0032495_RESPONSE_TO_MURAMYL_DIPEPTIDE","GO_BP","501727_GO_0032495_RESPONSE_TO_MURAMYL_DIPEPTIDE",12,-1.2272,0.22,0.32,-1.0281,0.41,0.97,-0.8515,0.68,0.96
"C3_MicroRNA_targets:C3_MIR_37_CACTTTG_MIR_520G_MIR_520H","C3_MicroRNA_targets","C3_MIR_37_CACTTTG_MIR_520G_MIR_520H",236,-1.2271,0.083,0.3,0.8009,0.95,1,1.1329,0.17,1
"GO_BP:496070_GO_0015949_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION","GO_BP","496070_GO_0015949_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION",19,-1.2271,0.2,0.32,0.8991,0.61,1,-1.5195,0.038,0.53
"GO_BP:489125_GO_0003333_AMINO_ACID_TRANSMEMBRANE_TRANSPORT","GO_BP","489125_GO_0003333_AMINO_ACID_TRANSMEMBRANE_TRANSPORT",58,-1.2269,0.15,0.32,-1.0843,0.32,0.96,-1.0694,0.35,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1501_NADLER_HYPERGLYCEMIA_AT_OBESITY","C2_Chemical_and_genetic_perturbations","C2_CGP_1501_NADLER_HYPERGLYCEMIA_AT_OBESITY",57,-1.2268,0.17,0.24,-0.916,0.61,1,-1.0303,0.38,0.71
"GO_BP:516345_GO_0071421_MANGANESE_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","516345_GO_0071421_MANGANESE_ION_TRANSMEMBRANE_TRANSPORT",5,-1.2268,0.23,0.32,-0.6896,0.84,1,0.8284,0.66,1
"GO_MF:506105_GO_0043014_ALPHA_TUBULIN_BINDING","GO_MF","506105_GO_0043014_ALPHA_TUBULIN_BINDING",24,-1.2267,0.18,0.37,-0.6449,0.95,1,-0.8044,0.78,0.96
"WikiPathways:198840_WP272_BLOOD_CLOTTING_CASCADE","WikiPathways","198840_WP272_BLOOD_CLOTTING_CASCADE",23,-1.2267,0.19,0.27,-1.0064,0.44,0.99,1.1222,0.28,0.67
"GO_CC:514747_GO_0061202_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE_MEMBRANE","GO_CC","514747_GO_0061202_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE_MEMBRANE",7,-1.2265,0.23,0.4,-0.7976,0.7,1,-1.4523,0.068,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_1128_PETRETTO_BLOOD_PRESSURE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1128_PETRETTO_BLOOD_PRESSURE_DN",7,-1.2263,0.22,0.25,-0.9531,0.53,1,-1.4679,0.075,0.31
"GO_BP:496856_GO_0050821_PROTEIN_STABILIZATION","GO_BP","496856_GO_0050821_PROTEIN_STABILIZATION",101,-1.2261,0.12,0.32,0.9074,0.67,1,-1.0394,0.34,0.82
"GO_BP:753991_GO_1901021_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","753991_GO_1901021_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",22,-1.226,0.19,0.32,-1.1146,0.3,0.94,1.0237,0.43,0.83
"GO_BP:491283_GO_0006342_CHROMATIN_SILENCING","GO_BP","491283_GO_0006342_CHROMATIN_SILENCING",57,-1.226,0.18,0.32,-1.7906,0,0.49,-1.1323,0.25,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1750_INGA_TP53_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1750_INGA_TP53_TARGETS",17,-1.2258,0.2,0.25,-0.6424,0.92,1,-1.2321,0.21,0.49
"C2_Chemical_and_genetic_perturbations:C2_CGP_2229_MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2229_MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP",24,-1.2258,0.22,0.25,0.8459,0.69,0.97,1.0376,0.4,0.92
"GO_BP:512060_GO_0051150_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION","GO_BP","512060_GO_0051150_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION",15,-1.2258,0.21,0.32,-1.1663,0.27,0.91,1.0387,0.4,0.82
"GO_BP:948498_GO_1902692_REGULATION_OF_NEUROBLAST_PROLIFERATION","GO_BP","948498_GO_1902692_REGULATION_OF_NEUROBLAST_PROLIFERATION",28,-1.2258,0.17,0.32,-0.8756,0.64,1,0.8074,0.78,1
"KEGG_pathway:HSA00531_GLYCOSAMINOGLYCAN_DEGRADATION","KEGG_pathway","HSA00531_GLYCOSAMINOGLYCAN_DEGRADATION",19,-1.2258,0.2,0.2,-0.7561,0.81,1,0.6201,0.95,1
"GO_BP:490992_GO_0006004_FUCOSE_METABOLIC_PROCESS","GO_BP","490992_GO_0006004_FUCOSE_METABOLIC_PROCESS",18,-1.2257,0.21,0.32,0.6815,0.89,1,-0.9802,0.46,0.87
"C7_Immunologic_signatures:C7_ALL_1650_GSE3982_MAC_VS_BASOPHIL_DN","C7_Immunologic_signatures","C7_ALL_1650_GSE3982_MAC_VS_BASOPHIL_DN",197,-1.2257,0.096,0.15,1.1445,0.15,0.33,-1.0359,0.36,0.65
"KEGG_compound:C03740__5_L_GLUTAMYL_L_AMINO_ACID_L_GAMMA_GLUTAMYL_L_AMINO_ACID","KEGG_compound","C03740__5_L_GLUTAMYL_L_AMINO_ACID_L_GAMMA_GLUTAMYL_L_AMINO_ACID",5,-1.2257,0.21,0.36,-0.6552,0.89,1,-0.7907,0.72,0.85
"GO_BP:755129_GO_2001023_REGULATION_OF_RESPONSE_TO_DRUG","GO_BP","755129_GO_2001023_REGULATION_OF_RESPONSE_TO_DRUG",5,-1.2257,0.21,0.32,0.6517,0.88,1,-1.3214,0.15,0.63
"GO_BP:507937_GO_0045589_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION","GO_BP","507937_GO_0045589_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION",11,-1.2256,0.2,0.32,-1.0639,0.38,0.96,-0.6183,0.92,1
"C6_Oncogenic_signatures:C6_ALL_82_BRCA1_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_82_BRCA1_DN_V1_UP",125,-1.2255,0.11,0.15,-1.2492,0.088,0.37,1.391,0.027,0.12
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_207_BIOCARTA_TPO_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_207_BIOCARTA_TPO_PATHWAY",24,-1.2255,0.19,0.32,0.864,0.67,0.91,-1.1179,0.31,0.62
"GO_BP:502368_GO_0033147_NEGATIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","502368_GO_0033147_NEGATIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY",11,-1.2254,0.21,0.32,0.7637,0.78,1,-0.5616,0.97,1
"C3_TF_targets:C3_TFT_408_V_FXR_IR1_Q6","C3_TF_targets","C3_TFT_408_V_FXR_IR1_Q6",109,-1.2253,0.13,0.16,-1.0162,0.41,0.73,-0.7895,0.93,1
"GO_MF:511942_GO_0051010_MICROTUBULE_PLUS_END_BINDING","GO_MF","511942_GO_0051010_MICROTUBULE_PLUS_END_BINDING",11,-1.2253,0.21,0.38,0.6862,0.86,1,-0.4709,0.99,1
"KEGG_compound:C04405__2S_3S_3_HYDROXY_2_METHYLBUTANOYL_COA_S_3_HYDROXY_2_METHYLBUTYRYL_COA","KEGG_compound","C04405__2S_3S_3_HYDROXY_2_METHYLBUTANOYL_COA_S_3_HYDROXY_2_METHYLBUTYRYL_COA",5,-1.2252,0.24,0.36,1.1173,0.34,1,-1.2248,0.22,0.43
"C1_Positional:C1_ALL_64_CHR10P15","C1_Positional","C1_ALL_64_CHR10P15",43,-1.2251,0.16,0.75,-0.4131,1,1,-0.7767,0.85,1
"GO_BP:512834_GO_0051984_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION","GO_BP","512834_GO_0051984_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION",13,-1.2251,0.22,0.32,0.5598,0.96,1,-0.8396,0.67,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1309_FRASOR_RESPONSE_TO_ESTRADIOL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1309_FRASOR_RESPONSE_TO_ESTRADIOL_UP",37,-1.2249,0.19,0.25,-1.0607,0.33,0.97,0.9859,0.47,0.97
"GO_BP:752436_GO_0086070_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_COMMUNICATION","GO_BP","752436_GO_0086070_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_COMMUNICATION",7,-1.2249,0.22,0.32,0.8584,0.61,1,1.1454,0.29,0.73
"KEGG_pathway:HSA04721_SYNAPTIC_VESICLE_CYCLE","KEGG_pathway","HSA04721_SYNAPTIC_VESICLE_CYCLE",62,-1.2248,0.15,0.2,1.0386,0.38,0.83,0.8819,0.69,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2650_ZHAN_EARLY_DIFFERENTIATION_GENES_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2650_ZHAN_EARLY_DIFFERENTIATION_GENES_DN",42,-1.2248,0.16,0.25,-0.7707,0.86,1,-1.0602,0.33,0.68
"C7_Immunologic_signatures:C7_ALL_677_GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_677_GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDM_UP",198,-1.2247,0.078,0.15,0.8134,0.93,1,-1.2818,0.036,0.16
"GO_CC:504183_GO_0034992_MICROTUBULE_ORGANIZING_CENTER_ATTACHMENT_SITE","GO_CC","504183_GO_0034992_MICROTUBULE_ORGANIZING_CENTER_ATTACHMENT_SITE",7,-1.2246,0.25,0.4,-0.9552,0.49,0.89,-1.3684,0.11,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_3392_CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3392_CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP",33,-1.2246,0.18,0.25,-1.2714,0.13,0.71,-1.2033,0.19,0.51
"GO_BP:486623_GO_0000083_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","486623_GO_0000083_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",26,-1.2246,0.19,0.33,-0.5232,0.99,1,-1.1927,0.22,0.74
"GO_CC:490850_GO_0005826_ACTOMYOSIN_CONTRACTILE_RING","GO_CC","490850_GO_0005826_ACTOMYOSIN_CONTRACTILE_RING",5,-1.2246,0.25,0.4,-0.9991,0.47,0.87,-1.1823,0.31,0.82
"C7_Immunologic_signatures:C7_ALL_732_GSE17721_0_5H_VS_4H_PAM3CSK4_BMDM_DN","C7_Immunologic_signatures","C7_ALL_732_GSE17721_0_5H_VS_4H_PAM3CSK4_BMDM_DN",197,-1.2245,0.088,0.15,1.0363,0.36,0.63,-0.8384,0.91,1
"GO_BP:499330_GO_0022412_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM","GO_BP","499330_GO_0022412_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM",231,-1.2244,0.076,0.33,-1.1107,0.19,0.94,0.93,0.69,0.92
"C1_Positional:C1_ALL_262_CHR4Q25","C1_Positional","C1_ALL_262_CHR4Q25",34,-1.2243,0.2,0.74,0.7448,0.9,0.98,-1.0463,0.4,0.85
"C7_Immunologic_signatures:C7_ALL_504_GSE17721_CTRL_VS_CPG_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_504_GSE17721_CTRL_VS_CPG_6H_BMDM_DN",199,-1.2243,0.086,0.15,0.9221,0.67,0.97,-0.8057,0.96,1
"GO_BP:505613_GO_0042476_ODONTOGENESIS","GO_BP","505613_GO_0042476_ODONTOGENESIS",101,-1.2241,0.14,0.33,-1.21,0.14,0.88,1.2166,0.11,0.71
"GO_BP:494780_GO_0010715_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY","GO_BP","494780_GO_0010715_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY",9,-1.2241,0.21,0.33,-0.7426,0.79,1,-1.2705,0.2,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_25_WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_25_WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP",107,-1.2241,0.13,0.25,1.3872,0.013,0.3,-0.7702,0.94,0.97
"C3_TF_targets:C3_TFT_313_V_ATF4_Q2","C3_TF_targets","C3_TFT_313_V_ATF4_Q2",255,-1.2241,0.088,0.16,-1.1457,0.14,0.45,-1.0027,0.43,0.76
"GO_BP:486626_GO_0000086_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","486626_GO_0000086_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE",141,-1.224,0.12,0.33,-0.7692,0.95,1,-1.5776,0,0.52
"GO_BP:502304_GO_0033083_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION","GO_BP","502304_GO_0033083_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION",8,-1.2237,0.25,0.33,0.7224,0.82,1,0.5714,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1586_FAELT_B_CLL_WITH_VH3_21_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1586_FAELT_B_CLL_WITH_VH3_21_DN",49,-1.2237,0.16,0.25,0.9433,0.57,0.87,-1.2777,0.11,0.45
"C3_TF_targets:C3_TFT_485_V_DR4_Q2","C3_TF_targets","C3_TFT_485_V_DR4_Q2",255,-1.2237,0.072,0.16,-1.2365,0.053,0.29,-0.9267,0.68,0.9
"C7_Immunologic_signatures:C7_ALL_712_GSE17721_0_5H_VS_8H_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_712_GSE17721_0_5H_VS_8H_LPS_BMDM_DN",196,-1.2235,0.1,0.15,0.6777,1,1,-0.886,0.78,0.97
"C7_Immunologic_signatures:C7_ALL_1800_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN","C7_Immunologic_signatures","C7_ALL_1800_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN",197,-1.2234,0.083,0.15,-0.6259,1,1,-1.074,0.29,0.56
"C1_Positional:C1_ALL_27_CHR15Q26","C1_Positional","C1_ALL_27_CHR15Q26",73,-1.2233,0.14,0.73,1.0705,0.32,0.66,1.3089,0.083,0.46
"GO_BP:491772_GO_0006921_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS","GO_BP","491772_GO_0006921_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS",69,-1.2232,0.15,0.33,-0.649,0.99,1,-0.6884,0.98,0.99
"C3_TF_targets:C3_TFT_420_V_GATA_Q6","C3_TF_targets","C3_TFT_420_V_GATA_Q6",191,-1.2232,0.08,0.16,-0.9465,0.62,0.88,1.0936,0.21,1
"GO_MF:510184_GO_0048020_CCR_CHEMOKINE_RECEPTOR_BINDING","GO_MF","510184_GO_0048020_CCR_CHEMOKINE_RECEPTOR_BINDING",16,-1.223,0.21,0.38,1.4667,0.075,0.4,1.3997,0.074,0.51
"GO_CC:503905_GO_0034705_POTASSIUM_CHANNEL_COMPLEX","GO_CC","503905_GO_0034705_POTASSIUM_CHANNEL_COMPLEX",80,-1.223,0.14,0.4,-1.2477,0.079,0.65,1.0915,0.25,0.91
"C6_Oncogenic_signatures:C6_ALL_116_CRX_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_116_CRX_DN_V1_UP",123,-1.223,0.13,0.15,-1.6689,0,0.06,-1.5441,0.0021,0.23
"GO_BP:495249_GO_0014855_STRIATED_MUSCLE_CELL_PROLIFERATION","GO_BP","495249_GO_0014855_STRIATED_MUSCLE_CELL_PROLIFERATION",16,-1.2229,0.23,0.33,-0.9183,0.57,1,-0.7952,0.73,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1717_SU_THYMUS","C2_Chemical_and_genetic_perturbations","C2_CGP_1717_SU_THYMUS",20,-1.2229,0.18,0.25,1.2976,0.14,0.4,0.6,0.96,1
"GO_BP:499857_GO_0030518_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","499857_GO_0030518_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY",77,-1.2228,0.15,0.33,-0.6319,0.99,1,-1.0592,0.32,0.81
"GO_BP:754613_GO_1901661_QUINONE_METABOLIC_PROCESS","GO_BP","754613_GO_1901661_QUINONE_METABOLIC_PROCESS",30,-1.2227,0.18,0.33,-0.6651,0.94,1,-0.8517,0.71,0.96
"KEGG_compound:C03033_BETA_D_GLUCURONOSIDE_O_BETA_D_GLUCURONOSIDE_GLUCURONIDE_BETA_D_GLUCURONIDE","KEGG_compound","C03033_BETA_D_GLUCURONOSIDE_O_BETA_D_GLUCURONOSIDE_GLUCURONIDE_BETA_D_GLUCURONIDE",21,-1.2226,0.2,0.36,1.8246,0,0.028,2.4237,0,0
"C7_Immunologic_signatures:C7_ALL_1518_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN","C7_Immunologic_signatures","C7_ALL_1518_GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN",199,-1.2226,0.092,0.16,1.0283,0.4,0.65,0.8396,0.88,1
"GO_BP:504906_GO_0035729_CELLULAR_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR_STIMULUS","GO_BP","504906_GO_0035729_CELLULAR_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR_STIMULUS",7,-1.2225,0.25,0.33,-0.6097,0.93,1,-1.0606,0.39,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2988_NIELSEN_LEIOMYOSARCOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2988_NIELSEN_LEIOMYOSARCOMA_DN",18,-1.2224,0.2,0.25,0.8529,0.67,0.97,1.0625,0.37,0.9
"C7_Immunologic_signatures:C7_ALL_1442_GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN","C7_Immunologic_signatures","C7_ALL_1442_GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN",197,-1.2224,0.084,0.16,0.7247,1,1,-1.0157,0.4,0.7
"GO_BP:493766_GO_0009651_RESPONSE_TO_SALT_STRESS","GO_BP","493766_GO_0009651_RESPONSE_TO_SALT_STRESS",24,-1.2224,0.19,0.33,0.9593,0.53,1,-1.2609,0.17,0.67
"GO_BP:495086_GO_0014013_REGULATION_OF_GLIOGENESIS","GO_BP","495086_GO_0014013_REGULATION_OF_GLIOGENESIS",73,-1.2222,0.15,0.33,0.8318,0.79,1,1.2409,0.1,0.71
"REACTOME:105696_REACT_1183_ERK2_ACTIVATION","REACTOME","105696_REACT_1183_ERK2_ACTIVATION",9,-1.2222,0.21,0.36,-0.5043,0.98,1,-1.0698,0.39,0.74
"C7_Immunologic_signatures:C7_ALL_510_GSE17721_CTRL_VS_CPG_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_510_GSE17721_CTRL_VS_CPG_24H_BMDM_DN",195,-1.2221,0.09,0.16,1.033,0.34,0.64,-0.9158,0.7,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1426_LEE_LIVER_CANCER_E2F1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1426_LEE_LIVER_CANCER_E2F1_DN",61,-1.222,0.16,0.25,-0.9593,0.51,1,-1.0531,0.35,0.68
"GO_BP:491136_GO_0006164_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","491136_GO_0006164_PURINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",123,-1.222,0.12,0.33,0.984,0.49,1,-1.2971,0.058,0.64
"C6_Oncogenic_signatures:C6_ALL_33_VEGF_A_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_33_VEGF_A_UP_V1_DN",192,-1.2219,0.1,0.15,1.3792,0.0091,0.26,-0.728,0.99,0.99
"GO_BP:501169_GO_0031929_TOR_SIGNALING","GO_BP","501169_GO_0031929_TOR_SIGNALING",16,-1.2217,0.21,0.33,0.6791,0.9,1,0.4891,1,1
"GO_CC:501652_GO_0032420_STEREOCILIUM","GO_CC","501652_GO_0032420_STEREOCILIUM",28,-1.2217,0.19,0.4,-1.4098,0.08,0.67,1.1117,0.31,0.9
"GO_BP:849968_GO_1902267_REGULATION_OF_POLYAMINE_TRANSMEMBRANE_TRANSPORT","GO_BP","849968_GO_1902267_REGULATION_OF_POLYAMINE_TRANSMEMBRANE_TRANSPORT",5,-1.2217,0.24,0.33,-0.5765,0.93,1,-0.9361,0.54,0.9
"GO_BP:754812_GO_1901861_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","754812_GO_1901861_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT",134,-1.2217,0.12,0.33,-0.883,0.73,1,-0.9775,0.48,0.88
"GO_MF:495662_GO_0015467_G_PROTEIN_ACTIVATED_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY","GO_MF","495662_GO_0015467_G_PROTEIN_ACTIVATED_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",6,-1.2216,0.26,0.38,1.0133,0.43,0.87,-0.6536,0.89,1
"WikiPathways:198883_WP22_IL_9_SIGNALING_PATHWAY","WikiPathways","198883_WP22_IL_9_SIGNALING_PATHWAY",24,-1.2216,0.2,0.27,0.9402,0.54,1,-0.5754,0.99,0.99
"GO_BP:493989_GO_0009895_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS","GO_BP","493989_GO_0009895_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS",205,-1.2216,0.088,0.33,0.8106,0.93,1,-0.7332,1,1
"C7_Immunologic_signatures:C7_ALL_448_GSE17721_CTRL_VS_LPS_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_448_GSE17721_CTRL_VS_LPS_0_5H_BMDM_DN",191,-1.2216,0.1,0.16,-0.7877,0.94,1,-1.1171,0.2,0.45
"C4_Cancer_gene_neighborhoods:C4_CGN_45_MORF_STK17A","C4_Cancer_gene_neighborhoods","C4_CGN_45_MORF_STK17A",165,-1.2215,0.1,0.3,-1.0812,0.27,0.76,-0.9674,0.54,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_824_TSUNODA_CISPLATIN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_824_TSUNODA_CISPLATIN_RESISTANCE_DN",48,-1.2215,0.18,0.25,0.775,0.87,1,1.0075,0.44,0.96
"GO_MF:489348_GO_0003847_1_ALKYL_2_ACETYLGLYCEROPHOSPHOCHOLINE_ESTERASE_ACTIVITY","GO_MF","489348_GO_0003847_1_ALKYL_2_ACETYLGLYCEROPHOSPHOCHOLINE_ESTERASE_ACTIVITY",5,-1.2213,0.21,0.38,1.2637,0.22,0.64,0.8002,0.7,1
"C3_MicroRNA_targets:C3_MIR_67_AAAGGAT_MIR_501","C3_MicroRNA_targets","C3_MIR_67_AAAGGAT_MIR_501",123,-1.2213,0.13,0.31,-0.7793,0.94,1,-0.9813,0.51,1
"GO_BP:495953_GO_0015825_L_SERINE_TRANSPORT","GO_BP","495953_GO_0015825_L_SERINE_TRANSPORT",8,-1.2212,0.23,0.33,0.9784,0.49,1,0.6716,0.89,1
"GO_BP:491648_GO_0006775_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS","GO_BP","491648_GO_0006775_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS",54,-1.2211,0.17,0.33,-1.3554,0.069,0.96,1.4803,0.019,0.58
"C1_Positional:C1_ALL_117_CHR8Q12","C1_Positional","C1_ALL_117_CHR8Q12",30,-1.221,0.18,0.73,1.498,0.027,0.29,-0.8172,0.77,0.98
"GO_BP:504867_GO_0035690_CELLULAR_RESPONSE_TO_DRUG","GO_BP","504867_GO_0035690_CELLULAR_RESPONSE_TO_DRUG",54,-1.2209,0.17,0.33,-0.7529,0.9,1,1.2588,0.12,0.69
"GO_BP:507970_GO_0045622_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION","GO_BP","507970_GO_0045622_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION",22,-1.2209,0.19,0.33,-1.4849,0.044,0.83,-0.8231,0.74,0.97
"GO_BP:514131_GO_0060576_INTESTINAL_EPITHELIAL_CELL_DEVELOPMENT","GO_BP","514131_GO_0060576_INTESTINAL_EPITHELIAL_CELL_DEVELOPMENT",13,-1.2209,0.21,0.33,0.8966,0.62,1,1.1964,0.25,0.72
"GO_BP:495121_GO_0014049_POSITIVE_REGULATION_OF_GLUTAMATE_SECRETION","GO_BP","495121_GO_0014049_POSITIVE_REGULATION_OF_GLUTAMATE_SECRETION",5,-1.2208,0.21,0.33,-0.7726,0.75,1,-1.4011,0.099,0.58
"C7_Immunologic_signatures:C7_ALL_1257_GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1257_GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP",174,-1.2205,0.093,0.16,1.0381,0.34,0.62,-1.0489,0.33,0.61
"GO_BP:505720_GO_0042594_RESPONSE_TO_STARVATION","GO_BP","505720_GO_0042594_RESPONSE_TO_STARVATION",165,-1.2205,0.11,0.33,0.6615,1,1,-0.8422,0.85,0.96
"GO_BP:1129328_GO_0098801_REGULATION_OF_RENAL_SYSTEM_PROCESS","GO_BP","1129328_GO_0098801_REGULATION_OF_RENAL_SYSTEM_PROCESS",35,-1.2204,0.2,0.33,1.7371,0.0041,0.15,1.382,0.052,0.64
"GO_BP:506923_GO_0043903_REGULATION_OF_SYMBIOSIS_ENCOMPASSING_MUTUALISM_THROUGH_PARASITISM","GO_BP","506923_GO_0043903_REGULATION_OF_SYMBIOSIS_ENCOMPASSING_MUTUALISM_THROUGH_PARASITISM",204,-1.2204,0.093,0.33,1.6546,0,0.24,-1.1751,0.12,0.73
"GO_BP:492111_GO_0007346_REGULATION_OF_MITOTIC_CELL_CYCLE","GO_BP","492111_GO_0007346_REGULATION_OF_MITOTIC_CELL_CYCLE",413,-1.2203,0.055,0.33,1.1223,0.12,0.88,-1.2349,0.018,0.7
"C3_TF_targets:C3_TFT_353_V_SP3_Q3","C3_TF_targets","C3_TFT_353_V_SP3_Q3",240,-1.2202,0.07,0.17,-1.4243,0.0034,0.15,-1.204,0.069,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_2217_VICENT_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2217_VICENT_METASTASIS_UP",14,-1.2202,0.23,0.25,0.6791,0.88,1,0.6372,0.93,1
"REACTOME:105670_REACT_831_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE","REACTOME","105670_REACT_831_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE",5,-1.2202,0.25,0.36,0.6701,0.87,1,-1.067,0.39,0.75
"GO_BP:513935_GO_0060379_CARDIAC_MUSCLE_CELL_MYOBLAST_DIFFERENTIATION","GO_BP","513935_GO_0060379_CARDIAC_MUSCLE_CELL_MYOBLAST_DIFFERENTIATION",10,-1.2201,0.23,0.33,-0.6532,0.91,1,1.8574,0.006,0.21
"C2_Chemical_and_genetic_perturbations:C2_CGP_139_DOANE_RESPONSE_TO_ANDROGEN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_139_DOANE_RESPONSE_TO_ANDROGEN_UP",180,-1.2201,0.1,0.25,-0.9815,0.49,1,-1.174,0.12,0.55
"GO_BP:501996_GO_0032770_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY","GO_BP","501996_GO_0032770_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY",25,-1.2201,0.2,0.33,0.8939,0.64,1,0.9532,0.53,0.9
"GO_BP:502917_GO_0033700_PHOSPHOLIPID_EFFLUX","GO_BP","502917_GO_0033700_PHOSPHOLIPID_EFFLUX",14,-1.2201,0.21,0.33,-0.8584,0.67,1,1.1196,0.31,0.75
"GO_BP:516788_GO_0071867_RESPONSE_TO_MONOAMINE","GO_BP","516788_GO_0071867_RESPONSE_TO_MONOAMINE",26,-1.22,0.21,0.33,-0.788,0.78,1,0.8826,0.66,0.96
"C4_Cancer_gene_neighborhoods:C4_CGN_160_MORF_PTPRB","C4_Cancer_gene_neighborhoods","C4_CGN_160_MORF_PTPRB",243,-1.22,0.083,0.3,-1.0195,0.4,0.82,1.2094,0.071,0.42
"GO_MF:490636_GO_0005540_HYALURONIC_ACID_BINDING","GO_MF","490636_GO_0005540_HYALURONIC_ACID_BINDING",22,-1.2199,0.2,0.38,-1.0535,0.38,0.86,1.1328,0.28,0.8
"C7_Immunologic_signatures:C7_ALL_644_GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_644_GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDM_DN",196,-1.2199,0.084,0.16,1.3335,0.012,0.074,-0.9833,0.5,0.76
"GO_BP:513904_GO_0060348_BONE_DEVELOPMENT","GO_BP","513904_GO_0060348_BONE_DEVELOPMENT",162,-1.2198,0.11,0.33,-1.2563,0.051,0.91,-0.9783,0.51,0.87
"GO_BP:495935_GO_0015804_NEUTRAL_AMINO_ACID_TRANSPORT","GO_BP","495935_GO_0015804_NEUTRAL_AMINO_ACID_TRANSPORT",30,-1.2198,0.21,0.33,0.8893,0.63,1,-1.0114,0.43,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_2250_MITSIADES_RESPONSE_TO_APLIDIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2250_MITSIADES_RESPONSE_TO_APLIDIN_DN",249,-1.2198,0.085,0.25,0.9446,0.63,0.87,-1.519,0,0.29
"GO_MF:752446_GO_0086080_PROTEIN_BINDING_INVOLVED_IN_HETEROTYPIC_CELL_CELL_ADHESION","GO_MF","752446_GO_0086080_PROTEIN_BINDING_INVOLVED_IN_HETEROTYPIC_CELL_CELL_ADHESION",9,-1.2198,0.22,0.38,-0.77,0.77,1,-0.8613,0.62,0.91
"C7_Immunologic_signatures:C7_ALL_546_GSE17721_POLYIC_VS_PAM3CSK4_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_546_GSE17721_POLYIC_VS_PAM3CSK4_0_5H_BMDM_DN",197,-1.2196,0.094,0.16,1.0494,0.34,0.59,0.8432,0.88,1
"GO_BP:497975_GO_0019098_REPRODUCTIVE_BEHAVIOR","GO_BP","497975_GO_0019098_REPRODUCTIVE_BEHAVIOR",78,-1.2195,0.16,0.33,0.8262,0.81,1,-0.825,0.82,0.97
"GO_BP:491137_GO_0006165_NUCLEOSIDE_DIPHOSPHATE_PHOSPHORYLATION","GO_BP","491137_GO_0006165_NUCLEOSIDE_DIPHOSPHATE_PHOSPHORYLATION",18,-1.2193,0.22,0.33,-0.82,0.7,1,-0.9221,0.57,0.91
"GO_CC:494018_GO_0009925_BASAL_PLASMA_MEMBRANE","GO_CC","494018_GO_0009925_BASAL_PLASMA_MEMBRANE",29,-1.2193,0.19,0.41,-1.1862,0.23,0.68,-0.8977,0.62,1
"REACTOME:105909_REACT_18325_REGULATION_OF_INSULIN_SECRETION","REACTOME","105909_REACT_18325_REGULATION_OF_INSULIN_SECRETION",76,-1.2192,0.13,0.36,-0.9608,0.53,1,0.7784,0.9,1
"GO_MF:489304_GO_0003785_ACTIN_MONOMER_BINDING","GO_MF","489304_GO_0003785_ACTIN_MONOMER_BINDING",19,-1.2191,0.2,0.38,0.7656,0.8,1,-1.1077,0.33,0.7
"C4_Cancer_gene_neighborhoods:C4_CGN_70_MORF_CASP2","C4_Cancer_gene_neighborhoods","C4_CGN_70_MORF_CASP2",100,-1.2189,0.13,0.3,-0.8165,0.87,1,1.0678,0.32,0.64
"C7_Immunologic_signatures:C7_ALL_503_GSE17721_CTRL_VS_CPG_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_503_GSE17721_CTRL_VS_CPG_6H_BMDM_UP",198,-1.2188,0.088,0.16,0.938,0.67,0.94,-1.2944,0.019,0.14
"REACTOME:106379_REACT_18290_CALCITONIN_LIKE_LIGAND_RECEPTORS","REACTOME","106379_REACT_18290_CALCITONIN_LIKE_LIGAND_RECEPTORS",9,-1.2188,0.23,0.36,-1.2058,0.24,0.82,0.6952,0.86,1
"GO_BP:948853_GO_0044839_CELL_CYCLE_G2_M_PHASE_TRANSITION","GO_BP","948853_GO_0044839_CELL_CYCLE_G2_M_PHASE_TRANSITION",141,-1.2187,0.11,0.33,-0.7746,0.95,1,-1.6058,0.002,0.52
"GO_MF:490578_GO_0005436_SODIUM_PHOSPHATE_SYMPORTER_ACTIVITY","GO_MF","490578_GO_0005436_SODIUM_PHOSPHATE_SYMPORTER_ACTIVITY",8,-1.2186,0.24,0.38,0.7393,0.8,1,-1.5857,0.04,0.36
"GO_CC:496367_GO_0016328_LATERAL_PLASMA_MEMBRANE","GO_CC","496367_GO_0016328_LATERAL_PLASMA_MEMBRANE",47,-1.2186,0.18,0.41,-1.276,0.11,0.66,-1.2294,0.16,0.74
"GO_BP:499061_GO_0021781_GLIAL_CELL_FATE_COMMITMENT","GO_BP","499061_GO_0021781_GLIAL_CELL_FATE_COMMITMENT",15,-1.2184,0.21,0.33,1.0436,0.39,0.95,0.7745,0.78,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1800_GENTILE_UV_RESPONSE_CLUSTER_D2","C2_Chemical_and_genetic_perturbations","C2_CGP_1800_GENTILE_UV_RESPONSE_CLUSTER_D2",41,-1.2184,0.18,0.25,1.132,0.25,0.58,0.6978,0.95,1
"REACTOME:119553_REACT_19183_CD28_CO_STIMULATION","REACTOME","119553_REACT_19183_CD28_CO_STIMULATION",32,-1.2184,0.19,0.36,0.6013,0.98,1,-0.9797,0.49,0.87
"GO_BP:494604_GO_0010535_POSITIVE_REGULATION_OF_ACTIVATION_OF_JAK2_KINASE_ACTIVITY","GO_BP","494604_GO_0010535_POSITIVE_REGULATION_OF_ACTIVATION_OF_JAK2_KINASE_ACTIVITY",6,-1.2182,0.22,0.33,-1.0915,0.38,0.95,-1.0458,0.4,0.82
"GO_BP:513259_GO_0052472_MODULATION_BY_HOST_OF_SYMBIONT_TRANSCRIPTION","GO_BP","513259_GO_0052472_MODULATION_BY_HOST_OF_SYMBIONT_TRANSCRIPTION",22,-1.2182,0.22,0.33,0.8575,0.68,1,-1.003,0.44,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_2420_BLUM_RESPONSE_TO_SALIRASIB_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2420_BLUM_RESPONSE_TO_SALIRASIB_UP",243,-1.2182,0.094,0.26,1.3056,0.017,0.39,-0.6801,1,0.99
"C4_Cancer_modules:C4_CM_241_MODULE_272","C4_Cancer_modules","C4_CM_241_MODULE_272",12,-1.2181,0.22,0.26,-0.6735,0.88,1,0.7591,0.8,1
"GO_BP:505590_GO_0042451_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS","GO_BP","505590_GO_0042451_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS",112,-1.2181,0.15,0.33,1.0608,0.32,0.94,-1.1421,0.18,0.75
"GO_MF:511945_GO_0051020_GTPASE_BINDING","GO_MF","511945_GO_0051020_GTPASE_BINDING",239,-1.2181,0.077,0.38,-1.1503,0.15,0.81,-0.9136,0.73,0.87
"C3_TF_targets:C3_TFT_294_V_NKX22_01","C3_TF_targets","C3_TFT_294_V_NKX22_01",183,-1.2181,0.11,0.17,-1.1811,0.13,0.39,1.1306,0.17,0.98
"KEGG_pathway:HSA04622_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY","KEGG_pathway","HSA04622_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY",65,-1.2181,0.17,0.21,-0.7411,0.93,1,-1.5632,0.0021,0.11
"GO_BP:518926_GO_2000279_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS","GO_BP","518926_GO_2000279_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS",17,-1.2179,0.22,0.33,0.791,0.78,1,0.7842,0.81,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2029_MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2029_MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP",10,-1.2179,0.23,0.26,0.5427,0.98,1,1.267,0.17,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_1837_WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH","C2_Chemical_and_genetic_perturbations","C2_CGP_1837_WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH",60,-1.2178,0.17,0.26,0.7982,0.85,0.99,-1.0804,0.3,0.65
"C3_MicroRNA_targets:C3_MIR_11_CACTGCC_MIR_34A_MIR_34C_MIR_449","C3_MicroRNA_targets","C3_MIR_11_CACTGCC_MIR_34A_MIR_34C_MIR_449",274,-1.2178,0.087,0.31,-1.0247,0.38,1,-1.1685,0.1,1
"GO_BP:514325_GO_0060770_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT","GO_BP","514325_GO_0060770_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT",7,-1.2176,0.23,0.33,0.6574,0.89,1,-0.8161,0.69,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_3212_RAFFEL_VEGFA_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3212_RAFFEL_VEGFA_TARGETS_UP",9,-1.2176,0.22,0.26,1.122,0.3,0.6,0.8998,0.57,1
"KEGG_compound:C00957_MERCAPTOPYRUVATE_3_MERCAPTOPYRUVIC_ACID_3_MERCAPTOPYRUVATE","KEGG_compound","C00957_MERCAPTOPYRUVATE_3_MERCAPTOPYRUVIC_ACID_3_MERCAPTOPYRUVATE",9,-1.2175,0.23,0.37,-0.8153,0.71,1,-1.2506,0.2,0.41
"C6_Oncogenic_signatures:C6_ALL_158_KRAS_AMP_LUNG_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_158_KRAS_AMP_LUNG_UP_V1_DN",132,-1.2174,0.13,0.16,-0.7948,0.92,0.99,1.1451,0.16,0.35
"GO_MF:496401_GO_0016413_O_ACETYLTRANSFERASE_ACTIVITY","GO_MF","496401_GO_0016413_O_ACETYLTRANSFERASE_ACTIVITY",6,-1.2173,0.25,0.39,0.614,0.92,1,-0.6641,0.86,1
"KEGG_compound:C00078_L_TRYPTOPHAN_TRYPTOPHAN_S_ALPHA_AMINO_BETA_3_INDOLYL_PROPIONIC_ACID","KEGG_compound","C00078_L_TRYPTOPHAN_TRYPTOPHAN_S_ALPHA_AMINO_BETA_3_INDOLYL_PROPIONIC_ACID",9,-1.2173,0.22,0.37,-1.4803,0.072,0.33,-1.0064,0.46,0.64
"C3_TF_targets:C3_TFT_103_V_PAX5_02","C3_TF_targets","C3_TFT_103_V_PAX5_02",17,-1.2173,0.19,0.17,0.773,0.8,1,-1.1432,0.26,0.46
"GO_BP:517294_GO_0072378_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION","GO_BP","517294_GO_0072378_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION",22,-1.2172,0.22,0.33,0.9851,0.46,1,0.8741,0.63,0.96
"C3_TF_targets:C3_TFT_544_YGCANTGCR_UNKNOWN","C3_TF_targets","C3_TFT_544_YGCANTGCR_UNKNOWN",123,-1.2171,0.13,0.17,0.8054,0.9,1,-0.8436,0.86,0.98
"GO_BP:517444_GO_0072539_T_HELPER_17_CELL_DIFFERENTIATION","GO_BP","517444_GO_0072539_T_HELPER_17_CELL_DIFFERENTIATION",5,-1.2169,0.25,0.33,-0.7624,0.75,1,-0.8751,0.6,0.94
"REACTOME:106114_REACT_1190_TRIGLYCERIDE_BIOSYNTHESIS","REACTOME","106114_REACT_1190_TRIGLYCERIDE_BIOSYNTHESIS",45,-1.2168,0.19,0.37,0.7729,0.86,1,-1.4864,0.027,0.38
"GO_CC:502215_GO_0032993_PROTEIN_DNA_COMPLEX","GO_CC","502215_GO_0032993_PROTEIN_DNA_COMPLEX",153,-1.2167,0.11,0.41,-1.3043,0.051,0.65,-1.3954,0.014,0.59
"GO_MF:490260_GO_0004970_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY","GO_MF","490260_GO_0004970_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY",19,-1.2167,0.2,0.39,0.9236,0.57,0.95,2.1139,0,0.0063
"GO_CC:499965_GO_0030660_GOLGI_ASSOCIATED_VESICLE_MEMBRANE","GO_CC","499965_GO_0030660_GOLGI_ASSOCIATED_VESICLE_MEMBRANE",45,-1.2167,0.17,0.41,0.9507,0.54,0.83,-0.8671,0.7,1
"GO_MF:490546_GO_0005355_GLUCOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490546_GO_0005355_GLUCOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",12,-1.2165,0.2,0.39,-1.095,0.35,0.84,-1.0212,0.41,0.77
"C7_Immunologic_signatures:C7_ALL_208_GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_208_GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN",161,-1.2165,0.1,0.16,-1.1011,0.23,1,1.3562,0.017,0.2
"C7_Immunologic_signatures:C7_ALL_417_GSE15930_STIM_VS_STIM_AND_IL_12_48H_CD8_T_CELL_UP","C7_Immunologic_signatures","C7_ALL_417_GSE15930_STIM_VS_STIM_AND_IL_12_48H_CD8_T_CELL_UP",197,-1.2165,0.11,0.16,1.2419,0.051,0.16,-0.9376,0.64,0.88
"GO_BP:492883_GO_0008635_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS_BY_CYTOCHROME_C","GO_BP","492883_GO_0008635_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS_BY_CYTOCHROME_C",8,-1.2165,0.24,0.33,0.7962,0.74,1,-0.872,0.63,0.95
"C7_Immunologic_signatures:C7_ALL_751_GSE17721_12H_VS_24H_CPG_BMDM_UP","C7_Immunologic_signatures","C7_ALL_751_GSE17721_12H_VS_24H_CPG_BMDM_UP",194,-1.2164,0.11,0.16,1.1325,0.16,0.36,0.9155,0.7,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_471_BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_471_BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP",16,-1.2164,0.22,0.26,1.5782,0.04,0.16,-0.9584,0.49,0.81
"KEGG_reaction:R02746_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_ACYLHYDROLASE_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_H2O_SN_GLYCERO_3_PHOSPHOCHOLINE_FATTY_ACID","KEGG_reaction","R02746_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_ACYLHYDROLASE_1_ACYL_SN_GLYCERO_3_PHOSPHOCHOLINE_H2O_SN_GLYCERO_3_PHOSPHOCHOLINE_FATTY_ACID",5,-1.2163,0.24,0.35,-1.0104,0.46,0.81,0.5108,0.97,0.98
"GO_BP:500174_GO_0030879_MAMMARY_GLAND_DEVELOPMENT","GO_BP","500174_GO_0030879_MAMMARY_GLAND_DEVELOPMENT",122,-1.2163,0.15,0.33,0.9369,0.63,1,1.1177,0.21,0.75
"REACTOME:730341_REACT_150417_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET_","REACTOME","730341_REACT_150417_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET_",8,-1.2162,0.25,0.37,-1.239,0.24,0.78,-0.8853,0.62,0.97
"GO_BP:491587_GO_0006700_C21_STEROID_HORMONE_BIOSYNTHETIC_PROCESS","GO_BP","491587_GO_0006700_C21_STEROID_HORMONE_BIOSYNTHETIC_PROCESS",15,-1.2162,0.22,0.33,-1.0399,0.4,0.98,0.8358,0.71,0.99
"GO_BP:492012_GO_0007214_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY","GO_BP","492012_GO_0007214_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY",23,-1.2162,0.21,0.33,-1.3863,0.091,1,-0.9919,0.45,0.85
"GO_BP:498967_GO_0021684_CEREBELLAR_GRANULAR_LAYER_FORMATION","GO_BP","498967_GO_0021684_CEREBELLAR_GRANULAR_LAYER_FORMATION",10,-1.2161,0.24,0.33,1.2185,0.23,0.76,0.6436,0.93,1
"GO_BP:516934_GO_0072015_GLOMERULAR_VISCERAL_EPITHELIAL_CELL_DEVELOPMENT","GO_BP","516934_GO_0072015_GLOMERULAR_VISCERAL_EPITHELIAL_CELL_DEVELOPMENT",8,-1.2161,0.24,0.33,-0.8447,0.67,1,-0.9225,0.55,0.91
"C3_TF_targets:C3_TFT_376_V_CACCCBINDINGFACTOR_Q6","C3_TF_targets","C3_TFT_376_V_CACCCBINDINGFACTOR_Q6",263,-1.2161,0.083,0.17,-1.3385,0.016,0.19,-1.0544,0.28,0.62
"C3_TF_targets:C3_TFT_373_V_ZF5_01","C3_TF_targets","C3_TFT_373_V_ZF5_01",231,-1.216,0.081,0.17,-0.8126,0.96,1,-1.0133,0.41,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_477_TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_477_TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP",7,-1.2159,0.24,0.26,1.1368,0.31,0.57,1.3421,0.13,0.58
"GO_BP:507509_GO_0045117_AZOLE_TRANSPORT","GO_BP","507509_GO_0045117_AZOLE_TRANSPORT",18,-1.2159,0.22,0.33,0.7663,0.8,1,0.9961,0.47,0.86
"KEGG_compound:C05271_TRANS_HEX_2_ENOYL_COA_2E_HEXENOYL_COA","KEGG_compound","C05271_TRANS_HEX_2_ENOYL_COA_2E_HEXENOYL_COA",10,-1.2158,0.22,0.37,0.5491,0.97,1,-1.7049,0.02,0.071
"C1_Positional:C1_ALL_212_CHR15Q","C1_Positional","C1_ALL_212_CHR15Q",8,-1.2157,0.23,0.73,1.2459,0.21,0.59,-1.52,0.042,0.61
"GO_BP:513603_GO_0060045_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION","GO_BP","513603_GO_0060045_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION",19,-1.2157,0.21,0.33,-0.6791,0.9,1,1.1501,0.26,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_909_HATADA_METHYLATED_IN_LUNG_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_909_HATADA_METHYLATED_IN_LUNG_CANCER_UP",384,-1.2157,0.057,0.26,-1.125,0.13,0.89,1.1087,0.18,0.88
"GO_BP:505747_GO_0042633_HAIR_CYCLE","GO_BP","505747_GO_0042633_HAIR_CYCLE",82,-1.2156,0.14,0.33,0.8694,0.75,1,0.8889,0.71,0.95
"GO_BP:500823_GO_0031572_G2_DNA_DAMAGE_CHECKPOINT","GO_BP","500823_GO_0031572_G2_DNA_DAMAGE_CHECKPOINT",35,-1.2156,0.18,0.33,-0.615,0.99,1,-1.3207,0.11,0.63
"C6_Oncogenic_signatures:C6_ALL_13_RAPA_EARLY_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_13_RAPA_EARLY_UP_V1_DN",177,-1.2156,0.13,0.16,-1.0928,0.26,0.57,-1.1665,0.12,0.44
"GO_BP:489050_GO_0003256_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_MYOCARDIAL_PRECURSOR_CELL_DIFFERENTIATION","GO_BP","489050_GO_0003256_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_MYOCARDIAL_PRECURSOR_CELL_DIFFERENTIATION",7,-1.2156,0.24,0.33,-0.9348,0.55,1,1.6938,0.0079,0.42
"WikiPathways:198763_WP554_ACE_INHIBITOR_PATHWAY","WikiPathways","198763_WP554_ACE_INHIBITOR_PATHWAY",17,-1.2156,0.22,0.28,1.4711,0.069,0.36,1.054,0.38,0.84
"GO_BP:506538_GO_0043507_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY","GO_BP","506538_GO_0043507_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY",60,-1.2155,0.17,0.33,-0.9509,0.54,1,-0.9207,0.61,0.91
"GO_BP:508732_GO_0046471_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS","GO_BP","508732_GO_0046471_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS",33,-1.2154,0.19,0.33,-0.8203,0.73,1,-0.881,0.65,0.94
"GO_BP:491088_GO_0006109_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS","GO_BP","491088_GO_0006109_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS",157,-1.2154,0.11,0.33,0.9695,0.54,1,1.1796,0.11,0.72
"GO_MF:511281_GO_0050291_SPHINGOSINE_N_ACYLTRANSFERASE_ACTIVITY","GO_MF","511281_GO_0050291_SPHINGOSINE_N_ACYLTRANSFERASE_ACTIVITY",6,-1.2154,0.24,0.39,-1.3378,0.15,0.7,-1.3316,0.16,0.55
"GO_MF:511834_GO_0050897_COBALT_ION_BINDING","GO_MF","511834_GO_0050897_COBALT_ION_BINDING",5,-1.2154,0.25,0.39,-0.6988,0.85,1,-1.1919,0.29,0.59
"GO_MF:500794_GO_0031543_PEPTIDYL_PROLINE_DIOXYGENASE_ACTIVITY","GO_MF","500794_GO_0031543_PEPTIDYL_PROLINE_DIOXYGENASE_ACTIVITY",13,-1.2152,0.23,0.39,-1.0538,0.39,0.87,-1.4322,0.064,0.44
"KEGG_pathway:HSA00120_PRIMARY_BILE_ACID_BIOSYNTHESIS","KEGG_pathway","HSA00120_PRIMARY_BILE_ACID_BIOSYNTHESIS",16,-1.2152,0.21,0.21,1.0615,0.37,0.85,-0.8603,0.65,0.89
"C4_Cancer_gene_neighborhoods:C4_CGN_23_MORF_MDM2","C4_Cancer_gene_neighborhoods","C4_CGN_23_MORF_MDM2",271,-1.2152,0.075,0.31,-1.2214,0.066,0.69,1.0819,0.24,0.63
"GO_BP:497171_GO_0018200_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION","GO_BP","497171_GO_0018200_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION",29,-1.2151,0.19,0.34,-0.8664,0.66,1,-1.2865,0.14,0.65
"GO_BP:493453_GO_0009260_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","493453_GO_0009260_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",152,-1.2151,0.13,0.34,0.9064,0.73,1,-1.2353,0.079,0.7
"GO_BP:515430_GO_0070498_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY","GO_BP","515430_GO_0070498_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY",12,-1.2151,0.23,0.34,-0.9358,0.52,1,0.8428,0.65,0.99
"GO_BP:504641_GO_0035457_CELLULAR_RESPONSE_TO_INTERFERON_ALPHA","GO_BP","504641_GO_0035457_CELLULAR_RESPONSE_TO_INTERFERON_ALPHA",8,-1.215,0.22,0.34,1.2122,0.26,0.77,-0.6234,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_799_MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_799_MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN",20,-1.215,0.21,0.26,1.5127,0.035,0.2,-1.3918,0.08,0.36
"GO_BP:753003_GO_1900003_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_BP","753003_GO_1900003_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY",6,-1.2149,0.22,0.34,1.2199,0.23,0.77,-0.7652,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2812_FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2812_FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN",76,-1.2148,0.14,0.26,-1.0579,0.35,0.98,-1.523,0.0063,0.29
"GO_BP:1184356_GO_0061687_DETOXIFICATION_OF_INORGANIC_COMPOUND","GO_BP","1184356_GO_0061687_DETOXIFICATION_OF_INORGANIC_COMPOUND",7,-1.2148,0.23,0.34,1.1941,0.25,0.79,-0.5509,0.97,1
"GO_CC:487451_GO_0001527_MICROFIBRIL","GO_CC","487451_GO_0001527_MICROFIBRIL",9,-1.2146,0.23,0.41,0.6082,0.93,0.99,-1.0802,0.35,0.93
"GO_BP:513715_GO_0060157_URINARY_BLADDER_DEVELOPMENT","GO_BP","513715_GO_0060157_URINARY_BLADDER_DEVELOPMENT",5,-1.2146,0.25,0.34,0.8933,0.58,1,1.3089,0.19,0.67
"GO_MF:490616_GO_0005507_COPPER_ION_BINDING","GO_MF","490616_GO_0005507_COPPER_ION_BINDING",53,-1.2145,0.18,0.39,-0.6539,0.98,1,-1.209,0.17,0.57
"GO_BP:513940_GO_0060384_INNERVATION","GO_BP","513940_GO_0060384_INNERVATION",21,-1.2145,0.18,0.34,-1.1812,0.24,0.91,0.9524,0.52,0.9
"GO_BP:499686_GO_0030282_BONE_MINERALIZATION","GO_BP","499686_GO_0030282_BONE_MINERALIZATION",37,-1.2143,0.21,0.34,-1.2915,0.12,0.88,-0.7924,0.81,0.99
"C1_Positional:C1_ALL_38_CHR3P22","C1_Positional","C1_ALL_38_CHR3P22",59,-1.2143,0.15,0.73,-0.862,0.71,0.97,-1.034,0.38,0.85
"GO_BP:500348_GO_0031058_POSITIVE_REGULATION_OF_HISTONE_MODIFICATION","GO_BP","500348_GO_0031058_POSITIVE_REGULATION_OF_HISTONE_MODIFICATION",61,-1.2142,0.18,0.34,-1.2337,0.13,0.9,-1.037,0.36,0.82
"GO_BP:503552_GO_0034350_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS","GO_BP","503552_GO_0034350_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS",7,-1.2141,0.25,0.34,0.9236,0.54,1,1.1763,0.27,0.72
"GO_BP:504292_GO_0035107_APPENDAGE_MORPHOGENESIS","GO_BP","504292_GO_0035107_APPENDAGE_MORPHOGENESIS",147,-1.2141,0.13,0.34,-0.9224,0.66,1,1.2692,0.054,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_3315_RATTENBACHER_BOUND_BY_CELF1","C2_Chemical_and_genetic_perturbations","C2_CGP_3315_RATTENBACHER_BOUND_BY_CELF1",438,-1.2141,0.048,0.26,-0.8102,0.99,1,-0.912,0.81,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_758_XU_AKT1_TARGETS_6HR","C2_Chemical_and_genetic_perturbations","C2_CGP_758_XU_AKT1_TARGETS_6HR",27,-1.214,0.21,0.26,1.3445,0.075,0.35,-1.6156,0.0099,0.23
"C3_TF_targets:C3_TFT_210_V_WHN_B","C3_TF_targets","C3_TFT_210_V_WHN_B",249,-1.214,0.096,0.17,-0.8408,0.92,1,-0.9723,0.52,0.81
"C4_Cancer_modules:C4_CM_356_MODULE_430","C4_Cancer_modules","C4_CM_356_MODULE_430",55,-1.214,0.17,0.27,-0.7964,0.84,0.98,-1.5377,0.018,0.13
"REACTOME:477115_REACT_111064_DAG_AND_IP3_SIGNALING","REACTOME","477115_REACT_111064_DAG_AND_IP3_SIGNALING",34,-1.2138,0.19,0.37,-0.9736,0.51,1,-1.5223,0.034,0.33
"GO_BP:506409_GO_0043370_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION","GO_BP","506409_GO_0043370_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION",26,-1.2138,0.19,0.34,-1.4474,0.062,0.9,-0.7016,0.91,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1905_TSENG_IRS1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1905_TSENG_IRS1_TARGETS_UP",111,-1.2137,0.14,0.26,1.5152,0.0021,0.2,1.0248,0.42,0.95
"GO_BP:492379_GO_0007638_MECHANOSENSORY_BEHAVIOR","GO_BP","492379_GO_0007638_MECHANOSENSORY_BEHAVIOR",11,-1.2137,0.23,0.34,-0.7885,0.78,1,1.5588,0.039,0.49
"C2_Chemical_and_genetic_perturbations:C2_CGP_2145_CLAUS_PGR_POSITIVE_MENINGIOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2145_CLAUS_PGR_POSITIVE_MENINGIOMA_DN",12,-1.2136,0.21,0.26,0.681,0.88,1,-1.4339,0.096,0.34
"GO_BP:492343_GO_0007602_PHOTOTRANSDUCTION","GO_BP","492343_GO_0007602_PHOTOTRANSDUCTION",111,-1.2136,0.13,0.34,-1.1039,0.24,0.94,-0.9847,0.48,0.86
"C7_Immunologic_signatures:C7_ALL_457_GSE17721_CTRL_VS_LPS_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_457_GSE17721_CTRL_VS_LPS_8H_BMDM_UP",199,-1.2135,0.097,0.17,1.1224,0.17,0.38,-1.3323,0.014,0.11
"REACTOME:105672_REACT_607_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE","REACTOME","105672_REACT_607_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE",5,-1.2134,0.27,0.37,0.6809,0.85,1,-1.064,0.38,0.75
"GO_BP:753987_GO_1901017_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","753987_GO_1901017_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",10,-1.2134,0.22,0.34,-0.8965,0.6,1,-1.343,0.14,0.61
"GO_MF:516178_GO_0071253_CONNEXIN_BINDING","GO_MF","516178_GO_0071253_CONNEXIN_BINDING",5,-1.2134,0.25,0.39,1.1706,0.3,0.73,1.2097,0.27,0.71
"GO_BP:1022098_GO_0098661_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORT","GO_BP","1022098_GO_0098661_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORT",120,-1.2134,0.13,0.34,-0.9175,0.67,1,1.179,0.14,0.72
"GO_MF:492716_GO_0008420_CTD_PHOSPHATASE_ACTIVITY","GO_MF","492716_GO_0008420_CTD_PHOSPHATASE_ACTIVITY",6,-1.2134,0.24,0.39,0.5879,0.94,1,-0.7317,0.79,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_3061_CHICAS_RB1_TARGETS_GROWING","C2_Chemical_and_genetic_perturbations","C2_CGP_3061_CHICAS_RB1_TARGETS_GROWING",238,-1.2133,0.1,0.26,0.9123,0.73,0.91,-1.3885,0,0.36
"GO_CC:487594_GO_0005868_CYTOPLASMIC_DYNEIN_COMPLEX","GO_CC","487594_GO_0005868_CYTOPLASMIC_DYNEIN_COMPLEX",26,-1.2132,0.21,0.41,-0.9957,0.46,0.85,0.7254,0.87,1
"C4_Cancer_gene_neighborhoods:C4_CGN_51_MORF_TFDP2","C4_Cancer_gene_neighborhoods","C4_CGN_51_MORF_TFDP2",223,-1.2132,0.1,0.31,-1.2113,0.1,0.69,-0.9411,0.65,0.98
"GO_MF:489513_GO_0004046_AMINOACYLASE_ACTIVITY","GO_MF","489513_GO_0004046_AMINOACYLASE_ACTIVITY",5,-1.2132,0.24,0.39,1.4848,0.053,0.39,-1.7531,0.002,0.22
"C1_Positional:C1_ALL_67_CHR11Q12","C1_Positional","C1_ALL_67_CHR11Q12",143,-1.2131,0.12,0.72,-0.8892,0.74,1,-1.4029,0.012,0.59
"GO_MF:490564_GO_0005384_MANGANESE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490564_GO_0005384_MANGANESE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-1.213,0.24,0.39,-0.6902,0.85,1,0.8356,0.66,1
"C3_TF_targets:C3_TFT_54_V_EVI1_05","C3_TF_targets","C3_TFT_54_V_EVI1_05",168,-1.2128,0.13,0.18,1.2683,0.053,0.51,-1.032,0.38,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_3071_HOELZEL_NF1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3071_HOELZEL_NF1_TARGETS_DN",109,-1.2127,0.14,0.26,0.9764,0.52,0.82,1.292,0.07,0.69
"GO_MF:490418_GO_0030297_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY","GO_MF","490418_GO_0030297_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY",5,-1.2127,0.22,0.39,1.1142,0.37,0.77,0.6693,0.87,1
"REACTOME:833830_REACT_163910_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION","REACTOME","833830_REACT_163910_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION",12,-1.2126,0.23,0.37,-1.0094,0.43,0.99,1.0461,0.39,0.97
"GO_BP:516240_GO_0071316_CELLULAR_RESPONSE_TO_NICOTINE","GO_BP","516240_GO_0071316_CELLULAR_RESPONSE_TO_NICOTINE",8,-1.2126,0.22,0.34,-1.093,0.35,0.95,-1.4906,0.063,0.54
"REACTOME:187218_REACT_23810_CALNEXIN_CALRETICULIN_CYCLE","REACTOME","187218_REACT_23810_CALNEXIN_CALRETICULIN_CYCLE",11,-1.2126,0.23,0.37,0.7283,0.84,1,-1.1828,0.23,0.62
"C4_Cancer_modules:C4_CM_233_MODULE_257","C4_Cancer_modules","C4_CM_233_MODULE_257",156,-1.2125,0.12,0.27,-1.095,0.26,0.7,-0.878,0.78,0.88
"GO_BP:752387_GO_0086015_SA_NODE_CELL_ACTION_POTENTIAL","GO_BP","752387_GO_0086015_SA_NODE_CELL_ACTION_POTENTIAL",7,-1.2124,0.24,0.34,0.8577,0.62,1,1.1742,0.27,0.72
"GO_BP:488872_GO_0035809_REGULATION_OF_URINE_VOLUME","GO_BP","488872_GO_0035809_REGULATION_OF_URINE_VOLUME",19,-1.2124,0.19,0.34,1.3112,0.14,0.66,1.6687,0.008,0.39
"GO_BP:487979_GO_0002090_REGULATION_OF_RECEPTOR_INTERNALIZATION","GO_BP","487979_GO_0002090_REGULATION_OF_RECEPTOR_INTERNALIZATION",29,-1.2123,0.19,0.34,-0.7418,0.87,1,0.9134,0.57,0.93
"C7_Immunologic_signatures:C7_ALL_1019_GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1019_GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP",193,-1.2123,0.12,0.17,1.1221,0.19,0.38,-0.8262,0.92,1
"C3_TF_targets:C3_TFT_328_V_CEBPGAMMA_Q6","C3_TF_targets","C3_TFT_328_V_CEBPGAMMA_Q6",250,-1.2122,0.085,0.18,1.193,0.065,0.71,1.3339,0.0098,0.65
"GO_BP:488208_GO_0002335_MATURE_B_CELL_DIFFERENTIATION","GO_BP","488208_GO_0002335_MATURE_B_CELL_DIFFERENTIATION",13,-1.2122,0.21,0.34,-0.5064,0.99,1,-0.7729,0.79,1
"GO_BP:508771_GO_0046512_SPHINGOSINE_BIOSYNTHETIC_PROCESS","GO_BP","508771_GO_0046512_SPHINGOSINE_BIOSYNTHETIC_PROCESS",6,-1.2121,0.22,0.34,0.719,0.83,1,-1.3809,0.14,0.59
"GO_BP:507825_GO_0045475_LOCOMOTOR_RHYTHM","GO_BP","507825_GO_0045475_LOCOMOTOR_RHYTHM",7,-1.2121,0.25,0.34,-0.6751,0.89,1,-0.9505,0.54,0.89
"C7_Immunologic_signatures:C7_ALL_1015_GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1015_GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP",192,-1.212,0.11,0.17,-0.9267,0.66,1,-1.309,0.031,0.13
"C7_Immunologic_signatures:C7_ALL_439_GSE17580_TREG_VS_TEFF_UP","C7_Immunologic_signatures","C7_ALL_439_GSE17580_TREG_VS_TEFF_UP",200,-1.2119,0.11,0.17,0.9388,0.63,0.93,-1.0326,0.36,0.65
"C4_Cancer_modules:C4_CM_369_MODULE_453","C4_Cancer_modules","C4_CM_369_MODULE_453",43,-1.2119,0.18,0.27,0.8797,0.67,0.89,-0.9697,0.48,0.75
"GO_MF:496282_GO_0016208_AMP_BINDING","GO_MF","496282_GO_0016208_AMP_BINDING",9,-1.2118,0.24,0.39,0.7058,0.85,1,-1.034,0.43,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_3346_HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3346_HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN",14,-1.2117,0.23,0.26,-0.6433,0.94,1,0.9341,0.54,1
"GO_MF:513784_GO_0060228_PHOSPHATIDYLCHOLINE_STEROL_O_ACYLTRANSFERASE_ACTIVATOR_ACTIVITY","GO_MF","513784_GO_0060228_PHOSPHATIDYLCHOLINE_STEROL_O_ACYLTRANSFERASE_ACTIVATOR_ACTIVITY",6,-1.2116,0.24,0.39,-1.0309,0.44,0.88,0.9557,0.52,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_274_SENESE_HDAC1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_274_SENESE_HDAC1_TARGETS_DN",255,-1.2115,0.085,0.26,-1.1578,0.12,0.84,0.876,0.85,1
"GO_BP:755363_GO_2001257_REGULATION_OF_CATION_CHANNEL_ACTIVITY","GO_BP","755363_GO_2001257_REGULATION_OF_CATION_CHANNEL_ACTIVITY",73,-1.2115,0.17,0.34,-1.2485,0.11,0.91,0.963,0.51,0.89
"C7_Immunologic_signatures:C7_ALL_112_GSE12366_GC_VS_MEMORY_BCELL_DN","C7_Immunologic_signatures","C7_ALL_112_GSE12366_GC_VS_MEMORY_BCELL_DN",194,-1.2115,0.1,0.17,0.9569,0.6,0.88,-0.8739,0.81,0.99
"GO_BP:510607_GO_0048538_THYMUS_DEVELOPMENT","GO_BP","510607_GO_0048538_THYMUS_DEVELOPMENT",38,-1.2114,0.17,0.34,-0.735,0.89,1,0.6726,0.96,1
"KEGG_pathway:HSA00900_TERPENOID_BACKBONE_BIOSYNTHESIS","KEGG_pathway","HSA00900_TERPENOID_BACKBONE_BIOSYNTHESIS",22,-1.2112,0.22,0.22,0.592,0.97,1,-1.0814,0.34,0.55
"C6_Oncogenic_signatures:C6_ALL_43_WNT_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_43_WNT_UP_V1_DN",155,-1.2111,0.12,0.16,1.1892,0.09,0.43,1.1362,0.18,0.34
"REACTOME:730316_REACT_150260_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES","REACTOME","730316_REACT_150260_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES",11,-1.2111,0.23,0.37,1.0527,0.38,0.66,-1.2845,0.16,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_2434_YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2434_YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN",257,-1.211,0.087,0.26,-1.2513,0.045,0.74,-0.957,0.58,0.81
"GO_MF:496680_GO_0016769_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS","GO_MF","496680_GO_0016769_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS",22,-1.2109,0.21,0.39,-1.0671,0.4,0.87,-1.2772,0.15,0.59
"C3_TF_targets:C3_TFT_482_V_AR_Q6","C3_TF_targets","C3_TFT_482_V_AR_Q6",246,-1.2109,0.085,0.18,-1.0617,0.29,0.64,-1.0558,0.29,0.62
"REACTOME:576267_REACT_118722_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM","REACTOME","576267_REACT_118722_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM",6,-1.2109,0.23,0.37,-1.2589,0.19,0.72,-0.7562,0.75,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_288_TIEN_INTESTINE_PROBIOTICS_6HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_288_TIEN_INTESTINE_PROBIOTICS_6HR_DN",167,-1.2109,0.11,0.26,1.3473,0.016,0.35,0.9173,0.67,1
"C3_TF_targets:C3_TFT_35_V_YY1_01","C3_TF_targets","C3_TFT_35_V_YY1_01",240,-1.2107,0.096,0.18,-0.8286,0.93,1,-0.9824,0.5,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1559_RADMACHER_AML_PROGNOSIS","C2_Chemical_and_genetic_perturbations","C2_CGP_1559_RADMACHER_AML_PROGNOSIS",78,-1.2107,0.16,0.26,1.0026,0.44,0.79,0.8567,0.76,1
"GO_BP:487977_GO_0002088_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE","GO_BP","487977_GO_0002088_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE",65,-1.2106,0.16,0.34,1.1404,0.23,0.85,0.9519,0.55,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_3220_PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3220_PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP",332,-1.2106,0.082,0.26,-0.7839,0.98,1,-0.9665,0.58,0.8
"C7_Immunologic_signatures:C7_ALL_69_GSE11057_CD4_CENT_MEM_VS_PBMC_UP","C7_Immunologic_signatures","C7_ALL_69_GSE11057_CD4_CENT_MEM_VS_PBMC_UP",198,-1.2106,0.11,0.17,-0.9144,0.7,1,-1.6895,0,0.00099
"C3_MicroRNA_targets:C3_MIR_93_ATAGGAA_MIR_202","C3_MicroRNA_targets","C3_MIR_93_ATAGGAA_MIR_202",102,-1.2106,0.15,0.33,-0.6608,1,1,-1.0169,0.39,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2232_TING_SILENCED_BY_DICER","C2_Chemical_and_genetic_perturbations","C2_CGP_2232_TING_SILENCED_BY_DICER",30,-1.2106,0.19,0.26,1.0117,0.44,0.78,-1.018,0.42,0.73
"GO_BP:503405_GO_0034199_ACTIVATION_OF_PROTEIN_KINASE_A_ACTIVITY","GO_BP","503405_GO_0034199_ACTIVATION_OF_PROTEIN_KINASE_A_ACTIVITY",17,-1.2105,0.22,0.34,0.8485,0.67,1,-1.1741,0.24,0.73
"C7_Immunologic_signatures:C7_ALL_1409_GSE360_CTRL_VS_L_MAJOR_DC_UP","C7_Immunologic_signatures","C7_ALL_1409_GSE360_CTRL_VS_L_MAJOR_DC_UP",196,-1.2103,0.093,0.17,0.9428,0.64,0.92,-1.0322,0.37,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_2860_GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2860_GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN",55,-1.2103,0.17,0.26,-0.7722,0.88,1,-1.2536,0.11,0.47
"C1_Positional:C1_ALL_18_CHR20P12","C1_Positional","C1_ALL_18_CHR20P12",35,-1.2102,0.2,0.72,0.904,0.62,0.85,0.8769,0.67,0.87
"OMIM_gene:OMIM176884_PROTEIN_TYROSINE_PHOSPHATASE_RECEPTOR_TYPE_ALPHA_PTPRA","OMIM_gene","OMIM176884_PROTEIN_TYROSINE_PHOSPHATASE_RECEPTOR_TYPE_ALPHA_PTPRA",5,-1.2102,0.26,0.86,1.1516,0.31,1,-0.9873,0.49,1
"GO_BP:514126_GO_0060571_MORPHOGENESIS_OF_AN_EPITHELIAL_FOLD","GO_BP","514126_GO_0060571_MORPHOGENESIS_OF_AN_EPITHELIAL_FOLD",18,-1.2102,0.23,0.34,-0.8277,0.72,1,1.2845,0.14,0.69
"GO_CC:490706_GO_0005640_NUCLEAR_OUTER_MEMBRANE","GO_CC","490706_GO_0005640_NUCLEAR_OUTER_MEMBRANE",23,-1.2102,0.2,0.42,0.8967,0.6,0.9,-1.0894,0.34,0.93
"GO_BP:498091_GO_0019240_CITRULLINE_BIOSYNTHETIC_PROCESS","GO_BP","498091_GO_0019240_CITRULLINE_BIOSYNTHETIC_PROCESS",8,-1.2102,0.24,0.34,0.8722,0.6,1,0.7722,0.75,1
"C7_Immunologic_signatures:C7_ALL_405_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_405_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP",198,-1.2102,0.12,0.17,-0.7621,0.98,1,-0.9827,0.51,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_363_HAHTOLA_MYCOSIS_FUNGOIDES_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_363_HAHTOLA_MYCOSIS_FUNGOIDES_DN",15,-1.21,0.22,0.26,1.2409,0.19,0.45,-1.5822,0.035,0.25
"REACTOME:106150_REACT_11057_METABOLISM_OF_STEROID_HORMONES_AND_VITAMIN_D","REACTOME","106150_REACT_11057_METABOLISM_OF_STEROID_HORMONES_AND_VITAMIN_D",32,-1.21,0.2,0.37,-0.9106,0.6,1,0.9785,0.48,1
"GO_BP:1039894_GO_0061640_CYTOSKELETON_DEPENDENT_CYTOKINESIS","GO_BP","1039894_GO_0061640_CYTOSKELETON_DEPENDENT_CYTOKINESIS",39,-1.2099,0.2,0.34,1.0539,0.34,0.94,0.7848,0.85,1
"GO_BP:517443_GO_0072538_T_HELPER_17_TYPE_IMMUNE_RESPONSE","GO_BP","517443_GO_0072538_T_HELPER_17_TYPE_IMMUNE_RESPONSE",5,-1.2098,0.26,0.34,-0.7874,0.74,1,-0.8477,0.65,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_3221_PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3221_PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN",425,-1.2097,0.061,0.26,1.0819,0.19,0.66,-1.0446,0.3,0.7
"GO_BP:504602_GO_0035418_PROTEIN_LOCALIZATION_TO_SYNAPSE","GO_BP","504602_GO_0035418_PROTEIN_LOCALIZATION_TO_SYNAPSE",15,-1.2096,0.22,0.34,-1.2319,0.22,0.9,-1.2431,0.17,0.69
"GO_MF:508785_GO_0046527_GLUCOSYLTRANSFERASE_ACTIVITY","GO_MF","508785_GO_0046527_GLUCOSYLTRANSFERASE_ACTIVITY",12,-1.2096,0.24,0.39,0.794,0.74,1,-1.3809,0.11,0.52
"C1_Positional:C1_ALL_270_CHR5Q32","C1_Positional","C1_ALL_270_CHR5Q32",31,-1.2095,0.2,0.71,1.1341,0.26,0.64,1.0898,0.33,0.71
"GO_BP:493917_GO_0009813_FLAVONOID_BIOSYNTHETIC_PROCESS","GO_BP","493917_GO_0009813_FLAVONOID_BIOSYNTHETIC_PROCESS",21,-1.2095,0.22,0.34,1.7536,0.011,0.14,2.266,0,0.00089
"GO_BP:516575_GO_0071651_POSITIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION","GO_BP","516575_GO_0071651_POSITIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION",5,-1.2094,0.27,0.34,-1.1179,0.35,0.94,0.7922,0.7,1
"C7_Immunologic_signatures:C7_ALL_90_GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN","C7_Immunologic_signatures","C7_ALL_90_GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN",193,-1.2094,0.11,0.17,0.7501,1,1,1.2916,0.013,0.4
"GO_MF:515337_GO_0070405_AMMONIUM_ION_BINDING","GO_MF","515337_GO_0070405_AMMONIUM_ION_BINDING",58,-1.2093,0.17,0.39,-1.2252,0.15,0.85,1.2873,0.096,0.65
"GO_BP:512180_GO_0051295_ESTABLISHMENT_OF_MEIOTIC_SPINDLE_LOCALIZATION","GO_BP","512180_GO_0051295_ESTABLISHMENT_OF_MEIOTIC_SPINDLE_LOCALIZATION",5,-1.2093,0.26,0.34,1.0424,0.44,0.96,1.3858,0.14,0.63
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_184_BIOCARTA_SHH_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_184_BIOCARTA_SHH_PATHWAY",15,-1.2089,0.22,0.34,1.2246,0.2,0.67,-1.1174,0.31,0.61
"C7_Immunologic_signatures:C7_ALL_130_GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN","C7_Immunologic_signatures","C7_ALL_130_GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN",195,-1.2089,0.097,0.17,0.9259,0.66,0.96,-0.867,0.84,0.99
"GO_MF:487380_GO_0001158_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING","GO_MF","487380_GO_0001158_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING",73,-1.2088,0.17,0.39,-1.2738,0.1,0.81,-1.5253,0.01,0.39
"C7_Immunologic_signatures:C7_ALL_730_GSE17721_0_5H_VS_12H_PAM3CSK4_BMDM_DN","C7_Immunologic_signatures","C7_ALL_730_GSE17721_0_5H_VS_12H_PAM3CSK4_BMDM_DN",197,-1.2087,0.11,0.17,1.6462,0,0.0013,-0.7373,0.99,1
"GO_BP:498838_GO_0021554_OPTIC_NERVE_DEVELOPMENT","GO_BP","498838_GO_0021554_OPTIC_NERVE_DEVELOPMENT",11,-1.2085,0.24,0.34,-0.7093,0.83,1,1.0882,0.33,0.77
"GO_BP:495931_GO_0015800_ACIDIC_AMINO_ACID_TRANSPORT","GO_BP","495931_GO_0015800_ACIDIC_AMINO_ACID_TRANSPORT",20,-1.2085,0.21,0.34,0.7489,0.83,1,-1.1437,0.27,0.74
"GO_BP:861226_GO_0097501_STRESS_RESPONSE_TO_METAL_ION","GO_BP","861226_GO_0097501_STRESS_RESPONSE_TO_METAL_ION",5,-1.2084,0.25,0.34,-0.7226,0.8,1,-0.7087,0.84,0.99
"C1_Positional:C1_ALL_88_CHR17Q23","C1_Positional","C1_ALL_88_CHR17Q23",78,-1.2084,0.16,0.7,-0.8308,0.8,0.97,-1.0876,0.29,0.78
"GO_BP:514928_GO_0061383_TRABECULA_MORPHOGENESIS","GO_BP","514928_GO_0061383_TRABECULA_MORPHOGENESIS",38,-1.2084,0.19,0.34,-1.0113,0.41,0.98,-1.083,0.33,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_2958_TRACEY_RESISTANCE_TO_IFNA2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2958_TRACEY_RESISTANCE_TO_IFNA2_UP",6,-1.2083,0.24,0.27,1.5388,0.033,0.18,1.1506,0.28,0.83
"GO_MF:489479_GO_0042626_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_SUBSTANCES","GO_MF","489479_GO_0042626_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_SUBSTANCES",97,-1.2082,0.18,0.39,0.8441,0.8,1,-0.9928,0.47,0.79
"GO_BP:515038_GO_0070100_NEGATIVE_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY","GO_BP","515038_GO_0070100_NEGATIVE_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY",5,-1.2082,0.25,0.34,-0.7124,0.81,1,0.6371,0.88,1
"C7_Immunologic_signatures:C7_ALL_1527_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP","C7_Immunologic_signatures","C7_ALL_1527_GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP",195,-1.2079,0.12,0.18,0.899,0.75,1,-1.3427,0.0086,0.1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2254_SAGIV_CD24_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2254_SAGIV_CD24_TARGETS_UP",21,-1.2079,0.22,0.27,-1.1103,0.3,0.9,0.8906,0.64,1
"C7_Immunologic_signatures:C7_ALL_465_GSE17721_CTRL_VS_POLYIC_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_465_GSE17721_CTRL_VS_POLYIC_1H_BMDM_UP",198,-1.2078,0.1,0.18,1.1276,0.17,0.37,-0.9086,0.72,0.93
"GO_MF:503683_GO_0034481_CHONDROITIN_SULFOTRANSFERASE_ACTIVITY","GO_MF","503683_GO_0034481_CHONDROITIN_SULFOTRANSFERASE_ACTIVITY",5,-1.2078,0.24,0.39,0.6853,0.86,1,-0.7961,0.7,0.97
"C7_Immunologic_signatures:C7_ALL_725_GSE17721_4H_VS_24H_POLYIC_BMDM_UP","C7_Immunologic_signatures","C7_ALL_725_GSE17721_4H_VS_24H_POLYIC_BMDM_UP",198,-1.2078,0.1,0.18,1.5956,0,0.0032,-0.8597,0.86,1
"KEGG_compound:C00334_4_AMINOBUTANOATE_4_AMINOBUTANOIC_ACID_4_AMINOBUTYRATE_4_AMINOBUTYRIC_ACID_GAMMA_AMINOBUTYRIC_ACID_GABA","KEGG_compound","C00334_4_AMINOBUTANOATE_4_AMINOBUTANOIC_ACID_4_AMINOBUTYRATE_4_AMINOBUTYRIC_ACID_GAMMA_AMINOBUTYRIC_ACID_GABA",11,-1.2077,0.23,0.38,0.6739,0.87,1,-1.373,0.11,0.31
"C7_Immunologic_signatures:C7_ALL_950_GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN","C7_Immunologic_signatures","C7_ALL_950_GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN",194,-1.2077,0.11,0.18,1.1788,0.086,0.26,-1.4445,0.0061,0.037
"C7_Immunologic_signatures:C7_ALL_668_GSE17721_LPS_VS_CPG_16H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_668_GSE17721_LPS_VS_CPG_16H_BMDM_DN",198,-1.2076,0.12,0.18,1.296,0.024,0.11,-0.9522,0.58,0.85
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_167_BIOCARTA_ERK5_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_167_BIOCARTA_ERK5_PATHWAY",18,-1.2075,0.2,0.34,-0.8431,0.7,1,-0.6225,0.95,0.99
"GO_BP:495924_GO_0015793_GLYCEROL_TRANSPORT","GO_BP","495924_GO_0015793_GLYCEROL_TRANSPORT",11,-1.2073,0.24,0.34,-0.6564,0.89,1,-0.7415,0.8,1
"GO_BP:492729_GO_0050819_NEGATIVE_REGULATION_OF_COAGULATION","GO_BP","492729_GO_0050819_NEGATIVE_REGULATION_OF_COAGULATION",46,-1.2073,0.18,0.34,1.3451,0.074,0.61,1.5552,0.0099,0.5
"C7_Immunologic_signatures:C7_ALL_1834_GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN","C7_Immunologic_signatures","C7_ALL_1834_GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN",187,-1.2073,0.12,0.18,-1.5593,0,0.029,-1.1086,0.2,0.48
"GO_BP:518827_GO_2000179_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION","GO_BP","518827_GO_2000179_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION",40,-1.2073,0.19,0.34,0.879,0.67,1,1.0481,0.37,0.81
"GO_BP:512729_GO_0051873_KILLING_BY_HOST_OF_SYMBIONT_CELLS","GO_BP","512729_GO_0051873_KILLING_BY_HOST_OF_SYMBIONT_CELLS",6,-1.2071,0.24,0.34,1.5577,0.041,0.34,0.6149,0.94,1
"GO_BP:508154_GO_0045833_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS","GO_BP","508154_GO_0045833_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS",71,-1.2071,0.17,0.34,-0.8481,0.76,1,0.9195,0.62,0.93
"GO_BP:491713_GO_0015813_L_GLUTAMATE_TRANSPORT","GO_BP","491713_GO_0015813_L_GLUTAMATE_TRANSPORT",19,-1.207,0.22,0.34,0.7493,0.82,1,-1.1103,0.29,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_721_FARMER_BREAST_CANCER_CLUSTER_4","C2_Chemical_and_genetic_perturbations","C2_CGP_721_FARMER_BREAST_CANCER_CLUSTER_4",16,-1.207,0.23,0.27,0.9865,0.47,0.81,1.3757,0.079,0.52
"KEGG_reaction:R04751_HEXANOYL_COA_ELECTRON_TRANSFER_FLAVOPROTEIN_2_3_OXIDOREDUCTASE_HEXANOYL_COA_FAD_TRANS_HEX_2_ENOYL_COA_FADH2","KEGG_reaction","R04751_HEXANOYL_COA_ELECTRON_TRANSFER_FLAVOPROTEIN_2_3_OXIDOREDUCTASE_HEXANOYL_COA_FAD_TRANS_HEX_2_ENOYL_COA_FADH2",6,-1.207,0.23,0.36,-0.5618,0.95,1,-1.6977,0.0081,0.06
"GO_BP:492174_GO_0007413_AXONAL_FASCICULATION","GO_BP","492174_GO_0007413_AXONAL_FASCICULATION",19,-1.2069,0.23,0.34,-1.4048,0.081,0.98,-0.7737,0.8,1
"C7_Immunologic_signatures:C7_ALL_1400_GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN","C7_Immunologic_signatures","C7_ALL_1400_GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN",199,-1.2069,0.095,0.18,1.1677,0.099,0.28,0.9437,0.63,1
"REACTOME:187171_REACT_24019_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1_","REACTOME","187171_REACT_24019_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1_",19,-1.2069,0.22,0.38,1.2082,0.19,0.44,-0.9422,0.53,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1125_BENPORATH_ES_CORE_NINE","C2_Chemical_and_genetic_perturbations","C2_CGP_1125_BENPORATH_ES_CORE_NINE",9,-1.2069,0.24,0.27,-1.1047,0.35,0.91,-0.883,0.62,0.9
"GO_BP:512804_GO_0051954_POSITIVE_REGULATION_OF_AMINE_TRANSPORT","GO_BP","512804_GO_0051954_POSITIVE_REGULATION_OF_AMINE_TRANSPORT",27,-1.2067,0.22,0.34,-0.8148,0.75,1,-0.7322,0.88,0.99
"GO_BP:508425_GO_0046129_PURINE_RIBONUCLEOSIDE_BIOSYNTHETIC_PROCESS","GO_BP","508425_GO_0046129_PURINE_RIBONUCLEOSIDE_BIOSYNTHETIC_PROCESS",112,-1.2067,0.14,0.34,1.09,0.26,0.92,-1.1334,0.18,0.75
"REACTOME:477119_REACT_111080_SPRY_REGULATION_OF_FGF_SIGNALING","REACTOME","477119_REACT_111080_SPRY_REGULATION_OF_FGF_SIGNALING",16,-1.2065,0.23,0.38,1.0619,0.36,0.64,0.6472,0.93,1
"GO_BP:751702_GO_0044557_RELAXATION_OF_SMOOTH_MUSCLE","GO_BP","751702_GO_0044557_RELAXATION_OF_SMOOTH_MUSCLE",8,-1.2065,0.24,0.34,1.1947,0.25,0.79,-0.8638,0.65,0.95
"GO_BP:491789_GO_0006940_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION","GO_BP","491789_GO_0006940_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION",49,-1.2065,0.18,0.34,-1.0194,0.43,0.97,-0.9453,0.55,0.89
"GO_MF:752449_GO_0086083_CELL_ADHESIVE_PROTEIN_BINDING_INVOLVED_IN_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_COMMUNICATION","GO_MF","752449_GO_0086083_CELL_ADHESIVE_PROTEIN_BINDING_INVOLVED_IN_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_COMMUNICATION",6,-1.2064,0.27,0.39,-0.5903,0.92,1,0.8152,0.67,1
"C6_Oncogenic_signatures:C6_ALL_160_KRAS_DF_V1_DN","C6_Oncogenic_signatures","C6_ALL_160_KRAS_DF_V1_DN",182,-1.2064,0.12,0.17,-1.0198,0.4,0.63,-1.0536,0.33,0.6
"GO_BP:513638_GO_0060080_REGULATION_OF_INHIBITORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL","GO_BP","513638_GO_0060080_REGULATION_OF_INHIBITORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL",12,-1.2062,0.26,0.35,-1.257,0.19,0.91,0.8527,0.67,0.98
"C7_Immunologic_signatures:C7_ALL_1636_GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1636_GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN",194,-1.2062,0.12,0.18,1.1077,0.2,0.42,-1.2622,0.034,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_1998_DOUGLAS_BMI1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1998_DOUGLAS_BMI1_TARGETS_DN",312,-1.2062,0.075,0.27,1.4185,0,0.28,-1.1772,0.077,0.54
"GO_MF:490011_GO_0004691_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY","GO_MF","490011_GO_0004691_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY",7,-1.2061,0.24,0.39,1.0984,0.36,0.79,-0.8595,0.63,0.91
"GO_BP:511970_GO_0051045_NEGATIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS","GO_BP","511970_GO_0051045_NEGATIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS",6,-1.2059,0.26,0.35,0.6658,0.85,1,1.1428,0.32,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_3351_HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3351_HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP",27,-1.2059,0.21,0.27,0.5133,0.99,1,-1.158,0.23,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1826_GENTILE_UV_HIGH_DOSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1826_GENTILE_UV_HIGH_DOSE_DN",312,-1.2058,0.076,0.27,1.2351,0.031,0.45,1.079,0.2,0.87
"GO_BP:507260_GO_0044253_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS","GO_BP","507260_GO_0044253_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_METABOLIC_PROCESS",34,-1.2058,0.2,0.35,-1.1375,0.26,0.93,1.0106,0.44,0.84
"C7_Immunologic_signatures:C7_ALL_699_GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_699_GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDM_UP",197,-1.2058,0.1,0.18,1.3596,0.012,0.057,-0.8397,0.91,1
"GO_BP:505177_GO_0040019_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT","GO_BP","505177_GO_0040019_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT",25,-1.2058,0.21,0.35,-1.2712,0.15,0.89,-0.694,0.93,0.99
"C3_TF_targets:C3_TFT_509_RTTTNNNYTGGM_UNKNOWN","C3_TF_targets","C3_TFT_509_RTTTNNNYTGGM_UNKNOWN",150,-1.2056,0.13,0.19,0.9411,0.62,1,1.0594,0.31,1
"C7_Immunologic_signatures:C7_ALL_190_GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_190_GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN",160,-1.2055,0.13,0.18,-1.3943,0.019,0.23,1.5224,0,0.031
"GO_BP:508870_GO_0046622_POSITIVE_REGULATION_OF_ORGAN_GROWTH","GO_BP","508870_GO_0046622_POSITIVE_REGULATION_OF_ORGAN_GROWTH",35,-1.2055,0.2,0.35,0.7764,0.82,1,0.9777,0.47,0.88
"C7_Immunologic_signatures:C7_ALL_607_GSE17721_LPS_VS_PAM3CSK4_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_607_GSE17721_LPS_VS_PAM3CSK4_6H_BMDM_UP",199,-1.2055,0.12,0.18,1.0082,0.41,0.71,-0.997,0.48,0.73
"GO_BP:508336_GO_0046039_GTP_METABOLIC_PROCESS","GO_BP","508336_GO_0046039_GTP_METABOLIC_PROCESS",12,-1.2055,0.23,0.35,-0.8091,0.72,1,-0.9957,0.46,0.85
"C3_TF_targets:C3_TFT_41_V_HEN1_01","C3_TF_targets","C3_TFT_41_V_HEN1_01",193,-1.2054,0.094,0.19,-0.8233,0.93,1,0.8113,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3074_DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3074_DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP",226,-1.2054,0.11,0.27,0.9349,0.67,0.89,-0.8853,0.82,0.89
"GO_BP:504239_GO_0035051_CARDIOCYTE_DIFFERENTIATION","GO_BP","504239_GO_0035051_CARDIOCYTE_DIFFERENTIATION",101,-1.2052,0.15,0.35,-1.0735,0.3,0.95,0.997,0.45,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_1961_LEE_AGING_MUSCLE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1961_LEE_AGING_MUSCLE_UP",44,-1.2052,0.2,0.27,0.8729,0.72,0.95,-1.2244,0.14,0.5
"C4_Cancer_modules:C4_CM_412_MODULE_533","C4_Cancer_modules","C4_CM_412_MODULE_533",43,-1.205,0.21,0.28,-1.4527,0.036,0.49,0.9469,0.57,0.95
"GO_MF:489233_GO_0003680_AT_DNA_BINDING","GO_MF","489233_GO_0003680_AT_DNA_BINDING",8,-1.205,0.25,0.39,-1.444,0.077,0.63,1.0567,0.39,0.83
"C4_Cancer_modules:C4_CM_254_MODULE_288","C4_Cancer_modules","C4_CM_254_MODULE_288",36,-1.2049,0.18,0.28,1.4769,0.037,0.13,1.9293,0,0.017
"C2_Chemical_and_genetic_perturbations:C2_CGP_761_SHI_SPARC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_761_SHI_SPARC_TARGETS_DN",11,-1.2049,0.26,0.27,-1.293,0.15,0.71,-1.483,0.075,0.31
"GO_BP:948900_GO_1902745_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION","GO_BP","948900_GO_1902745_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION",16,-1.2048,0.23,0.35,0.8578,0.68,1,0.7198,0.84,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1857_LEE_CALORIE_RESTRICTION_NEOCORTEX_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1857_LEE_CALORIE_RESTRICTION_NEOCORTEX_DN",86,-1.2048,0.15,0.27,-1.0466,0.38,0.97,-1.2227,0.12,0.5
"GO_MF:496399_GO_0016411_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY","GO_MF","496399_GO_0016411_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY",16,-1.2048,0.21,0.39,-0.8079,0.74,1,-1.1881,0.24,0.59
"GO_BP:501565_GO_0032330_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION","GO_BP","501565_GO_0032330_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION",42,-1.2047,0.19,0.35,-1.0468,0.38,0.97,1.4101,0.041,0.62
"GO_BP:498893_GO_0021610_FACIAL_NERVE_MORPHOGENESIS","GO_BP","498893_GO_0021610_FACIAL_NERVE_MORPHOGENESIS",11,-1.2045,0.23,0.35,-0.8757,0.63,1,0.9632,0.5,0.89
"GO_MF:490485_GO_0005251_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY","GO_MF","490485_GO_0005251_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",35,-1.2044,0.2,0.39,-1.3105,0.11,0.75,1.3148,0.094,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_3023_WHITFIELD_CELL_CYCLE_M_G1","C2_Chemical_and_genetic_perturbations","C2_CGP_3023_WHITFIELD_CELL_CYCLE_M_G1",146,-1.2042,0.13,0.27,1.1826,0.11,0.51,-0.8476,0.83,0.93
"GO_BP:517095_GO_0072179_NEPHRIC_DUCT_FORMATION","GO_BP","517095_GO_0072179_NEPHRIC_DUCT_FORMATION",5,-1.2041,0.25,0.35,-0.8175,0.7,1,0.8968,0.58,0.95
"GO_BP:512043_GO_0051133_REGULATION_OF_NK_T_CELL_ACTIVATION","GO_BP","512043_GO_0051133_REGULATION_OF_NK_T_CELL_ACTIVATION",6,-1.204,0.27,0.35,-1.2406,0.2,0.91,-1.5117,0.049,0.53
"GO_BP:512424_GO_0051546_KERATINOCYTE_MIGRATION","GO_BP","512424_GO_0051546_KERATINOCYTE_MIGRATION",5,-1.2039,0.26,0.35,0.9676,0.5,1,1.3432,0.12,0.65
"C4_Cancer_modules:C4_CM_99_MODULE_104","C4_Cancer_modules","C4_CM_99_MODULE_104",337,-1.2039,0.081,0.28,-1.2216,0.054,0.62,1.3283,0.0075,0.39
"KEGG_compound:C00033_ACETATE_ACETIC_ACID_ETHANOIC_ACID","KEGG_compound","C00033_ACETATE_ACETIC_ACID_ETHANOIC_ACID",29,-1.2038,0.21,0.38,1.0223,0.42,1,-1.1037,0.33,0.53
"GO_BP:501312_GO_0032075_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY","GO_BP","501312_GO_0032075_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY",74,-1.2038,0.16,0.35,-0.7419,0.92,1,-1.2142,0.14,0.72
"C3_MicroRNA_targets:C3_MIR_169_ACTGCCT_MIR_34B","C3_MicroRNA_targets","C3_MIR_169_ACTGCCT_MIR_34B",216,-1.2037,0.097,0.34,-0.8847,0.8,1,-1.0585,0.29,1
"GO_BP:755375_GO_2001269_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","755375_GO_2001269_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",6,-1.2037,0.25,0.35,0.7255,0.82,1,-0.9937,0.48,0.85
"GO_BP:507972_GO_0045624_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION","GO_BP","507972_GO_0045624_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION",15,-1.2037,0.23,0.35,-1.3597,0.11,0.97,-0.882,0.62,0.94
"C7_Immunologic_signatures:C7_ALL_948_GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN","C7_Immunologic_signatures","C7_ALL_948_GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN",196,-1.2034,0.11,0.18,-1.043,0.36,1,0.8099,0.96,1
"GO_BP:512714_GO_0051852_DISRUPTION_BY_HOST_OF_SYMBIONT_CELLS","GO_BP","512714_GO_0051852_DISRUPTION_BY_HOST_OF_SYMBIONT_CELLS",6,-1.2034,0.25,0.35,1.5566,0.046,0.34,0.604,0.93,1
"GO_BP:518617_GO_0097067_CELLULAR_RESPONSE_TO_THYROID_HORMONE_STIMULUS","GO_BP","518617_GO_0097067_CELLULAR_RESPONSE_TO_THYROID_HORMONE_STIMULUS",11,-1.2034,0.25,0.35,0.9013,0.6,1,1.1234,0.31,0.74
"GO_BP:503642_GO_0034440_LIPID_OXIDATION","GO_BP","503642_GO_0034440_LIPID_OXIDATION",65,-1.2034,0.17,0.35,1.3384,0.067,0.62,-1.206,0.16,0.73
"C4_Cancer_gene_neighborhoods:C4_CGN_182_MORF_THRA","C4_Cancer_gene_neighborhoods","C4_CGN_182_MORF_THRA",51,-1.2033,0.17,0.33,-1.1438,0.24,0.68,1.1082,0.27,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_259_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_259_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN",8,-1.2032,0.24,0.27,0.8956,0.58,0.93,-1.6367,0.023,0.22
"C3_MicroRNA_targets:C3_MIR_76_GCTTGAA_MIR_498","C3_MicroRNA_targets","C3_MIR_76_GCTTGAA_MIR_498",111,-1.203,0.17,0.34,1.0053,0.45,1,0.9316,0.63,1
"KEGG_compound:C03345_2_METHYLBUT_2_ENOYL_COA_TRANS_2_METHYLBUT_2_ENOYL_COA_TIGLYL_COA_E_2_METHYLCROTONOYL_COA_METHYLCROTONOYL_COA_METHYLCROTONYL_COA_TIGLOYL_COA_2_METHYLCROTANOYL_COA","KEGG_compound","C03345_2_METHYLBUT_2_ENOYL_COA_TRANS_2_METHYLBUT_2_ENOYL_COA_TIGLYL_COA_E_2_METHYLCROTONOYL_COA_METHYLCROTONOYL_COA_METHYLCROTONYL_COA_TIGLOYL_COA_2_METHYLCROTANOYL_COA",6,-1.2027,0.25,0.38,0.8476,0.64,1,-1.5845,0.043,0.17
"GO_BP:495828_GO_0015693_MAGNESIUM_ION_TRANSPORT","GO_BP","495828_GO_0015693_MAGNESIUM_ION_TRANSPORT",15,-1.2027,0.23,0.35,-0.8754,0.64,1,-0.8203,0.74,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_726_HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_726_HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER",13,-1.2026,0.24,0.27,0.5853,0.96,1,0.7853,0.76,1
"REACTOME:576272_REACT_118721_SIGNALING_BY_NOTCH2","REACTOME","576272_REACT_118721_SIGNALING_BY_NOTCH2",32,-1.2026,0.18,0.38,-0.7788,0.84,1,-0.9813,0.47,0.87
"GO_BP:948111_GO_1902668_NEGATIVE_REGULATION_OF_AXON_GUIDANCE","GO_BP","948111_GO_1902668_NEGATIVE_REGULATION_OF_AXON_GUIDANCE",11,-1.2024,0.24,0.35,-1.0403,0.42,0.98,1.1109,0.34,0.75
"GO_CC:490908_GO_0030121_AP_1_ADAPTOR_COMPLEX","GO_CC","490908_GO_0030121_AP_1_ADAPTOR_COMPLEX",5,-1.2023,0.26,0.43,-0.8141,0.69,1,-1.276,0.21,0.69
"GO_BP:513155_GO_0052312_MODULATION_OF_TRANSCRIPTION_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","513155_GO_0052312_MODULATION_OF_TRANSCRIPTION_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",23,-1.2023,0.22,0.35,0.8673,0.66,1,-0.9661,0.52,0.88
"C3_TF_targets:C3_TFT_52_V_EVI1_03","C3_TF_targets","C3_TFT_52_V_EVI1_03",55,-1.2023,0.18,0.19,0.7767,0.88,1,1.3461,0.072,0.85
"GO_BP:495966_GO_0015840_UREA_TRANSPORT","GO_BP","495966_GO_0015840_UREA_TRANSPORT",7,-1.2022,0.28,0.35,-0.8286,0.69,1,-0.9595,0.51,0.88
"C4_Cancer_modules:C4_CM_8_MODULE_8","C4_Cancer_modules","C4_CM_8_MODULE_8",415,-1.2022,0.069,0.28,1.5777,0,0.083,-1.0575,0.26,0.6
"C7_Immunologic_signatures:C7_ALL_896_GSE20715_WT_VS_TLR4_KO_LUNG_DN","C7_Immunologic_signatures","C7_ALL_896_GSE20715_WT_VS_TLR4_KO_LUNG_DN",196,-1.2022,0.11,0.18,-1.1429,0.18,1,-1.183,0.11,0.31
"GO_MF:496432_GO_0016454_C_PALMITOYLTRANSFERASE_ACTIVITY","GO_MF","496432_GO_0016454_C_PALMITOYLTRANSFERASE_ACTIVITY",5,-1.2021,0.26,0.4,-1.4038,0.1,0.65,-1.1942,0.3,0.59
"GO_BP:514725_GO_0061180_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT","GO_BP","514725_GO_0061180_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT",60,-1.2021,0.18,0.35,-0.7544,0.9,1,0.7936,0.87,1
"C7_Immunologic_signatures:C7_ALL_453_GSE17721_CTRL_VS_LPS_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_453_GSE17721_CTRL_VS_LPS_4H_BMDM_UP",200,-1.2021,0.11,0.18,1.0332,0.37,0.64,-0.8235,0.93,1
"GO_BP:493342_GO_0009145_PURINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493342_GO_0009145_PURINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",65,-1.202,0.17,0.35,1.2444,0.1,0.74,-0.9866,0.46,0.86
"C4_Cancer_gene_neighborhoods:C4_CGN_261_GCM_RAP2A","C4_Cancer_gene_neighborhoods","C4_CGN_261_GCM_RAP2A",34,-1.202,0.2,0.33,-0.8485,0.72,1,-0.9862,0.47,0.88
"GO_BP:506533_GO_0043502_REGULATION_OF_MUSCLE_ADAPTATION","GO_BP","506533_GO_0043502_REGULATION_OF_MUSCLE_ADAPTATION",46,-1.2019,0.18,0.35,-0.8784,0.68,1,-1.4384,0.031,0.56
"GO_BP:752439_GO_0086073_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_ADHESION_INVOLVED_IN_CELL_COMMUNICATION","GO_BP","752439_GO_0086073_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_ADHESION_INVOLVED_IN_CELL_COMMUNICATION",6,-1.2019,0.25,0.35,-0.5962,0.92,1,0.8228,0.69,1
"GO_BP:487952_GO_0002062_CHONDROCYTE_DIFFERENTIATION","GO_BP","487952_GO_0002062_CHONDROCYTE_DIFFERENTIATION",62,-1.2019,0.17,0.35,-1.5452,0.022,0.74,-1.0428,0.33,0.82
"C3_TF_targets:C3_TFT_32_V_MYOGNF1_01","C3_TF_targets","C3_TFT_32_V_MYOGNF1_01",48,-1.2017,0.17,0.19,-0.7809,0.83,1,-0.9248,0.58,0.88
"KEGG_compound:C00671__S_3_METHYL_2_OXOPENTANOIC_ACID_S_3_METHYL_2_OXOPENTANOATE_3S_3_METHYL_2_OXOPENTANOIC_ACID_3S_3_METHYL_2_OXOPENTANOATE","KEGG_compound","C00671__S_3_METHYL_2_OXOPENTANOIC_ACID_S_3_METHYL_2_OXOPENTANOATE_3S_3_METHYL_2_OXOPENTANOIC_ACID_3S_3_METHYL_2_OXOPENTANOATE",5,-1.2014,0.26,0.38,-0.6357,0.92,1,-0.9622,0.52,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_1841_MCCLUNG_COCAIN_REWARD_4WK","C2_Chemical_and_genetic_perturbations","C2_CGP_1841_MCCLUNG_COCAIN_REWARD_4WK",72,-1.2014,0.17,0.28,-0.9542,0.53,1,-0.9647,0.54,0.8
"C7_Immunologic_signatures:C7_ALL_372_GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN","C7_Immunologic_signatures","C7_ALL_372_GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN",195,-1.2013,0.13,0.18,1.0605,0.29,0.56,0.7427,0.99,1
"C3_MicroRNA_targets:C3_MIR_188_ATGTACA_MIR_493","C3_MicroRNA_targets","C3_MIR_188_ATGTACA_MIR_493",311,-1.2013,0.081,0.34,0.7992,0.99,1,0.8677,0.88,1
"GO_BP:849768_GO_0044793_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS","GO_BP","849768_GO_0044793_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS",7,-1.2013,0.26,0.35,0.8543,0.64,1,1.0099,0.45,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_2121_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2121_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP",55,-1.2012,0.19,0.28,1.013,0.39,0.78,-0.7967,0.85,0.96
"GO_BP:921146_GO_1902547_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS","GO_BP","921146_GO_1902547_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS",9,-1.2012,0.25,0.35,-0.9924,0.47,1,1.2392,0.19,0.71
"GO_BP:1025360_GO_1903224_REGULATION_OF_ENDODERMAL_CELL_DIFFERENTIATION","GO_BP","1025360_GO_1903224_REGULATION_OF_ENDODERMAL_CELL_DIFFERENTIATION",6,-1.2011,0.28,0.35,1.4018,0.12,0.55,-0.745,0.79,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_283_HUMMEL_BURKITTS_LYMPHOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_283_HUMMEL_BURKITTS_LYMPHOMA_UP",42,-1.2011,0.2,0.28,0.7504,0.88,1,-1.1078,0.29,0.62
"REACTOME:771584_REACT_160125_VISUAL_PHOTOTRANSDUCTION","REACTOME","771584_REACT_160125_VISUAL_PHOTOTRANSDUCTION",93,-1.2011,0.16,0.39,0.8936,0.67,0.91,-1.0161,0.42,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1057_RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1057_RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP",121,-1.201,0.16,0.28,0.7727,0.96,1,0.8515,0.81,1
"C4_Cancer_gene_neighborhoods:C4_CGN_24_MORF_MT4","C4_Cancer_gene_neighborhoods","C4_CGN_24_MORF_MT4",240,-1.2009,0.11,0.33,-1.1295,0.17,0.71,-1.1913,0.11,0.45
"KEGG_pathway:HSA04012_ERBB_SIGNALING_PATHWAY","KEGG_pathway","HSA04012_ERBB_SIGNALING_PATHWAY",86,-1.2009,0.18,0.23,-0.8232,0.81,1,-1.0557,0.33,0.6
"C1_Positional:C1_ALL_258_CHR2Q12","C1_Positional","C1_ALL_258_CHR2Q12",41,-1.2007,0.2,0.72,1.1337,0.26,0.63,1.6014,0.0096,0.23
"GO_BP:505928_GO_0042832_DEFENSE_RESPONSE_TO_PROTOZOAN","GO_BP","505928_GO_0042832_DEFENSE_RESPONSE_TO_PROTOZOAN",17,-1.2006,0.22,0.35,-0.8516,0.67,1,-0.786,0.79,1
"C7_Immunologic_signatures:C7_ALL_761_GSE17721_4_VS_24H_GARDIQUIMOD_BMDM_UP","C7_Immunologic_signatures","C7_ALL_761_GSE17721_4_VS_24H_GARDIQUIMOD_BMDM_UP",198,-1.2006,0.12,0.18,1.414,0.0072,0.034,0.7714,0.97,1
"GO_BP:514583_GO_0061035_REGULATION_OF_CARTILAGE_DEVELOPMENT","GO_BP","514583_GO_0061035_REGULATION_OF_CARTILAGE_DEVELOPMENT",58,-1.2006,0.19,0.35,-1.2744,0.1,0.89,1.4304,0.037,0.61
"GO_BP:508720_GO_0046459_SHORT_CHAIN_FATTY_ACID_METABOLIC_PROCESS","GO_BP","508720_GO_0046459_SHORT_CHAIN_FATTY_ACID_METABOLIC_PROCESS",18,-1.2006,0.24,0.35,0.6978,0.89,1,-1.4386,0.062,0.56
"WikiPathways:672460_WP2064_NEURAL_CREST_DIFFERENTIATION","WikiPathways","672460_WP2064_NEURAL_CREST_DIFFERENTIATION",96,-1.2005,0.16,0.3,-1.0788,0.3,0.94,1.0012,0.44,0.9
"KEGG_pathway:HSA00620_PYRUVATE_METABOLISM","KEGG_pathway","HSA00620_PYRUVATE_METABOLISM",40,-1.2005,0.21,0.23,1.0199,0.45,0.86,-1.8112,0.002,0.021
"C7_Immunologic_signatures:C7_ALL_1_KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1_KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP",199,-1.2004,0.12,0.19,0.9854,0.47,0.79,-1.0151,0.39,0.69
"OMIM_gene:OMIM300822_OPSIN_1_LONG_WAVE_SENSITIVE_OPN1LW","OMIM_gene","OMIM300822_OPSIN_1_LONG_WAVE_SENSITIVE_OPN1LW",8,-1.2003,0.24,0.85,0.558,0.97,0.99,-0.8754,0.64,0.91
"C6_Oncogenic_signatures:C6_ALL_94_ESC_J1_UP_EARLY_V1_UP","C6_Oncogenic_signatures","C6_ALL_94_ESC_J1_UP_EARLY_V1_UP",168,-1.2002,0.14,0.18,-1.1534,0.17,0.48,0.9476,0.61,0.67
"GO_BP:513579_GO_0060021_PALATE_DEVELOPMENT","GO_BP","513579_GO_0060021_PALATE_DEVELOPMENT",84,-1.2002,0.17,0.35,-1.051,0.35,0.97,1.0901,0.29,0.77
"KEGG_compound:C04646_6_THIOINOSINE_5_MONOPHOSPHATE_9_5_PHOSPHO_1_RIBOFURANOSYL_6_MERCAPTOPURINE","KEGG_compound","C04646_6_THIOINOSINE_5_MONOPHOSPHATE_9_5_PHOSPHO_1_RIBOFURANOSYL_6_MERCAPTOPURINE",5,-1.2,0.24,0.38,-0.8383,0.65,1,-1.1505,0.3,0.5
"C7_Immunologic_signatures:C7_ALL_1878_GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1878_GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN",199,-1.2,0.13,0.19,1.1893,0.088,0.25,-0.9148,0.7,0.92
"C7_Immunologic_signatures:C7_ALL_1311_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP","C7_Immunologic_signatures","C7_ALL_1311_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP",192,-1.2,0.13,0.19,-0.9099,0.71,1,0.9135,0.7,1
"KEGG_compound:C00468_ESTRONE_3_HYDROXY_1_3_5_10_ESTRATRIEN_17_ONE","KEGG_compound","C00468_ESTRONE_3_HYDROXY_1_3_5_10_ESTRATRIEN_17_ONE",29,-1.2,0.21,0.38,1.807,0.0022,0.031,1.4698,0.057,0.19
"GO_BP:508356_GO_0046060_DATP_METABOLIC_PROCESS","GO_BP","508356_GO_0046060_DATP_METABOLIC_PROCESS",7,-1.2,0.27,0.35,0.8178,0.69,1,-1.4969,0.075,0.54
"GO_BP:492327_GO_0007585_RESPIRATORY_GASEOUS_EXCHANGE","GO_BP","492327_GO_0007585_RESPIRATORY_GASEOUS_EXCHANGE",44,-1.1999,0.18,0.35,0.7664,0.85,1,0.8569,0.71,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3281_PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3281_PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN",105,-1.1999,0.15,0.28,1.1156,0.22,0.6,-1.0828,0.29,0.65
"GO_BP:513658_GO_0060100_POSITIVE_REGULATION_OF_PHAGOCYTOSIS_ENGULFMENT","GO_BP","513658_GO_0060100_POSITIVE_REGULATION_OF_PHAGOCYTOSIS_ENGULFMENT",6,-1.1999,0.25,0.35,-0.6078,0.93,1,0.8144,0.7,1
"GO_CC:500716_GO_0031465_CUL4B_RING_E3_UBIQUITIN_LIGASE_COMPLEX","GO_CC","500716_GO_0031465_CUL4B_RING_E3_UBIQUITIN_LIGASE_COMPLEX",5,-1.1999,0.25,0.44,0.9383,0.53,0.85,-1.2686,0.23,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_119_HUTTMANN_B_CLL_POOR_SURVIVAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_119_HUTTMANN_B_CLL_POOR_SURVIVAL_DN",59,-1.1998,0.19,0.28,-0.9457,0.56,1,-1.329,0.069,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2399_BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2399_BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP",49,-1.1997,0.18,0.28,0.6817,0.96,1,-0.988,0.45,0.77
"GO_CC:501148_GO_0031907_MICROBODY_LUMEN","GO_CC","501148_GO_0031907_MICROBODY_LUMEN",36,-1.1996,0.19,0.43,0.8726,0.65,0.91,-1.7044,0.0062,0.59
"C4_Cancer_modules:C4_CM_242_MODULE_273","C4_Cancer_modules","C4_CM_242_MODULE_273",52,-1.1996,0.2,0.28,1.6041,0.0022,0.074,0.4926,1,1
"C7_Immunologic_signatures:C7_ALL_377_GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP","C7_Immunologic_signatures","C7_ALL_377_GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP",189,-1.1996,0.12,0.19,0.9565,0.6,0.88,-1.1501,0.15,0.37
"C7_Immunologic_signatures:C7_ALL_697_GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_697_GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDM_UP",198,-1.1995,0.13,0.19,0.9258,0.69,0.96,-0.7103,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1620_NATSUME_RESPONSE_TO_INTERFERON_BETA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1620_NATSUME_RESPONSE_TO_INTERFERON_BETA_UP",70,-1.1994,0.18,0.28,0.8808,0.72,0.94,-1.4111,0.025,0.35
"REACTOME:187179_REACT_24987_GABA_A_RECEPTOR_ACTIVATION","REACTOME","187179_REACT_24987_GABA_A_RECEPTOR_ACTIVATION",12,-1.1994,0.25,0.39,-0.9303,0.52,1,1.8983,0.0061,0.16
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_63_BIOCARTA_EPHA4_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_63_BIOCARTA_EPHA4_PATHWAY",10,-1.1994,0.25,0.35,0.7949,0.73,0.99,-1.5184,0.066,0.33
"C7_Immunologic_signatures:C7_ALL_1320_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1320_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN",192,-1.1993,0.1,0.19,-0.715,1,1,1.0844,0.25,1
"C3_MicroRNA_targets:C3_MIR_140_CTTTGTA_MIR_524","C3_MicroRNA_targets","C3_MIR_140_CTTTGTA_MIR_524",430,-1.1993,0.057,0.34,0.8734,0.94,1,-0.9386,0.7,1
"GO_BP:506268_GO_0043200_RESPONSE_TO_AMINO_ACID","GO_BP","506268_GO_0043200_RESPONSE_TO_AMINO_ACID",85,-1.1992,0.18,0.35,0.9189,0.65,1,0.9176,0.66,0.93
"GO_MF:500043_GO_0030742_GTP_DEPENDENT_PROTEIN_BINDING","GO_MF","500043_GO_0030742_GTP_DEPENDENT_PROTEIN_BINDING",17,-1.1992,0.24,0.4,0.7137,0.87,1,-0.5681,0.97,1
"GO_CC:490828_GO_0030137_COPI_COATED_VESICLE","GO_CC","490828_GO_0030137_COPI_COATED_VESICLE",20,-1.1992,0.24,0.43,1.588,0.031,0.13,-0.5687,0.98,1
"GO_MF:496718_GO_0016820_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES_CATALYZING_TRANSMEMBRANE_MOVEMENT_OF_SUBSTANCES","GO_MF","496718_GO_0016820_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES_CATALYZING_TRANSMEMBRANE_MOVEMENT_OF_SUBSTANCES",98,-1.1991,0.16,0.4,0.8421,0.83,1,-0.9965,0.41,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_702_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22","C2_Chemical_and_genetic_perturbations","C2_CGP_702_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22",11,-1.1991,0.27,0.28,-0.9204,0.57,1,-0.8023,0.7,0.95
"GO_MF:506590_GO_0043559_INSULIN_BINDING","GO_MF","506590_GO_0043559_INSULIN_BINDING",5,-1.1991,0.25,0.4,1.1121,0.36,0.77,-1.2692,0.19,0.58
"KEGG_compound:C20877_VERY_LONG_CHAIN_3_OXOACYL_COA","KEGG_compound","C20877_VERY_LONG_CHAIN_3_OXOACYL_COA",8,-1.199,0.26,0.38,-1.0793,0.38,0.96,-1.3545,0.12,0.33
"C7_Immunologic_signatures:C7_ALL_701_GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_701_GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDM_UP",196,-1.199,0.12,0.19,1.0318,0.35,0.64,-0.7452,0.99,1
"C3_TF_targets:C3_TFT_477_V_PR_02","C3_TF_targets","C3_TFT_477_V_PR_02",129,-1.199,0.14,0.19,-0.775,0.94,1,0.8208,0.89,1
"GO_BP:513994_GO_0060439_TRACHEA_MORPHOGENESIS","GO_BP","513994_GO_0060439_TRACHEA_MORPHOGENESIS",7,-1.1989,0.26,0.35,0.8379,0.64,1,1.393,0.13,0.63
"C7_Immunologic_signatures:C7_ALL_211_GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_211_GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP",197,-1.1988,0.14,0.19,-1.1579,0.14,0.96,-0.795,0.97,1
"GO_BP:512636_GO_0051764_ACTIN_CROSSLINK_FORMATION","GO_BP","512636_GO_0051764_ACTIN_CROSSLINK_FORMATION",5,-1.1988,0.24,0.35,-0.7538,0.75,1,1.2595,0.22,0.69
"GO_BP:751232_GO_0036315_CELLULAR_RESPONSE_TO_STEROL","GO_BP","751232_GO_0036315_CELLULAR_RESPONSE_TO_STEROL",16,-1.1988,0.23,0.35,-0.6027,0.97,1,-0.9851,0.44,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_2184_IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2184_IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN",347,-1.1987,0.082,0.28,0.8039,0.99,0.99,1.0891,0.21,0.87
"GO_BP:511829_GO_0050891_MULTICELLULAR_ORGANISMAL_WATER_HOMEOSTASIS","GO_BP","511829_GO_0050891_MULTICELLULAR_ORGANISMAL_WATER_HOMEOSTASIS",57,-1.1986,0.19,0.35,1.5042,0.016,0.4,1.0045,0.44,0.85
"GO_CC:490851_GO_0005827_POLAR_MICROTUBULE","GO_CC","490851_GO_0005827_POLAR_MICROTUBULE",5,-1.1986,0.24,0.43,-1.0536,0.41,0.83,-1.2923,0.2,0.66
"KEGG_pathway:HSA05160_HEPATITIS_C","KEGG_pathway","HSA05160_HEPATITIS_C",127,-1.1985,0.14,0.23,0.7554,0.97,1,-1.2701,0.052,0.31
"C7_Immunologic_signatures:C7_ALL_122_GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN","C7_Immunologic_signatures","C7_ALL_122_GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN",198,-1.1984,0.11,0.19,-0.7635,0.98,1,-0.9841,0.5,0.76
"GO_BP:512470_GO_0051592_RESPONSE_TO_CALCIUM_ION","GO_BP","512470_GO_0051592_RESPONSE_TO_CALCIUM_ION",101,-1.1983,0.17,0.35,0.995,0.45,0.98,1.2477,0.085,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_1858_CUI_TCF21_TARGETS_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1858_CUI_TCF21_TARGETS_2_UP",419,-1.1982,0.071,0.28,1.2598,0.018,0.43,-0.9931,0.47,0.76
"C3_MicroRNA_targets:C3_MIR_198_ATTCTTT_MIR_186","C3_MicroRNA_targets","C3_MIR_198_ATTCTTT_MIR_186",268,-1.1982,0.097,0.34,1.1962,0.066,1,1.0724,0.25,1
"C3_TF_targets:C3_TFT_173_V_EGR1_01","C3_TF_targets","C3_TFT_173_V_EGR1_01",266,-1.1982,0.12,0.2,-0.9405,0.64,0.89,0.963,0.54,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1759_BROWNE_HCMV_INFECTION_48HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1759_BROWNE_HCMV_INFECTION_48HR_DN",495,-1.1981,0.055,0.28,0.9083,0.88,0.91,-1.0284,0.34,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_968_GALIE_TUMOR_ANGIOGENESIS","C2_Chemical_and_genetic_perturbations","C2_CGP_968_GALIE_TUMOR_ANGIOGENESIS",8,-1.1981,0.24,0.28,0.6877,0.85,1,0.9931,0.44,0.96
"C7_Immunologic_signatures:C7_ALL_673_GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_673_GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDM_UP",194,-1.198,0.12,0.19,0.831,0.92,1,-0.9532,0.56,0.84
"C7_Immunologic_signatures:C7_ALL_495_GSE17721_CTRL_VS_CPG_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_495_GSE17721_CTRL_VS_CPG_0_5H_BMDM_UP",198,-1.198,0.12,0.19,0.6935,1,1,-1.2302,0.058,0.23
"KEGG_compound:C00041_L_ALANINE_L_2_AMINOPROPIONIC_ACID_L_ALPHA_ALANINE","KEGG_compound","C00041_L_ALANINE_L_2_AMINOPROPIONIC_ACID_L_ALPHA_ALANINE",11,-1.1977,0.25,0.38,-0.9169,0.56,1,1.0822,0.36,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_1095_COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1095_COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN",28,-1.1977,0.21,0.28,1.3179,0.11,0.38,1.954,0,0.13
"GO_BP:493498_GO_0009314_RESPONSE_TO_RADIATION","GO_BP","493498_GO_0009314_RESPONSE_TO_RADIATION",447,-1.1977,0.061,0.36,-0.9009,0.82,1,-1.0713,0.2,0.8
"GO_BP:516791_GO_0071870_CELLULAR_RESPONSE_TO_CATECHOLAMINE_STIMULUS","GO_BP","516791_GO_0071870_CELLULAR_RESPONSE_TO_CATECHOLAMINE_STIMULUS",23,-1.1976,0.23,0.36,0.7148,0.9,1,0.8092,0.76,1
"C3_TF_targets:C3_TFT_142_V_SP1_Q6","C3_TF_targets","C3_TFT_142_V_SP1_Q6",254,-1.1975,0.12,0.2,-1.2342,0.057,0.3,-1.2863,0.024,0.25
"GO_MF:490023_GO_0004707_MAP_KINASE_ACTIVITY","GO_MF","490023_GO_0004707_MAP_KINASE_ACTIVITY",13,-1.1973,0.24,0.4,-1.0973,0.34,0.84,-0.8622,0.63,0.91
"C7_Immunologic_signatures:C7_ALL_687_GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_687_GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDM_UP",197,-1.1973,0.13,0.19,0.9024,0.75,1,-0.7291,1,1
"C7_Immunologic_signatures:C7_ALL_358_GSE15659_TREG_VS_TCONV_DN","C7_Immunologic_signatures","C7_ALL_358_GSE15659_TREG_VS_TCONV_DN",179,-1.1971,0.12,0.19,0.9638,0.56,0.86,-0.7948,0.96,1
"REACTOME:161025_REACT_20558_SMOOTH_MUSCLE_CONTRACTION","REACTOME","161025_REACT_20558_SMOOTH_MUSCLE_CONTRACTION",28,-1.197,0.22,0.39,1.364,0.084,0.25,-0.9533,0.51,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2979_ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE","C2_Chemical_and_genetic_perturbations","C2_CGP_2979_ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE",18,-1.197,0.24,0.28,-1.098,0.32,0.91,-0.909,0.58,0.87
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_80_BIOCARTA_SET_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_80_BIOCARTA_SET_PATHWAY",11,-1.197,0.24,0.35,1.2778,0.19,0.65,-1.6192,0.028,0.36
"C7_Immunologic_signatures:C7_ALL_1414_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN","C7_Immunologic_signatures","C7_ALL_1414_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN",196,-1.1969,0.12,0.19,-0.9411,0.62,1,-1.149,0.13,0.37
"C2_Chemical_and_genetic_perturbations:C2_CGP_1104_PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1104_PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN",165,-1.1969,0.14,0.28,1.1409,0.15,0.57,-1.3567,0.01,0.39
"GO_BP:511929_GO_0050996_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS","GO_BP","511929_GO_0050996_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS",20,-1.1969,0.26,0.36,-1.2271,0.2,0.88,-1.0965,0.32,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_372_KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_372_KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN",64,-1.1969,0.18,0.28,-0.7681,0.88,1,0.9507,0.57,1
"GO_BP:502224_GO_0033002_MUSCLE_CELL_PROLIFERATION","GO_BP","502224_GO_0033002_MUSCLE_CELL_PROLIFERATION",19,-1.1968,0.22,0.36,-0.6561,0.92,1,-0.9146,0.57,0.92
"GO_MF:504359_GO_0035174_HISTONE_SERINE_KINASE_ACTIVITY","GO_MF","504359_GO_0035174_HISTONE_SERINE_KINASE_ACTIVITY",9,-1.1968,0.23,0.4,-0.814,0.69,1,-1.3352,0.15,0.54
"C7_Immunologic_signatures:C7_ALL_328_GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN","C7_Immunologic_signatures","C7_ALL_328_GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN",198,-1.1968,0.12,0.19,1.4784,0,0.016,1.0062,0.42,1
"GO_MF:496727_GO_0016830_CARBON_CARBON_LYASE_ACTIVITY","GO_MF","496727_GO_0016830_CARBON_CARBON_LYASE_ACTIVITY",48,-1.1968,0.19,0.4,-0.8497,0.73,1,-0.6791,0.97,1
"REACTOME:833810_REACT_163874_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS","REACTOME","833810_REACT_163874_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS",42,-1.1968,0.2,0.39,1.3207,0.08,0.3,1.3649,0.07,0.68
"GO_MF:513428_GO_0052689_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY","GO_MF","513428_GO_0052689_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY",117,-1.1966,0.14,0.4,1.1389,0.18,0.75,0.8721,0.77,0.97
"GO_BP:1184393_GO_1903867_EXTRAEMBRYONIC_MEMBRANE_DEVELOPMENT","GO_BP","1184393_GO_1903867_EXTRAEMBRYONIC_MEMBRANE_DEVELOPMENT",5,-1.1966,0.26,0.36,-1.0593,0.43,0.96,-1.5244,0.045,0.53
"C7_Immunologic_signatures:C7_ALL_717_GSE17721_0_5H_VS_12H_POLYIC_BMDM_UP","C7_Immunologic_signatures","C7_ALL_717_GSE17721_0_5H_VS_12H_POLYIC_BMDM_UP",198,-1.1964,0.12,0.19,1.4672,0.0051,0.018,-0.8875,0.81,0.97
"GO_BP:488663_GO_0002790_PEPTIDE_SECRETION","GO_BP","488663_GO_0002790_PEPTIDE_SECRETION",59,-1.1964,0.17,0.36,0.956,0.51,1,1.0734,0.29,0.78
"GO_BP:752408_GO_0086042_CARDIAC_MUSCLE_CELL_CARDIAC_MUSCLE_CELL_ADHESION","GO_BP","752408_GO_0086042_CARDIAC_MUSCLE_CELL_CARDIAC_MUSCLE_CELL_ADHESION",6,-1.1961,0.27,0.36,-0.5969,0.95,1,0.7939,0.71,1
"C1_Positional:C1_ALL_231_CHRXP22","C1_Positional","C1_ALL_231_CHRXP22",124,-1.1961,0.15,0.72,1.1615,0.16,0.63,-1.0075,0.42,0.87
"KEGG_pathway:HSA04340_HEDGEHOG_SIGNALING_PATHWAY","KEGG_pathway","HSA04340_HEDGEHOG_SIGNALING_PATHWAY",50,-1.1961,0.19,0.23,-0.9395,0.59,0.96,0.9136,0.62,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3095_PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3095_PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN",155,-1.196,0.13,0.28,0.8858,0.76,0.94,-0.7911,0.95,0.96
"C4_Cancer_gene_neighborhoods:C4_CGN_26_MORF_MSH3","C4_Cancer_gene_neighborhoods","C4_CGN_26_MORF_MSH3",239,-1.196,0.11,0.33,-1.3495,0.022,0.48,-0.9708,0.55,0.91
"REACTOME:187098_REACT_25026_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY","REACTOME","187098_REACT_25026_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY",14,-1.1959,0.25,0.39,1.0359,0.38,0.69,-1.6402,0.019,0.23
"C3_TF_targets:C3_TFT_317_V_PPARA_02","C3_TF_targets","C3_TFT_317_V_PPARA_02",126,-1.1959,0.15,0.2,-1.368,0.026,0.19,0.7224,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_84_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_84_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP",72,-1.1958,0.17,0.28,0.9865,0.45,0.81,-0.8056,0.83,0.95
"REACTOME:187188_REACT_23826_PASSIVE_TRANSPORT_BY_AQUAPORINS","REACTOME","187188_REACT_23826_PASSIVE_TRANSPORT_BY_AQUAPORINS",11,-1.1958,0.24,0.39,-0.6459,0.93,1,-0.7377,0.8,1
"GO_BP:512838_GO_0051988_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE","GO_BP","512838_GO_0051988_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE",11,-1.1957,0.25,0.36,-0.6486,0.91,1,-1.2631,0.19,0.67
"GO_MF:495527_GO_0015276_LIGAND_GATED_ION_CHANNEL_ACTIVITY","GO_MF","495527_GO_0015276_LIGAND_GATED_ION_CHANNEL_ACTIVITY",141,-1.1957,0.14,0.4,-1.2264,0.089,0.85,1.8002,0,0.12
"GO_BP:494575_GO_0010506_REGULATION_OF_AUTOPHAGY","GO_BP","494575_GO_0010506_REGULATION_OF_AUTOPHAGY",235,-1.1957,0.11,0.36,1.0729,0.24,0.93,0.7663,0.99,1
"GO_BP:498669_GO_0019886_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II","GO_BP","498669_GO_0019886_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II",91,-1.1954,0.18,0.36,1.0389,0.37,0.96,-0.6402,1,1
"GO_BP:488892_GO_0003096_RENAL_SODIUM_ION_TRANSPORT","GO_BP","488892_GO_0003096_RENAL_SODIUM_ION_TRANSPORT",5,-1.1954,0.25,0.36,-1.3857,0.081,0.99,-1.0362,0.43,0.82
"C4_Cancer_gene_neighborhoods:C4_CGN_424_GNF2_TYK2","C4_Cancer_gene_neighborhoods","C4_CGN_424_GNF2_TYK2",33,-1.1954,0.23,0.33,1.1353,0.28,0.31,-0.8777,0.67,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2284_BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING","C2_Chemical_and_genetic_perturbations","C2_CGP_2284_BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING",244,-1.1954,0.12,0.28,-0.8673,0.86,1,-1.0049,0.44,0.75
"GO_BP:501714_GO_0032482_RAB_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","501714_GO_0032482_RAB_PROTEIN_SIGNAL_TRANSDUCTION",70,-1.1953,0.18,0.36,0.8721,0.72,1,-0.9008,0.67,0.92
"C7_Immunologic_signatures:C7_ALL_1200_GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1200_GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN",195,-1.1953,0.13,0.19,0.9976,0.44,0.74,-0.6965,1,1
"GO_BP:496195_GO_0016102_DITERPENOID_BIOSYNTHETIC_PROCESS","GO_BP","496195_GO_0016102_DITERPENOID_BIOSYNTHETIC_PROCESS",7,-1.1953,0.24,0.36,-0.9663,0.49,1,-0.9565,0.5,0.88
"GO_BP:502095_GO_0032873_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_MAPK_CASCADE","GO_BP","502095_GO_0032873_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_MAPK_CASCADE",38,-1.1953,0.22,0.36,1.1493,0.25,0.84,0.9489,0.54,0.9
"GO_BP:508899_GO_0046653_TETRAHYDROFOLATE_METABOLIC_PROCESS","GO_BP","508899_GO_0046653_TETRAHYDROFOLATE_METABOLIC_PROCESS",18,-1.1953,0.23,0.36,-0.8787,0.63,1,-0.833,0.72,0.97
"C1_Positional:C1_ALL_206_CHR21Q22","C1_Positional","C1_ALL_206_CHR21Q22",159,-1.1952,0.13,0.71,0.6898,1,1,-0.8581,0.84,0.99
"GO_MF:501287_GO_0032050_CLATHRIN_HEAVY_CHAIN_BINDING","GO_MF","501287_GO_0032050_CLATHRIN_HEAVY_CHAIN_BINDING",5,-1.1951,0.26,0.41,-0.73,0.79,1,0.6803,0.84,1
"GO_BP:516417_GO_0071493_CELLULAR_RESPONSE_TO_UV_B","GO_BP","516417_GO_0071493_CELLULAR_RESPONSE_TO_UV_B",8,-1.195,0.27,0.36,-0.8928,0.56,1,0.8671,0.62,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1085_RICKMAN_HEAD_AND_NECK_CANCER_A","C2_Chemical_and_genetic_perturbations","C2_CGP_1085_RICKMAN_HEAD_AND_NECK_CANCER_A",96,-1.1948,0.15,0.28,1.1166,0.22,0.6,1.1985,0.14,0.77
"C3_MicroRNA_targets:C3_MIR_179_ACTGTAG_MIR_139","C3_MicroRNA_targets","C3_MIR_179_ACTGTAG_MIR_139",121,-1.1947,0.17,0.34,1.1507,0.16,1,0.8478,0.81,1
"C7_Immunologic_signatures:C7_ALL_1776_GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN","C7_Immunologic_signatures","C7_ALL_1776_GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN",199,-1.1947,0.14,0.19,0.9163,0.73,0.99,-1.1632,0.12,0.34
"GO_BP:519032_GO_2000392_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS","GO_BP","519032_GO_2000392_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS",6,-1.1946,0.26,0.36,-0.8216,0.69,1,-0.8139,0.69,0.98
"GO_BP:491384_GO_0006482_PROTEIN_DEMETHYLATION","GO_BP","491384_GO_0006482_PROTEIN_DEMETHYLATION",37,-1.1945,0.21,0.36,-1.6435,0.0092,0.7,-0.9577,0.53,0.88
"C3_MicroRNA_targets:C3_MIR_32_ACTGTGA_MIR_27A_MIR_27B","C3_MicroRNA_targets","C3_MIR_32_ACTGTGA_MIR_27A_MIR_27B",466,-1.1945,0.066,0.34,-0.869,0.88,1,-0.9643,0.61,1
"C7_Immunologic_signatures:C7_ALL_164_GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN","C7_Immunologic_signatures","C7_ALL_164_GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN",197,-1.1944,0.14,0.19,1.2387,0.05,0.17,0.8325,0.89,1
"GO_BP:513628_GO_0060070_CANONICAL_WNT_SIGNALING_PATHWAY","GO_BP","513628_GO_0060070_CANONICAL_WNT_SIGNALING_PATHWAY",84,-1.1942,0.17,0.36,-1.0611,0.35,0.96,1.4604,0.02,0.59
"C7_Immunologic_signatures:C7_ALL_743_GSE17721_0_5H_VS_4H_CPG_BMDM_UP","C7_Immunologic_signatures","C7_ALL_743_GSE17721_0_5H_VS_4H_CPG_BMDM_UP",200,-1.194,0.12,0.19,0.643,1,1,-1.3334,0.026,0.11
"GO_MF:498654_GO_0019871_SODIUM_CHANNEL_INHIBITOR_ACTIVITY","GO_MF","498654_GO_0019871_SODIUM_CHANNEL_INHIBITOR_ACTIVITY",5,-1.194,0.25,0.41,-1.0559,0.41,0.87,-1.4678,0.06,0.42
"C7_Immunologic_signatures:C7_ALL_386_GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_386_GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN",198,-1.1939,0.13,0.19,-1.0318,0.37,1,-0.9669,0.55,0.8
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_23_BIOCARTA_BCR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_23_BIOCARTA_BCR_PATHWAY",34,-1.1939,0.21,0.35,-0.6453,0.96,1,-1.5665,0.0061,0.34
"GO_BP:501611_GO_0032376_POSITIVE_REGULATION_OF_CHOLESTEROL_TRANSPORT","GO_BP","501611_GO_0032376_POSITIVE_REGULATION_OF_CHOLESTEROL_TRANSPORT",15,-1.1938,0.23,0.36,0.6874,0.89,1,0.8163,0.69,1
"GO_BP:512331_GO_0051453_REGULATION_OF_INTRACELLULAR_PH","GO_BP","512331_GO_0051453_REGULATION_OF_INTRACELLULAR_PH",44,-1.1938,0.21,0.36,-1.0203,0.42,0.97,-0.7956,0.82,0.99
"GO_MF:495448_GO_0015179_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495448_GO_0015179_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",43,-1.1936,0.22,0.41,1.0042,0.45,0.87,-0.9321,0.55,0.84
"KEGG_pathway:HSA05211_RENAL_CELL_CARCINOMA","KEGG_pathway","HSA05211_RENAL_CELL_CARCINOMA",65,-1.1935,0.19,0.24,1.0839,0.31,0.81,0.8584,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3079_FIGUEROA_AML_METHYLATION_CLUSTER_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3079_FIGUEROA_AML_METHYLATION_CLUSTER_1_DN",46,-1.1935,0.2,0.28,0.7828,0.84,1,-0.9572,0.55,0.81
"GO_CC:499557_GO_0030128_CLATHRIN_COAT_OF_ENDOCYTIC_VESICLE","GO_CC","499557_GO_0030128_CLATHRIN_COAT_OF_ENDOCYTIC_VESICLE",12,-1.1935,0.26,0.44,0.9345,0.53,0.85,0.6312,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3068_LU_EZH2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3068_LU_EZH2_TARGETS_UP",281,-1.1934,0.092,0.28,0.8643,0.91,0.96,-1.1505,0.13,0.58
"GO_BP:506453_GO_0043415_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION","GO_BP","506453_GO_0043415_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION",5,-1.1933,0.26,0.36,-0.9615,0.5,1,-1.1433,0.34,0.74
"REACTOME:106471_REACT_15530_PKA_ACTIVATION","REACTOME","106471_REACT_15530_PKA_ACTIVATION",16,-1.1933,0.24,0.4,0.9935,0.45,0.77,-1.1344,0.29,0.67
"GO_BP:512668_GO_0051797_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT","GO_BP","512668_GO_0051797_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT",14,-1.1933,0.22,0.36,-1.0361,0.4,0.98,-0.9772,0.49,0.87
"C7_Immunologic_signatures:C7_ALL_146_GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN","C7_Immunologic_signatures","C7_ALL_146_GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN",199,-1.1932,0.13,0.19,0.9977,0.48,0.74,-1.1745,0.12,0.33
"C4_Cancer_modules:C4_CM_386_MODULE_485","C4_Cancer_modules","C4_CM_386_MODULE_485",52,-1.1932,0.2,0.29,-1.0145,0.44,0.79,-1.5823,0.012,0.12
"C2_Chemical_and_genetic_perturbations:C2_CGP_2727_CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2727_CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP",73,-1.1931,0.19,0.28,-1.3341,0.066,0.69,-1.2515,0.099,0.47
"C7_Immunologic_signatures:C7_ALL_1095_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1095_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP",200,-1.193,0.12,0.19,1.6867,0,0.00082,0.6448,1,1
"GO_BP:491723_GO_0006857_OLIGOPEPTIDE_TRANSPORT","GO_BP","491723_GO_0006857_OLIGOPEPTIDE_TRANSPORT",6,-1.193,0.28,0.36,-1.2117,0.26,0.88,1.1846,0.27,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_399_CASTELLANO_HRAS_AND_NRAS_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_399_CASTELLANO_HRAS_AND_NRAS_TARGETS_UP",5,-1.193,0.26,0.28,-0.9222,0.56,1,-1.2849,0.18,0.44
"GO_MF:489660_GO_0008237_METALLOPEPTIDASE_ACTIVITY","GO_MF","489660_GO_0008237_METALLOPEPTIDASE_ACTIVITY",180,-1.1928,0.14,0.41,0.8168,0.94,1,1.152,0.15,0.78
"GO_BP:499702_GO_0030300_REGULATION_OF_INTESTINAL_CHOLESTEROL_ABSORPTION","GO_BP","499702_GO_0030300_REGULATION_OF_INTESTINAL_CHOLESTEROL_ABSORPTION",7,-1.1926,0.27,0.36,-1.5276,0.051,0.77,-0.6391,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1078_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1078_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP",8,-1.1926,0.26,0.29,-1.1467,0.29,0.85,0.818,0.73,1
"C6_Oncogenic_signatures:C6_ALL_148_SIRNA_EIF4GI_UP","C6_Oncogenic_signatures","C6_ALL_148_SIRNA_EIF4GI_UP",93,-1.1926,0.17,0.19,1.2571,0.082,0.36,-1.4469,0.004,0.17
"GO_BP:496031_GO_0015909_LONG_CHAIN_FATTY_ACID_TRANSPORT","GO_BP","496031_GO_0015909_LONG_CHAIN_FATTY_ACID_TRANSPORT",37,-1.1926,0.2,0.36,0.7475,0.88,1,1.3348,0.081,0.64
"GO_BP:518745_GO_2000096_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY","GO_BP","518745_GO_2000096_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY",7,-1.1925,0.26,0.36,0.6678,0.87,1,-1.0884,0.36,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2755_YAGI_AML_WITH_INV_16_TRANSLOCATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2755_YAGI_AML_WITH_INV_16_TRANSLOCATION",414,-1.1924,0.072,0.29,1.3872,0,0.3,-0.8472,0.95,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_2367_DONATO_CELL_CYCLE_TRETINOIN","C2_Chemical_and_genetic_perturbations","C2_CGP_2367_DONATO_CELL_CYCLE_TRETINOIN",6,-1.1924,0.28,0.29,-0.6951,0.85,1,-1.4817,0.052,0.31
"GO_MF:983695_GO_0098634_PROTEIN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION","GO_MF","983695_GO_0098634_PROTEIN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION",6,-1.1924,0.24,0.41,-1.156,0.29,0.81,-1.0874,0.39,0.7
"C7_Immunologic_signatures:C7_ALL_191_GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_191_GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP",180,-1.1923,0.13,0.19,1.1467,0.15,0.33,1.7345,0,0.00093
"GO_BP:510921_GO_0048872_HOMEOSTASIS_OF_NUMBER_OF_CELLS","GO_BP","510921_GO_0048872_HOMEOSTASIS_OF_NUMBER_OF_CELLS",177,-1.1923,0.13,0.36,1.2289,0.066,0.75,-1.1035,0.22,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_1490_ROETH_TERT_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1490_ROETH_TERT_TARGETS_DN",8,-1.1923,0.26,0.29,0.8308,0.65,0.98,1.4222,0.1,0.55
"C7_Immunologic_signatures:C7_ALL_569_GSE17721_PAM3CSK4_VS_CPG_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_569_GSE17721_PAM3CSK4_VS_CPG_4H_BMDM_UP",200,-1.1923,0.12,0.19,-0.9611,0.57,1,-0.7937,0.96,1
"C3_TF_targets:C3_TFT_53_V_EVI1_04","C3_TF_targets","C3_TFT_53_V_EVI1_04",231,-1.1922,0.12,0.2,1.1291,0.14,0.98,-0.8864,0.81,0.94
"C7_Immunologic_signatures:C7_ALL_3_KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_3_KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP",196,-1.1922,0.13,0.19,1.3297,0.012,0.077,-0.9107,0.72,0.93
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_211_BIOCARTA_TRKA_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_211_BIOCARTA_TRKA_PATHWAY",12,-1.1921,0.25,0.35,-0.7786,0.77,1,-0.8683,0.63,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_386_YEMELYANOV_GR_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_386_YEMELYANOV_GR_TARGETS_DN",10,-1.1919,0.26,0.29,-1.3368,0.14,0.69,-0.7566,0.79,0.97
"KEGG_reaction:R07046_ARACHIDONATE_OXYGEN_NADPH_H_19_S_HETE_NADP_H2O","KEGG_reaction","R07046_ARACHIDONATE_OXYGEN_NADPH_H_19_S_HETE_NADP_H2O",6,-1.1919,0.26,0.38,-1.4555,0.072,0.24,-1.7864,0.0059,0.028
"GO_BP:519314_GO_2000675_NEGATIVE_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS","GO_BP","519314_GO_2000675_NEGATIVE_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS",6,-1.1918,0.26,0.36,1.3104,0.16,0.66,1.0981,0.35,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_3290_DELACROIX_RAR_BOUND_ES","C2_Chemical_and_genetic_perturbations","C2_CGP_3290_DELACROIX_RAR_BOUND_ES",450,-1.1918,0.072,0.29,-0.9388,0.67,1,-0.963,0.6,0.8
"GO_BP:507929_GO_0045581_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION","GO_BP","507929_GO_0045581_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION",26,-1.1918,0.22,0.36,-1.4524,0.066,0.9,0.6604,0.94,1
"GO_BP:487672_GO_0001776_LEUKOCYTE_HOMEOSTASIS","GO_BP","487672_GO_0001776_LEUKOCYTE_HOMEOSTASIS",62,-1.1917,0.19,0.36,0.7476,0.92,1,-1.2111,0.15,0.72
"C3_TF_targets:C3_TFT_384_V_OSF2_Q6","C3_TF_targets","C3_TFT_384_V_OSF2_Q6",258,-1.1917,0.1,0.2,-0.8829,0.81,0.99,0.905,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1712_LEE_AGING_CEREBELLUM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1712_LEE_AGING_CEREBELLUM_DN",82,-1.1917,0.18,0.29,0.9382,0.59,0.88,-0.9578,0.53,0.81
"GO_MF:490071_GO_0004758_SERINE_C_PALMITOYLTRANSFERASE_ACTIVITY","GO_MF","490071_GO_0004758_SERINE_C_PALMITOYLTRANSFERASE_ACTIVITY",5,-1.1916,0.26,0.41,-1.4036,0.098,0.64,-1.21,0.28,0.57
"GO_BP:508170_GO_0045851_PH_REDUCTION","GO_BP","508170_GO_0045851_PH_REDUCTION",27,-1.1916,0.23,0.36,-0.6374,0.96,1,0.698,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2676_ROME_INSULIN_TARGETS_IN_MUSCLE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2676_ROME_INSULIN_TARGETS_IN_MUSCLE_DN",193,-1.1915,0.12,0.29,-1.3995,0.0084,0.59,-0.911,0.71,0.87
"GO_BP:491848_GO_0007017_MICROTUBULE_BASED_PROCESS","GO_BP","491848_GO_0007017_MICROTUBULE_BASED_PROCESS",478,-1.1914,0.072,0.36,-0.8842,0.89,1,-1.2976,0.0021,0.65
"GO_BP:491482_GO_0006586_INDOLALKYLAMINE_METABOLIC_PROCESS","GO_BP","491482_GO_0006586_INDOLALKYLAMINE_METABOLIC_PROCESS",23,-1.1914,0.23,0.36,-1.1473,0.28,0.93,-1.2876,0.14,0.65
"C3_MicroRNA_targets:C3_MIR_40_AAGCCAT_MIR_135A_MIR_135B","C3_MicroRNA_targets","C3_MIR_40_AAGCCAT_MIR_135A_MIR_135B",330,-1.1912,0.11,0.34,-0.6971,1,1,-0.8503,0.93,1
"C4_Cancer_modules:C4_CM_333_MODULE_397","C4_Cancer_modules","C4_CM_333_MODULE_397",120,-1.1911,0.15,0.3,-0.9799,0.51,0.82,-1.5797,0,0.12
"REACTOME:119540_REACT_19290_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA","REACTOME","119540_REACT_19290_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA",47,-1.191,0.2,0.4,0.7876,0.82,1,-0.8789,0.71,0.96
"KEGG_pathway:HSA04550_SIGNALING_PATHWAYS_REGULATING_PLURIPOTENCY_OF_STEM_CELLS","KEGG_pathway","HSA04550_SIGNALING_PATHWAYS_REGULATING_PLURIPOTENCY_OF_STEM_CELLS",140,-1.1909,0.17,0.24,-1.1973,0.12,0.51,1.0886,0.26,0.96
"C1_Positional:C1_ALL_249_CHR3Q25","C1_Positional","C1_ALL_249_CHR3Q25",53,-1.1908,0.19,0.72,-1.056,0.35,1,-1.1799,0.2,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_225_LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_225_LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN",7,-1.1908,0.25,0.29,-1.2744,0.19,0.71,-1.4968,0.066,0.3
"C4_Cancer_gene_neighborhoods:C4_CGN_237_GCM_LTK","C4_Cancer_gene_neighborhoods","C4_CGN_237_GCM_LTK",43,-1.1908,0.21,0.34,-0.9854,0.47,0.86,-0.7276,0.93,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_64_BIOCARTA_EPO_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_64_BIOCARTA_EPO_PATHWAY",19,-1.1907,0.23,0.35,-1.2749,0.16,1,-1.123,0.29,0.64
"GO_BP:503553_GO_0034351_NEGATIVE_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS","GO_BP","503553_GO_0034351_NEGATIVE_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS",7,-1.1906,0.26,0.36,0.9353,0.56,1,1.1917,0.25,0.72
"GO_BP:495005_GO_0010940_POSITIVE_REGULATION_OF_NECROTIC_CELL_DEATH","GO_BP","495005_GO_0010940_POSITIVE_REGULATION_OF_NECROTIC_CELL_DEATH",5,-1.1906,0.28,0.36,0.6475,0.89,1,0.9681,0.51,0.89
"GO_BP:512094_GO_0051188_COFACTOR_BIOSYNTHETIC_PROCESS","GO_BP","512094_GO_0051188_COFACTOR_BIOSYNTHETIC_PROCESS",129,-1.1905,0.15,0.36,1.1058,0.23,0.9,-1.5789,0,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1757_YIH_RESPONSE_TO_ARSENITE_C2","C2_Chemical_and_genetic_perturbations","C2_CGP_1757_YIH_RESPONSE_TO_ARSENITE_C2",18,-1.1904,0.25,0.29,0.7428,0.87,1,-1.0666,0.36,0.67
"C1_Positional:C1_ALL_121_CHR8P21","C1_Positional","C1_ALL_121_CHR8P21",76,-1.1902,0.18,0.71,-0.7879,0.88,0.96,0.8124,0.84,0.92
"GO_CC:499591_GO_0030173_INTEGRAL_COMPONENT_OF_GOLGI_MEMBRANE","GO_CC","499591_GO_0030173_INTEGRAL_COMPONENT_OF_GOLGI_MEMBRANE",44,-1.1902,0.22,0.45,0.6679,0.98,0.99,-0.6018,0.98,1
"C7_Immunologic_signatures:C7_ALL_429_GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_429_GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP",199,-1.1901,0.14,0.2,1.3163,0.024,0.088,-1.2592,0.039,0.18
"REACTOME:530738_REACT_115720_PLCG1_EVENTS_IN_ERBB2_SIGNALING","REACTOME","530738_REACT_115720_PLCG1_EVENTS_IN_ERBB2_SIGNALING",37,-1.19,0.21,0.4,-0.9225,0.6,1,-1.4123,0.045,0.4
"REACTOME:105806_REACT_1006_POLO_LIKE_KINASE_MEDIATED_EVENTS","REACTOME","105806_REACT_1006_POLO_LIKE_KINASE_MEDIATED_EVENTS",16,-1.1899,0.23,0.4,-0.4978,0.99,1,-0.8991,0.56,0.95
"GO_BP:501198_GO_0031958_CORTICOSTEROID_RECEPTOR_SIGNALING_PATHWAY","GO_BP","501198_GO_0031958_CORTICOSTEROID_RECEPTOR_SIGNALING_PATHWAY",12,-1.1898,0.27,0.37,-0.8572,0.66,1,-1.1272,0.31,0.76
"OMIM_gene:OMIM600140_CREB_BINDING_PROTEIN_CREBBP","OMIM_gene","OMIM600140_CREB_BINDING_PROTEIN_CREBBP",5,-1.1897,0.25,0.84,0.4993,0.98,0.98,-1.0366,0.41,1
"GO_BP:508868_GO_0046620_REGULATION_OF_ORGAN_GROWTH","GO_BP","508868_GO_0046620_REGULATION_OF_ORGAN_GROWTH",74,-1.1897,0.18,0.37,0.7736,0.92,1,1.0814,0.31,0.77
"GO_BP:491407_GO_0006509_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS","GO_BP","491407_GO_0006509_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS",22,-1.1897,0.22,0.37,0.4569,1,1,-1.0228,0.42,0.83
"C7_Immunologic_signatures:C7_ALL_1431_GSE360_DC_VS_MAC_UP","C7_Immunologic_signatures","C7_ALL_1431_GSE360_DC_VS_MAC_UP",198,-1.1896,0.14,0.2,0.7319,1,1,-0.8926,0.77,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2167_FINETTI_BREAST_CANCERS_KINOME_BLUE","C2_Chemical_and_genetic_perturbations","C2_CGP_2167_FINETTI_BREAST_CANCERS_KINOME_BLUE",20,-1.1896,0.23,0.29,-1.4811,0.051,0.49,-0.9804,0.47,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2759_MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2759_MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3",56,-1.1896,0.2,0.29,1.0938,0.25,0.64,1.1053,0.29,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1635_BRACHAT_RESPONSE_TO_CISPLATIN","C2_Chemical_and_genetic_perturbations","C2_CGP_1635_BRACHAT_RESPONSE_TO_CISPLATIN",22,-1.1894,0.22,0.29,0.8925,0.62,0.93,0.9384,0.55,1
"GO_BP:516789_GO_0071868_CELLULAR_RESPONSE_TO_MONOAMINE_STIMULUS","GO_BP","516789_GO_0071868_CELLULAR_RESPONSE_TO_MONOAMINE_STIMULUS",23,-1.1894,0.23,0.37,0.7227,0.89,1,0.8212,0.73,1
"GO_BP:492169_GO_0007406_NEGATIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION","GO_BP","492169_GO_0007406_NEGATIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION",7,-1.1893,0.26,0.37,-1.1438,0.29,0.93,-1.1603,0.3,0.73
"GO_BP:498637_GO_0019852_L_ASCORBIC_ACID_METABOLIC_PROCESS","GO_BP","498637_GO_0019852_L_ASCORBIC_ACID_METABOLIC_PROCESS",11,-1.1892,0.25,0.37,-1.3529,0.13,0.95,-0.5758,0.98,1
"OMIM_gene:OMIM600947_HUNTINGTIN_ASSOCIATED_PROTEIN_1_HAP1","OMIM_gene","OMIM600947_HUNTINGTIN_ASSOCIATED_PROTEIN_1_HAP1",6,-1.1892,0.29,0.8,0.5288,0.97,0.99,-0.9236,0.55,1
"GO_BP:519404_GO_2000765_REGULATION_OF_CYTOPLASMIC_TRANSLATION","GO_BP","519404_GO_2000765_REGULATION_OF_CYTOPLASMIC_TRANSLATION",6,-1.1892,0.26,0.37,-1.0653,0.4,0.96,-0.9616,0.5,0.88
"GO_BP:506341_GO_0043276_ANOIKIS","GO_BP","506341_GO_0043276_ANOIKIS",5,-1.1892,0.29,0.37,-0.6908,0.83,1,-0.5364,0.96,1
"GO_BP:753004_GO_1900004_NEGATIVE_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_BP","753004_GO_1900004_NEGATIVE_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY",6,-1.189,0.28,0.37,1.2078,0.25,0.78,-0.7651,0.74,1
"GO_BP:494330_GO_0010256_ENDOMEMBRANE_SYSTEM_ORGANIZATION","GO_BP","494330_GO_0010256_ENDOMEMBRANE_SYSTEM_ORGANIZATION",404,-1.1889,0.09,0.37,0.9854,0.5,1,0.7364,1,1
"GO_BP:497777_GO_0018879_BIPHENYL_METABOLIC_PROCESS","GO_BP","497777_GO_0018879_BIPHENYL_METABOLIC_PROCESS",6,-1.1888,0.26,0.37,1.0189,0.44,0.97,1.6861,0.0099,0.4
"C6_Oncogenic_signatures:C6_ALL_87_MTOR_UP_N4_V1_DN","C6_Oncogenic_signatures","C6_ALL_87_MTOR_UP_N4_V1_DN",185,-1.1887,0.13,0.19,-0.7387,0.99,1,-1.1388,0.16,0.45
"GO_BP:488797_GO_0002924_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN","GO_BP","488797_GO_0002924_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN",6,-1.1886,0.26,0.37,-0.8657,0.62,1,0.8897,0.58,0.95
"GO_MF:499460_GO_0045125_BIOACTIVE_LIPID_RECEPTOR_ACTIVITY","GO_MF","499460_GO_0045125_BIOACTIVE_LIPID_RECEPTOR_ACTIVITY",9,-1.1886,0.26,0.41,1.0602,0.37,0.83,0.8508,0.65,0.98
"GO_BP:512532_GO_0051656_ESTABLISHMENT_OF_ORGANELLE_LOCALIZATION","GO_BP","512532_GO_0051656_ESTABLISHMENT_OF_ORGANELLE_LOCALIZATION",291,-1.1885,0.097,0.37,1.2457,0.045,0.74,-0.9383,0.66,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_3353_HOLLEMAN_DAUNORUBICIN_ALL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3353_HOLLEMAN_DAUNORUBICIN_ALL_UP",7,-1.1884,0.26,0.29,-1.0666,0.37,0.96,-0.8574,0.64,0.92
"C3_TF_targets:C3_TFT_312_V_ATF3_Q6","C3_TF_targets","C3_TFT_312_V_ATF3_Q6",244,-1.1881,0.14,0.21,-0.9381,0.65,0.89,-0.8618,0.88,0.97
"GO_BP:849985_GO_1902284_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE","GO_BP","849985_GO_1902284_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE",17,-1.188,0.23,0.37,-1.193,0.25,0.9,1.0393,0.39,0.82
"GO_BP:497792_GO_0018894_DIBENZO_P_DIOXIN_METABOLIC_PROCESS","GO_BP","497792_GO_0018894_DIBENZO_P_DIOXIN_METABOLIC_PROCESS",6,-1.1879,0.27,0.37,0.7632,0.77,1,1.1537,0.31,0.73
"GO_BP:513599_GO_0060041_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE","GO_BP","513599_GO_0060041_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE",131,-1.1879,0.14,0.37,-1.1671,0.14,0.91,1.2668,0.048,0.69
"GO_CC:487083_GO_0000790_NUCLEAR_CHROMATIN","GO_CC","487083_GO_0000790_NUCLEAR_CHROMATIN",253,-1.1878,0.12,0.45,-1.5093,0,0.63,-1.659,0,0.49
"C2_Chemical_and_genetic_perturbations:C2_CGP_1768_KIM_GASTRIC_CANCER_CHEMOSENSITIVITY","C2_Chemical_and_genetic_perturbations","C2_CGP_1768_KIM_GASTRIC_CANCER_CHEMOSENSITIVITY",97,-1.1876,0.17,0.29,-0.9125,0.64,1,0.8911,0.71,1
"C7_Immunologic_signatures:C7_ALL_1424_GSE360_CTRL_VS_T_GONDII_MAC_DN","C7_Immunologic_signatures","C7_ALL_1424_GSE360_CTRL_VS_T_GONDII_MAC_DN",197,-1.1871,0.12,0.2,-0.8519,0.83,1,-1.0419,0.34,0.63
"C7_Immunologic_signatures:C7_ALL_1503_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP","C7_Immunologic_signatures","C7_ALL_1503_GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP",198,-1.1869,0.15,0.2,0.8502,0.87,1,-0.8747,0.84,0.99
"OMIM_gene:OMIM603344_USO1_VESICLE_DOCKING_PROTEIN_S_CEREVISIAE_HOMOLOG_OF_USO1","OMIM_gene","OMIM603344_USO1_VESICLE_DOCKING_PROTEIN_S_CEREVISIAE_HOMOLOG_OF_USO1",5,-1.1868,0.29,0.77,-1.086,0.4,1,0.8569,0.64,1
"C7_Immunologic_signatures:C7_ALL_877_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP","C7_Immunologic_signatures","C7_ALL_877_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP",200,-1.1866,0.12,0.2,0.6968,1,1,0.9151,0.72,1
"C7_Immunologic_signatures:C7_ALL_780_GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_780_GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN",198,-1.1864,0.14,0.2,-0.6994,1,1,-1.3762,0.0063,0.077
"C2_Chemical_and_genetic_perturbations:C2_CGP_1324_PENG_LEUCINE_DEPRIVATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1324_PENG_LEUCINE_DEPRIVATION_DN",186,-1.1863,0.14,0.29,1.3021,0.037,0.39,-1.4822,0,0.31
"GO_BP:514272_GO_0060717_CHORION_DEVELOPMENT","GO_BP","514272_GO_0060717_CHORION_DEVELOPMENT",5,-1.1863,0.26,0.37,-1.0843,0.36,0.96,-1.5132,0.053,0.53
"GO_BP:494085_GO_0010002_CARDIOBLAST_DIFFERENTIATION","GO_BP","494085_GO_0010002_CARDIOBLAST_DIFFERENTIATION",13,-1.1861,0.24,0.37,-0.6804,0.9,1,1.5718,0.036,0.47
"GO_BP:993419_GO_1903077_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE","GO_BP","993419_GO_1903077_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",18,-1.1861,0.23,0.37,0.9418,0.51,1,0.5775,0.96,1
"REACTOME:205243_REACT_27161_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION","REACTOME","205243_REACT_27161_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION",78,-1.1861,0.2,0.41,-0.7584,0.92,1,0.817,0.84,1
"C7_Immunologic_signatures:C7_ALL_1385_GSE339_CD4POS_VS_CD4CD8DN_DC_UP","C7_Immunologic_signatures","C7_ALL_1385_GSE339_CD4POS_VS_CD4CD8DN_DC_UP",199,-1.1861,0.14,0.2,0.9261,0.7,0.96,-1.1974,0.099,0.29
"C1_Positional:C1_ALL_194_CHR1P12","C1_Positional","C1_ALL_194_CHR1P12",16,-1.1861,0.26,0.71,-1.0664,0.36,1,-1.0157,0.43,0.86
"GO_BP:497080_GO_0018105_PEPTIDYL_SERINE_PHOSPHORYLATION","GO_BP","497080_GO_0018105_PEPTIDYL_SERINE_PHOSPHORYLATION",103,-1.186,0.16,0.37,-1.1551,0.2,0.92,-1.4526,0.017,0.54
"C3_MicroRNA_targets:C3_MIR_165_GCTGAGT_MIR_512_5P","C3_MicroRNA_targets","C3_MIR_165_GCTGAGT_MIR_512_5P",50,-1.1858,0.21,0.35,0.8141,0.82,1,-0.9102,0.6,1
"GO_MF:492396_GO_0008022_PROTEIN_C_TERMINUS_BINDING","GO_MF","492396_GO_0008022_PROTEIN_C_TERMINUS_BINDING",166,-1.1856,0.15,0.42,1.0013,0.45,0.87,-1.1783,0.13,0.6
"GO_BP:516392_GO_0071468_CELLULAR_RESPONSE_TO_ACIDIC_PH","GO_BP","516392_GO_0071468_CELLULAR_RESPONSE_TO_ACIDIC_PH",7,-1.1856,0.26,0.37,-1.252,0.22,0.91,-1.0064,0.43,0.84
"C7_Immunologic_signatures:C7_ALL_215_GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_215_GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP",199,-1.1855,0.14,0.21,1.1378,0.16,0.34,-0.9255,0.71,0.9
"GO_BP:494740_GO_0010675_REGULATION_OF_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS","GO_BP","494740_GO_0010675_REGULATION_OF_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS",149,-1.1855,0.16,0.37,0.9802,0.5,1,1.2447,0.067,0.7
"GO_BP:514763_GO_0061218_NEGATIVE_REGULATION_OF_MESONEPHROS_DEVELOPMENT","GO_BP","514763_GO_0061218_NEGATIVE_REGULATION_OF_MESONEPHROS_DEVELOPMENT",6,-1.1855,0.3,0.37,-0.6772,0.86,1,0.8526,0.64,0.98
"GO_BP:505746_GO_0042632_CHOLESTEROL_HOMEOSTASIS","GO_BP","505746_GO_0042632_CHOLESTEROL_HOMEOSTASIS",62,-1.1853,0.2,0.37,-0.9973,0.44,0.99,1.1032,0.27,0.76
"C3_MicroRNA_targets:C3_MIR_98_CTGAGCC_MIR_24","C3_MicroRNA_targets","C3_MIR_98_CTGAGCC_MIR_24",228,-1.1851,0.13,0.35,-1.1845,0.088,1,-0.9406,0.65,1
"GO_BP:489074_GO_0003281_VENTRICULAR_SEPTUM_DEVELOPMENT","GO_BP","489074_GO_0003281_VENTRICULAR_SEPTUM_DEVELOPMENT",43,-1.1851,0.21,0.37,-0.9984,0.46,0.99,1.2059,0.17,0.72
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_92_BIOCARTA_IL2_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_92_BIOCARTA_IL2_PATHWAY",22,-1.1849,0.22,0.36,0.5406,0.99,0.99,-0.9045,0.61,0.83
"GO_BP:510426_GO_0048319_AXIAL_MESODERM_MORPHOGENESIS","GO_BP","510426_GO_0048319_AXIAL_MESODERM_MORPHOGENESIS",5,-1.1849,0.26,0.37,-1.2914,0.2,0.88,-0.6717,0.86,1
"C4_Cancer_modules:C4_CM_7_MODULE_7","C4_Cancer_modules","C4_CM_7_MODULE_7",229,-1.1848,0.12,0.3,1.0756,0.25,0.58,0.9529,0.58,0.94
"GO_MF:499386_GO_0022841_POTASSIUM_ION_LEAK_CHANNEL_ACTIVITY","GO_MF","499386_GO_0022841_POTASSIUM_ION_LEAK_CHANNEL_ACTIVITY",15,-1.1848,0.25,0.42,1.1828,0.23,0.73,0.6159,0.95,1
"C3_MicroRNA_targets:C3_MIR_189_GCATTTG_MIR_105","C3_MicroRNA_targets","C3_MIR_189_GCATTTG_MIR_105",173,-1.1848,0.13,0.35,-0.6877,1,1,-0.7497,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1271_STANELLE_E2F1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1271_STANELLE_E2F1_TARGETS",28,-1.1847,0.23,0.3,-1.289,0.15,0.7,-0.8518,0.7,0.92
"GO_BP:498237_GO_0019395_FATTY_ACID_OXIDATION","GO_BP","498237_GO_0019395_FATTY_ACID_OXIDATION",64,-1.1846,0.19,0.37,1.3374,0.068,0.62,-1.2643,0.1,0.67
"GO_BP:518987_GO_2000341_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION","GO_BP","518987_GO_2000341_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION",6,-1.1845,0.26,0.37,-1.3052,0.18,0.88,-1.0332,0.44,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1930_YIH_RESPONSE_TO_ARSENITE_C1","C2_Chemical_and_genetic_perturbations","C2_CGP_1930_YIH_RESPONSE_TO_ARSENITE_C1",24,-1.1844,0.25,0.3,-0.8825,0.64,1,-1.3276,0.12,0.41
"C7_Immunologic_signatures:C7_ALL_562_GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_562_GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDM_DN",199,-1.1844,0.14,0.21,1.4475,0,0.023,-0.7412,0.99,1
"REACTOME:105691_REACT_634_RAF_MAP_KINASE_CASCADE","REACTOME","105691_REACT_634_RAF_MAP_KINASE_CASCADE",17,-1.1842,0.24,0.41,0.6107,0.97,1,-0.9754,0.48,0.88
"C3_TF_targets:C3_TFT_132_V_USF_Q6","C3_TF_targets","C3_TFT_132_V_USF_Q6",255,-1.1842,0.13,0.22,0.9016,0.77,1,-0.9764,0.53,0.8
"GO_BP:496497_GO_0016540_PROTEIN_AUTOPROCESSING","GO_BP","496497_GO_0016540_PROTEIN_AUTOPROCESSING",10,-1.1841,0.24,0.37,-1.2969,0.15,0.88,-1.0196,0.42,0.83
"GO_BP:982498_GO_1902930_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS","GO_BP","982498_GO_1902930_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS",40,-1.1841,0.21,0.37,-0.8577,0.7,1,1.3029,0.08,0.67
"GO_BP:501155_GO_0031915_POSITIVE_REGULATION_OF_SYNAPTIC_PLASTICITY","GO_BP","501155_GO_0031915_POSITIVE_REGULATION_OF_SYNAPTIC_PLASTICITY",6,-1.1841,0.26,0.37,-1.2939,0.18,0.88,-1.5137,0.06,0.53
"GO_BP:510440_GO_0048333_MESODERMAL_CELL_DIFFERENTIATION","GO_BP","510440_GO_0048333_MESODERMAL_CELL_DIFFERENTIATION",27,-1.1841,0.23,0.37,-0.8124,0.76,1,0.9372,0.56,0.91
"C3_TF_targets:C3_TFT_519_TCCATTKW_UNKNOWN","C3_TF_targets","C3_TFT_519_TCCATTKW_UNKNOWN",234,-1.184,0.13,0.22,-0.9594,0.57,0.85,1.3544,0.0076,1
"GO_BP:506598_GO_0043567_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","506598_GO_0043567_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",22,-1.1838,0.24,0.37,-0.7773,0.81,1,1.2239,0.2,0.71
"C7_Immunologic_signatures:C7_ALL_427_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP","C7_Immunologic_signatures","C7_ALL_427_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP",199,-1.1837,0.13,0.21,1.1118,0.18,0.41,-0.8737,0.85,0.99
"GO_BP:505517_GO_0042373_VITAMIN_K_METABOLIC_PROCESS","GO_BP","505517_GO_0042373_VITAMIN_K_METABOLIC_PROCESS",7,-1.1836,0.26,0.37,0.765,0.75,1,-0.8979,0.58,0.93
"GO_BP:491416_GO_0006520_CELLULAR_AMINO_ACID_METABOLIC_PROCESS","GO_BP","491416_GO_0006520_CELLULAR_AMINO_ACID_METABOLIC_PROCESS",348,-1.1836,0.1,0.37,-0.8132,0.98,1,-1.3823,0.0021,0.59
"GO_BP:982500_GO_1902932_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS","GO_BP","982500_GO_1902932_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS",19,-1.1835,0.24,0.37,-0.8881,0.61,1,1.2843,0.14,0.69
"C7_Immunologic_signatures:C7_ALL_1866_GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN","C7_Immunologic_signatures","C7_ALL_1866_GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN",195,-1.1835,0.13,0.21,-1.0593,0.31,1,-1.0362,0.35,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_607_DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_607_DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN",84,-1.1834,0.19,0.3,-1.1932,0.13,0.8,-1.2196,0.11,0.5
"C4_Cancer_modules:C4_CM_176_MODULE_188","C4_Cancer_modules","C4_CM_176_MODULE_188",134,-1.1833,0.16,0.31,1.0276,0.4,0.68,-1.3934,0.014,0.22
"GO_BP:518340_GO_0090200_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA","GO_BP","518340_GO_0090200_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA",28,-1.1831,0.23,0.37,0.6207,0.98,1,-1.6104,0.014,0.53
"GO_BP:512410_GO_0051532_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","512410_GO_0051532_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS",12,-1.1831,0.26,0.37,-1.5895,0.019,0.72,-1.2408,0.2,0.69
"C3_MicroRNA_targets:C3_MIR_143_ATGCTGG_MIR_338","C3_MicroRNA_targets","C3_MIR_143_ATGCTGG_MIR_338",114,-1.183,0.18,0.35,-0.8727,0.76,1,0.883,0.73,1
"GO_BP:494782_GO_0010717_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION","GO_BP","494782_GO_0010717_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION",56,-1.183,0.19,0.37,-1.186,0.18,0.9,0.8938,0.66,0.95
"GO_BP:510691_GO_0048634_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT","GO_BP","510691_GO_0048634_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT",136,-1.183,0.17,0.37,-0.874,0.77,1,-1.0589,0.34,0.81
"GO_MF:490527_GO_0005326_NEUROTRANSMITTER_TRANSPORTER_ACTIVITY","GO_MF","490527_GO_0005326_NEUROTRANSMITTER_TRANSPORTER_ACTIVITY",23,-1.1829,0.25,0.42,-1.2079,0.19,0.81,-1.3145,0.11,0.56
"GO_BP:515015_GO_0070076_HISTONE_LYSINE_DEMETHYLATION","GO_BP","515015_GO_0070076_HISTONE_LYSINE_DEMETHYLATION",34,-1.1827,0.22,0.37,-1.5608,0.015,0.7,-0.8273,0.75,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1290_LEE_LIVER_CANCER_MYC_TGFA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1290_LEE_LIVER_CANCER_MYC_TGFA_DN",64,-1.1827,0.21,0.3,-0.8803,0.7,1,-0.9218,0.61,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_2097_TESAR_ALK_TARGETS_EPISC_3D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2097_TESAR_ALK_TARGETS_EPISC_3D_UP",5,-1.1826,0.28,0.3,0.9216,0.58,0.9,-0.9721,0.49,0.8
"GO_BP:508593_GO_0046329_NEGATIVE_REGULATION_OF_JNK_CASCADE","GO_BP","508593_GO_0046329_NEGATIVE_REGULATION_OF_JNK_CASCADE",33,-1.1826,0.23,0.37,0.7155,0.93,1,-0.8562,0.7,0.96
"KEGG_reaction:R04545_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_5_BISPHOSPHATE_3_PHOSPHOTRANSFERASE_ATP_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_ADP_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE","KEGG_reaction","R04545_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_5_BISPHOSPHATE_3_PHOSPHOTRANSFERASE_ATP_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_ADP_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE",8,-1.1826,0.26,0.39,-0.7934,0.73,1,-0.7085,0.84,0.89
"C7_Immunologic_signatures:C7_ALL_1212_GSE27786_CD8_TCELL_VS_MONO_MAC_DN","C7_Immunologic_signatures","C7_ALL_1212_GSE27786_CD8_TCELL_VS_MONO_MAC_DN",197,-1.1824,0.14,0.21,-0.8264,0.92,1,0.8153,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2183_IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2183_IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP",173,-1.1822,0.14,0.3,1.1345,0.17,0.57,-0.8868,0.8,0.89
"REACTOME:106470_REACT_15497_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB","REACTOME","106470_REACT_15497_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB",17,-1.1821,0.25,0.41,0.8959,0.6,0.91,-1.077,0.36,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1122_STARK_HYPPOCAMPUS_22Q11_DELETION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1122_STARK_HYPPOCAMPUS_22Q11_DELETION_UP",51,-1.1821,0.2,0.3,-1.2882,0.11,0.69,-0.6693,0.97,0.99
"GO_BP:516155_GO_0071229_CELLULAR_RESPONSE_TO_ACID_CHEMICAL","GO_BP","516155_GO_0071229_CELLULAR_RESPONSE_TO_ACID_CHEMICAL",147,-1.1821,0.15,0.37,1.0344,0.34,0.96,1.3184,0.038,0.66
"C3_MicroRNA_targets:C3_MIR_144_ACATATC_MIR_190","C3_MicroRNA_targets","C3_MIR_144_ACATATC_MIR_190",60,-1.1821,0.22,0.35,-0.8112,0.79,1,-0.9047,0.65,1
"GO_BP:506650_GO_0043619_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_OXIDATIVE_STRESS","GO_BP","506650_GO_0043619_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_OXIDATIVE_STRESS",10,-1.1821,0.27,0.37,0.9253,0.56,1,1.2453,0.19,0.7
"GO_BP:515167_GO_0070232_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS","GO_BP","515167_GO_0070232_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS",33,-1.1821,0.23,0.37,0.9515,0.55,1,1.0562,0.37,0.8
"C3_MicroRNA_targets:C3_MIR_147_ACCAAAG_MIR_9","C3_MicroRNA_targets","C3_MIR_147_ACCAAAG_MIR_9",494,-1.1819,0.079,0.34,-0.9909,0.49,1,-0.9884,0.49,1
"GO_BP:506380_GO_0043320_NATURAL_KILLER_CELL_DEGRANULATION","GO_BP","506380_GO_0043320_NATURAL_KILLER_CELL_DEGRANULATION",6,-1.1819,0.26,0.37,1.0741,0.37,0.93,-0.9947,0.45,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_2261_SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2261_SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN",35,-1.1818,0.23,0.3,1.0185,0.4,0.77,-0.8896,0.66,0.89
"GO_CC:500474_GO_0031211_ENDOPLASMIC_RETICULUM_PALMITOYLTRANSFERASE_COMPLEX","GO_CC","500474_GO_0031211_ENDOPLASMIC_RETICULUM_PALMITOYLTRANSFERASE_COMPLEX",6,-1.1817,0.27,0.46,-1.3428,0.16,0.63,-1.3105,0.15,0.63
"GO_BP:491975_GO_0007172_SIGNAL_COMPLEX_ASSEMBLY","GO_BP","491975_GO_0007172_SIGNAL_COMPLEX_ASSEMBLY",8,-1.1817,0.26,0.37,1.3184,0.14,0.65,1.0313,0.42,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_820_YANAGIHARA_ESX1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_820_YANAGIHARA_ESX1_TARGETS",30,-1.1817,0.23,0.3,0.7886,0.79,1,0.6912,0.94,1
"GO_MF:499588_GO_0030170_PYRIDOXAL_PHOSPHATE_BINDING","GO_MF","499588_GO_0030170_PYRIDOXAL_PHOSPHATE_BINDING",53,-1.1816,0.22,0.42,-0.9519,0.52,0.95,-1.2367,0.14,0.59
"REACTOME:106263_REACT_1698_METABOLISM_OF_NUCLEOTIDES","REACTOME","106263_REACT_1698_METABOLISM_OF_NUCLEOTIDES",79,-1.1816,0.18,0.41,0.7489,0.97,1,-1.0982,0.27,0.71
"GO_CC:490811_GO_0005782_PEROXISOMAL_MATRIX","GO_CC","490811_GO_0005782_PEROXISOMAL_MATRIX",34,-1.1816,0.22,0.46,0.7937,0.79,0.96,-1.8503,0,0.38
"GO_BP:507954_GO_0045606_POSITIVE_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION","GO_BP","507954_GO_0045606_POSITIVE_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION",18,-1.1815,0.25,0.38,-1.1376,0.27,0.93,0.7291,0.85,1
"GO_MF:511632_GO_0050660_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING","GO_MF","511632_GO_0050660_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING",69,-1.1814,0.2,0.42,0.6906,0.98,1,-1.3908,0.029,0.51
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_43_BIOCARTA_VDR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_43_BIOCARTA_VDR_PATHWAY",12,-1.1814,0.27,0.36,-0.9845,0.49,1,-1.0588,0.38,0.68
"C4_Cancer_gene_neighborhoods:C4_CGN_239_GCM_MAP4K4","C4_Cancer_gene_neighborhoods","C4_CGN_239_GCM_MAP4K4",169,-1.1813,0.15,0.36,-0.9938,0.47,0.88,-1.1398,0.17,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1855_LIANG_SILENCED_BY_METHYLATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1855_LIANG_SILENCED_BY_METHYLATION_UP",29,-1.1813,0.22,0.3,-0.9312,0.57,1,1.3381,0.098,0.59
"C4_Cancer_modules:C4_CM_213_MODULE_234","C4_Cancer_modules","C4_CM_213_MODULE_234",51,-1.1812,0.21,0.31,1.0514,0.36,0.62,1.0579,0.34,0.85
"KEGG_compound:C00550_SPHINGOMYELIN","KEGG_compound","C00550_SPHINGOMYELIN",7,-1.1812,0.27,0.41,0.7594,0.77,1,1.0511,0.4,0.64
"GO_CC:496879_GO_0017059_SERINE_C_PALMITOYLTRANSFERASE_COMPLEX","GO_CC","496879_GO_0017059_SERINE_C_PALMITOYLTRANSFERASE_COMPLEX",6,-1.1808,0.29,0.46,-1.3101,0.15,0.64,-1.3241,0.17,0.63
"GO_BP:506047_GO_0042953_LIPOPROTEIN_TRANSPORT","GO_BP","506047_GO_0042953_LIPOPROTEIN_TRANSPORT",13,-1.1808,0.26,0.38,0.8305,0.71,1,1.2294,0.22,0.7
"GO_BP:506499_GO_0043467_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY","GO_BP","506499_GO_0043467_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY",75,-1.1806,0.18,0.38,1.029,0.39,0.97,1.0905,0.29,0.77
"GO_CC:486674_GO_0000138_GOLGI_TRANS_CISTERNA","GO_CC","486674_GO_0000138_GOLGI_TRANS_CISTERNA",5,-1.1805,0.27,0.46,0.6704,0.87,0.99,-0.9691,0.51,1
"GO_BP:491013_GO_0006027_GLYCOSAMINOGLYCAN_CATABOLIC_PROCESS","GO_BP","491013_GO_0006027_GLYCOSAMINOGLYCAN_CATABOLIC_PROCESS",58,-1.1805,0.19,0.38,-0.754,0.9,1,1.1997,0.16,0.72
"C3_TF_targets:C3_TFT_87_V_GATA1_03","C3_TF_targets","C3_TFT_87_V_GATA1_03",234,-1.1803,0.14,0.22,1.1629,0.12,0.86,1.2943,0.024,0.58
"GO_BP:494955_GO_0010891_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE","GO_BP","494955_GO_0010891_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE",5,-1.1803,0.27,0.38,-0.6764,0.87,1,-0.8588,0.64,0.96
"C3_MicroRNA_targets:C3_MIR_163_AGTCTTA_MIR_499","C3_MicroRNA_targets","C3_MIR_163_AGTCTTA_MIR_499",74,-1.1802,0.19,0.34,0.7627,0.92,1,-0.6996,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_802_DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_802_DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP",18,-1.1801,0.24,0.3,0.61,0.97,1,0.8396,0.69,1
"C7_Immunologic_signatures:C7_ALL_1556_GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1556_GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN",196,-1.1801,0.15,0.21,0.7201,1,1,-0.6874,1,1
"KEGG_compound:C00584_PROSTAGLANDIN_E2_5Z_13E_15S_11ALPHA_15_DIHYDROXY_9_OXOPROSTA_5_13_DIENOATE_5Z_13E_15S_11ALPHA_15_DIHYDROXY_9_OXOPROST_13_ENOATE_DINOPROSTONE_PGE2","KEGG_compound","C00584_PROSTAGLANDIN_E2_5Z_13E_15S_11ALPHA_15_DIHYDROXY_9_OXOPROSTA_5_13_DIENOATE_5Z_13E_15S_11ALPHA_15_DIHYDROXY_9_OXOPROST_13_ENOATE_DINOPROSTONE_PGE2",5,-1.1801,0.27,0.41,0.6527,0.87,1,0.6807,0.83,0.98
"GO_MF:499435_GO_0048018_RECEPTOR_AGONIST_ACTIVITY","GO_MF","499435_GO_0048018_RECEPTOR_AGONIST_ACTIVITY",15,-1.1801,0.26,0.43,-0.7877,0.78,1,1.3792,0.1,0.56
"GO_CC:506156_GO_0043073_GERM_CELL_NUCLEUS","GO_CC","506156_GO_0043073_GERM_CELL_NUCLEUS",22,-1.18,0.26,0.46,-1.2443,0.16,0.63,-1.2015,0.2,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_331_GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_331_GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN",10,-1.1799,0.27,0.3,0.7258,0.82,1,-1.14,0.3,0.59
"C4_Cancer_gene_neighborhoods:C4_CGN_80_MORF_CTSB","C4_Cancer_gene_neighborhoods","C4_CGN_80_MORF_CTSB",180,-1.1799,0.15,0.36,1.063,0.27,0.44,1.3042,0.028,0.3
"C3_MicroRNA_targets:C3_MIR_58_GTGTGAG_MIR_342","C3_MicroRNA_targets","C3_MIR_58_GTGTGAG_MIR_342",65,-1.1799,0.2,0.34,-0.7618,0.89,1,-1.1271,0.23,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3245_SERVITJA_LIVER_HNF1A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3245_SERVITJA_LIVER_HNF1A_TARGETS_DN",153,-1.1799,0.16,0.3,1.2485,0.057,0.44,1.0322,0.37,0.93
"GO_CC:492611_GO_0008290_F_ACTIN_CAPPING_PROTEIN_COMPLEX","GO_CC","492611_GO_0008290_F_ACTIN_CAPPING_PROTEIN_COMPLEX",9,-1.1798,0.25,0.46,0.9161,0.56,0.87,-0.9583,0.5,1
"C7_Immunologic_signatures:C7_ALL_388_GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_388_GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN",198,-1.1795,0.15,0.22,-1.3982,0.0017,0.22,-1.0754,0.27,0.56
"C7_Immunologic_signatures:C7_ALL_575_GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_575_GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_UP",200,-1.1794,0.13,0.22,1.3977,0.0046,0.038,-1.1196,0.17,0.45
"GO_BP:505561_GO_0042420_DOPAMINE_CATABOLIC_PROCESS","GO_BP","505561_GO_0042420_DOPAMINE_CATABOLIC_PROCESS",5,-1.1793,0.29,0.38,0.7994,0.74,1,-1.4819,0.049,0.53
"C4_Cancer_modules:C4_CM_251_MODULE_285","C4_Cancer_modules","C4_CM_251_MODULE_285",49,-1.1792,0.21,0.31,-0.998,0.45,0.79,-1.1183,0.27,0.5
"C3_TF_targets:C3_TFT_525_TGTYNNNNNRGCARM_UNKNOWN","C3_TF_targets","C3_TFT_525_TGTYNNNNNRGCARM_UNKNOWN",83,-1.1791,0.2,0.22,0.7812,0.9,1,-0.9351,0.6,0.88
"GO_MF:750742_GO_0001190_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION","GO_MF","750742_GO_0001190_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION",40,-1.179,0.22,0.43,-1.326,0.096,0.73,0.796,0.81,1
"REACTOME:187203_REACT_23765_REDUCTION_OF_CYTOSOLIC_CA_LEVELS","REACTOME","187203_REACT_23765_REDUCTION_OF_CYTOSOLIC_CA_LEVELS",10,-1.179,0.25,0.42,-1.2983,0.16,0.67,-0.9044,0.53,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_181_BARRIER_COLON_CANCER_RECURRENCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_181_BARRIER_COLON_CANCER_RECURRENCE_DN",20,-1.179,0.26,0.3,-1.0025,0.44,1,-1.5208,0.05,0.29
"C3_TF_targets:C3_TFT_216_CCAWYNNGAAR_UNKNOWN","C3_TF_targets","C3_TFT_216_CCAWYNNGAAR_UNKNOWN",143,-1.1789,0.17,0.22,0.8101,0.89,1,-1.1051,0.22,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2760_YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2760_YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP",39,-1.1789,0.22,0.3,0.6546,0.97,1,-1.3408,0.084,0.4
"C7_Immunologic_signatures:C7_ALL_1323_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP","C7_Immunologic_signatures","C7_ALL_1323_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP",195,-1.1788,0.15,0.22,1.0137,0.43,0.7,-1.15,0.14,0.37
"C7_Immunologic_signatures:C7_ALL_608_GSE17721_LPS_VS_PAM3CSK4_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_608_GSE17721_LPS_VS_PAM3CSK4_6H_BMDM_DN",198,-1.1788,0.16,0.22,1.2432,0.033,0.16,-1.2771,0.04,0.16
"C2_Chemical_and_genetic_perturbations:C2_CGP_3085_FIGUEROA_AML_METHYLATION_CLUSTER_4_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3085_FIGUEROA_AML_METHYLATION_CLUSTER_4_DN",13,-1.1787,0.26,0.3,-0.6066,0.96,1,-1.0506,0.4,0.69
"GO_BP:486621_GO_0000080_MITOTIC_G1_PHASE","GO_BP","486621_GO_0000080_MITOTIC_G1_PHASE",30,-1.1785,0.22,0.38,1.049,0.4,0.95,-1.3652,0.077,0.59
"GO_CC:499805_GO_0030427_SITE_OF_POLARIZED_GROWTH","GO_CC","499805_GO_0030427_SITE_OF_POLARIZED_GROWTH",129,-1.1785,0.18,0.46,0.7007,0.99,0.99,-1.0425,0.34,0.99
"GO_MF:496743_GO_0016849_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY","GO_MF","496743_GO_0016849_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY",22,-1.1784,0.24,0.43,-0.5875,0.97,1,-1.5905,0.027,0.38
"WikiPathways:198802_WP1591_HEART_DEVELOPMENT","WikiPathways","198802_WP1591_HEART_DEVELOPMENT",42,-1.1784,0.23,0.33,-1.3983,0.064,0.95,1.3899,0.054,0.48
"GO_BP:500891_GO_0031642_NEGATIVE_REGULATION_OF_MYELINATION","GO_BP","500891_GO_0031642_NEGATIVE_REGULATION_OF_MYELINATION",6,-1.1782,0.28,0.38,0.9546,0.5,1,0.8209,0.68,1
"GO_MF:499871_GO_0030545_RECEPTOR_REGULATOR_ACTIVITY","GO_MF","499871_GO_0030545_RECEPTOR_REGULATOR_ACTIVITY",43,-1.178,0.22,0.43,-0.9967,0.48,0.91,-0.8068,0.83,0.96
"C4_Cancer_modules:C4_CM_100_MODULE_105","C4_Cancer_modules","C4_CM_100_MODULE_105",198,-1.1778,0.16,0.31,1.4522,0,0.15,-1.1638,0.12,0.44
"C7_Immunologic_signatures:C7_ALL_640_GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_640_GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDM_DN",199,-1.1777,0.14,0.22,0.9559,0.58,0.88,-0.9978,0.45,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2278_ITO_PTTG1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2278_ITO_PTTG1_TARGETS_UP",12,-1.1777,0.26,0.3,1.5421,0.042,0.17,1.1363,0.29,0.84
"C3_TF_targets:C3_TFT_506_RNTCANNRNNYNATTW_UNKNOWN","C3_TF_targets","C3_TFT_506_RNTCANNRNNYNATTW_UNKNOWN",60,-1.1776,0.2,0.23,-1.1583,0.21,0.43,-0.8021,0.85,1
"C3_MicroRNA_targets:C3_MIR_193_CAGCACT_MIR_512_3P","C3_MicroRNA_targets","C3_MIR_193_CAGCACT_MIR_512_3P",155,-1.1776,0.15,0.34,-0.758,0.98,1,0.9178,0.67,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2191_RIZKI_TUMOR_INVASIVENESS_3D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2191_RIZKI_TUMOR_INVASIVENESS_3D_DN",267,-1.1776,0.13,0.3,1.1054,0.19,0.62,-1.014,0.4,0.73
"KEGG_compound:C00058_FORMATE_METHANOIC_ACID_FORMIC_ACID","KEGG_compound","C00058_FORMATE_METHANOIC_ACID_FORMIC_ACID",9,-1.1775,0.28,0.41,-0.8739,0.62,1,-1.4455,0.095,0.26
"C2_Chemical_and_genetic_perturbations:C2_CGP_2342_GRADE_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2342_GRADE_METASTASIS_DN",45,-1.1774,0.21,0.3,1.4117,0.049,0.28,-1.1833,0.19,0.53
"REACTOME:645296_REACT_121096_EGFR_TRANSACTIVATION_BY_GASTRIN","REACTOME","645296_REACT_121096_EGFR_TRANSACTIVATION_BY_GASTRIN",9,-1.1774,0.27,0.42,0.5972,0.94,1,0.6614,0.9,1
"GO_BP:487599_GO_0001696_GASTRIC_ACID_SECRETION","GO_BP","487599_GO_0001696_GASTRIC_ACID_SECRETION",6,-1.1774,0.28,0.38,-0.6429,0.9,1,-0.9318,0.54,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2773_MIKKELSEN_IPS_WITH_HCP_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2773_MIKKELSEN_IPS_WITH_HCP_H3K27ME3",95,-1.1773,0.18,0.3,1.7858,0,0.047,1.5478,0.0058,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_1762_BURTON_ADIPOGENESIS_5","C2_Chemical_and_genetic_perturbations","C2_CGP_1762_BURTON_ADIPOGENESIS_5",126,-1.1773,0.16,0.3,1.6928,0,0.087,-0.8616,0.79,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_655_HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3","C2_Chemical_and_genetic_perturbations","C2_CGP_655_HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3",7,-1.1773,0.27,0.3,-1.3951,0.096,0.59,-1.2072,0.26,0.51
"GO_BP:513578_GO_0060020_BERGMANN_GLIAL_CELL_DIFFERENTIATION","GO_BP","513578_GO_0060020_BERGMANN_GLIAL_CELL_DIFFERENTIATION",5,-1.1772,0.28,0.38,0.9111,0.55,1,1.1246,0.34,0.74
"C7_Immunologic_signatures:C7_ALL_1762_GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1762_GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN",186,-1.1772,0.14,0.22,0.8917,0.8,1,-0.8251,0.92,1
"C3_MicroRNA_targets:C3_MIR_160_TCATCTC_MIR_143","C3_MicroRNA_targets","C3_MIR_160_TCATCTC_MIR_143",146,-1.1771,0.17,0.34,-1.2772,0.053,1,-1.055,0.32,1
"C3_TF_targets:C3_TFT_445_V_MYB_Q5_01","C3_TF_targets","C3_TFT_445_V_MYB_Q5_01",263,-1.177,0.12,0.23,0.9118,0.74,1,-0.8641,0.9,0.97
"GO_BP:518694_GO_2000045_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","518694_GO_2000045_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",134,-1.177,0.17,0.38,1.372,0.024,0.58,-1.3735,0.018,0.59
"GO_BP:519155_GO_2000515_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION","GO_BP","519155_GO_2000515_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",11,-1.1768,0.28,0.38,-1.0099,0.42,0.98,-0.5491,0.97,1
"REACTOME:161000_REACT_22351_DCC_MEDIATED_ATTRACTIVE_SIGNALING","REACTOME","161000_REACT_22351_DCC_MEDIATED_ATTRACTIVE_SIGNALING",14,-1.1767,0.26,0.42,0.7529,0.79,1,-0.4639,1,1
"C4_Cancer_modules:C4_CM_223_MODULE_244","C4_Cancer_modules","C4_CM_223_MODULE_244",187,-1.1767,0.14,0.31,0.8796,0.82,0.88,-1.5144,0.0021,0.14
"GO_BP:982276_GO_0090559_REGULATION_OF_MEMBRANE_PERMEABILITY","GO_BP","982276_GO_0090559_REGULATION_OF_MEMBRANE_PERMEABILITY",32,-1.1767,0.22,0.38,1.1756,0.22,0.81,-0.8643,0.69,0.95
"C3_TF_targets:C3_TFT_397_V_IRF1_Q6","C3_TF_targets","C3_TFT_397_V_IRF1_Q6",250,-1.1767,0.12,0.23,0.8128,0.96,1,0.8235,0.95,1
"GO_BP:504449_GO_0035265_ORGAN_GROWTH","GO_BP","504449_GO_0035265_ORGAN_GROWTH",64,-1.1766,0.2,0.38,0.9308,0.6,1,0.8705,0.72,0.97
"C3_MicroRNA_targets:C3_MIR_38_GGGACCA_MIR_133A_MIR_133B","C3_MicroRNA_targets","C3_MIR_38_GGGACCA_MIR_133A_MIR_133B",199,-1.1765,0.17,0.34,-0.9708,0.51,1,0.8396,0.9,1
"C7_Immunologic_signatures:C7_ALL_1348_GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1348_GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN",200,-1.1765,0.15,0.22,-0.8847,0.76,1,-1.062,0.31,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2858_CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL","C2_Chemical_and_genetic_perturbations","C2_CGP_2858_CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL",16,-1.1765,0.24,0.31,1.1192,0.3,0.6,0.8446,0.71,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_278_SENESE_HDAC2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_278_SENESE_HDAC2_TARGETS_DN",125,-1.1764,0.18,0.31,1.3849,0.018,0.31,-0.9962,0.46,0.76
"GO_BP:751079_GO_0036159_INNER_DYNEIN_ARM_ASSEMBLY","GO_BP","751079_GO_0036159_INNER_DYNEIN_ARM_ASSEMBLY",7,-1.1764,0.29,0.38,-1.3326,0.16,0.9,-0.7628,0.77,1
"KEGG_pathway:HSA04920_ADIPOCYTOKINE_SIGNALING_PATHWAY","KEGG_pathway","HSA04920_ADIPOCYTOKINE_SIGNALING_PATHWAY",70,-1.1764,0.21,0.26,-0.8076,0.87,1,-0.9849,0.48,0.72
"C7_Immunologic_signatures:C7_ALL_1505_GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP","C7_Immunologic_signatures","C7_ALL_1505_GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP",200,-1.1763,0.14,0.22,1.1162,0.2,0.4,0.8276,0.94,1
"GO_BP:511672_GO_0050701_INTERLEUKIN_1_SECRETION","GO_BP","511672_GO_0050701_INTERLEUKIN_1_SECRETION",6,-1.1763,0.27,0.38,0.8811,0.64,1,0.7334,0.78,1
"GO_BP:494402_GO_0010332_RESPONSE_TO_GAMMA_RADIATION","GO_BP","494402_GO_0010332_RESPONSE_TO_GAMMA_RADIATION",44,-1.1762,0.2,0.38,0.8176,0.8,1,1.2406,0.14,0.71
"C7_Immunologic_signatures:C7_ALL_1796_GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1796_GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN",193,-1.1762,0.15,0.22,1.3055,0.024,0.097,0.7949,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_690_MATTIOLI_MGUS_VS_PCL","C2_Chemical_and_genetic_perturbations","C2_CGP_690_MATTIOLI_MGUS_VS_PCL",102,-1.1761,0.18,0.31,1.6937,0,0.087,-1.3114,0.067,0.42
"GO_BP:487851_GO_0001961_POSITIVE_REGULATION_OF_CYTOKINE_MEDIATED_SIGNALING_PATHWAY","GO_BP","487851_GO_0001961_POSITIVE_REGULATION_OF_CYTOKINE_MEDIATED_SIGNALING_PATHWAY",26,-1.176,0.24,0.38,-0.824,0.74,1,-0.8637,0.66,0.95
"C4_Cancer_modules:C4_CM_54_MODULE_58","C4_Cancer_modules","C4_CM_54_MODULE_58",21,-1.1759,0.25,0.31,-0.9218,0.56,0.88,-0.7702,0.8,1
"KEGG_pathway:HSA05218_MELANOMA","KEGG_pathway","HSA05218_MELANOMA",63,-1.1758,0.23,0.26,0.9187,0.62,1,0.9803,0.48,1
"WikiPathways:198835_WP47_HEDGEHOG_SIGNALING_PATHWAY","WikiPathways","198835_WP47_HEDGEHOG_SIGNALING_PATHWAY",21,-1.1758,0.25,0.33,-1.276,0.15,0.99,-1.3316,0.12,0.41
"GO_MF:487626_GO_0001727_LIPID_KINASE_ACTIVITY","GO_MF","487626_GO_0001727_LIPID_KINASE_ACTIVITY",6,-1.1758,0.29,0.43,-0.87,0.62,1,-0.4876,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_610_TURJANSKI_MAPK7_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_610_TURJANSKI_MAPK7_TARGETS",8,-1.1756,0.28,0.31,-0.5991,0.95,1,0.7109,0.83,1
"C3_MicroRNA_targets:C3_MIR_167_AGCTCCT_MIR_28","C3_MicroRNA_targets","C3_MIR_167_AGCTCCT_MIR_28",89,-1.1756,0.18,0.34,-1.1782,0.15,1,-0.9327,0.61,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1120_STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1120_STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP",193,-1.1756,0.15,0.31,-0.6689,1,1,-0.7666,0.97,0.97
"KEGG_compound:C05973_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_L_1_LYSOPHOSPHATIDYLETHANOLAMINE_O_2_ACYL_SN_GLYCERO_3_PHOSPHO_ETHANOLAMINE","KEGG_compound","C05973_2_ACYL_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_L_1_LYSOPHOSPHATIDYLETHANOLAMINE_O_2_ACYL_SN_GLYCERO_3_PHOSPHO_ETHANOLAMINE",5,-1.1753,0.29,0.41,-0.6765,0.83,1,-0.6953,0.82,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1739_MEDINA_SMARCA4_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1739_MEDINA_SMARCA4_TARGETS",44,-1.1753,0.21,0.31,-1.4022,0.046,0.58,-1.4665,0.031,0.31
"GO_MF:514955_GO_0070016_ARMADILLO_REPEAT_DOMAIN_BINDING","GO_MF","514955_GO_0070016_ARMADILLO_REPEAT_DOMAIN_BINDING",11,-1.1753,0.27,0.43,-0.7091,0.84,1,-0.9083,0.6,0.87
"GO_BP:492648_GO_0008333_ENDOSOME_TO_LYSOSOME_TRANSPORT","GO_BP","492648_GO_0008333_ENDOSOME_TO_LYSOSOME_TRANSPORT",30,-1.1753,0.23,0.38,-0.5611,0.99,1,-1.1343,0.27,0.75
"GO_BP:754607_GO_1901655_CELLULAR_RESPONSE_TO_KETONE","GO_BP","754607_GO_1901655_CELLULAR_RESPONSE_TO_KETONE",36,-1.1753,0.23,0.38,1.0745,0.36,0.93,1.2506,0.13,0.7
"C3_TF_targets:C3_TFT_361_V_ATF1_Q6","C3_TF_targets","C3_TFT_361_V_ATF1_Q6",229,-1.1753,0.15,0.23,0.9322,0.68,1,-1.1497,0.14,0.46
"GO_MF:507852_GO_0045502_DYNEIN_BINDING","GO_MF","507852_GO_0045502_DYNEIN_BINDING",18,-1.1751,0.24,0.43,-0.9556,0.51,0.95,-0.9715,0.49,0.8
"C3_MicroRNA_targets:C3_MIR_182_TTTTGAG_MIR_373","C3_MicroRNA_targets","C3_MIR_182_TTTTGAG_MIR_373",223,-1.1751,0.14,0.33,0.9088,0.74,1,-0.7446,1,1
"GO_BP:488191_GO_0002318_MYELOID_PROGENITOR_CELL_DIFFERENTIATION","GO_BP","488191_GO_0002318_MYELOID_PROGENITOR_CELL_DIFFERENTIATION",7,-1.1751,0.28,0.38,-1.0704,0.38,0.96,-1.254,0.21,0.68
"OMIM_gene:OMIM611266_POTE_ANKYRIN_DOMAIN_FAMILY_MEMBER_K_PSEUDOGENE_POTEKP","OMIM_gene","OMIM611266_POTE_ANKYRIN_DOMAIN_FAMILY_MEMBER_K_PSEUDOGENE_POTEKP",7,-1.1751,0.28,0.76,1.4165,0.11,0.85,1.2235,0.24,1
"GO_BP:506411_GO_0043372_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION","GO_BP","506411_GO_0043372_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION",19,-1.1751,0.25,0.38,-1.3482,0.11,0.93,-0.7585,0.79,1
"GO_BP:516244_GO_0071320_CELLULAR_RESPONSE_TO_CAMP","GO_BP","516244_GO_0071320_CELLULAR_RESPONSE_TO_CAMP",44,-1.175,0.22,0.38,-0.8776,0.67,1,0.9813,0.48,0.87
"C6_Oncogenic_signatures:C6_ALL_123_RB_P107_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_123_RB_P107_DN_V1_DN",116,-1.175,0.19,0.21,1.1738,0.15,0.4,0.569,1,1
"GO_BP:506319_GO_0043252_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT","GO_BP","506319_GO_0043252_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT",13,-1.175,0.26,0.38,-1.1785,0.28,0.91,1.7255,0.01,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_2210_YAMASHITA_METHYLATED_IN_PROSTATE_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_2210_YAMASHITA_METHYLATED_IN_PROSTATE_CANCER",53,-1.1749,0.22,0.31,-1.1278,0.25,0.89,1.3551,0.074,0.56
"GO_BP:501608_GO_0032373_POSITIVE_REGULATION_OF_STEROL_TRANSPORT","GO_BP","501608_GO_0032373_POSITIVE_REGULATION_OF_STEROL_TRANSPORT",15,-1.1749,0.24,0.38,0.7029,0.89,1,0.8311,0.68,0.99
"REACTOME:1127574_REACT_264618_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS","REACTOME","1127574_REACT_264618_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS",13,-1.1748,0.23,0.42,1.1004,0.31,0.58,0.646,0.92,1
"GO_BP:501331_GO_0032094_RESPONSE_TO_FOOD","GO_BP","501331_GO_0032094_RESPONSE_TO_FOOD",16,-1.1748,0.25,0.38,-1.1781,0.23,0.91,-1.6752,0.018,0.57
"GO_BP:753159_GO_1900165_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_SECRETION","GO_BP","753159_GO_1900165_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_SECRETION",5,-1.1748,0.26,0.38,-0.9978,0.5,0.99,0.8242,0.67,1
"GO_BP:503595_GO_0034393_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","503595_GO_0034393_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS",5,-1.1748,0.31,0.38,-0.7432,0.77,1,-1.174,0.29,0.73
"C1_Positional:C1_ALL_29_CHR4P12","C1_Positional","C1_ALL_29_CHR4P12",19,-1.1747,0.25,0.75,-0.9763,0.5,1,1.1222,0.29,0.73
"GO_BP:512120_GO_0051224_NEGATIVE_REGULATION_OF_PROTEIN_TRANSPORT","GO_BP","512120_GO_0051224_NEGATIVE_REGULATION_OF_PROTEIN_TRANSPORT",169,-1.1746,0.16,0.38,0.7529,0.99,1,-0.9427,0.63,0.89
"C3_TF_targets:C3_TFT_149_V_NFY_C","C3_TF_targets","C3_TFT_149_V_NFY_C",241,-1.1746,0.15,0.23,-0.9094,0.71,0.95,-1.2364,0.054,0.3
"GO_BP:516747_GO_0071825_PROTEIN_LIPID_COMPLEX_SUBUNIT_ORGANIZATION","GO_BP","516747_GO_0071825_PROTEIN_LIPID_COMPLEX_SUBUNIT_ORGANIZATION",33,-1.1745,0.24,0.38,0.811,0.74,1,1.4157,0.071,0.62
"KEGG_pathway:HSA00533_GLYCOSAMINOGLYCAN_BIOSYNTHESIS","KEGG_pathway","HSA00533_GLYCOSAMINOGLYCAN_BIOSYNTHESIS",15,-1.1744,0.26,0.26,-0.6087,0.96,1,0.8726,0.64,1
"C7_Immunologic_signatures:C7_ALL_1158_GSE27786_LSK_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1158_GSE27786_LSK_VS_NEUTROPHIL_DN",198,-1.1743,0.15,0.22,0.9093,0.73,1,-0.7594,0.99,1
"C7_Immunologic_signatures:C7_ALL_295_GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_295_GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP",198,-1.1742,0.16,0.22,1.3173,0.023,0.087,-1.0753,0.24,0.56
"GO_BP:490569_GO_0043267_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT","GO_BP","490569_GO_0043267_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT",22,-1.1742,0.25,0.38,-0.8225,0.74,1,-1.0353,0.4,0.82
"C7_Immunologic_signatures:C7_ALL_735_GSE17721_0_5H_VS_24H_PAM3CSK4_BMDM_UP","C7_Immunologic_signatures","C7_ALL_735_GSE17721_0_5H_VS_24H_PAM3CSK4_BMDM_UP",198,-1.1741,0.14,0.22,1.6125,0,0.0024,0.8633,0.85,1
"REACTOME:105669_REACT_963_APOPTOTIC_FACTOR_MEDIATED_RESPONSE","REACTOME","105669_REACT_963_APOPTOTIC_FACTOR_MEDIATED_RESPONSE",7,-1.1741,0.27,0.42,0.9346,0.53,0.85,0.7402,0.79,1
"GO_BP:511938_GO_0051005_NEGATIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY","GO_BP","511938_GO_0051005_NEGATIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY",5,-1.1741,0.29,0.39,0.5968,0.91,1,1.6889,0.0019,0.4
"C3_TF_targets:C3_TFT_112_V_RORA2_01","C3_TF_targets","C3_TFT_112_V_RORA2_01",144,-1.174,0.16,0.23,-1.061,0.34,0.63,-0.9218,0.67,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1753_LINDVALL_IMMORTALIZED_BY_TERT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1753_LINDVALL_IMMORTALIZED_BY_TERT_DN",78,-1.174,0.21,0.31,-1.168,0.18,0.83,1.3798,0.038,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1164_SHIN_B_CELL_LYMPHOMA_CLUSTER_1","C2_Chemical_and_genetic_perturbations","C2_CGP_1164_SHIN_B_CELL_LYMPHOMA_CLUSTER_1",13,-1.174,0.25,0.31,-1.167,0.26,0.83,-1.0104,0.44,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_1542_NGUYEN_NOTCH1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1542_NGUYEN_NOTCH1_TARGETS_DN",86,-1.1739,0.19,0.31,-0.9686,0.5,1,-0.8807,0.71,0.9
"GO_BP:496040_GO_0015918_STEROL_TRANSPORT","GO_BP","496040_GO_0015918_STEROL_TRANSPORT",49,-1.1738,0.21,0.39,0.9391,0.58,1,1.6931,0.0019,0.41
"GO_BP:500599_GO_0031340_POSITIVE_REGULATION_OF_VESICLE_FUSION","GO_BP","500599_GO_0031340_POSITIVE_REGULATION_OF_VESICLE_FUSION",8,-1.1738,0.27,0.39,0.9655,0.51,1,-1.1897,0.26,0.74
"GO_MF:490459_GO_0005217_INTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY","GO_MF","490459_GO_0005217_INTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY",23,-1.1738,0.27,0.43,0.7833,0.76,1,1.3032,0.13,0.66
"C7_Immunologic_signatures:C7_ALL_947_GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP","C7_Immunologic_signatures","C7_ALL_947_GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP",189,-1.1737,0.16,0.22,0.7482,0.99,1,-0.9498,0.58,0.85
"GO_BP:487477_GO_0001539_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY","GO_BP","487477_GO_0001539_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY",11,-1.1736,0.28,0.39,-1.6954,0.016,0.6,0.4541,1,1
"C7_Immunologic_signatures:C7_ALL_1856_GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN","C7_Immunologic_signatures","C7_ALL_1856_GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN",192,-1.1733,0.15,0.22,-0.8376,0.86,1,1.0794,0.27,1
"GO_MF:501232_GO_0031994_INSULIN_LIKE_GROWTH_FACTOR_I_BINDING","GO_MF","501232_GO_0031994_INSULIN_LIKE_GROWTH_FACTOR_I_BINDING",8,-1.1733,0.29,0.43,0.767,0.75,1,0.7953,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3173_SUMI_HNF4A_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3173_SUMI_HNF4A_TARGETS",31,-1.173,0.24,0.31,-1.032,0.38,0.97,1.3093,0.12,0.66
"GO_BP:514527_GO_0060972_LEFT_RIGHT_PATTERN_FORMATION","GO_BP","514527_GO_0060972_LEFT_RIGHT_PATTERN_FORMATION",24,-1.1729,0.24,0.39,-1.9804,0,0.48,-1.3664,0.076,0.59
"C7_Immunologic_signatures:C7_ALL_523_GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_523_GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDM_UP",200,-1.1729,0.15,0.22,1.4522,0.0045,0.022,0.7404,0.99,1
"REACTOME:106463_REACT_12077_SIGNALLING_TO_P38_VIA_RIT_AND_RIN","REACTOME","106463_REACT_12077_SIGNALLING_TO_P38_VIA_RIT_AND_RIN",21,-1.1729,0.26,0.43,-0.545,0.99,1,-0.9963,0.45,0.84
"GO_BP:507475_GO_0045075_REGULATION_OF_INTERLEUKIN_12_BIOSYNTHETIC_PROCESS","GO_BP","507475_GO_0045075_REGULATION_OF_INTERLEUKIN_12_BIOSYNTHETIC_PROCESS",9,-1.1728,0.27,0.39,-1.2066,0.23,0.88,-1.1616,0.27,0.73
"GO_MF:499372_GO_0022821_POTASSIUM_ION_ANTIPORTER_ACTIVITY","GO_MF","499372_GO_0022821_POTASSIUM_ION_ANTIPORTER_ACTIVITY",7,-1.1728,0.29,0.43,0.7274,0.82,1,0.7522,0.78,1
"C7_Immunologic_signatures:C7_ALL_1489_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP","C7_Immunologic_signatures","C7_ALL_1489_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP",190,-1.1727,0.16,0.23,1.2805,0.026,0.12,1.077,0.25,1
"REACTOME:187172_REACT_23824_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP_","REACTOME","187172_REACT_23824_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP_",12,-1.1726,0.25,0.43,1.3098,0.14,0.31,0.7423,0.81,1
"GO_BP:514116_GO_0060561_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS","GO_BP","514116_GO_0060561_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS",17,-1.1725,0.26,0.39,-1.2316,0.19,0.9,-0.707,0.87,0.99
"C4_Cancer_modules:C4_CM_315_MODULE_367","C4_Cancer_modules","C4_CM_315_MODULE_367",29,-1.1725,0.22,0.32,0.8355,0.75,0.93,1.6628,0.013,0.13
"GO_CC:514745_GO_0061200_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE","GO_CC","514745_GO_0061200_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE",7,-1.1724,0.27,0.47,-0.8207,0.69,1,-1.464,0.081,0.53
"GO_BP:495109_GO_0014037_SCHWANN_CELL_DIFFERENTIATION","GO_BP","495109_GO_0014037_SCHWANN_CELL_DIFFERENTIATION",31,-1.1724,0.24,0.39,-1.0685,0.35,0.96,-1.3213,0.1,0.63
"KEGG_compound:C16218__2E_OCTADECENOYL_COA_TRANS_OCTADEC_2_ENOYL_COA","KEGG_compound","C16218__2E_OCTADECENOYL_COA_TRANS_OCTADEC_2_ENOYL_COA",6,-1.1723,0.28,0.42,1.0965,0.36,1,-1.661,0.022,0.099
"C2_Chemical_and_genetic_perturbations:C2_CGP_623_BAKER_HEMATOPOESIS_STAT5_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_623_BAKER_HEMATOPOESIS_STAT5_TARGETS",7,-1.1723,0.29,0.31,-0.855,0.63,1,1.0615,0.37,0.9
"GO_BP:517005_GO_0072089_STEM_CELL_PROLIFERATION","GO_BP","517005_GO_0072089_STEM_CELL_PROLIFERATION",59,-1.1722,0.22,0.39,-0.7612,0.89,1,1.0327,0.39,0.82
"GO_BP:501512_GO_0032277_NEGATIVE_REGULATION_OF_GONADOTROPIN_SECRETION","GO_BP","501512_GO_0032277_NEGATIVE_REGULATION_OF_GONADOTROPIN_SECRETION",7,-1.1721,0.26,0.39,0.9297,0.53,1,-1.3442,0.15,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_3303_GUILLAUMOND_KLF10_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3303_GUILLAUMOND_KLF10_TARGETS_UP",49,-1.1721,0.2,0.31,0.8738,0.71,0.95,-1.029,0.41,0.71
"GO_BP:508151_GO_0045830_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING","GO_BP","508151_GO_0045830_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING",14,-1.1718,0.27,0.39,-1.6399,0.023,0.69,-1.1687,0.24,0.73
"GO_BP:498242_GO_0019400_ALDITOL_METABOLIC_PROCESS","GO_BP","498242_GO_0019400_ALDITOL_METABOLIC_PROCESS",25,-1.1717,0.24,0.39,0.8151,0.75,1,-1.3212,0.11,0.63
"C7_Immunologic_signatures:C7_ALL_44_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN","C7_Immunologic_signatures","C7_ALL_44_GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN",186,-1.1716,0.15,0.23,-0.7029,1,1,-1.591,0,0.0062
"REACTOME:366221_REACT_75908_POTASSIUM_CHANNELS","REACTOME","366221_REACT_75908_POTASSIUM_CHANNELS",98,-1.1714,0.19,0.43,-1.1151,0.26,0.88,1.2631,0.096,0.78
"GO_BP:488118_GO_0002244_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION","GO_BP","488118_GO_0002244_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION",113,-1.1713,0.19,0.39,0.9139,0.68,1,-0.8593,0.79,0.96
"C7_Immunologic_signatures:C7_ALL_741_GSE17721_0_5H_VS_12H_CPG_BMDM_UP","C7_Immunologic_signatures","C7_ALL_741_GSE17721_0_5H_VS_12H_CPG_BMDM_UP",200,-1.1713,0.14,0.23,1.4629,0.0024,0.019,-1.2851,0.038,0.15
"GO_BP:498181_GO_0019336_PHENOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS","GO_BP","498181_GO_0019336_PHENOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS",7,-1.1712,0.28,0.39,1.0414,0.43,0.96,-0.9606,0.5,0.88
"GO_BP:1129209_GO_0044872_LIPOPROTEIN_LOCALIZATION","GO_BP","1129209_GO_0044872_LIPOPROTEIN_LOCALIZATION",13,-1.171,0.25,0.39,0.8337,0.67,1,1.2226,0.21,0.71
"C3_TF_targets:C3_TFT_100_V_AHR_01","C3_TF_targets","C3_TFT_100_V_AHR_01",64,-1.1709,0.21,0.24,-1.0614,0.33,0.63,-1.1453,0.21,0.46
"WikiPathways:198762_WP1471_TOR_SIGNALING","WikiPathways","198762_WP1471_TOR_SIGNALING",34,-1.1709,0.24,0.34,0.5997,0.98,1,0.8948,0.62,1
"C3_MicroRNA_targets:C3_MIR_18_ACATTCC_MIR_1_MIR_206","C3_MicroRNA_targets","C3_MIR_18_ACATTCC_MIR_1_MIR_206",296,-1.1708,0.12,0.34,0.9448,0.65,1,0.8478,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_685_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21","C2_Chemical_and_genetic_perturbations","C2_CGP_685_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21",6,-1.1708,0.27,0.31,0.7013,0.83,1,0.8882,0.59,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_752_XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_752_XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP",35,-1.1707,0.25,0.31,-0.5888,0.98,1,1.4192,0.075,0.55
"GO_BP:505565_GO_0042424_CATECHOLAMINE_CATABOLIC_PROCESS","GO_BP","505565_GO_0042424_CATECHOLAMINE_CATABOLIC_PROCESS",6,-1.1705,0.29,0.39,0.7024,0.84,1,-1.2976,0.19,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_3103_THILLAINADESAN_ZNF217_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3103_THILLAINADESAN_ZNF217_TARGETS_UP",44,-1.1705,0.23,0.31,1.0127,0.42,0.78,-0.7657,0.89,0.97
"GO_BP:498745_GO_0019985_TRANSLESION_SYNTHESIS","GO_BP","498745_GO_0019985_TRANSLESION_SYNTHESIS",12,-1.1704,0.26,0.39,-1.1417,0.29,0.93,-1.1847,0.27,0.73
"GO_BP:518339_GO_0090199_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA","GO_BP","518339_GO_0090199_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA",45,-1.1704,0.23,0.39,1.0892,0.32,0.92,-0.8691,0.71,0.95
"C7_Immunologic_signatures:C7_ALL_1305_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1305_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP",194,-1.1704,0.17,0.23,0.7833,0.96,1,1.0961,0.23,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1681_SESTO_RESPONSE_TO_UV_C2","C2_Chemical_and_genetic_perturbations","C2_CGP_1681_SESTO_RESPONSE_TO_UV_C2",54,-1.1704,0.2,0.31,1.1209,0.23,0.6,1.067,0.32,0.89
"C4_Cancer_modules:C4_CM_134_MODULE_139","C4_Cancer_modules","C4_CM_134_MODULE_139",75,-1.1703,0.2,0.32,-1.2032,0.18,0.62,-1.0622,0.34,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_1432_FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1432_FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP",63,-1.1702,0.23,0.31,1.3345,0.055,0.36,-1.1729,0.17,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_3382_ZWANG_EGF_PERSISTENTLY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3382_ZWANG_EGF_PERSISTENTLY_UP",32,-1.1701,0.24,0.31,0.8896,0.65,0.94,-1.0777,0.31,0.66
"GO_CC:499804_GO_0030426_GROWTH_CONE","GO_CC","499804_GO_0030426_GROWTH_CONE",126,-1.1701,0.18,0.48,0.6601,1,0.99,-1.0599,0.32,0.97
"GO_BP:499465_GO_0023058_ADAPTATION_OF_SIGNALING_PATHWAY","GO_BP","499465_GO_0023058_ADAPTATION_OF_SIGNALING_PATHWAY",20,-1.17,0.25,0.39,-1.2481,0.19,0.91,1.2208,0.21,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_972_WILLIAMS_ESR1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_972_WILLIAMS_ESR1_TARGETS_UP",26,-1.17,0.25,0.31,0.8952,0.63,0.93,-0.973,0.5,0.79
"KEGG_compound:C14749_19_S_HETE_19S_HYDROXYEICOSATETRAENOIC_ACID_19S_HYDROXYICOSATETRAENOIC_ACID_19S_HYDROXY_ARACHIDONIC_ACID","KEGG_compound","C14749_19_S_HETE_19S_HYDROXYEICOSATETRAENOIC_ACID_19S_HYDROXYICOSATETRAENOIC_ACID_19S_HYDROXY_ARACHIDONIC_ACID",6,-1.17,0.27,0.42,-1.448,0.11,0.37,-1.7956,0.0019,0.036
"REACTOME:160977_REACT_22279_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM","REACTOME","160977_REACT_22279_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM",184,-1.17,0.15,0.43,-0.5441,1,1,-1.0292,0.38,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_886_KIM_MYCN_AMPLIFICATION_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_886_KIM_MYCN_AMPLIFICATION_TARGETS_DN",100,-1.1699,0.19,0.31,-0.734,0.95,1,-0.9828,0.47,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_861_MAINA_VHL_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_861_MAINA_VHL_TARGETS_UP",10,-1.1698,0.28,0.31,-1.2965,0.18,0.7,-1.4372,0.086,0.33
"C2_Chemical_and_genetic_perturbations:C2_CGP_2905_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2905_NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN",70,-1.1697,0.2,0.31,-1.2406,0.13,0.75,0.9731,0.52,0.97
"C7_Immunologic_signatures:C7_ALL_1374_GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1374_GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN",199,-1.1697,0.16,0.23,-0.755,0.98,1,-1.1482,0.13,0.37
"GO_BP:516793_GO_0071872_CELLULAR_RESPONSE_TO_EPINEPHRINE_STIMULUS","GO_BP","516793_GO_0071872_CELLULAR_RESPONSE_TO_EPINEPHRINE_STIMULUS",11,-1.1695,0.25,0.39,-0.7471,0.8,1,-0.9673,0.49,0.88
"GO_BP:495022_GO_0010957_NEGATIVE_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS","GO_BP","495022_GO_0010957_NEGATIVE_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS",5,-1.1695,0.31,0.39,-1.1641,0.31,0.91,-1.2079,0.27,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1744_DELASERNA_MYOD_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1744_DELASERNA_MYOD_TARGETS_UP",89,-1.1694,0.19,0.31,-0.9619,0.53,1,-1.0417,0.38,0.7
"GO_BP:508747_GO_0046487_GLYOXYLATE_METABOLIC_PROCESS","GO_BP","508747_GO_0046487_GLYOXYLATE_METABOLIC_PROCESS",8,-1.1692,0.29,0.39,1.1043,0.34,0.9,-0.8631,0.63,0.95
"C3_MicroRNA_targets:C3_MIR_133_GAGCCAG_MIR_149","C3_MicroRNA_targets","C3_MIR_133_GAGCCAG_MIR_149",143,-1.1692,0.17,0.34,-1.0745,0.3,1,-0.955,0.56,1
"GO_BP:514064_GO_0060509_TYPE_I_PNEUMOCYTE_DIFFERENTIATION","GO_BP","514064_GO_0060509_TYPE_I_PNEUMOCYTE_DIFFERENTIATION",7,-1.1689,0.3,0.39,0.7683,0.76,1,-0.7351,0.77,1
"GO_BP:490988_GO_0006000_FRUCTOSE_METABOLIC_PROCESS","GO_BP","490988_GO_0006000_FRUCTOSE_METABOLIC_PROCESS",11,-1.1688,0.27,0.39,0.4691,0.99,1,-0.7091,0.85,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1655_RHODES_CANCER_META_SIGNATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_1655_RHODES_CANCER_META_SIGNATURE",64,-1.1688,0.2,0.31,1.0747,0.32,0.67,-1.4619,0.018,0.31
"GO_CC:490705_GO_0005639_INTEGRAL_COMPONENT_OF_NUCLEAR_INNER_MEMBRANE","GO_CC","490705_GO_0005639_INTEGRAL_COMPONENT_OF_NUCLEAR_INNER_MEMBRANE",13,-1.1686,0.27,0.48,-0.8775,0.61,0.96,0.7583,0.79,1
"GO_BP:501647_GO_0032415_REGULATION_OF_SODIUM_PROTON_ANTIPORTER_ACTIVITY","GO_BP","501647_GO_0032415_REGULATION_OF_SODIUM_PROTON_ANTIPORTER_ACTIVITY",6,-1.1685,0.3,0.39,0.8601,0.64,1,-0.8288,0.66,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1367_CHEOK_RESPONSE_TO_HD_MTX_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1367_CHEOK_RESPONSE_TO_HD_MTX_DN",24,-1.1684,0.25,0.32,-0.8855,0.63,1,-1.1875,0.22,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1009_LIU_NASOPHARYNGEAL_CARCINOMA","C2_Chemical_and_genetic_perturbations","C2_CGP_1009_LIU_NASOPHARYNGEAL_CARCINOMA",67,-1.1684,0.23,0.31,1.5626,0.011,0.16,-0.7341,0.94,0.98
"GO_BP:519307_GO_2000668_REGULATION_OF_DENDRITIC_CELL_APOPTOTIC_PROCESS","GO_BP","519307_GO_2000668_REGULATION_OF_DENDRITIC_CELL_APOPTOTIC_PROCESS",6,-1.1684,0.28,0.39,-1.3148,0.18,0.88,-1.151,0.32,0.74
"GO_MF:496893_GO_0017080_SODIUM_CHANNEL_REGULATOR_ACTIVITY","GO_MF","496893_GO_0017080_SODIUM_CHANNEL_REGULATOR_ACTIVITY",34,-1.1683,0.23,0.44,-0.9078,0.62,0.98,-1.6163,0.012,0.37
"C2_Chemical_and_genetic_perturbations:C2_CGP_2326_MATZUK_STEROIDOGENESIS","C2_Chemical_and_genetic_perturbations","C2_CGP_2326_MATZUK_STEROIDOGENESIS",7,-1.1683,0.3,0.31,0.6178,0.91,1,1.1464,0.31,0.83
"C4_Cancer_modules:C4_CM_16_MODULE_17","C4_Cancer_modules","C4_CM_16_MODULE_17",358,-1.1683,0.11,0.32,1.6628,0,0.055,-1.1261,0.14,0.49
"C7_Immunologic_signatures:C7_ALL_1722_GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1722_GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN",198,-1.1683,0.14,0.23,0.8754,0.8,1,-1.0564,0.27,0.6
"C3_TF_targets:C3_TFT_69_V_CDPCR3_01","C3_TF_targets","C3_TFT_69_V_CDPCR3_01",51,-1.1683,0.22,0.24,-0.869,0.7,0.99,1.3254,0.07,0.6
"C7_Immunologic_signatures:C7_ALL_485_GSE17721_CTRL_VS_PAM3CSK4_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_485_GSE17721_CTRL_VS_PAM3CSK4_4H_BMDM_UP",198,-1.1682,0.15,0.23,1.2468,0.071,0.16,-1.4601,0.0042,0.033
"GO_BP:498820_GO_0021536_DIENCEPHALON_DEVELOPMENT","GO_BP","498820_GO_0021536_DIENCEPHALON_DEVELOPMENT",74,-1.1681,0.21,0.39,-1.0123,0.42,0.98,1.1079,0.26,0.76
"GO_BP:487479_GO_0001541_OVARIAN_FOLLICLE_DEVELOPMENT","GO_BP","487479_GO_0001541_OVARIAN_FOLLICLE_DEVELOPMENT",46,-1.1679,0.23,0.39,0.841,0.72,1,1.1862,0.18,0.72
"GO_BP:498443_GO_0019614_CATECHOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS","GO_BP","498443_GO_0019614_CATECHOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS",6,-1.1679,0.28,0.39,0.7356,0.78,1,-1.2784,0.19,0.66
"GO_BP:500198_GO_0030903_NOTOCHORD_DEVELOPMENT","GO_BP","500198_GO_0030903_NOTOCHORD_DEVELOPMENT",18,-1.1678,0.26,0.39,-0.8567,0.67,1,-1.2845,0.16,0.65
"GO_BP:491373_GO_0006470_PROTEIN_DEPHOSPHORYLATION","GO_BP","491373_GO_0006470_PROTEIN_DEPHOSPHORYLATION",155,-1.1678,0.17,0.39,1.0003,0.44,0.98,-0.7588,0.98,1
"GO_BP:505748_GO_0042634_REGULATION_OF_HAIR_CYCLE","GO_BP","505748_GO_0042634_REGULATION_OF_HAIR_CYCLE",20,-1.1676,0.26,0.39,-1.2854,0.16,0.89,-0.8776,0.65,0.94
"GO_BP:496942_GO_0017145_STEM_CELL_DIVISION","GO_BP","496942_GO_0017145_STEM_CELL_DIVISION",33,-1.1676,0.25,0.39,-0.7337,0.87,1,-1.187,0.2,0.73
"GO_BP:514161_GO_0060606_TUBE_CLOSURE","GO_BP","514161_GO_0060606_TUBE_CLOSURE",81,-1.1676,0.21,0.39,-0.7499,0.93,1,-0.8968,0.69,0.93
"GO_BP:513976_GO_0060420_REGULATION_OF_HEART_GROWTH","GO_BP","513976_GO_0060420_REGULATION_OF_HEART_GROWTH",42,-1.1674,0.22,0.39,0.871,0.69,1,1.459,0.036,0.59
"C4_Cancer_gene_neighborhoods:C4_CGN_131_MORF_MLLT10","C4_Cancer_gene_neighborhoods","C4_CGN_131_MORF_MLLT10",290,-1.1674,0.14,0.38,-1.0271,0.38,0.82,1.0924,0.21,0.62
"GO_CC:490844_GO_0005819_SPINDLE","GO_CC","490844_GO_0005819_SPINDLE",283,-1.167,0.14,0.48,0.9635,0.57,0.82,-1.3734,0.0084,0.6
"C3_TF_targets:C3_TFT_354_V_TCF1P_Q6","C3_TF_targets","C3_TFT_354_V_TCF1P_Q6",256,-1.167,0.13,0.24,-0.8697,0.82,1,1.0572,0.31,1
"C4_Cancer_modules:C4_CM_394_MODULE_497","C4_Cancer_modules","C4_CM_394_MODULE_497",28,-1.1669,0.26,0.32,-1.6951,0.0039,0.18,-1.1584,0.25,0.44
"C7_Immunologic_signatures:C7_ALL_309_GSE1460_DP_VS_CD4_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_309_GSE1460_DP_VS_CD4_THYMOCYTE_UP",196,-1.1668,0.16,0.24,0.9618,0.57,0.86,-1.1885,0.099,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_32_LIU_SOX4_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_32_LIU_SOX4_TARGETS_DN",307,-1.1668,0.14,0.32,0.9646,0.59,0.84,-1.1437,0.11,0.58
"C3_MicroRNA_targets:C3_MIR_23_ACTGAAA_MIR_30A_3P_MIR_30E_3P","C3_MicroRNA_targets","C3_MIR_23_ACTGAAA_MIR_30A_3P_MIR_30E_3P",199,-1.1666,0.15,0.34,-0.9231,0.67,1,-0.8573,0.88,1
"GO_BP:510907_GO_0048857_NEURAL_NUCLEUS_DEVELOPMENT","GO_BP","510907_GO_0048857_NEURAL_NUCLEUS_DEVELOPMENT",66,-1.1663,0.2,0.4,0.8863,0.68,1,0.6689,0.99,1
"GO_BP:495215_GO_0014819_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION","GO_BP","495215_GO_0014819_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION",9,-1.1663,0.29,0.4,-1.0372,0.41,0.98,0.9467,0.52,0.91
"GO_BP:507966_GO_0045618_POSITIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION","GO_BP","507966_GO_0045618_POSITIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION",13,-1.1662,0.27,0.4,-1.0254,0.42,0.97,-0.7615,0.81,1
"KEGG_pathway:HSA00511_OTHER_GLYCAN_DEGRADATION","KEGG_pathway","HSA00511_OTHER_GLYCAN_DEGRADATION",18,-1.1661,0.28,0.27,0.6576,0.92,1,-0.4865,0.99,1
"GO_BP:501979_GO_0032753_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION","GO_BP","501979_GO_0032753_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION",17,-1.166,0.27,0.4,-0.9121,0.58,1,-0.7332,0.83,1
"C7_Immunologic_signatures:C7_ALL_1011_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP","C7_Immunologic_signatures","C7_ALL_1011_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP",198,-1.166,0.16,0.24,1.2871,0.037,0.11,-1.0114,0.42,0.7
"GO_BP:505450_GO_0042303_MOLTING_CYCLE","GO_BP","505450_GO_0042303_MOLTING_CYCLE",89,-1.1659,0.23,0.4,0.7601,0.93,1,0.9785,0.51,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_543_DARWICHE_PAPILLOMA_RISK_HIGH_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_543_DARWICHE_PAPILLOMA_RISK_HIGH_DN",172,-1.1659,0.18,0.32,-0.9332,0.64,1,-1.0865,0.24,0.65
"GO_BP:516298_GO_0071374_CELLULAR_RESPONSE_TO_PARATHYROID_HORMONE_STIMULUS","GO_BP","516298_GO_0071374_CELLULAR_RESPONSE_TO_PARATHYROID_HORMONE_STIMULUS",5,-1.1659,0.3,0.4,-1.2428,0.21,0.91,0.8798,0.6,0.96
"C3_TF_targets:C3_TFT_547_YKACATTT_UNKNOWN","C3_TF_targets","C3_TFT_547_YKACATTT_UNKNOWN",270,-1.1658,0.14,0.24,0.955,0.63,1,-1.0402,0.3,0.64
"GO_BP:512818_GO_0051968_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC","GO_BP","512818_GO_0051968_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC",18,-1.1658,0.25,0.4,-1.091,0.32,0.95,1.3608,0.11,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2504_PIONTEK_PKD1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2504_PIONTEK_PKD1_TARGETS_UP",35,-1.1658,0.25,0.32,1.1641,0.23,0.53,1.3779,0.082,0.53
"GO_BP:501670_GO_0032438_MELANOSOME_ORGANIZATION","GO_BP","501670_GO_0032438_MELANOSOME_ORGANIZATION",22,-1.1656,0.25,0.4,-0.6682,0.91,1,0.5892,0.98,1
"GO_BP:504808_GO_0035630_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION","GO_BP","504808_GO_0035630_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION",5,-1.1656,0.29,0.4,0.8383,0.68,1,0.894,0.6,0.95
"C6_Oncogenic_signatures:C6_ALL_69_RAF_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_69_RAF_UP_V1_DN",191,-1.1656,0.16,0.22,0.8853,0.76,0.95,1.1567,0.12,0.33
"GO_BP:506181_GO_0043101_PURINE_CONTAINING_COMPOUND_SALVAGE","GO_BP","506181_GO_0043101_PURINE_CONTAINING_COMPOUND_SALVAGE",16,-1.1656,0.27,0.4,0.7669,0.78,1,-1.1309,0.3,0.75
"WikiPathways:755438_WP2011_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS","WikiPathways","755438_WP2011_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS",16,-1.1656,0.29,0.34,-0.5321,0.98,1,0.7219,0.88,1
"C7_Immunologic_signatures:C7_ALL_478_GSE17721_CTRL_VS_POLYIC_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_478_GSE17721_CTRL_VS_POLYIC_24H_BMDM_DN",196,-1.1655,0.16,0.24,-0.7675,0.98,1,-0.978,0.51,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_2856_CAIRO_LIVER_DEVELOPMENT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2856_CAIRO_LIVER_DEVELOPMENT_UP",162,-1.1652,0.17,0.32,-0.9422,0.59,1,1.2175,0.096,0.75
"GO_BP:492457_GO_0008090_RETROGRADE_AXON_CARGO_TRANSPORT","GO_BP","492457_GO_0008090_RETROGRADE_AXON_CARGO_TRANSPORT",6,-1.1652,0.28,0.4,-0.7214,0.81,1,-0.9376,0.51,0.9
"GO_MF:506591_GO_0043560_INSULIN_RECEPTOR_SUBSTRATE_BINDING","GO_MF","506591_GO_0043560_INSULIN_RECEPTOR_SUBSTRATE_BINDING",12,-1.1652,0.28,0.45,-0.8101,0.73,1,-1.4772,0.083,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_2079_ZHENG_FOXP3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2079_ZHENG_FOXP3_TARGETS_UP",26,-1.1652,0.26,0.32,1.182,0.22,0.51,1.0363,0.4,0.93
"GO_BP:491793_GO_0050954_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS","GO_BP","491793_GO_0050954_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS",153,-1.1652,0.18,0.4,0.9376,0.62,1,1.3889,0.019,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_523_LUCAS_HNF4A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_523_LUCAS_HNF4A_TARGETS_DN",8,-1.1651,0.29,0.32,-0.72,0.82,1,1.0716,0.37,0.89
"GO_BP:1026091_GO_1903319_POSITIVE_REGULATION_OF_PROTEIN_MATURATION","GO_BP","1026091_GO_1903319_POSITIVE_REGULATION_OF_PROTEIN_MATURATION",14,-1.1651,0.27,0.4,-1.4135,0.084,0.95,-0.9098,0.56,0.92
"GO_BP:504812_GO_0035634_RESPONSE_TO_STILBENOID","GO_BP","504812_GO_0035634_RESPONSE_TO_STILBENOID",5,-1.1649,0.28,0.4,-0.9909,0.49,1,-1.4355,0.099,0.56
"C2_Chemical_and_genetic_perturbations:C2_CGP_2797_KESHELAVA_MULTIPLE_DRUG_RESISTANCE","C2_Chemical_and_genetic_perturbations","C2_CGP_2797_KESHELAVA_MULTIPLE_DRUG_RESISTANCE",87,-1.1649,0.2,0.32,-0.8712,0.73,1,-1.1331,0.21,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_442_GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_442_GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN",81,-1.1647,0.21,0.32,-0.7556,0.92,1,-1.0831,0.29,0.65
"GO_BP:491012_GO_0006026_AMINOGLYCAN_CATABOLIC_PROCESS","GO_BP","491012_GO_0006026_AMINOGLYCAN_CATABOLIC_PROCESS",65,-1.1647,0.23,0.4,1.0401,0.37,0.96,1.2098,0.16,0.71
"C6_Oncogenic_signatures:C6_ALL_71_PRC1_BMI_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_71_PRC1_BMI_UP_V1_DN",174,-1.1646,0.17,0.22,-1.0918,0.26,0.56,-1.0229,0.41,0.62
"GO_BP:487661_GO_0001765_MEMBRANE_RAFT_ASSEMBLY","GO_BP","487661_GO_0001765_MEMBRANE_RAFT_ASSEMBLY",8,-1.1645,0.27,0.4,0.8216,0.69,1,1.5138,0.064,0.55
"GO_CC:500490_GO_0031229_INTRINSIC_COMPONENT_OF_NUCLEAR_INNER_MEMBRANE","GO_CC","500490_GO_0031229_INTRINSIC_COMPONENT_OF_NUCLEAR_INNER_MEMBRANE",13,-1.1645,0.27,0.48,-0.8756,0.62,0.95,0.7438,0.85,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_183_BIOCARTA_SODD_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_183_BIOCARTA_SODD_PATHWAY",10,-1.1644,0.28,0.39,-0.8664,0.62,1,0.6579,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1157_SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1157_SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",27,-1.1644,0.25,0.32,-0.8858,0.64,1,0.8447,0.71,1
"GO_BP:493421_GO_0009225_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS","GO_BP","493421_GO_0009225_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS",31,-1.1643,0.24,0.4,-0.6931,0.92,1,-1.2459,0.16,0.68
"C4_Cancer_modules:C4_CM_270_MODULE_308","C4_Cancer_modules","C4_CM_270_MODULE_308",71,-1.1643,0.23,0.33,0.6984,0.97,1,-1.7053,0,0.083
"GO_MF:493551_GO_0009374_BIOTIN_BINDING","GO_MF","493551_GO_0009374_BIOTIN_BINDING",5,-1.1641,0.28,0.45,-1.3006,0.18,0.77,-1.1065,0.36,0.7
"GO_BP:510603_GO_0048532_ANATOMICAL_STRUCTURE_ARRANGEMENT","GO_BP","510603_GO_0048532_ANATOMICAL_STRUCTURE_ARRANGEMENT",20,-1.164,0.26,0.4,-0.9589,0.52,1,0.8386,0.71,0.99
"REACTOME:106339_REACT_12606_GRB2_EVENTS_IN_EGFR_SIGNALING","REACTOME","106339_REACT_12606_GRB2_EVENTS_IN_EGFR_SIGNALING",21,-1.1639,0.26,0.44,0.7411,0.87,1,-0.9243,0.58,0.93
"C3_MicroRNA_targets:C3_MIR_180_GTGCAAA_MIR_507","C3_MicroRNA_targets","C3_MIR_180_GTGCAAA_MIR_507",128,-1.1639,0.18,0.35,-0.9225,0.66,1,-0.8599,0.81,1
"GO_CC:490914_GO_0005915_ZONULA_ADHERENS","GO_CC","490914_GO_0005915_ZONULA_ADHERENS",8,-1.1638,0.28,0.48,-1.3606,0.12,0.6,0.9956,0.46,1
"GO_BP:498629_GO_0046689_RESPONSE_TO_MERCURY_ION","GO_BP","498629_GO_0046689_RESPONSE_TO_MERCURY_ION",15,-1.1637,0.24,0.4,-1.1207,0.31,0.94,0.8211,0.72,1
"WikiPathways:760635_WP2361_GASTRIC_CANCER_NETWORK_1","WikiPathways","760635_WP2361_GASTRIC_CANCER_NETWORK_1",41,-1.1637,0.23,0.34,-1.2151,0.15,0.95,-1.0468,0.37,0.65
"C3_TF_targets:C3_TFT_22_V_CREBP1_01","C3_TF_targets","C3_TFT_22_V_CREBP1_01",180,-1.1637,0.17,0.25,-1.1838,0.12,0.39,-0.9479,0.6,0.85
"C3_TF_targets:C3_TFT_184_V_RREB1_01","C3_TF_targets","C3_TFT_184_V_RREB1_01",201,-1.1637,0.16,0.25,-1.2332,0.064,0.29,-0.9228,0.68,0.88
"KEGG_reaction:R01175_BUTANOYL_COA_ELECTRON_TRANSFER_FLAVOPROTEIN_2_3_OXIDOREDUCTASE_BUTANOYL_COA_FAD_FADH2_CROTONOYL_COA","KEGG_reaction","R01175_BUTANOYL_COA_ELECTRON_TRANSFER_FLAVOPROTEIN_2_3_OXIDOREDUCTASE_BUTANOYL_COA_FAD_FADH2_CROTONOYL_COA",5,-1.1636,0.27,0.41,-0.5252,0.96,0.99,-1.5673,0.035,0.17
"KEGG_module:HSA_M00693_CELL_CYCLE","KEGG_module","HSA_M00693_CELL_CYCLE",10,-1.1635,0.29,0.64,0.5775,0.97,1,-0.833,0.68,0.91
"GO_BP:486716_GO_0000185_ACTIVATION_OF_MAPKKK_ACTIVITY","GO_BP","486716_GO_0000185_ACTIVATION_OF_MAPKKK_ACTIVITY",9,-1.1635,0.29,0.4,-1.5722,0.049,0.73,-1.4592,0.079,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1110_BENPORATH_NOS_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1110_BENPORATH_NOS_TARGETS",178,-1.1634,0.17,0.32,0.9209,0.69,0.9,0.8626,0.84,1
"GO_BP:497180_GO_0018209_PEPTIDYL_SERINE_MODIFICATION","GO_BP","497180_GO_0018209_PEPTIDYL_SERINE_MODIFICATION",122,-1.1634,0.19,0.4,-1.2163,0.096,0.88,-1.4437,0.011,0.55
"REACTOME:106374_REACT_18289_P2Y_RECEPTORS","REACTOME","106374_REACT_18289_P2Y_RECEPTORS",12,-1.1634,0.28,0.44,1.8152,0.002,0.019,0.788,0.74,1
"GO_BP:499848_GO_0030509_BMP_SIGNALING_PATHWAY","GO_BP","499848_GO_0030509_BMP_SIGNALING_PATHWAY",76,-1.1633,0.21,0.4,-0.9014,0.66,1,1.0155,0.43,0.84
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_36_BIOCARTA_G2_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_36_BIOCARTA_G2_PATHWAY",24,-1.1631,0.27,0.38,-0.7116,0.88,1,-1.1215,0.29,0.62
"KEGG_pathway:HSA04152_AMPK_SIGNALING_PATHWAY","KEGG_pathway","HSA04152_AMPK_SIGNALING_PATHWAY",122,-1.1631,0.18,0.27,0.8291,0.86,1,0.8922,0.68,1
"GO_BP:849932_GO_1902231_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE","GO_BP","849932_GO_1902231_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE",7,-1.163,0.28,0.4,-1.0161,0.44,0.98,0.6582,0.9,1
"GO_BP:501511_GO_0032276_REGULATION_OF_GONADOTROPIN_SECRETION","GO_BP","501511_GO_0032276_REGULATION_OF_GONADOTROPIN_SECRETION",9,-1.1629,0.29,0.4,0.8403,0.66,1,-1.4334,0.084,0.56
"GO_BP:518329_GO_0090189_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS","GO_BP","518329_GO_0090189_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS",23,-1.1629,0.25,0.4,1.1853,0.21,0.8,1.1423,0.27,0.73
"C3_TF_targets:C3_TFT_511_RYCACNNRNNRNCAG_UNKNOWN","C3_TF_targets","C3_TFT_511_RYCACNNRNNRNCAG_UNKNOWN",74,-1.1629,0.22,0.25,-1.3593,0.042,0.19,0.805,0.87,1
"C3_TF_targets:C3_TFT_273_V_POU3F2_01","C3_TF_targets","C3_TFT_273_V_POU3F2_01",94,-1.1629,0.19,0.25,1.309,0.067,0.5,-0.9366,0.57,0.88
"GO_MF:496779_GO_0016892_ENDORIBONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS","GO_MF","496779_GO_0016892_ENDORIBONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS",8,-1.1629,0.29,0.45,1.4237,0.082,0.47,0.9473,0.53,0.91
"C4_Cancer_modules:C4_CM_325_MODULE_382","C4_Cancer_modules","C4_CM_325_MODULE_382",22,-1.1628,0.25,0.33,-0.8602,0.68,0.93,1.2783,0.14,0.49
"C1_Positional:C1_ALL_108_CHR9P11","C1_Positional","C1_ALL_108_CHR9P11",12,-1.1626,0.28,0.78,-1.1613,0.28,1,-0.8718,0.62,0.98
"GO_BP:500675_GO_0031424_KERATINIZATION","GO_BP","500675_GO_0031424_KERATINIZATION",34,-1.1626,0.23,0.4,1.4133,0.061,0.54,1.2653,0.13,0.69
"GO_BP:513596_GO_0060038_CARDIAC_MUSCLE_CELL_PROLIFERATION","GO_BP","513596_GO_0060038_CARDIAC_MUSCLE_CELL_PROLIFERATION",13,-1.1625,0.28,0.4,-0.9816,0.51,1,-0.7384,0.81,1
"C7_Immunologic_signatures:C7_ALL_1148_GSE27786_LSK_VS_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1148_GSE27786_LSK_VS_CD4_TCELL_DN",197,-1.1623,0.16,0.24,0.7794,0.97,1,-1.0599,0.29,0.59
"GO_MF:501063_GO_0031821_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_BINDING","GO_MF","501063_GO_0031821_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_BINDING",7,-1.1622,0.3,0.45,0.6394,0.91,1,-1.2432,0.22,0.6
"C7_Immunologic_signatures:C7_ALL_969_GSE22886_NEUTROPHIL_VS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_969_GSE22886_NEUTROPHIL_VS_MONOCYTE_UP",184,-1.1621,0.16,0.24,1.4418,0.0065,0.024,1.6767,0,0.0026
"C7_Immunologic_signatures:C7_ALL_1782_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1782_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN",198,-1.1621,0.17,0.24,0.7552,1,1,0.8249,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_524_ZIRN_TRETINOIN_RESPONSE_WT1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_524_ZIRN_TRETINOIN_RESPONSE_WT1_UP",23,-1.162,0.26,0.32,1.0956,0.33,0.64,1.5235,0.038,0.47
"C3_TF_targets:C3_TFT_276_V_HIF1_Q5","C3_TF_targets","C3_TFT_276_V_HIF1_Q5",239,-1.1619,0.15,0.25,-0.94,0.64,0.89,-0.99,0.48,0.78
"REACTOME:106173_REACT_238_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION_","REACTOME","106173_REACT_238_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION_",16,-1.1617,0.24,0.44,-1.1332,0.29,0.89,-0.8306,0.67,1
"GO_BP:499900_GO_0030579_UBIQUITIN_DEPENDENT_SMAD_PROTEIN_CATABOLIC_PROCESS","GO_BP","499900_GO_0030579_UBIQUITIN_DEPENDENT_SMAD_PROTEIN_CATABOLIC_PROCESS",6,-1.1617,0.29,0.4,-0.6032,0.94,1,0.7618,0.75,1
"C3_TF_targets:C3_TFT_332_V_FOXM1_01","C3_TF_targets","C3_TFT_332_V_FOXM1_01",239,-1.1616,0.15,0.25,-1.091,0.24,0.57,-0.9158,0.71,0.9
"GO_CC:501810_GO_0032584_GROWTH_CONE_MEMBRANE","GO_CC","501810_GO_0032584_GROWTH_CONE_MEMBRANE",8,-1.1615,0.27,0.49,-1.2366,0.2,0.63,-1.0351,0.41,0.97
"GO_BP:509058_GO_0046835_CARBOHYDRATE_PHOSPHORYLATION","GO_BP","509058_GO_0046835_CARBOHYDRATE_PHOSPHORYLATION",24,-1.1615,0.26,0.4,-0.7138,0.89,1,-0.9147,0.57,0.92
"C1_Positional:C1_ALL_264_CHR5Q34","C1_Positional","C1_ALL_264_CHR5Q34",24,-1.1615,0.25,0.77,-1.3607,0.11,1,0.9819,0.49,0.79
"GO_BP:504250_GO_0035065_REGULATION_OF_HISTONE_ACETYLATION","GO_BP","504250_GO_0035065_REGULATION_OF_HISTONE_ACETYLATION",43,-1.1614,0.23,0.4,-0.7691,0.88,1,-1.4254,0.049,0.57
"GO_BP:494342_GO_0010269_RESPONSE_TO_SELENIUM_ION","GO_BP","494342_GO_0010269_RESPONSE_TO_SELENIUM_ION",5,-1.1614,0.29,0.4,0.7356,0.8,1,1.0712,0.41,0.78
"GO_BP:518152_GO_0090005_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE","GO_BP","518152_GO_0090005_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",13,-1.1614,0.28,0.4,0.7115,0.84,1,0.7366,0.82,1
"GO_BP:1184420_GO_1903894_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE","GO_BP","1184420_GO_1903894_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE",10,-1.1614,0.28,0.4,-1.2361,0.19,0.9,-1.5162,0.053,0.54
"C7_Immunologic_signatures:C7_ALL_703_GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_703_GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDM_UP",198,-1.1613,0.17,0.24,1.4557,0.0047,0.021,0.9246,0.66,1
"REACTOME:106234_REACT_1906_TRANSPORT_OF_GAMMA_CARBOXYLATED_PROTEIN_PRECURSORS_FROM_THE_ENDOPLASMIC_RETICULUM_TO_THE_GOLGI_APPARATUS","REACTOME","106234_REACT_1906_TRANSPORT_OF_GAMMA_CARBOXYLATED_PROTEIN_PRECURSORS_FROM_THE_ENDOPLASMIC_RETICULUM_TO_THE_GOLGI_APPARATUS",8,-1.1612,0.28,0.44,-1.0227,0.42,0.98,-1.3658,0.13,0.47
"C1_Positional:C1_ALL_139_CHR3P26","C1_Positional","C1_ALL_139_CHR3P26",20,-1.1611,0.27,0.76,-1.0095,0.44,1,-1.4233,0.069,0.66
"GO_CC:503564_GO_0034362_LOW_DENSITY_LIPOPROTEIN_PARTICLE","GO_CC","503564_GO_0034362_LOW_DENSITY_LIPOPROTEIN_PARTICLE",14,-1.1611,0.28,0.49,0.6187,0.94,0.99,1.1656,0.25,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_72_DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_72_DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP",326,-1.1611,0.13,0.33,0.837,0.95,0.97,-1.0204,0.39,0.73
"GO_BP:499645_GO_0030239_MYOFIBRIL_ASSEMBLY","GO_BP","499645_GO_0030239_MYOFIBRIL_ASSEMBLY",48,-1.1611,0.23,0.4,-1.562,0.0056,0.71,-0.9056,0.61,0.92
"GO_MF:496713_GO_0016814_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES","GO_MF","496713_GO_0016814_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES",35,-1.1611,0.25,0.45,-1.0493,0.38,0.86,-1.1315,0.29,0.67
"C7_Immunologic_signatures:C7_ALL_410_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_410_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN",199,-1.1611,0.15,0.25,1.4947,0.0023,0.014,-1.2816,0.041,0.16
"GO_BP:512452_GO_0051574_POSITIVE_REGULATION_OF_HISTONE_H3_K9_METHYLATION","GO_BP","512452_GO_0051574_POSITIVE_REGULATION_OF_HISTONE_H3_K9_METHYLATION",6,-1.161,0.3,0.4,0.9745,0.49,1,1.0291,0.42,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_749_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_749_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",19,-1.161,0.26,0.33,-1.2278,0.2,0.77,0.8034,0.77,1
"KEGG_pathway:HSA05032_MORPHINE_ADDICTION","KEGG_pathway","HSA05032_MORPHINE_ADDICTION",90,-1.161,0.2,0.27,-1.0581,0.33,0.74,-1.2462,0.088,0.34
"GO_BP:505849_GO_0042743_HYDROGEN_PEROXIDE_METABOLIC_PROCESS","GO_BP","505849_GO_0042743_HYDROGEN_PEROXIDE_METABOLIC_PROCESS",34,-1.1607,0.24,0.4,1.3055,0.089,0.66,-1.0463,0.37,0.82
"GO_BP:499126_GO_0021846_CELL_PROLIFERATION_IN_FOREBRAIN","GO_BP","499126_GO_0021846_CELL_PROLIFERATION_IN_FOREBRAIN",29,-1.1607,0.25,0.4,-1.013,0.44,0.98,1.1029,0.3,0.76
"GO_BP:512202_GO_0051318_G1_PHASE","GO_BP","512202_GO_0051318_G1_PHASE",34,-1.1607,0.25,0.4,1.0676,0.32,0.94,-1.4449,0.045,0.55
"C7_Immunologic_signatures:C7_ALL_1079_GSE25087_FETAL_VS_ADULT_TREG_UP","C7_Immunologic_signatures","C7_ALL_1079_GSE25087_FETAL_VS_ADULT_TREG_UP",197,-1.1606,0.16,0.25,1.2648,0.038,0.14,-1.1129,0.19,0.46
"GO_MF:495659_GO_0015459_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY","GO_MF","495659_GO_0015459_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY",43,-1.1605,0.23,0.45,-1.1405,0.24,0.81,-0.9355,0.54,0.85
"GO_BP:494765_GO_0010700_NEGATIVE_REGULATION_OF_NOREPINEPHRINE_SECRETION","GO_BP","494765_GO_0010700_NEGATIVE_REGULATION_OF_NOREPINEPHRINE_SECRETION",8,-1.1605,0.28,0.4,0.9736,0.49,1,-0.8857,0.61,0.94
"GO_MF:505333_GO_0042171_LYSOPHOSPHATIDIC_ACID_ACYLTRANSFERASE_ACTIVITY","GO_MF","505333_GO_0042171_LYSOPHOSPHATIDIC_ACID_ACYLTRANSFERASE_ACTIVITY",11,-1.1605,0.29,0.45,-0.5722,0.94,1,-1.0632,0.36,0.74
"GO_BP:508396_GO_0046100_HYPOXANTHINE_METABOLIC_PROCESS","GO_BP","508396_GO_0046100_HYPOXANTHINE_METABOLIC_PROCESS",6,-1.1603,0.3,0.4,0.9384,0.55,1,-1.2186,0.24,0.71
"C4_Cancer_modules:C4_CM_345_MODULE_414","C4_Cancer_modules","C4_CM_345_MODULE_414",17,-1.1603,0.26,0.33,2.053,0,0.0018,0.6353,0.92,1
"REACTOME:106129_REACT_1887_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA","REACTOME","106129_REACT_1887_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA",5,-1.1603,0.3,0.44,0.9721,0.51,0.8,-1.3973,0.095,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_77_DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_77_DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN",15,-1.1602,0.26,0.33,0.8333,0.71,0.98,-1.1837,0.23,0.53
"KEGG_compound:C00951_ESTRADIOL_17BETA_ESTRADIOL_BETA_ESTRADIOL","KEGG_compound","C00951_ESTRADIOL_17BETA_ESTRADIOL_BETA_ESTRADIOL",28,-1.1602,0.27,0.43,1.8089,0,0.032,1.3687,0.075,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_1919_YIH_RESPONSE_TO_ARSENITE_C3","C2_Chemical_and_genetic_perturbations","C2_CGP_1919_YIH_RESPONSE_TO_ARSENITE_C3",36,-1.1602,0.25,0.33,1.1715,0.19,0.53,-0.8168,0.76,0.94
"GO_BP:511626_GO_0050654_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS","GO_BP","511626_GO_0050654_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS",59,-1.1601,0.22,0.4,0.8492,0.77,1,0.9934,0.46,0.87
"GO_BP:488027_GO_0002138_RETINOIC_ACID_BIOSYNTHETIC_PROCESS","GO_BP","488027_GO_0002138_RETINOIC_ACID_BIOSYNTHETIC_PROCESS",6,-1.1601,0.29,0.4,-0.9467,0.52,1,-0.8952,0.57,0.93
"GO_BP:504968_GO_0035791_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY","GO_BP","504968_GO_0035791_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY",5,-1.1601,0.31,0.4,1.1551,0.33,0.83,1.2654,0.21,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_426_CHIN_BREAST_CANCER_COPY_NUMBER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_426_CHIN_BREAST_CANCER_COPY_NUMBER_DN",13,-1.1599,0.28,0.33,-1.0417,0.38,0.98,-0.914,0.56,0.86
"C3_TF_targets:C3_TFT_605_TAAWWATAG_V_RSRFC4_Q2","C3_TF_targets","C3_TFT_605_TAAWWATAG_V_RSRFC4_Q2",165,-1.1598,0.18,0.25,-0.9008,0.72,0.96,-1.1214,0.16,0.49
"GO_BP:506654_GO_0043623_CELLULAR_PROTEIN_COMPLEX_ASSEMBLY","GO_BP","506654_GO_0043623_CELLULAR_PROTEIN_COMPLEX_ASSEMBLY",285,-1.1598,0.16,0.4,1.0762,0.25,0.93,-1.1885,0.087,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_627_BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_627_BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER",22,-1.1598,0.26,0.33,-0.8643,0.66,1,1.1927,0.22,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2479_REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2479_REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS",8,-1.1597,0.3,0.33,0.669,0.87,1,-0.7145,0.83,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_556_HU_ANGIOGENESIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_556_HU_ANGIOGENESIS_DN",37,-1.1597,0.23,0.33,1.6486,0.0022,0.11,-1.1613,0.22,0.56
"GO_MF:495517_GO_0042887_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495517_GO_0042887_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",14,-1.1596,0.28,0.45,-1.0734,0.36,0.86,-1.3713,0.098,0.51
"C7_Immunologic_signatures:C7_ALL_1260_GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1260_GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN",166,-1.1596,0.19,0.25,-1.0519,0.35,1,0.9366,0.62,1
"GO_BP:506121_GO_0043032_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION","GO_BP","506121_GO_0043032_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION",9,-1.1596,0.28,0.4,1.7146,0.018,0.18,0.9673,0.5,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_2962_HO_LIVER_CANCER_VASCULAR_INVASION","C2_Chemical_and_genetic_perturbations","C2_CGP_2962_HO_LIVER_CANCER_VASCULAR_INVASION",12,-1.1596,0.29,0.33,-0.7367,0.8,1,-1.3568,0.13,0.39
"GO_BP:495938_GO_0015807_L_AMINO_ACID_TRANSPORT","GO_BP","495938_GO_0015807_L_AMINO_ACID_TRANSPORT",52,-1.1595,0.23,0.4,0.8635,0.71,1,-0.9559,0.51,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1581_KAMMINGA_EZH2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1581_KAMMINGA_EZH2_TARGETS",41,-1.1595,0.26,0.33,1.2246,0.16,0.46,-2.2444,0,0.0027
"GO_BP:752958_GO_0097459_IRON_ION_IMPORT_INTO_CELL","GO_BP","752958_GO_0097459_IRON_ION_IMPORT_INTO_CELL",7,-1.1594,0.3,0.4,-0.5931,0.93,1,0.7909,0.71,1
"GO_BP:508589_GO_0046324_REGULATION_OF_GLUCOSE_IMPORT","GO_BP","508589_GO_0046324_REGULATION_OF_GLUCOSE_IMPORT",49,-1.1593,0.22,0.4,-0.7538,0.9,1,-1.1667,0.2,0.73
"GO_BP:491868_GO_0007041_LYSOSOMAL_TRANSPORT","GO_BP","491868_GO_0007041_LYSOSOMAL_TRANSPORT",49,-1.1591,0.22,0.4,-0.7026,0.95,1,-1.0271,0.41,0.82
"GO_BP:493324_GO_0009127_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493324_GO_0009127_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",68,-1.159,0.22,0.4,1.3871,0.037,0.57,-0.994,0.46,0.85
"GO_BP:504723_GO_0035542_REGULATION_OF_SNARE_COMPLEX_ASSEMBLY","GO_BP","504723_GO_0035542_REGULATION_OF_SNARE_COMPLEX_ASSEMBLY",8,-1.1589,0.32,0.4,-0.9476,0.51,1,-0.5636,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1498_NEMETH_INFLAMMATORY_RESPONSE_LPS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1498_NEMETH_INFLAMMATORY_RESPONSE_LPS_DN",32,-1.1589,0.25,0.33,1.0512,0.38,0.71,-0.9613,0.5,0.8
"GO_BP:514929_GO_0061384_HEART_TRABECULA_MORPHOGENESIS","GO_BP","514929_GO_0061384_HEART_TRABECULA_MORPHOGENESIS",25,-1.1589,0.25,0.4,-1.0349,0.39,0.98,-0.9713,0.52,0.87
"GO_BP:508146_GO_0045823_POSITIVE_REGULATION_OF_HEART_CONTRACTION","GO_BP","508146_GO_0045823_POSITIVE_REGULATION_OF_HEART_CONTRACTION",27,-1.1589,0.26,0.4,-0.8545,0.66,1,0.9015,0.62,0.94
"GO_BP:490342_GO_0007178_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY","GO_BP","490342_GO_0007178_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY",217,-1.1588,0.16,0.4,0.8186,0.94,1,1.083,0.25,0.77
"C7_Immunologic_signatures:C7_ALL_471_GSE17721_CTRL_VS_POLYIC_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_471_GSE17721_CTRL_VS_POLYIC_6H_BMDM_UP",198,-1.1588,0.16,0.25,1.492,0.0024,0.014,-0.9185,0.7,0.92
"GO_BP:502807_GO_0033591_RESPONSE_TO_L_ASCORBIC_ACID","GO_BP","502807_GO_0033591_RESPONSE_TO_L_ASCORBIC_ACID",5,-1.1587,0.29,0.4,1.0177,0.46,0.97,-0.7322,0.81,0.99
"GO_BP:513971_GO_0060415_MUSCLE_TISSUE_MORPHOGENESIS","GO_BP","513971_GO_0060415_MUSCLE_TISSUE_MORPHOGENESIS",63,-1.1586,0.23,0.4,1.2183,0.14,0.76,1.5283,0.012,0.53
"GO_BP:518484_GO_0090344_NEGATIVE_REGULATION_OF_CELL_AGING","GO_BP","518484_GO_0090344_NEGATIVE_REGULATION_OF_CELL_AGING",16,-1.1586,0.27,0.4,-0.565,0.98,1,-0.5186,0.99,1
"GO_BP:499703_GO_0030301_CHOLESTEROL_TRANSPORT","GO_BP","499703_GO_0030301_CHOLESTEROL_TRANSPORT",49,-1.1585,0.24,0.4,0.9598,0.52,1,1.7161,0.0019,0.41
"GO_BP:507984_GO_0045636_POSITIVE_REGULATION_OF_MELANOCYTE_DIFFERENTIATION","GO_BP","507984_GO_0045636_POSITIVE_REGULATION_OF_MELANOCYTE_DIFFERENTIATION",5,-1.1585,0.29,0.4,1.1096,0.37,0.89,0.6473,0.89,1
"C1_Positional:C1_ALL_84_CHR9P21","C1_Positional","C1_ALL_84_CHR9P21",32,-1.1584,0.24,0.76,0.8414,0.73,0.92,-1.0885,0.31,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_3192_BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2","C2_Chemical_and_genetic_perturbations","C2_CGP_3192_BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2",72,-1.1584,0.23,0.33,2.2813,0,0.00017,-1.0743,0.31,0.66
"GO_BP:489225_GO_0003433_CHONDROCYTE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS","GO_BP","489225_GO_0003433_CHONDROCYTE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS",5,-1.1583,0.3,0.4,-1.497,0.035,0.82,-1.08,0.39,0.79
"C3_TF_targets:C3_TFT_448_V_AP2_Q6_01","C3_TF_targets","C3_TFT_448_V_AP2_Q6_01",267,-1.1583,0.14,0.25,-1.2855,0.031,0.25,-0.9577,0.6,0.83
"C3_TF_targets:C3_TFT_169_V_NKX25_01","C3_TF_targets","C3_TFT_169_V_NKX25_01",118,-1.1583,0.19,0.25,-1.3342,0.047,0.2,0.7598,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1440_HASLINGER_B_CLL_WITH_17P13_DELETION","C2_Chemical_and_genetic_perturbations","C2_CGP_1440_HASLINGER_B_CLL_WITH_17P13_DELETION",21,-1.1583,0.28,0.33,0.7392,0.84,1,-1.0516,0.37,0.69
"GO_BP:512530_GO_0051654_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION","GO_BP","512530_GO_0051654_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION",12,-1.1582,0.28,0.4,-0.7706,0.77,1,-0.6455,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_404_CHEBOTAEV_GR_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_404_CHEBOTAEV_GR_TARGETS_DN",117,-1.1582,0.2,0.33,-1.0043,0.47,1,1.0717,0.3,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_3379_ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR","C2_Chemical_and_genetic_perturbations","C2_CGP_3379_ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR",8,-1.1581,0.29,0.33,-0.7175,0.81,1,-1.3301,0.16,0.41
"C3_TF_targets:C3_TFT_224_V_MSX1_01","C3_TF_targets","C3_TFT_224_V_MSX1_01",167,-1.1581,0.18,0.25,1.0047,0.46,1,-1.0134,0.4,0.73
"GO_CC:516470_GO_0071546_PI_BODY","GO_CC","516470_GO_0071546_PI_BODY",5,-1.1581,0.33,0.49,-0.9953,0.46,0.84,0.8901,0.61,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2991_NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2991_NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN",18,-1.1579,0.26,0.33,-1.063,0.38,0.96,-1.0869,0.35,0.65
"GO_BP:491103_GO_0006122_MITOCHONDRIAL_ELECTRON_TRANSPORT_UBIQUINOL_TO_CYTOCHROME_C","GO_BP","491103_GO_0006122_MITOCHONDRIAL_ELECTRON_TRANSPORT_UBIQUINOL_TO_CYTOCHROME_C",7,-1.1579,0.3,0.4,0.8019,0.7,1,-0.8931,0.62,0.93
"GO_CC:921157_GO_1990246_UNIPLEX_COMPLEX","GO_CC","921157_GO_1990246_UNIPLEX_COMPLEX",5,-1.1579,0.29,0.49,1.363,0.1,0.33,-0.6584,0.87,1
"GO_BP:487886_GO_0001996_POSITIVE_REGULATION_OF_HEART_RATE_BY_EPINEPHRINE_NOREPINEPHRINE","GO_BP","487886_GO_0001996_POSITIVE_REGULATION_OF_HEART_RATE_BY_EPINEPHRINE_NOREPINEPHRINE",5,-1.1578,0.29,0.4,1.4497,0.086,0.49,0.7067,0.81,1
"C7_Immunologic_signatures:C7_ALL_1499_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP","C7_Immunologic_signatures","C7_ALL_1499_GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP",198,-1.1578,0.17,0.25,0.7829,0.97,1,-0.8553,0.87,1
"C7_Immunologic_signatures:C7_ALL_1420_GSE360_CTRL_VS_L_DONOVANI_MAC_DN","C7_Immunologic_signatures","C7_ALL_1420_GSE360_CTRL_VS_L_DONOVANI_MAC_DN",199,-1.1577,0.17,0.25,0.9687,0.54,0.84,-0.8704,0.85,0.99
"KEGG_compound:C03460_2_METHYLPROP_2_ENOYL_COA_METHACRYLYL_COA_METHYLACRYLYL_COA","KEGG_compound","C03460_2_METHYLPROP_2_ENOYL_COA_METHACRYLYL_COA_METHYLACRYLYL_COA",7,-1.1577,0.29,0.44,0.8199,0.7,1,-1.5097,0.052,0.22
"C3_TF_targets:C3_TFT_413_V_MYB_Q3","C3_TF_targets","C3_TFT_413_V_MYB_Q3",246,-1.1576,0.14,0.25,-1.0546,0.31,0.64,-0.8876,0.81,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_2332_MATZUK_PREOVULATORY_FOLLICLE","C2_Chemical_and_genetic_perturbations","C2_CGP_2332_MATZUK_PREOVULATORY_FOLLICLE",10,-1.1575,0.29,0.33,-1.1309,0.3,0.88,-0.9848,0.44,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_1656_NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1656_NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP",18,-1.1575,0.26,0.33,1.6117,0.023,0.13,1.5941,0.033,0.43
"C7_Immunologic_signatures:C7_ALL_1737_GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1737_GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP",199,-1.1574,0.17,0.25,0.748,0.99,1,-1.0752,0.25,0.56
"C3_MicroRNA_targets:C3_MIR_120_CAGCTTT_MIR_320","C3_MicroRNA_targets","C3_MIR_120_CAGCTTT_MIR_320",252,-1.1573,0.14,0.36,1.0962,0.22,1,1.0383,0.35,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_203_BIOCARTA_STRESS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_203_BIOCARTA_STRESS_PATHWAY",25,-1.1573,0.25,0.39,-0.8805,0.63,1,-1.0654,0.35,0.67
"GO_BP:491821_GO_0006984_ER_NUCLEUS_SIGNALING_PATHWAY","GO_BP","491821_GO_0006984_ER_NUCLEUS_SIGNALING_PATHWAY",21,-1.1573,0.25,0.41,-1.1664,0.25,0.91,-1.1748,0.25,0.73
"GO_BP:753717_GO_1900746_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY","GO_BP","753717_GO_1900746_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY",8,-1.1573,0.31,0.41,-0.9323,0.56,1,1.2,0.24,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1478_HASLINGER_B_CLL_WITH_13Q14_DELETION","C2_Chemical_and_genetic_perturbations","C2_CGP_1478_HASLINGER_B_CLL_WITH_13Q14_DELETION",24,-1.1572,0.29,0.33,-1.1597,0.26,0.83,-1.3964,0.074,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_961_OHM_EMBRYONIC_CARCINOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_961_OHM_EMBRYONIC_CARCINOMA_DN",8,-1.1572,0.3,0.33,-0.4866,0.98,1,-1.1869,0.26,0.53
"WikiPathways:198879_WP61_DELTA_NOTCH_SIGNALING_PATHWAY","WikiPathways","198879_WP61_DELTA_NOTCH_SIGNALING_PATHWAY",83,-1.1571,0.23,0.35,-0.8037,0.86,1,-1.0466,0.35,0.65
"GO_BP:492838_GO_0030048_ACTIN_FILAMENT_BASED_MOVEMENT","GO_BP","492838_GO_0030048_ACTIN_FILAMENT_BASED_MOVEMENT",63,-1.1571,0.23,0.41,-1.0128,0.45,0.98,-0.7689,0.9,1
"GO_BP:512283_GO_0051402_NEURON_APOPTOTIC_PROCESS","GO_BP","512283_GO_0051402_NEURON_APOPTOTIC_PROCESS",38,-1.1571,0.25,0.41,0.9218,0.6,1,1.2247,0.17,0.71
"C4_Cancer_modules:C4_CM_212_MODULE_233","C4_Cancer_modules","C4_CM_212_MODULE_233",22,-1.157,0.26,0.33,0.554,0.99,1,-0.6971,0.9,1
"C7_Immunologic_signatures:C7_ALL_1245_GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP","C7_Immunologic_signatures","C7_ALL_1245_GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP",167,-1.157,0.19,0.25,1.1222,0.18,0.38,1.6353,0,0.0053
"OMIM_gene:OMIM107280_SERPIN_PEPTIDASE_INHIBITOR_CLADE_A_MEMBER_3_SERPINA3","OMIM_gene","OMIM107280_SERPIN_PEPTIDASE_INHIBITOR_CLADE_A_MEMBER_3_SERPINA3",7,-1.157,0.27,0.78,1.4334,0.093,1,1.2123,0.24,1
"REACTOME:106464_REACT_12005_PROLONGED_ERK_ACTIVATION_EVENTS","REACTOME","106464_REACT_12005_PROLONGED_ERK_ACTIVATION_EVENTS",27,-1.1568,0.24,0.45,0.6561,0.95,1,-0.879,0.66,0.96
"REACTOME:106060_REACT_1439_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION","REACTOME","106060_REACT_1439_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION",22,-1.1568,0.25,0.45,1.7484,0.0061,0.033,1.2085,0.18,0.83
"REACTOME:1127505_REACT_268299_VXPX_CARGO_TARGETING_TO_CILIUM","REACTOME","1127505_REACT_268299_VXPX_CARGO_TARGETING_TO_CILIUM",21,-1.1568,0.26,0.45,-1.0477,0.38,0.94,-1.0957,0.34,0.71
"GO_BP:504487_GO_0035303_REGULATION_OF_DEPHOSPHORYLATION","GO_BP","504487_GO_0035303_REGULATION_OF_DEPHOSPHORYLATION",125,-1.1566,0.21,0.41,-0.8112,0.9,1,0.874,0.76,0.96
"GO_MF:499385_GO_0022840_LEAK_CHANNEL_ACTIVITY","GO_MF","499385_GO_0022840_LEAK_CHANNEL_ACTIVITY",16,-1.1566,0.28,0.46,1.1908,0.23,0.72,-0.8285,0.72,0.95
"GO_MF:490025_GO_0004709_MAP_KINASE_KINASE_KINASE_ACTIVITY","GO_MF","490025_GO_0004709_MAP_KINASE_KINASE_KINASE_ACTIVITY",25,-1.1565,0.26,0.46,-1.5489,0.027,0.53,-1.0949,0.31,0.7
"GO_BP:512471_GO_0051593_RESPONSE_TO_FOLIC_ACID","GO_BP","512471_GO_0051593_RESPONSE_TO_FOLIC_ACID",10,-1.1564,0.27,0.41,-0.6385,0.9,1,-0.592,0.95,1
"GO_BP:508733_GO_0046473_PHOSPHATIDIC_ACID_METABOLIC_PROCESS","GO_BP","508733_GO_0046473_PHOSPHATIDIC_ACID_METABOLIC_PROCESS",29,-1.1563,0.25,0.41,0.7993,0.8,1,-1.1652,0.22,0.73
"C6_Oncogenic_signatures:C6_ALL_126_RB_P130_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_126_RB_P130_DN_V1_UP",119,-1.1563,0.2,0.24,-0.9427,0.6,0.83,-1.3317,0.037,0.32
"GO_MF:496712_GO_0016813_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES","GO_MF","496712_GO_0016813_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES",12,-1.1562,0.28,0.46,-1.4151,0.1,0.66,1.1408,0.27,0.79
"GO_BP:514193_GO_0060638_MESENCHYMAL_EPITHELIAL_CELL_SIGNALING","GO_BP","514193_GO_0060638_MESENCHYMAL_EPITHELIAL_CELL_SIGNALING",8,-1.1562,0.31,0.41,1.2795,0.2,0.7,1.6174,0.022,0.41
"GO_MF:499387_GO_0022842_NARROW_PORE_CHANNEL_ACTIVITY","GO_MF","499387_GO_0022842_NARROW_PORE_CHANNEL_ACTIVITY",16,-1.1562,0.28,0.46,1.1559,0.28,0.74,-0.813,0.74,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1_NAKAMURA_CANCER_MICROENVIRONMENT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1_NAKAMURA_CANCER_MICROENVIRONMENT_UP",22,-1.1562,0.26,0.33,-0.6722,0.93,1,-1.0194,0.44,0.73
"GO_MF:502775_GO_0033558_PROTEIN_DEACETYLASE_ACTIVITY","GO_MF","502775_GO_0033558_PROTEIN_DEACETYLASE_ACTIVITY",26,-1.156,0.25,0.46,-1.4169,0.073,0.66,-1.7642,0.0061,0.23
"GO_BP:487676_GO_0001780_NEUTROPHIL_HOMEOSTASIS","GO_BP","487676_GO_0001780_NEUTROPHIL_HOMEOSTASIS",7,-1.156,0.29,0.41,-0.7742,0.75,1,-1.2464,0.19,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_1875_GENTILE_UV_RESPONSE_CLUSTER_D1","C2_Chemical_and_genetic_perturbations","C2_CGP_1875_GENTILE_UV_RESPONSE_CLUSTER_D1",18,-1.156,0.27,0.33,1.0345,0.4,0.74,1.6491,0.027,0.32
"KEGG_compound:C00445_5_10_METHENYLTETRAHYDROFOLATE","KEGG_compound","C00445_5_10_METHENYLTETRAHYDROFOLATE",8,-1.1559,0.27,0.44,0.6004,0.93,1,-0.863,0.64,0.79
"GO_BP:518562_GO_0097012_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR","GO_BP","518562_GO_0097012_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR",6,-1.1558,0.31,0.41,-1.422,0.1,0.94,0.8585,0.63,0.97
"KEGG_compound:C00186__S_LACTATE_L_LACTATE_L_LACTIC_ACID","KEGG_compound","C00186__S_LACTATE_L_LACTATE_L_LACTIC_ACID",5,-1.1558,0.32,0.44,-0.8821,0.6,1,-0.7904,0.72,0.85
"C3_TF_targets:C3_TFT_226_V_EN1_01","C3_TF_targets","C3_TFT_226_V_EN1_01",107,-1.1557,0.22,0.26,-0.7969,0.89,1,0.9649,0.53,1
"C7_Immunologic_signatures:C7_ALL_999_GSE22886_TH1_VS_TH2_48H_ACT_UP","C7_Immunologic_signatures","C7_ALL_999_GSE22886_TH1_VS_TH2_48H_ACT_UP",192,-1.1556,0.18,0.25,-1.0618,0.32,1,1.2567,0.044,0.51
"GO_BP:513525_GO_0055092_STEROL_HOMEOSTASIS","GO_BP","513525_GO_0055092_STEROL_HOMEOSTASIS",63,-1.1556,0.24,0.41,-0.9456,0.56,1,1.1677,0.21,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2944_SENGUPTA_EBNA1_ANTICORRELATED","C2_Chemical_and_genetic_perturbations","C2_CGP_2944_SENGUPTA_EBNA1_ANTICORRELATED",161,-1.1556,0.19,0.33,-1.6772,0,0.37,-1.0783,0.27,0.66
"KEGG_pathway:HSA05214_GLIOMA","KEGG_pathway","HSA05214_GLIOMA",64,-1.1556,0.22,0.28,0.8028,0.83,1,-0.9132,0.64,0.84
"KEGG_module:HSA_M00032_LYSINE_DEGRADATION_LYSINE_SACCHAROPINE_ACETOACETYL_COA","KEGG_module","HSA_M00032_LYSINE_DEGRADATION_LYSINE_SACCHAROPINE_ACETOACETYL_COA",11,-1.1556,0.29,0.64,-0.7484,0.8,1,-1.7138,0.014,0.17
"C3_MicroRNA_targets:C3_MIR_174_AAGCACT_MIR_520F","C3_MicroRNA_targets","C3_MIR_174_AAGCACT_MIR_520F",235,-1.1555,0.15,0.36,0.7526,1,1,-1.088,0.2,1
"C1_Positional:C1_ALL_74_CHR15Q11","C1_Positional","C1_ALL_74_CHR15Q11",48,-1.1553,0.23,0.76,0.9268,0.59,0.82,1.013,0.42,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_2317_BOCHKIS_FOXA2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2317_BOCHKIS_FOXA2_TARGETS",419,-1.1553,0.12,0.33,0.9772,0.54,0.82,-0.9398,0.71,0.84
"C3_MicroRNA_targets:C3_MIR_66_CTTGTAT_MIR_381","C3_MicroRNA_targets","C3_MIR_66_CTTGTAT_MIR_381",204,-1.1552,0.17,0.36,0.9133,0.74,1,-0.9294,0.65,1
"REACTOME:161013_REACT_22426_ASPARAGINE_N_LINKED_GLYCOSYLATION","REACTOME","161013_REACT_22426_ASPARAGINE_N_LINKED_GLYCOSYLATION",118,-1.1552,0.19,0.45,0.837,0.87,0.97,-0.9299,0.63,0.93
"KEGG_module:HSA_M00079_KERATAN_SULFATE_DEGRADATION","KEGG_module","HSA_M00079_KERATAN_SULFATE_DEGRADATION",5,-1.1552,0.32,0.62,-0.7998,0.71,1,-0.984,0.47,0.79
"C4_Cancer_modules:C4_CM_314_MODULE_366","C4_Cancer_modules","C4_CM_314_MODULE_366",33,-1.1551,0.26,0.34,-1.0939,0.32,0.69,-1.0334,0.41,0.63
"GO_CC:487073_GO_0000780_CONDENSED_NUCLEAR_CHROMOSOME_CENTROMERIC_REGION","GO_CC","487073_GO_0000780_CONDENSED_NUCLEAR_CHROMOSOME_CENTROMERIC_REGION",16,-1.1551,0.28,0.5,-0.9561,0.53,0.9,-1.2745,0.15,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1365_POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1365_POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN",58,-1.1551,0.25,0.33,2.1387,0,0.0013,-0.843,0.74,0.93
"C3_TF_targets:C3_TFT_556_YYCATTCAWW_UNKNOWN","C3_TF_targets","C3_TFT_556_YYCATTCAWW_UNKNOWN",186,-1.155,0.18,0.26,-0.9194,0.67,0.93,-0.9449,0.6,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_1258_KENNY_CTNNB1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1258_KENNY_CTNNB1_TARGETS_UP",50,-1.155,0.23,0.33,0.9957,0.47,0.81,-0.8268,0.8,0.94
"KEGG_compound:C05141_ESTRIOL_1_3_5_10_ESTRATRIENE_3_16_ALPHA_17BETA_TRIOL","KEGG_compound","C05141_ESTRIOL_1_3_5_10_ESTRATRIENE_3_16_ALPHA_17BETA_TRIOL",26,-1.155,0.26,0.44,1.8502,0.0021,0.022,1.5237,0.028,0.15
"GO_CC:486914_GO_0000421_AUTOPHAGIC_VACUOLE_MEMBRANE","GO_CC","486914_GO_0000421_AUTOPHAGIC_VACUOLE_MEMBRANE",23,-1.1548,0.26,0.49,-0.9048,0.61,0.96,-0.5698,0.99,1
"C4_Cancer_modules:C4_CM_385_MODULE_484","C4_Cancer_modules","C4_CM_385_MODULE_484",42,-1.1547,0.27,0.34,1.3884,0.053,0.2,-1.4696,0.023,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_1673_WANG_SMARCE1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1673_WANG_SMARCE1_TARGETS_DN",364,-1.1547,0.12,0.33,1.5576,0,0.17,-0.9841,0.51,0.78
"WikiPathways:198799_WP363_WNT_SIGNALING_PATHWAY_NETPATH","WikiPathways","198799_WP363_WNT_SIGNALING_PATHWAY_NETPATH",114,-1.1546,0.21,0.35,-0.8169,0.89,1,-0.9245,0.64,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_1621_BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1621_BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP",388,-1.1546,0.13,0.33,0.9191,0.77,0.9,-0.8729,0.91,0.91
"REACTOME:105908_REACT_15428_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS_","REACTOME","105908_REACT_15428_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS_",20,-1.1544,0.28,0.45,2.005,0,0.0022,1.1017,0.32,0.95
"GO_BP:496349_GO_0034260_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY","GO_BP","496349_GO_0034260_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY",22,-1.1543,0.27,0.41,-0.834,0.7,1,-1.3372,0.096,0.61
"GO_MF:495461_GO_0015193_L_PROLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495461_GO_0015193_L_PROLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-1.1543,0.31,0.46,-1.2056,0.25,0.82,-0.5486,0.97,1
"GO_BP:488898_GO_0035810_POSITIVE_REGULATION_OF_URINE_VOLUME","GO_BP","488898_GO_0035810_POSITIVE_REGULATION_OF_URINE_VOLUME",13,-1.1542,0.27,0.41,1.1488,0.3,0.84,2.0222,0.0019,0.033
"GO_BP:495132_GO_0014060_REGULATION_OF_EPINEPHRINE_SECRETION","GO_BP","495132_GO_0014060_REGULATION_OF_EPINEPHRINE_SECRETION",7,-1.1542,0.3,0.41,-1.232,0.24,0.9,0.862,0.62,0.97
"REACTOME:161059_REACT_20524_SIGNAL_AMPLIFICATION","REACTOME","161059_REACT_20524_SIGNAL_AMPLIFICATION",31,-1.154,0.24,0.45,0.9921,0.45,0.76,0.9241,0.61,1
"WikiPathways:198805_WP45_G1_TO_S_CELL_CYCLE_CONTROL","WikiPathways","198805_WP45_G1_TO_S_CELL_CYCLE_CONTROL",68,-1.1539,0.23,0.35,0.8423,0.78,1,-1.593,0.0039,0.32
"GO_BP:515297_GO_0070365_HEPATOCYTE_DIFFERENTIATION","GO_BP","515297_GO_0070365_HEPATOCYTE_DIFFERENTIATION",9,-1.1539,0.29,0.41,-0.404,1,1,-1.6042,0.028,0.51
"GO_MF:490190_GO_0042605_PEPTIDE_ANTIGEN_BINDING","GO_MF","490190_GO_0042605_PEPTIDE_ANTIGEN_BINDING",31,-1.1538,0.25,0.46,-0.4617,1,1,0.5755,0.99,1
"C3_TF_targets:C3_TFT_264_V_ZIC3_01","C3_TF_targets","C3_TFT_264_V_ZIC3_01",247,-1.1538,0.17,0.26,-1.1497,0.13,0.45,-0.985,0.52,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_1865_MMS_MOUSE_LYMPH_HIGH_4HRS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1865_MMS_MOUSE_LYMPH_HIGH_4HRS_UP",36,-1.1538,0.25,0.33,1.3249,0.11,0.37,-0.8225,0.77,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_212_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_212_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN",72,-1.1538,0.22,0.33,1.6219,0.002,0.13,0.8838,0.73,1
"REACTOME:187085_REACT_25120_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING","REACTOME","187085_REACT_25120_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING",12,-1.1536,0.3,0.45,-0.883,0.61,1,-0.6628,0.9,1
"C3_MicroRNA_targets:C3_MIR_74_GTATTAT_MIR_369_3P","C3_MicroRNA_targets","C3_MIR_74_GTATTAT_MIR_369_3P",206,-1.1535,0.18,0.36,0.8255,0.94,1,-0.9313,0.67,1
"GO_BP:496105_GO_0015988_ENERGY_COUPLED_PROTON_TRANSMEMBRANE_TRANSPORT_AGAINST_ELECTROCHEMICAL_GRADIENT","GO_BP","496105_GO_0015988_ENERGY_COUPLED_PROTON_TRANSMEMBRANE_TRANSPORT_AGAINST_ELECTROCHEMICAL_GRADIENT",29,-1.1531,0.25,0.41,1.6423,0.021,0.25,0.8246,0.75,1
"KEGG_compound:C00352_D_GLUCOSAMINE_6_PHOSPHATE_D_GLUCOSAMINE_PHOSPHATE","KEGG_compound","C00352_D_GLUCOSAMINE_6_PHOSPHATE_D_GLUCOSAMINE_PHOSPHATE",10,-1.1529,0.29,0.44,-0.7069,0.86,1,-0.7887,0.75,0.85
"C7_Immunologic_signatures:C7_ALL_1694_GSE3982_BASOPHIL_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_1694_GSE3982_BASOPHIL_VS_TH1_DN",199,-1.1529,0.18,0.26,0.9156,0.72,0.99,-1.0297,0.36,0.66
"GO_BP:503571_GO_0034369_PLASMA_LIPOPROTEIN_PARTICLE_REMODELING","GO_BP","503571_GO_0034369_PLASMA_LIPOPROTEIN_PARTICLE_REMODELING",23,-1.1529,0.27,0.41,-0.4968,0.99,1,1.3355,0.11,0.65
"C3_TF_targets:C3_TFT_126_V_CREBP1_Q2","C3_TF_targets","C3_TFT_126_V_CREBP1_Q2",251,-1.1528,0.17,0.26,-0.8883,0.79,0.98,-0.837,0.92,0.98
"REACTOME:119545_REACT_19187_CLATHRIN_DERIVED_VESICLE_BUDDING","REACTOME","119545_REACT_19187_CLATHRIN_DERIVED_VESICLE_BUDDING",70,-1.152,0.23,0.45,0.9647,0.52,0.8,-0.6571,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_51_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_51_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN",327,-1.1519,0.15,0.34,-1.1631,0.1,0.83,-0.9635,0.57,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1889_KYNG_RESPONSE_TO_H2O2_VIA_ERCC6","C2_Chemical_and_genetic_perturbations","C2_CGP_1889_KYNG_RESPONSE_TO_H2O2_VIA_ERCC6",17,-1.1519,0.28,0.34,1.2302,0.16,0.46,-1.3159,0.13,0.41
"C0_Hallmark:H_ALL_5_HALLMARK_WNT_BETA_CATENIN_SIGNALING","C0_Hallmark","H_ALL_5_HALLMARK_WNT_BETA_CATENIN_SIGNALING",42,-1.1519,0.25,0.24,-0.9869,0.45,0.92,-1.3385,0.072,0.096
"GO_BP:499849_GO_0030510_REGULATION_OF_BMP_SIGNALING_PATHWAY","GO_BP","499849_GO_0030510_REGULATION_OF_BMP_SIGNALING_PATHWAY",72,-1.1519,0.23,0.41,0.8064,0.83,1,1.2378,0.12,0.71
"GO_BP:753006_GO_1900006_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT","GO_BP","753006_GO_1900006_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT",43,-1.1518,0.25,0.41,-1.2201,0.17,0.88,-1.1715,0.2,0.73
"GO_BP:511657_GO_0050685_POSITIVE_REGULATION_OF_MRNA_PROCESSING","GO_BP","511657_GO_0050685_POSITIVE_REGULATION_OF_MRNA_PROCESSING",34,-1.1518,0.27,0.41,-1.2258,0.18,0.88,-1.4816,0.044,0.53
"GO_BP:502150_GO_0032928_REGULATION_OF_SUPEROXIDE_ANION_GENERATION","GO_BP","502150_GO_0032928_REGULATION_OF_SUPEROXIDE_ANION_GENERATION",11,-1.1517,0.31,0.41,1.0372,0.39,0.96,0.7025,0.86,1
"GO_MF:490423_GO_0005158_INSULIN_RECEPTOR_BINDING","GO_MF","490423_GO_0005158_INSULIN_RECEPTOR_BINDING",32,-1.1515,0.25,0.47,0.9424,0.56,0.94,1.2363,0.15,0.69
"C3_MicroRNA_targets:C3_MIR_72_ATACTGT_MIR_144","C3_MicroRNA_targets","C3_MIR_72_ATACTGT_MIR_144",198,-1.1514,0.17,0.36,0.7296,1,1,-0.7747,0.97,1
"GO_BP:500918_GO_0031669_CELLULAR_RESPONSE_TO_NUTRIENT_LEVELS","GO_BP","500918_GO_0031669_CELLULAR_RESPONSE_TO_NUTRIENT_LEVELS",191,-1.1513,0.2,0.41,0.7365,0.99,1,1.0123,0.41,0.84
"GO_BP:493589_GO_0009416_RESPONSE_TO_LIGHT_STIMULUS","GO_BP","493589_GO_0009416_RESPONSE_TO_LIGHT_STIMULUS",332,-1.151,0.15,0.41,-0.9421,0.65,1,-1.057,0.29,0.81
"GO_BP:494533_GO_0010463_MESENCHYMAL_CELL_PROLIFERATION","GO_BP","494533_GO_0010463_MESENCHYMAL_CELL_PROLIFERATION",12,-1.151,0.29,0.41,-1.0674,0.38,0.96,1.1289,0.31,0.74
"GO_CC:849819_GO_0097481_NEURONAL_POSTSYNAPTIC_DENSITY","GO_CC","849819_GO_0097481_NEURONAL_POSTSYNAPTIC_DENSITY",20,-1.1509,0.27,0.5,-1.1178,0.32,0.75,1.4733,0.043,0.64
"GO_MF:496937_GO_0017137_RAB_GTPASE_BINDING","GO_MF","496937_GO_0017137_RAB_GTPASE_BINDING",87,-1.1508,0.21,0.47,-0.9258,0.63,0.97,0.9204,0.63,0.94
"GO_BP:983710_GO_1902991_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS","GO_BP","983710_GO_1902991_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS",12,-1.1507,0.29,0.41,0.9496,0.52,1,-0.8636,0.65,0.95
"C7_Immunologic_signatures:C7_ALL_1569_GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1569_GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP",197,-1.1505,0.19,0.26,1.4009,0.0048,0.037,-1.1369,0.15,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_1097_GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1097_GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP",69,-1.1505,0.24,0.34,1.4245,0.031,0.28,1.0878,0.3,0.87
"GO_BP:495854_GO_0015721_BILE_ACID_AND_BILE_SALT_TRANSPORT","GO_BP","495854_GO_0015721_BILE_ACID_AND_BILE_SALT_TRANSPORT",26,-1.1505,0.26,0.42,-1.23,0.18,0.89,1.0878,0.33,0.77
"C1_Positional:C1_ALL_141_CHR11P12","C1_Positional","C1_ALL_141_CHR11P12",13,-1.1504,0.27,0.77,0.4275,1,1,0.7078,0.88,0.96
"C4_Cancer_gene_neighborhoods:C4_CGN_347_GNF2_DNM1","C4_Cancer_gene_neighborhoods","C4_CGN_347_GNF2_DNM1",72,-1.1504,0.24,0.42,-1.2108,0.15,0.66,-1.0062,0.44,0.84
"GO_BP:1184422_GO_1903896_POSITIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE","GO_BP","1184422_GO_1903896_POSITIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE",8,-1.1502,0.31,0.42,-1.2528,0.19,0.91,-1.5616,0.048,0.52
"KEGG_compound:C06754_CHLOROACETALDEHYDE_2_CHLOROETHANAL","KEGG_compound","C06754_CHLOROACETALDEHYDE_2_CHLOROETHANAL",6,-1.1502,0.32,0.44,-0.7784,0.71,1,0.6279,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1951_BROWNE_HCMV_INFECTION_24HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1951_BROWNE_HCMV_INFECTION_24HR_UP",147,-1.1501,0.22,0.34,-0.9883,0.47,1,-1.0756,0.29,0.66
"C4_Cancer_modules:C4_CM_236_MODULE_262","C4_Cancer_modules","C4_CM_236_MODULE_262",14,-1.1501,0.29,0.34,1.4104,0.093,0.18,1.9981,0,0.032
"GO_BP:502562_GO_0033344_CHOLESTEROL_EFFLUX","GO_BP","502562_GO_0033344_CHOLESTEROL_EFFLUX",26,-1.1501,0.26,0.42,-1.179,0.23,0.91,1.6782,0.0098,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_2155_LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2155_LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP",74,-1.15,0.23,0.34,-0.8631,0.72,1,-0.8423,0.77,0.93
"REACTOME:645291_REACT_121036_THE_ACTIVATION_OF_ARYLSULFATASES","REACTOME","645291_REACT_121036_THE_ACTIVATION_OF_ARYLSULFATASES",13,-1.15,0.28,0.46,-0.6203,0.92,1,-1.1535,0.28,0.65
"C4_Cancer_gene_neighborhoods:C4_CGN_32_MORF_PSMF1","C4_Cancer_gene_neighborhoods","C4_CGN_32_MORF_PSMF1",163,-1.15,0.19,0.42,-1.188,0.14,0.68,-1.1031,0.23,0.62
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_14_BIOCARTA_ACE2_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_14_BIOCARTA_ACE2_PATHWAY",13,-1.15,0.29,0.4,1.1468,0.27,0.67,1.0333,0.41,1
"GO_CC:490884_GO_0005876_SPINDLE_MICROTUBULE","GO_CC","490884_GO_0005876_SPINDLE_MICROTUBULE",55,-1.15,0.24,0.5,0.7317,0.92,0.99,-1.2278,0.12,0.74
"C6_Oncogenic_signatures:C6_ALL_98_ESC_V6_5_UP_EARLY_V1_UP","C6_Oncogenic_signatures","C6_ALL_98_ESC_V6_5_UP_EARLY_V1_UP",156,-1.1499,0.2,0.25,-1.3167,0.041,0.4,-1.2219,0.081,0.34
"C7_Immunologic_signatures:C7_ALL_316_GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN","C7_Immunologic_signatures","C7_ALL_316_GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN",200,-1.1498,0.19,0.27,1.2865,0.029,0.11,-0.957,0.58,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_3155_MAEKAWA_ATF2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3155_MAEKAWA_ATF2_TARGETS",24,-1.1497,0.27,0.34,-1.0399,0.38,0.97,0.9852,0.48,0.97
"C3_MicroRNA_targets:C3_MIR_42_ACAGGGT_MIR_10A_MIR_10B","C3_MicroRNA_targets","C3_MIR_42_ACAGGGT_MIR_10A_MIR_10B",122,-1.1494,0.21,0.36,-1.0637,0.34,1,-0.8572,0.81,1
"C3_TF_targets:C3_TFT_171_V_PPARA_01","C3_TF_targets","C3_TFT_171_V_PPARA_01",37,-1.1494,0.24,0.27,0.7891,0.83,1,-0.7308,0.91,1
"GO_BP:495227_GO_0014831_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION","GO_BP","495227_GO_0014831_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION",5,-1.1493,0.31,0.42,-0.9973,0.49,0.99,0.8145,0.68,1
"GO_BP:491056_GO_0006071_GLYCEROL_METABOLIC_PROCESS","GO_BP","491056_GO_0006071_GLYCEROL_METABOLIC_PROCESS",20,-1.1491,0.28,0.42,0.6534,0.94,1,-1.1127,0.33,0.76
"C4_Cancer_gene_neighborhoods:C4_CGN_128_MORF_MAP2K7","C4_Cancer_gene_neighborhoods","C4_CGN_128_MORF_MAP2K7",175,-1.1489,0.18,0.42,-1.1096,0.22,0.72,1.3222,0.021,0.28
"C6_Oncogenic_signatures:C6_ALL_59_SRC_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_59_SRC_UP_V1_DN",164,-1.1489,0.19,0.25,0.9726,0.52,0.91,-0.8387,0.91,0.9
"GO_BP:516709_GO_0071786_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION","GO_BP","516709_GO_0071786_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION",9,-1.1487,0.29,0.42,0.621,0.92,1,-0.9731,0.48,0.88
"C4_Cancer_modules:C4_CM_296_MODULE_340","C4_Cancer_modules","C4_CM_296_MODULE_340",26,-1.1485,0.28,0.34,-0.9715,0.49,0.84,-0.809,0.74,0.99
"GO_BP:503569_GO_0034367_MACROMOLECULAR_COMPLEX_REMODELING","GO_BP","503569_GO_0034367_MACROMOLECULAR_COMPLEX_REMODELING",23,-1.1485,0.27,0.42,-0.4855,1,1,1.3314,0.097,0.64
"KEGG_reaction:R00703__S_LACTATE_NAD_OXIDOREDUCTASE_S_LACTATE_NAD_PYRUVATE_NADH_H_","KEGG_reaction","R00703__S_LACTATE_NAD_OXIDOREDUCTASE_S_LACTATE_NAD_PYRUVATE_NADH_H_",5,-1.1484,0.31,0.43,-0.8767,0.61,0.96,-0.8226,0.68,0.84
"GO_MF:515424_GO_0070492_OLIGOSACCHARIDE_BINDING","GO_MF","515424_GO_0070492_OLIGOSACCHARIDE_BINDING",8,-1.1483,0.29,0.47,-0.902,0.59,0.99,-1.2437,0.24,0.6
"REACTOME:161039_REACT_20625_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE","REACTOME","161039_REACT_20625_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE",7,-1.1483,0.31,0.46,0.6836,0.87,1,-0.6125,0.93,1
"GO_MF:515815_GO_0070888_E_BOX_BINDING","GO_MF","515815_GO_0070888_E_BOX_BINDING",32,-1.1483,0.26,0.47,0.8073,0.78,1,-1.1079,0.29,0.7
"KEGG_enzyme:2.7.1.107_DIACYLGLYCEROL_KINASE_ATP_DIGLYCERIDE_KINASE_AMBIGUOUS_1_2_DIACYLGLYCEROL_KINASE_PHOSPHORYLATING_AMBIGUOUS_1_2_DIACYLGLYCEROL_KINASE_AMBIGUOUS_SN_1_2_DIACYLGLYCEROL_KINASE_AMBIGUOUS_DG_KINASE_AMBIGUOUS_DGK_AMBIGUOUS_ATP_DIACYLGLYCEROL_PHOSPHOTRANSFERASE_ARACHIDONOYL_SPECIFIC_DIACYLGLYCEROL_KINASE_DIACYLGLYCEROL_ATP_KINASE_ATP_1_2_DIACYLGLYCEROL_3_PHOSPHOTRANSFERASE_DIACYLGLYCEROL_KINASE_ATP_DEPENDENT_","KEGG_enzyme","2.7.1.107_DIACYLGLYCEROL_KINASE_ATP_DIGLYCERIDE_KINASE_AMBIGUOUS_1_2_DIACYLGLYCEROL_KINASE_PHOSPHORYLATING_AMBIGUOUS_1_2_DIACYLGLYCEROL_KINASE_AMBIGUOUS_SN_1_2_DIACYLGLYCEROL_KINASE_AMBIGUOUS_DG_KINASE_AMBIGUOUS_DGK_AMBIGUOUS_ATP_DIACYLGLYCEROL_PHOSPHOTRANSFERASE_ARACHIDONOYL_SPECIFIC_DIACYLGLYCEROL_KINASE_DIACYLGLYCEROL_ATP_KINASE_ATP_1_2_DIACYLGLYCEROL_3_PHOSPHOTRANSFERASE_DIACYLGLYCEROL_KINASE_ATP_DEPENDENT_",10,-1.1482,0.3,0.54,-1.7115,0.013,0.078,-1.0797,0.37,0.66
"GO_BP:518990_GO_2000344_POSITIVE_REGULATION_OF_ACROSOME_REACTION","GO_BP","518990_GO_2000344_POSITIVE_REGULATION_OF_ACROSOME_REACTION",5,-1.1482,0.3,0.42,-1.3483,0.12,0.93,-1.4084,0.096,0.57
"GO_BP:1025340_GO_0098732_MACROMOLECULE_DEACYLATION","GO_BP","1025340_GO_0098732_MACROMOLECULE_DEACYLATION",47,-1.1481,0.26,0.42,-1.205,0.18,0.89,-1.4778,0.03,0.54
"GO_MF:489342_GO_0003841_1_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY","GO_MF","489342_GO_0003841_1_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY",11,-1.1481,0.29,0.47,-0.5894,0.95,1,-1.0346,0.4,0.76
"GO_CC:503906_GO_0034706_SODIUM_CHANNEL_COMPLEX","GO_CC","503906_GO_0034706_SODIUM_CHANNEL_COMPLEX",17,-1.1481,0.29,0.51,-0.9538,0.51,0.88,1.0379,0.4,0.97
"GO_BP:512374_GO_0051496_POSITIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY","GO_BP","512374_GO_0051496_POSITIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY",40,-1.148,0.27,0.42,-1.2901,0.11,0.88,0.8828,0.65,0.96
"GO_BP:752262_GO_0072698_PROTEIN_LOCALIZATION_TO_MICROTUBULE_CYTOSKELETON","GO_BP","752262_GO_0072698_PROTEIN_LOCALIZATION_TO_MICROTUBULE_CYTOSKELETON",16,-1.1479,0.29,0.42,-0.8339,0.73,1,-0.7242,0.84,0.99
"C3_TF_targets:C3_TFT_139_ATGGYGGA_UNKNOWN","C3_TF_targets","C3_TFT_139_ATGGYGGA_UNKNOWN",101,-1.1478,0.23,0.27,-0.7867,0.9,1,-0.9336,0.61,0.88
"GO_BP:518561_GO_0097011_CELLULAR_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS","GO_BP","518561_GO_0097011_CELLULAR_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS",6,-1.1477,0.31,0.42,-1.4143,0.096,0.95,0.8626,0.65,0.97
"GO_BP:507449_GO_0045048_PROTEIN_INSERTION_INTO_ER_MEMBRANE","GO_BP","507449_GO_0045048_PROTEIN_INSERTION_INTO_ER_MEMBRANE",5,-1.1476,0.3,0.42,0.8397,0.66,1,-0.6837,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_137_DOANE_BREAST_CANCER_CLASSES_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_137_DOANE_BREAST_CANCER_CLASSES_UP",71,-1.1475,0.25,0.34,0.9094,0.65,0.91,-0.8722,0.71,0.91
"C7_Immunologic_signatures:C7_ALL_350_GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_350_GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN",200,-1.1475,0.16,0.27,0.8391,0.89,1,-1.3715,0.016,0.08
"GO_BP:849986_GO_1902285_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE","GO_BP","849986_GO_1902285_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE",6,-1.1475,0.32,0.42,-1.0222,0.43,0.97,0.8584,0.64,0.97
"GO_BP:812238_GO_1902115_REGULATION_OF_ORGANELLE_ASSEMBLY","GO_BP","812238_GO_1902115_REGULATION_OF_ORGANELLE_ASSEMBLY",111,-1.1474,0.23,0.42,0.6082,1,1,-1.1266,0.22,0.75
"GO_MF:489796_GO_0046030_INOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY","GO_MF","489796_GO_0046030_INOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY",8,-1.1474,0.32,0.47,-1.0044,0.44,0.9,0.6816,0.88,1
"GO_BP:752846_GO_0097345_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION","GO_BP","752846_GO_0097345_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION",10,-1.1473,0.3,0.42,1.1201,0.35,0.88,-1.3423,0.12,0.61
"C3_TF_targets:C3_TFT_162_V_STAT3_01","C3_TF_targets","C3_TFT_162_V_STAT3_01",21,-1.1473,0.28,0.27,0.9647,0.52,1,-1.1957,0.21,0.36
"C4_Cancer_modules:C4_CM_410_MODULE_530","C4_Cancer_modules","C4_CM_410_MODULE_530",16,-1.1472,0.28,0.35,1.141,0.3,0.47,0.597,0.96,1
"GO_MF:500796_GO_0031545_PEPTIDYL_PROLINE_4_DIOXYGENASE_ACTIVITY","GO_MF","500796_GO_0031545_PEPTIDYL_PROLINE_4_DIOXYGENASE_ACTIVITY",9,-1.1471,0.29,0.47,-1.0266,0.45,0.88,-1.4514,0.073,0.43
"GO_BP:491032_GO_0006047_UDP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS","GO_BP","491032_GO_0006047_UDP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS",10,-1.147,0.29,0.42,-0.7332,0.84,1,-0.4582,1,1
"GO_BP:500783_GO_0031532_ACTIN_CYTOSKELETON_REORGANIZATION","GO_BP","500783_GO_0031532_ACTIN_CYTOSKELETON_REORGANIZATION",47,-1.147,0.24,0.42,-1.0803,0.32,0.95,-0.8053,0.81,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1137_AMIT_EGF_RESPONSE_240_HELA","C2_Chemical_and_genetic_perturbations","C2_CGP_1137_AMIT_EGF_RESPONSE_240_HELA",60,-1.147,0.23,0.34,-0.891,0.66,1,1.2075,0.17,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2720_BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2720_BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN",50,-1.1469,0.24,0.34,0.7554,0.89,1,-1.341,0.063,0.4
"GO_MF:501366_GO_0032129_HISTONE_DEACETYLASE_ACTIVITY_H3_K9_SPECIFIC_","GO_MF","501366_GO_0032129_HISTONE_DEACETYLASE_ACTIVITY_H3_K9_SPECIFIC_",13,-1.1468,0.29,0.47,-1.2659,0.18,0.83,-1.7742,0.008,0.25
"GO_MF:486804_GO_0000287_MAGNESIUM_ION_BINDING","GO_MF","486804_GO_0000287_MAGNESIUM_ION_BINDING",191,-1.1467,0.19,0.47,-0.7291,0.99,1,-1.5058,0.0022,0.41
"GO_MF:983693_GO_0098632_PROTEIN_BINDING_INVOLVED_IN_CELL_CELL_ADHESION","GO_MF","983693_GO_0098632_PROTEIN_BINDING_INVOLVED_IN_CELL_CELL_ADHESION",10,-1.1466,0.29,0.47,-0.7772,0.76,1,-0.8392,0.69,0.94
"GO_BP:506539_GO_0043508_NEGATIVE_REGULATION_OF_JUN_KINASE_ACTIVITY","GO_BP","506539_GO_0043508_NEGATIVE_REGULATION_OF_JUN_KINASE_ACTIVITY",14,-1.1465,0.31,0.42,0.8415,0.69,1,0.9308,0.56,0.92
"GO_MF:490406_GO_0005143_INTERLEUKIN_12_RECEPTOR_BINDING","GO_MF","490406_GO_0005143_INTERLEUKIN_12_RECEPTOR_BINDING",5,-1.1464,0.32,0.47,-1.253,0.2,0.84,-1.2357,0.23,0.58
"C3_MicroRNA_targets:C3_MIR_170_GTTAAAG_MIR_302B","C3_MicroRNA_targets","C3_MIR_170_GTTAAAG_MIR_302B",69,-1.1464,0.24,0.37,0.975,0.53,1,1.036,0.39,1
"GO_BP:507484_GO_0045084_POSITIVE_REGULATION_OF_INTERLEUKIN_12_BIOSYNTHETIC_PROCESS","GO_BP","507484_GO_0045084_POSITIVE_REGULATION_OF_INTERLEUKIN_12_BIOSYNTHETIC_PROCESS",7,-1.1463,0.29,0.42,-1.1507,0.3,0.92,-0.8703,0.6,0.95
"GO_BP:1129553_GO_1903729_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION","GO_BP","1129553_GO_1903729_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION",62,-1.1463,0.23,0.42,0.8982,0.66,1,0.9672,0.52,0.89
"C4_Cancer_gene_neighborhoods:C4_CGN_149_MORF_PPP2R5B","C4_Cancer_gene_neighborhoods","C4_CGN_149_MORF_PPP2R5B",169,-1.1463,0.2,0.42,-1.3083,0.042,0.54,0.8807,0.79,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_700_LUI_THYROID_CANCER_CLUSTER_4","C2_Chemical_and_genetic_perturbations","C2_CGP_700_LUI_THYROID_CANCER_CLUSTER_4",12,-1.1462,0.29,0.35,-1.3265,0.13,0.69,0.708,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1808_TAKAO_RESPONSE_TO_UVB_RADIATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1808_TAKAO_RESPONSE_TO_UVB_RADIATION_DN",98,-1.1462,0.23,0.34,1.569,0,0.16,0.7661,0.94,1
"REACTOME:106099_REACT_1946_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING","REACTOME","106099_REACT_1946_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING",17,-1.1462,0.27,0.46,1.0028,0.46,0.75,-1.1082,0.32,0.7
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_71_BIOCARTA_FAS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_71_BIOCARTA_FAS_PATHWAY",30,-1.146,0.25,0.4,-0.9086,0.63,1,-1.2914,0.13,0.51
"C7_Immunologic_signatures:C7_ALL_731_GSE17721_0_5H_VS_4H_PAM3CSK4_BMDM_UP","C7_Immunologic_signatures","C7_ALL_731_GSE17721_0_5H_VS_4H_PAM3CSK4_BMDM_UP",199,-1.146,0.19,0.27,1.3784,0.0045,0.046,-1.1137,0.18,0.46
"C6_Oncogenic_signatures:C6_ALL_164_TBK1_DN_48HRS_DN","C6_Oncogenic_signatures","C6_ALL_164_TBK1_DN_48HRS_DN",50,-1.1458,0.25,0.25,1.3121,0.083,0.36,-1.209,0.16,0.37
"GO_BP:504467_GO_0035283_CENTRAL_NERVOUS_SYSTEM_SEGMENTATION","GO_BP","504467_GO_0035283_CENTRAL_NERVOUS_SYSTEM_SEGMENTATION",5,-1.1458,0.31,0.42,-0.7351,0.79,1,0.9978,0.46,0.86
"KEGG_compound:C05337_CHENODEOXYCHOLOYL_COA_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLANOYL_COA","KEGG_compound","C05337_CHENODEOXYCHOLOYL_COA_3ALPHA_7ALPHA_DIHYDROXY_5BETA_CHOLANOYL_COA",7,-1.1456,0.31,0.45,1.0516,0.41,1,-1.0789,0.4,0.55
"C7_Immunologic_signatures:C7_ALL_1575_GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP","C7_Immunologic_signatures","C7_ALL_1575_GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP",197,-1.1456,0.18,0.27,-0.8008,0.93,1,-1.2515,0.069,0.19
"GO_BP:491542_GO_0006654_PHOSPHATIDIC_ACID_BIOSYNTHETIC_PROCESS","GO_BP","491542_GO_0006654_PHOSPHATIDIC_ACID_BIOSYNTHETIC_PROCESS",29,-1.1455,0.27,0.42,0.7896,0.79,1,-1.167,0.22,0.73
"C7_Immunologic_signatures:C7_ALL_891_GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP","C7_Immunologic_signatures","C7_ALL_891_GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP",197,-1.1454,0.19,0.27,-0.7438,0.99,1,-1.1614,0.12,0.35
"GO_BP:506391_GO_0043331_RESPONSE_TO_DSRNA","GO_BP","506391_GO_0043331_RESPONSE_TO_DSRNA",61,-1.1454,0.24,0.42,1.0247,0.39,0.97,-1.1244,0.22,0.75
"C3_TF_targets:C3_TFT_371_V_TFIIA_Q6","C3_TF_targets","C3_TFT_371_V_TFIIA_Q6",243,-1.1452,0.17,0.27,-1.3107,0.016,0.23,-1.0543,0.28,0.62
"GO_BP:492032_GO_0007252_I_KAPPAB_PHOSPHORYLATION","GO_BP","492032_GO_0007252_I_KAPPAB_PHOSPHORYLATION",12,-1.1452,0.31,0.42,-0.7299,0.82,1,-0.9025,0.58,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_3213_RAFFEL_VEGFA_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3213_RAFFEL_VEGFA_TARGETS_DN",5,-1.1451,0.32,0.35,-0.6435,0.87,1,1.684,0.012,0.27
"C7_Immunologic_signatures:C7_ALL_135_GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP","C7_Immunologic_signatures","C7_ALL_135_GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP",191,-1.1451,0.19,0.28,-0.6641,1,1,-1.0998,0.24,0.5
"KEGG_reaction:R03104_3_MERCAPTOLACTATE_NAD_OXIDOREDUCTASE_3_MERCAPTOLACTATE_NAD_MERCAPTOPYRUVATE_NADH_H_","KEGG_reaction","R03104_3_MERCAPTOLACTATE_NAD_OXIDOREDUCTASE_3_MERCAPTOLACTATE_NAD_MERCAPTOPYRUVATE_NADH_H_",5,-1.1449,0.33,0.43,-0.8652,0.63,0.97,-0.8332,0.63,0.83
"KEGG_module:HSA_M00073_N_GLYCAN_PRECURSOR_TRIMMING","KEGG_module","HSA_M00073_N_GLYCAN_PRECURSOR_TRIMMING",6,-1.1449,0.3,0.62,-1.0229,0.45,1,-0.9853,0.47,0.82
"C7_Immunologic_signatures:C7_ALL_403_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_403_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP",197,-1.1448,0.19,0.28,-0.9194,0.68,1,-1.2185,0.071,0.24
"C2_Chemical_and_genetic_perturbations:C2_CGP_1458_CROMER_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1458_CROMER_METASTASIS_UP",79,-1.1447,0.24,0.35,0.8401,0.82,0.98,-1.2651,0.097,0.46
"C1_Positional:C1_ALL_122_CHR5Q35","C1_Positional","C1_ALL_122_CHR5Q35",114,-1.1447,0.23,0.78,-0.8638,0.76,0.98,-0.7657,0.94,1
"KEGG_module:HSA_M00147_NADH_DEHYDROGENASE_UBIQUINONE_1_BETA_SUBCOMPLEX","KEGG_module","HSA_M00147_NADH_DEHYDROGENASE_UBIQUINONE_1_BETA_SUBCOMPLEX",14,-1.1446,0.3,0.61,1.9713,0.002,0.0064,0.5646,0.97,1
"C7_Immunologic_signatures:C7_ALL_883_GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP","C7_Immunologic_signatures","C7_ALL_883_GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP",195,-1.1446,0.18,0.28,0.8785,0.83,1,-0.9947,0.45,0.73
"KEGG_compound:C00780_SEROTONIN_3_2_AMINOETHYL_1H_INDOL_5_OL_5_HYDROXYTRYPTAMINE_ENTERAMINE","KEGG_compound","C00780_SEROTONIN_3_2_AMINOETHYL_1H_INDOL_5_OL_5_HYDROXYTRYPTAMINE_ENTERAMINE",8,-1.1446,0.31,0.45,-0.8195,0.71,1,-0.9521,0.53,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_969_GALIE_TUMOR_STEMNESS_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_969_GALIE_TUMOR_STEMNESS_GENES",5,-1.1446,0.32,0.35,-0.6855,0.82,1,1.118,0.37,0.85
"GO_BP:518676_GO_2000027_REGULATION_OF_ORGAN_MORPHOGENESIS","GO_BP","518676_GO_2000027_REGULATION_OF_ORGAN_MORPHOGENESIS",151,-1.1446,0.2,0.42,1.0283,0.38,0.97,1.3152,0.032,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_1236_DING_LUNG_CANCER_MUTATED_FREQUENTLY","C2_Chemical_and_genetic_perturbations","C2_CGP_1236_DING_LUNG_CANCER_MUTATED_FREQUENTLY",12,-1.1445,0.29,0.35,-1.3019,0.15,0.69,-1.217,0.21,0.5
"REACTOME:106265_REACT_522_PURINE_METABOLISM","REACTOME","106265_REACT_522_PURINE_METABOLISM",33,-1.1444,0.27,0.47,0.4125,1,1,-0.7127,0.91,1
"GO_MF:490024_GO_0004708_MAP_KINASE_KINASE_ACTIVITY","GO_MF","490024_GO_0004708_MAP_KINASE_KINASE_ACTIVITY",22,-1.1444,0.27,0.47,-1.0801,0.34,0.85,-1.2465,0.17,0.6
"C1_Positional:C1_ALL_92_CHR3Q26","C1_Positional","C1_ALL_92_CHR3Q26",62,-1.1443,0.24,0.77,-0.8713,0.73,1,1.1667,0.18,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_113_THUM_SYSTOLIC_HEART_FAILURE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_113_THUM_SYSTOLIC_HEART_FAILURE_DN",234,-1.1442,0.17,0.35,-0.7992,0.96,1,-1.0088,0.43,0.74
"GO_BP:504567_GO_0035383_THIOESTER_METABOLIC_PROCESS","GO_BP","504567_GO_0035383_THIOESTER_METABOLIC_PROCESS",63,-1.1442,0.24,0.42,-0.8385,0.77,1,-1.725,0.002,0.64
"GO_BP:494871_GO_0010807_REGULATION_OF_SYNAPTIC_VESICLE_PRIMING","GO_BP","494871_GO_0010807_REGULATION_OF_SYNAPTIC_VESICLE_PRIMING",5,-1.144,0.32,0.42,-1.3638,0.12,0.97,0.9274,0.55,0.92
"GO_BP:752161_GO_0061418_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA","GO_BP","752161_GO_0061418_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA",29,-1.1439,0.27,0.42,1.2065,0.2,0.78,-0.6378,0.97,1
"C3_TF_targets:C3_TFT_73_ACCTGTTG_UNKNOWN","C3_TF_targets","C3_TFT_73_ACCTGTTG_UNKNOWN",149,-1.1439,0.2,0.28,-1.0502,0.34,0.64,-0.9685,0.55,0.81
"GO_BP:508397_GO_0046101_HYPOXANTHINE_BIOSYNTHETIC_PROCESS","GO_BP","508397_GO_0046101_HYPOXANTHINE_BIOSYNTHETIC_PROCESS",5,-1.1438,0.34,0.42,0.6938,0.87,1,-1.1796,0.28,0.73
"GO_BP:514915_GO_0061370_TESTOSTERONE_BIOSYNTHETIC_PROCESS","GO_BP","514915_GO_0061370_TESTOSTERONE_BIOSYNTHETIC_PROCESS",5,-1.1437,0.32,0.42,-0.7449,0.76,1,1.0921,0.39,0.77
"C3_MicroRNA_targets:C3_MIR_137_GGCACAT_MIR_455","C3_MicroRNA_targets","C3_MIR_137_GGCACAT_MIR_455",57,-1.1437,0.26,0.37,-0.9216,0.61,1,-0.9812,0.46,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2328_MATZUK_CENTRAL_FOR_FEMALE_FERTILITY","C2_Chemical_and_genetic_perturbations","C2_CGP_2328_MATZUK_CENTRAL_FOR_FEMALE_FERTILITY",28,-1.1437,0.27,0.35,-1.6574,0.013,0.36,-0.8277,0.75,0.94
"C7_Immunologic_signatures:C7_ALL_424_GSE15930_STIM_VS_STIM_AND_IL_12_72H_CD8_T_CELL_DN","C7_Immunologic_signatures","C7_ALL_424_GSE15930_STIM_VS_STIM_AND_IL_12_72H_CD8_T_CELL_DN",195,-1.1436,0.2,0.28,1.2706,0.032,0.13,0.958,0.55,1
"REACTOME:119520_REACT_19259_SEMA4D_IN_SEMAPHORIN_SIGNALING","REACTOME","119520_REACT_19259_SEMA4D_IN_SEMAPHORIN_SIGNALING",27,-1.1435,0.27,0.47,-0.7845,0.8,1,-0.8455,0.71,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_484_MISSIAGLIA_REGULATED_BY_METHYLATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_484_MISSIAGLIA_REGULATED_BY_METHYLATION_DN",120,-1.1435,0.23,0.35,0.9486,0.57,0.87,-1.4341,0.0019,0.34
"C7_Immunologic_signatures:C7_ALL_1426_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN","C7_Immunologic_signatures","C7_ALL_1426_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN",200,-1.1432,0.18,0.28,-0.776,0.98,1,-0.9017,0.74,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2339_CHUNG_BLISTER_CYTOTOXICITY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2339_CHUNG_BLISTER_CYTOTOXICITY_UP",133,-1.1431,0.21,0.35,1.6684,0,0.1,1.1251,0.19,0.85
"GO_BP:504639_GO_0035455_RESPONSE_TO_INTERFERON_ALPHA","GO_BP","504639_GO_0035455_RESPONSE_TO_INTERFERON_ALPHA",17,-1.1431,0.28,0.43,1.5605,0.032,0.34,-0.6288,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3119_KANG_AR_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3119_KANG_AR_TARGETS_DN",18,-1.1431,0.29,0.35,0.6973,0.89,1,1.3829,0.089,0.54
"C7_Immunologic_signatures:C7_ALL_1239_GSE2826_WT_VS_XID_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1239_GSE2826_WT_VS_XID_BCELL_UP",193,-1.143,0.18,0.28,1.141,0.16,0.34,-0.9,0.75,0.95
"REACTOME:106165_REACT_11235_TRANS_GOLGI_NETWORK_VESICLE_BUDDING","REACTOME","106165_REACT_11235_TRANS_GOLGI_NETWORK_VESICLE_BUDDING",70,-1.143,0.23,0.47,0.9569,0.53,0.82,-0.6503,0.99,1
"GO_MF:496051_GO_0015929_HEXOSAMINIDASE_ACTIVITY","GO_MF","496051_GO_0015929_HEXOSAMINIDASE_ACTIVITY",15,-1.1429,0.29,0.47,-0.6648,0.89,1,0.4876,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3012_BROWNE_HCMV_INFECTION_30MIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3012_BROWNE_HCMV_INFECTION_30MIN_DN",150,-1.1429,0.22,0.35,0.9456,0.62,0.87,-0.9913,0.49,0.77
"GO_BP:505773_GO_0042659_REGULATION_OF_CELL_FATE_SPECIFICATION","GO_BP","505773_GO_0042659_REGULATION_OF_CELL_FATE_SPECIFICATION",18,-1.1429,0.27,0.43,-1.0839,0.34,0.96,-0.9981,0.44,0.85
"GO_MF:499877_GO_0030551_CYCLIC_NUCLEOTIDE_BINDING","GO_MF","499877_GO_0030551_CYCLIC_NUCLEOTIDE_BINDING",38,-1.1428,0.27,0.47,0.9762,0.49,0.9,-0.9864,0.44,0.79
"GO_BP:491527_GO_0006637_ACYL_COA_METABOLIC_PROCESS","GO_BP","491527_GO_0006637_ACYL_COA_METABOLIC_PROCESS",63,-1.1428,0.24,0.43,-0.8301,0.79,1,-1.7094,0,0.64
"GO_MF:499433_GO_0042608_T_CELL_RECEPTOR_BINDING","GO_MF","499433_GO_0042608_T_CELL_RECEPTOR_BINDING",7,-1.1428,0.32,0.47,1.1567,0.31,0.74,-1.6513,0.01,0.33
"GO_MF:490528_GO_0005328_NEUROTRANSMITTER_SODIUM_SYMPORTER_ACTIVITY","GO_MF","490528_GO_0005328_NEUROTRANSMITTER_SODIUM_SYMPORTER_ACTIVITY",18,-1.1427,0.29,0.47,-1.4436,0.075,0.63,-1.649,0.02,0.32
"C7_Immunologic_signatures:C7_ALL_1392_GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN","C7_Immunologic_signatures","C7_ALL_1392_GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN",194,-1.1426,0.2,0.28,1.2588,0.038,0.14,0.8728,0.81,1
"REACTOME:366165_REACT_75776_NOD1_2_SIGNALING_PATHWAY","REACTOME","366165_REACT_75776_NOD1_2_SIGNALING_PATHWAY",32,-1.1425,0.29,0.47,-0.8678,0.68,1,-0.7963,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1922_TSENG_ADIPOGENIC_POTENTIAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1922_TSENG_ADIPOGENIC_POTENTIAL_DN",43,-1.1424,0.26,0.35,1.293,0.099,0.4,1.2777,0.1,0.69
"GO_BP:781978_GO_1901989_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION","GO_BP","781978_GO_1901989_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION",48,-1.1424,0.26,0.43,0.6455,0.98,1,-1.4053,0.049,0.58
"GO_MF:496732_GO_0016836_HYDRO_LYASE_ACTIVITY","GO_MF","496732_GO_0016836_HYDRO_LYASE_ACTIVITY",47,-1.1423,0.25,0.47,0.9874,0.45,0.89,-1.503,0.016,0.41
"GO_MF:490028_GO_0004712_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY","GO_MF","490028_GO_0004712_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY",49,-1.1423,0.26,0.47,-1.1881,0.19,0.79,-1.2599,0.12,0.59
"KEGG_reaction:R01000_2_HYDROXYBUTYRATE_NAD_OXIDOREDUCTASE_2_HYDROXYBUTANOIC_ACID_NAD_2_OXOBUTANOATE_NADH_H_","KEGG_reaction","R01000_2_HYDROXYBUTYRATE_NAD_OXIDOREDUCTASE_2_HYDROXYBUTANOIC_ACID_NAD_2_OXOBUTANOATE_NADH_H_",5,-1.1421,0.34,0.43,-0.8802,0.59,0.97,-0.8156,0.66,0.83
"C3_TF_targets:C3_TFT_212_V_ATF_B","C3_TF_targets","C3_TFT_212_V_ATF_B",183,-1.142,0.2,0.28,-1.0357,0.39,0.68,-1.0604,0.3,0.63
"GO_BP:514758_GO_0061213_POSITIVE_REGULATION_OF_MESONEPHROS_DEVELOPMENT","GO_BP","514758_GO_0061213_POSITIVE_REGULATION_OF_MESONEPHROS_DEVELOPMENT",22,-1.142,0.28,0.43,1.1653,0.25,0.82,1.0698,0.35,0.78
"GO_BP:512807_GO_0051957_POSITIVE_REGULATION_OF_AMINO_ACID_TRANSPORT","GO_BP","512807_GO_0051957_POSITIVE_REGULATION_OF_AMINO_ACID_TRANSPORT",10,-1.1419,0.29,0.43,-0.7298,0.84,1,-1.5602,0.035,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_1421_NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1421_NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP",152,-1.1418,0.22,0.35,1.575,0.0024,0.16,-0.6902,1,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_345_WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_345_WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN",14,-1.1418,0.29,0.35,1.5629,0.04,0.16,-0.6371,0.91,0.99
"C3_MicroRNA_targets:C3_MIR_52_ATGTTAA_MIR_302C","C3_MicroRNA_targets","C3_MIR_52_ATGTTAA_MIR_302C",238,-1.1418,0.18,0.37,0.919,0.72,1,0.7767,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_772_BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3","C2_Chemical_and_genetic_perturbations","C2_CGP_772_BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3",7,-1.1417,0.32,0.35,-1.251,0.21,0.74,-0.7665,0.75,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1563_XU_RESPONSE_TO_TRETINOIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1563_XU_RESPONSE_TO_TRETINOIN_DN",12,-1.1416,0.3,0.35,1.016,0.43,0.78,-1.0408,0.39,0.7
"GO_BP:491586_GO_0006699_BILE_ACID_BIOSYNTHETIC_PROCESS","GO_BP","491586_GO_0006699_BILE_ACID_BIOSYNTHETIC_PROCESS",20,-1.1416,0.29,0.43,1.2493,0.17,0.73,1.0992,0.32,0.76
"GO_BP:513969_GO_0060413_ATRIAL_SEPTUM_MORPHOGENESIS","GO_BP","513969_GO_0060413_ATRIAL_SEPTUM_MORPHOGENESIS",14,-1.1414,0.3,0.43,-0.9942,0.47,1,0.8898,0.61,0.95
"REACTOME:187106_REACT_25078_INTERFERON_GAMMA_SIGNALING","REACTOME","187106_REACT_25078_INTERFERON_GAMMA_SIGNALING",89,-1.1414,0.24,0.47,0.7269,0.97,1,-1.1214,0.24,0.68
"GO_BP:494930_GO_0010866_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS","GO_BP","494930_GO_0010866_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS",17,-1.1413,0.28,0.43,1.0679,0.35,0.94,-1.1361,0.29,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_2657_LIU_VAV3_PROSTATE_CARCINOGENESIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2657_LIU_VAV3_PROSTATE_CARCINOGENESIS_DN",15,-1.1411,0.3,0.35,1.3234,0.14,0.37,-0.7096,0.86,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_3135_BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D","C2_Chemical_and_genetic_perturbations","C2_CGP_3135_BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D",272,-1.1411,0.18,0.35,0.9395,0.63,0.88,-0.9195,0.73,0.85
"GO_BP:753111_GO_1900116_EXTRACELLULAR_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION","GO_BP","753111_GO_1900116_EXTRACELLULAR_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION",14,-1.141,0.28,0.43,1.0509,0.36,0.95,-0.7807,0.77,1
"REACTOME:119556_REACT_19405_CTLA4_INHIBITORY_SIGNALING","REACTOME","119556_REACT_19405_CTLA4_INHIBITORY_SIGNALING",22,-1.1409,0.27,0.47,0.6368,0.95,1,-1.2229,0.2,0.58
"GO_BP:491143_GO_0006171_CAMP_BIOSYNTHETIC_PROCESS","GO_BP","491143_GO_0006171_CAMP_BIOSYNTHETIC_PROCESS",16,-1.1409,0.29,0.43,-0.9191,0.56,1,-1.4026,0.078,0.58
"C7_Immunologic_signatures:C7_ALL_1416_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN","C7_Immunologic_signatures","C7_ALL_1416_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN",195,-1.1409,0.19,0.28,-0.9807,0.5,1,0.9299,0.67,1
"C7_Immunologic_signatures:C7_ALL_1798_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1798_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN",196,-1.1409,0.2,0.28,0.6629,1,1,-0.8762,0.83,0.98
"GO_BP:512467_GO_0051589_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT","GO_BP","512467_GO_0051589_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT",12,-1.1408,0.31,0.43,0.8436,0.63,1,-1.4104,0.084,0.57
"C7_Immunologic_signatures:C7_ALL_245_GSE14308_TH2_VS_TH17_UP","C7_Immunologic_signatures","C7_ALL_245_GSE14308_TH2_VS_TH17_UP",198,-1.1406,0.2,0.28,1.4397,0.0069,0.025,-0.9105,0.73,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_464_CAIRO_PML_TARGETS_BOUND_BY_MYC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_464_CAIRO_PML_TARGETS_BOUND_BY_MYC_DN",14,-1.1406,0.29,0.35,-0.7104,0.85,1,-1.0778,0.37,0.66
"C4_Cancer_modules:C4_CM_221_MODULE_242","C4_Cancer_modules","C4_CM_221_MODULE_242",204,-1.1406,0.19,0.36,-1.1031,0.22,0.71,1.5219,0,0.19
"GO_BP:492849_GO_0008589_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY","GO_BP","492849_GO_0008589_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY",65,-1.1405,0.26,0.43,-1.0052,0.45,0.98,-0.9837,0.49,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_2587_HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2587_HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP",21,-1.1405,0.29,0.35,-0.6936,0.91,1,1.5569,0.026,0.44
"KEGG_pathway:HSA04932_NON_ALCOHOLIC_FATTY_LIVER_DISEASE_NAFLD_","KEGG_pathway","HSA04932_NON_ALCOHOLIC_FATTY_LIVER_DISEASE_NAFLD_",143,-1.1404,0.23,0.3,1.7708,0,0.017,-0.6302,1,1
"C7_Immunologic_signatures:C7_ALL_1297_GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP","C7_Immunologic_signatures","C7_ALL_1297_GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP",195,-1.1404,0.19,0.28,-1.3379,0.017,0.37,1.1515,0.14,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_3189_BILANGES_SERUM_SENSITIVE_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_3189_BILANGES_SERUM_SENSITIVE_GENES",84,-1.1402,0.24,0.35,1.4817,0.023,0.23,0.8353,0.83,1
"GO_BP:500543_GO_0031284_POSITIVE_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY","GO_BP","500543_GO_0031284_POSITIVE_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY",10,-1.1401,0.29,0.43,-1.3571,0.13,0.97,0.9421,0.54,0.91
"GO_BP:510653_GO_0048592_EYE_MORPHOGENESIS","GO_BP","510653_GO_0048592_EYE_MORPHOGENESIS",139,-1.1401,0.23,0.43,-1.0131,0.43,0.98,1.4342,0.013,0.6
"KEGG_reaction:R04452_1_ALKYL_2_ACETYL_SN_GLYCERO_3_PHOSPHOCHOLINE_ACETOHYDROLASE_2_ACETYL_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE_H2O_1_ORGANYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_ACETATE","KEGG_reaction","R04452_1_ALKYL_2_ACETYL_SN_GLYCERO_3_PHOSPHOCHOLINE_ACETOHYDROLASE_2_ACETYL_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE_H2O_1_ORGANYL_2_LYSO_SN_GLYCERO_3_PHOSPHOCHOLINE_ACETATE",5,-1.14,0.32,0.43,1.2768,0.2,0.69,0.825,0.68,0.82
"GO_BP:510894_GO_0048844_ARTERY_MORPHOGENESIS","GO_BP","510894_GO_0048844_ARTERY_MORPHOGENESIS",49,-1.14,0.25,0.43,0.6498,0.98,1,1.6695,0.0081,0.41
"GO_BP:515651_GO_0070723_RESPONSE_TO_CHOLESTEROL","GO_BP","515651_GO_0070723_RESPONSE_TO_CHOLESTEROL",20,-1.1399,0.29,0.43,-0.6443,0.94,1,-0.5791,0.98,1
"C7_Immunologic_signatures:C7_ALL_27_GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_27_GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP",196,-1.1399,0.18,0.28,-1.1591,0.15,0.96,0.853,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_470_BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_470_BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN",31,-1.1398,0.29,0.35,-1.7431,0.0038,0.37,-1.2635,0.14,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_65_CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_65_CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN",375,-1.1398,0.14,0.35,-0.9165,0.76,1,-1.0668,0.25,0.67
"GO_BP:500154_GO_0030856_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","500154_GO_0030856_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION",111,-1.1398,0.21,0.43,-1.0246,0.41,0.97,0.9226,0.65,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_910_HATADA_METHYLATED_IN_LUNG_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_910_HATADA_METHYLATED_IN_LUNG_CANCER_DN",35,-1.1398,0.27,0.35,1.2986,0.12,0.39,1.7435,0.0039,0.26
"GO_CC:490819_GO_0005791_ROUGH_ENDOPLASMIC_RETICULUM","GO_CC","490819_GO_0005791_ROUGH_ENDOPLASMIC_RETICULUM",60,-1.1398,0.26,0.52,0.9207,0.6,0.87,0.652,0.99,1
"KEGG_reaction:R02240_ATP_1_2_DIACYLGLYCEROL_3_PHOSPHOTRANSFERASE_ATP_1_2_DIACYL_SN_GLYCEROL_ADP_PHOSPHATIDATE","KEGG_reaction","R02240_ATP_1_2_DIACYLGLYCEROL_3_PHOSPHOTRANSFERASE_ATP_1_2_DIACYL_SN_GLYCEROL_ADP_PHOSPHATIDATE",10,-1.1397,0.31,0.42,-1.6891,0.011,0.041,-1.0636,0.36,0.52
"KEGG_module:HSA_M00078_HEPARAN_SULFATE_DEGRADATION","KEGG_module","HSA_M00078_HEPARAN_SULFATE_DEGRADATION",9,-1.1396,0.29,0.6,-0.614,0.93,1,0.9622,0.52,1
"C7_Immunologic_signatures:C7_ALL_624_GSE17721_POLYIC_VS_CPG_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_624_GSE17721_POLYIC_VS_CPG_4H_BMDM_DN",196,-1.1395,0.2,0.28,1.2431,0.059,0.16,0.9701,0.54,1
"GO_BP:513582_GO_0060024_RHYTHMIC_SYNAPTIC_TRANSMISSION","GO_BP","513582_GO_0060024_RHYTHMIC_SYNAPTIC_TRANSMISSION",6,-1.1395,0.33,0.43,-1.1783,0.27,0.91,0.5565,0.95,1
"GO_BP:499852_GO_0030513_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY","GO_BP","499852_GO_0030513_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY",27,-1.1395,0.29,0.43,0.8493,0.7,1,-1.1142,0.29,0.76
"C3_TF_targets:C3_TFT_11_V_EVI1_06","C3_TF_targets","C3_TFT_11_V_EVI1_06",20,-1.1394,0.27,0.28,-1.1774,0.23,0.39,-0.9026,0.6,0.92
"REACTOME:106376_REACT_18365_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS","REACTOME","106376_REACT_18365_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS",9,-1.1393,0.31,0.47,0.8036,0.73,1,0.807,0.69,1
"REACTOME:105703_REACT_13543_XENOBIOTICS","REACTOME","105703_REACT_13543_XENOBIOTICS",21,-1.1392,0.27,0.47,-1.5186,0.037,0.43,1.3589,0.088,0.69
"GO_MF:490360_GO_0005092_GDP_DISSOCIATION_INHIBITOR_ACTIVITY","GO_MF","490360_GO_0005092_GDP_DISSOCIATION_INHIBITOR_ACTIVITY",10,-1.1391,0.29,0.48,-0.6118,0.94,1,-1.0031,0.45,0.79
"C7_Immunologic_signatures:C7_ALL_1730_GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1730_GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN",196,-1.139,0.2,0.29,1.8265,0,3.3e-05,-1.2601,0.037,0.18
"GO_BP:516633_GO_0071709_MEMBRANE_ASSEMBLY","GO_BP","516633_GO_0071709_MEMBRANE_ASSEMBLY",20,-1.1389,0.3,0.43,0.8599,0.7,1,1.452,0.054,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_828_MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_828_MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP",223,-1.1389,0.19,0.35,1.0351,0.34,0.74,0.8131,0.96,1
"REACTOME:106368_REACT_17064_SEROTONIN_RECEPTORS","REACTOME","106368_REACT_17064_SEROTONIN_RECEPTORS",12,-1.1388,0.32,0.47,1.0569,0.39,0.65,1.6312,0.012,0.34
"GO_BP:508728_GO_0046467_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS","GO_BP","508728_GO_0046467_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS",97,-1.1387,0.24,0.43,0.6482,1,1,-0.9447,0.6,0.89
"GO_BP:494043_GO_0009954_PROXIMAL_DISTAL_PATTERN_FORMATION","GO_BP","494043_GO_0009954_PROXIMAL_DISTAL_PATTERN_FORMATION",30,-1.1387,0.28,0.43,1.3084,0.11,0.66,1.1147,0.29,0.75
"GO_BP:500835_GO_0031585_REGULATION_OF_INOSITOL_1_4_5_TRISPHOSPHATE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY","GO_BP","500835_GO_0031585_REGULATION_OF_INOSITOL_1_4_5_TRISPHOSPHATE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY",5,-1.1386,0.32,0.43,-0.8055,0.72,1,0.869,0.62,0.96
"GO_BP:504705_GO_0035524_PROLINE_TRANSMEMBRANE_TRANSPORT","GO_BP","504705_GO_0035524_PROLINE_TRANSMEMBRANE_TRANSPORT",5,-1.1386,0.33,0.43,-1.199,0.28,0.9,-0.5505,0.97,1
"REACTOME:105985_REACT_6266_EARLY_PHASE_OF_HIV_LIFE_CYCLE","REACTOME","105985_REACT_6266_EARLY_PHASE_OF_HIV_LIFE_CYCLE",14,-1.1385,0.31,0.47,1.2121,0.19,0.43,0.7965,0.76,1
"REACTOME:106338_REACT_12478_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA","REACTOME","106338_REACT_12478_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA",36,-1.1383,0.3,0.47,-0.8562,0.69,1,-1.4449,0.03,0.39
"GO_CC:925904_GO_1902555_ENDORIBONUCLEASE_COMPLEX","GO_CC","925904_GO_1902555_ENDORIBONUCLEASE_COMPLEX",6,-1.1383,0.32,0.52,-0.8973,0.59,0.95,-0.9943,0.48,1
"KEGG_compound:C00857_DEAMINO_NAD_DEAMIDO_NAD_DEAMIDO_NAD","KEGG_compound","C00857_DEAMINO_NAD_DEAMIDO_NAD_DEAMIDO_NAD",7,-1.1382,0.31,0.46,-0.57,0.95,1,-1.4741,0.082,0.24
"GO_BP:491081_GO_0006103_2_OXOGLUTARATE_METABOLIC_PROCESS","GO_BP","491081_GO_0006103_2_OXOGLUTARATE_METABOLIC_PROCESS",16,-1.1382,0.29,0.43,-0.7493,0.82,1,-1.2942,0.14,0.64
"GO_BP:494732_GO_0010669_EPITHELIAL_STRUCTURE_MAINTENANCE","GO_BP","494732_GO_0010669_EPITHELIAL_STRUCTURE_MAINTENANCE",19,-1.1381,0.28,0.43,-1.0939,0.32,0.95,0.9385,0.53,0.91
"GO_MF:489750_GO_0004385_GUANYLATE_KINASE_ACTIVITY","GO_MF","489750_GO_0004385_GUANYLATE_KINASE_ACTIVITY",12,-1.1381,0.31,0.48,-1.1877,0.24,0.79,-1.3793,0.092,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_2436_FIRESTEIN_CTNNB1_PATHWAY","C2_Chemical_and_genetic_perturbations","C2_CGP_2436_FIRESTEIN_CTNNB1_PATHWAY",32,-1.1381,0.28,0.36,-0.8856,0.63,1,0.8079,0.76,1
"C7_Immunologic_signatures:C7_ALL_1829_GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP","C7_Immunologic_signatures","C7_ALL_1829_GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP",197,-1.138,0.2,0.29,0.8942,0.77,1,-1.2233,0.06,0.24
"REACTOME:106485_REACT_299_SIGNALING_BY_NOTCH","REACTOME","106485_REACT_299_SIGNALING_BY_NOTCH",111,-1.1379,0.23,0.47,-0.9125,0.67,1,-0.9282,0.59,0.92
"GO_BP:495313_GO_0015012_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS","GO_BP","495313_GO_0015012_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS",21,-1.1379,0.3,0.43,0.8147,0.77,1,-0.9143,0.58,0.92
"GO_BP:512527_GO_0051651_MAINTENANCE_OF_LOCATION_IN_CELL","GO_BP","512527_GO_0051651_MAINTENANCE_OF_LOCATION_IN_CELL",118,-1.1379,0.22,0.43,0.7749,0.93,1,-0.7123,0.98,0.99
"C7_Immunologic_signatures:C7_ALL_543_GSE17721_LPS_VS_POLYIC_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_543_GSE17721_LPS_VS_POLYIC_24H_BMDM_UP",197,-1.1379,0.19,0.29,1.2494,0.053,0.15,-0.8058,0.96,1
"GO_BP:493301_GO_0009101_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS","GO_BP","493301_GO_0009101_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS",341,-1.1378,0.17,0.43,0.9073,0.83,1,-0.7629,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2865_WINNEPENNINCKX_MELANOMA_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2865_WINNEPENNINCKX_MELANOMA_METASTASIS_UP",161,-1.1377,0.21,0.36,0.9472,0.61,0.87,-1.5438,0,0.28
"GO_BP:501820_GO_0032594_PROTEIN_TRANSPORT_WITHIN_LIPID_BILAYER","GO_BP","501820_GO_0032594_PROTEIN_TRANSPORT_WITHIN_LIPID_BILAYER",7,-1.1376,0.31,0.43,-0.7492,0.79,1,-0.9509,0.52,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_2190_RIZKI_TUMOR_INVASIVENESS_3D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2190_RIZKI_TUMOR_INVASIVENESS_3D_UP",205,-1.1376,0.2,0.36,-0.9203,0.7,1,0.951,0.59,1
"GO_BP:506505_GO_0043473_PIGMENTATION","GO_BP","506505_GO_0043473_PIGMENTATION",89,-1.1375,0.24,0.43,1.2487,0.095,0.73,-0.861,0.75,0.96
"GO_BP:503844_GO_0034644_CELLULAR_RESPONSE_TO_UV","GO_BP","503844_GO_0034644_CELLULAR_RESPONSE_TO_UV",52,-1.1375,0.24,0.43,0.7453,0.89,1,-1.1609,0.21,0.73
"KEGG_compound:C11557_1_PHOSPHATIDYL_1D_MYO_INOSITOL_5_PHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_5_PHOSPHATE_","KEGG_compound","C11557_1_PHOSPHATIDYL_1D_MYO_INOSITOL_5_PHOSPHATE_1_2_DIACYL_SN_GLYCERO_3_PHOSPHO_1_MYO_INOSITOL_5_PHOSPHATE_",5,-1.1374,0.34,0.46,-0.8952,0.57,1,-1.2929,0.17,0.36
"C3_TF_targets:C3_TFT_430_V_MYC_Q2","C3_TF_targets","C3_TFT_430_V_MYC_Q2",180,-1.1374,0.21,0.29,0.8783,0.82,1,-1.1994,0.096,0.35
"C3_TF_targets:C3_TFT_405_V_HNF4_DR1_Q3","C3_TF_targets","C3_TFT_405_V_HNF4_DR1_Q3",250,-1.1374,0.18,0.29,-1.0747,0.26,0.61,-1.3983,0,0.27
"GO_BP:507949_GO_0045601_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION","GO_BP","507949_GO_0045601_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION",14,-1.1373,0.3,0.43,-0.7897,0.75,1,0.9815,0.49,0.88
"GO_CC:498616_GO_0019814_IMMUNOGLOBULIN_COMPLEX","GO_CC","498616_GO_0019814_IMMUNOGLOBULIN_COMPLEX",5,-1.1372,0.33,0.53,0.8538,0.65,0.91,-1.2161,0.26,0.76
"GO_BP:487921_GO_0002031_G_PROTEIN_COUPLED_RECEPTOR_INTERNALIZATION","GO_BP","487921_GO_0002031_G_PROTEIN_COUPLED_RECEPTOR_INTERNALIZATION",12,-1.1371,0.29,0.43,-0.8256,0.7,1,1.6269,0.023,0.4
"C7_Immunologic_signatures:C7_ALL_1413_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP","C7_Immunologic_signatures","C7_ALL_1413_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP",192,-1.137,0.21,0.29,0.8913,0.77,1,-0.7244,0.99,1
"GO_BP:512568_GO_0051693_ACTIN_FILAMENT_CAPPING","GO_BP","512568_GO_0051693_ACTIN_FILAMENT_CAPPING",31,-1.1369,0.25,0.43,-1.0011,0.44,0.99,-1.4725,0.039,0.54
"GO_BP:505571_GO_0042430_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","505571_GO_0042430_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS",28,-1.1369,0.29,0.43,-1.1879,0.23,0.9,-1.1638,0.24,0.73
"GO_BP:496108_GO_0015991_ATP_HYDROLYSIS_COUPLED_PROTON_TRANSPORT","GO_BP","496108_GO_0015991_ATP_HYDROLYSIS_COUPLED_PROTON_TRANSPORT",29,-1.1368,0.27,0.43,1.629,0.011,0.26,0.8454,0.72,0.99
"C3_MicroRNA_targets:C3_MIR_177_GCAAGGA_MIR_502","C3_MicroRNA_targets","C3_MIR_177_GCAAGGA_MIR_502",70,-1.1368,0.26,0.38,-0.8346,0.81,1,-1.3671,0.032,1
"GO_BP:493751_GO_0009635_RESPONSE_TO_HERBICIDE","GO_BP","493751_GO_0009635_RESPONSE_TO_HERBICIDE",8,-1.1368,0.32,0.43,0.8944,0.6,1,-0.7129,0.84,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1254_CERVERA_SDHB_TARGETS_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1254_CERVERA_SDHB_TARGETS_1_DN",35,-1.1367,0.28,0.36,-0.9811,0.48,1,1.1217,0.27,0.85
"GO_BP:512324_GO_0051446_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE","GO_BP","512324_GO_0051446_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE",14,-1.1367,0.29,0.43,-1.01,0.43,0.98,-0.9156,0.56,0.92
"C7_Immunologic_signatures:C7_ALL_1573_GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_1573_GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP",193,-1.1367,0.2,0.29,0.7541,0.99,1,-1.0256,0.39,0.67
"REACTOME:106520_REACT_15425_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE","REACTOME","106520_REACT_15425_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE",18,-1.1367,0.3,0.47,-1.1617,0.25,0.85,1.1942,0.23,0.84
"C7_Immunologic_signatures:C7_ALL_1779_GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP","C7_Immunologic_signatures","C7_ALL_1779_GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP",196,-1.1363,0.2,0.29,0.893,0.77,1,-1.1817,0.093,0.32
"GO_BP:513954_GO_0060398_REGULATION_OF_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","513954_GO_0060398_REGULATION_OF_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY",5,-1.1362,0.34,0.43,-0.8913,0.59,1,-0.8428,0.66,0.96
"C7_Immunologic_signatures:C7_ALL_1425_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP","C7_Immunologic_signatures","C7_ALL_1425_GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP",196,-1.1362,0.2,0.29,0.7579,0.99,1,-0.7288,0.99,1
"REACTOME:1183566_REACT_355146_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2","REACTOME","1183566_REACT_355146_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2",45,-1.1362,0.27,0.47,-1.2296,0.15,0.79,-1.3407,0.075,0.52
"C4_Cancer_modules:C4_CM_66_MODULE_70","C4_Cancer_modules","C4_CM_66_MODULE_70",41,-1.1361,0.27,0.36,-0.9146,0.59,0.88,-0.834,0.77,0.96
"C3_MicroRNA_targets:C3_MIR_21_AATGTGA_MIR_23A_MIR_23B","C3_MicroRNA_targets","C3_MIR_21_AATGTGA_MIR_23A_MIR_23B",412,-1.136,0.16,0.38,1.0584,0.28,1,1.1168,0.12,1
"GO_BP:508097_GO_0045760_POSITIVE_REGULATION_OF_ACTION_POTENTIAL","GO_BP","508097_GO_0045760_POSITIVE_REGULATION_OF_ACTION_POTENTIAL",11,-1.136,0.33,0.43,-1.6908,0.013,0.59,-1.2584,0.17,0.67
"GO_BP:506430_GO_0043392_NEGATIVE_REGULATION_OF_DNA_BINDING","GO_BP","506430_GO_0043392_NEGATIVE_REGULATION_OF_DNA_BINDING",45,-1.1359,0.29,0.43,1.399,0.049,0.55,0.8969,0.62,0.95
"C7_Immunologic_signatures:C7_ALL_287_GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP","C7_Immunologic_signatures","C7_ALL_287_GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP",200,-1.1359,0.19,0.29,-0.9536,0.58,1,-1.2953,0.023,0.14
"C2_Chemical_and_genetic_perturbations:C2_CGP_2686_VALK_AML_CLUSTER_10","C2_Chemical_and_genetic_perturbations","C2_CGP_2686_VALK_AML_CLUSTER_10",31,-1.1358,0.28,0.36,-1.0191,0.43,0.98,1.0761,0.33,0.88
"C4_Cancer_gene_neighborhoods:C4_CGN_77_MORF_CNTN1","C4_Cancer_gene_neighborhoods","C4_CGN_77_MORF_CNTN1",106,-1.1358,0.24,0.45,-0.9109,0.66,1,0.7055,0.99,1
"GO_BP:491590_GO_0006703_ESTROGEN_BIOSYNTHETIC_PROCESS","GO_BP","491590_GO_0006703_ESTROGEN_BIOSYNTHETIC_PROCESS",9,-1.1357,0.3,0.43,1.125,0.3,0.87,1.0145,0.44,0.84
"C7_Immunologic_signatures:C7_ALL_654_GSE17721_LPS_VS_CPG_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_654_GSE17721_LPS_VS_CPG_0_5H_BMDM_DN",197,-1.1356,0.22,0.29,0.9715,0.57,0.83,-0.8862,0.81,0.97
"GO_MF:496623_GO_0016701_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN","GO_MF","496623_GO_0016701_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN",26,-1.1355,0.28,0.48,-0.9475,0.51,0.94,-1.6144,0.0098,0.37
"OMIM_gene:OMIM600503_SUB1_S_CEREVISIAE_HOMOLOG_OF_SUB1","OMIM_gene","OMIM600503_SUB1_S_CEREVISIAE_HOMOLOG_OF_SUB1",5,-1.1354,0.34,0.81,-0.7354,0.77,0.96,-0.645,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_61_GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_61_GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN",36,-1.1354,0.26,0.36,1.5944,0.017,0.14,-1.1725,0.23,0.55
"KEGG_compound:C00011_CO2_CARBON_DIOXIDE","KEGG_compound","C00011_CO2_CARBON_DIOXIDE",95,-1.1353,0.23,0.46,-0.9587,0.53,1,-1.5007,0.0059,0.22
"GO_BP:777522_GO_1901970_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION","GO_BP","777522_GO_1901970_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION",8,-1.1352,0.3,0.44,0.751,0.77,1,-1.0935,0.35,0.78
"REACTOME:1127671_REACT_264098_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION","REACTOME","1127671_REACT_264098_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION",122,-1.1351,0.24,0.47,-1.3987,0.02,0.53,-1.2564,0.084,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_3055_VERHAAK_GLIOBLASTOMA_CLASSICAL","C2_Chemical_and_genetic_perturbations","C2_CGP_3055_VERHAAK_GLIOBLASTOMA_CLASSICAL",161,-1.135,0.2,0.36,-0.9513,0.59,1,1.2261,0.084,0.74
"GO_BP:486791_GO_0000272_POLYSACCHARIDE_CATABOLIC_PROCESS","GO_BP","486791_GO_0000272_POLYSACCHARIDE_CATABOLIC_PROCESS",24,-1.135,0.3,0.44,-0.8428,0.71,1,-1.6309,0.01,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_2205_POS_HISTAMINE_RESPONSE_NETWORK","C2_Chemical_and_genetic_perturbations","C2_CGP_2205_POS_HISTAMINE_RESPONSE_NETWORK",31,-1.1348,0.26,0.36,0.6508,0.95,1,1.4271,0.048,0.55
"GO_BP:491849_GO_0007018_MICROTUBULE_BASED_MOVEMENT","GO_BP","491849_GO_0007018_MICROTUBULE_BASED_MOVEMENT",184,-1.1348,0.22,0.44,-0.9771,0.51,1,-1.0424,0.34,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_2263_SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2263_SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN",9,-1.1347,0.3,0.36,-1.5014,0.077,0.45,-1.1149,0.31,0.61
"C3_TF_targets:C3_TFT_380_V_USF2_Q6","C3_TF_targets","C3_TFT_380_V_USF2_Q6",245,-1.1347,0.18,0.29,0.9364,0.63,1,-1.0458,0.32,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_1307_PENG_GLUTAMINE_DEPRIVATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1307_PENG_GLUTAMINE_DEPRIVATION_UP",37,-1.1345,0.29,0.36,-0.9892,0.46,1,-0.8025,0.8,0.95
"GO_MF:489811_GO_0004459_L_LACTATE_DEHYDROGENASE_ACTIVITY","GO_MF","489811_GO_0004459_L_LACTATE_DEHYDROGENASE_ACTIVITY",5,-1.1345,0.34,0.49,-0.8915,0.61,1,-0.815,0.69,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2373_SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM","C2_Chemical_and_genetic_perturbations","C2_CGP_2373_SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM",5,-1.1343,0.32,0.36,1.3233,0.15,0.37,0.8643,0.62,1
"REACTOME:187103_REACT_25229_INTERFERON_SIGNALING","REACTOME","187103_REACT_25229_INTERFERON_SIGNALING",189,-1.1342,0.19,0.47,1.3447,0.008,0.27,-1.4202,0.0021,0.4
"C4_Cancer_modules:C4_CM_284_MODULE_325","C4_Cancer_modules","C4_CM_284_MODULE_325",53,-1.1342,0.26,0.37,-0.9068,0.63,0.9,-1.3928,0.04,0.22
"C4_Cancer_modules:C4_CM_179_MODULE_191","C4_Cancer_modules","C4_CM_179_MODULE_191",15,-1.1341,0.29,0.36,1.5197,0.047,0.11,1.9785,0,0.015
"C2_Chemical_and_genetic_perturbations:C2_CGP_1492_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1492_LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN",163,-1.1341,0.19,0.36,0.9887,0.48,0.81,-1.6458,0,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_2257_SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2257_SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN",85,-1.1341,0.25,0.36,-0.8868,0.69,1,-1.0369,0.38,0.71
"GO_BP:503455_GO_0034250_POSITIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS","GO_BP","503455_GO_0034250_POSITIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS",9,-1.134,0.34,0.44,0.9365,0.5,1,-1.1448,0.3,0.75
"C7_Immunologic_signatures:C7_ALL_754_GSE17721_0_5H_VS_12H_GARDIQUIMOD_BMDM_DN","C7_Immunologic_signatures","C7_ALL_754_GSE17721_0_5H_VS_12H_GARDIQUIMOD_BMDM_DN",198,-1.134,0.21,0.29,0.7745,0.99,1,-0.9356,0.67,0.88
"GO_MF:496645_GO_0016725_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS","GO_MF","496645_GO_0016725_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS",10,-1.134,0.34,0.49,1.3655,0.12,0.5,1.0609,0.36,0.83
"OMIM_gene:OMIM608749_BROMODOMAIN_CONTAINING_PROTEIN_4_BRD4","OMIM_gene","OMIM608749_BROMODOMAIN_CONTAINING_PROTEIN_4_BRD4",6,-1.1338,0.34,0.78,0.7244,0.79,1,-0.9646,0.51,1
"C7_Immunologic_signatures:C7_ALL_893_GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_893_GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP",196,-1.1337,0.21,0.29,1.0011,0.47,0.73,0.9944,0.47,1
"GO_MF:509160_GO_0046969_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H3_K9_SPECIFIC_","GO_MF","509160_GO_0046969_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H3_K9_SPECIFIC_",13,-1.1337,0.31,0.49,-1.2564,0.16,0.84,-1.7725,0.012,0.24
"C3_TF_targets:C3_TFT_378_V_HNF3ALPHA_Q6","C3_TF_targets","C3_TFT_378_V_HNF3ALPHA_Q6",199,-1.1337,0.21,0.29,-0.9479,0.58,0.89,-0.8753,0.83,0.96
"GO_BP:499723_GO_0030322_STABILIZATION_OF_MEMBRANE_POTENTIAL","GO_BP","499723_GO_0030322_STABILIZATION_OF_MEMBRANE_POTENTIAL",16,-1.1335,0.3,0.44,1.1976,0.23,0.78,0.7134,0.86,1
"GO_BP:505172_GO_0040014_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH","GO_BP","505172_GO_0040014_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH",69,-1.1334,0.26,0.44,0.9894,0.48,0.99,-0.7732,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2131_MCGOWAN_RSP6_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2131_MCGOWAN_RSP6_TARGETS_UP",17,-1.1334,0.29,0.36,0.881,0.62,0.94,1.0094,0.44,0.96
"GO_BP:513886_GO_0060330_REGULATION_OF_RESPONSE_TO_INTERFERON_GAMMA","GO_BP","513886_GO_0060330_REGULATION_OF_RESPONSE_TO_INTERFERON_GAMMA",25,-1.1334,0.27,0.44,0.883,0.62,1,-1.0749,0.34,0.8
"GO_BP:494970_GO_0010906_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS","GO_BP","494970_GO_0010906_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS",95,-1.1334,0.24,0.44,0.7239,0.97,1,-0.8325,0.83,0.97
"GO_MF:489251_GO_0003705_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY","GO_MF","489251_GO_0003705_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",89,-1.1333,0.25,0.49,0.9408,0.59,0.94,0.9296,0.62,0.94
"C7_Immunologic_signatures:C7_ALL_573_GSE17721_PAM3CSK4_VS_CPG_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_573_GSE17721_PAM3CSK4_VS_CPG_8H_BMDM_UP",197,-1.1333,0.2,0.3,0.9131,0.75,0.99,-1.0502,0.31,0.61
"GO_BP:515599_GO_0070669_RESPONSE_TO_INTERLEUKIN_2","GO_BP","515599_GO_0070669_RESPONSE_TO_INTERLEUKIN_2",7,-1.1333,0.33,0.44,1.5001,0.062,0.41,-1.0504,0.4,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_78_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_78_SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP",401,-1.1333,0.15,0.36,1.2424,0.025,0.45,-1.0687,0.24,0.67
"GO_MF:495480_GO_0015216_PURINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495480_GO_0015216_PURINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-1.1332,0.33,0.49,-0.778,0.74,1,-1.6662,0.014,0.32
"GO_BP:808772_GO_1902101_POSITIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE","GO_BP","808772_GO_1902101_POSITIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE",8,-1.1332,0.32,0.44,0.7379,0.79,1,-1.0885,0.36,0.78
"REACTOME:106235_REACT_733_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS","REACTOME","106235_REACT_733_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS",9,-1.1332,0.31,0.47,0.864,0.66,0.95,-1.1034,0.33,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_2337_MATZUK_SPERMATOZOA","C2_Chemical_and_genetic_perturbations","C2_CGP_2337_MATZUK_SPERMATOZOA",109,-1.1331,0.23,0.36,0.7227,0.98,1,-0.9898,0.46,0.77
"GO_BP:517118_GO_0072202_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT","GO_BP","517118_GO_0072202_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT",10,-1.1331,0.31,0.44,-0.9506,0.51,1,0.6238,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2094_WANG_LSD1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2094_WANG_LSD1_TARGETS_DN",38,-1.1331,0.27,0.36,-1.0155,0.42,0.99,1.0459,0.38,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_3196_KIM_TIAL1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3196_KIM_TIAL1_TARGETS",31,-1.1331,0.29,0.36,1.2574,0.15,0.43,0.7891,0.81,1
"C7_Immunologic_signatures:C7_ALL_1850_GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1850_GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN",191,-1.133,0.21,0.3,1.5778,0,0.0043,-1.0983,0.23,0.5
"GO_BP:505343_GO_0042182_KETONE_CATABOLIC_PROCESS","GO_BP","505343_GO_0042182_KETONE_CATABOLIC_PROCESS",7,-1.133,0.32,0.44,0.8411,0.68,1,-1.0603,0.41,0.8
"GO_BP:517318_GO_0072402_RESPONSE_TO_DNA_INTEGRITY_CHECKPOINT_SIGNALING","GO_BP","517318_GO_0072402_RESPONSE_TO_DNA_INTEGRITY_CHECKPOINT_SIGNALING",5,-1.133,0.34,0.44,-0.9447,0.53,1,-1.0712,0.41,0.8
"C4_Cancer_modules:C4_CM_378_MODULE_465","C4_Cancer_modules","C4_CM_378_MODULE_465",15,-1.1329,0.3,0.36,0.7979,0.76,0.98,1.0026,0.45,0.94
"C7_Immunologic_signatures:C7_ALL_871_GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_871_GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP",193,-1.1329,0.21,0.3,0.8096,0.94,1,-0.842,0.87,1
"GO_MF:507331_GO_0044325_ION_CHANNEL_BINDING","GO_MF","507331_GO_0044325_ION_CHANNEL_BINDING",85,-1.1329,0.26,0.49,0.7272,0.96,1,0.7318,0.96,1
"GO_BP:518379_GO_0090239_REGULATION_OF_HISTONE_H4_ACETYLATION","GO_BP","518379_GO_0090239_REGULATION_OF_HISTONE_H4_ACETYLATION",9,-1.1329,0.3,0.44,-0.7328,0.8,1,0.5422,0.98,1
"GO_CC:490824_GO_0005796_GOLGI_LUMEN","GO_CC","490824_GO_0005796_GOLGI_LUMEN",81,-1.1328,0.24,0.53,1.4051,0.023,0.29,1.7773,0,0.24
"C3_TF_targets:C3_TFT_207_V_MYCMAX_B","C3_TF_targets","C3_TFT_207_V_MYCMAX_B",258,-1.1328,0.2,0.29,-0.71,1,1,-0.862,0.89,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2942_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16","C2_Chemical_and_genetic_perturbations","C2_CGP_2942_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16",75,-1.1328,0.26,0.36,-0.9155,0.64,1,0.9579,0.55,0.98
"GO_BP:498455_GO_0019626_SHORT_CHAIN_FATTY_ACID_CATABOLIC_PROCESS","GO_BP","498455_GO_0019626_SHORT_CHAIN_FATTY_ACID_CATABOLIC_PROCESS",7,-1.1328,0.33,0.44,-0.7898,0.75,1,-1.3388,0.15,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_2710_BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2710_BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN",27,-1.1327,0.29,0.36,1.494,0.047,0.21,1.1375,0.27,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_240_MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_240_MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP",137,-1.1327,0.22,0.36,0.8172,0.89,0.98,-0.9707,0.53,0.8
"GO_BP:513772_GO_0060216_DEFINITIVE_HEMOPOIESIS","GO_BP","513772_GO_0060216_DEFINITIVE_HEMOPOIESIS",20,-1.1327,0.3,0.44,-0.8553,0.69,1,-1.1957,0.21,0.74
"REACTOME:106030_REACT_1230_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN","REACTOME","106030_REACT_1230_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN",13,-1.1327,0.31,0.47,-0.681,0.89,1,-0.9247,0.55,0.93
"GO_BP:519286_GO_2000647_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION","GO_BP","519286_GO_2000647_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION",15,-1.1327,0.32,0.44,-0.7566,0.78,1,-0.8211,0.71,0.97
"GO_BP:492134_GO_0007369_GASTRULATION","GO_BP","492134_GO_0007369_GASTRULATION",150,-1.1326,0.21,0.44,0.9164,0.7,1,1.1053,0.24,0.76
"C7_Immunologic_signatures:C7_ALL_527_GSE17721_LPS_VS_POLYIC_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_527_GSE17721_LPS_VS_POLYIC_0_5H_BMDM_UP",195,-1.1324,0.22,0.3,0.8406,0.92,1,-0.9778,0.53,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_2678_VALK_AML_CLUSTER_2","C2_Chemical_and_genetic_perturbations","C2_CGP_2678_VALK_AML_CLUSTER_2",29,-1.1324,0.28,0.36,1.1558,0.22,0.55,0.7355,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2682_VALK_AML_CLUSTER_6","C2_Chemical_and_genetic_perturbations","C2_CGP_2682_VALK_AML_CLUSTER_6",33,-1.1324,0.27,0.36,1.738,0.0064,0.064,-1.3547,0.094,0.39
"GO_BP:507254_GO_0044247_CELLULAR_POLYSACCHARIDE_CATABOLIC_PROCESS","GO_BP","507254_GO_0044247_CELLULAR_POLYSACCHARIDE_CATABOLIC_PROCESS",22,-1.1324,0.3,0.44,-0.9162,0.57,1,-1.5148,0.045,0.53
"WikiPathways:672450_WP1971_INTEGRATED_CANCER_PATHWAY","WikiPathways","672450_WP1971_INTEGRATED_CANCER_PATHWAY",35,-1.1322,0.29,0.39,-0.9192,0.58,1,-1.6794,0.004,0.36
"C7_Immunologic_signatures:C7_ALL_407_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_407_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP",196,-1.1322,0.22,0.3,-0.8041,0.95,1,-0.9019,0.74,0.95
"GO_MF:490371_GO_0005105_TYPE_1_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING","GO_MF","490371_GO_0005105_TYPE_1_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING",5,-1.1322,0.34,0.49,-1.5146,0.038,0.55,0.8186,0.69,1
"REACTOME:106408_REACT_7964_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION","REACTOME","106408_REACT_7964_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION",5,-1.1322,0.33,0.47,0.9711,0.5,0.8,-0.9572,0.51,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_922_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3","C2_Chemical_and_genetic_perturbations","C2_CGP_922_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3",65,-1.1321,0.26,0.36,1.4181,0.033,0.28,1.1277,0.23,0.84
"GO_BP:518192_GO_0090051_NEGATIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS","GO_BP","518192_GO_0090051_NEGATIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS",8,-1.1321,0.33,0.44,-1.2788,0.19,0.89,-1.1221,0.32,0.76
"GO_BP:510922_GO_0048873_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE","GO_BP","510922_GO_0048873_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE",24,-1.1319,0.3,0.44,-0.7137,0.89,1,0.7612,0.83,1
"GO_BP:754492_GO_1901532_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION","GO_BP","754492_GO_1901532_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION",39,-1.1319,0.28,0.44,-1.3242,0.093,0.89,-0.9733,0.5,0.88
"C3_TF_targets:C3_TFT_609_TCANNTGAY_V_SREBP1_01","C3_TF_targets","C3_TFT_609_TCANNTGAY_V_SREBP1_01",466,-1.1318,0.15,0.3,0.8085,1,1,-0.7703,1,1
"KEGG_compound:C05984_2_HYDROXYBUTANOIC_ACID_2_HYDROXYBUTYRATE_2_HYDROXYBUTYRIC_ACID","KEGG_compound","C05984_2_HYDROXYBUTANOIC_ACID_2_HYDROXYBUTYRATE_2_HYDROXYBUTYRIC_ACID",5,-1.1317,0.33,0.46,-0.8882,0.58,1,-0.8062,0.68,0.84
"C7_Immunologic_signatures:C7_ALL_867_GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_867_GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_UP",200,-1.1316,0.21,0.3,0.7926,0.97,1,-1.1656,0.13,0.34
"C7_Immunologic_signatures:C7_ALL_341_GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_341_GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP",200,-1.1314,0.2,0.3,1.5194,0,0.0094,-1.0645,0.27,0.58
"WikiPathways:755440_WP2263_PROSTATE_CANCER","WikiPathways","755440_WP2263_PROSTATE_CANCER",108,-1.1314,0.23,0.39,0.6558,1,1,-1.2786,0.052,0.45
"C7_Immunologic_signatures:C7_ALL_1749_GSE6269_FLU_VS_E_COLI_INF_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1749_GSE6269_FLU_VS_E_COLI_INF_PBMC_UP",161,-1.1314,0.23,0.3,0.8724,0.79,1,-1.3194,0.05,0.12
"GO_BP:518701_GO_2000052_POSITIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY","GO_BP","518701_GO_2000052_POSITIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY",8,-1.1313,0.31,0.44,-0.8678,0.63,1,-0.8748,0.63,0.94
"KEGG_pathway:HSA04330_NOTCH_SIGNALING_PATHWAY","KEGG_pathway","HSA04330_NOTCH_SIGNALING_PATHWAY",48,-1.1313,0.26,0.32,-1.1987,0.16,0.52,0.5859,0.99,1
"GO_CC:506273_GO_0043205_FIBRIL","GO_CC","506273_GO_0043205_FIBRIL",13,-1.1311,0.29,0.54,1.0262,0.45,0.74,-0.9814,0.46,1
"C7_Immunologic_signatures:C7_ALL_1218_GSE27786_NKCELL_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1218_GSE27786_NKCELL_VS_NEUTROPHIL_DN",191,-1.131,0.21,0.3,0.8477,0.88,1,-0.9592,0.56,0.82
"GO_MF:490573_GO_0005416_CATION_AMINO_ACID_SYMPORTER_ACTIVITY","GO_MF","490573_GO_0005416_CATION_AMINO_ACID_SYMPORTER_ACTIVITY",13,-1.1306,0.31,0.49,-1.3693,0.11,0.7,-1.5363,0.03,0.4
"C7_Immunologic_signatures:C7_ALL_1838_GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN","C7_Immunologic_signatures","C7_ALL_1838_GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN",196,-1.1305,0.2,0.3,0.8465,0.92,1,-0.9975,0.46,0.73
"GO_BP:513805_GO_0060249_ANATOMICAL_STRUCTURE_HOMEOSTASIS","GO_BP","513805_GO_0060249_ANATOMICAL_STRUCTURE_HOMEOSTASIS",350,-1.1305,0.18,0.44,-0.9447,0.63,1,0.9182,0.76,0.93
"GO_BP:504768_GO_0035589_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","504768_GO_0035589_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY",14,-1.1305,0.32,0.44,1.7769,0.008,0.12,1.0599,0.41,0.79
"C7_Immunologic_signatures:C7_ALL_95_GSE11924_TFH_VS_TH1_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_95_GSE11924_TFH_VS_TH1_CD4_TCELL_UP",199,-1.1304,0.23,0.3,-0.7052,1,1,-1.1653,0.098,0.34
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_127_BIOCARTA_NOS1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_127_BIOCARTA_NOS1_PATHWAY",21,-1.1304,0.31,0.42,1.628,0.009,0.28,-1.1889,0.22,0.58
"GO_BP:493349_GO_0009152_PURINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","493349_GO_0009152_PURINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",117,-1.1304,0.24,0.44,0.9659,0.55,1,-1.1553,0.19,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_1963_MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1963_MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN",13,-1.1303,0.31,0.37,0.9073,0.57,0.91,-0.6852,0.89,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_757_XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_757_XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN",88,-1.1302,0.26,0.37,-0.836,0.79,1,-1.0406,0.35,0.7
"GO_BP:508471_GO_0046173_POLYOL_BIOSYNTHETIC_PROCESS","GO_BP","508471_GO_0046173_POLYOL_BIOSYNTHETIC_PROCESS",23,-1.1302,0.29,0.44,-0.9302,0.56,1,-1.2525,0.17,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_238_MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_238_MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP",271,-1.1301,0.19,0.37,1.0327,0.34,0.75,-1.0099,0.41,0.74
"GO_BP:495300_GO_0014910_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION","GO_BP","495300_GO_0014910_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION",36,-1.13,0.29,0.44,1.0247,0.41,0.97,1.0903,0.31,0.77
"KEGG_compound:C01245_D_MYO_INOSITOL_1_4_5_TRISPHOSPHATE_1D_MYO_INOSITOL_1_4_5_TRISPHOSPHATE_INOSITOL_1_4_5_TRISPHOSPHATE_INS_1_4_5_P3","KEGG_compound","C01245_D_MYO_INOSITOL_1_4_5_TRISPHOSPHATE_1D_MYO_INOSITOL_1_4_5_TRISPHOSPHATE_INOSITOL_1_4_5_TRISPHOSPHATE_INS_1_4_5_P3",21,-1.13,0.3,0.47,-1.3321,0.13,0.59,0.7786,0.78,0.9
"C4_Cancer_modules:C4_CM_422_MODULE_557","C4_Cancer_modules","C4_CM_422_MODULE_557",11,-1.13,0.32,0.37,-1.0498,0.38,0.72,-1.561,0.036,0.12
"C7_Immunologic_signatures:C7_ALL_343_GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_343_GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP",199,-1.1299,0.23,0.3,1.4134,0.0025,0.034,-1.1869,0.088,0.31
"KEGG_compound:C00083_MALONYL_COA_MALONYL_COENZYME_A","KEGG_compound","C00083_MALONYL_COA_MALONYL_COENZYME_A",12,-1.1299,0.3,0.46,-1.0493,0.39,0.99,-1.3241,0.12,0.34
"GO_BP:499726_GO_0030325_ADRENAL_GLAND_DEVELOPMENT","GO_BP","499726_GO_0030325_ADRENAL_GLAND_DEVELOPMENT",27,-1.1299,0.29,0.44,0.9046,0.61,1,0.6641,0.95,1
"GO_BP:494983_GO_0010919_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","494983_GO_0010919_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS",11,-1.1297,0.31,0.44,1.4209,0.079,0.53,1.6909,0.022,0.41
"GO_MF:496751_GO_0016859_CIS_TRANS_ISOMERASE_ACTIVITY","GO_MF","496751_GO_0016859_CIS_TRANS_ISOMERASE_ACTIVITY",43,-1.1297,0.28,0.49,1.1587,0.23,0.74,-0.7479,0.9,0.99
"GO_BP:515869_GO_0070942_NEUTROPHIL_MEDIATED_CYTOTOXICITY","GO_BP","515869_GO_0070942_NEUTROPHIL_MEDIATED_CYTOTOXICITY",5,-1.1297,0.34,0.44,1.4368,0.073,0.51,-0.6151,0.9,1
"C1_Positional:C1_ALL_208_CHR4Q34","C1_Positional","C1_ALL_208_CHR4Q34",15,-1.1297,0.32,0.82,1.2302,0.19,0.59,1.0796,0.35,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_1551_MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP","C2_Chemical_and_genetic_perturbations","C2_CGP_1551_MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP",25,-1.1296,0.29,0.37,0.8642,0.64,0.96,-0.8864,0.65,0.89
"GO_BP:515179_GO_0070244_NEGATIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS","GO_BP","515179_GO_0070244_NEGATIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS",7,-1.1295,0.32,0.44,0.8116,0.67,1,1.2211,0.24,0.71
"KEGG_compound:C00344_PHOSPHATIDYLGLYCEROL_3_3_SN_PHOSPHATIDYL_GLYCEROL_3_3_PHOSPHATIDYL_GLYCEROL_PTDGRO","KEGG_compound","C00344_PHOSPHATIDYLGLYCEROL_3_3_SN_PHOSPHATIDYL_GLYCEROL_3_3_PHOSPHATIDYL_GLYCEROL_PTDGRO",6,-1.1295,0.35,0.46,-0.5809,0.95,1,-1.1053,0.34,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1279_BASSO_B_LYMPHOCYTE_NETWORK","C2_Chemical_and_genetic_perturbations","C2_CGP_1279_BASSO_B_LYMPHOCYTE_NETWORK",143,-1.1294,0.24,0.37,1.5507,0,0.17,-1.0822,0.26,0.65
"GO_BP:1026085_GO_1903313_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS","GO_BP","1026085_GO_1903313_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS",41,-1.1294,0.29,0.44,-1.1385,0.24,0.93,-1.5966,0.016,0.51
"GO_BP:754611_GO_1901659_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","754611_GO_1901659_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS",134,-1.1293,0.23,0.44,1.0767,0.3,0.93,-1.0648,0.27,0.8
"REACTOME:161076_REACT_22151_TRANSPORT_OF_NUCLEOTIDE_SUGARS","REACTOME","161076_REACT_22151_TRANSPORT_OF_NUCLEOTIDE_SUGARS",9,-1.1293,0.33,0.48,-1.2217,0.21,0.79,-1.2535,0.19,0.55
"C7_Immunologic_signatures:C7_ALL_634_GSE17721_POLYIC_VS_CPG_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_634_GSE17721_POLYIC_VS_CPG_24H_BMDM_DN",198,-1.1292,0.23,0.3,1.4224,0.0024,0.031,-0.8134,0.94,1
"C7_Immunologic_signatures:C7_ALL_826_GSE17974_0_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_826_GSE17974_0_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN",194,-1.129,0.22,0.3,1.0743,0.27,0.51,-1.1858,0.098,0.31
"REACTOME:161049_REACT_22344_NUCLEOSOME_ASSEMBLY","REACTOME","161049_REACT_22344_NUCLEOSOME_ASSEMBLY",71,-1.129,0.25,0.48,-1.3222,0.064,0.62,-1.6438,0,0.23
"C3_MicroRNA_targets:C3_MIR_63_ACTGCAG_MIR_17_3P","C3_MicroRNA_targets","C3_MIR_63_ACTGCAG_MIR_17_3P",109,-1.1287,0.23,0.39,0.9711,0.5,1,0.7701,0.92,1
"C4_Cancer_gene_neighborhoods:C4_CGN_71_MORF_CD8A","C4_Cancer_gene_neighborhoods","C4_CGN_71_MORF_CD8A",120,-1.1287,0.25,0.46,-1.0641,0.32,0.74,1.6295,0.0018,0.13
"C7_Immunologic_signatures:C7_ALL_798_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_798_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN",199,-1.1286,0.21,0.3,0.7636,0.99,1,-1.5064,0,0.02
"GO_BP:993418_GO_1903076_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE","GO_BP","993418_GO_1903076_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",56,-1.1286,0.28,0.44,1.083,0.31,0.92,0.9075,0.62,0.93
"GO_BP:510770_GO_0048715_NEGATIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION","GO_BP","510770_GO_0048715_NEGATIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION",12,-1.1285,0.3,0.44,-0.67,0.9,1,0.9148,0.58,0.93
"KEGG_pathway:HSA00650_BUTANOATE_METABOLISM","KEGG_pathway","HSA00650_BUTANOATE_METABOLISM",26,-1.1285,0.29,0.32,0.8529,0.71,1,-1.9361,0,0.039
"GO_BP:502850_GO_0033634_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN","GO_BP","502850_GO_0033634_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN",5,-1.1284,0.33,0.44,-0.6271,0.89,1,-1.1689,0.31,0.73
"GO_BP:510377_GO_0048263_DETERMINATION_OF_DORSAL_IDENTITY","GO_BP","510377_GO_0048263_DETERMINATION_OF_DORSAL_IDENTITY",5,-1.1282,0.34,0.44,1.5459,0.041,0.35,1.0836,0.4,0.77
"C7_Immunologic_signatures:C7_ALL_709_GSE17721_0_5H_VS_4H_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_709_GSE17721_0_5H_VS_4H_LPS_BMDM_UP",197,-1.1282,0.23,0.3,1.5296,0,0.0084,-0.8306,0.91,1
"KEGG_compound:C00085_D_FRUCTOSE_6_PHOSPHATE_D_FRUCTOSE_6_PHOSPHORIC_ACID_NEUBERG_ESTER","KEGG_compound","C00085_D_FRUCTOSE_6_PHOSPHATE_D_FRUCTOSE_6_PHOSPHORIC_ACID_NEUBERG_ESTER",9,-1.1282,0.32,0.46,0.6618,0.89,1,0.626,0.93,1
"GO_BP:849770_GO_0061525_HINDGUT_DEVELOPMENT","GO_BP","849770_GO_0061525_HINDGUT_DEVELOPMENT",8,-1.1282,0.3,0.44,1.2007,0.26,0.78,1.2758,0.19,0.69
"GO_BP:752786_GO_0097285_CELL_TYPE_SPECIFIC_APOPTOTIC_PROCESS","GO_BP","752786_GO_0097285_CELL_TYPE_SPECIFIC_APOPTOTIC_PROCESS",94,-1.1281,0.26,0.44,1.0831,0.29,0.92,1.0622,0.32,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_964_COWLING_MYCN_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_964_COWLING_MYCN_TARGETS",43,-1.1281,0.28,0.37,-1.2232,0.16,0.78,-0.9444,0.51,0.83
"GO_BP:518708_GO_2000059_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","518708_GO_2000059_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",8,-1.1281,0.32,0.44,-0.9348,0.53,1,-1.4605,0.076,0.54
"C7_Immunologic_signatures:C7_ALL_1846_GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN","C7_Immunologic_signatures","C7_ALL_1846_GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN",196,-1.128,0.21,0.3,1.1913,0.1,0.24,1.3742,0.013,0.17
"GO_MF:498068_GO_0019213_DEACETYLASE_ACTIVITY","GO_MF","498068_GO_0019213_DEACETYLASE_ACTIVITY",38,-1.128,0.27,0.49,-1.021,0.4,0.89,-1.3588,0.062,0.53
"GO_BP:492879_GO_0008630_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE","GO_BP","492879_GO_0008630_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE",78,-1.1279,0.25,0.45,-0.6413,0.99,1,-1.0866,0.28,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2156_LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2156_LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN",45,-1.1278,0.28,0.37,-0.7634,0.88,1,-0.7936,0.85,0.96
"GO_BP:500313_GO_0031023_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION","GO_BP","500313_GO_0031023_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION",69,-1.1278,0.26,0.45,0.5728,1,1,-1.6367,0.002,0.53
"GO_BP:753186_GO_1900193_REGULATION_OF_OOCYTE_MATURATION","GO_BP","753186_GO_1900193_REGULATION_OF_OOCYTE_MATURATION",5,-1.1277,0.34,0.45,-1.5875,0.024,0.71,-0.9027,0.57,0.92
"GO_MF:515262_GO_0070330_AROMATASE_ACTIVITY","GO_MF","515262_GO_0070330_AROMATASE_ACTIVITY",22,-1.1277,0.32,0.49,-1.4778,0.045,0.59,1.2544,0.16,0.66
"GO_BP:488368_GO_0002495_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II","GO_BP","488368_GO_0002495_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II",93,-1.1276,0.24,0.45,1.126,0.21,0.87,-0.6643,0.99,1
"C3_TF_targets:C3_TFT_113_V_COUP_01","C3_TF_targets","C3_TFT_113_V_COUP_01",258,-1.1275,0.18,0.31,-1.1132,0.22,0.51,-0.9247,0.72,0.88
"REACTOME:833818_REACT_163810_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE","REACTOME","833818_REACT_163810_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE",5,-1.1275,0.34,0.48,0.9768,0.51,0.79,-0.9427,0.55,0.91
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_123_BIOCARTA_VIP_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_123_BIOCARTA_VIP_PATHWAY",25,-1.1274,0.27,0.43,1.1537,0.23,0.67,-1.0587,0.35,0.67
"C3_TF_targets:C3_TFT_404_V_PPAR_DR1_Q2","C3_TF_targets","C3_TFT_404_V_PPAR_DR1_Q2",250,-1.1273,0.21,0.3,-1.117,0.19,0.5,-0.8638,0.89,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_732_KOMMAGANI_TP63_GAMMA_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_732_KOMMAGANI_TP63_GAMMA_TARGETS",9,-1.1272,0.31,0.37,-0.8021,0.7,1,0.6507,0.91,1
"C7_Immunologic_signatures:C7_ALL_695_GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_695_GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDM_UP",197,-1.1271,0.21,0.31,0.8123,0.94,1,-0.7782,0.98,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_210_BIOCARTA_TFF_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_210_BIOCARTA_TFF_PATHWAY",21,-1.1271,0.29,0.42,0.9938,0.46,0.82,0.9288,0.55,1
"C7_Immunologic_signatures:C7_ALL_1701_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_1701_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP",189,-1.127,0.23,0.31,-1.0756,0.28,1,-1.379,0.0067,0.075
"C7_Immunologic_signatures:C7_ALL_435_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_435_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP",193,-1.127,0.24,0.31,1.5249,0,0.0088,0.8216,0.91,1
"REACTOME:1127625_REACT_264295_S45_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED","REACTOME","1127625_REACT_264295_S45_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED",15,-1.127,0.31,0.48,0.693,0.87,1,-0.9303,0.54,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_2935_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9","C2_Chemical_and_genetic_perturbations","C2_CGP_2935_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9",75,-1.1269,0.25,0.37,1.2633,0.095,0.42,-1.2182,0.14,0.5
"C2_Chemical_and_genetic_perturbations:C2_CGP_3161_PASINI_SUZ12_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3161_PASINI_SUZ12_TARGETS_UP",110,-1.1269,0.24,0.37,0.7783,0.94,1,0.8178,0.88,1
"C7_Immunologic_signatures:C7_ALL_558_GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_558_GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDM_DN",199,-1.1269,0.23,0.31,1.5005,0,0.012,-1.1458,0.14,0.38
"GO_BP:510694_GO_0048638_REGULATION_OF_DEVELOPMENTAL_GROWTH","GO_BP","510694_GO_0048638_REGULATION_OF_DEVELOPMENTAL_GROWTH",236,-1.1268,0.2,0.45,-0.8855,0.8,1,1.065,0.3,0.79
"GO_BP:517133_GO_0072217_NEGATIVE_REGULATION_OF_METANEPHROS_DEVELOPMENT","GO_BP","517133_GO_0072217_NEGATIVE_REGULATION_OF_METANEPHROS_DEVELOPMENT",9,-1.1267,0.33,0.45,-0.8212,0.69,1,-0.9847,0.47,0.86
"C1_Positional:C1_ALL_326_CHR2P14","C1_Positional","C1_ALL_326_CHR2P14",29,-1.1266,0.29,0.82,1.4418,0.064,0.31,0.8,0.8,0.92
"GO_BP:497167_GO_0018196_PEPTIDYL_ASPARAGINE_MODIFICATION","GO_BP","497167_GO_0018196_PEPTIDYL_ASPARAGINE_MODIFICATION",125,-1.1266,0.25,0.45,0.9712,0.54,1,-0.8728,0.8,0.95
"GO_BP:491740_GO_0006879_CELLULAR_IRON_ION_HOMEOSTASIS","GO_BP","491740_GO_0006879_CELLULAR_IRON_ION_HOMEOSTASIS",65,-1.1264,0.27,0.45,1.2874,0.075,0.69,1.1245,0.23,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_3069_LU_EZH2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3069_LU_EZH2_TARGETS_DN",394,-1.1264,0.17,0.37,0.9307,0.73,0.89,-0.9287,0.73,0.84
"GO_BP:752842_GO_0097341_ZYMOGEN_INHIBITION","GO_BP","752842_GO_0097341_ZYMOGEN_INHIBITION",10,-1.1262,0.34,0.45,-0.976,0.49,1,0.9607,0.5,0.9
"GO_MF:496540_GO_0016597_AMINO_ACID_BINDING","GO_MF","496540_GO_0016597_AMINO_ACID_BINDING",89,-1.1262,0.26,0.49,1.1556,0.19,0.74,-1.1005,0.24,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_2597_LI_WILMS_TUMOR","C2_Chemical_and_genetic_perturbations","C2_CGP_2597_LI_WILMS_TUMOR",27,-1.1261,0.26,0.37,0.9453,0.55,0.87,1.494,0.038,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_2889_DANG_MYC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2889_DANG_MYC_TARGETS_UP",141,-1.126,0.25,0.37,1.8791,0,0.023,-1.1485,0.17,0.58
"GO_BP:492203_GO_0007442_HINDGUT_MORPHOGENESIS","GO_BP","492203_GO_0007442_HINDGUT_MORPHOGENESIS",7,-1.126,0.32,0.45,1.5565,0.046,0.33,1.2773,0.17,0.69
"C7_Immunologic_signatures:C7_ALL_241_GSE14026_TH1_VS_TH17_UP","C7_Immunologic_signatures","C7_ALL_241_GSE14026_TH1_VS_TH17_UP",190,-1.1259,0.21,0.31,1.0678,0.28,0.53,0.8927,0.76,1
"C7_Immunologic_signatures:C7_ALL_1848_GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1848_GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN",194,-1.1259,0.22,0.31,1.3908,0.0067,0.041,-1.1071,0.2,0.48
"GO_BP:511949_GO_0051024_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_SECRETION","GO_BP","511949_GO_0051024_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_SECRETION",11,-1.1257,0.31,0.45,0.7572,0.81,1,0.4803,1,1
"GO_MF:500266_GO_0030976_THIAMINE_PYROPHOSPHATE_BINDING","GO_MF","500266_GO_0030976_THIAMINE_PYROPHOSPHATE_BINDING",5,-1.1256,0.34,0.5,-0.9249,0.54,0.96,-1.2922,0.17,0.59
"C3_TF_targets:C3_TFT_551_YRTCANNRCGC_UNKNOWN","C3_TF_targets","C3_TFT_551_YRTCANNRCGC_UNKNOWN",64,-1.1256,0.27,0.31,-1.1674,0.2,0.41,-1.3263,0.079,0.25
"GO_MF:509118_GO_0046912_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS_ACYL_GROUPS_CONVERTED_INTO_ALKYL_ON_TRANSFER","GO_MF","509118_GO_0046912_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS_ACYL_GROUPS_CONVERTED_INTO_ALKYL_ON_TRANSFER",5,-1.1255,0.33,0.49,0.6501,0.87,1,-1.0939,0.35,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_919_KARAKAS_TGFB1_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_919_KARAKAS_TGFB1_SIGNALING",17,-1.1255,0.29,0.37,1.1401,0.28,0.57,-0.6663,0.9,0.99
"GO_BP:506617_GO_0043586_TONGUE_DEVELOPMENT","GO_BP","506617_GO_0043586_TONGUE_DEVELOPMENT",20,-1.1255,0.28,0.45,0.7371,0.86,1,1.0119,0.44,0.84
"KEGG_enzyme:1.1.1.27_L_LACTATE_DEHYDROGENASE_LACTIC_ACID_DEHYDROGENASE_L_NLDH_L_LACTATE_DEHYDROGENASE_L_LACTIC_DEHYDROGENASE_L_LACTIC_ACID_DEHYDROGENASE_LACTATE_DEHYDROGENASE_LACTATE_DEHYDROGENASE_NAD_DEPENDENT_LACTIC_DEHYDROGENASE_NAD_LACTATE_DEHYDROGENASE","KEGG_enzyme","1.1.1.27_L_LACTATE_DEHYDROGENASE_LACTIC_ACID_DEHYDROGENASE_L_NLDH_L_LACTATE_DEHYDROGENASE_L_LACTIC_DEHYDROGENASE_L_LACTIC_ACID_DEHYDROGENASE_LACTATE_DEHYDROGENASE_LACTATE_DEHYDROGENASE_NAD_DEPENDENT_LACTIC_DEHYDROGENASE_NAD_LACTATE_DEHYDROGENASE",5,-1.1255,0.31,0.53,-0.8767,0.63,0.81,-0.8113,0.69,0.99
"GO_BP:498875_GO_0021591_VENTRICULAR_SYSTEM_DEVELOPMENT","GO_BP","498875_GO_0021591_VENTRICULAR_SYSTEM_DEVELOPMENT",26,-1.1255,0.29,0.45,0.6915,0.92,1,0.6737,0.94,1
"GO_MF:492797_GO_0008517_FOLIC_ACID_TRANSPORTER_ACTIVITY","GO_MF","492797_GO_0008517_FOLIC_ACID_TRANSPORTER_ACTIVITY",7,-1.1254,0.35,0.49,-1.0527,0.41,0.86,-0.804,0.72,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1731_WANG_CISPLATIN_RESPONSE_AND_XPC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1731_WANG_CISPLATIN_RESPONSE_AND_XPC_DN",224,-1.1252,0.2,0.37,0.8458,0.93,0.97,-0.823,0.95,0.94
"GO_MF:486680_GO_0000146_MICROFILAMENT_MOTOR_ACTIVITY","GO_MF","486680_GO_0000146_MICROFILAMENT_MOTOR_ACTIVITY",21,-1.1252,0.29,0.49,-0.8805,0.64,1,1.4437,0.062,0.51
"GO_BP:499614_GO_0030204_CHONDROITIN_SULFATE_METABOLIC_PROCESS","GO_BP","499614_GO_0030204_CHONDROITIN_SULFATE_METABOLIC_PROCESS",56,-1.1251,0.27,0.45,0.7933,0.86,1,0.9768,0.48,0.88
"GO_BP:505237_GO_0042048_OLFACTORY_BEHAVIOR","GO_BP","505237_GO_0042048_OLFACTORY_BEHAVIOR",7,-1.1251,0.33,0.45,-0.9257,0.55,1,1.191,0.26,0.72
"GO_BP:1026082_GO_1903310_POSITIVE_REGULATION_OF_CHROMATIN_MODIFICATION","GO_BP","1026082_GO_1903310_POSITIVE_REGULATION_OF_CHROMATIN_MODIFICATION",65,-1.1251,0.26,0.45,-1.0952,0.28,0.95,-1.0456,0.37,0.82
"GO_BP:487575_GO_0001662_BEHAVIORAL_FEAR_RESPONSE","GO_BP","487575_GO_0001662_BEHAVIORAL_FEAR_RESPONSE",27,-1.125,0.32,0.45,1.0164,0.42,0.97,1.6173,0.025,0.41
"GO_BP:514848_GO_0061303_CORNEA_DEVELOPMENT_IN_CAMERA_TYPE_EYE","GO_BP","514848_GO_0061303_CORNEA_DEVELOPMENT_IN_CAMERA_TYPE_EYE",10,-1.1249,0.31,0.45,-0.9948,0.47,0.99,1.7094,0.014,0.42
"C7_Immunologic_signatures:C7_ALL_920_GSE22045_TREG_VS_TCONV_DN","C7_Immunologic_signatures","C7_ALL_920_GSE22045_TREG_VS_TCONV_DN",185,-1.1249,0.22,0.31,0.8295,0.9,1,-0.9984,0.44,0.73
"GO_MF:495355_GO_0035005_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_3_KINASE_ACTIVITY","GO_MF","495355_GO_0035005_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_3_KINASE_ACTIVITY",7,-1.1249,0.32,0.49,0.9274,0.54,0.95,1.0982,0.35,0.81
"REACTOME:576249_REACT_118700_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS","REACTOME","576249_REACT_118700_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS",34,-1.1249,0.3,0.49,-0.7523,0.86,1,-1.7877,0,0.18
"GO_BP:493359_GO_0009163_NUCLEOSIDE_BIOSYNTHETIC_PROCESS","GO_BP","493359_GO_0009163_NUCLEOSIDE_BIOSYNTHETIC_PROCESS",134,-1.1248,0.25,0.45,1.0743,0.28,0.93,-1.0388,0.36,0.82
"GO_BP:781981_GO_1901992_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION","GO_BP","781981_GO_1901992_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION",45,-1.1248,0.27,0.45,0.6184,0.99,1,-1.4306,0.027,0.56
"C3_TF_targets:C3_TFT_543_YGACNNYACAR_UNKNOWN","C3_TF_targets","C3_TFT_543_YGACNNYACAR_UNKNOWN",90,-1.1247,0.26,0.31,1.0478,0.34,1,1.1962,0.15,0.71
"C4_Cancer_gene_neighborhoods:C4_CGN_75_MORF_CDH4","C4_Cancer_gene_neighborhoods","C4_CGN_75_MORF_CDH4",131,-1.1247,0.24,0.47,-1.1688,0.17,0.67,1.2332,0.079,0.4
"GO_BP:512096_GO_0051193_REGULATION_OF_COFACTOR_METABOLIC_PROCESS","GO_BP","512096_GO_0051193_REGULATION_OF_COFACTOR_METABOLIC_PROCESS",41,-1.1246,0.28,0.45,1.2619,0.12,0.72,1.2396,0.14,0.71
"GO_MF:486595_GO_0009055_ELECTRON_CARRIER_ACTIVITY","GO_MF","486595_GO_0009055_ELECTRON_CARRIER_ACTIVITY",95,-1.1246,0.23,0.49,2.0904,0,0.0053,-0.7586,0.93,0.99
"GO_BP:508163_GO_0045842_POSITIVE_REGULATION_OF_MITOTIC_METAPHASE_ANAPHASE_TRANSITION","GO_BP","508163_GO_0045842_POSITIVE_REGULATION_OF_MITOTIC_METAPHASE_ANAPHASE_TRANSITION",8,-1.1246,0.32,0.45,0.746,0.8,1,-1.0615,0.39,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_3321_YU_BAP1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3321_YU_BAP1_TARGETS",29,-1.1245,0.31,0.37,1.0224,0.4,0.77,-1.2313,0.18,0.49
"GO_BP:502789_GO_0033572_TRANSFERRIN_TRANSPORT","GO_BP","502789_GO_0033572_TRANSFERRIN_TRANSPORT",33,-1.1242,0.31,0.45,0.7775,0.88,1,1.3473,0.088,0.65
"GO_BP:514998_GO_0070059_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS","GO_BP","514998_GO_0070059_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS",28,-1.1242,0.29,0.45,-1.189,0.21,0.9,-1.5372,0.027,0.53
"GO_CC:490703_GO_0005637_NUCLEAR_INNER_MEMBRANE","GO_CC","490703_GO_0005637_NUCLEAR_INNER_MEMBRANE",44,-1.1241,0.28,0.55,0.7028,0.95,0.99,-1.3554,0.08,0.6
"GO_BP:500196_GO_0030901_MIDBRAIN_DEVELOPMENT","GO_BP","500196_GO_0030901_MIDBRAIN_DEVELOPMENT",77,-1.1241,0.25,0.45,1.1286,0.21,0.87,1.3645,0.053,0.64
"GO_MF:490579_GO_0005451_MONOVALENT_CATION_PROTON_ANTIPORTER_ACTIVITY","GO_MF","490579_GO_0005451_MONOVALENT_CATION_PROTON_ANTIPORTER_ACTIVITY",10,-1.1241,0.32,0.49,-0.7537,0.79,1,0.9491,0.54,0.92
"GO_BP:494697_GO_0010633_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION","GO_BP","494697_GO_0010633_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION",46,-1.124,0.29,0.45,0.6971,0.96,1,0.9851,0.47,0.87
"C3_TF_targets:C3_TFT_403_GCTNWTTGK_UNKNOWN","C3_TF_targets","C3_TFT_403_GCTNWTTGK_UNKNOWN",295,-1.1239,0.19,0.31,1.0226,0.37,1,0.9442,0.59,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1916_BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1916_BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN",60,-1.1239,0.27,0.37,-0.9725,0.51,1,-1.238,0.13,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_547_MAHADEVAN_IMATINIB_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_547_MAHADEVAN_IMATINIB_RESISTANCE_DN",19,-1.1238,0.29,0.37,1.1197,0.29,0.6,1.2203,0.2,0.75
"KEGG_compound:C00718_AMYLOSE_AMYLOSE_CHAIN_1_4_ALPHA_D_GLUCOSYL_N_1_4_ALPHA_D_GLUCOSYL_N_1_1_4_ALPHA_D_GLUCOSYL_N_1_4_1_4_ALPHA_D_GLUCOSYL_N_1_D_GLUCOSE_1_4_ALPHA_D_GLUCAN","KEGG_compound","C00718_AMYLOSE_AMYLOSE_CHAIN_1_4_ALPHA_D_GLUCOSYL_N_1_4_ALPHA_D_GLUCOSYL_N_1_1_4_ALPHA_D_GLUCOSYL_N_1_4_1_4_ALPHA_D_GLUCOSYL_N_1_D_GLUCOSE_1_4_ALPHA_D_GLUCAN",7,-1.1237,0.32,0.47,-1.3176,0.17,0.6,-1.4123,0.11,0.27
"C7_Immunologic_signatures:C7_ALL_86_GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN","C7_Immunologic_signatures","C7_ALL_86_GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN",190,-1.1236,0.22,0.31,0.9905,0.47,0.77,0.7926,0.96,1
"GO_MF:496746_GO_0016853_ISOMERASE_ACTIVITY","GO_MF","496746_GO_0016853_ISOMERASE_ACTIVITY",156,-1.1236,0.22,0.49,1.0032,0.47,0.87,-1.2239,0.066,0.58
"GO_BP:1129497_GO_1903671_NEGATIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS","GO_BP","1129497_GO_1903671_NEGATIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS",8,-1.1235,0.34,0.45,-1.2417,0.22,0.91,-1.1084,0.34,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_57_SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_57_SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN",51,-1.1235,0.27,0.37,-0.7662,0.87,1,-1.0941,0.32,0.64
"GO_BP:513894_GO_0060338_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY","GO_BP","513894_GO_0060338_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY",36,-1.1234,0.3,0.45,0.878,0.66,1,-1.2608,0.13,0.67
"C7_Immunologic_signatures:C7_ALL_1536_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN","C7_Immunologic_signatures","C7_ALL_1536_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN",198,-1.1232,0.21,0.31,-0.8165,0.93,1,-1.0716,0.27,0.57
"C4_Cancer_gene_neighborhoods:C4_CGN_138_MORF_ORC1L","C4_Cancer_gene_neighborhoods","C4_CGN_138_MORF_ORC1L",69,-1.1232,0.27,0.47,0.6892,0.98,1,-0.6749,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1802_VISALA_AGING_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1802_VISALA_AGING_LYMPHOCYTE_DN",19,-1.1232,0.3,0.38,1.1189,0.29,0.6,-0.7719,0.81,0.97
"GO_BP:507086_GO_0044070_REGULATION_OF_ANION_TRANSPORT","GO_BP","507086_GO_0044070_REGULATION_OF_ANION_TRANSPORT",123,-1.1232,0.25,0.45,0.8502,0.82,1,1.0669,0.32,0.79
"GO_BP:497245_GO_0018279_PROTEIN_N_LINKED_GLYCOSYLATION_VIA_ASPARAGINE","GO_BP","497245_GO_0018279_PROTEIN_N_LINKED_GLYCOSYLATION_VIA_ASPARAGINE",124,-1.1232,0.23,0.45,0.9799,0.5,1,-0.9141,0.67,0.92
"GO_MF:500741_GO_0031490_CHROMATIN_DNA_BINDING","GO_MF","500741_GO_0031490_CHROMATIN_DNA_BINDING",70,-1.1232,0.27,0.49,0.8584,0.76,1,-0.813,0.83,0.96
"GO_BP:514323_GO_0060768_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT","GO_BP","514323_GO_0060768_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT",9,-1.1231,0.32,0.45,0.5891,0.96,1,1.0754,0.35,0.78
"C3_TF_targets:C3_TFT_310_V_ERR1_Q2","C3_TF_targets","C3_TFT_310_V_ERR1_Q2",256,-1.1231,0.21,0.31,-0.8629,0.85,1,-0.9615,0.56,0.82
"GO_BP:504760_GO_0035581_SEQUESTERING_OF_EXTRACELLULAR_LIGAND_FROM_RECEPTOR","GO_BP","504760_GO_0035581_SEQUESTERING_OF_EXTRACELLULAR_LIGAND_FROM_RECEPTOR",8,-1.123,0.34,0.45,1.0019,0.44,0.98,-1.6257,0.025,0.52
"GO_CC:502862_GO_0033646_HOST_INTRACELLULAR_PART","GO_CC","502862_GO_0033646_HOST_INTRACELLULAR_PART",6,-1.123,0.36,0.55,-0.9558,0.53,0.89,-0.7704,0.75,1
"C4_Cancer_gene_neighborhoods:C4_CGN_60_MORF_AP2M1","C4_Cancer_gene_neighborhoods","C4_CGN_60_MORF_AP2M1",219,-1.123,0.2,0.46,2.2562,0,0,-0.7551,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2463_DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2463_DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP",12,-1.123,0.3,0.38,-0.4892,0.99,1,0.9566,0.49,0.99
"GO_MF:497892_GO_0019003_GDP_BINDING","GO_MF","497892_GO_0019003_GDP_BINDING",50,-1.123,0.29,0.49,1.493,0.022,0.39,-0.7953,0.83,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1962_CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB","C2_Chemical_and_genetic_perturbations","C2_CGP_1962_CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB",17,-1.123,0.33,0.38,1.0796,0.33,0.66,1.2804,0.17,0.69
"GO_MF:505242_GO_0042056_CHEMOATTRACTANT_ACTIVITY","GO_MF","505242_GO_0042056_CHEMOATTRACTANT_ACTIVITY",22,-1.1227,0.3,0.49,1.2081,0.2,0.7,1.2977,0.14,0.65
"GO_BP:494954_GO_0010890_POSITIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE","GO_BP","494954_GO_0010890_POSITIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE",7,-1.1227,0.33,0.45,0.6807,0.86,1,0.7053,0.84,1
"C7_Immunologic_signatures:C7_ALL_878_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN","C7_Immunologic_signatures","C7_ALL_878_GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN",198,-1.1225,0.21,0.31,-0.9707,0.51,1,-1.17,0.13,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_1096_BALDWIN_PRKCI_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1096_BALDWIN_PRKCI_TARGETS_UP",35,-1.1225,0.29,0.38,1.2778,0.11,0.42,0.9153,0.6,1
"C7_Immunologic_signatures:C7_ALL_1049_GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP","C7_Immunologic_signatures","C7_ALL_1049_GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP",198,-1.1225,0.23,0.31,1.0011,0.43,0.73,-1.3636,0.021,0.084
"GO_BP:755373_GO_2001267_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","755373_GO_2001267_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",10,-1.1225,0.31,0.45,1.3546,0.13,0.61,-1.1462,0.3,0.74
"GO_BP:510293_GO_0048168_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY","GO_BP","510293_GO_0048168_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY",48,-1.1224,0.28,0.45,-1.1245,0.27,0.94,-1.0368,0.4,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1977_JIANG_AGING_HYPOTHALAMUS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1977_JIANG_AGING_HYPOTHALAMUS_UP",47,-1.1223,0.3,0.38,1.796,0,0.044,-1.526,0.014,0.29
"KEGG_compound:C00361_DGDP_2_DEOXYGUANOSINE_5_DIPHOSPHATE","KEGG_compound","C00361_DGDP_2_DEOXYGUANOSINE_5_DIPHOSPHATE",17,-1.1223,0.3,0.47,0.4722,1,1,-1.3887,0.08,0.3
"C2_Chemical_and_genetic_perturbations:C2_CGP_1690_PAL_PRMT5_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1690_PAL_PRMT5_TARGETS_UP",202,-1.122,0.22,0.38,1.3649,0.01,0.33,-1.0692,0.29,0.67
"GO_BP:751684_GO_0044539_LONG_CHAIN_FATTY_ACID_IMPORT","GO_BP","751684_GO_0044539_LONG_CHAIN_FATTY_ACID_IMPORT",7,-1.122,0.34,0.45,0.8201,0.67,1,0.9308,0.53,0.92
"GO_BP:504588_GO_0035404_HISTONE_SERINE_PHOSPHORYLATION","GO_BP","504588_GO_0035404_HISTONE_SERINE_PHOSPHORYLATION",11,-1.1219,0.33,0.45,-0.8018,0.74,1,-1.1706,0.24,0.73
"GO_BP:488566_GO_0002693_POSITIVE_REGULATION_OF_CELLULAR_EXTRAVASATION","GO_BP","488566_GO_0002693_POSITIVE_REGULATION_OF_CELLULAR_EXTRAVASATION",6,-1.1218,0.34,0.45,0.966,0.5,1,0.9423,0.52,0.91
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_108_BIOCARTA_INTRINSIC_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_108_BIOCARTA_INTRINSIC_PATHWAY",23,-1.1218,0.31,0.43,1.0999,0.31,0.72,1.1587,0.27,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1680_SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B","C2_Chemical_and_genetic_perturbations","C2_CGP_1680_SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B",23,-1.1216,0.29,0.38,1.1904,0.24,0.5,-1.04,0.4,0.7
"GO_BP:510654_GO_0048593_CAMERA_TYPE_EYE_MORPHOGENESIS","GO_BP","510654_GO_0048593_CAMERA_TYPE_EYE_MORPHOGENESIS",107,-1.1216,0.26,0.45,1.0535,0.32,0.95,1.6368,0,0.4
"WikiPathways:198833_WP176_FOLATE_METABOLISM","WikiPathways","198833_WP176_FOLATE_METABOLISM",22,-1.1215,0.29,0.4,1.1751,0.22,0.91,-0.7766,0.8,0.95
"GO_MF:496696_GO_0016790_THIOLESTER_HYDROLASE_ACTIVITY","GO_MF","496696_GO_0016790_THIOLESTER_HYDROLASE_ACTIVITY",29,-1.1214,0.3,0.5,-0.8981,0.59,0.99,-1.0465,0.38,0.75
"GO_BP:513988_GO_0060433_BRONCHUS_DEVELOPMENT","GO_BP","513988_GO_0060433_BRONCHUS_DEVELOPMENT",7,-1.121,0.34,0.45,0.9906,0.45,0.99,1.116,0.33,0.75
"GO_MF:490452_GO_0005201_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT","GO_MF","490452_GO_0005201_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT",74,-1.121,0.26,0.5,-1.292,0.079,0.8,1.5232,0.006,0.4
"C4_Cancer_modules:C4_CM_203_MODULE_218","C4_Cancer_modules","C4_CM_203_MODULE_218",19,-1.1209,0.3,0.39,-1.8512,0,0.1,1.2059,0.23,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_1584_HASLINGER_B_CLL_WITH_6Q21_DELETION","C2_Chemical_and_genetic_perturbations","C2_CGP_1584_HASLINGER_B_CLL_WITH_6Q21_DELETION",20,-1.1209,0.29,0.38,-0.9883,0.46,1,-0.916,0.6,0.86
"GO_MF:496728_GO_0016831_CARBOXY_LYASE_ACTIVITY","GO_MF","496728_GO_0016831_CARBOXY_LYASE_ACTIVITY",33,-1.1208,0.3,0.5,-0.9401,0.55,0.96,-0.7274,0.89,0.99
"GO_BP:510376_GO_0048262_DETERMINATION_OF_DORSAL_VENTRAL_ASYMMETRY","GO_BP","510376_GO_0048262_DETERMINATION_OF_DORSAL_VENTRAL_ASYMMETRY",5,-1.1208,0.35,0.45,1.5182,0.055,0.38,1.1388,0.33,0.73
"GO_BP:517339_GO_0072423_RESPONSE_TO_DNA_DAMAGE_CHECKPOINT_SIGNALING","GO_BP","517339_GO_0072423_RESPONSE_TO_DNA_DAMAGE_CHECKPOINT_SIGNALING",5,-1.1207,0.35,0.45,-0.9429,0.54,1,-1.0506,0.42,0.81
"GO_BP:513531_GO_0055098_RESPONSE_TO_LOW_DENSITY_LIPOPROTEIN_PARTICLE","GO_BP","513531_GO_0055098_RESPONSE_TO_LOW_DENSITY_LIPOPROTEIN_PARTICLE",6,-1.1205,0.35,0.45,1.0592,0.39,0.94,1.2246,0.24,0.71
"GO_MF:489254_GO_0003708_RETINOIC_ACID_RECEPTOR_ACTIVITY","GO_MF","489254_GO_0003708_RETINOIC_ACID_RECEPTOR_ACTIVITY",7,-1.1204,0.33,0.5,-0.9487,0.51,0.94,-1.0864,0.37,0.7
"GO_MF:496691_GO_0016782_TRANSFERASE_ACTIVITY_TRANSFERRING_SULFUR_CONTAINING_GROUPS","GO_MF","496691_GO_0016782_TRANSFERASE_ACTIVITY_TRANSFERRING_SULFUR_CONTAINING_GROUPS",60,-1.1204,0.26,0.5,1.9063,0,0.031,1.5621,0.0058,0.38
"C7_Immunologic_signatures:C7_ALL_496_GSE17721_CTRL_VS_CPG_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_496_GSE17721_CTRL_VS_CPG_0_5H_BMDM_DN",192,-1.1204,0.22,0.32,0.9067,0.72,1,-0.988,0.48,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_2835_LOPEZ_MESOTHELIOMA_SURVIVAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2835_LOPEZ_MESOTHELIOMA_SURVIVAL_UP",11,-1.1204,0.33,0.38,0.6165,0.95,1,-1.0102,0.43,0.74
"GO_BP:512238_GO_0051354_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY","GO_BP","512238_GO_0051354_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY",23,-1.1202,0.3,0.45,0.7428,0.83,1,-0.9431,0.53,0.89
"GO_BP:514295_GO_0060740_PROSTATE_GLAND_EPITHELIUM_MORPHOGENESIS","GO_BP","514295_GO_0060740_PROSTATE_GLAND_EPITHELIUM_MORPHOGENESIS",23,-1.1201,0.3,0.46,1.0192,0.42,0.97,1.5378,0.028,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_2771_MIKKELSEN_MEF_LCP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2771_MIKKELSEN_MEF_LCP_WITH_H3K27ME3",63,-1.12,0.27,0.38,-1.1139,0.26,0.9,-1.2926,0.088,0.43
"GO_BP:487562_GO_0001649_OSTEOBLAST_DIFFERENTIATION","GO_BP","487562_GO_0001649_OSTEOBLAST_DIFFERENTIATION",118,-1.1197,0.24,0.46,1.3375,0.039,0.62,0.9707,0.52,0.89
"GO_BP:488377_GO_0002504_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II","GO_BP","488377_GO_0002504_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II",93,-1.1197,0.27,0.46,1.1343,0.21,0.86,-0.6666,0.99,1
"GO_BP:508258_GO_0045956_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS","GO_BP","508258_GO_0045956_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS",15,-1.1197,0.34,0.46,-1.625,0.026,0.69,-1.2979,0.15,0.65
"GO_BP:492420_GO_0008045_MOTOR_NEURON_AXON_GUIDANCE","GO_BP","492420_GO_0008045_MOTOR_NEURON_AXON_GUIDANCE",26,-1.1196,0.3,0.46,-1.1153,0.27,0.94,0.8375,0.74,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1393_SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1393_SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN",43,-1.1195,0.29,0.38,1.3947,0.057,0.3,-1.0669,0.33,0.67
"C7_Immunologic_signatures:C7_ALL_198_GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_198_GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN",197,-1.1195,0.24,0.32,1.5499,0,0.0061,-1.082,0.25,0.54
"GO_BP:753040_GO_1900044_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION","GO_BP","753040_GO_1900044_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION",6,-1.1195,0.35,0.46,-0.8082,0.69,1,-0.8059,0.72,0.98
"C7_Immunologic_signatures:C7_ALL_765_GSE17974_0H_VS_0_5H_IN_VITRO_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_765_GSE17974_0H_VS_0_5H_IN_VITRO_ACT_CD4_TCELL_UP",183,-1.1194,0.24,0.32,-0.9751,0.52,1,-1.0529,0.32,0.61
"GO_BP:514502_GO_0060947_CARDIAC_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION","GO_BP","514502_GO_0060947_CARDIAC_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION",6,-1.1192,0.34,0.46,0.7047,0.84,1,1.1597,0.3,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1993_BILD_E2F3_ONCOGENIC_SIGNATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_1993_BILD_E2F3_ONCOGENIC_SIGNATURE",242,-1.1191,0.22,0.38,-0.8015,0.96,1,-1.1282,0.17,0.59
"GO_BP:513890_GO_0060334_REGULATION_OF_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY","GO_BP","513890_GO_0060334_REGULATION_OF_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY",24,-1.119,0.3,0.46,0.9373,0.53,1,-1.0854,0.32,0.79
"C7_Immunologic_signatures:C7_ALL_1316_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN","C7_Immunologic_signatures","C7_ALL_1316_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN",196,-1.119,0.23,0.32,0.9105,0.72,1,0.7702,0.97,1
"KEGG_pathway:HSA05120_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION","KEGG_pathway","HSA05120_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION",67,-1.119,0.27,0.34,0.9267,0.57,1,0.8562,0.75,1
"C1_Positional:C1_ALL_69_CHR1P31","C1_Positional","C1_ALL_69_CHR1P31",80,-1.1188,0.28,0.84,1.2489,0.095,0.59,0.9319,0.61,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1664_KAYO_CALORIE_RESTRICTION_MUSCLE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1664_KAYO_CALORIE_RESTRICTION_MUSCLE_DN",83,-1.1188,0.28,0.38,1.5767,0.0046,0.16,-0.8325,0.82,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1376_ASTON_MAJOR_DEPRESSIVE_DISORDER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1376_ASTON_MAJOR_DEPRESSIVE_DISORDER_UP",48,-1.1188,0.28,0.38,-0.8473,0.75,1,-1.0749,0.33,0.66
"GO_BP:505642_GO_0042511_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT1_PROTEIN","GO_BP","505642_GO_0042511_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT1_PROTEIN",9,-1.1187,0.3,0.46,-1.2401,0.21,0.91,-1.3081,0.17,0.64
"GO_CC:500489_GO_0031228_INTRINSIC_COMPONENT_OF_GOLGI_MEMBRANE","GO_CC","500489_GO_0031228_INTRINSIC_COMPONENT_OF_GOLGI_MEMBRANE",49,-1.1187,0.29,0.56,0.8205,0.79,0.94,0.7608,0.89,1
"GO_MF:512770_GO_0051920_PEROXIREDOXIN_ACTIVITY","GO_MF","512770_GO_0051920_PEROXIREDOXIN_ACTIVITY",7,-1.1187,0.33,0.5,1.3549,0.16,0.52,-1.312,0.17,0.56
"C4_Cancer_gene_neighborhoods:C4_CGN_121_MORF_KDR","C4_Cancer_gene_neighborhoods","C4_CGN_121_MORF_KDR",89,-1.1187,0.28,0.47,1.1038,0.25,0.36,1.4525,0.02,0.2
"GO_BP:503570_GO_0034368_PROTEIN_LIPID_COMPLEX_REMODELING","GO_BP","503570_GO_0034368_PROTEIN_LIPID_COMPLEX_REMODELING",23,-1.1187,0.3,0.46,-0.4996,1,1,1.3014,0.15,0.67
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_74_BIOCARTA_FIBRINOLYSIS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_74_BIOCARTA_FIBRINOLYSIS_PATHWAY",12,-1.1187,0.32,0.43,1.4285,0.086,0.48,1.4772,0.065,1
"C7_Immunologic_signatures:C7_ALL_866_GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_866_GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN",200,-1.1186,0.22,0.32,0.7262,0.99,1,-1.0514,0.29,0.61
"GO_BP:503581_GO_0034379_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY","GO_BP","503581_GO_0034379_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY",8,-1.1185,0.32,0.46,-0.8561,0.64,1,1.4724,0.082,0.58
"GO_CC:921094_GO_0097539_CILIARY_TRANSITION_FIBER","GO_CC","921094_GO_0097539_CILIARY_TRANSITION_FIBER",5,-1.1185,0.35,0.56,-1.2502,0.23,0.66,-1.3974,0.11,0.6
"GO_BP:503594_GO_0034392_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","503594_GO_0034392_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS",5,-1.1184,0.35,0.46,0.6121,0.92,1,1.2371,0.27,0.7
"C7_Immunologic_signatures:C7_ALL_51_GSE10325_BCELL_VS_LUPUS_BCELL_UP","C7_Immunologic_signatures","C7_ALL_51_GSE10325_BCELL_VS_LUPUS_BCELL_UP",187,-1.1184,0.23,0.32,-1.0795,0.29,1,0.9319,0.65,1
"GO_BP:517299_GO_0072383_PLUS_END_DIRECTED_VESICLE_TRANSPORT_ALONG_MICROTUBULE","GO_BP","517299_GO_0072383_PLUS_END_DIRECTED_VESICLE_TRANSPORT_ALONG_MICROTUBULE",6,-1.1182,0.34,0.46,0.8646,0.62,1,0.6085,0.9,1
"GO_BP:517248_GO_0072332_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR","GO_BP","517248_GO_0072332_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR",48,-1.118,0.29,0.46,-0.5294,1,1,-1.5243,0.01,0.53
"C3_TF_targets:C3_TFT_418_V_STAT_Q6","C3_TF_targets","C3_TFT_418_V_STAT_Q6",257,-1.118,0.2,0.32,-0.7614,0.98,1,-1.0292,0.34,0.67
"GO_BP:518150_GO_0090003_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE","GO_BP","518150_GO_0090003_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",44,-1.1179,0.27,0.46,0.957,0.55,1,1.049,0.37,0.81
"C4_Cancer_modules:C4_CM_184_MODULE_197","C4_Cancer_modules","C4_CM_184_MODULE_197",172,-1.1178,0.23,0.39,1.0089,0.41,0.7,-1.2714,0.045,0.32
"C7_Immunologic_signatures:C7_ALL_1371_GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1371_GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP",199,-1.1177,0.23,0.32,0.6048,1,1,-1.3417,0.011,0.1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3139_CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY","C2_Chemical_and_genetic_perturbations","C2_CGP_3139_CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY",34,-1.1177,0.28,0.38,1.4401,0.052,0.26,1.4656,0.041,0.53
"REACTOME:1127679_REACT_263902_O_LINKED_GLYCOSYLATION","REACTOME","1127679_REACT_263902_O_LINKED_GLYCOSYLATION",102,-1.1176,0.27,0.5,-0.8774,0.72,1,1.5429,0.0019,0.44
"C2_Chemical_and_genetic_perturbations:C2_CGP_1126_BENPORATH_ES_CORE_NINE_CORRELATED","C2_Chemical_and_genetic_perturbations","C2_CGP_1126_BENPORATH_ES_CORE_NINE_CORRELATED",99,-1.1173,0.25,0.38,-0.7651,0.93,1,-0.9366,0.59,0.84
"GO_BP:514451_GO_0060896_NEURAL_PLATE_PATTERN_SPECIFICATION","GO_BP","514451_GO_0060896_NEURAL_PLATE_PATTERN_SPECIFICATION",9,-1.1172,0.32,0.46,-1.2774,0.19,0.89,1.186,0.27,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1379_FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1379_FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP",150,-1.1172,0.23,0.38,1.9318,0,0.014,-0.7389,0.98,0.98
"GO_BP:513436_GO_0055003_CARDIAC_MYOFIBRIL_ASSEMBLY","GO_BP","513436_GO_0055003_CARDIAC_MYOFIBRIL_ASSEMBLY",15,-1.1171,0.32,0.46,-1.7145,0.011,0.76,1.1526,0.29,0.73
"C4_Cancer_gene_neighborhoods:C4_CGN_175_MORF_RUNX1","C4_Cancer_gene_neighborhoods","C4_CGN_175_MORF_RUNX1",146,-1.1171,0.24,0.47,-0.9735,0.52,0.86,0.7811,0.94,1
"C7_Immunologic_signatures:C7_ALL_1510_GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN","C7_Immunologic_signatures","C7_ALL_1510_GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN",198,-1.1171,0.23,0.32,1.3968,0.013,0.038,-1.0481,0.32,0.62
"KEGG_compound:C00258_D_GLYCERATE_GLYCERATE_R_GLYCERATE_GLYCERIC_ACID","KEGG_compound","C00258_D_GLYCERATE_GLYCERATE_R_GLYCERATE_GLYCERIC_ACID",7,-1.1171,0.33,0.48,0.6421,0.9,1,-0.8735,0.6,0.78
"C3_TF_targets:C3_TFT_220_V_PAX4_01","C3_TF_targets","C3_TFT_220_V_PAX4_01",253,-1.117,0.22,0.32,-0.7818,0.98,1,0.8378,0.92,1
"GO_BP:500906_GO_0031657_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","500906_GO_0031657_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",8,-1.117,0.32,0.46,-0.7724,0.78,1,1.0977,0.34,0.76
"GO_BP:508381_GO_0046085_ADENOSINE_METABOLIC_PROCESS","GO_BP","508381_GO_0046085_ADENOSINE_METABOLIC_PROCESS",15,-1.1169,0.33,0.46,-0.6613,0.92,1,-1.1933,0.24,0.74
"GO_BP:514080_GO_0060525_PROSTATE_GLANDULAR_ACINUS_DEVELOPMENT","GO_BP","514080_GO_0060525_PROSTATE_GLANDULAR_ACINUS_DEVELOPMENT",12,-1.1168,0.33,0.46,1.1035,0.33,0.9,1.3064,0.14,0.67
"GO_BP:500589_GO_0031330_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS","GO_BP","500589_GO_0031330_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS",167,-1.1167,0.25,0.46,1.0334,0.37,0.96,-0.7043,1,0.99
"GO_BP:491388_GO_0006487_PROTEIN_N_LINKED_GLYCOSYLATION","GO_BP","491388_GO_0006487_PROTEIN_N_LINKED_GLYCOSYLATION",132,-1.1167,0.28,0.46,0.9356,0.63,1,-0.933,0.63,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_53_WATANABE_COLON_CANCER_MSI_VS_MSS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_53_WATANABE_COLON_CANCER_MSI_VS_MSS_DN",77,-1.1167,0.29,0.38,1.291,0.062,0.4,-0.9458,0.58,0.83
"GO_BP:512182_GO_0051297_CENTROSOME_ORGANIZATION","GO_BP","512182_GO_0051297_CENTROSOME_ORGANIZATION",63,-1.1166,0.29,0.46,0.6086,0.99,1,-1.6647,0.0039,0.55
"C4_Cancer_modules:C4_CM_144_MODULE_152","C4_Cancer_modules","C4_CM_144_MODULE_152",124,-1.1166,0.25,0.39,2.4118,0,0,-0.807,0.92,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_89_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_89_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN",85,-1.1166,0.27,0.38,0.9429,0.59,0.87,-1.0841,0.31,0.65
"GO_CC:506686_GO_0043656_INTRACELLULAR_REGION_OF_HOST","GO_CC","506686_GO_0043656_INTRACELLULAR_REGION_OF_HOST",6,-1.1165,0.32,0.56,-0.9502,0.54,0.89,-0.7889,0.75,1
"GO_BP:517302_GO_0072386_PLUS_END_DIRECTED_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE","GO_BP","517302_GO_0072386_PLUS_END_DIRECTED_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE",6,-1.1165,0.34,0.46,0.8605,0.65,1,0.6035,0.93,1
"C3_MicroRNA_targets:C3_MIR_171_GACAATC_MIR_219","C3_MicroRNA_targets","C3_MIR_171_GACAATC_MIR_219",143,-1.1164,0.24,0.42,-1.1408,0.18,1,1.0361,0.36,1
"GO_BP:514452_GO_0060897_NEURAL_PLATE_REGIONALIZATION","GO_BP","514452_GO_0060897_NEURAL_PLATE_REGIONALIZATION",7,-1.1164,0.32,0.46,-1.0278,0.42,0.97,1.3251,0.16,0.65
"GO_MF:752700_GO_0097199_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY","GO_MF","752700_GO_0097199_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",7,-1.1163,0.35,0.5,-0.9337,0.55,0.96,-0.9382,0.54,0.85
"GO_BP:506527_GO_0043496_REGULATION_OF_PROTEIN_HOMODIMERIZATION_ACTIVITY","GO_BP","506527_GO_0043496_REGULATION_OF_PROTEIN_HOMODIMERIZATION_ACTIVITY",18,-1.1161,0.31,0.46,1.0554,0.38,0.94,0.6367,0.93,1
"REACTOME:161050_REACT_22186_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE","REACTOME","161050_REACT_22186_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE",71,-1.116,0.28,0.5,-1.3065,0.084,0.66,-1.6349,0,0.24
"C4_Cancer_gene_neighborhoods:C4_CGN_181_MORF_THPO","C4_Cancer_gene_neighborhoods","C4_CGN_181_MORF_THPO",122,-1.1159,0.27,0.47,1.2228,0.091,0.19,1.3767,0.014,0.24
"GO_BP:508612_GO_0046348_AMINO_SUGAR_CATABOLIC_PROCESS","GO_BP","508612_GO_0046348_AMINO_SUGAR_CATABOLIC_PROCESS",13,-1.1159,0.34,0.46,1.2335,0.2,0.75,0.73,0.84,1
"GO_BP:519143_GO_2000503_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS","GO_BP","519143_GO_2000503_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS",6,-1.1159,0.32,0.46,1.271,0.19,0.71,1.2498,0.22,0.69
"GO_BP:512802_GO_0051952_REGULATION_OF_AMINE_TRANSPORT","GO_BP","512802_GO_0051952_REGULATION_OF_AMINE_TRANSPORT",76,-1.1159,0.28,0.46,1.0143,0.4,0.97,1.2361,0.12,0.7
"REACTOME:1127629_REACT_264092_MISSPLICED_GSK3BETA_MUTANTS_STABILIZE_BETA_CATENIN","REACTOME","1127629_REACT_264092_MISSPLICED_GSK3BETA_MUTANTS_STABILIZE_BETA_CATENIN",15,-1.1158,0.33,0.5,0.7077,0.86,1,-0.9052,0.58,0.95
"GO_BP:516792_GO_0071871_RESPONSE_TO_EPINEPHRINE","GO_BP","516792_GO_0071871_RESPONSE_TO_EPINEPHRINE",13,-1.1157,0.32,0.46,-0.6536,0.92,1,-0.9082,0.57,0.92
"KEGG_compound:C05823_3_MERCAPTOLACTATE_L_3_MERCAPTOLACTATE_R_3_MERCAPTOLACTATE","KEGG_compound","C05823_3_MERCAPTOLACTATE_L_3_MERCAPTOLACTATE_R_3_MERCAPTOLACTATE",5,-1.1157,0.37,0.48,-0.8667,0.66,1,-0.8054,0.69,0.84
"C7_Immunologic_signatures:C7_ALL_968_GSE22886_NEUTROPHIL_VS_DC_DN","C7_Immunologic_signatures","C7_ALL_968_GSE22886_NEUTROPHIL_VS_DC_DN",200,-1.1156,0.23,0.33,2.2421,0,0,-0.8592,0.86,1
"C3_TF_targets:C3_TFT_154_V_TATA_C","C3_TF_targets","C3_TFT_154_V_TATA_C",264,-1.1155,0.23,0.33,1.1549,0.11,0.85,-0.9939,0.46,0.78
"C7_Immunologic_signatures:C7_ALL_1704_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN","C7_Immunologic_signatures","C7_ALL_1704_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN",200,-1.1154,0.25,0.33,1.3365,0.012,0.072,-1.273,0.033,0.17
"C3_TF_targets:C3_TFT_431_V_AP2_Q3","C3_TF_targets","C3_TFT_431_V_AP2_Q3",247,-1.1153,0.25,0.33,-0.9701,0.56,0.82,-0.7844,0.99,1
"C7_Immunologic_signatures:C7_ALL_713_GSE17721_0_5H_VS_24H_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_713_GSE17721_0_5H_VS_24H_LPS_BMDM_UP",195,-1.1152,0.24,0.33,1.5642,0,0.0051,-0.6832,1,1
"GO_BP:513457_GO_0055024_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","513457_GO_0055024_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",47,-1.1152,0.29,0.46,-0.8004,0.81,1,1.5388,0.0075,0.53
"C7_Immunologic_signatures:C7_ALL_617_GSE17721_POLYIC_VS_CPG_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_617_GSE17721_POLYIC_VS_CPG_0_5H_BMDM_UP",195,-1.1152,0.23,0.33,-0.8956,0.74,1,-1.0581,0.3,0.6
"GO_BP:506600_GO_0043569_NEGATIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","506600_GO_0043569_NEGATIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",7,-1.1151,0.35,0.46,0.6876,0.86,1,1.1402,0.31,0.73
"GO_BP:501919_GO_0032693_NEGATIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION","GO_BP","501919_GO_0032693_NEGATIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION",15,-1.1151,0.33,0.46,-0.8363,0.69,1,0.8891,0.6,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1235_DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY","C2_Chemical_and_genetic_perturbations","C2_CGP_1235_DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY",26,-1.115,0.34,0.39,-1.1239,0.29,0.89,-1.3546,0.088,0.39
"C7_Immunologic_signatures:C7_ALL_753_GSE17721_0_5H_VS_12H_GARDIQUIMOD_BMDM_UP","C7_Immunologic_signatures","C7_ALL_753_GSE17721_0_5H_VS_12H_GARDIQUIMOD_BMDM_UP",199,-1.115,0.24,0.33,1.4497,0.0024,0.022,-0.9732,0.52,0.79
"GO_MF:512255_GO_0051371_MUSCLE_ALPHA_ACTININ_BINDING","GO_MF","512255_GO_0051371_MUSCLE_ALPHA_ACTININ_BINDING",9,-1.1149,0.34,0.51,-1.0753,0.39,0.86,1.0845,0.37,0.81
"GO_BP:513819_GO_0060263_REGULATION_OF_RESPIRATORY_BURST","GO_BP","513819_GO_0060263_REGULATION_OF_RESPIRATORY_BURST",9,-1.1148,0.34,0.46,0.6635,0.89,1,-1.3135,0.14,0.64
"GO_MF:507434_GO_0045028_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY","GO_MF","507434_GO_0045028_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY",14,-1.1147,0.33,0.5,1.7436,0.015,0.12,1.0977,0.34,0.81
"C7_Immunologic_signatures:C7_ALL_25_GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_25_GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP",196,-1.1147,0.24,0.33,1.7883,0,0.00017,-0.8357,0.88,1
"C7_Immunologic_signatures:C7_ALL_1150_GSE27786_LSK_VS_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1150_GSE27786_LSK_VS_CD8_TCELL_DN",198,-1.1146,0.25,0.33,1.045,0.34,0.6,-0.8166,0.94,1
"C3_TF_targets:C3_TFT_345_V_MAZ_Q6","C3_TF_targets","C3_TFT_345_V_MAZ_Q6",189,-1.1145,0.25,0.33,-0.9755,0.53,0.82,-0.9819,0.5,0.79
"WikiPathways:672451_WP2203_TSLP_SIGNALING_PATHWAY","WikiPathways","672451_WP2203_TSLP_SIGNALING_PATHWAY",37,-1.1144,0.29,0.41,0.8619,0.67,1,-0.7967,0.81,0.97
"C3_MicroRNA_targets:C3_MIR_94_CCAGGTT_MIR_490","C3_MicroRNA_targets","C3_MIR_94_CCAGGTT_MIR_490",65,-1.1144,0.28,0.42,-0.7818,0.9,1,-0.7011,0.97,1
"GO_BP:516359_GO_0071435_POTASSIUM_ION_EXPORT","GO_BP","516359_GO_0071435_POTASSIUM_ION_EXPORT",10,-1.1143,0.33,0.46,-0.8513,0.65,1,-0.8079,0.72,0.98
"GO_BP:508086_GO_0045747_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY","GO_BP","508086_GO_0045747_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY",24,-1.1143,0.32,0.46,0.6901,0.92,1,0.7102,0.91,1
"WikiPathways:672447_WP2018_RANKL_RANK_SIGNALING_PATHWAY","WikiPathways","672447_WP2018_RANKL_RANK_SIGNALING_PATHWAY",54,-1.114,0.3,0.41,-0.8192,0.78,1,-0.6651,0.98,1
"GO_BP:499962_GO_0051196_REGULATION_OF_COENZYME_METABOLIC_PROCESS","GO_BP","499962_GO_0051196_REGULATION_OF_COENZYME_METABOLIC_PROCESS",41,-1.1139,0.3,0.46,1.2683,0.12,0.71,1.2915,0.1,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_1911_DAZARD_UV_RESPONSE_CLUSTER_G1","C2_Chemical_and_genetic_perturbations","C2_CGP_1911_DAZARD_UV_RESPONSE_CLUSTER_G1",67,-1.1138,0.27,0.39,1.8486,0,0.028,-0.9149,0.63,0.86
"GO_BP:755358_GO_2001252_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION","GO_BP","755358_GO_2001252_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION",82,-1.1137,0.29,0.46,-0.8947,0.7,1,-1.105,0.28,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_91_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_91_TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN",72,-1.1135,0.27,0.39,-0.8485,0.75,1,0.836,0.81,1
"GO_BP:491082_GO_0006104_SUCCINYL_COA_METABOLIC_PROCESS","GO_BP","491082_GO_0006104_SUCCINYL_COA_METABOLIC_PROCESS",5,-1.1135,0.38,0.46,-0.4393,1,1,-0.8017,0.73,0.99
"GO_BP:491588_GO_0006701_PROGESTERONE_BIOSYNTHETIC_PROCESS","GO_BP","491588_GO_0006701_PROGESTERONE_BIOSYNTHETIC_PROCESS",7,-1.1135,0.32,0.46,-1.1179,0.32,0.94,1.1458,0.29,0.73
"KEGG_pathway:HSA04672_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION","KEGG_pathway","HSA04672_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION",44,-1.1134,0.3,0.34,-0.9503,0.52,0.96,0.6674,0.96,1
"GO_BP:488152_GO_0002279_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488152_GO_0002279_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",17,-1.1134,0.32,0.46,-0.7702,0.78,1,-1.0754,0.35,0.8
"GO_BP:511948_GO_0051023_REGULATION_OF_IMMUNOGLOBULIN_SECRETION","GO_BP","511948_GO_0051023_REGULATION_OF_IMMUNOGLOBULIN_SECRETION",16,-1.1134,0.31,0.46,-0.8406,0.68,1,-0.7655,0.79,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2842_FOURNIER_ACINAR_DEVELOPMENT_LATE_2","C2_Chemical_and_genetic_perturbations","C2_CGP_2842_FOURNIER_ACINAR_DEVELOPMENT_LATE_2",276,-1.1133,0.23,0.39,1.426,0,0.28,0.8026,0.99,1
"GO_MF:506433_GO_0043395_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING","GO_MF","506433_GO_0043395_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING",15,-1.1133,0.33,0.51,-0.9586,0.51,0.96,0.7472,0.82,1
"GO_BP:488975_GO_0003181_ATRIOVENTRICULAR_VALVE_MORPHOGENESIS","GO_BP","488975_GO_0003181_ATRIOVENTRICULAR_VALVE_MORPHOGENESIS",15,-1.1133,0.32,0.46,-0.8199,0.72,1,1.0312,0.41,0.82
"GO_CC:507231_GO_0044224_JUXTAPARANODE_REGION_OF_AXON","GO_CC","507231_GO_0044224_JUXTAPARANODE_REGION_OF_AXON",9,-1.1132,0.33,0.57,-1.2493,0.21,0.66,-1.3923,0.095,0.6
"C7_Immunologic_signatures:C7_ALL_93_GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP","C7_Immunologic_signatures","C7_ALL_93_GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP",191,-1.1131,0.24,0.33,1.6105,0,0.0025,1.1034,0.2,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2562_VANTVEER_BREAST_CANCER_ESR1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2562_VANTVEER_BREAST_CANCER_ESR1_UP",165,-1.113,0.26,0.39,-1.3757,0.025,0.63,-1.3713,0.012,0.38
"GO_BP:498887_GO_0021604_CRANIAL_NERVE_STRUCTURAL_ORGANIZATION","GO_BP","498887_GO_0021604_CRANIAL_NERVE_STRUCTURAL_ORGANIZATION",13,-1.113,0.33,0.46,-0.7054,0.86,1,0.8117,0.71,1
"GO_MF:489819_GO_0004467_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY","GO_MF","489819_GO_0004467_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY",13,-1.1128,0.31,0.51,0.8971,0.57,0.98,0.763,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1725_CHUANG_OXIDATIVE_STRESS_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1725_CHUANG_OXIDATIVE_STRESS_RESPONSE_UP",27,-1.1128,0.32,0.39,-0.9611,0.5,1,-0.9211,0.59,0.85
"GO_BP:518232_GO_0090092_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY","GO_BP","518232_GO_0090092_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY",211,-1.1125,0.23,0.46,1.0545,0.29,0.94,1.0467,0.32,0.81
"GO_BP:500006_GO_0030705_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT","GO_BP","500006_GO_0030705_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT",105,-1.1125,0.26,0.46,0.7936,0.92,1,-1.0755,0.29,0.8
"GO_BP:498828_GO_0021544_SUBPALLIUM_DEVELOPMENT","GO_BP","498828_GO_0021544_SUBPALLIUM_DEVELOPMENT",21,-1.1124,0.33,0.46,-1.0412,0.38,0.98,-0.9318,0.55,0.9
"REACTOME:106023_REACT_11103_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION","REACTOME","106023_REACT_11103_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION",10,-1.1124,0.34,0.51,1.0741,0.36,0.62,-1.2009,0.25,0.61
"GO_BP:752841_GO_0097340_INHIBITION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_BP","752841_GO_0097340_INHIBITION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",10,-1.1121,0.34,0.47,-0.9706,0.47,1,0.9437,0.52,0.91
"GO_BP:512167_GO_0051281_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL","GO_BP","512167_GO_0051281_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL",27,-1.112,0.33,0.47,1.3102,0.11,0.66,-1.2497,0.17,0.68
"C6_Oncogenic_signatures:C6_ALL_118_CRX_NRL_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_118_CRX_NRL_DN_V1_UP",134,-1.1119,0.26,0.31,-1.6743,0,0.11,-1.7347,0,0.062
"C1_Positional:C1_ALL_233_CHR12Q21","C1_Positional","C1_ALL_233_CHR12Q21",45,-1.1119,0.3,0.85,1.0943,0.32,0.63,0.7879,0.83,0.93
"C7_Immunologic_signatures:C7_ALL_1165_GSE27786_LIN_NEG_VS_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1165_GSE27786_LIN_NEG_VS_CD8_TCELL_UP",199,-1.1118,0.23,0.33,0.9524,0.6,0.89,-1.0335,0.34,0.65
"GO_BP:754342_GO_1901380_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","754342_GO_1901380_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT",14,-1.1114,0.33,0.47,-0.7349,0.84,1,-1.2618,0.18,0.67
"C1_Positional:C1_ALL_151_CHR18Q12","C1_Positional","C1_ALL_151_CHR18Q12",46,-1.1114,0.3,0.85,1.1191,0.26,0.63,-1.0587,0.35,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_2929_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3","C2_Chemical_and_genetic_perturbations","C2_CGP_2929_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3",14,-1.1113,0.33,0.39,1.3159,0.14,0.38,-1.1872,0.23,0.53
"GO_BP:492107_GO_0007343_EGG_ACTIVATION","GO_BP","492107_GO_0007343_EGG_ACTIVATION",7,-1.1112,0.35,0.47,-1.6129,0.023,0.7,-1.7043,0.018,0.63
"C3_TF_targets:C3_TFT_223_V_PAX4_04","C3_TF_targets","C3_TFT_223_V_PAX4_04",212,-1.1112,0.24,0.33,-0.9006,0.73,0.95,-0.9317,0.69,0.89
"GO_BP:505784_GO_0042670_RETINAL_CONE_CELL_DIFFERENTIATION","GO_BP","505784_GO_0042670_RETINAL_CONE_CELL_DIFFERENTIATION",9,-1.1112,0.33,0.47,1.2623,0.2,0.72,1.4645,0.067,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2992_NIELSEN_SCHWANNOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2992_NIELSEN_SCHWANNOMA_DN",17,-1.1111,0.33,0.39,0.9219,0.57,0.9,0.9774,0.48,0.96
"REACTOME:833798_REACT_163875_SPERM_MOTILITY_AND_TAXES","REACTOME","833798_REACT_163875_SPERM_MOTILITY_AND_TAXES",9,-1.1109,0.32,0.51,-1.7285,0.0041,0.13,-0.8509,0.65,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_398_CASTELLANO_HRAS_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_398_CASTELLANO_HRAS_TARGETS_DN",6,-1.1107,0.36,0.39,0.9839,0.5,0.81,-0.952,0.53,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_976_GROSS_ELK3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_976_GROSS_ELK3_TARGETS_UP",26,-1.1107,0.31,0.39,-0.9952,0.48,1,0.8906,0.63,1
"REACTOME:160942_REACT_21391_MITOTIC_G2_G2_M_PHASES","REACTOME","160942_REACT_21391_MITOTIC_G2_G2_M_PHASES",116,-1.1107,0.27,0.51,-0.6103,1,1,-1.5458,0.0021,0.3
"GO_BP:510804_GO_0048753_PIGMENT_GRANULE_ORGANIZATION","GO_BP","510804_GO_0048753_PIGMENT_GRANULE_ORGANIZATION",23,-1.1106,0.31,0.47,-0.7553,0.82,1,0.5424,0.99,1
"GO_BP:502026_GO_0032803_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_CATABOLIC_PROCESS","GO_BP","502026_GO_0032803_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_CATABOLIC_PROCESS",5,-1.1104,0.34,0.47,-0.9463,0.54,1,-0.9341,0.54,0.9
"GO_BP:508805_GO_0046549_RETINAL_CONE_CELL_DEVELOPMENT","GO_BP","508805_GO_0046549_RETINAL_CONE_CELL_DEVELOPMENT",9,-1.1104,0.35,0.47,1.2432,0.2,0.74,1.4508,0.079,0.58
"OMIM_gene:OMIM603025_PHOSPHATIDYLINOSITOL_BINDING_CLATHRIN_ASSEMBLY_PROTEIN_PICALM","OMIM_gene","OMIM603025_PHOSPHATIDYLINOSITOL_BINDING_CLATHRIN_ASSEMBLY_PROTEIN_PICALM",6,-1.1104,0.34,0.81,-0.922,0.55,0.86,-1.0204,0.45,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2192_RIZKI_TUMOR_INVASIVENESS_2D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2192_RIZKI_TUMOR_INVASIVENESS_2D_UP",69,-1.1103,0.28,0.39,-0.8381,0.74,1,-0.8309,0.83,0.94
"C4_Cancer_modules:C4_CM_250_MODULE_284","C4_Cancer_modules","C4_CM_250_MODULE_284",45,-1.1102,0.28,0.4,0.8377,0.76,0.94,0.8246,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2180_YOKOE_CANCER_TESTIS_ANTIGENS","C2_Chemical_and_genetic_perturbations","C2_CGP_2180_YOKOE_CANCER_TESTIS_ANTIGENS",37,-1.1101,0.3,0.39,-1.3818,0.071,0.62,-0.8994,0.58,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1571_ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1571_ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN",51,-1.1101,0.31,0.39,0.7341,0.91,1,-1.0338,0.39,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_3241_JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3241_JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN",92,-1.11,0.27,0.39,1.1171,0.23,0.6,-1.1056,0.25,0.62
"GO_CC:493992_GO_0009898_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE","GO_CC","493992_GO_0009898_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE",54,-1.1099,0.3,0.57,0.8858,0.67,0.91,-0.9986,0.43,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2552_SCHRAETS_MLL_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2552_SCHRAETS_MLL_TARGETS_UP",35,-1.1099,0.3,0.39,1.0862,0.31,0.65,-1.1251,0.27,0.6
"GO_BP:487650_GO_0001754_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION","GO_BP","487650_GO_0001754_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION",42,-1.1099,0.29,0.47,-1.3652,0.071,0.98,0.9906,0.48,0.86
"REACTOME:161047_REACT_21254_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS","REACTOME","161047_REACT_21254_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS",20,-1.1097,0.31,0.51,-0.7869,0.77,1,-0.7038,0.89,1
"GO_BP:499042_GO_0021762_SUBSTANTIA_NIGRA_DEVELOPMENT","GO_BP","499042_GO_0021762_SUBSTANTIA_NIGRA_DEVELOPMENT",46,-1.1097,0.31,0.47,1.1002,0.29,0.9,0.7116,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2236_MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2236_MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP",66,-1.1094,0.28,0.4,-0.9867,0.48,1,-1.3109,0.063,0.42
"GO_BP:493270_GO_0009069_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS","GO_BP","493270_GO_0009069_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS",34,-1.1094,0.32,0.47,0.7801,0.84,1,-1.0919,0.32,0.78
"GO_BP:506363_GO_0043303_MAST_CELL_DEGRANULATION","GO_BP","506363_GO_0043303_MAST_CELL_DEGRANULATION",17,-1.1094,0.34,0.47,-0.7711,0.77,1,-1.0929,0.32,0.78
"REACTOME:106425_REACT_570_IRS_ACTIVATION","REACTOME","106425_REACT_570_IRS_ACTIVATION",5,-1.1092,0.39,0.51,0.678,0.86,1,0.6708,0.84,1
"GO_BP:491721_GO_0006855_DRUG_TRANSMEMBRANE_TRANSPORT","GO_BP","491721_GO_0006855_DRUG_TRANSMEMBRANE_TRANSPORT",17,-1.1092,0.33,0.47,-0.9845,0.46,1,1.0129,0.44,0.84
"KEGG_module:HSA_M00050_GUANINE_RIBONUCLEOTIDE_BIOSYNTHESIS_IMP_GDP_GTP","KEGG_module","HSA_M00050_GUANINE_RIBONUCLEOTIDE_BIOSYNTHESIS_IMP_GDP_GTP",13,-1.1092,0.33,0.65,-0.7635,0.78,1,-1.5403,0.041,0.29
"C7_Immunologic_signatures:C7_ALL_161_GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP","C7_Immunologic_signatures","C7_ALL_161_GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP",192,-1.109,0.27,0.34,-0.9684,0.51,1,-0.9923,0.48,0.74
"C6_Oncogenic_signatures:C6_ALL_24_CSR_LATE_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_24_CSR_LATE_UP_V1_UP",160,-1.109,0.26,0.32,1.6706,0,0.071,-0.99,0.48,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_932_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_932_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP",43,-1.1088,0.32,0.4,1.2961,0.1,0.4,-0.7696,0.87,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3362_LIM_MAMMARY_STEM_CELL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3362_LIM_MAMMARY_STEM_CELL_DN",424,-1.1088,0.21,0.4,1.2129,0.02,0.48,-1.0567,0.26,0.68
"KEGG_compound:C00236_3_PHOSPHO_D_GLYCEROYL_PHOSPHATE_1_3_BISPHOSPHO_D_GLYCERATE_R_2_HYDROXY_3_PHOSPHONOOXY_1_MONOANHYDRIDE_WITH_PHOSPHORIC_PROPANOIC_ACID_D_GLYCERATE_1_3_DIPHOSPHATE","KEGG_compound","C00236_3_PHOSPHO_D_GLYCEROYL_PHOSPHATE_1_3_BISPHOSPHO_D_GLYCERATE_R_2_HYDROXY_3_PHOSPHONOOXY_1_MONOANHYDRIDE_WITH_PHOSPHORIC_PROPANOIC_ACID_D_GLYCERATE_1_3_DIPHOSPHATE",8,-1.1088,0.34,0.49,1.2987,0.19,0.74,-0.9872,0.47,0.66
"C4_Cancer_gene_neighborhoods:C4_CGN_124_MORF_LTK","C4_Cancer_gene_neighborhoods","C4_CGN_124_MORF_LTK",142,-1.1086,0.28,0.49,-1.2096,0.091,0.65,-1.1784,0.13,0.47
"GO_BP:499078_GO_0021798_FOREBRAIN_DORSAL_VENTRAL_PATTERN_FORMATION","GO_BP","499078_GO_0021798_FOREBRAIN_DORSAL_VENTRAL_PATTERN_FORMATION",7,-1.1085,0.34,0.47,-1.037,0.4,0.98,0.8001,0.71,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1957_JI_RESPONSE_TO_FSH_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1957_JI_RESPONSE_TO_FSH_UP",74,-1.1085,0.27,0.4,0.9189,0.61,0.9,-1.1641,0.2,0.56
"C3_TF_targets:C3_TFT_263_V_ZIC2_01","C3_TF_targets","C3_TFT_263_V_ZIC2_01",243,-1.1084,0.24,0.34,-1.3436,0.0067,0.19,-1.0485,0.34,0.64
"GO_BP:510172_GO_0048002_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN","GO_BP","510172_GO_0048002_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN",192,-1.1084,0.25,0.47,1.6475,0,0.24,0.6066,1,1
"REACTOME:106462_REACT_12065_P38MAPK_EVENTS","REACTOME","106462_REACT_12065_P38MAPK_EVENTS",13,-1.1083,0.33,0.51,0.8056,0.74,1,1.135,0.29,0.92
"GO_BP:501712_GO_0032480_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION","GO_BP","501712_GO_0032480_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION",41,-1.1082,0.32,0.47,1.5071,0.04,0.4,-1.6832,0,0.62
"GO_BP:511861_GO_0050926_REGULATION_OF_POSITIVE_CHEMOTAXIS","GO_BP","511861_GO_0050926_REGULATION_OF_POSITIVE_CHEMOTAXIS",25,-1.1081,0.33,0.47,0.7191,0.9,1,-0.7796,0.81,1
"GO_BP:495082_GO_0014009_GLIAL_CELL_PROLIFERATION","GO_BP","495082_GO_0014009_GLIAL_CELL_PROLIFERATION",8,-1.1079,0.35,0.47,0.8145,0.68,1,1.0917,0.36,0.77
"GO_BP:502034_GO_0032811_NEGATIVE_REGULATION_OF_EPINEPHRINE_SECRETION","GO_BP","502034_GO_0032811_NEGATIVE_REGULATION_OF_EPINEPHRINE_SECRETION",6,-1.1077,0.36,0.47,-1.2011,0.23,0.89,-1.0223,0.43,0.83
"C7_Immunologic_signatures:C7_ALL_759_GSE17721_0_5H_VS_24H_GARDIQUIMOD_BMDM_UP","C7_Immunologic_signatures","C7_ALL_759_GSE17721_0_5H_VS_24H_GARDIQUIMOD_BMDM_UP",199,-1.1076,0.26,0.34,1.2074,0.075,0.21,-0.808,0.95,1
"GO_BP:506309_GO_0043242_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY","GO_BP","506309_GO_0043242_NEGATIVE_REGULATION_OF_PROTEIN_COMPLEX_DISASSEMBLY",62,-1.1076,0.3,0.47,-1.0825,0.32,0.95,-1.3297,0.071,0.62
"GO_BP:517417_GO_0072512_TRIVALENT_INORGANIC_CATION_TRANSPORT","GO_BP","517417_GO_0072512_TRIVALENT_INORGANIC_CATION_TRANSPORT",37,-1.1076,0.31,0.47,0.9077,0.63,1,1.4779,0.037,0.58
"GO_BP:510700_GO_0048644_MUSCLE_ORGAN_MORPHOGENESIS","GO_BP","510700_GO_0048644_MUSCLE_ORGAN_MORPHOGENESIS",69,-1.1075,0.28,0.47,1.1859,0.17,0.8,1.4208,0.035,0.61
"GO_BP:514118_GO_0060563_NEUROEPITHELIAL_CELL_DIFFERENTIATION","GO_BP","514118_GO_0060563_NEUROEPITHELIAL_CELL_DIFFERENTIATION",64,-1.1075,0.3,0.47,1.0523,0.35,0.95,1.363,0.052,0.64
"GO_MF:496642_GO_0016722_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS","GO_MF","496642_GO_0016722_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS",19,-1.1074,0.32,0.52,1.071,0.34,0.82,-0.6767,0.91,1
"GO_BP:488088_GO_0002209_BEHAVIORAL_DEFENSE_RESPONSE","GO_BP","488088_GO_0002209_BEHAVIORAL_DEFENSE_RESPONSE",28,-1.1073,0.32,0.47,1.1646,0.26,0.82,1.7823,0,0.32
"KEGG_compound:C00127_GLUTATHIONE_DISULFIDE_GSSG_OXIGLUTATIONE_OXIDIZED_GLUTATHIONE","KEGG_compound","C00127_GLUTATHIONE_DISULFIDE_GSSG_OXIGLUTATIONE_OXIDIZED_GLUTATHIONE",9,-1.1072,0.34,0.49,0.8155,0.71,1,1.23,0.2,0.51
"GO_MF:496894_GO_0017081_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY","GO_MF","496894_GO_0017081_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY",16,-1.1072,0.34,0.52,0.7967,0.75,1,1.0492,0.37,0.84
"REACTOME:105813_REACT_765_MITOTIC_PROPHASE","REACTOME","105813_REACT_765_MITOTIC_PROPHASE",135,-1.1072,0.27,0.51,-1.0775,0.29,0.91,-1.2151,0.096,0.59
"GO_BP:515104_GO_0070167_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT","GO_BP","515104_GO_0070167_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT",72,-1.1071,0.28,0.47,-1.3679,0.044,0.99,1.2607,0.13,0.69
"GO_BP:487980_GO_0002091_NEGATIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION","GO_BP","487980_GO_0002091_NEGATIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION",6,-1.107,0.38,0.47,-0.8657,0.61,1,-0.7706,0.75,1
"C0_Hallmark:H_ALL_27_HALLMARK_E2F_TARGETS","C0_Hallmark","H_ALL_27_HALLMARK_E2F_TARGETS",200,-1.107,0.24,0.31,1.1298,0.15,0.33,-1.9844,0,0.0015
"GO_MF:506099_GO_0043008_ATP_DEPENDENT_PROTEIN_BINDING","GO_MF","506099_GO_0043008_ATP_DEPENDENT_PROTEIN_BINDING",7,-1.1069,0.37,0.52,-0.7478,0.79,1,0.9484,0.51,0.92
"GO_BP:501245_GO_0032008_POSITIVE_REGULATION_OF_TOR_SIGNALING","GO_BP","501245_GO_0032008_POSITIVE_REGULATION_OF_TOR_SIGNALING",21,-1.1068,0.32,0.47,1.0462,0.39,0.95,0.6592,0.94,1
"GO_MF:506068_GO_0042974_RETINOIC_ACID_RECEPTOR_BINDING","GO_MF","506068_GO_0042974_RETINOIC_ACID_RECEPTOR_BINDING",30,-1.1067,0.32,0.52,-0.8257,0.73,1,0.8632,0.69,0.98
"GO_BP:514852_GO_0061307_CARDIAC_NEURAL_CREST_CELL_DIFFERENTIATION_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","514852_GO_0061307_CARDIAC_NEURAL_CREST_CELL_DIFFERENTIATION_INVOLVED_IN_HEART_DEVELOPMENT",8,-1.1067,0.35,0.47,-0.8246,0.68,1,-0.7372,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_424_MARKEY_RB1_ACUTE_LOF_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_424_MARKEY_RB1_ACUTE_LOF_DN",226,-1.1066,0.25,0.4,1.4106,0.0024,0.29,-1.5768,0,0.25
"C1_Positional:C1_ALL_223_CHR11Q13","C1_Positional","C1_ALL_223_CHR11Q13",268,-1.1065,0.24,0.85,-1.1724,0.13,1,-1.2809,0.023,0.49
"GO_BP:492373_GO_0007632_VISUAL_BEHAVIOR","GO_BP","492373_GO_0007632_VISUAL_BEHAVIOR",52,-1.1065,0.31,0.47,-1.0043,0.42,0.99,0.7289,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_227_BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_227_BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN",32,-1.1064,0.3,0.4,-1.0457,0.38,0.97,-1.2499,0.17,0.47
"GO_BP:505599_GO_0042462_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT","GO_BP","505599_GO_0042462_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT",31,-1.1063,0.32,0.47,-1.0303,0.39,0.98,1.1311,0.27,0.74
"GO_MF:500990_GO_0031748_D1_DOPAMINE_RECEPTOR_BINDING","GO_MF","500990_GO_0031748_D1_DOPAMINE_RECEPTOR_BINDING",8,-1.1063,0.32,0.52,-1.4081,0.1,0.65,-0.8725,0.59,0.9
"C0_Hallmark:H_ALL_50_HALLMARK_PANCREAS_BETA_CELLS","C0_Hallmark","H_ALL_50_HALLMARK_PANCREAS_BETA_CELLS",34,-1.1062,0.33,0.31,1.1315,0.25,0.35,-1.101,0.31,0.31
"GO_BP:510768_GO_0048713_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION","GO_BP","510768_GO_0048713_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION",27,-1.1061,0.33,0.47,1.3158,0.12,0.65,1.6675,0.019,0.39
"REACTOME:1127627_REACT_264636_S37_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED","REACTOME","1127627_REACT_264636_S37_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED",15,-1.1059,0.33,0.52,0.6785,0.88,1,-0.908,0.61,0.95
"GO_MF:500250_GO_0030957_TAT_PROTEIN_BINDING","GO_MF","500250_GO_0030957_TAT_PROTEIN_BINDING",7,-1.1059,0.33,0.52,1.0574,0.39,0.83,-1.1879,0.27,0.59
"REACTOME:477138_REACT_111118_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION","REACTOME","477138_REACT_111118_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION",42,-1.1058,0.3,0.51,-0.5759,0.99,1,0.786,0.86,1
"C4_Cancer_modules:C4_CM_265_MODULE_301","C4_Cancer_modules","C4_CM_265_MODULE_301",153,-1.1058,0.27,0.41,1.1644,0.13,0.44,-1.3234,0.033,0.28
"C7_Immunologic_signatures:C7_ALL_342_GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_342_GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN",198,-1.1057,0.26,0.35,0.6215,1,1,-0.7847,0.97,1
"C1_Positional:C1_ALL_298_CHR16P11","C1_Positional","C1_ALL_298_CHR16P11",109,-1.1057,0.28,0.85,-1.6328,0,1,-1.054,0.34,0.87
"GO_MF:489975_GO_0004645_PHOSPHORYLASE_ACTIVITY","GO_MF","489975_GO_0004645_PHOSPHORYLASE_ACTIVITY",6,-1.1056,0.36,0.52,-1.2094,0.23,0.81,-1.6585,0.008,0.33
"GO_BP:499322_GO_0022404_MOLTING_CYCLE_PROCESS","GO_BP","499322_GO_0022404_MOLTING_CYCLE_PROCESS",81,-1.1055,0.29,0.47,-0.7211,0.94,1,1.0774,0.31,0.78
"GO_BP:513601_GO_0060043_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION","GO_BP","513601_GO_0060043_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION",28,-1.1055,0.32,0.47,0.6885,0.91,1,1.4173,0.053,0.62
"C3_TF_targets:C3_TFT_60_V_IK3_01","C3_TF_targets","C3_TFT_60_V_IK3_01",216,-1.1054,0.25,0.35,-0.8878,0.77,0.98,0.9522,0.58,1
"GO_BP:514315_GO_0060760_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS","GO_BP","514315_GO_0060760_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS",27,-1.1053,0.32,0.47,0.8163,0.74,1,0.8325,0.73,0.99
"GO_CC:505715_GO_0042588_ZYMOGEN_GRANULE","GO_CC","505715_GO_0042588_ZYMOGEN_GRANULE",12,-1.1052,0.36,0.58,1.5237,0.044,0.17,0.6314,0.91,1
"KEGG_compound:C16545_TAMOXIFEN_N_OXIDE","KEGG_compound","C16545_TAMOXIFEN_N_OXIDE",5,-1.105,0.38,0.49,0.6838,0.85,1,-0.7973,0.7,0.84
"GO_BP:515037_GO_0070099_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY","GO_BP","515037_GO_0070099_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY",8,-1.1049,0.34,0.48,-0.8262,0.68,1,1.09,0.36,0.77
"C7_Immunologic_signatures:C7_ALL_1166_GSE27786_LIN_NEG_VS_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1166_GSE27786_LIN_NEG_VS_CD8_TCELL_DN",199,-1.1049,0.25,0.35,1.0439,0.32,0.61,-0.9699,0.52,0.8
"GO_BP:512654_GO_0051782_NEGATIVE_REGULATION_OF_CELL_DIVISION","GO_BP","512654_GO_0051782_NEGATIVE_REGULATION_OF_CELL_DIVISION",71,-1.1047,0.3,0.48,0.6843,0.98,1,-0.9661,0.5,0.88
"GO_MF:486780_GO_0046961_PROTON_TRANSPORTING_ATPASE_ACTIVITY_ROTATIONAL_MECHANISM","GO_MF","486780_GO_0046961_PROTON_TRANSPORTING_ATPASE_ACTIVITY_ROTATIONAL_MECHANISM",22,-1.1047,0.33,0.52,1.6848,0.011,0.18,0.9122,0.58,0.94
"GO_MF:496755_GO_0016863_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_C_C_BONDS","GO_MF","496755_GO_0016863_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_C_C_BONDS",14,-1.1047,0.34,0.52,0.6954,0.86,1,-0.6895,0.87,1
"C1_Positional:C1_ALL_281_CHR1Q24","C1_Positional","C1_ALL_281_CHR1Q24",49,-1.1046,0.31,0.84,1.0048,0.43,0.75,0.9673,0.51,0.79
"GO_BP:501244_GO_0032007_NEGATIVE_REGULATION_OF_TOR_SIGNALING","GO_BP","501244_GO_0032007_NEGATIVE_REGULATION_OF_TOR_SIGNALING",23,-1.1045,0.32,0.48,-0.8251,0.72,1,0.7407,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3208_VANLOO_SP3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3208_VANLOO_SP3_TARGETS_UP",8,-1.1045,0.32,0.4,0.8345,0.68,0.98,-1.108,0.34,0.62
"C7_Immunologic_signatures:C7_ALL_1170_GSE27786_LIN_NEG_VS_NKTCELL_DN","C7_Immunologic_signatures","C7_ALL_1170_GSE27786_LIN_NEG_VS_NKTCELL_DN",198,-1.1044,0.25,0.35,0.7455,0.99,1,0.7321,1,1
"KEGG_pathway:HSA04962_VASOPRESSIN_REGULATED_WATER_REABSORPTION","KEGG_pathway","HSA04962_VASOPRESSIN_REGULATED_WATER_REABSORPTION",44,-1.1041,0.32,0.36,0.7294,0.92,1,-1.0001,0.47,0.69
"C7_Immunologic_signatures:C7_ALL_1317_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1317_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP",184,-1.1041,0.24,0.35,-1.3478,0.019,0.37,-1.1727,0.11,0.33
"GO_BP:517436_GO_0072531_PYRIMIDINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT","GO_BP","517436_GO_0072531_PYRIMIDINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT",11,-1.1041,0.35,0.48,-1.212,0.25,0.88,-0.5402,0.98,1
"C3_TF_targets:C3_TFT_402_V_DR1_Q3","C3_TF_targets","C3_TFT_402_V_DR1_Q3",247,-1.104,0.24,0.35,-1.1142,0.2,0.51,-1.2023,0.085,0.35
"C4_Cancer_gene_neighborhoods:C4_CGN_89_MORF_DMPK","C4_Cancer_gene_neighborhoods","C4_CGN_89_MORF_DMPK",168,-1.1039,0.27,0.5,-0.8813,0.77,1,1.1875,0.13,0.45
"C3_MicroRNA_targets:C3_MIR_159_GTGCCAA_MIR_96","C3_MicroRNA_targets","C3_MIR_159_GTGCCAA_MIR_96",300,-1.1038,0.24,0.44,-0.9274,0.68,1,-0.9343,0.68,1
"REACTOME:1127534_REACT_268561_RA_BIOSYNTHESIS_PATHWAY","REACTOME","1127534_REACT_268561_RA_BIOSYNTHESIS_PATHWAY",20,-1.1038,0.33,0.52,-1.279,0.15,0.68,0.9129,0.58,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1486_ZHAN_MULTIPLE_MYELOMA_LB_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1486_ZHAN_MULTIPLE_MYELOMA_LB_UP",44,-1.1037,0.32,0.4,-0.8562,0.74,1,-0.849,0.72,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_864_GRUETZMANN_PANCREATIC_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_864_GRUETZMANN_PANCREATIC_CANCER_DN",198,-1.1037,0.26,0.4,1.5067,0,0.21,-1.024,0.37,0.72
"GO_BP:508229_GO_0045922_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS","GO_BP","508229_GO_0045922_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS",23,-1.1037,0.32,0.48,0.8864,0.64,1,1.3805,0.085,0.64
"GO_BP:519240_GO_2000601_POSITIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION","GO_BP","519240_GO_2000601_POSITIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION",7,-1.1036,0.36,0.48,-0.817,0.7,1,-0.7994,0.72,0.99
"GO_MF:504565_GO_0035381_ATP_GATED_ION_CHANNEL_ACTIVITY","GO_MF","504565_GO_0035381_ATP_GATED_ION_CHANNEL_ACTIVITY",7,-1.1036,0.34,0.52,-0.8054,0.71,1,0.6532,0.87,1
"KEGG_compound:C00109_2_OXOBUTANOATE_2_KETOBUTYRIC_ACID_2_OXOBUTYRIC_ACID_2_OXOBUTYRATE_2_OXOBUTANOIC_ACID_ALPHA_KETOBUTYRIC_ACID_ALPHA_KETOBUTYRATE","KEGG_compound","C00109_2_OXOBUTANOATE_2_KETOBUTYRIC_ACID_2_OXOBUTYRIC_ACID_2_OXOBUTYRATE_2_OXOBUTANOIC_ACID_ALPHA_KETOBUTYRIC_ACID_ALPHA_KETOBUTYRATE",8,-1.1036,0.35,0.49,0.7955,0.71,1,1.2305,0.22,0.52
"REACTOME:106465_REACT_12076_FRS2_MEDIATED_ACTIVATION","REACTOME","106465_REACT_12076_FRS2_MEDIATED_ACTIVATION",25,-1.1035,0.31,0.52,0.6794,0.93,1,-0.8802,0.64,0.97
"C3_TF_targets:C3_TFT_124_V_CREB_Q2","C3_TF_targets","C3_TFT_124_V_CREB_Q2",261,-1.1034,0.23,0.35,-0.9273,0.69,0.92,-1.0755,0.24,0.6
"C3_MicroRNA_targets:C3_MIR_22_CACTGTG_MIR_128A_MIR_128B","C3_MicroRNA_targets","C3_MIR_22_CACTGTG_MIR_128A_MIR_128B",333,-1.1034,0.23,0.44,0.9708,0.56,1,-0.8713,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2398_BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2398_BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN",57,-1.1032,0.28,0.41,0.8886,0.68,0.94,0.9348,0.56,1
"KEGG_module:HSA_M00094_CERAMIDE_BIOSYNTHESIS","KEGG_module","HSA_M00094_CERAMIDE_BIOSYNTHESIS",12,-1.1031,0.32,0.65,-1.1893,0.26,1,-1.308,0.16,0.48
"WikiPathways:198904_WP688_CATALYTIC_CYCLE_OF_MAMMALIAN_FMOS","WikiPathways","198904_WP688_CATALYTIC_CYCLE_OF_MAMMALIAN_FMOS",5,-1.1031,0.36,0.43,0.672,0.85,1,-0.7974,0.73,0.98
"C7_Immunologic_signatures:C7_ALL_179_GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP","C7_Immunologic_signatures","C7_ALL_179_GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP",199,-1.103,0.25,0.35,1.1025,0.19,0.44,-1.3407,0.024,0.1
"GO_BP:501243_GO_0032006_REGULATION_OF_TOR_SIGNALING","GO_BP","501243_GO_0032006_REGULATION_OF_TOR_SIGNALING",52,-1.103,0.31,0.48,0.7172,0.94,1,0.8013,0.82,1
"GO_MF:489656_GO_0004222_METALLOENDOPEPTIDASE_ACTIVITY","GO_MF","489656_GO_0004222_METALLOENDOPEPTIDASE_ACTIVITY",102,-1.1029,0.3,0.52,-0.963,0.54,0.95,1.2719,0.091,0.65
"GO_BP:500290_GO_0031000_RESPONSE_TO_CAFFEINE","GO_BP","500290_GO_0031000_RESPONSE_TO_CAFFEINE",15,-1.1027,0.34,0.48,1.2191,0.21,0.77,1.2128,0.21,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_2037_TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2037_TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP",17,-1.1027,0.33,0.41,1.0428,0.39,0.73,0.9404,0.56,1
"GO_BP:500919_GO_0031670_CELLULAR_RESPONSE_TO_NUTRIENT","GO_BP","500919_GO_0031670_CELLULAR_RESPONSE_TO_NUTRIENT",54,-1.1026,0.28,0.48,0.8091,0.82,1,1.6338,0.0099,0.41
"GO_BP:486599_GO_0000052_CITRULLINE_METABOLIC_PROCESS","GO_BP","486599_GO_0000052_CITRULLINE_METABOLIC_PROCESS",12,-1.1025,0.34,0.48,0.7071,0.85,1,0.9313,0.55,0.92
"GO_MF:496928_GO_0017128_PHOSPHOLIPID_SCRAMBLASE_ACTIVITY","GO_MF","496928_GO_0017128_PHOSPHOLIPID_SCRAMBLASE_ACTIVITY",9,-1.1025,0.34,0.52,1.0558,0.39,0.83,-0.7616,0.78,0.99
"GO_CC:513743_GO_0060187_CELL_POLE","GO_CC","513743_GO_0060187_CELL_POLE",9,-1.1025,0.35,0.59,1.1384,0.3,0.6,0.6065,0.94,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_21_BIOCARTA_BCELLSURVIVAL_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_21_BIOCARTA_BCELLSURVIVAL_PATHWAY",16,-1.1024,0.33,0.45,1.098,0.34,0.71,0.8209,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1156_SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1156_SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",81,-1.1023,0.31,0.41,1.2355,0.12,0.45,-0.8903,0.71,0.89
"REACTOME:119521_REACT_19266_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION","REACTOME","119521_REACT_19266_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION",8,-1.1023,0.36,0.52,-0.8298,0.65,1,-0.7857,0.72,1
"GO_BP:505689_GO_0042559_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","505689_GO_0042559_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",16,-1.1021,0.33,0.48,0.8555,0.66,1,-0.8753,0.61,0.95
"GO_BP:487832_GO_0001941_POSTSYNAPTIC_MEMBRANE_ORGANIZATION","GO_BP","487832_GO_0001941_POSTSYNAPTIC_MEMBRANE_ORGANIZATION",21,-1.1021,0.34,0.48,-1.434,0.067,0.93,0.779,0.8,1
"GO_BP:488890_GO_0003094_GLOMERULAR_FILTRATION","GO_BP","488890_GO_0003094_GLOMERULAR_FILTRATION",9,-1.102,0.34,0.48,0.5351,0.98,1,-1.2477,0.22,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_3377_WARTERS_RESPONSE_TO_IR_SKIN","C2_Chemical_and_genetic_perturbations","C2_CGP_3377_WARTERS_RESPONSE_TO_IR_SKIN",79,-1.102,0.28,0.41,0.7402,0.94,1,-1.1458,0.2,0.58
"C4_Cancer_gene_neighborhoods:C4_CGN_6_MORF_BCL2L11","C4_Cancer_gene_neighborhoods","C4_CGN_6_MORF_BCL2L11",179,-1.102,0.27,0.5,1.1565,0.14,0.27,1.3433,0.024,0.28
"GO_MF:489417_GO_0046933_PROTON_TRANSPORTING_ATP_SYNTHASE_ACTIVITY_ROTATIONAL_MECHANISM","GO_MF","489417_GO_0046933_PROTON_TRANSPORTING_ATP_SYNTHASE_ACTIVITY_ROTATIONAL_MECHANISM",11,-1.102,0.35,0.52,1.7694,0.0083,0.1,0.5245,0.98,1
"C4_Cancer_modules:C4_CM_323_MODULE_379","C4_Cancer_modules","C4_CM_323_MODULE_379",194,-1.1019,0.27,0.42,-1.0938,0.23,0.68,1.5778,0,0.17
"GO_MF:489848_GO_0004499_N_N_DIMETHYLANILINE_MONOOXYGENASE_ACTIVITY","GO_MF","489848_GO_0004499_N_N_DIMETHYLANILINE_MONOOXYGENASE_ACTIVITY",5,-1.1018,0.36,0.52,0.6971,0.85,1,-0.7765,0.75,0.98
"C3_MicroRNA_targets:C3_MIR_2_CTACCTC_LET_7A_LET_7B_LET_7C_LET_7D_LET_7E_LET_7F_MIR_98_LET_7G_LET_7I","C3_MicroRNA_targets","C3_MIR_2_CTACCTC_LET_7A_LET_7B_LET_7C_LET_7D_LET_7E_LET_7F_MIR_98_LET_7G_LET_7I",387,-1.1017,0.22,0.44,-0.8615,0.92,1,1.0054,0.43,1
"GO_BP:500211_GO_0030916_OTIC_VESICLE_FORMATION","GO_BP","500211_GO_0030916_OTIC_VESICLE_FORMATION",8,-1.1016,0.37,0.48,-0.9518,0.52,1,-0.7916,0.7,0.99
"GO_MF:496343_GO_0016290_PALMITOYL_COA_HYDROLASE_ACTIVITY","GO_MF","496343_GO_0016290_PALMITOYL_COA_HYDROLASE_ACTIVITY",11,-1.1014,0.35,0.52,0.6419,0.9,1,-0.9024,0.6,0.87
"GO_BP:493265_GO_0009064_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS","GO_BP","493265_GO_0009064_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS",60,-1.1013,0.3,0.48,-1.1238,0.24,0.94,-1.1866,0.17,0.73
"GO_CC:507679_GO_0045323_INTERLEUKIN_1_RECEPTOR_COMPLEX","GO_CC","507679_GO_0045323_INTERLEUKIN_1_RECEPTOR_COMPLEX",5,-1.1013,0.37,0.59,-0.6655,0.85,1,0.7492,0.78,1
"GO_CC:515780_GO_0070852_CELL_BODY_FIBER","GO_CC","515780_GO_0070852_CELL_BODY_FIBER",6,-1.1012,0.37,0.59,-1.2485,0.2,0.65,1.4971,0.058,0.57
"C7_Immunologic_signatures:C7_ALL_530_GSE17721_LPS_VS_POLYIC_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_530_GSE17721_LPS_VS_POLYIC_1H_BMDM_DN",195,-1.1011,0.25,0.36,0.6915,1,1,-0.8266,0.95,1
"GO_BP:488964_GO_0003170_HEART_VALVE_DEVELOPMENT","GO_BP","488964_GO_0003170_HEART_VALVE_DEVELOPMENT",28,-1.101,0.31,0.48,-0.9639,0.5,1,1.0376,0.38,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1353_DER_IFN_BETA_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1353_DER_IFN_BETA_RESPONSE_UP",102,-1.1009,0.28,0.41,1.7039,0,0.081,-1.2151,0.11,0.51
"C7_Immunologic_signatures:C7_ALL_1106_GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1106_GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN",188,-1.1009,0.26,0.36,0.8635,0.85,1,0.7464,0.99,1
"GO_BP:983739_GO_1903020_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS","GO_BP","983739_GO_1903020_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS",14,-1.1009,0.35,0.48,-0.8009,0.74,1,-0.7775,0.81,1
"REACTOME:161005_REACT_22266_INTERACTION_BETWEEN_L1_AND_ANKYRINS","REACTOME","161005_REACT_22266_INTERACTION_BETWEEN_L1_AND_ANKYRINS",29,-1.1009,0.33,0.52,-1.4783,0.041,0.46,0.9613,0.52,1
"GO_MF:505440_GO_0042289_MHC_CLASS_II_PROTEIN_BINDING","GO_MF","505440_GO_0042289_MHC_CLASS_II_PROTEIN_BINDING",5,-1.1008,0.37,0.52,0.9521,0.52,0.93,-1.2224,0.28,0.58
"KEGG_pathway:HSA04722_NEUROTROPHIN_SIGNALING_PATHWAY","KEGG_pathway","HSA04722_NEUROTROPHIN_SIGNALING_PATHWAY",117,-1.1007,0.29,0.36,0.739,0.98,1,-0.9127,0.69,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_606_DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_606_DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP",62,-1.1007,0.29,0.41,-0.9519,0.57,1,-1.2355,0.14,0.49
"GO_BP:517576_GO_0072673_LAMELLIPODIUM_MORPHOGENESIS","GO_BP","517576_GO_0072673_LAMELLIPODIUM_MORPHOGENESIS",5,-1.1007,0.36,0.48,0.7566,0.75,1,-0.6069,0.93,1
"GO_MF:492799_GO_0008519_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","492799_GO_0008519_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",22,-1.1006,0.34,0.52,-0.7201,0.89,1,-1.1582,0.24,0.63
"C4_Cancer_gene_neighborhoods:C4_CGN_362_GNF2_IGFBP1","C4_Cancer_gene_neighborhoods","C4_CGN_362_GNF2_IGFBP1",29,-1.1006,0.34,0.5,1.655,0.0062,0.0094,1.33,0.11,0.28
"GO_BP:499266_GO_0021987_CEREBRAL_CORTEX_DEVELOPMENT","GO_BP","499266_GO_0021987_CEREBRAL_CORTEX_DEVELOPMENT",93,-1.1004,0.29,0.48,0.6231,1,1,1.0451,0.36,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_166_WIKMAN_ASBESTOS_LUNG_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_166_WIKMAN_ASBESTOS_LUNG_CANCER_UP",17,-1.1,0.32,0.41,0.9978,0.44,0.8,-0.8886,0.62,0.9
"C4_Cancer_modules:C4_CM_194_MODULE_207","C4_Cancer_modules","C4_CM_194_MODULE_207",220,-1.1,0.26,0.42,-0.9242,0.66,0.88,0.8903,0.79,1
"GO_CC:501181_GO_0031941_FILAMENTOUS_ACTIN","GO_CC","501181_GO_0031941_FILAMENTOUS_ACTIN",25,-1.0998,0.32,0.59,-1.0655,0.36,0.82,0.8711,0.64,1
"KEGG_module:HSA_M00085_FATTY_ACID_BIOSYNTHESIS_ELONGATION_MITOCHONDRIA","KEGG_module","HSA_M00085_FATTY_ACID_BIOSYNTHESIS_ELONGATION_MITOCHONDRIA",6,-1.0998,0.37,0.64,0.8911,0.59,0.89,-1.0613,0.38,0.71
"C3_TF_targets:C3_TFT_189_V_P53_02","C3_TF_targets","C3_TFT_189_V_P53_02",249,-1.0997,0.26,0.36,-0.8776,0.82,0.99,-0.852,0.9,0.97
"GO_BP:499148_GO_0021869_FOREBRAIN_VENTRICULAR_ZONE_PROGENITOR_CELL_DIVISION","GO_BP","499148_GO_0021869_FOREBRAIN_VENTRICULAR_ZONE_PROGENITOR_CELL_DIVISION",5,-1.0996,0.37,0.48,-1.0314,0.46,0.98,1.5141,0.053,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_830_LI_WILMS_TUMOR_ANAPLASTIC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_830_LI_WILMS_TUMOR_ANAPLASTIC_UP",19,-1.0996,0.35,0.41,1.1918,0.23,0.5,-1.2363,0.19,0.49
"C2_Chemical_and_genetic_perturbations:C2_CGP_2006_DURCHDEWALD_SKIN_CARCINOGENESIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2006_DURCHDEWALD_SKIN_CARCINOGENESIS_UP",87,-1.0995,0.3,0.41,1.1227,0.22,0.6,-1.1983,0.13,0.52
"GO_BP:754868_GO_1990001_INHIBITION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_BP","754868_GO_1990001_INHIBITION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS",10,-1.0994,0.33,0.48,-0.9734,0.48,1,0.9529,0.49,0.9
"C3_MicroRNA_targets:C3_MIR_102_ATGTTTC_MIR_494","C3_MicroRNA_targets","C3_MIR_102_ATGTTTC_MIR_494",160,-1.0994,0.29,0.44,-1.0644,0.33,1,-1.087,0.25,1
"GO_BP:490596_GO_0006906_VESICLE_FUSION","GO_BP","490596_GO_0006906_VESICLE_FUSION",87,-1.0993,0.29,0.48,0.938,0.6,1,-1.0353,0.37,0.82
"C4_Cancer_modules:C4_CM_217_MODULE_238","C4_Cancer_modules","C4_CM_217_MODULE_238",159,-1.0993,0.29,0.42,1.097,0.23,0.54,-1.3528,0.0081,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_833_MANN_RESPONSE_TO_AMIFOSTINE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_833_MANN_RESPONSE_TO_AMIFOSTINE_UP",20,-1.0992,0.35,0.41,1.0548,0.37,0.7,-0.7842,0.78,0.96
"GO_BP:508062_GO_0045717_NEGATIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS","GO_BP","508062_GO_0045717_NEGATIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS",10,-1.099,0.34,0.48,0.6415,0.9,1,-0.8116,0.7,0.98
"GO_BP:519065_GO_2000425_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE","GO_BP","519065_GO_2000425_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE",10,-1.099,0.36,0.48,-1.0432,0.41,0.98,1.0444,0.4,0.81
"GO_BP:504519_GO_0035335_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION","GO_BP","504519_GO_0035335_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION",97,-1.0989,0.29,0.48,1.0846,0.28,0.92,1.0463,0.34,0.81
"C7_Immunologic_signatures:C7_ALL_1034_GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN","C7_Immunologic_signatures","C7_ALL_1034_GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN",197,-1.0989,0.27,0.36,1.0096,0.44,0.71,-0.9394,0.63,0.88
"GO_MF:500971_GO_0031726_CCR1_CHEMOKINE_RECEPTOR_BINDING","GO_MF","500971_GO_0031726_CCR1_CHEMOKINE_RECEPTOR_BINDING",7,-1.0989,0.35,0.52,1.2491,0.22,0.68,1.0992,0.36,0.81
"KEGG_compound:C00354_D_FRUCTOSE_1_6_BISPHOSPHATE","KEGG_compound","C00354_D_FRUCTOSE_1_6_BISPHOSPHATE",5,-1.0988,0.38,0.5,-0.6724,0.87,1,0.7919,0.72,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_2110_KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2110_KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION",15,-1.0987,0.34,0.41,-0.4783,0.99,1,0.8298,0.73,1
"GO_BP:501263_GO_0032026_RESPONSE_TO_MAGNESIUM_ION","GO_BP","501263_GO_0032026_RESPONSE_TO_MAGNESIUM_ION",16,-1.0984,0.33,0.49,1.2817,0.15,0.7,1.7271,0.0039,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_3194_BILANGES_SERUM_SENSITIVE_VIA_TSC2","C2_Chemical_and_genetic_perturbations","C2_CGP_3194_BILANGES_SERUM_SENSITIVE_VIA_TSC2",39,-1.0983,0.32,0.41,-1.3078,0.1,0.69,-1.1692,0.21,0.55
"REACTOME:730340_REACT_150134_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE_","REACTOME","730340_REACT_150134_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE_",9,-1.0982,0.34,0.53,-1.0183,0.45,0.98,-0.8006,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2427_ALONSO_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2427_ALONSO_METASTASIS_DN",24,-1.0982,0.34,0.41,0.6933,0.9,1,-0.8159,0.76,0.94
"GO_BP:515870_GO_0070943_NEUTROPHIL_MEDIATED_KILLING_OF_SYMBIONT_CELL","GO_BP","515870_GO_0070943_NEUTROPHIL_MEDIATED_KILLING_OF_SYMBIONT_CELL",5,-1.0982,0.36,0.49,1.4122,0.088,0.54,-0.6114,0.91,1
"GO_CC:502204_GO_0032982_MYOSIN_FILAMENT","GO_CC","502204_GO_0032982_MYOSIN_FILAMENT",21,-1.0982,0.34,0.59,-1.3843,0.08,0.63,0.8691,0.65,1
"GO_BP:500124_GO_0030825_POSITIVE_REGULATION_OF_CGMP_METABOLIC_PROCESS","GO_BP","500124_GO_0030825_POSITIVE_REGULATION_OF_CGMP_METABOLIC_PROCESS",19,-1.0981,0.34,0.49,-0.7221,0.86,1,-0.9438,0.55,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1853_KUNINGER_IGF1_VS_PDGFB_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1853_KUNINGER_IGF1_VS_PDGFB_TARGETS_UP",78,-1.0981,0.31,0.41,-1.9903,0,0.083,-1.5488,0.0061,0.27
"C2_Chemical_and_genetic_perturbations:C2_CGP_1629_WU_HBX_TARGETS_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1629_WU_HBX_TARGETS_2_DN",14,-1.0981,0.34,0.41,-0.7582,0.78,1,-0.8814,0.62,0.9
"GO_BP:506696_GO_0043666_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY","GO_BP","506696_GO_0043666_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY",33,-1.0979,0.32,0.49,0.7296,0.9,1,-0.5258,1,1
"GO_MF:501273_GO_0032036_MYOSIN_HEAVY_CHAIN_BINDING","GO_MF","501273_GO_0032036_MYOSIN_HEAVY_CHAIN_BINDING",9,-1.0978,0.34,0.52,-1.4071,0.098,0.64,1.0524,0.37,0.84
"C6_Oncogenic_signatures:C6_ALL_55_E2F3_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_55_E2F3_UP_V1_DN",152,-1.0976,0.26,0.34,-1.0155,0.41,0.64,1.0863,0.25,0.37
"GO_MF:512306_GO_0051428_PEPTIDE_HORMONE_RECEPTOR_BINDING","GO_MF","512306_GO_0051428_PEPTIDE_HORMONE_RECEPTOR_BINDING",16,-1.0976,0.34,0.52,-1.1427,0.27,0.81,-1.6913,0.012,0.31
"GO_MF:496454_GO_0016504_PEPTIDASE_ACTIVATOR_ACTIVITY","GO_MF","496454_GO_0016504_PEPTIDASE_ACTIVATOR_ACTIVITY",37,-1.0975,0.32,0.52,1.2067,0.18,0.69,-0.901,0.59,0.87
"GO_BP:1134003_GO_1903828_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION","GO_BP","1134003_GO_1903828_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION",108,-1.0975,0.29,0.49,-0.6282,1,1,-1.1757,0.16,0.73
"C1_Positional:C1_ALL_325_CHR14Q31","C1_Positional","C1_ALL_325_CHR14Q31",23,-1.0975,0.35,0.86,-0.8798,0.65,1,1.0139,0.45,0.75
"C7_Immunologic_signatures:C7_ALL_698_GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_698_GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDM_DN",198,-1.0974,0.27,0.37,0.9988,0.48,0.74,-1.0156,0.42,0.69
"KEGG_pathway:HSA04662_B_CELL_RECEPTOR_SIGNALING_PATHWAY","KEGG_pathway","HSA04662_B_CELL_RECEPTOR_SIGNALING_PATHWAY",72,-1.0974,0.31,0.37,-0.5315,1,1,-1.2026,0.14,0.37
"REACTOME:645345_REACT_121100_LINOLEIC_ACID_LA_METABOLISM","REACTOME","645345_REACT_121100_LINOLEIC_ACID_LA_METABOLISM",8,-1.0974,0.36,0.53,-1.4905,0.049,0.47,-1.8242,0.002,0.17
"GO_BP:516033_GO_0071107_RESPONSE_TO_PARATHYROID_HORMONE","GO_BP","516033_GO_0071107_RESPONSE_TO_PARATHYROID_HORMONE",8,-1.0974,0.37,0.49,-1.0465,0.41,0.97,0.7618,0.79,1
"C3_TF_targets:C3_TFT_271_CRGAARNNNNCGA_UNKNOWN","C3_TF_targets","C3_TFT_271_CRGAARNNNNCGA_UNKNOWN",47,-1.0974,0.3,0.36,0.8299,0.76,1,-0.9931,0.46,0.78
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_171_BIOCARTA_ACH_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_171_BIOCARTA_ACH_PATHWAY",16,-1.0973,0.35,0.46,0.8527,0.67,0.91,1.051,0.38,1
"GO_BP:513837_GO_0060281_REGULATION_OF_OOCYTE_DEVELOPMENT","GO_BP","513837_GO_0060281_REGULATION_OF_OOCYTE_DEVELOPMENT",9,-1.0972,0.34,0.49,-1.2224,0.24,0.88,-0.8998,0.57,0.92
"REACTOME:576265_REACT_118744_PRE_NOTCH_EXPRESSION_AND_PROCESSING","REACTOME","576265_REACT_118744_PRE_NOTCH_EXPRESSION_AND_PROCESSING",45,-1.0972,0.32,0.53,-1.0385,0.36,0.96,0.8142,0.81,1
"REACTOME:187205_REACT_23847_GP1B_IX_V_ACTIVATION_SIGNALLING","REACTOME","187205_REACT_23847_GP1B_IX_V_ACTIVATION_SIGNALLING",10,-1.097,0.34,0.53,1.1629,0.28,0.49,0.6257,0.94,1
"C4_Cancer_modules:C4_CM_338_MODULE_403","C4_Cancer_modules","C4_CM_338_MODULE_403",46,-1.097,0.3,0.42,1.1519,0.24,0.46,-1.7183,0.0021,0.083
"GO_BP:488973_GO_0003179_HEART_VALVE_MORPHOGENESIS","GO_BP","488973_GO_0003179_HEART_VALVE_MORPHOGENESIS",26,-1.097,0.35,0.49,-1.0518,0.39,0.97,0.9288,0.56,0.92
"C3_TF_targets:C3_TFT_450_V_CREB_Q4_01","C3_TF_targets","C3_TFT_450_V_CREB_Q4_01",208,-1.0968,0.27,0.36,-0.8016,0.95,1,-0.9634,0.55,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_2334_MATZUK_SPERMATOGONIA","C2_Chemical_and_genetic_perturbations","C2_CGP_2334_MATZUK_SPERMATOGONIA",22,-1.0968,0.31,0.42,0.7716,0.8,1,0.7555,0.83,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2302_ZHANG_BREAST_CANCER_PROGENITORS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2302_ZHANG_BREAST_CANCER_PROGENITORS_DN",145,-1.0967,0.29,0.42,-0.6421,1,1,0.9251,0.67,1
"GO_CC:493471_GO_0009279_CELL_OUTER_MEMBRANE","GO_CC","493471_GO_0009279_CELL_OUTER_MEMBRANE",5,-1.0965,0.37,0.59,0.6948,0.82,0.99,1.2697,0.21,0.75
"C7_Immunologic_signatures:C7_ALL_1196_GSE27786_CD4_TCELL_VS_NKTCELL_DN","C7_Immunologic_signatures","C7_ALL_1196_GSE27786_CD4_TCELL_VS_NKTCELL_DN",196,-1.0965,0.27,0.37,0.8642,0.85,1,-0.9156,0.69,0.92
"GO_BP:497922_GO_0019042_VIRAL_LATENCY","GO_BP","497922_GO_0019042_VIRAL_LATENCY",11,-1.0965,0.35,0.49,0.8263,0.69,1,-1.0752,0.37,0.8
"REACTOME:160988_REACT_15452_PEPTIDE_HORMONE_BIOSYNTHESIS","REACTOME","160988_REACT_15452_PEPTIDE_HORMONE_BIOSYNTHESIS",13,-1.0965,0.36,0.53,-1.0079,0.45,0.99,-1.1072,0.32,0.7
"GO_BP:518314_GO_0090174_ORGANELLE_MEMBRANE_FUSION","GO_BP","518314_GO_0090174_ORGANELLE_MEMBRANE_FUSION",92,-1.0965,0.3,0.49,0.9432,0.59,1,-1.0341,0.36,0.82
"GO_MF:511628_GO_0050656_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BINDING","GO_MF","511628_GO_0050656_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BINDING",6,-1.0965,0.38,0.53,1.0109,0.47,0.87,-0.742,0.77,0.99
"KEGG_reaction:R08266_TAMOXIFEN_NADPH_OXYGEN_OXIDOREDUCTASE_N_OXIDE_FORMING_TAMOXIFEN_OXYGEN_NADPH_H_TAMOXIFEN_N_OXIDE_NADP_H2O","KEGG_reaction","R08266_TAMOXIFEN_NADPH_OXYGEN_OXIDOREDUCTASE_N_OXIDE_FORMING_TAMOXIFEN_OXYGEN_NADPH_H_TAMOXIFEN_N_OXIDE_NADP_H2O",5,-1.0963,0.35,0.49,0.6887,0.85,1,-0.8038,0.7,0.84
"C7_Immunologic_signatures:C7_ALL_1335_GSE30083_SP3_VS_SP4_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1335_GSE30083_SP3_VS_SP4_THYMOCYTE_UP",195,-1.0963,0.27,0.37,-0.9672,0.55,1,-0.9601,0.58,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_3305_FORTSCHEGGER_PHF8_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3305_FORTSCHEGGER_PHF8_TARGETS_UP",270,-1.0963,0.26,0.42,-0.861,0.88,1,-0.8138,0.97,0.94
"C7_Immunologic_signatures:C7_ALL_19_GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_19_GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP",200,-1.0963,0.28,0.37,0.6314,1,1,0.6836,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3331_PECE_MAMMARY_STEM_CELL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3331_PECE_MAMMARY_STEM_CELL_UP",144,-1.0962,0.28,0.42,2.8899,0,0,0.84,0.84,1
"GO_MF:492767_GO_0008483_TRANSAMINASE_ACTIVITY","GO_MF","492767_GO_0008483_TRANSAMINASE_ACTIVITY",20,-1.0962,0.34,0.53,-0.9247,0.58,0.96,-1.2368,0.17,0.59
"REACTOME:645303_REACT_121313_KERATAN_SULFATE_DEGRADATION","REACTOME","645303_REACT_121313_KERATAN_SULFATE_DEGRADATION",12,-1.0962,0.35,0.53,-0.8678,0.64,1,1.0878,0.34,0.95
"GO_BP:518190_GO_0090049_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS","GO_BP","518190_GO_0090049_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS",16,-1.0961,0.34,0.49,-1.1847,0.24,0.9,-1.1824,0.24,0.73
"REACTOME:106501_REACT_15334_DARPP_32_EVENTS","REACTOME","106501_REACT_15334_DARPP_32_EVENTS",27,-1.096,0.31,0.53,1.1029,0.31,0.58,-1.4733,0.043,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_172_WANG_LMO4_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_172_WANG_LMO4_TARGETS_UP",366,-1.0959,0.24,0.42,1.2726,0.021,0.42,0.739,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2052_LEIN_MIDBRAIN_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_2052_LEIN_MIDBRAIN_MARKERS",77,-1.0957,0.3,0.42,0.9602,0.53,0.85,0.8891,0.72,1
"GO_BP:488347_GO_0002474_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I","GO_BP","488347_GO_0002474_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I",107,-1.0957,0.28,0.49,1.8581,0,0.059,0.619,1,1
"C3_TF_targets:C3_TFT_363_V_E4F1_Q6","C3_TF_targets","C3_TFT_363_V_E4F1_Q6",282,-1.0956,0.23,0.36,-0.7576,0.99,1,-0.9506,0.63,0.85
"GO_BP:498561_GO_0019748_SECONDARY_METABOLIC_PROCESS","GO_BP","498561_GO_0019748_SECONDARY_METABOLIC_PROCESS",47,-1.0955,0.31,0.49,-0.9476,0.55,1,1.3565,0.073,0.64
"KEGG_enzyme:1.14.13.8_FLAVIN_CONTAINING_MONOOXYGENASE_DIMETHYLANILINE_OXIDASE_DIMETHYLANILINE_N_OXIDASE_FAD_CONTAINING_MONOOXYGENASE_N_N_DIMETHYLANILINE_MONOOXYGENASE_DMA_OXIDASE_FLAVIN_MIXED_FUNCTION_OXIDASE_ZIEGLER_S_ENZYME_MIXED_FUNCTION_AMINE_OXIDASE_FMO_FMO_I_FMO_II_FMO1_FMO2_FMO3_FMO4_FMO5_FLAVIN_MONOOXYGENASE_METHYLPHENYLTETRAHYDROPYRIDINE_N_MONOOXYGENASE_1_METHYL_4_PHENYL_1_2_3_6_TETRAHYDROPYRIDINE_OXYGEN_N_OXIDOREDUCTASE_DIMETHYLANILINE_MONOOXYGENASE_N_OXIDE_FORMING_","KEGG_enzyme","1.14.13.8_FLAVIN_CONTAINING_MONOOXYGENASE_DIMETHYLANILINE_OXIDASE_DIMETHYLANILINE_N_OXIDASE_FAD_CONTAINING_MONOOXYGENASE_N_N_DIMETHYLANILINE_MONOOXYGENASE_DMA_OXIDASE_FLAVIN_MIXED_FUNCTION_OXIDASE_ZIEGLER_S_ENZYME_MIXED_FUNCTION_AMINE_OXIDASE_FMO_FMO_I_FMO_II_FMO1_FMO2_FMO3_FMO4_FMO5_FLAVIN_MONOOXYGENASE_METHYLPHENYLTETRAHYDROPYRIDINE_N_MONOOXYGENASE_1_METHYL_4_PHENYL_1_2_3_6_TETRAHYDROPYRIDINE_OXYGEN_N_OXIDOREDUCTASE_DIMETHYLANILINE_MONOOXYGENASE_N_OXIDE_FORMING_",5,-1.0955,0.37,0.54,0.6904,0.83,1,-0.7717,0.76,0.99
"C7_Immunologic_signatures:C7_ALL_1683_GSE3982_BCELL_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_1683_GSE3982_BCELL_VS_TH1_UP",197,-1.0955,0.27,0.37,0.7597,0.98,1,-0.9633,0.54,0.81
"WikiPathways:198773_WP43_CYTOCHROME_P450","WikiPathways","198773_WP43_CYTOCHROME_P450",61,-1.0955,0.31,0.44,0.9572,0.54,1,1.3171,0.057,0.47
"GO_BP:505594_GO_0042455_RIBONUCLEOSIDE_BIOSYNTHETIC_PROCESS","GO_BP","505594_GO_0042455_RIBONUCLEOSIDE_BIOSYNTHETIC_PROCESS",125,-1.0953,0.29,0.49,1.1109,0.23,0.89,-1.1174,0.22,0.76
"OMIM_gene:OMIM603444_FAR_UPSTREAM_ELEMENT_BINDING_PROTEIN_1_FUBP1","OMIM_gene","OMIM603444_FAR_UPSTREAM_ELEMENT_BINDING_PROTEIN_1_FUBP1",5,-1.0953,0.38,0.81,0.8771,0.59,1,1.2733,0.2,1
"GO_BP:496950_GO_0017156_CALCIUM_ION_DEPENDENT_EXOCYTOSIS","GO_BP","496950_GO_0017156_CALCIUM_ION_DEPENDENT_EXOCYTOSIS",30,-1.0949,0.31,0.49,0.6889,0.95,1,1.047,0.39,0.81
"GO_BP:512833_GO_0051983_REGULATION_OF_CHROMOSOME_SEGREGATION","GO_BP","512833_GO_0051983_REGULATION_OF_CHROMOSOME_SEGREGATION",67,-1.0948,0.31,0.49,0.9538,0.54,1,-1.1382,0.23,0.75
"GO_BP:491424_GO_0006528_ASPARAGINE_METABOLIC_PROCESS","GO_BP","491424_GO_0006528_ASPARAGINE_METABOLIC_PROCESS",5,-1.0945,0.38,0.49,-0.586,0.92,1,-0.9548,0.51,0.89
"C7_Immunologic_signatures:C7_ALL_488_GSE17721_CTRL_VS_PAM3CSK4_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_488_GSE17721_CTRL_VS_PAM3CSK4_6H_BMDM_DN",195,-1.0944,0.29,0.37,1.17,0.13,0.28,1.214,0.076,0.66
"C7_Immunologic_signatures:C7_ALL_1448_GSE360_L_DONOVANI_VS_T_GONDII_DC_DN","C7_Immunologic_signatures","C7_ALL_1448_GSE360_L_DONOVANI_VS_T_GONDII_DC_DN",194,-1.0944,0.28,0.37,-1.0498,0.33,1,-1.1651,0.11,0.34
"REACTOME:106409_REACT_7956_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION","REACTOME","106409_REACT_7956_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION",6,-1.0943,0.38,0.53,1.1719,0.29,0.48,-0.9012,0.58,0.95
"GO_BP:487491_GO_0001553_LUTEINIZATION","GO_BP","487491_GO_0001553_LUTEINIZATION",8,-1.0943,0.35,0.49,0.9251,0.52,1,1.2507,0.22,0.7
"REACTOME:1127628_REACT_264581_S33_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED","REACTOME","1127628_REACT_264581_S33_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED",15,-1.0942,0.33,0.53,0.6797,0.91,1,-0.9421,0.54,0.91
"C0_Hallmark:H_ALL_9_HALLMARK_G2M_CHECKPOINT","C0_Hallmark","H_ALL_9_HALLMARK_G2M_CHECKPOINT",200,-1.0942,0.29,0.32,0.9026,0.73,0.92,-1.6152,0,0.015
"GO_MF:496643_GO_0016723_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS_NAD_OR_NADP_AS_ACCEPTOR","GO_MF","496643_GO_0016723_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS_NAD_OR_NADP_AS_ACCEPTOR",12,-1.0942,0.37,0.53,0.7753,0.76,1,-0.6659,0.9,1
"C6_Oncogenic_signatures:C6_ALL_53_BCAT_BILD_ET_AL_DN","C6_Oncogenic_signatures","C6_ALL_53_BCAT_BILD_ET_AL_DN",44,-1.0941,0.34,0.34,-0.8624,0.7,0.96,-0.9698,0.5,0.69
"GO_BP:491781_GO_0006930_SUBSTRATE_DEPENDENT_CELL_MIGRATION_CELL_EXTENSION","GO_BP","491781_GO_0006930_SUBSTRATE_DEPENDENT_CELL_MIGRATION_CELL_EXTENSION",7,-1.0941,0.36,0.49,0.7242,0.82,1,-0.8352,0.69,0.97
"C1_Positional:C1_ALL_283_CHRXQ26","C1_Positional","C1_ALL_283_CHRXQ26",52,-1.094,0.3,0.86,1.457,0.03,0.31,-1.1875,0.19,0.7
"GO_BP:499323_GO_0022405_HAIR_CYCLE_PROCESS","GO_BP","499323_GO_0022405_HAIR_CYCLE_PROCESS",73,-1.094,0.3,0.49,0.8161,0.82,1,1.015,0.43,0.84
"GO_BP:489136_GO_0003344_PERICARDIUM_MORPHOGENESIS","GO_BP","489136_GO_0003344_PERICARDIUM_MORPHOGENESIS",5,-1.094,0.38,0.49,-0.8177,0.71,1,1.084,0.39,0.77
"GO_CC:507401_GO_0044453_NUCLEAR_MEMBRANE_PART","GO_CC","507401_GO_0044453_NUCLEAR_MEMBRANE_PART",14,-1.094,0.34,0.6,-0.8121,0.7,1,0.6618,0.91,1
"REACTOME:645294_REACT_120726_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_","REACTOME","645294_REACT_120726_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_",16,-1.0938,0.35,0.53,1.2354,0.18,0.41,-1.2817,0.16,0.54
"GO_BP:495817_GO_0015682_FERRIC_IRON_TRANSPORT","GO_BP","495817_GO_0015682_FERRIC_IRON_TRANSPORT",37,-1.0938,0.32,0.49,0.9033,0.65,1,1.4578,0.044,0.59
"GO_MF:495444_GO_0015172_ACIDIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495444_GO_0015172_ACIDIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-1.0938,0.35,0.53,0.9831,0.46,0.89,-0.9452,0.54,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1845_CHANG_IMMORTALIZED_BY_HPV31_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1845_CHANG_IMMORTALIZED_BY_HPV31_UP",82,-1.0937,0.29,0.42,-1.2043,0.16,0.8,-1.0852,0.27,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_2300_IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2300_IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN",106,-1.0937,0.29,0.42,-0.9735,0.5,1,0.8989,0.7,1
"GO_BP:499490_GO_0030031_CELL_PROJECTION_ASSEMBLY","GO_BP","499490_GO_0030031_CELL_PROJECTION_ASSEMBLY",231,-1.0935,0.29,0.49,0.6806,1,1,-1.1102,0.2,0.76
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_214_BIOCARTA_VEGF_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_214_BIOCARTA_VEGF_PATHWAY",29,-1.0935,0.33,0.46,1.1627,0.24,0.68,0.8037,0.77,1
"GO_CC:486695_GO_0000164_PROTEIN_PHOSPHATASE_TYPE_1_COMPLEX","GO_CC","486695_GO_0000164_PROTEIN_PHOSPHATASE_TYPE_1_COMPLEX",8,-1.0935,0.38,0.6,-0.8995,0.58,0.96,0.8521,0.63,1
"OMIM_gene:OMIM607751_TASTE_RECEPTOR_TYPE_2_MEMBER_38_TAS2R38","OMIM_gene","OMIM607751_TASTE_RECEPTOR_TYPE_2_MEMBER_38_TAS2R38",5,-1.0934,0.4,0.79,0.9362,0.53,1,0.9817,0.46,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_3146_MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3146_MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP",7,-1.0934,0.36,0.42,1.2837,0.2,0.41,-0.6812,0.86,0.99
"C3_TF_targets:C3_TFT_339_V_HOXA4_Q2","C3_TF_targets","C3_TFT_339_V_HOXA4_Q2",257,-1.0933,0.25,0.37,0.9386,0.64,1,1.2641,0.029,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_2057_LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES","C2_Chemical_and_genetic_perturbations","C2_CGP_2057_LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES",37,-1.0933,0.31,0.42,1.1754,0.21,0.53,-0.9647,0.51,0.8
"GO_MF:490222_GO_0004931_EXTRACELLULAR_ATP_GATED_CATION_CHANNEL_ACTIVITY","GO_MF","490222_GO_0004931_EXTRACELLULAR_ATP_GATED_CATION_CHANNEL_ACTIVITY",7,-1.0931,0.36,0.53,-0.8062,0.69,1,0.6241,0.92,1
"GO_BP:487958_GO_0002068_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT","GO_BP","487958_GO_0002068_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT",16,-1.093,0.34,0.49,-1.2599,0.16,0.91,1.0426,0.41,0.81
"REACTOME:1127626_REACT_264127_T41_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED","REACTOME","1127626_REACT_264127_T41_MUTANTS_OF_BETA_CATENIN_AREN_T_PHOSPHORYLATED",15,-1.0928,0.36,0.53,0.6899,0.87,1,-0.919,0.58,0.94
"GO_BP:506972_GO_0043954_CELLULAR_COMPONENT_MAINTENANCE","GO_BP","506972_GO_0043954_CELLULAR_COMPONENT_MAINTENANCE",23,-1.0928,0.32,0.49,-1.2275,0.2,0.88,1.252,0.19,0.69
"GO_BP:515247_GO_0070314_G1_TO_G0_TRANSITION","GO_BP","515247_GO_0070314_G1_TO_G0_TRANSITION",7,-1.0927,0.34,0.49,-0.5988,0.94,1,-0.8028,0.73,0.99
"KEGG_compound:C00097_L_CYSTEINE_L_2_AMINO_3_MERCAPTOPROPIONIC_ACID","KEGG_compound","C00097_L_CYSTEINE_L_2_AMINO_3_MERCAPTOPROPIONIC_ACID",14,-1.0927,0.35,0.51,0.8663,0.63,1,-1.2597,0.17,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_1063_FRIDMAN_IMMORTALIZATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1063_FRIDMAN_IMMORTALIZATION_DN",33,-1.0927,0.32,0.42,0.7986,0.8,0.99,-0.9333,0.57,0.84
"GO_MF:500295_GO_0031005_FILAMIN_BINDING","GO_MF","500295_GO_0031005_FILAMIN_BINDING",8,-1.0927,0.35,0.53,-1.0353,0.42,0.88,0.9234,0.53,0.94
"GO_MF:504171_GO_0034979_NAD_DEPENDENT_PROTEIN_DEACETYLASE_ACTIVITY","GO_MF","504171_GO_0034979_NAD_DEPENDENT_PROTEIN_DEACETYLASE_ACTIVITY",17,-1.0926,0.37,0.53,-1.4007,0.091,0.62,-1.9143,0.0021,0.16
"C7_Immunologic_signatures:C7_ALL_647_GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_647_GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDM_UP",199,-1.0926,0.28,0.38,1.4921,0.0022,0.014,-1.0602,0.32,0.59
"GO_BP:491637_GO_0006760_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","491637_GO_0006760_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS",25,-1.0926,0.35,0.49,-0.8993,0.62,1,-0.8518,0.69,0.96
"C3_MicroRNA_targets:C3_MIR_130_GACAGGG_MIR_339","C3_MicroRNA_targets","C3_MIR_130_GACAGGG_MIR_339",67,-1.0925,0.31,0.46,-0.8634,0.75,1,-0.9292,0.59,1
"GO_BP:487739_GO_0001843_NEURAL_TUBE_CLOSURE","GO_BP","487739_GO_0001843_NEURAL_TUBE_CLOSURE",79,-1.0924,0.31,0.49,-0.7399,0.95,1,-0.7974,0.88,0.99
"C7_Immunologic_signatures:C7_ALL_678_GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_678_GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDM_DN",200,-1.0923,0.29,0.38,0.9705,0.52,0.83,-0.7148,1,1
"GO_BP:496305_GO_0016239_POSITIVE_REGULATION_OF_MACROAUTOPHAGY","GO_BP","496305_GO_0016239_POSITIVE_REGULATION_OF_MACROAUTOPHAGY",16,-1.0923,0.36,0.49,0.7934,0.77,1,-0.5582,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2311_BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2311_BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP",22,-1.0923,0.33,0.42,0.6376,0.95,1,-1.2404,0.17,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_191_GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_191_GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP",117,-1.0922,0.29,0.42,1.2657,0.073,0.42,-0.9478,0.56,0.83
"C7_Immunologic_signatures:C7_ALL_970_GSE22886_NEUTROPHIL_VS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_970_GSE22886_NEUTROPHIL_VS_MONOCYTE_DN",200,-1.0922,0.27,0.38,2.164,0,0,-0.6555,1,1
"C3_TF_targets:C3_TFT_261_V_AR_Q2","C3_TF_targets","C3_TFT_261_V_AR_Q2",123,-1.0922,0.3,0.37,-0.7304,0.97,1,0.885,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2543_RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2543_RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN",16,-1.0921,0.33,0.42,1.4243,0.085,0.28,-0.7247,0.86,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_453_GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_453_GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP",38,-1.0921,0.31,0.42,-0.9631,0.51,1,0.7736,0.84,1
"GO_BP:492670_GO_0008361_REGULATION_OF_CELL_SIZE","GO_BP","492670_GO_0008361_REGULATION_OF_CELL_SIZE",105,-1.092,0.3,0.49,-0.8634,0.76,1,0.8807,0.73,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1627_SU_PANCREAS","C2_Chemical_and_genetic_perturbations","C2_CGP_1627_SU_PANCREAS",49,-1.092,0.32,0.42,-0.8247,0.79,1,0.6909,0.96,1
"C7_Immunologic_signatures:C7_ALL_521_GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_521_GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDM_UP",200,-1.0918,0.29,0.38,1.4986,0.0047,0.013,-1.1306,0.17,0.41
"C3_TF_targets:C3_TFT_406_V_COUP_DR1_Q6","C3_TF_targets","C3_TFT_406_V_COUP_DR1_Q6",239,-1.0917,0.28,0.37,-0.9788,0.5,0.81,-1.242,0.042,0.3
"C4_Cancer_modules:C4_CM_19_MODULE_20","C4_Cancer_modules","C4_CM_19_MODULE_20",79,-1.0917,0.3,0.43,0.7616,0.92,0.99,-0.9692,0.52,0.74
"GO_BP:513980_GO_0060425_LUNG_MORPHOGENESIS","GO_BP","513980_GO_0060425_LUNG_MORPHOGENESIS",45,-1.0917,0.32,0.49,1.1153,0.24,0.88,1.622,0.0061,0.4
"GO_BP:514130_GO_0060575_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","514130_GO_0060575_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION",18,-1.0916,0.35,0.49,0.9889,0.47,0.99,1.0793,0.34,0.77
"C7_Immunologic_signatures:C7_ALL_506_GSE17721_CTRL_VS_CPG_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_506_GSE17721_CTRL_VS_CPG_8H_BMDM_DN",198,-1.0916,0.28,0.38,0.8946,0.75,1,-1.1667,0.12,0.34
"GO_MF:511751_GO_0050780_DOPAMINE_RECEPTOR_BINDING","GO_MF","511751_GO_0050780_DOPAMINE_RECEPTOR_BINDING",13,-1.0916,0.37,0.53,-1.138,0.27,0.8,-0.702,0.86,1
"C4_Cancer_gene_neighborhoods:C4_CGN_172_MORF_RBBP8","C4_Cancer_gene_neighborhoods","C4_CGN_172_MORF_RBBP8",208,-1.0915,0.28,0.52,-0.758,0.99,1,-1.3017,0.018,0.28
"GO_MF:490039_GO_0004725_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY","GO_MF","490039_GO_0004725_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY",100,-1.0914,0.3,0.53,1.1417,0.21,0.75,1.079,0.3,0.81
"GO_BP:493577_GO_0009404_TOXIN_METABOLIC_PROCESS","GO_BP","493577_GO_0009404_TOXIN_METABOLIC_PROCESS",13,-1.0913,0.36,0.5,-0.9018,0.58,1,1.1029,0.34,0.76
"GO_BP:511977_GO_0051052_REGULATION_OF_DNA_METABOLIC_PROCESS","GO_BP","511977_GO_0051052_REGULATION_OF_DNA_METABOLIC_PROCESS",275,-1.0913,0.27,0.5,0.7765,0.99,1,-1.1575,0.095,0.74
"GO_BP:491074_GO_0006091_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY","GO_BP","491074_GO_0006091_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY",374,-1.0913,0.25,0.5,1.6435,0,0.25,-0.9736,0.53,0.88
"GO_BP:512125_GO_0051231_SPINDLE_ELONGATION","GO_BP","512125_GO_0051231_SPINDLE_ELONGATION",8,-1.0912,0.37,0.5,0.6976,0.85,1,-0.8842,0.62,0.94
"GO_MF:494022_GO_0009931_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY","GO_MF","494022_GO_0009931_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",9,-1.0911,0.36,0.53,-1.0998,0.35,0.83,-0.6238,0.92,1
"REACTOME:1127624_REACT_263863_PHOSPHORYLATION_SITE_MUTANTS_OF_CTNNB1_ARE_NOT_TARGETED_TO_THE_PROTEASOME_BY_THE_DESTRUCTION_COMPLEX","REACTOME","1127624_REACT_263863_PHOSPHORYLATION_SITE_MUTANTS_OF_CTNNB1_ARE_NOT_TARGETED_TO_THE_PROTEASOME_BY_THE_DESTRUCTION_COMPLEX",15,-1.0911,0.37,0.53,0.6967,0.89,1,-0.9078,0.57,0.95
"C7_Immunologic_signatures:C7_ALL_1458_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN","C7_Immunologic_signatures","C7_ALL_1458_GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN",196,-1.0909,0.29,0.38,1.0059,0.44,0.72,0.9039,0.74,1
"GO_BP:1039897_GO_0090596_SENSORY_ORGAN_MORPHOGENESIS","GO_BP","1039897_GO_0090596_SENSORY_ORGAN_MORPHOGENESIS",243,-1.0905,0.26,0.5,-0.8976,0.77,1,1.4549,0.0038,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_358_HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_358_HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP",176,-1.0905,0.29,0.42,1.7156,0,0.074,-0.9142,0.72,0.86
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_11_BIOCARTA_AKT_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_11_BIOCARTA_AKT_PATHWAY",22,-1.0905,0.33,0.46,0.9561,0.5,0.84,0.7335,0.87,1
"GO_BP:512516_GO_0051640_ORGANELLE_LOCALIZATION","GO_BP","512516_GO_0051640_ORGANELLE_LOCALIZATION",362,-1.0905,0.24,0.5,1.1903,0.05,0.8,-0.978,0.52,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_885_KIM_MYCN_AMPLIFICATION_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_885_KIM_MYCN_AMPLIFICATION_TARGETS_UP",91,-1.0904,0.3,0.42,-1.0566,0.33,0.97,-1.2923,0.062,0.43
"GO_MF:490218_GO_0042813_WNT_ACTIVATED_RECEPTOR_ACTIVITY","GO_MF","490218_GO_0042813_WNT_ACTIVATED_RECEPTOR_ACTIVITY",20,-1.0904,0.35,0.53,-1.1821,0.26,0.78,0.9425,0.54,0.92
"GO_BP:493411_GO_0009215_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS","GO_BP","493411_GO_0009215_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS",11,-1.0904,0.37,0.5,0.8784,0.64,1,-1.5757,0.024,0.53
"GO_BP:503517_GO_0034314_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION","GO_BP","503517_GO_0034314_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION",18,-1.0903,0.34,0.5,0.8958,0.62,1,-0.8904,0.62,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1417_IIZUKA_LIVER_CANCER_EARLY_RECURRENCE","C2_Chemical_and_genetic_perturbations","C2_CGP_1417_IIZUKA_LIVER_CANCER_EARLY_RECURRENCE",11,-1.0901,0.35,0.42,0.7176,0.85,1,0.4899,0.99,1
"GO_BP:487738_GO_0001842_NEURAL_FOLD_FORMATION","GO_BP","487738_GO_0001842_NEURAL_FOLD_FORMATION",7,-1.09,0.36,0.5,-0.7029,0.83,1,0.8808,0.6,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_469_BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_469_BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP",31,-1.09,0.34,0.42,1.4302,0.054,0.27,0.9828,0.47,0.96
"REACTOME:187099_REACT_25039_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10","REACTOME","187099_REACT_25039_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10",12,-1.0898,0.36,0.53,0.7191,0.84,1,-0.8731,0.63,0.96
"C7_Immunologic_signatures:C7_ALL_323_GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_323_GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP",193,-1.0896,0.28,0.38,1.091,0.21,0.47,-0.9965,0.46,0.73
"GO_BP:501764_GO_0032534_REGULATION_OF_MICROVILLUS_ASSEMBLY","GO_BP","501764_GO_0032534_REGULATION_OF_MICROVILLUS_ASSEMBLY",5,-1.0896,0.39,0.5,-0.6313,0.88,1,0.8834,0.59,0.95
"GO_BP:492245_GO_0007492_ENDODERM_DEVELOPMENT","GO_BP","492245_GO_0007492_ENDODERM_DEVELOPMENT",75,-1.0894,0.32,0.5,-0.9959,0.47,0.99,1.107,0.23,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_901_SEMBA_FHIT_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_901_SEMBA_FHIT_TARGETS_DN",10,-1.0892,0.36,0.43,0.7566,0.78,1,-0.9069,0.58,0.87
"C7_Immunologic_signatures:C7_ALL_736_GSE17721_0_5H_VS_24H_PAM3CSK4_BMDM_DN","C7_Immunologic_signatures","C7_ALL_736_GSE17721_0_5H_VS_24H_PAM3CSK4_BMDM_DN",197,-1.0892,0.27,0.38,1.2815,0.034,0.12,-0.6664,1,1
"GO_BP:514584_GO_0061036_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT","GO_BP","514584_GO_0061036_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT",27,-1.0891,0.33,0.5,-1.1111,0.3,0.94,1.1474,0.24,0.73
"C7_Immunologic_signatures:C7_ALL_475_GSE17721_CTRL_VS_POLYIC_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_475_GSE17721_CTRL_VS_POLYIC_12H_BMDM_UP",199,-1.0891,0.26,0.38,1.2801,0.036,0.12,-1.2674,0.044,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_1479_HOFMANN_CELL_LYMPHOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1479_HOFMANN_CELL_LYMPHOMA_UP",50,-1.089,0.33,0.43,-0.622,0.98,1,-0.9337,0.57,0.84
"GO_BP:511865_GO_0050930_INDUCTION_OF_POSITIVE_CHEMOTAXIS","GO_BP","511865_GO_0050930_INDUCTION_OF_POSITIVE_CHEMOTAXIS",13,-1.0889,0.36,0.5,-0.8643,0.64,1,-0.7939,0.75,0.99
"C6_Oncogenic_signatures:C6_ALL_64_CAMP_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_64_CAMP_UP_V1_UP",197,-1.0889,0.29,0.35,1.5769,0.0023,0.096,-0.9475,0.62,0.7
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_87_BIOCARTA_HCMV_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_87_BIOCARTA_HCMV_PATHWAY",17,-1.0888,0.36,0.46,0.7183,0.85,1,-0.8968,0.6,0.84
"REACTOME:106049_REACT_1178_DISINHIBITION_OF_SNARE_FORMATION","REACTOME","106049_REACT_1178_DISINHIBITION_OF_SNARE_FORMATION",5,-1.0888,0.37,0.53,-0.7044,0.84,1,-0.9488,0.52,0.91
"GO_BP:752390_GO_0086019_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION","GO_BP","752390_GO_0086019_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION",19,-1.0887,0.35,0.5,0.7676,0.81,1,1.0542,0.38,0.8
"GO_BP:1129496_GO_1903670_REGULATION_OF_SPROUTING_ANGIOGENESIS","GO_BP","1129496_GO_1903670_REGULATION_OF_SPROUTING_ANGIOGENESIS",19,-1.0886,0.35,0.5,-1.2734,0.16,0.89,-1.1882,0.25,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1082_KOYAMA_SEMA3B_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1082_KOYAMA_SEMA3B_TARGETS_UP",280,-1.0886,0.26,0.43,0.8827,0.84,0.94,1.0817,0.22,0.88
"GO_BP:517312_GO_0072396_RESPONSE_TO_CELL_CYCLE_CHECKPOINT_SIGNALING","GO_BP","517312_GO_0072396_RESPONSE_TO_CELL_CYCLE_CHECKPOINT_SIGNALING",5,-1.0886,0.39,0.5,-0.9391,0.55,1,-1.0845,0.4,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_1040_RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1040_RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP",5,-1.0885,0.37,0.43,-0.8399,0.63,1,-0.6823,0.84,0.99
"REACTOME:187173_REACT_24941_CIRCADIAN_CLOCK","REACTOME","187173_REACT_24941_CIRCADIAN_CLOCK",62,-1.0883,0.32,0.53,0.8196,0.84,0.99,-0.6019,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_184_MORF_TNFRSF6","C4_Cancer_gene_neighborhoods","C4_CGN_184_MORF_TNFRSF6",160,-1.0883,0.28,0.52,-1.0724,0.3,0.75,1.3893,0.017,0.23
"C4_Cancer_gene_neighborhoods:C4_CGN_4_MORF_BNIP1","C4_Cancer_gene_neighborhoods","C4_CGN_4_MORF_BNIP1",184,-1.0882,0.29,0.52,-1.1061,0.23,0.72,-1.0454,0.33,0.73
"C3_MicroRNA_targets:C3_MIR_27_GTATGAT_MIR_154_MIR_487","C3_MicroRNA_targets","C3_MIR_27_GTATGAT_MIR_154_MIR_487",68,-1.0882,0.32,0.47,0.7705,0.88,1,-0.8731,0.74,1
"GO_BP:492778_GO_0017121_PHOSPHOLIPID_SCRAMBLING","GO_BP","492778_GO_0017121_PHOSPHOLIPID_SCRAMBLING",11,-1.0881,0.34,0.5,0.7393,0.78,1,-0.8389,0.67,0.97
"C6_Oncogenic_signatures:C6_ALL_67_MEK_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_67_MEK_UP_V1_DN",191,-1.088,0.28,0.35,1.1198,0.2,0.5,-1.2682,0.041,0.34
"GO_BP:501668_GO_0032436_POSITIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","501668_GO_0032436_POSITIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",58,-1.088,0.32,0.5,0.8231,0.81,1,-1.278,0.083,0.65
"GO_BP:518269_GO_0090129_POSITIVE_REGULATION_OF_SYNAPSE_MATURATION","GO_BP","518269_GO_0090129_POSITIVE_REGULATION_OF_SYNAPSE_MATURATION",10,-1.088,0.36,0.5,-1.0576,0.41,0.96,-1.3425,0.13,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_2726_CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2726_CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN",51,-1.0879,0.32,0.43,-1.089,0.3,0.93,-0.886,0.67,0.89
"GO_BP:507469_GO_0045069_REGULATION_OF_VIRAL_GENOME_REPLICATION","GO_BP","507469_GO_0045069_REGULATION_OF_VIRAL_GENOME_REPLICATION",68,-1.0878,0.33,0.5,1.5573,0.012,0.33,-1.4118,0.028,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_1678_RODWELL_AGING_KIDNEY_NO_BLOOD_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1678_RODWELL_AGING_KIDNEY_NO_BLOOD_DN",148,-1.0877,0.28,0.43,1.5957,0.0024,0.14,-1.1215,0.17,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_1825_BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1825_BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP",27,-1.0877,0.34,0.43,-0.6785,0.92,1,0.8637,0.7,1
"C4_Cancer_modules:C4_CM_387_MODULE_486","C4_Cancer_modules","C4_CM_387_MODULE_486",100,-1.0876,0.32,0.44,-1.6489,0.0018,0.19,-1.5241,0.0059,0.14
"C7_Immunologic_signatures:C7_ALL_1624_GSE3982_MAST_CELL_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_1624_GSE3982_MAST_CELL_VS_TH1_DN",196,-1.0876,0.28,0.39,1.0344,0.33,0.63,-1.2885,0.029,0.15
"C7_Immunologic_signatures:C7_ALL_329_GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_329_GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP",187,-1.0875,0.29,0.39,1.0294,0.35,0.65,-1.0111,0.41,0.7
"KEGG_compound:C01194_1_PHOSPHATIDYL_D_MYO_INOSITOL_1_PHOSPHATIDYL_1D_MYO_INOSITOL_1_PHOSPHATIDYL_MYO_INOSITOL_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHATIDYL_1_D_INOSITOL_1_2_DIACYL_SN_GLYCERO_3_PHOSPHOINOSITOL_PHOSPHATIDYLINOSITOL","KEGG_compound","C01194_1_PHOSPHATIDYL_D_MYO_INOSITOL_1_PHOSPHATIDYL_1D_MYO_INOSITOL_1_PHOSPHATIDYL_MYO_INOSITOL_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHATIDYL_1_D_INOSITOL_1_2_DIACYL_SN_GLYCERO_3_PHOSPHOINOSITOL_PHOSPHATIDYLINOSITOL",22,-1.0874,0.35,0.52,0.8605,0.68,1,-0.8412,0.7,0.81
"GO_BP:500127_GO_0030828_POSITIVE_REGULATION_OF_CGMP_BIOSYNTHETIC_PROCESS","GO_BP","500127_GO_0030828_POSITIVE_REGULATION_OF_CGMP_BIOSYNTHETIC_PROCESS",17,-1.0872,0.34,0.5,-1.0025,0.45,0.99,-1.0565,0.38,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_3020_WHITFIELD_CELL_CYCLE_S","C2_Chemical_and_genetic_perturbations","C2_CGP_3020_WHITFIELD_CELL_CYCLE_S",161,-1.0872,0.3,0.43,-0.7305,0.98,1,-1.3127,0.033,0.42
"GO_BP:488426_GO_0002553_HISTAMINE_SECRETION_BY_MAST_CELL","GO_BP","488426_GO_0002553_HISTAMINE_SECRETION_BY_MAST_CELL",5,-1.0871,0.39,0.5,0.904,0.59,1,-1.0531,0.44,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_681_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8","C2_Chemical_and_genetic_perturbations","C2_CGP_681_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8",12,-1.087,0.35,0.43,-0.6934,0.87,1,-1.2777,0.15,0.45
"GO_MF:492506_GO_0008157_PROTEIN_PHOSPHATASE_1_BINDING","GO_MF","492506_GO_0008157_PROTEIN_PHOSPHATASE_1_BINDING",13,-1.087,0.34,0.54,-0.645,0.91,1,-1.1921,0.24,0.6
"C7_Immunologic_signatures:C7_ALL_1805_GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1805_GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP",198,-1.0869,0.3,0.39,1.1128,0.19,0.41,-0.7788,0.97,1
"REACTOME:1127532_REACT_263982_CA2_PATHWAY","REACTOME","1127532_REACT_263982_CA2_PATHWAY",60,-1.0869,0.32,0.54,-0.9922,0.46,0.99,-0.9044,0.66,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_297_SABATES_COLORECTAL_ADENOMA_SIZE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_297_SABATES_COLORECTAL_ADENOMA_SIZE_DN",12,-1.0868,0.36,0.43,1.1199,0.32,0.6,-1.2224,0.21,0.5
"REACTOME:1127685_REACT_263961_HDMS_DEMETHYLATE_HISTONES","REACTOME","1127685_REACT_263961_HDMS_DEMETHYLATE_HISTONES",45,-1.0868,0.35,0.54,-1.8619,0,0.059,-1.1564,0.22,0.65
"GO_BP:502846_GO_0033630_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN","GO_BP","502846_GO_0033630_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN",17,-1.0868,0.36,0.5,0.8283,0.72,1,0.821,0.7,1
"WikiPathways:198820_WP528_ACETYLCHOLINE_SYNTHESIS","WikiPathways","198820_WP528_ACETYLCHOLINE_SYNTHESIS",7,-1.0866,0.37,0.45,1.1143,0.34,0.97,0.674,0.86,1
"C7_Immunologic_signatures:C7_ALL_473_GSE17721_CTRL_VS_POLYIC_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_473_GSE17721_CTRL_VS_POLYIC_8H_BMDM_UP",198,-1.0866,0.29,0.39,1.6488,0,0.0013,-0.7992,0.97,1
"REACTOME:187092_REACT_25195_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING","REACTOME","187092_REACT_25195_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING",13,-1.0866,0.38,0.54,1.4513,0.086,0.18,0.724,0.83,1
"C3_TF_targets:C3_TFT_576_TGATTTRY_V_GFI1_01","C3_TF_targets","C3_TFT_576_TGATTTRY_V_GFI1_01",280,-1.0865,0.28,0.38,1.1976,0.072,0.71,1.3386,0.014,0.74
"C4_Cancer_modules:C4_CM_366_MODULE_447","C4_Cancer_modules","C4_CM_366_MODULE_447",38,-1.0865,0.33,0.44,1.6102,0.0086,0.072,-1.0123,0.42,0.68
"C7_Immunologic_signatures:C7_ALL_1627_GSE3982_DC_VS_MAC_UP","C7_Immunologic_signatures","C7_ALL_1627_GSE3982_DC_VS_MAC_UP",189,-1.0864,0.29,0.39,0.7099,1,1,-0.966,0.55,0.81
"GO_BP:1129370_GO_1903543_POSITIVE_REGULATION_OF_EXOSOMAL_SECRETION","GO_BP","1129370_GO_1903543_POSITIVE_REGULATION_OF_EXOSOMAL_SECRETION",12,-1.0864,0.35,0.5,1.2582,0.18,0.72,1.3156,0.13,0.66
"GO_BP:507567_GO_0045185_MAINTENANCE_OF_PROTEIN_LOCATION","GO_BP","507567_GO_0045185_MAINTENANCE_OF_PROTEIN_LOCATION",114,-1.0864,0.32,0.5,0.7723,0.95,1,-0.8449,0.84,0.96
"REACTOME:1127686_REACT_268728_PKMTS_METHYLATE_HISTONE_LYSINES","REACTOME","1127686_REACT_268728_PKMTS_METHYLATE_HISTONE_LYSINES",61,-1.0864,0.33,0.54,-1.6056,0.0038,0.33,-1.3217,0.06,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_451_GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_451_GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP",167,-1.0863,0.29,0.43,-0.8564,0.84,1,0.9488,0.58,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1242_ONDER_CDH1_TARGETS_3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1242_ONDER_CDH1_TARGETS_3_UP",17,-1.0863,0.33,0.43,0.6865,0.88,1,-0.7673,0.8,0.97
"GO_BP:493319_GO_0009120_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS","GO_BP","493319_GO_0009120_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS",7,-1.0861,0.36,0.5,0.7351,0.81,1,-0.5922,0.93,1
"C1_Positional:C1_ALL_209_CHR11Q23","C1_Positional","C1_ALL_209_CHR11Q23",127,-1.0861,0.31,0.88,1.0151,0.41,0.75,-1.2534,0.077,0.56
"GO_BP:508227_GO_0045920_NEGATIVE_REGULATION_OF_EXOCYTOSIS","GO_BP","508227_GO_0045920_NEGATIVE_REGULATION_OF_EXOCYTOSIS",22,-1.0861,0.34,0.5,1.3994,0.077,0.55,0.9933,0.44,0.86
"GO_BP:507106_GO_0044091_MEMBRANE_BIOGENESIS","GO_BP","507106_GO_0044091_MEMBRANE_BIOGENESIS",25,-1.0861,0.34,0.5,0.9596,0.52,1,1.2195,0.2,0.71
"GO_BP:495133_GO_0014061_REGULATION_OF_NOREPINEPHRINE_SECRETION","GO_BP","495133_GO_0014061_REGULATION_OF_NOREPINEPHRINE_SECRETION",13,-1.0861,0.35,0.5,1.1641,0.25,0.82,-0.9218,0.56,0.91
"REACTOME:833811_REACT_163942_SYNDECAN_INTERACTIONS","REACTOME","833811_REACT_163942_SYNDECAN_INTERACTIONS",20,-1.0861,0.35,0.53,1.1949,0.21,0.45,1.0356,0.4,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2198_CHENG_IMPRINTED_BY_ESTRADIOL","C2_Chemical_and_genetic_perturbations","C2_CGP_2198_CHENG_IMPRINTED_BY_ESTRADIOL",110,-1.086,0.29,0.43,0.71,0.99,1,-0.9081,0.66,0.87
"GO_BP:511817_GO_0050879_MULTICELLULAR_ORGANISMAL_MOVEMENT","GO_BP","511817_GO_0050879_MULTICELLULAR_ORGANISMAL_MOVEMENT",35,-1.0859,0.34,0.5,-1.2784,0.12,0.89,-1.2722,0.13,0.66
"GO_BP:499324_GO_0022406_MEMBRANE_DOCKING","GO_BP","499324_GO_0022406_MEMBRANE_DOCKING",76,-1.0857,0.32,0.5,-0.8404,0.79,1,-1.0143,0.41,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_2933_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7","C2_Chemical_and_genetic_perturbations","C2_CGP_2933_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7",75,-1.0854,0.32,0.43,1.1986,0.17,0.49,-0.7104,0.97,0.98
"REACTOME:105801_REACT_2203_G2_M_TRANSITION","REACTOME","105801_REACT_2203_G2_M_TRANSITION",114,-1.0854,0.31,0.54,-0.5884,1,1,-1.5695,0,0.28
"REACTOME:187178_REACT_25199_GABA_RECEPTOR_ACTIVATION","REACTOME","187178_REACT_25199_GABA_RECEPTOR_ACTIVATION",52,-1.0854,0.33,0.53,-1.1608,0.24,0.85,1.0267,0.41,0.99
"GO_BP:506646_GO_0043615_ASTROCYTE_CELL_MIGRATION","GO_BP","506646_GO_0043615_ASTROCYTE_CELL_MIGRATION",6,-1.0854,0.39,0.5,1.3985,0.12,0.55,1.3731,0.11,0.65
"KEGG_reaction:R05795_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_3_PHOSPHOTRANSFERASE_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_ADP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_4_BISPHOSPHATE","KEGG_reaction","R05795_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_3_PHOSPHOTRANSFERASE_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_ADP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_4_BISPHOSPHATE",7,-1.0853,0.38,0.5,-0.7116,0.82,1,-0.7867,0.73,0.85
"GO_BP:499307_GO_0022028_TANGENTIAL_MIGRATION_FROM_THE_SUBVENTRICULAR_ZONE_TO_THE_OLFACTORY_BULB","GO_BP","499307_GO_0022028_TANGENTIAL_MIGRATION_FROM_THE_SUBVENTRICULAR_ZONE_TO_THE_OLFACTORY_BULB",8,-1.0853,0.36,0.5,-1.6034,0.034,0.7,0.6403,0.91,1
"GO_BP:493300_GO_0009100_GLYCOPROTEIN_METABOLIC_PROCESS","GO_BP","493300_GO_0009100_GLYCOPROTEIN_METABOLIC_PROCESS",389,-1.0853,0.27,0.5,0.8522,0.96,1,0.7969,0.99,1
"GO_CC:500199_GO_0030904_RETROMER_COMPLEX","GO_CC","500199_GO_0030904_RETROMER_COMPLEX",22,-1.0852,0.34,0.62,0.7764,0.78,0.97,-0.5808,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1964_SASSON_FSH_RESPONSE","C2_Chemical_and_genetic_perturbations","C2_CGP_1964_SASSON_FSH_RESPONSE",9,-1.0849,0.35,0.43,0.9857,0.49,0.81,1.0466,0.42,0.93
"KEGG_compound:C05139_16ALPHA_HYDROXYDEHYDROEPIANDROSTERONE_5_ANDROSTENE_3BETA_16ALPHA_DIOL_17_ONE","KEGG_compound","C05139_16ALPHA_HYDROXYDEHYDROEPIANDROSTERONE_5_ANDROSTENE_3BETA_16ALPHA_DIOL_17_ONE",9,-1.0848,0.36,0.52,0.8056,0.71,1,1.08,0.39,0.64
"GO_MF:489649_GO_0004198_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_MF","489649_GO_0004198_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",19,-1.0848,0.35,0.54,-0.9501,0.52,0.95,-0.7557,0.83,0.99
"GO_BP:488351_GO_0002478_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN","GO_BP","488351_GO_0002478_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN",168,-1.0847,0.31,0.5,1.65,0,0.25,-0.6354,1,1
"GO_MF:499430_GO_0030594_NEUROTRANSMITTER_RECEPTOR_ACTIVITY","GO_MF","499430_GO_0030594_NEUROTRANSMITTER_RECEPTOR_ACTIVITY",74,-1.0845,0.33,0.54,-1.1531,0.21,0.81,1.9556,0,0.031
"KEGG_pathway:HSA05221_ACUTE_MYELOID_LEUKEMIA","KEGG_pathway","HSA05221_ACUTE_MYELOID_LEUKEMIA",57,-1.0845,0.32,0.39,0.538,1,1,-0.778,0.87,0.96
"GO_BP:752620_GO_0097119_POSTSYNAPTIC_DENSITY_PROTEIN_95_CLUSTERING","GO_BP","752620_GO_0097119_POSTSYNAPTIC_DENSITY_PROTEIN_95_CLUSTERING",6,-1.0845,0.37,0.5,-1.3887,0.12,1,0.9755,0.51,0.88
"GO_BP:502302_GO_0033081_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS","GO_BP","502302_GO_0033081_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS",23,-1.0844,0.36,0.5,-1.1207,0.3,0.94,-0.724,0.88,0.99
"GO_BP:492346_GO_0007605_SENSORY_PERCEPTION_OF_SOUND","GO_BP","492346_GO_0007605_SENSORY_PERCEPTION_OF_SOUND",137,-1.0839,0.31,0.51,0.9677,0.55,1,1.4671,0.0058,0.59
"KEGG_pathway:HSA05016_HUNTINGTON_S_DISEASE","KEGG_pathway","HSA05016_HUNTINGTON_S_DISEASE",183,-1.0838,0.31,0.39,1.9344,0,0.0042,-0.508,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1083_KOYAMA_SEMA3B_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1083_KOYAMA_SEMA3B_TARGETS_DN",400,-1.0836,0.28,0.43,-0.8739,0.88,1,-0.9387,0.69,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_2449_SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2449_SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP",13,-1.0836,0.37,0.43,-1.4452,0.081,0.53,-0.9938,0.46,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2807_FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2807_FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP",71,-1.0836,0.32,0.43,-1.1129,0.28,0.9,-1.5495,0.0081,0.27
"GO_BP:488800_GO_0003002_REGIONALIZATION","GO_BP","488800_GO_0003002_REGIONALIZATION",330,-1.083,0.27,0.51,-1.0736,0.26,0.96,1.2119,0.065,0.71
"REACTOME:1183595_REACT_355021_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS","REACTOME","1183595_REACT_355021_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS",9,-1.0828,0.36,0.54,-0.6827,0.86,1,-0.8374,0.67,1
"GO_MF:492460_GO_0008093_CYTOSKELETAL_ADAPTOR_ACTIVITY","GO_MF","492460_GO_0008093_CYTOSKELETAL_ADAPTOR_ACTIVITY",12,-1.0828,0.39,0.54,-0.9061,0.59,0.98,-0.9839,0.47,0.79
"GO_BP:512694_GO_0051823_REGULATION_OF_SYNAPSE_STRUCTURAL_PLASTICITY","GO_BP","512694_GO_0051823_REGULATION_OF_SYNAPSE_STRUCTURAL_PLASTICITY",8,-1.0828,0.37,0.51,0.7037,0.84,1,-0.9578,0.52,0.88
"GO_BP:514936_GO_0065005_PROTEIN_LIPID_COMPLEX_ASSEMBLY","GO_BP","514936_GO_0065005_PROTEIN_LIPID_COMPLEX_ASSEMBLY",19,-1.0827,0.37,0.51,-1.0055,0.47,0.98,1.2962,0.14,0.67
"C7_Immunologic_signatures:C7_ALL_1022_GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1022_GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN",199,-1.0826,0.31,0.4,1.4764,0.0024,0.016,0.9128,0.69,1
"GO_BP:511932_GO_0050999_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY","GO_BP","511932_GO_0050999_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY",40,-1.0826,0.35,0.51,0.9183,0.59,1,1.0405,0.37,0.82
"GO_BP:753110_GO_1900115_EXTRACELLULAR_REGULATION_OF_SIGNAL_TRANSDUCTION","GO_BP","753110_GO_1900115_EXTRACELLULAR_REGULATION_OF_SIGNAL_TRANSDUCTION",18,-1.0824,0.35,0.51,1.1392,0.26,0.85,0.6924,0.91,1
"GO_MF:489643_GO_0004177_AMINOPEPTIDASE_ACTIVITY","GO_MF","489643_GO_0004177_AMINOPEPTIDASE_ACTIVITY",41,-1.0824,0.34,0.54,-0.857,0.68,1,-0.9319,0.61,0.84
"GO_CC:487087_GO_0000796_CONDENSIN_COMPLEX","GO_CC","487087_GO_0000796_CONDENSIN_COMPLEX",6,-1.0824,0.38,0.62,0.4723,1,1,-1.1896,0.28,0.81
"C7_Immunologic_signatures:C7_ALL_371_GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP","C7_Immunologic_signatures","C7_ALL_371_GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP",186,-1.0823,0.3,0.4,1.141,0.16,0.34,-1.0851,0.24,0.53
"GO_MF:498632_GO_0019841_RETINOL_BINDING","GO_MF","498632_GO_0019841_RETINOL_BINDING",12,-1.0823,0.35,0.54,-0.9823,0.47,0.93,1.0824,0.35,0.81
"C3_MicroRNA_targets:C3_MIR_41_ATGCTGC_MIR_103_MIR_107","C3_MicroRNA_targets","C3_MIR_41_ATGCTGC_MIR_103_MIR_107",220,-1.0823,0.29,0.48,0.8927,0.77,1,0.9184,0.72,1
"C7_Immunologic_signatures:C7_ALL_565_GSE17721_PAM3CSK4_VS_CPG_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_565_GSE17721_PAM3CSK4_VS_CPG_1H_BMDM_UP",193,-1.0823,0.28,0.4,1.1493,0.14,0.32,-0.7528,0.99,1
"GO_BP:512112_GO_0051216_CARTILAGE_DEVELOPMENT","GO_BP","512112_GO_0051216_CARTILAGE_DEVELOPMENT",150,-1.0822,0.32,0.51,-1.136,0.19,0.93,1.1698,0.14,0.72
"GO_BP:492621_GO_0008300_ISOPRENOID_CATABOLIC_PROCESS","GO_BP","492621_GO_0008300_ISOPRENOID_CATABOLIC_PROCESS",7,-1.0821,0.39,0.51,-1.3262,0.16,0.89,-0.7946,0.73,0.99
"GO_BP:750959_GO_0036037_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION","GO_BP","750959_GO_0036037_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION",8,-1.082,0.37,0.51,0.686,0.86,1,1.1833,0.25,0.72
"GO_BP:488314_GO_0002441_HISTAMINE_SECRETION_INVOLVED_IN_INFLAMMATORY_RESPONSE","GO_BP","488314_GO_0002441_HISTAMINE_SECRETION_INVOLVED_IN_INFLAMMATORY_RESPONSE",5,-1.082,0.38,0.51,0.8962,0.59,1,-1.0786,0.39,0.8
"GO_CC:515748_GO_0070820_TERTIARY_GRANULE","GO_CC","515748_GO_0070820_TERTIARY_GRANULE",6,-1.0818,0.38,0.62,-0.8125,0.69,1,0.5793,0.94,1
"GO_BP:507078_GO_0044062_REGULATION_OF_EXCRETION","GO_BP","507078_GO_0044062_REGULATION_OF_EXCRETION",25,-1.0818,0.34,0.51,1.6115,0.019,0.28,1.1281,0.26,0.74
"C3_TF_targets:C3_TFT_46_V_GATA1_01","C3_TF_targets","C3_TFT_46_V_GATA1_01",236,-1.0817,0.28,0.39,-0.829,0.9,1,-0.7759,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_105_HOOI_ST7_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_105_HOOI_ST7_TARGETS_DN",120,-1.0816,0.31,0.44,-1.0308,0.38,0.97,1.0899,0.29,0.88
"GO_BP:518381_GO_0090241_NEGATIVE_REGULATION_OF_HISTONE_H4_ACETYLATION","GO_BP","518381_GO_0090241_NEGATIVE_REGULATION_OF_HISTONE_H4_ACETYLATION",5,-1.0816,0.41,0.51,0.572,0.96,1,-0.5306,0.97,1
"GO_BP:754831_GO_1901880_NEGATIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION","GO_BP","754831_GO_1901880_NEGATIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION",59,-1.0816,0.35,0.51,-0.9369,0.56,1,-1.3495,0.053,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_2106_JEPSEN_SMRT_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2106_JEPSEN_SMRT_TARGETS",32,-1.0815,0.34,0.44,0.9545,0.51,0.86,1.3775,0.072,0.53
"REACTOME:106510_REACT_11045_SIGNALING_BY_WNT","REACTOME","106510_REACT_11045_SIGNALING_BY_WNT",322,-1.0814,0.29,0.54,-0.8149,0.96,1,-1.0245,0.38,0.8
"GO_MF:495357_GO_0046935_1_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY","GO_MF","495357_GO_0046935_1_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY",6,-1.0813,0.35,0.54,-0.7978,0.73,1,-0.8306,0.67,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_865_JAZAG_TGFB1_SIGNALING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_865_JAZAG_TGFB1_SIGNALING_UP",106,-1.0813,0.32,0.44,-0.6807,0.99,1,-0.8402,0.84,0.93
"WikiPathways:698758_WP2276_GLIAL_CELL_DIFFERENTIATION","WikiPathways","698758_WP2276_GLIAL_CELL_DIFFERENTIATION",7,-1.0811,0.36,0.46,0.7187,0.82,1,0.8538,0.64,1
"C7_Immunologic_signatures:C7_ALL_556_GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_556_GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDM_DN",199,-1.0809,0.3,0.4,1.4294,0.0046,0.029,-1.099,0.21,0.5
"GO_BP:491762_GO_0006904_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS","GO_BP","491762_GO_0006904_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS",47,-1.0809,0.35,0.51,0.9389,0.57,1,-0.7617,0.87,1
"C7_Immunologic_signatures:C7_ALL_1089_GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1089_GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP",194,-1.0807,0.29,0.4,0.9371,0.63,0.94,-1.0935,0.22,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_174_WANG_CLIM2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_174_WANG_CLIM2_TARGETS_UP",259,-1.0807,0.29,0.44,-0.9194,0.7,1,0.8681,0.87,1
"C3_TF_targets:C3_TFT_428_V_USF_Q6_01","C3_TF_targets","C3_TFT_428_V_USF_Q6_01",236,-1.0806,0.3,0.4,1.0048,0.42,1,0.8821,0.83,1
"GO_BP:492018_GO_0007220_NOTCH_RECEPTOR_PROCESSING","GO_BP","492018_GO_0007220_NOTCH_RECEPTOR_PROCESSING",22,-1.0806,0.35,0.51,0.8566,0.69,1,-1.1552,0.24,0.73
"REACTOME:119551_REACT_19333_G_ALPHA_Z_SIGNALLING_EVENTS","REACTOME","119551_REACT_19333_G_ALPHA_Z_SIGNALLING_EVENTS",45,-1.0805,0.35,0.54,-0.9609,0.52,1,-1.0437,0.4,0.79
"REACTOME:905990_REACT_169208_GLYCOGEN_SYNTHESIS","REACTOME","905990_REACT_169208_GLYCOGEN_SYNTHESIS",15,-1.0804,0.35,0.54,1.407,0.078,0.22,-1.4671,0.056,0.38
"GO_BP:1051069_GO_1903429_REGULATION_OF_CELL_MATURATION","GO_BP","1051069_GO_1903429_REGULATION_OF_CELL_MATURATION",13,-1.0803,0.37,0.51,-0.9882,0.46,1,1.2271,0.21,0.71
"C3_MicroRNA_targets:C3_MIR_56_AGTCAGC_MIR_345","C3_MicroRNA_targets","C3_MIR_56_AGTCAGC_MIR_345",59,-1.0803,0.31,0.48,-0.9296,0.57,1,-0.9826,0.46,1
"GO_BP:508735_GO_0046475_GLYCEROPHOSPHOLIPID_CATABOLIC_PROCESS","GO_BP","508735_GO_0046475_GLYCEROPHOSPHOLIPID_CATABOLIC_PROCESS",9,-1.0802,0.38,0.51,-0.4975,0.98,1,0.8315,0.64,0.99
"GO_BP:501343_GO_0032106_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS","GO_BP","501343_GO_0032106_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS",22,-1.0801,0.37,0.51,-0.8347,0.72,1,-0.775,0.78,1
"GO_BP:513581_GO_0060023_SOFT_PALATE_DEVELOPMENT","GO_BP","513581_GO_0060023_SOFT_PALATE_DEVELOPMENT",5,-1.08,0.4,0.51,-0.7384,0.77,1,1.1489,0.33,0.73
"KEGG_compound:C03227_3_HYDROXY_L_KYNURENINE","KEGG_compound","C03227_3_HYDROXY_L_KYNURENINE",5,-1.08,0.38,0.53,-1.2973,0.19,0.63,-1.3783,0.12,0.31
"WikiPathways:705377_WP2371_PARKINSONS_DISEASE_PATHWAY","WikiPathways","705377_WP2371_PARKINSONS_DISEASE_PATHWAY",39,-1.0799,0.33,0.46,-0.5726,1,1,-1.4119,0.047,0.39
"GO_BP:496149_GO_0016050_VESICLE_ORGANIZATION","GO_BP","496149_GO_0016050_VESICLE_ORGANIZATION",232,-1.0799,0.29,0.51,1.3824,0.0047,0.57,0.8234,0.93,1
"KEGG_enzyme:2.3.1.51_1_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_1_ACYL_SN_GLYCERO_3_PHOSPHATE_ACYLTRANSFERASE_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_ACYLTRANSFERASE_1_ACYLGLYCERO_3_PHOSPHATE_ACYLTRANSFERASE_1_ACYLGLYCEROLPHOSPHATE_ACYLTRANSFERASE_1_ACYLGLYCEROPHOSPHATE_ACYLTRANSFERASE_LYSOPHOSPHATIDIC_ACID_ACYLTRANSFERASE","KEGG_enzyme","2.3.1.51_1_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_1_ACYL_SN_GLYCERO_3_PHOSPHATE_ACYLTRANSFERASE_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_ACYLTRANSFERASE_1_ACYLGLYCERO_3_PHOSPHATE_ACYLTRANSFERASE_1_ACYLGLYCEROLPHOSPHATE_ACYLTRANSFERASE_1_ACYLGLYCEROPHOSPHATE_ACYLTRANSFERASE_LYSOPHOSPHATIDIC_ACID_ACYLTRANSFERASE",9,-1.0798,0.38,0.52,-0.7653,0.75,0.93,-1.2754,0.18,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_3376_GHANDHI_BYSTANDER_IRRADIATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3376_GHANDHI_BYSTANDER_IRRADIATION_DN",12,-1.0797,0.35,0.44,-1.3971,0.096,0.59,0.9781,0.47,0.97
"GO_BP:514989_GO_0070050_NEURON_CELLULAR_HOMEOSTASIS","GO_BP","514989_GO_0070050_NEURON_CELLULAR_HOMEOSTASIS",7,-1.0796,0.37,0.51,1.0244,0.41,0.97,0.5631,0.95,1
"GO_MF:750781_GO_0038036_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_ACTIVITY","GO_MF","750781_GO_0038036_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_ACTIVITY",5,-1.0794,0.4,0.55,0.7157,0.8,1,-1.0848,0.35,0.7
"GO_BP:752651_GO_0097150_NEURONAL_STEM_CELL_MAINTENANCE","GO_BP","752651_GO_0097150_NEURONAL_STEM_CELL_MAINTENANCE",18,-1.0793,0.38,0.51,-0.5694,0.97,1,0.8824,0.64,0.95
"GO_BP:510584_GO_0048512_CIRCADIAN_BEHAVIOR","GO_BP","510584_GO_0048512_CIRCADIAN_BEHAVIOR",15,-1.0793,0.35,0.51,-0.8892,0.63,1,-1.0207,0.41,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1013_RAHMAN_TP53_TARGETS_PHOSPHORYLATED","C2_Chemical_and_genetic_perturbations","C2_CGP_1013_RAHMAN_TP53_TARGETS_PHOSPHORYLATED",21,-1.0792,0.37,0.44,1.7836,0.002,0.048,-0.78,0.79,0.96
"GO_BP:499515_GO_0030073_INSULIN_SECRETION","GO_BP","499515_GO_0030073_INSULIN_SECRETION",38,-1.0792,0.31,0.51,1.2391,0.14,0.75,1.3792,0.073,0.64
"C3_TF_targets:C3_TFT_102_V_PAX5_01","C3_TF_targets","C3_TFT_102_V_PAX5_01",150,-1.0791,0.31,0.4,-0.9582,0.53,0.85,-0.9871,0.48,0.79
"C3_TF_targets:C3_TFT_194_CCANNAGRKGGC_UNKNOWN","C3_TF_targets","C3_TFT_194_CCANNAGRKGGC_UNKNOWN",115,-1.079,0.33,0.4,1.0757,0.29,1,-1.1108,0.22,0.52
"C7_Immunologic_signatures:C7_ALL_490_GSE17721_CTRL_VS_PAM3CSK4_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_490_GSE17721_CTRL_VS_PAM3CSK4_8H_BMDM_DN",199,-1.079,0.3,0.4,-0.6805,1,1,0.8699,0.81,1
"C7_Immunologic_signatures:C7_ALL_143_GSE13229_MATURE_VS_INTMATURE_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_143_GSE13229_MATURE_VS_INTMATURE_NKCELL_UP",191,-1.0789,0.31,0.4,-1.1032,0.22,1,-0.891,0.8,0.96
"REACTOME:119531_REACT_19230_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING","REACTOME","119531_REACT_19230_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING",9,-1.0789,0.38,0.54,-0.976,0.48,1,-0.9791,0.47,0.87
"GO_BP:488222_GO_0002349_HISTAMINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE","GO_BP","488222_GO_0002349_HISTAMINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE",5,-1.0789,0.4,0.51,0.8933,0.58,1,-1.0744,0.39,0.8
"REACTOME:1127520_REACT_264532_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS","REACTOME","1127520_REACT_264532_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS",7,-1.0789,0.38,0.54,0.5203,0.97,1,0.9527,0.52,1
"GO_CC:948516_GO_1902710_GABA_RECEPTOR_COMPLEX","GO_CC","948516_GO_1902710_GABA_RECEPTOR_COMPLEX",5,-1.0788,0.41,0.63,0.7663,0.75,0.97,1.8058,0,0.21
"C1_Positional:C1_ALL_160_CHR5Q","C1_Positional","C1_ALL_160_CHR5Q",6,-1.0788,0.36,0.9,-0.802,0.72,0.97,-1.3144,0.17,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_1485_ASTIER_INTEGRIN_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_1485_ASTIER_INTEGRIN_SIGNALING",59,-1.0788,0.33,0.44,-1.0353,0.4,0.98,0.7652,0.88,1
"GO_BP:488958_GO_0003164_HIS_PURKINJE_SYSTEM_DEVELOPMENT","GO_BP","488958_GO_0003164_HIS_PURKINJE_SYSTEM_DEVELOPMENT",5,-1.0787,0.41,0.51,-1.5303,0.043,0.76,-1.0575,0.37,0.81
"REACTOME:576273_REACT_118862_SIGNALING_BY_NOTCH3","REACTOME","576273_REACT_118862_SIGNALING_BY_NOTCH3",11,-1.0787,0.37,0.54,-0.9513,0.53,1,-0.6416,0.91,1
"C3_MicroRNA_targets:C3_MIR_216_CCACACA_MIR_147","C3_MicroRNA_targets","C3_MIR_216_CCACACA_MIR_147",62,-1.0786,0.34,0.48,-0.4985,1,1,-0.7901,0.87,1
"C7_Immunologic_signatures:C7_ALL_326_GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN","C7_Immunologic_signatures","C7_ALL_326_GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN",199,-1.0784,0.3,0.41,1.3397,0.017,0.07,0.913,0.7,1
"REACTOME:106538_REACT_18422_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS","REACTOME","106538_REACT_18422_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS",16,-1.0783,0.37,0.54,-1.4145,0.059,0.5,0.7753,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1809_YIH_RESPONSE_TO_ARSENITE_C4","C2_Chemical_and_genetic_perturbations","C2_CGP_1809_YIH_RESPONSE_TO_ARSENITE_C4",18,-1.0782,0.34,0.44,-0.7168,0.86,1,-1.1029,0.3,0.62
"KEGG_pathway:HSA04350_TGF_BETA_SIGNALING_PATHWAY","KEGG_pathway","HSA04350_TGF_BETA_SIGNALING_PATHWAY",80,-1.0781,0.33,0.4,-1.0021,0.44,0.87,1.024,0.41,1
"C7_Immunologic_signatures:C7_ALL_592_GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_592_GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDM_DN",198,-1.078,0.3,0.41,-0.7423,0.99,1,-0.9818,0.51,0.77
"C7_Immunologic_signatures:C7_ALL_1618_GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1618_GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN",192,-1.078,0.31,0.41,-1.0899,0.26,1,-0.9717,0.51,0.79
"WikiPathways:672464_WP1991_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION","WikiPathways","672464_WP1991_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION",13,-1.078,0.36,0.46,-1.2711,0.18,0.95,1.0102,0.42,0.89
"GO_BP:513847_GO_0060291_LONG_TERM_SYNAPTIC_POTENTIATION","GO_BP","513847_GO_0060291_LONG_TERM_SYNAPTIC_POTENTIATION",31,-1.078,0.34,0.51,-1.1765,0.22,0.9,-0.7349,0.91,1
"REACTOME:119529_REACT_19342_INACTIVATION_OF_CDC42_AND_RAC","REACTOME","119529_REACT_19342_INACTIVATION_OF_CDC42_AND_RAC",9,-1.0778,0.36,0.54,-1.2284,0.24,0.79,0.7673,0.78,1
"GO_BP:511934_GO_0051001_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY","GO_BP","511934_GO_0051001_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY",8,-1.0778,0.39,0.51,-0.9963,0.46,0.99,1.0335,0.41,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1700_RAMASWAMY_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1700_RAMASWAMY_METASTASIS_DN",58,-1.0778,0.34,0.44,0.9404,0.57,0.88,-0.762,0.89,0.97
"GO_MF:504436_GO_0035252_UDP_XYLOSYLTRANSFERASE_ACTIVITY","GO_MF","504436_GO_0035252_UDP_XYLOSYLTRANSFERASE_ACTIVITY",5,-1.0778,0.39,0.55,0.7477,0.78,1,-0.7704,0.73,0.98
"REACTOME:161002_REACT_22228_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING","REACTOME","161002_REACT_22228_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING",10,-1.0777,0.37,0.54,-1.2925,0.15,0.66,-1.0699,0.36,0.75
"C7_Immunologic_signatures:C7_ALL_129_GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP","C7_Immunologic_signatures","C7_ALL_129_GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP",193,-1.0776,0.31,0.41,1.4169,0.005,0.033,-1.1677,0.12,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_2566_WALLACE_JAK2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2566_WALLACE_JAK2_TARGETS_UP",26,-1.0776,0.37,0.44,0.909,0.6,0.91,-1.3651,0.075,0.39
"WikiPathways:672453_WP2197_ENDOTHELIN","WikiPathways","672453_WP2197_ENDOTHELIN",33,-1.0776,0.36,0.45,0.8912,0.66,1,0.7486,0.87,1
"C7_Immunologic_signatures:C7_ALL_1005_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP","C7_Immunologic_signatures","C7_ALL_1005_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP",200,-1.0776,0.3,0.41,0.7749,0.98,1,-1.4995,0.0042,0.022
"GO_CC:513635_GO_0060077_INHIBITORY_SYNAPSE","GO_CC","513635_GO_0060077_INHIBITORY_SYNAPSE",9,-1.0773,0.38,0.63,-0.8782,0.61,0.96,-1.1643,0.26,0.84
"C7_Immunologic_signatures:C7_ALL_720_GSE17721_0_5H_VS_4H_POLYIC_BMDM_DN","C7_Immunologic_signatures","C7_ALL_720_GSE17721_0_5H_VS_4H_POLYIC_BMDM_DN",199,-1.0772,0.3,0.41,1.2326,0.067,0.18,-0.718,1,1
"GO_BP:488922_GO_0003128_HEART_FIELD_SPECIFICATION","GO_BP","488922_GO_0003128_HEART_FIELD_SPECIFICATION",8,-1.0772,0.37,0.52,-0.7699,0.76,1,1.0733,0.36,0.78
"C3_TF_targets:C3_TFT_529_TTANWNANTGGM_UNKNOWN","C3_TF_targets","C3_TFT_529_TTANWNANTGGM_UNKNOWN",59,-1.0771,0.35,0.4,0.9094,0.61,1,0.6398,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2980_ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE","C2_Chemical_and_genetic_perturbations","C2_CGP_2980_ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE",18,-1.0771,0.37,0.44,-0.8673,0.62,1,-1.1172,0.31,0.61
"C4_Cancer_modules:C4_CM_384_MODULE_481","C4_Cancer_modules","C4_CM_384_MODULE_481",86,-1.077,0.32,0.46,1.0133,0.41,0.71,-0.8325,0.83,0.96
"C1_Positional:C1_ALL_16_CHR1P11","C1_Positional","C1_ALL_16_CHR1P11",8,-1.0769,0.37,0.89,1.0604,0.4,0.67,-1.3723,0.1,0.48
"REACTOME:161035_REACT_20593_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS","REACTOME","161035_REACT_20593_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS",37,-1.0769,0.36,0.54,0.8306,0.78,0.97,-1.1219,0.28,0.68
"KEGG_compound:C01180_4_METHYLTHIO_2_OXOBUTANOIC_ACID_4_METHYLTHIO_2_OXOBUTANOATE_2_KETO_4_METHYLTHIOBUTYRIC_ACID_2_OXO_4_METHYLTHIOBUTANOATE_2_OXO_4_METHYLTHIOBUTANOIC_ACID","KEGG_compound","C01180_4_METHYLTHIO_2_OXOBUTANOIC_ACID_4_METHYLTHIO_2_OXOBUTANOATE_2_KETO_4_METHYLTHIOBUTYRIC_ACID_2_OXO_4_METHYLTHIOBUTANOATE_2_OXO_4_METHYLTHIOBUTANOIC_ACID",5,-1.0768,0.4,0.53,-1.0325,0.46,1,-1.2888,0.18,0.37
"GO_BP:495076_GO_0014003_OLIGODENDROCYTE_DEVELOPMENT","GO_BP","495076_GO_0014003_OLIGODENDROCYTE_DEVELOPMENT",32,-1.0767,0.36,0.52,0.9971,0.44,0.98,0.7109,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2446_GRESHOCK_CANCER_COPY_NUMBER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2446_GRESHOCK_CANCER_COPY_NUMBER_UP",319,-1.0767,0.3,0.45,0.6935,1,1,-1.2646,0.019,0.46
"C3_TF_targets:C3_TFT_422_V_HNF3_Q6","C3_TF_targets","C3_TFT_422_V_HNF3_Q6",181,-1.0765,0.32,0.4,-0.9071,0.69,0.95,0.9441,0.61,1
"C4_Cancer_gene_neighborhoods:C4_CGN_133_MORF_MYL3","C4_Cancer_gene_neighborhoods","C4_CGN_133_MORF_MYL3",69,-1.0765,0.33,0.55,-1.3801,0.06,0.46,1.4187,0.027,0.23
"GO_BP:516484_GO_0071560_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS","GO_BP","516484_GO_0071560_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS",168,-1.0763,0.33,0.52,-0.7697,0.97,1,1.1894,0.1,0.72
"C6_Oncogenic_signatures:C6_ALL_165_TBK1_DN_48HRS_UP","C6_Oncogenic_signatures","C6_ALL_165_TBK1_DN_48HRS_UP",50,-1.0763,0.34,0.37,0.929,0.58,0.9,-1.0072,0.44,0.63
"C3_MicroRNA_targets:C3_MIR_39_GACTGTT_MIR_212_MIR_132","C3_MicroRNA_targets","C3_MIR_39_GACTGTT_MIR_212_MIR_132",161,-1.0762,0.32,0.48,0.8582,0.85,1,-0.8765,0.78,1
"GO_BP:486573_GO_0000022_MITOTIC_SPINDLE_ELONGATION","GO_BP","486573_GO_0000022_MITOTIC_SPINDLE_ELONGATION",8,-1.0762,0.38,0.52,0.6964,0.86,1,-0.8745,0.6,0.94
"GO_BP:492562_GO_0019835_CYTOLYSIS","GO_BP","492562_GO_0019835_CYTOLYSIS",23,-1.0762,0.36,0.52,0.8311,0.72,1,-1.3278,0.11,0.62
"KEGG_pathway:HSA05213_ENDOMETRIAL_CANCER","KEGG_pathway","HSA05213_ENDOMETRIAL_CANCER",52,-1.0761,0.35,0.4,0.5618,1,1,-0.7242,0.94,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_689_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12","C2_Chemical_and_genetic_perturbations","C2_CGP_689_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12",11,-1.0759,0.36,0.45,-0.7989,0.73,1,-0.8958,0.59,0.89
"C6_Oncogenic_signatures:C6_ALL_93_ESC_J1_UP_EARLY_V1_DN","C6_Oncogenic_signatures","C6_ALL_93_ESC_J1_UP_EARLY_V1_DN",154,-1.0756,0.31,0.37,-0.9264,0.65,0.86,1.2992,0.047,0.19
"KEGG_pathway:HSA05168_HERPES_SIMPLEX_INFECTION","KEGG_pathway","HSA05168_HERPES_SIMPLEX_INFECTION",176,-1.0756,0.33,0.4,0.8297,0.91,1,-1.2122,0.084,0.36
"GO_MF:517265_GO_0072349_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","517265_GO_0072349_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",12,-1.0754,0.38,0.55,-1.4199,0.086,0.67,1.036,0.41,0.85
"C3_TF_targets:C3_TFT_331_V_EFC_Q6","C3_TF_targets","C3_TFT_331_V_EFC_Q6",259,-1.0754,0.29,0.4,-0.9302,0.66,0.91,-0.9658,0.57,0.81
"GO_BP:849923_GO_1902222_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS","GO_BP","849923_GO_1902222_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS",9,-1.0754,0.38,0.52,-0.8266,0.68,1,-0.7023,0.84,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2818_WEBER_METHYLATED_ICP_IN_SPERM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2818_WEBER_METHYLATED_ICP_IN_SPERM_DN",13,-1.0753,0.36,0.45,1.1014,0.33,0.63,1.4051,0.092,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1434_GOLDRATH_IMMUNE_MEMORY","C2_Chemical_and_genetic_perturbations","C2_CGP_1434_GOLDRATH_IMMUNE_MEMORY",65,-1.0752,0.32,0.45,-0.7577,0.89,1,-1.2325,0.15,0.49
"GO_BP:492152_GO_0007389_PATTERN_SPECIFICATION_PROCESS","GO_BP","492152_GO_0007389_PATTERN_SPECIFICATION_PROCESS",424,-1.0751,0.28,0.52,-1.026,0.37,0.98,1.3343,0.002,0.64
"C7_Immunologic_signatures:C7_ALL_1529_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1529_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP",188,-1.075,0.29,0.41,1.0778,0.26,0.51,-0.8648,0.84,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_111_BIOCARTA_LECTIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_111_BIOCARTA_LECTIN_PATHWAY",11,-1.075,0.38,0.48,-1.1122,0.31,1,0.6411,0.93,1
"C7_Immunologic_signatures:C7_ALL_702_GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_702_GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDM_DN",196,-1.0749,0.29,0.41,1.5975,0,0.0032,0.9393,0.63,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2442_WANG_TUMOR_INVASIVENESS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2442_WANG_TUMOR_INVASIVENESS_UP",374,-1.0748,0.29,0.45,2.0409,0,0.0039,-1.1103,0.15,0.62
"GO_BP:519038_GO_2000398_REGULATION_OF_THYMOCYTE_AGGREGATION","GO_BP","519038_GO_2000398_REGULATION_OF_THYMOCYTE_AGGREGATION",23,-1.0748,0.37,0.52,-1.1308,0.28,0.93,-0.7167,0.9,0.99
"C3_TF_targets:C3_TFT_160_V_STAT1_01","C3_TF_targets","C3_TFT_160_V_STAT1_01",67,-1.0747,0.33,0.41,-0.7275,0.94,1,-0.9771,0.49,0.81
"GO_BP:491379_GO_0006477_PROTEIN_SULFATION","GO_BP","491379_GO_0006477_PROTEIN_SULFATION",6,-1.0747,0.39,0.52,-0.4535,0.99,1,0.8501,0.61,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_387_LAU_APOPTOSIS_CDKN2A_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_387_LAU_APOPTOSIS_CDKN2A_UP",55,-1.0747,0.33,0.45,1.1475,0.22,0.56,-1.3624,0.049,0.39
"C2_Chemical_and_genetic_perturbations:C2_CGP_245_MULLIGHAN_MLL_SIGNATURE_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_245_MULLIGHAN_MLL_SIGNATURE_2_DN",279,-1.0745,0.31,0.45,1.1267,0.15,0.59,-1.164,0.1,0.56
"C4_Cancer_modules:C4_CM_293_MODULE_334","C4_Cancer_modules","C4_CM_293_MODULE_334",163,-1.0744,0.32,0.46,1.276,0.049,0.3,0.9361,0.65,0.95
"C3_TF_targets:C3_TFT_243_V_MEIS1BHOXA9_01","C3_TF_targets","C3_TFT_243_V_MEIS1BHOXA9_01",133,-1.0743,0.34,0.41,1.074,0.27,1,0.8139,0.89,1
"GO_BP:488195_GO_0002322_B_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488195_GO_0002322_B_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE",5,-1.0743,0.42,0.52,-0.8867,0.61,1,0.7366,0.78,1
"GO_BP:752768_GO_0097267_OMEGA_HYDROXYLASE_P450_PATHWAY","GO_BP","752768_GO_0097267_OMEGA_HYDROXYLASE_P450_PATHWAY",9,-1.0741,0.38,0.52,-1.0254,0.43,0.97,-0.8022,0.72,0.99
"GO_BP:512746_GO_0051891_POSITIVE_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION","GO_BP","512746_GO_0051891_POSITIVE_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION",5,-1.074,0.39,0.52,-1.0367,0.43,0.98,1.565,0.033,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_149_BORCZUK_MALIGNANT_MESOTHELIOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_149_BORCZUK_MALIGNANT_MESOTHELIOMA_UP",305,-1.0737,0.3,0.45,1.8804,0,0.023,-1.0278,0.35,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_1505_YU_MYC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1505_YU_MYC_TARGETS_DN",55,-1.0736,0.36,0.45,-0.8659,0.7,1,-1.2466,0.11,0.48
"GO_CC:486824_GO_0000307_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX","GO_CC","486824_GO_0000307_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX",20,-1.0736,0.39,0.64,-0.5778,0.98,1,-0.8665,0.67,1
"GO_BP:509050_GO_0046827_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS","GO_BP","509050_GO_0046827_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS",14,-1.0735,0.37,0.52,-0.7248,0.83,1,-0.4917,0.99,1
"GO_MF:500655_GO_0031404_CHLORIDE_ION_BINDING","GO_MF","500655_GO_0031404_CHLORIDE_ION_BINDING",5,-1.0734,0.41,0.56,0.9908,0.48,0.89,-1.231,0.25,0.57
"C7_Immunologic_signatures:C7_ALL_933_GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_933_GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP",190,-1.0732,0.3,0.42,1.657,0,0.0012,-1.3638,0.019,0.085
"C7_Immunologic_signatures:C7_ALL_1475_GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP","C7_Immunologic_signatures","C7_ALL_1475_GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP",190,-1.0731,0.3,0.42,1.3929,0.012,0.04,-0.7634,0.98,1
"C7_Immunologic_signatures:C7_ALL_443_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP","C7_Immunologic_signatures","C7_ALL_443_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP",196,-1.0731,0.31,0.42,0.6668,1,1,-1.2546,0.058,0.19
"GO_BP:501567_GO_0032332_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION","GO_BP","501567_GO_0032332_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION",18,-1.073,0.39,0.52,-0.992,0.47,1,0.718,0.87,1
"C4_Cancer_gene_neighborhoods:C4_CGN_69_MORF_CASP10","C4_Cancer_gene_neighborhoods","C4_CGN_69_MORF_CASP10",113,-1.073,0.32,0.55,-0.976,0.49,0.86,-1.0882,0.26,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_744_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_744_HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",33,-1.0729,0.38,0.45,1.4579,0.038,0.25,1.3829,0.061,0.54
"C3_TF_targets:C3_TFT_463_V_SP1_Q6_01","C3_TF_targets","C3_TFT_463_V_SP1_Q6_01",242,-1.0727,0.31,0.41,-1.4664,0.0035,0.13,-1.2039,0.058,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_1637_LU_AGING_BRAIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1637_LU_AGING_BRAIN_DN",153,-1.0727,0.32,0.45,0.9553,0.55,0.86,-1.0494,0.32,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2782_KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2782_KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN",7,-1.0727,0.36,0.45,0.8969,0.58,0.93,-0.9766,0.5,0.79
"REACTOME:161033_REACT_20563_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS","REACTOME","161033_REACT_20563_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS",41,-1.0727,0.36,0.55,-0.8006,0.8,1,-0.9388,0.57,0.92
"GO_BP:511900_GO_0050966_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN","GO_BP","511900_GO_0050966_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN",9,-1.0727,0.38,0.52,-1.1644,0.26,0.91,-1.1883,0.25,0.73
"C7_Immunologic_signatures:C7_ALL_1250_GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1250_GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN",181,-1.0726,0.31,0.42,1.0726,0.23,0.52,-1.3958,0.0065,0.066
"GO_BP:494678_GO_0010614_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_HYPERTROPHY","GO_BP","494678_GO_0010614_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_HYPERTROPHY",10,-1.0726,0.38,0.52,-0.6552,0.92,1,-0.8096,0.71,0.98
"GO_BP:497181_GO_0018210_PEPTIDYL_THREONINE_MODIFICATION","GO_BP","497181_GO_0018210_PEPTIDYL_THREONINE_MODIFICATION",49,-1.0724,0.34,0.52,-0.6182,0.99,1,-1.0078,0.42,0.84
"GO_BP:513514_GO_0055081_ANION_HOMEOSTASIS","GO_BP","513514_GO_0055081_ANION_HOMEOSTASIS",41,-1.0723,0.36,0.52,-1.0758,0.34,0.95,0.9051,0.62,0.94
"REACTOME:105926_REACT_9480_GAP_JUNCTION_TRAFFICKING_AND_REGULATION","REACTOME","105926_REACT_9480_GAP_JUNCTION_TRAFFICKING_AND_REGULATION",29,-1.0722,0.36,0.55,-0.9117,0.59,1,1.0835,0.32,0.94
"GO_BP:505557_GO_0042416_DOPAMINE_BIOSYNTHETIC_PROCESS","GO_BP","505557_GO_0042416_DOPAMINE_BIOSYNTHETIC_PROCESS",10,-1.0721,0.38,0.52,-1.0206,0.43,0.97,-1.6709,0.016,0.56
"C3_TF_targets:C3_TFT_540_YAATNRNNNYNATT_UNKNOWN","C3_TF_targets","C3_TFT_540_YAATNRNNNYNATT_UNKNOWN",101,-1.0721,0.35,0.41,0.8505,0.81,1,0.8471,0.81,1
"GO_BP:752934_GO_0097435_FIBRIL_ORGANIZATION","GO_BP","752934_GO_0097435_FIBRIL_ORGANIZATION",16,-1.072,0.38,0.52,0.5566,0.97,1,-0.8532,0.68,0.96
"C7_Immunologic_signatures:C7_ALL_1845_GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP","C7_Immunologic_signatures","C7_ALL_1845_GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP",200,-1.0719,0.32,0.42,1.4569,0.0025,0.02,-0.9344,0.64,0.89
"GO_BP:511663_GO_0050691_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST","GO_BP","511663_GO_0050691_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST",30,-1.0719,0.38,0.52,-1.0858,0.35,0.96,-1.6359,0.0041,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_3102_GABRIELY_MIR21_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3102_GABRIELY_MIR21_TARGETS",289,-1.0719,0.31,0.45,0.9529,0.63,0.86,-0.9975,0.47,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2831_SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2831_SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",82,-1.0718,0.34,0.45,1.4279,0.024,0.28,-0.8765,0.7,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1062_FRIDMAN_SENESCENCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1062_FRIDMAN_SENESCENCE_DN",12,-1.0718,0.39,0.45,-1.1138,0.32,0.9,0.6907,0.85,1
"GO_BP:516483_GO_0071559_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA","GO_BP","516483_GO_0071559_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA",168,-1.0717,0.32,0.52,-0.7738,0.97,1,1.1865,0.12,0.72
"C7_Immunologic_signatures:C7_ALL_346_GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_346_GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN",194,-1.0716,0.32,0.42,0.7225,0.99,1,0.6849,0.99,1
"C7_Immunologic_signatures:C7_ALL_838_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN","C7_Immunologic_signatures","C7_ALL_838_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN",182,-1.0716,0.32,0.42,0.8109,0.92,1,-1.4562,0.0045,0.033
"GO_BP:501346_GO_0032109_POSITIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS","GO_BP","501346_GO_0032109_POSITIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS",22,-1.0716,0.35,0.52,-0.8499,0.66,1,-0.7707,0.8,1
"GO_MF:493113_GO_0008889_GLYCEROPHOSPHODIESTER_PHOSPHODIESTERASE_ACTIVITY","GO_MF","493113_GO_0008889_GLYCEROPHOSPHODIESTER_PHOSPHODIESTERASE_ACTIVITY",7,-1.0716,0.37,0.56,1.2805,0.18,0.63,-1.6791,0.022,0.3
"GO_BP:491155_GO_0006183_GTP_BIOSYNTHETIC_PROCESS","GO_BP","491155_GO_0006183_GTP_BIOSYNTHETIC_PROCESS",10,-1.0715,0.38,0.52,-0.9088,0.57,1,-1.2412,0.18,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_3248_KOHOUTEK_CCNT2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3248_KOHOUTEK_CCNT2_TARGETS",57,-1.0713,0.34,0.45,1.2394,0.14,0.45,0.8661,0.71,1
"GO_BP:496207_GO_0016114_TERPENOID_BIOSYNTHETIC_PROCESS","GO_BP","496207_GO_0016114_TERPENOID_BIOSYNTHETIC_PROCESS",11,-1.0713,0.39,0.53,-0.9422,0.54,1,-0.8488,0.67,0.96
"C7_Immunologic_signatures:C7_ALL_313_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP","C7_Immunologic_signatures","C7_ALL_313_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP",198,-1.0713,0.32,0.42,1.0354,0.36,0.63,-1.2735,0.039,0.17
"C7_Immunologic_signatures:C7_ALL_1093_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1093_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP",195,-1.0712,0.31,0.42,1.4927,0,0.014,-0.8587,0.85,1
"GO_BP:501760_GO_0032530_REGULATION_OF_MICROVILLUS_ORGANIZATION","GO_BP","501760_GO_0032530_REGULATION_OF_MICROVILLUS_ORGANIZATION",6,-1.0711,0.42,0.53,-0.6417,0.91,1,0.8372,0.66,0.99
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_137_BIOCARTA_PLCE_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_137_BIOCARTA_PLCE_PATHWAY",12,-1.071,0.39,0.49,-0.879,0.62,1,-0.9837,0.47,0.78
"GO_BP:513870_GO_0060314_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY","GO_BP","513870_GO_0060314_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY",27,-1.071,0.37,0.53,1.3256,0.11,0.64,1.3408,0.12,0.65
"GO_BP:516391_GO_0071467_CELLULAR_RESPONSE_TO_PH","GO_BP","516391_GO_0071467_CELLULAR_RESPONSE_TO_PH",16,-1.0708,0.38,0.53,-1.4986,0.064,0.81,-1.195,0.24,0.74
"GO_BP:510277_GO_0048147_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION","GO_BP","510277_GO_0048147_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION",28,-1.0707,0.37,0.53,0.9373,0.56,1,0.7591,0.85,1
"GO_BP:503843_GO_0034643_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION_MICROTUBULE_MEDIATED","GO_BP","503843_GO_0034643_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION_MICROTUBULE_MEDIATED",9,-1.0707,0.4,0.53,-0.9451,0.53,1,-0.7371,0.8,1
"GO_MF:503391_GO_0034185_APOLIPOPROTEIN_BINDING","GO_MF","503391_GO_0034185_APOLIPOPROTEIN_BINDING",16,-1.0707,0.37,0.56,0.8857,0.59,0.99,0.9174,0.56,0.94
"C7_Immunologic_signatures:C7_ALL_690_GSE17721_LPS_VS_GARDIQUIMOD_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_690_GSE17721_LPS_VS_GARDIQUIMOD_0_5H_BMDM_DN",197,-1.0706,0.33,0.42,0.8711,0.84,1,-1.0573,0.29,0.6
"WikiPathways:920968_WP2112_IL17_SIGNALING_PATHWAY","WikiPathways","920968_WP2112_IL17_SIGNALING_PATHWAY",29,-1.0706,0.36,0.46,-0.5032,1,1,0.6619,0.94,1
"GO_MF:499678_GO_0030274_LIM_DOMAIN_BINDING","GO_MF","499678_GO_0030274_LIM_DOMAIN_BINDING",7,-1.0705,0.39,0.56,-0.8368,0.67,1,-1.2364,0.24,0.59
"GO_BP:513454_GO_0055021_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH","GO_BP","513454_GO_0055021_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH",36,-1.0705,0.36,0.53,0.7334,0.9,1,1.5116,0.028,0.55
"GO_BP:492655_GO_0008344_ADULT_LOCOMOTORY_BEHAVIOR","GO_BP","492655_GO_0008344_ADULT_LOCOMOTORY_BEHAVIOR",78,-1.0705,0.35,0.53,-1.0098,0.43,0.98,0.9382,0.58,0.91
"GO_CC:502487_GO_0033268_NODE_OF_RANVIER","GO_CC","502487_GO_0033268_NODE_OF_RANVIER",16,-1.0704,0.37,0.64,-1.2935,0.15,0.67,0.8273,0.74,1
"GO_CC:925891_GO_0098562_CYTOPLASMIC_SIDE_OF_MEMBRANE","GO_CC","925891_GO_0098562_CYTOPLASMIC_SIDE_OF_MEMBRANE",66,-1.0702,0.34,0.64,0.8348,0.8,0.93,-0.8611,0.76,1
"GO_BP:504741_GO_0035561_REGULATION_OF_CHROMATIN_BINDING","GO_BP","504741_GO_0035561_REGULATION_OF_CHROMATIN_BINDING",9,-1.0702,0.37,0.53,-1.2774,0.2,0.89,-0.75,0.79,1
"GO_BP:494903_GO_0010839_NEGATIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION","GO_BP","494903_GO_0010839_NEGATIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION",12,-1.0701,0.36,0.53,-1.2374,0.21,0.9,-1.3966,0.11,0.58
"C6_Oncogenic_signatures:C6_ALL_81_BRCA1_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_81_BRCA1_DN_V1_DN",133,-1.0699,0.34,0.38,-1.3039,0.041,0.36,0.8994,0.73,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_1722_JI_RESPONSE_TO_FSH_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1722_JI_RESPONSE_TO_FSH_DN",58,-1.0699,0.37,0.46,1.3883,0.048,0.3,0.7,0.97,1
"REACTOME:730306_REACT_150180_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES","REACTOME","730306_REACT_150180_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES",54,-1.0698,0.35,0.55,-1.2944,0.082,0.67,1.3701,0.056,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_3089_FIGUEROA_AML_METHYLATION_CLUSTER_6_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3089_FIGUEROA_AML_METHYLATION_CLUSTER_6_DN",35,-1.0698,0.36,0.46,1.0934,0.31,0.64,0.8633,0.71,1
"GO_BP:515355_GO_0070423_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_SIGNALING_PATHWAY","GO_BP","515355_GO_0070423_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_SIGNALING_PATHWAY",29,-1.0698,0.35,0.53,0.8442,0.72,1,-0.9309,0.57,0.9
"GO_BP:488699_GO_0002826_NEGATIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE","GO_BP","488699_GO_0002826_NEGATIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE",6,-1.0696,0.37,0.53,0.9141,0.57,1,0.5347,0.98,1
"GO_CC:487078_GO_0000785_CHROMATIN","GO_CC","487078_GO_0000785_CHROMATIN",414,-1.0695,0.29,0.64,-1.2579,0.016,0.68,-1.4671,0.0021,0.54
"GO_BP:494933_GO_0010869_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS","GO_BP","494933_GO_0010869_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS",20,-1.0694,0.37,0.53,1.3583,0.089,0.6,0.8924,0.65,0.95
"GO_BP:503536_GO_0034333_ADHERENS_JUNCTION_ASSEMBLY","GO_BP","503536_GO_0034333_ADHERENS_JUNCTION_ASSEMBLY",32,-1.0693,0.38,0.53,-1.3895,0.084,1,-0.7415,0.88,1
"GO_BP:501899_GO_0032673_REGULATION_OF_INTERLEUKIN_4_PRODUCTION","GO_BP","501899_GO_0032673_REGULATION_OF_INTERLEUKIN_4_PRODUCTION",26,-1.0692,0.37,0.53,0.9337,0.57,1,0.7424,0.87,1
"GO_MF:504439_GO_0035255_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING","GO_MF","504439_GO_0035255_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING",19,-1.0692,0.38,0.56,-1.274,0.17,0.82,0.8955,0.6,0.97
"C7_Immunologic_signatures:C7_ALL_1177_GSE27786_BCELL_VS_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1177_GSE27786_BCELL_VS_CD4_TCELL_UP",200,-1.0692,0.32,0.42,0.7988,0.96,1,-0.9352,0.64,0.88
"C1_Positional:C1_ALL_106_CHR5Q31","C1_Positional","C1_ALL_106_CHR5Q31",199,-1.0692,0.35,0.91,1.2429,0.041,0.58,1.5149,0,0.29
"GO_BP:504780_GO_0035601_PROTEIN_DEACYLATION","GO_BP","504780_GO_0035601_PROTEIN_DEACYLATION",46,-1.0692,0.35,0.53,-1.143,0.24,0.93,-1.3912,0.045,0.58
"C1_Positional:C1_ALL_214_CHR2Q33","C1_Positional","C1_ALL_214_CHR2Q33",93,-1.0692,0.34,0.9,1.0125,0.42,0.74,-1.2857,0.065,0.49
"GO_MF:492677_GO_0008374_O_ACYLTRANSFERASE_ACTIVITY","GO_MF","492677_GO_0008374_O_ACYLTRANSFERASE_ACTIVITY",38,-1.0691,0.37,0.56,-0.9562,0.52,0.95,-0.7291,0.9,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2027_CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4","C2_Chemical_and_genetic_perturbations","C2_CGP_2027_CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4",297,-1.069,0.3,0.46,1.0585,0.3,0.7,-1.1029,0.18,0.62
"C1_Positional:C1_ALL_246_CHR13Q33","C1_Positional","C1_ALL_246_CHR13Q33",18,-1.0689,0.37,0.89,-1.5246,0.026,0.53,-1.3497,0.11,0.44
"GO_BP:503788_GO_0034587_PIRNA_METABOLIC_PROCESS","GO_BP","503788_GO_0034587_PIRNA_METABOLIC_PROCESS",27,-1.0689,0.38,0.53,1.175,0.25,0.81,0.9322,0.57,0.92
"GO_BP:486906_GO_0000413_PROTEIN_PEPTIDYL_PROLYL_ISOMERIZATION","GO_BP","486906_GO_0000413_PROTEIN_PEPTIDYL_PROLYL_ISOMERIZATION",41,-1.0689,0.38,0.53,1.2894,0.095,0.69,-0.7886,0.82,0.99
"C7_Immunologic_signatures:C7_ALL_373_GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP","C7_Immunologic_signatures","C7_ALL_373_GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP",186,-1.0689,0.32,0.43,0.9917,0.49,0.76,-1.2611,0.055,0.18
"GO_BP:514156_GO_0060601_LATERAL_SPROUTING_FROM_AN_EPITHELIUM","GO_BP","514156_GO_0060601_LATERAL_SPROUTING_FROM_AN_EPITHELIUM",7,-1.0688,0.36,0.53,1.276,0.21,0.7,1.7574,0.0078,0.35
"C3_TF_targets:C3_TFT_227_CCCNNNNNNAAGWT_UNKNOWN","C3_TF_targets","C3_TFT_227_CCCNNNNNNAAGWT_UNKNOWN",102,-1.0688,0.35,0.42,1.1844,0.14,0.74,-0.9543,0.57,0.84
"C3_TF_targets:C3_TFT_501_MYAATNNNNNNNGGC_UNKNOWN","C3_TF_targets","C3_TFT_501_MYAATNNNNNNNGGC_UNKNOWN",108,-1.0687,0.34,0.42,-0.8006,0.89,1,0.7228,0.98,1
"C7_Immunologic_signatures:C7_ALL_422_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN","C7_Immunologic_signatures","C7_ALL_422_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN",199,-1.0686,0.33,0.43,1.0921,0.23,0.47,-0.9548,0.61,0.84
"REACTOME:161015_REACT_22387_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS","REACTOME","161015_REACT_22387_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS",52,-1.0686,0.36,0.56,-0.5699,0.98,1,0.7869,0.85,1
"GO_BP:518301_GO_0090161_GOLGI_RIBBON_FORMATION","GO_BP","518301_GO_0090161_GOLGI_RIBBON_FORMATION",9,-1.0685,0.38,0.53,0.7522,0.78,1,-0.8203,0.69,0.97
"GO_BP:515914_GO_0070988_DEMETHYLATION","GO_BP","515914_GO_0070988_DEMETHYLATION",62,-1.0684,0.36,0.53,-1.3626,0.047,0.97,-0.9426,0.58,0.89
"GO_BP:496270_GO_0016188_SYNAPTIC_VESICLE_MATURATION","GO_BP","496270_GO_0016188_SYNAPTIC_VESICLE_MATURATION",8,-1.0684,0.37,0.53,-1.108,0.36,0.94,-0.8318,0.67,0.97
"GO_BP:487791_GO_0001895_RETINA_HOMEOSTASIS","GO_BP","487791_GO_0001895_RETINA_HOMEOSTASIS",60,-1.0684,0.37,0.53,1.3443,0.048,0.61,1.205,0.15,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_3234_SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3234_SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP",25,-1.0684,0.39,0.46,-0.7736,0.8,1,-0.9634,0.5,0.8
"GO_BP:489115_GO_0003323_TYPE_B_PANCREATIC_CELL_DEVELOPMENT","GO_BP","489115_GO_0003323_TYPE_B_PANCREATIC_CELL_DEVELOPMENT",11,-1.0683,0.37,0.53,0.9702,0.49,1,1.0375,0.39,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_310_KIM_WT1_TARGETS_12HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_310_KIM_WT1_TARGETS_12HR_DN",209,-1.0681,0.33,0.46,1.3978,0.0093,0.29,0.9809,0.52,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3391_ZWANG_EGF_PERSISTENTLY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3391_ZWANG_EGF_PERSISTENTLY_DN",61,-1.0681,0.35,0.46,-0.9352,0.57,1,-1.1369,0.23,0.59
"GO_BP:491260_GO_0006301_POSTREPLICATION_REPAIR","GO_BP","491260_GO_0006301_POSTREPLICATION_REPAIR",24,-1.068,0.36,0.53,-0.7027,0.9,1,-1.0337,0.4,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_3152_KIM_PTEN_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3152_KIM_PTEN_TARGETS_UP",18,-1.0677,0.36,0.46,1.3761,0.1,0.31,-0.92,0.61,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_3332_PECE_MAMMARY_STEM_CELL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3332_PECE_MAMMARY_STEM_CELL_DN",156,-1.0676,0.33,0.46,0.9061,0.73,0.92,0.7463,0.99,1
"C1_Positional:C1_ALL_305_CHR18P11","C1_Positional","C1_ALL_305_CHR18P11",72,-1.0676,0.36,0.89,0.9845,0.52,0.78,0.9014,0.66,0.84
"GO_BP:500485_GO_0031223_AUDITORY_BEHAVIOR","GO_BP","500485_GO_0031223_AUDITORY_BEHAVIOR",8,-1.0675,0.39,0.53,-0.99,0.46,1,1.6294,0.022,0.41
"GO_MF:511653_GO_0050681_ANDROGEN_RECEPTOR_BINDING","GO_MF","511653_GO_0050681_ANDROGEN_RECEPTOR_BINDING",39,-1.0675,0.37,0.57,0.6783,0.96,1,0.9259,0.56,0.94
"GO_BP:491719_GO_0006851_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT","GO_BP","491719_GO_0006851_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT",9,-1.0674,0.38,0.53,1.0161,0.44,0.97,0.8812,0.59,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2921_MIKKELSEN_NPC_ICP_WITH_H3K4ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2921_MIKKELSEN_NPC_ICP_WITH_H3K4ME3",442,-1.0673,0.31,0.46,0.86,0.94,0.96,-1.0628,0.25,0.68
"GO_MF:499699_GO_0030296_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY","GO_MF","499699_GO_0030296_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY",14,-1.0673,0.38,0.57,-0.9304,0.56,0.97,-0.9053,0.58,0.87
"GO_BP:494724_GO_0010661_POSITIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","494724_GO_0010661_POSITIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS",14,-1.0673,0.37,0.53,0.7911,0.74,1,0.8693,0.62,0.97
"C3_TF_targets:C3_TFT_493_GTTGNYNNRGNAAC_UNKNOWN","C3_TF_targets","C3_TFT_493_GTTGNYNNRGNAAC_UNKNOWN",106,-1.0673,0.34,0.42,0.9341,0.62,1,-1.0939,0.26,0.56
"C2_Chemical_and_genetic_perturbations:C2_CGP_450_GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_450_GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN",8,-1.0673,0.37,0.46,1.3532,0.13,0.34,0.9458,0.52,1
"KEGG_compound:C00129_ISOPENTENYL_DIPHOSPHATE_DELTA3_ISOPENTENYL_DIPHOSPHATE_DELTA3_METHYL_3_BUTENYL_DIPHOSPHATE","KEGG_compound","C00129_ISOPENTENYL_DIPHOSPHATE_DELTA3_ISOPENTENYL_DIPHOSPHATE_DELTA3_METHYL_3_BUTENYL_DIPHOSPHATE",9,-1.0671,0.4,0.54,-0.7199,0.86,1,-0.9464,0.5,0.71
"GO_MF:496633_GO_0016712_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN","GO_MF","496633_GO_0016712_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN",30,-1.0671,0.35,0.57,-1.4928,0.029,0.58,1.4523,0.055,0.51
"REACTOME:833814_REACT_163699_SCAVENGING_BY_CLASS_A_RECEPTORS","REACTOME","833814_REACT_163699_SCAVENGING_BY_CLASS_A_RECEPTORS",19,-1.067,0.35,0.56,0.9438,0.52,0.84,0.8641,0.65,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_796_KANG_GIST_WITH_PDGFRA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_796_KANG_GIST_WITH_PDGFRA_UP",50,-1.0669,0.36,0.46,0.7442,0.9,1,1.145,0.25,0.83
"C6_Oncogenic_signatures:C6_ALL_187_KRAS_PROSTATE_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_187_KRAS_PROSTATE_UP_V1_UP",128,-1.0669,0.34,0.38,-1.1003,0.24,0.57,-1.1401,0.18,0.46
"GO_BP:491455_GO_0006559_L_PHENYLALANINE_CATABOLIC_PROCESS","GO_BP","491455_GO_0006559_L_PHENYLALANINE_CATABOLIC_PROCESS",9,-1.0669,0.39,0.53,-0.8227,0.72,1,-0.6777,0.87,1
"KEGG_compound:C04253_ELECTRON_TRANSFERRING_FLAVOPROTEIN_ELECTRON_TRANSFER_FLAVOPROTEIN","KEGG_compound","C04253_ELECTRON_TRANSFERRING_FLAVOPROTEIN_ELECTRON_TRANSFER_FLAVOPROTEIN",5,-1.0669,0.42,0.54,0.6448,0.86,1,-1.7412,0.01,0.056
"C2_Chemical_and_genetic_perturbations:C2_CGP_4_WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_4_WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN",20,-1.0668,0.38,0.46,-1.2575,0.16,0.74,1.0169,0.42,0.95
"GO_BP:983711_GO_1902992_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS","GO_BP","983711_GO_1902992_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS",8,-1.0668,0.39,0.53,-0.7435,0.79,1,-1.0033,0.45,0.85
"C7_Immunologic_signatures:C7_ALL_1750_GSE6269_FLU_VS_E_COLI_INF_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1750_GSE6269_FLU_VS_E_COLI_INF_PBMC_DN",151,-1.0668,0.31,0.43,1.9371,0,0,-0.7654,0.96,1
"C7_Immunologic_signatures:C7_ALL_1096_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1096_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN",199,-1.0667,0.32,0.43,-0.6833,1,1,-1.0916,0.21,0.52
"GO_CC:499808_GO_0030430_HOST_CELL_CYTOPLASM","GO_CC","499808_GO_0030430_HOST_CELL_CYTOPLASM",5,-1.0662,0.41,0.65,-1.0618,0.39,0.82,-0.701,0.83,1
"GO_BP:507472_GO_0045072_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS","GO_BP","507472_GO_0045072_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS",16,-1.066,0.38,0.53,-0.613,0.94,1,0.7398,0.82,1
"KEGG_pathway:HSA05220_CHRONIC_MYELOID_LEUKEMIA","KEGG_pathway","HSA05220_CHRONIC_MYELOID_LEUKEMIA",73,-1.066,0.35,0.41,-0.6089,1,1,-0.8355,0.81,0.9
"GO_BP:517126_GO_0072210_METANEPHRIC_NEPHRON_DEVELOPMENT","GO_BP","517126_GO_0072210_METANEPHRIC_NEPHRON_DEVELOPMENT",34,-1.066,0.36,0.53,0.8322,0.73,1,1.7068,0.0021,0.42
"GO_CC:488067_GO_0002178_PALMITOYLTRANSFERASE_COMPLEX","GO_CC","488067_GO_0002178_PALMITOYLTRANSFERASE_COMPLEX",8,-1.066,0.39,0.65,-0.9435,0.53,0.9,-1.3134,0.15,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2440_ZHOU_PANCREATIC_BETA_CELL","C2_Chemical_and_genetic_perturbations","C2_CGP_2440_ZHOU_PANCREATIC_BETA_CELL",10,-1.0659,0.4,0.46,0.9348,0.52,0.89,1.3998,0.097,0.55
"C1_Positional:C1_ALL_274_CHR1Q22","C1_Positional","C1_ALL_274_CHR1Q22",76,-1.0659,0.34,0.88,-1.0887,0.28,1,-1.3945,0.04,0.51
"C7_Immunologic_signatures:C7_ALL_1729_GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1729_GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP",200,-1.0658,0.32,0.43,0.7067,1,1,0.9199,0.68,1
"KEGG_pathway:HSA00860_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM","KEGG_pathway","HSA00860_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM",42,-1.0657,0.36,0.41,1.8469,0,0.0087,1.3635,0.075,0.4
"C3_TF_targets:C3_TFT_307_V_STAT5A_04","C3_TF_targets","C3_TFT_307_V_STAT5A_04",207,-1.0657,0.33,0.42,0.878,0.79,1,1.0713,0.29,1
"C7_Immunologic_signatures:C7_ALL_711_GSE17721_0_5H_VS_8H_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_711_GSE17721_0_5H_VS_8H_LPS_BMDM_UP",197,-1.0656,0.32,0.43,1.2652,0.047,0.14,-1.0718,0.26,0.57
"REACTOME:106325_REACT_9431_METABOLISM_OF_PORPHYRINS","REACTOME","106325_REACT_9431_METABOLISM_OF_PORPHYRINS",17,-1.0653,0.39,0.56,0.9369,0.54,0.85,-1.1418,0.27,0.67
"C7_Immunologic_signatures:C7_ALL_1429_GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP","C7_Immunologic_signatures","C7_ALL_1429_GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP",198,-1.065,0.35,0.43,1.4089,0.005,0.035,-0.9511,0.62,0.85
"C7_Immunologic_signatures:C7_ALL_872_GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_872_GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN",197,-1.065,0.33,0.43,1.4107,0,0.034,0.7526,1,1
"GO_BP:515997_GO_0071071_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS","GO_BP","515997_GO_0071071_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS",11,-1.065,0.38,0.53,0.8305,0.64,1,1.6007,0.028,0.43
"GO_MF:487204_GO_0000980_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING","GO_MF","487204_GO_0000980_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING",57,-1.0649,0.36,0.57,-1.2709,0.12,0.82,-1.6308,0.0097,0.34
"GO_BP:510766_GO_0048711_POSITIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION","GO_BP","510766_GO_0048711_POSITIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION",10,-1.0649,0.4,0.53,-1.1967,0.25,0.89,0.6724,0.87,1
"GO_CC:513634_GO_0060076_EXCITATORY_SYNAPSE","GO_CC","513634_GO_0060076_EXCITATORY_SYNAPSE",22,-1.0649,0.38,0.65,-1.3237,0.13,0.65,1.3492,0.11,0.75
"KEGG_compound:C04570_REDUCED_ELECTRON_TRANSFERRING_FLAVOPROTEIN_REDUCED_ELECTRON_TRANSFER_FLAVOPROTEIN","KEGG_compound","C04570_REDUCED_ELECTRON_TRANSFERRING_FLAVOPROTEIN_REDUCED_ELECTRON_TRANSFER_FLAVOPROTEIN",5,-1.0648,0.41,0.54,0.6764,0.85,1,-1.7669,0.002,0.047
"C3_TF_targets:C3_TFT_464_V_SP1_Q4_01","C3_TF_targets","C3_TFT_464_V_SP1_Q4_01",256,-1.0647,0.34,0.42,-1.3772,0.015,0.19,-1.4056,0.0041,0.31
"OMIM_gene:OMIM602621_COXSACKIEVIRUS_AND_ADENOVIRUS_RECEPTOR_CXADR","OMIM_gene","OMIM602621_COXSACKIEVIRUS_AND_ADENOVIRUS_RECEPTOR_CXADR",6,-1.0647,0.39,0.83,-1.0454,0.42,0.76,0.6348,0.89,1
"GO_BP:494866_GO_0010801_NEGATIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION","GO_BP","494866_GO_0010801_NEGATIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION",13,-1.0646,0.39,0.53,1.1918,0.24,0.79,-0.6297,0.94,1
"C4_Cancer_gene_neighborhoods:C4_CGN_279_CAR_MYST2","C4_Cancer_gene_neighborhoods","C4_CGN_279_CAR_MYST2",26,-1.0645,0.37,0.57,-1.1806,0.23,0.69,0.7619,0.83,1
"GO_BP:518470_GO_0090330_REGULATION_OF_PLATELET_AGGREGATION","GO_BP","518470_GO_0090330_REGULATION_OF_PLATELET_AGGREGATION",12,-1.0644,0.4,0.53,1.2828,0.17,0.7,0.7594,0.78,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_915_FURUKAWA_DUSP6_TARGETS_PCI35_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_915_FURUKAWA_DUSP6_TARGETS_PCI35_UP",72,-1.0644,0.36,0.46,0.9931,0.43,0.81,-0.8582,0.76,0.92
"GO_BP:504928_GO_0035751_REGULATION_OF_LYSOSOMAL_LUMEN_PH","GO_BP","504928_GO_0035751_REGULATION_OF_LYSOSOMAL_LUMEN_PH",5,-1.0644,0.42,0.53,-0.5898,0.93,1,-0.7852,0.7,1
"GO_BP:503962_GO_0034763_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT","GO_BP","503962_GO_0034763_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT",62,-1.0643,0.35,0.53,1.0747,0.33,0.93,-0.8854,0.69,0.94
"GO_MF:754628_GO_1901677_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","754628_GO_1901677_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",24,-1.0641,0.36,0.57,-0.8241,0.74,1,-1.1427,0.26,0.65
"GO_BP:1129564_GO_1903749_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION","GO_BP","1129564_GO_1903749_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION",92,-1.0641,0.37,0.53,1.24,0.11,0.75,-0.8838,0.72,0.94
"GO_CC:492610_GO_0008287_PROTEIN_SERINE_THREONINE_PHOSPHATASE_COMPLEX","GO_CC","492610_GO_0008287_PROTEIN_SERINE_THREONINE_PHOSPHATASE_COMPLEX",45,-1.0641,0.37,0.65,-0.7856,0.83,1,-0.9183,0.59,1
"C1_Positional:C1_ALL_89_CHR14Q23","C1_Positional","C1_ALL_89_CHR14Q23",47,-1.064,0.36,0.88,0.7579,0.87,0.98,-0.9137,0.62,0.94
"GO_BP:488703_GO_0002830_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE","GO_BP","488703_GO_0002830_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE",12,-1.064,0.38,0.54,0.9332,0.53,1,-1.0739,0.37,0.8
"GO_MF:487449_GO_0004197_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_MF","487449_GO_0004197_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY",102,-1.0639,0.34,0.57,-0.7741,0.92,1,-0.7458,0.97,0.99
"C3_TF_targets:C3_TFT_491_GTCNYYATGR_UNKNOWN","C3_TF_targets","C3_TFT_491_GTCNYYATGR_UNKNOWN",111,-1.0639,0.34,0.43,-0.9901,0.48,0.78,-1.0473,0.33,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_908_KREPPEL_CD99_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_908_KREPPEL_CD99_TARGETS_DN",8,-1.0639,0.39,0.47,-0.5918,0.93,1,-0.7075,0.84,0.98
"REACTOME:530745_REACT_115828_DOWNREGULATION_OF_ERBB4_SIGNALING","REACTOME","530745_REACT_115828_DOWNREGULATION_OF_ERBB4_SIGNALING",8,-1.0638,0.38,0.56,1.5016,0.057,0.14,-1.2255,0.22,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_1396_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1396_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN",21,-1.0637,0.36,0.47,1.4119,0.089,0.29,0.8525,0.69,1
"GO_BP:494886_GO_0010822_POSITIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION","GO_BP","494886_GO_0010822_POSITIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION",136,-1.0637,0.35,0.54,1.2799,0.051,0.7,-0.9649,0.55,0.88
"C1_Positional:C1_ALL_186_CHR4P15","C1_Positional","C1_ALL_186_CHR4P15",47,-1.0634,0.36,0.87,0.8136,0.77,0.93,-1.0438,0.36,0.84
"GO_MF:489282_GO_0003755_PEPTIDYL_PROLYL_CIS_TRANS_ISOMERASE_ACTIVITY","GO_MF","489282_GO_0003755_PEPTIDYL_PROLYL_CIS_TRANS_ISOMERASE_ACTIVITY",41,-1.0634,0.37,0.57,1.3064,0.09,0.6,-0.8131,0.8,0.96
"C4_Cancer_modules:C4_CM_137_MODULE_145","C4_Cancer_modules","C4_CM_137_MODULE_145",108,-1.0633,0.34,0.48,0.9299,0.64,0.8,-1.3953,0.019,0.22
"GO_BP:495191_GO_0014743_REGULATION_OF_MUSCLE_HYPERTROPHY","GO_BP","495191_GO_0014743_REGULATION_OF_MUSCLE_HYPERTROPHY",30,-1.0633,0.38,0.54,-0.6677,0.93,1,-1.2209,0.17,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_194_OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_194_OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN",267,-1.0632,0.33,0.47,1.2434,0.042,0.45,-0.8423,0.93,0.93
"GO_MF:490375_GO_0005109_FRIZZLED_BINDING","GO_MF","490375_GO_0005109_FRIZZLED_BINDING",37,-1.0632,0.38,0.57,-1.4007,0.058,0.63,1.0295,0.43,0.86
"GO_MF:490288_GO_0005001_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY","GO_MF","490288_GO_0005001_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY",17,-1.0631,0.38,0.57,1.4346,0.062,0.45,-0.6479,0.93,1
"C1_Positional:C1_ALL_116_CHR13Q34","C1_Positional","C1_ALL_116_CHR13Q34",37,-1.0631,0.36,0.87,-1.1937,0.2,1,-1.4192,0.05,0.62
"GO_MF:501684_GO_0032452_HISTONE_DEMETHYLASE_ACTIVITY","GO_MF","501684_GO_0032452_HISTONE_DEMETHYLASE_ACTIVITY",33,-1.0628,0.36,0.57,-1.6181,0.015,0.45,-0.795,0.8,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1489_BROWN_MYELOID_CELL_DEVELOPMENT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1489_BROWN_MYELOID_CELL_DEVELOPMENT_DN",129,-1.0626,0.35,0.47,1.0638,0.29,0.69,-1.4478,0.0041,0.32
"OMIM_gene:OMIM103220_SOLUTE_CARRIER_FAMILY_25_MITOCHONDRIAL_CARRIER_ADENINE_NUCLEOTIDE_TRANSLOCATOR_MEMBER_4_SLC25A4","OMIM_gene","OMIM103220_SOLUTE_CARRIER_FAMILY_25_MITOCHONDRIAL_CARRIER_ADENINE_NUCLEOTIDE_TRANSLOCATOR_MEMBER_4_SLC25A4",5,-1.0625,0.42,0.81,-0.7545,0.75,1,-0.906,0.59,0.97
"GO_BP:946557_GO_0098900_REGULATION_OF_ACTION_POTENTIAL","GO_BP","946557_GO_0098900_REGULATION_OF_ACTION_POTENTIAL",30,-1.0625,0.39,0.54,-1.2332,0.14,0.9,1.1872,0.19,0.72
"GO_MF:496624_GO_0016702_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN_INCORPORATION_OF_TWO_ATOMS_OF_OXYGEN","GO_MF","496624_GO_0016702_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN_INCORPORATION_OF_TWO_ATOMS_OF_OXYGEN",25,-1.0625,0.36,0.57,-0.8256,0.74,1,-1.6246,0.013,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_2639_MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED","C2_Chemical_and_genetic_perturbations","C2_CGP_2639_MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED",23,-1.0625,0.38,0.47,-1.1864,0.21,0.81,-0.7744,0.82,0.97
"C7_Immunologic_signatures:C7_ALL_476_GSE17721_CTRL_VS_POLYIC_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_476_GSE17721_CTRL_VS_POLYIC_12H_BMDM_DN",198,-1.0624,0.31,0.44,0.7867,0.98,1,0.8252,0.91,1
"GO_BP:488951_GO_0003157_ENDOCARDIUM_DEVELOPMENT","GO_BP","488951_GO_0003157_ENDOCARDIUM_DEVELOPMENT",11,-1.0624,0.4,0.54,-0.7311,0.81,1,1.3025,0.15,0.67
"GO_BP:491991_GO_0007191_ADENYLATE_CYCLASE_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","491991_GO_0007191_ADENYLATE_CYCLASE_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY",11,-1.0623,0.39,0.54,1.3347,0.15,0.62,0.9436,0.53,0.91
"GO_CC:496436_GO_0016459_MYOSIN_COMPLEX","GO_CC","496436_GO_0016459_MYOSIN_COMPLEX",62,-1.0623,0.36,0.65,-1.0746,0.34,0.81,-0.7853,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2405_KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2405_KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION",32,-1.0623,0.37,0.47,0.9283,0.57,0.89,-0.6024,0.98,0.99
"GO_BP:498079_GO_0019227_NEURONAL_ACTION_POTENTIAL_PROPAGATION","GO_BP","498079_GO_0019227_NEURONAL_ACTION_POTENTIAL_PROPAGATION",8,-1.0623,0.39,0.54,-0.7336,0.82,1,-0.9127,0.57,0.92
"GO_BP:492888_GO_0008645_HEXOSE_TRANSPORT","GO_BP","492888_GO_0008645_HEXOSE_TRANSPORT",72,-1.0623,0.38,0.54,0.9207,0.62,1,0.7327,0.94,1
"C3_TF_targets:C3_TFT_172_CATRRAGC_UNKNOWN","C3_TF_targets","C3_TFT_172_CATRRAGC_UNKNOWN",133,-1.0622,0.37,0.43,0.9946,0.5,1,0.8591,0.8,1
"C3_TF_targets:C3_TFT_280_V_AP2GAMMA_01","C3_TF_targets","C3_TFT_280_V_AP2GAMMA_01",248,-1.062,0.31,0.43,-1.2605,0.047,0.26,-1.0913,0.22,0.57
"GO_BP:492267_GO_0048535_LYMPH_NODE_DEVELOPMENT","GO_BP","492267_GO_0048535_LYMPH_NODE_DEVELOPMENT",17,-1.0619,0.37,0.54,0.6584,0.92,1,-0.5698,0.97,1
"C1_Positional:C1_ALL_137_CHR13Q22","C1_Positional","C1_ALL_137_CHR13Q22",16,-1.0619,0.37,0.86,-0.8909,0.61,1,0.9928,0.46,0.77
"GO_MF:504438_GO_0035254_GLUTAMATE_RECEPTOR_BINDING","GO_MF","504438_GO_0035254_GLUTAMATE_RECEPTOR_BINDING",31,-1.0619,0.36,0.57,-1.3576,0.081,0.69,1.2473,0.16,0.67
"KEGG_pathway:HSA05210_COLORECTAL_CANCER","KEGG_pathway","HSA05210_COLORECTAL_CANCER",62,-1.0619,0.36,0.42,-0.8035,0.85,0.99,-1.0096,0.43,0.67
"C4_Cancer_gene_neighborhoods:C4_CGN_159_MORF_PTPN9","C4_Cancer_gene_neighborhoods","C4_CGN_159_MORF_PTPN9",58,-1.0618,0.35,0.58,-0.8414,0.74,1,0.6837,0.96,1
"C4_Cancer_gene_neighborhoods:C4_CGN_226_GCM_DLG1","C4_Cancer_gene_neighborhoods","C4_CGN_226_GCM_DLG1",77,-1.0617,0.37,0.57,0.7324,0.96,1,-1.3125,0.086,0.27
"GO_BP:492035_GO_0007256_ACTIVATION_OF_JNKK_ACTIVITY","GO_BP","492035_GO_0007256_ACTIVATION_OF_JNKK_ACTIVITY",6,-1.0617,0.41,0.54,-0.892,0.59,1,-1.1398,0.31,0.75
"GO_MF:490520_GO_0005313_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490520_GO_0005313_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-1.0617,0.38,0.57,0.9664,0.47,0.91,-0.9442,0.52,0.84
"GO_CC:503566_GO_0034364_HIGH_DENSITY_LIPOPROTEIN_PARTICLE","GO_CC","503566_GO_0034364_HIGH_DENSITY_LIPOPROTEIN_PARTICLE",25,-1.0616,0.35,0.65,0.9658,0.51,0.83,0.9771,0.49,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2035_LOPES_METHYLATED_IN_COLON_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2035_LOPES_METHYLATED_IN_COLON_CANCER_DN",28,-1.0616,0.38,0.47,0.9366,0.52,0.88,0.9729,0.48,0.97
"REACTOME:161061_REACT_19140_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1","REACTOME","161061_REACT_19140_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1",24,-1.0616,0.38,0.57,0.7713,0.84,1,0.9512,0.55,1
"C3_MicroRNA_targets:C3_MIR_190_CAGTCAC_MIR_134","C3_MicroRNA_targets","C3_MIR_190_CAGTCAC_MIR_134",52,-1.0616,0.35,0.52,0.6372,0.97,1,0.7056,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_82_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_82_TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP",43,-1.0615,0.36,0.47,0.6967,0.95,1,-1.3361,0.083,0.41
"GO_BP:491515_GO_0006622_PROTEIN_TARGETING_TO_LYSOSOME","GO_BP","491515_GO_0006622_PROTEIN_TARGETING_TO_LYSOSOME",13,-1.0615,0.39,0.54,0.7813,0.78,1,0.6932,0.87,1
"KEGG_pathway:HSA00532_GLYCOSAMINOGLYCAN_BIOSYNTHESIS","KEGG_pathway","HSA00532_GLYCOSAMINOGLYCAN_BIOSYNTHESIS",20,-1.0614,0.35,0.42,0.4552,1,1,0.772,0.78,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_739_AIYAR_COBRA1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_739_AIYAR_COBRA1_TARGETS_DN",28,-1.0614,0.37,0.47,0.9465,0.52,0.87,-1.4496,0.042,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_2967_MURAKAMI_UV_RESPONSE_1HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2967_MURAKAMI_UV_RESPONSE_1HR_UP",15,-1.0614,0.38,0.47,1.6139,0.02,0.13,1.1059,0.31,0.88
"GO_BP:487981_GO_0002092_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION","GO_BP","487981_GO_0002092_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION",20,-1.0613,0.38,0.54,-0.6726,0.91,1,1.0407,0.38,0.82
"C7_Immunologic_signatures:C7_ALL_511_GSE17721_CTRL_VS_GARDIQUIMOD_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_511_GSE17721_CTRL_VS_GARDIQUIMOD_0_5H_BMDM_UP",200,-1.061,0.33,0.44,1.0706,0.25,0.52,-0.7017,1,1
"GO_BP:507418_GO_0045008_DEPYRIMIDINATION","GO_BP","507418_GO_0045008_DEPYRIMIDINATION",5,-1.061,0.43,0.54,1.3812,0.13,0.57,-0.832,0.67,0.97
"GO_BP:491954_GO_0007141_MALE_MEIOSIS_I","GO_BP","491954_GO_0007141_MALE_MEIOSIS_I",16,-1.0607,0.38,0.54,-0.757,0.8,1,-0.6812,0.9,1
"GO_BP:499620_GO_0030210_HEPARIN_BIOSYNTHETIC_PROCESS","GO_BP","499620_GO_0030210_HEPARIN_BIOSYNTHETIC_PROCESS",8,-1.0606,0.38,0.54,0.8056,0.72,1,-0.8983,0.59,0.93
"GO_MF:496868_GO_0017046_PEPTIDE_HORMONE_BINDING","GO_MF","496868_GO_0017046_PEPTIDE_HORMONE_BINDING",35,-1.0604,0.37,0.57,1.5603,0.028,0.33,1.2767,0.14,0.65
"C1_Positional:C1_ALL_44_CHR3P14","C1_Positional","C1_ALL_44_CHR3P14",41,-1.0604,0.37,0.86,1.2979,0.087,0.53,0.8011,0.83,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1924_NIELSEN_LEIOMYOSARCOMA_CNN1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1924_NIELSEN_LEIOMYOSARCOMA_CNN1_UP",19,-1.0601,0.37,0.47,-0.8852,0.61,1,-0.8407,0.69,0.93
"C3_MicroRNA_targets:C3_MIR_124_GCAAGAC_MIR_431","C3_MicroRNA_targets","C3_MIR_124_GCAAGAC_MIR_431",45,-1.06,0.36,0.52,0.7629,0.88,1,0.8933,0.65,1
"C4_Cancer_gene_neighborhoods:C4_CGN_144_MORF_PML","C4_Cancer_gene_neighborhoods","C4_CGN_144_MORF_PML",140,-1.0599,0.35,0.57,-0.9875,0.51,0.87,-1.0849,0.28,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2196_OSADA_ASCL1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2196_OSADA_ASCL1_TARGETS_UP",43,-1.0598,0.36,0.47,-0.781,0.84,1,-0.8546,0.71,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_2127_KONDO_EZH2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2127_KONDO_EZH2_TARGETS",239,-1.0598,0.33,0.47,1.1649,0.11,0.53,1.4434,0.0059,0.53
"GO_CC:502240_GO_0033018_SARCOPLASMIC_RETICULUM_LUMEN","GO_CC","502240_GO_0033018_SARCOPLASMIC_RETICULUM_LUMEN",8,-1.0598,0.38,0.65,-0.8317,0.69,0.99,0.6285,0.9,1
"REACTOME:645327_REACT_121280_SYNTHESIS_OF_PG","REACTOME","645327_REACT_121280_SYNTHESIS_OF_PG",8,-1.0597,0.38,0.57,0.8025,0.73,1,0.8263,0.68,1
"C7_Immunologic_signatures:C7_ALL_455_GSE17721_CTRL_VS_LPS_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_455_GSE17721_CTRL_VS_LPS_6H_BMDM_UP",200,-1.0595,0.35,0.45,1.1107,0.18,0.42,-1.0241,0.38,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_2493_JU_AGING_TERC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2493_JU_AGING_TERC_TARGETS_UP",9,-1.0595,0.4,0.47,0.9214,0.54,0.9,0.8746,0.62,1
"GO_BP:753037_GO_1900040_REGULATION_OF_INTERLEUKIN_2_SECRETION","GO_BP","753037_GO_1900040_REGULATION_OF_INTERLEUKIN_2_SECRETION",7,-1.0595,0.4,0.54,-0.9476,0.53,1,1.1962,0.26,0.72
"C4_Cancer_modules:C4_CM_57_MODULE_61","C4_Cancer_modules","C4_CM_57_MODULE_61",50,-1.0593,0.35,0.49,1.2374,0.13,0.34,-1.0105,0.44,0.68
"GO_BP:496864_GO_0046886_POSITIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS","GO_BP","496864_GO_0046886_POSITIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS",9,-1.0591,0.38,0.54,1.0941,0.35,0.91,0.7767,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1145_AMIT_SERUM_RESPONSE_20_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1145_AMIT_SERUM_RESPONSE_20_MCF10A",21,-1.0589,0.37,0.47,1.1543,0.22,0.55,-0.8584,0.68,0.92
"GO_CC:501370_GO_0032133_CHROMOSOME_PASSENGER_COMPLEX","GO_CC","501370_GO_0032133_CHROMOSOME_PASSENGER_COMPLEX",5,-1.0589,0.41,0.65,-1.0007,0.49,0.87,-1.2711,0.21,0.69
"C7_Immunologic_signatures:C7_ALL_1738_GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1738_GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN",197,-1.0589,0.34,0.45,1.8129,0,2.9e-05,-0.8598,0.87,1
"GO_BP:491687_GO_0006818_HYDROGEN_TRANSPORT","GO_BP","491687_GO_0006818_HYDROGEN_TRANSPORT",119,-1.0588,0.35,0.54,1.7812,0,0.12,0.6864,0.99,1
"C7_Immunologic_signatures:C7_ALL_1589_GSE3982_EOSINOPHIL_VS_MAC_UP","C7_Immunologic_signatures","C7_ALL_1589_GSE3982_EOSINOPHIL_VS_MAC_UP",193,-1.0587,0.35,0.45,-0.7768,0.97,1,-0.7505,0.99,1
"C4_Cancer_modules:C4_CM_44_MODULE_48","C4_Cancer_modules","C4_CM_44_MODULE_48",317,-1.0585,0.34,0.49,-0.9344,0.65,0.88,0.9875,0.49,0.97
"GO_MF:492536_GO_0008194_UDP_GLYCOSYLTRANSFERASE_ACTIVITY","GO_MF","492536_GO_0008194_UDP_GLYCOSYLTRANSFERASE_ACTIVITY",133,-1.0585,0.35,0.57,1.1568,0.14,0.74,1.283,0.061,0.65
"C7_Immunologic_signatures:C7_ALL_633_GSE17721_POLYIC_VS_CPG_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_633_GSE17721_POLYIC_VS_CPG_24H_BMDM_UP",194,-1.0584,0.36,0.45,1.3894,0.012,0.041,0.7854,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1989_SUZUKI_RESPONSE_TO_TSA","C2_Chemical_and_genetic_perturbations","C2_CGP_1989_SUZUKI_RESPONSE_TO_TSA",21,-1.0584,0.41,0.47,0.6851,0.9,1,-1.014,0.41,0.73
"GO_CC:486679_GO_0000145_EXOCYST","GO_CC","486679_GO_0000145_EXOCYST",17,-1.0583,0.39,0.65,-0.8926,0.63,0.95,-0.8692,0.64,1
"GO_BP:1129254_GO_0089711_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORT","GO_BP","1129254_GO_0089711_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORT",13,-1.0583,0.4,0.54,0.9759,0.46,1,-0.9419,0.54,0.89
"GO_MF:500947_GO_0031701_ANGIOTENSIN_RECEPTOR_BINDING","GO_MF","500947_GO_0031701_ANGIOTENSIN_RECEPTOR_BINDING",11,-1.0582,0.41,0.57,1.4035,0.091,0.47,0.9769,0.47,0.89
"C7_Immunologic_signatures:C7_ALL_414_GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN","C7_Immunologic_signatures","C7_ALL_414_GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN",196,-1.0581,0.34,0.45,1.1501,0.14,0.32,0.7158,1,1
"C1_Positional:C1_ALL_280_CHR8Q11","C1_Positional","C1_ALL_280_CHR8Q11",22,-1.0581,0.37,0.86,0.7581,0.85,0.98,1.0629,0.35,0.7
"GO_BP:489306_GO_0030042_ACTIN_FILAMENT_DEPOLYMERIZATION","GO_BP","489306_GO_0030042_ACTIN_FILAMENT_DEPOLYMERIZATION",8,-1.058,0.4,0.54,-1.0876,0.36,0.95,-0.869,0.63,0.95
"C3_TF_targets:C3_TFT_211_V_ZF5_B","C3_TF_targets","C3_TFT_211_V_ZF5_B",233,-1.0579,0.34,0.44,-1.1692,0.13,0.41,0.7894,0.97,1
"GO_BP:505330_GO_0042168_HEME_METABOLIC_PROCESS","GO_BP","505330_GO_0042168_HEME_METABOLIC_PROCESS",30,-1.0579,0.39,0.54,1.0745,0.36,0.93,-1.0537,0.38,0.81
"GO_BP:493568_GO_0009395_PHOSPHOLIPID_CATABOLIC_PROCESS","GO_BP","493568_GO_0009395_PHOSPHOLIPID_CATABOLIC_PROCESS",25,-1.0578,0.38,0.54,-0.6312,0.95,1,1.1985,0.21,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_697_LUI_THYROID_CANCER_CLUSTER_1","C2_Chemical_and_genetic_perturbations","C2_CGP_697_LUI_THYROID_CANCER_CLUSTER_1",51,-1.0578,0.37,0.48,-1.1727,0.21,0.82,-0.9017,0.65,0.88
"C7_Immunologic_signatures:C7_ALL_524_GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_524_GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDM_DN",192,-1.0578,0.34,0.45,1.1936,0.095,0.24,-0.9437,0.63,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1511_WANG_TARGETS_OF_MLL_CBP_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1511_WANG_TARGETS_OF_MLL_CBP_FUSION_DN",45,-1.0578,0.36,0.47,1.1402,0.26,0.57,-1.0414,0.36,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_1894_BURTON_ADIPOGENESIS_11","C2_Chemical_and_genetic_perturbations","C2_CGP_1894_BURTON_ADIPOGENESIS_11",57,-1.0575,0.36,0.48,0.839,0.77,0.98,0.7927,0.85,1
"C3_TF_targets:C3_TFT_469_GGCNNMSMYNTTG_UNKNOWN","C3_TF_targets","C3_TFT_469_GGCNNMSMYNTTG_UNKNOWN",75,-1.0575,0.37,0.44,1.3486,0.042,0.4,-0.9768,0.5,0.81
"GO_MF:492492_GO_0008138_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY","GO_MF","492492_GO_0008138_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY",42,-1.0574,0.36,0.57,0.8186,0.77,1,1.134,0.26,0.8
"GO_MF:509161_GO_0046970_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H4_K16_SPECIFIC_","GO_MF","509161_GO_0046970_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H4_K16_SPECIFIC_",12,-1.0574,0.4,0.57,-1.1912,0.27,0.79,-1.7398,0.008,0.24
"C7_Immunologic_signatures:C7_ALL_778_GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_778_GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN",199,-1.0573,0.36,0.45,-1.0277,0.39,1,-1.3165,0.031,0.12
"GO_BP:499239_GO_0021960_ANTERIOR_COMMISSURE_MORPHOGENESIS","GO_BP","499239_GO_0021960_ANTERIOR_COMMISSURE_MORPHOGENESIS",6,-1.0573,0.41,0.55,1.0017,0.45,0.98,-1.1743,0.29,0.73
"GO_BP:487613_GO_0001710_MESODERMAL_CELL_FATE_COMMITMENT","GO_BP","487613_GO_0001710_MESODERMAL_CELL_FATE_COMMITMENT",13,-1.0573,0.4,0.55,1.3568,0.11,0.6,1.0199,0.42,0.84
"GO_BP:491265_GO_0006306_DNA_METHYLATION","GO_BP","491265_GO_0006306_DNA_METHYLATION",71,-1.0572,0.36,0.55,-1.714,0,0.72,-1.4084,0.039,0.57
"C1_Positional:C1_ALL_310_CHR6P","C1_Positional","C1_ALL_310_CHR6P",8,-1.0572,0.39,0.85,-1.5383,0.045,0.59,-0.6938,0.87,0.99
"C7_Immunologic_signatures:C7_ALL_411_GSE15930_STIM_VS_STIM_AND_IL_12_24H_CD8_T_CELL_UP","C7_Immunologic_signatures","C7_ALL_411_GSE15930_STIM_VS_STIM_AND_IL_12_24H_CD8_T_CELL_UP",198,-1.0572,0.36,0.45,1.7088,0,0.00056,-1.1399,0.14,0.39
"C3_TF_targets:C3_TFT_357_V_TEL2_Q6","C3_TF_targets","C3_TFT_357_V_TEL2_Q6",233,-1.057,0.34,0.44,0.8065,0.97,1,-0.9008,0.77,0.92
"GO_BP:502835_GO_0033619_MEMBRANE_PROTEIN_PROTEOLYSIS","GO_BP","502835_GO_0033619_MEMBRANE_PROTEIN_PROTEOLYSIS",34,-1.057,0.38,0.55,0.5907,0.99,1,-1.1294,0.25,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_622_BAKER_HEMATOPOIESIS_STAT3_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_622_BAKER_HEMATOPOIESIS_STAT3_TARGETS",16,-1.057,0.39,0.48,1.3396,0.13,0.35,1.0764,0.36,0.88
"GO_MF:490465_GO_0005223_INTRACELLULAR_CGMP_ACTIVATED_CATION_CHANNEL_ACTIVITY","GO_MF","490465_GO_0005223_INTRACELLULAR_CGMP_ACTIVATED_CATION_CHANNEL_ACTIVITY",7,-1.0567,0.4,0.57,0.6895,0.85,1,1.6914,0.017,0.2
"GO_MF:500669_GO_0031418_L_ASCORBIC_ACID_BINDING","GO_MF","500669_GO_0031418_L_ASCORBIC_ACID_BINDING",21,-1.0564,0.38,0.57,-1.0652,0.39,0.86,-1.755,0.008,0.22
"GO_BP:508440_GO_0051197_POSITIVE_REGULATION_OF_COENZYME_METABOLIC_PROCESS","GO_BP","508440_GO_0051197_POSITIVE_REGULATION_OF_COENZYME_METABOLIC_PROCESS",13,-1.0564,0.38,0.55,1.2097,0.22,0.78,1.6643,0.012,0.39
"KEGG_reaction:R00089_ATP_DIPHOSPHATE_LYASE_CYCLIZING_3_5_CYCLIC_AMP_FORMING_ATP_3_5_CYCLIC_AMP_DIPHOSPHATE","KEGG_reaction","R00089_ATP_DIPHOSPHATE_LYASE_CYCLIZING_3_5_CYCLIC_AMP_FORMING_ATP_3_5_CYCLIC_AMP_DIPHOSPHATE",10,-1.0563,0.4,0.54,-1.0947,0.35,0.68,-1.3056,0.15,0.49
"C2_Chemical_and_genetic_perturbations:C2_CGP_1456_VERNELL_RETINOBLASTOMA_PATHWAY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1456_VERNELL_RETINOBLASTOMA_PATHWAY_DN",22,-1.0562,0.38,0.48,-0.6123,0.95,1,1.5647,0.027,0.43
"OMIM_gene:OMIM600538_PEROXIREDOXIN_2_PRDX2","OMIM_gene","OMIM600538_PEROXIREDOXIN_2_PRDX2",5,-1.0561,0.43,0.79,1.3339,0.15,0.84,1.3622,0.14,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2195_FUJII_YBX1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2195_FUJII_YBX1_TARGETS_DN",201,-1.0561,0.36,0.48,1.1001,0.19,0.63,-1.3445,0.0041,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_1604_BROWNE_HCMV_INFECTION_20HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1604_BROWNE_HCMV_INFECTION_20HR_UP",240,-1.0561,0.34,0.48,-1.0569,0.3,0.97,-1.1365,0.14,0.59
"C6_Oncogenic_signatures:C6_ALL_95_ESC_J1_UP_LATE_V1_DN","C6_Oncogenic_signatures","C6_ALL_95_ESC_J1_UP_LATE_V1_DN",174,-1.056,0.34,0.41,-0.9107,0.68,0.87,-1.1513,0.16,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_2492_LUDWICZEK_TREATING_IRON_OVERLOAD","C2_Chemical_and_genetic_perturbations","C2_CGP_2492_LUDWICZEK_TREATING_IRON_OVERLOAD",7,-1.0559,0.42,0.48,1.1834,0.27,0.51,1.2627,0.2,0.7
"C7_Immunologic_signatures:C7_ALL_1243_GSE2826_XID_VS_BTK_KO_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1243_GSE2826_XID_VS_BTK_KO_BCELL_UP",196,-1.0558,0.38,0.45,1.509,0.0072,0.011,-0.8863,0.8,0.97
"GO_BP:518410_GO_0090270_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_PRODUCTION","GO_BP","518410_GO_0090270_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_PRODUCTION",5,-1.0557,0.43,0.55,-1.0489,0.39,0.97,-1.2585,0.22,0.67
"GO_BP:509093_GO_0046880_REGULATION_OF_FOLLICLE_STIMULATING_HORMONE_SECRETION","GO_BP","509093_GO_0046880_REGULATION_OF_FOLLICLE_STIMULATING_HORMONE_SECRETION",5,-1.0556,0.42,0.55,0.8903,0.57,1,-1.415,0.091,0.57
"C7_Immunologic_signatures:C7_ALL_714_GSE17721_0_5H_VS_24H_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_714_GSE17721_0_5H_VS_24H_LPS_BMDM_DN",199,-1.0554,0.33,0.45,0.906,0.73,1,-0.9274,0.68,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2330_MATZUK_EARLY_ANTRAL_FOLLICLE","C2_Chemical_and_genetic_perturbations","C2_CGP_2330_MATZUK_EARLY_ANTRAL_FOLLICLE",13,-1.0554,0.41,0.48,1.0405,0.42,0.73,1.0057,0.45,0.96
"WikiPathways:198858_WP1602_NICOTINE_ACTIVITY_ON_DOPAMINERGIC_NEURONS","WikiPathways","198858_WP1602_NICOTINE_ACTIVITY_ON_DOPAMINERGIC_NEURONS",21,-1.0552,0.38,0.49,-0.8872,0.64,1,-0.9673,0.49,0.75
"KEGG_compound:C16608_DEMETHYLCITALOPRAM","KEGG_compound","C16608_DEMETHYLCITALOPRAM",5,-1.0551,0.41,0.56,-0.9719,0.5,1,-0.5864,0.94,0.97
"C3_MicroRNA_targets:C3_MIR_210_TGCAAAC_MIR_452","C3_MicroRNA_targets","C3_MIR_210_TGCAAAC_MIR_452",106,-1.0551,0.36,0.53,-0.9071,0.67,1,1.0305,0.39,1
"GO_BP:499629_GO_0030219_MEGAKARYOCYTE_DIFFERENTIATION","GO_BP","499629_GO_0030219_MEGAKARYOCYTE_DIFFERENTIATION",21,-1.055,0.4,0.55,0.9875,0.47,0.99,-1.1987,0.22,0.73
"GO_BP:509676_GO_0047497_MITOCHONDRION_TRANSPORT_ALONG_MICROTUBULE","GO_BP","509676_GO_0047497_MITOCHONDRION_TRANSPORT_ALONG_MICROTUBULE",9,-1.055,0.39,0.55,-0.9283,0.54,1,-0.7289,0.83,0.99
"GO_BP:504215_GO_0035025_POSITIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","504215_GO_0035025_POSITIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION",11,-1.0549,0.41,0.55,0.724,0.82,1,0.4734,1,1
"GO_MF:490460_GO_0005218_INTRACELLULAR_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY","GO_MF","490460_GO_0005218_INTRACELLULAR_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY",10,-1.0548,0.4,0.58,-0.9224,0.54,0.96,-0.6947,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2206_DAIRKEE_CANCER_PRONE_RESPONSE_E2","C2_Chemical_and_genetic_perturbations","C2_CGP_2206_DAIRKEE_CANCER_PRONE_RESPONSE_E2",28,-1.0547,0.41,0.48,-0.8527,0.71,1,-1.0171,0.43,0.73
"GO_BP:516987_GO_0072070_LOOP_OF_HENLE_DEVELOPMENT","GO_BP","516987_GO_0072070_LOOP_OF_HENLE_DEVELOPMENT",10,-1.0547,0.38,0.55,-1.3101,0.16,0.87,1.1286,0.31,0.74
"GO_BP:518364_GO_0090224_REGULATION_OF_SPINDLE_ORGANIZATION","GO_BP","518364_GO_0090224_REGULATION_OF_SPINDLE_ORGANIZATION",24,-1.0546,0.37,0.55,1.0897,0.34,0.92,-0.7779,0.8,1
"C7_Immunologic_signatures:C7_ALL_1042_GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN","C7_Immunologic_signatures","C7_ALL_1042_GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN",197,-1.0545,0.35,0.46,1.4859,0,0.015,-0.9111,0.69,0.93
"GO_BP:494936_GO_0010872_REGULATION_OF_CHOLESTEROL_ESTERIFICATION","GO_BP","494936_GO_0010872_REGULATION_OF_CHOLESTEROL_ESTERIFICATION",10,-1.0545,0.41,0.55,0.9,0.57,1,1.2503,0.23,0.69
"REACTOME:106540_REACT_7970_TELOMERE_MAINTENANCE","REACTOME","106540_REACT_7970_TELOMERE_MAINTENANCE",78,-1.0545,0.36,0.58,-1.0494,0.36,0.94,-1.645,0,0.24
"KEGG_pathway:HSA00310_LYSINE_DEGRADATION","KEGG_pathway","HSA00310_LYSINE_DEGRADATION",52,-1.0544,0.38,0.43,-1.387,0.05,0.36,-1.439,0.023,0.15
"GO_BP:499853_GO_0030514_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY","GO_BP","499853_GO_0030514_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY",42,-1.0544,0.38,0.55,0.7232,0.93,1,1.5888,0.0083,0.44
"C2_Chemical_and_genetic_perturbations:C2_CGP_3124_BHAT_ESR1_TARGETS_VIA_AKT1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3124_BHAT_ESR1_TARGETS_VIA_AKT1_UP",276,-1.0543,0.35,0.48,-1.3113,0.018,0.69,0.8876,0.86,1
"GO_BP:493348_GO_0009151_PURINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS","GO_BP","493348_GO_0009151_PURINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS",16,-1.0543,0.4,0.55,0.827,0.72,1,-1.3844,0.1,0.59
"GO_MF:496670_GO_0016757_TRANSFERASE_ACTIVITY_TRANSFERRING_GLYCOSYL_GROUPS","GO_MF","496670_GO_0016757_TRANSFERASE_ACTIVITY_TRANSFERRING_GLYCOSYL_GROUPS",269,-1.0542,0.34,0.58,1.1301,0.14,0.75,0.8492,0.91,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2348_GRADE_COLON_VS_RECTAL_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2348_GRADE_COLON_VS_RECTAL_CANCER_DN",55,-1.0541,0.36,0.48,-0.9592,0.52,1,-0.6726,0.96,0.99
"GO_BP:508144_GO_0045821_POSITIVE_REGULATION_OF_GLYCOLYTIC_PROCESS","GO_BP","508144_GO_0045821_POSITIVE_REGULATION_OF_GLYCOLYTIC_PROCESS",13,-1.0541,0.42,0.55,1.1653,0.26,0.82,1.6373,0.019,0.41
"REACTOME:106056_REACT_15381_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS","REACTOME","106056_REACT_15381_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS",15,-1.0541,0.41,0.58,1.853,0.0021,0.013,1.2061,0.21,0.83
"GO_CC:506357_GO_0043296_APICAL_JUNCTION_COMPLEX","GO_CC","506357_GO_0043296_APICAL_JUNCTION_COMPLEX",123,-1.0538,0.37,0.66,-0.9982,0.45,0.86,0.9178,0.65,1
"C7_Immunologic_signatures:C7_ALL_1314_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN","C7_Immunologic_signatures","C7_ALL_1314_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN",197,-1.0538,0.35,0.46,-0.8964,0.75,1,-1.1989,0.067,0.28
"GO_BP:491378_GO_0006476_PROTEIN_DEACETYLATION","GO_BP","491378_GO_0006476_PROTEIN_DEACETYLATION",43,-1.0537,0.39,0.55,-1.2722,0.13,0.89,-1.4483,0.033,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_2360_NAKAMURA_METASTASIS_MODEL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2360_NAKAMURA_METASTASIS_MODEL_UP",42,-1.0536,0.37,0.48,0.9575,0.53,0.86,1.2315,0.16,0.74
"KEGG_reaction:R08391_RETINOATE_NADPH_H_OXYGEN_ALL_TRANS_5_6_EPOXYRETINOIC_ACID_NADP_H2O","KEGG_reaction","R08391_RETINOATE_NADPH_H_OXYGEN_ALL_TRANS_5_6_EPOXYRETINOIC_ACID_NADP_H2O",5,-1.0536,0.41,0.54,-1.3437,0.13,0.35,1.1914,0.28,0.54
"REACTOME:1183569_REACT_355227_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING","REACTOME","1183569_REACT_355227_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING",28,-1.0536,0.39,0.58,0.7612,0.84,1,0.7324,0.88,1
"GO_CC:1025426_GO_1903293_PHOSPHATASE_COMPLEX","GO_CC","1025426_GO_1903293_PHOSPHATASE_COMPLEX",45,-1.0536,0.39,0.66,-0.7883,0.82,1,-0.9229,0.59,1
"REACTOME:1183518_REACT_355457_DISEASES_OF_SIGNAL_TRANSDUCTION","REACTOME","1183518_REACT_355457_DISEASES_OF_SIGNAL_TRANSDUCTION",259,-1.0535,0.34,0.58,0.9235,0.72,0.87,-0.9203,0.72,0.94
"GO_BP:512097_GO_0051194_POSITIVE_REGULATION_OF_COFACTOR_METABOLIC_PROCESS","GO_BP","512097_GO_0051194_POSITIVE_REGULATION_OF_COFACTOR_METABOLIC_PROCESS",13,-1.0535,0.4,0.55,1.2085,0.23,0.78,1.6644,0.018,0.4
"GO_CC:507223_GO_0044216_OTHER_ORGANISM_CELL","GO_CC","507223_GO_0044216_OTHER_ORGANISM_CELL",11,-1.0534,0.4,0.66,-1.3285,0.14,0.65,1.0799,0.37,0.94
"C1_Positional:C1_ALL_149_CHRXQ23","C1_Positional","C1_ALL_149_CHRXQ23",15,-1.0534,0.4,0.86,-1.5026,0.046,0.52,0.9407,0.53,0.82
"GO_MF:492489_GO_0008134_TRANSCRIPTION_FACTOR_BINDING","GO_MF","492489_GO_0008134_TRANSCRIPTION_FACTOR_BINDING",472,-1.0534,0.33,0.58,0.7055,1,1,-1.0133,0.43,0.78
"GO_CC:516471_GO_0071547_PIP_BODY","GO_CC","516471_GO_0071547_PIP_BODY",5,-1.0533,0.44,0.66,-0.4887,0.99,1,-1.4824,0.067,0.52
"C7_Immunologic_signatures:C7_ALL_53_GSE10325_MYELOID_VS_LUPUS_MYELOID_UP","C7_Immunologic_signatures","C7_ALL_53_GSE10325_MYELOID_VS_LUPUS_MYELOID_UP",188,-1.0532,0.36,0.46,-1.0154,0.41,1,-0.9937,0.48,0.74
"C7_Immunologic_signatures:C7_ALL_206_GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_206_GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN",152,-1.0532,0.37,0.46,-1.1997,0.11,0.81,1.7737,0,0.00033
"GO_BP:496350_GO_0045744_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY","GO_BP","496350_GO_0045744_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY",71,-1.0531,0.37,0.55,0.8738,0.74,1,-1.2076,0.13,0.73
"GO_BP:513775_GO_0060219_CAMERA_TYPE_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION","GO_BP","513775_GO_0060219_CAMERA_TYPE_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION",15,-1.0529,0.39,0.55,-0.8975,0.6,1,1.3364,0.12,0.65
"C7_Immunologic_signatures:C7_ALL_181_GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP","C7_Immunologic_signatures","C7_ALL_181_GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP",199,-1.0528,0.37,0.46,1.0086,0.42,0.71,0.7945,0.98,1
"GO_BP:487833_GO_0001942_HAIR_FOLLICLE_DEVELOPMENT","GO_BP","487833_GO_0001942_HAIR_FOLLICLE_DEVELOPMENT",72,-1.0527,0.38,0.55,0.835,0.77,1,1.0203,0.42,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1099_HE_PTEN_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1099_HE_PTEN_TARGETS_UP",15,-1.0526,0.37,0.48,0.8036,0.76,0.99,-0.8031,0.74,0.95
"C1_Positional:C1_ALL_161_CHR21Q21","C1_Positional","C1_ALL_161_CHR21Q21",17,-1.0526,0.39,0.85,-0.9235,0.57,1,-1.5953,0.018,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_1815_EHRLICH_ICF_SYNDROM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1815_EHRLICH_ICF_SYNDROM_DN",14,-1.0525,0.39,0.48,-1.2599,0.18,0.74,0.8871,0.63,1
"GO_MF:495791_GO_0015651_QUATERNARY_AMMONIUM_GROUP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495791_GO_0015651_QUATERNARY_AMMONIUM_GROUP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-1.0525,0.4,0.58,-1.0301,0.4,0.88,-0.6736,0.87,1
"REACTOME:106041_REACT_18407_G_ALPHA_12_13_SIGNALLING_EVENTS","REACTOME","106041_REACT_18407_G_ALPHA_12_13_SIGNALLING_EVENTS",75,-1.0525,0.37,0.58,-0.9316,0.59,1,-0.97,0.49,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_3067_GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB","C2_Chemical_and_genetic_perturbations","C2_CGP_3067_GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB",142,-1.0522,0.36,0.48,1.2537,0.065,0.43,0.7227,0.99,1
"GO_BP:492609_GO_0008286_INSULIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","492609_GO_0008286_INSULIN_RECEPTOR_SIGNALING_PATHWAY",141,-1.0522,0.36,0.55,-0.7795,0.96,1,-0.6824,0.99,1
"C3_TF_targets:C3_TFT_537_WWTAAGGC_UNKNOWN","C3_TF_targets","C3_TFT_537_WWTAAGGC_UNKNOWN",137,-1.0521,0.35,0.45,0.7829,0.96,1,1.2535,0.058,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1846_MODY_HIPPOCAMPUS_PRENATAL","C2_Chemical_and_genetic_perturbations","C2_CGP_1846_MODY_HIPPOCAMPUS_PRENATAL",42,-1.052,0.37,0.48,2.1218,0,0.0016,-1.371,0.068,0.38
"C4_Cancer_modules:C4_CM_133_MODULE_138","C4_Cancer_modules","C4_CM_133_MODULE_138",85,-1.052,0.38,0.5,0.8715,0.74,0.89,-1.5163,0.0063,0.15
"GO_BP:513809_GO_0060253_NEGATIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION","GO_BP","513809_GO_0060253_NEGATIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION",9,-1.052,0.42,0.55,-0.4403,1,1,1.181,0.25,0.72
"GO_MF:492439_GO_0008066_GLUTAMATE_RECEPTOR_ACTIVITY","GO_MF","492439_GO_0008066_GLUTAMATE_RECEPTOR_ACTIVITY",27,-1.052,0.39,0.58,1.2093,0.2,0.7,2.2416,0,0.00077
"REACTOME:106499_REACT_15312_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY","REACTOME","106499_REACT_15312_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY",10,-1.052,0.41,0.58,-1.1222,0.31,0.89,-1.0763,0.37,0.73
"GO_BP:492322_GO_0048102_AUTOPHAGIC_CELL_DEATH","GO_BP","492322_GO_0048102_AUTOPHAGIC_CELL_DEATH",6,-1.0519,0.41,0.55,-0.6327,0.91,1,-1.3737,0.11,0.59
"GO_BP:514199_GO_0060644_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","514199_GO_0060644_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION",16,-1.0519,0.39,0.55,0.8228,0.73,1,0.9762,0.51,0.88
"GO_BP:517571_GO_0072668_TUBULIN_COMPLEX_BIOGENESIS","GO_BP","517571_GO_0072668_TUBULIN_COMPLEX_BIOGENESIS",8,-1.0519,0.41,0.55,-0.9034,0.6,1,-1.41,0.11,0.57
"GO_BP:506531_GO_0043500_MUSCLE_ADAPTATION","GO_BP","506531_GO_0043500_MUSCLE_ADAPTATION",29,-1.0518,0.38,0.55,-1.1849,0.22,0.91,0.9899,0.46,0.87
"GO_MF:499654_GO_0030249_GUANYLATE_CYCLASE_REGULATOR_ACTIVITY","GO_MF","499654_GO_0030249_GUANYLATE_CYCLASE_REGULATOR_ACTIVITY",7,-1.0515,0.4,0.58,-0.8108,0.71,1,-1.2138,0.24,0.57
"C1_Positional:C1_ALL_98_CHR6P21","C1_Positional","C1_ALL_98_CHR6P21",353,-1.0515,0.35,0.85,-1.3323,0.01,0.89,-0.9137,0.78,0.95
"C7_Immunologic_signatures:C7_ALL_1563_GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP","C7_Immunologic_signatures","C7_ALL_1563_GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP",196,-1.0515,0.34,0.46,1.4055,0.0096,0.035,-0.6831,1,1
"KEGG_pathway:HSA00330_ARGININE_AND_PROLINE_METABOLISM","KEGG_pathway","HSA00330_ARGININE_AND_PROLINE_METABOLISM",58,-1.0515,0.38,0.43,-1.0707,0.33,0.72,-1.1095,0.27,0.5
"GO_BP:494540_GO_0010470_REGULATION_OF_GASTRULATION","GO_BP","494540_GO_0010470_REGULATION_OF_GASTRULATION",31,-1.0514,0.39,0.55,-1.1272,0.27,0.94,-0.9968,0.47,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_59_GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_59_GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN",483,-1.0514,0.32,0.48,1.0593,0.25,0.7,-0.9513,0.66,0.82
"GO_BP:498795_GO_0021511_SPINAL_CORD_PATTERNING","GO_BP","498795_GO_0021511_SPINAL_CORD_PATTERNING",24,-1.0512,0.39,0.55,-1.4427,0.066,0.91,0.8696,0.66,0.96
"GO_BP:493329_GO_0009132_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS","GO_BP","493329_GO_0009132_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS",35,-1.0512,0.39,0.55,0.7079,0.92,1,-1.0588,0.36,0.81
"GO_BP:493321_GO_0009124_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493321_GO_0009124_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",87,-1.051,0.38,0.55,1.4169,0.022,0.53,-0.7931,0.92,0.99
"GO_BP:494527_GO_0010457_CENTRIOLE_CENTRIOLE_COHESION","GO_BP","494527_GO_0010457_CENTRIOLE_CENTRIOLE_COHESION",6,-1.051,0.4,0.55,-1.2771,0.19,0.89,-0.6754,0.88,1
"REACTOME:106351_REACT_9413_FGFR2C_LIGAND_BINDING_AND_ACTIVATION","REACTOME","106351_REACT_9413_FGFR2C_LIGAND_BINDING_AND_ACTIVATION",10,-1.051,0.39,0.58,-1.3182,0.14,0.62,0.6469,0.91,1
"GO_BP:499841_GO_0030500_REGULATION_OF_BONE_MINERALIZATION","GO_BP","499841_GO_0030500_REGULATION_OF_BONE_MINERALIZATION",64,-1.051,0.36,0.55,-1.2691,0.095,0.89,1.2793,0.089,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2200_DE_YY1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2200_DE_YY1_TARGETS_DN",92,-1.051,0.38,0.49,1.336,0.038,0.35,-0.9614,0.55,0.8
"GO_BP:499657_GO_0030252_GROWTH_HORMONE_SECRETION","GO_BP","499657_GO_0030252_GROWTH_HORMONE_SECRETION",8,-1.0509,0.41,0.55,-0.9355,0.54,1,-0.8829,0.61,0.94
"C7_Immunologic_signatures:C7_ALL_1495_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP","C7_Immunologic_signatures","C7_ALL_1495_GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP",196,-1.0509,0.37,0.46,1.0093,0.39,0.71,-1.0332,0.37,0.65
"C7_Immunologic_signatures:C7_ALL_1869_GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1869_GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP",199,-1.0507,0.37,0.46,1.0823,0.24,0.49,-0.9837,0.49,0.77
"GO_BP:496101_GO_0015992_PROTON_TRANSPORT","GO_BP","496101_GO_0015992_PROTON_TRANSPORT",117,-1.0506,0.37,0.56,1.7873,0,0.11,0.6794,0.99,1
"GO_BP:513684_GO_0060126_SOMATOTROPIN_SECRETING_CELL_DIFFERENTIATION","GO_BP","513684_GO_0060126_SOMATOTROPIN_SECRETING_CELL_DIFFERENTIATION",5,-1.0506,0.44,0.56,-1.1144,0.36,0.93,-0.5898,0.93,1
"C7_Immunologic_signatures:C7_ALL_1048_GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN","C7_Immunologic_signatures","C7_ALL_1048_GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN",199,-1.0506,0.36,0.46,1.4109,0.0048,0.035,-0.8284,0.9,1
"C4_Cancer_gene_neighborhoods:C4_CGN_53_MORF_MYC","C4_Cancer_gene_neighborhoods","C4_CGN_53_MORF_MYC",78,-1.0506,0.37,0.6,0.7629,0.92,1,-1.0792,0.31,0.65
"GO_BP:494808_GO_0010743_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION","GO_BP","494808_GO_0010743_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION",27,-1.0504,0.39,0.56,1.551,0.029,0.34,1.3657,0.091,0.64
"REACTOME:106246_REACT_17050_FOLDING_OF_ACTIN_BY_CCT_TRIC","REACTOME","106246_REACT_17050_FOLDING_OF_ACTIN_BY_CCT_TRIC",9,-1.0504,0.4,0.58,1.5644,0.029,0.11,-1.1794,0.25,0.63
"C4_Cancer_modules:C4_CM_260_MODULE_295","C4_Cancer_modules","C4_CM_260_MODULE_295",20,-1.0503,0.37,0.5,1.2798,0.12,0.3,-1.1662,0.25,0.45
"C4_Cancer_modules:C4_CM_365_MODULE_445","C4_Cancer_modules","C4_CM_365_MODULE_445",14,-1.0503,0.39,0.5,-1.2313,0.2,0.61,-1.1433,0.3,0.47
"GO_BP:507573_GO_0045191_REGULATION_OF_ISOTYPE_SWITCHING","GO_BP","507573_GO_0045191_REGULATION_OF_ISOTYPE_SWITCHING",22,-1.0502,0.38,0.56,-1.2608,0.16,0.91,-1.1011,0.33,0.77
"C7_Immunologic_signatures:C7_ALL_1145_GSE27786_LSK_VS_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1145_GSE27786_LSK_VS_BCELL_UP",198,-1.0501,0.35,0.47,0.6502,1,1,-1.1647,0.11,0.34
"KEGG_compound:C20879_VERY_LONG_CHAIN_TRANS_2_3_DEHYDROACYL_COA","KEGG_compound","C20879_VERY_LONG_CHAIN_TRANS_2_3_DEHYDROACYL_COA",5,-1.05,0.42,0.57,1.2614,0.23,0.78,-1.5165,0.033,0.22
"WikiPathways:920978_WP1528_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART","WikiPathways","920978_WP1528_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART",24,-1.0499,0.39,0.5,0.7531,0.83,1,-0.795,0.8,0.97
"C3_TF_targets:C3_TFT_550_YRCCAKNNGNCGC_UNKNOWN","C3_TF_targets","C3_TFT_550_YRCCAKNNGNCGC_UNKNOWN",65,-1.0499,0.37,0.46,-0.8756,0.72,0.98,0.8478,0.74,1
"GO_BP:492331_GO_0007589_BODY_FLUID_SECRETION","GO_BP","492331_GO_0007589_BODY_FLUID_SECRETION",68,-1.0497,0.39,0.56,0.8699,0.72,1,1.1618,0.2,0.73
"GO_CC:490827_GO_0030126_COPI_VESICLE_COAT","GO_CC","490827_GO_0030126_COPI_VESICLE_COAT",14,-1.0497,0.41,0.66,1.4255,0.075,0.27,-0.4523,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1105_BENPORATH_ES_1","C2_Chemical_and_genetic_perturbations","C2_CGP_1105_BENPORATH_ES_1",374,-1.0497,0.37,0.49,1.0197,0.36,0.77,-1.3733,0.0043,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_628_NAKAMURA_LUNG_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_628_NAKAMURA_LUNG_CANCER",8,-1.0496,0.41,0.49,-1.2464,0.19,0.75,-1.0271,0.41,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_2851_PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2851_PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN",23,-1.0494,0.37,0.49,1.7942,0.0065,0.045,0.8474,0.7,1
"REACTOME:1127620_REACT_264030_AXIN_MISSENSE_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX","REACTOME","1127620_REACT_264030_AXIN_MISSENSE_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX",14,-1.0494,0.41,0.58,0.6532,0.92,1,-1.2767,0.18,0.54
"GO_BP:513880_GO_0060324_FACE_DEVELOPMENT","GO_BP","513880_GO_0060324_FACE_DEVELOPMENT",46,-1.0494,0.39,0.56,-0.7367,0.9,1,0.942,0.55,0.91
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_170_BIOCARTA_MITOCHONDRIA_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_170_BIOCARTA_MITOCHONDRIA_PATHWAY",21,-1.0494,0.38,0.52,-0.4797,1,1,0.7529,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1300_SMITH_TERT_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1300_SMITH_TERT_TARGETS_UP",144,-1.0492,0.38,0.49,1.3602,0.023,0.33,0.9258,0.66,1
"C7_Immunologic_signatures:C7_ALL_1467_GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP","C7_Immunologic_signatures","C7_ALL_1467_GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP",193,-1.0492,0.35,0.47,-1.0013,0.46,1,-1.1472,0.16,0.37
"C2_Chemical_and_genetic_perturbations:C2_CGP_2945_YIH_RESPONSE_TO_ARSENITE_C5","C2_Chemical_and_genetic_perturbations","C2_CGP_2945_YIH_RESPONSE_TO_ARSENITE_C5",10,-1.0492,0.4,0.49,1.0973,0.34,0.64,1.3104,0.16,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_452_GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_452_GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN",19,-1.0491,0.38,0.49,-1.2054,0.23,0.8,-1.0686,0.36,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_1276_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3","C2_Chemical_and_genetic_perturbations","C2_CGP_1276_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3",8,-1.0491,0.4,0.49,-1.3718,0.12,0.63,-1.6027,0.031,0.24
"GO_BP:512147_GO_0051256_MITOTIC_SPINDLE_MIDZONE_ASSEMBLY","GO_BP","512147_GO_0051256_MITOTIC_SPINDLE_MIDZONE_ASSEMBLY",7,-1.0491,0.42,0.56,0.9462,0.52,1,-0.7378,0.79,1
"GO_MF:509157_GO_0046965_RETINOID_X_RECEPTOR_BINDING","GO_MF","509157_GO_0046965_RETINOID_X_RECEPTOR_BINDING",16,-1.0491,0.41,0.59,0.8511,0.66,1,1.0437,0.39,0.85
"GO_BP:499063_GO_0021783_PREGANGLIONIC_PARASYMPATHETIC_FIBER_DEVELOPMENT","GO_BP","499063_GO_0021783_PREGANGLIONIC_PARASYMPATHETIC_FIBER_DEVELOPMENT",16,-1.049,0.39,0.56,-0.8242,0.68,1,1.1736,0.23,0.72
"GO_BP:505717_GO_0042590_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I","GO_BP","505717_GO_0042590_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I",79,-1.0488,0.39,0.56,1.9827,0,0.015,0.5264,1,1
"GO_BP:492338_GO_0007597_BLOOD_COAGULATION_INTRINSIC_PATHWAY","GO_BP","492338_GO_0007597_BLOOD_COAGULATION_INTRINSIC_PATHWAY",18,-1.0488,0.4,0.56,-1.1018,0.31,0.94,-0.751,0.85,1
"GO_BP:491979_GO_0007179_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY","GO_BP","491979_GO_0007179_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY",133,-1.0488,0.37,0.56,0.7986,0.91,1,1.0876,0.27,0.77
"C7_Immunologic_signatures:C7_ALL_107_GSE12366_GC_BCELL_VS_PLASMA_CELL_UP","C7_Immunologic_signatures","C7_ALL_107_GSE12366_GC_BCELL_VS_PLASMA_CELL_UP",197,-1.0487,0.36,0.47,1.0585,0.32,0.56,-1.0832,0.24,0.54
"GO_BP:493460_GO_0009267_CELLULAR_RESPONSE_TO_STARVATION","GO_BP","493460_GO_0009267_CELLULAR_RESPONSE_TO_STARVATION",136,-1.0486,0.38,0.56,0.6762,1,1,0.7232,0.99,1
"GO_BP:499278_GO_0021999_NEURAL_PLATE_ANTERIOR_POSTERIOR_REGIONALIZATION","GO_BP","499278_GO_0021999_NEURAL_PLATE_ANTERIOR_POSTERIOR_REGIONALIZATION",5,-1.0484,0.44,0.56,-0.7608,0.8,1,1.1709,0.3,0.72
"GO_BP:504514_GO_0035330_REGULATION_OF_HIPPO_SIGNALING","GO_BP","504514_GO_0035330_REGULATION_OF_HIPPO_SIGNALING",8,-1.0483,0.4,0.56,-0.9483,0.52,1,-0.6949,0.87,0.99
"GO_BP:491490_GO_0006595_POLYAMINE_METABOLIC_PROCESS","GO_BP","491490_GO_0006595_POLYAMINE_METABOLIC_PROCESS",21,-1.0483,0.4,0.56,-0.7547,0.84,1,-1.3272,0.11,0.62
"GO_MF:490363_GO_0005095_GTPASE_INHIBITOR_ACTIVITY","GO_MF","490363_GO_0005095_GTPASE_INHIBITOR_ACTIVITY",14,-1.0481,0.4,0.59,-1.1282,0.3,0.81,-1.4537,0.059,0.43
"KEGG_compound:C07572_CITALOPRAM","KEGG_compound","C07572_CITALOPRAM",5,-1.0479,0.42,0.57,-0.9428,0.54,1,-0.5887,0.93,0.97
"REACTOME:106223_REACT_12389_ENOS_ACTIVATION_AND_REGULATION","REACTOME","106223_REACT_12389_ENOS_ACTIVATION_AND_REGULATION",20,-1.0479,0.4,0.59,0.7588,0.81,1,-0.6743,0.91,1
"GO_BP:494078_GO_0009994_OOCYTE_DIFFERENTIATION","GO_BP","494078_GO_0009994_OOCYTE_DIFFERENTIATION",33,-1.0478,0.38,0.56,-1.3979,0.06,1,-1.022,0.39,0.83
"WikiPathways:198806_WP138_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY","WikiPathways","198806_WP138_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY",86,-1.0477,0.39,0.5,0.809,0.88,1,0.8061,0.85,1
"C3_TF_targets:C3_TFT_76_V_TAXCREB_02","C3_TF_targets","C3_TFT_76_V_TAXCREB_02",25,-1.0476,0.39,0.46,0.8472,0.71,1,-0.6325,0.96,1
"GO_CC:503476_GO_0034273_ATG1_UKL1_SIGNALING_COMPLEX","GO_CC","503476_GO_0034273_ATG1_UKL1_SIGNALING_COMPLEX",5,-1.0476,0.44,0.67,0.5442,0.95,1,-0.853,0.67,1
"C0_Hallmark:H_ALL_6_HALLMARK_TGF_BETA_SIGNALING","C0_Hallmark","H_ALL_6_HALLMARK_TGF_BETA_SIGNALING",54,-1.0476,0.39,0.41,-0.5839,1,1,1.4711,0.017,0.067
"REACTOME:1183600_REACT_355604_VESICLE_MEDIATED_TRANSPORT","REACTOME","1183600_REACT_355604_VESICLE_MEDIATED_TRANSPORT",237,-1.0474,0.35,0.59,1.4019,0,0.22,0.7888,0.97,1
"KEGG_compound:C00229_ACYL_CARRIER_PROTEIN_ACP_ACYL_CARRIER_PROTEIN_HOLO_ACYL_CARRIER_PROTEIN_","KEGG_compound","C00229_ACYL_CARRIER_PROTEIN_ACP_ACYL_CARRIER_PROTEIN_HOLO_ACYL_CARRIER_PROTEIN_",19,-1.0474,0.39,0.57,-0.6072,0.96,1,-0.9558,0.51,0.71
"C4_Cancer_modules:C4_CM_274_MODULE_313","C4_Cancer_modules","C4_CM_274_MODULE_313",17,-1.0473,0.39,0.51,0.8782,0.66,0.88,-1.0903,0.34,0.55
"REACTOME:187102_REACT_25271_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING","REACTOME","187102_REACT_25271_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING",33,-1.0473,0.39,0.59,1.6754,0.013,0.058,-1.4194,0.045,0.4
"GO_BP:501954_GO_0032728_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION","GO_BP","501954_GO_0032728_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION",25,-1.0471,0.39,0.56,-0.6727,0.93,1,-1.1777,0.21,0.74
"C7_Immunologic_signatures:C7_ALL_142_GSE13229_IMM_VS_INTMATURE_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_142_GSE13229_IMM_VS_INTMATURE_NKCELL_DN",199,-1.0471,0.37,0.47,0.8904,0.8,1,-1.0198,0.4,0.68
"GO_BP:514594_GO_0061046_REGULATION_OF_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS","GO_BP","514594_GO_0061046_REGULATION_OF_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS",6,-1.047,0.42,0.56,-1.3716,0.12,0.98,1.0502,0.4,0.8
"GO_BP:502119_GO_0032897_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION","GO_BP","502119_GO_0032897_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION",25,-1.0469,0.4,0.56,0.9966,0.43,0.98,-0.8128,0.76,0.98
"REACTOME:119522_REACT_19277_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE","REACTOME","119522_REACT_19277_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE",24,-1.0469,0.41,0.59,-0.922,0.59,1,-0.9477,0.53,0.91
"GO_BP:504596_GO_0035412_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS","GO_BP","504596_GO_0035412_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS",23,-1.0468,0.42,0.56,-0.7834,0.78,1,-1.5816,0.019,0.53
"GO_BP:502146_GO_0032924_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","502146_GO_0032924_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY",20,-1.0468,0.4,0.56,-0.8703,0.65,1,0.8517,0.69,0.98
"C7_Immunologic_signatures:C7_ALL_367_GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP","C7_Immunologic_signatures","C7_ALL_367_GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP",190,-1.0467,0.36,0.47,-0.9019,0.75,1,-1.0464,0.34,0.62
"C7_Immunologic_signatures:C7_ALL_1887_GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1887_GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP",200,-1.0465,0.37,0.47,1.6861,0,0.00081,2.2342,0,0
"GO_BP:493455_GO_0009262_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS","GO_BP","493455_GO_0009262_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS",35,-1.0465,0.39,0.56,1.4821,0.029,0.44,-1.4685,0.034,0.54
"C7_Immunologic_signatures:C7_ALL_1013_GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1013_GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP",195,-1.0464,0.37,0.47,0.9708,0.54,0.83,-1.4335,0.0042,0.041
"KEGG_compound:C00143_5_10_METHYLENETETRAHYDROFOLATE_6R_5_10_METHYLENETETRAHYDROFOLATE_5_10_METHYLENE_THF","KEGG_compound","C00143_5_10_METHYLENETETRAHYDROFOLATE_6R_5_10_METHYLENETETRAHYDROFOLATE_5_10_METHYLENE_THF",11,-1.0463,0.41,0.57,-0.6113,0.94,1,-0.7137,0.83,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_511_LUI_THYROID_CANCER_PAX8_PPARG_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_511_LUI_THYROID_CANCER_PAX8_PPARG_DN",45,-1.0461,0.39,0.49,2.0861,0,0.0023,-1.3463,0.077,0.4
"C7_Immunologic_signatures:C7_ALL_1533_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP","C7_Immunologic_signatures","C7_ALL_1533_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP",186,-1.046,0.36,0.47,1.0335,0.35,0.64,1.1862,0.12,0.78
"C7_Immunologic_signatures:C7_ALL_1161_GSE27786_LIN_NEG_VS_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1161_GSE27786_LIN_NEG_VS_BCELL_UP",199,-1.046,0.36,0.47,1.1637,0.089,0.29,-1.1258,0.16,0.43
"GO_CC:502870_GO_0033655_HOST_CELL_CYTOPLASM_PART","GO_CC","502870_GO_0033655_HOST_CELL_CYTOPLASM_PART",5,-1.0459,0.42,0.67,-1.0806,0.37,0.81,-0.7276,0.79,1
"C1_Positional:C1_ALL_291_CHR2Q35","C1_Positional","C1_ALL_291_CHR2Q35",53,-1.0459,0.37,0.86,-0.8129,0.82,0.99,1.1138,0.29,0.72
"KEGG_compound:C05378_BETA_D_FRUCTOSE_1_6_BISPHOSPHATE","KEGG_compound","C05378_BETA_D_FRUCTOSE_1_6_BISPHOSPHATE",8,-1.0458,0.42,0.57,-0.5641,0.97,1,0.5956,0.94,1
"GO_BP:491572_GO_0006684_SPHINGOMYELIN_METABOLIC_PROCESS","GO_BP","491572_GO_0006684_SPHINGOMYELIN_METABOLIC_PROCESS",13,-1.0458,0.4,0.56,0.6698,0.91,1,1.1071,0.32,0.76
"C4_Cancer_modules:C4_CM_279_MODULE_320","C4_Cancer_modules","C4_CM_279_MODULE_320",20,-1.0458,0.39,0.51,0.7271,0.87,1,-0.7221,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2791_SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2791_SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP",67,-1.0457,0.39,0.49,1.2591,0.11,0.43,-0.7611,0.9,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2928_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2","C2_Chemical_and_genetic_perturbations","C2_CGP_2928_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2",82,-1.0457,0.38,0.49,-1.041,0.38,0.97,-1.3325,0.05,0.4
"GO_MF:492646_GO_0008331_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY","GO_MF","492646_GO_0008331_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY",11,-1.0455,0.39,0.59,-1.2764,0.17,0.81,0.7643,0.77,1
"C1_Positional:C1_ALL_323_CHR4Q32","C1_Positional","C1_ALL_323_CHR4Q32",35,-1.0455,0.38,0.85,1.6965,0.0042,0.16,-0.9951,0.46,0.91
"GO_BP:510614_GO_0048546_DIGESTIVE_TRACT_MORPHOGENESIS","GO_BP","510614_GO_0048546_DIGESTIVE_TRACT_MORPHOGENESIS",51,-1.0455,0.41,0.56,0.9701,0.52,1,1.7858,0,0.32
"GO_BP:504803_GO_0035624_RECEPTOR_TRANSACTIVATION","GO_BP","504803_GO_0035624_RECEPTOR_TRANSACTIVATION",5,-1.0453,0.44,0.56,-1.089,0.39,0.95,-0.5744,0.95,1
"GO_BP:1184587_GO_1904063_NEGATIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT","GO_BP","1184587_GO_1904063_NEGATIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT",44,-1.0452,0.39,0.56,-0.7408,0.9,1,-1.1755,0.21,0.73
"C7_Immunologic_signatures:C7_ALL_671_GSE17721_POLYIC_VS_GARDIQUIMOD_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_671_GSE17721_POLYIC_VS_GARDIQUIMOD_0_5H_BMDM_UP",191,-1.0452,0.37,0.48,1.0894,0.23,0.47,-1.239,0.055,0.21
"C4_Cancer_gene_neighborhoods:C4_CGN_111_MORF_IFNA1","C4_Cancer_gene_neighborhoods","C4_CGN_111_MORF_IFNA1",196,-1.0451,0.37,0.61,-0.9904,0.46,0.87,1.2559,0.064,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_449_GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_449_GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP",26,-1.045,0.39,0.5,0.8692,0.64,0.95,1.231,0.18,0.74
"REACTOME:119565_REACT_19275_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS","REACTOME","119565_REACT_19275_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS",5,-1.0448,0.43,0.59,-0.9496,0.55,1,1.206,0.27,0.82
"C7_Immunologic_signatures:C7_ALL_1734_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1734_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN",196,-1.0447,0.37,0.48,1.4481,0.0024,0.023,-0.87,0.81,0.99
"OMIM_gene:OMIM188830_PROTEIN_KINASE_CAMP_DEPENDENT_REGULATORY_TYPE_I_ALPHA_PRKAR1A","OMIM_gene","OMIM188830_PROTEIN_KINASE_CAMP_DEPENDENT_REGULATORY_TYPE_I_ALPHA_PRKAR1A",6,-1.0447,0.44,0.79,-1.0577,0.4,0.81,0.6432,0.9,1
"C7_Immunologic_signatures:C7_ALL_680_GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_680_GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDM_DN",198,-1.0447,0.38,0.48,1.0965,0.23,0.45,-0.7994,0.95,1
"OMIM_gene:OMIM603881_NUCLEAR_RECEPTOR_SUBFAMILY_1_GROUP_I_MEMBER_3_NR1I3","OMIM_gene","OMIM603881_NUCLEAR_RECEPTOR_SUBFAMILY_1_GROUP_I_MEMBER_3_NR1I3",6,-1.0445,0.42,0.77,-1.0568,0.4,0.78,0.6471,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3120_PILON_KLF1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3120_PILON_KLF1_TARGETS_UP",494,-1.0444,0.36,0.5,1.3256,0.0056,0.37,0.9312,0.74,1
"GO_BP:510842_GO_0048791_CALCIUM_ION_DEPENDENT_EXOCYTOSIS_OF_NEUROTRANSMITTER","GO_BP","510842_GO_0048791_CALCIUM_ION_DEPENDENT_EXOCYTOSIS_OF_NEUROTRANSMITTER",33,-1.0443,0.39,0.56,0.9802,0.48,1,-1.3146,0.091,0.64
"REACTOME:105656_REACT_964_INTRINSIC_PATHWAY_FOR_APOPTOSIS","REACTOME","105656_REACT_964_INTRINSIC_PATHWAY_FOR_APOPTOSIS",38,-1.0443,0.39,0.59,0.8632,0.68,0.94,-0.8003,0.82,1
"KEGG_compound:C16680_ALL_TRANS_5_6_EPOXYRETINOIC_ACID_ALL_TRANS_5_6_EPOXY_5_6_DIHYDRORETINOIC_ACID","KEGG_compound","C16680_ALL_TRANS_5_6_EPOXYRETINOIC_ACID_ALL_TRANS_5_6_EPOXY_5_6_DIHYDRORETINOIC_ACID",5,-1.0442,0.44,0.57,-1.3711,0.12,0.51,1.1946,0.29,0.57
"C6_Oncogenic_signatures:C6_ALL_120_NRL_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_120_NRL_DN_V1_UP",127,-1.0442,0.38,0.43,-1.2972,0.059,0.37,-1.1456,0.16,0.45
"GO_CC:501223_GO_0031985_GOLGI_CISTERNA","GO_CC","501223_GO_0031985_GOLGI_CISTERNA",92,-1.0441,0.37,0.67,0.8664,0.77,0.91,0.6502,0.99,1
"GO_BP:506410_GO_0043371_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION","GO_BP","506410_GO_0043371_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION",9,-1.0439,0.42,0.57,-1.0394,0.4,0.98,0.5325,0.98,1
"C1_Positional:C1_ALL_105_CHR5P14","C1_Positional","C1_ALL_105_CHR5P14",15,-1.0438,0.39,0.85,-0.8829,0.61,1,1.3522,0.12,0.43
"GO_BP:517280_GO_0072364_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS_BY_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER","GO_BP","517280_GO_0072364_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS_BY_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER",7,-1.0438,0.42,0.57,-0.93,0.56,1,-0.9556,0.51,0.89
"C7_Immunologic_signatures:C7_ALL_168_GSE13411_NAIVE_VS_MEMORY_BCELL_DN","C7_Immunologic_signatures","C7_ALL_168_GSE13411_NAIVE_VS_MEMORY_BCELL_DN",197,-1.0437,0.37,0.48,1.309,0.026,0.094,-1.0638,0.31,0.58
"GO_BP:493397_GO_0009201_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493397_GO_0009201_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",70,-1.0437,0.4,0.57,1.1897,0.16,0.79,-0.9252,0.6,0.91
"GO_BP:486799_GO_0000281_MITOTIC_CYTOKINESIS","GO_BP","486799_GO_0000281_MITOTIC_CYTOKINESIS",28,-1.0436,0.41,0.57,0.7722,0.81,1,0.6686,0.95,1
"OMIM_gene:OMIM602783_SPG7_GENE_SPG7","OMIM_gene","OMIM602783_SPG7_GENE_SPG7",6,-1.0436,0.44,0.75,-1.0763,0.37,0.86,0.6423,0.88,1
"REACTOME:1127615_REACT_264621_TRUNCATED_APC_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX","REACTOME","1127615_REACT_264621_TRUNCATED_APC_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX",14,-1.0435,0.41,0.59,0.6543,0.92,1,-1.2408,0.19,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_494_ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_494_ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP",59,-1.0435,0.4,0.5,-0.9542,0.56,1,0.8685,0.71,1
"WikiPathways:198876_WP404_NUCLEOTIDE_METABOLISM","WikiPathways","198876_WP404_NUCLEOTIDE_METABOLISM",20,-1.0434,0.39,0.5,0.9174,0.57,1,-1.0426,0.38,0.63
"GO_BP:489285_GO_0006334_NUCLEOSOME_ASSEMBLY","GO_BP","489285_GO_0006334_NUCLEOSOME_ASSEMBLY",129,-1.0433,0.39,0.57,-1.169,0.15,0.91,-1.537,0.0022,0.53
"GO_BP:496016_GO_0015893_DRUG_TRANSPORT","GO_BP","496016_GO_0015893_DRUG_TRANSPORT",24,-1.0433,0.41,0.57,-1.2507,0.18,0.91,-0.9902,0.46,0.86
"GO_BP:504224_GO_0035036_SPERM_EGG_RECOGNITION","GO_BP","504224_GO_0035036_SPERM_EGG_RECOGNITION",43,-1.0433,0.39,0.57,-0.9682,0.52,1,0.9058,0.62,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_1050_FUJIWARA_PARK2_IN_LIVER_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1050_FUJIWARA_PARK2_IN_LIVER_CANCER_DN",5,-1.0432,0.43,0.5,-1.59,0.032,0.43,1.24,0.22,0.76
"C4_Cancer_gene_neighborhoods:C4_CGN_141_MORF_PDCD1","C4_Cancer_gene_neighborhoods","C4_CGN_141_MORF_PDCD1",69,-1.0431,0.39,0.61,1.0455,0.37,0.47,1.624,0.0062,0.12
"GO_BP:492366_GO_0007625_GROOMING_BEHAVIOR","GO_BP","492366_GO_0007625_GROOMING_BEHAVIOR",13,-1.0431,0.42,0.57,0.8572,0.67,1,-0.7061,0.85,0.99
"KEGG_compound:C00036_OXALOACETATE_OXALACETIC_ACID_OXALOACETIC_ACID_2_OXOBUTANEDIOIC_ACID_2_OXOSUCCINIC_ACID_KETO_OXALOACETATE","KEGG_compound","C00036_OXALOACETATE_OXALACETIC_ACID_OXALOACETIC_ACID_2_OXOBUTANEDIOIC_ACID_2_OXOSUCCINIC_ACID_KETO_OXALOACETATE",12,-1.0431,0.43,0.57,0.8336,0.71,1,-1.2346,0.2,0.42
"GO_BP:494676_GO_0010612_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION","GO_BP","494676_GO_0010612_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION",5,-1.043,0.44,0.57,-1.1166,0.35,0.94,-1.3184,0.17,0.63
"REACTOME:1183565_REACT_355069_FRS_MEDIATED_FGFR2_SIGNALING","REACTOME","1183565_REACT_355069_FRS_MEDIATED_FGFR2_SIGNALING",32,-1.043,0.39,0.59,-0.752,0.85,1,-0.8658,0.68,0.97
"GO_BP:494939_GO_0010875_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX","GO_BP","494939_GO_0010875_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX",13,-1.043,0.43,0.57,0.7407,0.83,1,0.8276,0.69,1
"C1_Positional:C1_ALL_167_CHR15Q22","C1_Positional","C1_ALL_167_CHR15Q22",81,-1.043,0.4,0.84,1.045,0.35,0.7,-1.4004,0.027,0.56
"GO_BP:518559_GO_0097009_ENERGY_HOMEOSTASIS","GO_BP","518559_GO_0097009_ENERGY_HOMEOSTASIS",8,-1.0429,0.4,0.57,-0.6986,0.86,1,-0.8886,0.57,0.93
"C7_Immunologic_signatures:C7_ALL_33_GSE10239_NAIVE_VS_DAY4_5_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_33_GSE10239_NAIVE_VS_DAY4_5_EFF_CD8_TCELL_UP",199,-1.0428,0.37,0.48,1.4314,0,0.028,-0.9834,0.51,0.76
"C4_Cancer_modules:C4_CM_131_MODULE_136","C4_Cancer_modules","C4_CM_131_MODULE_136",483,-1.0427,0.36,0.51,0.8886,0.91,0.87,-0.9132,0.81,0.84
"GO_BP:488933_GO_0003139_SECONDARY_HEART_FIELD_SPECIFICATION","GO_BP","488933_GO_0003139_SECONDARY_HEART_FIELD_SPECIFICATION",8,-1.0427,0.4,0.57,-0.7752,0.76,1,1.088,0.36,0.77
"C7_Immunologic_signatures:C7_ALL_1898_GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1898_GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN",200,-1.0425,0.36,0.48,1.2863,0.057,0.11,0.8334,0.9,1
"C7_Immunologic_signatures:C7_ALL_675_GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_675_GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDM_UP",199,-1.0425,0.39,0.48,1.0774,0.27,0.51,-0.7648,0.99,1
"C7_Immunologic_signatures:C7_ALL_370_GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN","C7_Immunologic_signatures","C7_ALL_370_GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN",195,-1.0425,0.38,0.48,0.9372,0.66,0.94,0.8714,0.83,1
"C7_Immunologic_signatures:C7_ALL_134_GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN","C7_Immunologic_signatures","C7_ALL_134_GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN",200,-1.0424,0.37,0.48,1.8071,0,2.8e-05,-0.732,1,1
"GO_BP:511980_GO_0051055_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS","GO_BP","511980_GO_0051055_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS",41,-1.0424,0.39,0.57,0.835,0.74,1,-0.7792,0.86,1
"GO_MF:495507_GO_0015245_FATTY_ACID_TRANSPORTER_ACTIVITY","GO_MF","495507_GO_0015245_FATTY_ACID_TRANSPORTER_ACTIVITY",8,-1.0422,0.42,0.6,1.0566,0.38,0.83,1.2076,0.24,0.71
"C7_Immunologic_signatures:C7_ALL_632_GSE17721_POLYIC_VS_CPG_16H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_632_GSE17721_POLYIC_VS_CPG_16H_BMDM_DN",199,-1.0421,0.39,0.48,1.4607,0.0023,0.02,-0.9287,0.66,0.89
"C3_TF_targets:C3_TFT_5_V_CMYB_01","C3_TF_targets","C3_TFT_5_V_CMYB_01",247,-1.042,0.39,0.47,-1.051,0.3,0.64,0.6469,1,1
"REACTOME:106372_REACT_18302_LEUKOTRIENE_RECEPTORS","REACTOME","106372_REACT_18302_LEUKOTRIENE_RECEPTORS",5,-1.0419,0.44,0.59,-0.7506,0.77,1,-0.884,0.62,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1425_COLLER_MYC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1425_COLLER_MYC_TARGETS_DN",9,-1.0419,0.42,0.5,-0.7694,0.8,1,0.6484,0.9,1
"GO_BP:518667_GO_2000018_REGULATION_OF_MALE_GONAD_DEVELOPMENT","GO_BP","518667_GO_2000018_REGULATION_OF_MALE_GONAD_DEVELOPMENT",10,-1.0418,0.43,0.57,-1.2774,0.2,0.89,1.5375,0.039,0.52
"C3_MicroRNA_targets:C3_MIR_13_CTCTAGA_MIR_526C_MIR_518F_MIR_526A","C3_MicroRNA_targets","C3_MIR_13_CTCTAGA_MIR_526C_MIR_518F_MIR_526A",58,-1.0417,0.4,0.56,-0.8181,0.8,1,-1.1209,0.24,1
"C4_Cancer_modules:C4_CM_249_MODULE_281","C4_Cancer_modules","C4_CM_249_MODULE_281",28,-1.0417,0.41,0.51,1.3986,0.064,0.19,1.3355,0.1,0.41
"GO_MF:498672_GO_0019894_KINESIN_BINDING","GO_MF","498672_GO_0019894_KINESIN_BINDING",32,-1.0415,0.4,0.6,-1.5299,0.027,0.53,-0.998,0.45,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_1001_FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1001_FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN",95,-1.0415,0.39,0.5,0.8126,0.89,0.98,-0.979,0.49,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_1323_WILLERT_WNT_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_1323_WILLERT_WNT_SIGNALING",21,-1.0414,0.39,0.5,1.419,0.066,0.28,1.1691,0.25,0.8
"KEGG_module:HSA_M00104_BILE_ACID_BIOSYNTHESIS_CHOLESTEROL_CHOLATE_CHENODEOXYCHOLATE","KEGG_module","HSA_M00104_BILE_ACID_BIOSYNTHESIS_CHOLESTEROL_CHOLATE_CHENODEOXYCHOLATE",12,-1.0414,0.4,0.75,0.9451,0.51,0.91,-0.8611,0.66,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1245_ZEILSTRA_CD44_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1245_ZEILSTRA_CD44_TARGETS_UP",7,-1.0414,0.42,0.5,1.3338,0.15,0.36,1.3873,0.12,0.54
"REACTOME:576275_REACT_118607_SIGNALING_BY_HIPPO","REACTOME","576275_REACT_118607_SIGNALING_BY_HIPPO",20,-1.0412,0.38,0.59,0.681,0.91,1,-0.5688,0.98,1
"C7_Immunologic_signatures:C7_ALL_1258_GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1258_GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN",182,-1.0411,0.38,0.48,1.0684,0.28,0.53,1.0647,0.3,1
"GO_MF:496671_GO_0016758_TRANSFERASE_ACTIVITY_TRANSFERRING_HEXOSYL_GROUPS","GO_MF","496671_GO_0016758_TRANSFERASE_ACTIVITY_TRANSFERRING_HEXOSYL_GROUPS",196,-1.041,0.36,0.6,1.1787,0.11,0.73,0.8742,0.82,0.97
"C7_Immunologic_signatures:C7_ALL_1047_GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP","C7_Immunologic_signatures","C7_ALL_1047_GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP",198,-1.0409,0.39,0.48,1.2475,0.057,0.16,-1.182,0.12,0.32
"GO_BP:492014_GO_0007216_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","492014_GO_0007216_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY",13,-1.0409,0.41,0.57,-1.0136,0.43,0.98,1.7178,0.0082,0.41
"KEGG_module:HSA_M00688_MAPK_JNK_SIGNALING","KEGG_module","HSA_M00688_MAPK_JNK_SIGNALING",21,-1.0407,0.41,0.73,-1.4827,0.062,0.68,-1.6306,0.016,0.24
"C7_Immunologic_signatures:C7_ALL_1629_GSE3982_DC_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1629_GSE3982_DC_VS_NEUTROPHIL_UP",200,-1.0407,0.39,0.48,1.4714,0.0024,0.017,-1.3278,0.013,0.11
"GO_BP:514577_GO_0061029_EYELID_DEVELOPMENT_IN_CAMERA_TYPE_EYE","GO_BP","514577_GO_0061029_EYELID_DEVELOPMENT_IN_CAMERA_TYPE_EYE",11,-1.0406,0.4,0.57,0.9064,0.59,1,0.7792,0.76,1
"GO_BP:512438_GO_0051560_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS","GO_BP","512438_GO_0051560_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS",15,-1.0405,0.41,0.57,0.7567,0.81,1,0.9532,0.52,0.9
"KEGG_enzyme:1.14.14.1_UNSPECIFIC_MONOOXYGENASE_MICROSOMAL_MONOOXYGENASE_XENOBIOTIC_MONOOXYGENASE_ARYL_4_MONOOXYGENASE_ARYL_HYDROCARBON_HYDROXYLASE_MICROSOMAL_P_450_FLAVOPROTEIN_LINKED_MONOOXYGENASE_FLAVOPROTEIN_MONOOXYGENASE","KEGG_enzyme","1.14.14.1_UNSPECIFIC_MONOOXYGENASE_MICROSOMAL_MONOOXYGENASE_XENOBIOTIC_MONOOXYGENASE_ARYL_4_MONOOXYGENASE_ARYL_HYDROCARBON_HYDROXYLASE_MICROSOMAL_P_450_FLAVOPROTEIN_LINKED_MONOOXYGENASE_FLAVOPROTEIN_MONOOXYGENASE",21,-1.0404,0.4,0.54,-1.6818,0.0077,0.068,1.3593,0.1,0.47
"GO_BP:492264_GO_0007512_ADULT_HEART_DEVELOPMENT","GO_BP","492264_GO_0007512_ADULT_HEART_DEVELOPMENT",15,-1.0404,0.41,0.57,-1.7505,0.011,0.58,1.5532,0.03,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_1234_TCGA_GLIOBLASTOMA_COPY_NUMBER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1234_TCGA_GLIOBLASTOMA_COPY_NUMBER_DN",29,-1.0404,0.38,0.5,-0.527,0.99,1,-1.1457,0.25,0.58
"GO_BP:512015_GO_0051101_REGULATION_OF_DNA_BINDING","GO_BP","512015_GO_0051101_REGULATION_OF_DNA_BINDING",81,-1.0403,0.39,0.57,1.5526,0.0066,0.34,0.8279,0.84,1
"GO_BP:513692_GO_0060134_PREPULSE_INHIBITION","GO_BP","513692_GO_0060134_PREPULSE_INHIBITION",12,-1.0402,0.43,0.57,1.3873,0.11,0.57,1.3626,0.12,0.64
"GO_BP:505688_GO_0042558_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","505688_GO_0042558_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",32,-1.0402,0.4,0.57,0.703,0.93,1,-0.9239,0.57,0.91
"GO_BP:491106_GO_0045454_CELL_REDOX_HOMEOSTASIS","GO_BP","491106_GO_0045454_CELL_REDOX_HOMEOSTASIS",61,-1.0401,0.4,0.57,1.1196,0.25,0.88,-0.9058,0.65,0.92
"C7_Immunologic_signatures:C7_ALL_1626_GSE3982_MAST_CELL_VS_TH2_DN","C7_Immunologic_signatures","C7_ALL_1626_GSE3982_MAST_CELL_VS_TH2_DN",198,-1.0401,0.36,0.48,1.1136,0.21,0.41,-1.1843,0.09,0.31
"GO_BP:492885_GO_0008637_APOPTOTIC_MITOCHONDRIAL_CHANGES","GO_BP","492885_GO_0008637_APOPTOTIC_MITOCHONDRIAL_CHANGES",62,-1.0401,0.4,0.57,1.2509,0.13,0.73,-1.1146,0.28,0.76
"C4_Cancer_modules:C4_CM_418_MODULE_544","C4_Cancer_modules","C4_CM_418_MODULE_544",85,-1.0399,0.39,0.52,1.0249,0.39,0.68,-0.8417,0.82,0.95
"GO_MF:489766_GO_0004407_HISTONE_DEACETYLASE_ACTIVITY","GO_MF","489766_GO_0004407_HISTONE_DEACETYLASE_ACTIVITY",25,-1.0399,0.42,0.6,-1.2816,0.15,0.8,-1.6894,0.0097,0.31
"GO_BP:519067_GO_2000427_POSITIVE_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE","GO_BP","519067_GO_2000427_POSITIVE_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE",7,-1.0398,0.44,0.57,-1.196,0.26,0.89,1.1886,0.27,0.72
"GO_BP:510658_GO_0048599_OOCYTE_DEVELOPMENT","GO_BP","510658_GO_0048599_OOCYTE_DEVELOPMENT",31,-1.0397,0.4,0.57,-1.3899,0.062,1,-1.1839,0.21,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1224_NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_1224_NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER",92,-1.0397,0.39,0.5,-1.0498,0.36,0.97,-0.8924,0.71,0.89
"GO_BP:517098_GO_0072182_REGULATION_OF_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","517098_GO_0072182_REGULATION_OF_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION",14,-1.0396,0.43,0.57,-0.7666,0.78,1,-0.9453,0.53,0.89
"GO_BP:499605_GO_0030195_NEGATIVE_REGULATION_OF_BLOOD_COAGULATION","GO_BP","499605_GO_0030195_NEGATIVE_REGULATION_OF_BLOOD_COAGULATION",43,-1.0395,0.4,0.57,1.329,0.067,0.63,1.5934,0.012,0.44
"GO_BP:502341_GO_0033120_POSITIVE_REGULATION_OF_RNA_SPLICING","GO_BP","502341_GO_0033120_POSITIVE_REGULATION_OF_RNA_SPLICING",25,-1.0395,0.4,0.57,-0.8703,0.67,1,-1.0623,0.37,0.8
"REACTOME:771602_REACT_160205_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS","REACTOME","771602_REACT_160205_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS",21,-1.0394,0.4,0.6,0.8939,0.61,0.91,-1.4803,0.04,0.38
"GO_BP:507971_GO_0045623_NEGATIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION","GO_BP","507971_GO_0045623_NEGATIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION",9,-1.0393,0.42,0.57,-1.0258,0.43,0.97,0.5102,0.99,1
"GO_BP:514034_GO_0060479_LUNG_CELL_DIFFERENTIATION","GO_BP","514034_GO_0060479_LUNG_CELL_DIFFERENTIATION",27,-1.0392,0.4,0.57,0.9205,0.58,1,1.2658,0.15,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_323_MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_323_MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN",12,-1.0391,0.4,0.51,-0.8395,0.66,1,0.8895,0.62,1
"GO_BP:488565_GO_0002692_NEGATIVE_REGULATION_OF_CELLULAR_EXTRAVASATION","GO_BP","488565_GO_0002692_NEGATIVE_REGULATION_OF_CELLULAR_EXTRAVASATION",5,-1.0391,0.41,0.57,-1.2252,0.25,0.88,-0.8511,0.65,0.96
"REACTOME:106222_REACT_12508_METABOLISM_OF_NITRIC_OXIDE","REACTOME","106222_REACT_12508_METABOLISM_OF_NITRIC_OXIDE",20,-1.0389,0.39,0.6,0.7637,0.81,1,-0.6915,0.9,1
"GO_BP:982482_GO_1902914_REGULATION_OF_PROTEIN_POLYUBIQUITINATION","GO_BP","982482_GO_1902914_REGULATION_OF_PROTEIN_POLYUBIQUITINATION",8,-1.0388,0.43,0.57,-0.6123,0.93,1,-0.5834,0.95,1
"OMIM_gene:OMIM604896_MKKS_GENE_MKKS","OMIM_gene","OMIM604896_MKKS_GENE_MKKS",5,-1.0388,0.44,0.74,0.7182,0.82,1,-0.7076,0.82,1
"GO_MF:495320_GO_0015020_GLUCURONOSYLTRANSFERASE_ACTIVITY","GO_MF","495320_GO_0015020_GLUCURONOSYLTRANSFERASE_ACTIVITY",34,-1.0387,0.41,0.6,1.4041,0.058,0.49,1.497,0.038,0.43
"REACTOME:1127621_REACT_264511_AMER1_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX","REACTOME","1127621_REACT_264511_AMER1_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX",14,-1.0387,0.4,0.6,0.6567,0.91,1,-1.2585,0.17,0.55
"GO_BP:495144_GO_0014072_RESPONSE_TO_ISOQUINOLINE_ALKALOID","GO_BP","495144_GO_0014072_RESPONSE_TO_ISOQUINOLINE_ALKALOID",30,-1.0387,0.42,0.57,-0.9896,0.48,1,0.6978,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2963_GERHOLD_RESPONSE_TO_TZD_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2963_GERHOLD_RESPONSE_TO_TZD_UP",6,-1.0385,0.43,0.51,-1.0826,0.37,0.94,0.8404,0.67,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_852_DAIRKEE_TERT_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_852_DAIRKEE_TERT_TARGETS_UP",374,-1.0384,0.39,0.51,1.6369,0,0.12,-0.7355,1,0.98
"C7_Immunologic_signatures:C7_ALL_1797_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1797_GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP",191,-1.0383,0.4,0.49,-0.9474,0.59,1,0.9407,0.6,1
"GO_BP:493569_GO_0009396_FOLIC_ACID_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","493569_GO_0009396_FOLIC_ACID_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",10,-1.0383,0.42,0.57,-0.6823,0.86,1,-0.9141,0.57,0.92
"GO_BP:488119_GO_0002246_WOUND_HEALING_INVOLVED_IN_INFLAMMATORY_RESPONSE","GO_BP","488119_GO_0002246_WOUND_HEALING_INVOLVED_IN_INFLAMMATORY_RESPONSE",6,-1.0383,0.46,0.57,0.845,0.63,1,1.3035,0.17,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_1507_ZHAN_MULTIPLE_MYELOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1507_ZHAN_MULTIPLE_MYELOMA_UP",64,-1.0381,0.4,0.51,0.8254,0.81,0.98,-0.9818,0.47,0.78
"GO_MF:494921_GO_0010857_CALCIUM_DEPENDENT_PROTEIN_KINASE_ACTIVITY","GO_MF","494921_GO_0010857_CALCIUM_DEPENDENT_PROTEIN_KINASE_ACTIVITY",10,-1.0381,0.43,0.6,-1.0434,0.41,0.87,-0.7022,0.84,1
"C1_Positional:C1_ALL_143_CHR6Q","C1_Positional","C1_ALL_143_CHR6Q",5,-1.0379,0.43,0.85,1.4974,0.061,0.28,-0.9398,0.53,0.97
"GO_BP:499624_GO_0030214_HYALURONAN_CATABOLIC_PROCESS","GO_BP","499624_GO_0030214_HYALURONAN_CATABOLIC_PROCESS",15,-1.0379,0.4,0.57,-1.1681,0.26,0.91,0.8601,0.65,0.97
"C7_Immunologic_signatures:C7_ALL_610_GSE17721_LPS_VS_PAM3CSK4_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_610_GSE17721_LPS_VS_PAM3CSK4_8H_BMDM_DN",197,-1.0378,0.4,0.49,1.6871,0,8e-04,-0.8376,0.89,1
"GO_BP:517432_GO_0072527_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","517432_GO_0072527_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",76,-1.0378,0.39,0.57,0.9403,0.59,1,-1.174,0.19,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_621_BAKER_HEMATOPOESIS_STAT1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_621_BAKER_HEMATOPOESIS_STAT1_TARGETS",10,-1.0377,0.42,0.51,0.815,0.73,0.98,-0.6207,0.94,0.99
"GO_BP:519335_GO_2000696_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT","GO_BP","519335_GO_2000696_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",16,-1.0375,0.43,0.57,-0.749,0.82,1,-0.9655,0.5,0.88
"WikiPathways:198857_WP205_IL_7_SIGNALING_PATHWAY","WikiPathways","198857_WP205_IL_7_SIGNALING_PATHWAY",44,-1.0375,0.41,0.51,0.7114,0.93,1,-0.761,0.87,0.95
"GO_MF:501683_GO_0032451_DEMETHYLASE_ACTIVITY","GO_MF","501683_GO_0032451_DEMETHYLASE_ACTIVITY",41,-1.0375,0.41,0.6,-1.403,0.044,0.64,-0.9724,0.52,0.8
"GO_BP:498804_GO_0021520_SPINAL_CORD_MOTOR_NEURON_CELL_FATE_SPECIFICATION","GO_BP","498804_GO_0021520_SPINAL_CORD_MOTOR_NEURON_CELL_FATE_SPECIFICATION",11,-1.0375,0.42,0.57,0.9904,0.5,0.99,1.4534,0.071,0.58
"C3_MicroRNA_targets:C3_MIR_92_AGGCACT_MIR_515_3P","C3_MicroRNA_targets","C3_MIR_92_AGGCACT_MIR_515_3P",88,-1.0374,0.4,0.57,-0.7454,0.94,1,0.6676,0.99,1
"GO_BP:1133934_GO_0098773_SKIN_EPIDERMIS_DEVELOPMENT","GO_BP","1133934_GO_0098773_SKIN_EPIDERMIS_DEVELOPMENT",73,-1.0373,0.38,0.57,0.8453,0.82,1,0.9932,0.45,0.86
"GO_BP:511886_GO_0050951_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS","GO_BP","511886_GO_0050951_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS",17,-1.0372,0.42,0.57,-1.2287,0.21,0.89,-0.9061,0.59,0.92
"GO_CC:499690_GO_0030286_DYNEIN_COMPLEX","GO_CC","499690_GO_0030286_DYNEIN_COMPLEX",40,-1.0372,0.4,0.69,-1.1632,0.22,0.68,-0.5562,1,1
"GO_BP:750987_GO_0036065_FUCOSYLATION","GO_BP","750987_GO_0036065_FUCOSYLATION",25,-1.0371,0.4,0.57,0.7056,0.89,1,-0.8021,0.76,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2271_SMID_BREAST_CANCER_ERBB2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2271_SMID_BREAST_CANCER_ERBB2_DN",5,-1.0371,0.45,0.51,0.9666,0.5,0.84,-1.1143,0.35,0.61
"REACTOME:1127617_REACT_263992_APC_TRUNCATION_MUTANTS_HAVE_IMPAIRED_AXIN_BINDING","REACTOME","1127617_REACT_263992_APC_TRUNCATION_MUTANTS_HAVE_IMPAIRED_AXIN_BINDING",14,-1.0369,0.41,0.6,0.6593,0.91,1,-1.2742,0.17,0.55
"GO_BP:506316_GO_0043249_ERYTHROCYTE_MATURATION","GO_BP","506316_GO_0043249_ERYTHROCYTE_MATURATION",12,-1.0369,0.42,0.57,0.9102,0.57,1,-1.4253,0.08,0.57
"GO_BP:501262_GO_0032025_RESPONSE_TO_COBALT_ION","GO_BP","501262_GO_0032025_RESPONSE_TO_COBALT_ION",6,-1.0368,0.43,0.57,0.7043,0.85,1,-0.9215,0.54,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1480_GUO_HEX_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1480_GUO_HEX_TARGETS_DN",63,-1.0368,0.41,0.51,1.7322,0.0046,0.067,0.755,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1887_DAZARD_RESPONSE_TO_UV_NHEK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1887_DAZARD_RESPONSE_TO_UV_NHEK_DN",317,-1.0367,0.39,0.51,-0.6102,1,1,0.8411,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_200_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_200_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN",25,-1.0363,0.41,0.51,1.2589,0.15,0.43,0.949,0.54,1
"GO_BP:488739_GO_0002866_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS","GO_BP","488739_GO_0002866_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS",7,-1.0362,0.44,0.58,-0.6646,0.87,1,-0.7054,0.83,0.99
"GO_BP:505024_GO_0035855_MEGAKARYOCYTE_DEVELOPMENT","GO_BP","505024_GO_0035855_MEGAKARYOCYTE_DEVELOPMENT",15,-1.0362,0.4,0.58,0.9613,0.49,1,-0.8386,0.68,0.97
"GO_BP:513872_GO_0060316_POSITIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY","GO_BP","513872_GO_0060316_POSITIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY",10,-1.0361,0.42,0.58,0.8996,0.59,1,1.3546,0.13,0.64
"GO_BP:499612_GO_0030202_HEPARIN_METABOLIC_PROCESS","GO_BP","499612_GO_0030202_HEPARIN_METABOLIC_PROCESS",8,-1.0361,0.45,0.58,0.8134,0.69,1,-0.8937,0.58,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_3191_BILANGES_RAPAMYCIN_SENSITIVE_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_3191_BILANGES_RAPAMYCIN_SENSITIVE_GENES",39,-1.0361,0.4,0.51,1.9047,0,0.019,-0.8186,0.8,0.94
"GO_BP:494934_GO_0010870_POSITIVE_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS","GO_BP","494934_GO_0010870_POSITIVE_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS",11,-1.036,0.41,0.58,0.6357,0.91,1,0.9496,0.51,0.9
"C4_Cancer_modules:C4_CM_25_MODULE_26","C4_Cancer_modules","C4_CM_25_MODULE_26",202,-1.036,0.39,0.52,-0.7113,1,1,0.8595,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1992_BILD_MYC_ONCOGENIC_SIGNATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_1992_BILD_MYC_ONCOGENIC_SIGNATURE",204,-1.0359,0.4,0.51,-1.157,0.12,0.84,-1.2869,0.034,0.44
"GO_BP:492118_GO_0009880_EMBRYONIC_PATTERN_SPECIFICATION","GO_BP","492118_GO_0009880_EMBRYONIC_PATTERN_SPECIFICATION",66,-1.0359,0.4,0.58,-0.7751,0.88,1,0.9765,0.5,0.88
"C7_Immunologic_signatures:C7_ALL_936_GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_936_GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN",198,-1.0359,0.4,0.5,1.3617,0.0071,0.056,1.0999,0.2,0.98
"GO_BP:500157_GO_0030859_POLARIZED_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","500157_GO_0030859_POLARIZED_EPITHELIAL_CELL_DIFFERENTIATION",9,-1.0358,0.42,0.58,0.6228,0.92,1,0.647,0.92,1
"C7_Immunologic_signatures:C7_ALL_1179_GSE27786_BCELL_VS_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1179_GSE27786_BCELL_VS_CD8_TCELL_UP",199,-1.0358,0.38,0.5,-0.7659,0.98,1,-0.9503,0.59,0.85
"GO_BP:508030_GO_0045685_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION","GO_BP","508030_GO_0045685_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION",51,-1.0357,0.41,0.58,0.7905,0.86,1,1.297,0.078,0.67
"GO_BP:508157_GO_0045836_POSITIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION","GO_BP","508157_GO_0045836_POSITIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION",13,-1.0356,0.42,0.58,1.048,0.4,0.95,-0.9127,0.56,0.92
"GO_BP:491871_GO_0007044_CELL_SUBSTRATE_JUNCTION_ASSEMBLY","GO_BP","491871_GO_0007044_CELL_SUBSTRATE_JUNCTION_ASSEMBLY",39,-1.0356,0.4,0.58,-0.7579,0.85,1,1.2661,0.13,0.69
"C7_Immunologic_signatures:C7_ALL_1342_GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1342_GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN",199,-1.0356,0.39,0.5,1.4903,0.0026,0.014,0.8342,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_638_SEIDEN_ONCOGENESIS_BY_MET","C2_Chemical_and_genetic_perturbations","C2_CGP_638_SEIDEN_ONCOGENESIS_BY_MET",88,-1.0356,0.41,0.51,1.9634,0,0.01,-1.2104,0.13,0.51
"GO_BP:505649_GO_0042518_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN","GO_BP","505649_GO_0042518_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT3_PROTEIN",5,-1.0356,0.45,0.58,-0.6079,0.91,1,-1.0047,0.49,0.84
"GO_BP:491649_GO_0006776_VITAMIN_A_METABOLIC_PROCESS","GO_BP","491649_GO_0006776_VITAMIN_A_METABOLIC_PROCESS",8,-1.0355,0.43,0.58,1.1726,0.26,0.81,1.2719,0.2,0.69
"C7_Immunologic_signatures:C7_ALL_1363_GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1363_GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP",191,-1.0353,0.39,0.5,-1.0798,0.28,1,0.9795,0.5,1
"C3_TF_targets:C3_TFT_31_V_NMYC_01","C3_TF_targets","C3_TFT_31_V_NMYC_01",269,-1.0353,0.39,0.49,1.0555,0.3,1,-1.0746,0.25,0.6
"GO_MF:490036_GO_0004722_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY","GO_MF","490036_GO_0004722_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY",53,-1.0353,0.41,0.61,0.942,0.54,0.94,-1.393,0.057,0.51
"C3_TF_targets:C3_TFT_181_V_TATA_01","C3_TF_targets","C3_TFT_181_V_TATA_01",234,-1.0352,0.37,0.49,-1.0476,0.32,0.65,-1.1838,0.086,0.37
"C2_Chemical_and_genetic_perturbations:C2_CGP_1216_NIKOLSKY_BREAST_CANCER_19P13_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1216_NIKOLSKY_BREAST_CANCER_19P13_AMPLICON",5,-1.0351,0.44,0.51,-0.8176,0.69,1,-1.3769,0.12,0.38
"C6_Oncogenic_signatures:C6_ALL_131_RPS14_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_131_RPS14_DN_V1_DN",183,-1.035,0.38,0.45,-0.828,0.89,0.96,-1.4342,0.0022,0.15
"GO_CC:505714_GO_0042587_GLYCOGEN_GRANULE","GO_CC","505714_GO_0042587_GLYCOGEN_GRANULE",6,-1.0349,0.43,0.69,0.9199,0.55,0.87,0.9432,0.51,1
"C1_Positional:C1_ALL_35_CHR12Q14","C1_Positional","C1_ALL_35_CHR12Q14",41,-1.0349,0.41,0.85,0.9163,0.64,0.84,0.9128,0.61,0.84
"GO_BP:506285_GO_0043217_MYELIN_MAINTENANCE","GO_BP","506285_GO_0043217_MYELIN_MAINTENANCE",12,-1.0349,0.44,0.58,0.7373,0.81,1,-0.7182,0.86,0.99
"GO_BP:487857_GO_0001967_SUCKLING_BEHAVIOR","GO_BP","487857_GO_0001967_SUCKLING_BEHAVIOR",14,-1.0348,0.42,0.58,-0.7402,0.81,1,0.5454,0.97,1
"C7_Immunologic_signatures:C7_ALL_1570_GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1570_GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN",194,-1.0348,0.39,0.5,-1.0859,0.24,1,-0.7574,0.99,1
"GO_CC:849733_GO_0036379_MYOFILAMENT","GO_CC","849733_GO_0036379_MYOFILAMENT",25,-1.0347,0.4,0.69,-1.2786,0.12,0.66,-1.3355,0.1,0.61
"C1_Positional:C1_ALL_290_CHR7Q34","C1_Positional","C1_ALL_290_CHR7Q34",50,-1.0347,0.4,0.85,-0.9013,0.64,1,-1.0193,0.43,0.86
"GO_BP:517007_GO_0072091_REGULATION_OF_STEM_CELL_PROLIFERATION","GO_BP","517007_GO_0072091_REGULATION_OF_STEM_CELL_PROLIFERATION",89,-1.0346,0.39,0.58,1.0056,0.45,0.98,1.3673,0.043,0.64
"C7_Immunologic_signatures:C7_ALL_652_GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_652_GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDM_DN",196,-1.0346,0.38,0.5,1.1866,0.1,0.25,-0.8093,0.95,1
"GO_MF:495399_GO_0015125_BILE_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495399_GO_0015125_BILE_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",9,-1.0346,0.41,0.61,-1.8607,0.0038,0.15,1.2225,0.21,0.7
"GO_MF:495543_GO_0015299_SOLUTE_PROTON_ANTIPORTER_ACTIVITY","GO_MF","495543_GO_0015299_SOLUTE_PROTON_ANTIPORTER_ACTIVITY",16,-1.0345,0.42,0.61,-0.9202,0.55,0.96,1.0161,0.43,0.85
"GO_MF:486607_GO_0000062_FATTY_ACYL_COA_BINDING","GO_MF","486607_GO_0000062_FATTY_ACYL_COA_BINDING",18,-1.0341,0.43,0.61,0.6427,0.94,1,-1.3571,0.12,0.53
"C7_Immunologic_signatures:C7_ALL_1908_GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN","C7_Immunologic_signatures","C7_ALL_1908_GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN",198,-1.0341,0.4,0.5,1.0377,0.33,0.62,0.8266,0.9,1
"REACTOME:119554_REACT_19358_CD28_DEPENDENT_PI3K_AKT_SIGNALING","REACTOME","119554_REACT_19358_CD28_DEPENDENT_PI3K_AKT_SIGNALING",21,-1.034,0.4,0.6,0.6072,0.99,1,-0.8838,0.63,0.97
"GO_BP:502235_GO_0033013_TETRAPYRROLE_METABOLIC_PROCESS","GO_BP","502235_GO_0033013_TETRAPYRROLE_METABOLIC_PROCESS",59,-1.0339,0.43,0.58,1.3414,0.074,0.62,-1.0772,0.31,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1883_WHITESIDE_CISPLATIN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1883_WHITESIDE_CISPLATIN_RESISTANCE_DN",12,-1.0339,0.44,0.51,1.9074,0.002,0.018,-0.576,0.97,0.99
"GO_BP:492547_GO_0008206_BILE_ACID_METABOLIC_PROCESS","GO_BP","492547_GO_0008206_BILE_ACID_METABOLIC_PROCESS",38,-1.0338,0.4,0.58,1.1086,0.3,0.89,1.2377,0.13,0.7
"GO_MF:511930_GO_0050997_QUATERNARY_AMMONIUM_GROUP_BINDING","GO_MF","511930_GO_0050997_QUATERNARY_AMMONIUM_GROUP_BINDING",34,-1.0337,0.41,0.61,-1.7598,0.0054,0.23,0.8878,0.64,0.97
"C7_Immunologic_signatures:C7_ALL_563_GSE17721_PAM3CSK4_VS_CPG_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_563_GSE17721_PAM3CSK4_VS_CPG_0_5H_BMDM_UP",199,-1.0337,0.41,0.5,-0.9441,0.59,1,-0.9294,0.66,0.89
"GO_MF:498053_GO_0019198_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY","GO_MF","498053_GO_0019198_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY",17,-1.0335,0.44,0.61,1.423,0.062,0.47,-0.6526,0.92,1
"GO_CC:490818_GO_0005790_SMOOTH_ENDOPLASMIC_RETICULUM","GO_CC","490818_GO_0005790_SMOOTH_ENDOPLASMIC_RETICULUM",30,-1.0335,0.41,0.69,1.0466,0.37,0.72,0.9279,0.55,1
"C7_Immunologic_signatures:C7_ALL_541_GSE17721_LPS_VS_POLYIC_16H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_541_GSE17721_LPS_VS_POLYIC_16H_BMDM_UP",198,-1.0335,0.41,0.5,1.525,0,0.0089,0.7192,0.99,1
"REACTOME:106055_REACT_15443_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS","REACTOME","106055_REACT_15443_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS",15,-1.0334,0.42,0.6,1.8767,0,0.01,1.0597,0.37,0.97
"REACTOME:771575_REACT_160111_UBIQUINOL_BIOSYNTHESIS","REACTOME","771575_REACT_160111_UBIQUINOL_BIOSYNTHESIS",7,-1.0334,0.43,0.6,-0.7468,0.75,1,0.8696,0.62,1
"GO_BP:515356_GO_0070424_REGULATION_OF_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_SIGNALING_PATHWAY","GO_BP","515356_GO_0070424_REGULATION_OF_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_SIGNALING_PATHWAY",6,-1.0332,0.42,0.58,0.4763,0.99,1,0.6808,0.88,1
"GO_BP:508114_GO_0045777_POSITIVE_REGULATION_OF_BLOOD_PRESSURE","GO_BP","508114_GO_0045777_POSITIVE_REGULATION_OF_BLOOD_PRESSURE",37,-1.0332,0.41,0.58,1.3506,0.092,0.61,1.1311,0.24,0.74
"GO_MF:496609_GO_0016679_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS","GO_MF","496609_GO_0016679_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS",9,-1.0332,0.41,0.61,1.2639,0.18,0.65,-0.8637,0.6,0.91
"C1_Positional:C1_ALL_77_CHR3Q24","C1_Positional","C1_ALL_77_CHR3Q24",17,-1.0332,0.43,0.85,0.9588,0.51,0.81,-0.8365,0.69,1
"GO_BP:507939_GO_0045591_POSITIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION","GO_BP","507939_GO_0045591_POSITIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION",6,-1.0331,0.45,0.58,-0.743,0.81,1,-1.3525,0.13,0.6
"C7_Immunologic_signatures:C7_ALL_1369_GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1369_GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP",198,-1.0331,0.39,0.5,1.0407,0.35,0.61,-0.9733,0.54,0.79
"REACTOME:1127618_REACT_264496_AXIN_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX_ACTIVATING_WNT_SIGNALING","REACTOME","1127618_REACT_264496_AXIN_MUTANTS_DESTABILIZE_THE_DESTRUCTION_COMPLEX_ACTIVATING_WNT_SIGNALING",14,-1.0331,0.42,0.6,0.6412,0.91,1,-1.2648,0.18,0.54
"C4_Cancer_gene_neighborhoods:C4_CGN_119_MORF_JAK3","C4_Cancer_gene_neighborhoods","C4_CGN_119_MORF_JAK3",93,-1.033,0.4,0.63,-1.0404,0.37,0.81,-1.2191,0.12,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_42_FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_42_FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN",6,-1.033,0.41,0.52,-0.5122,0.98,1,1.2753,0.2,0.68
"GO_CC:506286_GO_0043218_COMPACT_MYELIN","GO_CC","506286_GO_0043218_COMPACT_MYELIN",16,-1.033,0.42,0.69,0.9659,0.48,0.83,0.9634,0.51,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3320_FOSTER_KDM1A_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3320_FOSTER_KDM1A_TARGETS_DN",209,-1.0329,0.4,0.52,-0.8696,0.81,1,-1.4309,0.008,0.34
"C0_Hallmark:H_ALL_47_HALLMARK_SPERMATOGENESIS","C0_Hallmark","H_ALL_47_HALLMARK_SPERMATOGENESIS",132,-1.0328,0.41,0.43,-1.072,0.32,0.86,-1.3115,0.036,0.11
"GO_MF:512115_GO_0051219_PHOSPHOPROTEIN_BINDING","GO_MF","512115_GO_0051219_PHOSPHOPROTEIN_BINDING",50,-1.0327,0.42,0.61,1.2277,0.14,0.7,-0.7786,0.87,0.97
"GO_BP:513737_GO_0060180_FEMALE_MATING_BEHAVIOR","GO_BP","513737_GO_0060180_FEMALE_MATING_BEHAVIOR",9,-1.0326,0.43,0.58,0.6659,0.9,1,-1.3616,0.12,0.6
"GO_BP:515187_GO_0070252_ACTIN_MEDIATED_CELL_CONTRACTION","GO_BP","515187_GO_0070252_ACTIN_MEDIATED_CELL_CONTRACTION",46,-1.0325,0.4,0.58,-1.025,0.42,0.97,-1.0152,0.44,0.83
"GO_BP:512226_GO_0051342_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY","GO_BP","512226_GO_0051342_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY",8,-1.0325,0.44,0.58,1.0318,0.43,0.97,-0.8733,0.61,0.95
"GO_BP:487508_GO_0001570_VASCULOGENESIS","GO_BP","487508_GO_0001570_VASCULOGENESIS",64,-1.0324,0.43,0.58,0.821,0.84,1,1.3924,0.044,0.63
"REACTOME:1127518_REACT_264034_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE","REACTOME","1127518_REACT_264034_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE",31,-1.0324,0.42,0.6,-0.4851,1,1,-0.8499,0.67,0.99
"C7_Immunologic_signatures:C7_ALL_887_GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP","C7_Immunologic_signatures","C7_ALL_887_GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP",192,-1.0323,0.4,0.5,-1.3407,0.025,0.37,-1.0592,0.31,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_1188_COLLIS_PRKDC_SUBSTRATES","C2_Chemical_and_genetic_perturbations","C2_CGP_1188_COLLIS_PRKDC_SUBSTRATES",19,-1.0322,0.42,0.52,-0.8767,0.63,1,-1.0215,0.44,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_691_MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA","C2_Chemical_and_genetic_perturbations","C2_CGP_691_MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA",16,-1.0322,0.41,0.52,0.3584,1,1,-1.1154,0.3,0.61
"GO_MF:492488_GO_0008131_PRIMARY_AMINE_OXIDASE_ACTIVITY","GO_MF","492488_GO_0008131_PRIMARY_AMINE_OXIDASE_ACTIVITY",6,-1.0322,0.46,0.61,-1.2036,0.28,0.81,-1.1764,0.26,0.6
"GO_CC:507222_GO_0044215_OTHER_ORGANISM","GO_CC","507222_GO_0044215_OTHER_ORGANISM",12,-1.0321,0.45,0.69,-1.3746,0.11,0.62,1.2041,0.22,0.83
"GO_BP:1184426_GO_1903900_REGULATION_OF_VIRAL_LIFE_CYCLE","GO_BP","1184426_GO_1903900_REGULATION_OF_VIRAL_LIFE_CYCLE",175,-1.0321,0.39,0.58,1.688,0,0.21,-1.0787,0.26,0.8
"GO_BP:495880_GO_0015749_MONOSACCHARIDE_TRANSPORT","GO_BP","495880_GO_0015749_MONOSACCHARIDE_TRANSPORT",74,-1.032,0.4,0.58,0.8737,0.75,1,0.7295,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_428_GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_428_GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN",229,-1.032,0.4,0.52,-0.9706,0.55,1,-1.1863,0.094,0.53
"GO_CC:515022_GO_0070083_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE_MEMBRANE","GO_CC","515022_GO_0070083_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE_MEMBRANE",5,-1.0319,0.48,0.69,-0.7036,0.83,1,-1.4687,0.056,0.55
"GO_MF:496676_GO_0016763_TRANSFERASE_ACTIVITY_TRANSFERRING_PENTOSYL_GROUPS","GO_MF","496676_GO_0016763_TRANSFERASE_ACTIVITY_TRANSFERRING_PENTOSYL_GROUPS",50,-1.0318,0.41,0.61,-0.604,0.99,1,-1.355,0.076,0.52
"REACTOME:1127623_REACT_263893_TRUNCATIONS_OF_AMER1_DESTABILIZE_THE_DESTRUCTION_COMPLEX","REACTOME","1127623_REACT_263893_TRUNCATIONS_OF_AMER1_DESTABILIZE_THE_DESTRUCTION_COMPLEX",14,-1.0318,0.45,0.6,0.6496,0.91,1,-1.2496,0.17,0.56
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_186_BIOCARTA_SPRY_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_186_BIOCARTA_SPRY_PATHWAY",18,-1.0317,0.42,0.55,-0.9272,0.56,1,0.8074,0.73,1
"C7_Immunologic_signatures:C7_ALL_756_GSE17721_0_5H_VS_4H_GARDIQUIMOD_BMDM_DN","C7_Immunologic_signatures","C7_ALL_756_GSE17721_0_5H_VS_4H_GARDIQUIMOD_BMDM_DN",198,-1.0316,0.41,0.5,1.0774,0.25,0.51,-0.8231,0.92,1
"GO_BP:494289_GO_0010212_RESPONSE_TO_IONIZING_RADIATION","GO_BP","494289_GO_0010212_RESPONSE_TO_IONIZING_RADIATION",125,-1.0316,0.4,0.58,0.9119,0.63,1,-1.0136,0.42,0.84
"GO_BP:488880_GO_0003084_POSITIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE","GO_BP","488880_GO_0003084_POSITIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE",15,-1.0316,0.42,0.58,1.0386,0.39,0.96,-1.0037,0.44,0.85
"KEGG_compound:C00067_FORMALDEHYDE_METHANAL_OXOMETHANE_OXOMETHYLENE_METHYLENE_OXIDE_FORMALIN","KEGG_compound","C00067_FORMALDEHYDE_METHANAL_OXOMETHANE_OXOMETHYLENE_METHYLENE_OXIDE_FORMALIN",12,-1.0316,0.44,0.59,-1.2192,0.22,0.76,-0.9335,0.54,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2452_BEIER_GLIOMA_STEM_CELL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2452_BEIER_GLIOMA_STEM_CELL_UP",37,-1.0316,0.42,0.52,0.7458,0.88,1,1.0693,0.35,0.89
"GO_BP:488955_GO_0003161_CARDIAC_CONDUCTION_SYSTEM_DEVELOPMENT","GO_BP","488955_GO_0003161_CARDIAC_CONDUCTION_SYSTEM_DEVELOPMENT",14,-1.0315,0.42,0.58,0.7143,0.86,1,-1.1547,0.27,0.74
"GO_CC:499594_GO_0030176_INTEGRAL_COMPONENT_OF_ENDOPLASMIC_RETICULUM_MEMBRANE","GO_CC","499594_GO_0030176_INTEGRAL_COMPONENT_OF_ENDOPLASMIC_RETICULUM_MEMBRANE",113,-1.0313,0.41,0.69,0.886,0.75,0.91,-1.0943,0.24,0.92
"C1_Positional:C1_ALL_308_CHR6Q12","C1_Positional","C1_ALL_308_CHR6Q12",16,-1.0313,0.43,0.84,-0.7692,0.78,0.96,-0.7813,0.79,1
"GO_BP:1184543_GO_1904019_EPITHELIAL_CELL_APOPTOTIC_PROCESS","GO_BP","1184543_GO_1904019_EPITHELIAL_CELL_APOPTOTIC_PROCESS",22,-1.0313,0.41,0.58,1.0213,0.44,0.97,0.7911,0.76,1
"GO_BP:777516_GO_0044772_MITOTIC_CELL_CYCLE_PHASE_TRANSITION","GO_BP","777516_GO_0044772_MITOTIC_CELL_CYCLE_PHASE_TRANSITION",295,-1.0312,0.39,0.58,1.1156,0.13,0.88,-1.4833,0,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2852_CAIRO_HEPATOBLASTOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2852_CAIRO_HEPATOBLASTOMA_UP",207,-1.0311,0.41,0.52,1.1199,0.18,0.6,-1.0098,0.41,0.74
"C7_Immunologic_signatures:C7_ALL_110_GSE12366_GC_VS_NAIVE_BCELL_DN","C7_Immunologic_signatures","C7_ALL_110_GSE12366_GC_VS_NAIVE_BCELL_DN",196,-1.031,0.4,0.5,0.8938,0.78,1,-0.9655,0.55,0.81
"C1_Positional:C1_ALL_129_CHR7P14","C1_Positional","C1_ALL_129_CHR7P14",47,-1.031,0.42,0.84,0.9752,0.51,0.79,-1.3159,0.072,0.48
"C3_TF_targets:C3_TFT_578_RGTTAMWNATT_V_HNF1_01","C3_TF_targets","C3_TFT_578_RGTTAMWNATT_V_HNF1_01",70,-1.0309,0.42,0.5,0.9624,0.53,1,0.9701,0.51,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2227_MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2227_MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP",18,-1.0308,0.43,0.52,1.5382,0.039,0.18,-1.0962,0.34,0.63
"GO_CC:487104_GO_0000813_ESCRT_I_COMPLEX","GO_CC","487104_GO_0000813_ESCRT_I_COMPLEX",9,-1.0308,0.42,0.69,1.1384,0.3,0.6,-0.628,0.9,1
"KEGG_module:HSA_M00095_C5_ISOPRENOID_BIOSYNTHESIS_MEVALONATE_PATHWAY","KEGG_module","HSA_M00095_C5_ISOPRENOID_BIOSYNTHESIS_MEVALONATE_PATHWAY",10,-1.0307,0.43,0.73,-0.9281,0.54,1,-0.8286,0.68,0.9
"REACTOME:106044_REACT_2202_EFFECTS_OF_PIP2_HYDROLYSIS","REACTOME","106044_REACT_2202_EFFECTS_OF_PIP2_HYDROLYSIS",25,-1.0307,0.41,0.61,-1.5953,0.019,0.33,-1.4617,0.045,0.37
"REACTOME:119544_REACT_19241_REGULATION_OF_LIPID_METABOLISM_BY_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_ALPHA_PPARALPHA_","REACTOME","119544_REACT_19241_REGULATION_OF_LIPID_METABOLISM_BY_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_ALPHA_PPARALPHA_",114,-1.0305,0.41,0.6,-0.7112,0.98,1,0.9603,0.53,1
"C4_Cancer_modules:C4_CM_371_MODULE_455","C4_Cancer_modules","C4_CM_371_MODULE_455",37,-1.0303,0.42,0.53,0.7135,0.92,1,0.568,0.99,1
"KEGG_compound:C00026_2_OXOGLUTARATE_OXOGLUTARIC_ACID_2_KETOGLUTARIC_ACID_ALPHA_KETOGLUTARIC_ACID","KEGG_compound","C00026_2_OXOGLUTARATE_OXOGLUTARIC_ACID_2_KETOGLUTARIC_ACID_ALPHA_KETOGLUTARIC_ACID",42,-1.0303,0.41,0.59,-0.9347,0.56,1,-1.4943,0.025,0.23
"GO_BP:494592_GO_0010523_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL","GO_BP","494592_GO_0010523_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL",9,-1.0302,0.43,0.58,-1.2401,0.19,0.91,-1.4194,0.095,0.57
"GO_BP:506942_GO_0043922_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION","GO_BP","506942_GO_0043922_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION",13,-1.0301,0.43,0.58,0.7852,0.75,1,-0.5596,0.97,1
"GO_MF:507697_GO_0045340_MERCURY_ION_BINDING","GO_MF","507697_GO_0045340_MERCURY_ION_BINDING",5,-1.0301,0.44,0.61,1.1652,0.32,0.73,-0.978,0.51,0.8
"KEGG_compound:C00631_2_PHOSPHO_D_GLYCERATE_D_GLYCERATE_2_PHOSPHATE_2_PHOSPHO_R_GLYCERATE","KEGG_compound","C00631_2_PHOSPHO_D_GLYCERATE_D_GLYCERATE_2_PHOSPHATE_2_PHOSPHO_R_GLYCERATE",8,-1.03,0.43,0.58,-0.759,0.77,1,0.6349,0.92,1
"C3_TF_targets:C3_TFT_157_V_SREBP1_02","C3_TF_targets","C3_TFT_157_V_SREBP1_02",87,-1.03,0.42,0.5,-0.8774,0.72,0.98,-0.798,0.86,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_12_BIOCARTA_ALK_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_12_BIOCARTA_ALK_PATHWAY",36,-1.03,0.43,0.55,-0.8923,0.65,1,1.1769,0.22,1
"GO_BP:494885_GO_0010821_REGULATION_OF_MITOCHONDRION_ORGANIZATION","GO_BP","494885_GO_0010821_REGULATION_OF_MITOCHONDRION_ORGANIZATION",302,-1.0298,0.41,0.58,1.2041,0.043,0.78,0.8074,0.98,1
"C3_TF_targets:C3_TFT_85_V_PBX1_02","C3_TF_targets","C3_TFT_85_V_PBX1_02",125,-1.0298,0.42,0.5,0.7679,0.96,1,-0.8646,0.8,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2673_ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2673_ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN",15,-1.0296,0.43,0.52,0.731,0.85,1,-0.9032,0.61,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_806_DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_806_DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN",483,-1.0295,0.4,0.52,-0.5747,1,1,-1.1245,0.11,0.6
"C4_Cancer_modules:C4_CM_421_MODULE_552","C4_Cancer_modules","C4_CM_421_MODULE_552",18,-1.0295,0.44,0.53,-0.7339,0.84,1,-1.5271,0.055,0.14
"C4_Cancer_modules:C4_CM_307_MODULE_356","C4_Cancer_modules","C4_CM_307_MODULE_356",146,-1.0294,0.4,0.53,0.9149,0.73,0.82,-1.0441,0.35,0.62
"GO_BP:754133_GO_1901166_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT","GO_BP","754133_GO_1901166_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT",5,-1.0294,0.46,0.59,1.3653,0.15,0.6,1.4795,0.051,0.58
"C4_Cancer_modules:C4_CM_374_MODULE_458","C4_Cancer_modules","C4_CM_374_MODULE_458",36,-1.0292,0.42,0.53,-1.2015,0.17,0.62,-1.5939,0.012,0.13
"C2_Chemical_and_genetic_perturbations:C2_CGP_2821_PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2821_PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP",56,-1.0291,0.43,0.52,1.2513,0.12,0.44,-1.5516,0.0075,0.27
"GO_BP:492016_GO_0007218_NEUROPEPTIDE_SIGNALING_PATHWAY","GO_BP","492016_GO_0007218_NEUROPEPTIDE_SIGNALING_PATHWAY",80,-1.0291,0.42,0.59,-0.9895,0.48,1,1.7048,0.0039,0.42
"GO_BP:754301_GO_1901339_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY","GO_BP","754301_GO_1901339_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY",6,-1.0291,0.44,0.59,-0.6785,0.85,1,-0.664,0.86,1
"C4_Cancer_modules:C4_CM_68_MODULE_72","C4_Cancer_modules","C4_CM_68_MODULE_72",306,-1.0288,0.41,0.53,1.202,0.064,0.39,-0.961,0.58,0.75
"GO_BP:491432_GO_0006536_GLUTAMATE_METABOLIC_PROCESS","GO_BP","491432_GO_0006536_GLUTAMATE_METABOLIC_PROCESS",21,-1.0287,0.41,0.59,0.7572,0.83,1,-1.1744,0.21,0.73
"GO_BP:510872_GO_0048821_ERYTHROCYTE_DEVELOPMENT","GO_BP","510872_GO_0048821_ERYTHROCYTE_DEVELOPMENT",27,-1.0287,0.43,0.59,1.396,0.086,0.56,-1.1802,0.23,0.73
"C4_Cancer_gene_neighborhoods:C4_CGN_243_GCM_MSN","C4_Cancer_gene_neighborhoods","C4_CGN_243_GCM_MSN",28,-1.0285,0.43,0.64,1.5112,0.021,0.029,-0.7318,0.89,1
"GO_BP:499135_GO_0021855_HYPOTHALAMUS_CELL_MIGRATION","GO_BP","499135_GO_0021855_HYPOTHALAMUS_CELL_MIGRATION",5,-1.0284,0.45,0.59,1.3311,0.17,0.63,1.4401,0.076,0.59
"KEGG_compound:C01134_PANTETHEINE_4_PHOSPHATE_4_PHOSPHOPANTETHEINE_PHOSPHOPANTETHEINE_D_PANTETHEINE_4_PHOSPHATE","KEGG_compound","C01134_PANTETHEINE_4_PHOSPHATE_4_PHOSPHOPANTETHEINE_PHOSPHOPANTETHEINE_D_PANTETHEINE_4_PHOSPHATE",9,-1.0283,0.41,0.59,-0.597,0.93,1,-0.7614,0.75,0.88
"C3_MicroRNA_targets:C3_MIR_113_AATGGAG_MIR_136","C3_MicroRNA_targets","C3_MIR_113_AATGGAG_MIR_136",79,-1.0282,0.42,0.59,0.7775,0.9,1,-0.9285,0.61,1
"C6_Oncogenic_signatures:C6_ALL_186_KRAS_PROSTATE_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_186_KRAS_PROSTATE_UP_V1_DN",134,-1.0281,0.42,0.46,1.1785,0.13,0.42,-1.0286,0.35,0.6
"REACTOME:1127533_REACT_267785_SIGNALING_BY_RETINOIC_ACID","REACTOME","1127533_REACT_267785_SIGNALING_BY_RETINOIC_ACID",40,-1.028,0.4,0.61,-1.328,0.081,0.61,0.8446,0.77,1
"KEGG_compound:C00670_SN_GLYCERO_3_PHOSPHOCHOLINE_GLYCEROPHOSPHOCHOLINE","KEGG_compound","C00670_SN_GLYCERO_3_PHOSPHOCHOLINE_GLYCEROPHOSPHOCHOLINE",8,-1.0278,0.42,0.59,-0.889,0.59,1,0.8165,0.7,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_896_WANG_RESPONSE_TO_BEXAROTENE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_896_WANG_RESPONSE_TO_BEXAROTENE_UP",33,-1.0278,0.42,0.52,1.1759,0.24,0.53,-1.1041,0.3,0.62
"C7_Immunologic_signatures:C7_ALL_820_GSE17974_0_5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_820_GSE17974_0_5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN",198,-1.0277,0.41,0.51,0.9339,0.65,0.94,-1.4538,0.0042,0.033
"REACTOME:530749_REACT_116145_PPARA_ACTIVATES_GENE_EXPRESSION","REACTOME","530749_REACT_116145_PPARA_ACTIVATES_GENE_EXPRESSION",111,-1.0277,0.4,0.61,-0.6628,0.99,1,0.9813,0.5,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3343_HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3343_HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP",38,-1.0275,0.42,0.52,0.7366,0.91,1,-0.8693,0.7,0.91
"C7_Immunologic_signatures:C7_ALL_552_GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_552_GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDM_DN",198,-1.0274,0.43,0.51,0.9377,0.63,0.94,0.7461,0.99,1
"GO_MF:489888_GO_0004551_NUCLEOTIDE_DIPHOSPHATASE_ACTIVITY","GO_MF","489888_GO_0004551_NUCLEOTIDE_DIPHOSPHATASE_ACTIVITY",9,-1.0274,0.42,0.62,1.0852,0.35,0.81,-0.9844,0.48,0.79
"GO_BP:777514_GO_0044770_CELL_CYCLE_PHASE_TRANSITION","GO_BP","777514_GO_0044770_CELL_CYCLE_PHASE_TRANSITION",300,-1.0274,0.42,0.59,1.1198,0.15,0.88,-1.5137,0.0021,0.53
"C7_Immunologic_signatures:C7_ALL_959_GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP","C7_Immunologic_signatures","C7_ALL_959_GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP",200,-1.0274,0.41,0.51,1.7437,0,0.00034,-1.3231,0.019,0.12
"C3_TF_targets:C3_TFT_474_V_PR_01","C3_TF_targets","C3_TFT_474_V_PR_01",140,-1.0273,0.41,0.51,0.948,0.57,1,-0.6952,0.99,1
"GO_BP:755365_GO_2001259_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY","GO_BP","755365_GO_2001259_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY",31,-1.0273,0.42,0.59,-0.6516,0.94,1,1.3824,0.069,0.64
"GO_BP:491727_GO_0006862_NUCLEOTIDE_TRANSPORT","GO_BP","491727_GO_0006862_NUCLEOTIDE_TRANSPORT",21,-1.0272,0.43,0.59,-0.8599,0.69,1,-1.0783,0.34,0.79
"GO_BP:510889_GO_0048839_INNER_EAR_DEVELOPMENT","GO_BP","510889_GO_0048839_INNER_EAR_DEVELOPMENT",172,-1.0272,0.4,0.59,1.0107,0.39,0.98,1.4569,0.008,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_707_SCHLOSSER_SERUM_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_707_SCHLOSSER_SERUM_RESPONSE_UP",131,-1.0272,0.41,0.52,-1.275,0.068,0.71,-1.1299,0.19,0.59
"REACTOME:576269_REACT_118859_SIGNALING_BY_NOTCH1","REACTOME","576269_REACT_118859_SIGNALING_BY_NOTCH1",73,-1.027,0.42,0.61,-0.7173,0.96,1,-1.0256,0.38,0.8
"GO_CC:504863_GO_0035686_SPERM_FIBROUS_SHEATH","GO_CC","504863_GO_0035686_SPERM_FIBROUS_SHEATH",10,-1.0269,0.44,0.7,-1.4746,0.076,0.61,-1.3027,0.16,0.63
"GO_BP:499860_GO_0030521_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","499860_GO_0030521_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY",41,-1.0269,0.42,0.59,-0.9769,0.48,1,-0.7719,0.86,1
"GO_BP:491057_GO_0006072_GLYCEROL_3_PHOSPHATE_METABOLIC_PROCESS","GO_BP","491057_GO_0006072_GLYCEROL_3_PHOSPHATE_METABOLIC_PROCESS",6,-1.0267,0.42,0.59,1.3295,0.14,0.63,-0.9733,0.51,0.88
"REACTOME:106446_REACT_13526_NADE_MODULATES_DEATH_SIGNALLING","REACTOME","106446_REACT_13526_NADE_MODULATES_DEATH_SIGNALLING",6,-1.0266,0.45,0.61,0.5025,0.98,1,0.7471,0.8,1
"C7_Immunologic_signatures:C7_ALL_724_GSE17721_0_5H_VS_24H_POLYIC_BMDM_DN","C7_Immunologic_signatures","C7_ALL_724_GSE17721_0_5H_VS_24H_POLYIC_BMDM_DN",196,-1.0266,0.42,0.52,0.8008,0.95,1,0.7295,1,1
"C7_Immunologic_signatures:C7_ALL_30_GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_30_GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN",200,-1.0265,0.4,0.51,1.1376,0.14,0.34,-1.2602,0.044,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_2293_WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2293_WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN",37,-1.0265,0.43,0.53,-1.4406,0.061,0.53,-1.1843,0.22,0.53
"GO_BP:519375_GO_2000736_REGULATION_OF_STEM_CELL_DIFFERENTIATION","GO_BP","519375_GO_2000736_REGULATION_OF_STEM_CELL_DIFFERENTIATION",100,-1.0262,0.42,0.59,-0.9823,0.5,1,0.9248,0.62,0.92
"GO_MF:511311_GO_0050321_TAU_PROTEIN_KINASE_ACTIVITY","GO_MF","511311_GO_0050321_TAU_PROTEIN_KINASE_ACTIVITY",12,-1.0262,0.42,0.62,-0.9528,0.51,0.95,-1.5057,0.052,0.41
"GO_MF:489895_GO_0004559_ALPHA_MANNOSIDASE_ACTIVITY","GO_MF","489895_GO_0004559_ALPHA_MANNOSIDASE_ACTIVITY",14,-1.0262,0.41,0.62,-0.3804,1,1,-1.3187,0.13,0.56
"C7_Immunologic_signatures:C7_ALL_428_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN","C7_Immunologic_signatures","C7_ALL_428_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN",195,-1.0262,0.41,0.52,1.4081,0.0047,0.035,1.0815,0.25,1
"GO_BP:493339_GO_0009142_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493339_GO_0009142_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",81,-1.0262,0.41,0.59,1.1586,0.19,0.83,-0.9299,0.62,0.9
"C7_Immunologic_signatures:C7_ALL_667_GSE17721_LPS_VS_CPG_16H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_667_GSE17721_LPS_VS_CPG_16H_BMDM_UP",195,-1.0259,0.42,0.52,0.9458,0.59,0.91,-1.159,0.14,0.35
"GO_BP:488775_GO_0002902_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS","GO_BP","488775_GO_0002902_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS",18,-1.0258,0.44,0.59,0.4903,1,1,-0.936,0.55,0.9
"C3_TF_targets:C3_TFT_303_V_STAT1_03","C3_TF_targets","C3_TFT_303_V_STAT1_03",244,-1.0258,0.4,0.51,-0.8942,0.78,0.97,-0.8845,0.8,0.95
"GO_BP:500260_GO_0030968_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE","GO_BP","500260_GO_0030968_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE",100,-1.0258,0.41,0.59,0.7085,0.97,1,-0.9472,0.56,0.89
"GO_BP:518696_GO_2000047_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN","GO_BP","518696_GO_2000047_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN",10,-1.0257,0.43,0.59,1.3572,0.16,0.6,1.6434,0.026,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_875_CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_875_CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN",38,-1.0256,0.41,0.53,0.8896,0.63,0.94,-1.0589,0.34,0.68
"GO_BP:488313_GO_0002440_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE","GO_BP","488313_GO_0002440_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE",64,-1.0256,0.42,0.59,0.65,1,1,-1.3,0.074,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_695_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5","C2_Chemical_and_genetic_perturbations","C2_CGP_695_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5",5,-1.0256,0.43,0.53,-1.034,0.44,0.97,-1.2437,0.2,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_2986_NIELSEN_GIST","C2_Chemical_and_genetic_perturbations","C2_CGP_2986_NIELSEN_GIST",96,-1.0255,0.41,0.53,-0.7861,0.92,1,-0.7039,0.98,0.98
"C7_Immunologic_signatures:C7_ALL_272_GSE14308_INDUCED_VS_NATURAL_TREG_DN","C7_Immunologic_signatures","C7_ALL_272_GSE14308_INDUCED_VS_NATURAL_TREG_DN",199,-1.0255,0.41,0.52,0.9628,0.6,0.86,-0.7896,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_264_PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_264_PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN",43,-1.0255,0.43,0.53,-0.9957,0.45,1,-1.0308,0.4,0.71
"GO_BP:512647_GO_0051775_RESPONSE_TO_REDOX_STATE","GO_BP","512647_GO_0051775_RESPONSE_TO_REDOX_STATE",11,-1.0254,0.44,0.59,0.8019,0.71,1,0.4537,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2989_NIELSEN_SYNOVIAL_SARCOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2989_NIELSEN_SYNOVIAL_SARCOMA_UP",18,-1.0253,0.44,0.53,-0.7327,0.84,1,0.8789,0.66,1
"C7_Immunologic_signatures:C7_ALL_145_GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP","C7_Immunologic_signatures","C7_ALL_145_GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP",200,-1.0251,0.4,0.52,0.9634,0.52,0.86,0.8287,0.91,1
"C7_Immunologic_signatures:C7_ALL_423_GSE15930_STIM_VS_STIM_AND_IL_12_72H_CD8_T_CELL_UP","C7_Immunologic_signatures","C7_ALL_423_GSE15930_STIM_VS_STIM_AND_IL_12_72H_CD8_T_CELL_UP",197,-1.0251,0.41,0.52,1.1478,0.15,0.32,-1.0544,0.31,0.6
"GO_BP:491196_GO_0006228_UTP_BIOSYNTHETIC_PROCESS","GO_BP","491196_GO_0006228_UTP_BIOSYNTHETIC_PROCESS",11,-1.025,0.42,0.59,-0.8476,0.67,1,-1.2195,0.2,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_3122_BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3122_BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP",207,-1.025,0.42,0.53,-1.1026,0.22,0.92,0.9495,0.58,1
"C7_Immunologic_signatures:C7_ALL_1186_GSE27786_BCELL_VS_ERYTHROBLAST_DN","C7_Immunologic_signatures","C7_ALL_1186_GSE27786_BCELL_VS_ERYTHROBLAST_DN",191,-1.0249,0.41,0.52,-0.9823,0.5,1,-0.9472,0.6,0.86
"GO_BP:516284_GO_0071360_CELLULAR_RESPONSE_TO_EXOGENOUS_DSRNA","GO_BP","516284_GO_0071360_CELLULAR_RESPONSE_TO_EXOGENOUS_DSRNA",8,-1.0248,0.43,0.59,1.5643,0.025,0.34,-0.9747,0.51,0.88
"GO_MF:492681_GO_0008378_GALACTOSYLTRANSFERASE_ACTIVITY","GO_MF","492681_GO_0008378_GALACTOSYLTRANSFERASE_ACTIVITY",33,-1.0247,0.43,0.62,1.048,0.39,0.83,1.1626,0.23,0.77
"GO_BP:505491_GO_0042347_NEGATIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS","GO_BP","505491_GO_0042347_NEGATIVE_REGULATION_OF_NF_KAPPAB_IMPORT_INTO_NUCLEUS",15,-1.0247,0.44,0.59,1.0443,0.39,0.95,-0.8862,0.62,0.94
"REACTOME:106059_REACT_326_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION","REACTOME","106059_REACT_326_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION",22,-1.0247,0.43,0.61,-1.0889,0.32,0.9,-0.6585,0.93,1
"GO_MF:495464_GO_0015197_PEPTIDE_TRANSPORTER_ACTIVITY","GO_MF","495464_GO_0015197_PEPTIDE_TRANSPORTER_ACTIVITY",8,-1.0247,0.45,0.62,-1.4108,0.11,0.67,-0.9354,0.52,0.85
"GO_CC:750978_GO_0036056_FILTRATION_DIAPHRAGM","GO_CC","750978_GO_0036056_FILTRATION_DIAPHRAGM",8,-1.0244,0.44,0.7,-1.4035,0.11,0.65,-1.4482,0.074,0.5
"WikiPathways:198905_WP229_IRINOTECAN_PATHWAY","WikiPathways","198905_WP229_IRINOTECAN_PATHWAY",13,-1.0241,0.44,0.53,0.5541,0.97,1,1.3377,0.14,0.47
"GO_BP:487494_GO_0001556_OOCYTE_MATURATION","GO_BP","487494_GO_0001556_OOCYTE_MATURATION",17,-1.024,0.41,0.59,-1.3004,0.15,0.89,-1.2927,0.14,0.65
"C7_Immunologic_signatures:C7_ALL_1839_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP","C7_Immunologic_signatures","C7_ALL_1839_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP",198,-1.0237,0.43,0.52,2.0961,0,0,-1.4818,0.0043,0.026
"REACTOME:106456_REACT_11064_ACTIVATION_OF_TRKA_RECEPTORS","REACTOME","106456_REACT_11064_ACTIVATION_OF_TRKA_RECEPTORS",6,-1.0237,0.47,0.61,-0.9684,0.51,1,1.2269,0.25,0.8
"GO_MF:490319_GO_0005035_DEATH_RECEPTOR_ACTIVITY","GO_MF","490319_GO_0005035_DEATH_RECEPTOR_ACTIVITY",11,-1.0232,0.44,0.62,0.8071,0.73,1,0.9593,0.48,0.9
"GO_BP:494759_GO_0010694_POSITIVE_REGULATION_OF_ALKALINE_PHOSPHATASE_ACTIVITY","GO_BP","494759_GO_0010694_POSITIVE_REGULATION_OF_ALKALINE_PHOSPHATASE_ACTIVITY",6,-1.0231,0.44,0.6,-0.7475,0.78,1,-0.8735,0.62,0.95
"GO_CC:501653_GO_0032421_STEREOCILIUM_BUNDLE","GO_CC","501653_GO_0032421_STEREOCILIUM_BUNDLE",38,-1.023,0.42,0.7,-1.5396,0.021,0.6,-0.9056,0.58,1
"C1_Positional:C1_ALL_237_CHRXQ13","C1_Positional","C1_ALL_237_CHRXQ13",67,-1.0229,0.44,0.86,0.9486,0.56,0.82,-1.0916,0.31,0.81
"GO_BP:1025334_GO_0090594_INFLAMMATORY_RESPONSE_TO_WOUNDING","GO_BP","1025334_GO_0090594_INFLAMMATORY_RESPONSE_TO_WOUNDING",6,-1.0229,0.45,0.6,0.836,0.66,1,1.3113,0.17,0.66
"GO_BP:510726_GO_0048671_NEGATIVE_REGULATION_OF_COLLATERAL_SPROUTING","GO_BP","510726_GO_0048671_NEGATIVE_REGULATION_OF_COLLATERAL_SPROUTING",7,-1.0228,0.44,0.6,0.5877,0.94,1,-1.0163,0.45,0.83
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_101_BIOCARTA_IL7_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_101_BIOCARTA_IL7_PATHWAY",17,-1.0227,0.43,0.55,1.0262,0.42,0.83,-0.6798,0.91,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1611_MCCLUNG_DELTA_FOSB_TARGETS_8WK","C2_Chemical_and_genetic_perturbations","C2_CGP_1611_MCCLUNG_DELTA_FOSB_TARGETS_8WK",46,-1.0227,0.45,0.53,0.6258,0.98,1,0.6606,0.96,1
"KEGG_enzyme:2.4.1.175_GLUCURONOSYL_N_ACETYLGALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE_N_ACETYLGALACTOSAMINYLTRANSFERASE_II_UDP_N_ACETYL_D_GALACTOSAMINE_D_GLUCURONYL_N_ACETYL_1_3_BETA_D_GALACTOSAMINYLPROTEOGLYCAN_BETA_1_4_N_ACETYLGALACTOSAMINYLTRANSFERASE_CHONDROITIN_SYNTHASE_GLUCURONYL_N_ACETYLGALACTOSAMINYLPROTEOGLYCAN_BETA_1_4_N_ACETYLGALACTOSAMINYLTRANSFERASE_URIDINE_DIPHOSPHOACETYLGALACTOSAMINE_CHONDROITIN_ACETYLGALACTOSAMINYLTRANSFERASE_II_UDP_N_ACETYL_D_GALACTOSAMINE_BETA_D_GLUCURONOSYL_1_3_N_ACETYL_BETA_D_GALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE","KEGG_enzyme","2.4.1.175_GLUCURONOSYL_N_ACETYLGALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE_N_ACETYLGALACTOSAMINYLTRANSFERASE_II_UDP_N_ACETYL_D_GALACTOSAMINE_D_GLUCURONYL_N_ACETYL_1_3_BETA_D_GALACTOSAMINYLPROTEOGLYCAN_BETA_1_4_N_ACETYLGALACTOSAMINYLTRANSFERASE_CHONDROITIN_SYNTHASE_GLUCURONYL_N_ACETYLGALACTOSAMINYLPROTEOGLYCAN_BETA_1_4_N_ACETYLGALACTOSAMINYLTRANSFERASE_URIDINE_DIPHOSPHOACETYLGALACTOSAMINE_CHONDROITIN_ACETYLGALACTOSAMINYLTRANSFERASE_II_UDP_N_ACETYL_D_GALACTOSAMINE_BETA_D_GLUCURONOSYL_1_3_N_ACETYL_BETA_D_GALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE",5,-1.0226,0.45,0.53,0.7204,0.82,1,0.9382,0.54,0.8
"GO_CC:499714_GO_0030314_JUNCTIONAL_MEMBRANE_COMPLEX","GO_CC","499714_GO_0030314_JUNCTIONAL_MEMBRANE_COMPLEX",7,-1.0225,0.44,0.7,0.993,0.46,0.8,-1.005,0.47,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2077_ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2077_ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP",12,-1.0224,0.45,0.53,0.8161,0.71,0.98,0.8917,0.61,1
"C3_MicroRNA_targets:C3_MIR_154_TACAATC_MIR_508","C3_MicroRNA_targets","C3_MIR_154_TACAATC_MIR_508",65,-1.0224,0.43,0.6,1.0124,0.41,1,-0.7217,0.95,1
"REACTOME:645281_REACT_120863_ACTIVATED_POINT_MUTANTS_OF_FGFR2","REACTOME","645281_REACT_120863_ACTIVATED_POINT_MUTANTS_OF_FGFR2",11,-1.0223,0.44,0.62,-1.43,0.085,0.5,0.8512,0.67,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1411_WONG_IFNA2_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1411_WONG_IFNA2_RESISTANCE_DN",33,-1.0223,0.4,0.53,1.328,0.092,0.36,0.9361,0.56,1
"C3_TF_targets:C3_TFT_82_V_USF_02","C3_TF_targets","C3_TFT_82_V_USF_02",267,-1.0223,0.4,0.52,1.109,0.18,1,0.8693,0.87,1
"C7_Immunologic_signatures:C7_ALL_1065_GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP","C7_Immunologic_signatures","C7_ALL_1065_GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP",200,-1.0223,0.42,0.52,1.2928,0.021,0.11,-1.5591,0,0.0096
"GO_MF:496936_GO_0017136_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY","GO_MF","496936_GO_0017136_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY",16,-1.0222,0.44,0.62,-1.2588,0.19,0.83,-1.86,0.002,0.15
"KEGG_pathway:HSA00250_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM","KEGG_pathway","HSA00250_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM",34,-1.0222,0.43,0.48,-1.2054,0.19,0.52,-1.1838,0.2,0.39
"GO_BP:515164_GO_0070229_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS","GO_BP","515164_GO_0070229_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS",30,-1.0222,0.43,0.6,0.9023,0.61,1,-1.1122,0.28,0.76
"C7_Immunologic_signatures:C7_ALL_1306_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1306_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN",198,-1.0222,0.42,0.52,1.0679,0.27,0.53,-1.0657,0.28,0.58
"GO_BP:497073_GO_0018095_PROTEIN_POLYGLUTAMYLATION","GO_BP","497073_GO_0018095_PROTEIN_POLYGLUTAMYLATION",9,-1.0222,0.42,0.6,0.8544,0.66,1,-1.2843,0.16,0.65
"KEGG_module:HSA_M00141_C1_UNIT_INTERCONVERSION_EUKARYOTES","KEGG_module","HSA_M00141_C1_UNIT_INTERCONVERSION_EUKARYOTES",6,-1.0221,0.45,0.74,-0.5373,0.97,1,-1.0242,0.44,0.78
"GO_MF:506876_GO_0043855_CYCLIC_NUCLEOTIDE_GATED_ION_CHANNEL_ACTIVITY","GO_MF","506876_GO_0043855_CYCLIC_NUCLEOTIDE_GATED_ION_CHANNEL_ACTIVITY",11,-1.022,0.45,0.62,0.8799,0.6,1,1.7782,0.0058,0.14
"C2_Chemical_and_genetic_perturbations:C2_CGP_2987_NIELSEN_LEIOMYOSARCOMA_CNN1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2987_NIELSEN_LEIOMYOSARCOMA_CNN1_DN",20,-1.0219,0.45,0.53,-0.6567,0.92,1,0.6924,0.9,1
"GO_BP:755135_GO_2001029_REGULATION_OF_CELLULAR_GLUCURONIDATION","GO_BP","755135_GO_2001029_REGULATION_OF_CELLULAR_GLUCURONIDATION",9,-1.0219,0.44,0.6,0.7104,0.85,1,1.7664,0.0079,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_2276_KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2276_KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP",9,-1.0218,0.44,0.53,1.1172,0.31,0.6,0.636,0.92,1
"C4_Cancer_modules:C4_CM_431_MODULE_576","C4_Cancer_modules","C4_CM_431_MODULE_576",106,-1.0218,0.42,0.54,0.9475,0.58,0.78,-1.0338,0.37,0.63
"C1_Positional:C1_ALL_120_CHR6P23","C1_Positional","C1_ALL_120_CHR6P23",17,-1.0218,0.42,0.85,0.6038,0.97,1,-0.9398,0.56,0.98
"GO_BP:948084_GO_0061591_CALCIUM_ACTIVATED_GALACTOSYLCERAMIDE_SCRAMBLING","GO_BP","948084_GO_0061591_CALCIUM_ACTIVATED_GALACTOSYLCERAMIDE_SCRAMBLING",5,-1.0218,0.46,0.6,1.1538,0.32,0.83,-0.7996,0.71,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1684_NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1684_NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP",18,-1.0216,0.41,0.53,1.305,0.15,0.39,0.9909,0.46,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2439_ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR","C2_Chemical_and_genetic_perturbations","C2_CGP_2439_ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR",11,-1.0216,0.46,0.53,0.8494,0.65,0.97,1.9224,0,0.14
"C4_Cancer_modules:C4_CM_119_MODULE_124","C4_Cancer_modules","C4_CM_119_MODULE_124",96,-1.0215,0.4,0.54,1.2704,0.073,0.3,-1.3169,0.054,0.29
"C3_MicroRNA_targets:C3_MIR_64_GTTTGTT_MIR_495","C3_MicroRNA_targets","C3_MIR_64_GTTTGTT_MIR_495",256,-1.0214,0.43,0.6,1.042,0.29,1,1.0444,0.32,1
"C3_TF_targets:C3_TFT_323_V_MYCMAX_03","C3_TF_targets","C3_TFT_323_V_MYCMAX_03",252,-1.0214,0.43,0.52,1.0109,0.43,1,-0.8102,0.96,1
"KEGG_pathway:HSA05223_NON_SMALL_CELL_LUNG_CANCER","KEGG_pathway","HSA05223_NON_SMALL_CELL_LUNG_CANCER",56,-1.0213,0.42,0.48,-0.8091,0.8,1,-1.0352,0.35,0.62
"C3_MicroRNA_targets:C3_MIR_112_ATATGCA_MIR_448","C3_MicroRNA_targets","C3_MIR_112_ATATGCA_MIR_448",210,-1.0213,0.42,0.6,0.7566,0.99,1,-0.9835,0.51,1
"C3_TF_targets:C3_TFT_503_RACTNNRTTTNC_UNKNOWN","C3_TF_targets","C3_TFT_503_RACTNNRTTTNC_UNKNOWN",120,-1.0212,0.43,0.52,-0.6723,1,1,-1.4933,0.004,0.29
"C3_MicroRNA_targets:C3_MIR_187_GGCACTT_MIR_519E","C3_MicroRNA_targets","C3_MIR_187_GGCACTT_MIR_519E",120,-1.0211,0.44,0.6,0.7245,0.98,1,-1.005,0.42,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_810_HEIDENBLAD_AMPLICON_8Q24_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_810_HEIDENBLAD_AMPLICON_8Q24_DN",46,-1.021,0.41,0.53,0.5332,1,1,0.8091,0.83,1
"GO_BP:510294_GO_0048169_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY","GO_BP","510294_GO_0048169_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY",28,-1.021,0.43,0.6,-0.8986,0.61,1,-1.1385,0.25,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_2045_HILLION_HMGA1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2045_HILLION_HMGA1_TARGETS",87,-1.021,0.43,0.53,1.8651,0,0.026,0.8231,0.84,1
"GO_BP:493419_GO_0009223_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS","GO_BP","493419_GO_0009223_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS",9,-1.0209,0.44,0.6,1.4974,0.054,0.41,-1.2659,0.18,0.67
"KEGG_compound:C00448_TRANS_TRANS_FARNESYL_DIPHOSPHATE_FARNESYL_DIPHOSPHATE_FARNESYL_PYROPHOSPHATE_2_TRANS_6_TRANS_FARNESYL_DIPHOSPHATE_2E_6E_FARNESYL_DIPHOSPHATE","KEGG_compound","C00448_TRANS_TRANS_FARNESYL_DIPHOSPHATE_FARNESYL_DIPHOSPHATE_FARNESYL_PYROPHOSPHATE_2_TRANS_6_TRANS_FARNESYL_DIPHOSPHATE_2E_6E_FARNESYL_DIPHOSPHATE",10,-1.0209,0.44,0.6,0.762,0.79,1,-0.8167,0.74,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_177_VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_177_VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN",131,-1.0209,0.42,0.53,-0.7786,0.94,1,-0.9026,0.71,0.88
"GO_BP:510295_GO_0048170_POSITIVE_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY","GO_BP","510295_GO_0048170_POSITIVE_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY",7,-1.0209,0.46,0.6,-1.3915,0.1,1,-1.0492,0.4,0.81
"GO_BP:510720_GO_0048665_NEURON_FATE_SPECIFICATION","GO_BP","510720_GO_0048665_NEURON_FATE_SPECIFICATION",27,-1.0208,0.44,0.6,1.6313,0.011,0.26,1.4495,0.053,0.58
"GO_CC:500560_GO_0031301_INTEGRAL_COMPONENT_OF_ORGANELLE_MEMBRANE","GO_CC","500560_GO_0031301_INTEGRAL_COMPONENT_OF_ORGANELLE_MEMBRANE",234,-1.0207,0.43,0.7,0.8836,0.84,0.9,-0.9677,0.57,1
"GO_BP:502545_GO_0033327_LEYDIG_CELL_DIFFERENTIATION","GO_BP","502545_GO_0033327_LEYDIG_CELL_DIFFERENTIATION",12,-1.0207,0.44,0.6,-0.8881,0.61,1,1.1416,0.3,0.73
"GO_BP:518341_GO_0090201_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA","GO_BP","518341_GO_0090201_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA",18,-1.0206,0.42,0.6,1.3474,0.1,0.61,1.216,0.19,0.71
"GO_BP:492177_GO_0007416_SYNAPSE_ASSEMBLY","GO_BP","492177_GO_0007416_SYNAPSE_ASSEMBLY",56,-1.0205,0.42,0.6,-0.8942,0.64,1,1.5187,0.016,0.55
"C7_Immunologic_signatures:C7_ALL_1098_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN","C7_Immunologic_signatures","C7_ALL_1098_GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN",198,-1.0205,0.41,0.53,1.41,0.0026,0.035,-1.0096,0.42,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_2776_MIKKELSEN_IPS_ICP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2776_MIKKELSEN_IPS_ICP_WITH_H3K27ME3",51,-1.0204,0.43,0.54,-1.155,0.21,0.84,-1.0201,0.41,0.73
"REACTOME:366222_REACT_75896_CA2_ACTIVATED_K_CHANNELS","REACTOME","366222_REACT_75896_CA2_ACTIVATED_K_CHANNELS",9,-1.0204,0.43,0.62,0.8224,0.71,0.98,0.876,0.6,1
"C3_TF_targets:C3_TFT_49_V_EVI1_01","C3_TF_targets","C3_TFT_49_V_EVI1_01",16,-1.0204,0.45,0.52,0.9631,0.51,1,-1.3996,0.078,0.28
"C7_Immunologic_signatures:C7_ALL_1367_GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1367_GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP",198,-1.0204,0.43,0.53,1.134,0.15,0.35,-0.8319,0.91,1
"C7_Immunologic_signatures:C7_ALL_357_GSE15659_TREG_VS_TCONV_UP","C7_Immunologic_signatures","C7_ALL_357_GSE15659_TREG_VS_TCONV_UP",183,-1.0204,0.44,0.53,-0.9757,0.5,1,-1.1251,0.15,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_11_NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_11_NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP",280,-1.0203,0.45,0.54,1.2984,0.02,0.39,-0.9675,0.54,0.8
"C3_MicroRNA_targets:C3_MIR_19_AAGTCCA_MIR_422B_MIR_422A","C3_MicroRNA_targets","C3_MIR_19_AAGTCCA_MIR_422B_MIR_422A",70,-1.0203,0.4,0.59,-0.9177,0.63,1,-1.2029,0.15,1
"GO_BP:501642_GO_0032410_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY","GO_BP","501642_GO_0032410_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY",47,-1.0199,0.41,0.6,1.0309,0.38,0.97,-1.1745,0.2,0.73
"C3_MicroRNA_targets:C3_MIR_81_GGTGAAG_MIR_412","C3_MicroRNA_targets","C3_MIR_81_GGTGAAG_MIR_412",60,-1.0197,0.42,0.59,-0.8314,0.79,1,-1.2058,0.16,1
"REACTOME:187181_REACT_25330_ACTIVATION_OF_GABAB_RECEPTORS","REACTOME","187181_REACT_25330_ACTIVATION_OF_GABAB_RECEPTORS",38,-1.0196,0.46,0.62,-0.9149,0.58,1,-0.8943,0.63,0.96
"C7_Immunologic_signatures:C7_ALL_1185_GSE27786_BCELL_VS_ERYTHROBLAST_UP","C7_Immunologic_signatures","C7_ALL_1185_GSE27786_BCELL_VS_ERYTHROBLAST_UP",198,-1.0196,0.44,0.53,1.0475,0.33,0.6,0.7042,1,1
"KEGG_pathway:HSA00270_CYSTEINE_AND_METHIONINE_METABOLISM","KEGG_pathway","HSA00270_CYSTEINE_AND_METHIONINE_METABOLISM",36,-1.0195,0.43,0.48,0.9641,0.51,0.95,-1.2424,0.15,0.34
"C1_Positional:C1_ALL_213_CHR7Q","C1_Positional","C1_ALL_213_CHR7Q",9,-1.0195,0.43,0.85,1.2013,0.25,0.64,0.7911,0.74,0.93
"GO_CC:501222_GO_0031984_ORGANELLE_SUBCOMPARTMENT","GO_CC","501222_GO_0031984_ORGANELLE_SUBCOMPARTMENT",280,-1.0193,0.42,0.7,1.0099,0.41,0.77,0.8576,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1029_GOUYER_TATI_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1029_GOUYER_TATI_TARGETS_DN",17,-1.0193,0.45,0.54,-1.5367,0.046,0.43,1.1498,0.27,0.83
"GO_BP:501822_GO_0032596_PROTEIN_TRANSPORT_INTO_MEMBRANE_RAFT","GO_BP","501822_GO_0032596_PROTEIN_TRANSPORT_INTO_MEMBRANE_RAFT",6,-1.0192,0.47,0.6,-0.7837,0.74,1,-1.0431,0.4,0.82
"C6_Oncogenic_signatures:C6_ALL_124_RB_P107_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_124_RB_P107_DN_V1_UP",131,-1.0191,0.44,0.48,0.9416,0.62,0.93,-1.5103,0.0043,0.12
"GO_CC:515020_GO_0070081_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE","GO_CC","515020_GO_0070081_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE",5,-1.0191,0.46,0.7,-0.6987,0.81,1,-1.4647,0.071,0.54
"C7_Immunologic_signatures:C7_ALL_1403_GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1403_GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP",197,-1.019,0.44,0.53,2.3086,0,0,-1.3476,0.017,0.098
"GO_CC:500488_GO_0031227_INTRINSIC_COMPONENT_OF_ENDOPLASMIC_RETICULUM_MEMBRANE","GO_CC","500488_GO_0031227_INTRINSIC_COMPONENT_OF_ENDOPLASMIC_RETICULUM_MEMBRANE",118,-1.0188,0.43,0.7,0.8566,0.82,0.92,-1.1194,0.22,0.91
"C7_Immunologic_signatures:C7_ALL_1792_GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1792_GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN",194,-1.0188,0.45,0.53,-0.914,0.69,1,-0.9296,0.65,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_377_CHOW_RASSF1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_377_CHOW_RASSF1_TARGETS_UP",27,-1.0188,0.42,0.54,1.4441,0.053,0.26,-0.7193,0.92,0.98
"REACTOME:645280_REACT_121155_FGFR2_MUTANT_RECEPTOR_ACTIVATION","REACTOME","645280_REACT_121155_FGFR2_MUTANT_RECEPTOR_ACTIVATION",11,-1.0187,0.44,0.62,-1.4221,0.085,0.49,0.8749,0.62,1
"C4_Cancer_modules:C4_CM_219_MODULE_240","C4_Cancer_modules","C4_CM_219_MODULE_240",18,-1.0182,0.43,0.55,0.8673,0.64,0.89,-1.0915,0.33,0.55
"C7_Immunologic_signatures:C7_ALL_1565_GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP","C7_Immunologic_signatures","C7_ALL_1565_GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP",193,-1.0182,0.42,0.53,1.6016,0.0023,0.003,-0.9407,0.66,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_2794_NAKAYAMA_FGF2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2794_NAKAYAMA_FGF2_TARGETS",29,-1.0182,0.44,0.54,1.6561,0.015,0.11,0.9911,0.47,0.97
"GO_BP:499727_GO_0030326_EMBRYONIC_LIMB_MORPHOGENESIS","GO_BP","499727_GO_0030326_EMBRYONIC_LIMB_MORPHOGENESIS",126,-1.018,0.42,0.6,-0.93,0.63,1,1.2498,0.083,0.69
"C7_Immunologic_signatures:C7_ALL_684_GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_684_GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDM_DN",199,-1.018,0.43,0.53,1.4988,0,0.013,-0.8749,0.83,0.99
"GO_BP:491867_GO_0007040_LYSOSOME_ORGANIZATION","GO_BP","491867_GO_0007040_LYSOSOME_ORGANIZATION",46,-1.018,0.42,0.6,0.7053,0.94,1,0.6153,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1970_MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1970_MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN",271,-1.018,0.42,0.54,1.4454,0,0.26,-0.8825,0.82,0.9
"REACTOME:106151_REACT_11038_PREGNENOLONE_BIOSYNTHESIS","REACTOME","106151_REACT_11038_PREGNENOLONE_BIOSYNTHESIS",9,-1.018,0.44,0.62,-1.0309,0.42,0.97,1.0531,0.37,0.96
"GO_BP:503239_GO_0034030_RIBONUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","503239_GO_0034030_RIBONUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS",17,-1.0179,0.44,0.6,-0.9243,0.54,1,-0.7367,0.81,1
"KEGG_module:HSA_M00676_PI3K_AKT_SIGNALING","KEGG_module","HSA_M00676_PI3K_AKT_SIGNALING",15,-1.0177,0.43,0.73,0.7875,0.75,0.92,0.6926,0.87,1
"GO_BP:514593_GO_0061045_NEGATIVE_REGULATION_OF_WOUND_HEALING","GO_BP","514593_GO_0061045_NEGATIVE_REGULATION_OF_WOUND_HEALING",51,-1.0177,0.45,0.6,1.2071,0.16,0.78,1.5867,0.008,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_2043_HOWLIN_CITED1_TARGETS_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2043_HOWLIN_CITED1_TARGETS_2_UP",17,-1.0176,0.43,0.54,0.8728,0.64,0.95,-0.7965,0.74,0.96
"C7_Immunologic_signatures:C7_ALL_561_GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_561_GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDM_UP",200,-1.0175,0.43,0.53,1.0351,0.38,0.63,0.8673,0.81,1
"REACTOME:187212_REACT_25325_AUF1_HNRNP_D0_DESTABILIZES_MRNA","REACTOME","187212_REACT_25325_AUF1_HNRNP_D0_DESTABILIZES_MRNA",55,-1.0175,0.42,0.62,1.8182,0,0.018,-1.2298,0.14,0.57
"GO_BP:491264_GO_0006305_DNA_ALKYLATION","GO_BP","491264_GO_0006305_DNA_ALKYLATION",73,-1.0175,0.44,0.6,-1.7023,0,0.68,-1.382,0.042,0.59
"C7_Immunologic_signatures:C7_ALL_580_GSE17721_PAM3CSK4_VS_CPG_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_580_GSE17721_PAM3CSK4_VS_CPG_24H_BMDM_DN",198,-1.0175,0.43,0.53,1.0452,0.33,0.6,-0.9147,0.7,0.92
"C3_TF_targets:C3_TFT_238_CCGNMNNTNACG_UNKNOWN","C3_TF_targets","C3_TFT_238_CCGNMNNTNACG_UNKNOWN",77,-1.0174,0.44,0.53,0.898,0.66,1,-0.8979,0.67,0.92
"C7_Immunologic_signatures:C7_ALL_497_GSE17721_CTRL_VS_CPG_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_497_GSE17721_CTRL_VS_CPG_1H_BMDM_UP",198,-1.0174,0.43,0.53,1.1943,0.11,0.24,-1.0366,0.35,0.64
"C4_Cancer_modules:C4_CM_192_MODULE_205","C4_Cancer_modules","C4_CM_192_MODULE_205",297,-1.0173,0.45,0.55,-0.9425,0.64,0.89,-0.9666,0.58,0.74
"WikiPathways:219802_WP1982_SREBP_SIGNALLING","WikiPathways","219802_WP1982_SREBP_SIGNALLING",60,-1.0171,0.42,0.54,0.8677,0.74,1,-0.7107,0.96,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2512_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2512_ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN",39,-1.017,0.44,0.54,0.9274,0.58,0.89,-0.8448,0.78,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_145_WANG_RESPONSE_TO_FORSKOLIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_145_WANG_RESPONSE_TO_FORSKOLIN_DN",9,-1.017,0.44,0.54,0.689,0.87,1,-0.8323,0.68,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_473_BARIS_THYROID_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_473_BARIS_THYROID_CANCER_UP",23,-1.0169,0.43,0.54,0.8956,0.6,0.93,-1.014,0.46,0.73
"GO_BP:518095_GO_0080171_LYTIC_VACUOLE_ORGANIZATION","GO_BP","518095_GO_0080171_LYTIC_VACUOLE_ORGANIZATION",46,-1.0169,0.43,0.61,0.6903,0.94,1,0.6317,0.99,1
"WikiPathways:920977_WP2446_RB_IN_CANCER","WikiPathways","920977_WP2446_RB_IN_CANCER",87,-1.0166,0.45,0.54,0.9444,0.58,1,-1.6232,0.004,0.35
"GO_MF:492840_GO_0016887_ATPASE_ACTIVITY","GO_MF","492840_GO_0016887_ATPASE_ACTIVITY",386,-1.0166,0.43,0.63,-0.8637,0.91,1,-1.2201,0.023,0.57
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_216_BIOCARTA_WNT_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_216_BIOCARTA_WNT_PATHWAY",26,-1.0165,0.44,0.56,0.6341,0.96,1,-0.7914,0.78,0.91
"GO_BP:495989_GO_0015865_PURINE_NUCLEOTIDE_TRANSPORT","GO_BP","495989_GO_0015865_PURINE_NUCLEOTIDE_TRANSPORT",9,-1.0164,0.44,0.61,-0.6798,0.86,1,-1.3796,0.12,0.58
"C3_MicroRNA_targets:C3_MIR_82_AGGGCCA_MIR_328","C3_MicroRNA_targets","C3_MIR_82_AGGGCCA_MIR_328",79,-1.0164,0.43,0.6,-0.8117,0.84,1,0.752,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1723_WESTON_VEGFA_TARGETS_12HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1723_WESTON_VEGFA_TARGETS_12HR",32,-1.0164,0.43,0.54,1.0634,0.32,0.69,0.7356,0.88,1
"C7_Immunologic_signatures:C7_ALL_1638_GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1638_GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN",197,-1.0163,0.45,0.54,1.1052,0.2,0.43,-1.2916,0.037,0.15
"GO_BP:503572_GO_0034370_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_REMODELING","GO_BP","503572_GO_0034370_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_REMODELING",9,-1.0163,0.44,0.61,-1.3214,0.13,0.89,-0.9879,0.45,0.86
"GO_BP:750874_GO_0035947_REGULATION_OF_GLUCONEOGENESIS_BY_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER","GO_BP","750874_GO_0035947_REGULATION_OF_GLUCONEOGENESIS_BY_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER",5,-1.0163,0.46,0.61,-0.776,0.75,1,-0.6917,0.85,0.99
"GO_BP:487982_GO_0002093_AUDITORY_RECEPTOR_CELL_MORPHOGENESIS","GO_BP","487982_GO_0002093_AUDITORY_RECEPTOR_CELL_MORPHOGENESIS",12,-1.0163,0.43,0.61,0.6613,0.87,1,0.6894,0.87,1
"GO_CC:506287_GO_0043219_LATERAL_LOOP","GO_CC","506287_GO_0043219_LATERAL_LOOP",5,-1.0162,0.45,0.71,0.7431,0.79,0.98,-0.6716,0.87,1
"C3_TF_targets:C3_TFT_12_V_ATF_01","C3_TF_targets","C3_TFT_12_V_ATF_01",253,-1.0161,0.44,0.53,-0.79,0.97,1,-0.9248,0.7,0.89
"GO_BP:948081_GO_0061588_CALCIUM_ACTIVATED_PHOSPHOLIPID_SCRAMBLING","GO_BP","948081_GO_0061588_CALCIUM_ACTIVATED_PHOSPHOLIPID_SCRAMBLING",5,-1.0161,0.48,0.61,1.1419,0.32,0.85,-0.7945,0.7,0.99
"GO_BP:752706_GO_0097205_RENAL_FILTRATION","GO_BP","752706_GO_0097205_RENAL_FILTRATION",10,-1.0161,0.45,0.61,-0.6092,0.95,1,-1.0251,0.42,0.83
"REACTOME:105807_REACT_15479_CENTROSOME_MATURATION","REACTOME","105807_REACT_15479_CENTROSOME_MATURATION",72,-1.016,0.44,0.62,-0.8813,0.7,1,-1.5528,0.01,0.3
"GO_CC:490734_GO_0005680_ANAPHASE_PROMOTING_COMPLEX","GO_CC","490734_GO_0005680_ANAPHASE_PROMOTING_COMPLEX",21,-1.0159,0.43,0.71,0.997,0.47,0.79,-0.7941,0.76,1
"GO_BP:505381_GO_0042220_RESPONSE_TO_COCAINE","GO_BP","505381_GO_0042220_RESPONSE_TO_COCAINE",35,-1.0159,0.45,0.61,-0.8549,0.69,1,1.1554,0.25,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_3235_SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3235_SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN",8,-1.0158,0.44,0.54,1.341,0.12,0.35,0.7931,0.73,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2123_KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2123_KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3",88,-1.0157,0.43,0.54,1.0121,0.44,0.78,-0.9617,0.53,0.8
"GO_BP:488640_GO_0002767_IMMUNE_RESPONSE_INHIBITING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","488640_GO_0002767_IMMUNE_RESPONSE_INHIBITING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY",5,-1.0157,0.47,0.61,0.8439,0.66,1,-0.5101,0.99,1
"C3_TF_targets:C3_TFT_321_V_HTF_01","C3_TF_targets","C3_TFT_321_V_HTF_01",71,-1.0156,0.43,0.53,-0.7075,0.96,1,0.7217,0.95,1
"KEGG_compound:C00245_TAURINE_2_AMINOETHANESULFONIC_ACID_AMINOETHYLSULFONIC_ACID","KEGG_compound","C00245_TAURINE_2_AMINOETHANESULFONIC_ACID_AMINOETHYLSULFONIC_ACID",7,-1.0155,0.45,0.6,0.7587,0.78,1,-0.6838,0.86,0.92
"GO_BP:491144_GO_0006172_ADP_BIOSYNTHETIC_PROCESS","GO_BP","491144_GO_0006172_ADP_BIOSYNTHETIC_PROCESS",5,-1.0153,0.44,0.61,-0.7835,0.73,1,-0.8328,0.67,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3300_FU_INTERACT_WITH_ALKBH8","C2_Chemical_and_genetic_perturbations","C2_CGP_3300_FU_INTERACT_WITH_ALKBH8",13,-1.0153,0.45,0.54,1.8422,0.004,0.03,-1.3235,0.15,0.41
"C3_TF_targets:C3_TFT_516_SYATTGTG_UNKNOWN","C3_TF_targets","C3_TFT_516_SYATTGTG_UNKNOWN",228,-1.0152,0.44,0.53,-1.2033,0.082,0.35,-1.1388,0.15,0.46
"GO_CC:750979_GO_0036057_SLIT_DIAPHRAGM","GO_CC","750979_GO_0036057_SLIT_DIAPHRAGM",8,-1.0152,0.45,0.71,-1.4185,0.084,0.67,-1.4573,0.086,0.52
"C7_Immunologic_signatures:C7_ALL_127_GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP","C7_Immunologic_signatures","C7_ALL_127_GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP",197,-1.0151,0.45,0.54,1.9588,0,0,-1.2049,0.077,0.27
"C7_Immunologic_signatures:C7_ALL_1318_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1318_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN",198,-1.015,0.45,0.54,1.7611,0,0.00026,0.6021,1,1
"GO_BP:752679_GO_0097178_RUFFLE_ASSEMBLY","GO_BP","752679_GO_0097178_RUFFLE_ASSEMBLY",9,-1.0149,0.45,0.61,-0.8103,0.7,1,-0.5996,0.96,1
"GO_BP:491778_GO_0006927_TRANSFORMED_CELL_APOPTOTIC_PROCESS","GO_BP","491778_GO_0006927_TRANSFORMED_CELL_APOPTOTIC_PROCESS",7,-1.0147,0.45,0.61,-0.8511,0.67,1,-1.2789,0.19,0.66
"KEGG_module:HSA_M00679_BMP_SIGNALING","KEGG_module","HSA_M00679_BMP_SIGNALING",22,-1.0146,0.46,0.72,-0.9703,0.49,1,1.5192,0.042,0.65
"GO_BP:753043_GO_1900047_NEGATIVE_REGULATION_OF_HEMOSTASIS","GO_BP","753043_GO_1900047_NEGATIVE_REGULATION_OF_HEMOSTASIS",43,-1.0146,0.44,0.61,1.3216,0.093,0.64,1.5918,0.015,0.44
"REACTOME:106334_REACT_12472_REGULATORY_RNA_PATHWAYS","REACTOME","106334_REACT_12472_REGULATORY_RNA_PATHWAYS",128,-1.0145,0.43,0.62,-1.1282,0.2,0.89,-1.3329,0.049,0.52
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_5_BIOCARTA_AMI_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_5_BIOCARTA_AMI_PATHWAY",20,-1.0145,0.44,0.56,1.4603,0.073,0.43,1.2968,0.13,1
"GO_BP:506170_GO_0043090_AMINO_ACID_IMPORT","GO_BP","506170_GO_0043090_AMINO_ACID_IMPORT",14,-1.0144,0.44,0.61,-0.8417,0.64,1,0.7807,0.77,1
"GO_BP:514523_GO_0060968_REGULATION_OF_GENE_SILENCING","GO_BP","514523_GO_0060968_REGULATION_OF_GENE_SILENCING",37,-1.0143,0.45,0.61,-1.351,0.092,0.93,-1.1462,0.26,0.74
"GO_CC:490920_GO_0005921_GAP_JUNCTION","GO_CC","490920_GO_0005921_GAP_JUNCTION",28,-1.0143,0.45,0.71,-1.2632,0.15,0.67,1.4489,0.054,0.66
"GO_BP:512132_GO_0051238_SEQUESTERING_OF_METAL_ION","GO_BP","512132_GO_0051238_SEQUESTERING_OF_METAL_ION",11,-1.0143,0.44,0.61,1.4252,0.088,0.53,0.4521,1,1
"GO_BP:491149_GO_0006177_GMP_BIOSYNTHETIC_PROCESS","GO_BP","491149_GO_0006177_GMP_BIOSYNTHETIC_PROCESS",5,-1.0142,0.47,0.61,-0.627,0.89,1,-1.3724,0.11,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_312_ELVIDGE_HYPOXIA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_312_ELVIDGE_HYPOXIA_DN",146,-1.0142,0.44,0.55,1.033,0.35,0.75,-1.0566,0.31,0.68
"GO_CC:496388_GO_0016363_NUCLEAR_MATRIX","GO_CC","496388_GO_0016363_NUCLEAR_MATRIX",93,-1.0142,0.44,0.7,0.6173,1,0.99,-0.8782,0.72,1
"REACTOME:106054_REACT_15523_INTEGRIN_ALPHAIIB_BETA3_SIGNALING","REACTOME","106054_REACT_15523_INTEGRIN_ALPHAIIB_BETA3_SIGNALING",27,-1.0142,0.43,0.62,1.4107,0.081,0.21,0.8033,0.78,1
"GO_BP:493443_GO_0009250_GLUCAN_BIOSYNTHETIC_PROCESS","GO_BP","493443_GO_0009250_GLUCAN_BIOSYNTHETIC_PROCESS",27,-1.0142,0.44,0.61,0.8932,0.62,1,-1.6373,0.0079,0.54
"GO_BP:849794_GO_0061549_SYMPATHETIC_GANGLION_DEVELOPMENT","GO_BP","849794_GO_0061549_SYMPATHETIC_GANGLION_DEVELOPMENT",9,-1.0141,0.46,0.61,0.8661,0.61,1,1.7483,0.0076,0.37
"C4_Cancer_modules:C4_CM_428_MODULE_571","C4_Cancer_modules","C4_CM_428_MODULE_571",15,-1.0141,0.45,0.55,-0.9309,0.53,0.87,-0.9631,0.5,0.75
"C7_Immunologic_signatures:C7_ALL_1566_GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN","C7_Immunologic_signatures","C7_ALL_1566_GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN",193,-1.014,0.43,0.54,1.1399,0.16,0.34,0.8742,0.83,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3380_ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR","C2_Chemical_and_genetic_perturbations","C2_CGP_3380_ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR",85,-1.014,0.43,0.55,0.9934,0.45,0.81,-1.5411,0.0059,0.27
"GO_MF:490477_GO_0005243_GAP_JUNCTION_CHANNEL_ACTIVITY","GO_MF","490477_GO_0005243_GAP_JUNCTION_CHANNEL_ACTIVITY",13,-1.0139,0.42,0.64,-1.1394,0.31,0.82,1.1153,0.33,0.81
"GO_BP:511743_GO_0050772_POSITIVE_REGULATION_OF_AXONOGENESIS","GO_BP","511743_GO_0050772_POSITIVE_REGULATION_OF_AXONOGENESIS",56,-1.0138,0.45,0.61,-0.8069,0.82,1,1.0034,0.43,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_698_LUI_THYROID_CANCER_CLUSTER_2","C2_Chemical_and_genetic_perturbations","C2_CGP_698_LUI_THYROID_CANCER_CLUSTER_2",42,-1.0138,0.44,0.55,-1.249,0.15,0.74,-1.3515,0.078,0.39
"GO_BP:508289_GO_0045989_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION","GO_BP","508289_GO_0045989_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION",10,-1.0138,0.45,0.61,-0.9819,0.49,1,0.9089,0.58,0.93
"GO_MF:490037_GO_0004723_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY","GO_MF","490037_GO_0004723_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY",6,-1.0133,0.47,0.64,-0.5741,0.95,1,-1.0708,0.39,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1163_SUNG_METASTASIS_STROMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1163_SUNG_METASTASIS_STROMA_DN",53,-1.0132,0.44,0.55,1.2251,0.13,0.46,0.885,0.67,1
"GO_BP:514554_GO_0060999_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT","GO_BP","514554_GO_0060999_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT",20,-1.013,0.45,0.61,-1.2367,0.18,0.9,-0.7953,0.75,0.99
"GO_CC:507224_GO_0044217_OTHER_ORGANISM_PART","GO_CC","507224_GO_0044217_OTHER_ORGANISM_PART",12,-1.013,0.45,0.7,-1.3879,0.093,0.65,1.1974,0.23,0.84
"GO_BP:491289_GO_0006346_METHYLATION_DEPENDENT_CHROMATIN_SILENCING","GO_BP","491289_GO_0006346_METHYLATION_DEPENDENT_CHROMATIN_SILENCING",6,-1.0129,0.46,0.61,-1.4642,0.077,0.87,0.7453,0.78,1
"GO_MF:508596_GO_0046332_SMAD_BINDING","GO_MF","508596_GO_0046332_SMAD_BINDING",67,-1.0129,0.45,0.64,-0.648,0.99,1,1.1147,0.25,0.81
"GO_CC:490922_GO_0005923_TIGHT_JUNCTION","GO_CC","490922_GO_0005923_TIGHT_JUNCTION",107,-1.0129,0.45,0.7,-1.0324,0.39,0.84,0.9264,0.62,1
"REACTOME:161066_REACT_20547_METAL_ION_SLC_TRANSPORTERS","REACTOME","161066_REACT_20547_METAL_ION_SLC_TRANSPORTERS",24,-1.0128,0.43,0.63,-0.7924,0.78,1,-0.8945,0.61,0.96
"GO_BP:505465_GO_0042321_NEGATIVE_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP","GO_BP","505465_GO_0042321_NEGATIVE_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP",5,-1.0127,0.46,0.61,-1.0876,0.39,0.95,-0.9782,0.49,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_2634_MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2634_MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3",12,-1.0127,0.43,0.55,-1.3059,0.16,0.69,-1.1148,0.31,0.61
"GO_MF:492622_GO_0008301_DNA_BINDING_BENDING","GO_MF","492622_GO_0008301_DNA_BINDING_BENDING",18,-1.0126,0.44,0.64,1.0054,0.44,0.87,-1.2547,0.18,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_938_SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_938_SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP",478,-1.0126,0.45,0.55,1.4739,0,0.23,-1.2989,0.0064,0.43
"GO_BP:501738_GO_0032507_MAINTENANCE_OF_PROTEIN_LOCATION_IN_CELL","GO_BP","501738_GO_0032507_MAINTENANCE_OF_PROTEIN_LOCATION_IN_CELL",107,-1.0125,0.42,0.61,0.7064,0.97,1,-0.7351,0.97,1
"GO_MF:504509_GO_0035325_TOLL_LIKE_RECEPTOR_BINDING","GO_MF","504509_GO_0035325_TOLL_LIKE_RECEPTOR_BINDING",6,-1.0124,0.46,0.64,0.69,0.85,1,-0.6772,0.85,1
"GO_MF:490463_GO_0005221_INTRACELLULAR_CYCLIC_NUCLEOTIDE_ACTIVATED_CATION_CHANNEL_ACTIVITY","GO_MF","490463_GO_0005221_INTRACELLULAR_CYCLIC_NUCLEOTIDE_ACTIVATED_CATION_CHANNEL_ACTIVITY",11,-1.0124,0.45,0.64,0.8882,0.6,0.99,1.737,0.012,0.17
"GO_BP:501566_GO_0032331_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION","GO_BP","501566_GO_0032331_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION",16,-1.012,0.46,0.61,-1.5548,0.034,0.72,1.6867,0.01,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2738_KAPOSI_LIVER_CANCER_MET_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2738_KAPOSI_LIVER_CANCER_MET_DN",5,-1.012,0.49,0.55,0.8359,0.65,0.98,-1.0949,0.38,0.64
"REACTOME:187180_REACT_25031_GABA_B_RECEPTOR_ACTIVATION","REACTOME","187180_REACT_25031_GABA_B_RECEPTOR_ACTIVATION",38,-1.0119,0.46,0.63,-0.9217,0.57,1,-0.8839,0.68,0.97
"GO_MF:490615_GO_0005506_IRON_ION_BINDING","GO_MF","490615_GO_0005506_IRON_ION_BINDING",166,-1.0118,0.45,0.64,1.2184,0.097,0.7,-1.0852,0.22,0.71
"GO_MF:490443_GO_0005179_HORMONE_ACTIVITY","GO_MF","490443_GO_0005179_HORMONE_ACTIVITY",103,-1.0118,0.44,0.64,-1.6783,0,0.37,1.3431,0.042,0.64
"C7_Immunologic_signatures:C7_ALL_219_GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_219_GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP",185,-1.0118,0.45,0.55,-0.846,0.89,1,-0.9898,0.46,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1263_SWEET_KRAS_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1263_SWEET_KRAS_TARGETS_DN",63,-1.0117,0.44,0.55,1.5851,0.0091,0.15,1.3651,0.069,0.55
"REACTOME:105808_REACT_15296_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES","REACTOME","105808_REACT_15296_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES",72,-1.0117,0.43,0.63,-0.873,0.72,1,-1.5652,0.0041,0.28
"C1_Positional:C1_ALL_118_CHR4Q22","C1_Positional","C1_ALL_118_CHR4Q22",30,-1.0117,0.45,0.87,1.15,0.25,0.63,-1.4654,0.039,0.68
"GO_CC:507310_GO_0044304_MAIN_AXON","GO_CC","507310_GO_0044304_MAIN_AXON",54,-1.0116,0.44,0.7,-1.47,0.03,0.59,-1.3856,0.043,0.59
"GO_CC:506312_GO_0043245_EXTRAORGANISMAL_SPACE","GO_CC","506312_GO_0043245_EXTRAORGANISMAL_SPACE",12,-1.0113,0.42,0.7,-1.397,0.098,0.64,1.2149,0.22,0.83
"C7_Immunologic_signatures:C7_ALL_284_GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN","C7_Immunologic_signatures","C7_ALL_284_GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN",199,-1.0113,0.44,0.55,1.1539,0.12,0.31,-1.5282,0.002,0.015
"C7_Immunologic_signatures:C7_ALL_1080_GSE25087_FETAL_VS_ADULT_TREG_DN","C7_Immunologic_signatures","C7_ALL_1080_GSE25087_FETAL_VS_ADULT_TREG_DN",191,-1.0113,0.46,0.55,-0.9491,0.58,1,-1.0688,0.26,0.57
"C7_Immunologic_signatures:C7_ALL_119_GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP","C7_Immunologic_signatures","C7_ALL_119_GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP",195,-1.0112,0.44,0.55,-0.853,0.85,1,-1.3824,0.012,0.074
"KEGG_compound:C00681_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_2_LYSOPHOSPHATIDATE_LYSOPHOSPHATIDATE_LYSOPHOSPHATIDIC_ACID","KEGG_compound","C00681_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_2_LYSOPHOSPHATIDATE_LYSOPHOSPHATIDATE_LYSOPHOSPHATIDIC_ACID",14,-1.0112,0.43,0.61,0.754,0.81,1,-0.8172,0.72,0.83
"GO_BP:500352_GO_0031062_POSITIVE_REGULATION_OF_HISTONE_METHYLATION","GO_BP","500352_GO_0031062_POSITIVE_REGULATION_OF_HISTONE_METHYLATION",27,-1.011,0.43,0.61,-0.6743,0.93,1,-0.8854,0.65,0.94
"GO_BP:752606_GO_0097105_PRESYNAPTIC_MEMBRANE_ASSEMBLY","GO_BP","752606_GO_0097105_PRESYNAPTIC_MEMBRANE_ASSEMBLY",9,-1.011,0.46,0.61,1.0791,0.34,0.93,0.7654,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2380_YAGUE_PRETUMOR_DRUG_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2380_YAGUE_PRETUMOR_DRUG_RESISTANCE_DN",13,-1.011,0.44,0.55,1.0609,0.39,0.69,1.0618,0.38,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2179_OUILLETTE_CLL_13Q14_DELETION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2179_OUILLETTE_CLL_13Q14_DELETION_DN",58,-1.0109,0.44,0.55,-1.0934,0.3,0.93,-1.179,0.19,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_2391_CHEN_HOXA5_TARGETS_9HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2391_CHEN_HOXA5_TARGETS_9HR_UP",222,-1.0109,0.44,0.55,-0.9343,0.65,1,0.9013,0.78,1
"GO_BP:513597_GO_0060039_PERICARDIUM_DEVELOPMENT","GO_BP","513597_GO_0060039_PERICARDIUM_DEVELOPMENT",17,-1.0109,0.45,0.61,-0.9243,0.56,1,1.1759,0.24,0.72
"GO_BP:507569_GO_0045187_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP","GO_BP","507569_GO_0045187_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP",17,-1.0109,0.46,0.61,-0.9173,0.57,1,0.959,0.52,0.9
"C7_Immunologic_signatures:C7_ALL_1169_GSE27786_LIN_NEG_VS_NKTCELL_UP","C7_Immunologic_signatures","C7_ALL_1169_GSE27786_LIN_NEG_VS_NKTCELL_UP",197,-1.0109,0.45,0.55,1.0346,0.33,0.63,-1.1621,0.13,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_1159_JEON_SMAD6_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1159_JEON_SMAD6_TARGETS_UP",24,-1.0108,0.43,0.55,-0.8563,0.67,1,1.1285,0.26,0.85
"GO_MF:496914_GO_0017112_RAB_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY","GO_MF","496914_GO_0017112_RAB_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",30,-1.0107,0.44,0.64,-0.8176,0.77,1,0.9464,0.53,0.91
"GO_CC:490702_GO_0005635_NUCLEAR_ENVELOPE","GO_CC","490702_GO_0005635_NUCLEAR_ENVELOPE",376,-1.0104,0.45,0.7,0.9926,0.47,0.79,-1.1003,0.18,0.93
"C7_Immunologic_signatures:C7_ALL_365_GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP","C7_Immunologic_signatures","C7_ALL_365_GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP",189,-1.0104,0.45,0.55,0.9677,0.57,0.84,-1.0108,0.44,0.7
"GO_BP:491006_GO_0006020_INOSITOL_METABOLIC_PROCESS","GO_BP","491006_GO_0006020_INOSITOL_METABOLIC_PROCESS",11,-1.0102,0.45,0.62,-1.4989,0.042,0.82,-0.6638,0.92,1
"GO_BP:516996_GO_0072079_NEPHRON_TUBULE_FORMATION","GO_BP","516996_GO_0072079_NEPHRON_TUBULE_FORMATION",17,-1.0101,0.45,0.62,0.6594,0.92,1,1.6398,0.019,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_563_MOTAMED_RESPONSE_TO_ANDROGEN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_563_MOTAMED_RESPONSE_TO_ANDROGEN_DN",6,-1.0101,0.49,0.55,-1.0187,0.46,0.98,-1.2256,0.24,0.5
"GO_BP:500398_GO_0031111_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION","GO_BP","500398_GO_0031111_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION",32,-1.0101,0.44,0.62,-0.8433,0.72,1,-1.3565,0.085,0.6
"GO_BP:500879_GO_0031629_SYNAPTIC_VESICLE_FUSION_TO_PRESYNAPTIC_MEMBRANE","GO_BP","500879_GO_0031629_SYNAPTIC_VESICLE_FUSION_TO_PRESYNAPTIC_MEMBRANE",12,-1.0098,0.46,0.62,0.555,0.98,1,-0.7362,0.83,1
"GO_MF:500878_GO_0031628_OPIOID_RECEPTOR_BINDING","GO_MF","500878_GO_0031628_OPIOID_RECEPTOR_BINDING",6,-1.0097,0.48,0.64,-0.5882,0.94,1,-0.66,0.88,1
"C3_TF_targets:C3_TFT_279_V_AP2ALPHA_01","C3_TF_targets","C3_TFT_279_V_AP2ALPHA_01",239,-1.0096,0.44,0.54,-1.1772,0.11,0.39,-0.7051,1,1
"REACTOME:106169_REACT_13_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES","REACTOME","106169_REACT_13_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES",189,-1.0096,0.45,0.63,1.1202,0.16,0.56,-1.4534,0.0041,0.39
"C2_Chemical_and_genetic_perturbations:C2_CGP_1484_MUNSHI_MULTIPLE_MYELOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1484_MUNSHI_MULTIPLE_MYELOMA_DN",11,-1.0095,0.44,0.55,0.9484,0.52,0.87,-0.6856,0.9,0.99
"GO_CC:752698_GO_0097197_TETRASPANIN_ENRICHED_MICRODOMAIN","GO_CC","752698_GO_0097197_TETRASPANIN_ENRICHED_MICRODOMAIN",7,-1.0095,0.47,0.7,-0.4713,0.99,1,-1.2503,0.22,0.7
"GO_BP:505851_GO_0042745_CIRCADIAN_SLEEP_WAKE_CYCLE","GO_BP","505851_GO_0042745_CIRCADIAN_SLEEP_WAKE_CYCLE",7,-1.0093,0.47,0.62,-0.6509,0.89,1,0.7508,0.81,1
"C3_TF_targets:C3_TFT_382_V_SF1_Q6","C3_TF_targets","C3_TFT_382_V_SF1_Q6",253,-1.0092,0.46,0.54,-0.8006,0.96,1,-1.191,0.088,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_109_PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_109_PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN",144,-1.0091,0.44,0.55,1.7181,0.0023,0.073,1.1241,0.21,0.84
"GO_BP:505078_GO_0035909_AORTA_MORPHOGENESIS","GO_BP","505078_GO_0035909_AORTA_MORPHOGENESIS",23,-1.009,0.45,0.62,-0.9714,0.48,1,-0.7403,0.85,1
"GO_BP:755392_GO_2001286_REGULATION_OF_CAVEOLIN_MEDIATED_ENDOCYTOSIS","GO_BP","755392_GO_2001286_REGULATION_OF_CAVEOLIN_MEDIATED_ENDOCYTOSIS",5,-1.009,0.47,0.62,0.9537,0.52,1,0.5136,0.97,1
"KEGG_compound:C00212_ADENOSINE","KEGG_compound","C00212_ADENOSINE",16,-1.0087,0.45,0.61,-0.7813,0.78,1,-1.5057,0.057,0.22
"GO_BP:491984_GO_0007184_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","491984_GO_0007184_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS",8,-1.0085,0.46,0.62,-1.4715,0.051,0.85,0.9319,0.53,0.92
"C4_Cancer_modules:C4_CM_148_MODULE_156","C4_Cancer_modules","C4_CM_148_MODULE_156",20,-1.0085,0.46,0.56,0.9044,0.6,0.84,-0.7883,0.78,0.98
"GO_BP:754939_GO_2000833_POSITIVE_REGULATION_OF_STEROID_HORMONE_SECRETION","GO_BP","754939_GO_2000833_POSITIVE_REGULATION_OF_STEROID_HORMONE_SECRETION",11,-1.0085,0.46,0.62,1.5389,0.045,0.36,0.9745,0.48,0.88
"C3_MicroRNA_targets:C3_MIR_47_GGCCAGT_MIR_193A_MIR_193B","C3_MicroRNA_targets","C3_MIR_47_GGCCAGT_MIR_193A_MIR_193B",87,-1.0084,0.46,0.61,-0.8467,0.78,1,-0.7934,0.9,1
"GO_BP:496523_GO_0016575_HISTONE_DEACETYLATION","GO_BP","496523_GO_0016575_HISTONE_DEACETYLATION",41,-1.0083,0.46,0.62,-1.115,0.27,0.94,-1.3483,0.082,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_1231_GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11","C2_Chemical_and_genetic_perturbations","C2_CGP_1231_GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11",62,-1.0083,0.44,0.55,0.7853,0.86,1,0.7621,0.91,1
"GO_BP:512803_GO_0051953_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT","GO_BP","512803_GO_0051953_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT",30,-1.0083,0.45,0.62,-1.1853,0.2,0.91,-1.0763,0.34,0.8
"GO_BP:494958_GO_0010894_NEGATIVE_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS","GO_BP","494958_GO_0010894_NEGATIVE_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS",20,-1.0082,0.43,0.62,-0.9346,0.56,1,-0.8969,0.63,0.93
"REACTOME:645304_REACT_121314_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM","REACTOME","645304_REACT_121314_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM",52,-1.0082,0.45,0.63,1.4275,0.034,0.2,1.3982,0.047,0.69
"GO_MF:496342_GO_0016289_COA_HYDROLASE_ACTIVITY","GO_MF","496342_GO_0016289_COA_HYDROLASE_ACTIVITY",18,-1.0081,0.46,0.64,-1.062,0.38,0.86,-1.0384,0.39,0.76
"GO_BP:503407_GO_0034201_RESPONSE_TO_OLEIC_ACID","GO_BP","503407_GO_0034201_RESPONSE_TO_OLEIC_ACID",6,-1.0081,0.48,0.62,-1.351,0.13,0.93,-1.0278,0.41,0.83
"GO_BP:492017_GO_0007219_NOTCH_SIGNALING_PATHWAY","GO_BP","492017_GO_0007219_NOTCH_SIGNALING_PATHWAY",132,-1.0079,0.45,0.62,-0.8029,0.9,1,-0.7793,0.94,1
"GO_BP:491695_GO_0006828_MANGANESE_ION_TRANSPORT","GO_BP","491695_GO_0006828_MANGANESE_ION_TRANSPORT",13,-1.0077,0.46,0.62,-1.2287,0.2,0.89,-0.9538,0.52,0.89
"C7_Immunologic_signatures:C7_ALL_244_GSE14308_TH2_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_244_GSE14308_TH2_VS_TH1_DN",198,-1.0076,0.44,0.56,0.7393,0.99,1,0.7833,0.97,1
"GO_BP:508245_GO_0045939_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS","GO_BP","508245_GO_0045939_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS",22,-1.0076,0.45,0.62,-0.8526,0.68,1,-0.7635,0.82,1
"GO_BP:752821_GO_0097320_MEMBRANE_TUBULATION","GO_BP","752821_GO_0097320_MEMBRANE_TUBULATION",11,-1.0075,0.44,0.62,0.8098,0.73,1,-0.8312,0.67,0.97
"C3_MicroRNA_targets:C3_MIR_121_CCATCCA_MIR_432","C3_MicroRNA_targets","C3_MIR_121_CCATCCA_MIR_432",56,-1.0075,0.43,0.61,-0.957,0.53,1,-0.7749,0.88,1
"GO_CC:490937_GO_0005942_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX","GO_CC","490937_GO_0005942_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX",18,-1.0075,0.45,0.71,0.9529,0.5,0.83,0.847,0.68,1
"KEGG_compound:C03069_3_METHYLCROTONYL_COA_3_METHYLBUT_2_ENOYL_COA_3_METHYLCROTONOYL_COA_DIMETHYLACRYLOYL_COA","KEGG_compound","C03069_3_METHYLCROTONYL_COA_3_METHYLBUT_2_ENOYL_COA_3_METHYLCROTONOYL_COA_DIMETHYLACRYLOYL_COA",7,-1.0075,0.47,0.61,1.2011,0.26,0.85,-1.6634,0.025,0.099
"GO_BP:501711_GO_0032479_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION","GO_BP","501711_GO_0032479_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION",111,-1.0074,0.43,0.62,1.034,0.38,0.96,-1.3664,0.032,0.59
"C3_MicroRNA_targets:C3_MIR_191_TCCAGAG_MIR_518C","C3_MicroRNA_targets","C3_MIR_191_TCCAGAG_MIR_518C",148,-1.0074,0.45,0.61,-0.9481,0.57,1,1.0902,0.23,1
"GO_BP:493269_GO_0009068_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS","GO_BP","493269_GO_0009068_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS",17,-1.0073,0.43,0.62,1.0349,0.43,0.96,0.8976,0.59,0.95
"GO_BP:512045_GO_0051135_POSITIVE_REGULATION_OF_NK_T_CELL_ACTIVATION","GO_BP","512045_GO_0051135_POSITIVE_REGULATION_OF_NK_T_CELL_ACTIVATION",5,-1.0073,0.47,0.62,-1.2214,0.26,0.88,-1.5299,0.046,0.53
"GO_MF:489485_GO_0004016_ADENYLATE_CYCLASE_ACTIVITY","GO_MF","489485_GO_0004016_ADENYLATE_CYCLASE_ACTIVITY",11,-1.0071,0.45,0.64,-1.0096,0.43,0.89,-1.3302,0.13,0.55
"GO_BP:495889_GO_0015758_GLUCOSE_TRANSPORT","GO_BP","495889_GO_0015758_GLUCOSE_TRANSPORT",71,-1.0071,0.45,0.62,0.9213,0.63,1,0.7441,0.94,1
"GO_BP:504298_GO_0035113_EMBRYONIC_APPENDAGE_MORPHOGENESIS","GO_BP","504298_GO_0035113_EMBRYONIC_APPENDAGE_MORPHOGENESIS",129,-1.007,0.45,0.62,-0.9145,0.67,1,1.2132,0.1,0.71
"C3_TF_targets:C3_TFT_561_TGACGTCA_V_ATF3_Q6","C3_TF_targets","C3_TFT_561_TGACGTCA_V_ATF3_Q6",228,-1.007,0.45,0.55,0.8051,0.96,1,-0.9175,0.72,0.89
"C7_Immunologic_signatures:C7_ALL_243_GSE14308_TH2_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_243_GSE14308_TH2_VS_TH1_UP",199,-1.0069,0.45,0.56,1.2077,0.07,0.21,0.8831,0.79,1
"C3_TF_targets:C3_TFT_606_TGACCTTG_V_SF1_Q6","C3_TF_targets","C3_TFT_606_TGACCTTG_V_SF1_Q6",244,-1.0068,0.46,0.55,1.0615,0.28,1,-0.9864,0.48,0.79
"GO_CC:506288_GO_0043220_SCHMIDT_LANTERMAN_INCISURE","GO_CC","506288_GO_0043220_SCHMIDT_LANTERMAN_INCISURE",12,-1.0067,0.45,0.71,0.5398,0.98,1,-0.7536,0.8,1
"REACTOME:105934_REACT_11049_FORMATION_OF_ANNULAR_GAP_JUNCTIONS","REACTOME","105934_REACT_11049_FORMATION_OF_ANNULAR_GAP_JUNCTIONS",9,-1.0066,0.44,0.63,1.1933,0.27,0.45,0.6602,0.91,1
"GO_BP:754000_GO_1901030_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","754000_GO_1901030_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",33,-1.0066,0.45,0.62,0.5743,0.98,1,-0.9998,0.45,0.85
"OMIM_gene:OMIM602880_GROWTH_DIFFERENTIATION_FACTOR_1_GDF1","OMIM_gene","OMIM602880_GROWTH_DIFFERENTIATION_FACTOR_1_GDF1",5,-1.0066,0.48,0.78,-1.3396,0.15,0.82,-1.6287,0.014,1
"GO_BP:516696_GO_0071773_CELLULAR_RESPONSE_TO_BMP_STIMULUS","GO_BP","516696_GO_0071773_CELLULAR_RESPONSE_TO_BMP_STIMULUS",20,-1.0065,0.43,0.62,-0.9578,0.53,1,1.6664,0.01,0.39
"C2_Chemical_and_genetic_perturbations:C2_CGP_734_HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2","C2_Chemical_and_genetic_perturbations","C2_CGP_734_HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2",18,-1.0064,0.45,0.56,0.7737,0.78,1,-1.3539,0.088,0.39
"GO_BP:753120_GO_1900125_REGULATION_OF_HYALURONAN_BIOSYNTHETIC_PROCESS","GO_BP","753120_GO_1900125_REGULATION_OF_HYALURONAN_BIOSYNTHETIC_PROCESS",6,-1.0064,0.47,0.62,0.6228,0.9,1,-1.1587,0.28,0.74
"C3_TF_targets:C3_TFT_51_ACAWNRNSRCGG_UNKNOWN","C3_TF_targets","C3_TFT_51_ACAWNRNSRCGG_UNKNOWN",63,-1.0064,0.45,0.55,-0.7389,0.92,1,-0.9078,0.64,0.91
"C3_MicroRNA_targets:C3_MIR_109_TATCTGG_MIR_488","C3_MicroRNA_targets","C3_MIR_109_TATCTGG_MIR_488",62,-1.0064,0.45,0.61,0.62,0.99,1,0.8454,0.77,1
"GO_BP:506547_GO_0043516_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR","GO_BP","506547_GO_0043516_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",27,-1.0062,0.46,0.62,0.8867,0.66,1,-1.259,0.16,0.67
"GO_CC:925888_GO_0097546_CILIARY_BASE","GO_CC","925888_GO_0097546_CILIARY_BASE",21,-1.0062,0.46,0.71,1.1501,0.28,0.59,-1.0406,0.39,0.99
"GO_BP:513587_GO_0060029_CONVERGENT_EXTENSION_INVOLVED_IN_ORGANOGENESIS","GO_BP","513587_GO_0060029_CONVERGENT_EXTENSION_INVOLVED_IN_ORGANOGENESIS",6,-1.0062,0.48,0.62,1.4205,0.082,0.53,1.4301,0.08,0.61
"C7_Immunologic_signatures:C7_ALL_467_GSE17721_CTRL_VS_POLYIC_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_467_GSE17721_CTRL_VS_POLYIC_2H_BMDM_UP",197,-1.006,0.44,0.56,1.1541,0.14,0.31,-1.0527,0.32,0.61
"C7_Immunologic_signatures:C7_ALL_1164_GSE27786_LIN_NEG_VS_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1164_GSE27786_LIN_NEG_VS_CD4_TCELL_DN",198,-1.0059,0.47,0.56,0.7779,0.98,1,-1.1065,0.21,0.48
"GO_BP:495243_GO_0014848_URINARY_TRACT_SMOOTH_MUSCLE_CONTRACTION","GO_BP","495243_GO_0014848_URINARY_TRACT_SMOOTH_MUSCLE_CONTRACTION",9,-1.0059,0.47,0.62,-0.695,0.84,1,0.932,0.52,0.92
"GO_BP:514620_GO_0061072_IRIS_MORPHOGENESIS","GO_BP","514620_GO_0061072_IRIS_MORPHOGENESIS",7,-1.0057,0.47,0.62,-0.8028,0.71,1,1.1428,0.31,0.73
"GO_BP:517266_GO_0072350_TRICARBOXYLIC_ACID_METABOLIC_PROCESS","GO_BP","517266_GO_0072350_TRICARBOXYLIC_ACID_METABOLIC_PROCESS",37,-1.0057,0.45,0.62,1.5244,0.029,0.37,-1.5082,0.043,0.54
"GO_BP:491899_GO_0007076_MITOTIC_CHROMOSOME_CONDENSATION","GO_BP","491899_GO_0007076_MITOTIC_CHROMOSOME_CONDENSATION",13,-1.0056,0.44,0.62,-1.0102,0.42,0.98,-1.2309,0.22,0.7
"GO_BP:486996_GO_0000578_EMBRYONIC_AXIS_SPECIFICATION","GO_BP","486996_GO_0000578_EMBRYONIC_AXIS_SPECIFICATION",37,-1.0054,0.45,0.62,-0.9928,0.44,1,-0.9438,0.56,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_913_CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_913_CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP",5,-1.0054,0.47,0.56,0.8149,0.69,0.98,0.7746,0.75,1
"GO_MF:509792_GO_0047617_ACYL_COA_HYDROLASE_ACTIVITY","GO_MF","509792_GO_0047617_ACYL_COA_HYDROLASE_ACTIVITY",14,-1.0053,0.46,0.65,-1.1137,0.32,0.82,-0.9862,0.48,0.79
"KEGG_pathway:HSA00430_TAURINE_AND_HYPOTAURINE_METABOLISM","KEGG_pathway","HSA00430_TAURINE_AND_HYPOTAURINE_METABOLISM",10,-1.0052,0.45,0.51,0.9062,0.57,1,-0.8384,0.68,0.9
"C4_Cancer_modules:C4_CM_330_MODULE_392","C4_Cancer_modules","C4_CM_330_MODULE_392",18,-1.005,0.44,0.57,1.1255,0.32,0.49,-1.884,0.0062,0.027
"GO_BP:489113_GO_0003321_POSITIVE_REGULATION_OF_BLOOD_PRESSURE_BY_EPINEPHRINE_NOREPINEPHRINE","GO_BP","489113_GO_0003321_POSITIVE_REGULATION_OF_BLOOD_PRESSURE_BY_EPINEPHRINE_NOREPINEPHRINE",7,-1.0049,0.47,0.62,1.2964,0.19,0.67,1.0769,0.37,0.78
"GO_MF:512029_GO_0051117_ATPASE_BINDING","GO_MF","512029_GO_0051117_ATPASE_BINDING",45,-1.0049,0.44,0.65,-0.7036,0.94,1,-1.0738,0.32,0.72
"C3_TF_targets:C3_TFT_9_V_ELK1_01","C3_TF_targets","C3_TFT_9_V_ELK1_01",266,-1.0047,0.47,0.55,1.4187,0.0025,0.29,0.9288,0.68,1
"C3_TF_targets:C3_TFT_289_V_AR_01","C3_TF_targets","C3_TFT_289_V_AR_01",153,-1.0047,0.45,0.55,-0.6876,0.99,1,0.9821,0.47,1
"GO_BP:752765_GO_0097264_SELF_PROTEOLYSIS","GO_BP","752765_GO_0097264_SELF_PROTEOLYSIS",5,-1.0047,0.48,0.62,0.989,0.47,0.99,-0.8905,0.6,0.93
"GO_BP:510857_GO_0048806_GENITALIA_DEVELOPMENT","GO_BP","510857_GO_0048806_GENITALIA_DEVELOPMENT",44,-1.0047,0.45,0.62,0.914,0.59,1,1.1437,0.23,0.73
"C1_Positional:C1_ALL_1_CHR5Q23","C1_Positional","C1_ALL_1_CHR5Q23",57,-1.0046,0.44,0.88,1.3297,0.049,0.5,0.9508,0.55,0.81
"C7_Immunologic_signatures:C7_ALL_1456_GSE360_L_MAJOR_VS_T_GONDII_DC_DN","C7_Immunologic_signatures","C7_ALL_1456_GSE360_L_MAJOR_VS_T_GONDII_DC_DN",193,-1.0046,0.46,0.56,-1.0871,0.27,1,1.1055,0.2,0.98
"GO_MF:489648_GO_0004190_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_MF","489648_GO_0004190_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY",23,-1.0045,0.46,0.65,0.8865,0.64,0.99,0.8244,0.73,1
"REACTOME:1127515_REACT_264567_REPRESSION_OF_WNT_TARGET_GENES","REACTOME","1127515_REACT_264567_REPRESSION_OF_WNT_TARGET_GENES",13,-1.0045,0.46,0.64,-0.6815,0.89,1,0.8931,0.58,1
"KEGG_compound:C00327_L_CITRULLINE_2_AMINO_5_UREIDOVALERIC_ACID_CITRULLINE","KEGG_compound","C00327_L_CITRULLINE_2_AMINO_5_UREIDOVALERIC_ACID_CITRULLINE",5,-1.0045,0.46,0.61,-1.105,0.36,0.92,0.8701,0.6,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1410_REN_BOUND_BY_E2F","C2_Chemical_and_genetic_perturbations","C2_CGP_1410_REN_BOUND_BY_E2F",61,-1.0044,0.44,0.56,1.0394,0.37,0.73,-1.6159,0,0.23
"C2_Chemical_and_genetic_perturbations:C2_CGP_980_GROSS_HIF1A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_980_GROSS_HIF1A_TARGETS_UP",8,-1.0043,0.46,0.56,0.9271,0.55,0.9,0.7651,0.79,1
"REACTOME:1183549_REACT_355405_C_TYPE_LECTIN_RECEPTORS_CLRS_","REACTOME","1183549_REACT_355405_C_TYPE_LECTIN_RECEPTORS_CLRS_",124,-1.0043,0.45,0.64,1.5171,0.0047,0.14,-1.0664,0.31,0.75
"GO_MF:499765_GO_0030374_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_TRANSCRIPTION_COACTIVATOR_ACTIVITY","GO_MF","499765_GO_0030374_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_TRANSCRIPTION_COACTIVATOR_ACTIVITY",50,-1.0043,0.46,0.65,-0.809,0.81,1,-1.1044,0.28,0.7
"C7_Immunologic_signatures:C7_ALL_630_GSE17721_POLYIC_VS_CPG_12H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_630_GSE17721_POLYIC_VS_CPG_12H_BMDM_DN",195,-1.0042,0.46,0.56,1.2098,0.063,0.21,-0.8334,0.9,1
"GO_BP:514585_GO_0061037_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT","GO_BP","514585_GO_0061037_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT",22,-1.0041,0.44,0.62,-1.6259,0.024,0.7,1.6199,0.022,0.4
"C6_Oncogenic_signatures:C6_ALL_91_DCA_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_91_DCA_UP_V1_DN",174,-1.0038,0.47,0.51,-1.1481,0.18,0.48,-0.947,0.61,0.69
"GO_BP:1025320_GO_0044854_PLASMA_MEMBRANE_RAFT_ASSEMBLY","GO_BP","1025320_GO_0044854_PLASMA_MEMBRANE_RAFT_ASSEMBLY",5,-1.0036,0.47,0.62,-0.6576,0.88,1,1.5363,0.052,0.52
"KEGG_module:HSA_M00077_CHONDROITIN_SULFATE_DEGRADATION","KEGG_module","HSA_M00077_CHONDROITIN_SULFATE_DEGRADATION",8,-1.0036,0.46,0.73,-0.8316,0.66,1,1.0183,0.42,1
"KEGG_compound:C05689_SE_METHYL_L_SELENOCYSTEINE","KEGG_compound","C05689_SE_METHYL_L_SELENOCYSTEINE",5,-1.0035,0.47,0.61,-0.8747,0.63,1,-1.5047,0.037,0.22
"GO_BP:494822_GO_0010757_NEGATIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION","GO_BP","494822_GO_0010757_NEGATIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION",5,-1.0035,0.49,0.62,-0.814,0.68,1,1.1144,0.36,0.75
"C7_Immunologic_signatures:C7_ALL_1125_GSE2706_R848_VS_LPS_2H_STIM_DC_UP","C7_Immunologic_signatures","C7_ALL_1125_GSE2706_R848_VS_LPS_2H_STIM_DC_UP",171,-1.0035,0.46,0.56,-0.8319,0.9,1,1.1195,0.19,0.95
"C4_Cancer_modules:C4_CM_398_MODULE_505","C4_Cancer_modules","C4_CM_398_MODULE_505",15,-1.0034,0.45,0.57,1.351,0.11,0.23,-1.7048,0.0084,0.079
"C1_Positional:C1_ALL_31_CHR2Q22","C1_Positional","C1_ALL_31_CHR2Q22",17,-1.0034,0.47,0.88,0.7209,0.88,0.99,-0.7209,0.86,0.99
"GO_MF:504435_GO_0035251_UDP_GLUCOSYLTRANSFERASE_ACTIVITY","GO_MF","504435_GO_0035251_UDP_GLUCOSYLTRANSFERASE_ACTIVITY",9,-1.0033,0.45,0.65,0.9341,0.52,0.94,-1.2197,0.23,0.57
"GO_BP:513999_GO_0060444_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS","GO_BP","513999_GO_0060444_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS",23,-1.0033,0.44,0.62,-0.7296,0.86,1,0.8894,0.64,0.95
"C3_TF_targets:C3_TFT_364_V_ETF_Q6","C3_TF_targets","C3_TFT_364_V_ETF_Q6",114,-1.0033,0.47,0.55,1.0229,0.39,1,-0.9013,0.7,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1331_BECKER_TAMOXIFEN_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1331_BECKER_TAMOXIFEN_RESISTANCE_UP",49,-1.0033,0.47,0.56,-0.8473,0.74,1,-1.159,0.2,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_339_WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_339_WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN",196,-1.0032,0.47,0.56,1.3125,0.027,0.38,0.9777,0.53,0.96
"C7_Immunologic_signatures:C7_ALL_67_GSE11057_CD4_EFF_MEM_VS_PBMC_UP","C7_Immunologic_signatures","C7_ALL_67_GSE11057_CD4_EFF_MEM_VS_PBMC_UP",197,-1.0032,0.46,0.57,0.9197,0.72,0.98,-1.2517,0.044,0.19
"GO_BP:506407_GO_0043368_POSITIVE_T_CELL_SELECTION","GO_BP","506407_GO_0043368_POSITIVE_T_CELL_SELECTION",19,-1.0031,0.45,0.63,-1.343,0.11,0.92,-0.7945,0.75,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2702_DING_LUNG_CANCER_BY_MUTATION_RATE","C2_Chemical_and_genetic_perturbations","C2_CGP_2702_DING_LUNG_CANCER_BY_MUTATION_RATE",20,-1.0031,0.46,0.56,-0.8414,0.71,1,0.7622,0.83,1
"C7_Immunologic_signatures:C7_ALL_1307_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1307_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP",192,-1.003,0.48,0.57,0.8011,0.93,1,-0.7905,0.97,1
"GO_BP:488133_GO_0002260_LYMPHOCYTE_HOMEOSTASIS","GO_BP","488133_GO_0002260_LYMPHOCYTE_HOMEOSTASIS",52,-1.003,0.43,0.63,0.9146,0.62,1,-0.9434,0.57,0.89
"C4_Cancer_gene_neighborhoods:C4_CGN_280_CAR_TNFRSF25","C4_Cancer_gene_neighborhoods","C4_CGN_280_CAR_TNFRSF25",29,-1.003,0.45,0.71,-0.897,0.63,1,0.8168,0.78,1
"C3_MicroRNA_targets:C3_MIR_153_TCTGATA_MIR_361","C3_MicroRNA_targets","C3_MIR_153_TCTGATA_MIR_361",91,-1.0027,0.48,0.61,1.0349,0.37,1,-0.9506,0.53,1
"GO_BP:512185_GO_0051301_CELL_DIVISION","GO_BP","512185_GO_0051301_CELL_DIVISION",459,-1.0027,0.48,0.63,1.0417,0.32,0.96,-1.1147,0.11,0.76
"GO_BP:505859_GO_0042753_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM","GO_BP","505859_GO_0042753_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM",16,-1.0027,0.46,0.63,1.3096,0.15,0.66,1.037,0.41,0.82
"GO_BP:492005_GO_0007207_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","492005_GO_0007207_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY",6,-1.0027,0.49,0.63,0.9152,0.54,1,1.3786,0.12,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2910_MIKKELSEN_ES_HCP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2910_MIKKELSEN_ES_HCP_WITH_H3K27ME3",40,-1.0026,0.45,0.56,1.4169,0.043,0.28,2.1242,0,0.038
"C7_Immunologic_signatures:C7_ALL_902_GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN","C7_Immunologic_signatures","C7_ALL_902_GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN",199,-1.0025,0.48,0.57,1.4618,0.0069,0.019,-0.7098,1,1
"REACTOME:187228_REACT_23832_NEPHRIN_INTERACTIONS","REACTOME","187228_REACT_23832_NEPHRIN_INTERACTIONS",22,-1.0024,0.45,0.64,-1.0118,0.45,0.99,-1.401,0.066,0.42
"GO_BP:501341_GO_0032104_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS","GO_BP","501341_GO_0032104_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS",64,-1.0022,0.47,0.63,-0.7174,0.94,1,-0.8506,0.75,0.96
"GO_BP:487140_GO_0000910_CYTOKINESIS","GO_BP","487140_GO_0000910_CYTOKINESIS",96,-1.0022,0.46,0.63,0.9993,0.44,0.98,0.7011,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2631_SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL","C2_Chemical_and_genetic_perturbations","C2_CGP_2631_SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL",65,-1.0021,0.46,0.57,-0.6047,0.99,1,-1.2289,0.099,0.49
"C7_Immunologic_signatures:C7_ALL_247_GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_247_GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP",198,-1.002,0.48,0.57,1.1707,0.096,0.28,-0.831,0.92,1
"GO_BP:505484_GO_0042340_KERATAN_SULFATE_CATABOLIC_PROCESS","GO_BP","505484_GO_0042340_KERATAN_SULFATE_CATABOLIC_PROCESS",12,-1.0019,0.45,0.63,0.6455,0.92,1,1.0689,0.36,0.78
"GO_CC:501205_GO_0031965_NUCLEAR_MEMBRANE","GO_CC","501205_GO_0031965_NUCLEAR_MEMBRANE",256,-1.0019,0.48,0.72,0.9701,0.51,0.82,-1.0439,0.33,1
"C3_MicroRNA_targets:C3_MIR_101_CCCACAT_MIR_299_3P","C3_MicroRNA_targets","C3_MIR_101_CCCACAT_MIR_299_3P",54,-1.0018,0.47,0.61,0.9168,0.64,1,-0.9755,0.51,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_899_REN_MIF_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_899_REN_MIF_TARGETS_DN",5,-1.0017,0.48,0.57,0.6212,0.9,1,-1.4199,0.1,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_3140_CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY","C2_Chemical_and_genetic_perturbations","C2_CGP_3140_CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY",38,-1.0017,0.46,0.57,-0.9414,0.52,1,-1.033,0.37,0.71
"GO_BP:518421_GO_0090281_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT","GO_BP","518421_GO_0090281_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT",5,-1.0016,0.47,0.63,0.9681,0.5,1,1.4619,0.07,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_1259_CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1259_CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN",21,-1.0015,0.46,0.57,1.1133,0.3,0.61,0.6716,0.91,1
"GO_MF:490481_GO_0005247_VOLTAGE_GATED_CHLORIDE_CHANNEL_ACTIVITY","GO_MF","490481_GO_0005247_VOLTAGE_GATED_CHLORIDE_CHANNEL_ACTIVITY",9,-1.0015,0.47,0.65,-1.1648,0.28,0.8,-0.8736,0.61,0.9
"GO_BP:512330_GO_0051452_INTRACELLULAR_PH_REDUCTION","GO_BP","512330_GO_0051452_INTRACELLULAR_PH_REDUCTION",24,-1.0014,0.48,0.63,-0.6147,0.96,1,0.5453,1,1
"GO_BP:505750_GO_0042636_NEGATIVE_REGULATION_OF_HAIR_CYCLE","GO_BP","505750_GO_0042636_NEGATIVE_REGULATION_OF_HAIR_CYCLE",5,-1.0014,0.47,0.63,-0.7034,0.81,1,-1.4081,0.1,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_204_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_204_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN",10,-1.0014,0.47,0.57,1.188,0.25,0.51,-1.0633,0.39,0.68
"GO_BP:495061_GO_0010996_RESPONSE_TO_AUDITORY_STIMULUS","GO_BP","495061_GO_0010996_RESPONSE_TO_AUDITORY_STIMULUS",15,-1.0012,0.46,0.63,-0.7905,0.76,1,1.2113,0.21,0.71
"GO_CC:490806_GO_0005776_AUTOPHAGIC_VACUOLE","GO_CC","490806_GO_0005776_AUTOPHAGIC_VACUOLE",53,-1.0012,0.46,0.72,-0.552,1,1,-0.7243,0.93,1
"GO_BP:494624_GO_0010559_REGULATION_OF_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS","GO_BP","494624_GO_0010559_REGULATION_OF_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS",29,-1.0011,0.44,0.63,-0.7402,0.85,1,-0.837,0.71,0.97
"KEGG_pathway:HSA00630_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM","KEGG_pathway","HSA00630_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM",28,-1.0011,0.47,0.52,0.9025,0.61,1,-1.2076,0.17,0.36
"C4_Cancer_modules:C4_CM_177_MODULE_189","C4_Cancer_modules","C4_CM_177_MODULE_189",23,-1.0011,0.46,0.57,0.9321,0.57,0.81,-1.5866,0.02,0.12
"REACTOME:477122_REACT_111119_ANTIGEN_PROCESSING_CROSS_PRESENTATION","REACTOME","477122_REACT_111119_ANTIGEN_PROCESSING_CROSS_PRESENTATION",81,-1.001,0.46,0.64,1.8816,0,0.0099,0.5936,1,1
"GO_MF:492725_GO_0008430_SELENIUM_BINDING","GO_MF","492725_GO_0008430_SELENIUM_BINDING",14,-1.001,0.47,0.65,1.0592,0.37,0.83,0.6601,0.93,1
"GO_BP:1022088_GO_0044851_HAIR_CYCLE_PHASE","GO_BP","1022088_GO_0044851_HAIR_CYCLE_PHASE",14,-1.0009,0.46,0.63,-1.3794,0.11,0.99,-0.8061,0.72,0.98
"GO_MF:515499_GO_0070569_URIDYLYLTRANSFERASE_ACTIVITY","GO_MF","515499_GO_0070569_URIDYLYLTRANSFERASE_ACTIVITY",7,-1.0007,0.47,0.65,-1.0711,0.36,0.86,-0.7947,0.7,0.97
"GO_BP:515764_GO_0070836_CAVEOLA_ASSEMBLY","GO_BP","515764_GO_0070836_CAVEOLA_ASSEMBLY",5,-1.0007,0.48,0.63,-0.6825,0.83,1,1.5618,0.038,0.49
"C1_Positional:C1_ALL_255_CHR2P25","C1_Positional","C1_ALL_255_CHR2P25",54,-1.0006,0.47,0.88,1.4663,0.019,0.3,0.8092,0.81,0.92
"C3_TF_targets:C3_TFT_125_V_CREB_Q4","C3_TF_targets","C3_TFT_125_V_CREB_Q4",264,-1.0006,0.47,0.56,-0.9104,0.76,0.95,-0.8776,0.86,0.96
"GO_BP:494119_GO_0010039_RESPONSE_TO_IRON_ION","GO_BP","494119_GO_0010039_RESPONSE_TO_IRON_ION",24,-1.0005,0.46,0.63,1.1798,0.19,0.8,-1.0956,0.32,0.78
"GO_BP:491466_GO_0006570_TYROSINE_METABOLIC_PROCESS","GO_BP","491466_GO_0006570_TYROSINE_METABOLIC_PROCESS",9,-1.0005,0.48,0.63,-0.9513,0.52,1,0.7521,0.77,1
"GO_BP:487512_GO_0001574_GANGLIOSIDE_BIOSYNTHETIC_PROCESS","GO_BP","487512_GO_0001574_GANGLIOSIDE_BIOSYNTHETIC_PROCESS",7,-1.0005,0.48,0.63,0.6179,0.93,1,0.9309,0.52,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_731_LA_MEN1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_731_LA_MEN1_TARGETS",22,-1.0005,0.44,0.57,-0.7714,0.79,1,0.8139,0.75,1
"C7_Immunologic_signatures:C7_ALL_1154_GSE27786_LSK_VS_NKTCELL_DN","C7_Immunologic_signatures","C7_ALL_1154_GSE27786_LSK_VS_NKTCELL_DN",199,-1.0004,0.48,0.57,1.139,0.15,0.34,0.774,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2970_KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2970_KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN",46,-1.0003,0.45,0.57,1.3326,0.067,0.36,-1.3942,0.048,0.36
"GO_BP:508364_GO_0046068_CGMP_METABOLIC_PROCESS","GO_BP","508364_GO_0046068_CGMP_METABOLIC_PROCESS",23,-1.0003,0.47,0.63,-1.003,0.45,0.99,-0.9595,0.53,0.88
"GO_BP:1144982_GO_1903844_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS","GO_BP","1144982_GO_1903844_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS",101,-1.0002,0.45,0.63,0.9958,0.47,0.98,0.7762,0.92,1
"GO_BP:513602_GO_0060044_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION","GO_BP","513602_GO_0060044_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION",8,-1.0002,0.47,0.63,0.97,0.51,1,1.268,0.2,0.69
"OMIM_gene:OMIM158343_ATP_BINDING_CASSETTE_SUBFAMILY_C_MEMBER_1_ABCC1","OMIM_gene","OMIM158343_ATP_BINDING_CASSETTE_SUBFAMILY_C_MEMBER_1_ABCC1",5,-1.0001,0.48,0.77,-1.0965,0.39,1,0.6051,0.92,1
"GO_BP:501874_GO_0032648_REGULATION_OF_INTERFERON_BETA_PRODUCTION","GO_BP","501874_GO_0032648_REGULATION_OF_INTERFERON_BETA_PRODUCTION",37,-1.0001,0.46,0.63,-0.7393,0.88,1,-1.2671,0.15,0.67
"C7_Immunologic_signatures:C7_ALL_571_GSE17721_PAM3CSK4_VS_CPG_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_571_GSE17721_PAM3CSK4_VS_CPG_6H_BMDM_UP",200,-1.0001,0.47,0.57,0.9746,0.51,0.82,-1.0415,0.35,0.63
"GO_BP:754262_GO_1901298_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH","GO_BP","754262_GO_1901298_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH",6,-1.0001,0.48,0.63,1.757,0.004,0.13,1.2503,0.23,0.7
"GO_BP:506274_GO_0043206_EXTRACELLULAR_FIBRIL_ORGANIZATION","GO_BP","506274_GO_0043206_EXTRACELLULAR_FIBRIL_ORGANIZATION",12,-0.9997,0.46,0.63,0.6415,0.9,1,0.5185,0.98,1
"C1_Positional:C1_ALL_204_CHR8Q23","C1_Positional","C1_ALL_204_CHR8Q23",23,-0.9997,0.47,0.88,1.3586,0.084,0.46,0.8655,0.68,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_536_NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_536_NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP",29,-0.9996,0.47,0.57,-0.8123,0.73,1,-0.866,0.68,0.91
"GO_BP:488456_GO_0002583_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN","GO_BP","488456_GO_0002583_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN",7,-0.9995,0.48,0.63,-1.4951,0.056,0.81,-1.1848,0.26,0.73
"GO_MF:495529_GO_0015278_CALCIUM_RELEASE_CHANNEL_ACTIVITY","GO_MF","495529_GO_0015278_CALCIUM_RELEASE_CHANNEL_ACTIVITY",15,-0.9995,0.46,0.65,-1.2173,0.22,0.83,0.6017,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_933_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_933_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN",45,-0.9993,0.47,0.57,1.2044,0.19,0.49,-0.8503,0.74,0.92
"GO_BP:503576_GO_0034374_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING","GO_BP","503576_GO_0034374_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING",10,-0.9992,0.48,0.63,0.9053,0.57,1,1.2349,0.21,0.7
"GO_BP:495217_GO_0014821_PHASIC_SMOOTH_MUSCLE_CONTRACTION","GO_BP","495217_GO_0014821_PHASIC_SMOOTH_MUSCLE_CONTRACTION",16,-0.9991,0.47,0.63,-1.0004,0.44,0.99,-0.9931,0.47,0.85
"GO_MF:498730_GO_0019966_INTERLEUKIN_1_BINDING","GO_MF","498730_GO_0019966_INTERLEUKIN_1_BINDING",7,-0.999,0.45,0.65,0.6706,0.88,1,1.2435,0.21,0.68
"C4_Cancer_modules:C4_CM_397_MODULE_503","C4_Cancer_modules","C4_CM_397_MODULE_503",108,-0.9989,0.45,0.58,0.9496,0.58,0.78,-0.9936,0.46,0.7
"C7_Immunologic_signatures:C7_ALL_1356_GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1356_GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN",199,-0.9989,0.47,0.57,1.232,0.073,0.18,-1.227,0.073,0.23
"GO_BP:492342_GO_0007601_VISUAL_PERCEPTION","GO_BP","492342_GO_0007601_VISUAL_PERCEPTION",195,-0.9988,0.47,0.63,-1.3952,0.018,1,-1.0627,0.28,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2995_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2995_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN",9,-0.9988,0.47,0.57,0.8266,0.69,0.98,0.7671,0.77,1
"GO_MF:500684_GO_0031433_TELETHONIN_BINDING","GO_MF","500684_GO_0031433_TELETHONIN_BINDING",5,-0.9987,0.48,0.65,-1.7665,0.0019,0.23,1.2356,0.24,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2498_PALOMERO_GSI_SENSITIVITY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2498_PALOMERO_GSI_SENSITIVITY_DN",6,-0.9986,0.49,0.57,0.5667,0.95,1,0.7961,0.7,1
"GO_BP:516466_GO_0071542_DOPAMINERGIC_NEURON_DIFFERENTIATION","GO_BP","516466_GO_0071542_DOPAMINERGIC_NEURON_DIFFERENTIATION",12,-0.9985,0.44,0.63,1.0244,0.42,0.97,0.9253,0.55,0.92
"GO_BP:506427_GO_0043388_POSITIVE_REGULATION_OF_DNA_BINDING","GO_BP","506427_GO_0043388_POSITIVE_REGULATION_OF_DNA_BINDING",35,-0.9985,0.48,0.63,1.3755,0.086,0.58,-0.9105,0.6,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_2866_HAHTOLA_CTCL_CUTANEOUS","C2_Chemical_and_genetic_perturbations","C2_CGP_2866_HAHTOLA_CTCL_CUTANEOUS",25,-0.9984,0.46,0.57,1.5505,0.045,0.17,0.9047,0.59,1
"C3_TF_targets:C3_TFT_322_V_ARNT_02","C3_TF_targets","C3_TFT_322_V_ARNT_02",247,-0.9984,0.48,0.56,0.9629,0.55,1,-1.0385,0.34,0.65
"GO_BP:503075_GO_0033866_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","503075_GO_0033866_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS",17,-0.9984,0.48,0.63,-0.9401,0.55,1,-0.7505,0.81,1
"GO_BP:494381_GO_0010310_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS","GO_BP","494381_GO_0010310_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS",11,-0.9983,0.46,0.63,-0.5961,0.94,1,0.9662,0.51,0.89
"GO_CC:515097_GO_0070160_OCCLUDING_JUNCTION","GO_CC","515097_GO_0070160_OCCLUDING_JUNCTION",108,-0.9983,0.49,0.72,-1.0364,0.37,0.84,0.932,0.63,1
"KEGG_pathway:HSA04744_PHOTOTRANSDUCTION","KEGG_pathway","HSA04744_PHOTOTRANSDUCTION",26,-0.9982,0.48,0.52,-1.4664,0.045,0.42,-0.8595,0.68,0.89
"C3_MicroRNA_targets:C3_MIR_128_CTACTAG_MIR_325","C3_MicroRNA_targets","C3_MIR_128_CTACTAG_MIR_325",18,-0.998,0.45,0.62,-1.006,0.44,1,-0.5467,0.98,1
"C4_Cancer_gene_neighborhoods:C4_CGN_235_GCM_IL6ST","C4_Cancer_gene_neighborhoods","C4_CGN_235_GCM_IL6ST",54,-0.9979,0.46,0.72,1.4149,0.027,0.056,-0.6437,0.99,1
"GO_BP:487517_GO_0001578_MICROTUBULE_BUNDLE_FORMATION","GO_BP","487517_GO_0001578_MICROTUBULE_BUNDLE_FORMATION",41,-0.9978,0.48,0.63,1.0752,0.32,0.93,0.8187,0.77,1
"GO_BP:510386_GO_0048278_VESICLE_DOCKING","GO_BP","510386_GO_0048278_VESICLE_DOCKING",64,-0.9978,0.48,0.63,-0.8715,0.71,1,-0.8998,0.68,0.93
"GO_MF:496393_GO_0016405_COA_LIGASE_ACTIVITY","GO_MF","496393_GO_0016405_COA_LIGASE_ACTIVITY",8,-0.9977,0.49,0.65,-1.1283,0.32,0.82,-1.3252,0.17,0.55
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_197_BIOCARTA_41BB_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_197_BIOCARTA_41BB_PATHWAY",17,-0.9975,0.46,0.59,-1.0636,0.37,1,-0.9847,0.49,0.78
"GO_CC:750791_GO_0002199_ZONA_PELLUCIDA_RECEPTOR_COMPLEX","GO_CC","750791_GO_0002199_ZONA_PELLUCIDA_RECEPTOR_COMPLEX",10,-0.9975,0.48,0.72,1.1104,0.32,0.63,-1.1461,0.28,0.87
"C7_Immunologic_signatures:C7_ALL_426_GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN","C7_Immunologic_signatures","C7_ALL_426_GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN",200,-0.9972,0.46,0.58,1.4077,0.0052,0.035,0.7341,1,1
"REACTOME:119575_REACT_19188_INOSITOL_TRANSPORTERS","REACTOME","119575_REACT_19188_INOSITOL_TRANSPORTERS",7,-0.997,0.45,0.65,-1.1852,0.27,0.85,-1.6972,0.0099,0.22
"GO_BP:501344_GO_0032107_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS","GO_BP","501344_GO_0032107_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS",64,-0.997,0.46,0.63,-0.7122,0.95,1,-0.8568,0.76,0.96
"C4_Cancer_modules:C4_CM_318_MODULE_372","C4_Cancer_modules","C4_CM_318_MODULE_372",24,-0.9968,0.47,0.58,-0.9674,0.53,0.85,-1.5779,0.026,0.12
"GO_BP:505546_GO_0042403_THYROID_HORMONE_METABOLIC_PROCESS","GO_BP","505546_GO_0042403_THYROID_HORMONE_METABOLIC_PROCESS",14,-0.9968,0.49,0.63,1.013,0.42,0.97,0.9447,0.54,0.91
"GO_MF:496949_GO_0017154_SEMAPHORIN_RECEPTOR_ACTIVITY","GO_MF","496949_GO_0017154_SEMAPHORIN_RECEPTOR_ACTIVITY",10,-0.9967,0.46,0.65,-1.1273,0.28,0.81,-0.9791,0.48,0.8
"GO_BP:514042_GO_0060487_LUNG_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","514042_GO_0060487_LUNG_EPITHELIAL_CELL_DIFFERENTIATION",26,-0.9967,0.47,0.63,0.9538,0.53,1,1.1043,0.3,0.76
"GO_BP:948897_GO_1902742_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT","GO_BP","948897_GO_1902742_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT",22,-0.9967,0.47,0.63,-1.2253,0.2,0.88,-0.6561,0.95,1
"GO_MF:496046_GO_0015924_MANNOSYL_OLIGOSACCHARIDE_MANNOSIDASE_ACTIVITY","GO_MF","496046_GO_0015924_MANNOSYL_OLIGOSACCHARIDE_MANNOSIDASE_ACTIVITY",10,-0.9966,0.48,0.65,-0.7922,0.75,1,-1.0556,0.39,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_818_FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES","C2_Chemical_and_genetic_perturbations","C2_CGP_818_FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES",7,-0.9966,0.49,0.57,0.9665,0.48,0.84,-0.662,0.89,0.99
"GO_BP:504817_GO_0035640_EXPLORATION_BEHAVIOR","GO_BP","504817_GO_0035640_EXPLORATION_BEHAVIOR",19,-0.9966,0.47,0.63,0.7319,0.88,1,0.8207,0.72,0.99
"C3_MicroRNA_targets:C3_MIR_221_GTAGGCA_MIR_189","C3_MicroRNA_targets","C3_MIR_221_GTAGGCA_MIR_189",28,-0.9965,0.47,0.62,-0.6729,0.95,1,-0.933,0.57,1
"GO_BP:506322_GO_0043255_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS","GO_BP","506322_GO_0043255_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS",84,-0.9963,0.47,0.63,0.816,0.84,1,0.9916,0.48,0.86
"C7_Immunologic_signatures:C7_ALL_600_GSE17721_LPS_VS_PAM3CSK4_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_600_GSE17721_LPS_VS_PAM3CSK4_0_5H_BMDM_DN",196,-0.9963,0.48,0.58,1.0472,0.35,0.6,0.8206,0.93,1
"GO_BP:519015_GO_2000369_REGULATION_OF_CLATHRIN_MEDIATED_ENDOCYTOSIS","GO_BP","519015_GO_2000369_REGULATION_OF_CLATHRIN_MEDIATED_ENDOCYTOSIS",11,-0.9962,0.47,0.63,0.4948,0.99,1,0.5177,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1475_WANG_TARGETS_OF_MLL_CBP_FUSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1475_WANG_TARGETS_OF_MLL_CBP_FUSION_UP",44,-0.9959,0.48,0.58,1.2251,0.17,0.46,-0.5996,0.99,0.99
"GO_CC:500375_GO_0031088_PLATELET_DENSE_GRANULE_MEMBRANE","GO_CC","500375_GO_0031088_PLATELET_DENSE_GRANULE_MEMBRANE",5,-0.9959,0.49,0.72,0.5231,0.98,1,-0.9125,0.56,1
"GO_BP:753074_GO_1900078_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS","GO_BP","753074_GO_1900078_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS",15,-0.9957,0.48,0.63,0.6681,0.91,1,-0.8691,0.64,0.95
"GO_BP:781976_GO_1901987_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION","GO_BP","781976_GO_1901987_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION",347,-0.9957,0.51,0.63,1.2676,0.029,0.71,-1.4125,0,0.58
"GO_BP:514633_GO_0061085_REGULATION_OF_HISTONE_H3_K27_METHYLATION","GO_BP","514633_GO_0061085_REGULATION_OF_HISTONE_H3_K27_METHYLATION",9,-0.9957,0.48,0.63,-0.866,0.62,1,-0.6414,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1644_HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1644_HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR",37,-0.9957,0.46,0.58,0.8233,0.78,0.98,-0.7993,0.79,0.95
"C4_Cancer_gene_neighborhoods:C4_CGN_82_MORF_DAP","C4_Cancer_gene_neighborhoods","C4_CGN_82_MORF_DAP",78,-0.9954,0.49,0.72,2.1005,0,0.00013,-1.1419,0.21,0.54
"GO_BP:519424_GO_2000785_REGULATION_OF_AUTOPHAGIC_VACUOLE_ASSEMBLY","GO_BP","519424_GO_2000785_REGULATION_OF_AUTOPHAGIC_VACUOLE_ASSEMBLY",15,-0.9954,0.47,0.64,1.1177,0.29,0.88,-0.6381,0.94,1
"GO_BP:512293_GO_0051414_RESPONSE_TO_CORTISOL","GO_BP","512293_GO_0051414_RESPONSE_TO_CORTISOL",6,-0.9954,0.5,0.63,-1.0227,0.44,0.97,0.7815,0.75,1
"GO_BP:504674_GO_0035493_SNARE_COMPLEX_ASSEMBLY","GO_BP","504674_GO_0035493_SNARE_COMPLEX_ASSEMBLY",7,-0.9953,0.49,0.63,0.8126,0.71,1,-0.7267,0.8,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1819_BROWNE_HCMV_INFECTION_18HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1819_BROWNE_HCMV_INFECTION_18HR_UP",178,-0.9952,0.49,0.58,-0.7626,0.97,1,-1.0733,0.28,0.66
"C7_Immunologic_signatures:C7_ALL_1312_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN","C7_Immunologic_signatures","C7_ALL_1312_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN",200,-0.9951,0.49,0.58,1.0088,0.41,0.71,-1.3512,0.02,0.095
"GO_BP:518241_GO_0090101_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY","GO_BP","518241_GO_0090101_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY",109,-0.9946,0.46,0.64,0.9815,0.52,1,0.9251,0.65,0.92
"GO_BP:492142_GO_0007379_SEGMENT_SPECIFICATION","GO_BP","492142_GO_0007379_SEGMENT_SPECIFICATION",16,-0.9945,0.45,0.64,0.8272,0.69,1,-0.9126,0.59,0.91
"GO_BP:753710_GO_1900739_REGULATION_OF_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","753710_GO_1900739_REGULATION_OF_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",26,-0.9944,0.45,0.64,0.5858,0.98,1,-1.1543,0.26,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2396_CADWELL_ATG16L1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2396_CADWELL_ATG16L1_TARGETS_DN",67,-0.9943,0.48,0.58,-0.6138,0.99,1,-1.0696,0.31,0.67
"GO_BP:750894_GO_0035967_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN","GO_BP","750894_GO_0035967_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN",111,-0.9943,0.48,0.64,0.6306,1,1,-1.0501,0.34,0.81
"C7_Immunologic_signatures:C7_ALL_653_GSE17721_LPS_VS_CPG_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_653_GSE17721_LPS_VS_CPG_0_5H_BMDM_UP",197,-0.9942,0.47,0.59,0.8854,0.8,1,-0.9587,0.56,0.82
"GO_BP:505320_GO_0042157_LIPOPROTEIN_METABOLIC_PROCESS","GO_BP","505320_GO_0042157_LIPOPROTEIN_METABOLIC_PROCESS",120,-0.994,0.48,0.64,-0.9459,0.57,1,-0.8645,0.79,0.95
"GO_BP:488875_GO_0035813_REGULATION_OF_RENAL_SODIUM_EXCRETION","GO_BP","488875_GO_0035813_REGULATION_OF_RENAL_SODIUM_EXCRETION",22,-0.9939,0.47,0.64,1.7563,0.0086,0.13,1.1739,0.24,0.72
"GO_BP:495087_GO_0014014_NEGATIVE_REGULATION_OF_GLIOGENESIS","GO_BP","495087_GO_0014014_NEGATIVE_REGULATION_OF_GLIOGENESIS",34,-0.9939,0.45,0.64,-1.0317,0.4,0.98,1.2052,0.2,0.72
"GO_BP:502163_GO_0032941_SECRETION_BY_TISSUE","GO_BP","502163_GO_0032941_SECRETION_BY_TISSUE",62,-0.9938,0.48,0.64,0.928,0.59,1,1.1854,0.17,0.72
"C4_Cancer_modules:C4_CM_145_MODULE_153","C4_Cancer_modules","C4_CM_145_MODULE_153",29,-0.9937,0.48,0.58,1.208,0.18,0.39,1.4939,0.036,0.22
"KEGG_module:HSA_M00076_DERMATAN_SULFATE_DEGRADATION","KEGG_module","HSA_M00076_DERMATAN_SULFATE_DEGRADATION",9,-0.9937,0.48,0.73,-0.843,0.65,1,0.9466,0.53,1
"GO_BP:501499_GO_0032264_IMP_SALVAGE","GO_BP","501499_GO_0032264_IMP_SALVAGE",5,-0.9936,0.48,0.64,-0.8061,0.72,1,-0.8839,0.6,0.94
"REACTOME:576266_REACT_118568_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION","REACTOME","576266_REACT_118568_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION",29,-0.9935,0.47,0.66,-1.423,0.06,0.5,0.8198,0.77,1
"GO_BP:487942_GO_0002052_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION","GO_BP","487942_GO_0002052_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION",19,-0.9934,0.46,0.64,0.9942,0.46,0.99,1.1453,0.25,0.73
"GO_CC:499968_GO_0030663_COPI_COATED_VESICLE_MEMBRANE","GO_CC","499968_GO_0030663_COPI_COATED_VESICLE_MEMBRANE",16,-0.9933,0.47,0.73,1.5265,0.048,0.18,0.4687,0.99,1
"GO_BP:948083_GO_0061590_CALCIUM_ACTIVATED_PHOSPHATIDYLCHOLINE_SCRAMBLING","GO_BP","948083_GO_0061590_CALCIUM_ACTIVATED_PHOSPHATIDYLCHOLINE_SCRAMBLING",5,-0.9933,0.5,0.64,1.1446,0.31,0.84,-0.7987,0.72,0.99
"C3_TF_targets:C3_TFT_21_V_CREB_01","C3_TF_targets","C3_TFT_21_V_CREB_01",260,-0.9932,0.51,0.58,0.8217,0.96,1,-0.9751,0.5,0.8
"KEGG_pathway:HSA05212_PANCREATIC_CANCER","KEGG_pathway","HSA05212_PANCREATIC_CANCER",66,-0.9931,0.49,0.53,0.7169,0.97,1,0.7852,0.85,1
"GO_BP:512481_GO_0051604_PROTEIN_MATURATION","GO_BP","512481_GO_0051604_PROTEIN_MATURATION",27,-0.9931,0.48,0.64,0.7426,0.85,1,-1.3121,0.15,0.64
"C4_Cancer_gene_neighborhoods:C4_CGN_194_GCM_ATM","C4_Cancer_gene_neighborhoods","C4_CGN_194_GCM_ATM",26,-0.9931,0.45,0.73,-0.6408,0.96,1,-1.4132,0.072,0.16
"GO_BP:500894_GO_0031645_NEGATIVE_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS","GO_BP","500894_GO_0031645_NEGATIVE_REGULATION_OF_NEUROLOGICAL_SYSTEM_PROCESS",12,-0.9929,0.46,0.64,0.7405,0.82,1,-0.9657,0.51,0.88
"C7_Immunologic_signatures:C7_ALL_359_GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_359_GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP",182,-0.9927,0.49,0.59,0.9632,0.54,0.86,-1.2602,0.042,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_165_NOJIMA_SFRP2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_165_NOJIMA_SFRP2_TARGETS_DN",25,-0.9927,0.47,0.58,1.5036,0.021,0.21,-1.0688,0.34,0.67
"GO_BP:754751_GO_1901800_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS","GO_BP","754751_GO_1901800_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS",63,-0.9924,0.48,0.64,0.8619,0.74,1,-1.2974,0.089,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_800_DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_800_DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP",27,-0.9923,0.45,0.58,-0.7455,0.85,1,1.5925,0.026,0.42
"GO_MF:501197_GO_0031957_VERY_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY","GO_MF","501197_GO_0031957_VERY_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY",8,-0.9922,0.48,0.66,0.8128,0.68,1,0.6424,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2959_BAUS_TFF2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2959_BAUS_TFF2_TARGETS_UP",29,-0.9922,0.47,0.58,1.1469,0.24,0.56,-0.7052,0.91,0.99
"C7_Immunologic_signatures:C7_ALL_762_GSE17721_4_VS_24H_GARDIQUIMOD_BMDM_DN","C7_Immunologic_signatures","C7_ALL_762_GSE17721_4_VS_24H_GARDIQUIMOD_BMDM_DN",200,-0.9922,0.48,0.59,1.2897,0.036,0.11,-1.1549,0.13,0.36
"GO_BP:777529_GO_1901977_NEGATIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT","GO_BP","777529_GO_1901977_NEGATIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT",5,-0.9921,0.49,0.64,-1.3023,0.17,0.89,-0.9591,0.5,0.88
"GO_BP:518957_GO_2000311_REGULATION_OF_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLE_PROPIONATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY","GO_BP","518957_GO_2000311_REGULATION_OF_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLE_PROPIONATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY",19,-0.9918,0.49,0.64,-1.1428,0.27,0.93,-0.7554,0.84,1
"C1_Positional:C1_ALL_115_CHR6P25","C1_Positional","C1_ALL_115_CHR6P25",38,-0.9918,0.48,0.89,0.5312,1,1,-0.8775,0.68,0.99
"C7_Immunologic_signatures:C7_ALL_1615_GSE3982_MAST_CELL_VS_BASOPHIL_UP","C7_Immunologic_signatures","C7_ALL_1615_GSE3982_MAST_CELL_VS_BASOPHIL_UP",195,-0.9918,0.49,0.59,1.1495,0.13,0.32,0.861,0.86,1
"C3_MicroRNA_targets:C3_MIR_49_TCTGATC_MIR_383","C3_MicroRNA_targets","C3_MIR_49_TCTGATC_MIR_383",48,-0.9917,0.46,0.63,-0.9223,0.59,1,-0.8781,0.67,1
"GO_BP:504168_GO_0034976_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS","GO_BP","504168_GO_0034976_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS",167,-0.9917,0.48,0.64,0.7588,0.98,1,-1.1846,0.11,0.73
"GO_BP:503242_GO_0034033_PURINE_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","503242_GO_0034033_PURINE_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS",17,-0.9916,0.46,0.64,-0.9231,0.58,1,-0.728,0.85,0.99
"C7_Immunologic_signatures:C7_ALL_369_GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP","C7_Immunologic_signatures","C7_ALL_369_GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP",185,-0.9916,0.49,0.59,1.186,0.11,0.25,-1.0083,0.42,0.7
"C7_Immunologic_signatures:C7_ALL_88_GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN","C7_Immunologic_signatures","C7_ALL_88_GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN",189,-0.9914,0.49,0.59,1.2182,0.073,0.2,1.0519,0.31,1
"GO_BP:512479_GO_0051601_EXOCYST_LOCALIZATION","GO_BP","512479_GO_0051601_EXOCYST_LOCALIZATION",6,-0.9914,0.48,0.64,-0.7695,0.76,1,0.59,0.94,1
"WikiPathways:198844_WP673_ERBB_SIGNALING_PATHWAY","WikiPathways","198844_WP673_ERBB_SIGNALING_PATHWAY",54,-0.9913,0.46,0.59,0.7014,0.96,1,0.8013,0.86,1
"C1_Positional:C1_ALL_169_CHR1Q31","C1_Positional","C1_ALL_169_CHR1Q31",42,-0.9912,0.48,0.89,1.4943,0.021,0.27,1.0835,0.31,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_2291_WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2291_WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN",5,-0.9912,0.52,0.58,0.8369,0.64,0.97,1.2309,0.24,0.73
"GO_BP:1133967_GO_1903792_NEGATIVE_REGULATION_OF_ANION_TRANSPORT","GO_BP","1133967_GO_1903792_NEGATIVE_REGULATION_OF_ANION_TRANSPORT",30,-0.9911,0.47,0.64,1.0124,0.42,0.97,1.2252,0.17,0.7
"GO_BP:1025323_GO_0044857_PLASMA_MEMBRANE_RAFT_ORGANIZATION","GO_BP","1025323_GO_0044857_PLASMA_MEMBRANE_RAFT_ORGANIZATION",5,-0.9911,0.5,0.64,-0.6661,0.87,1,1.525,0.054,0.54
"C6_Oncogenic_signatures:C6_ALL_76_PRC2_EZH2_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_76_PRC2_EZH2_UP_V1_UP",188,-0.9911,0.5,0.54,1.0071,0.46,0.79,-1.093,0.25,0.49
"C7_Immunologic_signatures:C7_ALL_638_GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_638_GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDM_DN",199,-0.9909,0.48,0.59,1.6064,0,0.0027,0.9157,0.71,1
"C7_Immunologic_signatures:C7_ALL_263_GSE14308_TH17_VS_INDUCED_TREG_UP","C7_Immunologic_signatures","C7_ALL_263_GSE14308_TH17_VS_INDUCED_TREG_UP",199,-0.9908,0.49,0.59,1.0538,0.29,0.58,-0.9721,0.52,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_1064_SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1064_SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP",172,-0.9908,0.48,0.58,1.4729,0,0.23,0.8185,0.93,1
"GO_CC:499976_GO_0030673_AXOLEMMA","GO_CC","499976_GO_0030673_AXOLEMMA",13,-0.9908,0.48,0.73,-1.3212,0.15,0.64,-0.7928,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2694_VALK_AML_WITH_EVI1","C2_Chemical_and_genetic_perturbations","C2_CGP_2694_VALK_AML_WITH_EVI1",23,-0.9907,0.49,0.58,0.5489,0.98,1,0.7367,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2453_BEIER_GLIOMA_STEM_CELL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2453_BEIER_GLIOMA_STEM_CELL_DN",65,-0.9907,0.47,0.58,0.8285,0.82,0.98,0.9427,0.56,1
"C7_Immunologic_signatures:C7_ALL_409_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_409_GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP",197,-0.9906,0.5,0.59,0.7607,0.99,1,-1.2417,0.042,0.21
"C3_MicroRNA_targets:C3_MIR_26_TCTATGA_MIR_376A_MIR_376B","C3_MicroRNA_targets","C3_MIR_26_TCTATGA_MIR_376A_MIR_376B",83,-0.9904,0.49,0.63,1.0502,0.33,1,-0.8159,0.85,1
"KEGG_compound:C01185_NICOTINATE_D_RIBONUCLEOTIDE_BETA_NICOTINATE_D_RIBONUCLEOTIDE_NICOTINATE_RIBONUCLEOTIDE_NICOTINIC_ACID_RIBONUCLEOTIDE","KEGG_compound","C01185_NICOTINATE_D_RIBONUCLEOTIDE_BETA_NICOTINATE_D_RIBONUCLEOTIDE_NICOTINATE_RIBONUCLEOTIDE_NICOTINIC_ACID_RIBONUCLEOTIDE",19,-0.9903,0.46,0.64,0.8728,0.64,1,-1.8973,0,0.11
"C4_Cancer_gene_neighborhoods:C4_CGN_357_GNF2_HLA_C","C4_Cancer_gene_neighborhoods","C4_CGN_357_GNF2_HLA_C",47,-0.9903,0.48,0.73,1.1922,0.19,0.23,-1.0921,0.31,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2193_RIZKI_TUMOR_INVASIVENESS_2D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2193_RIZKI_TUMOR_INVASIVENESS_2D_DN",62,-0.9903,0.49,0.59,1.3436,0.07,0.35,-1.2119,0.14,0.51
"REACTOME:1127548_REACT_263908_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA","REACTOME","1127548_REACT_263908_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA",15,-0.9903,0.49,0.66,0.5634,0.99,1,-0.8323,0.7,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2256_SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2256_SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP",38,-0.9901,0.49,0.59,1.2195,0.18,0.47,-1.3526,0.07,0.39
"GO_BP:518302_GO_0090162_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY","GO_BP","518302_GO_0090162_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY",16,-0.9899,0.48,0.64,1.1842,0.22,0.8,-0.9275,0.57,0.9
"GO_MF:489329_GO_0003828_ALPHA_N_ACETYLNEURAMINATE_ALPHA_2_8_SIALYLTRANSFERASE_ACTIVITY","GO_MF","489329_GO_0003828_ALPHA_N_ACETYLNEURAMINATE_ALPHA_2_8_SIALYLTRANSFERASE_ACTIVITY",5,-0.9899,0.48,0.67,0.7618,0.77,1,0.6952,0.83,1
"C1_Positional:C1_ALL_193_CHR3P21","C1_Positional","C1_ALL_193_CHR3P21",229,-0.9899,0.5,0.88,0.9299,0.7,0.83,-0.8359,0.92,0.99
"C4_Cancer_modules:C4_CM_311_MODULE_361","C4_Cancer_modules","C4_CM_311_MODULE_361",144,-0.9898,0.5,0.59,1.3245,0.049,0.25,-1.2998,0.038,0.3
"GO_BP:492034_GO_0007254_JNK_CASCADE","GO_BP","492034_GO_0007254_JNK_CASCADE",83,-0.9898,0.48,0.64,0.7157,0.97,1,-1.1245,0.25,0.75
"GO_BP:509060_GO_0046838_PHOSPHORYLATED_CARBOHYDRATE_DEPHOSPHORYLATION","GO_BP","509060_GO_0046838_PHOSPHORYLATED_CARBOHYDRATE_DEPHOSPHORYLATION",11,-0.9898,0.46,0.64,0.5721,0.97,1,0.6591,0.9,1
"GO_BP:508291_GO_0045991_CARBON_CATABOLITE_ACTIVATION_OF_TRANSCRIPTION","GO_BP","508291_GO_0045991_CARBON_CATABOLITE_ACTIVATION_OF_TRANSCRIPTION",5,-0.9898,0.51,0.64,-0.9241,0.56,1,0.628,0.89,1
"GO_CC:501143_GO_0031902_LATE_ENDOSOME_MEMBRANE","GO_CC","501143_GO_0031902_LATE_ENDOSOME_MEMBRANE",100,-0.9897,0.47,0.73,1.6482,0,0.087,0.8156,0.87,1
"GO_BP:501526_GO_0032291_AXON_ENSHEATHMENT_IN_CENTRAL_NERVOUS_SYSTEM","GO_BP","501526_GO_0032291_AXON_ENSHEATHMENT_IN_CENTRAL_NERVOUS_SYSTEM",15,-0.9895,0.47,0.64,-0.7652,0.79,1,-0.917,0.6,0.91
"REACTOME:187097_REACT_25359_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS","REACTOME","187097_REACT_25359_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS",76,-0.9894,0.48,0.66,1.1114,0.23,0.56,-1.4621,0.026,0.38
"REACTOME:1183573_REACT_355514_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR3","REACTOME","1183573_REACT_355514_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR3",44,-0.9894,0.48,0.66,-1.1685,0.2,0.85,-1.4149,0.034,0.4
"GO_CC:496487_GO_0016528_SARCOPLASM","GO_CC","496487_GO_0016528_SARCOPLASM",64,-0.9892,0.48,0.73,-1.3683,0.057,0.61,-0.9768,0.49,1
"GO_MF:490006_GO_0004683_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY","GO_MF","490006_GO_0004683_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY",30,-0.989,0.5,0.67,-1.0925,0.3,0.84,-0.9793,0.51,0.8
"GO_BP:488705_GO_0002832_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS","GO_BP","488705_GO_0002832_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS",27,-0.9889,0.48,0.64,1.1867,0.22,0.8,0.5805,0.99,1
"GO_BP:513562_GO_0060004_REFLEX","GO_BP","513562_GO_0060004_REFLEX",19,-0.9889,0.48,0.64,0.9448,0.54,1,-0.945,0.52,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1756_RODWELL_AGING_KIDNEY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1756_RODWELL_AGING_KIDNEY_DN",143,-0.9889,0.48,0.59,1.5706,0.0023,0.16,-1.1869,0.13,0.53
"GO_BP:491853_GO_0007023_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY","GO_BP","491853_GO_0007023_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY",5,-0.9889,0.5,0.64,-0.7603,0.75,1,-0.9469,0.56,0.89
"GO_BP:496219_GO_0016126_STEROL_BIOSYNTHETIC_PROCESS","GO_BP","496219_GO_0016126_STEROL_BIOSYNTHETIC_PROCESS",41,-0.9888,0.47,0.64,0.8613,0.7,1,0.7984,0.81,1
"C6_Oncogenic_signatures:C6_ALL_32_PIGF_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_32_PIGF_UP_V1_UP",189,-0.9887,0.5,0.54,1.0746,0.27,0.6,-0.8386,0.9,0.89
"GO_BP:489126_GO_0003334_KERATINOCYTE_DEVELOPMENT","GO_BP","489126_GO_0003334_KERATINOCYTE_DEVELOPMENT",9,-0.9887,0.48,0.64,-0.514,0.98,1,0.5176,0.98,1
"GO_BP:492419_GO_0030534_ADULT_BEHAVIOR","GO_BP","492419_GO_0030534_ADULT_BEHAVIOR",130,-0.9886,0.49,0.64,-1.3437,0.029,0.92,1.1945,0.11,0.72
"C4_Cancer_modules:C4_CM_389_MODULE_489","C4_Cancer_modules","C4_CM_389_MODULE_489",30,-0.9885,0.48,0.59,-1.1206,0.29,0.66,-1.3763,0.086,0.23
"GO_CC:1184380_GO_0098791_GOLGI_SUBCOMPARTMENT","GO_CC","1184380_GO_0098791_GOLGI_SUBCOMPARTMENT",273,-0.9885,0.52,0.73,1.0216,0.36,0.75,0.8911,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2289_MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_2289_MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER",41,-0.9884,0.49,0.59,-1.1819,0.2,0.82,-0.9269,0.59,0.84
"GO_BP:516695_GO_0071772_RESPONSE_TO_BMP","GO_BP","516695_GO_0071772_RESPONSE_TO_BMP",20,-0.9884,0.47,0.64,-0.9509,0.53,1,1.6609,0.017,0.39
"C7_Immunologic_signatures:C7_ALL_1329_GSE30083_SP1_VS_SP4_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1329_GSE30083_SP1_VS_SP4_THYMOCYTE_UP",196,-0.9884,0.51,0.6,0.7185,1,1,-1.1962,0.092,0.29
"GO_BP:496847_GO_0017015_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY","GO_BP","496847_GO_0017015_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY",101,-0.9883,0.5,0.64,1.0118,0.44,0.97,0.7693,0.93,1
"GO_BP:516746_GO_0071824_PROTEIN_DNA_COMPLEX_SUBUNIT_ORGANIZATION","GO_BP","516746_GO_0071824_PROTEIN_DNA_COMPLEX_SUBUNIT_ORGANIZATION",201,-0.9882,0.51,0.64,-1.1529,0.14,0.92,-1.4529,0.0064,0.54
"C7_Immunologic_signatures:C7_ALL_1105_GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1105_GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP",191,-0.9882,0.51,0.6,1.0247,0.39,0.66,-1.3665,0.02,0.084
"C7_Immunologic_signatures:C7_ALL_752_GSE17721_12H_VS_24H_CPG_BMDM_DN","C7_Immunologic_signatures","C7_ALL_752_GSE17721_12H_VS_24H_CPG_BMDM_DN",197,-0.9882,0.51,0.6,1.5974,0,0.0031,-1.289,0.036,0.15
"REACTOME:530753_REACT_115639_SULFUR_AMINO_ACID_METABOLISM","REACTOME","530753_REACT_115639_SULFUR_AMINO_ACID_METABOLISM",22,-0.9881,0.47,0.66,0.4288,1,1,-1.7341,0.002,0.19
"KEGG_compound:C16681_9_CIS_RETINAL","KEGG_compound","C16681_9_CIS_RETINAL",9,-0.988,0.48,0.64,0.9554,0.5,1,-0.8752,0.65,0.78
"GO_BP:504541_GO_0035357_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY","GO_BP","504541_GO_0035357_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY",6,-0.9878,0.51,0.65,0.95,0.51,1,0.9193,0.55,0.92
"C1_Positional:C1_ALL_23_CHRYP11","C1_Positional","C1_ALL_23_CHRYP11",6,-0.9877,0.49,0.88,-0.7527,0.77,0.97,1.0345,0.43,0.73
"C7_Immunologic_signatures:C7_ALL_297_GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_297_GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP",198,-0.9877,0.52,0.6,1.351,0.0024,0.061,-0.9497,0.61,0.85
"GO_BP:496063_GO_0015942_FORMATE_METABOLIC_PROCESS","GO_BP","496063_GO_0015942_FORMATE_METABOLIC_PROCESS",6,-0.9877,0.49,0.65,0.7696,0.76,1,1.1118,0.36,0.75
"C1_Positional:C1_ALL_271_CHR20Q11","C1_Positional","C1_ALL_271_CHR20Q11",109,-0.9876,0.5,0.88,0.8561,0.82,0.9,0.7755,0.94,0.94
"REACTOME:771587_REACT_160214_SIGNALING_BY_NOTCH1_IN_CANCER","REACTOME","771587_REACT_160214_SIGNALING_BY_NOTCH1_IN_CANCER",57,-0.9876,0.49,0.67,-0.6809,0.97,1,-1.2937,0.1,0.54
"C3_TF_targets:C3_TFT_128_ATCMNTCCGY_UNKNOWN","C3_TF_targets","C3_TFT_128_ATCMNTCCGY_UNKNOWN",51,-0.9875,0.48,0.59,-0.7904,0.84,1,-1.0611,0.36,0.63
"KEGG_compound:C05703_METHANESELENOL_METHYLSELENOL","KEGG_compound","C05703_METHANESELENOL_METHYLSELENOL",6,-0.9875,0.52,0.64,0.7508,0.75,1,-1.4338,0.084,0.26
"C2_Chemical_and_genetic_perturbations:C2_CGP_917_WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_917_WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP",13,-0.9875,0.45,0.59,0.7819,0.77,1,1.0413,0.42,0.93
"GO_BP:509152_GO_0046958_NONASSOCIATIVE_LEARNING","GO_BP","509152_GO_0046958_NONASSOCIATIVE_LEARNING",5,-0.9873,0.5,0.65,1.0694,0.37,0.93,1.0712,0.39,0.78
"GO_BP:514127_GO_0060572_MORPHOGENESIS_OF_AN_EPITHELIAL_BUD","GO_BP","514127_GO_0060572_MORPHOGENESIS_OF_AN_EPITHELIAL_BUD",8,-0.9873,0.48,0.65,-0.9547,0.51,1,-0.7469,0.79,1
"C1_Positional:C1_ALL_175_CHR1P34","C1_Positional","C1_ALL_175_CHR1P34",162,-0.9873,0.52,0.87,-0.9628,0.54,1,-0.9625,0.56,0.95
"GO_CC:752726_GO_0097225_SPERM_MIDPIECE","GO_CC","752726_GO_0097225_SPERM_MIDPIECE",10,-0.9873,0.47,0.73,-1.2902,0.17,0.67,-0.9474,0.53,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1150_AMIT_SERUM_RESPONSE_480_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1150_AMIT_SERUM_RESPONSE_480_MCF10A",37,-0.9871,0.48,0.59,1.4475,0.039,0.26,0.9398,0.56,1
"GO_BP:511888_GO_0050953_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS","GO_BP","511888_GO_0050953_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS",199,-0.987,0.48,0.65,-1.3504,0.014,0.93,1.0404,0.36,0.82
"C3_TF_targets:C3_TFT_337_CYTAGCAAY_UNKNOWN","C3_TF_targets","C3_TFT_337_CYTAGCAAY_UNKNOWN",147,-0.9869,0.49,0.59,-0.8584,0.8,1,-0.8994,0.7,0.92
"GO_MF:490059_GO_0004745_RETINOL_DEHYDROGENASE_ACTIVITY","GO_MF","490059_GO_0004745_RETINOL_DEHYDROGENASE_ACTIVITY",16,-0.9868,0.49,0.67,1.1587,0.25,0.74,1.0217,0.4,0.86
"GO_CC:982479_GO_1902911_PROTEIN_KINASE_COMPLEX","GO_CC","982479_GO_1902911_PROTEIN_KINASE_COMPLEX",87,-0.9867,0.48,0.73,0.8243,0.86,0.94,0.8272,0.83,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2202_MCCABE_BOUND_BY_HOXC6","C2_Chemical_and_genetic_perturbations","C2_CGP_2202_MCCABE_BOUND_BY_HOXC6",423,-0.9866,0.52,0.59,1.0421,0.31,0.73,-0.887,0.88,0.9
"C7_Immunologic_signatures:C7_ALL_1735_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1735_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP",197,-0.9864,0.51,0.6,1.0718,0.28,0.52,-1.0029,0.43,0.72
"GO_BP:503954_GO_0034755_IRON_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","503954_GO_0034755_IRON_ION_TRANSMEMBRANE_TRANSPORT",5,-0.9864,0.49,0.65,0.9875,0.49,0.99,-1.0105,0.45,0.84
"REACTOME:106458_REACT_11046_NGF_INDEPENDANT_TRKA_ACTIVATION","REACTOME","106458_REACT_11046_NGF_INDEPENDANT_TRKA_ACTIVATION",5,-0.9863,0.51,0.67,-0.8969,0.57,1,0.9373,0.53,1
"GO_BP:494042_GO_0009953_DORSAL_VENTRAL_PATTERN_FORMATION","GO_BP","494042_GO_0009953_DORSAL_VENTRAL_PATTERN_FORMATION",94,-0.9863,0.5,0.65,-1.2613,0.085,0.91,1.3302,0.047,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_738_AIYAR_COBRA1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_738_AIYAR_COBRA1_TARGETS_UP",39,-0.9862,0.49,0.59,1.161,0.21,0.54,-0.7143,0.92,0.98
"KEGG_pathway:HSA05033_NICOTINE_ADDICTION","KEGG_pathway","HSA05033_NICOTINE_ADDICTION",38,-0.9862,0.49,0.54,1.1545,0.24,0.66,2.0052,0,0.0042
"GO_BP:519248_GO_2000609_REGULATION_OF_THYROID_HORMONE_GENERATION","GO_BP","519248_GO_2000609_REGULATION_OF_THYROID_HORMONE_GENERATION",5,-0.9862,0.51,0.65,-1.1675,0.3,0.91,0.7098,0.82,1
"C6_Oncogenic_signatures:C6_ALL_147_SIRNA_EIF4GI_DN","C6_Oncogenic_signatures","C6_ALL_147_SIRNA_EIF4GI_DN",96,-0.9861,0.5,0.54,1.2418,0.11,0.35,-1.0116,0.44,0.63
"KEGG_reaction:R01280_PALMITATE_COA_LIGASE_AMP_FORMING_ATP_HEXADECANOIC_ACID_COA_AMP_PALMITOYL_COA_DIPHOSPHATE","KEGG_reaction","R01280_PALMITATE_COA_LIGASE_AMP_FORMING_ATP_HEXADECANOIC_ACID_COA_AMP_PALMITOYL_COA_DIPHOSPHATE",7,-0.9861,0.48,0.64,0.5822,0.96,1,0.714,0.83,0.94
"GO_BP:508348_GO_0046051_UTP_METABOLIC_PROCESS","GO_BP","508348_GO_0046051_UTP_METABOLIC_PROCESS",12,-0.9859,0.48,0.65,-0.845,0.67,1,-1.2275,0.21,0.7
"C3_MicroRNA_targets:C3_MIR_86_GCTCTTG_MIR_335","C3_MicroRNA_targets","C3_MIR_86_GCTCTTG_MIR_335",86,-0.9859,0.48,0.63,0.8055,0.91,1,0.9019,0.68,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_296_SABATES_COLORECTAL_ADENOMA_SIZE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_296_SABATES_COLORECTAL_ADENOMA_SIZE_UP",23,-0.9859,0.49,0.59,-1.5195,0.047,0.44,-1.1172,0.31,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_92_CHANDRAN_METASTASIS_TOP50_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_92_CHANDRAN_METASTASIS_TOP50_UP",38,-0.9858,0.49,0.59,0.8794,0.67,0.94,-1.2177,0.17,0.5
"WikiPathways:198854_WP136_PHASE_I_NON_P450","WikiPathways","198854_WP136_PHASE_I_NON_P450",6,-0.9858,0.49,0.6,1.7057,0.023,0.11,0.6835,0.83,1
"GO_MF:757162_GO_0044769_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS_ROTATIONAL_MECHANISM","GO_MF","757162_GO_0044769_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS_ROTATIONAL_MECHANISM",25,-0.9856,0.49,0.67,1.7998,0.0041,0.079,0.7928,0.81,1
"GO_MF:492537_GO_0008195_PHOSPHATIDATE_PHOSPHATASE_ACTIVITY","GO_MF","492537_GO_0008195_PHOSPHATIDATE_PHOSPHATASE_ACTIVITY",11,-0.9856,0.48,0.67,0.7997,0.72,1,1.2412,0.19,0.68
"GO_BP:516427_GO_0071503_RESPONSE_TO_HEPARIN","GO_BP","516427_GO_0071503_RESPONSE_TO_HEPARIN",6,-0.9855,0.48,0.65,-1.9435,0.002,0.33,1.1742,0.28,0.72
"GO_CC:490835_GO_0030667_SECRETORY_GRANULE_MEMBRANE","GO_CC","490835_GO_0030667_SECRETORY_GRANULE_MEMBRANE",71,-0.9854,0.49,0.73,1.3975,0.032,0.3,-1.0041,0.43,1
"KEGG_compound:C00407_L_ISOLEUCINE_2_AMINO_3_METHYLVALERIC_ACID","KEGG_compound","C00407_L_ISOLEUCINE_2_AMINO_3_METHYLVALERIC_ACID",5,-0.9853,0.5,0.64,0.7605,0.77,1,0.8321,0.68,0.89
"GO_BP:506943_GO_0043923_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION","GO_BP","506943_GO_0043923_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION",12,-0.9853,0.49,0.65,0.8911,0.58,1,-1.2317,0.21,0.7
"C4_Cancer_modules:C4_CM_178_MODULE_190","C4_Cancer_modules","C4_CM_178_MODULE_190",11,-0.9853,0.49,0.6,1.3393,0.14,0.24,1.3285,0.14,0.4
"C2_Chemical_and_genetic_perturbations:C2_CGP_129_LIU_TARGETS_OF_VMYB_VS_CMYB_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_129_LIU_TARGETS_OF_VMYB_VS_CMYB_UP",19,-0.9852,0.5,0.59,-0.9996,0.45,1,-1.6801,0.0097,0.2
"OMIM_gene:OMIM608160_SRY_BOX_9_SOX9","OMIM_gene","OMIM608160_SRY_BOX_9_SOX9",5,-0.9852,0.49,0.78,-1.488,0.063,1,-1.1307,0.34,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3365_LIM_MAMMARY_LUMINAL_MATURE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3365_LIM_MAMMARY_LUMINAL_MATURE_UP",115,-0.9851,0.5,0.59,-0.8313,0.84,1,0.8036,0.9,1
"GO_BP:499856_GO_0030517_NEGATIVE_REGULATION_OF_AXON_EXTENSION","GO_BP","499856_GO_0030517_NEGATIVE_REGULATION_OF_AXON_EXTENSION",23,-0.985,0.47,0.65,-1.0541,0.39,0.97,0.8998,0.6,0.94
"GO_BP:781979_GO_1901990_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION","GO_BP","781979_GO_1901990_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION",214,-0.9848,0.52,0.65,1.4199,0.0023,0.53,-1.2325,0.065,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_706_LUI_TARGETS_OF_PAX8_PPARG_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_706_LUI_TARGETS_OF_PAX8_PPARG_FUSION",34,-0.9848,0.48,0.59,2.0994,0,0.0019,-1.3169,0.093,0.41
"GO_CC:500777_GO_0031526_BRUSH_BORDER_MEMBRANE","GO_CC","500777_GO_0031526_BRUSH_BORDER_MEMBRANE",45,-0.9848,0.51,0.73,-0.7321,0.91,1,1.2092,0.15,0.82
"GO_BP:515040_GO_0070102_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY","GO_BP","515040_GO_0070102_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY",8,-0.9847,0.47,0.65,0.5868,0.95,1,0.7732,0.73,1
"C4_Cancer_gene_neighborhoods:C4_CGN_274_GCM_VAV1","C4_Cancer_gene_neighborhoods","C4_CGN_274_GCM_VAV1",47,-0.9844,0.49,0.74,-0.6102,0.99,1,-0.8844,0.65,1
"GO_MF:490380_GO_0005114_TYPE_II_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING","GO_MF","490380_GO_0005114_TYPE_II_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING",7,-0.9844,0.5,0.67,-1.2597,0.21,0.84,-1.0089,0.44,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_834_MANN_RESPONSE_TO_AMIFOSTINE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_834_MANN_RESPONSE_TO_AMIFOSTINE_DN",10,-0.9844,0.45,0.59,1.9201,0.0039,0.016,0.7179,0.84,1
"GO_MF:492713_GO_0008417_FUCOSYLTRANSFERASE_ACTIVITY","GO_MF","492713_GO_0008417_FUCOSYLTRANSFERASE_ACTIVITY",14,-0.9844,0.5,0.67,0.6706,0.89,1,-1.0986,0.32,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_3210_YUAN_ZNF143_PARTNERS","C2_Chemical_and_genetic_perturbations","C2_CGP_3210_YUAN_ZNF143_PARTNERS",21,-0.9843,0.47,0.59,0.5941,0.98,1,-0.9279,0.55,0.84
"GO_BP:751870_GO_0044728_DNA_METHYLATION_OR_DEMETHYLATION","GO_BP","751870_GO_0044728_DNA_METHYLATION_OR_DEMETHYLATION",87,-0.9843,0.5,0.65,-1.481,0.0072,0.84,-1.4443,0.016,0.55
"GO_BP:754152_GO_1901185_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY","GO_BP","754152_GO_1901185_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY",44,-0.9842,0.48,0.65,1.221,0.14,0.77,1.076,0.31,0.78
"GO_BP:494981_GO_0010917_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL","GO_BP","494981_GO_0010917_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL",5,-0.9842,0.52,0.65,0.8519,0.64,1,-1.1257,0.36,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1724_KRASNOSELSKAYA_ILF3_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1724_KRASNOSELSKAYA_ILF3_TARGETS_UP",38,-0.9839,0.48,0.6,1.6464,0.009,0.11,-0.8135,0.8,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_2626_ELLWOOD_MYC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2626_ELLWOOD_MYC_TARGETS_DN",40,-0.9839,0.49,0.6,1.627,0.016,0.12,-0.7427,0.89,0.98
"GO_BP:516654_GO_0071731_RESPONSE_TO_NITRIC_OXIDE","GO_BP","516654_GO_0071731_RESPONSE_TO_NITRIC_OXIDE",12,-0.9837,0.48,0.65,0.774,0.78,1,0.819,0.7,1
"GO_BP:518817_GO_2000169_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION","GO_BP","518817_GO_2000169_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION",5,-0.9837,0.51,0.65,0.74,0.8,1,-0.7937,0.73,0.99
"GO_BP:495284_GO_0014891_STRIATED_MUSCLE_ATROPHY","GO_BP","495284_GO_0014891_STRIATED_MUSCLE_ATROPHY",6,-0.9833,0.5,0.65,0.9227,0.56,1,0.7398,0.8,1
"C3_TF_targets:C3_TFT_453_V_E2F_Q6_01","C3_TF_targets","C3_TFT_453_V_E2F_Q6_01",239,-0.983,0.53,0.6,-0.7602,0.98,1,-1.3035,0.015,0.24
"GO_BP:490966_GO_0005978_GLYCOGEN_BIOSYNTHETIC_PROCESS","GO_BP","490966_GO_0005978_GLYCOGEN_BIOSYNTHETIC_PROCESS",27,-0.983,0.48,0.65,0.9135,0.58,1,-1.6696,0.014,0.55
"GO_BP:492369_GO_0007628_ADULT_WALKING_BEHAVIOR","GO_BP","492369_GO_0007628_ADULT_WALKING_BEHAVIOR",34,-0.9829,0.49,0.65,-1.2257,0.17,0.88,0.9813,0.48,0.87
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_165_BIOCARTA_CARDIACEGF_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_165_BIOCARTA_CARDIACEGF_PATHWAY",18,-0.9829,0.48,0.61,1.1651,0.24,0.69,0.9523,0.51,1
"GO_CC:490887_GO_0005881_CYTOPLASMIC_MICROTUBULE","GO_CC","490887_GO_0005881_CYTOPLASMIC_MICROTUBULE",54,-0.9827,0.5,0.73,0.569,1,1,-0.9622,0.51,1
"GO_BP:488982_GO_0003188_HEART_VALVE_FORMATION","GO_BP","488982_GO_0003188_HEART_VALVE_FORMATION",12,-0.9826,0.47,0.65,0.7231,0.84,1,1.0094,0.45,0.85
"C7_Immunologic_signatures:C7_ALL_436_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_436_GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN",198,-0.9824,0.52,0.61,1.1643,0.12,0.29,-1.268,0.037,0.18
"GO_BP:503820_GO_0034620_CELLULAR_RESPONSE_TO_UNFOLDED_PROTEIN","GO_BP","503820_GO_0034620_CELLULAR_RESPONSE_TO_UNFOLDED_PROTEIN",103,-0.9824,0.51,0.65,0.6615,1,1,-1.023,0.4,0.83
"REACTOME:771593_REACT_160243_CONSTITUTIVE_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS","REACTOME","771593_REACT_160243_CONSTITUTIVE_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS",57,-0.9824,0.5,0.67,-0.6844,0.95,1,-1.2955,0.073,0.54
"GO_BP:946575_GO_1902600_HYDROGEN_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","946575_GO_1902600_HYDROGEN_ION_TRANSMEMBRANE_TRANSPORT",96,-0.9823,0.51,0.65,2.0275,0,0.0094,0.8276,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1615_IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS","C2_Chemical_and_genetic_perturbations","C2_CGP_1615_IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS",10,-0.9823,0.49,0.6,0.7949,0.72,0.99,-0.9848,0.49,0.78
"GO_BP:493422_GO_0009226_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS","GO_BP","493422_GO_0009226_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS",16,-0.9823,0.5,0.65,-0.7651,0.77,1,-1.0604,0.4,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1206_NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1206_NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON",151,-0.9821,0.5,0.6,-1.0856,0.27,0.94,-1.3353,0.017,0.41
"GO_BP:491239_GO_0006275_REGULATION_OF_DNA_REPLICATION","GO_BP","491239_GO_0006275_REGULATION_OF_DNA_REPLICATION",116,-0.982,0.51,0.65,0.7173,0.98,1,-0.9604,0.54,0.88
"GO_MF:489678_GO_0004312_FATTY_ACID_SYNTHASE_ACTIVITY","GO_MF","489678_GO_0004312_FATTY_ACID_SYNTHASE_ACTIVITY",7,-0.9819,0.5,0.68,-0.9362,0.53,0.96,0.6058,0.94,1
"KEGG_compound:C00483_TYRAMINE_2_P_HYDROXYPHENYL_ETHYLAMINE","KEGG_compound","C00483_TYRAMINE_2_P_HYDROXYPHENYL_ETHYLAMINE",6,-0.9817,0.51,0.64,-1.2178,0.25,0.75,-1.5648,0.034,0.18
"GO_CC:487094_GO_0000803_SEX_CHROMOSOME","GO_CC","487094_GO_0000803_SEX_CHROMOSOME",25,-0.9816,0.49,0.74,-1.018,0.41,0.84,-1.168,0.25,0.85
"GO_BP:505081_GO_0035912_DORSAL_AORTA_MORPHOGENESIS","GO_BP","505081_GO_0035912_DORSAL_AORTA_MORPHOGENESIS",5,-0.9814,0.5,0.66,-1.008,0.47,0.98,0.9053,0.57,0.94
"C3_TF_targets:C3_TFT_183_CCAATNNSNNNGCG_UNKNOWN","C3_TF_targets","C3_TFT_183_CCAATNNSNNNGCG_UNKNOWN",56,-0.9813,0.5,0.61,1.1018,0.28,1,0.8529,0.75,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_114_BIOCARTA_MAPK_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_114_BIOCARTA_MAPK_PATHWAY",87,-0.9813,0.49,0.61,-1.2688,0.1,1,-1.1883,0.14,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_1549_ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1549_ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN",19,-0.9813,0.51,0.6,0.5205,0.99,1,-0.974,0.49,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_3025_KARLSSON_TGFB1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3025_KARLSSON_TGFB1_TARGETS_UP",126,-0.9813,0.49,0.6,1.798,0,0.044,0.8323,0.87,1
"GO_BP:515425_GO_0070493_THROMBIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","515425_GO_0070493_THROMBIN_RECEPTOR_SIGNALING_PATHWAY",9,-0.9812,0.48,0.66,1.6107,0.033,0.28,0.7232,0.82,1
"GO_BP:519377_GO_2000738_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION","GO_BP","519377_GO_2000738_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION",45,-0.9811,0.5,0.66,-1.1908,0.2,0.9,-0.9636,0.5,0.88
"GO_MF:496726_GO_0016829_LYASE_ACTIVITY","GO_MF","496726_GO_0016829_LYASE_ACTIVITY",170,-0.981,0.51,0.68,1.349,0.018,0.52,-1.1519,0.16,0.64
"C3_TF_targets:C3_TFT_251_V_E2F1_Q3","C3_TF_targets","C3_TFT_251_V_E2F1_Q3",243,-0.981,0.53,0.6,0.8765,0.83,1,-1.4151,0.0084,0.3
"GO_BP:494783_GO_0010718_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION","GO_BP","494783_GO_0010718_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION",29,-0.9808,0.51,0.66,-1.1366,0.26,0.93,-0.9966,0.46,0.85
"C4_Cancer_modules:C4_CM_182_MODULE_195","C4_Cancer_modules","C4_CM_182_MODULE_195",143,-0.9807,0.5,0.61,0.9934,0.44,0.72,-0.9389,0.64,0.79
"C3_TF_targets:C3_TFT_452_V_E2F_Q4_01","C3_TF_targets","C3_TFT_452_V_E2F_Q4_01",237,-0.9807,0.54,0.6,-0.726,1,1,-1.5042,0,0.6
"GO_BP:491374_GO_0006471_PROTEIN_ADP_RIBOSYLATION","GO_BP","491374_GO_0006471_PROTEIN_ADP_RIBOSYLATION",19,-0.9805,0.48,0.66,-1.3878,0.084,1,-1.5402,0.022,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_2175_WALLACE_PROSTATE_CANCER_RACE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2175_WALLACE_PROSTATE_CANCER_RACE_DN",84,-0.9804,0.5,0.6,0.8133,0.87,0.98,0.68,0.98,1
"C4_Cancer_modules:C4_CM_115_MODULE_120","C4_Cancer_modules","C4_CM_115_MODULE_120",70,-0.9803,0.49,0.6,0.9188,0.61,0.81,-0.914,0.6,0.84
"C4_Cancer_modules:C4_CM_149_MODULE_157","C4_Cancer_modules","C4_CM_149_MODULE_157",105,-0.9803,0.51,0.6,-0.9017,0.69,0.87,0.9613,0.55,0.96
"GO_CC:512172_GO_0051286_CELL_TIP","GO_CC","512172_GO_0051286_CELL_TIP",7,-0.9801,0.48,0.74,1.052,0.38,0.71,0.5453,0.98,1
"GO_BP:498072_GO_0019217_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS","GO_BP","498072_GO_0019217_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS",77,-0.98,0.49,0.66,1.0619,0.32,0.94,1.1933,0.17,0.72
"GO_BP:496952_GO_0017158_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS","GO_BP","496952_GO_0017158_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS",55,-0.9799,0.52,0.66,-1.0822,0.32,0.95,-1.3058,0.093,0.64
"GO_BP:518640_GO_0097090_PRESYNAPTIC_MEMBRANE_ORGANIZATION","GO_BP","518640_GO_0097090_PRESYNAPTIC_MEMBRANE_ORGANIZATION",11,-0.9799,0.51,0.66,-0.9571,0.51,1,0.9261,0.54,0.92
"C1_Positional:C1_ALL_203_CHR4P13","C1_Positional","C1_ALL_203_CHR4P13",14,-0.9798,0.47,0.89,-0.7279,0.83,0.98,1.0222,0.41,0.75
"C7_Immunologic_signatures:C7_ALL_266_GSE14308_TH17_VS_NATURAL_TREG_DN","C7_Immunologic_signatures","C7_ALL_266_GSE14308_TH17_VS_NATURAL_TREG_DN",196,-0.9798,0.51,0.62,-0.9856,0.5,1,0.8813,0.8,1
"WikiPathways:219801_WP1984_INTEGRATED_BREAST_CANCER_PATHWAY","WikiPathways","219801_WP1984_INTEGRATED_BREAST_CANCER_PATHWAY",151,-0.9798,0.51,0.6,0.5251,1,0.99,-1.0368,0.37,0.63
"GO_BP:508585_GO_0046320_REGULATION_OF_FATTY_ACID_OXIDATION","GO_BP","508585_GO_0046320_REGULATION_OF_FATTY_ACID_OXIDATION",24,-0.9797,0.49,0.66,0.8997,0.6,1,1.1881,0.22,0.72
"GO_BP:752205_GO_0061462_PROTEIN_LOCALIZATION_TO_LYSOSOME","GO_BP","752205_GO_0061462_PROTEIN_LOCALIZATION_TO_LYSOSOME",16,-0.9797,0.48,0.66,0.8957,0.59,1,0.7068,0.87,1
"GO_MF:514942_GO_0070001_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY","GO_MF","514942_GO_0070001_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY",25,-0.9796,0.51,0.68,0.7383,0.86,1,0.8337,0.73,1
"GO_BP:502155_GO_0032933_SREBP_SIGNALING_PATHWAY","GO_BP","502155_GO_0032933_SREBP_SIGNALING_PATHWAY",7,-0.9795,0.49,0.66,-0.961,0.51,1,-0.5997,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1537_VERNELL_RETINOBLASTOMA_PATHWAY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1537_VERNELL_RETINOBLASTOMA_PATHWAY_UP",70,-0.9795,0.48,0.6,1.0623,0.36,0.69,-1.5734,0.01,0.25
"C3_TF_targets:C3_TFT_497_KMCATNNWGGA_UNKNOWN","C3_TF_targets","C3_TFT_497_KMCATNNWGGA_UNKNOWN",88,-0.9794,0.51,0.61,-0.9819,0.47,0.8,0.6776,0.99,1
"GO_BP:499843_GO_0030502_NEGATIVE_REGULATION_OF_BONE_MINERALIZATION","GO_BP","499843_GO_0030502_NEGATIVE_REGULATION_OF_BONE_MINERALIZATION",15,-0.9793,0.5,0.66,1.1045,0.3,0.9,1.4893,0.057,0.57
"GO_BP:752605_GO_0097104_POSTSYNAPTIC_MEMBRANE_ASSEMBLY","GO_BP","752605_GO_0097104_POSTSYNAPTIC_MEMBRANE_ASSEMBLY",6,-0.9792,0.51,0.66,-0.8832,0.62,1,0.6793,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1898_RAMASWAMY_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1898_RAMASWAMY_METASTASIS_UP",66,-0.9787,0.49,0.6,0.7617,0.88,1,-0.9317,0.61,0.84
"GO_BP:517560_GO_0072657_PROTEIN_LOCALIZATION_TO_MEMBRANE","GO_BP","517560_GO_0072657_PROTEIN_LOCALIZATION_TO_MEMBRANE",349,-0.9785,0.56,0.66,2.6912,0,0,0.637,1,1
"GO_BP:494713_GO_0010649_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING","GO_BP","494713_GO_0010649_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING",13,-0.9785,0.49,0.66,1.3175,0.14,0.65,1.0354,0.41,0.82
"GO_BP:495282_GO_0014889_MUSCLE_ATROPHY","GO_BP","495282_GO_0014889_MUSCLE_ATROPHY",7,-0.9784,0.47,0.66,0.8947,0.61,1,0.7069,0.83,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3129_JOHNSTONE_PARVB_TARGETS_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3129_JOHNSTONE_PARVB_TARGETS_2_DN",332,-0.9782,0.56,0.61,1.5457,0,0.17,0.8345,0.96,1
"C3_MicroRNA_targets:C3_MIR_30_TAGGTCA_MIR_192_MIR_215","C3_MicroRNA_targets","C3_MIR_30_TAGGTCA_MIR_192_MIR_215",46,-0.9782,0.49,0.65,0.9749,0.5,1,-0.6518,0.97,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2085_YEGNASUBRAMANIAN_PROSTATE_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_2085_YEGNASUBRAMANIAN_PROSTATE_CANCER",116,-0.9781,0.48,0.61,1.2027,0.13,0.48,-1.114,0.22,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_816_FUNG_IL2_SIGNALING_1","C2_Chemical_and_genetic_perturbations","C2_CGP_816_FUNG_IL2_SIGNALING_1",11,-0.9781,0.49,0.6,0.9037,0.6,0.92,-0.8115,0.74,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_604_DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_604_DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP",26,-0.9779,0.5,0.61,-1.0311,0.4,0.98,-1.1179,0.3,0.61
"GO_BP:508759_GO_0046500_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS","GO_BP","508759_GO_0046500_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS",14,-0.9779,0.5,0.66,-1.3285,0.13,0.89,-1.8119,0.008,0.51
"GO_BP:506413_GO_0043374_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION","GO_BP","506413_GO_0043374_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION",7,-0.9779,0.49,0.66,0.7206,0.82,1,1.1567,0.29,0.73
"C3_MicroRNA_targets:C3_MIR_151_AAAGACA_MIR_511","C3_MicroRNA_targets","C3_MIR_151_AAAGACA_MIR_511",199,-0.9776,0.54,0.65,0.9509,0.59,1,1.1795,0.1,1
"REACTOME:105933_REACT_11035_GAP_JUNCTION_DEGRADATION","REACTOME","105933_REACT_11035_GAP_JUNCTION_DEGRADATION",10,-0.9775,0.5,0.68,1.0758,0.37,0.62,0.5678,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2056_LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES","C2_Chemical_and_genetic_perturbations","C2_CGP_2056_LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES",17,-0.9775,0.5,0.61,-1.1433,0.28,0.86,-0.8472,0.71,0.93
"GO_BP:502305_GO_0033084_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION_IN_THYMUS","GO_BP","502305_GO_0033084_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION_IN_THYMUS",7,-0.9774,0.5,0.66,0.7225,0.8,1,0.6283,0.92,1
"C3_TF_targets:C3_TFT_254_V_TITF1_Q3","C3_TF_targets","C3_TFT_254_V_TITF1_Q3",230,-0.9773,0.55,0.61,-1.0334,0.35,0.69,0.8774,0.81,1
"GO_BP:518330_GO_0090190_POSITIVE_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS","GO_BP","518330_GO_0090190_POSITIVE_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS",19,-0.9771,0.49,0.66,1.2577,0.17,0.72,1.1555,0.25,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_3160_CHANGOLKAR_H2AFY_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3160_CHANGOLKAR_H2AFY_TARGETS_DN",40,-0.9771,0.51,0.61,1.0379,0.41,0.74,0.9927,0.47,0.96
"GO_BP:753711_GO_1900740_POSITIVE_REGULATION_OF_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","753711_GO_1900740_POSITIVE_REGULATION_OF_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY",26,-0.9771,0.49,0.66,0.5828,0.99,1,-1.1705,0.24,0.73
"OMIM_gene:OMIM604891_NCK_ASSOCIATED_PROTEIN_1_NCKAP1","OMIM_gene","OMIM604891_NCK_ASSOCIATED_PROTEIN_1_NCKAP1",8,-0.977,0.48,0.77,0.6113,0.93,1,-0.9833,0.48,1
"REACTOME:771592_REACT_160301_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER","REACTOME","771592_REACT_160301_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER",57,-0.9769,0.52,0.68,-0.6725,0.97,1,-1.3082,0.075,0.55
"C1_Positional:C1_ALL_46_CHR15Q24","C1_Positional","C1_ALL_46_CHR15Q24",75,-0.9768,0.5,0.89,-1,0.45,1,0.9441,0.57,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_364_PROVENZANI_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_364_PROVENZANI_METASTASIS_UP",194,-0.9768,0.53,0.61,1.6551,0,0.11,-1.1624,0.14,0.56
"GO_BP:494867_GO_0010803_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY","GO_BP","494867_GO_0010803_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY",16,-0.9767,0.53,0.66,-0.4451,1,1,0.7077,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1949_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1949_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP",18,-0.9766,0.49,0.61,-0.9552,0.51,1,-0.8743,0.61,0.9
"GO_BP:512166_GO_0051280_NEGATIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL","GO_BP","512166_GO_0051280_NEGATIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL",5,-0.9764,0.52,0.66,-0.7576,0.75,1,-1.1975,0.28,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_2908_CHANDRAN_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2908_CHANDRAN_METASTASIS_UP",214,-0.9757,0.55,0.61,-0.9293,0.67,1,-1.0967,0.23,0.63
"GO_BP:491491_GO_0006596_POLYAMINE_BIOSYNTHETIC_PROCESS","GO_BP","491491_GO_0006596_POLYAMINE_BIOSYNTHETIC_PROCESS",13,-0.9757,0.49,0.66,-0.7171,0.83,1,-0.7603,0.79,1
"C7_Immunologic_signatures:C7_ALL_1490_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN","C7_Immunologic_signatures","C7_ALL_1490_GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN",197,-0.9756,0.51,0.63,1.0022,0.45,0.73,-1.0778,0.25,0.55
"C4_Cancer_gene_neighborhoods:C4_CGN_8_MORF_BRCA1","C4_Cancer_gene_neighborhoods","C4_CGN_8_MORF_BRCA1",258,-0.9753,0.54,0.76,-1.0888,0.23,0.75,0.7809,0.99,1
"GO_BP:504275_GO_0035090_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY","GO_BP","504275_GO_0035090_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY",7,-0.9752,0.47,0.66,1.2274,0.21,0.76,-1.5717,0.046,0.53
"KEGG_module:HSA_M00683_HIPPO_SIGNALING","KEGG_module","HSA_M00683_HIPPO_SIGNALING",15,-0.9752,0.47,0.76,-0.6281,0.95,1,-1.299,0.16,0.48
"C3_TF_targets:C3_TFT_127_V_MYB_Q6","C3_TF_targets","C3_TFT_127_V_MYB_Q6",248,-0.9751,0.55,0.62,-0.8558,0.88,1,0.8695,0.85,1
"GO_BP:491857_GO_0007029_ENDOPLASMIC_RETICULUM_ORGANIZATION","GO_BP","491857_GO_0007029_ENDOPLASMIC_RETICULUM_ORGANIZATION",40,-0.975,0.52,0.66,0.594,0.99,1,-0.9685,0.51,0.88
"GO_BP:517200_GO_0072284_METANEPHRIC_S_SHAPED_BODY_MORPHOGENESIS","GO_BP","517200_GO_0072284_METANEPHRIC_S_SHAPED_BODY_MORPHOGENESIS",5,-0.975,0.5,0.66,1.1017,0.37,0.9,1.0634,0.39,0.79
"GO_BP:505055_GO_0035886_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION","GO_BP","505055_GO_0035886_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION",12,-0.975,0.48,0.66,-0.7331,0.82,1,0.9042,0.57,0.94
"C7_Immunologic_signatures:C7_ALL_926_GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN","C7_Immunologic_signatures","C7_ALL_926_GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN",200,-0.9748,0.55,0.63,1.648,0,0.0013,-0.8757,0.82,0.98
"GO_BP:499595_GO_0030177_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY","GO_BP","499595_GO_0030177_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY",158,-0.9747,0.53,0.67,1.2018,0.078,0.78,-0.6918,1,0.99
"GO_BP:510800_GO_0048747_MUSCLE_FIBER_DEVELOPMENT","GO_BP","510800_GO_0048747_MUSCLE_FIBER_DEVELOPMENT",42,-0.9745,0.5,0.67,-1.2976,0.1,0.89,-1.0019,0.48,0.85
"C7_Immunologic_signatures:C7_ALL_1094_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1094_GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN",199,-0.9745,0.54,0.63,0.8868,0.78,1,-1.1569,0.13,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_2044_HOWLIN_CITED1_TARGETS_2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2044_HOWLIN_CITED1_TARGETS_2_DN",17,-0.9744,0.51,0.61,-0.5789,0.97,1,0.8503,0.68,1
"C7_Immunologic_signatures:C7_ALL_1871_GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1871_GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP",197,-0.9743,0.53,0.63,1.3702,0.017,0.051,-0.9805,0.5,0.77
"GO_MF:496740_GO_0016846_CARBON_SULFUR_LYASE_ACTIVITY","GO_MF","496740_GO_0016846_CARBON_SULFUR_LYASE_ACTIVITY",11,-0.9743,0.5,0.69,0.9689,0.49,0.91,-0.8496,0.66,0.93
"GO_BP:494803_GO_0010738_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING","GO_BP","494803_GO_0010738_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING",17,-0.9743,0.5,0.67,0.9569,0.51,1,1.4731,0.063,0.58
"GO_BP:496276_GO_0016202_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","496276_GO_0016202_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT",96,-0.9742,0.52,0.67,-0.8356,0.81,1,1.0661,0.34,0.79
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_144_BIOCARTA_AKAPCENTROSOME_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_144_BIOCARTA_AKAPCENTROSOME_PATHWAY",15,-0.9742,0.5,0.62,1.1972,0.21,0.68,-1.0476,0.39,0.68
"GO_MF:496944_GO_0017147_WNT_PROTEIN_BINDING","GO_MF","496944_GO_0017147_WNT_PROTEIN_BINDING",27,-0.974,0.49,0.69,-0.9183,0.6,0.97,0.876,0.65,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_927_SCHMAHL_PDGF_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_927_SCHMAHL_PDGF_SIGNALING",9,-0.974,0.5,0.61,0.5771,0.96,1,-1.0176,0.43,0.73
"GO_BP:510425_GO_0048318_AXIAL_MESODERM_DEVELOPMENT","GO_BP","510425_GO_0048318_AXIAL_MESODERM_DEVELOPMENT",8,-0.9739,0.49,0.67,-0.8852,0.6,1,0.7712,0.74,1
"GO_BP:518178_GO_0090031_POSITIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS","GO_BP","518178_GO_0090031_POSITIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS",6,-0.9739,0.49,0.67,0.7923,0.69,1,0.6359,0.91,1
"GO_BP:494926_GO_0010862_POSITIVE_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION","GO_BP","494926_GO_0010862_POSITIVE_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION",45,-0.9739,0.5,0.67,0.8895,0.64,1,1.1702,0.21,0.72
"GO_MF:506340_GO_0043274_PHOSPHOLIPASE_BINDING","GO_MF","506340_GO_0043274_PHOSPHOLIPASE_BINDING",16,-0.9739,0.49,0.69,0.9512,0.52,0.93,-1.3692,0.1,0.51
"GO_BP:754630_GO_1901679_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT","GO_BP","754630_GO_1901679_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT",12,-0.9739,0.48,0.67,-1.0367,0.41,0.98,-1.275,0.19,0.66
"C7_Immunologic_signatures:C7_ALL_1759_GSE6269_STREP_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1759_GSE6269_STREP_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP",177,-0.9738,0.52,0.63,1.0437,0.37,0.61,0.8223,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_272_ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_272_ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN",44,-0.9737,0.5,0.61,-0.6361,0.98,1,-0.9558,0.51,0.81
"C4_Cancer_gene_neighborhoods:C4_CGN_231_GCM_FCGR2B","C4_Cancer_gene_neighborhoods","C4_CGN_231_GCM_FCGR2B",37,-0.9737,0.51,0.76,-0.7346,0.89,1,0.7058,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2055_LEIN_CEREBELLUM_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_2055_LEIN_CEREBELLUM_MARKERS",82,-0.9735,0.51,0.61,-0.809,0.85,1,1.1484,0.19,0.83
"GO_CC:490832_GO_0030133_TRANSPORT_VESICLE","GO_CC","490832_GO_0030133_TRANSPORT_VESICLE",164,-0.9733,0.52,0.75,1.19,0.093,0.55,-0.872,0.82,1
"GO_BP:503582_GO_0034380_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY","GO_BP","503582_GO_0034380_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY",8,-0.9732,0.49,0.67,-1.1355,0.3,0.93,-0.7479,0.79,1
"C4_Cancer_modules:C4_CM_324_MODULE_381","C4_Cancer_modules","C4_CM_324_MODULE_381",12,-0.9732,0.49,0.62,-1.2847,0.18,0.53,-1.6319,0.026,0.11
"GO_BP:513645_GO_0060087_RELAXATION_OF_VASCULAR_SMOOTH_MUSCLE","GO_BP","513645_GO_0060087_RELAXATION_OF_VASCULAR_SMOOTH_MUSCLE",7,-0.9732,0.5,0.67,1.2019,0.25,0.78,-0.7735,0.74,1
"GO_BP:781992_GO_1902003_REGULATION_OF_BETA_AMYLOID_FORMATION","GO_BP","781992_GO_1902003_REGULATION_OF_BETA_AMYLOID_FORMATION",10,-0.9731,0.48,0.67,1.0282,0.43,0.97,-0.7783,0.75,1
"KEGG_compound:C00343_THIOREDOXIN_DISULFIDE_OXIDIZED_THIOREDOXIN_THIOREDOXIN_SULFIDE","KEGG_compound","C00343_THIOREDOXIN_DISULFIDE_OXIDIZED_THIOREDOXIN_THIOREDOXIN_SULFIDE",7,-0.9731,0.51,0.66,1.0626,0.4,1,-1.3453,0.14,0.33
"GO_BP:1129562_GO_1903747_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION","GO_BP","1129562_GO_1903747_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION",99,-0.9731,0.53,0.67,1.2648,0.087,0.71,-0.9918,0.44,0.85
"GO_BP:752655_GO_0097154_GABAERGIC_NEURON_DIFFERENTIATION","GO_BP","752655_GO_0097154_GABAERGIC_NEURON_DIFFERENTIATION",9,-0.9731,0.48,0.67,-1.7037,0.012,0.7,-1.0526,0.37,0.81
"C7_Immunologic_signatures:C7_ALL_1865_GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP","C7_Immunologic_signatures","C7_ALL_1865_GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP",197,-0.973,0.54,0.64,0.8254,0.93,1,-1.0092,0.41,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_388_LAU_APOPTOSIS_CDKN2A_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_388_LAU_APOPTOSIS_CDKN2A_DN",5,-0.9729,0.53,0.61,0.5017,0.98,1,-0.7078,0.83,0.98
"GO_BP:494529_GO_0010459_NEGATIVE_REGULATION_OF_HEART_RATE","GO_BP","494529_GO_0010459_NEGATIVE_REGULATION_OF_HEART_RATE",10,-0.9729,0.51,0.67,1.3867,0.1,0.57,1.36,0.12,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_1982_TSENG_ADIPOGENIC_POTENTIAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1982_TSENG_ADIPOGENIC_POTENTIAL_UP",30,-0.9728,0.5,0.61,-0.9742,0.49,1,-0.9236,0.59,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_644_ROVERSI_GLIOMA_COPY_NUMBER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_644_ROVERSI_GLIOMA_COPY_NUMBER_UP",99,-0.9728,0.53,0.61,0.5655,1,1,-0.7559,0.95,0.97
"GO_BP:505875_GO_0042769_DNA_DAMAGE_RESPONSE_DETECTION_OF_DNA_DAMAGE","GO_BP","505875_GO_0042769_DNA_DAMAGE_RESPONSE_DETECTION_OF_DNA_DAMAGE",9,-0.9728,0.5,0.67,-0.697,0.85,1,-1.1595,0.28,0.73
"GO_BP:491760_GO_0006900_MEMBRANE_BUDDING","GO_BP","491760_GO_0006900_MEMBRANE_BUDDING",68,-0.9726,0.5,0.67,1.8279,0,0.077,0.9741,0.51,0.88
"GO_BP:516205_GO_0071281_CELLULAR_RESPONSE_TO_IRON_ION","GO_BP","516205_GO_0071281_CELLULAR_RESPONSE_TO_IRON_ION",6,-0.9725,0.5,0.67,1.2908,0.17,0.69,1.1959,0.25,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_314_ELVIDGE_HYPOXIA_BY_DMOG_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_314_ELVIDGE_HYPOXIA_BY_DMOG_DN",59,-0.9725,0.51,0.61,0.8957,0.7,0.93,0.7467,0.92,1
"GO_BP:505683_GO_0042552_MYELINATION","GO_BP","505683_GO_0042552_MYELINATION",85,-0.9723,0.54,0.67,0.7347,0.96,1,-0.8084,0.87,0.99
"GO_BP:492045_GO_0007266_RHO_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","492045_GO_0007266_RHO_PROTEIN_SIGNAL_TRANSDUCTION",49,-0.9723,0.51,0.67,0.969,0.52,1,0.7982,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1277_GOLUB_ALL_VS_AML_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1277_GOLUB_ALL_VS_AML_UP",24,-0.9722,0.49,0.61,0.6196,0.98,1,-1.5191,0.044,0.29
"C1_Positional:C1_ALL_158_CHR14Q32","C1_Positional","C1_ALL_158_CHR14Q32",127,-0.9722,0.54,0.89,-0.9239,0.62,1,-1.0495,0.35,0.86
"GO_BP:510491_GO_0048384_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY","GO_BP","510491_GO_0048384_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY",18,-0.9722,0.51,0.67,0.7391,0.85,1,0.6521,0.93,1
"REACTOME:771594_REACT_160248_SIGNALING_BY_NOTCH1_HD_PEST_DOMAIN_MUTANTS_IN_CANCER","REACTOME","771594_REACT_160248_SIGNALING_BY_NOTCH1_HD_PEST_DOMAIN_MUTANTS_IN_CANCER",57,-0.9722,0.5,0.69,-0.6686,0.97,1,-1.2912,0.097,0.54
"GO_BP:519412_GO_2000773_NEGATIVE_REGULATION_OF_CELLULAR_SENESCENCE","GO_BP","519412_GO_2000773_NEGATIVE_REGULATION_OF_CELLULAR_SENESCENCE",10,-0.972,0.51,0.67,-0.7293,0.82,1,-0.5981,0.95,1
"KEGG_compound:C00149__S_MALATE_L_MALATE_L_APPLE_ACID_L_MALIC_ACID_L_2_HYDROXYBUTANEDIOIC_ACID_MALATE_MALIC_ACID","KEGG_compound","C00149__S_MALATE_L_MALATE_L_APPLE_ACID_L_MALIC_ACID_L_2_HYDROXYBUTANEDIOIC_ACID_MALATE_MALIC_ACID",6,-0.972,0.52,0.66,1.1159,0.35,1,0.5401,0.97,1
"KEGG_module:HSA_M00086_BETA_OXIDATION_ACYL_COA_SYNTHESIS","KEGG_module","HSA_M00086_BETA_OXIDATION_ACYL_COA_SYNTHESIS",7,-0.972,0.5,0.75,0.5724,0.96,0.99,0.7147,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2046_HILLION_HMGA1B_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2046_HILLION_HMGA1B_TARGETS",89,-0.972,0.52,0.61,1.9845,0,0.0075,-0.6336,1,0.99
"OMIM_gene:OMIM603819_STEROID_RECEPTOR_RNA_ACTIVATOR_1_SRA1","OMIM_gene","OMIM603819_STEROID_RECEPTOR_RNA_ACTIVATOR_1_SRA1",5,-0.9717,0.52,0.76,-1.4811,0.045,0.8,-1.1272,0.35,1
"C1_Positional:C1_ALL_226_CHR6Q25","C1_Positional","C1_ALL_226_CHR6Q25",56,-0.9717,0.5,0.89,-0.9354,0.59,1,-1.1048,0.29,0.79
"KEGG_compound:C00135_L_HISTIDINE_S_ALPHA_AMINO_1H_IMIDAZOLE_4_PROPIONIC_ACID","KEGG_compound","C00135_L_HISTIDINE_S_ALPHA_AMINO_1H_IMIDAZOLE_4_PROPIONIC_ACID",8,-0.9714,0.49,0.66,-0.6957,0.85,1,0.5269,0.98,1
"GO_BP:488185_GO_0002312_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488185_GO_0002312_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE",33,-0.9714,0.5,0.67,0.7456,0.86,1,-0.8547,0.71,0.96
"REACTOME:771595_REACT_160254_CONSTITUTIVE_SIGNALING_BY_NOTCH1_HD_PEST_DOMAIN_MUTANTS","REACTOME","771595_REACT_160254_CONSTITUTIVE_SIGNALING_BY_NOTCH1_HD_PEST_DOMAIN_MUTANTS",57,-0.9714,0.51,0.69,-0.6665,0.98,1,-1.297,0.076,0.55
"REACTOME:645314_REACT_120906_SYNTHESIS_OF_PA","REACTOME","645314_REACT_120906_SYNTHESIS_OF_PA",26,-0.9714,0.51,0.69,1.0667,0.36,0.63,-0.9992,0.45,0.84
"GO_BP:497078_GO_0018103_PROTEIN_C_LINKED_GLYCOSYLATION","GO_BP","497078_GO_0018103_PROTEIN_C_LINKED_GLYCOSYLATION",5,-0.9713,0.52,0.67,0.7393,0.78,1,-1.4083,0.095,0.57
"GO_CC:752600_GO_0090543_FLEMMING_BODY","GO_CC","752600_GO_0090543_FLEMMING_BODY",8,-0.9713,0.49,0.75,1.2931,0.17,0.41,-0.5364,0.97,1
"KEGG_reaction:R00434_GTP_DIPHOSPHATE_LYASE_CYCLIZING_3_5_CYCLIC_GMP_FORMING_GTP_3_5_CYCLIC_GMP_DIPHOSPHATE","KEGG_reaction","R00434_GTP_DIPHOSPHATE_LYASE_CYCLIZING_3_5_CYCLIC_GMP_FORMING_GTP_3_5_CYCLIC_GMP_DIPHOSPHATE",18,-0.9711,0.48,0.66,-0.7695,0.81,1,-1.6016,0.019,0.13
"KEGG_compound:C00455_NICOTINAMIDE_D_RIBONUCLEOTIDE_NMN_NICOTINAMIDE_MONONUCLEOTIDE_NICOTINAMIDE_RIBONUCLEOTIDE_NICOTINAMIDE_NUCLEOTIDE_BETA_NICOTINAMIDE_D_RIBONUCLEOTIDE_BETA_NICOTINAMIDE_RIBONUCLEOTIDE_BETA_NICOTINAMIDE_MONONUCLEOTIDE","KEGG_compound","C00455_NICOTINAMIDE_D_RIBONUCLEOTIDE_NMN_NICOTINAMIDE_MONONUCLEOTIDE_NICOTINAMIDE_RIBONUCLEOTIDE_NICOTINAMIDE_NUCLEOTIDE_BETA_NICOTINAMIDE_D_RIBONUCLEOTIDE_BETA_NICOTINAMIDE_RIBONUCLEOTIDE_BETA_NICOTINAMIDE_MONONUCLEOTIDE",19,-0.9709,0.51,0.65,0.8176,0.73,1,-1.6421,0.0077,0.11
"GO_BP:518482_GO_0090342_REGULATION_OF_CELL_AGING","GO_BP","518482_GO_0090342_REGULATION_OF_CELL_AGING",31,-0.9708,0.49,0.67,-0.8722,0.67,1,-0.533,1,1
"GO_BP:509075_GO_0046855_INOSITOL_PHOSPHATE_DEPHOSPHORYLATION","GO_BP","509075_GO_0046855_INOSITOL_PHOSPHATE_DEPHOSPHORYLATION",10,-0.9705,0.48,0.67,-0.5021,0.98,1,0.6504,0.92,1
"C1_Positional:C1_ALL_254_CHR4Q27","C1_Positional","C1_ALL_254_CHR4Q27",12,-0.9704,0.49,0.89,0.7614,0.77,0.99,-0.5699,0.96,1
"REACTOME:106249_REACT_11193_METABOLISM_OF_VITAMINS_AND_COFACTORS","REACTOME","106249_REACT_11193_METABOLISM_OF_VITAMINS_AND_COFACTORS",86,-0.9704,0.51,0.69,0.8308,0.83,0.97,-1.2151,0.13,0.59
"GO_MF:492434_GO_0008061_CHITIN_BINDING","GO_MF","492434_GO_0008061_CHITIN_BINDING",8,-0.9703,0.5,0.7,1.7334,0.012,0.12,1.019,0.42,0.86
"GO_CC:490656_GO_0005583_FIBRILLAR_COLLAGEN_TRIMER","GO_CC","490656_GO_0005583_FIBRILLAR_COLLAGEN_TRIMER",13,-0.9703,0.51,0.76,-1.1457,0.26,0.7,-1.0831,0.35,0.92
"REACTOME:1183555_REACT_355503_CD209_DC_SIGN_SIGNALING","REACTOME","1183555_REACT_355503_CD209_DC_SIGN_SIGNALING",21,-0.9702,0.51,0.69,0.9905,0.43,0.77,-1.1889,0.22,0.61
"GO_CC:850020_GO_1990111_SPERMATOPROTEASOME_COMPLEX","GO_CC","850020_GO_1990111_SPERMATOPROTEASOME_COMPLEX",5,-0.97,0.52,0.75,0.6761,0.85,0.98,-1.4521,0.06,0.5
"KEGG_compound:C00342_THIOREDOXIN_REDUCED_THIOREDOXIN","KEGG_compound","C00342_THIOREDOXIN_REDUCED_THIOREDOXIN",7,-0.97,0.5,0.65,1.0439,0.4,1,-1.3355,0.16,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_1996_BILD_CTNNB1_ONCOGENIC_SIGNATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_1996_BILD_CTNNB1_ONCOGENIC_SIGNATURE",81,-0.9699,0.53,0.62,-0.8044,0.87,1,-0.8941,0.7,0.89
"GO_BP:753990_GO_1901020_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","753990_GO_1901020_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",20,-0.9697,0.51,0.67,0.8181,0.73,1,0.6851,0.91,1
"C7_Immunologic_signatures:C7_ALL_28_GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_28_GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN",200,-0.9697,0.54,0.65,1.04,0.36,0.62,-1.101,0.21,0.5
"GO_BP:501995_GO_0032769_NEGATIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY","GO_BP","501995_GO_0032769_NEGATIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY",12,-0.9696,0.5,0.67,-0.9807,0.49,1,0.9255,0.56,0.92
"REACTOME:106480_REACT_12435_RETROGRADE_NEUROTROPHIN_SIGNALLING","REACTOME","106480_REACT_12435_RETROGRADE_NEUROTROPHIN_SIGNALLING",13,-0.9696,0.5,0.69,0.6411,0.92,1,-0.7531,0.83,1
"REACTOME:187192_REACT_25283_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING","REACTOME","187192_REACT_25283_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING",28,-0.9695,0.49,0.69,0.8634,0.65,0.95,1.3534,0.098,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_2960_BAUS_TFF2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2960_BAUS_TFF2_TARGETS_DN",10,-0.9695,0.5,0.62,0.7679,0.77,1,-0.9348,0.54,0.84
"C7_Immunologic_signatures:C7_ALL_380_GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_380_GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN",200,-0.9694,0.54,0.65,1.1397,0.15,0.34,-1.154,0.14,0.36
"C3_MicroRNA_targets:C3_MIR_185_CCAGGGG_MIR_331","C3_MicroRNA_targets","C3_MIR_185_CCAGGGG_MIR_331",96,-0.9692,0.52,0.67,-1.7022,0,0.08,-1.3222,0.044,1
"GO_BP:518191_GO_0090050_POSITIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS","GO_BP","518191_GO_0090050_POSITIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS",7,-0.9692,0.5,0.67,-0.6947,0.84,1,-0.9376,0.54,0.9
"GO_BP:502417_GO_0033197_RESPONSE_TO_VITAMIN_E","GO_BP","502417_GO_0033197_RESPONSE_TO_VITAMIN_E",12,-0.9691,0.52,0.67,1.0158,0.42,0.97,1.2763,0.16,0.69
"GO_BP:491070_GO_0006085_ACETYL_COA_BIOSYNTHETIC_PROCESS","GO_BP","491070_GO_0006085_ACETYL_COA_BIOSYNTHETIC_PROCESS",5,-0.9691,0.52,0.67,0.7072,0.83,1,-1.2823,0.18,0.65
"GO_MF:492627_GO_0008307_STRUCTURAL_CONSTITUENT_OF_MUSCLE","GO_MF","492627_GO_0008307_STRUCTURAL_CONSTITUENT_OF_MUSCLE",39,-0.9689,0.51,0.7,-1.2294,0.15,0.84,-0.7405,0.9,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2645_WENDT_COHESIN_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2645_WENDT_COHESIN_TARGETS_UP",33,-0.9688,0.51,0.62,0.9566,0.54,0.86,-0.9855,0.47,0.78
"GO_BP:489174_GO_0003382_EPITHELIAL_CELL_MORPHOGENESIS","GO_BP","489174_GO_0003382_EPITHELIAL_CELL_MORPHOGENESIS",45,-0.9685,0.51,0.67,-1.3712,0.063,0.98,1.056,0.37,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_3233_LIU_TOPBP1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3233_LIU_TOPBP1_TARGETS",16,-0.9684,0.52,0.62,1.2436,0.17,0.45,0.7544,0.82,1
"REACTOME:106100_REACT_1525_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS","REACTOME","106100_REACT_1525_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS",5,-0.9683,0.5,0.69,1.4326,0.085,0.2,0.9315,0.54,1
"GO_BP:510760_GO_0048705_SKELETAL_SYSTEM_MORPHOGENESIS","GO_BP","510760_GO_0048705_SKELETAL_SYSTEM_MORPHOGENESIS",206,-0.9683,0.54,0.67,-1.3524,0.017,0.95,1.1651,0.11,0.73
"KEGG_compound:C00643_5_HYDROXY_L_TRYPTOPHAN_OXITRIPTAN","KEGG_compound","C00643_5_HYDROXY_L_TRYPTOPHAN_OXITRIPTAN",5,-0.9681,0.55,0.66,-1.2706,0.17,0.68,-0.9936,0.48,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_417_CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_417_CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP",33,-0.968,0.51,0.62,-0.4191,1,1,0.5363,1,1
"REACTOME:730337_REACT_150201_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES","REACTOME","730337_REACT_150201_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES",6,-0.9678,0.51,0.69,0.8893,0.62,0.91,-0.7193,0.81,1
"GO_MF:489905_GO_0004571_MANNOSYL_OLIGOSACCHARIDE_1_2_ALPHA_MANNOSIDASE_ACTIVITY","GO_MF","489905_GO_0004571_MANNOSYL_OLIGOSACCHARIDE_1_2_ALPHA_MANNOSIDASE_ACTIVITY",8,-0.9678,0.5,0.7,-0.7173,0.82,1,-0.9283,0.54,0.85
"C7_Immunologic_signatures:C7_ALL_931_GSE22886_NAIVE_VS_MEMORY_TCELL_UP","C7_Immunologic_signatures","C7_ALL_931_GSE22886_NAIVE_VS_MEMORY_TCELL_UP",195,-0.9675,0.55,0.65,-1.0266,0.38,1,-0.6232,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2451_MIKI_COEXPRESSED_WITH_CYP19A1","C2_Chemical_and_genetic_perturbations","C2_CGP_2451_MIKI_COEXPRESSED_WITH_CYP19A1",7,-0.9675,0.5,0.62,0.6991,0.83,1,0.9308,0.54,1
"KEGG_module:HSA_M00691_DNA_DAMAGE_INDUCED_CELL_CYCLE_CHECKPOINTS","KEGG_module","HSA_M00691_DNA_DAMAGE_INDUCED_CELL_CYCLE_CHECKPOINTS",7,-0.9675,0.51,0.74,-0.6373,0.91,1,-0.9237,0.56,0.89
"C6_Oncogenic_signatures:C6_ALL_129_CAHOY_NEURONAL","C6_Oncogenic_signatures","C6_ALL_129_CAHOY_NEURONAL",99,-0.9674,0.54,0.58,1.1572,0.2,0.42,1.1283,0.22,0.34
"C1_Positional:C1_ALL_100_CHR5Q15","C1_Positional","C1_ALL_100_CHR5Q15",20,-0.9672,0.49,0.89,-0.9846,0.48,0.99,-1.3942,0.1,0.48
"C3_MicroRNA_targets:C3_MIR_202_ATCATGA_MIR_433","C3_MicroRNA_targets","C3_MIR_202_ATCATGA_MIR_433",115,-0.9672,0.54,0.67,0.9119,0.66,1,-0.6989,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_198_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_198_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN",54,-0.9671,0.52,0.62,0.7672,0.88,1,-1.0826,0.31,0.65
"WikiPathways:198834_WP422_MAPK_CASCADE","WikiPathways","198834_WP422_MAPK_CASCADE",29,-0.967,0.52,0.62,-0.6977,0.91,1,-0.9452,0.54,0.8
"WikiPathways:198884_WP231_TNF_ALPHA_NF_KB_SIGNALING_PATHWAY","WikiPathways","198884_WP231_TNF_ALPHA_NF_KB_SIGNALING_PATHWAY",190,-0.967,0.56,0.62,1.1622,0.11,0.9,-1.1695,0.11,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_2469_BOYLAN_MULTIPLE_MYELOMA_D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2469_BOYLAN_MULTIPLE_MYELOMA_D_UP",87,-0.9669,0.54,0.62,0.7405,0.95,1,-0.7683,0.93,0.97
"GO_BP:519287_GO_2000648_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION","GO_BP","519287_GO_2000648_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION",65,-0.9668,0.52,0.68,1.1385,0.23,0.85,1.5496,0.014,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_2593_LEE_SP4_THYMOCYTE","C2_Chemical_and_genetic_perturbations","C2_CGP_2593_LEE_SP4_THYMOCYTE",14,-0.9667,0.51,0.62,1.2356,0.19,0.45,1.4581,0.064,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1428_FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1428_FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN",25,-0.9666,0.52,0.62,0.9045,0.6,0.92,0.9932,0.45,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_617_APPIERTO_RESPONSE_TO_FENRETINIDE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_617_APPIERTO_RESPONSE_TO_FENRETINIDE_DN",51,-0.9665,0.52,0.62,1.4118,0.043,0.29,-1.2186,0.14,0.5
"C2_Chemical_and_genetic_perturbations:C2_CGP_1751_MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1751_MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP",81,-0.9665,0.53,0.62,-0.6878,0.97,1,-0.9512,0.54,0.82
"REACTOME:105906_REACT_18368_IRE1ALPHA_ACTIVATES_CHAPERONES","REACTOME","105906_REACT_18368_IRE1ALPHA_ACTIVATES_CHAPERONES",59,-0.9665,0.51,0.7,0.757,0.92,1,-0.7552,0.92,1
"GO_BP:491651_GO_0006778_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","491651_GO_0006778_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS",39,-0.9665,0.51,0.68,1.1574,0.22,0.83,-1.3472,0.077,0.61
"GO_BP:511761_GO_0050792_REGULATION_OF_VIRAL_PROCESS","GO_BP","511761_GO_0050792_REGULATION_OF_VIRAL_PROCESS",185,-0.9664,0.54,0.68,1.6884,0,0.21,-1.125,0.19,0.76
"GO_BP:982499_GO_1902931_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS","GO_BP","982499_GO_1902931_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS",15,-0.9662,0.53,0.68,-1.1197,0.3,0.94,-0.6597,0.91,1
"C0_Hallmark:H_ALL_24_HALLMARK_UNFOLDED_PROTEIN_RESPONSE","C0_Hallmark","H_ALL_24_HALLMARK_UNFOLDED_PROTEIN_RESPONSE",112,-0.9661,0.54,0.57,1.3482,0.026,0.074,-0.9753,0.54,0.56
"KEGG_module:HSA_M00089_TRIACYLGLYCEROL_BIOSYNTHESIS","KEGG_module","HSA_M00089_TRIACYLGLYCEROL_BIOSYNTHESIS",16,-0.9661,0.53,0.73,0.7661,0.78,0.91,0.8093,0.73,1
"GO_BP:516473_GO_0071549_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS","GO_BP","516473_GO_0071549_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS",18,-0.966,0.51,0.68,1.3449,0.13,0.61,1.1904,0.24,0.72
"GO_BP:508001_GO_0045653_NEGATIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION","GO_BP","508001_GO_0045653_NEGATIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION",17,-0.966,0.5,0.68,-1.2681,0.18,0.89,-1.1954,0.22,0.74
"REACTOME:187202_REACT_23905_PLATELET_CALCIUM_HOMEOSTASIS","REACTOME","187202_REACT_23905_PLATELET_CALCIUM_HOMEOSTASIS",19,-0.9659,0.5,0.7,-1.3421,0.1,0.6,-1.4344,0.07,0.39
"C2_Chemical_and_genetic_perturbations:C2_CGP_2704_CHEN_LIVER_METABOLISM_QTL_CIS","C2_Chemical_and_genetic_perturbations","C2_CGP_2704_CHEN_LIVER_METABOLISM_QTL_CIS",92,-0.9659,0.53,0.62,0.9552,0.56,0.86,-0.7549,0.95,0.97
"GO_BP:517155_GO_0072239_METANEPHRIC_GLOMERULUS_VASCULATURE_DEVELOPMENT","GO_BP","517155_GO_0072239_METANEPHRIC_GLOMERULUS_VASCULATURE_DEVELOPMENT",7,-0.9659,0.51,0.68,-0.6584,0.87,1,1.1723,0.29,0.72
"C3_TF_targets:C3_TFT_95_ACTWSNACTNY_UNKNOWN","C3_TF_targets","C3_TFT_95_ACTWSNACTNY_UNKNOWN",103,-0.9658,0.53,0.64,-0.712,0.98,1,-0.8648,0.78,0.97
"GO_BP:514089_GO_0060534_TRACHEA_CARTILAGE_DEVELOPMENT","GO_BP","514089_GO_0060534_TRACHEA_CARTILAGE_DEVELOPMENT",6,-0.9657,0.51,0.68,-0.8988,0.59,1,1.0727,0.36,0.78
"C4_Cancer_modules:C4_CM_135_MODULE_141","C4_Cancer_modules","C4_CM_135_MODULE_141",15,-0.9656,0.52,0.63,-1.2443,0.19,0.58,1.0172,0.43,0.93
"GO_BP:493365_GO_0009169_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS","GO_BP","493365_GO_0009169_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS",381,-0.9655,0.58,0.68,-0.8437,0.94,1,-1.2097,0.04,0.73
"C7_Immunologic_signatures:C7_ALL_760_GSE17721_0_5H_VS_24H_GARDIQUIMOD_BMDM_DN","C7_Immunologic_signatures","C7_ALL_760_GSE17721_0_5H_VS_24H_GARDIQUIMOD_BMDM_DN",199,-0.9652,0.55,0.66,1.1558,0.13,0.31,-1.0532,0.32,0.61
"C1_Positional:C1_ALL_230_CHR9Q21","C1_Positional","C1_ALL_230_CHR9Q21",53,-0.9652,0.51,0.89,1.0352,0.38,0.72,1.1107,0.27,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1960_BROWNE_HCMV_INFECTION_6HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1960_BROWNE_HCMV_INFECTION_6HR_DN",160,-0.9649,0.56,0.63,1.0141,0.44,0.78,1.2101,0.087,0.78
"C4_Cancer_modules:C4_CM_222_MODULE_243","C4_Cancer_modules","C4_CM_222_MODULE_243",80,-0.9647,0.54,0.63,1.5414,0.0022,0.096,1.1166,0.23,0.74
"GO_BP:751435_GO_0039528_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY_IN_RESPONSE_TO_VIRUS","GO_BP","751435_GO_0039528_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY_IN_RESPONSE_TO_VIRUS",6,-0.9646,0.51,0.68,1.2017,0.26,0.78,-1.4727,0.059,0.54
"GO_BP:501688_GO_0032456_ENDOCYTIC_RECYCLING","GO_BP","501688_GO_0032456_ENDOCYTIC_RECYCLING",18,-0.9646,0.5,0.68,0.5903,0.97,1,0.6826,0.91,1
"GO_BP:505877_GO_0042771_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR","GO_BP","505877_GO_0042771_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR",30,-0.9646,0.53,0.68,-0.7121,0.9,1,-1.3435,0.087,0.61
"GO_BP:501496_GO_0032261_PURINE_NUCLEOTIDE_SALVAGE","GO_BP","501496_GO_0032261_PURINE_NUCLEOTIDE_SALVAGE",8,-0.9646,0.5,0.68,0.6952,0.83,1,-1.2537,0.22,0.68
"GO_MF:494915_GO_0010851_CYCLASE_REGULATOR_ACTIVITY","GO_MF","494915_GO_0010851_CYCLASE_REGULATOR_ACTIVITY",8,-0.9646,0.53,0.71,-0.8562,0.63,1,-0.8985,0.58,0.87
"GO_BP:506245_GO_0043173_NUCLEOTIDE_SALVAGE","GO_BP","506245_GO_0043173_NUCLEOTIDE_SALVAGE",14,-0.9645,0.53,0.68,-0.6806,0.9,1,-1.1127,0.3,0.76
"GO_MF:490354_GO_0005086_ARF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY","GO_MF","490354_GO_0005086_ARF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",18,-0.9645,0.51,0.71,-1.0037,0.43,0.9,1.4106,0.071,0.52
"GO_BP:515023_GO_0070085_GLYCOSYLATION","GO_BP","515023_GO_0070085_GLYCOSYLATION",300,-0.9645,0.58,0.68,0.9392,0.69,1,-0.8964,0.8,0.93
"GO_BP:518890_GO_2000243_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS","GO_BP","518890_GO_2000243_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS",122,-0.9644,0.54,0.68,1.4286,0.0024,0.52,0.8287,0.86,1
"C3_TF_targets:C3_TFT_57_V_ZID_01","C3_TF_targets","C3_TFT_57_V_ZID_01",253,-0.9644,0.57,0.64,-1.0575,0.3,0.64,-0.8635,0.86,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3108_CHYLA_CBFA2T3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3108_CHYLA_CBFA2T3_TARGETS_DN",236,-0.9644,0.54,0.63,0.9941,0.48,0.81,0.9384,0.64,1
"C4_Cancer_modules:C4_CM_218_MODULE_239","C4_Cancer_modules","C4_CM_218_MODULE_239",120,-0.9644,0.55,0.63,1.5326,0.0091,0.1,-0.6717,0.99,1
"GO_BP:518620_GO_0097070_DUCTUS_ARTERIOSUS_CLOSURE","GO_BP","518620_GO_0097070_DUCTUS_ARTERIOSUS_CLOSURE",5,-0.9642,0.52,0.68,1.5821,0.031,0.31,1.8097,0,0.27
"C1_Positional:C1_ALL_236_CHR12Q23","C1_Positional","C1_ALL_236_CHR12Q23",69,-0.9642,0.53,0.88,1.0965,0.27,0.64,0.9319,0.55,0.83
"GO_BP:1022157_GO_1903170_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","1022157_GO_1903170_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT",20,-0.9642,0.51,0.68,0.8207,0.7,1,0.689,0.89,1
"GO_BP:497182_GO_0018211_PEPTIDYL_TRYPTOPHAN_MODIFICATION","GO_BP","497182_GO_0018211_PEPTIDYL_TRYPTOPHAN_MODIFICATION",5,-0.9642,0.54,0.68,0.7501,0.75,1,-1.3937,0.11,0.58
"C3_TF_targets:C3_TFT_265_V_NKX3A_01","C3_TF_targets","C3_TFT_265_V_NKX3A_01",225,-0.9641,0.56,0.64,1.1227,0.17,0.97,1.5889,0,0.25
"C7_Immunologic_signatures:C7_ALL_1515_GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP","C7_Immunologic_signatures","C7_ALL_1515_GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP",200,-0.9641,0.56,0.66,-0.843,0.87,1,-1.242,0.056,0.21
"C2_Chemical_and_genetic_perturbations:C2_CGP_2871_KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2871_KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN",220,-0.964,0.56,0.63,1.2743,0.036,0.42,-0.7803,0.99,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_3110_CARD_MIR302A_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3110_CARD_MIR302A_TARGETS",77,-0.964,0.52,0.63,-0.6406,0.99,1,0.8494,0.78,1
"C3_TF_targets:C3_TFT_23_V_CREBP1CJUN_01","C3_TF_targets","C3_TFT_23_V_CREBP1CJUN_01",256,-0.9639,0.56,0.64,0.7683,1,1,-0.8674,0.87,0.97
"GO_MF:490539_GO_0005346_PURINE_RIBONUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490539_GO_0005346_PURINE_RIBONUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-0.9638,0.53,0.71,-0.8311,0.68,1,-1.6016,0.023,0.37
"GO_BP:488763_GO_0002890_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE","GO_BP","488763_GO_0002890_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE",10,-0.9635,0.5,0.68,-0.7609,0.77,1,0.8742,0.65,0.96
"GO_BP:510447_GO_0048340_PARAXIAL_MESODERM_MORPHOGENESIS","GO_BP","510447_GO_0048340_PARAXIAL_MESODERM_MORPHOGENESIS",9,-0.9634,0.5,0.68,0.8068,0.73,1,-0.5632,0.98,1
"GO_BP:751886_GO_0044744_PROTEIN_TARGETING_TO_NUCLEUS","GO_BP","751886_GO_0044744_PROTEIN_TARGETING_TO_NUCLEUS",96,-0.9634,0.54,0.68,0.7225,0.98,1,-1.0618,0.34,0.8
"GO_BP:849867_GO_1902165_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR","GO_BP","849867_GO_1902165_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR",15,-0.9634,0.52,0.68,-0.7907,0.75,1,1.0247,0.44,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1209_NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1209_NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON",14,-0.9633,0.5,0.63,-0.6923,0.87,1,0.8271,0.7,1
"GO_BP:495031_GO_0010966_REGULATION_OF_PHOSPHATE_TRANSPORT","GO_BP","495031_GO_0010966_REGULATION_OF_PHOSPHATE_TRANSPORT",5,-0.9629,0.53,0.68,-1.2425,0.23,0.91,0.9875,0.48,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1938_NIELSEN_LEIOMYOSARCOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1938_NIELSEN_LEIOMYOSARCOMA_UP",17,-0.9629,0.52,0.63,-0.7598,0.8,1,0.8257,0.71,1
"C7_Immunologic_signatures:C7_ALL_1658_GSE3982_MAC_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_1658_GSE3982_MAC_VS_TH1_DN",196,-0.9629,0.57,0.66,0.9677,0.55,0.84,-1.1966,0.1,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_2730_CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2730_CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN",192,-0.9629,0.55,0.63,2.401,0,0,-0.8967,0.76,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2604_BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS","C2_Chemical_and_genetic_perturbations","C2_CGP_2604_BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS",8,-0.9629,0.52,0.63,-0.9956,0.49,1,-0.6274,0.91,0.99
"GO_BP:516549_GO_0071625_VOCALIZATION_BEHAVIOR","GO_BP","516549_GO_0071625_VOCALIZATION_BEHAVIOR",13,-0.9628,0.52,0.68,-0.9845,0.49,1,1.0158,0.4,0.84
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_120_BIOCARTA_IGF1R_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_120_BIOCARTA_IGF1R_PATHWAY",23,-0.9624,0.51,0.63,1.1412,0.29,0.66,-0.6239,0.96,0.99
"C7_Immunologic_signatures:C7_ALL_1692_GSE3982_BASOPHIL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1692_GSE3982_BASOPHIL_VS_NKCELL_DN",192,-0.9624,0.58,0.66,0.7949,0.96,1,1.0346,0.35,1
"C7_Immunologic_signatures:C7_ALL_1771_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP","C7_Immunologic_signatures","C7_ALL_1771_GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP",199,-0.9623,0.57,0.66,1.3803,0.0093,0.045,-0.8976,0.77,0.95
"C4_Cancer_gene_neighborhoods:C4_CGN_240_GCM_MAPK10","C4_Cancer_gene_neighborhoods","C4_CGN_240_GCM_MAPK10",77,-0.9623,0.55,0.79,-0.8601,0.75,1,-1.3095,0.076,0.27
"KEGG_compound:C01227_DEHYDROEPIANDROSTERONE_3BETA_HYDROXYANDROST_5_EN_17_ONE_DEHYDROISOANDROSTERONE_DHA_DHEA","KEGG_compound","C01227_DEHYDROEPIANDROSTERONE_3BETA_HYDROXYANDROST_5_EN_17_ONE_DEHYDROISOANDROSTERONE_DHA_DHEA",13,-0.9623,0.51,0.66,0.9997,0.44,1,0.9265,0.57,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_566_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_566_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP",6,-0.9623,0.51,0.63,-1.049,0.4,0.97,-0.8729,0.61,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_629_GALLUZZI_PERMEABILIZE_MITOCHONDRIA","C2_Chemical_and_genetic_perturbations","C2_CGP_629_GALLUZZI_PERMEABILIZE_MITOCHONDRIA",42,-0.962,0.53,0.63,0.7537,0.86,1,-1.1906,0.19,0.53
"GO_MF:498601_GO_0019798_PROCOLLAGEN_PROLINE_DIOXYGENASE_ACTIVITY","GO_MF","498601_GO_0019798_PROCOLLAGEN_PROLINE_DIOXYGENASE_ACTIVITY",7,-0.962,0.53,0.71,-0.97,0.5,0.94,-0.8769,0.63,0.9
"GO_MF:498090_GO_0019239_DEAMINASE_ACTIVITY","GO_MF","498090_GO_0019239_DEAMINASE_ACTIVITY",29,-0.9619,0.52,0.71,-0.5825,0.99,1,-0.8438,0.72,0.93
"C7_Immunologic_signatures:C7_ALL_1133_GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP","C7_Immunologic_signatures","C7_ALL_1133_GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP",172,-0.9618,0.56,0.66,-1.2408,0.079,0.65,-0.962,0.56,0.82
"GO_BP:510758_GO_0048703_EMBRYONIC_VISCEROCRANIUM_MORPHOGENESIS","GO_BP","510758_GO_0048703_EMBRYONIC_VISCEROCRANIUM_MORPHOGENESIS",9,-0.9618,0.51,0.68,-0.7749,0.73,1,-0.727,0.81,0.99
"GO_BP:489199_GO_0003407_NEURAL_RETINA_DEVELOPMENT","GO_BP","489199_GO_0003407_NEURAL_RETINA_DEVELOPMENT",44,-0.9618,0.52,0.68,-0.8929,0.65,1,1.4554,0.045,0.58
"REACTOME:160989_REACT_15398_GLYCOPROTEIN_HORMONES","REACTOME","160989_REACT_15398_GLYCOPROTEIN_HORMONES",11,-0.9618,0.51,0.7,-0.8903,0.59,1,-1.1766,0.25,0.63
"C4_Cancer_gene_neighborhoods:C4_CGN_269_GCM_TEC","C4_Cancer_gene_neighborhoods","C4_CGN_269_GCM_TEC",31,-0.9618,0.53,0.79,-0.8098,0.77,1,-0.5833,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_479_WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_479_WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP",26,-0.9618,0.52,0.63,0.7714,0.81,1,0.9652,0.53,0.97
"GO_MF:486812_GO_0000295_ADENINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","486812_GO_0000295_ADENINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-0.9617,0.52,0.71,-0.832,0.65,1,-1.5976,0.034,0.37
"GO_BP:493325_GO_0009128_PURINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS","GO_BP","493325_GO_0009128_PURINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS",382,-0.9617,0.6,0.68,-0.8476,0.94,1,-1.2121,0.038,0.72
"GO_MF:489271_GO_0003727_SINGLE_STRANDED_RNA_BINDING","GO_MF","489271_GO_0003727_SINGLE_STRANDED_RNA_BINDING",58,-0.9616,0.51,0.71,0.6593,0.99,1,-1.2216,0.14,0.57
"C4_Cancer_gene_neighborhoods:C4_CGN_371_GNF2_LYN","C4_Cancer_gene_neighborhoods","C4_CGN_371_GNF2_LYN",27,-0.9616,0.51,0.78,1.0377,0.37,0.48,-0.7911,0.81,1
"C7_Immunologic_signatures:C7_ALL_660_GSE17721_LPS_VS_CPG_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_660_GSE17721_LPS_VS_CPG_4H_BMDM_DN",200,-0.9616,0.57,0.66,1.3956,0.0044,0.039,-0.8977,0.74,0.95
"C4_Cancer_gene_neighborhoods:C4_CGN_316_GNF2_SMC4L1","C4_Cancer_gene_neighborhoods","C4_CGN_316_GNF2_SMC4L1",84,-0.9616,0.53,0.78,1.5336,0.0087,0.024,-1.626,0.006,0.072
"GO_MF:983700_GO_0098639_COLLAGEN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION","GO_MF","983700_GO_0098639_COLLAGEN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION",5,-0.9615,0.55,0.71,-1.1026,0.38,0.84,-0.9923,0.49,0.79
"GO_BP:754615_GO_1901663_QUINONE_BIOSYNTHETIC_PROCESS","GO_BP","754615_GO_1901663_QUINONE_BIOSYNTHETIC_PROCESS",14,-0.9614,0.51,0.68,0.8964,0.61,1,-0.9492,0.53,0.89
"GO_BP:492892_GO_0045987_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION","GO_BP","492892_GO_0045987_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION",23,-0.9613,0.52,0.68,-0.83,0.72,1,-1.047,0.38,0.82
"REACTOME:106250_REACT_11238_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS","REACTOME","106250_REACT_11238_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS",86,-0.9611,0.53,0.7,0.8263,0.84,0.98,-1.237,0.093,0.57
"GO_BP:506548_GO_0043517_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR","GO_BP","506548_GO_0043517_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",13,-0.9611,0.5,0.68,0.6112,0.96,1,-1.1804,0.26,0.74
"GO_BP:510361_GO_0048246_MACROPHAGE_CHEMOTAXIS","GO_BP","510361_GO_0048246_MACROPHAGE_CHEMOTAXIS",13,-0.961,0.51,0.68,1.4046,0.1,0.55,1.2587,0.17,0.69
"C4_Cancer_modules:C4_CM_109_MODULE_114","C4_Cancer_modules","C4_CM_109_MODULE_114",338,-0.9609,0.59,0.63,3.2044,0,0,0.6793,1,1
"GO_BP:513905_GO_0060349_BONE_MORPHOGENESIS","GO_BP","513905_GO_0060349_BONE_MORPHOGENESIS",87,-0.9609,0.54,0.68,-1.3767,0.028,0.99,-0.9135,0.67,0.91
"C7_Immunologic_signatures:C7_ALL_317_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP","C7_Immunologic_signatures","C7_ALL_317_GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP",199,-0.9608,0.57,0.67,1.8351,0,0,-0.7724,0.97,1
"C7_Immunologic_signatures:C7_ALL_1562_GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1562_GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN",187,-0.9607,0.56,0.66,0.9504,0.6,0.89,-0.7652,0.98,1
"GO_BP:497341_GO_0018406_PROTEIN_C_LINKED_GLYCOSYLATION_VIA_2_ALPHA_MANNOSYL_L_TRYPTOPHAN","GO_BP","497341_GO_0018406_PROTEIN_C_LINKED_GLYCOSYLATION_VIA_2_ALPHA_MANNOSYL_L_TRYPTOPHAN",5,-0.9605,0.52,0.69,0.7473,0.78,1,-1.4404,0.076,0.56
"GO_BP:492376_GO_0007635_CHEMOSENSORY_BEHAVIOR","GO_BP","492376_GO_0007635_CHEMOSENSORY_BEHAVIOR",11,-0.9603,0.52,0.69,-1.2454,0.21,0.91,1.4594,0.068,0.59
"C7_Immunologic_signatures:C7_ALL_599_GSE17721_LPS_VS_PAM3CSK4_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_599_GSE17721_LPS_VS_PAM3CSK4_0_5H_BMDM_UP",192,-0.9603,0.57,0.67,1.2275,0.061,0.18,0.8765,0.81,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1184_MORI_PLASMA_CELL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1184_MORI_PLASMA_CELL_UP",51,-0.9602,0.53,0.63,1.348,0.069,0.35,-0.5905,0.99,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1575_IGLESIAS_E2F_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1575_IGLESIAS_E2F_TARGETS_DN",14,-0.9602,0.52,0.63,1.277,0.18,0.42,1.5847,0.018,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2290_WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2290_WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP",21,-0.96,0.52,0.63,0.6469,0.95,1,-1.1074,0.3,0.62
"GO_BP:1129405_GO_1903579_NEGATIVE_REGULATION_OF_ATP_METABOLIC_PROCESS","GO_BP","1129405_GO_1903579_NEGATIVE_REGULATION_OF_ATP_METABOLIC_PROCESS",13,-0.96,0.54,0.69,-0.9378,0.54,1,0.932,0.53,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1679_INGRAM_SHH_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1679_INGRAM_SHH_TARGETS",7,-0.96,0.5,0.63,0.9815,0.49,0.81,0.8716,0.61,1
"C7_Immunologic_signatures:C7_ALL_728_GSE17721_12H_VS_24H_POLYIC_BMDM_DN","C7_Immunologic_signatures","C7_ALL_728_GSE17721_12H_VS_24H_POLYIC_BMDM_DN",199,-0.96,0.56,0.67,1.2556,0.024,0.15,-1.0637,0.29,0.58
"GO_BP:498636_GO_0046929_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION","GO_BP","498636_GO_0046929_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION",7,-0.9599,0.53,0.69,0.9479,0.51,1,-1.1698,0.29,0.73
"GO_CC:507387_GO_0044438_MICROBODY_PART","GO_CC","507387_GO_0044438_MICROBODY_PART",80,-0.9598,0.56,0.78,0.9581,0.54,0.83,-1.3213,0.069,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_2076_ZHENG_FOXP3_TARGETS_IN_THYMUS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2076_ZHENG_FOXP3_TARGETS_IN_THYMUS_DN",12,-0.9596,0.52,0.63,1.5484,0.037,0.17,0.7902,0.74,1
"GO_BP:507588_GO_0045214_SARCOMERE_ORGANIZATION","GO_BP","507588_GO_0045214_SARCOMERE_ORGANIZATION",27,-0.9593,0.53,0.69,-1.3546,0.088,0.96,1.1151,0.27,0.75
"GO_MF:498682_GO_0019905_SYNTAXIN_BINDING","GO_MF","498682_GO_0019905_SYNTAXIN_BINDING",86,-0.9593,0.52,0.71,0.9548,0.55,0.92,-1.1604,0.17,0.63
"GO_BP:487845_GO_0001955_BLOOD_VESSEL_MATURATION","GO_BP","487845_GO_0001955_BLOOD_VESSEL_MATURATION",8,-0.9592,0.53,0.69,1.1513,0.3,0.84,0.5964,0.94,1
"GO_BP:511819_GO_0050881_MUSCULOSKELETAL_MOVEMENT","GO_BP","511819_GO_0050881_MUSCULOSKELETAL_MOVEMENT",34,-0.9592,0.51,0.69,-1.3411,0.096,0.91,-1.0505,0.35,0.81
"KEGG_compound:C01353_CARBONIC_ACID_DIHYDROGEN_CARBONATE_H2CO3","KEGG_compound","C01353_CARBONIC_ACID_DIHYDROGEN_CARBONATE_H2CO3",11,-0.9591,0.51,0.67,-0.9911,0.47,1,-1.8752,0.0039,0.076
"GO_BP:514316_GO_0060761_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS","GO_BP","514316_GO_0060761_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS",38,-0.959,0.55,0.69,-0.7846,0.82,1,1.1298,0.27,0.74
"GO_BP:510347_GO_0048227_PLASMA_MEMBRANE_TO_ENDOSOME_TRANSPORT","GO_BP","510347_GO_0048227_PLASMA_MEMBRANE_TO_ENDOSOME_TRANSPORT",8,-0.959,0.51,0.69,1.0661,0.37,0.94,0.6262,0.92,1
"GO_BP:487854_GO_0001964_STARTLE_RESPONSE","GO_BP","487854_GO_0001964_STARTLE_RESPONSE",23,-0.9589,0.52,0.69,1.4687,0.038,0.47,0.9452,0.53,0.91
"GO_BP:500346_GO_0031056_REGULATION_OF_HISTONE_MODIFICATION","GO_BP","500346_GO_0031056_REGULATION_OF_HISTONE_MODIFICATION",108,-0.9589,0.55,0.69,-0.8013,0.88,1,-1.0564,0.33,0.81
"GO_MF:506215_GO_0043142_SINGLE_STRANDED_DNA_DEPENDENT_ATPASE_ACTIVITY","GO_MF","506215_GO_0043142_SINGLE_STRANDED_DNA_DEPENDENT_ATPASE_ACTIVITY",5,-0.9589,0.52,0.71,-0.7407,0.77,1,0.6803,0.83,1
"GO_CC:490831_GO_0005802_TRANS_GOLGI_NETWORK","GO_CC","490831_GO_0005802_TRANS_GOLGI_NETWORK",166,-0.9588,0.57,0.78,0.8115,0.93,0.95,0.9206,0.68,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1091_RICKMAN_HEAD_AND_NECK_CANCER_F","C2_Chemical_and_genetic_perturbations","C2_CGP_1091_RICKMAN_HEAD_AND_NECK_CANCER_F",49,-0.9588,0.53,0.63,-1.0018,0.44,1,1.0419,0.38,0.93
"C1_Positional:C1_ALL_187_CHR12P11","C1_Positional","C1_ALL_187_CHR12P11",42,-0.9587,0.51,0.89,0.7978,0.8,0.95,0.8747,0.68,0.87
"GO_BP:512448_GO_0051570_REGULATION_OF_HISTONE_H3_K9_METHYLATION","GO_BP","512448_GO_0051570_REGULATION_OF_HISTONE_H3_K9_METHYLATION",11,-0.9586,0.55,0.69,0.3973,1,1,-0.714,0.86,0.99
"C7_Immunologic_signatures:C7_ALL_1645_GSE3982_MAC_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1645_GSE3982_MAC_VS_NEUTROPHIL_UP",198,-0.9585,0.57,0.67,1.6406,0,0.0014,-0.938,0.63,0.88
"GO_BP:515785_GO_0070857_REGULATION_OF_BILE_ACID_BIOSYNTHETIC_PROCESS","GO_BP","515785_GO_0070857_REGULATION_OF_BILE_ACID_BIOSYNTHETIC_PROCESS",7,-0.9584,0.52,0.69,-0.7636,0.78,1,-1.2512,0.22,0.68
"C7_Immunologic_signatures:C7_ALL_520_GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_520_GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDM_DN",196,-0.9583,0.56,0.67,1.443,0.0025,0.024,1.0671,0.28,1
"GO_BP:507570_GO_0045188_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP","GO_BP","507570_GO_0045188_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP",7,-0.9582,0.51,0.69,-1.101,0.34,0.94,0.8705,0.62,0.96
"GO_BP:493584_GO_0009411_RESPONSE_TO_UV","GO_BP","493584_GO_0009411_RESPONSE_TO_UV",119,-0.9582,0.54,0.69,0.8109,0.9,1,-1.1674,0.17,0.73
"GO_CC:500379_GO_0031092_PLATELET_ALPHA_GRANULE_MEMBRANE","GO_CC","500379_GO_0031092_PLATELET_ALPHA_GRANULE_MEMBRANE",8,-0.958,0.52,0.78,1.6387,0.024,0.092,-1.3646,0.13,0.62
"C7_Immunologic_signatures:C7_ALL_1732_GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1732_GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN",198,-0.958,0.58,0.67,-0.8362,0.87,1,-1.208,0.078,0.27
"C7_Immunologic_signatures:C7_ALL_898_GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN","C7_Immunologic_signatures","C7_ALL_898_GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN",198,-0.958,0.57,0.67,0.8106,0.94,1,-0.9684,0.54,0.8
"GO_BP:499644_GO_0030238_MALE_SEX_DETERMINATION","GO_BP","499644_GO_0030238_MALE_SEX_DETERMINATION",13,-0.958,0.53,0.69,-1.5977,0.022,0.68,-1.2149,0.23,0.72
"GO_BP:508427_GO_0046131_PYRIMIDINE_RIBONUCLEOSIDE_METABOLIC_PROCESS","GO_BP","508427_GO_0046131_PYRIMIDINE_RIBONUCLEOSIDE_METABOLIC_PROCESS",34,-0.958,0.53,0.69,0.5603,0.99,1,-1.0529,0.38,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_884_KIM_MYC_AMPLIFICATION_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_884_KIM_MYC_AMPLIFICATION_TARGETS_DN",95,-0.9579,0.55,0.64,0.9353,0.6,0.89,0.8698,0.74,1
"C6_Oncogenic_signatures:C6_ALL_74_PRC2_EDD_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_74_PRC2_EDD_UP_V1_UP",191,-0.9579,0.57,0.6,-1.295,0.03,0.33,-1.2049,0.083,0.37
"C3_MicroRNA_targets:C3_MIR_79_TGAGATT_MIR_216","C3_MicroRNA_targets","C3_MIR_79_TGAGATT_MIR_216",106,-0.9579,0.57,0.69,0.8008,0.91,1,-0.7397,0.97,1
"REACTOME:105865_REACT_1924_ATM_MEDIATED_PHOSPHORYLATION_OF_REPAIR_PROTEINS","REACTOME","105865_REACT_1924_ATM_MEDIATED_PHOSPHORYLATION_OF_REPAIR_PROTEINS",5,-0.9576,0.53,0.71,-0.9498,0.55,1,-1.3959,0.089,0.41
"C7_Immunologic_signatures:C7_ALL_445_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP","C7_Immunologic_signatures","C7_ALL_445_GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP",200,-0.9576,0.59,0.67,-0.9782,0.52,1,-1.3228,0.025,0.12
"KEGG_compound:C04598_2_ACETYL_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE_PLATELET_ACTIVATING_FACTOR_PAF","KEGG_compound","C04598_2_ACETYL_1_ALKYL_SN_GLYCERO_3_PHOSPHOCHOLINE_PLATELET_ACTIVATING_FACTOR_PAF",10,-0.9574,0.52,0.67,1.1072,0.32,1,0.5497,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_684_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2","C2_Chemical_and_genetic_perturbations","C2_CGP_684_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2",5,-0.9571,0.55,0.64,-0.677,0.87,1,0.5663,0.95,1
"GO_CC:496437_GO_0016460_MYOSIN_II_COMPLEX","GO_CC","496437_GO_0016460_MYOSIN_II_COMPLEX",25,-0.9571,0.54,0.78,-1.0753,0.36,0.82,0.7063,0.89,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_129_BIOCARTA_RARRXR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_129_BIOCARTA_RARRXR_PATHWAY",15,-0.957,0.51,0.64,0.7072,0.88,1,0.7211,0.85,1
"GO_MF:490535_GO_0005338_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490535_GO_0005338_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-0.9569,0.52,0.71,-0.8343,0.67,1,-0.6439,0.91,1
"GO_MF:495479_GO_0015215_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495479_GO_0015215_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",17,-0.9568,0.54,0.71,-0.8369,0.68,1,-1.2772,0.15,0.59
"GO_BP:488451_GO_0002578_NEGATIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION","GO_BP","488451_GO_0002578_NEGATIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION",5,-0.9568,0.52,0.69,-0.5671,0.96,1,-0.5809,0.95,1
"C7_Immunologic_signatures:C7_ALL_84_GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN","C7_Immunologic_signatures","C7_ALL_84_GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN",193,-0.9568,0.57,0.67,1.4088,0.0068,0.035,-0.929,0.68,0.89
"REACTOME:119541_REACT_19145_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA","REACTOME","119541_REACT_19145_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA",19,-0.9567,0.52,0.71,-0.9086,0.58,1,-0.6853,0.92,1
"GO_BP:493355_GO_0009158_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS","GO_BP","493355_GO_0009158_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS",381,-0.9566,0.61,0.69,-0.8395,0.95,1,-1.2191,0.038,0.71
"C7_Immunologic_signatures:C7_ALL_363_GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP","C7_Immunologic_signatures","C7_ALL_363_GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP",188,-0.9565,0.58,0.67,1.268,0.037,0.13,-1.2049,0.076,0.27
"GO_BP:502372_GO_0033151_V_D_J_RECOMBINATION","GO_BP","502372_GO_0033151_V_D_J_RECOMBINATION",17,-0.9565,0.52,0.69,0.8266,0.72,1,-1.145,0.27,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_891_YANG_BREAST_CANCER_ESR1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_891_YANG_BREAST_CANCER_ESR1_DN",25,-0.9564,0.54,0.64,0.9173,0.6,0.9,1.1357,0.26,0.83
"C4_Cancer_gene_neighborhoods:C4_CGN_173_MORF_RBM8A","C4_Cancer_gene_neighborhoods","C4_CGN_173_MORF_RBM8A",83,-0.9563,0.56,0.79,-0.7836,0.89,1,0.8557,0.77,1
"GO_BP:491905_GO_0007084_MITOTIC_NUCLEAR_ENVELOPE_REASSEMBLY","GO_BP","491905_GO_0007084_MITOTIC_NUCLEAR_ENVELOPE_REASSEMBLY",10,-0.9562,0.54,0.69,1.014,0.39,0.97,0.7474,0.8,1
"GO_BP:489286_GO_0034728_NUCLEOSOME_ORGANIZATION","GO_BP","489286_GO_0034728_NUCLEOSOME_ORGANIZATION",155,-0.9559,0.57,0.69,-1.1615,0.14,0.92,-1.4969,0,0.54
"C7_Immunologic_signatures:C7_ALL_23_GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_23_GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP",200,-0.9557,0.59,0.67,1.2762,0.05,0.12,-0.8827,0.78,0.97
"KEGG_reaction:R00132_CARBONATE_HYDRO_LYASE_CARBON_DIOXIDE_FORMING_CARBONIC_ACID_HYDRO_LYASE_CARBONIC_ACID_CO2_H2O","KEGG_reaction","R00132_CARBONATE_HYDRO_LYASE_CARBON_DIOXIDE_FORMING_CARBONIC_ACID_HYDRO_LYASE_CARBONIC_ACID_CO2_H2O",11,-0.9557,0.53,0.68,-1.0084,0.44,0.78,-1.8692,0,0.11
"C3_MicroRNA_targets:C3_MIR_122_CATGTAA_MIR_496","C3_MicroRNA_targets","C3_MIR_122_CATGTAA_MIR_496",173,-0.9555,0.59,0.69,1.1915,0.1,1,-0.8215,0.91,1
"GO_BP:493322_GO_0009125_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS","GO_BP","493322_GO_0009125_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS",384,-0.9555,0.61,0.69,-0.8453,0.95,1,-1.2338,0.03,0.7
"KEGG_module:HSA_M00158_F_TYPE_ATPASE_EUKARYOTES","KEGG_module","HSA_M00158_F_TYPE_ATPASE_EUKARYOTES",15,-0.9554,0.5,0.74,2.1928,0,0,-0.8709,0.66,0.93
"GO_BP:754189_GO_1901222_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING","GO_BP","754189_GO_1901222_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING",29,-0.9554,0.52,0.69,1.4114,0.071,0.54,1.276,0.12,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1975_BROWNE_HCMV_INFECTION_12HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1975_BROWNE_HCMV_INFECTION_12HR_DN",101,-0.9553,0.55,0.64,1.0552,0.32,0.7,1.3023,0.048,0.68
"C7_Immunologic_signatures:C7_ALL_1010_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN","C7_Immunologic_signatures","C7_ALL_1010_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN",200,-0.9553,0.58,0.67,1.4733,0.0023,0.017,-0.7746,0.99,1
"GO_BP:496271_GO_0016197_ENDOSOMAL_TRANSPORT","GO_BP","496271_GO_0016197_ENDOSOMAL_TRANSPORT",216,-0.9552,0.58,0.69,1.0391,0.35,0.96,-0.6895,1,0.99
"GO_BP:516524_GO_0071600_OTIC_VESICLE_MORPHOGENESIS","GO_BP","516524_GO_0071600_OTIC_VESICLE_MORPHOGENESIS",10,-0.9551,0.53,0.69,-1.0817,0.35,0.95,-1.0427,0.41,0.82
"GO_BP:506129_GO_0043043_PEPTIDE_BIOSYNTHETIC_PROCESS","GO_BP","506129_GO_0043043_PEPTIDE_BIOSYNTHETIC_PROCESS",24,-0.955,0.53,0.69,0.915,0.59,1,-1.3936,0.07,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_506_VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_506_VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",16,-0.9549,0.54,0.64,-0.848,0.66,1,0.7926,0.76,1
"GO_CC:501392_GO_0032156_SEPTIN_CYTOSKELETON","GO_CC","501392_GO_0032156_SEPTIN_CYTOSKELETON",12,-0.9549,0.51,0.78,-1.1657,0.27,0.68,-1.3376,0.14,0.62
"C7_Immunologic_signatures:C7_ALL_285_GSE14350_TREG_VS_TEFF_UP","C7_Immunologic_signatures","C7_ALL_285_GSE14350_TREG_VS_TEFF_UP",200,-0.9545,0.6,0.68,0.6379,1,1,-0.9592,0.55,0.82
"C4_Cancer_gene_neighborhoods:C4_CGN_296_GNF2_FEN1","C4_Cancer_gene_neighborhoods","C4_CGN_296_GNF2_FEN1",56,-0.9545,0.53,0.79,1.5253,0.02,0.026,-1.5666,0.014,0.08
"C7_Immunologic_signatures:C7_ALL_545_GSE17721_POLYIC_VS_PAM3CSK4_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_545_GSE17721_POLYIC_VS_PAM3CSK4_0_5H_BMDM_UP",191,-0.9544,0.57,0.68,1.1603,0.11,0.3,-1.1526,0.13,0.36
"GO_BP:501650_GO_0032418_LYSOSOME_LOCALIZATION","GO_BP","501650_GO_0032418_LYSOSOME_LOCALIZATION",25,-0.9543,0.54,0.69,1.0733,0.33,0.93,-0.9183,0.58,0.91
"REACTOME:645262_REACT_120916_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA","REACTOME","645262_REACT_120916_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA",18,-0.9543,0.52,0.72,1.6147,0.018,0.088,-0.7725,0.81,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3286_ROLEF_GLIS3_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3286_ROLEF_GLIS3_TARGETS",31,-0.9543,0.54,0.64,-0.9787,0.46,1,-1.0483,0.36,0.69
"REACTOME:833822_REACT_163773_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION","REACTOME","833822_REACT_163773_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION",13,-0.9542,0.48,0.71,0.7531,0.81,1,-0.7902,0.76,1
"GO_BP:1026072_GO_1903300_NEGATIVE_REGULATION_OF_HEXOKINASE_ACTIVITY","GO_BP","1026072_GO_1903300_NEGATIVE_REGULATION_OF_HEXOKINASE_ACTIVITY",6,-0.9542,0.51,0.69,-0.8536,0.62,1,-0.8983,0.59,0.93
"GO_BP:491211_GO_0006244_PYRIMIDINE_NUCLEOTIDE_CATABOLIC_PROCESS","GO_BP","491211_GO_0006244_PYRIMIDINE_NUCLEOTIDE_CATABOLIC_PROCESS",10,-0.9539,0.54,0.69,1.4817,0.08,0.44,-1.2508,0.18,0.68
"C7_Immunologic_signatures:C7_ALL_1221_GSE27786_NKTCELL_VS_ERYTHROBLAST_UP","C7_Immunologic_signatures","C7_ALL_1221_GSE27786_NKTCELL_VS_ERYTHROBLAST_UP",199,-0.9537,0.58,0.68,0.9851,0.51,0.79,-0.9011,0.75,0.94
"GO_CC:490890_GO_0005885_ARP2_3_PROTEIN_COMPLEX","GO_CC","490890_GO_0005885_ARP2_3_PROTEIN_COMPLEX",12,-0.9537,0.53,0.78,1.0352,0.39,0.73,-0.7037,0.87,1
"REACTOME:576276_REACT_118713_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION","REACTOME","576276_REACT_118713_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION",29,-0.9537,0.54,0.71,-0.8155,0.77,1,-1.0529,0.36,0.77
"C6_Oncogenic_signatures:C6_ALL_78_PRC2_SUZ12_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_78_PRC2_SUZ12_UP_V1_UP",176,-0.9532,0.59,0.61,-1.0417,0.35,0.58,-0.9474,0.62,0.69
"C7_Immunologic_signatures:C7_ALL_1108_GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1108_GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN",180,-0.9532,0.57,0.68,0.941,0.62,0.93,-1.0617,0.32,0.59
"GO_BP:508139_GO_0045814_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC","GO_BP","508139_GO_0045814_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC",109,-0.9531,0.55,0.7,-1.2132,0.13,0.88,-1.033,0.37,0.82
"GO_BP:511416_GO_0050433_REGULATION_OF_CATECHOLAMINE_SECRETION","GO_BP","511416_GO_0050433_REGULATION_OF_CATECHOLAMINE_SECRETION",36,-0.953,0.53,0.7,1.2762,0.12,0.7,1.3524,0.082,0.64
"GO_MF:498060_GO_0019205_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY","GO_MF","498060_GO_0019205_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY",48,-0.9529,0.56,0.72,-0.9571,0.53,0.95,-1.1201,0.26,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2116_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS","C2_Chemical_and_genetic_perturbations","C2_CGP_2116_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS",33,-0.9529,0.52,0.65,0.8271,0.76,0.98,0.8021,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2976_ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE","C2_Chemical_and_genetic_perturbations","C2_CGP_2976_ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE",17,-0.9528,0.52,0.65,-0.6594,0.91,1,-1.045,0.38,0.7
"KEGG_compound:C00119_5_PHOSPHO_ALPHA_D_RIBOSE_1_DIPHOSPHATE_5_PHOSPHORIBOSYL_DIPHOSPHATE_5_PHOSPHORIBOSYL_1_PYROPHOSPHATE_PRPP","KEGG_compound","C00119_5_PHOSPHO_ALPHA_D_RIBOSE_1_DIPHOSPHATE_5_PHOSPHORIBOSYL_DIPHOSPHATE_5_PHOSPHORIBOSYL_1_PYROPHOSPHATE_PRPP",11,-0.9528,0.52,0.67,1.4388,0.11,0.42,-0.9389,0.54,0.72
"C3_MicroRNA_targets:C3_MIR_162_AGTCTAG_MIR_151","C3_MicroRNA_targets","C3_MIR_162_AGTCTAG_MIR_151",24,-0.9526,0.52,0.69,0.5951,0.98,1,-1.2808,0.14,1
"GO_MF:490441_GO_0042043_NEUREXIN_FAMILY_PROTEIN_BINDING","GO_MF","490441_GO_0042043_NEUREXIN_FAMILY_PROTEIN_BINDING",13,-0.9526,0.5,0.72,-1.0218,0.45,0.89,-0.9846,0.47,0.79
"GO_BP:506084_GO_0042992_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS","GO_BP","506084_GO_0042992_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_IMPORT_INTO_NUCLEUS",35,-0.9526,0.52,0.7,0.6707,0.94,1,-1.327,0.069,0.62
"KEGG_compound:C00270_N_ACETYLNEURAMINATE_N_ACETYLNEURAMINIC_ACID_5_ACETAMIDO_3_5_DIDEOXY_D_GLYCERO_D_GALACTO_2_NONULOSONIC_ACID_NEU5AC","KEGG_compound","C00270_N_ACETYLNEURAMINATE_N_ACETYLNEURAMINIC_ACID_5_ACETAMIDO_3_5_DIDEOXY_D_GLYCERO_D_GALACTO_2_NONULOSONIC_ACID_NEU5AC",7,-0.9525,0.53,0.67,0.8752,0.64,1,1.0335,0.41,0.65
"KEGG_compound:C00311_ISOCITRATE_ISOCITRIC_ACID_1_HYDROXYTRICARBALLYLIC_ACID_1_HYDROXYPROPANE_1_2_3_TRICARBOXYLIC_ACID","KEGG_compound","C00311_ISOCITRATE_ISOCITRIC_ACID_1_HYDROXYTRICARBALLYLIC_ACID_1_HYDROXYPROPANE_1_2_3_TRICARBOXYLIC_ACID",7,-0.9524,0.54,0.67,0.9612,0.5,1,-1.37,0.13,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_2188_CAMPS_COLON_CANCER_COPY_NUMBER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2188_CAMPS_COLON_CANCER_COPY_NUMBER_UP",87,-0.9523,0.56,0.65,-1.2119,0.15,0.8,-1.0236,0.41,0.72
"KEGG_compound:C00009_ORTHOPHOSPHATE_PHOSPHATE_PHOSPHORIC_ACID_ORTHOPHOSPHORIC_ACID","KEGG_compound","C00009_ORTHOPHOSPHATE_PHOSPHATE_PHOSPHORIC_ACID_ORTHOPHOSPHORIC_ACID",140,-0.9521,0.57,0.67,0.8679,0.79,1,-1.1846,0.14,0.46
"GO_CC:486739_GO_0016469_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX","GO_CC","486739_GO_0016469_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX",46,-0.9521,0.54,0.78,1.9431,0,0.0063,0.7435,0.91,1
"GO_MF:515445_GO_0070513_DEATH_DOMAIN_BINDING","GO_MF","515445_GO_0070513_DEATH_DOMAIN_BINDING",8,-0.9518,0.53,0.72,0.6757,0.86,1,0.8628,0.63,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_156_NEWMAN_ERCC6_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_156_NEWMAN_ERCC6_TARGETS_DN",35,-0.9516,0.53,0.65,-0.987,0.47,1,1.0701,0.35,0.89
"REACTOME:1127531_REACT_264533_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2","REACTOME","1127531_REACT_264533_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2",13,-0.9516,0.53,0.72,0.9103,0.57,0.89,0.6884,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3002_WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53","C2_Chemical_and_genetic_perturbations","C2_CGP_3002_WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53",12,-0.9515,0.54,0.65,-1.1483,0.27,0.85,-0.7578,0.8,0.97
"KEGG_compound:C00037_GLYCINE_AMINOACETIC_ACID_GLY","KEGG_compound","C00037_GLYCINE_AMINOACETIC_ACID_GLY",23,-0.9515,0.53,0.67,0.8618,0.69,1,-1.0473,0.39,0.6
"GO_BP:493267_GO_0009066_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS","GO_BP","493267_GO_0009066_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS",49,-0.9515,0.54,0.7,-0.7324,0.93,1,-1.3985,0.045,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_2675_ROME_INSULIN_TARGETS_IN_MUSCLE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2675_ROME_INSULIN_TARGETS_IN_MUSCLE_UP",441,-0.9514,0.61,0.65,2.286,0,0.00018,-0.9675,0.6,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2459_LEE_LIVER_CANCER_SURVIVAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2459_LEE_LIVER_CANCER_SURVIVAL_DN",172,-0.9514,0.59,0.65,2.1075,0,0.0018,0.7165,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_591_LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_591_LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP",176,-0.9514,0.59,0.65,0.7972,0.94,0.99,-1.1444,0.17,0.58
"C4_Cancer_modules:C4_CM_392_MODULE_493","C4_Cancer_modules","C4_CM_392_MODULE_493",68,-0.9514,0.57,0.65,-0.9576,0.55,0.86,-1.3874,0.035,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_1562_ZHAN_MULTIPLE_MYELOMA_HP_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1562_ZHAN_MULTIPLE_MYELOMA_HP_UP",48,-0.9513,0.55,0.65,1.7513,0.0043,0.06,-1.4602,0.018,0.31
"KEGG_module:HSA_M00075_N_GLYCAN_BIOSYNTHESIS_COMPLEX_TYPE","KEGG_module","HSA_M00075_N_GLYCAN_BIOSYNTHESIS_COMPLEX_TYPE",16,-0.9513,0.53,0.73,-0.5094,0.98,1,-1.4151,0.067,0.46
"GO_MF:490293_GO_0005007_FIBROBLAST_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY","GO_MF","490293_GO_0005007_FIBROBLAST_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",5,-0.9512,0.55,0.72,-1.3671,0.14,0.69,1.143,0.31,0.79
"KEGG_compound:C00014_AMMONIA_NH3","KEGG_compound","C00014_AMMONIA_NH3",47,-0.9511,0.53,0.67,-0.8717,0.7,1,0.9282,0.58,0.78
"KEGG_pathway:HSA00360_PHENYLALANINE_METABOLISM","KEGG_pathway","HSA00360_PHENYLALANINE_METABOLISM",18,-0.951,0.53,0.61,-1.2755,0.16,0.45,-0.9515,0.51,0.77
"C3_TF_targets:C3_TFT_195_V_RFX1_02","C3_TF_targets","C3_TFT_195_V_RFX1_02",272,-0.951,0.61,0.67,-1.0751,0.26,0.61,-0.992,0.47,0.78
"GO_BP:501586_GO_0032351_NEGATIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS","GO_BP","501586_GO_0032351_NEGATIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS",9,-0.951,0.53,0.7,-0.8793,0.62,1,0.9325,0.54,0.92
"GO_BP:515166_GO_0070231_T_CELL_APOPTOTIC_PROCESS","GO_BP","515166_GO_0070231_T_CELL_APOPTOTIC_PROCESS",15,-0.9507,0.54,0.7,1.2689,0.17,0.71,0.5347,0.98,1
"GO_BP:515860_GO_0070933_HISTONE_H4_DEACETYLATION","GO_BP","515860_GO_0070933_HISTONE_H4_DEACETYLATION",17,-0.9506,0.54,0.7,-1.0311,0.4,0.98,-1.562,0.026,0.52
"C4_Cancer_modules:C4_CM_215_MODULE_236","C4_Cancer_modules","C4_CM_215_MODULE_236",18,-0.9505,0.52,0.65,-0.8865,0.64,0.91,0.8628,0.63,1
"GO_BP:508032_GO_0045687_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION","GO_BP","508032_GO_0045687_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION",25,-0.9505,0.53,0.7,1.0661,0.35,0.93,1.0669,0.34,0.79
"C3_MicroRNA_targets:C3_MIR_211_CAGCCTC_MIR_485_5P","C3_MicroRNA_targets","C3_MIR_211_CAGCCTC_MIR_485_5P",143,-0.9504,0.59,0.69,-1.0106,0.43,1,-0.7286,0.99,1
"GO_BP:495944_GO_0015816_GLYCINE_TRANSPORT","GO_BP","495944_GO_0015816_GLYCINE_TRANSPORT",9,-0.9504,0.53,0.7,0.6299,0.9,1,-1.306,0.16,0.64
"C7_Immunologic_signatures:C7_ALL_669_GSE17721_LPS_VS_CPG_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_669_GSE17721_LPS_VS_CPG_24H_BMDM_UP",192,-0.9504,0.58,0.69,-0.8122,0.94,1,-1.0972,0.22,0.5
"GO_BP:506451_GO_0043413_MACROMOLECULE_GLYCOSYLATION","GO_BP","506451_GO_0043413_MACROMOLECULE_GLYCOSYLATION",290,-0.9503,0.6,0.7,0.9105,0.75,1,-0.8862,0.84,0.94
"GO_BP:499667_GO_0030262_APOPTOTIC_NUCLEAR_CHANGES","GO_BP","499667_GO_0030262_APOPTOTIC_NUCLEAR_CHANGES",30,-0.9502,0.54,0.7,-0.6475,0.95,1,-1.0344,0.41,0.82
"GO_CC:490810_GO_0044439_PEROXISOMAL_PART","GO_CC","490810_GO_0044439_PEROXISOMAL_PART",79,-0.9501,0.54,0.79,1.0238,0.4,0.75,-1.3574,0.04,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_577_ABDULRAHMAN_KIDNEY_CANCER_VHL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_577_ABDULRAHMAN_KIDNEY_CANCER_VHL_UP",5,-0.95,0.53,0.65,-1.1989,0.25,0.79,-1.3999,0.085,0.36
"GO_BP:491387_GO_0006486_PROTEIN_GLYCOSYLATION","GO_BP","491387_GO_0006486_PROTEIN_GLYCOSYLATION",289,-0.95,0.61,0.7,0.9114,0.74,1,-0.8801,0.87,0.94
"GO_BP:494625_GO_0010560_POSITIVE_REGULATION_OF_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS","GO_BP","494625_GO_0010560_POSITIVE_REGULATION_OF_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS",12,-0.95,0.52,0.7,-0.8167,0.71,1,-0.7983,0.74,0.99
"GO_BP:491875_GO_0007050_CELL_CYCLE_ARREST","GO_BP","491875_GO_0007050_CELL_CYCLE_ARREST",140,-0.9499,0.56,0.7,-0.761,0.96,1,-0.9432,0.59,0.89
"GO_BP:510392_GO_0048284_ORGANELLE_FUSION","GO_BP","510392_GO_0048284_ORGANELLE_FUSION",110,-0.9495,0.58,0.7,1.1795,0.14,0.8,-1.0563,0.32,0.81
"GO_BP:491263_GO_0006304_DNA_MODIFICATION","GO_BP","491263_GO_0006304_DNA_MODIFICATION",103,-0.9495,0.56,0.7,-1.2441,0.11,0.91,-1.4339,0.016,0.56
"C2_Chemical_and_genetic_perturbations:C2_CGP_2930_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4","C2_Chemical_and_genetic_perturbations","C2_CGP_2930_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4",15,-0.9493,0.53,0.65,0.8612,0.67,0.96,0.779,0.78,1
"GO_BP:518754_GO_2000105_POSITIVE_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION","GO_BP","518754_GO_2000105_POSITIVE_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION",13,-0.9493,0.53,0.7,-0.7357,0.84,1,-1.1604,0.25,0.73
"C4_Cancer_gene_neighborhoods:C4_CGN_364_GNF2_INPP5D","C4_Cancer_gene_neighborhoods","C4_CGN_364_GNF2_INPP5D",43,-0.9493,0.54,0.8,1.387,0.057,0.066,-0.8259,0.76,1
"REACTOME:645259_REACT_121311_CELLULAR_RESPONSE_TO_HYPOXIA","REACTOME","645259_REACT_121311_CELLULAR_RESPONSE_TO_HYPOXIA",25,-0.9493,0.53,0.72,1.4425,0.05,0.19,0.756,0.86,1
"C7_Immunologic_signatures:C7_ALL_526_GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_526_GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDM_DN",196,-0.9492,0.58,0.69,1.3371,0.031,0.071,-0.8155,0.95,1
"C4_Cancer_gene_neighborhoods:C4_CGN_309_GNF2_RFC3","C4_Cancer_gene_neighborhoods","C4_CGN_309_GNF2_RFC3",41,-0.9492,0.54,0.8,1.5068,0.027,0.029,-1.4656,0.024,0.13
"REACTOME:771585_REACT_160156_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION_","REACTOME","771585_REACT_160156_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION_",22,-0.9491,0.53,0.72,1.1098,0.31,0.56,-1.3613,0.1,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_3326_BOUDOUKHA_BOUND_BY_IGF2BP2","C2_Chemical_and_genetic_perturbations","C2_CGP_3326_BOUDOUKHA_BOUND_BY_IGF2BP2",107,-0.9491,0.57,0.65,1.7214,0,0.071,-0.771,0.95,0.97
"GO_BP:502532_GO_0033314_MITOTIC_DNA_REPLICATION_CHECKPOINT","GO_BP","502532_GO_0033314_MITOTIC_DNA_REPLICATION_CHECKPOINT",5,-0.9491,0.54,0.7,1.1671,0.29,0.82,1.125,0.35,0.74
"GO_CC:502399_GO_0033179_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN","GO_CC","502399_GO_0033179_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN",10,-0.9491,0.53,0.79,-0.7476,0.79,1,0.9276,0.55,1
"GO_BP:505609_GO_0042472_INNER_EAR_MORPHOGENESIS","GO_BP","505609_GO_0042472_INNER_EAR_MORPHOGENESIS",96,-0.9491,0.58,0.7,0.8287,0.83,1,1.4488,0.017,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_2329_MATZUK_EMBRYONIC_GERM_CELL","C2_Chemical_and_genetic_perturbations","C2_CGP_2329_MATZUK_EMBRYONIC_GERM_CELL",18,-0.9489,0.54,0.65,-1.1869,0.21,0.81,1.0591,0.36,0.89
"GO_BP:518790_GO_2000142_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION","GO_BP","518790_GO_2000142_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION",23,-0.9488,0.55,0.7,0.7903,0.79,1,0.7412,0.83,1
"KEGG_pathway:HSA05012_PARKINSON_S_DISEASE","KEGG_pathway","HSA05012_PARKINSON_S_DISEASE",126,-0.9486,0.59,0.61,2.4353,0,0,-0.7697,0.94,0.96
"GO_BP:493312_GO_0009113_PURINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS","GO_BP","493312_GO_0009113_PURINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS",12,-0.9486,0.52,0.7,0.93,0.54,1,-1.1659,0.26,0.73
"GO_BP:499289_GO_0022010_CENTRAL_NERVOUS_SYSTEM_MYELINATION","GO_BP","499289_GO_0022010_CENTRAL_NERVOUS_SYSTEM_MYELINATION",14,-0.9486,0.54,0.7,-0.7486,0.8,1,-0.9057,0.58,0.92
"GO_BP:498364_GO_0019530_TAURINE_METABOLIC_PROCESS","GO_BP","498364_GO_0019530_TAURINE_METABOLIC_PROCESS",7,-0.9485,0.53,0.7,0.9385,0.55,1,0.586,0.95,1
"GO_BP:518447_GO_0090307_MITOTIC_SPINDLE_ASSEMBLY","GO_BP","518447_GO_0090307_MITOTIC_SPINDLE_ASSEMBLY",29,-0.9484,0.55,0.7,0.7933,0.78,1,-1.1855,0.22,0.73
"GO_BP:516472_GO_0071548_RESPONSE_TO_DEXAMETHASONE","GO_BP","516472_GO_0071548_RESPONSE_TO_DEXAMETHASONE",21,-0.9483,0.51,0.7,1.2413,0.18,0.75,1.063,0.37,0.79
"GO_MF:504424_GO_0035240_DOPAMINE_BINDING","GO_MF","504424_GO_0035240_DOPAMINE_BINDING",10,-0.9482,0.52,0.73,1.2206,0.22,0.7,0.6953,0.86,1
"GO_BP:497279_GO_0018317_PROTEIN_C_LINKED_GLYCOSYLATION_VIA_TRYPTOPHAN","GO_BP","497279_GO_0018317_PROTEIN_C_LINKED_GLYCOSYLATION_VIA_TRYPTOPHAN",5,-0.9482,0.56,0.7,0.7474,0.8,1,-1.3987,0.11,0.58
"GO_BP:500908_GO_0031659_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","500908_GO_0031659_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",7,-0.948,0.53,0.7,-0.8342,0.67,1,1.1887,0.26,0.72
"C3_TF_targets:C3_TFT_83_V_MYCMAX_02","C3_TF_targets","C3_TFT_83_V_MYCMAX_02",262,-0.948,0.61,0.68,1.2008,0.075,0.73,-0.9453,0.62,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_582_EGUCHI_CELL_CYCLE_RB1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_582_EGUCHI_CELL_CYCLE_RB1_TARGETS",23,-0.948,0.52,0.65,1.502,0.039,0.21,-1.5608,0.02,0.27
"C2_Chemical_and_genetic_perturbations:C2_CGP_1965_CHEN_ETV5_TARGETS_TESTIS","C2_Chemical_and_genetic_perturbations","C2_CGP_1965_CHEN_ETV5_TARGETS_TESTIS",20,-0.948,0.53,0.65,-0.61,0.96,1,-1.0368,0.38,0.71
"GO_BP:488250_GO_0002377_IMMUNOGLOBULIN_PRODUCTION","GO_BP","488250_GO_0002377_IMMUNOGLOBULIN_PRODUCTION",43,-0.9478,0.54,0.7,0.5894,0.99,1,-1.381,0.062,0.59
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_168_BIOCARTA_MAL_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_168_BIOCARTA_MAL_PATHWAY",19,-0.9478,0.54,0.65,0.456,1,1,-0.5707,0.99,0.99
"C1_Positional:C1_ALL_289_CHR1Q44","C1_Positional","C1_ALL_289_CHR1Q44",71,-0.9476,0.58,0.92,1.3801,0.036,0.43,1.6551,0.0038,0.22
"GO_BP:519433_GO_2000794_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS","GO_BP","519433_GO_2000794_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS",7,-0.9476,0.54,0.7,-0.8179,0.71,1,-0.7731,0.75,1
"C7_Immunologic_signatures:C7_ALL_1586_GSE3982_EOSINOPHIL_VS_MAST_CELL_DN","C7_Immunologic_signatures","C7_ALL_1586_GSE3982_EOSINOPHIL_VS_MAST_CELL_DN",197,-0.9474,0.58,0.69,1.7555,0,3e-04,-1.2525,0.053,0.19
"GO_BP:486638_GO_0000096_SULFUR_AMINO_ACID_METABOLIC_PROCESS","GO_BP","486638_GO_0000096_SULFUR_AMINO_ACID_METABOLIC_PROCESS",44,-0.9472,0.56,0.7,-0.7441,0.87,1,-1.9146,0,0.49
"GO_BP:505845_GO_0042738_EXOGENOUS_DRUG_CATABOLIC_PROCESS","GO_BP","505845_GO_0042738_EXOGENOUS_DRUG_CATABOLIC_PROCESS",21,-0.9472,0.53,0.7,-1.8023,0.0057,0.45,1.2694,0.17,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_142_DOANE_BREAST_CANCER_ESR1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_142_DOANE_BREAST_CANCER_ESR1_DN",46,-0.9471,0.56,0.65,0.8659,0.71,0.96,1.094,0.32,0.88
"GO_BP:513450_GO_0055017_CARDIAC_MUSCLE_TISSUE_GROWTH","GO_BP","513450_GO_0055017_CARDIAC_MUSCLE_TISSUE_GROWTH",22,-0.9471,0.54,0.7,1.0616,0.38,0.94,-1.0296,0.39,0.83
"KEGG_reaction:R04404_PHOSPHATIDYL_MYO_INOSITOL_4_5_BISPHOSPHATE_4_PHOSPHOHYDROLASE_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_H2O_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_ORTHOPHOSPHATE","KEGG_reaction","R04404_PHOSPHATIDYL_MYO_INOSITOL_4_5_BISPHOSPHATE_4_PHOSPHOHYDROLASE_1_PHOSPHATIDYL_D_MYO_INOSITOL_4_5_BISPHOSPHATE_H2O_1_PHOSPHATIDYL_1D_MYO_INOSITOL_4_PHOSPHATE_ORTHOPHOSPHATE",5,-0.9471,0.53,0.69,-0.9985,0.47,0.79,0.7509,0.75,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_808_DIRMEIER_LMP1_RESPONSE_LATE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_808_DIRMEIER_LMP1_RESPONSE_LATE_DN",31,-0.947,0.55,0.65,1.8992,0,0.02,-0.8309,0.72,0.94
"GO_BP:946566_GO_0098909_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_REGULATION_OF_CONTRACTION","GO_BP","946566_GO_0098909_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_REGULATION_OF_CONTRACTION",12,-0.947,0.53,0.7,0.8385,0.67,1,1.5327,0.043,0.53
"GO_BP:513774_GO_0060218_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION","GO_BP","513774_GO_0060218_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION",12,-0.9469,0.54,0.7,-0.8768,0.61,1,0.9762,0.48,0.88
"GO_BP:508859_GO_0046605_REGULATION_OF_CENTROSOME_CYCLE","GO_BP","508859_GO_0046605_REGULATION_OF_CENTROSOME_CYCLE",37,-0.9469,0.54,0.7,-0.7821,0.82,1,-0.9299,0.56,0.9
"GO_BP:500897_GO_0031648_PROTEIN_DESTABILIZATION","GO_BP","500897_GO_0031648_PROTEIN_DESTABILIZATION",27,-0.9469,0.56,0.7,0.7885,0.79,1,-1.0291,0.4,0.83
"C7_Immunologic_signatures:C7_ALL_1353_GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1353_GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP",200,-0.9468,0.6,0.69,-0.6728,1,1,-1.37,0.012,0.081
"GO_BP:513975_GO_0060419_HEART_GROWTH","GO_BP","513975_GO_0060419_HEART_GROWTH",23,-0.9467,0.51,0.7,1.1558,0.24,0.83,-1.0383,0.4,0.82
"C7_Immunologic_signatures:C7_ALL_1228_GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1228_GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN",199,-0.9464,0.6,0.69,-0.7831,0.95,1,-0.8058,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1041_RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1041_RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN",8,-0.9464,0.54,0.65,0.8421,0.66,0.97,0.6463,0.91,1
"GO_BP:493747_GO_0009629_RESPONSE_TO_GRAVITY","GO_BP","493747_GO_0009629_RESPONSE_TO_GRAVITY",8,-0.9462,0.53,0.7,0.8102,0.69,1,1.2956,0.17,0.67
"GO_BP:515439_GO_0070507_REGULATION_OF_MICROTUBULE_CYTOSKELETON_ORGANIZATION","GO_BP","515439_GO_0070507_REGULATION_OF_MICROTUBULE_CYTOSKELETON_ORGANIZATION",115,-0.9461,0.58,0.7,0.793,0.93,1,-1.0118,0.42,0.84
"C3_TF_targets:C3_TFT_527_TNCATNTCCYR_UNKNOWN","C3_TF_targets","C3_TFT_527_TNCATNTCCYR_UNKNOWN",131,-0.9461,0.57,0.68,0.7103,0.99,1,-1.4197,0.013,0.31
"GO_BP:519364_GO_2000725_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION","GO_BP","519364_GO_2000725_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION",18,-0.946,0.52,0.7,-0.766,0.82,1,1.3009,0.11,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_2186_IWANAGA_CARCINOGENESIS_BY_KRAS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2186_IWANAGA_CARCINOGENESIS_BY_KRAS_DN",119,-0.946,0.58,0.65,0.7468,0.95,1,0.8697,0.76,1
"GO_BP:505701_GO_0042573_RETINOIC_ACID_METABOLIC_PROCESS","GO_BP","505701_GO_0042573_RETINOIC_ACID_METABOLIC_PROCESS",20,-0.9459,0.54,0.7,-1.3101,0.12,0.87,1.0766,0.35,0.78
"REACTOME:833821_REACT_163743_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION","REACTOME","833821_REACT_163743_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION",5,-0.9457,0.55,0.73,0.59,0.93,1,0.8076,0.69,1
"REACTOME:645260_REACT_120815_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN","REACTOME","645260_REACT_120815_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN",25,-0.9456,0.56,0.73,1.4572,0.059,0.18,0.7585,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_605_DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_605_DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN",88,-0.9455,0.57,0.66,-1.0529,0.35,0.97,-1.2151,0.13,0.51
"C7_Immunologic_signatures:C7_ALL_462_GSE17721_CTRL_VS_LPS_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_462_GSE17721_CTRL_VS_LPS_24H_BMDM_DN",200,-0.9454,0.62,0.7,1.1854,0.11,0.25,-0.8514,0.87,1
"C1_Positional:C1_ALL_302_CHR6Q22","C1_Positional","C1_ALL_302_CHR6Q22",63,-0.9454,0.55,0.92,0.9287,0.61,0.82,-1.0511,0.34,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1928_JIANG_HYPOXIA_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_1928_JIANG_HYPOXIA_CANCER",82,-0.9453,0.55,0.66,1.3785,0.04,0.31,0.9029,0.66,1
"GO_BP:491728_GO_0006863_PURINE_NUCLEOBASE_TRANSPORT","GO_BP","491728_GO_0006863_PURINE_NUCLEOBASE_TRANSPORT",5,-0.9453,0.55,0.71,-0.6886,0.82,1,-1.2387,0.23,0.69
"GO_BP:504499_GO_0035315_HAIR_CELL_DIFFERENTIATION","GO_BP","504499_GO_0035315_HAIR_CELL_DIFFERENTIATION",36,-0.9452,0.54,0.71,0.48,1,1,1.2183,0.19,0.71
"C1_Positional:C1_ALL_65_CHR18Q21","C1_Positional","C1_ALL_65_CHR18Q21",73,-0.9452,0.57,0.91,0.9364,0.58,0.83,-0.7287,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3334_MIZUSHIMA_AUTOPHAGOSOME_FORMATION","C2_Chemical_and_genetic_perturbations","C2_CGP_3334_MIZUSHIMA_AUTOPHAGOSOME_FORMATION",19,-0.9451,0.54,0.66,-0.6791,0.89,1,-0.7216,0.88,0.98
"GO_BP:491724_GO_0006858_EXTRACELLULAR_TRANSPORT","GO_BP","491724_GO_0006858_EXTRACELLULAR_TRANSPORT",6,-0.9448,0.53,0.71,1.2044,0.25,0.78,-0.5571,0.96,1
"GO_BP:489284_GO_0006333_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY","GO_BP","489284_GO_0006333_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY",163,-0.9447,0.59,0.71,-1.1627,0.14,0.92,-1.5196,0.002,0.53
"C7_Immunologic_signatures:C7_ALL_249_GSE14308_TH2_VS_INDUCED_TREG_UP","C7_Immunologic_signatures","C7_ALL_249_GSE14308_TH2_VS_INDUCED_TREG_UP",195,-0.9445,0.6,0.7,1.063,0.29,0.55,-0.6693,1,1
"REACTOME:106525_REACT_15309_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE","REACTOME","106525_REACT_15309_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE",17,-0.9444,0.54,0.73,-1.2205,0.21,0.79,1.4414,0.064,0.6
"GO_BP:507577_GO_0045199_MAINTENANCE_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY","GO_BP","507577_GO_0045199_MAINTENANCE_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY",6,-0.9444,0.54,0.71,1.3701,0.13,0.59,-1.3669,0.12,0.59
"GO_BP:1129368_GO_1903541_REGULATION_OF_EXOSOMAL_SECRETION","GO_BP","1129368_GO_1903541_REGULATION_OF_EXOSOMAL_SECRETION",15,-0.9444,0.54,0.71,1.3025,0.13,0.66,1.4465,0.072,0.59
"GO_MF:489355_GO_0003854_3_BETA_HYDROXY_DELTA5_STEROID_DEHYDROGENASE_ACTIVITY","GO_MF","489355_GO_0003854_3_BETA_HYDROXY_DELTA5_STEROID_DEHYDROGENASE_ACTIVITY",5,-0.9444,0.54,0.74,-0.8279,0.67,1,1.3351,0.12,0.66
"KEGG_compound:C00412_STEAROYL_COA_STEARYL_COA_STEARYL_COENZYME_A","KEGG_compound","C00412_STEAROYL_COA_STEARYL_COA_STEARYL_COENZYME_A",8,-0.9444,0.55,0.68,-0.6383,0.9,1,0.807,0.7,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_472_BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_472_BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN",12,-0.9443,0.55,0.66,-1.249,0.19,0.75,-0.852,0.66,0.92
"GO_MF:503938_GO_0034739_HISTONE_DEACETYLASE_ACTIVITY_H4_K16_SPECIFIC_","GO_MF","503938_GO_0034739_HISTONE_DEACETYLASE_ACTIVITY_H4_K16_SPECIFIC_",13,-0.9443,0.54,0.73,-1.2521,0.18,0.83,-1.7588,0.008,0.23
"GO_BP:868042_GO_0044801_SINGLE_ORGANISM_MEMBRANE_FUSION","GO_BP","868042_GO_0044801_SINGLE_ORGANISM_MEMBRANE_FUSION",120,-0.9443,0.58,0.71,1.1985,0.12,0.78,-1.0933,0.25,0.78
"WikiPathways:198769_WP12_OSTEOCLAST_SIGNALING","WikiPathways","198769_WP12_OSTEOCLAST_SIGNALING",16,-0.9442,0.56,0.66,1.2931,0.16,0.67,0.603,0.97,1
"C4_Cancer_modules:C4_CM_153_MODULE_162","C4_Cancer_modules","C4_CM_153_MODULE_162",18,-0.9441,0.54,0.66,-1.832,0.0038,0.086,-0.9453,0.53,0.78
"C4_Cancer_modules:C4_CM_139_MODULE_147","C4_Cancer_modules","C4_CM_139_MODULE_147",106,-0.9441,0.61,0.66,0.9841,0.49,0.73,-0.9013,0.7,0.85
"REACTOME:106284_REACT_655_PYRIMIDINE_SALVAGE_REACTIONS","REACTOME","106284_REACT_655_PYRIMIDINE_SALVAGE_REACTIONS",9,-0.9441,0.54,0.73,-0.7463,0.79,1,0.6941,0.86,1
"C7_Immunologic_signatures:C7_ALL_76_GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN","C7_Immunologic_signatures","C7_ALL_76_GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN",193,-0.944,0.59,0.7,0.8589,0.87,1,1.0868,0.26,1
"GO_BP:491823_GO_0006987_ACTIVATION_OF_SIGNALING_PROTEIN_ACTIVITY_INVOLVED_IN_UNFOLDED_PROTEIN_RESPONSE","GO_BP","491823_GO_0006987_ACTIVATION_OF_SIGNALING_PROTEIN_ACTIVITY_INVOLVED_IN_UNFOLDED_PROTEIN_RESPONSE",70,-0.944,0.58,0.71,0.6159,1,1,-0.9104,0.63,0.92
"GO_BP:512529_GO_0051653_SPINDLE_LOCALIZATION","GO_BP","512529_GO_0051653_SPINDLE_LOCALIZATION",31,-0.944,0.55,0.71,0.7037,0.93,1,0.9926,0.44,0.86
"C7_Immunologic_signatures:C7_ALL_716_GSE17721_12H_VS_24H_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_716_GSE17721_12H_VS_24H_LPS_BMDM_DN",197,-0.9439,0.61,0.7,1.2477,0.055,0.16,-1.0713,0.28,0.57
"C7_Immunologic_signatures:C7_ALL_1707_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP","C7_Immunologic_signatures","C7_ALL_1707_GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP",191,-0.9439,0.61,0.7,0.8212,0.91,1,-0.9852,0.5,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_949_PUJANA_BRCA2_PCC_NETWORK","C2_Chemical_and_genetic_perturbations","C2_CGP_949_PUJANA_BRCA2_PCC_NETWORK",422,-0.9438,0.65,0.66,1.2664,0.026,0.42,-1.4078,0,0.35
"GO_MF:490243_GO_0004952_DOPAMINE_NEUROTRANSMITTER_RECEPTOR_ACTIVITY","GO_MF","490243_GO_0004952_DOPAMINE_NEUROTRANSMITTER_RECEPTOR_ACTIVITY",6,-0.9438,0.53,0.73,1.1503,0.3,0.74,1.1783,0.25,0.75
"GO_BP:502409_GO_0033189_RESPONSE_TO_VITAMIN_A","GO_BP","502409_GO_0033189_RESPONSE_TO_VITAMIN_A",14,-0.9438,0.55,0.71,0.9945,0.44,0.98,1.4358,0.083,0.6
"C4_Cancer_modules:C4_CM_287_MODULE_328","C4_Cancer_modules","C4_CM_287_MODULE_328",14,-0.9437,0.53,0.66,-1.8174,0.0078,0.076,0.886,0.65,1
"C7_Immunologic_signatures:C7_ALL_1315_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP","C7_Immunologic_signatures","C7_ALL_1315_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP",192,-0.9437,0.6,0.7,1.0024,0.44,0.73,0.7908,0.96,1
"WikiPathways:198868_WP1403_AMPK_SIGNALING","WikiPathways","198868_WP1403_AMPK_SIGNALING",68,-0.9436,0.58,0.66,0.7029,0.97,1,-0.9446,0.55,0.8
"GO_CC:752939_GO_0097440_APICAL_DENDRITE","GO_CC","752939_GO_0097440_APICAL_DENDRITE",7,-0.9436,0.54,0.8,-0.8751,0.59,0.95,-1.0964,0.37,0.92
"C3_TF_targets:C3_TFT_193_V_RFX1_01","C3_TF_targets","C3_TFT_193_V_RFX1_01",252,-0.9435,0.61,0.69,0.9156,0.72,1,-1.0983,0.21,0.55
"C7_Immunologic_signatures:C7_ALL_265_GSE14308_TH17_VS_NATURAL_TREG_UP","C7_Immunologic_signatures","C7_ALL_265_GSE14308_TH17_VS_NATURAL_TREG_UP",199,-0.9434,0.6,0.7,1.3694,0.012,0.051,-0.9022,0.76,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2213_OUYANG_PROSTATE_CANCER_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_2213_OUYANG_PROSTATE_CANCER_MARKERS",19,-0.9434,0.55,0.66,1.1606,0.25,0.54,1.0043,0.42,0.96
"GO_BP:495976_GO_0015851_NUCLEOBASE_TRANSPORT","GO_BP","495976_GO_0015851_NUCLEOBASE_TRANSPORT",7,-0.9434,0.54,0.71,-0.9346,0.53,1,-1.1282,0.32,0.76
"REACTOME:366230_REACT_75770_VOLTAGE_GATED_POTASSIUM_CHANNELS","REACTOME","366230_REACT_75770_VOLTAGE_GATED_POTASSIUM_CHANNELS",43,-0.9432,0.55,0.73,-1.337,0.086,0.6,1.1301,0.25,0.91
"C4_Cancer_modules:C4_CM_326_MODULE_385","C4_Cancer_modules","C4_CM_326_MODULE_385",27,-0.9431,0.56,0.66,1.2008,0.19,0.39,1.5813,0.014,0.18
"C7_Immunologic_signatures:C7_ALL_1358_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1358_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN",200,-0.9431,0.62,0.7,0.774,0.98,1,-0.9207,0.67,0.91
"GO_CC:500559_GO_0031300_INTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE","GO_CC","500559_GO_0031300_INTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE",255,-0.943,0.61,0.8,0.9222,0.71,0.87,-0.9009,0.79,1
"GO_BP:516144_GO_0071218_CELLULAR_RESPONSE_TO_MISFOLDED_PROTEIN","GO_BP","516144_GO_0071218_CELLULAR_RESPONSE_TO_MISFOLDED_PROTEIN",9,-0.943,0.55,0.71,0.5366,0.97,1,-0.8137,0.72,0.98
"REACTOME:1127637_REACT_267615_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES","REACTOME","1127637_REACT_267615_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES",6,-0.943,0.52,0.73,-0.6025,0.92,1,0.9498,0.53,1
"GO_BP:495116_GO_0014044_SCHWANN_CELL_DEVELOPMENT","GO_BP","495116_GO_0014044_SCHWANN_CELL_DEVELOPMENT",25,-0.9428,0.55,0.71,-0.7919,0.79,1,-1.5573,0.029,0.51
"GO_BP:519141_GO_2000501_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS","GO_BP","519141_GO_2000501_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS",9,-0.9427,0.53,0.71,1.2218,0.23,0.76,1.425,0.092,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_2445_JIANG_TIP30_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2445_JIANG_TIP30_TARGETS_DN",24,-0.9426,0.55,0.66,-0.9492,0.52,1,-1.6114,0.018,0.23
"GO_BP:493383_GO_0009187_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS","GO_BP","493383_GO_0009187_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS",56,-0.9425,0.56,0.71,-1.2816,0.092,0.89,-1.6748,0.0019,0.56
"GO_BP:500748_GO_0031497_CHROMATIN_ASSEMBLY","GO_BP","500748_GO_0031497_CHROMATIN_ASSEMBLY",143,-0.9425,0.59,0.71,-1.1236,0.21,0.94,-1.5319,0.0042,0.53
"KEGG_compound:C04742__15S_15_HYDROXY_5_8_11_CIS_13_TRANS_EICOSATETRAENOATE_15S_15_HYDROXY_5_8_11_CIS_13_TRANS_ICOSATETRAENOATE_5Z_8Z_11Z_13E_15S_15_HYDROXYICOSA_5_8_11_13_TETRAENOIC_ACID_15_S_HETE","KEGG_compound","C04742__15S_15_HYDROXY_5_8_11_CIS_13_TRANS_EICOSATETRAENOATE_15S_15_HYDROXY_5_8_11_CIS_13_TRANS_ICOSATETRAENOATE_5Z_8Z_11Z_13E_15S_15_HYDROXYICOSA_5_8_11_13_TETRAENOIC_ACID_15_S_HETE",6,-0.9424,0.53,0.68,0.5362,0.98,1,1.5465,0.046,0.13
"GO_BP:491186_GO_0006216_CYTIDINE_CATABOLIC_PROCESS","GO_BP","491186_GO_0006216_CYTIDINE_CATABOLIC_PROCESS",9,-0.9421,0.51,0.71,0.786,0.75,1,-0.9666,0.48,0.88
"C7_Immunologic_signatures:C7_ALL_1372_GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1372_GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN",195,-0.942,0.61,0.7,1.2023,0.089,0.22,-0.7567,0.98,1
"GO_CC:500591_GO_0031332_RNAI_EFFECTOR_COMPLEX","GO_CC","500591_GO_0031332_RNAI_EFFECTOR_COMPLEX",11,-0.942,0.55,0.8,-0.8608,0.61,0.96,-1.0403,0.42,0.98
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_204_BIOCARTA_TNFR1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_204_BIOCARTA_TNFR1_PATHWAY",29,-0.942,0.56,0.66,-0.7989,0.78,1,-1.1227,0.27,0.63
"GO_BP:514344_GO_0060789_HAIR_FOLLICLE_PLACODE_FORMATION","GO_BP","514344_GO_0060789_HAIR_FOLLICLE_PLACODE_FORMATION",6,-0.9418,0.56,0.71,1.0805,0.38,0.92,-0.6735,0.84,1
"GO_CC:505738_GO_0042622_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE","GO_CC","505738_GO_0042622_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE",15,-0.9416,0.54,0.8,-1.2825,0.15,0.66,0.861,0.62,1
"KEGG_module:HSA_M00337_IMMUNOPROTEASOME","KEGG_module","HSA_M00337_IMMUNOPROTEASOME",17,-0.9416,0.55,0.73,1.7689,0.0079,0.051,-1.0978,0.32,0.65
"GO_BP:494061_GO_0009972_CYTIDINE_DEAMINATION","GO_BP","494061_GO_0009972_CYTIDINE_DEAMINATION",9,-0.9416,0.52,0.71,0.8074,0.72,1,-0.9544,0.51,0.89
"GO_BP:491943_GO_0007130_SYNAPTONEMAL_COMPLEX_ASSEMBLY","GO_BP","491943_GO_0007130_SYNAPTONEMAL_COMPLEX_ASSEMBLY",17,-0.9416,0.53,0.71,-0.702,0.87,1,0.7321,0.86,1
"C7_Immunologic_signatures:C7_ALL_1422_GSE360_CTRL_VS_L_MAJOR_MAC_DN","C7_Immunologic_signatures","C7_ALL_1422_GSE360_CTRL_VS_L_MAJOR_MAC_DN",196,-0.9413,0.63,0.7,-0.9175,0.7,1,-1.0811,0.26,0.54
"REACTOME:730307_REACT_150268_ANCHORING_FIBRIL_FORMATION","REACTOME","730307_REACT_150268_ANCHORING_FIBRIL_FORMATION",7,-0.9412,0.55,0.73,-0.4759,0.99,1,1.7533,0.002,0.4
"GO_BP:497923_GO_0019043_ESTABLISHMENT_OF_VIRAL_LATENCY","GO_BP","497923_GO_0019043_ESTABLISHMENT_OF_VIRAL_LATENCY",10,-0.9411,0.57,0.71,1.0593,0.38,0.94,-0.9585,0.5,0.88
"C7_Immunologic_signatures:C7_ALL_1014_GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1014_GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN",200,-0.941,0.59,0.7,1.5123,0,0.01,-1.2876,0.028,0.15
"C7_Immunologic_signatures:C7_ALL_195_GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_195_GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP",193,-0.941,0.6,0.7,-0.6978,1,1,0.8855,0.79,1
"GO_BP:491583_GO_0006695_CHOLESTEROL_BIOSYNTHETIC_PROCESS","GO_BP","491583_GO_0006695_CHOLESTEROL_BIOSYNTHETIC_PROCESS",36,-0.9409,0.55,0.71,-0.7719,0.84,1,0.698,0.94,1
"C1_Positional:C1_ALL_127_CHR12P12","C1_Positional","C1_ALL_127_CHR12P12",59,-0.9409,0.55,0.92,1.0149,0.42,0.74,-0.9929,0.47,0.9
"GO_MF:490471_GO_0005230_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY","GO_MF","490471_GO_0005230_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY",72,-0.9408,0.59,0.74,-1.3564,0.048,0.69,1.9288,0,0.036
"REACTOME:1183559_REACT_110235_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1","REACTOME","1183559_REACT_110235_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1",44,-0.9407,0.57,0.73,-0.8978,0.65,1,-1.2878,0.11,0.54
"C7_Immunologic_signatures:C7_ALL_199_GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_199_GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP",162,-0.9407,0.6,0.7,-1.2543,0.072,0.61,1.5978,0,0.0092
"C1_Positional:C1_ALL_313_CHR9P24","C1_Positional","C1_ALL_313_CHR9P24",46,-0.9406,0.56,0.91,1.1591,0.22,0.62,1.2242,0.13,0.61
"C3_TF_targets:C3_TFT_419_V_AHR_Q5","C3_TF_targets","C3_TFT_419_V_AHR_Q5",213,-0.9404,0.63,0.7,-0.6859,1,1,-1.1501,0.12,0.46
"GO_BP:488626_GO_0002753_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY","GO_BP","488626_GO_0002753_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY",35,-0.9403,0.57,0.71,1.0602,0.36,0.94,-1.1013,0.31,0.77
"GO_BP:506516_GO_0043484_REGULATION_OF_RNA_SPLICING","GO_BP","506516_GO_0043484_REGULATION_OF_RNA_SPLICING",87,-0.9403,0.59,0.71,-0.8051,0.84,1,-0.9018,0.71,0.92
"GO_BP:487866_GO_0001976_NEUROLOGICAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE","GO_BP","487866_GO_0001976_NEUROLOGICAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE",18,-0.9402,0.53,0.71,-1.1014,0.32,0.94,0.9912,0.49,0.86
"C7_Immunologic_signatures:C7_ALL_1581_GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP","C7_Immunologic_signatures","C7_ALL_1581_GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP",197,-0.9402,0.63,0.7,1.7898,0,0.00017,-0.791,0.95,1
"C4_Cancer_modules:C4_CM_294_MODULE_335","C4_Cancer_modules","C4_CM_294_MODULE_335",14,-0.9401,0.52,0.67,0.7661,0.79,0.99,-0.9185,0.54,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_287_TIEN_INTESTINE_PROBIOTICS_6HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_287_TIEN_INTESTINE_PROBIOTICS_6HR_UP",55,-0.9401,0.54,0.67,2.826,0,0,0.9972,0.45,0.97
"C1_Positional:C1_ALL_322_CHR17P12","C1_Positional","C1_ALL_322_CHR17P12",26,-0.9399,0.55,0.91,1.0075,0.42,0.74,0.8689,0.66,0.87
"C4_Cancer_gene_neighborhoods:C4_CGN_263_GCM_RING1","C4_Cancer_gene_neighborhoods","C4_CGN_263_GCM_RING1",104,-0.9399,0.59,0.82,0.8067,0.89,0.98,0.8774,0.73,1
"GO_BP:506715_GO_0043687_POST_TRANSLATIONAL_PROTEIN_MODIFICATION","GO_BP","506715_GO_0043687_POST_TRANSLATIONAL_PROTEIN_MODIFICATION",256,-0.9399,0.63,0.71,1.0134,0.41,0.97,0.6961,1,1
"GO_CC:498651_GO_0019867_OUTER_MEMBRANE","GO_CC","498651_GO_0019867_OUTER_MEMBRANE",173,-0.9396,0.62,0.8,1.4093,0.0071,0.29,-0.9239,0.67,1
"KEGG_reaction:R07035_GLUTATHIONE_15_HPETE_OXIDOREDUCTASE_2_GLUTATHIONE_15_S_HPETE_GLUTATHIONE_DISULFIDE_15S_15_HYDROXY_5_8_11_CIS_13_TRANS_EICOSATETRAENOATE_H2O","KEGG_reaction","R07035_GLUTATHIONE_15_HPETE_OXIDOREDUCTASE_2_GLUTATHIONE_15_S_HPETE_GLUTATHIONE_DISULFIDE_15S_15_HYDROXY_5_8_11_CIS_13_TRANS_EICOSATETRAENOATE_H2O",6,-0.9396,0.57,0.7,0.5396,0.98,1,1.5575,0.058,0.1
"C7_Immunologic_signatures:C7_ALL_512_GSE17721_CTRL_VS_GARDIQUIMOD_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_512_GSE17721_CTRL_VS_GARDIQUIMOD_0_5H_BMDM_DN",197,-0.9396,0.64,0.71,0.9802,0.51,0.8,-1.0511,0.32,0.61
"GO_BP:491389_GO_0006488_DOLICHOL_LINKED_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS","GO_BP","491389_GO_0006488_DOLICHOL_LINKED_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS",67,-0.9396,0.59,0.71,0.8897,0.67,1,0.6233,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2347_GRADE_COLON_VS_RECTAL_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2347_GRADE_COLON_VS_RECTAL_CANCER_UP",37,-0.9395,0.59,0.67,1.0012,0.45,0.8,-1.0249,0.42,0.72
"C3_TF_targets:C3_TFT_429_V_HIF1_Q3","C3_TF_targets","C3_TFT_429_V_HIF1_Q3",223,-0.9395,0.63,0.7,0.8445,0.91,1,-0.8288,0.95,0.99
"GO_BP:911331_GO_0097503_SIALYLATION","GO_BP","911331_GO_0097503_SIALYLATION",20,-0.9394,0.57,0.71,0.5674,0.98,1,0.8446,0.67,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2059_GAVIN_FOXP3_TARGETS_CLUSTER_T7","C2_Chemical_and_genetic_perturbations","C2_CGP_2059_GAVIN_FOXP3_TARGETS_CLUSTER_T7",98,-0.9394,0.59,0.67,2.0746,0,0.0026,-0.8868,0.74,0.9
"GO_BP:925942_GO_1902593_SINGLE_ORGANISM_NUCLEAR_IMPORT","GO_BP","925942_GO_1902593_SINGLE_ORGANISM_NUCLEAR_IMPORT",98,-0.9394,0.59,0.71,0.7105,0.99,1,-1.0647,0.34,0.8
"REACTOME:105864_REACT_204_ATM_MEDIATED_RESPONSE_TO_DNA_DOUBLE_STRAND_BREAK","REACTOME","105864_REACT_204_ATM_MEDIATED_RESPONSE_TO_DNA_DOUBLE_STRAND_BREAK",5,-0.9393,0.55,0.73,-0.95,0.5,1,-1.4088,0.1,0.4
"C7_Immunologic_signatures:C7_ALL_1538_GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1538_GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN",160,-0.9393,0.63,0.71,-0.8896,0.75,1,-1.4197,0.006,0.049
"C4_Cancer_modules:C4_CM_232_MODULE_256","C4_Cancer_modules","C4_CM_232_MODULE_256",61,-0.9392,0.57,0.67,1.0554,0.35,0.62,-0.797,0.85,0.99
"C4_Cancer_gene_neighborhoods:C4_CGN_62_MORF_ARAF1","C4_Cancer_gene_neighborhoods","C4_CGN_62_MORF_ARAF1",78,-0.9391,0.59,0.81,-0.717,0.95,1,-0.5444,1,1
"GO_BP:488586_GO_0002713_NEGATIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY","GO_BP","488586_GO_0002713_NEGATIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY",10,-0.9391,0.54,0.71,-0.7679,0.77,1,0.8699,0.61,0.96
"REACTOME:187229_REACT_25299_DSCAM_INTERACTIONS","REACTOME","187229_REACT_25299_DSCAM_INTERACTIONS",11,-0.9391,0.53,0.73,-1.266,0.19,0.71,-0.7518,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1995_BILD_SRC_ONCOGENIC_SIGNATURE","C2_Chemical_and_genetic_perturbations","C2_CGP_1995_BILD_SRC_ONCOGENIC_SIGNATURE",61,-0.939,0.57,0.67,-0.7144,0.96,1,-1.4924,0.01,0.3
"GO_BP:516469_GO_0071545_INOSITOL_PHOSPHATE_CATABOLIC_PROCESS","GO_BP","516469_GO_0071545_INOSITOL_PHOSPHATE_CATABOLIC_PROCESS",11,-0.939,0.51,0.71,0.547,0.98,1,0.6892,0.86,1
"GO_BP:489090_GO_0003298_PHYSIOLOGICAL_MUSCLE_HYPERTROPHY","GO_BP","489090_GO_0003298_PHYSIOLOGICAL_MUSCLE_HYPERTROPHY",6,-0.9387,0.55,0.71,1.6066,0.02,0.28,0.8225,0.69,1
"C7_Immunologic_signatures:C7_ALL_1578_GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1578_GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN",191,-0.9387,0.62,0.71,0.7143,1,1,-1.5144,0.0021,0.018
"REACTOME:730335_REACT_150209_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS","REACTOME","730335_REACT_150209_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS",6,-0.9386,0.54,0.73,0.8451,0.66,0.96,1.2316,0.26,0.8
"GO_BP:494080_GO_0009996_NEGATIVE_REGULATION_OF_CELL_FATE_SPECIFICATION","GO_BP","494080_GO_0009996_NEGATIVE_REGULATION_OF_CELL_FATE_SPECIFICATION",7,-0.9385,0.53,0.71,-0.83,0.66,1,-0.9662,0.5,0.88
"C4_Cancer_modules:C4_CM_247_MODULE_279","C4_Cancer_modules","C4_CM_247_MODULE_279",138,-0.9385,0.61,0.66,1.2772,0.044,0.3,0.9548,0.58,0.95
"GO_MF:754633_GO_1901682_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","754633_GO_1901682_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",25,-0.9383,0.57,0.74,0.6492,0.96,1,0.9606,0.52,0.9
"REACTOME:730349_REACT_150238_SIGNALING_BY_ACTIVIN","REACTOME","730349_REACT_150238_SIGNALING_BY_ACTIVIN",13,-0.9382,0.55,0.73,-0.5184,0.99,1,0.6795,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1617_BURTON_ADIPOGENESIS_10","C2_Chemical_and_genetic_perturbations","C2_CGP_1617_BURTON_ADIPOGENESIS_10",30,-0.9381,0.53,0.67,1.0929,0.33,0.64,-0.8604,0.68,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1650_WESTON_VEGFA_TARGETS_6HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1650_WESTON_VEGFA_TARGETS_6HR",55,-0.9381,0.57,0.67,1.0045,0.45,0.79,1.1311,0.26,0.84
"C7_Immunologic_signatures:C7_ALL_1021_GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1021_GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP",197,-0.9381,0.61,0.71,0.9142,0.72,0.99,-1.1567,0.13,0.36
"GO_MF:516809_GO_0071889_14_3_3_PROTEIN_BINDING","GO_MF","516809_GO_0071889_14_3_3_PROTEIN_BINDING",18,-0.938,0.56,0.74,-1.3016,0.14,0.77,-1.3249,0.12,0.55
"KEGG_compound:C16265_N_ACETYLGALACTOSAMINE_4_SULFATE","KEGG_compound","C16265_N_ACETYLGALACTOSAMINE_4_SULFATE",5,-0.938,0.55,0.68,0.7404,0.77,1,-1.1152,0.35,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1914_MURAKAMI_UV_RESPONSE_24HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1914_MURAKAMI_UV_RESPONSE_24HR",19,-0.9378,0.57,0.67,0.7768,0.78,1,0.6076,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1008_LIU_BREAST_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_1008_LIU_BREAST_CANCER",26,-0.9377,0.55,0.67,0.7602,0.84,1,-0.7596,0.84,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1424_PENG_RAPAMYCIN_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1424_PENG_RAPAMYCIN_RESPONSE_DN",243,-0.9375,0.63,0.67,1.8001,0,0.044,-0.9097,0.73,0.87
"C7_Immunologic_signatures:C7_ALL_1252_GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1252_GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN",180,-0.9374,0.61,0.71,1.1669,0.11,0.29,-1.3293,0.017,0.11
"GO_MF:495361_GO_0015078_HYDROGEN_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495361_GO_0015078_HYDROGEN_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",92,-0.9374,0.61,0.74,1.9844,0,0.013,1.0185,0.44,0.86
"REACTOME:105832_REACT_6820_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B","REACTOME","105832_REACT_6820_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B",21,-0.9373,0.57,0.73,1.267,0.16,0.36,-1.1194,0.3,0.68
"GO_BP:501225_GO_0031987_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR","GO_BP","501225_GO_0031987_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR",6,-0.9372,0.56,0.72,-0.4205,1,1,1.4415,0.083,0.59
"C3_TF_targets:C3_TFT_161_CAGNYGKNAAA_UNKNOWN","C3_TF_targets","C3_TFT_161_CAGNYGKNAAA_UNKNOWN",72,-0.937,0.56,0.7,1.3196,0.059,0.49,-1.2022,0.16,0.34
"GO_BP:514573_GO_0061025_MEMBRANE_FUSION","GO_BP","514573_GO_0061025_MEMBRANE_FUSION",156,-0.937,0.62,0.72,1.4054,0.02,0.55,-0.9718,0.49,0.88
"KEGG_reaction:R07825_G12336_H2O_DWA_2_N_ACETYLGALACTOSAMINE_4_SULFATE","KEGG_reaction","R07825_G12336_H2O_DWA_2_N_ACETYLGALACTOSAMINE_4_SULFATE",5,-0.9369,0.55,0.69,0.74,0.79,1,-1.1085,0.38,0.47
"REACTOME:105652_REACT_1432_TNF_SIGNALING","REACTOME","105652_REACT_1432_TNF_SIGNALING",14,-0.9368,0.57,0.73,-0.9075,0.57,1,-0.7036,0.88,1
"C3_TF_targets:C3_TFT_507_RRAGTTGT_UNKNOWN","C3_TF_targets","C3_TFT_507_RRAGTTGT_UNKNOWN",246,-0.9366,0.63,0.7,0.881,0.82,1,1.0153,0.42,1
"GO_CC:506266_GO_0043198_DENDRITIC_SHAFT","GO_CC","506266_GO_0043198_DENDRITIC_SHAFT",35,-0.9366,0.58,0.8,-1.0858,0.33,0.81,1.0566,0.35,0.99
"GO_BP:519283_GO_2000644_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS","GO_BP","519283_GO_2000644_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS",7,-0.9365,0.54,0.72,-0.8885,0.6,1,-0.7388,0.81,1
"C7_Immunologic_signatures:C7_ALL_1302_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1302_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN",184,-0.9363,0.63,0.71,-0.9,0.74,1,-1.0449,0.34,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_2825_SYED_ESTRADIOL_RESPONSE","C2_Chemical_and_genetic_perturbations","C2_CGP_2825_SYED_ESTRADIOL_RESPONSE",19,-0.9361,0.55,0.67,1.0482,0.37,0.72,-1.2505,0.17,0.47
"GO_BP:489003_GO_0003209_CARDIAC_ATRIUM_MORPHOGENESIS","GO_BP","489003_GO_0003209_CARDIAC_ATRIUM_MORPHOGENESIS",27,-0.936,0.55,0.72,1.0099,0.44,0.98,1.1814,0.22,0.72
"REACTOME:161014_REACT_22433_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN","REACTOME","161014_REACT_22433_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN",67,-0.9359,0.58,0.73,0.8461,0.75,0.96,-0.644,1,1
"REACTOME:105799_REACT_1915_G2_PHASE","REACTOME","105799_REACT_1915_G2_PHASE",5,-0.9359,0.57,0.73,0.6851,0.85,1,0.6691,0.86,1
"GO_BP:515105_GO_0070168_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT","GO_BP","515105_GO_0070168_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT",17,-0.9359,0.55,0.72,0.9417,0.53,1,1.4,0.084,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_101_ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_101_ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN",374,-0.9359,0.67,0.67,1.1181,0.17,0.6,-0.9197,0.76,0.85
"REACTOME:1127513_REACT_263991_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY","REACTOME","1127513_REACT_263991_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY",28,-0.9357,0.56,0.73,0.564,0.98,1,-0.9524,0.51,0.9
"GO_BP:502353_GO_0033132_NEGATIVE_REGULATION_OF_GLUCOKINASE_ACTIVITY","GO_BP","502353_GO_0033132_NEGATIVE_REGULATION_OF_GLUCOKINASE_ACTIVITY",6,-0.9355,0.55,0.72,-0.8442,0.67,1,-0.8648,0.63,0.95
"GO_BP:516326_GO_0071402_CELLULAR_RESPONSE_TO_LIPOPROTEIN_PARTICLE_STIMULUS","GO_BP","516326_GO_0071402_CELLULAR_RESPONSE_TO_LIPOPROTEIN_PARTICLE_STIMULUS",5,-0.9354,0.56,0.72,1.0175,0.46,0.97,1.3029,0.2,0.67
"GO_BP:516629_GO_0071705_NITROGEN_COMPOUND_TRANSPORT","GO_BP","516629_GO_0071705_NITROGEN_COMPOUND_TRANSPORT",471,-0.9353,0.67,0.72,0.8448,0.98,1,-0.8881,0.91,0.94
"KEGG_pathway:HSA04110_CELL_CYCLE","KEGG_pathway","HSA04110_CELL_CYCLE",124,-0.9352,0.61,0.63,1.1058,0.24,0.78,-1.3045,0.046,0.26
"GO_BP:509091_GO_0046877_REGULATION_OF_SALIVA_SECRETION","GO_BP","509091_GO_0046877_REGULATION_OF_SALIVA_SECRETION",6,-0.9352,0.58,0.72,-1.2067,0.28,0.89,-0.5585,0.95,1
"REACTOME:187219_REACT_25091_ER_QUALITY_CONTROL_COMPARTMENT_ERQC_","REACTOME","187219_REACT_25091_ER_QUALITY_CONTROL_COMPARTMENT_ERQC_",6,-0.9352,0.56,0.73,-0.713,0.8,1,-1.2429,0.22,0.57
"C7_Immunologic_signatures:C7_ALL_1664_GSE3982_NEUTROPHIL_VS_BASOPHIL_DN","C7_Immunologic_signatures","C7_ALL_1664_GSE3982_NEUTROPHIL_VS_BASOPHIL_DN",198,-0.9351,0.62,0.71,1.8372,0,0,-1.0924,0.23,0.52
"GO_BP:517425_GO_0072520_SEMINIFEROUS_TUBULE_DEVELOPMENT","GO_BP","517425_GO_0072520_SEMINIFEROUS_TUBULE_DEVELOPMENT",9,-0.935,0.55,0.72,0.8161,0.7,1,-1.0581,0.39,0.81
"C7_Immunologic_signatures:C7_ALL_539_GSE17721_LPS_VS_POLYIC_12H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_539_GSE17721_LPS_VS_POLYIC_12H_BMDM_UP",199,-0.9349,0.64,0.71,0.9072,0.73,1,-0.9161,0.67,0.92
"GO_MF:489898_GO_0004563_BETA_N_ACETYLHEXOSAMINIDASE_ACTIVITY","GO_MF","489898_GO_0004563_BETA_N_ACETYLHEXOSAMINIDASE_ACTIVITY",5,-0.9349,0.56,0.75,-0.848,0.64,1,-0.5607,0.96,1
"C3_MicroRNA_targets:C3_MIR_214_TAATAAT_MIR_126","C3_MicroRNA_targets","C3_MIR_214_TAATAAT_MIR_126",218,-0.9349,0.64,0.73,1.1817,0.094,1,1.2743,0.034,0.95
"GO_BP:512533_GO_0051657_MAINTENANCE_OF_ORGANELLE_LOCATION","GO_BP","512533_GO_0051657_MAINTENANCE_OF_ORGANELLE_LOCATION",8,-0.9349,0.57,0.72,0.7476,0.82,1,-0.4611,0.99,1
"KEGG_module:HSA_M00682_NOTCH_SIGNALING","KEGG_module","HSA_M00682_NOTCH_SIGNALING",16,-0.9348,0.53,0.73,-1.1347,0.31,1,0.5604,0.97,1
"GO_BP:781990_GO_1902001_FATTY_ACID_TRANSMEMBRANE_TRANSPORT","GO_BP","781990_GO_1902001_FATTY_ACID_TRANSMEMBRANE_TRANSPORT",11,-0.9347,0.55,0.72,-0.8927,0.59,1,0.9988,0.44,0.86
"KEGG_compound:C00301_ADP_RIBOSE_ADP_D_RIBOSE_ADENOSINE_DIPHOSPHATE_RIBOSE","KEGG_compound","C00301_ADP_RIBOSE_ADP_D_RIBOSE_ADENOSINE_DIPHOSPHATE_RIBOSE",5,-0.9344,0.56,0.69,0.9384,0.53,1,0.7383,0.77,0.94
"C7_Immunologic_signatures:C7_ALL_755_GSE17721_0_5H_VS_4H_GARDIQUIMOD_BMDM_UP","C7_Immunologic_signatures","C7_ALL_755_GSE17721_0_5H_VS_4H_GARDIQUIMOD_BMDM_UP",199,-0.9343,0.62,0.72,1.4591,0,0.02,-0.7168,1,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_132_BIOCARTA_P38MAPK_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_132_BIOCARTA_P38MAPK_PATHWAY",40,-0.9343,0.55,0.67,-1.0843,0.33,1,-1.1157,0.28,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_1225_WHITEHURST_PACLITAXEL_SENSITIVITY","C2_Chemical_and_genetic_perturbations","C2_CGP_1225_WHITEHURST_PACLITAXEL_SENSITIVITY",36,-0.9343,0.56,0.67,0.763,0.86,1,-0.745,0.87,0.98
"GO_BP:500403_GO_0031116_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION","GO_BP","500403_GO_0031116_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION",11,-0.9343,0.56,0.72,-0.4042,1,1,-1.2001,0.22,0.73
"OMIM_gene:OMIM107773_NUCLEAR_RECEPTOR_SUBFAMILY_2_GROUP_F_MEMBER_2_NR2F2","OMIM_gene","OMIM107773_NUCLEAR_RECEPTOR_SUBFAMILY_2_GROUP_F_MEMBER_2_NR2F2",6,-0.9343,0.57,0.81,-1.2248,0.23,1,1.196,0.27,1
"GO_BP:509110_GO_0046902_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY","GO_BP","509110_GO_0046902_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY",29,-0.9343,0.57,0.72,1.2048,0.19,0.78,-0.9535,0.52,0.89
"C3_MicroRNA_targets:C3_MIR_207_CGTCTTA_MIR_208","C3_MicroRNA_targets","C3_MIR_207_CGTCTTA_MIR_208",8,-0.9342,0.55,0.73,-0.8781,0.6,1,0.589,0.92,1
"C3_MicroRNA_targets:C3_MIR_213_GGTAACC_MIR_409_5P","C3_MicroRNA_targets","C3_MIR_213_GGTAACC_MIR_409_5P",33,-0.9342,0.54,0.72,-1.1842,0.21,1,-1.0083,0.43,1
"C4_Cancer_gene_neighborhoods:C4_CGN_229_GCM_FANCC","C4_Cancer_gene_neighborhoods","C4_CGN_229_GCM_FANCC",119,-0.9341,0.6,0.82,0.7405,0.98,1,0.815,0.87,1
"GO_BP:492675_GO_0008366_AXON_ENSHEATHMENT","GO_BP","492675_GO_0008366_AXON_ENSHEATHMENT",89,-0.9341,0.59,0.72,-0.7823,0.91,1,-0.8586,0.8,0.96
"KEGG_pathway:HSA00061_FATTY_ACID_BIOSYNTHESIS","KEGG_pathway","HSA00061_FATTY_ACID_BIOSYNTHESIS",13,-0.9338,0.55,0.63,-0.4711,1,1,-0.8467,0.68,0.9
"GO_MF:486683_GO_0000149_SNARE_BINDING","GO_MF","486683_GO_0000149_SNARE_BINDING",116,-0.9336,0.6,0.75,0.8519,0.83,1,-0.9387,0.6,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_545_DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_545_DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN",170,-0.9336,0.63,0.68,-0.8272,0.88,1,-0.9301,0.64,0.84
"GO_BP:489093_GO_0003301_PHYSIOLOGICAL_CARDIAC_MUSCLE_HYPERTROPHY","GO_BP","489093_GO_0003301_PHYSIOLOGICAL_CARDIAC_MUSCLE_HYPERTROPHY",6,-0.9336,0.56,0.72,1.6221,0.025,0.27,0.8179,0.7,1
"GO_CC:496425_GO_0016442_RISC_COMPLEX","GO_CC","496425_GO_0016442_RISC_COMPLEX",11,-0.9336,0.54,0.81,-0.8596,0.66,0.95,-1.0374,0.42,0.98
"C1_Positional:C1_ALL_321_CHR11P13","C1_Positional","C1_ALL_321_CHR11P13",39,-0.9334,0.55,0.92,0.737,0.9,0.99,0.6212,0.98,0.98
"GO_BP:505632_GO_0042501_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN","GO_BP","505632_GO_0042501_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN",5,-0.9333,0.57,0.72,-1.1391,0.35,0.93,-1.4592,0.078,0.54
"GO_BP:507429_GO_0045022_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT","GO_BP","507429_GO_0045022_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT",20,-0.9333,0.56,0.72,-0.6321,0.94,1,-0.9348,0.54,0.9
"C3_TF_targets:C3_TFT_37_V_IRF2_01","C3_TF_targets","C3_TFT_37_V_IRF2_01",123,-0.9332,0.62,0.71,0.7871,0.94,1,-1.2357,0.097,0.3
"GO_BP:494571_GO_0010501_RNA_SECONDARY_STRUCTURE_UNWINDING","GO_BP","494571_GO_0010501_RNA_SECONDARY_STRUCTURE_UNWINDING",7,-0.9332,0.56,0.72,-1.2836,0.17,0.89,-0.8439,0.64,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_578_ABDULRAHMAN_KIDNEY_CANCER_VHL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_578_ABDULRAHMAN_KIDNEY_CANCER_VHL_DN",14,-0.9332,0.56,0.68,0.968,0.49,0.84,-1.0334,0.41,0.71
"GO_BP:498515_GO_0019692_DEOXYRIBOSE_PHOSPHATE_METABOLIC_PROCESS","GO_BP","498515_GO_0019692_DEOXYRIBOSE_PHOSPHATE_METABOLIC_PROCESS",32,-0.9332,0.57,0.72,1.4078,0.073,0.55,-1.4948,0.03,0.54
"GO_BP:494864_GO_0010799_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION","GO_BP","494864_GO_0010799_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION",29,-0.9331,0.58,0.72,1.4314,0.042,0.52,1.3405,0.095,0.65
"C7_Immunologic_signatures:C7_ALL_259_GSE14308_TH1_VS_NATURAL_TREG_UP","C7_Immunologic_signatures","C7_ALL_259_GSE14308_TH1_VS_NATURAL_TREG_UP",191,-0.933,0.64,0.72,1.2339,0.06,0.18,-0.8521,0.88,1
"C6_Oncogenic_signatures:C6_ALL_5_EGFR_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_5_EGFR_UP_V1_DN",191,-0.933,0.62,0.65,0.8273,0.91,1,-1.0469,0.33,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_2134_KANG_CISPLATIN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2134_KANG_CISPLATIN_RESISTANCE_DN",8,-0.9329,0.55,0.68,1.3811,0.12,0.31,0.6941,0.84,1
"GO_BP:492330_GO_0007588_EXCRETION","GO_BP","492330_GO_0007588_EXCRETION",48,-0.9329,0.58,0.72,-1.2942,0.11,0.88,1.4134,0.049,0.62
"GO_BP:502757_GO_0033539_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE","GO_BP","502757_GO_0033539_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE",6,-0.9328,0.58,0.72,0.9113,0.57,1,-1.4558,0.065,0.55
"GO_BP:489411_GO_0006606_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","489411_GO_0006606_PROTEIN_IMPORT_INTO_NUCLEUS",94,-0.9328,0.61,0.72,0.7724,0.94,1,-1.0191,0.39,0.83
"GO_BP:500401_GO_0031114_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION","GO_BP","500401_GO_0031114_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION",25,-0.9327,0.54,0.72,0.8829,0.65,1,-0.7723,0.81,1
"GO_CC:515314_GO_0070382_EXOCYTIC_VESICLE","GO_CC","515314_GO_0070382_EXOCYTIC_VESICLE",10,-0.9326,0.52,0.81,1.0098,0.45,0.77,0.9112,0.59,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2712_BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2712_BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN",19,-0.9326,0.58,0.68,1.0745,0.34,0.67,0.9153,0.57,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3115_WIERENGA_PML_INTERACTOME","C2_Chemical_and_genetic_perturbations","C2_CGP_3115_WIERENGA_PML_INTERACTOME",41,-0.9326,0.57,0.68,1.8627,0,0.026,-0.7261,0.93,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2975_ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN","C2_Chemical_and_genetic_perturbations","C2_CGP_2975_ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN",17,-0.9325,0.55,0.68,-0.66,0.93,1,-0.8733,0.65,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_2335_MATZUK_SPERMATOCYTE","C2_Chemical_and_genetic_perturbations","C2_CGP_2335_MATZUK_SPERMATOCYTE",69,-0.9324,0.58,0.68,-1.2696,0.097,0.71,-0.99,0.46,0.77
"KEGG_compound:C01074_N_ACETYLGALACTOSAMINE_N_ACETYLCHONDROSAMINE_2_ACETAMIDO_2_DEOXYGALACTOSE_GALNAC","KEGG_compound","C01074_N_ACETYLGALACTOSAMINE_N_ACETYLCHONDROSAMINE_2_ACETAMIDO_2_DEOXYGALACTOSE_GALNAC",5,-0.9324,0.58,0.69,0.7344,0.81,1,-1.1255,0.35,0.52
"GO_BP:516926_GO_0072007_MESANGIAL_CELL_DIFFERENTIATION","GO_BP","516926_GO_0072007_MESANGIAL_CELL_DIFFERENTIATION",6,-0.9324,0.56,0.72,0.5145,0.98,1,0.5048,0.98,1
"GO_BP:505174_GO_0040016_EMBRYONIC_CLEAVAGE","GO_BP","505174_GO_0040016_EMBRYONIC_CLEAVAGE",7,-0.9323,0.53,0.72,0.9451,0.53,1,-0.6147,0.92,1
"C7_Immunologic_signatures:C7_ALL_1162_GSE27786_LIN_NEG_VS_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1162_GSE27786_LIN_NEG_VS_BCELL_DN",197,-0.9323,0.65,0.72,1.1345,0.16,0.35,-1.0189,0.41,0.69
"REACTOME:1183594_REACT_355252_RHO_GTPASES_ACTIVATE_FORMINS","REACTOME","1183594_REACT_355252_RHO_GTPASES_ACTIVATE_FORMINS",114,-0.9322,0.61,0.74,1.1221,0.2,0.55,-1.0854,0.29,0.72
"GO_BP:1184481_GO_1903955_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION","GO_BP","1184481_GO_1903955_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION",66,-0.9322,0.6,0.72,1.4145,0.043,0.54,-0.6281,1,1
"GO_MF:496797_GO_0016917_GABA_RECEPTOR_ACTIVITY","GO_MF","496797_GO_0016917_GABA_RECEPTOR_ACTIVITY",20,-0.932,0.57,0.75,-1.3141,0.12,0.74,1.427,0.079,0.52
"GO_MF:496689_GO_0016780_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS","GO_MF","496689_GO_0016780_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS",17,-0.932,0.56,0.75,0.8538,0.67,1,-0.6765,0.92,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_155_BIOCARTA_EIF4_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_155_BIOCARTA_EIF4_PATHWAY",24,-0.932,0.58,0.67,0.8693,0.65,0.92,-1.0055,0.45,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_1895_BROWNE_HCMV_INFECTION_12HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1895_BROWNE_HCMV_INFECTION_12HR_UP",108,-0.932,0.59,0.68,-0.6491,1,1,-0.8811,0.75,0.9
"GO_BP:982420_GO_1902850_MICROTUBULE_CYTOSKELETON_ORGANIZATION_INVOLVED_IN_MITOSIS","GO_BP","982420_GO_1902850_MICROTUBULE_CYTOSKELETON_ORGANIZATION_INVOLVED_IN_MITOSIS",34,-0.9316,0.58,0.72,1.037,0.36,0.96,-1.1413,0.27,0.75
"C7_Immunologic_signatures:C7_ALL_257_GSE14308_TH1_VS_INDUCED_TREG_UP","C7_Immunologic_signatures","C7_ALL_257_GSE14308_TH1_VS_INDUCED_TREG_UP",195,-0.9315,0.63,0.72,1.199,0.1,0.23,-0.8568,0.89,1
"GO_MF:506385_GO_0043325_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING","GO_MF","506385_GO_0043325_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING",21,-0.9315,0.57,0.75,-0.8222,0.73,1,-1.3715,0.084,0.52
"GO_BP:499168_GO_0021889_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION","GO_BP","499168_GO_0021889_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION",14,-0.9314,0.56,0.72,1.0696,0.38,0.93,1.5068,0.06,0.55
"GO_CC:490876_GO_0005865_STRIATED_MUSCLE_THIN_FILAMENT","GO_CC","490876_GO_0005865_STRIATED_MUSCLE_THIN_FILAMENT",22,-0.9312,0.56,0.81,-1.193,0.23,0.68,-1.3612,0.09,0.62
"GO_BP:516573_GO_0071649_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION","GO_BP","516573_GO_0071649_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION",6,-0.9312,0.54,0.73,-0.5738,0.94,1,1.1316,0.32,0.74
"C1_Positional:C1_ALL_317_CHR8P22","C1_Positional","C1_ALL_317_CHR8P22",35,-0.9309,0.55,0.92,1.5385,0.022,0.29,1.9347,0,0.017
"KEGG_compound:C00091_SUCCINYL_COA_SUCCINYL_COENZYME_A","KEGG_compound","C00091_SUCCINYL_COA_SUCCINYL_COENZYME_A",15,-0.9309,0.55,0.69,1.0919,0.34,1,-1.4145,0.074,0.27
"GO_BP:516807_GO_0071887_LEUKOCYTE_APOPTOTIC_PROCESS","GO_BP","516807_GO_0071887_LEUKOCYTE_APOPTOTIC_PROCESS",24,-0.9308,0.56,0.73,1.2311,0.19,0.75,1.0036,0.45,0.85
"C7_Immunologic_signatures:C7_ALL_344_GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN","C7_Immunologic_signatures","C7_ALL_344_GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN",198,-0.9308,0.62,0.72,0.9233,0.67,0.97,0.5621,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2125_KONDO_COLON_CANCER_HCP_WITH_H3K27ME1","C2_Chemical_and_genetic_perturbations","C2_CGP_2125_KONDO_COLON_CANCER_HCP_WITH_H3K27ME1",25,-0.9307,0.56,0.68,-0.8136,0.73,1,0.8703,0.66,1
"GO_BP:519280_GO_2000641_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT","GO_BP","519280_GO_2000641_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT",12,-0.9307,0.56,0.73,0.7743,0.78,1,0.6845,0.87,1
"GO_BP:510796_GO_0048742_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT","GO_BP","510796_GO_0048742_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT",11,-0.9307,0.56,0.73,0.9364,0.53,1,-1.5297,0.04,0.52
"GO_BP:492041_GO_0007262_STAT_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","492041_GO_0007262_STAT_PROTEIN_IMPORT_INTO_NUCLEUS",5,-0.9306,0.57,0.73,1.1882,0.26,0.79,-0.9393,0.53,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1710_JIANG_VHL_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1710_JIANG_VHL_TARGETS",138,-0.9306,0.6,0.68,1.5829,0,0.15,-1.1048,0.24,0.62
"GO_BP:488638_GO_0002765_IMMUNE_RESPONSE_INHIBITING_SIGNAL_TRANSDUCTION","GO_BP","488638_GO_0002765_IMMUNE_RESPONSE_INHIBITING_SIGNAL_TRANSDUCTION",6,-0.9306,0.56,0.73,-0.9251,0.57,1,-0.5495,0.97,1
"KEGG_compound:C00015_UDP_URIDINE_5_DIPHOSPHATE","KEGG_compound","C00015_UDP_URIDINE_5_DIPHOSPHATE",62,-0.9305,0.58,0.69,1.207,0.16,0.86,0.9998,0.42,0.7
"GO_BP:496945_GO_0017148_NEGATIVE_REGULATION_OF_TRANSLATION","GO_BP","496945_GO_0017148_NEGATIVE_REGULATION_OF_TRANSLATION",76,-0.9305,0.6,0.73,1.0016,0.43,0.98,-1.1719,0.17,0.74
"GO_BP:514287_GO_0060732_POSITIVE_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","514287_GO_0060732_POSITIVE_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS",9,-0.9305,0.55,0.73,1.6267,0.021,0.26,1.5471,0.044,0.52
"C7_Immunologic_signatures:C7_ALL_822_GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_822_GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN",199,-0.9303,0.63,0.72,1.0905,0.22,0.47,-1.5723,0.0021,0.0083
"C7_Immunologic_signatures:C7_ALL_303_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP","C7_Immunologic_signatures","C7_ALL_303_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP",200,-0.9302,0.61,0.72,1.8324,0,0,-1.1713,0.11,0.34
"C3_TF_targets:C3_TFT_247_V_E2F_Q3","C3_TF_targets","C3_TFT_247_V_E2F_Q3",226,-0.9302,0.65,0.72,0.705,1,1,-1.4358,0.0022,0.3
"GO_BP:497859_GO_0018963_PHTHALATE_METABOLIC_PROCESS","GO_BP","497859_GO_0018963_PHTHALATE_METABOLIC_PROCESS",6,-0.9301,0.57,0.73,1.3938,0.1,0.56,1.5381,0.046,0.53
"C3_MicroRNA_targets:C3_MIR_145_CTCCAAG_MIR_432","C3_MicroRNA_targets","C3_MIR_145_CTCCAAG_MIR_432",83,-0.9301,0.6,0.73,-1.0102,0.42,1,0.8949,0.68,1
"GO_MF:492676_GO_0008373_SIALYLTRANSFERASE_ACTIVITY","GO_MF","492676_GO_0008373_SIALYLTRANSFERASE_ACTIVITY",20,-0.9299,0.56,0.76,0.5774,0.99,1,0.8229,0.71,1
"C7_Immunologic_signatures:C7_ALL_636_GSE17721_PAM3CSK4_VS_GADIQUIMOD_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_636_GSE17721_PAM3CSK4_VS_GADIQUIMOD_0_5H_BMDM_DN",198,-0.9299,0.63,0.72,0.967,0.54,0.84,-1.0944,0.21,0.51
"GO_BP:491437_GO_0006541_GLUTAMINE_METABOLIC_PROCESS","GO_BP","491437_GO_0006541_GLUTAMINE_METABOLIC_PROCESS",23,-0.9299,0.57,0.73,-1.3536,0.11,0.95,-1.5693,0.019,0.52
"REACTOME:1127503_REACT_267965_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE","REACTOME","1127503_REACT_267965_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE",89,-0.9298,0.59,0.74,-0.8813,0.73,1,-1.8796,0.0021,0.14
"C2_Chemical_and_genetic_perturbations:C2_CGP_866_JAZAG_TGFB1_SIGNALING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_866_JAZAG_TGFB1_SIGNALING_DN",34,-0.9298,0.57,0.68,0.8701,0.7,0.96,-1.2119,0.19,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_1338_PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1338_PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP",19,-0.9297,0.56,0.68,1.4545,0.072,0.25,-0.9992,0.44,0.76
"GO_CC:505893_GO_0042788_POLYSOMAL_RIBOSOME","GO_CC","505893_GO_0042788_POLYSOMAL_RIBOSOME",6,-0.9297,0.56,0.81,0.8698,0.59,0.91,-0.5376,0.97,1
"GO_BP:497169_GO_0018198_PEPTIDYL_CYSTEINE_MODIFICATION","GO_BP","497169_GO_0018198_PEPTIDYL_CYSTEINE_MODIFICATION",17,-0.9296,0.56,0.73,1.2456,0.18,0.74,-0.7363,0.84,1
"C4_Cancer_gene_neighborhoods:C4_CGN_17_MORF_FDXR","C4_Cancer_gene_neighborhoods","C4_CGN_17_MORF_FDXR",220,-0.9295,0.64,0.83,-0.8586,0.85,1,-1.1807,0.091,0.46
"GO_MF:1039900_GO_0090599_ALPHA_GLUCOSIDASE_ACTIVITY","GO_MF","1039900_GO_0090599_ALPHA_GLUCOSIDASE_ACTIVITY",6,-0.9295,0.54,0.76,-0.5886,0.94,1,-0.8174,0.71,0.96
"GO_BP:514597_GO_0061049_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT","GO_BP","514597_GO_0061049_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT",6,-0.9294,0.55,0.73,1.6377,0.014,0.25,0.8184,0.7,1
"WikiPathways:198774_WP366_TGF_BETA_RECEPTOR_SIGNALING_PATHWAY","WikiPathways","198774_WP366_TGF_BETA_RECEPTOR_SIGNALING_PATHWAY",154,-0.9293,0.63,0.68,1.0529,0.3,1,-0.8493,0.85,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_463_CAIRO_PML_TARGETS_BOUND_BY_MYC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_463_CAIRO_PML_TARGETS_BOUND_BY_MYC_UP",23,-0.9293,0.58,0.68,1.1492,0.27,0.56,-0.6822,0.91,0.99
"C3_MicroRNA_targets:C3_MIR_80_GTCAACC_MIR_380_5P","C3_MicroRNA_targets","C3_MIR_80_GTCAACC_MIR_380_5P",22,-0.9293,0.57,0.73,-0.6901,0.91,1,1.3106,0.13,1
"GO_BP:499592_GO_0030174_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION_INITIATION","GO_BP","499592_GO_0030174_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION_INITIATION",6,-0.9293,0.56,0.73,0.6168,0.92,1,-0.5744,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1045_WOTTON_RUNX_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1045_WOTTON_RUNX_TARGETS_UP",21,-0.9292,0.58,0.68,1.126,0.31,0.59,1.492,0.043,0.47
"REACTOME:833797_REACT_163914_FERTILIZATION","REACTOME","833797_REACT_163914_FERTILIZATION",22,-0.9289,0.56,0.74,-1.0904,0.33,0.9,1.0711,0.35,0.94
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_105_BIOCARTA_GLEEVEC_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_105_BIOCARTA_GLEEVEC_PATHWAY",23,-0.9289,0.58,0.67,0.6691,0.92,1,-0.8888,0.63,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_3335_KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES","C2_Chemical_and_genetic_perturbations","C2_CGP_3335_KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES",267,-0.9286,0.65,0.68,1.2573,0.03,0.43,1.1091,0.18,0.88
"C7_Immunologic_signatures:C7_ALL_528_GSE17721_LPS_VS_POLYIC_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_528_GSE17721_LPS_VS_POLYIC_0_5H_BMDM_DN",190,-0.9285,0.63,0.73,0.9267,0.68,0.96,0.8404,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1896_NIELSEN_SCHWANNOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1896_NIELSEN_SCHWANNOMA_UP",18,-0.9284,0.55,0.68,-1.05,0.4,0.97,-0.9704,0.48,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_880_WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_880_WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP",72,-0.9284,0.58,0.68,-0.9177,0.63,1,-1.1085,0.26,0.62
"OMIM_gene:OMIM605631_NAPSIN_A_NAPSA","OMIM_gene","OMIM605631_NAPSIN_A_NAPSA",9,-0.9283,0.56,0.8,0.597,0.95,1,-1.0453,0.42,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1494_HALMOS_CEBPA_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1494_HALMOS_CEBPA_TARGETS_DN",46,-0.9282,0.58,0.68,1.1451,0.24,0.56,0.771,0.9,1
"GO_BP:516428_GO_0071504_CELLULAR_RESPONSE_TO_HEPARIN","GO_BP","516428_GO_0071504_CELLULAR_RESPONSE_TO_HEPARIN",5,-0.9279,0.59,0.73,-1.8373,0,0.43,1.0375,0.43,0.82
"C7_Immunologic_signatures:C7_ALL_1703_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP","C7_Immunologic_signatures","C7_ALL_1703_GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP",194,-0.9278,0.64,0.73,-0.9728,0.52,1,-0.926,0.67,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_352_RODRIGUES_THYROID_CARCINOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_352_RODRIGUES_THYROID_CARCINOMA_UP",16,-0.9277,0.57,0.68,1.1301,0.28,0.58,-0.6846,0.89,0.99
"KEGG_compound:C05356_5_S_HPETE_5_S_HYDROPEROXY_6_TRANS_8_11_14_CIS_EICOSATETRAENOIC_ACID_6E_8Z_11Z_14Z_5S_5_HYDROPEROXYEICOSA_6_8_11_14_TETRAENOATE_6E_8Z_11Z_14Z_5S_5_HYDROPEROXYEICOSA_6_8_11_14_TETRAENOIC_ACID_5S_6E_8Z_11Z_14Z_5_HYDROPEROXYICOSA_6_8_11_14_TETRAENOATE","KEGG_compound","C05356_5_S_HPETE_5_S_HYDROPEROXY_6_TRANS_8_11_14_CIS_EICOSATETRAENOIC_ACID_6E_8Z_11Z_14Z_5S_5_HYDROPEROXYEICOSA_6_8_11_14_TETRAENOATE_6E_8Z_11Z_14Z_5S_5_HYDROPEROXYEICOSA_6_8_11_14_TETRAENOIC_ACID_5S_6E_8Z_11Z_14Z_5_HYDROPEROXYICOSA_6_8_11_14_TETRAENOATE",7,-0.9276,0.54,0.69,0.5822,0.94,1,1.5684,0.044,0.11
"GO_BP:518189_GO_0090045_POSITIVE_REGULATION_OF_DEACETYLASE_ACTIVITY","GO_BP","518189_GO_0090045_POSITIVE_REGULATION_OF_DEACETYLASE_ACTIVITY",6,-0.9275,0.56,0.73,-0.8408,0.65,1,0.5944,0.92,1
"GO_BP:513445_GO_0055012_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION","GO_BP","513445_GO_0055012_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION",20,-0.9275,0.57,0.73,-1.0423,0.4,0.98,0.8598,0.64,0.97
"C7_Immunologic_signatures:C7_ALL_1445_GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP","C7_Immunologic_signatures","C7_ALL_1445_GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP",198,-0.9273,0.63,0.73,1.0075,0.44,0.71,0.8759,0.81,1
"GO_BP:982256_GO_0044843_CELL_CYCLE_G1_S_PHASE_TRANSITION","GO_BP","982256_GO_0044843_CELL_CYCLE_G1_S_PHASE_TRANSITION",170,-0.9271,0.64,0.73,1.5907,0,0.3,-1.1892,0.093,0.74
"GO_CC:490334_GO_0005778_PEROXISOMAL_MEMBRANE","GO_CC","490334_GO_0005778_PEROXISOMAL_MEMBRANE",54,-0.927,0.59,0.82,0.9483,0.57,0.83,-0.9882,0.46,1
"GO_CC:516489_GO_0071565_NBAF_COMPLEX","GO_CC","516489_GO_0071565_NBAF_COMPLEX",13,-0.9269,0.56,0.81,-1.2294,0.21,0.64,-1.674,0.024,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_454_GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_454_GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN",9,-0.9268,0.55,0.68,0.6455,0.91,1,0.7554,0.75,1
"C7_Immunologic_signatures:C7_ALL_1537_GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1537_GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP",182,-0.9268,0.64,0.73,-1.0666,0.3,1,1.0421,0.34,1
"GO_BP:488507_GO_0002634_REGULATION_OF_GERMINAL_CENTER_FORMATION","GO_BP","488507_GO_0002634_REGULATION_OF_GERMINAL_CENTER_FORMATION",9,-0.9268,0.55,0.73,-1.6455,0.029,0.7,-1.0692,0.37,0.8
"GO_BP:486605_GO_0000060_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION","GO_BP","486605_GO_0000060_PROTEIN_IMPORT_INTO_NUCLEUS_TRANSLOCATION",24,-0.9266,0.56,0.73,-1.2099,0.21,0.88,-1.1487,0.26,0.74
"GO_MF:515233_GO_0070300_PHOSPHATIDIC_ACID_BINDING","GO_MF","515233_GO_0070300_PHOSPHATIDIC_ACID_BINDING",10,-0.9266,0.56,0.76,-0.5905,0.93,1,-0.9261,0.54,0.85
"KEGG_compound:C01120_SPHINGANINE_1_PHOSPHATE_DIHYDROSPHINGOSINE_1_PHOSPHATE","KEGG_compound","C01120_SPHINGANINE_1_PHOSPHATE_DIHYDROSPHINGOSINE_1_PHOSPHATE",8,-0.9266,0.57,0.69,0.8927,0.6,1,1.0828,0.37,0.65
"C3_MicroRNA_targets:C3_MIR_45_ACACTGG_MIR_199A_MIR_199B","C3_MicroRNA_targets","C3_MIR_45_ACACTGG_MIR_199A_MIR_199B",157,-0.9265,0.62,0.73,0.774,0.96,1,1.2851,0.048,1
"C7_Immunologic_signatures:C7_ALL_177_GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP","C7_Immunologic_signatures","C7_ALL_177_GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP",198,-0.9265,0.64,0.73,-0.6678,1,1,-1.7881,0,0.00018
"KEGG_reaction:R07034_GLUTATHIONE_5_HPETE_OXIDOREDUCTASE_2_GLUTATHIONE_5_S_HPETE_GLUTATHIONE_DISULFIDE_5_S_HETE_H2O","KEGG_reaction","R07034_GLUTATHIONE_5_HPETE_OXIDOREDUCTASE_2_GLUTATHIONE_5_S_HPETE_GLUTATHIONE_DISULFIDE_5_S_HETE_H2O",6,-0.9264,0.57,0.71,0.5318,0.98,0.99,1.5272,0.041,0.12
"GO_MF:496584_GO_0016645_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS","GO_MF","496584_GO_0016645_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS",25,-0.9263,0.57,0.76,-0.7461,0.86,1,0.7798,0.8,1
"GO_MF:502484_GO_0033265_CHOLINE_BINDING","GO_MF","502484_GO_0033265_CHOLINE_BINDING",5,-0.9262,0.6,0.76,-1.1579,0.33,0.81,0.625,0.93,1
"GO_CC:486748_GO_0000228_NUCLEAR_CHROMOSOME","GO_CC","486748_GO_0000228_NUCLEAR_CHROMOSOME",426,-0.9261,0.7,0.81,-1.1576,0.092,0.68,-1.5331,0,0.48
"REACTOME:833796_REACT_163848_REPRODUCTION","REACTOME","833796_REACT_163848_REPRODUCTION",22,-0.926,0.57,0.75,-1.0955,0.34,0.91,1.0899,0.35,0.95
"GO_BP:516406_GO_0071482_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS","GO_BP","516406_GO_0071482_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS",92,-0.9259,0.61,0.73,-0.6414,0.99,1,-1.1991,0.14,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_3336_KUMAR_AUTOPHAGY_NETWORK","C2_Chemical_and_genetic_perturbations","C2_CGP_3336_KUMAR_AUTOPHAGY_NETWORK",71,-0.9258,0.6,0.69,0.9176,0.65,0.9,0.8095,0.85,1
"GO_BP:508244_GO_0045938_POSITIVE_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP","GO_BP","508244_GO_0045938_POSITIVE_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP",6,-0.9257,0.56,0.73,1.351,0.12,0.61,1.3259,0.16,0.65
"GO_BP:492357_GO_0007616_LONG_TERM_MEMORY","GO_BP","492357_GO_0007616_LONG_TERM_MEMORY",27,-0.9255,0.57,0.73,-1.3233,0.1,0.88,-0.8381,0.73,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2761_YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2761_YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN",62,-0.9255,0.6,0.69,-0.8861,0.68,1,0.8669,0.71,1
"C4_Cancer_gene_neighborhoods:C4_CGN_166_MORF_RAB6A","C4_Cancer_gene_neighborhoods","C4_CGN_166_MORF_RAB6A",68,-0.9254,0.6,0.84,1.6724,0,0.008,-0.9682,0.51,0.91
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_90_BIOCARTA_IGF1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_90_BIOCARTA_IGF1_PATHWAY",21,-0.9252,0.55,0.67,0.7937,0.75,0.98,1.2501,0.18,1
"C1_Positional:C1_ALL_238_CHR1P36","C1_Positional","C1_ALL_238_CHR1P36",362,-0.9251,0.7,0.93,-0.8777,0.86,1,-0.8493,0.94,0.97
"GO_CC:507402_GO_0044454_NUCLEAR_CHROMOSOME_PART","GO_CC","507402_GO_0044454_NUCLEAR_CHROMOSOME_PART",375,-0.9249,0.7,0.81,-1.1958,0.056,0.7,-1.5339,0,0.5
"GO_BP:500476_GO_0031214_BIOMINERAL_TISSUE_DEVELOPMENT","GO_BP","500476_GO_0031214_BIOMINERAL_TISSUE_DEVELOPMENT",67,-0.9249,0.61,0.73,-1.0119,0.42,0.98,1.1259,0.25,0.74
"GO_BP:486622_GO_0000082_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","486622_GO_0000082_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",169,-0.9246,0.63,0.74,1.6013,0,0.29,-1.1876,0.085,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1704_VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1704_VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP",15,-0.9246,0.56,0.69,0.7613,0.81,1,-1.4501,0.065,0.32
"GO_MF:492628_GO_0008308_VOLTAGE_GATED_ANION_CHANNEL_ACTIVITY","GO_MF","492628_GO_0008308_VOLTAGE_GATED_ANION_CHANNEL_ACTIVITY",15,-0.9244,0.57,0.76,-0.6773,0.89,1,-1.3405,0.12,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_3060_CHICAS_RB1_TARGETS_LOW_SERUM","C2_Chemical_and_genetic_perturbations","C2_CGP_3060_CHICAS_RB1_TARGETS_LOW_SERUM",96,-0.9241,0.6,0.69,1.9891,0,0.0073,0.8804,0.73,1
"GO_BP:510608_GO_0048539_BONE_MARROW_DEVELOPMENT","GO_BP","510608_GO_0048539_BONE_MARROW_DEVELOPMENT",6,-0.924,0.57,0.74,0.7124,0.83,1,0.7065,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2393_LIN_NPAS4_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2393_LIN_NPAS4_TARGETS_UP",160,-0.9239,0.63,0.69,1.4044,0.0071,0.29,-0.8872,0.79,0.9
"GO_BP:502365_GO_0033144_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","502365_GO_0033144_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY",32,-0.9238,0.58,0.74,-0.8403,0.72,1,0.8626,0.69,0.97
"GO_CC:501808_GO_0032580_GOLGI_CISTERNA_MEMBRANE","GO_CC","501808_GO_0032580_GOLGI_CISTERNA_MEMBRANE",74,-0.9238,0.6,0.82,0.869,0.74,0.91,0.7501,0.91,1
"GO_BP:514532_GO_0060977_CORONARY_VASCULATURE_MORPHOGENESIS","GO_BP","514532_GO_0060977_CORONARY_VASCULATURE_MORPHOGENESIS",10,-0.9238,0.56,0.74,-0.6355,0.93,1,-0.692,0.86,0.99
"GO_BP:499866_GO_0030539_MALE_GENITALIA_DEVELOPMENT","GO_BP","499866_GO_0030539_MALE_GENITALIA_DEVELOPMENT",20,-0.9238,0.56,0.74,0.83,0.71,1,1.1114,0.32,0.75
"GO_BP:493309_GO_0009110_VITAMIN_BIOSYNTHETIC_PROCESS","GO_BP","493309_GO_0009110_VITAMIN_BIOSYNTHETIC_PROCESS",23,-0.9237,0.56,0.74,0.8581,0.67,1,1.0257,0.42,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1531_STAEGE_EWING_FAMILY_TUMOR","C2_Chemical_and_genetic_perturbations","C2_CGP_1531_STAEGE_EWING_FAMILY_TUMOR",32,-0.9233,0.58,0.69,-0.6928,0.92,1,1.665,0.012,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_587_RIZ_ERYTHROID_DIFFERENTIATION","C2_Chemical_and_genetic_perturbations","C2_CGP_587_RIZ_ERYTHROID_DIFFERENTIATION",77,-0.9233,0.62,0.69,1.0439,0.36,0.73,-1.0027,0.44,0.75
"GO_BP:861516_GO_1902373_NEGATIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS","GO_BP","861516_GO_1902373_NEGATIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS",5,-0.9232,0.56,0.74,0.4686,0.99,1,-0.9321,0.57,0.9
"GO_BP:753146_GO_1900151_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY","GO_BP","753146_GO_1900151_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY",14,-0.9232,0.58,0.74,-0.8453,0.65,1,-1.0218,0.41,0.83
"C7_Immunologic_signatures:C7_ALL_1852_GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1852_GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN",186,-0.9232,0.64,0.74,1.1624,0.11,0.3,1.2821,0.045,0.42
"C1_Positional:C1_ALL_132_CHR15Q13","C1_Positional","C1_ALL_132_CHR15Q13",46,-0.9231,0.58,0.93,-1.0277,0.4,1,-0.9788,0.49,0.94
"KEGG_compound:C00526_DEOXYURIDINE_2_DEOXYURIDINE_2_DEOXYURIDINE","KEGG_compound","C00526_DEOXYURIDINE_2_DEOXYURIDINE_2_DEOXYURIDINE",17,-0.923,0.58,0.7,-0.4983,0.99,1,-0.6694,0.91,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1958_LEE_CALORIE_RESTRICTION_MUSCLE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1958_LEE_CALORIE_RESTRICTION_MUSCLE_DN",49,-0.9229,0.6,0.69,0.9784,0.51,0.82,-1.1056,0.28,0.62
"GO_BP:498774_GO_0020027_HEMOGLOBIN_METABOLIC_PROCESS","GO_BP","498774_GO_0020027_HEMOGLOBIN_METABOLIC_PROCESS",12,-0.9229,0.55,0.74,1.612,0.028,0.28,-1.2257,0.19,0.71
"GO_BP:500245_GO_0030952_ESTABLISHMENT_OR_MAINTENANCE_OF_CYTOSKELETON_POLARITY","GO_BP","500245_GO_0030952_ESTABLISHMENT_OR_MAINTENANCE_OF_CYTOSKELETON_POLARITY",5,-0.9228,0.55,0.74,-0.6084,0.92,1,0.72,0.78,1
"KEGG_reaction:R03362_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHOTRANSFERASE_ATP_1_PHOSPHATIDYL_D_MYO_INOSITOL_ADP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHATE","KEGG_reaction","R03362_ATP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHOTRANSFERASE_ATP_1_PHOSPHATIDYL_D_MYO_INOSITOL_ADP_1_PHOSPHATIDYL_1D_MYO_INOSITOL_3_PHOSPHATE",5,-0.9226,0.58,0.71,-0.7963,0.71,1,-0.8525,0.64,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_3032_NOUSHMEHR_GBM_SOMATIC_MUTATED","C2_Chemical_and_genetic_perturbations","C2_CGP_3032_NOUSHMEHR_GBM_SOMATIC_MUTATED",9,-0.9225,0.58,0.69,-0.7314,0.8,1,-1.0755,0.37,0.66
"GO_BP:499707_GO_0030307_POSITIVE_REGULATION_OF_CELL_GROWTH","GO_BP","499707_GO_0030307_POSITIVE_REGULATION_OF_CELL_GROWTH",112,-0.9225,0.64,0.74,0.6984,1,1,0.8624,0.77,0.97
"GO_BP:750919_GO_0035994_RESPONSE_TO_MUSCLE_STRETCH","GO_BP","750919_GO_0035994_RESPONSE_TO_MUSCLE_STRETCH",10,-0.9225,0.54,0.74,-1.3801,0.096,1,0.8528,0.66,0.98
"KEGG_reaction:R07824_G13043_H2O_DWA_2_N_ACETYLGALACTOSAMINE","KEGG_reaction","R07824_G13043_H2O_DWA_2_N_ACETYLGALACTOSAMINE",5,-0.9223,0.59,0.7,0.7394,0.78,1,-1.1396,0.33,0.45
"C7_Immunologic_signatures:C7_ALL_311_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP","C7_Immunologic_signatures","C7_ALL_311_GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP",200,-0.9222,0.66,0.74,1.2319,0.065,0.18,-0.9679,0.58,0.8
"GO_BP:494938_GO_0010874_REGULATION_OF_CHOLESTEROL_EFFLUX","GO_BP","494938_GO_0010874_REGULATION_OF_CHOLESTEROL_EFFLUX",18,-0.922,0.59,0.74,1.1775,0.23,0.81,0.6776,0.91,1
"REACTOME:187216_REACT_25218_HUR_STABILIZES_MRNA","REACTOME","187216_REACT_25218_HUR_STABILIZES_MRNA",8,-0.9219,0.56,0.75,-0.8832,0.59,1,-1.2715,0.19,0.55
"GO_MF:509664_GO_0047485_PROTEIN_N_TERMINUS_BINDING","GO_MF","509664_GO_0047485_PROTEIN_N_TERMINUS_BINDING",93,-0.9218,0.61,0.77,1.3871,0.023,0.48,-1.1023,0.25,0.7
"KEGG_compound:C00002_ATP_ADENOSINE_5_TRIPHOSPHATE","KEGG_compound","C00002_ATP_ADENOSINE_5_TRIPHOSPHATE",292,-0.9218,0.7,0.7,-0.6324,1,1,-1.3665,0.0087,0.31
"GO_BP:508383_GO_0046087_CYTIDINE_METABOLIC_PROCESS","GO_BP","508383_GO_0046087_CYTIDINE_METABOLIC_PROCESS",9,-0.9218,0.58,0.74,0.8101,0.69,1,-0.9747,0.49,0.88
"GO_BP:494730_GO_0010667_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","494730_GO_0010667_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_APOPTOTIC_PROCESS",8,-0.9217,0.54,0.74,-0.8666,0.62,1,-1,0.46,0.85
"REACTOME:119546_REACT_19400_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS","REACTOME","119546_REACT_19400_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS",54,-0.9215,0.58,0.75,1.1697,0.21,0.48,-0.5692,1,1
"GO_BP:508074_GO_0045732_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS","GO_BP","508074_GO_0045732_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS",216,-0.9215,0.67,0.74,1.3212,0.0048,0.64,-1.0943,0.23,0.78
"REACTOME:1127614_REACT_264125_SIGNALING_BY_WNT_IN_CANCER","REACTOME","1127614_REACT_264125_SIGNALING_BY_WNT_IN_CANCER",34,-0.9215,0.59,0.75,-0.8314,0.76,1,0.9688,0.49,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2984_RUAN_RESPONSE_TO_TROGLITAZONE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2984_RUAN_RESPONSE_TO_TROGLITAZONE_DN",18,-0.9214,0.56,0.69,1.2497,0.21,0.44,0.8979,0.6,1
"GO_BP:491473_GO_0006577_AMINO_ACID_BETAINE_METABOLIC_PROCESS","GO_BP","491473_GO_0006577_AMINO_ACID_BETAINE_METABOLIC_PROCESS",17,-0.9213,0.56,0.74,-1.0663,0.37,0.96,-1.6465,0.02,0.52
"C2_Chemical_and_genetic_perturbations:C2_CGP_1754_DAZARD_RESPONSE_TO_UV_SCC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1754_DAZARD_RESPONSE_TO_UV_SCC_DN",123,-0.9213,0.59,0.69,1.0313,0.38,0.75,0.882,0.77,1
"C7_Immunologic_signatures:C7_ALL_1063_GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP","C7_Immunologic_signatures","C7_ALL_1063_GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP",200,-0.9212,0.66,0.74,1.3429,0.019,0.067,-1.0579,0.3,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_300_SCIBETTA_KDM5B_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_300_SCIBETTA_KDM5B_TARGETS_UP",19,-0.9212,0.58,0.69,-0.7899,0.75,1,-1.0909,0.33,0.64
"GO_MF:490464_GO_0005222_INTRACELLULAR_CAMP_ACTIVATED_CATION_CHANNEL_ACTIVITY","GO_MF","490464_GO_0005222_INTRACELLULAR_CAMP_ACTIVATED_CATION_CHANNEL_ACTIVITY",8,-0.9211,0.57,0.77,1.1997,0.23,0.7,1.6633,0.01,0.24
"KEGG_reaction:R00274_GLUTATHIONE_HYDROGEN_PEROXIDE_OXIDOREDUCTASE_HYDROGEN_PEROXIDE_2_GLUTATHIONE_GLUTATHIONE_DISULFIDE_2_H2O","KEGG_reaction","R00274_GLUTATHIONE_HYDROGEN_PEROXIDE_OXIDOREDUCTASE_HYDROGEN_PEROXIDE_2_GLUTATHIONE_GLUTATHIONE_DISULFIDE_2_H2O",6,-0.921,0.59,0.69,0.5311,0.97,0.99,1.5776,0.047,0.089
"C1_Positional:C1_ALL_78_CHR22Q11","C1_Positional","C1_ALL_78_CHR22Q11",148,-0.9208,0.64,0.93,-1.0918,0.26,1,-1.3412,0.006,0.43
"GO_BP:501849_GO_0032623_INTERLEUKIN_2_PRODUCTION","GO_BP","501849_GO_0032623_INTERLEUKIN_2_PRODUCTION",7,-0.9208,0.54,0.74,0.7791,0.74,1,1.0854,0.35,0.77
"C7_Immunologic_signatures:C7_ALL_1235_GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1235_GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP",192,-0.9206,0.66,0.74,0.9759,0.49,0.82,-1.1595,0.13,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_1830_KANG_DOXORUBICIN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1830_KANG_DOXORUBICIN_RESISTANCE_DN",19,-0.9206,0.57,0.69,0.7633,0.8,1,0.6436,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2719_BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2719_BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP",45,-0.9205,0.59,0.69,1.1452,0.24,0.56,-1.4724,0.031,0.31
"GO_MF:500670_GO_0031419_COBALAMIN_BINDING","GO_MF","500670_GO_0031419_COBALAMIN_BINDING",9,-0.9203,0.58,0.77,0.6885,0.88,1,-1.0973,0.36,0.7
"GO_MF:490009_GO_0004689_PHOSPHORYLASE_KINASE_ACTIVITY","GO_MF","490009_GO_0004689_PHOSPHORYLASE_KINASE_ACTIVITY",5,-0.9202,0.57,0.77,-1.2833,0.16,0.81,-1.3801,0.099,0.51
"GO_BP:510627_GO_0048562_EMBRYONIC_ORGAN_MORPHOGENESIS","GO_BP","510627_GO_0048562_EMBRYONIC_ORGAN_MORPHOGENESIS",277,-0.9201,0.69,0.74,-0.9054,0.78,1,1.4571,0.0019,0.58
"GO_BP:501523_GO_0032288_MYELIN_ASSEMBLY","GO_BP","501523_GO_0032288_MYELIN_ASSEMBLY",19,-0.9201,0.59,0.74,-0.521,0.99,1,0.962,0.51,0.9
"KEGG_module:HSA_M00010_CITRATE_CYCLE_FIRST_CARBON_OXIDATION_OXALOACETATE_2_OXOGLUTARATE","KEGG_module","HSA_M00010_CITRATE_CYCLE_FIRST_CARBON_OXIDATION_OXALOACETATE_2_OXOGLUTARATE",8,-0.9201,0.57,0.75,0.9438,0.54,0.89,-1.3432,0.15,0.52
"GO_MF:499878_GO_0030552_CAMP_BINDING","GO_MF","499878_GO_0030552_CAMP_BINDING",24,-0.9198,0.59,0.77,1.1845,0.21,0.73,-1.1044,0.3,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_1516_ZHAN_MULTIPLE_MYELOMA_CD2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1516_ZHAN_MULTIPLE_MYELOMA_CD2_UP",45,-0.9198,0.6,0.69,1.1578,0.22,0.54,1.1825,0.2,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_1416_GRANDVAUX_IRF3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1416_GRANDVAUX_IRF3_TARGETS_DN",18,-0.9197,0.58,0.69,0.9562,0.54,0.86,0.818,0.73,1
"C7_Immunologic_signatures:C7_ALL_212_GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_212_GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN",196,-0.9196,0.66,0.75,1.6674,0,0.00097,-1.0315,0.34,0.66
"REACTOME:106377_REACT_18426_OPSINS","REACTOME","106377_REACT_18426_OPSINS",8,-0.9196,0.6,0.76,-1.5082,0.063,0.44,-1.6007,0.027,0.25
"GO_BP:512205_GO_0051321_MEIOTIC_CELL_CYCLE","GO_BP","512205_GO_0051321_MEIOTIC_CELL_CYCLE",161,-0.9195,0.65,0.74,-0.7963,0.94,1,-1.3251,0.024,0.63
"GO_BP:752173_GO_0061430_BONE_TRABECULA_MORPHOGENESIS","GO_BP","752173_GO_0061430_BONE_TRABECULA_MORPHOGENESIS",11,-0.9195,0.56,0.74,-1.0435,0.39,0.98,-0.7192,0.84,0.99
"GO_CC:499552_GO_0030120_VESICLE_COAT","GO_CC","499552_GO_0030120_VESICLE_COAT",47,-0.9193,0.6,0.82,1.1999,0.17,0.53,-0.8915,0.64,1
"GO_MF:512109_GO_0051213_DIOXYGENASE_ACTIVITY","GO_MF","512109_GO_0051213_DIOXYGENASE_ACTIVITY",87,-0.9193,0.64,0.77,-0.7154,0.97,1,-1.2574,0.098,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_3275_PLASARI_TGFB1_TARGETS_1HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3275_PLASARI_TGFB1_TARGETS_1HR_DN",6,-0.9192,0.57,0.7,1.3174,0.16,0.38,-0.6428,0.91,0.99
"GO_BP:505503_GO_0042359_VITAMIN_D_METABOLIC_PROCESS","GO_BP","505503_GO_0042359_VITAMIN_D_METABOLIC_PROCESS",11,-0.9189,0.56,0.74,-1.1485,0.3,0.93,1.1589,0.28,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_812_HEIDENBLAD_AMPLICON_12P11_12_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_812_HEIDENBLAD_AMPLICON_12P11_12_DN",30,-0.9189,0.6,0.7,-0.601,0.98,1,-1.0089,0.42,0.74
"GO_BP:494987_GO_0010923_NEGATIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY","GO_BP","494987_GO_0010923_NEGATIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY",65,-0.9189,0.61,0.74,-0.8984,0.65,1,1.0321,0.4,0.82
"WikiPathways:198764_WP1531_VITAMIN_D_SYNTHESIS","WikiPathways","198764_WP1531_VITAMIN_D_SYNTHESIS",7,-0.9188,0.57,0.7,-0.6087,0.92,1,0.7719,0.76,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_104_BIOCARTA_RACCYCD_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_104_BIOCARTA_RACCYCD_PATHWAY",26,-0.9187,0.58,0.68,0.6127,0.98,1,-1.1112,0.31,0.61
"GO_BP:503518_GO_0034315_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION","GO_BP","503518_GO_0034315_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION",15,-0.9186,0.56,0.74,0.7353,0.84,1,-0.5241,0.99,1
"C7_Immunologic_signatures:C7_ALL_321_GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP","C7_Immunologic_signatures","C7_ALL_321_GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP",198,-0.9186,0.67,0.75,-1.1345,0.18,1,-1.3112,0.021,0.13
"C3_TF_targets:C3_TFT_499_KTGGYRSGAA_UNKNOWN","C3_TF_targets","C3_TFT_499_KTGGYRSGAA_UNKNOWN",75,-0.9185,0.6,0.74,-0.6215,1,1,-1.0566,0.34,0.62
"REACTOME:685552_REACT_147904_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP_","REACTOME","685552_REACT_147904_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP_",41,-0.9185,0.6,0.76,-0.6152,0.99,1,-1.0934,0.3,0.71
"GO_CC:488005_GO_0002116_SEMAPHORIN_RECEPTOR_COMPLEX","GO_CC","488005_GO_0002116_SEMAPHORIN_RECEPTOR_COMPLEX",7,-0.9184,0.59,0.82,-1.4205,0.096,0.68,-0.842,0.67,1
"C4_Cancer_gene_neighborhoods:C4_CGN_157_MORF_PTEN","C4_Cancer_gene_neighborhoods","C4_CGN_157_MORF_PTEN",82,-0.9184,0.62,0.85,0.6494,0.99,1,0.5901,1,1
"C3_TF_targets:C3_TFT_299_V_STAT1_02","C3_TF_targets","C3_TFT_299_V_STAT1_02",250,-0.9181,0.66,0.74,0.9562,0.59,1,-0.9402,0.68,0.87
"GO_BP:511908_GO_0050974_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION","GO_BP","511908_GO_0050974_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION",26,-0.9181,0.58,0.74,-1.1366,0.25,0.93,-1.4844,0.043,0.53
"C4_Cancer_gene_neighborhoods:C4_CGN_169_MORF_RAGE","C4_Cancer_gene_neighborhoods","C4_CGN_169_MORF_RAGE",141,-0.9181,0.63,0.85,-1,0.43,0.86,-1.0655,0.31,0.68
"C7_Immunologic_signatures:C7_ALL_1007_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP","C7_Immunologic_signatures","C7_ALL_1007_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP",200,-0.918,0.66,0.75,0.8407,0.88,1,-1.1648,0.12,0.34
"KEGG_module:HSA_M00029_UREA_CYCLE","KEGG_module","HSA_M00029_UREA_CYCLE",6,-0.918,0.61,0.74,-0.6516,0.86,1,0.7389,0.8,1
"GO_BP:499150_GO_0021871_FOREBRAIN_REGIONALIZATION","GO_BP","499150_GO_0021871_FOREBRAIN_REGIONALIZATION",23,-0.9179,0.57,0.74,0.7243,0.87,1,1.3136,0.1,0.66
"GO_BP:517264_GO_0072348_SULFUR_COMPOUND_TRANSPORT","GO_BP","517264_GO_0072348_SULFUR_COMPOUND_TRANSPORT",30,-0.9179,0.57,0.74,-0.6425,0.96,1,0.8366,0.76,0.99
"C3_TF_targets:C3_TFT_508_RRCCGTTA_UNKNOWN","C3_TF_targets","C3_TFT_508_RRCCGTTA_UNKNOWN",85,-0.9179,0.63,0.74,-0.7327,0.94,1,0.6879,0.99,1
"C4_Cancer_gene_neighborhoods:C4_CGN_19_MORF_GPX4","C4_Cancer_gene_neighborhoods","C4_CGN_19_MORF_GPX4",55,-0.9179,0.61,0.84,2.1162,0,0.00011,0.5187,1,1
"C4_Cancer_modules:C4_CM_151_MODULE_159","C4_Cancer_modules","C4_CM_151_MODULE_159",81,-0.9179,0.61,0.71,2.1855,0,0.00021,0.4414,1,1
"GO_MF:496585_GO_0016646_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR","GO_MF","496585_GO_0016646_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR",18,-0.9178,0.57,0.77,0.6991,0.89,1,-0.7191,0.86,0.99
"GO_MF:495381_GO_0015106_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495381_GO_0015106_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-0.9178,0.56,0.77,-0.7568,0.78,1,-0.8646,0.6,0.91
"C3_TF_targets:C3_TFT_389_V_E2F4DP1_01","C3_TF_targets","C3_TFT_389_V_E2F4DP1_01",237,-0.9177,0.67,0.74,-0.902,0.75,0.96,-1.1939,0.081,0.36
"KEGG_compound:C05332_PHENETHYLAMINE_2_PHENYLETHYLAMINE_BETA_PHENYLETHYLAMINE_PHENYLETHYLAMINE","KEGG_compound","C05332_PHENETHYLAMINE_2_PHENYLETHYLAMINE_BETA_PHENYLETHYLAMINE_PHENYLETHYLAMINE",5,-0.9177,0.58,0.7,-1.2548,0.24,0.7,-1.4589,0.068,0.24
"GO_BP:511639_GO_0050667_HOMOCYSTEINE_METABOLIC_PROCESS","GO_BP","511639_GO_0050667_HOMOCYSTEINE_METABOLIC_PROCESS",8,-0.9176,0.57,0.75,0.7697,0.76,1,-1.4761,0.07,0.54
"GO_MF:496781_GO_0016894_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS","GO_MF","496781_GO_0016894_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS",17,-0.9174,0.56,0.77,1.5583,0.034,0.32,1.3716,0.12,0.57
"REACTOME:1127516_REACT_264596_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT","REACTOME","1127516_REACT_264596_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT",226,-0.9172,0.66,0.76,0.8663,0.86,0.94,-0.9318,0.66,0.93
"GO_MF:510561_GO_0048487_BETA_TUBULIN_BINDING","GO_MF","510561_GO_0048487_BETA_TUBULIN_BINDING",35,-0.9171,0.59,0.77,1.1716,0.21,0.73,-0.5194,1,1
"GO_BP:491493_GO_0006598_POLYAMINE_CATABOLIC_PROCESS","GO_BP","491493_GO_0006598_POLYAMINE_CATABOLIC_PROCESS",5,-0.9168,0.59,0.75,-1.0301,0.44,0.98,0.9164,0.56,0.93
"C7_Immunologic_signatures:C7_ALL_1163_GSE27786_LIN_NEG_VS_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1163_GSE27786_LIN_NEG_VS_CD4_TCELL_UP",197,-0.9167,0.68,0.75,1.1763,0.11,0.27,-0.9172,0.7,0.92
"GO_BP:491550_GO_0006662_GLYCEROL_ETHER_METABOLIC_PROCESS","GO_BP","491550_GO_0006662_GLYCEROL_ETHER_METABOLIC_PROCESS",13,-0.9166,0.6,0.75,0.8516,0.68,1,-1.2389,0.21,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2388_LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK","C2_Chemical_and_genetic_perturbations","C2_CGP_2388_LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK",17,-0.9166,0.6,0.7,1.1918,0.22,0.5,1.69,0.0078,0.27
"C4_Cancer_gene_neighborhoods:C4_CGN_139_MORF_PAPSS1","C4_Cancer_gene_neighborhoods","C4_CGN_139_MORF_PAPSS1",103,-0.9165,0.65,0.84,1.9042,0,0.00079,-1.314,0.052,0.27
"KEGG_enzyme:1.11.1.9_GLUTATHIONE_PEROXIDASE_GSH_PEROXIDASE_SELENIUM_GLUTATHIONE_PEROXIDASE_REDUCED_GLUTATHIONE_PEROXIDASE","KEGG_enzyme","1.11.1.9_GLUTATHIONE_PEROXIDASE_GSH_PEROXIDASE_SELENIUM_GLUTATHIONE_PEROXIDASE_REDUCED_GLUTATHIONE_PEROXIDASE",6,-0.9165,0.59,0.66,0.54,0.96,0.97,1.5789,0.032,0.22
"GO_BP:500397_GO_0031110_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION","GO_BP","500397_GO_0031110_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION",53,-0.9164,0.59,0.75,0.7218,0.93,1,-1.2545,0.11,0.68
"C7_Immunologic_signatures:C7_ALL_1783_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1783_GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP",200,-0.9163,0.68,0.75,0.8594,0.89,1,-0.7234,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2230_MCCABE_HOXC6_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2230_MCCABE_HOXC6_TARGETS_UP",9,-0.9163,0.58,0.7,-0.8346,0.69,1,-0.5545,0.96,0.99
"GO_BP:510756_GO_0048701_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS","GO_BP","510756_GO_0048701_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS",42,-0.9158,0.59,0.75,-1.0216,0.44,0.97,0.8594,0.71,0.97
"GO_BP:1129476_GO_1903650_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT","GO_BP","1129476_GO_1903650_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT",85,-0.9158,0.63,0.75,-0.6708,0.99,1,-1.2326,0.1,0.7
"REACTOME:106104_REACT_2122_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION","REACTOME","106104_REACT_2122_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION",8,-0.9157,0.58,0.76,0.6683,0.88,1,-1.0986,0.32,0.71
"C7_Immunologic_signatures:C7_ALL_275_GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP","C7_Immunologic_signatures","C7_ALL_275_GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP",197,-0.9157,0.68,0.75,0.8214,0.95,1,-1.204,0.088,0.27
"GO_BP:498797_GO_0021513_SPINAL_CORD_DORSAL_VENTRAL_PATTERNING","GO_BP","498797_GO_0021513_SPINAL_CORD_DORSAL_VENTRAL_PATTERNING",22,-0.9157,0.59,0.75,-1.1581,0.28,0.92,0.8845,0.64,0.95
"GO_BP:488971_GO_0003177_PULMONARY_VALVE_DEVELOPMENT","GO_BP","488971_GO_0003177_PULMONARY_VALVE_DEVELOPMENT",9,-0.9155,0.58,0.75,-0.8598,0.62,1,-0.793,0.73,0.99
"GO_BP:754937_GO_2000831_REGULATION_OF_STEROID_HORMONE_SECRETION","GO_BP","754937_GO_2000831_REGULATION_OF_STEROID_HORMONE_SECRETION",16,-0.9154,0.58,0.75,1.2987,0.15,0.67,0.8609,0.67,0.97
"C3_MicroRNA_targets:C3_MIR_217_TAATGTG_MIR_323","C3_MicroRNA_targets","C3_MIR_217_TAATGTG_MIR_323",159,-0.9153,0.68,0.75,0.6613,1,1,-0.9778,0.49,1
"KEGG_reaction:R10905_HYALURONIC_ACID_H2O_HYALURONIC_ACID_G00526","KEGG_reaction","R10905_HYALURONIC_ACID_H2O_HYALURONIC_ACID_G00526",5,-0.9153,0.6,0.7,0.7563,0.74,1,-1.1232,0.35,0.46
"GO_MF:503654_GO_0034452_DYNACTIN_BINDING","GO_MF","503654_GO_0034452_DYNACTIN_BINDING",8,-0.9151,0.56,0.77,-1.2399,0.21,0.85,-0.9915,0.48,0.79
"GO_BP:490969_GO_0005981_REGULATION_OF_GLYCOGEN_CATABOLIC_PROCESS","GO_BP","490969_GO_0005981_REGULATION_OF_GLYCOGEN_CATABOLIC_PROCESS",6,-0.9149,0.57,0.75,-1.1417,0.31,0.93,0.9458,0.49,0.91
"KEGG_compound:C00422_TRIACYLGLYCEROL_TRIGLYCERIDE","KEGG_compound","C00422_TRIACYLGLYCEROL_TRIGLYCERIDE",11,-0.9148,0.55,0.71,-0.9995,0.46,1,1.1765,0.25,0.58
"GO_BP:512146_GO_0051255_SPINDLE_MIDZONE_ASSEMBLY","GO_BP","512146_GO_0051255_SPINDLE_MIDZONE_ASSEMBLY",9,-0.9147,0.59,0.75,0.6528,0.9,1,-0.7338,0.83,1
"GO_MF:489689_GO_0005381_IRON_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","489689_GO_0005381_IRON_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-0.9146,0.58,0.77,1.0514,0.41,0.83,-1.0591,0.39,0.74
"KEGG_compound:C00473_RETINOL_ALL_TRANS_RETINOL_VITAMIN_A_VITAMIN_A1","KEGG_compound","C00473_RETINOL_ALL_TRANS_RETINOL_VITAMIN_A_VITAMIN_A1",23,-0.9146,0.58,0.7,1.4575,0.052,0.39,-0.9654,0.5,0.7
"OMIM_gene:OMIM179605_PERIPHERIN_2_MOUSE_HOMOLOG_OF_PRPH2","OMIM_gene","OMIM179605_PERIPHERIN_2_MOUSE_HOMOLOG_OF_PRPH2",5,-0.9144,0.57,0.8,-0.8635,0.64,0.94,-0.6874,0.84,1
"GO_BP:501176_GO_0031936_NEGATIVE_REGULATION_OF_CHROMATIN_SILENCING","GO_BP","501176_GO_0031936_NEGATIVE_REGULATION_OF_CHROMATIN_SILENCING",9,-0.9144,0.59,0.75,0.7445,0.8,1,0.6665,0.89,1
"GO_BP:488978_GO_0003184_PULMONARY_VALVE_MORPHOGENESIS","GO_BP","488978_GO_0003184_PULMONARY_VALVE_MORPHOGENESIS",9,-0.9144,0.57,0.75,-0.8518,0.65,1,-0.7613,0.76,1
"GO_BP:491543_GO_0006655_PHOSPHATIDYLGLYCEROL_BIOSYNTHETIC_PROCESS","GO_BP","491543_GO_0006655_PHOSPHATIDYLGLYCEROL_BIOSYNTHETIC_PROCESS",13,-0.9144,0.59,0.75,0.5979,0.95,1,0.5975,0.95,1
"GO_BP:491940_GO_0007127_MEIOSIS_I","GO_BP","491940_GO_0007127_MEIOSIS_I",74,-0.9143,0.62,0.75,-0.8188,0.82,1,-1.3063,0.049,0.64
"GO_MF:751042_GO_0036122_BMP_BINDING","GO_MF","751042_GO_0036122_BMP_BINDING",6,-0.914,0.58,0.77,0.9574,0.53,0.92,1.1124,0.34,0.81
"C1_Positional:C1_ALL_275_CHR6Q26","C1_Positional","C1_ALL_275_CHR6Q26",11,-0.914,0.58,0.94,0.9133,0.57,0.84,0.9761,0.48,0.78
"GO_CC:494439_GO_0010369_CHROMOCENTER","GO_CC","494439_GO_0010369_CHROMOCENTER",12,-0.9139,0.59,0.83,-0.9839,0.47,0.86,-0.9911,0.46,1
"C4_Cancer_modules:C4_CM_227_MODULE_249","C4_Cancer_modules","C4_CM_227_MODULE_249",21,-0.9139,0.6,0.71,0.931,0.58,0.8,-1.0835,0.32,0.56
"GO_BP:499681_GO_0030277_MAINTENANCE_OF_GASTROINTESTINAL_EPITHELIUM","GO_BP","499681_GO_0030277_MAINTENANCE_OF_GASTROINTESTINAL_EPITHELIUM",15,-0.9139,0.58,0.75,1.0097,0.43,0.98,0.8837,0.62,0.95
"KEGG_pathway:HSA05216_THYROID_CANCER","KEGG_pathway","HSA05216_THYROID_CANCER",29,-0.9139,0.6,0.67,1.0646,0.35,0.86,0.9092,0.59,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1527_JAIN_NFKB_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_1527_JAIN_NFKB_SIGNALING",75,-0.9139,0.63,0.71,1.0015,0.46,0.8,-1.3531,0.05,0.39
"C7_Immunologic_signatures:C7_ALL_1346_GSE31082_DN_VS_DP_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1346_GSE31082_DN_VS_DP_THYMOCYTE_DN",200,-0.9139,0.69,0.76,-0.8643,0.81,1,-0.9286,0.67,0.89
"GO_BP:492051_GO_0007272_ENSHEATHMENT_OF_NEURONS","GO_BP","492051_GO_0007272_ENSHEATHMENT_OF_NEURONS",90,-0.9138,0.63,0.75,-0.7807,0.91,1,-0.8591,0.77,0.96
"C3_TF_targets:C3_TFT_554_YTTCCNNNGGAMR_UNKNOWN","C3_TF_targets","C3_TFT_554_YTTCCNNNGGAMR_UNKNOWN",50,-0.9136,0.61,0.75,0.8812,0.67,1,-1.2707,0.12,0.26
"GO_BP:490618_GO_0005513_DETECTION_OF_CALCIUM_ION","GO_BP","490618_GO_0005513_DETECTION_OF_CALCIUM_ION",14,-0.9136,0.57,0.75,0.8765,0.63,1,0.912,0.57,0.93
"GO_MF:496767_GO_0016878_ACID_THIOL_LIGASE_ACTIVITY","GO_MF","496767_GO_0016878_ACID_THIOL_LIGASE_ACTIVITY",20,-0.9136,0.57,0.77,0.7715,0.82,1,-1.0133,0.44,0.78
"REACTOME:730311_REACT_150331_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES","REACTOME","730311_REACT_150331_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES",30,-0.9134,0.58,0.76,-1.1337,0.28,0.9,1.5757,0.018,0.46
"GO_CC:490840_GO_0005814_CENTRIOLE","GO_CC","490840_GO_0005814_CENTRIOLE",91,-0.9134,0.61,0.83,-1.1923,0.13,0.67,-1.7471,0,0.79
"WikiPathways:198878_WP732_SEROTONIN_RECEPTOR_2_AND_ELK_SRF_GATA4_SIGNALING","WikiPathways","198878_WP732_SEROTONIN_RECEPTOR_2_AND_ELK_SRF_GATA4_SIGNALING",17,-0.9132,0.59,0.71,-0.7699,0.8,1,0.9439,0.53,1
"C7_Immunologic_signatures:C7_ALL_123_GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP","C7_Immunologic_signatures","C7_ALL_123_GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP",194,-0.913,0.67,0.76,1.1998,0.083,0.23,-0.9972,0.45,0.73
"GO_MF:490270_GO_0004983_NEUROPEPTIDE_Y_RECEPTOR_ACTIVITY","GO_MF","490270_GO_0004983_NEUROPEPTIDE_Y_RECEPTOR_ACTIVITY",8,-0.9128,0.59,0.77,-1.2495,0.21,0.83,1.4872,0.058,0.44
"GO_BP:753148_GO_1900153_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY","GO_BP","753148_GO_1900153_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY",14,-0.9126,0.58,0.75,-0.8535,0.65,1,-1.0647,0.39,0.8
"KEGG_compound:C00376_RETINAL_VITAMIN_A_ALDEHYDE_RETINENE_ALL_TRANS_RETINAL_ALL_TRANS_VITAMIN_A_ALDEHYDE_ALL_TRANS_RETINENE","KEGG_compound","C00376_RETINAL_VITAMIN_A_ALDEHYDE_RETINENE_ALL_TRANS_RETINAL_ALL_TRANS_VITAMIN_A_ALDEHYDE_ALL_TRANS_RETINENE",22,-0.9125,0.59,0.71,1.5422,0.039,0.25,1.0828,0.34,0.65
"C4_Cancer_gene_neighborhoods:C4_CGN_344_GNF2_DDX5","C4_Cancer_gene_neighborhoods","C4_CGN_344_GNF2_DDX5",63,-0.9121,0.62,0.85,-0.6028,0.99,1,-1.0541,0.38,0.71
"GO_BP:487911_GO_0002021_RESPONSE_TO_DIETARY_EXCESS","GO_BP","487911_GO_0002021_RESPONSE_TO_DIETARY_EXCESS",16,-0.9121,0.6,0.75,0.9479,0.53,1,0.9101,0.58,0.93
"C6_Oncogenic_signatures:C6_ALL_169_JAK2_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_169_JAK2_DN_V1_UP",163,-0.9121,0.66,0.7,-1.1021,0.25,0.58,1.1825,0.12,0.3
"GO_BP:492887_GO_0008643_CARBOHYDRATE_TRANSPORT","GO_BP","492887_GO_0008643_CARBOHYDRATE_TRANSPORT",111,-0.912,0.64,0.75,0.7834,0.93,1,-0.6071,1,1
"REACTOME:905995_REACT_169121_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF_","REACTOME","905995_REACT_169121_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF_",16,-0.9118,0.6,0.77,1.1838,0.26,0.46,0.7506,0.84,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_790_SCHRAMM_INHBA_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_790_SCHRAMM_INHBA_TARGETS_UP",6,-0.9118,0.57,0.71,0.6825,0.85,1,1.5037,0.055,0.48
"GO_BP:505244_GO_0042059_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","505244_GO_0042059_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",43,-0.9118,0.6,0.75,1.3156,0.1,0.65,0.9226,0.6,0.92
"REACTOME:530768_REACT_115871_SIGNALING_BY_EGFR_IN_CANCER","REACTOME","530768_REACT_115871_SIGNALING_BY_EGFR_IN_CANCER",19,-0.9117,0.58,0.77,1.3688,0.11,0.25,-0.9657,0.5,0.89
"GO_BP:517159_GO_0072243_METANEPHRIC_NEPHRON_EPITHELIUM_DEVELOPMENT","GO_BP","517159_GO_0072243_METANEPHRIC_NEPHRON_EPITHELIUM_DEVELOPMENT",18,-0.9117,0.58,0.75,0.735,0.85,1,0.7969,0.75,1
"REACTOME:1183580_REACT_355216_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4","REACTOME","1183580_REACT_355216_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4",44,-0.9116,0.61,0.76,-1.3281,0.092,0.61,-1.4532,0.027,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_136_CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_136_CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN",50,-0.9115,0.6,0.71,-0.9406,0.57,1,-1.2356,0.14,0.49
"GO_BP:513881_GO_0060325_FACE_MORPHOGENESIS","GO_BP","513881_GO_0060325_FACE_MORPHOGENESIS",35,-0.9114,0.6,0.75,0.7846,0.81,1,-0.722,0.91,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1314_IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1314_IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP",27,-0.9114,0.6,0.71,1.2513,0.16,0.44,0.7001,0.91,1
"GO_MF:509806_GO_0047631_ADP_RIBOSE_DIPHOSPHATASE_ACTIVITY","GO_MF","509806_GO_0047631_ADP_RIBOSE_DIPHOSPHATASE_ACTIVITY",5,-0.9113,0.6,0.78,-0.7066,0.82,1,0.7127,0.82,1
"GO_BP:849976_GO_1902275_REGULATION_OF_CHROMATIN_ORGANIZATION","GO_BP","849976_GO_1902275_REGULATION_OF_CHROMATIN_ORGANIZATION",128,-0.9111,0.65,0.75,0.6325,1,1,-1.0197,0.41,0.83
"GO_BP:505033_GO_0035864_RESPONSE_TO_POTASSIUM_ION","GO_BP","505033_GO_0035864_RESPONSE_TO_POTASSIUM_ION",9,-0.9109,0.58,0.75,-0.916,0.55,1,0.6131,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2089_STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2089_STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP",31,-0.9109,0.6,0.71,0.7799,0.85,1,-1.0119,0.44,0.74
"C7_Immunologic_signatures:C7_ALL_1855_GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP","C7_Immunologic_signatures","C7_ALL_1855_GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP",199,-0.9108,0.67,0.76,0.8852,0.8,1,0.8751,0.81,1
"GO_BP:507558_GO_0045176_APICAL_PROTEIN_LOCALIZATION","GO_BP","507558_GO_0045176_APICAL_PROTEIN_LOCALIZATION",11,-0.9107,0.57,0.75,1.3187,0.14,0.65,0.6972,0.87,1
"GO_BP:502453_GO_0033233_REGULATION_OF_PROTEIN_SUMOYLATION","GO_BP","502453_GO_0033233_REGULATION_OF_PROTEIN_SUMOYLATION",17,-0.9106,0.58,0.75,0.6962,0.88,1,0.8304,0.72,0.99
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_8_BIOCARTA_ARAP_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_8_BIOCARTA_ARAP_PATHWAY",17,-0.9103,0.58,0.69,0.598,0.97,1,0.7034,0.87,1
"GO_BP:751600_GO_0044387_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY_BY_REGULATION_OF_PROTEIN_PHOSPHORYLATION","GO_BP","751600_GO_0044387_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY_BY_REGULATION_OF_PROTEIN_PHOSPHORYLATION",6,-0.9102,0.58,0.76,0.926,0.56,1,0.6782,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2715_BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2715_BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP",52,-0.91,0.62,0.71,1.2518,0.11,0.44,-0.881,0.69,0.9
"C7_Immunologic_signatures:C7_ALL_1103_GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1103_GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP",189,-0.91,0.68,0.77,-1.004,0.43,1,-0.9648,0.56,0.81
"C7_Immunologic_signatures:C7_ALL_254_GSE14308_TH1_VS_TH17_DN","C7_Immunologic_signatures","C7_ALL_254_GSE14308_TH1_VS_TH17_DN",199,-0.9099,0.7,0.77,1.0851,0.22,0.48,0.6038,1,1
"GO_CC:490946_GO_0005952_CAMP_DEPENDENT_PROTEIN_KINASE_COMPLEX","GO_CC","490946_GO_0005952_CAMP_DEPENDENT_PROTEIN_KINASE_COMPLEX",9,-0.9098,0.58,0.84,0.9556,0.49,0.83,-0.8646,0.64,1
"REACTOME:1127576_REACT_268006_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_VARIANTS_IN_CANCER","REACTOME","1127576_REACT_268006_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_VARIANTS_IN_CANCER",19,-0.9096,0.58,0.77,1.3464,0.12,0.27,-0.9641,0.51,0.89
"GO_BP:501939_GO_0032713_NEGATIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION","GO_BP","501939_GO_0032713_NEGATIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION",6,-0.9096,0.58,0.76,0.9611,0.5,1,-0.7244,0.83,0.99
"REACTOME:161036_REACT_20568_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS","REACTOME","161036_REACT_20568_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS",29,-0.9095,0.61,0.77,0.7944,0.82,1,-1.2004,0.19,0.6
"C3_TF_targets:C3_TFT_449_V_CREB_Q2_01","C3_TF_targets","C3_TFT_449_V_CREB_Q2_01",218,-0.9095,0.7,0.76,-0.8436,0.9,1,-1.0292,0.36,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_1849_IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR","C2_Chemical_and_genetic_perturbations","C2_CGP_1849_IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR",148,-0.9094,0.68,0.71,1.7273,0,0.068,0.6637,1,1
"GO_BP:495952_GO_0015824_PROLINE_TRANSPORT","GO_BP","495952_GO_0015824_PROLINE_TRANSPORT",9,-0.9094,0.58,0.76,0.6502,0.89,1,0.4645,1,1
"REACTOME:685554_REACT_147867_TRANSLOCATION_OF_GLUT4_TO_THE_PLASMA_MEMBRANE","REACTOME","685554_REACT_147867_TRANSLOCATION_OF_GLUT4_TO_THE_PLASMA_MEMBRANE",62,-0.9092,0.62,0.77,1.1228,0.24,0.55,0.8723,0.73,1
"GO_MF:489792_GO_0004438_PHOSPHATIDYLINOSITOL_3_PHOSPHATASE_ACTIVITY","GO_MF","489792_GO_0004438_PHOSPHATIDYLINOSITOL_3_PHOSPHATASE_ACTIVITY",8,-0.9092,0.58,0.78,0.5592,0.96,1,-0.8814,0.61,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_845_OXFORD_RALA_OR_RALB_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_845_OXFORD_RALA_OR_RALB_TARGETS_DN",24,-0.9091,0.6,0.71,-1.2213,0.17,0.78,-0.8096,0.77,0.95
"GO_MF:487327_GO_0001104_RNA_POLYMERASE_II_TRANSCRIPTION_COFACTOR_ACTIVITY","GO_MF","487327_GO_0001104_RNA_POLYMERASE_II_TRANSCRIPTION_COFACTOR_ACTIVITY",82,-0.9089,0.66,0.78,-0.8928,0.67,1,0.8488,0.78,0.98
"GO_BP:510769_GO_0048714_POSITIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION","GO_BP","510769_GO_0048714_POSITIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION",11,-0.9089,0.58,0.76,1.6562,0.024,0.24,1.4843,0.066,0.58
"C4_Cancer_modules:C4_CM_380_MODULE_471","C4_Cancer_modules","C4_CM_380_MODULE_471",9,-0.9087,0.56,0.72,0.5233,0.98,1,0.6756,0.88,1
"GO_MF:490625_GO_0005523_TROPOMYOSIN_BINDING","GO_MF","490625_GO_0005523_TROPOMYOSIN_BINDING",13,-0.9084,0.59,0.78,-0.9675,0.47,0.94,-1.3425,0.13,0.53
"C4_Cancer_modules:C4_CM_408_MODULE_525","C4_Cancer_modules","C4_CM_408_MODULE_525",65,-0.9083,0.63,0.72,0.8257,0.77,0.94,-0.8309,0.82,0.96
"C4_Cancer_modules:C4_CM_143_MODULE_151","C4_Cancer_modules","C4_CM_143_MODULE_151",318,-0.9082,0.75,0.72,3.2789,0,0,0.7146,1,1
"GO_BP:504489_GO_0035305_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION","GO_BP","504489_GO_0035305_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION",71,-0.908,0.65,0.76,0.7924,0.9,1,0.9802,0.48,0.87
"GO_BP:508788_GO_0046530_PHOTORECEPTOR_CELL_DIFFERENTIATION","GO_BP","508788_GO_0046530_PHOTORECEPTOR_CELL_DIFFERENTIATION",50,-0.908,0.62,0.76,-1.3391,0.091,0.91,0.9929,0.43,0.86
"GO_BP:499809_GO_0030431_SLEEP","GO_BP","499809_GO_0030431_SLEEP",13,-0.908,0.6,0.76,-0.7532,0.8,1,0.9203,0.58,0.92
"C7_Immunologic_signatures:C7_ALL_325_GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP","C7_Immunologic_signatures","C7_ALL_325_GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP",186,-0.9079,0.71,0.77,0.8744,0.8,1,-1.4087,0.011,0.056
"C3_TF_targets:C3_TFT_391_V_E2F1DP1RB_01","C3_TF_targets","C3_TFT_391_V_E2F1DP1RB_01",229,-0.9078,0.69,0.76,-0.9052,0.76,0.95,-1.2473,0.045,0.29
"GO_BP:495290_GO_0014898_CARDIAC_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS","GO_BP","495290_GO_0014898_CARDIAC_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS",11,-0.9076,0.59,0.76,-1.1575,0.28,0.92,-0.7497,0.81,1
"GO_BP:503586_GO_0034384_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE","GO_BP","503586_GO_0034384_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE",6,-0.9075,0.58,0.76,-0.924,0.58,1,-0.8516,0.63,0.96
"C4_Cancer_gene_neighborhoods:C4_CGN_129_MORF_MAP3K14","C4_Cancer_gene_neighborhoods","C4_CGN_129_MORF_MAP3K14",113,-0.9075,0.67,0.85,0.9025,0.7,0.83,0.9919,0.47,0.82
"C3_TF_targets:C3_TFT_255_V_HMX1_01","C3_TF_targets","C3_TFT_255_V_HMX1_01",43,-0.9073,0.61,0.76,-1.0065,0.45,0.75,1.0241,0.41,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3149_STEGER_ADIPOGENESIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3149_STEGER_ADIPOGENESIS_DN",24,-0.9073,0.6,0.72,1.2221,0.19,0.46,-0.5653,0.98,0.99
"C3_MicroRNA_targets:C3_MIR_35_ACTACCT_MIR_196A_MIR_196B","C3_MicroRNA_targets","C3_MIR_35_ACTACCT_MIR_196A_MIR_196B",145,-0.9072,0.69,0.77,0.878,0.78,1,1.1797,0.14,1
"GO_MF:506562_GO_0043531_ADP_BINDING","GO_MF","506562_GO_0043531_ADP_BINDING",30,-0.9071,0.61,0.78,-0.7946,0.79,1,-1.1325,0.26,0.66
"C4_Cancer_modules:C4_CM_122_MODULE_127","C4_Cancer_modules","C4_CM_122_MODULE_127",26,-0.9071,0.6,0.72,0.8959,0.62,0.86,-1.4214,0.064,0.21
"C2_Chemical_and_genetic_perturbations:C2_CGP_836_DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_836_DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP",6,-0.9069,0.59,0.72,-0.5976,0.93,1,1.1048,0.35,0.88
"GO_BP:499077_GO_0021797_FOREBRAIN_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION","GO_BP","499077_GO_0021797_FOREBRAIN_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION",5,-0.9069,0.61,0.76,-0.8683,0.6,1,-0.9845,0.49,0.86
"GO_BP:510560_GO_0048486_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT","GO_BP","510560_GO_0048486_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT",19,-0.9068,0.57,0.76,-0.654,0.92,1,1.0741,0.37,0.78
"REACTOME:106205_REACT_2071_PYRUVATE_METABOLISM","REACTOME","106205_REACT_2071_PYRUVATE_METABOLISM",22,-0.9067,0.59,0.77,1.2235,0.19,0.42,-1.0821,0.32,0.73
"GO_BP:515802_GO_0070874_NEGATIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS","GO_BP","515802_GO_0070874_NEGATIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS",9,-0.9067,0.6,0.76,0.5793,0.95,1,-0.7667,0.77,1
"GO_BP:505624_GO_0042491_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION","GO_BP","505624_GO_0042491_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION",30,-0.9066,0.61,0.76,-0.4853,1,1,1.0706,0.34,0.78
"C7_Immunologic_signatures:C7_ALL_1600_GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1600_GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN",196,-0.9065,0.69,0.77,1.6023,0,0.0029,-1.4552,0.0064,0.033
"C2_Chemical_and_genetic_perturbations:C2_CGP_2471_BOYLAN_MULTIPLE_MYELOMA_C_D_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2471_BOYLAN_MULTIPLE_MYELOMA_C_D_UP",138,-0.9064,0.67,0.72,1.0112,0.43,0.78,-1.3623,0.021,0.39
"GO_BP:512178_GO_0051293_ESTABLISHMENT_OF_SPINDLE_LOCALIZATION","GO_BP","512178_GO_0051293_ESTABLISHMENT_OF_SPINDLE_LOCALIZATION",28,-0.9063,0.61,0.76,0.6455,0.96,1,1.0778,0.33,0.78
"C7_Immunologic_signatures:C7_ALL_378_GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN","C7_Immunologic_signatures","C7_ALL_378_GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN",193,-0.9063,0.67,0.77,1.0184,0.39,0.69,0.7519,0.98,1
"C3_TF_targets:C3_TFT_513_RYTGCNWTGGNR_UNKNOWN","C3_TF_targets","C3_TFT_513_RYTGCNWTGGNR_UNKNOWN",116,-0.9061,0.66,0.76,-0.8604,0.8,1,1.127,0.23,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2402_CONRAD_GERMLINE_STEM_CELL","C2_Chemical_and_genetic_perturbations","C2_CGP_2402_CONRAD_GERMLINE_STEM_CELL",11,-0.906,0.6,0.72,0.9347,0.54,0.88,-1.1731,0.26,0.55
"C7_Immunologic_signatures:C7_ALL_721_GSE17721_0_5H_VS_8H_POLYIC_BMDM_UP","C7_Immunologic_signatures","C7_ALL_721_GSE17721_0_5H_VS_8H_POLYIC_BMDM_UP",194,-0.9059,0.69,0.77,1.4476,0.0024,0.023,-1.1307,0.16,0.42
"REACTOME:1127554_REACT_264071_HSF1_ACTIVATION","REACTOME","1127554_REACT_264071_HSF1_ACTIVATION",12,-0.9059,0.58,0.77,1.5062,0.047,0.14,-1.2224,0.21,0.58
"GO_BP:510400_GO_0048293_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGE_ISOTYPES","GO_BP","510400_GO_0048293_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGE_ISOTYPES",7,-0.9056,0.6,0.76,-1.1097,0.34,0.94,-0.7482,0.81,1
"GO_BP:506614_GO_0043583_EAR_DEVELOPMENT","GO_BP","506614_GO_0043583_EAR_DEVELOPMENT",196,-0.9056,0.67,0.76,1.0466,0.34,0.95,1.4823,0.002,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_529_STREICHER_LSM1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_529_STREICHER_LSM1_TARGETS_DN",19,-0.9055,0.6,0.72,-0.7836,0.75,1,0.853,0.64,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_925_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6","C2_Chemical_and_genetic_perturbations","C2_CGP_925_SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6",45,-0.9053,0.61,0.72,-0.9729,0.5,1,-0.9902,0.46,0.77
"GO_BP:517059_GO_0072143_MESANGIAL_CELL_DEVELOPMENT","GO_BP","517059_GO_0072143_MESANGIAL_CELL_DEVELOPMENT",5,-0.9053,0.59,0.76,0.5829,0.94,1,0.465,0.99,1
"GO_BP:490219_GO_0016055_WNT_SIGNALING_PATHWAY","GO_BP","490219_GO_0016055_WNT_SIGNALING_PATHWAY",237,-0.9049,0.72,0.76,0.8102,0.96,1,1.0928,0.22,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_3219_PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3219_PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN",177,-0.9047,0.69,0.72,0.9557,0.59,0.86,-1.2639,0.048,0.46
"C7_Immunologic_signatures:C7_ALL_975_GSE22886_NAIVE_TCELL_VS_DC_UP","C7_Immunologic_signatures","C7_ALL_975_GSE22886_NAIVE_TCELL_VS_DC_UP",196,-0.9047,0.69,0.78,2.6709,0,0,-1.4817,0,0.026
"GO_BP:504818_GO_0035641_LOCOMOTORY_EXPLORATION_BEHAVIOR","GO_BP","504818_GO_0035641_LOCOMOTORY_EXPLORATION_BEHAVIOR",9,-0.9046,0.59,0.76,-1.3658,0.1,0.99,-1.2743,0.21,0.66
"GO_BP:502367_GO_0033146_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","502367_GO_0033146_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY",26,-0.9046,0.59,0.76,1.0574,0.37,0.94,-0.6703,0.94,1
"GO_BP:491862_GO_0007035_VACUOLAR_ACIDIFICATION","GO_BP","491862_GO_0007035_VACUOLAR_ACIDIFICATION",13,-0.9045,0.58,0.76,-0.6796,0.87,1,0.7645,0.77,1
"C7_Immunologic_signatures:C7_ALL_99_GSE11924_TFH_VS_TH17_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_99_GSE11924_TFH_VS_TH17_CD4_TCELL_UP",197,-0.9045,0.69,0.78,-0.9593,0.56,1,-1.0234,0.37,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_1476_STONER_ESOPHAGEAL_CARCINOGENESIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1476_STONER_ESOPHAGEAL_CARCINOGENESIS_UP",39,-0.9043,0.61,0.72,1.2308,0.16,0.46,-0.7689,0.86,0.97
"GO_BP:517121_GO_0072205_METANEPHRIC_COLLECTING_DUCT_DEVELOPMENT","GO_BP","517121_GO_0072205_METANEPHRIC_COLLECTING_DUCT_DEVELOPMENT",8,-0.9041,0.58,0.76,-0.8896,0.58,1,1.3814,0.11,0.64
"GO_MF:750817_GO_0052744_PHOSPHATIDYLINOSITOL_MONOPHOSPHATE_PHOSPHATASE_ACTIVITY","GO_MF","750817_GO_0052744_PHOSPHATIDYLINOSITOL_MONOPHOSPHATE_PHOSPHATASE_ACTIVITY",8,-0.904,0.58,0.79,0.5509,0.96,1,-0.8676,0.64,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1747_KAYO_AGING_MUSCLE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1747_KAYO_AGING_MUSCLE_DN",120,-0.904,0.68,0.72,1.9595,0,0.011,0.7004,0.99,1
"C7_Immunologic_signatures:C7_ALL_214_GSE13493_DP_VS_CD8POS_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_214_GSE13493_DP_VS_CD8POS_THYMOCYTE_DN",197,-0.9039,0.68,0.78,1.1013,0.21,0.44,-0.8618,0.85,1
"GO_MF:490340_GO_0005068_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ADAPTOR_ACTIVITY","GO_MF","490340_GO_0005068_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ADAPTOR_ACTIVITY",9,-0.9037,0.6,0.79,1.5412,0.053,0.34,1.2049,0.24,0.71
"GO_BP:505580_GO_0042440_PIGMENT_METABOLIC_PROCESS","GO_BP","505580_GO_0042440_PIGMENT_METABOLIC_PROCESS",64,-0.9035,0.64,0.77,1.0126,0.43,0.97,0.9612,0.55,0.9
"GO_BP:518839_GO_2000192_NEGATIVE_REGULATION_OF_FATTY_ACID_TRANSPORT","GO_BP","518839_GO_2000192_NEGATIVE_REGULATION_OF_FATTY_ACID_TRANSPORT",8,-0.9035,0.61,0.77,0.9665,0.49,1,1.0356,0.41,0.82
"GO_BP:507478_GO_0045078_POSITIVE_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS","GO_BP","507478_GO_0045078_POSITIVE_REGULATION_OF_INTERFERON_GAMMA_BIOSYNTHETIC_PROCESS",12,-0.9032,0.59,0.77,-0.5402,0.98,1,0.824,0.73,1
"C3_TF_targets:C3_TFT_282_CTCNANGTGNY_UNKNOWN","C3_TF_targets","C3_TFT_282_CTCNANGTGNY_UNKNOWN",84,-0.9031,0.63,0.77,-1.0884,0.29,0.57,-1.1107,0.26,0.51
"GO_BP:518428_GO_0090288_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS","GO_BP","518428_GO_0090288_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS",102,-0.9031,0.66,0.77,1.0839,0.27,0.92,-0.8589,0.81,0.96
"GO_BP:501459_GO_0032224_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC","GO_BP","501459_GO_0032224_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC",6,-0.903,0.58,0.77,0.9368,0.52,1,-1.0497,0.42,0.81
"GO_BP:512522_GO_0051646_MITOCHONDRION_LOCALIZATION","GO_BP","512522_GO_0051646_MITOCHONDRION_LOCALIZATION",27,-0.903,0.6,0.77,-0.9325,0.55,1,0.6529,0.96,1
"C7_Immunologic_signatures:C7_ALL_1301_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1301_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP",194,-0.903,0.7,0.78,1.2753,0.048,0.12,0.708,1,1
"C7_Immunologic_signatures:C7_ALL_361_GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP","C7_Immunologic_signatures","C7_ALL_361_GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP",189,-0.9029,0.69,0.78,0.9098,0.71,1,-0.9885,0.5,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_597_RIZ_ERYTHROID_DIFFERENTIATION_12HR","C2_Chemical_and_genetic_perturbations","C2_CGP_597_RIZ_ERYTHROID_DIFFERENTIATION_12HR",42,-0.9024,0.63,0.72,-0.6764,0.94,1,0.9719,0.5,0.97
"GO_BP:849930_GO_1902229_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE","GO_BP","849930_GO_1902229_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE",34,-0.9021,0.61,0.77,0.9921,0.48,0.99,0.9187,0.6,0.92
"GO_BP:946568_GO_0098911_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL","GO_BP","946568_GO_0098911_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",8,-0.9021,0.58,0.77,0.8595,0.62,1,1.428,0.11,0.61
"GO_BP:491858_GO_0007030_GOLGI_ORGANIZATION","GO_BP","491858_GO_0007030_GOLGI_ORGANIZATION",76,-0.902,0.64,0.77,-0.5956,1,1,-0.7151,0.97,0.99
"GO_BP:517577_GO_0072674_MULTINUCLEAR_OSTEOCLAST_DIFFERENTIATION","GO_BP","517577_GO_0072674_MULTINUCLEAR_OSTEOCLAST_DIFFERENTIATION",5,-0.9019,0.62,0.77,0.9664,0.52,1,-1.4866,0.069,0.53
"C3_TF_targets:C3_TFT_80_V_MAX_01","C3_TF_targets","C3_TFT_80_V_MAX_01",257,-0.9018,0.71,0.77,1.0465,0.31,1,-0.81,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1726_KEEN_RESPONSE_TO_ROSIGLITAZONE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1726_KEEN_RESPONSE_TO_ROSIGLITAZONE_UP",37,-0.9015,0.61,0.73,0.9486,0.55,0.87,-1.1301,0.26,0.59
"C4_Cancer_gene_neighborhoods:C4_CGN_331_GNF2_CD48","C4_Cancer_gene_neighborhoods","C4_CGN_331_GNF2_CD48",32,-0.9015,0.63,0.87,1.3026,0.12,0.12,-1.1289,0.28,0.56
"KEGG_module:HSA_M00687_MAPK_ERK1_2_SIGNALING","KEGG_module","HSA_M00687_MAPK_ERK1_2_SIGNALING",8,-0.9015,0.61,0.75,-0.7842,0.74,1,-0.5848,0.97,1
"GO_BP:751213_GO_0036295_CELLULAR_RESPONSE_TO_INCREASED_OXYGEN_LEVELS","GO_BP","751213_GO_0036295_CELLULAR_RESPONSE_TO_INCREASED_OXYGEN_LEVELS",9,-0.9014,0.56,0.77,0.8854,0.62,1,1.5019,0.066,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_343_MAYBURD_RESPONSE_TO_L663536_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_343_MAYBURD_RESPONSE_TO_L663536_DN",55,-0.9013,0.64,0.73,1.4474,0.023,0.26,-0.7852,0.87,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1252_LANDEMAINE_LUNG_METASTASIS","C2_Chemical_and_genetic_perturbations","C2_CGP_1252_LANDEMAINE_LUNG_METASTASIS",21,-0.9013,0.61,0.73,0.8246,0.72,0.98,0.9858,0.46,0.97
"GO_BP:505855_GO_0042749_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE","GO_BP","505855_GO_0042749_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE",18,-0.9012,0.61,0.77,-0.8455,0.67,1,1.1099,0.31,0.75
"C4_Cancer_modules:C4_CM_329_MODULE_389","C4_Cancer_modules","C4_CM_329_MODULE_389",210,-0.9012,0.7,0.73,-1.0018,0.44,0.79,0.9235,0.67,0.96
"GO_BP:496174_GO_0016081_SYNAPTIC_VESICLE_DOCKING","GO_BP","496174_GO_0016081_SYNAPTIC_VESICLE_DOCKING",8,-0.9011,0.6,0.77,-0.745,0.81,1,1.0939,0.36,0.77
"GO_BP:514665_GO_0061117_NEGATIVE_REGULATION_OF_HEART_GROWTH","GO_BP","514665_GO_0061117_NEGATIVE_REGULATION_OF_HEART_GROWTH",11,-0.9011,0.61,0.77,0.9467,0.5,1,1.2306,0.19,0.71
"KEGG_pathway:HSA00260_GLYCINE_SERINE_AND_THREONINE_METABOLISM","KEGG_pathway","HSA00260_GLYCINE_SERINE_AND_THREONINE_METABOLISM",38,-0.9008,0.62,0.69,-0.99,0.48,0.89,-0.7693,0.86,0.95
"KEGG_compound:C04805_5_S_HETE_5_HYDROXYEICOSATETRAENOATE_5_HETE_6E_8Z_11Z_14Z_5S_5_HYDROXYICOSA_6_8_11_14_TETRAENOIC_ACID","KEGG_compound","C04805_5_S_HETE_5_HYDROXYEICOSATETRAENOATE_5_HETE_6E_8Z_11Z_14Z_5S_5_HYDROXYICOSA_6_8_11_14_TETRAENOIC_ACID",6,-0.9008,0.61,0.72,0.5406,0.96,1,1.5743,0.039,0.12
"C7_Immunologic_signatures:C7_ALL_586_GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_586_GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDM_DN",200,-0.9007,0.71,0.78,1.6335,0,0.0016,0.779,0.98,1
"GO_BP:754747_GO_1901796_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR","GO_BP","754747_GO_1901796_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",48,-0.9007,0.62,0.77,-0.8617,0.69,1,-1.188,0.19,0.73
"GO_CC:487646_GO_0001750_PHOTORECEPTOR_OUTER_SEGMENT","GO_CC","487646_GO_0001750_PHOTORECEPTOR_OUTER_SEGMENT",56,-0.9005,0.64,0.86,-0.9295,0.58,0.92,1.1056,0.28,0.89
"KEGG_enzyme:2.7.4.6_NUCLEOSIDE_DIPHOSPHATE_KINASE_NUCLEOSIDE_5_DIPHOSPHATE_KINASE_NUCLEOSIDE_DIPHOSPHATE_UDP_KINASE_NUCLEOSIDE_DIPHOSPHOKINASE_NUCLEOTIDE_PHOSPHATE_KINASE_UDP_KINASE_URIDINE_DIPHOSPHATE_KINASE","KEGG_enzyme","2.7.4.6_NUCLEOSIDE_DIPHOSPHATE_KINASE_NUCLEOSIDE_5_DIPHOSPHATE_KINASE_NUCLEOSIDE_DIPHOSPHATE_UDP_KINASE_NUCLEOSIDE_DIPHOSPHOKINASE_NUCLEOTIDE_PHOSPHATE_KINASE_UDP_KINASE_URIDINE_DIPHOSPHATE_KINASE",8,-0.9005,0.6,0.64,-0.6937,0.84,0.91,-1.2848,0.18,0.45
"GO_MF:490623_GO_0005520_INSULIN_LIKE_GROWTH_FACTOR_BINDING","GO_MF","490623_GO_0005520_INSULIN_LIKE_GROWTH_FACTOR_BINDING",24,-0.9004,0.62,0.79,0.7278,0.88,1,1.2014,0.2,0.72
"GO_CC:502396_GO_0033176_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX","GO_CC","502396_GO_0033176_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX",22,-0.9003,0.62,0.85,0.7628,0.81,0.98,1.3451,0.13,0.71
"GO_BP:508231_GO_0045924_REGULATION_OF_FEMALE_RECEPTIVITY","GO_BP","508231_GO_0045924_REGULATION_OF_FEMALE_RECEPTIVITY",8,-0.9003,0.56,0.77,0.679,0.87,1,-1.3732,0.12,0.59
"GO_BP:752130_GO_0061387_REGULATION_OF_EXTENT_OF_CELL_GROWTH","GO_BP","752130_GO_0061387_REGULATION_OF_EXTENT_OF_CELL_GROWTH",71,-0.9003,0.67,0.77,-0.9308,0.6,1,0.9793,0.47,0.88
"C3_TF_targets:C3_TFT_219_V_PAX3_01","C3_TF_targets","C3_TFT_219_V_PAX3_01",21,-0.9002,0.61,0.77,-1.3614,0.11,0.19,-0.9265,0.58,0.89
"GO_CC:501296_GO_0032059_BLEB","GO_CC","501296_GO_0032059_BLEB",7,-0.9,0.6,0.85,0.5807,0.95,1,0.7905,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1598_GENTILE_UV_RESPONSE_CLUSTER_D9","C2_Chemical_and_genetic_perturbations","C2_CGP_1598_GENTILE_UV_RESPONSE_CLUSTER_D9",28,-0.9,0.61,0.73,1.2433,0.16,0.44,0.894,0.62,1
"GO_MF:496927_GO_0017127_CHOLESTEROL_TRANSPORTER_ACTIVITY","GO_MF","496927_GO_0017127_CHOLESTEROL_TRANSPORTER_ACTIVITY",18,-0.8999,0.59,0.79,-1.139,0.28,0.81,1.2768,0.15,0.65
"C7_Immunologic_signatures:C7_ALL_953_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP","C7_Immunologic_signatures","C7_ALL_953_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP",197,-0.8998,0.72,0.79,1.0879,0.23,0.47,-0.8002,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2295_WEBER_METHYLATED_HCP_IN_SPERM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2295_WEBER_METHYLATED_HCP_IN_SPERM_UP",19,-0.8998,0.58,0.73,-1.6586,0.019,0.37,-1.2535,0.16,0.47
"GO_BP:514601_GO_0061053_SOMITE_DEVELOPMENT","GO_BP","514601_GO_0061053_SOMITE_DEVELOPMENT",73,-0.8997,0.66,0.77,-0.9454,0.56,1,0.9771,0.49,0.88
"GO_BP:499258_GO_0021979_HYPOTHALAMUS_CELL_DIFFERENTIATION","GO_BP","499258_GO_0021979_HYPOTHALAMUS_CELL_DIFFERENTIATION",8,-0.8997,0.59,0.77,-1.0582,0.39,0.96,0.9646,0.5,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1990_BURTON_ADIPOGENESIS_PEAK_AT_16HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1990_BURTON_ADIPOGENESIS_PEAK_AT_16HR",40,-0.8995,0.63,0.73,1.2895,0.1,0.4,-1.3943,0.054,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_1613_BROWNE_HCMV_INFECTION_16HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1613_BROWNE_HCMV_INFECTION_16HR_UP",224,-0.8995,0.71,0.73,0.9199,0.73,0.9,-0.8157,0.95,0.94
"C4_Cancer_modules:C4_CM_246_MODULE_278","C4_Cancer_modules","C4_CM_246_MODULE_278",34,-0.8995,0.62,0.73,-0.6169,0.96,1,-1.1796,0.2,0.43
"GO_BP:507103_GO_0044088_REGULATION_OF_VACUOLE_ORGANIZATION","GO_BP","507103_GO_0044088_REGULATION_OF_VACUOLE_ORGANIZATION",18,-0.8994,0.6,0.77,0.8483,0.67,1,-0.639,0.94,1
"C1_Positional:C1_ALL_285_CHR3P23","C1_Positional","C1_ALL_285_CHR3P23",13,-0.8992,0.59,0.97,-0.9886,0.48,1,-0.8076,0.73,0.98
"C1_Positional:C1_ALL_101_CHR2Q13","C1_Positional","C1_ALL_101_CHR2Q13",32,-0.8988,0.62,0.97,0.7536,0.87,0.98,1.3505,0.087,0.41
"C3_TF_targets:C3_TFT_314_V_E2F_03","C3_TF_targets","C3_TFT_314_V_E2F_03",245,-0.8988,0.72,0.77,0.9548,0.57,1,-1.2372,0.031,0.3
"GO_MF:490040_GO_0004726_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY","GO_MF","490040_GO_0004726_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY",7,-0.8986,0.6,0.79,1.0476,0.41,0.83,-0.8603,0.64,0.91
"REACTOME:160134_REACT_21281_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX","REACTOME","160134_REACT_21281_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX",26,-0.8986,0.61,0.78,0.7017,0.9,1,-0.714,0.89,1
"C7_Immunologic_signatures:C7_ALL_261_GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_261_GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP",200,-0.8986,0.72,0.79,1.2136,0.089,0.2,-1.2194,0.058,0.24
"C7_Immunologic_signatures:C7_ALL_794_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_794_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN",198,-0.8985,0.7,0.79,0.8245,0.91,1,-1.0149,0.38,0.69
"GO_CC:752729_GO_0097228_SPERM_PRINCIPAL_PIECE","GO_CC","752729_GO_0097228_SPERM_PRINCIPAL_PIECE",16,-0.8984,0.58,0.85,-1.6408,0.02,0.33,0.6509,0.92,1
"GO_BP:754041_GO_1901072_GLUCOSAMINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS","GO_BP","754041_GO_1901072_GLUCOSAMINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS",8,-0.8983,0.61,0.77,1.591,0.032,0.3,0.9641,0.47,0.89
"GO_BP:511846_GO_0050910_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SOUND","GO_BP","511846_GO_0050910_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SOUND",14,-0.8983,0.61,0.77,0.6638,0.91,1,-1.4533,0.073,0.55
"C1_Positional:C1_ALL_36_CHR2Q36","C1_Positional","C1_ALL_36_CHR2Q36",40,-0.8983,0.65,0.96,-1.1937,0.2,1,1.0665,0.32,0.7
"KEGG_compound:C20878_VERY_LONG_CHAIN_3R_3_HYDROXYACYL_COA","KEGG_compound","C20878_VERY_LONG_CHAIN_3R_3_HYDROXYACYL_COA",5,-0.8982,0.61,0.73,1.0263,0.45,1,-1.524,0.039,0.21
"GO_MF:495389_GO_0015114_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495389_GO_0015114_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,-0.8982,0.62,0.79,-0.9281,0.55,0.97,0.9813,0.48,0.88
"REACTOME:730310_REACT_150366_ELASTIC_FIBRE_FORMATION","REACTOME","730310_REACT_150366_ELASTIC_FIBRE_FORMATION",41,-0.8979,0.64,0.78,-0.9249,0.61,1,1.6821,0.002,0.42
"GO_MF:503396_GO_0034190_APOLIPOPROTEIN_RECEPTOR_BINDING","GO_MF","503396_GO_0034190_APOLIPOPROTEIN_RECEPTOR_BINDING",6,-0.8977,0.58,0.79,0.756,0.77,1,0.3713,1,1
"GO_BP:508234_GO_0045927_POSITIVE_REGULATION_OF_GROWTH","GO_BP","508234_GO_0045927_POSITIVE_REGULATION_OF_GROWTH",191,-0.8976,0.69,0.77,0.8449,0.92,1,0.9437,0.61,0.91
"GO_BP:491276_GO_0006323_DNA_PACKAGING","GO_BP","491276_GO_0006323_DNA_PACKAGING",177,-0.8976,0.7,0.77,-1.1418,0.18,0.93,-1.5918,0,0.51
"GO_BP:515999_GO_0071073_POSITIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS","GO_BP","515999_GO_0071073_POSITIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS",7,-0.8976,0.59,0.77,0.6062,0.93,1,1.609,0.025,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2118_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS","C2_Chemical_and_genetic_perturbations","C2_CGP_2118_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS",12,-0.8976,0.61,0.73,1.1351,0.28,0.57,-0.8924,0.62,0.89
"GO_BP:502815_GO_0033599_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION","GO_BP","502815_GO_0033599_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION",16,-0.8975,0.6,0.77,-0.8874,0.62,1,1.1393,0.3,0.73
"GO_CC:490678_GO_0005606_LAMININ_1_COMPLEX","GO_CC","490678_GO_0005606_LAMININ_1_COMPLEX",7,-0.8971,0.6,0.86,1.1363,0.31,0.6,1.1867,0.29,0.82
"C7_Immunologic_signatures:C7_ALL_362_GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN","C7_Immunologic_signatures","C7_ALL_362_GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN",190,-0.8971,0.7,0.79,-0.7535,0.98,1,0.8729,0.79,1
"GO_MF:499567_GO_0030145_MANGANESE_ION_BINDING","GO_MF","499567_GO_0030145_MANGANESE_ION_BINDING",48,-0.8969,0.64,0.79,0.8762,0.7,1,-1.0557,0.36,0.74
"GO_BP:508877_GO_0046629_GAMMA_DELTA_T_CELL_ACTIVATION","GO_BP","508877_GO_0046629_GAMMA_DELTA_T_CELL_ACTIVATION",5,-0.8966,0.63,0.77,-1.496,0.053,0.81,-1.1716,0.3,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_934_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_934_LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP",38,-0.8965,0.64,0.73,1.1668,0.21,0.53,-0.9062,0.62,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_3347_HOLLEMAN_DAUNORUBICIN_B_ALL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3347_HOLLEMAN_DAUNORUBICIN_B_ALL_UP",10,-0.8965,0.59,0.73,-1.3352,0.15,0.69,-0.6138,0.94,0.99
"GO_BP:504466_GO_0035282_SEGMENTATION","GO_BP","504466_GO_0035282_SEGMENTATION",96,-0.8964,0.67,0.78,0.8119,0.85,1,1.0226,0.43,0.83
"C7_Immunologic_signatures:C7_ALL_1156_GSE27786_LSK_VS_ERYTHROBLAST_DN","C7_Immunologic_signatures","C7_ALL_1156_GSE27786_LSK_VS_ERYTHROBLAST_DN",193,-0.8963,0.7,0.79,1.1603,0.12,0.3,-1.0066,0.42,0.71
"REACTOME:771591_REACT_160089_CONSTITUTIVE_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS","REACTOME","771591_REACT_160089_CONSTITUTIVE_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS",15,-0.8962,0.64,0.79,0.9028,0.61,0.9,-1.5265,0.047,0.33
"C4_Cancer_modules:C4_CM_416_MODULE_540","C4_Cancer_modules","C4_CM_416_MODULE_540",10,-0.896,0.6,0.73,1.1922,0.25,0.4,1.3527,0.14,0.4
"GO_MF:490166_GO_0004865_PROTEIN_SERINE_THREONINE_PHOSPHATASE_INHIBITOR_ACTIVITY","GO_MF","490166_GO_0004865_PROTEIN_SERINE_THREONINE_PHOSPHATASE_INHIBITOR_ACTIVITY",6,-0.896,0.61,0.8,0.9614,0.5,0.91,0.6227,0.91,1
"GO_BP:492059_GO_0007281_GERM_CELL_DEVELOPMENT","GO_BP","492059_GO_0007281_GERM_CELL_DEVELOPMENT",185,-0.8954,0.71,0.78,-1.0791,0.3,0.95,-0.8083,0.96,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_1770_GENTILE_UV_RESPONSE_CLUSTER_D5","C2_Chemical_and_genetic_perturbations","C2_CGP_1770_GENTILE_UV_RESPONSE_CLUSTER_D5",39,-0.8954,0.63,0.73,-0.7213,0.9,1,1.0478,0.38,0.93
"GO_BP:504621_GO_0035437_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ENDOPLASMIC_RETICULUM","GO_BP","504621_GO_0035437_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ENDOPLASMIC_RETICULUM",10,-0.8952,0.59,0.78,0.7704,0.77,1,0.9758,0.47,0.88
"OMIM_gene:OMIM176801_PROSAPOSIN_PSAP_SAPOSIN_A_INCLUDED_SAPA_INCLUDED","OMIM_gene","OMIM176801_PROSAPOSIN_PSAP_SAPOSIN_A_INCLUDED_SAPA_INCLUDED",5,-0.8951,0.62,0.81,-1.0245,0.46,0.74,1.4428,0.079,1
"GO_BP:511802_GO_0050859_NEGATIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY","GO_BP","511802_GO_0050859_NEGATIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY",5,-0.8951,0.62,0.78,-0.8323,0.68,1,-0.9628,0.53,0.88
"GO_BP:501740_GO_0032509_ENDOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY","GO_BP","501740_GO_0032509_ENDOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY",6,-0.895,0.6,0.78,1.1824,0.26,0.8,-0.6808,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2418_MALONEY_RESPONSE_TO_17AAG_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2418_MALONEY_RESPONSE_TO_17AAG_DN",78,-0.8949,0.66,0.74,2.2634,0,0.00025,-0.8034,0.85,0.95
"C7_Immunologic_signatures:C7_ALL_327_GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP","C7_Immunologic_signatures","C7_ALL_327_GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP",194,-0.8948,0.71,0.8,1.2025,0.07,0.22,-0.7465,1,1
"REACTOME:106349_REACT_9390_FGFR2_LIGAND_BINDING_AND_ACTIVATION","REACTOME","106349_REACT_9390_FGFR2_LIGAND_BINDING_AND_ACTIVATION",14,-0.8948,0.62,0.79,-1.0805,0.35,0.91,0.7419,0.82,1
"C7_Immunologic_signatures:C7_ALL_289_GSE14350_IL2RB_KO_VS_WT_TREG_UP","C7_Immunologic_signatures","C7_ALL_289_GSE14350_IL2RB_KO_VS_WT_TREG_UP",198,-0.8947,0.74,0.79,0.9351,0.69,0.94,-0.8484,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1771_BRACHAT_RESPONSE_TO_METHOTREXATE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1771_BRACHAT_RESPONSE_TO_METHOTREXATE_UP",26,-0.8947,0.62,0.74,0.704,0.9,1,1.1212,0.29,0.85
"C7_Immunologic_signatures:C7_ALL_554_GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_554_GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDM_DN",196,-0.8947,0.7,0.79,1.5978,0,0.0031,-0.8768,0.83,0.98
"KEGG_compound:C16162__9Z_12Z_15Z_OCTADECATRIENOYL_COA_ALPHA_LINOLENOYL_COA","KEGG_compound","C16162__9Z_12Z_15Z_OCTADECATRIENOYL_COA_ALPHA_LINOLENOYL_COA",5,-0.8947,0.58,0.73,-0.631,0.91,1,-0.7522,0.76,0.88
"GO_BP:514531_GO_0060976_CORONARY_VASCULATURE_DEVELOPMENT","GO_BP","514531_GO_0060976_CORONARY_VASCULATURE_DEVELOPMENT",15,-0.8945,0.61,0.78,0.638,0.94,1,0.8546,0.67,0.98
"GO_BP:499867_GO_0030540_FEMALE_GENITALIA_DEVELOPMENT","GO_BP","499867_GO_0030540_FEMALE_GENITALIA_DEVELOPMENT",16,-0.8944,0.63,0.78,-0.902,0.6,1,1.104,0.31,0.76
"GO_CC:501208_GO_0031968_ORGANELLE_OUTER_MEMBRANE","GO_CC","501208_GO_0031968_ORGANELLE_OUTER_MEMBRANE",166,-0.8944,0.71,0.86,1.448,0,0.25,-0.989,0.47,1
"KEGG_compound:C00234_10_FORMYLTETRAHYDROFOLATE_10_FORMYL_THF","KEGG_compound","C00234_10_FORMYLTETRAHYDROFOLATE_10_FORMYL_THF",9,-0.8943,0.59,0.73,0.5594,0.97,1,-0.9526,0.53,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_3311_PHONG_TNF_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3311_PHONG_TNF_TARGETS_DN",8,-0.8942,0.62,0.74,-0.645,0.89,1,0.8841,0.59,1
"GO_MF:505909_GO_0042806_FUCOSE_BINDING","GO_MF","505909_GO_0042806_FUCOSE_BINDING",6,-0.8941,0.6,0.8,0.7757,0.74,1,-0.6732,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3267_IM_SREBF1A_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3267_IM_SREBF1A_TARGETS",5,-0.8938,0.61,0.74,-1.1296,0.33,0.88,-1.2427,0.24,0.48
"GO_BP:753174_GO_1900181_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS","GO_BP","753174_GO_1900181_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS",61,-0.8938,0.64,0.78,-0.7971,0.85,1,-1.2023,0.15,0.73
"GO_BP:495999_GO_0051181_COFACTOR_TRANSPORT","GO_BP","495999_GO_0051181_COFACTOR_TRANSPORT",24,-0.8937,0.63,0.78,-1.1727,0.23,0.91,-0.959,0.53,0.88
"GO_CC:501144_GO_0031903_MICROBODY_MEMBRANE","GO_CC","501144_GO_0031903_MICROBODY_MEMBRANE",55,-0.8937,0.65,0.86,0.9628,0.52,0.82,-0.9718,0.5,1
"C7_Immunologic_signatures:C7_ALL_1296_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1296_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN",195,-0.8932,0.72,0.8,0.7871,0.98,1,0.7604,0.97,1
"GO_BP:510381_GO_0048268_CLATHRIN_COAT_ASSEMBLY","GO_BP","510381_GO_0048268_CLATHRIN_COAT_ASSEMBLY",13,-0.8931,0.59,0.78,1.2738,0.18,0.71,-0.4724,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_517_HUMMERICH_BENIGN_SKIN_TUMOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_517_HUMMERICH_BENIGN_SKIN_TUMOR_DN",18,-0.8931,0.61,0.74,-1.1812,0.24,0.82,-0.6918,0.9,0.99
"GO_BP:508428_GO_0046132_PYRIMIDINE_RIBONUCLEOSIDE_BIOSYNTHETIC_PROCESS","GO_BP","508428_GO_0046132_PYRIMIDINE_RIBONUCLEOSIDE_BIOSYNTHETIC_PROCESS",23,-0.8929,0.62,0.78,-0.5872,0.96,1,-0.9452,0.52,0.89
"GO_CC:487084_GO_0000791_EUCHROMATIN","GO_CC","487084_GO_0000791_EUCHROMATIN",29,-0.8929,0.61,0.86,-0.8111,0.77,1,-0.7048,0.92,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_215_BIOCARTA_VITCB_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_215_BIOCARTA_VITCB_PATHWAY",11,-0.8927,0.62,0.71,-1.1568,0.27,1,0.6644,0.89,1
"C7_Immunologic_signatures:C7_ALL_351_GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_351_GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP",198,-0.8926,0.72,0.8,-1.1473,0.17,1,-1.3087,0.025,0.13
"GO_BP:502103_GO_0032881_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS","GO_BP","502103_GO_0032881_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS",43,-0.8925,0.65,0.78,-0.5493,1,1,0.6218,0.98,1
"REACTOME:1127632_REACT_264378_RNF_MUTANTS_SHOW_ENHANCED_WNT_SIGNALING_AND_PROLIFERATION","REACTOME","1127632_REACT_264378_RNF_MUTANTS_SHOW_ENHANCED_WNT_SIGNALING_AND_PROLIFERATION",8,-0.8924,0.62,0.79,-0.9832,0.47,1,1.3486,0.14,0.7
"C7_Immunologic_signatures:C7_ALL_288_GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN","C7_Immunologic_signatures","C7_ALL_288_GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN",191,-0.8921,0.72,0.8,-0.8182,0.93,1,-1.3917,0.01,0.068
"REACTOME:106231_REACT_1069_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION","REACTOME","106231_REACT_1069_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION",36,-0.8921,0.62,0.79,0.7332,0.89,1,-0.8821,0.66,0.97
"GO_BP:504747_GO_0035567_NON_CANONICAL_WNT_SIGNALING_PATHWAY","GO_BP","504747_GO_0035567_NON_CANONICAL_WNT_SIGNALING_PATHWAY",35,-0.8921,0.64,0.78,-0.9351,0.55,1,1.0768,0.31,0.78
"GO_BP:510799_GO_0048745_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","510799_GO_0048745_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT",20,-0.892,0.64,0.78,-1.2618,0.16,0.91,-0.9837,0.43,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_3214_TERAO_AOX4_TARGETS_HG_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3214_TERAO_AOX4_TARGETS_HG_UP",28,-0.892,0.62,0.74,0.6461,0.95,1,-1.1773,0.21,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_402_CASTELLANO_NRAS_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_402_CASTELLANO_NRAS_TARGETS_DN",14,-0.8919,0.6,0.74,0.5792,0.97,1,1.0229,0.41,0.94
"C7_Immunologic_signatures:C7_ALL_187_GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP","C7_Immunologic_signatures","C7_ALL_187_GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP",199,-0.8919,0.72,0.8,1.6881,0,0.00079,-0.8924,0.77,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2501_SEKI_INFLAMMATORY_RESPONSE_LPS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2501_SEKI_INFLAMMATORY_RESPONSE_LPS_DN",22,-0.8917,0.64,0.74,-1.1119,0.3,0.9,-0.9614,0.51,0.8
"C7_Immunologic_signatures:C7_ALL_833_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP","C7_Immunologic_signatures","C7_ALL_833_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP",164,-0.8915,0.71,0.8,1.3782,0.0084,0.046,1.5111,0.0059,0.035
"GO_BP:496100_GO_0015980_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS","GO_BP","496100_GO_0015980_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS",308,-0.8914,0.76,0.78,1.7657,0,0.13,-0.8923,0.8,0.93
"GO_BP:514935_GO_0065004_PROTEIN_DNA_COMPLEX_ASSEMBLY","GO_BP","514935_GO_0065004_PROTEIN_DNA_COMPLEX_ASSEMBLY",153,-0.8913,0.71,0.78,-1.0653,0.29,0.96,-1.4454,0.0062,0.55
"GO_MF:487325_GO_0001102_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING","GO_MF","487325_GO_0001102_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING",36,-0.8913,0.64,0.8,-1.1536,0.24,0.81,0.965,0.49,0.9
"GO_BP:498211_GO_0019368_FATTY_ACID_ELONGATION_UNSATURATED_FATTY_ACID","GO_BP","498211_GO_0019368_FATTY_ACID_ELONGATION_UNSATURATED_FATTY_ACID",5,-0.8913,0.6,0.78,-0.9662,0.52,1,-1.087,0.4,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_1130_PETRETTO_HEART_MASS_QTL_CIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1130_PETRETTO_HEART_MASS_QTL_CIS_DN",24,-0.8912,0.62,0.74,1.1798,0.22,0.52,-0.8883,0.63,0.9
"KEGG_compound:C16217_3_HYDROXYOCTADECANOYL_COA_3_HYDROXYSTEAROYL_COA_BETA_HYDROXYSTEAROYL_COA","KEGG_compound","C16217_3_HYDROXYOCTADECANOYL_COA_3_HYDROXYSTEAROYL_COA_BETA_HYDROXYSTEAROYL_COA",5,-0.8911,0.64,0.73,1.0435,0.42,1,-1.5242,0.049,0.22
"GO_BP:492348_GO_0050909_SENSORY_PERCEPTION_OF_TASTE","GO_BP","492348_GO_0050909_SENSORY_PERCEPTION_OF_TASTE",60,-0.891,0.65,0.78,-0.8781,0.7,1,-1.0337,0.39,0.82
"GO_MF:490472_GO_0005231_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY","GO_MF","490472_GO_0005231_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY",49,-0.891,0.65,0.8,-1.3688,0.063,0.69,1.6188,0.0021,0.3
"WikiPathways:198887_WP299_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY","WikiPathways","198887_WP299_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY",33,-0.891,0.63,0.74,-0.9353,0.55,1,1.1951,0.2,0.65
"GO_BP:491939_GO_0007126_MEIOTIC_NUCLEAR_DIVISION","GO_BP","491939_GO_0007126_MEIOTIC_NUCLEAR_DIVISION",121,-0.8909,0.7,0.78,-0.9933,0.48,1,-1.3999,0.021,0.58
"C3_MicroRNA_targets:C3_MIR_62_GTGCCAT_MIR_183","C3_MicroRNA_targets","C3_MIR_62_GTGCCAT_MIR_183",170,-0.8907,0.73,0.8,1.591,0,0.54,0.783,0.95,1
"GO_BP:492898_GO_0008652_CELLULAR_AMINO_ACID_BIOSYNTHETIC_PROCESS","GO_BP","492898_GO_0008652_CELLULAR_AMINO_ACID_BIOSYNTHETIC_PROCESS",91,-0.8907,0.68,0.78,-0.7461,0.95,1,-1.3441,0.035,0.61
"GO_BP:508726_GO_0046465_DOLICHYL_DIPHOSPHATE_METABOLIC_PROCESS","GO_BP","508726_GO_0046465_DOLICHYL_DIPHOSPHATE_METABOLIC_PROCESS",5,-0.8906,0.6,0.78,-1.3478,0.15,0.92,0.4985,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2020_MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2020_MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP",393,-0.8904,0.76,0.74,1.078,0.22,0.67,-0.8078,0.99,0.95
"GO_MF:511721_GO_0050750_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING","GO_MF","511721_GO_0050750_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING",15,-0.8904,0.61,0.8,-1.3246,0.13,0.73,-1.1458,0.28,0.65
"GO_BP:514091_GO_0060536_CARTILAGE_MORPHOGENESIS","GO_BP","514091_GO_0060536_CARTILAGE_MORPHOGENESIS",12,-0.8901,0.61,0.78,-0.9766,0.49,1,1.0927,0.33,0.77
"KEGG_pathway:HSA04130_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT","KEGG_pathway","HSA04130_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT",34,-0.89,0.63,0.71,1.1941,0.18,0.55,0.7393,0.89,1
"GO_BP:514724_GO_0061179_NEGATIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS","GO_BP","514724_GO_0061179_NEGATIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS",6,-0.8898,0.61,0.78,0.5313,0.99,1,-0.7316,0.8,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_159_GAL_LEUKEMIC_STEM_CELL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_159_GAL_LEUKEMIC_STEM_CELL_UP",130,-0.8898,0.7,0.74,0.9857,0.49,0.81,-0.9752,0.48,0.79
"GO_MF:496756_GO_0016864_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_S_S_BONDS","GO_MF","496756_GO_0016864_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_S_S_BONDS",22,-0.8898,0.6,0.8,-0.7463,0.86,1,-1.2329,0.18,0.58
"C3_MicroRNA_targets:C3_MIR_172_CGCAAAA_MIR_450","C3_MicroRNA_targets","C3_MIR_172_CGCAAAA_MIR_450",9,-0.8898,0.61,0.8,-1.0626,0.38,1,0.7009,0.84,1
"GO_BP:491752_GO_0006892_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT","GO_BP","491752_GO_0006892_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT",102,-0.8897,0.7,0.78,1.041,0.36,0.96,-0.9057,0.67,0.92
"GO_MF:502908_GO_0033691_SIALIC_ACID_BINDING","GO_MF","502908_GO_0033691_SIALIC_ACID_BINDING",9,-0.8896,0.62,0.8,-0.6706,0.88,1,0.7222,0.83,1
"WikiPathways:198798_WP1423_GANGLIO_SPHINGOLIPID_METABOLISM","WikiPathways","198798_WP1423_GANGLIO_SPHINGOLIPID_METABOLISM",11,-0.8896,0.6,0.74,1.0507,0.39,1,0.8087,0.69,1
"GO_CC:490724_GO_0005667_TRANSCRIPTION_FACTOR_COMPLEX","GO_CC","490724_GO_0005667_TRANSCRIPTION_FACTOR_COMPLEX",285,-0.8895,0.75,0.86,0.7449,1,0.98,0.7993,0.98,1
"C7_Immunologic_signatures:C7_ALL_1147_GSE27786_LSK_VS_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1147_GSE27786_LSK_VS_CD4_TCELL_UP",198,-0.8895,0.74,0.8,1.0332,0.31,0.64,-1.0146,0.41,0.69
"REACTOME:106350_REACT_9416_FGFR2B_LIGAND_BINDING_AND_ACTIVATION","REACTOME","106350_REACT_9416_FGFR2B_LIGAND_BINDING_AND_ACTIVATION",6,-0.8894,0.61,0.8,0.6931,0.84,1,-0.6649,0.88,1
"REACTOME:106450_REACT_13696_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL","REACTOME","106450_REACT_13696_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL",13,-0.8893,0.62,0.8,1.0608,0.39,0.65,0.6554,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1945_RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1945_RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP",22,-0.8893,0.64,0.74,1.195,0.19,0.49,-0.8552,0.7,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1075_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1075_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN",32,-0.8892,0.63,0.74,-0.8106,0.8,1,-0.835,0.73,0.93
"GO_MF:515035_GO_0070097_DELTA_CATENIN_BINDING","GO_MF","515035_GO_0070097_DELTA_CATENIN_BINDING",7,-0.8892,0.61,0.8,-1.704,0.0039,0.31,-1.2455,0.22,0.59
"GO_BP:921147_GO_1902548_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS","GO_BP","921147_GO_1902548_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS",5,-0.8892,0.64,0.79,-0.695,0.86,1,0.7644,0.75,1
"GO_BP:516242_GO_0071318_CELLULAR_RESPONSE_TO_ATP","GO_BP","516242_GO_0071318_CELLULAR_RESPONSE_TO_ATP",10,-0.8891,0.61,0.79,0.8892,0.59,1,1.316,0.13,0.66
"GO_BP:982377_GO_1902807_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION","GO_BP","982377_GO_1902807_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION",103,-0.8889,0.69,0.79,1.4803,0.009,0.44,-1.1628,0.17,0.73
"REACTOME:106138_REACT_17017_BETA_OXIDATION_OF_PRISTANOYL_COA","REACTOME","106138_REACT_17017_BETA_OXIDATION_OF_PRISTANOYL_COA",8,-0.8888,0.61,0.8,1.1786,0.26,0.47,-1.4363,0.086,0.39
"GO_BP:808770_GO_1902099_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE","GO_BP","808770_GO_1902099_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE",49,-0.8888,0.64,0.79,0.8475,0.76,1,-0.8407,0.77,0.96
"REACTOME:105927_REACT_9411_GAP_JUNCTION_TRAFFICKING","REACTOME","105927_REACT_9411_GAP_JUNCTION_TRAFFICKING",27,-0.8887,0.62,0.79,-1.0056,0.42,0.98,1.1502,0.26,0.89
"C7_Immunologic_signatures:C7_ALL_1721_GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1721_GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP",198,-0.8886,0.73,0.81,1.2254,0.064,0.19,-0.8704,0.83,0.99
"C7_Immunologic_signatures:C7_ALL_615_GSE17721_LPS_VS_PAM3CSK4_24H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_615_GSE17721_LPS_VS_PAM3CSK4_24H_BMDM_UP",200,-0.8886,0.71,0.81,0.9278,0.67,0.96,-0.8544,0.86,1
"GO_BP:504279_GO_0035094_RESPONSE_TO_NICOTINE","GO_BP","504279_GO_0035094_RESPONSE_TO_NICOTINE",38,-0.8885,0.64,0.79,-1.1047,0.3,0.94,-0.962,0.52,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_837_DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_837_DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN",29,-0.8885,0.6,0.74,-1.2154,0.2,0.8,-1.3679,0.08,0.38
"C7_Immunologic_signatures:C7_ALL_246_GSE14308_TH2_VS_TH17_DN","C7_Immunologic_signatures","C7_ALL_246_GSE14308_TH2_VS_TH17_DN",199,-0.8885,0.74,0.8,-0.8162,0.92,1,-1.0284,0.37,0.66
"REACTOME:106053_REACT_278_PLATELET_AGGREGATION_PLUG_FORMATION_","REACTOME","106053_REACT_278_PLATELET_AGGREGATION_PLUG_FORMATION_",37,-0.8883,0.64,0.79,1.1972,0.19,0.45,0.8178,0.8,1
"GO_BP:486798_GO_0000280_NUCLEAR_DIVISION","GO_BP","486798_GO_0000280_NUCLEAR_DIVISION",439,-0.8882,0.79,0.79,1.1592,0.071,0.83,-1.1697,0.048,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_420_NADERI_BREAST_CANCER_PROGNOSIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_420_NADERI_BREAST_CANCER_PROGNOSIS_DN",18,-0.8882,0.61,0.75,1.3038,0.12,0.39,1.0958,0.31,0.88
"GO_MF:489287_GO_0042393_HISTONE_BINDING","GO_MF","489287_GO_0042393_HISTONE_BINDING",163,-0.8881,0.73,0.8,-1.2157,0.087,0.82,-1.3276,0.035,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_1923_DAZARD_UV_RESPONSE_CLUSTER_G6","C2_Chemical_and_genetic_perturbations","C2_CGP_1923_DAZARD_UV_RESPONSE_CLUSTER_G6",152,-0.888,0.72,0.75,0.9531,0.59,0.86,0.7619,0.97,1
"C7_Immunologic_signatures:C7_ALL_286_GSE14350_TREG_VS_TEFF_DN","C7_Immunologic_signatures","C7_ALL_286_GSE14350_TREG_VS_TEFF_DN",187,-0.8879,0.72,0.81,-0.8949,0.73,1,0.8995,0.78,1
"GO_BP:491176_GO_0006206_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS","GO_BP","491176_GO_0006206_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS",33,-0.8876,0.64,0.79,0.9575,0.54,1,-0.9323,0.57,0.9
"C1_Positional:C1_ALL_171_CHR13Q14","C1_Positional","C1_ALL_171_CHR13Q14",84,-0.8875,0.67,0.98,-0.914,0.63,1,0.9063,0.65,0.84
"C7_Immunologic_signatures:C7_ALL_1428_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN","C7_Immunologic_signatures","C7_ALL_1428_GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN",196,-0.8873,0.75,0.81,1.0296,0.39,0.65,-0.8471,0.91,1
"GO_BP:516478_GO_0071554_CELL_WALL_ORGANIZATION_OR_BIOGENESIS","GO_BP","516478_GO_0071554_CELL_WALL_ORGANIZATION_OR_BIOGENESIS",9,-0.8872,0.61,0.79,-1.1997,0.24,0.9,-1.4468,0.083,0.55
"GO_BP:516219_GO_0071295_CELLULAR_RESPONSE_TO_VITAMIN","GO_BP","516219_GO_0071295_CELLULAR_RESPONSE_TO_VITAMIN",42,-0.8872,0.65,0.79,0.7576,0.88,1,1.6092,0.015,0.42
"GO_BP:517489_GO_0072584_CAVEOLIN_MEDIATED_ENDOCYTOSIS","GO_BP","517489_GO_0072584_CAVEOLIN_MEDIATED_ENDOCYTOSIS",5,-0.8872,0.6,0.79,-0.4736,0.99,1,0.888,0.6,0.95
"GO_BP:518426_GO_0090286_CYTOSKELETAL_ANCHORING_AT_NUCLEAR_MEMBRANE","GO_BP","518426_GO_0090286_CYTOSKELETAL_ANCHORING_AT_NUCLEAR_MEMBRANE",7,-0.8872,0.62,0.79,-1.097,0.35,0.95,-1.1468,0.33,0.74
"GO_CC:499550_GO_0030117_MEMBRANE_COAT","GO_CC","499550_GO_0030117_MEMBRANE_COAT",87,-0.8871,0.69,0.87,1.2785,0.072,0.43,-0.7117,0.98,1
"C1_Positional:C1_ALL_306_CHR17Q11","C1_Positional","C1_ALL_306_CHR17Q11",108,-0.887,0.7,0.98,0.9166,0.66,0.84,0.9452,0.6,0.82
"C0_Hallmark:H_ALL_41_HALLMARK_HEME_METABOLISM","C0_Hallmark","H_ALL_41_HALLMARK_HEME_METABOLISM",198,-0.8869,0.73,0.73,1.8367,0,0.0014,-1.2488,0.042,0.14
"GO_MF:516869_GO_0071949_FAD_BINDING","GO_MF","516869_GO_0071949_FAD_BINDING",10,-0.8869,0.61,0.81,0.7531,0.79,1,0.84,0.68,0.99
"GO_MF:492781_GO_0016595_GLUTAMATE_BINDING","GO_MF","492781_GO_0016595_GLUTAMATE_BINDING",9,-0.8868,0.63,0.81,1.2451,0.21,0.69,0.9132,0.57,0.94
"C3_MicroRNA_targets:C3_MIR_184_GGGATGC_MIR_324_5P","C3_MicroRNA_targets","C3_MIR_184_GGGATGC_MIR_324_5P",48,-0.8865,0.65,0.8,-0.9839,0.48,1,0.6548,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2763_MEISSNER_BRAIN_HCP_WITH_H3K4ME2","C2_Chemical_and_genetic_perturbations","C2_CGP_2763_MEISSNER_BRAIN_HCP_WITH_H3K4ME2",17,-0.8865,0.62,0.75,-1.0559,0.4,0.96,-0.6778,0.91,0.99
"C7_Immunologic_signatures:C7_ALL_1904_GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1904_GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN",200,-0.8865,0.75,0.81,1.3107,0.033,0.092,1.1996,0.093,0.72
"REACTOME:530771_REACT_18273_XBP1_S_ACTIVATES_CHAPERONE_GENES","REACTOME","530771_REACT_18273_XBP1_S_ACTIVATES_CHAPERONE_GENES",57,-0.8865,0.66,0.8,0.8248,0.78,0.98,-0.7619,0.9,1
"GO_BP:751350_GO_0038092_NODAL_SIGNALING_PATHWAY","GO_BP","751350_GO_0038092_NODAL_SIGNALING_PATHWAY",9,-0.8864,0.62,0.79,-1.43,0.086,0.92,-0.6498,0.9,1
"GO_BP:993420_GO_1903078_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE","GO_BP","993420_GO_1903078_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",28,-0.8863,0.63,0.79,-0.6924,0.92,1,1.4074,0.061,0.63
"GO_BP:506118_GO_0043029_T_CELL_HOMEOSTASIS","GO_BP","506118_GO_0043029_T_CELL_HOMEOSTASIS",33,-0.886,0.64,0.79,1.0516,0.35,0.95,-0.8409,0.73,0.96
"GO_BP:504971_GO_0035794_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY","GO_BP","504971_GO_0035794_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY",15,-0.8859,0.61,0.79,0.8928,0.62,1,-1.5924,0.025,0.51
"GO_MF:490165_GO_0004864_PROTEIN_PHOSPHATASE_INHIBITOR_ACTIVITY","GO_MF","490165_GO_0004864_PROTEIN_PHOSPHATASE_INHIBITOR_ACTIVITY",33,-0.8858,0.63,0.81,-1.0305,0.41,0.88,-0.9912,0.45,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_876_INAMURA_LUNG_CANCER_SCC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_876_INAMURA_LUNG_CANCER_SCC_UP",13,-0.8857,0.62,0.75,-0.6051,0.95,1,-1.3347,0.12,0.41
"GO_BP:508194_GO_0045880_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY","GO_BP","508194_GO_0045880_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY",26,-0.8857,0.61,0.79,0.8196,0.74,1,0.9141,0.6,0.93
"GO_BP:491154_GO_0006182_CGMP_BIOSYNTHETIC_PROCESS","GO_BP","491154_GO_0006182_CGMP_BIOSYNTHETIC_PROCESS",15,-0.8854,0.64,0.79,-0.9788,0.5,1,-1.3776,0.091,0.58
"REACTOME:1127527_REACT_264224_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING","REACTOME","1127527_REACT_264224_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING",143,-0.8853,0.71,0.8,1.1905,0.11,0.45,-0.9666,0.54,0.88
"C3_MicroRNA_targets:C3_MIR_33_TGCACGA_MIR_517A_MIR_517C","C3_MicroRNA_targets","C3_MIR_33_TGCACGA_MIR_517A_MIR_517C",17,-0.8853,0.63,0.8,-0.9893,0.46,1,-0.858,0.68,1
"KEGG_module:HSA_M00034_METHIONINE_SALVAGE_PATHWAY","KEGG_module","HSA_M00034_METHIONINE_SALVAGE_PATHWAY",11,-0.8853,0.6,0.77,0.715,0.82,0.94,-1.7776,0.004,0.12
"GO_BP:518937_GO_2000291_REGULATION_OF_MYOBLAST_PROLIFERATION","GO_BP","518937_GO_2000291_REGULATION_OF_MYOBLAST_PROLIFERATION",8,-0.8853,0.62,0.79,-0.7288,0.81,1,1.4088,0.094,0.63
"GO_CC:503601_GO_0034399_NUCLEAR_PERIPHERY","GO_CC","503601_GO_0034399_NUCLEAR_PERIPHERY",111,-0.8852,0.7,0.87,-0.7358,0.96,1,-0.7752,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_478_TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_478_TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN",29,-0.885,0.62,0.75,1.4389,0.064,0.26,1.2069,0.19,0.77
"GO_BP:751078_GO_0036158_OUTER_DYNEIN_ARM_ASSEMBLY","GO_BP","751078_GO_0036158_OUTER_DYNEIN_ARM_ASSEMBLY",8,-0.885,0.64,0.79,-1.374,0.12,0.99,-0.4571,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3261_PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3261_PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP",13,-0.8848,0.62,0.75,0.6534,0.91,1,-0.7193,0.83,0.98
"GO_BP:751347_GO_0038089_POSITIVE_REGULATION_OF_CELL_MIGRATION_BY_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY","GO_BP","751347_GO_0038089_POSITIVE_REGULATION_OF_CELL_MIGRATION_BY_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY",5,-0.8848,0.63,0.79,-1.1099,0.36,0.94,-1.0096,0.47,0.84
"GO_BP:489133_GO_0003341_CILIUM_MOVEMENT","GO_BP","489133_GO_0003341_CILIUM_MOVEMENT",31,-0.8847,0.62,0.79,-1.6809,0.0075,0.59,-0.9711,0.49,0.87
"GO_CC:501814_GO_0032588_TRANS_GOLGI_NETWORK_MEMBRANE","GO_CC","501814_GO_0032588_TRANS_GOLGI_NETWORK_MEMBRANE",41,-0.8846,0.65,0.87,0.7014,0.94,0.99,-0.8774,0.67,1
"C7_Immunologic_signatures:C7_ALL_1354_GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1354_GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN",199,-0.8845,0.75,0.81,0.7025,1,1,-0.8606,0.83,1
"C7_Immunologic_signatures:C7_ALL_621_GSE17721_POLYIC_VS_CPG_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_621_GSE17721_POLYIC_VS_CPG_2H_BMDM_UP",199,-0.8845,0.73,0.81,1.2891,0.016,0.11,-0.7423,0.99,1
"REACTOME:530769_REACT_115852_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS","REACTOME","530769_REACT_115852_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS",19,-0.8845,0.64,0.8,1.3459,0.11,0.27,-0.9612,0.51,0.89
"KEGG_pathway:HSA00750_VITAMIN_B6_METABOLISM","KEGG_pathway","HSA00750_VITAMIN_B6_METABOLISM",6,-0.8844,0.64,0.72,0.9662,0.51,0.96,-0.8588,0.64,0.88
"GO_MF:515645_GO_0070717_POLY_PURINE_TRACT_BINDING","GO_MF","515645_GO_0070717_POLY_PURINE_TRACT_BINDING",16,-0.8844,0.62,0.81,0.6947,0.89,1,-0.6461,0.93,1
"C7_Immunologic_signatures:C7_ALL_643_GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_643_GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDM_UP",200,-0.8842,0.73,0.81,1.0714,0.27,0.52,-1.091,0.25,0.52
"GO_BP:502016_GO_0032793_POSITIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY","GO_BP","502016_GO_0032793_POSITIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY",14,-0.8842,0.61,0.79,-1.1776,0.25,0.9,-0.7967,0.74,0.99
"GO_MF:496687_GO_0016778_DIPHOSPHOTRANSFERASE_ACTIVITY","GO_MF","496687_GO_0016778_DIPHOSPHOTRANSFERASE_ACTIVITY",6,-0.8842,0.6,0.81,0.8108,0.69,1,-1.3126,0.15,0.56
"C7_Immunologic_signatures:C7_ALL_1858_GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN","C7_Immunologic_signatures","C7_ALL_1858_GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN",199,-0.8842,0.75,0.81,1.1272,0.15,0.37,-0.7766,0.97,1
"GO_CC:499689_GO_0030285_INTEGRAL_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE","GO_CC","499689_GO_0030285_INTEGRAL_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE",7,-0.884,0.61,0.87,-1.5179,0.05,0.63,-0.7229,0.83,1
"GO_BP:491307_GO_0006379_MRNA_CLEAVAGE","GO_BP","491307_GO_0006379_MRNA_CLEAVAGE",19,-0.8839,0.63,0.79,-0.972,0.47,1,-0.9043,0.59,0.92
"GO_MF:511931_GO_0050998_NITRIC_OXIDE_SYNTHASE_BINDING","GO_MF","511931_GO_0050998_NITRIC_OXIDE_SYNTHASE_BINDING",16,-0.8838,0.64,0.81,0.8928,0.59,0.99,0.9479,0.52,0.92
"GO_BP:752687_GO_0097186_AMELOGENESIS","GO_BP","752687_GO_0097186_AMELOGENESIS",15,-0.8838,0.62,0.79,-1.2437,0.2,0.91,1.2654,0.16,0.69
"GO_MF:496902_GO_0017091_AU_RICH_ELEMENT_BINDING","GO_MF","496902_GO_0017091_AU_RICH_ELEMENT_BINDING",18,-0.8836,0.63,0.81,0.7878,0.77,1,-1.1907,0.23,0.59
"GO_MF:495594_GO_0015370_SOLUTE_SODIUM_SYMPORTER_ACTIVITY","GO_MF","495594_GO_0015370_SOLUTE_SODIUM_SYMPORTER_ACTIVITY",51,-0.8831,0.65,0.81,-1.647,0.0056,0.4,-1.546,0.015,0.41
"GO_CC:490839_GO_0005813_CENTROSOME","GO_CC","490839_GO_0005813_CENTROSOME",450,-0.8831,0.82,0.87,0.6952,1,0.99,-1.6284,0,0.39
"C2_Chemical_and_genetic_perturbations:C2_CGP_315_ELVIDGE_HIF1A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_315_ELVIDGE_HIF1A_TARGETS_UP",67,-0.883,0.68,0.75,1.1015,0.27,0.63,-0.8858,0.68,0.89
"KEGG_module:HSA_M00058_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE_BACKBONE","KEGG_module","HSA_M00058_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE_BACKBONE",6,-0.883,0.61,0.76,0.7732,0.74,0.92,0.9506,0.5,1
"GO_BP:495030_GO_0010965_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION","GO_BP","495030_GO_0010965_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION",45,-0.8829,0.65,0.79,0.9416,0.56,1,-0.8991,0.64,0.93
"GO_MF:911269_GO_0036442_HYDROGEN_EXPORTING_ATPASE_ACTIVITY","GO_MF","911269_GO_0036442_HYDROGEN_EXPORTING_ATPASE_ACTIVITY",26,-0.8828,0.63,0.81,1.5673,0.019,0.32,0.8492,0.7,0.98
"GO_BP:492557_GO_0008216_SPERMIDINE_METABOLIC_PROCESS","GO_BP","492557_GO_0008216_SPERMIDINE_METABOLIC_PROCESS",7,-0.8827,0.61,0.79,-1.1428,0.28,0.93,-1.4526,0.059,0.54
"GO_BP:512475_GO_0051597_RESPONSE_TO_METHYLMERCURY","GO_BP","512475_GO_0051597_RESPONSE_TO_METHYLMERCURY",8,-0.8826,0.63,0.79,1.4587,0.084,0.48,0.9172,0.56,0.93
"C7_Immunologic_signatures:C7_ALL_1253_GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1253_GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP",185,-0.8826,0.75,0.81,1.596,0,0.0032,1.1797,0.13,0.79
"GO_BP:509059_GO_0046836_GLYCOLIPID_TRANSPORT","GO_BP","509059_GO_0046836_GLYCOLIPID_TRANSPORT",7,-0.8824,0.58,0.79,0.6594,0.89,1,0.66,0.87,1
"C4_Cancer_modules:C4_CM_180_MODULE_192","C4_Cancer_modules","C4_CM_180_MODULE_192",109,-0.8823,0.72,0.76,1.2641,0.072,0.31,0.9565,0.57,0.95
"GO_MF:501233_GO_0031995_INSULIN_LIKE_GROWTH_FACTOR_II_BINDING","GO_MF","501233_GO_0031995_INSULIN_LIKE_GROWTH_FACTOR_II_BINDING",7,-0.8823,0.62,0.81,0.8395,0.68,1,0.8692,0.62,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2112_KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2112_KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION",87,-0.8822,0.67,0.75,-0.746,0.94,1,-1.0699,0.3,0.67
"GO_BP:510695_GO_0048639_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH","GO_BP","510695_GO_0048639_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH",117,-0.8822,0.69,0.79,-0.6814,1,1,0.9884,0.47,0.87
"REACTOME:187198_REACT_23876_PLATELET_HOMEOSTASIS","REACTOME","187198_REACT_23876_PLATELET_HOMEOSTASIS",77,-0.8822,0.68,0.8,-0.8487,0.76,1,-1.1675,0.16,0.63
"GO_BP:516827_GO_0071907_DETERMINATION_OF_DIGESTIVE_TRACT_LEFT_RIGHT_ASYMMETRY","GO_BP","516827_GO_0071907_DETERMINATION_OF_DIGESTIVE_TRACT_LEFT_RIGHT_ASYMMETRY",7,-0.8821,0.62,0.79,-1.4293,0.098,0.92,-0.9563,0.5,0.88
"C4_Cancer_gene_neighborhoods:C4_CGN_142_MORF_PDPK1","C4_Cancer_gene_neighborhoods","C4_CGN_142_MORF_PDPK1",74,-0.8821,0.68,0.91,0.5545,1,1,-0.6357,1,1
"C3_MicroRNA_targets:C3_MIR_69_CTACTGT_MIR_199A","C3_MicroRNA_targets","C3_MIR_69_CTACTGT_MIR_199A",182,-0.882,0.73,0.8,-0.8729,0.8,1,1.1139,0.2,1
"GO_BP:499177_GO_0021898_COMMITMENT_OF_MULTIPOTENT_STEM_CELLS_TO_NEURONAL_LINEAGE_IN_FOREBRAIN","GO_BP","499177_GO_0021898_COMMITMENT_OF_MULTIPOTENT_STEM_CELLS_TO_NEURONAL_LINEAGE_IN_FOREBRAIN",5,-0.8818,0.64,0.8,-0.862,0.6,1,-0.7889,0.72,0.99
"GO_BP:1026080_GO_1903308_REGULATION_OF_CHROMATIN_MODIFICATION","GO_BP","1026080_GO_1903308_REGULATION_OF_CHROMATIN_MODIFICATION",121,-0.8817,0.73,0.8,-0.7184,0.98,1,-1.0319,0.38,0.82
"REACTOME:1127669_REACT_268530_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS","REACTOME","1127669_REACT_268530_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS",100,-0.8813,0.71,0.8,-1.1216,0.23,0.88,-1.175,0.14,0.63
"GO_BP:502187_GO_0032965_REGULATION_OF_COLLAGEN_BIOSYNTHETIC_PROCESS","GO_BP","502187_GO_0032965_REGULATION_OF_COLLAGEN_BIOSYNTHETIC_PROCESS",28,-0.8813,0.64,0.8,1.0172,0.42,0.97,1.424,0.053,0.61
"GO_BP:508429_GO_0046133_PYRIMIDINE_RIBONUCLEOSIDE_CATABOLIC_PROCESS","GO_BP","508429_GO_0046133_PYRIMIDINE_RIBONUCLEOSIDE_CATABOLIC_PROCESS",10,-0.8812,0.62,0.8,0.8414,0.66,1,-0.9584,0.51,0.88
"C1_Positional:C1_ALL_58_CHR5Q21","C1_Positional","C1_ALL_58_CHR5Q21",26,-0.8812,0.66,0.99,-0.5267,1,1,-1.0687,0.34,0.84
"C4_Cancer_gene_neighborhoods:C4_CGN_292_GNF2_CCNA1","C4_Cancer_gene_neighborhoods","C4_CGN_292_GNF2_CCNA1",66,-0.8811,0.7,0.91,-1.2656,0.1,0.53,-1.1841,0.19,0.46
"REACTOME:1127497_REACT_264212_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS","REACTOME","1127497_REACT_264212_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS",42,-0.8811,0.64,0.8,0.816,0.77,0.99,-0.784,0.83,1
"REACTOME:576256_REACT_118764_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS","REACTOME","576256_REACT_118764_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS",26,-0.881,0.66,0.8,0.8107,0.77,0.99,-0.7213,0.87,1
"GO_MF:496489_GO_0016530_METALLOCHAPERONE_ACTIVITY","GO_MF","496489_GO_0016530_METALLOCHAPERONE_ACTIVITY",5,-0.8806,0.64,0.81,1.1271,0.35,0.75,-0.542,0.96,1
"GO_CC:925892_GO_0098563_INTRINSIC_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE","GO_CC","925892_GO_0098563_INTRINSIC_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE",7,-0.8804,0.63,0.87,-1.4988,0.058,0.59,-0.7052,0.81,1
"GO_BP:751847_GO_0044704_SINGLE_ORGANISM_REPRODUCTIVE_BEHAVIOR","GO_BP","751847_GO_0044704_SINGLE_ORGANISM_REPRODUCTIVE_BEHAVIOR",52,-0.8804,0.68,0.8,-0.8713,0.71,1,0.9256,0.6,0.92
"GO_CC:487969_GO_0002080_ACROSOMAL_MEMBRANE","GO_CC","487969_GO_0002080_ACROSOMAL_MEMBRANE",20,-0.8803,0.64,0.87,0.7196,0.87,0.99,0.9821,0.49,1
"GO_BP:501645_GO_0032413_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","501645_GO_0032413_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",39,-0.8801,0.69,0.8,-0.7708,0.86,1,-1.1942,0.18,0.74
"KEGG_module:HSA_M00385_CUL4_DDB1_DDB2_COMPLEX","KEGG_module","HSA_M00385_CUL4_DDB1_DDB2_COMPLEX",5,-0.88,0.64,0.75,0.7289,0.8,0.94,-1.2733,0.19,0.49
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_134_BIOCARTA_PDGF_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_134_BIOCARTA_PDGF_PATHWAY",32,-0.88,0.65,0.73,0.7639,0.84,1,0.7122,0.92,1
"GO_BP:505506_GO_0042362_FAT_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS","GO_BP","505506_GO_0042362_FAT_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS",12,-0.8799,0.63,0.8,1.0307,0.39,0.97,1.3337,0.14,0.64
"C7_Immunologic_signatures:C7_ALL_549_GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_549_GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDM_UP",199,-0.8797,0.74,0.82,0.6651,1,1,-1.1266,0.14,0.43
"GO_BP:510725_GO_0048670_REGULATION_OF_COLLATERAL_SPROUTING","GO_BP","510725_GO_0048670_REGULATION_OF_COLLATERAL_SPROUTING",14,-0.8796,0.63,0.8,0.6597,0.91,1,0.8919,0.6,0.95
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_19_BIOCARTA_ATM_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_19_BIOCARTA_ATM_PATHWAY",20,-0.8795,0.63,0.73,-0.837,0.71,1,-1.2098,0.21,0.57
"C7_Immunologic_signatures:C7_ALL_591_GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_591_GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDM_UP",198,-0.8794,0.75,0.82,1.1847,0.088,0.25,0.658,1,1
"GO_BP:512080_GO_0051170_NUCLEAR_IMPORT","GO_BP","512080_GO_0051170_NUCLEAR_IMPORT",102,-0.8792,0.69,0.8,0.8124,0.9,1,-1.0415,0.37,0.82
"GO_BP:505337_GO_0042176_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS","GO_BP","505337_GO_0042176_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS",375,-0.8792,0.8,0.8,1.1673,0.071,0.82,-0.9746,0.54,0.88
"GO_BP:491433_GO_0006537_GLUTAMATE_BIOSYNTHETIC_PROCESS","GO_BP","491433_GO_0006537_GLUTAMATE_BIOSYNTHETIC_PROCESS",5,-0.8791,0.63,0.8,-1.1872,0.27,0.9,-1.2985,0.16,0.65
"GO_MF:493053_GO_0008823_CUPRIC_REDUCTASE_ACTIVITY","GO_MF","493053_GO_0008823_CUPRIC_REDUCTASE_ACTIVITY",5,-0.8791,0.62,0.81,1.2963,0.17,0.62,1.196,0.27,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1972_URS_ADIPOCYTE_DIFFERENTIATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1972_URS_ADIPOCYTE_DIFFERENTIATION_DN",29,-0.8791,0.65,0.76,1.5023,0.029,0.21,0.6902,0.92,1
"GO_CC:503568_GO_0034366_SPHERICAL_HIGH_DENSITY_LIPOPROTEIN_PARTICLE","GO_CC","503568_GO_0034366_SPHERICAL_HIGH_DENSITY_LIPOPROTEIN_PARTICLE",7,-0.879,0.63,0.87,0.9293,0.53,0.86,-0.505,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3041_STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3041_STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP",48,-0.8789,0.65,0.76,-0.852,0.73,1,-1.1454,0.25,0.58
"C7_Immunologic_signatures:C7_ALL_1723_GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1723_GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP",198,-0.8789,0.76,0.82,1.5196,0.0024,0.0094,-1.0214,0.4,0.68
"C7_Immunologic_signatures:C7_ALL_267_GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP","C7_Immunologic_signatures","C7_ALL_267_GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP",198,-0.8789,0.75,0.82,0.7642,0.99,1,-0.7715,0.99,1
"GO_BP:504589_GO_0035405_HISTONE_THREONINE_PHOSPHORYLATION","GO_BP","504589_GO_0035405_HISTONE_THREONINE_PHOSPHORYLATION",7,-0.8788,0.6,0.8,0.9151,0.55,1,-0.5821,0.94,1
"GO_BP:499105_GO_0021825_SUBSTRATE_DEPENDENT_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION","GO_BP","499105_GO_0021825_SUBSTRATE_DEPENDENT_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION",5,-0.8787,0.62,0.8,0.6763,0.86,1,0.7706,0.75,1
"GO_BP:507525_GO_0045136_DEVELOPMENT_OF_SECONDARY_SEXUAL_CHARACTERISTICS","GO_BP","507525_GO_0045136_DEVELOPMENT_OF_SECONDARY_SEXUAL_CHARACTERISTICS",11,-0.8787,0.64,0.8,1.0813,0.36,0.92,0.8917,0.6,0.95
"GO_BP:494831_GO_0010766_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSPORT","GO_BP","494831_GO_0010766_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSPORT",10,-0.8786,0.62,0.8,0.9283,0.56,1,-1.6501,0.022,0.52
"GO_BP:500350_GO_0031060_REGULATION_OF_HISTONE_METHYLATION","GO_BP","500350_GO_0031060_REGULATION_OF_HISTONE_METHYLATION",43,-0.8786,0.66,0.8,-0.5973,0.99,1,-0.8897,0.65,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_1014_WEI_MIR34A_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1014_WEI_MIR34A_TARGETS",146,-0.8785,0.73,0.76,1.2141,0.087,0.47,0.7899,0.96,1
"GO_MF:489283_GO_0003756_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY","GO_MF","489283_GO_0003756_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY",22,-0.8784,0.64,0.81,-0.7578,0.81,1,-1.2415,0.15,0.6
"GO_BP:488356_GO_0002483_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN","GO_BP","488356_GO_0002483_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN",11,-0.8783,0.63,0.8,1.1714,0.25,0.81,-0.6143,0.94,1
"GO_BP:755364_GO_2001258_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY","GO_BP","755364_GO_2001258_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY",22,-0.8782,0.64,0.8,-0.8124,0.73,1,-0.7412,0.85,1
"GO_MF:504369_GO_0035184_HISTONE_THREONINE_KINASE_ACTIVITY","GO_MF","504369_GO_0035184_HISTONE_THREONINE_KINASE_ACTIVITY",7,-0.878,0.62,0.81,0.928,0.53,0.95,-0.5989,0.93,1
"GO_BP:493333_GO_0009136_PURINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493333_GO_0009136_PURINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",6,-0.8779,0.65,0.8,-0.4959,0.99,1,-0.7549,0.76,1
"GO_MF:496409_GO_0016421_COA_CARBOXYLASE_ACTIVITY","GO_MF","496409_GO_0016421_COA_CARBOXYLASE_ACTIVITY",6,-0.8777,0.63,0.81,0.5849,0.95,1,-1.5371,0.04,0.41
"C6_Oncogenic_signatures:C6_ALL_54_BCAT_BILD_ET_AL_UP","C6_Oncogenic_signatures","C6_ALL_54_BCAT_BILD_ET_AL_UP",45,-0.8777,0.68,0.77,1.09,0.3,0.56,-0.9621,0.51,0.71
"GO_CC:507845_GO_0045495_POLE_PLASM","GO_CC","507845_GO_0045495_POLE_PLASM",13,-0.8776,0.66,0.87,-0.7058,0.85,1,1.1853,0.27,0.82
"REACTOME:161016_REACT_22230_SYNTHESIS_OF_DOLICHYL_PHOSPHATE","REACTOME","161016_REACT_22230_SYNTHESIS_OF_DOLICHYL_PHOSPHATE",5,-0.8775,0.63,0.81,-1.3403,0.15,0.6,0.5101,0.97,1
"GO_BP:499634_GO_0030224_MONOCYTE_DIFFERENTIATION","GO_BP","499634_GO_0030224_MONOCYTE_DIFFERENTIATION",16,-0.8774,0.65,0.8,-0.8394,0.68,1,1.3596,0.099,0.64
"GO_BP:491890_GO_0007067_MITOTIC_NUCLEAR_DIVISION","GO_BP","491890_GO_0007067_MITOTIC_NUCLEAR_DIVISION",338,-0.8774,0.8,0.8,1.3358,0,0.62,-0.9903,0.46,0.86
"C1_Positional:C1_ALL_32_CHR9Q33","C1_Positional","C1_ALL_32_CHR9Q33",63,-0.8774,0.68,0.99,0.8688,0.72,0.89,1.3166,0.069,0.45
"C1_Positional:C1_ALL_196_CHR10Q26","C1_Positional","C1_ALL_196_CHR10Q26",102,-0.8773,0.72,0.98,-0.8687,0.77,0.98,1.0392,0.39,0.72
"GO_BP:490991_GO_0006003_FRUCTOSE_2_6_BISPHOSPHATE_METABOLIC_PROCESS","GO_BP","490991_GO_0006003_FRUCTOSE_2_6_BISPHOSPHATE_METABOLIC_PROCESS",5,-0.8773,0.64,0.8,-0.603,0.93,1,0.9079,0.56,0.93
"C7_Immunologic_signatures:C7_ALL_352_GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_352_GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN",198,-0.8772,0.75,0.82,1.023,0.39,0.67,-0.9795,0.5,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_648_RASHI_RESPONSE_TO_IONIZING_RADIATION_4","C2_Chemical_and_genetic_perturbations","C2_CGP_648_RASHI_RESPONSE_TO_IONIZING_RADIATION_4",61,-0.8772,0.69,0.76,1.0577,0.35,0.7,-1.2188,0.14,0.5
"C4_Cancer_modules:C4_CM_413_MODULE_534","C4_Cancer_modules","C4_CM_413_MODULE_534",18,-0.8772,0.64,0.77,0.7273,0.85,1,-1.2804,0.15,0.31
"REACTOME:105752_REACT_407_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX","REACTOME","105752_REACT_407_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX",12,-0.877,0.61,0.81,0.8895,0.58,0.91,-0.6887,0.89,1
"GO_MF:490378_GO_0005112_NOTCH_BINDING","GO_MF","490378_GO_0005112_NOTCH_BINDING",15,-0.8769,0.61,0.81,-1.2121,0.22,0.82,-0.7359,0.84,0.99
"GO_BP:509048_GO_0046825_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS","GO_BP","509048_GO_0046825_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS",28,-0.8769,0.65,0.8,-0.818,0.77,1,-0.8059,0.79,0.98
"C7_Immunologic_signatures:C7_ALL_1859_GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP","C7_Immunologic_signatures","C7_ALL_1859_GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP",199,-0.8769,0.75,0.82,1.009,0.4,0.71,-1.0108,0.4,0.7
"GO_BP:499545_GO_0030111_REGULATION_OF_WNT_SIGNALING_PATHWAY","GO_BP","499545_GO_0030111_REGULATION_OF_WNT_SIGNALING_PATHWAY",287,-0.8769,0.78,0.8,1.1628,0.085,0.82,0.8724,0.85,0.96
"C1_Positional:C1_ALL_52_CHR11Q22","C1_Positional","C1_ALL_52_CHR11Q22",52,-0.8769,0.68,0.98,0.7277,0.92,0.99,-0.8208,0.81,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2082_SANSOM_APC_MYC_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2082_SANSOM_APC_MYC_TARGETS",215,-0.8768,0.77,0.76,-0.7942,0.97,1,-1.2984,0.029,0.43
"C4_Cancer_modules:C4_CM_193_MODULE_206","C4_Cancer_modules","C4_CM_193_MODULE_206",152,-0.8766,0.75,0.77,-0.8313,0.86,0.96,-1.1418,0.16,0.47
"C1_Positional:C1_ALL_220_CHR11Q25","C1_Positional","C1_ALL_220_CHR11Q25",19,-0.8765,0.64,0.97,-1.0073,0.44,1,-0.6901,0.91,0.99
"C4_Cancer_gene_neighborhoods:C4_CGN_41_MORF_RFC5","C4_Cancer_gene_neighborhoods","C4_CGN_41_MORF_RFC5",76,-0.8765,0.69,0.91,1.036,0.37,0.49,-0.7397,0.95,1
"C7_Immunologic_signatures:C7_ALL_268_GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN","C7_Immunologic_signatures","C7_ALL_268_GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN",200,-0.8765,0.78,0.83,1.2517,0.041,0.15,0.7063,1,1
"GO_BP:517253_GO_0072337_MODIFIED_AMINO_ACID_TRANSPORT","GO_BP","517253_GO_0072337_MODIFIED_AMINO_ACID_TRANSPORT",23,-0.8765,0.64,0.8,-1.3489,0.11,0.93,-0.6908,0.91,0.99
"GO_BP:498666_GO_0019883_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN","GO_BP","498666_GO_0019883_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN",13,-0.8765,0.61,0.8,1.0822,0.34,0.92,-0.7467,0.81,1
"GO_CC:500165_GO_0030867_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE","GO_CC","500165_GO_0030867_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE",17,-0.8765,0.62,0.87,1.0292,0.44,0.74,-0.4983,0.99,1
"GO_BP:514082_GO_0060527_PROSTATE_EPITHELIAL_CORD_ARBORIZATION_INVOLVED_IN_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS","GO_BP","514082_GO_0060527_PROSTATE_EPITHELIAL_CORD_ARBORIZATION_INVOLVED_IN_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS",7,-0.8764,0.62,0.8,1.1294,0.3,0.87,1.3058,0.18,0.67
"GO_BP:511750_GO_0050779_RNA_DESTABILIZATION","GO_BP","511750_GO_0050779_RNA_DESTABILIZATION",10,-0.8764,0.64,0.8,-0.5102,0.98,1,-1.1071,0.31,0.77
"KEGG_compound:C00049_L_ASPARTATE_L_ASPARTIC_ACID_2_AMINOSUCCINIC_ACID_L_ASP","KEGG_compound","C00049_L_ASPARTATE_L_ASPARTIC_ACID_2_AMINOSUCCINIC_ACID_L_ASP",15,-0.8762,0.66,0.75,-1.0936,0.34,0.93,0.5121,0.99,0.99
"GO_BP:507052_GO_0044036_CELL_WALL_MACROMOLECULE_METABOLIC_PROCESS","GO_BP","507052_GO_0044036_CELL_WALL_MACROMOLECULE_METABOLIC_PROCESS",9,-0.876,0.63,0.8,-1.2229,0.24,0.88,-1.4247,0.09,0.57
"GO_CC:490803_GO_0005771_MULTIVESICULAR_BODY","GO_CC","490803_GO_0005771_MULTIVESICULAR_BODY",31,-0.8759,0.65,0.87,1.5257,0.043,0.18,0.7864,0.84,1
"GO_MF:489797_GO_0004445_INOSITOL_POLYPHOSPHATE_5_PHOSPHATASE_ACTIVITY","GO_MF","489797_GO_0004445_INOSITOL_POLYPHOSPHATE_5_PHOSPHATASE_ACTIVITY",6,-0.8759,0.63,0.81,-1.1929,0.25,0.8,-0.6399,0.87,1
"C7_Immunologic_signatures:C7_ALL_1478_GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN","C7_Immunologic_signatures","C7_ALL_1478_GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN",198,-0.8758,0.74,0.83,0.8085,0.95,1,-1.3745,0.014,0.078
"C1_Positional:C1_ALL_166_CHR17P11","C1_Positional","C1_ALL_166_CHR17P11",84,-0.8757,0.71,0.97,-0.9435,0.56,1,-0.7486,0.96,1
"REACTOME:106327_REACT_1046_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE","REACTOME","106327_REACT_1046_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE",43,-0.8755,0.67,0.81,1.5744,0.022,0.11,-1.2863,0.1,0.54
"GO_BP:505598_GO_0042461_PHOTORECEPTOR_CELL_DEVELOPMENT","GO_BP","505598_GO_0042461_PHOTORECEPTOR_CELL_DEVELOPMENT",39,-0.8754,0.66,0.8,-1.0373,0.38,0.98,1.1183,0.29,0.75
"GO_BP:502701_GO_0033483_GAS_HOMEOSTASIS","GO_BP","502701_GO_0033483_GAS_HOMEOSTASIS",9,-0.8753,0.62,0.8,1.3457,0.14,0.62,1.1865,0.24,0.72
"C1_Positional:C1_ALL_245_CHR17Q21","C1_Positional","C1_ALL_245_CHR17Q21",271,-0.8753,0.8,0.96,-1.1572,0.097,1,-1.1528,0.11,0.67
"GO_MF:495599_GO_0015377_CATION_CHLORIDE_SYMPORTER_ACTIVITY","GO_MF","495599_GO_0015377_CATION_CHLORIDE_SYMPORTER_ACTIVITY",8,-0.8752,0.62,0.81,-1.221,0.21,0.85,0.6669,0.88,1
"REACTOME:771590_REACT_160133_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER","REACTOME","771590_REACT_160133_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER",15,-0.8751,0.67,0.81,0.8713,0.65,0.94,-1.4773,0.051,0.38
"GO_BP:750997_GO_0036075_REPLACEMENT_OSSIFICATION","GO_BP","750997_GO_0036075_REPLACEMENT_OSSIFICATION",29,-0.875,0.66,0.8,-1.355,0.055,0.96,-0.7941,0.8,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_317_ELVIDGE_HIF2A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_317_ELVIDGE_HIF2A_TARGETS_UP",6,-0.875,0.63,0.77,0.5825,0.94,1,-0.7223,0.85,0.98
"GO_CC:513849_GO_0060293_GERM_PLASM","GO_CC","513849_GO_0060293_GERM_PLASM",13,-0.875,0.65,0.87,-0.6831,0.89,1,1.1902,0.24,0.85
"GO_BP:513455_GO_0055022_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH","GO_BP","513455_GO_0055022_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH",11,-0.8748,0.64,0.8,0.9362,0.53,1,1.2381,0.21,0.71
"GO_BP:514081_GO_0060526_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS","GO_BP","514081_GO_0060526_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS",7,-0.8746,0.65,0.8,1.1488,0.27,0.84,1.3277,0.16,0.65
"GO_BP:517088_GO_0072172_MESONEPHRIC_TUBULE_FORMATION","GO_BP","517088_GO_0072172_MESONEPHRIC_TUBULE_FORMATION",9,-0.8745,0.63,0.8,1.3199,0.16,0.64,1.2269,0.21,0.71
"GO_BP:487583_GO_0001672_REGULATION_OF_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY","GO_BP","487583_GO_0001672_REGULATION_OF_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY",7,-0.8745,0.63,0.8,1.1582,0.3,0.83,0.8174,0.71,1
"C7_Immunologic_signatures:C7_ALL_1222_GSE27786_NKTCELL_VS_ERYTHROBLAST_DN","C7_Immunologic_signatures","C7_ALL_1222_GSE27786_NKTCELL_VS_ERYTHROBLAST_DN",196,-0.8745,0.75,0.83,-1.0326,0.38,1,1.0682,0.3,1
"GO_MF:490355_GO_0005087_RAN_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY","GO_MF","490355_GO_0005087_RAN_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",6,-0.8745,0.62,0.81,-1.1269,0.32,0.81,-1.3463,0.12,0.53
"GO_BP:492901_GO_0008655_PYRIMIDINE_CONTAINING_COMPOUND_SALVAGE","GO_BP","492901_GO_0008655_PYRIMIDINE_CONTAINING_COMPOUND_SALVAGE",10,-0.8744,0.63,0.8,-0.7828,0.76,1,0.6394,0.93,1
"KEGG_reaction:R02326_ATP_DCDP_PHOSPHOTRANSFERASE_ATP_DCDP_ADP_DCTP","KEGG_reaction","R02326_ATP_DCDP_PHOSPHOTRANSFERASE_ATP_DCDP_ADP_DCTP",8,-0.8743,0.64,0.76,-0.6862,0.87,1,-1.2921,0.17,0.5
"C2_Chemical_and_genetic_perturbations:C2_CGP_2189_CAMPS_COLON_CANCER_COPY_NUMBER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2189_CAMPS_COLON_CANCER_COPY_NUMBER_DN",65,-0.8743,0.69,0.77,-0.9936,0.45,1,-0.9871,0.46,0.77
"C3_TF_targets:C3_TFT_388_V_E2F1DP2_01","C3_TF_targets","C3_TFT_388_V_E2F1DP2_01",234,-0.8743,0.78,0.83,-0.8467,0.89,1,-1.2702,0.034,0.26
"GO_MF:516853_GO_0071933_ARP2_3_COMPLEX_BINDING","GO_MF","516853_GO_0071933_ARP2_3_COMPLEX_BINDING",8,-0.8742,0.62,0.81,1.3998,0.1,0.48,1.0611,0.38,0.83
"GO_BP:519376_GO_2000737_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION","GO_BP","519376_GO_2000737_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION",39,-0.8741,0.67,0.8,-0.7637,0.85,1,0.9027,0.62,0.94
"GO_BP:505455_GO_0042308_NEGATIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","505455_GO_0042308_NEGATIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS",55,-0.874,0.69,0.8,-0.7857,0.85,1,-1.2689,0.12,0.66
"KEGG_compound:C00996_FERRICYTOCHROME_B5","KEGG_compound","C00996_FERRICYTOCHROME_B5",7,-0.874,0.62,0.76,-0.6611,0.87,1,0.6588,0.88,1
"REACTOME:106273_REACT_1923_PURINE_SALVAGE","REACTOME","106273_REACT_1923_PURINE_SALVAGE",13,-0.874,0.63,0.81,0.6635,0.92,1,-0.7089,0.84,1
"GO_MF:489289_GO_0042623_ATPASE_ACTIVITY_COUPLED","GO_MF","489289_GO_0042623_ATPASE_ACTIVITY_COUPLED",274,-0.874,0.78,0.81,-0.785,0.98,1,-1.1391,0.13,0.66
"GO_BP:502188_GO_0032966_NEGATIVE_REGULATION_OF_COLLAGEN_BIOSYNTHETIC_PROCESS","GO_BP","502188_GO_0032966_NEGATIVE_REGULATION_OF_COLLAGEN_BIOSYNTHETIC_PROCESS",5,-0.8738,0.66,0.8,0.9455,0.54,1,1.2302,0.25,0.71
"GO_CC:506258_GO_0043186_P_GRANULE","GO_CC","506258_GO_0043186_P_GRANULE",13,-0.8736,0.63,0.87,-0.6836,0.9,1,1.1802,0.24,0.82
"GO_CC:752912_GO_0097413_LEWY_BODY","GO_CC","752912_GO_0097413_LEWY_BODY",5,-0.8736,0.61,0.87,-0.9954,0.45,0.85,-0.8849,0.63,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1705_CHUANG_OXIDATIVE_STRESS_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1705_CHUANG_OXIDATIVE_STRESS_RESPONSE_DN",11,-0.8736,0.61,0.77,-0.93,0.54,1,-1.3195,0.16,0.41
"GO_BP:493271_GO_0009070_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS","GO_BP","493271_GO_0009070_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS",13,-0.8734,0.64,0.8,0.8219,0.72,1,-1.1307,0.29,0.75
"GO_BP:502436_GO_0033216_FERRIC_IRON_IMPORT","GO_BP","502436_GO_0033216_FERRIC_IRON_IMPORT",5,-0.8734,0.64,0.8,1.3081,0.18,0.66,1.1297,0.35,0.74
"REACTOME:1127517_REACT_264384_WNT_MEDIATED_ACTIVATION_OF_DVL","REACTOME","1127517_REACT_264384_WNT_MEDIATED_ACTIVATION_OF_DVL",8,-0.8734,0.62,0.81,0.9434,0.53,0.84,-0.7164,0.82,1
"GO_BP:494952_GO_0010888_NEGATIVE_REGULATION_OF_LIPID_STORAGE","GO_BP","494952_GO_0010888_NEGATIVE_REGULATION_OF_LIPID_STORAGE",16,-0.8734,0.62,0.8,0.7962,0.74,1,-0.6308,0.92,1
"KEGG_reaction:R00156_ATP_UDP_PHOSPHOTRANSFERASE_ATP_UDP_ADP_UTP","KEGG_reaction","R00156_ATP_UDP_PHOSPHOTRANSFERASE_ATP_UDP_ADP_UTP",8,-0.8733,0.63,0.75,-0.678,0.87,1,-1.2721,0.19,0.49
"GO_MF:498063_GO_0019208_PHOSPHATASE_REGULATOR_ACTIVITY","GO_MF","498063_GO_0019208_PHOSPHATASE_REGULATOR_ACTIVITY",80,-0.8733,0.71,0.81,1.1273,0.24,0.75,-0.976,0.49,0.8
"GO_BP:491686_GO_0006817_PHOSPHATE_ION_TRANSPORT","GO_BP","491686_GO_0006817_PHOSPHATE_ION_TRANSPORT",14,-0.8733,0.62,0.8,-0.8078,0.74,1,0.9094,0.6,0.93
"KEGG_compound:C02050_LINOLEOYL_COA_9Z_12Z_OCTADECADIENOYL_COA","KEGG_compound","C02050_LINOLEOYL_COA_9Z_12Z_OCTADECADIENOYL_COA",5,-0.8733,0.62,0.75,-0.6196,0.9,1,-0.7562,0.76,0.88
"GO_BP:496308_GO_0016242_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY","GO_BP","496308_GO_0016242_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY",12,-0.8732,0.65,0.8,0.6247,0.91,1,-0.7481,0.8,1
"GO_CC:925903_GO_1902554_SERINE_THREONINE_PROTEIN_KINASE_COMPLEX","GO_CC","925903_GO_1902554_SERINE_THREONINE_PROTEIN_KINASE_COMPLEX",68,-0.8732,0.69,0.87,0.9322,0.6,0.86,0.8668,0.72,1
"GO_BP:505338_GO_0042177_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS","GO_BP","505338_GO_0042177_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS",108,-0.8732,0.72,0.8,1.041,0.37,0.96,-0.7431,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_369_COLDREN_GEFITINIB_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_369_COLDREN_GEFITINIB_RESISTANCE_UP",85,-0.8732,0.71,0.77,-0.6227,1,1,0.7264,0.97,1
"GO_CC:517273_GO_0072357_PTW_PP1_PHOSPHATASE_COMPLEX","GO_CC","517273_GO_0072357_PTW_PP1_PHOSPHATASE_COMPLEX",7,-0.8729,0.63,0.87,0.8266,0.69,0.94,0.5889,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_763_AGARWAL_AKT_PATHWAY_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_763_AGARWAL_AKT_PATHWAY_TARGETS",9,-0.8728,0.62,0.77,1.0711,0.36,0.68,0.8365,0.68,1
"GO_BP:510757_GO_0048702_EMBRYONIC_NEUROCRANIUM_MORPHOGENESIS","GO_BP","510757_GO_0048702_EMBRYONIC_NEUROCRANIUM_MORPHOGENESIS",5,-0.8726,0.62,0.81,0.8363,0.67,1,-0.4524,0.99,1
"C6_Oncogenic_signatures:C6_ALL_140_PDGF_ERK_DN_V1_UP","C6_Oncogenic_signatures","C6_ALL_140_PDGF_ERK_DN_V1_UP",136,-0.8725,0.76,0.77,1.148,0.18,0.43,-0.9733,0.51,0.71
"GO_BP:754130_GO_1901163_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION","GO_BP","754130_GO_1901163_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION",7,-0.8724,0.62,0.81,1.4299,0.1,0.52,0.7713,0.73,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1220_NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1220_NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON",31,-0.8724,0.68,0.77,-0.7485,0.84,1,-0.9391,0.56,0.83
"GO_BP:750924_GO_0035999_TETRAHYDROFOLATE_INTERCONVERSION","GO_BP","750924_GO_0035999_TETRAHYDROFOLATE_INTERCONVERSION",7,-0.8723,0.65,0.81,-0.6263,0.91,1,-0.9024,0.59,0.92
"GO_BP:491390_GO_0006489_DOLICHYL_DIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","491390_GO_0006489_DOLICHYL_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",5,-0.8723,0.64,0.81,-1.3538,0.15,0.95,0.4918,0.98,1
"C7_Immunologic_signatures:C7_ALL_1760_GSE6269_STREP_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1760_GSE6269_STREP_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN",179,-0.8721,0.76,0.83,0.9018,0.74,1,-1.1903,0.091,0.3
"GO_BP:510896_GO_0048846_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE","GO_BP","510896_GO_0048846_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE",7,-0.8721,0.62,0.81,-1.0124,0.45,0.98,1.3379,0.15,0.65
"C7_Immunologic_signatures:C7_ALL_1101_GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1101_GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP",188,-0.872,0.76,0.83,0.7896,0.95,1,-1.0012,0.45,0.72
"C1_Positional:C1_ALL_54_CHR16Q22","C1_Positional","C1_ALL_54_CHR16Q22",144,-0.872,0.73,0.97,1.1184,0.21,0.62,0.743,0.97,0.95
"GO_MF:500743_GO_0031492_NUCLEOSOMAL_DNA_BINDING","GO_MF","500743_GO_0031492_NUCLEOSOMAL_DNA_BINDING",30,-0.8719,0.67,0.82,-0.942,0.56,0.95,-1.099,0.3,0.7
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_142_BIOCARTA_PS1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_142_BIOCARTA_PS1_PATHWAY",14,-0.8719,0.62,0.74,-0.7941,0.73,1,0.5681,0.98,0.98
"GO_BP:500889_GO_0031640_KILLING_OF_CELLS_OF_OTHER_ORGANISM","GO_BP","500889_GO_0031640_KILLING_OF_CELLS_OF_OTHER_ORGANISM",20,-0.8718,0.64,0.81,1.693,0.014,0.2,1.3588,0.11,0.64
"GO_BP:508158_GO_0045837_NEGATIVE_REGULATION_OF_MEMBRANE_POTENTIAL","GO_BP","508158_GO_0045837_NEGATIVE_REGULATION_OF_MEMBRANE_POTENTIAL",13,-0.8718,0.64,0.81,-0.8462,0.66,1,-1.3068,0.14,0.64
"GO_BP:505234_GO_0042045_EPITHELIAL_FLUID_TRANSPORT","GO_BP","505234_GO_0042045_EPITHELIAL_FLUID_TRANSPORT",5,-0.8716,0.64,0.81,0.9255,0.56,1,1.2607,0.23,0.69
"C3_TF_targets:C3_TFT_387_V_E2F1DP1_01","C3_TF_targets","C3_TFT_387_V_E2F1DP1_01",234,-0.8714,0.81,0.83,-0.8282,0.92,1,-1.273,0.029,0.26
"C7_Immunologic_signatures:C7_ALL_1256_GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1256_GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN",164,-0.8714,0.74,0.83,-1.1145,0.21,1,0.9937,0.43,1
"GO_BP:751577_GO_0044364_DISRUPTION_OF_CELLS_OF_OTHER_ORGANISM","GO_BP","751577_GO_0044364_DISRUPTION_OF_CELLS_OF_OTHER_ORGANISM",20,-0.8713,0.64,0.81,1.7284,0.01,0.16,1.3752,0.078,0.64
"GO_BP:517123_GO_0072207_METANEPHRIC_EPITHELIUM_DEVELOPMENT","GO_BP","517123_GO_0072207_METANEPHRIC_EPITHELIUM_DEVELOPMENT",22,-0.8712,0.66,0.81,0.9383,0.51,1,1.2376,0.18,0.7
"GO_BP:516402_GO_0071478_CELLULAR_RESPONSE_TO_RADIATION","GO_BP","516402_GO_0071478_CELLULAR_RESPONSE_TO_RADIATION",133,-0.8712,0.76,0.81,0.8859,0.74,1,-1.0738,0.29,0.8
"C1_Positional:C1_ALL_185_CHR8Q21","C1_Positional","C1_ALL_185_CHR8Q21",51,-0.8711,0.68,0.96,1.1961,0.15,0.63,0.9715,0.51,0.78
"GO_MF:500303_GO_0031013_TROPONIN_I_BINDING","GO_MF","500303_GO_0031013_TROPONIN_I_BINDING",6,-0.8709,0.62,0.82,-0.7183,0.83,1,-0.6105,0.92,1
"GO_BP:509046_GO_0046823_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT","GO_BP","509046_GO_0046823_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT",64,-0.8709,0.69,0.81,0.6041,1,1,-1.2947,0.083,0.64
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_174_BIOCARTA_RANMS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_174_BIOCARTA_RANMS_PATHWAY",10,-0.8709,0.64,0.73,-1.1595,0.28,1,-1.5092,0.067,0.32
"REACTOME:106435_REACT_6836_RELEASE_OF_EIF4E","REACTOME","106435_REACT_6836_RELEASE_OF_EIF4E",8,-0.8708,0.63,0.81,-0.7828,0.75,1,-1.1917,0.24,0.61
"KEGG_reaction:R03530_ATP_DIDP_PHOSPHOTRANSFERASE_ATP_DIDP_ADP_DITP","KEGG_reaction","R03530_ATP_DIDP_PHOSPHOTRANSFERASE_ATP_DIDP_ADP_DITP",8,-0.8707,0.64,0.75,-0.6798,0.87,1,-1.2945,0.18,0.51
"C7_Immunologic_signatures:C7_ALL_1018_GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN","C7_Immunologic_signatures","C7_ALL_1018_GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN",199,-0.8705,0.79,0.84,0.9708,0.54,0.83,-1.2919,0.031,0.15
"C4_Cancer_gene_neighborhoods:C4_CGN_86_MORF_DDX11","C4_Cancer_gene_neighborhoods","C4_CGN_86_MORF_DDX11",153,-0.8705,0.78,0.92,0.7203,0.99,1,-0.9523,0.59,0.95
"GO_BP:491956_GO_0007143_FEMALE_MEIOTIC_DIVISION","GO_BP","491956_GO_0007143_FEMALE_MEIOTIC_DIVISION",19,-0.8703,0.64,0.81,-0.7925,0.77,1,-0.8891,0.62,0.93
"C7_Immunologic_signatures:C7_ALL_1867_GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP","C7_Immunologic_signatures","C7_ALL_1867_GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP",199,-0.8701,0.77,0.84,0.8909,0.78,1,0.8208,0.92,1
"GO_MF:498670_GO_0019888_PROTEIN_PHOSPHATASE_REGULATOR_ACTIVITY","GO_MF","498670_GO_0019888_PROTEIN_PHOSPHATASE_REGULATOR_ACTIVITY",71,-0.8701,0.7,0.82,1.0424,0.37,0.83,-0.9748,0.5,0.8
"GO_BP:513902_GO_0060346_BONE_TRABECULA_FORMATION","GO_BP","513902_GO_0060346_BONE_TRABECULA_FORMATION",8,-0.8701,0.65,0.81,-0.8387,0.67,1,0.9425,0.53,0.91
"C3_MicroRNA_targets:C3_MIR_206_ATTACAT_MIR_380_3P","C3_MicroRNA_targets","C3_MIR_206_ATTACAT_MIR_380_3P",101,-0.87,0.73,0.83,1.1109,0.24,1,0.9433,0.56,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_93_CHANDRAN_METASTASIS_TOP50_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_93_CHANDRAN_METASTASIS_TOP50_DN",45,-0.87,0.67,0.77,1.2999,0.093,0.39,0.6273,0.99,1
"KEGG_reaction:R02093_ATP_DTDP_PHOSPHOTRANSFERASE_ATP_DTDP_ADP_DTTP","KEGG_reaction","R02093_ATP_DTDP_PHOSPHOTRANSFERASE_ATP_DTDP_ADP_DTTP",8,-0.87,0.62,0.74,-0.694,0.86,1,-1.2529,0.22,0.44
"GO_BP:490595_GO_0007033_VACUOLE_ORGANIZATION","GO_BP","490595_GO_0007033_VACUOLE_ORGANIZATION",100,-0.87,0.73,0.81,1.0081,0.45,0.98,-0.6486,1,1
"GO_BP:505073_GO_0035904_AORTA_DEVELOPMENT","GO_BP","505073_GO_0035904_AORTA_DEVELOPMENT",26,-0.8698,0.66,0.81,-0.7314,0.87,1,1.1731,0.22,0.72
"GO_BP:506177_GO_0043097_PYRIMIDINE_NUCLEOSIDE_SALVAGE","GO_BP","506177_GO_0043097_PYRIMIDINE_NUCLEOSIDE_SALVAGE",10,-0.8695,0.64,0.81,-0.7658,0.78,1,0.6302,0.92,1
"GO_BP:511854_GO_0050919_NEGATIVE_CHEMOTAXIS","GO_BP","511854_GO_0050919_NEGATIVE_CHEMOTAXIS",19,-0.8694,0.65,0.81,1.3455,0.13,0.62,1.6144,0.027,0.41
"GO_BP:515249_GO_0070316_REGULATION_OF_G0_TO_G1_TRANSITION","GO_BP","515249_GO_0070316_REGULATION_OF_G0_TO_G1_TRANSITION",7,-0.8694,0.63,0.81,-1.1225,0.32,0.93,-0.7256,0.79,0.99
"GO_BP:506172_GO_0043092_L_AMINO_ACID_IMPORT","GO_BP","506172_GO_0043092_L_AMINO_ACID_IMPORT",12,-0.8691,0.64,0.81,-0.7329,0.82,1,0.8658,0.65,0.97
"GO_MF:496736_GO_0016841_AMMONIA_LYASE_ACTIVITY","GO_MF","496736_GO_0016841_AMMONIA_LYASE_ACTIVITY",5,-0.8689,0.62,0.82,1.4681,0.058,0.4,1.5888,0.028,0.35
"C3_TF_targets:C3_TFT_390_V_E2F4DP2_01","C3_TF_targets","C3_TFT_390_V_E2F4DP2_01",234,-0.8689,0.78,0.84,-0.8419,0.91,1,-1.2779,0.024,0.26
"GO_BP:853112_GO_1902337_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS","GO_BP","853112_GO_1902337_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS",10,-0.8688,0.62,0.81,0.7825,0.76,1,0.6693,0.89,1
"GO_BP:501718_GO_0032486_RAP_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","501718_GO_0032486_RAP_PROTEIN_SIGNAL_TRANSDUCTION",10,-0.8686,0.62,0.81,0.8213,0.67,1,-0.9086,0.56,0.92
"C3_TF_targets:C3_TFT_167_V_ARNT_01","C3_TF_targets","C3_TFT_167_V_ARNT_01",258,-0.8685,0.77,0.84,1.0227,0.36,1,-0.8015,0.98,1
"C4_Cancer_gene_neighborhoods:C4_CGN_112_MORF_IKBKG","C4_Cancer_gene_neighborhoods","C4_CGN_112_MORF_IKBKG",134,-0.8685,0.75,0.92,-0.585,1,1,-0.6535,1,1
"GO_MF:490314_GO_0005031_TUMOR_NECROSIS_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY","GO_MF","490314_GO_0005031_TUMOR_NECROSIS_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY",9,-0.8684,0.64,0.82,1.0399,0.42,0.83,1.1855,0.27,0.75
"KEGG_compound:C03035_GAMMA_LINOLENOYL_COA","KEGG_compound","C03035_GAMMA_LINOLENOYL_COA",5,-0.8684,0.63,0.76,-0.6278,0.89,1,-0.7757,0.72,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_2481_GU_PDEF_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2481_GU_PDEF_TARGETS_DN",35,-0.8683,0.65,0.78,-1.0032,0.44,1,0.6535,0.96,1
"GO_BP:506599_GO_0043568_POSITIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","506599_GO_0043568_POSITIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",13,-0.8681,0.65,0.81,-0.9664,0.49,1,-0.9688,0.5,0.88
"C7_Immunologic_signatures:C7_ALL_116_GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN","C7_Immunologic_signatures","C7_ALL_116_GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN",197,-0.8681,0.77,0.84,0.9855,0.52,0.79,-1.1003,0.22,0.5
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_122_BIOCARTA_NGF_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_122_BIOCARTA_NGF_PATHWAY",18,-0.8673,0.65,0.74,0.7932,0.75,0.97,0.7898,0.78,1
"GO_BP:501701_GO_0032469_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS","GO_BP","501701_GO_0032469_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS",20,-0.8673,0.67,0.81,-0.8407,0.71,1,-1.1098,0.3,0.76
"C3_TF_targets:C3_TFT_374_V_PAX8_01","C3_TF_targets","C3_TFT_374_V_PAX8_01",36,-0.8671,0.67,0.84,-1.0973,0.32,0.56,-1.0845,0.33,0.58
"GO_BP:488182_GO_0002309_T_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488182_GO_0002309_T_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE",6,-0.8671,0.65,0.81,1.2528,0.22,0.73,0.8135,0.67,1
"C4_Cancer_modules:C4_CM_363_MODULE_440","C4_Cancer_modules","C4_CM_363_MODULE_440",19,-0.867,0.66,0.78,-0.8149,0.73,0.96,-0.6929,0.87,1
"GO_BP:849889_GO_1902187_NEGATIVE_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL","GO_BP","849889_GO_1902187_NEGATIVE_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL",18,-0.8669,0.65,0.81,0.7454,0.82,1,-1.0293,0.42,0.83
"GO_BP:514271_GO_0060716_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT","GO_BP","514271_GO_0060716_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT",20,-0.8669,0.65,0.81,-0.8778,0.63,1,0.6685,0.94,1
"C7_Immunologic_signatures:C7_ALL_1001_GSE22886_IL2_VS_IL15_STIM_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1001_GSE22886_IL2_VS_IL15_STIM_NKCELL_UP",185,-0.8669,0.77,0.84,-1.1007,0.23,1,1.0558,0.32,1
"GO_CC:486793_GO_0000275_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_CATALYTIC_CORE_F_1_","GO_CC","486793_GO_0000275_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_CATALYTIC_CORE_F_1_",5,-0.8667,0.64,0.88,1.3937,0.11,0.3,-0.5501,0.96,1
"GO_BP:487828_GO_0001937_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION","GO_BP","487828_GO_0001937_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION",29,-0.8667,0.67,0.81,1.1753,0.23,0.81,1.373,0.081,0.64
"KEGG_compound:C00197_3_PHOSPHO_D_GLYCERATE_D_GLYCERATE_3_PHOSPHATE_3_PHOSPHO_R_GLYCERATE_3_PHOSPHOGLYCERATE","KEGG_compound","C00197_3_PHOSPHO_D_GLYCERATE_D_GLYCERATE_3_PHOSPHATE_3_PHOSPHO_R_GLYCERATE_3_PHOSPHOGLYCERATE",11,-0.8666,0.66,0.76,-0.7116,0.84,1,0.5708,0.95,1
"KEGG_compound:C00606_3_SULFINO_L_ALANINE_L_CYSTEINESULFINIC_ACID_3_SULPHINO_L_ALANINE_3_SULFINOALANINE","KEGG_compound","C00606_3_SULFINO_L_ALANINE_L_CYSTEINESULFINIC_ACID_3_SULPHINO_L_ALANINE_3_SULFINOALANINE",6,-0.8666,0.64,0.76,1.1473,0.32,0.96,-0.8805,0.61,0.78
"KEGG_compound:C00999_FERROCYTOCHROME_B5","KEGG_compound","C00999_FERROCYTOCHROME_B5",7,-0.8665,0.65,0.76,-0.6697,0.88,1,0.6543,0.88,0.99
"C7_Immunologic_signatures:C7_ALL_940_GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN","C7_Immunologic_signatures","C7_ALL_940_GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN",191,-0.8665,0.77,0.84,-0.8781,0.78,1,-1.1839,0.12,0.31
"GO_MF:489259_GO_0003714_TRANSCRIPTION_COREPRESSOR_ACTIVITY","GO_MF","489259_GO_0003714_TRANSCRIPTION_COREPRESSOR_ACTIVITY",204,-0.8664,0.75,0.82,-0.7537,0.99,1,-1.2289,0.066,0.58
"GO_BP:754180_GO_1901213_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","754180_GO_1901213_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_HEART_DEVELOPMENT",13,-0.8663,0.68,0.81,-0.6143,0.94,1,1.3246,0.13,0.65
"GO_BP:498625_GO_0019827_STEM_CELL_MAINTENANCE","GO_BP","498625_GO_0019827_STEM_CELL_MAINTENANCE",132,-0.866,0.75,0.81,-0.7907,0.94,1,-0.8061,0.93,0.99
"C7_Immunologic_signatures:C7_ALL_383_GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_383_GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP",199,-0.8658,0.76,0.84,1.2493,0.043,0.15,0.8103,0.95,1
"GO_BP:505861_GO_0042755_EATING_BEHAVIOR","GO_BP","505861_GO_0042755_EATING_BEHAVIOR",21,-0.8656,0.67,0.81,0.944,0.53,1,1.4043,0.077,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_183_SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_183_SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN",5,-0.8652,0.65,0.78,0.9265,0.55,0.89,1.422,0.094,0.54
"GO_BP:492455_GO_0008088_AXON_CARGO_TRANSPORT","GO_BP","492455_GO_0008088_AXON_CARGO_TRANSPORT",39,-0.8652,0.66,0.81,0.9411,0.51,1,0.7013,0.94,1
"GO_BP:487848_GO_0001958_ENDOCHONDRAL_OSSIFICATION","GO_BP","487848_GO_0001958_ENDOCHONDRAL_OSSIFICATION",29,-0.8651,0.69,0.81,-1.3649,0.093,0.98,-0.7826,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_531_BUSA_SAM68_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_531_BUSA_SAM68_TARGETS_DN",6,-0.865,0.64,0.78,1.3434,0.15,0.35,-0.7378,0.79,0.98
"REACTOME:106473_REACT_15408_CAM_PDE_1_ACTIVATION","REACTOME","106473_REACT_15408_CAM_PDE_1_ACTIVATION",6,-0.865,0.65,0.82,0.9692,0.49,0.8,-0.8894,0.6,0.96
"C7_Immunologic_signatures:C7_ALL_1198_GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN","C7_Immunologic_signatures","C7_ALL_1198_GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN",192,-0.8647,0.77,0.85,-0.9104,0.7,1,0.8868,0.76,1
"GO_BP:493446_GO_0009253_PEPTIDOGLYCAN_CATABOLIC_PROCESS","GO_BP","493446_GO_0009253_PEPTIDOGLYCAN_CATABOLIC_PROCESS",5,-0.8646,0.65,0.81,-0.6845,0.86,1,1.2786,0.2,0.69
"KEGG_reaction:R02331_ATP_DUDP_PHOSPHOTRANSFERASE_ATP_DUDP_ADP_DUTP","KEGG_reaction","R02331_ATP_DUDP_PHOSPHOTRANSFERASE_ATP_DUDP_ADP_DUTP",8,-0.8645,0.66,0.75,-0.6954,0.86,1,-1.2643,0.2,0.48
"KEGG_module:HSA_M00409_ESCRT_I_COMPLEX","KEGG_module","HSA_M00409_ESCRT_I_COMPLEX",8,-0.8645,0.66,0.76,1.1086,0.34,0.68,-0.6816,0.85,1
"GO_BP:514568_GO_0061014_POSITIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS","GO_BP","514568_GO_0061014_POSITIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS",18,-0.8644,0.65,0.82,-0.7538,0.81,1,-1.1767,0.24,0.74
"GO_BP:508321_GO_0046021_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_MITOTIC","GO_BP","508321_GO_0046021_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_MITOTIC",6,-0.8644,0.64,0.81,-1.124,0.32,0.94,-0.7492,0.78,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_292_ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_292_ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN",278,-0.8643,0.79,0.78,-0.8532,0.88,1,0.9867,0.47,0.97
"GO_BP:488168_GO_0002295_T_HELPER_CELL_LINEAGE_COMMITMENT","GO_BP","488168_GO_0002295_T_HELPER_CELL_LINEAGE_COMMITMENT",6,-0.8642,0.65,0.82,-1.0359,0.42,0.98,0.9136,0.55,0.93
"GO_MF:495510_GO_0015248_STEROL_TRANSPORTER_ACTIVITY","GO_MF","495510_GO_0015248_STEROL_TRANSPORTER_ACTIVITY",19,-0.8641,0.66,0.82,-1.1453,0.28,0.81,1.4031,0.085,0.52
"KEGG_pathway:HSA00020_CITRATE_CYCLE_TCA_CYCLE_","KEGG_pathway","HSA00020_CITRATE_CYCLE_TCA_CYCLE_",30,-0.864,0.66,0.76,1.6999,0.0063,0.031,-1.6617,0.01,0.061
"KEGG_reaction:R00330_ATP_GDP_PHOSPHOTRANSFERASE_ATP_GDP_ADP_GTP","KEGG_reaction","R00330_ATP_GDP_PHOSPHOTRANSFERASE_ATP_GDP_ADP_GTP",8,-0.864,0.63,0.74,-0.6701,0.89,0.99,-1.2582,0.2,0.45
"GO_BP:751011_GO_0036089_CLEAVAGE_FURROW_FORMATION","GO_BP","751011_GO_0036089_CLEAVAGE_FURROW_FORMATION",7,-0.864,0.66,0.82,0.9837,0.45,1,0.9205,0.56,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_336_BIDUS_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_336_BIDUS_METASTASIS_UP",213,-0.8639,0.82,0.78,1.3646,0.012,0.33,-0.7586,0.99,0.97
"GO_BP:486789_GO_0000270_PEPTIDOGLYCAN_METABOLIC_PROCESS","GO_BP","486789_GO_0000270_PEPTIDOGLYCAN_METABOLIC_PROCESS",5,-0.8638,0.64,0.82,-0.6907,0.84,1,1.274,0.21,0.69
"GO_MF:495755_GO_0015605_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495755_GO_0015605_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",18,-0.8638,0.66,0.82,-0.8328,0.68,1,-1.2771,0.15,0.58
"GO_BP:493416_GO_0009220_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","493416_GO_0009220_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",24,-0.8637,0.68,0.82,-0.5343,0.99,1,-0.9068,0.61,0.92
"GO_BP:491087_GO_0006102_ISOCITRATE_METABOLIC_PROCESS","GO_BP","491087_GO_0006102_ISOCITRATE_METABOLIC_PROCESS",5,-0.8636,0.64,0.82,0.932,0.55,1,-1.27,0.2,0.66
"C2_Chemical_and_genetic_perturbations:C2_CGP_2014_CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2014_CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP",20,-0.8635,0.68,0.79,0.7189,0.9,1,0.9889,0.48,0.97
"GO_CC:486750_GO_0000794_CONDENSED_NUCLEAR_CHROMOSOME","GO_CC","486750_GO_0000794_CONDENSED_NUCLEAR_CHROMOSOME",75,-0.8634,0.71,0.88,-1.0718,0.33,0.81,-0.9324,0.63,1
"REACTOME:906013_REACT_169238_DEFECTS_IN_BIOTIN_BTN_METABOLISM","REACTOME","906013_REACT_169238_DEFECTS_IN_BIOTIN_BTN_METABOLISM",7,-0.8634,0.63,0.83,-0.6893,0.86,1,-1.5025,0.063,0.35
"GO_BP:502431_GO_0033211_ADIPONECTIN_ACTIVATED_SIGNALING_PATHWAY","GO_BP","502431_GO_0033211_ADIPONECTIN_ACTIVATED_SIGNALING_PATHWAY",6,-0.8633,0.63,0.82,1.127,0.33,0.87,0.3913,1,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_1_BIOCARTA_RELA_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_1_BIOCARTA_RELA_PATHWAY",16,-0.8632,0.66,0.74,-0.726,0.82,1,0.6684,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2819_WEBER_METHYLATED_LCP_IN_SPERM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2819_WEBER_METHYLATED_LCP_IN_SPERM_UP",14,-0.8632,0.66,0.79,-1.6629,0.019,0.39,0.6495,0.92,1
"C3_MicroRNA_targets:C3_MIR_129_CCTGAGT_MIR_510","C3_MicroRNA_targets","C3_MIR_129_CCTGAGT_MIR_510",42,-0.8631,0.69,0.84,0.8988,0.64,1,0.6872,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_946_PUJANA_BREAST_CANCER_LIT_INT_NETWORK","C2_Chemical_and_genetic_perturbations","C2_CGP_946_PUJANA_BREAST_CANCER_LIT_INT_NETWORK",101,-0.8631,0.73,0.79,0.8251,0.87,0.98,-1.4616,0.0041,0.31
"GO_BP:514707_GO_0061162_ESTABLISHMENT_OF_MONOPOLAR_CELL_POLARITY","GO_BP","514707_GO_0061162_ESTABLISHMENT_OF_MONOPOLAR_CELL_POLARITY",11,-0.8629,0.65,0.82,-0.9254,0.55,1,-0.9724,0.49,0.87
"GO_MF:752045_GO_0052851_FERRIC_CHELATE_REDUCTASE_NADPH_ACTIVITY","GO_MF","752045_GO_0052851_FERRIC_CHELATE_REDUCTASE_NADPH_ACTIVITY",5,-0.8627,0.66,0.83,1.2819,0.18,0.64,1.1622,0.3,0.77
"GO_BP:507951_GO_0045603_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION","GO_BP","507951_GO_0045603_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION",10,-0.8623,0.64,0.82,0.6905,0.86,1,1.5028,0.072,0.56
"GO_MF:498067_GO_0019212_PHOSPHATASE_INHIBITOR_ACTIVITY","GO_MF","498067_GO_0019212_PHOSPHATASE_INHIBITOR_ACTIVITY",35,-0.8622,0.68,0.83,-0.9738,0.48,0.94,-1.0963,0.31,0.7
"GO_BP:515841_GO_0070914_UV_DAMAGE_EXCISION_REPAIR","GO_BP","515841_GO_0070914_UV_DAMAGE_EXCISION_REPAIR",9,-0.8617,0.65,0.82,-0.9501,0.51,1,-0.8807,0.64,0.94
"GO_BP:491367_GO_0051131_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY","GO_BP","491367_GO_0051131_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY",13,-0.8617,0.66,0.82,1.3068,0.13,0.66,-1.1929,0.23,0.74
"C7_Immunologic_signatures:C7_ALL_537_GSE17721_LPS_VS_POLYIC_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_537_GSE17721_LPS_VS_POLYIC_8H_BMDM_UP",200,-0.8615,0.78,0.85,1.6562,0,0.0012,0.7616,0.98,1
"GO_BP:513595_GO_0060037_PHARYNGEAL_SYSTEM_DEVELOPMENT","GO_BP","513595_GO_0060037_PHARYNGEAL_SYSTEM_DEVELOPMENT",16,-0.8614,0.64,0.82,-1.1757,0.23,0.9,1.4572,0.07,0.58
"GO_MF:496773_GO_0016885_LIGASE_ACTIVITY_FORMING_CARBON_CARBON_BONDS","GO_MF","496773_GO_0016885_LIGASE_ACTIVITY_FORMING_CARBON_CARBON_BONDS",7,-0.8613,0.64,0.83,-0.6882,0.86,1,-1.4829,0.059,0.42
"C1_Positional:C1_ALL_25_CHR11Q","C1_Positional","C1_ALL_25_CHR11Q",7,-0.8611,0.65,0.98,-0.9956,0.48,1,1.3082,0.17,0.45
"REACTOME:1127681_REACT_264155_CHROMATIN_ORGANIZATION","REACTOME","1127681_REACT_264155_CHROMATIN_ORGANIZATION",250,-0.861,0.8,0.83,-1.3627,0.012,0.56,-1.3062,0.026,0.55
"KEGG_module:HSA_M00428_EIF4F_COMPLEX","KEGG_module","HSA_M00428_EIF4F_COMPLEX",8,-0.861,0.64,0.76,0.6645,0.86,0.97,-1.3695,0.12,0.54
"GO_MF:492507_GO_0008158_HEDGEHOG_RECEPTOR_ACTIVITY","GO_MF","492507_GO_0008158_HEDGEHOG_RECEPTOR_ACTIVITY",10,-0.8609,0.66,0.83,-1.1018,0.33,0.83,1.1241,0.31,0.81
"WikiPathways:672452_WP2036_TWEAK_SIGNALING_PATHWAY","WikiPathways","672452_WP2036_TWEAK_SIGNALING_PATHWAY",41,-0.8608,0.68,0.79,-0.6342,0.96,1,0.5816,1,1
"GO_MF:498723_GO_0019957_C_C_CHEMOKINE_BINDING","GO_MF","498723_GO_0019957_C_C_CHEMOKINE_BINDING",6,-0.8608,0.66,0.83,1.3417,0.15,0.53,1.6706,0.012,0.24
"WikiPathways:198866_WP496_STEROID_BIOSYNTHESIS","WikiPathways","198866_WP496_STEROID_BIOSYNTHESIS",10,-0.8607,0.66,0.79,1.1179,0.32,0.99,-0.8769,0.6,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2115_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD","C2_Chemical_and_genetic_perturbations","C2_CGP_2115_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD",30,-0.8607,0.69,0.79,0.9034,0.63,0.92,0.8058,0.76,1
"GO_BP:493364_GO_0009168_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493364_GO_0009168_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",59,-0.8607,0.7,0.82,1.3956,0.043,0.56,-0.7645,0.9,1
"GO_BP:501698_GO_0032466_NEGATIVE_REGULATION_OF_CYTOKINESIS","GO_BP","501698_GO_0032466_NEGATIVE_REGULATION_OF_CYTOKINESIS",7,-0.8604,0.63,0.82,-0.6683,0.88,1,-1.2492,0.22,0.68
"GO_BP:518792_GO_2000144_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION","GO_BP","518792_GO_2000144_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION",17,-0.8604,0.68,0.82,-0.9303,0.55,1,0.675,0.9,1
"GO_MF:487299_GO_0001076_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY","GO_MF","487299_GO_0001076_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",121,-0.8604,0.75,0.83,-0.927,0.65,0.97,0.8311,0.86,1
"C7_Immunologic_signatures:C7_ALL_792_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_792_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN",196,-0.8604,0.8,0.85,0.8416,0.91,1,-0.8055,0.95,1
"C7_Immunologic_signatures:C7_ALL_451_GSE17721_CTRL_VS_LPS_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_451_GSE17721_CTRL_VS_LPS_2H_BMDM_UP",198,-0.8603,0.8,0.85,1.4172,0.007,0.033,-0.7225,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2441_ISHIKAWA_STING_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_2441_ISHIKAWA_STING_SIGNALING",8,-0.8602,0.66,0.79,0.6205,0.93,1,-1.4101,0.1,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_1512_HADDAD_B_LYMPHOCYTE_PROGENITOR","C2_Chemical_and_genetic_perturbations","C2_CGP_1512_HADDAD_B_LYMPHOCYTE_PROGENITOR",285,-0.86,0.83,0.79,-0.7642,0.99,1,-1.2772,0.032,0.45
"GO_MF:504204_GO_0035014_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY","GO_MF","504204_GO_0035014_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY",8,-0.8599,0.64,0.83,-0.7786,0.71,1,-0.7758,0.74,0.98
"GO_BP:505456_GO_0042310_VASOCONSTRICTION","GO_BP","505456_GO_0042310_VASOCONSTRICTION",30,-0.8598,0.68,0.82,1.3782,0.084,0.58,1.3895,0.069,0.63
"GO_BP:503271_GO_0034063_STRESS_GRANULE_ASSEMBLY","GO_BP","503271_GO_0034063_STRESS_GRANULE_ASSEMBLY",9,-0.8598,0.64,0.82,-1.033,0.43,0.98,-1.164,0.28,0.73
"KEGG_reaction:R03408_DEHYDROEPIANDROSTERONE_H_OXYGEN_NADPH_16ALPHA_HYDROXYDEHYDROEPIANDROSTERONE_NADP_H2O","KEGG_reaction","R03408_DEHYDROEPIANDROSTERONE_H_OXYGEN_NADPH_16ALPHA_HYDROXYDEHYDROEPIANDROSTERONE_NADP_H2O",7,-0.8595,0.65,0.74,0.9517,0.52,1,-1.0412,0.39,0.55
"GO_BP:492372_GO_0007631_FEEDING_BEHAVIOR","GO_BP","492372_GO_0007631_FEEDING_BEHAVIOR",77,-0.8595,0.73,0.82,-1.1154,0.25,0.94,1.813,0,0.27
"C2_Chemical_and_genetic_perturbations:C2_CGP_2524_NICK_RESPONSE_TO_PROC_TREATMENT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2524_NICK_RESPONSE_TO_PROC_TREATMENT_DN",27,-0.8594,0.69,0.79,1.2186,0.19,0.47,0.7948,0.8,1
"GO_MF:496750_GO_0016857_RACEMASE_AND_EPIMERASE_ACTIVITY_ACTING_ON_CARBOHYDRATES_AND_DERIVATIVES","GO_MF","496750_GO_0016857_RACEMASE_AND_EPIMERASE_ACTIVITY_ACTING_ON_CARBOHYDRATES_AND_DERIVATIVES",9,-0.8594,0.64,0.83,-0.802,0.71,1,-0.5377,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_595_RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2","C2_Chemical_and_genetic_perturbations","C2_CGP_595_RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2",25,-0.8592,0.67,0.79,-0.7215,0.88,1,1.0903,0.34,0.88
"REACTOME:106536_REACT_18347_GLUTAMATE_BINDING_ACTIVATION_OF_AMPA_RECEPTORS_AND_SYNAPTIC_PLASTICITY","REACTOME","106536_REACT_18347_GLUTAMATE_BINDING_ACTIVATION_OF_AMPA_RECEPTORS_AND_SYNAPTIC_PLASTICITY",30,-0.8592,0.67,0.83,-1.3702,0.075,0.56,-0.7868,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_104_HOOI_ST7_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_104_HOOI_ST7_TARGETS_UP",92,-0.8591,0.75,0.79,1.0275,0.39,0.76,1.0093,0.43,0.96
"KEGG_pathway:HSA00790_FOLATE_BIOSYNTHESIS","KEGG_pathway","HSA00790_FOLATE_BIOSYNTHESIS",14,-0.8591,0.66,0.76,1.0536,0.38,0.82,0.8334,0.7,1
"GO_BP:488984_GO_0003190_ATRIOVENTRICULAR_VALVE_FORMATION","GO_BP","488984_GO_0003190_ATRIOVENTRICULAR_VALVE_FORMATION",7,-0.859,0.66,0.82,1.1957,0.26,0.79,1.2448,0.2,0.7
"REACTOME:161008_REACT_22312_NEUROFASCIN_INTERACTIONS","REACTOME","161008_REACT_22312_NEUROFASCIN_INTERACTIONS",6,-0.859,0.64,0.83,-1.0628,0.4,0.92,-0.831,0.68,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3278_PLASARI_NFIC_TARGETS_BASAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3278_PLASARI_NFIC_TARGETS_BASAL_UP",27,-0.859,0.68,0.79,1.5947,0.012,0.14,-0.9259,0.59,0.84
"GO_MF:515627_GO_0070697_ACTIVIN_RECEPTOR_BINDING","GO_MF","515627_GO_0070697_ACTIVIN_RECEPTOR_BINDING",5,-0.8588,0.66,0.83,-0.9002,0.59,0.99,0.7347,0.8,1
"C7_Immunologic_signatures:C7_ALL_144_GSE13229_MATURE_VS_INTMATURE_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_144_GSE13229_MATURE_VS_INTMATURE_NKCELL_DN",199,-0.8586,0.79,0.86,0.9576,0.54,0.88,-0.791,0.96,1
"C7_Immunologic_signatures:C7_ALL_1050_GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN","C7_Immunologic_signatures","C7_ALL_1050_GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN",200,-0.8584,0.81,0.86,1.5841,0.0024,0.0039,-0.9721,0.53,0.79
"KEGG_module:HSA_M00160_V_TYPE_ATPASE_EUKARYOTES","KEGG_module","HSA_M00160_V_TYPE_ATPASE_EUKARYOTES",23,-0.8583,0.67,0.75,0.8759,0.6,0.9,1.1999,0.21,0.77
"GO_BP:755330_GO_2001224_POSITIVE_REGULATION_OF_NEURON_MIGRATION","GO_BP","755330_GO_2001224_POSITIVE_REGULATION_OF_NEURON_MIGRATION",7,-0.8582,0.64,0.82,-0.9478,0.52,1,-0.8505,0.64,0.96
"KEGG_reaction:R01137_ATP_DADP_PHOSPHOTRANSFERASE_ATP_DADP_ADP_DATP","KEGG_reaction","R01137_ATP_DADP_PHOSPHOTRANSFERASE_ATP_DADP_ADP_DATP",8,-0.8581,0.66,0.74,-0.6817,0.85,1,-1.2699,0.17,0.48
"GO_BP:501755_GO_0032525_SOMITE_ROSTRAL_CAUDAL_AXIS_SPECIFICATION","GO_BP","501755_GO_0032525_SOMITE_ROSTRAL_CAUDAL_AXIS_SPECIFICATION",11,-0.858,0.67,0.82,-1.3447,0.12,0.93,0.6037,0.94,1
"GO_BP:514884_GO_0061339_ESTABLISHMENT_OR_MAINTENANCE_OF_MONOPOLAR_CELL_POLARITY","GO_BP","514884_GO_0061339_ESTABLISHMENT_OR_MAINTENANCE_OF_MONOPOLAR_CELL_POLARITY",11,-0.858,0.65,0.82,-0.9369,0.54,1,-0.9773,0.49,0.87
"KEGG_compound:C01345_DITP_2_DEOXYINOSINE_5_TRIPHOSPHATE_2_DEOXYINOSINE_5_TRIPHOSPHATE","KEGG_compound","C01345_DITP_2_DEOXYINOSINE_5_TRIPHOSPHATE_2_DEOXYINOSINE_5_TRIPHOSPHATE",9,-0.858,0.66,0.77,-0.6041,0.94,1,-1.3845,0.12,0.3
"GO_BP:491080_GO_0006101_CITRATE_METABOLIC_PROCESS","GO_BP","491080_GO_0006101_CITRATE_METABOLIC_PROCESS",33,-0.858,0.67,0.82,1.8468,0.002,0.064,-1.4979,0.034,0.54
"GO_BP:507973_GO_0045625_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION","GO_BP","507973_GO_0045625_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION",8,-0.8579,0.66,0.82,0.5756,0.96,1,0.4688,1,1
"GO_MF:504678_GO_0035497_CAMP_RESPONSE_ELEMENT_BINDING","GO_MF","504678_GO_0035497_CAMP_RESPONSE_ELEMENT_BINDING",12,-0.8579,0.66,0.83,-0.8834,0.62,1,-0.5703,0.97,1
"GO_BP:500834_GO_0031584_ACTIVATION_OF_PHOSPHOLIPASE_D_ACTIVITY","GO_BP","500834_GO_0031584_ACTIVATION_OF_PHOSPHOLIPASE_D_ACTIVITY",5,-0.8576,0.66,0.82,1.1301,0.34,0.87,-0.8048,0.71,0.99
"C7_Immunologic_signatures:C7_ALL_103_GSE11924_TH1_VS_TH17_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_103_GSE11924_TH1_VS_TH17_CD4_TCELL_UP",193,-0.8576,0.8,0.86,-0.9349,0.63,1,1.1628,0.13,0.83
"GO_BP:499666_GO_0030261_CHROMOSOME_CONDENSATION","GO_BP","499666_GO_0030261_CHROMOSOME_CONDENSATION",28,-0.8576,0.67,0.82,-0.9417,0.5,1,-1.1914,0.2,0.74
"C7_Immunologic_signatures:C7_ALL_1237_GSE28237_EARLY_VS_LATE_GC_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1237_GSE28237_EARLY_VS_LATE_GC_BCELL_UP",195,-0.8576,0.8,0.86,-0.8507,0.88,1,0.8902,0.75,1
"C3_TF_targets:C3_TFT_253_V_E2F1_Q6","C3_TF_targets","C3_TFT_253_V_E2F1_Q6",232,-0.8575,0.83,0.86,0.8124,0.96,1,-1.3394,0.0083,0.25
"GO_BP:492036_GO_0007257_ACTIVATION_OF_JUN_KINASE_ACTIVITY","GO_BP","492036_GO_0007257_ACTIVATION_OF_JUN_KINASE_ACTIVITY",35,-0.8575,0.7,0.82,-0.7332,0.92,1,-0.8227,0.8,0.97
"GO_BP:491083_GO_0006105_SUCCINATE_METABOLIC_PROCESS","GO_BP","491083_GO_0006105_SUCCINATE_METABOLIC_PROCESS",10,-0.8574,0.66,0.82,1.4396,0.082,0.51,-1.1234,0.31,0.76
"GO_MF:494608_GO_0051787_MISFOLDED_PROTEIN_BINDING","GO_MF","494608_GO_0051787_MISFOLDED_PROTEIN_BINDING",11,-0.8573,0.66,0.83,0.7291,0.85,1,-0.7467,0.79,0.99
"REACTOME:1127682_REACT_264165_CHROMATIN_MODIFYING_ENZYMES","REACTOME","1127682_REACT_264165_CHROMATIN_MODIFYING_ENZYMES",250,-0.8573,0.81,0.83,-1.3665,0.0052,0.56,-1.2993,0.019,0.55
"GO_BP:517117_GO_0072201_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION","GO_BP","517117_GO_0072201_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION",6,-0.8572,0.65,0.82,0.8048,0.71,1,0.9414,0.56,0.91
"REACTOME:106438_REACT_1109_INSULIN_RECEPTOR_RECYCLING","REACTOME","106438_REACT_1109_INSULIN_RECEPTOR_RECYCLING",24,-0.857,0.67,0.83,0.834,0.7,0.97,1.057,0.36,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1667_MURAKAMI_UV_RESPONSE_6HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1667_MURAKAMI_UV_RESPONSE_6HR_DN",19,-0.857,0.67,0.79,-0.9347,0.54,1,0.8253,0.72,1
"GO_BP:518457_GO_0090317_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT","GO_BP","518457_GO_0090317_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT",75,-0.8568,0.72,0.82,-0.6159,0.99,1,-1.1954,0.16,0.74
"GO_BP:505415_GO_0042256_MATURE_RIBOSOME_ASSEMBLY","GO_BP","505415_GO_0042256_MATURE_RIBOSOME_ASSEMBLY",6,-0.8568,0.67,0.82,1.3281,0.17,0.63,0.6117,0.93,1
"WikiPathways:198893_WP400_P38_MAPK_SIGNALING_PATHWAY","WikiPathways","198893_WP400_P38_MAPK_SIGNALING_PATHWAY",34,-0.8567,0.68,0.79,-1.0718,0.33,0.94,-1.0564,0.36,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1430_PENG_GLUTAMINE_DEPRIVATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1430_PENG_GLUTAMINE_DEPRIVATION_DN",334,-0.8566,0.83,0.8,1.4444,0.0026,0.26,-1.1886,0.058,0.53
"WikiPathways:672461_WP2007_IRON_METABOLISM_IN_PLACENTA","WikiPathways","672461_WP2007_IRON_METABOLISM_IN_PLACENTA",12,-0.8566,0.64,0.79,1.2399,0.22,0.79,0.8917,0.62,1
"REACTOME:730314_REACT_150182_MASTL_FACILITATES_MITOTIC_PROGRESSION","REACTOME","730314_REACT_150182_MASTL_FACILITATES_MITOTIC_PROGRESSION",10,-0.8564,0.66,0.83,0.577,0.96,1,-0.761,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2499_SOUCEK_MYC_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2499_SOUCEK_MYC_TARGETS",8,-0.8564,0.65,0.8,1.4796,0.08,0.23,1.4055,0.095,0.54
"GO_BP:517498_GO_0072595_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE","GO_BP","517498_GO_0072595_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE",25,-0.8563,0.68,0.82,0.5556,0.99,1,-0.6773,0.93,1
"C7_Immunologic_signatures:C7_ALL_1508_GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN","C7_Immunologic_signatures","C7_ALL_1508_GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN",199,-0.8563,0.8,0.86,1.0096,0.39,0.72,-1.3197,0.017,0.12
"GO_BP:493567_GO_0009394_2_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS","GO_BP","493567_GO_0009394_2_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS",30,-0.8562,0.69,0.82,1.4564,0.035,0.48,-1.4869,0.032,0.53
"GO_MF:496263_GO_0016174_NAD_P_H_OXIDASE_ACTIVITY","GO_MF","496263_GO_0016174_NAD_P_H_OXIDASE_ACTIVITY",6,-0.8562,0.66,0.83,-0.8094,0.68,1,-1.2221,0.25,0.57
"GO_BP:754191_GO_1901224_POSITIVE_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING","GO_BP","754191_GO_1901224_POSITIVE_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING",23,-0.8562,0.68,0.82,1.4561,0.054,0.48,1.132,0.27,0.74
"GO_MF:502017_GO_0032794_GTPASE_ACTIVATING_PROTEIN_BINDING","GO_MF","502017_GO_0032794_GTPASE_ACTIVATING_PROTEIN_BINDING",12,-0.856,0.65,0.83,-0.852,0.67,1,-0.9895,0.47,0.79
"REACTOME:1127577_REACT_268269_SIGNALING_BY_EGFRVIII_IN_CANCER","REACTOME","1127577_REACT_268269_SIGNALING_BY_EGFRVIII_IN_CANCER",15,-0.856,0.68,0.83,0.9348,0.54,0.85,-0.8179,0.7,1
"GO_BP:491841_GO_0007006_MITOCHONDRIAL_MEMBRANE_ORGANIZATION","GO_BP","491841_GO_0007006_MITOCHONDRIAL_MEMBRANE_ORGANIZATION",50,-0.8559,0.73,0.83,1.526,0.015,0.37,-1.2095,0.15,0.73
"KEGG_reaction:R00722_ATP_IDP_PHOSPHOTRANSFERASE_ATP_IDP_ADP_ITP","KEGG_reaction","R00722_ATP_IDP_PHOSPHOTRANSFERASE_ATP_IDP_ADP_ITP",8,-0.8559,0.65,0.73,-0.6886,0.85,1,-1.2602,0.22,0.46
"GO_BP:513717_GO_0060159_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","513717_GO_0060159_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY",6,-0.8558,0.66,0.83,-0.8321,0.68,1,-0.5627,0.95,1
"C7_Immunologic_signatures:C7_ALL_1247_GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1247_GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP",168,-0.8557,0.81,0.86,1.1166,0.18,0.4,1.1356,0.15,0.91
"GO_BP:849764_GO_0044788_MODULATION_BY_HOST_OF_VIRAL_PROCESS","GO_BP","849764_GO_0044788_MODULATION_BY_HOST_OF_VIRAL_PROCESS",12,-0.8556,0.66,0.83,0.8864,0.63,1,1.0147,0.45,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_733_LUND_SILENCED_BY_METHYLATION","C2_Chemical_and_genetic_perturbations","C2_CGP_733_LUND_SILENCED_BY_METHYLATION",16,-0.8555,0.66,0.8,0.7356,0.84,1,0.9055,0.59,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3318_ZHANG_ADIPOGENESIS_BY_BMP7","C2_Chemical_and_genetic_perturbations","C2_CGP_3318_ZHANG_ADIPOGENESIS_BY_BMP7",14,-0.8555,0.65,0.8,0.6529,0.92,1,0.7541,0.79,1
"GO_BP:752960_GO_0097461_FERRIC_IRON_IMPORT_INTO_CELL","GO_BP","752960_GO_0097461_FERRIC_IRON_IMPORT_INTO_CELL",5,-0.8555,0.67,0.83,1.2935,0.17,0.68,1.1313,0.35,0.74
"GO_BP:504492_GO_0035308_NEGATIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION","GO_BP","504492_GO_0035308_NEGATIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION",6,-0.8554,0.66,0.83,1.02,0.46,0.97,-1.3009,0.2,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_665_NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA","C2_Chemical_and_genetic_perturbations","C2_CGP_665_NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA",7,-0.8552,0.63,0.8,-1.3952,0.11,0.59,-1.3747,0.12,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_3157_LINSLEY_MIR16_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3157_LINSLEY_MIR16_TARGETS",206,-0.8552,0.8,0.8,0.8493,0.88,0.97,0.7472,0.99,1
"KEGG_compound:C01344_DIDP_2_DEOXYINOSINE_5_DIPHOSPHATE_2_DEOXYINOSINE_5_DIPHOSPHATE","KEGG_compound","C01344_DIDP_2_DEOXYINOSINE_5_DIPHOSPHATE_2_DEOXYINOSINE_5_DIPHOSPHATE",9,-0.855,0.65,0.77,-0.6969,0.86,1,-1.4452,0.087,0.26
"GO_CC:490786_GO_0005753_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX","GO_CC","490786_GO_0005753_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX",21,-0.8549,0.69,0.9,2.1627,0.002,0.00034,-0.6873,0.9,1
"REACTOME:119538_REACT_19189_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN","REACTOME","119538_REACT_19189_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN",15,-0.8549,0.68,0.83,0.7961,0.77,0.99,-0.6508,0.94,1
"C1_Positional:C1_ALL_55_CHR11Q24","C1_Positional","C1_ALL_55_CHR11Q24",70,-0.8549,0.72,0.99,1.1229,0.24,0.63,1.1952,0.17,0.65
"GO_MF:502829_GO_0033613_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING","GO_MF","502829_GO_0033613_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING",55,-0.8548,0.72,0.83,-0.9944,0.46,0.91,0.9428,0.55,0.92
"GO_BP:502266_GO_0033045_REGULATION_OF_SISTER_CHROMATID_SEGREGATION","GO_BP","502266_GO_0033045_REGULATION_OF_SISTER_CHROMATID_SEGREGATION",46,-0.8548,0.69,0.83,1.0251,0.39,0.97,-0.8656,0.72,0.95
"REACTOME:576248_REACT_118773_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR_","REACTOME","576248_REACT_118773_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR_",189,-0.8547,0.8,0.83,1.1146,0.19,0.56,-1.1301,0.19,0.68
"GO_BP:506412_GO_0043373_CD4_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT","GO_BP","506412_GO_0043373_CD4_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT",7,-0.8546,0.65,0.83,-1.17,0.3,0.91,0.7943,0.74,1
"GO_BP:500364_GO_0031076_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT","GO_BP","500364_GO_0031076_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT",38,-0.8546,0.68,0.83,1.0012,0.46,0.98,1.2647,0.14,0.68
"C7_Immunologic_signatures:C7_ALL_567_GSE17721_PAM3CSK4_VS_CPG_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_567_GSE17721_PAM3CSK4_VS_CPG_2H_BMDM_UP",195,-0.8546,0.8,0.86,-0.9163,0.7,1,-0.9917,0.49,0.74
"GO_BP:754955_GO_2000849_REGULATION_OF_GLUCOCORTICOID_SECRETION","GO_BP","754955_GO_2000849_REGULATION_OF_GLUCOCORTICOID_SECRETION",9,-0.8545,0.65,0.83,0.7983,0.72,1,-0.6313,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2216_GAUTSCHI_SRC_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_2216_GAUTSCHI_SRC_SIGNALING",8,-0.8544,0.67,0.8,-1.202,0.24,0.8,1.1201,0.34,0.85
"GO_BP:513815_GO_0060259_REGULATION_OF_FEEDING_BEHAVIOR","GO_BP","513815_GO_0060259_REGULATION_OF_FEEDING_BEHAVIOR",14,-0.8544,0.68,0.83,1.0458,0.39,0.95,1.3549,0.1,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2815_WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2815_WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN",8,-0.8544,0.68,0.8,-1.0416,0.42,0.98,0.9391,0.54,1
"C3_TF_targets:C3_TFT_156_V_SREBP1_01","C3_TF_targets","C3_TFT_156_V_SREBP1_01",166,-0.8543,0.79,0.86,1.2899,0.039,0.5,-0.8669,0.84,0.97
"GO_BP:508307_GO_0046007_NEGATIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION","GO_BP","508307_GO_0046007_NEGATIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION",8,-0.8543,0.64,0.83,0.7372,0.81,1,0.5922,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_429_VANHARANTA_UTERINE_FIBROID_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_429_VANHARANTA_UTERINE_FIBROID_UP",43,-0.8542,0.71,0.8,0.8134,0.8,0.98,0.963,0.5,0.97
"GO_BP:513604_GO_0060046_REGULATION_OF_ACROSOME_REACTION","GO_BP","513604_GO_0060046_REGULATION_OF_ACROSOME_REACTION",11,-0.8542,0.67,0.83,-1.0041,0.46,0.99,-1.2327,0.21,0.7
"GO_BP:493376_GO_0009180_PURINE_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493376_GO_0009180_PURINE_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",6,-0.8541,0.66,0.83,-0.4945,0.98,1,-0.7701,0.75,1
"GO_BP:512656_GO_0051784_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION","GO_BP","512656_GO_0051784_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION",57,-0.854,0.72,0.83,0.603,1,1,-0.9658,0.52,0.88
"GO_BP:496510_GO_0016559_PEROXISOME_FISSION","GO_BP","496510_GO_0016559_PEROXISOME_FISSION",10,-0.8539,0.65,0.83,0.8111,0.69,1,-0.9993,0.45,0.85
"KEGG_compound:C01243_1D_MYO_INOSITOL_1_3_4_TRISPHOSPHATE_D_MYO_INOSITOL_1_3_4_TRISPHOSPHATE_INOSITOL_1_3_4_TRISPHOSPHATE","KEGG_compound","C01243_1D_MYO_INOSITOL_1_3_4_TRISPHOSPHATE_D_MYO_INOSITOL_1_3_4_TRISPHOSPHATE_INOSITOL_1_3_4_TRISPHOSPHATE",5,-0.8537,0.66,0.77,-0.6016,0.91,1,0.8987,0.59,0.82
"GO_MF:492983_GO_0016651_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H","GO_MF","492983_GO_0016651_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H",94,-0.8537,0.75,0.83,1.6817,0,0.17,-0.9178,0.63,0.86
"GO_BP:505587_GO_0042447_HORMONE_CATABOLIC_PROCESS","GO_BP","505587_GO_0042447_HORMONE_CATABOLIC_PROCESS",8,-0.8536,0.65,0.83,1.5604,0.044,0.33,0.7173,0.83,1
"WikiPathways:920974_WP1533_VITAMIN_B12_METABOLISM","WikiPathways","920974_WP1533_VITAMIN_B12_METABOLISM",18,-0.8534,0.67,0.79,1.4183,0.06,0.43,-1.1569,0.26,0.58
"C4_Cancer_gene_neighborhoods:C4_CGN_306_GNF2_PRDX2","C4_Cancer_gene_neighborhoods","C4_CGN_306_GNF2_PRDX2",30,-0.8532,0.68,0.95,1.6861,0.01,0.0071,-1.3885,0.077,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_585_IVANOV_MUTATED_IN_COLON_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_585_IVANOV_MUTATED_IN_COLON_CANCER",13,-0.8531,0.67,0.8,0.5582,0.97,1,0.7614,0.79,1
"GO_BP:510493_GO_0048386_POSITIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY","GO_BP","510493_GO_0048386_POSITIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY",5,-0.8531,0.68,0.83,-1.5612,0.035,0.71,-1.1076,0.37,0.77
"KEGG_compound:C00942_3_5_CYCLIC_GMP_GUANOSINE_3_5_CYCLIC_MONOPHOSPHATE_GUANOSINE_3_5_CYCLIC_PHOSPHATE_CYCLIC_GMP_CGMP","KEGG_compound","C00942_3_5_CYCLIC_GMP_GUANOSINE_3_5_CYCLIC_MONOPHOSPHATE_GUANOSINE_3_5_CYCLIC_PHOSPHATE_CYCLIC_GMP_CGMP",34,-0.8529,0.7,0.77,-0.8506,0.72,1,-1.4391,0.056,0.26
"REACTOME:106537_REACT_18307_TRAFFICKING_OF_AMPA_RECEPTORS","REACTOME","106537_REACT_18307_TRAFFICKING_OF_AMPA_RECEPTORS",30,-0.8527,0.69,0.84,-1.3638,0.09,0.57,-0.803,0.78,1
"C4_Cancer_modules:C4_CM_409_MODULE_528","C4_Cancer_modules","C4_CM_409_MODULE_528",10,-0.8527,0.65,0.81,0.5077,0.99,1,0.7648,0.75,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1625_WEBER_METHYLATED_IN_COLON_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_1625_WEBER_METHYLATED_IN_COLON_CANCER",17,-0.8527,0.66,0.8,-1.3291,0.11,0.69,0.9121,0.58,1
"GO_CC:490823_GO_0005795_GOLGI_STACK","GO_CC","490823_GO_0005795_GOLGI_STACK",124,-0.8526,0.77,0.9,1.0011,0.46,0.79,0.6458,1,1
"REACTOME:1127526_REACT_264276_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS","REACTOME","1127526_REACT_264276_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS",5,-0.8526,0.66,0.83,-1.0679,0.41,0.91,-1.1564,0.33,0.65
"GO_BP:516283_GO_0071359_CELLULAR_RESPONSE_TO_DSRNA","GO_BP","516283_GO_0071359_CELLULAR_RESPONSE_TO_DSRNA",31,-0.8526,0.68,0.83,1.0852,0.33,0.92,-1.1668,0.23,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1528_ROETH_TERT_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1528_ROETH_TERT_TARGETS_UP",14,-0.8524,0.67,0.8,2.025,0,0.0047,-1.1645,0.28,0.56
"C3_MicroRNA_targets:C3_MIR_53_GGATCCG_MIR_127","C3_MicroRNA_targets","C3_MIR_53_GGATCCG_MIR_127",11,-0.8522,0.67,0.85,1.1425,0.28,1,-0.8104,0.72,1
"C6_Oncogenic_signatures:C6_ALL_89_PTEN_DN_V2_DN","C6_Oncogenic_signatures","C6_ALL_89_PTEN_DN_V2_DN",137,-0.8521,0.81,0.81,-0.9255,0.63,0.85,-1.2528,0.059,0.33
"C7_Immunologic_signatures:C7_ALL_242_GSE14026_TH1_VS_TH17_DN","C7_Immunologic_signatures","C7_ALL_242_GSE14026_TH1_VS_TH17_DN",194,-0.8521,0.79,0.87,1.1026,0.19,0.44,-1.222,0.057,0.24
"GO_BP:489076_GO_0003283_ATRIAL_SEPTUM_DEVELOPMENT","GO_BP","489076_GO_0003283_ATRIAL_SEPTUM_DEVELOPMENT",17,-0.852,0.66,0.83,-1.151,0.27,0.93,1.1456,0.29,0.73
"GO_BP:911463_GO_1902475_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT","GO_BP","911463_GO_1902475_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT",23,-0.852,0.67,0.83,0.9268,0.57,1,0.9307,0.56,0.92
"C1_Positional:C1_ALL_72_CHR2Q24","C1_Positional","C1_ALL_72_CHR2Q24",43,-0.852,0.71,0.99,0.8268,0.78,0.92,0.8175,0.78,0.92
"GO_BP:503965_GO_0034766_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","503965_GO_0034766_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORT",54,-0.8517,0.73,0.83,0.9841,0.46,1,-0.8572,0.73,0.96
"GO_BP:494829_GO_0010764_NEGATIVE_REGULATION_OF_FIBROBLAST_MIGRATION","GO_BP","494829_GO_0010764_NEGATIVE_REGULATION_OF_FIBROBLAST_MIGRATION",6,-0.8515,0.67,0.83,-0.662,0.87,1,-0.6505,0.87,1
"GO_BP:491696_GO_0006829_ZINC_II_ION_TRANSPORT","GO_BP","491696_GO_0006829_ZINC_II_ION_TRANSPORT",25,-0.8515,0.69,0.83,0.9392,0.56,1,-0.7827,0.81,1
"GO_MF:489800_GO_0004448_ISOCITRATE_DEHYDROGENASE_ACTIVITY","GO_MF","489800_GO_0004448_ISOCITRATE_DEHYDROGENASE_ACTIVITY",5,-0.8515,0.66,0.83,0.94,0.54,0.94,-1.1764,0.29,0.6
"C7_Immunologic_signatures:C7_ALL_1207_GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP","C7_Immunologic_signatures","C7_ALL_1207_GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP",200,-0.8514,0.81,0.87,-0.7887,0.95,1,-0.8902,0.78,0.96
"C3_TF_targets:C3_TFT_589_RYTGCNNRGNAAC_V_MIF1_01","C3_TF_targets","C3_TFT_589_RYTGCNNRGNAAC_V_MIF1_01",85,-0.8513,0.73,0.87,-0.9786,0.49,0.8,0.7745,0.93,1
"GO_BP:754917_GO_2000811_NEGATIVE_REGULATION_OF_ANOIKIS","GO_BP","754917_GO_2000811_NEGATIVE_REGULATION_OF_ANOIKIS",16,-0.8513,0.67,0.83,1.0239,0.42,0.97,1.513,0.07,0.55
"C3_MicroRNA_targets:C3_MIR_91_GGCAGAC_MIR_346","C3_MicroRNA_targets","C3_MIR_91_GGCAGAC_MIR_346",41,-0.8511,0.71,0.85,-1.0839,0.3,1,-1.4725,0.034,1
"C1_Positional:C1_ALL_99_CHR17Q","C1_Positional","C1_ALL_99_CHR17Q",9,-0.8511,0.66,0.99,-1.0224,0.42,1,-1.3456,0.12,0.44
"GO_BP:501703_GO_0032471_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_CALCIUM_ION_CONCENTRATION","GO_BP","501703_GO_0032471_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_CALCIUM_ION_CONCENTRATION",8,-0.8511,0.64,0.83,-0.4691,0.99,1,0.8353,0.68,0.99
"REACTOME:771589_REACT_160106_CONSTITUTIVE_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT","REACTOME","771589_REACT_160106_CONSTITUTIVE_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT",7,-0.851,0.68,0.84,-1.176,0.31,0.86,-0.8166,0.67,1
"GO_BP:491856_GO_0007028_CYTOPLASM_ORGANIZATION","GO_BP","491856_GO_0007028_CYTOPLASM_ORGANIZATION",8,-0.8509,0.66,0.83,-0.8544,0.63,1,1.4845,0.068,0.58
"C7_Immunologic_signatures:C7_ALL_1753_GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1753_GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP",169,-0.8509,0.8,0.87,1.2447,0.051,0.16,-1.5692,0.0021,0.0083
"REACTOME:906014_REACT_169312_DEFECTIVE_HLCS_CAUSES_MULTIPLE_CARBOXYLASE_DEFICIENCY","REACTOME","906014_REACT_169312_DEFECTIVE_HLCS_CAUSES_MULTIPLE_CARBOXYLASE_DEFICIENCY",7,-0.8509,0.69,0.84,-0.6797,0.87,1,-1.4834,0.063,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_1880_SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1880_SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN",29,-0.8509,0.71,0.8,-0.8861,0.66,1,0.7159,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1326_KENNY_CTNNB1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1326_KENNY_CTNNB1_TARGETS_DN",52,-0.8508,0.73,0.8,1.0728,0.32,0.67,0.5936,0.99,1
"GO_BP:512034_GO_0051123_RNA_POLYMERASE_II_TRANSCRIPTIONAL_PREINITIATION_COMPLEX_ASSEMBLY","GO_BP","512034_GO_0051123_RNA_POLYMERASE_II_TRANSCRIPTIONAL_PREINITIATION_COMPLEX_ASSEMBLY",5,-0.8508,0.66,0.83,1.0775,0.38,0.93,-0.5748,0.93,1
"GO_CC:496477_GO_0016514_SWI_SNF_COMPLEX","GO_CC","496477_GO_0016514_SWI_SNF_COMPLEX",14,-0.8507,0.66,0.9,-0.9109,0.57,0.96,-1.6958,0.01,0.55
"REACTOME:106224_REACT_12477_ENOS_ACTIVATION","REACTOME","106224_REACT_12477_ENOS_ACTIVATION",10,-0.8505,0.64,0.84,0.8127,0.72,0.99,-0.6692,0.89,1
"KEGG_reaction:R00124_ATP_ADP_PHOSPHATRANSFERASE_ATP_ADP_ADP_ATP","KEGG_reaction","R00124_ATP_ADP_PHOSPHATRANSFERASE_ATP_ADP_ADP_ATP",8,-0.8504,0.67,0.74,-0.6816,0.88,1,-1.2847,0.18,0.49
"C4_Cancer_modules:C4_CM_21_MODULE_22","C4_Cancer_modules","C4_CM_21_MODULE_22",45,-0.8501,0.73,0.81,2.2153,0,0.00027,0.6808,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3014_BROWNE_HCMV_INFECTION_1HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3014_BROWNE_HCMV_INFECTION_1HR_DN",220,-0.85,0.83,0.8,-0.823,0.93,1,0.8658,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2939_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13","C2_Chemical_and_genetic_perturbations","C2_CGP_2939_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13",172,-0.8498,0.82,0.8,2.4382,0,0,-0.6861,1,0.99
"OMIM_gene:OMIM163970_SOLUTE_CARRIER_FAMILY_6_NEUROTRANSMITTER_TRANSPORTER_NORADRENALINE_MEMBER_2_SLC6A2","OMIM_gene","OMIM163970_SOLUTE_CARRIER_FAMILY_6_NEUROTRANSMITTER_TRANSPORTER_NORADRENALINE_MEMBER_2_SLC6A2",8,-0.8497,0.65,0.87,0.8052,0.73,1,-0.6425,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3164_BAKKER_FOXO3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3164_BAKKER_FOXO3_TARGETS_DN",182,-0.8496,0.82,0.8,0.9895,0.46,0.81,-0.9248,0.66,0.85
"C7_Immunologic_signatures:C7_ALL_581_GSE17721_CPG_VS_GARDIQUIMOD_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_581_GSE17721_CPG_VS_GARDIQUIMOD_0_5H_BMDM_UP",193,-0.8496,0.82,0.87,1.2282,0.061,0.18,-0.6914,1,1
"GO_BP:492061_GO_0007283_SPERMATOGENESIS","GO_BP","492061_GO_0007283_SPERMATOGENESIS",422,-0.8494,0.87,0.83,-1.0722,0.25,0.96,-0.9465,0.68,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_206_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_206_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN",25,-0.8493,0.67,0.8,-1.1187,0.29,0.89,0.825,0.74,1
"GO_BP:502268_GO_0033047_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION","GO_BP","502268_GO_0033047_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION",46,-0.8491,0.71,0.83,1.009,0.44,0.98,-0.8648,0.71,0.95
"GO_BP:491627_GO_0006744_UBIQUINONE_BIOSYNTHETIC_PROCESS","GO_BP","491627_GO_0006744_UBIQUINONE_BIOSYNTHETIC_PROCESS",12,-0.8491,0.66,0.83,0.9242,0.54,1,-1.0453,0.4,0.82
"GO_MF:492785_GO_0008504_MONOAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","492785_GO_0008504_MONOAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-0.8491,0.65,0.84,-0.8926,0.6,1,-1.7245,0.012,0.27
"GO_BP:512439_GO_0051561_POSITIVE_REGULATION_OF_MITOCHONDRIAL_CALCIUM_ION_CONCENTRATION","GO_BP","512439_GO_0051561_POSITIVE_REGULATION_OF_MITOCHONDRIAL_CALCIUM_ION_CONCENTRATION",9,-0.8491,0.67,0.83,0.6573,0.89,1,-1.1474,0.3,0.74
"GO_BP:508204_GO_0045896_REGULATION_OF_TRANSCRIPTION_DURING_MITOSIS","GO_BP","508204_GO_0045896_REGULATION_OF_TRANSCRIPTION_DURING_MITOSIS",7,-0.8491,0.66,0.83,-1.0532,0.39,0.97,-0.8939,0.61,0.93
"GO_BP:506549_GO_0043518_NEGATIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR","GO_BP","506549_GO_0043518_NEGATIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",12,-0.8491,0.68,0.83,0.8354,0.68,1,-1.0155,0.42,0.84
"GO_CC:507239_GO_0044232_ORGANELLE_MEMBRANE_CONTACT_SITE","GO_CC","507239_GO_0044232_ORGANELLE_MEMBRANE_CONTACT_SITE",11,-0.8491,0.67,0.9,0.7924,0.73,0.96,-0.6125,0.95,1
"GO_BP:752538_GO_0090481_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORT","GO_BP","752538_GO_0090481_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORT",5,-0.849,0.65,0.83,-1.0348,0.44,0.98,0.856,0.62,0.98
"GO_BP:506922_GO_0043902_POSITIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS","GO_BP","506922_GO_0043902_POSITIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS",144,-0.8489,0.79,0.83,1.5205,0,0.38,-0.7668,0.96,1
"GO_MF:496759_GO_0016868_INTRAMOLECULAR_TRANSFERASE_ACTIVITY_PHOSPHOTRANSFERASES","GO_MF","496759_GO_0016868_INTRAMOLECULAR_TRANSFERASE_ACTIVITY_PHOSPHOTRANSFERASES",11,-0.8489,0.65,0.84,-0.8731,0.65,1,-0.7071,0.85,1
"GO_BP:502107_GO_0032885_REGULATION_OF_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS","GO_BP","502107_GO_0032885_REGULATION_OF_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS",36,-0.8489,0.71,0.83,-0.4266,1,1,0.692,0.93,1
"REACTOME:1183529_REACT_355208_DISEASES_OF_METABOLISM","REACTOME","1183529_REACT_355208_DISEASES_OF_METABOLISM",35,-0.8488,0.73,0.84,1.2019,0.19,0.44,-1.0938,0.29,0.71
"GO_BP:755350_GO_2001244_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","755350_GO_2001244_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",53,-0.8486,0.72,0.83,0.9578,0.56,1,-0.7939,0.85,0.99
"GO_MF:496611_GO_0016681_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS_CYTOCHROME_AS_ACCEPTOR","GO_MF","496611_GO_0016681_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS_CYTOCHROME_AS_ACCEPTOR",8,-0.8485,0.69,0.84,1.5254,0.041,0.36,0.7458,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1499_GALE_APL_WITH_FLT3_MUTATED_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1499_GALE_APL_WITH_FLT3_MUTATED_DN",17,-0.8484,0.66,0.8,1.0916,0.33,0.64,0.5397,0.98,1
"GO_BP:498953_GO_0021670_LATERAL_VENTRICLE_DEVELOPMENT","GO_BP","498953_GO_0021670_LATERAL_VENTRICLE_DEVELOPMENT",12,-0.8484,0.68,0.83,0.5574,0.97,1,-0.8369,0.68,0.96
"C7_Immunologic_signatures:C7_ALL_203_GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_203_GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP",184,-0.8484,0.81,0.87,1.6975,0,0.00069,1.1102,0.21,0.96
"C7_Immunologic_signatures:C7_ALL_560_GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_560_GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDM_DN",199,-0.8482,0.79,0.87,1.6553,0,0.0012,-0.8072,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_743_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_743_HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",7,-0.8482,0.66,0.8,0.911,0.56,0.91,0.9783,0.48,0.97
"GO_BP:495050_GO_0010985_NEGATIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE","GO_BP","495050_GO_0010985_NEGATIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE",7,-0.8481,0.66,0.83,-1.4481,0.077,0.9,-0.8967,0.56,0.93
"GO_BP:849793_GO_0061548_GANGLION_DEVELOPMENT","GO_BP","849793_GO_0061548_GANGLION_DEVELOPMENT",13,-0.8481,0.68,0.83,0.6562,0.91,1,1.7095,0.0097,0.43
"REACTOME:1127578_REACT_267817_CONSTITUTIVE_SIGNALING_BY_EGFRVIII","REACTOME","1127578_REACT_267817_CONSTITUTIVE_SIGNALING_BY_EGFRVIII",15,-0.8481,0.67,0.84,0.9498,0.5,0.83,-0.804,0.74,1
"C7_Immunologic_signatures:C7_ALL_154_GSE13306_TREG_VS_TCONV_DN","C7_Immunologic_signatures","C7_ALL_154_GSE13306_TREG_VS_TCONV_DN",200,-0.848,0.83,0.87,1.1798,0.088,0.26,-1.0435,0.33,0.62
"C4_Cancer_modules:C4_CM_420_MODULE_547","C4_Cancer_modules","C4_CM_420_MODULE_547",14,-0.8479,0.66,0.81,0.6378,0.92,1,-0.9755,0.49,0.74
"GO_BP:511656_GO_0050684_REGULATION_OF_MRNA_PROCESSING","GO_BP","511656_GO_0050684_REGULATION_OF_MRNA_PROCESSING",93,-0.8478,0.77,0.83,-1.0481,0.36,0.97,-0.9731,0.49,0.88
"GO_BP:519289_GO_2000650_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_BP","519289_GO_2000650_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",7,-0.8478,0.64,0.83,1.0962,0.37,0.91,-1.5335,0.046,0.53
"GO_BP:982373_GO_1902803_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT","GO_BP","982373_GO_1902803_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT",25,-0.8478,0.7,0.83,0.7876,0.83,1,0.9236,0.55,0.92
"KEGG_reaction:R00570_ATP_CDP_PHOSPHOTRANSFERASE_ATP_CDP_ADP_CTP","KEGG_reaction","R00570_ATP_CDP_PHOSPHOTRANSFERASE_ATP_CDP_ADP_CTP",8,-0.8477,0.69,0.73,-0.6623,0.89,0.99,-1.2586,0.2,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_1436_ROSS_AML_WITH_AML1_ETO_FUSION","C2_Chemical_and_genetic_perturbations","C2_CGP_1436_ROSS_AML_WITH_AML1_ETO_FUSION",76,-0.8476,0.74,0.81,-0.671,0.98,1,1.1763,0.19,0.79
"C4_Cancer_modules:C4_CM_358_MODULE_432","C4_Cancer_modules","C4_CM_358_MODULE_432",15,-0.8475,0.68,0.81,-0.6326,0.94,1,0.704,0.86,1
"GO_BP:750994_GO_0036072_DIRECT_OSSIFICATION","GO_BP","750994_GO_0036072_DIRECT_OSSIFICATION",6,-0.8474,0.67,0.83,-0.9649,0.52,1,0.7572,0.77,1
"GO_BP:948905_GO_1902750_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION","GO_BP","948905_GO_1902750_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION",10,-0.8474,0.67,0.83,1.3294,0.14,0.63,0.9473,0.53,0.9
"C1_Positional:C1_ALL_247_CHR11P15","C1_Positional","C1_ALL_247_CHR11P15",290,-0.8474,0.85,0.99,1.0966,0.19,0.65,1.1949,0.063,0.64
"GO_MF:492394_GO_0008020_G_PROTEIN_COUPLED_PHOTORECEPTOR_ACTIVITY","GO_MF","492394_GO_0008020_G_PROTEIN_COUPLED_PHOTORECEPTOR_ACTIVITY",7,-0.8474,0.66,0.84,-1.477,0.056,0.58,-0.918,0.55,0.86
"C3_TF_targets:C3_TFT_40_AAGWWRNYGGC_UNKNOWN","C3_TF_targets","C3_TFT_40_AAGWWRNYGGC_UNKNOWN",120,-0.8473,0.77,0.87,-0.8763,0.75,0.98,-0.8697,0.77,0.97
"GO_BP:502108_GO_0032886_REGULATION_OF_MICROTUBULE_BASED_PROCESS","GO_BP","502108_GO_0032886_REGULATION_OF_MICROTUBULE_BASED_PROCESS",139,-0.8473,0.8,0.83,0.8271,0.9,1,-1.0468,0.34,0.82
"GO_BP:510349_GO_0048232_MALE_GAMETE_GENERATION","GO_BP","510349_GO_0048232_MALE_GAMETE_GENERATION",423,-0.8473,0.86,0.83,-1.0601,0.3,0.96,-0.944,0.68,0.89
"GO_MF:496704_GO_0016799_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS","GO_MF","496704_GO_0016799_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS",21,-0.8472,0.69,0.84,1.389,0.084,0.48,-0.7884,0.8,0.97
"GO_BP:987845_GO_1903044_PROTEIN_LOCALIZATION_TO_MEMBRANE_RAFT","GO_BP","987845_GO_1903044_PROTEIN_LOCALIZATION_TO_MEMBRANE_RAFT",7,-0.847,0.68,0.83,-0.7238,0.81,1,0.8093,0.69,1
"GO_BP:518946_GO_2000300_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS","GO_BP","518946_GO_2000300_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS",18,-0.847,0.68,0.83,-0.7323,0.85,1,1.0795,0.34,0.78
"REACTOME:1183598_REACT_355048_TRANSCRIPTIONAL_REGULATION_BY_TP53","REACTOME","1183598_REACT_355048_TRANSCRIPTIONAL_REGULATION_BY_TP53",64,-0.8467,0.73,0.84,1.3575,0.039,0.26,-0.6653,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1834_CHEN_PDGF_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1834_CHEN_PDGF_TARGETS",19,-0.8465,0.66,0.81,-1.0643,0.39,0.96,-0.6317,0.95,0.99
"GO_BP:495131_GO_0014059_REGULATION_OF_DOPAMINE_SECRETION","GO_BP","495131_GO_0014059_REGULATION_OF_DOPAMINE_SECRETION",19,-0.8464,0.7,0.83,1.1182,0.31,0.88,1.3415,0.11,0.65
"GO_BP:515169_GO_0070234_POSITIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS","GO_BP","515169_GO_0070234_POSITIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS",14,-0.8463,0.68,0.83,-0.6159,0.94,1,-0.9701,0.49,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_3116_ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3116_ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP",84,-0.8462,0.75,0.81,-0.7977,0.88,1,-1.5536,0,0.27
"C7_Immunologic_signatures:C7_ALL_1008_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN","C7_Immunologic_signatures","C7_ALL_1008_GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN",200,-0.8461,0.82,0.88,1.8464,0,0,-0.9556,0.6,0.83
"GO_BP:754676_GO_1901725_REGULATION_OF_HISTONE_DEACETYLASE_ACTIVITY","GO_BP","754676_GO_1901725_REGULATION_OF_HISTONE_DEACETYLASE_ACTIVITY",5,-0.8461,0.67,0.83,-0.7415,0.79,1,-0.4737,0.98,1
"GO_BP:495225_GO_0014829_VASCULAR_SMOOTH_MUSCLE_CONTRACTION","GO_BP","495225_GO_0014829_VASCULAR_SMOOTH_MUSCLE_CONTRACTION",13,-0.8459,0.7,0.83,1.5573,0.035,0.34,0.9807,0.47,0.87
"KEGG_compound:C00288_HCO3_BICARBONATE_HYDROGEN_CARBONATE_ACID_CARBONATE","KEGG_compound","C00288_HCO3_BICARBONATE_HYDROGEN_CARBONATE_ACID_CARBONATE",21,-0.8457,0.72,0.78,-0.8406,0.71,1,-1.8018,0.0019,0.037
"GO_MF:500686_GO_0031435_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING","GO_MF","500686_GO_0031435_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING",22,-0.8457,0.69,0.84,-0.8835,0.64,1,-0.8829,0.65,0.89
"GO_BP:508237_GO_0045930_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE","GO_BP","508237_GO_0045930_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE",221,-0.8455,0.82,0.84,1.3231,0.014,0.64,-0.9138,0.72,0.92
"GO_BP:493414_GO_0009218_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS","GO_BP","493414_GO_0009218_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS",26,-0.8454,0.69,0.84,-0.5103,1,1,-0.8586,0.68,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_456_GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_456_GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN",22,-0.8454,0.71,0.81,0.8651,0.65,0.96,-0.9064,0.62,0.87
"C7_Immunologic_signatures:C7_ALL_1725_GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1725_GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP",198,-0.8453,0.81,0.88,1.0511,0.31,0.59,-1.0152,0.38,0.69
"REACTOME:1183551_REACT_188329_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION","REACTOME","1183551_REACT_188329_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION",13,-0.8453,0.66,0.84,0.5214,0.99,1,-1.5171,0.043,0.34
"GO_BP:505617_GO_0042481_REGULATION_OF_ODONTOGENESIS","GO_BP","505617_GO_0042481_REGULATION_OF_ODONTOGENESIS",25,-0.845,0.69,0.84,-0.7596,0.82,1,1.3213,0.11,0.66
"KEGG_compound:C01233_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_GLYCEROPHOSPHOETHANOLAMINE","KEGG_compound","C01233_SN_GLYCERO_3_PHOSPHOETHANOLAMINE_GLYCEROPHOSPHOETHANOLAMINE",7,-0.8449,0.66,0.78,-0.7592,0.74,1,0.7099,0.81,0.96
"REACTOME:119562_REACT_19314_SODIUM_PROTON_EXCHANGERS","REACTOME","119562_REACT_19314_SODIUM_PROTON_EXCHANGERS",9,-0.8445,0.67,0.84,-0.8212,0.7,1,0.9395,0.53,1
"C7_Immunologic_signatures:C7_ALL_394_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_394_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN",199,-0.8445,0.83,0.88,1.8144,0,3e-05,-1.024,0.38,0.67
"GO_BP:987847_GO_1903046_MEIOTIC_CELL_CYCLE_PROCESS","GO_BP","987847_GO_1903046_MEIOTIC_CELL_CYCLE_PROCESS",95,-0.8444,0.78,0.84,-0.731,0.94,1,-1.2809,0.077,0.65
"GO_BP:515859_GO_0070932_HISTONE_H3_DEACETYLATION","GO_BP","515859_GO_0070932_HISTONE_H3_DEACETYLATION",22,-0.8441,0.68,0.84,-0.9711,0.49,1,-1.4521,0.043,0.54
"GO_MF:490027_GO_0004711_RIBOSOMAL_PROTEIN_S6_KINASE_ACTIVITY","GO_MF","490027_GO_0004711_RIBOSOMAL_PROTEIN_S6_KINASE_ACTIVITY",7,-0.8439,0.68,0.84,-0.5073,0.98,1,-1.1944,0.26,0.59
"GO_CC:502239_GO_0033017_SARCOPLASMIC_RETICULUM_MEMBRANE","GO_CC","502239_GO_0033017_SARCOPLASMIC_RETICULUM_MEMBRANE",36,-0.8439,0.72,0.91,-0.7778,0.83,1,0.9031,0.63,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3040_STAMBOLSKY_BOUND_BY_MUTATED_TP53","C2_Chemical_and_genetic_perturbations","C2_CGP_3040_STAMBOLSKY_BOUND_BY_MUTATED_TP53",18,-0.8437,0.69,0.81,0.7635,0.82,1,-0.8405,0.69,0.93
"C7_Immunologic_signatures:C7_ALL_534_GSE17721_LPS_VS_POLYIC_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_534_GSE17721_LPS_VS_POLYIC_4H_BMDM_DN",199,-0.8435,0.84,0.88,1.5712,0,0.0047,-1.0557,0.31,0.6
"C3_MicroRNA_targets:C3_MIR_138_GTCGATC_MIR_369_5P","C3_MicroRNA_targets","C3_MIR_138_GTCGATC_MIR_369_5P",5,-0.8435,0.66,0.86,-1.468,0.076,0.54,-1.0066,0.45,1
"GO_BP:513646_GO_0060088_AUDITORY_RECEPTOR_CELL_STEREOCILIUM_ORGANIZATION","GO_BP","513646_GO_0060088_AUDITORY_RECEPTOR_CELL_STEREOCILIUM_ORGANIZATION",9,-0.8434,0.67,0.84,-0.3965,1,1,-0.8331,0.69,0.97
"GO_MF:495786_GO_0015645_FATTY_ACID_LIGASE_ACTIVITY","GO_MF","495786_GO_0015645_FATTY_ACID_LIGASE_ACTIVITY",15,-0.8433,0.69,0.84,0.8837,0.61,1,0.7844,0.76,1
"GO_BP:501599_GO_0032364_OXYGEN_HOMEOSTASIS","GO_BP","501599_GO_0032364_OXYGEN_HOMEOSTASIS",6,-0.8432,0.67,0.84,1.537,0.049,0.36,0.6977,0.86,1
"REACTOME:106476_REACT_12442_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS","REACTOME","106476_REACT_12442_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS",9,-0.843,0.66,0.84,-1.1847,0.25,0.85,-0.9697,0.52,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2870_KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2870_KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP",92,-0.8429,0.77,0.81,1.5101,0.013,0.2,0.7235,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1108_BENPORATH_OCT4_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1108_BENPORATH_OCT4_TARGETS",289,-0.8427,0.86,0.81,1.2072,0.059,0.48,0.9192,0.72,1
"GO_BP:518783_GO_2000134_NEGATIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","518783_GO_2000134_NEGATIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE",101,-0.8425,0.77,0.84,1.5809,0.0023,0.31,-1.1635,0.17,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2209_YAMASHITA_SILENCED_BY_METHYLATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2209_YAMASHITA_SILENCED_BY_METHYLATION",6,-0.8425,0.68,0.81,0.7121,0.83,1,-0.7889,0.73,0.96
"GO_BP:513906_GO_0060350_ENDOCHONDRAL_BONE_MORPHOGENESIS","GO_BP","513906_GO_0060350_ENDOCHONDRAL_BONE_MORPHOGENESIS",54,-0.8424,0.71,0.84,-1.4967,0.013,0.81,-0.8451,0.75,0.96
"KEGG_module:HSA_M00044_TYROSINE_DEGRADATION_TYROSINE_HOMOGENTISATE","KEGG_module","HSA_M00044_TYROSINE_DEGRADATION_TYROSINE_HOMOGENTISATE",5,-0.8424,0.7,0.76,-1.3894,0.095,0.79,1.0068,0.45,1
"C1_Positional:C1_ALL_201_CHR20P11","C1_Positional","C1_ALL_201_CHR20P11",48,-0.8423,0.75,0.99,1.5307,0.013,0.27,1.3759,0.053,0.41
"GO_MF:496602_GO_0016670_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR","GO_MF","496602_GO_0016670_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR",6,-0.8423,0.65,0.84,-0.649,0.89,1,-1.0948,0.35,0.7
"C4_Cancer_modules:C4_CM_4_MODULE_4","C4_Cancer_modules","C4_CM_4_MODULE_4",21,-0.8422,0.7,0.82,0.9482,0.52,0.78,-0.7102,0.89,1
"GO_MF:495470_GO_0015205_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495470_GO_0015205_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.8422,0.68,0.84,-1.2471,0.22,0.83,-0.8912,0.61,0.88
"GO_BP:518291_GO_0090151_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRIAL_MEMBRANE","GO_BP","518291_GO_0090151_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRIAL_MEMBRANE",8,-0.8421,0.68,0.84,1.2736,0.2,0.71,-1.0875,0.36,0.78
"GO_BP:491440_GO_0006544_GLYCINE_METABOLIC_PROCESS","GO_BP","491440_GO_0006544_GLYCINE_METABOLIC_PROCESS",15,-0.842,0.69,0.84,0.4959,0.99,1,-0.74,0.81,1
"GO_CC:500172_GO_0030877_BETA_CATENIN_DESTRUCTION_COMPLEX","GO_CC","500172_GO_0030877_BETA_CATENIN_DESTRUCTION_COMPLEX",10,-0.8419,0.67,0.91,-0.4764,0.99,1,-0.929,0.56,1
"GO_BP:518371_GO_0090231_REGULATION_OF_SPINDLE_CHECKPOINT","GO_BP","518371_GO_0090231_REGULATION_OF_SPINDLE_CHECKPOINT",16,-0.8416,0.7,0.84,0.7556,0.8,1,0.7023,0.88,1
"C4_Cancer_modules:C4_CM_216_MODULE_237","C4_Cancer_modules","C4_CM_216_MODULE_237",58,-0.8414,0.76,0.81,0.8813,0.69,0.89,-0.9121,0.63,0.84
"C1_Positional:C1_ALL_134_CHR6Q15","C1_Positional","C1_ALL_134_CHR6Q15",19,-0.8414,0.69,0.99,-0.871,0.65,1,1.0218,0.39,0.74
"GO_BP:501746_GO_0032515_NEGATIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY","GO_BP","501746_GO_0032515_NEGATIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY",10,-0.8414,0.69,0.84,0.717,0.85,1,-0.7846,0.73,1
"GO_BP:511746_GO_0050775_POSITIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS","GO_BP","511746_GO_0050775_POSITIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS",24,-0.8413,0.68,0.84,-1.4283,0.076,0.93,-1.2742,0.14,0.66
"GO_BP:513448_GO_0055015_VENTRICULAR_CARDIAC_MUSCLE_CELL_DEVELOPMENT","GO_BP","513448_GO_0055015_VENTRICULAR_CARDIAC_MUSCLE_CELL_DEVELOPMENT",13,-0.8413,0.68,0.84,-1.1469,0.27,0.93,0.9235,0.57,0.92
"GO_BP:495037_GO_0010972_NEGATIVE_REGULATION_OF_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","495037_GO_0010972_NEGATIVE_REGULATION_OF_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE",9,-0.841,0.67,0.84,1.2312,0.2,0.75,0.8222,0.7,1
"C6_Oncogenic_signatures:C6_ALL_35_BCAT_GDS748_DN","C6_Oncogenic_signatures","C6_ALL_35_BCAT_GDS748_DN",43,-0.841,0.73,0.83,-0.835,0.74,0.97,-1.1038,0.28,0.51
"REACTOME:730346_REACT_150210_IGF1R_SIGNALING_CASCADE","REACTOME","730346_REACT_150210_IGF1R_SIGNALING_CASCADE",86,-0.8409,0.78,0.85,0.7572,0.94,1,0.6744,0.99,1
"REACTOME:730345_REACT_150359_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R_","REACTOME","730345_REACT_150359_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R_",86,-0.8408,0.77,0.84,0.7534,0.95,1,0.6625,0.99,1
"GO_MF:495605_GO_0015385_SODIUM_PROTON_ANTIPORTER_ACTIVITY","GO_MF","495605_GO_0015385_SODIUM_PROTON_ANTIPORTER_ACTIVITY",9,-0.8408,0.66,0.84,-0.8078,0.72,1,0.949,0.52,0.92
"C7_Immunologic_signatures:C7_ALL_38_GSE10325_CD4_TCELL_VS_BCELL_DN","C7_Immunologic_signatures","C7_ALL_38_GSE10325_CD4_TCELL_VS_BCELL_DN",185,-0.8408,0.81,0.88,-0.7551,0.99,1,-1.4919,0.0066,0.024
"REACTOME:1183599_REACT_355377_TP53_REGULATES_METABOLIC_GENES","REACTOME","1183599_REACT_355377_TP53_REGULATES_METABOLIC_GENES",64,-0.8407,0.74,0.84,1.3294,0.068,0.29,-0.6582,0.98,1
"GO_BP:514427_GO_0060872_SEMICIRCULAR_CANAL_DEVELOPMENT","GO_BP","514427_GO_0060872_SEMICIRCULAR_CANAL_DEVELOPMENT",8,-0.8405,0.66,0.84,0.7017,0.85,1,1.3485,0.13,0.65
"C3_TF_targets:C3_TFT_26_V_E2F_02","C3_TF_targets","C3_TFT_26_V_E2F_02",234,-0.8404,0.84,0.89,-0.8387,0.9,1,-1.2581,0.039,0.28
"KEGG_pathway:HSA04140_REGULATION_OF_AUTOPHAGY","KEGG_pathway","HSA04140_REGULATION_OF_AUTOPHAGY",34,-0.8402,0.72,0.79,0.636,0.97,1,-0.8092,0.79,0.92
"GO_BP:491953_GO_0007140_MALE_MEIOSIS","GO_BP","491953_GO_0007140_MALE_MEIOSIS",35,-0.8402,0.72,0.84,-0.9809,0.47,1,-0.9479,0.55,0.89
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_173_BIOCARTA_CDC42RAC_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_173_BIOCARTA_CDC42RAC_PATHWAY",16,-0.8402,0.68,0.77,1.8636,0.0042,0.092,0.9797,0.49,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_862_MAINA_VHL_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_862_MAINA_VHL_TARGETS_DN",17,-0.8401,0.69,0.82,0.6013,0.96,1,0.9378,0.54,1
"GO_MF:495455_GO_0015186_L_GLUTAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495455_GO_0015186_L_GLUTAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",5,-0.84,0.69,0.84,-0.877,0.62,1,-0.9868,0.48,0.79
"REACTOME:187211_REACT_24994_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS","REACTOME","187211_REACT_24994_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS",87,-0.84,0.77,0.84,1.8175,0,0.018,-0.8551,0.77,0.98
"GO_MF:752871_GO_0097372_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H3_K18_SPECIFIC_","GO_MF","752871_GO_0097372_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H3_K18_SPECIFIC_",12,-0.8397,0.66,0.84,-1.2655,0.17,0.83,-1.6403,0.017,0.34
"GO_BP:515801_GO_0070873_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS","GO_BP","515801_GO_0070873_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS",35,-0.8397,0.73,0.84,-0.6558,0.96,1,0.8083,0.78,1
"GO_BP:514321_GO_0060766_NEGATIVE_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","514321_GO_0060766_NEGATIVE_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY",14,-0.8396,0.69,0.84,-1.0248,0.41,0.97,0.8947,0.57,0.95
"KEGG_compound:C00134_PUTRESCINE_1_4_BUTANEDIAMINE_1_4_DIAMINOBUTANE_TETRAMETHYLENEDIAMINE_BUTANE_1_4_DIAMINE","KEGG_compound","C00134_PUTRESCINE_1_4_BUTANEDIAMINE_1_4_DIAMINOBUTANE_TETRAMETHYLENEDIAMINE_BUTANE_1_4_DIAMINE",7,-0.8396,0.67,0.79,-0.9783,0.49,1,-0.7364,0.75,0.9
"GO_MF:496889_GO_0017075_SYNTAXIN_1_BINDING","GO_MF","496889_GO_0017075_SYNTAXIN_1_BINDING",18,-0.8395,0.7,0.84,-1.0106,0.43,0.89,-1.0183,0.45,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_2943_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17","C2_Chemical_and_genetic_perturbations","C2_CGP_2943_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17",180,-0.8395,0.82,0.82,2.1603,0,0.0011,-0.9689,0.53,0.8
"KEGG_compound:C02843_LONG_CHAIN_ACYL_COA","KEGG_compound","C02843_LONG_CHAIN_ACYL_COA",7,-0.8394,0.68,0.79,0.5632,0.95,1,-0.8424,0.66,0.81
"C7_Immunologic_signatures:C7_ALL_1110_GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1110_GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN",190,-0.8393,0.85,0.89,0.883,0.79,1,0.8549,0.85,1
"C1_Positional:C1_ALL_96_CHR4Q24","C1_Positional","C1_ALL_96_CHR4Q24",17,-0.8392,0.7,0.99,1.4566,0.055,0.3,-1.3945,0.083,0.54
"GO_CC:500496_GO_0031235_INTRINSIC_COMPONENT_OF_THE_CYTOPLASMIC_SIDE_OF_THE_PLASMA_MEMBRANE","GO_CC","500496_GO_0031235_INTRINSIC_COMPONENT_OF_THE_CYTOPLASMIC_SIDE_OF_THE_PLASMA_MEMBRANE",14,-0.8391,0.69,0.92,-0.7948,0.76,1,-0.8061,0.73,1
"C7_Immunologic_signatures:C7_ALL_1241_GSE2826_WT_VS_BTK_KO_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1241_GSE2826_WT_VS_BTK_KO_BCELL_UP",199,-0.8391,0.83,0.89,0.845,0.89,1,-0.9377,0.62,0.88
"GO_BP:501737_GO_0032506_CYTOKINETIC_PROCESS","GO_BP","501737_GO_0032506_CYTOKINETIC_PROCESS",13,-0.8391,0.71,0.84,0.7545,0.82,1,1.1245,0.32,0.74
"GO_MF:492857_GO_0008601_PROTEIN_PHOSPHATASE_TYPE_2A_REGULATOR_ACTIVITY","GO_MF","492857_GO_0008601_PROTEIN_PHOSPHATASE_TYPE_2A_REGULATOR_ACTIVITY",20,-0.8391,0.7,0.84,1.0764,0.34,0.82,-1.2339,0.19,0.58
"GO_BP:506408_GO_0043369_CD4_POSITIVE_OR_CD8_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT","GO_BP","506408_GO_0043369_CD4_POSITIVE_OR_CD8_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT",8,-0.8391,0.67,0.84,-1.2921,0.17,0.88,0.7084,0.85,1
"REACTOME:1183583_REACT_355588_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING","REACTOME","1183583_REACT_355588_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING",27,-0.8388,0.7,0.84,-0.7907,0.79,1,0.6079,0.99,1
"GO_MF:487130_GO_0000900_TRANSLATION_REPRESSOR_ACTIVITY_NUCLEIC_ACID_BINDING","GO_MF","487130_GO_0000900_TRANSLATION_REPRESSOR_ACTIVITY_NUCLEIC_ACID_BINDING",9,-0.8386,0.68,0.84,-1.2089,0.25,0.81,-1.3155,0.15,0.56
"C7_Immunologic_signatures:C7_ALL_855_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP","C7_Immunologic_signatures","C7_ALL_855_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP",160,-0.8386,0.8,0.89,-1.4194,0.014,0.19,-1.4215,0.012,0.048
"GO_BP:491569_GO_0006681_GALACTOSYLCERAMIDE_METABOLIC_PROCESS","GO_BP","491569_GO_0006681_GALACTOSYLCERAMIDE_METABOLIC_PROCESS",5,-0.8386,0.68,0.84,0.9498,0.52,1,-0.7253,0.81,0.99
"GO_BP:487678_GO_0001782_B_CELL_HOMEOSTASIS","GO_BP","487678_GO_0001782_B_CELL_HOMEOSTASIS",24,-0.8382,0.72,0.84,0.5972,0.97,1,0.4837,1,1
"C3_TF_targets:C3_TFT_467_V_E2F1_Q3_01","C3_TF_targets","C3_TFT_467_V_E2F1_Q3_01",237,-0.8382,0.86,0.89,-0.8975,0.75,0.96,-1.3068,0.028,0.25
"REACTOME:1183597_REACT_355072_TNFR1_MEDIATED_PROAPOPTOTIC_SIGNALING","REACTOME","1183597_REACT_355072_TNFR1_MEDIATED_PROAPOPTOTIC_SIGNALING",12,-0.8382,0.68,0.85,-0.9993,0.44,0.98,-0.7883,0.74,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_205_BIOCARTA_TNFR2_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_205_BIOCARTA_TNFR2_PATHWAY",18,-0.8382,0.69,0.77,-0.6485,0.93,1,-0.6705,0.91,0.99
"GO_BP:493902_GO_0009798_AXIS_SPECIFICATION","GO_BP","493902_GO_0009798_AXIS_SPECIFICATION",85,-0.8381,0.78,0.84,-1.374,0.038,0.99,0.9103,0.68,0.93
"GO_BP:514397_GO_0060842_ARTERIAL_ENDOTHELIAL_CELL_DIFFERENTIATION","GO_BP","514397_GO_0060842_ARTERIAL_ENDOTHELIAL_CELL_DIFFERENTIATION",5,-0.8381,0.68,0.84,1.0393,0.42,0.96,1.0985,0.36,0.76
"GO_BP:508064_GO_0045719_NEGATIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS","GO_BP","508064_GO_0045719_NEGATIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS",8,-0.838,0.68,0.84,0.5545,0.97,1,-0.8489,0.65,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2623_MIKKELSEN_DEDIFFERENTIATED_STATE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2623_MIKKELSEN_DEDIFFERENTIATED_STATE_DN",7,-0.838,0.66,0.82,-1.0572,0.38,0.97,1.1974,0.25,0.77
"GO_MF:514947_GO_0070006_METALLOAMINOPEPTIDASE_ACTIVITY","GO_MF","514947_GO_0070006_METALLOAMINOPEPTIDASE_ACTIVITY",5,-0.8378,0.65,0.84,1.3015,0.17,0.61,0.6265,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_809_HEIDENBLAD_AMPLICON_8Q24_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_809_HEIDENBLAD_AMPLICON_8Q24_UP",40,-0.8377,0.72,0.82,-0.8143,0.79,1,-0.8785,0.67,0.9
"GO_BP:509061_GO_0046839_PHOSPHOLIPID_DEPHOSPHORYLATION","GO_BP","509061_GO_0046839_PHOSPHOLIPID_DEPHOSPHORYLATION",22,-0.8377,0.71,0.84,-0.9797,0.5,1,-0.6286,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3240_JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3240_JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP",114,-0.8376,0.79,0.82,1.2198,0.093,0.47,-0.8563,0.8,0.92
"C7_Immunologic_signatures:C7_ALL_1362_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN","C7_Immunologic_signatures","C7_ALL_1362_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN",200,-0.8373,0.86,0.89,1.0825,0.23,0.49,-0.8873,0.8,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_425_CHIN_BREAST_CANCER_COPY_NUMBER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_425_CHIN_BREAST_CANCER_COPY_NUMBER_UP",25,-0.8373,0.71,0.82,-0.9955,0.44,1,0.7953,0.77,1
"KEGG_compound:C00158_CITRATE_CITRIC_ACID_2_HYDROXY_1_2_3_PROPANETRICARBOXYLIC_ACID_2_HYDROXYTRICARBALLYLIC_ACID","KEGG_compound","C00158_CITRATE_CITRIC_ACID_2_HYDROXY_1_2_3_PROPANETRICARBOXYLIC_ACID_2_HYDROXYTRICARBALLYLIC_ACID",5,-0.8371,0.68,0.79,-0.5113,0.98,1,-1.1375,0.34,0.51
"GO_BP:508288_GO_0045988_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION","GO_BP","508288_GO_0045988_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION",6,-0.837,0.68,0.85,0.8352,0.65,1,-0.5794,0.95,1
"GO_BP:1026083_GO_1903311_REGULATION_OF_MRNA_METABOLIC_PROCESS","GO_BP","1026083_GO_1903311_REGULATION_OF_MRNA_METABOLIC_PROCESS",104,-0.837,0.8,0.85,-0.9706,0.48,1,-1.0439,0.34,0.82
"REACTOME:105923_REACT_18339_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION","REACTOME","105923_REACT_18339_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION",27,-0.837,0.72,0.85,-0.681,0.92,1,0.9614,0.51,1
"GO_BP:781977_GO_1901988_NEGATIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION","GO_BP","781977_GO_1901988_NEGATIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION",286,-0.837,0.86,0.85,1.3476,0.016,0.61,-1.3088,0.0043,0.64
"REACTOME:106160_REACT_11123_MEMBRANE_TRAFFICKING","REACTOME","106160_REACT_11123_MEMBRANE_TRAFFICKING",199,-0.8369,0.84,0.85,1.4174,0,0.21,0.9197,0.69,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_975_WILLIAMS_ESR2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_975_WILLIAMS_ESR2_TARGETS_DN",11,-0.8369,0.68,0.82,0.9879,0.47,0.81,0.6448,0.9,1
"GO_BP:492666_GO_0008356_ASYMMETRIC_CELL_DIVISION","GO_BP","492666_GO_0008356_ASYMMETRIC_CELL_DIVISION",5,-0.8369,0.66,0.85,0.842,0.67,1,-1.3114,0.19,0.64
"KEGG_reaction:R01857_ATP_DGDP_PHOSPHOTRANSFERASE_ATP_DGDP_ADP_DGTP","KEGG_reaction","R01857_ATP_DGDP_PHOSPHOTRANSFERASE_ATP_DGDP_ADP_DGTP",8,-0.8368,0.69,0.74,-0.6711,0.9,1,-1.2822,0.17,0.49
"GO_BP:512381_GO_0051503_ADENINE_NUCLEOTIDE_TRANSPORT","GO_BP","512381_GO_0051503_ADENINE_NUCLEOTIDE_TRANSPORT",8,-0.8367,0.68,0.85,-0.7067,0.84,1,-1.3403,0.13,0.61
"GO_BP:1026092_GO_1903320_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL","GO_BP","1026092_GO_1903320_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL",240,-0.8367,0.85,0.85,1.3731,0.0022,0.58,-0.9626,0.58,0.88
"REACTOME:771588_REACT_160082_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT","REACTOME","771588_REACT_160082_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT",7,-0.8365,0.68,0.84,-1.1628,0.3,0.85,-0.8074,0.7,1
"GO_BP:493856_GO_0009744_RESPONSE_TO_SUCROSE","GO_BP","493856_GO_0009744_RESPONSE_TO_SUCROSE",6,-0.8364,0.68,0.85,1.2663,0.22,0.71,1.2416,0.24,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_2260_SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2260_SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP",18,-0.8363,0.68,0.82,0.8647,0.65,0.96,-1.2932,0.14,0.43
"GO_BP:492104_GO_0007340_ACROSOME_REACTION","GO_BP","492104_GO_0007340_ACROSOME_REACTION",14,-0.836,0.72,0.85,-0.7973,0.75,1,-1.0894,0.35,0.78
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_182_BIOCARTA_IGF1MTOR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_182_BIOCARTA_IGF1MTOR_PATHWAY",20,-0.8357,0.72,0.77,1.5083,0.038,0.39,-0.7267,0.85,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_3393_CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3393_CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN",19,-0.8356,0.7,0.82,0.8297,0.72,0.98,-1.5398,0.043,0.27
"GO_MF:489652_GO_0008234_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY","GO_MF","489652_GO_0008234_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY",152,-0.8356,0.82,0.85,0.7082,0.98,1,0.8012,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1308_WELCH_GATA1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1308_WELCH_GATA1_TARGETS",21,-0.8352,0.71,0.82,1.1344,0.28,0.57,-1.2336,0.17,0.49
"C7_Immunologic_signatures:C7_ALL_764_GSE17721_12H_VS_24H_GARDIQUIMOD_BMDM_DN","C7_Immunologic_signatures","C7_ALL_764_GSE17721_12H_VS_24H_GARDIQUIMOD_BMDM_DN",199,-0.8352,0.84,0.89,1.4779,0.0071,0.016,-1.1672,0.12,0.34
"C7_Immunologic_signatures:C7_ALL_645_GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_645_GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDM_UP",198,-0.8351,0.83,0.89,1.2808,0.033,0.12,-1.0005,0.45,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1852_CHIBA_RESPONSE_TO_TSA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1852_CHIBA_RESPONSE_TO_TSA_DN",23,-0.8349,0.71,0.82,0.8972,0.61,0.93,1.1949,0.21,0.78
"GO_MF:496660_GO_0016747_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS","GO_MF","496660_GO_0016747_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS",194,-0.8349,0.84,0.85,-0.8835,0.77,1,-0.9875,0.49,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_647_RASHI_RESPONSE_TO_IONIZING_RADIATION_3","C2_Chemical_and_genetic_perturbations","C2_CGP_647_RASHI_RESPONSE_TO_IONIZING_RADIATION_3",48,-0.8348,0.72,0.82,-1.0339,0.4,0.97,-0.8828,0.67,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1205_NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1205_NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON",8,-0.8347,0.69,0.82,1.108,0.33,0.62,1.3367,0.18,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_1151_GEORGES_CELL_CYCLE_MIR192_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1151_GEORGES_CELL_CYCLE_MIR192_TARGETS",62,-0.8342,0.76,0.82,0.9965,0.48,0.8,-0.9333,0.59,0.84
"GO_BP:504744_GO_0035564_REGULATION_OF_KIDNEY_SIZE","GO_BP","504744_GO_0035564_REGULATION_OF_KIDNEY_SIZE",5,-0.8342,0.67,0.85,1.3638,0.12,0.6,-1.1245,0.36,0.75
"GO_CC:510549_GO_0048475_COATED_MEMBRANE","GO_CC","510549_GO_0048475_COATED_MEMBRANE",93,-0.8341,0.78,0.92,1.2788,0.064,0.43,-0.6284,1,1
"GO_BP:487850_GO_0001960_NEGATIVE_REGULATION_OF_CYTOKINE_MEDIATED_SIGNALING_PATHWAY","GO_BP","487850_GO_0001960_NEGATIVE_REGULATION_OF_CYTOKINE_MEDIATED_SIGNALING_PATHWAY",34,-0.8339,0.73,0.85,-0.7302,0.9,1,1.2228,0.17,0.71
"GO_BP:755128_GO_2001022_POSITIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS","GO_BP","755128_GO_2001022_POSITIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS",56,-0.8337,0.75,0.85,0.8019,0.84,1,-0.9844,0.49,0.86
"GO_BP:488599_GO_0002726_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION","GO_BP","488599_GO_0002726_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION",10,-0.8337,0.69,0.85,-1.1319,0.29,0.93,-0.5542,0.97,1
"GO_CC:495149_GO_0014701_JUNCTIONAL_SARCOPLASMIC_RETICULUM_MEMBRANE","GO_CC","495149_GO_0014701_JUNCTIONAL_SARCOPLASMIC_RETICULUM_MEMBRANE",10,-0.8337,0.71,0.92,1.2268,0.21,0.49,1.2774,0.17,0.73
"C4_Cancer_gene_neighborhoods:C4_CGN_134_MORF_MYST2","C4_Cancer_gene_neighborhoods","C4_CGN_134_MORF_MYST2",68,-0.8337,0.78,0.99,0.7264,0.94,1,-0.8067,0.83,1
"GO_CC:499712_GO_0030312_EXTERNAL_ENCAPSULATING_STRUCTURE","GO_CC","499712_GO_0030312_EXTERNAL_ENCAPSULATING_STRUCTURE",18,-0.8333,0.71,0.92,1.0667,0.35,0.69,1.6102,0.023,0.42
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_151_BIOCARTA_CHREBP2_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_151_BIOCARTA_CHREBP2_PATHWAY",42,-0.833,0.74,0.77,1.2443,0.13,0.67,0.6983,0.93,1
"GO_BP:502364_GO_0033143_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","502364_GO_0033143_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY",59,-0.8329,0.77,0.85,0.8821,0.7,1,0.8386,0.8,0.99
"GO_MF:492531_GO_0008188_NEUROPEPTIDE_RECEPTOR_ACTIVITY","GO_MF","492531_GO_0008188_NEUROPEPTIDE_RECEPTOR_ACTIVITY",41,-0.8327,0.73,0.85,1.1614,0.24,0.74,1.9077,0,0.042
"GO_BP:499170_GO_0021891_OLFACTORY_BULB_INTERNEURON_DEVELOPMENT","GO_BP","499170_GO_0021891_OLFACTORY_BULB_INTERNEURON_DEVELOPMENT",9,-0.8327,0.68,0.85,-0.6897,0.85,1,1.3266,0.16,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_831_LI_WILMS_TUMOR_ANAPLASTIC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_831_LI_WILMS_TUMOR_ANAPLASTIC_DN",5,-0.8327,0.7,0.83,-1.1934,0.25,0.81,-0.5627,0.95,0.99
"GO_BP:508206_GO_0045898_REGULATION_OF_RNA_POLYMERASE_II_TRANSCRIPTIONAL_PREINITIATION_COMPLEX_ASSEMBLY","GO_BP","508206_GO_0045898_REGULATION_OF_RNA_POLYMERASE_II_TRANSCRIPTIONAL_PREINITIATION_COMPLEX_ASSEMBLY",6,-0.8327,0.69,0.85,0.9539,0.52,1,1.1613,0.29,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_2972_ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL","C2_Chemical_and_genetic_perturbations","C2_CGP_2972_ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL",16,-0.8325,0.72,0.83,-0.9933,0.47,1,-0.9031,0.59,0.88
"GO_BP:504515_GO_0035331_NEGATIVE_REGULATION_OF_HIPPO_SIGNALING","GO_BP","504515_GO_0035331_NEGATIVE_REGULATION_OF_HIPPO_SIGNALING",5,-0.8324,0.69,0.85,-1.3263,0.15,0.89,-0.9017,0.56,0.92
"GO_BP:500432_GO_0031145_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","500432_GO_0031145_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",83,-0.8324,0.79,0.85,1.7583,0,0.13,-1.1771,0.17,0.74
"GO_BP:497166_GO_0018195_PEPTIDYL_ARGININE_MODIFICATION","GO_BP","497166_GO_0018195_PEPTIDYL_ARGININE_MODIFICATION",16,-0.8322,0.7,0.85,-0.6907,0.87,1,0.8583,0.66,0.97
"GO_BP:494576_GO_0010507_NEGATIVE_REGULATION_OF_AUTOPHAGY","GO_BP","494576_GO_0010507_NEGATIVE_REGULATION_OF_AUTOPHAGY",30,-0.8322,0.71,0.85,0.5418,0.99,1,-0.6976,0.92,0.99
"REACTOME:106419_REACT_498_SIGNALING_BY_INSULIN_RECEPTOR","REACTOME","106419_REACT_498_SIGNALING_BY_INSULIN_RECEPTOR",108,-0.8322,0.81,0.85,0.7961,0.89,1,0.7338,0.97,1
"C7_Immunologic_signatures:C7_ALL_686_GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_686_GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDM_DN",200,-0.8322,0.84,0.9,1.4995,0.0046,0.013,-0.8508,0.86,1
"GO_BP:503574_GO_0034372_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING","GO_BP","503574_GO_0034372_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING",7,-0.8321,0.67,0.85,-1,0.43,0.99,0.7361,0.78,1
"GO_BP:491820_GO_0006983_ER_OVERLOAD_RESPONSE","GO_BP","491820_GO_0006983_ER_OVERLOAD_RESPONSE",10,-0.832,0.7,0.85,-1.0768,0.36,0.95,-1.3309,0.14,0.62
"KEGG_pathway:HSA00230_PURINE_METABOLISM","KEGG_pathway","HSA00230_PURINE_METABOLISM",171,-0.8317,0.83,0.81,0.8937,0.74,1,-1.3165,0.022,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_3027_WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3027_WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP",22,-0.8317,0.71,0.83,1.3396,0.11,0.35,-1.0802,0.36,0.65
"GO_BP:491085_GO_0006107_OXALOACETATE_METABOLIC_PROCESS","GO_BP","491085_GO_0006107_OXALOACETATE_METABOLIC_PROCESS",11,-0.8317,0.71,0.85,0.9844,0.46,1,-1.2029,0.23,0.73
"GO_BP:494779_GO_0010714_POSITIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS","GO_BP","494779_GO_0010714_POSITIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS",25,-0.8315,0.7,0.85,-0.9876,0.5,1,1.258,0.17,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2603_BRUNEAU_SEPTATION_VENTRICULAR","C2_Chemical_and_genetic_perturbations","C2_CGP_2603_BRUNEAU_SEPTATION_VENTRICULAR",10,-0.8313,0.68,0.83,-1.0729,0.38,0.95,-0.8843,0.62,0.9
"C7_Immunologic_signatures:C7_ALL_1248_GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1248_GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN",168,-0.8309,0.83,0.9,-1.0702,0.27,1,1.3232,0.025,0.29
"C2_Chemical_and_genetic_perturbations:C2_CGP_892_YANG_BREAST_CANCER_ESR1_LASER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_892_YANG_BREAST_CANCER_ESR1_LASER_UP",34,-0.8309,0.73,0.83,-0.6661,0.94,1,-1.0444,0.38,0.7
"OMIM_gene:OMIM603817_DEVELOPMENT_AND_DIFFERENTIATION_ENHANCING_FACTOR_2_DDEF2","OMIM_gene","OMIM603817_DEVELOPMENT_AND_DIFFERENTIATION_ENHANCING_FACTOR_2_DDEF2",6,-0.8309,0.67,0.88,0.9707,0.47,1,-0.9469,0.52,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_60_BIOCARTA_EGF_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_60_BIOCARTA_EGF_PATHWAY",31,-0.8309,0.71,0.77,0.8275,0.75,0.95,-0.8162,0.76,0.88
"C7_Immunologic_signatures:C7_ALL_1548_GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN","C7_Immunologic_signatures","C7_ALL_1548_GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN",199,-0.8307,0.86,0.9,1.2564,0.045,0.15,0.7742,0.98,1
"KEGG_compound:C00705_DCDP_2_DEOXYCYTIDINE_DIPHOSPHATE_2_DEOXYCYTIDINE_5_DIPHOSPHATE","KEGG_compound","C00705_DCDP_2_DEOXYCYTIDINE_DIPHOSPHATE_2_DEOXYCYTIDINE_5_DIPHOSPHATE",17,-0.8307,0.68,0.8,1.04,0.4,1,-1.3708,0.086,0.32
"GO_BP:513879_GO_0060323_HEAD_MORPHOGENESIS","GO_BP","513879_GO_0060323_HEAD_MORPHOGENESIS",40,-0.8305,0.72,0.85,0.7291,0.91,1,-0.7864,0.82,1
"REACTOME:576274_REACT_118636_SIGNALING_BY_NOTCH4","REACTOME","576274_REACT_118636_SIGNALING_BY_NOTCH4",11,-0.8305,0.69,0.85,-0.9334,0.55,1,-1.1215,0.29,0.68
"GO_BP:510761_GO_0048706_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT","GO_BP","510761_GO_0048706_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT",124,-0.8305,0.81,0.85,-0.9231,0.65,1,1.1943,0.14,0.72
"GO_BP:512335_GO_0051457_MAINTENANCE_OF_PROTEIN_LOCATION_IN_NUCLEUS","GO_BP","512335_GO_0051457_MAINTENANCE_OF_PROTEIN_LOCATION_IN_NUCLEUS",15,-0.8305,0.7,0.85,-0.6669,0.89,1,-1.1643,0.26,0.73
"GO_BP:502180_GO_0032958_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","502180_GO_0032958_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS",6,-0.8303,0.68,0.85,0.6703,0.84,1,-0.8897,0.61,0.93
"C7_Immunologic_signatures:C7_ALL_1514_GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN","C7_Immunologic_signatures","C7_ALL_1514_GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN",198,-0.8302,0.87,0.9,1.7021,0,0.00061,-1.0409,0.35,0.63
"GO_BP:491995_GO_0007195_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","491995_GO_0007195_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY",5,-0.8302,0.7,0.85,-0.606,0.92,1,0.8114,0.69,1
"GO_MF:517447_GO_0072542_PROTEIN_PHOSPHATASE_ACTIVATOR_ACTIVITY","GO_MF","517447_GO_0072542_PROTEIN_PHOSPHATASE_ACTIVATOR_ACTIVITY",8,-0.8298,0.72,0.85,1.2121,0.23,0.7,-0.9373,0.54,0.84
"GO_BP:514305_GO_0060750_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_ELONGATION","GO_BP","514305_GO_0060750_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_ELONGATION",5,-0.8298,0.71,0.85,1.1382,0.33,0.85,1.0544,0.42,0.8
"GO_BP:491626_GO_0006743_UBIQUINONE_METABOLIC_PROCESS","GO_BP","491626_GO_0006743_UBIQUINONE_METABOLIC_PROCESS",13,-0.8297,0.69,0.85,0.9403,0.55,1,-0.9633,0.5,0.88
"GO_MF:489472_GO_0004000_ADENOSINE_DEAMINASE_ACTIVITY","GO_MF","489472_GO_0004000_ADENOSINE_DEAMINASE_ACTIVITY",11,-0.8297,0.71,0.85,-0.7981,0.74,1,-1.2387,0.21,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_1355_CHESLER_BRAIN_HIGHEST_EXPRESSION","C2_Chemical_and_genetic_perturbations","C2_CGP_1355_CHESLER_BRAIN_HIGHEST_EXPRESSION",40,-0.8296,0.74,0.83,1.403,0.053,0.29,0.564,0.99,1
"REACTOME:1127535_REACT_264508_SIGNALING_BY_HEDGEHOG","REACTOME","1127535_REACT_264508_SIGNALING_BY_HEDGEHOG",135,-0.8295,0.82,0.85,1.4745,0.0093,0.16,-0.8708,0.8,0.97
"GO_BP:489210_GO_0003418_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DIFFERENTIATION","GO_BP","489210_GO_0003418_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DIFFERENTIATION",5,-0.8292,0.71,0.85,-1.5139,0.051,0.81,-1.1033,0.38,0.77
"GO_CC:490761_GO_0005719_NUCLEAR_EUCHROMATIN","GO_CC","490761_GO_0005719_NUCLEAR_EUCHROMATIN",23,-0.829,0.73,0.93,-0.6925,0.9,1,-0.8009,0.75,1
"GO_BP:491861_GO_0007034_VACUOLAR_TRANSPORT","GO_BP","491861_GO_0007034_VACUOLAR_TRANSPORT",76,-0.829,0.79,0.85,0.8267,0.82,1,-0.976,0.49,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2400_BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2400_BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN",38,-0.8287,0.75,0.83,-0.9576,0.51,1,-0.9442,0.55,0.83
"GO_MF:489945_GO_0004614_PHOSPHOGLUCOMUTASE_ACTIVITY","GO_MF","489945_GO_0004614_PHOSPHOGLUCOMUTASE_ACTIVITY",5,-0.8287,0.68,0.85,-0.8024,0.71,1,-1.2245,0.25,0.58
"REACTOME:530770_REACT_18423_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES","REACTOME","530770_REACT_18423_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES",10,-0.8287,0.72,0.85,-0.6647,0.9,1,0.9634,0.48,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1861_WENG_POR_TARGETS_GLOBAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1861_WENG_POR_TARGETS_GLOBAL_UP",19,-0.8285,0.71,0.83,-0.71,0.86,1,-0.7886,0.77,0.96
"GO_CC:500466_GO_0031201_SNARE_COMPLEX","GO_CC","500466_GO_0031201_SNARE_COMPLEX",49,-0.8284,0.73,0.93,1.0385,0.39,0.73,-0.709,0.94,1
"KEGG_pathway:HSA00510_N_GLYCAN_BIOSYNTHESIS","KEGG_pathway","HSA00510_N_GLYCAN_BIOSYNTHESIS",49,-0.8283,0.75,0.81,0.8566,0.72,1,-1.2894,0.083,0.28
"REACTOME:645263_REACT_121092_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR","REACTOME","645263_REACT_121092_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR",9,-0.8282,0.67,0.85,0.7095,0.84,1,1.2321,0.2,0.8
"GO_BP:495189_GO_0014741_NEGATIVE_REGULATION_OF_MUSCLE_HYPERTROPHY","GO_BP","495189_GO_0014741_NEGATIVE_REGULATION_OF_MUSCLE_HYPERTROPHY",12,-0.8281,0.68,0.86,-0.9026,0.57,1,-0.7814,0.75,1
"C7_Immunologic_signatures:C7_ALL_1652_GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1652_GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN",190,-0.828,0.85,0.9,1.0832,0.24,0.49,-0.9178,0.71,0.92
"GO_CC:507398_GO_0044450_MICROTUBULE_ORGANIZING_CENTER_PART","GO_CC","507398_GO_0044450_MICROTUBULE_ORGANIZING_CENTER_PART",129,-0.8279,0.81,0.93,-1.0396,0.36,0.84,-1.7337,0,0.68
"GO_BP:507685_GO_0045329_CARNITINE_BIOSYNTHETIC_PROCESS","GO_BP","507685_GO_0045329_CARNITINE_BIOSYNTHETIC_PROCESS",5,-0.8278,0.69,0.86,0.7019,0.81,1,-1.543,0.047,0.53
"GO_BP:506092_GO_0043001_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT","GO_BP","506092_GO_0043001_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT",26,-0.8278,0.75,0.86,0.8674,0.68,1,0.8101,0.73,1
"GO_CC:501210_GO_0031970_ORGANELLE_ENVELOPE_LUMEN","GO_CC","501210_GO_0031970_ORGANELLE_ENVELOPE_LUMEN",79,-0.8278,0.8,0.92,1.7935,0,0.029,-0.8921,0.67,1
"GO_BP:495013_GO_0010948_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS","GO_BP","495013_GO_0010948_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS",335,-0.8278,0.9,0.86,1.3398,0,0.62,-1.2395,0.051,0.69
"GO_BP:501461_GO_0032226_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC","GO_BP","501461_GO_0032226_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC",7,-0.8278,0.68,0.86,-1.1817,0.26,0.91,1.3076,0.18,0.67
"GO_BP:491178_GO_0006220_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS","GO_BP","491178_GO_0006220_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS",43,-0.8278,0.76,0.86,1.1119,0.29,0.89,-0.9716,0.5,0.88
"GO_BP:508430_GO_0046134_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS","GO_BP","508430_GO_0046134_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS",32,-0.8277,0.74,0.86,-0.6006,0.98,1,-0.7366,0.88,1
"C7_Immunologic_signatures:C7_ALL_449_GSE17721_CTRL_VS_LPS_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_449_GSE17721_CTRL_VS_LPS_1H_BMDM_UP",196,-0.8276,0.85,0.9,1.0202,0.4,0.68,-1.0447,0.33,0.62
"C7_Immunologic_signatures:C7_ALL_324_GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_324_GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN",199,-0.8275,0.86,0.9,1.932,0,0,0.7781,0.96,1
"GO_BP:509133_GO_0046928_REGULATION_OF_NEUROTRANSMITTER_SECRETION","GO_BP","509133_GO_0046928_REGULATION_OF_NEUROTRANSMITTER_SECRETION",47,-0.8275,0.74,0.86,0.9059,0.62,1,1.1473,0.23,0.73
"GO_BP:494460_GO_0010390_HISTONE_MONOUBIQUITINATION","GO_BP","494460_GO_0010390_HISTONE_MONOUBIQUITINATION",23,-0.8273,0.73,0.86,0.579,0.98,1,-0.7739,0.82,1
"GO_BP:495245_GO_0014850_RESPONSE_TO_MUSCLE_ACTIVITY","GO_BP","495245_GO_0014850_RESPONSE_TO_MUSCLE_ACTIVITY",13,-0.8273,0.71,0.86,0.9973,0.47,0.98,1.6417,0.016,0.41
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_136_BIOCARTA_PTDINS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_136_BIOCARTA_PTDINS_PATHWAY",23,-0.8271,0.72,0.77,-1.1037,0.3,1,-1.1713,0.22,0.58
"GO_BP:491732_GO_0006868_GLUTAMINE_TRANSPORT","GO_BP","491732_GO_0006868_GLUTAMINE_TRANSPORT",5,-0.827,0.68,0.86,-0.8678,0.62,1,-0.9684,0.51,0.88
"GO_BP:491514_GO_0006621_PROTEIN_RETENTION_IN_ER_LUMEN","GO_BP","491514_GO_0006621_PROTEIN_RETENTION_IN_ER_LUMEN",9,-0.8268,0.7,0.86,0.8095,0.71,1,0.8354,0.67,0.99
"GO_MF:487329_GO_0001106_RNA_POLYMERASE_II_TRANSCRIPTION_COREPRESSOR_ACTIVITY","GO_MF","487329_GO_0001106_RNA_POLYMERASE_II_TRANSCRIPTION_COREPRESSOR_ACTIVITY",25,-0.8268,0.75,0.86,1.0574,0.36,0.83,-1.4022,0.072,0.5
"C7_Immunologic_signatures:C7_ALL_1842_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN","C7_Immunologic_signatures","C7_ALL_1842_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN",191,-0.8266,0.86,0.9,-1.0528,0.33,1,-0.9836,0.5,0.76
"C7_Immunologic_signatures:C7_ALL_1205_GSE27786_CD8_TCELL_VS_NKTCELL_UP","C7_Immunologic_signatures","C7_ALL_1205_GSE27786_CD8_TCELL_VS_NKTCELL_UP",195,-0.8266,0.86,0.9,0.9555,0.58,0.88,-1.3463,0.021,0.099
"OMIM_gene:OMIM605553_POLY_A_POLYMERASE_ALPHA_PAPOLA","OMIM_gene","OMIM605553_POLY_A_POLYMERASE_ALPHA_PAPOLA",6,-0.8263,0.67,0.87,0.9499,0.55,1,-0.967,0.51,1
"GO_BP:498217_GO_0019374_GALACTOLIPID_METABOLIC_PROCESS","GO_BP","498217_GO_0019374_GALACTOLIPID_METABOLIC_PROCESS",5,-0.8262,0.71,0.86,0.9448,0.53,1,-0.759,0.75,1
"GO_BP:517223_GO_0072307_REGULATION_OF_METANEPHRIC_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","517223_GO_0072307_REGULATION_OF_METANEPHRIC_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION",8,-0.8261,0.69,0.86,-0.78,0.76,1,-1.3154,0.18,0.64
"REACTOME:1183527_REACT_355468_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER","REACTOME","1183527_REACT_355468_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER",24,-0.8261,0.71,0.86,-1.0784,0.35,0.91,-1.0737,0.35,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_1016_LIAO_HAVE_SOX4_BINDING_SITES","C2_Chemical_and_genetic_perturbations","C2_CGP_1016_LIAO_HAVE_SOX4_BINDING_SITES",40,-0.8261,0.76,0.83,-0.6377,0.97,1,-0.6219,0.98,0.99
"C7_Immunologic_signatures:C7_ALL_216_GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN","C7_Immunologic_signatures","C7_ALL_216_GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN",195,-0.826,0.86,0.9,-0.9603,0.56,1,-0.8042,0.93,1
"GO_BP:491656_GO_0006783_HEME_BIOSYNTHETIC_PROCESS","GO_BP","491656_GO_0006783_HEME_BIOSYNTHETIC_PROCESS",21,-0.826,0.72,0.86,1.1985,0.23,0.78,-1.0704,0.35,0.8
"C1_Positional:C1_ALL_150_CHR2P15","C1_Positional","C1_ALL_150_CHR2P15",14,-0.8256,0.71,1,-0.8429,0.69,0.96,-1.5564,0.037,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_228_BILBAN_B_CLL_LPL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_228_BILBAN_B_CLL_LPL_UP",62,-0.8255,0.77,0.83,0.8387,0.82,0.98,0.8441,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1874_HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2","C2_Chemical_and_genetic_perturbations","C2_CGP_1874_HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2",163,-0.8254,0.84,0.83,1.3767,0.0094,0.31,0.8165,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1566_XU_CREBBP_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1566_XU_CREBBP_TARGETS_UP",25,-0.8254,0.74,0.83,0.7101,0.89,1,0.7831,0.82,1
"GO_BP:510759_GO_0048704_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS","GO_BP","510759_GO_0048704_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS",94,-0.8254,0.8,0.86,0.8685,0.74,1,1.2369,0.12,0.7
"GO_BP:513694_GO_0060136_EMBRYONIC_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY","GO_BP","513694_GO_0060136_EMBRYONIC_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY",6,-0.8253,0.68,0.86,-0.5669,0.94,1,-0.6008,0.93,1
"C4_Cancer_modules:C4_CM_235_MODULE_261","C4_Cancer_modules","C4_CM_235_MODULE_261",99,-0.8251,0.8,0.84,0.7175,0.97,1,-0.7164,0.96,1
"GO_BP:508446_GO_0046148_PIGMENT_BIOSYNTHETIC_PROCESS","GO_BP","508446_GO_0046148_PIGMENT_BIOSYNTHETIC_PROCESS",49,-0.8249,0.76,0.86,1.0295,0.39,0.97,-1.1825,0.17,0.73
"GO_BP:499855_GO_0030516_REGULATION_OF_AXON_EXTENSION","GO_BP","499855_GO_0030516_REGULATION_OF_AXON_EXTENSION",60,-0.8245,0.81,0.86,-0.9439,0.56,1,0.9544,0.54,0.9
"REACTOME:1127683_REACT_264245_HATS_ACETYLATE_HISTONES","REACTOME","1127683_REACT_264245_HATS_ACETYLATE_HISTONES",140,-0.8245,0.82,0.86,-1.1748,0.14,0.86,-1.1552,0.16,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_409_LINDGREN_BLADDER_CANCER_CLUSTER_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_409_LINDGREN_BLADDER_CANCER_CLUSTER_1_UP",118,-0.8244,0.82,0.84,1.8379,0,0.031,-0.7366,0.97,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2917_MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2917_MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3",6,-0.8243,0.71,0.84,-1.3149,0.18,0.7,-1.5526,0.034,0.27
"C3_TF_targets:C3_TFT_325_V_ALX4_01","C3_TF_targets","C3_TFT_325_V_ALX4_01",16,-0.8242,0.72,0.91,0.703,0.89,1,-1.1607,0.27,0.43
"GO_BP:514511_GO_0060956_ENDOCARDIAL_CELL_DIFFERENTIATION","GO_BP","514511_GO_0060956_ENDOCARDIAL_CELL_DIFFERENTIATION",6,-0.8238,0.71,0.86,-0.8941,0.59,1,1.4739,0.076,0.58
"C7_Immunologic_signatures:C7_ALL_875_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP","C7_Immunologic_signatures","C7_ALL_875_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP",198,-0.8238,0.86,0.91,-0.7066,1,1,-0.9939,0.47,0.74
"GO_CC:486658_GO_0000118_HISTONE_DEACETYLASE_COMPLEX","GO_CC","486658_GO_0000118_HISTONE_DEACETYLASE_COMPLEX",55,-0.8236,0.77,0.93,-0.8873,0.66,0.96,-1.4358,0.036,0.51
"GO_BP:512466_GO_0051588_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT","GO_BP","512466_GO_0051588_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT",65,-0.8236,0.77,0.86,0.8381,0.79,1,1.0935,0.3,0.77
"C4_Cancer_modules:C4_CM_316_MODULE_368","C4_Cancer_modules","C4_CM_316_MODULE_368",18,-0.8235,0.71,0.84,-1.3701,0.1,0.52,1.4044,0.087,0.32
"GO_BP:492848_GO_0008588_RELEASE_OF_CYTOPLASMIC_SEQUESTERED_NF_KAPPAB","GO_BP","492848_GO_0008588_RELEASE_OF_CYTOPLASMIC_SEQUESTERED_NF_KAPPAB",5,-0.8234,0.69,0.86,0.6244,0.91,1,0.7489,0.76,1
"GO_BP:492337_GO_0007595_LACTATION","GO_BP","492337_GO_0007595_LACTATION",39,-0.8233,0.75,0.86,1.2048,0.18,0.78,0.9666,0.53,0.89
"KEGG_compound:C14819_FE3_FE_III_FERRIC_ION_IRON_3_","KEGG_compound","C14819_FE3_FE_III_FERRIC_ION_IRON_3_",5,-0.8233,0.69,0.8,1.0577,0.39,1,0.9814,0.48,0.71
"GO_BP:514647_GO_0061099_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY","GO_BP","514647_GO_0061099_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY",17,-0.8233,0.73,0.86,-0.6586,0.91,1,0.9815,0.47,0.87
"GO_MF:504440_GO_0035256_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_BINDING","GO_MF","504440_GO_0035256_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_BINDING",6,-0.8232,0.68,0.86,-1.2009,0.26,0.81,1.0103,0.48,0.86
"C7_Immunologic_signatures:C7_ALL_13_GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_13_GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP",199,-0.8232,0.87,0.91,0.7739,0.99,1,-1.0439,0.32,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_2567_AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2567_AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP",292,-0.8232,0.89,0.84,1.1296,0.12,0.58,-0.9281,0.72,0.84
"GO_MF:503796_GO_0034595_PHOSPHATIDYLINOSITOL_PHOSPHATE_5_PHOSPHATASE_ACTIVITY","GO_MF","503796_GO_0034595_PHOSPHATIDYLINOSITOL_PHOSPHATE_5_PHOSPHATASE_ACTIVITY",11,-0.8231,0.73,0.86,-0.5891,0.96,1,-0.6761,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_791_SCHRAMM_INHBA_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_791_SCHRAMM_INHBA_TARGETS_DN",23,-0.8231,0.74,0.84,0.7603,0.83,1,-0.5942,0.98,0.99
"C4_Cancer_modules:C4_CM_157_MODULE_166","C4_Cancer_modules","C4_CM_157_MODULE_166",54,-0.823,0.8,0.84,1.0096,0.43,0.7,-0.7935,0.85,0.99
"GO_BP:488236_GO_0002363_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT","GO_BP","488236_GO_0002363_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT",8,-0.8229,0.71,0.86,-1.2718,0.19,0.89,0.7082,0.83,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2102_TESAR_JAK_TARGETS_MOUSE_ES_D3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2102_TESAR_JAK_TARGETS_MOUSE_ES_D3_DN",8,-0.8229,0.71,0.84,-1.6444,0.018,0.36,-1.4516,0.099,0.32
"WikiPathways:198756_WP241_ONE_CARBON_METABOLISM","WikiPathways","198756_WP241_ONE_CARBON_METABOLISM",29,-0.8228,0.75,0.84,-0.9001,0.63,1,-1.1155,0.3,0.58
"GO_BP:750897_GO_0035970_PEPTIDYL_THREONINE_DEPHOSPHORYLATION","GO_BP","750897_GO_0035970_PEPTIDYL_THREONINE_DEPHOSPHORYLATION",9,-0.8228,0.69,0.86,0.392,1,1,-0.7326,0.8,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2494_JU_AGING_TERC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2494_JU_AGING_TERC_TARGETS_DN",5,-0.8227,0.71,0.84,1.5373,0.029,0.18,-1.2712,0.23,0.45
"GO_CC:505548_GO_0042405_NUCLEAR_INCLUSION_BODY","GO_CC","505548_GO_0042405_NUCLEAR_INCLUSION_BODY",10,-0.8227,0.69,0.93,-0.9611,0.5,0.89,-0.6557,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2625_ELLWOOD_MYC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2625_ELLWOOD_MYC_TARGETS_UP",12,-0.8227,0.69,0.84,0.6382,0.92,1,0.5483,0.98,1
"GO_CC:501142_GO_0031901_EARLY_ENDOSOME_MEMBRANE","GO_CC","501142_GO_0031901_EARLY_ENDOSOME_MEMBRANE",101,-0.8227,0.81,0.93,0.8351,0.85,0.93,0.828,0.83,1
"GO_BP:492515_GO_0019079_VIRAL_GENOME_REPLICATION","GO_BP","492515_GO_0019079_VIRAL_GENOME_REPLICATION",20,-0.8226,0.72,0.86,0.98,0.47,1,0.8842,0.65,0.95
"GO_MF:500742_GO_0031491_NUCLEOSOME_BINDING","GO_MF","500742_GO_0031491_NUCLEOSOME_BINDING",43,-0.8225,0.76,0.86,-0.9252,0.58,0.96,-1.188,0.2,0.59
"GO_BP:495281_GO_0014888_STRIATED_MUSCLE_ADAPTATION","GO_BP","495281_GO_0014888_STRIATED_MUSCLE_ADAPTATION",24,-0.8225,0.73,0.86,-1.0978,0.31,0.95,-0.8387,0.74,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2327_MATZUK_MEIOTIC_AND_DNA_REPAIR","C2_Chemical_and_genetic_perturbations","C2_CGP_2327_MATZUK_MEIOTIC_AND_DNA_REPAIR",38,-0.8224,0.75,0.84,-1.3177,0.1,0.7,-1.104,0.29,0.62
"C1_Positional:C1_ALL_22_CHR14Q11","C1_Positional","C1_ALL_22_CHR14Q11",132,-0.8223,0.83,1,-1.1598,0.16,1,0.8984,0.72,0.84
"REACTOME:1183579_REACT_355580_FRS2_MEDIATED_FGFR4_SIGNALING","REACTOME","1183579_REACT_355580_FRS2_MEDIATED_FGFR4_SIGNALING",31,-0.8222,0.73,0.86,-0.8377,0.74,1,-0.9645,0.5,0.89
"KEGG_reaction:R02241_ACYL_COA_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_2_O_ACYLTRANSFERASE_PHOSPHATIDATE_COA_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_ACYL_COA","KEGG_reaction","R02241_ACYL_COA_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_2_O_ACYLTRANSFERASE_PHOSPHATIDATE_COA_1_ACYL_SN_GLYCEROL_3_PHOSPHATE_ACYL_COA",8,-0.822,0.72,0.76,0.7167,0.83,1,-1.1033,0.34,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_1171_SHIN_B_CELL_LYMPHOMA_CLUSTER_9","C2_Chemical_and_genetic_perturbations","C2_CGP_1171_SHIN_B_CELL_LYMPHOMA_CLUSTER_9",19,-0.822,0.73,0.84,0.7683,0.8,1,-1.5289,0.036,0.29
"C7_Immunologic_signatures:C7_ALL_97_GSE11924_TFH_VS_TH2_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_97_GSE11924_TFH_VS_TH2_CD4_TCELL_UP",199,-0.8219,0.87,0.91,-0.9684,0.53,1,-1.2622,0.043,0.18
"GO_CC:502397_GO_0033177_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_PROTON_TRANSPORTING_DOMAIN","GO_CC","502397_GO_0033177_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_PROTON_TRANSPORTING_DOMAIN",21,-0.8219,0.74,0.93,1.4701,0.057,0.23,0.6302,0.95,1
"GO_CC:490776_GO_0005741_MITOCHONDRIAL_OUTER_MEMBRANE","GO_CC","490776_GO_0005741_MITOCHONDRIAL_OUTER_MEMBRANE",140,-0.8219,0.85,0.93,1.4288,0.018,0.28,-0.8628,0.8,1
"GO_BP:499513_GO_0030071_REGULATION_OF_MITOTIC_METAPHASE_ANAPHASE_TRANSITION","GO_BP","499513_GO_0030071_REGULATION_OF_MITOTIC_METAPHASE_ANAPHASE_TRANSITION",47,-0.8217,0.78,0.86,0.8537,0.73,1,-0.8423,0.78,0.96
"GO_BP:510360_GO_0048245_EOSINOPHIL_CHEMOTAXIS","GO_BP","510360_GO_0048245_EOSINOPHIL_CHEMOTAXIS",7,-0.8217,0.7,0.86,1.5841,0.038,0.31,1.934,0.0038,0.1
"GO_BP:989120_GO_1903055_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION","GO_BP","989120_GO_1903055_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION",9,-0.8215,0.71,0.86,-0.7377,0.79,1,0.8748,0.63,0.96
"GO_BP:491915_GO_0007096_REGULATION_OF_EXIT_FROM_MITOSIS","GO_BP","491915_GO_0007096_REGULATION_OF_EXIT_FROM_MITOSIS",12,-0.8214,0.69,0.86,0.8622,0.66,1,0.6194,0.92,1
"GO_BP:511954_GO_0051029_RRNA_TRANSPORT","GO_BP","511954_GO_0051029_RRNA_TRANSPORT",5,-0.8214,0.69,0.86,1.278,0.21,0.7,-1.4776,0.055,0.54
"C1_Positional:C1_ALL_148_CHR8P23","C1_Positional","C1_ALL_148_CHR8P23",70,-0.8213,0.79,1,0.9375,0.55,0.84,1.4702,0.016,0.31
"C7_Immunologic_signatures:C7_ALL_227_GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP","C7_Immunologic_signatures","C7_ALL_227_GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP",172,-0.8213,0.86,0.91,-0.7003,0.99,1,0.9466,0.58,1
"REACTOME:730348_REACT_150203_IRS_RELATED_EVENTS_TRIGGERED_BY_IGF1R","REACTOME","730348_REACT_150203_IRS_RELATED_EVENTS_TRIGGERED_BY_IGF1R",83,-0.8212,0.79,0.86,0.8025,0.85,1,0.6969,0.98,1
"REACTOME:1127524_REACT_264580_REGULATION_OF_FZD_BY_UBIQUITINATION","REACTOME","1127524_REACT_264580_REGULATION_OF_FZD_BY_UBIQUITINATION",20,-0.8211,0.73,0.86,0.7031,0.9,1,1.4542,0.081,0.61
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_150_BIOCARTA_RB_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_150_BIOCARTA_RB_PATHWAY",13,-0.821,0.71,0.78,-0.7539,0.8,1,-1.3601,0.12,0.46
"GO_BP:754193_GO_1901228_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","754193_GO_1901228_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_HEART_DEVELOPMENT",5,-0.8206,0.7,0.86,0.8601,0.62,1,1.6427,0.016,0.41
"GO_BP:505289_GO_0042117_MONOCYTE_ACTIVATION","GO_BP","505289_GO_0042117_MONOCYTE_ACTIVATION",8,-0.8205,0.69,0.86,-0.721,0.82,1,1.3374,0.14,0.65
"GO_MF:496934_GO_0017134_FIBROBLAST_GROWTH_FACTOR_BINDING","GO_MF","496934_GO_0017134_FIBROBLAST_GROWTH_FACTOR_BINDING",20,-0.8204,0.73,0.86,1.012,0.43,0.87,0.9737,0.48,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_2411_QI_PLASMACYTOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2411_QI_PLASMACYTOMA_DN",97,-0.8204,0.81,0.84,1.3828,0.023,0.31,0.8692,0.76,1
"GO_BP:514383_GO_0060828_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY","GO_BP","514383_GO_0060828_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY",220,-0.8204,0.87,0.86,1.1495,0.13,0.84,0.9155,0.71,0.93
"C7_Immunologic_signatures:C7_ALL_1486_GSE360_L_MAJOR_VS_T_GONDII_MAC_DN","C7_Immunologic_signatures","C7_ALL_1486_GSE360_L_MAJOR_VS_T_GONDII_MAC_DN",196,-0.8204,0.87,0.91,0.9662,0.55,0.85,-1.1737,0.11,0.33
"GO_CC:752880_GO_0097381_PHOTORECEPTOR_DISC_MEMBRANE","GO_CC","752880_GO_0097381_PHOTORECEPTOR_DISC_MEMBRANE",13,-0.82,0.69,0.93,-1.8152,0.0038,0.27,-1.645,0.014,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2208_DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2","C2_Chemical_and_genetic_perturbations","C2_CGP_2208_DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2",117,-0.8197,0.82,0.84,1.425,0.0095,0.28,-1.0139,0.41,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_233_PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_233_PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN",21,-0.8197,0.74,0.84,1.2349,0.2,0.45,-0.9302,0.53,0.84
"C4_Cancer_gene_neighborhoods:C4_CGN_66_MORF_BMPR2","C4_Cancer_gene_neighborhoods","C4_CGN_66_MORF_BMPR2",50,-0.8197,0.76,1,-0.7587,0.85,1,0.7449,0.9,1
"GO_MF:496954_GO_0017160_RAL_GTPASE_BINDING","GO_MF","496954_GO_0017160_RAL_GTPASE_BINDING",13,-0.8197,0.73,0.87,-1.2349,0.21,0.84,0.5574,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2401_CONRAD_STEM_CELL","C2_Chemical_and_genetic_perturbations","C2_CGP_2401_CONRAD_STEM_CELL",38,-0.8194,0.74,0.84,0.7793,0.83,1,0.6625,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1948_SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1948_SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN",21,-0.8194,0.75,0.84,-0.8157,0.73,1,-0.8846,0.63,0.9
"WikiPathways:198776_WP666_HYPOTHETICAL_NETWORK_FOR_DRUG_ADDICTION","WikiPathways","198776_WP666_HYPOTHETICAL_NETWORK_FOR_DRUG_ADDICTION",32,-0.8192,0.75,0.84,-0.9276,0.59,1,1.1265,0.28,0.68
"C4_Cancer_modules:C4_CM_9_MODULE_9","C4_Cancer_modules","C4_CM_9_MODULE_9",119,-0.8191,0.81,0.84,-0.8698,0.76,0.93,0.8505,0.81,1
"C3_MicroRNA_targets:C3_MIR_192_CACCAGC_MIR_138","C3_MicroRNA_targets","C3_MIR_192_CACCAGC_MIR_138",224,-0.8191,0.9,0.9,-0.686,1,1,-0.994,0.48,1
"GO_BP:506343_GO_0043278_RESPONSE_TO_MORPHINE","GO_BP","506343_GO_0043278_RESPONSE_TO_MORPHINE",25,-0.819,0.76,0.87,-0.7903,0.79,1,0.6195,0.96,1
"WikiPathways:198831_WP1604_CODEINE_AND_MORPHINE_METABOLISM","WikiPathways","198831_WP1604_CODEINE_AND_MORPHINE_METABOLISM",8,-0.8189,0.69,0.84,0.7911,0.71,1,-1.304,0.17,0.45
"C7_Immunologic_signatures:C7_ALL_1841_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP","C7_Immunologic_signatures","C7_ALL_1841_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP",198,-0.8188,0.85,0.91,1.6569,0,0.0012,-0.9256,0.66,0.9
"C4_Cancer_gene_neighborhoods:C4_CGN_65_MORF_BMI1","C4_Cancer_gene_neighborhoods","C4_CGN_65_MORF_BMI1",81,-0.8188,0.79,1,1.409,0.018,0.058,-1.1368,0.22,0.55
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_39_BIOCARTA_CERAMIDE_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_39_BIOCARTA_CERAMIDE_PATHWAY",22,-0.8188,0.74,0.78,0.7122,0.9,1,-0.6069,0.96,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_1194_KAUFFMANN_DNA_REPLICATION_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_1194_KAUFFMANN_DNA_REPLICATION_GENES",146,-0.8186,0.84,0.84,1.1965,0.12,0.49,-1.2709,0.057,0.45
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_46_BIOCARTA_CTCF_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_46_BIOCARTA_CTCF_PATHWAY",23,-0.8186,0.74,0.77,1.3666,0.089,0.51,-0.8462,0.71,0.91
"GO_BP:510765_GO_0048710_REGULATION_OF_ASTROCYTE_DIFFERENTIATION","GO_BP","510765_GO_0048710_REGULATION_OF_ASTROCYTE_DIFFERENTIATION",25,-0.8186,0.73,0.87,-1.5644,0.022,0.72,0.8682,0.67,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_180_BARRIER_COLON_CANCER_RECURRENCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_180_BARRIER_COLON_CANCER_RECURRENCE_UP",41,-0.8185,0.78,0.84,1.8711,0.0021,0.025,0.8232,0.75,1
"REACTOME:1183576_REACT_355144_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING","REACTOME","1183576_REACT_355144_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING",27,-0.8184,0.75,0.86,0.8165,0.75,0.99,0.6153,0.97,1
"GO_BP:512102_GO_0051205_PROTEIN_INSERTION_INTO_MEMBRANE","GO_BP","512102_GO_0051205_PROTEIN_INSERTION_INTO_MEMBRANE",14,-0.8184,0.72,0.87,1.1343,0.28,0.86,0.8338,0.69,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1736_MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1736_MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN",52,-0.8182,0.77,0.84,-1.0219,0.41,0.98,-0.8229,0.79,0.94
"GO_BP:504452_GO_0035268_PROTEIN_MANNOSYLATION","GO_BP","504452_GO_0035268_PROTEIN_MANNOSYLATION",18,-0.8181,0.72,0.87,-0.5548,0.98,1,-1.1423,0.28,0.75
"GO_BP:487441_GO_0001502_CARTILAGE_CONDENSATION","GO_BP","487441_GO_0001502_CARTILAGE_CONDENSATION",22,-0.8179,0.74,0.87,-1.439,0.059,0.91,1.2126,0.2,0.71
"REACTOME:530763_REACT_115697_PROLACTIN_RECEPTOR_SIGNALING","REACTOME","530763_REACT_115697_PROLACTIN_RECEPTOR_SIGNALING",14,-0.8177,0.73,0.86,0.8507,0.68,0.96,-0.6804,0.9,1
"OMIM_gene:OMIM167805_REGENERATING_ISLET_DERIVED_3_ALPHA_REG3A","OMIM_gene","OMIM167805_REGENERATING_ISLET_DERIVED_3_ALPHA_REG3A",6,-0.8175,0.7,0.86,0.9629,0.51,1,-0.9439,0.51,1
"WikiPathways:698759_WP2290_RALA_DOWNSTREAM_REGULATED_GENES","WikiPathways","698759_WP2290_RALA_DOWNSTREAM_REGULATED_GENES",9,-0.8174,0.71,0.83,1.2209,0.21,0.83,0.7114,0.83,1
"GO_BP:487847_GO_0001957_INTRAMEMBRANOUS_OSSIFICATION","GO_BP","487847_GO_0001957_INTRAMEMBRANOUS_OSSIFICATION",6,-0.8174,0.71,0.87,-0.9607,0.52,1,0.7179,0.81,1
"REACTOME:1127495_REACT_264351_MITOCHONDRIAL_BIOGENESIS","REACTOME","1127495_REACT_264351_MITOCHONDRIAL_BIOGENESIS",51,-0.8173,0.8,0.86,0.8394,0.76,0.96,0.8713,0.7,1
"REACTOME:1127582_REACT_264430_MYOCLONIC_EPILEPSY_OF_LAFORA","REACTOME","1127582_REACT_264430_MYOCLONIC_EPILEPSY_OF_LAFORA",10,-0.8173,0.7,0.86,1.3271,0.15,0.29,-1.2089,0.23,0.59
"REACTOME:366224_REACT_75918_INWARDLY_RECTIFYING_K_CHANNELS","REACTOME","366224_REACT_75918_INWARDLY_RECTIFYING_K_CHANNELS",30,-0.8173,0.74,0.86,0.8604,0.71,0.94,1.0134,0.44,1
"C7_Immunologic_signatures:C7_ALL_1295_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1295_GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP",187,-0.8172,0.86,0.92,0.8947,0.78,1,1.2588,0.051,0.51
"GO_BP:1025350_GO_1903214_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION","GO_BP","1025350_GO_1903214_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION",73,-0.8172,0.79,0.87,1.3755,0.036,0.58,-0.7636,0.93,1
"GO_BP:512543_GO_0051668_LOCALIZATION_WITHIN_MEMBRANE","GO_BP","512543_GO_0051668_LOCALIZATION_WITHIN_MEMBRANE",42,-0.817,0.76,0.87,1.7576,0,0.13,0.7201,0.93,1
"KEGG_compound:C00093_SN_GLYCEROL_3_PHOSPHATE_GLYCEROPHOSPHORIC_ACID_D_GLYCEROL_1_PHOSPHATE","KEGG_compound","C00093_SN_GLYCEROL_3_PHOSPHATE_GLYCEROPHOSPHORIC_ACID_D_GLYCEROL_1_PHOSPHATE",12,-0.8168,0.73,0.81,1.669,0.024,0.1,1.1214,0.31,0.63
"GO_BP:513816_GO_0060260_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER","GO_BP","513816_GO_0060260_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER",15,-0.8166,0.72,0.87,0.722,0.88,1,-0.6756,0.9,1
"C7_Immunologic_signatures:C7_ALL_1246_GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN","C7_Immunologic_signatures","C7_ALL_1246_GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN",174,-0.8164,0.86,0.92,0.922,0.68,0.97,0.9076,0.71,1
"GO_BP:499262_GO_0021983_PITUITARY_GLAND_DEVELOPMENT","GO_BP","499262_GO_0021983_PITUITARY_GLAND_DEVELOPMENT",43,-0.8162,0.78,0.87,-1.1291,0.28,0.94,1.6336,0.0042,0.4
"WikiPathways:198839_WP501_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE","WikiPathways","198839_WP501_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE",15,-0.8161,0.71,0.83,0.9531,0.54,1,1.3437,0.12,0.49
"REACTOME:106369_REACT_16942_HORMONE_LIGAND_BINDING_RECEPTORS","REACTOME","106369_REACT_16942_HORMONE_LIGAND_BINDING_RECEPTORS",11,-0.816,0.7,0.86,-1.3711,0.1,0.57,1.4113,0.081,0.67
"GO_BP:516349_GO_0071425_HEMATOPOIETIC_STEM_CELL_PROLIFERATION","GO_BP","516349_GO_0071425_HEMATOPOIETIC_STEM_CELL_PROLIFERATION",13,-0.8159,0.71,0.87,0.9061,0.58,1,1.3395,0.11,0.65
"GO_BP:1053350_GO_0098743_CELL_AGGREGATION","GO_BP","1053350_GO_0098743_CELL_AGGREGATION",22,-0.8156,0.72,0.87,-1.4055,0.067,0.98,1.2324,0.15,0.71
"GO_BP:754303_GO_1901341_POSITIVE_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY","GO_BP","754303_GO_1901341_POSITIVE_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY",5,-0.8156,0.71,0.87,0.7167,0.81,1,0.5062,0.98,1
"GO_MF:492403_GO_0050811_GABA_RECEPTOR_BINDING","GO_MF","492403_GO_0050811_GABA_RECEPTOR_BINDING",13,-0.8156,0.73,0.87,1.0169,0.41,0.87,-0.77,0.8,0.98
"GO_BP:491268_GO_0006309_APOPTOTIC_DNA_FRAGMENTATION","GO_BP","491268_GO_0006309_APOPTOTIC_DNA_FRAGMENTATION",17,-0.8155,0.7,0.87,0.973,0.49,1,-1.1662,0.25,0.73
"REACTOME:160948_REACT_21352_RNA_POLYMERASE_I_RNA_POLYMERASE_III_AND_MITOCHONDRIAL_TRANSCRIPTION","REACTOME","160948_REACT_21352_RNA_POLYMERASE_I_RNA_POLYMERASE_III_AND_MITOCHONDRIAL_TRANSCRIPTION",143,-0.8153,0.84,0.86,-1.1984,0.13,0.83,-1.2166,0.1,0.59
"C4_Cancer_gene_neighborhoods:C4_CGN_238_GCM_MAP1B","C4_Cancer_gene_neighborhoods","C4_CGN_238_GCM_MAP1B",65,-0.8151,0.79,1,-0.7596,0.89,1,-0.6854,0.98,1
"GO_BP:503488_GO_0034285_RESPONSE_TO_DISACCHARIDE","GO_BP","503488_GO_0034285_RESPONSE_TO_DISACCHARIDE",7,-0.815,0.68,0.87,1.0106,0.42,0.98,-0.8884,0.57,0.93
"REACTOME:1183530_REACT_355504_DISEASES_OF_CARBOHYDRATE_METABOLISM","REACTOME","1183530_REACT_355504_DISEASES_OF_CARBOHYDRATE_METABOLISM",10,-0.815,0.7,0.86,1.3456,0.13,0.27,-1.1926,0.26,0.61
"GO_BP:516655_GO_0071732_CELLULAR_RESPONSE_TO_NITRIC_OXIDE","GO_BP","516655_GO_0071732_CELLULAR_RESPONSE_TO_NITRIC_OXIDE",10,-0.8145,0.69,0.87,0.883,0.62,1,1.1859,0.25,0.72
"GO_BP:514039_GO_0060484_LUNG_ASSOCIATED_MESENCHYME_DEVELOPMENT","GO_BP","514039_GO_0060484_LUNG_ASSOCIATED_MESENCHYME_DEVELOPMENT",9,-0.8145,0.72,0.87,-0.8402,0.67,1,1.1771,0.27,0.72
"GO_BP:495260_GO_0014866_SKELETAL_MYOFIBRIL_ASSEMBLY","GO_BP","495260_GO_0014866_SKELETAL_MYOFIBRIL_ASSEMBLY",7,-0.8145,0.69,0.87,-1.7001,0.013,0.64,-1.0489,0.39,0.81
"GO_BP:505195_GO_0040037_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","505195_GO_0040037_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",14,-0.8144,0.73,0.87,0.9988,0.44,0.98,1.2769,0.17,0.69
"GO_MF:515496_GO_0070566_ADENYLYLTRANSFERASE_ACTIVITY","GO_MF","515496_GO_0070566_ADENYLYLTRANSFERASE_ACTIVITY",24,-0.8144,0.76,0.87,1.3201,0.11,0.58,0.9331,0.54,0.94
"GO_MF:506276_GO_0043208_GLYCOSPHINGOLIPID_BINDING","GO_MF","506276_GO_0043208_GLYCOSPHINGOLIPID_BINDING",8,-0.8144,0.71,0.87,1.0147,0.45,0.87,0.871,0.63,0.97
"GO_BP:512187_GO_0051303_ESTABLISHMENT_OF_CHROMOSOME_LOCALIZATION","GO_BP","512187_GO_0051303_ESTABLISHMENT_OF_CHROMOSOME_LOCALIZATION",51,-0.8143,0.78,0.87,1.467,0.022,0.47,-0.7852,0.88,1
"C3_TF_targets:C3_TFT_494_GTTNYYNNGGTNA_UNKNOWN","C3_TF_targets","C3_TFT_494_GTTNYYNNGGTNA_UNKNOWN",86,-0.8142,0.82,0.93,-1.0679,0.33,0.62,1.0542,0.34,1
"C1_Positional:C1_ALL_294_CHR18Q11","C1_Positional","C1_ALL_294_CHR18Q11",30,-0.8142,0.74,1,-0.6142,0.96,0.99,1.0775,0.34,0.7
"GO_MF:501234_GO_0031996_THIOESTERASE_BINDING","GO_MF","501234_GO_0031996_THIOESTERASE_BINDING",14,-0.8139,0.71,0.87,0.7856,0.76,1,0.7243,0.85,1
"REACTOME:833795_REACT_163919_INACTIVATION_RECOVERY_AND_REGULATION_OF_THE_PHOTOTRANSDUCTION_CASCADE","REACTOME","833795_REACT_163919_INACTIVATION_RECOVERY_AND_REGULATION_OF_THE_PHOTOTRANSDUCTION_CASCADE",30,-0.8139,0.74,0.86,-1.0804,0.35,0.91,-1.0089,0.42,0.82
"C1_Positional:C1_ALL_19_CHR7P13","C1_Positional","C1_ALL_19_CHR7P13",40,-0.8137,0.77,1,-0.793,0.81,0.96,-0.9223,0.57,0.98
"GO_BP:515030_GO_0070092_REGULATION_OF_GLUCAGON_SECRETION","GO_BP","515030_GO_0070092_REGULATION_OF_GLUCAGON_SECRETION",5,-0.8137,0.72,0.87,-1.1805,0.29,0.91,-0.6208,0.91,1
"GO_BP:504488_GO_0035304_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION","GO_BP","504488_GO_0035304_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION",25,-0.8135,0.76,0.87,1.0687,0.34,0.93,0.7265,0.88,1
"GO_BP:505866_GO_0042760_VERY_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS","GO_BP","505866_GO_0042760_VERY_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS",5,-0.8131,0.71,0.87,0.9823,0.47,1,0.6752,0.87,1
"GO_MF:496731_GO_0016835_CARBON_OXYGEN_LYASE_ACTIVITY","GO_MF","496731_GO_0016835_CARBON_OXYGEN_LYASE_ACTIVITY",66,-0.813,0.81,0.87,1.5212,0.011,0.37,-1.2322,0.12,0.58
"GO_BP:495009_GO_0010944_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_COMPETITIVE_PROMOTER_BINDING","GO_BP","495009_GO_0010944_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_COMPETITIVE_PROMOTER_BINDING",10,-0.8127,0.7,0.87,-1.2903,0.15,0.88,0.6666,0.89,1
"C1_Positional:C1_ALL_278_CHR1Q41","C1_Positional","C1_ALL_278_CHR1Q41",35,-0.8127,0.76,1,0.8744,0.67,0.89,-0.7606,0.85,1
"GO_BP:513769_GO_0060213_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING","GO_BP","513769_GO_0060213_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING",11,-0.8126,0.7,0.87,-0.7823,0.77,1,-1.228,0.2,0.7
"GO_BP:491370_GO_0006465_SIGNAL_PEPTIDE_PROCESSING","GO_BP","491370_GO_0006465_SIGNAL_PEPTIDE_PROCESSING",8,-0.8125,0.69,0.87,1.413,0.092,0.54,1.1613,0.29,0.73
"C1_Positional:C1_ALL_184_CHR20P13","C1_Positional","C1_ALL_184_CHR20P13",70,-0.8121,0.81,1,-0.7139,0.95,0.98,-0.8765,0.73,0.98
"KEGG_compound:C00012_PEPTIDE","KEGG_compound","C00012_PEPTIDE",7,-0.8119,0.71,0.82,1.0301,0.42,1,-0.9152,0.56,0.75
"GO_BP:505047_GO_0035878_NAIL_DEVELOPMENT","GO_BP","505047_GO_0035878_NAIL_DEVELOPMENT",8,-0.8117,0.72,0.87,0.6836,0.88,1,0.9548,0.53,0.9
"C7_Immunologic_signatures:C7_ALL_1598_GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1598_GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN",197,-0.8116,0.86,0.92,1.6811,0,0.00084,-1.2781,0.04,0.16
"GO_BP:501472_GO_0032237_ACTIVATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY","GO_BP","501472_GO_0032237_ACTIVATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY",5,-0.8116,0.7,0.87,0.7246,0.78,1,0.4988,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2946_MOOTHA_PYR","C2_Chemical_and_genetic_perturbations","C2_CGP_2946_MOOTHA_PYR",8,-0.8115,0.71,0.85,1.412,0.092,0.29,-1.1968,0.24,0.52
"C4_Cancer_gene_neighborhoods:C4_CGN_253_GCM_PRKAG1","C4_Cancer_gene_neighborhoods","C4_CGN_253_GCM_PRKAG1",48,-0.8114,0.78,1,0.8528,0.75,0.92,0.8402,0.75,1
"REACTOME:1127538_REACT_268323_HEDGEHOG_OFF_STATE","REACTOME","1127538_REACT_268323_HEDGEHOG_OFF_STATE",100,-0.8114,0.83,0.87,1.7006,0,0.048,-0.9454,0.6,0.91
"GO_BP:515178_GO_0070243_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS","GO_BP","515178_GO_0070243_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS",14,-0.8113,0.73,0.87,0.7523,0.81,1,1.2365,0.21,0.7
"C3_TF_targets:C3_TFT_425_GGAMTNNNNNTCCY_UNKNOWN","C3_TF_targets","C3_TFT_425_GGAMTNNNNNTCCY_UNKNOWN",115,-0.8113,0.84,0.93,-0.832,0.84,1,-1.2077,0.095,0.34
"GO_BP:514854_GO_0061309_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS","GO_BP","514854_GO_0061309_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS",6,-0.8112,0.7,0.87,0.593,0.94,1,0.8251,0.69,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1483_ZHAN_MULTIPLE_MYELOMA_SPIKED","C2_Chemical_and_genetic_perturbations","C2_CGP_1483_ZHAN_MULTIPLE_MYELOMA_SPIKED",22,-0.8112,0.75,0.85,1.1129,0.32,0.61,0.9064,0.6,1
"GO_BP:487846_GO_0001956_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION","GO_BP","487846_GO_0001956_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION",11,-0.811,0.73,0.87,0.8538,0.66,1,1.112,0.33,0.75
"GO_BP:508031_GO_0045686_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION","GO_BP","508031_GO_0045686_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION",23,-0.8109,0.71,0.87,-1.1032,0.33,0.94,1.1496,0.25,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1817_GENTILE_UV_RESPONSE_CLUSTER_D6","C2_Chemical_and_genetic_perturbations","C2_CGP_1817_GENTILE_UV_RESPONSE_CLUSTER_D6",37,-0.8108,0.79,0.85,1.081,0.33,0.66,0.9261,0.58,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1698_MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8","C2_Chemical_and_genetic_perturbations","C2_CGP_1698_MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8",15,-0.8108,0.73,0.85,0.5095,0.99,1,-0.7314,0.85,0.98
"GO_BP:502494_GO_0033275_ACTIN_MYOSIN_FILAMENT_SLIDING","GO_BP","502494_GO_0033275_ACTIN_MYOSIN_FILAMENT_SLIDING",37,-0.8107,0.76,0.87,1.0755,0.31,0.93,0.9543,0.54,0.9
"KEGG_pathway:HSA00400_PHENYLALANINE_TYROSINE_AND_TRYPTOPHAN_BIOSYNTHESIS","KEGG_pathway","HSA00400_PHENYLALANINE_TYROSINE_AND_TRYPTOPHAN_BIOSYNTHESIS",5,-0.8107,0.73,0.83,0.6696,0.85,1,0.7075,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2282_BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2282_BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP",31,-0.8107,0.76,0.85,1.0214,0.42,0.77,0.7175,0.89,1
"C7_Immunologic_signatures:C7_ALL_1351_GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1351_GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP",199,-0.8106,0.87,0.92,1.2526,0.032,0.15,-1.1715,0.11,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_3019_WHITFIELD_CELL_CYCLE_G1_S","C2_Chemical_and_genetic_perturbations","C2_CGP_3019_WHITFIELD_CELL_CYCLE_G1_S",143,-0.8106,0.84,0.85,0.685,1,1,-0.8454,0.86,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_2711_BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2711_BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP",65,-0.8105,0.8,0.85,1.0706,0.32,0.68,-0.8512,0.78,0.92
"GO_BP:515162_GO_0070227_LYMPHOCYTE_APOPTOTIC_PROCESS","GO_BP","515162_GO_0070227_LYMPHOCYTE_APOPTOTIC_PROCESS",19,-0.8104,0.73,0.87,1.4309,0.08,0.52,1.1079,0.33,0.76
"C7_Immunologic_signatures:C7_ALL_390_GSE15767_MED_VS_SCS_MAC_LN_DN","C7_Immunologic_signatures","C7_ALL_390_GSE15767_MED_VS_SCS_MAC_LN_DN",199,-0.8104,0.87,0.92,1.1358,0.16,0.35,-0.911,0.7,0.93
"GO_BP:507432_GO_0045026_PLASMA_MEMBRANE_FUSION","GO_BP","507432_GO_0045026_PLASMA_MEMBRANE_FUSION",12,-0.8103,0.71,0.87,0.864,0.63,1,-1.2468,0.19,0.68
"REACTOME:1183572_REACT_355212_FRS_MEDIATED_FGFR3_SIGNALING","REACTOME","1183572_REACT_355212_FRS_MEDIATED_FGFR3_SIGNALING",31,-0.81,0.76,0.87,-0.6581,0.95,1,-0.9713,0.51,0.88
"GO_MF:489517_GO_0017110_NUCLEOSIDE_DIPHOSPHATASE_ACTIVITY","GO_MF","489517_GO_0017110_NUCLEOSIDE_DIPHOSPHATASE_ACTIVITY",12,-0.8099,0.72,0.88,0.5949,0.93,1,-1.0062,0.45,0.79
"GO_BP:492456_GO_0008089_ANTEROGRADE_AXON_CARGO_TRANSPORT","GO_BP","492456_GO_0008089_ANTEROGRADE_AXON_CARGO_TRANSPORT",24,-0.8099,0.74,0.87,1.236,0.16,0.75,0.8428,0.7,0.99
"WikiPathways:198903_WP383_STRIATED_MUSCLE_CONTRACTION","WikiPathways","198903_WP383_STRIATED_MUSCLE_CONTRACTION",37,-0.8098,0.76,0.84,1.1788,0.21,0.93,-0.7626,0.86,0.95
"GO_BP:499500_GO_0030049_MUSCLE_FILAMENT_SLIDING","GO_BP","499500_GO_0030049_MUSCLE_FILAMENT_SLIDING",37,-0.8097,0.76,0.87,1.0466,0.36,0.95,0.9526,0.56,0.9
"C7_Immunologic_signatures:C7_ALL_1696_GSE3982_BASOPHIL_VS_TH2_DN","C7_Immunologic_signatures","C7_ALL_1696_GSE3982_BASOPHIL_VS_TH2_DN",195,-0.8096,0.88,0.93,1.2573,0.043,0.15,-1.3357,0.025,0.11
"GO_BP:500208_GO_0030913_PARANODAL_JUNCTION_ASSEMBLY","GO_BP","500208_GO_0030913_PARANODAL_JUNCTION_ASSEMBLY",7,-0.8096,0.7,0.87,-0.5132,0.98,1,1.1794,0.3,0.72
"GO_BP:516204_GO_0071280_CELLULAR_RESPONSE_TO_COPPER_ION","GO_BP","516204_GO_0071280_CELLULAR_RESPONSE_TO_COPPER_ION",6,-0.8096,0.71,0.87,0.8175,0.69,1,-0.5199,0.98,1
"GO_BP:489140_GO_0003348_CARDIAC_ENDOTHELIAL_CELL_DIFFERENTIATION","GO_BP","489140_GO_0003348_CARDIAC_ENDOTHELIAL_CELL_DIFFERENTIATION",6,-0.8096,0.72,0.87,-0.8833,0.59,1,1.5012,0.057,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_1084_COURTOIS_SENESCENCE_TRIGGERS","C2_Chemical_and_genetic_perturbations","C2_CGP_1084_COURTOIS_SENESCENCE_TRIGGERS",6,-0.8095,0.73,0.85,-0.7198,0.81,1,-0.8427,0.65,0.93
"GO_MF:492788_GO_0008508_BILE_ACID_SODIUM_SYMPORTER_ACTIVITY","GO_MF","492788_GO_0008508_BILE_ACID_SODIUM_SYMPORTER_ACTIVITY",6,-0.8095,0.7,0.88,-1.6575,0.0083,0.4,1.177,0.26,0.74
"C7_Immunologic_signatures:C7_ALL_1051_GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP","C7_Immunologic_signatures","C7_ALL_1051_GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP",199,-0.8093,0.88,0.93,-0.6773,1,1,-0.9014,0.77,0.94
"C7_Immunologic_signatures:C7_ALL_1215_GSE27786_NKCELL_VS_ERYTHROBLAST_UP","C7_Immunologic_signatures","C7_ALL_1215_GSE27786_NKCELL_VS_ERYTHROBLAST_UP",200,-0.8091,0.89,0.93,1.0769,0.26,0.51,-0.8245,0.93,1
"GO_CC:490907_GO_0030119_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX","GO_CC","490907_GO_0030119_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX",40,-0.8091,0.75,0.94,0.982,0.46,0.81,-0.5923,0.99,1
"C7_Immunologic_signatures:C7_ALL_293_GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_293_GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP",195,-0.8088,0.88,0.93,1.0632,0.3,0.55,-1.0645,0.29,0.58
"GO_BP:516321_GO_0071397_CELLULAR_RESPONSE_TO_CHOLESTEROL","GO_BP","516321_GO_0071397_CELLULAR_RESPONSE_TO_CHOLESTEROL",13,-0.8088,0.74,0.88,-0.5659,0.97,1,-0.8691,0.63,0.95
"GO_BP:501460_GO_0032225_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC","GO_BP","501460_GO_0032225_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC",16,-0.8088,0.73,0.88,-0.984,0.49,1,0.8435,0.71,0.99
"KEGG_compound:C00369_STARCH","KEGG_compound","C00369_STARCH",10,-0.8085,0.71,0.82,-1.0214,0.42,1,-1.3911,0.1,0.3
"GO_BP:494892_GO_0010828_POSITIVE_REGULATION_OF_GLUCOSE_TRANSPORT","GO_BP","494892_GO_0010828_POSITIVE_REGULATION_OF_GLUCOSE_TRANSPORT",31,-0.8085,0.75,0.88,1.122,0.26,0.88,0.9033,0.59,0.94
"C7_Immunologic_signatures:C7_ALL_831_GSE18148_CBFB_KO_VS_WT_TREG_UP","C7_Immunologic_signatures","C7_ALL_831_GSE18148_CBFB_KO_VS_WT_TREG_UP",179,-0.8085,0.88,0.93,0.9316,0.64,0.95,1.3883,0.0078,0.15
"GO_BP:505858_GO_0042752_REGULATION_OF_CIRCADIAN_RHYTHM","GO_BP","505858_GO_0042752_REGULATION_OF_CIRCADIAN_RHYTHM",89,-0.8085,0.82,0.88,-0.9776,0.49,1,-0.9171,0.65,0.91
"GO_BP:516264_GO_0071340_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING","GO_BP","516264_GO_0071340_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING",7,-0.8085,0.69,0.88,-0.9567,0.52,1,0.9588,0.5,0.9
"KEGG_reaction:R10092_CARBONATE_HYDRO_LYASE_CARBON_DIOXIDE_FORMING_HCO3_H_CO2_H2O","KEGG_reaction","R10092_CARBONATE_HYDRO_LYASE_CARBON_DIOXIDE_FORMING_HCO3_H_CO2_H2O",13,-0.8083,0.72,0.77,0.7981,0.76,1,-1.4458,0.082,0.33
"GO_BP:491957_GO_0007144_FEMALE_MEIOSIS_I","GO_BP","491957_GO_0007144_FEMALE_MEIOSIS_I",6,-0.8081,0.72,0.88,-0.9661,0.49,1,-0.9856,0.47,0.86
"GO_BP:516285_GO_0071361_CELLULAR_RESPONSE_TO_ETHANOL","GO_BP","516285_GO_0071361_CELLULAR_RESPONSE_TO_ETHANOL",8,-0.8078,0.72,0.88,1.0177,0.46,0.97,0.8643,0.65,0.97
"GO_BP:504448_GO_0035264_MULTICELLULAR_ORGANISM_GROWTH","GO_BP","504448_GO_0035264_MULTICELLULAR_ORGANISM_GROWTH",76,-0.8077,0.83,0.88,-0.9054,0.65,1,-1.2633,0.1,0.67
"GO_CC:506262_GO_0043194_AXON_INITIAL_SEGMENT","GO_CC","506262_GO_0043194_AXON_INITIAL_SEGMENT",10,-0.8076,0.7,0.94,-1.4517,0.091,0.62,1.1406,0.3,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_840_OXFORD_RALB_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_840_OXFORD_RALB_TARGETS_DN",9,-0.8076,0.71,0.86,0.9933,0.45,0.81,-1.4968,0.048,0.3
"GO_MF:987827_GO_0061631_UBIQUITIN_CONJUGATING_ENZYME_ACTIVITY","GO_MF","987827_GO_0061631_UBIQUITIN_CONJUGATING_ENZYME_ACTIVITY",19,-0.8073,0.74,0.88,0.7836,0.78,1,-1.0556,0.37,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_1283_CHESLER_BRAIN_QTL_CIS","C2_Chemical_and_genetic_perturbations","C2_CGP_1283_CHESLER_BRAIN_QTL_CIS",74,-0.8072,0.81,0.86,1.2549,0.11,0.43,-1.126,0.21,0.6
"C1_Positional:C1_ALL_165_CHR10Q22","C1_Positional","C1_ALL_165_CHR10Q22",98,-0.8071,0.83,1,0.7921,0.89,0.95,0.9608,0.52,0.79
"C6_Oncogenic_signatures:C6_ALL_145_YAP1_DN","C6_Oncogenic_signatures","C6_ALL_145_YAP1_DN",42,-0.807,0.76,0.88,-1.0264,0.39,0.62,-1.196,0.17,0.38
"GO_BP:508890_GO_0046642_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION","GO_BP","508890_GO_0046642_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION",6,-0.8068,0.7,0.88,1.2514,0.21,0.73,0.9612,0.5,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1052_GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1052_GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN",171,-0.8068,0.89,0.86,1.5691,0,0.16,-1.0295,0.36,0.71
"C3_TF_targets:C3_TFT_381_GCGNNANTTCC_UNKNOWN","C3_TF_targets","C3_TFT_381_GCGNNANTTCC_UNKNOWN",123,-0.8068,0.83,0.94,1.0462,0.35,1,-0.749,0.96,1
"GO_BP:501756_GO_0032526_RESPONSE_TO_RETINOIC_ACID","GO_BP","501756_GO_0032526_RESPONSE_TO_RETINOIC_ACID",108,-0.8067,0.84,0.88,1.1971,0.12,0.78,1.4562,0.014,0.58
"C1_Positional:C1_ALL_45_CHR22Q","C1_Positional","C1_ALL_45_CHR22Q",6,-0.8067,0.73,1,0.6969,0.84,1,1.1231,0.31,0.74
"C3_TF_targets:C3_TFT_165_V_MEF2_04","C3_TF_targets","C3_TFT_165_V_MEF2_04",24,-0.8064,0.76,0.94,0.5516,0.99,1,-0.7852,0.8,1
"GO_BP:506620_GO_0043589_SKIN_MORPHOGENESIS","GO_BP","506620_GO_0043589_SKIN_MORPHOGENESIS",9,-0.8063,0.75,0.88,-0.9555,0.53,1,0.9365,0.57,0.91
"GO_BP:518319_GO_0090179_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_NEURAL_TUBE_CLOSURE","GO_BP","518319_GO_0090179_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_NEURAL_TUBE_CLOSURE",13,-0.806,0.72,0.88,1.1647,0.26,0.82,-0.8942,0.6,0.93
"REACTOME:1127581_REACT_264090_GLYCOGEN_STORAGE_DISEASES","REACTOME","1127581_REACT_264090_GLYCOGEN_STORAGE_DISEASES",10,-0.8059,0.72,0.87,1.3011,0.15,0.32,-1.2108,0.24,0.59
"C3_MicroRNA_targets:C3_MIR_208_ATCTTGC_MIR_31","C3_MicroRNA_targets","C3_MIR_208_ATCTTGC_MIR_31",77,-0.8058,0.82,0.92,0.7732,0.91,1,0.7897,0.9,1
"GO_BP:496435_GO_0016458_GENE_SILENCING","GO_BP","496435_GO_0016458_GENE_SILENCING",121,-0.8058,0.84,0.88,-1.2818,0.061,0.89,-1.0806,0.27,0.79
"GO_BP:510991_GO_0050000_CHROMOSOME_LOCALIZATION","GO_BP","510991_GO_0050000_CHROMOSOME_LOCALIZATION",51,-0.8057,0.79,0.88,1.4628,0.024,0.48,-0.7707,0.88,1
"C1_Positional:C1_ALL_288_CHR2P12","C1_Positional","C1_ALL_288_CHR2P12",24,-0.8057,0.77,1,1.3712,0.1,0.44,-1.0258,0.41,0.87
"GO_BP:488340_GO_0002467_GERMINAL_CENTER_FORMATION","GO_BP","488340_GO_0002467_GERMINAL_CENTER_FORMATION",8,-0.8056,0.71,0.88,-1.1761,0.26,0.9,-0.726,0.81,0.99
"GO_MF:495531_GO_0015280_LIGAND_GATED_SODIUM_CHANNEL_ACTIVITY","GO_MF","495531_GO_0015280_LIGAND_GATED_SODIUM_CHANNEL_ACTIVITY",8,-0.8056,0.71,0.88,-1.2008,0.26,0.81,-0.463,0.98,1
"GO_BP:486613_GO_0000070_MITOTIC_SISTER_CHROMATID_SEGREGATION","GO_BP","486613_GO_0000070_MITOTIC_SISTER_CHROMATID_SEGREGATION",77,-0.8055,0.81,0.88,1.0269,0.39,0.97,-0.9862,0.5,0.86
"C7_Immunologic_signatures:C7_ALL_1016_GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1016_GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN",200,-0.8054,0.89,0.93,1.8154,0,3.1e-05,-1.2169,0.079,0.25
"GO_BP:513997_GO_0060442_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS","GO_BP","513997_GO_0060442_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS",11,-0.8052,0.72,0.88,1.0926,0.35,0.91,1.5515,0.04,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_1847_BURTON_ADIPOGENESIS_4","C2_Chemical_and_genetic_perturbations","C2_CGP_1847_BURTON_ADIPOGENESIS_4",46,-0.805,0.77,0.86,1.1876,0.18,0.51,-0.7624,0.87,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1080_SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1080_SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP",20,-0.8048,0.75,0.86,0.8868,0.61,0.94,1.0799,0.36,0.87
"C4_Cancer_gene_neighborhoods:C4_CGN_201_GCM_HDAC1","C4_Cancer_gene_neighborhoods","C4_CGN_201_GCM_HDAC1",38,-0.8048,0.78,1,1.4456,0.037,0.045,-0.9873,0.44,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1359_ZUCCHI_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1359_ZUCCHI_METASTASIS_UP",42,-0.8047,0.79,0.86,1.3621,0.076,0.33,-0.9686,0.5,0.8
"GO_BP:514300_GO_0060745_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_PREGNANCY","GO_BP","514300_GO_0060745_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_PREGNANCY",5,-0.8047,0.71,0.88,-0.8623,0.63,1,-0.9144,0.56,0.92
"C1_Positional:C1_ALL_221_CHR5Q11","C1_Positional","C1_ALL_221_CHR5Q11",39,-0.8047,0.79,1,0.8658,0.7,0.89,-0.9213,0.57,0.97
"GO_BP:518403_GO_0090263_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY","GO_BP","518403_GO_0090263_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY",127,-0.8047,0.87,0.88,1.2501,0.072,0.73,0.6654,1,1
"GO_CC:499551_GO_0030118_CLATHRIN_COAT","GO_CC","499551_GO_0030118_CLATHRIN_COAT",45,-0.8047,0.76,0.95,1.0869,0.3,0.67,-0.7775,0.85,1
"GO_BP:495228_GO_0014832_URINARY_BLADDER_SMOOTH_MUSCLE_CONTRACTION","GO_BP","495228_GO_0014832_URINARY_BLADDER_SMOOTH_MUSCLE_CONTRACTION",7,-0.8045,0.74,0.88,0.7197,0.82,1,1.1086,0.31,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2269_SMID_BREAST_CANCER_LUMINAL_A_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2269_SMID_BREAST_CANCER_LUMINAL_A_DN",18,-0.8045,0.74,0.86,1.078,0.34,0.66,-1.2044,0.19,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_3265_LOPEZ_TRANSLATION_VIA_FN1_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_3265_LOPEZ_TRANSLATION_VIA_FN1_SIGNALING",35,-0.8045,0.77,0.86,1.3415,0.099,0.35,-1.3806,0.062,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_2336_MATZUK_SPERMATID_DIFFERENTIATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2336_MATZUK_SPERMATID_DIFFERENTIATION",36,-0.8044,0.76,0.86,1.152,0.22,0.55,-0.7286,0.91,0.98
"REACTOME:576250_REACT_118638_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR_","REACTOME","576250_REACT_118638_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR_",161,-0.8044,0.88,0.88,1.2028,0.083,0.44,-0.8781,0.79,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_682_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23","C2_Chemical_and_genetic_perturbations","C2_CGP_682_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23",19,-0.8039,0.73,0.86,-0.9315,0.55,1,-1.161,0.24,0.56
"GO_BP:514853_GO_0061308_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","514853_GO_0061308_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_HEART_DEVELOPMENT",6,-0.8038,0.73,0.88,0.5873,0.95,1,0.8308,0.68,0.99
"GO_CC:502398_GO_0033178_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_CATALYTIC_DOMAIN","GO_CC","502398_GO_0033178_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_CATALYTIC_DOMAIN",17,-0.8038,0.74,0.95,1.859,0.004,0.016,0.8244,0.71,1
"REACTOME:105781_REACT_1321_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION","REACTOME","105781_REACT_1321_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION",10,-0.8037,0.72,0.88,0.7771,0.76,1,-0.9293,0.53,0.93
"GO_BP:519411_GO_2000772_REGULATION_OF_CELLULAR_SENESCENCE","GO_BP","519411_GO_2000772_REGULATION_OF_CELLULAR_SENESCENCE",23,-0.8033,0.76,0.88,-0.8922,0.64,1,0.5746,0.99,1
"GO_CC:507611_GO_0045239_TRICARBOXYLIC_ACID_CYCLE_ENZYME_COMPLEX","GO_CC","507611_GO_0045239_TRICARBOXYLIC_ACID_CYCLE_ENZYME_COMPLEX",11,-0.803,0.75,0.95,0.8749,0.61,0.92,-1.6207,0.021,0.37
"REACTOME:105765_REACT_152_CELL_CYCLE_MITOTIC","REACTOME","105765_REACT_152_CELL_CYCLE_MITOTIC",475,-0.8027,0.95,0.88,1.215,0.042,0.43,-1.4702,0,0.38
"C4_Cancer_gene_neighborhoods:C4_CGN_283_GNF2_BNIP2","C4_Cancer_gene_neighborhoods","C4_CGN_283_GNF2_BNIP2",34,-0.8027,0.78,1,1.7175,0.0022,0.0054,0.5417,1,1
"GO_BP:491982_GO_0007182_COMMON_PARTNER_SMAD_PROTEIN_PHOSPHORYLATION","GO_BP","491982_GO_0007182_COMMON_PARTNER_SMAD_PROTEIN_PHOSPHORYLATION",6,-0.8026,0.73,0.88,-0.9029,0.58,1,0.8062,0.71,1
"GO_BP:514004_GO_0060449_BUD_ELONGATION_INVOLVED_IN_LUNG_BRANCHING","GO_BP","514004_GO_0060449_BUD_ELONGATION_INVOLVED_IN_LUNG_BRANCHING",5,-0.8025,0.7,0.88,-1.0712,0.41,0.96,1.153,0.32,0.73
"GO_BP:508290_GO_0045990_CARBON_CATABOLITE_REGULATION_OF_TRANSCRIPTION","GO_BP","508290_GO_0045990_CARBON_CATABOLITE_REGULATION_OF_TRANSCRIPTION",7,-0.8025,0.72,0.88,-0.6061,0.93,1,1.0355,0.41,0.82
"C4_Cancer_modules:C4_CM_32_MODULE_36","C4_Cancer_modules","C4_CM_32_MODULE_36",160,-0.8024,0.88,0.87,1.2797,0.053,0.3,0.7242,0.99,1
"GO_MF:505926_GO_0042826_HISTONE_DEACETYLASE_BINDING","GO_MF","505926_GO_0042826_HISTONE_DEACETYLASE_BINDING",79,-0.8023,0.82,0.88,0.6296,1,1,0.9254,0.6,0.94
"C7_Immunologic_signatures:C7_ALL_1656_GSE3982_MAC_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1656_GSE3982_MAC_VS_NKCELL_DN",191,-0.8023,0.9,0.93,0.9134,0.71,0.99,-1.3281,0.019,0.11
"GO_BP:491281_GO_0006337_NUCLEOSOME_DISASSEMBLY","GO_BP","491281_GO_0006337_NUCLEOSOME_DISASSEMBLY",17,-0.8022,0.72,0.88,0.843,0.69,1,-1.0422,0.41,0.82
"GO_BP:494041_GO_0009952_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION","GO_BP","494041_GO_0009952_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION",195,-0.8021,0.9,0.88,1.0507,0.33,0.95,1.2395,0.087,0.71
"C1_Positional:C1_ALL_97_CHR7Q31","C1_Positional","C1_ALL_97_CHR7Q31",85,-0.8018,0.82,1,-1.0556,0.37,1,1.0992,0.25,0.73
"GO_MF:489273_GO_0003730_MRNA_3_UTR_BINDING","GO_MF","489273_GO_0003730_MRNA_3_UTR_BINDING",36,-0.8017,0.78,0.88,-0.8516,0.73,1,-1.196,0.19,0.59
"GO_BP:494891_GO_0010827_REGULATION_OF_GLUCOSE_TRANSPORT","GO_BP","494891_GO_0010827_REGULATION_OF_GLUCOSE_TRANSPORT",86,-0.8016,0.86,0.88,0.9394,0.59,1,-0.8558,0.8,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1877_RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1877_RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP",15,-0.8016,0.75,0.86,0.9836,0.47,0.81,1.0551,0.39,0.91
"C1_Positional:C1_ALL_34_CHR3Q28","C1_Positional","C1_ALL_34_CHR3Q28",21,-0.8015,0.76,0.99,1.1705,0.25,0.61,1.188,0.21,0.65
"GO_BP:505034_GO_0035865_CELLULAR_RESPONSE_TO_POTASSIUM_ION","GO_BP","505034_GO_0035865_CELLULAR_RESPONSE_TO_POTASSIUM_ION",7,-0.8013,0.73,0.88,-0.698,0.85,1,-0.7693,0.75,1
"KEGG_compound:C00117_D_RIBOSE_5_PHOSPHATE_RIBOSE_5_PHOSPHATE","KEGG_compound","C00117_D_RIBOSE_5_PHOSPHATE_RIBOSE_5_PHOSPHATE",13,-0.8013,0.72,0.83,1.4479,0.071,0.4,0.8952,0.58,0.82
"GO_BP:512116_GO_0051220_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN","GO_BP","512116_GO_0051220_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN",32,-0.8012,0.77,0.88,0.844,0.72,1,-0.5,1,1
"C7_Immunologic_signatures:C7_ALL_315_GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP","C7_Immunologic_signatures","C7_ALL_315_GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP",190,-0.8011,0.9,0.94,-0.5886,1,1,-1.1746,0.12,0.33
"REACTOME:161038_REACT_20510_RSK_ACTIVATION","REACTOME","161038_REACT_20510_RSK_ACTIVATION",6,-0.8009,0.72,0.88,-0.7019,0.84,1,-1.4195,0.098,0.4
"C3_MicroRNA_targets:C3_MIR_141_CTGTTAC_MIR_194","C3_MicroRNA_targets","C3_MIR_141_CTGTTAC_MIR_194",106,-0.8008,0.83,0.92,0.7423,0.97,1,0.7095,0.99,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_26_BIOCARTA_RANKL_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_26_BIOCARTA_RANKL_PATHWAY",14,-0.8008,0.73,0.79,0.8677,0.63,0.91,0.6354,0.92,1
"GO_BP:494660_GO_0010596_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION","GO_BP","494660_GO_0010596_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION",33,-0.8005,0.77,0.88,-0.7213,0.89,1,0.9162,0.61,0.93
"C1_Positional:C1_ALL_61_CHR1P35","C1_Positional","C1_ALL_61_CHR1P35",98,-0.8005,0.84,0.99,-1.1339,0.2,1,-0.8668,0.76,0.97
"GO_MF:490454_GO_0005212_STRUCTURAL_CONSTITUENT_OF_EYE_LENS","GO_MF","490454_GO_0005212_STRUCTURAL_CONSTITUENT_OF_EYE_LENS",19,-0.7995,0.76,0.89,1.1286,0.29,0.75,-1.9152,0.002,0.2
"C1_Positional:C1_ALL_229_CHRXP11","C1_Positional","C1_ALL_229_CHRXP11",140,-0.7995,0.88,0.98,-1.1779,0.15,1,-1.1593,0.14,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2622_MIKKELSEN_DEDIFFERENTIATED_STATE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2622_MIKKELSEN_DEDIFFERENTIATED_STATE_UP",8,-0.7995,0.72,0.87,-1.1751,0.26,0.83,1.1776,0.25,0.79
"GO_BP:504700_GO_0035519_PROTEIN_K29_LINKED_UBIQUITINATION","GO_BP","504700_GO_0035519_PROTEIN_K29_LINKED_UBIQUITINATION",5,-0.7993,0.72,0.89,0.6263,0.91,1,-1.2653,0.22,0.67
"GO_BP:518177_GO_0090030_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS","GO_BP","518177_GO_0090030_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS",13,-0.7992,0.73,0.89,1.0305,0.41,0.97,1.0755,0.36,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2114_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS","C2_Chemical_and_genetic_perturbations","C2_CGP_2114_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS",40,-0.7992,0.76,0.87,0.8872,0.66,0.94,0.7766,0.84,1
"GO_BP:499630_GO_0030220_PLATELET_FORMATION","GO_BP","499630_GO_0030220_PLATELET_FORMATION",16,-0.7992,0.76,0.89,1.0641,0.35,0.94,0.6848,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1051_GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1051_GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP",57,-0.7989,0.82,0.87,-1.2839,0.09,0.7,-1.0601,0.35,0.68
"GO_BP:499318_GO_0022400_REGULATION_OF_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY","GO_BP","499318_GO_0022400_REGULATION_OF_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY",31,-0.7989,0.78,0.89,-1.0896,0.32,0.95,-1.0414,0.37,0.82
"GO_BP:946558_GO_0098901_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL","GO_BP","946558_GO_0098901_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",17,-0.7986,0.76,0.89,0.6831,0.89,1,1.4004,0.082,0.63
"GO_BP:492773_GO_0046058_CAMP_METABOLIC_PROCESS","GO_BP","492773_GO_0046058_CAMP_METABOLIC_PROCESS",34,-0.7984,0.78,0.89,-1.1008,0.34,0.94,-1.5386,0.03,0.54
"GO_CC:518588_GO_0097038_PERINUCLEAR_ENDOPLASMIC_RETICULUM","GO_CC","518588_GO_0097038_PERINUCLEAR_ENDOPLASMIC_RETICULUM",11,-0.798,0.73,0.95,-0.6087,0.95,1,1.0265,0.43,0.99
"GO_BP:487906_GO_0002016_REGULATION_OF_BLOOD_VOLUME_BY_RENIN_ANGIOTENSIN","GO_BP","487906_GO_0002016_REGULATION_OF_BLOOD_VOLUME_BY_RENIN_ANGIOTENSIN",10,-0.7979,0.73,0.89,1.281,0.18,0.7,0.5855,0.95,1
"GO_BP:500749_GO_0031498_CHROMATIN_DISASSEMBLY","GO_BP","500749_GO_0031498_CHROMATIN_DISASSEMBLY",17,-0.7976,0.73,0.89,0.8376,0.72,1,-1.0439,0.39,0.81
"C7_Immunologic_signatures:C7_ALL_955_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP","C7_Immunologic_signatures","C7_ALL_955_GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP",198,-0.7976,0.9,0.94,1.335,0.018,0.073,-0.9024,0.76,0.95
"GO_MF:750757_GO_0001205_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION","GO_MF","750757_GO_0001205_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_POSITIVE_REGULATION_OF_TRANSCRIPTION",23,-0.7976,0.75,0.89,-0.5794,0.97,1,-0.5579,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1007_LIU_LIVER_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_1007_LIU_LIVER_CANCER",37,-0.7976,0.78,0.87,1.0965,0.3,0.64,0.7596,0.84,1
"GO_BP:502208_GO_0032986_PROTEIN_DNA_COMPLEX_DISASSEMBLY","GO_BP","502208_GO_0032986_PROTEIN_DNA_COMPLEX_DISASSEMBLY",17,-0.7974,0.75,0.89,0.8389,0.69,1,-1.0446,0.39,0.81
"GO_BP:513792_GO_0060236_REGULATION_OF_MITOTIC_SPINDLE_ORGANIZATION","GO_BP","513792_GO_0060236_REGULATION_OF_MITOTIC_SPINDLE_ORGANIZATION",20,-0.7974,0.76,0.89,1.2618,0.16,0.72,-0.4716,1,1
"REACTOME:1127542_REACT_268718_HEDGEHOG_ON_STATE","REACTOME","1127542_REACT_268718_HEDGEHOG_ON_STATE",84,-0.7972,0.86,0.88,1.6748,0,0.058,-0.4738,1,1
"GO_BP:516961_GO_0072044_COLLECTING_DUCT_DEVELOPMENT","GO_BP","516961_GO_0072044_COLLECTING_DUCT_DEVELOPMENT",12,-0.7972,0.75,0.89,-1.2672,0.17,0.89,1.5942,0.026,0.44
"GO_BP:506015_GO_0042921_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY","GO_BP","506015_GO_0042921_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY",8,-0.7971,0.73,0.89,-0.6759,0.88,1,-0.6263,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1173_ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1173_ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN",103,-0.7969,0.84,0.87,0.7261,0.98,1,-0.9873,0.48,0.77
"GO_BP:515190_GO_0070255_REGULATION_OF_MUCUS_SECRETION","GO_BP","515190_GO_0070255_REGULATION_OF_MUCUS_SECRETION",11,-0.7969,0.73,0.89,1.4372,0.08,0.51,1.1506,0.3,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_3109_FUKUSHIMA_TNFSF11_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3109_FUKUSHIMA_TNFSF11_TARGETS",16,-0.7965,0.75,0.87,-0.9713,0.52,1,1.1274,0.29,0.84
"C7_Immunologic_signatures:C7_ALL_63_GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_63_GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP",197,-0.7964,0.92,0.94,0.8581,0.88,1,-1.33,0.024,0.11
"C7_Immunologic_signatures:C7_ALL_564_GSE17721_PAM3CSK4_VS_CPG_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_564_GSE17721_PAM3CSK4_VS_CPG_0_5H_BMDM_DN",196,-0.7964,0.9,0.94,1.6551,0,0.0012,-1.0459,0.33,0.62
"C3_MicroRNA_targets:C3_MIR_44_GCGCCTT_MIR_525_MIR_524","C3_MicroRNA_targets","C3_MIR_44_GCGCCTT_MIR_525_MIR_524",15,-0.7961,0.75,0.92,1.1275,0.3,1,0.9086,0.61,1
"GO_BP:515824_GO_0070897_DNA_TEMPLATED_TRANSCRIPTIONAL_PREINITIATION_COMPLEX_ASSEMBLY","GO_BP","515824_GO_0070897_DNA_TEMPLATED_TRANSCRIPTIONAL_PREINITIATION_COMPLEX_ASSEMBLY",7,-0.7961,0.73,0.89,1.0878,0.37,0.92,-0.4803,0.99,1
"GO_BP:510634_GO_0048569_POST_EMBRYONIC_ORGAN_DEVELOPMENT","GO_BP","510634_GO_0048569_POST_EMBRYONIC_ORGAN_DEVELOPMENT",12,-0.7961,0.75,0.89,-0.7229,0.83,1,-1.0163,0.41,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_24_KORKOLA_SEMINOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_24_KORKOLA_SEMINOMA_DN",11,-0.7959,0.73,0.87,-1.0783,0.38,0.95,-0.7731,0.75,0.97
"GO_CC:500778_GO_0031527_FILOPODIUM_MEMBRANE","GO_CC","500778_GO_0031527_FILOPODIUM_MEMBRANE",17,-0.7958,0.75,0.95,0.704,0.86,0.99,1.154,0.27,0.84
"GO_BP:494459_GO_0010389_REGULATION_OF_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","494459_GO_0010389_REGULATION_OF_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE",37,-0.7958,0.79,0.89,1.2248,0.16,0.76,-0.932,0.57,0.9
"GO_MF:496627_GO_0016706_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_2_OXOGLUTARATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_EACH_OF_OXYGEN_INTO_BOTH_DONORS","GO_MF","496627_GO_0016706_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_2_OXOGLUTARATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_EACH_OF_OXYGEN_INTO_BOTH_DONORS",48,-0.7956,0.79,0.89,-0.7436,0.9,1,-1.0911,0.29,0.7
"REACTOME:1127528_REACT_264199_PCP_CE_PATHWAY","REACTOME","1127528_REACT_264199_PCP_CE_PATHWAY",91,-0.7954,0.86,0.88,1.5531,0.0044,0.12,-0.7715,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2287_GALI_TP53_TARGETS_APOPTOTIC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2287_GALI_TP53_TARGETS_APOPTOTIC_DN",6,-0.7953,0.73,0.87,-0.5322,0.97,1,-0.751,0.79,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3294_MALIK_REPRESSED_BY_ESTROGEN","C2_Chemical_and_genetic_perturbations","C2_CGP_3294_MALIK_REPRESSED_BY_ESTROGEN",12,-0.795,0.75,0.87,-1.0007,0.45,1,1.3987,0.096,0.55
"GO_MF:496636_GO_0016715_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_ASCORBATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN","GO_MF","496636_GO_0016715_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_ASCORBATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN",5,-0.7949,0.73,0.89,-0.6955,0.86,1,-1.5325,0.037,0.39
"GO_BP:501238_GO_0032000_POSITIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION","GO_BP","501238_GO_0032000_POSITIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION",8,-0.7949,0.75,0.89,0.796,0.72,1,-0.9453,0.51,0.89
"GO_BP:492103_GO_0007339_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA","GO_BP","492103_GO_0007339_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA",31,-0.7946,0.8,0.89,0.9612,0.5,1,0.8071,0.77,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_208_BIOCARTA_CREB_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_208_BIOCARTA_CREB_PATHWAY",27,-0.7945,0.77,0.8,1.1976,0.21,0.7,-1.1664,0.27,0.58
"GO_BP:495049_GO_0010984_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE","GO_BP","495049_GO_0010984_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE",12,-0.7944,0.74,0.89,-1.3306,0.14,0.9,0.6538,0.92,1
"REACTOME:106239_REACT_1830_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR","REACTOME","106239_REACT_1830_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR",7,-0.7944,0.73,0.89,-0.7919,0.73,1,-0.6977,0.85,1
"GO_BP:754493_GO_1901533_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION","GO_BP","754493_GO_1901533_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION",22,-0.7943,0.76,0.89,-1.3906,0.077,1,-1.0497,0.39,0.81
"REACTOME:187201_REACT_23767_CGMP_EFFECTS","REACTOME","187201_REACT_23767_CGMP_EFFECTS",18,-0.7939,0.73,0.88,0.7731,0.78,1,0.9009,0.61,1
"GO_BP:513617_GO_0060059_EMBRYONIC_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE","GO_BP","513617_GO_0060059_EMBRYONIC_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE",8,-0.7936,0.74,0.89,0.9488,0.52,1,1.1515,0.29,0.73
"GO_CC:497910_GO_0019028_VIRAL_CAPSID","GO_CC","497910_GO_0019028_VIRAL_CAPSID",6,-0.7935,0.78,0.96,-0.9971,0.49,0.86,-0.9122,0.58,1
"GO_BP:504597_GO_0035413_POSITIVE_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS","GO_BP","504597_GO_0035413_POSITIVE_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS",11,-0.7934,0.74,0.89,0.9611,0.51,1,-1.1135,0.31,0.76
"GO_MF:493074_GO_0019104_DNA_N_GLYCOSYLASE_ACTIVITY","GO_MF","493074_GO_0019104_DNA_N_GLYCOSYLASE_ACTIVITY",13,-0.7934,0.74,0.89,1.5157,0.055,0.37,-1.0428,0.38,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_2848_HOSHIDA_LIVER_CANCER_SUBCLASS_S2","C2_Chemical_and_genetic_perturbations","C2_CGP_2848_HOSHIDA_LIVER_CANCER_SUBCLASS_S2",115,-0.7933,0.88,0.87,1.6011,0,0.14,-0.9856,0.49,0.78
"GO_BP:497013_GO_0018027_PEPTIDYL_LYSINE_DIMETHYLATION","GO_BP","497013_GO_0018027_PEPTIDYL_LYSINE_DIMETHYLATION",9,-0.7933,0.73,0.89,-0.7831,0.73,1,-0.9089,0.58,0.92
"GO_CC:496873_GO_0017053_TRANSCRIPTIONAL_REPRESSOR_COMPLEX","GO_CC","496873_GO_0017053_TRANSCRIPTIONAL_REPRESSOR_COMPLEX",71,-0.7932,0.83,0.95,1.0305,0.42,0.74,-0.8126,0.84,1
"GO_BP:1022150_GO_1903146_REGULATION_OF_MITOCHONDRION_DEGRADATION","GO_BP","1022150_GO_1903146_REGULATION_OF_MITOCHONDRION_DEGRADATION",140,-0.7926,0.89,0.89,1.1349,0.17,0.86,0.8984,0.7,0.95
"GO_BP:501285_GO_0032048_CARDIOLIPIN_METABOLIC_PROCESS","GO_BP","501285_GO_0032048_CARDIOLIPIN_METABOLIC_PROCESS",13,-0.7925,0.75,0.89,-0.9582,0.53,1,-1.0525,0.41,0.81
"REACTOME:1127587_REACT_268749_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE","REACTOME","1127587_REACT_268749_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE",18,-0.7922,0.76,0.89,1.4156,0.082,0.21,1.0845,0.34,0.96
"WikiPathways:698755_WP2289_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY","WikiPathways","698755_WP2289_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY",17,-0.7922,0.74,0.86,-1.0082,0.44,1,-1.2723,0.17,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_1500_ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1500_ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP",89,-0.7921,0.87,0.87,0.6883,0.98,1,-0.916,0.65,0.86
"GO_MF:506256_GO_0043184_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_BINDING","GO_MF","506256_GO_0043184_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_BINDING",6,-0.792,0.75,0.89,1.4043,0.081,0.49,1.1073,0.34,0.81
"GO_BP:514598_GO_0061050_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT","GO_BP","514598_GO_0061050_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT",6,-0.7919,0.73,0.89,0.6711,0.85,1,1.0128,0.44,0.84
"C1_Positional:C1_ALL_293_CHR16P13","C1_Positional","C1_ALL_293_CHR16P13",264,-0.7919,0.93,0.99,-1.0842,0.24,1,-1.3155,0.012,0.47
"GO_BP:754347_GO_1901385_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY","GO_BP","754347_GO_1901385_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY",19,-0.7918,0.75,0.89,-1.1085,0.31,0.94,-0.6205,0.96,1
"GO_BP:1144983_GO_1903845_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS","GO_BP","1144983_GO_1903845_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS",72,-0.7915,0.84,0.89,1.0194,0.4,0.97,-0.8351,0.82,0.97
"GO_CC:751046_GO_0036126_SPERM_FLAGELLUM","GO_CC","751046_GO_0036126_SPERM_FLAGELLUM",40,-0.7915,0.8,0.96,-1.3654,0.082,0.61,-0.787,0.84,1
"GO_BP:491532_GO_0006642_TRIGLYCERIDE_MOBILIZATION","GO_BP","491532_GO_0006642_TRIGLYCERIDE_MOBILIZATION",5,-0.7913,0.71,0.89,0.5026,0.99,1,1.1782,0.31,0.72
"REACTOME:105928_REACT_9509_GAP_JUNCTION_ASSEMBLY","REACTOME","105928_REACT_9509_GAP_JUNCTION_ASSEMBLY",18,-0.7913,0.77,0.89,-1.3198,0.13,0.62,1.4698,0.042,0.56
"C4_Cancer_gene_neighborhoods:C4_CGN_171_MORF_RAP1A","C4_Cancer_gene_neighborhoods","C4_CGN_171_MORF_RAP1A",137,-0.7912,0.9,1,0.7214,0.99,1,-1.2517,0.051,0.36
"C1_Positional:C1_ALL_21_CHR8Q22","C1_Positional","C1_ALL_21_CHR8Q22",72,-0.7912,0.86,0.99,1.564,0.0021,0.27,0.9847,0.48,0.79
"GO_BP:491393_GO_0006493_PROTEIN_O_LINKED_GLYCOSYLATION","GO_BP","491393_GO_0006493_PROTEIN_O_LINKED_GLYCOSYLATION",97,-0.7909,0.87,0.89,0.6553,1,1,0.9024,0.69,0.94
"GO_BP:513767_GO_0060211_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING","GO_BP","513767_GO_0060211_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING",11,-0.7906,0.74,0.89,-0.7943,0.73,1,-1.2099,0.24,0.73
"GO_MF:496581_GO_0016641_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR","GO_MF","496581_GO_0016641_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR",15,-0.7905,0.77,0.9,-1.3409,0.13,0.7,-0.6977,0.86,1
"C7_Immunologic_signatures:C7_ALL_1823_GSE7852_THYMUS_VS_FAT_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1823_GSE7852_THYMUS_VS_FAT_TCONV_UP",199,-0.7905,0.92,0.95,1.3031,0.019,0.099,0.9248,0.68,1
"REACTOME:161069_REACT_20603_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY","REACTOME","161069_REACT_20603_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY",10,-0.7904,0.75,0.89,-0.9104,0.57,1,-1.2972,0.17,0.55
"GO_BP:513949_GO_0060393_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION","GO_BP","513949_GO_0060393_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION",57,-0.7903,0.83,0.89,1.0947,0.29,0.91,1.4731,0.021,0.58
"GO_BP:494626_GO_0010561_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS","GO_BP","494626_GO_0010561_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS",10,-0.7903,0.75,0.89,-0.6585,0.88,1,-0.6634,0.89,1
"GO_BP:491854_GO_0007026_NEGATIVE_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION","GO_BP","491854_GO_0007026_NEGATIVE_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION",23,-0.7903,0.78,0.89,0.9518,0.52,1,-0.9201,0.56,0.91
"GO_MF:500948_GO_0031702_TYPE_1_ANGIOTENSIN_RECEPTOR_BINDING","GO_MF","500948_GO_0031702_TYPE_1_ANGIOTENSIN_RECEPTOR_BINDING",10,-0.7901,0.76,0.9,1.5057,0.06,0.38,1.0947,0.34,0.81
"GO_MF:506463_GO_0043425_BHLH_TRANSCRIPTION_FACTOR_BINDING","GO_MF","506463_GO_0043425_BHLH_TRANSCRIPTION_FACTOR_BINDING",27,-0.7901,0.81,0.9,-0.6818,0.91,1,-0.7665,0.85,0.98
"GO_BP:489130_GO_0003338_METANEPHROS_MORPHOGENESIS","GO_BP","489130_GO_0003338_METANEPHROS_MORPHOGENESIS",26,-0.79,0.77,0.89,0.8959,0.63,1,1.526,0.035,0.54
"GO_BP:499851_GO_0030512_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY","GO_BP","499851_GO_0030512_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY",72,-0.7899,0.84,0.89,0.9981,0.49,0.98,-0.8222,0.83,0.97
"C4_Cancer_gene_neighborhoods:C4_CGN_1_MORF_ATRX","C4_Cancer_gene_neighborhoods","C4_CGN_1_MORF_ATRX",210,-0.7897,0.93,1,-0.7557,0.98,1,-1.0927,0.23,0.64
"GO_BP:503895_GO_0034695_RESPONSE_TO_PROSTAGLANDIN_E","GO_BP","503895_GO_0034695_RESPONSE_TO_PROSTAGLANDIN_E",15,-0.7895,0.76,0.89,0.9987,0.45,0.98,1.4059,0.079,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1292_GOLDRATH_HOMEOSTATIC_PROLIFERATION","C2_Chemical_and_genetic_perturbations","C2_CGP_1292_GOLDRATH_HOMEOSTATIC_PROLIFERATION",170,-0.7891,0.89,0.88,2.0465,0,0.0038,0.6837,1,1
"C1_Positional:C1_ALL_234_CHR8P12","C1_Positional","C1_ALL_234_CHR8P12",36,-0.7891,0.77,0.99,-0.9467,0.55,1,1.3777,0.056,0.43
"REACTOME:1127588_REACT_268678_DEFECTIVE_B3GAT3_CAUSES_JDSSDHD","REACTOME","1127588_REACT_268678_DEFECTIVE_B3GAT3_CAUSES_JDSSDHD",18,-0.7887,0.74,0.89,1.403,0.087,0.22,1.0763,0.35,0.94
"GO_BP:508900_GO_0046654_TETRAHYDROFOLATE_BIOSYNTHETIC_PROCESS","GO_BP","508900_GO_0046654_TETRAHYDROFOLATE_BIOSYNTHETIC_PROCESS",5,-0.7887,0.75,0.9,-0.8499,0.66,1,-0.8664,0.63,0.95
"KEGG_compound:C00155_L_HOMOCYSTEINE_L_2_AMINO_4_MERCAPTOBUTYRIC_ACID_HOMOCYSTEINE","KEGG_compound","C00155_L_HOMOCYSTEINE_L_2_AMINO_4_MERCAPTOBUTYRIC_ACID_HOMOCYSTEINE",5,-0.7884,0.74,0.85,-1.2229,0.23,0.77,-1.4269,0.076,0.26
"GO_BP:499037_GO_0021756_STRIATUM_DEVELOPMENT","GO_BP","499037_GO_0021756_STRIATUM_DEVELOPMENT",15,-0.7883,0.75,0.9,-0.9789,0.49,1,-0.6945,0.88,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2602_SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5","C2_Chemical_and_genetic_perturbations","C2_CGP_2602_SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5",69,-0.788,0.84,0.88,-1.307,0.074,0.69,-1.1467,0.21,0.58
"REACTOME:833793_REACT_163722_THE_PHOTOTRANSDUCTION_CASCADE","REACTOME","833793_REACT_163722_THE_PHOTOTRANSDUCTION_CASCADE",31,-0.7879,0.79,0.89,-1.0386,0.39,0.96,-1.0931,0.3,0.71
"C4_Cancer_gene_neighborhoods:C4_CGN_281_CAR_WBSCR22","C4_Cancer_gene_neighborhoods","C4_CGN_281_CAR_WBSCR22",35,-0.7875,0.81,1,-1.1748,0.21,0.69,-0.8989,0.64,1
"KEGG_compound:C00035_GDP_GUANOSINE_5_DIPHOSPHATE_GUANOSINE_DIPHOSPHATE","KEGG_compound","C00035_GDP_GUANOSINE_5_DIPHOSPHATE_GUANOSINE_DIPHOSPHATE",36,-0.7875,0.81,0.85,0.8931,0.63,1,-1.0882,0.32,0.55
"GO_BP:507084_GO_0044068_MODULATION_BY_SYMBIONT_OF_HOST_CELLULAR_PROCESS","GO_BP","507084_GO_0044068_MODULATION_BY_SYMBIONT_OF_HOST_CELLULAR_PROCESS",14,-0.7875,0.77,0.9,0.8068,0.74,1,0.792,0.76,1
"GO_BP:512659_GO_0051788_RESPONSE_TO_MISFOLDED_PROTEIN","GO_BP","512659_GO_0051788_RESPONSE_TO_MISFOLDED_PROTEIN",11,-0.7874,0.75,0.9,0.6533,0.89,1,-0.8582,0.64,0.96
"GO_BP:517189_GO_0072273_METANEPHRIC_NEPHRON_MORPHOGENESIS","GO_BP","517189_GO_0072273_METANEPHRIC_NEPHRON_MORPHOGENESIS",21,-0.7873,0.77,0.9,-0.781,0.79,1,1.5802,0.031,0.45
"C7_Immunologic_signatures:C7_ALL_479_GSE17721_CTRL_VS_PAM3CSK4_0_5H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_479_GSE17721_CTRL_VS_PAM3CSK4_0_5H_BMDM_UP",198,-0.7872,0.91,0.95,1.4054,0.0048,0.035,-0.9706,0.53,0.79
"GO_BP:518276_GO_0090136_EPITHELIAL_CELL_CELL_ADHESION","GO_BP","518276_GO_0090136_EPITHELIAL_CELL_CELL_ADHESION",14,-0.7871,0.76,0.9,-1.6427,0.012,0.7,-1.3611,0.11,0.6
"C7_Immunologic_signatures:C7_ALL_252_GSE14308_TH2_VS_NATURAL_TREG_DN","C7_Immunologic_signatures","C7_ALL_252_GSE14308_TH2_VS_NATURAL_TREG_DN",195,-0.787,0.92,0.95,-0.9512,0.58,1,-1.2439,0.063,0.2
"C3_TF_targets:C3_TFT_458_GGCNKCCATNK_UNKNOWN","C3_TF_targets","C3_TFT_458_GGCNKCCATNK_UNKNOWN",119,-0.7867,0.88,0.96,1.3585,0.022,0.41,0.8295,0.85,1
"GO_BP:501588_GO_0032353_NEGATIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS","GO_BP","501588_GO_0032353_NEGATIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS",8,-0.7866,0.74,0.9,-0.951,0.51,1,1.0069,0.43,0.85
"C7_Immunologic_signatures:C7_ALL_100_GSE11924_TFH_VS_TH17_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_100_GSE11924_TFH_VS_TH17_CD4_TCELL_DN",199,-0.7866,0.91,0.95,1.3275,0.026,0.079,-0.8094,0.95,1
"GO_MF:499679_GO_0030275_LRR_DOMAIN_BINDING","GO_MF","499679_GO_0030275_LRR_DOMAIN_BINDING",17,-0.7865,0.75,0.9,-1.0542,0.39,0.87,-0.7325,0.85,0.99
"C4_Cancer_modules:C4_CM_58_MODULE_62","C4_Cancer_modules","C4_CM_58_MODULE_62",89,-0.7863,0.89,0.89,2.5549,0,0,0.6277,1,1
"GO_MF:496635_GO_0016714_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_PTERIDINE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN","GO_MF","496635_GO_0016714_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_PTERIDINE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN",7,-0.7862,0.74,0.9,1.2831,0.18,0.64,0.6082,0.94,1
"GO_BP:500647_GO_0031396_REGULATION_OF_PROTEIN_UBIQUITINATION","GO_BP","500647_GO_0031396_REGULATION_OF_PROTEIN_UBIQUITINATION",221,-0.7862,0.92,0.9,1.4457,0.0047,0.5,-1.0442,0.34,0.81
"OMIM_gene:OMIM611409_OCA2_GENE","OMIM_gene","OMIM611409_OCA2_GENE",7,-0.7862,0.77,0.89,0.7308,0.79,1,0.7859,0.7,1
"C1_Positional:C1_ALL_140_CHR17Q12","C1_Positional","C1_ALL_140_CHR17Q12",80,-0.7861,0.85,0.99,1.3056,0.073,0.52,-0.7281,0.95,0.99
"C7_Immunologic_signatures:C7_ALL_1310_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN","C7_Immunologic_signatures","C7_ALL_1310_GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN",199,-0.7857,0.92,0.95,1.2801,0.033,0.12,-1.0806,0.27,0.54
"GO_BP:492019_GO_0007221_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NOTCH_RECEPTOR_TARGET","GO_BP","492019_GO_0007221_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NOTCH_RECEPTOR_TARGET",5,-0.7857,0.73,0.9,-0.9021,0.58,1,-0.5665,0.92,1
"REACTOME:105922_REACT_6759_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING","REACTOME","105922_REACT_6759_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING",16,-0.7856,0.76,0.89,2.2325,0,5.9e-05,-0.8923,0.59,0.96
"GO_BP:494302_GO_0010225_RESPONSE_TO_UV_C","GO_BP","494302_GO_0010225_RESPONSE_TO_UV_C",11,-0.7855,0.77,0.9,-0.8289,0.69,1,-0.8258,0.7,0.97
"C3_TF_targets:C3_TFT_17_V_CETS1P54_01","C3_TF_targets","C3_TFT_17_V_CETS1P54_01",259,-0.7854,0.93,0.96,1.2097,0.047,0.74,0.613,1,1
"GO_BP:491768_GO_0006914_AUTOPHAGY","GO_BP","491768_GO_0006914_AUTOPHAGY",139,-0.7854,0.89,0.9,1.3472,0.028,0.61,-0.8042,0.93,0.99
"GO_MF:508873_GO_0046625_SPHINGOLIPID_BINDING","GO_MF","508873_GO_0046625_SPHINGOLIPID_BINDING",13,-0.785,0.76,0.9,0.9335,0.53,0.94,-0.7369,0.83,0.99
"GO_BP:496315_GO_0016255_ATTACHMENT_OF_GPI_ANCHOR_TO_PROTEIN","GO_BP","496315_GO_0016255_ATTACHMENT_OF_GPI_ANCHOR_TO_PROTEIN",7,-0.785,0.75,0.9,-0.7727,0.74,1,-0.7195,0.82,0.99
"KEGG_compound:C00360_DAMP_2_DEOXYADENOSINE_5_PHOSPHATE_2_DEOXYADENOSINE_5_MONOPHOSPHATE_DEOXYADENYLIC_ACID_DEOXYADENOSINE_MONOPHOSPHATE","KEGG_compound","C00360_DAMP_2_DEOXYADENOSINE_5_PHOSPHATE_2_DEOXYADENOSINE_5_MONOPHOSPHATE_DEOXYADENYLIC_ACID_DEOXYADENOSINE_MONOPHOSPHATE",17,-0.785,0.74,0.85,-0.8509,0.68,1,-0.828,0.71,0.82
"GO_BP:500355_GO_0031065_POSITIVE_REGULATION_OF_HISTONE_DEACETYLATION","GO_BP","500355_GO_0031065_POSITIVE_REGULATION_OF_HISTONE_DEACETYLATION",13,-0.7848,0.76,0.9,-1.4314,0.093,0.93,-0.775,0.76,1
"GO_BP:513853_GO_0060297_REGULATION_OF_SARCOMERE_ORGANIZATION","GO_BP","513853_GO_0060297_REGULATION_OF_SARCOMERE_ORGANIZATION",7,-0.7845,0.74,0.9,-0.9939,0.47,0.99,-1.0007,0.45,0.85
"GO_BP:500719_GO_0031468_NUCLEAR_ENVELOPE_REASSEMBLY","GO_BP","500719_GO_0031468_NUCLEAR_ENVELOPE_REASSEMBLY",13,-0.7844,0.75,0.9,1.2228,0.22,0.76,0.9784,0.51,0.88
"GO_BP:499183_GO_0021904_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING","GO_BP","499183_GO_0021904_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING",21,-0.7842,0.77,0.9,0.7793,0.77,1,1.4883,0.036,0.57
"GO_BP:750843_GO_0036342_POST_ANAL_TAIL_MORPHOGENESIS","GO_BP","750843_GO_0036342_POST_ANAL_TAIL_MORPHOGENESIS",18,-0.7842,0.78,0.9,1.1598,0.24,0.83,0.9581,0.51,0.9
"GO_BP:495035_GO_0010970_MICROTUBULE_BASED_TRANSPORT","GO_BP","495035_GO_0010970_MICROTUBULE_BASED_TRANSPORT",96,-0.7837,0.86,0.9,0.964,0.54,1,-0.8149,0.88,0.98
"GO_BP:491090_GO_0006111_REGULATION_OF_GLUCONEOGENESIS","GO_BP","491090_GO_0006111_REGULATION_OF_GLUCONEOGENESIS",36,-0.7834,0.82,0.9,0.8356,0.71,1,-0.8568,0.7,0.96
"GO_BP:488934_GO_0003140_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY_IN_LATERAL_MESODERM","GO_BP","488934_GO_0003140_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY_IN_LATERAL_MESODERM",5,-0.7832,0.75,0.9,-0.938,0.54,1,-1.0142,0.48,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1734_SIMBULAN_PARP1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1734_SIMBULAN_PARP1_TARGETS_UP",31,-0.7832,0.79,0.89,1.0026,0.44,0.8,1.4951,0.04,0.47
"GO_BP:507545_GO_0045162_CLUSTERING_OF_VOLTAGE_GATED_SODIUM_CHANNELS","GO_BP","507545_GO_0045162_CLUSTERING_OF_VOLTAGE_GATED_SODIUM_CHANNELS",7,-0.7832,0.76,0.9,-1.1294,0.3,0.94,0.6885,0.85,1
"C4_Cancer_gene_neighborhoods:C4_CGN_234_GCM_HMGA2","C4_Cancer_gene_neighborhoods","C4_CGN_234_GCM_HMGA2",115,-0.7829,0.87,1,0.7736,0.96,1,1.0918,0.28,0.62
"C3_TF_targets:C3_TFT_277_V_ROAZ_01","C3_TF_targets","C3_TFT_277_V_ROAZ_01",10,-0.7829,0.76,0.97,0.6643,0.9,1,0.7719,0.75,1
"GO_BP:495912_GO_0015781_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSPORT","GO_BP","495912_GO_0015781_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSPORT",6,-0.7827,0.73,0.9,-1.0161,0.45,0.98,-0.6656,0.9,1
"C7_Immunologic_signatures:C7_ALL_1583_GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP","C7_Immunologic_signatures","C7_ALL_1583_GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP",198,-0.7825,0.93,0.96,1.8597,0,0,-0.7434,0.99,1
"GO_BP:504463_GO_0035279_MRNA_CLEAVAGE_INVOLVED_IN_GENE_SILENCING_BY_MIRNA","GO_BP","504463_GO_0035279_MRNA_CLEAVAGE_INVOLVED_IN_GENE_SILENCING_BY_MIRNA",5,-0.7825,0.77,0.9,-1.1183,0.38,0.94,-0.7689,0.77,1
"GO_BP:508110_GO_0045773_POSITIVE_REGULATION_OF_AXON_EXTENSION","GO_BP","508110_GO_0045773_POSITIVE_REGULATION_OF_AXON_EXTENSION",31,-0.7824,0.79,0.9,-0.9602,0.52,1,0.865,0.69,0.97
"GO_MF:496753_GO_0016861_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_INTERCONVERTING_ALDOSES_AND_KETOSES","GO_MF","496753_GO_0016861_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_INTERCONVERTING_ALDOSES_AND_KETOSES",11,-0.7815,0.76,0.9,0.8347,0.66,1,-0.83,0.68,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2568_AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2568_AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN",234,-0.7814,0.92,0.89,1.396,0.013,0.3,0.7793,0.99,1
"GO_MF:498724_GO_0019958_C_X_C_CHEMOKINE_BINDING","GO_MF","498724_GO_0019958_C_X_C_CHEMOKINE_BINDING",5,-0.7813,0.76,0.9,1.1365,0.34,0.75,1.745,0.0085,0.16
"GO_BP:486570_GO_0000018_REGULATION_OF_DNA_RECOMBINATION","GO_BP","486570_GO_0000018_REGULATION_OF_DNA_RECOMBINATION",55,-0.7813,0.83,0.9,-0.7157,0.94,1,-1.0672,0.33,0.8
"KEGG_compound:C00112_CDP_CYTIDINE_5_DIPHOSPHATE_CYTIDINE_DIPHOSPHATE","KEGG_compound","C00112_CDP_CYTIDINE_5_DIPHOSPHATE_CYTIDINE_DIPHOSPHATE",20,-0.781,0.77,0.85,0.9937,0.46,1,-1.3323,0.12,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_2392_CHEN_HOXA5_TARGETS_9HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2392_CHEN_HOXA5_TARGETS_9HR_DN",41,-0.7809,0.83,0.89,0.9012,0.62,0.92,-1.0291,0.42,0.71
"GO_BP:510189_GO_0048025_NEGATIVE_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME","GO_BP","510189_GO_0048025_NEGATIVE_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME",18,-0.7809,0.76,0.9,-1.2072,0.22,0.89,-0.7786,0.8,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_158_BIOCARTA_PGC1A_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_158_BIOCARTA_PGC1A_PATHWAY",23,-0.7809,0.78,0.81,0.6097,0.96,1,-1.029,0.42,0.71
"REACTOME:161012_REACT_22161_POST_TRANSLATIONAL_PROTEIN_MODIFICATION","REACTOME","161012_REACT_22161_POST_TRANSLATIONAL_PROTEIN_MODIFICATION",347,-0.7809,0.97,0.9,1.0326,0.32,0.69,0.7478,1,1
"REACTOME:645278_REACT_121141_SIGNALING_BY_FGFR1_FUSION_MUTANTS","REACTOME","645278_REACT_121141_SIGNALING_BY_FGFR1_FUSION_MUTANTS",19,-0.7808,0.78,0.9,0.8552,0.67,0.95,-0.823,0.72,1
"GO_MF:987826_GO_0061630_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY","GO_MF","987826_GO_0061630_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY",72,-0.7807,0.88,0.9,0.9899,0.47,0.88,0.5914,1,1
"REACTOME:187101_REACT_24969_TRAF6_MEDIATED_NF_KB_ACTIVATION","REACTOME","187101_REACT_24969_TRAF6_MEDIATED_NF_KB_ACTIVATION",24,-0.7807,0.8,0.9,0.8748,0.64,0.93,-1.0104,0.44,0.82
"GO_CC:502400_GO_0033180_PROTON_TRANSPORTING_V_TYPE_ATPASE_V1_DOMAIN","GO_CC","502400_GO_0033180_PROTON_TRANSPORTING_V_TYPE_ATPASE_V1_DOMAIN",9,-0.7804,0.77,0.97,1.3931,0.13,0.3,1.3166,0.15,0.71
"GO_MF:489697_GO_0004331_FRUCTOSE_2_6_BISPHOSPHATE_2_PHOSPHATASE_ACTIVITY","GO_MF","489697_GO_0004331_FRUCTOSE_2_6_BISPHOSPHATE_2_PHOSPHATASE_ACTIVITY",5,-0.7803,0.74,0.9,0.5337,0.97,1,1.0403,0.42,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_1709_HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR","C2_Chemical_and_genetic_perturbations","C2_CGP_1709_HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR",55,-0.7802,0.81,0.89,1.7564,0.0023,0.058,-0.8455,0.75,0.93
"C3_TF_targets:C3_TFT_14_V_E2F_01","C3_TF_targets","C3_TFT_14_V_E2F_01",67,-0.78,0.87,0.97,-1.0346,0.39,0.68,-1.3524,0.059,0.27
"C7_Immunologic_signatures:C7_ALL_682_GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_682_GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDM_DN",200,-0.7798,0.93,0.96,1.0648,0.29,0.54,-1.1001,0.22,0.5
"GO_BP:861512_GO_1902369_NEGATIVE_REGULATION_OF_RNA_CATABOLIC_PROCESS","GO_BP","861512_GO_1902369_NEGATIVE_REGULATION_OF_RNA_CATABOLIC_PROCESS",7,-0.7797,0.74,0.9,0.9574,0.54,1,-0.8083,0.69,0.98
"REACTOME:105905_REACT_18348_ATF6_ALPHA_ACTIVATES_CHAPERONES","REACTOME","105905_REACT_18348_ATF6_ALPHA_ACTIVATES_CHAPERONES",12,-0.7795,0.77,0.9,-0.7149,0.86,1,0.9886,0.49,1
"C6_Oncogenic_signatures:C6_ALL_114_EIF4E_UP","C6_Oncogenic_signatures","C6_ALL_114_EIF4E_UP",96,-0.7795,0.87,0.92,1.1133,0.23,0.5,-0.9723,0.51,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_3137_BRUINS_UVC_RESPONSE_EARLY_LATE","C2_Chemical_and_genetic_perturbations","C2_CGP_3137_BRUINS_UVC_RESPONSE_EARLY_LATE",315,-0.7794,0.95,0.89,1.1634,0.09,0.54,-0.8548,0.93,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_1207_NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1207_NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON",45,-0.7792,0.82,0.89,-0.9327,0.57,1,-1.0832,0.31,0.65
"REACTOME:106420_REACT_1195_INSULIN_RECEPTOR_SIGNALLING_CASCADE","REACTOME","106420_REACT_1195_INSULIN_RECEPTOR_SIGNALLING_CASCADE",85,-0.779,0.86,0.9,0.7621,0.93,1,-0.6836,0.99,1
"C4_Cancer_gene_neighborhoods:C4_CGN_200_GCM_GSTA4","C4_Cancer_gene_neighborhoods","C4_CGN_200_GCM_GSTA4",66,-0.779,0.84,1,-1.0245,0.39,0.82,-0.7926,0.86,1
"GO_BP:781980_GO_1901991_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION","GO_BP","781980_GO_1901991_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION",145,-0.7789,0.9,0.91,1.5905,0,0.3,-0.9681,0.55,0.88
"GO_BP:849960_GO_1902259_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY","GO_BP","849960_GO_1902259_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",10,-0.7788,0.75,0.91,-1.1825,0.26,0.91,0.9364,0.55,0.91
"GO_BP:494725_GO_0010662_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","494725_GO_0010662_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS",18,-0.7788,0.77,0.91,1.0445,0.38,0.95,0.9777,0.48,0.88
"GO_BP:491248_GO_0006285_BASE_EXCISION_REPAIR_AP_SITE_FORMATION","GO_BP","491248_GO_0006285_BASE_EXCISION_REPAIR_AP_SITE_FORMATION",8,-0.7787,0.77,0.91,1.083,0.35,0.92,-0.9116,0.56,0.92
"GO_BP:508408_GO_0046112_NUCLEOBASE_BIOSYNTHETIC_PROCESS","GO_BP","508408_GO_0046112_NUCLEOBASE_BIOSYNTHETIC_PROCESS",16,-0.7787,0.77,0.91,1.3347,0.14,0.62,-0.9329,0.57,0.9
"GO_BP:488807_GO_0003009_SKELETAL_MUSCLE_CONTRACTION","GO_BP","488807_GO_0003009_SKELETAL_MUSCLE_CONTRACTION",23,-0.7785,0.78,0.91,-1.4727,0.05,0.85,-0.8852,0.62,0.94
"GO_MF:487383_GO_0001161_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING","GO_MF","487383_GO_0001161_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING",6,-0.7783,0.74,0.91,-0.6569,0.88,1,0.9873,0.47,0.88
"WikiPathways:198907_WP1541_ENERGY_METABOLISM","WikiPathways","198907_WP1541_ENERGY_METABOLISM",48,-0.7783,0.82,0.88,0.6229,0.99,1,0.9048,0.62,1
"C7_Immunologic_signatures:C7_ALL_1327_GSE30083_SP1_VS_SP3_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1327_GSE30083_SP1_VS_SP3_THYMOCYTE_UP",196,-0.7782,0.91,0.96,1.2343,0.063,0.18,0.7799,0.98,1
"GO_BP:499718_GO_0030318_MELANOCYTE_DIFFERENTIATION","GO_BP","499718_GO_0030318_MELANOCYTE_DIFFERENTIATION",21,-0.7782,0.8,0.91,1.4294,0.083,0.52,1.2714,0.15,0.69
"C7_Immunologic_signatures:C7_ALL_1654_GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1654_GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN",193,-0.7782,0.94,0.96,0.9854,0.49,0.79,-1.2583,0.046,0.19
"REACTOME:576258_REACT_118563_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1","REACTOME","576258_REACT_118563_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1",21,-0.7781,0.78,0.9,0.8683,0.66,0.94,-0.626,0.96,1
"GO_BP:492893_GO_0046878_POSITIVE_REGULATION_OF_SALIVA_SECRETION","GO_BP","492893_GO_0046878_POSITIVE_REGULATION_OF_SALIVA_SECRETION",5,-0.7781,0.76,0.91,-1.0562,0.41,0.97,-0.5207,0.97,1
"GO_BP:512768_GO_0051918_NEGATIVE_REGULATION_OF_FIBRINOLYSIS","GO_BP","512768_GO_0051918_NEGATIVE_REGULATION_OF_FIBRINOLYSIS",10,-0.778,0.77,0.91,0.8545,0.61,1,1.5856,0.041,0.44
"GO_BP:497928_GO_0019048_MODULATION_BY_VIRUS_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY","GO_BP","497928_GO_0019048_MODULATION_BY_VIRUS_OF_HOST_MORPHOLOGY_OR_PHYSIOLOGY",22,-0.7779,0.79,0.91,0.8788,0.63,1,0.9953,0.46,0.86
"GO_BP:911418_GO_1902430_NEGATIVE_REGULATION_OF_BETA_AMYLOID_FORMATION","GO_BP","911418_GO_1902430_NEGATIVE_REGULATION_OF_BETA_AMYLOID_FORMATION",6,-0.7778,0.76,0.91,-0.772,0.74,1,-0.7682,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1074_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1074_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP",10,-0.7777,0.76,0.89,0.72,0.85,1,-1.2156,0.22,0.51
"GO_MF:507220_GO_0044213_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING","GO_MF","507220_GO_0044213_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING",6,-0.7776,0.74,0.91,-0.657,0.89,1,0.9949,0.45,0.88
"GO_BP:495139_GO_0014067_NEGATIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING","GO_BP","495139_GO_0014067_NEGATIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING",11,-0.7775,0.77,0.91,0.6593,0.89,1,-0.6773,0.88,1
"C3_TF_targets:C3_TFT_468_V_E2F1_Q4_01","C3_TF_targets","C3_TFT_468_V_E2F1_Q4_01",228,-0.7773,0.94,0.97,-0.7541,0.99,1,-1.3252,0.017,0.24
"C7_Immunologic_signatures:C7_ALL_788_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_788_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN",198,-0.7772,0.93,0.96,1.445,0.0023,0.023,1.2271,0.061,0.62
"GO_BP:489264_GO_0042994_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR","GO_BP","489264_GO_0042994_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR",18,-0.777,0.77,0.91,0.8336,0.7,1,-1.0004,0.46,0.85
"GO_MF:515670_GO_0070742_C2H2_ZINC_FINGER_DOMAIN_BINDING","GO_MF","515670_GO_0070742_C2H2_ZINC_FINGER_DOMAIN_BINDING",16,-0.777,0.8,0.91,0.6777,0.9,1,-0.6539,0.92,1
"GO_BP:505672_GO_0042541_HEMOGLOBIN_BIOSYNTHETIC_PROCESS","GO_BP","505672_GO_0042541_HEMOGLOBIN_BIOSYNTHETIC_PROCESS",6,-0.7769,0.73,0.91,1.2305,0.22,0.75,-0.765,0.77,1
"C1_Positional:C1_ALL_188_CHR9P13","C1_Positional","C1_ALL_188_CHR9P13",62,-0.7767,0.84,1,0.9499,0.53,0.82,0.7458,0.92,0.96
"GO_MF:751944_GO_0052743_INOSITOL_TETRAKISPHOSPHATE_PHOSPHATASE_ACTIVITY","GO_MF","751944_GO_0052743_INOSITOL_TETRAKISPHOSPHATE_PHOSPHATASE_ACTIVITY",5,-0.7766,0.77,0.91,-0.6337,0.88,1,-0.7403,0.77,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2298_TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C","C2_Chemical_and_genetic_perturbations","C2_CGP_2298_TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C",452,-0.7766,0.97,0.89,0.9211,0.8,0.9,-0.9419,0.67,0.83
"GO_BP:494888_GO_0010824_REGULATION_OF_CENTROSOME_DUPLICATION","GO_BP","494888_GO_0010824_REGULATION_OF_CENTROSOME_DUPLICATION",33,-0.7766,0.83,0.91,0.6738,0.94,1,-0.7118,0.91,0.99
"C7_Immunologic_signatures:C7_ALL_1146_GSE27786_LSK_VS_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1146_GSE27786_LSK_VS_BCELL_DN",199,-0.7765,0.93,0.96,1.1245,0.18,0.38,-0.6763,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1451_ZHAN_MULTIPLE_MYELOMA_SUBGROUPS","C2_Chemical_and_genetic_perturbations","C2_CGP_1451_ZHAN_MULTIPLE_MYELOMA_SUBGROUPS",30,-0.7762,0.81,0.89,1.7611,0.0062,0.057,-0.8369,0.72,0.93
"REACTOME:187200_REACT_23862_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE","REACTOME","187200_REACT_23862_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE",24,-0.776,0.8,0.9,0.8349,0.71,0.97,0.8601,0.66,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1203_NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1203_NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON",126,-0.776,0.89,0.89,1.3956,0.016,0.3,1.2405,0.093,0.76
"GO_MF:489688_GO_0004322_FERROXIDASE_ACTIVITY","GO_MF","489688_GO_0004322_FERROXIDASE_ACTIVITY",6,-0.7759,0.75,0.91,0.8826,0.6,1,-0.7641,0.76,0.98
"KEGG_compound:C00130_IMP_INOSINIC_ACID_INOSINE_MONOPHOSPHATE_INOSINE_5_MONOPHOSPHATE_INOSINE_5_PHOSPHATE_5_INOSINATE_5_INOSINIC_ACID_5_INOSINE_MONOPHOSPHATE_5_IMP","KEGG_compound","C00130_IMP_INOSINIC_ACID_INOSINE_MONOPHOSPHATE_INOSINE_5_MONOPHOSPHATE_INOSINE_5_PHOSPHATE_5_INOSINATE_5_INOSINIC_ACID_5_INOSINE_MONOPHOSPHATE_5_IMP",28,-0.7757,0.8,0.86,-0.5438,1,1,-1.0283,0.41,0.62
"GO_CC:752921_GO_0097422_TUBULAR_ENDOSOME","GO_CC","752921_GO_0097422_TUBULAR_ENDOSOME",5,-0.7757,0.74,0.98,1.2997,0.17,0.4,-0.4744,0.99,1
"GO_BP:494699_GO_0010635_REGULATION_OF_MITOCHONDRIAL_FUSION","GO_BP","494699_GO_0010635_REGULATION_OF_MITOCHONDRIAL_FUSION",6,-0.7756,0.78,0.91,0.6762,0.86,1,0.6869,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2495_ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS","C2_Chemical_and_genetic_perturbations","C2_CGP_2495_ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS",14,-0.7756,0.76,0.89,-0.7822,0.78,1,-0.6052,0.98,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_673_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15","C2_Chemical_and_genetic_perturbations","C2_CGP_673_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15",10,-0.7753,0.76,0.89,-0.7131,0.83,1,-0.8175,0.72,0.94
"GO_BP:514537_GO_0060982_CORONARY_ARTERY_MORPHOGENESIS","GO_BP","514537_GO_0060982_CORONARY_ARTERY_MORPHOGENESIS",6,-0.7753,0.78,0.91,-0.7596,0.76,1,0.7879,0.71,1
"C7_Immunologic_signatures:C7_ALL_1882_GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1882_GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN",200,-0.7751,0.93,0.96,1.929,0,0,0.5943,1,1
"C7_Immunologic_signatures:C7_ALL_1254_GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_1254_GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN",178,-0.7751,0.92,0.96,0.7401,0.99,1,-1.2266,0.067,0.23
"GO_BP:507976_GO_0045628_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION","GO_BP","507976_GO_0045628_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION",9,-0.775,0.76,0.91,-1.1099,0.33,0.94,-0.6255,0.9,1
"C4_Cancer_gene_neighborhoods:C4_CGN_155_MORF_PRKAR1A","C4_Cancer_gene_neighborhoods","C4_CGN_155_MORF_PRKAR1A",144,-0.775,0.91,1,2.1888,0,2.1e-05,-0.7941,0.94,1
"GO_MF:500366_GO_0031078_HISTONE_DEACETYLASE_ACTIVITY_H3_K14_SPECIFIC_","GO_MF","500366_GO_0031078_HISTONE_DEACETYLASE_ACTIVITY_H3_K14_SPECIFIC_",12,-0.7748,0.75,0.91,-1.1804,0.24,0.78,-1.6044,0.033,0.37
"GO_BP:751293_GO_0038030_NON_CANONICAL_WNT_SIGNALING_PATHWAY_VIA_MAPK_CASCADE","GO_BP","751293_GO_0038030_NON_CANONICAL_WNT_SIGNALING_PATHWAY_VIA_MAPK_CASCADE",6,-0.7745,0.76,0.91,-1.084,0.37,0.96,0.8239,0.7,1
"GO_BP:488453_GO_0002580_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II","GO_BP","488453_GO_0002580_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II",5,-0.7745,0.76,0.91,-0.9802,0.5,1,-0.6239,0.9,1
"GO_BP:513522_GO_0055089_FATTY_ACID_HOMEOSTASIS","GO_BP","513522_GO_0055089_FATTY_ACID_HOMEOSTASIS",11,-0.7745,0.76,0.91,0.7178,0.81,1,0.8715,0.62,0.96
"C3_MicroRNA_targets:C3_MIR_36_TTGGAGA_MIR_515_5P_MIR_519E","C3_MicroRNA_targets","C3_MIR_36_TTGGAGA_MIR_515_5P_MIR_519E",146,-0.774,0.91,0.95,-0.7034,0.99,1,-0.74,0.99,1
"GO_BP:493285_GO_0009084_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS","GO_BP","493285_GO_0009084_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS",19,-0.7739,0.78,0.91,-0.8343,0.7,1,-1.2322,0.19,0.7
"GO_BP:493310_GO_0009111_VITAMIN_CATABOLIC_PROCESS","GO_BP","493310_GO_0009111_VITAMIN_CATABOLIC_PROCESS",10,-0.7738,0.78,0.91,-1.3369,0.15,0.9,1.288,0.17,0.68
"GO_MF:492806_GO_0008527_TASTE_RECEPTOR_ACTIVITY","GO_MF","492806_GO_0008527_TASTE_RECEPTOR_ACTIVITY",31,-0.7737,0.81,0.91,0.7787,0.82,1,1.3032,0.12,0.67
"GO_BP:491069_GO_0006084_ACETYL_COA_METABOLIC_PROCESS","GO_BP","491069_GO_0006084_ACETYL_COA_METABOLIC_PROCESS",19,-0.7736,0.78,0.91,-0.9371,0.52,1,-1.4923,0.044,0.54
"KEGG_pathway:HSA00910_NITROGEN_METABOLISM","KEGG_pathway","HSA00910_NITROGEN_METABOLISM",17,-0.7734,0.77,0.89,-0.7417,0.85,1,-1.6051,0.018,0.096
"GO_BP:492447_GO_0008078_MESODERMAL_CELL_MIGRATION","GO_BP","492447_GO_0008078_MESODERMAL_CELL_MIGRATION",6,-0.7734,0.77,0.91,-0.9753,0.5,1,-0.9753,0.5,0.88
"GO_BP:496326_GO_0016266_O_GLYCAN_PROCESSING","GO_BP","496326_GO_0016266_O_GLYCAN_PROCESSING",56,-0.7731,0.84,0.91,0.8541,0.73,1,1.3683,0.059,0.65
"GO_BP:491427_GO_0006531_ASPARTATE_METABOLIC_PROCESS","GO_BP","491427_GO_0006531_ASPARTATE_METABOLIC_PROCESS",7,-0.773,0.78,0.91,1.2022,0.24,0.78,-1.0071,0.43,0.84
"C1_Positional:C1_ALL_307_CHRXQ24","C1_Positional","C1_ALL_307_CHRXQ24",29,-0.7728,0.82,1,-0.6182,0.97,1,-1.5414,0.014,0.62
"GO_CC:490712_GO_0005652_NUCLEAR_LAMINA","GO_CC","490712_GO_0005652_NUCLEAR_LAMINA",8,-0.7726,0.78,0.98,-1.2527,0.21,0.67,-0.856,0.63,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2915_MIKKELSEN_ES_LCP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2915_MIKKELSEN_ES_LCP_WITH_H3K27ME3",12,-0.7723,0.76,0.9,0.9681,0.5,0.84,1.235,0.21,0.74
"GO_BP:514065_GO_0060510_TYPE_II_PNEUMOCYTE_DIFFERENTIATION","GO_BP","514065_GO_0060510_TYPE_II_PNEUMOCYTE_DIFFERENTIATION",5,-0.7722,0.76,0.91,1.5179,0.058,0.38,1.1747,0.32,0.72
"C7_Immunologic_signatures:C7_ALL_101_GSE11924_TH1_VS_TH2_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_101_GSE11924_TH1_VS_TH2_CD4_TCELL_UP",197,-0.7722,0.93,0.97,0.7959,0.95,1,-0.7383,0.99,1
"GO_BP:514320_GO_0060765_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","514320_GO_0060765_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY",23,-0.7721,0.79,0.91,-0.5869,0.98,1,1.0199,0.46,0.84
"GO_BP:514469_GO_0060914_HEART_FORMATION","GO_BP","514469_GO_0060914_HEART_FORMATION",11,-0.7721,0.76,0.91,-1.0839,0.35,0.95,1.2046,0.23,0.72
"KEGG_compound:C00356__S_3_HYDROXY_3_METHYLGLUTARYL_COA_HYDROXYMETHYLGLUTARYL_COA_HYDROXYMETHYLGLUTAROYL_COENZYME_A_HMG_COA_3_HYDROXY_3_METHYLGLUTARYL_COA","KEGG_compound","C00356__S_3_HYDROXY_3_METHYLGLUTARYL_COA_HYDROXYMETHYLGLUTARYL_COA_HYDROXYMETHYLGLUTAROYL_COENZYME_A_HMG_COA_3_HYDROXY_3_METHYLGLUTARYL_COA",6,-0.7719,0.77,0.86,0.8567,0.63,1,0.8915,0.61,0.82
"GO_BP:491421_GO_0006525_ARGININE_METABOLIC_PROCESS","GO_BP","491421_GO_0006525_ARGININE_METABOLIC_PROCESS",16,-0.7717,0.77,0.91,-1.2511,0.18,0.91,-0.7791,0.8,1
"GO_BP:496183_GO_0046326_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT","GO_BP","496183_GO_0046326_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT",28,-0.7717,0.81,0.91,1.0012,0.44,0.98,-0.8376,0.7,0.96
"GO_BP:492661_GO_0051013_MICROTUBULE_SEVERING","GO_BP","492661_GO_0051013_MICROTUBULE_SEVERING",8,-0.7715,0.77,0.91,-0.7162,0.85,1,-0.8559,0.63,0.96
"C4_Cancer_modules:C4_CM_305_MODULE_354","C4_Cancer_modules","C4_CM_305_MODULE_354",17,-0.7714,0.79,0.91,1.4266,0.075,0.17,1.2708,0.18,0.5
"GO_MF:486641_GO_0000099_SULFUR_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","486641_GO_0000099_SULFUR_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",7,-0.7714,0.76,0.91,-0.7872,0.73,1,1.1317,0.33,0.8
"C7_Immunologic_signatures:C7_ALL_209_GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP","C7_Immunologic_signatures","C7_ALL_209_GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP",184,-0.7714,0.93,0.97,1.6703,0,0.00097,2.0576,0,0.00011
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_113_BIOCARTA_EGFR_SMRTE_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_113_BIOCARTA_EGFR_SMRTE_PATHWAY",11,-0.7713,0.78,0.82,0.6135,0.94,1,-0.5789,0.95,0.99
"REACTOME:645305_REACT_121408_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS","REACTOME","645305_REACT_121408_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS",25,-0.7712,0.82,0.9,1.3425,0.11,0.27,1.1092,0.32,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_967_OZEN_MIR125B1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_967_OZEN_MIR125B1_TARGETS",25,-0.7711,0.8,0.9,-0.6534,0.93,1,-0.7558,0.84,0.97
"GO_BP:502186_GO_0032964_COLLAGEN_BIOSYNTHETIC_PROCESS","GO_BP","502186_GO_0032964_COLLAGEN_BIOSYNTHETIC_PROCESS",6,-0.7709,0.77,0.91,-1.2129,0.24,0.88,0.8663,0.6,0.97
"GO_BP:516211_GO_0071287_CELLULAR_RESPONSE_TO_MANGANESE_ION","GO_BP","516211_GO_0071287_CELLULAR_RESPONSE_TO_MANGANESE_ION",5,-0.7709,0.76,0.91,0.5497,0.95,1,0.603,0.9,1
"C7_Immunologic_signatures:C7_ALL_1144_GSE27786_LSK_VS_LIN_NEG_CELL_DN","C7_Immunologic_signatures","C7_ALL_1144_GSE27786_LSK_VS_LIN_NEG_CELL_DN",197,-0.7707,0.93,0.97,1.3745,0.0069,0.048,0.7547,0.99,1
"C7_Immunologic_signatures:C7_ALL_928_GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN","C7_Immunologic_signatures","C7_ALL_928_GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN",199,-0.7706,0.94,0.97,1.9869,0,0,-0.9355,0.65,0.88
"GO_BP:510418_GO_0048311_MITOCHONDRION_DISTRIBUTION","GO_BP","510418_GO_0048311_MITOCHONDRION_DISTRIBUTION",9,-0.7706,0.75,0.91,-1.3186,0.14,0.89,-0.7146,0.83,0.99
"GO_BP:488874_GO_0035811_NEGATIVE_REGULATION_OF_URINE_VOLUME","GO_BP","488874_GO_0035811_NEGATIVE_REGULATION_OF_URINE_VOLUME",5,-0.7706,0.73,0.91,1.1809,0.27,0.8,0.9286,0.52,0.92
"C7_Immunologic_signatures:C7_ALL_958_GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN","C7_Immunologic_signatures","C7_ALL_958_GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN",200,-0.7705,0.93,0.97,1.743,0,0.00033,-1.3295,0.02,0.11
"GO_MF:501278_GO_0032041_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H3_K14_SPECIFIC_","GO_MF","501278_GO_0032041_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY_H3_K14_SPECIFIC_",12,-0.7704,0.77,0.91,-1.1933,0.24,0.8,-1.6067,0.025,0.37
"GO_BP:751294_GO_0038031_NON_CANONICAL_WNT_SIGNALING_PATHWAY_VIA_JNK_CASCADE","GO_BP","751294_GO_0038031_NON_CANONICAL_WNT_SIGNALING_PATHWAY_VIA_JNK_CASCADE",5,-0.7703,0.76,0.91,0.9315,0.55,1,0.8513,0.63,0.98
"GO_MF:495438_GO_0015165_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495438_GO_0015165_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.7703,0.75,0.91,-1.0145,0.46,0.89,-0.667,0.87,1
"GO_BP:517309_GO_0072393_MICROTUBULE_ANCHORING_AT_MICROTUBULE_ORGANIZING_CENTER","GO_BP","517309_GO_0072393_MICROTUBULE_ANCHORING_AT_MICROTUBULE_ORGANIZING_CENTER",6,-0.7702,0.76,0.91,-0.9557,0.51,1,-1.445,0.084,0.55
"GO_BP:515192_GO_0070257_POSITIVE_REGULATION_OF_MUCUS_SECRETION","GO_BP","515192_GO_0070257_POSITIVE_REGULATION_OF_MUCUS_SECRETION",8,-0.7696,0.75,0.91,1.2813,0.18,0.7,0.8605,0.64,0.97
"C4_Cancer_gene_neighborhoods:C4_CGN_76_MORF_CDK2","C4_Cancer_gene_neighborhoods","C4_CGN_76_MORF_CDK2",72,-0.7695,0.88,1,1.3991,0.041,0.062,-0.9801,0.47,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1006_GOUYER_TUMOR_INVASIVENESS","C2_Chemical_and_genetic_perturbations","C2_CGP_1006_GOUYER_TUMOR_INVASIVENESS",9,-0.7693,0.76,0.9,0.9735,0.49,0.83,1.5659,0.038,0.43
"GO_BP:502265_GO_0033044_REGULATION_OF_CHROMOSOME_ORGANIZATION","GO_BP","502265_GO_0033044_REGULATION_OF_CHROMOSOME_ORGANIZATION",196,-0.7692,0.92,0.91,0.8761,0.82,1,-0.9561,0.61,0.88
"C3_TF_targets:C3_TFT_615_GCCATNTTG_V_YY1_Q6","C3_TF_targets","C3_TFT_615_GCCATNTTG_V_YY1_Q6",429,-0.7691,0.97,0.98,0.9816,0.52,1,-0.906,0.83,0.91
"GO_BP:502024_GO_0032801_RECEPTOR_CATABOLIC_PROCESS","GO_BP","502024_GO_0032801_RECEPTOR_CATABOLIC_PROCESS",12,-0.7687,0.77,0.91,-1.4446,0.078,0.91,-1.0279,0.42,0.83
"GO_MF:490425_GO_0005160_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING","GO_MF","490425_GO_0005160_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING",47,-0.7685,0.83,0.91,0.896,0.65,0.98,1.0021,0.44,0.87
"GO_BP:496860_GO_0017038_PROTEIN_IMPORT","GO_BP","496860_GO_0017038_PROTEIN_IMPORT",129,-0.7682,0.91,0.91,1.0892,0.28,0.92,-0.995,0.45,0.85
"C2_Chemical_and_genetic_perturbations:C2_CGP_3078_FIGUEROA_AML_METHYLATION_CLUSTER_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3078_FIGUEROA_AML_METHYLATION_CLUSTER_1_UP",120,-0.7682,0.89,0.9,1.1089,0.23,0.62,1.206,0.11,0.77
"C4_Cancer_gene_neighborhoods:C4_CGN_327_GNF2_CBFB","C4_Cancer_gene_neighborhoods","C4_CGN_327_GNF2_CBFB",30,-0.7682,0.81,1,1.3526,0.11,0.084,-1.4578,0.033,0.13
"C4_Cancer_gene_neighborhoods:C4_CGN_9_MORF_BUB1","C4_Cancer_gene_neighborhoods","C4_CGN_9_MORF_BUB1",52,-0.768,0.86,1,1.8792,0,0.001,-0.8109,0.85,1
"GO_BP:493742_GO_0009624_RESPONSE_TO_NEMATODE","GO_BP","493742_GO_0009624_RESPONSE_TO_NEMATODE",5,-0.7679,0.78,0.91,-0.6668,0.87,1,-0.7105,0.81,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1329_CHESLER_BRAIN_QTL_TRANS","C2_Chemical_and_genetic_perturbations","C2_CGP_1329_CHESLER_BRAIN_QTL_TRANS",6,-0.7678,0.77,0.9,0.9181,0.54,0.9,-0.723,0.78,0.98
"GO_MF:489430_GO_0003950_NAD_ADP_RIBOSYLTRANSFERASE_ACTIVITY","GO_MF","489430_GO_0003950_NAD_ADP_RIBOSYLTRANSFERASE_ACTIVITY",25,-0.7677,0.81,0.91,-0.8927,0.6,1,-1.4329,0.053,0.44
"GO_MF:490379_GO_0005113_PATCHED_BINDING","GO_MF","490379_GO_0005113_PATCHED_BINDING",7,-0.7675,0.78,0.91,-0.811,0.72,1,0.8987,0.57,0.96
"C7_Immunologic_signatures:C7_ALL_957_GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP","C7_Immunologic_signatures","C7_ALL_957_GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP",194,-0.7674,0.94,0.97,1.1682,0.11,0.28,0.8193,0.92,1
"GO_BP:501713_GO_0032481_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION","GO_BP","501713_GO_0032481_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION",77,-0.7673,0.86,0.91,1.0397,0.36,0.96,-1.1978,0.15,0.73
"REACTOME:105658_REACT_697_ACTIVATION_OF_BH3_ONLY_PROTEINS","REACTOME","105658_REACT_697_ACTIVATION_OF_BH3_ONLY_PROTEINS",25,-0.7673,0.82,0.91,0.5535,0.99,1,-1.3618,0.085,0.47
"GO_BP:989117_GO_1903052_POSITIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS","GO_BP","989117_GO_1903052_POSITIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS",146,-0.7672,0.93,0.91,1.5907,0,0.3,-1.1139,0.2,0.76
"GO_MF:1129219_GO_0061650_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY","GO_MF","1129219_GO_0061650_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY",20,-0.7672,0.8,0.91,0.7925,0.75,1,-1.0443,0.41,0.75
"C6_Oncogenic_signatures:C6_ALL_168_JAK2_DN_V1_DN","C6_Oncogenic_signatures","C6_ALL_168_JAK2_DN_V1_DN",147,-0.767,0.93,0.93,-1.2576,0.076,0.37,-0.952,0.56,0.71
"GO_MF:496644_GO_0016724_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS_OXYGEN_AS_ACCEPTOR","GO_MF","496644_GO_0016724_OXIDOREDUCTASE_ACTIVITY_OXIDIZING_METAL_IONS_OXYGEN_AS_ACCEPTOR",6,-0.7669,0.78,0.91,0.9046,0.58,0.98,-0.7625,0.76,0.99
"GO_BP:515862_GO_0070935_3_UTR_MEDIATED_MRNA_STABILIZATION","GO_BP","515862_GO_0070935_3_UTR_MEDIATED_MRNA_STABILIZATION",11,-0.7669,0.76,0.91,0.6824,0.89,1,-0.733,0.82,0.99
"GO_BP:516966_GO_0072049_COMMA_SHAPED_BODY_MORPHOGENESIS","GO_BP","516966_GO_0072049_COMMA_SHAPED_BODY_MORPHOGENESIS",5,-0.7667,0.79,0.92,-0.6931,0.84,1,1.0744,0.39,0.78
"GO_BP:751260_GO_0036344_PLATELET_MORPHOGENESIS","GO_BP","751260_GO_0036344_PLATELET_MORPHOGENESIS",17,-0.7666,0.8,0.91,1.0284,0.42,0.97,0.6605,0.91,1
"C3_TF_targets:C3_TFT_252_V_E2F1_Q4","C3_TF_targets","C3_TFT_252_V_E2F1_Q4",243,-0.7665,0.94,0.98,0.8889,0.84,1,-1.2096,0.065,0.34
"GO_BP:500892_GO_0031643_POSITIVE_REGULATION_OF_MYELINATION","GO_BP","500892_GO_0031643_POSITIVE_REGULATION_OF_MYELINATION",8,-0.7665,0.76,0.91,0.9327,0.55,1,-0.9319,0.53,0.9
"GO_CC:507625_GO_0045259_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX","GO_CC","507625_GO_0045259_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX",22,-0.7664,0.81,0.99,2.2136,0,0.00022,-0.7069,0.9,1
"C7_Immunologic_signatures:C7_ALL_1308_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1308_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN",197,-0.7664,0.96,0.97,0.7294,0.99,1,-0.7319,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2371_CLIMENT_BREAST_CANCER_COPY_NUMBER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2371_CLIMENT_BREAST_CANCER_COPY_NUMBER_UP",22,-0.7662,0.81,0.9,-1.077,0.35,0.95,1.3299,0.13,0.61
"REACTOME:106193_REACT_14820_METABOLISM_OF_POLYAMINES","REACTOME","106193_REACT_14820_METABOLISM_OF_POLYAMINES",15,-0.7661,0.77,0.91,-0.7529,0.8,1,-1.2844,0.17,0.53
"C3_TF_targets:C3_TFT_532_WCAANNNYCAG_UNKNOWN","C3_TF_targets","C3_TFT_532_WCAANNNYCAG_UNKNOWN",250,-0.766,0.95,0.98,0.7748,0.99,1,-0.9699,0.54,0.8
"GO_BP:492033_GO_0007253_CYTOPLASMIC_SEQUESTERING_OF_NF_KAPPAB","GO_BP","492033_GO_0007253_CYTOPLASMIC_SEQUESTERING_OF_NF_KAPPAB",6,-0.7659,0.75,0.92,1.2626,0.17,0.72,-0.733,0.78,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_717_FARMER_BREAST_CANCER_CLUSTER_8","C2_Chemical_and_genetic_perturbations","C2_CGP_717_FARMER_BREAST_CANCER_CLUSTER_8",7,-0.7657,0.77,0.9,-0.5992,0.94,1,0.6798,0.88,1
"C1_Positional:C1_ALL_6_CHR10Q23","C1_Positional","C1_ALL_6_CHR10Q23",94,-0.7657,0.88,1,1.1002,0.27,0.65,1.1191,0.25,0.72
"GO_BP:1039918_GO_1903364_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS","GO_BP","1039918_GO_1903364_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS",151,-0.7657,0.92,0.92,1.5348,0,0.36,-1.1361,0.19,0.75
"GO_BP:513945_GO_0060389_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION","GO_BP","513945_GO_0060389_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION",12,-0.7654,0.77,0.92,0.6267,0.92,1,1.2051,0.23,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_658_IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM","C2_Chemical_and_genetic_perturbations","C2_CGP_658_IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM",6,-0.7654,0.78,0.9,-1.0446,0.42,0.97,-1.2607,0.21,0.46
"C2_Chemical_and_genetic_perturbations:C2_CGP_2968_MURAKAMI_UV_RESPONSE_1HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2968_MURAKAMI_UV_RESPONSE_1HR_DN",10,-0.7653,0.77,0.9,-0.8683,0.6,1,0.7641,0.78,1
"GO_BP:491190_GO_0006221_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","491190_GO_0006221_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS",30,-0.7652,0.83,0.92,0.6756,0.93,1,-0.8425,0.72,0.96
"GO_BP:503710_GO_0034508_CENTROMERE_COMPLEX_ASSEMBLY","GO_BP","503710_GO_0034508_CENTROMERE_COMPLEX_ASSEMBLY",48,-0.7652,0.86,0.92,-0.954,0.52,1,-1.2391,0.14,0.69
"GO_BP:494250_GO_0010171_BODY_MORPHOGENESIS","GO_BP","494250_GO_0010171_BODY_MORPHOGENESIS",51,-0.7651,0.85,0.92,0.7893,0.86,1,-1.0058,0.45,0.84
"C1_Positional:C1_ALL_10_CHRXP21","C1_Positional","C1_ALL_10_CHRXP21",26,-0.7651,0.81,1,1.8326,0,0.098,1.4423,0.046,0.35
"GO_MF:496775_GO_0016888_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS","GO_MF","496775_GO_0016888_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS",14,-0.7647,0.79,0.91,-0.8072,0.73,1,-0.5571,0.97,1
"GO_MF:489557_GO_0004089_CARBONATE_DEHYDRATASE_ACTIVITY","GO_MF","489557_GO_0004089_CARBONATE_DEHYDRATASE_ACTIVITY",15,-0.7647,0.79,0.91,0.7419,0.82,1,-1.4657,0.068,0.42
"GO_BP:491501_GO_0006607_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","491501_GO_0006607_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS",14,-0.7646,0.78,0.92,-0.4601,1,1,-1.1803,0.25,0.74
"C7_Immunologic_signatures:C7_ALL_1219_GSE27786_NKCELL_VS_MONO_MAC_UP","C7_Immunologic_signatures","C7_ALL_1219_GSE27786_NKCELL_VS_MONO_MAC_UP",200,-0.7646,0.94,0.97,1.4211,0.0091,0.031,0.7299,1,1
"GO_BP:508083_GO_0045743_POSITIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","508083_GO_0045743_POSITIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",7,-0.7644,0.77,0.92,0.6571,0.9,1,0.7523,0.79,1
"C7_Immunologic_signatures:C7_ALL_155_GSE13306_RA_VS_UNTREATED_TREG_UP","C7_Immunologic_signatures","C7_ALL_155_GSE13306_RA_VS_UNTREATED_TREG_UP",197,-0.7642,0.95,0.97,1.2469,0.051,0.16,0.9288,0.63,1
"GO_MF:494064_GO_0009975_CYCLASE_ACTIVITY","GO_MF","494064_GO_0009975_CYCLASE_ACTIVITY",22,-0.7639,0.8,0.91,0.7312,0.87,1,-1.5289,0.038,0.39
"GO_BP:510224_GO_0048069_EYE_PIGMENTATION","GO_BP","510224_GO_0048069_EYE_PIGMENTATION",7,-0.7639,0.79,0.92,0.8299,0.7,1,-1.1195,0.34,0.76
"C1_Positional:C1_ALL_202_CHR5Q22","C1_Positional","C1_ALL_202_CHR5Q22",22,-0.7636,0.8,1,1.1289,0.27,0.63,-0.7349,0.86,1
"GO_BP:514022_GO_0060467_NEGATIVE_REGULATION_OF_FERTILIZATION","GO_BP","514022_GO_0060467_NEGATIVE_REGULATION_OF_FERTILIZATION",6,-0.7636,0.78,0.92,-1.1688,0.28,0.91,-1.2754,0.19,0.66
"GO_BP:493353_GO_0009156_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493353_GO_0009156_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",73,-0.763,0.89,0.92,1.4642,0.018,0.48,-0.6556,0.98,1
"GO_MF:489235_GO_0003682_CHROMATIN_BINDING","GO_MF","489235_GO_0003682_CHROMATIN_BINDING",444,-0.763,0.99,0.91,-0.7044,1,1,-1.0478,0.28,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_554_CORRADETTI_MTOR_PATHWAY_REGULATORS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_554_CORRADETTI_MTOR_PATHWAY_REGULATORS_DN",6,-0.763,0.77,0.91,-0.6417,0.88,1,0.9942,0.46,0.97
"GO_BP:489198_GO_0003406_RETINAL_PIGMENT_EPITHELIUM_DEVELOPMENT","GO_BP","489198_GO_0003406_RETINAL_PIGMENT_EPITHELIUM_DEVELOPMENT",6,-0.7628,0.8,0.92,-1.4153,0.094,0.95,-0.5525,0.97,1
"GO_BP:517247_GO_0072331_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR","GO_BP","517247_GO_0072331_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",129,-0.7628,0.91,0.92,1.5283,0,0.37,-1.2974,0.048,0.64
"GO_BP:507320_GO_0044314_PROTEIN_K27_LINKED_UBIQUITINATION","GO_BP","507320_GO_0044314_PROTEIN_K27_LINKED_UBIQUITINATION",5,-0.7626,0.78,0.92,0.6731,0.87,1,-1.2719,0.21,0.66
"REACTOME:105809_REACT_15510_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES","REACTOME","105809_REACT_15510_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES",11,-0.7625,0.77,0.91,0.5007,0.99,1,-0.6208,0.93,1
"C1_Positional:C1_ALL_130_CHR6Q21","C1_Positional","C1_ALL_130_CHR6Q21",56,-0.7624,0.86,0.99,1.1976,0.18,0.64,-0.95,0.54,0.97
"GO_BP:499581_GO_0030163_PROTEIN_CATABOLIC_PROCESS","GO_BP","499581_GO_0030163_PROTEIN_CATABOLIC_PROCESS",481,-0.7622,0.98,0.92,1.3351,0.0055,0.62,-0.9543,0.64,0.89
"GO_BP:812233_GO_1902110_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_BP","812233_GO_1902110_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS",12,-0.762,0.76,0.92,1.2716,0.2,0.71,-1.3456,0.13,0.61
"GO_BP:487109_GO_0000819_SISTER_CHROMATID_SEGREGATION","GO_BP","487109_GO_0000819_SISTER_CHROMATID_SEGREGATION",84,-0.762,0.88,0.92,1.0192,0.41,0.97,-1.0917,0.28,0.78
"C7_Immunologic_signatures:C7_ALL_1262_GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN","C7_Immunologic_signatures","C7_ALL_1262_GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN",196,-0.762,0.95,0.97,2.1424,0,0,-1.2467,0.049,0.2
"GO_BP:512266_GO_0051382_KINETOCHORE_ASSEMBLY","GO_BP","512266_GO_0051382_KINETOCHORE_ASSEMBLY",10,-0.7616,0.77,0.92,-0.9322,0.52,1,-0.8386,0.68,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_877_INAMURA_LUNG_CANCER_SCC_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_877_INAMURA_LUNG_CANCER_SCC_DN",14,-0.7616,0.78,0.91,-1.0749,0.35,0.96,1.4304,0.073,0.56
"C3_TF_targets:C3_TFT_451_V_E2F_Q3_01","C3_TF_targets","C3_TFT_451_V_E2F_Q3_01",235,-0.7615,0.94,0.98,-0.6902,1,1,-1.3652,0.0083,0.27
"C2_Chemical_and_genetic_perturbations:C2_CGP_584_MARKS_ACETYLATED_NON_HISTONE_PROTEINS","C2_Chemical_and_genetic_perturbations","C2_CGP_584_MARKS_ACETYLATED_NON_HISTONE_PROTEINS",15,-0.7611,0.8,0.91,0.6774,0.89,1,-1.277,0.15,0.45
"GO_BP:489024_GO_0003230_CARDIAC_ATRIUM_DEVELOPMENT","GO_BP","489024_GO_0003230_CARDIAC_ATRIUM_DEVELOPMENT",30,-0.7611,0.83,0.92,-0.9663,0.5,1,1.3164,0.09,0.66
"GO_MF:498368_GO_0019534_TOXIN_TRANSPORTER_ACTIVITY","GO_MF","498368_GO_0019534_TOXIN_TRANSPORTER_ACTIVITY",9,-0.761,0.77,0.91,-1.1918,0.24,0.79,0.781,0.77,1
"GO_BP:505187_GO_0040029_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC","GO_BP","505187_GO_0040029_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC",234,-0.7609,0.96,0.92,-1.0277,0.37,0.97,-1.1873,0.075,0.73
"C3_TF_targets:C3_TFT_79_V_MYCMAX_01","C3_TF_targets","C3_TFT_79_V_MYCMAX_01",251,-0.7609,0.97,0.98,0.8535,0.89,1,-1.1858,0.059,0.37
"GO_CC:496488_GO_0016529_SARCOPLASMIC_RETICULUM","GO_CC","496488_GO_0016529_SARCOPLASMIC_RETICULUM",57,-0.7608,0.86,0.99,-1.3176,0.076,0.64,-0.9056,0.66,1
"REACTOME:105763_REACT_1041_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS","REACTOME","105763_REACT_1041_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS",18,-0.7607,0.81,0.92,1.2154,0.23,0.43,-0.5894,0.98,1
"C3_MicroRNA_targets:C3_MIR_107_TCCGTCC_MIR_184","C3_MicroRNA_targets","C3_MIR_107_TCCGTCC_MIR_184",13,-0.7603,0.77,0.96,-1.1648,0.26,1,-1.1691,0.25,1
"C7_Immunologic_signatures:C7_ALL_1690_GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1690_GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN",196,-0.7602,0.95,0.97,0.8183,0.94,1,-0.7648,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_632_MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_632_MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER",53,-0.7601,0.88,0.91,1.4832,0.029,0.23,0.9257,0.59,1
"GO_BP:487652_GO_0001756_SOMITOGENESIS","GO_BP","487652_GO_0001756_SOMITOGENESIS",62,-0.7601,0.87,0.92,0.8688,0.75,1,0.9475,0.57,0.91
"KEGG_compound:C00061_FMN_RIBOFLAVIN_5_PHOSPHATE_FLAVIN_MONONUCLEOTIDE","KEGG_compound","C00061_FMN_RIBOFLAVIN_5_PHOSPHATE_FLAVIN_MONONUCLEOTIDE",8,-0.76,0.75,0.88,1.2514,0.21,0.79,-0.8795,0.63,0.78
"GO_BP:518483_GO_0090343_POSITIVE_REGULATION_OF_CELL_AGING","GO_BP","518483_GO_0090343_POSITIVE_REGULATION_OF_CELL_AGING",6,-0.76,0.77,0.92,-1.02,0.43,0.97,-0.715,0.8,0.99
"C3_TF_targets:C3_TFT_168_V_AHRARNT_02","C3_TF_targets","C3_TFT_168_V_AHRARNT_02",15,-0.7599,0.8,0.98,0.8371,0.67,1,1.0806,0.34,1
"GO_BP:850007_GO_1902306_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","850007_GO_1902306_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT",8,-0.7598,0.79,0.92,1.0578,0.39,0.94,-1.6481,0.017,0.52
"KEGG_compound:C06800_AFLATOXIN_B1","KEGG_compound","C06800_AFLATOXIN_B1",5,-0.7595,0.78,0.87,-0.838,0.67,1,1.6625,0.008,0.061
"REACTOME:1127525_REACT_264383_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS","REACTOME","1127525_REACT_264383_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS",15,-0.7593,0.8,0.92,-0.9722,0.49,1,1.5208,0.06,0.47
"GO_MF:489258_GO_0003713_TRANSCRIPTION_COACTIVATOR_ACTIVITY","GO_MF","489258_GO_0003713_TRANSCRIPTION_COACTIVATOR_ACTIVITY",289,-0.7593,0.96,0.92,0.7308,1,1,-0.8742,0.88,0.9
"GO_BP:494672_GO_0010608_POSTTRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION","GO_BP","494672_GO_0010608_POSTTRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION",477,-0.7591,0.98,0.92,1.3518,0.0024,0.61,-1.1492,0.079,0.74
"GO_BP:754563_GO_1901607_ALPHA_AMINO_ACID_BIOSYNTHETIC_PROCESS","GO_BP","754563_GO_1901607_ALPHA_AMINO_ACID_BIOSYNTHETIC_PROCESS",80,-0.759,0.89,0.92,-0.715,0.96,1,-1.3915,0.029,0.58
"GO_BP:491642_GO_0006768_BIOTIN_METABOLIC_PROCESS","GO_BP","491642_GO_0006768_BIOTIN_METABOLIC_PROCESS",11,-0.7589,0.8,0.92,0.7441,0.8,1,-1.5104,0.061,0.53
"GO_BP:509049_GO_0046826_NEGATIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS","GO_BP","509049_GO_0046826_NEGATIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS",7,-0.7588,0.77,0.92,1.0744,0.38,0.93,-1.1674,0.27,0.73
"C1_Positional:C1_ALL_112_CHR5Q14","C1_Positional","C1_ALL_112_CHR5Q14",42,-0.7587,0.82,0.99,1.5178,0.018,0.28,0.9098,0.6,0.84
"GO_BP:754127_GO_1901160_PRIMARY_AMINO_COMPOUND_METABOLIC_PROCESS","GO_BP","754127_GO_1901160_PRIMARY_AMINO_COMPOUND_METABOLIC_PROCESS",13,-0.7587,0.79,0.92,-1.066,0.36,0.96,-1.0724,0.36,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_3325_VANOEVELEN_MYOGENESIS_SIN3A_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3325_VANOEVELEN_MYOGENESIS_SIN3A_TARGETS",220,-0.7579,0.96,0.91,1.5284,0,0.18,0.6749,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_266_GCM_SMO","C4_Cancer_gene_neighborhoods","C4_CGN_266_GCM_SMO",59,-0.7578,0.88,1,-1.2864,0.091,0.54,-0.9127,0.64,1
"C1_Positional:C1_ALL_173_CHR14Q12","C1_Positional","C1_ALL_173_CHR14Q12",24,-0.7578,0.82,0.99,0.5718,0.97,1,-1.4676,0.048,0.76
"GO_MF:506553_GO_0043522_LEUCINE_ZIPPER_DOMAIN_BINDING","GO_MF","506553_GO_0043522_LEUCINE_ZIPPER_DOMAIN_BINDING",11,-0.7576,0.78,0.92,-1.2853,0.18,0.82,-0.933,0.57,0.84
"OMIM_gene:OMIM605143_ACTIN_RELATED_PROTEIN_1A_ACTR1A","OMIM_gene","OMIM605143_ACTIN_RELATED_PROTEIN_1A_ACTR1A",5,-0.7575,0.76,0.92,-1.1523,0.31,1,0.8932,0.59,1
"REACTOME:106257_REACT_11153_BIOTIN_TRANSPORT_AND_METABOLISM","REACTOME","106257_REACT_11153_BIOTIN_TRANSPORT_AND_METABOLISM",11,-0.7575,0.77,0.92,0.7392,0.8,1,-1.5064,0.049,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_1383_DER_IFN_GAMMA_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1383_DER_IFN_GAMMA_RESPONSE_DN",11,-0.7574,0.81,0.91,0.9357,0.53,0.89,-0.6713,0.88,0.99
"GO_CC:490872_GO_0005859_MUSCLE_MYOSIN_COMPLEX","GO_CC","490872_GO_0005859_MUSCLE_MYOSIN_COMPLEX",18,-0.7573,0.81,1,-1.1371,0.28,0.72,0.9071,0.6,1
"KEGG_compound:C00105_UMP_URIDYLIC_ACID_URIDINE_MONOPHOSPHATE_URIDINE_5_MONOPHOSPHATE_5_URIDYLIC_ACID","KEGG_compound","C00105_UMP_URIDYLIC_ACID_URIDINE_MONOPHOSPHATE_URIDINE_5_MONOPHOSPHATE_5_URIDYLIC_ACID",27,-0.7572,0.83,0.88,0.9816,0.46,1,-1.2419,0.17,0.42
"GO_BP:513459_GO_0055026_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","513459_GO_0055026_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",16,-0.7572,0.8,0.92,0.8022,0.75,1,1.2976,0.12,0.67
"GO_BP:492020_GO_0007224_SMOOTHENED_SIGNALING_PATHWAY","GO_BP","492020_GO_0007224_SMOOTHENED_SIGNALING_PATHWAY",73,-0.757,0.9,0.92,-1.1597,0.2,0.92,-0.8571,0.77,0.96
"GO_BP:508799_GO_0046543_DEVELOPMENT_OF_SECONDARY_FEMALE_SEXUAL_CHARACTERISTICS","GO_BP","508799_GO_0046543_DEVELOPMENT_OF_SECONDARY_FEMALE_SEXUAL_CHARACTERISTICS",9,-0.757,0.79,0.92,1.1585,0.3,0.83,0.9415,0.5,0.91
"REACTOME:1127507_REACT_268425_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM","REACTOME","1127507_REACT_268425_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM",5,-0.757,0.78,0.92,-0.6787,0.85,1,-0.8067,0.7,1
"GO_CC:505731_GO_0042611_MHC_PROTEIN_COMPLEX","GO_CC","505731_GO_0042611_MHC_PROTEIN_COMPLEX",35,-0.7568,0.84,0.99,0.5874,0.99,1,-0.5674,0.99,1
"C1_Positional:C1_ALL_75_CHR1Q43","C1_Positional","C1_ALL_75_CHR1Q43",15,-0.7566,0.82,0.99,0.9759,0.49,0.8,-0.9598,0.49,0.95
"GO_MF:496768_GO_0016879_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS","GO_MF","496768_GO_0016879_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS",57,-0.7566,0.87,0.92,-0.6454,0.98,1,-0.9365,0.57,0.85
"REACTOME:160941_REACT_21267_MITOTIC_G1_G1_S_PHASES","REACTOME","160941_REACT_21267_MITOTIC_G1_G1_S_PHASES",135,-0.7563,0.93,0.92,1.8774,0,0.01,-1.2383,0.082,0.57
"GO_CC:490732_GO_0005677_CHROMATIN_SILENCING_COMPLEX","GO_CC","490732_GO_0005677_CHROMATIN_SILENCING_COMPLEX",8,-0.7562,0.79,0.99,0.5666,0.95,1,-0.6284,0.92,1
"KEGG_reaction:R09408_AFLATOXIN_B1_OXYGEN_NADPH_H_AFLATOXIN_B1_EXO_8_9_EPOXIDE_H2O_NADP_","KEGG_reaction","R09408_AFLATOXIN_B1_OXYGEN_NADPH_H_AFLATOXIN_B1_EXO_8_9_EPOXIDE_H2O_NADP_",5,-0.7562,0.77,0.84,-0.8132,0.72,1,1.7118,0.018,0.029
"GO_BP:493384_GO_0009188_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493384_GO_0009188_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",7,-0.7561,0.79,0.92,0.7702,0.74,1,-0.7579,0.77,1
"GO_BP:512183_GO_0051298_CENTROSOME_DUPLICATION","GO_BP","512183_GO_0051298_CENTROSOME_DUPLICATION",23,-0.756,0.83,0.92,-1.2415,0.17,0.91,-1.5257,0.027,0.53
"GO_BP:502189_GO_0032967_POSITIVE_REGULATION_OF_COLLAGEN_BIOSYNTHETIC_PROCESS","GO_BP","502189_GO_0032967_POSITIVE_REGULATION_OF_COLLAGEN_BIOSYNTHETIC_PROCESS",23,-0.7556,0.85,0.92,-1.0275,0.43,0.97,1.3266,0.11,0.65
"GO_BP:512787_GO_0051937_CATECHOLAMINE_TRANSPORT","GO_BP","512787_GO_0051937_CATECHOLAMINE_TRANSPORT",14,-0.7556,0.78,0.92,1.0134,0.43,0.97,-1.3678,0.13,0.59
"GO_BP:510242_GO_0048087_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION","GO_BP","510242_GO_0048087_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION",9,-0.7555,0.78,0.92,1.1007,0.31,0.9,0.6387,0.91,1
"REACTOME:105764_REACT_1072_INACTIVATION_OF_APC_C_VIA_DIRECT_INHIBITION_OF_THE_APC_C_COMPLEX","REACTOME","105764_REACT_1072_INACTIVATION_OF_APC_C_VIA_DIRECT_INHIBITION_OF_THE_APC_C_COMPLEX",18,-0.7553,0.81,0.92,1.2103,0.21,0.43,-0.6055,0.96,1
"GO_BP:492556_GO_0008215_SPERMINE_METABOLIC_PROCESS","GO_BP","492556_GO_0008215_SPERMINE_METABOLIC_PROCESS",5,-0.7552,0.77,0.92,-1.0679,0.4,0.96,0.8054,0.7,1
"GO_BP:490967_GO_0005979_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS","GO_BP","490967_GO_0005979_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS",28,-0.7551,0.83,0.92,-0.3794,1,1,0.8471,0.69,0.98
"GO_BP:517064_GO_0072148_EPITHELIAL_CELL_FATE_COMMITMENT","GO_BP","517064_GO_0072148_EPITHELIAL_CELL_FATE_COMMITMENT",15,-0.7549,0.81,0.92,0.6992,0.87,1,1.3222,0.14,0.66
"REACTOME:833800_REACT_163933_INTERACTION_WITH_THE_ZONA_PELLUCIDA","REACTOME","833800_REACT_163933_INTERACTION_WITH_THE_ZONA_PELLUCIDA",8,-0.7547,0.77,0.92,-0.6481,0.93,1,0.9958,0.47,1
"GO_BP:505076_GO_0035907_DORSAL_AORTA_DEVELOPMENT","GO_BP","505076_GO_0035907_DORSAL_AORTA_DEVELOPMENT",6,-0.7543,0.8,0.92,-0.7976,0.71,1,1.1905,0.26,0.72
"GO_BP:512367_GO_0051489_REGULATION_OF_FILOPODIUM_ASSEMBLY","GO_BP","512367_GO_0051489_REGULATION_OF_FILOPODIUM_ASSEMBLY",36,-0.754,0.83,0.92,0.7919,0.83,1,1.1954,0.2,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1030_CAFFAREL_RESPONSE_TO_THC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1030_CAFFAREL_RESPONSE_TO_THC_UP",33,-0.7538,0.86,0.92,0.6865,0.94,1,0.7523,0.85,1
"GO_BP:491302_GO_0006367_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER","GO_BP","491302_GO_0006367_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER",189,-0.7534,0.95,0.93,0.8063,0.95,1,0.8582,0.83,0.97
"GO_BP:506601_GO_0043570_MAINTENANCE_OF_DNA_REPEAT_ELEMENTS","GO_BP","506601_GO_0043570_MAINTENANCE_OF_DNA_REPEAT_ELEMENTS",5,-0.7531,0.78,0.93,-1.1695,0.31,0.91,-1.3105,0.17,0.64
"GO_BP:500888_GO_0031639_PLASMINOGEN_ACTIVATION","GO_BP","500888_GO_0031639_PLASMINOGEN_ACTIVATION",7,-0.7527,0.79,0.93,-1.2965,0.18,0.88,-1.3013,0.19,0.65
"C4_Cancer_modules:C4_CM_82_MODULE_87","C4_Cancer_modules","C4_CM_82_MODULE_87",44,-0.7526,0.87,0.93,1.8564,0.0022,0.013,-0.6358,0.98,1
"REACTOME:106332_REACT_13819_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS","REACTOME","106332_REACT_13819_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS",17,-0.7524,0.84,0.92,-0.9912,0.48,0.99,0.9293,0.56,1
"GO_BP:505669_GO_0042538_HYPEROSMOTIC_SALINITY_RESPONSE","GO_BP","505669_GO_0042538_HYPEROSMOTIC_SALINITY_RESPONSE",8,-0.7523,0.78,0.93,1.5077,0.052,0.4,1.1904,0.26,0.72
"C3_TF_targets:C3_TFT_510_RYAAAKNNNNNNTTGW_UNKNOWN","C3_TF_targets","C3_TFT_510_RYAAAKNNNNNNTTGW_UNKNOWN",80,-0.7523,0.9,0.98,0.8205,0.84,1,0.8588,0.78,1
"GO_MF:499978_GO_0030676_RAC_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY","GO_MF","499978_GO_0030676_RAC_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",13,-0.7522,0.8,0.92,-0.916,0.55,0.97,0.5786,0.97,1
"C1_Positional:C1_ALL_146_CHR16P12","C1_Positional","C1_ALL_146_CHR16P12",88,-0.752,0.9,0.99,-0.6982,0.97,0.98,-0.6634,1,0.99
"GO_CC:505711_GO_0042584_CHROMAFFIN_GRANULE_MEMBRANE","GO_CC","505711_GO_0042584_CHROMAFFIN_GRANULE_MEMBRANE",6,-0.752,0.78,1,0.9685,0.51,0.83,-1.3481,0.1,0.6
"C4_Cancer_gene_neighborhoods:C4_CGN_2_MORF_ATOX1","C4_Cancer_gene_neighborhoods","C4_CGN_2_MORF_ATOX1",80,-0.7519,0.9,1,2.0299,0,0.00024,-0.5136,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1346_CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE","C2_Chemical_and_genetic_perturbations","C2_CGP_1346_CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE",35,-0.7519,0.85,0.92,1.2252,0.19,0.47,-1.1562,0.23,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_3257_WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR","C2_Chemical_and_genetic_perturbations","C2_CGP_3257_WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR",29,-0.7519,0.82,0.92,0.8892,0.64,0.93,-0.7882,0.81,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_787_TERAMOTO_OPN_TARGETS_CLUSTER_6","C2_Chemical_and_genetic_perturbations","C2_CGP_787_TERAMOTO_OPN_TARGETS_CLUSTER_6",27,-0.7519,0.82,0.92,-1.4735,0.048,0.5,-1.426,0.061,0.33
"GO_BP:515791_GO_0070863_POSITIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM","GO_BP","515791_GO_0070863_POSITIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM",5,-0.7516,0.79,0.93,1.2987,0.19,0.67,-0.823,0.68,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1204_NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1204_NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON",152,-0.7515,0.95,0.92,1.0617,0.29,0.69,0.9775,0.5,0.96
"GO_CC:486686_GO_0000152_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX","GO_CC","486686_GO_0000152_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX",38,-0.7512,0.85,1,1.0565,0.36,0.71,-0.7892,0.83,1
"C7_Immunologic_signatures:C7_ALL_1739_GSE5960_TH1_VS_ANERGIC_TH1_UP","C7_Immunologic_signatures","C7_ALL_1739_GSE5960_TH1_VS_ANERGIC_TH1_UP",197,-0.7512,0.96,0.98,1.778,0,0.00021,0.7688,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_652_IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM","C2_Chemical_and_genetic_perturbations","C2_CGP_652_IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM",31,-0.7511,0.84,0.92,1.1708,0.24,0.53,-1.0276,0.43,0.71
"GO_BP:518151_GO_0090004_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE","GO_BP","518151_GO_0090004_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE",26,-0.7511,0.83,0.93,0.8037,0.77,1,1.441,0.062,0.59
"GO_BP:506174_GO_0043094_CELLULAR_METABOLIC_COMPOUND_SALVAGE","GO_BP","506174_GO_0043094_CELLULAR_METABOLIC_COMPOUND_SALVAGE",37,-0.751,0.86,0.93,-0.738,0.87,1,-1.1695,0.21,0.73
"REACTOME:106328_REACT_13698_REGULATION_OF_BETA_CELL_DEVELOPMENT","REACTOME","106328_REACT_13698_REGULATION_OF_BETA_CELL_DEVELOPMENT",26,-0.7508,0.84,0.92,-0.9463,0.54,1,1.2118,0.2,0.84
"GO_BP:504619_GO_0035435_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","504619_GO_0035435_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORT",12,-0.7508,0.8,0.93,-0.582,0.96,1,-0.8646,0.64,0.95
"GO_BP:491284_GO_0048096_CHROMATIN_MEDIATED_MAINTENANCE_OF_TRANSCRIPTION","GO_BP","491284_GO_0048096_CHROMATIN_MEDIATED_MAINTENANCE_OF_TRANSCRIPTION",7,-0.7508,0.79,0.93,-0.7194,0.82,1,-0.9685,0.48,0.88
"GO_BP:516425_GO_0071501_CELLULAR_RESPONSE_TO_STEROL_DEPLETION","GO_BP","516425_GO_0071501_CELLULAR_RESPONSE_TO_STEROL_DEPLETION",9,-0.7507,0.8,0.93,-0.8501,0.66,1,-0.6301,0.89,1
"C1_Positional:C1_ALL_199_CHR2P21","C1_Positional","C1_ALL_199_CHR2P21",41,-0.7504,0.88,0.98,-1.0688,0.35,1,-0.6804,0.97,0.99
"GO_BP:495288_GO_0014896_MUSCLE_HYPERTROPHY","GO_BP","495288_GO_0014896_MUSCLE_HYPERTROPHY",24,-0.7503,0.82,0.93,-0.7614,0.83,1,1.4263,0.076,0.61
"GO_CC:507409_GO_0044462_EXTERNAL_ENCAPSULATING_STRUCTURE_PART","GO_CC","507409_GO_0044462_EXTERNAL_ENCAPSULATING_STRUCTURE_PART",14,-0.7503,0.79,1,1.2333,0.17,0.48,1.5765,0.036,0.46
"GO_BP:782528_GO_1902017_REGULATION_OF_CILIUM_ASSEMBLY","GO_BP","782528_GO_1902017_REGULATION_OF_CILIUM_ASSEMBLY",40,-0.7502,0.85,0.93,-0.6111,0.98,1,-1.2039,0.18,0.73
"WikiPathways:198846_WP28_SELENIUM_METABOLISM_AND_SELENOPROTEINS","WikiPathways","198846_WP28_SELENIUM_METABOLISM_AND_SELENOPROTEINS",40,-0.7498,0.87,0.91,0.9564,0.53,1,-0.8566,0.71,0.92
"GO_BP:493382_GO_0009186_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS","GO_BP","493382_GO_0009186_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS",9,-0.7498,0.82,0.93,1.2179,0.22,0.76,-0.6279,0.91,1
"C1_Positional:C1_ALL_3_CHR8Q24","C1_Positional","C1_ALL_3_CHR8Q24",154,-0.7498,0.93,0.98,-0.7784,0.96,0.97,-0.8348,0.91,0.98
"GO_MF:489467_GO_0003995_ACYL_COA_DEHYDROGENASE_ACTIVITY","GO_MF","489467_GO_0003995_ACYL_COA_DEHYDROGENASE_ACTIVITY",15,-0.7496,0.82,0.93,0.625,0.92,1,-1.8266,0.0062,0.19
"C7_Immunologic_signatures:C7_ALL_772_GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_772_GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN",199,-0.7495,0.96,0.98,1.0091,0.42,0.71,0.8854,0.78,1
"GO_BP:948271_GO_1902686_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_PROGRAMMED_CELL_DEATH","GO_BP","948271_GO_1902686_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_PROGRAMMED_CELL_DEATH",12,-0.7494,0.82,0.93,1.3029,0.15,0.66,-1.331,0.14,0.62
"GO_BP:514567_GO_0061013_REGULATION_OF_MRNA_CATABOLIC_PROCESS","GO_BP","514567_GO_0061013_REGULATION_OF_MRNA_CATABOLIC_PROCESS",21,-0.7489,0.8,0.93,-0.807,0.75,1,-1.0825,0.34,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_1185_MORI_PLASMA_CELL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1185_MORI_PLASMA_CELL_DN",33,-0.7488,0.84,0.92,1.1733,0.23,0.53,-0.883,0.68,0.9
"GO_BP:497802_GO_0018904_ETHER_METABOLIC_PROCESS","GO_BP","497802_GO_0018904_ETHER_METABOLIC_PROCESS",24,-0.7488,0.83,0.93,1.0434,0.38,0.95,-1.2916,0.14,0.65
"KEGG_compound:C00044_GTP_GUANOSINE_5_TRIPHOSPHATE","KEGG_compound","C00044_GTP_GUANOSINE_5_TRIPHOSPHATE",81,-0.7488,0.91,0.88,0.6633,1,1,-1.3017,0.058,0.36
"C7_Immunologic_signatures:C7_ALL_1677_GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1677_GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP",193,-0.7488,0.95,0.98,1.0772,0.25,0.51,-1.2855,0.041,0.15
"C7_Immunologic_signatures:C7_ALL_1539_GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1539_GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP",195,-0.7486,0.96,0.98,1.394,0.0024,0.039,0.9953,0.47,1
"GO_CC:487164_GO_0000940_CONDENSED_CHROMOSOME_OUTER_KINETOCHORE","GO_CC","487164_GO_0000940_CONDENSED_CHROMOSOME_OUTER_KINETOCHORE",13,-0.7482,0.8,1,1.0415,0.38,0.72,-0.8614,0.65,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2936_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10","C2_Chemical_and_genetic_perturbations","C2_CGP_2936_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10",69,-0.7481,0.89,0.92,1.989,0,0.0072,-1.1811,0.17,0.54
"GO_BP:505868_GO_0042762_REGULATION_OF_SULFUR_METABOLIC_PROCESS","GO_BP","505868_GO_0042762_REGULATION_OF_SULFUR_METABOLIC_PROCESS",18,-0.748,0.83,0.93,1.1829,0.24,0.8,-1.0951,0.32,0.78
"GO_BP:513675_GO_0060117_AUDITORY_RECEPTOR_CELL_DEVELOPMENT","GO_BP","513675_GO_0060117_AUDITORY_RECEPTOR_CELL_DEVELOPMENT",16,-0.7479,0.82,0.93,0.5099,1,1,0.8811,0.63,0.95
"GO_BP:493903_GO_0009799_SPECIFICATION_OF_SYMMETRY","GO_BP","493903_GO_0009799_SPECIFICATION_OF_SYMMETRY",100,-0.7478,0.92,0.93,-1.0317,0.39,0.98,1.2745,0.089,0.69
"C4_Cancer_gene_neighborhoods:C4_CGN_264_GCM_SMARCC1","C4_Cancer_gene_neighborhoods","C4_CGN_264_GCM_SMARCC1",37,-0.7476,0.86,1,1.19,0.21,0.23,-0.6969,0.93,1
"GO_MF:490264_GO_0004977_MELANOCORTIN_RECEPTOR_ACTIVITY","GO_MF","490264_GO_0004977_MELANOCORTIN_RECEPTOR_ACTIVITY",6,-0.7476,0.8,0.93,-0.8662,0.62,1,0.7687,0.75,1
"C7_Immunologic_signatures:C7_ALL_726_GSE17721_4H_VS_24H_POLYIC_BMDM_DN","C7_Immunologic_signatures","C7_ALL_726_GSE17721_4H_VS_24H_POLYIC_BMDM_DN",200,-0.7476,0.96,0.98,1.1981,0.07,0.23,0.7961,0.96,1
"C7_Immunologic_signatures:C7_ALL_515_GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_515_GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDM_UP",195,-0.7475,0.96,0.98,1.3342,0.024,0.073,-1.0328,0.38,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1032_CAFFAREL_RESPONSE_TO_THC_8HR_5_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1032_CAFFAREL_RESPONSE_TO_THC_8HR_5_UP",16,-0.7474,0.83,0.92,0.8222,0.71,0.98,-0.8451,0.65,0.93
"GO_BP:498168_GO_0019323_PENTOSE_CATABOLIC_PROCESS","GO_BP","498168_GO_0019323_PENTOSE_CATABOLIC_PROCESS",5,-0.7473,0.77,0.93,0.805,0.7,1,-0.6427,0.88,1
"C7_Immunologic_signatures:C7_ALL_1604_GSE3982_EOSINOPHIL_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_1604_GSE3982_EOSINOPHIL_VS_TH1_DN",198,-0.7471,0.95,0.98,1.6458,0,0.0013,-1.4616,0.002,0.033
"GO_BP:508901_GO_0046655_FOLIC_ACID_METABOLIC_PROCESS","GO_BP","508901_GO_0046655_FOLIC_ACID_METABOLIC_PROCESS",10,-0.747,0.8,0.93,-0.7828,0.75,1,-1.405,0.098,0.58
"GO_BP:507327_GO_0044321_RESPONSE_TO_LEPTIN","GO_BP","507327_GO_0044321_RESPONSE_TO_LEPTIN",13,-0.7469,0.81,0.93,1.0288,0.43,0.97,0.9232,0.54,0.92
"C7_Immunologic_signatures:C7_ALL_256_GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_256_GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN",194,-0.7468,0.96,0.98,0.6877,1,1,-0.8478,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2902_WONG_EMBRYONIC_STEM_CELL_CORE","C2_Chemical_and_genetic_perturbations","C2_CGP_2902_WONG_EMBRYONIC_STEM_CELL_CORE",335,-0.7468,0.98,0.92,2.2548,0,0.00039,-1.2781,0.026,0.45
"GO_BP:504645_GO_0035461_VITAMIN_TRANSMEMBRANE_TRANSPORT","GO_BP","504645_GO_0035461_VITAMIN_TRANSMEMBRANE_TRANSPORT",8,-0.7468,0.79,0.93,-1.0458,0.39,0.97,-1.0277,0.43,0.82
"GO_MF:490013_GO_0004693_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY","GO_MF","490013_GO_0004693_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY",32,-0.7468,0.87,0.93,-0.9523,0.52,0.95,-1.5339,0.024,0.4
"GO_BP:948904_GO_1902749_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION","GO_BP","948904_GO_1902749_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION",39,-0.7465,0.87,0.93,1.2677,0.12,0.71,-0.8756,0.68,0.95
"GO_BP:492319_GO_0007569_CELL_AGING","GO_BP","492319_GO_0007569_CELL_AGING",61,-0.7462,0.89,0.93,-0.6129,0.99,1,-0.6556,0.99,1
"GO_CC:505927_GO_0042827_PLATELET_DENSE_GRANULE","GO_CC","505927_GO_0042827_PLATELET_DENSE_GRANULE",6,-0.7461,0.79,1,0.7217,0.82,0.99,-0.8019,0.73,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1297_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS","C2_Chemical_and_genetic_perturbations","C2_CGP_1297_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS",65,-0.746,0.9,0.92,1.3933,0.03,0.3,-1.2708,0.092,0.45
"C7_Immunologic_signatures:C7_ALL_78_GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN","C7_Immunologic_signatures","C7_ALL_78_GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN",196,-0.7459,0.95,0.98,1.2204,0.076,0.19,1.1119,0.22,0.96
"GO_CC:493534_GO_0045240_DIHYDROLIPOYL_DEHYDROGENASE_COMPLEX","GO_CC","493534_GO_0045240_DIHYDROLIPOYL_DEHYDROGENASE_COMPLEX",8,-0.7459,0.79,1,0.6064,0.92,0.99,-1.6064,0.021,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_798_MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_798_MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP",19,-0.7458,0.83,0.92,1.4468,0.063,0.26,0.6955,0.87,1
"KEGG_compound:C00025_L_GLUTAMATE_L_GLUTAMIC_ACID_L_GLUTAMINIC_ACID_GLUTAMATE","KEGG_compound","C00025_L_GLUTAMATE_L_GLUTAMIC_ACID_L_GLUTAMINIC_ACID_GLUTAMATE",53,-0.7457,0.87,0.89,-0.8232,0.8,1,-1.3514,0.064,0.33
"REACTOME:685551_REACT_147797_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF_","REACTOME","685551_REACT_147797_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF_",54,-0.7454,0.9,0.93,-0.3886,1,1,-1.0634,0.35,0.75
"GO_CC:498582_GO_0019773_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX","GO_CC","498582_GO_0019773_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",8,-0.7454,0.79,0.99,1.5085,0.059,0.19,-0.6399,0.91,1
"GO_BP:503454_GO_0034249_NEGATIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS","GO_BP","503454_GO_0034249_NEGATIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS",7,-0.7452,0.78,0.93,-0.7233,0.81,1,-0.6617,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2751_YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2751_YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN",9,-0.7452,0.8,0.92,0.6314,0.9,1,0.7256,0.81,1
"KEGG_pathway:HSA01210_2_OXOCARBOXYLIC_ACID_METABOLISM","KEGG_pathway","HSA01210_2_OXOCARBOXYLIC_ACID_METABOLISM",17,-0.745,0.82,0.92,0.7434,0.82,1,-1.1739,0.25,0.4
"GO_CC:507627_GO_0045261_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_CATALYTIC_CORE_F_1_","GO_CC","507627_GO_0045261_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_CATALYTIC_CORE_F_1_",6,-0.745,0.8,0.99,1.5247,0.047,0.18,-0.5919,0.94,1
"GO_CC:490762_GO_0005720_NUCLEAR_HETEROCHROMATIN","GO_CC","490762_GO_0005720_NUCLEAR_HETEROCHROMATIN",33,-0.7449,0.85,0.99,-0.7767,0.81,1,-0.7868,0.85,1
"GO_BP:498707_GO_0019934_CGMP_MEDIATED_SIGNALING","GO_BP","498707_GO_0019934_CGMP_MEDIATED_SIGNALING",9,-0.7444,0.82,0.93,1.3755,0.12,0.58,1.0931,0.37,0.77
"GO_MF:489332_GO_0003831_BETA_N_ACETYLGLUCOSAMINYLGLYCOPEPTIDE_BETA_1_4_GALACTOSYLTRANSFERASE_ACTIVITY","GO_MF","489332_GO_0003831_BETA_N_ACETYLGLUCOSAMINYLGLYCOPEPTIDE_BETA_1_4_GALACTOSYLTRANSFERASE_ACTIVITY",5,-0.7443,0.8,0.93,-0.6046,0.93,1,-0.5188,0.97,1
"GO_BP:506679_GO_0043649_DICARBOXYLIC_ACID_CATABOLIC_PROCESS","GO_BP","506679_GO_0043649_DICARBOXYLIC_ACID_CATABOLIC_PROCESS",14,-0.744,0.81,0.93,1.4611,0.083,0.48,-0.9614,0.51,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1319_CHANG_POU5F1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1319_CHANG_POU5F1_TARGETS_UP",15,-0.7439,0.79,0.92,-1.4434,0.054,0.53,-1.0946,0.33,0.63
"GO_MF:496125_GO_0016015_MORPHOGEN_ACTIVITY","GO_MF","496125_GO_0016015_MORPHOGEN_ACTIVITY",5,-0.7439,0.79,0.93,-1.0196,0.44,0.89,1.3204,0.17,0.67
"GO_CC:752948_GO_0097449_ASTROCYTE_PROJECTION","GO_CC","752948_GO_0097449_ASTROCYTE_PROJECTION",7,-0.7435,0.78,0.99,-1.0619,0.38,0.82,0.8702,0.63,1
"GO_BP:489205_GO_0003413_CHONDROCYTE_DIFFERENTIATION_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS","GO_BP","489205_GO_0003413_CHONDROCYTE_DIFFERENTIATION_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS",8,-0.7435,0.8,0.93,-1.6004,0.035,0.68,-1.2171,0.23,0.71
"C7_Immunologic_signatures:C7_ALL_1234_GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1234_GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN",198,-0.7433,0.97,0.98,1.646,0,0.0013,-0.8283,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_727_HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_727_HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER",6,-0.7432,0.77,0.92,0.8813,0.6,0.94,1.1564,0.31,0.83
"REACTOME:106016_REACT_9406_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION","REACTOME","106016_REACT_9406_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION",5,-0.743,0.79,0.93,1.286,0.2,0.34,-0.9148,0.59,0.94
"GO_BP:508586_GO_0046321_POSITIVE_REGULATION_OF_FATTY_ACID_OXIDATION","GO_BP","508586_GO_0046321_POSITIVE_REGULATION_OF_FATTY_ACID_OXIDATION",12,-0.7428,0.8,0.93,1.1286,0.31,0.87,1.1591,0.25,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_561_SHIRAISHI_PLZF_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_561_SHIRAISHI_PLZF_TARGETS_DN",8,-0.7426,0.81,0.92,1.2088,0.21,0.48,-1.68,0.0084,0.2
"REACTOME:105751_REACT_897_G2_M_DNA_DAMAGE_CHECKPOINT","REACTOME","105751_REACT_897_G2_M_DNA_DAMAGE_CHECKPOINT",16,-0.7424,0.82,0.93,0.4985,0.99,1,-0.9832,0.47,0.87
"GO_BP:497263_GO_0018298_PROTEIN_CHROMOPHORE_LINKAGE","GO_BP","497263_GO_0018298_PROTEIN_CHROMOPHORE_LINKAGE",11,-0.7423,0.81,0.93,-1.4445,0.09,0.91,-1.4707,0.05,0.54
"KEGG_pathway:HSA04710_CIRCADIAN_RHYTHM","KEGG_pathway","HSA04710_CIRCADIAN_RHYTHM",30,-0.7422,0.85,0.92,0.535,0.99,1,1.1816,0.2,0.64
"GO_MF:494259_GO_0010181_FMN_BINDING","GO_MF","494259_GO_0010181_FMN_BINDING",15,-0.7421,0.8,0.93,-0.9708,0.51,0.94,0.9733,0.5,0.89
"GO_BP:501695_GO_0032463_NEGATIVE_REGULATION_OF_PROTEIN_HOMOOLIGOMERIZATION","GO_BP","501695_GO_0032463_NEGATIVE_REGULATION_OF_PROTEIN_HOMOOLIGOMERIZATION",6,-0.742,0.79,0.93,1.0637,0.41,0.94,-1.1257,0.33,0.75
"GO_BP:505092_GO_0038003_OPIOID_RECEPTOR_SIGNALING_PATHWAY","GO_BP","505092_GO_0038003_OPIOID_RECEPTOR_SIGNALING_PATHWAY",8,-0.7419,0.81,0.93,0.634,0.91,1,0.8079,0.71,1
"GO_BP:849872_GO_1902170_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES","GO_BP","849872_GO_1902170_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES",13,-0.7415,0.81,0.93,0.6495,0.9,1,0.9117,0.56,0.93
"GO_CC:499509_GO_0030061_MITOCHONDRIAL_CRISTA","GO_CC","499509_GO_0030061_MITOCHONDRIAL_CRISTA",7,-0.7415,0.79,0.99,0.6159,0.92,0.99,1.679,0.01,0.37
"GO_BP:494634_GO_0010569_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION","GO_BP","494634_GO_0010569_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION",15,-0.7415,0.81,0.93,1.0734,0.37,0.93,0.7832,0.75,1
"GO_BP:516994_GO_0072077_RENAL_VESICLE_MORPHOGENESIS","GO_BP","516994_GO_0072077_RENAL_VESICLE_MORPHOGENESIS",12,-0.7415,0.83,0.93,-0.9958,0.46,0.99,1.6558,0.014,0.39
"C4_Cancer_modules:C4_CM_423_MODULE_560","C4_Cancer_modules","C4_CM_423_MODULE_560",12,-0.7414,0.78,0.94,0.5063,0.99,1,1.2808,0.17,0.5
"GO_BP:488233_GO_0002360_T_CELL_LINEAGE_COMMITMENT","GO_BP","488233_GO_0002360_T_CELL_LINEAGE_COMMITMENT",12,-0.7414,0.81,0.93,-1.392,0.082,1,-0.8446,0.67,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1956_GENTILE_RESPONSE_CLUSTER_D3","C2_Chemical_and_genetic_perturbations","C2_CGP_1956_GENTILE_RESPONSE_CLUSTER_D3",61,-0.7411,0.9,0.93,1.2199,0.14,0.47,-0.8287,0.8,0.94
"GO_BP:494360_GO_0010288_RESPONSE_TO_LEAD_ION","GO_BP","494360_GO_0010288_RESPONSE_TO_LEAD_ION",12,-0.7409,0.82,0.93,1.1234,0.29,0.88,0.9401,0.54,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1211_NIKOLSKY_BREAST_CANCER_16P13_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1211_NIKOLSKY_BREAST_CANCER_16P13_AMPLICON",114,-0.7409,0.93,0.93,-0.9872,0.47,1,-0.9985,0.43,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_1477_STONER_ESOPHAGEAL_CARCINOGENESIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1477_STONER_ESOPHAGEAL_CARCINOGENESIS_DN",7,-0.7409,0.79,0.93,-0.5748,0.96,1,0.7316,0.79,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2379_YAGUE_PRETUMOR_DRUG_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2379_YAGUE_PRETUMOR_DRUG_RESISTANCE_UP",8,-0.7408,0.81,0.92,-0.5206,0.97,1,1.17,0.27,0.8
"REACTOME:106424_REACT_762_IRS_RELATED_EVENTS","REACTOME","106424_REACT_762_IRS_RELATED_EVENTS",81,-0.7408,0.91,0.93,0.8015,0.87,0.99,-0.6528,0.99,1
"GO_BP:509012_GO_0046785_MICROTUBULE_POLYMERIZATION","GO_BP","509012_GO_0046785_MICROTUBULE_POLYMERIZATION",21,-0.7407,0.86,0.93,0.5632,0.98,1,-0.794,0.75,0.99
"GO_BP:514306_GO_0060751_BRANCH_ELONGATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_BRANCHING","GO_BP","514306_GO_0060751_BRANCH_ELONGATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_BRANCHING",6,-0.7407,0.8,0.93,0.9437,0.51,1,1.0022,0.45,0.85
"GO_MF:492858_GO_0008603_CAMP_DEPENDENT_PROTEIN_KINASE_REGULATOR_ACTIVITY","GO_MF","492858_GO_0008603_CAMP_DEPENDENT_PROTEIN_KINASE_REGULATOR_ACTIVITY",9,-0.7407,0.82,0.93,0.7998,0.72,1,0.7416,0.81,1
"GO_BP:487500_GO_0001561_FATTY_ACID_ALPHA_OXIDATION","GO_BP","487500_GO_0001561_FATTY_ACID_ALPHA_OXIDATION",6,-0.7407,0.81,0.93,1.4261,0.092,0.52,0.7131,0.83,1
"GO_CC:501818_GO_0032592_INTEGRAL_COMPONENT_OF_MITOCHONDRIAL_MEMBRANE","GO_CC","501818_GO_0032592_INTEGRAL_COMPONENT_OF_MITOCHONDRIAL_MEMBRANE",39,-0.7407,0.88,0.99,0.9374,0.55,0.85,-0.6933,0.95,1
"C3_MicroRNA_targets:C3_MIR_48_CGCTGCT_MIR_503","C3_MicroRNA_targets","C3_MIR_48_CGCTGCT_MIR_503",24,-0.7406,0.82,0.98,-0.8275,0.73,1,1.3653,0.094,0.97
"GO_CC:500493_GO_0031232_EXTRINSIC_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE","GO_CC","500493_GO_0031232_EXTRINSIC_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE",7,-0.7405,0.8,0.99,-1.2477,0.21,0.64,-1.0079,0.44,1
"KEGG_pathway:HSA00534_GLYCOSAMINOGLYCAN_BIOSYNTHESIS","KEGG_pathway","HSA00534_GLYCOSAMINOGLYCAN_BIOSYNTHESIS",24,-0.7403,0.84,0.92,1.3527,0.12,0.27,1.0734,0.35,1
"GO_BP:493587_GO_0009414_RESPONSE_TO_WATER_DEPRIVATION","GO_BP","493587_GO_0009414_RESPONSE_TO_WATER_DEPRIVATION",5,-0.7403,0.8,0.93,0.7693,0.77,1,-0.861,0.62,0.96
"KEGG_pathway:HSA04966_COLLECTING_DUCT_ACID_SECRETION","KEGG_pathway","HSA04966_COLLECTING_DUCT_ACID_SECRETION",26,-0.7402,0.85,0.92,1.0787,0.35,0.82,0.9446,0.54,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_560_SHIRAISHI_PLZF_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_560_SHIRAISHI_PLZF_TARGETS_UP",10,-0.7399,0.81,0.93,-0.719,0.84,1,0.7204,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_432_VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_432_VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN",36,-0.7396,0.86,0.93,0.6598,0.95,1,-0.5505,1,0.99
"GO_BP:491177_GO_0006213_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS","GO_BP","491177_GO_0006213_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS",51,-0.7395,0.9,0.94,0.7124,0.94,1,-0.9982,0.45,0.85
"GO_BP:518602_GO_0097052_L_KYNURENINE_METABOLIC_PROCESS","GO_BP","518602_GO_0097052_L_KYNURENINE_METABOLIC_PROCESS",5,-0.7395,0.82,0.94,0.7603,0.77,1,-1.3542,0.14,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_2304_BERNARD_PPAPDC1B_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2304_BERNARD_PPAPDC1B_TARGETS_UP",40,-0.7392,0.88,0.93,1.169,0.23,0.53,1.0995,0.29,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1288_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS","C2_Chemical_and_genetic_perturbations","C2_CGP_1288_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS",184,-0.7391,0.96,0.93,1.3308,0.023,0.36,-0.9411,0.63,0.83
"C7_Immunologic_signatures:C7_ALL_348_GSE15215_CD2_POS_VS_NEG_PDC_DN","C7_Immunologic_signatures","C7_ALL_348_GSE15215_CD2_POS_VS_NEG_PDC_DN",200,-0.739,0.97,0.99,1.3552,0.016,0.059,-0.8782,0.81,0.98
"GO_BP:514649_GO_0061101_NEUROENDOCRINE_CELL_DIFFERENTIATION","GO_BP","514649_GO_0061101_NEUROENDOCRINE_CELL_DIFFERENTIATION",7,-0.7385,0.81,0.94,-1.2003,0.27,0.9,0.678,0.88,1
"GO_BP:500693_GO_0031442_POSITIVE_REGULATION_OF_MRNA_3_END_PROCESSING","GO_BP","500693_GO_0031442_POSITIVE_REGULATION_OF_MRNA_3_END_PROCESSING",16,-0.7383,0.82,0.94,-0.8932,0.6,1,-1.0255,0.41,0.83
"C7_Immunologic_signatures:C7_ALL_1321_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP","C7_Immunologic_signatures","C7_ALL_1321_GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP",198,-0.7383,0.97,0.99,0.8818,0.8,1,-1.0259,0.36,0.67
"GO_BP:753236_GO_1900246_POSITIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY","GO_BP","753236_GO_1900246_POSITIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY",6,-0.7383,0.78,0.94,0.8228,0.69,1,-1.3938,0.12,0.58
"REACTOME:105834_REACT_6867_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE","REACTOME","105834_REACT_6867_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE",17,-0.738,0.82,0.93,1.0452,0.38,0.67,-0.5394,1,1
"GO_MF:490272_GO_0004985_OPIOID_RECEPTOR_ACTIVITY","GO_MF","490272_GO_0004985_OPIOID_RECEPTOR_ACTIVITY",8,-0.7373,0.81,0.93,0.6382,0.9,1,0.8061,0.7,1
"C4_Cancer_gene_neighborhoods:C4_CGN_43_MORF_RPA2","C4_Cancer_gene_neighborhoods","C4_CGN_43_MORF_RPA2",193,-0.7372,0.96,1,1.3469,0.022,0.087,-0.9385,0.63,0.98
"GO_MF:777519_GO_0097472_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY","GO_MF","777519_GO_0097472_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY",32,-0.737,0.84,0.93,-0.9537,0.54,0.95,-1.5346,0.014,0.4
"REACTOME:105866_REACT_97_RECRUITMENT_OF_REPAIR_AND_SIGNALING_PROTEINS_TO_DOUBLE_STRAND_BREAKS","REACTOME","105866_REACT_97_RECRUITMENT_OF_REPAIR_AND_SIGNALING_PROTEINS_TO_DOUBLE_STRAND_BREAKS",8,-0.737,0.8,0.93,-0.9099,0.56,1,-1.2295,0.22,0.57
"GO_BP:1039915_GO_1903361_PROTEIN_LOCALIZATION_TO_BASOLATERAL_PLASMA_MEMBRANE","GO_BP","1039915_GO_1903361_PROTEIN_LOCALIZATION_TO_BASOLATERAL_PLASMA_MEMBRANE",5,-0.7366,0.78,0.94,1.4078,0.1,0.55,0.8515,0.63,0.98
"GO_CC:486900_GO_0000407_PRE_AUTOPHAGOSOMAL_STRUCTURE","GO_CC","486900_GO_0000407_PRE_AUTOPHAGOSOMAL_STRUCTURE",35,-0.7366,0.86,0.99,0.7853,0.81,0.96,-0.5577,0.99,1
"GO_BP:491753_GO_0006893_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT","GO_BP","491753_GO_0006893_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT",38,-0.7365,0.87,0.94,0.7451,0.9,1,-0.7017,0.94,0.99
"GO_BP:493396_GO_0009200_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS","GO_BP","493396_GO_0009200_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS",18,-0.7365,0.83,0.94,1.0029,0.45,0.98,-1.2675,0.15,0.67
"GO_BP:519313_GO_2000674_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS","GO_BP","519313_GO_2000674_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS",9,-0.7365,0.81,0.94,1.0206,0.4,0.97,0.8659,0.6,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1089_RICKMAN_HEAD_AND_NECK_CANCER_D","C2_Chemical_and_genetic_perturbations","C2_CGP_1089_RICKMAN_HEAD_AND_NECK_CANCER_D",30,-0.7364,0.86,0.93,1.126,0.26,0.59,0.9625,0.49,0.97
"GO_BP:515814_GO_0070886_POSITIVE_REGULATION_OF_CALCINEURIN_NFAT_SIGNALING_CASCADE","GO_BP","515814_GO_0070886_POSITIVE_REGULATION_OF_CALCINEURIN_NFAT_SIGNALING_CASCADE",5,-0.7361,0.82,0.94,-0.8029,0.73,1,0.6726,0.85,1
"GO_MF:486775_GO_0005283_SODIUM_AMINO_ACID_SYMPORTER_ACTIVITY","GO_MF","486775_GO_0005283_SODIUM_AMINO_ACID_SYMPORTER_ACTIVITY",9,-0.7361,0.8,0.93,-1.3226,0.15,0.72,-1.4907,0.052,0.42
"C7_Immunologic_signatures:C7_ALL_1644_GSE3982_DC_VS_TH2_DN","C7_Immunologic_signatures","C7_ALL_1644_GSE3982_DC_VS_TH2_DN",198,-0.7361,0.97,0.99,1.2391,0.041,0.17,-1.1683,0.14,0.34
"C2_Chemical_and_genetic_perturbations:C2_CGP_1079_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1079_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN",5,-0.7359,0.79,0.93,-1.015,0.46,0.99,-0.8157,0.7,0.94
"GO_CC:496438_GO_0016461_UNCONVENTIONAL_MYOSIN_COMPLEX","GO_CC","496438_GO_0016461_UNCONVENTIONAL_MYOSIN_COMPLEX",8,-0.7357,0.81,0.99,-0.5992,0.92,1,-0.6453,0.9,1
"GO_BP:495992_GO_0015868_PURINE_RIBONUCLEOTIDE_TRANSPORT","GO_BP","495992_GO_0015868_PURINE_RIBONUCLEOTIDE_TRANSPORT",7,-0.7356,0.8,0.94,-0.8055,0.72,1,-1.3535,0.14,0.6
"REACTOME:1127521_REACT_264178_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX","REACTOME","1127521_REACT_264178_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX",42,-0.7356,0.89,0.93,0.7482,0.89,1,0.8161,0.81,1
"GO_BP:503703_GO_0034501_PROTEIN_LOCALIZATION_TO_KINETOCHORE","GO_BP","503703_GO_0034501_PROTEIN_LOCALIZATION_TO_KINETOCHORE",10,-0.7349,0.84,0.94,0.7436,0.8,1,-0.7781,0.75,1
"GO_MF:492663_GO_0008353_RNA_POLYMERASE_II_CARBOXY_TERMINAL_DOMAIN_KINASE_ACTIVITY","GO_MF","492663_GO_0008353_RNA_POLYMERASE_II_CARBOXY_TERMINAL_DOMAIN_KINASE_ACTIVITY",17,-0.7349,0.82,0.94,0.5899,0.97,1,-0.9342,0.54,0.84
"GO_MF:499847_GO_0030507_SPECTRIN_BINDING","GO_MF","499847_GO_0030507_SPECTRIN_BINDING",25,-0.7348,0.85,0.93,0.7819,0.81,1,1.1987,0.19,0.72
"C3_TF_targets:C3_TFT_250_V_E2F_Q6","C3_TF_targets","C3_TFT_250_V_E2F_Q6",232,-0.7346,0.97,1,0.7738,0.98,1,-1.3357,0.014,0.25
"C2_Chemical_and_genetic_perturbations:C2_CGP_3034_NOUSHMEHR_GBM_SILENCED_BY_METHYLATION","C2_Chemical_and_genetic_perturbations","C2_CGP_3034_NOUSHMEHR_GBM_SILENCED_BY_METHYLATION",50,-0.7346,0.88,0.93,0.9433,0.58,0.87,1.0762,0.34,0.88
"REACTOME:106281_REACT_957_PYRIMIDINE_METABOLISM","REACTOME","106281_REACT_957_PYRIMIDINE_METABOLISM",24,-0.7345,0.84,0.93,0.4611,1,1,0.7722,0.82,1
"C7_Immunologic_signatures:C7_ALL_398_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_398_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN",200,-0.7345,0.97,0.99,2.1568,0,0,-0.9815,0.5,0.77
"GO_BP:500692_GO_0031441_NEGATIVE_REGULATION_OF_MRNA_3_END_PROCESSING","GO_BP","500692_GO_0031441_NEGATIVE_REGULATION_OF_MRNA_3_END_PROCESSING",10,-0.7344,0.81,0.94,0.8403,0.68,1,-0.6252,0.93,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_209_BIOCARTA_CARM1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_209_BIOCARTA_CARM1_PATHWAY",13,-0.7344,0.82,0.87,1.1662,0.26,0.72,-0.9812,0.49,0.77
"GO_BP:754954_GO_2000848_POSITIVE_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION","GO_BP","754954_GO_2000848_POSITIVE_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION",7,-0.7341,0.81,0.94,1.7709,0.006,0.12,0.7635,0.78,1
"REACTOME:160979_REACT_993_PROPIONYL_COA_CATABOLISM","REACTOME","160979_REACT_993_PROPIONYL_COA_CATABOLISM",5,-0.7341,0.81,0.93,0.9519,0.54,0.83,-0.8746,0.63,0.96
"GO_MF:1129228_GO_0061659_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY","GO_MF","1129228_GO_0061659_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY",75,-0.734,0.9,0.93,0.9749,0.52,0.9,0.5916,1,1
"GO_BP:514304_GO_0060749_MAMMARY_GLAND_ALVEOLUS_DEVELOPMENT","GO_BP","514304_GO_0060749_MAMMARY_GLAND_ALVEOLUS_DEVELOPMENT",20,-0.7339,0.84,0.94,1.221,0.19,0.77,1.678,0.014,0.41
"C7_Immunologic_signatures:C7_ALL_339_GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_339_GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP",200,-0.7339,0.97,0.99,1.5519,0.0023,0.0061,0.7899,0.97,1
"GO_MF:506460_GO_0043422_PROTEIN_KINASE_B_BINDING","GO_MF","506460_GO_0043422_PROTEIN_KINASE_B_BINDING",11,-0.7338,0.81,0.93,-0.5393,0.98,1,0.5542,0.97,1
"GO_BP:494333_GO_0010259_MULTICELLULAR_ORGANISMAL_AGING","GO_BP","494333_GO_0010259_MULTICELLULAR_ORGANISMAL_AGING",26,-0.7332,0.85,0.94,-0.944,0.56,1,-1.2429,0.18,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_2467_BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2467_BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP",26,-0.732,0.87,0.93,-0.7465,0.84,1,-0.8637,0.67,0.91
"C3_TF_targets:C3_TFT_81_V_USF_01","C3_TF_targets","C3_TFT_81_V_USF_01",256,-0.7319,0.98,1,1.2779,0.014,0.49,0.9341,0.65,1
"C7_Immunologic_signatures:C7_ALL_1857_GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP","C7_Immunologic_signatures","C7_ALL_1857_GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP",197,-0.7318,0.97,0.99,1.2588,0.057,0.14,-0.7905,0.97,1
"GO_BP:516438_GO_0071514_GENETIC_IMPRINTING","GO_BP","516438_GO_0071514_GENETIC_IMPRINTING",24,-0.7316,0.85,0.94,-1.4328,0.063,0.92,0.8312,0.74,0.99
"C7_Immunologic_signatures:C7_ALL_796_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_796_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN",198,-0.7314,0.96,0.99,1.4599,0.0095,0.02,-1.4376,0,0.04
"GO_MF:750743_GO_0001191_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION","GO_MF","750743_GO_0001191_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION",36,-0.7314,0.89,0.94,1.0521,0.37,0.83,-1.4398,0.057,0.43
"GO_BP:488352_GO_0002479_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I_TAP_DEPENDENT","GO_BP","488352_GO_0002479_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I_TAP_DEPENDENT",75,-0.7313,0.93,0.94,2.0237,0,0.0095,0.5356,1,1
"GO_BP:502390_GO_0033169_HISTONE_H3_K9_DEMETHYLATION","GO_BP","502390_GO_0033169_HISTONE_H3_K9_DEMETHYLATION",8,-0.7309,0.81,0.94,-1.1702,0.27,0.91,0.5333,0.97,1
"GO_BP:495280_GO_0014887_CARDIAC_MUSCLE_ADAPTATION","GO_BP","495280_GO_0014887_CARDIAC_MUSCLE_ADAPTATION",12,-0.7308,0.83,0.94,-1.2973,0.15,0.88,0.8429,0.69,0.99
"GO_BP:513695_GO_0060137_MATERNAL_PROCESS_INVOLVED_IN_PARTURITION","GO_BP","513695_GO_0060137_MATERNAL_PROCESS_INVOLVED_IN_PARTURITION",7,-0.7307,0.78,0.94,0.9913,0.48,0.99,-0.8693,0.61,0.95
"GO_BP:514635_GO_0061087_POSITIVE_REGULATION_OF_HISTONE_H3_K27_METHYLATION","GO_BP","514635_GO_0061087_POSITIVE_REGULATION_OF_HISTONE_H3_K27_METHYLATION",6,-0.7307,0.8,0.94,-1.2477,0.21,0.91,-0.8863,0.61,0.94
"GO_BP:513843_GO_0060287_EPITHELIAL_CILIUM_MOVEMENT_INVOLVED_IN_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY","GO_BP","513843_GO_0060287_EPITHELIAL_CILIUM_MOVEMENT_INVOLVED_IN_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY",8,-0.7305,0.78,0.94,-1.5289,0.049,0.77,-0.7943,0.74,0.99
"C4_Cancer_gene_neighborhoods:C4_CGN_250_GCM_PFN1","C4_Cancer_gene_neighborhoods","C4_CGN_250_GCM_PFN1",51,-0.7303,0.9,1,2.3514,0,0,-0.7091,0.95,1
"GO_BP:504491_GO_0035307_POSITIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION","GO_BP","504491_GO_0035307_POSITIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION",21,-0.7299,0.83,0.94,0.8191,0.74,1,0.796,0.81,1
"GO_MF:492727_GO_0008432_JUN_KINASE_BINDING","GO_MF","492727_GO_0008432_JUN_KINASE_BINDING",6,-0.7298,0.8,0.94,-0.8903,0.59,1,-0.6125,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3178_AZARE_STAT3_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3178_AZARE_STAT3_TARGETS",24,-0.7297,0.85,0.93,1.0384,0.41,0.74,1.0649,0.36,0.9
"GO_BP:516967_GO_0072050_S_SHAPED_BODY_MORPHOGENESIS","GO_BP","516967_GO_0072050_S_SHAPED_BODY_MORPHOGENESIS",7,-0.7297,0.8,0.94,0.4307,1,1,1.368,0.12,0.65
"GO_BP:507576_GO_0045198_ESTABLISHMENT_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY","GO_BP","507576_GO_0045198_ESTABLISHMENT_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY",6,-0.729,0.81,0.94,0.7763,0.76,1,-0.7264,0.8,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2820_WEBER_METHYLATED_LCP_IN_SPERM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2820_WEBER_METHYLATED_LCP_IN_SPERM_DN",6,-0.7285,0.81,0.93,1.2858,0.2,0.41,1.3882,0.12,0.55
"GO_MF:491308_GO_0008143_POLY_A_BINDING","GO_MF","491308_GO_0008143_POLY_A_BINDING",13,-0.7282,0.83,0.94,0.6503,0.91,1,-0.6697,0.9,1
"GO_BP:505507_GO_0042363_FAT_SOLUBLE_VITAMIN_CATABOLIC_PROCESS","GO_BP","505507_GO_0042363_FAT_SOLUBLE_VITAMIN_CATABOLIC_PROCESS",9,-0.728,0.82,0.94,-1.3858,0.12,0.99,1.2111,0.22,0.71
"GO_BP:500648_GO_0031397_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION","GO_BP","500648_GO_0031397_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION",115,-0.7279,0.95,0.94,1.7296,0,0.16,-0.8497,0.81,0.96
"GO_BP:502340_GO_0033119_NEGATIVE_REGULATION_OF_RNA_SPLICING","GO_BP","502340_GO_0033119_NEGATIVE_REGULATION_OF_RNA_SPLICING",21,-0.7278,0.86,0.94,-1.0037,0.43,0.99,-0.7501,0.85,1
"C3_TF_targets:C3_TFT_74_V_CREB_02","C3_TF_targets","C3_TFT_74_V_CREB_02",249,-0.7278,0.98,1,0.8872,0.83,1,-0.8419,0.92,0.98
"GO_BP:498846_GO_0021562_VESTIBULOCOCHLEAR_NERVE_DEVELOPMENT","GO_BP","498846_GO_0021562_VESTIBULOCOCHLEAR_NERVE_DEVELOPMENT",7,-0.7275,0.82,0.94,0.9628,0.49,1,1.6128,0.029,0.41
"C1_Positional:C1_ALL_136_CHR3Q12","C1_Positional","C1_ALL_136_CHR3Q12",35,-0.7273,0.9,1,1.0971,0.3,0.65,-1.1702,0.2,0.69
"GO_BP:505623_GO_0042490_MECHANORECEPTOR_DIFFERENTIATION","GO_BP","505623_GO_0042490_MECHANORECEPTOR_DIFFERENTIATION",56,-0.7271,0.9,0.95,-0.7325,0.93,1,1.4575,0.033,0.58
"GO_BP:496181_GO_0045727_POSITIVE_REGULATION_OF_TRANSLATION","GO_BP","496181_GO_0045727_POSITIVE_REGULATION_OF_TRANSLATION",71,-0.7268,0.93,0.95,1.4608,0.013,0.48,-0.9084,0.65,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_2874_KYNG_WERNER_SYNDROM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2874_KYNG_WERNER_SYNDROM_UP",19,-0.7268,0.85,0.94,1.4048,0.084,0.29,0.7043,0.86,1
"KEGG_compound:C00096_GDP_MANNOSE_GDP_D_MANNOSE_GDP_ALPHA_D_MANNOSE","KEGG_compound","C00096_GDP_MANNOSE_GDP_D_MANNOSE_GDP_ALPHA_D_MANNOSE",6,-0.7267,0.84,0.91,-0.9209,0.57,1,-0.7377,0.81,0.9
"GO_BP:494811_GO_0010746_REGULATION_OF_PLASMA_MEMBRANE_LONG_CHAIN_FATTY_ACID_TRANSPORT","GO_BP","494811_GO_0010746_REGULATION_OF_PLASMA_MEMBRANE_LONG_CHAIN_FATTY_ACID_TRANSPORT",5,-0.7266,0.8,0.95,0.9445,0.55,1,-0.6606,0.87,1
"GO_BP:495053_GO_0010988_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE","GO_BP","495053_GO_0010988_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE",6,-0.7265,0.81,0.95,-1.2992,0.18,0.89,-1.4064,0.094,0.58
"REACTOME:645351_REACT_121388_ABACAVIR_METABOLISM","REACTOME","645351_REACT_121388_ABACAVIR_METABOLISM",5,-0.7264,0.8,0.94,0.6995,0.85,1,-0.6466,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1789_MA_PITUITARY_FETAL_VS_ADULT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1789_MA_PITUITARY_FETAL_VS_ADULT_UP",28,-0.7263,0.88,0.94,0.9606,0.51,0.85,1.0913,0.29,0.88
"C4_Cancer_modules:C4_CM_77_MODULE_82","C4_Cancer_modules","C4_CM_77_MODULE_82",24,-0.7262,0.86,0.95,1.2539,0.15,0.32,-0.4669,1,1
"GO_BP:925940_GO_1902591_SINGLE_ORGANISM_MEMBRANE_BUDDING","GO_BP","925940_GO_1902591_SINGLE_ORGANISM_MEMBRANE_BUDDING",34,-0.7261,0.86,0.95,1.6863,0.0042,0.21,0.7099,0.91,1
"GO_BP:512360_GO_0051482_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION_INVOLVED_IN_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_SIGNALING_PATHWAY","GO_BP","512360_GO_0051482_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION_INVOLVED_IN_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_SIGNALING_PATHWAY",15,-0.726,0.83,0.95,1.1512,0.29,0.84,2.0404,0,0.029
"GO_BP:493957_GO_0009855_DETERMINATION_OF_BILATERAL_SYMMETRY","GO_BP","493957_GO_0009855_DETERMINATION_OF_BILATERAL_SYMMETRY",95,-0.7257,0.94,0.95,-0.9432,0.61,1,1.2599,0.086,0.69
"GO_BP:849868_GO_1902166_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR","GO_BP","849868_GO_1902166_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR",13,-0.7257,0.81,0.95,-0.7996,0.71,1,0.8359,0.68,0.99
"GO_BP:515852_GO_0070925_ORGANELLE_ASSEMBLY","GO_BP","515852_GO_0070925_ORGANELLE_ASSEMBLY",384,-0.7254,0.99,0.95,0.9153,0.79,1,-1.0775,0.22,0.8
"GO_MF:509125_GO_0046920_ALPHA_1_3_FUCOSYLTRANSFERASE_ACTIVITY","GO_MF","509125_GO_0046920_ALPHA_1_3_FUCOSYLTRANSFERASE_ACTIVITY",8,-0.7252,0.81,0.94,0.6176,0.92,1,-0.8986,0.57,0.87
"GO_MF:492736_GO_0008443_PHOSPHOFRUCTOKINASE_ACTIVITY","GO_MF","492736_GO_0008443_PHOSPHOFRUCTOKINASE_ACTIVITY",7,-0.7252,0.8,0.94,0.5931,0.94,1,0.6795,0.85,1
"GO_CC:487639_GO_0001741_XY_BODY","GO_CC","487639_GO_0001741_XY_BODY",14,-0.7251,0.84,1,-0.9545,0.52,0.88,-0.9916,0.48,1
"GO_BP:489091_GO_0003299_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS","GO_BP","489091_GO_0003299_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS",12,-0.7251,0.82,0.95,-1.2794,0.18,0.89,0.8379,0.67,0.99
"GO_BP:514299_GO_0060744_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_THELARCHE","GO_BP","514299_GO_0060744_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_THELARCHE",6,-0.725,0.81,0.95,1.2259,0.23,0.76,1.099,0.36,0.76
"REACTOME:161037_REACT_20546_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR","REACTOME","161037_REACT_20546_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR",19,-0.725,0.85,0.94,0.9137,0.55,0.89,-0.9777,0.48,0.87
"C1_Positional:C1_ALL_287_CHR9Q31","C1_Positional","C1_ALL_287_CHR9Q31",57,-0.7249,0.91,1,1.3444,0.055,0.47,1.3517,0.062,0.42
"C4_Cancer_gene_neighborhoods:C4_CGN_100_MORF_FANCG","C4_Cancer_gene_neighborhoods","C4_CGN_100_MORF_FANCG",164,-0.7247,0.97,1,0.7542,0.99,1,-1.2219,0.078,0.41
"GO_BP:948858_GO_0097576_VACUOLE_FUSION","GO_BP","948858_GO_0097576_VACUOLE_FUSION",9,-0.7246,0.84,0.95,1.2154,0.24,0.77,-1.0138,0.43,0.84
"GO_BP:502280_GO_0033059_CELLULAR_PIGMENTATION","GO_BP","502280_GO_0033059_CELLULAR_PIGMENTATION",48,-0.7245,0.92,0.95,1.2357,0.14,0.75,0.898,0.64,0.95
"GO_BP:505508_GO_0042364_WATER_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS","GO_BP","505508_GO_0042364_WATER_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS",11,-0.7242,0.82,0.95,0.4779,1,1,-0.8763,0.63,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_267_UDAYAKUMAR_MED1_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_267_UDAYAKUMAR_MED1_TARGETS_UP",134,-0.7241,0.95,0.94,1.0084,0.44,0.79,-0.5562,1,0.99
"GO_BP:489016_GO_0003222_VENTRICULAR_TRABECULA_MYOCARDIUM_MORPHOGENESIS","GO_BP","489016_GO_0003222_VENTRICULAR_TRABECULA_MYOCARDIUM_MORPHOGENESIS",11,-0.7235,0.83,0.95,-0.7807,0.77,1,-0.8752,0.62,0.94
"GO_MF:513538_GO_0055106_UBIQUITIN_PROTEIN_TRANSFERASE_REGULATOR_ACTIVITY","GO_MF","513538_GO_0055106_UBIQUITIN_PROTEIN_TRANSFERASE_REGULATOR_ACTIVITY",7,-0.7232,0.81,0.94,0.7567,0.78,1,-1.0332,0.41,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_257_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_257_TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN",16,-0.723,0.84,0.94,1.6362,0.012,0.12,-1.5251,0.044,0.29
"C1_Positional:C1_ALL_135_CHR4Q31","C1_Positional","C1_ALL_135_CHR4Q31",70,-0.7228,0.92,1,1.1899,0.15,0.6,-1.1742,0.18,0.7
"GO_BP:513951_GO_0060395_SMAD_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","513951_GO_0060395_SMAD_PROTEIN_SIGNAL_TRANSDUCTION",49,-0.7227,0.91,0.95,0.9085,0.62,1,0.9673,0.53,0.89
"GO_BP:508160_GO_0045839_NEGATIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION","GO_BP","508160_GO_0045839_NEGATIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION",48,-0.7222,0.91,0.95,0.7778,0.88,1,-0.5776,1,1
"KEGG_compound:C16682_9_CIS_RETINOL","KEGG_compound","C16682_9_CIS_RETINOL",6,-0.7219,0.82,0.91,-0.6766,0.84,1,-1.1572,0.29,0.5
"GO_BP:502778_GO_0033561_REGULATION_OF_WATER_LOSS_VIA_SKIN","GO_BP","502778_GO_0033561_REGULATION_OF_WATER_LOSS_VIA_SKIN",20,-0.7219,0.86,0.95,1.704,0.019,0.19,1.2579,0.18,0.69
"C4_Cancer_modules:C4_CM_45_MODULE_49","C4_Cancer_modules","C4_CM_45_MODULE_49",284,-0.7214,0.99,0.95,-0.9052,0.77,0.88,0.9607,0.59,0.95
"GO_BP:1039912_GO_1903358_REGULATION_OF_GOLGI_ORGANIZATION","GO_BP","1039912_GO_1903358_REGULATION_OF_GOLGI_ORGANIZATION",9,-0.7214,0.82,0.95,-0.4279,1,1,-0.5829,0.97,1
"C7_Immunologic_signatures:C7_ALL_481_GSE17721_CTRL_VS_PAM3CSK4_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_481_GSE17721_CTRL_VS_PAM3CSK4_1H_BMDM_UP",200,-0.7212,0.98,0.99,1.2645,0.045,0.14,-0.8112,0.94,1
"GO_MF:492483_GO_0008121_UBIQUINOL_CYTOCHROME_C_REDUCTASE_ACTIVITY","GO_MF","492483_GO_0008121_UBIQUINOL_CYTOCHROME_C_REDUCTASE_ACTIVITY",7,-0.7212,0.79,0.94,1.4589,0.096,0.41,0.7181,0.85,1
"GO_BP:514559_GO_0061004_PATTERN_SPECIFICATION_INVOLVED_IN_KIDNEY_DEVELOPMENT","GO_BP","514559_GO_0061004_PATTERN_SPECIFICATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",8,-0.7212,0.79,0.95,-1.0691,0.35,0.96,1.2179,0.24,0.71
"WikiPathways:198875_WP531_MISMATCH_REPAIR","WikiPathways","198875_WP531_MISMATCH_REPAIR",9,-0.7211,0.82,0.94,0.6731,0.87,1,-1.3767,0.1,0.37
"GO_MF:498652_GO_0019869_CHLORIDE_CHANNEL_INHIBITOR_ACTIVITY","GO_MF","498652_GO_0019869_CHLORIDE_CHANNEL_INHIBITOR_ACTIVITY",9,-0.7211,0.84,0.94,0.6711,0.88,1,1.0217,0.41,0.86
"GO_BP:502821_GO_0033605_POSITIVE_REGULATION_OF_CATECHOLAMINE_SECRETION","GO_BP","502821_GO_0033605_POSITIVE_REGULATION_OF_CATECHOLAMINE_SECRETION",10,-0.7209,0.83,0.95,1.0861,0.36,0.92,0.9974,0.47,0.86
"GO_BP:512661_GO_0051790_SHORT_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS","GO_BP","512661_GO_0051790_SHORT_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS",7,-0.7209,0.83,0.95,0.6606,0.9,1,-1.4638,0.075,0.54
"C1_Positional:C1_ALL_232_CHR1P32","C1_Positional","C1_ALL_232_CHR1P32",80,-0.7209,0.93,1,-0.66,0.98,1,0.7655,0.91,0.94
"GO_BP:512267_GO_0051383_KINETOCHORE_ORGANIZATION","GO_BP","512267_GO_0051383_KINETOCHORE_ORGANIZATION",12,-0.7208,0.82,0.95,-0.8068,0.72,1,-0.9362,0.52,0.9
"GO_BP:754129_GO_1901162_PRIMARY_AMINO_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","754129_GO_1901162_PRIMARY_AMINO_COMPOUND_BIOSYNTHETIC_PROCESS",5,-0.7208,0.83,0.95,-1.1074,0.36,0.94,-0.8814,0.6,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_3340_ROESSLER_LIVER_CANCER_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3340_ROESSLER_LIVER_CANCER_METASTASIS_DN",51,-0.7208,0.9,0.94,0.8114,0.8,0.98,-0.7737,0.88,0.97
"C7_Immunologic_signatures:C7_ALL_128_GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN","C7_Immunologic_signatures","C7_ALL_128_GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN",195,-0.7206,0.98,0.99,-0.864,0.83,1,-0.9339,0.65,0.89
"GO_BP:509076_GO_0046856_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION","GO_BP","509076_GO_0046856_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION",17,-0.7206,0.84,0.95,-1.0876,0.33,0.95,-0.5237,0.99,1
"REACTOME:1127631_REACT_264594_MISSPLICED_LRP5_MUTANTS_HAVE_ENHANCED_BETA_CATENIN_DEPENDENT_SIGNALING","REACTOME","1127631_REACT_264594_MISSPLICED_LRP5_MUTANTS_HAVE_ENHANCED_BETA_CATENIN_DEPENDENT_SIGNALING",6,-0.7206,0.83,0.94,-0.6699,0.88,1,1.0817,0.35,0.94
"GO_BP:501527_GO_0032292_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT","GO_BP","501527_GO_0032292_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT",22,-0.7206,0.87,0.95,-0.8544,0.67,1,-1.5577,0.023,0.51
"REACTOME:105849_REACT_1064_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1","REACTOME","105849_REACT_1064_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1",9,-0.7206,0.83,0.94,1.2261,0.21,0.42,-0.828,0.71,1
"GO_BP:499290_GO_0022011_MYELINATION_IN_PERIPHERAL_NERVOUS_SYSTEM","GO_BP","499290_GO_0022011_MYELINATION_IN_PERIPHERAL_NERVOUS_SYSTEM",22,-0.7205,0.86,0.95,-0.8405,0.71,1,-1.5703,0.029,0.53
"GO_BP:501184_GO_0031944_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS","GO_BP","501184_GO_0031944_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS",5,-0.7205,0.81,0.95,1.1834,0.29,0.8,1.0958,0.35,0.77
"GO_CC:499510_GO_0030062_MITOCHONDRIAL_TRICARBOXYLIC_ACID_CYCLE_ENZYME_COMPLEX","GO_CC","499510_GO_0030062_MITOCHONDRIAL_TRICARBOXYLIC_ACID_CYCLE_ENZYME_COMPLEX",6,-0.7203,0.83,1,0.9147,0.57,0.86,-1.4513,0.063,0.5
"GO_BP:519120_GO_2000480_NEGATIVE_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY","GO_BP","519120_GO_2000480_NEGATIVE_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY",8,-0.7202,0.84,0.95,1.3108,0.16,0.66,-0.605,0.94,1
"C7_Immunologic_signatures:C7_ALL_173_GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP","C7_Immunologic_signatures","C7_ALL_173_GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP",199,-0.7202,0.99,0.99,0.8263,0.92,1,-1.0162,0.4,0.69
"GO_CC:513727_GO_0060170_CILIARY_MEMBRANE","GO_CC","513727_GO_0060170_CILIARY_MEMBRANE",69,-0.72,0.93,1,-1.2535,0.11,0.68,-0.8805,0.72,1
"GO_MF:492530_GO_0008187_POLY_PYRIMIDINE_TRACT_BINDING","GO_MF","492530_GO_0008187_POLY_PYRIMIDINE_TRACT_BINDING",15,-0.7198,0.84,0.94,-0.8369,0.73,1,-1.2231,0.21,0.58
"C4_Cancer_modules:C4_CM_302_MODULE_349","C4_Cancer_modules","C4_CM_302_MODULE_349",17,-0.7197,0.85,0.95,-0.8301,0.69,0.96,-0.8997,0.6,0.85
"GO_MF:506652_GO_0043621_PROTEIN_SELF_ASSOCIATION","GO_MF","506652_GO_0043621_PROTEIN_SELF_ASSOCIATION",39,-0.7195,0.9,0.94,-0.851,0.72,1,-1.192,0.19,0.6
"GO_MF:515119_GO_0070182_DNA_POLYMERASE_BINDING","GO_MF","515119_GO_0070182_DNA_POLYMERASE_BINDING",8,-0.7194,0.81,0.94,-1.0734,0.35,0.86,-1.0526,0.38,0.74
"GO_BP:508140_GO_0045815_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC","GO_BP","508140_GO_0045815_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC",19,-0.7194,0.85,0.95,0.7358,0.85,1,-0.7507,0.84,1
"GO_BP:486611_GO_0007059_CHROMOSOME_SEGREGATION","GO_BP","486611_GO_0007059_CHROMOSOME_SEGREGATION",202,-0.7192,0.98,0.95,1.0243,0.39,0.97,-1.0102,0.41,0.84
"GO_MF:496054_GO_0015932_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","496054_GO_0015932_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",32,-0.7192,0.88,0.94,-0.9496,0.52,0.95,-1.2478,0.13,0.59
"GO_BP:494070_GO_0046033_AMP_METABOLIC_PROCESS","GO_BP","494070_GO_0046033_AMP_METABOLIC_PROCESS",13,-0.7192,0.83,0.95,0.7321,0.83,1,-1.0685,0.34,0.8
"KEGG_module:HSA_M00386_CUL4_DDB1_CSA_COMPLEX","KEGG_module","HSA_M00386_CUL4_DDB1_CSA_COMPLEX",5,-0.7189,0.81,0.93,0.6289,0.9,0.99,-1.3672,0.12,0.51
"GO_BP:517568_GO_0072665_PROTEIN_LOCALIZATION_TO_VACUOLE","GO_BP","517568_GO_0072665_PROTEIN_LOCALIZATION_TO_VACUOLE",30,-0.7189,0.88,0.95,0.9788,0.48,1,-0.5441,0.99,1
"GO_MF:994740_GO_0097617_ANNEALING_ACTIVITY","GO_MF","994740_GO_0097617_ANNEALING_ACTIVITY",8,-0.7185,0.84,0.94,-1.2508,0.21,0.83,-0.6221,0.93,1
"C4_Cancer_modules:C4_CM_73_MODULE_78","C4_Cancer_modules","C4_CM_73_MODULE_78",20,-0.7185,0.86,0.95,-0.8288,0.72,0.95,-1.164,0.26,0.45
"GO_BP:505804_GO_0042695_THELARCHE","GO_BP","505804_GO_0042695_THELARCHE",6,-0.7181,0.83,0.95,1.2319,0.24,0.76,1.1186,0.33,0.75
"GO_CC:515508_GO_0070578_RISC_LOADING_COMPLEX","GO_CC","515508_GO_0070578_RISC_LOADING_COMPLEX",6,-0.718,0.81,1,-1.1324,0.34,0.72,-0.7951,0.7,1
"GO_BP:514922_GO_0061377_MAMMARY_GLAND_LOBULE_DEVELOPMENT","GO_BP","514922_GO_0061377_MAMMARY_GLAND_LOBULE_DEVELOPMENT",20,-0.7178,0.86,0.95,1.2199,0.21,0.77,1.6891,0.0081,0.41
"GO_BP:517401_GO_0072488_AMMONIUM_TRANSMEMBRANE_TRANSPORT","GO_BP","517401_GO_0072488_AMMONIUM_TRANSMEMBRANE_TRANSPORT",23,-0.7177,0.86,0.95,-0.6986,0.89,1,0.8521,0.69,0.98
"C1_Positional:C1_ALL_56_CHR5Q12","C1_Positional","C1_ALL_56_CHR5Q12",37,-0.7174,0.88,1,1.1847,0.19,0.6,0.7444,0.91,0.95
"GO_MF:496798_GO_0016922_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_BINDING","GO_MF","496798_GO_0016922_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_BINDING",19,-0.7172,0.86,0.94,1.2311,0.2,0.7,0.7341,0.85,1
"GO_BP:512788_GO_0051938_L_GLUTAMATE_IMPORT","GO_BP","512788_GO_0051938_L_GLUTAMATE_IMPORT",7,-0.7172,0.82,0.95,0.4676,0.99,1,-0.819,0.67,0.98
"GO_BP:487971_GO_0002082_REGULATION_OF_OXIDATIVE_PHOSPHORYLATION","GO_BP","487971_GO_0002082_REGULATION_OF_OXIDATIVE_PHOSPHORYLATION",10,-0.7171,0.84,0.95,1.385,0.093,0.57,0.8125,0.71,1
"C4_Cancer_modules:C4_CM_335_MODULE_400","C4_Cancer_modules","C4_CM_335_MODULE_400",16,-0.7169,0.85,0.95,1.1364,0.28,0.48,-0.9673,0.51,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_1576_HOEGERKORP_CD44_TARGETS_TEMPORAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1576_HOEGERKORP_CD44_TARGETS_TEMPORAL_UP",12,-0.7168,0.83,0.94,-0.5449,0.97,1,0.7324,0.83,1
"GO_BP:777518_GO_0044774_MITOTIC_DNA_INTEGRITY_CHECKPOINT","GO_BP","777518_GO_0044774_MITOTIC_DNA_INTEGRITY_CHECKPOINT",107,-0.7168,0.95,0.95,1.5609,0.0022,0.34,-0.9824,0.48,0.87
"GO_BP:504209_GO_0035019_SOMATIC_STEM_CELL_MAINTENANCE","GO_BP","504209_GO_0035019_SOMATIC_STEM_CELL_MAINTENANCE",69,-0.7168,0.92,0.95,0.9383,0.56,1,0.9286,0.6,0.92
"GO_BP:489098_GO_0003306_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","489098_GO_0003306_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",7,-0.7158,0.85,0.95,1.3426,0.14,0.62,1.3623,0.13,0.64
"GO_BP:491634_GO_0006754_ATP_BIOSYNTHETIC_PROCESS","GO_BP","491634_GO_0006754_ATP_BIOSYNTHETIC_PROCESS",34,-0.7157,0.89,0.95,1.6798,0.01,0.21,0.5041,1,1
"GO_MF:517951_GO_0080025_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING","GO_MF","517951_GO_0080025_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING",19,-0.7156,0.83,0.94,-0.8587,0.66,1,0.5799,0.99,1
"C1_Positional:C1_ALL_14_CHR18Q23","C1_Positional","C1_ALL_14_CHR18Q23",18,-0.7156,0.86,0.99,0.8313,0.7,0.92,-0.7072,0.87,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_318_ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_318_ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP",41,-0.7155,0.91,0.95,1.1961,0.18,0.49,-1.0704,0.33,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_1019_TONG_INTERACT_WITH_PTTG1","C2_Chemical_and_genetic_perturbations","C2_CGP_1019_TONG_INTERACT_WITH_PTTG1",57,-0.7152,0.91,0.95,1.7109,0,0.076,-0.5946,1,0.99
"GO_BP:501187_GO_0031947_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS","GO_BP","501187_GO_0031947_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS",5,-0.7152,0.82,0.95,1.153,0.3,0.83,1.1076,0.35,0.76
"REACTOME:530740_REACT_115662_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING","REACTOME","530740_REACT_115662_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING",13,-0.7148,0.82,0.95,0.9914,0.43,0.76,-0.9022,0.6,0.95
"REACTOME:106362_REACT_16973_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS","REACTOME","106362_REACT_16973_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS",7,-0.7146,0.85,0.95,-0.797,0.73,1,1.6986,0.015,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_3322_RAO_BOUND_BY_SALL4_ISOFORM_A","C2_Chemical_and_genetic_perturbations","C2_CGP_3322_RAO_BOUND_BY_SALL4_ISOFORM_A",173,-0.7144,0.98,0.95,1.2685,0.047,0.42,1.2791,0.048,0.69
"GO_BP:487943_GO_0002053_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION","GO_BP","487943_GO_0002053_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION",35,-0.7141,0.89,0.95,1.3832,0.048,0.57,1.8427,0.0019,0.23
"C7_Immunologic_signatures:C7_ALL_1230_GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN","C7_Immunologic_signatures","C7_ALL_1230_GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN",199,-0.7141,0.97,1,1.1802,0.078,0.26,0.7075,0.99,1
"GO_BP:493608_GO_0009437_CARNITINE_METABOLIC_PROCESS","GO_BP","493608_GO_0009437_CARNITINE_METABOLIC_PROCESS",12,-0.714,0.84,0.95,0.5304,0.98,1,-1.2819,0.16,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_552_OZANNE_AP1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_552_OZANNE_AP1_TARGETS_DN",5,-0.7139,0.82,0.95,0.9954,0.48,0.81,0.6392,0.89,1
"GO_MF:506464_GO_0043426_MRF_BINDING","GO_MF","506464_GO_0043426_MRF_BINDING",5,-0.7139,0.84,0.94,0.9314,0.54,0.94,-0.903,0.6,0.87
"C1_Positional:C1_ALL_73_CHR22Q13","C1_Positional","C1_ALL_73_CHR22Q13",181,-0.7139,0.97,0.99,0.8075,0.93,0.94,-1.0412,0.35,0.84
"GO_BP:503706_GO_0034504_PROTEIN_LOCALIZATION_TO_NUCLEUS","GO_BP","503706_GO_0034504_PROTEIN_LOCALIZATION_TO_NUCLEUS",140,-0.7136,0.97,0.95,0.8577,0.82,1,-0.9103,0.69,0.92
"GO_BP:513985_GO_0060430_LUNG_SACCULE_DEVELOPMENT","GO_BP","513985_GO_0060430_LUNG_SACCULE_DEVELOPMENT",7,-0.7133,0.82,0.95,-1.5884,0.028,0.72,0.8116,0.71,1
"C7_Immunologic_signatures:C7_ALL_226_GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN","C7_Immunologic_signatures","C7_ALL_226_GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN",190,-0.7132,0.99,1,2.0113,0,0,0.8634,0.84,1
"C4_Cancer_gene_neighborhoods:C4_CGN_127_MORF_MAP2K2","C4_Cancer_gene_neighborhoods","C4_CGN_127_MORF_MAP2K2",132,-0.7129,0.97,1,2.1201,0,0.00011,-1.0682,0.28,0.68
"C4_Cancer_gene_neighborhoods:C4_CGN_418_GNF2_TM4SF2","C4_Cancer_gene_neighborhoods","C4_CGN_418_GNF2_TM4SF2",26,-0.7127,0.9,1,-1.3232,0.13,0.51,1.4892,0.04,0.18
"GO_BP:494580_GO_0010511_REGULATION_OF_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS","GO_BP","494580_GO_0010511_REGULATION_OF_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS",6,-0.7126,0.84,0.95,0.8852,0.58,1,1.7206,0.0039,0.42
"GO_BP:489129_GO_0003337_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS","GO_BP","489129_GO_0003337_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS",9,-0.7124,0.82,0.95,1.0898,0.36,0.92,1.7195,0.019,0.42
"C7_Immunologic_signatures:C7_ALL_273_GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP","C7_Immunologic_signatures","C7_ALL_273_GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP",189,-0.7122,0.98,1,-0.7453,0.98,1,-0.6285,1,1
"REACTOME:161048_REACT_22172_CHROMOSOME_MAINTENANCE","REACTOME","161048_REACT_22172_CHROMOSOME_MAINTENANCE",106,-0.712,0.97,0.95,-0.8908,0.69,1,-1.5554,0.01,0.3
"GO_BP:502455_GO_0033235_POSITIVE_REGULATION_OF_PROTEIN_SUMOYLATION","GO_BP","502455_GO_0033235_POSITIVE_REGULATION_OF_PROTEIN_SUMOYLATION",12,-0.7119,0.86,0.95,-0.538,0.98,1,0.8156,0.71,1
"GO_MF:489932_GO_0016018_CYCLOSPORIN_A_BINDING","GO_MF","489932_GO_0016018_CYCLOSPORIN_A_BINDING",7,-0.7119,0.83,0.94,1.2296,0.21,0.7,0.5918,0.93,1
"GO_CC:500571_GO_0031312_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE","GO_CC","500571_GO_0031312_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE",19,-0.7117,0.86,1,-0.7824,0.76,1,-0.7135,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2157_LIN_MELANOMA_COPY_NUMBER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2157_LIN_MELANOMA_COPY_NUMBER_UP",70,-0.7116,0.94,0.95,0.9378,0.59,0.88,-1.0868,0.27,0.65
"C7_Immunologic_signatures:C7_ALL_604_GSE17721_LPS_VS_PAM3CSK4_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_604_GSE17721_LPS_VS_PAM3CSK4_2H_BMDM_DN",194,-0.7116,0.98,1,0.9841,0.5,0.79,-1.0687,0.27,0.57
"GO_BP:516965_GO_0072048_RENAL_SYSTEM_PATTERN_SPECIFICATION","GO_BP","516965_GO_0072048_RENAL_SYSTEM_PATTERN_SPECIFICATION",8,-0.7115,0.82,0.95,-1.0563,0.4,0.97,1.189,0.24,0.72
"C7_Immunologic_signatures:C7_ALL_856_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN","C7_Immunologic_signatures","C7_ALL_856_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN",177,-0.7113,0.98,1,-1.3592,0.025,0.34,0.8507,0.83,1
"GO_BP:491912_GO_0007093_MITOTIC_CELL_CYCLE_CHECKPOINT","GO_BP","491912_GO_0007093_MITOTIC_CELL_CYCLE_CHECKPOINT",165,-0.7113,0.98,0.95,1.3749,0.014,0.58,-0.9745,0.51,0.88
"GO_MF:515334_GO_0070402_NADPH_BINDING","GO_MF","515334_GO_0070402_NADPH_BINDING",11,-0.7112,0.86,0.94,0.7886,0.75,1,-0.6169,0.94,1
"GO_BP:1026093_GO_1903321_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL","GO_BP","1026093_GO_1903321_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL",120,-0.7111,0.95,0.95,1.7029,0,0.19,-0.8292,0.86,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_936_SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_936_SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP",14,-0.711,0.86,0.95,1.3227,0.14,0.37,-0.7402,0.83,0.98
"GO_MF:511298_GO_0050308_SUGAR_PHOSPHATASE_ACTIVITY","GO_MF","511298_GO_0050308_SUGAR_PHOSPHATASE_ACTIVITY",10,-0.7109,0.86,0.94,1.015,0.42,0.87,1.2697,0.18,0.65
"GO_BP:516481_GO_0071557_HISTONE_H3_K27_DEMETHYLATION","GO_BP","516481_GO_0071557_HISTONE_H3_K27_DEMETHYLATION",5,-0.7109,0.83,0.95,-1.0822,0.41,0.95,0.4199,1,1
"GO_BP:808771_GO_1902100_NEGATIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE","GO_BP","808771_GO_1902100_NEGATIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE",40,-0.7107,0.92,0.95,0.9319,0.59,1,-0.8067,0.79,0.99
"C7_Immunologic_signatures:C7_ALL_918_GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN","C7_Immunologic_signatures","C7_ALL_918_GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN",198,-0.7107,0.99,1,1.0113,0.42,0.71,-1.1264,0.18,0.43
"GO_BP:493901_GO_0009794_REGULATION_OF_MITOTIC_CELL_CYCLE_EMBRYONIC","GO_BP","493901_GO_0009794_REGULATION_OF_MITOTIC_CELL_CYCLE_EMBRYONIC",5,-0.7107,0.81,0.95,-0.8591,0.62,1,1.2288,0.25,0.71
"GO_BP:501257_GO_0032020_ISG15_PROTEIN_CONJUGATION","GO_BP","501257_GO_0032020_ISG15_PROTEIN_CONJUGATION",6,-0.7102,0.83,0.95,1.0079,0.44,0.98,-1.4,0.12,0.58
"GO_MF:496591_GO_0016655_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR","GO_MF","496591_GO_0016655_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR",53,-0.7101,0.93,0.94,1.9967,0,0.013,0.6007,0.99,1
"C7_Immunologic_signatures:C7_ALL_1304_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1304_GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN",192,-0.7099,0.98,1,1.3533,0.016,0.06,0.7025,1,1
"C4_Cancer_modules:C4_CM_210_MODULE_227","C4_Cancer_modules","C4_CM_210_MODULE_227",15,-0.7094,0.88,0.95,1.5323,0.04,0.098,-1.8474,0.0039,0.03
"GO_MF:513535_GO_0055103_LIGASE_REGULATOR_ACTIVITY","GO_MF","513535_GO_0055103_LIGASE_REGULATOR_ACTIVITY",8,-0.709,0.83,0.94,0.67,0.88,1,-1.2641,0.2,0.58
"GO_BP:849954_GO_1902253_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR","GO_BP","849954_GO_1902253_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR",21,-0.7081,0.88,0.96,0.6378,0.96,1,-0.8076,0.75,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2701_DING_LUNG_CANCER_MUTATED_RECURRENTLY","C2_Chemical_and_genetic_perturbations","C2_CGP_2701_DING_LUNG_CANCER_MUTATED_RECURRENTLY",6,-0.7075,0.82,0.95,-0.6226,0.88,1,-1.2422,0.22,0.48
"GO_BP:517569_GO_0072666_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE","GO_BP","517569_GO_0072666_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE",27,-0.7074,0.87,0.96,0.9304,0.55,1,-0.5991,0.98,1
"C3_TF_targets:C3_TFT_248_V_E2F_Q4","C3_TF_targets","C3_TFT_248_V_E2F_Q4",234,-0.7074,0.99,1,0.8182,0.95,1,-1.2632,0.038,0.27
"GO_MF:495488_GO_0051184_COFACTOR_TRANSPORTER_ACTIVITY","GO_MF","495488_GO_0051184_COFACTOR_TRANSPORTER_ACTIVITY",20,-0.707,0.88,0.95,-1.4924,0.051,0.58,-0.887,0.61,0.88
"GO_BP:495911_GO_0015780_NUCLEOTIDE_SUGAR_TRANSPORT","GO_BP","495911_GO_0015780_NUCLEOTIDE_SUGAR_TRANSPORT",7,-0.7067,0.84,0.96,-0.9681,0.49,1,-0.6076,0.93,1
"GO_MF:750729_GO_0036310_ANNEALING_HELICASE_ACTIVITY","GO_MF","750729_GO_0036310_ANNEALING_HELICASE_ACTIVITY",8,-0.7067,0.85,0.95,-1.2388,0.22,0.84,-0.6121,0.94,1
"GO_BP:500399_GO_0031112_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION","GO_BP","500399_GO_0031112_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION",17,-0.7065,0.85,0.96,0.6686,0.91,1,0.8272,0.7,1
"C4_Cancer_gene_neighborhoods:C4_CGN_74_MORF_CDC2L5","C4_Cancer_gene_neighborhoods","C4_CGN_74_MORF_CDC2L5",138,-0.7064,0.98,1,-0.9481,0.57,0.91,-1.2627,0.065,0.35
"GO_BP:494667_GO_0010603_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY","GO_BP","494667_GO_0010603_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY",8,-0.7063,0.85,0.96,0.5331,0.98,1,-1.4642,0.071,0.54
"GO_MF:505912_GO_0042809_VITAMIN_D_RECEPTOR_BINDING","GO_MF","505912_GO_0042809_VITAMIN_D_RECEPTOR_BINDING",15,-0.7061,0.87,0.95,0.6916,0.9,1,-0.7322,0.82,0.99
"GO_BP:517483_GO_0072578_NEUROTRANSMITTER_GATED_ION_CHANNEL_CLUSTERING","GO_BP","517483_GO_0072578_NEUROTRANSMITTER_GATED_ION_CHANNEL_CLUSTERING",8,-0.7056,0.84,0.96,0.6694,0.87,1,1.0112,0.44,0.84
"C4_Cancer_modules:C4_CM_354_MODULE_427","C4_Cancer_modules","C4_CM_354_MODULE_427",114,-0.7055,0.96,0.95,1.262,0.078,0.31,0.8773,0.76,1
"GO_BP:511658_GO_0050686_NEGATIVE_REGULATION_OF_MRNA_PROCESSING","GO_BP","511658_GO_0050686_NEGATIVE_REGULATION_OF_MRNA_PROCESSING",29,-0.7055,0.91,0.96,-0.9757,0.5,1,-0.7108,0.92,0.99
"GO_BP:516988_GO_0072071_KIDNEY_INTERSTITIAL_FIBROBLAST_DIFFERENTIATION","GO_BP","516988_GO_0072071_KIDNEY_INTERSTITIAL_FIBROBLAST_DIFFERENTIATION",7,-0.7053,0.85,0.96,-0.6203,0.92,1,0.8301,0.66,0.99
"REACTOME:530747_REACT_115606_O_LINKED_GLYCOSYLATION_OF_MUCINS","REACTOME","530747_REACT_115606_O_LINKED_GLYCOSYLATION_OF_MUCINS",63,-0.7052,0.94,0.96,-0.66,0.98,1,1.47,0.019,0.58
"GO_BP:849931_GO_1902230_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE","GO_BP","849931_GO_1902230_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE",27,-0.7051,0.89,0.96,1.1397,0.24,0.85,0.9908,0.44,0.86
"GO_BP:499236_GO_0021957_CORTICOSPINAL_TRACT_MORPHOGENESIS","GO_BP","499236_GO_0021957_CORTICOSPINAL_TRACT_MORPHOGENESIS",7,-0.705,0.82,0.96,-0.4454,1,1,-0.7017,0.83,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_958_KHETCHOUMIAN_TRIM24_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_958_KHETCHOUMIAN_TRIM24_TARGETS_DN",7,-0.705,0.86,0.95,-1.522,0.044,0.45,-0.9926,0.47,0.76
"C4_Cancer_gene_neighborhoods:C4_CGN_257_GCM_PTPRU","C4_Cancer_gene_neighborhoods","C4_CGN_257_GCM_PTPRU",52,-0.7049,0.93,1,0.7496,0.9,1,1.319,0.089,0.27
"REACTOME:771573_REACT_160113_NUCLEAR_ENVELOPE_REASSEMBLY","REACTOME","771573_REACT_160113_NUCLEAR_ENVELOPE_REASSEMBLY",13,-0.7048,0.86,0.95,1.1953,0.25,0.45,-0.5514,0.97,1
"GO_MF:515343_GO_0070411_I_SMAD_BINDING","GO_MF","515343_GO_0070411_I_SMAD_BINDING",11,-0.7044,0.84,0.95,-0.6017,0.94,1,1.312,0.14,0.66
"GO_BP:493370_GO_0009174_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493370_GO_0009174_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",11,-0.7043,0.85,0.96,0.9322,0.55,1,0.9048,0.59,0.94
"GO_BP:508854_GO_0046600_NEGATIVE_REGULATION_OF_CENTRIOLE_REPLICATION","GO_BP","508854_GO_0046600_NEGATIVE_REGULATION_OF_CENTRIOLE_REPLICATION",6,-0.7042,0.86,0.96,-0.6386,0.89,1,0.5736,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1689_VIETOR_IFRD1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1689_VIETOR_IFRD1_TARGETS",23,-0.7041,0.88,0.95,0.8089,0.77,0.98,-1.0506,0.37,0.69
"GO_BP:494935_GO_0010871_NEGATIVE_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS","GO_BP","494935_GO_0010871_NEGATIVE_REGULATION_OF_RECEPTOR_BIOSYNTHETIC_PROCESS",6,-0.704,0.84,0.96,1.2267,0.25,0.76,0.7571,0.77,1
"GO_BP:496303_GO_0016236_MACROAUTOPHAGY","GO_BP","496303_GO_0016236_MACROAUTOPHAGY",61,-0.7037,0.94,0.96,1.0629,0.33,0.94,-0.5835,1,1
"C6_Oncogenic_signatures:C6_ALL_2_GLI1_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_2_GLI1_UP_V1_UP",27,-0.7036,0.89,0.98,1.2429,0.18,0.37,-0.7026,0.92,0.99
"GO_BP:491486_GO_0006590_THYROID_HORMONE_GENERATION","GO_BP","491486_GO_0006590_THYROID_HORMONE_GENERATION",10,-0.7036,0.84,0.96,0.9675,0.47,1,0.8804,0.61,0.95
"GO_BP:504691_GO_0035510_DNA_DEALKYLATION","GO_BP","504691_GO_0035510_DNA_DEALKYLATION",18,-0.7035,0.87,0.96,0.9621,0.51,1,-1.2857,0.16,0.65
"GO_MF:495579_GO_0015347_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495579_GO_0015347_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.7031,0.85,0.95,1.0632,0.39,0.83,1.524,0.041,0.4
"GO_MF:495475_GO_0015211_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495475_GO_0015211_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",8,-0.7029,0.83,0.95,-0.751,0.78,1,-1.4626,0.076,0.42
"GO_BP:491191_GO_0006222_UMP_BIOSYNTHETIC_PROCESS","GO_BP","491191_GO_0006222_UMP_BIOSYNTHETIC_PROCESS",11,-0.7027,0.85,0.96,0.9315,0.54,1,0.9111,0.59,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_926_LIEN_BREAST_CARCINOMA_METAPLASTIC","C2_Chemical_and_genetic_perturbations","C2_CGP_926_LIEN_BREAST_CARCINOMA_METAPLASTIC",35,-0.7023,0.91,0.95,1.2703,0.11,0.42,1.0956,0.29,0.88
"C6_Oncogenic_signatures:C6_ALL_60_SRC_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_60_SRC_UP_V1_UP",161,-0.7022,0.98,0.97,-1.3863,0.022,0.38,-0.9547,0.56,0.72
"GO_BP:513575_GO_0060017_PARATHYROID_GLAND_DEVELOPMENT","GO_BP","513575_GO_0060017_PARATHYROID_GLAND_DEVELOPMENT",7,-0.7019,0.86,0.96,1.2159,0.24,0.76,1.1918,0.28,0.72
"GO_BP:513600_GO_0060042_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE","GO_BP","513600_GO_0060042_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE",48,-0.7017,0.92,0.96,0.9978,0.44,0.98,1.7638,0,0.34
"C7_Immunologic_signatures:C7_ALL_601_GSE17721_LPS_VS_PAM3CSK4_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_601_GSE17721_LPS_VS_PAM3CSK4_1H_BMDM_UP",198,-0.7017,0.99,1,1.4903,0,0.014,-0.9091,0.71,0.93
"C7_Immunologic_signatures:C7_ALL_1197_GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP","C7_Immunologic_signatures","C7_ALL_1197_GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP",200,-0.7014,0.98,1,1.0188,0.37,0.68,0.5981,1,1
"C1_Positional:C1_ALL_242_CHR2Q","C1_Positional","C1_ALL_242_CHR2Q",5,-0.7013,0.85,1,1.0673,0.41,0.66,-0.8715,0.61,0.97
"GO_BP:512369_GO_0051491_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY","GO_BP","512369_GO_0051491_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY",24,-0.7012,0.9,0.96,-0.8849,0.66,1,1.0503,0.38,0.8
"GO_BP:506077_GO_0042984_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS","GO_BP","506077_GO_0042984_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS",7,-0.7012,0.85,0.96,-0.9472,0.51,1,-0.9187,0.55,0.91
"GO_BP:754228_GO_1901264_CARBOHYDRATE_DERIVATIVE_TRANSPORT","GO_BP","754228_GO_1901264_CARBOHYDRATE_DERIVATIVE_TRANSPORT",42,-0.7012,0.9,0.96,0.7551,0.88,1,-0.8953,0.62,0.93
"GO_BP:508789_GO_0046532_REGULATION_OF_PHOTORECEPTOR_CELL_DIFFERENTIATION","GO_BP","508789_GO_0046532_REGULATION_OF_PHOTORECEPTOR_CELL_DIFFERENTIATION",5,-0.7011,0.84,0.96,-1.0614,0.41,0.96,-1.3835,0.11,0.59
"GO_MF:750758_GO_0001206_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION","GO_MF","750758_GO_0001206_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY_INVOLVED_IN_NEGATIVE_REGULATION_OF_TRANSCRIPTION",6,-0.7011,0.81,0.95,0.4642,0.99,1,-0.6256,0.91,1
"REACTOME:106472_REACT_15502_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB","REACTOME","106472_REACT_15502_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB",5,-0.701,0.87,0.96,1.0789,0.4,0.62,-0.7144,0.84,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2713_BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2713_BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP",39,-0.7007,0.91,0.95,0.7741,0.87,1,-0.9124,0.62,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_789_TERAMOTO_OPN_TARGETS_CLUSTER_8","C2_Chemical_and_genetic_perturbations","C2_CGP_789_TERAMOTO_OPN_TARGETS_CLUSTER_8",8,-0.7007,0.85,0.95,-1.1238,0.33,0.89,1.18,0.26,0.8
"C1_Positional:C1_ALL_252_CHR14Q22","C1_Positional","C1_ALL_252_CHR14Q22",63,-0.7005,0.94,0.99,-0.8125,0.82,0.97,0.9095,0.63,0.84
"C7_Immunologic_signatures:C7_ALL_264_GSE14308_TH17_VS_INDUCED_TREG_DN","C7_Immunologic_signatures","C7_ALL_264_GSE14308_TH17_VS_INDUCED_TREG_DN",199,-0.7003,0.99,1,1.1488,0.13,0.32,0.9155,0.71,1
"GO_BP:755118_GO_2001012_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_RENAL_SYSTEM_DEVELOPMENT","GO_BP","755118_GO_2001012_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_RENAL_SYSTEM_DEVELOPMENT",8,-0.7001,0.87,0.96,-1.3496,0.14,0.93,1.1526,0.29,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_720_FARMER_BREAST_CANCER_CLUSTER_5","C2_Chemical_and_genetic_perturbations","C2_CGP_720_FARMER_BREAST_CANCER_CLUSTER_5",19,-0.6999,0.88,0.95,0.8473,0.67,0.97,-1.2687,0.17,0.45
"GO_MF:516482_GO_0071558_HISTONE_DEMETHYLASE_ACTIVITY_H3_K27_SPECIFIC_","GO_MF","516482_GO_0071558_HISTONE_DEMETHYLASE_ACTIVITY_H3_K27_SPECIFIC_",5,-0.6999,0.85,0.95,-1.1033,0.36,0.84,0.4403,1,1
"GO_CC:500335_GO_0031045_DENSE_CORE_GRANULE","GO_CC","500335_GO_0031045_DENSE_CORE_GRANULE",12,-0.6997,0.85,1,-0.8694,0.63,0.95,0.7846,0.75,1
"C1_Positional:C1_ALL_170_CHR10Q24","C1_Positional","C1_ALL_170_CHR10Q24",104,-0.6996,0.98,0.99,1.1289,0.22,0.62,0.9207,0.61,0.83
"GO_MF:505436_GO_0042285_XYLOSYLTRANSFERASE_ACTIVITY","GO_MF","505436_GO_0042285_XYLOSYLTRANSFERASE_ACTIVITY",7,-0.6995,0.84,0.95,0.7532,0.79,1,-0.8547,0.64,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_2345_GRADE_COLON_AND_RECTAL_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2345_GRADE_COLON_AND_RECTAL_CANCER_UP",285,-0.6993,1,0.96,2.0376,0,0.004,-0.7354,1,0.98
"GO_BP:488254_GO_0002381_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE","GO_BP","488254_GO_0002381_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE",26,-0.699,0.88,0.96,-0.5793,0.98,1,-1.0828,0.32,0.79
"GO_MF:490566_GO_0005388_CALCIUM_TRANSPORTING_ATPASE_ACTIVITY","GO_MF","490566_GO_0005388_CALCIUM_TRANSPORTING_ATPASE_ACTIVITY",9,-0.6989,0.85,0.95,-1.0307,0.43,0.88,0.8807,0.62,0.97
"GO_BP:510188_GO_0048024_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME","GO_BP","510188_GO_0048024_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME",57,-0.6988,0.94,0.96,-0.8888,0.68,1,-0.8361,0.8,0.97
"GO_BP:493369_GO_0009173_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS","GO_BP","493369_GO_0009173_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS",11,-0.6987,0.85,0.96,0.9226,0.54,1,0.9194,0.54,0.93
"GO_BP:518179_GO_0090032_NEGATIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS","GO_BP","518179_GO_0090032_NEGATIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS",6,-0.6986,0.87,0.96,0.9268,0.54,1,1.0718,0.38,0.78
"GO_BP:493764_GO_0009649_ENTRAINMENT_OF_CIRCADIAN_CLOCK","GO_BP","493764_GO_0009649_ENTRAINMENT_OF_CIRCADIAN_CLOCK",24,-0.6983,0.91,0.96,0.806,0.77,1,-1.1199,0.29,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_1867_LIANG_SILENCED_BY_METHYLATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1867_LIANG_SILENCED_BY_METHYLATION_DN",11,-0.6981,0.86,0.96,1.7408,0.01,0.063,-0.8569,0.68,0.92
"GO_MF:490227_GO_0004936_ALPHA_ADRENERGIC_RECEPTOR_ACTIVITY","GO_MF","490227_GO_0004936_ALPHA_ADRENERGIC_RECEPTOR_ACTIVITY",6,-0.6981,0.83,0.95,-1.1696,0.29,0.79,0.7419,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2705_BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2705_BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP",113,-0.6981,0.97,0.96,-0.8259,0.85,1,-0.6705,1,0.99
"GO_MF:496045_GO_0015923_MANNOSIDASE_ACTIVITY","GO_MF","496045_GO_0015923_MANNOSIDASE_ACTIVITY",15,-0.698,0.86,0.95,0.4508,0.99,1,-1.191,0.24,0.59
"GO_BP:491441_GO_0006545_GLYCINE_BIOSYNTHETIC_PROCESS","GO_BP","491441_GO_0006545_GLYCINE_BIOSYNTHETIC_PROCESS",6,-0.6979,0.85,0.96,0.8523,0.66,1,-1.0662,0.36,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1588_XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1588_XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN",15,-0.6977,0.88,0.96,1.4002,0.11,0.29,-0.8275,0.68,0.94
"GO_BP:508346_GO_0046049_UMP_METABOLIC_PROCESS","GO_BP","508346_GO_0046049_UMP_METABOLIC_PROCESS",11,-0.6976,0.87,0.96,0.9438,0.5,1,0.9194,0.57,0.92
"GO_BP:513680_GO_0060122_INNER_EAR_RECEPTOR_STEREOCILIUM_ORGANIZATION","GO_BP","513680_GO_0060122_INNER_EAR_RECEPTOR_STEREOCILIUM_ORGANIZATION",18,-0.6974,0.86,0.96,0.4965,1,1,0.9851,0.48,0.87
"GO_MF:487207_GO_0000983_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY","GO_MF","487207_GO_0000983_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY",11,-0.6971,0.88,0.95,-0.6513,0.91,1,1.28,0.16,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_22_KORKOLA_CHORIOCARCINOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_22_KORKOLA_CHORIOCARCINOMA_DN",11,-0.697,0.85,0.96,-0.815,0.71,1,0.6847,0.87,1
"GO_CC:757166_GO_0090544_BAF_TYPE_COMPLEX","GO_CC","757166_GO_0090544_BAF_TYPE_COMPLEX",19,-0.6969,0.89,1,-1.1619,0.27,0.68,-1.7149,0.018,0.65
"GO_BP:510870_GO_0048819_REGULATION_OF_HAIR_FOLLICLE_MATURATION","GO_BP","510870_GO_0048819_REGULATION_OF_HAIR_FOLLICLE_MATURATION",5,-0.6968,0.82,0.96,-0.7152,0.83,1,1.2031,0.26,0.72
"GO_CC:507389_GO_0044441_CILIARY_PART","GO_CC","507389_GO_0044441_CILIARY_PART",288,-0.6966,1,1,-1.1823,0.093,0.69,-1.0583,0.27,0.97
"C1_Positional:C1_ALL_87_CHR2Q34","C1_Positional","C1_ALL_87_CHR2Q34",16,-0.6966,0.88,0.99,-1.0409,0.41,1,1.5757,0.039,0.25
"GO_BP:494631_GO_0010566_REGULATION_OF_KETONE_BIOSYNTHETIC_PROCESS","GO_BP","494631_GO_0010566_REGULATION_OF_KETONE_BIOSYNTHETIC_PROCESS",7,-0.6962,0.84,0.96,0.9237,0.57,1,1.2528,0.22,0.7
"REACTOME:366245_REACT_75881_METHIONINE_SALVAGE_PATHWAY","REACTOME","366245_REACT_75881_METHIONINE_SALVAGE_PATHWAY",6,-0.696,0.83,0.96,-0.4812,0.99,1,-1.4222,0.082,0.4
"KEGG_compound:C00536_TRIPHOSPHATE_TRIPHOSPHORIC_ACID_TRIPOLYPHOSPHATE_INORGANIC_TRIPHOSPHATE","KEGG_compound","C00536_TRIPHOSPHATE_TRIPHOSPHORIC_ACID_TRIPOLYPHOSPHATE_INORGANIC_TRIPHOSPHATE",5,-0.6957,0.85,0.94,1.3781,0.13,0.55,-0.6733,0.85,0.92
"C4_Cancer_gene_neighborhoods:C4_CGN_361_GNF2_IGF1","C4_Cancer_gene_neighborhoods","C4_CGN_361_GNF2_IGF1",26,-0.6953,0.89,1,1.193,0.22,0.23,1.9018,0,0.02
"C3_TF_targets:C3_TFT_359_GATGKMRGCG_UNKNOWN","C3_TF_targets","C3_TFT_359_GATGKMRGCG_UNKNOWN",66,-0.6952,0.95,1,0.7771,0.88,1,0.87,0.73,1
"GO_BP:491652_GO_0006779_PORPHYRIN_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","491652_GO_0006779_PORPHYRIN_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",27,-0.6951,0.89,0.96,1.1935,0.2,0.79,-1.38,0.083,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_3225_WACKER_HYPOXIA_TARGETS_OF_VHL","C2_Chemical_and_genetic_perturbations","C2_CGP_3225_WACKER_HYPOXIA_TARGETS_OF_VHL",13,-0.695,0.87,0.96,-0.6317,0.92,1,0.9147,0.56,1
"GO_BP:781993_GO_1902004_POSITIVE_REGULATION_OF_BETA_AMYLOID_FORMATION","GO_BP","781993_GO_1902004_POSITIVE_REGULATION_OF_BETA_AMYLOID_FORMATION",5,-0.6948,0.85,0.96,1.3888,0.11,0.57,-1.2017,0.28,0.73
"GO_BP:498603_GO_0019800_PEPTIDE_CROSS_LINKING_VIA_CHONDROITIN_4_SULFATE_GLYCOSAMINOGLYCAN","GO_BP","498603_GO_0019800_PEPTIDE_CROSS_LINKING_VIA_CHONDROITIN_4_SULFATE_GLYCOSAMINOGLYCAN",6,-0.6948,0.85,0.96,-1.5922,0.031,0.71,1.2913,0.2,0.68
"GO_BP:492619_GO_0008298_INTRACELLULAR_MRNA_LOCALIZATION","GO_BP","492619_GO_0008298_INTRACELLULAR_MRNA_LOCALIZATION",9,-0.6947,0.84,0.96,-0.7181,0.86,1,0.6564,0.89,1
"REACTOME:160136_REACT_21368_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1","REACTOME","160136_REACT_21368_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1",16,-0.6946,0.87,0.96,-0.5403,0.98,1,-0.9186,0.57,0.93
"GO_BP:487736_GO_0001840_NEURAL_PLATE_DEVELOPMENT","GO_BP","487736_GO_0001840_NEURAL_PLATE_DEVELOPMENT",13,-0.6946,0.87,0.96,-1.0761,0.36,0.95,-0.8398,0.7,0.96
"REACTOME:1127551_REACT_8017_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A","REACTOME","1127551_REACT_8017_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A",23,-0.6946,0.89,0.96,1.4415,0.061,0.19,-1.0408,0.39,0.79
"GO_BP:489092_GO_0003300_CARDIAC_MUSCLE_HYPERTROPHY","GO_BP","489092_GO_0003300_CARDIAC_MUSCLE_HYPERTROPHY",20,-0.6945,0.87,0.96,-0.811,0.73,1,1.1895,0.2,0.72
"GO_BP:500827_GO_0031577_SPINDLE_CHECKPOINT","GO_BP","500827_GO_0031577_SPINDLE_CHECKPOINT",40,-0.6944,0.91,0.96,1.1085,0.29,0.89,-0.847,0.74,0.96
"GO_BP:501183_GO_0031943_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS","GO_BP","501183_GO_0031943_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS",9,-0.6943,0.85,0.96,0.7992,0.73,1,1.1254,0.3,0.74
"GO_BP:513896_GO_0060340_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY","GO_BP","513896_GO_0060340_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY",8,-0.6942,0.87,0.96,1.013,0.45,0.97,0.8871,0.6,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_841_OXFORD_RALB_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_841_OXFORD_RALB_TARGETS_UP",8,-0.6941,0.87,0.96,1.0561,0.41,0.7,-1.0016,0.45,0.75
"KEGG_compound:C00110_DOLICHYL_PHOSPHATE_DOLICHOL_PHOSPHATE","KEGG_compound","C00110_DOLICHYL_PHOSPHATE_DOLICHOL_PHOSPHATE",7,-0.6939,0.86,0.94,-0.7804,0.73,1,-0.6611,0.9,0.93
"GO_CC:508835_GO_0046581_INTERCELLULAR_CANALICULUS","GO_CC","508835_GO_0046581_INTERCELLULAR_CANALICULUS",7,-0.6936,0.86,1,1.6626,0.01,0.081,-0.986,0.48,1
"C3_TF_targets:C3_TFT_566_SGCGSSAAA_V_E2F1DP2_01","C3_TF_targets","C3_TFT_566_SGCGSSAAA_V_E2F1DP2_01",167,-0.6932,0.98,1,0.7655,0.96,1,-1.2099,0.092,0.34
"GO_MF:496852_GO_0017022_MYOSIN_BINDING","GO_MF","496852_GO_0017022_MYOSIN_BINDING",51,-0.693,0.93,0.95,1.1606,0.22,0.74,0.9626,0.52,0.9
"GO_BP:495113_GO_0014041_REGULATION_OF_NEURON_MATURATION","GO_BP","495113_GO_0014041_REGULATION_OF_NEURON_MATURATION",7,-0.693,0.83,0.96,1.0262,0.45,0.97,1.4185,0.096,0.62
"C4_Cancer_modules:C4_CM_383_MODULE_480","C4_Cancer_modules","C4_CM_383_MODULE_480",96,-0.6928,0.96,0.96,1.2004,0.11,0.39,0.9149,0.65,0.95
"GO_MF:495661_GO_0015464_ACETYLCHOLINE_RECEPTOR_ACTIVITY","GO_MF","495661_GO_0015464_ACETYLCHOLINE_RECEPTOR_ACTIVITY",19,-0.6928,0.9,0.95,-1.5121,0.048,0.55,1.2262,0.2,0.69
"C3_TF_targets:C3_TFT_348_GAANYNYGACNY_UNKNOWN","C3_TF_targets","C3_TFT_348_GAANYNYGACNY_UNKNOWN",74,-0.6928,0.94,1,0.6574,0.99,1,-0.8315,0.82,0.99
"GO_BP:504322_GO_0035137_HINDLIMB_MORPHOGENESIS","GO_BP","504322_GO_0035137_HINDLIMB_MORPHOGENESIS",37,-0.6927,0.93,0.96,-1.0191,0.43,0.97,0.999,0.46,0.86
"GO_BP:516991_GO_0072074_KIDNEY_MESENCHYME_DEVELOPMENT","GO_BP","516991_GO_0072074_KIDNEY_MESENCHYME_DEVELOPMENT",17,-0.6927,0.88,0.96,-1.1292,0.29,0.94,0.9862,0.47,0.87
"GO_BP:517077_GO_0072161_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT","GO_BP","517077_GO_0072161_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT",8,-0.6925,0.86,0.96,-1.3508,0.14,0.93,1.1779,0.26,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2994_DASU_IL6_SIGNALING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2994_DASU_IL6_SIGNALING_DN",7,-0.6924,0.86,0.96,-0.7404,0.8,1,0.6928,0.85,1
"C1_Positional:C1_ALL_107_CHR2P24","C1_Positional","C1_ALL_107_CHR2P24",49,-0.692,0.94,0.99,1.0791,0.33,0.65,1.0941,0.29,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1631_JIANG_AGING_CEREBRAL_CORTEX_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1631_JIANG_AGING_CEREBRAL_CORTEX_UP",36,-0.6919,0.92,0.96,1.2672,0.12,0.42,-0.4785,1,1
"KEGG_reaction:R00328_GDP_PHOSPHOHYDROLASE_GDP_H2O_GMP_ORTHOPHOSPHATE","KEGG_reaction","R00328_GDP_PHOSPHOHYDROLASE_GDP_H2O_GMP_ORTHOPHOSPHATE",6,-0.6919,0.85,0.91,0.7417,0.78,1,0.6373,0.89,0.98
"C1_Positional:C1_ALL_68_CHR17Q22","C1_Positional","C1_ALL_68_CHR17Q22",27,-0.6915,0.89,0.98,-0.988,0.47,1,0.8873,0.65,0.86
"GO_BP:495027_GO_0010962_REGULATION_OF_GLUCAN_BIOSYNTHETIC_PROCESS","GO_BP","495027_GO_0010962_REGULATION_OF_GLUCAN_BIOSYNTHETIC_PROCESS",30,-0.6911,0.91,0.96,-0.4344,1,1,0.8047,0.78,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3262_PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3262_PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN",6,-0.691,0.85,0.96,1.2973,0.15,0.39,1.2389,0.23,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_2951_LY_AGING_OLD_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2951_LY_AGING_OLD_UP",6,-0.6908,0.83,0.96,-1.0733,0.38,0.95,1.0103,0.43,0.96
"C7_Immunologic_signatures:C7_ALL_1685_GSE3982_BCELL_VS_TH2_UP","C7_Immunologic_signatures","C7_ALL_1685_GSE3982_BCELL_VS_TH2_UP",196,-0.6908,0.99,1,-0.7226,0.99,1,-0.73,1,1
"C4_Cancer_modules:C4_CM_346_MODULE_415","C4_Cancer_modules","C4_CM_346_MODULE_415",13,-0.6907,0.88,0.96,-1.97,0,0.051,1.0752,0.37,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_2886_ZHAN_MULTIPLE_MYELOMA_PR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2886_ZHAN_MULTIPLE_MYELOMA_PR_DN",44,-0.6906,0.93,0.96,0.8237,0.78,0.98,-0.7586,0.88,0.97
"GO_BP:508059_GO_0045714_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BIOSYNTHETIC_PROCESS","GO_BP","508059_GO_0045714_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BIOSYNTHETIC_PROCESS",7,-0.6906,0.86,0.96,0.9446,0.53,1,-0.6059,0.94,1
"C3_MicroRNA_targets:C3_MIR_199_CTCTATG_MIR_368","C3_MicroRNA_targets","C3_MIR_199_CTCTATG_MIR_368",40,-0.6905,0.9,1,1.2338,0.15,1,0.9362,0.56,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2158_LIN_MELANOMA_COPY_NUMBER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2158_LIN_MELANOMA_COPY_NUMBER_DN",41,-0.6904,0.93,0.96,1.5382,0.031,0.18,0.5688,1,1
"KEGG_reaction:R00155_UDP_PHOSPHOHYDROLASE_UDP_H2O_UMP_ORTHOPHOSPHATE","KEGG_reaction","R00155_UDP_PHOSPHOHYDROLASE_UDP_H2O_UMP_ORTHOPHOSPHATE",6,-0.6902,0.85,0.9,0.7511,0.78,1,0.6669,0.86,0.98
"REACTOME:771574_REACT_160242_INITIATION_OF_NUCLEAR_ENVELOPE_REFORMATION","REACTOME","771574_REACT_160242_INITIATION_OF_NUCLEAR_ENVELOPE_REFORMATION",13,-0.69,0.89,0.96,1.2007,0.23,0.44,-0.5536,0.96,1
"WikiPathways:198859_WP325_TRIACYLGLYCERIDE_SYNTHESIS","WikiPathways","198859_WP325_TRIACYLGLYCERIDE_SYNTHESIS",23,-0.69,0.9,0.97,1.1293,0.3,0.97,0.8462,0.7,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_699_LUI_THYROID_CANCER_CLUSTER_3","C2_Chemical_and_genetic_perturbations","C2_CGP_699_LUI_THYROID_CANCER_CLUSTER_3",28,-0.6898,0.89,0.96,2.4313,0,0,-1.1088,0.29,0.62
"C7_Immunologic_signatures:C7_ALL_381_GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_381_GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP",200,-0.6897,1,1,1.0067,0.43,0.72,-0.9105,0.7,0.93
"GO_MF:504654_GO_0035473_LIPASE_BINDING","GO_MF","504654_GO_0035473_LIPASE_BINDING",6,-0.6893,0.84,0.95,0.9565,0.49,0.92,1.1798,0.28,0.75
"REACTOME:106573_REACT_15480_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT","REACTOME","106573_REACT_15480_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT",43,-0.6893,0.93,0.96,-1.0418,0.37,0.95,-1.0102,0.44,0.82
"C7_Immunologic_signatures:C7_ALL_776_GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_776_GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN",198,-0.6892,0.99,1,1.0816,0.23,0.49,-0.8427,0.91,1
"GO_BP:849879_GO_1902177_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","849879_GO_1902177_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",6,-0.6891,0.85,0.97,-1.178,0.27,0.91,-0.9134,0.55,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1161_WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT","C2_Chemical_and_genetic_perturbations","C2_CGP_1161_WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT",63,-0.6889,0.95,0.96,1.2268,0.14,0.46,1.0801,0.31,0.87
"GO_BP:519181_GO_2000542_NEGATIVE_REGULATION_OF_GASTRULATION","GO_BP","519181_GO_2000542_NEGATIVE_REGULATION_OF_GASTRULATION",7,-0.6888,0.85,0.97,-0.9405,0.55,1,-1.34,0.15,0.61
"KEGG_compound:C00272_TETRAHYDROBIOPTERIN_5_6_7_8_TETRAHYDROBIOPTERIN_2_AMINO_6_1_2_DIHYDROXYPROPYL_5_6_7_8_TETRAHYDORO_4_1H_PTERIDINONE_L_ERYTHRO_TETRAHYDROBIOPTERIN","KEGG_compound","C00272_TETRAHYDROBIOPTERIN_5_6_7_8_TETRAHYDROBIOPTERIN_2_AMINO_6_1_2_DIHYDROXYPROPYL_5_6_7_8_TETRAHYDORO_4_1H_PTERIDINONE_L_ERYTHRO_TETRAHYDROBIOPTERIN",6,-0.6883,0.86,0.94,0.9591,0.51,1,-1.026,0.43,0.62
"GO_BP:505445_GO_0042297_VOCAL_LEARNING","GO_BP","505445_GO_0042297_VOCAL_LEARNING",5,-0.6878,0.85,0.97,-1.0946,0.38,0.95,1.375,0.13,0.64
"GO_BP:514861_GO_0061316_CANONICAL_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","514861_GO_0061316_CANONICAL_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",5,-0.6871,0.85,0.97,-0.7179,0.8,1,0.9439,0.52,0.91
"GO_BP:504650_GO_0035469_DETERMINATION_OF_PANCREATIC_LEFT_RIGHT_ASYMMETRY","GO_BP","504650_GO_0035469_DETERMINATION_OF_PANCREATIC_LEFT_RIGHT_ASYMMETRY",5,-0.6869,0.85,0.97,-1.3527,0.12,0.95,-0.6353,0.88,1
"GO_BP:982302_GO_0098597_OBSERVATIONAL_LEARNING","GO_BP","982302_GO_0098597_OBSERVATIONAL_LEARNING",5,-0.6868,0.86,0.97,-1.0784,0.38,0.95,1.3729,0.13,0.64
"GO_BP:491079_GO_0006099_TRICARBOXYLIC_ACID_CYCLE","GO_BP","491079_GO_0006099_TRICARBOXYLIC_ACID_CYCLE",29,-0.6867,0.91,0.97,1.9319,0.0021,0.028,-1.4659,0.053,0.54
"GO_BP:514742_GO_0061197_FUNGIFORM_PAPILLA_MORPHOGENESIS","GO_BP","514742_GO_0061197_FUNGIFORM_PAPILLA_MORPHOGENESIS",5,-0.6865,0.85,0.97,-1.046,0.42,0.97,0.8696,0.64,0.97
"GO_BP:514558_GO_0061003_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS","GO_BP","514558_GO_0061003_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS",9,-0.6865,0.86,0.97,-1.2973,0.17,0.89,-0.6595,0.89,1
"GO_BP:512738_GO_0051883_KILLING_OF_CELLS_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","512738_GO_0051883_KILLING_OF_CELLS_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",10,-0.6861,0.87,0.97,1.4982,0.069,0.41,0.6521,0.91,1
"GO_BP:491827_GO_0006991_RESPONSE_TO_STEROL_DEPLETION","GO_BP","491827_GO_0006991_RESPONSE_TO_STEROL_DEPLETION",10,-0.6859,0.88,0.97,-0.7621,0.76,1,-0.705,0.87,0.99
"C1_Positional:C1_ALL_138_CHR15Q15","C1_Positional","C1_ALL_138_CHR15Q15",76,-0.6859,0.97,0.98,-0.9236,0.6,1,0.9318,0.6,0.82
"KEGG_compound:C00546_METHYLGLYOXAL_PYRUVALDEHYDE_PYRUVIC_ALDEHYDE_2_KETOPROPIONALDEHYDE_2_OXOPROPANAL","KEGG_compound","C00546_METHYLGLYOXAL_PYRUVALDEHYDE_PYRUVIC_ALDEHYDE_2_KETOPROPIONALDEHYDE_2_OXOPROPANAL",8,-0.6857,0.85,0.95,-0.9044,0.58,1,-1.5398,0.043,0.21
"KEGG_module:HSA_M00152_CYTOCHROME_BC1_COMPLEX","KEGG_module","HSA_M00152_CYTOCHROME_BC1_COMPLEX",10,-0.6855,0.86,0.95,1.5656,0.035,0.13,0.6936,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1595_FAELT_B_CLL_WITH_VH3_21_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1595_FAELT_B_CLL_WITH_VH3_21_UP",44,-0.6853,0.93,0.96,-0.5499,1,1,1.0405,0.4,0.92
"C3_MicroRNA_targets:C3_MIR_203_CAGCAGG_MIR_370","C3_MicroRNA_targets","C3_MIR_203_CAGCAGG_MIR_370",153,-0.685,0.98,1,-1.416,0.0086,0.56,-1.0542,0.32,1
"REACTOME:105825_REACT_6828_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS","REACTOME","105825_REACT_6828_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS",83,-0.6849,0.97,0.97,1.8999,0,0.0081,-1.0338,0.39,0.8
"C7_Immunologic_signatures:C7_ALL_864_GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_864_GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN",200,-0.6849,0.99,1,0.9936,0.47,0.76,-1.0018,0.43,0.72
"GO_BP:501186_GO_0031946_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS","GO_BP","501186_GO_0031946_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS",7,-0.6848,0.87,0.97,0.8247,0.69,1,1.0699,0.38,0.78
"C7_Immunologic_signatures:C7_ALL_1227_GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1227_GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP",193,-0.6847,0.99,1,1.2323,0.069,0.18,-0.8945,0.76,0.96
"GO_BP:507348_GO_0044342_TYPE_B_PANCREATIC_CELL_PROLIFERATION","GO_BP","507348_GO_0044342_TYPE_B_PANCREATIC_CELL_PROLIFERATION",8,-0.6846,0.86,0.97,-0.8611,0.63,1,-1.3443,0.15,0.61
"GO_BP:752621_GO_0097120_RECEPTOR_LOCALIZATION_TO_SYNAPSE","GO_BP","752621_GO_0097120_RECEPTOR_LOCALIZATION_TO_SYNAPSE",8,-0.6846,0.87,0.97,-0.7028,0.84,1,-0.7682,0.77,1
"GO_BP:512689_GO_0051818_DISRUPTION_OF_CELLS_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","512689_GO_0051818_DISRUPTION_OF_CELLS_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",10,-0.6845,0.86,0.97,1.4713,0.095,0.46,0.6674,0.88,1
"REACTOME:160944_REACT_21279_REGULATION_OF_MITOTIC_CELL_CYCLE","REACTOME","160944_REACT_21279_REGULATION_OF_MITOTIC_CELL_CYCLE",83,-0.6843,0.96,0.97,1.8717,0,0.011,-1.0304,0.38,0.8
"KEGG_reaction:R08379_RETINOL_NADP_OXIDOREDUCTASE_RETINOL_NADP_RETINAL_NADPH_H_","KEGG_reaction","R08379_RETINOL_NADP_OXIDOREDUCTASE_RETINOL_NADP_RETINAL_NADPH_H_",7,-0.6842,0.88,0.9,0.7662,0.73,1,-0.8208,0.69,0.83
"GO_CC:925902_GO_0098573_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_MEMBRANE","GO_CC","925902_GO_0098573_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_MEMBRANE",41,-0.6842,0.94,1,1.0002,0.45,0.79,-0.7432,0.9,1
"GO_BP:1022195_GO_1903209_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH","GO_BP","1022195_GO_1903209_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH",8,-0.6842,0.86,0.97,-1.2064,0.23,0.88,-1.007,0.45,0.84
"GO_BP:501666_GO_0032434_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","501666_GO_0032434_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",128,-0.6839,0.98,0.97,1.1049,0.23,0.9,-0.9741,0.51,0.88
"GO_BP:510369_GO_0048255_MRNA_STABILIZATION","GO_BP","510369_GO_0048255_MRNA_STABILIZATION",28,-0.6836,0.9,0.97,1.0053,0.43,0.98,-0.7294,0.88,0.99
"GO_BP:491468_GO_0006572_TYROSINE_CATABOLIC_PROCESS","GO_BP","491468_GO_0006572_TYROSINE_CATABOLIC_PROCESS",5,-0.6836,0.84,0.97,-1.2523,0.22,0.91,0.9647,0.5,0.89
"GO_CC:490834_GO_0030658_TRANSPORT_VESICLE_MEMBRANE","GO_CC","490834_GO_0030658_TRANSPORT_VESICLE_MEMBRANE",82,-0.6835,0.96,1,1.063,0.32,0.7,-0.9818,0.5,1
"GO_BP:517433_GO_0072528_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","517433_GO_0072528_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",38,-0.6831,0.92,0.97,0.6333,0.98,1,-0.8826,0.66,0.94
"C3_TF_targets:C3_TFT_553_YTCCCRNNAGGY_UNKNOWN","C3_TF_targets","C3_TFT_553_YTCCCRNNAGGY_UNKNOWN",72,-0.683,0.95,1,-0.9329,0.59,0.9,-1.3129,0.072,0.24
"C4_Cancer_gene_neighborhoods:C4_CGN_90_MORF_EI24","C4_Cancer_gene_neighborhoods","C4_CGN_90_MORF_EI24",143,-0.6829,0.98,1,2.1263,0,0.00012,-1.2021,0.11,0.44
"C2_Chemical_and_genetic_perturbations:C2_CGP_2610_ZHANG_TLX_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2610_ZHANG_TLX_TARGETS_UP",89,-0.6825,0.98,0.96,1.0044,0.44,0.79,-1.3724,0.034,0.38
"GO_BP:519022_GO_2000382_POSITIVE_REGULATION_OF_MESODERM_DEVELOPMENT","GO_BP","519022_GO_2000382_POSITIVE_REGULATION_OF_MESODERM_DEVELOPMENT",5,-0.6823,0.88,0.97,0.5771,0.94,1,0.8896,0.59,0.95
"GO_CC:507372_GO_0044423_VIRION_PART","GO_CC","507372_GO_0044423_VIRION_PART",11,-0.6822,0.88,1,-0.8468,0.68,0.97,0.6721,0.9,1
"REACTOME:105734_REACT_11184_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS","REACTOME","105734_REACT_11184_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS",10,-0.6821,0.89,0.97,-1.3507,0.12,0.59,1.2762,0.18,0.78
"GO_BP:983712_GO_1902993_POSITIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS","GO_BP","983712_GO_1902993_POSITIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS",5,-0.6812,0.89,0.97,1.3458,0.13,0.62,-1.2035,0.28,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_3216_TERAO_AOX4_TARGETS_SKIN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3216_TERAO_AOX4_TARGETS_SKIN_UP",38,-0.6809,0.93,0.96,-0.8759,0.67,1,0.8422,0.73,1
"C7_Immunologic_signatures:C7_ALL_1229_GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP","C7_Immunologic_signatures","C7_ALL_1229_GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP",193,-0.6806,0.99,1,0.7205,1,1,-1.1632,0.12,0.34
"GO_MF:500193_GO_0030898_ACTIN_DEPENDENT_ATPASE_ACTIVITY","GO_MF","500193_GO_0030898_ACTIN_DEPENDENT_ATPASE_ACTIVITY",12,-0.6805,0.87,0.96,-0.6394,0.93,1,1.2595,0.18,0.65
"GO_BP:506399_GO_0043353_ENUCLEATE_ERYTHROCYTE_DIFFERENTIATION","GO_BP","506399_GO_0043353_ENUCLEATE_ERYTHROCYTE_DIFFERENTIATION",8,-0.6802,0.87,0.97,-0.5191,0.98,1,-0.6975,0.85,0.99
"GO_BP:491811_GO_0006972_HYPEROSMOTIC_RESPONSE","GO_BP","491811_GO_0006972_HYPEROSMOTIC_RESPONSE",23,-0.6801,0.9,0.97,1.0973,0.29,0.9,-0.8808,0.63,0.94
"GO_BP:487030_GO_0000733_DNA_STRAND_RENATURATION","GO_BP","487030_GO_0000733_DNA_STRAND_RENATURATION",9,-0.6801,0.85,0.97,-1.197,0.26,0.9,-1.0059,0.45,0.84
"GO_BP:493941_GO_0009838_ABSCISSION","GO_BP","493941_GO_0009838_ABSCISSION",6,-0.68,0.86,0.97,0.973,0.49,1,-0.7538,0.79,1
"GO_BP:505290_GO_0042118_ENDOTHELIAL_CELL_ACTIVATION","GO_BP","505290_GO_0042118_ENDOTHELIAL_CELL_ACTIVATION",9,-0.6797,0.9,0.97,0.5998,0.93,1,-1.0434,0.4,0.82
"GO_CC:1051067_GO_0097651_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_I","GO_CC","1051067_GO_0097651_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_I",5,-0.6797,0.84,1,1.3847,0.12,0.3,1.4722,0.072,0.63
"GO_MF:505904_GO_0042800_HISTONE_METHYLTRANSFERASE_ACTIVITY_H3_K4_SPECIFIC_","GO_MF","505904_GO_0042800_HISTONE_METHYLTRANSFERASE_ACTIVITY_H3_K4_SPECIFIC_",17,-0.6795,0.9,0.96,-0.7194,0.86,1,-0.5409,0.99,1
"GO_BP:518744_GO_2000095_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY","GO_BP","518744_GO_2000095_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY",13,-0.6795,0.86,0.97,0.7232,0.84,1,-1.1789,0.25,0.73
"GO_CC:499560_GO_0030131_CLATHRIN_ADAPTOR_COMPLEX","GO_CC","499560_GO_0030131_CLATHRIN_ADAPTOR_COMPLEX",32,-0.6792,0.92,1,0.9845,0.49,0.81,0.5601,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_704_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13","C2_Chemical_and_genetic_perturbations","C2_CGP_704_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13",6,-0.6791,0.86,0.96,-0.8824,0.6,1,-1.2168,0.26,0.5
"GO_MF:503618_GO_0034416_BISPHOSPHOGLYCERATE_PHOSPHATASE_ACTIVITY","GO_MF","503618_GO_0034416_BISPHOSPHOGLYCERATE_PHOSPHATASE_ACTIVITY",5,-0.6789,0.86,0.96,-0.8359,0.66,1,1.0828,0.37,0.81
"C4_Cancer_modules:C4_CM_258_MODULE_293","C4_Cancer_modules","C4_CM_258_MODULE_293",11,-0.6787,0.88,0.96,0.717,0.85,1,-0.7615,0.79,0.99
"GO_BP:982303_GO_0098598_LEARNED_VOCALIZATION_BEHAVIOR_OR_VOCAL_LEARNING","GO_BP","982303_GO_0098598_LEARNED_VOCALIZATION_BEHAVIOR_OR_VOCAL_LEARNING",5,-0.6783,0.83,0.97,-1.0665,0.42,0.96,1.3703,0.14,0.64
"GO_BP:492653_GO_0048148_BEHAVIORAL_RESPONSE_TO_COCAINE","GO_BP","492653_GO_0048148_BEHAVIORAL_RESPONSE_TO_COCAINE",12,-0.6782,0.87,0.97,-1.2178,0.21,0.88,0.9286,0.56,0.92
"C1_Positional:C1_ALL_211_CHR9Q34","C1_Positional","C1_ALL_211_CHR9Q34",229,-0.6781,1,0.99,-1.059,0.3,1,-1.1635,0.13,0.69
"GO_MF:752539_GO_0090482_VITAMIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","752539_GO_0090482_VITAMIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.678,0.86,0.96,-1.0634,0.4,0.86,-0.6875,0.85,1
"REACTOME:106108_REACT_11082_IMPORT_OF_PALMITOYL_COA_INTO_THE_MITOCHONDRIAL_MATRIX","REACTOME","106108_REACT_11082_IMPORT_OF_PALMITOYL_COA_INTO_THE_MITOCHONDRIAL_MATRIX",11,-0.6779,0.88,0.97,-0.7984,0.75,1,1.11,0.34,0.96
"GO_BP:505862_GO_0042756_DRINKING_BEHAVIOR","GO_BP","505862_GO_0042756_DRINKING_BEHAVIOR",8,-0.6779,0.86,0.97,1.0722,0.36,0.93,1.4811,0.067,0.58
"GO_BP:512430_GO_0051552_FLAVONE_METABOLIC_PROCESS","GO_BP","512430_GO_0051552_FLAVONE_METABOLIC_PROCESS",6,-0.6773,0.89,0.97,0.979,0.49,1,1.8685,0,0.2
"GO_BP:784757_GO_1902033_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION","GO_BP","784757_GO_1902033_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION",5,-0.6773,0.85,0.97,1.1144,0.34,0.88,0.9198,0.55,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_18_KORKOLA_EMBRYONAL_CARCINOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_18_KORKOLA_EMBRYONAL_CARCINOMA_DN",12,-0.6772,0.88,0.97,-0.8979,0.59,1,0.6457,0.92,1
"C3_MicroRNA_targets:C3_MIR_57_ACACTCC_MIR_122A","C3_MicroRNA_targets","C3_MIR_57_ACACTCC_MIR_122A",75,-0.6771,0.97,1,0.7236,0.95,1,-0.8952,0.68,1
"GO_BP:510190_GO_0048026_POSITIVE_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME","GO_BP","510190_GO_0048026_POSITIVE_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME",16,-0.677,0.9,0.97,-0.7296,0.83,1,-1.1329,0.3,0.75
"OMIM_gene:OMIM611756_ROPN1_LIKE_PROTEIN_ROPN1L","OMIM_gene","OMIM611756_ROPN1_LIKE_PROTEIN_ROPN1L",7,-0.6769,0.89,1,-0.6174,0.91,0.94,0.581,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3000_JIANG_HYPOXIA_VIA_VHL","C2_Chemical_and_genetic_perturbations","C2_CGP_3000_JIANG_HYPOXIA_VIA_VHL",34,-0.6767,0.92,0.97,1.477,0.032,0.23,-0.9404,0.54,0.83
"C4_Cancer_modules:C4_CM_248_MODULE_280","C4_Cancer_modules","C4_CM_248_MODULE_280",44,-0.6767,0.94,0.96,1.3615,0.093,0.22,1.2403,0.14,0.53
"GO_BP:514011_GO_0060456_POSITIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS","GO_BP","514011_GO_0060456_POSITIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS",10,-0.6764,0.88,0.97,0.7505,0.82,1,-0.7422,0.78,1
"C1_Positional:C1_ALL_192_CHR13Q12","C1_Positional","C1_ALL_192_CHR13Q12",81,-0.6764,0.96,0.98,1.6294,0,0.22,1.0675,0.35,0.7
"GO_BP:509009_GO_0046782_REGULATION_OF_VIRAL_TRANSCRIPTION","GO_BP","509009_GO_0046782_REGULATION_OF_VIRAL_TRANSCRIPTION",80,-0.6761,0.97,0.97,1.3617,0.032,0.6,0.5591,1,1
"C7_Immunologic_signatures:C7_ALL_1733_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1733_GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP",200,-0.6761,0.99,1,1.0888,0.25,0.47,-1.0175,0.4,0.69
"C7_Immunologic_signatures:C7_ALL_1853_GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP","C7_Immunologic_signatures","C7_ALL_1853_GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP",200,-0.676,0.99,1,0.9479,0.64,0.9,-1.0663,0.28,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_63_GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_63_GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN",66,-0.6759,0.96,0.97,1.5499,0.0067,0.17,-0.8404,0.8,0.93
"GO_BP:494868_GO_0010804_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY","GO_BP","494868_GO_0010804_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY",10,-0.6758,0.88,0.97,-0.5973,0.92,1,1.0531,0.36,0.8
"GO_CC:504437_GO_0035253_CILIARY_ROOTLET","GO_CC","504437_GO_0035253_CILIARY_ROOTLET",9,-0.6757,0.89,1,-0.7186,0.84,1,-0.7636,0.79,1
"GO_BP:752469_GO_0086103_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_PROCESS","GO_BP","752469_GO_0086103_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_PROCESS",6,-0.6756,0.89,0.97,0.7766,0.75,1,1.5103,0.058,0.55
"GO_BP:514741_GO_0061196_FUNGIFORM_PAPILLA_DEVELOPMENT","GO_BP","514741_GO_0061196_FUNGIFORM_PAPILLA_DEVELOPMENT",6,-0.6748,0.86,0.97,-0.9677,0.48,1,0.9513,0.49,0.9
"GO_BP:506568_GO_0043537_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION","GO_BP","506568_GO_0043537_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION",21,-0.6747,0.91,0.97,-0.6805,0.91,1,0.6806,0.89,1
"GO_BP:982301_GO_0098596_IMITATIVE_LEARNING","GO_BP","982301_GO_0098596_IMITATIVE_LEARNING",5,-0.6747,0.88,0.97,-1.0517,0.4,0.97,1.3854,0.14,0.63
"GO_BP:1022085_GO_0044848_BIOLOGICAL_PHASE","GO_BP","1022085_GO_0044848_BIOLOGICAL_PHASE",362,-0.6746,1,0.97,1.4941,0,0.42,-1.2086,0.055,0.73
"GO_CC:501811_GO_0032585_MULTIVESICULAR_BODY_MEMBRANE","GO_CC","501811_GO_0032585_MULTIVESICULAR_BODY_MEMBRANE",7,-0.6741,0.87,1,1.1247,0.33,0.61,-0.6891,0.86,1
"GO_BP:755244_GO_2001138_REGULATION_OF_PHOSPHOLIPID_TRANSPORT","GO_BP","755244_GO_2001138_REGULATION_OF_PHOSPHOLIPID_TRANSPORT",7,-0.674,0.86,0.97,-0.8889,0.59,1,0.5729,0.95,1
"GO_BP:495940_GO_0015809_ARGININE_TRANSPORT","GO_BP","495940_GO_0015809_ARGININE_TRANSPORT",6,-0.6737,0.86,0.97,1.0046,0.45,0.98,1.4588,0.08,0.59
"C7_Immunologic_signatures:C7_ALL_499_GSE17721_CTRL_VS_CPG_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_499_GSE17721_CTRL_VS_CPG_2H_BMDM_UP",197,-0.6735,1,1,1.0877,0.25,0.47,-0.8806,0.82,0.97
"GO_MF:515811_GO_0070883_PRE_MIRNA_BINDING","GO_MF","515811_GO_0070883_PRE_MIRNA_BINDING",7,-0.6733,0.87,0.96,-1.1247,0.33,0.81,-0.77,0.76,0.98
"REACTOME:106475_REACT_12564_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL","REACTOME","106475_REACT_12564_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL",13,-0.6733,0.89,0.97,-0.7981,0.73,1,-0.9965,0.45,0.84
"KEGG_reaction:R08383_9_CIS_RETINOL_NADP_9_CIS_RETINAL_NADPH_H_","KEGG_reaction","R08383_9_CIS_RETINOL_NADP_9_CIS_RETINAL_NADPH_H_",5,-0.6732,0.87,0.9,-0.6152,0.91,0.99,-0.8672,0.63,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_1730_WU_HBX_TARGETS_3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1730_WU_HBX_TARGETS_3_UP",18,-0.6732,0.9,0.97,1.5574,0.021,0.17,0.8125,0.73,1
"GO_BP:488357_GO_0002484_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I_VIA_ER_PATHWAY","GO_BP","488357_GO_0002484_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I_VIA_ER_PATHWAY",5,-0.6731,0.87,0.97,1.1336,0.33,0.86,-0.5616,0.96,1
"GO_MF:498722_GO_0019956_CHEMOKINE_BINDING","GO_MF","498722_GO_0019956_CHEMOKINE_BINDING",13,-0.6731,0.88,0.96,1.7068,0.0099,0.15,2.0681,0,0.0087
"GO_MF:515342_GO_0070410_CO_SMAD_BINDING","GO_MF","515342_GO_0070410_CO_SMAD_BINDING",12,-0.673,0.89,0.96,-0.8607,0.65,1,0.7875,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3217_TERAO_AOX4_TARGETS_SKIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3217_TERAO_AOX4_TARGETS_SKIN_DN",27,-0.673,0.92,0.97,0.924,0.57,0.9,-0.7298,0.88,0.98
"KEGG_enzyme:2.4.2.30_NAD_ADP_RIBOSYLTRANSFERASE_POLY_ADP_RIBOSE_SYNTHASE_ADP_RIBOSYLTRANSFERASE_POLYMERIZING_NAD_ADP_RIBOSYLTRANSFERASE_PARP_PARP_1_NAD_POLY_ADENINE_DIPHOSPHATE_D_RIBOSYL_ACCEPTOR_ADP_D_RIBOSYL_TRANSFERASE_INCORRECT_NAD_POLY_ADENOSINE_DIPHOSPHATE_D_RIBOSYL_ACCEPTOR_ADP_D_RIBOSYL_TRANSFERASE","KEGG_enzyme","2.4.2.30_NAD_ADP_RIBOSYLTRANSFERASE_POLY_ADP_RIBOSE_SYNTHASE_ADP_RIBOSYLTRANSFERASE_POLYMERIZING_NAD_ADP_RIBOSYLTRANSFERASE_PARP_PARP_1_NAD_POLY_ADENINE_DIPHOSPHATE_D_RIBOSYL_ACCEPTOR_ADP_D_RIBOSYL_TRANSFERASE_INCORRECT_NAD_POLY_ADENOSINE_DIPHOSPHATE_D_RIBOSYL_ACCEPTOR_ADP_D_RIBOSYL_TRANSFERASE",17,-0.6729,0.89,0.88,0.6822,0.9,0.99,-0.979,0.46,0.73
"GO_BP:518318_GO_0090178_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY_INVOLVED_IN_NEURAL_TUBE_CLOSURE","GO_BP","518318_GO_0090178_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY_INVOLVED_IN_NEURAL_TUBE_CLOSURE",14,-0.6729,0.9,0.97,1.1647,0.25,0.82,0.939,0.54,0.91
"KEGG_pathway:HSA00670_ONE_CARBON_POOL_BY_FOLATE","KEGG_pathway","HSA00670_ONE_CARBON_POOL_BY_FOLATE",20,-0.6727,0.9,0.97,0.7656,0.78,1,-0.9128,0.56,0.83
"GO_BP:512468_GO_0051590_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT","GO_BP","512468_GO_0051590_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT",16,-0.6725,0.89,0.97,-0.6904,0.86,1,1.1684,0.26,0.72
"GO_BP:506615_GO_0043584_NOSE_DEVELOPMENT","GO_BP","506615_GO_0043584_NOSE_DEVELOPMENT",16,-0.6722,0.9,0.97,-0.8412,0.67,1,0.9845,0.48,0.87
"GO_BP:492133_GO_0007368_DETERMINATION_OF_LEFT_RIGHT_SYMMETRY","GO_BP","492133_GO_0007368_DETERMINATION_OF_LEFT_RIGHT_SYMMETRY",89,-0.6716,0.97,0.97,-1.0689,0.32,0.96,1.0849,0.29,0.77
"GO_CC:500566_GO_0031307_INTEGRAL_COMPONENT_OF_MITOCHONDRIAL_OUTER_MEMBRANE","GO_CC","500566_GO_0031307_INTEGRAL_COMPONENT_OF_MITOCHONDRIAL_OUTER_MEMBRANE",17,-0.6714,0.88,1,-0.6981,0.88,1,-0.9237,0.56,1
"GO_BP:519148_GO_2000508_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS","GO_BP","519148_GO_2000508_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS",5,-0.6713,0.88,0.97,0.7069,0.84,1,-0.6717,0.85,1
"GO_CC:497895_GO_0019012_VIRION","GO_CC","497895_GO_0019012_VIRION",11,-0.6712,0.89,1,-0.8664,0.63,0.95,0.6761,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1011_LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_1011_LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER",214,-0.6711,0.99,0.97,1.3001,0.012,0.39,0.8567,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_625_AUNG_GASTRIC_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_625_AUNG_GASTRIC_CANCER",52,-0.671,0.96,0.97,0.8169,0.83,0.98,-1.1395,0.23,0.59
"GO_BP:501914_GO_0032688_NEGATIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION","GO_BP","501914_GO_0032688_NEGATIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION",9,-0.6709,0.88,0.97,-0.8429,0.67,1,-1.4836,0.069,0.53
"C3_TF_targets:C3_TFT_407_V_LXR_DR4_Q3","C3_TF_targets","C3_TFT_407_V_LXR_DR4_Q3",91,-0.6708,0.98,1,-1.1261,0.23,0.49,0.9744,0.53,1
"GO_BP:491972_GO_0007168_RECEPTOR_GUANYLYL_CYCLASE_SIGNALING_PATHWAY","GO_BP","491972_GO_0007168_RECEPTOR_GUANYLYL_CYCLASE_SIGNALING_PATHWAY",11,-0.6708,0.89,0.97,-1.2135,0.22,0.88,-1.5973,0.028,0.51
"GO_BP:492664_GO_0008354_GERM_CELL_MIGRATION","GO_BP","492664_GO_0008354_GERM_CELL_MIGRATION",11,-0.6708,0.9,0.97,0.7418,0.81,1,1.4339,0.083,0.6
"REACTOME:106063_REACT_12621_TIE2_SIGNALING","REACTOME","106063_REACT_12621_TIE2_SIGNALING",18,-0.6708,0.9,0.97,0.9248,0.55,0.87,-0.8024,0.78,1
"GO_BP:502306_GO_0033085_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS","GO_BP","502306_GO_0033085_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS",8,-0.6705,0.87,0.97,-1.4809,0.086,0.83,-0.6728,0.88,1
"GO_BP:491412_GO_0006515_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEIN_CATABOLIC_PROCESS","GO_BP","491412_GO_0006515_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEIN_CATABOLIC_PROCESS",13,-0.6704,0.88,0.97,0.8039,0.75,1,-0.9234,0.56,0.91
"C3_MicroRNA_targets:C3_MIR_96_CGGTGTG_MIR_220","C3_MicroRNA_targets","C3_MIR_96_CGGTGTG_MIR_220",6,-0.6704,0.87,1,0.6328,0.92,1,0.8663,0.65,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1633_HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC","C2_Chemical_and_genetic_perturbations","C2_CGP_1633_HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC",50,-0.6702,0.95,0.97,1.4918,0.03,0.22,-0.7339,0.92,0.98
"C1_Positional:C1_ALL_2_CHR16Q24","C1_Positional","C1_ALL_2_CHR16Q24",86,-0.67,0.98,0.98,0.6492,0.99,1,1.0128,0.4,0.74
"C4_Cancer_gene_neighborhoods:C4_CGN_215_GCM_CDH5","C4_Cancer_gene_neighborhoods","C4_CGN_215_GCM_CDH5",33,-0.6699,0.93,1,-0.8589,0.7,1,1.0882,0.34,0.61
"GO_BP:516383_GO_0071459_PROTEIN_LOCALIZATION_TO_CHROMOSOME_CENTROMERIC_REGION","GO_BP","516383_GO_0071459_PROTEIN_LOCALIZATION_TO_CHROMOSOME_CENTROMERIC_REGION",12,-0.6699,0.89,0.97,0.5886,0.94,1,-1.0956,0.35,0.78
"GO_BP:755246_GO_2001140_POSITIVE_REGULATION_OF_PHOSPHOLIPID_TRANSPORT","GO_BP","755246_GO_2001140_POSITIVE_REGULATION_OF_PHOSPHOLIPID_TRANSPORT",7,-0.6697,0.86,0.97,-0.8641,0.64,1,0.5806,0.95,1
"GO_CC:799471_GO_1990075_PERICILIARY_MEMBRANE_COMPARTMENT","GO_CC","799471_GO_1990075_PERICILIARY_MEMBRANE_COMPARTMENT",6,-0.6693,0.87,1,-0.5369,0.97,1,0.9251,0.55,1
"GO_BP:514701_GO_0061156_PULMONARY_ARTERY_MORPHOGENESIS","GO_BP","514701_GO_0061156_PULMONARY_ARTERY_MORPHOGENESIS",5,-0.669,0.84,0.97,-0.972,0.5,1,0.9431,0.53,0.91
"GO_MF:496766_GO_0016877_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS","GO_MF","496766_GO_0016877_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS",40,-0.6689,0.96,0.96,0.9651,0.54,0.91,-0.9354,0.56,0.84
"REACTOME:106426_REACT_332_IRS_MEDIATED_SIGNALLING","REACTOME","106426_REACT_332_IRS_MEDIATED_SIGNALLING",79,-0.6689,0.97,0.97,0.8176,0.86,0.99,0.6489,0.99,1
"GO_BP:503171_GO_0033962_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY","GO_BP","503171_GO_0033962_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY",9,-0.6688,0.89,0.97,-0.704,0.85,1,-0.6553,0.88,1
"GO_BP:499058_GO_0021778_OLIGODENDROCYTE_CELL_FATE_SPECIFICATION","GO_BP","499058_GO_0021778_OLIGODENDROCYTE_CELL_FATE_SPECIFICATION",5,-0.6686,0.87,0.97,0.8785,0.61,1,0.7214,0.8,1
"GO_BP:502900_GO_0033683_NUCLEOTIDE_EXCISION_REPAIR_DNA_INCISION","GO_BP","502900_GO_0033683_NUCLEOTIDE_EXCISION_REPAIR_DNA_INCISION",8,-0.6683,0.88,0.97,0.9243,0.55,1,-0.5911,0.94,1
"GO_BP:505578_GO_0042438_MELANIN_BIOSYNTHETIC_PROCESS","GO_BP","505578_GO_0042438_MELANIN_BIOSYNTHETIC_PROCESS",13,-0.6682,0.89,0.97,-0.751,0.83,1,-0.7921,0.75,0.99
"GO_BP:507252_GO_0044245_POLYSACCHARIDE_DIGESTION","GO_BP","507252_GO_0044245_POLYSACCHARIDE_DIGESTION",5,-0.6681,0.87,0.97,0.9512,0.51,1,0.7716,0.77,1
"GO_BP:777517_GO_0044773_MITOTIC_DNA_DAMAGE_CHECKPOINT","GO_BP","777517_GO_0044773_MITOTIC_DNA_DAMAGE_CHECKPOINT",101,-0.668,0.98,0.97,1.5108,0.0066,0.39,-0.9679,0.52,0.88
"GO_CC:492625_GO_0016281_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_4F_COMPLEX","GO_CC","492625_GO_0016281_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_4F_COMPLEX",9,-0.6676,0.88,1,1.4212,0.074,0.28,-1.3905,0.11,0.59
"GO_BP:519365_GO_2000726_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION","GO_BP","519365_GO_2000726_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION",6,-0.6672,0.87,0.97,0.7315,0.8,1,1.0582,0.4,0.8
"GO_CC:490928_GO_0005929_CILIUM","GO_CC","490928_GO_0005929_CILIUM",431,-0.6671,1,1,-1.1326,0.12,0.73,-0.9912,0.5,1
"GO_BP:1129216_GO_0061647_HISTONE_H3_K9_MODIFICATION","GO_BP","1129216_GO_0061647_HISTONE_H3_K9_MODIFICATION",27,-0.6668,0.95,0.97,-1.3031,0.13,0.89,-1.474,0.045,0.54
"GO_BP:490999_GO_0006013_MANNOSE_METABOLIC_PROCESS","GO_BP","490999_GO_0006013_MANNOSE_METABOLIC_PROCESS",7,-0.6665,0.9,0.97,0.5967,0.93,1,-0.8323,0.67,0.97
"GO_BP:502097_GO_0032875_REGULATION_OF_DNA_ENDOREDUPLICATION","GO_BP","502097_GO_0032875_REGULATION_OF_DNA_ENDOREDUPLICATION",8,-0.6664,0.9,0.97,1.0468,0.41,0.95,-1.3776,0.11,0.59
"GO_BP:510569_GO_0048496_MAINTENANCE_OF_ORGAN_IDENTITY","GO_BP","510569_GO_0048496_MAINTENANCE_OF_ORGAN_IDENTITY",5,-0.6663,0.87,0.97,0.7815,0.73,1,1.0368,0.44,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1257_BYSTRYKH_SCP2_QTL","C2_Chemical_and_genetic_perturbations","C2_CGP_1257_BYSTRYKH_SCP2_QTL",6,-0.6663,0.87,0.97,0.4116,1,1,-0.7996,0.72,0.95
"GO_CC:498683_GO_0019907_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVATING_KINASE_HOLOENZYME_COMPLEX","GO_CC","498683_GO_0019907_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVATING_KINASE_HOLOENZYME_COMPLEX",6,-0.6661,0.88,1,0.7071,0.82,0.99,-0.854,0.63,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1129_PETRETTO_HEART_MASS_QTL_CIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1129_PETRETTO_HEART_MASS_QTL_CIS_UP",28,-0.666,0.93,0.97,0.8636,0.66,0.96,0.6093,0.98,1
"WikiPathways:920989_WP1530_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE","WikiPathways","920989_WP1530_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE",9,-0.666,0.89,0.98,0.5654,0.96,1,-0.654,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_521_HUMMERICH_MALIGNANT_SKIN_TUMOR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_521_HUMMERICH_MALIGNANT_SKIN_TUMOR_DN",18,-0.6658,0.9,0.97,-0.79,0.76,1,-0.666,0.93,0.99
"GO_BP:754039_GO_1901070_GUANOSINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","754039_GO_1901070_GUANOSINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",17,-0.6658,0.89,0.97,-0.7591,0.82,1,-1.3199,0.12,0.63
"REACTOME:106329_REACT_13778_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS","REACTOME","106329_REACT_13778_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS",5,-0.6656,0.88,0.97,0.859,0.65,0.95,0.8967,0.61,1
"GO_BP:519039_GO_2000399_NEGATIVE_REGULATION_OF_THYMOCYTE_AGGREGATION","GO_BP","519039_GO_2000399_NEGATIVE_REGULATION_OF_THYMOCYTE_AGGREGATION",8,-0.6654,0.88,0.97,-1.5102,0.073,0.81,-0.6832,0.86,1
"GO_BP:492652_GO_0008340_DETERMINATION_OF_ADULT_LIFESPAN","GO_BP","492652_GO_0008340_DETERMINATION_OF_ADULT_LIFESPAN",11,-0.6651,0.89,0.97,-1.0591,0.37,0.96,-1.1554,0.27,0.74
"C3_MicroRNA_targets:C3_MIR_16_AGCGCTT_MIR_518F_MIR_518E_MIR_518A","C3_MicroRNA_targets","C3_MIR_16_AGCGCTT_MIR_518F_MIR_518E_MIR_518A",18,-0.6649,0.89,1,0.8281,0.68,1,-0.9152,0.61,1
"GO_MF:496600_GO_0016668_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_NAD_P_AS_ACCEPTOR","GO_MF","496600_GO_0016668_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_NAD_P_AS_ACCEPTOR",9,-0.6648,0.87,0.96,1.0933,0.35,0.8,-1.5818,0.038,0.36
"GO_CC:486685_GO_0000151_UBIQUITIN_LIGASE_COMPLEX","GO_CC","486685_GO_0000151_UBIQUITIN_LIGASE_COMPLEX",188,-0.6647,1,1,1.1005,0.23,0.64,-1.0439,0.34,0.99
"REACTOME:106477_REACT_12447_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK","REACTOME","106477_REACT_12447_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK",8,-0.6645,0.88,0.97,-0.5738,0.96,1,-1.3651,0.12,0.47
"C1_Positional:C1_ALL_86_CHR2P11","C1_Positional","C1_ALL_86_CHR2P11",53,-0.6643,0.97,0.98,1.0695,0.33,0.66,-0.8727,0.72,0.99
"C3_TF_targets:C3_TFT_470_V_E2F1_Q6_01","C3_TF_targets","C3_TFT_470_V_E2F1_Q6_01",236,-0.664,1,1,-0.7661,0.99,1,-1.3366,0.01,0.25
"GO_MF:496770_GO_0016881_ACID_AMINO_ACID_LIGASE_ACTIVITY","GO_MF","496770_GO_0016881_ACID_AMINO_ACID_LIGASE_ACTIVITY",21,-0.6636,0.93,0.96,-0.6944,0.88,1,0.7613,0.82,1
"GO_BP:507264_GO_0044257_CELLULAR_PROTEIN_CATABOLIC_PROCESS","GO_BP","507264_GO_0044257_CELLULAR_PROTEIN_CATABOLIC_PROCESS",444,-0.6636,1,0.97,1.3572,0,0.6,-0.9433,0.71,0.89
"GO_BP:506246_GO_0043174_NUCLEOSIDE_SALVAGE","GO_BP","506246_GO_0043174_NUCLEOSIDE_SALVAGE",15,-0.6633,0.9,0.97,0.5829,0.96,1,-1.024,0.42,0.83
"GO_BP:486616_GO_0000075_CELL_CYCLE_CHECKPOINT","GO_BP","486616_GO_0000075_CELL_CYCLE_CHECKPOINT",249,-0.6633,1,0.97,1.3844,0.0048,0.57,-1.1487,0.12,0.74
"C7_Immunologic_signatures:C7_ALL_1009_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP","C7_Immunologic_signatures","C7_ALL_1009_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP",199,-0.6632,1,1,-0.7469,0.99,1,-1.0395,0.35,0.63
"GO_BP:496208_GO_0016115_TERPENOID_CATABOLIC_PROCESS","GO_BP","496208_GO_0016115_TERPENOID_CATABOLIC_PROCESS",5,-0.6628,0.87,0.97,-0.9643,0.53,1,-0.8922,0.62,0.93
"C7_Immunologic_signatures:C7_ALL_260_GSE14308_TH1_VS_NATURAL_TREG_DN","C7_Immunologic_signatures","C7_ALL_260_GSE14308_TH1_VS_NATURAL_TREG_DN",198,-0.6626,1,1,0.7356,0.99,1,-0.7979,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2211_OUYANG_PROSTATE_CANCER_PROGRESSION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2211_OUYANG_PROSTATE_CANCER_PROGRESSION_UP",19,-0.6623,0.9,0.97,-0.7752,0.81,1,-0.5952,0.96,0.99
"WikiPathways:198818_WP561_HEME_BIOSYNTHESIS","WikiPathways","198818_WP561_HEME_BIOSYNTHESIS",9,-0.6618,0.9,0.98,1.0266,0.43,1,-1.5529,0.046,0.28
"GO_CC:500715_GO_0031464_CUL4A_RING_E3_UBIQUITIN_LIGASE_COMPLEX","GO_CC","500715_GO_0031464_CUL4A_RING_E3_UBIQUITIN_LIGASE_COMPLEX",9,-0.6618,0.89,1,1.1349,0.28,0.59,-1.3271,0.13,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_382_ENK_UV_RESPONSE_KERATINOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_382_ENK_UV_RESPONSE_KERATINOCYTE_DN",485,-0.6617,1,0.97,1.4747,0,0.23,-0.8391,0.98,0.93
"GO_CC:983679_GO_0090575_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_COMPLEX","GO_CC","983679_GO_0090575_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_COMPLEX",82,-0.6615,0.97,1,0.9817,0.5,0.81,0.6819,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1745_BURTON_ADIPOGENESIS_12","C2_Chemical_and_genetic_perturbations","C2_CGP_1745_BURTON_ADIPOGENESIS_12",36,-0.6613,0.94,0.97,1.1833,0.24,0.51,0.6935,0.94,1
"GO_BP:506226_GO_0043153_ENTRAINMENT_OF_CIRCADIAN_CLOCK_BY_PHOTOPERIOD","GO_BP","506226_GO_0043153_ENTRAINMENT_OF_CIRCADIAN_CLOCK_BY_PHOTOPERIOD",20,-0.661,0.91,0.97,0.8827,0.63,1,-1.2614,0.17,0.67
"KEGG_compound:C00269_CDP_DIACYLGLYCEROL_CDP_1_2_DIACYLGLYCEROL_1_2_DIACYL_SN_GLYCERO_3_CYTIDINE_5_DIPHOSPHATE","KEGG_compound","C00269_CDP_DIACYLGLYCEROL_CDP_1_2_DIACYLGLYCEROL_1_2_DIACYL_SN_GLYCERO_3_CYTIDINE_5_DIPHOSPHATE",5,-0.6609,0.89,0.97,0.9256,0.54,1,-0.6866,0.85,0.92
"GO_BP:518540_GO_0090400_STRESS_INDUCED_PREMATURE_SENESCENCE","GO_BP","518540_GO_0090400_STRESS_INDUCED_PREMATURE_SENESCENCE",8,-0.6608,0.91,0.97,-1.2027,0.24,0.89,-1.2061,0.26,0.73
"C7_Immunologic_signatures:C7_ALL_224_GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN","C7_Immunologic_signatures","C7_ALL_224_GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN",190,-0.6608,1,1,2.5522,0,0,0.714,1,1
"REACTOME:1183585_REACT_355192_RHO_GTPASES_ACTIVATE_ROCKS","REACTOME","1183585_REACT_355192_RHO_GTPASES_ACTIVATE_ROCKS",17,-0.6607,0.91,0.98,0.9443,0.53,0.84,-0.5673,0.97,1
"GO_BP:498816_GO_0021532_NEURAL_TUBE_PATTERNING","GO_BP","498816_GO_0021532_NEURAL_TUBE_PATTERNING",36,-0.6606,0.94,0.97,-0.8936,0.63,1,0.9148,0.61,0.93
"GO_BP:493415_GO_0009219_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS","GO_BP","493415_GO_0009219_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS",14,-0.6606,0.91,0.97,1.6148,0.019,0.28,-1.0057,0.46,0.84
"GO_BP:491408_GO_0051603_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS","GO_BP","491408_GO_0051603_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS",429,-0.6603,1,0.97,1.3394,0.0052,0.62,-0.9122,0.79,0.91
"GO_BP:518254_GO_0090114_COPII_COATED_VESICLE_BUDDING","GO_BP","518254_GO_0090114_COPII_COATED_VESICLE_BUDDING",19,-0.66,0.92,0.97,1.4521,0.075,0.49,0.5689,0.98,1
"GO_BP:491872_GO_0007045_CELL_SUBSTRATE_ADHERENS_JUNCTION_ASSEMBLY","GO_BP","491872_GO_0007045_CELL_SUBSTRATE_ADHERENS_JUNCTION_ASSEMBLY",23,-0.66,0.91,0.97,-0.8858,0.65,1,0.8882,0.64,0.95
"GO_BP:518125_GO_0085020_PROTEIN_K6_LINKED_UBIQUITINATION","GO_BP","518125_GO_0085020_PROTEIN_K6_LINKED_UBIQUITINATION",8,-0.6599,0.88,0.97,0.9394,0.55,1,-1.058,0.39,0.81
"GO_BP:487962_GO_0002072_OPTIC_CUP_MORPHOGENESIS_INVOLVED_IN_CAMERA_TYPE_EYE_DEVELOPMENT","GO_BP","487962_GO_0002072_OPTIC_CUP_MORPHOGENESIS_INVOLVED_IN_CAMERA_TYPE_EYE_DEVELOPMENT",8,-0.6599,0.9,0.97,1.0663,0.39,0.94,1.3462,0.15,0.65
"GO_CC:505871_GO_0042765_GPI_ANCHOR_TRANSAMIDASE_COMPLEX","GO_CC","505871_GO_0042765_GPI_ANCHOR_TRANSAMIDASE_COMPLEX",5,-0.6598,0.88,1,-0.6953,0.83,1,-1.0496,0.41,0.98
"GO_BP:513846_GO_0060290_TRANSDIFFERENTIATION","GO_BP","513846_GO_0060290_TRANSDIFFERENTIATION",5,-0.6595,0.88,0.97,0.8468,0.64,1,1.3375,0.13,0.65
"C4_Cancer_gene_neighborhoods:C4_CGN_143_MORF_PHB","C4_Cancer_gene_neighborhoods","C4_CGN_143_MORF_PHB",124,-0.6587,0.99,1,1.0413,0.36,0.48,-0.743,0.98,1
"GO_BP:518968_GO_2000322_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY","GO_BP","518968_GO_2000322_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY",7,-0.6585,0.89,0.98,-0.9511,0.51,1,-1.0106,0.43,0.84
"GO_BP:495995_GO_0015871_CHOLINE_TRANSPORT","GO_BP","495995_GO_0015871_CHOLINE_TRANSPORT",5,-0.6584,0.89,0.97,-0.7618,0.79,1,0.4866,0.99,1
"GO_MF:489590_GO_0004126_CYTIDINE_DEAMINASE_ACTIVITY","GO_MF","489590_GO_0004126_CYTIDINE_DEAMINASE_ACTIVITY",8,-0.6583,0.9,0.97,0.7844,0.72,1,-0.7229,0.82,0.99
"C7_Immunologic_signatures:C7_ALL_193_GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_193_GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP",180,-0.6583,1,1,2.2225,0,0,1.4778,0.002,0.055
"C4_Cancer_gene_neighborhoods:C4_CGN_188_MORF_UBE2A","C4_Cancer_gene_neighborhoods","C4_CGN_188_MORF_UBE2A",50,-0.6582,0.97,1,1.3891,0.048,0.065,-0.768,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3215_TERAO_AOX4_TARGETS_HG_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3215_TERAO_AOX4_TARGETS_HG_DN",6,-0.6582,0.87,0.97,-0.9135,0.56,1,1.4226,0.089,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_676_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16","C2_Chemical_and_genetic_perturbations","C2_CGP_676_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16",9,-0.6577,0.88,0.97,0.6738,0.88,1,0.6167,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2136_STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2136_STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP",125,-0.6576,0.98,0.97,1.364,0.02,0.33,0.6623,1,1
"GO_BP:493327_GO_0009130_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493327_GO_0009130_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",13,-0.6574,0.91,0.98,0.9021,0.59,1,0.8242,0.69,1
"GO_MF:490063_GO_0004749_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_ACTIVITY","GO_MF","490063_GO_0004749_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_ACTIVITY",5,-0.6573,0.89,0.97,0.8453,0.62,1,-1.0928,0.37,0.7
"GO_BP:517057_GO_0072141_RENAL_INTERSTITIAL_FIBROBLAST_DEVELOPMENT","GO_BP","517057_GO_0072141_RENAL_INTERSTITIAL_FIBROBLAST_DEVELOPMENT",6,-0.6573,0.88,0.98,-0.7012,0.82,1,0.785,0.75,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_119_BIOCARTA_MTOR_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_119_BIOCARTA_MTOR_PATHWAY",23,-0.6566,0.94,0.95,1.4164,0.068,0.48,-1.0528,0.36,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_883_KIM_MYC_AMPLIFICATION_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_883_KIM_MYC_AMPLIFICATION_TARGETS_UP",198,-0.6564,1,0.97,1.8115,0,0.04,-0.865,0.87,0.91
"GO_CC:507306_GO_0044300_CEREBELLAR_MOSSY_FIBER","GO_CC","507306_GO_0044300_CEREBELLAR_MOSSY_FIBER",7,-0.6564,0.9,1,-1.0446,0.39,0.84,-1.507,0.056,0.49
"GO_BP:487492_GO_0001554_LUTEOLYSIS","GO_BP","487492_GO_0001554_LUTEOLYSIS",5,-0.6564,0.88,0.98,1.0391,0.43,0.96,1.2929,0.2,0.68
"GO_BP:502791_GO_0033574_RESPONSE_TO_TESTOSTERONE","GO_BP","502791_GO_0033574_RESPONSE_TO_TESTOSTERONE",28,-0.6564,0.93,0.98,0.8537,0.71,1,1.4665,0.042,0.59
"GO_BP:498706_GO_0019933_CAMP_MEDIATED_SIGNALING","GO_BP","498706_GO_0019933_CAMP_MEDIATED_SIGNALING",23,-0.6562,0.94,0.98,0.9854,0.47,1,1.1907,0.21,0.72
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_16_BIOCARTA_DNAFRAGMENT_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_16_BIOCARTA_DNAFRAGMENT_PATHWAY",10,-0.6561,0.9,0.94,1.1757,0.25,0.71,-0.7025,0.84,0.98
"C1_Positional:C1_ALL_62_CHR3P12","C1_Positional","C1_ALL_62_CHR3P12",14,-0.6559,0.91,0.98,0.9478,0.56,0.82,1.0184,0.43,0.74
"C7_Immunologic_signatures:C7_ALL_719_GSE17721_0_5H_VS_4H_POLYIC_BMDM_UP","C7_Immunologic_signatures","C7_ALL_719_GSE17721_0_5H_VS_4H_POLYIC_BMDM_UP",195,-0.6559,1,1,1.4161,0.0049,0.033,-0.9174,0.68,0.92
"GO_BP:504464_GO_0035280_MIRNA_LOADING_ONTO_RISC_INVOLVED_IN_GENE_SILENCING_BY_MIRNA","GO_BP","504464_GO_0035280_MIRNA_LOADING_ONTO_RISC_INVOLVED_IN_GENE_SILENCING_BY_MIRNA",7,-0.6553,0.9,0.98,-0.9044,0.57,1,-0.7574,0.75,1
"GO_BP:499059_GO_0021779_OLIGODENDROCYTE_CELL_FATE_COMMITMENT","GO_BP","499059_GO_0021779_OLIGODENDROCYTE_CELL_FATE_COMMITMENT",5,-0.6552,0.9,0.98,0.8591,0.61,1,0.7114,0.82,1
"KEGG_pathway:HSA00190_OXIDATIVE_PHOSPHORYLATION","KEGG_pathway","HSA00190_OXIDATIVE_PHOSPHORYLATION",116,-0.6551,0.99,0.98,2.5837,0,0,0.9463,0.6,1
"GO_BP:498668_GO_0019885_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I","GO_BP","498668_GO_0019885_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I",9,-0.655,0.9,0.98,1.405,0.11,0.55,-0.7097,0.85,0.99
"GO_BP:499060_GO_0021780_GLIAL_CELL_FATE_SPECIFICATION","GO_BP","499060_GO_0021780_GLIAL_CELL_FATE_SPECIFICATION",5,-0.655,0.88,0.98,0.8575,0.65,1,0.7014,0.83,1
"GO_BP:496531_GO_0016584_NUCLEOSOME_POSITIONING","GO_BP","496531_GO_0016584_NUCLEOSOME_POSITIONING",8,-0.6548,0.9,0.98,1.1894,0.26,0.79,0.8981,0.59,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_127_LIU_CMYB_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_127_LIU_CMYB_TARGETS_DN",7,-0.6545,0.89,0.97,1.2676,0.21,0.42,1.1333,0.3,0.84
"GO_CC:516705_GO_0071782_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK","GO_CC","516705_GO_0071782_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK",9,-0.6545,0.91,1,0.8769,0.63,0.91,-0.6034,0.92,1
"GO_BP:752402_GO_0086036_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_POTENTIAL","GO_BP","752402_GO_0086036_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_POTENTIAL",8,-0.6545,0.91,0.98,-1.466,0.07,0.87,1.4228,0.1,0.62
"GO_BP:511933_GO_0051000_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY","GO_BP","511933_GO_0051000_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY",18,-0.6543,0.9,0.98,1.0451,0.39,0.95,1.2243,0.2,0.71
"GO_BP:510205_GO_0048041_FOCAL_ADHESION_ASSEMBLY","GO_BP","510205_GO_0048041_FOCAL_ADHESION_ASSEMBLY",23,-0.6542,0.92,0.98,-0.8998,0.61,1,0.8701,0.64,0.96
"REACTOME:105812_REACT_910_M_PHASE","REACTOME","105812_REACT_910_M_PHASE",296,-0.654,1,0.98,1.2787,0.021,0.35,-1.2307,0.035,0.58
"GO_BP:517199_GO_0072283_METANEPHRIC_RENAL_VESICLE_MORPHOGENESIS","GO_BP","517199_GO_0072283_METANEPHRIC_RENAL_VESICLE_MORPHOGENESIS",11,-0.6539,0.9,0.98,1.0971,0.33,0.9,1.7644,0.002,0.34
"C3_MicroRNA_targets:C3_MIR_114_CCTGTGA_MIR_513","C3_MicroRNA_targets","C3_MIR_114_CCTGTGA_MIR_513",123,-0.6538,0.99,1,-0.7903,0.89,1,0.696,1,1
"GO_BP:921133_GO_1902534_SINGLE_ORGANISM_MEMBRANE_INVAGINATION","GO_BP","921133_GO_1902534_SINGLE_ORGANISM_MEMBRANE_INVAGINATION",15,-0.6537,0.92,0.98,0.9839,0.48,1,0.6677,0.93,1
"REACTOME:106445_REACT_13643_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS","REACTOME","106445_REACT_13643_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS",15,-0.6536,0.9,0.98,1.1923,0.22,0.45,-0.8289,0.69,1
"GO_BP:516100_GO_0071174_MITOTIC_SPINDLE_CHECKPOINT","GO_BP","516100_GO_0071174_MITOTIC_SPINDLE_CHECKPOINT",35,-0.6533,0.93,0.98,1.0371,0.39,0.96,-0.6596,0.95,1
"KEGG_reaction:R02124_RETINOL_NAD_OXIDOREDUCTASE_RETINOL_NAD_RETINAL_NADH_H_","KEGG_reaction","R02124_RETINOL_NAD_OXIDOREDUCTASE_RETINOL_NAD_RETINAL_NADH_H_",11,-0.6533,0.91,0.92,1.6657,0.012,0.08,0.7942,0.76,0.86
"GO_BP:487725_GO_0001829_TROPHECTODERMAL_CELL_DIFFERENTIATION","GO_BP","487725_GO_0001829_TROPHECTODERMAL_CELL_DIFFERENTIATION",18,-0.6529,0.91,0.98,-0.7118,0.88,1,-0.8557,0.66,0.96
"GO_MF:489408_GO_0003923_GPI_ANCHOR_TRANSAMIDASE_ACTIVITY","GO_MF","489408_GO_0003923_GPI_ANCHOR_TRANSAMIDASE_ACTIVITY",5,-0.6528,0.88,0.97,-0.6891,0.86,1,-1.0678,0.39,0.73
"GO_BP:505420_GO_0042268_REGULATION_OF_CYTOLYSIS","GO_BP","505420_GO_0042268_REGULATION_OF_CYTOLYSIS",8,-0.6525,0.89,0.98,1.1877,0.29,0.79,-0.5618,0.96,1
"GO_MF:496747_GO_0016854_RACEMASE_AND_EPIMERASE_ACTIVITY","GO_MF","496747_GO_0016854_RACEMASE_AND_EPIMERASE_ACTIVITY",15,-0.6517,0.91,0.97,0.8058,0.73,1,-0.6781,0.9,1
"GO_BP:519150_GO_2000510_POSITIVE_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS","GO_BP","519150_GO_2000510_POSITIVE_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS",5,-0.6517,0.89,0.98,0.7171,0.8,1,-0.6751,0.84,1
"GO_BP:513598_GO_0060040_RETINAL_BIPOLAR_NEURON_DIFFERENTIATION","GO_BP","513598_GO_0060040_RETINAL_BIPOLAR_NEURON_DIFFERENTIATION",5,-0.6515,0.88,0.98,0.9731,0.51,1,1.474,0.071,0.58
"C7_Immunologic_signatures:C7_ALL_201_GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_201_GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP",188,-0.6515,1,1,-1.0834,0.26,1,0.8414,0.9,1
"KEGG_compound:C00021_S_ADENOSYL_L_HOMOCYSTEINE_S_ADENOSYLHOMOCYSTEINE","KEGG_compound","C00021_S_ADENOSYL_L_HOMOCYSTEINE_S_ADENOSYLHOMOCYSTEINE",56,-0.6514,0.97,0.97,-0.9716,0.49,1,-1.3324,0.061,0.34
"GO_BP:506075_GO_0042982_AMYLOID_PRECURSOR_PROTEIN_METABOLIC_PROCESS","GO_BP","506075_GO_0042982_AMYLOID_PRECURSOR_PROTEIN_METABOLIC_PROCESS",11,-0.6513,0.91,0.98,0.5367,0.98,1,-1.1473,0.28,0.74
"GO_BP:503920_GO_0034720_HISTONE_H3_K4_DEMETHYLATION","GO_BP","503920_GO_0034720_HISTONE_H3_K4_DEMETHYLATION",6,-0.6508,0.9,0.98,-0.6141,0.91,1,-0.7585,0.76,1
"GO_BP:487978_GO_0002089_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE","GO_BP","487978_GO_0002089_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE",22,-0.6503,0.93,0.98,1.086,0.32,0.92,1.3646,0.097,0.64
"REACTOME:645334_REACT_120836_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE","REACTOME","645334_REACT_120836_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE",18,-0.6502,0.92,0.98,0.4701,1,1,0.7645,0.8,1
"GO_BP:505876_GO_0042770_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE","GO_BP","505876_GO_0042770_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE",104,-0.6497,0.99,0.98,1.5994,0.0045,0.29,-1.125,0.24,0.75
"C4_Cancer_gene_neighborhoods:C4_CGN_260_GCM_RAN","C4_Cancer_gene_neighborhoods","C4_CGN_260_GCM_RAN",196,-0.6494,1,1,0.8986,0.78,0.83,-0.8083,0.94,1
"GO_CC:925884_GO_0097542_CILIARY_TIP","GO_CC","925884_GO_0097542_CILIARY_TIP",43,-0.6491,0.96,1,0.9175,0.58,0.87,-0.9529,0.52,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_49_KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_49_KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN",13,-0.6491,0.91,0.98,-0.8862,0.62,1,-1.2713,0.18,0.45
"KEGG_module:HSA_M00430_EXON_JUNCTION_COMPLEX_EJC_","KEGG_module","HSA_M00430_EXON_JUNCTION_COMPLEX_EJC_",18,-0.6489,0.91,0.98,-0.6095,0.96,1,-0.8077,0.75,0.93
"GO_MF:497980_GO_0019103_PYRIMIDINE_NUCLEOTIDE_BINDING","GO_MF","497980_GO_0019103_PYRIMIDINE_NUCLEOTIDE_BINDING",6,-0.6485,0.89,0.97,1.1509,0.31,0.74,-1.1142,0.34,0.7
"GO_BP:508162_GO_0045841_NEGATIVE_REGULATION_OF_MITOTIC_METAPHASE_ANAPHASE_TRANSITION","GO_BP","508162_GO_0045841_NEGATIVE_REGULATION_OF_MITOTIC_METAPHASE_ANAPHASE_TRANSITION",37,-0.6484,0.96,0.98,0.9553,0.56,1,-0.747,0.88,1
"GO_BP:505313_GO_0042147_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI","GO_BP","505313_GO_0042147_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI",67,-0.6484,0.98,0.98,0.7185,0.95,1,0.7481,0.94,1
"REACTOME:1127541_REACT_268156_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME","REACTOME","1127541_REACT_268156_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",60,-0.6479,0.97,0.98,2.1267,0,0.00045,-0.6459,0.99,1
"GO_BP:752356_GO_0075713_ESTABLISHMENT_OF_INTEGRATED_PROVIRAL_LATENCY","GO_BP","752356_GO_0075713_ESTABLISHMENT_OF_INTEGRATED_PROVIRAL_LATENCY",8,-0.6478,0.9,0.98,1.364,0.12,0.6,-0.7351,0.8,1
"GO_MF:492643_GO_0008327_METHYL_CPG_BINDING","GO_MF","492643_GO_0008327_METHYL_CPG_BINDING",11,-0.6477,0.9,0.97,-0.9607,0.53,0.95,0.7619,0.8,1
"GO_BP:493757_GO_0009642_RESPONSE_TO_LIGHT_INTENSITY","GO_BP","493757_GO_0009642_RESPONSE_TO_LIGHT_INTENSITY",9,-0.6474,0.91,0.98,-1.5715,0.04,0.72,-0.9375,0.55,0.9
"GO_MF:510191_GO_0048027_MRNA_5_UTR_BINDING","GO_MF","510191_GO_0048027_MRNA_5_UTR_BINDING",7,-0.6473,0.88,0.97,1.1951,0.26,0.71,0.6664,0.87,1
"GO_BP:508920_GO_0046676_NEGATIVE_REGULATION_OF_INSULIN_SECRETION","GO_BP","508920_GO_0046676_NEGATIVE_REGULATION_OF_INSULIN_SECRETION",31,-0.6471,0.93,0.98,-0.872,0.66,1,-1.0532,0.35,0.81
"GO_BP:494992_GO_0010927_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS","GO_BP","494992_GO_0010927_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS",216,-0.6469,1,0.98,-0.9918,0.47,1,-1.0078,0.44,0.84
"C1_Positional:C1_ALL_316_CHR16Q11","C1_Positional","C1_ALL_316_CHR16Q11",7,-0.6465,0.88,0.98,0.5046,0.99,1,1.1556,0.3,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_971_KAUFFMANN_MELANOMA_RELAPSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_971_KAUFFMANN_MELANOMA_RELAPSE_DN",6,-0.646,0.87,0.98,-0.5523,0.96,1,-0.7873,0.73,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1457_HASLINGER_B_CLL_WITH_MUTATED_VH_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_1457_HASLINGER_B_CLL_WITH_MUTATED_VH_GENES",18,-0.6458,0.91,0.98,1.1654,0.27,0.53,0.953,0.51,0.99
"GO_BP:491245_GO_0006282_REGULATION_OF_DNA_REPAIR","GO_BP","491245_GO_0006282_REGULATION_OF_DNA_REPAIR",61,-0.6458,0.97,0.98,0.8312,0.78,1,-0.9505,0.57,0.89
"GO_BP:516224_GO_0071300_CELLULAR_RESPONSE_TO_RETINOIC_ACID","GO_BP","516224_GO_0071300_CELLULAR_RESPONSE_TO_RETINOIC_ACID",61,-0.6457,0.98,0.98,1.1128,0.24,0.89,1.5919,0.01,0.44
"C3_MicroRNA_targets:C3_MIR_89_ATAACCT_MIR_154","C3_MicroRNA_targets","C3_MIR_89_ATAACCT_MIR_154",60,-0.6455,0.98,1,0.7513,0.89,1,-0.7846,0.89,1
"GO_BP:491478_GO_0006582_MELANIN_METABOLIC_PROCESS","GO_BP","491478_GO_0006582_MELANIN_METABOLIC_PROCESS",14,-0.6453,0.9,0.98,-0.8563,0.63,1,-0.8429,0.7,0.96
"C3_TF_targets:C3_TFT_349_V_NRF1_Q6","C3_TF_targets","C3_TFT_349_V_NRF1_Q6",254,-0.6453,1,1,-0.9635,0.56,0.84,-0.6474,1,1
"GO_BP:512824_GO_0051974_NEGATIVE_REGULATION_OF_TELOMERASE_ACTIVITY","GO_BP","512824_GO_0051974_NEGATIVE_REGULATION_OF_TELOMERASE_ACTIVITY",8,-0.6452,0.9,0.98,0.732,0.8,1,-0.6876,0.87,0.99
"C4_Cancer_gene_neighborhoods:C4_CGN_268_GCM_SUPT4H1","C4_Cancer_gene_neighborhoods","C4_CGN_268_GCM_SUPT4H1",56,-0.6451,0.97,1,0.5605,1,1,-0.6344,0.99,1
"GO_CC:507240_GO_0044233_ER_MITOCHONDRION_MEMBRANE_CONTACT_SITE","GO_CC","507240_GO_0044233_ER_MITOCHONDRION_MEMBRANE_CONTACT_SITE",7,-0.6449,0.9,1,1.3907,0.11,0.3,1.1902,0.27,0.84
"C7_Immunologic_signatures:C7_ALL_532_GSE17721_LPS_VS_POLYIC_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_532_GSE17721_LPS_VS_POLYIC_2H_BMDM_DN",200,-0.6449,1,1,1.6254,0,0.0019,0.8552,0.87,1
"GO_BP:518949_GO_2000303_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS","GO_BP","518949_GO_2000303_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS",5,-0.6446,0.89,0.98,-1.0784,0.38,0.95,-0.538,0.97,1
"REACTOME:576271_REACT_118780_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION","REACTOME","576271_REACT_118780_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION",47,-0.6446,0.96,0.98,0.7332,0.94,1,0.8737,0.69,1
"C4_Cancer_gene_neighborhoods:C4_CGN_39_MORF_RFC1","C4_Cancer_gene_neighborhoods","C4_CGN_39_MORF_RFC1",109,-0.6445,0.99,1,0.9928,0.5,0.6,-0.8633,0.78,1
"REACTOME:366161_REACT_75820_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION","REACTOME","366161_REACT_75820_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION",255,-0.6442,1,0.98,1.5948,0,0.096,-0.786,0.99,1
"GO_BP:495299_GO_0014909_SMOOTH_MUSCLE_CELL_MIGRATION","GO_BP","495299_GO_0014909_SMOOTH_MUSCLE_CELL_MIGRATION",7,-0.6441,0.9,0.98,1.24,0.21,0.75,0.8331,0.66,0.99
"GO_CC:504330_GO_0035145_EXON_EXON_JUNCTION_COMPLEX","GO_CC","504330_GO_0035145_EXON_EXON_JUNCTION_COMPLEX",21,-0.6439,0.94,1,-0.7134,0.87,1,0.6446,0.96,1
"GO_MF:489592_GO_0004128_CYTOCHROME_B5_REDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H","GO_MF","489592_GO_0004128_CYTOCHROME_B5_REDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H",7,-0.6438,0.9,0.97,-0.6346,0.91,1,0.6168,0.92,1
"GO_BP:812239_GO_1902116_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY","GO_BP","812239_GO_1902116_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY",15,-0.6438,0.91,0.98,-0.5031,0.99,1,0.7469,0.82,1
"GO_BP:515913_GO_0070986_LEFT_RIGHT_AXIS_SPECIFICATION","GO_BP","515913_GO_0070986_LEFT_RIGHT_AXIS_SPECIFICATION",14,-0.6437,0.89,0.98,-1.7882,0.0075,0.48,-0.9594,0.51,0.88
"GO_BP:491434_GO_0006538_GLUTAMATE_CATABOLIC_PROCESS","GO_BP","491434_GO_0006538_GLUTAMATE_CATABOLIC_PROCESS",6,-0.6435,0.9,0.98,1.0229,0.45,0.97,-0.8814,0.61,0.94
"C1_Positional:C1_ALL_217_CHR6P12","C1_Positional","C1_ALL_217_CHR6P12",52,-0.6434,0.96,0.98,1.1799,0.2,0.59,-1.0203,0.4,0.86
"GO_BP:513527_GO_0055094_RESPONSE_TO_LIPOPROTEIN_PARTICLE","GO_BP","513527_GO_0055094_RESPONSE_TO_LIPOPROTEIN_PARTICLE",11,-0.6434,0.91,0.98,1.083,0.37,0.92,1.5412,0.032,0.52
"C3_TF_targets:C3_TFT_152_V_SEF1_C","C3_TF_targets","C3_TFT_152_V_SEF1_C",5,-0.6431,0.88,1,-0.6655,0.85,1,0.8131,0.66,1
"KEGG_reaction:R00961_IDP_PHOSPHOHYDROLASE_INOSINE_DIPHOSPHATE_PHOSPHATASE_IDP_H2O_IMP_ORTHOPHOSPHATE","KEGG_reaction","R00961_IDP_PHOSPHOHYDROLASE_INOSINE_DIPHOSPHATE_PHOSPHATASE_IDP_H2O_IMP_ORTHOPHOSPHATE",7,-0.6431,0.89,0.92,0.6091,0.92,1,-0.8448,0.66,0.82
"KEGG_compound:C00460_DUTP_2_DEOXYURIDINE_5_TRIPHOSPHATE","KEGG_compound","C00460_DUTP_2_DEOXYURIDINE_5_TRIPHOSPHATE",13,-0.6431,0.91,0.98,-0.6881,0.87,1,-1.2251,0.21,0.43
"GO_MF:494917_GO_0010853_CYCLASE_ACTIVATOR_ACTIVITY","GO_MF","494917_GO_0010853_CYCLASE_ACTIVATOR_ACTIVITY",6,-0.643,0.9,0.97,-1.0034,0.47,0.9,-0.7255,0.78,0.99
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_148_BIOCARTA_RAS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_148_BIOCARTA_RAS_PATHWAY",23,-0.6425,0.94,0.95,1.2603,0.14,0.65,1.2381,0.19,1
"GO_BP:1039916_GO_1903362_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS","GO_BP","1039916_GO_1903362_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS",270,-0.6425,1,0.98,1.3354,0.015,0.62,-1.0408,0.33,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1968_DASU_IL6_SIGNALING_SCAR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1968_DASU_IL6_SIGNALING_SCAR_DN",15,-0.6418,0.94,0.98,1.0785,0.35,0.67,1.401,0.11,0.55
"GO_MF:500685_GO_0031434_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING","GO_MF","500685_GO_0031434_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING",17,-0.6412,0.93,0.97,-0.8335,0.7,1,-0.6207,0.95,1
"GO_BP:513586_GO_0060028_CONVERGENT_EXTENSION_INVOLVED_IN_AXIS_ELONGATION","GO_BP","513586_GO_0060028_CONVERGENT_EXTENSION_INVOLVED_IN_AXIS_ELONGATION",5,-0.6411,0.9,0.98,-0.8407,0.68,1,-1.0914,0.37,0.78
"WikiPathways:198786_WP183_PROTEASOME_DEGRADATION","WikiPathways","198786_WP183_PROTEASOME_DEGRADATION",65,-0.641,0.99,0.99,1.871,0,0.027,-0.9765,0.47,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1286_IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1286_IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN",11,-0.641,0.91,0.98,1.0108,0.45,0.78,0.7468,0.81,1
"OMIM_gene:OMIM602322_TELOMERASE_RNA_COMPONENT_TERC","OMIM_gene","OMIM602322_TELOMERASE_RNA_COMPONENT_TERC",6,-0.641,0.9,1,0.8869,0.6,1,1.16,0.27,1
"C4_Cancer_gene_neighborhoods:C4_CGN_163_MORF_RAB1A","C4_Cancer_gene_neighborhoods","C4_CGN_163_MORF_RAB1A",195,-0.6406,1,1,2.0507,0,0.00018,0.8442,0.89,1
"GO_BP:754922_GO_2000816_NEGATIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION","GO_BP","754922_GO_2000816_NEGATIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION",37,-0.6404,0.95,0.98,0.9704,0.49,1,-0.7484,0.88,1
"GO_BP:497934_GO_0019054_MODULATION_BY_VIRUS_OF_HOST_PROCESS","GO_BP","497934_GO_0019054_MODULATION_BY_VIRUS_OF_HOST_PROCESS",11,-0.6404,0.91,0.98,0.9306,0.54,1,0.8419,0.69,0.99
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_198_BIOCARTA_KREB_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_198_BIOCARTA_KREB_PATHWAY",8,-0.6402,0.89,0.95,1.0181,0.42,0.83,-1.336,0.15,0.48
"REACTOME:477130_REACT_111057_SIGNALING_BY_NODAL","REACTOME","477130_REACT_111057_SIGNALING_BY_NODAL",18,-0.64,0.94,0.98,-0.4086,1,1,-0.829,0.71,1
"C4_Cancer_gene_neighborhoods:C4_CGN_78_MORF_CSNK1D","C4_Cancer_gene_neighborhoods","C4_CGN_78_MORF_CSNK1D",70,-0.6399,0.99,1,0.8237,0.82,0.97,0.7357,0.94,1
"GO_MF:501685_GO_0032453_HISTONE_DEMETHYLASE_ACTIVITY_H3_K4_SPECIFIC_","GO_MF","501685_GO_0032453_HISTONE_DEMETHYLASE_ACTIVITY_H3_K4_SPECIFIC_",6,-0.6392,0.89,0.97,-0.6319,0.91,1,-0.7603,0.78,0.99
"GO_CC:505710_GO_0042583_CHROMAFFIN_GRANULE","GO_CC","505710_GO_0042583_CHROMAFFIN_GRANULE",7,-0.6391,0.91,1,1.2102,0.24,0.51,-1.2669,0.19,0.68
"GO_BP:493326_GO_0009129_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS","GO_BP","493326_GO_0009129_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS",14,-0.6387,0.91,0.98,0.8206,0.69,1,0.7163,0.85,1
"GO_BP:514350_GO_0060795_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER","GO_BP","514350_GO_0060795_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER",25,-0.6384,0.94,0.98,1.2014,0.22,0.78,1.0434,0.39,0.81
"C3_MicroRNA_targets:C3_MIR_70_CAAGGAT_MIR_362","C3_MicroRNA_targets","C3_MIR_70_CAAGGAT_MIR_362",66,-0.6383,0.97,0.99,0.712,0.95,1,0.8452,0.76,1
"GO_BP:503551_GO_0034349_GLIAL_CELL_APOPTOTIC_PROCESS","GO_BP","503551_GO_0034349_GLIAL_CELL_APOPTOTIC_PROCESS",6,-0.6382,0.89,0.98,0.9399,0.52,1,-0.8618,0.64,0.95
"GO_BP:502269_GO_0033048_NEGATIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION","GO_BP","502269_GO_0033048_NEGATIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION",37,-0.638,0.96,0.98,0.9782,0.49,1,-0.7405,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1904_MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5","C2_Chemical_and_genetic_perturbations","C2_CGP_1904_MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5",23,-0.6379,0.96,0.98,1.007,0.46,0.79,-0.9295,0.52,0.84
"GO_BP:498456_GO_0019627_UREA_METABOLIC_PROCESS","GO_BP","498456_GO_0019627_UREA_METABOLIC_PROCESS",13,-0.6376,0.91,0.98,-0.8909,0.59,1,-0.9661,0.5,0.88
"GO_BP:486598_GO_0000050_UREA_CYCLE","GO_BP","486598_GO_0000050_UREA_CYCLE",12,-0.6371,0.92,0.98,-0.8512,0.67,1,-1.1334,0.3,0.75
"KEGG_module:HSA_M00694_CGMP_SIGNALING","KEGG_module","HSA_M00694_CGMP_SIGNALING",10,-0.637,0.91,0.97,0.8637,0.64,0.91,1.3637,0.12,0.71
"REACTOME:1127502_REACT_268265_ASSEMBLY_OF_THE_PRIMARY_CILIUM","REACTOME","1127502_REACT_268265_ASSEMBLY_OF_THE_PRIMARY_CILIUM",179,-0.6364,1,0.98,-0.6535,1,1,-1.579,0,0.27
"GO_BP:489208_GO_0003416_ENDOCHONDRAL_BONE_GROWTH","GO_BP","489208_GO_0003416_ENDOCHONDRAL_BONE_GROWTH",18,-0.636,0.93,0.98,-1.3431,0.082,0.92,0.7712,0.8,1
"REACTOME:105659_REACT_549_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA","REACTOME","105659_REACT_549_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA",15,-0.6358,0.94,0.98,0.6074,0.96,1,-0.9706,0.5,0.88
"REACTOME:106336_REACT_12034_SIGNALING_BY_BMP","REACTOME","106336_REACT_12034_SIGNALING_BY_BMP",22,-0.6357,0.93,0.98,-0.8064,0.77,1,1.4395,0.059,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_3104_THILLAINADESAN_ZNF217_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3104_THILLAINADESAN_ZNF217_TARGETS_DN",9,-0.6356,0.92,0.98,1.1748,0.25,0.52,-1.2323,0.22,0.49
"C7_Immunologic_signatures:C7_ALL_1183_GSE27786_BCELL_VS_NKTCELL_UP","C7_Immunologic_signatures","C7_ALL_1183_GSE27786_BCELL_VS_NKTCELL_UP",200,-0.6356,1,1,1.0278,0.35,0.65,-0.7295,1,1
"GO_BP:486617_GO_0000076_DNA_REPLICATION_CHECKPOINT","GO_BP","486617_GO_0000076_DNA_REPLICATION_CHECKPOINT",12,-0.6354,0.91,0.98,1.1058,0.32,0.89,1.0504,0.39,0.8
"KEGG_module:HSA_M00180_RNA_POLYMERASE_II_EUKARYOTES","KEGG_module","HSA_M00180_RNA_POLYMERASE_II_EUKARYOTES",14,-0.6354,0.93,0.96,0.9671,0.48,0.92,0.5958,0.95,1
"GO_BP:504252_GO_0035067_NEGATIVE_REGULATION_OF_HISTONE_ACETYLATION","GO_BP","504252_GO_0035067_NEGATIVE_REGULATION_OF_HISTONE_ACETYLATION",14,-0.6352,0.92,0.98,1.2822,0.17,0.7,-1.0154,0.43,0.84
"GO_BP:519042_GO_2000402_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION","GO_BP","519042_GO_2000402_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION",7,-0.6351,0.91,0.98,1.0383,0.42,0.96,1.0655,0.39,0.79
"GO_MF:510282_GO_0048156_TAU_PROTEIN_BINDING","GO_MF","510282_GO_0048156_TAU_PROTEIN_BINDING",9,-0.6349,0.93,0.98,0.9979,0.45,0.88,-1.1913,0.25,0.59
"GO_MF:494410_GO_0010340_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY","GO_MF","494410_GO_0010340_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY",5,-0.6347,0.9,0.97,0.8622,0.61,1,-1.2737,0.2,0.58
"GO_BP:508329_GO_0046031_ADP_METABOLIC_PROCESS","GO_BP","508329_GO_0046031_ADP_METABOLIC_PROCESS",9,-0.6346,0.91,0.98,-0.957,0.54,1,-0.563,0.95,1
"GO_BP:946578_GO_1902603_CARNITINE_TRANSMEMBRANE_TRANSPORT","GO_BP","946578_GO_1902603_CARNITINE_TRANSMEMBRANE_TRANSPORT",12,-0.6341,0.92,0.98,-0.6849,0.86,1,1.1829,0.24,0.72
"GO_BP:487960_GO_0002070_EPITHELIAL_CELL_MATURATION","GO_BP","487960_GO_0002070_EPITHELIAL_CELL_MATURATION",16,-0.6339,0.92,0.98,1.079,0.36,0.93,1.3916,0.073,0.63
"C3_TF_targets:C3_TFT_432_V_CREB_Q3","C3_TF_targets","C3_TFT_432_V_CREB_Q3",250,-0.6339,1,1,1.1156,0.17,1,-0.898,0.77,0.92
"REACTOME:105769_REACT_1783_G1_S_TRANSITION","REACTOME","105769_REACT_1783_G1_S_TRANSITION",109,-0.6338,0.99,0.98,1.9559,0,0.0043,-1.1706,0.14,0.63
"GO_MF:496048_GO_0015926_GLUCOSIDASE_ACTIVITY","GO_MF","496048_GO_0015926_GLUCOSIDASE_ACTIVITY",10,-0.6337,0.91,0.97,-0.9403,0.55,0.96,-1.1178,0.32,0.69
"KEGG_compound:C00559_DEOXYADENOSINE_2_DEOXYADENOSINE","KEGG_compound","C00559_DEOXYADENOSINE_2_DEOXYADENOSINE",11,-0.6337,0.92,0.99,0.5024,0.99,1,-1.0809,0.33,0.55
"GO_BP:491544_GO_0006656_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS","GO_BP","491544_GO_0006656_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS",25,-0.6335,0.94,0.98,-0.7281,0.88,1,1.129,0.3,0.74
"GO_BP:502369_GO_0033148_POSITIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","502369_GO_0033148_POSITIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY",7,-0.6333,0.89,0.98,0.8196,0.7,1,-0.9676,0.5,0.88
"GO_BP:508798_GO_0046541_SALIVA_SECRETION","GO_BP","508798_GO_0046541_SALIVA_SECRETION",6,-0.6332,0.91,0.98,1.0515,0.41,0.95,1.2578,0.21,0.69
"GO_BP:507454_GO_0045053_PROTEIN_RETENTION_IN_GOLGI_APPARATUS","GO_BP","507454_GO_0045053_PROTEIN_RETENTION_IN_GOLGI_APPARATUS",5,-0.6331,0.92,0.98,-0.8497,0.65,1,-0.7924,0.75,0.99
"GO_BP:516830_GO_0071910_DETERMINATION_OF_LIVER_LEFT_RIGHT_ASYMMETRY","GO_BP","516830_GO_0071910_DETERMINATION_OF_LIVER_LEFT_RIGHT_ASYMMETRY",6,-0.6329,0.9,0.98,-1.3654,0.12,0.99,0.6014,0.93,1
"REACTOME:730342_REACT_150237_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS","REACTOME","730342_REACT_150237_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS",6,-0.6327,0.91,0.98,0.9241,0.54,0.87,-0.6859,0.85,1
"GO_MF:496855_GO_0017025_TBP_CLASS_PROTEIN_BINDING","GO_MF","496855_GO_0017025_TBP_CLASS_PROTEIN_BINDING",17,-0.6324,0.92,0.97,1.2287,0.19,0.7,-0.7528,0.81,0.99
"GO_BP:506618_GO_0043587_TONGUE_MORPHOGENESIS","GO_BP","506618_GO_0043587_TONGUE_MORPHOGENESIS",8,-0.6324,0.91,0.98,-0.6664,0.87,1,-1.0313,0.42,0.82
"GO_CC:502805_GO_0033588_ELONGATOR_HOLOENZYME_COMPLEX","GO_CC","502805_GO_0033588_ELONGATOR_HOLOENZYME_COMPLEX",6,-0.6322,0.93,1,1.0711,0.36,0.69,-0.8574,0.66,1
"GO_BP:494524_GO_0010454_NEGATIVE_REGULATION_OF_CELL_FATE_COMMITMENT","GO_BP","494524_GO_0010454_NEGATIVE_REGULATION_OF_CELL_FATE_COMMITMENT",11,-0.6322,0.93,0.98,-1.124,0.32,0.94,1.1927,0.24,0.72
"GO_MF:495487_GO_0051183_VITAMIN_TRANSPORTER_ACTIVITY","GO_MF","495487_GO_0051183_VITAMIN_TRANSPORTER_ACTIVITY",18,-0.6317,0.93,0.97,-1.4704,0.055,0.6,0.4595,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_217_GCM_CRKL","C4_Cancer_gene_neighborhoods","C4_CGN_217_GCM_CRKL",64,-0.6316,0.98,1,0.8533,0.76,0.92,-0.7825,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_823_TSUNODA_CISPLATIN_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_823_TSUNODA_CISPLATIN_RESISTANCE_UP",14,-0.6314,0.91,0.98,-1.1219,0.31,0.89,1.1995,0.23,0.77
"GO_BP:502267_GO_0033046_NEGATIVE_REGULATION_OF_SISTER_CHROMATID_SEGREGATION","GO_BP","502267_GO_0033046_NEGATIVE_REGULATION_OF_SISTER_CHROMATID_SEGREGATION",37,-0.6314,0.95,0.98,0.9666,0.51,1,-0.7462,0.87,1
"KEGG_compound:C01346_DUDP_2_DEOXYURIDINE_5_DIPHOSPHATE","KEGG_compound","C01346_DUDP_2_DEOXYURIDINE_5_DIPHOSPHATE",12,-0.6312,0.94,0.99,-0.6769,0.9,1,-1.2288,0.2,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_1291_IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1291_IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN",25,-0.6312,0.94,0.98,0.7144,0.86,1,0.5778,0.98,1
"OMIM_gene:OMIM600287_GLYCYL_TRNA_SYNTHETASE_GARS","OMIM_gene","OMIM600287_GLYCYL_TRNA_SYNTHETASE_GARS",5,-0.631,0.91,1,0.8429,0.65,1,-0.7254,0.82,1
"GO_MF:512848_GO_0051998_PROTEIN_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY","GO_MF","512848_GO_0051998_PROTEIN_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY",5,-0.631,0.91,0.97,0.869,0.62,1,-1.2795,0.21,0.59
"GO_BP:496517_GO_0016569_COVALENT_CHROMATIN_MODIFICATION","GO_BP","496517_GO_0016569_COVALENT_CHROMATIN_MODIFICATION",322,-0.6307,1,0.98,-0.9159,0.74,1,-1.1376,0.12,0.75
"GO_BP:506520_GO_0043489_RNA_STABILIZATION","GO_BP","506520_GO_0043489_RNA_STABILIZATION",29,-0.6306,0.95,0.98,0.9984,0.44,0.98,-0.7477,0.88,1
"GO_BP:506518_GO_0043487_REGULATION_OF_RNA_STABILITY","GO_BP","506518_GO_0043487_REGULATION_OF_RNA_STABILITY",53,-0.6303,0.98,0.98,0.9594,0.55,1,-0.8191,0.79,0.98
"KEGG_compound:C00294_INOSINE","KEGG_compound","C00294_INOSINE",11,-0.6301,0.92,0.98,0.4995,0.98,1,-1.0765,0.36,0.55
"GO_MF:499655_GO_0030250_GUANYLATE_CYCLASE_ACTIVATOR_ACTIVITY","GO_MF","499655_GO_0030250_GUANYLATE_CYCLASE_ACTIVATOR_ACTIVITY",6,-0.6301,0.91,0.97,-1.0146,0.46,0.89,-0.7292,0.8,0.99
"GO_BP:519317_GO_2000678_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING","GO_BP","519317_GO_2000678_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING",16,-0.6299,0.92,0.98,1.533,0.046,0.36,1.2597,0.17,0.69
"GO_BP:518538_GO_0090398_CELLULAR_SENESCENCE","GO_BP","518538_GO_0090398_CELLULAR_SENESCENCE",28,-0.6298,0.95,0.98,-1.064,0.38,0.96,-0.7918,0.79,0.99
"GO_BP:496518_GO_0016570_HISTONE_MODIFICATION","GO_BP","496518_GO_0016570_HISTONE_MODIFICATION",317,-0.6293,1,0.98,-0.8841,0.84,1,-1.1926,0.064,0.74
"GO_BP:502130_GO_0032908_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION","GO_BP","502130_GO_0032908_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION",7,-0.6292,0.91,0.98,1.3065,0.13,0.66,1.4104,0.11,0.63
"GO_BP:507459_GO_0045059_POSITIVE_THYMIC_T_CELL_SELECTION","GO_BP","507459_GO_0045059_POSITIVE_THYMIC_T_CELL_SELECTION",8,-0.6291,0.92,0.98,-0.886,0.6,1,0.732,0.82,1
"GO_BP:493330_GO_0009133_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493330_GO_0009133_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",9,-0.6291,0.9,0.98,0.7833,0.74,1,-0.9871,0.47,0.86
"GO_BP:499099_GO_0021819_LAYER_FORMATION_IN_CEREBRAL_CORTEX","GO_BP","499099_GO_0021819_LAYER_FORMATION_IN_CEREBRAL_CORTEX",12,-0.6288,0.93,0.98,-0.7659,0.78,1,1.2356,0.19,0.7
"GO_CC:490894_GO_0005892_ACETYLCHOLINE_GATED_CHANNEL_COMPLEX","GO_CC","490894_GO_0005892_ACETYLCHOLINE_GATED_CHANNEL_COMPLEX",18,-0.6284,0.95,1,-2.0223,0,0.04,1.015,0.4,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2146_WONG_MITOCHONDRIA_GENE_MODULE","C2_Chemical_and_genetic_perturbations","C2_CGP_2146_WONG_MITOCHONDRIA_GENE_MODULE",216,-0.6283,1,0.98,2.3739,0,0,-0.9322,0.65,0.84
"GO_BP:494865_GO_0010800_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION","GO_BP","494865_GO_0010800_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION",19,-0.6276,0.94,0.98,1.4075,0.08,0.55,1.564,0.034,0.48
"GO_BP:518035_GO_0080111_DNA_DEMETHYLATION","GO_BP","518035_GO_0080111_DNA_DEMETHYLATION",15,-0.6272,0.93,0.98,0.9822,0.46,1,-1.0939,0.32,0.78
"GO_BP:491983_GO_0007183_SMAD_PROTEIN_COMPLEX_ASSEMBLY","GO_BP","491983_GO_0007183_SMAD_PROTEIN_COMPLEX_ASSEMBLY",8,-0.6271,0.91,0.98,-0.671,0.87,1,1.087,0.36,0.77
"C1_Positional:C1_ALL_42_CHR2Q32","C1_Positional","C1_ALL_42_CHR2Q32",42,-0.626,0.97,0.99,1.0343,0.4,0.71,0.8469,0.76,0.9
"GO_BP:516403_GO_0071479_CELLULAR_RESPONSE_TO_IONIZING_RADIATION","GO_BP","516403_GO_0071479_CELLULAR_RESPONSE_TO_IONIZING_RADIATION",47,-0.6259,0.97,0.98,1.1585,0.21,0.83,-0.8825,0.65,0.94
"C3_TF_targets:C3_TFT_473_V_AR_02","C3_TF_targets","C3_TFT_473_V_AR_02",39,-0.6259,0.97,1,0.8456,0.76,1,1.1236,0.27,0.9
"GO_CC:994746_GO_0036464_CYTOPLASMIC_RIBONUCLEOPROTEIN_GRANULE","GO_CC","994746_GO_0036464_CYTOPLASMIC_RIBONUCLEOPROTEIN_GRANULE",121,-0.6258,1,1,1.2865,0.058,0.42,-1.0154,0.4,1
"GO_CC:492398_GO_0008024_POSITIVE_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX_B","GO_CC","492398_GO_0008024_POSITIVE_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX_B",5,-0.6257,0.9,1,1.2121,0.24,0.51,1.3053,0.19,0.72
"REACTOME:645319_REACT_121238_SYNTHESIS_OF_PC","REACTOME","645319_REACT_121238_SYNTHESIS_OF_PC",19,-0.6252,0.93,0.99,-0.515,0.98,1,0.9452,0.54,1
"GO_BP:512835_GO_0051985_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION","GO_BP","512835_GO_0051985_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION",40,-0.6251,0.97,0.98,1.0418,0.38,0.96,-0.6899,0.92,0.99
"GO_BP:491462_GO_0006566_THREONINE_METABOLIC_PROCESS","GO_BP","491462_GO_0006566_THREONINE_METABOLIC_PROCESS",6,-0.625,0.92,0.98,1.3665,0.12,0.59,1.162,0.29,0.73
"GO_BP:493763_GO_0009648_PHOTOPERIODISM","GO_BP","493763_GO_0009648_PHOTOPERIODISM",23,-0.625,0.94,0.98,-0.8889,0.64,1,-1.1274,0.3,0.76
"GO_MF:490603_GO_0005484_SNAP_RECEPTOR_ACTIVITY","GO_MF","490603_GO_0005484_SNAP_RECEPTOR_ACTIVITY",37,-0.6248,0.96,0.98,1.1937,0.17,0.71,0.8391,0.74,0.99
"C4_Cancer_modules:C4_CM_61_MODULE_65","C4_Cancer_modules","C4_CM_61_MODULE_65",10,-0.6248,0.93,0.99,1.0102,0.43,0.7,-1.2766,0.18,0.31
"C2_Chemical_and_genetic_perturbations:C2_CGP_1336_TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1336_TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN",38,-0.6247,0.97,0.98,1.0233,0.42,0.77,-0.9396,0.55,0.84
"GO_BP:518969_GO_2000323_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY","GO_BP","518969_GO_2000323_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY",6,-0.6245,0.91,0.98,-0.9121,0.56,1,-0.5542,0.94,1
"GO_MF:496959_GO_0017169_CDP_ALCOHOL_PHOSPHATIDYLTRANSFERASE_ACTIVITY","GO_MF","496959_GO_0017169_CDP_ALCOHOL_PHOSPHATIDYLTRANSFERASE_ACTIVITY",8,-0.6243,0.93,0.98,-0.5335,0.98,1,-0.4992,0.99,1
"KEGG_module:HSA_M00009_CITRATE_CYCLE_TCA_CYCLE_KREBS_CYCLE_","KEGG_module","HSA_M00009_CITRATE_CYCLE_TCA_CYCLE_KREBS_CYCLE_",22,-0.6232,0.95,0.96,1.6208,0.021,0.12,-1.4871,0.058,0.38
"KEGG_reaction:R01234_GUANOSINE_3_5_CYCLIC_PHOSPHATE_5_NUCLEOTIDOHYDROLASE_3_5_CYCLIC_GMP_H2O_GMP","KEGG_reaction","R01234_GUANOSINE_3_5_CYCLIC_PHOSPHATE_5_NUCLEOTIDOHYDROLASE_3_5_CYCLIC_GMP_H2O_GMP",16,-0.6232,0.95,0.93,-0.7634,0.81,1,0.8548,0.66,0.79
"C1_Positional:C1_ALL_66_CHR1P33","C1_Positional","C1_ALL_66_CHR1P33",41,-0.6231,0.98,0.98,-1.2183,0.16,1,-1.4484,0.042,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_1200_NIKOLSKY_BREAST_CANCER_7P15_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1200_NIKOLSKY_BREAST_CANCER_7P15_AMPLICON",10,-0.6226,0.93,0.98,1.6593,0.018,0.11,-0.6194,0.94,0.99
"WikiPathways:198758_WP497_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS","WikiPathways","198758_WP497_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS",20,-0.6221,0.95,0.99,-0.6603,0.93,1,-0.7929,0.8,0.95
"GO_CC:504947_GO_0035770_RIBONUCLEOPROTEIN_GRANULE","GO_CC","504947_GO_0035770_RIBONUCLEOPROTEIN_GRANULE",121,-0.6219,1,1,1.3016,0.042,0.4,-1.0143,0.39,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_754_XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_754_XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP",14,-0.6219,0.93,0.98,-0.7852,0.75,1,0.9205,0.54,1
"GO_BP:1026094_GO_1903322_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL","GO_BP","1026094_GO_1903322_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL",171,-0.6218,1,0.98,1.5669,0,0.33,-0.7991,0.94,0.99
"KEGG_compound:C00226_PRIMARY_ALCOHOL_1_ALCOHOL","KEGG_compound","C00226_PRIMARY_ALCOHOL_1_ALCOHOL",9,-0.6215,0.93,0.99,-0.9578,0.52,1,-1.1215,0.31,0.53
"GO_BP:508944_GO_0046716_MUSCLE_CELL_CELLULAR_HOMEOSTASIS","GO_BP","508944_GO_0046716_MUSCLE_CELL_CELLULAR_HOMEOSTASIS",18,-0.6214,0.95,0.98,-0.6726,0.9,1,0.8552,0.68,0.98
"GO_BP:508853_GO_0046599_REGULATION_OF_CENTRIOLE_REPLICATION","GO_BP","508853_GO_0046599_REGULATION_OF_CENTRIOLE_REPLICATION",13,-0.6212,0.94,0.98,0.7732,0.76,1,-0.9593,0.5,0.88
"GO_BP:513584_GO_0060026_CONVERGENT_EXTENSION","GO_BP","513584_GO_0060026_CONVERGENT_EXTENSION",14,-0.6203,0.94,0.98,0.9346,0.53,1,0.9333,0.55,0.92
"GO_BP:486618_GO_0000077_DNA_DAMAGE_CHECKPOINT","GO_BP","486618_GO_0000077_DNA_DAMAGE_CHECKPOINT",144,-0.6192,1,0.98,1.3485,0.013,0.61,-1.1464,0.15,0.74
"C7_Immunologic_signatures:C7_ALL_692_GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_692_GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDM_DN",197,-0.6192,1,1,1.5906,0,0.0036,-0.7199,0.99,1
"GO_CC:489322_GO_0042612_MHC_CLASS_I_PROTEIN_COMPLEX","GO_CC","489322_GO_0042612_MHC_CLASS_I_PROTEIN_COMPLEX",11,-0.6191,0.93,1,1.0856,0.35,0.67,-0.7835,0.74,1
"GO_BP:512227_GO_0051343_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY","GO_BP","512227_GO_0051343_POSITIVE_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY",5,-0.6187,0.9,0.98,1.0518,0.42,0.95,-0.7501,0.78,1
"GO_BP:515849_GO_0070922_SMALL_RNA_LOADING_ONTO_RISC","GO_BP","515849_GO_0070922_SMALL_RNA_LOADING_ONTO_RISC",8,-0.6181,0.93,0.98,-0.8743,0.61,1,-0.7035,0.86,0.99
"GO_BP:486807_GO_0000290_DEADENYLATION_DEPENDENT_DECAPPING_OF_NUCLEAR_TRANSCRIBED_MRNA","GO_BP","486807_GO_0000290_DEADENYLATION_DEPENDENT_DECAPPING_OF_NUCLEAR_TRANSCRIBED_MRNA",7,-0.6179,0.92,0.98,0.8252,0.67,1,-0.9217,0.54,0.91
"GO_BP:492596_GO_0008272_SULFATE_TRANSPORT","GO_BP","492596_GO_0008272_SULFATE_TRANSPORT",13,-0.6178,0.93,0.98,1.0568,0.38,0.94,1.0147,0.42,0.84
"GO_BP:754848_GO_1901897_REGULATION_OF_RELAXATION_OF_CARDIAC_MUSCLE","GO_BP","754848_GO_1901897_REGULATION_OF_RELAXATION_OF_CARDIAC_MUSCLE",6,-0.6178,0.93,0.98,-0.936,0.57,1,-0.8633,0.63,0.95
"GO_MF:489677_GO_0004311_FARNESYLTRANSTRANSFERASE_ACTIVITY","GO_MF","489677_GO_0004311_FARNESYLTRANSTRANSFERASE_ACTIVITY",5,-0.6173,0.9,0.98,0.5966,0.93,1,1,0.46,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_782_HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_782_HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER",31,-0.6169,0.98,0.99,0.7587,0.85,1,-0.9186,0.6,0.85
"GO_BP:513671_GO_0060113_INNER_EAR_RECEPTOR_CELL_DIFFERENTIATION","GO_BP","513671_GO_0060113_INNER_EAR_RECEPTOR_CELL_DIFFERENTIATION",51,-0.6162,0.97,0.98,-0.7122,0.95,1,1.4998,0.015,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_2703_TCGA_GLIOBLASTOMA_MUTATED","C2_Chemical_and_genetic_perturbations","C2_CGP_2703_TCGA_GLIOBLASTOMA_MUTATED",8,-0.6156,0.91,0.99,1.2352,0.21,0.45,-0.875,0.63,0.9
"KEGG_compound:C00575_3_5_CYCLIC_AMP_CYCLIC_ADENYLIC_ACID_CYCLIC_AMP_ADENOSINE_3_5_PHOSPHATE_ADENOSINE_3_5_CYCLIC_PHOSPHATE_CAMP","KEGG_compound","C00575_3_5_CYCLIC_AMP_CYCLIC_ADENYLIC_ACID_CYCLIC_AMP_ADENOSINE_3_5_PHOSPHATE_ADENOSINE_3_5_CYCLIC_PHOSPHATE_CAMP",26,-0.6156,0.95,0.99,-1.2632,0.14,0.69,-1.5325,0.029,0.21
"GO_BP:493375_GO_0009179_PURINE_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS","GO_BP","493375_GO_0009179_PURINE_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS",14,-0.615,0.95,0.98,0.4842,1,1,-0.867,0.68,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2822_PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2822_PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN",9,-0.6149,0.94,0.99,-0.6318,0.93,1,-0.8759,0.63,0.9
"GO_BP:503856_GO_0034656_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_CATABOLIC_PROCESS","GO_BP","503856_GO_0034656_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_CATABOLIC_PROCESS",6,-0.6143,0.9,0.99,0.9297,0.5,1,-0.7083,0.83,0.99
"GO_MF:487278_GO_0001055_RNA_POLYMERASE_II_ACTIVITY","GO_MF","487278_GO_0001055_RNA_POLYMERASE_II_ACTIVITY",9,-0.6142,0.94,0.98,0.7488,0.78,1,0.5056,0.97,1
"C0_Hallmark:H_ALL_34_HALLMARK_OXIDATIVE_PHOSPHORYLATION","C0_Hallmark","H_ALL_34_HALLMARK_OXIDATIVE_PHOSPHORYLATION",200,-0.6135,1,1,2.7033,0,0,-0.9138,0.72,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_2376_TSUDA_ALVEOLAR_SOFT_PART_SARCOMA","C2_Chemical_and_genetic_perturbations","C2_CGP_2376_TSUDA_ALVEOLAR_SOFT_PART_SARCOMA",10,-0.6133,0.94,0.99,1.1649,0.25,0.53,1.2888,0.18,0.69
"GO_BP:516621_GO_0071697_ECTODERMAL_PLACODE_MORPHOGENESIS","GO_BP","516621_GO_0071697_ECTODERMAL_PLACODE_MORPHOGENESIS",22,-0.6133,0.96,0.99,0.7611,0.82,1,-1.0762,0.35,0.8
"GO_MF:510602_GO_0048531_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY","GO_MF","510602_GO_0048531_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY",9,-0.6122,0.93,0.98,1.3493,0.14,0.53,1.2876,0.17,0.66
"GO_BP:754046_GO_1901077_REGULATION_OF_RELAXATION_OF_MUSCLE","GO_BP","754046_GO_1901077_REGULATION_OF_RELAXATION_OF_MUSCLE",7,-0.6122,0.93,0.99,-0.6517,0.87,1,-0.7612,0.75,1
"C3_TF_targets:C3_TFT_84_ACTAYRNNNCCCR_UNKNOWN","C3_TF_targets","C3_TFT_84_ACTAYRNNNCCCR_UNKNOWN",447,-0.6119,1,1,0.8624,0.96,1,-1.3722,0.0022,0.28
"C2_Chemical_and_genetic_perturbations:C2_CGP_1139_AMIT_EGF_RESPONSE_20_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1139_AMIT_EGF_RESPONSE_20_MCF10A",14,-0.6117,0.93,0.99,1.53,0.038,0.18,1.1773,0.27,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_175_WANG_CLIM2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_175_WANG_CLIM2_TARGETS_DN",184,-0.6117,1,0.99,1.6298,0,0.12,0.6991,1,1
"GO_BP:493332_GO_0009135_PURINE_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS","GO_BP","493332_GO_0009135_PURINE_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS",14,-0.6116,0.94,0.99,0.4735,0.99,1,-0.8579,0.65,0.96
"GO_BP:516620_GO_0071696_ECTODERMAL_PLACODE_DEVELOPMENT","GO_BP","516620_GO_0071696_ECTODERMAL_PLACODE_DEVELOPMENT",22,-0.6115,0.94,0.99,0.7617,0.82,1,-1.054,0.39,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_3097_LI_DCP2_BOUND_MRNA","C2_Chemical_and_genetic_perturbations","C2_CGP_3097_LI_DCP2_BOUND_MRNA",89,-0.6115,0.99,0.99,1.5954,0.0046,0.14,-1.04,0.36,0.7
"GO_BP:515136_GO_0070199_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME","GO_BP","515136_GO_0070199_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME",6,-0.6113,0.93,0.99,0.8725,0.61,1,-0.9582,0.5,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2372_CLIMENT_BREAST_CANCER_COPY_NUMBER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2372_CLIMENT_BREAST_CANCER_COPY_NUMBER_DN",8,-0.6111,0.94,0.99,0.499,0.98,1,1.6192,0.026,0.36
"GO_MF:489793_GO_0004439_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY","GO_MF","489793_GO_0004439_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY",7,-0.6109,0.93,0.98,-0.473,0.99,1,0.4363,0.99,1
"GO_BP:752179_GO_0061436_ESTABLISHMENT_OF_SKIN_BARRIER","GO_BP","752179_GO_0061436_ESTABLISHMENT_OF_SKIN_BARRIER",17,-0.6107,0.95,0.99,1.8178,0.0064,0.085,1.2862,0.15,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_762_WAESCH_ANAPHASE_PROMOTING_COMPLEX","C2_Chemical_and_genetic_perturbations","C2_CGP_762_WAESCH_ANAPHASE_PROMOTING_COMPLEX",12,-0.61,0.94,0.99,-0.7658,0.77,1,-0.8449,0.65,0.93
"GO_CC:925869_GO_0038201_TOR_COMPLEX","GO_CC","925869_GO_0038201_TOR_COMPLEX",11,-0.6099,0.95,1,0.6905,0.86,0.99,0.6058,0.95,1
"GO_CC:486760_GO_0000242_PERICENTRIOLAR_MATERIAL","GO_CC","486760_GO_0000242_PERICENTRIOLAR_MATERIAL",17,-0.6097,0.94,1,0.7774,0.79,0.97,-1.3358,0.13,0.61
"GO_BP:493381_GO_0009185_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS","GO_BP","493381_GO_0009185_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS",17,-0.609,0.95,0.99,0.6363,0.93,1,-0.8067,0.74,0.99
"GO_BP:502838_GO_0033622_INTEGRIN_ACTIVATION","GO_BP","502838_GO_0033622_INTEGRIN_ACTIVATION",6,-0.609,0.93,0.99,-1.1713,0.29,0.91,1.0231,0.44,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1352_DISTECHE_ESCAPED_FROM_X_INACTIVATION","C2_Chemical_and_genetic_perturbations","C2_CGP_1352_DISTECHE_ESCAPED_FROM_X_INACTIVATION",13,-0.609,0.96,0.99,1.2066,0.22,0.48,-1.1779,0.24,0.54
"GO_BP:516304_GO_0071380_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS","GO_BP","516304_GO_0071380_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS",9,-0.6081,0.95,0.99,1.0135,0.43,0.97,1.4583,0.074,0.59
"GO_MF:500740_GO_0031489_MYOSIN_V_BINDING","GO_MF","500740_GO_0031489_MYOSIN_V_BINDING",17,-0.608,0.96,0.98,1.0462,0.39,0.83,-0.9249,0.57,0.85
"GO_BP:518418_GO_0090278_NEGATIVE_REGULATION_OF_PEPTIDE_HORMONE_SECRETION","GO_BP","518418_GO_0090278_NEGATIVE_REGULATION_OF_PEPTIDE_HORMONE_SECRETION",36,-0.607,0.98,0.99,-0.9178,0.6,1,-1.0274,0.42,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_555_HU_ANGIOGENESIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_555_HU_ANGIOGENESIS_UP",19,-0.6062,0.95,0.99,0.805,0.75,0.99,1.0528,0.36,0.91
"GO_BP:518471_GO_0090331_NEGATIVE_REGULATION_OF_PLATELET_AGGREGATION","GO_BP","518471_GO_0090331_NEGATIVE_REGULATION_OF_PLATELET_AGGREGATION",7,-0.6061,0.94,0.99,1.3863,0.13,0.57,1.2823,0.19,0.69
"WikiPathways:739008_WP2333_TRANS_SULFURATION_PATHWAY","WikiPathways","739008_WP2333_TRANS_SULFURATION_PATHWAY",9,-0.6061,0.92,1,-0.6559,0.88,1,-1.4333,0.092,0.42
"GO_BP:989115_GO_1903050_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS","GO_BP","989115_GO_1903050_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS",260,-0.606,1,0.99,1.3753,0,0.58,-1.03,0.36,0.83
"GO_BP:488860_GO_0003062_REGULATION_OF_HEART_RATE_BY_CHEMICAL_SIGNAL","GO_BP","488860_GO_0003062_REGULATION_OF_HEART_RATE_BY_CHEMICAL_SIGNAL",7,-0.606,0.94,0.99,1.2492,0.22,0.73,1.2886,0.19,0.68
"KEGG_compound:C14770_11_12_EET_5Z_8Z_14Z_11_12_EPOXYEICOSA_5_8_14_TRIENOIC_ACID_5Z_8Z_14Z_11_12_EPOXYICOSA_5_8_14_TRIENOIC_ACID","KEGG_compound","C14770_11_12_EET_5Z_8Z_14Z_11_12_EPOXYEICOSA_5_8_14_TRIENOIC_ACID_5Z_8Z_14Z_11_12_EPOXYICOSA_5_8_14_TRIENOIC_ACID",5,-0.606,0.93,0.99,-1.2036,0.28,0.77,-0.7146,0.81,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1144_AMIT_EGF_RESPONSE_480_MCF10A","C2_Chemical_and_genetic_perturbations","C2_CGP_1144_AMIT_EGF_RESPONSE_480_MCF10A",43,-0.6059,0.98,0.99,0.8199,0.79,0.98,0.9658,0.51,0.97
"C4_Cancer_gene_neighborhoods:C4_CGN_197_GCM_BCL2L1","C4_Cancer_gene_neighborhoods","C4_CGN_197_GCM_BCL2L1",35,-0.6056,0.97,1,0.7163,0.91,1,0.5434,0.99,1
"GO_BP:486594_GO_0000046_AUTOPHAGIC_VACUOLE_FUSION","GO_BP","486594_GO_0000046_AUTOPHAGIC_VACUOLE_FUSION",8,-0.6054,0.94,0.99,1.24,0.21,0.75,-0.6189,0.92,1
"REACTOME:105904_REACT_18356_UNFOLDED_PROTEIN_RESPONSE_UPR_","REACTOME","105904_REACT_18356_UNFOLDED_PROTEIN_RESPONSE_UPR_",89,-0.6043,0.99,0.99,1.0478,0.35,0.67,0.6332,1,1
"GO_BP:754952_GO_2000846_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION","GO_BP","754952_GO_2000846_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION",11,-0.6043,0.94,0.99,1.3419,0.12,0.62,0.6423,0.9,1
"GO_BP:500691_GO_0031440_REGULATION_OF_MRNA_3_END_PROCESSING","GO_BP","500691_GO_0031440_REGULATION_OF_MRNA_3_END_PROCESSING",26,-0.6043,0.97,0.99,-0.6284,0.96,1,-0.7371,0.88,1
"REACTOME:160139_REACT_21326_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS","REACTOME","160139_REACT_21326_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS",10,-0.6037,0.93,0.99,-1.3,0.15,0.67,-1.1672,0.27,0.63
"GO_CC:516129_GO_0071203_WASH_COMPLEX","GO_CC","516129_GO_0071203_WASH_COMPLEX",11,-0.6036,0.95,1,1.2215,0.22,0.5,-0.8082,0.69,1
"GO_BP:495289_GO_0014897_STRIATED_MUSCLE_HYPERTROPHY","GO_BP","495289_GO_0014897_STRIATED_MUSCLE_HYPERTROPHY",22,-0.6027,0.96,0.99,-0.9037,0.61,1,1.259,0.15,0.69
"REACTOME:106342_REACT_12484_EGFR_DOWNREGULATION","REACTOME","106342_REACT_12484_EGFR_DOWNREGULATION",26,-0.602,0.97,0.99,1.4142,0.075,0.21,1.0844,0.33,0.95
"KEGG_compound:C02188_PROTEIN_LYSINE_PEPTIDYL_L_LYSINE","KEGG_compound","C02188_PROTEIN_LYSINE_PEPTIDYL_L_LYSINE",30,-0.6019,0.97,0.99,-1.4292,0.064,0.41,-1.0833,0.31,0.55
"GO_BP:516095_GO_0071169_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN","GO_BP","516095_GO_0071169_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN",6,-0.6019,0.93,0.99,0.8634,0.64,1,-0.9722,0.49,0.88
"GO_BP:507046_GO_0044030_REGULATION_OF_DNA_METHYLATION","GO_BP","507046_GO_0044030_REGULATION_OF_DNA_METHYLATION",14,-0.6015,0.95,0.99,1.0183,0.4,0.97,0.6615,0.91,1
"C4_Cancer_modules:C4_CM_292_MODULE_333","C4_Cancer_modules","C4_CM_292_MODULE_333",28,-0.6009,0.97,0.99,1.1518,0.24,0.45,-1.0435,0.4,0.62
"GO_MF:489491_GO_0004022_ALCOHOL_DEHYDROGENASE_NAD_ACTIVITY","GO_MF","489491_GO_0004022_ALCOHOL_DEHYDROGENASE_NAD_ACTIVITY",8,-0.6007,0.93,0.98,1.5433,0.041,0.34,1.3719,0.13,0.57
"C4_Cancer_modules:C4_CM_402_MODULE_514","C4_Cancer_modules","C4_CM_402_MODULE_514",10,-0.6007,0.94,0.99,-1.2583,0.21,0.58,-1.45,0.074,0.18
"C2_Chemical_and_genetic_perturbations:C2_CGP_1778_GAJATE_RESPONSE_TO_TRABECTEDIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1778_GAJATE_RESPONSE_TO_TRABECTEDIN_DN",19,-0.6005,0.97,0.99,-1.0695,0.36,0.96,-1.4981,0.043,0.3
"GO_BP:487853_GO_0001963_SYNAPTIC_TRANSMISSION_DOPAMINERGIC","GO_BP","487853_GO_0001963_SYNAPTIC_TRANSMISSION_DOPAMINERGIC",14,-0.6004,0.97,0.99,1.4619,0.068,0.48,-0.8301,0.72,0.97
"C4_Cancer_gene_neighborhoods:C4_CGN_199_GCM_ERBB2IP","C4_Cancer_gene_neighborhoods","C4_CGN_199_GCM_ERBB2IP",64,-0.6004,0.99,1,0.843,0.75,0.94,-0.8939,0.66,1
"C4_Cancer_gene_neighborhoods:C4_CGN_28_MORF_PRDX3","C4_Cancer_gene_neighborhoods","C4_CGN_28_MORF_PRDX3",85,-0.6001,1,1,2.5075,0,0,-0.8163,0.82,1
"KEGG_module:HSA_M00681_ACTIVIN_SIGNALING","KEGG_module","HSA_M00681_ACTIVIN_SIGNALING",10,-0.6,0.93,0.96,-0.6919,0.85,1,0.5054,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_161_CHOI_ATL_CHRONIC_VS_ACUTE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_161_CHOI_ATL_CHRONIC_VS_ACUTE_DN",18,-0.5998,0.95,0.99,1.8542,0,0.028,-1.0666,0.36,0.67
"C4_Cancer_gene_neighborhoods:C4_CGN_16_MORF_ESPL1","C4_Cancer_gene_neighborhoods","C4_CGN_16_MORF_ESPL1",61,-0.5992,0.99,1,1.627,0.0043,0.012,-1.2836,0.093,0.32
"GO_BP:491017_GO_0006032_CHITIN_CATABOLIC_PROCESS","GO_BP","491017_GO_0006032_CHITIN_CATABOLIC_PROCESS",7,-0.5988,0.94,0.99,1.6499,0.015,0.25,0.9682,0.49,0.89
"GO_BP:489209_GO_0003417_GROWTH_PLATE_CARTILAGE_DEVELOPMENT","GO_BP","489209_GO_0003417_GROWTH_PLATE_CARTILAGE_DEVELOPMENT",12,-0.5984,0.94,0.99,-1.3164,0.14,0.89,0.9367,0.55,0.91
"GO_BP:515514_GO_0070584_MITOCHONDRION_MORPHOGENESIS","GO_BP","515514_GO_0070584_MITOCHONDRION_MORPHOGENESIS",19,-0.598,0.96,0.99,1.1801,0.24,0.8,1.1562,0.24,0.73
"WikiPathways:198783_WP106_ALANINE_AND_ASPARTATE_METABOLISM","WikiPathways","198783_WP106_ALANINE_AND_ASPARTATE_METABOLISM",11,-0.5978,0.95,0.99,1.4978,0.057,0.34,-1.0056,0.44,0.68
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_161_BIOCARTA_LEPTIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_161_BIOCARTA_LEPTIN_PATHWAY",11,-0.5967,0.95,0.97,0.9212,0.54,0.91,1.007,0.45,1
"GO_BP:492814_GO_0061136_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS","GO_BP","492814_GO_0061136_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS",191,-0.5966,1,0.99,1.0796,0.25,0.93,-1.0205,0.4,0.83
"GO_BP:508171_GO_0045852_PH_ELEVATION","GO_BP","508171_GO_0045852_PH_ELEVATION",5,-0.5964,0.93,0.99,0.6558,0.87,1,1.435,0.076,0.6
"C3_TF_targets:C3_TFT_42_V_YY1_02","C3_TF_targets","C3_TFT_42_V_YY1_02",243,-0.5963,1,1,0.743,1,1,-0.7115,1,1
"GO_BP:516029_GO_0071103_DNA_CONFORMATION_CHANGE","GO_BP","516029_GO_0071103_DNA_CONFORMATION_CHANGE",235,-0.5959,1,0.99,-0.9538,0.58,1,-1.5188,0,0.53
"GO_MF:509223_GO_0047035_TESTOSTERONE_DEHYDROGENASE_NAD_ACTIVITY","GO_MF","509223_GO_0047035_TESTOSTERONE_DEHYDROGENASE_NAD_ACTIVITY",6,-0.5958,0.93,0.98,1.5866,0.044,0.31,-1.0563,0.4,0.74
"GO_BP:491015_GO_0006030_CHITIN_METABOLIC_PROCESS","GO_BP","491015_GO_0006030_CHITIN_METABOLIC_PROCESS",7,-0.5955,0.94,0.99,1.6928,0.014,0.2,0.9889,0.47,0.87
"GO_MF:489903_GO_0004568_CHITINASE_ACTIVITY","GO_MF","489903_GO_0004568_CHITINASE_ACTIVITY",7,-0.5955,0.92,0.98,1.6405,0.012,0.22,0.9926,0.45,0.88
"GO_BP:1047421_GO_1903421_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING","GO_BP","1047421_GO_1903421_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING",6,-0.5947,0.93,0.99,0.906,0.58,1,0.6261,0.91,1
"GO_BP:493616_GO_0009445_PUTRESCINE_METABOLIC_PROCESS","GO_BP","493616_GO_0009445_PUTRESCINE_METABOLIC_PROCESS",5,-0.5945,0.95,0.99,-0.9437,0.54,1,-0.8152,0.7,0.98
"GO_BP:510317_GO_0048194_GOLGI_VESICLE_BUDDING","GO_BP","510317_GO_0048194_GOLGI_VESICLE_BUDDING",16,-0.594,0.95,0.99,1.5608,0.029,0.34,0.7446,0.81,1
"GO_BP:513677_GO_0060119_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT","GO_BP","513677_GO_0060119_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT",32,-0.5939,0.98,0.99,-0.5969,0.97,1,1.08,0.33,0.77
"KEGG_compound:C00250_PYRIDOXAL","KEGG_compound","C00250_PYRIDOXAL",5,-0.5935,0.93,1,0.934,0.54,1,-0.6933,0.83,0.92
"GO_BP:494039_GO_0009950_DORSAL_VENTRAL_AXIS_SPECIFICATION","GO_BP","494039_GO_0009950_DORSAL_VENTRAL_AXIS_SPECIFICATION",16,-0.5934,0.95,0.99,-1.374,0.093,0.99,1.0025,0.44,0.85
"KEGG_compound:C00131_DATP_2_DEOXYADENOSINE_5_TRIPHOSPHATE_DEOXYADENOSINE_5_TRIPHOSPHATE_DEOXYADENOSINE_TRIPHOSPHATE","KEGG_compound","C00131_DATP_2_DEOXYADENOSINE_5_TRIPHOSPHATE_DEOXYADENOSINE_5_TRIPHOSPHATE_DEOXYADENOSINE_TRIPHOSPHATE",25,-0.5929,0.96,1,0.5775,0.98,1,-1.374,0.07,0.31
"GO_BP:755362_GO_2001256_REGULATION_OF_STORE_OPERATED_CALCIUM_ENTRY","GO_BP","755362_GO_2001256_REGULATION_OF_STORE_OPERATED_CALCIUM_ENTRY",8,-0.5918,0.96,0.99,-1.0545,0.37,0.97,1.3188,0.13,0.66
"GO_BP:755126_GO_2001020_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS","GO_BP","755126_GO_2001020_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS",131,-0.5915,1,0.99,1.1492,0.17,0.84,0.6716,1,1
"GO_MF:509731_GO_0047555_3_5_CYCLIC_GMP_PHOSPHODIESTERASE_ACTIVITY","GO_MF","509731_GO_0047555_3_5_CYCLIC_GMP_PHOSPHODIESTERASE_ACTIVITY",11,-0.5909,0.95,0.99,-1.0669,0.38,0.86,0.9032,0.59,0.95
"C3_TF_targets:C3_TFT_545_YGCGYRCGC_UNKNOWN","C3_TF_targets","C3_TFT_545_YGCGYRCGC_UNKNOWN",318,-0.5908,1,1,-0.7573,0.99,1,-1.017,0.4,0.72
"KEGG_compound:C00510_OLEOYL_COA_9Z_OCTADECENOYL_COA","KEGG_compound","C00510_OLEOYL_COA_9Z_OCTADECENOYL_COA",6,-0.5907,0.94,0.99,-0.7261,0.81,1,1.0958,0.38,0.65
"GO_BP:754809_GO_1901858_REGULATION_OF_MITOCHONDRIAL_DNA_METABOLIC_PROCESS","GO_BP","754809_GO_1901858_REGULATION_OF_MITOCHONDRIAL_DNA_METABOLIC_PROCESS",6,-0.5904,0.94,0.99,-0.5276,0.97,1,0.9577,0.51,0.9
"C4_Cancer_gene_neighborhoods:C4_CGN_15_MORF_ERCC2","C4_Cancer_gene_neighborhoods","C4_CGN_15_MORF_ERCC2",101,-0.5904,1,1,0.5694,1,1,-1.3264,0.043,0.26
"GO_BP:512332_GO_0051454_INTRACELLULAR_PH_ELEVATION","GO_BP","512332_GO_0051454_INTRACELLULAR_PH_ELEVATION",5,-0.5897,0.94,0.99,0.6402,0.87,1,1.4288,0.089,0.61
"GO_BP:1026084_GO_1903312_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS","GO_BP","1026084_GO_1903312_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS",34,-0.5894,0.97,0.99,-0.8775,0.63,1,-0.6356,0.96,1
"GO_BP:517003_GO_0072087_RENAL_VESICLE_DEVELOPMENT","GO_BP","517003_GO_0072087_RENAL_VESICLE_DEVELOPMENT",13,-0.5894,0.96,0.99,-1.0207,0.43,0.97,1.6412,0.016,0.4
"KEGG_compound:C00286_DGTP_2_DEOXYGUANOSINE_5_TRIPHOSPHATE_DEOXYGUANOSINE_5_TRIPHOSPHATE_DEOXYGUANOSINE_TRIPHOSPHATE","KEGG_compound","C00286_DGTP_2_DEOXYGUANOSINE_5_TRIPHOSPHATE_DEOXYGUANOSINE_5_TRIPHOSPHATE_DEOXYGUANOSINE_TRIPHOSPHATE",26,-0.5894,0.97,0.99,0.6098,0.96,1,-1.3069,0.11,0.36
"C3_TF_targets:C3_TFT_496_KCCGNSWTTT_UNKNOWN","C3_TF_targets","C3_TFT_496_KCCGNSWTTT_UNKNOWN",104,-0.5892,1,1,-0.655,1,1,-0.9892,0.46,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2814_WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2814_WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP",12,-0.5886,0.96,0.99,-1.5959,0.025,0.42,0.8983,0.61,1
"GO_BP:500821_GO_0031570_DNA_INTEGRITY_CHECKPOINT","GO_BP","500821_GO_0031570_DNA_INTEGRITY_CHECKPOINT",155,-0.5884,1,0.99,1.4063,0.0024,0.55,-1.0686,0.27,0.8
"GO_BP:508601_GO_0046337_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS","GO_BP","508601_GO_0046337_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS",15,-0.5882,0.96,0.99,0.5797,0.97,1,-0.7046,0.87,0.99
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_106_BIOCARTA_INSULIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_106_BIOCARTA_INSULIN_PATHWAY",21,-0.588,0.97,0.97,-0.697,0.89,1,1.0697,0.35,1
"C4_Cancer_gene_neighborhoods:C4_CGN_267_GCM_SUFU","C4_Cancer_gene_neighborhoods","C4_CGN_267_GCM_SUFU",77,-0.588,0.99,1,-0.5703,1,1,0.8146,0.85,1
"GO_BP:494568_GO_0010498_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS","GO_BP","494568_GO_0010498_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS",272,-0.5878,1,0.99,1.387,0.0046,0.57,-0.8542,0.9,0.96
"GO_BP:519396_GO_2000757_NEGATIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION","GO_BP","519396_GO_2000757_NEGATIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION",15,-0.5876,0.96,0.99,1.2231,0.21,0.76,-1.0328,0.42,0.82
"GO_MF:515626_GO_0070696_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_BINDING","GO_MF","515626_GO_0070696_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_BINDING",13,-0.5876,0.96,0.99,0.6164,0.95,1,-0.8022,0.73,0.97
"GO_MF:487308_GO_0001085_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING","GO_MF","487308_GO_0001085_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING",92,-0.5875,1,0.98,0.6966,0.98,1,-0.8769,0.75,0.9
"OMIM_gene:OMIM609901_ANKYRIN_REPEAT_AND_STERILE_ALPHA_MOTIF_DOMAINS_CONTAINING_PROTEIN_4B_ANKS4B","OMIM_gene","OMIM609901_ANKYRIN_REPEAT_AND_STERILE_ALPHA_MOTIF_DOMAINS_CONTAINING_PROTEIN_4B_ANKS4B",5,-0.5874,0.94,1,-1.1838,0.28,1,1.0532,0.41,0.99
"GO_BP:497012_GO_0018026_PEPTIDYL_LYSINE_MONOMETHYLATION","GO_BP","497012_GO_0018026_PEPTIDYL_LYSINE_MONOMETHYLATION",6,-0.587,0.95,0.99,-0.6286,0.89,1,-1.1115,0.34,0.76
"GO_BP:487959_GO_0002069_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_MATURATION","GO_BP","487959_GO_0002069_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_MATURATION",6,-0.5869,0.93,0.99,0.6738,0.85,1,1.0356,0.4,0.82
"GO_BP:515219_GO_0070286_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY","GO_BP","515219_GO_0070286_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY",15,-0.5868,0.97,0.99,-1.4595,0.075,0.88,-0.6926,0.88,0.99
"GO_CC:489480_GO_0043190_ATP_BINDING_CASSETTE_ABC_TRANSPORTER_COMPLEX","GO_CC","489480_GO_0043190_ATP_BINDING_CASSETTE_ABC_TRANSPORTER_COMPLEX",8,-0.5866,0.95,1,-1.505,0.048,0.62,-1.0247,0.42,0.99
"GO_BP:491411_GO_0006513_PROTEIN_MONOUBIQUITINATION","GO_BP","491411_GO_0006513_PROTEIN_MONOUBIQUITINATION",46,-0.5863,0.99,0.99,0.8322,0.78,1,-1.0289,0.4,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_878_INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_878_INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP",14,-0.5863,0.96,0.99,1.0115,0.45,0.78,-0.8486,0.65,0.93
"KEGG_compound:C14771_14_15_EET_5Z_8Z_11Z_14_15_EPOXYEICOSA_5_8_11_TRIENOIC_ACID_5Z_8Z_11Z_14_15_EPOXYICOSA_5_8_11_TRIENOIC_ACID","KEGG_compound","C14771_14_15_EET_5Z_8Z_11Z_14_15_EPOXYEICOSA_5_8_11_TRIENOIC_ACID_5Z_8Z_11Z_14_15_EPOXYICOSA_5_8_11_TRIENOIC_ACID",5,-0.5862,0.95,0.99,-1.2254,0.25,0.78,-0.7335,0.77,0.9
"GO_BP:494598_GO_0010529_NEGATIVE_REGULATION_OF_TRANSPOSITION","GO_BP","494598_GO_0010529_NEGATIVE_REGULATION_OF_TRANSPOSITION",9,-0.5862,0.96,0.99,0.9373,0.56,1,-1.0447,0.42,0.81
"GO_BP:494597_GO_0010528_REGULATION_OF_TRANSPOSITION","GO_BP","494597_GO_0010528_REGULATION_OF_TRANSPOSITION",9,-0.5861,0.95,0.99,0.9511,0.5,1,-1.048,0.4,0.81
"REACTOME:106326_REACT_9465_HEME_BIOSYNTHESIS","REACTOME","106326_REACT_9465_HEME_BIOSYNTHESIS",11,-0.5857,0.96,1,1.0851,0.35,0.61,-1.3357,0.14,0.52
"REACTOME:477137_REACT_111083_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT","REACTOME","477137_REACT_111083_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT",135,-0.5855,1,1,2.6442,0,0,-0.6995,1,1
"KEGG_compound:C00019_S_ADENOSYL_L_METHIONINE_S_ADENOSYLMETHIONINE_ADOMET_SAM","KEGG_compound","C00019_S_ADENOSYL_L_METHIONINE_S_ADENOSYLMETHIONINE_ADOMET_SAM",59,-0.5848,0.99,0.99,-0.727,0.94,1,-1.2399,0.14,0.42
"GO_BP:510492_GO_0048385_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY","GO_BP","510492_GO_0048385_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY",22,-0.5841,0.97,0.99,-1.0602,0.35,0.96,-0.9162,0.6,0.91
"C4_Cancer_gene_neighborhoods:C4_CGN_198_GCM_BECN1","C4_Cancer_gene_neighborhoods","C4_CGN_198_GCM_BECN1",68,-0.5841,1,1,1.4844,0.017,0.035,0.5662,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_612_TURJANSKI_MAPK14_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_612_TURJANSKI_MAPK14_TARGETS",10,-0.5839,0.93,0.99,-0.9053,0.59,1,-0.7327,0.81,0.98
"REACTOME:366163_REACT_75795_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC","REACTOME","366163_REACT_75795_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC",24,-0.5833,0.97,1,1.242,0.16,0.4,-0.4773,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_708_SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC","C2_Chemical_and_genetic_perturbations","C2_CGP_708_SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC",107,-0.5831,1,0.99,1.1493,0.17,0.56,-0.7573,0.96,0.97
"GO_CC:500565_GO_0031306_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_OUTER_MEMBRANE","GO_CC","500565_GO_0031306_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_OUTER_MEMBRANE",18,-0.5822,0.97,1,-0.6166,0.96,1,-0.8822,0.62,1
"GO_CC:516739_GO_0071817_MMXD_COMPLEX","GO_CC","516739_GO_0071817_MMXD_COMPLEX",5,-0.5814,0.93,1,0.9701,0.47,0.83,-0.6912,0.84,1
"GO_CC:501276_GO_0032039_INTEGRATOR_COMPLEX","GO_CC","501276_GO_0032039_INTEGRATOR_COMPLEX",13,-0.581,0.96,1,-0.6401,0.9,1,-1.041,0.39,0.99
"GO_BP:488665_GO_0002792_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION","GO_BP","488665_GO_0002792_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION",37,-0.5807,0.98,0.99,-0.9021,0.62,1,-1.0062,0.44,0.84
"REACTOME:106455_REACT_13443_REGULATED_PROTEOLYSIS_OF_P75NTR","REACTOME","106455_REACT_13443_REGULATED_PROTEOLYSIS_OF_P75NTR",10,-0.5802,0.96,1,0.6167,0.93,1,-1.0245,0.41,0.8
"GO_CC:490731_GO_0005675_HOLO_TFIIH_COMPLEX","GO_CC","490731_GO_0005675_HOLO_TFIIH_COMPLEX",12,-0.5801,0.97,1,0.7376,0.82,0.98,-0.6321,0.92,1
"OMIM_gene:OMIM606622_SWI_SNF_RELATED_MATRIX_ASSOCIATED_ACTIN_DEPENDENT_REGULATOR_OF_CHROMATIN_SUBFAMILY_A_LIKE_PROTEIN_1_SMARCAL1","OMIM_gene","OMIM606622_SWI_SNF_RELATED_MATRIX_ASSOCIATED_ACTIN_DEPENDENT_REGULATOR_OF_CHROMATIN_SUBFAMILY_A_LIKE_PROTEIN_1_SMARCAL1",5,-0.5795,0.93,1,-1.1944,0.26,1,1.0924,0.37,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_68_IGARASHI_ATF4_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_68_IGARASHI_ATF4_TARGETS_UP",6,-0.5794,0.94,0.99,-1.2667,0.19,0.72,-0.769,0.78,0.97
"GO_BP:518230_GO_0090090_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY","GO_BP","518230_GO_0090090_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY",152,-0.579,1,0.99,1.4866,0.0047,0.43,0.8958,0.75,0.95
"OMIM_gene:OMIM606157_PANTOTHENATE_KINASE_2_PANK2","OMIM_gene","OMIM606157_PANTOTHENATE_KINASE_2_PANK2",5,-0.5789,0.95,1,-1.1839,0.28,1,1.0652,0.4,1
"REACTOME:1127546_REACT_268444_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS","REACTOME","1127546_REACT_268444_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS",18,-0.5787,0.97,1,0.9457,0.52,0.84,-0.923,0.57,0.93
"GO_BP:486731_GO_0019941_MODIFICATION_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","486731_GO_0019941_MODIFICATION_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",399,-0.5785,1,0.99,1.3117,0.0027,0.66,-0.9329,0.72,0.9
"GO_BP:518451_GO_0090311_REGULATION_OF_PROTEIN_DEACETYLATION","GO_BP","518451_GO_0090311_REGULATION_OF_PROTEIN_DEACETYLATION",32,-0.5781,0.99,0.99,-1.1223,0.27,0.93,0.67,0.94,1
"REACTOME:106504_REACT_6844_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX","REACTOME","106504_REACT_6844_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX",72,-0.5776,1,1,1.1119,0.26,0.56,-0.6385,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_47_FRASOR_TAMOXIFEN_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_47_FRASOR_TAMOXIFEN_RESPONSE_DN",11,-0.5775,0.96,0.99,-0.6616,0.9,1,-1.5018,0.062,0.3
"KEGG_compound:C00363_DTDP_DEOXYTHYMIDINE_5_DIPHOSPHATE","KEGG_compound","C00363_DTDP_DEOXYTHYMIDINE_5_DIPHOSPHATE",14,-0.5772,0.96,0.99,-0.5008,0.99,1,-1.2525,0.18,0.41
"GO_BP:505840_GO_0042733_EMBRYONIC_DIGIT_MORPHOGENESIS","GO_BP","505840_GO_0042733_EMBRYONIC_DIGIT_MORPHOGENESIS",60,-0.5771,0.99,0.99,0.9107,0.62,1,1.2113,0.14,0.71
"REACTOME:106544_REACT_7993_TELOMERE_C_STRAND_SYNTHESIS_INITIATION","REACTOME","106544_REACT_7993_TELOMERE_C_STRAND_SYNTHESIS_INITIATION",6,-0.5768,0.95,1,-0.5976,0.93,1,-1.6302,0.012,0.24
"WikiPathways:198767_WP288_NLR_PROTEINS","WikiPathways","198767_WP288_NLR_PROTEINS",8,-0.5766,0.96,1,-0.5072,0.99,1,-0.7788,0.76,0.95
"GO_BP:506235_GO_0043162_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY","GO_BP","506235_GO_0043162_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY",18,-0.5766,0.98,0.99,1.6508,0.012,0.25,0.571,0.98,1
"REACTOME:106247_REACT_16907_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS","REACTOME","106247_REACT_16907_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS",29,-0.5762,0.98,0.99,1.1604,0.25,0.49,0.6728,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2953_NAKAMURA_ADIPOGENESIS_EARLY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2953_NAKAMURA_ADIPOGENESIS_EARLY_DN",37,-0.576,0.98,0.99,1.4066,0.062,0.29,1.2365,0.14,0.74
"GO_BP:512558_GO_0051683_ESTABLISHMENT_OF_GOLGI_LOCALIZATION","GO_BP","512558_GO_0051683_ESTABLISHMENT_OF_GOLGI_LOCALIZATION",6,-0.5758,0.95,0.99,1.4827,0.069,0.44,0.9468,0.51,0.91
"GO_BP:519418_GO_2000779_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR","GO_BP","519418_GO_2000779_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR",27,-0.5752,0.98,0.99,0.741,0.86,1,0.5344,0.99,1
"REACTOME:105785_REACT_2244_DNA_REPLICATION_INITIATION","REACTOME","105785_REACT_2244_DNA_REPLICATION_INITIATION",6,-0.5749,0.94,0.99,-0.603,0.93,1,-1.6657,0.01,0.22
"GO_BP:496300_GO_0016233_TELOMERE_CAPPING","GO_BP","496300_GO_0016233_TELOMERE_CAPPING",5,-0.5748,0.95,0.99,0.6609,0.89,1,-0.7984,0.7,0.99
"GO_BP:508080_GO_0045739_POSITIVE_REGULATION_OF_DNA_REPAIR","GO_BP","508080_GO_0045739_POSITIVE_REGULATION_OF_DNA_REPAIR",28,-0.5745,0.98,0.99,0.6873,0.93,1,-1.2811,0.13,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1070_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1070_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP",15,-0.5744,0.98,0.99,-0.9959,0.48,1,-0.8388,0.69,0.93
"GO_BP:504297_GO_0035112_GENITALIA_MORPHOGENESIS","GO_BP","504297_GO_0035112_GENITALIA_MORPHOGENESIS",10,-0.5728,0.96,0.99,-0.5486,0.96,1,0.6883,0.87,1
"GO_MF:507678_GO_0045322_UNMETHYLATED_CPG_BINDING","GO_MF","507678_GO_0045322_UNMETHYLATED_CPG_BINDING",5,-0.5725,0.95,0.99,-1.3867,0.12,0.66,0.8663,0.62,0.98
"C4_Cancer_gene_neighborhoods:C4_CGN_61_MORF_AP3D1","C4_Cancer_gene_neighborhoods","C4_CGN_61_MORF_AP3D1",130,-0.5716,1,1,2.166,0,2e-05,-0.9935,0.46,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_2671_ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2671_ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN",30,-0.5713,0.98,0.99,1.8802,0.0043,0.023,0.5858,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_839_OXFORD_RALA_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_839_OXFORD_RALA_TARGETS_DN",10,-0.5709,0.95,0.99,0.7162,0.81,1,0.7938,0.69,1
"REACTOME:106109_REACT_12528_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX","REACTOME","106109_REACT_12528_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX",14,-0.5706,0.95,0.99,1.0778,0.35,0.62,-1.0202,0.43,0.81
"C4_Cancer_modules:C4_CM_204_MODULE_219","C4_Cancer_modules","C4_CM_204_MODULE_219",27,-0.5678,0.98,1,1.3782,0.072,0.2,-1.2952,0.12,0.31
"GO_BP:500353_GO_0031063_REGULATION_OF_HISTONE_DEACETYLATION","GO_BP","500353_GO_0031063_REGULATION_OF_HISTONE_DEACETYLATION",24,-0.5672,0.98,0.99,-1.2511,0.17,0.91,-0.582,0.98,1
"GO_BP:506234_GO_0043161_PROTEASOME_MEDIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","506234_GO_0043161_PROTEASOME_MEDIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",265,-0.5671,1,0.99,1.3595,0.012,0.6,-0.8595,0.87,0.96
"OMIM_gene:OMIM607211_CASPASE_RECRUITMENT_DOMAIN_CONTAINING_PROTEIN_14_CARD14","OMIM_gene","OMIM607211_CASPASE_RECRUITMENT_DOMAIN_CONTAINING_PROTEIN_14_CARD14",6,-0.5659,0.96,0.99,1.0597,0.39,1,-0.6917,0.83,1
"GO_CC:496535_GO_0016589_NURF_COMPLEX","GO_CC","496535_GO_0016589_NURF_COMPLEX",6,-0.5659,0.95,1,-1.0298,0.43,0.83,-0.7365,0.79,1
"GO_BP:497199_GO_0018231_PEPTIDYL_S_DIACYLGLYCEROL_L_CYSTEINE_BIOSYNTHETIC_PROCESS_FROM_PEPTIDYL_CYSTEINE","GO_BP","497199_GO_0018231_PEPTIDYL_S_DIACYLGLYCEROL_L_CYSTEINE_BIOSYNTHETIC_PROCESS_FROM_PEPTIDYL_CYSTEINE",5,-0.5655,0.96,0.99,0.7052,0.83,1,0.57,0.95,1
"KEGG_compound:C00082_L_TYROSINE_S_3_P_HYDROXYPHENYL_ALANINE_S_2_AMINO_3_P_HYDROXYPHENYL_PROPIONIC_ACID_TYROSINE","KEGG_compound","C00082_L_TYROSINE_S_3_P_HYDROXYPHENYL_ALANINE_S_2_AMINO_3_P_HYDROXYPHENYL_PROPIONIC_ACID_TYROSINE",11,-0.5655,0.96,1,0.9075,0.58,1,1.0763,0.36,0.61
"C3_TF_targets:C3_TFT_392_GCGSCMNTTT_UNKNOWN","C3_TF_targets","C3_TFT_392_GCGSCMNTTT_UNKNOWN",68,-0.5653,0.99,1,-0.5949,1,1,-0.917,0.62,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_525_ZIRN_TRETINOIN_RESPONSE_WT1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_525_ZIRN_TRETINOIN_RESPONSE_WT1_DN",6,-0.5644,0.97,0.99,0.6424,0.89,1,0.8557,0.65,1
"REACTOME:106197_REACT_9472_DIGESTION_OF_DIETARY_CARBOHYDRATE","REACTOME","106197_REACT_9472_DIGESTION_OF_DIETARY_CARBOHYDRATE",8,-0.5642,0.96,1,-0.6496,0.9,1,0.9566,0.51,1
"GO_BP:490990_GO_0006002_FRUCTOSE_6_PHOSPHATE_METABOLIC_PROCESS","GO_BP","490990_GO_0006002_FRUCTOSE_6_PHOSPHATE_METABOLIC_PROCESS",6,-0.5642,0.96,0.99,-0.9617,0.5,1,0.6016,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2585_HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2585_HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP",10,-0.5635,0.96,0.99,-1.121,0.32,0.89,-1.3948,0.11,0.36
"GO_BP:512451_GO_0051573_NEGATIVE_REGULATION_OF_HISTONE_H3_K9_METHYLATION","GO_BP","512451_GO_0051573_NEGATIVE_REGULATION_OF_HISTONE_H3_K9_METHYLATION",6,-0.5628,0.95,0.99,-0.8723,0.6,1,-1.0991,0.35,0.77
"GO_MF:489279_GO_0003747_TRANSLATION_RELEASE_FACTOR_ACTIVITY","GO_MF","489279_GO_0003747_TRANSLATION_RELEASE_FACTOR_ACTIVITY",6,-0.5627,0.96,0.99,0.9668,0.53,0.91,-1.2113,0.27,0.57
"GO_BP:499811_GO_0030433_ER_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","499811_GO_0030433_ER_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",43,-0.5627,0.99,0.99,0.9962,0.47,0.98,-0.7341,0.91,1
"GO_MF:492448_GO_0008079_TRANSLATION_TERMINATION_FACTOR_ACTIVITY","GO_MF","492448_GO_0008079_TRANSLATION_TERMINATION_FACTOR_ACTIVITY",6,-0.5617,0.94,0.99,0.9347,0.55,0.94,-1.2461,0.2,0.59
"GO_CC:493535_GO_0045254_PYRUVATE_DEHYDROGENASE_COMPLEX","GO_CC","493535_GO_0045254_PYRUVATE_DEHYDROGENASE_COMPLEX",5,-0.5617,0.95,1,1.1092,0.36,0.63,-1.114,0.35,0.89
"REACTOME:1183590_REACT_355321_RHO_GTPASES_ACTIVATE_KTN1","REACTOME","1183590_REACT_355321_RHO_GTPASES_ACTIVATE_KTN1",11,-0.5615,0.95,1,0.6698,0.92,1,-0.8235,0.72,1
"REACTOME:161017_REACT_22394_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE","REACTOME","161017_REACT_22394_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE",5,-0.5614,0.97,0.99,-1.0767,0.39,0.9,-0.3373,1,1
"GO_BP:491033_GO_0006048_UDP_N_ACETYLGLUCOSAMINE_BIOSYNTHETIC_PROCESS","GO_BP","491033_GO_0006048_UDP_N_ACETYLGLUCOSAMINE_BIOSYNTHETIC_PROCESS",5,-0.5613,0.96,0.99,-1.0552,0.42,0.97,-0.3462,1,1
"GO_MF:487277_GO_0001054_RNA_POLYMERASE_I_ACTIVITY","GO_MF","487277_GO_0001054_RNA_POLYMERASE_I_ACTIVITY",12,-0.5607,0.98,0.99,0.909,0.61,0.98,-0.8489,0.67,0.93
"GO_BP:849888_GO_1902186_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL","GO_BP","849888_GO_1902186_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL",31,-0.5604,0.98,0.99,1.2597,0.16,0.72,-0.9238,0.59,0.91
"REACTOME:530748_REACT_115835_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS","REACTOME","530748_REACT_115835_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS",25,-0.5595,0.98,0.99,-0.9084,0.59,1,1.3685,0.08,0.7
"GO_BP:497198_GO_0018230_PEPTIDYL_L_CYSTEINE_S_PALMITOYLATION","GO_BP","497198_GO_0018230_PEPTIDYL_L_CYSTEINE_S_PALMITOYLATION",5,-0.559,0.96,0.99,0.7015,0.82,1,0.5715,0.94,1
"C4_Cancer_modules:C4_CM_136_MODULE_143","C4_Cancer_modules","C4_CM_136_MODULE_143",13,-0.5589,0.98,0.99,-0.5827,0.96,1,-1.1311,0.3,0.49
"GO_BP:500678_GO_0031427_RESPONSE_TO_METHOTREXATE","GO_BP","500678_GO_0031427_RESPONSE_TO_METHOTREXATE",5,-0.5577,0.96,1,-1.0747,0.4,0.96,-1.2423,0.23,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_397_CASTELLANO_HRAS_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_397_CASTELLANO_HRAS_TARGETS_UP",5,-0.5574,0.96,0.99,1.293,0.18,0.4,1.0107,0.47,0.96
"KEGG_module:HSA_M00182_RNA_POLYMERASE_I_EUKARYOTES","KEGG_module","HSA_M00182_RNA_POLYMERASE_I_EUKARYOTES",12,-0.5572,0.96,0.97,0.9051,0.55,0.92,-0.848,0.65,0.92
"GO_BP:491410_GO_0006511_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","491410_GO_0006511_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",391,-0.5571,1,1,1.3134,0.0024,0.66,-0.8962,0.85,0.93
"GO_BP:754629_GO_1901678_IRON_COORDINATION_ENTITY_TRANSPORT","GO_BP","754629_GO_1901678_IRON_COORDINATION_ENTITY_TRANSPORT",12,-0.5566,0.97,1,-1.1573,0.3,0.92,0.8815,0.62,0.96
"GO_BP:493456_GO_0009263_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","493456_GO_0009263_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",12,-0.5565,0.97,1,1.111,0.33,0.89,-1.0514,0.38,0.81
"GO_BP:494251_GO_0010172_EMBRYONIC_BODY_MORPHOGENESIS","GO_BP","494251_GO_0010172_EMBRYONIC_BODY_MORPHOGENESIS",10,-0.5563,0.96,0.99,-0.6635,0.9,1,-0.9651,0.51,0.88
"C4_Cancer_gene_neighborhoods:C4_CGN_167_MORF_RAC1","C4_Cancer_gene_neighborhoods","C4_CGN_167_MORF_RAC1",213,-0.5559,1,1,1.9454,0,0.00053,-0.6013,1,1
"GO_CC:487085_GO_0000792_HETEROCHROMATIN","GO_CC","487085_GO_0000792_HETEROCHROMATIN",74,-0.5558,1,1,-0.5559,1,1,-0.8447,0.79,1
"C1_Positional:C1_ALL_259_CHR8Q13","C1_Positional","C1_ALL_259_CHR8Q13",42,-0.5557,0.99,1,0.8857,0.66,0.89,-0.925,0.58,0.98
"GO_BP:510415_GO_0048308_ORGANELLE_INHERITANCE","GO_BP","510415_GO_0048308_ORGANELLE_INHERITANCE",10,-0.555,0.97,1,0.686,0.87,1,0.8115,0.71,1
"GO_BP:496058_GO_0015937_COENZYME_A_BIOSYNTHETIC_PROCESS","GO_BP","496058_GO_0015937_COENZYME_A_BIOSYNTHETIC_PROCESS",11,-0.5546,0.96,1,-0.7002,0.89,1,-0.732,0.81,0.99
"GO_BP:504742_GO_0035562_NEGATIVE_REGULATION_OF_CHROMATIN_BINDING","GO_BP","504742_GO_0035562_NEGATIVE_REGULATION_OF_CHROMATIN_BINDING",5,-0.5544,0.95,0.99,-0.953,0.54,1,0.613,0.91,1
"GO_CC:492458_GO_0008091_SPECTRIN","GO_CC","492458_GO_0008091_SPECTRIN",9,-0.5542,0.96,1,-1.385,0.12,0.64,-1.1227,0.32,0.91
"KEGG_compound:C00018_PYRIDOXAL_PHOSPHATE_PYRIDOXAL_5_PHOSPHATE_PYRIDOXAL_5_PHOSPHATE_PLP","KEGG_compound","C00018_PYRIDOXAL_PHOSPHATE_PYRIDOXAL_5_PHOSPHATE_PYRIDOXAL_5_PHOSPHATE_PLP",5,-0.5541,0.96,1,0.8669,0.62,1,-1.3037,0.16,0.36
"REACTOME:105900_REACT_1181_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX","REACTOME","105900_REACT_1181_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX",15,-0.5524,0.98,0.99,1.4114,0.083,0.21,-0.7949,0.73,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_9_PYEON_HPV_POSITIVE_TUMORS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_9_PYEON_HPV_POSITIVE_TUMORS_UP",96,-0.552,1,0.99,-0.8059,0.85,1,-1.6899,0.0021,0.2
"GO_MF:514944_GO_0070003_THREONINE_TYPE_PEPTIDASE_ACTIVITY","GO_MF","514944_GO_0070003_THREONINE_TYPE_PEPTIDASE_ACTIVITY",21,-0.5516,0.98,0.99,1.5386,0.029,0.34,-0.9533,0.5,0.83
"GO_BP:506132_GO_0043046_DNA_METHYLATION_INVOLVED_IN_GAMETE_GENERATION","GO_BP","506132_GO_0043046_DNA_METHYLATION_INVOLVED_IN_GAMETE_GENERATION",15,-0.5515,0.98,1,-0.7618,0.8,1,0.9013,0.6,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_1888_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1888_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP",18,-0.5514,0.98,0.99,-0.7133,0.86,1,-0.7619,0.8,0.97
"GO_MF:510370_GO_0048256_FLAP_ENDONUCLEASE_ACTIVITY","GO_MF","510370_GO_0048256_FLAP_ENDONUCLEASE_ACTIVITY",7,-0.5514,0.97,0.99,0.7227,0.81,1,0.5726,0.96,1
"GO_BP:493261_GO_0009060_AEROBIC_RESPIRATION","GO_BP","493261_GO_0009060_AEROBIC_RESPIRATION",48,-0.5488,0.99,1,1.5851,0.0042,0.31,-1.2703,0.12,0.66
"GO_BP:492068_GO_0007290_SPERMATID_NUCLEUS_ELONGATION","GO_BP","492068_GO_0007290_SPERMATID_NUCLEUS_ELONGATION",5,-0.5468,0.97,1,0.5163,0.99,1,1.5451,0.032,0.52
"KEGG_compound:C00346_ETHANOLAMINE_PHOSPHATE_O_PHOSPHORYLETHANOLAMINE_PHOSPHOETHANOLAMINE_O_PHOSPHOETHANOLAMINE","KEGG_compound","C00346_ETHANOLAMINE_PHOSPHATE_O_PHOSPHORYLETHANOLAMINE_PHOSPHOETHANOLAMINE_O_PHOSPHOETHANOLAMINE",8,-0.5463,0.97,1,0.4899,0.99,1,0.9665,0.48,0.73
"C1_Positional:C1_ALL_219_CHR16Q23","C1_Positional","C1_ALL_219_CHR16Q23",30,-0.5463,0.99,1,1.4523,0.056,0.3,0.9958,0.45,0.77
"GO_BP:491072_GO_0006089_LACTATE_METABOLIC_PROCESS","GO_BP","491072_GO_0006089_LACTATE_METABOLIC_PROCESS",7,-0.546,0.99,1,1.4053,0.092,0.55,1.0978,0.36,0.76
"GO_BP:491513_GO_0006620_POSTTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE","GO_BP","491513_GO_0006620_POSTTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE",6,-0.546,0.98,1,0.812,0.7,1,0.6283,0.9,1
"C3_MicroRNA_targets:C3_MIR_12_TACGGGT_MIR_99A_MIR_100_MIR_99B","C3_MicroRNA_targets","C3_MIR_12_TACGGGT_MIR_99A_MIR_100_MIR_99B",23,-0.5449,0.99,1,0.8353,0.7,1,-0.8778,0.65,1
"GO_CC:490859_GO_0005839_PROTEASOME_CORE_COMPLEX","GO_CC","490859_GO_0005839_PROTEASOME_CORE_COMPLEX",20,-0.5434,0.98,1,1.5788,0.029,0.13,-0.9395,0.53,1
"GO_BP:489008_GO_0003214_CARDIAC_LEFT_VENTRICLE_MORPHOGENESIS","GO_BP","489008_GO_0003214_CARDIAC_LEFT_VENTRICLE_MORPHOGENESIS",13,-0.5422,0.98,1,0.5209,0.99,1,1.158,0.29,0.73
"GO_CC:502029_GO_0032806_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX","GO_CC","502029_GO_0032806_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX",21,-0.542,0.98,1,1.1616,0.25,0.57,0.7711,0.79,1
"GO_MF:515630_GO_0070700_BMP_RECEPTOR_BINDING","GO_MF","515630_GO_0070700_BMP_RECEPTOR_BINDING",8,-0.5413,0.97,1,0.8701,0.63,1,-0.8448,0.68,0.93
"GO_CC:911504_GO_1990204_OXIDOREDUCTASE_COMPLEX","GO_CC","911504_GO_1990204_OXIDOREDUCTASE_COMPLEX",85,-0.5412,1,1,2.2752,0,0,-0.9008,0.69,1
"GO_MF:489665_GO_0004298_THREONINE_TYPE_ENDOPEPTIDASE_ACTIVITY","GO_MF","489665_GO_0004298_THREONINE_TYPE_ENDOPEPTIDASE_ACTIVITY",21,-0.5405,0.99,0.99,1.4942,0.056,0.39,-0.9497,0.53,0.83
"GO_BP:510767_GO_0048712_NEGATIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION","GO_BP","510767_GO_0048712_NEGATIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION",13,-0.5405,0.98,1,-1.3138,0.15,0.87,1.0712,0.38,0.78
"GO_MF:495728_GO_0015556_C4_DICARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495728_GO_0015556_C4_DICARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.5402,0.98,0.99,-1.2202,0.23,0.84,-0.7852,0.71,0.97
"GO_BP:506519_GO_0043488_REGULATION_OF_MRNA_STABILITY","GO_BP","506519_GO_0043488_REGULATION_OF_MRNA_STABILITY",49,-0.5397,1,1,0.9844,0.5,1,-0.8841,0.69,0.94
"C4_Cancer_gene_neighborhoods:C4_CGN_223_GCM_DEAF1","C4_Cancer_gene_neighborhoods","C4_CGN_223_GCM_DEAF1",28,-0.5383,0.99,1,0.7242,0.91,1,-1.1482,0.24,0.52
"C4_Cancer_modules:C4_CM_98_MODULE_103","C4_Cancer_modules","C4_CM_98_MODULE_103",12,-0.5383,0.98,1,1.8215,0.0039,0.019,1.0184,0.42,0.94
"C4_Cancer_modules:C4_CM_76_MODULE_81","C4_Cancer_modules","C4_CM_76_MODULE_81",20,-0.5376,0.98,0.99,2.0475,0,0.0019,-0.5806,0.98,1
"GO_BP:491851_GO_0007020_MICROTUBULE_NUCLEATION","GO_BP","491851_GO_0007020_MICROTUBULE_NUCLEATION",16,-0.5371,0.98,1,-0.5163,0.99,1,-0.7499,0.81,1
"GO_CC:507553_GO_0045171_INTERCELLULAR_BRIDGE","GO_CC","507553_GO_0045171_INTERCELLULAR_BRIDGE",42,-0.5357,0.99,1,0.4925,1,1,-0.9989,0.45,1
"GO_BP:517435_GO_0072530_PURINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT","GO_BP","517435_GO_0072530_PURINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT",6,-0.5356,0.97,1,-0.9358,0.52,1,-1.4711,0.059,0.54
"GO_BP:516398_GO_0071474_CELLULAR_HYPEROSMOTIC_RESPONSE","GO_BP","516398_GO_0071474_CELLULAR_HYPEROSMOTIC_RESPONSE",8,-0.5346,0.97,1,-0.6668,0.89,1,-1.2538,0.21,0.68
"REACTOME:645266_REACT_121111_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY","REACTOME","645266_REACT_121111_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY",23,-0.5336,0.99,1,1.0479,0.37,0.67,-0.6181,0.97,1
"GO_BP:491361_GO_0006449_REGULATION_OF_TRANSLATIONAL_TERMINATION","GO_BP","491361_GO_0006449_REGULATION_OF_TRANSLATIONAL_TERMINATION",8,-0.5335,0.97,1,0.6992,0.86,1,-1.0943,0.34,0.78
"GO_MF:495449_GO_0015180_L_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495449_GO_0015180_L_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.5334,0.97,0.99,-0.5406,0.97,1,-0.7047,0.83,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_633_GILMORE_CORE_NFKB_PATHWAY","C2_Chemical_and_genetic_perturbations","C2_CGP_633_GILMORE_CORE_NFKB_PATHWAY",14,-0.5329,0.99,1,-0.9465,0.53,1,-1.2656,0.18,0.46
"GO_BP:493377_GO_0009181_PURINE_RIBONUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS","GO_BP","493377_GO_0009181_PURINE_RIBONUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS",5,-0.5329,0.97,1,0.7508,0.79,1,-0.8535,0.63,0.96
"GO_MF:490390_GO_0005127_CILIARY_NEUROTROPHIC_FACTOR_RECEPTOR_BINDING","GO_MF","490390_GO_0005127_CILIARY_NEUROTROPHIC_FACTOR_RECEPTOR_BINDING",5,-0.5328,0.97,0.99,-1.1136,0.35,0.82,0.7328,0.78,1
"GO_BP:506662_GO_0043632_MODIFICATION_DEPENDENT_MACROMOLECULE_CATABOLIC_PROCESS","GO_BP","506662_GO_0043632_MODIFICATION_DEPENDENT_MACROMOLECULE_CATABOLIC_PROCESS",412,-0.5325,1,1,1.3715,0.0025,0.58,-0.9244,0.74,0.91
"GO_BP:502352_GO_0033131_REGULATION_OF_GLUCOKINASE_ACTIVITY","GO_BP","502352_GO_0033131_REGULATION_OF_GLUCOKINASE_ACTIVITY",10,-0.532,0.97,1,0.7012,0.84,1,0.7793,0.78,1
"GO_CC:490774_GO_0005736_DNA_DIRECTED_RNA_POLYMERASE_I_COMPLEX","GO_CC","490774_GO_0005736_DNA_DIRECTED_RNA_POLYMERASE_I_COMPLEX",13,-0.5315,0.98,1,0.8859,0.63,0.91,-0.9252,0.55,1
"REACTOME:105683_REACT_13462_ACTIVATION_OF_DNA_FRAGMENTATION_FACTOR","REACTOME","105683_REACT_13462_ACTIVATION_OF_DNA_FRAGMENTATION_FACTOR",13,-0.5311,0.99,1,1.3794,0.081,0.24,0.8041,0.74,1
"GO_BP:777641_GO_1901984_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION","GO_BP","777641_GO_1901984_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION",16,-0.5305,0.98,1,1.4989,0.047,0.41,-0.9933,0.47,0.85
"GO_BP:496057_GO_0015936_COENZYME_A_METABOLIC_PROCESS","GO_BP","496057_GO_0015936_COENZYME_A_METABOLIC_PROCESS",18,-0.5304,0.98,1,0.8784,0.62,1,-0.914,0.57,0.92
"REACTOME:105682_REACT_1213_APOPTOSIS_INDUCED_DNA_FRAGMENTATION","REACTOME","105682_REACT_1213_APOPTOSIS_INDUCED_DNA_FRAGMENTATION",13,-0.5295,0.97,1,1.3944,0.1,0.23,0.8253,0.71,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1212_NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1212_NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON",52,-0.5294,1,1,-0.8165,0.8,1,0.7934,0.85,1
"GO_MF:499397_GO_0022858_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","499397_GO_0022858_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,-0.5283,0.97,0.99,-0.5604,0.95,1,-0.7219,0.8,0.99
"C3_TF_targets:C3_TFT_260_CGGAARNGGCNG_UNKNOWN","C3_TF_targets","C3_TFT_260_CGGAARNGGCNG_UNKNOWN",50,-0.5268,1,1,1.1441,0.23,0.9,0.8537,0.71,1
"GO_BP:516936_GO_0072017_DISTAL_TUBULE_DEVELOPMENT","GO_BP","516936_GO_0072017_DISTAL_TUBULE_DEVELOPMENT",11,-0.526,0.98,1,-0.8077,0.72,1,0.9932,0.48,0.86
"GO_BP:493334_GO_0009137_PURINE_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS","GO_BP","493334_GO_0009137_PURINE_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS",5,-0.5257,0.98,1,0.7442,0.78,1,-0.8322,0.66,0.97
"GO_BP:492301_GO_0007549_DOSAGE_COMPENSATION","GO_BP","492301_GO_0007549_DOSAGE_COMPENSATION",8,-0.5255,0.98,1,1.2018,0.24,0.78,0.47,1,1
"GO_MF:492591_GO_0008266_POLY_U_RNA_BINDING","GO_MF","492591_GO_0008266_POLY_U_RNA_BINDING",13,-0.5249,0.98,0.99,-0.5861,0.96,1,-1.0406,0.41,0.75
"GO_CC:757167_GO_0090545_CHD_TYPE_COMPLEX","GO_CC","757167_GO_0090545_CHD_TYPE_COMPLEX",18,-0.5248,0.99,1,-1.0148,0.44,0.84,-1.0405,0.41,0.99
"GO_BP:1026071_GO_1903299_REGULATION_OF_HEXOKINASE_ACTIVITY","GO_BP","1026071_GO_1903299_REGULATION_OF_HEXOKINASE_ACTIVITY",10,-0.5247,0.98,1,0.6898,0.85,1,0.7629,0.8,1
"GO_BP:510420_GO_0048313_GOLGI_INHERITANCE","GO_BP","510420_GO_0048313_GOLGI_INHERITANCE",9,-0.5242,0.99,1,0.694,0.85,1,0.7147,0.83,1
"GO_BP:755079_GO_2000973_REGULATION_OF_PRO_B_CELL_DIFFERENTIATION","GO_BP","755079_GO_2000973_REGULATION_OF_PRO_B_CELL_DIFFERENTIATION",5,-0.5241,0.97,1,-1.0909,0.38,0.95,1.2727,0.2,0.69
"GO_MF:490200_GO_0004904_INTERFERON_RECEPTOR_ACTIVITY","GO_MF","490200_GO_0004904_INTERFERON_RECEPTOR_ACTIVITY",5,-0.5241,0.97,0.99,1.2209,0.24,0.71,1.4325,0.096,0.52
"GO_BP:504453_GO_0035269_PROTEIN_O_LINKED_MANNOSYLATION","GO_BP","504453_GO_0035269_PROTEIN_O_LINKED_MANNOSYLATION",14,-0.522,0.98,1,-0.6593,0.89,1,-0.8432,0.66,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2233_BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1","C2_Chemical_and_genetic_perturbations","C2_CGP_2233_BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1",12,-0.5205,0.98,1,1.7133,0.016,0.075,1.0103,0.43,0.96
"GO_BP:516094_GO_0071168_PROTEIN_LOCALIZATION_TO_CHROMATIN","GO_BP","516094_GO_0071168_PROTEIN_LOCALIZATION_TO_CHROMATIN",11,-0.5203,0.98,1,1.1117,0.32,0.89,-1.2129,0.23,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1189_COLLIS_PRKDC_REGULATORS","C2_Chemical_and_genetic_perturbations","C2_CGP_1189_COLLIS_PRKDC_REGULATORS",15,-0.5201,0.98,1,1.6498,0.03,0.11,-0.6716,0.9,0.99
"GO_BP:491099_GO_0022904_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN","GO_BP","491099_GO_0022904_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN",107,-0.5197,1,1,2.6379,0,0,0.5993,1,1
"GO_BP:754624_GO_1901673_REGULATION_OF_MITOTIC_SPINDLE_ASSEMBLY","GO_BP","754624_GO_1901673_REGULATION_OF_MITOTIC_SPINDLE_ASSEMBLY",13,-0.5192,0.98,1,1.1144,0.31,0.88,0.7449,0.8,1
"GO_BP:495984_GO_0015860_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT","GO_BP","495984_GO_0015860_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT",6,-0.5192,0.96,1,-0.9109,0.56,1,-1.4735,0.066,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_609_TURJANSKI_MAPK8_AND_MAPK9_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_609_TURJANSKI_MAPK8_AND_MAPK9_TARGETS",8,-0.5189,0.98,1,-1.2365,0.22,0.76,-1.2396,0.23,0.48
"GO_CC:496529_GO_0016581_NURD_COMPLEX","GO_CC","496529_GO_0016581_NURD_COMPLEX",18,-0.5181,0.99,1,-1.0173,0.43,0.84,-1.0208,0.4,1
"GO_BP:493387_GO_0009191_RIBONUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS","GO_BP","493387_GO_0009191_RIBONUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS",7,-0.5172,0.97,1,0.6515,0.89,1,-0.7897,0.73,0.99
"GO_CC:503253_GO_0034045_PRE_AUTOPHAGOSOMAL_STRUCTURE_MEMBRANE","GO_CC","503253_GO_0034045_PRE_AUTOPHAGOSOMAL_STRUCTURE_MEMBRANE",15,-0.5171,0.99,1,0.8748,0.63,0.91,0.3938,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_108_MORF_GNB1","C4_Cancer_gene_neighborhoods","C4_CGN_108_MORF_GNB1",305,-0.5167,1,1,2.1057,0,0.00013,-1.0723,0.25,0.67
"GO_BP:751442_GO_0039535_REGULATION_OF_RIG_I_SIGNALING_PATHWAY","GO_BP","751442_GO_0039535_REGULATION_OF_RIG_I_SIGNALING_PATHWAY",10,-0.5153,0.98,1,0.8516,0.66,1,-1.4405,0.081,0.56
"GO_BP:501175_GO_0031935_REGULATION_OF_CHROMATIN_SILENCING","GO_BP","501175_GO_0031935_REGULATION_OF_CHROMATIN_SILENCING",15,-0.5149,0.99,1,0.7859,0.78,1,-0.7174,0.84,0.99
"REACTOME:477131_REACT_111059_REGULATION_OF_SIGNALING_BY_NODAL","REACTOME","477131_REACT_111059_REGULATION_OF_SIGNALING_BY_NODAL",8,-0.514,0.98,1,-0.7525,0.77,1,-0.6882,0.84,1
"GO_CC:498684_GO_0019908_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX","GO_CC","498684_GO_0019908_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX",9,-0.5136,0.97,1,0.7004,0.83,0.99,-0.8829,0.61,1
"GO_MF:489749_GO_0004383_GUANYLATE_CYCLASE_ACTIVITY","GO_MF","489749_GO_0004383_GUANYLATE_CYCLASE_ACTIVITY",8,-0.5133,0.98,1,1.0995,0.33,0.79,-1.6496,0.019,0.33
"KEGG_pathway:HSA03450_NON_HOMOLOGOUS_END_JOINING","KEGG_pathway","HSA03450_NON_HOMOLOGOUS_END_JOINING",13,-0.5133,0.99,1,1.2523,0.16,0.48,-1.0155,0.42,0.66
"KEGG_compound:C01179_3_4_HYDROXYPHENYL_PYRUVATE_4_HYDROXYPHENYLPYRUVATE_P_HYDROXYPHENYLPYRUVIC_ACID","KEGG_compound","C01179_3_4_HYDROXYPHENYL_PYRUVATE_4_HYDROXYPHENYLPYRUVATE_P_HYDROXYPHENYLPYRUVIC_ACID",6,-0.5128,0.98,1,-0.9759,0.48,1,1.1062,0.36,0.65
"KEGG_compound:C00166_PHENYLPYRUVATE_PHENYLPYRUVIC_ACID_ALPHA_KETOHYDROCINNAMIC_ACID_KETO_PHENYLPYRUVATE_3_PHENYL_2_OXOPROPANOATE_2_OXO_3_PHENYLPROPANOATE","KEGG_compound","C00166_PHENYLPYRUVATE_PHENYLPYRUVIC_ACID_ALPHA_KETOHYDROCINNAMIC_ACID_KETO_PHENYLPYRUVATE_3_PHENYL_2_OXOPROPANOATE_2_OXO_3_PHENYLPROPANOATE",6,-0.5126,0.97,1,-0.9484,0.54,1,1.0942,0.35,0.65
"KEGG_compound:C00104_IDP_INOSINE_5_DIPHOSPHATE_INOSINE_DIPHOSPHATE","KEGG_compound","C00104_IDP_INOSINE_5_DIPHOSPHATE_INOSINE_DIPHOSPHATE",26,-0.5125,0.99,1,0.525,1,1,-1.2954,0.11,0.36
"C4_Cancer_gene_neighborhoods:C4_CGN_79_MORF_CSNK2B","C4_Cancer_gene_neighborhoods","C4_CGN_79_MORF_CSNK2B",288,-0.5123,1,1,2.3606,0,0,-0.9705,0.57,0.91
"GO_BP:516686_GO_0071763_NUCLEAR_MEMBRANE_ORGANIZATION","GO_BP","516686_GO_0071763_NUCLEAR_MEMBRANE_ORGANIZATION",6,-0.5119,0.98,1,0.4087,1,1,-0.4592,0.99,1
"GO_CC:490854_GO_0005832_CHAPERONIN_CONTAINING_T_COMPLEX","GO_CC","490854_GO_0005832_CHAPERONIN_CONTAINING_T_COMPLEX",9,-0.5117,0.98,1,1.7651,0.017,0.035,-1.1778,0.26,0.83
"GO_BP:507690_GO_0045333_CELLULAR_RESPIRATION","GO_BP","507690_GO_0045333_CELLULAR_RESPIRATION",154,-0.5113,1,1,2.4407,0,0,-0.6629,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_170_MORF_RAN","C4_Cancer_gene_neighborhoods","C4_CGN_170_MORF_RAN",269,-0.5111,1,1,2.849,0,0,-0.9227,0.74,1
"WikiPathways:198870_WP623_OXIDATIVE_PHOSPHORYLATION","WikiPathways","198870_WP623_OXIDATIVE_PHOSPHORYLATION",53,-0.5105,1,1,2.617,0,0,0.9192,0.58,1
"GO_CC:490852_GO_0005828_KINETOCHORE_MICROTUBULE","GO_CC","490852_GO_0005828_KINETOCHORE_MICROTUBULE",6,-0.5102,0.98,1,-0.5044,0.98,1,-1.0184,0.43,1
"GO_BP:518699_GO_2000050_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY","GO_BP","518699_GO_2000050_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY",15,-0.51,0.99,1,0.6594,0.91,1,-1.1722,0.25,0.74
"GO_BP:514857_GO_0061312_BMP_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","514857_GO_0061312_BMP_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",5,-0.5098,0.99,1,-0.647,0.87,1,0.7158,0.83,1
"GO_BP:512446_GO_0051568_HISTONE_H3_K4_METHYLATION","GO_BP","512446_GO_0051568_HISTONE_H3_K4_METHYLATION",28,-0.5081,1,1,0.5587,0.99,1,-1.0087,0.44,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_688_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6","C2_Chemical_and_genetic_perturbations","C2_CGP_688_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6",5,-0.5075,0.98,1,-0.5929,0.93,1,-1.1584,0.31,0.57
"GO_BP:514099_GO_0060544_REGULATION_OF_NECROPTOTIC_PROCESS","GO_BP","514099_GO_0060544_REGULATION_OF_NECROPTOTIC_PROCESS",12,-0.5071,0.99,1,-0.7793,0.76,1,-0.6526,0.9,1
"GO_BP:499731_GO_0030330_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR","GO_BP","499731_GO_0030330_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",89,-0.507,1,1,1.6476,0.0023,0.24,-1.0664,0.3,0.8
"GO_CC:862183_GO_0044798_NUCLEAR_TRANSCRIPTION_FACTOR_COMPLEX","GO_CC","862183_GO_0044798_NUCLEAR_TRANSCRIPTION_FACTOR_COMPLEX",104,-0.5066,1,1,0.9556,0.55,0.83,0.7245,0.97,1
"GO_BP:494522_GO_0010452_HISTONE_H3_K36_METHYLATION","GO_BP","494522_GO_0010452_HISTONE_H3_K36_METHYLATION",6,-0.505,0.99,1,-0.6575,0.87,1,-0.4934,0.98,1
"GO_BP:491459_GO_0006563_L_SERINE_METABOLIC_PROCESS","GO_BP","491459_GO_0006563_L_SERINE_METABOLIC_PROCESS",8,-0.5048,0.99,1,0.8619,0.64,1,1.2212,0.24,0.71
"GO_CC:490704_GO_0005638_LAMIN_FILAMENT","GO_CC","490704_GO_0005638_LAMIN_FILAMENT",5,-0.5047,0.98,1,-1.0225,0.45,0.84,0.8578,0.63,1
"GO_BP:491761_GO_0006901_VESICLE_COATING","GO_BP","491761_GO_0006901_VESICLE_COATING",39,-0.5045,1,1,1.739,0.002,0.15,0.7004,0.92,1
"GO_BP:519316_GO_2000677_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING","GO_BP","519316_GO_2000677_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING",26,-0.5041,1,1,1.4801,0.048,0.44,1.1654,0.23,0.73
"GO_BP:486593_GO_0000045_AUTOPHAGIC_VACUOLE_ASSEMBLY","GO_BP","486593_GO_0000045_AUTOPHAGIC_VACUOLE_ASSEMBLY",45,-0.504,1,1,1.0618,0.34,0.94,0.6521,0.98,1
"GO_BP:491505_GO_0006611_PROTEIN_EXPORT_FROM_NUCLEUS","GO_BP","491505_GO_0006611_PROTEIN_EXPORT_FROM_NUCLEUS",27,-0.5038,1,1,0.6974,0.91,1,-0.8459,0.71,0.96
"C4_Cancer_gene_neighborhoods:C4_CGN_214_GCM_CBFB","C4_Cancer_gene_neighborhoods","C4_CGN_214_GCM_CBFB",70,-0.5037,1,1,1.9218,0,0.00068,-1.1329,0.24,0.55
"GO_BP:491139_GO_0006167_AMP_BIOSYNTHETIC_PROCESS","GO_BP","491139_GO_0006167_AMP_BIOSYNTHETIC_PROCESS",6,-0.5033,0.98,1,1.0084,0.45,0.98,-1.3079,0.15,0.64
"GO_BP:493331_GO_0009134_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS","GO_BP","493331_GO_0009134_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS",8,-0.503,0.98,1,0.8509,0.63,1,-0.8703,0.63,0.95
"GO_CC:500564_GO_0031305_INTEGRAL_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE","GO_CC","500564_GO_0031305_INTEGRAL_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE",15,-0.5025,0.99,1,1.1769,0.24,0.55,0.6127,0.94,1
"GO_BP:495939_GO_0015808_L_ALANINE_TRANSPORT","GO_BP","495939_GO_0015808_L_ALANINE_TRANSPORT",7,-0.5006,0.99,1,-0.4752,1,1,-0.5803,0.93,1
"GO_BP:514007_GO_0060452_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION","GO_BP","514007_GO_0060452_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION",7,-0.5002,0.99,1,-0.9188,0.56,1,0.7775,0.76,1
"GO_BP:491107_GO_0022900_ELECTRON_TRANSPORT_CHAIN","GO_BP","491107_GO_0022900_ELECTRON_TRANSPORT_CHAIN",109,-0.4999,1,1,2.6387,0,0,0.5839,1,1
"GO_BP:1022189_GO_1903203_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_DEATH","GO_BP","1022189_GO_1903203_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_DEATH",9,-0.4994,0.99,1,1.6624,0.02,0.23,0.8206,0.71,0.99
"GO_BP:489099_GO_0003307_REGULATION_OF_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","489099_GO_0003307_REGULATION_OF_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",8,-0.4983,0.99,1,-0.7048,0.81,1,-0.9299,0.52,0.9
"GO_MF:512307_GO_0051429_CORTICOTROPIN_RELEASING_HORMONE_RECEPTOR_BINDING","GO_MF","512307_GO_0051429_CORTICOTROPIN_RELEASING_HORMONE_RECEPTOR_BINDING",5,-0.498,0.98,1,-1.3446,0.13,0.7,-1.5071,0.039,0.42
"GO_BP:512814_GO_0051964_NEGATIVE_REGULATION_OF_SYNAPSE_ASSEMBLY","GO_BP","512814_GO_0051964_NEGATIVE_REGULATION_OF_SYNAPSE_ASSEMBLY",5,-0.4976,0.97,1,0.9119,0.58,1,1.4389,0.077,0.6
"KEGG_compound:C01042_N_ACETYL_L_ASPARTATE_N_ACETYL_L_ASPARTIC_ACID","KEGG_compound","C01042_N_ACETYL_L_ASPARTATE_N_ACETYL_L_ASPARTIC_ACID",5,-0.4972,0.99,1,-0.8847,0.61,1,1.2505,0.21,0.49
"GO_BP:497954_GO_0019076_VIRAL_RELEASE_FROM_HOST_CELL","GO_BP","497954_GO_0019076_VIRAL_RELEASE_FROM_HOST_CELL",6,-0.4963,0.99,1,1.3876,0.15,0.57,-0.5132,0.98,1
"GO_CC:515008_GO_0070069_CYTOCHROME_COMPLEX","GO_CC","515008_GO_0070069_CYTOCHROME_COMPLEX",13,-0.4945,0.99,1,1.6188,0.025,0.1,0.5398,0.96,1
"REACTOME:106330_REACT_13673_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS","REACTOME","106330_REACT_13673_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS",5,-0.4944,0.98,1,-0.5485,0.95,1,-0.6797,0.85,1
"GO_BP:498710_GO_0048016_INOSITOL_PHOSPHATE_MEDIATED_SIGNALING","GO_BP","498710_GO_0048016_INOSITOL_PHOSPHATE_MEDIATED_SIGNALING",13,-0.4934,0.99,1,-0.9575,0.5,1,0.8233,0.73,1
"GO_BP:946559_GO_0098902_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL","GO_BP","946559_GO_0098902_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL",5,-0.4932,0.99,1,0.8904,0.6,1,-1.3252,0.18,0.63
"REACTOME:106260_REACT_11167_METABOLISM_OF_FOLATE_AND_PTERINES","REACTOME","106260_REACT_11167_METABOLISM_OF_FOLATE_AND_PTERINES",9,-0.4925,0.98,1,-0.7843,0.73,1,-1.2688,0.19,0.55
"GO_BP:499646_GO_0030240_SKELETAL_MUSCLE_THIN_FILAMENT_ASSEMBLY","GO_BP","499646_GO_0030240_SKELETAL_MUSCLE_THIN_FILAMENT_ASSEMBLY",5,-0.4917,0.99,1,-1.3977,0.09,1,0.7683,0.74,1
"KEGG_pathway:HSA00604_GLYCOSPHINGOLIPID_BIOSYNTHESIS","KEGG_pathway","HSA00604_GLYCOSPHINGOLIPID_BIOSYNTHESIS",15,-0.4907,0.99,1,0.6591,0.91,1,0.6889,0.89,1
"C1_Positional:C1_ALL_60_CHRXQ12","C1_Positional","C1_ALL_60_CHRXQ12",15,-0.4896,0.99,1,-0.971,0.48,1,-1.2865,0.16,0.51
"GO_CC:500563_GO_0031304_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE","GO_CC","500563_GO_0031304_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE",16,-0.4889,0.99,1,1.149,0.27,0.59,0.5392,0.98,1
"REACTOME:105991_REACT_6918_INTEGRATION_OF_PROVIRUS","REACTOME","105991_REACT_6918_INTEGRATION_OF_PROVIRUS",9,-0.4885,1,1,1.242,0.22,0.4,-0.6943,0.86,1
"KEGG_compound:C00144_GMP_GUANOSINE_5_PHOSPHATE_GUANOSINE_MONOPHOSPHATE_GUANOSINE_5_MONOPHOSPHATE_GUANYLIC_ACID","KEGG_compound","C00144_GMP_GUANOSINE_5_PHOSPHATE_GUANOSINE_MONOPHOSPHATE_GUANOSINE_5_MONOPHOSPHATE_GUANYLIC_ACID",40,-0.4812,1,1,0.8055,0.81,1,-1.148,0.24,0.51
"GO_BP:494244_GO_0010165_RESPONSE_TO_X_RAY","GO_BP","494244_GO_0010165_RESPONSE_TO_X_RAY",25,-0.4799,0.99,1,0.703,0.9,1,-1.0003,0.45,0.85
"GO_BP:517311_GO_0072395_SIGNAL_TRANSDUCTION_INVOLVED_IN_CELL_CYCLE_CHECKPOINT","GO_BP","517311_GO_0072395_SIGNAL_TRANSDUCTION_INVOLVED_IN_CELL_CYCLE_CHECKPOINT",71,-0.4797,1,1,1.6876,0.0044,0.21,-1.0994,0.28,0.78
"GO_BP:751220_GO_0036302_ATRIOVENTRICULAR_CANAL_DEVELOPMENT","GO_BP","751220_GO_0036302_ATRIOVENTRICULAR_CANAL_DEVELOPMENT",7,-0.4796,0.99,1,0.9436,0.5,1,1.6736,0.012,0.4
"GO_BP:505464_GO_0042320_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_REM_SLEEP","GO_BP","505464_GO_0042320_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_REM_SLEEP",6,-0.4795,0.99,1,1.7678,0.0084,0.13,0.9275,0.54,0.92
"GO_BP:487782_GO_0001886_ENDOTHELIAL_CELL_MORPHOGENESIS","GO_BP","487782_GO_0001886_ENDOTHELIAL_CELL_MORPHOGENESIS",11,-0.4793,1,1,-1.2958,0.16,0.88,1.1913,0.25,0.72
"REACTOME:105993_REACT_9058_2_LTR_CIRCLE_FORMATION","REACTOME","105993_REACT_9058_2_LTR_CIRCLE_FORMATION",7,-0.4783,0.99,1,1.225,0.24,0.42,-0.6024,0.93,1
"KEGG_compound:C00387_GUANOSINE","KEGG_compound","C00387_GUANOSINE",10,-0.4777,1,1,0.4823,1,1,-1.1271,0.31,0.52
"GO_MF:512415_GO_0051537_2_IRON_2_SULFUR_CLUSTER_BINDING","GO_MF","512415_GO_0051537_2_IRON_2_SULFUR_CLUSTER_BINDING",19,-0.4775,1,1,2.0766,0,0.0064,0.917,0.56,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_1418_RADAEVA_RESPONSE_TO_IFNA1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1418_RADAEVA_RESPONSE_TO_IFNA1_DN",10,-0.4771,0.99,1,1.0323,0.39,0.75,1.0356,0.41,0.93
"GO_MF:496590_GO_0016653_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_HEME_PROTEIN_AS_ACCEPTOR","GO_MF","496590_GO_0016653_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_HEME_PROTEIN_AS_ACCEPTOR",12,-0.4764,0.99,1,-0.9818,0.47,0.93,0.5954,0.94,1
"OMIM_gene:OMIM605734_TRANSMEMBRANE_PROTEIN_WITH_EGF_LIKE_AND_2_FOLLISTATIN_LIKE_DOMAINS_2_TMEFF2","OMIM_gene","OMIM605734_TRANSMEMBRANE_PROTEIN_WITH_EGF_LIKE_AND_2_FOLLISTATIN_LIKE_DOMAINS_2_TMEFF2",7,-0.4739,0.98,1,1.3334,0.12,0.77,1.44,0.1,1
"GO_BP:492031_GO_0007250_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY","GO_BP","492031_GO_0007250_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY",19,-0.4734,0.99,1,1.6397,0.016,0.25,1.2683,0.17,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_71_ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_71_ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN",70,-0.4724,1,1,1.3425,0.068,0.35,-1.4297,0.023,0.33
"GO_BP:506683_GO_0043653_MITOCHONDRIAL_FRAGMENTATION_INVOLVED_IN_APOPTOTIC_PROCESS","GO_BP","506683_GO_0043653_MITOCHONDRIAL_FRAGMENTATION_INVOLVED_IN_APOPTOTIC_PROCESS",9,-0.4717,0.99,1,-0.5025,1,1,-0.9676,0.48,0.88
"KEGG_compound:C00235_DIMETHYLALLYL_DIPHOSPHATE_2_ISOPENTENYL_DIPHOSPHATE_DELTA2_ISOPENTENYL_DIPHOSPHATE_DIMETHYLALLYL_PYROPHOSPHATE_DMAPP_MONOPRENYL_DIPHOSPHATE_PRENYL_DIPHOSPHATE","KEGG_compound","C00235_DIMETHYLALLYL_DIPHOSPHATE_2_ISOPENTENYL_DIPHOSPHATE_DELTA2_ISOPENTENYL_DIPHOSPHATE_DIMETHYLALLYL_PYROPHOSPHATE_DMAPP_MONOPRENYL_DIPHOSPHATE_PRENYL_DIPHOSPHATE",5,-0.4707,0.99,1,0.8953,0.59,1,-1.0074,0.46,0.64
"KEGG_compound:C01762_XANTHOSINE","KEGG_compound","C01762_XANTHOSINE",10,-0.4705,1,1,0.4806,1,1,-1.1421,0.26,0.51
"GO_BP:512521_GO_0051645_GOLGI_LOCALIZATION","GO_BP","512521_GO_0051645_GOLGI_LOCALIZATION",11,-0.4703,0.99,1,0.8632,0.63,1,-0.578,0.96,1
"GO_BP:1129419_GO_1903593_REGULATION_OF_HISTAMINE_SECRETION_BY_MAST_CELL","GO_BP","1129419_GO_1903593_REGULATION_OF_HISTAMINE_SECRETION_BY_MAST_CELL",6,-0.4672,0.99,1,1.6496,0.0083,0.25,0.56,0.96,1
"GO_BP:488900_GO_0003105_NEGATIVE_REGULATION_OF_GLOMERULAR_FILTRATION","GO_BP","488900_GO_0003105_NEGATIVE_REGULATION_OF_GLOMERULAR_FILTRATION",6,-0.4662,0.99,1,1.6035,0.035,0.29,1.1219,0.34,0.75
"GO_BP:508331_GO_0046034_ATP_METABOLIC_PROCESS","GO_BP","508331_GO_0046034_ATP_METABOLIC_PROCESS",108,-0.4662,1,1,2.1522,0,0.0015,0.7531,0.96,1
"REACTOME:106266_REACT_1776_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS","REACTOME","106266_REACT_1776_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS",11,-0.4652,1,1,0.6779,0.89,1,-0.8248,0.7,1
"GO_BP:508337_GO_0046040_IMP_METABOLIC_PROCESS","GO_BP","508337_GO_0046040_IMP_METABOLIC_PROCESS",14,-0.4626,0.99,1,0.7305,0.83,1,-0.592,0.95,1
"KEGG_compound:C00214_THYMIDINE_DEOXYTHYMIDINE","KEGG_compound","C00214_THYMIDINE_DEOXYTHYMIDINE",12,-0.4624,1,1,-0.4728,0.99,1,-0.9287,0.53,0.73
"GO_CC:496443_GO_0016471_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX","GO_CC","496443_GO_0016471_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX",11,-0.4621,1,1,-0.756,0.8,1,1.2957,0.16,0.72
"GO_BP:508315_GO_0046015_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE","GO_BP","508315_GO_0046015_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE",6,-0.462,0.99,1,-0.59,0.93,1,1.469,0.057,0.58
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_61_BIOCARTA_ETC_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_61_BIOCARTA_ETC_PATHWAY",11,-0.461,1,1,1.3205,0.16,0.55,-1.165,0.27,0.58
"GO_BP:518309_GO_0090169_REGULATION_OF_SPINDLE_ASSEMBLY","GO_BP","518309_GO_0090169_REGULATION_OF_SPINDLE_ASSEMBLY",15,-0.4594,0.99,1,1.2843,0.17,0.7,0.7918,0.78,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2716_BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2716_BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN",10,-0.4574,1,1,-1.0448,0.39,0.97,-1.1894,0.23,0.53
"C4_Cancer_gene_neighborhoods:C4_CGN_148_MORF_PPP2R4","C4_Cancer_gene_neighborhoods","C4_CGN_148_MORF_PPP2R4",51,-0.4569,1,1,1.9632,0,5e-04,-0.6241,0.99,1
"GO_MF:496799_GO_0046966_THYROID_HORMONE_RECEPTOR_BINDING","GO_MF","496799_GO_0046966_THYROID_HORMONE_RECEPTOR_BINDING",27,-0.4558,1,1,0.8419,0.72,1,0.5373,0.99,1
"GO_BP:496428_GO_0016445_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS","GO_BP","496428_GO_0016445_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS",28,-0.4479,1,1,0.8467,0.73,1,-1.2333,0.18,0.7
"WikiPathways:198863_WP712_ESTROGEN_SIGNALING_PATHWAY","WikiPathways","198863_WP712_ESTROGEN_SIGNALING_PATHWAY",19,-0.4459,1,1,-0.8347,0.7,1,-1.0448,0.4,0.63
"GO_MF:490020_GO_0004704_NF_KAPPAB_INDUCING_KINASE_ACTIVITY","GO_MF","490020_GO_0004704_NF_KAPPAB_INDUCING_KINASE_ACTIVITY",6,-0.4453,1,1,-0.6689,0.85,1,1.2574,0.21,0.66
"GO_BP:502366_GO_0033145_POSITIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","502366_GO_0033145_POSITIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY",11,-0.4451,1,1,1.1846,0.25,0.8,-0.9161,0.59,0.91
"GO_CC:510311_GO_0048188_SET1C_COMPASS_COMPLEX","GO_CC","510311_GO_0048188_SET1C_COMPASS_COMPLEX",9,-0.4442,1,1,0.6288,0.91,0.99,-0.9278,0.54,1
"GO_CC:502282_GO_0033061_DNA_RECOMBINASE_MEDIATOR_COMPLEX","GO_CC","502282_GO_0033061_DNA_RECOMBINASE_MEDIATOR_COMPLEX",7,-0.4432,0.99,1,-0.67,0.88,1,-0.981,0.46,1
"KEGG_compound:C03150_NICOTINAMIDE_BETA_RIBOSIDE_N_RIBOSYLNICOTINAMIDE_1_BETA_D_RIBOFURANOSYL_NICOTINAMIDE","KEGG_compound","C03150_NICOTINAMIDE_BETA_RIBOSIDE_N_RIBOSYLNICOTINAMIDE_1_BETA_D_RIBOFURANOSYL_NICOTINAMIDE",12,-0.4349,1,1,0.6677,0.91,1,-1.1363,0.31,0.51
"GO_CC:515750_GO_0070822_SIN3_TYPE_COMPLEX","GO_CC","515750_GO_0070822_SIN3_TYPE_COMPLEX",15,-0.4294,1,1,-0.6752,0.91,1,-1.2917,0.15,0.65
"REACTOME:105819_REACT_1932_MITOTIC_TELOPHASE_CYTOKINESIS","REACTOME","105819_REACT_1932_MITOTIC_TELOPHASE_CYTOKINESIS",14,-0.4261,1,1,1.0778,0.33,0.62,-1.1279,0.29,0.67
"KEGG_compound:C05841_NICOTINATE_D_RIBONUCLEOSIDE_BETA_D_RIBOSYLNICOTINATE","KEGG_compound","C05841_NICOTINATE_D_RIBONUCLEOSIDE_BETA_D_RIBOSYLNICOTINATE",12,-0.4237,1,1,0.6754,0.91,1,-1.0965,0.33,0.54
"GO_CC:515351_GO_0070419_NONHOMOLOGOUS_END_JOINING_COMPLEX","GO_CC","515351_GO_0070419_NONHOMOLOGOUS_END_JOINING_COMPLEX",7,-0.4214,1,1,1.0427,0.41,0.72,-0.9996,0.45,1
"GO_BP:486732_GO_0042787_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","486732_GO_0042787_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",58,-0.4168,1,1,-0.8893,0.69,1,-1.1543,0.2,0.73
"C4_Cancer_gene_neighborhoods:C4_CGN_302_GNF2_TDG","C4_Cancer_gene_neighborhoods","C4_CGN_302_GNF2_TDG",35,-0.4156,1,1,0.9373,0.57,0.74,-1.104,0.31,0.62
"GO_BP:519254_GO_2000615_REGULATION_OF_HISTONE_H3_K9_ACETYLATION","GO_BP","519254_GO_2000615_REGULATION_OF_HISTONE_H3_K9_ACETYLATION",7,-0.4127,1,1,-1.0598,0.4,0.96,-1.4109,0.091,0.57
"GO_MF:489883_GO_0004535_POLY_A_SPECIFIC_RIBONUCLEASE_ACTIVITY","GO_MF","489883_GO_0004535_POLY_A_SPECIFIC_RIBONUCLEASE_ACTIVITY",11,-0.4078,1,1,0.797,0.73,1,-1.2599,0.19,0.58
"GO_BP:496800_GO_0016925_PROTEIN_SUMOYLATION","GO_BP","496800_GO_0016925_PROTEIN_SUMOYLATION",27,-0.4043,1,1,1.0942,0.32,0.91,-0.7899,0.84,0.99
"GO_MF:496776_GO_0016889_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS","GO_MF","496776_GO_0016889_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS",9,-0.4042,1,1,1.2223,0.21,0.71,1.4057,0.092,0.51
"KEGG_compound:C00081_ITP_INOSINE_5_TRIPHOSPHATE_INOSINE_TRIPHOSPHATE_INOSINE_TRIPOLYPHOSPHATE","KEGG_compound","C00081_ITP_INOSINE_5_TRIPHOSPHATE_INOSINE_TRIPHOSPHATE_INOSINE_TRIPOLYPHOSPHATE",22,-0.4041,1,1,0.7419,0.83,1,-1.4825,0.044,0.23
"WikiPathways:198895_WP438_NON_HOMOLOGOUS_END_JOINING","WikiPathways","198895_WP438_NON_HOMOLOGOUS_END_JOINING",6,-0.4023,1,1,1.1635,0.28,0.93,-1.4129,0.11,0.4
"GO_BP:513817_GO_0060261_POSITIVE_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER","GO_BP","513817_GO_0060261_POSITIVE_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER",10,-0.3997,1,1,-0.758,0.76,1,-0.596,0.95,1
"GO_BP:516396_GO_0071472_CELLULAR_RESPONSE_TO_SALT_STRESS","GO_BP","516396_GO_0071472_CELLULAR_RESPONSE_TO_SALT_STRESS",5,-0.3959,1,1,0.997,0.46,0.98,-1.005,0.48,0.84
"GO_BP:496180_GO_0045722_POSITIVE_REGULATION_OF_GLUCONEOGENESIS","GO_BP","496180_GO_0045722_POSITIVE_REGULATION_OF_GLUCONEOGENESIS",12,-0.3899,1,1,0.7296,0.83,1,-0.4974,0.99,1
"GO_CC:983705_GO_0098644_COMPLEX_OF_COLLAGEN_TRIMERS","GO_CC","983705_GO_0098644_COMPLEX_OF_COLLAGEN_TRIMERS",11,-0.3822,1,1,-0.9045,0.59,0.96,0.8579,0.65,1
"OMIM_gene:OMIM601592_RECEPTOR_ASSOCIATED_PROTEIN_OF_THE_SYNAPSE_43_KD_RAPSN","OMIM_gene","OMIM601592_RECEPTOR_ASSOCIATED_PROTEIN_OF_THE_SYNAPSE_43_KD_RAPSN",5,-0.377,1,1,-0.7231,0.8,0.95,0.8592,0.64,1
"C3_MicroRNA_targets:C3_MIR_115_AACGGTT_MIR_451","C3_MicroRNA_targets","C3_MIR_115_AACGGTT_MIR_451",12,-0.3231,1,1,-0.669,0.9,1,0.5175,0.99,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_195_BIOCARTA_TGFB_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_195_BIOCARTA_TGFB_PATHWAY",19,0.3898,1,1,-0.8012,0.75,1,0.7409,0.84,1
"GO_MF:489577_GO_0004112_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY","GO_MF","489577_GO_0004112_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY",25,0.4161,1,1,-1.2359,0.17,0.84,-1.1731,0.24,0.61
"GO_CC:516720_GO_0071797_LUBAC_COMPLEX","GO_CC","516720_GO_0071797_LUBAC_COMPLEX",5,0.4189,0.99,1,-0.7483,0.77,1,-1.0364,0.4,0.98
"GO_CC:490868_GO_0005852_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX","GO_CC","490868_GO_0005852_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX",16,0.4213,1,1,2.1047,0,0.00054,0.6885,0.89,1
"GO_BP:512823_GO_0051973_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY","GO_BP","512823_GO_0051973_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY",7,0.4257,1,1,-0.834,0.64,1,-0.7355,0.78,1
"GO_BP:508613_GO_0046349_AMINO_SUGAR_BIOSYNTHETIC_PROCESS","GO_BP","508613_GO_0046349_AMINO_SUGAR_BIOSYNTHETIC_PROCESS",7,0.4258,1,1,-0.9997,0.45,0.99,0.6178,0.92,1
"GO_BP:502069_GO_0032847_REGULATION_OF_CELLULAR_PH_REDUCTION","GO_BP","502069_GO_0032847_REGULATION_OF_CELLULAR_PH_REDUCTION",6,0.4261,1,1,-0.6912,0.83,1,-1.661,0.022,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1672_SESTO_RESPONSE_TO_UV_C4","C2_Chemical_and_genetic_perturbations","C2_CGP_1672_SESTO_RESPONSE_TO_UV_C4",19,0.4268,1,1,0.7723,0.79,1,1.3889,0.078,0.55
"GO_BP:491750_GO_0006890_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ER","GO_BP","491750_GO_0006890_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ER",33,0.4331,1,1,0.9307,0.57,1,-0.737,0.9,1
"GO_BP:496430_GO_0016447_SOMATIC_RECOMBINATION_OF_IMMUNOGLOBULIN_GENE_SEGMENTS","GO_BP","496430_GO_0016447_SOMATIC_RECOMBINATION_OF_IMMUNOGLOBULIN_GENE_SEGMENTS",23,0.4475,1,1,0.7454,0.84,1,-1.2155,0.21,0.72
"GO_BP:515103_GO_0070166_ENAMEL_MINERALIZATION","GO_BP","515103_GO_0070166_ENAMEL_MINERALIZATION",7,0.4542,1,1,-1.0343,0.42,0.98,1.1917,0.27,0.72
"GO_BP:493482_GO_0009298_GDP_MANNOSE_BIOSYNTHETIC_PROCESS","GO_BP","493482_GO_0009298_GDP_MANNOSE_BIOSYNTHETIC_PROCESS",5,0.4543,0.99,1,1.1059,0.33,0.9,-0.8404,0.66,0.96
"REACTOME:161018_REACT_22423_SYNTHESIS_OF_GDP_MANNOSE","REACTOME","161018_REACT_22423_SYNTHESIS_OF_GDP_MANNOSE",5,0.4579,1,1,1.1177,0.35,0.56,-0.8253,0.69,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1374_KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1374_KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP",12,0.4586,0.99,1,1.249,0.21,0.44,0.8514,0.66,1
"KEGG_compound:C00881_DEOXYCYTIDINE_2_DEOXYCYTIDINE","KEGG_compound","C00881_DEOXYCYTIDINE_2_DEOXYCYTIDINE",12,0.4604,0.99,1,0.6169,0.94,1,-0.9211,0.56,0.74
"GO_BP:491757_GO_0006896_GOLGI_TO_VACUOLE_TRANSPORT","GO_BP","491757_GO_0006896_GOLGI_TO_VACUOLE_TRANSPORT",8,0.462,1,1,0.9477,0.53,1,0.4917,0.99,1
"GO_MF:510202_GO_0048038_QUINONE_BINDING","GO_MF","510202_GO_0048038_QUINONE_BINDING",17,0.4622,1,1,0.8004,0.73,1,0.5209,0.99,1
"GO_MF:489579_GO_0004114_3_5_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY","GO_MF","489579_GO_0004114_3_5_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY",24,0.4668,1,1,-1.1391,0.28,0.81,-1.2153,0.2,0.57
"C4_Cancer_gene_neighborhoods:C4_CGN_259_GCM_RAF1","C4_Cancer_gene_neighborhoods","C4_CGN_259_GCM_RAF1",43,0.4698,1,1,1.0739,0.33,0.42,-0.8012,0.83,1
"C4_Cancer_modules:C4_CM_141_MODULE_149","C4_Cancer_modules","C4_CM_141_MODULE_149",37,0.4719,1,1,2.4203,0,0,0.687,0.94,1
"GO_BP:487629_GO_0001731_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX","GO_BP","487629_GO_0001731_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX",18,0.4771,0.99,1,2.1557,0,0.0014,0.727,0.84,1
"GO_BP:491266_GO_0006307_DNA_DEALKYLATION_INVOLVED_IN_DNA_REPAIR","GO_BP","491266_GO_0006307_DNA_DEALKYLATION_INVOLVED_IN_DNA_REPAIR",7,0.4771,0.99,1,1.1012,0.34,0.9,-1.1894,0.26,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_725_JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_725_JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER",40,0.4773,1,1,1.2925,0.11,0.4,-0.7018,0.96,0.99
"GO_BP:512447_GO_0051569_REGULATION_OF_HISTONE_H3_K4_METHYLATION","GO_BP","512447_GO_0051569_REGULATION_OF_HISTONE_H3_K4_METHYLATION",21,0.4777,1,1,0.7856,0.76,1,-0.9999,0.46,0.85
"GO_MF:515025_GO_0070087_CHROMO_SHADOW_DOMAIN_BINDING","GO_MF","515025_GO_0070087_CHROMO_SHADOW_DOMAIN_BINDING",6,0.4818,0.99,1,-0.6495,0.88,1,-0.9568,0.52,0.82
"GO_MF:489474_GO_0004003_ATP_DEPENDENT_DNA_HELICASE_ACTIVITY","GO_MF","489474_GO_0004003_ATP_DEPENDENT_DNA_HELICASE_ACTIVITY",33,0.4822,1,1,-0.6325,0.97,1,-1.2199,0.18,0.57
"REACTOME:105692_REACT_962_MEK_ACTIVATION","REACTOME","105692_REACT_962_MEK_ACTIVATION",7,0.4856,0.99,1,1.1679,0.28,0.48,0.8247,0.69,1
"GO_CC:496528_GO_0016580_SIN3_COMPLEX","GO_CC","496528_GO_0016580_SIN3_COMPLEX",13,0.4951,0.99,1,0.4779,1,1,-1.4376,0.073,0.51
"GO_BP:515770_GO_0070842_AGGRESOME_ASSEMBLY","GO_BP","515770_GO_0070842_AGGRESOME_ASSEMBLY",5,0.4975,0.99,1,-0.7188,0.79,1,-1.0459,0.45,0.82
"WikiPathways:198761_WP1434_OSTEOPONTIN_SIGNALING","WikiPathways","198761_WP1434_OSTEOPONTIN_SIGNALING",11,0.498,1,1,0.5954,0.95,1,1.3188,0.13,0.49
"GO_BP:505775_GO_0042661_REGULATION_OF_MESODERMAL_CELL_FATE_SPECIFICATION","GO_BP","505775_GO_0042661_REGULATION_OF_MESODERMAL_CELL_FATE_SPECIFICATION",7,0.5004,0.99,1,0.8403,0.68,1,1.47,0.087,0.58
"GO_CC:494564_GO_0010494_CYTOPLASMIC_STRESS_GRANULE","GO_CC","494564_GO_0010494_CYTOPLASMIC_STRESS_GRANULE",31,0.5006,1,1,1.2555,0.14,0.45,-0.9031,0.61,1
"C4_Cancer_gene_neighborhoods:C4_CGN_7_MORF_BECN1","C4_Cancer_gene_neighborhoods","C4_CGN_7_MORF_BECN1",102,0.502,1,1,1.7806,0,0.0029,0.803,0.9,1
"GO_BP:511661_GO_0050689_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST","GO_BP","511661_GO_0050689_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST",5,0.5031,0.99,1,0.963,0.5,1,0.7465,0.75,1
"GO_BP:512412_GO_0051534_NEGATIVE_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","512412_GO_0051534_NEGATIVE_REGULATION_OF_NFAT_PROTEIN_IMPORT_INTO_NUCLEUS",5,0.5037,0.98,1,-0.9127,0.59,1,-0.8255,0.69,0.97
"REACTOME:105693_REACT_614_RAF_PHOSPHORYLATES_MEK","REACTOME","105693_REACT_614_RAF_PHOSPHORYLATES_MEK",7,0.5043,0.98,1,1.145,0.3,0.52,0.8095,0.74,1
"KEGG_compound:C04352__R_4_PHOSPHOPANTOTHENOYL_L_CYSTEINE_N_R_4_PHOSPHOPANTOTHENOYL_L_CYSTEINE","KEGG_compound","C04352__R_4_PHOSPHOPANTOTHENOYL_L_CYSTEINE_N_R_4_PHOSPHOPANTOTHENOYL_L_CYSTEINE",6,0.5047,0.99,1,-0.676,0.87,1,0.8079,0.7,0.88
"REACTOME:106008_REACT_6818_ASSEMBLY_OF_THE_HIV_VIRION","REACTOME","106008_REACT_6818_ASSEMBLY_OF_THE_HIV_VIRION",13,0.5058,0.99,1,1.7328,0.0041,0.037,-0.7585,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2458_MOOTHA_TCA","C2_Chemical_and_genetic_perturbations","C2_CGP_2458_MOOTHA_TCA",16,0.508,1,1,1.6576,0.024,0.11,-1.4191,0.073,0.34
"REACTOME:106163_REACT_11208_GOLGI_TO_ER_RETROGRADE_TRANSPORT","REACTOME","106163_REACT_11208_GOLGI_TO_ER_RETROGRADE_TRANSPORT",11,0.5093,0.99,1,1.2301,0.21,0.42,0.8906,0.6,1
"GO_BP:515769_GO_0070841_INCLUSION_BODY_ASSEMBLY","GO_BP","515769_GO_0070841_INCLUSION_BODY_ASSEMBLY",6,0.5145,0.99,1,0.6668,0.87,1,-1.0165,0.43,0.83
"GO_BP:508365_GO_0046069_CGMP_CATABOLIC_PROCESS","GO_BP","508365_GO_0046069_CGMP_CATABOLIC_PROCESS",6,0.5151,0.98,1,-0.9835,0.47,1,1.4193,0.1,0.62
"GO_BP:488855_GO_0003057_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION_BY_CHEMICAL_SIGNAL","GO_BP","488855_GO_0003057_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION_BY_CHEMICAL_SIGNAL",7,0.5159,1,1,-0.5732,0.96,1,0.7926,0.73,1
"GO_BP:492864_GO_0008611_ETHER_LIPID_BIOSYNTHETIC_PROCESS","GO_BP","492864_GO_0008611_ETHER_LIPID_BIOSYNTHETIC_PROCESS",5,0.5165,0.98,1,0.9672,0.53,1,-1.126,0.36,0.75
"REACTOME:106164_REACT_11096_COPI_MEDIATED_TRANSPORT","REACTOME","106164_REACT_11096_COPI_MEDIATED_TRANSPORT",11,0.5177,0.99,1,1.2017,0.26,0.44,0.8986,0.58,1
"REACTOME:771597_REACT_160305_LOSS_OF_FUNCTION_OF_FBXW7_IN_CANCER_AND_NOTCH1_SIGNALING","REACTOME","771597_REACT_160305_LOSS_OF_FUNCTION_OF_FBXW7_IN_CANCER_AND_NOTCH1_SIGNALING",5,0.518,0.98,1,0.623,0.92,1,-1.0288,0.44,0.8
"GO_BP:494879_GO_0010815_BRADYKININ_CATABOLIC_PROCESS","GO_BP","494879_GO_0010815_BRADYKININ_CATABOLIC_PROCESS",5,0.5188,0.97,1,-0.6701,0.88,1,0.653,0.89,1
"GO_BP:486915_GO_0000422_MITOCHONDRION_DEGRADATION","GO_BP","486915_GO_0000422_MITOCHONDRION_DEGRADATION",36,0.5201,1,1,1.3048,0.1,0.66,-0.6635,0.97,1
"GO_MF:503913_GO_0034713_TYPE_I_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING","GO_MF","503913_GO_0034713_TYPE_I_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING",9,0.5206,0.99,1,-0.7601,0.77,1,0.8428,0.63,0.99
"GO_BP:487868_GO_0001978_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CAROTID_SINUS_BARORECEPTOR_FEEDBACK","GO_BP","487868_GO_0001978_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CAROTID_SINUS_BARORECEPTOR_FEEDBACK",6,0.522,0.98,1,-1.2781,0.21,0.89,1.2368,0.23,0.7
"WikiPathways:198890_WP186_HOMOLOGOUS_RECOMBINATION","WikiPathways","198890_WP186_HOMOLOGOUS_RECOMBINATION",14,0.5228,0.99,1,0.6119,0.93,1,-0.785,0.75,0.96
"GO_BP:494218_GO_0010138_PYRIMIDINE_RIBONUCLEOTIDE_SALVAGE","GO_BP","494218_GO_0010138_PYRIMIDINE_RIBONUCLEOTIDE_SALVAGE",5,0.5232,0.97,1,-0.6951,0.85,1,0.7931,0.72,1
"GO_BP:752883_GO_0097384_CELLULAR_LIPID_BIOSYNTHETIC_PROCESS","GO_BP","752883_GO_0097384_CELLULAR_LIPID_BIOSYNTHETIC_PROCESS",5,0.5236,0.98,1,1.0033,0.45,0.98,-1.1074,0.37,0.77
"GO_CC:501282_GO_0032045_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_COMPLEX","GO_CC","501282_GO_0032045_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_COMPLEX",7,0.5243,0.98,1,0.9993,0.46,0.79,-0.8321,0.65,1
"C4_Cancer_modules:C4_CM_110_MODULE_115","C4_Cancer_modules","C4_CM_110_MODULE_115",27,0.5246,1,1,2.2927,0,0,-0.5702,0.99,1
"GO_BP:491831_GO_0006995_CELLULAR_RESPONSE_TO_NITROGEN_STARVATION","GO_BP","491831_GO_0006995_CELLULAR_RESPONSE_TO_NITROGEN_STARVATION",19,0.5247,1,1,0.8933,0.62,1,0.6792,0.92,1
"REACTOME:771596_REACT_160099_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER","REACTOME","771596_REACT_160099_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER",5,0.5254,0.97,1,0.6286,0.91,1,-1.0132,0.45,0.82
"GO_BP:501497_GO_0032262_PYRIMIDINE_NUCLEOTIDE_SALVAGE","GO_BP","501497_GO_0032262_PYRIMIDINE_NUCLEOTIDE_SALVAGE",5,0.5265,0.99,1,-0.6919,0.85,1,0.802,0.72,1
"GO_BP:754463_GO_1901503_ETHER_BIOSYNTHETIC_PROCESS","GO_BP","754463_GO_1901503_ETHER_BIOSYNTHETIC_PROCESS",5,0.5272,0.99,1,0.9992,0.44,0.98,-1.1354,0.35,0.75
"OMIM_gene:OMIM300205_EMOPAMIL_BINDING_PROTEIN_EBP","OMIM_gene","OMIM300205_EMOPAMIL_BINDING_PROTEIN_EBP",5,0.5275,0.97,0.97,-0.5741,0.95,0.94,-1.1173,0.36,1
"GO_BP:502816_GO_0033600_NEGATIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION","GO_BP","502816_GO_0033600_NEGATIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION",5,0.5278,0.97,1,0.7544,0.77,1,-1.2018,0.29,0.73
"GO_MF:486580_GO_0000030_MANNOSYLTRANSFERASE_ACTIVITY","GO_MF","486580_GO_0000030_MANNOSYLTRANSFERASE_ACTIVITY",22,0.5293,1,1,1.1359,0.28,0.75,-1.0013,0.44,0.78
"GO_BP:508763_GO_0046504_GLYCEROL_ETHER_BIOSYNTHETIC_PROCESS","GO_BP","508763_GO_0046504_GLYCEROL_ETHER_BIOSYNTHETIC_PROCESS",5,0.5312,0.97,1,1.0002,0.45,0.98,-1.156,0.31,0.74
"GO_MF:518219_GO_0090079_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING","GO_MF","518219_GO_0090079_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING",17,0.5319,0.99,1,-1.0183,0.42,0.89,-0.9936,0.45,0.79
"GO_BP:507214_GO_0044206_UMP_SALVAGE","GO_BP","507214_GO_0044206_UMP_SALVAGE",5,0.5327,0.96,1,-0.6927,0.84,1,0.8129,0.68,1
"C1_Positional:C1_ALL_82_CHR12P","C1_Positional","C1_ALL_82_CHR12P",5,0.533,0.97,0.99,-1.4987,0.034,0.46,-1.3641,0.16,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_608_TURJANSKI_MAPK1_AND_MAPK2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_608_TURJANSKI_MAPK1_AND_MAPK2_TARGETS",12,0.5338,0.98,1,-0.4537,1,1,-0.6966,0.87,0.99
"KEGG_compound:C16633_5_FLUOROURIDINE","KEGG_compound","C16633_5_FLUOROURIDINE",5,0.534,0.95,1,-0.6915,0.83,1,0.8127,0.69,0.89
"OMIM_gene:OMIM605590_SPLICING_FACTOR_3B_SUBUNIT_1_SF3B1","OMIM_gene","OMIM605590_SPLICING_FACTOR_3B_SUBUNIT_1_SF3B1",5,0.5349,0.97,0.99,-1.0787,0.4,0.9,-1.1553,0.32,1
"GO_BP:519105_GO_2000465_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY","GO_BP","519105_GO_2000465_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY",8,0.535,0.98,1,-1.2087,0.23,0.88,0.7276,0.81,1
"GO_BP:515238_GO_0070305_RESPONSE_TO_CGMP","GO_BP","515238_GO_0070305_RESPONSE_TO_CGMP",7,0.536,0.96,1,-0.6528,0.87,1,0.7676,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1058_RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1058_RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN",15,0.5361,0.99,1,-0.8276,0.71,1,-1.2045,0.21,0.51
"REACTOME:1183550_REACT_188323_CLEC7A_DECTIN_1_SIGNALING","REACTOME","1183550_REACT_188323_CLEC7A_DECTIN_1_SIGNALING",100,0.5372,1,1,1.72,0,0.041,-0.8291,0.85,1
"GO_BP:517078_GO_0072162_METANEPHRIC_MESENCHYMAL_CELL_DIFFERENTIATION","GO_BP","517078_GO_0072162_METANEPHRIC_MESENCHYMAL_CELL_DIFFERENTIATION",5,0.5376,0.98,1,-1.5314,0.046,0.76,0.7905,0.72,1
"GO_CC:501172_GO_0031932_TORC2_COMPLEX","GO_CC","501172_GO_0031932_TORC2_COMPLEX",8,0.5392,0.99,1,1.0567,0.4,0.71,0.9121,0.57,1
"GO_BP:868064_GO_1902402_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_DNA_DAMAGE_CHECKPOINT","GO_BP","868064_GO_1902402_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_DNA_DAMAGE_CHECKPOINT",68,0.5409,1,1,1.6514,0,0.25,-1.1961,0.13,0.74
"GO_BP:501579_GO_0032344_REGULATION_OF_ALDOSTERONE_METABOLIC_PROCESS","GO_BP","501579_GO_0032344_REGULATION_OF_ALDOSTERONE_METABOLIC_PROCESS",6,0.5417,0.97,1,0.9793,0.47,1,1.365,0.12,0.64
"GO_MF:515558_GO_0070628_PROTEASOME_BINDING","GO_MF","515558_GO_0070628_PROTEASOME_BINDING",10,0.5419,0.98,1,1.5343,0.051,0.35,-0.6726,0.9,1
"GO_BP:493354_GO_0009157_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493354_GO_0009157_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS",6,0.542,0.98,1,0.9026,0.58,1,0.9712,0.49,0.88
"C4_Cancer_gene_neighborhoods:C4_CGN_145_MORF_PPP1CA","C4_Cancer_gene_neighborhoods","C4_CGN_145_MORF_PPP1CA",169,0.5425,1,1,2.7316,0,0,-0.5686,1,1
"OMIM_gene:OMIM612990_ADDITIONAL_SEX_COMBS_LIKE_1_ASXL1","OMIM_gene","OMIM612990_ADDITIONAL_SEX_COMBS_LIKE_1_ASXL1",5,0.543,0.96,1,-1.0444,0.43,0.73,-1.1245,0.34,1
"GO_BP:1039930_GO_1903376_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","1039930_GO_1903376_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",7,0.543,0.98,1,1.411,0.1,0.54,0.8756,0.6,0.96
"GO_BP:515863_GO_0070936_PROTEIN_K48_LINKED_UBIQUITINATION","GO_BP","515863_GO_0070936_PROTEIN_K48_LINKED_UBIQUITINATION",45,0.544,1,1,1.0147,0.43,0.97,0.682,0.96,1
"GO_BP:506593_GO_0043562_CELLULAR_RESPONSE_TO_NITROGEN_LEVELS","GO_BP","506593_GO_0043562_CELLULAR_RESPONSE_TO_NITROGEN_LEVELS",19,0.5446,0.99,1,0.8739,0.62,1,0.6745,0.92,1
"REACTOME:645264_REACT_121061_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER","REACTOME","645264_REACT_121061_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER",43,0.5446,1,1,0.8205,0.8,0.99,0.6532,0.98,1
"GO_BP:513947_GO_0060391_POSITIVE_REGULATION_OF_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","513947_GO_0060391_POSITIVE_REGULATION_OF_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS",11,0.5447,0.99,1,-1.1378,0.3,0.93,0.6981,0.87,1
"OMIM_gene:OMIM612839_TET_ONCOGENE_FAMILY_MEMBER_2_TET2","OMIM_gene","OMIM612839_TET_ONCOGENE_FAMILY_MEMBER_2_TET2",5,0.5456,0.96,1,-1.0897,0.35,1,-1.1418,0.33,1
"GO_BP:504787_GO_0035608_PROTEIN_DEGLUTAMYLATION","GO_BP","504787_GO_0035608_PROTEIN_DEGLUTAMYLATION",6,0.5461,0.98,1,-1.0245,0.42,0.97,-1.0821,0.35,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_705_GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION","C2_Chemical_and_genetic_perturbations","C2_CGP_705_GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION",14,0.5463,0.99,1,-0.5455,0.98,1,0.6123,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_634_SCHEIDEREIT_IKK_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_634_SCHEIDEREIT_IKK_TARGETS",18,0.5477,0.99,1,0.6005,0.96,1,1.0516,0.39,0.92
"GO_BP:501582_GO_0032347_REGULATION_OF_ALDOSTERONE_BIOSYNTHETIC_PROCESS","GO_BP","501582_GO_0032347_REGULATION_OF_ALDOSTERONE_BIOSYNTHETIC_PROCESS",6,0.5489,0.97,1,1.0132,0.45,0.97,1.3136,0.14,0.66
"GO_CC:989110_GO_0098651_BASEMENT_MEMBRANE_COLLAGEN_TRIMER","GO_CC","989110_GO_0098651_BASEMENT_MEMBRANE_COLLAGEN_TRIMER",8,0.549,0.98,1,0.8979,0.6,0.9,1.0782,0.36,0.93
"GO_BP:754787_GO_1901836_REGULATION_OF_TRANSCRIPTION_OF_NUCLEAR_LARGE_RRNA_TRANSCRIPT_FROM_RNA_POLYMERASE_I_PROMOTER","GO_BP","754787_GO_1901836_REGULATION_OF_TRANSCRIPTION_OF_NUCLEAR_LARGE_RRNA_TRANSCRIPT_FROM_RNA_POLYMERASE_I_PROMOTER",5,0.5497,0.95,1,1.1084,0.37,0.89,0.8802,0.62,0.95
"OMIM_gene:OMIM605066_TYROSINE_3_MONOOXYGENASE_TRYPTOPHAN_5_MONOOXYGENASE_ACTIVATION_PROTEIN_EPSILON_ISOFORM_YWHAE","OMIM_gene","OMIM605066_TYROSINE_3_MONOOXYGENASE_TRYPTOPHAN_5_MONOOXYGENASE_ACTIVATION_PROTEIN_EPSILON_ISOFORM_YWHAE",5,0.5498,0.96,1,-1.0787,0.38,0.96,-1.1544,0.32,1
"GO_BP:517329_GO_0072413_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_CELL_CYCLE_CHECKPOINT","GO_BP","517329_GO_0072413_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_CELL_CYCLE_CHECKPOINT",68,0.5505,1,1,1.6482,0.0021,0.24,-1.2032,0.13,0.73
"GO_BP:502190_GO_0032968_POSITIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER","GO_BP","502190_GO_0032968_POSITIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER",14,0.5508,0.99,1,1.3168,0.15,0.65,1.0428,0.39,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_168_RODRIGUES_DCC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_168_RODRIGUES_DCC_TARGETS_UP",5,0.5508,0.97,1,0.5982,0.93,1,0.6311,0.89,1
"GO_BP:868065_GO_1902403_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_DNA_INTEGRITY_CHECKPOINT","GO_BP","868065_GO_1902403_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_DNA_INTEGRITY_CHECKPOINT",68,0.5512,1,1,1.6346,0.0021,0.25,-1.1864,0.21,0.73
"GO_BP:517090_GO_0072174_METANEPHRIC_TUBULE_FORMATION","GO_BP","517090_GO_0072174_METANEPHRIC_TUBULE_FORMATION",6,0.5516,0.95,1,-1.3732,0.1,0.98,1.1672,0.28,0.73
"GO_MF:495523_GO_0015271_OUTWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY","GO_MF","495523_GO_0015271_OUTWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",10,0.5518,0.98,1,-0.9635,0.5,0.95,1.1027,0.33,0.81
"GO_CC:501171_GO_0031931_TORC1_COMPLEX","GO_CC","501171_GO_0031931_TORC1_COMPLEX",6,0.5528,0.97,1,-1.271,0.21,0.66,-0.7086,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2424_ALONSO_METASTASIS_EMT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2424_ALONSO_METASTASIS_EMT_DN",5,0.5539,0.95,1,0.7901,0.72,1,-1.2725,0.2,0.45
"KEGG_compound:C05544_PROTEIN_N6_METHYL_L_LYSINE","KEGG_compound","C05544_PROTEIN_N6_METHYL_L_LYSINE",25,0.5543,1,1,-1.4221,0.047,0.41,-1.0068,0.43,0.64
"GO_BP:505256_GO_0042074_CELL_MIGRATION_INVOLVED_IN_GASTRULATION","GO_BP","505256_GO_0042074_CELL_MIGRATION_INVOLVED_IN_GASTRULATION",12,0.5544,0.99,1,-1.4198,0.11,0.94,-1.3392,0.13,0.61
"OMIM_gene:OMIM100725_CHOLINERGIC_RECEPTOR_NICOTINIC_EPSILON_POLYPEPTIDE_CHRNE","OMIM_gene","OMIM100725_CHOLINERGIC_RECEPTOR_NICOTINIC_EPSILON_POLYPEPTIDE_CHRNE",5,0.5547,0.95,1,-1.465,0.07,0.67,0.4139,1,1
"GO_MF:495308_GO_0015002_HEME_COPPER_TERMINAL_OXIDASE_ACTIVITY","GO_MF","495308_GO_0015002_HEME_COPPER_TERMINAL_OXIDASE_ACTIVITY",21,0.5557,0.99,1,2.0529,0,0.0082,0.9915,0.46,0.88
"GO_BP:512009_GO_0051095_REGULATION_OF_HELICASE_ACTIVITY","GO_BP","512009_GO_0051095_REGULATION_OF_HELICASE_ACTIVITY",9,0.556,0.98,1,1.3586,0.12,0.6,-1.1686,0.27,0.73
"GO_BP:500343_GO_0031053_PRIMARY_MIRNA_PROCESSING","GO_BP","500343_GO_0031053_PRIMARY_MIRNA_PROCESSING",6,0.5562,0.97,1,-0.6479,0.88,1,-0.5652,0.94,1
"GO_CC:502721_GO_0033503_HULC_COMPLEX","GO_CC","502721_GO_0033503_HULC_COMPLEX",5,0.5564,0.96,1,1.1699,0.31,0.56,-1.1541,0.32,0.85
"KEGG_pathway:HSA03015_MRNA_SURVEILLANCE_PATHWAY","KEGG_pathway","HSA03015_MRNA_SURVEILLANCE_PATHWAY",86,0.5567,1,0.99,0.9312,0.61,1,-0.6227,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_786_TERAMOTO_OPN_TARGETS_CLUSTER_5","C2_Chemical_and_genetic_perturbations","C2_CGP_786_TERAMOTO_OPN_TARGETS_CLUSTER_5",7,0.557,0.97,1,0.5305,0.98,1,-0.4925,0.99,1
"REACTOME:160963_REACT_6341_MITOCHONDRIAL_UNCOUPLING_PROTEINS","REACTOME","160963_REACT_6341_MITOCHONDRIAL_UNCOUPLING_PROTEINS",5,0.5571,0.94,1,-0.9545,0.53,1,0.5153,0.96,1
"GO_BP:948906_GO_1902751_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION","GO_BP","948906_GO_1902751_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION",16,0.5575,0.99,1,0.7638,0.79,1,-0.7645,0.79,1
"C4_Cancer_gene_neighborhoods:C4_CGN_21_MORF_HDAC1","C4_Cancer_gene_neighborhoods","C4_CGN_21_MORF_HDAC1",255,0.558,1,1,2.4419,0,0,-0.9585,0.61,0.93
"GO_BP:498498_GO_0019673_GDP_MANNOSE_METABOLIC_PROCESS","GO_BP","498498_GO_0019673_GDP_MANNOSE_METABOLIC_PROCESS",9,0.5584,0.97,1,0.839,0.69,1,-0.5486,0.98,1
"GO_BP:499350_GO_0022615_PROTEIN_TO_MEMBRANE_DOCKING","GO_BP","499350_GO_0022615_PROTEIN_TO_MEMBRANE_DOCKING",7,0.5586,0.96,1,0.8549,0.66,1,-1.0991,0.35,0.77
"GO_MF:500927_GO_0031681_G_PROTEIN_BETA_SUBUNIT_BINDING","GO_MF","500927_GO_0031681_G_PROTEIN_BETA_SUBUNIT_BINDING",9,0.5621,0.96,1,1.3773,0.11,0.49,0.7606,0.77,1
"GO_BP:510331_GO_0048208_COPII_VESICLE_COATING","GO_BP","510331_GO_0048208_COPII_VESICLE_COATING",15,0.5629,0.97,1,1.351,0.12,0.61,-0.7106,0.87,0.99
"GO_MF:504221_GO_0035033_HISTONE_DEACETYLASE_REGULATOR_ACTIVITY","GO_MF","504221_GO_0035033_HISTONE_DEACETYLASE_REGULATOR_ACTIVITY",5,0.5633,0.95,1,-1.1524,0.31,0.8,-1.2605,0.21,0.59
"REACTOME:160965_REACT_6196_THE_PROTON_BUFFERING_MODEL","REACTOME","160965_REACT_6196_THE_PROTON_BUFFERING_MODEL",5,0.5638,0.95,1,-0.9488,0.52,1,0.5154,0.97,1
"KEGG_compound:C05546_PROTEIN_N6_N6_N6_TRIMETHYL_L_LYSINE","KEGG_compound","C05546_PROTEIN_N6_N6_N6_TRIMETHYL_L_LYSINE",25,0.5638,0.99,1,-1.4212,0.059,0.41,-1.0155,0.44,0.64
"GO_BP:502098_GO_0032876_NEGATIVE_REGULATION_OF_DNA_ENDOREDUPLICATION","GO_BP","502098_GO_0032876_NEGATIVE_REGULATION_OF_DNA_ENDOREDUPLICATION",5,0.564,0.94,1,0.7485,0.78,1,-1.0251,0.43,0.83
"GO_BP:512821_GO_0051971_POSITIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE","GO_BP","512821_GO_0051971_POSITIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE",5,0.5649,0.95,1,-1.3421,0.16,0.92,0.9628,0.49,0.89
"KEGG_reaction:R03875_PROTEIN_LYSINE_S_ADENOSYL_L_METHIONINE_PROTEIN_N6_METHYL_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE","KEGG_reaction","R03875_PROTEIN_LYSINE_S_ADENOSYL_L_METHIONINE_PROTEIN_N6_METHYL_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE",25,0.5649,1,0.97,-1.4268,0.067,0.26,-1.0363,0.41,0.55
"GO_BP:517347_GO_0072431_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_G1_DNA_DAMAGE_CHECKPOINT","GO_BP","517347_GO_0072431_SIGNAL_TRANSDUCTION_INVOLVED_IN_MITOTIC_G1_DNA_DAMAGE_CHECKPOINT",67,0.5652,1,1,1.6802,0.0022,0.21,-1.1555,0.2,0.74
"GO_BP:495036_GO_0010971_POSITIVE_REGULATION_OF_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","495036_GO_0010971_POSITIVE_REGULATION_OF_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE",16,0.5656,0.99,1,0.7345,0.86,1,-0.7551,0.8,1
"GO_MF:496607_GO_0016676_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR","GO_MF","496607_GO_0016676_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR",21,0.5663,0.99,1,2.0303,0,0.0097,0.9988,0.45,0.88
"KEGG_compound:C03492_D_4_PHOSPHOPANTOTHENATE_R_4_PHOSPHOPANTOTHENATE","KEGG_compound","C03492_D_4_PHOSPHOPANTOTHENATE_R_4_PHOSPHOPANTOTHENATE",5,0.5712,0.97,1,-0.8099,0.72,1,-0.5732,0.93,0.97
"GO_MF:489593_GO_0004129_CYTOCHROME_C_OXIDASE_ACTIVITY","GO_MF","489593_GO_0004129_CYTOCHROME_C_OXIDASE_ACTIVITY",21,0.5716,0.98,1,1.9999,0,0.013,1.0153,0.41,0.85
"GO_CC:496920_GO_0017119_GOLGI_TRANSPORT_COMPLEX","GO_CC","496920_GO_0017119_GOLGI_TRANSPORT_COMPLEX",11,0.5722,0.97,1,-0.7786,0.75,1,-1.2782,0.18,0.69
"GO_BP:515315_GO_0070383_DNA_CYTOSINE_DEAMINATION","GO_BP","515315_GO_0070383_DNA_CYTOSINE_DEAMINATION",5,0.5723,0.95,1,0.4635,0.99,1,-1.136,0.33,0.75
"GO_MF:515460_GO_0070530_K63_LINKED_POLYUBIQUITIN_BINDING","GO_MF","515460_GO_0070530_K63_LINKED_POLYUBIQUITIN_BINDING",15,0.5727,0.98,1,-1.178,0.25,0.78,-1.3579,0.1,0.53
"GO_CC:507640_GO_0045275_RESPIRATORY_CHAIN_COMPLEX_III","GO_CC","507640_GO_0045275_RESPIRATORY_CHAIN_COMPLEX_III",6,0.5728,0.95,1,1.3043,0.19,0.4,0.5059,0.98,1
"KEGG_reaction:R04867_S_ADENOSYL_L_METHIONINE_CYTOCHROME_C_L_LYSINE_N6_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_PROTEIN_N6_N6_DIMETHYL_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE_PROTEIN_N6_N6_N6_TRIMETHYL_L_LYSINE","KEGG_reaction","R04867_S_ADENOSYL_L_METHIONINE_CYTOCHROME_C_L_LYSINE_N6_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_PROTEIN_N6_N6_DIMETHYL_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE_PROTEIN_N6_N6_N6_TRIMETHYL_L_LYSINE",25,0.5731,0.99,0.98,-1.433,0.059,0.26,-1.0266,0.4,0.56
"KEGG_reaction:R04866_S_ADENOSYL_L_METHIONINE_CYTOCHROME_C_L_LYSINE_N6_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_PROTEIN_N6_METHYL_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE_PROTEIN_N6_N6_DIMETHYL_L_LYSINE","KEGG_reaction","R04866_S_ADENOSYL_L_METHIONINE_CYTOCHROME_C_L_LYSINE_N6_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_PROTEIN_N6_METHYL_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE_PROTEIN_N6_N6_DIMETHYL_L_LYSINE",25,0.5732,0.98,0.99,-1.4196,0.053,0.25,-1.0109,0.41,0.58
"GO_BP:510330_GO_0048207_VESICLE_TARGETING_ROUGH_ER_TO_CIS_GOLGI","GO_BP","510330_GO_0048207_VESICLE_TARGETING_ROUGH_ER_TO_CIS_GOLGI",15,0.5735,0.98,1,1.3585,0.13,0.6,-0.7207,0.85,0.99
"C1_Positional:C1_ALL_71_CHR14Q13","C1_Positional","C1_ALL_71_CHR14Q13",26,0.5736,0.99,1,0.9562,0.52,0.81,-0.8203,0.74,0.98
"KEGG_enzyme:1.6.2.2_CYTOCHROME_B5_REDUCTASE_CYTOCHROME_B5_REDUCTASE_DIHYDRONICOTINAMIDE_ADENINE_DINUCLEOTIDE_CYTOCHROME_B5_REDUCTASE_REDUCED_NICOTINAMIDE_ADENINEDINUCLEOTIDE_CYTOCHROME_B5_REDUCTASE_NADH_FERRICYTOCHROME_B5_OXIDOREDUCTASE_NADH_CYTOCHROME_B5_REDUCTASE_NADH_5ALPHA_REDUCTASE_NADH_CYTOCHROME_B5_REDUCTASE","KEGG_enzyme","1.6.2.2_CYTOCHROME_B5_REDUCTASE_CYTOCHROME_B5_REDUCTASE_DIHYDRONICOTINAMIDE_ADENINE_DINUCLEOTIDE_CYTOCHROME_B5_REDUCTASE_REDUCED_NICOTINAMIDE_ADENINEDINUCLEOTIDE_CYTOCHROME_B5_REDUCTASE_NADH_FERRICYTOCHROME_B5_OXIDOREDUCTASE_NADH_CYTOCHROME_B5_REDUCTASE_NADH_5ALPHA_REDUCTASE_NADH_CYTOCHROME_B5_REDUCTASE",5,0.574,0.94,0.95,0.7395,0.78,1,-0.4694,0.99,0.99
"GO_MF:512417_GO_0051539_4_IRON_4_SULFUR_CLUSTER_BINDING","GO_MF","512417_GO_0051539_4_IRON_4_SULFUR_CLUSTER_BINDING",38,0.5746,0.99,1,1.0838,0.32,0.81,-1.2755,0.13,0.58
"GO_CC:497913_GO_0019031_VIRAL_ENVELOPE","GO_CC","497913_GO_0019031_VIRAL_ENVELOPE",5,0.5747,0.95,1,-1.1798,0.29,0.68,1.3458,0.14,0.72
"GO_CC:490784_GO_0005750_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III","GO_CC","490784_GO_0005750_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III",6,0.5757,0.94,1,1.3302,0.14,0.37,0.5071,0.98,1
"GO_BP:494636_GO_0010571_POSITIVE_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION","GO_BP","494636_GO_0010571_POSITIVE_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION",5,0.5765,0.95,1,-1.0633,0.41,0.96,-1.0456,0.4,0.82
"GO_BP:519145_GO_2000505_REGULATION_OF_ENERGY_HOMEOSTASIS","GO_BP","519145_GO_2000505_REGULATION_OF_ENERGY_HOMEOSTASIS",11,0.5767,0.97,1,1.4251,0.078,0.52,1.5775,0.035,0.45
"GO_BP:868062_GO_1902400_INTRACELLULAR_SIGNAL_TRANSDUCTION_INVOLVED_IN_G1_DNA_DAMAGE_CHECKPOINT","GO_BP","868062_GO_1902400_INTRACELLULAR_SIGNAL_TRANSDUCTION_INVOLVED_IN_G1_DNA_DAMAGE_CHECKPOINT",67,0.5769,1,1,1.6739,0.0045,0.22,-1.1569,0.2,0.74
"GO_CC:751255_GO_0036338_VIRAL_MEMBRANE","GO_CC","751255_GO_0036338_VIRAL_MEMBRANE",5,0.5774,0.97,1,-1.1698,0.29,0.69,1.3267,0.16,0.7
"GO_BP:510322_GO_0048199_VESICLE_TARGETING_TO_FROM_OR_WITHIN_GOLGI","GO_BP","510322_GO_0048199_VESICLE_TARGETING_TO_FROM_OR_WITHIN_GOLGI",28,0.578,0.99,1,1.6298,0.017,0.26,0.7913,0.81,1
"REACTOME:105903_REACT_15550_INSULIN_PROCESSING","REACTOME","105903_REACT_15550_INSULIN_PROCESSING",25,0.5789,0.98,1,-0.7173,0.87,1,-0.6668,0.93,1
"GO_MF:492494_GO_0008140_CAMP_RESPONSE_ELEMENT_BINDING_PROTEIN_BINDING","GO_MF","492494_GO_0008140_CAMP_RESPONSE_ELEMENT_BINDING_PROTEIN_BINDING",11,0.5789,0.95,1,-0.6647,0.88,1,-0.9914,0.42,0.79
"REACTOME:160964_REACT_6258_THE_FATTY_ACID_CYCLING_MODEL","REACTOME","160964_REACT_6258_THE_FATTY_ACID_CYCLING_MODEL",5,0.5792,0.95,1,-0.9375,0.55,1,0.5105,0.98,1
"REACTOME:106511_REACT_11063_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX","REACTOME","106511_REACT_11063_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX",81,0.5794,1,1,1.9122,0,0.0072,-0.7782,0.92,1
"REACTOME:730325_REACT_150188_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL","REACTOME","730325_REACT_150188_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL",10,0.5804,0.96,1,0.4676,1,1,0.472,0.99,1
"GO_BP:1133954_GO_1903779_REGULATION_OF_CARDIAC_CONDUCTION","GO_BP","1133954_GO_1903779_REGULATION_OF_CARDIAC_CONDUCTION",16,0.5812,0.98,1,1.8468,0.0022,0.065,1.5379,0.037,0.52
"GO_BP:493253_GO_0009048_DOSAGE_COMPENSATION_BY_INACTIVATION_OF_X_CHROMOSOME","GO_BP","493253_GO_0009048_DOSAGE_COMPENSATION_BY_INACTIVATION_OF_X_CHROMOSOME",6,0.5812,0.95,1,0.988,0.47,0.99,-0.6539,0.88,1
"GO_CC:500210_GO_0030915_SMC5_SMC6_COMPLEX","GO_CC","500210_GO_0030915_SMC5_SMC6_COMPLEX",7,0.5813,0.95,1,1.2154,0.25,0.51,-0.9548,0.55,1
"GO_MF:489869_GO_0004520_ENDODEOXYRIBONUCLEASE_ACTIVITY","GO_MF","489869_GO_0004520_ENDODEOXYRIBONUCLEASE_ACTIVITY",45,0.5823,0.99,1,1.134,0.26,0.75,0.9479,0.55,0.91
"KEGG_compound:C00079_L_PHENYLALANINE_S_ALPHA_AMINO_BETA_PHENYLPROPIONIC_ACID","KEGG_compound","C00079_L_PHENYLALANINE_S_ALPHA_AMINO_BETA_PHENYLPROPIONIC_ACID",10,0.5827,0.95,1,0.842,0.65,1,-0.713,0.84,0.9
"KEGG_reaction:R00100_NADH_FERRICYTOCHROME_B5_OXIDOREDUCTASE_NADH_2_FERRICYTOCHROME_B5_NAD_2_FERROCYTOCHROME_B5_H_","KEGG_reaction","R00100_NADH_FERRICYTOCHROME_B5_OXIDOREDUCTASE_NADH_2_FERRICYTOCHROME_B5_NAD_2_FERROCYTOCHROME_B5_H_",5,0.5833,0.94,1,0.7527,0.78,1,-0.4609,1,0.99
"KEGG_module:HSA_M00154_CYTOCHROME_C_OXIDASE","KEGG_module","HSA_M00154_CYTOCHROME_C_OXIDASE",18,0.5836,0.98,0.96,1.9614,0.0021,0.007,0.9919,0.45,1
"C1_Positional:C1_ALL_131_CHRYQ11","C1_Positional","C1_ALL_131_CHRYQ11",14,0.5847,0.97,1,0.867,0.62,0.89,1.0945,0.32,0.74
"GO_BP:491815_GO_0006977_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_CELL_CYCLE_ARREST","GO_BP","491815_GO_0006977_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_CELL_CYCLE_ARREST",66,0.5851,1,1,1.6607,0.0066,0.24,-1.1001,0.26,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_671_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7","C2_Chemical_and_genetic_perturbations","C2_CGP_671_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7",7,0.5854,0.93,1,0.9544,0.53,0.86,0.9535,0.51,0.99
"OMIM_gene:OMIM606406_NUCLEAR_PORE_COMPLEX_INTERACTING_PROTEIN_NPIP","OMIM_gene","OMIM606406_NUCLEAR_PORE_COMPLEX_INTERACTING_PROTEIN_NPIP",7,0.5878,0.95,1,-1.5414,0.034,1,-0.7562,0.77,1
"KEGG_compound:C15602_QUINONE","KEGG_compound","C15602_QUINONE",6,0.5879,0.93,1,1.2738,0.2,0.78,-1.0849,0.38,0.55
"GO_BP:497959_GO_0019082_VIRAL_PROTEIN_PROCESSING","GO_BP","497959_GO_0019082_VIRAL_PROTEIN_PROCESSING",12,0.5883,0.95,1,1.7783,0.0063,0.12,0.6491,0.91,1
"REACTOME:105823_REACT_1707_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX","REACTOME","105823_REACT_1707_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX",11,0.5886,0.97,1,0.8506,0.67,0.96,-0.8146,0.7,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_213_RUNNE_GENDER_EFFECT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_213_RUNNE_GENDER_EFFECT_UP",9,0.5894,0.94,1,-0.7393,0.78,1,-1.0026,0.46,0.75
"KEGG_compound:C01528_HYDROGEN_SELENIDE_SELENIDE","KEGG_compound","C01528_HYDROGEN_SELENIDE_SELENIDE",6,0.5894,0.94,1,1.0395,0.42,1,-1.4799,0.068,0.24
"GO_MF:490186_GO_0004889_ACETYLCHOLINE_ACTIVATED_CATION_SELECTIVE_CHANNEL_ACTIVITY","GO_MF","490186_GO_0004889_ACETYLCHOLINE_ACTIVATED_CATION_SELECTIVE_CHANNEL_ACTIVITY",17,0.5894,0.96,1,-1.9519,0.0019,0.18,1.0896,0.36,0.81
"C1_Positional:C1_ALL_200_CHR19Q12","C1_Positional","C1_ALL_200_CHR19Q12",12,0.5902,0.95,1,1.1463,0.27,0.63,-0.786,0.76,1
"GO_BP:501563_GO_0032328_ALANINE_TRANSPORT","GO_BP","501563_GO_0032328_ALANINE_TRANSPORT",9,0.5908,0.94,1,0.94,0.52,1,-0.8077,0.69,0.99
"REACTOME:106171_REACT_847_UREA_CYCLE","REACTOME","106171_REACT_847_UREA_CYCLE",9,0.5913,0.95,1,-0.7027,0.86,1,-0.9669,0.5,0.89
"C3_MicroRNA_targets:C3_MIR_168_AGCGCAG_MIR_191","C3_MicroRNA_targets","C3_MIR_168_AGCGCAG_MIR_191",13,0.5915,0.95,0.99,1.0715,0.36,1,0.7372,0.82,1
"REACTOME:530766_REACT_115893_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS","REACTOME","530766_REACT_115893_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS",11,0.5915,0.96,1,1.6594,0.023,0.065,-0.8046,0.73,1
"GO_MF:496606_GO_0016675_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS","GO_MF","496606_GO_0016675_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS",23,0.5918,0.98,1,2.0188,0,0.011,1.0363,0.39,0.85
"GO_BP:853113_GO_1902338_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS","GO_BP","853113_GO_1902338_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS",6,0.5925,0.93,1,1.3693,0.14,0.59,0.929,0.53,0.92
"GO_BP:508774_GO_0046516_HYPUSINE_METABOLIC_PROCESS","GO_BP","508774_GO_0046516_HYPUSINE_METABOLIC_PROCESS",5,0.5942,0.94,1,1.1672,0.31,0.82,0.4338,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_106_MORF_G22P1","C4_Cancer_gene_neighborhoods","C4_CGN_106_MORF_G22P1",172,0.5947,1,1,2.6099,0,0,-0.9501,0.61,0.95
"GO_BP:496429_GO_0016446_SOMATIC_HYPERMUTATION_OF_IMMUNOGLOBULIN_GENES","GO_BP","496429_GO_0016446_SOMATIC_HYPERMUTATION_OF_IMMUNOGLOBULIN_GENES",11,0.595,0.96,1,0.579,0.97,1,-1.4256,0.088,0.57
"GO_CC:516905_GO_0071986_RAGULATOR_COMPLEX","GO_CC","516905_GO_0071986_RAGULATOR_COMPLEX",6,0.5953,0.92,1,1.3972,0.11,0.3,0.6788,0.83,1
"GO_MF:499381_GO_0022835_TRANSMITTER_GATED_CHANNEL_ACTIVITY","GO_MF","499381_GO_0022835_TRANSMITTER_GATED_CHANNEL_ACTIVITY",9,0.5961,0.95,1,-1.3475,0.15,0.7,1.274,0.18,0.65
"REACTOME:1127572_REACT_263857_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_F_BONT_F_","REACTOME","1127572_REACT_263857_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_F_BONT_F_",5,0.5965,0.92,1,-1.0195,0.46,0.98,1.2402,0.24,0.79
"GO_BP:512819_GO_0051969_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE","GO_BP","512819_GO_0051969_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE",10,0.5971,0.95,1,-1.0035,0.47,0.99,-1.2462,0.18,0.68
"GO_CC:517933_GO_0080008_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX","GO_CC","517933_GO_0080008_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX",23,0.5979,0.99,1,1.1013,0.31,0.64,-1.3468,0.1,0.6
"GO_CC:487460_GO_0001520_OUTER_DENSE_FIBER","GO_CC","487460_GO_0001520_OUTER_DENSE_FIBER",8,0.6005,0.93,1,-1.7916,0.0038,0.21,-0.7359,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_493_SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_493_SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN",17,0.6007,0.96,1,-0.8228,0.7,1,-0.8349,0.7,0.93
"GO_MF:511984_GO_0051059_NF_KAPPAB_BINDING","GO_MF","511984_GO_0051059_NF_KAPPAB_BINDING",29,0.6007,0.98,1,1.0085,0.44,0.87,-1.0164,0.44,0.77
"GO_BP:511418_GO_0050435_BETA_AMYLOID_METABOLIC_PROCESS","GO_BP","511418_GO_0050435_BETA_AMYLOID_METABOLIC_PROCESS",13,0.6014,0.96,1,1.0362,0.37,0.96,0.8597,0.64,0.97
"GO_CC:496943_GO_0017146_N_METHYL_D_ASPARTATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX","GO_CC","496943_GO_0017146_N_METHYL_D_ASPARTATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX",11,0.6014,0.95,1,0.9198,0.55,0.87,1.6664,0.015,0.32
"GO_BP:494971_GO_0010907_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS","GO_BP","494971_GO_0010907_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS",32,0.6015,0.99,1,0.5717,0.99,1,0.9271,0.57,0.92
"REACTOME:1127558_REACT_115860_SYNTHESIS_AND_PROCESSING_OF_GAG_GAGPOL_POLYPROTEINS","REACTOME","1127558_REACT_115860_SYNTHESIS_AND_PROCESSING_OF_GAG_GAGPOL_POLYPROTEINS",11,0.6027,0.95,1,1.6356,0.023,0.076,-0.8025,0.72,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_624_SEIDEN_MET_SIGNALING","C2_Chemical_and_genetic_perturbations","C2_CGP_624_SEIDEN_MET_SIGNALING",19,0.6034,0.97,1,1.575,0.017,0.16,-0.7337,0.85,0.98
"GO_MF:489401_GO_0003916_DNA_TOPOISOMERASE_ACTIVITY","GO_MF","489401_GO_0003916_DNA_TOPOISOMERASE_ACTIVITY",6,0.6036,0.92,1,0.7415,0.79,1,-0.6509,0.9,1
"GO_BP:488083_GO_0002204_SOMATIC_RECOMBINATION_OF_IMMUNOGLOBULIN_GENES_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488083_GO_0002204_SOMATIC_RECOMBINATION_OF_IMMUNOGLOBULIN_GENES_INVOLVED_IN_IMMUNE_RESPONSE",18,0.6037,0.96,1,0.9731,0.49,1,-0.9985,0.45,0.85
"GO_BP:518713_GO_2000064_REGULATION_OF_CORTISOL_BIOSYNTHETIC_PROCESS","GO_BP","518713_GO_2000064_REGULATION_OF_CORTISOL_BIOSYNTHETIC_PROCESS",5,0.6038,0.91,1,0.7839,0.76,1,1.1898,0.28,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2863_GUTIERREZ_MULTIPLE_MYELOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2863_GUTIERREZ_MULTIPLE_MYELOMA_DN",35,0.6041,0.98,1,2.0934,0,0.002,0.6421,0.97,1
"GO_BP:508334_GO_0046037_GMP_METABOLIC_PROCESS","GO_BP","508334_GO_0046037_GMP_METABOLIC_PROCESS",9,0.6045,0.93,1,-0.5273,0.98,1,-1.2985,0.17,0.65
"REACTOME:1127571_REACT_263924_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BONT_D_","REACTOME","1127571_REACT_263924_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BONT_D_",5,0.6053,0.91,1,-1.026,0.44,0.98,1.2682,0.2,0.78
"GO_BP:503969_GO_0034770_HISTONE_H4_K20_METHYLATION","GO_BP","503969_GO_0034770_HISTONE_H4_K20_METHYLATION",7,0.6073,0.93,1,-0.8491,0.64,1,0.4825,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2957_VERRECCHIA_RESPONSE_TO_TGFB1_C6","C2_Chemical_and_genetic_perturbations","C2_CGP_2957_VERRECCHIA_RESPONSE_TO_TGFB1_C6",5,0.6079,0.92,1,0.6147,0.93,1,-0.648,0.89,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2313_JONES_TCOF1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2313_JONES_TCOF1_TARGETS",5,0.6084,0.9,1,1.1471,0.31,0.56,-0.7864,0.75,0.96
"GO_BP:517338_GO_0072422_SIGNAL_TRANSDUCTION_INVOLVED_IN_DNA_DAMAGE_CHECKPOINT","GO_BP","517338_GO_0072422_SIGNAL_TRANSDUCTION_INVOLVED_IN_DNA_DAMAGE_CHECKPOINT",70,0.6084,1,1,1.6879,0,0.21,-1.139,0.2,0.75
"GO_BP:488087_GO_0002208_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS_INVOLVED_IN_IMMUNE_RESPONSE","GO_BP","488087_GO_0002208_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS_INVOLVED_IN_IMMUNE_RESPONSE",18,0.6101,0.94,1,0.9908,0.45,0.99,-0.9712,0.48,0.87
"GO_BP:504789_GO_0035610_PROTEIN_SIDE_CHAIN_DEGLUTAMYLATION","GO_BP","504789_GO_0035610_PROTEIN_SIDE_CHAIN_DEGLUTAMYLATION",5,0.6106,0.91,1,-0.8094,0.69,1,-1.0251,0.46,0.83
"GO_BP:512449_GO_0051571_POSITIVE_REGULATION_OF_HISTONE_H3_K4_METHYLATION","GO_BP","512449_GO_0051571_POSITIVE_REGULATION_OF_HISTONE_H3_K4_METHYLATION",12,0.6107,0.94,1,0.6167,0.93,1,-0.7429,0.82,1
"C4_Cancer_gene_neighborhoods:C4_CGN_179_MORF_SS18","C4_Cancer_gene_neighborhoods","C4_CGN_179_MORF_SS18",62,0.6112,1,1,0.7107,0.95,1,-0.9247,0.59,1
"GO_BP:507491_GO_0045091_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE","GO_BP","507491_GO_0045091_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE",8,0.6113,0.94,1,0.5375,0.97,1,-1.1397,0.32,0.75
"GO_BP:493358_GO_0009162_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS","GO_BP","493358_GO_0009162_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS",9,0.6118,0.94,1,0.9807,0.49,1,-0.6025,0.93,1
"GO_BP:517317_GO_0072401_SIGNAL_TRANSDUCTION_INVOLVED_IN_DNA_INTEGRITY_CHECKPOINT","GO_BP","517317_GO_0072401_SIGNAL_TRANSDUCTION_INVOLVED_IN_DNA_INTEGRITY_CHECKPOINT",70,0.6119,1,1,1.68,0,0.21,-1.1285,0.25,0.76
"C4_Cancer_modules:C4_CM_20_MODULE_21","C4_Cancer_modules","C4_CM_20_MODULE_21",10,0.6122,0.95,1,0.6456,0.93,1,0.7643,0.76,1
"KEGG_compound:C15603_HYDROQUINONE_P_HYDROQUINONE_QUINOL_REDUCED_QUINONE","KEGG_compound","C15603_HYDROQUINONE_P_HYDROQUINONE_QUINOL_REDUCED_QUINONE",6,0.6125,0.91,1,1.2713,0.18,0.77,-1.0875,0.38,0.55
"GO_MF:486893_GO_0000400_FOUR_WAY_JUNCTION_DNA_BINDING","GO_MF","486893_GO_0000400_FOUR_WAY_JUNCTION_DNA_BINDING",9,0.6132,0.95,1,-0.8182,0.71,1,-1.3781,0.099,0.51
"REACTOME:906027_REACT_169263_TGFBR1_KD_MUTANTS_IN_CANCER","REACTOME","906027_REACT_169263_TGFBR1_KD_MUTANTS_IN_CANCER",7,0.6134,0.93,1,-0.7415,0.77,1,1.1014,0.37,0.95
"GO_BP:515756_GO_0070828_HETEROCHROMATIN_ORGANIZATION","GO_BP","515756_GO_0070828_HETEROCHROMATIN_ORGANIZATION",12,0.614,0.94,1,0.7158,0.85,1,0.8412,0.67,0.99
"GO_BP:487636_GO_0001738_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM","GO_BP","487636_GO_0001738_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM",23,0.6145,0.97,1,1.2385,0.17,0.75,1.1812,0.24,0.72
"GO_CC:487637_GO_0001739_SEX_CHROMATIN","GO_CC","487637_GO_0001739_SEX_CHROMATIN",7,0.6146,0.92,1,0.5307,0.98,1,0.4705,0.98,1
"GO_BP:500433_GO_0031146_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","500433_GO_0031146_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",21,0.6147,0.98,1,0.6969,0.9,1,-0.8295,0.71,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1881_DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4","C2_Chemical_and_genetic_perturbations","C2_CGP_1881_DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4",11,0.6149,0.94,1,-0.8659,0.62,1,-0.9618,0.5,0.8
"GO_MF:498058_GO_0019203_CARBOHYDRATE_PHOSPHATASE_ACTIVITY","GO_MF","498058_GO_0019203_CARBOHYDRATE_PHOSPHATASE_ACTIVITY",11,0.615,0.94,1,1.1294,0.3,0.75,1.1205,0.31,0.81
"GO_BP:507572_GO_0045190_ISOTYPE_SWITCHING","GO_BP","507572_GO_0045190_ISOTYPE_SWITCHING",18,0.6155,0.96,1,0.9811,0.45,1,-0.9897,0.47,0.86
"REACTOME:106089_REACT_6323_HOST_INTERACTIONS_WITH_INFLUENZA_FACTORS","REACTOME","106089_REACT_6323_HOST_INTERACTIONS_WITH_INFLUENZA_FACTORS",5,0.6157,0.91,1,-0.8163,0.68,1,-0.6883,0.83,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_777_KORKOLA_EMBRYONAL_CARCINOMA","C2_Chemical_and_genetic_perturbations","C2_CGP_777_KORKOLA_EMBRYONAL_CARCINOMA",13,0.6161,0.95,1,0.8626,0.63,0.96,-0.5812,0.97,0.99
"OMIM_gene:OMIM606186_CALCYCLIN_BINDING_PROTEIN_CACYBP","OMIM_gene","OMIM606186_CALCYCLIN_BINDING_PROTEIN_CACYBP",5,0.6161,0.9,1,-0.6881,0.83,0.92,-0.8175,0.7,0.97
"GO_MF:499688_GO_0030284_ESTROGEN_RECEPTOR_ACTIVITY","GO_MF","499688_GO_0030284_ESTROGEN_RECEPTOR_ACTIVITY",5,0.6166,0.9,1,0.7875,0.73,1,0.8136,0.68,1
"OMIM_gene:OMIM602487_HEAT_RESPONSIVE_PROTEIN_12_HRSP12","OMIM_gene","OMIM602487_HEAT_RESPONSIVE_PROTEIN_12_HRSP12",5,0.6167,0.9,1,0.6827,0.85,1,-1.1051,0.37,1
"GO_BP:504430_GO_0035246_PEPTIDYL_ARGININE_N_METHYLATION","GO_BP","504430_GO_0035246_PEPTIDYL_ARGININE_N_METHYLATION",9,0.6172,0.9,1,-0.7226,0.83,1,-1.2755,0.18,0.66
"REACTOME:161028_REACT_22336_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS","REACTOME","161028_REACT_22336_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS",13,0.6183,0.93,1,-1.7925,0.012,0.085,0.9527,0.49,1
"OMIM_gene:OMIM612409_RNA_BINDING_MOTIF_PROTEIN_14_RBM14","OMIM_gene","OMIM612409_RNA_BINDING_MOTIF_PROTEIN_14_RBM14",5,0.6183,0.9,1,-0.6691,0.86,0.91,-0.8279,0.65,0.97
"REACTOME:906025_REACT_169311_LOSS_OF_FUNCTION_OF_TGFBR1_IN_CANCER","REACTOME","906025_REACT_169311_LOSS_OF_FUNCTION_OF_TGFBR1_IN_CANCER",7,0.6202,0.92,1,-0.7486,0.78,1,1.0863,0.33,0.95
"GO_BP:502147_GO_0032925_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","502147_GO_0032925_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY",21,0.6208,0.97,1,-0.9134,0.56,1,-0.6364,0.96,1
"GO_BP:502148_GO_0032926_NEGATIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","502148_GO_0032926_NEGATIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY",9,0.6208,0.91,1,-1.2825,0.17,0.89,-0.6866,0.86,0.99
"GO_BP:487776_GO_0001880_MULLERIAN_DUCT_REGRESSION","GO_BP","487776_GO_0001880_MULLERIAN_DUCT_REGRESSION",5,0.6212,0.91,1,-1.1986,0.29,0.9,1.3382,0.15,0.65
"GO_BP:516245_GO_0071321_CELLULAR_RESPONSE_TO_CGMP","GO_BP","516245_GO_0071321_CELLULAR_RESPONSE_TO_CGMP",6,0.6212,0.93,1,-0.675,0.85,1,0.7025,0.83,1
"GO_CC:486932_GO_0000439_CORE_TFIIH_COMPLEX","GO_CC","486932_GO_0000439_CORE_TFIIH_COMPLEX",8,0.6214,0.9,1,1.3024,0.16,0.4,-0.5619,0.96,1
"GO_BP:517092_GO_0072176_NEPHRIC_DUCT_DEVELOPMENT","GO_BP","517092_GO_0072176_NEPHRIC_DUCT_DEVELOPMENT",12,0.6217,0.94,1,-0.818,0.7,1,0.6592,0.92,1
"GO_BP:512822_GO_0051972_REGULATION_OF_TELOMERASE_ACTIVITY","GO_BP","512822_GO_0051972_REGULATION_OF_TELOMERASE_ACTIVITY",14,0.6219,0.95,1,0.5393,0.99,1,-0.8038,0.76,0.99
"KEGG_pathway:HSA04120_UBIQUITIN_MEDIATED_PROTEOLYSIS","KEGG_pathway","HSA04120_UBIQUITIN_MEDIATED_PROTEOLYSIS",137,0.6225,1,1,0.9463,0.58,0.99,-0.7187,0.99,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2019_YANG_MUC2_TARGETS_COLON_3MO_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2019_YANG_MUC2_TARGETS_COLON_3MO_DN",5,0.6228,0.91,1,-0.5192,0.97,1,-0.8005,0.71,0.95
"REACTOME:161022_REACT_21314_RELAXIN_RECEPTORS","REACTOME","161022_REACT_21314_RELAXIN_RECEPTORS",7,0.623,0.91,1,-1.1481,0.29,0.86,-1.6064,0.022,0.24
"KEGG_reaction:R00191_ADENOSINE_3_5_PHOSPHATE_5_NUCLEOTIDOHYDROLASE_3_5_CYCLIC_AMP_H2O_AMP","KEGG_reaction","R00191_ADENOSINE_3_5_PHOSPHATE_5_NUCLEOTIDOHYDROLASE_3_5_CYCLIC_AMP_H2O_AMP",16,0.6238,0.96,0.99,-1.0654,0.38,0.71,-1.4314,0.073,0.33
"REACTOME:106103_REACT_705_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS","REACTOME","106103_REACT_705_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS",7,0.624,0.91,1,1.0603,0.4,0.65,1.0239,0.42,1
"GO_BP:511417_GO_0050434_POSITIVE_REGULATION_OF_VIRAL_TRANSCRIPTION","GO_BP","511417_GO_0050434_POSITIVE_REGULATION_OF_VIRAL_TRANSCRIPTION",57,0.6248,0.98,1,1.4442,0.015,0.5,0.6148,1,1
"GO_BP:750914_GO_0035989_TENDON_DEVELOPMENT","GO_BP","750914_GO_0035989_TENDON_DEVELOPMENT",6,0.6249,0.91,1,-1.7826,0.0039,0.47,0.8357,0.68,0.99
"GO_BP:519020_GO_2000380_REGULATION_OF_MESODERM_DEVELOPMENT","GO_BP","519020_GO_2000380_REGULATION_OF_MESODERM_DEVELOPMENT",13,0.626,0.93,1,0.7868,0.76,1,1.0816,0.37,0.77
"GO_BP:518634_GO_0097084_VASCULAR_SMOOTH_MUSCLE_CELL_DEVELOPMENT","GO_BP","518634_GO_0097084_VASCULAR_SMOOTH_MUSCLE_CELL_DEVELOPMENT",6,0.6261,0.91,1,0.5939,0.94,1,-0.6121,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2887_DANG_REGULATED_BY_MYC_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2887_DANG_REGULATED_BY_MYC_UP",70,0.6263,1,1,-0.73,0.92,1,-0.7354,0.95,0.98
"GO_BP:516084_GO_0071158_POSITIVE_REGULATION_OF_CELL_CYCLE_ARREST","GO_BP","516084_GO_0071158_POSITIVE_REGULATION_OF_CELL_CYCLE_ARREST",86,0.6266,1,1,1.5918,0.0022,0.3,-0.9214,0.64,0.91
"GO_BP:1129616_GO_1990542_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT","GO_BP","1129616_GO_1990542_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT",44,0.6271,0.99,1,1.9539,0,0.021,-0.6384,0.97,1
"GO_BP:487720_GO_0001824_BLASTOCYST_DEVELOPMENT","GO_BP","487720_GO_0001824_BLASTOCYST_DEVELOPMENT",68,0.6277,1,1,1.0221,0.39,0.97,-1.1075,0.26,0.77
"GO_BP:508745_GO_0046485_ETHER_LIPID_METABOLIC_PROCESS","GO_BP","508745_GO_0046485_ETHER_LIPID_METABOLIC_PROCESS",8,0.6278,0.93,1,0.8564,0.62,1,-1.1871,0.27,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1036_CAFFAREL_RESPONSE_TO_THC_24HR_3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1036_CAFFAREL_RESPONSE_TO_THC_24HR_3_UP",7,0.6287,0.92,1,1.2709,0.21,0.42,0.6792,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1327_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1327_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP",10,0.6288,0.93,1,1.5071,0.07,0.21,0.9502,0.51,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1687_GEISS_RESPONSE_TO_DSRNA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1687_GEISS_RESPONSE_TO_DSRNA_DN",16,0.6289,0.93,1,1.0657,0.34,0.68,-0.8878,0.6,0.9
"GO_BP:751319_GO_0038061_NIK_NF_KAPPAB_SIGNALING","GO_BP","751319_GO_0038061_NIK_NF_KAPPAB_SIGNALING",31,0.6292,0.98,1,1.196,0.2,0.79,1.2012,0.2,0.72
"REACTOME:645292_REACT_120850_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS","REACTOME","645292_REACT_120850_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS",32,0.6295,0.98,1,1.3135,0.13,0.31,0.5666,0.99,1
"KEGG_reaction:R06075_GDP_L_FUCOSE_SIALYL_3_PARAGLOBOSIDE_GDP_IV3NEUAC_III3FUC_NLC4CER","KEGG_reaction","R06075_GDP_L_FUCOSE_SIALYL_3_PARAGLOBOSIDE_GDP_IV3NEUAC_III3FUC_NLC4CER",5,0.6301,0.92,1,-0.6926,0.82,1,-0.9143,0.59,0.72
"GO_BP:487777_GO_0001881_RECEPTOR_RECYCLING","GO_BP","487777_GO_0001881_RECEPTOR_RECYCLING",8,0.6309,0.92,1,0.6654,0.88,1,1.2319,0.22,0.71
"GO_MF:754434_GO_1901474_AZOLE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","754434_GO_1901474_AZOLE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,0.6311,0.91,1,0.5139,0.97,1,1.0699,0.37,0.82
"GO_MF:496334_GO_0016274_PROTEIN_ARGININE_N_METHYLTRANSFERASE_ACTIVITY","GO_MF","496334_GO_0016274_PROTEIN_ARGININE_N_METHYLTRANSFERASE_ACTIVITY",9,0.6312,0.92,1,-0.7196,0.82,1,-1.2793,0.19,0.59
"GO_BP:496522_GO_0016574_HISTONE_UBIQUITINATION","GO_BP","496522_GO_0016574_HISTONE_UBIQUITINATION",36,0.6316,0.99,1,0.7909,0.82,1,-0.6967,0.94,0.99
"KEGG_module:HSA_M00290_HOLO_TFIIH_COMPLEX","KEGG_module","HSA_M00290_HOLO_TFIIH_COMPLEX",11,0.6318,0.92,0.94,1.1799,0.25,0.55,-0.4839,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2008_LI_CYTIDINE_ANALOGS_CYCTOTOXICITY","C2_Chemical_and_genetic_perturbations","C2_CGP_2008_LI_CYTIDINE_ANALOGS_CYCTOTOXICITY",15,0.6319,0.96,1,1.1456,0.27,0.56,0.6814,0.91,1
"C4_Cancer_gene_neighborhoods:C4_CGN_11_MORF_CTBP1","C4_Cancer_gene_neighborhoods","C4_CGN_11_MORF_CTBP1",169,0.632,1,1,2.3985,0,0,-0.8025,0.94,1
"GO_BP:504692_GO_0035511_OXIDATIVE_DNA_DEMETHYLATION","GO_BP","504692_GO_0035511_OXIDATIVE_DNA_DEMETHYLATION",7,0.6322,0.91,1,0.927,0.53,1,-1.0207,0.42,0.83
"GO_BP:751438_GO_0039531_REGULATION_OF_VIRAL_INDUCED_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY","GO_BP","751438_GO_0039531_REGULATION_OF_VIRAL_INDUCED_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY",11,0.6331,0.94,1,1.0885,0.36,0.92,-0.9545,0.52,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_148_LAIHO_COLORECTAL_CANCER_SERRATED_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_148_LAIHO_COLORECTAL_CANCER_SERRATED_DN",84,0.6339,1,1,-1.1536,0.22,0.85,-1.2187,0.087,0.5
"GO_MF:496333_GO_0016273_ARGININE_N_METHYLTRANSFERASE_ACTIVITY","GO_MF","496333_GO_0016273_ARGININE_N_METHYLTRANSFERASE_ACTIVITY",9,0.6339,0.91,1,-0.7218,0.82,1,-1.2789,0.18,0.59
"GO_MF:489820_GO_0004468_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY_ACTING_ON_ACETYL_PHOSPHATE_AS_DONOR","GO_MF","489820_GO_0004468_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY_ACTING_ON_ACETYL_PHOSPHATE_AS_DONOR",5,0.634,0.88,1,-1.2162,0.25,0.83,-0.6514,0.87,1
"REACTOME:106161_REACT_11203_ER_TO_GOLGI_TRANSPORT","REACTOME","106161_REACT_11203_ER_TO_GOLGI_TRANSPORT",9,0.635,0.93,1,0.6703,0.89,1,-0.599,0.94,1
"GO_BP:868044_GO_0044803_MULTI_ORGANISM_MEMBRANE_ORGANIZATION","GO_BP","868044_GO_0044803_MULTI_ORGANISM_MEMBRANE_ORGANIZATION",19,0.6357,0.94,1,1.2302,0.19,0.75,1.1617,0.28,0.73
"GO_BP:491969_GO_0007164_ESTABLISHMENT_OF_TISSUE_POLARITY","GO_BP","491969_GO_0007164_ESTABLISHMENT_OF_TISSUE_POLARITY",15,0.636,0.94,1,1.0838,0.36,0.92,1.0793,0.37,0.77
"GO_BP:868045_GO_0044804_NUCLEOPHAGY","GO_BP","868045_GO_0044804_NUCLEOPHAGY",25,0.6368,0.96,1,1.1694,0.22,0.81,0.4883,1,1
"WikiPathways:755437_WP2113_TYPE_III_INTERFERON_SIGNALING","WikiPathways","755437_WP2113_TYPE_III_INTERFERON_SIGNALING",10,0.6371,0.92,1,-0.5556,0.97,1,-0.8543,0.66,0.92
"GO_BP:503704_GO_0034502_PROTEIN_LOCALIZATION_TO_CHROMOSOME","GO_BP","503704_GO_0034502_PROTEIN_LOCALIZATION_TO_CHROMOSOME",31,0.6378,0.98,1,1.0766,0.34,0.93,-0.9989,0.43,0.85
"REACTOME:105921_REACT_6305_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_","REACTOME","105921_REACT_6305_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_",96,0.6381,1,1,2.7197,0,0,0.5492,1,1
"GO_MF:506212_GO_0043139_5_3_DNA_HELICASE_ACTIVITY","GO_MF","506212_GO_0043139_5_3_DNA_HELICASE_ACTIVITY",7,0.6384,0.89,1,0.5532,0.96,1,-0.5839,0.95,1
"GO_BP:514519_GO_0060964_REGULATION_OF_GENE_SILENCING_BY_MIRNA","GO_BP","514519_GO_0060964_REGULATION_OF_GENE_SILENCING_BY_MIRNA",9,0.6397,0.93,1,-1.2477,0.21,0.91,-1.107,0.34,0.77
"OMIM_gene:OMIM172480_PHOSPHOSERINE_PHOSPHATASE_PSPH","OMIM_gene","OMIM172480_PHOSPHOSERINE_PHOSPHATASE_PSPH",5,0.64,0.88,1,0.6918,0.86,1,-1.101,0.38,1
"GO_BP:487034_GO_0000737_DNA_CATABOLIC_PROCESS_ENDONUCLEOLYTIC","GO_BP","487034_GO_0000737_DNA_CATABOLIC_PROCESS_ENDONUCLEOLYTIC",59,0.6402,0.99,1,1.1724,0.19,0.81,-0.741,0.93,1
"REACTOME:106535_REACT_15461_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS","REACTOME","106535_REACT_15461_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS",15,0.6403,0.95,1,-1.8224,0.0042,0.071,1.193,0.25,0.84
"GO_MF:487122_GO_0000832_INOSITOL_HEXAKISPHOSPHATE_5_KINASE_ACTIVITY","GO_MF","487122_GO_0000832_INOSITOL_HEXAKISPHOSPHATE_5_KINASE_ACTIVITY",5,0.6407,0.89,1,-0.4693,1,1,-0.6122,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1210_NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1210_NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON",21,0.6413,0.95,1,0.646,0.96,1,0.9395,0.55,1
"REACTOME:106162_REACT_12507_COPII_COAT_PROTEIN_2_MEDIATED_VESICLE_TRANSPORT","REACTOME","106162_REACT_12507_COPII_COAT_PROTEIN_2_MEDIATED_VESICLE_TRANSPORT",9,0.6418,0.9,1,0.6775,0.87,1,-0.6106,0.91,1
"C3_TF_targets:C3_TFT_424_V_YY1_Q6","C3_TF_targets","C3_TFT_424_V_YY1_Q6",246,0.642,1,0.99,1.0434,0.33,1,-0.7246,1,1
"GO_BP:495316_GO_0015015_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_ENZYMATIC_MODIFICATION","GO_BP","495316_GO_0015015_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_ENZYMATIC_MODIFICATION",5,0.6426,0.89,1,1.5919,0.022,0.31,1.6284,0.031,0.41
"C4_Cancer_gene_neighborhoods:C4_CGN_97_MORF_ERH","C4_Cancer_gene_neighborhoods","C4_CGN_97_MORF_ERH",115,0.644,1,1,2.6514,0,0,-0.8866,0.71,1
"GO_MF:507510_GO_0045118_AZOLE_TRANSPORTER_ACTIVITY","GO_MF","507510_GO_0045118_AZOLE_TRANSPORTER_ACTIVITY",6,0.6448,0.9,1,0.5071,0.98,1,1.0829,0.36,0.81
"GO_BP:512462_GO_0051584_REGULATION_OF_DOPAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION","GO_BP","512462_GO_0051584_REGULATION_OF_DOPAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION",9,0.6451,0.89,1,1.0213,0.43,0.97,0.5798,0.96,1
"GO_MF:492519_GO_0008171_O_METHYLTRANSFERASE_ACTIVITY","GO_MF","492519_GO_0008171_O_METHYLTRANSFERASE_ACTIVITY",16,0.6452,0.93,1,1.136,0.29,0.75,0.7827,0.77,1
"KEGG_enzyme:2.7.4.21_INOSITOL_HEXAKISPHOSPHATE_KINASE_ATP_1D_MYO_INOSITOL_HEXAKISPHOSPHATE_PHOSPHOTRANSFERASE_IP6K","KEGG_enzyme","2.7.4.21_INOSITOL_HEXAKISPHOSPHATE_KINASE_ATP_1D_MYO_INOSITOL_HEXAKISPHOSPHATE_PHOSPHOTRANSFERASE_IP6K",5,0.6453,0.88,0.97,-0.4594,0.99,0.99,-0.6181,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2473_BOYLAN_MULTIPLE_MYELOMA_C_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2473_BOYLAN_MULTIPLE_MYELOMA_C_UP",47,0.6453,0.99,1,1.1383,0.23,0.57,0.8567,0.71,1
"GO_BP:518293_GO_0090153_REGULATION_OF_SPHINGOLIPID_BIOSYNTHETIC_PROCESS","GO_BP","518293_GO_0090153_REGULATION_OF_SPHINGOLIPID_BIOSYNTHETIC_PROCESS",7,0.6458,0.89,1,-0.7515,0.78,1,0.7861,0.73,1
"GO_BP:503700_GO_0034498_EARLY_ENDOSOME_TO_GOLGI_TRANSPORT","GO_BP","503700_GO_0034498_EARLY_ENDOSOME_TO_GOLGI_TRANSPORT",10,0.6459,0.93,1,1.0978,0.34,0.9,-0.6136,0.93,1
"C4_Cancer_modules:C4_CM_52_MODULE_56","C4_Cancer_modules","C4_CM_52_MODULE_56",12,0.6468,0.92,1,0.9622,0.5,0.76,-0.7652,0.77,0.99
"GO_BP:493410_GO_0009214_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS","GO_BP","493410_GO_0009214_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS",17,0.6474,0.94,1,-1.1073,0.31,0.94,-1.3213,0.13,0.63
"GO_CC:515461_GO_0070531_BRCA1_A_COMPLEX","GO_CC","515461_GO_0070531_BRCA1_A_COMPLEX",7,0.6475,0.89,1,1.1637,0.28,0.57,-0.8629,0.63,1
"GO_BP:1039917_GO_1903363_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS","GO_BP","1039917_GO_1903363_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS",74,0.6482,1,1,1.1899,0.15,0.79,-0.9338,0.61,0.9
"GO_BP:494890_GO_0010826_NEGATIVE_REGULATION_OF_CENTROSOME_DUPLICATION","GO_BP","494890_GO_0010826_NEGATIVE_REGULATION_OF_CENTROSOME_DUPLICATION",10,0.6487,0.89,1,1.0746,0.35,0.93,0.9474,0.49,0.9
"GO_BP:500324_GO_0031034_MYOSIN_FILAMENT_ASSEMBLY","GO_BP","500324_GO_0031034_MYOSIN_FILAMENT_ASSEMBLY",5,0.6488,0.88,1,-1.5468,0.032,0.75,-0.9447,0.51,0.89
"REACTOME:161029_REACT_22352_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS","REACTOME","161029_REACT_22352_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS",10,0.649,0.89,1,-1.7809,0.0058,0.091,1.3035,0.18,0.76
"REACTOME:161027_REACT_22126_ACTIVATION_OF_NICOTINIC_ACETYLCHOLINE_RECEPTORS","REACTOME","161027_REACT_22126_ACTIVATION_OF_NICOTINIC_ACETYLCHOLINE_RECEPTORS",15,0.6491,0.92,1,-1.8715,0.006,0.058,1.18,0.24,0.86
"GO_BP:514702_GO_0061157_MRNA_DESTABILIZATION","GO_BP","514702_GO_0061157_MRNA_DESTABILIZATION",7,0.6492,0.89,1,0.6467,0.9,1,-0.9511,0.51,0.89
"GO_MF:515498_GO_0070568_GUANYLYLTRANSFERASE_ACTIVITY","GO_MF","515498_GO_0070568_GUANYLYLTRANSFERASE_ACTIVITY",5,0.6495,0.89,1,0.6888,0.84,1,0.6402,0.86,1
"GO_CC:911279_GO_0036452_ESCRT_COMPLEX","GO_CC","911279_GO_0036452_ESCRT_COMPLEX",21,0.6497,0.95,1,1.4161,0.072,0.28,0.9522,0.51,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3171_VANDESLUIS_NORMAL_EMBRYOS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3171_VANDESLUIS_NORMAL_EMBRYOS_UP",5,0.6502,0.9,1,1.2894,0.21,0.4,1.0407,0.41,0.92
"GO_CC:501626_GO_0032391_PHOTORECEPTOR_CONNECTING_CILIUM","GO_CC","501626_GO_0032391_PHOTORECEPTOR_CONNECTING_CILIUM",31,0.6505,0.98,1,-0.7628,0.85,1,-0.8917,0.64,1
"GO_CC:983672_GO_0090568_NUCLEAR_TRANSCRIPTIONAL_REPRESSOR_COMPLEX","GO_CC","983672_GO_0090568_NUCLEAR_TRANSCRIPTIONAL_REPRESSOR_COMPLEX",20,0.6507,0.93,1,-0.7069,0.87,1,-1.1192,0.29,0.9
"GO_CC:496547_GO_0016605_PML_BODY","GO_CC","496547_GO_0016605_PML_BODY",92,0.6513,1,1,1.198,0.14,0.53,0.6942,0.98,1
"GO_BP:511852_GO_0050917_SENSORY_PERCEPTION_OF_UMAMI_TASTE","GO_BP","511852_GO_0050917_SENSORY_PERCEPTION_OF_UMAMI_TASTE",6,0.6514,0.9,1,-1.3289,0.16,0.89,-0.9715,0.51,0.87
"GO_BP:494579_GO_0010510_REGULATION_OF_ACETYL_COA_BIOSYNTHETIC_PROCESS_FROM_PYRUVATE","GO_BP","494579_GO_0010510_REGULATION_OF_ACETYL_COA_BIOSYNTHETIC_PROCESS_FROM_PYRUVATE",12,0.6518,0.92,1,1.2166,0.21,0.77,-1.0888,0.34,0.78
"GO_BP:753211_GO_1900221_REGULATION_OF_BETA_AMYLOID_CLEARANCE","GO_BP","753211_GO_1900221_REGULATION_OF_BETA_AMYLOID_CLEARANCE",6,0.6518,0.9,1,-1.0675,0.4,0.96,0.9401,0.54,0.91
"REACTOME:833808_REACT_163812_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1_","REACTOME","833808_REACT_163812_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1_",5,0.652,0.89,1,1.6231,0.018,0.083,0.6671,0.86,1
"GO_BP:512790_GO_0051940_REGULATION_OF_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION","GO_BP","512790_GO_0051940_REGULATION_OF_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION",9,0.6537,0.88,1,1.0067,0.45,0.98,0.5842,0.94,1
"GO_BP:514187_GO_0060632_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT","GO_BP","514187_GO_0060632_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT",15,0.6538,0.94,1,0.7712,0.77,1,-1.1279,0.29,0.76
"GO_MF:487118_GO_0000828_INOSITOL_HEXAKISPHOSPHATE_KINASE_ACTIVITY","GO_MF","487118_GO_0000828_INOSITOL_HEXAKISPHOSPHATE_KINASE_ACTIVITY",5,0.654,0.86,1,-0.4559,0.99,1,-0.6061,0.93,1
"GO_BP:513946_GO_0060390_REGULATION_OF_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS","GO_BP","513946_GO_0060390_REGULATION_OF_SMAD_PROTEIN_IMPORT_INTO_NUCLEUS",14,0.6541,0.94,1,-1.0521,0.38,0.97,-0.7664,0.77,1
"GO_MF:751938_GO_0052723_INOSITOL_HEXAKISPHOSPHATE_1_KINASE_ACTIVITY","GO_MF","751938_GO_0052723_INOSITOL_HEXAKISPHOSPHATE_1_KINASE_ACTIVITY",5,0.6547,0.85,1,-0.4614,1,1,-0.6123,0.92,1
"GO_BP:982452_GO_1902884_POSITIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS","GO_BP","982452_GO_1902884_POSITIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS",10,0.6549,0.91,1,0.9828,0.48,1,-1.0984,0.34,0.78
"GO_BP:500323_GO_0031033_MYOSIN_FILAMENT_ORGANIZATION","GO_BP","500323_GO_0031033_MYOSIN_FILAMENT_ORGANIZATION",5,0.6568,0.87,1,-1.5066,0.046,0.82,-0.9267,0.55,0.9
"REACTOME:771586_REACT_160083_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION_","REACTOME","771586_REACT_160083_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION_",6,0.657,0.89,1,1.2582,0.19,0.37,1.3126,0.18,0.75
"C3_MicroRNA_targets:C3_MIR_90_TCTAGAG_MIR_517","C3_MicroRNA_targets","C3_MIR_90_TCTAGAG_MIR_517",45,0.6581,0.97,1,0.8131,0.8,1,0.6834,0.96,1
"GO_BP:499171_GO_0021892_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DIFFERENTIATION","GO_BP","499171_GO_0021892_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DIFFERENTIATION",8,0.6582,0.91,1,-1.5315,0.05,0.77,-1.0964,0.34,0.78
"REACTOME:161032_REACT_22303_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS","REACTOME","161032_REACT_22303_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS",12,0.6588,0.91,1,-1.747,0.0058,0.12,1.4886,0.07,0.54
"REACTOME:105740_REACT_2254_G1_S_DNA_DAMAGE_CHECKPOINTS","REACTOME","105740_REACT_2254_G1_S_DNA_DAMAGE_CHECKPOINTS",60,0.659,0.96,1,1.804,0,0.02,-1.0103,0.44,0.82
"GO_BP:503924_GO_0034724_DNA_REPLICATION_INDEPENDENT_NUCLEOSOME_ORGANIZATION","GO_BP","503924_GO_0034724_DNA_REPLICATION_INDEPENDENT_NUCLEOSOME_ORGANIZATION",53,0.6592,0.99,1,-0.9086,0.62,1,-1.4948,0.019,0.54
"GO_MF:492779_GO_0008499_UDP_GALACTOSE_BETA_N_ACETYLGLUCOSAMINE_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY","GO_MF","492779_GO_0008499_UDP_GALACTOSE_BETA_N_ACETYLGLUCOSAMINE_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY",7,0.6594,0.88,1,1.3787,0.13,0.49,1.5022,0.057,0.43
"GO_MF:751939_GO_0052724_INOSITOL_HEXAKISPHOSPHATE_3_KINASE_ACTIVITY","GO_MF","751939_GO_0052724_INOSITOL_HEXAKISPHOSPHATE_3_KINASE_ACTIVITY",5,0.6597,0.85,1,-0.4566,1,1,-0.6002,0.94,1
"OMIM_gene:OMIM604061_SEPTIN_9_SEPT9","OMIM_gene","OMIM604061_SEPTIN_9_SEPT9",5,0.6601,0.86,1,-0.8102,0.68,1,-0.7088,0.84,1
"REACTOME:106366_REACT_16968_DOPAMINE_RECEPTORS","REACTOME","106366_REACT_16968_DOPAMINE_RECEPTORS",5,0.6604,0.86,1,1.2165,0.28,0.43,1.4452,0.089,0.61
"C3_TF_targets:C3_TFT_520_TCCCRNNRTGC_UNKNOWN","C3_TF_targets","C3_TFT_520_TCCCRNNRTGC_UNKNOWN",211,0.6609,1,1,0.9775,0.52,1,-1.2395,0.048,0.3
"GO_BP:508069_GO_0045725_POSITIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS","GO_BP","508069_GO_0045725_POSITIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS",14,0.661,0.9,1,-0.6062,0.95,1,1.054,0.41,0.8
"GO_BP:502354_GO_0033133_POSITIVE_REGULATION_OF_GLUCOKINASE_ACTIVITY","GO_BP","502354_GO_0033133_POSITIVE_REGULATION_OF_GLUCOKINASE_ACTIVITY",5,0.6617,0.89,1,1.0112,0.46,0.98,1.1849,0.31,0.72
"REACTOME:105770_REACT_1574_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION","REACTOME","105770_REACT_1574_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION",65,0.6626,1,1,2.1437,0,0.00036,-0.6998,0.98,1
"GO_BP:504431_GO_0035247_PEPTIDYL_ARGININE_OMEGA_N_METHYLATION","GO_BP","504431_GO_0035247_PEPTIDYL_ARGININE_OMEGA_N_METHYLATION",8,0.6632,0.91,1,-0.7575,0.78,1,-1.3104,0.16,0.64
"GO_BP:849955_GO_1902254_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR","GO_BP","849955_GO_1902254_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR",16,0.6637,0.91,1,-0.7342,0.83,1,0.9879,0.46,0.87
"GO_MF:496337_GO_0016278_LYSINE_N_METHYLTRANSFERASE_ACTIVITY","GO_MF","496337_GO_0016278_LYSINE_N_METHYLTRANSFERASE_ACTIVITY",47,0.664,0.99,1,-1.0603,0.34,0.86,-0.9709,0.53,0.8
"REACTOME:730313_REACT_150266_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION","REACTOME","730313_REACT_150266_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION",11,0.664,0.9,1,1.2226,0.23,0.42,-0.723,0.82,1
"REACTOME:105863_REACT_1587_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS","REACTOME","105863_REACT_1587_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS",17,0.6642,0.93,1,-0.7045,0.87,1,-1.2801,0.16,0.54
"C4_Cancer_gene_neighborhoods:C4_CGN_34_MORF_RAD21","C4_Cancer_gene_neighborhoods","C4_CGN_34_MORF_RAD21",182,0.6643,1,1,2.3566,0,0,-0.7255,1,1
"GO_BP:487614_GO_0001711_ENDODERMAL_CELL_FATE_COMMITMENT","GO_BP","487614_GO_0001711_ENDODERMAL_CELL_FATE_COMMITMENT",13,0.6653,0.9,1,0.7483,0.81,1,0.8786,0.63,0.96
"GO_BP:495991_GO_0015867_ATP_TRANSPORT","GO_BP","495991_GO_0015867_ATP_TRANSPORT",6,0.6659,0.87,1,0.8535,0.66,1,-0.9607,0.51,0.88
"OMIM_gene:OMIM606382_MEMBRANE_ASSOCIATED_GUANYLATE_KINASE_WW_AND_PDZ_DOMAINS_CONTAINING_2_MAGI2","OMIM_gene","OMIM606382_MEMBRANE_ASSOCIATED_GUANYLATE_KINASE_WW_AND_PDZ_DOMAINS_CONTAINING_2_MAGI2",6,0.6666,0.87,1,0.6311,0.9,1,-0.5075,0.98,1
"GO_BP:753393_GO_1900409_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS","GO_BP","753393_GO_1900409_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS",10,0.6668,0.92,1,1.0131,0.43,0.97,-1.102,0.34,0.77
"REACTOME:105862_REACT_1874_HOMOLOGOUS_RECOMBINATION_REPAIR","REACTOME","105862_REACT_1874_HOMOLOGOUS_RECOMBINATION_REPAIR",17,0.6669,0.93,1,-0.7085,0.88,1,-1.2684,0.17,0.55
"KEGG_compound:C00330_DEOXYGUANOSINE_2_DEOXYGUANOSINE","KEGG_compound","C00330_DEOXYGUANOSINE_2_DEOXYGUANOSINE",11,0.6672,0.91,1,0.8788,0.6,1,-0.945,0.53,0.71
"C1_Positional:C1_ALL_172_CHR11P","C1_Positional","C1_ALL_172_CHR11P",5,0.6673,0.87,0.99,1.5934,0.016,0.23,0.6499,0.86,0.98
"GO_BP:497177_GO_0018206_PEPTIDYL_METHIONINE_MODIFICATION","GO_BP","497177_GO_0018206_PEPTIDYL_METHIONINE_MODIFICATION",10,0.6675,0.89,1,1.0983,0.34,0.91,1.0933,0.34,0.77
"C4_Cancer_gene_neighborhoods:C4_CGN_44_MORF_RRM1","C4_Cancer_gene_neighborhoods","C4_CGN_44_MORF_RRM1",102,0.6676,1,1,1.8426,0,0.0014,-1.2535,0.085,0.36
"C2_Chemical_and_genetic_perturbations:C2_CGP_3356_HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3356_HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN",25,0.668,0.94,1,1.6302,0.019,0.12,1.6865,0.0041,0.27
"KEGG_compound:C00299_URIDINE","KEGG_compound","C00299_URIDINE",15,0.668,0.92,1,0.5409,0.99,1,-0.8178,0.7,0.83
"GO_CC:500382_GO_0031095_PLATELET_DENSE_TUBULAR_NETWORK_MEMBRANE","GO_CC","500382_GO_0031095_PLATELET_DENSE_TUBULAR_NETWORK_MEMBRANE",9,0.6681,0.9,1,-1.2574,0.19,0.67,-1.0088,0.43,1
"GO_BP:912528_GO_0044819_MITOTIC_G1_S_TRANSITION_CHECKPOINT","GO_BP","912528_GO_0044819_MITOTIC_G1_S_TRANSITION_CHECKPOINT",77,0.6683,1,1,1.6106,0.011,0.28,-0.8156,0.83,0.98
"C4_Cancer_gene_neighborhoods:C4_CGN_12_MORF_CCNF","C4_Cancer_gene_neighborhoods","C4_CGN_12_MORF_CCNF",78,0.6684,1,1,0.8927,0.67,0.84,-0.9008,0.66,1
"GO_BP:508860_GO_0046606_NEGATIVE_REGULATION_OF_CENTROSOME_CYCLE","GO_BP","508860_GO_0046606_NEGATIVE_REGULATION_OF_CENTROSOME_CYCLE",10,0.6687,0.89,1,1.0727,0.37,0.93,0.9456,0.52,0.91
"GO_MF:489774_GO_0004415_HYALURONONGLUCOSAMINIDASE_ACTIVITY","GO_MF","489774_GO_0004415_HYALURONONGLUCOSAMINIDASE_ACTIVITY",8,0.6687,0.88,1,0.6816,0.87,1,0.9956,0.46,0.88
"GO_CC:490749_GO_0005697_TELOMERASE_HOLOENZYME_COMPLEX","GO_CC","490749_GO_0005697_TELOMERASE_HOLOENZYME_COMPLEX",6,0.6687,0.86,1,-0.688,0.83,1,0.7902,0.71,1
"GO_BP:755127_GO_2001021_NEGATIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS","GO_BP","755127_GO_2001021_NEGATIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS",45,0.6689,0.98,1,1.1754,0.21,0.81,0.9748,0.48,0.88
"GO_BP:1051070_GO_1903430_NEGATIVE_REGULATION_OF_CELL_MATURATION","GO_BP","1051070_GO_1903430_NEGATIVE_REGULATION_OF_CELL_MATURATION",7,0.6694,0.88,1,0.9639,0.5,1,1.4296,0.088,0.61
"GO_BP:849925_GO_1902224_KETONE_BODY_METABOLIC_PROCESS","GO_BP","849925_GO_1902224_KETONE_BODY_METABOLIC_PROCESS",9,0.6697,0.89,1,1.2019,0.25,0.78,-0.6586,0.89,1
"GO_MF:500843_GO_0031593_POLYUBIQUITIN_BINDING","GO_MF","500843_GO_0031593_POLYUBIQUITIN_BINDING",36,0.6698,0.94,1,-0.935,0.56,0.96,-1.1427,0.27,0.65
"GO_MF:496556_GO_0016615_MALATE_DEHYDROGENASE_ACTIVITY","GO_MF","496556_GO_0016615_MALATE_DEHYDROGENASE_ACTIVITY",7,0.6699,0.86,1,1.2267,0.21,0.7,1.0861,0.36,0.81
"GO_BP:519378_GO_2000739_REGULATION_OF_MESENCHYMAL_STEM_CELL_DIFFERENTIATION","GO_BP","519378_GO_2000739_REGULATION_OF_MESENCHYMAL_STEM_CELL_DIFFERENTIATION",6,0.6699,0.86,1,0.8544,0.65,1,0.8412,0.66,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2362_GRATIAS_RETINOBLASTOMA_16Q24","C2_Chemical_and_genetic_perturbations","C2_CGP_2362_GRATIAS_RETINOBLASTOMA_16Q24",17,0.6706,0.91,1,1.0468,0.4,0.72,1.0331,0.41,0.93
"GO_BP:503288_GO_0034080_CENP_A_CONTAINING_NUCLEOSOME_ASSEMBLY","GO_BP","503288_GO_0034080_CENP_A_CONTAINING_NUCLEOSOME_ASSEMBLY",42,0.6707,0.97,1,-0.9525,0.53,1,-1.3842,0.062,0.59
"REACTOME:1127496_REACT_264544_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION","REACTOME","1127496_REACT_264544_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION",10,0.6708,0.89,1,0.847,0.63,0.96,1.3739,0.11,0.73
"GO_CC:487156_GO_0000932_CYTOPLASMIC_MRNA_PROCESSING_BODY","GO_CC","487156_GO_0000932_CYTOPLASMIC_MRNA_PROCESSING_BODY",62,0.6709,1,1,0.7692,0.92,0.97,-0.978,0.49,1
"GO_MF:492579_GO_0008252_NUCLEOTIDASE_ACTIVITY","GO_MF","492579_GO_0008252_NUCLEOTIDASE_ACTIVITY",15,0.6712,0.91,1,0.5383,0.98,1,-1.5319,0.026,0.39
"GO_BP:1039895_GO_0061641_CENP_A_CONTAINING_CHROMATIN_ORGANIZATION","GO_BP","1039895_GO_0061641_CENP_A_CONTAINING_CHROMATIN_ORGANIZATION",42,0.6714,0.96,1,-0.9588,0.52,1,-1.3805,0.058,0.59
"GO_BP:514524_GO_0060969_NEGATIVE_REGULATION_OF_GENE_SILENCING","GO_BP","514524_GO_0060969_NEGATIVE_REGULATION_OF_GENE_SILENCING",15,0.6718,0.91,1,0.5982,0.95,1,-0.7297,0.83,0.99
"GO_BP:493385_GO_0009189_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493385_GO_0009189_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS",5,0.6719,0.84,1,0.9428,0.52,1,-1.0119,0.43,0.84
"GO_CC:490763_GO_0005721_PERICENTRIC_HETEROCHROMATIN","GO_CC","490763_GO_0005721_PERICENTRIC_HETEROCHROMATIN",14,0.672,0.91,1,0.5157,0.99,1,-0.9136,0.58,1
"GO_BP:491280_GO_0006336_DNA_REPLICATION_INDEPENDENT_NUCLEOSOME_ASSEMBLY","GO_BP","491280_GO_0006336_DNA_REPLICATION_INDEPENDENT_NUCLEOSOME_ASSEMBLY",53,0.6723,0.98,1,-0.8969,0.68,1,-1.4946,0.024,0.54
"C4_Cancer_gene_neighborhoods:C4_CGN_286_GNF2_BUB3","C4_Cancer_gene_neighborhoods","C4_CGN_286_GNF2_BUB3",28,0.6723,0.94,1,1.8394,0.0022,0.0015,-1.1017,0.31,0.62
"GO_MF:496338_GO_0016279_PROTEIN_LYSINE_N_METHYLTRANSFERASE_ACTIVITY","GO_MF","496338_GO_0016279_PROTEIN_LYSINE_N_METHYLTRANSFERASE_ACTIVITY",47,0.6723,0.96,1,-1.0763,0.32,0.86,-0.9614,0.52,0.82
"GO_MF:492755_GO_0008469_HISTONE_ARGININE_N_METHYLTRANSFERASE_ACTIVITY","GO_MF","492755_GO_0008469_HISTONE_ARGININE_N_METHYLTRANSFERASE_ACTIVITY",8,0.6727,0.88,1,-0.7587,0.78,1,-1.3009,0.17,0.57
"C3_TF_targets:C3_TFT_488_GGGNRMNNYCAT_UNKNOWN","C3_TF_targets","C3_TFT_488_GGGNRMNNYCAT_UNKNOWN",79,0.6731,1,1,0.9214,0.61,1,0.645,0.99,1
"GO_MF:498066_GO_0019211_PHOSPHATASE_ACTIVATOR_ACTIVITY","GO_MF","498066_GO_0019211_PHOSPHATASE_ACTIVATOR_ACTIVITY",11,0.6733,0.88,1,1.4485,0.064,0.43,0.581,0.96,1
"C4_Cancer_modules:C4_CM_24_MODULE_25","C4_Cancer_modules","C4_CM_24_MODULE_25",13,0.6734,0.91,1,1.9301,0,0.0064,0.6696,0.9,1
"OMIM_gene:OMIM609205_DAB2_INTERACTING_PROTEIN_DAB2IP","OMIM_gene","OMIM609205_DAB2_INTERACTING_PROTEIN_DAB2IP",6,0.6744,0.87,1,0.6518,0.88,1,-0.5242,0.98,1
"REACTOME:161031_REACT_22149_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS","REACTOME","161031_REACT_22149_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS",15,0.6746,0.91,1,-1.8389,0.0061,0.067,1.1756,0.25,0.87
"GO_BP:494293_GO_0010216_MAINTENANCE_OF_DNA_METHYLATION","GO_BP","494293_GO_0010216_MAINTENANCE_OF_DNA_METHYLATION",5,0.6753,0.84,1,-0.7721,0.72,1,-0.729,0.79,0.99
"GO_CC:515401_GO_0070469_RESPIRATORY_CHAIN","GO_CC","515401_GO_0070469_RESPIRATORY_CHAIN",69,0.6755,0.99,1,2.6263,0,0,0.7095,0.97,1
"REACTOME:105783_REACT_9029_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY","REACTOME","105783_REACT_9029_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY",66,0.6761,0.99,1,2.1546,0,0.00026,-0.7504,0.92,1
"GO_BP:1026073_GO_1903301_POSITIVE_REGULATION_OF_HEXOKINASE_ACTIVITY","GO_BP","1026073_GO_1903301_POSITIVE_REGULATION_OF_HEXOKINASE_ACTIVITY",5,0.6761,0.84,1,1.0219,0.44,0.97,1.1857,0.3,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_1087_RICKMAN_HEAD_AND_NECK_CANCER_B","C2_Chemical_and_genetic_perturbations","C2_CGP_1087_RICKMAN_HEAD_AND_NECK_CANCER_B",43,0.6764,0.96,1,1.0204,0.41,0.77,-0.8862,0.68,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1807_IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM","C2_Chemical_and_genetic_perturbations","C2_CGP_1807_IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM",31,0.6764,0.95,1,1.1365,0.24,0.57,-0.808,0.78,0.95
"GO_BP:500552_GO_0031293_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS","GO_BP","500552_GO_0031293_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS",17,0.6764,0.94,1,0.7678,0.82,1,-0.6711,0.93,1
"GO_BP:492254_GO_0007501_MESODERMAL_CELL_FATE_SPECIFICATION","GO_BP","492254_GO_0007501_MESODERMAL_CELL_FATE_SPECIFICATION",6,0.6765,0.84,1,1.5108,0.058,0.39,-0.8521,0.64,0.96
"GO_BP:491619_GO_0006734_NADH_METABOLIC_PROCESS","GO_BP","491619_GO_0006734_NADH_METABOLIC_PROCESS",9,0.6767,0.87,1,0.7776,0.76,1,-1.2351,0.22,0.7
"OMIM_gene:OMIM606235_THIOREDOXIN_REDUCTASE_3_TXNRD3","OMIM_gene","OMIM606235_THIOREDOXIN_REDUCTASE_3_TXNRD3",6,0.6775,0.87,1,0.6658,0.87,1,-1.3701,0.14,1
"GO_CC:516465_GO_0071541_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX_EIF3M","GO_CC","516465_GO_0071541_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX_EIF3M",7,0.6777,0.88,1,1.931,0,0.0071,0.9848,0.47,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1123_STARK_HYPPOCAMPUS_22Q11_DELETION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1123_STARK_HYPPOCAMPUS_22Q11_DELETION_DN",19,0.6785,0.92,1,-0.5528,0.98,1,-1.0545,0.37,0.68
"GO_MF:489465_GO_0003993_ACID_PHOSPHATASE_ACTIVITY","GO_MF","489465_GO_0003993_ACID_PHOSPHATASE_ACTIVITY",11,0.6795,0.87,1,1.379,0.11,0.49,0.5695,0.97,1
"WikiPathways:198787_WP78_TCA_CYCLE","WikiPathways","198787_WP78_TCA_CYCLE",17,0.6816,0.89,1,1.676,0.014,0.11,-1.2116,0.2,0.53
"GO_MF:492580_GO_0008253_5_NUCLEOTIDASE_ACTIVITY","GO_MF","492580_GO_0008253_5_NUCLEOTIDASE_ACTIVITY",13,0.6818,0.89,1,0.5188,0.99,1,-1.4517,0.066,0.43
"GO_BP:518469_GO_0090329_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION","GO_BP","518469_GO_0090329_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION",35,0.6818,0.95,1,0.7151,0.91,1,-0.9373,0.56,0.9
"GO_MF:495391_GO_0015116_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495391_GO_0015116_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",12,0.6819,0.88,1,1.144,0.29,0.76,1.1546,0.28,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2998_HOFFMAN_CLOCK_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2998_HOFFMAN_CLOCK_TARGETS_DN",10,0.682,0.86,1,1.4733,0.07,0.23,-0.6997,0.85,0.99
"GO_BP:512458_GO_0051580_REGULATION_OF_NEUROTRANSMITTER_UPTAKE","GO_BP","512458_GO_0051580_REGULATION_OF_NEUROTRANSMITTER_UPTAKE",13,0.6824,0.89,1,-1.2239,0.21,0.88,-0.7538,0.8,1
"REACTOME:105881_REACT_1022_NONHOMOLOGOUS_END_JOINING_NHEJ_","REACTOME","105881_REACT_1022_NONHOMOLOGOUS_END_JOINING_NHEJ_",6,0.6826,0.87,1,1.2461,0.2,0.4,0.8705,0.61,1
"KEGG_module:HSA_M00382_SCF_FBS_COMPLEX","KEGG_module","HSA_M00382_SCF_FBS_COMPLEX",5,0.6826,0.81,0.91,0.8532,0.65,0.92,-1.1678,0.31,0.56
"GO_BP:518452_GO_0090312_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION","GO_BP","518452_GO_0090312_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION",17,0.6829,0.92,1,-1.1521,0.29,0.92,-0.6712,0.92,1
"GO_BP:491086_GO_0006108_MALATE_METABOLIC_PROCESS","GO_BP","491086_GO_0006108_MALATE_METABOLIC_PROCESS",7,0.683,0.87,1,1.2113,0.24,0.78,1.1118,0.34,0.75
"GO_MF:497010_GO_0018024_HISTONE_LYSINE_N_METHYLTRANSFERASE_ACTIVITY","GO_MF","497010_GO_0018024_HISTONE_LYSINE_N_METHYLTRANSFERASE_ACTIVITY",40,0.6833,0.96,1,-0.9579,0.5,0.95,-0.5874,0.99,1
"REACTOME:106432_REACT_6964_MTORC1_MEDIATED_SIGNALLING","REACTOME","106432_REACT_6964_MTORC1_MEDIATED_SIGNALLING",13,0.6834,0.9,1,1.1308,0.3,0.54,-0.9734,0.49,0.88
"GO_BP:911330_GO_0097502_MANNOSYLATION","GO_BP","911330_GO_0097502_MANNOSYLATION",30,0.6841,0.96,1,1.153,0.24,0.83,-1.1272,0.27,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_3341_HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3341_HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP",22,0.6852,0.92,1,1.2126,0.2,0.48,-0.7351,0.83,0.98
"GO_BP:506131_GO_0043045_DNA_METHYLATION_INVOLVED_IN_EMBRYO_DEVELOPMENT","GO_BP","506131_GO_0043045_DNA_METHYLATION_INVOLVED_IN_EMBRYO_DEVELOPMENT",6,0.6857,0.86,1,-1.1058,0.36,0.94,1.1358,0.34,0.74
"GO_MF:504249_GO_0035064_METHYLATED_HISTONE_BINDING","GO_MF","504249_GO_0035064_METHYLATED_HISTONE_BINDING",50,0.6861,0.97,1,-0.9812,0.49,0.92,-0.9448,0.55,0.84
"GO_BP:491169_GO_0006198_CAMP_CATABOLIC_PROCESS","GO_BP","491169_GO_0006198_CAMP_CATABOLIC_PROCESS",15,0.6866,0.89,1,-1.0298,0.43,0.98,-1.353,0.094,0.6
"GO_CC:515533_GO_0070603_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX","GO_CC","515533_GO_0070603_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX",68,0.6867,0.99,1,-0.9955,0.46,0.85,-1.5819,0.002,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_2746_WANG_RECURRENT_LIVER_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2746_WANG_RECURRENT_LIVER_CANCER_UP",20,0.6868,0.92,1,1.342,0.096,0.35,-1.4306,0.062,0.33
"OMIM_gene:OMIM612294_DEP_DOMAIN_CONTAINING_PROTEIN_7_DEPDC7","OMIM_gene","OMIM612294_DEP_DOMAIN_CONTAINING_PROTEIN_7_DEPDC7",6,0.6876,0.82,1,0.65,0.87,1,-1.369,0.13,1
"REACTOME:1127539_REACT_268366_GLI3_IS_PROCESSED_TO_GLI3R_BY_THE_PROTEASOME","REACTOME","1127539_REACT_268366_GLI3_IS_PROCESSED_TO_GLI3R_BY_THE_PROTEASOME",59,0.6877,0.98,1,2.1091,0,5e-04,-0.6463,0.99,1
"GO_BP:808750_GO_0044783_G1_DNA_DAMAGE_CHECKPOINT","GO_BP","808750_GO_0044783_G1_DNA_DAMAGE_CHECKPOINT",77,0.6882,0.98,1,1.6491,0.0023,0.24,-0.8694,0.77,0.95
"GO_CC:516488_GO_0071564_NPBAF_COMPLEX","GO_CC","516488_GO_0071564_NPBAF_COMPLEX",12,0.6884,0.87,1,0.6329,0.94,1,-0.9754,0.48,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_40_DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_40_DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN",20,0.6887,0.92,1,-0.9193,0.57,1,0.7916,0.79,1
"GO_BP:504212_GO_0035022_POSITIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION","GO_BP","504212_GO_0035022_POSITIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION",5,0.6902,0.83,1,0.821,0.69,1,0.483,0.99,1
"GO_BP:517093_GO_0072177_MESONEPHRIC_DUCT_DEVELOPMENT","GO_BP","517093_GO_0072177_MESONEPHRIC_DUCT_DEVELOPMENT",9,0.6905,0.89,1,1.1366,0.3,0.85,-0.7517,0.79,1
"OMIM_gene:OMIM608074_PROGRAMMED_CELL_DEATH_6_INTERACTING_PROTEIN_PDCD6IP","OMIM_gene","OMIM608074_PROGRAMMED_CELL_DEATH_6_INTERACTING_PROTEIN_PDCD6IP",6,0.6906,0.85,1,0.6316,0.92,1,-0.5157,0.98,1
"REACTOME:833809_REACT_163646_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9_","REACTOME","833809_REACT_163646_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9_",6,0.6906,0.86,1,1.6208,0.019,0.084,0.7279,0.81,1
"GO_BP:1026104_GO_1903332_REGULATION_OF_PROTEIN_FOLDING","GO_BP","1026104_GO_1903332_REGULATION_OF_PROTEIN_FOLDING",5,0.6909,0.8,1,1.4201,0.11,0.53,0.7502,0.79,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2224_WORSCHECH_TUMOR_REJECTION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2224_WORSCHECH_TUMOR_REJECTION_DN",10,0.691,0.88,1,1.2008,0.24,0.49,0.8251,0.67,1
"GO_MF:499762_GO_0030371_TRANSLATION_REPRESSOR_ACTIVITY","GO_MF","499762_GO_0030371_TRANSLATION_REPRESSOR_ACTIVITY",18,0.692,0.9,1,0.8081,0.76,1,-1.1475,0.26,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_760_SHI_SPARC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_760_SHI_SPARC_TARGETS_UP",24,0.6924,0.93,1,0.8606,0.69,0.96,0.7648,0.82,1
"OMIM_gene:OMIM602746_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_MEMBER_14_TNFRSF14","OMIM_gene","OMIM602746_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_MEMBER_14_TNFRSF14",6,0.6925,0.83,1,0.6438,0.9,1,-1.4091,0.099,1
"GO_BP:498694_GO_0019919_PEPTIDYL_ARGININE_METHYLATION_TO_ASYMMETRICAL_DIMETHYL_ARGININE","GO_BP","498694_GO_0019919_PEPTIDYL_ARGININE_METHYLATION_TO_ASYMMETRICAL_DIMETHYL_ARGININE",7,0.6927,0.82,1,-0.5207,0.97,1,-1.2143,0.25,0.72
"C4_Cancer_gene_neighborhoods:C4_CGN_398_GNF2_RAB3A","C4_Cancer_gene_neighborhoods","C4_CGN_398_GNF2_RAB3A",37,0.6941,0.97,1,-1.3259,0.093,0.53,-1.0185,0.42,0.81
"REACTOME:106558_REACT_975_RNA_POL_II_CTD_PHOSPHORYLATION_AND_INTERACTION_WITH_CE","REACTOME","106558_REACT_975_RNA_POL_II_CTD_PHOSPHORYLATION_AND_INTERACTION_WITH_CE",27,0.6942,0.92,1,1.365,0.091,0.26,0.7323,0.87,1
"C3_MicroRNA_targets:C3_MIR_119_TCTGGAC_MIR_198","C3_MicroRNA_targets","C3_MIR_119_TCTGGAC_MIR_198",83,0.6948,0.99,1,0.8351,0.8,1,1.1468,0.22,1
"GO_CC:500666_GO_0031415_NATA_COMPLEX","GO_CC","500666_GO_0031415_NATA_COMPLEX",5,0.695,0.81,1,-0.8094,0.69,1,0.9501,0.53,1
"C1_Positional:C1_ALL_241_CHR3P13","C1_Positional","C1_ALL_241_CHR3P13",9,0.695,0.84,0.99,1.0168,0.46,0.75,0.7674,0.75,0.94
"GO_BP:499442_GO_0023021_TERMINATION_OF_SIGNAL_TRANSDUCTION","GO_BP","499442_GO_0023021_TERMINATION_OF_SIGNAL_TRANSDUCTION",42,0.695,0.97,1,1.0172,0.4,0.97,-1.1841,0.19,0.73
"GO_MF:492600_GO_0008276_PROTEIN_METHYLTRANSFERASE_ACTIVITY","GO_MF","492600_GO_0008276_PROTEIN_METHYLTRANSFERASE_ACTIVITY",72,0.6951,0.98,1,-0.698,0.97,1,-1.2358,0.13,0.59
"REACTOME:161034_REACT_20594_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION","REACTOME","161034_REACT_20594_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION",17,0.6952,0.91,1,0.8756,0.61,0.93,1.1716,0.26,0.87
"GO_BP:491291_GO_0006349_REGULATION_OF_GENE_EXPRESSION_BY_GENETIC_IMPRINTING","GO_BP","491291_GO_0006349_REGULATION_OF_GENE_EXPRESSION_BY_GENETIC_IMPRINTING",18,0.6953,0.88,1,-1.3377,0.12,0.91,0.9714,0.47,0.89
"WikiPathways:198860_WP111_ELECTRON_TRANSPORT_CHAIN","WikiPathways","198860_WP111_ELECTRON_TRANSPORT_CHAIN",92,0.6959,1,1,2.7023,0,0,0.6779,0.99,1
"GO_BP:488439_GO_0002566_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_SOMATIC_MUTATION","GO_BP","488439_GO_0002566_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_SOMATIC_MUTATION",12,0.696,0.88,1,0.7582,0.78,1,-1.4011,0.093,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_1740_KANG_FLUOROURACIL_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1740_KANG_FLUOROURACIL_RESISTANCE_UP",22,0.6962,0.92,1,1.2009,0.21,0.49,1.363,0.088,0.55
"C1_Positional:C1_ALL_153_CHR14Q","C1_Positional","C1_ALL_153_CHR14Q",7,0.6963,0.86,1,1.3068,0.18,0.53,0.7057,0.84,0.95
"GO_BP:507416_GO_0045006_DNA_DEAMINATION","GO_BP","507416_GO_0045006_DNA_DEAMINATION",9,0.6966,0.85,1,1.1173,0.29,0.88,0.7669,0.74,1
"GO_BP:491457_GO_0006561_PROLINE_BIOSYNTHETIC_PROCESS","GO_BP","491457_GO_0006561_PROLINE_BIOSYNTHETIC_PROCESS",7,0.6967,0.82,1,1.0829,0.37,0.92,0.6897,0.87,1
"GO_MF:504426_GO_0035242_PROTEIN_ARGININE_OMEGA_N_ASYMMETRIC_METHYLTRANSFERASE_ACTIVITY","GO_MF","504426_GO_0035242_PROTEIN_ARGININE_OMEGA_N_ASYMMETRIC_METHYLTRANSFERASE_ACTIVITY",7,0.6969,0.86,1,-0.5268,0.98,1,-1.2154,0.23,0.57
"GO_MF:505241_GO_0042054_HISTONE_METHYLTRANSFERASE_ACTIVITY","GO_MF","505241_GO_0042054_HISTONE_METHYLTRANSFERASE_ACTIVITY",51,0.6969,0.97,1,-0.8796,0.66,1,-0.8519,0.73,0.92
"C4_Cancer_gene_neighborhoods:C4_CGN_203_GCM_RAD21","C4_Cancer_gene_neighborhoods","C4_CGN_203_GCM_RAD21",37,0.6973,0.97,1,1.7868,0.0022,0.0026,-0.5356,1,1
"REACTOME:161041_REACT_20661_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKK","REACTOME","161041_REACT_20661_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKK",6,0.6973,0.84,1,1.0363,0.39,0.69,0.5847,0.94,1
"GO_BP:491535_GO_0006646_PHOSPHATIDYLETHANOLAMINE_BIOSYNTHETIC_PROCESS","GO_BP","491535_GO_0006646_PHOSPHATIDYLETHANOLAMINE_BIOSYNTHETIC_PROCESS",14,0.6976,0.86,1,0.5619,0.97,1,-0.6319,0.95,1
"GO_BP:515068_GO_0070131_POSITIVE_REGULATION_OF_MITOCHONDRIAL_TRANSLATION","GO_BP","515068_GO_0070131_POSITIVE_REGULATION_OF_MITOCHONDRIAL_TRANSLATION",6,0.6979,0.82,1,1.0755,0.36,0.93,-0.6726,0.87,1
"KEGG_compound:C00268_DIHYDROBIOPTERIN_6_7_DIHYDROBIOPTERIN_QUINOID_DIHYDROBIOPTERIN_6R_6_L_ERYTHRO_1_2_DIHYDROXYPROPYL_7_8_DIHYDRO_6H_PTERIN","KEGG_compound","C00268_DIHYDROBIOPTERIN_6_7_DIHYDROBIOPTERIN_QUINOID_DIHYDROBIOPTERIN_6R_6_L_ERYTHRO_1_2_DIHYDROXYPROPYL_7_8_DIHYDRO_6H_PTERIN",7,0.698,0.82,1,1.3285,0.15,0.68,-0.6346,0.89,0.95
"GO_BP:519182_GO_2000543_POSITIVE_REGULATION_OF_GASTRULATION","GO_BP","519182_GO_2000543_POSITIVE_REGULATION_OF_GASTRULATION",9,0.698,0.86,1,0.899,0.58,1,-0.9089,0.57,0.92
"GO_BP:491910_GO_0007091_METAPHASE_ANAPHASE_TRANSITION_OF_MITOTIC_CELL_CYCLE","GO_BP","491910_GO_0007091_METAPHASE_ANAPHASE_TRANSITION_OF_MITOTIC_CELL_CYCLE",7,0.6981,0.82,1,1.0114,0.44,0.98,-0.9439,0.51,0.89
"GO_MF:511670_GO_0050699_WW_DOMAIN_BINDING","GO_MF","511670_GO_0050699_WW_DOMAIN_BINDING",22,0.6982,0.91,1,1.0738,0.34,0.82,-1.0318,0.39,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_618_NAGY_TFTC_COMPONENTS_HUMAN","C2_Chemical_and_genetic_perturbations","C2_CGP_618_NAGY_TFTC_COMPONENTS_HUMAN",19,0.6986,0.89,1,-0.8178,0.73,1,-1.3586,0.096,0.39
"GO_BP:495832_GO_0015697_QUATERNARY_AMMONIUM_GROUP_TRANSPORT","GO_BP","495832_GO_0015697_QUATERNARY_AMMONIUM_GROUP_TRANSPORT",18,0.6989,0.88,1,-1.1146,0.3,0.94,1.0413,0.39,0.82
"GO_CC:490779_GO_0005744_MITOCHONDRIAL_INNER_MEMBRANE_PRESEQUENCE_TRANSLOCASE_COMPLEX","GO_CC","490779_GO_0005744_MITOCHONDRIAL_INNER_MEMBRANE_PRESEQUENCE_TRANSLOCASE_COMPLEX",8,0.6991,0.85,1,1.0787,0.34,0.67,0.6984,0.85,1
"C4_Cancer_modules:C4_CM_317_MODULE_371","C4_Cancer_modules","C4_CM_317_MODULE_371",26,0.6993,0.91,1,1.5951,0.013,0.074,1.135,0.26,0.72
"REACTOME:160974_REACT_21393_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK","REACTOME","160974_REACT_21393_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK",13,0.6994,0.87,1,0.6873,0.89,1,1.2553,0.18,0.77
"GO_BP:512767_GO_0051917_REGULATION_OF_FIBRINOLYSIS","GO_BP","512767_GO_0051917_REGULATION_OF_FIBRINOLYSIS",14,0.6994,0.9,1,-1.0632,0.39,0.96,1.4785,0.049,0.58
"REACTOME:833828_REACT_163994_FCERI_MEDIATED_NF_KB_ACTIVATION","REACTOME","833828_REACT_163994_FCERI_MEDIATED_NF_KB_ACTIVATION",23,0.6995,0.9,1,-0.623,0.95,1,-0.6721,0.93,1
"GO_MF:490097_GO_0004791_THIOREDOXIN_DISULFIDE_REDUCTASE_ACTIVITY","GO_MF","490097_GO_0004791_THIOREDOXIN_DISULFIDE_REDUCTASE_ACTIVITY",5,0.6996,0.84,1,-0.6093,0.93,1,-1.3172,0.15,0.56
"GO_BP:492436_GO_0008063_TOLL_SIGNALING_PATHWAY","GO_BP","492436_GO_0008063_TOLL_SIGNALING_PATHWAY",5,0.7003,0.83,1,0.8445,0.66,1,-0.5376,0.96,1
"GO_CC:487126_GO_0000836_HRD1P_UBIQUITIN_LIGASE_COMPLEX","GO_CC","487126_GO_0000836_HRD1P_UBIQUITIN_LIGASE_COMPLEX",5,0.7005,0.8,1,1.1837,0.29,0.54,1.1085,0.33,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_1536_FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1536_FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN",48,0.7005,0.96,1,1.921,0,0.016,-0.8478,0.75,0.93
"GO_BP:504160_GO_0034968_HISTONE_LYSINE_METHYLATION","GO_BP","504160_GO_0034968_HISTONE_LYSINE_METHYLATION",57,0.7008,0.96,1,-0.6782,0.98,1,-0.9485,0.55,0.89
"REACTOME:530761_REACT_115831_ISG15_ANTIVIRAL_MECHANISM","REACTOME","530761_REACT_115831_ISG15_ANTIVIRAL_MECHANISM",72,0.7008,0.99,1,1.4515,0.014,0.18,-1.2463,0.13,0.56
"GO_BP:490600_GO_0006903_VESICLE_TARGETING","GO_BP","490600_GO_0006903_VESICLE_TARGETING",39,0.7011,0.95,1,1.6719,0.013,0.22,0.6146,0.99,1
"REACTOME:105919_REACT_1785_CITRIC_ACID_CYCLE_TCA_CYCLE_","REACTOME","105919_REACT_1785_CITRIC_ACID_CYCLE_TCA_CYCLE_",19,0.7016,0.93,1,1.7313,0.0065,0.038,-1.3134,0.13,0.55
"GO_BP:512235_GO_0051351_POSITIVE_REGULATION_OF_LIGASE_ACTIVITY","GO_BP","512235_GO_0051351_POSITIVE_REGULATION_OF_LIGASE_ACTIVITY",93,0.7016,0.99,1,1.8873,0,0.043,-0.8979,0.71,0.93
"GO_MF:492595_GO_0008271_SECONDARY_ACTIVE_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","492595_GO_0008271_SECONDARY_ACTIVE_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",12,0.7017,0.84,1,1.1327,0.26,0.75,1.1312,0.3,0.79
"GO_BP:505860_GO_0042754_NEGATIVE_REGULATION_OF_CIRCADIAN_RHYTHM","GO_BP","505860_GO_0042754_NEGATIVE_REGULATION_OF_CIRCADIAN_RHYTHM",13,0.7019,0.87,1,-1.2328,0.21,0.9,-0.6333,0.94,1
"REACTOME:106142_REACT_9405_CHOLESTEROL_BIOSYNTHESIS","REACTOME","106142_REACT_9405_CHOLESTEROL_BIOSYNTHESIS",23,0.702,0.92,1,0.9064,0.61,0.9,-0.6828,0.89,1
"GO_BP:496003_GO_0015879_CARNITINE_TRANSPORT","GO_BP","496003_GO_0015879_CARNITINE_TRANSPORT",13,0.7025,0.87,1,-0.8189,0.71,1,1.1352,0.3,0.74
"REACTOME:160962_REACT_22393_RESPIRATORY_ELECTRON_TRANSPORT","REACTOME","160962_REACT_22393_RESPIRATORY_ELECTRON_TRANSPORT",75,0.7027,1,1,2.58,0,0,0.6279,0.99,1
"REACTOME:105891_REACT_1941_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX","REACTOME","105891_REACT_1941_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX",29,0.703,0.93,1,1.3758,0.075,0.24,0.6808,0.94,1
"GO_CC:487125_GO_0000835_ER_UBIQUITIN_LIGASE_COMPLEX","GO_CC","487125_GO_0000835_ER_UBIQUITIN_LIGASE_COMPLEX",5,0.7032,0.83,1,1.187,0.3,0.54,1.124,0.35,0.88
"GO_BP:491282_GO_0006338_CHROMATIN_REMODELING","GO_BP","491282_GO_0006338_CHROMATIN_REMODELING",157,0.7034,0.99,1,-0.8926,0.75,1,-1.3719,0.015,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2325_MATZUK_POST_IMPLANTATION_AND_POST_PARTUM","C2_Chemical_and_genetic_perturbations","C2_CGP_2325_MATZUK_POST_IMPLANTATION_AND_POST_PARTUM",13,0.7039,0.88,1,1.2904,0.13,0.4,1.238,0.21,0.74
"GO_CC:500300_GO_0031010_ISWI_TYPE_COMPLEX","GO_CC","500300_GO_0031010_ISWI_TYPE_COMPLEX",10,0.7041,0.84,1,-0.8859,0.61,0.96,-1.0979,0.34,0.92
"GO_BP:497008_GO_0018022_PEPTIDYL_LYSINE_METHYLATION","GO_BP","497008_GO_0018022_PEPTIDYL_LYSINE_METHYLATION",64,0.7041,0.98,1,-0.8131,0.82,1,-1.1272,0.24,0.75
"GO_BP:518384_GO_0090244_WNT_SIGNALING_PATHWAY_INVOLVED_IN_SOMITOGENESIS","GO_BP","518384_GO_0090244_WNT_SIGNALING_PATHWAY_INVOLVED_IN_SOMITOGENESIS",7,0.7042,0.79,1,-1.0575,0.38,0.96,0.8943,0.59,0.95
"C4_Cancer_gene_neighborhoods:C4_CGN_207_GCM_AIP","C4_Cancer_gene_neighborhoods","C4_CGN_207_GCM_AIP",40,0.7045,0.95,1,0.7955,0.82,0.99,-0.9309,0.58,0.99
"GO_BP:505878_GO_0042772_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_RESULTING_IN_TRANSCRIPTION","GO_BP","505878_GO_0042772_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_RESULTING_IN_TRANSCRIPTION",15,0.7047,0.88,1,0.7681,0.81,1,-0.576,0.97,1
"REACTOME:105673_REACT_666_SMAC_MEDIATED_APOPTOTIC_RESPONSE","REACTOME","105673_REACT_666_SMAC_MEDIATED_APOPTOTIC_RESPONSE",5,0.7048,0.82,1,1.3927,0.14,0.23,1.3758,0.14,0.73
"GO_MF:506112_GO_0043022_RIBOSOME_BINDING","GO_MF","506112_GO_0043022_RIBOSOME_BINDING",31,0.7048,0.94,1,1.7787,0.0022,0.094,1.0592,0.36,0.83
"GO_MF:515507_GO_0070577_LYSINE_ACETYLATED_HISTONE_BINDING","GO_MF","515507_GO_0070577_LYSINE_ACETYLATED_HISTONE_BINDING",17,0.7049,0.91,1,-0.7675,0.81,1,-0.7106,0.86,1
"GO_BP:489100_GO_0003308_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT","GO_BP","489100_GO_0003308_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT",5,0.7051,0.82,1,0.898,0.57,1,1.4987,0.061,0.55
"C2_Chemical_and_genetic_perturbations:C2_CGP_2147_WONG_PROTEASOME_GENE_MODULE","C2_Chemical_and_genetic_perturbations","C2_CGP_2147_WONG_PROTEASOME_GENE_MODULE",49,0.7056,0.95,1,1.5736,0.013,0.16,-0.9063,0.67,0.87
"KEGG_compound:C00655_XANTHOSINE_5_PHOSPHATE_XANTHYLIC_ACID_XMP_9_D_RIBOSYLXANTHINE_5_PHOSPHATE","KEGG_compound","C00655_XANTHOSINE_5_PHOSPHATE_XANTHYLIC_ACID_XMP_9_D_RIBOSYLXANTHINE_5_PHOSPHATE",15,0.7057,0.85,1,0.6904,0.9,1,-1.468,0.068,0.24
"C2_Chemical_and_genetic_perturbations:C2_CGP_2753_MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2753_MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN",10,0.7063,0.83,1,1.4638,0.087,0.24,0.9976,0.46,0.97
"GO_BP:504912_GO_0035735_INTRACILIARY_TRANSPORT_INVOLVED_IN_CILIUM_MORPHOGENESIS","GO_BP","504912_GO_0035735_INTRACILIARY_TRANSPORT_INVOLVED_IN_CILIUM_MORPHOGENESIS",6,0.7069,0.81,1,0.7202,0.81,1,1.2671,0.21,0.69
"GO_MF:504434_GO_0035250_UDP_GALACTOSYLTRANSFERASE_ACTIVITY","GO_MF","504434_GO_0035250_UDP_GALACTOSYLTRANSFERASE_ACTIVITY",19,0.7073,0.89,1,1.1653,0.23,0.74,1.4502,0.059,0.5
"GO_BP:502845_GO_0033629_NEGATIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN","GO_BP","502845_GO_0033629_NEGATIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN",11,0.7077,0.85,1,0.7877,0.75,1,1.3377,0.13,0.65
"GO_BP:495964_GO_0015838_AMINO_ACID_BETAINE_TRANSPORT","GO_BP","495964_GO_0015838_AMINO_ACID_BETAINE_TRANSPORT",13,0.7079,0.86,1,-0.8219,0.72,1,1.1361,0.31,0.74
"GO_BP:808751_GO_0044784_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE","GO_BP","808751_GO_0044784_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE",7,0.7084,0.82,1,1.0078,0.45,0.98,-0.9312,0.54,0.9
"GO_MF:489872_GO_0004523_RNA_DNA_HYBRID_RIBONUCLEASE_ACTIVITY","GO_MF","489872_GO_0004523_RNA_DNA_HYBRID_RIBONUCLEASE_ACTIVITY",6,0.7086,0.8,1,1.5149,0.038,0.37,-0.7132,0.81,1
"GO_BP:500822_GO_0031571_MITOTIC_G1_DNA_DAMAGE_CHECKPOINT","GO_BP","500822_GO_0031571_MITOTIC_G1_DNA_DAMAGE_CHECKPOINT",76,0.7091,0.98,1,1.6703,0.0021,0.22,-0.8295,0.82,0.97
"C4_Cancer_gene_neighborhoods:C4_CGN_29_MORF_PCNA","C4_Cancer_gene_neighborhoods","C4_CGN_29_MORF_PCNA",83,0.7095,0.98,1,2.2343,0,0,-1.3302,0.057,0.25
"KEGG_module:HSA_M00380_SCF_BTRC_COMPLEX","KEGG_module","HSA_M00380_SCF_BTRC_COMPLEX",5,0.7097,0.81,0.9,0.9239,0.54,0.9,-0.5585,0.93,1
"REACTOME:105675_REACT_1767_SMAC_MEDIATED_DISSOCIATION_OF_IAP_CASPASE_COMPLEXES","REACTOME","105675_REACT_1767_SMAC_MEDIATED_DISSOCIATION_OF_IAP_CASPASE_COMPLEXES",5,0.7098,0.79,1,1.3936,0.14,0.23,1.3896,0.13,0.7
"REACTOME:106000_REACT_6237_RNA_POL_II_CTD_PHOSPHORYLATION_AND_INTERACTION_WITH_CE","REACTOME","106000_REACT_6237_RNA_POL_II_CTD_PHOSPHORYLATION_AND_INTERACTION_WITH_CE",27,0.7108,0.93,1,1.3434,0.087,0.27,0.747,0.86,1
"KEGG_compound:C05284_11BETA_HYDROXYANDROST_4_ENE_3_17_DIONE_ANDROST_4_ENE_3_17_DIONE_11BETA_OL_4_ANDROSTEN_11BETA_OL_3_17_DIONE","KEGG_compound","C05284_11BETA_HYDROXYANDROST_4_ENE_3_17_DIONE_ANDROST_4_ENE_3_17_DIONE_11BETA_OL_4_ANDROSTEN_11BETA_OL_3_17_DIONE",9,0.7112,0.85,1,1.243,0.22,0.81,-1.6202,0.018,0.13
"GO_MF:501417_GO_0032182_UBIQUITIN_LIKE_PROTEIN_BINDING","GO_MF","501417_GO_0032182_UBIQUITIN_LIKE_PROTEIN_BINDING",95,0.7116,0.98,1,0.6765,0.99,1,-1.2701,0.079,0.58
"GO_MF:506203_GO_0043130_UBIQUITIN_BINDING","GO_MF","506203_GO_0043130_UBIQUITIN_BINDING",84,0.7123,0.98,1,0.7436,0.96,1,-1.2266,0.12,0.58
"GO_CC:515582_GO_0070652_HAUS_COMPLEX","GO_CC","515582_GO_0070652_HAUS_COMPLEX",8,0.7126,0.82,1,1.3221,0.15,0.38,-1.0607,0.36,0.98
"GO_BP:512010_GO_0051096_POSITIVE_REGULATION_OF_HELICASE_ACTIVITY","GO_BP","512010_GO_0051096_POSITIVE_REGULATION_OF_HELICASE_ACTIVITY",6,0.7127,0.8,1,0.9998,0.44,0.98,-0.928,0.52,0.9
"GO_BP:491381_GO_0006479_PROTEIN_METHYLATION","GO_BP","491381_GO_0006479_PROTEIN_METHYLATION",102,0.7139,0.99,1,-0.593,1,1,-1.2373,0.09,0.69
"REACTOME:105674_REACT_2190_SMAC_BINDS_TO_IAPS","REACTOME","105674_REACT_2190_SMAC_BINDS_TO_IAPS",5,0.7144,0.83,1,1.3521,0.14,0.26,1.3655,0.12,0.69
"GO_BP:510564_GO_0048490_ANTEROGRADE_SYNAPTIC_VESICLE_TRANSPORT","GO_BP","510564_GO_0048490_ANTEROGRADE_SYNAPTIC_VESICLE_TRANSPORT",15,0.7146,0.89,1,1.4411,0.081,0.51,1.114,0.29,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1020_SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1020_SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP",9,0.7147,0.82,1,-0.706,0.85,1,-1.2053,0.23,0.51
"C1_Positional:C1_ALL_239_CHR2P23","C1_Positional","C1_ALL_239_CHR2P23",80,0.7148,0.99,0.99,0.6429,0.99,1,-0.7856,0.91,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_69_BIOCARTA_EIF_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_69_BIOCARTA_EIF_PATHWAY",16,0.7149,0.85,0.93,1.3878,0.1,0.53,-0.8072,0.74,0.88
"REACTOME:106047_REACT_162_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS","REACTOME","106047_REACT_162_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS",9,0.7155,0.83,1,-0.9625,0.49,1,-1.5825,0.04,0.27
"GO_BP:513442_GO_0055009_ATRIAL_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS","GO_BP","513442_GO_0055009_ATRIAL_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS",6,0.7157,0.77,1,0.9151,0.57,1,1.6931,0.004,0.41
"KEGG_compound:C06124_SPHINGOSINE_1_PHOSPHATE_SPHING_4_ENINE_1_PHOSPHATE_S1P","KEGG_compound","C06124_SPHINGOSINE_1_PHOSPHATE_SPHING_4_ENINE_1_PHOSPHATE_S1P",6,0.716,0.81,1,1.0157,0.46,1,1.3237,0.17,0.39
"REACTOME:530760_REACT_115676_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES","REACTOME","530760_REACT_115676_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES",72,0.7163,0.99,1,1.4351,0.036,0.19,-1.2299,0.15,0.58
"GO_CC:490720_GO_0005662_DNA_REPLICATION_FACTOR_A_COMPLEX","GO_CC","490720_GO_0005662_DNA_REPLICATION_FACTOR_A_COMPLEX",14,0.7164,0.87,1,1.2011,0.22,0.53,-0.7469,0.82,1
"GO_MF:490429_GO_0005165_NEUROTROPHIN_RECEPTOR_BINDING","GO_MF","490429_GO_0005165_NEUROTROPHIN_RECEPTOR_BINDING",9,0.7167,0.82,1,0.9316,0.52,0.94,0.9985,0.42,0.87
"GO_MF:507564_GO_0045182_TRANSLATION_REGULATOR_ACTIVITY","GO_MF","507564_GO_0045182_TRANSLATION_REGULATOR_ACTIVITY",34,0.7176,0.93,1,1.2198,0.16,0.7,-1.0641,0.36,0.74
"REACTOME:1127504_REACT_267624_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE","REACTOME","1127504_REACT_267624_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE",51,0.7177,0.96,1,0.7994,0.81,1,-1.1391,0.23,0.67
"GO_BP:501522_GO_0032287_PERIPHERAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE","GO_BP","501522_GO_0032287_PERIPHERAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE",7,0.7179,0.82,1,0.7868,0.73,1,-0.8876,0.6,0.93
"GO_CC:500168_GO_0030870_MRE11_COMPLEX","GO_CC","500168_GO_0030870_MRE11_COMPLEX",6,0.7181,0.8,1,0.8223,0.66,0.94,-0.7909,0.72,1
"GO_BP:505050_GO_0035881_AMACRINE_CELL_DIFFERENTIATION","GO_BP","505050_GO_0035881_AMACRINE_CELL_DIFFERENTIATION",5,0.7185,0.81,1,-0.6883,0.84,1,1.5441,0.046,0.52
"GO_MF:757231_GO_1990050_PHOSPHATIDIC_ACID_TRANSPORTER_ACTIVITY","GO_MF","757231_GO_1990050_PHOSPHATIDIC_ACID_TRANSPORTER_ACTIVITY",5,0.7192,0.82,1,1.1012,0.37,0.79,1.0894,0.39,0.81
"GO_BP:516861_GO_0071941_NITROGEN_CYCLE_METABOLIC_PROCESS","GO_BP","516861_GO_0071941_NITROGEN_CYCLE_METABOLIC_PROCESS",14,0.7194,0.87,1,-0.6616,0.91,1,-0.8944,0.6,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_2896_DORN_ADENOVIRUS_INFECTION_32HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2896_DORN_ADENOVIRUS_INFECTION_32HR_UP",11,0.7211,0.83,1,1.0922,0.33,0.64,1.1481,0.29,0.82
"GO_BP:486643_GO_0000101_SULFUR_AMINO_ACID_TRANSPORT","GO_BP","486643_GO_0000101_SULFUR_AMINO_ACID_TRANSPORT",6,0.7214,0.8,1,-0.7687,0.75,1,1.1204,0.34,0.75
"C3_MicroRNA_targets:C3_MIR_183_TAGAACC_MIR_182","C3_MicroRNA_targets","C3_MIR_183_TAGAACC_MIR_182",38,0.7216,0.9,1,-0.7649,0.86,1,-0.928,0.58,1
"GO_MF:509068_GO_0046848_HYDROXYAPATITE_BINDING","GO_MF","509068_GO_0046848_HYDROXYAPATITE_BINDING",5,0.7219,0.81,1,-1.2117,0.23,0.81,-1.4474,0.081,0.44
"KEGG_module:HSA_M00404_COPII_COMPLEX","KEGG_module","HSA_M00404_COPII_COMPLEX",11,0.7223,0.82,0.9,0.8377,0.68,0.93,-0.526,0.99,1
"REACTOME:105861_REACT_2054_DOUBLE_STRAND_BREAK_REPAIR","REACTOME","105861_REACT_2054_DOUBLE_STRAND_BREAK_REPAIR",23,0.7232,0.86,1,0.9155,0.57,0.89,-1.1324,0.27,0.67
"GO_BP:519107_GO_2000467_POSITIVE_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY","GO_BP","519107_GO_2000467_POSITIVE_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY",5,0.7233,0.78,1,-1.3465,0.15,0.92,1.2425,0.22,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_2508_FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2508_FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP",23,0.7234,0.86,1,0.8526,0.66,0.97,-1.2819,0.15,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_3044_STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3044_STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN",22,0.7235,0.88,1,1.0248,0.39,0.76,0.7547,0.85,1
"GO_BP:508257_GO_0045955_NEGATIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS","GO_BP","508257_GO_0045955_NEGATIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS",8,0.7235,0.81,1,1.2047,0.25,0.78,1.2032,0.23,0.72
"GO_BP:489022_GO_0003228_ATRIAL_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","489022_GO_0003228_ATRIAL_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT",6,0.7236,0.81,1,0.9177,0.56,1,1.6818,0.019,0.41
"GO_BP:501692_GO_0032460_NEGATIVE_REGULATION_OF_PROTEIN_OLIGOMERIZATION","GO_BP","501692_GO_0032460_NEGATIVE_REGULATION_OF_PROTEIN_OLIGOMERIZATION",10,0.7239,0.84,1,0.9214,0.54,1,-1.2782,0.16,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_1132_PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1132_PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN",7,0.7247,0.82,1,1.3201,0.16,0.37,0.7557,0.76,1
"GO_BP:1129425_GO_1903599_POSITIVE_REGULATION_OF_MITOCHONDRION_DEGRADATION","GO_BP","1129425_GO_1903599_POSITIVE_REGULATION_OF_MITOCHONDRION_DEGRADATION",8,0.7248,0.8,1,1.1927,0.26,0.79,-0.6783,0.85,1
"C4_Cancer_gene_neighborhoods:C4_CGN_146_MORF_PPP1CC","C4_Cancer_gene_neighborhoods","C4_CGN_146_MORF_PPP1CC",165,0.725,1,1,1.8482,0,0.0014,-1.3317,0.019,0.26
"GO_BP:504301_GO_0035116_EMBRYONIC_HINDLIMB_MORPHOGENESIS","GO_BP","504301_GO_0035116_EMBRYONIC_HINDLIMB_MORPHOGENESIS",30,0.7255,0.92,1,-1.04,0.38,0.98,0.9124,0.62,0.93
"GO_CC:502061_GO_0032838_CELL_PROJECTION_CYTOPLASM","GO_CC","502061_GO_0032838_CELL_PROJECTION_CYTOPLASM",109,0.7256,0.99,1,-1.0532,0.34,0.83,-0.8016,0.9,1
"GO_CC:490873_GO_0005861_TROPONIN_COMPLEX","GO_CC","490873_GO_0005861_TROPONIN_COMPLEX",8,0.7256,0.83,1,0.918,0.54,0.87,-0.9881,0.49,1
"GO_BP:487634_GO_0001736_ESTABLISHMENT_OF_PLANAR_POLARITY","GO_BP","487634_GO_0001736_ESTABLISHMENT_OF_PLANAR_POLARITY",14,0.7257,0.83,1,1.1655,0.26,0.82,1.1573,0.25,0.73
"GO_BP:488954_GO_0003160_ENDOCARDIUM_MORPHOGENESIS","GO_BP","488954_GO_0003160_ENDOCARDIUM_MORPHOGENESIS",6,0.7271,0.79,1,-0.6113,0.91,1,1.4079,0.11,0.63
"GO_BP:518700_GO_2000051_NEGATIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY","GO_BP","518700_GO_2000051_NEGATIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY",6,0.7272,0.77,1,-0.8724,0.59,1,-0.8076,0.7,0.98
"KEGG_module:HSA_M00307_PYRUVATE_OXIDATION_PYRUVATE_ACETYL_COA","KEGG_module","HSA_M00307_PYRUVATE_OXIDATION_PYRUVATE_ACETYL_COA",5,0.7279,0.79,0.91,1.5964,0.017,0.12,-0.7321,0.81,0.99
"GO_CC:500191_GO_0030896_CHECKPOINT_CLAMP_COMPLEX","GO_CC","500191_GO_0030896_CHECKPOINT_CLAMP_COMPLEX",5,0.728,0.79,1,-1.1665,0.31,0.69,0.8107,0.7,1
"GO_BP:510225_GO_0048070_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION","GO_BP","510225_GO_0048070_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION",17,0.7283,0.88,1,1.4074,0.083,0.55,-0.9477,0.52,0.89
"C4_Cancer_gene_neighborhoods:C4_CGN_85_MORF_DDB1","C4_Cancer_gene_neighborhoods","C4_CGN_85_MORF_DDB1",244,0.7287,1,1,1.3587,0.0071,0.081,-0.8664,0.88,1
"GO_BP:506130_GO_0043044_ATP_DEPENDENT_CHROMATIN_REMODELING","GO_BP","506130_GO_0043044_ATP_DEPENDENT_CHROMATIN_REMODELING",72,0.7288,0.97,1,-1.156,0.19,0.92,-1.699,0.0043,0.62
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_33_BIOCARTA_CD40_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_33_BIOCARTA_CD40_PATHWAY",15,0.7295,0.84,0.96,0.8945,0.6,0.91,-0.6588,0.91,0.98
"GO_CC:490788_GO_0045263_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_COUPLING_FACTOR_F_O_","GO_CC","490788_GO_0045263_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_COUPLING_FACTOR_F_O_",11,0.7297,0.83,1,1.9103,0.002,0.0093,0.6052,0.96,1
"REACTOME:105892_REACT_2222_DUAL_INCISION_REACTION_IN_TC_NER","REACTOME","105892_REACT_2222_DUAL_INCISION_REACTION_IN_TC_NER",29,0.7298,0.88,1,1.3874,0.063,0.23,0.6852,0.92,1
"REACTOME:119563_REACT_19315_CATION_COUPLED_CHLORIDE_COTRANSPORTERS","REACTOME","119563_REACT_19315_CATION_COUPLED_CHLORIDE_COTRANSPORTERS",7,0.7298,0.8,1,-1.1036,0.33,0.9,0.7292,0.79,1
"C4_Cancer_modules:C4_CM_245_MODULE_277","C4_Cancer_modules","C4_CM_245_MODULE_277",54,0.7301,0.92,1,0.9871,0.45,0.72,-1.0841,0.28,0.56
"KEGG_compound:C00364_DTMP_THYMIDINE_5_PHOSPHATE_DEOXYTHYMIDINE_5_PHOSPHATE_THYMIDYLIC_ACID_5_THYMIDYLIC_ACID_THYMIDINE_MONOPHOSPHATE_DEOXYTHYMIDYLIC_ACID_THYMIDYLATE","KEGG_compound","C00364_DTMP_THYMIDINE_5_PHOSPHATE_DEOXYTHYMIDINE_5_PHOSPHATE_THYMIDYLIC_ACID_5_THYMIDYLIC_ACID_THYMIDINE_MONOPHOSPHATE_DEOXYTHYMIDYLIC_ACID_THYMIDYLATE",15,0.7303,0.86,1,-0.486,0.99,1,-0.9053,0.58,0.76
"GO_BP:500345_GO_0031055_CHROMATIN_REMODELING_AT_CENTROMERE","GO_BP","500345_GO_0031055_CHROMATIN_REMODELING_AT_CENTROMERE",44,0.7303,0.94,1,-0.8876,0.66,1,-1.2714,0.11,0.66
"GO_BP:508760_GO_0046501_PROTOPORPHYRINOGEN_IX_METABOLIC_PROCESS","GO_BP","508760_GO_0046501_PROTOPORPHYRINOGEN_IX_METABOLIC_PROCESS",11,0.7305,0.83,1,1.3065,0.14,0.66,-1.1955,0.23,0.74
"GO_MF:504381_GO_0035197_SIRNA_BINDING","GO_MF","504381_GO_0035197_SIRNA_BINDING",6,0.7305,0.78,1,-1.4277,0.082,0.65,-1.1147,0.34,0.7
"KEGG_compound:C00065_L_SERINE_L_2_AMINO_3_HYDROXYPROPIONIC_ACID_L_3_HYDROXY_ALANINE_SERINE","KEGG_compound","C00065_L_SERINE_L_2_AMINO_3_HYDROXYPROPIONIC_ACID_L_3_HYDROXY_ALANINE_SERINE",14,0.7306,0.84,1,0.9829,0.46,1,1.1194,0.3,0.63
"GO_BP:516992_GO_0072075_METANEPHRIC_MESENCHYME_DEVELOPMENT","GO_BP","516992_GO_0072075_METANEPHRIC_MESENCHYME_DEVELOPMENT",13,0.7309,0.84,1,-1.2375,0.21,0.9,0.7632,0.78,1
"GO_MF:515497_GO_0070567_CYTIDYLYLTRANSFERASE_ACTIVITY","GO_MF","515497_GO_0070567_CYTIDYLYLTRANSFERASE_ACTIVITY",8,0.7309,0.79,1,1.2597,0.2,0.65,0.7862,0.73,1
"GO_CC:983703_GO_0098642_NETWORK_FORMING_COLLAGEN_TRIMER","GO_CC","983703_GO_0098642_NETWORK_FORMING_COLLAGEN_TRIMER",7,0.731,0.78,1,-0.8734,0.6,0.94,0.926,0.55,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2092_STEIN_ESRRA_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2092_STEIN_ESRRA_TARGETS_DN",104,0.7312,0.99,1,1.2213,0.1,0.47,-0.9538,0.56,0.82
"GO_CC:983706_GO_0098645_COLLAGEN_NETWORK","GO_CC","983706_GO_0098645_COLLAGEN_NETWORK",7,0.7312,0.79,1,-0.8542,0.64,0.96,0.9375,0.52,1
"GO_BP:503591_GO_0034389_LIPID_PARTICLE_ORGANIZATION","GO_BP","503591_GO_0034389_LIPID_PARTICLE_ORGANIZATION",15,0.7315,0.85,1,0.7514,0.81,1,0.4625,0.99,1
"GO_BP:507326_GO_0044320_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS","GO_BP","507326_GO_0044320_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS",10,0.732,0.8,1,1.3634,0.12,0.6,0.893,0.61,0.95
"GO_CC:503653_GO_0034451_CENTRIOLAR_SATELLITE","GO_CC","503653_GO_0034451_CENTRIOLAR_SATELLITE",18,0.7325,0.83,1,-1.0326,0.39,0.85,-1.0016,0.46,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3344_HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3344_HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN",15,0.7327,0.82,1,2.1908,0,0.00059,-0.631,0.95,0.99
"GO_BP:500344_GO_0031054_PRE_MIRNA_PROCESSING","GO_BP","500344_GO_0031054_PRE_MIRNA_PROCESSING",12,0.7327,0.82,1,-0.7999,0.74,1,-0.87,0.63,0.95
"REACTOME:645265_REACT_120734_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION","REACTOME","645265_REACT_120734_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION",31,0.7328,0.92,1,1.0197,0.39,0.72,0.6969,0.9,1
"GO_BP:514239_GO_0060684_EPITHELIAL_MESENCHYMAL_CELL_SIGNALING","GO_BP","514239_GO_0060684_EPITHELIAL_MESENCHYMAL_CELL_SIGNALING",6,0.733,0.78,1,1.1373,0.33,0.85,1.3302,0.14,0.65
"GO_MF:496735_GO_0016840_CARBON_NITROGEN_LYASE_ACTIVITY","GO_MF","496735_GO_0016840_CARBON_NITROGEN_LYASE_ACTIVITY",9,0.7334,0.8,1,1.2374,0.21,0.69,1.548,0.049,0.37
"REACTOME:833794_REACT_163932_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE","REACTOME","833794_REACT_163932_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE",10,0.7334,0.8,1,-1.5723,0.036,0.37,-0.9714,0.5,0.88
"C4_Cancer_gene_neighborhoods:C4_CGN_48_MORF_SOD1","C4_Cancer_gene_neighborhoods","C4_CGN_48_MORF_SOD1",278,0.734,1,1,2.5289,0,0,-0.994,0.48,0.88
"GO_BP:502149_GO_0032927_POSITIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","502149_GO_0032927_POSITIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY",8,0.7341,0.8,1,0.5348,0.97,1,0.5152,0.98,1
"C1_Positional:C1_ALL_26_CHR4P14","C1_Positional","C1_ALL_26_CHR4P14",26,0.7342,0.89,0.99,0.9991,0.46,0.76,-0.6043,0.97,1
"GO_MF:512453_GO_0051575_5_DEOXYRIBOSE_5_PHOSPHATE_LYASE_ACTIVITY","GO_MF","512453_GO_0051575_5_DEOXYRIBOSE_5_PHOSPHATE_LYASE_ACTIVITY",5,0.7348,0.8,1,1.4836,0.051,0.39,0.9192,0.56,0.94
"GO_BP:493417_GO_0009221_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","493417_GO_0009221_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",6,0.7348,0.79,1,1.049,0.42,0.95,-0.4508,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_670_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25","C2_Chemical_and_genetic_perturbations","C2_CGP_670_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25",8,0.7348,0.8,1,1.3417,0.13,0.35,-0.6384,0.9,0.99
"GO_MF:498596_GO_0019787_UBIQUITIN_LIKE_PROTEIN_TRANSFERASE_ACTIVITY","GO_MF","498596_GO_0019787_UBIQUITIN_LIKE_PROTEIN_TRANSFERASE_ACTIVITY",310,0.735,1,1,1.1732,0.081,0.74,0.778,1,1
"GO_MF:496859_GO_0017034_RAP_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY","GO_MF","496859_GO_0017034_RAP_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY",5,0.7352,0.76,1,0.7354,0.78,1,-0.938,0.53,0.85
"GO_BP:516034_GO_0071108_PROTEIN_K48_LINKED_DEUBIQUITINATION","GO_BP","516034_GO_0071108_PROTEIN_K48_LINKED_DEUBIQUITINATION",18,0.7353,0.87,1,-0.6974,0.9,1,-0.9819,0.49,0.87
"GO_BP:514343_GO_0060788_ECTODERMAL_PLACODE_FORMATION","GO_BP","514343_GO_0060788_ECTODERMAL_PLACODE_FORMATION",18,0.7354,0.86,1,0.873,0.66,1,-0.823,0.75,0.97
"GO_BP:497344_GO_0018410_C_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION","GO_BP","497344_GO_0018410_C_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION",38,0.736,0.91,1,0.9336,0.54,1,0.6015,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1071_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1071_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN",10,0.7363,0.86,1,1.1731,0.26,0.53,-1.1026,0.33,0.62
"C2_Chemical_and_genetic_perturbations:C2_CGP_2894_DORN_ADENOVIRUS_INFECTION_24HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2894_DORN_ADENOVIRUS_INFECTION_24HR_UP",11,0.7366,0.86,1,0.4478,0.99,1,1.2149,0.21,0.76
"C4_Cancer_gene_neighborhoods:C4_CGN_202_GCM_PSME1","C4_Cancer_gene_neighborhoods","C4_CGN_202_GCM_PSME1",85,0.7371,0.97,1,2.6928,0,0,-0.5649,1,1
"GO_BP:514685_GO_0061140_LUNG_SECRETORY_CELL_DIFFERENTIATION","GO_BP","514685_GO_0061140_LUNG_SECRETORY_CELL_DIFFERENTIATION",10,0.7371,0.85,1,1.6453,0.019,0.25,1.4817,0.06,0.58
"GO_BP:504167_GO_0034975_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM","GO_BP","504167_GO_0034975_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM",9,0.7375,0.8,1,1.1309,0.3,0.87,0.8264,0.68,1
"C4_Cancer_modules:C4_CM_332_MODULE_396","C4_Cancer_modules","C4_CM_332_MODULE_396",10,0.7376,0.81,1,-0.662,0.88,1,-1.1663,0.27,0.45
"GO_BP:491456_GO_0006560_PROLINE_METABOLIC_PROCESS","GO_BP","491456_GO_0006560_PROLINE_METABOLIC_PROCESS",8,0.7379,0.8,1,1.1238,0.33,0.88,0.9881,0.5,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1513_PARK_HSC_AND_MULTIPOTENT_PROGENITORS","C2_Chemical_and_genetic_perturbations","C2_CGP_1513_PARK_HSC_AND_MULTIPOTENT_PROGENITORS",49,0.7384,0.92,1,1.5651,0.0041,0.16,-0.9927,0.48,0.76
"KEGG_compound:C00064_L_GLUTAMINE_L_2_AMINOGLUTARAMIC_ACID","KEGG_compound","C00064_L_GLUTAMINE_L_2_AMINOGLUTARAMIC_ACID",17,0.7385,0.85,1,-1.0601,0.36,0.99,-1.1869,0.24,0.46
"GO_BP:491310_GO_0006384_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_III_PROMOTER","GO_BP","491310_GO_0006384_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_III_PROMOTER",7,0.7396,0.77,1,-0.5082,0.98,1,0.5702,0.95,1
"C4_Cancer_gene_neighborhoods:C4_CGN_321_GNF2_ANP32B","C4_Cancer_gene_neighborhoods","C4_CGN_321_GNF2_ANP32B",37,0.74,0.89,1,1.7118,0.011,0.0056,-1.3004,0.096,0.28
"REACTOME:771576_REACT_160176_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY","REACTOME","771576_REACT_160176_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY",13,0.74,0.82,1,1.1129,0.31,0.56,0.5388,0.98,1
"C7_Immunologic_signatures:C7_ALL_345_GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_345_GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP",199,0.7401,1,1,1.2934,0.024,0.11,0.6742,1,1
"GO_BP:515789_GO_0070861_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM","GO_BP","515789_GO_0070861_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM",6,0.7406,0.78,1,1.3784,0.11,0.58,-0.5841,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_58_GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_58_GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP",25,0.7406,0.89,1,1.0012,0.46,0.8,-0.8205,0.73,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_2105_GAZIN_EPIGENETIC_SILENCING_BY_KRAS","C2_Chemical_and_genetic_perturbations","C2_CGP_2105_GAZIN_EPIGENETIC_SILENCING_BY_KRAS",25,0.7409,0.91,1,-0.8444,0.7,1,-0.8438,0.74,0.93
"GO_MF:489438_GO_0003958_NADPH_HEMOPROTEIN_REDUCTASE_ACTIVITY","GO_MF","489438_GO_0003958_NADPH_HEMOPROTEIN_REDUCTASE_ACTIVITY",7,0.741,0.78,1,-0.8265,0.69,1,0.7556,0.78,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3029_WANG_METASTASIS_OF_BREAST_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_3029_WANG_METASTASIS_OF_BREAST_CANCER",15,0.7415,0.84,1,1.17,0.25,0.53,-0.6844,0.89,0.99
"GO_BP:861238_GO_1902358_SULFATE_TRANSMEMBRANE_TRANSPORT","GO_BP","861238_GO_1902358_SULFATE_TRANSMEMBRANE_TRANSPORT",11,0.7415,0.79,1,1.2348,0.21,0.75,1.1311,0.3,0.74
"C3_TF_targets:C3_TFT_515_SNACANNNYSYAGA_UNKNOWN","C3_TF_targets","C3_TFT_515_SNACANNNYSYAGA_UNKNOWN",88,0.7417,0.99,1,-0.677,0.98,1,-0.8536,0.8,0.97
"GO_BP:989116_GO_1903051_NEGATIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS","GO_BP","989116_GO_1903051_NEGATIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS",69,0.7419,0.95,1,1.201,0.13,0.78,-0.9947,0.46,0.85
"GO_MF:490164_GO_0004862_CAMP_DEPENDENT_PROTEIN_KINASE_INHIBITOR_ACTIVITY","GO_MF","490164_GO_0004862_CAMP_DEPENDENT_PROTEIN_KINASE_INHIBITOR_ACTIVITY",8,0.7419,0.8,1,1.442,0.086,0.44,0.8841,0.63,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3086_FIGUEROA_AML_METHYLATION_CLUSTER_5_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3086_FIGUEROA_AML_METHYLATION_CLUSTER_5_UP",12,0.7423,0.82,1,-0.5878,0.96,1,0.7351,0.83,1
"KEGG_compound:C00365_DUMP_DEOXYURIDYLIC_ACID_DEOXYURIDINE_MONOPHOSPHATE_DEOXYURIDINE_5_PHOSPHATE_2_DEOXYURIDINE_5_PHOSPHATE","KEGG_compound","C00365_DUMP_DEOXYURIDYLIC_ACID_DEOXYURIDINE_MONOPHOSPHATE_DEOXYURIDINE_5_PHOSPHATE_2_DEOXYURIDINE_5_PHOSPHATE",16,0.7425,0.86,1,0.5741,0.98,1,-0.8801,0.63,0.78
"GO_BP:487721_GO_0001825_BLASTOCYST_FORMATION","GO_BP","487721_GO_0001825_BLASTOCYST_FORMATION",29,0.743,0.89,1,0.9735,0.49,1,-1.0519,0.36,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_2009_LI_CYTIDINE_ANALOG_PATHWAY","C2_Chemical_and_genetic_perturbations","C2_CGP_2009_LI_CYTIDINE_ANALOG_PATHWAY",17,0.7435,0.84,1,1.0798,0.35,0.67,-1.2666,0.19,0.46
"GO_BP:491039_GO_0006054_N_ACETYLNEURAMINATE_METABOLIC_PROCESS","GO_BP","491039_GO_0006054_N_ACETYLNEURAMINATE_METABOLIC_PROCESS",9,0.7436,0.81,1,0.5552,0.97,1,-0.582,0.96,1
"REACTOME:906016_REACT_169122_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER","REACTOME","906016_REACT_169122_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER",8,0.7436,0.8,1,-0.6675,0.86,1,1.1498,0.3,0.89
"GO_CC:490791_GO_0005758_MITOCHONDRIAL_INTERMEMBRANE_SPACE","GO_CC","490791_GO_0005758_MITOCHONDRIAL_INTERMEMBRANE_SPACE",69,0.7438,0.96,1,1.7817,0,0.032,-0.8853,0.7,1
"GO_BP:751075_GO_0036155_ACYLGLYCEROL_ACYL_CHAIN_REMODELING","GO_BP","751075_GO_0036155_ACYLGLYCEROL_ACYL_CHAIN_REMODELING",5,0.7438,0.78,1,0.9212,0.56,1,0.7073,0.82,1
"GO_MF:503685_GO_0034483_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY","GO_MF","503685_GO_0034483_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY",13,0.7441,0.79,1,1.9846,0,0.014,2.0229,0.0021,0.014
"GO_BP:501286_GO_0032049_CARDIOLIPIN_BIOSYNTHETIC_PROCESS","GO_BP","501286_GO_0032049_CARDIOLIPIN_BIOSYNTHETIC_PROCESS",7,0.7442,0.77,1,-0.5464,0.96,1,0.5711,0.94,1
"C1_Positional:C1_ALL_257_CHR1P","C1_Positional","C1_ALL_257_CHR1P",7,0.7442,0.78,0.99,1.0936,0.36,0.63,-0.525,0.98,1
"GO_BP:497946_GO_0019068_VIRION_ASSEMBLY","GO_BP","497946_GO_0019068_VIRION_ASSEMBLY",36,0.7445,0.93,1,1.602,0.015,0.29,0.8107,0.8,1
"GO_BP:510727_GO_0048672_POSITIVE_REGULATION_OF_COLLATERAL_SPROUTING","GO_BP","510727_GO_0048672_POSITIVE_REGULATION_OF_COLLATERAL_SPROUTING",7,0.7445,0.81,1,0.6415,0.9,1,0.8559,0.62,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2187_DER_IFN_ALPHA_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2187_DER_IFN_ALPHA_RESPONSE_DN",6,0.7446,0.78,1,1.2788,0.2,0.42,1.2897,0.19,0.69
"GO_BP:751295_GO_0038032_TERMINATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY","GO_BP","751295_GO_0038032_TERMINATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY",39,0.7453,0.89,1,1.0499,0.35,0.95,-1.2197,0.17,0.71
"GO_CC:946556_GO_0098576_LUMENAL_SIDE_OF_MEMBRANE","GO_CC","946556_GO_0098576_LUMENAL_SIDE_OF_MEMBRANE",26,0.7453,0.9,1,0.7786,0.8,0.97,0.6682,0.93,1
"GO_CC:516382_GO_0071458_INTEGRAL_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE","GO_CC","516382_GO_0071458_INTEGRAL_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE",6,0.7454,0.77,1,0.705,0.83,0.99,0.8835,0.62,1
"GO_BP:488079_GO_0002200_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS","GO_BP","488079_GO_0002200_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS",47,0.7454,0.93,1,1.0559,0.35,0.94,-1.1342,0.25,0.75
"OMIM_gene:OMIM607075_PDGFA_ASSOCIATED_PROTEIN_1_PDAP1","OMIM_gene","OMIM607075_PDGFA_ASSOCIATED_PROTEIN_1_PDAP1",9,0.7457,0.78,1,0.9951,0.43,1,-0.6678,0.88,1
"GO_MF:498598_GO_0019789_SUMO_TRANSFERASE_ACTIVITY","GO_MF","498598_GO_0019789_SUMO_TRANSFERASE_ACTIVITY",10,0.746,0.8,1,1.1883,0.25,0.72,0.7527,0.78,1
"GO_CC:500629_GO_0031371_UBIQUITIN_CONJUGATING_ENZYME_COMPLEX","GO_CC","500629_GO_0031371_UBIQUITIN_CONJUGATING_ENZYME_COMPLEX",10,0.7462,0.78,1,1.1682,0.28,0.56,-0.7263,0.83,1
"GO_CC:921101_GO_0098553_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE","GO_CC","921101_GO_0098553_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE",26,0.7462,0.87,1,0.7983,0.76,0.96,0.661,0.93,1
"KEGG_module:HSA_M00120_COENZYME_A_BIOSYNTHESIS_PANTOTHENATE_COA","KEGG_module","HSA_M00120_COENZYME_A_BIOSYNTHESIS_PANTOTHENATE_COA",7,0.7473,0.79,0.9,-0.5463,0.97,1,0.7845,0.72,1
"C4_Cancer_gene_neighborhoods:C4_CGN_151_MORF_PPP5C","C4_Cancer_gene_neighborhoods","C4_CGN_151_MORF_PPP5C",91,0.7473,0.96,1,-0.5931,1,1,-0.9629,0.54,0.92
"GO_CC:490722_GO_0005665_DNA_DIRECTED_RNA_POLYMERASE_II_CORE_COMPLEX","GO_CC","490722_GO_0005665_DNA_DIRECTED_RNA_POLYMERASE_II_CORE_COMPLEX",16,0.7474,0.8,1,1.2018,0.21,0.53,0.8026,0.76,1
"GO_BP:498674_GO_0019896_AXON_TRANSPORT_OF_MITOCHONDRION","GO_BP","498674_GO_0019896_AXON_TRANSPORT_OF_MITOCHONDRION",5,0.7476,0.74,1,-0.6272,0.9,1,1.0753,0.4,0.78
"GO_MF:501637_GO_0032405_MUTLALPHA_COMPLEX_BINDING","GO_MF","501637_GO_0032405_MUTLALPHA_COMPLEX_BINDING",6,0.748,0.77,1,0.4928,0.99,1,-1.5009,0.061,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2624_MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY","C2_Chemical_and_genetic_perturbations","C2_CGP_2624_MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY",10,0.7485,0.82,1,0.9993,0.46,0.8,0.827,0.69,1
"GO_BP:508124_GO_0045793_POSITIVE_REGULATION_OF_CELL_SIZE","GO_BP","508124_GO_0045793_POSITIVE_REGULATION_OF_CELL_SIZE",9,0.7488,0.8,1,0.986,0.48,1,-0.8244,0.7,0.97
"GO_BP:491913_GO_0007094_MITOTIC_SPINDLE_ASSEMBLY_CHECKPOINT","GO_BP","491913_GO_0007094_MITOTIC_SPINDLE_ASSEMBLY_CHECKPOINT",32,0.7489,0.87,1,0.9176,0.6,1,-0.6727,0.94,1
"GO_CC:501658_GO_0032426_STEREOCILIUM_BUNDLE_TIP","GO_CC","501658_GO_0032426_STEREOCILIUM_BUNDLE_TIP",8,0.749,0.79,1,-1.2785,0.21,0.66,-1.3414,0.15,0.61
"REACTOME:187086_REACT_25380_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX","REACTOME","187086_REACT_25380_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX",10,0.7491,0.78,1,1.4459,0.093,0.19,-0.8992,0.6,0.95
"REACTOME:645315_REACT_121122_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG","REACTOME","645315_REACT_121122_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG",5,0.7495,0.75,1,0.9218,0.54,0.87,0.7039,0.82,1
"REACTOME:160972_REACT_21387_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK","REACTOME","160972_REACT_21387_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK",19,0.7501,0.86,1,0.7919,0.76,1,0.9551,0.52,1
"GO_BP:510788_GO_0048733_SEBACEOUS_GLAND_DEVELOPMENT","GO_BP","510788_GO_0048733_SEBACEOUS_GLAND_DEVELOPMENT",7,0.7502,0.77,1,-0.5433,0.96,1,1.136,0.3,0.74
"GO_CC:516480_GO_0071556_INTEGRAL_COMPONENT_OF_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE","GO_CC","516480_GO_0071556_INTEGRAL_COMPONENT_OF_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE",26,0.751,0.87,1,0.787,0.78,0.96,0.6683,0.93,1
"KEGG_module:HSA_M00072_N_GLYCOSYLATION_BY_OLIGOSACCHARYLTRANSFERASE","KEGG_module","HSA_M00072_N_GLYCOSYLATION_BY_OLIGOSACCHARYLTRANSFERASE",7,0.7513,0.78,0.91,0.9489,0.55,0.92,-0.7745,0.75,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1202_NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1202_NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON",54,0.7517,0.91,1,0.8072,0.82,0.98,1.0707,0.31,0.89
"KEGG_compound:C00062_L_ARGININE_S_2_AMINO_5_GUANIDINOVALERIC_ACID_L_ARG","KEGG_compound","C00062_L_ARGININE_S_2_AMINO_5_GUANIDINOVALERIC_ACID_L_ARG",11,0.7521,0.8,1,-1.1755,0.27,0.82,0.9327,0.56,0.78
"GO_BP:488435_GO_0002562_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_GERMLINE_RECOMBINATION_WITHIN_A_SINGLE_LOCUS","GO_BP","488435_GO_0002562_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_GERMLINE_RECOMBINATION_WITHIN_A_SINGLE_LOCUS",39,0.7525,0.91,1,0.971,0.5,1,-1.2025,0.18,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_1344_CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1344_CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP",13,0.7533,0.81,1,-1.1525,0.28,0.85,-1.2246,0.21,0.5
"C4_Cancer_gene_neighborhoods:C4_CGN_208_GCM_ANP32B","C4_Cancer_gene_neighborhoods","C4_CGN_208_GCM_ANP32B",36,0.7533,0.9,1,2.1245,0,0.00012,-0.4494,1,1
"GO_BP:499074_GO_0021794_THALAMUS_DEVELOPMENT","GO_BP","499074_GO_0021794_THALAMUS_DEVELOPMENT",11,0.7534,0.8,1,0.7045,0.85,1,-0.6801,0.88,1
"C4_Cancer_gene_neighborhoods:C4_CGN_254_GCM_PRKCG","C4_Cancer_gene_neighborhoods","C4_CGN_254_GCM_PRKCG",59,0.7534,0.94,1,-0.7766,0.86,1,1.0004,0.45,0.81
"C4_Cancer_gene_neighborhoods:C4_CGN_135_MORF_NME2","C4_Cancer_gene_neighborhoods","C4_CGN_135_MORF_NME2",155,0.7536,0.99,1,3.2607,0,0,-0.6773,1,1
"REACTOME:105741_REACT_85_P53_DEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT","REACTOME","105741_REACT_85_P53_DEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT",57,0.7537,0.93,1,1.8377,0,0.015,-1.0035,0.44,0.83
"GO_BP:505191_GO_0040033_NEGATIVE_REGULATION_OF_TRANSLATION_NCRNA_MEDIATED","GO_BP","505191_GO_0040033_NEGATIVE_REGULATION_OF_TRANSLATION_NCRNA_MEDIATED",9,0.7541,0.82,1,-1.3292,0.16,0.9,-1.0701,0.36,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_196_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_196_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN",23,0.7541,0.9,1,-0.6982,0.88,1,0.7545,0.84,1
"KEGG_module:HSA_M00340_PROTEASOME_20S_CORE_PARTICLE","KEGG_module","HSA_M00340_PROTEASOME_20S_CORE_PARTICLE",15,0.7542,0.81,0.93,1.6693,0.022,0.084,-0.7211,0.86,0.99
"GO_BP:486628_GO_0000088_MITOTIC_PROPHASE","GO_BP","486628_GO_0000088_MITOTIC_PROPHASE",76,0.7544,0.93,1,0.7019,0.97,1,-0.6865,0.98,0.99
"GO_BP:496427_GO_0016444_SOMATIC_CELL_DNA_RECOMBINATION","GO_BP","496427_GO_0016444_SOMATIC_CELL_DNA_RECOMBINATION",39,0.7548,0.91,1,0.9683,0.5,1,-1.2023,0.17,0.73
"GO_BP:506087_GO_0042996_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT","GO_BP","506087_GO_0042996_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT",8,0.7551,0.78,1,0.7254,0.8,1,1.0111,0.44,0.84
"GO_BP:500205_GO_0030910_OLFACTORY_PLACODE_FORMATION","GO_BP","500205_GO_0030910_OLFACTORY_PLACODE_FORMATION",6,0.7551,0.78,1,0.7843,0.76,1,0.7904,0.74,1
"C4_Cancer_gene_neighborhoods:C4_CGN_228_GCM_ERCC4","C4_Cancer_gene_neighborhoods","C4_CGN_228_GCM_ERCC4",26,0.7551,0.86,1,0.6841,0.92,1,0.93,0.57,0.97
"GO_CC:500282_GO_0030992_INTRACILIARY_TRANSPORT_PARTICLE_B","GO_CC","500282_GO_0030992_INTRACILIARY_TRANSPORT_PARTICLE_B",18,0.7554,0.84,1,0.6401,0.93,0.99,-1.0147,0.4,1
"GO_BP:514101_GO_0060546_NEGATIVE_REGULATION_OF_NECROPTOTIC_PROCESS","GO_BP","514101_GO_0060546_NEGATIVE_REGULATION_OF_NECROPTOTIC_PROCESS",9,0.7557,0.78,1,-0.7749,0.76,1,-0.5719,0.96,1
"GO_BP:496060_GO_0015939_PANTOTHENATE_METABOLIC_PROCESS","GO_BP","496060_GO_0015939_PANTOTHENATE_METABOLIC_PROCESS",12,0.7558,0.81,1,1.2794,0.19,0.7,-0.7861,0.76,1
"GO_BP:911315_GO_0039702_VIRAL_BUDDING_VIA_HOST_ESCRT_COMPLEX","GO_BP","911315_GO_0039702_VIRAL_BUDDING_VIA_HOST_ESCRT_COMPLEX",12,0.7559,0.81,1,1.3348,0.13,0.62,1.068,0.34,0.78
"GO_MF:502828_GO_0033612_RECEPTOR_SERINE_THREONINE_KINASE_BINDING","GO_MF","502828_GO_0033612_RECEPTOR_SERINE_THREONINE_KINASE_BINDING",14,0.7559,0.8,1,-0.5747,0.97,1,0.9214,0.56,0.94
"GO_BP:492554_GO_0008213_PROTEIN_ALKYLATION","GO_BP","492554_GO_0008213_PROTEIN_ALKYLATION",104,0.756,0.97,1,-0.5586,1,1,-1.2237,0.11,0.71
"C7_Immunologic_signatures:C7_ALL_1199_GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1199_GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP",199,0.7564,1,1,0.9924,0.5,0.76,-1.0125,0.4,0.7
"GO_CC:487077_GO_0000784_NUCLEAR_CHROMOSOME_TELOMERIC_REGION","GO_CC","487077_GO_0000784_NUCLEAR_CHROMOSOME_TELOMERIC_REGION",25,0.7566,0.85,1,0.8361,0.73,0.93,-0.5685,0.99,1
"GO_BP:491886_GO_0007063_REGULATION_OF_SISTER_CHROMATID_COHESION","GO_BP","491886_GO_0007063_REGULATION_OF_SISTER_CHROMATID_COHESION",11,0.7567,0.81,1,0.7379,0.82,1,-0.8612,0.61,0.96
"GO_BP:751292_GO_0038027_APOLIPOPROTEIN_A_I_MEDIATED_SIGNALING_PATHWAY","GO_BP","751292_GO_0038027_APOLIPOPROTEIN_A_I_MEDIATED_SIGNALING_PATHWAY",5,0.7569,0.72,1,1.0584,0.36,0.94,0.4793,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1381_MOOTHA_VOXPHOS","C2_Chemical_and_genetic_perturbations","C2_CGP_1381_MOOTHA_VOXPHOS",88,0.7575,0.95,1,2.5084,0,0,0.5492,1,1
"GO_CC:507403_GO_0044455_MITOCHONDRIAL_MEMBRANE_PART","GO_CC","507403_GO_0044455_MITOCHONDRIAL_MEMBRANE_PART",158,0.7575,0.99,1,2.524,0,0,0.7627,0.97,1
"GO_BP:491447_GO_0006551_LEUCINE_METABOLIC_PROCESS","GO_BP","491447_GO_0006551_LEUCINE_METABOLIC_PROCESS",7,0.7576,0.74,1,1.3415,0.15,0.62,-0.9507,0.52,0.89
"GO_MF:486566_GO_0000014_SINGLE_STRANDED_DNA_ENDODEOXYRIBONUCLEASE_ACTIVITY","GO_MF","486566_GO_0000014_SINGLE_STRANDED_DNA_ENDODEOXYRIBONUCLEASE_ACTIVITY",7,0.7576,0.79,1,0.8045,0.71,1,-0.837,0.68,0.94
"C3_MicroRNA_targets:C3_MIR_166_ACCATTT_MIR_522","C3_MicroRNA_targets","C3_MIR_166_ACCATTT_MIR_522",156,0.7583,0.98,1,0.7725,0.97,1,-0.7234,1,1
"GO_BP:487148_GO_0000920_CELL_SEPARATION_AFTER_CYTOKINESIS","GO_BP","487148_GO_0000920_CELL_SEPARATION_AFTER_CYTOKINESIS",18,0.7594,0.79,1,1.3557,0.1,0.6,0.8031,0.77,1
"GO_BP:510797_GO_0048743_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT","GO_BP","510797_GO_0048743_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT",6,0.7596,0.74,1,1.0548,0.4,0.94,0.9396,0.54,0.91
"GO_MF:490262_GO_0004972_N_METHYL_D_ASPARTATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY","GO_MF","490262_GO_0004972_N_METHYL_D_ASPARTATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY",8,0.7599,0.78,1,0.923,0.55,0.95,1.5076,0.052,0.43
"GO_BP:487735_GO_0001839_NEURAL_PLATE_MORPHOGENESIS","GO_BP","487735_GO_0001839_NEURAL_PLATE_MORPHOGENESIS",10,0.7614,0.75,1,-0.9513,0.51,1,-0.9201,0.55,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_3145_KIM_GLIS2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3145_KIM_GLIS2_TARGETS_DN",6,0.7614,0.74,1,1.2079,0.27,0.48,-0.827,0.69,0.94
"GO_BP:514455_GO_0060900_EMBRYONIC_CAMERA_TYPE_EYE_FORMATION","GO_BP","514455_GO_0060900_EMBRYONIC_CAMERA_TYPE_EYE_FORMATION",12,0.7618,0.79,1,1.7152,0.016,0.18,1.2947,0.15,0.67
"GO_BP:504267_GO_0035082_AXONEME_ASSEMBLY","GO_BP","504267_GO_0035082_AXONEME_ASSEMBLY",20,0.7621,0.85,1,1.2619,0.16,0.72,0.9629,0.49,0.89
"GO_BP:518455_GO_0090315_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE","GO_BP","518455_GO_0090315_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE",6,0.7623,0.75,1,0.6248,0.9,1,-0.6994,0.85,0.99
"GO_BP:849796_GO_0061551_TRIGEMINAL_GANGLION_DEVELOPMENT","GO_BP","849796_GO_0061551_TRIGEMINAL_GANGLION_DEVELOPMENT",5,0.7623,0.71,1,-0.8519,0.65,1,1.2033,0.27,0.72
"REACTOME:106158_REACT_13621_HDL_MEDIATED_LIPID_TRANSPORT","REACTOME","106158_REACT_13621_HDL_MEDIATED_LIPID_TRANSPORT",15,0.7624,0.79,1,-1.4872,0.065,0.46,0.984,0.46,1
"GO_BP:508275_GO_0045974_REGULATION_OF_TRANSLATION_NCRNA_MEDIATED","GO_BP","508275_GO_0045974_REGULATION_OF_TRANSLATION_NCRNA_MEDIATED",9,0.7624,0.77,1,-1.3543,0.11,0.95,-1.0804,0.38,0.79
"C2_Chemical_and_genetic_perturbations:C2_CGP_2296_BASSO_HAIRY_CELL_LEUKEMIA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2296_BASSO_HAIRY_CELL_LEUKEMIA_UP",5,0.7627,0.75,1,0.7222,0.81,1,-0.748,0.75,0.97
"KEGG_module:HSA_M00011_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2_OXOGLUTARATE_OXALOACETATE","KEGG_module","HSA_M00011_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2_OXOGLUTARATE_OXALOACETATE",14,0.763,0.8,0.93,1.6704,0.023,0.089,-1.1983,0.24,0.53
"GO_MF:495497_GO_0015232_HEME_TRANSPORTER_ACTIVITY","GO_MF","495497_GO_0015232_HEME_TRANSPORTER_ACTIVITY",8,0.7631,0.76,1,-1.442,0.079,0.62,-0.8328,0.68,0.94
"GO_CC:517288_GO_0072372_PRIMARY_CILIUM","GO_CC","517288_GO_0072372_PRIMARY_CILIUM",181,0.7633,0.99,1,-0.8954,0.76,0.95,-1.013,0.44,1
"GO_BP:495933_GO_0015802_BASIC_AMINO_ACID_TRANSPORT","GO_BP","495933_GO_0015802_BASIC_AMINO_ACID_TRANSPORT",11,0.764,0.78,1,1.1349,0.3,0.86,1.4642,0.069,0.59
"REACTOME:105743_REACT_1625_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE","REACTOME","105743_REACT_1625_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE",57,0.7641,0.93,1,1.829,0,0.017,-0.9938,0.46,0.84
"GO_BP:777528_GO_1901976_REGULATION_OF_CELL_CYCLE_CHECKPOINT","GO_BP","777528_GO_1901976_REGULATION_OF_CELL_CYCLE_CHECKPOINT",30,0.7642,0.86,1,1.0415,0.39,0.96,0.8525,0.71,0.98
"C4_Cancer_gene_neighborhoods:C4_CGN_211_GCM_BMPR2","C4_Cancer_gene_neighborhoods","C4_CGN_211_GCM_BMPR2",83,0.7643,0.96,1,1.1655,0.21,0.26,-0.6707,0.99,1
"GO_CC:486794_GO_0000276_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_COUPLING_FACTOR_F_O_","GO_CC","486794_GO_0000276_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_COUPLING_FACTOR_F_O_",6,0.7648,0.77,1,1.6014,0.027,0.12,0.5867,0.92,1
"GO_BP:500649_GO_0031398_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION","GO_BP","500649_GO_0031398_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION",155,0.765,0.98,1,1.6392,0,0.25,-0.8134,0.92,0.98
"KEGG_compound:C05545_PROTEIN_N6_N6_DIMETHYL_L_LYSINE","KEGG_compound","C05545_PROTEIN_N6_N6_DIMETHYL_L_LYSINE",27,0.7653,0.85,1,-1.3661,0.079,0.51,-0.9485,0.5,0.71
"GO_BP:498832_GO_0021548_PONS_DEVELOPMENT","GO_BP","498832_GO_0021548_PONS_DEVELOPMENT",13,0.7654,0.8,1,-1.1586,0.27,0.92,0.6787,0.88,1
"GO_MF:487322_GO_0001099_BASAL_RNA_POLYMERASE_II_TRANSCRIPTION_MACHINERY_BINDING","GO_MF","487322_GO_0001099_BASAL_RNA_POLYMERASE_II_TRANSCRIPTION_MACHINERY_BINDING",22,0.7658,0.81,1,-0.645,0.92,1,-0.8304,0.72,0.95
"KEGG_compound:C00459_DTTP_DEOXYTHYMIDINE_TRIPHOSPHATE_DEOXYTHYMIDINE_5_TRIPHOSPHATE_TTP","KEGG_compound","C00459_DTTP_DEOXYTHYMIDINE_TRIPHOSPHATE_DEOXYTHYMIDINE_5_TRIPHOSPHATE_TTP",25,0.7658,0.84,1,0.781,0.79,1,-1.3091,0.11,0.35
"REACTOME:187084_REACT_25018_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION","REACTOME","187084_REACT_25018_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION",10,0.7659,0.78,1,1.4464,0.089,0.19,-0.9048,0.58,0.95
"REACTOME:105794_REACT_1385_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND","REACTOME","105794_REACT_1385_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND",16,0.7661,0.8,1,1.3719,0.087,0.25,-1.2887,0.17,0.54
"KEGG_compound:C01885_1_ACYLGLYCEROL_GLYCERIDE_MONOGLYCERIDE_MONOACYLGLYCEROL_1_MONOACYLGLYCEROL","KEGG_compound","C01885_1_ACYLGLYCEROL_GLYCERIDE_MONOGLYCERIDE_MONOACYLGLYCEROL_1_MONOACYLGLYCEROL",12,0.7661,0.78,1,-0.8383,0.7,1,0.9717,0.5,0.72
"GO_CC:500713_GO_0031462_CUL2_RING_UBIQUITIN_LIGASE_COMPLEX","GO_CC","500713_GO_0031462_CUL2_RING_UBIQUITIN_LIGASE_COMPLEX",7,0.7667,0.75,1,1.3468,0.14,0.35,-0.553,0.97,1
"GO_MF:501686_GO_0032454_HISTONE_DEMETHYLASE_ACTIVITY_H3_K9_SPECIFIC_","GO_MF","501686_GO_0032454_HISTONE_DEMETHYLASE_ACTIVITY_H3_K9_SPECIFIC_",6,0.7671,0.72,1,-1.1144,0.35,0.82,-0.63,0.9,1
"GO_BP:516082_GO_0071156_REGULATION_OF_CELL_CYCLE_ARREST","GO_BP","516082_GO_0071156_REGULATION_OF_CELL_CYCLE_ARREST",106,0.7675,0.97,1,1.6576,0,0.24,-0.766,0.96,1
"GO_BP:849795_GO_0061550_CRANIAL_GANGLION_DEVELOPMENT","GO_BP","849795_GO_0061550_CRANIAL_GANGLION_DEVELOPMENT",5,0.768,0.71,1,-0.8398,0.65,1,1.2058,0.26,0.72
"GO_BP:487605_GO_0001702_GASTRULATION_WITH_MOUTH_FORMING_SECOND","GO_BP","487605_GO_0001702_GASTRULATION_WITH_MOUTH_FORMING_SECOND",30,0.7684,0.85,1,1.1039,0.3,0.9,1.0834,0.33,0.77
"GO_BP:488823_GO_0003025_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_BARORECEPTOR_FEEDBACK","GO_BP","488823_GO_0003025_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_BARORECEPTOR_FEEDBACK",7,0.7689,0.76,1,-1.1364,0.3,0.93,1.3788,0.12,0.64
"KEGG_pathway:HSA00130_UBIQUINONE_AND_OTHER_TERPENOID_QUINONE_BIOSYNTHESIS","KEGG_pathway","HSA00130_UBIQUINONE_AND_OTHER_TERPENOID_QUINONE_BIOSYNTHESIS",11,0.769,0.76,0.96,-1.3912,0.092,0.37,1.467,0.052,0.32
"GO_BP:514317_GO_0060762_REGULATION_OF_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS","GO_BP","514317_GO_0060762_REGULATION_OF_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS",6,0.7703,0.75,1,1.0228,0.45,0.97,1.282,0.19,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1034_CAFFAREL_RESPONSE_TO_THC_8HR_3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1034_CAFFAREL_RESPONSE_TO_THC_8HR_3_UP",5,0.7705,0.72,1,1.2191,0.27,0.47,0.8018,0.7,1
"C4_Cancer_gene_neighborhoods:C4_CGN_246_GCM_NCAM1","C4_Cancer_gene_neighborhoods","C4_CGN_246_GCM_NCAM1",128,0.7706,0.97,1,-0.8034,0.89,1,0.6456,1,1
"GO_BP:505663_GO_0042532_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN","GO_BP","505663_GO_0042532_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN",7,0.7709,0.75,1,0.6409,0.91,1,1.21,0.23,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_1268_PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1268_PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN",18,0.7715,0.82,1,1.8056,0.0065,0.041,-0.7613,0.82,0.97
"GO_BP:491655_GO_0006782_PROTOPORPHYRINOGEN_IX_BIOSYNTHETIC_PROCESS","GO_BP","491655_GO_0006782_PROTOPORPHYRINOGEN_IX_BIOSYNTHETIC_PROCESS",9,0.7717,0.77,1,1.0234,0.39,0.97,-1.2968,0.17,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2885_ZHAN_MULTIPLE_MYELOMA_MS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2885_ZHAN_MULTIPLE_MYELOMA_MS_DN",46,0.7719,0.91,1,1.2963,0.098,0.4,0.8678,0.72,1
"GO_MF:489913_GO_0004579_DOLICHYL_DIPHOSPHOOLIGOSACCHARIDE_PROTEIN_GLYCOTRANSFERASE_ACTIVITY","GO_MF","489913_GO_0004579_DOLICHYL_DIPHOSPHOOLIGOSACCHARIDE_PROTEIN_GLYCOTRANSFERASE_ACTIVITY",8,0.7723,0.75,1,1.148,0.29,0.75,-0.8976,0.57,0.87
"GO_MF:492461_GO_0008094_DNA_DEPENDENT_ATPASE_ACTIVITY","GO_MF","492461_GO_0008094_DNA_DEPENDENT_ATPASE_ACTIVITY",79,0.7726,0.95,1,-0.5923,1,1,-1.2347,0.12,0.58
"GO_BP:504462_GO_0035278_NEGATIVE_REGULATION_OF_TRANSLATION_INVOLVED_IN_GENE_SILENCING_BY_MIRNA","GO_BP","504462_GO_0035278_NEGATIVE_REGULATION_OF_TRANSLATION_INVOLVED_IN_GENE_SILENCING_BY_MIRNA",9,0.7728,0.76,1,-1.3511,0.14,0.94,-1.0688,0.38,0.8
"GO_MF:490144_GO_0004842_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY","GO_MF","490144_GO_0004842_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY",296,0.773,1,1,1.1154,0.16,0.77,0.7545,1,1
"GO_BP:491516_GO_0006623_PROTEIN_TARGETING_TO_VACUOLE","GO_BP","491516_GO_0006623_PROTEIN_TARGETING_TO_VACUOLE",26,0.773,0.82,1,0.9697,0.52,1,-0.6148,0.95,1
"REACTOME:576257_REACT_118811_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN","REACTOME","576257_REACT_118811_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN",6,0.7735,0.72,1,0.6343,0.9,1,-0.7711,0.77,1
"GO_BP:505252_GO_0042069_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS","GO_BP","505252_GO_0042069_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS",16,0.7735,0.78,1,1.3903,0.082,0.57,-1.2203,0.22,0.71
"REACTOME:1183602_REACT_355390_FRUCTOSE_METABOLISM","REACTOME","1183602_REACT_355390_FRUCTOSE_METABOLISM",5,0.7737,0.74,1,-0.8961,0.61,1,-1.2667,0.22,0.54
"GO_BP:754748_GO_1901797_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR","GO_BP","754748_GO_1901797_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR",25,0.7738,0.84,1,0.8083,0.78,1,0.8246,0.74,1
"GO_BP:491100_GO_0006119_OXIDATIVE_PHOSPHORYLATION","GO_BP","491100_GO_0006119_OXIDATIVE_PHOSPHORYLATION",62,0.774,0.93,1,2.4326,0,0,0.8326,0.77,0.99
"GO_BP:516623_GO_0071699_OLFACTORY_PLACODE_MORPHOGENESIS","GO_BP","516623_GO_0071699_OLFACTORY_PLACODE_MORPHOGENESIS",6,0.7749,0.73,1,0.7705,0.75,1,0.7762,0.75,1
"GO_BP:519318_GO_2000679_POSITIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING","GO_BP","519318_GO_2000679_POSITIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING",9,0.7751,0.75,1,1.0306,0.4,0.97,-0.7321,0.82,0.99
"C1_Positional:C1_ALL_125_CHR3P24","C1_Positional","C1_ALL_125_CHR3P24",39,0.7754,0.89,0.96,-0.6486,0.98,1,-1.4054,0.043,0.63
"GO_MF:487321_GO_0001098_BASAL_TRANSCRIPTION_MACHINERY_BINDING","GO_MF","487321_GO_0001098_BASAL_TRANSCRIPTION_MACHINERY_BINDING",22,0.776,0.81,1,-0.6473,0.94,1,-0.8247,0.75,0.95
"C1_Positional:C1_ALL_28_CHR12Q15","C1_Positional","C1_ALL_28_CHR12Q15",25,0.7761,0.84,0.97,0.76,0.83,0.99,0.7358,0.86,0.95
"GO_MF:490019_GO_0004703_G_PROTEIN_COUPLED_RECEPTOR_KINASE_ACTIVITY","GO_MF","490019_GO_0004703_G_PROTEIN_COUPLED_RECEPTOR_KINASE_ACTIVITY",7,0.7762,0.75,1,-1.083,0.37,0.85,-1.0263,0.43,0.77
"GO_CC:500280_GO_0030990_INTRACILIARY_TRANSPORT_PARTICLE","GO_CC","500280_GO_0030990_INTRACILIARY_TRANSPORT_PARTICLE",29,0.7762,0.85,1,0.8414,0.74,0.92,-0.9263,0.57,1
"GO_BP:515177_GO_0070242_THYMOCYTE_APOPTOTIC_PROCESS","GO_BP","515177_GO_0070242_THYMOCYTE_APOPTOTIC_PROCESS",5,0.7764,0.74,1,0.8366,0.66,1,0.7432,0.76,1
"GO_BP:491253_GO_0006290_PYRIMIDINE_DIMER_REPAIR","GO_BP","491253_GO_0006290_PYRIMIDINE_DIMER_REPAIR",8,0.7765,0.74,1,-0.581,0.95,1,0.4729,1,1
"GO_CC:500714_GO_0031463_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX","GO_CC","500714_GO_0031463_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX",24,0.7773,0.82,1,0.7509,0.85,0.98,0.9339,0.55,1
"GO_CC:500381_GO_0031094_PLATELET_DENSE_TUBULAR_NETWORK","GO_CC","500381_GO_0031094_PLATELET_DENSE_TUBULAR_NETWORK",11,0.7774,0.75,1,-0.9943,0.46,0.84,-1.0695,0.35,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_1018_HASEGAWA_TUMORIGENESIS_BY_RET_C634R","C2_Chemical_and_genetic_perturbations","C2_CGP_1018_HASEGAWA_TUMORIGENESIS_BY_RET_C634R",11,0.7774,0.76,1,1.3786,0.11,0.31,0.7297,0.83,1
"GO_BP:512208_GO_0051324_PROPHASE","GO_BP","512208_GO_0051324_PROPHASE",80,0.7775,0.93,1,0.6582,0.99,1,-0.6696,1,1
"GO_BP:506491_GO_0043457_REGULATION_OF_CELLULAR_RESPIRATION","GO_BP","506491_GO_0043457_REGULATION_OF_CELLULAR_RESPIRATION",13,0.7776,0.77,1,1.4439,0.071,0.5,-0.8918,0.61,0.93
"GO_BP:488199_GO_0002326_B_CELL_LINEAGE_COMMITMENT","GO_BP","488199_GO_0002326_B_CELL_LINEAGE_COMMITMENT",5,0.7776,0.7,1,-1.1604,0.31,0.92,-1.1554,0.31,0.74
"GO_BP:1022123_GO_0098722_ASYMMETRIC_STEM_CELL_DIVISION","GO_BP","1022123_GO_0098722_ASYMMETRIC_STEM_CELL_DIVISION",6,0.778,0.72,1,-0.6173,0.92,1,-0.669,0.88,1
"GO_BP:1184371_GO_0098779_ACTIVATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION","GO_BP","1184371_GO_0098779_ACTIVATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION",7,0.7783,0.73,1,0.701,0.83,1,-0.6951,0.87,0.99
"GO_BP:777530_GO_1901978_POSITIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT","GO_BP","777530_GO_1901978_POSITIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT",9,0.7786,0.73,1,1.2193,0.23,0.77,0.7624,0.77,1
"GO_CC:487091_GO_0000800_LATERAL_ELEMENT","GO_CC","487091_GO_0000800_LATERAL_ELEMENT",11,0.7798,0.79,1,-0.936,0.53,0.91,1.1893,0.25,0.84
"GO_MF:493214_GO_0009008_DNA_METHYLTRANSFERASE_ACTIVITY","GO_MF","493214_GO_0009008_DNA_METHYLTRANSFERASE_ACTIVITY",5,0.7801,0.72,1,-1.0844,0.37,0.85,0.7445,0.74,1
"GO_BP:983727_GO_1903008_ORGANELLE_DISASSEMBLY","GO_BP","983727_GO_1903008_ORGANELLE_DISASSEMBLY",50,0.7802,0.87,1,1.3846,0.051,0.57,0.6137,0.98,1
"GO_BP:512209_GO_0051325_INTERPHASE","GO_BP","512209_GO_0051325_INTERPHASE",148,0.7809,0.98,1,1.8444,0,0.066,-1.2597,0.061,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_1106_BENPORATH_ES_2","C2_Chemical_and_genetic_perturbations","C2_CGP_1106_BENPORATH_ES_2",40,0.7813,0.87,1,-1.0157,0.41,0.99,-0.9912,0.47,0.77
"C7_Immunologic_signatures:C7_ALL_851_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP","C7_Immunologic_signatures","C7_ALL_851_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP",198,0.7814,0.98,1,1.5085,0,0.011,-0.8291,0.94,1
"GO_BP:495220_GO_0014824_ARTERY_SMOOTH_MUSCLE_CONTRACTION","GO_BP","495220_GO_0014824_ARTERY_SMOOTH_MUSCLE_CONTRACTION",8,0.7816,0.76,1,1.4183,0.11,0.53,0.7902,0.73,1
"WikiPathways:198809_WP197_CHOLESTEROL_BIOSYNTHESIS","WikiPathways","198809_WP197_CHOLESTEROL_BIOSYNTHESIS",17,0.7817,0.78,1,0.5982,0.96,1,0.7046,0.89,1
"GO_BP:754795_GO_1901844_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION","GO_BP","754795_GO_1901844_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION",9,0.7822,0.73,1,1.3915,0.13,0.57,0.972,0.49,0.88
"GO_MF:488051_GO_0002162_DYSTROGLYCAN_BINDING","GO_MF","488051_GO_0002162_DYSTROGLYCAN_BINDING",6,0.7822,0.72,1,1.2737,0.2,0.63,-0.782,0.72,0.97
"KEGG_compound:C05752_OCTANOYL_ACP_OCTANOYL_ACYL_CARRIER_PROTEIN_","KEGG_compound","C05752_OCTANOYL_ACP_OCTANOYL_ACYL_CARRIER_PROTEIN_",5,0.7822,0.7,1,-0.5873,0.93,1,-0.8974,0.61,0.76
"GO_BP:513682_GO_0060124_POSITIVE_REGULATION_OF_GROWTH_HORMONE_SECRETION","GO_BP","513682_GO_0060124_POSITIVE_REGULATION_OF_GROWTH_HORMONE_SECRETION",7,0.7823,0.75,1,0.6813,0.86,1,0.9406,0.53,0.91
"GO_MF:516777_GO_0071855_NEUROPEPTIDE_RECEPTOR_BINDING","GO_MF","516777_GO_0071855_NEUROPEPTIDE_RECEPTOR_BINDING",26,0.7824,0.84,1,-1.9752,0,0.26,-0.9258,0.59,0.85
"C4_Cancer_gene_neighborhoods:C4_CGN_252_GCM_PPP1CC","C4_Cancer_gene_neighborhoods","C4_CGN_252_GCM_PPP1CC",56,0.7826,0.91,1,2.3093,0,0,-0.681,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3345_HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3345_HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP",26,0.7828,0.82,1,3.0219,0,0,0.8144,0.77,1
"GO_BP:491756_GO_0006895_GOLGI_TO_ENDOSOME_TRANSPORT","GO_BP","491756_GO_0006895_GOLGI_TO_ENDOSOME_TRANSPORT",18,0.7832,0.77,1,0.5452,0.97,1,0.5808,0.97,1
"REACTOME:477112_REACT_111158_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS","REACTOME","477112_REACT_111158_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS",17,0.7835,0.75,0.99,-1.1709,0.24,0.86,0.6181,0.97,1
"C4_Cancer_gene_neighborhoods:C4_CGN_46_MORF_SMC1L1","C4_Cancer_gene_neighborhoods","C4_CGN_46_MORF_SMC1L1",62,0.7835,0.93,1,1.3926,0.039,0.064,-1.6194,0.0043,0.067
"C4_Cancer_gene_neighborhoods:C4_CGN_47_MORF_SP3","C4_Cancer_gene_neighborhoods","C4_CGN_47_MORF_SP3",80,0.7837,0.94,1,2.0657,0,0.00017,-0.5616,1,1
"GO_BP:505240_GO_0042053_REGULATION_OF_DOPAMINE_METABOLIC_PROCESS","GO_BP","505240_GO_0042053_REGULATION_OF_DOPAMINE_METABOLIC_PROCESS",15,0.7837,0.77,1,1.2574,0.2,0.72,-1.0468,0.38,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1124_STARK_BRAIN_22Q11_DELETION","C2_Chemical_and_genetic_perturbations","C2_CGP_1124_STARK_BRAIN_22Q11_DELETION",13,0.7837,0.75,1,0.7986,0.74,0.99,-0.8214,0.73,0.94
"GO_BP:494728_GO_0010665_REGULATION_OF_CARDIAC_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","494728_GO_0010665_REGULATION_OF_CARDIAC_MUSCLE_CELL_APOPTOTIC_PROCESS",15,0.7839,0.75,1,0.7492,0.81,1,1.1283,0.29,0.74
"GO_BP:512224_GO_0051340_REGULATION_OF_LIGASE_ACTIVITY","GO_BP","512224_GO_0051340_REGULATION_OF_LIGASE_ACTIVITY",110,0.784,0.93,1,1.9261,0,0.029,-0.8447,0.83,0.96
"C7_Immunologic_signatures:C7_ALL_1201_GSE27786_CD4_TCELL_VS_MONO_MAC_UP","C7_Immunologic_signatures","C7_ALL_1201_GSE27786_CD4_TCELL_VS_MONO_MAC_UP",200,0.7846,0.98,1,0.6865,1,1,-1.0813,0.25,0.54
"GO_BP:1026081_GO_1903309_NEGATIVE_REGULATION_OF_CHROMATIN_MODIFICATION","GO_BP","1026081_GO_1903309_NEGATIVE_REGULATION_OF_CHROMATIN_MODIFICATION",43,0.7851,0.85,1,1.0182,0.42,0.97,-0.7096,0.93,0.99
"GO_BP:515466_GO_0070536_PROTEIN_K63_LINKED_DEUBIQUITINATION","GO_BP","515466_GO_0070536_PROTEIN_K63_LINKED_DEUBIQUITINATION",20,0.7851,0.79,1,0.8041,0.77,1,-1.1209,0.3,0.76
"KEGG_compound:C00242_GUANINE_2_AMINO_6_HYDROXYPURINE","KEGG_compound","C00242_GUANINE_2_AMINO_6_HYDROXYPURINE",6,0.7856,0.71,1,0.955,0.53,1,1.1935,0.27,0.56
"GO_BP:753347_GO_1900363_REGULATION_OF_MRNA_POLYADENYLATION","GO_BP","753347_GO_1900363_REGULATION_OF_MRNA_POLYADENYLATION",9,0.7859,0.74,1,0.6996,0.83,1,1.0071,0.43,0.85
"GO_MF:754465_GO_1901505_CARBOHYDRATE_DERIVATIVE_TRANSPORTER_ACTIVITY","GO_MF","754465_GO_1901505_CARBOHYDRATE_DERIVATIVE_TRANSPORTER_ACTIVITY",31,0.7865,0.82,1,-0.6109,0.97,1,-0.7929,0.8,0.97
"GO_CC:496339_GO_0016282_EUKARYOTIC_43S_PREINITIATION_COMPLEX","GO_CC","496339_GO_0016282_EUKARYOTIC_43S_PREINITIATION_COMPLEX",15,0.7866,0.79,1,2.1297,0,0.00041,0.7972,0.75,1
"C6_Oncogenic_signatures:C6_ALL_162_TBK1_DF_DN","C6_Oncogenic_signatures","C6_ALL_162_TBK1_DF_DN",283,0.7869,1,0.95,1.2699,0.022,0.42,0.8622,0.9,0.84
"GO_CC:490660_GO_0005587_COLLAGEN_TYPE_IV_TRIMER","GO_CC","490660_GO_0005587_COLLAGEN_TYPE_IV_TRIMER",6,0.7872,0.72,1,-0.8048,0.7,1,0.7244,0.81,1
"GO_CC:502508_GO_0033290_EUKARYOTIC_48S_PREINITIATION_COMPLEX","GO_CC","502508_GO_0033290_EUKARYOTIC_48S_PREINITIATION_COMPLEX",15,0.7876,0.78,1,2.29,0,0,0.8151,0.72,1
"C7_Immunologic_signatures:C7_ALL_157_GSE13306_RA_VS_UNTREATED_TCONV_UP","C7_Immunologic_signatures","C7_ALL_157_GSE13306_RA_VS_UNTREATED_TCONV_UP",196,0.7877,0.98,1,-0.6564,1,1,1.1208,0.17,0.96
"KEGG_pathway:HSA04742_TASTE_TRANSDUCTION","KEGG_pathway","HSA04742_TASTE_TRANSDUCTION",48,0.7878,0.88,0.97,-1.0558,0.38,0.74,1.2579,0.15,0.57
"GO_BP:491448_GO_0006552_LEUCINE_CATABOLIC_PROCESS","GO_BP","491448_GO_0006552_LEUCINE_CATABOLIC_PROCESS",5,0.7882,0.69,1,1.1806,0.28,0.8,-1.116,0.38,0.76
"GO_BP:512582_GO_0051709_REGULATION_OF_KILLING_OF_CELLS_OF_OTHER_ORGANISM","GO_BP","512582_GO_0051709_REGULATION_OF_KILLING_OF_CELLS_OF_OTHER_ORGANISM",7,0.7884,0.72,1,-0.6301,0.93,1,-0.7414,0.76,1
"GO_BP:514183_GO_0060628_REGULATION_OF_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT","GO_BP","514183_GO_0060628_REGULATION_OF_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT",12,0.7886,0.74,1,1.2197,0.22,0.77,1.3443,0.13,0.65
"GO_BP:493398_GO_0009202_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493398_GO_0009202_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",6,0.7888,0.71,1,-0.5131,0.98,1,-0.8915,0.61,0.93
"GO_BP:751562_GO_0044349_DNA_EXCISION","GO_BP","751562_GO_0044349_DNA_EXCISION",22,0.7889,0.8,1,1.3628,0.091,0.6,-0.629,0.96,1
"GO_BP:494741_GO_0010676_POSITIVE_REGULATION_OF_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS","GO_BP","494741_GO_0010676_POSITIVE_REGULATION_OF_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS",59,0.789,0.91,1,1.1053,0.28,0.9,1.5599,0.014,0.49
"GO_BP:516622_GO_0071698_OLFACTORY_PLACODE_DEVELOPMENT","GO_BP","516622_GO_0071698_OLFACTORY_PLACODE_DEVELOPMENT",6,0.7892,0.74,1,0.7906,0.74,1,0.7944,0.71,1
"GO_BP:494670_GO_0010606_POSITIVE_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY","GO_BP","494670_GO_0010606_POSITIVE_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY",5,0.7894,0.7,1,0.8396,0.66,1,-1.3588,0.15,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_1387_SCHUHMACHER_MYC_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1387_SCHUHMACHER_MYC_TARGETS_UP",80,0.7894,0.94,1,1.1895,0.16,0.5,-1.3943,0.044,0.36
"C4_Cancer_gene_neighborhoods:C4_CGN_154_MORF_PRKAG1","C4_Cancer_gene_neighborhoods","C4_CGN_154_MORF_PRKAG1",222,0.7894,0.98,1,1.5408,0,0.023,-0.6195,1,1
"GO_MF:496462_GO_0016494_C_X_C_CHEMOKINE_RECEPTOR_ACTIVITY","GO_MF","496462_GO_0016494_C_X_C_CHEMOKINE_RECEPTOR_ACTIVITY",8,0.7895,0.72,1,1.6553,0.021,0.19,1.7787,0.006,0.14
"C7_Immunologic_signatures:C7_ALL_136_GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN","C7_Immunologic_signatures","C7_ALL_136_GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN",200,0.7896,0.99,1,1.6644,0,0.001,-0.9767,0.49,0.78
"C3_MicroRNA_targets:C3_MIR_77_GTGGTGA_MIR_197","C3_MicroRNA_targets","C3_MIR_77_GTGGTGA_MIR_197",71,0.7896,0.91,1,-0.7926,0.89,1,0.7316,0.94,1
"GO_BP:506269_GO_0043201_RESPONSE_TO_LEUCINE","GO_BP","506269_GO_0043201_RESPONSE_TO_LEUCINE",6,0.7904,0.74,1,0.7612,0.76,1,0.7926,0.7,1
"GO_MF:487929_GO_0002039_P53_BINDING","GO_MF","487929_GO_0002039_P53_BINDING",57,0.7905,0.87,1,0.626,0.99,1,-0.6289,1,1
"GO_BP:514008_GO_0060453_REGULATION_OF_GASTRIC_ACID_SECRETION","GO_BP","514008_GO_0060453_REGULATION_OF_GASTRIC_ACID_SECRETION",5,0.7907,0.68,1,0.5883,0.94,1,-1.317,0.17,0.63
"GO_BP:518707_GO_2000058_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","518707_GO_2000058_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",96,0.791,0.93,1,1.6801,0,0.21,-0.9115,0.66,0.92
"GO_BP:486883_GO_0000381_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME","GO_BP","486883_GO_0000381_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME",29,0.7911,0.82,1,-1.1283,0.29,0.93,-1.0357,0.37,0.82
"GO_BP:512048_GO_0051138_POSITIVE_REGULATION_OF_NK_T_CELL_DIFFERENTIATION","GO_BP","512048_GO_0051138_POSITIVE_REGULATION_OF_NK_T_CELL_DIFFERENTIATION",5,0.7916,0.72,1,0.9672,0.52,1,-0.9056,0.56,0.92
"GO_BP:512569_GO_0051694_POINTED_END_ACTIN_FILAMENT_CAPPING","GO_BP","512569_GO_0051694_POINTED_END_ACTIN_FILAMENT_CAPPING",7,0.7921,0.73,1,-1.2205,0.24,0.88,-1.3217,0.16,0.63
"C4_Cancer_gene_neighborhoods:C4_CGN_212_GCM_CALM1","C4_Cancer_gene_neighborhoods","C4_CGN_212_GCM_CALM1",108,0.7926,0.96,1,-0.6819,0.99,1,-0.9943,0.47,0.88
"GO_BP:751908_GO_0044766_MULTI_ORGANISM_TRANSPORT","GO_BP","751908_GO_0044766_MULTI_ORGANISM_TRANSPORT",36,0.7926,0.83,1,1.5696,0.017,0.33,-0.7329,0.9,0.99
"GO_CC:487106_GO_0000815_ESCRT_III_COMPLEX","GO_CC","487106_GO_0000815_ESCRT_III_COMPLEX",10,0.7927,0.7,1,1.0579,0.4,0.71,1.1349,0.31,0.87
"GO_BP:494272_GO_0035196_PRODUCTION_OF_MIRNAS_INVOLVED_IN_GENE_SILENCING_BY_MIRNA","GO_BP","494272_GO_0035196_PRODUCTION_OF_MIRNAS_INVOLVED_IN_GENE_SILENCING_BY_MIRNA",19,0.7932,0.77,1,-0.6467,0.95,1,-0.5738,0.97,1
"C7_Immunologic_signatures:C7_ALL_1831_GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP","C7_Immunologic_signatures","C7_ALL_1831_GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP",194,0.7937,1,1,1.2959,0.014,0.11,0.7549,0.99,1
"GO_MF:506597_GO_0043566_STRUCTURE_SPECIFIC_DNA_BINDING","GO_MF","506597_GO_0043566_STRUCTURE_SPECIFIC_DNA_BINDING",247,0.7937,1,1,1.2005,0.08,0.7,-0.8248,0.96,0.95
"GO_MF:490349_GO_0005078_MAP_KINASE_SCAFFOLD_ACTIVITY","GO_MF","490349_GO_0005078_MAP_KINASE_SCAFFOLD_ACTIVITY",7,0.7937,0.71,1,-1.106,0.33,0.84,0.6855,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1232_CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS","C2_Chemical_and_genetic_perturbations","C2_CGP_1232_CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS",49,0.7938,0.87,1,1.0326,0.39,0.75,0.7791,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1233_TCGA_GLIOBLASTOMA_COPY_NUMBER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1233_TCGA_GLIOBLASTOMA_COPY_NUMBER_UP",73,0.794,0.93,1,0.9764,0.5,0.82,1.3183,0.07,0.64
"REACTOME:105830_REACT_6904_PHOSPHORYLATION_OF_THE_APC_C","REACTOME","105830_REACT_6904_PHOSPHORYLATION_OF_THE_APC_C",17,0.7948,0.79,0.97,1.0963,0.31,0.59,-0.5872,0.96,1
"GO_MF:512594_GO_0051721_PROTEIN_PHOSPHATASE_2A_BINDING","GO_MF","512594_GO_0051721_PROTEIN_PHOSPHATASE_2A_BINDING",19,0.7951,0.76,1,0.8062,0.76,1,-0.813,0.73,0.96
"GO_BP:512046_GO_0051136_REGULATION_OF_NK_T_CELL_DIFFERENTIATION","GO_BP","512046_GO_0051136_REGULATION_OF_NK_T_CELL_DIFFERENTIATION",5,0.7952,0.71,1,0.9722,0.52,1,-0.8783,0.61,0.94
"REACTOME:1127688_REACT_264442_MISMATCH_REPAIR","REACTOME","1127688_REACT_264442_MISMATCH_REPAIR",16,0.7952,0.77,0.97,0.9184,0.54,0.88,-1.2634,0.18,0.54
"GO_BP:516099_GO_0071173_SPINDLE_ASSEMBLY_CHECKPOINT","GO_BP","516099_GO_0071173_SPINDLE_ASSEMBLY_CHECKPOINT",33,0.7953,0.84,1,0.8974,0.63,1,-0.655,0.96,1
"GO_BP:491903_GO_0007080_MITOTIC_METAPHASE_PLATE_CONGRESSION","GO_BP","491903_GO_0007080_MITOTIC_METAPHASE_PLATE_CONGRESSION",35,0.7957,0.82,1,1.6021,0.015,0.29,0.8006,0.81,1
"C7_Immunologic_signatures:C7_ALL_1283_GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP","C7_Immunologic_signatures","C7_ALL_1283_GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP",185,0.7961,0.97,1,1.0528,0.29,0.58,-1.1872,0.1,0.31
"C4_Cancer_modules:C4_CM_291_MODULE_332","C4_Cancer_modules","C4_CM_291_MODULE_332",45,0.7961,0.85,0.97,-0.7481,0.91,1,-0.7927,0.82,0.98
"C3_TF_targets:C3_TFT_447_GGCKCATGS_UNKNOWN","C3_TF_targets","C3_TFT_447_GGCKCATGS_UNKNOWN",65,0.7962,0.88,1,0.7367,0.94,1,-0.7539,0.92,1
"GO_BP:491720_GO_0006853_CARNITINE_SHUTTLE","GO_BP","491720_GO_0006853_CARNITINE_SHUTTLE",9,0.7969,0.72,1,-0.8114,0.69,1,1.1885,0.26,0.72
"GO_MF:489910_GO_0004576_OLIGOSACCHARYL_TRANSFERASE_ACTIVITY","GO_MF","489910_GO_0004576_OLIGOSACCHARYL_TRANSFERASE_ACTIVITY",9,0.7971,0.74,1,1.3131,0.15,0.59,-1.0083,0.43,0.78
"GO_MF:498687_GO_0019911_STRUCTURAL_CONSTITUENT_OF_MYELIN_SHEATH","GO_MF","498687_GO_0019911_STRUCTURAL_CONSTITUENT_OF_MYELIN_SHEATH",5,0.7973,0.7,1,0.9939,0.48,0.88,0.7927,0.72,1
"GO_BP:491267_GO_0006308_DNA_CATABOLIC_PROCESS","GO_BP","491267_GO_0006308_DNA_CATABOLIC_PROCESS",72,0.7973,0.9,1,1.2342,0.12,0.75,-0.7174,0.96,0.99
"C7_Immunologic_signatures:C7_ALL_248_GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_248_GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN",195,0.7974,0.98,1,0.6822,1,1,-0.7393,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_842_OXFORD_RALA_AND_RALB_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_842_OXFORD_RALA_AND_RALB_TARGETS_UP",10,0.7975,0.73,1,-1.1055,0.34,0.92,-1.2129,0.22,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_784_TERAMOTO_OPN_TARGETS_CLUSTER_3","C2_Chemical_and_genetic_perturbations","C2_CGP_784_TERAMOTO_OPN_TARGETS_CLUSTER_3",5,0.7976,0.7,1,0.6728,0.88,1,0.7012,0.84,1
"C4_Cancer_modules:C4_CM_426_MODULE_567","C4_Cancer_modules","C4_CM_426_MODULE_567",98,0.7977,0.89,0.99,1.3305,0.05,0.24,-0.6969,0.98,1
"C1_Positional:C1_ALL_47_CHR2P","C1_Positional","C1_ALL_47_CHR2P",9,0.7983,0.69,0.95,1.2815,0.18,0.54,-0.9285,0.55,0.99
"GO_MF:490346_GO_0030618_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_PATHWAY_SPECIFIC_CYTOPLASMIC_MEDIATOR_ACTIVITY","GO_MF","490346_GO_0030618_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_PATHWAY_SPECIFIC_CYTOPLASMIC_MEDIATOR_ACTIVITY",5,0.7983,0.69,1,-0.4177,1,1,1.1812,0.29,0.75
"C4_Cancer_modules:C4_CM_46_MODULE_50","C4_Cancer_modules","C4_CM_46_MODULE_50",13,0.7986,0.73,1,1.8928,0.0043,0.0087,-0.7069,0.85,1
"GO_MF:511704_GO_0050733_RS_DOMAIN_BINDING","GO_MF","511704_GO_0050733_RS_DOMAIN_BINDING",8,0.7986,0.72,1,-1.2149,0.21,0.82,0.7024,0.85,1
"GO_BP:493282_GO_0009081_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS","GO_BP","493282_GO_0009081_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS",23,0.7987,0.79,1,1.2393,0.18,0.75,-1.2083,0.2,0.73
"GO_BP:518407_GO_0090267_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_SPINDLE_ASSEMBLY_CHECKPOINT","GO_BP","518407_GO_0090267_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_SPINDLE_ASSEMBLY_CHECKPOINT",6,0.799,0.69,1,1.0098,0.46,0.98,0.7834,0.72,1
"GO_MF:492518_GO_0008170_N_METHYLTRANSFERASE_ACTIVITY","GO_MF","492518_GO_0008170_N_METHYLTRANSFERASE_ACTIVITY",72,0.7993,0.9,1,-0.8145,0.82,1,-0.8982,0.67,0.87
"GO_MF:506106_GO_0043015_GAMMA_TUBULIN_BINDING","GO_MF","506106_GO_0043015_GAMMA_TUBULIN_BINDING",20,0.7994,0.75,1,0.5869,0.97,1,-0.7159,0.87,1
"REACTOME:1127697_REACT_264617_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION","REACTOME","1127697_REACT_264617_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION",22,0.8007,0.77,0.97,1.4182,0.058,0.21,-0.6873,0.91,1
"C7_Immunologic_signatures:C7_ALL_1751_GSE6269_FLU_VS_STREP_AUREUS_INF_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1751_GSE6269_FLU_VS_STREP_AUREUS_INF_PBMC_UP",170,0.8007,0.99,1,1.0059,0.44,0.72,-2.0503,0,0
"GO_MF:506247_GO_0043175_RNA_POLYMERASE_CORE_ENZYME_BINDING","GO_MF","506247_GO_0043175_RNA_POLYMERASE_CORE_ENZYME_BINDING",22,0.8008,0.75,1,-0.6554,0.94,1,0.8344,0.7,1
"GO_BP:508250_GO_0045945_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER","GO_BP","508250_GO_0045945_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER",11,0.8018,0.74,1,-0.5862,0.95,1,0.9433,0.53,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_3143_IVANOVSKA_MIR106B_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3143_IVANOVSKA_MIR106B_TARGETS",90,0.8018,0.88,1,0.7741,0.92,1,0.9146,0.66,1
"OMIM_gene:OMIM164360_ATP_SYNTHASE_H_TRANSPORTING_MITOCHONDRIAL_F1_COMPLEX_ALPHA_SUBUNIT_1_ATP5A1","OMIM_gene","OMIM164360_ATP_SYNTHASE_H_TRANSPORTING_MITOCHONDRIAL_F1_COMPLEX_ALPHA_SUBUNIT_1_ATP5A1",5,0.8021,0.71,1,1.7895,0.002,0.23,0.987,0.48,0.98
"GO_BP:499080_GO_0021800_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION","GO_BP","499080_GO_0021800_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION",8,0.8022,0.71,1,0.7992,0.72,1,0.8209,0.67,0.99
"GO_MF:501371_GO_0032135_DNA_INSERTION_OR_DELETION_BINDING","GO_MF","501371_GO_0032135_DNA_INSERTION_OR_DELETION_BINDING",6,0.8023,0.7,1,-0.5942,0.93,1,-1.3804,0.12,0.51
"GO_BP:518753_GO_2000104_NEGATIVE_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION","GO_BP","518753_GO_2000104_NEGATIVE_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION",15,0.8024,0.72,1,-0.6378,0.92,1,-0.8325,0.72,0.97
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_29_BIOCARTA_CARM_ER_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_29_BIOCARTA_CARM_ER_PATHWAY",34,0.8026,0.81,0.9,-0.7363,0.89,1,-0.8395,0.73,0.89
"GO_BP:518534_GO_0090394_NEGATIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL","GO_BP","518534_GO_0090394_NEGATIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_MEMBRANE_POTENTIAL",6,0.803,0.7,1,-1.1376,0.31,0.93,-0.9029,0.59,0.92
"REACTOME:645276_REACT_120999_FGFR1_MUTANT_RECEPTOR_ACTIVATION","REACTOME","645276_REACT_120999_FGFR1_MUTANT_RECEPTOR_ACTIVATION",28,0.8031,0.77,0.97,0.685,0.95,1,0.7346,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2850_PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2850_PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP",188,0.8031,0.97,1,0.7996,0.96,0.99,-1.2829,0.042,0.45
"C3_MicroRNA_targets:C3_MIR_111_ACGCACA_MIR_210","C3_MicroRNA_targets","C3_MIR_111_ACGCACA_MIR_210",8,0.8033,0.71,1,-0.7611,0.78,1,-1.2403,0.21,1
"C1_Positional:C1_ALL_267_CHR7Q35","C1_Positional","C1_ALL_267_CHR7Q35",40,0.8036,0.8,0.95,-0.9177,0.6,1,1.2099,0.16,0.63
"GO_BP:487015_GO_0000718_NUCLEOTIDE_EXCISION_REPAIR_DNA_DAMAGE_REMOVAL","GO_BP","487015_GO_0000718_NUCLEOTIDE_EXCISION_REPAIR_DNA_DAMAGE_REMOVAL",22,0.8041,0.77,1,1.3579,0.084,0.6,-0.6187,0.96,1
"GO_BP:507123_GO_0044108_CELLULAR_ALCOHOL_BIOSYNTHETIC_PROCESS","GO_BP","507123_GO_0044108_CELLULAR_ALCOHOL_BIOSYNTHETIC_PROCESS",5,0.8042,0.69,1,-1.0024,0.47,0.99,-0.46,0.99,1
"GO_BP:496010_GO_0015886_HEME_TRANSPORT","GO_BP","496010_GO_0015886_HEME_TRANSPORT",9,0.8043,0.73,1,-1.2142,0.22,0.88,1.0445,0.41,0.81
"GO_BP:507122_GO_0044107_CELLULAR_ALCOHOL_METABOLIC_PROCESS","GO_BP","507122_GO_0044107_CELLULAR_ALCOHOL_METABOLIC_PROCESS",5,0.8048,0.68,1,-1.013,0.44,0.98,-0.4585,0.99,1
"GO_BP:491996_GO_0007196_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","491996_GO_0007196_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY",7,0.8053,0.71,1,1.4436,0.08,0.5,1.351,0.15,0.65
"KEGG_reaction:R02088_2_DEOXYADENOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DAMP_H2O_DEOXYADENOSINE_ORTHOPHOSPHATE","KEGG_reaction","R02088_2_DEOXYADENOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DAMP_H2O_DEOXYADENOSINE_ORTHOPHOSPHATE",9,0.8054,0.69,0.79,0.5571,0.95,1,-1.2019,0.24,0.41
"C2_Chemical_and_genetic_perturbations:C2_CGP_2898_DORN_ADENOVIRUS_INFECTION_48HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2898_DORN_ADENOVIRUS_INFECTION_48HR_UP",14,0.8054,0.72,1,0.9257,0.55,0.89,1.1922,0.25,0.78
"C3_TF_targets:C3_TFT_205_CCAWNWWNNNGGC_UNKNOWN","C3_TF_targets","C3_TFT_205_CCAWNWWNNNGGC_UNKNOWN",81,0.8059,0.87,1,1.2017,0.13,0.76,-0.6073,1,1
"REACTOME:1127540_REACT_267700_DEGRADATION_OF_GLI2_BY_THE_PROTEASOME","REACTOME","1127540_REACT_267700_DEGRADATION_OF_GLI2_BY_THE_PROTEASOME",59,0.8062,0.85,0.96,2.1547,0,0.00026,-0.715,0.95,1
"GO_BP:511978_GO_0051053_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS","GO_BP","511978_GO_0051053_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS",85,0.8063,0.89,1,0.8337,0.82,1,-0.9709,0.49,0.87
"REACTOME:645274_REACT_120736_SIGNALING_BY_FGFR_IN_DISEASE","REACTOME","645274_REACT_120736_SIGNALING_BY_FGFR_IN_DISEASE",39,0.8064,0.8,0.96,-0.7686,0.82,1,0.752,0.86,1
"GO_BP:507978_GO_0045630_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION","GO_BP","507978_GO_0045630_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION",6,0.8066,0.65,1,-0.8569,0.65,1,-0.7151,0.82,0.99
"GO_BP:755357_GO_2001251_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION","GO_BP","755357_GO_2001251_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION",92,0.8068,0.9,1,1.129,0.2,0.87,-0.7544,0.95,1
"GO_CC:507395_GO_0044447_AXONEME_PART","GO_CC","507395_GO_0044447_AXONEME_PART",29,0.8069,0.79,0.99,-1.6631,0.0071,0.32,0.6437,0.97,1
"GO_BP:505882_GO_0042776_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_PROTON_TRANSPORT","GO_BP","505882_GO_0042776_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_PROTON_TRANSPORT",17,0.8071,0.74,1,2.2246,0,0.00048,-0.9127,0.57,0.92
"C4_Cancer_gene_neighborhoods:C4_CGN_101_MORF_FBL","C4_Cancer_gene_neighborhoods","C4_CGN_101_MORF_FBL",140,0.8074,0.94,1,2.5073,0,0,-0.8552,0.83,1
"GO_CC:490921_GO_0005922_CONNEXON_COMPLEX","GO_CC","490921_GO_0005922_CONNEXON_COMPLEX",19,0.8076,0.72,0.99,-1.4436,0.064,0.63,1.4992,0.058,0.58
"GO_MF:493050_GO_0008821_CROSSOVER_JUNCTION_ENDODEOXYRIBONUCLEASE_ACTIVITY","GO_MF","493050_GO_0008821_CROSSOVER_JUNCTION_ENDODEOXYRIBONUCLEASE_ACTIVITY",6,0.8078,0.68,1,1.0675,0.41,0.82,1.3468,0.14,0.64
"GO_BP:511659_GO_0050687_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS","GO_BP","511659_GO_0050687_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS",17,0.808,0.74,1,1.4084,0.08,0.55,0.8025,0.74,1
"GO_MF:492532_GO_0008190_EUKARYOTIC_INITIATION_FACTOR_4E_BINDING","GO_MF","492532_GO_0008190_EUKARYOTIC_INITIATION_FACTOR_4E_BINDING",7,0.808,0.7,1,0.7135,0.82,1,-1.4008,0.11,0.5
"REACTOME:1127696_REACT_263856_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS","REACTOME","1127696_REACT_263856_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS",33,0.8081,0.82,0.96,1.2779,0.12,0.35,0.7737,0.84,1
"GO_BP:506315_GO_0043248_PROTEASOME_ASSEMBLY","GO_BP","506315_GO_0043248_PROTEASOME_ASSEMBLY",9,0.8081,0.72,1,1.5343,0.042,0.36,0.8416,0.69,0.99
"C1_Positional:C1_ALL_284_CHR3Q23","C1_Positional","C1_ALL_284_CHR3Q23",23,0.8084,0.76,0.96,1.5981,0.021,0.24,1.0908,0.31,0.73
"GO_BP:494951_GO_0010887_NEGATIVE_REGULATION_OF_CHOLESTEROL_STORAGE","GO_BP","494951_GO_0010887_NEGATIVE_REGULATION_OF_CHOLESTEROL_STORAGE",6,0.8084,0.7,1,1.3243,0.17,0.64,0.9865,0.49,0.87
"GO_BP:487728_GO_0001832_BLASTOCYST_GROWTH","GO_BP","487728_GO_0001832_BLASTOCYST_GROWTH",19,0.8086,0.78,1,0.8464,0.7,1,-0.9843,0.49,0.86
"GO_MF:496791_GO_0016907_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_ACTIVITY","GO_MF","496791_GO_0016907_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_ACTIVITY",5,0.8095,0.69,1,0.8706,0.62,1,1.4111,0.096,0.52
"REACTOME:1127529_REACT_264478_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS","REACTOME","1127529_REACT_264478_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS",63,0.8098,0.89,0.96,1.8134,0,0.019,-0.6773,0.98,1
"GO_BP:491816_GO_0006978_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR","GO_BP","491816_GO_0006978_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR",14,0.81,0.75,1,0.7969,0.75,1,-0.6059,0.96,1
"GO_BP:517151_GO_0072235_METANEPHRIC_DISTAL_TUBULE_DEVELOPMENT","GO_BP","517151_GO_0072235_METANEPHRIC_DISTAL_TUBULE_DEVELOPMENT",6,0.8102,0.67,1,1.0743,0.37,0.93,1.3232,0.16,0.65
"GO_BP:505315_GO_0042149_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION","GO_BP","505315_GO_0042149_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION",27,0.8103,0.77,1,0.5642,0.99,1,1.0345,0.38,0.82
"GO_BP:491160_GO_0006188_IMP_BIOSYNTHETIC_PROCESS","GO_BP","491160_GO_0006188_IMP_BIOSYNTHETIC_PROCESS",11,0.8106,0.72,1,0.5593,0.96,1,-0.6425,0.92,1
"REACTOME:1127509_REACT_268024_INTRAFLAGELLAR_TRANSPORT","REACTOME","1127509_REACT_268024_INTRAFLAGELLAR_TRANSPORT",41,0.8108,0.82,0.96,0.772,0.88,1,-0.6769,0.96,1
"GO_BP:493458_GO_0009265_2_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS","GO_BP","493458_GO_0009265_2_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS",9,0.8114,0.68,1,0.9494,0.54,1,-0.7848,0.73,1
"C3_MicroRNA_targets:C3_MIR_152_ATAAGCT_MIR_21","C3_MicroRNA_targets","C3_MIR_152_ATAAGCT_MIR_21",113,0.8115,0.91,1,1.0588,0.31,1,-0.6979,0.99,0.99
"GO_BP:488269_GO_0002396_MHC_PROTEIN_COMPLEX_ASSEMBLY","GO_BP","488269_GO_0002396_MHC_PROTEIN_COMPLEX_ASSEMBLY",6,0.812,0.68,1,-0.9337,0.55,1,0.5913,0.93,1
"GO_CC:490781_GO_0005746_MITOCHONDRIAL_RESPIRATORY_CHAIN","GO_CC","490781_GO_0005746_MITOCHONDRIAL_RESPIRATORY_CHAIN",62,0.8122,0.88,0.99,2.5853,0,0,0.7533,0.91,1
"KEGG_compound:C00630_2_METHYLPROPANOYL_COA_2_METHYLPROPIONYL_COA_ISOBUTYRYL_COA","KEGG_compound","C00630_2_METHYLPROPANOYL_COA_2_METHYLPROPIONYL_COA_ISOBUTYRYL_COA",5,0.8123,0.65,1,1.2024,0.25,0.87,-1.4371,0.092,0.26
"GO_BP:500212_GO_0030917_MIDBRAIN_HINDBRAIN_BOUNDARY_DEVELOPMENT","GO_BP","500212_GO_0030917_MIDBRAIN_HINDBRAIN_BOUNDARY_DEVELOPMENT",6,0.813,0.69,1,-1.0324,0.44,0.98,0.5756,0.95,1
"C1_Positional:C1_ALL_154_CHR11P14","C1_Positional","C1_ALL_154_CHR11P14",26,0.8134,0.78,0.96,0.8375,0.75,0.92,-0.8516,0.72,0.98
"GO_BP:925928_GO_1902579_MULTI_ORGANISM_LOCALIZATION","GO_BP","925928_GO_1902579_MULTI_ORGANISM_LOCALIZATION",36,0.8135,0.8,1,1.5416,0.028,0.36,-0.7135,0.92,0.99
"GO_BP:512317_GO_0051439_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY_INVOLVED_IN_MITOTIC_CELL_CYCLE","GO_BP","512317_GO_0051439_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY_INVOLVED_IN_MITOTIC_CELL_CYCLE",78,0.8146,0.9,1,1.987,0,0.015,-0.7513,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3348_HOLLEMAN_DAUNORUBICIN_B_ALL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3348_HOLLEMAN_DAUNORUBICIN_B_ALL_DN",12,0.8146,0.68,1,1.4722,0.081,0.23,1.0414,0.39,0.93
"GO_CC:515919_GO_0070993_TRANSLATION_PREINITIATION_COMPLEX","GO_CC","515919_GO_0070993_TRANSLATION_PREINITIATION_COMPLEX",16,0.8148,0.73,0.99,2.2729,0,0,0.9181,0.56,1
"GO_MF:489669_GO_0004303_ESTRADIOL_17_BETA_DEHYDROGENASE_ACTIVITY","GO_MF","489669_GO_0004303_ESTRADIOL_17_BETA_DEHYDROGENASE_ACTIVITY",9,0.8148,0.68,1,1.8955,0,0.033,-1.4184,0.12,0.47
"C2_Chemical_and_genetic_perturbations:C2_CGP_2033_PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2033_PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",49,0.8153,0.84,1,2.1488,0,0.0012,0.5387,1,1
"GO_BP:752386_GO_0086014_ATRIAL_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL","GO_BP","752386_GO_0086014_ATRIAL_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL",8,0.816,0.69,1,0.7816,0.73,1,-0.8072,0.71,0.98
"REACTOME:771572_REACT_160251_CLEARANCE_OF_NUCLEAR_ENVELOPE_MEMBRANES_FROM_CHROMATIN","REACTOME","771572_REACT_160251_CLEARANCE_OF_NUCLEAR_ENVELOPE_MEMBRANES_FROM_CHROMATIN",7,0.8164,0.69,0.96,1.435,0.074,0.19,-0.8735,0.58,0.96
"GO_BP:496519_GO_0016571_HISTONE_METHYLATION","GO_BP","496519_GO_0016571_HISTONE_METHYLATION",73,0.8164,0.89,1,-0.601,0.99,1,-0.9229,0.61,0.91
"GO_BP:495208_GO_0014812_MUSCLE_CELL_MIGRATION","GO_BP","495208_GO_0014812_MUSCLE_CELL_MIGRATION",16,0.8165,0.71,1,1.4626,0.048,0.48,1.1146,0.29,0.75
"REACTOME:160983_REACT_15513_AMINE_DERIVED_HORMONES","REACTOME","160983_REACT_15513_AMINE_DERIVED_HORMONES",15,0.8166,0.73,0.96,0.8833,0.63,0.92,1.6476,0.022,0.37
"GO_BP:515915_GO_0070989_OXIDATIVE_DEMETHYLATION","GO_BP","515915_GO_0070989_OXIDATIVE_DEMETHYLATION",15,0.8168,0.71,1,0.682,0.92,1,0.7839,0.8,1
"GO_BP:514102_GO_0060547_NEGATIVE_REGULATION_OF_NECROTIC_CELL_DEATH","GO_BP","514102_GO_0060547_NEGATIVE_REGULATION_OF_NECROTIC_CELL_DEATH",11,0.8175,0.7,1,-0.9625,0.53,1,0.7116,0.86,1
"KEGG_enzyme:2.7.7.7_DNA_DIRECTED_DNA_POLYMERASE_DNA_POLYMERASE_I_DNA_POLYMERASE_II_DNA_POLYMERASE_III_DNA_POLYMERASE_ALPHA_DNA_POLYMERASE_BETA_DNA_POLYMERASE_GAMMA_DNA_NUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DNA_NUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DEOXYRIBONUCLEATE_NUCLEOTIDYLTRANSFERASE_DEOXYNUCLEATE_POLYMERASE_DEOXYRIBONUCLEIC_ACID_DUPLICASE_DEOXYRIBONUCLEIC_ACID_POLYMERASE_DEOXYRIBONUCLEIC_DUPLICASE_DEOXYRIBONUCLEIC_POLYMERASE_DEOXYRIBONUCLEIC_POLYMERASE_I_DNA_DUPLICASE_DNA_NUCLEOTIDYLTRANSFERASE_DNA_POLYMERASE_DNA_REPLICASE_DNA_DEPENDENT_DNA_POLYMERASE_DUPLICASE_KLENOW_FRAGMENT_SEQUENASE_TAQ_DNA_POLYMERASE_TAQ_POL_I_TCA_DNA_POLYMERASE","KEGG_enzyme","2.7.7.7_DNA_DIRECTED_DNA_POLYMERASE_DNA_POLYMERASE_I_DNA_POLYMERASE_II_DNA_POLYMERASE_III_DNA_POLYMERASE_ALPHA_DNA_POLYMERASE_BETA_DNA_POLYMERASE_GAMMA_DNA_NUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DNA_NUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DEOXYRIBONUCLEATE_NUCLEOTIDYLTRANSFERASE_DEOXYNUCLEATE_POLYMERASE_DEOXYRIBONUCLEIC_ACID_DUPLICASE_DEOXYRIBONUCLEIC_ACID_POLYMERASE_DEOXYRIBONUCLEIC_DUPLICASE_DEOXYRIBONUCLEIC_POLYMERASE_DEOXYRIBONUCLEIC_POLYMERASE_I_DNA_DUPLICASE_DNA_NUCLEOTIDYLTRANSFERASE_DNA_POLYMERASE_DNA_REPLICASE_DNA_DEPENDENT_DNA_POLYMERASE_DUPLICASE_KLENOW_FRAGMENT_SEQUENASE_TAQ_DNA_POLYMERASE_TAQ_POL_I_TCA_DNA_POLYMERASE",17,0.8177,0.73,0.79,-1.157,0.28,0.69,0.6898,0.89,0.93
"GO_BP:512194_GO_0051310_METAPHASE_PLATE_CONGRESSION","GO_BP","512194_GO_0051310_METAPHASE_PLATE_CONGRESSION",41,0.818,0.81,1,1.4747,0.027,0.45,0.8151,0.79,1
"GO_BP:493407_GO_0009211_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS","GO_BP","493407_GO_0009211_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS",5,0.8181,0.67,1,0.7862,0.72,1,0.4204,1,1
"GO_MF:496948_GO_0017153_SODIUM_DICARBOXYLATE_SYMPORTER_ACTIVITY","GO_MF","496948_GO_0017153_SODIUM_DICARBOXYLATE_SYMPORTER_ACTIVITY",10,0.8187,0.69,1,-0.9316,0.55,0.97,-1,0.45,0.79
"REACTOME:106546_REACT_8027_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE","REACTOME","106546_REACT_8027_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE",12,0.8188,0.71,0.96,1.2638,0.18,0.37,-0.8641,0.65,0.97
"C7_Immunologic_signatures:C7_ALL_688_GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_688_GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDM_DN",197,0.8188,0.96,1,1.3847,0.016,0.043,0.9068,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2652_MILI_PSEUDOPODIA_CHEMOTAXIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2652_MILI_PSEUDOPODIA_CHEMOTAXIS_UP",74,0.8188,0.87,1,1.3137,0.063,0.38,0.9009,0.65,1
"KEGG_reaction:R01664_2_DEOXYCYTIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DCMP_H2O_DEOXYCYTIDINE_ORTHOPHOSPHATE","KEGG_reaction","R01664_2_DEOXYCYTIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DCMP_H2O_DEOXYCYTIDINE_ORTHOPHOSPHATE",9,0.8189,0.68,0.78,0.5631,0.96,1,-1.1992,0.23,0.41
"GO_CC:500717_GO_0031466_CUL5_RING_UBIQUITIN_LIGASE_COMPLEX","GO_CC","500717_GO_0031466_CUL5_RING_UBIQUITIN_LIGASE_COMPLEX",6,0.8189,0.68,0.98,1.557,0.017,0.15,1.1511,0.31,0.84
"GO_BP:505528_GO_0042384_CILIUM_ASSEMBLY","GO_BP","505528_GO_0042384_CILIUM_ASSEMBLY",137,0.8194,0.91,1,-0.7773,0.95,1,-1.1863,0.11,0.73
"REACTOME:105852_REACT_2174_DNA_DAMAGE_BYPASS","REACTOME","105852_REACT_2174_DNA_DAMAGE_BYPASS",46,0.8194,0.83,0.96,1.5394,0.019,0.13,-0.8172,0.79,1
"KEGG_reaction:R02323_NICOTINAMIDE_RIBONUCLEOTIDE_PHOSPHOHYDROLASE_NICOTINAMIDE_D_RIBONUCLEOTIDE_H2O_NICOTINAMIDE_BETA_RIBOSIDE_ORTHOPHOSPHATE","KEGG_reaction","R02323_NICOTINAMIDE_RIBONUCLEOTIDE_PHOSPHOHYDROLASE_NICOTINAMIDE_D_RIBONUCLEOTIDE_H2O_NICOTINAMIDE_BETA_RIBOSIDE_ORTHOPHOSPHATE",9,0.8194,0.69,0.8,0.5624,0.97,1,-1.1974,0.25,0.41
"GO_BP:517094_GO_0072178_NEPHRIC_DUCT_MORPHOGENESIS","GO_BP","517094_GO_0072178_NEPHRIC_DUCT_MORPHOGENESIS",9,0.8196,0.67,1,1.0485,0.36,0.95,-0.7724,0.77,1
"REACTOME:161074_REACT_22310_ORGANIC_ANION_TRANSPORT","REACTOME","161074_REACT_22310_ORGANIC_ANION_TRANSPORT",5,0.8197,0.64,0.96,1.7288,0.0021,0.038,-1.7385,0.0081,0.22
"GO_CC:500712_GO_0031461_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX","GO_CC","500712_GO_0031461_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX",105,0.8199,0.91,0.99,1.257,0.1,0.45,-0.8128,0.87,1
"KEGG_reaction:R02719_XANTHOSINE_5_PHOSPHATE_PHOSPHOHYDROLASE_XANTHOSINE_5_PHOSPHATE_H2O_XANTHOSINE_ORTHOPHOSPHATE","KEGG_reaction","R02719_XANTHOSINE_5_PHOSPHATE_PHOSPHOHYDROLASE_XANTHOSINE_5_PHOSPHATE_H2O_XANTHOSINE_ORTHOPHOSPHATE",9,0.8199,0.72,0.81,0.5647,0.96,1,-1.2133,0.25,0.42
"C7_Immunologic_signatures:C7_ALL_251_GSE14308_TH2_VS_NATURAL_TREG_UP","C7_Immunologic_signatures","C7_ALL_251_GSE14308_TH2_VS_NATURAL_TREG_UP",194,0.8201,0.97,1,1.1426,0.17,0.34,0.7509,0.98,1
"C7_Immunologic_signatures:C7_ALL_106_GSE11924_TH2_VS_TH17_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_106_GSE11924_TH2_VS_TH17_CD4_TCELL_DN",199,0.8202,0.98,1,0.9285,0.67,0.96,-1.2309,0.055,0.22
"GO_MF:489884_GO_0004536_DEOXYRIBONUCLEASE_ACTIVITY","GO_MF","489884_GO_0004536_DEOXYRIBONUCLEASE_ACTIVITY",59,0.8203,0.83,1,1.2199,0.15,0.7,0.9718,0.5,0.89
"GO_BP:489288_GO_0043486_HISTONE_EXCHANGE","GO_BP","489288_GO_0043486_HISTONE_EXCHANGE",51,0.8204,0.82,1,-0.9776,0.5,1,-1.521,0.022,0.53
"GO_BP:496310_GO_0016246_RNA_INTERFERENCE","GO_BP","496310_GO_0016246_RNA_INTERFERENCE",10,0.8208,0.69,1,-0.6945,0.86,1,-0.6764,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_611_TURJANSKI_MAPK11_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_611_TURJANSKI_MAPK11_TARGETS",5,0.8208,0.66,1,-0.9263,0.56,1,0.6774,0.87,1
"REACTOME:105795_REACT_70_REMOVAL_OF_THE_FLAP_INTERMEDIATE","REACTOME","105795_REACT_70_REMOVAL_OF_THE_FLAP_INTERMEDIATE",14,0.8209,0.73,0.96,1.4175,0.075,0.21,-1.0834,0.35,0.73
"C1_Positional:C1_ALL_295_CHR3Q27","C1_Positional","C1_ALL_295_CHR3Q27",56,0.821,0.81,0.96,1.1947,0.16,0.62,-1.1493,0.19,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_2456_MOOTHA_HUMAN_MITODB_6_2002","C2_Chemical_and_genetic_perturbations","C2_CGP_2456_MOOTHA_HUMAN_MITODB_6_2002",430,0.821,1,1,2.1894,0,0.00061,-0.992,0.47,0.76
"GO_BP:502236_GO_0033014_TETRAPYRROLE_BIOSYNTHETIC_PROCESS","GO_BP","502236_GO_0033014_TETRAPYRROLE_BIOSYNTHETIC_PROCESS",30,0.822,0.79,1,1.1985,0.19,0.78,-1.256,0.14,0.68
"GO_MF:490343_GO_0005072_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_CYTOPLASMIC_MEDIATOR_ACTIVITY","GO_MF","490343_GO_0005072_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_CYTOPLASMIC_MEDIATOR_ACTIVITY",10,0.8224,0.68,1,-0.5014,0.99,1,1.1159,0.31,0.81
"REACTOME:1183546_REACT_355196_IKBKG_DEFICIENCY_CAUSES_ANHIDROTIC_ECTODERMAL_DYSPLASIA_WITH_IMMUNODEFICIENCY_EDA_ID_VIA_TLR_","REACTOME","1183546_REACT_355196_IKBKG_DEFICIENCY_CAUSES_ANHIDROTIC_ECTODERMAL_DYSPLASIA_WITH_IMMUNODEFICIENCY_EDA_ID_VIA_TLR_",8,0.8227,0.68,0.96,-0.5078,0.99,1,-0.7602,0.78,1
"GO_BP:489144_GO_0003352_REGULATION_OF_CILIUM_MOVEMENT","GO_BP","489144_GO_0003352_REGULATION_OF_CILIUM_MOVEMENT",9,0.8233,0.68,1,-0.5979,0.93,1,-0.5102,0.99,1
"REACTOME:1127690_REACT_264347_MISMATCH_REPAIR_MMR_DIRECTED_BY_MSH2_MSH3_MUTSBETA_","REACTOME","1127690_REACT_264347_MISMATCH_REPAIR_MMR_DIRECTED_BY_MSH2_MSH3_MUTSBETA_",15,0.8233,0.72,0.96,0.9349,0.54,0.86,-1.1673,0.27,0.63
"C4_Cancer_modules:C4_CM_67_MODULE_71","C4_Cancer_modules","C4_CM_67_MODULE_71",22,0.824,0.78,0.99,-0.8193,0.74,0.95,-0.8942,0.63,0.85
"GO_BP:500340_GO_0031050_DSRNA_FRAGMENTATION","GO_BP","500340_GO_0031050_DSRNA_FRAGMENTATION",20,0.8241,0.73,1,-0.6072,0.96,1,-0.5719,0.99,1
"C4_Cancer_modules:C4_CM_303_MODULE_350","C4_Cancer_modules","C4_CM_303_MODULE_350",58,0.8252,0.83,1,1.5051,0.021,0.11,0.7987,0.85,1
"KEGG_module:HSA_M00383_ECV_COMPLEX","KEGG_module","HSA_M00383_ECV_COMPLEX",5,0.8254,0.65,0.85,1.4647,0.063,0.21,1.2676,0.22,0.77
"KEGG_reaction:R03346_NICOTINATE_D_RIBONUCLEOTIDE_PHOSPHOHYDROLASE_NICOTINATE_D_RIBONUCLEOTIDE_H2O_NICOTINATE_D_RIBONUCLEOSIDE_ORTHOPHOSPHATE","KEGG_reaction","R03346_NICOTINATE_D_RIBONUCLEOTIDE_PHOSPHOHYDROLASE_NICOTINATE_D_RIBONUCLEOTIDE_H2O_NICOTINATE_D_RIBONUCLEOSIDE_ORTHOPHOSPHATE",9,0.8256,0.69,0.82,0.5692,0.97,1,-1.1912,0.23,0.41
"GO_BP:515135_GO_0070198_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION","GO_BP","515135_GO_0070198_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION",6,0.8256,0.68,1,0.7989,0.7,1,-0.5467,0.96,1
"KEGG_reaction:R01126_INOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_IMP_H2O_INOSINE_ORTHOPHOSPHATE","KEGG_reaction","R01126_INOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_IMP_H2O_INOSINE_ORTHOPHOSPHATE",9,0.8261,0.67,0.83,0.5663,0.95,1,-1.1518,0.3,0.44
"GO_BP:491885_GO_0007062_SISTER_CHROMATID_COHESION","GO_BP","491885_GO_0007062_SISTER_CHROMATID_COHESION",27,0.8269,0.75,1,-0.6037,0.97,1,-0.9318,0.55,0.9
"GO_BP:1133947_GO_1903772_REGULATION_OF_VIRAL_BUDDING_VIA_HOST_ESCRT_COMPLEX","GO_BP","1133947_GO_1903772_REGULATION_OF_VIRAL_BUDDING_VIA_HOST_ESCRT_COMPLEX",5,0.8269,0.64,1,1.3047,0.17,0.66,0.8968,0.57,0.95
"REACTOME:645307_REACT_120752_HS_GAG_DEGRADATION","REACTOME","645307_REACT_120752_HS_GAG_DEGRADATION",21,0.8269,0.73,0.96,1.0684,0.35,0.63,1.0809,0.36,0.94
"REACTOME:105815_REACT_682_MITOTIC_PROMETAPHASE","REACTOME","105815_REACT_682_MITOTIC_PROMETAPHASE",109,0.8277,0.9,0.96,1.499,0.0044,0.15,-1.2354,0.12,0.57
"GO_CC:499476_GO_0030008_TRAPP_COMPLEX","GO_CC","499476_GO_0030008_TRAPP_COMPLEX",5,0.8279,0.68,0.97,0.9832,0.47,0.81,0.7056,0.81,1
"GO_BP:491413_GO_0006516_GLYCOPROTEIN_CATABOLIC_PROCESS","GO_BP","491413_GO_0006516_GLYCOPROTEIN_CATABOLIC_PROCESS",12,0.8282,0.69,1,0.9686,0.5,1,0.8163,0.72,1
"GO_MF:752541_GO_0090484_DRUG_TRANSPORTER_ACTIVITY","GO_MF","752541_GO_0090484_DRUG_TRANSPORTER_ACTIVITY",20,0.8285,0.7,1,-1.0119,0.43,0.89,1.0198,0.41,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_2178_OUILLETTE_CLL_13Q14_DELETION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2178_OUILLETTE_CLL_13Q14_DELETION_UP",73,0.8286,0.84,1,0.9045,0.67,0.92,0.6472,1,1
"GO_CC:492602_GO_0008278_COHESIN_COMPLEX","GO_CC","492602_GO_0008278_COHESIN_COMPLEX",12,0.8287,0.69,0.98,-0.6791,0.88,1,-0.6707,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2832_LOPEZ_EPITHELIOID_MESOTHELIOMA","C2_Chemical_and_genetic_perturbations","C2_CGP_2832_LOPEZ_EPITHELIOID_MESOTHELIOMA",16,0.8288,0.71,1,-1.4526,0.081,0.53,-1.0352,0.42,0.7
"GO_BP:508679_GO_0046416_D_AMINO_ACID_METABOLIC_PROCESS","GO_BP","508679_GO_0046416_D_AMINO_ACID_METABOLIC_PROCESS",5,0.8289,0.61,1,1.6381,0.0062,0.25,0.6903,0.84,1
"GO_BP:488070_GO_0002181_CYTOPLASMIC_TRANSLATION","GO_BP","488070_GO_0002181_CYTOPLASMIC_TRANSLATION",16,0.829,0.7,1,1.7614,0.0064,0.13,-0.7488,0.82,1
"KEGG_reaction:R01569_THYMIDYLATE_5_PHOSPHOHYDROLASE_DTMP_H2O_THYMIDINE_ORTHOPHOSPHATE","KEGG_reaction","R01569_THYMIDYLATE_5_PHOSPHOHYDROLASE_DTMP_H2O_THYMIDINE_ORTHOPHOSPHATE",9,0.829,0.69,0.84,0.5796,0.96,1,-1.1894,0.25,0.41
"C1_Positional:C1_ALL_292_CHR6Q14","C1_Positional","C1_ALL_292_CHR6Q14",35,0.8291,0.76,0.96,0.9621,0.5,0.81,-0.7689,0.86,1
"GO_BP:754498_GO_1901538_CHANGES_TO_DNA_METHYLATION_INVOLVED_IN_EMBRYO_DEVELOPMENT","GO_BP","754498_GO_1901538_CHANGES_TO_DNA_METHYLATION_INVOLVED_IN_EMBRYO_DEVELOPMENT",7,0.8293,0.69,1,-1.2645,0.19,0.9,1.1004,0.36,0.76
"GO_BP:512321_GO_0051443_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY","GO_BP","512321_GO_0051443_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY",88,0.8293,0.88,1,1.9598,0,0.02,-0.7516,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1967_WELCSH_BRCA1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1967_WELCSH_BRCA1_TARGETS_DN",141,0.8294,0.91,1,0.7567,0.97,1,-0.9566,0.55,0.81
"KEGG_reaction:R01968_2_DEOXYGUANOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DGMP_H2O_DEOXYGUANOSINE_ORTHOPHOSPHATE","KEGG_reaction","R01968_2_DEOXYGUANOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DGMP_H2O_DEOXYGUANOSINE_ORTHOPHOSPHATE",9,0.8294,0.66,0.86,0.545,0.97,1,-1.2291,0.21,0.43
"GO_MF:496394_GO_0016406_CARNITINE_O_ACYLTRANSFERASE_ACTIVITY","GO_MF","496394_GO_0016406_CARNITINE_O_ACYLTRANSFERASE_ACTIVITY",6,0.8294,0.63,1,-0.8017,0.7,1,1.0346,0.41,0.85
"C7_Immunologic_signatures:C7_ALL_628_GSE17721_POLYIC_VS_CPG_8H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_628_GSE17721_POLYIC_VS_CPG_8H_BMDM_DN",199,0.8294,0.94,1,1.61,0,0.0025,-0.925,0.67,0.9
"GO_BP:496154_GO_0016056_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY","GO_BP","496154_GO_0016056_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY",36,0.8294,0.77,1,-1.1161,0.28,0.94,-1.0489,0.39,0.81
"C4_Cancer_gene_neighborhoods:C4_CGN_35_MORF_RAD23A","C4_Cancer_gene_neighborhoods","C4_CGN_35_MORF_RAD23A",347,0.8297,0.98,1,2.3717,0,0,-0.981,0.52,0.89
"REACTOME:160973_REACT_21285_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1","REACTOME","160973_REACT_21285_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1",17,0.8297,0.69,0.96,0.9687,0.49,0.8,1.0507,0.38,0.96
"GO_BP:486806_GO_0000289_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING","GO_BP","486806_GO_0000289_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING",25,0.8299,0.73,1,0.9381,0.54,1,-1.4192,0.063,0.57
"GO_BP:516386_GO_0071462_CELLULAR_RESPONSE_TO_WATER_STIMULUS","GO_BP","516386_GO_0071462_CELLULAR_RESPONSE_TO_WATER_STIMULUS",6,0.8302,0.63,1,-0.557,0.96,1,-0.7962,0.72,0.99
"KEGG_reaction:R02102_2_DEOXYURIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DUMP_H2O_DEOXYURIDINE_ORTHOPHOSPHATE","KEGG_reaction","R02102_2_DEOXYURIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_DUMP_H2O_DEOXYURIDINE_ORTHOPHOSPHATE",9,0.8305,0.68,0.88,0.5709,0.96,1,-1.1752,0.27,0.41
"GO_BP:508220_GO_0045913_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS","GO_BP","508220_GO_0045913_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS",66,0.8309,0.83,1,1.2013,0.15,0.78,1.4515,0.026,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_2606_ZHANG_TLX_TARGETS_36HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2606_ZHANG_TLX_TARGETS_36HR_DN",185,0.8309,0.94,1,1.3628,0.012,0.33,-1.1057,0.22,0.62
"GO_MF:489992_GO_0004663_RAB_GERANYLGERANYLTRANSFERASE_ACTIVITY","GO_MF","489992_GO_0004663_RAB_GERANYLGERANYLTRANSFERASE_ACTIVITY",5,0.8317,0.61,1,0.6565,0.88,1,-0.8759,0.62,0.9
"GO_MF:489580_GO_0004115_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY","GO_MF","489580_GO_0004115_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY",11,0.8317,0.69,1,-1.1779,0.26,0.78,-1.6331,0.032,0.34
"KEGG_reaction:R00963_URIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_UMP_H2O_URIDINE_ORTHOPHOSPHATE","KEGG_reaction","R00963_URIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_UMP_H2O_URIDINE_ORTHOPHOSPHATE",9,0.8317,0.65,0.89,0.5652,0.96,1,-1.2122,0.24,0.41
"KEGG_reaction:R00511_CYTIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_CMP_H2O_CYTIDINE_ORTHOPHOSPHATE","KEGG_reaction","R00511_CYTIDINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_CMP_H2O_CYTIDINE_ORTHOPHOSPHATE",9,0.8318,0.67,0.91,0.556,0.98,1,-1.2092,0.22,0.4
"GO_MF:487556_GO_0001640_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_ACTIVITY","GO_MF","487556_GO_0001640_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_ACTIVITY",7,0.8326,0.67,1,1.427,0.12,0.47,1.3267,0.16,0.67
"GO_BP:515845_GO_0070918_PRODUCTION_OF_SMALL_RNA_INVOLVED_IN_GENE_SILENCING_BY_RNA","GO_BP","515845_GO_0070918_PRODUCTION_OF_SMALL_RNA_INVOLVED_IN_GENE_SILENCING_BY_RNA",20,0.8329,0.74,1,-0.6053,0.97,1,-0.5748,0.98,1
"C3_TF_targets:C3_TFT_29_AACYNNNNTTCCS_UNKNOWN","C3_TF_targets","C3_TFT_29_AACYNNNNTTCCS_UNKNOWN",93,0.833,0.88,1,0.874,0.74,1,-1.2389,0.094,0.3
"GO_BP:508252_GO_0045948_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION","GO_BP","508252_GO_0045948_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION",15,0.8333,0.69,1,-0.9452,0.53,1,0.5642,0.99,1
"GO_MF:492705_GO_0008409_5_3_EXONUCLEASE_ACTIVITY","GO_MF","492705_GO_0008409_5_3_EXONUCLEASE_ACTIVITY",11,0.8339,0.67,1,1.4967,0.054,0.39,-0.7601,0.81,0.99
"GO_CC:499693_GO_0030289_PROTEIN_PHOSPHATASE_4_COMPLEX","GO_CC","499693_GO_0030289_PROTEIN_PHOSPHATASE_4_COMPLEX",5,0.8341,0.65,0.97,0.7516,0.77,0.98,0.457,0.99,1
"REACTOME:105853_REACT_2198_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE","REACTOME","105853_REACT_2198_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE",37,0.8342,0.77,0.95,1.3595,0.087,0.26,-0.6146,0.98,1
"GO_BP:500337_GO_0031047_GENE_SILENCING_BY_RNA","GO_BP","500337_GO_0031047_GENE_SILENCING_BY_RNA",57,0.8343,0.8,1,0.507,1,1,-0.7784,0.89,1
"KEGG_enzyme:2.1.1.43_HISTONE_LYSINE_N_METHYLTRANSFERASE_PROTEIN_METHYLASE_III_PROTEIN_METHYLASE_3_PROTEIN_LYSINE_METHYLTRANSFERASE_PROTEIN_METHYLTRANSFERASE_II_PROTEIN_LYSINE_N_METHYLTRANSFERASE_HISTONE_H1_SPECIFIC_S_ADENOSYLMETHIONINE_PROTEIN_LYSINE_N_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_HISTONE_L_LYSINE_6_N_METHYLTRANSFERASE","KEGG_enzyme","2.1.1.43_HISTONE_LYSINE_N_METHYLTRANSFERASE_PROTEIN_METHYLASE_III_PROTEIN_METHYLASE_3_PROTEIN_LYSINE_METHYLTRANSFERASE_PROTEIN_METHYLTRANSFERASE_II_PROTEIN_LYSINE_N_METHYLTRANSFERASE_HISTONE_H1_SPECIFIC_S_ADENOSYLMETHIONINE_PROTEIN_LYSINE_N_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_HISTONE_L_LYSINE_6_N_METHYLTRANSFERASE",27,0.8344,0.74,0.83,-1.2617,0.17,0.55,-0.9864,0.48,0.78
"KEGG_reaction:R01227_GUANOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_GMP_H2O_GUANOSINE_ORTHOPHOSPHATE","KEGG_reaction","R01227_GUANOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_GMP_H2O_GUANOSINE_ORTHOPHOSPHATE",9,0.8344,0.65,0.93,0.5751,0.94,1,-1.2123,0.24,0.41
"KEGG_reaction:R00183_ADENOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_AMP_H2O_ADENOSINE_ORTHOPHOSPHATE","KEGG_reaction","R00183_ADENOSINE_5_MONOPHOSPHATE_PHOSPHOHYDROLASE_AMP_H2O_ADENOSINE_ORTHOPHOSPHATE",9,0.8345,0.66,0.95,0.5595,0.96,1,-1.1869,0.27,0.41
"GO_BP:1129498_GO_1903672_POSITIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS","GO_BP","1129498_GO_1903672_POSITIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS",9,0.8348,0.67,1,0.7941,0.7,1,-0.9514,0.52,0.89
"GO_MF:489388_GO_0003887_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY","GO_MF","489388_GO_0003887_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY",29,0.8348,0.75,1,-1.1218,0.29,0.81,-0.9345,0.55,0.84
"REACTOME:1183548_REACT_355226_IKBA_VARIANT_LEADS_TO_EDA_ID","REACTOME","1183548_REACT_355226_IKBA_VARIANT_LEADS_TO_EDA_ID",7,0.835,0.68,0.95,-0.4869,0.99,1,-0.5602,0.97,1
"GO_BP:755160_GO_2001054_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS","GO_BP","755160_GO_2001054_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS",9,0.8352,0.67,1,1.6351,0.016,0.25,1.4257,0.11,0.61
"GO_MF:503442_GO_0034237_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING","GO_MF","503442_GO_0034237_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING",10,0.8354,0.68,1,0.8309,0.69,1,0.674,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3105_PHESSE_TARGETS_OF_APC_AND_MBD2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3105_PHESSE_TARGETS_OF_APC_AND_MBD2_UP",19,0.8359,0.73,1,0.6886,0.87,1,0.7492,0.84,1
"GO_BP:506080_GO_0042987_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS","GO_BP","506080_GO_0042987_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS",8,0.8363,0.66,1,0.8875,0.6,1,-0.7746,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2969_KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2969_KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP",40,0.8363,0.77,1,1.2439,0.14,0.45,0.7305,0.92,1
"GO_BP:491860_GO_0007032_ENDOSOME_ORGANIZATION","GO_BP","491860_GO_0007032_ENDOSOME_ORGANIZATION",36,0.8364,0.75,1,1.0267,0.39,0.97,0.7052,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2647_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2647_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP",5,0.8365,0.63,1,-0.8188,0.7,1,-1.1671,0.33,0.56
"GO_CC:505030_GO_0035861_SITE_OF_DOUBLE_STRAND_BREAK","GO_CC","505030_GO_0035861_SITE_OF_DOUBLE_STRAND_BREAK",21,0.8367,0.71,0.97,0.9155,0.57,0.87,-0.651,0.95,1
"GO_BP:489152_GO_0003360_BRAINSTEM_DEVELOPMENT","GO_BP","489152_GO_0003360_BRAINSTEM_DEVELOPMENT",6,0.8367,0.63,1,-0.6735,0.86,1,0.5559,0.96,1
"GO_BP:502581_GO_0033363_SECRETORY_GRANULE_ORGANIZATION","GO_BP","502581_GO_0033363_SECRETORY_GRANULE_ORGANIZATION",28,0.8368,0.78,1,1.1432,0.26,0.84,1.5376,0.043,0.52
"GO_BP:515143_GO_0070208_PROTEIN_HETEROTRIMERIZATION","GO_BP","515143_GO_0070208_PROTEIN_HETEROTRIMERIZATION",11,0.8369,0.68,1,-1.0679,0.39,0.96,1.1637,0.29,0.73
"KEGG_compound:C16677_ALL_TRANS_4_HYDROXYRETINOIC_ACID","KEGG_compound","C16677_ALL_TRANS_4_HYDROXYRETINOIC_ACID",15,0.8371,0.71,1,-1.003,0.48,1,1.1291,0.27,0.63
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_147_BIOCARTA_RAC1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_147_BIOCARTA_RAC1_PATHWAY",22,0.8372,0.72,0.89,1.0194,0.43,0.84,-0.6124,0.97,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_982_GROSS_HYPOXIA_VIA_HIF1A_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_982_GROSS_HYPOXIA_VIA_HIF1A_UP",77,0.8376,0.85,1,1.2816,0.089,0.41,0.8771,0.72,1
"REACTOME:106553_REACT_953_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION","REACTOME","106553_REACT_953_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION",47,0.8376,0.8,0.95,0.7486,0.88,1,-0.59,0.99,1
"C7_Immunologic_signatures:C7_ALL_1082_GSE25087_FETAL_VS_ADULT_TCONV_DN","C7_Immunologic_signatures","C7_ALL_1082_GSE25087_FETAL_VS_ADULT_TCONV_DN",189,0.8377,0.96,1,-0.8583,0.84,1,-0.8265,0.91,1
"GO_BP:491997_GO_0007197_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY","GO_BP","491997_GO_0007197_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY",5,0.8379,0.64,1,0.8836,0.61,1,1.4004,0.096,0.63
"C1_Positional:C1_ALL_190_CHR3Q29","C1_Positional","C1_ALL_190_CHR3Q29",54,0.8379,0.78,0.95,-1.0982,0.27,1,-0.926,0.58,0.99
"GO_BP:510328_GO_0048205_COPI_COATING_OF_GOLGI_VESICLE","GO_BP","510328_GO_0048205_COPI_COATING_OF_GOLGI_VESICLE",13,0.838,0.68,1,1.6016,0.033,0.29,1.2707,0.19,0.69
"GO_CC:500665_GO_0031414_N_TERMINAL_PROTEIN_ACETYLTRANSFERASE_COMPLEX","GO_CC","500665_GO_0031414_N_TERMINAL_PROTEIN_ACETYLTRANSFERASE_COMPLEX",10,0.8381,0.68,0.97,-0.8502,0.65,0.97,0.7172,0.85,1
"GO_BP:499441_GO_0023019_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION","GO_BP","499441_GO_0023019_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION",21,0.8381,0.7,1,1.0509,0.39,0.95,1.1511,0.24,0.73
"GO_BP:494701_GO_0010637_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_FUSION","GO_BP","494701_GO_0010637_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_FUSION",5,0.8383,0.66,1,1.0273,0.46,0.97,0.7189,0.82,1
"C7_Immunologic_signatures:C7_ALL_1743_GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1743_GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP",171,0.8383,0.94,1,-1.5185,0.0017,0.054,-1.3151,0.037,0.12
"REACTOME:576278_REACT_118699_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS","REACTOME","576278_REACT_118699_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS",7,0.8385,0.65,0.95,-1.2822,0.17,0.67,-1.1092,0.35,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_3138_BRUINS_UVC_RESPONSE_MIDDLE","C2_Chemical_and_genetic_perturbations","C2_CGP_3138_BRUINS_UVC_RESPONSE_MIDDLE",97,0.8387,0.86,1,-0.8413,0.82,1,-0.7885,0.89,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_190_GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_190_GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN",330,0.8388,0.94,1,-1.6351,0,0.37,-0.8878,0.87,0.9
"GO_BP:516950_GO_0072033_RENAL_VESICLE_FORMATION","GO_BP","516950_GO_0072033_RENAL_VESICLE_FORMATION",5,0.8388,0.62,1,0.7612,0.74,1,1.216,0.24,0.71
"GO_MF:496912_GO_0017108_5_FLAP_ENDONUCLEASE_ACTIVITY","GO_MF","496912_GO_0017108_5_FLAP_ENDONUCLEASE_ACTIVITY",5,0.8389,0.64,1,0.838,0.64,1,0.516,0.98,1
"GO_BP:504699_GO_0035518_HISTONE_H2A_MONOUBIQUITINATION","GO_BP","504699_GO_0035518_HISTONE_H2A_MONOUBIQUITINATION",12,0.8392,0.68,1,0.8132,0.73,1,-0.7814,0.77,1
"C7_Immunologic_signatures:C7_ALL_641_GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_641_GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDM_UP",199,0.8398,0.96,1,1.0992,0.21,0.45,1.0597,0.27,1
"GO_MF:492827_GO_0008553_HYDROGEN_EXPORTING_ATPASE_ACTIVITY_PHOSPHORYLATIVE_MECHANISM","GO_MF","492827_GO_0008553_HYDROGEN_EXPORTING_ATPASE_ACTIVITY_PHOSPHORYLATIVE_MECHANISM",7,0.8398,0.66,1,1.2165,0.25,0.7,-0.7281,0.82,0.99
"KEGG_pathway:HSA00100_STEROID_BIOSYNTHESIS","KEGG_pathway","HSA00100_STEROID_BIOSYNTHESIS",20,0.84,0.68,0.91,-0.7032,0.88,1,-0.5844,0.97,1
"GO_BP:510475_GO_0048368_LATERAL_MESODERM_DEVELOPMENT","GO_BP","510475_GO_0048368_LATERAL_MESODERM_DEVELOPMENT",11,0.8401,0.66,1,-1.0355,0.42,0.98,-0.7139,0.82,0.99
"REACTOME:730315_REACT_150425_RESOLUTION_OF_SISTER_CHROMATID_COHESION","REACTOME","730315_REACT_150425_RESOLUTION_OF_SISTER_CHROMATID_COHESION",101,0.8403,0.9,0.95,1.424,0.016,0.2,-1.2117,0.11,0.59
"GO_MF:492638_GO_0008318_PROTEIN_PRENYLTRANSFERASE_ACTIVITY","GO_MF","492638_GO_0008318_PROTEIN_PRENYLTRANSFERASE_ACTIVITY",9,0.8405,0.66,1,0.9203,0.57,0.96,1.1109,0.34,0.81
"C7_Immunologic_signatures:C7_ALL_262_GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_262_GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN",195,0.8413,0.92,1,-0.7497,0.97,1,0.8107,0.94,1
"REACTOME:106433_REACT_6754_S6K1_MEDIATED_SIGNALLING","REACTOME","106433_REACT_6754_S6K1_MEDIATED_SIGNALLING",11,0.8414,0.67,0.95,1.2049,0.22,0.44,-0.868,0.64,0.97
"GO_BP:504238_GO_0035050_EMBRYONIC_HEART_TUBE_DEVELOPMENT","GO_BP","504238_GO_0035050_EMBRYONIC_HEART_TUBE_DEVELOPMENT",72,0.8414,0.84,1,-0.823,0.81,1,1.2384,0.11,0.71
"GO_BP:493284_GO_0009083_BRANCHED_CHAIN_AMINO_ACID_CATABOLIC_PROCESS","GO_BP","493284_GO_0009083_BRANCHED_CHAIN_AMINO_ACID_CATABOLIC_PROCESS",19,0.8418,0.73,1,1.156,0.24,0.83,-1.3796,0.099,0.58
"KEGG_reaction:R00376_DEOXYGUANOSINE_5_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DGTP_DNA_DIPHOSPHATE_DNA","KEGG_reaction","R00376_DEOXYGUANOSINE_5_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DGTP_DNA_DIPHOSPHATE_DNA",12,0.8418,0.67,0.96,0.8332,0.68,1,-1.1325,0.31,0.45
"GO_BP:494301_GO_0010224_RESPONSE_TO_UV_B","GO_BP","494301_GO_0010224_RESPONSE_TO_UV_B",17,0.8419,0.69,1,-1.0298,0.42,0.97,0.81,0.73,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_879_INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_879_INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN",5,0.8419,0.62,1,-0.7256,0.81,1,0.6508,0.88,1
"REACTOME:1183616_REACT_355250_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS","REACTOME","1183616_REACT_355250_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS",30,0.8423,0.7,0.95,1.5918,0.015,0.097,-0.844,0.72,0.99
"GO_BP:498824_GO_0021540_CORPUS_CALLOSUM_MORPHOGENESIS","GO_BP","498824_GO_0021540_CORPUS_CALLOSUM_MORPHOGENESIS",5,0.8424,0.62,1,-0.4245,1,1,1.3988,0.095,0.63
"GO_BP:491705_GO_0006839_MITOCHONDRIAL_TRANSPORT","GO_BP","491705_GO_0006839_MITOCHONDRIAL_TRANSPORT",143,0.8427,0.94,1,1.8722,0,0.052,-0.5906,1,1
"C6_Oncogenic_signatures:C6_ALL_16_HINATA_NFKB_MATRIX","C6_Oncogenic_signatures","C6_ALL_16_HINATA_NFKB_MATRIX",8,0.8436,0.65,0.98,0.8077,0.71,0.98,1.1296,0.32,0.34
"GO_BP:504300_GO_0035115_EMBRYONIC_FORELIMB_MORPHOGENESIS","GO_BP","504300_GO_0035115_EMBRYONIC_FORELIMB_MORPHOGENESIS",30,0.8441,0.75,1,-1.1155,0.3,0.94,0.8891,0.64,0.95
"REACTOME:160994_REACT_20514_DEADENYLATION_OF_MRNA","REACTOME","160994_REACT_20514_DEADENYLATION_OF_MRNA",23,0.8442,0.73,0.95,0.9651,0.49,0.8,-1.4818,0.034,0.38
"REACTOME:105829_REACT_6954_ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS","REACTOME","105829_REACT_6954_ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS",73,0.8442,0.82,0.95,2.0697,0,0.00092,-0.7573,0.93,1
"GO_BP:491025_GO_0006040_AMINO_SUGAR_METABOLIC_PROCESS","GO_BP","491025_GO_0006040_AMINO_SUGAR_METABOLIC_PROCESS",38,0.8442,0.74,1,1.0053,0.44,0.98,0.6948,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1073_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1073_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN",7,0.8444,0.64,1,0.527,0.99,1,-0.7473,0.78,0.97
"C4_Cancer_modules:C4_CM_97_MODULE_102","C4_Cancer_modules","C4_CM_97_MODULE_102",19,0.8445,0.69,0.99,1.1291,0.3,0.49,-1.1232,0.29,0.49
"C2_Chemical_and_genetic_perturbations:C2_CGP_1086_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3","C2_Chemical_and_genetic_perturbations","C2_CGP_1086_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3",5,0.8446,0.64,1,1.2207,0.24,0.47,-0.8175,0.67,0.94
"C4_Cancer_gene_neighborhoods:C4_CGN_174_MORF_REV3L","C4_Cancer_gene_neighborhoods","C4_CGN_174_MORF_REV3L",58,0.8447,0.8,1,0.7596,0.9,1,-0.5742,1,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_56_BIOCARTA_RNA_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_56_BIOCARTA_RNA_PATHWAY",10,0.8447,0.68,0.94,1.1995,0.25,0.72,-0.6837,0.89,0.99
"REACTOME:106335_REACT_12417_MICRORNA_MIRNA_BIOGENESIS","REACTOME","106335_REACT_12417_MICRORNA_MIRNA_BIOGENESIS",23,0.8449,0.71,0.95,0.7976,0.76,1,-0.6565,0.96,1
"GO_BP:754792_GO_1901841_REGULATION_OF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY","GO_BP","754792_GO_1901841_REGULATION_OF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY",7,0.8452,0.64,1,1.4057,0.12,0.55,0.5505,0.97,1
"GO_BP:492066_GO_0007288_SPERM_AXONEME_ASSEMBLY","GO_BP","492066_GO_0007288_SPERM_AXONEME_ASSEMBLY",7,0.8456,0.63,1,-0.6746,0.88,1,-1.0784,0.32,0.79
"REACTOME:105886_REACT_257_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER","REACTOME","105886_REACT_257_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER",21,0.8457,0.7,0.95,1.5198,0.037,0.14,-0.6573,0.93,1
"GO_BP:508649_GO_0046385_DEOXYRIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","508649_GO_0046385_DEOXYRIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS",9,0.8458,0.63,1,0.9656,0.48,1,-0.7588,0.78,1
"GO_BP:750891_GO_0035964_COPI_COATED_VESICLE_BUDDING","GO_BP","750891_GO_0035964_COPI_COATED_VESICLE_BUDDING",13,0.8473,0.68,1,1.5897,0.02,0.3,1.2856,0.18,0.69
"GO_BP:498708_GO_0019935_CYCLIC_NUCLEOTIDE_MEDIATED_SIGNALING","GO_BP","498708_GO_0019935_CYCLIC_NUCLEOTIDE_MEDIATED_SIGNALING",31,0.8474,0.71,1,1.2561,0.15,0.73,1.2689,0.14,0.69
"KEGG_compound:C00077_L_ORNITHINE_S_2_5_DIAMINOVALERIC_ACID_S_2_5_DIAMINOPENTANOIC_ACID_S_2_5_DIAMINOPENTANOATE","KEGG_compound","C00077_L_ORNITHINE_S_2_5_DIAMINOVALERIC_ACID_S_2_5_DIAMINOPENTANOIC_ACID_S_2_5_DIAMINOPENTANOATE",7,0.8475,0.63,1,-0.7409,0.8,1,0.879,0.63,0.84
"GO_BP:518242_GO_0090102_COCHLEA_DEVELOPMENT","GO_BP","518242_GO_0090102_COCHLEA_DEVELOPMENT",38,0.848,0.75,1,1.3573,0.091,0.6,0.9212,0.59,0.92
"GO_BP:491293_GO_0006352_DNA_TEMPLATED_TRANSCRIPTION_INITIATION","GO_BP","491293_GO_0006352_DNA_TEMPLATED_TRANSCRIPTION_INITIATION",224,0.8481,0.91,1,0.8582,0.87,1,0.8692,0.83,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2533_WU_ALZHEIMER_DISEASE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2533_WU_ALZHEIMER_DISEASE_UP",13,0.8483,0.65,1,-0.6728,0.87,1,1.1696,0.26,0.8
"GO_BP:517089_GO_0072173_METANEPHRIC_TUBULE_MORPHOGENESIS","GO_BP","517089_GO_0072173_METANEPHRIC_TUBULE_MORPHOGENESIS",11,0.8484,0.67,1,-1.0165,0.44,0.98,1.3673,0.13,0.65
"GO_CC:505826_GO_0042719_MITOCHONDRIAL_INTERMEMBRANE_SPACE_PROTEIN_TRANSPORTER_COMPLEX","GO_CC","505826_GO_0042719_MITOCHONDRIAL_INTERMEMBRANE_SPACE_PROTEIN_TRANSPORTER_COMPLEX",5,0.8484,0.62,0.95,1.3135,0.19,0.39,-0.6383,0.9,1
"GO_MF:500683_GO_0031432_TITIN_BINDING","GO_MF","500683_GO_0031432_TITIN_BINDING",13,0.8487,0.68,1,-0.6229,0.93,1,-1.042,0.42,0.75
"GO_MF:496638_GO_0016717_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_OXIDATION_OF_A_PAIR_OF_DONORS_RESULTING_IN_THE_REDUCTION_OF_MOLECULAR_OXYGEN_TO_TWO_MOLECULES_OF_WATER","GO_MF","496638_GO_0016717_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_OXIDATION_OF_A_PAIR_OF_DONORS_RESULTING_IN_THE_REDUCTION_OF_MOLECULAR_OXYGEN_TO_TWO_MOLECULES_OF_WATER",6,0.8488,0.62,1,-0.8516,0.64,1,-1.1581,0.29,0.63
"GO_CC:486663_GO_0000124_SAGA_COMPLEX","GO_CC","486663_GO_0000124_SAGA_COMPLEX",8,0.8491,0.62,0.95,0.8514,0.65,0.91,0.496,0.98,1
"REACTOME:105896_REACT_18265_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY","REACTOME","105896_REACT_18265_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY",10,0.8495,0.62,0.95,1.3704,0.14,0.25,-0.9708,0.49,0.88
"GO_CC:490807_GO_0005779_INTEGRAL_COMPONENT_OF_PEROXISOMAL_MEMBRANE","GO_CC","490807_GO_0005779_INTEGRAL_COMPONENT_OF_PEROXISOMAL_MEMBRANE",14,0.8497,0.65,0.96,1.4068,0.075,0.29,0.9027,0.58,1
"C4_Cancer_gene_neighborhoods:C4_CGN_67_MORF_BUB1B","C4_Cancer_gene_neighborhoods","C4_CGN_67_MORF_BUB1B",66,0.85,0.78,0.99,1.464,0.03,0.04,-1.2095,0.14,0.43
"GO_BP:491306_GO_0006378_MRNA_POLYADENYLATION","GO_BP","491306_GO_0006378_MRNA_POLYADENYLATION",28,0.8503,0.75,1,0.9386,0.57,1,-0.5806,0.99,1
"GO_BP:750796_GO_0002931_RESPONSE_TO_ISCHEMIA","GO_BP","750796_GO_0002931_RESPONSE_TO_ISCHEMIA",21,0.8503,0.72,1,-0.7143,0.88,1,-0.9346,0.53,0.9
"REACTOME:105887_REACT_311_DUAL_INCISION_REACTION_IN_GG_NER","REACTOME","105887_REACT_311_DUAL_INCISION_REACTION_IN_GG_NER",21,0.8506,0.73,0.95,1.5499,0.032,0.12,-0.6596,0.92,1
"GO_MF:492493_GO_0008139_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING","GO_MF","492493_GO_0008139_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING",8,0.8507,0.66,1,0.7768,0.74,1,-1.0102,0.45,0.78
"C4_Cancer_modules:C4_CM_92_MODULE_97","C4_Cancer_modules","C4_CM_92_MODULE_97",97,0.8509,0.82,1,0.7905,0.9,0.98,-0.5387,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_83_MORF_DAP3","C4_Cancer_gene_neighborhoods","C4_CGN_83_MORF_DAP3",195,0.8511,0.98,0.99,2.4942,0,0,-1.0219,0.41,0.8
"GO_BP:517105_GO_0072189_URETER_DEVELOPMENT","GO_BP","517105_GO_0072189_URETER_DEVELOPMENT",13,0.8514,0.64,1,0.8615,0.63,1,1.2604,0.19,0.69
"GO_BP:517237_GO_0072321_CHAPERONE_MEDIATED_PROTEIN_TRANSPORT","GO_BP","517237_GO_0072321_CHAPERONE_MEDIATED_PROTEIN_TRANSPORT",8,0.8515,0.65,1,1.1534,0.29,0.83,-1.1199,0.32,0.76
"C4_Cancer_gene_neighborhoods:C4_CGN_132_MORF_MTA1","C4_Cancer_gene_neighborhoods","C4_CGN_132_MORF_MTA1",102,0.8516,0.89,1,2.0531,0,0.00019,-0.6579,1,1
"GO_BP:489066_GO_0003272_ENDOCARDIAL_CUSHION_FORMATION","GO_BP","489066_GO_0003272_ENDOCARDIAL_CUSHION_FORMATION",12,0.8527,0.64,1,-0.8154,0.71,1,0.8219,0.69,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2801_TSAI_DNAJB4_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2801_TSAI_DNAJB4_TARGETS_DN",6,0.8527,0.62,1,1.552,0.024,0.17,1.0456,0.4,0.92
"GO_BP:488776_GO_0002903_NEGATIVE_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS","GO_BP","488776_GO_0002903_NEGATIVE_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS",11,0.8532,0.64,1,0.5456,0.97,1,-0.711,0.86,0.99
"GO_MF:495373_GO_0015095_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495373_GO_0015095_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,0.8534,0.68,1,0.7258,0.83,1,-0.6194,0.94,1
"GO_BP:489193_GO_0003401_AXIS_ELONGATION","GO_BP","489193_GO_0003401_AXIS_ELONGATION",25,0.8535,0.71,1,-0.8817,0.63,1,1.245,0.16,0.7
"REACTOME:106010_REACT_6288_HOST_INTERACTIONS_OF_HIV_FACTORS","REACTOME","106010_REACT_6288_HOST_INTERACTIONS_OF_HIV_FACTORS",127,0.8537,0.91,0.94,2.0908,0,0.00071,-0.9097,0.68,0.95
"KEGG_compound:C00475_CYTIDINE","KEGG_compound","C00475_CYTIDINE",13,0.8539,0.67,1,0.526,0.98,1,-0.9905,0.45,0.66
"GO_BP:494534_GO_0010464_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION","GO_BP","494534_GO_0010464_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION",41,0.8545,0.72,1,1.3578,0.063,0.6,1.7815,0.0058,0.31
"REACTOME:105731_REACT_6933_CONJUGATION_OF_BENZOATE_WITH_GLYCINE","REACTOME","105731_REACT_6933_CONJUGATION_OF_BENZOATE_WITH_GLYCINE",6,0.8546,0.61,0.95,-1.8018,0.002,0.08,1.0544,0.41,0.97
"REACTOME:119535_REACT_19373_TIGHT_JUNCTION_INTERACTIONS","REACTOME","119535_REACT_19373_TIGHT_JUNCTION_INTERACTIONS",29,0.855,0.73,0.95,-1.0011,0.44,0.99,1.0271,0.41,0.99
"REACTOME:1183558_REACT_355584_FRS_MEDIATED_FGFR1_SIGNALING","REACTOME","1183558_REACT_355584_FRS_MEDIATED_FGFR1_SIGNALING",31,0.855,0.69,0.95,0.852,0.71,0.96,-0.7925,0.82,1
"GO_MF:509163_GO_0046974_HISTONE_METHYLTRANSFERASE_ACTIVITY_H3_K9_SPECIFIC_","GO_MF","509163_GO_0046974_HISTONE_METHYLTRANSFERASE_ACTIVITY_H3_K9_SPECIFIC_",6,0.8551,0.59,1,-1.0147,0.46,0.89,-0.5943,0.93,1
"C4_Cancer_modules:C4_CM_72_MODULE_77","C4_Cancer_modules","C4_CM_72_MODULE_77",28,0.8551,0.68,1,2.1313,0,0.00065,-0.5343,0.99,1
"GO_BP:510316_GO_0048193_GOLGI_VESICLE_TRANSPORT","GO_BP","510316_GO_0048193_GOLGI_VESICLE_TRANSPORT",234,0.8553,0.92,1,1.2988,0.029,0.67,-0.6752,1,1
"C7_Immunologic_signatures:C7_ALL_694_GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_694_GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDM_DN",200,0.8559,0.94,1,1.9086,0,0,0.7396,0.99,1
"KEGG_reaction:R00378_DEOXYTHYMIDINE_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DTTP_DNA_DIPHOSPHATE_DNA","KEGG_reaction","R00378_DEOXYTHYMIDINE_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DTTP_DNA_DIPHOSPHATE_DNA",12,0.856,0.66,0.95,0.8571,0.67,1,-1.1761,0.26,0.42
"GO_BP:510323_GO_0048200_GOLGI_TRANSPORT_VESICLE_COATING","GO_BP","510323_GO_0048200_GOLGI_TRANSPORT_VESICLE_COATING",13,0.8562,0.66,1,1.6104,0.023,0.28,1.3052,0.14,0.67
"GO_BP:506985_GO_0043967_HISTONE_H4_ACETYLATION","GO_BP","506985_GO_0043967_HISTONE_H4_ACETYLATION",49,0.8567,0.73,1,0.5103,1,1,-0.9729,0.49,0.88
"GO_BP:501345_GO_0032108_NEGATIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS","GO_BP","501345_GO_0032108_NEGATIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS",27,0.8567,0.71,1,0.676,0.93,1,-0.7311,0.88,0.99
"C1_Positional:C1_ALL_183_CHR3P25","C1_Positional","C1_ALL_183_CHR3P25",75,0.857,0.81,0.92,-0.8464,0.78,0.97,0.858,0.74,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_3352_HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3352_HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN",19,0.857,0.7,1,2.2703,0,0.00021,-0.4802,1,1
"GO_BP:849962_GO_1902261_POSITIVE_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY","GO_BP","849962_GO_1902261_POSITIVE_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY",5,0.8571,0.64,1,-0.9422,0.54,1,0.7804,0.75,1
"GO_BP:507844_GO_0045494_PHOTORECEPTOR_CELL_MAINTENANCE","GO_BP","507844_GO_0045494_PHOTORECEPTOR_CELL_MAINTENANCE",31,0.8573,0.68,1,1.0703,0.34,0.93,1.6275,0.01,0.4
"KEGG_compound:C00122_FUMARATE_FUMARIC_ACID_TRANS_BUTENEDIOIC_ACID","KEGG_compound","C00122_FUMARATE_FUMARIC_ACID_TRANS_BUTENEDIOIC_ACID",9,0.8575,0.62,1,1.2696,0.2,0.77,-0.9142,0.57,0.74
"C4_Cancer_modules:C4_CM_228_MODULE_252","C4_Cancer_modules","C4_CM_228_MODULE_252",236,0.8576,0.93,1,1.5455,0,0.095,-1.2606,0.039,0.32
"GO_MF:502259_GO_0033038_BITTER_TASTE_RECEPTOR_ACTIVITY","GO_MF","502259_GO_0033038_BITTER_TASTE_RECEPTOR_ACTIVITY",20,0.8577,0.69,1,-0.871,0.65,1,1.473,0.064,0.48
"C4_Cancer_gene_neighborhoods:C4_CGN_265_GCM_SMARCD1","C4_Cancer_gene_neighborhoods","C4_CGN_265_GCM_SMARCD1",101,0.8577,0.84,0.99,0.8615,0.76,0.91,0.8049,0.89,1
"C6_Oncogenic_signatures:C6_ALL_4_E2F1_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_4_E2F1_UP_V1_UP",180,0.858,0.91,1,0.8965,0.75,0.95,-1.3105,0.024,0.34
"REACTOME:161040_REACT_20642_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII","REACTOME","161040_REACT_20642_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII",17,0.8582,0.7,0.95,1.1486,0.26,0.51,-0.8421,0.7,0.99
"GO_BP:1022190_GO_1903204_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_DEATH","GO_BP","1022190_GO_1903204_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_DEATH",7,0.8583,0.64,1,1.6562,0.014,0.24,0.9408,0.52,0.91
"GO_BP:502131_GO_0032909_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA2_PRODUCTION","GO_BP","502131_GO_0032909_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA2_PRODUCTION",8,0.8585,0.63,1,0.6883,0.85,1,1.5227,0.055,0.54
"GO_BP:518917_GO_2000270_NEGATIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS","GO_BP","518917_GO_2000270_NEGATIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS",8,0.8586,0.64,1,-0.771,0.76,1,0.8313,0.7,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1229_TESAR_ALK_TARGETS_HUMAN_ES_5D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1229_TESAR_ALK_TARGETS_HUMAN_ES_5D_DN",7,0.8587,0.64,1,-1.0021,0.46,1,-1.1381,0.32,0.59
"GO_BP:499321_GO_0022403_CELL_CYCLE_PHASE","GO_BP","499321_GO_0022403_CELL_CYCLE_PHASE",336,0.8588,0.94,1,1.6165,0,0.28,-1.1855,0.062,0.73
"GO_BP:1133993_GO_1903818_POSITIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY","GO_BP","1133993_GO_1903818_POSITIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY",5,0.8588,0.62,1,-0.9466,0.55,1,0.7938,0.74,1
"GO_BP:495873_GO_0015740_C4_DICARBOXYLATE_TRANSPORT","GO_BP","495873_GO_0015740_C4_DICARBOXYLATE_TRANSPORT",8,0.8592,0.63,1,-0.661,0.88,1,-0.8287,0.7,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2172_WALLACE_PROSTATE_CANCER_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2172_WALLACE_PROSTATE_CANCER_UP",20,0.8595,0.68,1,1.2599,0.17,0.43,-0.9423,0.56,0.83
"KEGG_compound:C04895_7_8_DIHYDRONEOPTERIN_3_TRIPHOSPHATE_2_AMINO_4_HYDROXY_6_ERYTHRO_1_2_3_TRIHYDROXYPROPYL_DIHYDROPTERIDINE_TRIPHOSPHATE_6_L_ERYTHRO_1_2_DIHYDROXYPROPYL_3_TRIPHOSPHATE_7_8_DIHYDROPTERIN_6_1S_2R_1_2_DIHYDROXY_3_TRIPHOSPHOOXYPROPYL_7_8_DIHYDROPTERIN","KEGG_compound","C04895_7_8_DIHYDRONEOPTERIN_3_TRIPHOSPHATE_2_AMINO_4_HYDROXY_6_ERYTHRO_1_2_3_TRIHYDROXYPROPYL_DIHYDROPTERIDINE_TRIPHOSPHATE_6_L_ERYTHRO_1_2_DIHYDROXYPROPYL_3_TRIPHOSPHATE_7_8_DIHYDROPTERIN_6_1S_2R_1_2_DIHYDROXY_3_TRIPHOSPHOOXYPROPYL_7_8_DIHYDROPTERIN",6,0.8596,0.61,1,1.253,0.22,0.8,1.0196,0.43,0.67
"KEGG_module:HSA_M00424_SHELTERIN_COMPLEX","KEGG_module","HSA_M00424_SHELTERIN_COMPLEX",6,0.8598,0.6,0.8,0.4954,0.99,0.99,-0.5505,0.96,1
"GO_BP:501691_GO_0032459_REGULATION_OF_PROTEIN_OLIGOMERIZATION","GO_BP","501691_GO_0032459_REGULATION_OF_PROTEIN_OLIGOMERIZATION",31,0.8599,0.72,1,1.2198,0.16,0.77,-1.6328,0.014,0.51
"GO_MF:509166_GO_0046977_TAP_BINDING","GO_MF","509166_GO_0046977_TAP_BINDING",7,0.8601,0.61,1,1.1842,0.26,0.73,0.4957,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2839_KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2839_KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN",24,0.8602,0.7,1,-0.9886,0.48,1,-1.566,0.026,0.26
"C2_Chemical_and_genetic_perturbations:C2_CGP_2294_WEBER_METHYLATED_HCP_IN_SPERM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2294_WEBER_METHYLATED_HCP_IN_SPERM_DN",24,0.8604,0.68,1,-1.0792,0.34,0.95,-0.8178,0.74,0.94
"GO_CC:486862_GO_0000346_TRANSCRIPTION_EXPORT_COMPLEX","GO_CC","486862_GO_0000346_TRANSCRIPTION_EXPORT_COMPLEX",13,0.8605,0.65,0.94,-0.7373,0.82,1,-0.5519,0.98,1
"GO_BP:752854_GO_0097354_PRENYLATION","GO_BP","752854_GO_0097354_PRENYLATION",10,0.8606,0.62,1,0.9484,0.53,1,1.1239,0.31,0.74
"C4_Cancer_modules:C4_CM_355_MODULE_429","C4_Cancer_modules","C4_CM_355_MODULE_429",14,0.8609,0.65,1,2.11,0,0.00092,-1.253,0.2,0.33
"GO_BP:517580_GO_0072677_EOSINOPHIL_MIGRATION","GO_BP","517580_GO_0072677_EOSINOPHIL_MIGRATION",8,0.861,0.64,1,1.5599,0.036,0.33,1.9981,0.002,0.046
"C2_Chemical_and_genetic_perturbations:C2_CGP_1713_EHRLICH_ICF_SYNDROM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1713_EHRLICH_ICF_SYNDROM_UP",11,0.8613,0.63,1,1.339,0.14,0.35,-0.8871,0.61,0.9
"OMIM_gene:OMIM613591_BUTYROPHILIN_SUBFAMILY_2_MEMBER_A2_BTN2A2","OMIM_gene","OMIM613591_BUTYROPHILIN_SUBFAMILY_2_MEMBER_A2_BTN2A2",5,0.8614,0.61,1,0.9429,0.55,1,-0.7882,0.72,0.98
"REACTOME:645352_REACT_121123_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE","REACTOME","645352_REACT_121123_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE",12,0.8616,0.62,0.94,0.8429,0.68,0.96,-1.538,0.039,0.31
"GO_CC:507511_GO_0045120_PRONUCLEUS","GO_CC","507511_GO_0045120_PRONUCLEUS",17,0.862,0.67,0.94,-0.8265,0.72,1,-1.1577,0.27,0.85
"GO_BP:491399_GO_0006501_C_TERMINAL_PROTEIN_LIPIDATION","GO_BP","491399_GO_0006501_C_TERMINAL_PROTEIN_LIPIDATION",32,0.862,0.69,1,0.8351,0.72,1,0.6937,0.93,1
"GO_MF:490436_GO_0005172_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_BINDING","GO_MF","490436_GO_0005172_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_BINDING",8,0.8622,0.64,1,1.437,0.085,0.45,0.8126,0.7,1
"GO_BP:518372_GO_0090232_POSITIVE_REGULATION_OF_SPINDLE_CHECKPOINT","GO_BP","518372_GO_0090232_POSITIVE_REGULATION_OF_SPINDLE_CHECKPOINT",7,0.8623,0.64,1,1.0222,0.42,0.97,0.5607,0.95,1
"GO_MF:496397_GO_0016409_PALMITOYLTRANSFERASE_ACTIVITY","GO_MF","496397_GO_0016409_PALMITOYLTRANSFERASE_ACTIVITY",35,0.8626,0.73,1,-1.2027,0.17,0.81,-0.8774,0.68,0.9
"REACTOME:106364_REACT_16943_MUSCARINIC_ACETYLCHOLINE_RECEPTORS","REACTOME","106364_REACT_16943_MUSCARINIC_ACETYLCHOLINE_RECEPTORS",5,0.8628,0.62,0.94,0.9073,0.57,0.9,1.4261,0.094,0.62
"GO_MF:489642_GO_0004176_ATP_DEPENDENT_PEPTIDASE_ACTIVITY","GO_MF","489642_GO_0004176_ATP_DEPENDENT_PEPTIDASE_ACTIVITY",7,0.8628,0.59,1,0.5618,0.95,1,0.6629,0.88,1
"GO_BP:498807_GO_0021523_SOMATIC_MOTOR_NEURON_DIFFERENTIATION","GO_BP","498807_GO_0021523_SOMATIC_MOTOR_NEURON_DIFFERENTIATION",6,0.8628,0.62,1,-1.0922,0.36,0.95,-1.1718,0.32,0.73
"GO_BP:501342_GO_0032105_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS","GO_BP","501342_GO_0032105_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS",27,0.8632,0.7,1,0.669,0.96,1,-0.7327,0.85,0.99
"GO_BP:513713_GO_0060155_PLATELET_DENSE_GRANULE_ORGANIZATION","GO_BP","513713_GO_0060155_PLATELET_DENSE_GRANULE_ORGANIZATION",8,0.8634,0.62,1,1.4569,0.1,0.48,1.2824,0.18,0.69
"GO_BP:518349_GO_0090209_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS","GO_BP","518349_GO_0090209_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS",7,0.8636,0.66,1,1.3032,0.17,0.67,-1.0653,0.38,0.8
"GO_BP:754750_GO_1901799_NEGATIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS","GO_BP","754750_GO_1901799_NEGATIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS",62,0.8638,0.79,1,1.2948,0.095,0.68,-0.8154,0.84,0.98
"GO_BP:752361_GO_0080182_HISTONE_H3_K4_TRIMETHYLATION","GO_BP","752361_GO_0080182_HISTONE_H3_K4_TRIMETHYLATION",10,0.8638,0.65,1,0.5453,0.97,1,-1.0853,0.35,0.79
"GO_BP:499596_GO_0030178_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY","GO_BP","499596_GO_0030178_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY",183,0.8639,0.94,1,1.432,0.012,0.52,0.828,0.9,1
"GO_CC:492577_GO_0008250_OLIGOSACCHARYLTRANSFERASE_COMPLEX","GO_CC","492577_GO_0008250_OLIGOSACCHARYLTRANSFERASE_COMPLEX",10,0.8639,0.65,0.94,1.3544,0.12,0.34,-0.8949,0.59,1
"GO_BP:514478_GO_0060923_CARDIAC_MUSCLE_CELL_FATE_COMMITMENT","GO_BP","514478_GO_0060923_CARDIAC_MUSCLE_CELL_FATE_COMMITMENT",6,0.8639,0.63,1,-0.7847,0.71,1,-0.8971,0.58,0.93
"GO_MF:752658_GO_0097157_PRE_MRNA_INTRONIC_BINDING","GO_MF","752658_GO_0097157_PRE_MRNA_INTRONIC_BINDING",5,0.8643,0.63,1,-1.2631,0.2,0.83,-0.6564,0.88,1
"KEGG_reaction:R08392_RETINOATE_NADPH_H_OXYGEN_ALL_TRANS_4_HYDROXYRETINOIC_ACID_NADP_H2O","KEGG_reaction","R08392_RETINOATE_NADPH_H_OXYGEN_ALL_TRANS_4_HYDROXYRETINOIC_ACID_NADP_H2O",15,0.8643,0.66,0.96,-0.9969,0.48,0.77,1.1343,0.28,0.61
"C2_Chemical_and_genetic_perturbations:C2_CGP_2461_MOOTHA_MITOCHONDRIA","C2_Chemical_and_genetic_perturbations","C2_CGP_2461_MOOTHA_MITOCHONDRIA",446,0.865,1,1,2.1258,0,0.0015,-1.1038,0.14,0.62
"GO_BP:782514_GO_0044782_CILIUM_ORGANIZATION","GO_BP","782514_GO_0044782_CILIUM_ORGANIZATION",155,0.8652,0.88,1,-0.8047,0.92,1,-1.2047,0.1,0.73
"GO_BP:503420_GO_0034214_PROTEIN_HEXAMERIZATION","GO_BP","503420_GO_0034214_PROTEIN_HEXAMERIZATION",7,0.8653,0.6,1,0.5697,0.95,1,0.8987,0.57,0.95
"REACTOME:1127689_REACT_264501_MISMATCH_REPAIR_MMR_DIRECTED_BY_MSH2_MSH6_MUTSALPHA_","REACTOME","1127689_REACT_264501_MISMATCH_REPAIR_MMR_DIRECTED_BY_MSH2_MSH6_MUTSALPHA_",15,0.8653,0.65,0.94,1.0092,0.43,0.74,-1.1882,0.26,0.61
"GO_MF:498727_GO_0019961_INTERFERON_BINDING","GO_MF","498727_GO_0019961_INTERFERON_BINDING",6,0.8654,0.59,1,1.2868,0.18,0.63,1.5622,0.037,0.39
"C2_Chemical_and_genetic_perturbations:C2_CGP_2025_CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2","C2_Chemical_and_genetic_perturbations","C2_CGP_2025_CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2",451,0.8654,1,1,-1.2001,0.048,0.79,-1.0871,0.19,0.65
"REACTOME:105835_REACT_6761_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1","REACTOME","105835_REACT_6761_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1",69,0.8655,0.75,0.94,1.949,0,0.0045,-0.7647,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2922_MIKKELSEN_NPC_WITH_LCP_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2922_MIKKELSEN_NPC_WITH_LCP_H3K27ME3",6,0.8658,0.58,1,0.8227,0.7,0.98,1.1121,0.34,0.87
"GO_BP:496266_GO_0016180_SNRNA_PROCESSING","GO_BP","496266_GO_0016180_SNRNA_PROCESSING",16,0.8659,0.68,1,-0.6398,0.95,1,-0.7134,0.88,0.99
"GO_BP:491576_GO_0006688_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS","GO_BP","491576_GO_0006688_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS",16,0.8661,0.64,1,0.8705,0.64,1,1.1154,0.3,0.75
"KEGG_reaction:R00377_DEOXYCYTIDINE_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DCTP_DNA_DIPHOSPHATE_DNA","KEGG_reaction","R00377_DEOXYCYTIDINE_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DCTP_DNA_DIPHOSPHATE_DNA",12,0.8662,0.65,0.98,0.8546,0.66,1,-1.1611,0.26,0.43
"C7_Immunologic_signatures:C7_ALL_1002_GSE22886_IL2_VS_IL15_STIM_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1002_GSE22886_IL2_VS_IL15_STIM_NKCELL_DN",193,0.8667,0.91,0.99,1.7391,0,0.00037,-0.8554,0.89,1
"GO_BP:513556_GO_0055129_L_PROLINE_BIOSYNTHETIC_PROCESS","GO_BP","513556_GO_0055129_L_PROLINE_BIOSYNTHETIC_PROCESS",5,0.8672,0.6,1,1.2406,0.24,0.75,0.783,0.72,1
"C3_TF_targets:C3_TFT_517_TAANNYSGCG_UNKNOWN","C3_TF_targets","C3_TFT_517_TAANNYSGCG_UNKNOWN",77,0.8673,0.76,1,1.2844,0.072,0.49,-0.6718,0.98,1
"GO_BP:501440_GO_0032205_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE","GO_BP","501440_GO_0032205_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE",10,0.8677,0.62,1,0.5299,0.98,1,0.4715,0.99,1
"REACTOME:1183586_REACT_355347_RHO_GTPASES_ACTIVATE_PAKS","REACTOME","1183586_REACT_355347_RHO_GTPASES_ACTIVATE_PAKS",23,0.8683,0.66,0.94,1.334,0.11,0.28,-0.8306,0.7,1
"GO_BP:516817_GO_0071897_DNA_BIOSYNTHETIC_PROCESS","GO_BP","516817_GO_0071897_DNA_BIOSYNTHETIC_PROCESS",53,0.8687,0.74,1,-1.1422,0.23,0.93,-1.0274,0.39,0.82
"GO_BP:507470_GO_0045070_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION","GO_BP","507470_GO_0045070_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION",26,0.8691,0.69,1,1.4071,0.067,0.55,-0.6894,0.92,0.99
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_94_BIOCARTA_IL4_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_94_BIOCARTA_IL4_PATHWAY",11,0.8692,0.64,0.96,0.6948,0.88,1,0.8989,0.57,1
"GO_MF:489240_GO_0003690_DOUBLE_STRANDED_DNA_BINDING","GO_MF","489240_GO_0003690_DOUBLE_STRANDED_DNA_BINDING",110,0.8692,0.81,1,1.1183,0.2,0.76,-0.7545,0.96,0.99
"GO_BP:752615_GO_0097114_N_METHYL_D_ASPARTATE_RECEPTOR_CLUSTERING","GO_BP","752615_GO_0097114_N_METHYL_D_ASPARTATE_RECEPTOR_CLUSTERING",5,0.8695,0.61,1,1.1471,0.34,0.84,1.3621,0.13,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2030_MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2030_MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN",8,0.8704,0.63,1,1.1846,0.27,0.51,1.1465,0.3,0.83
"GO_BP:487925_GO_0002035_BRAIN_RENIN_ANGIOTENSIN_SYSTEM","GO_BP","487925_GO_0002035_BRAIN_RENIN_ANGIOTENSIN_SYSTEM",5,0.8705,0.62,1,1.1231,0.35,0.88,-1.2898,0.19,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_2032_PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2032_PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",64,0.8706,0.73,1,1.7594,0,0.058,0.8445,0.75,1
"GO_CC:486649_GO_0000109_NUCLEOTIDE_EXCISION_REPAIR_COMPLEX","GO_CC","486649_GO_0000109_NUCLEOTIDE_EXCISION_REPAIR_COMPLEX",13,0.8708,0.64,0.93,0.9151,0.59,0.87,0.6416,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_712_SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_712_SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP",47,0.8711,0.73,1,0.7062,0.96,1,-1.2167,0.16,0.5
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_212_BIOCARTA_ARF_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_212_BIOCARTA_ARF_PATHWAY",17,0.8711,0.66,1,1.3211,0.12,0.57,-0.8457,0.69,0.9
"GO_CC:487154_GO_0000930_GAMMA_TUBULIN_COMPLEX","GO_CC","487154_GO_0000930_GAMMA_TUBULIN_COMPLEX",15,0.8712,0.64,0.93,0.7985,0.76,0.96,-0.8794,0.62,1
"C4_Cancer_gene_neighborhoods:C4_CGN_130_MORF_MBD4","C4_Cancer_gene_neighborhoods","C4_CGN_130_MORF_MBD4",86,0.8714,0.8,0.96,2.5007,0,0,0.6091,1,1
"GO_BP:501600_GO_0032365_INTRACELLULAR_LIPID_TRANSPORT","GO_BP","501600_GO_0032365_INTRACELLULAR_LIPID_TRANSPORT",19,0.8719,0.64,1,0.7262,0.87,1,1.3339,0.11,0.64
"C3_MicroRNA_targets:C3_MIR_127_GTCTACC_MIR_379","C3_MicroRNA_targets","C3_MIR_127_GTCTACC_MIR_379",22,0.872,0.66,1,1.4143,0.056,0.59,1.1418,0.27,1
"GO_MF:487217_GO_0000993_RNA_POLYMERASE_II_CORE_BINDING","GO_MF","487217_GO_0000993_RNA_POLYMERASE_II_CORE_BINDING",19,0.8722,0.67,1,-0.709,0.88,1,0.7169,0.87,1
"GO_BP:487882_GO_0001992_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_VASOPRESSIN","GO_BP","487882_GO_0001992_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_VASOPRESSIN",5,0.8723,0.62,1,0.6427,0.89,1,-1.2389,0.23,0.69
"GO_MF:490431_GO_0005167_NEUROTROPHIN_TRK_RECEPTOR_BINDING","GO_MF","490431_GO_0005167_NEUROTROPHIN_TRK_RECEPTOR_BINDING",6,0.8723,0.61,1,1.0783,0.38,0.82,0.8945,0.56,0.97
"GO_CC:515898_GO_0070971_ENDOPLASMIC_RETICULUM_EXIT_SITE","GO_CC","515898_GO_0070971_ENDOPLASMIC_RETICULUM_EXIT_SITE",11,0.8725,0.61,0.93,1.428,0.081,0.27,0.8819,0.62,1
"C7_Immunologic_signatures:C7_ALL_1167_GSE27786_LIN_NEG_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1167_GSE27786_LIN_NEG_VS_NKCELL_UP",198,0.8728,0.85,0.98,1.2727,0.039,0.13,-1.0607,0.26,0.59
"KEGG_reaction:R00375_DEOXYADENOSINE_5_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DATP_DNA_DIPHOSPHATE_DNA","KEGG_reaction","R00375_DEOXYADENOSINE_5_TRIPHOSPHATE_DNA_DEOXYNUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_DATP_DNA_DIPHOSPHATE_DNA",12,0.8729,0.6,0.99,0.8498,0.65,1,-1.1462,0.33,0.44
"GO_MF:490397_GO_0005134_INTERLEUKIN_2_RECEPTOR_BINDING","GO_MF","490397_GO_0005134_INTERLEUKIN_2_RECEPTOR_BINDING",5,0.8734,0.59,1,0.4349,0.99,1,0.6488,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2879_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS","C2_Chemical_and_genetic_perturbations","C2_CGP_2879_BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS",25,0.8737,0.67,1,1.2815,0.12,0.41,-1.4754,0.022,0.31
"C3_TF_targets:C3_TFT_347_V_NFMUE1_Q6","C3_TF_targets","C3_TFT_347_V_NFMUE1_Q6",246,0.8739,0.89,1,1.1597,0.11,0.85,0.6212,1,1
"GO_BP:752396_GO_0086026_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_SIGNALING","GO_BP","752396_GO_0086026_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_SIGNALING",9,0.8739,0.62,1,0.9912,0.46,0.99,-0.8258,0.68,0.97
"GO_CC:500492_GO_0031231_INTRINSIC_COMPONENT_OF_PEROXISOMAL_MEMBRANE","GO_CC","500492_GO_0031231_INTRINSIC_COMPONENT_OF_PEROXISOMAL_MEMBRANE",14,0.874,0.61,0.93,1.3958,0.11,0.3,0.9056,0.59,1
"REACTOME:477126_REACT_111056_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES_","REACTOME","477126_REACT_111056_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES_",49,0.8742,0.73,0.93,1.9799,0,0.0031,0.7644,0.88,1
"GO_BP:501457_GO_0032222_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC","GO_BP","501457_GO_0032222_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC",11,0.8745,0.63,1,-1.1497,0.3,0.93,-1.2069,0.24,0.73
"REACTOME:105899_REACT_829_REGULATION_OF_DNA_REPLICATION","REACTOME","105899_REACT_829_REGULATION_OF_DNA_REPLICATION",75,0.8746,0.78,0.93,2.0202,0,0.0017,-0.8798,0.73,0.96
"OMIM_gene:OMIM612869_ATTRACTIN_LIKE_1_ATRNL1","OMIM_gene","OMIM612869_ATTRACTIN_LIKE_1_ATRNL1",7,0.8747,0.6,1,1.5185,0.049,1,1.0722,0.39,1
"GO_BP:497300_GO_0018345_PROTEIN_PALMITOYLATION","GO_BP","497300_GO_0018345_PROTEIN_PALMITOYLATION",24,0.8747,0.64,1,-0.9388,0.56,1,-0.7216,0.87,0.99
"GO_MF:489532_GO_0004064_ARYLESTERASE_ACTIVITY","GO_MF","489532_GO_0004064_ARYLESTERASE_ACTIVITY",5,0.8747,0.6,1,1.2817,0.19,0.63,-1.0577,0.41,0.74
"GO_BP:504280_GO_0035095_BEHAVIORAL_RESPONSE_TO_NICOTINE","GO_BP","504280_GO_0035095_BEHAVIORAL_RESPONSE_TO_NICOTINE",7,0.875,0.6,1,-1.4593,0.079,0.88,-0.7087,0.81,0.99
"GO_CC:487092_GO_0000801_CENTRAL_ELEMENT","GO_CC","487092_GO_0000801_CENTRAL_ELEMENT",6,0.8754,0.6,0.93,1.1625,0.3,0.57,-0.743,0.77,1
"REACTOME:906020_REACT_169103_SMAD2_3_PHOSPHORYLATION_MOTIF_MUTANTS_IN_CANCER","REACTOME","906020_REACT_169103_SMAD2_3_PHOSPHORYLATION_MOTIF_MUTANTS_IN_CANCER",6,0.8756,0.58,0.93,-0.7942,0.76,1,1.0845,0.36,0.95
"REACTOME:1127593_REACT_268786_DEFECTIVE_CHST6_CAUSES_MCDC1","REACTOME","1127593_REACT_268786_DEFECTIVE_CHST6_CAUSES_MCDC1",7,0.8756,0.62,0.93,0.9257,0.56,0.87,1.2589,0.21,0.78
"GO_BP:499182_GO_0021903_ROSTROCAUDAL_NEURAL_TUBE_PATTERNING","GO_BP","499182_GO_0021903_ROSTROCAUDAL_NEURAL_TUBE_PATTERNING",11,0.876,0.65,1,-0.7955,0.77,1,0.4723,0.99,1
"GO_MF:503269_GO_0034061_DNA_POLYMERASE_ACTIVITY","GO_MF","503269_GO_0034061_DNA_POLYMERASE_ACTIVITY",33,0.8761,0.67,1,-0.9314,0.56,0.96,-0.8258,0.75,0.95
"GO_BP:518321_GO_0090181_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS","GO_BP","518321_GO_0090181_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS",19,0.8762,0.64,1,1.0775,0.34,0.93,0.9833,0.48,0.87
"GO_CC:492685_GO_0008385_IKAPPAB_KINASE_COMPLEX","GO_CC","492685_GO_0008385_IKAPPAB_KINASE_COMPLEX",11,0.8763,0.64,0.94,-0.6407,0.91,1,-0.7858,0.76,1
"GO_BP:496103_GO_0015986_ATP_SYNTHESIS_COUPLED_PROTON_TRANSPORT","GO_BP","496103_GO_0015986_ATP_SYNTHESIS_COUPLED_PROTON_TRANSPORT",24,0.8764,0.64,1,1.9211,0.0022,0.03,0.6536,0.92,1
"GO_BP:501601_GO_0032366_INTRACELLULAR_STEROL_TRANSPORT","GO_BP","501601_GO_0032366_INTRACELLULAR_STEROL_TRANSPORT",8,0.877,0.6,1,1.2622,0.2,0.72,1.4295,0.077,0.61
"C1_Positional:C1_ALL_79_CHR7P11","C1_Positional","C1_ALL_79_CHR7P11",18,0.8771,0.64,0.89,1.3161,0.13,0.53,1.0902,0.33,0.72
"GO_BP:517254_GO_0072338_CELLULAR_LACTAM_METABOLIC_PROCESS","GO_BP","517254_GO_0072338_CELLULAR_LACTAM_METABOLIC_PROCESS",5,0.8775,0.58,1,1.2855,0.18,0.7,1.1854,0.31,0.72
"GO_BP:499668_GO_0030263_APOPTOTIC_CHROMOSOME_CONDENSATION","GO_BP","499668_GO_0030263_APOPTOTIC_CHROMOSOME_CONDENSATION",5,0.8782,0.6,1,-0.647,0.88,1,0.4948,0.98,1
"C7_Immunologic_signatures:C7_ALL_1171_GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP","C7_Immunologic_signatures","C7_ALL_1171_GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP",200,0.8782,0.91,0.97,1.2232,0.067,0.19,-0.8169,0.96,1
"GO_BP:486889_GO_0000394_RNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION","GO_BP","486889_GO_0000394_RNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION",11,0.8784,0.59,1,1.6135,0.011,0.28,0.7672,0.78,1
"REACTOME:105831_REACT_6781_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS","REACTOME","105831_REACT_6781_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS",72,0.8784,0.73,0.93,2.091,0,0.00072,-0.7313,0.95,1
"GO_MF:496395_GO_0016407_ACETYLTRANSFERASE_ACTIVITY","GO_MF","496395_GO_0016407_ACETYLTRANSFERASE_ACTIVITY",97,0.8786,0.75,1,0.8669,0.76,1,-0.6283,1,1
"GO_CC:486687_GO_0000153_CYTOPLASMIC_UBIQUITIN_LIGASE_COMPLEX","GO_CC","486687_GO_0000153_CYTOPLASMIC_UBIQUITIN_LIGASE_COMPLEX",10,0.8788,0.59,0.94,1.6763,0.022,0.075,-0.5955,0.94,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_940_HUI_MAPK14_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_940_HUI_MAPK14_TARGETS_UP",20,0.8789,0.67,1,-0.7243,0.84,1,-1.1585,0.24,0.57
"GO_BP:515803_GO_0070875_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS","GO_BP","515803_GO_0070875_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS",17,0.879,0.62,1,-0.6712,0.91,1,1.1886,0.22,0.72
"GO_BP:755379_GO_2001273_REGULATION_OF_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS","GO_BP","755379_GO_2001273_REGULATION_OF_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS",11,0.879,0.63,1,-1.0615,0.37,0.96,-0.9709,0.5,0.87
"REACTOME:119564_REACT_19357_MULTIFUNCTIONAL_ANION_EXCHANGERS","REACTOME","119564_REACT_19357_MULTIFUNCTIONAL_ANION_EXCHANGERS",6,0.8793,0.59,0.93,0.9021,0.56,0.9,1.0326,0.41,0.98
"GO_BP:506661_GO_0043631_RNA_POLYADENYLATION","GO_BP","506661_GO_0043631_RNA_POLYADENYLATION",30,0.8796,0.71,1,0.8893,0.63,1,0.5388,1,1
"REACTOME:106255_REACT_11218_COENZYME_A_BIOSYNTHESIS","REACTOME","106255_REACT_11218_COENZYME_A_BIOSYNTHESIS",8,0.8798,0.59,0.93,0.6877,0.88,1,0.9436,0.54,1
"GO_BP:503753_GO_0034551_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY","GO_BP","503753_GO_0034551_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY",5,0.8803,0.56,1,0.6579,0.88,1,-1.1345,0.34,0.75
"KEGG_reaction:R03938_S_ADENOSYL_L_METHIONINE_HISTONE_L_LYSINE_N6_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_HISTONE_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE_HISTONE_N6_METHYL_L_LYSINE","KEGG_reaction","R03938_S_ADENOSYL_L_METHIONINE_HISTONE_L_LYSINE_N6_METHYLTRANSFERASE_S_ADENOSYL_L_METHIONINE_HISTONE_L_LYSINE_S_ADENOSYL_L_HOMOCYSTEINE_HISTONE_N6_METHYL_L_LYSINE",26,0.8803,0.63,1,-1.2808,0.14,0.44,-0.9541,0.54,0.66
"C1_Positional:C1_ALL_90_CHR5Q33","C1_Positional","C1_ALL_90_CHR5Q33",57,0.8805,0.7,0.9,1.1179,0.28,0.62,1.5709,0.0061,0.24
"GO_MF:496468_GO_0016500_PROTEIN_HORMONE_RECEPTOR_ACTIVITY","GO_MF","496468_GO_0016500_PROTEIN_HORMONE_RECEPTOR_ACTIVITY",10,0.8806,0.6,1,-0.8774,0.59,1,1.3928,0.094,0.53
"GO_BP:515180_GO_0070245_POSITIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS","GO_BP","515180_GO_0070245_POSITIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS",6,0.8806,0.6,1,-0.7374,0.8,1,0.914,0.56,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_2365_WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2365_WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP",21,0.8807,0.65,1,0.8337,0.71,0.98,-0.6583,0.94,0.99
"C7_Immunologic_signatures:C7_ALL_400_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_400_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN",200,0.8808,0.88,0.97,1.9575,0,0,-0.726,1,1
"C4_Cancer_modules:C4_CM_78_MODULE_83","C4_Cancer_modules","C4_CM_78_MODULE_83",318,0.8808,0.99,1,3.4374,0,0,-0.7008,1,1
"C1_Positional:C1_ALL_12_CHR6Q13","C1_Positional","C1_ALL_12_CHR6Q13",15,0.8808,0.63,0.91,1.1086,0.32,0.64,0.6672,0.91,0.97
"GO_MF:512418_GO_0051540_METAL_CLUSTER_BINDING","GO_MF","512418_GO_0051540_METAL_CLUSTER_BINDING",64,0.8808,0.73,1,1.7545,0,0.11,-0.9063,0.64,0.87
"GO_BP:487021_GO_0000724_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION","GO_BP","487021_GO_0000724_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION",70,0.8809,0.74,1,0.6713,0.99,1,-0.7629,0.93,1
"KEGG_compound:C03702_HISTONE_N6_METHYL_L_LYSINE","KEGG_compound","C03702_HISTONE_N6_METHYL_L_LYSINE",26,0.8811,0.68,1,-1.3131,0.12,0.6,-0.9541,0.52,0.71
"GO_BP:501441_GO_0032206_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE","GO_BP","501441_GO_0032206_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE",7,0.8813,0.6,1,0.5043,0.98,1,-0.7128,0.81,0.99
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_34_BIOCARTA_MCM_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_34_BIOCARTA_MCM_PATHWAY",18,0.8815,0.63,1,1.371,0.099,0.55,-1.2707,0.18,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1670_MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7","C2_Chemical_and_genetic_perturbations","C2_CGP_1670_MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7",18,0.8816,0.62,1,1.2425,0.16,0.45,-1.2076,0.21,0.51
"C2_Chemical_and_genetic_perturbations:C2_CGP_1226_STEGMEIER_PRE_MITOTIC_CELL_CYCLE_REGULATORS","C2_Chemical_and_genetic_perturbations","C2_CGP_1226_STEGMEIER_PRE_MITOTIC_CELL_CYCLE_REGULATORS",11,0.8816,0.61,1,0.8317,0.66,0.98,-0.9951,0.47,0.76
"GO_BP:510446_GO_0048339_PARAXIAL_MESODERM_DEVELOPMENT","GO_BP","510446_GO_0048339_PARAXIAL_MESODERM_DEVELOPMENT",15,0.8817,0.59,1,-0.6197,0.94,1,0.7894,0.75,1
"C7_Immunologic_signatures:C7_ALL_1660_GSE3982_MAC_VS_TH2_DN","C7_Immunologic_signatures","C7_ALL_1660_GSE3982_MAC_VS_TH2_DN",199,0.8819,0.88,0.97,1.0508,0.31,0.59,-1.4677,0,0.031
"GO_CC:504283_GO_0035098_ESC_E_Z_COMPLEX","GO_CC","504283_GO_0035098_ESC_E_Z_COMPLEX",16,0.8828,0.65,0.93,-0.5043,0.99,1,0.4784,1,1
"GO_CC:487103_GO_0000812_SWR1_COMPLEX","GO_CC","487103_GO_0000812_SWR1_COMPLEX",9,0.8829,0.59,0.94,0.7674,0.75,0.97,-0.7908,0.7,1
"C1_Positional:C1_ALL_114_CHR1Q42","C1_Positional","C1_ALL_114_CHR1Q42",95,0.883,0.77,0.92,0.9852,0.47,0.79,1.0528,0.35,0.71
"C1_Positional:C1_ALL_240_CHR2Q31","C1_Positional","C1_ALL_240_CHR2Q31",76,0.883,0.74,0.93,1.745,0.0022,0.14,0.7854,0.89,0.93
"GO_MF:490432_GO_0005168_NEUROTROPHIN_TRKA_RECEPTOR_BINDING","GO_MF","490432_GO_0005168_NEUROTROPHIN_TRKA_RECEPTOR_BINDING",5,0.8832,0.58,1,1.0623,0.41,0.83,0.8601,0.63,0.98
"GO_MF:495501_GO_0015238_DRUG_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495501_GO_0015238_DRUG_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",16,0.8832,0.64,1,-0.8005,0.74,1,1.1372,0.27,0.8
"GO_BP:515474_GO_0070544_HISTONE_H3_K36_DEMETHYLATION","GO_BP","515474_GO_0070544_HISTONE_H3_K36_DEMETHYLATION",7,0.8833,0.59,1,-0.8352,0.66,1,0.8809,0.6,0.95
"C7_Immunologic_signatures:C7_ALL_606_GSE17721_LPS_VS_PAM3CSK4_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_606_GSE17721_LPS_VS_PAM3CSK4_4H_BMDM_DN",199,0.8833,0.85,0.97,1.2779,0.037,0.12,0.6729,1,1
"C1_Positional:C1_ALL_109_CHR4Q26","C1_Positional","C1_ALL_109_CHR4Q26",22,0.8834,0.64,0.95,0.6175,0.96,1,-0.9171,0.58,0.96
"OMIM_gene:OMIM605889_PDZ_AND_LIM_DOMAIN_PROTEIN_3_PDLIM3","OMIM_gene","OMIM605889_PDZ_AND_LIM_DOMAIN_PROTEIN_3_PDLIM3",7,0.8837,0.58,1,1.4955,0.069,0.91,1.0764,0.38,1
"GO_BP:504598_GO_0035414_NEGATIVE_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS","GO_BP","504598_GO_0035414_NEGATIVE_REGULATION_OF_CATENIN_IMPORT_INTO_NUCLEUS",9,0.8838,0.62,1,-0.9142,0.56,1,-1.1196,0.33,0.76
"GO_BP:500354_GO_0031064_NEGATIVE_REGULATION_OF_HISTONE_DEACETYLATION","GO_BP","500354_GO_0031064_NEGATIVE_REGULATION_OF_HISTONE_DEACETYLATION",5,0.8841,0.58,1,-0.8383,0.68,1,-0.5242,0.97,1
"GO_CC:500166_GO_0030868_SMOOTH_ENDOPLASMIC_RETICULUM_MEMBRANE","GO_CC","500166_GO_0030868_SMOOTH_ENDOPLASMIC_RETICULUM_MEMBRANE",6,0.8842,0.59,0.94,1.059,0.39,0.71,1.1709,0.29,0.81
"GO_BP:487443_GO_0001504_NEUROTRANSMITTER_UPTAKE","GO_BP","487443_GO_0001504_NEUROTRANSMITTER_UPTAKE",14,0.8842,0.6,1,1.0303,0.43,0.97,-1.013,0.42,0.84
"GO_BP:516379_GO_0071455_CELLULAR_RESPONSE_TO_HYPEROXIA","GO_BP","516379_GO_0071455_CELLULAR_RESPONSE_TO_HYPEROXIA",7,0.8844,0.57,1,0.8956,0.59,1,1.5483,0.029,0.51
"KEGG_module:HSA_M00052_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHESIS_UMP_UDP_UTP_CDP_CTP","KEGG_module","HSA_M00052_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHESIS_UMP_UDP_UTP_CDP_CTP",12,0.8846,0.6,0.77,0.8238,0.71,0.93,-1.3289,0.12,0.5
"GO_BP:501667_GO_0032435_NEGATIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","501667_GO_0032435_NEGATIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",58,0.8846,0.69,1,1.3676,0.043,0.59,-0.773,0.9,1
"C1_Positional:C1_ALL_256_CHR6P24","C1_Positional","C1_ALL_256_CHR6P24",28,0.8848,0.67,0.96,1.2781,0.16,0.53,1.0615,0.34,0.7
"GO_MF:512414_GO_0051536_IRON_SULFUR_CLUSTER_BINDING","GO_MF","512414_GO_0051536_IRON_SULFUR_CLUSTER_BINDING",64,0.8854,0.7,1,1.7842,0,0.092,-0.9077,0.62,0.87
"GO_BP:508066_GO_0045721_NEGATIVE_REGULATION_OF_GLUCONEOGENESIS","GO_BP","508066_GO_0045721_NEGATIVE_REGULATION_OF_GLUCONEOGENESIS",11,0.8854,0.6,1,0.6394,0.92,1,-0.8683,0.65,0.95
"GO_MF:489988_GO_0004659_PRENYLTRANSFERASE_ACTIVITY","GO_MF","489988_GO_0004659_PRENYLTRANSFERASE_ACTIVITY",15,0.8855,0.61,1,1.2325,0.2,0.7,1.1323,0.28,0.8
"REACTOME:106547_REACT_7999_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND","REACTOME","106547_REACT_7999_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND",10,0.8857,0.6,0.92,1.413,0.091,0.21,-0.6122,0.93,1
"C1_Positional:C1_ALL_318_CHR14Q24","C1_Positional","C1_ALL_318_CHR14Q24",101,0.8866,0.73,0.97,0.7932,0.88,0.95,1.1144,0.24,0.73
"C7_Immunologic_signatures:C7_ALL_1203_GSE27786_CD8_TCELL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1203_GSE27786_CD8_TCELL_VS_NKCELL_UP",198,0.8868,0.82,0.97,1.1869,0.1,0.25,-0.9249,0.69,0.9
"GO_BP:501602_GO_0032367_INTRACELLULAR_CHOLESTEROL_TRANSPORT","GO_BP","501602_GO_0032367_INTRACELLULAR_CHOLESTEROL_TRANSPORT",8,0.8869,0.6,1,1.2731,0.18,0.71,1.4639,0.062,0.59
"GO_BP:505881_GO_0042775_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT","GO_BP","505881_GO_0042775_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT",52,0.887,0.71,1,2.37,0,4.6e-05,0.9812,0.48,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_1227_TESAR_ALK_TARGETS_HUMAN_ES_4D_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1227_TESAR_ALK_TARGETS_HUMAN_ES_4D_DN",6,0.8871,0.58,1,-0.9089,0.58,1,0.7966,0.71,1
"GO_MF:506248_GO_0043176_AMINE_BINDING","GO_MF","506248_GO_0043176_AMINE_BINDING",9,0.8871,0.61,1,1.2164,0.23,0.69,1.5826,0.042,0.36
"REACTOME:1127592_REACT_268431_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D_","REACTOME","1127592_REACT_268431_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D_",7,0.8872,0.58,0.92,0.9135,0.56,0.89,1.212,0.25,0.84
"REACTOME:105945_REACT_1470_MRNA_CAPPING","REACTOME","105945_REACT_1470_MRNA_CAPPING",29,0.8874,0.65,0.92,1.3789,0.052,0.24,0.8378,0.72,1
"GO_BP:502402_GO_0033182_REGULATION_OF_HISTONE_UBIQUITINATION","GO_BP","502402_GO_0033182_REGULATION_OF_HISTONE_UBIQUITINATION",8,0.8876,0.6,1,0.6233,0.93,1,0.7568,0.79,1
"KEGG_compound:C00255_RIBOFLAVIN_LACTOFLAVIN_7_8_DIMETHYL_10_RIBITYLISOALLOXAZINE_VITAMIN_B2","KEGG_compound","C00255_RIBOFLAVIN_LACTOFLAVIN_7_8_DIMETHYL_10_RIBITYLISOALLOXAZINE_VITAMIN_B2",6,0.8878,0.56,1,0.9701,0.49,1,0.604,0.93,1
"GO_BP:495095_GO_0014022_NEURAL_PLATE_ELONGATION","GO_BP","495095_GO_0014022_NEURAL_PLATE_ELONGATION",5,0.8879,0.59,1,0.8632,0.64,1,-0.9894,0.48,0.86
"C2_Chemical_and_genetic_perturbations:C2_CGP_619_NAGY_STAGA_COMPONENTS_HUMAN","C2_Chemical_and_genetic_perturbations","C2_CGP_619_NAGY_STAGA_COMPONENTS_HUMAN",15,0.888,0.59,1,-0.7145,0.85,1,-1.2368,0.19,0.49
"GO_MF:496578_GO_0016638_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS","GO_MF","496578_GO_0016638_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS",19,0.8882,0.62,1,-1.4786,0.055,0.59,-0.8448,0.69,0.93
"GO_BP:496102_GO_0015985_ENERGY_COUPLED_PROTON_TRANSPORT_DOWN_ELECTROCHEMICAL_GRADIENT","GO_BP","496102_GO_0015985_ENERGY_COUPLED_PROTON_TRANSPORT_DOWN_ELECTROCHEMICAL_GRADIENT",24,0.8883,0.65,1,1.9171,0.0022,0.032,0.659,0.94,1
"GO_BP:515464_GO_0070534_PROTEIN_K63_LINKED_UBIQUITINATION","GO_BP","515464_GO_0070534_PROTEIN_K63_LINKED_UBIQUITINATION",36,0.8892,0.63,1,1.1873,0.19,0.8,-1.4233,0.046,0.57
"GO_BP:496882_GO_0017062_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY","GO_BP","496882_GO_0017062_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY",5,0.8894,0.6,1,0.6751,0.85,1,-1.1274,0.35,0.76
"GO_MF:493977_GO_0009881_PHOTORECEPTOR_ACTIVITY","GO_MF","493977_GO_0009881_PHOTORECEPTOR_ACTIVITY",15,0.8902,0.57,1,-1.5942,0.025,0.48,-1.2892,0.16,0.59
"GO_BP:491859_GO_0007031_PEROXISOME_ORGANIZATION","GO_BP","491859_GO_0007031_PEROXISOME_ORGANIZATION",36,0.8903,0.66,1,1.1182,0.27,0.88,-0.8451,0.7,0.96
"OMIM_gene:OMIM148041_KERATIN_6A_KRT6A","OMIM_gene","OMIM148041_KERATIN_6A_KRT6A",5,0.8903,0.59,1,1.0486,0.41,1,0.6661,0.87,1
"KEGG_pathway:HSA00450_SELENOCOMPOUND_METABOLISM","KEGG_pathway","HSA00450_SELENOCOMPOUND_METABOLISM",17,0.8905,0.6,0.83,1.1953,0.22,0.57,-1.0687,0.34,0.57
"C2_Chemical_and_genetic_perturbations:C2_CGP_2238_ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2238_ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP",169,0.8905,0.79,1,1.8888,0,0.022,-0.7149,0.99,0.98
"KEGG_module:HSA_M00101_CHOLESTEROL_BIOSYNTHESIS_SQUALENE_2_3_EPOXIDE_CHOLESTEROL","KEGG_module","HSA_M00101_CHOLESTEROL_BIOSYNTHESIS_SQUALENE_2_3_EPOXIDE_CHOLESTEROL",11,0.8906,0.6,0.78,0.9886,0.49,0.9,-1.2544,0.19,0.49
"GO_BP:510595_GO_0048524_POSITIVE_REGULATION_OF_VIRAL_PROCESS","GO_BP","510595_GO_0048524_POSITIVE_REGULATION_OF_VIRAL_PROCESS",102,0.8911,0.75,1,1.7528,0,0.14,0.6733,0.99,1
"GO_BP:513629_GO_0060071_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY","GO_BP","513629_GO_0060071_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY",21,0.8911,0.61,1,0.9029,0.62,1,0.9964,0.45,0.86
"GO_BP:497176_GO_0018205_PEPTIDYL_LYSINE_MODIFICATION","GO_BP","497176_GO_0018205_PEPTIDYL_LYSINE_MODIFICATION",211,0.8915,0.8,1,-0.65,1,1,-1.0624,0.29,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_3090_FIGUEROA_AML_METHYLATION_CLUSTER_7_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3090_FIGUEROA_AML_METHYLATION_CLUSTER_7_UP",115,0.8916,0.77,1,1.1601,0.15,0.54,1.0605,0.32,0.9
"OMIM_gene:OMIM601597_B_CELL_TRANSLOCATION_GENE_2_BTG2","OMIM_gene","OMIM601597_B_CELL_TRANSLOCATION_GENE_2_BTG2",5,0.892,0.56,1,1.0465,0.4,1,0.6723,0.86,1
"REACTOME:106447_REACT_13695_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1","REACTOME","106447_REACT_13695_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1",6,0.8921,0.56,0.91,0.5933,0.93,1,1.2681,0.2,0.77
"C4_Cancer_gene_neighborhoods:C4_CGN_272_GCM_UBE2N","C4_Cancer_gene_neighborhoods","C4_CGN_272_GCM_UBE2N",155,0.8922,0.82,0.91,0.6264,1,1,-0.6775,1,1
"REACTOME:105771_REACT_9003_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21","REACTOME","105771_REACT_9003_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21",56,0.8922,0.7,0.91,2.1805,0,0.00019,-0.7046,0.95,1
"GO_BP:487022_GO_0000725_RECOMBINATIONAL_REPAIR","GO_BP","487022_GO_0000725_RECOMBINATIONAL_REPAIR",71,0.8928,0.69,1,0.7872,0.89,1,-0.7501,0.92,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2633_MEISSNER_ES_ICP_WITH_H3K4ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2633_MEISSNER_ES_ICP_WITH_H3K4ME3",32,0.893,0.64,1,-0.8091,0.78,1,-0.6891,0.93,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_947_PUJANA_XPRSS_INT_NETWORK","C2_Chemical_and_genetic_perturbations","C2_CGP_947_PUJANA_XPRSS_INT_NETWORK",168,0.8931,0.82,1,1.4336,0.0095,0.27,-1.4888,0.0042,0.31
"GO_BP:1129266_GO_0090611_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY","GO_BP","1129266_GO_0090611_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY",5,0.8935,0.56,1,1.3879,0.13,0.57,1.1747,0.29,0.72
"KEGG_compound:C02415_HISTONE_L_LYSINE","KEGG_compound","C02415_HISTONE_L_LYSINE",26,0.894,0.64,1,-1.3121,0.13,0.6,-0.9537,0.52,0.71
"REACTOME:119530_REACT_19226_ACTIVATION_OF_RAC","REACTOME","119530_REACT_19226_ACTIVATION_OF_RAC",13,0.894,0.61,0.91,0.9858,0.49,0.77,-0.9575,0.5,0.9
"GO_BP:518583_GO_0097033_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III_BIOGENESIS","GO_BP","518583_GO_0097033_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III_BIOGENESIS",5,0.8942,0.56,1,0.6775,0.86,1,-1.1439,0.31,0.74
"GO_BP:501446_GO_0032211_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE","GO_BP","501446_GO_0032211_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE",6,0.8944,0.56,1,-1.0263,0.45,0.98,-0.4013,1,1
"GO_BP:515861_GO_0070934_CRD_MEDIATED_MRNA_STABILIZATION","GO_BP","515861_GO_0070934_CRD_MEDIATED_MRNA_STABILIZATION",5,0.8944,0.54,1,1.0363,0.43,0.96,0.5894,0.91,1
"REACTOME:105755_REACT_2137_MITOTIC_SPINDLE_CHECKPOINT","REACTOME","105755_REACT_2137_MITOTIC_SPINDLE_CHECKPOINT",19,0.8944,0.61,0.91,1.2743,0.14,0.35,-0.617,0.95,1
"GO_BP:513827_GO_0060271_CILIUM_MORPHOGENESIS","GO_BP","513827_GO_0060271_CILIUM_MORPHOGENESIS",168,0.8951,0.84,1,-0.7951,0.92,1,-1.2469,0.056,0.68
"C7_Immunologic_signatures:C7_ALL_1579_GSE3982_DC_VS_MAC_LPS_STIM_UP","C7_Immunologic_signatures","C7_ALL_1579_GSE3982_DC_VS_MAC_LPS_STIM_UP",195,0.8964,0.78,0.95,1.389,0,0.041,-0.8439,0.87,1
"C3_MicroRNA_targets:C3_MIR_108_CACGTTT_MIR_302A","C3_MicroRNA_targets","C3_MIR_108_CACGTTT_MIR_302A",30,0.8966,0.62,1,0.6807,0.94,1,-0.7812,0.8,1
"GO_BP:491138_GO_0006166_PURINE_RIBONUCLEOSIDE_SALVAGE","GO_BP","491138_GO_0006166_PURINE_RIBONUCLEOSIDE_SALVAGE",5,0.8971,0.57,1,1.091,0.38,0.92,-1.7217,0.004,0.61
"OMIM_gene:OMIM609221_N_ACETYLTRANSFERASE_10_NAT10","OMIM_gene","OMIM609221_N_ACETYLTRANSFERASE_10_NAT10",7,0.8974,0.58,1,1.5323,0.055,1,1.0646,0.38,1
"C7_Immunologic_signatures:C7_ALL_114_GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN","C7_Immunologic_signatures","C7_ALL_114_GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN",197,0.8974,0.84,0.95,1.2978,0.038,0.11,-1.0453,0.35,0.62
"GO_MF:512722_GO_0051864_HISTONE_DEMETHYLASE_ACTIVITY_H3_K36_SPECIFIC_","GO_MF","512722_GO_0051864_HISTONE_DEMETHYLASE_ACTIVITY_H3_K36_SPECIFIC_",7,0.8975,0.59,1,-0.8309,0.67,1,0.8645,0.63,0.98
"GO_BP:494613_GO_0010544_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION","GO_BP","494613_GO_0010544_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION",15,0.8976,0.57,1,1.0404,0.4,0.96,1.445,0.062,0.59
"GO_BP:512179_GO_0051294_ESTABLISHMENT_OF_SPINDLE_ORIENTATION","GO_BP","512179_GO_0051294_ESTABLISHMENT_OF_SPINDLE_ORIENTATION",21,0.8983,0.6,1,0.732,0.86,1,0.9429,0.53,0.91
"GO_BP:487611_GO_0001708_CELL_FATE_SPECIFICATION","GO_BP","487611_GO_0001708_CELL_FATE_SPECIFICATION",61,0.8985,0.67,1,1.5217,0.0044,0.38,1.0273,0.36,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_2017_YANG_MUC2_TARGETS_DUODENUM_6MO_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2017_YANG_MUC2_TARGETS_DUODENUM_6MO_UP",6,0.8987,0.55,1,0.6993,0.83,1,-0.9577,0.49,0.81
"GO_BP:504556_GO_0035372_PROTEIN_LOCALIZATION_TO_MICROTUBULE","GO_BP","504556_GO_0035372_PROTEIN_LOCALIZATION_TO_MICROTUBULE",8,0.8987,0.55,1,1.0782,0.34,0.93,1.0075,0.46,0.85
"GO_BP:491400_GO_0018342_PROTEIN_PRENYLATION","GO_BP","491400_GO_0018342_PROTEIN_PRENYLATION",10,0.8993,0.57,1,0.9573,0.48,1,1.1323,0.31,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_1223_NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1223_NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON",17,0.8993,0.61,1,-1.2887,0.15,0.7,-0.7349,0.81,0.98
"GO_BP:493405_GO_0009209_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493405_GO_0009209_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",16,0.8994,0.56,1,-0.7306,0.83,1,-1.1075,0.32,0.77
"C7_Immunologic_signatures:C7_ALL_1193_GSE27786_CD4_TCELL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1193_GSE27786_CD4_TCELL_VS_NKCELL_UP",197,0.8995,0.85,0.95,1.1036,0.21,0.43,-0.9405,0.61,0.87
"GO_MF:492834_GO_0008565_PROTEIN_TRANSPORTER_ACTIVITY","GO_MF","492834_GO_0008565_PROTEIN_TRANSPORTER_ACTIVITY",81,0.8997,0.7,1,1.8208,0,0.064,-0.6469,1,1
"GO_MF:496656_GO_0016742_HYDROXYMETHYL_FORMYL_AND_RELATED_TRANSFERASE_ACTIVITY","GO_MF","496656_GO_0016742_HYDROXYMETHYL_FORMYL_AND_RELATED_TRANSFERASE_ACTIVITY",8,0.9001,0.58,1,0.8277,0.67,1,-0.8016,0.71,0.96
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_130_BIOCARTA_NUCLEARRS_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_130_BIOCARTA_NUCLEARRS_PATHWAY",14,0.9003,0.6,1,0.9554,0.5,0.83,1.1533,0.28,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3084_FIGUEROA_AML_METHYLATION_CLUSTER_4_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3084_FIGUEROA_AML_METHYLATION_CLUSTER_4_UP",110,0.9004,0.73,1,1.0823,0.28,0.66,0.9534,0.57,0.99
"KEGG_compound:C00239_DCMP_DEOXYCYTIDYLIC_ACID_DEOXYCYTIDINE_MONOPHOSPHATE_DEOXYCYTIDYLATE_2_DEOXYCYTIDINE_5_MONOPHOSPHATE","KEGG_compound","C00239_DCMP_DEOXYCYTIDYLIC_ACID_DEOXYCYTIDINE_MONOPHOSPHATE_DEOXYCYTIDYLATE_2_DEOXYCYTIDINE_5_MONOPHOSPHATE",14,0.9004,0.58,1,1.2781,0.16,0.79,-1.3283,0.11,0.34
"C1_Positional:C1_ALL_320_CHR15Q21","C1_Positional","C1_ALL_320_CHR15Q21",88,0.9005,0.7,0.95,0.879,0.73,0.89,0.9766,0.51,0.78
"C7_Immunologic_signatures:C7_ALL_132_GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN","C7_Immunologic_signatures","C7_ALL_132_GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN",199,0.9005,0.85,0.95,0.9649,0.56,0.85,-0.7292,1,1
"C7_Immunologic_signatures:C7_ALL_98_GSE11924_TFH_VS_TH2_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_98_GSE11924_TFH_VS_TH2_CD4_TCELL_DN",198,0.9006,0.84,0.95,1.44,0.0047,0.025,0.9258,0.67,1
"GO_BP:508587_GO_0046322_NEGATIVE_REGULATION_OF_FATTY_ACID_OXIDATION","GO_BP","508587_GO_0046322_NEGATIVE_REGULATION_OF_FATTY_ACID_OXIDATION",7,0.9013,0.59,1,0.8815,0.62,1,-0.7641,0.76,1
"GO_BP:495181_GO_0014733_REGULATION_OF_SKELETAL_MUSCLE_ADAPTATION","GO_BP","495181_GO_0014733_REGULATION_OF_SKELETAL_MUSCLE_ADAPTATION",6,0.9013,0.57,1,-0.7747,0.76,1,-0.8866,0.61,0.94
"GO_BP:493404_GO_0009208_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS","GO_BP","493404_GO_0009208_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS",17,0.9015,0.57,1,-0.7292,0.86,1,-1.1233,0.31,0.76
"C4_Cancer_modules:C4_CM_172_MODULE_182","C4_Cancer_modules","C4_CM_172_MODULE_182",99,0.9015,0.72,1,0.779,0.92,0.98,-0.5168,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2482_TOOKER_GEMCITABINE_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2482_TOOKER_GEMCITABINE_RESISTANCE_UP",79,0.9017,0.73,1,1.6877,0.0044,0.09,-0.714,0.97,0.98
"GO_MF:499373_GO_0022824_TRANSMITTER_GATED_ION_CHANNEL_ACTIVITY","GO_MF","499373_GO_0022824_TRANSMITTER_GATED_ION_CHANNEL_ACTIVITY",8,0.9019,0.58,1,-1.1637,0.27,0.8,1.0829,0.37,0.81
"C7_Immunologic_signatures:C7_ALL_176_GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN","C7_Immunologic_signatures","C7_ALL_176_GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN",198,0.9019,0.78,0.95,1.8548,0,0,-1.2281,0.063,0.23
"GO_MF:511127_GO_0050136_NADH_DEHYDROGENASE_QUINONE_ACTIVITY","GO_MF","511127_GO_0050136_NADH_DEHYDROGENASE_QUINONE_ACTIVITY",39,0.9022,0.6,1,2.3412,0,0.00018,0.8633,0.7,0.98
"C3_MicroRNA_targets:C3_MIR_215_ATGCACG_MIR_517B","C3_MicroRNA_targets","C3_MIR_215_ATGCACG_MIR_517B",20,0.9023,0.6,1,-0.5727,0.99,1,0.6789,0.92,1
"GO_CC:752924_GO_0097425_SMOOTH_ENDOPLASMIC_RETICULUM_PART","GO_CC","752924_GO_0097425_SMOOTH_ENDOPLASMIC_RETICULUM_PART",6,0.903,0.58,0.89,1.0449,0.41,0.72,1.1785,0.26,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_764_NEBEN_AML_WITH_FLT3_OR_NRAS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_764_NEBEN_AML_WITH_FLT3_OR_NRAS_UP",8,0.903,0.57,1,1.1877,0.25,0.51,1.2185,0.23,0.75
"GO_BP:517048_GO_0072132_MESENCHYME_MORPHOGENESIS","GO_BP","517048_GO_0072132_MESENCHYME_MORPHOGENESIS",28,0.9032,0.62,1,0.9029,0.61,1,1.0674,0.36,0.79
"GO_BP:512337_GO_0051459_REGULATION_OF_CORTICOTROPIN_SECRETION","GO_BP","512337_GO_0051459_REGULATION_OF_CORTICOTROPIN_SECRETION",5,0.9039,0.58,1,-0.7122,0.82,1,-1.1089,0.38,0.77
"GO_BP:487810_GO_0001919_REGULATION_OF_RECEPTOR_RECYCLING","GO_BP","487810_GO_0001919_REGULATION_OF_RECEPTOR_RECYCLING",18,0.9042,0.56,1,1.2189,0.19,0.77,-1.0424,0.38,0.82
"OMIM_gene:OMIM601184_DNAJ_HSP40_HOMOLOG_SUBFAMILY_C_MEMBER_3_DNAJC3","OMIM_gene","OMIM601184_DNAJ_HSP40_HOMOLOG_SUBFAMILY_C_MEMBER_3_DNAJC3",5,0.9042,0.53,1,1.2934,0.18,0.74,0.8485,0.67,1
"GO_BP:752432_GO_0086066_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_COMMUNICATION","GO_BP","752432_GO_0086066_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_COMMUNICATION",9,0.9061,0.57,1,0.9796,0.49,1,-0.8277,0.68,0.97
"GO_BP:1129331_GO_1903504_REGULATION_OF_MITOTIC_SPINDLE_CHECKPOINT","GO_BP","1129331_GO_1903504_REGULATION_OF_MITOTIC_SPINDLE_CHECKPOINT",11,0.9062,0.59,1,1.0581,0.37,0.94,1.2069,0.22,0.72
"GO_BP:487837_GO_0001947_HEART_LOOPING","GO_BP","487837_GO_0001947_HEART_LOOPING",52,0.9063,0.67,1,-0.86,0.71,1,1.1597,0.21,0.73
"GO_BP:487020_GO_0000723_TELOMERE_MAINTENANCE","GO_BP","487020_GO_0000723_TELOMERE_MAINTENANCE",75,0.9064,0.7,1,0.9579,0.54,1,-1.0382,0.36,0.82
"GO_BP:488997_GO_0003203_ENDOCARDIAL_CUSHION_MORPHOGENESIS","GO_BP","488997_GO_0003203_ENDOCARDIAL_CUSHION_MORPHOGENESIS",17,0.9066,0.59,1,0.6628,0.92,1,1.0882,0.32,0.77
"C4_Cancer_gene_neighborhoods:C4_CGN_393_GNF2_PPP6C","C4_Cancer_gene_neighborhoods","C4_CGN_393_GNF2_PPP6C",39,0.9066,0.64,0.87,2.2053,0,2.2e-05,0.9964,0.47,0.81
"REACTOME:105664_REACT_330_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS","REACTOME","105664_REACT_330_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS",8,0.907,0.56,0.88,0.9004,0.58,0.91,0.9615,0.51,1
"KEGG_compound:C00042_SUCCINATE_SUCCINIC_ACID_BUTANEDIONIC_ACID_ETHYLENESUCCINIC_ACID","KEGG_compound","C00042_SUCCINATE_SUCCINIC_ACID_BUTANEDIONIC_ACID_ETHYLENESUCCINIC_ACID",20,0.9077,0.58,1,0.8326,0.69,1,-1.5845,0.024,0.16
"GO_BP:947904_GO_0098586_CELLULAR_RESPONSE_TO_VIRUS","GO_BP","947904_GO_0098586_CELLULAR_RESPONSE_TO_VIRUS",10,0.9079,0.6,1,1.5798,0.041,0.31,0.7967,0.72,1
"GO_BP:491422_GO_0006526_ARGININE_BIOSYNTHETIC_PROCESS","GO_BP","491422_GO_0006526_ARGININE_BIOSYNTHETIC_PROCESS",6,0.908,0.54,1,-0.8197,0.68,1,-1.6631,0.01,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_719_FARMER_BREAST_CANCER_CLUSTER_6","C2_Chemical_and_genetic_perturbations","C2_CGP_719_FARMER_BREAST_CANCER_CLUSTER_6",16,0.908,0.59,1,-0.7445,0.84,1,-1.3529,0.1,0.39
"GO_BP:518709_GO_2000060_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS","GO_BP","518709_GO_2000060_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS",87,0.9081,0.7,1,1.8643,0,0.056,-0.7211,0.97,0.99
"C7_Immunologic_signatures:C7_ALL_1894_GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN","C7_Immunologic_signatures","C7_ALL_1894_GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN",176,0.9081,0.77,0.94,1.2592,0.063,0.14,1.1254,0.18,0.94
"GO_BP:518406_GO_0090266_REGULATION_OF_MITOTIC_CELL_CYCLE_SPINDLE_ASSEMBLY_CHECKPOINT","GO_BP","518406_GO_0090266_REGULATION_OF_MITOTIC_CELL_CYCLE_SPINDLE_ASSEMBLY_CHECKPOINT",11,0.9081,0.58,1,1.0601,0.39,0.94,1.2076,0.24,0.71
"GO_BP:486754_GO_0000236_MITOTIC_PROMETAPHASE","GO_BP","486754_GO_0000236_MITOTIC_PROMETAPHASE",101,0.9084,0.71,1,1.4887,0.0096,0.43,-1.1453,0.2,0.74
"C6_Oncogenic_signatures:C6_ALL_37_BCAT_100_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_37_BCAT_100_UP_V1_DN",39,0.9089,0.66,1,-1.3045,0.1,0.39,0.8957,0.64,0.76
"GO_BP:508605_GO_0046341_CDP_DIACYLGLYCEROL_METABOLIC_PROCESS","GO_BP","508605_GO_0046341_CDP_DIACYLGLYCEROL_METABOLIC_PROCESS",14,0.9093,0.58,1,1.2134,0.23,0.77,-0.639,0.94,1
"C4_Cancer_gene_neighborhoods:C4_CGN_107_MORF_GMPS","C4_Cancer_gene_neighborhoods","C4_CGN_107_MORF_GMPS",53,0.9094,0.62,0.87,2.0793,0,0.00016,-0.6017,1,1
"C7_Immunologic_signatures:C7_ALL_916_GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN","C7_Immunologic_signatures","C7_ALL_916_GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN",199,0.9095,0.79,0.94,0.805,0.97,1,-1.1517,0.15,0.36
"GO_CC:500189_GO_0030894_REPLISOME","GO_CC","500189_GO_0030894_REPLISOME",29,0.9095,0.6,0.88,1.2378,0.16,0.48,-0.9214,0.54,1
"GO_BP:513707_GO_0060149_NEGATIVE_REGULATION_OF_POSTTRANSCRIPTIONAL_GENE_SILENCING","GO_BP","513707_GO_0060149_NEGATIVE_REGULATION_OF_POSTTRANSCRIPTIONAL_GENE_SILENCING",6,0.9097,0.53,1,-0.7842,0.72,1,0.7228,0.78,1
"GO_BP:499076_GO_0021796_CEREBRAL_CORTEX_REGIONALIZATION","GO_BP","499076_GO_0021796_CEREBRAL_CORTEX_REGIONALIZATION",7,0.9097,0.57,1,-0.6418,0.91,1,1.0858,0.37,0.77
"GO_BP:501604_GO_0032369_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT","GO_BP","501604_GO_0032369_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT",25,0.9098,0.61,1,1.2793,0.14,0.7,1.0325,0.41,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_2961_KAMMINGA_SENESCENCE","C2_Chemical_and_genetic_perturbations","C2_CGP_2961_KAMMINGA_SENESCENCE",39,0.9098,0.59,1,-0.9949,0.46,1,0.8106,0.79,1
"GO_BP:508333_GO_0046036_CTP_METABOLIC_PROCESS","GO_BP","508333_GO_0046036_CTP_METABOLIC_PROCESS",15,0.91,0.58,1,-0.7157,0.86,1,-1.1382,0.28,0.75
"GO_CC:507636_GO_0045271_RESPIRATORY_CHAIN_COMPLEX_I","GO_CC","507636_GO_0045271_RESPIRATORY_CHAIN_COMPLEX_I",41,0.9101,0.61,0.89,2.4512,0,0,0.8691,0.72,1
"GO_CC:500188_GO_0030893_MEIOTIC_COHESIN_COMPLEX","GO_CC","500188_GO_0030893_MEIOTIC_COHESIN_COMPLEX",7,0.9101,0.53,0.89,0.6823,0.84,0.98,0.9313,0.55,1
"GO_BP:486565_GO_0000012_SINGLE_STRAND_BREAK_REPAIR","GO_BP","486565_GO_0000012_SINGLE_STRAND_BREAK_REPAIR",8,0.9102,0.54,1,1.1169,0.33,0.88,1.0192,0.47,0.84
"GO_CC:490861_GO_0005845_MRNA_CAP_BINDING_COMPLEX","GO_CC","490861_GO_0005845_MRNA_CAP_BINDING_COMPLEX",12,0.9112,0.57,0.89,1.0302,0.39,0.74,0.8159,0.67,1
"C3_TF_targets:C3_TFT_533_WCTCNATGGY_UNKNOWN","C3_TF_targets","C3_TFT_533_WCTCNATGGY_UNKNOWN",82,0.9116,0.65,1,1.3005,0.063,0.49,0.8578,0.8,1
"GO_CC:506632_GO_0043601_NUCLEAR_REPLISOME","GO_CC","506632_GO_0043601_NUCLEAR_REPLISOME",29,0.9118,0.6,0.89,1.2587,0.13,0.45,-0.9354,0.56,1
"GO_BP:488374_GO_0002501_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_PROTEIN_COMPLEX","GO_BP","488374_GO_0002501_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_PROTEIN_COMPLEX",5,0.9121,0.55,1,-1.1543,0.3,0.92,-0.6077,0.91,1
"KEGG_module:HSA_M00065_GPI_ANCHOR_BIOSYNTHESIS_CORE_OLIGOSACCHARIDE","KEGG_module","HSA_M00065_GPI_ANCHOR_BIOSYNTHESIS_CORE_OLIGOSACCHARIDE",8,0.9134,0.55,0.76,0.8353,0.66,0.92,0.8378,0.67,1
"REACTOME:105845_REACT_2156_CLEAVAGE_OF_THE_DAMAGED_PYRIMIDINE","REACTOME","105845_REACT_2156_CLEAVAGE_OF_THE_DAMAGED_PYRIMIDINE",8,0.9136,0.56,0.87,1.1507,0.29,0.51,-0.8659,0.63,0.97
"GO_BP:491242_GO_0006278_RNA_DEPENDENT_DNA_REPLICATION","GO_BP","491242_GO_0006278_RNA_DEPENDENT_DNA_REPLICATION",14,0.9141,0.55,1,1.1153,0.32,0.88,-0.6453,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2283_BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2283_BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN",22,0.9144,0.58,1,-0.7203,0.86,1,-1.1977,0.21,0.52
"GO_BP:509011_GO_0046784_VIRAL_MRNA_EXPORT_FROM_HOST_CELL_NUCLEUS","GO_BP","509011_GO_0046784_VIRAL_MRNA_EXPORT_FROM_HOST_CELL_NUCLEUS",8,0.9145,0.54,1,0.9077,0.57,1,-0.5273,0.98,1
"GO_BP:513705_GO_0060147_REGULATION_OF_POSTTRANSCRIPTIONAL_GENE_SILENCING","GO_BP","513705_GO_0060147_REGULATION_OF_POSTTRANSCRIPTIONAL_GENE_SILENCING",12,0.9146,0.59,1,-1.0585,0.38,0.96,-1.0732,0.38,0.8
"C1_Positional:C1_ALL_260_CHR2P16","C1_Positional","C1_ALL_260_CHR2P16",36,0.9147,0.62,0.92,0.4597,1,1,-0.855,0.71,0.99
"KEGG_compound:C05335_L_SELENOMETHIONINE","KEGG_compound","C05335_L_SELENOMETHIONINE",7,0.9148,0.57,1,0.8548,0.64,1,-1.0212,0.45,0.63
"REACTOME:1183562_REACT_355218_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING","REACTOME","1183562_REACT_355218_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING",27,0.9149,0.58,0.87,1.1828,0.2,0.46,0.8931,0.61,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_943_BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION","C2_Chemical_and_genetic_perturbations","C2_CGP_943_BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION",13,0.915,0.58,1,-0.5861,0.97,1,0.8891,0.59,1
"GO_BP:517086_GO_0072170_METANEPHRIC_TUBULE_DEVELOPMENT","GO_BP","517086_GO_0072170_METANEPHRIC_TUBULE_DEVELOPMENT",18,0.9152,0.56,1,-0.8648,0.65,1,1.3289,0.12,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_3349_HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3349_HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP",19,0.9153,0.57,1,1.2577,0.18,0.43,-0.6209,0.95,0.99
"GO_BP:510605_GO_0048536_SPLEEN_DEVELOPMENT","GO_BP","510605_GO_0048536_SPLEEN_DEVELOPMENT",35,0.9157,0.61,1,0.875,0.66,1,0.6914,0.95,1
"GO_BP:812231_GO_1902108_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS","GO_BP","812231_GO_1902108_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS",18,0.9158,0.59,1,1.4232,0.076,0.53,-1.0963,0.32,0.78
"C7_Immunologic_signatures:C7_ALL_1232_GSE27786_NEUTROPHIL_VS_MONO_MAC_DN","C7_Immunologic_signatures","C7_ALL_1232_GSE27786_NEUTROPHIL_VS_MONO_MAC_DN",198,0.916,0.77,0.92,1.5268,0,0.0086,-0.9191,0.69,0.92
"GO_BP:491948_GO_0007135_MEIOSIS_II","GO_BP","491948_GO_0007135_MEIOSIS_II",5,0.916,0.54,1,-0.679,0.85,1,-1.1706,0.3,0.73
"REACTOME:161009_REACT_22329_NRCAM_INTERACTIONS","REACTOME","161009_REACT_22329_NRCAM_INTERACTIONS",7,0.916,0.55,0.87,-1.0675,0.37,0.91,-0.9982,0.45,0.84
"C7_Immunologic_signatures:C7_ALL_1370_GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1370_GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN",199,0.9162,0.74,0.92,1.031,0.33,0.64,-0.9909,0.47,0.74
"GO_BP:512316_GO_0051438_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY","GO_BP","512316_GO_0051438_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY",104,0.9163,0.7,1,1.9677,0,0.018,-0.7242,0.98,0.99
"C7_Immunologic_signatures:C7_ALL_1741_GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1741_GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP",168,0.9164,0.74,0.93,1.8211,0,3.2e-05,-1.2455,0.073,0.2
"GO_BP:507544_GO_0045161_NEURONAL_ION_CHANNEL_CLUSTERING","GO_BP","507544_GO_0045161_NEURONAL_ION_CHANNEL_CLUSTERING",12,0.9164,0.56,1,-1.3011,0.16,0.89,-0.6997,0.87,0.99
"GO_BP:505569_GO_0042428_SEROTONIN_METABOLIC_PROCESS","GO_BP","505569_GO_0042428_SEROTONIN_METABOLIC_PROCESS",11,0.9165,0.54,1,-0.8847,0.6,1,-0.8391,0.67,0.97
"KEGG_enzyme:2.3.1.48_HISTONE_ACETYLTRANSFERASE_NUCLEOSOME_HISTONE_ACETYLTRANSFERASE_HISTONE_ACETOKINASE_HISTONE_ACETYLASE_HISTONE_TRANSACETYLASE","KEGG_enzyme","2.3.1.48_HISTONE_ACETYLTRANSFERASE_NUCLEOSOME_HISTONE_ACETYLTRANSFERASE_HISTONE_ACETOKINASE_HISTONE_ACETYLASE_HISTONE_TRANSACETYLASE",18,0.9165,0.56,0.75,0.7143,0.86,1,0.9108,0.6,0.78
"GO_MF:492520_GO_0008172_S_METHYLTRANSFERASE_ACTIVITY","GO_MF","492520_GO_0008172_S_METHYLTRANSFERASE_ACTIVITY",7,0.9167,0.53,1,-0.7976,0.71,1,-1.1562,0.3,0.63
"GO_CC:490860_GO_0005844_POLYSOME","GO_CC","490860_GO_0005844_POLYSOME",33,0.9167,0.6,0.89,1.2613,0.13,0.45,-0.8518,0.71,1
"GO_MF:492813_GO_0061133_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY","GO_MF","492813_GO_0061133_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY",5,0.9168,0.52,1,1.4041,0.11,0.48,0.5757,0.93,1
"GO_BP:501439_GO_0032204_REGULATION_OF_TELOMERE_MAINTENANCE","GO_BP","501439_GO_0032204_REGULATION_OF_TELOMERE_MAINTENANCE",16,0.917,0.58,1,0.5703,0.96,1,0.508,1,1
"C7_Immunologic_signatures:C7_ALL_1155_GSE27786_LSK_VS_ERYTHROBLAST_UP","C7_Immunologic_signatures","C7_ALL_1155_GSE27786_LSK_VS_ERYTHROBLAST_UP",200,0.917,0.81,0.93,1.3256,0.015,0.08,-0.8972,0.75,0.95
"GO_CC:500257_GO_0030964_NADH_DEHYDROGENASE_COMPLEX","GO_CC","500257_GO_0030964_NADH_DEHYDROGENASE_COMPLEX",41,0.9172,0.6,0.89,2.5509,0,0,0.8653,0.71,1
"GO_BP:500347_GO_0031057_NEGATIVE_REGULATION_OF_HISTONE_MODIFICATION","GO_BP","500347_GO_0031057_NEGATIVE_REGULATION_OF_HISTONE_MODIFICATION",34,0.9176,0.61,1,1.0212,0.41,0.97,-0.7248,0.91,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_894_YANG_BREAST_CANCER_ESR1_BULK_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_894_YANG_BREAST_CANCER_ESR1_BULK_UP",27,0.9178,0.57,1,1.0146,0.4,0.78,0.636,0.96,1
"GO_CC:503720_GO_0034518_RNA_CAP_BINDING_COMPLEX","GO_CC","503720_GO_0034518_RNA_CAP_BINDING_COMPLEX",12,0.918,0.55,0.89,1.0188,0.43,0.75,0.7969,0.73,1
"GO_BP:500351_GO_0031061_NEGATIVE_REGULATION_OF_HISTONE_METHYLATION","GO_BP","500351_GO_0031061_NEGATIVE_REGULATION_OF_HISTONE_METHYLATION",13,0.9183,0.56,1,-0.6364,0.95,1,0.5359,0.98,1
"GO_CC:490782_GO_0005747_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I","GO_CC","490782_GO_0005747_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I",41,0.9183,0.58,0.9,2.5413,0,0,0.8568,0.68,1
"C7_Immunologic_signatures:C7_ALL_392_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_392_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN",199,0.9189,0.79,0.93,1.8801,0,0,-1.0566,0.31,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_1281_SCHUHMACHER_MYC_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1281_SCHUHMACHER_MYC_TARGETS_DN",7,0.9191,0.51,1,1.1263,0.31,0.59,0.8885,0.62,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2100_TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2100_TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN",6,0.9191,0.53,1,-1.1418,0.32,0.86,-1.6408,0.024,0.22
"GO_BP:505879_GO_0042773_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT","GO_BP","505879_GO_0042773_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT",52,0.9192,0.61,1,2.4193,0,0,0.9973,0.44,0.86
"KEGG_module:HSA_M00680_TGF_BETA_SIGNALING","KEGG_module","HSA_M00680_TGF_BETA_SIGNALING",8,0.9192,0.56,0.76,-0.6815,0.88,1,0.5966,0.92,1
"GO_BP:491336_GO_0006417_REGULATION_OF_TRANSLATION","GO_BP","491336_GO_0006417_REGULATION_OF_TRANSLATION",272,0.9192,0.75,1,1.5135,0,0.39,-1.1142,0.17,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2526_NUTT_GBM_VS_AO_GLIOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2526_NUTT_GBM_VS_AO_GLIOMA_DN",45,0.9197,0.61,1,2.1547,0,0.0011,0.5633,1,1
"OMIM_gene:OMIM176820_KALLIKREIN_RELATED_PEPTIDASE_3_KLK3","OMIM_gene","OMIM176820_KALLIKREIN_RELATED_PEPTIDASE_3_KLK3",7,0.9197,0.53,1,1.0945,0.35,1,-0.9231,0.53,1
"REACTOME:833819_REACT_163993_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN","REACTOME","833819_REACT_163993_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN",14,0.9201,0.56,0.86,0.9653,0.52,0.8,-1.0482,0.39,0.78
"GO_BP:492404_GO_0050812_REGULATION_OF_ACYL_COA_BIOSYNTHETIC_PROCESS","GO_BP","492404_GO_0050812_REGULATION_OF_ACYL_COA_BIOSYNTHETIC_PROCESS",13,0.9203,0.55,1,1.4227,0.093,0.53,-1.184,0.23,0.73
"GO_BP:494037_GO_0009948_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION","GO_BP","494037_GO_0009948_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION",45,0.9204,0.63,1,-1.1467,0.22,0.93,0.9581,0.53,0.9
"GO_BP:491712_GO_0015810_ASPARTATE_TRANSPORT","GO_BP","491712_GO_0015810_ASPARTATE_TRANSPORT",7,0.9205,0.54,1,-0.6893,0.85,1,0.6924,0.86,1
"GO_BP:513631_GO_0060073_MICTURITION","GO_BP","513631_GO_0060073_MICTURITION",7,0.9208,0.53,1,0.8134,0.7,1,0.9073,0.57,0.93
"GO_MF:512262_GO_0051378_SEROTONIN_BINDING","GO_MF","512262_GO_0051378_SEROTONIN_BINDING",8,0.9208,0.55,1,1.0568,0.4,0.83,1.6992,0.022,0.2
"GO_BP:492349_GO_0050912_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE","GO_BP","492349_GO_0050912_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE",42,0.9211,0.6,1,0.862,0.69,1,1.0697,0.34,0.78
"KEGG_compound:C00164_ACETOACETATE_3_OXOBUTANOIC_ACID_BETA_KETOBUTYRIC_ACID_ACETOACETIC_ACID","KEGG_compound","C00164_ACETOACETATE_3_OXOBUTANOIC_ACID_BETA_KETOBUTYRIC_ACID_ACETOACETIC_ACID",8,0.9211,0.55,1,0.7885,0.73,1,-1.3015,0.16,0.36
"KEGG_module:HSA_M00057_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_LINKAGE_TETRASACCHARIDE","KEGG_module","HSA_M00057_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_LINKAGE_TETRASACCHARIDE",5,0.9215,0.55,0.78,-0.3998,1,1,0.6954,0.85,1
"GO_BP:495358_GO_0015074_DNA_INTEGRATION","GO_BP","495358_GO_0015074_DNA_INTEGRATION",10,0.9222,0.55,1,0.8066,0.72,1,0.5763,0.96,1
"GO_BP:501435_GO_0032200_TELOMERE_ORGANIZATION","GO_BP","501435_GO_0032200_TELOMERE_ORGANIZATION",76,0.9222,0.63,1,0.9281,0.61,1,-1.0252,0.39,0.83
"GO_BP:509020_GO_0046794_TRANSPORT_OF_VIRUS","GO_BP","509020_GO_0046794_TRANSPORT_OF_VIRUS",35,0.9224,0.59,1,1.5785,0.015,0.32,0.6638,0.95,1
"C1_Positional:C1_ALL_266_CHR2Q14","C1_Positional","C1_ALL_266_CHR2Q14",42,0.9228,0.62,0.91,1.4853,0.037,0.28,1.2461,0.14,0.56
"GO_BP:505176_GO_0040018_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH","GO_BP","505176_GO_0040018_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH",32,0.9229,0.61,1,1.1542,0.24,0.83,1.0616,0.38,0.79
"GO_MF:503418_GO_0034212_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY","GO_MF","503418_GO_0034212_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY",9,0.9233,0.54,1,0.7177,0.86,1,1.5006,0.057,0.43
"GO_BP:491305_GO_0006376_MRNA_SPLICE_SITE_SELECTION","GO_BP","491305_GO_0006376_MRNA_SPLICE_SITE_SELECTION",27,0.9235,0.58,1,-0.8714,0.64,1,-0.7654,0.84,1
"C4_Cancer_gene_neighborhoods:C4_CGN_10_MORF_BUB3","C4_Cancer_gene_neighborhoods","C4_CGN_10_MORF_BUB3",277,0.9236,0.8,0.83,2.395,0,0,-1.2703,0.047,0.34
"GO_BP:506586_GO_0043555_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS","GO_BP","506586_GO_0043555_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS",16,0.9238,0.56,1,0.9827,0.46,1,-1.074,0.36,0.8
"GO_CC:505716_GO_0042589_ZYMOGEN_GRANULE_MEMBRANE","GO_CC","505716_GO_0042589_ZYMOGEN_GRANULE_MEMBRANE",9,0.9239,0.54,0.89,1.7118,0.019,0.056,0.8977,0.6,1
"C7_Immunologic_signatures:C7_ALL_618_GSE17721_POLYIC_VS_CPG_0_5H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_618_GSE17721_POLYIC_VS_CPG_0_5H_BMDM_DN",199,0.9239,0.69,0.91,1.2799,0.032,0.12,-1.0099,0.4,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_1561_NOUZOVA_METHYLATED_IN_APL","C2_Chemical_and_genetic_perturbations","C2_CGP_1561_NOUZOVA_METHYLATED_IN_APL",65,0.9242,0.62,1,0.9992,0.47,0.8,1.4574,0.021,0.54
"C4_Cancer_gene_neighborhoods:C4_CGN_222_GCM_DDX5","C4_Cancer_gene_neighborhoods","C4_CGN_222_GCM_DDX5",65,0.9244,0.63,0.84,1.6268,0.0022,0.012,-0.4784,1,1
"GO_BP:487617_GO_0001714_ENDODERMAL_CELL_FATE_SPECIFICATION","GO_BP","487617_GO_0001714_ENDODERMAL_CELL_FATE_SPECIFICATION",6,0.9245,0.54,1,0.7754,0.74,1,-1.2643,0.21,0.67
"C7_Immunologic_signatures:C7_ALL_1821_GSE7852_LN_VS_FAT_TCONV_UP","C7_Immunologic_signatures","C7_ALL_1821_GSE7852_LN_VS_FAT_TCONV_UP",200,0.9245,0.72,0.92,1.0084,0.42,0.71,-0.9541,0.57,0.84
"GO_BP:505802_GO_0042693_MUSCLE_CELL_FATE_COMMITMENT","GO_BP","505802_GO_0042693_MUSCLE_CELL_FATE_COMMITMENT",13,0.9251,0.54,1,-0.7719,0.75,1,-1.0277,0.41,0.83
"GO_BP:512523_GO_0051647_NUCLEUS_LOCALIZATION","GO_BP","512523_GO_0051647_NUCLEUS_LOCALIZATION",22,0.9252,0.56,1,-0.9939,0.46,1,-1.2006,0.2,0.73
"GO_BP:492115_GO_0007350_BLASTODERM_SEGMENTATION","GO_BP","492115_GO_0007350_BLASTODERM_SEGMENTATION",21,0.9255,0.57,1,0.8301,0.73,1,1.2765,0.13,0.69
"GO_CC:504253_GO_0035068_MICRO_RIBONUCLEOPROTEIN_COMPLEX","GO_CC","504253_GO_0035068_MICRO_RIBONUCLEOPROTEIN_COMPLEX",7,0.9255,0.56,0.89,-1.0497,0.41,0.83,-0.7475,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2875_KYNG_WERNER_SYNDROM_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2875_KYNG_WERNER_SYNDROM_DN",29,0.9259,0.56,1,-0.7455,0.87,1,-0.8388,0.71,0.93
"GO_MF:492491_GO_0008137_NADH_DEHYDROGENASE_UBIQUINONE_ACTIVITY","GO_MF","492491_GO_0008137_NADH_DEHYDROGENASE_UBIQUINONE_ACTIVITY",39,0.9259,0.58,1,2.4018,0,0.00027,0.8873,0.64,0.97
"GO_BP:506452_GO_0043414_MACROMOLECULE_METHYLATION","GO_BP","506452_GO_0043414_MACROMOLECULE_METHYLATION",206,0.9259,0.76,1,-0.9224,0.68,1,-1.0109,0.43,0.84
"GO_BP:516772_GO_0071850_MITOTIC_CELL_CYCLE_ARREST","GO_BP","516772_GO_0071850_MITOTIC_CELL_CYCLE_ARREST",14,0.926,0.57,1,1.0156,0.46,0.97,-0.9275,0.55,0.9
"C7_Immunologic_signatures:C7_ALL_1606_GSE3982_EOSINOPHIL_VS_TH2_DN","C7_Immunologic_signatures","C7_ALL_1606_GSE3982_EOSINOPHIL_VS_TH2_DN",197,0.9262,0.76,0.92,1.6556,0,0.0012,-1.1182,0.17,0.45
"C4_Cancer_gene_neighborhoods:C4_CGN_18_MORF_FEN1","C4_Cancer_gene_neighborhoods","C4_CGN_18_MORF_FEN1",65,0.9265,0.6,0.84,2.0573,0,0.00017,-1.3512,0.061,0.23
"GO_BP:510619_GO_0048552_REGULATION_OF_METALLOENZYME_ACTIVITY","GO_BP","510619_GO_0048552_REGULATION_OF_METALLOENZYME_ACTIVITY",12,0.9266,0.55,1,1.0834,0.35,0.92,0.9795,0.48,0.88
"C3_TF_targets:C3_TFT_480_GGCNRNWCTTYS_UNKNOWN","C3_TF_targets","C3_TFT_480_GGCNRNWCTTYS_UNKNOWN",82,0.9268,0.61,1,1.0476,0.36,1,-0.7674,0.93,1
"GO_MF:491837_GO_0019237_CENTROMERIC_DNA_BINDING","GO_MF","491837_GO_0019237_CENTROMERIC_DNA_BINDING",7,0.9269,0.54,1,0.9618,0.5,0.92,-0.621,0.93,1
"C7_Immunologic_signatures:C7_ALL_18_GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_18_GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN",200,0.927,0.67,0.92,1.647,0,0.0013,-0.8688,0.84,0.99
"GO_BP:487729_GO_0001833_INNER_CELL_MASS_CELL_PROLIFERATION","GO_BP","487729_GO_0001833_INNER_CELL_MASS_CELL_PROLIFERATION",15,0.9273,0.52,1,0.9262,0.57,1,-0.7853,0.77,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1663_BROWNE_HCMV_INFECTION_10HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1663_BROWNE_HCMV_INFECTION_10HR_DN",56,0.928,0.58,1,1.0823,0.31,0.66,1.0198,0.41,0.95
"GO_BP:514522_GO_0060967_NEGATIVE_REGULATION_OF_GENE_SILENCING_BY_RNA","GO_BP","514522_GO_0060967_NEGATIVE_REGULATION_OF_GENE_SILENCING_BY_RNA",6,0.9283,0.52,1,-0.7966,0.72,1,0.718,0.79,1
"REACTOME:105777_REACT_1095_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX","REACTOME","105777_REACT_1095_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX",30,0.9285,0.55,0.84,1.4933,0.027,0.15,-1.441,0.058,0.39
"REACTOME:645341_REACT_120918_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE","REACTOME","645341_REACT_120918_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE",10,0.9288,0.54,0.85,0.7694,0.75,1,-0.7757,0.77,1
"GO_BP:488004_GO_0002115_STORE_OPERATED_CALCIUM_ENTRY","GO_BP","488004_GO_0002115_STORE_OPERATED_CALCIUM_ENTRY",5,0.9296,0.54,1,0.9188,0.57,1,-0.6678,0.87,1
"GO_MF:515118_GO_0070181_SMALL_RIBOSOMAL_SUBUNIT_RRNA_BINDING","GO_MF","515118_GO_0070181_SMALL_RIBOSOMAL_SUBUNIT_RRNA_BINDING",5,0.9297,0.51,1,1.5825,0.031,0.3,-0.7534,0.78,0.99
"REACTOME:187207_REACT_25073_MOLYBDENUM_COFACTOR_BIOSYNTHESIS","REACTOME","187207_REACT_25073_MOLYBDENUM_COFACTOR_BIOSYNTHESIS",6,0.9297,0.53,0.85,0.7627,0.76,1,0.7898,0.71,1
"GO_MF:501418_GO_0032183_SUMO_BINDING","GO_MF","501418_GO_0032183_SUMO_BINDING",12,0.9297,0.52,1,-0.5779,0.96,1,-0.9418,0.52,0.84
"GO_BP:750988_GO_0036066_PROTEIN_O_LINKED_FUCOSYLATION","GO_BP","750988_GO_0036066_PROTEIN_O_LINKED_FUCOSYLATION",12,0.9298,0.54,1,0.7601,0.79,1,0.722,0.84,1
"GO_CC:490863_GO_0005847_MRNA_CLEAVAGE_AND_POLYADENYLATION_SPECIFICITY_FACTOR_COMPLEX","GO_CC","490863_GO_0005847_MRNA_CLEAVAGE_AND_POLYADENYLATION_SPECIFICITY_FACTOR_COMPLEX",10,0.9301,0.53,0.88,1.3445,0.13,0.35,0.7277,0.81,1
"C7_Immunologic_signatures:C7_ALL_819_GSE17974_0_5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_819_GSE17974_0_5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP",193,0.9302,0.68,0.91,0.9738,0.53,0.82,1.1345,0.2,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_431_VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_431_VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP",66,0.9304,0.64,1,-1.0116,0.41,0.99,-0.9046,0.66,0.87
"GO_BP:486627_GO_0000087_MITOTIC_M_PHASE","GO_BP","486627_GO_0000087_MITOTIC_M_PHASE",235,0.9306,0.77,1,1.6683,0,0.23,-0.9286,0.67,0.9
"GO_MF:983686_GO_0097602_CULLIN_FAMILY_PROTEIN_BINDING","GO_MF","983686_GO_0097602_CULLIN_FAMILY_PROTEIN_BINDING",5,0.9307,0.51,1,1.0723,0.39,0.82,-0.3796,1,1
"C3_TF_targets:C3_TFT_71_V_NRF2_01","C3_TF_targets","C3_TFT_71_V_NRF2_01",270,0.931,0.81,1,1.5667,0,0.1,0.9304,0.69,1
"GO_BP:510903_GO_0048853_FOREBRAIN_MORPHOGENESIS","GO_BP","510903_GO_0048853_FOREBRAIN_MORPHOGENESIS",18,0.9311,0.57,1,1.0216,0.41,0.97,1.0888,0.35,0.77
"GO_BP:491403_GO_0006505_GPI_ANCHOR_METABOLIC_PROCESS","GO_BP","491403_GO_0006505_GPI_ANCHOR_METABOLIC_PROCESS",34,0.9313,0.58,1,0.9994,0.44,0.98,-0.7164,0.9,0.99
"GO_BP:491209_GO_0006241_CTP_BIOSYNTHETIC_PROCESS","GO_BP","491209_GO_0006241_CTP_BIOSYNTHETIC_PROCESS",15,0.9313,0.54,1,-0.7151,0.85,1,-1.1445,0.28,0.75
"GO_BP:501474_GO_0032239_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT","GO_BP","501474_GO_0032239_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT",12,0.9315,0.52,1,1.1177,0.32,0.88,0.8194,0.71,1
"C7_Immunologic_signatures:C7_ALL_333_GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_333_GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP",199,0.9317,0.74,0.91,1.627,0,0.0018,1.1171,0.18,0.95
"REACTOME:106179_REACT_197_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM","REACTOME","106179_REACT_197_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM",17,0.9319,0.53,0.84,1.2955,0.15,0.33,-1.4618,0.07,0.38
"GO_MF:486713_GO_0000182_RDNA_BINDING","GO_MF","486713_GO_0000182_RDNA_BINDING",7,0.932,0.53,1,-0.7183,0.81,1,0.4643,0.99,1
"GO_MF:489434_GO_0003954_NADH_DEHYDROGENASE_ACTIVITY","GO_MF","489434_GO_0003954_NADH_DEHYDROGENASE_ACTIVITY",39,0.9321,0.58,1,2.3436,0,0.00021,0.8801,0.67,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3051_KIM_ALL_DISORDERS_DURATION_CORR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3051_KIM_ALL_DISORDERS_DURATION_CORR_UP",9,0.9324,0.53,1,-1.3396,0.15,0.71,1.0981,0.33,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_482_KERLEY_RESPONSE_TO_CISPLATIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_482_KERLEY_RESPONSE_TO_CISPLATIN_DN",5,0.9324,0.52,1,-1.2055,0.26,0.8,0.8971,0.58,1
"GO_CC:504287_GO_0035102_PRC1_COMPLEX","GO_CC","504287_GO_0035102_PRC1_COMPLEX",13,0.9324,0.54,0.88,0.6871,0.88,0.99,0.5411,0.99,1
"REACTOME:1127536_REACT_264605_HEDGEHOG_LIGAND_BIOGENESIS","REACTOME","1127536_REACT_264605_HEDGEHOG_LIGAND_BIOGENESIS",63,0.9325,0.6,0.84,2.0159,0,0.0018,-0.6144,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_952_PUJANA_BRCA_CENTERED_NETWORK","C2_Chemical_and_genetic_perturbations","C2_CGP_952_PUJANA_BRCA_CENTERED_NETWORK",117,0.9328,0.68,1,1.5281,0.0065,0.18,-1.3862,0.018,0.37
"GO_MF:492836_GO_0008568_MICROTUBULE_SEVERING_ATPASE_ACTIVITY","GO_MF","492836_GO_0008568_MICROTUBULE_SEVERING_ATPASE_ACTIVITY",10,0.933,0.54,1,1.294,0.15,0.62,0.9928,0.44,0.88
"GO_CC:499556_GO_0030127_COPII_VESICLE_COAT","GO_CC","499556_GO_0030127_COPII_VESICLE_COAT",10,0.9335,0.55,0.88,1.0816,0.35,0.67,-0.5143,0.99,1
"GO_BP:511717_GO_0050746_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS","GO_BP","511717_GO_0050746_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS",10,0.9335,0.56,1,1.1559,0.27,0.83,0.8234,0.69,1
"GO_CC:500764_GO_0031513_NONMOTILE_PRIMARY_CILIUM","GO_CC","500764_GO_0031513_NONMOTILE_PRIMARY_CILIUM",116,0.9341,0.69,0.88,-0.895,0.7,0.95,0.8699,0.75,1
"GO_BP:514521_GO_0060966_REGULATION_OF_GENE_SILENCING_BY_RNA","GO_BP","514521_GO_0060966_REGULATION_OF_GENE_SILENCING_BY_RNA",12,0.9343,0.55,1,-1.0624,0.37,0.96,-1.0736,0.36,0.8
"GO_MF:506069_GO_0042975_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING","GO_MF","506069_GO_0042975_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING",10,0.935,0.56,1,-1.0579,0.37,0.87,0.9722,0.49,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_530_BUSA_SAM68_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_530_BUSA_SAM68_TARGETS_UP",7,0.9352,0.52,1,-0.7823,0.73,1,0.8389,0.68,1
"C1_Positional:C1_ALL_218_CHR7Q21","C1_Positional","C1_ALL_218_CHR7Q21",80,0.9354,0.56,0.89,0.8419,0.81,0.93,1.3433,0.05,0.4
"C7_Immunologic_signatures:C7_ALL_1298_GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN","C7_Immunologic_signatures","C7_ALL_1298_GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN",200,0.9354,0.66,0.9,1.3534,0.02,0.06,-1.1401,0.15,0.39
"OMIM_gene:OMIM609017_ERYTHROBLAST_MEMBRANE_ASSOCIATED_PROTEIN_ERMAP","OMIM_gene","OMIM609017_ERYTHROBLAST_MEMBRANE_ASSOCIATED_PROTEIN_ERMAP",5,0.9356,0.51,1,0.8593,0.64,1,-0.4522,0.99,0.99
"KEGG_compound:C00013_DIPHOSPHATE_DIPHOSPHORIC_ACID_PYROPHOSPHATE_PYROPHOSPHORIC_ACID_PPI","KEGG_compound","C00013_DIPHOSPHATE_DIPHOSPHORIC_ACID_PYROPHOSPHATE_PYROPHOSPHORIC_ACID_PPI",182,0.9356,0.68,1,1.1561,0.13,0.95,-1.1141,0.19,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_1027_SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1027_SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN",17,0.9359,0.53,1,-0.704,0.88,1,-1.5899,0.028,0.25
"C7_Immunologic_signatures:C7_ALL_584_GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_584_GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDM_DN",197,0.936,0.73,0.9,1.5664,0,0.005,-1.029,0.36,0.66
"GO_BP:518856_GO_2000209_REGULATION_OF_ANOIKIS","GO_BP","518856_GO_2000209_REGULATION_OF_ANOIKIS",22,0.9362,0.53,1,1.1276,0.29,0.87,1.1633,0.24,0.73
"GO_BP:514916_GO_0061371_DETERMINATION_OF_HEART_LEFT_RIGHT_ASYMMETRY","GO_BP","514916_GO_0061371_DETERMINATION_OF_HEART_LEFT_RIGHT_ASYMMETRY",55,0.9363,0.61,1,-1.0298,0.4,0.97,1.1268,0.25,0.74
"C4_Cancer_gene_neighborhoods:C4_CGN_30_MORF_PSMC1","C4_Cancer_gene_neighborhoods","C4_CGN_30_MORF_PSMC1",191,0.9369,0.7,0.81,2.5286,0,0,0.6386,1,1
"C7_Immunologic_signatures:C7_ALL_1223_GSE27786_NKTCELL_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1223_GSE27786_NKTCELL_VS_NEUTROPHIL_UP",199,0.937,0.67,0.9,1.1011,0.22,0.44,-1.0514,0.33,0.61
"GO_MF:515257_GO_0070324_THYROID_HORMONE_BINDING","GO_MF","515257_GO_0070324_THYROID_HORMONE_BINDING",6,0.937,0.51,1,-1.0201,0.44,0.89,0.6267,0.92,1
"C4_Cancer_modules:C4_CM_38_MODULE_42","C4_Cancer_modules","C4_CM_38_MODULE_42",25,0.9373,0.53,0.92,2.1782,0,0.00019,0.9233,0.6,0.95
"C7_Immunologic_signatures:C7_ALL_1129_GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP","C7_Immunologic_signatures","C7_ALL_1129_GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP",185,0.9376,0.73,0.91,-1.1831,0.13,0.88,0.8789,0.8,1
"GO_BP:491646_GO_0009235_COBALAMIN_METABOLIC_PROCESS","GO_BP","491646_GO_0009235_COBALAMIN_METABOLIC_PROCESS",19,0.9377,0.51,1,1.1075,0.32,0.89,0.689,0.91,1
"C4_Cancer_gene_neighborhoods:C4_CGN_206_GCM_ACTG1","C4_Cancer_gene_neighborhoods","C4_CGN_206_GCM_ACTG1",124,0.9377,0.64,0.81,2.9803,0,0,-0.5312,1,1
"GO_BP:486797_GO_0000279_M_PHASE","GO_BP","486797_GO_0000279_M_PHASE",239,0.9378,0.68,1,1.6394,0,0.25,-0.9214,0.71,0.91
"GO_BP:493345_GO_0009148_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS","GO_BP","493345_GO_0009148_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS",20,0.9378,0.52,1,-0.7372,0.84,1,-1.0027,0.43,0.85
"C4_Cancer_modules:C4_CM_175_MODULE_186","C4_Cancer_modules","C4_CM_175_MODULE_186",20,0.9379,0.52,0.95,-1.0239,0.42,0.78,1.163,0.24,0.68
"GO_BP:517198_GO_0072282_METANEPHRIC_NEPHRON_TUBULE_MORPHOGENESIS","GO_BP","517198_GO_0072282_METANEPHRIC_NEPHRON_TUBULE_MORPHOGENESIS",8,0.9382,0.52,1,-1.2512,0.21,0.91,0.9996,0.45,0.86
"GO_BP:751695_GO_0044550_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS","GO_BP","751695_GO_0044550_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS",17,0.9383,0.51,1,0.6442,0.93,1,0.7896,0.76,1
"GO_BP:513887_GO_0060331_NEGATIVE_REGULATION_OF_RESPONSE_TO_INTERFERON_GAMMA","GO_BP","513887_GO_0060331_NEGATIVE_REGULATION_OF_RESPONSE_TO_INTERFERON_GAMMA",5,0.9386,0.52,1,1.2873,0.19,0.69,1.1155,0.36,0.75
"C1_Positional:C1_ALL_279_CHR15Q14","C1_Positional","C1_ALL_279_CHR15Q14",43,0.9393,0.59,0.9,0.9628,0.52,0.81,-0.8536,0.72,0.98
"C7_Immunologic_signatures:C7_ALL_171_GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP","C7_Immunologic_signatures","C7_ALL_171_GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP",197,0.9397,0.73,0.9,1.1994,0.1,0.23,-0.9993,0.43,0.72
"GO_BP:753026_GO_1900029_POSITIVE_REGULATION_OF_RUFFLE_ASSEMBLY","GO_BP","753026_GO_1900029_POSITIVE_REGULATION_OF_RUFFLE_ASSEMBLY",6,0.9399,0.5,1,0.8585,0.64,1,-1.1792,0.27,0.74
"GO_BP:1184428_GO_1903902_POSITIVE_REGULATION_OF_VIRAL_LIFE_CYCLE","GO_BP","1184428_GO_1903902_POSITIVE_REGULATION_OF_VIRAL_LIFE_CYCLE",97,0.9406,0.61,1,1.7616,0,0.13,0.799,0.91,1
"GO_MF:498061_GO_0019206_NUCLEOSIDE_KINASE_ACTIVITY","GO_MF","498061_GO_0019206_NUCLEOSIDE_KINASE_ACTIVITY",11,0.9409,0.53,1,1.1392,0.29,0.76,-0.6265,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1010_LIU_COMMON_CANCER_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_1010_LIU_COMMON_CANCER_GENES",77,0.9409,0.61,1,0.8189,0.84,0.98,-0.9172,0.62,0.86
"GO_BP:506528_GO_0043497_REGULATION_OF_PROTEIN_HETERODIMERIZATION_ACTIVITY","GO_BP","506528_GO_0043497_REGULATION_OF_PROTEIN_HETERODIMERIZATION_ACTIVITY",8,0.9409,0.5,1,0.7825,0.74,1,0.8247,0.7,1
"GO_MF:512638_GO_0051766_INOSITOL_TRISPHOSPHATE_KINASE_ACTIVITY","GO_MF","512638_GO_0051766_INOSITOL_TRISPHOSPHATE_KINASE_ACTIVITY",8,0.9411,0.49,1,0.9971,0.45,0.88,1.1052,0.33,0.81
"GO_CC:507419_GO_0045009_CHITOSOME","GO_CC","507419_GO_0045009_CHITOSOME",8,0.9415,0.5,0.87,0.8891,0.59,0.91,-0.7436,0.8,1
"GO_MF:486787_GO_0000268_PEROXISOME_TARGETING_SEQUENCE_BINDING","GO_MF","486787_GO_0000268_PEROXISOME_TARGETING_SEQUENCE_BINDING",5,0.9417,0.52,1,-0.7739,0.74,1,-1.2788,0.19,0.59
"GO_MF:491838_GO_0042162_TELOMERIC_DNA_BINDING","GO_MF","491838_GO_0042162_TELOMERIC_DNA_BINDING",16,0.9419,0.53,1,0.6732,0.9,1,0.5282,0.99,1
"GO_BP:912525_GO_0039703_RNA_REPLICATION","GO_BP","912525_GO_0039703_RNA_REPLICATION",6,0.9423,0.51,1,-0.5392,0.97,1,-0.4925,0.99,1
"GO_BP:515406_GO_0070474_POSITIVE_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION","GO_BP","515406_GO_0070474_POSITIVE_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION",8,0.9424,0.51,1,-0.9548,0.52,1,-1.0211,0.43,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_1053_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1053_RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP",233,0.9425,0.7,1,0.9094,0.75,0.91,-1.309,0.025,0.42
"GO_BP:518156_GO_0090009_PRIMITIVE_STREAK_FORMATION","GO_BP","518156_GO_0090009_PRIMITIVE_STREAK_FORMATION",10,0.9429,0.51,1,0.8778,0.59,1,1.1326,0.28,0.74
"GO_BP:493344_GO_0009147_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS","GO_BP","493344_GO_0009147_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS",22,0.9432,0.51,1,-0.7468,0.83,1,-1.0349,0.41,0.82
"C7_Immunologic_signatures:C7_ALL_1360_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN","C7_Immunologic_signatures","C7_ALL_1360_GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN",198,0.9437,0.65,0.89,0.9744,0.52,0.82,-0.9836,0.48,0.77
"GO_BP:513892_GO_0060336_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY","GO_BP","513892_GO_0060336_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY",5,0.9441,0.5,1,1.2815,0.18,0.7,1.1265,0.35,0.74
"C7_Immunologic_signatures:C7_ALL_396_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_396_GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN",199,0.9443,0.73,0.89,1.8289,0,0,-1.0483,0.34,0.62
"C4_Cancer_gene_neighborhoods:C4_CGN_397_GNF2_PTX3","C4_Cancer_gene_neighborhoods","C4_CGN_397_GNF2_PTX3",36,0.9443,0.54,0.79,0.9014,0.62,0.83,1.2095,0.18,0.43
"C7_Immunologic_signatures:C7_ALL_258_GSE14308_TH1_VS_INDUCED_TREG_DN","C7_Immunologic_signatures","C7_ALL_258_GSE14308_TH1_VS_INDUCED_TREG_DN",196,0.9446,0.67,0.9,1.1877,0.095,0.25,0.7468,0.99,1
"GO_BP:494726_GO_0010663_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","494726_GO_0010663_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS",7,0.9446,0.52,1,1.2273,0.23,0.76,1.2817,0.19,0.69
"KEGG_reaction:R08945_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NAD_17_OXIDOREDUCTASE_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NAD_11BETA_HYDROXYANDROST_4_ENE_3_17_DIONE_NADH_H_","KEGG_reaction","R08945_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NAD_17_OXIDOREDUCTASE_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NAD_11BETA_HYDROXYANDROST_4_ENE_3_17_DIONE_NADH_H_",6,0.9451,0.51,0.87,1.5067,0.065,0.22,-1.3993,0.11,0.35
"C4_Cancer_gene_neighborhoods:C4_CGN_185_MORF_TPR","C4_Cancer_gene_neighborhoods","C4_CGN_185_MORF_TPR",145,0.9451,0.63,0.8,1.1063,0.2,0.36,-0.8955,0.72,1
"GO_BP:513791_GO_0060235_LENS_INDUCTION_IN_CAMERA_TYPE_EYE","GO_BP","513791_GO_0060235_LENS_INDUCTION_IN_CAMERA_TYPE_EYE",7,0.9457,0.5,1,0.7011,0.82,1,1.5116,0.063,0.55
"GO_BP:509147_GO_0046950_CELLULAR_KETONE_BODY_METABOLIC_PROCESS","GO_BP","509147_GO_0046950_CELLULAR_KETONE_BODY_METABOLIC_PROCESS",8,0.9458,0.5,1,1.0365,0.43,0.96,-0.9962,0.45,0.85
"GO_BP:497187_GO_0018216_PEPTIDYL_ARGININE_METHYLATION","GO_BP","497187_GO_0018216_PEPTIDYL_ARGININE_METHYLATION",11,0.9459,0.51,1,0.4895,0.99,1,-0.8104,0.74,0.98
"WikiPathways:198842_WP322_OSTEOBLAST_SIGNALING","WikiPathways","198842_WP322_OSTEOBLAST_SIGNALING",13,0.946,0.5,0.87,1.3143,0.15,0.62,1.1829,0.24,0.66
"GO_MF:496659_GO_0016746_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS","GO_MF","496659_GO_0016746_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS",233,0.9462,0.67,1,-0.8244,0.91,1,-0.9057,0.76,0.87
"GO_BP:493440_GO_0009247_GLYCOLIPID_BIOSYNTHETIC_PROCESS","GO_BP","493440_GO_0009247_GLYCOLIPID_BIOSYNTHETIC_PROCESS",50,0.9464,0.53,1,1.0368,0.38,0.96,0.8651,0.72,0.97
"GO_BP:505160_GO_0040001_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION","GO_BP","505160_GO_0040001_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION",20,0.9466,0.52,1,0.7607,0.82,1,1.1054,0.32,0.76
"C7_Immunologic_signatures:C7_ALL_1217_GSE27786_NKCELL_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1217_GSE27786_NKCELL_VS_NEUTROPHIL_UP",200,0.9469,0.67,0.89,1.4882,0.0048,0.014,0.8125,0.92,1
"C4_Cancer_gene_neighborhoods:C4_CGN_55_MORF_XRCC5","C4_Cancer_gene_neighborhoods","C4_CGN_55_MORF_XRCC5",235,0.9472,0.72,0.8,2.2114,0,2.2e-05,-1.0922,0.21,0.63
"GO_BP:488814_GO_0003016_RESPIRATORY_SYSTEM_PROCESS","GO_BP","488814_GO_0003016_RESPIRATORY_SYSTEM_PROCESS",11,0.9475,0.51,1,0.996,0.45,0.98,-0.6507,0.89,1
"C4_Cancer_gene_neighborhoods:C4_CGN_311_GNF2_RPA1","C4_Cancer_gene_neighborhoods","C4_CGN_311_GNF2_RPA1",28,0.9478,0.54,0.8,1.4788,0.043,0.036,-0.8638,0.68,1
"GO_CC:515703_GO_0070775_H3_HISTONE_ACETYLTRANSFERASE_COMPLEX","GO_CC","515703_GO_0070775_H3_HISTONE_ACETYLTRANSFERASE_COMPLEX",7,0.9481,0.47,0.85,-0.8931,0.61,0.95,0.6175,0.91,1
"C1_Positional:C1_ALL_324_CHR4Q11","C1_Positional","C1_ALL_324_CHR4Q11",14,0.9483,0.52,0.88,1.8247,0.0041,0.081,0.8443,0.66,0.9
"C7_Immunologic_signatures:C7_ALL_1189_GSE27786_BCELL_VS_MONO_MAC_UP","C7_Immunologic_signatures","C7_ALL_1189_GSE27786_BCELL_VS_MONO_MAC_UP",199,0.9485,0.62,0.89,0.9515,0.63,0.89,-0.8425,0.91,1
"REACTOME:833804_REACT_163862_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM","REACTOME","833804_REACT_163862_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM",20,0.9486,0.5,0.8,1.0463,0.38,0.67,0.6998,0.88,1
"C4_Cancer_modules:C4_CM_309_MODULE_358","C4_Cancer_modules","C4_CM_309_MODULE_358",79,0.9486,0.58,0.95,0.8323,0.84,0.93,-0.7931,0.9,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_573_CHOI_ATL_STAGE_PREDICTOR","C2_Chemical_and_genetic_perturbations","C2_CGP_573_CHOI_ATL_STAGE_PREDICTOR",44,0.949,0.53,1,2.0117,0,0.0054,0.8333,0.74,1
"GO_BP:513571_GO_0060013_RIGHTING_REFLEX","GO_BP","513571_GO_0060013_RIGHTING_REFLEX",7,0.9493,0.52,1,-1.1428,0.3,0.93,0.6819,0.86,1
"GO_BP:494729_GO_0010666_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_APOPTOTIC_PROCESS","GO_BP","494729_GO_0010666_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_APOPTOTIC_PROCESS",7,0.9494,0.5,1,1.2292,0.22,0.76,1.2692,0.2,0.69
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_163_BIOCARTA_AKAP13_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_163_BIOCARTA_AKAP13_PATHWAY",12,0.95,0.49,1,1.7002,0.008,0.25,1.0687,0.38,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2554_CHANG_CORE_SERUM_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2554_CHANG_CORE_SERUM_RESPONSE_UP",212,0.95,0.61,1,1.8553,0,0.028,-0.7922,0.97,0.96
"KEGG_compound:C00458_DCTP_DEOXYCYTIDINE_5_TRIPHOSPHATE_DEOXYCYTIDINE_TRIPHOSPHATE_2_DEOXYCYTIDINE_5_TRIPHOSPHATE","KEGG_compound","C00458_DCTP_DEOXYCYTIDINE_5_TRIPHOSPHATE_DEOXYCYTIDINE_TRIPHOSPHATE_2_DEOXYCYTIDINE_5_TRIPHOSPHATE",24,0.9501,0.55,1,0.7832,0.81,1,-1.2182,0.18,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_262_LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_262_LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN",7,0.9503,0.49,1,1.2705,0.19,0.42,-1.0937,0.36,0.64
"GO_BP:494906_GO_0010842_RETINA_LAYER_FORMATION","GO_BP","494906_GO_0010842_RETINA_LAYER_FORMATION",19,0.9506,0.54,1,-1.1544,0.27,0.92,0.746,0.82,1
"KEGG_module:HSA_M00412_ESCRT_III_COMPLEX","KEGG_module","HSA_M00412_ESCRT_III_COMPLEX",13,0.9506,0.51,0.74,1.2714,0.19,0.43,1.1772,0.28,0.75
"GO_MF:490076_GO_0004767_SPHINGOMYELIN_PHOSPHODIESTERASE_ACTIVITY","GO_MF","490076_GO_0004767_SPHINGOMYELIN_PHOSPHODIESTERASE_ACTIVITY",7,0.9508,0.49,1,1.0019,0.45,0.87,1.4257,0.1,0.51
"KEGG_compound:C00165_DIACYLGLYCEROL_DIGLYCERIDE","KEGG_compound","C00165_DIACYLGLYCEROL_DIGLYCERIDE",7,0.9509,0.49,1,0.8025,0.71,1,-0.6822,0.87,0.92
"GO_BP:507822_GO_0045472_RESPONSE_TO_ETHER","GO_BP","507822_GO_0045472_RESPONSE_TO_ETHER",5,0.951,0.52,1,1.1582,0.32,0.83,0.7414,0.77,1
"GO_CC:496539_GO_0016593_CDC73_PAF1_COMPLEX","GO_CC","496539_GO_0016593_CDC73_PAF1_COMPLEX",7,0.9511,0.51,0.85,1.0715,0.38,0.69,-0.7739,0.73,1
"GO_BP:515404_GO_0070472_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION","GO_BP","515404_GO_0070472_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION",10,0.9511,0.53,1,-0.8222,0.68,1,-0.8384,0.66,0.96
"KEGG_reaction:R06520_3_SN_PHOSPHATIDATE_PHOSPHOHYDROLASE_SPHINGANINE_1_PHOSPHATE_H2O_SPHINGANINE_ORTHOPHOSPHATE","KEGG_reaction","R06520_3_SN_PHOSPHATIDATE_PHOSPHOHYDROLASE_SPHINGANINE_1_PHOSPHATE_H2O_SPHINGANINE_ORTHOPHOSPHATE",5,0.9513,0.52,0.88,1.2094,0.26,0.87,1.2684,0.22,0.47
"C7_Immunologic_signatures:C7_ALL_1632_GSE3982_DC_VS_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1632_GSE3982_DC_VS_BCELL_DN",190,0.9514,0.64,0.88,0.9739,0.53,0.82,-1.1053,0.22,0.48
"C4_Cancer_gene_neighborhoods:C4_CGN_117_MORF_ITGA2","C4_Cancer_gene_neighborhoods","C4_CGN_117_MORF_ITGA2",52,0.9515,0.53,0.79,1.4324,0.03,0.05,1.3465,0.067,0.28
"REACTOME:105826_REACT_6837_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE","REACTOME","105826_REACT_6837_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE",77,0.9516,0.55,0.8,2.0349,0,0.0015,-0.7138,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1686_HEDENFALK_BREAST_CANCER_BRACX_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1686_HEDENFALK_BREAST_CANCER_BRACX_UP",20,0.9516,0.55,1,2.0957,0,0.0019,-0.5626,0.99,0.99
"GO_BP:755381_GO_2001275_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS","GO_BP","755381_GO_2001275_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS",6,0.9516,0.5,1,-0.5465,0.96,1,0.9309,0.53,0.92
"GO_BP:487403_GO_0001302_REPLICATIVE_CELL_AGING","GO_BP","487403_GO_0001302_REPLICATIVE_CELL_AGING",8,0.9518,0.49,1,0.6844,0.87,1,-0.7703,0.78,1
"REACTOME:187087_REACT_24918_IRAK1_RECRUITS_IKK_COMPLEX","REACTOME","187087_REACT_24918_IRAK1_RECRUITS_IKK_COMPLEX",11,0.9518,0.51,0.8,1.0109,0.43,0.73,0.9995,0.45,1
"C7_Immunologic_signatures:C7_ALL_1747_GSE6269_HEALTHY_VS_STREP_PNEUMO_INF_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1747_GSE6269_HEALTHY_VS_STREP_PNEUMO_INF_PBMC_UP",185,0.9519,0.61,0.89,-0.5949,1,1,-1.2225,0.082,0.24
"REACTOME:730308_REACT_150206_CROSSLINKING_OF_COLLAGEN_FIBRILS","REACTOME","730308_REACT_150206_CROSSLINKING_OF_COLLAGEN_FIBRILS",9,0.952,0.48,0.8,-1.006,0.44,0.98,1.1516,0.29,0.9
"GO_BP:491262_GO_0006303_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING","GO_BP","491262_GO_0006303_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING",21,0.9525,0.53,1,0.6844,0.9,1,-1.1117,0.31,0.76
"GO_BP:495216_GO_0014820_TONIC_SMOOTH_MUSCLE_CONTRACTION","GO_BP","495216_GO_0014820_TONIC_SMOOTH_MUSCLE_CONTRACTION",9,0.953,0.51,1,1.4596,0.071,0.48,0.591,0.95,1
"REACTOME:106554_REACT_1913_RNA_POLYMERASE_I_PROMOTER_ESCAPE","REACTOME","106554_REACT_1913_RNA_POLYMERASE_I_PROMOTER_ESCAPE",30,0.9533,0.54,0.8,1.1949,0.19,0.45,0.5198,1,1
"REACTOME:161030_REACT_22223_HIGHLY_SODIUM_PERMEABLE_ACETYLCHOLINE_NICOTINIC_RECEPTORS","REACTOME","161030_REACT_22223_HIGHLY_SODIUM_PERMEABLE_ACETYLCHOLINE_NICOTINIC_RECEPTORS",8,0.9533,0.51,0.81,-1.4369,0.077,0.51,-0.7051,0.88,1
"GO_BP:491963_GO_0007158_NEURON_CELL_CELL_ADHESION","GO_BP","491963_GO_0007158_NEURON_CELL_CELL_ADHESION",15,0.9534,0.5,1,-1.0801,0.35,0.95,0.7392,0.8,1
"KEGG_module:HSA_M00403_HRD1_SEL1_ERAD_COMPLEX","KEGG_module","HSA_M00403_HRD1_SEL1_ERAD_COMPLEX",13,0.9534,0.48,0.76,1.3263,0.14,0.36,0.8836,0.62,1
"C4_Cancer_gene_neighborhoods:C4_CGN_104_MORF_FRK","C4_Cancer_gene_neighborhoods","C4_CGN_104_MORF_FRK",105,0.9535,0.62,0.79,0.9068,0.68,0.82,1.3937,0.019,0.24
"C2_Chemical_and_genetic_perturbations:C2_CGP_3264_YANG_BCL3_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3264_YANG_BCL3_TARGETS_DN",8,0.9535,0.48,1,-1.1387,0.3,0.87,-1.4024,0.11,0.35
"KEGG_module:HSA_M00406_TREX_COMPLEX","KEGG_module","HSA_M00406_TREX_COMPLEX",8,0.9541,0.49,0.78,0.8931,0.59,0.92,-0.5201,0.98,1
"GO_BP:511848_GO_0050913_SENSORY_PERCEPTION_OF_BITTER_TASTE","GO_BP","511848_GO_0050913_SENSORY_PERCEPTION_OF_BITTER_TASTE",35,0.9541,0.53,1,-0.9858,0.49,1,1.1386,0.23,0.73
"KEGG_compound:C01157_HYDROXYPROLINE_L_HYDROXYPROLINE_TRANS_4_HYDROXY_L_PROLINE","KEGG_compound","C01157_HYDROXYPROLINE_L_HYDROXYPROLINE_TRANS_4_HYDROXY_L_PROLINE",6,0.9544,0.48,1,0.7905,0.72,1,0.6097,0.93,1
"REACTOME:161067_REACT_20530_ZINC_TRANSPORTERS","REACTOME","161067_REACT_20530_ZINC_TRANSPORTERS",16,0.9546,0.5,0.81,-0.8705,0.64,1,-1.0192,0.41,0.81
"GO_MF:487457_GO_0001517_N_ACETYLGLUCOSAMINE_6_O_SULFOTRANSFERASE_ACTIVITY","GO_MF","487457_GO_0001517_N_ACETYLGLUCOSAMINE_6_O_SULFOTRANSFERASE_ACTIVITY",5,0.9547,0.49,1,1.0542,0.41,0.83,1.3205,0.17,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_1328_WONG_IFNA2_RESISTANCE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1328_WONG_IFNA2_RESISTANCE_UP",16,0.9553,0.53,1,0.6794,0.91,1,0.6175,0.94,1
"REACTOME:106026_REACT_9031_VPU_MEDIATED_DEGRADATION_OF_CD4","REACTOME","106026_REACT_9031_VPU_MEDIATED_DEGRADATION_OF_CD4",51,0.9553,0.57,0.81,2.2251,0,5.8e-05,0.4936,1,1
"GO_CC:515704_GO_0070776_MOZ_MORF_HISTONE_ACETYLTRANSFERASE_COMPLEX","GO_CC","515704_GO_0070776_MOZ_MORF_HISTONE_ACETYLTRANSFERASE_COMPLEX",7,0.9555,0.5,0.84,-0.8928,0.61,0.95,0.614,0.94,1
"REACTOME:105844_REACT_702_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PYRIMIDINE","REACTOME","105844_REACT_702_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PYRIMIDINE",8,0.9556,0.49,0.81,1.1792,0.26,0.47,-0.8923,0.59,0.96
"GO_CC:502383_GO_0033162_MELANOSOME_MEMBRANE","GO_CC","502383_GO_0033162_MELANOSOME_MEMBRANE",8,0.956,0.49,0.85,0.8635,0.65,0.91,-0.7515,0.79,1
"GO_BP:515906_GO_0070979_PROTEIN_K11_LINKED_UBIQUITINATION","GO_BP","515906_GO_0070979_PROTEIN_K11_LINKED_UBIQUITINATION",27,0.9564,0.54,1,1.4245,0.063,0.52,-0.7282,0.87,0.99
"C1_Positional:C1_ALL_157_CHR20Q12","C1_Positional","C1_ALL_157_CHR20Q12",36,0.9565,0.52,0.87,1.1512,0.23,0.64,1.5462,0.024,0.27
"GO_BP:503448_GO_0034243_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER","GO_BP","503448_GO_0034243_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER",23,0.9574,0.5,1,1.2606,0.16,0.72,0.9577,0.51,0.9
"GO_BP:495996_GO_0015872_DOPAMINE_TRANSPORT","GO_BP","495996_GO_0015872_DOPAMINE_TRANSPORT",9,0.9578,0.48,1,1.1826,0.28,0.8,-1.3114,0.16,0.64
"GO_BP:491573_GO_0006685_SPHINGOMYELIN_CATABOLIC_PROCESS","GO_BP","491573_GO_0006685_SPHINGOMYELIN_CATABOLIC_PROCESS",6,0.958,0.48,1,1.0734,0.38,0.93,1.4629,0.082,0.59
"GO_CC:504182_GO_0034991_NUCLEAR_MEIOTIC_COHESIN_COMPLEX","GO_CC","504182_GO_0034991_NUCLEAR_MEIOTIC_COHESIN_COMPLEX",6,0.9581,0.51,0.85,0.7574,0.76,0.98,1.3608,0.15,0.76
"REACTOME:187083_REACT_25354_IRAK1_RECRUITS_IKK_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION","REACTOME","187083_REACT_25354_IRAK1_RECRUITS_IKK_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION",11,0.9582,0.49,0.8,0.9876,0.47,0.77,1.0132,0.42,1
"C4_Cancer_gene_neighborhoods:C4_CGN_95_MORF_EPHA7","C4_Cancer_gene_neighborhoods","C4_CGN_95_MORF_EPHA7",132,0.9583,0.59,0.78,-0.8317,0.87,1,1.4265,0.0097,0.24
"WikiPathways:198757_WP391_MITOCHONDRIAL_GENE_EXPRESSION","WikiPathways","198757_WP391_MITOCHONDRIAL_GENE_EXPRESSION",12,0.9586,0.51,0.92,0.8351,0.71,1,0.7761,0.76,1
"GO_BP:492008_GO_0007210_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY","GO_BP","492008_GO_0007210_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY",17,0.9586,0.5,1,1.4004,0.079,0.55,1.8302,0.0085,0.25
"C4_Cancer_modules:C4_CM_201_MODULE_214","C4_Cancer_modules","C4_CM_201_MODULE_214",26,0.9587,0.49,0.94,-1.1966,0.22,0.62,0.962,0.49,0.97
"GO_MF:489929_GO_0004596_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_ACTIVITY","GO_MF","489929_GO_0004596_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_ACTIVITY",8,0.9587,0.51,1,0.9784,0.47,0.9,1.4344,0.074,0.53
"C7_Immunologic_signatures:C7_ALL_96_GSE11924_TFH_VS_TH1_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_96_GSE11924_TFH_VS_TH1_CD4_TCELL_DN",194,0.959,0.54,0.86,1.6523,0,0.0012,-0.7935,0.96,1
"OMIM_gene:OMIM162150_PROPROTEIN_CONVERTASE_SUBTILISIN_KEXIN_TYPE_1_PCSK1","OMIM_gene","OMIM162150_PROPROTEIN_CONVERTASE_SUBTILISIN_KEXIN_TYPE_1_PCSK1",6,0.9593,0.51,1,1.0662,0.39,1,0.7141,0.8,1
"GO_CC:499478_GO_0030014_CCR4_NOT_COMPLEX","GO_CC","499478_GO_0030014_CCR4_NOT_COMPLEX",15,0.9599,0.48,0.85,0.9237,0.57,0.86,-1.2204,0.22,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_709_SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY","C2_Chemical_and_genetic_perturbations","C2_CGP_709_SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY",32,0.9601,0.51,1,1.5279,0.038,0.18,-0.8594,0.69,0.92
"GO_BP:512585_GO_0051712_POSITIVE_REGULATION_OF_KILLING_OF_CELLS_OF_OTHER_ORGANISM","GO_BP","512585_GO_0051712_POSITIVE_REGULATION_OF_KILLING_OF_CELLS_OF_OTHER_ORGANISM",6,0.9608,0.47,0.99,0.5972,0.96,1,-0.8161,0.69,0.98
"KEGG_pathway:HSA03050_PROTEASOME","KEGG_pathway","HSA03050_PROTEASOME",44,0.9608,0.52,0.67,2.1078,0,0.00054,0.5615,1,1
"C7_Immunologic_signatures:C7_ALL_271_GSE14308_INDUCED_VS_NATURAL_TREG_UP","C7_Immunologic_signatures","C7_ALL_271_GSE14308_INDUCED_VS_NATURAL_TREG_UP",198,0.9609,0.56,0.85,1.3542,0.022,0.059,-0.8701,0.83,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1267_LEI_HOXC8_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1267_LEI_HOXC8_TARGETS_UP",12,0.9612,0.49,1,1.7631,0.0041,0.056,2.065,0,0.045
"GO_BP:494826_GO_0010761_FIBROBLAST_MIGRATION","GO_BP","494826_GO_0010761_FIBROBLAST_MIGRATION",8,0.9614,0.47,0.99,-0.5105,0.97,1,-0.828,0.69,0.97
"C7_Immunologic_signatures:C7_ALL_133_GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP","C7_Immunologic_signatures","C7_ALL_133_GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP",196,0.9614,0.59,0.85,1.3389,0.012,0.07,1.0475,0.32,1
"GO_BP:493810_GO_0009698_PHENYLPROPANOID_METABOLIC_PROCESS","GO_BP","493810_GO_0009698_PHENYLPROPANOID_METABOLIC_PROCESS",9,0.9617,0.49,0.99,-1.3296,0.15,0.9,1.3335,0.13,0.64
"GO_BP:506088_GO_0042997_NEGATIVE_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT","GO_BP","506088_GO_0042997_NEGATIVE_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT",5,0.9618,0.48,1,-0.8421,0.64,1,-0.5561,0.97,1
"GO_BP:1129320_GO_0098763_MITOTIC_CELL_CYCLE_PHASE","GO_BP","1129320_GO_0098763_MITOTIC_CELL_CYCLE_PHASE",308,0.9618,0.6,1,1.7237,0,0.17,-1.1206,0.15,0.76
"GO_CC:493942_GO_0019005_SCF_UBIQUITIN_LIGASE_COMPLEX","GO_CC","493942_GO_0019005_SCF_UBIQUITIN_LIGASE_COMPLEX",30,0.9618,0.5,0.85,1.0974,0.3,0.65,-0.8267,0.74,1
"KEGG_reaction:R02353_ESTRADIOL_17BETA_NADP_17_OXIDOREDUCTASE_ESTRADIOL_17BETA_NADP_ESTRONE_NADPH_H_","KEGG_reaction","R02353_ESTRADIOL_17BETA_NADP_17_OXIDOREDUCTASE_ESTRADIOL_17BETA_NADP_ESTRONE_NADPH_H_",6,0.962,0.49,0.88,1.5254,0.049,0.22,-1.451,0.09,0.33
"GO_BP:491360_GO_0006448_REGULATION_OF_TRANSLATIONAL_ELONGATION","GO_BP","491360_GO_0006448_REGULATION_OF_TRANSLATIONAL_ELONGATION",23,0.9621,0.5,1,1.5821,0.02,0.31,-0.8911,0.61,0.93
"GO_MF:490280_GO_0004993_SEROTONIN_RECEPTOR_ACTIVITY","GO_MF","490280_GO_0004993_SEROTONIN_RECEPTOR_ACTIVITY",17,0.9623,0.51,1,1.3607,0.11,0.51,1.7768,0.0022,0.13
"GO_BP:502741_GO_0033523_HISTONE_H2B_UBIQUITINATION","GO_BP","502741_GO_0033523_HISTONE_H2B_UBIQUITINATION",9,0.9624,0.5,1,-0.6179,0.94,1,-0.6923,0.88,0.99
"GO_CC:502609_GO_0033391_CHROMATOID_BODY","GO_CC","502609_GO_0033391_CHROMATOID_BODY",12,0.9628,0.48,0.85,-1.1692,0.27,0.69,1.3666,0.12,0.77
"KEGG_pathway:HSA02010_ABC_TRANSPORTERS","KEGG_pathway","HSA02010_ABC_TRANSPORTERS",43,0.963,0.52,0.69,-1.0952,0.31,0.72,0.8471,0.73,1
"KEGG_compound:C00140_N_ACETYL_D_GLUCOSAMINE_N_ACETYLCHITOSAMINE_2_ACETAMIDO_2_DEOXY_D_GLUCOSE_GLCNAC","KEGG_compound","C00140_N_ACETYL_D_GLUCOSAMINE_N_ACETYLCHITOSAMINE_2_ACETAMIDO_2_DEOXY_D_GLUCOSE_GLCNAC",7,0.9632,0.49,1,0.8248,0.68,1,-1.1116,0.35,0.53
"GO_CC:515625_GO_0070695_FHF_COMPLEX","GO_CC","515625_GO_0070695_FHF_COMPLEX",5,0.9632,0.5,0.85,-0.8411,0.68,0.98,-0.879,0.59,1
"GO_CC:504282_GO_0035097_HISTONE_METHYLTRANSFERASE_COMPLEX","GO_CC","504282_GO_0035097_HISTONE_METHYLTRANSFERASE_COMPLEX",67,0.9633,0.5,0.86,0.6327,0.99,0.99,-1.0091,0.43,1
"C7_Immunologic_signatures:C7_ALL_1294_GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1294_GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN",195,0.9639,0.59,0.85,1.1742,0.088,0.27,-0.8065,0.95,1
"GO_BP:752614_GO_0097113_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLE_PROPIONATE_SELECTIVE_GLUTAMATE_RECEPTOR_CLUSTERING","GO_BP","752614_GO_0097113_ALPHA_AMINO_3_HYDROXY_5_METHYL_4_ISOXAZOLE_PROPIONATE_SELECTIVE_GLUTAMATE_RECEPTOR_CLUSTERING",5,0.964,0.5,0.99,-0.747,0.78,1,0.9276,0.54,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_811_HEIDENBLAD_AMPLICON_12P11_12_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_811_HEIDENBLAD_AMPLICON_12P11_12_UP",33,0.9643,0.5,1,1.2648,0.12,0.42,-0.6852,0.95,0.99
"REACTOME:161054_REACT_6344_TAT_MEDIATED_HIV_ELONGATION_ARREST_AND_RECOVERY","REACTOME","161054_REACT_6344_TAT_MEDIATED_HIV_ELONGATION_ARREST_AND_RECOVERY",30,0.9651,0.51,0.79,1.5362,0.016,0.13,1.0724,0.34,0.95
"GO_BP:499896_GO_0030575_NUCLEAR_BODY_ORGANIZATION","GO_BP","499896_GO_0030575_NUCLEAR_BODY_ORGANIZATION",7,0.9654,0.5,0.99,1.0655,0.38,0.94,-0.4706,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3088_FIGUEROA_AML_METHYLATION_CLUSTER_6_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3088_FIGUEROA_AML_METHYLATION_CLUSTER_6_UP",138,0.9656,0.56,1,0.9877,0.47,0.81,1.0403,0.37,0.92
"C4_Cancer_modules:C4_CM_63_MODULE_67","C4_Cancer_modules","C4_CM_63_MODULE_67",218,0.9659,0.57,0.95,0.9923,0.49,0.72,1.0096,0.39,0.95
"GO_BP:491404_GO_0006506_GPI_ANCHOR_BIOSYNTHETIC_PROCESS","GO_BP","491404_GO_0006506_GPI_ANCHOR_BIOSYNTHETIC_PROCESS",32,0.9659,0.49,0.99,1.0783,0.33,0.93,-0.7488,0.86,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2432_MUELLER_PLURINET","C2_Chemical_and_genetic_perturbations","C2_CGP_2432_MUELLER_PLURINET",298,0.9659,0.6,1,1.3695,0.008,0.32,-1.3598,0.0041,0.38
"GO_CC:518564_GO_0097014_CILIARY_CYTOPLASM","GO_CC","518564_GO_0097014_CILIARY_CYTOPLASM",91,0.9663,0.58,0.85,-1.1933,0.13,0.69,-0.6614,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_189_GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_189_GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP",77,0.9664,0.51,1,1.1026,0.25,0.63,0.8052,0.86,1
"GO_CC:487074_GO_0000781_CHROMOSOME_TELOMERIC_REGION","GO_CC","487074_GO_0000781_CHROMOSOME_TELOMERIC_REGION",57,0.9666,0.54,0.86,0.7704,0.88,0.97,-0.828,0.79,1
"C4_Cancer_gene_neighborhoods:C4_CGN_423_GNF2_TTN","C4_Cancer_gene_neighborhoods","C4_CGN_423_GNF2_TTN",25,0.9666,0.51,0.76,0.9604,0.48,0.68,-1.0593,0.35,0.69
"GO_BP:911307_GO_0039694_VIRAL_RNA_GENOME_REPLICATION","GO_BP","911307_GO_0039694_VIRAL_RNA_GENOME_REPLICATION",6,0.9667,0.47,0.99,-0.5336,0.96,1,-0.4936,0.98,1
"GO_BP:512213_GO_0051329_MITOTIC_INTERPHASE","GO_BP","512213_GO_0051329_MITOTIC_INTERPHASE",131,0.9667,0.54,0.99,2.0215,0,0.0097,-1.1969,0.12,0.73
"C2_Chemical_and_genetic_perturbations:C2_CGP_785_TERAMOTO_OPN_TARGETS_CLUSTER_4","C2_Chemical_and_genetic_perturbations","C2_CGP_785_TERAMOTO_OPN_TARGETS_CLUSTER_4",12,0.9668,0.48,1,0.9627,0.52,0.85,-1.0365,0.4,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_440_ODONNELL_METASTASIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_440_ODONNELL_METASTASIS_DN",23,0.9668,0.48,1,1.2716,0.16,0.42,1.1571,0.25,0.83
"C7_Immunologic_signatures:C7_ALL_1611_GSE3982_MAST_CELL_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1611_GSE3982_MAST_CELL_VS_NEUTROPHIL_UP",199,0.967,0.56,0.84,1.7882,0,0.00017,0.7891,0.97,1
"C1_Positional:C1_ALL_119_CHR7Q22","C1_Positional","C1_ALL_119_CHR7Q22",114,0.967,0.58,0.86,-0.813,0.88,1,1.1687,0.16,0.66
"KEGG_compound:C18075_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_11BETA_HYDROXYTESTOSTERONE","KEGG_compound","C18075_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_11BETA_HYDROXYTESTOSTERONE",6,0.967,0.48,1,1.5112,0.051,0.3,-1.431,0.084,0.26
"GO_BP:496424_GO_0016441_POSTTRANSCRIPTIONAL_GENE_SILENCING","GO_BP","496424_GO_0016441_POSTTRANSCRIPTIONAL_GENE_SILENCING",36,0.9673,0.51,0.99,-0.8568,0.69,1,-0.7467,0.89,1
"GO_CC:500838_GO_0031588_AMP_ACTIVATED_PROTEIN_KINASE_COMPLEX","GO_CC","500838_GO_0031588_AMP_ACTIVATED_PROTEIN_KINASE_COMPLEX",12,0.9673,0.48,0.86,0.9098,0.58,0.87,1.305,0.13,0.71
"GO_BP:925932_GO_1902583_MULTI_ORGANISM_INTRACELLULAR_TRANSPORT","GO_BP","925932_GO_1902583_MULTI_ORGANISM_INTRACELLULAR_TRANSPORT",32,0.9675,0.52,0.99,1.6794,0.01,0.21,-0.7501,0.86,1
"KEGG_enzyme:2.3.1.225_PROTEIN_S_ACYLTRANSFERASE_DHHC_PALMITOYL_TRANSFERASE_S_PROTEIN_ACYLTRANSFERASE_G_PROTEIN_PALMITOYLTRANSFERASE","KEGG_enzyme","2.3.1.225_PROTEIN_S_ACYLTRANSFERASE_DHHC_PALMITOYL_TRANSFERASE_S_PROTEIN_ACYLTRANSFERASE_G_PROTEIN_PALMITOYLTRANSFERASE",23,0.9675,0.48,0.73,-0.9043,0.61,0.9,-0.5788,0.99,1
"REACTOME:1127583_REACT_268324_DISEASES_OF_GLYCOSYLATION","REACTOME","1127583_REACT_268324_DISEASES_OF_GLYCOSYLATION",25,0.9678,0.51,0.78,1.2981,0.14,0.32,1.306,0.12,0.77
"C1_Positional:C1_ALL_182_CHR2Q21","C1_Positional","C1_ALL_182_CHR2Q21",52,0.9679,0.54,0.87,1.2162,0.14,0.61,1.0752,0.32,0.69
"GO_MF:515003_GO_0070064_PROLINE_RICH_REGION_BINDING","GO_MF","515003_GO_0070064_PROLINE_RICH_REGION_BINDING",19,0.968,0.48,1,-0.7371,0.82,1,0.6403,0.95,1
"GO_CC:994751_GO_0098687_CHROMOSOMAL_REGION","GO_CC","994751_GO_0098687_CHROMOSOMAL_REGION",225,0.9683,0.54,0.86,1.142,0.13,0.6,-0.9016,0.73,1
"C7_Immunologic_signatures:C7_ALL_547_GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_547_GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDM_UP",199,0.9684,0.55,0.83,1.3084,0.0094,0.094,-0.78,0.97,1
"C4_Cancer_modules:C4_CM_185_MODULE_198","C4_Cancer_modules","C4_CM_185_MODULE_198",301,0.9691,0.57,0.97,1.4495,0,0.15,-1.0585,0.27,0.6
"GO_MF:490475_GO_0005237_INHIBITORY_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY","GO_MF","490475_GO_0005237_INHIBITORY_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY",5,0.9693,0.5,1,-1.8583,0.0021,0.14,-1.6786,0.012,0.3
"GO_BP:512315_GO_0051437_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY_INVOLVED_IN_REGULATION_OF_MITOTIC_CELL_CYCLE_TRANSITION","GO_BP","512315_GO_0051437_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY_INVOLVED_IN_REGULATION_OF_MITOTIC_CELL_CYCLE_TRANSITION",72,0.9695,0.54,0.99,2.0668,0,0.0054,-0.7394,0.95,1
"GO_MF:492856_GO_0008599_PROTEIN_PHOSPHATASE_TYPE_1_REGULATOR_ACTIVITY","GO_MF","492856_GO_0008599_PROTEIN_PHOSPHATASE_TYPE_1_REGULATOR_ACTIVITY",12,0.9704,0.49,1,1.0113,0.46,0.87,-0.6176,0.95,1
"KEGG_reaction:R04682_ESTRIOL_NADP_17_OXIDOREDUCTASE_ESTRIOL_NADP_16ALPHA_HYDROXYESTRONE_NADPH_H_","KEGG_reaction","R04682_ESTRIOL_NADP_17_OXIDOREDUCTASE_ESTRIOL_NADP_16ALPHA_HYDROXYESTRONE_NADPH_H_",6,0.9706,0.49,0.89,1.4945,0.067,0.23,-1.465,0.065,0.31
"GO_BP:514157_GO_0060602_BRANCH_ELONGATION_OF_AN_EPITHELIUM","GO_BP","514157_GO_0060602_BRANCH_ELONGATION_OF_AN_EPITHELIUM",15,0.9708,0.49,0.98,0.9034,0.61,1,1.3053,0.13,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_1208_NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1208_NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON",15,0.9708,0.5,1,-1.1649,0.25,0.83,-0.9922,0.48,0.77
"GO_BP:491296_GO_0006356_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER","GO_BP","491296_GO_0006356_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER",21,0.971,0.52,0.99,0.9281,0.58,1,0.5879,0.98,1
"C7_Immunologic_signatures:C7_ALL_469_GSE17721_CTRL_VS_POLYIC_4H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_469_GSE17721_CTRL_VS_POLYIC_4H_BMDM_UP",198,0.9713,0.51,0.82,1.5278,0.0025,0.0085,-0.8368,0.91,1
"GO_BP:752359_GO_0075733_INTRACELLULAR_TRANSPORT_OF_VIRUS","GO_BP","752359_GO_0075733_INTRACELLULAR_TRANSPORT_OF_VIRUS",32,0.9715,0.49,0.99,1.6492,0.0061,0.25,-0.7453,0.88,1
"C7_Immunologic_signatures:C7_ALL_337_GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_337_GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP",200,0.9716,0.59,0.83,1.522,0,0.0092,0.9567,0.59,1
"GO_BP:1184365_GO_0097688_GLUTAMATE_RECEPTOR_CLUSTERING","GO_BP","1184365_GO_0097688_GLUTAMATE_RECEPTOR_CLUSTERING",5,0.9717,0.46,0.99,-0.7356,0.81,1,0.9444,0.53,0.91
"GO_CC:513649_GO_0060091_KINOCILIUM","GO_CC","513649_GO_0060091_KINOCILIUM",5,0.9719,0.46,0.86,-0.7595,0.77,1,-0.7832,0.73,1
"C4_Cancer_gene_neighborhoods:C4_CGN_196_GCM_BAG5","C4_Cancer_gene_neighborhoods","C4_CGN_196_GCM_BAG5",38,0.972,0.47,0.75,1.3075,0.1,0.11,-0.6357,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2487_FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2487_FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN",29,0.972,0.49,1,0.8096,0.77,0.98,0.8384,0.7,1
"REACTOME:106003_REACT_6162_TAT_MEDIATED_ELONGATION_OF_THE_HIV_1_TRANSCRIPT","REACTOME","106003_REACT_6162_TAT_MEDIATED_ELONGATION_OF_THE_HIV_1_TRANSCRIPT",42,0.972,0.51,0.78,1.5537,0.0091,0.12,1.007,0.42,1
"KEGG_reaction:R04681_ESTRIOL_NAD_17_OXIDOREDUCTASE_ESTRIOL_NAD_16ALPHA_HYDROXYESTRONE_NADH_H_","KEGG_reaction","R04681_ESTRIOL_NAD_17_OXIDOREDUCTASE_ESTRIOL_NAD_16ALPHA_HYDROXYESTRONE_NADH_H_",6,0.972,0.47,0.92,1.512,0.046,0.22,-1.3916,0.1,0.36
"REACTOME:105843_REACT_1405_DEPYRIMIDINATION","REACTOME","105843_REACT_1405_DEPYRIMIDINATION",8,0.9721,0.46,0.78,1.1569,0.29,0.5,-0.8824,0.59,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_930_TOMLINS_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_930_TOMLINS_METASTASIS_UP",13,0.9722,0.5,1,-0.9377,0.56,1,-0.7719,0.77,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_87_TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_87_TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN",7,0.9727,0.45,1,-0.9363,0.51,1,1.2205,0.22,0.75
"GO_BP:516523_GO_0071599_OTIC_VESICLE_DEVELOPMENT","GO_BP","516523_GO_0071599_OTIC_VESICLE_DEVELOPMENT",15,0.9732,0.51,0.98,-0.9473,0.51,1,-0.8528,0.68,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_208_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_208_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN",60,0.9736,0.56,1,1.048,0.36,0.72,0.9145,0.61,1
"GO_MF:509128_GO_0046923_ER_RETENTION_SEQUENCE_BINDING","GO_MF","509128_GO_0046923_ER_RETENTION_SEQUENCE_BINDING",5,0.9739,0.48,1,-0.9639,0.52,0.95,1.1061,0.38,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_3354_HOLLEMAN_DAUNORUBICIN_ALL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3354_HOLLEMAN_DAUNORUBICIN_ALL_DN",8,0.974,0.48,1,1.4526,0.082,0.25,0.8829,0.6,1
"GO_BP:491230_GO_0006266_DNA_LIGATION","GO_BP","491230_GO_0006266_DNA_LIGATION",11,0.9741,0.47,0.98,1.3876,0.12,0.57,-0.9435,0.53,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_361_HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_361_HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN",116,0.9743,0.53,1,1.871,0,0.024,-1.075,0.28,0.66
"REACTOME:105730_REACT_6889_CONJUGATION_OF_CARBOXYLIC_ACIDS","REACTOME","105730_REACT_6889_CONJUGATION_OF_CARBOXYLIC_ACIDS",9,0.9744,0.45,0.77,-1.5004,0.049,0.45,0.8911,0.59,1
"GO_BP:499570_GO_0030150_PROTEIN_IMPORT_INTO_MITOCHONDRIAL_MATRIX","GO_BP","499570_GO_0030150_PROTEIN_IMPORT_INTO_MITOCHONDRIAL_MATRIX",5,0.9746,0.47,0.98,1.1903,0.29,0.79,0.4291,1,1
"KEGG_module:HSA_M00092_PHOSPHATIDYLETHANOLAMINE_PE_BIOSYNTHESIS_ETHANOLAMINE_PE","KEGG_module","HSA_M00092_PHOSPHATIDYLETHANOLAMINE_PE_BIOSYNTHESIS_ETHANOLAMINE_PE",7,0.9746,0.48,0.76,0.6957,0.82,0.95,0.5669,0.96,1
"REACTOME:833806_REACT_163793_PROCESSING_AND_ACTIVATION_OF_SUMO","REACTOME","833806_REACT_163793_PROCESSING_AND_ACTIVATION_OF_SUMO",9,0.9746,0.48,0.78,1.5053,0.063,0.14,1.0108,0.43,1
"REACTOME:161055_REACT_6143_PAUSING_AND_RECOVERY_OF_TAT_MEDIATED_HIV_ELONGATION","REACTOME","161055_REACT_6143_PAUSING_AND_RECOVERY_OF_TAT_MEDIATED_HIV_ELONGATION",30,0.9751,0.49,0.78,1.534,0.02,0.13,1.0736,0.33,0.95
"REACTOME:1127584_REACT_268624_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM","REACTOME","1127584_REACT_268624_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM",25,0.9752,0.47,0.78,1.3041,0.12,0.32,1.3168,0.11,0.77
"C4_Cancer_gene_neighborhoods:C4_CGN_275_GCM_ZNF198","C4_Cancer_gene_neighborhoods","C4_CGN_275_GCM_ZNF198",118,0.9756,0.5,0.74,-0.5547,1,1,-0.532,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_630_HAEGERSTRAND_RESPONSE_TO_IMATINIB","C2_Chemical_and_genetic_perturbations","C2_CGP_630_HAEGERSTRAND_RESPONSE_TO_IMATINIB",9,0.9756,0.49,1,1.0031,0.45,0.79,0.7965,0.73,1
"GO_CC:489295_GO_0005930_AXONEME","GO_CC","489295_GO_0005930_AXONEME",80,0.9758,0.52,0.85,-1.1915,0.16,0.67,0.6652,0.99,1
"GO_BP:501610_GO_0032375_NEGATIVE_REGULATION_OF_CHOLESTEROL_TRANSPORT","GO_BP","501610_GO_0032375_NEGATIVE_REGULATION_OF_CHOLESTEROL_TRANSPORT",11,0.9761,0.43,0.98,0.8909,0.6,1,1.1112,0.31,0.75
"C4_Cancer_modules:C4_CM_282_MODULE_323","C4_Cancer_modules","C4_CM_282_MODULE_323",61,0.9762,0.5,0.98,1.4707,0.021,0.14,0.8191,0.82,1
"REACTOME:645306_REACT_121248_HS_GAG_BIOSYNTHESIS","REACTOME","645306_REACT_121248_HS_GAG_BIOSYNTHESIS",30,0.9763,0.5,0.78,1.7938,0.0062,0.022,1.269,0.13,0.79
"GO_MF:490565_GO_0005385_ZINC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","490565_GO_0005385_ZINC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",15,0.9765,0.48,1,-0.8618,0.64,1,-0.6763,0.89,1
"GO_BP:510587_GO_0048515_SPERMATID_DIFFERENTIATION","GO_BP","510587_GO_0048515_SPERMATID_DIFFERENTIATION",107,0.9766,0.5,0.98,-0.9467,0.59,1,-0.8962,0.72,0.93
"KEGG_enzyme:1.6.5.3_NADH_UBIQUINONE_REDUCTASE_H_TRANSLOCATING_UBIQUINONE_REDUCTASE_TYPE_1_DEHYDROGENASE_COMPLEX_1_DEHYDROGENASE_COENZYME_Q_REDUCTASE_COMPLEX_I_ELECTRON_TRANSPORT_CHAIN_COMPLEX_I_MITOCHONDRIAL_ELECTRON_TRANSPORT_COMPLEX_I_NADH_Q1_OXIDOREDUCTASE_DIHYDRONICOTINAMIDE_ADENINE_DINUCLEOTIDE_COENZYME_Q_REDUCTASE_DPNH_COENZYME_Q_REDUCTASE_DPNH_UBIQUINONE_REDUCTASE_MITOCHONDRIAL_ELECTRON_TRANSPORT_COMPLEX_1_MITOCHONDRIAL_ELECTRON_TRANSPORT_COMPLEX_I_NADH_COENZYME_Q1_REDUCTASE_NADH_COENZYME_Q_OXIDOREDUCTASE_NADH_COENZYME_Q_REDUCTASE_NADH_COQ_OXIDOREDUCTASE_NADH_COQ_REDUCTASE_NADH_UBIQUINONE_REDUCTASE_NADH_UBIQUINONE_OXIDOREDUCTASE_NADH_UBIQUINONE_1_REDUCTASE_REDUCED_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_COENZYME_Q_REDUCTASE_NADH_UBIQUINONE_OXIDOREDUCTASE_COMPLEX_NADH_Q6_OXIDOREDUCTASE_ELECTRON_TRANSFER_COMPLEX_I_NADH2_DEHYDROGENASE_UBIQUINONE_","KEGG_enzyme","1.6.5.3_NADH_UBIQUINONE_REDUCTASE_H_TRANSLOCATING_UBIQUINONE_REDUCTASE_TYPE_1_DEHYDROGENASE_COMPLEX_1_DEHYDROGENASE_COENZYME_Q_REDUCTASE_COMPLEX_I_ELECTRON_TRANSPORT_CHAIN_COMPLEX_I_MITOCHONDRIAL_ELECTRON_TRANSPORT_COMPLEX_I_NADH_Q1_OXIDOREDUCTASE_DIHYDRONICOTINAMIDE_ADENINE_DINUCLEOTIDE_COENZYME_Q_REDUCTASE_DPNH_COENZYME_Q_REDUCTASE_DPNH_UBIQUINONE_REDUCTASE_MITOCHONDRIAL_ELECTRON_TRANSPORT_COMPLEX_1_MITOCHONDRIAL_ELECTRON_TRANSPORT_COMPLEX_I_NADH_COENZYME_Q1_REDUCTASE_NADH_COENZYME_Q_OXIDOREDUCTASE_NADH_COENZYME_Q_REDUCTASE_NADH_COQ_OXIDOREDUCTASE_NADH_COQ_REDUCTASE_NADH_UBIQUINONE_REDUCTASE_NADH_UBIQUINONE_OXIDOREDUCTASE_NADH_UBIQUINONE_1_REDUCTASE_REDUCED_NICOTINAMIDE_ADENINE_DINUCLEOTIDE_COENZYME_Q_REDUCTASE_NADH_UBIQUINONE_OXIDOREDUCTASE_COMPLEX_NADH_Q6_OXIDOREDUCTASE_ELECTRON_TRANSFER_COMPLEX_I_NADH2_DEHYDROGENASE_UBIQUINONE_",7,0.9772,0.45,0.79,1.5,0.063,0.3,0.8514,0.62,0.82
"GO_BP:753034_GO_1900037_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA","GO_BP","753034_GO_1900037_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA",7,0.9773,0.46,0.98,0.5348,0.98,1,0.7209,0.83,1
"GO_CC:487089_GO_0000798_NUCLEAR_COHESIN_COMPLEX","GO_CC","487089_GO_0000798_NUCLEAR_COHESIN_COMPLEX",6,0.9774,0.47,0.85,0.7345,0.77,0.99,1.3666,0.14,0.75
"GO_BP:487763_GO_0001867_COMPLEMENT_ACTIVATION_LECTIN_PATHWAY","GO_BP","487763_GO_0001867_COMPLEMENT_ACTIVATION_LECTIN_PATHWAY",6,0.9775,0.49,0.98,1.3419,0.13,0.62,-1.0337,0.43,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1400_POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1400_POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN",43,0.9777,0.49,1,2.2748,0,0.00017,0.374,1,1
"GO_BP:487007_GO_0000710_MEIOTIC_MISMATCH_REPAIR","GO_BP","487007_GO_0000710_MEIOTIC_MISMATCH_REPAIR",5,0.9779,0.45,0.98,-1.2173,0.25,0.88,-1.273,0.19,0.66
"C4_Cancer_gene_neighborhoods:C4_CGN_177_MORF_SKP1A","C4_Cancer_gene_neighborhoods","C4_CGN_177_MORF_SKP1A",204,0.978,0.51,0.74,2.6506,0,0,0.7194,0.99,1
"GO_MF:506113_GO_0043023_RIBOSOMAL_LARGE_SUBUNIT_BINDING","GO_MF","506113_GO_0043023_RIBOSOMAL_LARGE_SUBUNIT_BINDING",7,0.9781,0.46,1,1.4984,0.065,0.39,0.8843,0.62,0.97
"GO_CC:752847_GO_0097346_INO80_TYPE_COMPLEX","GO_CC","752847_GO_0097346_INO80_TYPE_COMPLEX",21,0.9781,0.47,0.85,0.9035,0.61,0.89,-0.7367,0.85,1
"GO_MF:489246_GO_0003696_SATELLITE_DNA_BINDING","GO_MF","489246_GO_0003696_SATELLITE_DNA_BINDING",7,0.9782,0.46,1,1.0572,0.38,0.83,0.8587,0.64,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_2081_SANSOM_APC_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_2081_SANSOM_APC_TARGETS",204,0.9782,0.58,1,0.8337,0.91,0.98,-1.0198,0.4,0.73
"KEGG_reaction:R06227_GDP_L_FUCOSE_G00081_GDP_G00082","KEGG_reaction","R06227_GDP_L_FUCOSE_G00081_GDP_G00082",5,0.9787,0.48,0.93,1.1148,0.35,0.91,-0.717,0.82,0.91
"REACTOME:105750_REACT_828_G2_M_CHECKPOINTS","REACTOME","105750_REACT_828_G2_M_CHECKPOINTS",51,0.9787,0.43,0.78,1.3568,0.067,0.26,-1.2326,0.12,0.58
"GO_BP:491101_GO_0006120_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE","GO_BP","491101_GO_0006120_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE",39,0.9788,0.47,0.98,2.4596,0,0,1.1101,0.26,0.75
"REACTOME:1127549_REACT_267701_APC_CDC20_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS_PRIOR_TO_SATISFATION_OF_THE_CELL_CYCLE_CHECKPOINT","REACTOME","1127549_REACT_267701_APC_CDC20_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS_PRIOR_TO_SATISFATION_OF_THE_CELL_CYCLE_CHECKPOINT",70,0.9791,0.51,0.78,2.1418,0,0.00035,-0.6911,0.98,1
"GO_BP:500261_GO_0030970_RETROGRADE_PROTEIN_TRANSPORT_ER_TO_CYTOSOL","GO_BP","500261_GO_0030970_RETROGRADE_PROTEIN_TRANSPORT_ER_TO_CYTOSOL",5,0.9792,0.47,0.98,1.2978,0.19,0.67,1.1391,0.32,0.73
"OMIM_gene:OMIM603026_PLEOMORPHIC_ADENOMA_GENE_1_PLAG1_PLAG1_CTNNB1_FUSION_GENE_INCLUDED","OMIM_gene","OMIM603026_PLEOMORPHIC_ADENOMA_GENE_1_PLAG1_PLAG1_CTNNB1_FUSION_GENE_INCLUDED",5,0.9792,0.45,1,1.3751,0.11,0.94,-0.9102,0.59,0.99
"REACTOME:105839_REACT_804_BASE_EXCISION_REPAIR_AP_SITE_FORMATION","REACTOME","105839_REACT_804_BASE_EXCISION_REPAIR_AP_SITE_FORMATION",10,0.9792,0.43,0.78,1.2382,0.21,0.41,-0.7799,0.74,1
"GO_CC:506627_GO_0043596_NUCLEAR_REPLICATION_FORK","GO_CC","506627_GO_0043596_NUCLEAR_REPLICATION_FORK",39,0.9795,0.47,0.86,1.1714,0.21,0.56,-1.0839,0.32,0.93
"GO_BP:501694_GO_0032462_REGULATION_OF_PROTEIN_HOMOOLIGOMERIZATION","GO_BP","501694_GO_0032462_REGULATION_OF_PROTEIN_HOMOOLIGOMERIZATION",15,0.9797,0.47,0.98,1.3403,0.13,0.62,-1.0976,0.34,0.78
"REACTOME:105739_REACT_1538_CELL_CYCLE_CHECKPOINTS","REACTOME","105739_REACT_1538_CELL_CYCLE_CHECKPOINTS",125,0.9799,0.49,0.78,1.8934,0,0.0087,-1.1013,0.23,0.7
"GO_MF:515423_GO_0070491_REPRESSING_TRANSCRIPTION_FACTOR_BINDING","GO_MF","515423_GO_0070491_REPRESSING_TRANSCRIPTION_FACTOR_BINDING",53,0.98,0.46,1,0.8094,0.82,1,-0.9049,0.62,0.87
"REACTOME:106102_REACT_1988_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY","REACTOME","106102_REACT_1988_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY",5,0.98,0.46,0.78,0.9931,0.5,0.76,1.5757,0.026,0.44
"GO_BP:519267_GO_2000628_REGULATION_OF_MIRNA_METABOLIC_PROCESS","GO_BP","519267_GO_2000628_REGULATION_OF_MIRNA_METABOLIC_PROCESS",7,0.9803,0.45,0.98,0.8485,0.62,1,-1.0026,0.45,0.85
"C6_Oncogenic_signatures:C6_ALL_21_CSR_EARLY_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_21_CSR_EARLY_UP_V1_DN",122,0.9804,0.52,0.85,-0.8,0.89,0.99,-1.177,0.14,0.42
"C2_Chemical_and_genetic_perturbations:C2_CGP_3355_HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3355_HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP",22,0.9813,0.49,1,2.1932,0,0.00057,0.8893,0.63,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2608_ZHANG_TLX_TARGETS_60HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2608_ZHANG_TLX_TARGETS_60HR_DN",277,0.9818,0.57,1,1.4653,0,0.24,-1.2693,0.03,0.45
"REACTOME:105729_REACT_6971_AMINO_ACID_CONJUGATION","REACTOME","105729_REACT_6971_AMINO_ACID_CONJUGATION",9,0.9819,0.43,0.78,-1.4981,0.067,0.45,0.9031,0.57,1
"REACTOME:106381_REACT_18319_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS_","REACTOME","106381_REACT_18319_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS_",36,0.9822,0.47,0.78,0.6775,0.95,1,1.6613,0.006,0.4
"GO_BP:506576_GO_0043545_MOLYBDOPTERIN_COFACTOR_METABOLIC_PROCESS","GO_BP","506576_GO_0043545_MOLYBDOPTERIN_COFACTOR_METABOLIC_PROCESS",7,0.9827,0.49,0.97,0.917,0.56,1,0.7208,0.82,1
"GO_BP:516501_GO_0071577_ZINC_II_ION_TRANSMEMBRANE_TRANSPORT","GO_BP","516501_GO_0071577_ZINC_II_ION_TRANSMEMBRANE_TRANSPORT",15,0.9827,0.46,0.97,-0.8614,0.66,1,-0.6589,0.9,1
"REACTOME:105901_REACT_207_REMOVAL_OF_LICENSING_FACTORS_FROM_ORIGINS","REACTOME","105901_REACT_207_REMOVAL_OF_LICENSING_FACTORS_FROM_ORIGINS",72,0.9829,0.47,0.79,2.0743,0,0.00087,-0.8567,0.76,0.98
"GO_BP:505040_GO_0035871_PROTEIN_K11_LINKED_DEUBIQUITINATION","GO_BP","505040_GO_0035871_PROTEIN_K11_LINKED_DEUBIQUITINATION",10,0.9833,0.47,0.97,0.7472,0.79,1,0.5837,0.96,1
"REACTOME:576255_REACT_118823_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA","REACTOME","576255_REACT_118823_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA",67,0.9836,0.47,0.79,1.2108,0.13,0.43,-0.8173,0.85,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2996_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2996_BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP",9,0.9839,0.47,1,0.6646,0.87,1,0.6932,0.86,1
"KEGG_pathway:HSA00240_PYRIMIDINE_METABOLISM","KEGG_pathway","HSA00240_PYRIMIDINE_METABOLISM",102,0.984,0.47,0.66,1.0585,0.33,0.83,-0.9999,0.44,0.68
"C1_Positional:C1_ALL_94_CHR5P12","C1_Positional","C1_ALL_94_CHR5P12",14,0.9843,0.47,0.83,-1.0062,0.42,1,-0.6999,0.87,0.99
"GO_BP:493272_GO_0009071_SERINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS","GO_BP","493272_GO_0009071_SERINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS",10,0.9843,0.48,0.97,1.2302,0.2,0.75,1.5122,0.056,0.55
"GO_BP:501607_GO_0032372_NEGATIVE_REGULATION_OF_STEROL_TRANSPORT","GO_BP","501607_GO_0032372_NEGATIVE_REGULATION_OF_STEROL_TRANSPORT",11,0.9844,0.43,0.97,0.891,0.6,1,1.1157,0.34,0.75
"GO_BP:487519_GO_0001580_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_BITTER_TASTE","GO_BP","487519_GO_0001580_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_BITTER_TASTE",31,0.9846,0.47,0.97,-0.8134,0.78,1,1.1839,0.2,0.72
"GO_CC:750986_GO_0036064_CILIARY_BASAL_BODY","GO_CC","750986_GO_0036064_CILIARY_BASAL_BODY",84,0.9847,0.52,0.85,-0.6051,1,1,-1.0603,0.35,0.98
"GO_BP:512445_GO_0051567_HISTONE_H3_K9_METHYLATION","GO_BP","512445_GO_0051567_HISTONE_H3_K9_METHYLATION",12,0.9849,0.48,0.97,-0.8691,0.59,1,-0.69,0.85,0.99
"GO_MF:496763_GO_0016874_LIGASE_ACTIVITY","GO_MF","496763_GO_0016874_LIGASE_ACTIVITY",425,0.9849,0.63,1,1.0215,0.36,0.86,-0.8933,0.87,0.88
"GO_MF:496688_GO_0016779_NUCLEOTIDYLTRANSFERASE_ACTIVITY","GO_MF","496688_GO_0016779_NUCLEOTIDYLTRANSFERASE_ACTIVITY",123,0.9852,0.51,1,1.0421,0.35,0.83,-0.7507,0.97,0.99
"GO_MF:487862_GO_0001972_RETINOIC_ACID_BINDING","GO_MF","487862_GO_0001972_RETINOIC_ACID_BINDING",22,0.9854,0.46,1,1.0487,0.41,0.83,1.5326,0.026,0.38
"C2_Chemical_and_genetic_perturbations:C2_CGP_2486_FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2486_FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP",53,0.9855,0.49,1,2.6461,0,0,1.1411,0.24,0.83
"GO_BP:488072_GO_0002183_CYTOPLASMIC_TRANSLATIONAL_INITIATION","GO_BP","488072_GO_0002183_CYTOPLASMIC_TRANSLATIONAL_INITIATION",8,0.9857,0.46,0.97,1.4339,0.11,0.52,-0.5329,0.99,1
"C7_Immunologic_signatures:C7_ALL_416_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN","C7_Immunologic_signatures","C7_ALL_416_GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN",199,0.9859,0.55,0.76,1.4207,0,0.031,-0.9915,0.49,0.74
"GO_BP:500241_GO_0030948_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","500241_GO_0030948_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",7,0.9859,0.48,0.97,-0.6823,0.83,1,-0.7777,0.73,1
"GO_BP:492149_GO_0007386_COMPARTMENT_PATTERN_SPECIFICATION","GO_BP","492149_GO_0007386_COMPARTMENT_PATTERN_SPECIFICATION",5,0.9864,0.48,0.97,-0.7818,0.73,1,0.9109,0.55,0.93
"GO_BP:512578_GO_0051703_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS","GO_BP","512578_GO_0051703_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS",42,0.9865,0.48,0.97,0.7536,0.89,1,0.6455,0.98,1
"KEGG_reaction:R02352_ESTRADIOL_17BETA_NAD_17_OXIDOREDUCTASE_ESTRADIOL_17BETA_NAD_ESTRONE_NADH_H_","KEGG_reaction","R02352_ESTRADIOL_17BETA_NAD_17_OXIDOREDUCTASE_ESTRADIOL_17BETA_NAD_ESTRONE_NADH_H_",6,0.9865,0.46,0.94,1.5336,0.058,0.22,-1.4296,0.079,0.32
"C7_Immunologic_signatures:C7_ALL_138_GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN","C7_Immunologic_signatures","C7_ALL_138_GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN",198,0.9867,0.46,0.76,1.7846,0,0.00017,0.7185,1,1
"REACTOME:106001_REACT_6274_HIV_TRANSCRIPTION_ELONGATION","REACTOME","106001_REACT_6274_HIV_TRANSCRIPTION_ELONGATION",42,0.9868,0.47,0.78,1.5344,0.022,0.13,1.0018,0.45,1
"GO_BP:506034_GO_0042940_D_AMINO_ACID_TRANSPORT","GO_BP","506034_GO_0042940_D_AMINO_ACID_TRANSPORT",5,0.9869,0.44,0.97,0.6591,0.89,1,-0.9726,0.51,0.88
"REACTOME:106004_REACT_6346_FORMATION_OF_HIV_1_ELONGATION_COMPLEX_CONTAINING_HIV_1_TAT","REACTOME","106004_REACT_6346_FORMATION_OF_HIV_1_ELONGATION_COMPLEX_CONTAINING_HIV_1_TAT",42,0.9875,0.46,0.78,1.5607,0.024,0.12,1.0052,0.46,1
"GO_BP:505961_GO_0042866_PYRUVATE_BIOSYNTHETIC_PROCESS","GO_BP","505961_GO_0042866_PYRUVATE_BIOSYNTHETIC_PROCESS",5,0.9878,0.46,0.97,1.3391,0.16,0.62,1.0124,0.46,0.84
"GO_CC:516067_GO_0071141_SMAD_PROTEIN_COMPLEX","GO_CC","516067_GO_0071141_SMAD_PROTEIN_COMPLEX",5,0.9879,0.44,0.84,0.8377,0.66,0.93,1.0473,0.42,0.98
"C7_Immunologic_signatures:C7_ALL_21_GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_21_GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP",200,0.9882,0.52,0.75,1.2814,0.031,0.12,-0.85,0.85,1
"GO_MF:495446_GO_0015174_BASIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495446_GO_0015174_BASIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",9,0.9883,0.43,1,1.1733,0.27,0.74,1.3269,0.15,0.67
"REACTOME:161056_REACT_21376_PYRIMIDINE_BIOSYNTHESIS","REACTOME","161056_REACT_21376_PYRIMIDINE_BIOSYNTHESIS",6,0.9885,0.46,0.78,1.1912,0.27,0.45,1.0003,0.47,1
"C4_Cancer_gene_neighborhoods:C4_CGN_218_GCM_CSNK1A1","C4_Cancer_gene_neighborhoods","C4_CGN_218_GCM_CSNK1A1",36,0.9889,0.47,0.7,1.4933,0.019,0.033,-0.6213,0.98,1
"KEGG_reaction:R06025_GDP_L_FUCOSE_PARAGLOBOSIDE_GDP_III3FUC_NLC4CER","KEGG_reaction","R06025_GDP_L_FUCOSE_PARAGLOBOSIDE_GDP_III3FUC_NLC4CER",5,0.9891,0.47,0.97,1.1404,0.32,1,-0.7114,0.81,0.9
"GO_BP:518685_GO_2000036_REGULATION_OF_STEM_CELL_MAINTENANCE","GO_BP","518685_GO_2000036_REGULATION_OF_STEM_CELL_MAINTENANCE",17,0.9891,0.47,0.97,1.0496,0.39,0.95,-1.2538,0.17,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_2651_MILI_PSEUDOPODIA","C2_Chemical_and_genetic_perturbations","C2_CGP_2651_MILI_PSEUDOPODIA",43,0.9893,0.46,1,1.4136,0.038,0.28,0.8288,0.78,1
"C7_Immunologic_signatures:C7_ALL_165_GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP","C7_Immunologic_signatures","C7_ALL_165_GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP",194,0.9897,0.52,0.75,0.8868,0.78,1,-1.0325,0.36,0.65
"GO_BP:491887_GO_0007064_MITOTIC_SISTER_CHROMATID_COHESION","GO_BP","491887_GO_0007064_MITOTIC_SISTER_CHROMATID_COHESION",12,0.9897,0.44,0.97,-0.4527,1,1,-1.0003,0.45,0.85
"GO_BP:491617_GO_0051189_PROSTHETIC_GROUP_METABOLIC_PROCESS","GO_BP","491617_GO_0051189_PROSTHETIC_GROUP_METABOLIC_PROCESS",7,0.9899,0.46,0.97,0.9077,0.55,1,0.719,0.8,1
"GO_BP:499219_GO_0021940_POSITIVE_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION","GO_BP","499219_GO_0021940_POSITIVE_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION",7,0.9901,0.44,0.97,1.4332,0.08,0.52,0.857,0.64,0.97
"REACTOME:106236_REACT_1853_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS","REACTOME","106236_REACT_1853_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS",25,0.9903,0.46,0.78,1.0023,0.45,0.75,0.6266,0.97,1
"C7_Immunologic_signatures:C7_ALL_825_GSE17974_0_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_825_GSE17974_0_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP",197,0.9909,0.46,0.75,1.4014,0,0.037,1.0867,0.24,1
"GO_BP:491650_GO_0006777_MO_MOLYBDOPTERIN_COFACTOR_BIOSYNTHETIC_PROCESS","GO_BP","491650_GO_0006777_MO_MOLYBDOPTERIN_COFACTOR_BIOSYNTHETIC_PROCESS",7,0.9913,0.45,0.97,0.9152,0.56,1,0.7173,0.79,1
"REACTOME:645316_REACT_120919_SYNTHESIS_OF_PE","REACTOME","645316_REACT_120919_SYNTHESIS_OF_PE",12,0.9913,0.46,0.78,0.5611,0.98,1,0.6719,0.9,1
"C1_Positional:C1_ALL_296_CHR7Q11","C1_Positional","C1_ALL_296_CHR7Q11",115,0.9915,0.45,0.83,-0.7227,0.97,0.98,1.3631,0.025,0.43
"C7_Immunologic_signatures:C7_ALL_331_GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_331_GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP",192,0.9917,0.45,0.75,0.858,0.85,1,0.8926,0.77,1
"C4_Cancer_modules:C4_CM_93_MODULE_98","C4_Cancer_modules","C4_CM_93_MODULE_98",391,0.9918,0.46,0.96,1.6384,0,0.065,-0.8737,0.91,0.89
"GO_CC:502422_GO_0033202_DNA_HELICASE_COMPLEX","GO_CC","502422_GO_0033202_DNA_HELICASE_COMPLEX",14,0.9918,0.45,0.84,0.8086,0.73,0.95,-0.8809,0.63,1
"REACTOME:730319_REACT_150421_COHESIN_LOADING_ONTO_CHROMATIN","REACTOME","730319_REACT_150421_COHESIN_LOADING_ONTO_CHROMATIN",10,0.9919,0.46,0.78,1.102,0.31,0.58,-0.6094,0.95,1
"REACTOME:105748_REACT_2160_P53_INDEPENDENT_DNA_DAMAGE_RESPONSE","REACTOME","105748_REACT_2160_P53_INDEPENDENT_DNA_DAMAGE_RESPONSE",52,0.9919,0.48,0.79,2.1185,0,0.00047,-0.5604,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3165_BERGER_MBD2_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3165_BERGER_MBD2_TARGETS",5,0.992,0.45,1,0.7018,0.81,1,1.0406,0.43,0.92
"GO_BP:486639_GO_0000097_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS","GO_BP","486639_GO_0000097_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS",20,0.9923,0.45,0.97,0.6896,0.9,1,-1.6028,0.026,0.51
"GO_BP:498344_GO_0019509_L_METHIONINE_BIOSYNTHETIC_PROCESS_FROM_METHYLTHIOADENOSINE","GO_BP","498344_GO_0019509_L_METHIONINE_BIOSYNTHETIC_PROCESS_FROM_METHYLTHIOADENOSINE",9,0.9924,0.43,0.97,0.6566,0.87,1,-1.1067,0.34,0.77
"GO_BP:508982_GO_0046755_VIRAL_BUDDING","GO_BP","508982_GO_0046755_VIRAL_BUDDING",16,0.9926,0.43,0.97,1.5332,0.029,0.36,1.1462,0.27,0.73
"GO_MF:499873_GO_0030547_RECEPTOR_INHIBITOR_ACTIVITY","GO_MF","499873_GO_0030547_RECEPTOR_INHIBITOR_ACTIVITY",11,0.9926,0.46,1,-0.9253,0.58,0.97,1.0729,0.38,0.81
"REACTOME:105822_REACT_567_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION","REACTOME","105822_REACT_567_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION",6,0.993,0.45,0.79,1.0216,0.44,0.71,-0.9164,0.57,0.94
"GO_BP:513996_GO_0060441_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS","GO_BP","513996_GO_0060441_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS",28,0.9935,0.45,0.97,1.3453,0.098,0.61,1.6077,0.018,0.41
"GO_BP:517150_GO_0072234_METANEPHRIC_NEPHRON_TUBULE_DEVELOPMENT","GO_BP","517150_GO_0072234_METANEPHRIC_NEPHRON_TUBULE_DEVELOPMENT",15,0.9935,0.46,0.97,-0.833,0.7,1,0.9919,0.48,0.86
"GO_BP:491298_GO_0006359_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER","GO_BP","491298_GO_0006359_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER",22,0.9936,0.48,0.97,-0.552,0.98,1,0.9902,0.49,0.87
"GO_BP:498862_GO_0021578_HINDBRAIN_MATURATION","GO_BP","498862_GO_0021578_HINDBRAIN_MATURATION",6,0.9939,0.45,0.97,-0.8446,0.63,1,1.0684,0.38,0.78
"C7_Immunologic_signatures:C7_ALL_1271_GSE29618_BCELL_VS_PDC_UP","C7_Immunologic_signatures","C7_ALL_1271_GSE29618_BCELL_VS_PDC_UP",188,0.9943,0.49,0.74,1.1852,0.11,0.25,-0.8914,0.78,0.96
"C7_Immunologic_signatures:C7_ALL_1151_GSE27786_LSK_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1151_GSE27786_LSK_VS_NKCELL_UP",200,0.9944,0.45,0.75,0.8069,0.97,1,-1.1015,0.21,0.5
"GO_BP:925941_GO_1902592_MULTI_ORGANISM_MEMBRANE_BUDDING","GO_BP","925941_GO_1902592_MULTI_ORGANISM_MEMBRANE_BUDDING",16,0.9949,0.47,0.97,1.5745,0.042,0.32,1.1268,0.28,0.74
"C7_Immunologic_signatures:C7_ALL_1681_GSE3982_BCELL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1681_GSE3982_BCELL_VS_NKCELL_UP",191,0.9949,0.48,0.75,1.2152,0.073,0.2,-1.0216,0.39,0.68
"KEGG_reaction:R08980_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NADP_17_OXIDOREDUCTASE_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NADP_11BETA_HYDROXYANDROST_4_ENE_3_17_DIONE_NADPH_H_","KEGG_reaction","R08980_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NADP_17_OXIDOREDUCTASE_11BETA_17BETA_DIHYDROXY_4_ANDROSTEN_3_ONE_NADP_11BETA_HYDROXYANDROST_4_ENE_3_17_DIONE_NADPH_H_",6,0.9951,0.47,0.98,1.5189,0.044,0.22,-1.4368,0.088,0.34
"GO_CC:487068_GO_0000775_CHROMOSOME_CENTROMERIC_REGION","GO_CC","487068_GO_0000775_CHROMOSOME_CENTROMERIC_REGION",168,0.9953,0.47,0.83,1.2412,0.062,0.47,-0.7948,0.95,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_564_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_564_RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP",7,0.9954,0.44,1,0.7606,0.78,1,-1.2905,0.16,0.44
"KEGG_compound:C00362_DGMP_2_DEOXYGUANOSINE_5_MONOPHOSPHATE_2_DEOXYGUANOSINE_5_PHOSPHATE_DEOXYGUANYLIC_ACID_DEOXYGUANOSINE_MONOPHOSPHATE","KEGG_compound","C00362_DGMP_2_DEOXYGUANOSINE_5_MONOPHOSPHATE_2_DEOXYGUANOSINE_5_PHOSPHATE_DEOXYGUANYLIC_ACID_DEOXYGUANOSINE_MONOPHOSPHATE",12,0.9955,0.44,1,1.1235,0.3,1,-0.8632,0.64,0.8
"C1_Positional:C1_ALL_273_CHR5P15","C1_Positional","C1_ALL_273_CHR5P15",72,0.9957,0.47,0.83,0.9705,0.5,0.79,1.043,0.38,0.72
"REACTOME:530772_REACT_18355_ATF4_ACTIVATES_GENES","REACTOME","530772_REACT_18355_ATF4_ACTIVATES_GENES",24,0.9957,0.45,0.78,1.1318,0.28,0.54,0.9012,0.6,1
"OMIM_gene:OMIM603453_RECEPTOR_INTERACTING_SERINE_THREONINE_KINASE_1_RIPK1","OMIM_gene","OMIM603453_RECEPTOR_INTERACTING_SERINE_THREONINE_KINASE_1_RIPK1",5,0.9959,0.43,1,1.3078,0.17,0.74,1.0697,0.39,1
"C4_Cancer_gene_neighborhoods:C4_CGN_164_MORF_RAB3A","C4_Cancer_gene_neighborhoods","C4_CGN_164_MORF_RAB3A",84,0.9962,0.46,0.68,0.8993,0.67,0.83,1.2272,0.13,0.39
"C7_Immunologic_signatures:C7_ALL_1531_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP","C7_Immunologic_signatures","C7_ALL_1531_GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP",191,0.9963,0.45,0.75,1.0557,0.31,0.57,1.1773,0.11,0.8
"C3_MicroRNA_targets:C3_MIR_8_GCGCTTT_MIR_518B_MIR_518C_MIR_518D","C3_MicroRNA_targets","C3_MIR_8_GCGCTTT_MIR_518B_MIR_518C_MIR_518D",20,0.9963,0.46,1,1.4869,0.043,0.67,-0.9841,0.48,1
"GO_BP:488937_GO_0003143_EMBRYONIC_HEART_TUBE_MORPHOGENESIS","GO_BP","488937_GO_0003143_EMBRYONIC_HEART_TUBE_MORPHOGENESIS",58,0.9964,0.51,0.97,0.834,0.78,1,1.273,0.11,0.69
"GO_BP:491545_GO_0006657_CDP_CHOLINE_PATHWAY","GO_BP","491545_GO_0006657_CDP_CHOLINE_PATHWAY",7,0.9966,0.42,0.97,0.7109,0.82,1,0.6809,0.87,1
"GO_BP:518315_GO_0090175_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY","GO_BP","518315_GO_0090175_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY",22,0.9967,0.43,0.97,0.8698,0.64,1,1.0772,0.37,0.78
"KEGG_reaction:R06095_GDP_L_FUCOSE_IV2FUC_NLC4CER_GDP_III3_IV2FUC_NLC4CER","KEGG_reaction","R06095_GDP_L_FUCOSE_IV2FUC_NLC4CER_GDP_III3_IV2FUC_NLC4CER",5,0.9968,0.45,1,1.119,0.36,0.92,-0.7304,0.8,0.92
"C4_Cancer_gene_neighborhoods:C4_CGN_191_MORF_USP5","C4_Cancer_gene_neighborhoods","C4_CGN_191_MORF_USP5",52,0.997,0.44,0.69,1.4618,0.026,0.04,-0.6983,0.96,1
"GO_BP:505608_GO_0042471_EAR_MORPHOGENESIS","GO_BP","505608_GO_0042471_EAR_MORPHOGENESIS",116,0.9971,0.44,0.97,1.0719,0.31,0.93,1.5469,0.0042,0.51
"GO_MF:486896_GO_0000403_Y_FORM_DNA_BINDING","GO_MF","486896_GO_0000403_Y_FORM_DNA_BINDING",5,0.9976,0.45,1,-0.8348,0.64,1,-1.3835,0.11,0.52
"GO_BP:507002_GO_0043984_HISTONE_H4_K16_ACETYLATION","GO_BP","507002_GO_0043984_HISTONE_H4_K16_ACETYLATION",19,0.9976,0.44,0.97,-0.9053,0.57,1,-0.9781,0.46,0.87
"C4_Cancer_gene_neighborhoods:C4_CGN_54_MORF_XPC","C4_Cancer_gene_neighborhoods","C4_CGN_54_MORF_XPC",62,0.9976,0.48,0.69,1.8997,0,8e-04,0.8173,0.86,1
"GO_BP:510719_GO_0048664_NEURON_FATE_DETERMINATION","GO_BP","510719_GO_0048664_NEURON_FATE_DETERMINATION",7,0.9977,0.43,0.97,-0.6748,0.86,1,1.1024,0.35,0.76
"GO_BP:494650_GO_0010586_MIRNA_METABOLIC_PROCESS","GO_BP","494650_GO_0010586_MIRNA_METABOLIC_PROCESS",9,0.9979,0.44,0.97,-0.7124,0.82,1,0.8873,0.6,0.95
"KEGG_pathway:HSA00072_SYNTHESIS_AND_DEGRADATION_OF_KETONE_BODIES","KEGG_pathway","HSA00072_SYNTHESIS_AND_DEGRADATION_OF_KETONE_BODIES",10,0.998,0.45,0.65,0.7249,0.83,1,-1.4088,0.11,0.18
"REACTOME:645293_REACT_120727_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING","REACTOME","645293_REACT_120727_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING",26,0.9981,0.45,0.78,1.3425,0.1,0.27,-0.6141,0.97,1
"GO_BP:505833_GO_0042726_FLAVIN_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","505833_GO_0042726_FLAVIN_CONTAINING_COMPOUND_METABOLIC_PROCESS",5,0.9987,0.45,0.97,0.662,0.87,1,-0.7286,0.81,0.99
"C4_Cancer_gene_neighborhoods:C4_CGN_109_MORF_GSPT1","C4_Cancer_gene_neighborhoods","C4_CGN_109_MORF_GSPT1",49,0.9991,0.48,0.69,2.1812,0,2e-05,-0.9829,0.47,0.89
"GO_BP:501559_GO_0032324_MOLYBDOPTERIN_COFACTOR_BIOSYNTHETIC_PROCESS","GO_BP","501559_GO_0032324_MOLYBDOPTERIN_COFACTOR_BIOSYNTHETIC_PROCESS",7,0.9994,0.47,0.97,0.905,0.56,1,0.7025,0.84,1
"KEGG_reaction:R06230_GDP_L_FUCOSE_NLC6CER_GDP_III3FUC_NLC6CER","KEGG_reaction","R06230_GDP_L_FUCOSE_NLC6CER_GDP_III3FUC_NLC6CER",5,0.9994,0.45,1,1.1237,0.33,0.95,-0.6989,0.8,0.89
"GO_BP:494688_GO_0010624_REGULATION_OF_SCHWANN_CELL_PROLIFERATION","GO_BP","494688_GO_0010624_REGULATION_OF_SCHWANN_CELL_PROLIFERATION",5,0.9995,0.45,0.97,-0.7045,0.84,1,-0.8826,0.63,0.94
"GO_BP:498909_GO_0021626_CENTRAL_NERVOUS_SYSTEM_MATURATION","GO_BP","498909_GO_0021626_CENTRAL_NERVOUS_SYSTEM_MATURATION",6,0.9999,0.43,0.97,-0.8563,0.64,1,1.0804,0.38,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_2641_MEISSNER_BRAIN_ICP_WITH_H3K4ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2641_MEISSNER_BRAIN_ICP_WITH_H3K4ME3",29,1.0003,0.45,1,-0.6213,0.97,1,-0.655,0.94,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_416_KOINUMA_COLON_CANCER_MSI_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_416_KOINUMA_COLON_CANCER_MSI_DN",8,1.0003,0.42,1,1.4045,0.099,0.29,-0.9643,0.47,0.8
"GO_CC:504451_GO_0035267_NUA4_HISTONE_ACETYLTRANSFERASE_COMPLEX","GO_CC","504451_GO_0035267_NUA4_HISTONE_ACETYLTRANSFERASE_COMPLEX",15,1.0004,0.43,0.82,1.1346,0.28,0.59,0.5439,0.99,1
"GO_BP:504161_GO_0034969_HISTONE_ARGININE_METHYLATION","GO_BP","504161_GO_0034969_HISTONE_ARGININE_METHYLATION",10,1.0007,0.44,0.97,0.4627,0.99,1,-0.8205,0.7,0.98
"C4_Cancer_gene_neighborhoods:C4_CGN_59_MORF_ANP32B","C4_Cancer_gene_neighborhoods","C4_CGN_59_MORF_ANP32B",198,1.001,0.47,0.69,2.9241,0,0,-0.4682,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_663_LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q","C2_Chemical_and_genetic_perturbations","C2_CGP_663_LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q",116,1.0014,0.43,1,1.3909,0.018,0.3,0.6824,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3333_ABRAMSON_INTERACT_WITH_AIRE","C2_Chemical_and_genetic_perturbations","C2_CGP_3333_ABRAMSON_INTERACT_WITH_AIRE",45,1.0016,0.47,1,0.9398,0.57,0.88,-1.5013,0.022,0.3
"GO_BP:504380_GO_0035195_GENE_SILENCING_BY_MIRNA","GO_BP","504380_GO_0035195_GENE_SILENCING_BY_MIRNA",32,1.0017,0.42,0.97,-0.8122,0.76,1,-0.7229,0.88,0.99
"GO_BP:502906_GO_0033689_NEGATIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION","GO_BP","502906_GO_0033689_NEGATIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION",8,1.0018,0.46,0.97,-1.0696,0.39,0.96,1.0455,0.39,0.81
"GO_BP:508164_GO_0045843_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","508164_GO_0045843_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT",33,1.0024,0.45,0.97,0.8095,0.82,1,1.1121,0.3,0.75
"GO_CC:505703_GO_0042575_DNA_POLYMERASE_COMPLEX","GO_CC","505703_GO_0042575_DNA_POLYMERASE_COMPLEX",14,1.0025,0.45,0.82,-0.7896,0.75,1,0.7767,0.77,1
"REACTOME:905998_REACT_169385_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM","REACTOME","905998_REACT_169385_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM",18,1.0026,0.45,0.77,0.8821,0.62,0.92,-1.0329,0.39,0.8
"GO_MF:510183_GO_0048019_RECEPTOR_ANTAGONIST_ACTIVITY","GO_MF","510183_GO_0048019_RECEPTOR_ANTAGONIST_ACTIVITY",10,1.0026,0.42,1,0.8947,0.6,0.99,1.295,0.18,0.64
"C1_Positional:C1_ALL_11_CHR4Q12","C1_Positional","C1_ALL_11_CHR4Q12",33,1.003,0.43,0.82,1.1947,0.19,0.61,0.7144,0.9,0.96
"GO_BP:503577_GO_0034375_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING","GO_BP","503577_GO_0034375_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING",15,1.0031,0.45,0.97,-0.6528,0.9,1,1.0756,0.35,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_2698_JISON_SICKLE_CELL_DISEASE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2698_JISON_SICKLE_CELL_DISEASE_DN",178,1.0032,0.46,1,2.3723,0,0,-1.1977,0.087,0.52
"KEGG_module:HSA_M00036_LEUCINE_DEGRADATION_LEUCINE_ACETOACETATE_ACETYL_COA","KEGG_module","HSA_M00036_LEUCINE_DEGRADATION_LEUCINE_ACETOACETATE_ACETYL_COA",13,1.0034,0.44,0.72,1.5954,0.015,0.12,-1.2494,0.19,0.47
"C4_Cancer_gene_neighborhoods:C4_CGN_232_GCM_GSPT1","C4_Cancer_gene_neighborhoods","C4_CGN_232_GCM_GSPT1",168,1.0035,0.43,0.69,0.5835,1,1,0.6092,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3271_LE_NEURONAL_DIFFERENTIATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3271_LE_NEURONAL_DIFFERENTIATION_UP",18,1.0036,0.42,1,-0.9737,0.47,1,1.1031,0.33,0.88
"GO_BP:519419_GO_2000780_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR","GO_BP","519419_GO_2000780_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR",8,1.0037,0.44,0.97,0.6785,0.87,1,0.4101,1,1
"KEGG_enzyme:1.1.1.62_17BETA_ESTRADIOL_17_DEHYDROGENASE_20ALPHA_HYDROXYSTEROID_DEHYDROGENASE_17BETA_20ALPHA_HYDROXYSTEROID_DEHYDROGENASE_17BETA_ESTRADIOL_DEHYDROGENASE_ESTRADIOL_DEHYDROGENASE_ESTROGEN_17_OXIDOREDUCTASE_17BETA_HSD_HSD17B7","KEGG_enzyme","1.1.1.62_17BETA_ESTRADIOL_17_DEHYDROGENASE_20ALPHA_HYDROXYSTEROID_DEHYDROGENASE_17BETA_20ALPHA_HYDROXYSTEROID_DEHYDROGENASE_17BETA_ESTRADIOL_DEHYDROGENASE_ESTRADIOL_DEHYDROGENASE_ESTROGEN_17_OXIDOREDUCTASE_17BETA_HSD_HSD17B7",6,1.0037,0.44,0.83,1.5322,0.049,0.36,-1.4247,0.1,0.52
"KEGG_reaction:R06222_GDP_L_FUCOSE_G00084_GDP_G00085","KEGG_reaction","R06222_GDP_L_FUCOSE_G00084_GDP_G00085",5,1.0037,0.44,1,1.1346,0.32,1,-0.7096,0.84,0.9
"KEGG_compound:C00188_L_THREONINE_2_AMINO_3_HYDROXYBUTYRIC_ACID","KEGG_compound","C00188_L_THREONINE_2_AMINO_3_HYDROXYBUTYRIC_ACID",5,1.0039,0.44,1,1.0502,0.41,1,1.3929,0.099,0.29
"KEGG_enzyme:1.6.99.3_NADH_DEHYDROGENASE_CYTOCHROME_C_REDUCTASE_TYPE_1_DEHYDROGENASE_BETA_NADH_DEHYDROGENASE_DINUCLEOTIDE_DIAPHORASE_DIHYDROCODEHYDROGENASE_I_DEHYDROGENASE_DIHYDRONICOTINAMIDE_ADENINE_DINUCLEOTIDE_DEHYDROGENASE_DIPHOSPHOPYRIDINE_DIAPHORASE_DPNH_DIAPHORASE_NADH_DIAPHORASE_NADH_HYDROGENASE_NADH_OXIDOREDUCTASE_NADH_MENADIONE_OXIDOREDUCTASE_REDUCED_DIPHOSPHOPYRIDINE_NUCLEOTIDE_DIAPHORASE_NADH_CYTOCHROME_C_OXIDOREDUCTASE_NADH2_DEHYDROGENASE_NADH_ACCEPTOR_OXIDOREDUCTASE","KEGG_enzyme","1.6.99.3_NADH_DEHYDROGENASE_CYTOCHROME_C_REDUCTASE_TYPE_1_DEHYDROGENASE_BETA_NADH_DEHYDROGENASE_DINUCLEOTIDE_DIAPHORASE_DIHYDROCODEHYDROGENASE_I_DEHYDROGENASE_DIHYDRONICOTINAMIDE_ADENINE_DINUCLEOTIDE_DEHYDROGENASE_DIPHOSPHOPYRIDINE_DIAPHORASE_DPNH_DIAPHORASE_NADH_DIAPHORASE_NADH_HYDROGENASE_NADH_OXIDOREDUCTASE_NADH_MENADIONE_OXIDOREDUCTASE_REDUCED_DIPHOSPHOPYRIDINE_NUCLEOTIDE_DIAPHORASE_NADH_CYTOCHROME_C_OXIDOREDUCTASE_NADH2_DEHYDROGENASE_NADH_ACCEPTOR_OXIDOREDUCTASE",7,1.0039,0.45,0.95,1.4792,0.075,0.25,0.8359,0.65,0.78
"C4_Cancer_gene_neighborhoods:C4_CGN_314_GNF2_SMC1L1","C4_Cancer_gene_neighborhoods","C4_CGN_314_GNF2_SMC1L1",27,1.0042,0.45,0.69,1.3945,0.073,0.064,-1.2292,0.17,0.4
"GO_BP:503655_GO_0034453_MICROTUBULE_ANCHORING","GO_BP","503655_GO_0034453_MICROTUBULE_ANCHORING",29,1.0044,0.43,0.97,-0.7503,0.87,1,-0.8162,0.78,0.98
"GO_BP:504361_GO_0035176_SOCIAL_BEHAVIOR","GO_BP","504361_GO_0035176_SOCIAL_BEHAVIOR",41,1.0046,0.44,0.97,0.7694,0.84,1,0.6416,0.98,1
"GO_BP:925939_GO_1902590_MULTI_ORGANISM_ORGANELLE_ORGANIZATION","GO_BP","925939_GO_1902590_MULTI_ORGANISM_ORGANELLE_ORGANIZATION",16,1.0046,0.41,0.97,1.6085,0.016,0.28,1.1481,0.3,0.73
"GO_CC:496121_GO_0016011_DYSTROGLYCAN_COMPLEX","GO_CC","496121_GO_0016011_DYSTROGLYCAN_COMPLEX",6,1.0046,0.46,0.82,0.6414,0.9,1,-1.3524,0.13,0.6
"C1_Positional:C1_ALL_41_CHR12Q24","C1_Positional","C1_ALL_41_CHR12Q24",219,1.0047,0.45,0.84,-0.7353,0.99,0.98,-0.823,0.94,0.99
"GO_MF:492886_GO_0008641_SMALL_PROTEIN_ACTIVATING_ENZYME_ACTIVITY","GO_MF","492886_GO_0008641_SMALL_PROTEIN_ACTIVATING_ENZYME_ACTIVITY",10,1.005,0.45,1,1.2414,0.2,0.7,0.8227,0.67,1
"C4_Cancer_gene_neighborhoods:C4_CGN_192_MORF_WNT1","C4_Cancer_gene_neighborhoods","C4_CGN_192_MORF_WNT1",101,1.0057,0.44,0.69,-1.0029,0.43,0.88,1.1809,0.14,0.46
"GO_MF:503441_GO_0034236_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING","GO_MF","503441_GO_0034236_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING",12,1.0058,0.46,1,1.2981,0.14,0.61,0.5339,1,1
"GO_MF:509165_GO_0046976_HISTONE_METHYLTRANSFERASE_ACTIVITY_H3_K27_SPECIFIC_","GO_MF","509165_GO_0046976_HISTONE_METHYLTRANSFERASE_ACTIVITY_H3_K27_SPECIFIC_",5,1.0061,0.44,1,-1.108,0.37,0.83,-1.4437,0.06,0.43
"GO_BP:498542_GO_0019720_MO_MOLYBDOPTERIN_COFACTOR_METABOLIC_PROCESS","GO_BP","498542_GO_0019720_MO_MOLYBDOPTERIN_COFACTOR_METABOLIC_PROCESS",7,1.0062,0.44,0.97,0.9119,0.53,1,0.7353,0.8,1
"GO_CC:500301_GO_0031011_INO80_COMPLEX","GO_CC","500301_GO_0031011_INO80_COMPLEX",14,1.0062,0.44,0.82,0.8153,0.75,0.94,-0.8752,0.61,1
"KEGG_reaction:R06224_GDP_L_FUCOSE_G00085_GDP_G00086","KEGG_reaction","R06224_GDP_L_FUCOSE_G00085_GDP_G00086",5,1.0064,0.45,1,1.1072,0.35,0.91,-0.7228,0.81,0.91
"GO_MF:496250_GO_0016160_AMYLASE_ACTIVITY","GO_MF","496250_GO_0016160_AMYLASE_ACTIVITY",5,1.0068,0.45,1,0.6068,0.91,1,1.5338,0.046,0.39
"GO_MF:750927_GO_0036002_PRE_MRNA_BINDING","GO_MF","750927_GO_0036002_PRE_MRNA_BINDING",14,1.0068,0.42,1,-0.5208,0.99,1,-0.5362,0.97,1
"GO_BP:502740_GO_0033522_HISTONE_H2A_UBIQUITINATION","GO_BP","502740_GO_0033522_HISTONE_H2A_UBIQUITINATION",16,1.0069,0.42,0.97,0.6768,0.9,1,-0.9072,0.58,0.92
"C7_Immunologic_signatures:C7_ALL_1609_GSE3982_MAST_CELL_VS_MAC_UP","C7_Immunologic_signatures","C7_ALL_1609_GSE3982_MAST_CELL_VS_MAC_UP",197,1.007,0.4,0.69,1.559,0,0.0054,0.8521,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2636_MEISSNER_NPC_ICP_WITH_H3K4ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2636_MEISSNER_NPC_ICP_WITH_H3K4ME3",19,1.0078,0.43,1,0.8468,0.68,0.97,0.5869,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_173_WANG_LMO4_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_173_WANG_LMO4_TARGETS_DN",345,1.0081,0.42,1,1.542,0,0.17,0.9011,0.79,1
"KEGG_compound:C00148_L_PROLINE_2_PYRROLIDINECARBOXYLIC_ACID","KEGG_compound","C00148_L_PROLINE_2_PYRROLIDINECARBOXYLIC_ACID",9,1.0081,0.42,1,0.8663,0.63,1,-0.7321,0.83,0.9
"KEGG_reaction:R06039_GDP_L_FUCOSE_NLC8CER_GDP_G00084","KEGG_reaction","R06039_GDP_L_FUCOSE_NLC8CER_GDP_G00084",5,1.0082,0.46,1,1.135,0.35,1,-0.7055,0.82,0.89
"C7_Immunologic_signatures:C7_ALL_879_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_879_GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP",199,1.0085,0.43,0.69,-0.62,1,1,0.7497,0.99,1
"C4_Cancer_modules:C4_CM_240_MODULE_267","C4_Cancer_modules","C4_CM_240_MODULE_267",15,1.0087,0.43,0.93,-1.6878,0.015,0.16,1.1582,0.26,0.67
"GO_BP:506532_GO_0043501_SKELETAL_MUSCLE_ADAPTATION","GO_BP","506532_GO_0043501_SKELETAL_MUSCLE_ADAPTATION",8,1.0088,0.44,0.96,-1.2701,0.2,0.89,-0.9126,0.56,0.91
"KEGG_module:HSA_M00284_ORIGIN_RECOGNITION_COMPLEX","KEGG_module","HSA_M00284_ORIGIN_RECOGNITION_COMPLEX",6,1.0089,0.43,0.73,1.0408,0.39,0.8,-0.9187,0.54,0.86
"GO_BP:511951_GO_0051026_CHIASMA_ASSEMBLY","GO_BP","511951_GO_0051026_CHIASMA_ASSEMBLY",6,1.0091,0.42,0.96,0.5947,0.94,1,0.5524,0.96,1
"C7_Immunologic_signatures:C7_ALL_1893_GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1893_GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP",165,1.0092,0.43,0.69,-1.0014,0.46,1,1.0521,0.32,1
"OMIM_gene:OMIM606793_AMINOPEPTIDASE_PUROMYCIN_SENSITIVE_NPEPPS","OMIM_gene","OMIM606793_AMINOPEPTIDASE_PUROMYCIN_SENSITIVE_NPEPPS",5,1.0101,0.44,1,1.3747,0.12,0.84,-0.9258,0.56,1
"GO_BP:505550_GO_0042407_CRISTAE_FORMATION","GO_BP","505550_GO_0042407_CRISTAE_FORMATION",5,1.0102,0.42,0.96,0.8942,0.57,1,-0.881,0.61,0.94
"KEGG_pathway:HSA00514_OTHER_TYPES_OF_O_GLYCAN_BIOSYNTHESIS","KEGG_pathway","HSA00514_OTHER_TYPES_OF_O_GLYCAN_BIOSYNTHESIS",31,1.0106,0.46,0.64,1.0078,0.47,0.88,-1.0074,0.42,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_2978_ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE","C2_Chemical_and_genetic_perturbations","C2_CGP_2978_ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE",16,1.0108,0.41,1,0.7817,0.77,1,0.8165,0.71,1
"GO_MF:504382_GO_0035198_MIRNA_BINDING","GO_MF","504382_GO_0035198_MIRNA_BINDING",14,1.0109,0.4,1,-1.1254,0.31,0.81,-1.0779,0.35,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_2802_ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2802_ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN",44,1.0109,0.43,1,1.1786,0.18,0.52,0.9781,0.47,0.96
"KEGG_module:HSA_M00098_ACYLGLYCEROL_DEGRADATION","KEGG_module","HSA_M00098_ACYLGLYCEROL_DEGRADATION",9,1.011,0.42,0.75,1.0787,0.37,0.73,1.4014,0.11,0.66
"GO_BP:488511_GO_0002638_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION","GO_BP","488511_GO_0002638_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION",5,1.0111,0.43,0.96,0.7557,0.78,1,-0.7,0.87,0.99
"C7_Immunologic_signatures:C7_ALL_1512_GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN","C7_Immunologic_signatures","C7_ALL_1512_GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN",199,1.0113,0.41,0.69,1.1501,0.13,0.32,-0.8993,0.77,0.95
"GO_CC:498650_GO_0019866_ORGANELLE_INNER_MEMBRANE","GO_CC","498650_GO_0019866_ORGANELLE_INNER_MEMBRANE",486,1.0113,0.33,0.81,2.345,0,0,-0.8007,1,1
"GO_BP:514094_GO_0060539_DIAPHRAGM_DEVELOPMENT","GO_BP","514094_GO_0060539_DIAPHRAGM_DEVELOPMENT",9,1.0116,0.41,0.96,-0.594,0.94,1,1.6752,0.028,0.41
"GO_BP:508079_GO_0045738_NEGATIVE_REGULATION_OF_DNA_REPAIR","GO_BP","508079_GO_0045738_NEGATIVE_REGULATION_OF_DNA_REPAIR",9,1.0117,0.41,0.96,1.2899,0.17,0.69,0.4111,1,1
"GO_CC:502476_GO_0033256_I_KAPPAB_NF_KAPPAB_COMPLEX","GO_CC","502476_GO_0033256_I_KAPPAB_NF_KAPPAB_COMPLEX",8,1.0126,0.42,0.81,-0.6572,0.88,1,-1.1446,0.3,0.87
"REACTOME:106009_REACT_6359_BUDDING_AND_MATURATION_OF_HIV_VIRION","REACTOME","106009_REACT_6359_BUDDING_AND_MATURATION_OF_HIV_VIRION",26,1.013,0.42,0.74,1.8833,0,0.0098,0.9839,0.47,1
"REACTOME:105749_REACT_1614_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A","REACTOME","105749_REACT_1614_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A",52,1.0131,0.42,0.75,2.134,0.0022,0.00038,-0.5608,1,1
"KEGG_reaction:R06221_GDP_L_FUCOSE_V3FUC_NLC6CER_GDP_V3FUC_III3FUC_NLC6CER","KEGG_reaction","R06221_GDP_L_FUCOSE_V3FUC_NLC6CER_GDP_V3FUC_III3FUC_NLC6CER",5,1.0133,0.47,1,1.119,0.36,0.94,-0.7246,0.8,0.92
"C7_Immunologic_signatures:C7_ALL_368_GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN","C7_Immunologic_signatures","C7_ALL_368_GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN",193,1.0137,0.37,0.68,0.7122,1,1,0.9112,0.69,1
"GO_MF:498653_GO_0019870_POTASSIUM_CHANNEL_INHIBITOR_ACTIVITY","GO_MF","498653_GO_0019870_POTASSIUM_CHANNEL_INHIBITOR_ACTIVITY",8,1.0144,0.44,1,1.073,0.39,0.82,1.0354,0.4,0.85
"GO_BP:1184485_GO_1903959_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT","GO_BP","1184485_GO_1903959_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT",26,1.0145,0.42,0.95,0.9671,0.5,1,-0.8195,0.75,0.98
"C4_Cancer_gene_neighborhoods:C4_CGN_116_MORF_IL9","C4_Cancer_gene_neighborhoods","C4_CGN_116_MORF_IL9",90,1.0147,0.39,0.66,1.017,0.39,0.53,1.1931,0.14,0.45
"C7_Immunologic_signatures:C7_ALL_1214_GSE27786_NKCELL_VS_NKTCELL_DN","C7_Immunologic_signatures","C7_ALL_1214_GSE27786_NKCELL_VS_NKTCELL_DN",197,1.0147,0.34,0.68,1.0711,0.26,0.52,-1.2354,0.061,0.22
"C2_Chemical_and_genetic_perturbations:C2_CGP_1903_ABE_INNER_EAR","C2_Chemical_and_genetic_perturbations","C2_CGP_1903_ABE_INNER_EAR",48,1.0152,0.43,1,2.2204,0,0.00045,-0.9281,0.57,0.84
"KEGG_compound:C03402_L_ASPARAGINYL_TRNA_ASN_ASN_TRNA_ASN_ASPARAGINYL_TRNA_ASN_","KEGG_compound","C03402_L_ASPARAGINYL_TRNA_ASN_ASN_TRNA_ASN_ASPARAGINYL_TRNA_ASN_",5,1.0153,0.44,1,0.9056,0.58,1,-0.9983,0.46,0.65
"GO_BP:750913_GO_0035988_CHONDROCYTE_PROLIFERATION","GO_BP","750913_GO_0035988_CHONDROCYTE_PROLIFERATION",8,1.0153,0.44,0.95,-1.0767,0.37,0.95,1.4104,0.11,0.62
"GO_BP:500409_GO_0031122_CYTOPLASMIC_MICROTUBULE_ORGANIZATION","GO_BP","500409_GO_0031122_CYTOPLASMIC_MICROTUBULE_ORGANIZATION",34,1.0155,0.43,0.95,1.0714,0.35,0.93,0.9923,0.48,0.86
"C4_Cancer_modules:C4_CM_304_MODULE_352","C4_Cancer_modules","C4_CM_304_MODULE_352",17,1.016,0.44,0.94,1.0745,0.38,0.58,-1.0047,0.43,0.69
"C1_Positional:C1_ALL_4_CHR13Q11","C1_Positional","C1_ALL_4_CHR13Q11",13,1.016,0.42,0.81,0.6526,0.91,1,1.2562,0.2,0.56
"GO_BP:508185_GO_0045869_NEGATIVE_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE","GO_BP","508185_GO_0045869_NEGATIVE_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE",6,1.0164,0.43,0.95,0.7478,0.78,1,-0.8289,0.68,0.97
"GO_BP:491234_GO_0006270_DNA_REPLICATION_INITIATION","GO_BP","491234_GO_0006270_DNA_REPLICATION_INITIATION",25,1.0165,0.41,0.95,1.152,0.26,0.83,-1.6661,0.012,0.56
"REACTOME:105907_REACT_18277_PERK_REGULATES_GENE_EXPRESSION","REACTOME","105907_REACT_18277_PERK_REGULATES_GENE_EXPRESSION",27,1.0166,0.43,0.74,1.2689,0.14,0.36,1.0059,0.44,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1197_NIKOLSKY_BREAST_CANCER_5P15_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1197_NIKOLSKY_BREAST_CANCER_5P15_AMPLICON",25,1.0178,0.42,1,0.4439,1,1,0.8908,0.65,1
"GO_BP:513607_GO_0060049_REGULATION_OF_PROTEIN_GLYCOSYLATION","GO_BP","513607_GO_0060049_REGULATION_OF_PROTEIN_GLYCOSYLATION",11,1.018,0.44,0.95,1.1019,0.33,0.9,0.7867,0.78,1
"C7_Immunologic_signatures:C7_ALL_861_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP","C7_Immunologic_signatures","C7_ALL_861_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP",198,1.0181,0.4,0.67,1.4085,0,0.035,-0.7603,0.99,1
"C7_Immunologic_signatures:C7_ALL_238_GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN","C7_Immunologic_signatures","C7_ALL_238_GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN",199,1.019,0.39,0.67,0.8119,0.93,1,-1.0797,0.26,0.54
"C4_Cancer_gene_neighborhoods:C4_CGN_416_GNF2_TAL1","C4_Cancer_gene_neighborhoods","C4_CGN_416_GNF2_TAL1",72,1.0192,0.42,0.65,2.0079,0,0.00031,-1.5234,0.014,0.11
"GO_BP:494271_GO_0010193_RESPONSE_TO_OZONE","GO_BP","494271_GO_0010193_RESPONSE_TO_OZONE",5,1.0201,0.42,0.95,-1.1337,0.34,0.93,1.0588,0.4,0.8
"KEGG_reaction:R06076_GDP_L_FUCOSE_VI2FUC_NLC6_GDP_G00081","KEGG_reaction","R06076_GDP_L_FUCOSE_VI2FUC_NLC6_GDP_G00081",5,1.0204,0.41,1,1.1282,0.34,0.97,-0.7302,0.8,0.92
"GO_BP:486882_GO_0000380_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME","GO_BP","486882_GO_0000380_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME",11,1.0205,0.43,0.95,-0.9001,0.59,1,-1.2219,0.21,0.71
"WikiPathways:760637_WP2363_GASTRIC_CANCER_NETWORK_2","WikiPathways","760637_WP2363_GASTRIC_CANCER_NETWORK_2",33,1.021,0.4,0.82,1.5432,0.03,0.28,0.8282,0.73,1
"REACTOME:906019_REACT_169398_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER","REACTOME","906019_REACT_169398_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER",7,1.0213,0.43,0.73,-0.6863,0.85,1,1.1685,0.28,0.87
"GO_BP:492861_GO_0008608_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE","GO_BP","492861_GO_0008608_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE",12,1.0218,0.42,0.94,0.8429,0.7,1,-0.6662,0.9,1
"REACTOME:105828_REACT_6821_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1","REACTOME","105828_REACT_6821_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1",54,1.022,0.39,0.73,2.0333,0,0.0015,-0.6847,0.96,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_400_CASTELLANO_HRAS_AND_NRAS_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_400_CASTELLANO_HRAS_AND_NRAS_TARGETS_DN",7,1.0222,0.41,1,1.4588,0.086,0.25,1.3877,0.13,0.54
"C7_Immunologic_signatures:C7_ALL_696_GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDM_DN","C7_Immunologic_signatures","C7_ALL_696_GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDM_DN",199,1.0222,0.36,0.65,1.3173,0.009,0.088,0.7403,0.99,1
"C7_Immunologic_signatures:C7_ALL_801_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0_5H_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_801_GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0_5H_ACT_CD4_TCELL_UP",176,1.0222,0.42,0.66,1.8937,0,0,1.1602,0.15,0.83
"C7_Immunologic_signatures:C7_ALL_868_GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_868_GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_DN",198,1.0229,0.42,0.66,1.3066,0.015,0.096,-0.8104,0.93,1
"KEGG_reaction:R06038_GDP_L_FUCOSE_NLC6CER_GDP_V3FUC_NLC6CER","KEGG_reaction","R06038_GDP_L_FUCOSE_NLC6CER_GDP_V3FUC_NLC6CER",5,1.0231,0.42,1,1.1301,0.33,0.99,-0.7139,0.8,0.91
"C2_Chemical_and_genetic_perturbations:C2_CGP_1000_FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1000_FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP",166,1.0231,0.37,1,1.3488,0.014,0.34,0.7277,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1824_MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1824_MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP",23,1.0233,0.4,1,1.8178,0.0021,0.038,1.2388,0.16,0.74
"GO_BP:510904_GO_0048854_BRAIN_MORPHOGENESIS","GO_BP","510904_GO_0048854_BRAIN_MORPHOGENESIS",32,1.0234,0.41,0.94,1.0401,0.36,0.96,0.9898,0.47,0.87
"GO_BP:491300_GO_0006362_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_I_PROMOTER","GO_BP","491300_GO_0006362_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_I_PROMOTER",31,1.0235,0.41,0.94,1.1612,0.23,0.82,-0.4688,1,1
"GO_BP:491449_GO_0006553_LYSINE_METABOLIC_PROCESS","GO_BP","491449_GO_0006553_LYSINE_METABOLIC_PROCESS",9,1.0243,0.41,0.94,-1.1938,0.25,0.9,-1.228,0.22,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_620_NAGY_PCAF_COMPONENTS_HUMAN","C2_Chemical_and_genetic_perturbations","C2_CGP_620_NAGY_PCAF_COMPONENTS_HUMAN",9,1.0246,0.39,1,-0.6406,0.9,1,-0.6704,0.88,0.99
"GO_BP:491451_GO_0006555_METHIONINE_METABOLIC_PROCESS","GO_BP","491451_GO_0006555_METHIONINE_METABOLIC_PROCESS",19,1.0247,0.39,0.94,-0.5897,0.96,1,-1.3715,0.083,0.59
"GO_BP:497173_GO_0018202_PEPTIDYL_HISTIDINE_MODIFICATION","GO_BP","497173_GO_0018202_PEPTIDYL_HISTIDINE_MODIFICATION",16,1.0248,0.39,0.94,0.6278,0.94,1,-0.4574,1,1
"REACTOME:833807_REACT_163725_SUMO_IS_PROTEOLYTICALLY_PROCESSED","REACTOME","833807_REACT_163725_SUMO_IS_PROTEOLYTICALLY_PROCESSED",6,1.0249,0.41,0.72,1.4885,0.066,0.15,1.0592,0.41,0.96
"GO_BP:504898_GO_0035721_INTRACILIARY_RETROGRADE_TRANSPORT","GO_BP","504898_GO_0035721_INTRACILIARY_RETROGRADE_TRANSPORT",7,1.0251,0.43,0.94,-0.9761,0.47,1,0.5213,0.97,1
"C7_Immunologic_signatures:C7_ALL_483_GSE17721_CTRL_VS_PAM3CSK4_2H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_483_GSE17721_CTRL_VS_PAM3CSK4_2H_BMDM_UP",200,1.0255,0.32,0.65,1.1698,0.086,0.28,0.75,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1186_MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1186_MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP",109,1.0255,0.35,1,0.9199,0.68,0.9,-1.0908,0.27,0.64
"REACTOME:105747_REACT_1208_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT","REACTOME","105747_REACT_1208_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT",52,1.0258,0.4,0.72,2.1102,0,0.00052,-0.5602,1,1
"GO_CC:496122_GO_0016012_SARCOGLYCAN_COMPLEX","GO_CC","496122_GO_0016012_SARCOGLYCAN_COMPLEX",5,1.026,0.42,0.78,0.6867,0.86,0.99,-1.3788,0.13,0.6
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_172_BIOCARTA_PARKIN_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_172_BIOCARTA_PARKIN_PATHWAY",12,1.026,0.42,0.96,1.187,0.24,0.7,-1.3311,0.13,0.48
"REACTOME:106002_REACT_6319_FORMATION_OF_THE_HIV_1_EARLY_ELONGATION_COMPLEX","REACTOME","106002_REACT_6319_FORMATION_OF_THE_HIV_1_EARLY_ELONGATION_COMPLEX",33,1.026,0.39,0.73,1.4375,0.042,0.19,0.794,0.81,1
"REACTOME:187183_REACT_25004_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS","REACTOME","187183_REACT_25004_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS",24,1.0265,0.4,0.73,0.7778,0.79,1,1.1041,0.31,0.96
"GO_BP:505844_GO_0042737_DRUG_CATABOLIC_PROCESS","GO_BP","505844_GO_0042737_DRUG_CATABOLIC_PROCESS",23,1.0266,0.44,0.94,-1.7861,0.0096,0.47,1.3354,0.11,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_696_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18","C2_Chemical_and_genetic_perturbations","C2_CGP_696_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18",5,1.0267,0.42,1,0.6421,0.89,1,-0.4601,1,1
"GO_BP:501739_GO_0032508_DNA_DUPLEX_UNWINDING","GO_BP","501739_GO_0032508_DNA_DUPLEX_UNWINDING",55,1.0273,0.41,0.94,0.8432,0.74,1,-1.1501,0.21,0.74
"OMIM_gene:OMIM601895_TNF_RECEPTOR_ASSOCIATED_FACTOR_2_TRAF2","OMIM_gene","OMIM601895_TNF_RECEPTOR_ASSOCIATED_FACTOR_2_TRAF2",6,1.0273,0.41,1,1.103,0.34,1,-0.4892,0.99,1
"GO_BP:492098_GO_0007320_INSEMINATION","GO_BP","492098_GO_0007320_INSEMINATION",14,1.0274,0.39,0.94,1.0576,0.39,0.94,0.8031,0.72,1
"C7_Immunologic_signatures:C7_ALL_1225_GSE27786_NKTCELL_VS_MONO_MAC_UP","C7_Immunologic_signatures","C7_ALL_1225_GSE27786_NKTCELL_VS_MONO_MAC_UP",200,1.0274,0.37,0.65,1.2721,0.027,0.13,-0.9727,0.51,0.79
"GO_MF:496783_GO_0016896_EXORIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS","GO_MF","496783_GO_0016896_EXORIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS",29,1.0278,0.4,0.97,1.3403,0.086,0.53,-0.9597,0.54,0.82
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_154_BIOCARTA_EIF2_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_154_BIOCARTA_EIF2_PATHWAY",11,1.028,0.42,1,1.1329,0.27,0.66,-0.7054,0.85,0.99
"OMIM_gene:OMIM312610_RETINITIS_PIGMENTOSA_GTPASE_REGULATOR_RPGR","OMIM_gene","OMIM312610_RETINITIS_PIGMENTOSA_GTPASE_REGULATOR_RPGR",5,1.028,0.44,1,1.1286,0.35,1,-0.581,0.92,1
"GO_BP:517411_GO_0072498_EMBRYONIC_SKELETAL_JOINT_DEVELOPMENT","GO_BP","517411_GO_0072498_EMBRYONIC_SKELETAL_JOINT_DEVELOPMENT",16,1.0287,0.39,0.94,-1.2719,0.16,0.89,1.2191,0.2,0.71
"GO_BP:754813_GO_1901862_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","754813_GO_1901862_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT",33,1.0289,0.39,0.94,0.7887,0.82,1,1.1335,0.27,0.74
"GO_BP:515078_GO_0070141_RESPONSE_TO_UV_A","GO_BP","515078_GO_0070141_RESPONSE_TO_UV_A",6,1.0291,0.4,0.94,0.6513,0.91,1,1.135,0.32,0.74
"C1_Positional:C1_ALL_181_CHR18Q22","C1_Positional","C1_ALL_181_CHR18Q22",26,1.0296,0.42,0.79,1.1817,0.23,0.6,1.9613,0,0.015
"KEGG_compound:C00588_CHOLINE_PHOSPHATE_PHOSPHORYLCHOLINE_PHOSPHOCHOLINE_O_PHOSPHOCHOLINE","KEGG_compound","C00588_CHOLINE_PHOSPHATE_PHOSPHORYLCHOLINE_PHOSPHOCHOLINE_O_PHOSPHOCHOLINE",10,1.0296,0.41,1,0.7563,0.8,1,1.335,0.14,0.37
"C4_Cancer_gene_neighborhoods:C4_CGN_320_GNF2_ANK1","C4_Cancer_gene_neighborhoods","C4_CGN_320_GNF2_ANK1",73,1.0301,0.39,0.62,1.9252,0,0.00064,-1.577,0.0079,0.075
"C7_Immunologic_signatures:C7_ALL_1675_GSE3982_BCELL_VS_BASOPHIL_UP","C7_Immunologic_signatures","C7_ALL_1675_GSE3982_BCELL_VS_BASOPHIL_UP",193,1.0305,0.34,0.64,0.8251,0.91,1,-1.0213,0.39,0.68
"GO_CC:515864_GO_0070937_CRD_MEDIATED_MRNA_STABILITY_COMPLEX","GO_CC","515864_GO_0070937_CRD_MEDIATED_MRNA_STABILITY_COMPLEX",6,1.0307,0.39,0.77,1.3914,0.12,0.3,0.6196,0.89,1
"GO_BP:487023_GO_0000726_NON_RECOMBINATIONAL_REPAIR","GO_BP","487023_GO_0000726_NON_RECOMBINATIONAL_REPAIR",25,1.0307,0.4,0.94,0.6009,0.96,1,-1.1791,0.25,0.74
"GO_BP:505611_GO_0042474_MIDDLE_EAR_MORPHOGENESIS","GO_BP","505611_GO_0042474_MIDDLE_EAR_MORPHOGENESIS",23,1.0314,0.38,0.94,1.0991,0.3,0.9,1.3933,0.077,0.63
"GO_BP:491985_GO_0007185_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_SIGNALING_PATHWAY","GO_BP","491985_GO_0007185_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_SIGNALING_PATHWAY",6,1.0314,0.39,0.94,1.8316,0,0.074,1.1813,0.25,0.72
"GO_BP:492505_GO_0008156_NEGATIVE_REGULATION_OF_DNA_REPLICATION","GO_BP","492505_GO_0008156_NEGATIVE_REGULATION_OF_DNA_REPLICATION",42,1.0317,0.4,0.94,-0.5319,1,1,-0.8802,0.68,0.94
"GO_MF:486738_GO_0000217_DNA_SECONDARY_STRUCTURE_BINDING","GO_MF","486738_GO_0000217_DNA_SECONDARY_STRUCTURE_BINDING",18,1.0318,0.41,0.96,-0.6047,0.95,1,-0.8071,0.74,0.96
"GO_BP:504379_GO_0035194_POSTTRANSCRIPTIONAL_GENE_SILENCING_BY_RNA","GO_BP","504379_GO_0035194_POSTTRANSCRIPTIONAL_GENE_SILENCING_BY_RNA",35,1.032,0.35,0.94,-0.7657,0.85,1,-0.6911,0.93,0.99
"REACTOME:1183520_REACT_355221_SIGNALING_BY_FGFR1_MUTANTS","REACTOME","1183520_REACT_355221_SIGNALING_BY_FGFR1_MUTANTS",34,1.0324,0.37,0.72,0.8632,0.7,0.95,0.8354,0.74,1
"C4_Cancer_gene_neighborhoods:C4_CGN_251_GCM_PPM1D","C4_Cancer_gene_neighborhoods","C4_CGN_251_GCM_PPM1D",26,1.0326,0.39,0.62,-0.6565,0.95,1,0.9428,0.53,0.95
"GO_BP:486669_GO_0000132_ESTABLISHMENT_OF_MITOTIC_SPINDLE_ORIENTATION","GO_BP","486669_GO_0000132_ESTABLISHMENT_OF_MITOTIC_SPINDLE_ORIENTATION",18,1.0331,0.42,0.94,0.7875,0.77,1,1.1107,0.32,0.75
"C4_Cancer_gene_neighborhoods:C4_CGN_50_MORF_TERF2IP","C4_Cancer_gene_neighborhoods","C4_CGN_50_MORF_TERF2IP",114,1.0331,0.35,0.62,1.5758,0.0022,0.018,0.8954,0.71,1
"C4_Cancer_modules:C4_CM_278_MODULE_318","C4_Cancer_modules","C4_CM_278_MODULE_318",28,1.0332,0.37,0.91,-0.8811,0.64,0.91,-0.7102,0.88,1
"GO_MF:507012_GO_0043995_HISTONE_ACETYLTRANSFERASE_ACTIVITY_H4_K5_SPECIFIC_","GO_MF","507012_GO_0043995_HISTONE_ACETYLTRANSFERASE_ACTIVITY_H4_K5_SPECIFIC_",9,1.0333,0.41,0.96,-0.5779,0.95,1,0.6137,0.94,1
"KEGG_reaction:R02250_TRIACYLGLYCEROL_ACYLHYDROLASE_TRIACYLGLYCEROL_H2O_1_2_DIACYL_SN_GLYCEROL_FATTY_ACID","KEGG_reaction","R02250_TRIACYLGLYCEROL_ACYLHYDROLASE_TRIACYLGLYCEROL_H2O_1_2_DIACYL_SN_GLYCEROL_FATTY_ACID",8,1.0335,0.42,1,0.7193,0.81,1,1.2451,0.23,0.49
"GO_BP:502820_GO_0033604_NEGATIVE_REGULATION_OF_CATECHOLAMINE_SECRETION","GO_BP","502820_GO_0033604_NEGATIVE_REGULATION_OF_CATECHOLAMINE_SECRETION",13,1.0339,0.39,0.94,1.0776,0.36,0.93,1.2098,0.23,0.71
"GO_BP:495025_GO_0010960_MAGNESIUM_ION_HOMEOSTASIS","GO_BP","495025_GO_0010960_MAGNESIUM_ION_HOMEOSTASIS",11,1.034,0.38,0.94,0.9964,0.46,0.98,0.4682,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_308_GNF2_RAD23A","C4_Cancer_gene_neighborhoods","C4_CGN_308_GNF2_RAD23A",69,1.0342,0.4,0.63,1.9887,0,0.00035,-1.4705,0.019,0.14
"KEGG_module:HSA_M00295_BRCA1_ASSOCIATED_GENOME_SURVEILLANCE_COMPLEX_BASC_","KEGG_module","HSA_M00295_BRCA1_ASSOCIATED_GENOME_SURVEILLANCE_COMPLEX_BASC_",16,1.0349,0.37,0.72,1.2907,0.14,0.41,-1.2307,0.18,0.48
"REACTOME:906021_REACT_169165_SMAD2_3_MH2_DOMAIN_MUTANTS_IN_CANCER","REACTOME","906021_REACT_169165_SMAD2_3_MH2_DOMAIN_MUTANTS_IN_CANCER",7,1.035,0.42,0.71,-0.6927,0.87,1,1.1579,0.27,0.89
"GO_CC:492397_GO_0008023_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX","GO_CC","492397_GO_0008023_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX",42,1.0351,0.33,0.76,1.0519,0.34,0.71,0.7231,0.92,1
"OMIM_gene:OMIM176873_CYCLIN_DEPENDENT_KINASE_11B_CDK11B","OMIM_gene","OMIM176873_CYCLIN_DEPENDENT_KINASE_11B_CDK11B",7,1.0352,0.41,1,0.9801,0.46,1,-0.613,0.91,1
"GO_BP:518345_GO_0090205_POSITIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS","GO_BP","518345_GO_0090205_POSITIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS",5,1.036,0.42,0.93,0.7123,0.79,1,0.9088,0.55,0.93
"GO_MF:489393_GO_0003906_DNA_APURINIC_OR_APYRIMIDINIC_SITE_LYASE_ACTIVITY","GO_MF","489393_GO_0003906_DNA_APURINIC_OR_APYRIMIDINIC_SITE_LYASE_ACTIVITY",13,1.037,0.37,0.96,1.6721,0.018,0.17,1.13,0.28,0.79
"GO_BP:496169_GO_0016075_RRNA_CATABOLIC_PROCESS","GO_BP","496169_GO_0016075_RRNA_CATABOLIC_PROCESS",11,1.0371,0.39,0.93,0.8653,0.62,1,-0.5967,0.94,1
"GO_BP:1129550_GO_1903726_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS","GO_BP","1129550_GO_1903726_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS",7,1.0373,0.4,0.93,1.2772,0.21,0.7,1.369,0.12,0.65
"C4_Cancer_gene_neighborhoods:C4_CGN_310_GNF2_RFC4","C4_Cancer_gene_neighborhoods","C4_CGN_310_GNF2_RFC4",60,1.0374,0.4,0.62,1.4718,0.026,0.038,-1.4647,0.018,0.13
"REACTOME:1127550_REACT_6850_CDC20_PHOSPHO_APC_C_MEDIATED_DEGRADATION_OF_CYCLIN_A","REACTOME","1127550_REACT_6850_CDC20_PHOSPHO_APC_C_MEDIATED_DEGRADATION_OF_CYCLIN_A",69,1.0374,0.4,0.71,2.1367,0,0.00039,-0.5797,1,1
"REACTOME:833823_REACT_163977_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA","REACTOME","833823_REACT_163977_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA",16,1.0374,0.39,0.71,1.5019,0.062,0.15,-0.8683,0.65,0.97
"GO_MF:509162_GO_0046972_HISTONE_ACETYLTRANSFERASE_ACTIVITY_H4_K16_SPECIFIC_","GO_MF","509162_GO_0046972_HISTONE_ACETYLTRANSFERASE_ACTIVITY_H4_K16_SPECIFIC_",9,1.0374,0.42,0.96,-0.5926,0.96,1,0.629,0.92,1
"C1_Positional:C1_ALL_17_CHR9P12","C1_Positional","C1_ALL_17_CHR9P12",18,1.0375,0.39,0.78,-0.9505,0.54,1,1.3602,0.1,0.42
"GO_MF:515002_GO_0070063_RNA_POLYMERASE_BINDING","GO_MF","515002_GO_0070063_RNA_POLYMERASE_BINDING",35,1.0375,0.36,0.97,0.8791,0.66,1,1.0404,0.4,0.85
"GO_BP:491450_GO_0006554_LYSINE_CATABOLIC_PROCESS","GO_BP","491450_GO_0006554_LYSINE_CATABOLIC_PROCESS",9,1.0377,0.4,0.93,-1.181,0.24,0.91,-1.2373,0.21,0.69
"C2_Chemical_and_genetic_perturbations:C2_CGP_1821_ZHANG_RESPONSE_TO_CANTHARIDIN_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1821_ZHANG_RESPONSE_TO_CANTHARIDIN_DN",68,1.0378,0.33,0.98,2.2872,0,0.00019,-0.7796,0.89,0.96
"GO_BP:501940_GO_0032714_NEGATIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION","GO_BP","501940_GO_0032714_NEGATIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION",6,1.0379,0.4,0.93,1.3505,0.16,0.61,1.4753,0.088,0.58
"C1_Positional:C1_ALL_13_CHR2P22","C1_Positional","C1_ALL_13_CHR2P22",41,1.0387,0.36,0.79,1.2846,0.11,0.54,-0.826,0.77,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_3082_FIGUEROA_AML_METHYLATION_CLUSTER_3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3082_FIGUEROA_AML_METHYLATION_CLUSTER_3_UP",167,1.0387,0.33,0.98,1.3341,0.032,0.36,1.4302,0.004,0.56
"GO_BP:507532_GO_0045143_HOMOLOGOUS_CHROMOSOME_SEGREGATION","GO_BP","507532_GO_0045143_HOMOLOGOUS_CHROMOSOME_SEGREGATION",36,1.039,0.37,0.93,-0.7422,0.87,1,0.7075,0.93,1
"KEGG_compound:C00073_L_METHIONINE_METHIONINE_L_2_AMINO_4METHYLTHIOBUTYRIC_ACID","KEGG_compound","C00073_L_METHIONINE_METHIONINE_L_2_AMINO_4METHYLTHIOBUTYRIC_ACID",13,1.0393,0.39,1,-0.8313,0.68,1,-1.2203,0.21,0.43
"C4_Cancer_gene_neighborhoods:C4_CGN_413_GNF2_SPTB","C4_Cancer_gene_neighborhoods","C4_CGN_413_GNF2_SPTB",73,1.0395,0.35,0.62,1.9302,0,0.00063,-1.5816,0.011,0.075
"C7_Immunologic_signatures:C7_ALL_889_GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP","C7_Immunologic_signatures","C7_ALL_889_GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP",194,1.0397,0.26,0.59,1.221,0.078,0.19,-0.9723,0.51,0.79
"KEGG_reaction:R02541_SPHINGOMYELIN_CHOLINEPHOSPHOHYDROLASE_SPHINGOMYELIN_H2O_N_ACYLSPHINGOSINE_CHOLINE_PHOSPHATE","KEGG_reaction","R02541_SPHINGOMYELIN_CHOLINEPHOSPHOHYDROLASE_SPHINGOMYELIN_H2O_N_ACYLSPHINGOSINE_CHOLINE_PHOSPHATE",5,1.0401,0.42,1,1.0455,0.44,0.91,1.1769,0.29,0.55
"REACTOME:187189_REACT_24023_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS","REACTOME","187189_REACT_24023_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS",42,1.0406,0.38,0.71,0.84,0.74,0.96,-0.8902,0.65,0.96
"C4_Cancer_gene_neighborhoods:C4_CGN_195_GCM_BNIP1","C4_Cancer_gene_neighborhoods","C4_CGN_195_GCM_BNIP1",74,1.0409,0.35,0.62,1.2176,0.12,0.2,1.3316,0.058,0.29
"GO_BP:755159_GO_2001053_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS","GO_BP","755159_GO_2001053_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS",11,1.0409,0.39,0.93,1.7237,0.01,0.17,1.2526,0.18,0.69
"GO_CC:487086_GO_0000795_SYNAPTONEMAL_COMPLEX","GO_CC","487086_GO_0000795_SYNAPTONEMAL_COMPLEX",29,1.0413,0.39,0.75,-0.7273,0.88,1,0.9052,0.6,1
"REACTOME:366226_REACT_75831_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS","REACTOME","366226_REACT_75831_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS",24,1.0413,0.36,0.71,0.7692,0.8,1,1.0975,0.33,0.95
"REACTOME:161053_REACT_6244_PAUSING_AND_RECOVERY_OF_HIV_ELONGATION","REACTOME","161053_REACT_6244_PAUSING_AND_RECOVERY_OF_HIV_ELONGATION",31,1.0418,0.37,0.71,1.5479,0.015,0.12,1.1776,0.21,0.86
"KEGG_compound:C07047_IFOSFAMIDE_ISOPHOSPHAMIDE","KEGG_compound","C07047_IFOSFAMIDE_ISOPHOSPHAMIDE",5,1.0419,0.4,1,-0.9386,0.52,1,1.6408,0.0041,0.071
"GO_MF:496782_GO_0016895_EXODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS","GO_MF","496782_GO_0016895_EXODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS",15,1.042,0.39,0.96,1.2075,0.2,0.69,0.6396,0.94,1
"GO_CC:504511_GO_0035327_TRANSCRIPTIONALLY_ACTIVE_CHROMATIN","GO_CC","504511_GO_0035327_TRANSCRIPTIONALLY_ACTIVE_CHROMATIN",18,1.0431,0.38,0.75,0.747,0.84,0.98,-1.1564,0.24,0.85
"REACTOME:366225_REACT_75780_G_PROTEIN_GATED_POTASSIUM_CHANNELS","REACTOME","366225_REACT_75780_G_PROTEIN_GATED_POTASSIUM_CHANNELS",24,1.0431,0.41,0.71,0.7929,0.77,1,1.0908,0.33,0.96
"C7_Immunologic_signatures:C7_ALL_1339_GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_1339_GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP",199,1.0431,0.32,0.58,1.6934,0,0.00074,-1.1652,0.12,0.34
"GO_MF:507013_GO_0043996_HISTONE_ACETYLTRANSFERASE_ACTIVITY_H4_K8_SPECIFIC_","GO_MF","507013_GO_0043996_HISTONE_ACETYLTRANSFERASE_ACTIVITY_H4_K8_SPECIFIC_",9,1.0436,0.4,0.96,-0.5875,0.96,1,0.6294,0.93,1
"GO_BP:491834_GO_0006998_NUCLEAR_ENVELOPE_ORGANIZATION","GO_BP","491834_GO_0006998_NUCLEAR_ENVELOPE_ORGANIZATION",70,1.044,0.36,0.92,1.2361,0.13,0.75,0.6883,0.97,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_141_BIOCARTA_PLATELETAPP_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_141_BIOCARTA_PLATELETAPP_PATHWAY",14,1.0441,0.38,1,-0.7809,0.76,1,1.4145,0.089,1
"GO_BP:509148_GO_0046951_KETONE_BODY_BIOSYNTHETIC_PROCESS","GO_BP","509148_GO_0046951_KETONE_BODY_BIOSYNTHETIC_PROCESS",6,1.0442,0.38,0.92,0.8424,0.65,1,-0.7487,0.77,1
"KEGG_reaction:R02687_1_2_DIACYL_SN_GLYCEROL_ACYLHYDROLASE_1_2_DIACYL_SN_GLYCEROL_H2O_1_ACYLGLYCEROL_FATTY_ACID","KEGG_reaction","R02687_1_2_DIACYL_SN_GLYCEROL_ACYLHYDROLASE_1_2_DIACYL_SN_GLYCEROL_H2O_1_ACYLGLYCEROL_FATTY_ACID",8,1.0442,0.38,1,0.709,0.84,1,1.235,0.23,0.5
"REACTOME:1183519_REACT_355059_SIGNALING_BY_FGFR1_IN_DISEASE","REACTOME","1183519_REACT_355059_SIGNALING_BY_FGFR1_IN_DISEASE",34,1.045,0.37,0.71,0.8821,0.66,0.92,0.839,0.72,1
"GO_CC:496538_GO_0016592_MEDIATOR_COMPLEX","GO_CC","496538_GO_0016592_MEDIATOR_COMPLEX",36,1.0456,0.37,0.75,-0.589,0.99,1,1.2645,0.13,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_2122_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2122_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN",20,1.0457,0.37,0.96,0.932,0.56,0.89,0.9091,0.6,1
"C4_Cancer_gene_neighborhoods:C4_CGN_284_GNF2_BNIP3L","C4_Cancer_gene_neighborhoods","C4_CGN_284_GNF2_BNIP3L",68,1.0457,0.34,0.61,2.009,0,0.00031,-1.4094,0.033,0.16
"C7_Immunologic_signatures:C7_ALL_1614_GSE3982_MAST_CELL_VS_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1614_GSE3982_MAST_CELL_VS_BCELL_DN",194,1.0459,0.25,0.57,-0.7664,0.97,1,-0.9573,0.55,0.83
"C6_Oncogenic_signatures:C6_ALL_146_YAP1_UP","C6_Oncogenic_signatures","C6_ALL_146_YAP1_UP",47,1.0462,0.32,0.66,1.4201,0.031,0.22,-0.9966,0.46,0.65
"REACTOME:105820_REACT_1725_M_G1_TRANSITION","REACTOME","105820_REACT_1725_M_G1_TRANSITION",82,1.0468,0.36,0.7,2.0838,0,0.00075,-1.0771,0.31,0.74
"REACTOME:187187_REACT_23887_AQUAPORIN_MEDIATED_TRANSPORT","REACTOME","187187_REACT_23887_AQUAPORIN_MEDIATED_TRANSPORT",49,1.0469,0.34,0.71,0.7429,0.9,1,-0.8736,0.7,0.97
"GO_MF:503652_GO_0034450_UBIQUITIN_UBIQUITIN_LIGASE_ACTIVITY","GO_MF","503652_GO_0034450_UBIQUITIN_UBIQUITIN_LIGASE_ACTIVITY",10,1.047,0.39,0.96,1.3861,0.095,0.48,0.8771,0.62,0.96
"GO_BP:500824_GO_0031573_INTRA_S_DNA_DAMAGE_CHECKPOINT","GO_BP","500824_GO_0031573_INTRA_S_DNA_DAMAGE_CHECKPOINT",11,1.0473,0.4,0.91,-0.4921,0.99,1,-0.6649,0.88,1
"GO_CC:496120_GO_0016010_DYSTROPHIN_ASSOCIATED_GLYCOPROTEIN_COMPLEX","GO_CC","496120_GO_0016010_DYSTROPHIN_ASSOCIATED_GLYCOPROTEIN_COMPLEX",19,1.0477,0.4,0.75,-0.8213,0.73,1,-1.4141,0.086,0.57
"C7_Immunologic_signatures:C7_ALL_1266_GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN","C7_Immunologic_signatures","C7_ALL_1266_GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN",187,1.0479,0.36,0.57,1.4496,0.0045,0.022,-1.0802,0.24,0.54
"C4_Cancer_gene_neighborhoods:C4_CGN_42_MORF_RPA1","C4_Cancer_gene_neighborhoods","C4_CGN_42_MORF_RPA1",61,1.0483,0.33,0.61,1.6759,0.0067,0.0078,-1.0633,0.33,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_80_TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_80_TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP",67,1.0484,0.34,0.96,-0.8968,0.67,1,-0.9441,0.56,0.83
"REACTOME:105949_REACT_846_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX","REACTOME","105949_REACT_846_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX",33,1.0486,0.36,0.71,1.4757,0.049,0.16,0.7882,0.81,1
"GO_BP:488007_GO_0002118_AGGRESSIVE_BEHAVIOR","GO_BP","488007_GO_0002118_AGGRESSIVE_BEHAVIOR",10,1.0487,0.38,0.91,1.1343,0.3,0.86,-1.3116,0.16,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_3273_STEINER_ERYTHROCYTE_MEMBRANE_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_3273_STEINER_ERYTHROCYTE_MEMBRANE_GENES",15,1.0488,0.37,0.96,1.6682,0.028,0.1,-1.2879,0.16,0.44
"C2_Chemical_and_genetic_perturbations:C2_CGP_1634_DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1634_DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP",312,1.0488,0.26,0.97,1.7088,0,0.078,0.8438,0.93,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2117_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD","C2_Chemical_and_genetic_perturbations","C2_CGP_2117_KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD",24,1.0494,0.36,0.98,1.2761,0.16,0.42,-0.655,0.94,0.99
"C7_Immunologic_signatures:C7_ALL_921_GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP","C7_Immunologic_signatures","C7_ALL_921_GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP",198,1.0499,0.3,0.56,1.7685,0,0.00021,0.8734,0.82,1
"GO_MF:496788_GO_0016901_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR","GO_MF","496788_GO_0016901_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR",5,1.0499,0.39,0.96,0.5855,0.93,1,0.8278,0.69,1
"C1_Positional:C1_ALL_30_CHR9Q12","C1_Positional","C1_ALL_30_CHR9Q12",13,1.05,0.39,0.78,0.9339,0.54,0.83,1.6286,0.04,0.21
"GO_BP:515777_GO_0070849_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR","GO_BP","515777_GO_0070849_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR",26,1.0501,0.34,0.9,0.9107,0.61,1,-1.1798,0.21,0.73
"GO_BP:512723_GO_0051865_PROTEIN_AUTOUBIQUITINATION","GO_BP","512723_GO_0051865_PROTEIN_AUTOUBIQUITINATION",45,1.0502,0.35,0.91,1.3123,0.088,0.66,1.0795,0.3,0.77
"REACTOME:105948_REACT_833_RNA_POLYMERASE_II_TRANSCRIPTION_ELONGATION","REACTOME","105948_REACT_833_RNA_POLYMERASE_II_TRANSCRIPTION_ELONGATION",43,1.051,0.35,0.7,1.5911,0.004,0.097,1.0827,0.32,0.94
"GO_BP:496815_GO_0016973_POLY_A_MRNA_EXPORT_FROM_NUCLEUS","GO_BP","496815_GO_0016973_POLY_A_MRNA_EXPORT_FROM_NUCLEUS",10,1.051,0.37,0.9,-1.1197,0.31,0.94,-0.5529,0.97,1
"GO_BP:512329_GO_0051451_MYOBLAST_MIGRATION","GO_BP","512329_GO_0051451_MYOBLAST_MIGRATION",8,1.0513,0.36,0.91,-0.7534,0.78,1,-0.7405,0.79,1
"GO_CC:486751_GO_0000793_CONDENSED_CHROMOSOME","GO_CC","486751_GO_0000793_CONDENSED_CHROMOSOME",187,1.0516,0.27,0.74,1.2651,0.053,0.45,-0.8429,0.89,1
"C1_Positional:C1_ALL_312_CHRXQ22","C1_Positional","C1_ALL_312_CHRXQ22",78,1.0517,0.32,0.79,1.6197,0.0023,0.22,-0.9169,0.63,0.95
"GO_BP:492201_GO_0007440_FOREGUT_MORPHOGENESIS","GO_BP","492201_GO_0007440_FOREGUT_MORPHOGENESIS",11,1.0518,0.36,0.91,-0.9335,0.54,1,1.262,0.2,0.69
"C1_Positional:C1_ALL_37_CHR9Q22","C1_Positional","C1_ALL_37_CHR9Q22",94,1.0522,0.33,0.81,0.9354,0.58,0.83,0.9627,0.55,0.79
"GO_BP:750782_GO_0002190_CAP_INDEPENDENT_TRANSLATIONAL_INITIATION","GO_BP","750782_GO_0002190_CAP_INDEPENDENT_TRANSLATIONAL_INITIATION",5,1.0533,0.4,0.9,0.8194,0.66,1,-0.6758,0.86,1
"C7_Immunologic_signatures:C7_ALL_619_GSE17721_POLYIC_VS_CPG_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_619_GSE17721_POLYIC_VS_CPG_1H_BMDM_UP",199,1.0535,0.27,0.55,1.3587,0.0096,0.057,-0.7842,0.98,1
"GO_CC:487808_GO_0001917_PHOTORECEPTOR_INNER_SEGMENT","GO_CC","487808_GO_0001917_PHOTORECEPTOR_INNER_SEGMENT",28,1.0537,0.35,0.74,-1.2372,0.17,0.64,0.8412,0.72,1
"REACTOME:161052_REACT_22201_FORMATION_OF_HIV_ELONGATION_COMPLEX_IN_THE_ABSENCE_OF_HIV_TAT","REACTOME","161052_REACT_22201_FORMATION_OF_HIV_ELONGATION_COMPLEX_IN_THE_ABSENCE_OF_HIV_TAT",43,1.0537,0.34,0.7,1.5747,0.022,0.11,1.0902,0.31,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2955_NAKAMURA_ADIPOGENESIS_LATE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2955_NAKAMURA_ADIPOGENESIS_LATE_DN",37,1.0543,0.35,0.96,1.2907,0.12,0.4,1.1276,0.26,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_1264_SHEPARD_CRUSH_AND_BURN_MUTANT_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1264_SHEPARD_CRUSH_AND_BURN_MUTANT_UP",194,1.0546,0.3,0.97,1.3065,0.029,0.39,1.1292,0.16,0.85
"GO_BP:501236_GO_0031998_REGULATION_OF_FATTY_ACID_BETA_OXIDATION","GO_BP","501236_GO_0031998_REGULATION_OF_FATTY_ACID_BETA_OXIDATION",13,1.055,0.38,0.9,1.0378,0.39,0.96,-0.8242,0.7,0.97
"GO_BP:499174_GO_0021895_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION","GO_BP","499174_GO_0021895_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION",19,1.0551,0.34,0.9,-0.8817,0.61,1,-1.2413,0.16,0.69
"KEGG_compound:C00721_DEXTRIN","KEGG_compound","C00721_DEXTRIN",6,1.0554,0.38,1,0.646,0.89,1,1.6168,0.021,0.084
"GO_CC:492871_GO_0008622_EPSILON_DNA_POLYMERASE_COMPLEX","GO_CC","492871_GO_0008622_EPSILON_DNA_POLYMERASE_COMPLEX",5,1.0556,0.39,0.74,0.8117,0.7,0.95,-0.5408,0.97,1
"GO_MF:486855_GO_0000339_RNA_CAP_BINDING","GO_MF","486855_GO_0000339_RNA_CAP_BINDING",12,1.0559,0.35,0.94,1.038,0.42,0.83,-0.7399,0.8,0.99
"GO_CC:490877_GO_0005869_DYNACTIN_COMPLEX","GO_CC","490877_GO_0005869_DYNACTIN_COMPLEX",8,1.056,0.38,0.75,1.4977,0.067,0.2,0.63,0.91,1
"GO_BP:487035_GO_0000738_DNA_CATABOLIC_PROCESS_EXONUCLEOLYTIC","GO_BP","487035_GO_0000738_DNA_CATABOLIC_PROCESS_EXONUCLEOLYTIC",16,1.056,0.37,0.9,1.3102,0.12,0.66,0.6106,0.97,1
"C7_Immunologic_signatures:C7_ALL_1209_GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1209_GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP",199,1.0574,0.29,0.53,1.3779,0.012,0.046,-1.1141,0.18,0.46
"C1_Positional:C1_ALL_93_CHR10Q11","C1_Positional","C1_ALL_93_CHR10Q11",74,1.0574,0.33,0.81,1.264,0.089,0.55,1.088,0.29,0.71
"GO_BP:510803_GO_0048752_SEMICIRCULAR_CANAL_MORPHOGENESIS","GO_BP","510803_GO_0048752_SEMICIRCULAR_CANAL_MORPHOGENESIS",6,1.0576,0.38,0.9,1.0875,0.36,0.92,1.2352,0.23,0.7
"REACTOME:106360_REACT_16963_TACHYKININ_RECEPTORS_BIND_TACHYKININS","REACTOME","106360_REACT_16963_TACHYKININ_RECEPTORS_BIND_TACHYKININS",5,1.0577,0.39,0.69,-1.1566,0.31,0.85,1.0536,0.4,0.96
"GO_BP:497318_GO_0018377_PROTEIN_MYRISTOYLATION","GO_BP","497318_GO_0018377_PROTEIN_MYRISTOYLATION",5,1.0586,0.38,0.89,1.0046,0.46,0.98,-0.7308,0.77,0.99
"KEGG_compound:C05300_16ALPHA_HYDROXYESTRONE","KEGG_compound","C05300_16ALPHA_HYDROXYESTRONE",8,1.0588,0.36,1,1.3826,0.11,0.55,-1.3098,0.15,0.36
"GO_BP:492064_GO_0007286_SPERMATID_DEVELOPMENT","GO_BP","492064_GO_0007286_SPERMATID_DEVELOPMENT",102,1.0589,0.33,0.89,-0.8481,0.79,1,-0.7744,0.91,1
"GO_BP:510794_GO_0048739_CARDIAC_MUSCLE_FIBER_DEVELOPMENT","GO_BP","510794_GO_0048739_CARDIAC_MUSCLE_FIBER_DEVELOPMENT",8,1.059,0.36,0.9,-1.1679,0.29,0.91,1.3401,0.13,0.65
"KEGG_compound:C00075_UTP_URIDINE_5_TRIPHOSPHATE_URIDINE_TRIPHOSPHATE","KEGG_compound","C00075_UTP_URIDINE_5_TRIPHOSPHATE_URIDINE_TRIPHOSPHATE",55,1.0598,0.33,1,0.7619,0.91,1,-1.0335,0.37,0.61
"C4_Cancer_gene_neighborhoods:C4_CGN_220_GCM_CSNK2B","C4_Cancer_gene_neighborhoods","C4_CGN_220_GCM_CSNK2B",99,1.0599,0.31,0.57,2.8125,0,0,-0.7228,0.98,1
"GO_CC:487072_GO_0000779_CONDENSED_CHROMOSOME_CENTROMERIC_REGION","GO_CC","487072_GO_0000779_CONDENSED_CHROMOSOME_CENTROMERIC_REGION",100,1.0605,0.31,0.74,1.4121,0.015,0.29,-0.8739,0.75,1
"C7_Immunologic_signatures:C7_ALL_1594_GSE3982_EOSINOPHIL_VS_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1594_GSE3982_EOSINOPHIL_VS_BCELL_DN",193,1.0607,0.26,0.52,1.7272,0,0.00043,-1.3402,0.013,0.1
"GO_BP:752712_GO_0097211_CELLULAR_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE","GO_BP","752712_GO_0097211_CELLULAR_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE",6,1.0607,0.37,0.89,-1.4347,0.091,0.93,-0.7237,0.83,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_970_KAUFFMANN_MELANOMA_RELAPSE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_970_KAUFFMANN_MELANOMA_RELAPSE_UP",61,1.0615,0.32,0.95,1.3985,0.052,0.3,-1.1568,0.2,0.57
"GO_BP:504277_GO_0035092_SPERM_CHROMATIN_CONDENSATION","GO_BP","504277_GO_0035092_SPERM_CHROMATIN_CONDENSATION",8,1.0619,0.38,0.89,-0.8705,0.61,1,-1.3069,0.17,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_1285_IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1285_IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP",16,1.0624,0.33,0.95,1.4202,0.065,0.28,1.5914,0.028,0.41
"GO_BP:504321_GO_0035136_FORELIMB_MORPHOGENESIS","GO_BP","504321_GO_0035136_FORELIMB_MORPHOGENESIS",36,1.0628,0.33,0.89,-0.9593,0.53,1,1.0044,0.43,0.85
"GO_BP:518243_GO_0090103_COCHLEA_MORPHOGENESIS","GO_BP","518243_GO_0090103_COCHLEA_MORPHOGENESIS",22,1.0629,0.35,0.89,1.4499,0.057,0.49,0.8742,0.65,0.96
"C4_Cancer_gene_neighborhoods:C4_CGN_22_MORF_HDAC2","C4_Cancer_gene_neighborhoods","C4_CGN_22_MORF_HDAC2",279,1.063,0.19,0.57,2.2572,0,0,-1.0386,0.32,0.75
"REACTOME:106176_REACT_13565_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC_","REACTOME","106176_REACT_13565_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC_",50,1.0631,0.33,0.68,2.0307,0,0.0015,0.566,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_262_GCM_RBM8A","C4_Cancer_gene_neighborhoods","C4_CGN_262_GCM_RBM8A",81,1.0637,0.31,0.57,0.6983,0.97,1,0.8346,0.82,1
"GO_BP:496128_GO_0016024_CDP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS","GO_BP","496128_GO_0016024_CDP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS",13,1.0638,0.35,0.89,1.2333,0.21,0.75,0.4741,1,1
"KEGG_compound:C00020_AMP_ADENOSINE_5_MONOPHOSPHATE_ADENYLIC_ACID_ADENYLATE_5_AMP_5_ADENYLIC_ACID_5_ADENOSINE_MONOPHOSPHATE_ADENOSINE_5_PHOSPHATE","KEGG_compound","C00020_AMP_ADENOSINE_5_MONOPHOSPHATE_ADENYLIC_ACID_ADENYLATE_5_AMP_5_ADENYLIC_ACID_5_ADENOSINE_MONOPHOSPHATE_ADENOSINE_5_PHOSPHATE",132,1.0639,0.26,1,0.7881,0.93,1,-1.1754,0.13,0.47
"C4_Cancer_modules:C4_CM_86_MODULE_91","C4_Cancer_modules","C4_CM_86_MODULE_91",37,1.0641,0.33,0.83,2.1807,0,2e-04,0.8778,0.67,1
"C7_Immunologic_signatures:C7_ALL_1113_GSE2706_UNSTIM_VS_2H_R848_DC_UP","C7_Immunologic_signatures","C7_ALL_1113_GSE2706_UNSTIM_VS_2H_R848_DC_UP",188,1.0644,0.26,0.51,0.9712,0.55,0.83,-1.2291,0.07,0.23
"GO_BP:492361_GO_0007620_COPULATION","GO_BP","492361_GO_0007620_COPULATION",18,1.0645,0.37,0.89,1.4264,0.06,0.52,1.0181,0.44,0.84
"REACTOME:105744_REACT_309_STABILIZATION_OF_P53","REACTOME","105744_REACT_309_STABILIZATION_OF_P53",52,1.0647,0.32,0.68,2.1447,0,0.00036,-0.7165,0.94,1
"REACTOME:105898_REACT_734_DNA_REPLICATION_PRE_INITIATION","REACTOME","105898_REACT_734_DNA_REPLICATION_PRE_INITIATION",82,1.0648,0.29,0.68,2.0565,0,0.0012,-1.0833,0.3,0.72
"C4_Cancer_gene_neighborhoods:C4_CGN_13_MORF_CCNI","C4_Cancer_gene_neighborhoods","C4_CGN_13_MORF_CCNI",88,1.0649,0.31,0.57,2.7369,0,0,0.7552,0.96,1
"GO_MF:489765_GO_0004402_HISTONE_ACETYLTRANSFERASE_ACTIVITY","GO_MF","489765_GO_0004402_HISTONE_ACETYLTRANSFERASE_ACTIVITY",55,1.0652,0.35,0.92,0.7825,0.87,1,-0.5613,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_122_MORF_LCAT","C4_Cancer_gene_neighborhoods","C4_CGN_122_MORF_LCAT",126,1.0653,0.27,0.58,-0.98,0.52,0.86,1.4106,0.025,0.23
"GO_BP:489261_GO_0006363_TERMINATION_OF_RNA_POLYMERASE_I_TRANSCRIPTION","GO_BP","489261_GO_0006363_TERMINATION_OF_RNA_POLYMERASE_I_TRANSCRIPTION",31,1.0654,0.33,0.89,1.1409,0.27,0.85,0.7972,0.8,1
"GO_BP:752711_GO_0097210_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE","GO_BP","752711_GO_0097210_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE",6,1.0654,0.4,0.89,-1.4404,0.08,0.91,-0.7293,0.82,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_1779_LEE_AGING_MUSCLE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1779_LEE_AGING_MUSCLE_DN",46,1.0657,0.32,0.95,1.3423,0.075,0.35,1.222,0.14,0.75
"REACTOME:161051_REACT_6259_HIV_ELONGATION_ARREST_AND_RECOVERY","REACTOME","161051_REACT_6259_HIV_ELONGATION_ARREST_AND_RECOVERY",31,1.0659,0.35,0.68,1.519,0.039,0.14,1.1588,0.23,0.89
"GO_BP:501445_GO_0032210_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE","GO_BP","501445_GO_0032210_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE",8,1.0665,0.36,0.89,-0.5279,0.98,1,0.3736,1,1
"GO_BP:506574_GO_0043543_PROTEIN_ACYLATION","GO_BP","506574_GO_0043543_PROTEIN_ACYLATION",159,1.0666,0.25,0.89,-0.7738,0.97,1,-0.8851,0.75,0.94
"GO_BP:751215_GO_0036297_INTERSTRAND_CROSS_LINK_REPAIR","GO_BP","751215_GO_0036297_INTERSTRAND_CROSS_LINK_REPAIR",8,1.0666,0.36,0.89,-0.8584,0.63,1,-0.5471,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1201_NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1201_NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON",73,1.0668,0.31,0.95,0.9305,0.62,0.89,1.4164,0.029,0.55
"C4_Cancer_gene_neighborhoods:C4_CGN_165_MORF_RAB5A","C4_Cancer_gene_neighborhoods","C4_CGN_165_MORF_RAB5A",97,1.0672,0.28,0.58,2.2018,0,2.1e-05,1.4913,0.0095,0.19
"C2_Chemical_and_genetic_perturbations:C2_CGP_2816_WEBER_METHYLATED_ICP_IN_FIBROBLAST","C2_Chemical_and_genetic_perturbations","C2_CGP_2816_WEBER_METHYLATED_ICP_IN_FIBROBLAST",21,1.0675,0.31,0.96,1.2648,0.17,0.42,1.6751,0.015,0.27
"GO_BP:507890_GO_0045540_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS","GO_BP","507890_GO_0045540_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS",11,1.0676,0.34,0.89,1.0231,0.41,0.97,1.151,0.3,0.73
"REACTOME:105690_REACT_2077_RAF_ACTIVATION","REACTOME","105690_REACT_2077_RAF_ACTIVATION",5,1.0676,0.36,0.68,1.2741,0.2,0.35,0.8378,0.66,1
"C4_Cancer_gene_neighborhoods:C4_CGN_244_GCM_MYCL1","C4_Cancer_gene_neighborhoods","C4_CGN_244_GCM_MYCL1",23,1.0678,0.35,0.58,1.0424,0.38,0.48,1.0889,0.32,0.62
"GO_BP:751440_GO_0039533_REGULATION_OF_MDA_5_SIGNALING_PATHWAY","GO_BP","751440_GO_0039533_REGULATION_OF_MDA_5_SIGNALING_PATHWAY",5,1.0679,0.39,0.89,1.2916,0.19,0.68,-0.9966,0.5,0.85
"GO_MF:492733_GO_0008440_INOSITOL_1_4_5_TRISPHOSPHATE_3_KINASE_ACTIVITY","GO_MF","492733_GO_0008440_INOSITOL_1_4_5_TRISPHOSPHATE_3_KINASE_ACTIVITY",7,1.068,0.37,0.92,1.0204,0.45,0.86,1.1403,0.29,0.79
"C4_Cancer_gene_neighborhoods:C4_CGN_110_MORF_HEAB","C4_Cancer_gene_neighborhoods","C4_CGN_110_MORF_HEAB",81,1.0682,0.31,0.59,0.8101,0.88,0.98,-0.8786,0.71,1
"C4_Cancer_modules:C4_CM_211_MODULE_229","C4_Cancer_modules","C4_CM_211_MODULE_229",31,1.0683,0.36,0.85,0.8191,0.77,0.95,-0.7118,0.91,1
"GO_BP:491299_GO_0006361_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_I_PROMOTER","GO_BP","491299_GO_0006361_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_I_PROMOTER",34,1.0685,0.32,0.89,1.2198,0.16,0.77,0.8036,0.82,1
"REACTOME:105788_REACT_1221_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6","REACTOME","105788_REACT_1221_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6",50,1.0687,0.34,0.68,2.1964,0,0.00017,-0.4493,1,1
"REACTOME:161075_REACT_22285_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES","REACTOME","161075_REACT_22285_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES",37,1.0687,0.33,0.68,-0.921,0.6,1,0.7486,0.86,1
"C7_Immunologic_signatures:C7_ALL_857_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP","C7_Immunologic_signatures","C7_ALL_857_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP",193,1.0688,0.21,0.49,1.0887,0.24,0.47,1.0216,0.39,1
"REACTOME:106428_REACT_456_PKB_MEDIATED_EVENTS","REACTOME","106428_REACT_456_PKB_MEDIATED_EVENTS",30,1.069,0.32,0.68,1.2902,0.12,0.33,0.6134,0.97,1
"GO_MF:496772_GO_0016884_CARBON_NITROGEN_LIGASE_ACTIVITY_WITH_GLUTAMINE_AS_AMIDO_N_DONOR","GO_MF","496772_GO_0016884_CARBON_NITROGEN_LIGASE_ACTIVITY_WITH_GLUTAMINE_AS_AMIDO_N_DONOR",12,1.0692,0.35,0.92,0.451,0.99,1,-1.2111,0.23,0.57
"GO_BP:505321_GO_0042158_LIPOPROTEIN_BIOSYNTHETIC_PROCESS","GO_BP","505321_GO_0042158_LIPOPROTEIN_BIOSYNTHETIC_PROCESS",83,1.0699,0.33,0.89,0.7941,0.91,1,-0.7378,0.95,1
"C7_Immunologic_signatures:C7_ALL_1181_GSE27786_BCELL_VS_NKCELL_UP","C7_Immunologic_signatures","C7_ALL_1181_GSE27786_BCELL_VS_NKCELL_UP",199,1.07,0.25,0.49,1.071,0.27,0.52,-0.8678,0.82,0.99
"GO_BP:491395_GO_0006497_PROTEIN_LIPIDATION","GO_BP","491395_GO_0006497_PROTEIN_LIPIDATION",78,1.0705,0.27,0.89,0.8657,0.75,1,-0.7415,0.97,1
"GO_BP:491237_GO_0006273_LAGGING_STRAND_ELONGATION","GO_BP","491237_GO_0006273_LAGGING_STRAND_ELONGATION",6,1.0707,0.36,0.89,0.6571,0.88,1,0.8137,0.69,1
"C4_Cancer_gene_neighborhoods:C4_CGN_92_MORF_EIF3S6","C4_Cancer_gene_neighborhoods","C4_CGN_92_MORF_EIF3S6",122,1.0713,0.27,0.58,3.1073,0,0,-0.5834,1,1
"C6_Oncogenic_signatures:C6_ALL_10_GCNP_SHH_UP_EARLY_V1_UP","C6_Oncogenic_signatures","C6_ALL_10_GCNP_SHH_UP_EARLY_V1_UP",158,1.0714,0.27,0.67,1.2141,0.076,0.39,-1.0036,0.46,0.63
"REACTOME:105833_REACT_6871_APC_C_CDC20_MEDIATED_DEGRADATION_OF_SECURIN","REACTOME","105833_REACT_6871_APC_C_CDC20_MEDIATED_DEGRADATION_OF_SECURIN",64,1.0717,0.31,0.68,2.1308,0,0.00041,-0.5402,1,1
"GO_CC:487069_GO_0000776_KINETOCHORE","GO_CC","487069_GO_0000776_KINETOCHORE",117,1.0728,0.23,0.71,1.3708,0.021,0.32,-0.8253,0.89,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_27_BIOCARTA_CACAM_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_27_BIOCARTA_CACAM_PATHWAY",13,1.0734,0.36,1,1.1228,0.3,0.68,-0.6682,0.91,0.98
"C4_Cancer_gene_neighborhoods:C4_CGN_158_MORF_PTPN11","C4_Cancer_gene_neighborhoods","C4_CGN_158_MORF_PTPN11",108,1.0735,0.27,0.58,2.0464,0.0024,0.00021,-0.6577,1,1
"C7_Immunologic_signatures:C7_ALL_1233_GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP","C7_Immunologic_signatures","C7_ALL_1233_GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP",196,1.0736,0.23,0.48,0.8744,0.82,1,-1.0398,0.35,0.63
"REACTOME:106262_REACT_16969_STRIATED_MUSCLE_CONTRACTION","REACTOME","106262_REACT_16969_STRIATED_MUSCLE_CONTRACTION",30,1.0739,0.37,0.68,1.1165,0.28,0.56,0.8806,0.65,1
"C7_Immunologic_signatures:C7_ALL_82_GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN","C7_Immunologic_signatures","C7_ALL_82_GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN",191,1.0742,0.24,0.48,1.6398,0,0.0014,1.7956,0,0.00032
"C4_Cancer_gene_neighborhoods:C4_CGN_336_GNF2_CDH11","C4_Cancer_gene_neighborhoods","C4_CGN_336_GNF2_CDH11",25,1.0745,0.33,0.59,-0.9563,0.52,0.89,1.3245,0.12,0.29
"C4_Cancer_gene_neighborhoods:C4_CGN_91_MORF_EIF3S2","C4_Cancer_gene_neighborhoods","C4_CGN_91_MORF_EIF3S2",246,1.0751,0.25,0.59,2.5227,0,0,-0.9903,0.47,0.88
"C3_MicroRNA_targets:C3_MIR_175_AGGAGTG_MIR_483","C3_MicroRNA_targets","C3_MIR_175_AGGAGTG_MIR_483",64,1.0752,0.29,1,-0.923,0.59,1,0.7612,0.91,1
"GO_BP:751609_GO_0044458_MOTILE_CILIUM_ASSEMBLY","GO_BP","751609_GO_0044458_MOTILE_CILIUM_ASSEMBLY",8,1.076,0.36,0.87,0.934,0.53,1,0.8922,0.6,0.95
"GO_CC:490865_GO_0005849_MRNA_CLEAVAGE_FACTOR_COMPLEX","GO_CC","490865_GO_0005849_MRNA_CLEAVAGE_FACTOR_COMPLEX",15,1.0761,0.33,0.71,1.2275,0.2,0.49,0.5125,0.98,1
"GO_CC:492815_GO_0008540_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX","GO_CC","492815_GO_0008540_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",5,1.0764,0.38,0.71,1.3166,0.16,0.39,0.6238,0.91,1
"GO_MF:492679_GO_0008376_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY","GO_MF","492679_GO_0008376_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY",36,1.0772,0.31,0.9,-0.8369,0.75,1,1.3007,0.11,0.66
"GO_BP:510621_GO_0048554_POSITIVE_REGULATION_OF_METALLOENZYME_ACTIVITY","GO_BP","510621_GO_0048554_POSITIVE_REGULATION_OF_METALLOENZYME_ACTIVITY",6,1.0776,0.35,0.87,0.9096,0.57,1,0.797,0.71,1
"C4_Cancer_gene_neighborhoods:C4_CGN_88_MORF_DEK","C4_Cancer_gene_neighborhoods","C4_CGN_88_MORF_DEK",264,1.0782,0.2,0.59,2.6083,0,0,-0.7797,0.98,1
"C1_Positional:C1_ALL_251_CHR5P13","C1_Positional","C1_ALL_251_CHR5P13",48,1.0784,0.32,0.76,1.5335,0.017,0.28,1.3777,0.06,0.44
"C4_Cancer_modules:C4_CM_295_MODULE_337","C4_Cancer_modules","C4_CM_295_MODULE_337",62,1.0784,0.28,0.86,0.6401,0.98,1,-1.2891,0.086,0.31
"GO_CC:492598_GO_0008274_GAMMA_TUBULIN_RING_COMPLEX","GO_CC","492598_GO_0008274_GAMMA_TUBULIN_RING_COMPLEX",7,1.0785,0.35,0.71,1.1312,0.31,0.6,-0.6543,0.89,1
"REACTOME:685548_REACT_147841_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES","REACTOME","685548_REACT_147841_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES",17,1.0786,0.33,0.67,0.9959,0.45,0.76,-0.9136,0.58,0.94
"REACTOME:105857_REACT_127_DNA_DAMAGE_REVERSAL","REACTOME","105857_REACT_127_DNA_DAMAGE_REVERSAL",6,1.0788,0.37,0.67,1.3963,0.091,0.23,-0.7729,0.74,1
"GO_MF:489232_GO_0003678_DNA_HELICASE_ACTIVITY","GO_MF","489232_GO_0003678_DNA_HELICASE_ACTIVITY",50,1.0793,0.29,0.9,0.7862,0.83,1,-1.2656,0.13,0.58
"GO_MF:510510_GO_0048407_PLATELET_DERIVED_GROWTH_FACTOR_BINDING","GO_MF","510510_GO_0048407_PLATELET_DERIVED_GROWTH_FACTOR_BINDING",11,1.0793,0.35,0.91,0.5568,0.97,1,0.9936,0.47,0.88
"GO_MF:489877_GO_0004529_EXODEOXYRIBONUCLEASE_ACTIVITY","GO_MF","489877_GO_0004529_EXODEOXYRIBONUCLEASE_ACTIVITY",15,1.0797,0.35,0.92,1.1717,0.24,0.73,0.6217,0.94,1
"C4_Cancer_gene_neighborhoods:C4_CGN_219_GCM_CSNK1D","C4_Cancer_gene_neighborhoods","C4_CGN_219_GCM_CSNK1D",32,1.0798,0.3,0.59,1.2072,0.17,0.21,0.9432,0.56,0.96
"REACTOME:106494_REACT_15457_G_PROTEIN_ACTIVATION","REACTOME","106494_REACT_15457_G_PROTEIN_ACTIVATION",27,1.0799,0.31,0.67,-0.9897,0.48,0.99,-0.8384,0.72,1
"GO_BP:491376_GO_0006474_N_TERMINAL_PROTEIN_AMINO_ACID_ACETYLATION","GO_BP","491376_GO_0006474_N_TERMINAL_PROTEIN_AMINO_ACID_ACETYLATION",13,1.0805,0.36,0.86,0.7319,0.84,1,1.437,0.074,0.6
"C3_TF_targets:C3_TFT_182_V_NRSF_01","C3_TF_targets","C3_TFT_182_V_NRSF_01",92,1.0807,0.28,0.56,-1.2315,0.1,0.3,0.9975,0.46,1
"C4_Cancer_gene_neighborhoods:C4_CGN_270_GCM_TPR","C4_Cancer_gene_neighborhoods","C4_CGN_270_GCM_TPR",32,1.0808,0.33,0.59,1.4739,0.041,0.038,-0.5803,0.99,1
"GO_CC:502495_GO_0033276_TRANSCRIPTION_FACTOR_TFTC_COMPLEX","GO_CC","502495_GO_0033276_TRANSCRIPTION_FACTOR_TFTC_COMPLEX",14,1.0811,0.36,0.71,-0.6514,0.9,1,-0.6425,0.93,1
"C7_Immunologic_signatures:C7_ALL_307_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP","C7_Immunologic_signatures","C7_ALL_307_GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP",197,1.0827,0.2,0.44,1.2249,0.083,0.19,-1.1757,0.1,0.33
"C7_Immunologic_signatures:C7_ALL_770_GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_770_GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN",198,1.0828,0.24,0.45,1.0313,0.35,0.64,1.2594,0.036,0.52
"GO_MF:1039896_GO_0090595_ACETYL_COA_L_LYSINE_N6_ACETYLTRANSFERASE","GO_MF","1039896_GO_0090595_ACETYL_COA_L_LYSINE_N6_ACETYLTRANSFERASE",55,1.0831,0.27,0.91,0.7726,0.91,1,-0.56,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2940_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14","C2_Chemical_and_genetic_perturbations","C2_CGP_2940_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14",142,1.0832,0.26,0.9,1.4709,0.0046,0.24,-0.7641,0.98,0.97
"GO_CC:486784_GO_0005834_HETEROTRIMERIC_G_PROTEIN_COMPLEX","GO_CC","486784_GO_0005834_HETEROTRIMERIC_G_PROTEIN_COMPLEX",34,1.0833,0.33,0.71,1.0478,0.38,0.72,-1.0006,0.44,1
"GO_BP:496377_GO_0016338_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES","GO_BP","496377_GO_0016338_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES",20,1.0841,0.34,0.85,-1.2174,0.2,0.88,1.1168,0.32,0.75
"C4_Cancer_gene_neighborhoods:C4_CGN_120_MORF_JUND","C4_Cancer_gene_neighborhoods","C4_CGN_120_MORF_JUND",64,1.085,0.28,0.58,3.0901,0,0,0.9095,0.65,1
"GO_MF:494385_GO_0010314_PHOSPHATIDYLINOSITOL_5_PHOSPHATE_BINDING","GO_MF","494385_GO_0010314_PHOSPHATIDYLINOSITOL_5_PHOSPHATE_BINDING",10,1.0854,0.33,0.91,-0.7116,0.85,1,0.8557,0.68,0.98
"C7_Immunologic_signatures:C7_ALL_985_GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_985_GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP",199,1.0861,0.17,0.44,2.0601,0,0,-0.8126,0.94,1
"REACTOME:106556_REACT_1074_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION","REACTOME","106556_REACT_1074_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION",31,1.0861,0.29,0.66,1.156,0.23,0.5,0.7779,0.82,1
"C7_Immunologic_signatures:C7_ALL_228_GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN","C7_Immunologic_signatures","C7_ALL_228_GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN",193,1.087,0.21,0.44,2.0494,0,0,0.769,0.99,1
"REACTOME:105950_REACT_1845_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX","REACTOME","105950_REACT_1845_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX",43,1.087,0.32,0.66,1.5434,0.025,0.12,1.092,0.31,0.96
"C7_Immunologic_signatures:C7_ALL_847_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP","C7_Immunologic_signatures","C7_ALL_847_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP",197,1.0875,0.2,0.44,1.4227,0.0024,0.031,-0.9765,0.5,0.78
"GO_CC:490778_GO_0005743_MITOCHONDRIAL_INNER_MEMBRANE","GO_CC","490778_GO_0005743_MITOCHONDRIAL_INNER_MEMBRANE",442,1.0877,0.21,0.7,2.4499,0,0,-0.6957,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1890_KALMA_E2F1_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_1890_KALMA_E2F1_TARGETS",11,1.0877,0.35,0.89,1.7401,0.016,0.063,-0.6549,0.92,0.99
"GO_BP:1039931_GO_1903377_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","1039931_GO_1903377_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",5,1.0878,0.38,0.84,1.4445,0.06,0.5,0.9992,0.47,0.86
"REACTOME:160954_REACT_1096_PROCESSING_OF_INTRONLESS_PRE_MRNAS","REACTOME","160954_REACT_1096_PROCESSING_OF_INTRONLESS_PRE_MRNAS",14,1.0881,0.33,0.66,1.0689,0.36,0.63,0.6162,0.94,1
"GO_MF:501501_GO_0032266_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING","GO_MF","501501_GO_0032266_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING",26,1.0881,0.3,0.91,0.5169,1,1,-0.7037,0.89,1
"GO_BP:754168_GO_1901201_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY","GO_BP","754168_GO_1901201_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY",6,1.0887,0.35,0.84,0.7093,0.82,1,1.1762,0.28,0.72
"C7_Immunologic_signatures:C7_ALL_1591_GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1591_GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP",198,1.0887,0.21,0.44,1.6043,0.0046,0.0028,-0.8195,0.95,1
"GO_BP:849890_GO_1902188_POSITIVE_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL","GO_BP","849890_GO_1902188_POSITIVE_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL",14,1.0892,0.33,0.84,1.3426,0.13,0.62,1.1272,0.29,0.74
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_164_BIOCARTA_ATRBRCA_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_164_BIOCARTA_ATRBRCA_PATHWAY",21,1.0893,0.33,1,-0.555,0.99,1,-1.5146,0.027,0.32
"GO_CC:487155_GO_0000931_GAMMA_TUBULIN_LARGE_COMPLEX","GO_CC","487155_GO_0000931_GAMMA_TUBULIN_LARGE_COMPLEX",7,1.0893,0.37,0.7,1.1461,0.29,0.59,-0.6547,0.89,1
"GO_BP:518539_GO_0090399_REPLICATIVE_SENESCENCE","GO_BP","518539_GO_0090399_REPLICATIVE_SENESCENCE",11,1.0894,0.34,0.84,-0.9029,0.61,1,-1.0367,0.38,0.82
"GO_BP:508028_GO_0045683_NEGATIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT","GO_BP","508028_GO_0045683_NEGATIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT",15,1.0895,0.32,0.84,-0.6519,0.92,1,-0.6278,0.95,1
"GO_BP:505610_GO_0042473_OUTER_EAR_MORPHOGENESIS","GO_BP","505610_GO_0042473_OUTER_EAR_MORPHOGENESIS",8,1.0898,0.35,0.84,1.3031,0.17,0.67,0.9682,0.49,0.89
"C7_Immunologic_signatures:C7_ALL_1268_GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN","C7_Immunologic_signatures","C7_ALL_1268_GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN",176,1.09,0.23,0.44,-0.911,0.71,1,-1.0568,0.31,0.6
"C1_Positional:C1_ALL_210_CHR10P14","C1_Positional","C1_ALL_210_CHR10P14",21,1.0906,0.32,0.74,1.3124,0.13,0.53,0.8399,0.7,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_45_NAM_FXYD5_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_45_NAM_FXYD5_TARGETS_DN",18,1.0912,0.34,0.88,1.8143,0.0064,0.039,0.8219,0.72,1
"C6_Oncogenic_signatures:C6_ALL_151_SINGH_KRAS_DEPENDENCY_SIGNATURE_","C6_Oncogenic_signatures","C6_ALL_151_SINGH_KRAS_DEPENDENCY_SIGNATURE_",20,1.0914,0.33,0.76,-0.6446,0.93,1,1.352,0.13,0.15
"C4_Cancer_modules:C4_CM_202_MODULE_215","C4_Cancer_modules","C4_CM_202_MODULE_215",15,1.0914,0.32,0.85,-1.302,0.14,0.51,1.5679,0.036,0.18
"GO_BP:507704_GO_0045347_NEGATIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS","GO_BP","507704_GO_0045347_NEGATIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS",6,1.0918,0.35,0.84,1.3741,0.14,0.58,0.8071,0.68,1
"GO_CC:515393_GO_0070461_SAGA_TYPE_COMPLEX","GO_CC","515393_GO_0070461_SAGA_TYPE_COMPLEX",30,1.0921,0.33,0.7,0.8021,0.79,0.96,-0.8489,0.71,1
"C7_Immunologic_signatures:C7_ALL_402_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_402_GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN",200,1.0921,0.21,0.44,2.1684,0,0,-0.5837,1,1
"GO_BP:518857_GO_2000210_POSITIVE_REGULATION_OF_ANOIKIS","GO_BP","518857_GO_2000210_POSITIVE_REGULATION_OF_ANOIKIS",6,1.0922,0.36,0.84,1.0034,0.44,0.98,-0.88,0.62,0.94
"GO_BP:782516_GO_0061512_PROTEIN_LOCALIZATION_TO_CILIUM","GO_BP","782516_GO_0061512_PROTEIN_LOCALIZATION_TO_CILIUM",15,1.0922,0.34,0.84,0.8138,0.74,1,-0.586,0.96,1
"GO_MF:496398_GO_0016410_N_ACYLTRANSFERASE_ACTIVITY","GO_MF","496398_GO_0016410_N_ACYLTRANSFERASE_ACTIVITY",97,1.0927,0.25,0.9,-0.6412,1,1,-0.7075,0.99,1
"GO_BP:750784_GO_0002192_IRES_DEPENDENT_TRANSLATIONAL_INITIATION","GO_BP","750784_GO_0002192_IRES_DEPENDENT_TRANSLATIONAL_INITIATION",5,1.0931,0.34,0.84,0.8326,0.66,1,-0.6941,0.86,0.99
"C3_TF_targets:C3_TFT_215_V_GABP_B","C3_TF_targets","C3_TFT_215_V_GABP_B",259,1.0933,0.15,0.56,1.4712,0.0048,0.2,1.0688,0.27,1
"GO_BP:507521_GO_0045132_MEIOTIC_CHROMOSOME_SEGREGATION","GO_BP","507521_GO_0045132_MEIOTIC_CHROMOSOME_SEGREGATION",53,1.0936,0.28,0.84,0.7021,0.96,1,-0.9343,0.57,0.9
"C7_Immunologic_signatures:C7_ALL_1192_GSE27786_CD4_VS_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1192_GSE27786_CD4_VS_CD8_TCELL_DN",198,1.0937,0.21,0.43,1.4437,0.0048,0.024,-1.034,0.37,0.65
"C7_Immunologic_signatures:C7_ALL_1672_GSE3982_NEUTROPHIL_VS_TH1_DN","C7_Immunologic_signatures","C7_ALL_1672_GSE3982_NEUTROPHIL_VS_TH1_DN",200,1.0948,0.2,0.43,1.6799,0,0.00085,-1.0899,0.25,0.52
"KEGG_compound:C16679_ALL_TRANS_18_HYDROXYRETINOIC_ACID","KEGG_compound","C16679_ALL_TRANS_18_HYDROXYRETINOIC_ACID",14,1.0955,0.33,1,-0.9931,0.46,1,1.0995,0.34,0.65
"C2_Chemical_and_genetic_perturbations:C2_CGP_664_NAKAMURA_ALVEOLAR_EPITHELIUM","C2_Chemical_and_genetic_perturbations","C2_CGP_664_NAKAMURA_ALVEOLAR_EPITHELIUM",5,1.0961,0.36,0.87,0.4595,0.99,1,-1.0706,0.41,0.67
"REACTOME:771600_REACT_160163_SCAVENGING_OF_HEME_FROM_PLASMA","REACTOME","771600_REACT_160163_SCAVENGING_OF_HEME_FROM_PLASMA",12,1.0963,0.31,0.64,1.2887,0.17,0.34,-0.8197,0.71,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3292_KRIEG_KDM3A_TARGETS_NOT_HYPOXIA","C2_Chemical_and_genetic_perturbations","C2_CGP_3292_KRIEG_KDM3A_TARGETS_NOT_HYPOXIA",198,1.0965,0.18,0.88,1.5532,0,0.17,0.9375,0.67,1
"GO_BP:503861_GO_0034661_NCRNA_CATABOLIC_PROCESS","GO_BP","503861_GO_0034661_NCRNA_CATABOLIC_PROCESS",16,1.0965,0.32,0.83,0.7457,0.8,1,-0.7717,0.8,1
"REACTOME:106430_REACT_6838_MTOR_SIGNALLING","REACTOME","106430_REACT_6838_MTOR_SIGNALLING",29,1.0969,0.33,0.64,1.2846,0.15,0.34,0.6243,0.99,1
"GO_MF:487558_GO_0001642_GROUP_III_METABOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY","GO_MF","487558_GO_0001642_GROUP_III_METABOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY",5,1.0973,0.35,0.89,1.3866,0.11,0.48,1.6197,0.03,0.31
"C4_Cancer_gene_neighborhoods:C4_CGN_20_MORF_HAT1","C4_Cancer_gene_neighborhoods","C4_CGN_20_MORF_HAT1",175,1.0975,0.19,0.55,2.5896,0,0,-0.9146,0.7,1
"C7_Immunologic_signatures:C7_ALL_1216_GSE27786_NKCELL_VS_ERYTHROBLAST_DN","C7_Immunologic_signatures","C7_ALL_1216_GSE27786_NKCELL_VS_ERYTHROBLAST_DN",196,1.0977,0.21,0.42,1.0676,0.29,0.53,1.1645,0.13,0.83
"C2_Chemical_and_genetic_perturbations:C2_CGP_3169_VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3169_VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP",18,1.0979,0.31,0.88,1.4089,0.086,0.29,1.4496,0.066,0.54
"GO_BP:500173_GO_0030878_THYROID_GLAND_DEVELOPMENT","GO_BP","500173_GO_0030878_THYROID_GLAND_DEVELOPMENT",16,1.098,0.31,0.83,-0.8554,0.67,1,0.8934,0.61,0.95
"C4_Cancer_gene_neighborhoods:C4_CGN_36_MORF_RAD23B","C4_Cancer_gene_neighborhoods","C4_CGN_36_MORF_RAD23B",179,1.0981,0.24,0.55,2.4172,0,0,0.7099,1,1
"GO_BP:493908_GO_0009804_COUMARIN_METABOLIC_PROCESS","GO_BP","493908_GO_0009804_COUMARIN_METABOLIC_PROCESS",8,1.0982,0.31,0.83,-1.3319,0.17,0.91,1.4851,0.067,0.58
"C7_Immunologic_signatures:C7_ALL_58_GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN","C7_Immunologic_signatures","C7_ALL_58_GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN",188,1.0983,0.15,0.43,1.6442,0,0.0013,0.9118,0.72,1
"C1_Positional:C1_ALL_20_CHR4P16","C1_Positional","C1_ALL_20_CHR4P16",114,1.0985,0.21,0.73,0.6772,1,1,1.0762,0.29,0.7
"C2_Chemical_and_genetic_perturbations:C2_CGP_2403_THUM_MIR21_TARGETS_HEART_DISEASE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2403_THUM_MIR21_TARGETS_HEART_DISEASE_UP",16,1.0988,0.34,0.89,1.1428,0.26,0.56,0.8704,0.63,1
"GO_BP:493496_GO_0009312_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS","GO_BP","493496_GO_0009312_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS",14,1.0991,0.31,0.83,0.9225,0.56,1,1.0731,0.36,0.78
"GO_BP:486610_GO_0006260_DNA_REPLICATION","GO_BP","486610_GO_0006260_DNA_REPLICATION",207,1.0994,0.21,0.83,1.1514,0.12,0.84,-1.1872,0.11,0.73
"KEGG_reaction:R05916_UDP_N_ACETYL_D_GLUCOSAMINE_1_PHOSPHATIDYL_D_MYO_INOSITOL_UDP_G00143","KEGG_reaction","R05916_UDP_N_ACETYL_D_GLUCOSAMINE_1_PHOSPHATIDYL_D_MYO_INOSITOL_UDP_G00143",7,1.0997,0.32,1,1.1419,0.29,1,0.6104,0.93,0.98
"C4_Cancer_gene_neighborhoods:C4_CGN_152_MORF_PPP6C","C4_Cancer_gene_neighborhoods","C4_CGN_152_MORF_PPP6C",103,1.1006,0.24,0.55,2.1893,0,2.1e-05,1.1011,0.25,0.63
"KEGG_reaction:R08390_RETINOATE_NADPH_H_OXYGEN_ALL_TRANS_18_HYDROXYRETINOIC_ACID_NADP_H2O","KEGG_reaction","R08390_RETINOATE_NADPH_H_OXYGEN_ALL_TRANS_18_HYDROXYRETINOIC_ACID_NADP_H2O",14,1.1017,0.32,1,-0.9847,0.47,0.78,1.1073,0.32,0.61
"C7_Immunologic_signatures:C7_ALL_126_GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN","C7_Immunologic_signatures","C7_ALL_126_GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN",199,1.1027,0.17,0.41,1.2888,0.028,0.11,-0.7006,1,1
"GO_MF:486778_GO_0005337_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","486778_GO_0005337_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",13,1.1027,0.31,0.88,0.6229,0.93,1,-1.2047,0.22,0.58
"REACTOME:160939_REACT_20549_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1","REACTOME","160939_REACT_20549_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1",51,1.103,0.26,0.63,2.145,0,0.00037,-0.7842,0.89,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1674_SU_TESTIS","C2_Chemical_and_genetic_perturbations","C2_CGP_1674_SU_TESTIS",72,1.1037,0.24,0.87,-1.0744,0.31,0.95,-1.1329,0.23,0.59
"C2_Chemical_and_genetic_perturbations:C2_CGP_2435_FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION","C2_Chemical_and_genetic_perturbations","C2_CGP_2435_FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION",9,1.1038,0.33,0.88,1.0637,0.37,0.69,0.8622,0.63,1
"GO_CC:500209_GO_0030914_STAGA_COMPLEX","GO_CC","500209_GO_0030914_STAGA_COMPLEX",13,1.1052,0.32,0.67,-0.7026,0.86,1,-0.7946,0.77,1
"C1_Positional:C1_ALL_244_CHR3P11","C1_Positional","C1_ALL_244_CHR3P11",5,1.1055,0.32,0.73,1.1282,0.34,0.62,1.1324,0.34,0.72
"REACTOME:1183574_REACT_355197_SHC_MEDIATED_CASCADE_FGFR3","REACTOME","1183574_REACT_355197_SHC_MEDIATED_CASCADE_FGFR3",16,1.1058,0.31,0.62,-1.0734,0.35,0.9,0.6642,0.91,1
"GO_CC:500281_GO_0030991_INTRACILIARY_TRANSPORT_PARTICLE_A","GO_CC","500281_GO_0030991_INTRACILIARY_TRANSPORT_PARTICLE_A",7,1.1063,0.33,0.68,-0.6407,0.9,1,-0.5195,0.98,1
"GO_MF:505327_GO_0042165_NEUROTRANSMITTER_BINDING","GO_MF","505327_GO_0042165_NEUROTRANSMITTER_BINDING",17,1.1069,0.29,0.88,-1.7107,0.015,0.3,1.211,0.23,0.71
"GO_MF:488050_GO_0002161_AMINOACYL_TRNA_EDITING_ACTIVITY","GO_MF","488050_GO_0002161_AMINOACYL_TRNA_EDITING_ACTIVITY",12,1.1073,0.3,0.88,0.8231,0.71,1,-1.1742,0.25,0.6
"C2_Chemical_and_genetic_perturbations:C2_CGP_1316_KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1316_KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN",57,1.108,0.25,0.87,0.8563,0.78,0.96,-1.1672,0.2,0.56
"C2_Chemical_and_genetic_perturbations:C2_CGP_2620_MIKKELSEN_PLURIPOTENT_STATE_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2620_MIKKELSEN_PLURIPOTENT_STATE_UP",10,1.1081,0.27,0.88,-1.3579,0.12,0.66,-0.8158,0.72,0.94
"GO_MF:499706_GO_0030306_ADP_RIBOSYLATION_FACTOR_BINDING","GO_MF","499706_GO_0030306_ADP_RIBOSYLATION_FACTOR_BINDING",7,1.1081,0.33,0.89,-0.8268,0.69,1,1.0419,0.42,0.85
"GO_MF:490005_GO_0004679_AMP_ACTIVATED_PROTEIN_KINASE_ACTIVITY","GO_MF","490005_GO_0004679_AMP_ACTIVATED_PROTEIN_KINASE_ACTIVITY",7,1.1087,0.33,0.89,1.2747,0.19,0.64,1.464,0.08,0.49
"C4_Cancer_gene_neighborhoods:C4_CGN_150_MORF_PPP2R5E","C4_Cancer_gene_neighborhoods","C4_CGN_150_MORF_PPP2R5E",83,1.1089,0.2,0.53,1.6038,0.0046,0.014,0.8908,0.67,1
"GO_BP:492050_GO_0007271_SYNAPTIC_TRANSMISSION_CHOLINERGIC","GO_BP","492050_GO_0007271_SYNAPTIC_TRANSMISSION_CHOLINERGIC",20,1.109,0.31,0.8,-1.6213,0.019,0.7,1.3457,0.11,0.65
"GO_BP:491942_GO_0007129_SYNAPSIS","GO_BP","491942_GO_0007129_SYNAPSIS",34,1.1092,0.26,0.8,-0.8404,0.73,1,-0.7113,0.93,0.99
"GO_BP:491358_GO_0006446_REGULATION_OF_TRANSLATIONAL_INITIATION","GO_BP","491358_GO_0006446_REGULATION_OF_TRANSLATIONAL_INITIATION",71,1.1093,0.22,0.81,1.8387,0,0.069,-0.7532,0.93,1
"REACTOME:106567_REACT_63_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION","REACTOME","106567_REACT_63_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION",23,1.1094,0.32,0.62,0.9706,0.48,0.8,-0.9713,0.48,0.88
"GO_BP:518280_GO_0090140_REGULATION_OF_MITOCHONDRIAL_FISSION","GO_BP","518280_GO_0090140_REGULATION_OF_MITOCHONDRIAL_FISSION",13,1.1098,0.28,0.81,0.8606,0.67,1,-0.8034,0.73,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_657_LASTOWSKA_COAMPLIFIED_WITH_MYCN","C2_Chemical_and_genetic_perturbations","C2_CGP_657_LASTOWSKA_COAMPLIFIED_WITH_MYCN",40,1.1098,0.25,0.88,1.3823,0.056,0.31,1.1186,0.28,0.85
"GO_BP:507759_GO_0045402_REGULATION_OF_INTERLEUKIN_4_BIOSYNTHETIC_PROCESS","GO_BP","507759_GO_0045402_REGULATION_OF_INTERLEUKIN_4_BIOSYNTHETIC_PROCESS",5,1.1102,0.35,0.81,1.1216,0.33,0.88,1.1725,0.29,0.72
"C4_Cancer_gene_neighborhoods:C4_CGN_40_MORF_RFC4","C4_Cancer_gene_neighborhoods","C4_CGN_40_MORF_RFC4",151,1.1109,0.24,0.53,2.0894,0,0.00013,-1.2104,0.094,0.43
"C2_Chemical_and_genetic_perturbations:C2_CGP_2374_SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2374_SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP",24,1.1113,0.29,0.89,1.8496,0.0041,0.028,1.0897,0.33,0.87
"GO_BP:491229_GO_0006265_DNA_TOPOLOGICAL_CHANGE","GO_BP","491229_GO_0006265_DNA_TOPOLOGICAL_CHANGE",9,1.1118,0.3,0.8,1.2557,0.2,0.73,-0.7525,0.8,1
"C1_Positional:C1_ALL_15_CHR8P11","C1_Positional","C1_ALL_15_CHR8P11",42,1.1118,0.23,0.73,0.8709,0.68,0.89,1.0545,0.38,0.71
"GO_MF:495785_GO_0015643_TOXIC_SUBSTANCE_BINDING","GO_MF","495785_GO_0015643_TOXIC_SUBSTANCE_BINDING",11,1.1123,0.32,0.89,0.933,0.54,0.94,1.3025,0.17,0.66
"REACTOME:106353_REACT_9508_FGFR3B_LIGAND_BINDING_AND_ACTIVATION","REACTOME","106353_REACT_9508_FGFR3B_LIGAND_BINDING_AND_ACTIVATION",6,1.1126,0.31,0.61,-1.5502,0.029,0.39,0.789,0.72,1
"GO_BP:492247_GO_0007494_MIDGUT_DEVELOPMENT","GO_BP","492247_GO_0007494_MIDGUT_DEVELOPMENT",12,1.1135,0.29,0.8,1.7065,0.019,0.19,1.8152,0.002,0.28
"GO_BP:500758_GO_0031507_HETEROCHROMATIN_ASSEMBLY","GO_BP","500758_GO_0031507_HETEROCHROMATIN_ASSEMBLY",8,1.1138,0.33,0.8,0.8403,0.65,1,0.8655,0.62,0.97
"C7_Immunologic_signatures:C7_ALL_1774_GSE7460_CD8_TCELL_VS_TREG_ACT_DN","C7_Immunologic_signatures","C7_ALL_1774_GSE7460_CD8_TCELL_VS_TREG_ACT_DN",199,1.1147,0.15,0.37,1.5389,0,0.0073,-0.9917,0.46,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_1811_MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4","C2_Chemical_and_genetic_perturbations","C2_CGP_1811_MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4",21,1.1157,0.31,0.88,1.077,0.37,0.67,0.877,0.63,1
"C7_Immunologic_signatures:C7_ALL_1648_GSE3982_MAC_VS_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1648_GSE3982_MAC_VS_BCELL_DN",192,1.1157,0.13,0.37,0.9533,0.61,0.89,-1.3646,0.012,0.085
"C7_Immunologic_signatures:C7_ALL_1668_GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1668_GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN",197,1.116,0.14,0.37,1.7281,0,0.00041,-0.9315,0.64,0.89
"REACTOME:106427_REACT_976_PI3K_CASCADE","REACTOME","106427_REACT_976_PI3K_CASCADE",63,1.116,0.26,0.61,0.9635,0.52,0.8,0.833,0.77,1
"REACTOME:105786_REACT_2148_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE","REACTOME","105786_REACT_2148_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE",70,1.1161,0.24,0.61,2.0803,0,0.00083,-0.8452,0.76,0.99
"GO_CC:505526_GO_0042382_PARASPECKLES","GO_CC","505526_GO_0042382_PARASPECKLES",6,1.1162,0.34,0.66,0.6678,0.85,0.99,0.7804,0.71,1
"GO_CC:754890_GO_1990023_MITOTIC_SPINDLE_MIDZONE","GO_CC","754890_GO_1990023_MITOTIC_SPINDLE_MIDZONE",7,1.1162,0.33,0.66,0.8287,0.69,0.93,-1.1165,0.35,0.9
"KEGG_module:HSA_M00143_NADH_DEHYDROGENASE_UBIQUINONE_FE_S_PROTEIN_FLAVOPROTEIN_COMPLEX_MITOCHONDRIA","KEGG_module","HSA_M00143_NADH_DEHYDROGENASE_UBIQUINONE_FE_S_PROTEIN_FLAVOPROTEIN_COMPLEX_MITOCHONDRIA",11,1.1164,0.3,0.58,1.7617,0.0063,0.05,1.1081,0.33,0.86
"KEGG_compound:C00870_4_NITROPHENOL_P_NITROPHENOL_PNP_NIPHEN_4_HYDROXYNITROBENZENE","KEGG_compound","C00870_4_NITROPHENOL_P_NITROPHENOL_PNP_NIPHEN_4_HYDROXYNITROBENZENE",6,1.1164,0.32,1,1.6479,0.018,0.12,1.1726,0.3,0.58
"GO_CC:925911_GO_1902562_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX","GO_CC","925911_GO_1902562_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX",16,1.1164,0.29,0.67,1.1362,0.27,0.59,0.6079,0.96,1
"GO_BP:510676_GO_0048617_EMBRYONIC_FOREGUT_MORPHOGENESIS","GO_BP","510676_GO_0048617_EMBRYONIC_FOREGUT_MORPHOGENESIS",10,1.1167,0.3,0.79,-0.8167,0.67,1,1.286,0.18,0.69
"C4_Cancer_gene_neighborhoods:C4_CGN_354_GNF2_G22P1","C4_Cancer_gene_neighborhoods","C4_CGN_354_GNF2_G22P1",36,1.1171,0.28,0.52,1.7194,0.0086,0.0053,0.7073,0.92,1
"GO_BP:506719_GO_0043691_REVERSE_CHOLESTEROL_TRANSPORT","GO_BP","506719_GO_0043691_REVERSE_CHOLESTEROL_TRANSPORT",17,1.1172,0.29,0.79,-0.6507,0.93,1,0.7263,0.85,1
"C4_Cancer_gene_neighborhoods:C4_CGN_318_GNF2_XRCC5","C4_Cancer_gene_neighborhoods","C4_CGN_318_GNF2_XRCC5",75,1.1178,0.23,0.52,2.1377,0,7.9e-05,0.7526,0.92,1
"C4_Cancer_gene_neighborhoods:C4_CGN_87_MORF_DEAF1","C4_Cancer_gene_neighborhoods","C4_CGN_87_MORF_DEAF1",57,1.1182,0.24,0.53,2.3049,0,0,-1.0113,0.43,0.83
"GO_BP:502817_GO_0033601_POSITIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION","GO_BP","502817_GO_0033601_POSITIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION",6,1.1186,0.33,0.79,-1.2033,0.29,0.89,1.3683,0.12,0.65
"KEGG_module:HSA_M00405_THC_COMPLEX","KEGG_module","HSA_M00405_THC_COMPLEX",5,1.1187,0.31,0.59,0.904,0.57,0.91,-0.6753,0.85,1
"GO_BP:496041_GO_0015919_PEROXISOMAL_MEMBRANE_TRANSPORT","GO_BP","496041_GO_0015919_PEROXISOMAL_MEMBRANE_TRANSPORT",7,1.119,0.32,0.79,1.387,0.12,0.57,0.6343,0.91,1
"C1_Positional:C1_ALL_177_CHR6Q16","C1_Positional","C1_ALL_177_CHR6Q16",23,1.1191,0.25,0.73,1.2663,0.15,0.56,-0.9109,0.58,0.94
"C1_Positional:C1_ALL_83_CHR2Q11","C1_Positional","C1_ALL_83_CHR2Q11",63,1.1192,0.21,0.76,1.0344,0.39,0.72,1.0333,0.38,0.72
"GO_BP:495055_GO_0010990_REGULATION_OF_SMAD_PROTEIN_COMPLEX_ASSEMBLY","GO_BP","495055_GO_0010990_REGULATION_OF_SMAD_PROTEIN_COMPLEX_ASSEMBLY",5,1.12,0.33,0.79,-0.6672,0.87,1,1.0999,0.37,0.76
"C2_Chemical_and_genetic_perturbations:C2_CGP_3018_BROWNE_HCMV_INFECTION_4HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3018_BROWNE_HCMV_INFECTION_4HR_DN",252,1.1201,0.08,0.87,1.0257,0.37,0.76,1.2285,0.057,0.74
"C4_Cancer_gene_neighborhoods:C4_CGN_345_GNF2_DEK","C4_Cancer_gene_neighborhoods","C4_CGN_345_GNF2_DEK",58,1.121,0.26,0.52,1.9261,0,0.00062,-0.9327,0.62,1
"REACTOME:105925_REACT_18274_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION","REACTOME","105925_REACT_18274_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION",39,1.1212,0.27,0.6,1.1268,0.26,0.55,-0.7473,0.86,1
"GO_BP:491775_GO_0006924_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS","GO_BP","491775_GO_0006924_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS",6,1.1216,0.33,0.79,1.4452,0.082,0.5,0.5553,0.94,1
"C4_Cancer_gene_neighborhoods:C4_CGN_38_MORF_RAD54L","C4_Cancer_gene_neighborhoods","C4_CGN_38_MORF_RAD54L",105,1.1218,0.2,0.53,1.5513,0.0047,0.022,-0.8631,0.77,1
"GO_MF:752251_GO_0097371_MDM2_MDM4_FAMILY_PROTEIN_BINDING","GO_MF","752251_GO_0097371_MDM2_MDM4_FAMILY_PROTEIN_BINDING",6,1.1219,0.33,0.87,0.7763,0.74,1,-1.27,0.21,0.58
"GO_BP:508248_GO_0045943_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER","GO_BP","508248_GO_0045943_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER",12,1.1219,0.28,0.79,0.5694,0.96,1,-0.6763,0.89,1
"GO_BP:506194_GO_0043117_POSITIVE_REGULATION_OF_VASCULAR_PERMEABILITY","GO_BP","506194_GO_0043117_POSITIVE_REGULATION_OF_VASCULAR_PERMEABILITY",9,1.122,0.32,0.79,0.8401,0.68,1,1.159,0.26,0.73
"C4_Cancer_gene_neighborhoods:C4_CGN_300_GNF2_HAT1","C4_Cancer_gene_neighborhoods","C4_CGN_300_GNF2_HAT1",50,1.1223,0.23,0.53,2.3039,0,0,-1.0265,0.4,0.79
"C1_Positional:C1_ALL_50_CHR12Q22","C1_Positional","C1_ALL_50_CHR12Q22",31,1.1224,0.27,0.77,1.0244,0.42,0.73,1.1765,0.23,0.67
"C4_Cancer_gene_neighborhoods:C4_CGN_221_GCM_DDX11","C4_Cancer_gene_neighborhoods","C4_CGN_221_GCM_DDX11",44,1.1225,0.25,0.54,-0.9067,0.62,1,-0.9157,0.61,1
"REACTOME:105851_REACT_2192_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR","REACTOME","105851_REACT_2192_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR",7,1.1228,0.31,0.6,1.0771,0.36,0.62,-0.8803,0.61,0.97
"C4_Cancer_modules:C4_CM_373_MODULE_457","C4_Cancer_modules","C4_CM_373_MODULE_457",10,1.123,0.27,0.78,1.6311,0.028,0.064,-0.899,0.58,0.85
"REACTOME:366162_REACT_75842_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION","REACTOME","366162_REACT_75842_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",211,1.1232,0.12,0.6,1.6778,0,0.057,-0.8804,0.79,0.97
"GO_CC:505685_GO_0042555_MCM_COMPLEX","GO_CC","505685_GO_0042555_MCM_COMPLEX",11,1.1232,0.32,0.65,1.355,0.12,0.34,-1.2355,0.23,0.74
"REACTOME:106198_REACT_9441_HEXOSE_TRANSPORT","REACTOME","106198_REACT_9441_HEXOSE_TRANSPORT",46,1.1233,0.25,0.6,0.7971,0.83,1,-0.6778,0.95,1
"C7_Immunologic_signatures:C7_ALL_217_GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_217_GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP",191,1.1233,0.15,0.35,-0.695,1,1,-0.9115,0.72,0.93
"C2_Chemical_and_genetic_perturbations:C2_CGP_2844_BOYLAN_MULTIPLE_MYELOMA_PCA1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2844_BOYLAN_MULTIPLE_MYELOMA_PCA1_DN",8,1.1234,0.33,0.86,1.0664,0.39,0.68,0.9252,0.55,1
"GO_BP:752560_GO_0090503_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_EXONUCLEOLYTIC","GO_BP","752560_GO_0090503_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_EXONUCLEOLYTIC",30,1.1239,0.28,0.79,1.3014,0.13,0.67,-0.9448,0.55,0.89
"GO_MF:496668_GO_0016755_TRANSFERASE_ACTIVITY_TRANSFERRING_AMINO_ACYL_GROUPS","GO_MF","496668_GO_0016755_TRANSFERASE_ACTIVITY_TRANSFERRING_AMINO_ACYL_GROUPS",21,1.1239,0.28,0.87,1.0799,0.35,0.82,1.0585,0.39,0.83
"REACTOME:576251_REACT_118656_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS","REACTOME","576251_REACT_118656_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS",66,1.1241,0.21,0.6,2.0356,0,0.0015,-0.7038,0.97,1
"REACTOME:105787_REACT_1156_ORC1_REMOVAL_FROM_CHROMATIN","REACTOME","105787_REACT_1156_ORC1_REMOVAL_FROM_CHROMATIN",70,1.1243,0.21,0.61,2.1072,0,0.00049,-0.8355,0.8,1
"GO_BP:515129_GO_0070192_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOSIS","GO_BP","515129_GO_0070192_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOSIS",39,1.1246,0.26,0.79,-0.8133,0.77,1,-0.847,0.72,0.96
"GO_CC:490666_GO_0005593_FACIT_COLLAGEN_TRIMER","GO_CC","490666_GO_0005593_FACIT_COLLAGEN_TRIMER",7,1.1247,0.3,0.66,-1.0742,0.38,0.8,0.9815,0.49,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_769_SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS","C2_Chemical_and_genetic_perturbations","C2_CGP_769_SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS",36,1.1248,0.25,0.86,0.684,0.94,1,1.002,0.47,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_3126_JOHNSTONE_PARVB_TARGETS_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3126_JOHNSTONE_PARVB_TARGETS_1_UP",7,1.1254,0.29,0.87,0.8224,0.69,0.98,1.2628,0.19,0.71
"GO_BP:513950_GO_0060394_NEGATIVE_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION","GO_BP","513950_GO_0060394_NEGATIVE_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION",11,1.1258,0.28,0.78,1.0675,0.38,0.93,1.6628,0.029,0.39
"C3_TF_targets:C3_TFT_192_V_MIF1_01","C3_TF_targets","C3_TFT_192_V_MIF1_01",180,1.1262,0.12,0.48,-0.795,0.94,1,-0.8298,0.92,0.99
"C4_Cancer_gene_neighborhoods:C4_CGN_245_GCM_MYST2","C4_Cancer_gene_neighborhoods","C4_CGN_245_GCM_MYST2",173,1.1266,0.12,0.53,0.7895,0.96,1,0.7658,0.97,1
"GO_MF:490329_GO_0005048_SIGNAL_SEQUENCE_BINDING","GO_MF","490329_GO_0005048_SIGNAL_SEQUENCE_BINDING",23,1.1269,0.25,0.87,0.9021,0.57,0.98,-0.785,0.81,0.97
"C7_Immunologic_signatures:C7_ALL_1844_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN","C7_Immunologic_signatures","C7_ALL_1844_GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN",193,1.1272,0.056,0.34,0.9822,0.53,0.8,0.9146,0.69,1
"C0_Hallmark:H_ALL_8_HALLMARK_DNA_REPAIR","C0_Hallmark","H_ALL_8_HALLMARK_DNA_REPAIR",150,1.1276,0.16,0.19,1.757,0,0.0024,0.5688,1,1
"GO_MF:499835_GO_0030492_HEMOGLOBIN_BINDING","GO_MF","499835_GO_0030492_HEMOGLOBIN_BINDING",5,1.1277,0.32,0.87,1.8972,0,0.033,-1.0183,0.43,0.77
"C7_Immunologic_signatures:C7_ALL_1173_GSE27786_LIN_NEG_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1173_GSE27786_LIN_NEG_VS_NEUTROPHIL_UP",199,1.128,0.1,0.34,1.3123,0.028,0.091,0.8582,0.85,1
"GO_BP:495237_GO_0014842_REGULATION_OF_SATELLITE_CELL_PROLIFERATION","GO_BP","495237_GO_0014842_REGULATION_OF_SATELLITE_CELL_PROLIFERATION",8,1.1283,0.3,0.78,0.5917,0.94,1,-1.0295,0.43,0.83
"C4_Cancer_gene_neighborhoods:C4_CGN_372_GNF2_MAP2K3","C4_Cancer_gene_neighborhoods","C4_CGN_372_GNF2_MAP2K3",75,1.1284,0.22,0.53,2.0335,0,0.00023,-1.4268,0.027,0.15
"GO_MF:489272_GO_0003729_MRNA_BINDING","GO_MF","489272_GO_0003729_MRNA_BINDING",120,1.1285,0.19,0.88,1.3445,0.035,0.53,-1.1153,0.24,0.7
"C4_Cancer_gene_neighborhoods:C4_CGN_178_MORF_SNRP70","C4_Cancer_gene_neighborhoods","C4_CGN_178_MORF_SNRP70",62,1.1293,0.19,0.54,1.634,0.0043,0.011,0.4832,1,1
"GO_BP:518220_GO_0090080_POSITIVE_REGULATION_OF_MAPKKK_CASCADE_BY_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY","GO_BP","518220_GO_0090080_POSITIVE_REGULATION_OF_MAPKKK_CASCADE_BY_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY",5,1.1296,0.32,0.78,-1.1508,0.31,0.92,1.3925,0.11,0.63
"C7_Immunologic_signatures:C7_ALL_382_GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_382_GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN",191,1.1298,0.1,0.34,1.1464,0.16,0.33,1.1045,0.21,0.98
"GO_BP:494858_GO_0010793_REGULATION_OF_MRNA_EXPORT_FROM_NUCLEUS","GO_BP","494858_GO_0010793_REGULATION_OF_MRNA_EXPORT_FROM_NUCLEUS",6,1.1298,0.32,0.78,1.028,0.41,0.97,1.0554,0.37,0.8
"GO_CC:501514_GO_0032279_ASYMMETRIC_SYNAPSE","GO_CC","501514_GO_0032279_ASYMMETRIC_SYNAPSE",6,1.13,0.32,0.65,1.3701,0.15,0.32,0.8176,0.68,1
"REACTOME:161068_REACT_20582_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY","REACTOME","161068_REACT_20582_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY",6,1.1302,0.3,0.6,0.781,0.74,1,0.6877,0.84,1
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_143_BIOCARTA_PROTEASOME_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_143_BIOCARTA_PROTEASOME_PATHWAY",28,1.1306,0.25,1,2.1296,0,0.0046,1.0573,0.35,1
"GO_BP:501627_GO_0032392_DNA_GEOMETRIC_CHANGE","GO_BP","501627_GO_0032392_DNA_GEOMETRIC_CHANGE",57,1.1308,0.23,0.78,0.9017,0.69,1,-1.0879,0.3,0.78
"C7_Immunologic_signatures:C7_ALL_1211_GSE27786_CD8_TCELL_VS_MONO_MAC_UP","C7_Immunologic_signatures","C7_ALL_1211_GSE27786_CD8_TCELL_VS_MONO_MAC_UP",198,1.1308,0.11,0.34,1.3144,0.026,0.089,0.6476,1,1
"GO_BP:507415_GO_0045005_DNA_DEPENDENT_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY","GO_BP","507415_GO_0045005_DNA_DEPENDENT_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY",20,1.131,0.26,0.78,-0.5139,0.99,1,-1.1034,0.3,0.77
"GO_MF:489867_GO_0004518_NUCLEASE_ACTIVITY","GO_MF","489867_GO_0004518_NUCLEASE_ACTIVITY",179,1.1311,0.14,0.88,1.444,0.0095,0.44,0.9373,0.64,0.93
"KEGG_pathway:HSA04950_MATURITY_ONSET_DIABETES_OF_THE_YOUNG","KEGG_pathway","HSA04950_MATURITY_ONSET_DIABETES_OF_THE_YOUNG",21,1.1311,0.26,0.36,-1.0069,0.43,0.86,1.3985,0.068,0.34
"GO_BP:514012_GO_0060457_NEGATIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS","GO_BP","514012_GO_0060457_NEGATIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS",8,1.1315,0.31,0.78,-0.8182,0.7,1,0.5631,0.97,1
"GO_BP:510210_GO_0048048_EMBRYONIC_EYE_MORPHOGENESIS","GO_BP","510210_GO_0048048_EMBRYONIC_EYE_MORPHOGENESIS",31,1.132,0.27,0.78,1.2165,0.19,0.76,1.5179,0.036,0.55
"GO_CC:506261_GO_0043189_H4_H2A_HISTONE_ACETYLTRANSFERASE_COMPLEX","GO_CC","506261_GO_0043189_H4_H2A_HISTONE_ACETYLTRANSFERASE_COMPLEX",16,1.1322,0.27,0.65,1.1801,0.22,0.55,0.6041,0.95,1
"C1_Positional:C1_ALL_314_CHR11P11","C1_Positional","C1_ALL_314_CHR11P11",60,1.1325,0.24,0.76,0.6673,0.98,1,0.9772,0.49,0.79
"GO_BP:501332_GO_0032095_REGULATION_OF_RESPONSE_TO_FOOD","GO_BP","501332_GO_0032095_REGULATION_OF_RESPONSE_TO_FOOD",19,1.1329,0.25,0.78,-1.1338,0.29,0.93,-0.9392,0.53,0.9
"GO_CC:496549_GO_0016607_NUCLEAR_SPECK","GO_CC","496549_GO_0016607_NUCLEAR_SPECK",179,1.1331,0.14,0.65,0.7941,0.97,0.96,0.8414,0.87,1
"GO_MF:489868_GO_0004519_ENDONUCLEASE_ACTIVITY","GO_MF","489868_GO_0004519_ENDONUCLEASE_ACTIVITY",108,1.1334,0.16,0.88,1.3705,0.026,0.5,1.1166,0.23,0.82
"GO_MF:490651_GO_0017069_SNRNA_BINDING","GO_MF","490651_GO_0017069_SNRNA_BINDING",22,1.1343,0.26,0.88,1.1202,0.29,0.77,0.6312,0.95,1
"GO_BP:491749_GO_0006888_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT","GO_BP","491749_GO_0006888_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT",68,1.135,0.21,0.77,1.8506,0,0.063,0.9111,0.65,0.93
"REACTOME:771570_REACT_160255_NUCLEAR_ENVELOPE_BREAKDOWN","REACTOME","771570_REACT_160255_NUCLEAR_ENVELOPE_BREAKDOWN",50,1.1353,0.22,0.59,1.3649,0.055,0.25,0.5772,0.99,1
"GO_CC:495179_GO_0014731_SPECTRIN_ASSOCIATED_CYTOSKELETON","GO_CC","495179_GO_0014731_SPECTRIN_ASSOCIATED_CYTOSKELETON",8,1.1354,0.3,0.65,1.3125,0.17,0.39,-0.959,0.5,1
"GO_MF:489278_GO_0003746_TRANSLATION_ELONGATION_FACTOR_ACTIVITY","GO_MF","489278_GO_0003746_TRANSLATION_ELONGATION_FACTOR_ACTIVITY",18,1.1355,0.28,0.89,1.8917,0,0.033,0.7976,0.76,1
"GO_MF:486898_GO_0000405_BUBBLE_DNA_BINDING","GO_MF","486898_GO_0000405_BUBBLE_DNA_BINDING",6,1.1356,0.29,0.89,0.9867,0.46,0.89,1.2108,0.27,0.71
"C7_Immunologic_signatures:C7_ALL_1263_GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP","C7_Immunologic_signatures","C7_ALL_1263_GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP",187,1.1359,0.087,0.32,0.7678,0.98,1,1.0717,0.29,1
"REACTOME:106254_REACT_11172_VITAMIN_B5_PANTOTHENATE_METABOLISM","REACTOME","106254_REACT_11172_VITAMIN_B5_PANTOTHENATE_METABOLISM",12,1.136,0.31,0.59,1.2296,0.21,0.42,0.9302,0.55,1
"C1_Positional:C1_ALL_48_CHR13Q31","C1_Positional","C1_ALL_48_CHR13Q31",11,1.1362,0.28,0.78,1.2065,0.24,0.63,1.0475,0.38,0.71
"GO_CC:486995_GO_0000506_GLYCOSYLPHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_GPI_GNT_COMPLEX","GO_CC","486995_GO_0000506_GLYCOSYLPHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_GPI_GNT_COMPLEX",8,1.1364,0.3,0.65,1.1659,0.3,0.57,0.6274,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3227_IKEDA_MIR1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3227_IKEDA_MIR1_TARGETS_DN",7,1.1367,0.32,0.84,1.1966,0.26,0.49,-1.3126,0.16,0.42
"GO_BP:519021_GO_2000381_NEGATIVE_REGULATION_OF_MESODERM_DEVELOPMENT","GO_BP","519021_GO_2000381_NEGATIVE_REGULATION_OF_MESODERM_DEVELOPMENT",6,1.1375,0.32,0.77,1.0557,0.4,0.94,-0.9196,0.57,0.91
"REACTOME:105818_REACT_1275_MITOTIC_ANAPHASE","REACTOME","105818_REACT_1275_MITOTIC_ANAPHASE",173,1.1377,0.12,0.59,2.037,0,0.0015,-0.8579,0.83,0.98
"GO_MF:486706_GO_0000175_3_5_EXORIBONUCLEASE_ACTIVITY","GO_MF","486706_GO_0000175_3_5_EXORIBONUCLEASE_ACTIVITY",27,1.1377,0.26,0.89,1.2717,0.13,0.64,-1.0169,0.42,0.77
"GO_BP:509663_GO_0047484_REGULATION_OF_RESPONSE_TO_OSMOTIC_STRESS","GO_BP","509663_GO_0047484_REGULATION_OF_RESPONSE_TO_OSMOTIC_STRESS",8,1.1391,0.31,0.76,1.1395,0.3,0.85,0.8602,0.67,0.97
"REACTOME:106097_REACT_1665_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION","REACTOME","106097_REACT_1665_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION",32,1.1397,0.26,0.58,1.0148,0.43,0.73,-0.8206,0.76,1
"GO_BP:492067_GO_0007289_SPERMATID_NUCLEUS_DIFFERENTIATION","GO_BP","492067_GO_0007289_SPERMATID_NUCLEUS_DIFFERENTIATION",20,1.1398,0.25,0.76,1.2013,0.19,0.78,0.9577,0.51,0.9
"C2_Chemical_and_genetic_perturbations:C2_CGP_286_TIEN_INTESTINE_PROBIOTICS_2HR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_286_TIEN_INTESTINE_PROBIOTICS_2HR_DN",88,1.1405,0.2,0.83,1.3107,0.068,0.38,0.9846,0.47,0.97
"REACTOME:477124_REACT_111178_ER_PHAGOSOME_PATHWAY","REACTOME","477124_REACT_111178_ER_PHAGOSOME_PATHWAY",64,1.1407,0.2,0.58,2.2708,0,7.1e-05,0.6611,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2212_OUYANG_PROSTATE_CANCER_PROGRESSION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2212_OUYANG_PROSTATE_CANCER_PROGRESSION_DN",20,1.1408,0.25,0.84,-1.0416,0.4,0.97,-0.9429,0.53,0.83
"C4_Cancer_modules:C4_CM_142_MODULE_150","C4_Cancer_modules","C4_CM_142_MODULE_150",15,1.1409,0.26,0.75,2.1931,0,0.00025,0.9327,0.56,0.95
"C7_Immunologic_signatures:C7_ALL_202_GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_202_GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN",193,1.1412,0.1,0.31,2.4233,0,0,-1.0809,0.25,0.54
"GO_BP:491767_GO_0006913_NUCLEOCYTOPLASMIC_TRANSPORT","GO_BP","491767_GO_0006913_NUCLEOCYTOPLASMIC_TRANSPORT",230,1.1412,0.089,0.76,1.0599,0.29,0.94,-0.7749,0.98,1
"GO_BP:753348_GO_1900364_NEGATIVE_REGULATION_OF_MRNA_POLYADENYLATION","GO_BP","753348_GO_1900364_NEGATIVE_REGULATION_OF_MRNA_POLYADENYLATION",8,1.1413,0.29,0.76,0.8089,0.69,1,1.1385,0.3,0.73
"GO_BP:510692_GO_0048635_NEGATIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT","GO_BP","510692_GO_0048635_NEGATIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT",35,1.1416,0.25,0.76,0.8403,0.74,1,1.1023,0.33,0.76
"KEGG_reaction:R02239_1_2_DIACYL_SN_GLYCEROL_3_PHOSPHATE_PHOSPHOHYDROLASE_PHOSPHATIDATE_H2O_1_2_DIACYL_SN_GLYCEROL_ORTHOPHOSPHATE","KEGG_reaction","R02239_1_2_DIACYL_SN_GLYCEROL_3_PHOSPHATE_PHOSPHOHYDROLASE_PHOSPHATIDATE_H2O_1_2_DIACYL_SN_GLYCEROL_ORTHOPHOSPHATE",6,1.1418,0.29,1,1.345,0.15,0.53,1.2079,0.27,0.53
"C7_Immunologic_signatures:C7_ALL_1006_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN","C7_Immunologic_signatures","C7_ALL_1006_GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN",199,1.1426,0.14,0.31,1.6661,0,0.001,0.6506,1,1
"KEGG_module:HSA_M00389_APC_C_COMPLEX","KEGG_module","HSA_M00389_APC_C_COMPLEX",14,1.143,0.27,0.57,1.3749,0.11,0.31,0.7588,0.83,1
"GO_MF:495654_GO_0015450_P_P_BOND_HYDROLYSIS_DRIVEN_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","495654_GO_0015450_P_P_BOND_HYDROLYSIS_DRIVEN_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",6,1.1432,0.29,0.88,1.3901,0.1,0.48,1.1905,0.25,0.74
"C4_Cancer_modules:C4_CM_253_MODULE_287","C4_Cancer_modules","C4_CM_253_MODULE_287",49,1.1437,0.17,0.79,1.0834,0.31,0.57,1.396,0.035,0.33
"GO_MF:496757_GO_0016866_INTRAMOLECULAR_TRANSFERASE_ACTIVITY","GO_MF","496757_GO_0016866_INTRAMOLECULAR_TRANSFERASE_ACTIVITY",27,1.1443,0.23,0.89,1.0658,0.37,0.82,-0.7874,0.79,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_2937_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11","C2_Chemical_and_genetic_perturbations","C2_CGP_2937_YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11",103,1.1446,0.16,0.83,1.6824,0,0.093,0.9658,0.53,0.97
"REACTOME:1183613_REACT_355480_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX","REACTOME","1183613_REACT_355480_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX",28,1.1446,0.24,0.58,1.8065,0,0.02,-1.0388,0.4,0.79
"GO_BP:493268_GO_0009067_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS","GO_BP","493268_GO_0009067_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS",22,1.1446,0.25,0.76,0.7548,0.85,1,-1.6593,0.014,0.53
"REACTOME:105884_REACT_2253_GLOBAL_GENOMIC_NER_GG_NER_","REACTOME","105884_REACT_2253_GLOBAL_GENOMIC_NER_GG_NER_",35,1.1447,0.23,0.58,1.5081,0.032,0.14,-0.7074,0.94,1
"GO_CC:490792_GO_0005759_MITOCHONDRIAL_MATRIX","GO_CC","490792_GO_0005759_MITOCHONDRIAL_MATRIX",340,1.1452,0.074,0.64,1.7809,0,0.031,-1.3165,0.004,0.63
"GO_BP:501693_GO_0032461_POSITIVE_REGULATION_OF_PROTEIN_OLIGOMERIZATION","GO_BP","501693_GO_0032461_POSITIVE_REGULATION_OF_PROTEIN_OLIGOMERIZATION",20,1.1458,0.24,0.75,1.2785,0.16,0.7,-1.5385,0.038,0.54
"REACTOME:730317_REACT_150314_MITOTIC_METAPHASE_AND_ANAPHASE","REACTOME","730317_REACT_150314_MITOTIC_METAPHASE_AND_ANAPHASE",174,1.1471,0.099,0.58,2.0049,0,0.0021,-0.901,0.75,0.95
"GO_BP:492116_GO_0007351_TRIPARTITE_REGIONAL_SUBDIVISION","GO_BP","492116_GO_0007351_TRIPARTITE_REGIONAL_SUBDIVISION",15,1.1472,0.27,0.75,-0.7759,0.77,1,0.9131,0.56,0.93
"GO_MF:489990_GO_0004661_PROTEIN_GERANYLGERANYLTRANSFERASE_ACTIVITY","GO_MF","489990_GO_0004661_PROTEIN_GERANYLGERANYLTRANSFERASE_ACTIVITY",6,1.1473,0.28,0.89,1.0404,0.42,0.83,0.9827,0.48,0.89
"REACTOME:105897_REACT_383_DNA_REPLICATION","REACTOME","105897_REACT_383_DNA_REPLICATION",105,1.1476,0.18,0.58,2.0336,0,0.0015,-1.1631,0.15,0.64
"C7_Immunologic_signatures:C7_ALL_1674_GSE3982_NEUTROPHIL_VS_TH2_DN","C7_Immunologic_signatures","C7_ALL_1674_GSE3982_NEUTROPHIL_VS_TH2_DN",197,1.1479,0.1,0.29,1.4614,0.0022,0.02,-1.1793,0.11,0.32
"GO_BP:487019_GO_0000722_TELOMERE_MAINTENANCE_VIA_RECOMBINATION","GO_BP","487019_GO_0000722_TELOMERE_MAINTENANCE_VIA_RECOMBINATION",27,1.1482,0.25,0.75,1.3245,0.11,0.64,-1.0767,0.32,0.8
"GO_BP:495535_GO_0046931_PORE_COMPLEX_ASSEMBLY","GO_BP","495535_GO_0046931_PORE_COMPLEX_ASSEMBLY",13,1.1485,0.28,0.75,1.4382,0.074,0.51,0.5298,0.99,1
"REACTOME:105792_REACT_1792_POLYMERASE_SWITCHING","REACTOME","105792_REACT_1792_POLYMERASE_SWITCHING",14,1.1485,0.27,0.58,1.3529,0.11,0.26,-1.1852,0.24,0.62
"GO_BP:491402_GO_0018344_PROTEIN_GERANYLGERANYLATION","GO_BP","491402_GO_0018344_PROTEIN_GERANYLGERANYLATION",6,1.1486,0.28,0.75,1.0449,0.41,0.95,0.9977,0.45,0.86
"GO_BP:503699_GO_0034497_PROTEIN_LOCALIZATION_TO_PRE_AUTOPHAGOSOMAL_STRUCTURE","GO_BP","503699_GO_0034497_PROTEIN_LOCALIZATION_TO_PRE_AUTOPHAGOSOMAL_STRUCTURE",9,1.1488,0.29,0.75,0.635,0.91,1,0.5415,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1540_HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1540_HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP",65,1.149,0.21,0.82,1.236,0.14,0.45,-0.9391,0.56,0.83
"REACTOME:105782_REACT_899_S_PHASE","REACTOME","105782_REACT_899_S_PHASE",124,1.1494,0.14,0.58,2.0443,0,0.0014,-1.1079,0.24,0.7
"GO_BP:502482_GO_0033262_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION","GO_BP","502482_GO_0033262_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION",11,1.1503,0.31,0.75,-0.7177,0.84,1,-0.6425,0.91,1
"GO_CC:487584_GO_0001673_MALE_GERM_CELL_NUCLEUS","GO_CC","487584_GO_0001673_MALE_GERM_CELL_NUCLEUS",17,1.1507,0.26,0.63,-1.0843,0.35,0.81,-1.0395,0.39,0.98
"GO_CC:487075_GO_0000782_TELOMERE_CAP_COMPLEX","GO_CC","487075_GO_0000782_TELOMERE_CAP_COMPLEX",12,1.1507,0.28,0.63,0.8807,0.62,0.91,-0.7844,0.76,1
"C7_Immunologic_signatures:C7_ALL_269_GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP","C7_Immunologic_signatures","C7_ALL_269_GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP",196,1.151,0.11,0.29,1.2623,0.051,0.14,0.8687,0.83,1
"GO_BP:495056_GO_0010991_NEGATIVE_REGULATION_OF_SMAD_PROTEIN_COMPLEX_ASSEMBLY","GO_BP","495056_GO_0010991_NEGATIVE_REGULATION_OF_SMAD_PROTEIN_COMPLEX_ASSEMBLY",5,1.1517,0.31,0.75,-0.6588,0.87,1,1.0957,0.39,0.76
"GO_BP:513895_GO_0060339_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY","GO_BP","513895_GO_0060339_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY",5,1.1518,0.29,0.75,0.8595,0.63,1,0.8826,0.61,0.95
"GO_BP:491377_GO_0006475_INTERNAL_PROTEIN_AMINO_ACID_ACETYLATION","GO_BP","491377_GO_0006475_INTERNAL_PROTEIN_AMINO_ACID_ACETYLATION",111,1.1519,0.17,0.75,-0.5689,1,1,-0.8763,0.77,0.94
"GO_CC:490716_GO_0005657_REPLICATION_FORK","GO_CC","490716_GO_0005657_REPLICATION_FORK",62,1.1523,0.17,0.64,1.184,0.17,0.55,-1.1068,0.28,0.91
"GO_BP:499257_GO_0021978_TELENCEPHALON_REGIONALIZATION","GO_BP","499257_GO_0021978_TELENCEPHALON_REGIONALIZATION",12,1.1527,0.25,0.75,0.9007,0.58,1,1.5225,0.061,0.53
"GO_MF:489237_GO_0003684_DAMAGED_DNA_BINDING","GO_MF","489237_GO_0003684_DAMAGED_DNA_BINDING",57,1.1528,0.22,0.88,1.3945,0.031,0.48,-1.1669,0.18,0.61
"KEGG_compound:C00039_DNA_DNAN_DNAN_1_DEOXYRIBONUCLEOTIDE_N_DEOXYRIBONUCLEOTIDE_M_DEOXYRIBONUCLEOTIDE_N_M_DEOXYRIBONUCLEIC_ACID","KEGG_compound","C00039_DNA_DNAN_DNAN_1_DEOXYRIBONUCLEOTIDE_N_DEOXYRIBONUCLEOTIDE_M_DEOXYRIBONUCLEOTIDE_N_M_DEOXYRIBONUCLEIC_ACID",15,1.1529,0.27,1,0.6973,0.89,1,-0.8614,0.65,0.79
"GO_BP:494458_GO_0010388_CULLIN_DENEDDYLATION","GO_BP","494458_GO_0010388_CULLIN_DENEDDYLATION",9,1.1529,0.29,0.75,1.6079,0.037,0.28,0.7867,0.73,1
"GO_BP:491271_GO_0006312_MITOTIC_RECOMBINATION","GO_BP","491271_GO_0006312_MITOTIC_RECOMBINATION",34,1.1532,0.21,0.75,1.2618,0.14,0.72,-0.998,0.43,0.85
"C7_Immunologic_signatures:C7_ALL_790_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_790_GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN",199,1.1533,0.077,0.28,1.0982,0.23,0.45,0.8735,0.8,1
"C4_Cancer_gene_neighborhoods:C4_CGN_224_GCM_DENR","C4_Cancer_gene_neighborhoods","C4_CGN_224_GCM_DENR",49,1.1537,0.2,0.47,1.5426,0.015,0.023,-0.5385,1,1
"GO_MF:492539_GO_0008198_FERROUS_IRON_BINDING","GO_MF","492539_GO_0008198_FERROUS_IRON_BINDING",15,1.1539,0.24,0.88,1.8621,0.002,0.044,-1.0407,0.4,0.75
"GO_BP:509054_GO_0046831_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS","GO_BP","509054_GO_0046831_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS",10,1.154,0.27,0.75,0.9444,0.55,1,0.6067,0.93,1
"C4_Cancer_gene_neighborhoods:C4_CGN_81_MORF_CUL1","C4_Cancer_gene_neighborhoods","C4_CGN_81_MORF_CUL1",73,1.1544,0.17,0.48,1.8341,0,0.0016,0.4809,1,1
"GO_BP:500415_GO_0031128_DEVELOPMENTAL_INDUCTION","GO_BP","500415_GO_0031128_DEVELOPMENTAL_INDUCTION",30,1.1546,0.25,0.75,-1.0312,0.41,0.98,1.3135,0.1,0.66
"C7_Immunologic_signatures:C7_ALL_949_GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP","C7_Immunologic_signatures","C7_ALL_949_GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP",198,1.1546,0.1,0.28,0.9066,0.78,1,-0.9485,0.58,0.85
"C7_Immunologic_signatures:C7_ALL_1803_GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP","C7_Immunologic_signatures","C7_ALL_1803_GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP",199,1.1551,0.089,0.29,1.3876,0.0076,0.042,-0.9163,0.7,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_3098_WAGSCHAL_EHMT2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3098_WAGSCHAL_EHMT2_TARGETS_UP",11,1.1558,0.26,0.81,1.8525,0.0039,0.028,1.2285,0.21,0.73
"GO_BP:501696_GO_0032464_POSITIVE_REGULATION_OF_PROTEIN_HOMOOLIGOMERIZATION","GO_BP","501696_GO_0032464_POSITIVE_REGULATION_OF_PROTEIN_HOMOOLIGOMERIZATION",9,1.1558,0.28,0.75,1.4169,0.089,0.53,-0.8421,0.67,0.96
"GO_BP:510628_GO_0048563_POST_EMBRYONIC_ORGAN_MORPHOGENESIS","GO_BP","510628_GO_0048563_POST_EMBRYONIC_ORGAN_MORPHOGENESIS",6,1.156,0.28,0.75,1.0722,0.38,0.93,-0.7224,0.8,0.99
"GO_BP:754040_GO_1901071_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS","GO_BP","754040_GO_1901071_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS",25,1.1562,0.24,0.75,1.0582,0.36,0.94,0.8252,0.74,1
"GO_MF:490189_GO_0032395_MHC_CLASS_II_RECEPTOR_ACTIVITY","GO_MF","490189_GO_0032395_MHC_CLASS_II_RECEPTOR_ACTIVITY",10,1.1564,0.28,0.88,0.7357,0.79,1,-0.8382,0.67,0.94
"WikiPathways:198803_WP107_TRANSLATION_FACTORS","WikiPathways","198803_WP107_TRANSLATION_FACTORS",55,1.1566,0.16,0.52,2.3132,0,0,-0.5705,1,0.99
"REACTOME:730318_REACT_150471_SEPARATION_OF_SISTER_CHROMATIDS","REACTOME","730318_REACT_150471_SEPARATION_OF_SISTER_CHROMATIDS",162,1.1569,0.14,0.57,2.0404,0,0.0014,-0.8512,0.82,0.99
"REACTOME:771582_REACT_160130_RETINOID_CYCLE_DISEASE_EVENTS","REACTOME","771582_REACT_160130_RETINOID_CYCLE_DISEASE_EVENTS",9,1.1571,0.25,0.57,0.9217,0.53,0.87,-0.9776,0.48,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_2004_GHO_ATF5_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2004_GHO_ATF5_TARGETS_UP",13,1.1572,0.24,0.81,1.2403,0.18,0.45,1.2345,0.19,0.74
"C4_Cancer_gene_neighborhoods:C4_CGN_25_MORF_MSH2","C4_Cancer_gene_neighborhoods","C4_CGN_25_MORF_MSH2",61,1.1585,0.16,0.47,1.7713,0.0044,0.003,-1.3942,0.036,0.18
"GO_MF:494555_GO_0010485_H4_HISTONE_ACETYLTRANSFERASE_ACTIVITY","GO_MF","494555_GO_0010485_H4_HISTONE_ACETYLTRANSFERASE_ACTIVITY",16,1.1585,0.25,0.88,0.7247,0.81,1,0.7916,0.76,1
"C4_Cancer_gene_neighborhoods:C4_CGN_52_MORF_UNG","C4_Cancer_gene_neighborhoods","C4_CGN_52_MORF_UNG",76,1.1586,0.18,0.48,2.4278,0,0,-1.2616,0.083,0.35
"C2_Chemical_and_genetic_perturbations:C2_CGP_1694_HEDENFALK_BREAST_CANCER_BRACX_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1694_HEDENFALK_BREAST_CANCER_BRACX_DN",20,1.1587,0.23,0.81,1.0489,0.37,0.72,1.3807,0.087,0.53
"GO_BP:510388_GO_0048280_VESICLE_FUSION_WITH_GOLGI_APPARATUS","GO_BP","510388_GO_0048280_VESICLE_FUSION_WITH_GOLGI_APPARATUS",9,1.1591,0.28,0.75,1.2493,0.22,0.73,0.9281,0.55,0.92
"GO_BP:512314_GO_0051436_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY_INVOLVED_IN_MITOTIC_CELL_CYCLE","GO_BP","512314_GO_0051436_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY_INVOLVED_IN_MITOTIC_CELL_CYCLE",67,1.1592,0.18,0.75,2.2275,0,0.00047,0.6208,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_161_MORF_PTPRR","C4_Cancer_gene_neighborhoods","C4_CGN_161_MORF_PTPRR",96,1.1594,0.16,0.48,1.2443,0.099,0.17,1.6033,0.0019,0.11
"REACTOME:161062_REACT_20647_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR","REACTOME","161062_REACT_20647_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR",22,1.1599,0.23,0.57,1.0316,0.4,0.69,0.9892,0.47,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2207_DAIRKEE_CANCER_PRONE_RESPONSE_BPA","C2_Chemical_and_genetic_perturbations","C2_CGP_2207_DAIRKEE_CANCER_PRONE_RESPONSE_BPA",51,1.1605,0.21,0.81,1.5743,0.016,0.16,-0.8705,0.68,0.91
"C4_Cancer_gene_neighborhoods:C4_CGN_84_MORF_DCC","C4_Cancer_gene_neighborhoods","C4_CGN_84_MORF_DCC",105,1.1608,0.16,0.48,-0.6743,0.99,1,1.3923,0.018,0.24
"C4_Cancer_gene_neighborhoods:C4_CGN_305_GNF2_MSH6","C4_Cancer_gene_neighborhoods","C4_CGN_305_GNF2_MSH6",31,1.162,0.22,0.49,1.6881,0.01,0.0071,-1.3504,0.09,0.22
"C7_Immunologic_signatures:C7_ALL_1836_GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1836_GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN",200,1.1622,0.078,0.27,1.2912,0.032,0.11,-0.9161,0.73,0.92
"GO_BP:512204_GO_0051320_S_PHASE","GO_BP","512204_GO_0051320_S_PHASE",123,1.1624,0.14,0.74,2.0146,0,0.01,-1.1513,0.17,0.74
"GO_CC:516606_GO_0071682_ENDOCYTIC_VESICLE_LUMEN","GO_CC","516606_GO_0071682_ENDOCYTIC_VESICLE_LUMEN",17,1.1626,0.23,0.62,1.6468,0.015,0.087,-1.4572,0.05,0.51
"C7_Immunologic_signatures:C7_ALL_821_GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_821_GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP",197,1.1627,0.076,0.27,1.4657,0.0072,0.019,0.9643,0.55,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1221_NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1221_NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON",143,1.1628,0.12,0.81,1.0261,0.38,0.76,1.1701,0.15,0.8
"GO_BP:504994_GO_0035825_RECIPROCAL_DNA_RECOMBINATION","GO_BP","504994_GO_0035825_RECIPROCAL_DNA_RECOMBINATION",34,1.1632,0.22,0.74,0.7731,0.84,1,-1.0522,0.37,0.81
"GO_BP:519269_GO_2000630_POSITIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS","GO_BP","519269_GO_2000630_POSITIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS",5,1.1634,0.31,0.74,1.1917,0.28,0.79,-0.7155,0.79,0.99
"GO_BP:489060_GO_0003266_REGULATION_OF_SECONDARY_HEART_FIELD_CARDIOBLAST_PROLIFERATION","GO_BP","489060_GO_0003266_REGULATION_OF_SECONDARY_HEART_FIELD_CARDIOBLAST_PROLIFERATION",9,1.1635,0.26,0.74,-1.3268,0.15,0.9,1.4772,0.08,0.58
"REACTOME:187108_REACT_23898_RAP1_SIGNALLING","REACTOME","187108_REACT_23898_RAP1_SIGNALLING",16,1.1636,0.24,0.56,1.3647,0.11,0.25,-1.4521,0.071,0.38
"GO_CC:502489_GO_0033270_PARANODE_REGION_OF_AXON","GO_CC","502489_GO_0033270_PARANODE_REGION_OF_AXON",12,1.1644,0.26,0.62,-0.7574,0.81,1,1.0048,0.46,1
"GO_CC:487076_GO_0000783_NUCLEAR_TELOMERE_CAP_COMPLEX","GO_CC","487076_GO_0000783_NUCLEAR_TELOMERE_CAP_COMPLEX",12,1.1651,0.27,0.62,0.8899,0.61,0.91,-0.7953,0.74,1
"GO_MF:987849_GO_1990381_UBIQUITIN_SPECIFIC_PROTEASE_BINDING","GO_MF","987849_GO_1990381_UBIQUITIN_SPECIFIC_PROTEASE_BINDING",7,1.1656,0.28,0.87,0.9648,0.5,0.91,0.6878,0.84,1
"GO_MF:496701_GO_0016796_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS","GO_MF","496701_GO_0016796_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS",44,1.1668,0.19,0.88,1.4747,0.031,0.4,-0.7059,0.93,1
"C4_Cancer_modules:C4_CM_415_MODULE_539","C4_Cancer_modules","C4_CM_415_MODULE_539",16,1.1669,0.25,0.76,1.7387,0.013,0.037,-1.3342,0.13,0.28
"GO_BP:497329_GO_0018394_PEPTIDYL_LYSINE_ACETYLATION","GO_BP","497329_GO_0018394_PEPTIDYL_LYSINE_ACETYLATION",107,1.1669,0.16,0.73,0.5876,1,1,-0.8722,0.75,0.95
"GO_BP:515303_GO_0070371_ERK1_AND_ERK2_CASCADE","GO_BP","515303_GO_0070371_ERK1_AND_ERK2_CASCADE",16,1.167,0.25,0.74,0.8959,0.61,1,1.3049,0.12,0.67
"C7_Immunologic_signatures:C7_ALL_196_GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN","C7_Immunologic_signatures","C7_ALL_196_GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN",158,1.1674,0.091,0.26,1.3395,0.02,0.07,1.0718,0.28,1
"C7_Immunologic_signatures:C7_ALL_827_GSE17974_1_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_827_GSE17974_1_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP",197,1.1676,0.082,0.26,1.5379,0.0023,0.0074,1.2523,0.055,0.52
"GO_BP:491304_GO_0006370_7_METHYLGUANOSINE_MRNA_CAPPING","GO_BP","491304_GO_0006370_7_METHYLGUANOSINE_MRNA_CAPPING",32,1.1677,0.23,0.74,1.528,0.019,0.37,1.0293,0.42,0.83
"REACTOME:105791_REACT_1838_LEADING_STRAND_SYNTHESIS","REACTOME","105791_REACT_1838_LEADING_STRAND_SYNTHESIS",14,1.1681,0.25,0.55,1.3292,0.14,0.29,-1.1758,0.25,0.63
"GO_BP:488950_GO_0003156_REGULATION_OF_ORGAN_FORMATION","GO_BP","488950_GO_0003156_REGULATION_OF_ORGAN_FORMATION",28,1.1683,0.24,0.74,0.8063,0.8,1,1.4486,0.055,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_1153_SHEN_SMARCA2_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1153_SHEN_SMARCA2_TARGETS_UP",424,1.1694,0.022,0.8,2.0811,0,0.0024,0.721,1,1
"GO_MF:492775_GO_0008494_TRANSLATION_ACTIVATOR_ACTIVITY","GO_MF","492775_GO_0008494_TRANSLATION_ACTIVATOR_ACTIVITY",7,1.1696,0.27,0.87,0.7715,0.76,1,0.79,0.7,1
"REACTOME:1183535_REACT_355497_INFECTIOUS_DISEASE","REACTOME","1183535_REACT_355497_INFECTIOUS_DISEASE",372,1.1702,0.057,0.55,2.8058,0,0,0.866,0.9,1
"REACTOME:1127595_REACT_267741_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2","REACTOME","1127595_REACT_267741_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2",12,1.1713,0.24,0.55,1.501,0.048,0.14,0.8779,0.61,1
"C4_Cancer_modules:C4_CM_120_MODULE_125","C4_Cancer_modules","C4_CM_120_MODULE_125",44,1.1713,0.18,0.8,1.7017,0.0045,0.045,-1.194,0.17,0.41
"GO_BP:518290_GO_0090150_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE","GO_BP","518290_GO_0090150_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE",239,1.172,0.067,0.73,3.1155,0,0,0.74,1,1
"C7_Immunologic_signatures:C7_ALL_849_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP","C7_Immunologic_signatures","C7_ALL_849_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP",199,1.172,0.097,0.25,1.4992,0.0024,0.013,-0.959,0.57,0.82
"GO_BP:755120_GO_2001014_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION","GO_BP","755120_GO_2001014_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION",15,1.1724,0.24,0.73,0.5642,0.98,1,0.8099,0.73,1
"GO_BP:488896_GO_0003100_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_ENDOTHELIN","GO_BP","488896_GO_0003100_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_ENDOTHELIN",5,1.1726,0.27,0.73,-1.1712,0.31,0.91,-0.8493,0.67,0.96
"GO_BP:497050_GO_0018065_PROTEIN_COFACTOR_LINKAGE","GO_BP","497050_GO_0018065_PROTEIN_COFACTOR_LINKAGE",9,1.173,0.26,0.73,1.2097,0.22,0.77,0.7259,0.82,1
"REACTOME:105890_REACT_1628_TRANSCRIPTION_COUPLED_NER_TC_NER_","REACTOME","105890_REACT_1628_TRANSCRIPTION_COUPLED_NER_TC_NER_",46,1.1739,0.18,0.55,1.5918,0.011,0.097,-0.5471,1,1
"GO_MF:492989_GO_0008757_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY","GO_MF","492989_GO_0008757_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY",116,1.1743,0.16,0.87,-0.8223,0.88,1,-0.9727,0.52,0.8
"GO_BP:497009_GO_0018023_PEPTIDYL_LYSINE_TRIMETHYLATION","GO_BP","497009_GO_0018023_PEPTIDYL_LYSINE_TRIMETHYLATION",20,1.1756,0.24,0.72,0.5589,0.99,1,-0.962,0.5,0.88
"REACTOME:105837_REACT_216_DNA_REPAIR","REACTOME","105837_REACT_216_DNA_REPAIR",144,1.1759,0.12,0.55,1.5816,0,0.1,-0.9455,0.58,0.91
"REACTOME:105821_REACT_2243_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX","REACTOME","105821_REACT_2243_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX",67,1.1768,0.16,0.55,2.1098,0,0.00051,-0.7467,0.95,1
"GO_BP:492427_GO_0008053_MITOCHONDRIAL_FUSION","GO_BP","492427_GO_0008053_MITOCHONDRIAL_FUSION",15,1.1769,0.25,0.72,1.4797,0.06,0.44,0.7602,0.81,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3073_DEMAGALHAES_AGING_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3073_DEMAGALHAES_AGING_DN",15,1.1773,0.25,0.78,1.6793,0.0084,0.094,1.1623,0.26,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_3096_TSUTSUMI_FBXW8_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3096_TSUTSUMI_FBXW8_TARGETS",8,1.1775,0.26,0.79,0.9637,0.5,0.85,-0.8714,0.62,0.91
"KEGG_pathway:HSA00563_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS","KEGG_pathway","HSA00563_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS",25,1.1781,0.2,0.29,1.0418,0.39,0.84,-0.6876,0.91,1
"GO_BP:510655_GO_0048596_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS","GO_BP","510655_GO_0048596_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS",27,1.1781,0.21,0.72,1.4827,0.039,0.44,1.585,0.022,0.43
"GO_MF:500627_GO_0031369_TRANSLATION_INITIATION_FACTOR_BINDING","GO_MF","500627_GO_0031369_TRANSLATION_INITIATION_FACTOR_BINDING",24,1.1785,0.23,0.86,1.3252,0.12,0.57,0.7293,0.86,1
"GO_BP:495251_GO_0014857_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION","GO_BP","495251_GO_0014857_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION",8,1.1788,0.24,0.72,0.6068,0.94,1,-1.0198,0.41,0.83
"GO_MF:489875_GO_0004527_EXONUCLEASE_ACTIVITY","GO_MF","489875_GO_0004527_EXONUCLEASE_ACTIVITY",72,1.179,0.17,0.87,1.3444,0.051,0.53,-0.7987,0.87,0.97
"GO_BP:513907_GO_0060351_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS","GO_BP","513907_GO_0060351_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS",22,1.179,0.2,0.72,-1.2385,0.16,0.91,-1.1431,0.27,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_2023_MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2023_MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN",7,1.1791,0.24,0.79,0.9627,0.49,0.85,1.1538,0.28,0.83
"GO_BP:495982_GO_0015858_NUCLEOSIDE_TRANSPORT","GO_BP","495982_GO_0015858_NUCLEOSIDE_TRANSPORT",15,1.1794,0.23,0.72,0.6918,0.89,1,-1.0759,0.38,0.8
"REACTOME:106545_REACT_7987_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE","REACTOME","106545_REACT_7987_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE",14,1.1795,0.23,0.54,1.3601,0.099,0.26,-1.2009,0.22,0.61
"C4_Cancer_gene_neighborhoods:C4_CGN_56_MORF_AATF","C4_Cancer_gene_neighborhoods","C4_CGN_56_MORF_AATF",207,1.1796,0.096,0.44,2.0524,0,0.00018,-0.859,0.86,1
"GO_BP:516493_GO_0071569_PROTEIN_UFMYLATION","GO_BP","516493_GO_0071569_PROTEIN_UFMYLATION",6,1.1796,0.27,0.72,1.4031,0.09,0.55,0.7173,0.82,1
"C4_Cancer_gene_neighborhoods:C4_CGN_187_MORF_TTN","C4_Cancer_gene_neighborhoods","C4_CGN_187_MORF_TTN",48,1.1799,0.16,0.45,1.4048,0.046,0.06,1.6094,0.012,0.12
"GO_BP:487679_GO_0001783_B_CELL_APOPTOTIC_PROCESS","GO_BP","487679_GO_0001783_B_CELL_APOPTOTIC_PROCESS",6,1.181,0.25,0.72,1.3124,0.16,0.66,1.2665,0.22,0.69
"GO_BP:486728_GO_0000209_PROTEIN_POLYUBIQUITINATION","GO_BP","486728_GO_0000209_PROTEIN_POLYUBIQUITINATION",191,1.1817,0.053,0.72,1.8999,0,0.039,-0.6578,1,1
"GO_BP:493487_GO_0009303_RRNA_TRANSCRIPTION","GO_BP","493487_GO_0009303_RRNA_TRANSCRIPTION",20,1.1829,0.21,0.72,1.4432,0.054,0.5,-0.9262,0.58,0.9
"C1_Positional:C1_ALL_191_CHR16P","C1_Positional","C1_ALL_191_CHR16P",5,1.183,0.27,0.64,1.4111,0.093,0.36,1.2701,0.2,0.53
"GO_MF:498528_GO_0019706_PROTEIN_CYSTEINE_S_PALMITOYLTRANSFERASE_ACTIVITY","GO_MF","498528_GO_0019706_PROTEIN_CYSTEINE_S_PALMITOYLTRANSFERASE_ACTIVITY",25,1.183,0.23,0.87,-0.8386,0.71,1,-0.5531,1,1
"GO_BP:499215_GO_0021936_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION","GO_BP","499215_GO_0021936_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION",9,1.1831,0.24,0.72,1.3299,0.14,0.63,0.7684,0.77,1
"REACTOME:106187_REACT_1298_LYSINE_CATABOLISM","REACTOME","106187_REACT_1298_LYSINE_CATABOLISM",8,1.1843,0.26,0.54,-1.007,0.44,0.98,-1.3983,0.095,0.41
"C4_Cancer_gene_neighborhoods:C4_CGN_400_GNF2_RAN","C4_Cancer_gene_neighborhoods","C4_CGN_400_GNF2_RAN",86,1.1845,0.13,0.44,2.4979,0,0,-0.8707,0.75,1
"GO_BP:498715_GO_0045116_PROTEIN_NEDDYLATION","GO_BP","498715_GO_0045116_PROTEIN_NEDDYLATION",8,1.1854,0.25,0.72,1.5905,0.024,0.3,1.0029,0.45,0.85
"C7_Immunologic_signatures:C7_ALL_991_GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_991_GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP",200,1.1854,0.05,0.22,1.8781,0,0,-0.9782,0.5,0.77
"GO_BP:505850_GO_0042744_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS","GO_BP","505850_GO_0042744_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS",21,1.1859,0.23,0.72,1.3957,0.081,0.56,-0.9502,0.54,0.89
"KEGG_module:HSA_M00055_N_GLYCAN_PRECURSOR_BIOSYNTHESIS","KEGG_module","HSA_M00055_N_GLYCAN_PRECURSOR_BIOSYNTHESIS",14,1.1863,0.24,0.51,1.3591,0.13,0.33,-0.9196,0.56,0.88
"C2_Chemical_and_genetic_perturbations:C2_CGP_1199_NIKOLSKY_BREAST_CANCER_7P22_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1199_NIKOLSKY_BREAST_CANCER_7P22_AMPLICON",37,1.1866,0.19,0.77,0.8295,0.74,0.98,0.525,1,1
"GO_BP:501463_GO_0032228_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC","GO_BP","501463_GO_0032228_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC",32,1.1866,0.22,0.72,-1.0921,0.33,0.95,0.7456,0.87,1
"GO_BP:514481_GO_0060926_CARDIAC_PACEMAKER_CELL_DEVELOPMENT","GO_BP","514481_GO_0060926_CARDIAC_PACEMAKER_CELL_DEVELOPMENT",5,1.1869,0.26,0.72,-0.8489,0.66,1,-1.1437,0.35,0.74
"REACTOME:187195_REACT_25387_LIGAND_GATED_ION_CHANNEL_TRANSPORT","REACTOME","187195_REACT_25387_LIGAND_GATED_ION_CHANNEL_TRANSPORT",24,1.1873,0.21,0.53,-1.1386,0.28,0.89,1.1383,0.27,0.91
"KEGG_module:HSA_M00090_PHOSPHATIDYLCHOLINE_PC_BIOSYNTHESIS_CHOLINE_PC","KEGG_module","HSA_M00090_PHOSPHATIDYLCHOLINE_PC_BIOSYNTHESIS_CHOLINE_PC",6,1.1877,0.25,0.53,0.7917,0.72,0.94,0.7118,0.83,1
"GO_MF:503270_GO_0034062_RNA_POLYMERASE_ACTIVITY","GO_MF","503270_GO_0034062_RNA_POLYMERASE_ACTIVITY",44,1.1877,0.19,0.86,0.8934,0.66,0.99,-0.6089,0.99,1
"GO_BP:512079_GO_0051169_NUCLEAR_TRANSPORT","GO_BP","512079_GO_0051169_NUCLEAR_TRANSPORT",235,1.189,0.055,0.71,1.0913,0.19,0.91,-0.7363,1,1
"GO_BP:501292_GO_0032055_NEGATIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS","GO_BP","501292_GO_0032055_NEGATIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS",7,1.1892,0.27,0.71,-0.7451,0.77,1,-0.7715,0.75,1
"C7_Immunologic_signatures:C7_ALL_31_GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP","C7_Immunologic_signatures","C7_ALL_31_GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP",199,1.1893,0.073,0.21,1.2217,0.067,0.19,-0.9603,0.57,0.82
"KEGG_compound:C00101_TETRAHYDROFOLATE_5_6_7_8_TETRAHYDROFOLATE_TETRAHYDROFOLIC_ACID_THF_6S_TETRAHYDROFOLATE_6S_TETRAHYDROFOLIC_ACID_6S_THFA","KEGG_compound","C00101_TETRAHYDROFOLATE_5_6_7_8_TETRAHYDROFOLATE_TETRAHYDROFOLIC_ACID_THF_6S_TETRAHYDROFOLATE_6S_TETRAHYDROFOLIC_ACID_6S_THFA",20,1.1894,0.2,1,0.8717,0.64,1,-0.8818,0.64,0.78
"GO_BP:755122_GO_2001016_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION","GO_BP","755122_GO_2001016_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION",5,1.1894,0.26,0.72,-0.9413,0.54,1,-1.004,0.46,0.84
"C1_Positional:C1_ALL_303_CHR7Q32","C1_Positional","C1_ALL_303_CHR7Q32",50,1.1895,0.2,0.64,0.8228,0.79,0.93,-1.0935,0.28,0.82
"REACTOME:1183615_REACT_355324_TRANSLESION_SYNTHESIS_BY_POLI","REACTOME","1183615_REACT_355324_TRANSLESION_SYNTHESIS_BY_POLI",17,1.1907,0.2,0.53,1.8265,0.0021,0.017,-0.673,0.92,1
"GO_CC:497896_GO_0019013_VIRAL_NUCLEOCAPSID","GO_CC","497896_GO_0019013_VIRAL_NUCLEOCAPSID",5,1.1912,0.28,0.57,1.0221,0.45,0.75,-0.6908,0.85,1
"GO_BP:511997_GO_0051081_NUCLEAR_ENVELOPE_DISASSEMBLY","GO_BP","511997_GO_0051081_NUCLEAR_ENVELOPE_DISASSEMBLY",44,1.1915,0.2,0.71,1.2393,0.13,0.75,0.7872,0.86,1
"GO_BP:511719_GO_0050748_NEGATIVE_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS","GO_BP","511719_GO_0050748_NEGATIVE_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS",6,1.1917,0.25,0.71,0.888,0.57,1,0.9068,0.59,0.93
"C7_Immunologic_signatures:C7_ALL_1666_GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_1666_GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN",195,1.1919,0.052,0.21,1.4784,0.0049,0.016,-1.0605,0.32,0.59
"C4_Cancer_gene_neighborhoods:C4_CGN_33_MORF_PRKDC","C4_Cancer_gene_neighborhoods","C4_CGN_33_MORF_PRKDC",191,1.1919,0.088,0.43,1.9893,0,0.00035,-1.1721,0.11,0.48
"GO_MF:496965_GO_0017176_PHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY","GO_MF","496965_GO_0017176_PHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY",5,1.1923,0.28,0.86,1.3134,0.17,0.59,0.5859,0.92,1
"GO_BP:491246_GO_0006283_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR","GO_BP","491246_GO_0006283_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR",49,1.1924,0.18,0.71,1.584,0.01,0.31,-0.5678,1,1
"REACTOME:106200_REACT_212_GLUCOSE_TRANSPORT","REACTOME","106200_REACT_212_GLUCOSE_TRANSPORT",40,1.1928,0.19,0.53,0.8686,0.69,0.94,0.6466,0.97,1
"GO_BP:487586_GO_0001675_ACROSOME_ASSEMBLY","GO_BP","487586_GO_0001675_ACROSOME_ASSEMBLY",12,1.1929,0.25,0.71,0.8809,0.62,1,1.65,0.021,0.4
"GO_CC:490830_GO_0005801_CIS_GOLGI_NETWORK","GO_CC","490830_GO_0005801_CIS_GOLGI_NETWORK",36,1.1939,0.2,0.56,0.9742,0.49,0.82,0.8671,0.67,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3297_LIU_IL13_MEMORY_MODEL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3297_LIU_IL13_MEMORY_MODEL_DN",5,1.1939,0.3,0.76,1.1814,0.29,0.51,1.0692,0.39,0.89
"C2_Chemical_and_genetic_perturbations:C2_CGP_1856_SONG_TARGETS_OF_IE86_CMV_PROTEIN","C2_Chemical_and_genetic_perturbations","C2_CGP_1856_SONG_TARGETS_OF_IE86_CMV_PROTEIN",60,1.194,0.16,0.76,1.4143,0.032,0.28,-1.4818,0.021,0.31
"GO_BP:505014_GO_0035845_PHOTORECEPTOR_CELL_OUTER_SEGMENT_ORGANIZATION","GO_BP","505014_GO_0035845_PHOTORECEPTOR_CELL_OUTER_SEGMENT_ORGANIZATION",6,1.1942,0.23,0.71,0.7381,0.8,1,-0.6346,0.9,1
"GO_MF:492449_GO_0008080_N_ACETYLTRANSFERASE_ACTIVITY","GO_MF","492449_GO_0008080_N_ACETYLTRANSFERASE_ACTIVITY",82,1.1947,0.15,0.86,0.7329,0.96,1,0.6852,1,1
"REACTOME:1183560_REACT_355194_SHC_MEDIATED_CASCADE_FGFR1","REACTOME","1183560_REACT_355194_SHC_MEDIATED_CASCADE_FGFR1",16,1.1948,0.22,0.53,0.7437,0.82,1,0.9976,0.46,1
"GO_BP:491944_GO_0007131_RECIPROCAL_MEIOTIC_RECOMBINATION","GO_BP","491944_GO_0007131_RECIPROCAL_MEIOTIC_RECOMBINATION",34,1.1956,0.15,0.71,0.7487,0.86,1,-1.042,0.37,0.82
"REACTOME:1183525_REACT_355283_SIGNALING_BY_FGFR4_IN_DISEASE","REACTOME","1183525_REACT_355283_SIGNALING_BY_FGFR4_IN_DISEASE",22,1.1957,0.18,0.53,-1.0057,0.43,0.98,0.8675,0.69,1
"GO_MF:515206_GO_0070273_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING","GO_MF","515206_GO_0070273_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING",16,1.1959,0.23,0.86,-0.5511,0.97,1,-0.5102,0.99,1
"C4_Cancer_gene_neighborhoods:C4_CGN_168_MORF_RAF1","C4_Cancer_gene_neighborhoods","C4_CGN_168_MORF_RAF1",112,1.196,0.11,0.43,1.8092,0,0.002,1.0604,0.34,0.66
"GO_BP:515662_GO_0070734_HISTONE_H3_K27_METHYLATION","GO_BP","515662_GO_0070734_HISTONE_H3_K27_METHYLATION",6,1.1963,0.27,0.71,-1.0688,0.38,0.96,-1.424,0.097,0.57
"C1_Positional:C1_ALL_301_CHR3Q11","C1_Positional","C1_ALL_301_CHR3Q11",13,1.1963,0.22,0.65,0.6261,0.93,1,1.1531,0.27,0.67
"KEGG_pathway:HSA03420_NUCLEOTIDE_EXCISION_REPAIR","KEGG_pathway","HSA03420_NUCLEOTIDE_EXCISION_REPAIR",46,1.197,0.17,0.27,1.4991,0.026,0.1,-0.765,0.88,0.95
"C2_Chemical_and_genetic_perturbations:C2_CGP_2920_MIKKELSEN_NPC_ICP_WITH_H3K27ME3","C2_Chemical_and_genetic_perturbations","C2_CGP_2920_MIKKELSEN_NPC_ICP_WITH_H3K27ME3",12,1.1981,0.23,0.76,0.9357,0.56,0.88,0.9843,0.47,0.96
"GO_BP:515065_GO_0070127_TRNA_AMINOACYLATION_FOR_MITOCHONDRIAL_PROTEIN_TRANSLATION","GO_BP","515065_GO_0070127_TRNA_AMINOACYLATION_FOR_MITOCHONDRIAL_PROTEIN_TRANSLATION",5,1.1983,0.3,0.71,-1.2171,0.26,0.88,0.694,0.83,1
"GO_BP:507965_GO_0045617_NEGATIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION","GO_BP","507965_GO_0045617_NEGATIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION",7,1.1989,0.23,0.71,-1.4924,0.062,0.82,0.8312,0.67,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_2648_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2648_CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN",25,1.199,0.19,0.77,0.9908,0.46,0.81,0.7477,0.85,1
"C4_Cancer_gene_neighborhoods:C4_CGN_378_GNF2_MCM5","C4_Cancer_gene_neighborhoods","C4_CGN_378_GNF2_MCM5",61,1.1994,0.14,0.42,1.603,0.0086,0.014,-1.4381,0.042,0.14
"GO_CC:516130_GO_0071204_HISTONE_PRE_MRNA_3_END_PROCESSING_COMPLEX","GO_CC","516130_GO_0071204_HISTONE_PRE_MRNA_3_END_PROCESSING_COMPLEX",6,1.1997,0.24,0.56,1.4485,0.073,0.25,0.9729,0.5,1
"C7_Immunologic_signatures:C7_ALL_1567_GSE3982_CTRL_VS_LPS_4H_MAC_UP","C7_Immunologic_signatures","C7_ALL_1567_GSE3982_CTRL_VS_LPS_4H_MAC_UP",197,1.1999,0.048,0.19,1.4109,0.0094,0.034,-0.8076,0.96,1
"REACTOME:730343_REACT_150353_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS","REACTOME","730343_REACT_150353_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS",9,1.2001,0.25,0.52,0.8948,0.6,0.91,-0.647,0.89,1
"KEGG_reaction:R00443_UTP_RNA_URIDYLYLTRANSFERASE_UTP_RNA_DIPHOSPHATE_RNA","KEGG_reaction","R00443_UTP_RNA_URIDYLYLTRANSFERASE_UTP_RNA_DIPHOSPHATE_RNA",31,1.2004,0.19,1,0.8239,0.75,1,-0.5082,1,1
"GO_CC:486938_GO_0000445_THO_COMPLEX_PART_OF_TRANSCRIPTION_EXPORT_COMPLEX","GO_CC","486938_GO_0000445_THO_COMPLEX_PART_OF_TRANSCRIPTION_EXPORT_COMPLEX",6,1.2013,0.27,0.56,1.1873,0.27,0.55,-0.535,0.97,1
"GO_BP:514466_GO_0060911_CARDIAC_CELL_FATE_COMMITMENT","GO_BP","514466_GO_0060911_CARDIAC_CELL_FATE_COMMITMENT",11,1.2013,0.23,0.7,-0.8082,0.7,1,-1.0636,0.38,0.8
"C2_Chemical_and_genetic_perturbations:C2_CGP_2564_VANTVEER_BREAST_CANCER_BRCA1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2564_VANTVEER_BREAST_CANCER_BRCA1_UP",35,1.2025,0.17,0.76,0.9113,0.65,0.91,0.9023,0.59,1
"GO_BP:493287_GO_0009086_METHIONINE_BIOSYNTHETIC_PROCESS","GO_BP","493287_GO_0009086_METHIONINE_BIOSYNTHETIC_PROCESS",16,1.2032,0.2,0.7,-0.6191,0.94,1,-1.4908,0.056,0.54
"GO_MF:515344_GO_0070412_R_SMAD_BINDING","GO_MF","515344_GO_0070412_R_SMAD_BINDING",22,1.2032,0.2,0.85,-0.8832,0.66,1,1.2598,0.13,0.66
"GO_BP:515970_GO_0071044_HISTONE_MRNA_CATABOLIC_PROCESS","GO_BP","515970_GO_0071044_HISTONE_MRNA_CATABOLIC_PROCESS",14,1.2036,0.21,0.7,1.1324,0.29,0.86,1.251,0.18,0.7
"REACTOME:105883_REACT_1826_NUCLEOTIDE_EXCISION_REPAIR","REACTOME","105883_REACT_1826_NUCLEOTIDE_EXCISION_REPAIR",51,1.2037,0.14,0.51,1.6464,0.0084,0.071,-0.5679,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_147_MORF_PPP2CA","C4_Cancer_gene_neighborhoods","C4_CGN_147_MORF_PPP2CA",129,1.2039,0.069,0.42,2.2595,0,0,0.8048,0.92,1
"GO_BP:486630_GO_0000090_MITOTIC_ANAPHASE","GO_BP","486630_GO_0000090_MITOTIC_ANAPHASE",162,1.2039,0.056,0.7,2.0174,0,0.0099,-0.7337,0.99,0.99
"GO_BP:515515_GO_0070585_PROTEIN_LOCALIZATION_TO_MITOCHONDRION","GO_BP","515515_GO_0070585_PROTEIN_LOCALIZATION_TO_MITOCHONDRION",65,1.2041,0.13,0.7,1.8108,0,0.091,-0.5154,1,1
"KEGG_module:HSA_M00037_MELATONIN_BIOSYNTHESIS_TRYPTOPHAN_SEROTONIN_MELATONIN","KEGG_module","HSA_M00037_MELATONIN_BIOSYNTHESIS_TRYPTOPHAN_SEROTONIN_MELATONIN",5,1.2046,0.29,0.52,-0.8999,0.58,1,1.2851,0.18,0.78
"GO_MF:492618_GO_0008297_SINGLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY","GO_MF","492618_GO_0008297_SINGLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY",5,1.2054,0.25,0.85,0.8373,0.67,1,0.7256,0.8,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_184_SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_184_SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP",81,1.2054,0.11,0.76,1.2711,0.088,0.42,-1.0335,0.4,0.71
"GO_BP:754594_GO_1901642_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT","GO_BP","754594_GO_1901642_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT",11,1.2064,0.21,0.7,-0.7565,0.79,1,-1.2245,0.23,0.71
"KEGG_pathway:HSA03020_RNA_POLYMERASE","KEGG_pathway","HSA03020_RNA_POLYMERASE",31,1.2076,0.17,0.27,0.8258,0.76,1,-0.5082,1,1
"GO_CC:486994_GO_0000502_PROTEASOME_COMPLEX","GO_CC","486994_GO_0000502_PROTEASOME_COMPLEX",66,1.2079,0.15,0.55,2.109,0,0.00056,0.5546,1,1
"GO_MF:490350_GO_0051018_PROTEIN_KINASE_A_BINDING","GO_MF","490350_GO_0051018_PROTEIN_KINASE_A_BINDING",36,1.2087,0.18,0.85,0.9026,0.64,0.98,0.9717,0.5,0.89
"GO_BP:507550_GO_0045168_CELL_CELL_SIGNALING_INVOLVED_IN_CELL_FATE_COMMITMENT","GO_BP","507550_GO_0045168_CELL_CELL_SIGNALING_INVOLVED_IN_CELL_FATE_COMMITMENT",32,1.209,0.17,0.69,-0.9842,0.48,1,1.3613,0.079,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_2491_SPIRA_SMOKERS_LUNG_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2491_SPIRA_SMOKERS_LUNG_CANCER_DN",22,1.2093,0.18,0.76,1.1093,0.29,0.62,0.7861,0.79,1
"GO_BP:507651_GO_0045292_MRNA_CIS_SPLICING_VIA_SPLICEOSOME","GO_BP","507651_GO_0045292_MRNA_CIS_SPLICING_VIA_SPLICEOSOME",12,1.2096,0.22,0.69,-0.8084,0.71,1,-0.5445,0.98,1
"GO_BP:499784_GO_0030397_MEMBRANE_DISASSEMBLY","GO_BP","499784_GO_0030397_MEMBRANE_DISASSEMBLY",44,1.21,0.15,0.69,1.2326,0.14,0.75,0.7997,0.83,1
"KEGG_reaction:R00441_GTP_RNA_GUANYLYLTRANSFERASE_DNA_DIRECTED_GTP_RNA_GUANYLYLTRANSFERASE_RNA_DIRECTED_GTP_RNA_DIPHOSPHATE_RNA","KEGG_reaction","R00441_GTP_RNA_GUANYLYLTRANSFERASE_DNA_DIRECTED_GTP_RNA_GUANYLYLTRANSFERASE_RNA_DIRECTED_GTP_RNA_DIPHOSPHATE_RNA",31,1.2102,0.15,1,0.8295,0.72,1,-0.5114,1,1
"GO_BP:500412_GO_0031125_RRNA_3_END_PROCESSING","GO_BP","500412_GO_0031125_RRNA_3_END_PROCESSING",6,1.2104,0.27,0.69,1.4375,0.077,0.51,0.985,0.49,0.87
"GO_BP:489058_GO_0003264_REGULATION_OF_CARDIOBLAST_PROLIFERATION","GO_BP","489058_GO_0003264_REGULATION_OF_CARDIOBLAST_PROLIFERATION",9,1.2105,0.24,0.69,-1.3339,0.14,0.92,1.4675,0.067,0.59
"C4_Cancer_modules:C4_CM_150_MODULE_158","C4_Cancer_modules","C4_CM_150_MODULE_158",43,1.2109,0.14,0.72,1.6485,0.0066,0.061,-1.4199,0.045,0.2
"GO_BP:518445_GO_0090305_NUCLEIC_ACID_PHOSPHODIESTER_BOND_HYDROLYSIS","GO_BP","518445_GO_0090305_NUCLEIC_ACID_PHOSPHODIESTER_BOND_HYDROLYSIS",210,1.2116,0.039,0.69,1.3943,0.0073,0.56,0.7664,0.98,1
"GO_BP:487812_GO_0001921_POSITIVE_REGULATION_OF_RECEPTOR_RECYCLING","GO_BP","487812_GO_0001921_POSITIVE_REGULATION_OF_RECEPTOR_RECYCLING",10,1.2116,0.23,0.7,1.3307,0.15,0.63,-0.5524,0.97,1
"C7_Immunologic_signatures:C7_ALL_240_GSE14000_4H_VS_16H_LPS_DC_DN","C7_Immunologic_signatures","C7_ALL_240_GSE14000_4H_VS_16H_LPS_DC_DN",199,1.2118,0.048,0.17,1.2226,0.062,0.19,-0.7734,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2739_YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2739_YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP",53,1.212,0.15,0.76,2.7196,0,0,-0.8022,0.85,0.95
"OMIM_gene:OMIM611258_TUDOR_DOMAIN_CONTAINING_PROTEIN_7_TDRD7","OMIM_gene","OMIM611258_TUDOR_DOMAIN_CONTAINING_PROTEIN_7_TDRD7",6,1.2129,0.26,1,1.1271,0.33,1,0.5159,0.98,1
"GO_MF:489390_GO_0003899_DNA_DIRECTED_RNA_POLYMERASE_ACTIVITY","GO_MF","489390_GO_0003899_DNA_DIRECTED_RNA_POLYMERASE_ACTIVITY",43,1.2129,0.12,0.85,0.8649,0.72,1,-0.6067,0.99,1
"REACTOME:161063_REACT_21384_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS_","REACTOME","161063_REACT_21384_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS_",31,1.2133,0.15,0.5,1.0375,0.38,0.69,1.1139,0.29,0.95
"GO_BP:497122_GO_0018149_PEPTIDE_CROSS_LINKING","GO_BP","497122_GO_0018149_PEPTIDE_CROSS_LINKING",27,1.2137,0.19,0.69,-1.0767,0.34,0.95,1.915,0.002,0.13
"REACTOME:106238_REACT_952_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_","REACTOME","106238_REACT_952_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_",16,1.2139,0.22,0.5,1.1325,0.28,0.54,0.8561,0.66,1
"C0_Hallmark:H_ALL_28_HALLMARK_MYC_TARGETS_V1","C0_Hallmark","H_ALL_28_HALLMARK_MYC_TARGETS_V1",200,1.2142,0.046,0.14,2.6757,0,0,-1.0839,0.24,0.33
"KEGG_reaction:R00442_CTP_RNA_CYTIDYLYLTRANSFERASE_DNA_DIRECTED_CTP_RNA_CYTIDYLYLTRANSFERASE_RNA_DIRECTED_CTP_RNA_DIPHOSPHATE_RNA","KEGG_reaction","R00442_CTP_RNA_CYTIDYLYLTRANSFERASE_DNA_DIRECTED_CTP_RNA_CYTIDYLYLTRANSFERASE_RNA_DIRECTED_CTP_RNA_DIPHOSPHATE_RNA",31,1.2149,0.16,1,0.8245,0.75,1,-0.5183,1,1
"C7_Immunologic_signatures:C7_ALL_938_GSE22886_TCELL_VS_BCELL_NAIVE_DN","C7_Immunologic_signatures","C7_ALL_938_GSE22886_TCELL_VS_BCELL_NAIVE_DN",193,1.2151,0.039,0.17,0.6511,1,1,-1.0152,0.41,0.69
"GO_BP:515951_GO_0071025_RNA_SURVEILLANCE","GO_BP","515951_GO_0071025_RNA_SURVEILLANCE",9,1.2153,0.22,0.69,1.2246,0.23,0.76,0.6982,0.86,1
"GO_BP:499263_GO_0021984_ADENOHYPOPHYSIS_DEVELOPMENT","GO_BP","499263_GO_0021984_ADENOHYPOPHYSIS_DEVELOPMENT",14,1.2153,0.21,0.69,0.832,0.71,1,0.9847,0.48,0.87
"C4_Cancer_gene_neighborhoods:C4_CGN_412_GNF2_SPTA1","C4_Cancer_gene_neighborhoods","C4_CGN_412_GNF2_SPTA1",80,1.2154,0.094,0.4,2.0123,0,0.00027,-1.4945,0.017,0.11
"GO_BP:501465_GO_0032230_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC","GO_BP","501465_GO_0032230_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC",13,1.2156,0.21,0.69,-1.386,0.12,0.99,-1.3071,0.15,0.64
"KEGG_reaction:R00435_ATP_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_ATP_RNA_ADENYLYLTRANSFERASE_ATP_RNA_DIPHOSPHATE_RNA","KEGG_reaction","R00435_ATP_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_ATP_RNA_ADENYLYLTRANSFERASE_ATP_RNA_DIPHOSPHATE_RNA",31,1.2159,0.15,1,0.8074,0.76,1,-0.5036,1,0.99
"REACTOME:1183567_REACT_355225_SHC_MEDIATED_CASCADE_FGFR2","REACTOME","1183567_REACT_355225_SHC_MEDIATED_CASCADE_FGFR2",20,1.2162,0.18,0.5,-0.8197,0.76,1,0.7919,0.79,1
"REACTOME:105870_REACT_1763_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE","REACTOME","105870_REACT_1763_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE",7,1.2163,0.23,0.5,1.2254,0.22,0.42,-0.5493,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2204_POS_RESPONSE_TO_HISTAMINE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2204_POS_RESPONSE_TO_HISTAMINE_DN",11,1.2165,0.2,0.75,0.6796,0.88,1,1.4299,0.085,0.55
"GO_BP:491252_GO_0006289_NUCLEOTIDE_EXCISION_REPAIR","GO_BP","491252_GO_0006289_NUCLEOTIDE_EXCISION_REPAIR",82,1.2168,0.091,0.69,1.6278,0,0.26,-0.714,0.98,0.99
"GO_BP:517934_GO_0080009_MRNA_METHYLATION","GO_BP","517934_GO_0080009_MRNA_METHYLATION",5,1.2168,0.27,0.69,1.083,0.37,0.92,1.0507,0.41,0.8
"GO_BP:754380_GO_1901419_REGULATION_OF_RESPONSE_TO_ALCOHOL","GO_BP","754380_GO_1901419_REGULATION_OF_RESPONSE_TO_ALCOHOL",8,1.2182,0.21,0.69,1.0853,0.33,0.92,1.1708,0.26,0.72
"REACTOME:1183526_REACT_355202_SIGNALING_BY_FGFR4_MUTANTS","REACTOME","1183526_REACT_355202_SIGNALING_BY_FGFR4_MUTANTS",22,1.2185,0.15,0.5,-0.9953,0.46,0.99,0.86,0.69,1
"GO_BP:507001_GO_0043983_HISTONE_H4_K12_ACETYLATION","GO_BP","507001_GO_0043983_HISTONE_H4_K12_ACETYLATION",8,1.2185,0.23,0.69,-0.7494,0.79,1,-1.0694,0.37,0.8
"REACTOME:1183522_REACT_355511_SIGNALING_BY_FGFR2_MUTANTS","REACTOME","1183522_REACT_355511_SIGNALING_BY_FGFR2_MUTANTS",21,1.2185,0.19,0.5,-0.8956,0.62,1,0.9656,0.52,1
"C4_Cancer_gene_neighborhoods:C4_CGN_31_MORF_PSMC2","C4_Cancer_gene_neighborhoods","C4_CGN_31_MORF_PSMC2",117,1.2186,0.074,0.4,2.3823,0,0,1.3211,0.041,0.28
"GO_CC:487070_GO_0000777_CONDENSED_CHROMOSOME_KINETOCHORE","GO_CC","487070_GO_0000777_CONDENSED_CHROMOSOME_KINETOCHORE",93,1.2191,0.093,0.53,1.5048,0.0048,0.19,-0.8347,0.83,1
"C7_Immunologic_signatures:C7_ALL_1815_GSE7852_LN_VS_FAT_TREG_UP","C7_Immunologic_signatures","C7_ALL_1815_GSE7852_LN_VS_FAT_TREG_UP",200,1.2196,0.024,0.16,1.367,0.0091,0.052,-0.9734,0.5,0.79
"GO_BP:513962_GO_0060406_POSITIVE_REGULATION_OF_PENILE_ERECTION","GO_BP","513962_GO_0060406_POSITIVE_REGULATION_OF_PENILE_ERECTION",5,1.2197,0.26,0.69,1.5065,0.054,0.4,1.5893,0.04,0.44
"REACTOME:645349_REACT_121189_ABACAVIR_TRANSPORT_AND_METABOLISM","REACTOME","645349_REACT_121189_ABACAVIR_TRANSPORT_AND_METABOLISM",10,1.22,0.21,0.5,-0.7772,0.76,1,1.2951,0.17,0.75
"GO_BP:491261_GO_0006302_DOUBLE_STRAND_BREAK_REPAIR","GO_BP","491261_GO_0006302_DOUBLE_STRAND_BREAK_REPAIR",129,1.2203,0.079,0.69,1.0958,0.25,0.91,-0.8448,0.83,0.96
"GO_BP:513681_GO_0060123_REGULATION_OF_GROWTH_HORMONE_SECRETION","GO_BP","513681_GO_0060123_REGULATION_OF_GROWTH_HORMONE_SECRETION",10,1.2205,0.22,0.69,0.9764,0.48,1,1.4536,0.075,0.59
"REACTOME:105824_REACT_1949_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX","REACTOME","105824_REACT_1949_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX",58,1.2206,0.13,0.5,2.1078,0,0.00049,-0.4908,1,1
"C7_Immunologic_signatures:C7_ALL_774_GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN","C7_Immunologic_signatures","C7_ALL_774_GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN",200,1.2206,0.034,0.16,1.5982,0,0.0032,0.8655,0.84,1
"C4_Cancer_gene_neighborhoods:C4_CGN_5_MORF_BAG5","C4_Cancer_gene_neighborhoods","C4_CGN_5_MORF_BAG5",57,1.2208,0.13,0.4,2.495,0,0,1.0175,0.44,0.76
"GO_CC:500370_GO_0031083_BLOC_1_COMPLEX","GO_CC","500370_GO_0031083_BLOC_1_COMPLEX",14,1.2217,0.19,0.53,1.4489,0.067,0.25,1.6737,0.018,0.35
"KEGG_module:HSA_M00397_LSM_1_7_COMPLEX","KEGG_module","HSA_M00397_LSM_1_7_COMPLEX",7,1.2221,0.23,0.51,1.5301,0.054,0.16,0.702,0.84,1
"GO_BP:512759_GO_0051905_ESTABLISHMENT_OF_PIGMENT_GRANULE_LOCALIZATION","GO_BP","512759_GO_0051905_ESTABLISHMENT_OF_PIGMENT_GRANULE_LOCALIZATION",25,1.2225,0.18,0.69,1.1374,0.28,0.85,0.7184,0.9,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_953_SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_953_SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER",24,1.2228,0.19,0.74,1.4494,0.054,0.26,1.676,0.017,0.28
"REACTOME:1127594_REACT_267942_DEFECTIVE_EXT1_CAUSES_EXOSTOSES_1_TRPS2_AND_CHDS","REACTOME","1127594_REACT_267942_DEFECTIVE_EXT1_CAUSES_EXOSTOSES_1_TRPS2_AND_CHDS",12,1.223,0.2,0.5,1.5072,0.062,0.14,0.9001,0.57,1
"GO_BP:495836_GO_0015701_BICARBONATE_TRANSPORT","GO_BP","495836_GO_0015701_BICARBONATE_TRANSPORT",33,1.2236,0.17,0.69,1.2056,0.19,0.78,-1.3317,0.092,0.62
"REACTOME:576277_REACT_118560_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS","REACTOME","576277_REACT_118560_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS",9,1.2237,0.21,0.5,0.6761,0.88,1,-0.7955,0.73,1
"GO_BP:512206_GO_0051322_ANAPHASE","GO_BP","512206_GO_0051322_ANAPHASE",162,1.2238,0.065,0.69,2.0393,0,0.0079,-0.7147,0.99,0.99
"REACTOME:106080_REACT_6296_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS","REACTOME","106080_REACT_6296_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS",31,1.2243,0.16,0.5,0.9693,0.51,0.8,-0.8851,0.66,0.97
"GO_MF:498529_GO_0019707_PROTEIN_CYSTEINE_S_ACYLTRANSFERASE_ACTIVITY","GO_MF","498529_GO_0019707_PROTEIN_CYSTEINE_S_ACYLTRANSFERASE_ACTIVITY",25,1.2244,0.15,0.82,-0.8485,0.65,1,-0.5508,0.99,1
"GO_BP:486592_GO_0000042_PROTEIN_TARGETING_TO_GOLGI","GO_BP","486592_GO_0000042_PROTEIN_TARGETING_TO_GOLGI",18,1.225,0.19,0.69,0.6204,0.94,1,1.0612,0.38,0.79
"GO_BP:491029_GO_0006044_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS","GO_BP","491029_GO_0006044_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS",16,1.2252,0.2,0.69,0.57,0.98,1,0.8483,0.68,0.98
"C1_Positional:C1_ALL_297_CHR3Q21","C1_Positional","C1_ALL_297_CHR3Q21",108,1.2254,0.089,0.58,1.0654,0.31,0.66,-1.0487,0.35,0.85
"GO_CC:486863_GO_0000347_THO_COMPLEX","GO_CC","486863_GO_0000347_THO_COMPLEX",6,1.2255,0.23,0.52,1.1873,0.26,0.55,-0.5303,0.97,1
"C7_Immunologic_signatures:C7_ALL_655_GSE17721_LPS_VS_CPG_1H_BMDM_UP","C7_Immunologic_signatures","C7_ALL_655_GSE17721_LPS_VS_CPG_1H_BMDM_UP",198,1.2258,0.025,0.15,1.8075,0,2.9e-05,0.7466,0.99,1
"GO_BP:515107_GO_0070170_REGULATION_OF_TOOTH_MINERALIZATION","GO_BP","515107_GO_0070170_REGULATION_OF_TOOTH_MINERALIZATION",7,1.2268,0.23,0.69,0.7453,0.81,1,1.3979,0.11,0.63
"REACTOME:105944_REACT_2089_RNA_POLYMERASE_II_PROMOTER_ESCAPE","REACTOME","105944_REACT_2089_RNA_POLYMERASE_II_PROMOTER_ESCAPE",45,1.228,0.19,0.5,1.601,0.0087,0.092,0.9436,0.54,1
"REACTOME:105685_REACT_13648_REGULATION_OF_APOPTOSIS","REACTOME","105685_REACT_13648_REGULATION_OF_APOPTOSIS",50,1.2281,0.13,0.5,2.2483,0,6.2e-05,0.5035,1,1
"GO_BP:487461_GO_0001522_PSEUDOURIDINE_SYNTHESIS","GO_BP","487461_GO_0001522_PSEUDOURIDINE_SYNTHESIS",17,1.2286,0.2,0.68,1.2596,0.17,0.72,-1.0448,0.38,0.81
"C4_Cancer_gene_neighborhoods:C4_CGN_189_MORF_UBE2I","C4_Cancer_gene_neighborhoods","C4_CGN_189_MORF_UBE2I",239,1.2287,0.019,0.38,2.9221,0,0,0.5821,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2301_ZHANG_BREAST_CANCER_PROGENITORS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2301_ZHANG_BREAST_CANCER_PROGENITORS_UP",425,1.2288,0.02,0.73,1.7314,0,0.067,-1.0921,0.18,0.64
"GO_CC:499989_GO_0030687_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR","GO_CC","499989_GO_0030687_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR",5,1.2294,0.26,0.52,1.0446,0.42,0.72,0.8873,0.59,1
"C4_Cancer_gene_neighborhoods:C4_CGN_273_GCM_USP6","C4_Cancer_gene_neighborhoods","C4_CGN_273_GCM_USP6",70,1.2305,0.12,0.39,-0.7888,0.88,1,-0.6919,0.97,1
"GO_BP:494810_GO_0010745_NEGATIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION","GO_BP","494810_GO_0010745_NEGATIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION",13,1.2308,0.22,0.68,1.451,0.078,0.49,1.2187,0.2,0.71
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_193_BIOCARTA_TALL1_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_193_BIOCARTA_TALL1_PATHWAY",15,1.231,0.21,1,-1.3045,0.16,1,0.8777,0.63,1
"REACTOME:105854_REACT_8_TRANSLESION_SYNTHESIS_BY_REV1","REACTOME","105854_REACT_8_TRANSLESION_SYNTHESIS_BY_REV1",16,1.2314,0.21,0.5,1.8164,0.0086,0.018,-0.7514,0.81,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_466_OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_466_OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN",11,1.2318,0.22,0.73,1.2187,0.21,0.47,-1.1487,0.28,0.58
"C4_Cancer_gene_neighborhoods:C4_CGN_236_GCM_ING1","C4_Cancer_gene_neighborhoods","C4_CGN_236_GCM_ING1",66,1.2321,0.097,0.39,-0.7095,0.95,1,0.8354,0.77,1
"GO_MF:506114_GO_0043024_RIBOSOMAL_SMALL_SUBUNIT_BINDING","GO_MF","506114_GO_0043024_RIBOSOMAL_SMALL_SUBUNIT_BINDING",10,1.2325,0.17,0.81,0.826,0.7,1,0.6259,0.93,1
"GO_BP:496504_GO_0016553_BASE_CONVERSION_OR_SUBSTITUTION_EDITING","GO_BP","496504_GO_0016553_BASE_CONVERSION_OR_SUBSTITUTION_EDITING",7,1.2326,0.21,0.68,0.5069,0.98,1,-1.5778,0.031,0.53
"C3_TF_targets:C3_TFT_15_V_ELK1_02","C3_TF_targets","C3_TFT_15_V_ELK1_02",249,1.2328,0.011,0.22,1.7057,0,0.035,0.7497,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1517_HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY","C2_Chemical_and_genetic_perturbations","C2_CGP_1517_HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY",24,1.2328,0.15,0.74,1.0868,0.31,0.65,-0.6686,0.95,0.99
"REACTOME:771581_REACT_160102_DISEASES_ASSOCIATED_WITH_VISUAL_TRANSDUCTION","REACTOME","771581_REACT_160102_DISEASES_ASSOCIATED_WITH_VISUAL_TRANSDUCTION",9,1.233,0.2,0.5,0.8917,0.6,0.91,-0.9641,0.5,0.89
"GO_BP:512340_GO_0051462_REGULATION_OF_CORTISOL_SECRETION","GO_BP","512340_GO_0051462_REGULATION_OF_CORTISOL_SECRETION",5,1.2331,0.23,0.68,1.3912,0.11,0.57,-0.6885,0.83,0.99
"KEGG_module:HSA_M00414_BLOOM_S_SYNDROME_COMPLEX","KEGG_module","HSA_M00414_BLOOM_S_SYNDROME_COMPLEX",5,1.2332,0.26,0.51,1.3459,0.14,0.34,1.2011,0.29,0.81
"REACTOME:1183614_REACT_355158_TRANSLESION_SYNTHESIS_BY_POLK","REACTOME","1183614_REACT_355158_TRANSLESION_SYNTHESIS_BY_POLK",17,1.2332,0.19,0.5,1.806,0.0021,0.02,-0.6951,0.9,1
"GO_BP:496521_GO_0016573_HISTONE_ACETYLATION","GO_BP","496521_GO_0016573_HISTONE_ACETYLATION",100,1.2334,0.082,0.68,0.6588,1,1,-0.9077,0.67,0.92
"C2_Chemical_and_genetic_perturbations:C2_CGP_686_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30","C2_Chemical_and_genetic_perturbations","C2_CGP_686_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30",5,1.2335,0.25,0.74,1.1074,0.38,0.62,1.205,0.28,0.77
"C2_Chemical_and_genetic_perturbations:C2_CGP_188_OSMAN_BLADDER_CANCER_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_188_OSMAN_BLADDER_CANCER_DN",397,1.2345,0,0.75,2.2289,0,0.00038,0.6036,1,1
"GO_BP:501494_GO_0032259_METHYLATION","GO_BP","501494_GO_0032259_METHYLATION",296,1.2357,0.014,0.67,-0.8729,0.86,1,-0.8868,0.84,0.94
"C7_Immunologic_signatures:C7_ALL_36_GSE10239_MEMORY_VS_DAY4_5_EFF_CD8_TCELL_DN","C7_Immunologic_signatures","C7_ALL_36_GSE10239_MEMORY_VS_DAY4_5_EFF_CD8_TCELL_DN",199,1.236,0.041,0.14,1.9318,0,0,0.6894,1,1
"GO_BP:508947_GO_0046719_REGULATION_BY_VIRUS_OF_VIRAL_PROTEIN_LEVELS_IN_HOST_CELL","GO_BP","508947_GO_0046719_REGULATION_BY_VIRUS_OF_VIRAL_PROTEIN_LEVELS_IN_HOST_CELL",11,1.2364,0.24,0.67,1.5717,0.048,0.33,-0.7594,0.79,1
"REACTOME:105943_REACT_1851_RNA_POLYMERASE_II_TRANSCRIPTION_INITIATION","REACTOME","105943_REACT_1851_RNA_POLYMERASE_II_TRANSCRIPTION_INITIATION",45,1.2368,0.12,0.49,1.6122,0.011,0.088,0.9431,0.56,1
"REACTOME:1127494_REACT_264135_ORGANELLE_BIOGENESIS_AND_MAINTENANCE","REACTOME","1127494_REACT_264135_ORGANELLE_BIOGENESIS_AND_MAINTENANCE",320,1.237,0.029,0.5,1.5215,0,0.14,-1.0264,0.37,0.8
"C1_Positional:C1_ALL_7_CHR13Q13","C1_Positional","C1_ALL_7_CHR13Q13",28,1.2377,0.18,0.57,1.147,0.24,0.63,0.5988,0.98,0.98
"C2_Chemical_and_genetic_perturbations:C2_CGP_1077_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1077_SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN",8,1.2378,0.2,0.75,0.8121,0.7,0.98,-0.7652,0.76,0.97
"GO_BP:508512_GO_0046219_INDOLALKYLAMINE_BIOSYNTHETIC_PROCESS","GO_BP","508512_GO_0046219_INDOLALKYLAMINE_BIOSYNTHETIC_PROCESS",5,1.2386,0.26,0.67,-0.8934,0.58,1,1.2986,0.17,0.68
"GO_MF:499483_GO_0030020_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_TENSILE_STRENGTH","GO_MF","499483_GO_0030020_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_TENSILE_STRENGTH",6,1.2389,0.25,0.79,-1.537,0.058,0.54,-1.2806,0.19,0.6
"C7_Immunologic_signatures:C7_ALL_1208_GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN","C7_Immunologic_signatures","C7_ALL_1208_GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN",193,1.239,0.055,0.13,1.4242,0.0047,0.031,-0.938,0.62,0.88
"REACTOME:105942_REACT_834_RNA_POLYMERASE_II_TRANSCRIPTION_INITIATION_AND_PROMOTER_CLEARANCE","REACTOME","105942_REACT_834_RNA_POLYMERASE_II_TRANSCRIPTION_INITIATION_AND_PROMOTER_CLEARANCE",45,1.2391,0.097,0.5,1.603,0.0043,0.092,0.9507,0.52,1
"GO_MF:505328_GO_0042166_ACETYLCHOLINE_BINDING","GO_MF","505328_GO_0042166_ACETYLCHOLINE_BINDING",12,1.2391,0.2,0.8,-1.8351,0,0.12,1.1829,0.25,0.75
"GO_BP:516301_GO_0071377_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS","GO_BP","516301_GO_0071377_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS",37,1.2397,0.14,0.67,1.1123,0.27,0.89,-0.8138,0.79,0.98
"KEGG_enzyme:2.7.7.6_DNA_DIRECTED_RNA_POLYMERASE_RNA_POLYMERASE_RNA_NUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_RNA_POLYMERASE_I_RNA_POLYMERASE_II_RNA_POLYMERASE_III_C_RNA_FORMATION_FACTORS_DEOXYRIBONUCLEIC_ACID_DEPENDENT_RIBONUCLEIC_ACID_POLYMERASE_DNA_DEPENDENT_RIBONUCLEATE_NUCLEOTIDYLTRANSFERASE_DNA_DEPENDENT_RNA_NUCLEOTIDYLTRANSFERASE_DNA_DEPENDENT_RNA_POLYMERASE_RIBONUCLEATE_NUCLEOTIDYLTRANSFERASE_RIBONUCLEATE_POLYMERASE_C_RIBONUCLEIC_ACID_FORMATION_FACTORS_RIBONUCLEIC_ACID_NUCLEOTIDYLTRANSFERASE_RIBONUCLEIC_ACID_POLYMERASE_RIBONUCLEIC_ACID_TRANSCRIPTASE_RIBONUCLEIC_POLYMERASE_RIBONUCLEIC_TRANSCRIPTASE_RNA_NUCLEOTIDYLTRANSFERASE_RNA_TRANSCRIPTASE_TRANSCRIPTASE_RNA_NUCLEOTIDYLTRANSFERASE_I","KEGG_enzyme","2.7.7.6_DNA_DIRECTED_RNA_POLYMERASE_RNA_POLYMERASE_RNA_NUCLEOTIDYLTRANSFERASE_DNA_DIRECTED_RNA_POLYMERASE_I_RNA_POLYMERASE_II_RNA_POLYMERASE_III_C_RNA_FORMATION_FACTORS_DEOXYRIBONUCLEIC_ACID_DEPENDENT_RIBONUCLEIC_ACID_POLYMERASE_DNA_DEPENDENT_RIBONUCLEATE_NUCLEOTIDYLTRANSFERASE_DNA_DEPENDENT_RNA_NUCLEOTIDYLTRANSFERASE_DNA_DEPENDENT_RNA_POLYMERASE_RIBONUCLEATE_NUCLEOTIDYLTRANSFERASE_RIBONUCLEATE_POLYMERASE_C_RIBONUCLEIC_ACID_FORMATION_FACTORS_RIBONUCLEIC_ACID_NUCLEOTIDYLTRANSFERASE_RIBONUCLEIC_ACID_POLYMERASE_RIBONUCLEIC_ACID_TRANSCRIPTASE_RIBONUCLEIC_POLYMERASE_RIBONUCLEIC_TRANSCRIPTASE_RNA_NUCLEOTIDYLTRANSFERASE_RNA_TRANSCRIPTASE_TRANSCRIPTASE_RNA_NUCLEOTIDYLTRANSFERASE_I",7,1.2398,0.23,0.55,-0.8921,0.6,0.85,-0.7122,0.83,1
"C1_Positional:C1_ALL_59_CHR14Q21","C1_Positional","C1_ALL_59_CHR14Q21",40,1.2402,0.13,0.59,1.2268,0.16,0.59,1.1696,0.22,0.67
"GO_BP:508217_GO_0045910_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION","GO_BP","508217_GO_0045910_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION",15,1.2404,0.18,0.67,-0.7088,0.86,1,-0.9076,0.6,0.92
"GO_BP:515010_GO_0070071_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_ASSEMBLY","GO_BP","515010_GO_0070071_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_ASSEMBLY",9,1.2404,0.19,0.67,0.5893,0.95,1,1.2344,0.21,0.7
"REACTOME:106543_REACT_7961_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS","REACTOME","106543_REACT_7961_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS",23,1.2406,0.18,0.5,1.4696,0.038,0.17,-1.1495,0.26,0.66
"WikiPathways:198917_WP405_EUKARYOTIC_TRANSCRIPTION_INITIATION","WikiPathways","198917_WP405_EUKARYOTIC_TRANSCRIPTION_INITIATION",41,1.2414,0.13,0.41,1.2452,0.13,0.81,0.5985,1,1
"REACTOME:105941_REACT_1655_RNA_POLYMERASE_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING","REACTOME","105941_REACT_1655_RNA_POLYMERASE_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING",45,1.242,0.14,0.5,1.6113,0.01,0.088,0.9379,0.55,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_210_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_210_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN",11,1.2422,0.2,0.75,1.3734,0.1,0.32,1.4374,0.082,0.54
"GO_CC:490686_GO_0005614_INTERSTITIAL_MATRIX","GO_CC","490686_GO_0005614_INTERSTITIAL_MATRIX",15,1.2427,0.17,0.5,0.8731,0.63,0.91,1.9949,0,0.052
"KEGG_module:HSA_M00296_BER_COMPLEX","KEGG_module","HSA_M00296_BER_COMPLEX",10,1.2428,0.2,0.52,1.2605,0.19,0.44,0.868,0.63,1
"GO_BP:489249_GO_0006360_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER","GO_BP","489249_GO_0006360_TRANSCRIPTION_FROM_RNA_POLYMERASE_I_PROMOTER",37,1.2435,0.17,0.66,1.297,0.097,0.67,0.7308,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2386_LU_TUMOR_ENDOTHELIAL_MARKERS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2386_LU_TUMOR_ENDOTHELIAL_MARKERS_DN",5,1.2444,0.23,0.75,-1.0404,0.44,0.97,1.4567,0.061,0.53
"REACTOME:105998_REACT_6332_HIV_TRANSCRIPTION_INITIATION","REACTOME","105998_REACT_6332_HIV_TRANSCRIPTION_INITIATION",45,1.245,0.12,0.49,1.6077,0.0022,0.089,0.9483,0.53,1
"GO_CC:490727_GO_0005671_ADA2_GCN5_ADA3_TRANSCRIPTION_ACTIVATOR_COMPLEX","GO_CC","490727_GO_0005671_ADA2_GCN5_ADA3_TRANSCRIPTION_ACTIVATOR_COMPLEX",16,1.246,0.18,0.5,0.983,0.44,0.81,-0.6793,0.91,1
"GO_BP:506984_GO_0043966_HISTONE_H3_ACETYLATION","GO_BP","506984_GO_0043966_HISTONE_H3_ACETYLATION",48,1.246,0.095,0.66,0.6505,0.98,1,-1.0152,0.4,0.84
"GO_BP:491228_GO_0006264_MITOCHONDRIAL_DNA_REPLICATION","GO_BP","491228_GO_0006264_MITOCHONDRIAL_DNA_REPLICATION",12,1.2466,0.18,0.66,1.0061,0.44,0.98,-0.7371,0.82,1
"GO_CC:500765_GO_0031514_MOTILE_CILIUM","GO_CC","500765_GO_0031514_MOTILE_CILIUM",90,1.2471,0.064,0.5,-1.3806,0.029,0.63,-0.9536,0.54,1
"GO_BP:510902_GO_0048852_DIENCEPHALON_MORPHOGENESIS","GO_BP","510902_GO_0048852_DIENCEPHALON_MORPHOGENESIS",6,1.2473,0.23,0.66,1.312,0.21,0.66,1.528,0.04,0.53
"KEGG_module:HSA_M00395_DECAPPING_COMPLEX","KEGG_module","HSA_M00395_DECAPPING_COMPLEX",6,1.2477,0.2,0.54,1.2046,0.25,0.53,0.6214,0.89,1
"GO_CC:505759_GO_0042645_MITOCHONDRIAL_NUCLEOID","GO_CC","505759_GO_0042645_MITOCHONDRIAL_NUCLEOID",41,1.2477,0.12,0.5,1.4607,0.028,0.24,0.8142,0.78,1
"GO_CC:490829_GO_0030134_ER_TO_GOLGI_TRANSPORT_VESICLE","GO_CC","490829_GO_0030134_ER_TO_GOLGI_TRANSPORT_VESICLE",51,1.2482,0.11,0.51,1.4275,0.05,0.27,0.7109,0.95,1
"GO_BP:516288_GO_0071364_CELLULAR_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR_STIMULUS","GO_BP","516288_GO_0071364_CELLULAR_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR_STIMULUS",22,1.2486,0.16,0.66,0.9661,0.52,1,-1.1415,0.27,0.75
"C4_Cancer_gene_neighborhoods:C4_CGN_58_MORF_ACTG1","C4_Cancer_gene_neighborhoods","C4_CGN_58_MORF_ACTG1",138,1.2493,0.078,0.36,3.6144,0,0,-0.8798,0.78,1
"GO_MF:487326_GO_0001103_RNA_POLYMERASE_II_REPRESSING_TRANSCRIPTION_FACTOR_BINDING","GO_MF","487326_GO_0001103_RNA_POLYMERASE_II_REPRESSING_TRANSCRIPTION_FACTOR_BINDING",27,1.2496,0.14,0.78,0.905,0.64,0.98,0.8216,0.74,1
"REACTOME:105999_REACT_6253_RNA_POLYMERASE_II_HIV_PROMOTER_ESCAPE","REACTOME","105999_REACT_6253_RNA_POLYMERASE_II_HIV_PROMOTER_ESCAPE",45,1.2496,0.13,0.49,1.6013,0.016,0.093,0.9402,0.57,1
"GO_BP:515953_GO_0071027_NUCLEAR_RNA_SURVEILLANCE","GO_BP","515953_GO_0071027_NUCLEAR_RNA_SURVEILLANCE",7,1.2496,0.19,0.66,1.1732,0.25,0.81,0.7569,0.77,1
"GO_BP:501335_GO_0032098_REGULATION_OF_APPETITE","GO_BP","501335_GO_0032098_REGULATION_OF_APPETITE",21,1.25,0.17,0.66,-1.3737,0.079,0.99,-1.1441,0.28,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_1273_SHIPP_DLBCL_CURED_VS_FATAL_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1273_SHIPP_DLBCL_CURED_VS_FATAL_DN",43,1.252,0.12,0.73,1.5312,0.017,0.18,0.8518,0.73,1
"GO_MF:490145_GO_0004843_UBIQUITIN_SPECIFIC_PROTEASE_ACTIVITY","GO_MF","490145_GO_0004843_UBIQUITIN_SPECIFIC_PROTEASE_ACTIVITY",77,1.2521,0.073,0.78,1.0392,0.36,0.83,-0.6205,1,1
"GO_BP:514475_GO_0060920_CARDIAC_PACEMAKER_CELL_DIFFERENTIATION","GO_BP","514475_GO_0060920_CARDIAC_PACEMAKER_CELL_DIFFERENTIATION",6,1.2522,0.2,0.65,-0.6944,0.82,1,-1.2594,0.22,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_654_SUZUKI_AMPLIFIED_IN_ORAL_CANCER","C2_Chemical_and_genetic_perturbations","C2_CGP_654_SUZUKI_AMPLIFIED_IN_ORAL_CANCER",14,1.2525,0.16,0.74,-1.1452,0.29,0.85,-0.9688,0.51,0.8
"C7_Immunologic_signatures:C7_ALL_943_GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP","C7_Immunologic_signatures","C7_ALL_943_GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP",193,1.2526,0.043,0.11,-0.67,1,1,1.1288,0.17,0.92
"C1_Positional:C1_ALL_263_CHR20Q13","C1_Positional","C1_ALL_263_CHR20Q13",179,1.2528,0.048,0.58,0.9014,0.76,0.85,0.9288,0.67,0.82
"C6_Oncogenic_signatures:C6_ALL_7_ERB2_UP_V1_DN","C6_Oncogenic_signatures","C6_ALL_7_ERB2_UP_V1_DN",196,1.2531,0.043,0.27,1.5533,0,0.081,-0.858,0.87,0.89
"GO_BP:496527_GO_0016579_PROTEIN_DEUBIQUITINATION","GO_BP","496527_GO_0016579_PROTEIN_DEUBIQUITINATION",86,1.2533,0.083,0.65,0.9628,0.54,1,-0.8094,0.89,0.98
"C3_TF_targets:C3_TFT_150_CAGNWMCNNNGAC_UNKNOWN","C3_TF_targets","C3_TFT_150_CAGNWMCNNNGAC_UNKNOWN",81,1.2535,0.09,0.22,1.253,0.095,0.55,0.9749,0.5,1
"REACTOME:105793_REACT_312_LAGGING_STRAND_SYNTHESIS","REACTOME","105793_REACT_312_LAGGING_STRAND_SYNTHESIS",21,1.2537,0.16,0.48,1.6366,0.014,0.076,-1.0762,0.34,0.73
"GO_CC:500770_GO_0031519_PCG_PROTEIN_COMPLEX","GO_CC","500770_GO_0031519_PCG_PROTEIN_COMPLEX",44,1.2538,0.13,0.5,0.6417,0.97,1,0.5962,0.99,1
"GO_BP:518612_GO_0097062_DENDRITIC_SPINE_MAINTENANCE","GO_BP","518612_GO_0097062_DENDRITIC_SPINE_MAINTENANCE",7,1.254,0.21,0.65,0.8014,0.71,1,1.2274,0.21,0.71
"GO_BP:491269_GO_0006310_DNA_RECOMBINATION","GO_BP","491269_GO_0006310_DNA_RECOMBINATION",201,1.2542,0.027,0.65,1.2497,0.046,0.73,-0.8893,0.8,0.93
"GO_BP:486886_GO_0000389_MRNA_3_SPLICE_SITE_RECOGNITION","GO_BP","486886_GO_0000389_MRNA_3_SPLICE_SITE_RECOGNITION",5,1.2542,0.23,0.66,1.4347,0.08,0.51,1.2197,0.27,0.71
"GO_BP:516904_GO_0071985_MULTIVESICULAR_BODY_SORTING_PATHWAY","GO_BP","516904_GO_0071985_MULTIVESICULAR_BODY_SORTING_PATHWAY",7,1.2543,0.2,0.66,1.5416,0.04,0.36,-1.2427,0.24,0.69
"OMIM_gene:OMIM604311_MEDIATOR_COMPLEX_SUBUNIT_1_MED1","OMIM_gene","OMIM604311_MEDIATOR_COMPLEX_SUBUNIT_1_MED1",6,1.2544,0.23,1,1.3371,0.16,0.91,0.538,0.97,1
"GO_BP:491320_GO_0006398_HISTONE_MRNA_3_END_PROCESSING","GO_BP","491320_GO_0006398_HISTONE_MRNA_3_END_PROCESSING",5,1.2549,0.24,0.66,1.1935,0.28,0.79,0.8503,0.65,0.98
"C7_Immunologic_signatures:C7_ALL_1349_GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1349_GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP",200,1.2553,0.016,0.11,1.718,0,0.00045,1.0278,0.36,1
"GO_BP:505575_GO_0042435_INDOLE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS","GO_BP","505575_GO_0042435_INDOLE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS",5,1.2556,0.21,0.66,-0.8838,0.61,1,1.3051,0.19,0.67
"KEGG_compound:C01272_1D_MYO_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_D_MYO_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE","KEGG_compound","C01272_1D_MYO_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_D_MYO_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE",8,1.2556,0.19,1,0.7874,0.73,1,1.4816,0.082,0.19
"GO_BP:1129636_GO_1990564_PROTEIN_POLYUFMYLATION","GO_BP","1129636_GO_1990564_PROTEIN_POLYUFMYLATION",5,1.2561,0.23,0.66,1.4394,0.081,0.51,0.8258,0.67,1
"GO_BP:491244_GO_0006281_DNA_REPAIR","GO_BP","491244_GO_0006281_DNA_REPAIR",416,1.2566,0.029,0.66,1.3758,0,0.58,-1.014,0.4,0.84
"GO_BP:487028_GO_0000731_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR","GO_BP","487028_GO_0000731_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR",13,1.2568,0.17,0.66,-1.0235,0.43,0.97,-1.0672,0.37,0.8
"GO_CC:486937_GO_0000444_MIS12_MIND_TYPE_COMPLEX","GO_CC","486937_GO_0000444_MIS12_MIND_TYPE_COMPLEX",5,1.2568,0.24,0.5,1.2132,0.24,0.51,0.6274,0.89,1
"GO_BP:849938_GO_1902237_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","849938_GO_1902237_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY",8,1.257,0.19,0.66,1.0699,0.38,0.93,-0.8766,0.62,0.94
"C2_Chemical_and_genetic_perturbations:C2_CGP_3246_MADAN_DPPA4_TARGETS","C2_Chemical_and_genetic_perturbations","C2_CGP_3246_MADAN_DPPA4_TARGETS",44,1.2573,0.13,0.74,0.9269,0.57,0.89,0.9791,0.47,0.97
"C1_Positional:C1_ALL_180_CHR15Q25","C1_Positional","C1_ALL_180_CHR15Q25",56,1.258,0.11,0.6,0.9104,0.63,0.84,1.5058,0.018,0.29
"C4_Cancer_gene_neighborhoods:C4_CGN_209_GCM_APEX1","C4_Cancer_gene_neighborhoods","C4_CGN_209_GCM_APEX1",114,1.2584,0.072,0.34,2.8081,0,0,-0.5318,1,1
"C7_Immunologic_signatures:C7_ALL_1055_GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP","C7_Immunologic_signatures","C7_ALL_1055_GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP",199,1.2586,0,0.11,1.2721,0.049,0.13,-1.0254,0.35,0.67
"OMIM_gene:OMIM300017_FILAMIN_A_FLNA","OMIM_gene","OMIM300017_FILAMIN_A_FLNA",5,1.2586,0.24,1,0.8574,0.64,1,-1.2747,0.19,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3024_RAGHAVACHARI_PLATELET_SPECIFIC_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_3024_RAGHAVACHARI_PLATELET_SPECIFIC_GENES",70,1.2589,0.094,0.75,2.3499,0,7.1e-05,-1.2887,0.071,0.44
"GO_CC:911394_GO_0098536_DEUTEROSOME","GO_CC","911394_GO_0098536_DEUTEROSOME",5,1.2594,0.21,0.5,-0.7666,0.74,1,-1.1222,0.33,0.91
"GO_BP:518225_GO_0090085_REGULATION_OF_PROTEIN_DEUBIQUITINATION","GO_BP","518225_GO_0090085_REGULATION_OF_PROTEIN_DEUBIQUITINATION",6,1.26,0.24,0.66,1.3911,0.11,0.57,1.0353,0.42,0.82
"GO_MF:492490_GO_0008135_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING","GO_MF","492490_GO_0008135_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING",84,1.2602,0.076,0.77,2.3083,0,0.00015,0.7244,0.97,1
"GO_BP:488876_GO_0035815_POSITIVE_REGULATION_OF_RENAL_SODIUM_EXCRETION","GO_BP","488876_GO_0035815_POSITIVE_REGULATION_OF_RENAL_SODIUM_EXCRETION",13,1.2605,0.16,0.66,1.8396,0.0042,0.069,1.3762,0.097,0.64
"C7_Immunologic_signatures:C7_ALL_250_GSE14308_TH2_VS_INDUCED_TREG_DN","C7_Immunologic_signatures","C7_ALL_250_GSE14308_TH2_VS_INDUCED_TREG_DN",199,1.2606,0.017,0.11,1.2235,0.057,0.19,-0.6619,1,1
"C7_Immunologic_signatures:C7_ALL_942_GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN","C7_Immunologic_signatures","C7_ALL_942_GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN",191,1.261,0.023,0.11,0.6305,1,1,-0.9606,0.59,0.82
"C2_Chemical_and_genetic_perturbations:C2_CGP_1589_NOUZOVA_TRETINOIN_AND_H4_ACETYLATION","C2_Chemical_and_genetic_perturbations","C2_CGP_1589_NOUZOVA_TRETINOIN_AND_H4_ACETYLATION",143,1.2613,0.037,0.75,1.7544,0,0.058,1.4243,0.012,0.55
"GO_BP:501436_GO_0032201_TELOMERE_MAINTENANCE_VIA_SEMI_CONSERVATIVE_REPLICATION","GO_BP","501436_GO_0032201_TELOMERE_MAINTENANCE_VIA_SEMI_CONSERVATIVE_REPLICATION",23,1.2616,0.14,0.66,1.4568,0.044,0.48,-1.1727,0.24,0.74
"KEGG_enzyme:2.3.1.88_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_BETA_ENDORPHIN_ACETYLTRANSFERASE_PEPTIDE_ACETYLTRANSFERASE_PROTEIN_N_TERMINAL_ACETYLTRANSFERASE_NAT_NALPHA_ACETYLTRANSFERASE_AMINO_TERMINAL_AMINO_ACID_ACETYLATING_ENZYME_ACETYL_COA_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE","KEGG_enzyme","2.3.1.88_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_BETA_ENDORPHIN_ACETYLTRANSFERASE_PEPTIDE_ACETYLTRANSFERASE_PROTEIN_N_TERMINAL_ACETYLTRANSFERASE_NAT_NALPHA_ACETYLTRANSFERASE_AMINO_TERMINAL_AMINO_ACID_ACETYLATING_ENZYME_ACETYL_COA_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE",5,1.2621,0.21,0.61,0.8098,0.68,1,1.2427,0.22,0.63
"GO_CC:500227_GO_0030934_ANCHORING_COLLAGEN_COMPLEX","GO_CC","500227_GO_0030934_ANCHORING_COLLAGEN_COMPLEX",6,1.2631,0.19,0.49,-1.1588,0.29,0.68,0.7686,0.74,1
"GO_BP:496314_GO_0016254_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE","GO_BP","496314_GO_0016254_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE",16,1.2633,0.14,0.66,1.117,0.32,0.88,0.8435,0.72,0.99
"REACTOME:106345_REACT_9483_FGFR1_LIGAND_BINDING_AND_ACTIVATION","REACTOME","106345_REACT_9483_FGFR1_LIGAND_BINDING_AND_ACTIVATION",11,1.2636,0.16,0.46,-0.6086,0.94,1,0.9638,0.49,1
"GO_BP:486624_GO_0000084_MITOTIC_S_PHASE","GO_BP","486624_GO_0000084_MITOTIC_S_PHASE",117,1.2636,0.026,0.66,2.1236,0,0.0025,-1.1363,0.17,0.75
"REACTOME:1183521_REACT_355533_SIGNALING_BY_FGFR2_IN_DISEASE","REACTOME","1183521_REACT_355533_SIGNALING_BY_FGFR2_IN_DISEASE",21,1.2639,0.14,0.47,-0.9038,0.59,1,0.9857,0.48,1
"C7_Immunologic_signatures:C7_ALL_859_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP","C7_Immunologic_signatures","C7_ALL_859_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP",198,1.2645,0.034,0.11,1.4365,0.0048,0.026,0.9181,0.68,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3046_KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3046_KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN",32,1.2647,0.14,0.75,-1.0756,0.34,0.95,1.3982,0.06,0.54
"REACTOME:106005_REACT_6261_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT","REACTOME","106005_REACT_6261_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT",23,1.266,0.16,0.46,1.4392,0.062,0.19,0.9593,0.49,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1193_KAUFFMANN_DNA_REPAIR_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_1193_KAUFFMANN_DNA_REPAIR_GENES",228,1.2663,0.01,0.76,1.2037,0.063,0.48,-1.0089,0.43,0.74
"GO_BP:515954_GO_0071028_NUCLEAR_MRNA_SURVEILLANCE","GO_BP","515954_GO_0071028_NUCLEAR_MRNA_SURVEILLANCE",7,1.2668,0.21,0.65,1.1555,0.28,0.83,0.7625,0.77,1
"GO_BP:751044_GO_0036124_HISTONE_H3_K9_TRIMETHYLATION","GO_BP","751044_GO_0036124_HISTONE_H3_K9_TRIMETHYLATION",5,1.2671,0.22,0.65,-0.5869,0.91,1,-0.7811,0.74,1
"GO_BP:497328_GO_0018393_INTERNAL_PEPTIDYL_LYSINE_ACETYLATION","GO_BP","497328_GO_0018393_INTERNAL_PEPTIDYL_LYSINE_ACETYLATION",105,1.2675,0.071,0.65,0.5693,1,1,-0.8957,0.7,0.93
"GO_MF:490445_GO_0005184_NEUROPEPTIDE_HORMONE_ACTIVITY","GO_MF","490445_GO_0005184_NEUROPEPTIDE_HORMONE_ACTIVITY",23,1.2681,0.17,0.75,-1.7456,0.011,0.24,1.2996,0.12,0.65
"GO_BP:488992_GO_0003198_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION","GO_BP","488992_GO_0003198_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION",9,1.2685,0.2,0.65,0.7236,0.84,1,0.7879,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_562_MOTAMED_RESPONSE_TO_ANDROGEN_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_562_MOTAMED_RESPONSE_TO_ANDROGEN_UP",5,1.2688,0.22,0.76,0.8701,0.61,0.96,-0.6866,0.83,0.99
"REACTOME:160987_REACT_15439_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS","REACTOME","160987_REACT_15439_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS",5,1.269,0.22,0.46,-0.9078,0.57,1,1.3249,0.16,0.75
"GO_BP:501294_GO_0032057_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS","GO_BP","501294_GO_0032057_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS",5,1.269,0.21,0.65,0.8216,0.68,1,-0.6723,0.88,1
"GO_BP:512322_GO_0051444_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY","GO_BP","512322_GO_0051444_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY",74,1.2693,0.081,0.65,2.2382,0,0.00039,0.6419,0.99,1
"GO_BP:502358_GO_0033137_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION","GO_BP","502358_GO_0033137_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION",20,1.2693,0.15,0.66,1.3787,0.087,0.58,1.116,0.27,0.75
"GO_BP:499123_GO_0021843_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_INTERNEURON_MIGRATION","GO_BP","499123_GO_0021843_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_INTERNEURON_MIGRATION",9,1.2694,0.19,0.66,-1.8679,0.0039,0.41,0.813,0.68,1
"GO_BP:491487_GO_0006591_ORNITHINE_METABOLIC_PROCESS","GO_BP","491487_GO_0006591_ORNITHINE_METABOLIC_PROCESS",6,1.2699,0.19,0.66,0.9442,0.54,1,0.7709,0.72,1
"C1_Positional:C1_ALL_133_CHR3Q22","C1_Positional","C1_ALL_133_CHR3Q22",40,1.2714,0.094,0.59,0.8833,0.68,0.89,1.4961,0.035,0.29
"REACTOME:645283_REACT_121249_FGFR3_MUTANT_RECEPTOR_ACTIVATION","REACTOME","645283_REACT_121249_FGFR3_MUTANT_RECEPTOR_ACTIVATION",10,1.2728,0.19,0.46,-1.3874,0.091,0.54,0.6856,0.86,1
"GO_BP:753255_GO_1900271_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION","GO_BP","753255_GO_1900271_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION",5,1.2733,0.22,0.65,0.8382,0.67,1,0.7648,0.76,1
"KEGG_pathway:HSA03440_HOMOLOGOUS_RECOMBINATION","KEGG_pathway","HSA03440_HOMOLOGOUS_RECOMBINATION",28,1.2734,0.14,0.2,1.1812,0.22,0.58,0.7259,0.88,1
"GO_BP:754932_GO_2000826_REGULATION_OF_HEART_MORPHOGENESIS","GO_BP","754932_GO_2000826_REGULATION_OF_HEART_MORPHOGENESIS",24,1.2735,0.14,0.65,0.6964,0.91,1,1.3557,0.096,0.64
"C7_Immunologic_signatures:C7_ALL_1345_GSE31082_DN_VS_DP_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1345_GSE31082_DN_VS_DP_THYMOCYTE_UP",200,1.2735,0.0089,0.097,2.044,0,0,-0.7197,1,1
"GO_BP:496526_GO_0016578_HISTONE_DEUBIQUITINATION","GO_BP","496526_GO_0016578_HISTONE_DEUBIQUITINATION",20,1.274,0.13,0.65,-0.6925,0.91,1,-0.7773,0.78,1
"REACTOME:161060_REACT_20653_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12","REACTOME","161060_REACT_20653_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12",21,1.2753,0.14,0.46,0.8927,0.61,0.91,0.6342,0.96,1
"GO_BP:512017_GO_0051103_DNA_LIGATION_INVOLVED_IN_DNA_REPAIR","GO_BP","512017_GO_0051103_DNA_LIGATION_INVOLVED_IN_DNA_REPAIR",7,1.2754,0.2,0.65,1.0925,0.35,0.91,-0.8554,0.62,0.96
"REACTOME:105983_REACT_6185_HIV_INFECTION","REACTOME","105983_REACT_6185_HIV_INFECTION",221,1.2763,0.0099,0.46,2.286,0,3.8e-05,0.794,0.96,1
"GO_BP:501336_GO_0032099_NEGATIVE_REGULATION_OF_APPETITE","GO_BP","501336_GO_0032099_NEGATIVE_REGULATION_OF_APPETITE",11,1.2767,0.19,0.65,-0.7393,0.8,1,-0.8498,0.7,0.96
"GO_BP:499902_GO_0030581_SYMBIONT_INTRACELLULAR_PROTEIN_TRANSPORT_IN_HOST","GO_BP","499902_GO_0030581_SYMBIONT_INTRACELLULAR_PROTEIN_TRANSPORT_IN_HOST",5,1.2767,0.21,0.65,1.5622,0.028,0.34,0.7166,0.82,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3004_ONGUSAHA_BRCA1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3004_ONGUSAHA_BRCA1_TARGETS_DN",13,1.2771,0.15,0.74,1.6124,0.03,0.13,1.5126,0.046,0.48
"GO_BP:497937_GO_0019058_VIRAL_LIFE_CYCLE","GO_BP","497937_GO_0019058_VIRAL_LIFE_CYCLE",243,1.2772,0,0.65,3.0604,0,0,0.8496,0.9,0.98
"REACTOME:105957_REACT_1849_MRNA_3_END_PROCESSING","REACTOME","105957_REACT_1849_MRNA_3_END_PROCESSING",34,1.2786,0.12,0.45,0.7654,0.84,1,0.8238,0.77,1
"GO_BP:511851_GO_0050916_SENSORY_PERCEPTION_OF_SWEET_TASTE","GO_BP","511851_GO_0050916_SENSORY_PERCEPTION_OF_SWEET_TASTE",6,1.2795,0.23,0.65,-0.9418,0.53,1,0.7031,0.81,1
"C7_Immunologic_signatures:C7_ALL_1662_GSE3982_NEUTROPHIL_VS_BCELL_DN","C7_Immunologic_signatures","C7_ALL_1662_GSE3982_NEUTROPHIL_VS_BCELL_DN",198,1.2796,0.032,0.092,1.67,0,0.00096,-1.3356,0.012,0.11
"GO_BP:502973_GO_0033762_RESPONSE_TO_GLUCAGON","GO_BP","502973_GO_0033762_RESPONSE_TO_GLUCAGON",48,1.28,0.064,0.65,1.0794,0.3,0.93,-0.7107,0.94,0.99
"GO_BP:753102_GO_1900107_REGULATION_OF_NODAL_SIGNALING_PATHWAY","GO_BP","753102_GO_1900107_REGULATION_OF_NODAL_SIGNALING_PATHWAY",6,1.2818,0.18,0.65,-1.1848,0.27,0.9,-1.5147,0.067,0.53
"GO_BP:503584_GO_0034382_CHYLOMICRON_REMNANT_CLEARANCE","GO_BP","503584_GO_0034382_CHYLOMICRON_REMNANT_CLEARANCE",6,1.2826,0.21,0.65,0.7452,0.77,1,1.0782,0.35,0.78
"GO_MF:489247_GO_0003697_SINGLE_STRANDED_DNA_BINDING","GO_MF","489247_GO_0003697_SINGLE_STRANDED_DNA_BINDING",79,1.2826,0.067,0.72,1.7505,0,0.11,0.7447,0.95,1
"GO_BP:492854_GO_0008595_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION_EMBRYO","GO_BP","492854_GO_0008595_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION_EMBRYO",14,1.2834,0.16,0.65,-0.8394,0.68,1,0.7747,0.76,1
"OMIM_gene:OMIM604591_PHOSPHATIDYLETHANOLAMINE_BINDING_PROTEIN_1_PEBP1","OMIM_gene","OMIM604591_PHOSPHATIDYLETHANOLAMINE_BINDING_PROTEIN_1_PEBP1",5,1.2841,0.2,1,1.4183,0.087,0.99,0.5297,0.98,1
"GO_BP:491375_GO_0006473_PROTEIN_ACETYLATION","GO_BP","491375_GO_0006473_PROTEIN_ACETYLATION",124,1.2841,0.037,0.65,0.6962,1,1,-0.7157,0.99,0.99
"GO_MF:925868_GO_0036459_UBIQUITINYL_HYDROLASE_ACTIVITY","GO_MF","925868_GO_0036459_UBIQUITINYL_HYDROLASE_ACTIVITY",83,1.2843,0.059,0.72,1.0784,0.3,0.82,0.6678,0.99,1
"GO_BP:506986_GO_0043968_HISTONE_H2A_ACETYLATION","GO_BP","506986_GO_0043968_HISTONE_H2A_ACETYLATION",12,1.2843,0.15,0.65,1.0474,0.38,0.95,-0.5875,0.95,1
"C3_TF_targets:C3_TFT_311_V_PPARG_01","C3_TF_targets","C3_TFT_311_V_PPARG_01",43,1.2848,0.1,0.21,1.2259,0.16,0.67,0.9065,0.62,1
"REACTOME:106542_REACT_7974_TELOMERE_EXTENSION_BY_TELOMERASE","REACTOME","106542_REACT_7974_TELOMERE_EXTENSION_BY_TELOMERASE",6,1.2855,0.18,0.44,1.2649,0.21,0.37,-0.6874,0.86,1
"KEGG_compound:C00055_CMP_CYTIDINE_5_MONOPHOSPHATE_CYTIDYLIC_ACID","KEGG_compound","C00055_CMP_CYTIDINE_5_MONOPHOSPHATE_CYTIDYLIC_ACID",24,1.2863,0.12,1,1.4915,0.034,0.33,-0.8555,0.69,0.8
"REACTOME:576261_REACT_118595_MITOCHONDRIAL_PROTEIN_IMPORT","REACTOME","576261_REACT_118595_MITOCHONDRIAL_PROTEIN_IMPORT",54,1.2867,0.097,0.44,2.0897,0,7e-04,0.4392,1,1
"C7_Immunologic_signatures:C7_ALL_973_GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_973_GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP",200,1.2872,0.0083,0.086,2.5077,0,0,-0.777,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_666_NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS","C2_Chemical_and_genetic_perturbations","C2_CGP_666_NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS",13,1.2873,0.18,0.72,-1.035,0.41,0.97,-1.1796,0.24,0.54
"C2_Chemical_and_genetic_perturbations:C2_CGP_1035_CAFFAREL_RESPONSE_TO_THC_8HR_3_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1035_CAFFAREL_RESPONSE_TO_THC_8HR_3_DN",10,1.2873,0.17,0.73,1.0487,0.39,0.72,-1.054,0.39,0.68
"C2_Chemical_and_genetic_perturbations:C2_CGP_3386_ZWANG_DOWN_BY_2ND_EGF_PULSE","C2_Chemical_and_genetic_perturbations","C2_CGP_3386_ZWANG_DOWN_BY_2ND_EGF_PULSE",273,1.2881,0,0.74,-1.0914,0.23,0.93,0.9352,0.7,1
"C4_Cancer_gene_neighborhoods:C4_CGN_335_GNF2_CDC27","C4_Cancer_gene_neighborhoods","C4_CGN_335_GNF2_CDC27",60,1.2883,0.086,0.28,2.0835,0,0.00014,-1.2236,0.13,0.41
"GO_BP:491918_GO_0007099_CENTRIOLE_REPLICATION","GO_BP","491918_GO_0007099_CENTRIOLE_REPLICATION",11,1.2885,0.18,0.64,-0.8108,0.72,1,-0.853,0.64,0.96
"GO_BP:489263_GO_0006386_TERMINATION_OF_RNA_POLYMERASE_III_TRANSCRIPTION","GO_BP","489263_GO_0006386_TERMINATION_OF_RNA_POLYMERASE_III_TRANSCRIPTION",18,1.2891,0.16,0.64,0.8528,0.68,1,-0.474,0.99,1
"REACTOME:106352_REACT_9439_FGFR3_LIGAND_BINDING_AND_ACTIVATION","REACTOME","106352_REACT_9439_FGFR3_LIGAND_BINDING_AND_ACTIVATION",10,1.2897,0.16,0.44,-1.3744,0.12,0.57,0.6769,0.88,1
"GO_BP:512090_GO_0051182_COENZYME_TRANSPORT","GO_BP","512090_GO_0051182_COENZYME_TRANSPORT",5,1.2897,0.21,0.64,0.7566,0.75,1,-1.0287,0.44,0.82
"C1_Positional:C1_ALL_126_CHR7Q33","C1_Positional","C1_ALL_126_CHR7Q33",18,1.2903,0.14,0.57,0.8385,0.7,0.92,1.2206,0.19,0.61
"GO_BP:491842_GO_0007007_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION","GO_BP","491842_GO_0007007_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION",11,1.291,0.19,0.64,1.1391,0.3,0.85,-0.6741,0.9,1
"GO_BP:501333_GO_0032096_NEGATIVE_REGULATION_OF_RESPONSE_TO_FOOD","GO_BP","501333_GO_0032096_NEGATIVE_REGULATION_OF_RESPONSE_TO_FOOD",12,1.2917,0.16,0.64,-0.7667,0.75,1,-0.8801,0.62,0.94
"C4_Cancer_gene_neighborhoods:C4_CGN_388_GNF2_NS","C4_Cancer_gene_neighborhoods","C4_CGN_388_GNF2_NS",40,1.2918,0.093,0.28,2.3664,0,0,-0.5869,1,1
"GO_BP:502015_GO_0032792_NEGATIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY","GO_BP","502015_GO_0032792_NEGATIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY",5,1.2921,0.2,0.64,-0.7002,0.84,1,-1.1404,0.34,0.75
"GO_MF:499417_GO_0022884_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","499417_GO_0022884_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",20,1.2922,0.14,0.71,1.5745,0.03,0.31,1.171,0.24,0.75
"C2_Chemical_and_genetic_perturbations:C2_CGP_602_WAKASUGI_HAVE_ZNF143_BINDING_SITES","C2_Chemical_and_genetic_perturbations","C2_CGP_602_WAKASUGI_HAVE_ZNF143_BINDING_SITES",58,1.2923,0.084,0.74,0.6349,0.99,1,-0.9424,0.55,0.83
"WikiPathways:198771_WP466_DNA_REPLICATION","WikiPathways","198771_WP466_DNA_REPLICATION",42,1.2927,0.1,0.38,1.7052,0.0022,0.094,-1.2578,0.12,0.47
"GO_BP:501279_GO_0032042_MITOCHONDRIAL_DNA_METABOLIC_PROCESS","GO_BP","501279_GO_0032042_MITOCHONDRIAL_DNA_METABOLIC_PROCESS",16,1.2928,0.13,0.64,0.9064,0.56,1,-1.0327,0.39,0.82
"GO_BP:508222_GO_0045915_POSITIVE_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS","GO_BP","508222_GO_0045915_POSITIVE_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS",5,1.2936,0.2,0.64,1.3491,0.13,0.61,-1.3897,0.12,0.58
"GO_CC:493479_GO_0009295_NUCLEOID","GO_CC","493479_GO_0009295_NUCLEOID",43,1.294,0.1,0.44,1.4448,0.028,0.25,0.7751,0.84,1
"GO_BP:491751_GO_0006891_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT","GO_BP","491751_GO_0006891_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT",43,1.2942,0.098,0.64,0.8627,0.71,1,0.6678,0.97,1
"GO_BP:513828_GO_0060272_EMBRYONIC_SKELETAL_JOINT_MORPHOGENESIS","GO_BP","513828_GO_0060272_EMBRYONIC_SKELETAL_JOINT_MORPHOGENESIS",13,1.2945,0.13,0.64,-0.793,0.73,1,1.2263,0.2,0.71
"GO_BP:491833_GO_0006997_NUCLEUS_ORGANIZATION","GO_BP","491833_GO_0006997_NUCLEUS_ORGANIZATION",127,1.2946,0.047,0.65,1.5615,0.0046,0.34,0.8962,0.69,0.95
"GO_BP:512236_GO_0051352_NEGATIVE_REGULATION_OF_LIGASE_ACTIVITY","GO_BP","512236_GO_0051352_NEGATIVE_REGULATION_OF_LIGASE_ACTIVITY",74,1.2947,0.066,0.65,2.2605,0,0.00023,0.64,1,1
"REACTOME:106354_REACT_9510_FGFR3C_LIGAND_BINDING_AND_ACTIVATION","REACTOME","106354_REACT_9510_FGFR3C_LIGAND_BINDING_AND_ACTIVATION",10,1.2953,0.17,0.43,-1.4232,0.083,0.51,0.6843,0.88,1
"KEGG_compound:C00046_RNA_RNAN_RNAN_1_RNA_LINEAR_RIBONUCLEOTIDE_N_RIBONUCLEOTIDE_M_RIBONUCLEOTIDE_N_M_RIBONUCLEIC_ACID","KEGG_compound","C00046_RNA_RNAN_RNAN_1_RNA_LINEAR_RIBONUCLEOTIDE_N_RIBONUCLEOTIDE_M_RIBONUCLEOTIDE_N_M_RIBONUCLEIC_ACID",32,1.2955,0.085,1,0.9201,0.59,1,-0.4805,1,0.99
"GO_BP:501633_GO_0032401_ESTABLISHMENT_OF_MELANOSOME_LOCALIZATION","GO_BP","501633_GO_0032401_ESTABLISHMENT_OF_MELANOSOME_LOCALIZATION",24,1.2956,0.14,0.65,1.1337,0.27,0.86,0.772,0.8,1
"GO_BP:505255_GO_0042073_INTRACILIARY_TRANSPORT","GO_BP","505255_GO_0042073_INTRACILIARY_TRANSPORT",28,1.2964,0.12,0.65,-0.6914,0.94,1,-0.883,0.65,0.94
"GO_BP:500556_GO_0031297_REPLICATION_FORK_PROCESSING","GO_BP","500556_GO_0031297_REPLICATION_FORK_PROCESSING",15,1.2965,0.14,0.65,0.6335,0.94,1,-1.2997,0.15,0.65
"GO_BP:507000_GO_0043982_HISTONE_H4_K8_ACETYLATION","GO_BP","507000_GO_0043982_HISTONE_H4_K8_ACETYLATION",15,1.2971,0.13,0.65,0.4107,1,1,-0.5775,0.96,1
"GO_BP:508251_GO_0045947_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION","GO_BP","508251_GO_0045947_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION",19,1.2979,0.13,0.65,1.5554,0.035,0.33,-0.9308,0.56,0.9
"C7_Immunologic_signatures:C7_ALL_945_GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP","C7_Immunologic_signatures","C7_ALL_945_GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP",192,1.2986,0.023,0.075,-0.8822,0.78,1,-0.8036,0.94,1
"GO_BP:492015_GO_0007217_TACHYKININ_RECEPTOR_SIGNALING_PATHWAY","GO_BP","492015_GO_0007217_TACHYKININ_RECEPTOR_SIGNALING_PATHWAY",8,1.299,0.15,0.65,-1.111,0.34,0.94,0.5819,0.94,1
"GO_BP:491232_GO_0006268_DNA_UNWINDING_INVOLVED_IN_DNA_REPLICATION","GO_BP","491232_GO_0006268_DNA_UNWINDING_INVOLVED_IN_DNA_REPLICATION",10,1.3,0.17,0.65,1.0468,0.39,0.95,-0.8275,0.71,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_3080_FIGUEROA_AML_METHYLATION_CLUSTER_2_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3080_FIGUEROA_AML_METHYLATION_CLUSTER_2_UP",53,1.3,0.073,0.73,1.2256,0.15,0.47,0.9429,0.57,1
"C7_Immunologic_signatures:C7_ALL_1187_GSE27786_BCELL_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1187_GSE27786_BCELL_VS_NEUTROPHIL_UP",200,1.3002,0.0088,0.075,1.0237,0.41,0.67,-0.8231,0.93,1
"GO_BP:516083_GO_0071157_NEGATIVE_REGULATION_OF_CELL_CYCLE_ARREST","GO_BP","516083_GO_0071157_NEGATIVE_REGULATION_OF_CELL_CYCLE_ARREST",15,1.3002,0.12,0.65,1.3301,0.13,0.63,1.3849,0.1,0.63
"GO_BP:512581_GO_0051708_INTRACELLULAR_PROTEIN_TRANSPORT_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION","GO_BP","512581_GO_0051708_INTRACELLULAR_PROTEIN_TRANSPORT_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION",5,1.3011,0.19,0.65,1.5236,0.045,0.37,0.704,0.85,1
"REACTOME:187185_REACT_23892_TRANSPORT_OF_FATTY_ACIDS","REACTOME","187185_REACT_23892_TRANSPORT_OF_FATTY_ACIDS",7,1.3013,0.17,0.43,-1.1317,0.32,0.9,-1.5508,0.044,0.29
"GO_MF:489981_GO_0004652_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_ACTIVITY","GO_MF","489981_GO_0004652_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_ACTIVITY",8,1.3013,0.17,0.69,1.0039,0.44,0.87,1.1822,0.24,0.75
"C1_Positional:C1_ALL_57_CHR10P11","C1_Positional","C1_ALL_57_CHR10P11",31,1.302,0.13,0.57,0.8785,0.65,0.89,0.9783,0.47,0.79
"REACTOME:105858_REACT_2020_REVERSAL_OF_ALKYLATION_DAMAGE_BY_DNA_DIOXYGENASES","REACTOME","105858_REACT_2020_REVERSAL_OF_ALKYLATION_DAMAGE_BY_DNA_DIOXYGENASES",5,1.3022,0.19,0.43,1.3239,0.15,0.29,-0.8069,0.67,1
"GO_BP:491900_GO_0007077_MITOTIC_NUCLEAR_ENVELOPE_DISASSEMBLY","GO_BP","491900_GO_0007077_MITOTIC_NUCLEAR_ENVELOPE_DISASSEMBLY",42,1.3022,0.1,0.65,1.2691,0.11,0.71,0.8065,0.81,1
"REACTOME:105686_REACT_13464_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION","REACTOME","105686_REACT_13464_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION",49,1.3023,0.082,0.43,2.2762,0,3.7e-05,0.4667,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_192_GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_192_GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN",175,1.3035,0.019,0.73,-0.906,0.7,1,0.7094,1,1
"REACTOME:645284_REACT_121337_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR3","REACTOME","645284_REACT_121337_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR3",10,1.3044,0.14,0.43,-1.3963,0.094,0.53,0.6877,0.85,1
"C4_Cancer_gene_neighborhoods:C4_CGN_425_GNF2_UBE2I","C4_Cancer_gene_neighborhoods","C4_CGN_425_GNF2_UBE2I",44,1.3044,0.096,0.27,2.5239,0,0,0.6371,0.98,1
"GO_CC:490718_GO_0005663_DNA_REPLICATION_FACTOR_C_COMPLEX","GO_CC","490718_GO_0005663_DNA_REPLICATION_FACTOR_C_COMPLEX",6,1.3045,0.19,0.42,1.5184,0.047,0.18,-0.7605,0.77,1
"GO_BP:497939_GO_0019060_INTRACELLULAR_TRANSPORT_OF_VIRAL_PROTEIN_IN_HOST_CELL","GO_BP","497939_GO_0019060_INTRACELLULAR_TRANSPORT_OF_VIRAL_PROTEIN_IN_HOST_CELL",5,1.3046,0.18,0.65,1.5497,0.04,0.34,0.7175,0.79,1
"GO_MF:509933_GO_0047760_BUTYRATE_COA_LIGASE_ACTIVITY","GO_MF","509933_GO_0047760_BUTYRATE_COA_LIGASE_ACTIVITY",8,1.3049,0.14,0.69,-1.0112,0.45,0.89,-1.3431,0.13,0.54
"GO_BP:504243_GO_0035058_NONMOTILE_PRIMARY_CILIUM_ASSEMBLY","GO_BP","504243_GO_0035058_NONMOTILE_PRIMARY_CILIUM_ASSEMBLY",14,1.3051,0.14,0.65,0.6361,0.93,1,-0.939,0.54,0.9
"GO_CC:496546_GO_0016604_NUCLEAR_BODY","GO_CC","496546_GO_0016604_NUCLEAR_BODY",332,1.3053,0.015,0.42,1.2767,0.0071,0.43,0.9494,0.63,1
"GO_MF:501636_GO_0032404_MISMATCH_REPAIR_COMPLEX_BINDING","GO_MF","501636_GO_0032404_MISMATCH_REPAIR_COMPLEX_BINDING",12,1.3061,0.15,0.69,0.7235,0.84,1,-1.218,0.22,0.57
"GO_BP:487027_GO_0000730_DNA_RECOMBINASE_ASSEMBLY","GO_BP","487027_GO_0000730_DNA_RECOMBINASE_ASSEMBLY",5,1.3067,0.2,0.65,1.1807,0.29,0.8,-0.4692,0.99,1
"REACTOME:105784_REACT_2014_SYNTHESIS_OF_DNA","REACTOME","105784_REACT_2014_SYNTHESIS_OF_DNA",97,1.3077,0.065,0.43,2.1469,0,0.00035,-1.0843,0.29,0.72
"GO_BP:496836_GO_0017004_CYTOCHROME_COMPLEX_ASSEMBLY","GO_BP","496836_GO_0017004_CYTOCHROME_COMPLEX_ASSEMBLY",19,1.3081,0.15,0.64,1.1556,0.25,0.83,-0.9086,0.58,0.92
"C7_Immunologic_signatures:C7_ALL_233_GSE14000_UNSTIM_VS_4H_LPS_DC_UP","C7_Immunologic_signatures","C7_ALL_233_GSE14000_UNSTIM_VS_4H_LPS_DC_UP",197,1.3082,0.017,0.069,1.0555,0.3,0.57,-0.9362,0.64,0.88
"KEGG_module:HSA_M00128_UBIQUINONE_BIOSYNTHESIS_EUKARYOTES_4_HYDROXYBENZOATE_UBIQUINONE","KEGG_module","HSA_M00128_UBIQUINONE_BIOSYNTHESIS_EUKARYOTES_4_HYDROXYBENZOATE_UBIQUINONE",5,1.3084,0.19,0.44,0.8912,0.6,0.9,1.3043,0.19,0.78
"GO_BP:506589_GO_0043558_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS","GO_BP","506589_GO_0043558_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS",11,1.3085,0.16,0.64,1.2814,0.16,0.7,-0.9167,0.56,0.91
"C4_Cancer_gene_neighborhoods:C4_CGN_14_MORF_DNMT1","C4_Cancer_gene_neighborhoods","C4_CGN_14_MORF_DNMT1",118,1.3092,0.027,0.26,1.9458,0,0.00053,-1.0976,0.25,0.63
"WikiPathways:198768_WP311_SYNTHESIS_AND_DEGRADATION_OF_KETONE_BODIES","WikiPathways","198768_WP311_SYNTHESIS_AND_DEGRADATION_OF_KETONE_BODIES",5,1.3093,0.18,0.43,0.5593,0.96,1,-1.0848,0.37,0.63
"GO_BP:518281_GO_0090141_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FISSION","GO_BP","518281_GO_0090141_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FISSION",10,1.3095,0.16,0.64,1.0012,0.44,0.98,0.756,0.78,1
"GO_MF:495530_GO_0015279_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY","GO_MF","495530_GO_0015279_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY",11,1.3095,0.17,0.69,0.7393,0.82,1,-1.5256,0.034,0.39
"GO_BP:498886_GO_0021603_CRANIAL_NERVE_FORMATION","GO_BP","498886_GO_0021603_CRANIAL_NERVE_FORMATION",5,1.3099,0.18,0.65,0.6607,0.85,1,1.0508,0.4,0.8
"GO_MF:496405_GO_0016417_S_ACYLTRANSFERASE_ACTIVITY","GO_MF","496405_GO_0016417_S_ACYLTRANSFERASE_ACTIVITY",29,1.3101,0.096,0.7,0.8445,0.72,1,-0.5571,1,1
"GO_BP:486818_GO_0000301_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI","GO_BP","486818_GO_0000301_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI",19,1.3104,0.12,0.65,0.6638,0.93,1,1.0454,0.37,0.81
"C2_Chemical_and_genetic_perturbations:C2_CGP_631_MATHEW_FANCONI_ANEMIA_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_631_MATHEW_FANCONI_ANEMIA_GENES",11,1.3106,0.13,0.72,0.9291,0.54,0.89,-0.8051,0.73,0.95
"KEGG_module:HSA_M00146_NADH_DEHYDROGENASE_UBIQUINONE_1_ALPHA_SUBCOMPLEX","KEGG_module","HSA_M00146_NADH_DEHYDROGENASE_UBIQUINONE_1_ALPHA_SUBCOMPLEX",15,1.3118,0.14,0.46,1.6992,0.016,0.074,0.917,0.58,1
"KEGG_pathway:HSA00512_MUCIN_TYPE_O_GLYCAN_BIOSYNTHESIS","KEGG_pathway","HSA00512_MUCIN_TYPE_O_GLYCAN_BIOSYNTHESIS",31,1.3125,0.095,0.17,0.9104,0.58,1,1.1878,0.19,0.65
"GO_BP:948072_GO_0044827_MODULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION","GO_BP","948072_GO_0044827_MODULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION",7,1.3127,0.18,0.64,1.418,0.11,0.53,1.0107,0.46,0.84
"GO_BP:491500_GO_0006605_PROTEIN_TARGETING","GO_BP","491500_GO_0006605_PROTEIN_TARGETING",396,1.3136,0,0.64,2.6196,0,0,0.7698,1,1
"GO_BP:499106_GO_0021826_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_MIGRATION","GO_BP","499106_GO_0021826_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_MIGRATION",9,1.3137,0.17,0.65,-1.8567,0.0038,0.43,0.8127,0.7,1
"C4_Cancer_modules:C4_CM_281_MODULE_322","C4_Cancer_modules","C4_CM_281_MODULE_322",57,1.3138,0.067,0.47,1.604,0.011,0.073,1.0959,0.26,0.77
"C4_Cancer_gene_neighborhoods:C4_CGN_230_GCM_FANCL","C4_Cancer_gene_neighborhoods","C4_CGN_230_GCM_FANCL",24,1.3138,0.095,0.26,-0.826,0.75,1,-0.6811,0.91,1
"GO_CC:496537_GO_0016591_DNA_DIRECTED_RNA_POLYMERASE_II_HOLOENZYME","GO_CC","496537_GO_0016591_DNA_DIRECTED_RNA_POLYMERASE_II_HOLOENZYME",92,1.3145,0.048,0.41,1.4119,0.021,0.29,0.6593,0.99,1
"GO_BP:506999_GO_0043981_HISTONE_H4_K5_ACETYLATION","GO_BP","506999_GO_0043981_HISTONE_H4_K5_ACETYLATION",15,1.3154,0.13,0.64,0.3984,1,1,-0.581,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1131_PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1131_PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP",6,1.3155,0.19,0.71,1.3655,0.11,0.33,1.1088,0.34,0.88
"GO_BP:516752_GO_0071830_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_CLEARANCE","GO_BP","516752_GO_0071830_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_CLEARANCE",6,1.3157,0.18,0.64,0.7671,0.75,1,1.1042,0.33,0.76
"REACTOME:106227_REACT_12541_NOSTRIN_MEDIATED_ENOS_TRAFFICKING","REACTOME","106227_REACT_12541_NOSTRIN_MEDIATED_ENOS_TRAFFICKING",5,1.3162,0.18,0.41,-1.0256,0.45,0.97,0.9903,0.49,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_16_LU_TUMOR_VASCULATURE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_16_LU_TUMOR_VASCULATURE_DN",11,1.3163,0.15,0.73,1.453,0.08,0.25,1.468,0.072,0.53
"GO_BP:491311_GO_0006385_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_III_PROMOTER","GO_BP","491311_GO_0006385_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_III_PROMOTER",18,1.3171,0.12,0.64,0.8578,0.65,1,-0.4724,0.99,1
"GO_CC:489323_GO_0042613_MHC_CLASS_II_PROTEIN_COMPLEX","GO_CC","489323_GO_0042613_MHC_CLASS_II_PROTEIN_COMPLEX",14,1.3174,0.15,0.41,0.6861,0.88,0.98,-0.6017,0.96,1
"GO_MF:493230_GO_0016783_SULFURTRANSFERASE_ACTIVITY","GO_MF","493230_GO_0016783_SULFURTRANSFERASE_ACTIVITY",8,1.3176,0.15,0.69,1.2693,0.2,0.64,0.7967,0.74,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_675_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9","C2_Chemical_and_genetic_perturbations","C2_CGP_675_MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9",8,1.3181,0.14,0.74,1.0693,0.39,0.68,1.0946,0.36,0.88
"REACTOME:1127635_REACT_264623_HH_MUTANTS_ABROGATE_LIGAND_SECRETION","REACTOME","1127635_REACT_264623_HH_MUTANTS_ABROGATE_LIGAND_SECRETION",54,1.3182,0.08,0.41,2.2606,0,6.7e-05,0.7189,0.93,1
"C7_Immunologic_signatures:C7_ALL_854_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN","C7_Immunologic_signatures","C7_ALL_854_GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN",182,1.3184,0,0.061,1.391,0.0023,0.041,0.863,0.84,1
"GO_BP:507413_GO_0045003_DOUBLE_STRAND_BREAK_REPAIR_VIA_SYNTHESIS_DEPENDENT_STRAND_ANNEALING","GO_BP","507413_GO_0045003_DOUBLE_STRAND_BREAK_REPAIR_VIA_SYNTHESIS_DEPENDENT_STRAND_ANNEALING",5,1.319,0.18,0.64,1.2251,0.26,0.76,-0.4638,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2132_MCGOWAN_RSP6_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2132_MCGOWAN_RSP6_TARGETS_DN",5,1.3191,0.2,0.75,1.1234,0.35,0.6,1.6314,0.021,0.34
"REACTOME:905999_REACT_169429_DEFECTS_IN_COBALAMIN_B12_METABOLISM","REACTOME","905999_REACT_169429_DEFECTS_IN_COBALAMIN_B12_METABOLISM",11,1.3205,0.14,0.41,0.9053,0.57,0.9,0.8144,0.74,1
"GO_MF:751603_GO_0044390_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING","GO_MF","751603_GO_0044390_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING",14,1.321,0.13,0.69,0.9856,0.47,0.89,0.8573,0.64,0.98
"REACTOME:105873_REACT_2141_ASSEMBLY_OF_THE_RAD51_SSDNA_NUCLEOPROTEIN_COMPLEX","REACTOME","105873_REACT_2141_ASSEMBLY_OF_THE_RAD51_SSDNA_NUCLEOPROTEIN_COMPLEX",5,1.3215,0.16,0.41,1.1926,0.27,0.45,-0.4601,0.99,1
"REACTOME:105855_REACT_1287_TRANSLESION_SYNTHESIS_BY_POLH","REACTOME","105855_REACT_1287_TRANSLESION_SYNTHESIS_BY_POLH",19,1.3216,0.11,0.42,1.7812,0.0061,0.024,-0.6416,0.94,1
"GO_BP:516405_GO_0071481_CELLULAR_RESPONSE_TO_X_RAY","GO_BP","516405_GO_0071481_CELLULAR_RESPONSE_TO_X_RAY",5,1.3219,0.2,0.63,0.9129,0.56,1,0.6869,0.84,1
"REACTOME:106566_REACT_756_RNA_POLYMERASE_III_CHAIN_ELONGATION","REACTOME","106566_REACT_756_RNA_POLYMERASE_III_CHAIN_ELONGATION",18,1.3237,0.11,0.41,0.848,0.7,0.96,-0.469,1,1
"REACTOME:106017_REACT_9453_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G","REACTOME","106017_REACT_9453_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G",53,1.324,0.064,0.42,2.3632,0,0,0.6089,0.99,1
"REACTOME:187215_REACT_25042_KSRP_DESTABILIZES_MRNA","REACTOME","187215_REACT_25042_KSRP_DESTABILIZES_MRNA",17,1.324,0.14,0.42,1.5288,0.04,0.13,0.6445,0.93,1
"C7_Immunologic_signatures:C7_ALL_829_GSE17974_2_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_829_GSE17974_2_5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP",197,1.3245,0,0.058,1.3316,0.016,0.075,1.1747,0.11,0.78
"C2_Chemical_and_genetic_perturbations:C2_CGP_1814_GENTILE_UV_RESPONSE_CLUSTER_D7","C2_Chemical_and_genetic_perturbations","C2_CGP_1814_GENTILE_UV_RESPONSE_CLUSTER_D7",40,1.3245,0.05,0.75,1.8834,0,0.023,1.4068,0.043,0.55
"C4_Cancer_gene_neighborhoods:C4_CGN_193_MORF_ZNF10","C4_Cancer_gene_neighborhoods","C4_CGN_193_MORF_ZNF10",53,1.3253,0.045,0.25,0.684,0.96,1,1.2305,0.15,0.39
"GO_MF:487279_GO_0001056_RNA_POLYMERASE_III_ACTIVITY","GO_MF","487279_GO_0001056_RNA_POLYMERASE_III_ACTIVITY",18,1.3253,0.1,0.69,0.8662,0.64,1,-0.4701,1,1
"REACTOME:1127522_REACT_264438_DEGRADATION_OF_DVL","REACTOME","1127522_REACT_264438_DEGRADATION_OF_DVL",56,1.3254,0.075,0.42,2.2377,0,6.1e-05,0.5552,1,1
"GO_BP:515009_GO_0070070_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY","GO_BP","515009_GO_0070070_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY",6,1.3256,0.18,0.63,-0.7891,0.72,1,1.3297,0.17,0.64
"GO_CC:490723_GO_0005666_DNA_DIRECTED_RNA_POLYMERASE_III_COMPLEX","GO_CC","490723_GO_0005666_DNA_DIRECTED_RNA_POLYMERASE_III_COMPLEX",18,1.3258,0.11,0.4,0.8544,0.66,0.92,-0.4729,0.99,1
"GO_BP:512758_GO_0051904_PIGMENT_GRANULE_TRANSPORT","GO_BP","512758_GO_0051904_PIGMENT_GRANULE_TRANSPORT",24,1.326,0.13,0.63,1.321,0.11,0.64,0.7394,0.83,1
"GO_BP:494006_GO_0009912_AUDITORY_RECEPTOR_CELL_FATE_COMMITMENT","GO_BP","494006_GO_0009912_AUDITORY_RECEPTOR_CELL_FATE_COMMITMENT",6,1.3274,0.17,0.63,-0.63,0.88,1,0.9551,0.5,0.9
"KEGG_enzyme:2.7.7.19_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_NTP_POLYMERASE_RNA_ADENYLATING_ENZYME_AMP_POLYNUCLEOTIDYLEXOTRANSFERASE_ATP_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_ATP_POLYNUCLEOTIDYLEXOTRANSFERASE_POLY_A_POLYMERASE_POLY_A_SYNTHETASE_POLYADENYLATE_NUCLEOTIDYLTRANSFERASE_POLYADENYLATE_POLYMERASE_POLYADENYLATE_SYNTHETASE_POLYADENYLIC_ACID_POLYMERASE_POLYADENYLIC_POLYMERASE_TERMINAL_RIBOADENYLATE_TRANSFERASE_POLY_A_HYDROLASE_RNA_FORMATION_FACTORS_PF1_ADENOSINE_TRIPHOSPHATE_RIBONUCLEIC_ACID_ADENYLYLTRANSFERASE","KEGG_enzyme","2.7.7.19_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_NTP_POLYMERASE_RNA_ADENYLATING_ENZYME_AMP_POLYNUCLEOTIDYLEXOTRANSFERASE_ATP_POLYNUCLEOTIDE_ADENYLYLTRANSFERASE_ATP_POLYNUCLEOTIDYLEXOTRANSFERASE_POLY_A_POLYMERASE_POLY_A_SYNTHETASE_POLYADENYLATE_NUCLEOTIDYLTRANSFERASE_POLYADENYLATE_POLYMERASE_POLYADENYLATE_SYNTHETASE_POLYADENYLIC_ACID_POLYMERASE_POLYADENYLIC_POLYMERASE_TERMINAL_RIBOADENYLATE_TRANSFERASE_POLY_A_HYDROLASE_RNA_FORMATION_FACTORS_PF1_ADENOSINE_TRIPHOSPHATE_RIBONUCLEIC_ACID_ADENYLYLTRANSFERASE",8,1.3275,0.15,0.58,1.023,0.4,0.98,1.2102,0.25,0.59
"GO_CC:501665_GO_0032433_FILOPODIUM_TIP","GO_CC","501665_GO_0032433_FILOPODIUM_TIP",9,1.3288,0.16,0.4,0.5262,0.98,1,1.0101,0.43,0.99
"GO_BP:486762_GO_0000244_SPLICEOSOMAL_TRI_SNRNP_COMPLEX_ASSEMBLY","GO_BP","486762_GO_0000244_SPLICEOSOMAL_TRI_SNRNP_COMPLEX_ASSEMBLY",11,1.3298,0.13,0.62,-0.8428,0.64,1,0.872,0.63,0.96
"GO_CC:993456_GO_1990391_DNA_REPAIR_COMPLEX","GO_CC","993456_GO_1990391_DNA_REPAIR_COMPLEX",35,1.3308,0.1,0.4,0.7508,0.87,0.98,-0.9826,0.49,1
"GO_MF:489277_GO_0003743_TRANSLATION_INITIATION_FACTOR_ACTIVITY","GO_MF","489277_GO_0003743_TRANSLATION_INITIATION_FACTOR_ACTIVITY",51,1.3309,0.056,0.68,2.2705,0,0.00038,0.8576,0.75,0.98
"REACTOME:106132_REACT_1861_KETONE_BODY_METABOLISM","REACTOME","106132_REACT_1861_KETONE_BODY_METABOLISM",5,1.3311,0.17,0.41,0.549,0.96,1,-1.0509,0.42,0.78
"GO_MF:506213_GO_0043140_ATP_DEPENDENT_3_5_DNA_HELICASE_ACTIVITY","GO_MF","506213_GO_0043140_ATP_DEPENDENT_3_5_DNA_HELICASE_ACTIVITY",5,1.3314,0.2,0.69,0.8074,0.66,1,0.8449,0.66,0.99
"REACTOME:105754_REACT_6769_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS","REACTOME","105754_REACT_6769_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS",37,1.3318,0.085,0.42,1.4909,0.034,0.15,-1.1444,0.25,0.66
"C1_Positional:C1_ALL_248_CHR1P21","C1_Positional","C1_ALL_248_CHR1P21",33,1.332,0.11,0.52,1.0124,0.43,0.74,0.998,0.45,0.77
"REACTOME:1127636_REACT_263883_HH_MUTANTS_THAT_DON_T_UNDERGO_AUTOCATALYTIC_PROCESSING_ARE_DEGRADED_BY_ERAD","REACTOME","1127636_REACT_263883_HH_MUTANTS_THAT_DON_T_UNDERGO_AUTOCATALYTIC_PROCESSING_ARE_DEGRADED_BY_ERAD",54,1.3324,0.053,0.42,2.2691,0,6.9e-05,0.7234,0.92,1
"GO_BP:513524_GO_0055091_PHOSPHOLIPID_HOMEOSTASIS","GO_BP","513524_GO_0055091_PHOSPHOLIPID_HOMEOSTASIS",10,1.3329,0.14,0.62,0.8099,0.7,1,1.3203,0.15,0.66
"GO_MF:512735_GO_0051880_G_QUADRUPLEX_DNA_BINDING","GO_MF","512735_GO_0051880_G_QUADRUPLEX_DNA_BINDING",5,1.3336,0.17,0.69,1.2392,0.25,0.69,1.2997,0.19,0.65
"GO_BP:1184486_GO_1903960_NEGATIVE_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT","GO_BP","1184486_GO_1903960_NEGATIVE_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT",6,1.3353,0.18,0.61,0.9354,0.53,1,0.8504,0.66,0.98
"GO_BP:507003_GO_0043985_HISTONE_H4_R3_METHYLATION","GO_BP","507003_GO_0043985_HISTONE_H4_R3_METHYLATION",6,1.336,0.15,0.61,-0.9142,0.58,1,-0.7677,0.75,1
"C7_Immunologic_signatures:C7_ALL_1670_GSE3982_NEUTROPHIL_VS_NKCELL_DN","C7_Immunologic_signatures","C7_ALL_1670_GSE3982_NEUTROPHIL_VS_NKCELL_DN",194,1.3368,0.0084,0.05,1.6036,0.0025,0.0028,-1.144,0.16,0.38
"C4_Cancer_gene_neighborhoods:C4_CGN_380_GNF2_MLF1","C4_Cancer_gene_neighborhoods","C4_CGN_380_GNF2_MLF1",84,1.3379,0.029,0.23,-1.0014,0.43,0.87,-0.8431,0.82,1
"GO_BP:515011_GO_0070072_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY","GO_BP","515011_GO_0070072_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY",6,1.3395,0.16,0.6,-0.7964,0.72,1,1.335,0.15,0.64
"KEGG_pathway:HSA03022_BASAL_TRANSCRIPTION_FACTORS","KEGG_pathway","HSA03022_BASAL_TRANSCRIPTION_FACTORS",44,1.3398,0.062,0.15,1.4721,0.025,0.12,0.8587,0.71,1
"GO_CC:495069_GO_0012507_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE","GO_CC","495069_GO_0012507_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE",41,1.3398,0.046,0.39,1.2274,0.16,0.49,0.5785,0.99,1
"GO_MF:496418_GO_0016433_RRNA_ADENINE_METHYLTRANSFERASE_ACTIVITY","GO_MF","496418_GO_0016433_RRNA_ADENINE_METHYLTRANSFERASE_ACTIVITY",6,1.34,0.17,0.68,0.7505,0.75,1,0.9109,0.56,0.94
"GO_MF:501639_GO_0032407_MUTSALPHA_COMPLEX_BINDING","GO_MF","501639_GO_0032407_MUTSALPHA_COMPLEX_BINDING",5,1.3411,0.16,0.69,0.9919,0.47,0.89,0.7663,0.75,1
"GO_CC:504220_GO_0035032_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_III","GO_CC","504220_GO_0035032_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_III",5,1.3411,0.19,0.39,1.1205,0.34,0.61,1.0263,0.44,0.99
"KEGG_module:HSA_M00285_MCM_COMPLEX","KEGG_module","HSA_M00285_MCM_COMPLEX",6,1.3416,0.15,0.43,1.4947,0.067,0.18,-1.2522,0.21,0.48
"OMIM_gene:OMIM108345_N_ACETYLTRANSFERASE_1_NAT1","OMIM_gene","OMIM108345_N_ACETYLTRANSFERASE_1_NAT1",5,1.342,0.17,1,-0.7056,0.83,0.94,-0.9135,0.6,1
"REACTOME:106355_REACT_9452_FGFR4_LIGAND_BINDING_AND_ACTIVATION","REACTOME","106355_REACT_9452_FGFR4_LIGAND_BINDING_AND_ACTIVATION",10,1.3427,0.15,0.4,-1.7346,0.013,0.13,-0.6914,0.86,1
"GO_BP:517503_GO_0072600_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_GOLGI","GO_BP","517503_GO_0072600_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_GOLGI",20,1.3436,0.11,0.6,0.7036,0.89,1,1.2328,0.16,0.71
"GO_BP:487722_GO_0001826_INNER_CELL_MASS_CELL_DIFFERENTIATION","GO_BP","487722_GO_0001826_INNER_CELL_MASS_CELL_DIFFERENTIATION",5,1.3436,0.13,0.6,1.194,0.27,0.79,-1.3552,0.12,0.6
"KEGG_pathway:HSA03430_MISMATCH_REPAIR","KEGG_pathway","HSA03430_MISMATCH_REPAIR",23,1.3455,0.12,0.16,1.5209,0.037,0.096,-0.8758,0.63,0.87
"GO_BP:498435_GO_0019605_BUTYRATE_METABOLIC_PROCESS","GO_BP","498435_GO_0019605_BUTYRATE_METABOLIC_PROCESS",6,1.3461,0.17,0.59,0.3291,1,1,0.7361,0.78,1
"C1_Positional:C1_ALL_268_CHR5Q13","C1_Positional","C1_ALL_268_CHR5Q13",64,1.3469,0.024,0.51,1.6454,0,0.22,1.4405,0.025,0.34
"GO_MF:500874_GO_0031624_UBIQUITIN_CONJUGATING_ENZYME_BINDING","GO_MF","500874_GO_0031624_UBIQUITIN_CONJUGATING_ENZYME_BINDING",13,1.3486,0.12,0.68,0.6494,0.91,1,0.8917,0.6,0.97
"GO_MF:489241_GO_0003691_DOUBLE_STRANDED_TELOMERIC_DNA_BINDING","GO_MF","489241_GO_0003691_DOUBLE_STRANDED_TELOMERIC_DNA_BINDING",5,1.3488,0.16,0.69,1.0965,0.35,0.79,-0.6874,0.83,1
"GO_CC:490777_GO_0005742_MITOCHONDRIAL_OUTER_MEMBRANE_TRANSLOCASE_COMPLEX","GO_CC","490777_GO_0005742_MITOCHONDRIAL_OUTER_MEMBRANE_TRANSLOCASE_COMPLEX",8,1.3495,0.16,0.38,2.0043,0,0.0033,1.2309,0.24,0.82
"GO_MF:506111_GO_0043021_RIBONUCLEOPROTEIN_COMPLEX_BINDING","GO_MF","506111_GO_0043021_RIBONUCLEOPROTEIN_COMPLEX_BINDING",70,1.3498,0.027,0.7,1.9381,0,0.022,0.9409,0.56,0.92
"GO_BP:503707_GO_0034505_TOOTH_MINERALIZATION","GO_BP","503707_GO_0034505_TOOTH_MINERALIZATION",10,1.3507,0.13,0.58,0.8671,0.62,1,1.3463,0.13,0.65
"GO_CC:500369_GO_0031082_BLOC_COMPLEX","GO_CC","500369_GO_0031082_BLOC_COMPLEX",19,1.3526,0.093,0.38,1.5633,0.029,0.15,1.9562,0,0.058
"REACTOME:106264_REACT_1206_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE","REACTOME","106264_REACT_1206_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE",7,1.3533,0.16,0.38,0.7722,0.77,1,-0.5503,0.96,1
"GO_BP:515492_GO_0070562_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY","GO_BP","515492_GO_0070562_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY",6,1.3551,0.15,0.57,1.0193,0.44,0.97,1.3582,0.14,0.64
"GO_BP:510697_GO_0048641_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","510697_GO_0048641_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT",43,1.3553,0.052,0.58,0.8843,0.68,1,-0.8573,0.73,0.96
"GO_BP:516933_GO_0072014_PROXIMAL_TUBULE_DEVELOPMENT","GO_BP","516933_GO_0072014_PROXIMAL_TUBULE_DEVELOPMENT",6,1.3557,0.15,0.58,-1.0826,0.36,0.96,-0.6502,0.88,1
"GO_MF:489493_GO_0004024_ALCOHOL_DEHYDROGENASE_ACTIVITY_ZINC_DEPENDENT","GO_MF","489493_GO_0004024_ALCOHOL_DEHYDROGENASE_ACTIVITY_ZINC_DEPENDENT",5,1.3562,0.15,0.69,-1.8714,0,0.15,-1.9821,0,0.11
"GO_BP:512731_GO_0051875_PIGMENT_GRANULE_LOCALIZATION","GO_BP","512731_GO_0051875_PIGMENT_GRANULE_LOCALIZATION",28,1.3563,0.084,0.58,1.4009,0.08,0.55,1.0192,0.42,0.83
"GO_CC:503908_GO_0034708_METHYLTRANSFERASE_COMPLEX","GO_CC","503908_GO_0034708_METHYLTRANSFERASE_COMPLEX",83,1.3563,0.032,0.38,1.1577,0.19,0.57,-0.771,0.92,1
"REACTOME:106434_REACT_6772_S6K1_SIGNALLING","REACTOME","106434_REACT_6772_S6K1_SIGNALLING",5,1.3565,0.14,0.38,1.5106,0.045,0.14,-0.6599,0.86,1
"REACTOME:105981_REACT_15306_CYTOSOLIC_TRNA_AMINOACYLATION","REACTOME","105981_REACT_15306_CYTOSOLIC_TRNA_AMINOACYLATION",24,1.3571,0.085,0.38,1.9746,0,0.0033,-0.6039,0.96,1
"GO_BP:808753_GO_0044786_CELL_CYCLE_DNA_REPLICATION","GO_BP","808753_GO_0044786_CELL_CYCLE_DNA_REPLICATION",28,1.3571,0.086,0.58,1.5633,0.013,0.34,-1.1846,0.23,0.73
"GO_BP:502480_GO_0033260_NUCLEAR_DNA_REPLICATION","GO_BP","502480_GO_0033260_NUCLEAR_DNA_REPLICATION",27,1.358,0.085,0.58,1.603,0.014,0.29,-1.1968,0.21,0.73
"GO_MF:489885_GO_0004540_RIBONUCLEASE_ACTIVITY","GO_MF","489885_GO_0004540_RIBONUCLEASE_ACTIVITY",82,1.358,0.036,0.7,1.7348,0.0023,0.12,0.8838,0.7,0.97
"GO_BP:517558_GO_0072655_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION","GO_BP","517558_GO_0072655_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION",59,1.3584,0.073,0.58,1.9236,0,0.03,0.5317,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_3172_VANDESLUIS_NORMAL_EMBRYOS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_3172_VANDESLUIS_NORMAL_EMBRYOS_DN",24,1.3594,0.073,0.64,1.6956,0.0061,0.086,0.8468,0.75,1
"REACTOME:106380_REACT_18377_GLUCAGON_TYPE_LIGAND_RECEPTORS","REACTOME","106380_REACT_18377_GLUCAGON_TYPE_LIGAND_RECEPTORS",27,1.3597,0.095,0.38,0.867,0.67,0.94,1.0541,0.36,0.97
"REACTOME:187199_REACT_23946_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR","REACTOME","187199_REACT_23946_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR",18,1.3606,0.089,0.38,0.7801,0.79,1,0.7809,0.77,1
"GO_BP:487655_GO_0001759_ORGAN_INDUCTION","GO_BP","487655_GO_0001759_ORGAN_INDUCTION",16,1.3606,0.11,0.58,0.8208,0.73,1,1.2637,0.16,0.69
"GO_BP:500411_GO_0031124_MRNA_3_END_PROCESSING","GO_BP","500411_GO_0031124_MRNA_3_END_PROCESSING",87,1.3609,0.025,0.58,1.1569,0.17,0.83,0.4636,1,1
"GO_BP:506605_GO_0043574_PEROXISOMAL_TRANSPORT","GO_BP","506605_GO_0043574_PEROXISOMAL_TRANSPORT",19,1.361,0.11,0.58,1.2319,0.18,0.75,-0.7519,0.84,1
"GO_BP:506182_GO_0043102_AMINO_ACID_SALVAGE","GO_BP","506182_GO_0043102_AMINO_ACID_SALVAGE",11,1.3613,0.13,0.58,-0.7239,0.82,1,-1.2011,0.23,0.73
"GO_BP:513678_GO_0060120_INNER_EAR_RECEPTOR_CELL_FATE_COMMITMENT","GO_BP","513678_GO_0060120_INNER_EAR_RECEPTOR_CELL_FATE_COMMITMENT",6,1.3618,0.14,0.58,-0.6084,0.92,1,0.9787,0.5,0.88
"GO_BP:491258_GO_0006297_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING","GO_BP","491258_GO_0006297_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING",20,1.3619,0.11,0.59,1.3814,0.099,0.57,0.599,0.97,1
"GO_CC:487099_GO_0000808_ORIGIN_RECOGNITION_COMPLEX","GO_CC","487099_GO_0000808_ORIGIN_RECOGNITION_COMPLEX",9,1.3638,0.13,0.37,1.3041,0.16,0.4,-1.2586,0.19,0.68
"GO_BP:493982_GO_0009886_POST_EMBRYONIC_MORPHOGENESIS","GO_BP","493982_GO_0009886_POST_EMBRYONIC_MORPHOGENESIS",12,1.3642,0.12,0.58,0.98,0.48,1,0.8099,0.72,1
"C1_Positional:C1_ALL_309_CHR3Q","C1_Positional","C1_ALL_309_CHR3Q",6,1.3643,0.15,0.5,-1.0349,0.43,1,1.424,0.099,0.36
"REACTOME:1127523_REACT_263873_DEGRADATION_OF_AXIN","REACTOME","1127523_REACT_263873_DEGRADATION_OF_AXIN",54,1.3661,0.058,0.38,2.1336,0,0.00037,0.5022,1,1
"GO_BP:493623_GO_0009452_7_METHYLGUANOSINE_RNA_CAPPING","GO_BP","493623_GO_0009452_7_METHYLGUANOSINE_RNA_CAPPING",35,1.3665,0.062,0.58,1.6665,0.0022,0.23,1.2637,0.13,0.68
"GO_MF:492639_GO_0008320_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY","GO_MF","492639_GO_0008320_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY",14,1.3666,0.12,0.68,1.623,0.029,0.24,1.2263,0.2,0.7
"C4_Cancer_gene_neighborhoods:C4_CGN_249_GCM_NUMA1","C4_Cancer_gene_neighborhoods","C4_CGN_249_GCM_NUMA1",56,1.3668,0.04,0.2,0.486,1,1,0.6355,0.99,1
"GO_BP:518784_GO_2000136_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS","GO_BP","518784_GO_2000136_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS",16,1.3678,0.12,0.58,-0.9533,0.5,1,1.6739,0.0081,0.4
"GO_CC:490654_GO_0005579_MEMBRANE_ATTACK_COMPLEX","GO_CC","490654_GO_0005579_MEMBRANE_ATTACK_COMPLEX",7,1.3682,0.16,0.36,1.1015,0.36,0.64,1.3689,0.13,0.78
"GO_BP:501632_GO_0032400_MELANOSOME_LOCALIZATION","GO_BP","501632_GO_0032400_MELANOSOME_LOCALIZATION",27,1.3683,0.072,0.58,1.4329,0.05,0.52,1.072,0.35,0.78
"KEGG_pathway:HSA03410_BASE_EXCISION_REPAIR","KEGG_pathway","HSA03410_BASE_EXCISION_REPAIR",33,1.3685,0.059,0.15,1.5204,0.025,0.092,-0.5918,0.99,1
"GO_MF:500273_GO_0030983_MISMATCHED_DNA_BINDING","GO_MF","500273_GO_0030983_MISMATCHED_DNA_BINDING",12,1.3686,0.12,0.69,-0.5221,0.98,1,-1.0292,0.43,0.76
"GO_BP:513961_GO_0060405_REGULATION_OF_PENILE_ERECTION","GO_BP","513961_GO_0060405_REGULATION_OF_PENILE_ERECTION",7,1.3693,0.13,0.58,1.7097,0.008,0.18,1.7857,0.0059,0.32
"GO_BP:751180_GO_0036260_RNA_CAPPING","GO_BP","751180_GO_0036260_RNA_CAPPING",35,1.3698,0.056,0.58,1.6378,0.0083,0.25,1.2664,0.12,0.69
"GO_BP:501634_GO_0032402_MELANOSOME_TRANSPORT","GO_BP","501634_GO_0032402_MELANOSOME_TRANSPORT",23,1.3703,0.092,0.58,1.3045,0.13,0.66,0.7786,0.79,1
"GO_BP:503449_GO_0034244_NEGATIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER","GO_BP","503449_GO_0034244_NEGATIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER",9,1.3707,0.13,0.58,1.1484,0.27,0.84,0.6877,0.87,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2431_KRISHNAN_FURIN_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2431_KRISHNAN_FURIN_TARGETS_DN",13,1.3734,0.13,0.6,-0.8134,0.74,1,-0.594,0.95,0.99
"REACTOME:105797_REACT_4_UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D1","REACTOME","105797_REACT_4_UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D1",50,1.3737,0.039,0.37,2.255,0,6.4e-05,0.5969,1,1
"GO_BP:492654_GO_0008343_ADULT_FEEDING_BEHAVIOR","GO_BP","492654_GO_0008343_ADULT_FEEDING_BEHAVIOR",10,1.3741,0.11,0.58,-1.1484,0.3,0.93,1.3581,0.13,0.64
"GO_BP:491362_GO_0006450_REGULATION_OF_TRANSLATIONAL_FIDELITY","GO_BP","491362_GO_0006450_REGULATION_OF_TRANSLATIONAL_FIDELITY",16,1.3756,0.098,0.58,1.5442,0.032,0.35,-1.294,0.12,0.64
"GO_MF:489880_GO_0004532_EXORIBONUCLEASE_ACTIVITY","GO_MF","489880_GO_0004532_EXORIBONUCLEASE_ACTIVITY",33,1.3758,0.073,0.68,1.4191,0.056,0.47,-0.7869,0.79,0.97
"REACTOME:106347_REACT_9515_FGFR1C_LIGAND_BINDING_AND_ACTIVATION","REACTOME","106347_REACT_9515_FGFR1C_LIGAND_BINDING_AND_ACTIVATION",10,1.3758,0.15,0.37,-0.6864,0.87,1,1.005,0.44,1
"GO_CC:490726_GO_0005669_TRANSCRIPTION_FACTOR_TFIID_COMPLEX","GO_CC","490726_GO_0005669_TRANSCRIPTION_FACTOR_TFIID_COMPLEX",23,1.376,0.07,0.35,1.3185,0.1,0.39,-0.847,0.71,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2684_VALK_AML_CLUSTER_8","C2_Chemical_and_genetic_perturbations","C2_CGP_2684_VALK_AML_CLUSTER_8",26,1.3761,0.09,0.61,1.7553,0.006,0.058,-1.1437,0.26,0.58
"C2_Chemical_and_genetic_perturbations:C2_CGP_2412_TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA","C2_Chemical_and_genetic_perturbations","C2_CGP_2412_TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA",75,1.3766,0.039,0.62,1.5615,0.022,0.16,1.145,0.2,0.82
"GO_MF:498592_GO_0019783_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_PROTEASE_ACTIVITY","GO_MF","498592_GO_0019783_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_PROTEASE_ACTIVITY",85,1.3767,0.034,0.69,1.1258,0.22,0.75,0.615,1,1
"GO_MF:492704_GO_0008408_3_5_EXONUCLEASE_ACTIVITY","GO_MF","492704_GO_0008408_3_5_EXONUCLEASE_ACTIVITY",44,1.3777,0.063,0.7,1.2194,0.17,0.7,-0.897,0.68,0.87
"C4_Cancer_gene_neighborhoods:C4_CGN_213_GCM_CASP2","C4_Cancer_gene_neighborhoods","C4_CGN_213_GCM_CASP2",27,1.3782,0.065,0.18,-0.5632,0.98,1,-0.4665,1,1
"KEGG_module:HSA_M00181_RNA_POLYMERASE_III_EUKARYOTES","KEGG_module","HSA_M00181_RNA_POLYMERASE_III_EUKARYOTES",17,1.3787,0.092,0.39,0.7997,0.77,0.94,-0.6152,0.97,1
"REACTOME:105796_REACT_938_UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D","REACTOME","105796_REACT_938_UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D",50,1.3789,0.046,0.36,2.2552,0,6.6e-05,0.596,0.99,1
"GO_CC:490721_GO_0005664_NUCLEAR_ORIGIN_OF_REPLICATION_RECOGNITION_COMPLEX","GO_CC","490721_GO_0005664_NUCLEAR_ORIGIN_OF_REPLICATION_RECOGNITION_COMPLEX",9,1.379,0.12,0.35,1.3358,0.15,0.37,-1.2631,0.19,0.68
"C4_Cancer_gene_neighborhoods:C4_CGN_233_GCM_HBP1","C4_Cancer_gene_neighborhoods","C4_CGN_233_GCM_HBP1",69,1.3794,0.03,0.19,1.5354,0.01,0.024,0.7986,0.85,1
"GO_BP:491259_GO_0006298_MISMATCH_REPAIR","GO_BP","491259_GO_0006298_MISMATCH_REPAIR",30,1.3796,0.085,0.57,0.9038,0.6,1,-0.8487,0.72,0.96
"C4_Cancer_gene_neighborhoods:C4_CGN_227_GCM_DPF2","C4_Cancer_gene_neighborhoods","C4_CGN_227_GCM_DPF2",32,1.3802,0.062,0.19,1.2359,0.17,0.18,1.1145,0.29,0.61
"C4_Cancer_gene_neighborhoods:C4_CGN_73_MORF_CDC16","C4_Cancer_gene_neighborhoods","C4_CGN_73_MORF_CDC16",74,1.3803,0.017,0.2,1.6079,0.0089,0.014,-0.8691,0.73,1
"REACTOME:105951_REACT_1735_MRNA_SPLICING","REACTOME","105951_REACT_1735_MRNA_SPLICING",114,1.3815,0.016,0.36,1.8029,0,0.02,1.04,0.36,0.97
"REACTOME:1183611_REACT_355367_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY","REACTOME","1183611_REACT_355367_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY",7,1.3819,0.14,0.37,-0.7176,0.83,1,-0.4598,0.99,1
"GO_BP:491314_GO_0006390_TRANSCRIPTION_FROM_MITOCHONDRIAL_PROMOTER","GO_BP","491314_GO_0006390_TRANSCRIPTION_FROM_MITOCHONDRIAL_PROMOTER",10,1.3824,0.12,0.56,1.4037,0.095,0.55,0.8747,0.64,0.96
"C7_Immunologic_signatures:C7_ALL_335_GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP","C7_Immunologic_signatures","C7_ALL_335_GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP",200,1.3826,0,0.026,1.3609,0.011,0.056,1.2476,0.044,0.54
"GO_MF:492617_GO_0008296_3_5_EXODEOXYRIBONUCLEASE_ACTIVITY","GO_MF","492617_GO_0008296_3_5_EXODEOXYRIBONUCLEASE_ACTIVITY",8,1.383,0.13,0.69,1.1789,0.27,0.73,0.9149,0.55,0.94
"GO_BP:494827_GO_0010762_REGULATION_OF_FIBROBLAST_MIGRATION","GO_BP","494827_GO_0010762_REGULATION_OF_FIBROBLAST_MIGRATION",19,1.3851,0.1,0.56,0.7552,0.83,1,0.7469,0.83,1
"GO_BP:505901_GO_0042796_SNRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER","GO_BP","505901_GO_0042796_SNRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER",5,1.3852,0.12,0.56,0.5222,0.97,1,1.1726,0.3,0.72
"GO_BP:510890_GO_0048840_OTOLITH_DEVELOPMENT","GO_BP","510890_GO_0048840_OTOLITH_DEVELOPMENT",5,1.3864,0.16,0.56,1.1855,0.29,0.8,0.9039,0.57,0.94
"REACTOME:1183524_REACT_355313_SIGNALING_BY_FGFR3_MUTANTS","REACTOME","1183524_REACT_355313_SIGNALING_BY_FGFR3_MUTANTS",20,1.3868,0.075,0.36,-0.8403,0.69,1,0.9018,0.6,1
"KEGG_pathway:HSA03018_RNA_DEGRADATION","KEGG_pathway","HSA03018_RNA_DEGRADATION",74,1.3869,0.046,0.15,1.5531,0.0066,0.086,-0.8652,0.75,0.89
"REACTOME:105871_REACT_408_PRESYNAPTIC_PHASE_OF_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE","REACTOME","105871_REACT_408_PRESYNAPTIC_PHASE_OF_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE",6,1.3869,0.13,0.36,1.2109,0.26,0.44,-0.5806,0.94,1
"C4_Cancer_gene_neighborhoods:C4_CGN_389_GNF2_PA2G4","C4_Cancer_gene_neighborhoods","C4_CGN_389_GNF2_PA2G4",79,1.3871,0.016,0.19,2.392,0,0,-0.9012,0.68,1
"GO_BP:487574_GO_0001661_CONDITIONED_TASTE_AVERSION","GO_BP","487574_GO_0001661_CONDITIONED_TASTE_AVERSION",5,1.3892,0.13,0.55,-1.2551,0.22,0.91,1.2946,0.16,0.67
"C2_Chemical_and_genetic_perturbations:C2_CGP_2708_BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2708_BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP",188,1.3908,0.014,0.59,2.2073,0,0.00057,-0.7105,0.99,0.98
"GO_BP:503275_GO_0034067_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS","GO_BP","503275_GO_0034067_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS",32,1.3908,0.06,0.55,0.8117,0.79,1,0.9485,0.56,0.9
"GO_BP:516189_GO_0071265_L_METHIONINE_BIOSYNTHETIC_PROCESS","GO_BP","516189_GO_0071265_L_METHIONINE_BIOSYNTHETIC_PROCESS",11,1.3909,0.11,0.56,-0.7163,0.84,1,-1.2268,0.2,0.7
"C7_Immunologic_signatures:C7_ALL_80_GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN","C7_Immunologic_signatures","C7_ALL_80_GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN",193,1.3916,0.016,0.023,1.3588,0.012,0.057,1.3704,0.0038,0.18
"C4_Cancer_gene_neighborhoods:C4_CGN_176_MORF_SART1","C4_Cancer_gene_neighborhoods","C4_CGN_176_MORF_SART1",63,1.3919,0.037,0.19,2.6636,0,0,0.9576,0.57,0.92
"GO_BP:515066_GO_0070129_REGULATION_OF_MITOCHONDRIAL_TRANSLATION","GO_BP","515066_GO_0070129_REGULATION_OF_MITOCHONDRIAL_TRANSLATION",10,1.3944,0.11,0.55,1.1711,0.28,0.81,0.6754,0.88,1
"GO_MF:492529_GO_0008186_RNA_DEPENDENT_ATPASE_ACTIVITY","GO_MF","492529_GO_0008186_RNA_DEPENDENT_ATPASE_ACTIVITY",39,1.3949,0.05,0.67,0.7722,0.85,1,0.6081,0.98,1
"GO_CC:490737_GO_0005683_U7_SNRNP","GO_CC","490737_GO_0005683_U7_SNRNP",7,1.396,0.11,0.33,1.6582,0.011,0.083,1.1952,0.23,0.84
"GO_MF:489475_GO_0004004_ATP_DEPENDENT_RNA_HELICASE_ACTIVITY","GO_MF","489475_GO_0004004_ATP_DEPENDENT_RNA_HELICASE_ACTIVITY",38,1.3963,0.047,0.68,0.7996,0.8,1,0.6159,0.98,1
"GO_BP:516191_GO_0071267_L_METHIONINE_SALVAGE","GO_BP","516191_GO_0071267_L_METHIONINE_SALVAGE",11,1.3964,0.085,0.55,-0.731,0.8,1,-1.2086,0.22,0.73
"C3_TF_targets:C3_TFT_526_TMTCGCGANR_UNKNOWN","C3_TF_targets","C3_TFT_526_TMTCGCGANR_UNKNOWN",160,1.3966,0.012,0.11,1.3862,0.0045,0.35,-0.8764,0.79,0.96
"GO_BP:518786_GO_2000138_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS","GO_BP","518786_GO_2000138_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS",5,1.3977,0.12,0.55,0.9835,0.46,1,1.3666,0.15,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_1313_DER_IFN_BETA_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1313_DER_IFN_BETA_RESPONSE_DN",7,1.3983,0.11,0.58,0.7729,0.76,1,1.2354,0.23,0.74
"C7_Immunologic_signatures:C7_ALL_951_GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP","C7_Immunologic_signatures","C7_ALL_951_GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP",200,1.3985,0,0.022,1.4082,0.0096,0.035,-0.7824,0.97,1
"C4_Cancer_gene_neighborhoods:C4_CGN_241_GCM_MAX","C4_Cancer_gene_neighborhoods","C4_CGN_241_GCM_MAX",30,1.3997,0.056,0.19,1.5376,0.017,0.024,-0.6174,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2450_SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2450_SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN",8,1.3997,0.11,0.6,0.9806,0.46,0.81,1.4113,0.12,0.54
"GO_BP:510577_GO_0048505_REGULATION_OF_TIMING_OF_CELL_DIFFERENTIATION","GO_BP","510577_GO_0048505_REGULATION_OF_TIMING_OF_CELL_DIFFERENTIATION",11,1.4,0.089,0.54,-0.7933,0.72,1,0.8053,0.73,1
"GO_BP:491839_GO_0007004_TELOMERE_MAINTENANCE_VIA_TELOMERASE","GO_BP","491839_GO_0007004_TELOMERE_MAINTENANCE_VIA_TELOMERASE",11,1.4,0.11,0.54,1.3317,0.13,0.63,0.4446,0.99,1
"REACTOME:105836_REACT_6785_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C","REACTOME","105836_REACT_6785_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C",60,1.4014,0.047,0.34,2.3699,0,0,0.8016,0.85,1
"KEGG_compound:C00063_CTP_CYTIDINE_5_TRIPHOSPHATE_CYTIDINE_TRIPHOSPHATE","KEGG_compound","C00063_CTP_CYTIDINE_5_TRIPHOSPHATE_CYTIDINE_TRIPHOSPHATE",55,1.4014,0.052,0.75,0.8574,0.73,1,-0.6518,0.98,0.93
"GO_BP:514933_GO_0065002_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_TRANSPORT","GO_BP","514933_GO_0065002_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_TRANSPORT",37,1.4017,0.079,0.54,1.5118,0.033,0.39,-0.6875,0.96,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_918_WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_918_WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN",5,1.4019,0.12,0.61,1.209,0.25,0.48,-0.6753,0.86,0.99
"C4_Cancer_gene_neighborhoods:C4_CGN_72_MORF_CDC10","C4_Cancer_gene_neighborhoods","C4_CGN_72_MORF_CDC10",145,1.4027,0.0059,0.19,1.827,0,0.0016,0.4633,1,1
"REACTOME:1183523_REACT_355310_SIGNALING_BY_FGFR3_IN_DISEASE","REACTOME","1183523_REACT_355310_SIGNALING_BY_FGFR3_IN_DISEASE",20,1.4032,0.086,0.34,-0.8196,0.72,1,0.9101,0.56,1
"C4_Cancer_gene_neighborhoods:C4_CGN_375_GNF2_MBD4","C4_Cancer_gene_neighborhoods","C4_CGN_375_GNF2_MBD4",25,1.4042,0.071,0.19,2.3921,0,0,1.0578,0.39,0.66
"REACTOME:1183612_REACT_355510_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR","REACTOME","1183612_REACT_355510_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR",19,1.4048,0.088,0.34,1.5174,0.043,0.14,-0.786,0.78,1
"KEGG_module:HSA_M00048_INOSINE_MONOPHOSPHATE_BIOSYNTHESIS_PRPP_GLUTAMINE_IMP","KEGG_module","HSA_M00048_INOSINE_MONOPHOSPHATE_BIOSYNTHESIS_PRPP_GLUTAMINE_IMP",6,1.4048,0.12,0.37,0.9856,0.46,0.89,0.5579,0.96,1
"GO_MF:489238_GO_0003688_DNA_REPLICATION_ORIGIN_BINDING","GO_MF","489238_GO_0003688_DNA_REPLICATION_ORIGIN_BINDING",7,1.4053,0.13,0.66,1.5557,0.053,0.32,-1.0112,0.47,0.78
"C7_Immunologic_signatures:C7_ALL_189_GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP","C7_Immunologic_signatures","C7_ALL_189_GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP",197,1.4055,0,0.02,1.9579,0,0,1.7506,0,0.00064
"REACTOME:1183552_REACT_188330_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING","REACTOME","1183552_REACT_188330_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING",59,1.4068,0.043,0.34,2.179,0,0.00019,0.5566,1,1
"GO_BP:516404_GO_0071480_CELLULAR_RESPONSE_TO_GAMMA_RADIATION","GO_BP","516404_GO_0071480_CELLULAR_RESPONSE_TO_GAMMA_RADIATION",15,1.4073,0.083,0.53,1.0873,0.34,0.92,-0.9277,0.54,0.9
"C4_Cancer_gene_neighborhoods:C4_CGN_301_GNF2_HDAC1","C4_Cancer_gene_neighborhoods","C4_CGN_301_GNF2_HDAC1",110,1.4076,0.0059,0.19,1.9356,0,0.00058,-0.6031,1,1
"GO_BP:518916_GO_2000269_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS","GO_BP","518916_GO_2000269_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS",16,1.4095,0.085,0.53,1.024,0.42,0.97,-0.7782,0.75,1
"GO_BP:518918_GO_2000271_POSITIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS","GO_BP","518918_GO_2000271_POSITIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS",6,1.4095,0.12,0.53,0.8582,0.61,1,0.776,0.72,1
"GO_BP:948074_GO_0044829_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION","GO_BP","948074_GO_0044829_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION",5,1.4099,0.11,0.53,1.3447,0.14,0.61,1.1611,0.31,0.73
"C7_Immunologic_signatures:C7_ALL_117_GSE12366_NAIVE_VS_MEMORY_BCELL_UP","C7_Immunologic_signatures","C7_ALL_117_GSE12366_NAIVE_VS_MEMORY_BCELL_UP",190,1.4108,0,0.019,0.6062,1,1,-0.8435,0.91,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_945_JIANG_CORE_DUPLICON_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_945_JIANG_CORE_DUPLICON_GENES",11,1.4117,0.1,0.59,-1.0392,0.4,0.97,1.0692,0.38,0.89
"REACTOME:205244_REACT_27258_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT_","REACTOME","205244_REACT_27258_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT_",29,1.4123,0.063,0.33,2.0255,0,0.0016,1.3018,0.12,0.76
"GO_BP:499110_GO_0021830_INTERNEURON_MIGRATION_FROM_THE_SUBPALLIUM_TO_THE_CORTEX","GO_BP","499110_GO_0021830_INTERNEURON_MIGRATION_FROM_THE_SUBPALLIUM_TO_THE_CORTEX",5,1.4124,0.13,0.53,-1.6143,0.018,0.7,0.7237,0.81,1
"GO_CC:490741_GO_0005687_U4_SNRNP","GO_CC","490741_GO_0005687_U4_SNRNP",9,1.4132,0.089,0.31,1.6952,0.0082,0.064,1.1349,0.29,0.86
"GO_CC:487830_GO_0001939_FEMALE_PRONUCLEUS","GO_CC","487830_GO_0001939_FEMALE_PRONUCLEUS",8,1.4133,0.096,0.31,0.7246,0.82,0.99,-0.6928,0.85,1
"REACTOME:105952_REACT_467_MRNA_SPLICING_MAJOR_PATHWAY","REACTOME","105952_REACT_467_MRNA_SPLICING_MAJOR_PATHWAY",114,1.4154,0.031,0.33,1.8193,0,0.018,1.0491,0.34,0.96
"C7_Immunologic_signatures:C7_ALL_229_GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP","C7_Immunologic_signatures","C7_ALL_229_GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP",199,1.4157,0.008,0.019,1.5779,0,0.0043,-1.0181,0.4,0.69
"GO_MF:492405_GO_0008026_ATP_DEPENDENT_HELICASE_ACTIVITY","GO_MF","492405_GO_0008026_ATP_DEPENDENT_HELICASE_ACTIVITY",73,1.4159,0.027,0.64,0.8141,0.85,1,-0.7284,0.97,0.99
"C2_Chemical_and_genetic_perturbations:C2_CGP_3195_BILANGES_SERUM_RESPONSE_TRANSLATION","C2_Chemical_and_genetic_perturbations","C2_CGP_3195_BILANGES_SERUM_RESPONSE_TRANSLATION",35,1.416,0.049,0.59,2.8296,0,0,0.8363,0.76,1
"GO_BP:751885_GO_0044743_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_IMPORT","GO_BP","751885_GO_0044743_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_IMPORT",31,1.4161,0.04,0.52,1.57,0.028,0.33,-0.8262,0.74,0.97
"GO_BP:486553_GO_0000002_MITOCHONDRIAL_GENOME_MAINTENANCE","GO_BP","486553_GO_0000002_MITOCHONDRIAL_GENOME_MAINTENANCE",25,1.4167,0.061,0.52,0.8185,0.76,1,-0.7697,0.82,1
"GO_BP:486854_GO_0000338_PROTEIN_DENEDDYLATION","GO_BP","486854_GO_0000338_PROTEIN_DENEDDYLATION",12,1.4171,0.093,0.52,1.6572,0.019,0.24,1.0287,0.41,0.82
"C4_Cancer_modules:C4_CM_290_MODULE_331","C4_Cancer_modules","C4_CM_290_MODULE_331",74,1.4178,0.027,0.29,1.2789,0.098,0.3,0.7639,0.92,1
"GO_BP:491161_GO_0006189_DE_NOVO_IMP_BIOSYNTHETIC_PROCESS","GO_BP","491161_GO_0006189_DE_NOVO_IMP_BIOSYNTHETIC_PROCESS",6,1.4194,0.12,0.52,0.9819,0.49,1,0.5629,0.96,1
"GO_BP:505902_GO_0042797_TRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER","GO_BP","505902_GO_0042797_TRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER",6,1.4203,0.11,0.52,1.2991,0.17,0.67,0.7627,0.76,1
"REACTOME:106565_REACT_571_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER","REACTOME","106565_REACT_571_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER",28,1.4207,0.046,0.33,0.7363,0.89,1,-0.5982,0.99,1
"KEGG_pathway:HSA04122_SULFUR_RELAY_SYSTEM","KEGG_pathway","HSA04122_SULFUR_RELAY_SYSTEM",10,1.4225,0.11,0.13,1.0996,0.31,0.78,0.9916,0.43,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1761_MA_PITUITARY_FETAL_VS_ADULT_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1761_MA_PITUITARY_FETAL_VS_ADULT_DN",18,1.4233,0.093,0.59,1.1695,0.22,0.53,0.9013,0.59,1
"GO_CC:486664_GO_0000125_PCAF_COMPLEX","GO_CC","486664_GO_0000125_PCAF_COMPLEX",6,1.4235,0.13,0.3,0.964,0.5,0.82,1.3067,0.18,0.73
"GO_BP:515455_GO_0070525_THREONYLCARBAMOYLADENOSINE_METABOLIC_PROCESS","GO_BP","515455_GO_0070525_THREONYLCARBAMOYLADENOSINE_METABOLIC_PROCESS",5,1.4243,0.11,0.51,0.855,0.64,1,-0.7498,0.78,1
"GO_MF:506526_GO_0043495_PROTEIN_ANCHOR","GO_MF","506526_GO_0043495_PROTEIN_ANCHOR",8,1.4253,0.11,0.62,0.8569,0.66,1,0.9269,0.55,0.94
"GO_BP:492508_GO_0032786_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION","GO_BP","492508_GO_0032786_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION",24,1.4255,0.064,0.51,1.3939,0.074,0.56,1.215,0.2,0.71
"GO_BP:911392_GO_0098534_CENTRIOLE_ASSEMBLY","GO_BP","911392_GO_0098534_CENTRIOLE_ASSEMBLY",14,1.4258,0.093,0.51,-0.789,0.76,1,-0.8511,0.65,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_2414_CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2414_CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN",28,1.4278,0.08,0.59,1.653,0.011,0.11,0.6567,0.95,1
"GO_CC:490814_GO_0005786_SIGNAL_RECOGNITION_PARTICLE_ENDOPLASMIC_RETICULUM_TARGETING","GO_CC","490814_GO_0005786_SIGNAL_RECOGNITION_PARTICLE_ENDOPLASMIC_RETICULUM_TARGETING",6,1.4281,0.087,0.29,1.8163,0.0043,0.023,1.0524,0.4,0.98
"GO_BP:510844_GO_0048793_PRONEPHROS_DEVELOPMENT","GO_BP","510844_GO_0048793_PRONEPHROS_DEVELOPMENT",9,1.4292,0.098,0.51,-0.7077,0.86,1,-0.4647,0.99,1
"GO_CC:490740_GO_0005686_U2_SNRNP","GO_CC","490740_GO_0005686_U2_SNRNP",6,1.4293,0.11,0.3,1.6645,0.016,0.081,1.3459,0.13,0.73
"GO_BP:510699_GO_0048643_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","510699_GO_0048643_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT",17,1.4298,0.072,0.51,0.906,0.62,1,-0.7172,0.85,0.99
"GO_BP:510494_GO_0048387_NEGATIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY","GO_BP","510494_GO_0048387_NEGATIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY",16,1.4301,0.064,0.51,-0.8667,0.67,1,0.9167,0.57,0.93
"GO_BP:505896_GO_0042791_5S_CLASS_RRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_TYPE_1_PROMOTER","GO_BP","505896_GO_0042791_5S_CLASS_RRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_TYPE_1_PROMOTER",6,1.4307,0.094,0.51,1.3228,0.16,0.64,0.7498,0.81,1
"GO_BP:512270_GO_0051386_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY","GO_BP","512270_GO_0051386_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY",7,1.4307,0.098,0.51,1.5695,0.034,0.33,1.8882,0,0.17
"REACTOME:1127506_REACT_267948_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM","REACTOME","1127506_REACT_267948_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM",23,1.4318,0.057,0.31,1.2885,0.14,0.34,-0.7719,0.83,1
"GO_BP:507447_GO_0045046_PROTEIN_IMPORT_INTO_PEROXISOME_MEMBRANE","GO_BP","507447_GO_0045046_PROTEIN_IMPORT_INTO_PEROXISOME_MEMBRANE",6,1.4319,0.13,0.51,1.4792,0.073,0.44,0.6744,0.84,1
"GO_BP:492811_GO_0008535_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY","GO_BP","492811_GO_0008535_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY",14,1.4327,0.087,0.51,1.1242,0.31,0.88,-0.6636,0.91,1
"GO_BP:496168_GO_0016074_SNORNA_METABOLIC_PROCESS","GO_BP","496168_GO_0016074_SNORNA_METABOLIC_PROCESS",5,1.4338,0.11,0.51,1.3471,0.15,0.61,1.0275,0.44,0.83
"C7_Immunologic_signatures:C7_ALL_1347_GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1347_GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP",200,1.4371,0.008,0.014,1.8971,0,0,-0.8112,0.96,1
"GO_CC:983680_GO_0090576_RNA_POLYMERASE_III_TRANSCRIPTION_FACTOR_COMPLEX","GO_CC","983680_GO_0090576_RNA_POLYMERASE_III_TRANSCRIPTION_FACTOR_COMPLEX",7,1.4407,0.1,0.28,1.2404,0.21,0.47,0.598,0.94,1
"C1_Positional:C1_ALL_174_CHR4Q","C1_Positional","C1_ALL_174_CHR4Q",5,1.4426,0.1,0.35,1.3446,0.17,0.48,-0.7402,0.81,1
"GO_MF:490604_GO_0005487_NUCLEOCYTOPLASMIC_TRANSPORTER_ACTIVITY","GO_MF","490604_GO_0005487_NUCLEOCYTOPLASMIC_TRANSPORTER_ACTIVITY",14,1.4433,0.078,0.58,-0.7259,0.81,1,-0.6968,0.88,1
"GO_BP:491518_GO_0006626_PROTEIN_TARGETING_TO_MITOCHONDRION","GO_BP","491518_GO_0006626_PROTEIN_TARGETING_TO_MITOCHONDRION",56,1.4445,0.025,0.49,1.9316,0,0.028,0.6502,0.98,1
"GO_CC:486666_GO_0000127_TRANSCRIPTION_FACTOR_TFIIIC_COMPLEX","GO_CC","486666_GO_0000127_TRANSCRIPTION_FACTOR_TFIIIC_COMPLEX",6,1.4455,0.1,0.28,1.3173,0.16,0.39,0.7374,0.81,1
"KEGG_module:HSA_M00413_FA_CORE_COMPLEX","KEGG_module","HSA_M00413_FA_CORE_COMPLEX",10,1.4457,0.077,0.32,0.7189,0.84,0.94,-0.7178,0.84,0.98
"KEGG_compound:C02189__PROTEIN_L_SERINE_PROTEIN_SERINE_PROTEIN_L_SERINE","KEGG_compound","C02189__PROTEIN_L_SERINE_PROTEIN_SERINE_PROTEIN_L_SERINE",31,1.4471,0.031,0.66,-0.8063,0.75,1,0.8759,0.66,0.84
"GO_CC:510573_GO_0048500_SIGNAL_RECOGNITION_PARTICLE","GO_CC","510573_GO_0048500_SIGNAL_RECOGNITION_PARTICLE",6,1.4471,0.12,0.28,1.7994,0.0061,0.027,1.0387,0.45,0.98
"GO_CC:500679_GO_0031428_BOX_C_D_SNORNP_COMPLEX","GO_CC","500679_GO_0031428_BOX_C_D_SNORNP_COMPLEX",5,1.4472,0.095,0.28,1.5357,0.036,0.17,-0.3672,1,1
"C7_Immunologic_signatures:C7_ALL_1175_GSE27786_LIN_NEG_VS_MONO_MAC_UP","C7_Immunologic_signatures","C7_ALL_1175_GSE27786_LIN_NEG_VS_MONO_MAC_UP",198,1.4479,0,0.012,1.1889,0.072,0.25,-0.6627,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1532_GALE_APL_WITH_FLT3_MUTATED_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1532_GALE_APL_WITH_FLT3_MUTATED_UP",56,1.4491,0.021,0.54,1.2553,0.12,0.43,-0.5775,0.99,0.99
"C4_Cancer_gene_neighborhoods:C4_CGN_137_MORF_NPM1","C4_Cancer_gene_neighborhoods","C4_CGN_137_MORF_NPM1",162,1.4502,0,0.15,3.7332,0,0,-0.714,1,1
"C1_Positional:C1_ALL_43_CHR4Q35","C1_Positional","C1_ALL_43_CHR4Q35",37,1.4516,0.043,0.36,1.1878,0.2,0.6,-1.2067,0.18,0.65
"C4_Cancer_gene_neighborhoods:C4_CGN_94_MORF_EIF4E","C4_Cancer_gene_neighborhoods","C4_CGN_94_MORF_EIF4E",85,1.4519,0.023,0.15,1.5453,0.0045,0.023,0.6785,0.99,1
"REACTOME:187213_REACT_24915_BUTYRATE_RESPONSE_FACTOR_1_BRF1_DESTABILIZES_MRNA","REACTOME","187213_REACT_24915_BUTYRATE_RESPONSE_FACTOR_1_BRF1_DESTABILIZES_MRNA",17,1.4524,0.056,0.28,1.5445,0.036,0.12,0.9712,0.49,1
"WikiPathways:198775_WP1559_TFS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY","WikiPathways","198775_WP1559_TFS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY",9,1.4541,0.093,0.27,-0.7685,0.76,1,-0.6474,0.91,0.99
"KEGG_module:HSA_M00396_LSM_2_8_COMPLEX","KEGG_module","HSA_M00396_LSM_2_8_COMPLEX",7,1.4544,0.087,0.33,1.4098,0.085,0.27,0.8077,0.7,1
"GO_MF:495347_GO_0015057_THROMBIN_RECEPTOR_ACTIVITY","GO_MF","495347_GO_0015057_THROMBIN_RECEPTOR_ACTIVITY",5,1.4552,0.087,0.56,1.5821,0.02,0.3,0.68,0.82,1
"C4_Cancer_gene_neighborhoods:C4_CGN_49_MORF_TERF1","C4_Cancer_gene_neighborhoods","C4_CGN_49_MORF_TERF1",66,1.4554,0.015,0.15,1.2282,0.14,0.19,-0.4894,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2083_SANSOM_APC_TARGETS_REQUIRE_MYC","C2_Chemical_and_genetic_perturbations","C2_CGP_2083_SANSOM_APC_TARGETS_REQUIRE_MYC",207,1.456,0,0.54,0.8652,0.87,0.96,-1.017,0.37,0.73
"GO_BP:492877_GO_0008628_HORMONE_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY","GO_BP","492877_GO_0008628_HORMONE_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY",5,1.4563,0.099,0.46,-1.1972,0.27,0.9,0.696,0.83,1
"GO_BP:502210_GO_0032988_RIBONUCLEOPROTEIN_COMPLEX_DISASSEMBLY","GO_BP","502210_GO_0032988_RIBONUCLEOPROTEIN_COMPLEX_DISASSEMBLY",10,1.4565,0.091,0.46,1.4294,0.074,0.52,1.2034,0.21,0.72
"C2_Chemical_and_genetic_perturbations:C2_CGP_2292_WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2292_WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP",6,1.4567,0.096,0.56,-1.1236,0.32,0.89,1.1715,0.29,0.8
"REACTOME:106361_REACT_17041_VASOPRESSIN_LIKE_RECEPTORS","REACTOME","106361_REACT_17041_VASOPRESSIN_LIKE_RECEPTORS",6,1.457,0.1,0.28,-0.6646,0.9,1,-1.7344,0.012,0.2
"GO_MF:501419_GO_0032184_SUMO_POLYMER_BINDING","GO_MF","501419_GO_0032184_SUMO_POLYMER_BINDING",5,1.4574,0.1,0.56,0.866,0.65,1,0.9904,0.45,0.88
"GO_BP:502964_GO_0033753_ESTABLISHMENT_OF_RIBOSOME_LOCALIZATION","GO_BP","502964_GO_0033753_ESTABLISHMENT_OF_RIBOSOME_LOCALIZATION",6,1.4593,0.081,0.46,1.5581,0.037,0.34,1.3451,0.12,0.65
"REACTOME:106541_REACT_8030_EXTENSION_OF_TELOMERES","REACTOME","106541_REACT_8030_EXTENSION_OF_TELOMERES",29,1.4612,0.038,0.27,1.6145,0.015,0.087,-1.1965,0.21,0.61
"GO_BP:493488_GO_0009304_TRNA_TRANSCRIPTION","GO_BP","493488_GO_0009304_TRNA_TRANSCRIPTION",7,1.4616,0.093,0.46,1.2547,0.2,0.73,0.6057,0.92,1
"GO_BP:502013_GO_0032790_RIBOSOME_DISASSEMBLY","GO_BP","502013_GO_0032790_RIBOSOME_DISASSEMBLY",7,1.4629,0.081,0.46,1.5782,0.034,0.31,1.03,0.42,0.82
"REACTOME:106561_REACT_1371_RNA_POLYMERASE_III_TRANSCRIPTION","REACTOME","106561_REACT_1371_RNA_POLYMERASE_III_TRANSCRIPTION",40,1.4629,0.024,0.27,1.0299,0.4,0.69,-0.8917,0.62,0.96
"C2_Chemical_and_genetic_perturbations:C2_CGP_1059_RICKMAN_METASTASIS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1059_RICKMAN_METASTASIS_UP",340,1.4636,0,0.55,1.358,0.0073,0.33,-0.7935,0.99,0.96
"GO_MF:490710_GO_0008536_RAN_GTPASE_BINDING","GO_MF","490710_GO_0008536_RAN_GTPASE_BINDING",26,1.465,0.044,0.56,1.104,0.3,0.78,-0.9504,0.52,0.83
"REACTOME:160947_REACT_22107_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS","REACTOME","160947_REACT_22107_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS",64,1.4662,0.0041,0.27,1.7184,0.002,0.041,1.2117,0.16,0.83
"GO_BP:486601_GO_0000054_RIBOSOMAL_SUBUNIT_EXPORT_FROM_NUCLEUS","GO_BP","486601_GO_0000054_RIBOSOMAL_SUBUNIT_EXPORT_FROM_NUCLEUS",6,1.4664,0.088,0.45,1.5559,0.028,0.33,1.3717,0.14,0.64
"GO_CC:490773_GO_0005732_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX","GO_CC","490773_GO_0005732_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX",15,1.4666,0.046,0.26,1.6558,0.024,0.083,0.8222,0.7,1
"GO_BP:518213_GO_0090073_POSITIVE_REGULATION_OF_PROTEIN_HOMODIMERIZATION_ACTIVITY","GO_BP","518213_GO_0090073_POSITIVE_REGULATION_OF_PROTEIN_HOMODIMERIZATION_ACTIVITY",7,1.4668,0.061,0.45,1.2701,0.19,0.71,0.7446,0.81,1
"GO_BP:496509_GO_0016558_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX","GO_BP","496509_GO_0016558_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX",13,1.467,0.066,0.45,0.9491,0.53,1,-0.9539,0.51,0.89
"GO_BP:502430_GO_0033210_LEPTIN_MEDIATED_SIGNALING_PATHWAY","GO_BP","502430_GO_0033210_LEPTIN_MEDIATED_SIGNALING_PATHWAY",6,1.4672,0.086,0.46,1.3087,0.17,0.66,0.6238,0.89,1
"REACTOME:833803_REACT_163931_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY","REACTOME","833803_REACT_163931_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY",33,1.4672,0.038,0.27,1.2263,0.19,0.42,0.7233,0.91,1
"REACTOME:576252_REACT_118778_ACTIVATION_OF_RAS_IN_B_CELLS","REACTOME","576252_REACT_118778_ACTIVATION_OF_RAS_IN_B_CELLS",5,1.4676,0.075,0.28,1.5483,0.053,0.12,1.2779,0.21,0.78
"GO_CC:490738_GO_0005684_U2_TYPE_SPLICEOSOMAL_COMPLEX","GO_CC","490738_GO_0005684_U2_TYPE_SPLICEOSOMAL_COMPLEX",7,1.4676,0.076,0.26,1.4861,0.069,0.21,0.6218,0.93,1
"REACTOME:105996_REACT_6233_TRANSCRIPTION_OF_THE_HIV_GENOME","REACTOME","105996_REACT_6233_TRANSCRIPTION_OF_THE_HIV_GENOME",66,1.4686,0.018,0.28,1.7401,0.0021,0.035,1.2457,0.12,0.78
"GO_CC:486708_GO_0000177_CYTOPLASMIC_EXOSOME_RNASE_COMPLEX_","GO_CC","486708_GO_0000177_CYTOPLASMIC_EXOSOME_RNASE_COMPLEX_",9,1.4692,0.071,0.26,0.7381,0.8,0.99,-0.775,0.78,1
"REACTOME:106411_REACT_8028_TERMINAL_PATHWAY_OF_COMPLEMENT","REACTOME","106411_REACT_8028_TERMINAL_PATHWAY_OF_COMPLEMENT",7,1.4695,0.12,0.28,1.1013,0.34,0.58,1.3917,0.12,0.7
"GO_BP:496972_GO_0017183_PEPTIDYL_DIPHTHAMIDE_BIOSYNTHETIC_PROCESS_FROM_PEPTIDYL_HISTIDINE","GO_BP","496972_GO_0017183_PEPTIDYL_DIPHTHAMIDE_BIOSYNTHETIC_PROCESS_FROM_PEPTIDYL_HISTIDINE",8,1.4697,0.073,0.45,0.9995,0.46,0.98,0.7125,0.82,1
"GO_BP:502961_GO_0033750_RIBOSOME_LOCALIZATION","GO_BP","502961_GO_0033750_RIBOSOME_LOCALIZATION",6,1.4701,0.11,0.45,1.5205,0.056,0.38,1.3567,0.12,0.64
"C4_Cancer_modules:C4_CM_27_MODULE_28","C4_Cancer_modules","C4_CM_27_MODULE_28",32,1.4702,0.045,0.24,2.2994,0,0,1.1364,0.27,0.73
"GO_CC:500192_GO_0030897_HOPS_COMPLEX","GO_CC","500192_GO_0030897_HOPS_COMPLEX",12,1.4703,0.073,0.26,1.087,0.33,0.67,-0.854,0.66,1
"C1_Positional:C1_ALL_189_CHR2Q37","C1_Positional","C1_ALL_189_CHR2Q37",117,1.4724,0.012,0.35,1.2932,0.037,0.53,1.6582,0.0039,0.26
"REACTOME:105708_REACT_13450_VITAMINS","REACTOME","105708_REACT_13450_VITAMINS",6,1.4739,0.088,0.28,-0.9794,0.48,1,0.7705,0.76,1
"C4_Cancer_gene_neighborhoods:C4_CGN_247_GCM_NF2","C4_Cancer_gene_neighborhoods","C4_CGN_247_GCM_NF2",302,1.474,0,0.13,1.0962,0.19,0.38,0.6546,1,1
"GO_BP:516729_GO_0071806_PROTEIN_TRANSMEMBRANE_TRANSPORT","GO_BP","516729_GO_0071806_PROTEIN_TRANSMEMBRANE_TRANSPORT",47,1.4759,0.03,0.44,1.7268,0.0045,0.16,-0.5544,1,1
"KEGG_module:HSA_M00289_RF_C_COMPLEX","KEGG_module","HSA_M00289_RF_C_COMPLEX",5,1.4778,0.072,0.32,1.5194,0.049,0.16,1.0638,0.38,0.94
"GO_BP:752558_GO_0090501_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS","GO_BP","752558_GO_0090501_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS",85,1.4779,0.019,0.44,1.7935,0,0.11,0.8083,0.87,1
"GO_BP:500450_GO_0031163_METALLO_SULFUR_CLUSTER_ASSEMBLY","GO_BP","500450_GO_0031163_METALLO_SULFUR_CLUSTER_ASSEMBLY",18,1.48,0.056,0.44,1.7081,0.021,0.19,1.0665,0.37,0.79
"C7_Immunologic_signatures:C7_ALL_1285_GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP","C7_Immunologic_signatures","C7_ALL_1285_GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP",183,1.48,0.007,0.0071,0.9905,0.5,0.77,-1.1214,0.2,0.44
"C1_Positional:C1_ALL_250_CHR3Q13","C1_Positional","C1_ALL_250_CHR3Q13",81,1.4807,0.0041,0.37,1.5453,0,0.29,-0.6112,1,1
"GO_BP:496971_GO_0017182_PEPTIDYL_DIPHTHAMIDE_METABOLIC_PROCESS","GO_BP","496971_GO_0017182_PEPTIDYL_DIPHTHAMIDE_METABOLIC_PROCESS",8,1.4813,0.077,0.44,1.0326,0.39,0.96,0.7033,0.85,1
"KEGG_enzyme:2.3.2.13_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_TRANSGLUTAMINASE_FACTOR_XIIIA_FIBRINOLIGASE_FIBRIN_STABILIZING_FACTOR_GLUTAMINYLPEPTIDE_GAMMA_GLUTAMYLTRANSFERASE_POLYAMINE_TRANSGLUTAMINASE_TISSUE_TRANSGLUTAMINASE_R_GLUTAMINYL_PEPTIDE_AMINE_GAMMA_GLUTAMYL_TRANSFERASE","KEGG_enzyme","2.3.2.13_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_TRANSGLUTAMINASE_FACTOR_XIIIA_FIBRINOLIGASE_FIBRIN_STABILIZING_FACTOR_GLUTAMINYLPEPTIDE_GAMMA_GLUTAMYLTRANSFERASE_POLYAMINE_TRANSGLUTAMINASE_TISSUE_TRANSGLUTAMINASE_R_GLUTAMINYL_PEPTIDE_AMINE_GAMMA_GLUTAMYL_TRANSFERASE",8,1.4818,0.071,0.37,0.9108,0.58,1,1.4028,0.11,0.49
"C7_Immunologic_signatures:C7_ALL_1159_GSE27786_LSK_VS_MONO_MAC_UP","C7_Immunologic_signatures","C7_ALL_1159_GSE27786_LSK_VS_MONO_MAC_UP",198,1.4821,0,0.0072,1.1862,0.092,0.25,-0.9094,0.73,0.93
"REACTOME:160949_REACT_22339_RNA_POLYMERASE_III_ABORTIVE_AND_RETRACTIVE_INITIATION","REACTOME","160949_REACT_22339_RNA_POLYMERASE_III_ABORTIVE_AND_RETRACTIVE_INITIATION",40,1.4834,0.027,0.26,1.0337,0.38,0.69,-0.8757,0.67,0.97
"REACTOME:105895_REACT_18410_FANCONI_ANEMIA_PATHWAY","REACTOME","105895_REACT_18410_FANCONI_ANEMIA_PATHWAY",24,1.4862,0.046,0.26,1.407,0.076,0.22,-0.9074,0.6,0.95
"REACTOME:160951_REACT_1768_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA","REACTOME","160951_REACT_1768_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA",23,1.4865,0.058,0.27,1.5071,0.047,0.14,0.9598,0.51,1
"GO_BP:515170_GO_0070235_REGULATION_OF_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS","GO_BP","515170_GO_0070235_REGULATION_OF_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS",5,1.4872,0.081,0.43,1.1293,0.31,0.87,0.969,0.49,0.89
"GO_CC:513461_GO_0055029_NUCLEAR_DNA_DIRECTED_RNA_POLYMERASE_COMPLEX","GO_CC","513461_GO_0055029_NUCLEAR_DNA_DIRECTED_RNA_POLYMERASE_COMPLEX",115,1.4884,0.0056,0.24,1.325,0.036,0.38,-0.7188,0.99,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2872_KYNG_NORMAL_AGING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2872_KYNG_NORMAL_AGING_UP",18,1.4887,0.061,0.49,1.1415,0.27,0.56,0.6049,0.97,1
"GO_BP:490809_GO_0006625_PROTEIN_TARGETING_TO_PEROXISOME","GO_BP","490809_GO_0006625_PROTEIN_TARGETING_TO_PEROXISOME",17,1.4889,0.065,0.42,1.243,0.19,0.74,-0.7448,0.83,1
"GO_BP:517566_GO_0072663_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PEROXISOME","GO_BP","517566_GO_0072663_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PEROXISOME",18,1.4896,0.061,0.43,1.2679,0.18,0.71,-0.7618,0.8,1
"GO_BP:491247_GO_0006284_BASE_EXCISION_REPAIR","GO_BP","491247_GO_0006284_BASE_EXCISION_REPAIR",44,1.4897,0.039,0.43,1.6904,0.0042,0.21,-0.7668,0.86,1
"C1_Positional:C1_ALL_159_CHR7P22","C1_Positional","C1_ALL_159_CHR7P22",77,1.4898,0.0087,0.39,1.1335,0.21,0.62,1.1077,0.28,0.72
"GO_BP:518584_GO_0097034_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_IV_BIOGENESIS","GO_BP","518584_GO_0097034_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_IV_BIOGENESIS",7,1.4906,0.078,0.43,0.7216,0.83,1,-0.5905,0.94,1
"GO_CC:487831_GO_0001940_MALE_PRONUCLEUS","GO_CC","487831_GO_0001940_MALE_PRONUCLEUS",6,1.4915,0.089,0.24,1.1374,0.32,0.6,-0.7213,0.79,1
"GO_BP:487026_GO_0000729_DNA_DOUBLE_STRAND_BREAK_PROCESSING","GO_BP","487026_GO_0000729_DNA_DOUBLE_STRAND_BREAK_PROCESSING",10,1.4919,0.075,0.43,1.0091,0.43,0.98,0.9272,0.56,0.92
"KEGG_reaction:R08281_ALCOPHOSPHAMIDE_NAD_OXIDOREDUCTASE_ALDOPHOSPHAMIDE_NADH_H_ALCOPHOSPHAMIDE_NAD_","KEGG_reaction","R08281_ALCOPHOSPHAMIDE_NAD_OXIDOREDUCTASE_ALDOPHOSPHAMIDE_NADH_H_ALCOPHOSPHAMIDE_NAD_",7,1.4937,0.066,0.45,1.0947,0.33,0.9,1.033,0.43,0.61
"GO_BP:487987_GO_0002098_TRNA_WOBBLE_URIDINE_MODIFICATION","GO_BP","487987_GO_0002098_TRNA_WOBBLE_URIDINE_MODIFICATION",7,1.4948,0.069,0.42,1.5392,0.043,0.36,1.3168,0.16,0.66
"GO_BP:499306_GO_0022027_INTERKINETIC_NUCLEAR_MIGRATION","GO_BP","499306_GO_0022027_INTERKINETIC_NUCLEAR_MIGRATION",9,1.4958,0.063,0.42,0.6526,0.9,1,-0.6691,0.88,1
"GO_BP:496295_GO_0016226_IRON_SULFUR_CLUSTER_ASSEMBLY","GO_BP","496295_GO_0016226_IRON_SULFUR_CLUSTER_ASSEMBLY",18,1.4969,0.034,0.42,1.6991,0.0043,0.19,1.0796,0.34,0.78
"C4_Cancer_gene_neighborhoods:C4_CGN_350_GNF2_ELAC2","C4_Cancer_gene_neighborhoods","C4_CGN_350_GNF2_ELAC2",46,1.497,0.032,0.12,1.0626,0.34,0.44,-0.6921,0.93,1
"GO_BP:493442_GO_0009249_PROTEIN_LIPOYLATION","GO_BP","493442_GO_0009249_PROTEIN_LIPOYLATION",5,1.4977,0.058,0.42,0.917,0.55,1,0.7833,0.73,1
"C7_Immunologic_signatures:C7_ALL_1157_GSE27786_LSK_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_1157_GSE27786_LSK_VS_NEUTROPHIL_UP",199,1.4978,0,0.0059,1.3063,0.017,0.096,-0.7129,1,1
"GO_CC:490743_GO_0005689_U12_TYPE_SPLICEOSOMAL_COMPLEX","GO_CC","490743_GO_0005689_U12_TYPE_SPLICEOSOMAL_COMPLEX",24,1.498,0.046,0.24,2.0635,0.0021,0.0015,1.0833,0.35,0.94
"KEGG_compound:C00469_ETHANOL_ETHYL_ALCOHOL_METHYLCARBINOL","KEGG_compound","C00469_ETHANOL_ETHYL_ALCOHOL_METHYLCARBINOL",8,1.4982,0.078,0.56,1.0344,0.43,1,-0.9162,0.56,0.75
"GO_BP:515576_GO_0070646_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL","GO_BP","515576_GO_0070646_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL",102,1.499,0.0055,0.42,1.3152,0.043,0.65,-0.6504,1,1
"REACTOME:160985_REACT_15292_THYROXINE_BIOSYNTHESIS","REACTOME","160985_REACT_15292_THYROXINE_BIOSYNTHESIS",7,1.499,0.082,0.25,1.1126,0.33,0.56,1.1697,0.26,0.87
"C2_Chemical_and_genetic_perturbations:C2_CGP_2496_WAGNER_APO2_SENSITIVITY","C2_Chemical_and_genetic_perturbations","C2_CGP_2496_WAGNER_APO2_SENSITIVITY",25,1.4994,0.056,0.48,0.8379,0.74,0.98,0.8451,0.73,1
"KEGG_enzyme:1.1.1.1_ALCOHOL_DEHYDROGENASE_ALDEHYDE_REDUCTASE_ADH_ALCOHOL_DEHYDROGENASE_NAD_ALIPHATIC_ALCOHOL_DEHYDROGENASE_ETHANOL_DEHYDROGENASE_NAD_DEPENDENT_ALCOHOL_DEHYDROGENASE_NAD_SPECIFIC_AROMATIC_ALCOHOL_DEHYDROGENASE_NADH_ALCOHOL_DEHYDROGENASE_NADH_ALDEHYDE_DEHYDROGENASE_PRIMARY_ALCOHOL_DEHYDROGENASE_YEAST_ALCOHOL_DEHYDROGENASE","KEGG_enzyme","1.1.1.1_ALCOHOL_DEHYDROGENASE_ALDEHYDE_REDUCTASE_ADH_ALCOHOL_DEHYDROGENASE_NAD_ALIPHATIC_ALCOHOL_DEHYDROGENASE_ETHANOL_DEHYDROGENASE_NAD_DEPENDENT_ALCOHOL_DEHYDROGENASE_NAD_SPECIFIC_AROMATIC_ALCOHOL_DEHYDROGENASE_NADH_ALCOHOL_DEHYDROGENASE_NADH_ALDEHYDE_DEHYDROGENASE_PRIMARY_ALCOHOL_DEHYDROGENASE_YEAST_ALCOHOL_DEHYDROGENASE",7,1.5009,0.068,0.49,1.0857,0.37,0.96,1.0473,0.42,0.67
"GO_MF:489504_GO_0004035_ALKALINE_PHOSPHATASE_ACTIVITY","GO_MF","489504_GO_0004035_ALKALINE_PHOSPHATASE_ACTIVITY",6,1.5011,0.089,0.47,1.621,0.023,0.24,1.2338,0.24,0.69
"GO_BP:489262_GO_0006369_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION","GO_BP","489262_GO_0006369_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION",48,1.5015,0.02,0.42,1.2736,0.12,0.71,0.9554,0.5,0.9
"REACTOME:105893_REACT_74_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_TC_NER","REACTOME","105893_REACT_74_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_TC_NER",17,1.5017,0.053,0.25,1.3441,0.085,0.27,-0.8346,0.72,1
"REACTOME:160995_REACT_20619_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE","REACTOME","160995_REACT_20619_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE",11,1.5025,0.06,0.25,1.6561,0.02,0.067,0.9207,0.57,1
"KEGG_compound:C16586_2_PHENYL_1_3_PROPANEDIOL_MONOCARBAMATE","KEGG_compound","C16586_2_PHENYL_1_3_PROPANEDIOL_MONOCARBAMATE",7,1.5026,0.076,0.63,1.0721,0.38,1,1.0667,0.37,0.62
"C4_Cancer_modules:C4_CM_29_MODULE_32","C4_Cancer_modules","C4_CM_29_MODULE_32",241,1.5032,0,0.22,3.0837,0,0,0.7376,1,1
"GO_BP:486956_GO_0000463_MATURATION_OF_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_","GO_BP","486956_GO_0000463_MATURATION_OF_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_",5,1.5038,0.093,0.42,0.937,0.52,1,0.9844,0.49,0.87
"GO_BP:505821_GO_0042713_SPERM_EJACULATION","GO_BP","505821_GO_0042713_SPERM_EJACULATION",6,1.5043,0.074,0.42,0.8521,0.63,1,-0.9991,0.45,0.85
"GO_BP:486805_GO_0000288_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY","GO_BP","486805_GO_0000288_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY",55,1.5048,0.027,0.42,1.5225,0.017,0.38,-0.6472,0.97,1
"GO_BP:502833_GO_0033617_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY","GO_BP","502833_GO_0033617_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY",7,1.5059,0.067,0.42,0.7211,0.83,1,-0.5947,0.91,1
"GO_BP:505192_GO_0040034_REGULATION_OF_DEVELOPMENT_HETEROCHRONIC","GO_BP","505192_GO_0040034_REGULATION_OF_DEVELOPMENT_HETEROCHRONIC",12,1.507,0.077,0.42,-0.6676,0.89,1,0.9437,0.54,0.91
"GO_BP:516350_GO_0071426_RIBONUCLEOPROTEIN_COMPLEX_EXPORT_FROM_NUCLEUS","GO_BP","516350_GO_0071426_RIBONUCLEOPROTEIN_COMPLEX_EXPORT_FROM_NUCLEUS",6,1.5074,0.067,0.42,1.5516,0.057,0.34,1.356,0.15,0.64
"C2_Chemical_and_genetic_perturbations:C2_CGP_3301_SUZUKI_CTCFL_TARGETS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_3301_SUZUKI_CTCFL_TARGETS_UP",12,1.508,0.054,0.48,0.7538,0.82,1,-1.0826,0.35,0.65
"REACTOME:187214_REACT_25064_TRISTETRAPROLIN_TTP_DESTABILIZES_MRNA","REACTOME","187214_REACT_25064_TRISTETRAPROLIN_TTP_DESTABILIZES_MRNA",17,1.5084,0.03,0.25,1.6364,0.016,0.076,0.9469,0.52,1
"C4_Cancer_gene_neighborhoods:C4_CGN_216_GCM_CHUK","C4_Cancer_gene_neighborhoods","C4_CGN_216_GCM_CHUK",72,1.5088,0.0041,0.11,1.1657,0.19,0.26,0.7568,0.92,1
"KEGG_pathway:HSA03030_DNA_REPLICATION","KEGG_pathway","HSA03030_DNA_REPLICATION",36,1.5099,0.032,0.082,1.9856,0,0.0025,-0.9642,0.5,0.76
"GO_BP:491313_GO_0006388_TRNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION","GO_BP","491313_GO_0006388_TRNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION",10,1.5109,0.068,0.42,1.7789,0.0021,0.12,1.0995,0.35,0.76
"KEGG_reaction:R08306_2_PHENYL_1_3_PROPANEDIOL_MONOCARBAMATE_NAD_OXIDOREDUCTASE_2_PHENYL_1_3_PROPANEDIOL_MONOCARBAMATE_NAD_3_CARBAMOYL_2_PHENYLPROPIONALDEHYDE_NADH_H_","KEGG_reaction","R08306_2_PHENYL_1_3_PROPANEDIOL_MONOCARBAMATE_NAD_OXIDOREDUCTASE_2_PHENYL_1_3_PROPANEDIOL_MONOCARBAMATE_NAD_3_CARBAMOYL_2_PHENYLPROPIONALDEHYDE_NADH_H_",7,1.511,0.073,0.46,1.0914,0.35,0.87,1.0338,0.4,0.63
"GO_CC:503666_GO_0034464_BBSOME","GO_CC","503666_GO_0034464_BBSOME",10,1.5112,0.056,0.22,0.8206,0.69,0.94,-0.6287,0.92,1
"GO_CC:517451_GO_0072546_ER_MEMBRANE_PROTEIN_COMPLEX","GO_CC","517451_GO_0072546_ER_MEMBRANE_PROTEIN_COMPLEX",10,1.5116,0.075,0.23,1.593,0.019,0.12,0.9873,0.47,1
"KEGG_compound:C16551_ALCOPHOSPHAMIDE","KEGG_compound","C16551_ALCOPHOSPHAMIDE",7,1.512,0.075,0.7,1.079,0.37,1,1.0504,0.38,0.64
"GO_BP:491363_GO_0006451_TRANSLATIONAL_READTHROUGH","GO_BP","491363_GO_0006451_TRANSLATIONAL_READTHROUGH",6,1.512,0.065,0.42,-0.7016,0.83,1,0.7456,0.78,1
"C3_TF_targets:C3_TFT_414_GGAANCGGAANY_UNKNOWN","C3_TF_targets","C3_TFT_414_GGAANCGGAANY_UNKNOWN",105,1.5126,0.0055,0.063,2.091,0,0.00062,1.0902,0.27,1
"C7_Immunologic_signatures:C7_ALL_981_GSE22886_NAIVE_BCELL_VS_DC_UP","C7_Immunologic_signatures","C7_ALL_981_GSE22886_NAIVE_BCELL_VS_DC_UP",192,1.5138,0,0.0048,1.5431,0,0.0068,-0.8519,0.86,1
"GO_BP:496167_GO_0016073_SNRNA_METABOLIC_PROCESS","GO_BP","496167_GO_0016073_SNRNA_METABOLIC_PROCESS",28,1.5153,0.037,0.41,-0.7228,0.9,1,0.8071,0.77,1
"GO_BP:782530_GO_1902019_REGULATION_OF_CILIUM_DEPENDENT_CELL_MOTILITY","GO_BP","782530_GO_1902019_REGULATION_OF_CILIUM_DEPENDENT_CELL_MOTILITY",6,1.5155,0.06,0.42,0.7703,0.77,1,0.6713,0.85,1
"REACTOME:1183581_REACT_355159_SHC_MEDIATED_CASCADE_FGFR4","REACTOME","1183581_REACT_355159_SHC_MEDIATED_CASCADE_FGFR4",19,1.5156,0.036,0.24,-0.9538,0.52,1,-0.7503,0.83,1
"GO_BP:491303_GO_0006368_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER","GO_BP","491303_GO_0006368_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER",72,1.5163,0.019,0.42,1.803,0,0.097,1.1459,0.21,0.73
"C4_Cancer_gene_neighborhoods:C4_CGN_242_GCM_MLL","C4_Cancer_gene_neighborhoods","C4_CGN_242_GCM_MLL",174,1.5169,0,0.11,-0.5828,1,1,0.7802,0.96,1
"GO_BP:518650_GO_2000001_REGULATION_OF_DNA_DAMAGE_CHECKPOINT","GO_BP","518650_GO_2000001_REGULATION_OF_DNA_DAMAGE_CHECKPOINT",12,1.5172,0.068,0.42,1.0859,0.34,0.92,0.9735,0.51,0.88
"C1_Positional:C1_ALL_277_CHR11Q21","C1_Positional","C1_ALL_277_CHR11Q21",42,1.5174,0.01,0.38,-1.0281,0.44,1,-0.9715,0.5,0.95
"C7_Immunologic_signatures:C7_ALL_1057_GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP","C7_Immunologic_signatures","C7_ALL_1057_GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP",200,1.518,0,0.0048,1.9819,0,0,-0.706,1,1
"GO_BP:518453_GO_0090313_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE","GO_BP","518453_GO_0090313_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE",25,1.5181,0.037,0.42,1.1965,0.22,0.79,0.5821,0.97,1
"GO_BP:516352_GO_0071428_RRNA_CONTAINING_RIBONUCLEOPROTEIN_COMPLEX_EXPORT_FROM_NUCLEUS","GO_BP","516352_GO_0071428_RRNA_CONTAINING_RIBONUCLEOPROTEIN_COMPLEX_EXPORT_FROM_NUCLEUS",6,1.52,0.081,0.42,1.5691,0.031,0.33,1.3723,0.13,0.64
"GO_BP:504701_GO_0035520_MONOUBIQUITINATED_PROTEIN_DEUBIQUITINATION","GO_BP","504701_GO_0035520_MONOUBIQUITINATED_PROTEIN_DEUBIQUITINATION",9,1.5203,0.063,0.42,1.1691,0.25,0.81,1.1608,0.29,0.73
"GO_BP:492500_GO_0032785_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION","GO_BP","492500_GO_0032785_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION",10,1.5211,0.082,0.42,1.0833,0.33,0.92,0.7949,0.69,1
"GO_MF:492894_GO_0008649_RRNA_METHYLTRANSFERASE_ACTIVITY","GO_MF","492894_GO_0008649_RRNA_METHYLTRANSFERASE_ACTIVITY",11,1.5215,0.067,0.42,1.1025,0.31,0.79,0.8919,0.6,0.97
"REACTOME:105889_REACT_378_REPAIR_SYNTHESIS_OF_PATCH_27_30_BASES_LONG_BY_DNA_POLYMERASE","REACTOME","105889_REACT_378_REPAIR_SYNTHESIS_OF_PATCH_27_30_BASES_LONG_BY_DNA_POLYMERASE",15,1.5223,0.067,0.23,1.4736,0.069,0.16,0.586,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_99_GARY_CD5_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_99_GARY_CD5_TARGETS_DN",430,1.5224,0,0.45,2.0192,0,0.005,0.8046,0.99,1
"KEGG_compound:C16596_5_PHENYL_1_3_OXAZINANE_2_4_DIONE","KEGG_compound","C16596_5_PHENYL_1_3_OXAZINANE_2_4_DIONE",7,1.5233,0.069,0.78,1.0577,0.38,1,1.0403,0.41,0.64
"REACTOME:105838_REACT_1104_BASE_EXCISION_REPAIR","REACTOME","105838_REACT_1104_BASE_EXCISION_REPAIR",35,1.5235,0.022,0.23,1.4406,0.047,0.19,-0.7065,0.91,1
"GO_BP:518581_GO_0097031_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I_BIOGENESIS","GO_BP","518581_GO_0097031_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I_BIOGENESIS",17,1.5236,0.054,0.42,1.505,0.038,0.4,0.4377,1,1
"GO_BP:494897_GO_0010833_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING","GO_BP","494897_GO_0010833_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING",37,1.5247,0.0066,0.42,1.4448,0.047,0.5,-1.0219,0.43,0.83
"GO_BP:487190_GO_0000966_RNA_5_END_PROCESSING","GO_BP","487190_GO_0000966_RNA_5_END_PROCESSING",5,1.5248,0.06,0.42,1.0341,0.43,0.96,-0.5192,0.99,1
"KEGG_module:HSA_M00056_O_GLYCAN_BIOSYNTHESIS_MUCIN_TYPE_CORE","KEGG_module","HSA_M00056_O_GLYCAN_BIOSYNTHESIS_MUCIN_TYPE_CORE",27,1.525,0.022,0.27,0.7656,0.83,0.9,0.9409,0.55,0.98
"GO_BP:486785_GO_0000266_MITOCHONDRIAL_FISSION","GO_BP","486785_GO_0000266_MITOCHONDRIAL_FISSION",20,1.5263,0.042,0.42,-0.8113,0.74,1,1.0887,0.31,0.77
"REACTOME:105846_REACT_1893_RESOLUTION_OF_ABASIC_SITES_AP_SITES_","REACTOME","105846_REACT_1893_RESOLUTION_OF_ABASIC_SITES_AP_SITES_",35,1.5264,0.027,0.23,1.4648,0.031,0.17,-0.7086,0.91,1
"GO_CC:503915_GO_0034715_PICLN_SM_PROTEIN_COMPLEX","GO_CC","503915_GO_0034715_PICLN_SM_PROTEIN_COMPLEX",6,1.5264,0.055,0.21,1.8761,0,0.013,1.1163,0.33,0.9
"C7_Immunologic_signatures:C7_ALL_41_GSE10325_BCELL_VS_MYELOID_UP","C7_Immunologic_signatures","C7_ALL_41_GSE10325_BCELL_VS_MYELOID_UP",188,1.5266,0,0.0041,1.1405,0.16,0.34,-1.4595,0.0041,0.033
"GO_BP:489256_GO_0032784_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION","GO_BP","489256_GO_0032784_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION",42,1.5275,0.023,0.42,1.5361,0.019,0.36,1.1341,0.24,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_2154_LEE_METASTASIS_AND_RNA_PROCESSING_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2154_LEE_METASTASIS_AND_RNA_PROCESSING_UP",17,1.5284,0.044,0.46,1.5327,0.045,0.18,0.5906,0.98,1
"REACTOME:105974_REACT_1815_RECYCLING_OF_EIF2_GDP","REACTOME","105974_REACT_1815_RECYCLING_OF_EIF2_GDP",8,1.5291,0.056,0.23,1.2431,0.2,0.4,0.9751,0.49,1
"GO_BP:507680_GO_0045324_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT","GO_BP","507680_GO_0045324_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT",7,1.5294,0.064,0.42,1.3646,0.12,0.6,1.0912,0.36,0.77
"GO_CC:506307_GO_0043240_FANCONI_ANAEMIA_NUCLEAR_COMPLEX","GO_CC","506307_GO_0043240_FANCONI_ANAEMIA_NUCLEAR_COMPLEX",14,1.5295,0.038,0.21,0.7159,0.85,0.99,-0.8372,0.7,1
"C7_Immunologic_signatures:C7_ALL_1817_GSE7852_THYMUS_VS_FAT_TREG_UP","C7_Immunologic_signatures","C7_ALL_1817_GSE7852_THYMUS_VS_FAT_TREG_UP",200,1.5295,0,0.0042,1.8702,0,0,0.8591,0.88,1
"GO_BP:487454_GO_0001514_SELENOCYSTEINE_INCORPORATION","GO_BP","487454_GO_0001514_SELENOCYSTEINE_INCORPORATION",6,1.5296,0.065,0.42,-0.7144,0.82,1,0.7579,0.76,1
"KEGG_reaction:R00623_PRIMARY_ALCOHOL_NAD_OXIDOREDUCTASE_PRIMARY_ALCOHOL_NAD_ALDEHYDE_NADH_H_","KEGG_reaction","R00623_PRIMARY_ALCOHOL_NAD_OXIDOREDUCTASE_PRIMARY_ALCOHOL_NAD_ALDEHYDE_NADH_H_",7,1.5306,0.068,0.46,1.0931,0.35,0.88,1.0352,0.44,0.64
"GO_CC:486921_GO_0000428_DNA_DIRECTED_RNA_POLYMERASE_COMPLEX","GO_CC","486921_GO_0000428_DNA_DIRECTED_RNA_POLYMERASE_COMPLEX",115,1.5311,0,0.21,1.3297,0.03,0.37,-0.7169,0.99,1
"GO_BP:849769_GO_0044794_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS","GO_BP","849769_GO_0044794_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS",7,1.5317,0.071,0.42,0.899,0.59,1,1.0675,0.39,0.79
"GO_BP:515259_GO_0070327_THYROID_HORMONE_TRANSPORT","GO_BP","515259_GO_0070327_THYROID_HORMONE_TRANSPORT",5,1.5318,0.064,0.42,0.9716,0.51,1,1.2646,0.21,0.68
"GO_BP:498088_GO_0019236_RESPONSE_TO_PHEROMONE","GO_BP","498088_GO_0019236_RESPONSE_TO_PHEROMONE",5,1.5324,0.054,0.42,0.6801,0.85,1,1.4173,0.092,0.62
"C4_Cancer_gene_neighborhoods:C4_CGN_303_GNF2_MLH1","C4_Cancer_gene_neighborhoods","C4_CGN_303_GNF2_MLH1",42,1.5326,0.017,0.099,1.8432,0.0043,0.0014,-0.9763,0.48,0.9
"REACTOME:105850_REACT_1128_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY","REACTOME","105850_REACT_1128_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY",22,1.5326,0.03,0.23,1.4952,0.052,0.15,-0.7241,0.86,1
"GO_BP:486963_GO_0000470_MATURATION_OF_LSU_RRNA","GO_BP","486963_GO_0000470_MATURATION_OF_LSU_RRNA",6,1.5338,0.054,0.42,1.1151,0.35,0.88,1.1536,0.29,0.73
"GO_BP:513852_GO_0060296_REGULATION_OF_CILIUM_BEAT_FREQUENCY_INVOLVED_IN_CILIARY_MOTILITY","GO_BP","513852_GO_0060296_REGULATION_OF_CILIUM_BEAT_FREQUENCY_INVOLVED_IN_CILIARY_MOTILITY",6,1.5349,0.062,0.42,0.7886,0.71,1,0.6607,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2667_IRITANI_MAD1_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_2667_IRITANI_MAD1_TARGETS_DN",47,1.5349,0.0076,0.46,2.4207,0,0,-0.6157,0.99,0.99
"REACTOME:105888_REACT_1998_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER","REACTOME","105888_REACT_1998_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER",17,1.5359,0.039,0.23,1.341,0.12,0.27,-0.8085,0.73,1
"REACTOME:160956_REACT_13523_VITAMIN_D_CALCIFEROL_METABOLISM","REACTOME","160956_REACT_13523_VITAMIN_D_CALCIFEROL_METABOLISM",6,1.5362,0.066,0.23,-1.0508,0.41,0.95,1.1509,0.32,0.9
"KEGG_reaction:R00754_ETHANOL_NAD_OXIDOREDUCTASE_ETHANOL_NAD_ACETALDEHYDE_NADH_H_","KEGG_reaction","R00754_ETHANOL_NAD_OXIDOREDUCTASE_ETHANOL_NAD_ACETALDEHYDE_NADH_H_",7,1.5364,0.066,0.52,1.105,0.33,0.89,1.0533,0.39,0.64
"GO_MF:489268_GO_0003724_RNA_HELICASE_ACTIVITY","GO_MF","489268_GO_0003724_RNA_HELICASE_ACTIVITY",44,1.537,0.018,0.4,1.0782,0.29,0.82,0.7658,0.86,1
"REACTOME:105894_REACT_1993_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POLYMERASE_IN_TC_NER","REACTOME","105894_REACT_1993_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POLYMERASE_IN_TC_NER",15,1.5372,0.028,0.23,1.4479,0.073,0.19,0.5723,0.97,1
"GO_BP:502203_GO_0032981_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I_ASSEMBLY","GO_BP","502203_GO_0032981_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I_ASSEMBLY",17,1.5374,0.046,0.42,1.5213,0.048,0.38,0.431,1,1
"REACTOME:1127678_REACT_268628_SYNTHESIS_OF_DIPHTHAMIDE_EEF2","REACTOME","1127678_REACT_268628_SYNTHESIS_OF_DIPHTHAMIDE_EEF2",8,1.5381,0.06,0.23,1.0258,0.43,0.7,0.7144,0.83,1
"KEGG_reaction:R07105_TRICHLOROETHANOL_NAD_OXIDOREDUCTASE_CHLORAL_HYDRATE_NADH_H_TRICHLOROETHANOL_NAD_H2O","KEGG_reaction","R07105_TRICHLOROETHANOL_NAD_OXIDOREDUCTASE_CHLORAL_HYDRATE_NADH_H_TRICHLOROETHANOL_NAD_H2O",7,1.5398,0.063,0.62,1.0846,0.37,0.87,1.0659,0.37,0.63
"GO_MF:490130_GO_0004826_PHENYLALANINE_TRNA_LIGASE_ACTIVITY","GO_MF","490130_GO_0004826_PHENYLALANINE_TRNA_LIGASE_ACTIVITY",5,1.5415,0.043,0.39,1.4821,0.057,0.39,-0.7904,0.71,0.97
"KEGG_reaction:R04880_3_4_DIHYDROXYPHENYLETHYLENEGLYCOL_NAD_OXIDOREDUCTASE_3_4_DIHYDROXYPHENYLETHYLENEGLYCOL_NAD_3_4_DIHYDROXYMANDELALDEHYDE_NADH_H_","KEGG_reaction","R04880_3_4_DIHYDROXYPHENYLETHYLENEGLYCOL_NAD_OXIDOREDUCTASE_3_4_DIHYDROXYPHENYLETHYLENEGLYCOL_NAD_3_4_DIHYDROXYMANDELALDEHYDE_NADH_H_",7,1.5419,0.057,0.76,1.0832,0.37,0.85,1.0403,0.43,0.65
"GO_CC:516263_GO_0071339_MLL1_COMPLEX","GO_CC","516263_GO_0071339_MLL1_COMPLEX",27,1.5425,0.041,0.2,0.9504,0.51,0.83,-0.7131,0.88,1
"GO_BP:500624_GO_0031365_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION","GO_BP","500624_GO_0031365_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION",24,1.5433,0.036,0.41,1.151,0.25,0.83,1.3967,0.081,0.63
"GO_MF:490287_GO_0005000_VASOPRESSIN_RECEPTOR_ACTIVITY","GO_MF","490287_GO_0005000_VASOPRESSIN_RECEPTOR_ACTIVITY",7,1.5436,0.054,0.4,-0.635,0.91,1,-1.0576,0.38,0.74
"C2_Chemical_and_genetic_perturbations:C2_CGP_710_SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM","C2_Chemical_and_genetic_perturbations","C2_CGP_710_SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM",159,1.5456,0,0.45,2.551,0,0,-0.7546,0.98,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1669_RAMALHO_STEMNESS_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1669_RAMALHO_STEMNESS_UP",206,1.546,0,0.47,2.0546,0,0.0034,1.0974,0.22,0.88
"GO_CC:500175_GO_0030880_RNA_POLYMERASE_COMPLEX","GO_CC","500175_GO_0030880_RNA_POLYMERASE_COMPLEX",117,1.5466,0,0.2,1.3618,0.023,0.33,-0.6998,0.99,1
"GO_BP:1184373_GO_0098781_NCRNA_TRANSCRIPTION","GO_BP","1184373_GO_0098781_NCRNA_TRANSCRIPTION",30,1.5476,0.022,0.4,1.2111,0.18,0.78,-0.6197,0.97,1
"GO_BP:508804_GO_0046548_RETINAL_ROD_CELL_DEVELOPMENT","GO_BP","508804_GO_0046548_RETINAL_ROD_CELL_DEVELOPMENT",9,1.5483,0.046,0.4,0.8913,0.61,1,1.4007,0.11,0.63
"GO_CC:496332_GO_0016272_PREFOLDIN_COMPLEX","GO_CC","496332_GO_0016272_PREFOLDIN_COMPLEX",7,1.5498,0.057,0.2,1.398,0.097,0.3,1.1024,0.34,0.89
"GO_BP:494331_GO_0010257_NADH_DEHYDROGENASE_COMPLEX_ASSEMBLY","GO_BP","494331_GO_0010257_NADH_DEHYDROGENASE_COMPLEX_ASSEMBLY",17,1.5501,0.036,0.4,1.5117,0.043,0.39,0.4403,1,1
"C1_Positional:C1_ALL_178_CHR16Q21","C1_Positional","C1_ALL_178_CHR16Q21",21,1.5506,0.03,0.36,-0.903,0.6,1,0.9006,0.59,0.84
"C2_Chemical_and_genetic_perturbations:C2_CGP_2817_WEBER_METHYLATED_ICP_IN_SPERM_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2817_WEBER_METHYLATED_ICP_IN_SPERM_UP",8,1.5507,0.059,0.49,1.1039,0.33,0.62,1.4743,0.07,0.52
"GO_BP:513851_GO_0060295_REGULATION_OF_CILIUM_MOVEMENT_INVOLVED_IN_CELL_MOTILITY","GO_BP","513851_GO_0060295_REGULATION_OF_CILIUM_MOVEMENT_INVOLVED_IN_CELL_MOTILITY",6,1.5546,0.054,0.39,0.7936,0.72,1,0.6619,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1651_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_1651_BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP",14,1.5548,0.049,0.5,1.3047,0.15,0.39,0.5776,0.97,1
"GO_BP:506663_GO_0043633_POLYADENYLATION_DEPENDENT_RNA_CATABOLIC_PROCESS","GO_BP","506663_GO_0043633_POLYADENYLATION_DEPENDENT_RNA_CATABOLIC_PROCESS",5,1.5549,0.04,0.4,1.2991,0.19,0.67,1.1194,0.36,0.75
"GO_BP:506002_GO_0042908_XENOBIOTIC_TRANSPORT","GO_BP","506002_GO_0042908_XENOBIOTIC_TRANSPORT",5,1.5552,0.037,0.4,-0.7948,0.72,1,1.4451,0.076,0.59
"KEGG_compound:C16595_4_HYDROXY_5_PHENYLTETRAHYDRO_1_3_OXAZIN_2_ONE","KEGG_compound","C16595_4_HYDROXY_5_PHENYLTETRAHYDRO_1_3_OXAZIN_2_ONE",7,1.5556,0.051,0.8,1.0888,0.36,1,1.0448,0.4,0.64
"GO_BP:506658_GO_0043628_NCRNA_3_END_PROCESSING","GO_BP","506658_GO_0043628_NCRNA_3_END_PROCESSING",14,1.5586,0.043,0.4,1.8881,0.0044,0.043,1.6755,0.019,0.41
"C4_Cancer_gene_neighborhoods:C4_CGN_162_MORF_RAB11A","C4_Cancer_gene_neighborhoods","C4_CGN_162_MORF_RAB11A",60,1.5592,0.0077,0.085,1.7594,0,0.0035,1.0994,0.29,0.62
"REACTOME:106559_REACT_894_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION","REACTOME","106559_REACT_894_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION",43,1.5618,0.02,0.2,1.2303,0.15,0.42,1.0668,0.32,0.95
"GO_MF:489870_GO_0004521_ENDORIBONUCLEASE_ACTIVITY","GO_MF","489870_GO_0004521_ENDORIBONUCLEASE_ACTIVITY",42,1.5625,0.014,0.37,1.5186,0.024,0.37,1.1127,0.29,0.81
"GO_BP:500454_GO_0031167_RRNA_METHYLATION","GO_BP","500454_GO_0031167_RRNA_METHYLATION",12,1.5639,0.03,0.39,1.0926,0.31,0.91,1.0152,0.42,0.84
"GO_BP:496507_GO_0016556_MRNA_MODIFICATION","GO_BP","496507_GO_0016556_MRNA_MODIFICATION",12,1.5649,0.038,0.39,1.1865,0.25,0.8,0.9535,0.52,0.9
"REACTOME:160996_REACT_20518_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE","REACTOME","160996_REACT_20518_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE",15,1.5665,0.029,0.2,1.5001,0.047,0.15,0.8679,0.63,1
"C4_Cancer_gene_neighborhoods:C4_CGN_248_GCM_NPM1","C4_Cancer_gene_neighborhoods","C4_CGN_248_GCM_NPM1",116,1.5682,0,0.083,3.4414,0,0,-0.5679,1,1
"GO_BP:500410_GO_0031123_RNA_3_END_PROCESSING","GO_BP","500410_GO_0031123_RNA_3_END_PROCESSING",107,1.569,0,0.38,1.4033,0.022,0.55,0.7541,0.96,1
"C4_Cancer_gene_neighborhoods:C4_CGN_93_MORF_EIF4A2","C4_Cancer_gene_neighborhoods","C4_CGN_93_MORF_EIF4A2",137,1.5737,0,0.082,3.1623,0,0,-0.6965,1,1
"KEGG_reaction:R08310_4_HYDROXY_5_PHENYLTETRAHYDRO_1_3_OXAZIN_2_ONE_NAD_OXIDOREDUCTASE_4_HYDROXY_5_PHENYLTETRAHYDRO_1_3_OXAZIN_2_ONE_NAD_5_PHENYL_1_3_OXAZINANE_2_4_DIONE_NADH_H_","KEGG_reaction","R08310_4_HYDROXY_5_PHENYLTETRAHYDRO_1_3_OXAZIN_2_ONE_NAD_OXIDOREDUCTASE_4_HYDROXY_5_PHENYLTETRAHYDRO_1_3_OXAZIN_2_ONE_NAD_5_PHENYL_1_3_OXAZINANE_2_4_DIONE_NADH_H_",7,1.5741,0.051,0.83,1.0793,0.37,0.84,1.0209,0.43,0.59
"GO_MF:496655_GO_0016741_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS","GO_MF","496655_GO_0016741_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS",216,1.5764,0,0.34,0.8001,0.96,1,-0.7413,1,0.99
"REACTOME:106560_REACT_387_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION","REACTOME","106560_REACT_387_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION",43,1.5766,0.016,0.19,1.2144,0.15,0.43,1.0615,0.34,0.96
"GO_CC:505038_GO_0035869_CILIARY_TRANSITION_ZONE","GO_CC","505038_GO_0035869_CILIARY_TRANSITION_ZONE",25,1.5767,0.015,0.17,0.5375,0.99,1,-0.7184,0.89,1
"C4_Cancer_gene_neighborhoods:C4_CGN_57_MORF_ACP1","C4_Cancer_gene_neighborhoods","C4_CGN_57_MORF_ACP1",211,1.5782,0,0.083,2.6894,0,0,0.6544,1,1
"GO_MF:506211_GO_0043138_3_5_DNA_HELICASE_ACTIVITY","GO_MF","506211_GO_0043138_3_5_DNA_HELICASE_ACTIVITY",7,1.5784,0.035,0.35,1.0055,0.45,0.87,0.7809,0.73,1
"GO_MF:496887_GO_0017070_U6_SNRNA_BINDING","GO_MF","496887_GO_0017070_U6_SNRNA_BINDING",8,1.5787,0.049,0.36,1.0866,0.35,0.81,0.8825,0.6,0.97
"C2_Chemical_and_genetic_perturbations:C2_CGP_1237_DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER","C2_Chemical_and_genetic_perturbations","C2_CGP_1237_DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER",100,1.5821,0,0.45,1.8541,0,0.027,-0.5855,1,0.99
"GO_BP:517565_GO_0072662_PROTEIN_LOCALIZATION_TO_PEROXISOME","GO_BP","517565_GO_0072662_PROTEIN_LOCALIZATION_TO_PEROXISOME",19,1.5835,0.028,0.35,1.2218,0.19,0.76,-0.6944,0.89,0.99
"C2_BioCarta_Pathways:C2_CP_BIOCARTA_82_BIOCARTA_AHSP_PATHWAY","C2_BioCarta_Pathways","C2_CP_BIOCARTA_82_BIOCARTA_AHSP_PATHWAY",13,1.5858,0.04,0.55,1.7984,0.0041,0.14,-1.9625,0,0.091
"GO_MF:492632_GO_0008312_7S_RNA_BINDING","GO_MF","492632_GO_0008312_7S_RNA_BINDING",7,1.5868,0.039,0.35,1.7562,0.0042,0.11,1.0266,0.45,0.86
"GO_BP:514564_GO_0061009_COMMON_BILE_DUCT_DEVELOPMENT","GO_BP","514564_GO_0061009_COMMON_BILE_DUCT_DEVELOPMENT",5,1.5903,0.037,0.34,-1.0852,0.38,0.96,0.6729,0.88,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2683_VALK_AML_CLUSTER_7","C2_Chemical_and_genetic_perturbations","C2_CGP_2683_VALK_AML_CLUSTER_7",27,1.5904,0.019,0.45,1.5568,0.025,0.17,-0.9761,0.48,0.79
"REACTOME:645279_REACT_121153_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1","REACTOME","645279_REACT_121153_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1",9,1.592,0.033,0.17,-0.6641,0.87,1,1.1317,0.31,0.91
"GO_CC:515689_GO_0070761_PRE_SNORNP_COMPLEX","GO_CC","515689_GO_0070761_PRE_SNORNP_COMPLEX",6,1.592,0.034,0.16,1.2837,0.18,0.42,1.0742,0.39,0.94
"C1_Positional:C1_ALL_215_CHR8Q","C1_Positional","C1_ALL_215_CHR8Q",7,1.5926,0.042,0.32,0.9279,0.56,0.82,1.5327,0.052,0.27
"GO_MF:492522_GO_0008174_MRNA_METHYLTRANSFERASE_ACTIVITY","GO_MF","492522_GO_0008174_MRNA_METHYLTRANSFERASE_ACTIVITY",5,1.5931,0.035,0.35,1.377,0.12,0.49,1.3367,0.15,0.66
"GO_CC:503909_GO_0034709_METHYLOSOME","GO_CC","503909_GO_0034709_METHYLOSOME",10,1.5933,0.041,0.16,1.8306,0.0022,0.02,1.2136,0.22,0.82
"KEGG_pathway:HSA03040_SPLICEOSOME","KEGG_pathway","HSA03040_SPLICEOSOME",132,1.594,0,0.051,1.69,0.0023,0.031,1.0336,0.39,1
"GO_BP:517497_GO_0072594_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE","GO_BP","517497_GO_0072594_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE",343,1.5945,0,0.33,2.8289,0,0,0.8068,0.98,1
"GO_BP:507979_GO_0045631_REGULATION_OF_MECHANORECEPTOR_DIFFERENTIATION","GO_BP","507979_GO_0045631_REGULATION_OF_MECHANORECEPTOR_DIFFERENTIATION",5,1.5967,0.029,0.33,0.4545,0.99,1,-0.7803,0.73,1
"GO_CC:911481_GO_1902493_ACETYLTRANSFERASE_COMPLEX","GO_CC","911481_GO_1902493_ACETYLTRANSFERASE_COMPLEX",93,1.5972,0.0051,0.16,0.9554,0.57,0.83,-0.6681,1,1
"GO_BP:491840_GO_0007005_MITOCHONDRION_ORGANIZATION","GO_BP","491840_GO_0007005_MITOCHONDRION_ORGANIZATION",398,1.5975,0,0.33,2.0529,0,0.0066,0.8163,0.98,1
"GO_BP:755086_GO_2000980_REGULATION_OF_INNER_EAR_RECEPTOR_CELL_DIFFERENTIATION","GO_BP","755086_GO_2000980_REGULATION_OF_INNER_EAR_RECEPTOR_CELL_DIFFERENTIATION",5,1.5977,0.038,0.33,0.4617,1,1,-0.7683,0.76,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2438_ZHOU_PANCREATIC_EXOCRINE_PROGENITOR","C2_Chemical_and_genetic_perturbations","C2_CGP_2438_ZHOU_PANCREATIC_EXOCRINE_PROGENITOR",11,1.5995,0.036,0.45,1.1708,0.27,0.53,1.4116,0.075,0.55
"C4_Cancer_modules:C4_CM_152_MODULE_160","C4_Cancer_modules","C4_CM_152_MODULE_160",15,1.5998,0.03,0.14,1.5483,0.025,0.095,-0.5089,0.99,1
"GO_BP:487986_GO_0002097_TRNA_WOBBLE_BASE_MODIFICATION","GO_BP","487986_GO_0002097_TRNA_WOBBLE_BASE_MODIFICATION",8,1.6022,0.038,0.33,1.5078,0.048,0.4,1.4309,0.093,0.61
"GO_BP:512191_GO_0051307_MEIOTIC_CHROMOSOME_SEPARATION","GO_BP","512191_GO_0051307_MEIOTIC_CHROMOSOME_SEPARATION",11,1.6051,0.027,0.32,1.2005,0.24,0.78,-0.7359,0.84,1
"C4_Cancer_modules:C4_CM_128_MODULE_133","C4_Cancer_modules","C4_CM_128_MODULE_133",15,1.6054,0.031,0.16,1.6998,0.019,0.045,-0.781,0.76,0.99
"REACTOME:105789_REACT_932_DNA_STRAND_ELONGATION","REACTOME","105789_REACT_932_DNA_STRAND_ELONGATION",32,1.6069,0.019,0.16,1.8113,0.0021,0.019,-1.3133,0.12,0.55
"GO_CC:486662_GO_0000123_HISTONE_ACETYLTRANSFERASE_COMPLEX","GO_CC","486662_GO_0000123_HISTONE_ACETYLTRANSFERASE_COMPLEX",83,1.6105,0.0044,0.15,1.0064,0.42,0.77,-0.7245,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_711_SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_711_SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN",47,1.6117,0.0074,0.45,1.8488,0,0.028,0.5754,1,1
"GO_BP:494828_GO_0010763_POSITIVE_REGULATION_OF_FIBROBLAST_MIGRATION","GO_BP","494828_GO_0010763_POSITIVE_REGULATION_OF_FIBROBLAST_MIGRATION",8,1.6137,0.029,0.31,1.1816,0.28,0.8,0.9488,0.54,0.9
"GO_BP:504174_GO_0034982_MITOCHONDRIAL_PROTEIN_PROCESSING","GO_BP","504174_GO_0034982_MITOCHONDRIAL_PROTEIN_PROCESSING",6,1.6163,0.041,0.31,0.7001,0.83,1,-0.7316,0.8,0.99
"GO_BP:493485_GO_0009301_SNRNA_TRANSCRIPTION","GO_BP","493485_GO_0009301_SNRNA_TRANSCRIPTION",10,1.6189,0.02,0.3,0.6632,0.89,1,1.0194,0.45,0.84
"GO_MF:492516_GO_0008168_METHYLTRANSFERASE_ACTIVITY","GO_MF","492516_GO_0008168_METHYLTRANSFERASE_ACTIVITY",203,1.6197,0,0.3,0.7945,0.95,1,-0.7226,1,0.99
"OMIM_gene:OMIM600190_TRANSDUCIN_LIKE_ENHANCER_OF_SPLIT_3_TLE3","OMIM_gene","OMIM600190_TRANSDUCIN_LIKE_ENHANCER_OF_SPLIT_3_TLE3",5,1.6206,0.022,1,0.9909,0.48,1,1.0148,0.45,0.97
"GO_BP:512177_GO_0051292_NUCLEAR_PORE_COMPLEX_ASSEMBLY","GO_BP","512177_GO_0051292_NUCLEAR_PORE_COMPLEX_ASSEMBLY",9,1.6209,0.028,0.3,1.5346,0.039,0.36,0.6736,0.87,1
"GO_CC:499990_GO_0030688_PRERIBOSOME_SMALL_SUBUNIT_PRECURSOR","GO_CC","499990_GO_0030688_PRERIBOSOME_SMALL_SUBUNIT_PRECURSOR",6,1.621,0.028,0.14,0.8541,0.65,0.92,-0.7569,0.75,1
"GO_BP:505900_GO_0042795_SNRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER","GO_BP","505900_GO_0042795_SNRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER",7,1.6213,0.03,0.3,0.5836,0.95,1,1.2318,0.23,0.71
"GO_CC:500507_GO_0031248_PROTEIN_ACETYLTRANSFERASE_COMPLEX","GO_CC","500507_GO_0031248_PROTEIN_ACETYLTRANSFERASE_COMPLEX",93,1.6228,0,0.14,0.9346,0.6,0.86,-0.6656,0.99,1
"REACTOME:105953_REACT_1753_MRNA_SPLICING_MINOR_PATHWAY","REACTOME","105953_REACT_1753_MRNA_SPLICING_MINOR_PATHWAY",42,1.6252,0.018,0.14,1.8351,0,0.016,1.1942,0.2,0.85
"GO_CC:751809_GO_0044665_MLL1_2_COMPLEX","GO_CC","751809_GO_0044665_MLL1_2_COMPLEX",28,1.6273,0.0061,0.14,1.0142,0.44,0.76,-0.7043,0.94,1
"REACTOME:160993_REACT_20639_DEADENYLATION_DEPENDENT_MRNA_DECAY","REACTOME","160993_REACT_20639_DEADENYLATION_DEPENDENT_MRNA_DECAY",49,1.6284,0.0035,0.14,1.6783,0.0022,0.057,-0.6557,0.97,1
"GO_BP:491227_GO_0006261_DNA_DEPENDENT_DNA_REPLICATION","GO_BP","491227_GO_0006261_DNA_DEPENDENT_DNA_REPLICATION",93,1.6286,0,0.29,1.1422,0.19,0.85,-1.2555,0.093,0.68
"KEGG_module:HSA_M00351_SPLICEOSOME_U1_SNRNP","KEGG_module","HSA_M00351_SPLICEOSOME_U1_SNRNP",10,1.6293,0.037,0.16,1.9443,0,0.0081,1.2277,0.22,0.78
"C7_Immunologic_signatures:C7_ALL_1745_GSE6269_HEALTHY_VS_STREP_AUREUS_INF_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1745_GSE6269_HEALTHY_VS_STREP_AUREUS_INF_PBMC_UP",179,1.6312,0,0.00074,-0.9185,0.68,1,-1.1042,0.21,0.49
"GO_BP:496053_GO_0015931_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT","GO_BP","496053_GO_0015931_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT",176,1.6344,0,0.28,1.1719,0.12,0.81,-0.6573,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_186_MORF_TPT1","C4_Cancer_gene_neighborhoods","C4_CGN_186_MORF_TPT1",102,1.6357,0,0.052,3.6649,0,0,0.9873,0.48,0.83
"GO_CC:503590_GO_0034388_PWP2P_CONTAINING_SUBCOMPLEX_OF_90S_PRERIBOSOME","GO_CC","503590_GO_0034388_PWP2P_CONTAINING_SUBCOMPLEX_OF_90S_PRERIBOSOME",7,1.6367,0.039,0.13,1.2625,0.2,0.45,0.6909,0.86,1
"GO_BP:491396_GO_0006498_N_TERMINAL_PROTEIN_LIPIDATION","GO_BP","491396_GO_0006498_N_TERMINAL_PROTEIN_LIPIDATION",5,1.6372,0.029,0.28,0.9909,0.48,0.99,0.5028,0.98,1
"GO_MF:496411_GO_0016423_TRNA_GUANINE_METHYLTRANSFERASE_ACTIVITY","GO_MF","496411_GO_0016423_TRNA_GUANINE_METHYLTRANSFERASE_ACTIVITY",5,1.6379,0.017,0.27,1.2017,0.28,0.7,0.7637,0.75,1
"GO_BP:753113_GO_1900118_NEGATIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS","GO_BP","753113_GO_1900118_NEGATIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS",8,1.6387,0.037,0.28,1.3316,0.13,0.63,1.1069,0.33,0.76
"C1_Positional:C1_ALL_91_CHR6Q27","C1_Positional","C1_ALL_91_CHR6Q27",36,1.6396,0.0066,0.29,-0.8541,0.71,0.98,1.6438,0.012,0.21
"GO_CC:490867_GO_0005851_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2B_COMPLEX","GO_CC","490867_GO_0005851_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2B_COMPLEX",6,1.6404,0.029,0.13,1.114,0.35,0.62,0.9788,0.49,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2168_FINETTI_BREAST_CANCERS_KINOME_GRAY","C2_Chemical_and_genetic_perturbations","C2_CGP_2168_FINETTI_BREAST_CANCERS_KINOME_GRAY",15,1.6411,0.025,0.4,1.6703,0.017,0.1,1.0923,0.34,0.89
"C4_Cancer_gene_neighborhoods:C4_CGN_225_GCM_DFFA","C4_Cancer_gene_neighborhoods","C4_CGN_225_GCM_DFFA",129,1.6458,0,0.051,1.1779,0.13,0.24,0.6708,1,1
"REACTOME:106562_REACT_281_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION","REACTOME","106562_REACT_281_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION",35,1.6474,0.01,0.13,0.9474,0.52,0.84,-0.54,0.99,1
"GO_BP:491506_GO_0006612_PROTEIN_TARGETING_TO_MEMBRANE","GO_BP","491506_GO_0006612_PROTEIN_TARGETING_TO_MEMBRANE",160,1.6485,0,0.26,3.5723,0,0,0.9318,0.64,0.92
"KEGG_pathway:HSA03460_FANCONI_ANEMIA_PATHWAY","KEGG_pathway","HSA03460_FANCONI_ANEMIA_PATHWAY",52,1.6486,0.004,0.038,1.251,0.11,0.47,0.6276,0.99,1
"REACTOME:106557_REACT_1366_RNA_POLYMERASE_II_TRANSCRIPTION","REACTOME","106557_REACT_1366_RNA_POLYMERASE_II_TRANSCRIPTION",107,1.6499,0,0.13,1.6544,0,0.067,1.2498,0.077,0.79
"C7_Immunologic_signatures:C7_ALL_223_GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP","C7_Immunologic_signatures","C7_ALL_223_GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP",200,1.6501,0,5e-04,1.8385,0,0,0.9831,0.47,1
"GO_BP:502329_GO_0033108_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY","GO_BP","502329_GO_0033108_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY",28,1.6505,0.016,0.26,1.5853,0.022,0.31,-0.7647,0.81,1
"C7_Immunologic_signatures:C7_ALL_823_GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP","C7_Immunologic_signatures","C7_ALL_823_GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP",197,1.6516,0,0.00048,1.4051,0.0024,0.035,1.394,0.0072,0.15
"GO_BP:488957_GO_0003163_SINOATRIAL_NODE_DEVELOPMENT","GO_BP","488957_GO_0003163_SINOATRIAL_NODE_DEVELOPMENT",5,1.652,0.019,0.26,1.064,0.4,0.94,-1.7584,0.0021,0.63
"GO_MF:490370_GO_0005104_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING","GO_MF","490370_GO_0005104_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING",17,1.6529,0.039,0.25,-1.174,0.24,0.78,0.8134,0.76,1
"GO_BP:512188_GO_0051304_CHROMOSOME_SEPARATION","GO_BP","512188_GO_0051304_CHROMOSOME_SEPARATION",16,1.658,0.0083,0.25,0.8806,0.64,1,0.5876,0.96,1
"GO_CC:495534_GO_0046930_PORE_COMPLEX","GO_CC","495534_GO_0046930_PORE_COMPLEX",86,1.6584,0,0.12,1.5959,0.0046,0.12,0.5862,1,1
"GO_MF:489239_GO_0003689_DNA_CLAMP_LOADER_ACTIVITY","GO_MF","489239_GO_0003689_DNA_CLAMP_LOADER_ACTIVITY",6,1.6589,0.031,0.25,1.1437,0.32,0.75,1.2113,0.26,0.72
"C7_Immunologic_signatures:C7_ALL_983_GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_983_GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP",187,1.6608,0,0.00041,-0.6894,1,1,0.9229,0.67,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_202_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_202_GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN",12,1.662,0.017,0.38,1.6362,0.017,0.12,0.7858,0.73,1
"GO_MF:495513_GO_0015252_HYDROGEN_ION_CHANNEL_ACTIVITY","GO_MF","495513_GO_0015252_HYDROGEN_ION_CHANNEL_ACTIVITY",5,1.6627,0.023,0.26,-1.1833,0.28,0.78,-1.1088,0.38,0.7
"REACTOME:1183517_REACT_355174_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS","REACTOME","1183517_REACT_355174_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS",74,1.6636,0,0.12,1.5515,0.0088,0.12,-0.5109,1,1
"KEGG_module:HSA_M00398_SM_CORE_COMPLEX","KEGG_module","HSA_M00398_SM_CORE_COMPLEX",7,1.6638,0.031,0.14,1.8536,0,0.024,1.3359,0.17,0.74
"GO_MF:489982_GO_0004653_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY","GO_MF","489982_GO_0004653_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY",21,1.6674,0.0084,0.26,-0.7064,0.89,1,1.0166,0.43,0.85
"C1_Positional:C1_ALL_85_CHR4Q33","C1_Positional","C1_ALL_85_CHR4Q33",5,1.6681,0.014,0.31,1.1068,0.35,0.64,-0.945,0.53,0.98
"REACTOME:106564_REACT_1036_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER","REACTOME","106564_REACT_1036_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER",26,1.6683,0.021,0.12,1.0942,0.31,0.59,0.6496,0.96,1
"REACTOME:1183516_REACT_355247_SUMO_E3_LIGASES_SUMOYLATE_TARGET_PROTEINS","REACTOME","1183516_REACT_355247_SUMO_E3_LIGASES_SUMOYLATE_TARGET_PROTEINS",74,1.6708,0,0.12,1.5405,0.0088,0.13,-0.517,1,1
"C1_Positional:C1_ALL_40_CHR6P11","C1_Positional","C1_ALL_40_CHR6P11",7,1.6718,0.031,0.46,0.8362,0.69,0.92,1.4177,0.099,0.36
"GO_BP:500155_GO_0030857_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION","GO_BP","500155_GO_0030857_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION",32,1.672,0.009,0.23,-0.7409,0.88,1,0.85,0.71,0.98
"GO_BP:518454_GO_0090314_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE","GO_BP","518454_GO_0090314_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE",19,1.6729,0.017,0.23,1.1754,0.24,0.81,0.7284,0.84,1
"REACTOME:105790_REACT_6776_UNWINDING_OF_DNA","REACTOME","105790_REACT_6776_UNWINDING_OF_DNA",11,1.6745,0.02,0.12,1.5035,0.049,0.15,-1.2935,0.17,0.54
"GO_MF:502391_GO_0033170_PROTEIN_DNA_LOADING_ATPASE_ACTIVITY","GO_MF","502391_GO_0033170_PROTEIN_DNA_LOADING_ATPASE_ACTIVITY",6,1.6751,0.019,0.25,1.1728,0.28,0.73,1.2067,0.26,0.71
"GO_BP:489255_GO_0006383_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER","GO_BP","489255_GO_0006383_TRANSCRIPTION_FROM_RNA_POLYMERASE_III_PROMOTER",43,1.6759,0.0038,0.23,1.0732,0.34,0.93,0.8311,0.74,0.99
"GO_MF:489320_GO_0003810_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY","GO_MF","489320_GO_0003810_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY",9,1.6768,0.036,0.26,1.2114,0.23,0.7,1.4543,0.082,0.51
"GO_BP:487009_GO_0000712_RESOLUTION_OF_MEIOTIC_RECOMBINATION_INTERMEDIATES","GO_BP","487009_GO_0000712_RESOLUTION_OF_MEIOTIC_RECOMBINATION_INTERMEDIATES",10,1.6791,0.018,0.23,1.2875,0.19,0.69,0.8331,0.66,0.99
"GO_MF:492780_GO_0016594_GLYCINE_BINDING","GO_MF","492780_GO_0016594_GLYCINE_BINDING",14,1.6791,0.016,0.27,1.1778,0.25,0.73,-0.7917,0.74,0.97
"REACTOME:106563_REACT_347_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER","REACTOME","106563_REACT_347_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER",27,1.6797,0.012,0.11,1.209,0.19,0.44,0.6375,0.97,1
"GO_CC:490858_GO_0005838_PROTEASOME_REGULATORY_PARTICLE","GO_CC","490858_GO_0005838_PROTEASOME_REGULATORY_PARTICLE",17,1.6798,0.031,0.1,1.9546,0.0021,0.0053,1.2171,0.2,0.83
"C4_Cancer_gene_neighborhoods:C4_CGN_391_GNF2_PCAF","C4_Cancer_gene_neighborhoods","C4_CGN_391_GNF2_PCAF",36,1.68,0.0071,0.04,2.1716,0,2e-05,-1.5493,0.022,0.09
"GO_MF:494069_GO_0009982_PSEUDOURIDINE_SYNTHASE_ACTIVITY","GO_MF","494069_GO_0009982_PSEUDOURIDINE_SYNTHASE_ACTIVITY",13,1.6805,0.011,0.27,1.2962,0.16,0.61,-0.49,1,1
"GO_BP:516092_GO_0071166_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION","GO_BP","516092_GO_0071166_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION",8,1.6846,0.023,0.22,1.731,0.0061,0.16,1.2571,0.22,0.69
"KEGG_module:HSA_M00341_PROTEASOME_19S_REGULATORY_PARTICLE_PA700_","KEGG_module","HSA_M00341_PROTEASOME_19S_REGULATORY_PARTICLE_PA700_",18,1.6864,0.011,0.13,2.0366,0.002,0.0029,1.4101,0.063,0.72
"C4_Cancer_gene_neighborhoods:C4_CGN_190_MORF_UBE2N","C4_Cancer_gene_neighborhoods","C4_CGN_190_MORF_UBE2N",95,1.6882,0,0.039,2.2417,0,0,0.7477,0.95,1
"GO_BP:491323_GO_0006401_RNA_CATABOLIC_PROCESS","GO_BP","491323_GO_0006401_RNA_CATABOLIC_PROCESS",218,1.6883,0,0.22,3.2904,0,0,0.621,1,1
"KEGG_module:HSA_M00359_AMINOACYL_TRNA_BIOSYNTHESIS_EUKARYOTES","KEGG_module","HSA_M00359_AMINOACYL_TRNA_BIOSYNTHESIS_EUKARYOTES",38,1.6893,0.01,0.15,1.1864,0.2,0.55,-0.7537,0.86,0.97
"KEGG_pathway:HSA03060_PROTEIN_EXPORT","KEGG_pathway","HSA03060_PROTEIN_EXPORT",23,1.6949,0.009,0.033,1.9027,0.0021,0.0049,1.4223,0.065,0.39
"C7_Immunologic_signatures:C7_ALL_1763_GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1763_GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP",200,1.6958,0,0.00015,2.4806,0,0,-1.0292,0.38,0.66
"GO_CC:504809_GO_0035631_CD40_RECEPTOR_COMPLEX","GO_CC","504809_GO_0035631_CD40_RECEPTOR_COMPLEX",11,1.6962,0.011,0.093,-0.563,0.96,1,0.5847,0.97,1
"GO_BP:491836_GO_0007000_NUCLEOLUS_ORGANIZATION","GO_BP","491836_GO_0007000_NUCLEOLUS_ORGANIZATION",5,1.6967,0.021,0.21,1.6178,0.029,0.28,1.1515,0.31,0.73
"REACTOME:160950_REACT_125_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA","REACTOME","160950_REACT_125_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA",145,1.698,0,0.1,1.7886,0,0.023,1.0477,0.34,0.97
"GO_BP:486971_GO_0000478_ENDONUCLEOLYTIC_CLEAVAGE_INVOLVED_IN_RRNA_PROCESSING","GO_BP","486971_GO_0000478_ENDONUCLEOLYTIC_CLEAVAGE_INVOLVED_IN_RRNA_PROCESSING",7,1.7015,0.015,0.2,1.5161,0.048,0.38,0.9943,0.47,0.86
"GO_CC:500367_GO_0031080_NUCLEAR_PORE_OUTER_RING","GO_CC","500367_GO_0031080_NUCLEAR_PORE_OUTER_RING",10,1.7022,0.022,0.091,1.3155,0.14,0.39,1.2593,0.18,0.75
"GO_CC:750960_GO_0036038_TCTN_B9D_COMPLEX","GO_CC","750960_GO_0036038_TCTN_B9D_COMPLEX",13,1.7071,0.019,0.089,-0.5438,0.97,1,0.9292,0.55,1
"REACTOME:105984_REACT_6256_HIV_LIFE_CYCLE","REACTOME","105984_REACT_6256_HIV_LIFE_CYCLE",140,1.7077,0,0.096,2.0844,0,0.00076,1.2321,0.081,0.81
"GO_CC:490795_GO_0005762_MITOCHONDRIAL_LARGE_RIBOSOMAL_SUBUNIT","GO_CC","490795_GO_0005762_MITOCHONDRIAL_LARGE_RIBOSOMAL_SUBUNIT",22,1.7097,0.019,0.089,2.0287,0,0.0025,1.5769,0.024,0.48
"C2_Chemical_and_genetic_perturbations:C2_CGP_3190_BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES","C2_Chemical_and_genetic_perturbations","C2_CGP_3190_BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES",68,1.7108,0,0.28,3.5347,0,0,1.269,0.11,0.7
"KEGG_enzyme:2.4.1.41_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_PROTEIN_UDP_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_GALNAC_POLYPEPTIDE_N_ACETYLGALACTOSAMINYL_TRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_KAPPA_CASEIN_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_URIDINE_DIPHOSPHOACETYLGALACTOSAMINE_GLYCOPROTEIN_ACETYLGALACTOSAMINYLTRANSFERASE_GLYCOPROTEIN_ACETYLGALACTOSAMINYLTRANSFERASE_POLYPEPTIDE_N_ACETYLGALACTOSAMINE_TRANSFERASE_UDP_ACETYLGALACTOSAMINE_GLYCOPROTEIN_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_ACETYLGALACTOSAMINE_PEPTIDE_N_GALACTOSAMINYLTRANSFERASE_UDP_GALNAC_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYL_ALPHA_D_GALACTOSAMINE_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_GLYCOPROTEIN_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_PROTEIN_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_PROTEIN_N_ACETYLGALACTOSAMINYL_TRANSFERASE_PPGALNAC_T","KEGG_enzyme","2.4.1.41_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_PROTEIN_UDP_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_GALNAC_POLYPEPTIDE_N_ACETYLGALACTOSAMINYL_TRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_KAPPA_CASEIN_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_URIDINE_DIPHOSPHOACETYLGALACTOSAMINE_GLYCOPROTEIN_ACETYLGALACTOSAMINYLTRANSFERASE_GLYCOPROTEIN_ACETYLGALACTOSAMINYLTRANSFERASE_POLYPEPTIDE_N_ACETYLGALACTOSAMINE_TRANSFERASE_UDP_ACETYLGALACTOSAMINE_GLYCOPROTEIN_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_ACETYLGALACTOSAMINE_PEPTIDE_N_GALACTOSAMINYLTRANSFERASE_UDP_GALNAC_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYL_ALPHA_D_GALACTOSAMINE_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_GLYCOPROTEIN_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_PROTEIN_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_UDP_N_ACETYLGALACTOSAMINE_PROTEIN_N_ACETYLGALACTOSAMINYL_TRANSFERASE_PPGALNAC_T",21,1.7111,0.019,0.2,-0.7417,0.87,0.9,1.1194,0.3,0.69
"GO_MF:495327_GO_0019825_OXYGEN_BINDING","GO_MF","495327_GO_0019825_OXYGEN_BINDING",48,1.7114,0,0.23,1.4122,0.053,0.48,0.9716,0.5,0.89
"GO_CC:507393_GO_0044445_CYTOSOLIC_PART","GO_CC","507393_GO_0044445_CYTOSOLIC_PART",202,1.7124,0,0.089,3.2843,0,0,0.8795,0.8,1
"GO_CC:517572_GO_0072669_TRNA_SPLICING_LIGASE_COMPLEX","GO_CC","517572_GO_0072669_TRNA_SPLICING_LIGASE_COMPLEX",7,1.7167,0.026,0.089,1.7158,0.013,0.055,1.1341,0.32,0.86
"GO_BP:487187_GO_0000963_MITOCHONDRIAL_RNA_PROCESSING","GO_BP","487187_GO_0000963_MITOCHONDRIAL_RNA_PROCESSING",6,1.7182,0.018,0.18,1.3628,0.15,0.6,-0.7529,0.77,1
"C6_Oncogenic_signatures:C6_ALL_58_MYC_UP_V1_UP","C6_Oncogenic_signatures","C6_ALL_58_MYC_UP_V1_UP",169,1.7194,0,0.013,1.1919,0.11,0.44,-1.2372,0.068,0.32
"C2_Chemical_and_genetic_perturbations:C2_CGP_368_LIU_CDX2_TARGETS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_368_LIU_CDX2_TARGETS_DN",5,1.7234,0.0067,0.29,1.4966,0.055,0.21,1.7097,0.002,0.3
"GO_BP:512078_GO_0051168_NUCLEAR_EXPORT","GO_BP","512078_GO_0051168_NUCLEAR_EXPORT",111,1.7242,0,0.17,1.2334,0.11,0.75,0.8656,0.77,0.97
"GO_BP:491325_GO_0006403_RNA_LOCALIZATION","GO_BP","491325_GO_0006403_RNA_LOCALIZATION",156,1.7261,0,0.17,1.2149,0.079,0.77,0.613,1,1
"GO_BP:491294_GO_0006354_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION","GO_BP","491294_GO_0006354_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION",99,1.7274,0,0.17,1.6271,0,0.26,1.0034,0.45,0.85
"KEGG_reaction:R05907_UDP_N_ACETYL_D_GALACTOSAMINE_PROTEIN_L_SERINE_UDP_TN_ANTIGEN","KEGG_reaction","R05907_UDP_N_ACETYL_D_GALACTOSAMINE_PROTEIN_L_SERINE_UDP_TN_ANTIGEN",21,1.7277,0.009,0.38,-0.7406,0.85,1,1.1152,0.31,0.63
"C2_Chemical_and_genetic_perturbations:C2_CGP_1354_MANALO_HYPOXIA_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1354_MANALO_HYPOXIA_DN",289,1.7297,0,0.31,1.6797,0,0.095,-1.1067,0.19,0.62
"GO_BP:491235_GO_0006271_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION","GO_BP","491235_GO_0006271_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION",34,1.7319,0.0035,0.17,1.852,0.0022,0.063,-1.1323,0.26,0.75
"REACTOME:106203_REACT_6804_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN","REACTOME","106203_REACT_6804_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN",29,1.7325,0.0066,0.08,1.4772,0.059,0.16,1.1349,0.27,0.91
"REACTOME:833805_REACT_163823_SUMOYLATION","REACTOME","833805_REACT_163823_SUMOYLATION",79,1.7336,0,0.081,1.5589,0.0022,0.12,0.5386,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_258_GCM_RAB10","C4_Cancer_gene_neighborhoods","C4_CGN_258_GCM_RAB10",176,1.7353,0,0.027,1.523,0.0024,0.026,0.7755,0.96,1
"GO_BP:752559_GO_0090502_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_ENDONUCLEOLYTIC","GO_BP","752559_GO_0090502_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_ENDONUCLEOLYTIC",48,1.7401,0,0.16,1.6408,0.0021,0.25,1.0436,0.38,0.81
"GO_BP:486972_GO_0000479_ENDONUCLEOLYTIC_CLEAVAGE_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_","GO_BP","486972_GO_0000479_ENDONUCLEOLYTIC_CLEAVAGE_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_",7,1.7404,0.012,0.16,1.5279,0.052,0.37,1.0036,0.44,0.86
"GO_BP:487183_GO_0000959_MITOCHONDRIAL_RNA_METABOLIC_PROCESS","GO_BP","487183_GO_0000959_MITOCHONDRIAL_RNA_METABOLIC_PROCESS",21,1.744,0.0028,0.16,1.2535,0.17,0.73,0.7707,0.82,1
"C7_Immunologic_signatures:C7_ALL_843_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP","C7_Immunologic_signatures","C7_ALL_843_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP",198,1.7444,0,0,1.7539,0,3e-04,0.8911,0.78,1
"GO_CC:486832_GO_0000315_ORGANELLAR_LARGE_RIBOSOMAL_SUBUNIT","GO_CC","486832_GO_0000315_ORGANELLAR_LARGE_RIBOSOMAL_SUBUNIT",22,1.7448,0,0.073,1.9941,0.002,0.0035,1.5665,0.021,0.47
"GO_MF:496774_GO_0016886_LIGASE_ACTIVITY_FORMING_PHOSPHORIC_ESTER_BONDS","GO_MF","496774_GO_0016886_LIGASE_ACTIVITY_FORMING_PHOSPHORIC_ESTER_BONDS",6,1.7467,0.014,0.18,1.0357,0.41,0.83,1.1226,0.35,0.81
"GO_MF:489755_GO_0004386_HELICASE_ACTIVITY","GO_MF","489755_GO_0004386_HELICASE_ACTIVITY",153,1.7489,0,0.18,1.0733,0.29,0.82,-0.7956,0.94,0.97
"REACTOME:645350_REACT_120801_ABACAVIR_TRANSMEMBRANE_TRANSPORT","REACTOME","645350_REACT_120801_ABACAVIR_TRANSMEMBRANE_TRANSPORT",5,1.7505,0.0071,0.072,-0.9994,0.48,0.98,1.3675,0.11,0.69
"KEGG_module:HSA_M00391_EXOSOME_EUKARYOTES","KEGG_module","HSA_M00391_EXOSOME_EUKARYOTES",10,1.7518,0.018,0.11,1.5856,0.031,0.12,1.2506,0.21,0.77
"REACTOME:106076_REACT_6354_VIRAL_MESSENGER_RNA_SYNTHESIS","REACTOME","106076_REACT_6354_VIRAL_MESSENGER_RNA_SYNTHESIS",41,1.7532,0,0.071,1.6519,0.0069,0.068,1.0316,0.41,0.98
"C7_Immunologic_signatures:C7_ALL_1121_GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP","C7_Immunologic_signatures","C7_ALL_1121_GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP",191,1.7559,0,0,1.0536,0.29,0.58,1.2323,0.078,0.6
"GO_MF:498634_GO_0019843_RRNA_BINDING","GO_MF","498634_GO_0019843_RRNA_BINDING",39,1.7583,0.0035,0.18,2.545,0,0,1.0227,0.41,0.87
"GO_BP:489260_GO_0006353_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION","GO_BP","489260_GO_0006353_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION",92,1.7589,0,0.14,1.362,0.028,0.6,0.9648,0.53,0.89
"GO_BP:499351_GO_0022616_DNA_STRAND_ELONGATION","GO_BP","499351_GO_0022616_DNA_STRAND_ELONGATION",36,1.7598,0.006,0.14,1.7763,0,0.12,-1.1771,0.2,0.74
"C7_Immunologic_signatures:C7_ALL_1117_GSE2706_UNSTIM_VS_2H_LPS_DC_UP","C7_Immunologic_signatures","C7_ALL_1117_GSE2706_UNSTIM_VS_2H_LPS_DC_UP",186,1.7607,0,0,0.8647,0.83,1,1.1857,0.11,0.77
"GO_MF:499684_GO_0030280_STRUCTURAL_CONSTITUENT_OF_EPIDERMIS","GO_MF","499684_GO_0030280_STRUCTURAL_CONSTITUENT_OF_EPIDERMIS",6,1.7608,0.012,0.19,1.0479,0.41,0.83,1.1017,0.34,0.81
"GO_BP:505414_GO_0042255_RIBOSOME_ASSEMBLY","GO_BP","505414_GO_0042255_RIBOSOME_ASSEMBLY",28,1.7608,0.0029,0.14,2.3165,0,0.00011,1.2418,0.16,0.71
"GO_MF:496780_GO_0016893_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS","GO_MF","496780_GO_0016893_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS",35,1.7624,0,0.2,1.156,0.24,0.74,1.0181,0.43,0.85
"C7_Immunologic_signatures:C7_ALL_839_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP","C7_Immunologic_signatures","C7_ALL_839_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP",199,1.7627,0,0,1.5569,0,0.0056,-0.7748,0.98,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2861_GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2861_GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP",9,1.7636,0.013,0.27,1.1979,0.24,0.49,1.1162,0.31,0.85
"REACTOME:105964_REACT_1835_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT","REACTOME","105964_REACT_1835_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT",35,1.7656,0.0037,0.066,1.3785,0.068,0.24,0.8772,0.68,1
"REACTOME:160990_REACT_16925_GLYOXYLATE_METABOLISM","REACTOME","160990_REACT_16925_GLYOXYLATE_METABOLISM",5,1.7672,0.0072,0.066,1.39,0.096,0.23,1.5257,0.064,0.47
"GO_CC:499359_GO_0022624_PROTEASOME_ACCESSORY_COMPLEX","GO_CC","499359_GO_0022624_PROTEASOME_ACCESSORY_COMPLEX",24,1.7687,0,0.061,2.0921,0,0.00085,1.1762,0.21,0.82
"GO_BP:492649_GO_0008334_HISTONE_MRNA_METABOLIC_PROCESS","GO_BP","492649_GO_0008334_HISTONE_MRNA_METABOLIC_PROCESS",28,1.7711,0.0062,0.13,1.8962,0.0021,0.04,1.5002,0.032,0.56
"WikiPathways:198843_WP411_MRNA_PROCESSING","WikiPathways","198843_WP411_MRNA_PROCESSING",132,1.7751,0,0.04,1.3389,0.021,0.61,0.981,0.49,0.94
"GO_MF:499854_GO_0030515_SNORNA_BINDING","GO_MF","499854_GO_0030515_SNORNA_BINDING",26,1.7784,0.0029,0.18,1.8628,0.0021,0.045,-0.6027,0.97,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_123_CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_123_CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN",9,1.7836,0.017,0.26,1.9557,0.0021,0.011,0.8278,0.71,1
"GO_CC:486707_GO_0000176_NUCLEAR_EXOSOME_RNASE_COMPLEX_","GO_CC","486707_GO_0000176_NUCLEAR_EXOSOME_RNASE_COMPLEX_",10,1.784,0.02,0.054,1.431,0.089,0.27,1.2817,0.19,0.72
"GO_MF:514974_GO_0070035_PURINE_NTP_DEPENDENT_HELICASE_ACTIVITY","GO_MF","514974_GO_0070035_PURINE_NTP_DEPENDENT_HELICASE_ACTIVITY",113,1.7877,0,0.18,1.1371,0.19,0.76,-0.6914,0.99,1
"REACTOME:106011_REACT_6757_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS","REACTOME","106011_REACT_6757_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS",34,1.7877,0.0064,0.057,1.4824,0.047,0.16,0.8831,0.67,1
"GO_BP:512130_GO_0051236_ESTABLISHMENT_OF_RNA_LOCALIZATION","GO_BP","512130_GO_0051236_ESTABLISHMENT_OF_RNA_LOCALIZATION",146,1.7921,0,0.11,1.2317,0.086,0.75,0.6421,1,1
"C0_Hallmark:H_ALL_29_HALLMARK_MYC_TARGETS_V2","C0_Hallmark","H_ALL_29_HALLMARK_MYC_TARGETS_V2",58,1.7941,0,0.0018,1.6165,0.011,0.0094,-1.1654,0.2,0.21
"GO_BP:486688_GO_0000154_RRNA_MODIFICATION","GO_BP","486688_GO_0000154_RRNA_MODIFICATION",16,1.7954,0.0083,0.11,1.3649,0.099,0.6,1.0721,0.35,0.78
"GO_BP:511630_GO_0050658_RNA_TRANSPORT","GO_BP","511630_GO_0050658_RNA_TRANSPORT",146,1.7968,0,0.11,1.2381,0.077,0.75,0.6455,1,1
"C4_Cancer_modules:C4_CM_173_MODULE_183","C4_Cancer_modules","C4_CM_173_MODULE_183",65,1.7988,0,0.046,1.8107,0,0.02,1.2402,0.13,0.52
"GO_CC:490739_GO_0005685_U1_SNRNP","GO_CC","490739_GO_0005685_U1_SNRNP",15,1.8016,0.0079,0.048,1.8909,0.0019,0.011,1.2276,0.2,0.83
"GO_BP:486763_GO_0000245_SPLICEOSOMAL_COMPLEX_ASSEMBLY","GO_BP","486763_GO_0000245_SPLICEOSOMAL_COMPLEX_ASSEMBLY",51,1.802,0,0.11,1.2828,0.1,0.7,0.928,0.58,0.92
"GO_BP:486959_GO_0000466_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_","GO_BP","486959_GO_0000466_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_",12,1.8039,0.0054,0.11,1.5498,0.04,0.34,1.0077,0.42,0.85
"GO_CC:501535_GO_0032300_MISMATCH_REPAIR_COMPLEX","GO_CC","501535_GO_0032300_MISMATCH_REPAIR_COMPLEX",13,1.8059,0.0027,0.048,-0.6035,0.94,1,-0.9245,0.58,1
"REACTOME:106015_REACT_9395_NUCLEAR_IMPORT_OF_REV_PROTEIN","REACTOME","106015_REACT_9395_NUCLEAR_IMPORT_OF_REV_PROTEIN",31,1.8063,0,0.049,1.4208,0.052,0.21,0.708,0.9,1
"KEGG_module:HSA_M00352_SPLICEOSOME_U2_SNRNP","KEGG_module","HSA_M00352_SPLICEOSOME_U2_SNRNP",20,1.8097,0.0092,0.074,2.2446,0,0,1.6355,0.012,0.37
"GO_BP:510698_GO_0048642_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT","GO_BP","510698_GO_0048642_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT",12,1.8116,0.013,0.1,1.1281,0.3,0.87,1.1416,0.28,0.73
"GO_MF:496876_GO_0017056_STRUCTURAL_CONSTITUENT_OF_NUCLEAR_PORE","GO_MF","496876_GO_0017056_STRUCTURAL_CONSTITUENT_OF_NUCLEAR_PORE",10,1.8149,0.0053,0.15,1.5584,0.045,0.32,0.9074,0.58,0.95
"C7_Immunologic_signatures:C7_ALL_1281_GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP","C7_Immunologic_signatures","C7_ALL_1281_GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP",185,1.821,0,0,1.484,0.0024,0.015,-0.8904,0.77,0.96
"GO_CC:508797_GO_0046540_U4_U6_X_U5_TRI_SNRNP_COMPLEX","GO_CC","508797_GO_0046540_U4_U6_X_U5_TRI_SNRNP_COMPLEX",13,1.822,0.016,0.042,1.7732,0.008,0.033,1.018,0.41,0.98
"C4_Cancer_gene_neighborhoods:C4_CGN_205_GCM_TINF2","C4_Cancer_gene_neighborhoods","C4_CGN_205_GCM_TINF2",40,1.825,0,0.013,1.0735,0.33,0.42,1.0705,0.36,0.64
"KEGG_compound:C03201_1_ALKYL_2_ACYLGLYCEROL_2_ACYL_1_ALKYL_SN_GLYCEROL","KEGG_compound","C03201_1_ALKYL_2_ACYLGLYCEROL_2_ACYL_1_ALKYL_SN_GLYCEROL",7,1.8274,0.0077,0.12,1.5249,0.053,0.28,1.3236,0.14,0.38
"C4_Cancer_modules:C4_CM_105_MODULE_110","C4_Cancer_modules","C4_CM_105_MODULE_110",16,1.8305,0.011,0.045,1.5595,0.037,0.091,-0.6145,0.95,1
"GO_BP:511629_GO_0050657_NUCLEIC_ACID_TRANSPORT","GO_BP","511629_GO_0050657_NUCLEIC_ACID_TRANSPORT",147,1.8306,0,0.085,1.2508,0.059,0.73,0.6325,1,1
"REACTOME:105980_REACT_15482_TRNA_AMINOACYLATION","REACTOME","105980_REACT_15482_TRNA_AMINOACYLATION",42,1.8327,0.0035,0.04,1.5533,0.013,0.12,-0.728,0.92,1
"C4_Cancer_gene_neighborhoods:C4_CGN_369_GNF2_KPNB1","C4_Cancer_gene_neighborhoods","C4_CGN_369_GNF2_KPNB1",73,1.8328,0,0.013,1.889,0,0.00094,-0.6525,0.99,1
"GO_CC:911353_GO_0097526_SPLICEOSOMAL_TRI_SNRNP_COMPLEX","GO_CC","911353_GO_0097526_SPLICEOSOMAL_TRI_SNRNP_COMPLEX",13,1.8353,0.0079,0.037,1.8021,0.0088,0.027,1.0232,0.42,0.97
"GO_BP:506124_GO_0043038_AMINO_ACID_ACTIVATION","GO_BP","506124_GO_0043038_AMINO_ACID_ACTIVATION",52,1.8358,0,0.082,1.3357,0.057,0.62,-0.913,0.63,0.92
"C4_Cancer_modules:C4_CM_31_MODULE_35","C4_Cancer_modules","C4_CM_31_MODULE_35",16,1.8365,0.0079,0.056,1.3661,0.11,0.22,-0.5672,0.98,1
"REACTOME:160953_REACT_185_SLBP_INDEPENDENT_PROCESSING_OF_HISTONE_PRE_MRNAS","REACTOME","160953_REACT_185_SLBP_INDEPENDENT_PROCESSING_OF_HISTONE_PRE_MRNAS",10,1.8395,0.013,0.039,1.5986,0.033,0.093,1.4387,0.076,0.59
"C7_Immunologic_signatures:C7_ALL_841_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP","C7_Immunologic_signatures","C7_ALL_841_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP",199,1.8399,0,0,1.5982,0,0.0032,0.7867,0.98,1
"GO_BP:491324_GO_0006402_MRNA_CATABOLIC_PROCESS","GO_BP","491324_GO_0006402_MRNA_CATABOLIC_PROCESS",193,1.8436,0,0.078,3.3408,0,0,0.6861,1,1
"REACTOME:105970_REACT_1258_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S","REACTOME","105970_REACT_1258_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S",56,1.8458,0,0.037,3.3339,0,0,1.0716,0.32,0.95
"GO_MF:496765_GO_0016876_LIGASE_ACTIVITY_FORMING_AMINOACYL_TRNA_AND_RELATED_COMPOUNDS","GO_MF","496765_GO_0016876_LIGASE_ACTIVITY_FORMING_AMINOACYL_TRNA_AND_RELATED_COMPOUNDS",44,1.8486,0,0.12,1.3839,0.04,0.48,-0.7976,0.82,0.97
"REACTOME:105972_REACT_931_RIBOSOMAL_SCANNING_AND_START_CODON_RECOGNITION","REACTOME","105972_REACT_931_RIBOSOMAL_SCANNING_AND_START_CODON_RECOGNITION",55,1.8535,0.0038,0.036,3.3883,0,0,1.2086,0.15,0.83
"GO_BP:491835_GO_0006999_NUCLEAR_PORE_ORGANIZATION","GO_BP","491835_GO_0006999_NUCLEAR_PORE_ORGANIZATION",11,1.8544,0,0.071,1.684,0.022,0.21,0.9192,0.55,0.92
"C4_Cancer_gene_neighborhoods:C4_CGN_304_GNF2_MSH2","C4_Cancer_gene_neighborhoods","C4_CGN_304_GNF2_MSH2",28,1.858,0,0.011,1.9518,0.0022,0.00051,-1.0975,0.3,0.62
"GO_BP:506125_GO_0043039_TRNA_AMINOACYLATION","GO_BP","506125_GO_0043039_TRNA_AMINOACYLATION",50,1.8619,0,0.067,1.526,0.016,0.37,-0.7551,0.88,1
"REACTOME:105961_REACT_338_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS","REACTOME","105961_REACT_338_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS",36,1.8698,0.0033,0.031,1.394,0.072,0.23,0.8624,0.7,1
"GO_BP:511953_GO_0051028_MRNA_TRANSPORT","GO_BP","511953_GO_0051028_MRNA_TRANSPORT",126,1.8705,0,0.062,1.2471,0.058,0.73,0.8155,0.89,1
"REACTOME:105959_REACT_1281_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM","REACTOME","105959_REACT_1281_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM",55,1.872,0,0.031,1.1347,0.25,0.54,0.9453,0.56,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_2413_CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP","C2_Chemical_and_genetic_perturbations","C2_CGP_2413_CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP",52,1.8745,0,0.14,3.3645,0,0,-0.6758,0.97,0.99
"GO_CC:490736_GO_0005682_U5_SNRNP","GO_CC","490736_GO_0005682_U5_SNRNP",9,1.8755,0.0052,0.027,1.4771,0.06,0.22,0.8862,0.59,1
"REACTOME:105982_REACT_15302_MITOCHONDRIAL_TRNA_AMINOACYLATION","REACTOME","105982_REACT_15302_MITOCHONDRIAL_TRNA_AMINOACYLATION",21,1.876,0,0.031,0.8534,0.69,0.96,-0.6488,0.93,1
"REACTOME:105995_REACT_6361_LATE_PHASE_OF_HIV_LIFE_CYCLE","REACTOME","105995_REACT_6361_LATE_PHASE_OF_HIV_LIFE_CYCLE",127,1.8805,0,0.031,2.0731,0,0.00089,1.2986,0.05,0.76
"GO_BP:506946_GO_0043928_EXONUCLEOLYTIC_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_INVOLVED_IN_DEADENYLATION_DEPENDENT_DECAY","GO_BP","506946_GO_0043928_EXONUCLEOLYTIC_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_INVOLVED_IN_DEADENYLATION_DEPENDENT_DECAY",29,1.8812,0,0.057,1.9327,0,0.028,0.8984,0.61,0.95
"C7_Immunologic_signatures:C7_ALL_1405_GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP","C7_Immunologic_signatures","C7_ALL_1405_GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP",180,1.8816,0,0,1.9693,0,0,1.0131,0.39,1
"GO_BP:507953_GO_0045605_NEGATIVE_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION","GO_BP","507953_GO_0045605_NEGATIVE_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION",11,1.886,0,0.055,-0.8304,0.7,1,0.7603,0.79,1
"GO_MF:496764_GO_0016875_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS","GO_MF","496764_GO_0016875_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS",44,1.8891,0,0.091,1.3945,0.042,0.48,-0.8061,0.8,0.96
"GO_BP:486962_GO_0000469_CLEAVAGE_INVOLVED_IN_RRNA_PROCESSING","GO_BP","486962_GO_0000469_CLEAVAGE_INVOLVED_IN_RRNA_PROCESSING",11,1.8895,0.0048,0.054,1.6913,0.016,0.2,1.1665,0.26,0.73
"GO_MF:489886_GO_0004549_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY","GO_MF","489886_GO_0004549_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY",13,1.8904,0.0054,0.1,1.5655,0.026,0.32,1.1347,0.3,0.8
"REACTOME:105971_REACT_1979_TRANSLATION_INITIATION_COMPLEX_FORMATION","REACTOME","105971_REACT_1979_TRANSLATION_INITIATION_COMPLEX_FORMATION",55,1.8915,0,0.029,3.3615,0,0,1.166,0.21,0.87
"KEGG_reaction:R01176_BUTANOATE_COA_LIGASE_AMP_FORMING_ATP_BUTANOIC_ACID_COA_AMP_DIPHOSPHATE_BUTANOYL_COA","KEGG_reaction","R01176_BUTANOATE_COA_LIGASE_AMP_FORMING_ATP_BUTANOIC_ACID_COA_AMP_DIPHOSPHATE_BUTANOYL_COA",6,1.8927,0.0026,0.14,-0.7759,0.74,1,-1.0538,0.38,0.53
"C2_Chemical_and_genetic_perturbations:C2_CGP_10_PYEON_HPV_POSITIVE_TUMORS_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_10_PYEON_HPV_POSITIVE_TUMORS_DN",6,1.8954,0,0.14,1.1659,0.27,0.53,1.0914,0.37,0.88
"GO_MF:490116_GO_0004812_AMINOACYL_TRNA_LIGASE_ACTIVITY","GO_MF","490116_GO_0004812_AMINOACYL_TRNA_LIGASE_ACTIVITY",44,1.8958,0,0.11,1.3955,0.048,0.48,-0.8083,0.82,0.96
"GO_BP:491319_GO_0006397_MRNA_PROCESSING","GO_BP","491319_GO_0006397_MRNA_PROCESSING",423,1.8963,0,0.052,1.6831,0,0.21,1.0863,0.2,0.77
"KEGG_compound:C00246_BUTANOIC_ACID_BUTANOATE_BUTYRATE_BUTYRIC_ACID","KEGG_compound","C00246_BUTANOIC_ACID_BUTANOATE_BUTYRATE_BUTYRIC_ACID",6,1.8983,0,0.09,-0.7813,0.73,1,-1.0851,0.37,0.55
"GO_BP:491337_GO_0006418_TRNA_AMINOACYLATION_FOR_PROTEIN_TRANSLATION","GO_BP","491337_GO_0006418_TRNA_AMINOACYLATION_FOR_PROTEIN_TRANSLATION",47,1.9012,0.0039,0.05,1.4715,0.025,0.46,-0.7775,0.86,1
"C7_Immunologic_signatures:C7_ALL_1273_GSE29618_BCELL_VS_MDC_UP","C7_Immunologic_signatures","C7_ALL_1273_GSE29618_BCELL_VS_MDC_UP",184,1.9019,0,0,1.404,0.014,0.036,-0.7466,0.99,1
"REACTOME:106013_REACT_7991_VPR_MEDIATED_NUCLEAR_IMPORT_OF_PICS","REACTOME","106013_REACT_7991_VPR_MEDIATED_NUCLEAR_IMPORT_OF_PICS",31,1.9034,0,0.026,1.5801,0.03,0.1,1.0424,0.41,0.97
"C4_Cancer_gene_neighborhoods:C4_CGN_346_GNF2_DENR","C4_Cancer_gene_neighborhoods","C4_CGN_346_GNF2_DENR",51,1.9034,0,0.0059,1.9286,0,0.00063,0.9744,0.49,0.87
"GO_CC:490709_GO_0005643_NUCLEAR_PORE","GO_CC","490709_GO_0005643_NUCLEAR_PORE",70,1.9054,0,0.02,1.5641,0.0088,0.15,0.6528,0.99,1
"GO_CC:490728_GO_0005672_TRANSCRIPTION_FACTOR_TFIIA_COMPLEX","GO_CC","490728_GO_0005672_TRANSCRIPTION_FACTOR_TFIIA_COMPLEX",6,1.9117,0,0.02,1.5368,0.04,0.17,1.4552,0.083,0.65
"REACTOME:160952_REACT_1364_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS","REACTOME","160952_REACT_1364_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS",11,1.9121,0.0082,0.025,1.6517,0.0081,0.068,1.3805,0.1,0.72
"REACTOME:105963_REACT_424_TRANSPORT_OF_THE_SLBP_INDEPENDENT_MATURE_MRNA","REACTOME","105963_REACT_424_TRANSPORT_OF_THE_SLBP_INDEPENDENT_MATURE_MRNA",32,1.9144,0,0.025,1.3644,0.068,0.25,0.9418,0.56,1
"REACTOME:106014_REACT_6916_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS","REACTOME","106014_REACT_6916_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS",34,1.9158,0,0.025,1.5196,0.024,0.14,0.6004,0.99,1
"REACTOME:106068_REACT_6145_INFLUENZA_LIFE_CYCLE","REACTOME","106068_REACT_6145_INFLUENZA_LIFE_CYCLE",136,1.918,0,0.026,3.4816,0,0,0.9749,0.51,1
"GO_BP:486808_GO_0000291_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_EXONUCLEOLYTIC","GO_BP","486808_GO_0000291_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_EXONUCLEOLYTIC",31,1.9181,0,0.042,1.8708,0,0.052,0.7479,0.89,1
"GO_CC:486830_GO_0000313_ORGANELLAR_RIBOSOME","GO_CC","486830_GO_0000313_ORGANELLAR_RIBOSOME",63,1.9193,0,0.019,2.4026,0,0,1.2262,0.13,0.82
"GO_BP:491328_GO_0006406_MRNA_EXPORT_FROM_NUCLEUS","GO_BP","491328_GO_0006406_MRNA_EXPORT_FROM_NUCLEUS",70,1.9208,0,0.042,0.9256,0.6,1,0.9143,0.62,0.93
"REACTOME:106067_REACT_6167_INFLUENZA_INFECTION","REACTOME","106067_REACT_6167_INFLUENZA_INFECTION",141,1.9231,0,0.025,3.447,0,0,0.903,0.72,1
"GO_MF:486597_GO_0000049_TRNA_BINDING","GO_MF","486597_GO_0000049_TRNA_BINDING",41,1.9247,0.0037,0.089,1.7015,0.0043,0.15,1.078,0.33,0.81
"C7_Immunologic_signatures:C7_ALL_845_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP","C7_Immunologic_signatures","C7_ALL_845_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP",199,1.927,0,0,1.6857,0,8e-04,1.0812,0.27,1
"GO_BP:492576_GO_0008380_RNA_SPLICING","GO_BP","492576_GO_0008380_RNA_SPLICING",340,1.9344,0,0.036,1.8724,0,0.052,1.2019,0.058,0.72
"REACTOME:106073_REACT_6248_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS","REACTOME","106073_REACT_6248_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS",29,1.9348,0,0.022,1.5349,0.034,0.13,0.9337,0.54,1
"GO_BP:486953_GO_0000460_MATURATION_OF_5_8S_RRNA","GO_BP","486953_GO_0000460_MATURATION_OF_5_8S_RRNA",18,1.9362,0.0028,0.036,1.7898,0.0084,0.11,1.4214,0.082,0.62
"GO_CC:502020_GO_0032797_SMN_COMPLEX","GO_CC","502020_GO_0032797_SMN_COMPLEX",12,1.9366,0,0.016,1.8385,0.0063,0.019,1.4993,0.066,0.61
"GO_MF:489874_GO_0004526_RIBONUCLEASE_P_ACTIVITY","GO_MF","489874_GO_0004526_RIBONUCLEASE_P_ACTIVITY",10,1.9389,0.0047,0.091,1.3672,0.13,0.5,0.9669,0.48,0.9
"REACTOME:105960_REACT_1597_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRON_CONTAINING_TRANSCRIPT","REACTOME","105960_REACT_1597_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRON_CONTAINING_TRANSCRIPT",51,1.9397,0,0.021,1.0814,0.3,0.62,1.0084,0.45,1
"REACTOME:105969_REACT_1079_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX","REACTOME","105969_REACT_1079_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX",48,1.9439,0,0.022,3.2982,0,0,1.3418,0.076,0.71
"GO_BP:486579_GO_0000028_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY","GO_BP","486579_GO_0000028_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY",11,1.9451,0,0.034,2.2264,0,0.00046,1.0881,0.36,0.77
"GO_BP:486891_GO_0000398_MRNA_SPLICING_VIA_SPLICEOSOME","GO_BP","486891_GO_0000398_MRNA_SPLICING_VIA_SPLICEOSOME",226,1.946,0,0.034,1.7854,0,0.11,1.0987,0.19,0.76
"REACTOME:106007_REACT_6190_REV_MEDIATED_NUCLEAR_EXPORT_OF_HIV_RNA","REACTOME","106007_REACT_6190_REV_MEDIATED_NUCLEAR_EXPORT_OF_HIV_RNA",32,1.9462,0,0.022,1.4575,0.047,0.18,0.8115,0.76,1
"C4_Cancer_modules:C4_CM_328_MODULE_388","C4_Cancer_modules","C4_CM_328_MODULE_388",17,1.9471,0.0027,0.033,2.1911,0,0.00023,1.5426,0.04,0.19
"REACTOME:105962_REACT_405_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA","REACTOME","105962_REACT_405_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA",33,1.9515,0,0.021,1.3909,0.076,0.23,0.9129,0.6,1
"GO_CC:911332_GO_0097504_GEMINI_OF_COILED_BODIES","GO_CC","911332_GO_0097504_GEMINI_OF_COILED_BODIES",11,1.9539,0,0.014,1.6319,0.021,0.094,1.5404,0.043,0.54
"KEGG_pathway:HSA03013_RNA_TRANSPORT","KEGG_pathway","HSA03013_RNA_TRANSPORT",166,1.9542,0,0.0034,1.9248,0,0.004,0.9317,0.66,1
"GO_BP:506308_GO_0043241_PROTEIN_COMPLEX_DISASSEMBLY","GO_BP","506308_GO_0043241_PROTEIN_COMPLEX_DISASSEMBLY",219,1.9621,0,0.029,3.46,0,0,0.9324,0.63,0.92
"GO_BP:486879_GO_0000377_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS_WITH_BULGED_ADENOSINE_AS_NUCLEOPHILE","GO_BP","486879_GO_0000377_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS_WITH_BULGED_ADENOSINE_AS_NUCLEOPHILE",227,1.9723,0,0.026,1.7678,0,0.13,1.0941,0.23,0.77
"KEGG_compound:C00048_GLYOXYLATE_GLYOXALATE_GLYOXYLIC_ACID","KEGG_compound","C00048_GLYOXYLATE_GLYOXALATE_GLYOXYLIC_ACID",7,1.9729,0.0024,0.075,1.7293,0.01,0.062,1.759,0.0021,0.025
"GO_BP:495806_GO_0015669_GAS_TRANSPORT","GO_BP","495806_GO_0015669_GAS_TRANSPORT",20,1.974,0.0028,0.026,1.9818,0,0.016,-1.3336,0.11,0.62
"GO_BP:499832_GO_0030488_TRNA_METHYLATION","GO_BP","499832_GO_0030488_TRNA_METHYLATION",15,1.9828,0.0028,0.024,1.562,0.036,0.34,0.9928,0.47,0.86
"GO_CC:490794_GO_0005761_MITOCHONDRIAL_RIBOSOME","GO_CC","490794_GO_0005761_MITOCHONDRIAL_RIBOSOME",61,1.9831,0,0.011,2.4113,0,0,1.2489,0.12,0.78
"GO_CC:499983_GO_0030681_MULTIMERIC_RIBONUCLEASE_P_COMPLEX","GO_CC","499983_GO_0030681_MULTIMERIC_RIBONUCLEASE_P_COMPLEX",7,1.988,0,0.011,1.5554,0.032,0.15,1.047,0.38,0.98
"GO_CC:490796_GO_0005763_MITOCHONDRIAL_SMALL_RIBOSOMAL_SUBUNIT","GO_CC","490796_GO_0005763_MITOCHONDRIAL_SMALL_RIBOSOMAL_SUBUNIT",22,1.9919,0,0.011,1.9766,0,0.0042,1.3561,0.085,0.76
"GO_CC:486709_GO_0000178_EXOSOME_RNASE_COMPLEX_","GO_CC","486709_GO_0000178_EXOSOME_RNASE_COMPLEX_",21,1.9974,0,0.011,1.6342,0.01,0.093,1.0925,0.3,0.92
"GO_BP:486877_GO_0000375_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS","GO_BP","486877_GO_0000375_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS",230,1.9975,0,0.021,1.7938,0,0.11,1.1274,0.17,0.74
"GO_CC:486831_GO_0000314_ORGANELLAR_SMALL_RIBOSOMAL_SUBUNIT","GO_CC","486831_GO_0000314_ORGANELLAR_SMALL_RIBOSOMAL_SUBUNIT",22,1.9983,0,0.011,1.9732,0,0.0043,1.3234,0.12,0.7
"GO_CC:515939_GO_0071013_CATALYTIC_STEP_2_SPLICEOSOME","GO_CC","515939_GO_0071013_CATALYTIC_STEP_2_SPLICEOSOME",83,1.9991,0,0.012,1.9733,0,0.0044,1.3808,0.022,0.75
"C7_Immunologic_signatures:C7_ALL_979_GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP","C7_Immunologic_signatures","C7_ALL_979_GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP",196,1.9992,0,0,2.6033,0,0,-1.1941,0.095,0.29
"GO_CC:499979_GO_0030677_RIBONUCLEASE_P_COMPLEX","GO_CC","499979_GO_0030677_RIBONUCLEASE_P_COMPLEX",7,2.0035,0.0025,0.011,1.561,0.049,0.15,1.0502,0.4,0.98
"GO_BP:502206_GO_0032984_MACROMOLECULAR_COMPLEX_DISASSEMBLY","GO_BP","502206_GO_0032984_MACROMOLECULAR_COMPLEX_DISASSEMBLY",228,2.0035,0,0.02,3.4477,0,0,0.9876,0.48,0.87
"GO_BP:487450_GO_0001510_RNA_METHYLATION","GO_BP","487450_GO_0001510_RNA_METHYLATION",42,2.0091,0,0.019,1.5348,0.023,0.36,1.2649,0.14,0.69
"REACTOME:106082_REACT_6179_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY","REACTOME","106082_REACT_6179_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY",29,2.0109,0.0031,0.012,1.6081,0.011,0.09,0.9765,0.49,1
"GO_MF:492523_GO_0008175_TRNA_METHYLTRANSFERASE_ACTIVITY","GO_MF","492523_GO_0008175_TRNA_METHYLTRANSFERASE_ACTIVITY",15,2.0197,0,0.043,1.5837,0.028,0.3,0.9849,0.48,0.88
"C4_Cancer_gene_neighborhoods:C4_CGN_322_GNF2_APEX1","C4_Cancer_gene_neighborhoods","C4_CGN_322_GNF2_APEX1",92,2.0241,0,0.0027,2.0934,0,0.00013,0.5569,1,1
"C2_Chemical_and_genetic_perturbations:C2_CGP_1468_MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1468_MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN",73,2.0251,0,0.048,2.1461,0,0.0012,0.6456,0.99,1
"GO_CC:490714_GO_0005655_NUCLEOLAR_RIBONUCLEASE_P_COMPLEX","GO_CC","490714_GO_0005655_NUCLEOLAR_RIBONUCLEASE_P_COMPLEX",7,2.0285,0,0.0086,1.5621,0.06,0.15,1.0454,0.4,0.98
"GO_BP:491327_GO_0006405_RNA_EXPORT_FROM_NUCLEUS","GO_BP","491327_GO_0006405_RNA_EXPORT_FROM_NUCLEUS",78,2.0313,0,0.015,1.187,0.16,0.8,0.9842,0.49,0.87
"C7_Immunologic_signatures:C7_ALL_837_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP","C7_Immunologic_signatures","C7_ALL_837_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP",195,2.0323,0,0,1.815,0,3.1e-05,0.7416,1,1
"GO_MF:496778_GO_0016891_ENDORIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS","GO_MF","496778_GO_0016891_ENDORIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS",24,2.0376,0,0.043,1.4643,0.046,0.41,0.971,0.5,0.89
"KEGG_module:HSA_M00426_SURVIVAL_MOTOR_NEURON_SMN_COMPLEX","KEGG_module","HSA_M00426_SURVIVAL_MOTOR_NEURON_SMN_COMPLEX",10,2.0409,0,0.0071,1.7616,0.011,0.046,1.4768,0.068,0.69
"KEGG_pathway:HSA00970_AMINOACYL_TRNA_BIOSYNTHESIS","KEGG_pathway","HSA00970_AMINOACYL_TRNA_BIOSYNTHESIS",65,2.0443,0,0.00096,1.5885,0.0043,0.072,-0.7766,0.89,0.95
"GO_BP:515899_GO_0070972_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM","GO_BP","515899_GO_0070972_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM",134,2.0774,0,0.0079,3.6582,0,0,1.625,0.0019,0.4
"GO_BP:499353_GO_0022618_RIBONUCLEOPROTEIN_COMPLEX_ASSEMBLY","GO_BP","499353_GO_0022618_RIBONUCLEOPROTEIN_COMPLEX_ASSEMBLY",151,2.0796,0,0.0079,2.1797,0,0.0011,1.1394,0.18,0.73
"C4_Cancer_gene_neighborhoods:C4_CGN_343_GNF2_DAP3","C4_Cancer_gene_neighborhoods","C4_CGN_343_GNF2_DAP3",119,2.0813,0,0.0017,3.3727,0,0,1.1117,0.22,0.61
"GO_BP:495808_GO_0015671_OXYGEN_TRANSPORT","GO_BP","495808_GO_0015671_OXYGEN_TRANSPORT",15,2.0819,0,0.0079,1.9856,0,0.015,-1.3976,0.095,0.58
"GO_CC:490735_GO_0005681_SPLICEOSOMAL_COMPLEX","GO_CC","490735_GO_0005681_SPLICEOSOMAL_COMPLEX",160,2.0847,0,0.0041,2.0038,0,0.0033,1.4022,0.0057,0.77
"C1_Positional:C1_ALL_205_CHR19P12","C1_Positional","C1_ALL_205_CHR19P12",40,2.0863,0,0.017,2.0242,0,0.013,2.2186,0,0
"C4_Cancer_modules:C4_CM_28_MODULE_29","C4_Cancer_modules","C4_CM_28_MODULE_29",28,2.0879,0,0.012,2.9633,0,0,1.2301,0.17,0.54
"C4_Cancer_gene_neighborhoods:C4_CGN_271_GCM_TPT1","C4_Cancer_gene_neighborhoods","C4_CGN_271_GCM_TPT1",70,2.0887,0,0.0017,3.6265,0,0,1.1965,0.17,0.45
"C7_Immunologic_signatures:C7_ALL_1269_GSE29618_BCELL_VS_MONOCYTE_UP","C7_Immunologic_signatures","C7_ALL_1269_GSE29618_BCELL_VS_MONOCYTE_UP",182,2.0916,0,0,1.5168,0.0048,0.0097,-0.7017,1,1
"C4_Cancer_gene_neighborhoods:C4_CGN_402_GNF2_RBBP6","C4_Cancer_gene_neighborhoods","C4_CGN_402_GNF2_RBBP6",70,2.0966,0,0.002,2.3078,0,0,1.0003,0.48,0.81
"REACTOME:645346_REACT_120969_O2_CO2_EXCHANGE_IN_ERYTHROCYTES","REACTOME","645346_REACT_120969_O2_CO2_EXCHANGE_IN_ERYTHROCYTES",9,2.1001,0,0.0039,2.0747,0,0.00088,-0.8579,0.65,0.98
"C7_Immunologic_signatures:C7_ALL_835_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP","C7_Immunologic_signatures","C7_ALL_835_GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP",187,2.104,0,0,1.7482,0,0.00032,1.2107,0.088,0.67
"REACTOME:645347_REACT_121329_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN","REACTOME","645347_REACT_121329_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN",9,2.1174,0,0.0032,2.0533,0,0.0013,-0.8755,0.6,0.96
"GO_MF:487463_GO_0005344_OXYGEN_TRANSPORTER_ACTIVITY","GO_MF","487463_GO_0005344_OXYGEN_TRANSPORTER_ACTIVITY",13,2.118,0.0027,0.02,2.1744,0,0.0016,-1.7691,0.0059,0.23
"REACTOME:645348_REACT_121380_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE","REACTOME","645348_REACT_121380_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE",9,2.1217,0,0.0032,2.0877,0,0.00072,-0.8386,0.65,1
"GO_BP:516748_GO_0071826_RIBONUCLEOPROTEIN_COMPLEX_SUBUNIT_ORGANIZATION","GO_BP","516748_GO_0071826_RIBONUCLEOPROTEIN_COMPLEX_SUBUNIT_ORGANIZATION",163,2.1302,0,0.0042,2.237,0,0.00042,1.2358,0.058,0.7
"GO_CC:486712_GO_0022627_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT","GO_CC","486712_GO_0022627_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT",41,2.1345,0,0.0022,3.1713,0,0,1.3334,0.097,0.71
"C2_Chemical_and_genetic_perturbations:C2_CGP_1572_MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN","C2_Chemical_and_genetic_perturbations","C2_CGP_1572_MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN",171,2.162,0,0.012,2.293,0,0.00013,0.796,0.96,1
"C7_Immunologic_signatures:C7_ALL_47_GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP","C7_Immunologic_signatures","C7_ALL_47_GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP",188,2.1624,0,0,1.5378,0,0.0073,-1.3166,0.021,0.12
"GO_BP:506655_GO_0043624_CELLULAR_PROTEIN_COMPLEX_DISASSEMBLY","GO_BP","506655_GO_0043624_CELLULAR_PROTEIN_COMPLEX_DISASSEMBLY",200,2.1626,0,0.0028,3.549,0,0,1.0347,0.37,0.82
"C7_Immunologic_signatures:C7_ALL_225_GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP","C7_Immunologic_signatures","C7_ALL_225_GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP",199,2.1745,0,0,1.9687,0,0,1.1926,0.11,0.75
"GO_BP:487180_GO_0000956_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS","GO_BP","487180_GO_0000956_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS",181,2.1755,0,0.0024,3.4965,0,0,1.0132,0.42,0.84
"KEGG_module:HSA_M00427_NUCLEAR_PORE_COMPLEX","KEGG_module","HSA_M00427_NUCLEAR_PORE_COMPLEX",46,2.1906,0,0.0029,1.5451,0.0084,0.15,1.4317,0.042,0.74
"GO_BP:486884_GO_0000387_SPLICEOSOMAL_SNRNP_ASSEMBLY","GO_BP","486884_GO_0000387_SPLICEOSOMAL_SNRNP_ASSEMBLY",38,2.202,0,0.0016,1.9707,0,0.018,1.5238,0.031,0.54
"GO_CC:503919_GO_0034719_SMN_SM_PROTEIN_COMPLEX","GO_CC","503919_GO_0034719_SMN_SM_PROTEIN_COMPLEX",17,2.2139,0,0.00059,2.2741,0,0,1.6413,0.023,0.34
"GO_MF:492521_GO_0008173_RNA_METHYLTRANSFERASE_ACTIVITY","GO_MF","492521_GO_0008173_RNA_METHYLTRANSFERASE_ACTIVITY",39,2.2226,0,0.0079,1.5912,0.017,0.3,1.2632,0.13,0.65
"GO_BP:486715_GO_0000184_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY","GO_BP","486715_GO_0000184_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY",115,2.2432,0,0.00081,3.7356,0,0,1.2305,0.1,0.71
"GO_CC:495325_GO_0015030_CAJAL_BODY","GO_CC","495325_GO_0015030_CAJAL_BODY",50,2.2447,0,0.00039,1.8876,0,0.011,1.3984,0.043,0.75
"REACTOME:106074_REACT_6152_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION","REACTOME","106074_REACT_6152_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION",127,2.2486,0,0.00068,3.6624,0,0,1.2751,0.069,0.77
"GO_CC:911352_GO_0097525_SPLICEOSOMAL_SNRNP_COMPLEX","GO_CC","911352_GO_0097525_SPLICEOSOMAL_SNRNP_COMPLEX",37,2.2494,0,0.00042,2.0426,0,0.002,1.3006,0.095,0.72
"REACTOME:1127501_REACT_268261_MITOCHONDRIAL_TRANSLATION_TERMINATION","REACTOME","1127501_REACT_268261_MITOCHONDRIAL_TRANSLATION_TERMINATION",84,2.2495,0,0.00071,2.5893,0,0,1.2675,0.079,0.77
"GO_BP:505425_GO_0042273_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS","GO_BP","505425_GO_0042273_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS",21,2.2541,0,0.00074,2.4332,0,0,1.3389,0.12,0.65
"GO_BP:515062_GO_0070124_MITOCHONDRIAL_TRANSLATIONAL_INITIATION","GO_BP","515062_GO_0070124_MITOCHONDRIAL_TRANSLATIONAL_INITIATION",84,2.2552,0,0.00077,2.6207,0,0,1.2739,0.096,0.69
"KEGG_module:HSA_M00354_SPLICEOSOME_U4_U6_U5_TRI_SNRNP","KEGG_module","HSA_M00354_SPLICEOSOME_U4_U6_U5_TRI_SNRNP",30,2.2588,0,0.0033,2.1657,0,0,1.1716,0.22,0.72
"REACTOME:366241_REACT_75822_NONSENSE_MEDIATED_DECAY_NMD_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX_EJC_","REACTOME","366241_REACT_75822_NONSENSE_MEDIATED_DECAY_NMD_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX_EJC_",106,2.2638,0,7e-04,3.779,0,0,1.2495,0.086,0.78
"REACTOME:366240_REACT_75886_NONSENSE_MEDIATED_DECAY_NMD_","REACTOME","366240_REACT_75886_NONSENSE_MEDIATED_DECAY_NMD_",106,2.2733,0,0.00068,3.7522,0,0,1.2419,0.094,0.79
"GO_CC:507400_GO_0044452_NUCLEOLAR_PART","GO_CC","507400_GO_0044452_NUCLEOLAR_PART",56,2.288,0,0.00028,2.0064,0,0.0032,0.8809,0.68,1
"REACTOME:1127500_REACT_268133_MITOCHONDRIAL_TRANSLATION_ELONGATION","REACTOME","1127500_REACT_268133_MITOCHONDRIAL_TRANSLATION_ELONGATION",84,2.2969,0,0.00047,2.6143,0,0,1.2985,0.073,0.74
"GO_BP:515064_GO_0070126_MITOCHONDRIAL_TRANSLATIONAL_TERMINATION","GO_BP","515064_GO_0070126_MITOCHONDRIAL_TRANSLATIONAL_TERMINATION",84,2.3028,0,0.00039,2.6433,0,0,1.2778,0.072,0.69
"REACTOME:1127498_REACT_268551_MITOCHONDRIAL_TRANSLATION","REACTOME","1127498_REACT_268551_MITOCHONDRIAL_TRANSLATION",90,2.303,0,0.00044,2.6424,0,0,1.3473,0.035,0.7
"GO_BP:515063_GO_0070125_MITOCHONDRIAL_TRANSLATIONAL_ELONGATION","GO_BP","515063_GO_0070125_MITOCHONDRIAL_TRANSLATIONAL_ELONGATION",85,2.3127,0,0.00034,2.6303,0,0,1.3174,0.076,0.66
"GO_CC:490855_GO_0005833_HEMOGLOBIN_COMPLEX","GO_CC","490855_GO_0005833_HEMOGLOBIN_COMPLEX",11,2.3334,0,1e-04,2.3738,0,0,-1.6456,0.018,0.43
"GO_BP:517502_GO_0072599_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM","GO_BP","517502_GO_0072599_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM",115,2.3353,0,0.00022,3.7526,0,0,1.6581,0.0038,0.39
"GO_CC:489275_GO_0030532_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX","GO_CC","489275_GO_0030532_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX",45,2.3378,0,0.00011,2.1343,0,0.00042,1.385,0.048,0.77
"C4_Cancer_gene_neighborhoods:C4_CGN_349_GNF2_EIF3S6","C4_Cancer_gene_neighborhoods","C4_CGN_349_GNF2_EIF3S6",121,2.3384,0,0,3.7789,0,0,1.4725,0.0095,0.19
"REACTOME:1127499_REACT_267634_MITOCHONDRIAL_TRANSLATION_INITIATION","REACTOME","1127499_REACT_267634_MITOCHONDRIAL_TRANSLATION_INITIATION",84,2.3394,0,0.00027,2.6723,0,0,1.2478,0.11,0.78
"GO_BP:493622_GO_0009451_RNA_MODIFICATION","GO_BP","493622_GO_0009451_RNA_MODIFICATION",96,2.3447,0,0.00021,1.7415,0.0023,0.15,0.803,0.91,1
"GO_CC:486711_GO_0022625_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT","GO_CC","486711_GO_0022625_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT",50,2.3461,0,0.00012,3.5386,0,0,1.3495,0.069,0.76
"REACTOME:105965_REACT_1014_TRANSLATION","REACTOME","105965_REACT_1014_TRANSLATION",145,2.3483,0,0.00022,3.8312,0,0,1.4945,0.006,0.55
"GO_CC:496056_GO_0015935_SMALL_RIBOSOMAL_SUBUNIT","GO_CC","496056_GO_0015935_SMALL_RIBOSOMAL_SUBUNIT",65,2.3556,0,0.00014,3.2575,0,0,1.3449,0.054,0.69
"GO_BP:486955_GO_0000462_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_","GO_BP","486955_GO_0000462_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA_",28,2.3605,0,0.00015,2.1016,0,0.0035,0.9862,0.47,0.87
"REACTOME:105967_REACT_2099_CAP_DEPENDENT_TRANSLATION_INITIATION","REACTOME","105967_REACT_2099_CAP_DEPENDENT_TRANSLATION_INITIATION",112,2.387,0,7.4e-05,3.8617,0,0,1.3708,0.041,0.73
"REACTOME:160955_REACT_79_L13A_MEDIATED_TRANSLATIONAL_SILENCING_OF_CERULOPLASMIN_EXPRESSION","REACTOME","160955_REACT_79_L13A_MEDIATED_TRANSLATIONAL_SILENCING_OF_CERULOPLASMIN_EXPRESSION",104,2.3978,0,8.1e-05,3.895,0,0,1.4012,0.017,0.69
"GO_BP:507448_GO_0045047_PROTEIN_TARGETING_TO_ER","GO_BP","507448_GO_0045047_PROTEIN_TARGETING_TO_ER",111,2.4013,0,7.6e-05,3.7493,0,0,1.6691,0.0019,0.4
"GO_BP:501773_GO_0032543_MITOCHONDRIAL_TRANSLATION","GO_BP","501773_GO_0032543_MITOCHONDRIAL_TRANSLATION",102,2.4036,0,8e-05,2.5717,0,0,1.2671,0.08,0.69
"REACTOME:105968_REACT_1797_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS","REACTOME","105968_REACT_1797_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS",94,2.408,0,8.8e-05,3.9416,0,0,1.4804,0.0098,0.55
"REACTOME:105973_REACT_2085_GTP_HYDROLYSIS_AND_JOINING_OF_THE_60S_RIBOSOMAL_SUBUNIT","REACTOME","105973_REACT_2085_GTP_HYDROLYSIS_AND_JOINING_OF_THE_60S_RIBOSOMAL_SUBUNIT",105,2.4097,0,9.7e-05,3.8417,0,0,1.4437,0.013,0.61
"GO_CC:499988_GO_0030686_90S_PRERIBOSOME","GO_CC","499988_GO_0030686_90S_PRERIBOSOME",25,2.4105,0,0.00016,1.8774,0,0.013,0.9443,0.51,1
"C4_Cancer_gene_neighborhoods:C4_CGN_387_GNF2_NPM1","C4_Cancer_gene_neighborhoods","C4_CGN_387_GNF2_NPM1",72,2.4133,0,0,2.9936,0,0,1.0193,0.41,0.76
"REACTOME:106228_REACT_11052_METABOLISM_OF_NON_CODING_RNA","REACTOME","106228_REACT_11052_METABOLISM_OF_NON_CODING_RNA",50,2.4208,0,0.00011,2.1137,0,5e-04,1.5481,0.015,0.44
"GO_CC:496055_GO_0015934_LARGE_RIBOSOMAL_SUBUNIT","GO_CC","496055_GO_0015934_LARGE_RIBOSOMAL_SUBUNIT",78,2.4257,0,0,3.3914,0,0,1.5252,0.0039,0.55
"KEGG_pathway:HSA03008_RIBOSOME_BIOGENESIS_IN_EUKARYOTES","KEGG_pathway","HSA03008_RIBOSOME_BIOGENESIS_IN_EUKARYOTES",81,2.437,0,0,2.0718,0,0.0011,0.8663,0.74,1
"GO_BP:491332_GO_0006412_TRANSLATION","GO_BP","491332_GO_0006412_TRANSLATION",365,2.4377,0,5.5e-05,3.3523,0,0,1.1879,0.047,0.72
"C4_Cancer_gene_neighborhoods:C4_CGN_421_GNF2_TPT1","C4_Cancer_gene_neighborhoods","C4_CGN_421_GNF2_TPT1",38,2.4422,0,0,3.4211,0,0,1.806,0,0.038
"C3_TF_targets:C3_TFT_490_GKCGCNNNNNNNTGAYG_UNKNOWN","C3_TF_targets","C3_TFT_490_GKCGCNNNNNNNTGAYG_UNKNOWN",58,2.4474,0,0,1.9616,0,0.0027,1.1959,0.19,0.68
"C4_Cancer_gene_neighborhoods:C4_CGN_414_GNF2_ST13","C4_Cancer_gene_neighborhoods","C4_CGN_414_GNF2_ST13",64,2.4474,0,0,3.6571,0,0,1.3952,0.046,0.25
"GO_BP:491507_GO_0006613_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE","GO_BP","491507_GO_0006613_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE",109,2.4484,0,2.9e-05,3.7592,0,0,1.6122,0.0039,0.41
"REACTOME:106229_REACT_11066_SNRNP_ASSEMBLY","REACTOME","106229_REACT_11066_SNRNP_ASSEMBLY",50,2.4531,0,0.00012,2.1258,0,0.00046,1.5481,0.0064,0.45
"C2_Chemical_and_genetic_perturbations:C2_CGP_1217_NIKOLSKY_BREAST_CANCER_19Q13_1_AMPLICON","C2_Chemical_and_genetic_perturbations","C2_CGP_1217_NIKOLSKY_BREAST_CANCER_19Q13_1_AMPLICON",22,2.4592,0,0,1.7863,0.0043,0.047,1.885,0,0.18
"GO_BP:491508_GO_0006614_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE","GO_BP","491508_GO_0006614_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE",107,2.4608,0,0,3.779,0,0,1.6499,0,0.4
"C4_Cancer_gene_neighborhoods:C4_CGN_355_GNF2_GLTSCR2","C4_Cancer_gene_neighborhoods","C4_CGN_355_GNF2_GLTSCR2",31,2.4623,0,0,3.0862,0,0,1.2483,0.15,0.36
"REACTOME:105966_REACT_2159_EUKARYOTIC_TRANSLATION_INITIATION","REACTOME","105966_REACT_2159_EUKARYOTIC_TRANSLATION_INITIATION",112,2.4629,0,0.00014,3.8457,0,0,1.3686,0.028,0.71
"GO_BP:491322_GO_0006400_TRNA_MODIFICATION","GO_BP","491322_GO_0006400_TRNA_MODIFICATION",40,2.4684,0,0,1.7174,0.0043,0.17,1.2257,0.18,0.71
"GO_BP:491333_GO_0006413_TRANSLATIONAL_INITIATION","GO_BP","491333_GO_0006413_TRANSLATIONAL_INITIATION",221,2.4845,0,0,3.6733,0,0,1.3732,0.02,0.65
"REACTOME:105978_REACT_1986_EUKARYOTIC_TRANSLATION_TERMINATION","REACTOME","105978_REACT_1986_EUKARYOTIC_TRANSLATION_TERMINATION",84,2.5116,0,0,3.8178,0,0,1.5929,0,0.44
"WikiPathways:198853_WP477_CYTOPLASMIC_RIBOSOMAL_PROTEINS","WikiPathways","198853_WP477_CYTOPLASMIC_RIBOSOMAL_PROTEINS",104,2.5143,0,0,3.8574,0,0,1.4043,0.02,0.49
"REACTOME:106077_REACT_9491_VIRAL_MRNA_TRANSLATION","REACTOME","106077_REACT_9491_VIRAL_MRNA_TRANSLATION",84,2.5268,0,0,3.8386,0,0,1.5532,0.0082,0.45
"REACTOME:530746_REACT_115902_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE","REACTOME","530746_REACT_115902_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE",107,2.5289,0,0,3.8309,0,0,1.7265,0,0.39
"GO_BP:499833_GO_0030490_MATURATION_OF_SSU_RRNA","GO_BP","499833_GO_0030490_MATURATION_OF_SSU_RRNA",37,2.5421,0,0,2.2796,0,0.00015,1.2932,0.11,0.68
"GO_CC:501277_GO_0032040_SMALL_SUBUNIT_PROCESSOME","GO_CC","501277_GO_0032040_SMALL_SUBUNIT_PROCESSOME",32,2.5576,0,0,2.0745,0,0.0012,1.0076,0.45,0.99
"GO_MF:489276_GO_0003735_STRUCTURAL_CONSTITUENT_OF_RIBOSOME","GO_MF","489276_GO_0003735_STRUCTURAL_CONSTITUENT_OF_RIBOSOME",149,2.5609,0,0,3.6602,0,0,1.4179,0.0096,0.52
"GO_BP:507049_GO_0044033_MULTI_ORGANISM_METABOLIC_PROCESS","GO_BP","507049_GO_0044033_MULTI_ORGANISM_METABOLIC_PROCESS",126,2.5638,0,0,3.687,0,0,1.3968,0.02,0.63
"GO_CC:499360_GO_0022626_CYTOSOLIC_RIBOSOME","GO_CC","499360_GO_0022626_CYTOSOLIC_RIBOSOME",99,2.5726,0,0,3.8345,0,0,1.2926,0.07,0.71
"REACTOME:105976_REACT_1477_EUKARYOTIC_TRANSLATION_ELONGATION","REACTOME","105976_REACT_1477_EUKARYOTIC_TRANSLATION_ELONGATION",88,2.5789,0,0,3.8591,0,0,1.5642,0.01,0.45
"KEGG_pathway:HSA03010_RIBOSOME","KEGG_pathway","HSA03010_RIBOSOME",133,2.5792,0,0,3.7522,0,0,1.4066,0.012,0.35
"GO_BP:497957_GO_0019080_VIRAL_GENE_EXPRESSION","GO_BP","497957_GO_0019080_VIRAL_GENE_EXPRESSION",120,2.5793,0,0,3.6938,0,0,1.4691,0.002,0.59
"REACTOME:366242_REACT_75768_NONSENSE_MEDIATED_DECAY_NMD_INDEPENDENT_OF_THE_EXON_JUNCTION_COMPLEX_EJC_","REACTOME","366242_REACT_75768_NONSENSE_MEDIATED_DECAY_NMD_INDEPENDENT_OF_THE_EXON_JUNCTION_COMPLEX_EJC_",89,2.5896,0,0,3.8068,0,0,1.6408,0.0021,0.35
"GO_CC:490649_GO_0005840_RIBOSOME","GO_CC","490649_GO_0005840_RIBOSOME",212,2.5913,0,0,3.5712,0,0,1.2893,0.039,0.72
"C4_Cancer_gene_neighborhoods:C4_CGN_351_GNF2_FBL","C4_Cancer_gene_neighborhoods","C4_CGN_351_GNF2_FBL",146,2.5925,0,0,3.4581,0,0,1.0713,0.29,0.65
"KEGG_module:HSA_M00177_RIBOSOME_EUKARYOTES","KEGG_module","HSA_M00177_RIBOSOME_EUKARYOTES",88,2.6154,0,0,3.8616,0,0,1.779,0,0.31
"GO_BP:492410_GO_0008033_TRNA_PROCESSING","GO_BP","492410_GO_0008033_TRNA_PROCESSING",98,2.6224,0,0,1.9635,0,0.019,1.127,0.23,0.74
"GO_BP:505426_GO_0042274_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS","GO_BP","505426_GO_0042274_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS",48,2.6511,0,0,2.5196,0,0,1.4915,0.025,0.57
"GO_BP:491321_GO_0006399_TRNA_METABOLIC_PROCESS","GO_BP","491321_GO_0006399_TRNA_METABOLIC_PROCESS",149,2.6538,0,0,2.0249,0,0.0096,0.9843,0.51,0.87
"GO_BP:491335_GO_0006415_TRANSLATIONAL_TERMINATION","GO_BP","491335_GO_0006415_TRANSLATIONAL_TERMINATION",170,2.6804,0,0,3.7048,0,0,1.4182,0.013,0.62
"REACTOME:105977_REACT_1404_PEPTIDE_CHAIN_ELONGATION","REACTOME","105977_REACT_1404_PEPTIDE_CHAIN_ELONGATION",84,2.7036,0,0,3.9023,0,0,1.5758,0.011,0.48
"GO_BP:499348_GO_0022613_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS","GO_BP","499348_GO_0022613_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS",314,2.704,0,0,2.6368,0,0,1.3244,0.0058,0.65
"GO_BP:503860_GO_0034660_NCRNA_METABOLIC_PROCESS","GO_BP","503860_GO_0034660_NCRNA_METABOLIC_PROCESS",398,2.707,0,0,2.3909,0,2.4e-05,1.1524,0.087,0.73
"GO_CC:751604_GO_0044391_RIBOSOMAL_SUBUNIT","GO_CC","751604_GO_0044391_RIBOSOMAL_SUBUNIT",142,2.7129,0,0,3.7272,0,0,1.608,0,0.4
"GO_BP:497960_GO_0019083_VIRAL_TRANSCRIPTION","GO_BP","497960_GO_0019083_VIRAL_TRANSCRIPTION",110,2.7153,0,0,3.7253,0,0,1.631,0.0019,0.41
"GO_BP:491334_GO_0006414_TRANSLATIONAL_ELONGATION","GO_BP","491334_GO_0006414_TRANSLATIONAL_ELONGATION",186,2.7339,0,0,3.6665,0,0,1.512,0.0018,0.55
"GO_CC:499986_GO_0030684_PRERIBOSOME","GO_CC","499986_GO_0030684_PRERIBOSOME",45,2.7765,0,0,2.1707,0,0.00036,1.0542,0.35,0.99
"GO_BP:496166_GO_0016072_RRNA_METABOLIC_PROCESS","GO_BP","496166_GO_0016072_RRNA_METABOLIC_PROCESS",144,2.82,0,0,2.592,0,0,1.2677,0.046,0.69
"GO_BP:503672_GO_0034470_NCRNA_PROCESSING","GO_BP","503672_GO_0034470_NCRNA_PROCESSING",264,2.8349,0,0,2.4068,0,2.4e-05,1.1862,0.08,0.72
"GO_BP:491301_GO_0006364_RRNA_PROCESSING","GO_BP","491301_GO_0006364_RRNA_PROCESSING",139,2.8386,0,0,2.562,0,0,1.2588,0.066,0.69
"GO_BP:486555_GO_0042254_RIBOSOME_BIOGENESIS","GO_BP","486555_GO_0042254_RIBOSOME_BIOGENESIS",188,2.9023,0,0,2.71,0,0,1.3815,0.0037,0.64
